1175|NCT00128505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110181176|NCT00128505|Luteolytic Agents|luteolytic agents|mesh-ancestor
110181177|NCT00128505|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110181178|NCT00128505|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110181180|NCT00017576|Carboplatin|carboplatin|mesh-list
110181181|NCT00017576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110181183|NCT00017576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110181184|NCT00017576|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110181185|NCT00017576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110181186|NCT00017576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110181187|NCT00017576|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110181189|NCT00017576|Micronutrients|micronutrients|mesh-ancestor
110181190|NCT00017576|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110181191|NCT00017654|Cyclosporine|cyclosporine|mesh-list
110181192|NCT00017654|Methylprednisolone|methylprednisolone|mesh-list
110181193|NCT00017654|Cyclophosphamide|cyclophosphamide|mesh-list
110181194|NCT00017654|Cyclosporins|cyclosporins|mesh-list
110181195|NCT00017654|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110181196|NCT00017654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110181197|NCT00017654|Immunologic Factors|immunologic factors|mesh-ancestor
110181198|NCT00017654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110181199|NCT00017654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110181200|NCT00017654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110181201|NCT00017654|Alkylating Agents|alkylating agents|mesh-ancestor
110181202|NCT00017654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110181203|NCT00017654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110181204|NCT00017654|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110181205|NCT00017654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110181206|NCT00017654|Antifungal Agents|antifungal agents|mesh-ancestor
110181208|NCT00017654|Dermatologic Agents|dermatologic agents|mesh-ancestor
110181209|NCT00017654|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110181210|NCT00017654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110181211|NCT00017654|Antiemetics|antiemetics|mesh-ancestor
110181212|NCT00017654|Autonomic Agents|autonomic agents|mesh-ancestor
110181213|NCT00017654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110181214|NCT00017654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110181215|NCT00017654|Glucocorticoids|glucocorticoids|mesh-ancestor
110181216|NCT00017654|Hormones|hormones|mesh-ancestor
110181217|NCT00017654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110181218|NCT00017654|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110181219|NCT00017654|Protective Agents|protective agents|mesh-ancestor
110181220|NCT00394485|Tiotropium Bromide|tiotropium bromide|mesh-list
110181221|NCT00394485|Procaterol|procaterol|mesh-list
110181222|NCT00394485|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110181223|NCT00394485|Autonomic Agents|autonomic agents|mesh-ancestor
110181225|NCT00394485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110181226|NCT00394485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110181227|NCT00394485|Respiratory System Agents|respiratory system agents|mesh-ancestor
110181228|NCT00394485|Parasympatholytics|parasympatholytics|mesh-ancestor
110181229|NCT00394485|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110181230|NCT00394485|Cholinergic Agents|cholinergic agents|mesh-ancestor
110181231|NCT00394485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110181232|NCT00394485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110181233|NCT00394485|Sympathomimetics|sympathomimetics|mesh-ancestor
110181234|NCT00394485|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110181235|NCT00394485|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110181236|NCT00394485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110181237|NCT00394485|Adrenergic Agents|adrenergic agents|mesh-ancestor
110181238|NCT00017693|Interleukin-4|interleukin-4|mesh-list
110181239|NCT00017693|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110181240|NCT00017693|Immunologic Factors|immunologic factors|mesh-ancestor
110181241|NCT00017693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110181242|NCT00017693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110181243|NCT00017693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110181244|NCT00128466|Gentamicins|gentamicins|mesh-list
110181245|NCT00128466|Streptomycin|streptomycin|mesh-list
110181246|NCT00128466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110181247|NCT00128466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110181248|NCT00128466|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110181249|NCT00128466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110181250|NCT00128466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110181251|NCT00128427|Colchicine|colchicine|mesh-list
110181252|NCT00128427|Gout Suppressants|gout suppressants|mesh-ancestor
110181253|NCT00128427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110181254|NCT00128427|Tubulin Modulators|tubulin modulators|mesh-ancestor
110181255|NCT00128427|Antimitotic Agents|antimitotic agents|mesh-ancestor
110181256|NCT00128427|Mitosis Modulators|mitosis modulators|mesh-ancestor
110181257|NCT00128427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110181258|NCT00128427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110181259|NCT00006099|Antibodies|antibodies|mesh-list
110181260|NCT00006099|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110181261|NCT00006099|Immunologic Factors|immunologic factors|mesh-ancestor
110181262|NCT00006099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110181263|NCT00018603|Guanfacine|guanfacine|mesh-list
110181264|NCT00018603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110216602|NCT04709029|Dexamethasone|dexamethasone|mesh-list
110181265|NCT00018603|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110181266|NCT00018603|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110181267|NCT00018603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110181268|NCT00018603|Adrenergic Agents|adrenergic agents|mesh-ancestor
110181269|NCT00018603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110181270|NCT00018603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110181271|NCT00018603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110181272|NCT00018642|Haloperidol|haloperidol|mesh-list
110181273|NCT00018642|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110181274|NCT00018642|Haloperidol decanoate|haloperidol decanoate|mesh-list
110181275|NCT00018642|Antidepressive Agents|antidepressive agents|mesh-ancestor
110181276|NCT00018642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110181277|NCT00018642|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110181278|NCT00018642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110181279|NCT00018642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110181280|NCT00018642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110181281|NCT00018642|Antiemetics|antiemetics|mesh-ancestor
110181282|NCT00018642|Autonomic Agents|autonomic agents|mesh-ancestor
110181283|NCT00018642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110181284|NCT00018642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110181285|NCT00018642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110181287|NCT00018642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110181288|NCT00018642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110181289|NCT00018642|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110181290|NCT00018083|Efavirenz|efavirenz|mesh-list
110181292|NCT00018083|Rifabutin|rifabutin|mesh-list
110181293|NCT00018083|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110181294|NCT00018083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110181295|NCT00018083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110181296|NCT00018083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110181297|NCT00018083|Antiviral Agents|antiviral agents|mesh-ancestor
110181298|NCT00018083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110181299|NCT00018083|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110181300|NCT00018083|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110181301|NCT00018083|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110181302|NCT00018083|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110181303|NCT00018083|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110181304|NCT00018083|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110181306|NCT00018083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110181307|NCT00018083|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110181308|NCT00018083|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110181309|NCT00018083|Antimetabolites|antimetabolites|mesh-ancestor
110181310|NCT00018083|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110181311|NCT00018083|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110181312|NCT00018200|Benztropine|benztropine|mesh-list
110181313|NCT00018200|Fluoxetine|fluoxetine|mesh-list
110181314|NCT00018200|Desipramine|desipramine|mesh-list
110181315|NCT00018200|Clomipramine|clomipramine|mesh-list
110181316|NCT00018200|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110181317|NCT00018200|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110181318|NCT00018200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110181319|NCT00018200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110181320|NCT00018200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110181321|NCT00018200|Serotonin Agents|serotonin agents|mesh-ancestor
110181322|NCT00018200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110181323|NCT00018200|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110181324|NCT00018200|Antidepressive Agents|antidepressive agents|mesh-ancestor
110181325|NCT00018200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110285774|NCT00234195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110181326|NCT00018200|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110181327|NCT00018200|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110181329|NCT00018200|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110181331|NCT00018200|Adrenergic Agents|adrenergic agents|mesh-ancestor
110181332|NCT00018200|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110181333|NCT00018200|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110181334|NCT00018200|Parasympatholytics|parasympatholytics|mesh-ancestor
110181335|NCT00018200|Autonomic Agents|autonomic agents|mesh-ancestor
110181336|NCT00018200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110181337|NCT00018200|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110181338|NCT00018200|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110181339|NCT00018200|Cholinergic Agents|cholinergic agents|mesh-ancestor
110181340|NCT00018200|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110181341|NCT00018200|Dopamine Agents|dopamine agents|mesh-ancestor
110181343|NCT00018759|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110181344|NCT00018759|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110181345|NCT00018759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110181346|NCT00018759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110181347|NCT00018759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110181348|NCT00018759|Serotonin Agents|serotonin agents|mesh-ancestor
110181349|NCT00018759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110181350|NCT00018759|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110181351|NCT00018759|Antidepressive Agents|antidepressive agents|mesh-ancestor
110181352|NCT00018759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110181353|NCT00018759|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110181354|NCT00018759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110181355|NCT00018759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110181357|NCT04734353|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110181358|NCT04734353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110181360|NCT04734353|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110181361|NCT04734353|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110181362|NCT04734353|Purinergic Agents|purinergic agents|mesh-ancestor
110181363|NCT04734353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110181364|NCT04734353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110216653|NCT00264628|Casopitant|casopitant|mesh-list
110181365|NCT04734353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110181366|NCT00018954|Cytarabine|cytarabine|mesh-list
110181367|NCT00018954|Prednisone|prednisone|mesh-list
110181368|NCT00018954|Cyclophosphamide|cyclophosphamide|mesh-list
110181369|NCT00018954|Ifosfamide|ifosfamide|mesh-list
110181370|NCT00018954|Doxorubicin|doxorubicin|mesh-list
110181371|NCT00018954|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110181372|NCT00018954|Methotrexate|methotrexate|mesh-list
110181373|NCT00018954|Etoposide|etoposide|mesh-list
110181374|NCT00018954|Vincristine|vincristine|mesh-list
110181375|NCT00018954|Daunorubicin|daunorubicin|mesh-list
110181376|NCT00018954|Asparaginase|asparaginase|mesh-list
110181377|NCT00018954|Mercaptopurine|mercaptopurine|mesh-list
110181378|NCT00018954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110181379|NCT00018954|Immunologic Factors|immunologic factors|mesh-ancestor
110181380|NCT00018954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110181381|NCT00018954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110181382|NCT00018954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110181383|NCT00018954|Alkylating Agents|alkylating agents|mesh-ancestor
110181384|NCT00018954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110181385|NCT00018954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110181386|NCT00018954|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110181387|NCT00018954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110181388|NCT00018954|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110181389|NCT00018954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110181390|NCT00018954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110181391|NCT00018954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110181392|NCT00018954|Glucocorticoids|glucocorticoids|mesh-ancestor
110181394|NCT00018954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110181395|NCT00018954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110285791|NCT00209300|Mesalamine|mesalamine|mesh-list
110181396|NCT00018954|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110181397|NCT00018954|Abortifacient Agents|abortifacient agents|mesh-ancestor
110181398|NCT00018954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110181399|NCT00018954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110181400|NCT00018954|Antimetabolites|antimetabolites|mesh-ancestor
110181401|NCT00018954|Dermatologic Agents|dermatologic agents|mesh-ancestor
110181402|NCT00018954|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110181403|NCT00018954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110181404|NCT00018954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110181405|NCT00018954|Antiviral Agents|antiviral agents|mesh-ancestor
110181406|NCT00018954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110181407|NCT00018954|Tubulin Modulators|tubulin modulators|mesh-ancestor
110181408|NCT00018954|Antimitotic Agents|antimitotic agents|mesh-ancestor
110181409|NCT00018954|Mitosis Modulators|mitosis modulators|mesh-ancestor
110181410|NCT00018278|Donepezil|donepezil|mesh-list
110181411|NCT00018278|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110181412|NCT00018278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110181413|NCT00018278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110181414|NCT00018278|Cholinergic Agents|cholinergic agents|mesh-ancestor
110181415|NCT00018278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110181416|NCT00018278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110181417|NCT00018278|Nootropic Agents|nootropic agents|mesh-ancestor
110181418|NCT00019032|Antibodies|antibodies|mesh-list
110181419|NCT00019032|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110181420|NCT00019032|Immunologic Factors|immunologic factors|mesh-ancestor
110181421|NCT00019032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110181422|NCT00019071|Cladribine|cladribine|mesh-list
110181423|NCT00019071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110181424|NCT00019071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110181425|NCT00019071|Immunologic Factors|immunologic factors|mesh-ancestor
110181426|NCT00019071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110181427|NCT04734119|Anesthetics|anesthetics|mesh-list
110181428|NCT04734119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110181429|NCT04734119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110181430|NCT00018356|Testosterone|testosterone|mesh-list
110181431|NCT00018356|Androgens|androgens|mesh-ancestor
110181432|NCT00018356|Hormones|hormones|mesh-ancestor
110181433|NCT00018356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110181434|NCT00018356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110181435|NCT00019188|Interleukin-12|interleukin-12|mesh-list
110052850|NCT01482338|Contraceptive Agents|contraceptive agents|mesh-ancestor
110181436|NCT00019188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110181437|NCT00019188|Immunologic Factors|immunologic factors|mesh-ancestor
110181438|NCT00019188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110181439|NCT00019188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110181440|NCT00019188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110181441|NCT00019188|Growth Substances|growth substances|mesh-ancestor
110181442|NCT00019188|Growth Inhibitors|growth inhibitors|mesh-ancestor
110181443|NCT00019188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110181444|NCT00019227|Calcium|calcium|mesh-list
110181445|NCT00019227|Daclizumab|daclizumab|mesh-list
110181446|NCT00019227|Pentetic Acid|pentetic acid|mesh-list
110181447|NCT00019227|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110181448|NCT00019227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110181449|NCT00019227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110181450|NCT00019227|Immunologic Factors|immunologic factors|mesh-ancestor
110181451|NCT00019227|Antidotes|antidotes|mesh-ancestor
110181452|NCT00019227|Protective Agents|protective agents|mesh-ancestor
110181453|NCT00019227|Chelating Agents|chelating agents|mesh-ancestor
110181454|NCT00019227|Sequestering Agents|sequestering agents|mesh-ancestor
110181455|NCT00019227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110181456|NCT00019227|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110181457|NCT04734041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110181458|NCT00019344|Alvocidib|alvocidib|mesh-list
110181462|NCT00019344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110181463|NCT00019344|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110181464|NCT00019344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110181465|NCT00019344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110181466|NCT00019383|Aldesleukin|aldesleukin|mesh-list
110181467|NCT00019383|Sargramostim|sargramostim|mesh-list
110181468|NCT00019383|Freund's Adjuvant|freund's adjuvant|mesh-list
110181469|NCT00019383|Immunologic Factors|immunologic factors|mesh-ancestor
110181470|NCT00019383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110181471|NCT00019383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110181472|NCT00019383|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110181474|NCT00019383|Antiviral Agents|antiviral agents|mesh-ancestor
110181475|NCT00019383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110181476|NCT00019383|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110181477|NCT00019422|Carboplatin|carboplatin|mesh-list
110181478|NCT00019422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110181479|NCT00018551|Folic Acid|folic acid|mesh-list
110181480|NCT00018551|Hematinics|hematinics|mesh-ancestor
110181481|NCT00018551|Vitamin B Complex|vitamin b complex|mesh-ancestor
110181482|NCT00018551|Vitamins|vitamins|mesh-ancestor
110181483|NCT00018551|Micronutrients|micronutrients|mesh-ancestor
110181485|NCT00019461|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
110181486|NCT00019461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110181487|NCT00019461|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110181488|NCT00019461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110181489|NCT00019461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110181490|NCT00019461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110181491|NCT00019461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110181493|NCT00019500|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110181494|NCT00019500|Hormone Antagonists|hormone antagonists|mesh-ancestor
110181495|NCT00019500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110181496|NCT00019500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110181497|NCT00019500|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110181498|NCT00019500|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110181499|NCT00019500|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110181500|NCT00019539|Thalidomide|thalidomide|mesh-list
110181501|NCT00019539|Bevacizumab|bevacizumab|mesh-list
110181502|NCT00019539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110181503|NCT00019539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110181505|NCT00019539|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110181506|NCT00019539|Growth Substances|growth substances|mesh-ancestor
110181507|NCT00019539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110181508|NCT00019539|Growth Inhibitors|growth inhibitors|mesh-ancestor
110181509|NCT00019539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110181510|NCT00019539|Immunologic Factors|immunologic factors|mesh-ancestor
110181511|NCT00019539|Leprostatic Agents|leprostatic agents|mesh-ancestor
110181512|NCT00019539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110181513|NCT00019539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110181514|NCT00019695|Alendronate|alendronate|mesh-list
110181515|NCT00019695|Ketoconazole|ketoconazole|mesh-list
110181516|NCT00019695|Antifungal Agents|antifungal agents|mesh-ancestor
110181517|NCT00019695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110181518|NCT00019695|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110181519|NCT00019695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110181520|NCT00019695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110181521|NCT00019695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110181522|NCT00019695|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110181523|NCT00019695|Hormone Antagonists|hormone antagonists|mesh-ancestor
110181524|NCT00019695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110181525|NCT00019695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110181526|NCT00019695|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110181527|NCT00019695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110181528|NCT00019734|Aldesleukin|aldesleukin|mesh-list
110181529|NCT00019734|Vaccines|vaccines|mesh-list
110181530|NCT00019734|Immunologic Factors|immunologic factors|mesh-ancestor
110181531|NCT00019734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110181532|NCT00019734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110181533|NCT00019734|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110181534|NCT00019734|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110181535|NCT00019734|Antiviral Agents|antiviral agents|mesh-ancestor
110181537|NCT00019773|Capecitabine|capecitabine|mesh-list
110181538|NCT00019773|Oxaliplatin|oxaliplatin|mesh-list
110181539|NCT00019773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110181540|NCT00019773|Antimetabolites|antimetabolites|mesh-ancestor
110181541|NCT00019773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110181542|NCT00019773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110181544|NCT00019812|Trastuzumab|trastuzumab|mesh-list
110181545|NCT00019812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110181546|NCT00019812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110181547|NCT00019812|Tubulin Modulators|tubulin modulators|mesh-ancestor
110181548|NCT00019812|Antimitotic Agents|antimitotic agents|mesh-ancestor
110181549|NCT00019812|Mitosis Modulators|mitosis modulators|mesh-ancestor
110181550|NCT00019812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110181551|NCT00019812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110181553|NCT00019890|Immunologic Factors|immunologic factors|mesh-ancestor
110181554|NCT00019890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110181555|NCT00019968|Melphalan|melphalan|mesh-list
110181556|NCT00019968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110181557|NCT00019968|Alkylating Agents|alkylating agents|mesh-ancestor
110181558|NCT00019968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110181559|NCT00019968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110181560|NCT00019968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110181561|NCT00019968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110181563|NCT00019968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110181564|NCT00020007|Paclitaxel|paclitaxel|mesh-list
110181565|NCT00020007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110181566|NCT00020007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110181567|NCT00020007|Tubulin Modulators|tubulin modulators|mesh-ancestor
110181568|NCT00020007|Antimitotic Agents|antimitotic agents|mesh-ancestor
110181569|NCT00020007|Mitosis Modulators|mitosis modulators|mesh-ancestor
110181570|NCT00020007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110181572|NCT00142454|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110181573|NCT00142454|Immunologic Factors|immunologic factors|mesh-ancestor
110181574|NCT00142454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110181575|NCT00142454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110181576|NCT00142454|Interferon Inducers|interferon inducers|mesh-ancestor
110181577|NCT00020046|Thalidomide|thalidomide|mesh-list
110181578|NCT00020046|Docetaxel|docetaxel|mesh-list
110181579|NCT00020046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110181580|NCT00020046|Tubulin Modulators|tubulin modulators|mesh-ancestor
110181581|NCT00020046|Antimitotic Agents|antimitotic agents|mesh-ancestor
110181582|NCT00020046|Mitosis Modulators|mitosis modulators|mesh-ancestor
110181583|NCT00020046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110181584|NCT00020046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110181585|NCT00020046|Immunologic Factors|immunologic factors|mesh-ancestor
110181586|NCT00020046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110181587|NCT00020046|Leprostatic Agents|leprostatic agents|mesh-ancestor
110181588|NCT00020046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110181589|NCT00020046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110181590|NCT00020046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110181591|NCT00020046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110181592|NCT00020046|Growth Substances|growth substances|mesh-ancestor
110181593|NCT00020046|Growth Inhibitors|growth inhibitors|mesh-ancestor
110181595|NCT00020124|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110181596|NCT00020124|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110181597|NCT00020124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110181598|NCT00020124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110181599|NCT00020124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110181600|NCT00020124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110181601|NCT00020124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110181602|NCT00020202|Romidepsin|romidepsin|mesh-list
110181603|NCT00020202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110181604|NCT00020202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110181605|NCT00020202|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110181606|NCT00020202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110181607|NCT00020202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110181609|NCT05576675|Dsuvia|dsuvia|mesh-list
110181610|NCT05576675|Hydromorphone|hydromorphone|mesh-list
110181611|NCT05576675|Nalbuphine|nalbuphine|mesh-list
110181612|NCT05576675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110181613|NCT05576675|Narcotics|narcotics|mesh-ancestor
110181614|NCT05576675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110285797|NCT00209300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110181615|NCT05576675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110181617|NCT05576675|Sensory System Agents|sensory system agents|mesh-ancestor
110181618|NCT05576675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110181619|NCT05576675|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110181620|NCT05576675|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110181621|NCT05576675|Anesthetics, General|anesthetics, general|mesh-ancestor
110181622|NCT05576675|Anesthetics|anesthetics|mesh-ancestor
110181623|NCT00020358|Aldesleukin|aldesleukin|mesh-list
110181624|NCT00020358|Freund's Adjuvant|freund's adjuvant|mesh-list
110181625|NCT00020358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110181626|NCT00020358|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110181627|NCT00020358|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110181628|NCT00020358|Antiviral Agents|antiviral agents|mesh-ancestor
110181629|NCT00020358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110181630|NCT00020358|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110181632|NCT00020358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110181633|NCT00020397|Aldesleukin|aldesleukin|mesh-list
110181634|NCT00020397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110181635|NCT00020397|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110181636|NCT00020397|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110181637|NCT00020397|Antiviral Agents|antiviral agents|mesh-ancestor
110181638|NCT00020397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110181639|NCT00020475|Interleukin-2|interleukin-2|mesh-list
110181640|NCT00020475|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
110181641|NCT00020475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110181642|NCT00020475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110181643|NCT00020475|Analgesics|analgesics|mesh-ancestor
110181644|NCT00020475|Sensory System Agents|sensory system agents|mesh-ancestor
110181645|NCT00020475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110181646|NCT00020475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110181648|NCT00020475|Immunologic Factors|immunologic factors|mesh-ancestor
110181649|NCT05576480|Capecitabine|capecitabine|mesh-list
110181650|NCT05576480|Oxaliplatin|oxaliplatin|mesh-list
110181651|NCT05576480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110181652|NCT05576480|Antimetabolites|antimetabolites|mesh-ancestor
110181653|NCT05576480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110181654|NCT05576480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110181655|NCT00020631|Pirfenidone|pirfenidone|mesh-list
110181656|NCT00020631|Analgesics|analgesics|mesh-ancestor
110181657|NCT00020631|Sensory System Agents|sensory system agents|mesh-ancestor
110181658|NCT00020631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110181659|NCT00020631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110181660|NCT00020631|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110181661|NCT00020631|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110181662|NCT00020631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110181663|NCT00020631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110181664|NCT00020631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110181666|NCT05576324|Elexacaftor|elexacaftor|mesh-list
110181667|NCT05576324|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110181668|NCT05576324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110181669|NCT05576324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110181670|NCT00020709|Docetaxel|docetaxel|mesh-list
110181671|NCT00020709|Etoposide|etoposide|mesh-list
110181672|NCT00020709|Etoposide phosphate|etoposide phosphate|mesh-list
110181673|NCT00020709|Gefitinib|gefitinib|mesh-list
110181674|NCT00020709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110181675|NCT00020709|Tubulin Modulators|tubulin modulators|mesh-ancestor
110181676|NCT00020709|Antimitotic Agents|antimitotic agents|mesh-ancestor
110181677|NCT00020709|Mitosis Modulators|mitosis modulators|mesh-ancestor
110216713|NCT00265291|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110181678|NCT00020709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110181679|NCT00020709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110181680|NCT00020709|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110181681|NCT00020709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110181682|NCT00020709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110181683|NCT00020709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110181685|NCT00020748|Epirubicin|epirubicin|mesh-list
110181686|NCT00020748|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110181687|NCT00020748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110181688|NCT00020748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110181689|NCT00020748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110181690|NCT00020748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110181691|NCT00020748|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110181692|NCT00020748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110181693|NCT00020787|Cisplatin|cisplatin|mesh-list
110181694|NCT00020787|Fluorouracil|fluorouracil|mesh-list
110181695|NCT00020787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110181696|NCT00020787|Antimetabolites|antimetabolites|mesh-ancestor
110181697|NCT00020787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110181698|NCT00020787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110181699|NCT00020787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110181700|NCT00020787|Immunologic Factors|immunologic factors|mesh-ancestor
110181701|NCT00020787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110181702|NCT00020865|Levofloxacin|levofloxacin|mesh-list
110181703|NCT00020865|Cefepime|cefepime|mesh-list
110181704|NCT00020865|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110181705|NCT00020865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110181706|NCT00020865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110181707|NCT00020865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110181708|NCT00020865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110181709|NCT00020865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110181710|NCT00020865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110181711|NCT00020865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110181712|NCT00020865|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110181713|NCT00020865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110181714|NCT00020943|Leucovorin|leucovorin|mesh-list
110181715|NCT00020943|Cytarabine|cytarabine|mesh-list
110181716|NCT00020943|Prednisone|prednisone|mesh-list
110181717|NCT00020943|Cyclophosphamide|cyclophosphamide|mesh-list
110181718|NCT00020943|Carmustine|carmustine|mesh-list
110181719|NCT00020943|Rituximab|rituximab|mesh-list
110181720|NCT00020943|Doxorubicin|doxorubicin|mesh-list
110181721|NCT00020943|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110181722|NCT00020943|Methotrexate|methotrexate|mesh-list
110181723|NCT00020943|Etoposide|etoposide|mesh-list
110181724|NCT00020943|Vincristine|vincristine|mesh-list
110181726|NCT00020943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110181727|NCT00020943|Immunologic Factors|immunologic factors|mesh-ancestor
110181728|NCT00020943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110181729|NCT00020943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110181730|NCT00020943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110181731|NCT00020943|Alkylating Agents|alkylating agents|mesh-ancestor
110181732|NCT00020943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110181733|NCT00020943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110181734|NCT00020943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110181735|NCT00020943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110181736|NCT00020943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110181737|NCT00020943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110181738|NCT00020943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110181739|NCT00020943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110181740|NCT00020943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110181741|NCT00020943|Glucocorticoids|glucocorticoids|mesh-ancestor
110181742|NCT00020943|Hormones|hormones|mesh-ancestor
110181743|NCT00020943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110181744|NCT00020943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110181745|NCT00020943|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110181746|NCT00020943|Abortifacient Agents|abortifacient agents|mesh-ancestor
110181747|NCT00020943|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110181748|NCT00020943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110181749|NCT00020943|Antimetabolites|antimetabolites|mesh-ancestor
110181750|NCT00020943|Dermatologic Agents|dermatologic agents|mesh-ancestor
110181751|NCT00020943|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110181752|NCT00020943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110181753|NCT00020943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110181754|NCT00020943|Antiviral Agents|antiviral agents|mesh-ancestor
110181755|NCT00020943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110181756|NCT00020943|Antidotes|antidotes|mesh-ancestor
110181757|NCT00020943|Protective Agents|protective agents|mesh-ancestor
110181758|NCT00020943|Vitamin B Complex|vitamin b complex|mesh-ancestor
110181759|NCT00020943|Vitamins|vitamins|mesh-ancestor
110181760|NCT00020943|Micronutrients|micronutrients|mesh-ancestor
110181761|NCT00020943|Tubulin Modulators|tubulin modulators|mesh-ancestor
110181762|NCT00020943|Antimitotic Agents|antimitotic agents|mesh-ancestor
110181763|NCT00020943|Mitosis Modulators|mitosis modulators|mesh-ancestor
110181764|NCT00021060|Paclitaxel|paclitaxel|mesh-list
110181765|NCT00021060|Bevacizumab|bevacizumab|mesh-list
110181766|NCT00021060|Carboplatin|carboplatin|mesh-list
110181767|NCT00021060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110181769|NCT00021060|Immunoglobulins|immunoglobulins|mesh-list
110181770|NCT00021060|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110181771|NCT00021060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110181772|NCT00021060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110181773|NCT00021060|Tubulin Modulators|tubulin modulators|mesh-ancestor
110181774|NCT00021060|Antimitotic Agents|antimitotic agents|mesh-ancestor
110181775|NCT00021060|Mitosis Modulators|mitosis modulators|mesh-ancestor
110181776|NCT00021060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110181777|NCT00021060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110181778|NCT00021060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110181779|NCT00021060|Growth Substances|growth substances|mesh-ancestor
110181780|NCT00021060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110181781|NCT00021060|Growth Inhibitors|growth inhibitors|mesh-ancestor
110181782|NCT00021060|Immunologic Factors|immunologic factors|mesh-ancestor
110181783|NCT00021099|Epothilones|epothilones|mesh-list
110181784|NCT00021099|Epothilone B|epothilone b|mesh-list
110181785|NCT00021099|Tubulin Modulators|tubulin modulators|mesh-ancestor
110181786|NCT00021099|Antimitotic Agents|antimitotic agents|mesh-ancestor
110181787|NCT00021099|Mitosis Modulators|mitosis modulators|mesh-ancestor
110181788|NCT00021099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110181789|NCT00021099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110181790|NCT05574257|Propofol|propofol|mesh-list
110181791|NCT05574257|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110181792|NCT05574257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110181793|NCT05574257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110181794|NCT05574257|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110181795|NCT05574257|Anesthetics, General|anesthetics, general|mesh-ancestor
110181796|NCT05574257|Anesthetics|anesthetics|mesh-ancestor
110181797|NCT05574218|Glycine|glycine|mesh-list
110181798|NCT05574218|Glycine Agents|glycine agents|mesh-ancestor
110181799|NCT05574218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110181800|NCT05574218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110181801|NCT05574218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110181802|NCT00021138|Nicotine|nicotine|mesh-list
110181803|NCT00021138|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110181804|NCT00021138|Autonomic Agents|autonomic agents|mesh-ancestor
110181805|NCT00021138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110181806|NCT00021138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110181807|NCT00021138|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110181808|NCT00021138|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110181809|NCT00021138|Cholinergic Agents|cholinergic agents|mesh-ancestor
110181810|NCT00021138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110181811|NCT00021138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110181812|NCT00020670|Vaccines|vaccines|mesh-list
110181813|NCT00020670|Immunologic Factors|immunologic factors|mesh-ancestor
110181815|NCT05574179|Midazolam|midazolam|mesh-list
110181816|NCT05574179|Dexmedetomidine|dexmedetomidine|mesh-list
110181817|NCT05574179|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110181818|NCT05574179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110181819|NCT05574179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110181820|NCT05574179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110181821|NCT05574179|Analgesics|analgesics|mesh-ancestor
110181822|NCT05574179|Sensory System Agents|sensory system agents|mesh-ancestor
110181823|NCT05574179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110181824|NCT05574179|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110181825|NCT05574179|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110181826|NCT05574179|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110181827|NCT05574179|Adrenergic Agents|adrenergic agents|mesh-ancestor
110181828|NCT05574179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110181829|NCT05574179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110181830|NCT05574179|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110181831|NCT05574179|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110181832|NCT05574179|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110181833|NCT05574179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110181834|NCT05574179|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110181835|NCT05574179|Anesthetics, General|anesthetics, general|mesh-ancestor
110181836|NCT05574179|Anesthetics|anesthetics|mesh-ancestor
110181837|NCT05574179|GABA Modulators|gaba modulators|mesh-ancestor
110181838|NCT05574179|GABA Agents|gaba agents|mesh-ancestor
110181839|NCT00021216|Bortezomib|bortezomib|mesh-list
110181840|NCT00021216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110181841|NCT00021294|Eflornithine|eflornithine|mesh-list
110181842|NCT00021294|Triamcinolone|triamcinolone|mesh-list
110181843|NCT00021294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110181844|NCT00021294|Glucocorticoids|glucocorticoids|mesh-ancestor
110181845|NCT00021294|Hormones|hormones|mesh-ancestor
110181846|NCT00021294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110181847|NCT00021294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110181849|NCT00021294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110181850|NCT00021294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110181851|NCT00021294|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110181852|NCT00021294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110181853|NCT00021294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110181854|NCT00021294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110181855|NCT00021294|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
110181856|NCT00021333|Paclitaxel|paclitaxel|mesh-list
110181857|NCT00021333|Cisplatin|cisplatin|mesh-list
110181858|NCT00021333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110181859|NCT00021333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110181860|NCT00021333|Tubulin Modulators|tubulin modulators|mesh-ancestor
110181861|NCT00021333|Antimitotic Agents|antimitotic agents|mesh-ancestor
110181862|NCT00021333|Mitosis Modulators|mitosis modulators|mesh-ancestor
110181863|NCT00021333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110181864|NCT00021372|Paclitaxel|paclitaxel|mesh-list
110181865|NCT00021372|Estramustine|estramustine|mesh-list
110181866|NCT00021372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110181867|NCT00021372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110181868|NCT00021372|Tubulin Modulators|tubulin modulators|mesh-ancestor
110181869|NCT00021372|Antimitotic Agents|antimitotic agents|mesh-ancestor
110181870|NCT00021372|Mitosis Modulators|mitosis modulators|mesh-ancestor
110181871|NCT00021372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110181872|NCT00021372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110181873|NCT00021372|Alkylating Agents|alkylating agents|mesh-ancestor
110181874|NCT00021372|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110181875|NCT00392093|Estrogens|estrogens|mesh-list
110181876|NCT00392093|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110181877|NCT00392093|Hormones|hormones|mesh-ancestor
110181878|NCT00392093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110181879|NCT00392093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110181880|NCT00018161|Mecamylamine|mecamylamine|mesh-list
110181881|NCT00018161|Nicotine|nicotine|mesh-list
110181882|NCT00018161|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110181883|NCT00018161|Autonomic Agents|autonomic agents|mesh-ancestor
110181884|NCT00018161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110181885|NCT00018161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110181886|NCT00018161|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110181887|NCT00018161|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110181888|NCT00018161|Cholinergic Agents|cholinergic agents|mesh-ancestor
110181889|NCT00018161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110181890|NCT00018161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110181891|NCT00018161|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110181892|NCT00018161|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
110181893|NCT00018161|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
110181894|NCT00018161|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110181896|NCT00021450|Bicalutamide|bicalutamide|mesh-list
110181897|NCT00021450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110181898|NCT00021450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110181899|NCT00021450|Androgen Antagonists|androgen antagonists|mesh-ancestor
110181900|NCT00021450|Hormone Antagonists|hormone antagonists|mesh-ancestor
110181901|NCT00021450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110181902|NCT00021450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110181903|NCT00021489|Mycophenolic Acid|mycophenolic acid|mesh-list
110181904|NCT00021489|Abacavir|abacavir|mesh-list
110181905|NCT00021489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110181906|NCT00021489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110181907|NCT00021489|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110181908|NCT00021489|Antitubercular Agents|antitubercular agents|mesh-ancestor
110181909|NCT00021489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110181910|NCT00021489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110181911|NCT00021489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110181912|NCT00021489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110181913|NCT00021489|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110181914|NCT00021489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110181915|NCT00021489|Antiviral Agents|antiviral agents|mesh-ancestor
110181916|NCT00021489|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110181917|NCT00021489|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110181918|NCT00021528|Mirtazapine|mirtazapine|mesh-list
110181919|NCT00021528|Buspirone|buspirone|mesh-list
110181920|NCT00021528|Tranylcypromine|tranylcypromine|mesh-list
110181921|NCT00021528|Sertraline|sertraline|mesh-list
110181922|NCT00021528|Citalopram|citalopram|mesh-list
110181923|NCT00021528|Nortriptyline|nortriptyline|mesh-list
110181924|NCT00021528|Antidepressive Agents|antidepressive agents|mesh-ancestor
110181925|NCT00021528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110181926|NCT00021528|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110181927|NCT00021528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110181928|NCT00021528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110181929|NCT00021528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110181930|NCT00021528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110181931|NCT00021528|Serotonin Agents|serotonin agents|mesh-ancestor
110181932|NCT00021528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110181933|NCT00021528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110181934|NCT00021528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110181935|NCT00021528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110181936|NCT00021528|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110181937|NCT00021528|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110181938|NCT00021528|Histamine Antagonists|histamine antagonists|mesh-ancestor
110181939|NCT00021528|Histamine Agents|histamine agents|mesh-ancestor
110181940|NCT00021528|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110181941|NCT00021528|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110181942|NCT00021528|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110181943|NCT00021528|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110181944|NCT00021528|Adrenergic Agents|adrenergic agents|mesh-ancestor
110181945|NCT00021528|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110181946|NCT00021528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110181947|NCT00021528|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110181948|NCT00021528|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110181949|NCT00021528|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110181950|NCT00021528|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110181951|NCT00021528|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110181952|NCT00021567|Interferons|interferons|mesh-list
110181953|NCT00021567|Interferon-gamma|interferon-gamma|mesh-list
110181954|NCT00021567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110181955|NCT00021567|Antiviral Agents|antiviral agents|mesh-ancestor
110181956|NCT00021567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110181957|NCT00021645|Vitamin E|vitamin e|mesh-list
110181958|NCT00021645|Vitamins|vitamins|mesh-ancestor
110181959|NCT00021645|Micronutrients|micronutrients|mesh-ancestor
110181960|NCT00021645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110181961|NCT00021645|Antioxidants|antioxidants|mesh-ancestor
110181962|NCT00021645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110181963|NCT00021645|Protective Agents|protective agents|mesh-ancestor
110181964|NCT05573204|Vitamin E|vitamin e|mesh-list
110181965|NCT05573204|Vitamins|vitamins|mesh-ancestor
110181966|NCT05573204|Micronutrients|micronutrients|mesh-ancestor
110181967|NCT05573204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110181968|NCT05573204|Antioxidants|antioxidants|mesh-ancestor
110181969|NCT05573204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110181970|NCT05573204|Protective Agents|protective agents|mesh-ancestor
110181971|NCT00021996|Valdecoxib|valdecoxib|mesh-list
110181972|NCT00021996|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110181973|NCT00021996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110181974|NCT00021996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110181975|NCT00021996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110181976|NCT00021996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110181977|NCT00021996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110181978|NCT00021996|Analgesics|analgesics|mesh-ancestor
110181979|NCT00021996|Sensory System Agents|sensory system agents|mesh-ancestor
110181980|NCT00021996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110181981|NCT00021996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110181982|NCT00021996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110181983|NCT00021996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110181984|NCT00022074|Gabapentin|gabapentin|mesh-list
110181985|NCT00022074|Analgesics|analgesics|mesh-ancestor
110181986|NCT00022074|Sensory System Agents|sensory system agents|mesh-ancestor
110181987|NCT00022074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110181988|NCT00022074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216772|NCT00415831|Levodopa|levodopa|mesh-list
110181990|NCT00022074|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110181991|NCT00022074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110181992|NCT00022074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110181993|NCT00022074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110181994|NCT00022074|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110181995|NCT00022074|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110181996|NCT00022074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110181997|NCT00022074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110181998|NCT00022074|Antimanic Agents|antimanic agents|mesh-ancestor
110181999|NCT00022152|Vinorelbine|vinorelbine|mesh-list
110182000|NCT00022152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110182001|NCT00022152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110182002|NCT00022152|Tubulin Modulators|tubulin modulators|mesh-ancestor
110182003|NCT00022152|Antimitotic Agents|antimitotic agents|mesh-ancestor
110182004|NCT00022152|Mitosis Modulators|mitosis modulators|mesh-ancestor
110182005|NCT00022152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110182006|NCT00022191|Paclitaxel|paclitaxel|mesh-list
110182007|NCT00022191|Gemcitabine|gemcitabine|mesh-list
110182008|NCT00022191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110182009|NCT00022191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110182010|NCT00022191|Tubulin Modulators|tubulin modulators|mesh-ancestor
110182011|NCT00022191|Antimitotic Agents|antimitotic agents|mesh-ancestor
110182012|NCT00022191|Mitosis Modulators|mitosis modulators|mesh-ancestor
110182013|NCT00022191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110182014|NCT00022191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110182016|NCT00022230|Aldesleukin|aldesleukin|mesh-list
110182017|NCT00022230|Paclitaxel|paclitaxel|mesh-list
110182018|NCT00022230|Cyclophosphamide|cyclophosphamide|mesh-list
110182019|NCT00022230|Doxorubicin|doxorubicin|mesh-list
110182020|NCT00022230|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110182021|NCT00022230|Sargramostim|sargramostim|mesh-list
110182022|NCT00022230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110182023|NCT00022230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110182024|NCT00022230|Tubulin Modulators|tubulin modulators|mesh-ancestor
110182025|NCT00022230|Antimitotic Agents|antimitotic agents|mesh-ancestor
110182026|NCT00022230|Mitosis Modulators|mitosis modulators|mesh-ancestor
110182027|NCT00022230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110182028|NCT00022230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110182029|NCT00022230|Immunologic Factors|immunologic factors|mesh-ancestor
110182030|NCT00022230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110182031|NCT00022230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110182032|NCT00022230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110182033|NCT00022230|Alkylating Agents|alkylating agents|mesh-ancestor
110182034|NCT00022230|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110182035|NCT00022230|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110182036|NCT00022230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110182037|NCT00022230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110182038|NCT00022230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110182039|NCT00022230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110182040|NCT00022230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110182041|NCT00022230|Antiviral Agents|antiviral agents|mesh-ancestor
110182042|NCT00022230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110182043|NCT00022308|Irinotecan|irinotecan|mesh-list
110182044|NCT00022308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110216786|NCT00415831|Immunologic Factors|immunologic factors|mesh-ancestor
110182045|NCT00022308|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110182046|NCT00022308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110182047|NCT00022308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110182048|NCT00022308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110182049|NCT00022386|Epoetin Alfa|epoetin alfa|mesh-list
110182050|NCT00022386|Hematinics|hematinics|mesh-ancestor
110182051|NCT00022425|Perillyl alcohol|perillyl alcohol|mesh-list
110182052|NCT00022425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110182054|NCT00022425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110182056|NCT00022464|Temsirolimus|temsirolimus|mesh-list
110182057|NCT00022464|MTOR Inhibitors|mtor inhibitors|mesh-list
110182058|NCT00022464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110182059|NCT00022464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110182060|NCT00022464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110182061|NCT00022464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110182062|NCT00022464|Immunologic Factors|immunologic factors|mesh-ancestor
110182063|NCT00022464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110182064|NCT00022464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110182065|NCT00022464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110182066|NCT00022464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110182067|NCT00022464|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110182068|NCT00022464|Antifungal Agents|antifungal agents|mesh-ancestor
110182069|NCT00022542|Epothilones|epothilones|mesh-list
110182070|NCT00022542|Epothilone B|epothilone b|mesh-list
110182071|NCT00022542|Tubulin Modulators|tubulin modulators|mesh-ancestor
110182072|NCT00022542|Antimitotic Agents|antimitotic agents|mesh-ancestor
110182073|NCT00022542|Mitosis Modulators|mitosis modulators|mesh-ancestor
110182074|NCT00022542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110182075|NCT00022542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110182076|NCT00022581|Thalidomide|thalidomide|mesh-list
110182077|NCT00022581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110182078|NCT00022581|Immunologic Factors|immunologic factors|mesh-ancestor
110182079|NCT00022581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110182080|NCT00022581|Leprostatic Agents|leprostatic agents|mesh-ancestor
110182081|NCT00022581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110182082|NCT00022581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110182083|NCT00022581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110182084|NCT00022581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110182085|NCT00022581|Growth Substances|growth substances|mesh-ancestor
110182086|NCT00022581|Growth Inhibitors|growth inhibitors|mesh-ancestor
110182087|NCT00022581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110182089|NCT05551871|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110182090|NCT05551871|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110182091|NCT05551871|Antimetabolites|antimetabolites|mesh-ancestor
110182092|NCT05551871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110182093|NCT05551871|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110182094|NCT05551871|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110182095|NCT05551871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110182096|NCT00022620|Paclitaxel|paclitaxel|mesh-list
110182097|NCT00022620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110182098|NCT00022620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110182099|NCT00022620|Tubulin Modulators|tubulin modulators|mesh-ancestor
110182100|NCT00022620|Antimitotic Agents|antimitotic agents|mesh-ancestor
110182101|NCT00022620|Mitosis Modulators|mitosis modulators|mesh-ancestor
110182102|NCT00022620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110182103|NCT00022737|Leucovorin|leucovorin|mesh-list
110182104|NCT00022737|Cytarabine|cytarabine|mesh-list
110182105|NCT00022737|Cyclosporine|cyclosporine|mesh-list
110182106|NCT00022737|Dexamethasone|dexamethasone|mesh-list
110182107|NCT00022737|Cyclophosphamide|cyclophosphamide|mesh-list
110182108|NCT00022737|Ifosfamide|ifosfamide|mesh-list
110182109|NCT00022737|Methotrexate|methotrexate|mesh-list
110182110|NCT00022737|Etoposide|etoposide|mesh-list
110182111|NCT00022737|Vincristine|vincristine|mesh-list
110182112|NCT00022737|Etoposide phosphate|etoposide phosphate|mesh-list
110216806|NCT00102141|Diuretics|diuretics|mesh-ancestor
110182113|NCT00022737|Imatinib Mesylate|imatinib mesylate|mesh-list
110182114|NCT00022737|Daunorubicin|daunorubicin|mesh-list
110182115|NCT00022737|Asparaginase|asparaginase|mesh-list
110182116|NCT00022737|Mercaptopurine|mercaptopurine|mesh-list
110182117|NCT00022737|Pegaspargase|pegaspargase|mesh-list
110182118|NCT00022737|Cyclosporins|cyclosporins|mesh-list
110182119|NCT00022737|Levoleucovorin|levoleucovorin|mesh-list
110182120|NCT00022737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110182121|NCT00022737|Immunologic Factors|immunologic factors|mesh-ancestor
110182122|NCT00022737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110182123|NCT00022737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110182124|NCT00022737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110182125|NCT00022737|Alkylating Agents|alkylating agents|mesh-ancestor
110182126|NCT00022737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110182127|NCT00022737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110182128|NCT00022737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110182129|NCT00022737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110182130|NCT00022737|Antiemetics|antiemetics|mesh-ancestor
110182131|NCT00022737|Autonomic Agents|autonomic agents|mesh-ancestor
110182132|NCT00022737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110182133|NCT00022737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110182134|NCT00022737|Glucocorticoids|glucocorticoids|mesh-ancestor
110182135|NCT00022737|Hormones|hormones|mesh-ancestor
110182136|NCT00022737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110182138|NCT00022737|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110182139|NCT00022737|Abortifacient Agents|abortifacient agents|mesh-ancestor
110182140|NCT00022737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110182141|NCT00022737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110182142|NCT00022737|Antimetabolites|antimetabolites|mesh-ancestor
110182143|NCT00022737|Dermatologic Agents|dermatologic agents|mesh-ancestor
110182144|NCT00022737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110182145|NCT00022737|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110182146|NCT00022737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110182147|NCT00022737|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110182148|NCT00022737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110182150|NCT00022737|Antiviral Agents|antiviral agents|mesh-ancestor
110182151|NCT00022737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110182152|NCT00022737|Antidotes|antidotes|mesh-ancestor
110182153|NCT00022737|Protective Agents|protective agents|mesh-ancestor
110182154|NCT00022737|Vitamin B Complex|vitamin b complex|mesh-ancestor
110182155|NCT00022737|Vitamins|vitamins|mesh-ancestor
110182156|NCT00022737|Micronutrients|micronutrients|mesh-ancestor
110182157|NCT00022737|Tubulin Modulators|tubulin modulators|mesh-ancestor
110182158|NCT00022737|Antimitotic Agents|antimitotic agents|mesh-ancestor
110182159|NCT00022737|Mitosis Modulators|mitosis modulators|mesh-ancestor
110182160|NCT00022737|Antifungal Agents|antifungal agents|mesh-ancestor
110182161|NCT00022737|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110182162|NCT00022737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110182163|NCT00022737|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110182164|NCT00022893|Tositumomab I-131|tositumomab i-131|mesh-list
110182165|NCT00022893|Antibodies|antibodies|mesh-list
110182166|NCT00022893|Immunologic Factors|immunologic factors|mesh-ancestor
110182167|NCT00022893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110182169|NCT05514860|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
110182170|NCT00022932|Tositumomab I-131|tositumomab i-131|mesh-list
110182171|NCT00022932|Antibodies|antibodies|mesh-list
110182172|NCT00022932|Immunologic Factors|immunologic factors|mesh-ancestor
110182173|NCT00022932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110182174|NCT00022932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110182175|NCT00022971|Rituximab|rituximab|mesh-list
110182176|NCT00022971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110182177|NCT00022971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110182178|NCT00022971|Immunologic Factors|immunologic factors|mesh-ancestor
110182179|NCT00022971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110182180|NCT00022971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110182181|NCT05512754|Ibuprofen|ibuprofen|mesh-list
110182182|NCT05512754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110182183|NCT05512754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110182184|NCT05512754|Analgesics|analgesics|mesh-ancestor
110182185|NCT05512754|Sensory System Agents|sensory system agents|mesh-ancestor
110182186|NCT05512754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110182187|NCT05512754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110182188|NCT05512754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110182189|NCT05512754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110182190|NCT05512754|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110182191|NCT05512754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110182192|NCT05512754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110182193|NCT02971878|Thioctic Acid|thioctic acid|mesh-list
110182194|NCT02971878|Acetylcarnitine|acetylcarnitine|mesh-list
110182195|NCT02971878|Acetylcysteine|acetylcysteine|mesh-list
110182196|NCT02971878|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110182197|NCT02971878|Antioxidants|antioxidants|mesh-ancestor
110182198|NCT02971878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110182199|NCT02971878|Protective Agents|protective agents|mesh-ancestor
110182200|NCT02971878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110182201|NCT02971878|Vitamin B Complex|vitamin b complex|mesh-ancestor
110182203|NCT02971878|Micronutrients|micronutrients|mesh-ancestor
110182204|NCT02971878|Nootropic Agents|nootropic agents|mesh-ancestor
110182205|NCT02971878|Antiviral Agents|antiviral agents|mesh-ancestor
110182206|NCT02971878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110182207|NCT02971878|Expectorants|expectorants|mesh-ancestor
110182208|NCT02971878|Respiratory System Agents|respiratory system agents|mesh-ancestor
110182209|NCT02971878|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110182210|NCT02971878|Antidotes|antidotes|mesh-ancestor
110182212|NCT00023166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110182213|NCT00023166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110182214|NCT00023166|Tubulin Modulators|tubulin modulators|mesh-ancestor
110182215|NCT00023166|Antimitotic Agents|antimitotic agents|mesh-ancestor
110182216|NCT00023166|Mitosis Modulators|mitosis modulators|mesh-ancestor
110182217|NCT00023166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110182219|NCT00394992|Capecitabine|capecitabine|mesh-list
110182220|NCT00394992|Oxaliplatin|oxaliplatin|mesh-list
110182221|NCT00394992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110182222|NCT00394992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110182223|NCT00394992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110182224|NCT00394992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110182225|NCT00394992|Growth Substances|growth substances|mesh-ancestor
110182226|NCT00394992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110182228|NCT00394992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110182229|NCT00394992|Antimetabolites|antimetabolites|mesh-ancestor
110182230|NCT00394992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110182232|NCT00395031|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110182233|NCT00395031|Serotonin Agents|serotonin agents|mesh-ancestor
110182234|NCT00395031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110182235|NCT00395031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110182236|NCT00395031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110182237|NCT00395031|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110182238|NCT00395031|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110182239|NCT00395031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110182240|NCT00395031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110182241|NCT00395031|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110182242|NCT00395031|Dopamine Agents|dopamine agents|mesh-ancestor
110182243|NCT00395070|Temozolomide|temozolomide|mesh-list
110182244|NCT00395070|Dacarbazine|dacarbazine|mesh-list
110182245|NCT00395070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110182246|NCT00395070|Alkylating Agents|alkylating agents|mesh-ancestor
110182247|NCT00395070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110182248|NCT00395070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110182249|NCT00023244|Cyclosporine|cyclosporine|mesh-list
110182250|NCT00023244|Sirolimus|sirolimus|mesh-list
110182251|NCT00023244|Trimethoprim|trimethoprim|mesh-list
110216815|NCT00266344|Analgesics|analgesics|mesh-ancestor
110182252|NCT00023244|Sulfamethoxazole|sulfamethoxazole|mesh-list
110182253|NCT00023244|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110182254|NCT00023244|Prednisone|prednisone|mesh-list
110182255|NCT00023244|Methylprednisolone|methylprednisolone|mesh-list
110182256|NCT00023244|Tacrolimus|tacrolimus|mesh-list
110182257|NCT00023244|Cyclosporins|cyclosporins|mesh-list
110182258|NCT00023244|Basiliximab|basiliximab|mesh-list
110182259|NCT00023244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110182260|NCT00023244|Glucocorticoids|glucocorticoids|mesh-ancestor
110182261|NCT00023244|Hormones|hormones|mesh-ancestor
110182262|NCT00023244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110182263|NCT00023244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110182264|NCT00023244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110182265|NCT00023244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110182266|NCT00023244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110182267|NCT00023244|Immunologic Factors|immunologic factors|mesh-ancestor
110182268|NCT00023244|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110182269|NCT00023244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110285821|NCT00411437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110182270|NCT00023244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110182272|NCT00023244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110182273|NCT00023244|Dermatologic Agents|dermatologic agents|mesh-ancestor
110182274|NCT00023244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110182275|NCT00023244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110182276|NCT00023244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110182277|NCT00023244|Antiemetics|antiemetics|mesh-ancestor
110182278|NCT00023244|Autonomic Agents|autonomic agents|mesh-ancestor
110182279|NCT00023244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110182280|NCT00023244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110182281|NCT00023244|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110182282|NCT00023244|Protective Agents|protective agents|mesh-ancestor
110182283|NCT00023244|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110182284|NCT00023244|Antimalarials|antimalarials|mesh-ancestor
110182285|NCT00023244|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110182287|NCT00023244|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110182288|NCT00023244|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110182289|NCT00023244|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110182290|NCT00023244|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110182291|NCT00023283|Buprenorphine|buprenorphine|mesh-list
110182292|NCT00023283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110182293|NCT00023283|Narcotics|narcotics|mesh-ancestor
110182294|NCT00023283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110182295|NCT00023283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110182296|NCT00023283|Analgesics|analgesics|mesh-ancestor
110182297|NCT00023283|Sensory System Agents|sensory system agents|mesh-ancestor
110182298|NCT00023283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110182299|NCT00023283|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110182300|NCT00023361|Rifabutin|rifabutin|mesh-list
110182301|NCT00023361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110182302|NCT00023361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110182303|NCT00023361|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110182304|NCT00023361|Antitubercular Agents|antitubercular agents|mesh-ancestor
110182305|NCT00023400|Nelfinavir|nelfinavir|mesh-list
110182306|NCT00023400|Rifabutin|rifabutin|mesh-list
110182307|NCT00023400|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110182308|NCT00023400|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110182309|NCT00023400|Protease Inhibitors|protease inhibitors|mesh-ancestor
110182310|NCT00023400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110182311|NCT00023400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110182312|NCT00023400|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110182313|NCT00023400|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110182315|NCT00023400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110182316|NCT00023400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110182317|NCT00023400|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110182318|NCT00023400|Antitubercular Agents|antitubercular agents|mesh-ancestor
110182319|NCT05359172|Tranexamic Acid|tranexamic acid|mesh-list
110182320|NCT05359172|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110182321|NCT05359172|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110182322|NCT05359172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110182324|NCT05359172|Coagulants|coagulants|mesh-ancestor
110182325|NCT00023634|Sargramostim|sargramostim|mesh-list
110182326|NCT00023634|Immunologic Factors|immunologic factors|mesh-ancestor
110182327|NCT00023634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110182328|NCT00023751|Leucovorin|leucovorin|mesh-list
110182329|NCT00023751|Fluorouracil|fluorouracil|mesh-list
110182330|NCT00023751|Calcium|calcium|mesh-list
110182331|NCT00023751|Levoleucovorin|levoleucovorin|mesh-list
110182332|NCT00023751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110182333|NCT00023751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110182334|NCT00023751|Antimetabolites|antimetabolites|mesh-ancestor
110182335|NCT00023751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110182336|NCT00023751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110182337|NCT00023751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110182338|NCT00023751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110182339|NCT00023751|Immunologic Factors|immunologic factors|mesh-ancestor
110182340|NCT00023751|Antidotes|antidotes|mesh-ancestor
110182341|NCT00023751|Protective Agents|protective agents|mesh-ancestor
110182342|NCT00023751|Vitamin B Complex|vitamin b complex|mesh-ancestor
110182343|NCT00023751|Vitamins|vitamins|mesh-ancestor
110182344|NCT00023751|Micronutrients|micronutrients|mesh-ancestor
110182345|NCT00023790|Silicon|silicon|mesh-list
110182346|NCT00023790|Silicon phthalocyanine|silicon phthalocyanine|mesh-list
110182347|NCT00023790|Trace Elements|trace elements|mesh-ancestor
110182348|NCT00023790|Micronutrients|micronutrients|mesh-ancestor
110182349|NCT00023790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110182350|NCT00023790|Antimalarials|antimalarials|mesh-ancestor
110182351|NCT00023790|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110182352|NCT00023790|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110182353|NCT00023790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110182354|NCT00023790|Antiviral Agents|antiviral agents|mesh-ancestor
110182355|NCT00023790|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110182356|NCT00023790|Dermatologic Agents|dermatologic agents|mesh-ancestor
110182357|NCT02971982|Dexamethasone|dexamethasone|mesh-list
110182358|NCT02971982|Dexamethasone acetate|dexamethasone acetate|mesh-list
110182359|NCT02971982|Cyclophosphamide|cyclophosphamide|mesh-list
110182360|NCT02971982|Rituximab|rituximab|mesh-list
110182361|NCT02971982|Bortezomib|bortezomib|mesh-list
110182362|NCT02971982|BB 1101|bb 1101|mesh-list
110182363|NCT02971982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110182364|NCT02971982|Immunologic Factors|immunologic factors|mesh-ancestor
110182365|NCT02971982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110182366|NCT02971982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110182367|NCT02971982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110182368|NCT02971982|Alkylating Agents|alkylating agents|mesh-ancestor
110182369|NCT02971982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110182370|NCT02971982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110182371|NCT02971982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110182372|NCT02971982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110182373|NCT02971982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110182374|NCT02971982|Antiemetics|antiemetics|mesh-ancestor
110182375|NCT02971982|Autonomic Agents|autonomic agents|mesh-ancestor
110052854|NCT01482338|Progestins|progestins|mesh-ancestor
110182376|NCT02971982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110182377|NCT02971982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110182378|NCT02971982|Glucocorticoids|glucocorticoids|mesh-ancestor
110182380|NCT02971982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110182381|NCT02971982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110182382|NCT02971982|Protease Inhibitors|protease inhibitors|mesh-ancestor
110182383|NCT02971982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110182384|NCT00023829|Bicalutamide|bicalutamide|mesh-list
110182385|NCT00023829|Flutamide|flutamide|mesh-list
110182387|NCT00023829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110182388|NCT00023829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110182389|NCT00023829|Androgen Antagonists|androgen antagonists|mesh-ancestor
110182390|NCT00023829|Hormone Antagonists|hormone antagonists|mesh-ancestor
110182391|NCT00023829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110182392|NCT00023829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110182393|NCT00023868|Leucovorin|leucovorin|mesh-list
110182394|NCT00023868|Doxorubicin|doxorubicin|mesh-list
110182395|NCT00023868|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110182396|NCT00023868|Fluorouracil|fluorouracil|mesh-list
110182397|NCT00023868|Irinotecan|irinotecan|mesh-list
110182398|NCT00023868|Mitomycins|mitomycins|mesh-list
110182399|NCT00023868|Mitomycin|mitomycin|mesh-list
110182400|NCT00023868|Levoleucovorin|levoleucovorin|mesh-list
110182401|NCT00023868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110182403|NCT00023868|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110182404|NCT00023868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110182405|NCT00023868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110182406|NCT00023868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110182407|NCT00023868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110182408|NCT00023868|Antimetabolites|antimetabolites|mesh-ancestor
110182409|NCT00023868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110182410|NCT00023868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110182411|NCT00023868|Immunologic Factors|immunologic factors|mesh-ancestor
110182412|NCT00023868|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110182413|NCT00023868|Antidotes|antidotes|mesh-ancestor
110182414|NCT00023868|Protective Agents|protective agents|mesh-ancestor
110182415|NCT00023868|Vitamin B Complex|vitamin b complex|mesh-ancestor
110182416|NCT00023868|Vitamins|vitamins|mesh-ancestor
110182417|NCT00023868|Micronutrients|micronutrients|mesh-ancestor
110182418|NCT00023868|Alkylating Agents|alkylating agents|mesh-ancestor
110182419|NCT00023868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110182420|NCT00023907|Paclitaxel|paclitaxel|mesh-list
110182421|NCT00023907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110182422|NCT00023907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110182423|NCT00023907|Tubulin Modulators|tubulin modulators|mesh-ancestor
110182424|NCT00023907|Antimitotic Agents|antimitotic agents|mesh-ancestor
110182425|NCT00023907|Mitosis Modulators|mitosis modulators|mesh-ancestor
110182426|NCT00023907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110182427|NCT00023946|Epothilones|epothilones|mesh-list
110182428|NCT00023946|Epothilone B|epothilone b|mesh-list
110182429|NCT00023946|Tubulin Modulators|tubulin modulators|mesh-ancestor
110182430|NCT00023946|Antimitotic Agents|antimitotic agents|mesh-ancestor
110182431|NCT00023946|Mitosis Modulators|mitosis modulators|mesh-ancestor
110182432|NCT00023946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110182434|NCT05268185|Vaccines|vaccines|mesh-list
110182435|NCT05268185|Immunologic Factors|immunologic factors|mesh-ancestor
110182436|NCT05268185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110182437|NCT00024063|Orantinib|orantinib|mesh-list
110182438|NCT00024063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110182439|NCT00024063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110182440|NCT00024063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110182441|NCT00024141|Fluorouracil|fluorouracil|mesh-list
110182442|NCT00024141|Irinotecan|irinotecan|mesh-list
110182443|NCT00024141|Antimetabolites|antimetabolites|mesh-ancestor
110182444|NCT00024141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110182445|NCT00024141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110182446|NCT00024141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110182447|NCT00024141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110182448|NCT00024141|Immunologic Factors|immunologic factors|mesh-ancestor
110182449|NCT00024141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110182450|NCT00024141|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110182451|NCT00024141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110182452|NCT00024141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110182453|NCT05239286|Anesthetics|anesthetics|mesh-list
110182454|NCT05239286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110182455|NCT05239286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110182456|NCT00024180|Romidepsin|romidepsin|mesh-list
110182457|NCT00024180|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110182458|NCT00024180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110182459|NCT00024180|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110182460|NCT00024180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110182461|NCT00024180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110182463|NCT00024297|Anticoagulants|anticoagulants|mesh-ancestor
110182464|NCT00024336|Tamoxifen|tamoxifen|mesh-list
110182465|NCT00024336|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110182466|NCT00024336|Hormone Antagonists|hormone antagonists|mesh-ancestor
110182467|NCT00024336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110182468|NCT00024336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110182469|NCT00024336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110182470|NCT00024336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110182471|NCT00024336|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110182472|NCT00024336|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110182473|NCT00024336|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110182474|NCT00024375|Paclitaxel|paclitaxel|mesh-list
110182475|NCT00024375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110182476|NCT00024375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110182477|NCT00024375|Tubulin Modulators|tubulin modulators|mesh-ancestor
110182478|NCT00024375|Antimitotic Agents|antimitotic agents|mesh-ancestor
110182479|NCT00024375|Mitosis Modulators|mitosis modulators|mesh-ancestor
110182480|NCT00024375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110182481|NCT00024414|Paclitaxel|paclitaxel|mesh-list
110182482|NCT00024414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110182483|NCT00024414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110182484|NCT00024414|Tubulin Modulators|tubulin modulators|mesh-ancestor
110182485|NCT00024414|Antimitotic Agents|antimitotic agents|mesh-ancestor
110182486|NCT00024414|Mitosis Modulators|mitosis modulators|mesh-ancestor
110285835|NCT00234312|Serotonin Agents|serotonin agents|mesh-ancestor
110182487|NCT00024414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110182489|NCT00024453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110182490|NCT00024453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110182493|NCT00024492|Sensory System Agents|sensory system agents|mesh-ancestor
110182494|NCT00024492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110182495|NCT00024492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110182496|NCT00024492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110182497|NCT00024492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110182498|NCT00024492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110182499|NCT00024492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110182512|NCT00024570|Pseudomonas aeruginosa exotoxin A|pseudomonas aeruginosa exotoxin a|mesh-list
110182513|NCT00024570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110182515|NCT05080049|Hematinics|hematinics|mesh-ancestor
110182516|NCT00024687|Immunotoxins|immunotoxins|mesh-list
110182517|NCT00024687|Immunoconjugates|immunoconjugates|mesh-ancestor
110182518|NCT00024687|Immunologic Factors|immunologic factors|mesh-ancestor
110182519|NCT00024687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110182520|NCT05072444|QPX7728|qpx7728|mesh-list
110182521|NCT05072444|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110182522|NCT05072444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110182523|NCT05072444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110182524|NCT05072444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110182525|NCT05072444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110182526|NCT00025038|Cytarabine|cytarabine|mesh-list
110182527|NCT00025038|Cyclophosphamide|cyclophosphamide|mesh-list
110182528|NCT00025038|Fludarabine|fludarabine|mesh-list
110182529|NCT00025038|Fludarabine phosphate|fludarabine phosphate|mesh-list
110182530|NCT00025038|Tipifarnib|tipifarnib|mesh-list
110182531|NCT00025038|Isotretinoin|isotretinoin|mesh-list
110182532|NCT00025038|Thymoglobulin|thymoglobulin|mesh-list
110182533|NCT00025038|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110182534|NCT00025038|Immunoglobulins|immunoglobulins|mesh-list
110182535|NCT00025038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110182536|NCT00025038|Immunologic Factors|immunologic factors|mesh-ancestor
110182537|NCT00025038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110182538|NCT00025038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110182539|NCT00025038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110182540|NCT00025038|Alkylating Agents|alkylating agents|mesh-ancestor
110182541|NCT00025038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110182542|NCT00025038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110182543|NCT00025038|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110182544|NCT00025038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110182546|NCT00025038|Antiviral Agents|antiviral agents|mesh-ancestor
110182547|NCT00025038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110216884|NCT00073385|Mitosis Modulators|mitosis modulators|mesh-ancestor
110182592|NCT05051891|Rituximab|rituximab|mesh-list
110182593|NCT05051891|Doxorubicin|doxorubicin|mesh-list
110182594|NCT05051891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110182595|NCT05051891|Immunologic Factors|immunologic factors|mesh-ancestor
110182596|NCT05051891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110182597|NCT05051891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110182598|NCT05051891|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110182599|NCT05051891|Alkylating Agents|alkylating agents|mesh-ancestor
110182600|NCT05051891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110182601|NCT05051891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110182602|NCT05051891|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110182603|NCT05051891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110182604|NCT05051891|Glucocorticoids|glucocorticoids|mesh-ancestor
110182605|NCT05051891|Hormones|hormones|mesh-ancestor
110182606|NCT05051891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110182607|NCT05051891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110182608|NCT05051891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110182609|NCT05051891|Tubulin Modulators|tubulin modulators|mesh-ancestor
110182610|NCT05051891|Antimitotic Agents|antimitotic agents|mesh-ancestor
110182611|NCT05051891|Mitosis Modulators|mitosis modulators|mesh-ancestor
110182612|NCT05051891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110182613|NCT05051891|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110182614|NCT05051891|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110182615|NCT05051891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110182616|NCT05051891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110182617|NCT00025194|Estramustine|estramustine|mesh-list
110182618|NCT00025194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110182619|NCT00025194|Alkylating Agents|alkylating agents|mesh-ancestor
110182620|NCT00025194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110182621|NCT00025194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110182622|NCT00025194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110182623|NCT00025272|Carboplatin|carboplatin|mesh-list
110182626|NCT00025272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110182627|NCT00025272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110182628|NCT00025272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110182629|NCT00025272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110182630|NCT00025272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110182631|NCT00025272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110182632|NCT00025272|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110182633|NCT05023382|Teduglutide|teduglutide|mesh-list
110182634|NCT05023382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110182635|NCT05023382|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110182637|NCT05023382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110182638|NCT00025311|Topotecan|topotecan|mesh-list
110182639|NCT00025311|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110182640|NCT00025311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110182641|NCT00025311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110182642|NCT00025311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110182643|NCT00025311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110182645|NCT00025116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110182646|NCT00025116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110182647|NCT00025116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110182648|NCT00025116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110182649|NCT00025350|Gefitinib|gefitinib|mesh-list
110182650|NCT00025350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110182651|NCT00025350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110182652|NCT00025350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110182653|NCT00025350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110182654|NCT00025389|Paclitaxel|paclitaxel|mesh-list
110182655|NCT00025389|Bevacizumab|bevacizumab|mesh-list
110182656|NCT00025389|Carboplatin|carboplatin|mesh-list
110182657|NCT00025389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110182658|NCT00025389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110182659|NCT00025389|Tubulin Modulators|tubulin modulators|mesh-ancestor
110182660|NCT00025389|Antimitotic Agents|antimitotic agents|mesh-ancestor
110182661|NCT00025389|Mitosis Modulators|mitosis modulators|mesh-ancestor
110182662|NCT00025389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110182663|NCT00025389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110182664|NCT00025389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110182665|NCT00025389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110182666|NCT00025389|Growth Substances|growth substances|mesh-ancestor
110182667|NCT00025389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110182668|NCT00025389|Growth Inhibitors|growth inhibitors|mesh-ancestor
110182669|NCT00025428|Cyclophosphamide|cyclophosphamide|mesh-list
110182671|NCT00025428|Doxorubicin|doxorubicin|mesh-list
110182673|NCT00025428|Etoposide|etoposide|mesh-list
110182674|NCT00025428|Vincristine|vincristine|mesh-list
110182675|NCT00025428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110182676|NCT00025428|Immunologic Factors|immunologic factors|mesh-ancestor
110182677|NCT00025428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110182678|NCT00025428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110182679|NCT00025428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110182680|NCT00025428|Alkylating Agents|alkylating agents|mesh-ancestor
110182681|NCT00025428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110182682|NCT00025428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110182683|NCT00025428|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110182684|NCT00025428|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110182685|NCT00025428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110182686|NCT00025428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110182687|NCT00025428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110182688|NCT00025428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110182689|NCT00025428|Tubulin Modulators|tubulin modulators|mesh-ancestor
110182691|NCT00025428|Mitosis Modulators|mitosis modulators|mesh-ancestor
110182692|NCT00025467|Thalidomide|thalidomide|mesh-list
110182693|NCT00025467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110182694|NCT00025467|Immunologic Factors|immunologic factors|mesh-ancestor
110182695|NCT00025467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110182696|NCT00025467|Leprostatic Agents|leprostatic agents|mesh-ancestor
110182697|NCT00025467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110182698|NCT00025467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110182699|NCT00025467|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110182700|NCT00025467|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110182701|NCT00025467|Growth Substances|growth substances|mesh-ancestor
110182702|NCT00025467|Growth Inhibitors|growth inhibitors|mesh-ancestor
110182703|NCT00025467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110182705|NCT04964414|Glucocorticoids|glucocorticoids|mesh-list
110182706|NCT04964414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110182707|NCT04964414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110182708|NCT04964414|Autonomic Agents|autonomic agents|mesh-ancestor
110182709|NCT04964414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110182710|NCT04964414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110182711|NCT04964414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110182712|NCT04964414|Respiratory System Agents|respiratory system agents|mesh-ancestor
110182713|NCT04964414|Hormones|hormones|mesh-ancestor
110182714|NCT04964414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110182715|NCT00025545|Cyclophosphamide|cyclophosphamide|mesh-list
110182716|NCT00025545|Methotrexate|methotrexate|mesh-list
110182717|NCT00025545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110182719|NCT00025545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110182720|NCT00025545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110276163|NCT04171453|Analgesics|analgesics|mesh-ancestor
110182721|NCT00025545|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110182722|NCT00025545|Alkylating Agents|alkylating agents|mesh-ancestor
110182723|NCT00025545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110182724|NCT00025545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110182725|NCT00025545|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110182726|NCT00025545|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110182727|NCT00025545|Abortifacient Agents|abortifacient agents|mesh-ancestor
110182728|NCT00025545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110182729|NCT00025545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110182730|NCT00025545|Antimetabolites|antimetabolites|mesh-ancestor
110182731|NCT00025545|Dermatologic Agents|dermatologic agents|mesh-ancestor
110182732|NCT00025545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110182733|NCT00025545|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110182734|NCT00025545|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110182735|NCT00025584|Bortezomib|bortezomib|mesh-list
110182736|NCT00025584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110182737|NCT00025623|Cyclophosphamide|cyclophosphamide|mesh-list
110182738|NCT00025623|Carboplatin|carboplatin|mesh-list
110182739|NCT00025623|Doxorubicin|doxorubicin|mesh-list
110182740|NCT00025623|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110182742|NCT00025623|Vincristine|vincristine|mesh-list
110182743|NCT00025623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110182744|NCT00025623|Immunologic Factors|immunologic factors|mesh-ancestor
110182745|NCT00025623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110182746|NCT00025623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110182747|NCT00025623|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110182748|NCT00025623|Alkylating Agents|alkylating agents|mesh-ancestor
110182749|NCT00025623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110182750|NCT00025623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110182751|NCT00025623|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110182752|NCT00025623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110182753|NCT00025623|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110182754|NCT00025623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110182756|NCT00025623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110182757|NCT00025623|Tubulin Modulators|tubulin modulators|mesh-ancestor
110182758|NCT00025623|Antimitotic Agents|antimitotic agents|mesh-ancestor
110182759|NCT00025623|Mitosis Modulators|mitosis modulators|mesh-ancestor
110182761|NCT00025740|Paroxetine|paroxetine|mesh-list
110182762|NCT00025740|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110182763|NCT00025740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110286022|NCT01089790|Incretins|incretins|mesh-ancestor
110182764|NCT00025740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110182765|NCT00025740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110182766|NCT00025740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110182767|NCT00025740|Serotonin Agents|serotonin agents|mesh-ancestor
110182768|NCT00025740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110182769|NCT00025740|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110182770|NCT00025740|Antidepressive Agents|antidepressive agents|mesh-ancestor
110182771|NCT00025740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110182772|NCT00025740|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110182773|NCT00025740|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110182774|NCT00025740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110182779|NCT00025779|Methylphenidate|methylphenidate|mesh-list
110182780|NCT00025779|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110182781|NCT00025779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110182782|NCT00025779|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110182783|NCT00025779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110182784|NCT00025779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110182785|NCT00025779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110182786|NCT00025779|Dopamine Agents|dopamine agents|mesh-ancestor
110182787|NCT00025779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110182788|NCT00025779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110182789|NCT00025779|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110182790|NCT00025779|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110182791|NCT00025779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110182792|NCT00025779|Adrenergic Agents|adrenergic agents|mesh-ancestor
110182794|NCT00026052|Anticonvulsants|anticonvulsants|mesh-ancestor
110182795|NCT00026052|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110182796|NCT00026052|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110182797|NCT00026052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110182798|NCT00026052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110182799|NCT00026052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110182800|NCT00026052|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110182801|NCT00026052|Protective Agents|protective agents|mesh-ancestor
110182802|NCT00026091|Fenretinide|fenretinide|mesh-list
110182803|NCT00026091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110182804|NCT00026091|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110182805|NCT00026091|Protective Agents|protective agents|mesh-ancestor
110182806|NCT00026091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110182813|NCT00026130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110182815|NCT00026130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110182817|NCT00026169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110182818|NCT00026169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110182819|NCT00026169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110182820|NCT00026169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110182823|NCT04808414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110182824|NCT00026364|Leucovorin|leucovorin|mesh-list
110182825|NCT00026364|Fluorouracil|fluorouracil|mesh-list
110182826|NCT00026364|Irinotecan|irinotecan|mesh-list
110182827|NCT00026364|Gefitinib|gefitinib|mesh-list
110182828|NCT00026364|Calcium|calcium|mesh-list
110182829|NCT00026364|Levoleucovorin|levoleucovorin|mesh-list
110182830|NCT00026364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110182831|NCT00026364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110182832|NCT00026364|Antimetabolites|antimetabolites|mesh-ancestor
110182833|NCT00026364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110182834|NCT00026364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110182835|NCT00026364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110182836|NCT00026364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110182837|NCT00026364|Immunologic Factors|immunologic factors|mesh-ancestor
110182838|NCT00026364|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110182839|NCT00026364|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110182840|NCT00026364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110182841|NCT00026364|Antidotes|antidotes|mesh-ancestor
110286162|NCT00209924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110182842|NCT00026364|Protective Agents|protective agents|mesh-ancestor
110182843|NCT00026364|Vitamin B Complex|vitamin b complex|mesh-ancestor
110182846|NCT00026364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110182847|NCT00026403|Gemcitabine|gemcitabine|mesh-list
110182848|NCT00026403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110182849|NCT00026403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110182850|NCT00026403|Antimetabolites|antimetabolites|mesh-ancestor
110182851|NCT00026403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110182852|NCT00026442|Capecitabine|capecitabine|mesh-list
110182853|NCT00026442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110182854|NCT00026442|Antimetabolites|antimetabolites|mesh-ancestor
110182855|NCT00026442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110182856|NCT00026442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110182857|NCT04726280|Ropivacaine|ropivacaine|mesh-list
110182858|NCT04726280|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110182859|NCT04726280|Anesthetics, Local|anesthetics, local|mesh-ancestor
110182861|NCT04726280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110182862|NCT04726280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110182863|NCT04726280|Sensory System Agents|sensory system agents|mesh-ancestor
110276213|NCT02962830|Sufentanil|sufentanil|mesh-list
110182864|NCT04726280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110182866|NCT00026520|Interferon-alpha|interferon-alpha|mesh-list
110182867|NCT00026520|Thalidomide|thalidomide|mesh-list
110182868|NCT00026520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110182869|NCT00026520|Antiviral Agents|antiviral agents|mesh-ancestor
110182870|NCT00026520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110182871|NCT00026520|Immunologic Factors|immunologic factors|mesh-ancestor
110182872|NCT00026520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110182873|NCT00026520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110182874|NCT00026520|Leprostatic Agents|leprostatic agents|mesh-ancestor
110182875|NCT00026520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110286256|NCT00413790|Urological Agents|urological agents|mesh-ancestor
110182876|NCT00026520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110182877|NCT00026520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110182878|NCT00026520|Growth Substances|growth substances|mesh-ancestor
110182879|NCT00026520|Growth Inhibitors|growth inhibitors|mesh-ancestor
110182880|NCT00026637|Sertraline|sertraline|mesh-list
110182881|NCT00026637|Antidepressive Agents|antidepressive agents|mesh-ancestor
110182882|NCT00026637|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110182883|NCT00026637|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110182884|NCT00026637|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110182885|NCT00026637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110182886|NCT00026637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110182887|NCT00026637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110182888|NCT00026637|Serotonin Agents|serotonin agents|mesh-ancestor
110182889|NCT00026637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110182890|NCT04657094|Acalabrutinib|acalabrutinib|mesh-list
110182891|NCT04657094|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
110182892|NCT04657094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110182893|NCT04657094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110182894|NCT04657094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110182895|NCT04657094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110182896|NCT04610684|Carboplatin|carboplatin|mesh-list
110182897|NCT04610684|Etoposide|etoposide|mesh-list
110182898|NCT04610684|Atezolizumab|atezolizumab|mesh-list
110182899|NCT04610684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110182900|NCT04610684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110286361|NCT04570345|Analgesics|analgesics|mesh-ancestor
110182901|NCT04610684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110182902|NCT04610684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110182903|NCT04610684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110182904|NCT04610684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110182905|NCT04610684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110182906|NCT04610684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110182907|NCT00027066|Aspirin|aspirin|mesh-list
110182908|NCT00027066|Warfarin|warfarin|mesh-list
110182909|NCT00027066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110182910|NCT00027066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110182912|NCT00027066|Sensory System Agents|sensory system agents|mesh-ancestor
110182913|NCT00027066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110182914|NCT00027066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110182915|NCT00027066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110182916|NCT00027066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110182917|NCT00027066|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110182918|NCT00027066|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110182919|NCT00027066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110182920|NCT00027066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110182921|NCT00027066|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110182922|NCT00027066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110182923|NCT00027066|Antipyretics|antipyretics|mesh-ancestor
110182924|NCT00027066|Anticoagulants|anticoagulants|mesh-ancestor
110182925|NCT04473950|Naloxone|naloxone|mesh-list
110182926|NCT04473950|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110182927|NCT04473950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110182928|NCT04473950|Sensory System Agents|sensory system agents|mesh-ancestor
110182929|NCT04473950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110182930|NCT00027300|Natalizumab|natalizumab|mesh-list
110182931|NCT00027300|Immunologic Factors|immunologic factors|mesh-ancestor
110182932|NCT00027300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110182933|NCT00395382|Alendronate|alendronate|mesh-list
110182934|NCT00395382|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110182935|NCT00395382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110182937|NCT00027339|Lopinavir|lopinavir|mesh-list
110182938|NCT00027339|Indinavir|indinavir|mesh-list
110182939|NCT00027339|Fosamprenavir|fosamprenavir|mesh-list
110182940|NCT00027339|Tenofovir|tenofovir|mesh-list
110182941|NCT00027339|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110182942|NCT00027339|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110182943|NCT00027339|Protease Inhibitors|protease inhibitors|mesh-ancestor
110182944|NCT00027339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110182945|NCT00027339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110182947|NCT00027339|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110182948|NCT00027339|Antiviral Agents|antiviral agents|mesh-ancestor
110182949|NCT00027339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110182950|NCT00027339|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110286550|NCT00238056|Domperidone|domperidone|mesh-list
110182951|NCT00027339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110182952|NCT00027339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110182953|NCT00027339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110182955|NCT04206488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110182956|NCT04206488|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110182957|NCT04206488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110182958|NCT04206488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110182959|NCT04206488|Protective Agents|protective agents|mesh-ancestor
110182960|NCT04206488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110182962|NCT00027495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110182963|NCT00027495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110182965|NCT00027495|Sensory System Agents|sensory system agents|mesh-ancestor
110182966|NCT00027495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110182967|NCT00027495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110182968|NCT00027495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110182969|NCT00027495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110182970|NCT00027495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110182971|NCT00027495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110182972|NCT00027495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110182974|NCT00027534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110182975|NCT00027534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110182976|NCT00027534|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110182977|NCT00027534|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110182978|NCT00027573|Cyclophosphamide|cyclophosphamide|mesh-list
110182979|NCT00027573|Methotrexate|methotrexate|mesh-list
110182980|NCT00027573|Fludarabine|fludarabine|mesh-list
110182981|NCT00027573|Fludarabine phosphate|fludarabine phosphate|mesh-list
110182982|NCT00027573|Tacrolimus|tacrolimus|mesh-list
110182983|NCT00027573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110182984|NCT00027573|Immunologic Factors|immunologic factors|mesh-ancestor
110182985|NCT00027573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110182986|NCT00027573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110182987|NCT00027573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110182988|NCT00027573|Alkylating Agents|alkylating agents|mesh-ancestor
110182989|NCT00027573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110182990|NCT00027573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110182991|NCT00027573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110182992|NCT00027573|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110182993|NCT00027573|Abortifacient Agents|abortifacient agents|mesh-ancestor
110182994|NCT00027573|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110182995|NCT00027573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110182997|NCT00027573|Dermatologic Agents|dermatologic agents|mesh-ancestor
110182998|NCT00027573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110182999|NCT00027573|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110183000|NCT00027573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110183001|NCT00027573|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110183002|NCT00027612|Irinotecan|irinotecan|mesh-list
110183003|NCT00027612|Carmustine|carmustine|mesh-list
110183004|NCT00027612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110183005|NCT00027612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110183006|NCT00027612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110183007|NCT00027612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110183008|NCT00027612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110183009|NCT00027612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110183010|NCT00027612|Alkylating Agents|alkylating agents|mesh-ancestor
110183011|NCT00027690|Gefitinib|gefitinib|mesh-list
110183012|NCT00027690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110183013|NCT00027690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110183014|NCT00027690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110183015|NCT00027690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110183016|NCT00027768|Ethiodized Oil|ethiodized oil|mesh-list
110286787|NCT02894710|Lidocaine|lidocaine|mesh-list
110183017|NCT00027768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110183019|NCT00027807|Molgramostim|molgramostim|mesh-list
110183020|NCT00027807|Sargramostim|sargramostim|mesh-list
110183021|NCT00027807|Immunologic Factors|immunologic factors|mesh-ancestor
110183022|NCT00027807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110183023|NCT00027807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110183025|NCT00027807|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110183026|NCT00027807|Antiviral Agents|antiviral agents|mesh-ancestor
110183027|NCT00027807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110183028|NCT00392522|Nitrous Oxide|nitrous oxide|mesh-list
110183029|NCT00392522|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110183030|NCT00392522|Anesthetics, General|anesthetics, general|mesh-ancestor
110183031|NCT00392522|Anesthetics|anesthetics|mesh-ancestor
110183032|NCT00392522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110183033|NCT00392522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110183034|NCT00392522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110183035|NCT00392522|Analgesics|analgesics|mesh-ancestor
110183036|NCT00392522|Sensory System Agents|sensory system agents|mesh-ancestor
110183037|NCT00392522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110183038|NCT00027885|Cyclophosphamide|cyclophosphamide|mesh-list
110183039|NCT00027885|Bevacizumab|bevacizumab|mesh-list
110183040|NCT00027885|Docetaxel|docetaxel|mesh-list
110183041|NCT00027885|Doxorubicin|doxorubicin|mesh-list
110183042|NCT00027885|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110183043|NCT00027885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110183044|NCT00027885|Immunologic Factors|immunologic factors|mesh-ancestor
110183045|NCT00027885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110183046|NCT00027885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110183047|NCT00027885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110183048|NCT00027885|Alkylating Agents|alkylating agents|mesh-ancestor
110183049|NCT00027885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110183050|NCT00027885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110183051|NCT00027885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110183052|NCT00027885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110183053|NCT00027885|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110183054|NCT00027885|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110183055|NCT00027885|Growth Substances|growth substances|mesh-ancestor
110183056|NCT00027885|Growth Inhibitors|growth inhibitors|mesh-ancestor
110183057|NCT00027885|Tubulin Modulators|tubulin modulators|mesh-ancestor
110183058|NCT00027885|Antimitotic Agents|antimitotic agents|mesh-ancestor
110183059|NCT00027885|Mitosis Modulators|mitosis modulators|mesh-ancestor
110183060|NCT00027885|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110183061|NCT00027885|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110183062|NCT00027885|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110183063|NCT00027885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110183065|NCT00027924|Methotrexate|methotrexate|mesh-list
110183066|NCT00027924|Fludarabine phosphate|fludarabine phosphate|mesh-list
110183067|NCT00027924|Fludarabine|fludarabine|mesh-list
110183068|NCT00027924|Busulfan|busulfan|mesh-list
110183069|NCT00027924|Cyclosporins|cyclosporins|mesh-list
110183073|NCT00027924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110183074|NCT00027924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110183075|NCT00027924|Antimetabolites|antimetabolites|mesh-ancestor
110183076|NCT00027924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110183077|NCT00027924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110183078|NCT00027924|Dermatologic Agents|dermatologic agents|mesh-ancestor
110183080|NCT00027924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110183081|NCT00027924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110183082|NCT00027924|Immunologic Factors|immunologic factors|mesh-ancestor
110183083|NCT00027924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110183084|NCT00027924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110183085|NCT00027924|Antifungal Agents|antifungal agents|mesh-ancestor
110183086|NCT00027924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110183087|NCT00027924|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110183088|NCT00027924|Alkylating Agents|alkylating agents|mesh-ancestor
110183089|NCT00027924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110183090|NCT00027924|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110183091|NCT04022876|Carboplatin|carboplatin|mesh-list
110183093|NCT04022876|Topotecan|topotecan|mesh-list
110183094|NCT04022876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110183095|NCT04022876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110183096|NCT04022876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110183097|NCT04022876|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110183098|NCT04022876|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110183099|NCT04022876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110183100|NCT04022876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110183102|NCT00027963|Analgesics|analgesics|mesh-ancestor
110183103|NCT00027963|Sensory System Agents|sensory system agents|mesh-ancestor
110183104|NCT00027963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110183105|NCT00027963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110183106|NCT00027963|Anticonvulsants|anticonvulsants|mesh-ancestor
110183107|NCT00027963|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110183108|NCT00027963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110183109|NCT00027963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110183110|NCT00027963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110183111|NCT00027963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110183112|NCT00027963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110183113|NCT00027963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110183114|NCT00027963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110183115|NCT00027963|Antimanic Agents|antimanic agents|mesh-ancestor
110183118|NCT00395421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110183119|NCT00395499|Risperidone|risperidone|mesh-list
110183120|NCT00395499|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110183121|NCT00395499|Serotonin Agents|serotonin agents|mesh-ancestor
110183122|NCT00395499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110183123|NCT00395499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110183124|NCT00395499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110183125|NCT00395499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110183126|NCT00395499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110183127|NCT00395499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110183128|NCT00395499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110183129|NCT00395499|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110183131|NCT03960125|Imipramine|imipramine|mesh-list
110183132|NCT03960125|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110183133|NCT03960125|Antidepressive Agents|antidepressive agents|mesh-ancestor
110183134|NCT03960125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110183135|NCT03960125|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110183136|NCT03960125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110183137|NCT03960125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110183138|NCT03960125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110183139|NCT03960125|Adrenergic Agents|adrenergic agents|mesh-ancestor
110183140|NCT03960125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110183144|NCT00395655|Anticonvulsants|anticonvulsants|mesh-ancestor
110183145|NCT00395655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110183146|NCT00395655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110183149|NCT00395655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110183150|NCT00395655|Antimanic Agents|antimanic agents|mesh-ancestor
110183151|NCT00395655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110183152|NCT00395655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110183154|NCT00395655|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110183155|NCT00395655|Vasodilator Agents|vasodilator agents|mesh-ancestor
110183157|NCT00392561|Selenium|selenium|mesh-list
110183158|NCT00392561|Vitamins|vitamins|mesh-ancestor
110183159|NCT00392561|Micronutrients|micronutrients|mesh-ancestor
110183160|NCT00392561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110183162|NCT00392561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110183163|NCT00392561|Protective Agents|protective agents|mesh-ancestor
110183164|NCT00392561|Trace Elements|trace elements|mesh-ancestor
110183165|NCT00028275|Interferons|interferons|mesh-list
110183166|NCT00028275|Interferon-gamma|interferon-gamma|mesh-list
110183167|NCT00028275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110287068|NCT04668469|Vitamins|vitamins|mesh-list
110183168|NCT00028275|Antiviral Agents|antiviral agents|mesh-ancestor
110183169|NCT00028275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110183172|NCT03959969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110183173|NCT03959969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110183174|NCT03959969|Analgesics|analgesics|mesh-ancestor
110183175|NCT03959969|Sensory System Agents|sensory system agents|mesh-ancestor
110183176|NCT03959969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110183177|NCT03959969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110183178|NCT03959969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110183179|NCT03959969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110183180|NCT03959969|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110183181|NCT03959969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110183182|NCT03959969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110183183|NCT03959969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110183184|NCT03959969|Narcotics|narcotics|mesh-ancestor
110183185|NCT03959969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110183186|NCT00028314|Ritonavir|ritonavir|mesh-list
110183187|NCT00028314|Lopinavir|lopinavir|mesh-list
110183188|NCT00028314|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110183189|NCT00028314|Nevirapine|nevirapine|mesh-list
110183191|NCT00028314|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110183192|NCT00028314|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110183193|NCT00028314|Protease Inhibitors|protease inhibitors|mesh-ancestor
110183194|NCT00028314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110276409|NCT00554164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110183195|NCT00028314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110183196|NCT00028314|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110183197|NCT00028314|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110183198|NCT00028314|Antiviral Agents|antiviral agents|mesh-ancestor
110183199|NCT00028314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110183200|NCT00028314|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110183201|NCT00028314|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110183202|NCT00028314|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110183203|NCT00028314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110183204|NCT00028314|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110183205|NCT00028314|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110183206|NCT00028353|Toremifene|toremifene|mesh-list
110183207|NCT00028353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110183208|NCT00028353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110183209|NCT00028353|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110183210|NCT00028353|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110183211|NCT00028353|Hormone Antagonists|hormone antagonists|mesh-ancestor
110183212|NCT00028353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110183213|NCT00028353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110183214|NCT00028353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110183216|NCT03959852|Ketamine|ketamine|mesh-list
110183217|NCT03959852|Analgesics|analgesics|mesh-ancestor
110183218|NCT03959852|Sensory System Agents|sensory system agents|mesh-ancestor
110183219|NCT03959852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110183220|NCT03959852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110183221|NCT03959852|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110183222|NCT03959852|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110183223|NCT03959852|Anesthetics, General|anesthetics, general|mesh-ancestor
110183225|NCT03959852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110183226|NCT03959852|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110183227|NCT03959852|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110183228|NCT03959852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110276416|NCT00554164|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110183229|NCT03959852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110183230|NCT03959852|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110183231|NCT03959852|Narcotics|narcotics|mesh-ancestor
110183232|NCT03959852|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110183234|NCT00028431|Antibodies|antibodies|mesh-list
110183235|NCT00028431|Immunologic Factors|immunologic factors|mesh-ancestor
110183236|NCT00028431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110183237|NCT00028431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110183238|NCT00028431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110183239|NCT00028431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110183240|NCT00028431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110183241|NCT00028587|Paclitaxel|paclitaxel|mesh-list
110183242|NCT00028587|Carboplatin|carboplatin|mesh-list
110183243|NCT00028587|Bortezomib|bortezomib|mesh-list
110183244|NCT00028587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110183245|NCT00028587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110183246|NCT00028587|Tubulin Modulators|tubulin modulators|mesh-ancestor
110183247|NCT00028587|Antimitotic Agents|antimitotic agents|mesh-ancestor
110183248|NCT00028587|Mitosis Modulators|mitosis modulators|mesh-ancestor
110183249|NCT00028587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110183250|NCT04733196|Chlorhexidine|chlorhexidine|mesh-list
110183251|NCT04733196|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110183253|NCT04733196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110183254|NCT04733196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110183255|NCT04733196|Disinfectants|disinfectants|mesh-ancestor
110183256|NCT04733196|Dermatologic Agents|dermatologic agents|mesh-ancestor
110183257|NCT00028665|Cyclophosphamide|cyclophosphamide|mesh-list
110183258|NCT00028665|Carmustine|carmustine|mesh-list
110183259|NCT00028665|Rituximab|rituximab|mesh-list
110183260|NCT00028665|Etoposide|etoposide|mesh-list
110183261|NCT00028665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110183262|NCT00028665|Immunologic Factors|immunologic factors|mesh-ancestor
110183263|NCT00028665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110183264|NCT00028665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110183265|NCT00028665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110183266|NCT00028665|Alkylating Agents|alkylating agents|mesh-ancestor
110183267|NCT00028665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110183268|NCT00028665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110183269|NCT00028665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110183272|NCT00028665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110183273|NCT00028665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110183274|NCT00028665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110183276|NCT03959540|Opicapone|opicapone|mesh-list
110183277|NCT03959540|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110183278|NCT03959540|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110183279|NCT03959540|Dopamine Agents|dopamine agents|mesh-ancestor
110183280|NCT03959540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110183281|NCT03959540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110183282|NCT03959540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110183283|NCT03959540|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
110183284|NCT03959540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110183286|NCT00028743|Carboplatin|carboplatin|mesh-list
110183287|NCT00028743|Topotecan|topotecan|mesh-list
110183288|NCT00028743|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110183289|NCT00028743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110183290|NCT00028743|Tubulin Modulators|tubulin modulators|mesh-ancestor
110183291|NCT00028743|Antimitotic Agents|antimitotic agents|mesh-ancestor
110183292|NCT00028743|Mitosis Modulators|mitosis modulators|mesh-ancestor
110287328|NCT00212654|Landiolol|landiolol|mesh-list
110183293|NCT00028743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110183294|NCT00028743|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110183295|NCT00028743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110183296|NCT00028743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110183297|NCT03959501|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110183300|NCT03959501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110183302|NCT03959501|Hormones|hormones|mesh-ancestor
110183303|NCT03959501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110183304|NCT03959501|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110183305|NCT03959501|Protease Inhibitors|protease inhibitors|mesh-ancestor
110183307|NCT03959501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110183308|NCT03959501|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110183309|NCT00028782|Etanidazole|etanidazole|mesh-list
110183310|NCT00028782|Imidazole|imidazole|mesh-list
110183312|NCT00028782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110183313|NCT00028782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110183314|NCT00028821|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
110183315|NCT00028821|Estradiol|estradiol|mesh-list
110183316|NCT00028821|Estrogens|estrogens|mesh-ancestor
110183317|NCT00028821|Hormones|hormones|mesh-ancestor
110183318|NCT00028821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110183319|NCT00028821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110183320|NCT00028821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110183321|NCT00028821|Tubulin Modulators|tubulin modulators|mesh-ancestor
110183322|NCT00028821|Antimitotic Agents|antimitotic agents|mesh-ancestor
110183323|NCT00028821|Mitosis Modulators|mitosis modulators|mesh-ancestor
110183324|NCT00028821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110183325|NCT03959384|Poractant alfa|poractant alfa|mesh-list
110183326|NCT03959384|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
110183327|NCT03959384|Respiratory System Agents|respiratory system agents|mesh-ancestor
110183330|NCT00028860|Gemcitabine|gemcitabine|mesh-list
110183331|NCT00028860|Ifosfamide|ifosfamide|mesh-list
110183332|NCT00028860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110183333|NCT00028860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110183334|NCT00028860|Tubulin Modulators|tubulin modulators|mesh-ancestor
110217012|NCT00073658|Citalopram|citalopram|mesh-list
110183335|NCT00028860|Antimitotic Agents|antimitotic agents|mesh-ancestor
110183336|NCT00028860|Mitosis Modulators|mitosis modulators|mesh-ancestor
110183337|NCT00028860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110183338|NCT00028860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110183339|NCT00028860|Antimetabolites|antimetabolites|mesh-ancestor
110183340|NCT00028860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110183341|NCT00028860|Alkylating Agents|alkylating agents|mesh-ancestor
110183342|NCT00028899|Cytarabine|cytarabine|mesh-list
110183343|NCT00028899|Asparaginase|asparaginase|mesh-list
110183344|NCT00028899|Mitoxantrone|mitoxantrone|mesh-list
110183345|NCT00028899|Gemtuzumab|gemtuzumab|mesh-list
110183347|NCT00028899|Antimetabolites|antimetabolites|mesh-ancestor
110183348|NCT00028899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110183349|NCT00028899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110183350|NCT00028899|Antiviral Agents|antiviral agents|mesh-ancestor
110183351|NCT00028899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110183352|NCT00028899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110183353|NCT00028899|Immunologic Factors|immunologic factors|mesh-ancestor
110183354|NCT00028899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110183355|NCT00028899|Analgesics|analgesics|mesh-ancestor
110183356|NCT00028899|Sensory System Agents|sensory system agents|mesh-ancestor
110183357|NCT00028899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110183358|NCT00028899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110183359|NCT00028899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110183360|NCT00028899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110183361|NCT00028899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110183362|NCT00028899|Immunotoxins|immunotoxins|mesh-ancestor
110183363|NCT00028899|Immunoconjugates|immunoconjugates|mesh-ancestor
110183364|NCT03959306|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110183365|NCT03959306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110183367|NCT00028938|Carboplatin|carboplatin|mesh-list
110183368|NCT00028938|Epoetin Alfa|epoetin alfa|mesh-list
110183369|NCT00028938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110183370|NCT00028938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110183371|NCT00028938|Tubulin Modulators|tubulin modulators|mesh-ancestor
110183372|NCT00028938|Antimitotic Agents|antimitotic agents|mesh-ancestor
110183373|NCT00028938|Mitosis Modulators|mitosis modulators|mesh-ancestor
110183374|NCT00028938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110183376|NCT00029250|Allicin|allicin|mesh-list
110183377|NCT00029250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110183378|NCT00029250|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110183379|NCT00029250|Antimetabolites|antimetabolites|mesh-ancestor
110183380|NCT00029250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110183381|NCT00029250|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110183382|NCT00029250|Antioxidants|antioxidants|mesh-ancestor
110183383|NCT00029250|Protective Agents|protective agents|mesh-ancestor
110183384|NCT00029250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110183385|NCT00029250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110183386|NCT00029250|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110183387|NCT03959150|Capecitabine|capecitabine|mesh-list
110183388|NCT03959150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110183389|NCT03959150|Antimetabolites|antimetabolites|mesh-ancestor
110183390|NCT03959150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110183392|NCT00029328|Etanercept|etanercept|mesh-list
110183393|NCT00029328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110183394|NCT00029328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110183395|NCT00029328|Analgesics|analgesics|mesh-ancestor
110183396|NCT00029328|Sensory System Agents|sensory system agents|mesh-ancestor
110183397|NCT00029328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110183398|NCT00029328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110183399|NCT00029328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110183400|NCT00029328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110183401|NCT00029328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110183402|NCT00029328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110183403|NCT00029328|Immunologic Factors|immunologic factors|mesh-ancestor
110183405|NCT00029523|Methotrexate|methotrexate|mesh-list
110183406|NCT00029523|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110183407|NCT00029523|Abortifacient Agents|abortifacient agents|mesh-ancestor
110287728|NCT00240630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110183408|NCT00029523|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110183409|NCT00029523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110183410|NCT00029523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110183411|NCT00029523|Antimetabolites|antimetabolites|mesh-ancestor
110183412|NCT00029523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110183413|NCT00029523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110183414|NCT00029523|Dermatologic Agents|dermatologic agents|mesh-ancestor
110183415|NCT00029523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110183416|NCT00029523|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110183417|NCT00029523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110183418|NCT00029523|Immunologic Factors|immunologic factors|mesh-ancestor
110183419|NCT00029523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110287780|NCT00215345|Celecoxib|celecoxib|mesh-list
110183420|NCT00029523|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110183422|NCT00029523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110183423|NCT00392717|Atorvastatin|atorvastatin|mesh-list
110183424|NCT00392717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110183425|NCT00392717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110183426|NCT00392717|Antimetabolites|antimetabolites|mesh-ancestor
110287841|NCT00215501|Irinotecan|irinotecan|mesh-list
110183427|NCT00392717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110183428|NCT00392717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110183429|NCT00392717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110183430|NCT00392717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110183432|NCT00029679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110183433|NCT03958799|Vaccines|vaccines|mesh-list
110183434|NCT03958799|Immunologic Factors|immunologic factors|mesh-ancestor
110183435|NCT03958799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110183437|NCT00029757|Hormones|hormones|mesh-ancestor
110183438|NCT00029757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110183439|NCT00029757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110183440|NCT03958721|Capecitabine|capecitabine|mesh-list
110183441|NCT03958721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110183442|NCT03958721|Antimetabolites|antimetabolites|mesh-ancestor
110183443|NCT03958721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110183444|NCT03958721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110183445|NCT00029835|Rimonabant|rimonabant|mesh-list
110183446|NCT00029835|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110183447|NCT00029835|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
110183448|NCT00029835|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110183449|NCT00029835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110287970|NCT00557011|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
110183450|NCT00029835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110183452|NCT00029835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110183453|NCT00029835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110183454|NCT00395772|Vitamin K|vitamin k|mesh-list
110183455|NCT00395772|Heparin|heparin|mesh-list
110183456|NCT00395772|Rivaroxaban|rivaroxaban|mesh-list
110183457|NCT00395772|Vitamins|vitamins|mesh-ancestor
110183458|NCT00395772|Micronutrients|micronutrients|mesh-ancestor
110217028|NCT00073658|Antidepressive Agents|antidepressive agents|mesh-ancestor
110183460|NCT00395772|Anticoagulants|anticoagulants|mesh-ancestor
110183461|NCT00395772|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110183462|NCT00395772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110183463|NCT00395772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110183464|NCT00395772|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110183465|NCT00395772|Antithrombins|antithrombins|mesh-ancestor
110183466|NCT00395772|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110183467|NCT00395772|Protease Inhibitors|protease inhibitors|mesh-ancestor
110183468|NCT00395772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110183469|NCT00395772|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110183470|NCT00395772|Hemostatics|hemostatics|mesh-ancestor
110183471|NCT00395772|Coagulants|coagulants|mesh-ancestor
110183472|NCT00029874|Minocycline|minocycline|mesh-list
110183473|NCT00029874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110288084|NCT02961816|Vitamins|vitamins|mesh-ancestor
110183475|NCT00030030|Silymarin|silymarin|mesh-list
110183476|NCT00030030|Antioxidants|antioxidants|mesh-ancestor
110183477|NCT00030030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110183479|NCT00030030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110183480|NCT00030069|Calcitriol|calcitriol|mesh-list
110183481|NCT00030069|Dexamethasone|dexamethasone|mesh-list
110183482|NCT00030069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110183483|NCT00030069|Antiemetics|antiemetics|mesh-ancestor
110183484|NCT00030069|Autonomic Agents|autonomic agents|mesh-ancestor
110183485|NCT00030069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110183486|NCT00030069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110183487|NCT00030069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110183488|NCT00030069|Glucocorticoids|glucocorticoids|mesh-ancestor
110183489|NCT00030069|Hormones|hormones|mesh-ancestor
110183490|NCT00030069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110183491|NCT00030069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110183492|NCT00030069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110183493|NCT00030069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110183494|NCT00030069|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110183495|NCT00030069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110183496|NCT00030069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110183497|NCT00030069|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110183498|NCT00030069|Vitamins|vitamins|mesh-ancestor
110183499|NCT00030069|Micronutrients|micronutrients|mesh-ancestor
110183500|NCT00030069|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110183501|NCT03958097|Antibodies|antibodies|mesh-list
110288143|NCT00216164|Antimetabolites|antimetabolites|mesh-ancestor
110183502|NCT03958097|Immunologic Factors|immunologic factors|mesh-ancestor
110183503|NCT03958097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110183504|NCT00030342|Interferons|interferons|mesh-list
110183505|NCT00030342|Interferon-alpha|interferon-alpha|mesh-list
110183506|NCT00030342|Fluorouracil|fluorouracil|mesh-list
110183507|NCT00030342|Sargramostim|sargramostim|mesh-list
110183508|NCT00030342|Antimetabolites|antimetabolites|mesh-ancestor
110183509|NCT00030342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110183510|NCT00030342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110183511|NCT00030342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110183512|NCT00030342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110183513|NCT00030342|Immunologic Factors|immunologic factors|mesh-ancestor
110183514|NCT00030342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110183515|NCT00030342|Antiviral Agents|antiviral agents|mesh-ancestor
110183516|NCT00030342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110183518|NCT00030381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110183519|NCT00030381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110183521|NCT00030420|Docetaxel|docetaxel|mesh-list
110183522|NCT00030420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110183523|NCT00030420|Tubulin Modulators|tubulin modulators|mesh-ancestor
110288192|NCT00241137|Valsartan|valsartan|mesh-list
110183527|NCT00030420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110183528|NCT00030420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110183529|NCT00030420|Analgesics|analgesics|mesh-ancestor
110183530|NCT00030420|Sensory System Agents|sensory system agents|mesh-ancestor
110183531|NCT00030420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110183532|NCT00030420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110183533|NCT00030420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110183534|NCT00030420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110183535|NCT00030420|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110183536|NCT00030420|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110183537|NCT00030420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110183538|NCT00030459|Vinorelbine|vinorelbine|mesh-list
110183539|NCT00030459|Mitomycins|mitomycins|mesh-list
110183540|NCT00030459|Mitomycin|mitomycin|mesh-list
110183541|NCT00030459|Vinblastine|vinblastine|mesh-list
110183542|NCT00030459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110183543|NCT00030459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110183544|NCT00030459|Tubulin Modulators|tubulin modulators|mesh-ancestor
110183545|NCT00030459|Antimitotic Agents|antimitotic agents|mesh-ancestor
110183546|NCT00030459|Mitosis Modulators|mitosis modulators|mesh-ancestor
110183547|NCT00030459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110183548|NCT00030459|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110183549|NCT00030459|Alkylating Agents|alkylating agents|mesh-ancestor
110183550|NCT00030459|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110183551|NCT00030459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110183552|NCT00030498|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110183553|NCT00030498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110183554|NCT00030498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110183555|NCT00030498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110183556|NCT00030498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110183557|NCT03873857|Venetoclax|venetoclax|mesh-list
110183558|NCT03873857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110183559|NCT03866408|Pioglitazone|pioglitazone|mesh-list
110183560|NCT03866408|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110183561|NCT03866408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110183562|NCT00030537|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110183563|NCT00030537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110183564|NCT00030537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110183565|NCT00030537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110183566|NCT00030537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110183567|NCT00030576|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110288332|NCT04662658|Anesthetics|anesthetics|mesh-ancestor
110183568|NCT00030576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110183569|NCT00030576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110183570|NCT00030576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110183571|NCT00030576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110183573|NCT00030615|Azacitidine|azacitidine|mesh-list
110183574|NCT00030615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110183575|NCT00030615|Antimetabolites|antimetabolites|mesh-ancestor
110183576|NCT00030615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110183577|NCT00030615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110183578|NCT00030615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110183579|NCT03857087|Edetic Acid|edetic acid|mesh-list
110183580|NCT03857087|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110183581|NCT03857087|Chelating Agents|chelating agents|mesh-ancestor
110183582|NCT03857087|Sequestering Agents|sequestering agents|mesh-ancestor
110183583|NCT03857087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110183584|NCT03857087|Anticoagulants|anticoagulants|mesh-ancestor
110183585|NCT03857087|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110183586|NCT03857087|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110217056|NCT00268333|Vitamins|vitamins|mesh-ancestor
110288367|NCT00216827|Hormones|hormones|mesh-ancestor
110288369|NCT00216827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110183588|NCT00030654|Vinblastine|vinblastine|mesh-list
110183589|NCT00030654|Docetaxel|docetaxel|mesh-list
110183590|NCT00030654|Doxorubicin|doxorubicin|mesh-list
110183591|NCT00030654|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110183592|NCT00030654|Bicalutamide|bicalutamide|mesh-list
110183593|NCT00030654|Flutamide|flutamide|mesh-list
110183594|NCT00030654|Estramustine|estramustine|mesh-list
110183595|NCT00030654|Hormones|hormones|mesh-list
110183596|NCT00030654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110183597|NCT00030654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110183598|NCT00030654|Tubulin Modulators|tubulin modulators|mesh-ancestor
110183599|NCT00030654|Antimitotic Agents|antimitotic agents|mesh-ancestor
110183600|NCT00030654|Mitosis Modulators|mitosis modulators|mesh-ancestor
110183601|NCT00030654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110183602|NCT00030654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110183603|NCT00030654|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110183604|NCT00030654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110183605|NCT00030654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110183606|NCT00030654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110183607|NCT00030654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110183608|NCT00030654|Antifungal Agents|antifungal agents|mesh-ancestor
110276782|NCT04659070|Antimetabolites|antimetabolites|mesh-ancestor
110183609|NCT00030654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110183610|NCT00030654|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110183611|NCT00030654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110183612|NCT00030654|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110183613|NCT00030654|Hormone Antagonists|hormone antagonists|mesh-ancestor
110183614|NCT00030654|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110183615|NCT00030654|Androgen Antagonists|androgen antagonists|mesh-ancestor
110183616|NCT00030654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110183617|NCT00030654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110183618|NCT00030654|Alkylating Agents|alkylating agents|mesh-ancestor
110183619|NCT03852407|Cyclophosphamide|cyclophosphamide|mesh-list
110183620|NCT03852407|Melphalan|melphalan|mesh-list
110183621|NCT03852407|Fludarabine|fludarabine|mesh-list
110183622|NCT03852407|Thymoglobulin|thymoglobulin|mesh-list
110183623|NCT03852407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110183624|NCT03852407|Immunologic Factors|immunologic factors|mesh-ancestor
110183625|NCT03852407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110183626|NCT03852407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110183627|NCT03852407|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110183628|NCT03852407|Alkylating Agents|alkylating agents|mesh-ancestor
110183629|NCT03852407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110183630|NCT03852407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110183631|NCT03852407|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110183632|NCT00030693|Metronidazole|metronidazole|mesh-list
110183633|NCT00030693|Vaccines|vaccines|mesh-list
110183634|NCT00030693|Immunologic Factors|immunologic factors|mesh-ancestor
110183635|NCT00030693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110183636|NCT00030693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110183637|NCT00030693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110183638|NCT00030693|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110183639|NCT00030693|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110183640|NCT03823274|Aspirin|aspirin|mesh-list
110183641|NCT03823274|Clopidogrel|clopidogrel|mesh-list
110183642|NCT03823274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110183643|NCT03823274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110183644|NCT03823274|Analgesics|analgesics|mesh-ancestor
110183645|NCT03823274|Sensory System Agents|sensory system agents|mesh-ancestor
110183646|NCT03823274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110288614|NCT04646317|Dexmedetomidine|dexmedetomidine|mesh-list
110183647|NCT03823274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110183649|NCT03823274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110183650|NCT03823274|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110183651|NCT03823274|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110183652|NCT03823274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110183653|NCT03823274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110183654|NCT03823274|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110183655|NCT03823274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110183656|NCT03823274|Antipyretics|antipyretics|mesh-ancestor
110183657|NCT03823274|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110183658|NCT03823274|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110183659|NCT03823274|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110183660|NCT03823274|Purinergic Agents|purinergic agents|mesh-ancestor
110183661|NCT03823274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110183663|NCT00030732|Capecitabine|capecitabine|mesh-list
110183664|NCT00030732|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110183665|NCT00030732|Antimetabolites|antimetabolites|mesh-ancestor
110288660|NCT00558376|Laxatives|laxatives|mesh-ancestor
110183666|NCT00030732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110183667|NCT00030732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110183668|NCT00030810|Docetaxel|docetaxel|mesh-list
110183669|NCT00030810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110183670|NCT00030810|Tubulin Modulators|tubulin modulators|mesh-ancestor
110183671|NCT00030810|Antimitotic Agents|antimitotic agents|mesh-ancestor
110183672|NCT00030810|Mitosis Modulators|mitosis modulators|mesh-ancestor
110183673|NCT00030810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110183674|NCT00030849|Interferons|interferons|mesh-list
110183675|NCT00030849|Interferon-alpha|interferon-alpha|mesh-list
110183676|NCT00030849|Bexarotene|bexarotene|mesh-list
110183677|NCT00030849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110183678|NCT00030849|Antiviral Agents|antiviral agents|mesh-ancestor
110183679|NCT00030849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110183680|NCT00030849|Immunologic Factors|immunologic factors|mesh-ancestor
110183681|NCT00030849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110183682|NCT00030888|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
110183683|NCT00030888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110217079|NCT00268372|Docetaxel|docetaxel|mesh-list
110183685|NCT00030888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110288701|NCT04644484|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110183686|NCT00030888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110183687|NCT00030966|Natalizumab|natalizumab|mesh-list
110183688|NCT00030966|Immunologic Factors|immunologic factors|mesh-ancestor
110183689|NCT00030966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110183690|NCT03715205|Pembrolizumab|pembrolizumab|mesh-list
110183691|NCT03715205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110183692|NCT03715205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110183693|NCT03715205|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110183694|NCT03715205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110183695|NCT00031044|Enfuvirtide|enfuvirtide|mesh-list
110183696|NCT00031044|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110183697|NCT00031044|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110183698|NCT00031044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110183699|NCT00031044|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110183700|NCT00031044|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110288746|NCT04643821|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110183701|NCT00031044|Antiviral Agents|antiviral agents|mesh-ancestor
110183702|NCT00031044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110183703|NCT03698006|Ropivacaine|ropivacaine|mesh-list
110183704|NCT03698006|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110183705|NCT03698006|Anesthetics, Local|anesthetics, local|mesh-ancestor
110183706|NCT03698006|Anesthetics|anesthetics|mesh-ancestor
110183707|NCT03698006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110183708|NCT03698006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110183709|NCT03698006|Sensory System Agents|sensory system agents|mesh-ancestor
110183710|NCT03698006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110183711|NCT00031083|Interferons|interferons|mesh-list
110183712|NCT00031083|Interferon-beta|interferon-beta|mesh-list
110183713|NCT00031083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110183714|NCT00031083|Antiviral Agents|antiviral agents|mesh-ancestor
110183715|NCT00031083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110183717|NCT00031083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110183718|NCT03559985|Acetaminophen|acetaminophen|mesh-list
110183719|NCT03559985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110183720|NCT03559985|Analgesics|analgesics|mesh-ancestor
110183721|NCT03559985|Sensory System Agents|sensory system agents|mesh-ancestor
110183722|NCT03559985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110183723|NCT03559985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110183724|NCT03559985|Antipyretics|antipyretics|mesh-ancestor
110183725|NCT04711863|Fluvoxamine|fluvoxamine|mesh-list
110183726|NCT04711863|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110183727|NCT04711863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110183728|NCT04711863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110183729|NCT04711863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110183730|NCT04711863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110183731|NCT04711863|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110288870|NCT00559312|Glucocorticoids|glucocorticoids|mesh-ancestor
110183732|NCT04711863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110183733|NCT04711863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110183734|NCT04711863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110183736|NCT04711863|Serotonin Agents|serotonin agents|mesh-ancestor
110183737|NCT04711863|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110183739|NCT04711863|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110183740|NCT04711863|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110183741|NCT04711863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110183742|NCT04711863|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110183743|NCT00392912|Methyltestosterone|methyltestosterone|mesh-list
110183744|NCT00392912|Testosterone|testosterone|mesh-list
110183745|NCT00392912|Testosterone undecanoate|testosterone undecanoate|mesh-list
110183746|NCT00392912|Testosterone enanthate|testosterone enanthate|mesh-list
110183747|NCT00392912|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110183748|NCT00392912|Androgens|androgens|mesh-ancestor
110183749|NCT00392912|Hormones|hormones|mesh-ancestor
110183750|NCT00392912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110183751|NCT00392912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110183752|NCT00392912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110183753|NCT00392912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110183754|NCT00392912|Anabolic Agents|anabolic agents|mesh-ancestor
110288982|NCT00218855|Growth Inhibitors|growth inhibitors|mesh-ancestor
110289002|NCT04628884|Heparin|heparin|mesh-list
110183755|NCT04712058|Tenofovir|tenofovir|mesh-list
110183756|NCT04712058|Emtricitabine|emtricitabine|mesh-list
110183757|NCT04712058|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
110183758|NCT04712058|Antiviral Agents|antiviral agents|mesh-ancestor
110183759|NCT04712058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110183760|NCT04712058|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110183761|NCT04712058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110183762|NCT04712058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110183763|NCT04712058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110183764|NCT04712058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110183765|NCT04712058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110183766|NCT00393107|Cyclophosphamide|cyclophosphamide|mesh-list
110183767|NCT00393107|Rituximab|rituximab|mesh-list
110183768|NCT00393107|Fludarabine|fludarabine|mesh-list
110183769|NCT00393107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110183770|NCT00393107|Immunologic Factors|immunologic factors|mesh-ancestor
110183771|NCT00393107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110183772|NCT00393107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110183773|NCT00393107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110183774|NCT00393107|Alkylating Agents|alkylating agents|mesh-ancestor
110183775|NCT00393107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110183776|NCT00393107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110183777|NCT00393107|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110183778|NCT00393107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110183780|NCT04711668|Ketamine|ketamine|mesh-list
110183781|NCT04711668|Anesthetics, Local|anesthetics, local|mesh-ancestor
110183782|NCT04711668|Anesthetics|anesthetics|mesh-ancestor
110183783|NCT04711668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110183784|NCT04711668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110183785|NCT04711668|Sensory System Agents|sensory system agents|mesh-ancestor
110217138|NCT00073814|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110183786|NCT04711668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110183787|NCT04711668|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110289089|NCT00561691|Nimotuzumab|nimotuzumab|mesh-list
110183788|NCT04711668|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110183789|NCT04711668|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110183790|NCT04711668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110183791|NCT04711668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110183793|NCT04711668|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110183795|NCT04711668|Anesthetics, General|anesthetics, general|mesh-ancestor
110183796|NCT04711668|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110276929|NCT00205491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110183797|NCT04711668|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110183798|NCT04711668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110183800|NCT00031161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110183801|NCT00031161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110183802|NCT00031278|Trastuzumab|trastuzumab|mesh-list
110183803|NCT00031278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110183804|NCT00031278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110183805|NCT00031317|Clozapine|clozapine|mesh-list
110183806|NCT00031317|Paroxetine|paroxetine|mesh-list
110183807|NCT00031317|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110183808|NCT00031317|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110183809|NCT00031317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110183810|NCT00031317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110183811|NCT00031317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110183812|NCT00031317|Serotonin Agents|serotonin agents|mesh-ancestor
110183813|NCT00031317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110183814|NCT00031317|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110183815|NCT00031317|Antidepressive Agents|antidepressive agents|mesh-ancestor
110183816|NCT00031317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110183817|NCT00031317|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110183818|NCT00031317|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110183819|NCT00031317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110183820|NCT00031317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110183821|NCT00031317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110183822|NCT00031317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110183823|NCT00031317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110183824|NCT00031317|GABA Antagonists|gaba antagonists|mesh-ancestor
110183826|NCT00396045|Lenalidomide|lenalidomide|mesh-list
110183827|NCT00396045|Immunologic Factors|immunologic factors|mesh-ancestor
110183828|NCT00396045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110183829|NCT00396045|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110183830|NCT00396045|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110183831|NCT00396045|Growth Substances|growth substances|mesh-ancestor
110183832|NCT00396045|Growth Inhibitors|growth inhibitors|mesh-ancestor
110183833|NCT00396045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110183834|NCT00396240|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110183835|NCT00396240|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110183836|NCT00396240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110183837|NCT00396240|Antimetabolites|antimetabolites|mesh-ancestor
110183838|NCT00396240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110183839|NCT00396240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110183840|NCT00396240|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110183841|NCT00396240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110183842|NCT00031395|Clonidine|clonidine|mesh-list
110183843|NCT00031395|Methylphenidate|methylphenidate|mesh-list
110183844|NCT00031395|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110183845|NCT00031395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110183846|NCT00031395|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110183847|NCT00031395|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110183848|NCT00031395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110217162|NCT00102453|Antioxidants|antioxidants|mesh-ancestor
110183850|NCT00031395|Dopamine Agents|dopamine agents|mesh-ancestor
110183851|NCT00031395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110183853|NCT00031395|Sensory System Agents|sensory system agents|mesh-ancestor
110289330|NCT04624360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110183855|NCT00031395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110183856|NCT00031395|Sympatholytics|sympatholytics|mesh-ancestor
110183857|NCT00031395|Autonomic Agents|autonomic agents|mesh-ancestor
110183858|NCT00031395|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110183859|NCT00031395|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110183860|NCT00031395|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110183861|NCT00031395|Adrenergic Agents|adrenergic agents|mesh-ancestor
110183863|NCT00031434|Ganciclovir|ganciclovir|mesh-list
110183864|NCT00031434|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
110183865|NCT00031434|Antiviral Agents|antiviral agents|mesh-ancestor
110183866|NCT00031434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110183867|NCT00031434|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110183868|NCT00031434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110183869|NCT00031434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110183870|NCT03152123|Phentermine|phentermine|mesh-list
110183871|NCT03152123|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110183873|NCT03152123|Appetite Depressants|appetite depressants|mesh-ancestor
110183874|NCT03152123|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110183875|NCT03152123|Sympathomimetics|sympathomimetics|mesh-ancestor
110183876|NCT03152123|Autonomic Agents|autonomic agents|mesh-ancestor
110183877|NCT03152123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110183878|NCT03152123|Adrenergic Agents|adrenergic agents|mesh-ancestor
110183879|NCT03152123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110183880|NCT03152123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110183881|NCT00031473|Ribavirin|ribavirin|mesh-list
110183882|NCT00031473|Antimetabolites|antimetabolites|mesh-ancestor
110183883|NCT00031473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110183884|NCT00031473|Antiviral Agents|antiviral agents|mesh-ancestor
110183885|NCT00031473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110183886|NCT00031629|Gemcitabine|gemcitabine|mesh-list
110183887|NCT00031629|Docetaxel|docetaxel|mesh-list
110183888|NCT00031629|Lenograstim|lenograstim|mesh-list
110183889|NCT00031629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110183890|NCT00031629|Antimetabolites|antimetabolites|mesh-ancestor
110183891|NCT00031629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110183892|NCT00031629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110183893|NCT00031629|Tubulin Modulators|tubulin modulators|mesh-ancestor
110183894|NCT00031629|Antimitotic Agents|antimitotic agents|mesh-ancestor
110183895|NCT00031629|Mitosis Modulators|mitosis modulators|mesh-ancestor
110183896|NCT00031629|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110183897|NCT00031629|Immunologic Factors|immunologic factors|mesh-ancestor
110183898|NCT00031629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110183901|NCT03152084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110183902|NCT03152084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110183903|NCT03152084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110183905|NCT00031707|Megestrol Acetate|megestrol acetate|mesh-list
110183906|NCT00031707|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110183907|NCT00031707|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110183908|NCT00031707|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110183910|NCT00031707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110183911|NCT00031707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110183912|NCT00031707|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110183913|NCT00031707|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110183916|NCT00031707|Appetite Stimulants|appetite stimulants|mesh-ancestor
110183917|NCT00031707|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110277020|NCT00178100|Paroxetine|paroxetine|mesh-list
110183919|NCT00031746|Chelating Agents|chelating agents|mesh-ancestor
110183920|NCT00031746|Sequestering Agents|sequestering agents|mesh-ancestor
110183921|NCT00031746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110183922|NCT00031785|Megestrol|megestrol|mesh-list
110183923|NCT00031785|Megestrol Acetate|megestrol acetate|mesh-list
110183924|NCT00031785|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110183925|NCT00031785|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110183926|NCT00031785|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110183927|NCT00031785|Contraceptive Agents|contraceptive agents|mesh-ancestor
110183928|NCT00031785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110183929|NCT00031785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110183930|NCT00031785|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110183931|NCT00031785|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110183932|NCT00031785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110183933|NCT00031785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110183934|NCT00031785|Appetite Stimulants|appetite stimulants|mesh-ancestor
110183935|NCT00031785|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110183936|NCT03151772|Metformin|metformin|mesh-list
110183937|NCT03151772|Disulfiram|disulfiram|mesh-list
110183938|NCT03151772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110183939|NCT03151772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110183940|NCT03151772|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110183941|NCT03151772|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
110183942|NCT03151772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110183943|NCT03151772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110183945|NCT02971644|Trace Elements|trace elements|mesh-ancestor
110183946|NCT02971644|Micronutrients|micronutrients|mesh-ancestor
110183947|NCT02971644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110183948|NCT00031824|Cyclosporine|cyclosporine|mesh-list
110183949|NCT00031824|Hydroxychloroquine|hydroxychloroquine|mesh-list
110183951|NCT00031824|Tacrolimus|tacrolimus|mesh-list
110183952|NCT00031824|Cyclosporins|cyclosporins|mesh-list
110183953|NCT00031824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110183954|NCT00031824|Glucocorticoids|glucocorticoids|mesh-ancestor
110183955|NCT00031824|Hormones|hormones|mesh-ancestor
110183956|NCT00031824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110183957|NCT00031824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110183958|NCT00031824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110183960|NCT00031824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110183961|NCT00031824|Immunologic Factors|immunologic factors|mesh-ancestor
110183962|NCT00031824|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110183963|NCT00031824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110183964|NCT00031824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110183965|NCT00031824|Antifungal Agents|antifungal agents|mesh-ancestor
110183966|NCT00031824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110183967|NCT00031824|Dermatologic Agents|dermatologic agents|mesh-ancestor
110183968|NCT00031824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110183969|NCT00031824|Antimalarials|antimalarials|mesh-ancestor
110183970|NCT00031824|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110183971|NCT00031824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110183972|NCT00031863|Rofecoxib|rofecoxib|mesh-list
110183973|NCT00031863|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110183974|NCT00031863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110183975|NCT00031863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110183976|NCT00031863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110183977|NCT00031863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110183978|NCT00031863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110183980|NCT00031863|Sensory System Agents|sensory system agents|mesh-ancestor
110217179|NCT00268684|Temozolomide|temozolomide|mesh-list
110183981|NCT00031863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110183982|NCT00031863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110183983|NCT00031863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110183984|NCT00031863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110183985|NCT03151616|Cholinergic Antagonists|cholinergic antagonists|mesh-list
110183986|NCT03151616|Cholinergic Agents|cholinergic agents|mesh-ancestor
110183987|NCT03151616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110183988|NCT03151616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110277144|NCT00558142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110277145|NCT00558142|Expectorants|expectorants|mesh-ancestor
110277146|NCT00558142|Respiratory System Agents|respiratory system agents|mesh-ancestor
110277147|NCT00558142|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110289667|NCT00243204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110183989|NCT03151616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110183992|NCT00031902|Vincristine|vincristine|mesh-list
110183994|NCT00031902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110183995|NCT00031902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110183996|NCT00031902|Immunologic Factors|immunologic factors|mesh-ancestor
110183997|NCT00031902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110183998|NCT00031902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110184000|NCT00031902|Tubulin Modulators|tubulin modulators|mesh-ancestor
110184001|NCT00031902|Antimitotic Agents|antimitotic agents|mesh-ancestor
110184002|NCT00031902|Mitosis Modulators|mitosis modulators|mesh-ancestor
110184003|NCT00031902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110184004|NCT00031902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110184005|NCT00031902|Glucocorticoids|glucocorticoids|mesh-ancestor
110184006|NCT00031902|Hormones|hormones|mesh-ancestor
110184007|NCT00031902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110184008|NCT00031902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110184009|NCT00031902|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110184010|NCT00031941|Lenalidomide|lenalidomide|mesh-list
110184011|NCT00031941|Immunologic Factors|immunologic factors|mesh-ancestor
110289756|NCT00247494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110184012|NCT00031941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110184013|NCT00031941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110184014|NCT00031941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110184015|NCT00031941|Growth Substances|growth substances|mesh-ancestor
110184016|NCT00031941|Growth Inhibitors|growth inhibitors|mesh-ancestor
110184017|NCT00031941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110184018|NCT00031980|Cyclosporine|cyclosporine|mesh-list
110184019|NCT00031980|Cyclosporins|cyclosporins|mesh-list
110184020|NCT00031980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110184021|NCT00031980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110184022|NCT00031980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110184023|NCT00031980|Immunologic Factors|immunologic factors|mesh-ancestor
110184024|NCT00031980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110184025|NCT00031980|Antifungal Agents|antifungal agents|mesh-ancestor
110184026|NCT00031980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110184027|NCT00031980|Dermatologic Agents|dermatologic agents|mesh-ancestor
110184028|NCT00031980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110184029|NCT00031980|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110184030|NCT03151499|Rifampin|rifampin|mesh-list
110184031|NCT03151499|BI 409306|bi 409306|mesh-list
110184032|NCT03151499|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110184033|NCT03151499|Antitubercular Agents|antitubercular agents|mesh-ancestor
110289808|NCT04617613|Metronidazole|metronidazole|mesh-list
110184034|NCT03151499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110184035|NCT03151499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110184036|NCT03151499|Leprostatic Agents|leprostatic agents|mesh-ancestor
110184037|NCT03151499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110184038|NCT03151499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110184039|NCT03151499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110184040|NCT03151499|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110184041|NCT03151499|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110184042|NCT03151499|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110184043|NCT03151499|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110184044|NCT03151499|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110184045|NCT03151499|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110184046|NCT03151499|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110184053|NCT00032019|Vincristine|vincristine|mesh-list
110184054|NCT00032019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110184055|NCT00032019|Immunologic Factors|immunologic factors|mesh-ancestor
110184056|NCT00032019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110184057|NCT00032019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110184058|NCT00032019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110184059|NCT00032019|Alkylating Agents|alkylating agents|mesh-ancestor
110184060|NCT00032019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110184061|NCT00032019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110184062|NCT00032019|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110184063|NCT00032019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110184064|NCT00032019|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110184065|NCT00032019|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110184066|NCT00032019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110184067|NCT00032019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110184068|NCT00032019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110184069|NCT00032019|Glucocorticoids|glucocorticoids|mesh-ancestor
110184070|NCT00032019|Hormones|hormones|mesh-ancestor
110184071|NCT00032019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110184072|NCT00032019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110184073|NCT00032019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110184074|NCT00032019|Tubulin Modulators|tubulin modulators|mesh-ancestor
110184075|NCT00032019|Antimitotic Agents|antimitotic agents|mesh-ancestor
110184076|NCT00032019|Mitosis Modulators|mitosis modulators|mesh-ancestor
110184078|NCT03151460|Dopamine Agents|dopamine agents|mesh-list
110184079|NCT03151460|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110184080|NCT03151460|Sympathomimetics|sympathomimetics|mesh-ancestor
110184081|NCT03151460|Autonomic Agents|autonomic agents|mesh-ancestor
110184082|NCT03151460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110184083|NCT03151460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110184084|NCT03151460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110184085|NCT03151460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110184086|NCT03151460|Protective Agents|protective agents|mesh-ancestor
110184087|NCT00032097|Motexafin gadolinium|motexafin gadolinium|mesh-list
110184088|NCT00032097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110184089|NCT00032097|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110184090|NCT00032097|Dermatologic Agents|dermatologic agents|mesh-ancestor
110184091|NCT03151382|Tandospirone|tandospirone|mesh-list
110184092|NCT03151382|Donepezil|donepezil|mesh-list
110184093|NCT03151382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110184094|NCT03151382|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110184096|NCT03151382|Cholinergic Agents|cholinergic agents|mesh-ancestor
110184097|NCT03151382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110184098|NCT03151382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110184100|NCT03151382|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110184101|NCT03151382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110184103|NCT03151382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110184104|NCT03151382|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110184105|NCT03151382|Serotonin Agents|serotonin agents|mesh-ancestor
110184106|NCT00032136|Tamoxifen|tamoxifen|mesh-list
110184107|NCT00032136|Exemestane|exemestane|mesh-list
110184108|NCT00032136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110184109|NCT00032136|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110184112|NCT00032136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110184113|NCT00032136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110184114|NCT00032136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110184115|NCT00032136|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110184116|NCT00032136|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110184117|NCT00032136|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110184118|NCT00032136|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110184119|NCT00032136|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110184120|NCT00032136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110184121|NCT03151343|Empagliflozin|empagliflozin|mesh-list
110184122|NCT03151343|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110184123|NCT03151343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110184124|NCT03151343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110184125|NCT03151343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110184126|NCT00032175|Gemcitabine|gemcitabine|mesh-list
110184127|NCT00032175|Capecitabine|capecitabine|mesh-list
110184128|NCT00032175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110184129|NCT00032175|Antimetabolites|antimetabolites|mesh-ancestor
110184130|NCT00032175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110184131|NCT00032175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110184132|NCT04712279|Hydroxychloroquine|hydroxychloroquine|mesh-list
110184133|NCT04712279|Ivermectin|ivermectin|mesh-list
110184134|NCT04712279|Antimalarials|antimalarials|mesh-ancestor
110184135|NCT04712279|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110184136|NCT04712279|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110184137|NCT04712279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110184138|NCT04712279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110184139|NCT04712279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110184140|NCT04712279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110184142|NCT00032292|Immunologic Factors|immunologic factors|mesh-ancestor
110184143|NCT00032292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110184145|NCT03150914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110184146|NCT03150914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110184147|NCT03150914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110184148|NCT03150914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110184149|NCT03150914|Antifungal Agents|antifungal agents|mesh-ancestor
110184150|NCT03150914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110184151|NCT03150914|Immunologic Factors|immunologic factors|mesh-ancestor
110290021|NCT04615702|Antioxidants|antioxidants|mesh-ancestor
110184152|NCT03150914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110184153|NCT00032799|Natalizumab|natalizumab|mesh-list
110184154|NCT00032799|Immunologic Factors|immunologic factors|mesh-ancestor
110184155|NCT00032799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110184156|NCT03150836|Durvalumab|durvalumab|mesh-list
110184157|NCT03150836|Tremelimumab|tremelimumab|mesh-list
110184158|NCT03150836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110184159|NCT03150836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110184160|NCT00032838|Yohimbine|yohimbine|mesh-list
110184161|NCT00032838|Mydriatics|mydriatics|mesh-ancestor
110184162|NCT00032838|Autonomic Agents|autonomic agents|mesh-ancestor
110184163|NCT00032838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110184164|NCT00032838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110184165|NCT00032838|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110184166|NCT00032838|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110184168|NCT00032838|Adrenergic Agents|adrenergic agents|mesh-ancestor
110184169|NCT00032838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110184170|NCT00032838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110184171|NCT00032838|Urological Agents|urological agents|mesh-ancestor
110184172|NCT03150797|Melatonin|melatonin|mesh-list
110184173|NCT03150797|Antioxidants|antioxidants|mesh-ancestor
110184174|NCT03150797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110184175|NCT03150797|Protective Agents|protective agents|mesh-ancestor
110184177|NCT03150797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110184178|NCT03150680|Clopidogrel|clopidogrel|mesh-list
110184179|NCT03150680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110184180|NCT03150680|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110184181|NCT03150680|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110184182|NCT03150680|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110184183|NCT03150680|Purinergic Agents|purinergic agents|mesh-ancestor
110184184|NCT03150680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110184185|NCT03150680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110184186|NCT03150680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110184187|NCT00396396|Acetylcysteine|acetylcysteine|mesh-list
110184188|NCT00396396|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110184189|NCT00396396|Antiviral Agents|antiviral agents|mesh-ancestor
110290200|NCT00222053|Diphosphonates|diphosphonates|mesh-list
110184190|NCT00396396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110184191|NCT00396396|Expectorants|expectorants|mesh-ancestor
110184192|NCT00396396|Respiratory System Agents|respiratory system agents|mesh-ancestor
110184193|NCT00396396|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110184195|NCT00396396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110184196|NCT00396396|Protective Agents|protective agents|mesh-ancestor
110184197|NCT00396396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110184198|NCT00396396|Antidotes|antidotes|mesh-ancestor
110184199|NCT00032955|Buprenorphine|buprenorphine|mesh-list
110184200|NCT00032955|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
110290253|NCT00563875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110184201|NCT00032955|Naloxone|naloxone|mesh-list
110184202|NCT00032955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110184203|NCT00032955|Narcotics|narcotics|mesh-ancestor
110184204|NCT00032955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110184205|NCT00032955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110184207|NCT00032955|Sensory System Agents|sensory system agents|mesh-ancestor
110184208|NCT00032955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110184209|NCT00032955|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110184210|NCT03150524|Verapamil|verapamil|mesh-list
110184211|NCT03150524|Nimodipine|nimodipine|mesh-list
110184212|NCT03150524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110290307|NCT00251550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110184213|NCT03150524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110184214|NCT03150524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110184216|NCT03150524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110184217|NCT03150524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110184218|NCT03150524|Vasodilator Agents|vasodilator agents|mesh-ancestor
110184219|NCT03150524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110184220|NCT00033033|Reserpine|reserpine|mesh-list
110184221|NCT00033033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110184222|NCT00033033|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110184223|NCT00033033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110184224|NCT00033033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110184228|NCT00033033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110290366|NCT04610125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110184229|NCT00033033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110184230|NCT00033033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110184231|NCT00033033|Adrenergic Agents|adrenergic agents|mesh-ancestor
110184232|NCT00033033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110184234|NCT03150368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110184235|NCT03150368|Tubulin Modulators|tubulin modulators|mesh-ancestor
110184236|NCT03150368|Antimitotic Agents|antimitotic agents|mesh-ancestor
110184237|NCT03150368|Mitosis Modulators|mitosis modulators|mesh-ancestor
110184238|NCT03150368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110184240|NCT00033072|Antidepressive Agents|antidepressive agents|mesh-ancestor
110184241|NCT00033072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110184242|NCT00033072|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110184243|NCT00033072|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110184244|NCT00033072|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110184245|NCT00033072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110184248|NCT00033072|Protective Agents|protective agents|mesh-ancestor
110184249|NCT00033072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110184250|NCT03150290|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110184251|NCT03150290|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110184252|NCT03150290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110184254|NCT00033111|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110184255|NCT00033111|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110290483|NCT00564538|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110184259|NCT00033111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110184260|NCT00033111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110184261|NCT00033189|Ubiquinone|ubiquinone|mesh-list
110184262|NCT00033189|Coenzyme Q10|coenzyme q10|mesh-list
110184263|NCT00033189|Micronutrients|micronutrients|mesh-ancestor
110184264|NCT00033189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110184265|NCT00033189|Vitamins|vitamins|mesh-ancestor
110184266|NCT00033267|Sirolimus|sirolimus|mesh-list
110184267|NCT00033267|Temsirolimus|temsirolimus|mesh-list
110184268|NCT00033267|MTOR Inhibitors|mtor inhibitors|mesh-list
110184269|NCT00033267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110184270|NCT00033267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110184271|NCT00033267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290520|NCT00199160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110184272|NCT00033267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110184273|NCT00033267|Immunologic Factors|immunologic factors|mesh-ancestor
110184274|NCT00033267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110184275|NCT00033267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110184276|NCT00033267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110184277|NCT00033267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110184278|NCT00033267|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110184279|NCT00033267|Antifungal Agents|antifungal agents|mesh-ancestor
110184281|NCT00033306|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110184282|NCT00033306|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110184283|NCT00033306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110184284|NCT00033306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110184285|NCT00033306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110184287|NCT02984384|Heparin|heparin|mesh-list
110184288|NCT02984384|Enoxaparin|enoxaparin|mesh-list
110184289|NCT02984384|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110184290|NCT02984384|Tinzaparin|tinzaparin|mesh-list
110184291|NCT02984384|Dalteparin|dalteparin|mesh-list
110184292|NCT02984384|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110184293|NCT02984384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110184294|NCT02984384|Analgesics|analgesics|mesh-ancestor
110184295|NCT02984384|Sensory System Agents|sensory system agents|mesh-ancestor
110184296|NCT02984384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110184297|NCT02984384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110184298|NCT02984384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110184299|NCT02984384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110184300|NCT02984384|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110184301|NCT02984384|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110184302|NCT02984384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110184303|NCT02984384|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110184304|NCT02984384|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110184305|NCT02984384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110184306|NCT02984384|Antipyretics|antipyretics|mesh-ancestor
110184307|NCT02984384|Anticoagulants|anticoagulants|mesh-ancestor
110184309|NCT00033345|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110184310|NCT00033345|Protective Agents|protective agents|mesh-ancestor
110184311|NCT00033345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110184312|NCT00033345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110184314|NCT00033423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110184316|NCT00033423|Immunologic Factors|immunologic factors|mesh-ancestor
110184317|NCT00033423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110184318|NCT00033423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110184319|NCT00033462|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110184320|NCT00033462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110184321|NCT00033462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110184322|NCT00033462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110184323|NCT00033462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110184325|NCT00393263|Pimecrolimus|pimecrolimus|mesh-list
110184326|NCT00393263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110184327|NCT00393263|Glucocorticoids|glucocorticoids|mesh-ancestor
110184328|NCT00393263|Hormones|hormones|mesh-ancestor
110184329|NCT00393263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110184330|NCT00393263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110184331|NCT00393263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110184333|NCT00393263|Analgesics|analgesics|mesh-ancestor
110184334|NCT00393263|Sensory System Agents|sensory system agents|mesh-ancestor
110184335|NCT00393263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110184336|NCT00393263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110184337|NCT00393263|Dermatologic Agents|dermatologic agents|mesh-ancestor
110184338|NCT00393263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110184339|NCT00393263|Immunologic Factors|immunologic factors|mesh-ancestor
110184340|NCT00393263|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110184341|NCT00393263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110184342|NCT00393263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110184343|NCT00033618|Epothilones|epothilones|mesh-list
110184344|NCT00033618|Epothilone B|epothilone b|mesh-list
110290680|NCT00251940|Glyburide|glyburide|mesh-list
110184345|NCT00033618|Tubulin Modulators|tubulin modulators|mesh-ancestor
110184346|NCT00033618|Antimitotic Agents|antimitotic agents|mesh-ancestor
110184348|NCT00033618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110184349|NCT00033618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110184351|NCT00033696|Etoposide|etoposide|mesh-list
110184352|NCT00033696|Carboplatin|carboplatin|mesh-list
110184353|NCT00033696|Topotecan|topotecan|mesh-list
110184354|NCT00033696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110184355|NCT00033696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110184356|NCT00033696|Tubulin Modulators|tubulin modulators|mesh-ancestor
110184357|NCT00033696|Antimitotic Agents|antimitotic agents|mesh-ancestor
110184358|NCT00033696|Mitosis Modulators|mitosis modulators|mesh-ancestor
110184359|NCT00033696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110184360|NCT00033696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110184361|NCT00033696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110184362|NCT00033696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110184363|NCT00033696|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110184364|NCT02548559|Cannabidiol|cannabidiol|mesh-list
110184365|NCT02548559|Anticonvulsants|anticonvulsants|mesh-ancestor
110184366|NCT00033735|Fluorouracil|fluorouracil|mesh-list
110184367|NCT00033735|Irofulven|irofulven|mesh-list
110184368|NCT00033735|Antimetabolites|antimetabolites|mesh-ancestor
110184369|NCT00033735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110184370|NCT00033735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110184371|NCT00033735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110184372|NCT00033735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110184373|NCT00033735|Immunologic Factors|immunologic factors|mesh-ancestor
110184374|NCT00033735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110184375|NCT00033735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110184376|NCT00033735|Alkylating Agents|alkylating agents|mesh-ancestor
110184377|NCT00033813|Oxatomide|oxatomide|mesh-list
110184378|NCT00033813|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110184379|NCT00033813|Histamine Antagonists|histamine antagonists|mesh-ancestor
110184380|NCT00033813|Histamine Agents|histamine agents|mesh-ancestor
110184381|NCT00033813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110184382|NCT00033813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110184383|NCT00033813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110184384|NCT00033813|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110184385|NCT00033813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110184386|NCT00033813|Respiratory System Agents|respiratory system agents|mesh-ancestor
110184388|NCT00033891|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110184389|NCT00033891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110184390|NCT00033891|Dermatologic Agents|dermatologic agents|mesh-ancestor
110184391|NCT00033891|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110184392|NCT00033891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110184393|NCT02271893|Dextromethorphan|dextromethorphan|mesh-list
110184394|NCT02271893|Antitussive Agents|antitussive agents|mesh-ancestor
110184395|NCT02271893|Respiratory System Agents|respiratory system agents|mesh-ancestor
110184396|NCT02271893|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110184397|NCT02271893|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110184398|NCT02271893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110184399|NCT02271893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110184400|NCT02271893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110184402|NCT02149823|Oxytocics|oxytocics|mesh-ancestor
110184403|NCT02149823|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110184404|NCT02149823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110184405|NCT02971410|Simvastatin|simvastatin|mesh-list
110184406|NCT02971410|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110184407|NCT02971410|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110184408|NCT02971410|Antimetabolites|antimetabolites|mesh-ancestor
110184409|NCT02971410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110184410|NCT02971410|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110290831|NCT00252330|Amibegron|amibegron|mesh-list
110184411|NCT02971410|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110184412|NCT02971410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110184413|NCT02035397|Botulinum Toxins|botulinum toxins|mesh-list
110184414|NCT02035397|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110184415|NCT02035397|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110184416|NCT02035397|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110184417|NCT02035397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110184418|NCT02035397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110184419|NCT02035397|Cholinergic Agents|cholinergic agents|mesh-ancestor
110184420|NCT02035397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110184421|NCT02035397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110184422|NCT02035397|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110184423|NCT02035397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110184425|NCT00034047|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110184426|NCT00034047|Fertility Agents|fertility agents|mesh-ancestor
110184427|NCT00034047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110184428|NCT00034047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110184429|NCT00034086|Ritonavir|ritonavir|mesh-list
110184430|NCT00034086|Lopinavir|lopinavir|mesh-list
110184431|NCT00034086|Tenofovir|tenofovir|mesh-list
110184432|NCT00034086|Lamivudine|lamivudine|mesh-list
110184433|NCT00034086|Zidovudine|zidovudine|mesh-list
110184434|NCT00034086|Stavudine|stavudine|mesh-list
110184435|NCT00034086|Didanosine|didanosine|mesh-list
110184436|NCT00034086|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
110184437|NCT00034086|Vaccines|vaccines|mesh-list
110184438|NCT00034086|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110184439|NCT00034086|Immunologic Factors|immunologic factors|mesh-ancestor
110184440|NCT00034086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110184441|NCT00034086|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110184442|NCT00034086|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110184443|NCT00034086|Protease Inhibitors|protease inhibitors|mesh-ancestor
110184444|NCT00034086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110184445|NCT00034086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110184446|NCT00034086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110184447|NCT00034086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110184448|NCT00034086|Antiviral Agents|antiviral agents|mesh-ancestor
110184449|NCT00034086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110217294|NCT00074087|Doxorubicin|doxorubicin|mesh-list
110184450|NCT00034086|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110184451|NCT00034086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110184452|NCT00034086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110184453|NCT00034086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110184454|NCT00034086|Antimetabolites|antimetabolites|mesh-ancestor
110184455|NCT00034125|Tamoxifen|tamoxifen|mesh-list
110184456|NCT00034125|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110184457|NCT00034125|Hormone Antagonists|hormone antagonists|mesh-ancestor
110184458|NCT00034125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110184459|NCT00034125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110184460|NCT00034125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110184461|NCT00034125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110184462|NCT00034125|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110184463|NCT00034125|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110184464|NCT00034125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110184465|NCT00034164|Paclitaxel|paclitaxel|mesh-list
110184466|NCT00034164|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110184467|NCT00034164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110184468|NCT00034164|Tubulin Modulators|tubulin modulators|mesh-ancestor
110184469|NCT00034164|Antimitotic Agents|antimitotic agents|mesh-ancestor
110184470|NCT00034164|Mitosis Modulators|mitosis modulators|mesh-ancestor
110052871|NCT01482442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110184471|NCT00034164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110184472|NCT00034242|Immunoglobulins|immunoglobulins|mesh-list
110184473|NCT00034242|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110184474|NCT00034242|Antibodies|antibodies|mesh-list
110184475|NCT00034242|gamma-Globulins|gamma-globulins|mesh-list
110184476|NCT00034242|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110184477|NCT00034242|Immunologic Factors|immunologic factors|mesh-ancestor
110184478|NCT00034242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110184479|NCT01807325|Pancrelipase|pancrelipase|mesh-list
110184480|NCT01807325|Pancreatin|pancreatin|mesh-list
110184481|NCT01807325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110184482|NCT01807286|Dexamethasone|dexamethasone|mesh-list
110184483|NCT01807286|Melphalan|melphalan|mesh-list
110184484|NCT01807286|Pomalidomide|pomalidomide|mesh-list
110184485|NCT01807286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110184486|NCT01807286|Antiemetics|antiemetics|mesh-ancestor
110184487|NCT01807286|Autonomic Agents|autonomic agents|mesh-ancestor
110184488|NCT01807286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110184489|NCT01807286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110184490|NCT01807286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110184491|NCT01807286|Glucocorticoids|glucocorticoids|mesh-ancestor
110184492|NCT01807286|Hormones|hormones|mesh-ancestor
110184493|NCT01807286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110184494|NCT01807286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110184495|NCT01807286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110184496|NCT01807286|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110184497|NCT01807286|Alkylating Agents|alkylating agents|mesh-ancestor
110184498|NCT01807286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110184499|NCT01807286|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110217303|NCT00269542|Folic Acid|folic acid|mesh-list
110184500|NCT01807286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110184501|NCT01807286|Immunologic Factors|immunologic factors|mesh-ancestor
110184502|NCT01807286|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110184503|NCT01807286|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110184504|NCT01807286|Growth Substances|growth substances|mesh-ancestor
110184505|NCT01807286|Growth Inhibitors|growth inhibitors|mesh-ancestor
110184507|NCT00034359|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110184508|NCT00034359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110184509|NCT00034359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110184510|NCT00034359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110184511|NCT00034359|Antiviral Agents|antiviral agents|mesh-ancestor
110184512|NCT00034359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110184513|NCT00034359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110184514|NCT00034359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110184515|NCT00034593|Gemcitabine|gemcitabine|mesh-list
110184516|NCT00034593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110184517|NCT00034593|Antimetabolites|antimetabolites|mesh-ancestor
110184518|NCT00034593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110184519|NCT00034593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110184520|NCT00034632|Posaconazole|posaconazole|mesh-list
110184521|NCT00034632|Antifungal Agents|antifungal agents|mesh-ancestor
110184522|NCT00034632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110184523|NCT00034632|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110184524|NCT00034632|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110184525|NCT00034632|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110184526|NCT00034632|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110184527|NCT00034632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110184528|NCT00034632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110184529|NCT00034632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110184530|NCT00034632|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110184531|NCT00034632|Hormone Antagonists|hormone antagonists|mesh-ancestor
110184532|NCT00034632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110184533|NCT00034632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110184534|NCT00034671|Posaconazole|posaconazole|mesh-list
110184535|NCT00034671|Antifungal Agents|antifungal agents|mesh-ancestor
110184536|NCT00034671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110184537|NCT00034671|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110184538|NCT00034671|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110184539|NCT00034671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110184540|NCT00034671|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110184541|NCT00034671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110184542|NCT00034671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110184543|NCT00034671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110184544|NCT00034671|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110184545|NCT00034671|Hormone Antagonists|hormone antagonists|mesh-ancestor
110184546|NCT00034671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110184547|NCT00034671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110184548|NCT01806857|Quinidine|quinidine|mesh-list
110184549|NCT01806857|Dextromethorphan|dextromethorphan|mesh-list
110184550|NCT01806857|Antitussive Agents|antitussive agents|mesh-ancestor
110184551|NCT01806857|Respiratory System Agents|respiratory system agents|mesh-ancestor
110184552|NCT01806857|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110184553|NCT01806857|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110184554|NCT01806857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110184556|NCT01806857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110184557|NCT01806857|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110184558|NCT01806857|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110184559|NCT01806857|Adrenergic Agents|adrenergic agents|mesh-ancestor
110184560|NCT01806857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110184561|NCT01806857|Antimalarials|antimalarials|mesh-ancestor
110184562|NCT01806857|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110184563|NCT01806857|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110184564|NCT01806857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110184565|NCT01806857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110184566|NCT01806857|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110184567|NCT01806857|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110184569|NCT01806857|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110184570|NCT01806857|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110184571|NCT01806857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110184572|NCT01806857|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110184573|NCT01806857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110184575|NCT00034710|Antipruritics|antipruritics|mesh-ancestor
110184576|NCT00034710|Dermatologic Agents|dermatologic agents|mesh-ancestor
110184577|NCT00034710|Sensory System Agents|sensory system agents|mesh-ancestor
110184578|NCT00034710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110184579|NCT00034710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110184580|NCT00034749|Risperidone|risperidone|mesh-list
110184581|NCT00034749|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110184582|NCT00034749|Serotonin Agents|serotonin agents|mesh-ancestor
110184583|NCT00034749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110184584|NCT00034749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110184585|NCT00034749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110184586|NCT00034749|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110184587|NCT00034749|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110184588|NCT00034749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110184589|NCT00034749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110184590|NCT00034749|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110184591|NCT00034749|Dopamine Agents|dopamine agents|mesh-ancestor
110184592|NCT00034788|Becaplermin|becaplermin|mesh-list
110184593|NCT00034788|Anticoagulants|anticoagulants|mesh-ancestor
110184594|NCT00034788|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
110184595|NCT00034788|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110184596|NCT00034788|Growth Substances|growth substances|mesh-ancestor
110184597|NCT00034788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110184598|NCT00034866|Tipranavir|tipranavir|mesh-list
110217348|NCT00416221|Escitalopram|escitalopram|mesh-list
110184599|NCT00034866|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
110184600|NCT00034866|Protease Inhibitors|protease inhibitors|mesh-list
110184601|NCT00034866|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110184602|NCT00034866|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110184603|NCT00034866|Antiviral Agents|antiviral agents|mesh-ancestor
110184604|NCT00034866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110184605|NCT00034866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110184606|NCT00034866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110184607|NCT00034866|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110184608|NCT00034905|Risperidone|risperidone|mesh-list
110184609|NCT00034905|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110184610|NCT00034905|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110184612|NCT00034905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110184613|NCT00034905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110184614|NCT00034905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110184615|NCT00034905|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110184616|NCT00034905|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110184617|NCT00034905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110184618|NCT00034905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110184619|NCT00034905|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110184620|NCT00034905|Dopamine Agents|dopamine agents|mesh-ancestor
110184621|NCT00034905|Antidepressive Agents|antidepressive agents|mesh-ancestor
110184623|NCT01806311|Candesartan|candesartan|mesh-list
110184625|NCT01806311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110184626|NCT01806311|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110184627|NCT01806311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110184628|NCT01806311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110184629|NCT01806311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110184630|NCT01806311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110184631|NCT01806311|Vasodilator Agents|vasodilator agents|mesh-ancestor
110184632|NCT01806311|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110184633|NCT01806311|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110184634|NCT00034944|Aprepitant|aprepitant|mesh-list
110184635|NCT00034944|Antiemetics|antiemetics|mesh-ancestor
110184636|NCT00034944|Autonomic Agents|autonomic agents|mesh-ancestor
110184637|NCT00034944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110184638|NCT00034944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110184639|NCT00034944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110277578|NCT00179699|Pemetrexed|pemetrexed|mesh-list
110184640|NCT00034944|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110184641|NCT00034944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110184642|NCT00034944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110184643|NCT01806272|Vitamin B 12|vitamin b 12|mesh-list
110184644|NCT01806272|Hydroxocobalamin|hydroxocobalamin|mesh-list
110184646|NCT01806272|Micronutrients|micronutrients|mesh-ancestor
110184647|NCT01806272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110184648|NCT01806272|Vitamin B Complex|vitamin b complex|mesh-ancestor
110184649|NCT01806272|Hematinics|hematinics|mesh-ancestor
110184650|NCT00034983|Aprepitant|aprepitant|mesh-list
110184651|NCT00034983|Paroxetine|paroxetine|mesh-list
110184652|NCT00034983|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110184653|NCT00034983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110184654|NCT00034983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110184655|NCT00034983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110184656|NCT00034983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110184657|NCT00034983|Serotonin Agents|serotonin agents|mesh-ancestor
110184659|NCT00034983|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110184660|NCT00034983|Antidepressive Agents|antidepressive agents|mesh-ancestor
110184661|NCT00034983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110184662|NCT00034983|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110184663|NCT00034983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110184664|NCT00034983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110184666|NCT00034983|Autonomic Agents|autonomic agents|mesh-ancestor
110184667|NCT00034983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110184668|NCT00034983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110184669|NCT00034983|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110184670|NCT00035061|Pemetrexed|pemetrexed|mesh-list
110184671|NCT00035061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110184672|NCT00035061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110184673|NCT00035061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110184674|NCT00035061|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110184675|NCT00035061|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110184676|NCT00393497|Bevacizumab|bevacizumab|mesh-list
110184677|NCT00393497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110184678|NCT00393497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110291654|NCT00253539|Tamoxifen|tamoxifen|mesh-list
110184679|NCT00393497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110184680|NCT00393497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110184681|NCT00393497|Growth Substances|growth substances|mesh-ancestor
110184682|NCT00393497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110184683|NCT00393497|Growth Inhibitors|growth inhibitors|mesh-ancestor
110184684|NCT00035100|Epothilones|epothilones|mesh-list
110184685|NCT00035100|Epothilone B|epothilone b|mesh-list
110184686|NCT00035100|Tubulin Modulators|tubulin modulators|mesh-ancestor
110184687|NCT00035100|Antimitotic Agents|antimitotic agents|mesh-ancestor
110184688|NCT00035100|Mitosis Modulators|mitosis modulators|mesh-ancestor
110184689|NCT00035100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110184690|NCT00035100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110184691|NCT00035139|Methylphenidate|methylphenidate|mesh-list
110184692|NCT00035139|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110184693|NCT00035139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110184694|NCT00035139|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110184695|NCT00035139|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110184696|NCT00035139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110184697|NCT00035139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110184698|NCT00035139|Dopamine Agents|dopamine agents|mesh-ancestor
110184699|NCT00035139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110184700|NCT00035178|Argatroban|argatroban|mesh-list
110184701|NCT00035178|Antithrombins|antithrombins|mesh-ancestor
110184702|NCT00035178|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110184704|NCT00035178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110184705|NCT00035178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110184706|NCT00035178|Anticoagulants|anticoagulants|mesh-ancestor
110184707|NCT00035178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110184708|NCT00393614|Levetiracetam|levetiracetam|mesh-list
110184709|NCT00393614|Anticonvulsants|anticonvulsants|mesh-ancestor
110184710|NCT00393614|Nootropic Agents|nootropic agents|mesh-ancestor
110184711|NCT00035256|Teriparatide|teriparatide|mesh-list
110184712|NCT00035256|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
110184713|NCT00035256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110184714|NCT00035256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110184715|NCT00035256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110184717|NCT00035256|Hormone Antagonists|hormone antagonists|mesh-ancestor
110184718|NCT00035256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110184719|NCT00035256|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110184720|NCT00035256|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110184722|NCT00035295|Antiemetics|antiemetics|mesh-ancestor
110184723|NCT00035295|Autonomic Agents|autonomic agents|mesh-ancestor
110217385|NCT00269815|Dopamine Agents|dopamine agents|mesh-ancestor
110184724|NCT00035295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110184725|NCT00035295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110184726|NCT00035295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110184727|NCT00035295|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110184728|NCT00035295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110184729|NCT00035295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110184730|NCT01806116|Decitabine|decitabine|mesh-list
110184731|NCT01806116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110184732|NCT01806116|Antimetabolites|antimetabolites|mesh-ancestor
110291752|NCT04587115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110184733|NCT01806116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110184734|NCT01806116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110184735|NCT01806116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110184736|NCT00035451|Sotalol|sotalol|mesh-list
110184737|NCT00035451|Azimilide|azimilide|mesh-list
110184738|NCT00035451|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110184739|NCT00035451|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110184740|NCT00035451|Adrenergic Agents|adrenergic agents|mesh-ancestor
110184741|NCT00035451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110184742|NCT00035451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110184743|NCT00035451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110184744|NCT00035451|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110184745|NCT00035451|Sympatholytics|sympatholytics|mesh-ancestor
110184747|NCT00035451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110184748|NCT00035451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110184749|NCT00035451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110184750|NCT00035451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110184751|NCT01805999|Psyllium|psyllium|mesh-list
110184752|NCT01805999|Calcium polycarbophil|calcium polycarbophil|mesh-list
110184753|NCT01805999|Cathartics|cathartics|mesh-ancestor
110184754|NCT01805999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110184755|NCT01805999|Antidiarrheals|antidiarrheals|mesh-ancestor
110184756|NCT00035490|Azimilide|azimilide|mesh-list
110184757|NCT00035490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110291864|NCT00412997|Panobinostat|panobinostat|mesh-list
110184758|NCT00035490|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110184759|NCT00035490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110184760|NCT00035490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110184761|NCT00035490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110291933|NCT00223418|Serotonin Agents|serotonin agents|mesh-ancestor
110184762|NCT00035490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110184763|NCT00035607|Darbepoetin alfa|darbepoetin alfa|mesh-list
110184764|NCT00035607|Hematinics|hematinics|mesh-ancestor
110184765|NCT02971254|Sevoflurane|sevoflurane|mesh-list
110184766|NCT02971254|Desflurane|desflurane|mesh-list
110184767|NCT02971254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110184768|NCT02971254|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110184769|NCT02971254|Anesthetics, General|anesthetics, general|mesh-ancestor
110184771|NCT02971254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110184772|NCT02971254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110184773|NCT01805882|Sofosbuvir|sofosbuvir|mesh-list
110184774|NCT01805882|Ledipasvir|ledipasvir|mesh-list
110184775|NCT01805882|Antiviral Agents|antiviral agents|mesh-ancestor
110184776|NCT01805882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110184777|NCT00035802|Topiramate|topiramate|mesh-list
110184778|NCT00035802|Anticonvulsants|anticonvulsants|mesh-ancestor
110184779|NCT00035802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110184780|NCT00035802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110184781|NCT04732377|Dexmedetomidine|dexmedetomidine|mesh-list
110184783|NCT04732377|Anesthetics, Local|anesthetics, local|mesh-ancestor
110184784|NCT04732377|Anesthetics|anesthetics|mesh-ancestor
110184785|NCT04732377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110184786|NCT04732377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110184787|NCT04732377|Sensory System Agents|sensory system agents|mesh-ancestor
110184788|NCT04732377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110184789|NCT04732377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110184790|NCT04732377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110184792|NCT04732377|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110184793|NCT04732377|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110184794|NCT04732377|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110184795|NCT04732377|Adrenergic Agents|adrenergic agents|mesh-ancestor
110184796|NCT04732377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110184797|NCT04732377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110184798|NCT01805726|Dexmedetomidine|dexmedetomidine|mesh-list
110184799|NCT01805726|Alfentanil|alfentanil|mesh-list
110184800|NCT01805726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110217445|NCT00269971|Epoetin Alfa|epoetin alfa|mesh-list
110184801|NCT01805726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110184802|NCT01805726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110184803|NCT01805726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110184804|NCT01805726|Analgesics|analgesics|mesh-ancestor
110184805|NCT01805726|Sensory System Agents|sensory system agents|mesh-ancestor
110184806|NCT01805726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110184807|NCT01805726|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110184808|NCT01805726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110184809|NCT01805726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110184810|NCT01805726|Adrenergic Agents|adrenergic agents|mesh-ancestor
110184811|NCT01805726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110184812|NCT01805726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110184813|NCT01805726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110184815|NCT01805726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110184816|NCT01805726|Anesthetics, General|anesthetics, general|mesh-ancestor
110184818|NCT00035958|Prednisone|prednisone|mesh-list
110184819|NCT00035958|Etanercept|etanercept|mesh-list
110184820|NCT00035958|Methotrexate|methotrexate|mesh-list
110292234|NCT00415116|Carboplatin|carboplatin|mesh-list
110184821|NCT00035958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110184822|NCT00035958|Glucocorticoids|glucocorticoids|mesh-ancestor
110184823|NCT00035958|Hormones|hormones|mesh-ancestor
110184824|NCT00035958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110184825|NCT00035958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110184826|NCT00035958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110184827|NCT00035958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110184828|NCT00035958|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110184829|NCT00035958|Abortifacient Agents|abortifacient agents|mesh-ancestor
110184830|NCT00035958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110184831|NCT00035958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110184833|NCT00035958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110184834|NCT00035958|Dermatologic Agents|dermatologic agents|mesh-ancestor
110184835|NCT00035958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110184836|NCT00035958|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110184837|NCT00035958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110184838|NCT00035958|Immunologic Factors|immunologic factors|mesh-ancestor
110184839|NCT00035958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110184840|NCT00035958|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110184841|NCT00035958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110184842|NCT00035958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110184844|NCT00035958|Sensory System Agents|sensory system agents|mesh-ancestor
110184845|NCT00035958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110184846|NCT00035958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110184848|NCT01805687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110184849|NCT01805687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110184851|NCT01805687|Sensory System Agents|sensory system agents|mesh-ancestor
110184852|NCT01805687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110184853|NCT01805687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110184854|NCT01805687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110184855|NCT01805687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110184856|NCT01805687|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110184857|NCT01805687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110184858|NCT01805687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110184859|NCT01805687|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110184860|NCT01805687|Hormone Antagonists|hormone antagonists|mesh-ancestor
110184861|NCT01805687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110184862|NCT00035997|Zoledronic Acid|zoledronic acid|mesh-list
110184864|NCT00035997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110292441|NCT00224588|Anesthetics, General|anesthetics, general|mesh-ancestor
110184866|NCT01805570|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110184867|NCT01805570|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110184868|NCT01805570|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110184869|NCT01805570|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110184870|NCT01805570|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110184871|NCT01805570|Purinergic Agents|purinergic agents|mesh-ancestor
110184872|NCT01805570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110184873|NCT01805570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110184874|NCT01805570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110184876|NCT01805531|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110184877|NCT01805531|Antithrombins|antithrombins|mesh-ancestor
110184878|NCT01805531|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110184879|NCT01805531|Protease Inhibitors|protease inhibitors|mesh-ancestor
110184880|NCT01805531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110184881|NCT01805531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110184882|NCT01805531|Anticoagulants|anticoagulants|mesh-ancestor
110184883|NCT00036114|Aripiprazole|aripiprazole|mesh-list
110184884|NCT00036114|Antidepressive Agents|antidepressive agents|mesh-ancestor
110184885|NCT00036114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110184886|NCT00036114|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110184887|NCT00036114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110184888|NCT00036114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110184889|NCT00036114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110292501|NCT03453931|Hormones|hormones|mesh-ancestor
110184890|NCT00036114|Dopamine Agonists|dopamine agonists|mesh-ancestor
110184891|NCT00036114|Dopamine Agents|dopamine agents|mesh-ancestor
110184892|NCT00036114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110184893|NCT00036114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110184894|NCT00036114|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110184895|NCT00036114|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110184896|NCT00036114|Serotonin Agents|serotonin agents|mesh-ancestor
110184897|NCT00036114|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110184898|NCT00036114|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110184899|NCT00036114|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110184900|NCT00036114|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110184902|NCT01805453|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110184903|NCT01805453|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110292552|NCT00571636|Anesthetics|anesthetics|mesh-ancestor
110184904|NCT01805453|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110184905|NCT01805453|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110184906|NCT01805453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110184908|NCT00036153|Tacrolimus|tacrolimus|mesh-list
110184909|NCT00036153|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110184910|NCT00036153|Abortifacient Agents|abortifacient agents|mesh-ancestor
110184911|NCT00036153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110184912|NCT00036153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110184913|NCT00036153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110184914|NCT00036153|Antimetabolites|antimetabolites|mesh-ancestor
110184915|NCT00036153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110184916|NCT00036153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110184917|NCT00036153|Dermatologic Agents|dermatologic agents|mesh-ancestor
110184918|NCT00036153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110184919|NCT00036153|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110184920|NCT00036153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110184921|NCT00036153|Immunologic Factors|immunologic factors|mesh-ancestor
110184922|NCT00036153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110184923|NCT00036153|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110184924|NCT00036153|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110184926|NCT00036231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110184927|NCT00036231|Hormones|hormones|mesh-ancestor
110184928|NCT00036231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110184929|NCT00036231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110184930|NCT00036309|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110184931|NCT00036309|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110184932|NCT00036309|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110184934|NCT00036309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110184935|NCT00036309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110184936|NCT00036309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110184938|NCT00036309|Sensory System Agents|sensory system agents|mesh-ancestor
110184939|NCT00036309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110184940|NCT00036309|Antidepressive Agents|antidepressive agents|mesh-ancestor
110184942|NCT00036309|Dopamine Agents|dopamine agents|mesh-ancestor
110184943|NCT00036348|Aripiprazole|aripiprazole|mesh-list
110184945|NCT00036348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110184946|NCT00036348|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110184947|NCT00036348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110184948|NCT00036348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110184949|NCT00036348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110184950|NCT00036348|Dopamine Agonists|dopamine agonists|mesh-ancestor
110184951|NCT00036348|Dopamine Agents|dopamine agents|mesh-ancestor
110184952|NCT00036348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110184953|NCT00036348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110184954|NCT00036348|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110184955|NCT00036348|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110184956|NCT00036348|Serotonin Agents|serotonin agents|mesh-ancestor
110184957|NCT00036348|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110184958|NCT00036348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110184959|NCT00036348|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110184960|NCT00036348|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110184962|NCT00036387|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110184963|NCT00036387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110184964|NCT00036387|Dermatologic Agents|dermatologic agents|mesh-ancestor
110184965|NCT00036387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110184966|NCT00036387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110184967|NCT00036426|Immunomodulating Agents|immunomodulating agents|mesh-list
110184968|NCT00036426|Immunologic Factors|immunologic factors|mesh-ancestor
110184969|NCT00036426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110184970|NCT01466543|Udenafil|udenafil|mesh-list
110184971|NCT01466543|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110184972|NCT01466543|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110292757|NCT00225173|Bleomycin|bleomycin|mesh-list
110184973|NCT01466543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110184974|NCT01466543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110184975|NCT01466465|Vitamin D|vitamin d|mesh-list
110184976|NCT01466465|Cholecalciferol|cholecalciferol|mesh-list
110184977|NCT01466465|Vitamins|vitamins|mesh-ancestor
110184978|NCT01466465|Micronutrients|micronutrients|mesh-ancestor
110184979|NCT01466465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110184980|NCT01466465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110184981|NCT01466465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110184982|NCT00036504|Insulin Lispro|insulin lispro|mesh-list
110184983|NCT00036504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110184986|NCT00036543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110184987|NCT00036543|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
110184988|NCT00036543|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110184989|NCT00036543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110184991|NCT01466231|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110184992|NCT01466231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110184993|NCT01466231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110292817|NCT00225290|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110292821|NCT00573547|Fluoxetine|fluoxetine|mesh-list
110184994|NCT01466231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110184995|NCT01466231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110184996|NCT01466231|Immunologic Factors|immunologic factors|mesh-ancestor
110184997|NCT01466231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110184998|NCT01466231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110185000|NCT00036582|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110185001|NCT00036582|Serotonin Agents|serotonin agents|mesh-ancestor
110185002|NCT00036582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110185003|NCT00036582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110185004|NCT00036582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110185005|NCT00036582|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110185006|NCT00036582|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110185007|NCT00036582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110185008|NCT00036582|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110185009|NCT00036582|GABA Antagonists|gaba antagonists|mesh-ancestor
110185011|NCT01466114|Norethindrone|norethindrone|mesh-list
110185012|NCT01466114|Norethindrone Acetate|norethindrone acetate|mesh-list
110185013|NCT01466114|Progestins|progestins|mesh-list
110185014|NCT01466114|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110185015|NCT01466114|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110185016|NCT01466114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110185017|NCT01466114|Contraceptive Agents|contraceptive agents|mesh-ancestor
110185018|NCT01466114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110185019|NCT01466114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110185020|NCT01466114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110292931|NCT00574366|Everolimus|everolimus|mesh-list
110185021|NCT01466114|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110185022|NCT01466114|Hormones|hormones|mesh-ancestor
110185023|NCT01466114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110185024|NCT00036777|Carboplatin|carboplatin|mesh-list
110185025|NCT00036777|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
110185026|NCT00036777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110185027|NCT00036777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110185028|NCT00036777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110185029|NCT00036777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110185030|NCT01465919|Mirtazapine|mirtazapine|mesh-list
110185046|NCT01465919|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110185048|NCT01465919|Serotonin Agents|serotonin agents|mesh-ancestor
110185049|NCT01465919|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110185051|NCT00396513|Simvastatin|simvastatin|mesh-list
110185052|NCT00396513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110185053|NCT00396513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110185054|NCT00396513|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110185055|NCT00396513|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110185056|NCT00396513|Antimetabolites|antimetabolites|mesh-ancestor
110185057|NCT00396513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110185058|NCT00396513|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110185059|NCT00396513|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110185060|NCT00396513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110185061|NCT00036855|Rituximab|rituximab|mesh-list
110185062|NCT00036855|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110185063|NCT00036855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110277919|NCT00576706|Oxytocics|oxytocics|mesh-ancestor
110185064|NCT00036855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110185065|NCT00036855|Immunologic Factors|immunologic factors|mesh-ancestor
110185081|NCT01465685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110185082|NCT01465685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110185083|NCT01465685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110185085|NCT01465685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110185086|NCT01465685|Hallucinogens|hallucinogens|mesh-ancestor
110185087|NCT01465685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110185088|NCT01465685|Serotonin Agents|serotonin agents|mesh-ancestor
110185089|NCT01465685|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110052873|NCT01482468|Palonosetron|palonosetron|mesh-list
110185090|NCT01465685|Adrenergic Agents|adrenergic agents|mesh-ancestor
110185091|NCT00037011|Antibodies|antibodies|mesh-list
110185092|NCT00037011|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110185093|NCT00037011|Immunologic Factors|immunologic factors|mesh-ancestor
110185094|NCT00037011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110185095|NCT00037050|Vancomycin|vancomycin|mesh-list
110185096|NCT00037050|Linezolid|linezolid|mesh-list
110185097|NCT00037050|Oxacillin|oxacillin|mesh-list
110185098|NCT00037050|Dicloxacillin|dicloxacillin|mesh-list
110185099|NCT00037050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110185100|NCT00037050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110185101|NCT00037050|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110185102|NCT00037050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110185103|NCT00037050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110185104|NCT00037089|Tegafur|tegafur|mesh-list
110185105|NCT00037089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110185106|NCT00037089|Antimetabolites|antimetabolites|mesh-ancestor
110185107|NCT00037089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110185109|NCT01465568|Denosumab|denosumab|mesh-list
110185110|NCT01465568|Diphosphonates|diphosphonates|mesh-list
110277922|NCT00576706|Protective Agents|protective agents|mesh-ancestor
110185111|NCT01465568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110185112|NCT01465568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110185114|NCT00037206|Antifungal Agents|antifungal agents|mesh-ancestor
110185115|NCT00037206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110185116|NCT01465412|Adenosine|adenosine|mesh-list
110185117|NCT01465412|Analgesics|analgesics|mesh-ancestor
110185118|NCT01465412|Sensory System Agents|sensory system agents|mesh-ancestor
110185119|NCT01465412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110185120|NCT01465412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110185121|NCT01465412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110185122|NCT01465412|Vasodilator Agents|vasodilator agents|mesh-ancestor
110185123|NCT01465412|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110185124|NCT01465412|Purinergic Agonists|purinergic agonists|mesh-ancestor
110185125|NCT01465412|Purinergic Agents|purinergic agents|mesh-ancestor
110185126|NCT01465412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110185127|NCT01465412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110185128|NCT01465373|Progesterone|progesterone|mesh-list
110185129|NCT01465373|Progestins|progestins|mesh-ancestor
110185130|NCT01465373|Hormones|hormones|mesh-ancestor
110185131|NCT01465373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110185132|NCT01465373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110185133|NCT01465256|Aspirin|aspirin|mesh-list
110185134|NCT01465256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110185135|NCT01465256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110185136|NCT01465256|Analgesics|analgesics|mesh-ancestor
110185137|NCT01465256|Sensory System Agents|sensory system agents|mesh-ancestor
110293179|NCT04573153|Cathartics|cathartics|mesh-ancestor
110185138|NCT01465256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110185139|NCT01465256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110185140|NCT01465256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110185141|NCT01465256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110185142|NCT01465256|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110185143|NCT01465256|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110185144|NCT01465256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110185145|NCT01465256|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110185146|NCT01465256|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110185147|NCT01465256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110185148|NCT01465256|Antipyretics|antipyretics|mesh-ancestor
110185149|NCT00037479|Ceftriaxone|ceftriaxone|mesh-list
110185150|NCT00037479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110185151|NCT00037479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110185152|NCT01464983|Aspirin|aspirin|mesh-list
110185153|NCT01464983|Ibuprofen|ibuprofen|mesh-list
110185154|NCT01464983|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110185155|NCT01464983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110185156|NCT01464983|Analgesics|analgesics|mesh-ancestor
110185157|NCT01464983|Sensory System Agents|sensory system agents|mesh-ancestor
110185158|NCT01464983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110185159|NCT01464983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110185160|NCT01464983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110185161|NCT01464983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110185162|NCT01464983|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110185163|NCT01464983|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110185164|NCT01464983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110185170|NCT00037518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110185171|NCT00037518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110185172|NCT00037518|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
110185173|NCT00037518|Hormone Antagonists|hormone antagonists|mesh-ancestor
110185174|NCT00037518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110185176|NCT01464944|Acetaminophen|acetaminophen|mesh-list
110185177|NCT01464944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110185178|NCT01464944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110185179|NCT01464944|Analgesics|analgesics|mesh-ancestor
110185180|NCT01464944|Sensory System Agents|sensory system agents|mesh-ancestor
110185181|NCT01464944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110185182|NCT01464944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110185184|NCT01464944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110185185|NCT01464944|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110185186|NCT01464944|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110185187|NCT01464944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110185188|NCT01464944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110185189|NCT01464944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110185190|NCT01464944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110185191|NCT01464944|Antipyretics|antipyretics|mesh-ancestor
110185193|NCT00037596|Gemtuzumab|gemtuzumab|mesh-list
110185194|NCT00037596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110185195|NCT00037596|Antimetabolites|antimetabolites|mesh-ancestor
110185196|NCT00037596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110185197|NCT00037596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110185198|NCT00037596|Antiviral Agents|antiviral agents|mesh-ancestor
110185199|NCT00037596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110185200|NCT00037596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110185201|NCT00037596|Immunologic Factors|immunologic factors|mesh-ancestor
110185202|NCT00037596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110185203|NCT00037596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110185205|NCT00037596|Immunoconjugates|immunoconjugates|mesh-ancestor
110185206|NCT00037635|Cinacalcet|cinacalcet|mesh-list
110185207|NCT00037635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110185208|NCT00037635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110185212|NCT00037674|Topiramate|topiramate|mesh-list
110185213|NCT00037674|Anticonvulsants|anticonvulsants|mesh-ancestor
110185214|NCT00037674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110185215|NCT00037674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110185216|NCT00037752|Sibutramine|sibutramine|mesh-list
110185217|NCT00037752|Antidepressive Agents|antidepressive agents|mesh-ancestor
110185218|NCT00037752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110185219|NCT00037752|Appetite Depressants|appetite depressants|mesh-ancestor
110217651|NCT00271414|Narcotics|narcotics|mesh-ancestor
110185220|NCT00037752|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110185221|NCT01464671|Heparin|heparin|mesh-list
110185222|NCT01464671|Bivalirudin|bivalirudin|mesh-list
110185223|NCT01464671|Anticoagulants|anticoagulants|mesh-ancestor
110185224|NCT01464671|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110185225|NCT01464671|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110185226|NCT01464671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110185227|NCT01464671|Antithrombins|antithrombins|mesh-ancestor
110185228|NCT01464671|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110185229|NCT01464671|Protease Inhibitors|protease inhibitors|mesh-ancestor
110185230|NCT01464671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110185232|NCT00037869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110185233|NCT00037869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110185234|NCT00037869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110185235|NCT00037869|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110185236|NCT00393731|Misoprostol|misoprostol|mesh-list
110185237|NCT00393731|Oxytocin|oxytocin|mesh-list
110185238|NCT00393731|Oxytocics|oxytocics|mesh-ancestor
110185239|NCT00393731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110185240|NCT00393731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110185241|NCT00393731|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110185242|NCT00393731|Abortifacient Agents|abortifacient agents|mesh-ancestor
110185243|NCT00393731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110185244|NCT00393731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110185245|NCT00038025|Pentostatin|pentostatin|mesh-list
110185246|NCT00038025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110185247|NCT00038025|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
110185248|NCT00038025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110185249|NCT00038025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293460|NCT00226889|Bosentan|bosentan|mesh-list
110185250|NCT00393770|Acetylcarnitine|acetylcarnitine|mesh-list
110185251|NCT00393770|Vitamin B Complex|vitamin b complex|mesh-ancestor
110185252|NCT00393770|Vitamins|vitamins|mesh-ancestor
110185255|NCT00393770|Nootropic Agents|nootropic agents|mesh-ancestor
110185256|NCT00038064|Darbepoetin alfa|darbepoetin alfa|mesh-list
110185257|NCT00038064|Hematinics|hematinics|mesh-ancestor
110185258|NCT00038181|Thalidomide|thalidomide|mesh-list
110185259|NCT00038181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110185260|NCT00038181|Immunologic Factors|immunologic factors|mesh-ancestor
110185261|NCT00038181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110185262|NCT00038181|Leprostatic Agents|leprostatic agents|mesh-ancestor
110185263|NCT00038181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110278011|NCT00187005|Hormones|hormones|mesh-ancestor
110185264|NCT00038181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110185266|NCT00038181|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110185267|NCT00038181|Growth Substances|growth substances|mesh-ancestor
110185268|NCT00038181|Growth Inhibitors|growth inhibitors|mesh-ancestor
110185269|NCT00038181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110185270|NCT00038220|Ritonavir|ritonavir|mesh-list
110185272|NCT00038220|Tenofovir|tenofovir|mesh-list
110185273|NCT00038220|Lamivudine|lamivudine|mesh-list
110185274|NCT00038220|Efavirenz|efavirenz|mesh-list
110185275|NCT00038220|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110185276|NCT00038220|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110185277|NCT00038220|Protease Inhibitors|protease inhibitors|mesh-ancestor
110185278|NCT00038220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110185279|NCT00038220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110185280|NCT00038220|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110185281|NCT00038220|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110185283|NCT00038220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110185284|NCT00038220|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110185285|NCT00038220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110185286|NCT00038220|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110185287|NCT00038220|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110185288|NCT00038220|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110185289|NCT00038220|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110185290|NCT00038220|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110185291|NCT00038220|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110185292|NCT00038220|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110185293|NCT00038259|Aldesleukin|aldesleukin|mesh-list
110185294|NCT00038259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110185295|NCT00038259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110185296|NCT00038259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110185300|NCT00847418|Antidepressive Agents|antidepressive agents|mesh-ancestor
110185301|NCT00847418|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110185302|NCT05433597|Cisplatin|cisplatin|mesh-list
110185303|NCT05433597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110185304|NCT00847262|Amlodipine|amlodipine|mesh-list
110185305|NCT00847262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110185306|NCT00847262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110185307|NCT00847262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110185308|NCT00847262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110185309|NCT00847262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110185311|NCT00847262|Vasodilator Agents|vasodilator agents|mesh-ancestor
110185313|NCT00847223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110185314|NCT05433207|Eldecalcitol|eldecalcitol|mesh-list
110185315|NCT05433207|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110185316|NCT05433207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110185317|NCT00847106|Daclizumab|daclizumab|mesh-list
110185318|NCT00847106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110185319|NCT00847106|Immunologic Factors|immunologic factors|mesh-ancestor
110185320|NCT00847106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110185321|NCT00396669|Bupropion|bupropion|mesh-list
110185322|NCT00396669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110185323|NCT00396669|Antidepressive Agents|antidepressive agents|mesh-ancestor
110185324|NCT00396669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110185325|NCT00396669|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110185327|NCT00396669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110185328|NCT00396669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110185329|NCT00396669|Dopamine Agents|dopamine agents|mesh-ancestor
110185330|NCT00396669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110185331|NCT00396669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110185332|NCT00396669|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110185333|NCT00396669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110185334|NCT00396669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110185335|NCT00846989|Latanoprost|latanoprost|mesh-list
110185336|NCT00846989|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110185337|NCT00846989|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110185338|NCT00396747|Methylprednisolone|methylprednisolone|mesh-list
110185339|NCT00396747|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110185340|NCT00396747|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110185341|NCT00396747|Prednisolone|prednisolone|mesh-list
110185342|NCT00396747|Prednisolone acetate|prednisolone acetate|mesh-list
110185343|NCT00396747|Infliximab|infliximab|mesh-list
110185344|NCT00396747|Methotrexate|methotrexate|mesh-list
110185345|NCT00396747|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110185346|NCT00396747|Prednisolone phosphate|prednisolone phosphate|mesh-list
110185347|NCT00396747|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110185348|NCT00396747|Abortifacient Agents|abortifacient agents|mesh-ancestor
110185349|NCT00396747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110185350|NCT00396747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110185351|NCT00396747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110185352|NCT00396747|Antimetabolites|antimetabolites|mesh-ancestor
110185353|NCT00396747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110185354|NCT00396747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110185355|NCT00396747|Dermatologic Agents|dermatologic agents|mesh-ancestor
110185356|NCT00396747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110185357|NCT00396747|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110185358|NCT00396747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110185359|NCT00396747|Immunologic Factors|immunologic factors|mesh-ancestor
110185360|NCT00396747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110185361|NCT00396747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110185362|NCT00396747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110185363|NCT00396747|Antiemetics|antiemetics|mesh-ancestor
110185364|NCT00396747|Autonomic Agents|autonomic agents|mesh-ancestor
110185365|NCT00396747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110185366|NCT00396747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110185367|NCT00396747|Glucocorticoids|glucocorticoids|mesh-ancestor
110185368|NCT00396747|Hormones|hormones|mesh-ancestor
110185369|NCT00396747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110185370|NCT00396747|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110185371|NCT00396747|Protective Agents|protective agents|mesh-ancestor
110185372|NCT00396747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110185373|NCT00396747|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110185379|NCT00846950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110185380|NCT00846950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110185381|NCT00846950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110185382|NCT00846950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110185383|NCT00846950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110185384|NCT00846950|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110185385|NCT00846950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110185387|NCT00846950|GABA Modulators|gaba modulators|mesh-ancestor
110185388|NCT00846950|GABA Agents|gaba agents|mesh-ancestor
110185389|NCT00846950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110185390|NCT00846950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110185391|NCT00846950|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110185392|NCT00846950|Histamine Antagonists|histamine antagonists|mesh-ancestor
110185395|NCT05432934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110185396|NCT05432934|Antiemetics|antiemetics|mesh-ancestor
110185397|NCT05432934|Autonomic Agents|autonomic agents|mesh-ancestor
110185398|NCT05432934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110185399|NCT05432934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110185400|NCT05432934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110185401|NCT05432934|Glucocorticoids|glucocorticoids|mesh-ancestor
110185402|NCT05432934|Hormones|hormones|mesh-ancestor
110185403|NCT05432934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110185404|NCT05432934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110185405|NCT05432934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110185406|NCT00846911|Moxifloxacin|moxifloxacin|mesh-list
110185407|NCT00846911|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110185408|NCT00846911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110185409|NCT00846911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110185410|NCT00846911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110185411|NCT00846911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110185412|NCT00846911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110185413|NCT00846911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110185414|NCT00846911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110185415|NCT00846911|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110185417|NCT00846911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110185418|NCT00846911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110185419|NCT00846911|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110185421|NCT00846911|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110185422|NCT00846872|Mannitol|mannitol|mesh-list
110185423|NCT00846872|Hormones|hormones|mesh-list
110185424|NCT00846872|Secretagogues|secretagogues|mesh-list
110185425|NCT00846872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110185426|NCT00846872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110185427|NCT00846872|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110185428|NCT00846872|Diuretics|diuretics|mesh-ancestor
110185429|NCT00846872|Natriuretic Agents|natriuretic agents|mesh-ancestor
110185430|NCT05432778|Letermovir|letermovir|mesh-list
110185431|NCT05432778|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110185432|NCT05432778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110185433|NCT05432778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110185434|NCT05432778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110185435|NCT05432778|Antiviral Agents|antiviral agents|mesh-ancestor
110185436|NCT05432778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110185437|NCT00846755|Propylthiouracil|propylthiouracil|mesh-list
110185438|NCT00846755|Antimetabolites|antimetabolites|mesh-ancestor
110185439|NCT00846755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110185440|NCT00846755|Antithyroid Agents|antithyroid agents|mesh-ancestor
110185441|NCT00846755|Hormone Antagonists|hormone antagonists|mesh-ancestor
110185442|NCT00846755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110185443|NCT00846755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110185444|NCT00846716|Pioglitazone|pioglitazone|mesh-list
110185446|NCT00846716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110294023|NCT00236379|Serotonin Agents|serotonin agents|mesh-ancestor
110024934|NCT00355524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110185447|NCT00846716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110185448|NCT05432427|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110185449|NCT05432427|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110185450|NCT05432427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110185453|NCT00846677|Cholecalciferol|cholecalciferol|mesh-list
110185454|NCT00846677|Vitamins|vitamins|mesh-list
110185455|NCT00846677|Micronutrients|micronutrients|mesh-ancestor
110185456|NCT00846677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110185457|NCT00846677|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110185458|NCT00846677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110185459|NCT00846482|Oxaliplatin|oxaliplatin|mesh-list
110185460|NCT00846482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110185461|NCT05428683|Moxifloxacin|moxifloxacin|mesh-list
110185462|NCT05428683|Triamcinolone|triamcinolone|mesh-list
110185463|NCT05428683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110185464|NCT05428683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110185465|NCT05428683|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110185466|NCT05428683|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110185467|NCT05428683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110185468|NCT05428683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110185469|NCT05428683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110185470|NCT05428683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110185471|NCT05428683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110185472|NCT05428683|Glucocorticoids|glucocorticoids|mesh-ancestor
110185473|NCT05428683|Hormones|hormones|mesh-ancestor
110185474|NCT05428683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110185475|NCT05424549|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110185477|NCT00846443|Cisplatin|cisplatin|mesh-list
110185478|NCT00846443|Pemetrexed|pemetrexed|mesh-list
110185479|NCT00846443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110185480|NCT00846443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110185481|NCT00846443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110185482|NCT00846443|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110185487|NCT00846326|Oxymetazoline|oxymetazoline|mesh-list
110185488|NCT00846326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110185489|NCT00846326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110185490|NCT00846326|Autonomic Agents|autonomic agents|mesh-ancestor
110185491|NCT00846326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110185492|NCT00846326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110185493|NCT00846326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110185494|NCT00846326|Respiratory System Agents|respiratory system agents|mesh-ancestor
110185496|NCT00846326|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110185497|NCT00846326|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110185498|NCT00846326|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110185499|NCT00846326|Adrenergic Agents|adrenergic agents|mesh-ancestor
110185500|NCT00846326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110185501|NCT00846326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110185503|NCT00846326|Nasal Decongestants|nasal decongestants|mesh-ancestor
110294119|NCT00193219|Antimetabolites|antimetabolites|mesh-ancestor
110185504|NCT00846326|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110185505|NCT00846326|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110185506|NCT00846326|Mydriatics|mydriatics|mesh-ancestor
110185507|NCT00846326|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110185508|NCT00846326|Protective Agents|protective agents|mesh-ancestor
110185509|NCT05330013|Dapagliflozin|dapagliflozin|mesh-list
110185510|NCT05330013|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110185511|NCT05330013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110185512|NCT05330013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110185513|NCT05330013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110185514|NCT00846248|Chromium|chromium|mesh-list
110185515|NCT00846248|Trace Elements|trace elements|mesh-ancestor
110185517|NCT00846248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110185518|NCT00846131|Sorafenib|sorafenib|mesh-list
110185519|NCT00846131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110185520|NCT00846131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110185521|NCT00846131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110185522|NCT00846131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110185523|NCT05116059|Amphotericin B|amphotericin b|mesh-list
110185524|NCT05116059|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110185525|NCT05116059|Amebicides|amebicides|mesh-ancestor
110185526|NCT05116059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110185527|NCT05116059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110185528|NCT05116059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110185529|NCT05116059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110185534|NCT00277082|Camptothecin|camptothecin|mesh-list
110185535|NCT00277082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110185536|NCT00277082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110185537|NCT00277082|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110185538|NCT00277082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110185539|NCT00277082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110185540|NCT00277082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110185541|NCT04888377|Aspirin|aspirin|mesh-list
110185542|NCT04888377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110185543|NCT04888377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110185544|NCT04888377|Analgesics|analgesics|mesh-ancestor
110185545|NCT04888377|Sensory System Agents|sensory system agents|mesh-ancestor
110185546|NCT04888377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110185547|NCT04888377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110185548|NCT04888377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110185550|NCT04888377|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110185551|NCT04888377|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110185552|NCT04888377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110185553|NCT04888377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110185554|NCT04888377|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110185555|NCT04888377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110185556|NCT04888377|Antipyretics|antipyretics|mesh-ancestor
110185557|NCT00277043|Paclitaxel|paclitaxel|mesh-list
110185558|NCT00277043|Docetaxel|docetaxel|mesh-list
110185559|NCT00277043|Taxane|taxane|mesh-list
110185560|NCT00277043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110185561|NCT00277043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110185562|NCT00277043|Tubulin Modulators|tubulin modulators|mesh-ancestor
110185564|NCT00277043|Mitosis Modulators|mitosis modulators|mesh-ancestor
110185565|NCT00277043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110185566|NCT00276965|Lithium Carbonate|lithium carbonate|mesh-list
110185567|NCT00276965|Sertraline|sertraline|mesh-list
110185568|NCT00276965|Antidepressive Agents|antidepressive agents|mesh-ancestor
110185569|NCT00276965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110185570|NCT00276965|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110185572|NCT00276965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110185573|NCT00276965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110185574|NCT00276965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110185575|NCT00276965|Serotonin Agents|serotonin agents|mesh-ancestor
110185576|NCT00276965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110185577|NCT00276965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110185578|NCT00276965|Antimanic Agents|antimanic agents|mesh-ancestor
110185579|NCT00276965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110185580|NCT00276965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110185581|NCT00276926|Imatinib Mesylate|imatinib mesylate|mesh-list
110185582|NCT00276926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110185583|NCT00276926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110185584|NCT00276926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110185585|NCT00276926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110185587|NCT00396786|Rivaroxaban|rivaroxaban|mesh-list
110185588|NCT00396786|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110185589|NCT00396786|Antithrombins|antithrombins|mesh-ancestor
110185590|NCT00396786|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110294243|NCT00236691|Topiramate|topiramate|mesh-list
110185591|NCT00396786|Protease Inhibitors|protease inhibitors|mesh-ancestor
110185592|NCT00396786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110185593|NCT00396786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110185594|NCT00396786|Anticoagulants|anticoagulants|mesh-ancestor
110185595|NCT00396786|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110185596|NCT00396786|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110185597|NCT00276848|Vidarabine|vidarabine|mesh-list
110185598|NCT00276848|Cyclophosphamide|cyclophosphamide|mesh-list
110185599|NCT00276848|Fludarabine|fludarabine|mesh-list
110185600|NCT00276848|Fludarabine phosphate|fludarabine phosphate|mesh-list
110185601|NCT00276848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110185602|NCT00276848|Immunologic Factors|immunologic factors|mesh-ancestor
110185603|NCT00276848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110185604|NCT00276848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110185606|NCT00276848|Alkylating Agents|alkylating agents|mesh-ancestor
110185607|NCT00276848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110185608|NCT00276848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110185609|NCT00276848|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110185610|NCT00276848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110185612|NCT00276848|Antiviral Agents|antiviral agents|mesh-ancestor
110185613|NCT00276848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110185614|NCT00276809|Cytarabine|cytarabine|mesh-list
110185615|NCT00276809|Dexamethasone|dexamethasone|mesh-list
110185616|NCT00276809|Cyclophosphamide|cyclophosphamide|mesh-list
110185617|NCT00276809|Melphalan|melphalan|mesh-list
110185618|NCT00276809|Carmustine|carmustine|mesh-list
110185619|NCT00276809|Fludarabine|fludarabine|mesh-list
110185620|NCT00276809|Fludarabine phosphate|fludarabine phosphate|mesh-list
110185622|NCT00276809|Alemtuzumab|alemtuzumab|mesh-list
110185623|NCT00276809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110185624|NCT00276809|Immunologic Factors|immunologic factors|mesh-ancestor
110185625|NCT00276809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110185626|NCT00276809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110185627|NCT00276809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110185628|NCT00276809|Alkylating Agents|alkylating agents|mesh-ancestor
110185629|NCT00276809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110185630|NCT00276809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110185631|NCT00276809|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110185632|NCT00276809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110185633|NCT00276809|Antiemetics|antiemetics|mesh-ancestor
110185634|NCT00276809|Autonomic Agents|autonomic agents|mesh-ancestor
110185635|NCT00276809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110185636|NCT00276809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110185637|NCT00276809|Glucocorticoids|glucocorticoids|mesh-ancestor
110185638|NCT00276809|Hormones|hormones|mesh-ancestor
110185639|NCT00276809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110185640|NCT00276809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110185641|NCT00276809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110185642|NCT00276809|Antimetabolites|antimetabolites|mesh-ancestor
110185643|NCT00276809|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110185644|NCT00276809|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110185645|NCT00276809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110185646|NCT00276809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110185647|NCT00276809|Antiviral Agents|antiviral agents|mesh-ancestor
110185648|NCT00276809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110185649|NCT00276809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110185650|NCT00276770|Fluorides|fluorides|mesh-list
110185651|NCT00276770|Cariostatic Agents|cariostatic agents|mesh-ancestor
110185652|NCT00276770|Protective Agents|protective agents|mesh-ancestor
110185653|NCT00276770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110185654|NCT00276731|Cyclophosphamide|cyclophosphamide|mesh-list
110185655|NCT00276731|Carboplatin|carboplatin|mesh-list
110185656|NCT00276731|Etoposide|etoposide|mesh-list
110185657|NCT00276731|Vincristine|vincristine|mesh-list
110185658|NCT00276731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110185659|NCT00276731|Immunologic Factors|immunologic factors|mesh-ancestor
110185660|NCT00276731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110185661|NCT00276731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110185662|NCT00276731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110185663|NCT00276731|Alkylating Agents|alkylating agents|mesh-ancestor
110185664|NCT00276731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110185665|NCT00276731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110185666|NCT00276731|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110185667|NCT00276731|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110185668|NCT00276731|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110185669|NCT00276731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110185670|NCT00276731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110185671|NCT00276731|Tubulin Modulators|tubulin modulators|mesh-ancestor
110185672|NCT00276731|Antimitotic Agents|antimitotic agents|mesh-ancestor
110185673|NCT00276731|Mitosis Modulators|mitosis modulators|mesh-ancestor
110185675|NCT00276692|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110185676|NCT00276692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110185677|NCT00276692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110185678|NCT00276692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110185679|NCT00276692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110185680|NCT00276575|Bevacizumab|bevacizumab|mesh-list
110185681|NCT00276575|Everolimus|everolimus|mesh-list
110185682|NCT00276575|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110185683|NCT00276575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110185684|NCT00276575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110185685|NCT00276575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110185686|NCT00276575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110185687|NCT00276575|Growth Substances|growth substances|mesh-ancestor
110185688|NCT00276575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110185689|NCT00276575|Growth Inhibitors|growth inhibitors|mesh-ancestor
110185690|NCT00276575|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110185691|NCT00276575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110185692|NCT00276575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110185693|NCT00276575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110185694|NCT00276575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110185695|NCT00276575|Immunologic Factors|immunologic factors|mesh-ancestor
110185696|NCT00276536|Interferons|interferons|mesh-list
110185697|NCT00276536|Interferon-alpha|interferon-alpha|mesh-list
110185698|NCT00276536|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
110185699|NCT00276536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110185700|NCT00276536|Antiviral Agents|antiviral agents|mesh-ancestor
110185701|NCT00276536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110185702|NCT00276536|Immunologic Factors|immunologic factors|mesh-ancestor
110185703|NCT00276536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110185704|NCT00276497|Pioglitazone|pioglitazone|mesh-list
110185705|NCT00276497|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110185706|NCT00276497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110185708|NCT04430790|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110185709|NCT04430790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110185710|NCT04430790|Respiratory System Agents|respiratory system agents|mesh-ancestor
110185711|NCT00041340|Imatinib Mesylate|imatinib mesylate|mesh-list
110185712|NCT00041340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110185713|NCT00041340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110185714|NCT00041340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110185715|NCT00041340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110185716|NCT00276185|Botulinum Toxins|botulinum toxins|mesh-list
110185717|NCT00276185|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110185718|NCT00276185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110185719|NCT00276185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110185721|NCT00276185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110185722|NCT00276185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110185723|NCT00276146|Dipyridamole|dipyridamole|mesh-list
110185724|NCT00276146|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110185725|NCT00276146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110294607|NCT00258297|Gefitinib|gefitinib|mesh-list
110185726|NCT00276146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110185727|NCT00276146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110185728|NCT00276146|Vasodilator Agents|vasodilator agents|mesh-ancestor
110185729|NCT00276107|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110185730|NCT00276107|Immunologic Factors|immunologic factors|mesh-ancestor
110185731|NCT00276107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110185734|NCT04201665|Oxytocics|oxytocics|mesh-ancestor
110185735|NCT04201665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110185736|NCT04201665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110185737|NCT00276068|Lidocaine|lidocaine|mesh-list
110185738|NCT00276068|Desipramine|desipramine|mesh-list
110185739|NCT00276068|Anesthetics, Local|anesthetics, local|mesh-ancestor
110185740|NCT00276068|Anesthetics|anesthetics|mesh-ancestor
110185741|NCT00276068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110185742|NCT00276068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110185743|NCT00276068|Sensory System Agents|sensory system agents|mesh-ancestor
110185744|NCT00276068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110185745|NCT00276068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110185746|NCT00276068|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110185747|NCT00276068|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110185748|NCT00276068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110185749|NCT00276068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110185750|NCT00276068|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110185751|NCT00276068|Antidepressive Agents|antidepressive agents|mesh-ancestor
110185752|NCT00276068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110185753|NCT00276068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110185754|NCT00276068|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110185755|NCT00276068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110185756|NCT00276068|Adrenergic Agents|adrenergic agents|mesh-ancestor
110185757|NCT00276068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110185758|NCT00276029|Etanercept|etanercept|mesh-list
110185759|NCT00276029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110185760|NCT00276029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110185764|NCT00276029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110185766|NCT00276029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110185767|NCT00276029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110294756|NCT00265863|Mitomycins|mitomycins|mesh-list
110185768|NCT00276029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110185769|NCT00276029|Immunologic Factors|immunologic factors|mesh-ancestor
110185770|NCT00397059|Escitalopram|escitalopram|mesh-list
110185771|NCT00397059|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110185772|NCT00397059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110185773|NCT00397059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110185774|NCT00397059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110185775|NCT00397059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110185776|NCT00397059|Serotonin Agents|serotonin agents|mesh-ancestor
110185777|NCT00397059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110185778|NCT00275951|Cetuximab|cetuximab|mesh-list
110185779|NCT00275951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110185780|NCT00275951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110185781|NCT00275912|Oxcarbazepine|oxcarbazepine|mesh-list
110185782|NCT00275912|Anticonvulsants|anticonvulsants|mesh-ancestor
110185783|NCT00275912|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110185784|NCT00275912|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110185785|NCT00275912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110185786|NCT00275912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110185787|NCT00275912|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110185788|NCT00275912|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110185789|NCT00397098|Amibegron|amibegron|mesh-list
110185790|NCT00397098|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
110185791|NCT00397098|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110185792|NCT00397098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110185793|NCT00397098|Adrenergic Agents|adrenergic agents|mesh-ancestor
110185794|NCT00397098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110185795|NCT00397098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110185796|NCT00397098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110185797|NCT00397098|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110185799|NCT00275834|Anticonvulsants|anticonvulsants|mesh-ancestor
110185800|NCT00275834|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110185801|NCT00275834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110185802|NCT00275834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110185803|NCT00275834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110185804|NCT00275834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110185805|NCT00397176|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
110185806|NCT00397176|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110185807|NCT00397176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110185811|NCT00397176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110185812|NCT00397176|Antidepressive Agents|antidepressive agents|mesh-ancestor
110185815|NCT00275756|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110185816|NCT00275756|Dorzolamide|dorzolamide|mesh-list
110294871|NCT00202007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110185817|NCT00275756|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110185818|NCT00275756|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110185819|NCT00275756|Adrenergic Agents|adrenergic agents|mesh-ancestor
110185820|NCT00275756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110185821|NCT00275756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110185822|NCT00275756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110185823|NCT00275756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110185824|NCT00275756|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110185825|NCT00275756|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110185826|NCT00275756|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110185827|NCT00275756|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110185828|NCT00275756|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110185829|NCT00275756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110185831|NCT00275639|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110185832|NCT00275639|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110185833|NCT00275639|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110185834|NCT00275639|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110185835|NCT00275639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110185836|NCT03957057|Iron|iron|mesh-list
110278392|NCT00209118|Paroxetine|paroxetine|mesh-list
110185837|NCT03957057|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
110185838|NCT03957057|Trace Elements|trace elements|mesh-ancestor
110185839|NCT03957057|Micronutrients|micronutrients|mesh-ancestor
110185840|NCT03957057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110185841|NCT03957057|Hematinics|hematinics|mesh-ancestor
110185842|NCT00275600|Vitamin E|vitamin e|mesh-list
110185843|NCT00275600|Vitamins|vitamins|mesh-ancestor
110185844|NCT00275600|Micronutrients|micronutrients|mesh-ancestor
110185845|NCT00275600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110185846|NCT00275600|Antioxidants|antioxidants|mesh-ancestor
110185847|NCT00275600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110185850|NCT00275522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110185851|NCT00275522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110185852|NCT00275522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110185853|NCT00275522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110185854|NCT00275522|Antifungal Agents|antifungal agents|mesh-ancestor
110185855|NCT00275522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110185856|NCT00275522|Immunologic Factors|immunologic factors|mesh-ancestor
110185857|NCT00275522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110185858|NCT00275444|Tipranavir|tipranavir|mesh-list
110185859|NCT00275444|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110185860|NCT00275444|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110185861|NCT00275444|Antiviral Agents|antiviral agents|mesh-ancestor
110185862|NCT00275444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110185863|NCT00275405|Allyl sulfide|allyl sulfide|mesh-list
110185864|NCT00275405|Antioxidants|antioxidants|mesh-ancestor
110185865|NCT00275405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110185867|NCT00275405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110185868|NCT00275405|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110185869|NCT00275405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110185870|NCT00275405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110185871|NCT00275405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110185872|NCT00275249|Levorphanol|levorphanol|mesh-list
110185873|NCT00275249|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110278415|NCT00209313|Acyclovir|acyclovir|mesh-list
110185874|NCT00275249|Narcotics|narcotics|mesh-ancestor
110185875|NCT00275249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110185876|NCT00275249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110185877|NCT00275249|Analgesics|analgesics|mesh-ancestor
110185878|NCT00275249|Sensory System Agents|sensory system agents|mesh-ancestor
110052913|NCT01482897|Methylprednisolone|methylprednisolone|mesh-list
110185879|NCT00275249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110185880|NCT00275210|Oxaliplatin|oxaliplatin|mesh-list
110185881|NCT00275210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110185882|NCT00041535|Miglustat|miglustat|mesh-list
110185883|NCT00041535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110185884|NCT00041535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110185885|NCT00041535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110185886|NCT00041535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110185887|NCT00041535|Antiviral Agents|antiviral agents|mesh-ancestor
110185888|NCT00041535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110185889|NCT00041535|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110185890|NCT00041535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110185891|NCT00041535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110185892|NCT00041574|Nitric Oxide|nitric oxide|mesh-list
110185893|NCT00041574|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110185894|NCT00041574|Autonomic Agents|autonomic agents|mesh-ancestor
110185895|NCT00041574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110185896|NCT00041574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110185897|NCT00041574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110185898|NCT00041574|Respiratory System Agents|respiratory system agents|mesh-ancestor
110185899|NCT00041574|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110185901|NCT00041574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110185902|NCT00041574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110185903|NCT00041574|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110185904|NCT00041574|Vasodilator Agents|vasodilator agents|mesh-ancestor
110185905|NCT00041574|Gasotransmitters|gasotransmitters|mesh-ancestor
110185906|NCT00041574|Protective Agents|protective agents|mesh-ancestor
110185907|NCT00275132|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110185908|NCT00275132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110185909|NCT00275132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110185911|NCT00275132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110185912|NCT00275093|Sirolimus|sirolimus|mesh-list
110185913|NCT00275093|Temsirolimus|temsirolimus|mesh-list
110185914|NCT00275093|MTOR Inhibitors|mtor inhibitors|mesh-list
110185915|NCT00275093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110185917|NCT00275093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110295076|NCT00266214|Anesthetics|anesthetics|mesh-ancestor
110185918|NCT00275093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110185919|NCT00275093|Immunologic Factors|immunologic factors|mesh-ancestor
110185920|NCT00275093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110185921|NCT00275093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110185922|NCT00275093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110185923|NCT00275093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110185924|NCT00275093|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110185925|NCT00275093|Antifungal Agents|antifungal agents|mesh-ancestor
110185926|NCT00041652|Labetuzumab|labetuzumab|mesh-list
110185927|NCT00041652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110185928|NCT00041652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110185929|NCT03430596|Pramipexole|pramipexole|mesh-list
110185930|NCT03430596|Trihexyphenidyl|trihexyphenidyl|mesh-list
110185931|NCT03430596|Antioxidants|antioxidants|mesh-ancestor
110185932|NCT03430596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110185933|NCT03430596|Protective Agents|protective agents|mesh-ancestor
110185934|NCT03430596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110185935|NCT03430596|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110185936|NCT03430596|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110185937|NCT03430596|Dopamine Agonists|dopamine agonists|mesh-ancestor
110185939|NCT03430596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110185940|NCT03430596|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110185941|NCT03430596|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110185943|NCT00275054|Cyclophosphamide|cyclophosphamide|mesh-list
110185944|NCT00275054|Rituximab|rituximab|mesh-list
110185945|NCT00275054|Fludarabine|fludarabine|mesh-list
110185946|NCT00275054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110185947|NCT00275054|Immunologic Factors|immunologic factors|mesh-ancestor
110185948|NCT00275054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110185949|NCT00275054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110185950|NCT00275054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110185951|NCT00275054|Alkylating Agents|alkylating agents|mesh-ancestor
110185952|NCT00275054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110185953|NCT00275054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110185954|NCT00275054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110185955|NCT00275054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110185960|NCT03208179|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110185961|NCT03208179|Artenimol|artenimol|mesh-list
110185962|NCT03208179|Artemisinins|artemisinins|mesh-list
110185963|NCT03208179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110185964|NCT03208179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110185965|NCT03208179|Antimalarials|antimalarials|mesh-ancestor
110185966|NCT03208179|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110185967|NCT03208179|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110185968|NCT03208179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110185969|NCT03208179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110185970|NCT03208179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110185971|NCT03208179|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110185973|NCT00275015|Dexamethasone|dexamethasone|mesh-list
110185974|NCT00275015|Cyclophosphamide|cyclophosphamide|mesh-list
110185975|NCT00275015|Melphalan|melphalan|mesh-list
110185976|NCT00275015|Carmustine|carmustine|mesh-list
110185977|NCT00275015|Fludarabine|fludarabine|mesh-list
110185978|NCT00275015|Fludarabine phosphate|fludarabine phosphate|mesh-list
110185979|NCT00275015|Etoposide|etoposide|mesh-list
110185980|NCT00275015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110185981|NCT00275015|Immunologic Factors|immunologic factors|mesh-ancestor
110185982|NCT00275015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110185983|NCT00275015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110185984|NCT00275015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110185985|NCT00275015|Alkylating Agents|alkylating agents|mesh-ancestor
110185986|NCT00275015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110185987|NCT00275015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110185988|NCT00275015|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110185989|NCT00275015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110185991|NCT00275015|Autonomic Agents|autonomic agents|mesh-ancestor
110185992|NCT00275015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110185993|NCT00275015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110185994|NCT00275015|Glucocorticoids|glucocorticoids|mesh-ancestor
110185995|NCT00275015|Hormones|hormones|mesh-ancestor
110185996|NCT00275015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110217854|NCT00273481|Timolol|timolol|mesh-list
110185997|NCT00275015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110185998|NCT00275015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110186000|NCT00275015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110186001|NCT00275015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110186002|NCT00275015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110186003|NCT00275015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110186004|NCT00275015|Antiviral Agents|antiviral agents|mesh-ancestor
110186005|NCT00275015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110186006|NCT00274976|Alemtuzumab|alemtuzumab|mesh-list
110186010|NCT00130403|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110186011|NCT00130403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110186012|NCT00130403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186013|NCT00130403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110186014|NCT00130403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110186015|NCT00130403|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110186017|NCT03062826|Clopidogrel|clopidogrel|mesh-list
110186018|NCT03062826|Ticagrelor|ticagrelor|mesh-list
110186019|NCT03062826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110186020|NCT03062826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110186021|NCT03062826|Analgesics|analgesics|mesh-ancestor
110186022|NCT03062826|Sensory System Agents|sensory system agents|mesh-ancestor
110186023|NCT03062826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110186024|NCT03062826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110186025|NCT03062826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110186026|NCT03062826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110186027|NCT03062826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110186028|NCT03062826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110186029|NCT03062826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186030|NCT03062826|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110186031|NCT03062826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110186032|NCT03062826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110186033|NCT03062826|Antipyretics|antipyretics|mesh-ancestor
110186034|NCT03062826|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110186035|NCT03062826|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110186036|NCT03062826|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110186037|NCT03062826|Purinergic Agents|purinergic agents|mesh-ancestor
110186038|NCT03062826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110186039|NCT00130364|Pimecrolimus|pimecrolimus|mesh-list
110186040|NCT00130364|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110186041|NCT00130364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110186042|NCT00130364|Analgesics|analgesics|mesh-ancestor
110186043|NCT00130364|Sensory System Agents|sensory system agents|mesh-ancestor
110186045|NCT00130364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110186046|NCT00130364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110186047|NCT00130364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110186048|NCT00130364|Dermatologic Agents|dermatologic agents|mesh-ancestor
110186049|NCT00130364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110186050|NCT00130364|Immunologic Factors|immunologic factors|mesh-ancestor
110186051|NCT00130364|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110186052|NCT00130364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110186053|NCT00130364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186055|NCT00130325|Antitubercular Agents|antitubercular agents|mesh-ancestor
110186056|NCT00130325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110186057|NCT00130325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110186058|NCT00130325|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110186059|NCT00130325|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110186060|NCT00130325|Antimetabolites|antimetabolites|mesh-ancestor
110186062|NCT00130325|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110186063|NCT00041691|Labetuzumab|labetuzumab|mesh-list
110186064|NCT00041691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110186065|NCT00041691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110186067|NCT00394394|Amiloride|amiloride|mesh-list
110186068|NCT00394394|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110186069|NCT00394394|Protease Inhibitors|protease inhibitors|mesh-ancestor
110186070|NCT00394394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110186071|NCT00394394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186072|NCT00394394|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110186073|NCT00394394|Diuretics|diuretics|mesh-ancestor
110186074|NCT00394394|Natriuretic Agents|natriuretic agents|mesh-ancestor
110186075|NCT00394394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110186076|NCT00394394|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
110186077|NCT00394394|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110186078|NCT00394394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110186079|NCT00394394|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
110186080|NCT00394394|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110186081|NCT00130091|Clonidine|clonidine|mesh-list
110186082|NCT00130091|Analgesics|analgesics|mesh-ancestor
110186083|NCT00130091|Sensory System Agents|sensory system agents|mesh-ancestor
110186084|NCT00130091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110186085|NCT00130091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110186086|NCT00130091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110186087|NCT00130091|Sympatholytics|sympatholytics|mesh-ancestor
110186088|NCT00130091|Autonomic Agents|autonomic agents|mesh-ancestor
110186089|NCT00130091|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110186090|NCT00130091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110186091|NCT00130091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110186092|NCT00130091|Adrenergic Agents|adrenergic agents|mesh-ancestor
110186094|NCT00130091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186095|NCT00130013|Amoxicillin|amoxicillin|mesh-list
110186096|NCT00130013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110186097|NCT00130013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110186098|NCT00129857|HU 211|hu 211|mesh-list
110186099|NCT00129857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110186100|NCT00129857|Antiemetics|antiemetics|mesh-ancestor
110186101|NCT00129857|Autonomic Agents|autonomic agents|mesh-ancestor
110186102|NCT00129857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110186103|NCT00129857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110186104|NCT00129857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110186105|NCT00129857|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110186106|NCT00129857|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110186107|NCT00129857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110186108|NCT00129857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186109|NCT00129857|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110186110|NCT00129857|Protective Agents|protective agents|mesh-ancestor
110186112|NCT00129818|Antiviral Agents|antiviral agents|mesh-ancestor
110186113|NCT00129818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110186114|NCT00129818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110186115|NCT00129818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110186116|NCT00129818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186117|NCT00129506|Methotrexate|methotrexate|mesh-list
110186118|NCT00129506|Misoprostol|misoprostol|mesh-list
110186119|NCT00129506|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110186120|NCT00129506|Abortifacient Agents|abortifacient agents|mesh-ancestor
110186121|NCT00129506|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110186122|NCT00129506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295444|NCT00259662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110186123|NCT00129506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110186125|NCT00129506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186126|NCT00129506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110186127|NCT00129506|Dermatologic Agents|dermatologic agents|mesh-ancestor
110186128|NCT00129506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110186129|NCT00129506|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110186130|NCT00129506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110186131|NCT00129506|Immunologic Factors|immunologic factors|mesh-ancestor
110186132|NCT00129506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110186133|NCT00129506|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110186134|NCT00129506|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110186135|NCT00129506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110186136|NCT00129506|Oxytocics|oxytocics|mesh-ancestor
110186138|NCT00129233|Valsartan|valsartan|mesh-list
110186139|NCT00129233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110186141|NCT00129233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110186142|NCT00129233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186143|NCT00129233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110186144|NCT00129233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110186146|NCT00129233|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110186147|NCT00129233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110186148|NCT00129155|Treosulfan|treosulfan|mesh-list
110186149|NCT00129155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110186150|NCT00129155|Alkylating Agents|alkylating agents|mesh-ancestor
110186151|NCT00129155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186153|NCT00712881|Cyclophosphamide|cyclophosphamide|mesh-list
110186154|NCT00712881|Docetaxel|docetaxel|mesh-list
110186155|NCT00712881|Doxorubicin|doxorubicin|mesh-list
110186156|NCT00712881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110186157|NCT00712881|Trastuzumab|trastuzumab|mesh-list
110186158|NCT00712881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110186159|NCT00712881|Immunologic Factors|immunologic factors|mesh-ancestor
110186160|NCT00712881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110186161|NCT00712881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110186162|NCT00712881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110186163|NCT00712881|Alkylating Agents|alkylating agents|mesh-ancestor
110186164|NCT00712881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186165|NCT00712881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110186166|NCT00712881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110186167|NCT00712881|Tubulin Modulators|tubulin modulators|mesh-ancestor
110186168|NCT00712881|Antimitotic Agents|antimitotic agents|mesh-ancestor
110186169|NCT00712881|Mitosis Modulators|mitosis modulators|mesh-ancestor
110186170|NCT00712881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110186171|NCT00712881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110186172|NCT00712881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110186174|NCT00712881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110186175|NCT00042003|Decitabine|decitabine|mesh-list
110186176|NCT00042003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110186177|NCT00042003|Antimetabolites|antimetabolites|mesh-ancestor
110186178|NCT00042003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186179|NCT00042003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110186180|NCT00042003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110186182|NCT00129038|Dipyridamole|dipyridamole|mesh-list
110186183|NCT00129038|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
110186184|NCT00129038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110186185|NCT00129038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110186188|NCT00129038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110186189|NCT00129038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110186190|NCT00129038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110186191|NCT00129038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110295545|NCT04566211|Antacids|antacids|mesh-ancestor
110186192|NCT00129038|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110186193|NCT00129038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110186194|NCT00129038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186195|NCT00129038|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110186196|NCT00129038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110186197|NCT00129038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110186199|NCT00129038|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110186200|NCT00129038|Vasodilator Agents|vasodilator agents|mesh-ancestor
110186201|NCT00470223|Zoledronic Acid|zoledronic acid|mesh-list
110186202|NCT00470223|Doxorubicin|doxorubicin|mesh-list
110186203|NCT00470223|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110186204|NCT00470223|Methotrexate|methotrexate|mesh-list
110186206|NCT00470223|Ifosfamide|ifosfamide|mesh-list
110186207|NCT00470223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110186208|NCT00470223|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110186209|NCT00470223|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110186210|NCT00470223|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110186211|NCT00470223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110186212|NCT00470223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186213|NCT00470223|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110186214|NCT00470223|Abortifacient Agents|abortifacient agents|mesh-ancestor
110186215|NCT00470223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110186216|NCT00470223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110186217|NCT00470223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110186218|NCT00470223|Antimetabolites|antimetabolites|mesh-ancestor
110186219|NCT00470223|Dermatologic Agents|dermatologic agents|mesh-ancestor
110186220|NCT00470223|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110186221|NCT00470223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110186223|NCT00470223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110186224|NCT00470223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110186225|NCT00470223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110186226|NCT00470223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110186227|NCT00470223|Alkylating Agents|alkylating agents|mesh-ancestor
110186228|NCT00470223|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110186229|NCT00103389|Docetaxel|docetaxel|mesh-list
110186230|NCT00103389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110186231|NCT00103389|Tubulin Modulators|tubulin modulators|mesh-ancestor
110186232|NCT00103389|Antimitotic Agents|antimitotic agents|mesh-ancestor
110186233|NCT00103389|Mitosis Modulators|mitosis modulators|mesh-ancestor
110186234|NCT00103389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186235|NCT00128921|Bortezomib|bortezomib|mesh-list
110186236|NCT00128921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110186238|NCT00128804|Carotenoids|carotenoids|mesh-list
110186239|NCT00128804|Antioxidants|antioxidants|mesh-ancestor
110186240|NCT00128804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186241|NCT00128804|Protective Agents|protective agents|mesh-ancestor
110186242|NCT00128804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110186243|NCT00128804|Provitamins|provitamins|mesh-ancestor
110186244|NCT00128804|Vitamins|vitamins|mesh-ancestor
110186245|NCT00128804|Micronutrients|micronutrients|mesh-ancestor
110186246|NCT00097851|Docetaxel|docetaxel|mesh-list
110186247|NCT00097851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110186248|NCT00097851|Tubulin Modulators|tubulin modulators|mesh-ancestor
110186249|NCT00097851|Antimitotic Agents|antimitotic agents|mesh-ancestor
110186250|NCT00097851|Mitosis Modulators|mitosis modulators|mesh-ancestor
110295612|NCT00267267|Ezetimibe|ezetimibe|mesh-list
110186251|NCT00097851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186252|NCT00038376|Interferons|interferons|mesh-list
110186253|NCT00038376|Interferon-alpha|interferon-alpha|mesh-list
110186254|NCT00038376|Interferon alpha-2|interferon alpha-2|mesh-list
110186255|NCT00038376|Isotretinoin|isotretinoin|mesh-list
110186256|NCT00038376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110186257|NCT00038376|Antiviral Agents|antiviral agents|mesh-ancestor
110186258|NCT00038376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110186259|NCT00038376|Immunologic Factors|immunologic factors|mesh-ancestor
110186260|NCT00038376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110186261|NCT00038376|Dermatologic Agents|dermatologic agents|mesh-ancestor
110186263|NCT00128531|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110186264|NCT00128531|Fertility Agents|fertility agents|mesh-ancestor
110186265|NCT00128531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110186266|NCT00128531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110186267|NCT00128531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110186268|NCT00128531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110186269|NCT00038454|Chrysarobin|chrysarobin|mesh-list
110186270|NCT00038454|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110186271|NCT00038454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110186272|NCT00038454|Analgesics|analgesics|mesh-ancestor
110186273|NCT00038454|Sensory System Agents|sensory system agents|mesh-ancestor
110186274|NCT00038454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110186275|NCT00038454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110186276|NCT00038454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110186277|NCT00038454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110186278|NCT00128453|Colchicine|colchicine|mesh-list
110186279|NCT00128453|Gout Suppressants|gout suppressants|mesh-ancestor
110186280|NCT00128453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110186281|NCT00128453|Tubulin Modulators|tubulin modulators|mesh-ancestor
110186282|NCT00128453|Antimitotic Agents|antimitotic agents|mesh-ancestor
110186283|NCT00128453|Mitosis Modulators|mitosis modulators|mesh-ancestor
110186284|NCT00128453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186285|NCT00128453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110186286|NCT00128414|Colchicine|colchicine|mesh-list
110186287|NCT00128414|Gout Suppressants|gout suppressants|mesh-ancestor
110186289|NCT00128414|Tubulin Modulators|tubulin modulators|mesh-ancestor
110186290|NCT00128414|Antimitotic Agents|antimitotic agents|mesh-ancestor
110186291|NCT00128414|Mitosis Modulators|mitosis modulators|mesh-ancestor
110186292|NCT00128414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186293|NCT00128414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110186295|NCT00038493|Lonafarnib|lonafarnib|mesh-list
110186296|NCT00038493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110186297|NCT00038493|Alkylating Agents|alkylating agents|mesh-ancestor
110186298|NCT00038493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186299|NCT00038493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110186300|NCT00038493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110186302|NCT00038532|Saquinavir|saquinavir|mesh-list
110186303|NCT00038532|Amprenavir|amprenavir|mesh-list
110186304|NCT00038532|Efavirenz|efavirenz|mesh-list
110186305|NCT00038532|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110186306|NCT00038532|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110186307|NCT00038532|Protease Inhibitors|protease inhibitors|mesh-ancestor
110186308|NCT00038532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110186309|NCT00038532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186311|NCT00038532|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110186312|NCT00038532|Antiviral Agents|antiviral agents|mesh-ancestor
110186313|NCT00038532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110186314|NCT00038532|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110186315|NCT00038532|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110186316|NCT00038532|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110186317|NCT00038532|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110186318|NCT00038532|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110186319|NCT00038532|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110186320|NCT00038532|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110295706|NCT00232817|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110186321|NCT00038532|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110186322|NCT00038532|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110186323|NCT00038532|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110186324|NCT00038532|Antitubercular Agents|antitubercular agents|mesh-ancestor
110186325|NCT00038532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110186327|NCT00038571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110186328|NCT05770687|Dapagliflozin|dapagliflozin|mesh-list
110186329|NCT05770687|Empagliflozin|empagliflozin|mesh-list
110186330|NCT05770687|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
110186331|NCT05770687|Ertugliflozin|ertugliflozin|mesh-list
110186332|NCT05770687|Ipragliflozin|ipragliflozin|mesh-list
110186333|NCT05770687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186334|NCT05770687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110186335|NCT05770687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110186336|NCT05770323|Uric Acid|uric acid|mesh-list
110186337|NCT05770323|Antioxidants|antioxidants|mesh-ancestor
110186338|NCT05770323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186339|NCT05770323|Protective Agents|protective agents|mesh-ancestor
110186340|NCT05770323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110186341|NCT05769855|Ropivacaine|ropivacaine|mesh-list
110186342|NCT05769855|Anesthetics, Local|anesthetics, local|mesh-ancestor
110186343|NCT05769855|Anesthetics|anesthetics|mesh-ancestor
110186344|NCT05769855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110186345|NCT05769855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110186346|NCT05769855|Sensory System Agents|sensory system agents|mesh-ancestor
110186347|NCT05769855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110186348|NCT05769738|Furosemide|furosemide|mesh-list
110186349|NCT05769738|Diuretics|diuretics|mesh-list
110186350|NCT05769738|Natriuretic Agents|natriuretic agents|mesh-ancestor
110186351|NCT05769738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295750|NCT00232895|Anesthetics|anesthetics|mesh-ancestor
110186352|NCT05769738|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110186353|NCT05769738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110186354|NCT05769738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186355|NCT05769725|Docetaxel|docetaxel|mesh-list
110186356|NCT05769725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110186357|NCT05769725|Tubulin Modulators|tubulin modulators|mesh-ancestor
110186358|NCT05769725|Antimitotic Agents|antimitotic agents|mesh-ancestor
110186359|NCT05769725|Mitosis Modulators|mitosis modulators|mesh-ancestor
110186360|NCT05769725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186361|NCT05769660|Temozolomide|temozolomide|mesh-list
110186362|NCT05769660|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110186363|NCT05769660|Alkylating Agents|alkylating agents|mesh-ancestor
110186364|NCT05769660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186365|NCT05769660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110186366|NCT05769569|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110186367|NCT05769569|Antiviral Agents|antiviral agents|mesh-ancestor
110186368|NCT05769569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110186369|NCT05769049|Vaccines|vaccines|mesh-list
110186371|NCT05769049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110186372|NCT05768997|Darbepoetin alfa|darbepoetin alfa|mesh-list
110186373|NCT05768997|Hematinics|hematinics|mesh-ancestor
110278674|NCT00584662|Mydriatics|mydriatics|mesh-ancestor
110186374|NCT05768945|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
110186375|NCT05768945|Protease Inhibitors|protease inhibitors|mesh-ancestor
110186376|NCT05768945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110186377|NCT05768945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186378|NCT05768945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110186379|NCT05768945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110186380|NCT05765305|Chromium|chromium|mesh-list
110186381|NCT05765305|Letrozole|letrozole|mesh-list
110186382|NCT05765305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110186383|NCT05765305|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110186384|NCT05765305|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110186386|NCT05765305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186387|NCT05765305|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110186388|NCT05765305|Hormone Antagonists|hormone antagonists|mesh-ancestor
110186389|NCT05765305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110186390|NCT05765305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110186391|NCT05765305|Trace Elements|trace elements|mesh-ancestor
110186392|NCT05765305|Micronutrients|micronutrients|mesh-ancestor
110186393|NCT05762146|Perphenazine|perphenazine|mesh-list
110186394|NCT05762146|Riociguat|riociguat|mesh-list
110186395|NCT05762146|Propylthiouracil|propylthiouracil|mesh-list
110186396|NCT05762146|Enzyme Activators|enzyme activators|mesh-ancestor
110186397|NCT05762146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186398|NCT05762146|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110186399|NCT05762146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110186400|NCT05762146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110186401|NCT05762146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110186403|NCT05762146|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110186404|NCT05762146|Dopamine Agents|dopamine agents|mesh-ancestor
110186405|NCT05762146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110186406|NCT05762146|Antimetabolites|antimetabolites|mesh-ancestor
110186407|NCT05762146|Antithyroid Agents|antithyroid agents|mesh-ancestor
110186408|NCT05762146|Hormone Antagonists|hormone antagonists|mesh-ancestor
110186409|NCT05762146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110186410|NCT05760612|Trastuzumab|trastuzumab|mesh-list
110186411|NCT05760612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110186412|NCT05760612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110186413|NCT05760144|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110186414|NCT05760144|Etonogestrel|etonogestrel|mesh-list
110186415|NCT05760144|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110186416|NCT05760144|Contraceptive Agents|contraceptive agents|mesh-ancestor
110186417|NCT05760144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110186418|NCT05760144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110186419|NCT05760144|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110186420|NCT05760144|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110186421|NCT05760144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110186422|NCT05760144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110186423|NCT05744674|Ropivacaine|ropivacaine|mesh-list
110186424|NCT05744674|Anesthetics, Local|anesthetics, local|mesh-ancestor
110186426|NCT05744674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110186427|NCT05744674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110186429|NCT05744674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110186430|NCT05736978|Azacitidine|azacitidine|mesh-list
110186431|NCT05736978|Venetoclax|venetoclax|mesh-list
110186432|NCT05736978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110186434|NCT05736978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186435|NCT05736978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110186436|NCT05736978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110186437|NCT05736965|Azacitidine|azacitidine|mesh-list
110186439|NCT05736965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110186440|NCT05736965|Antimetabolites|antimetabolites|mesh-ancestor
110186441|NCT05736965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186442|NCT05736965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110186443|NCT05736965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110186444|NCT05706727|Phenylephrine|phenylephrine|mesh-list
110186445|NCT05706727|Oxymetazoline|oxymetazoline|mesh-list
110186446|NCT05706727|Mephentermine|mephentermine|mesh-list
110186447|NCT05706727|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110186448|NCT05706727|Mydriatics|mydriatics|mesh-ancestor
110186449|NCT05706727|Autonomic Agents|autonomic agents|mesh-ancestor
110186450|NCT05706727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110186451|NCT05706727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110186453|NCT05706727|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110186454|NCT05706727|Nasal Decongestants|nasal decongestants|mesh-ancestor
110186455|NCT05706727|Respiratory System Agents|respiratory system agents|mesh-ancestor
110186456|NCT05706727|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110186457|NCT05706727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110186458|NCT05706727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110186459|NCT05706727|Adrenergic Agents|adrenergic agents|mesh-ancestor
110186460|NCT05706727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110186461|NCT05706727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186462|NCT05706727|Protective Agents|protective agents|mesh-ancestor
110186463|NCT05697783|Fentanyl|fentanyl|mesh-list
110186465|NCT05697783|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110186466|NCT05697783|Narcotics|narcotics|mesh-ancestor
110186467|NCT05697783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110186468|NCT05697783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110186469|NCT05697783|Analgesics|analgesics|mesh-ancestor
110186470|NCT05697783|Sensory System Agents|sensory system agents|mesh-ancestor
110186471|NCT05697783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110186472|NCT05697783|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110186473|NCT05697783|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110186474|NCT05697783|Anesthetics, General|anesthetics, general|mesh-ancestor
110186475|NCT05697783|Anesthetics|anesthetics|mesh-ancestor
110186476|NCT05697783|Antitussive Agents|antitussive agents|mesh-ancestor
110186477|NCT05697783|Respiratory System Agents|respiratory system agents|mesh-ancestor
110186479|NCT05672225|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110186480|NCT05672225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110186481|NCT05672225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110186482|NCT05672225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110186484|NCT05672225|Sensory System Agents|sensory system agents|mesh-ancestor
110186485|NCT05672225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110186486|NCT05672225|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110186487|NCT05672225|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110186488|NCT05672225|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110186489|NCT05672225|Adrenergic Agents|adrenergic agents|mesh-ancestor
110186490|NCT05672225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110186491|NCT05672225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186492|NCT05657860|Guanfacine|guanfacine|mesh-list
110186493|NCT05657860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110186494|NCT05657860|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110186495|NCT05657860|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110186496|NCT05657860|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110186497|NCT05657860|Adrenergic Agents|adrenergic agents|mesh-ancestor
110186498|NCT05657860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110186499|NCT05657860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186500|NCT05657860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110186501|NCT05595603|Gentamicins|gentamicins|mesh-list
110186502|NCT05595603|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
110186503|NCT05595603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110186504|NCT05595603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110186505|NCT05595603|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110186506|NCT05595603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110186507|NCT05595603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186508|NCT05595603|Vasodilator Agents|vasodilator agents|mesh-ancestor
110186509|NCT05595603|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110186510|NCT05595603|Protective Agents|protective agents|mesh-ancestor
110186511|NCT05595603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110186512|NCT05568940|Tibolone|tibolone|mesh-list
110186513|NCT05568940|Androgen Antagonists|androgen antagonists|mesh-ancestor
110186514|NCT05568940|Hormone Antagonists|hormone antagonists|mesh-ancestor
110186515|NCT05568940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110186516|NCT05568940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110186517|NCT05568940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110186518|NCT05568940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110186519|NCT05568940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110186520|NCT05568940|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110186521|NCT05568940|Anabolic Agents|anabolic agents|mesh-ancestor
110186522|NCT05568940|Hormones|hormones|mesh-ancestor
110186523|NCT05562973|Psilocybin|psilocybin|mesh-list
110186524|NCT05562973|Hallucinogens|hallucinogens|mesh-ancestor
110186525|NCT05562973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110186526|NCT05562973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110186527|NCT05551299|Photosensitizing Agents|photosensitizing agents|mesh-list
110186528|NCT05551299|Dermatologic Agents|dermatologic agents|mesh-ancestor
110186529|NCT05543785|Ketorolac|ketorolac|mesh-list
110186530|NCT05543785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110186531|NCT05543785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110186532|NCT05543785|Analgesics|analgesics|mesh-ancestor
110186533|NCT05543785|Sensory System Agents|sensory system agents|mesh-ancestor
110186534|NCT05543785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110186535|NCT05543785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110186536|NCT05543785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110186538|NCT05543785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110186539|NCT05543785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110186540|NCT05543785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186541|NCT05457465|Cannabidiol|cannabidiol|mesh-list
110186542|NCT05457465|Anticonvulsants|anticonvulsants|mesh-ancestor
110186543|NCT05453955|Propofol|propofol|mesh-list
110186544|NCT05453955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110186545|NCT05453955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110186546|NCT05453955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110186547|NCT05453955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110186548|NCT05453955|Anesthetics, General|anesthetics, general|mesh-ancestor
110186550|NCT05427786|Nicorandil|nicorandil|mesh-list
110186551|NCT05427786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110186552|NCT05427786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110186553|NCT05427786|Vasodilator Agents|vasodilator agents|mesh-ancestor
110186554|NCT05427786|Vitamin B Complex|vitamin b complex|mesh-ancestor
110186555|NCT05427786|Vitamins|vitamins|mesh-ancestor
110186556|NCT05427786|Micronutrients|micronutrients|mesh-ancestor
110186557|NCT05427786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110186558|NCT05417776|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
110186560|NCT05417776|Sequestering Agents|sequestering agents|mesh-ancestor
110186561|NCT05417776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186562|NCT05402553|Ondansetron|ondansetron|mesh-list
110186563|NCT05402553|Antiemetics|antiemetics|mesh-ancestor
110186564|NCT05402553|Autonomic Agents|autonomic agents|mesh-ancestor
110186565|NCT05402553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110186566|NCT05402553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110186567|NCT05402553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110186568|NCT05402553|Antipruritics|antipruritics|mesh-ancestor
110186569|NCT05402553|Dermatologic Agents|dermatologic agents|mesh-ancestor
110186570|NCT05402553|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110186571|NCT05402553|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110186572|NCT05402553|Serotonin Agents|serotonin agents|mesh-ancestor
110186573|NCT05402553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110186574|NCT05402553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186575|NCT05379322|Adalimumab|adalimumab|mesh-list
110186576|NCT05379322|Golimumab|golimumab|mesh-list
110186577|NCT05379322|Etanercept|etanercept|mesh-list
110186578|NCT05379322|Upadacitinib|upadacitinib|mesh-list
110186579|NCT05379322|Tofacitinib|tofacitinib|mesh-list
110186580|NCT05379322|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
110186581|NCT05379322|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110186582|NCT05379322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110186583|NCT05379322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110186584|NCT05379322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110186585|NCT05379322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110186586|NCT05379322|Analgesics|analgesics|mesh-ancestor
110186587|NCT05379322|Sensory System Agents|sensory system agents|mesh-ancestor
110186588|NCT05379322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110186589|NCT05379322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110186590|NCT05379322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110186591|NCT05379322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110186592|NCT05379322|Immunologic Factors|immunologic factors|mesh-ancestor
110186593|NCT05379322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110186594|NCT05379322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110186595|NCT05379322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186596|NCT05301023|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110186598|NCT05301023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110186599|NCT05301023|Antitubercular Agents|antitubercular agents|mesh-ancestor
110186600|NCT05298696|Cilostazol|cilostazol|mesh-list
110186601|NCT05298696|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110186602|NCT05298696|Autonomic Agents|autonomic agents|mesh-ancestor
110186603|NCT05298696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110186604|NCT05298696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110186606|NCT05298696|Respiratory System Agents|respiratory system agents|mesh-ancestor
110186607|NCT05298696|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110186608|NCT05298696|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110186609|NCT05298696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186610|NCT05298696|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110186611|NCT05298696|Vasodilator Agents|vasodilator agents|mesh-ancestor
110186613|NCT05298696|Protective Agents|protective agents|mesh-ancestor
110186614|NCT05298696|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110186615|NCT05298696|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110186616|NCT05298696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110186617|NCT05287425|Ciprofloxacin|ciprofloxacin|mesh-list
110186618|NCT05287425|Gentamicins|gentamicins|mesh-list
110186619|NCT05287425|Benzalkonium Compounds|benzalkonium compounds|mesh-list
110186621|NCT05287425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110186622|NCT05287425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110186623|NCT05287425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110186624|NCT05287425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110186625|NCT05287425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110186626|NCT05287425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186627|NCT05287425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110186628|NCT05287425|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110186629|NCT05287425|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110186630|NCT05287425|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110186631|NCT05287425|Plasma Substitutes|plasma substitutes|mesh-ancestor
110186632|NCT05287425|Blood Substitutes|blood substitutes|mesh-ancestor
110186633|NCT05287425|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110186635|NCT05258721|Cariostatic Agents|cariostatic agents|mesh-ancestor
110186636|NCT05258721|Protective Agents|protective agents|mesh-ancestor
110186637|NCT05258721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110186638|NCT05232032|Nociceptin|nociceptin|mesh-list
110186639|NCT05232032|Vasodilator Agents|vasodilator agents|mesh-ancestor
110186641|NCT05215730|Trace Elements|trace elements|mesh-ancestor
110186642|NCT05215730|Micronutrients|micronutrients|mesh-ancestor
110186643|NCT05215730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110186644|NCT05209074|Ivosidenib|ivosidenib|mesh-list
110186645|NCT05209074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110186646|NCT05209074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110186647|NCT05209074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186649|NCT05192850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110186650|NCT05192850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110186651|NCT05111717|Desflurane|desflurane|mesh-list
110186652|NCT05111717|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110186653|NCT05111717|Anesthetics, General|anesthetics, general|mesh-ancestor
110186654|NCT05111717|Anesthetics|anesthetics|mesh-ancestor
110186655|NCT05111717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110186656|NCT05111717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110186658|NCT05105919|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110186659|NCT05105919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110186661|NCT05105919|Sensory System Agents|sensory system agents|mesh-ancestor
110186662|NCT05105919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110186663|NCT05105919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110186664|NCT05105919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110186666|NCT05105919|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110186667|NCT05105919|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110186668|NCT05105919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186669|NCT05105919|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110186670|NCT05105919|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110186671|NCT05105919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110186672|NCT05105919|Antipyretics|antipyretics|mesh-ancestor
110186673|NCT05054439|Paclitaxel|paclitaxel|mesh-list
110186674|NCT05054439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110186675|NCT05054439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110186676|NCT05054439|Tubulin Modulators|tubulin modulators|mesh-ancestor
110186677|NCT05054439|Antimitotic Agents|antimitotic agents|mesh-ancestor
110186678|NCT05054439|Mitosis Modulators|mitosis modulators|mesh-ancestor
110186679|NCT05054439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186681|NCT05049603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110186682|NCT05049603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110186683|NCT05049603|Antimetabolites|antimetabolites|mesh-ancestor
110186684|NCT05049603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186685|NCT05049603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110186686|NCT05049603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110186687|NCT05049603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110186688|NCT05037162|Fibrin fragment D|fibrin fragment d|mesh-list
110186689|NCT05037162|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110186690|NCT05037162|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110186691|NCT05037162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186692|NCT05037162|Hemostatics|hemostatics|mesh-ancestor
110186694|NCT05024318|Pembrolizumab|pembrolizumab|mesh-list
110186695|NCT05024318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110186696|NCT05024318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110186697|NCT05024318|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110186698|NCT05024318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186699|NCT05022654|Irinotecan|irinotecan|mesh-list
110186700|NCT05022654|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110186701|NCT05022654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110186702|NCT05022654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110186703|NCT05022654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186705|NCT05020457|Paclitaxel|paclitaxel|mesh-list
110186706|NCT05020457|Docetaxel|docetaxel|mesh-list
110186707|NCT05020457|Cisplatin|cisplatin|mesh-list
110186708|NCT05020457|Pemetrexed|pemetrexed|mesh-list
110186709|NCT05020457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110186710|NCT05020457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110186711|NCT05020457|Tubulin Modulators|tubulin modulators|mesh-ancestor
110186712|NCT05020457|Antimitotic Agents|antimitotic agents|mesh-ancestor
110186713|NCT05020457|Mitosis Modulators|mitosis modulators|mesh-ancestor
110186714|NCT05020457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110278807|NCT00408551|Vitamins|vitamins|mesh-ancestor
110186715|NCT05020457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110186716|NCT05020457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110186717|NCT05020457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110186718|NCT05020444|Cyclophosphamide|cyclophosphamide|mesh-list
110186719|NCT05020444|Fludarabine|fludarabine|mesh-list
110186720|NCT05020444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110186721|NCT05020444|Immunologic Factors|immunologic factors|mesh-ancestor
110186722|NCT05020444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110186723|NCT05020444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110186724|NCT05020444|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110186725|NCT05020444|Alkylating Agents|alkylating agents|mesh-ancestor
110186726|NCT05020444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186727|NCT05020444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110186728|NCT05020444|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110186731|NCT05012189|Antiviral Agents|antiviral agents|mesh-ancestor
110186732|NCT05012189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110186733|NCT05012189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110186734|NCT05012189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186735|NCT04985721|Tislelizumab|tislelizumab|mesh-list
110186736|NCT04985721|Pamiparib|pamiparib|mesh-list
110186737|NCT04985721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110186738|NCT04985721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110186739|NCT04985721|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110186740|NCT04985721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110186741|NCT04985721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186742|NCT04952610|Etripamil|etripamil|mesh-list
110186743|NCT04952610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110186744|NCT04952610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110186745|NCT04952610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186746|NCT04952610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110186747|NCT04952610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110186748|NCT04902911|Antibodies|antibodies|mesh-list
110186749|NCT04902911|Immunoglobulin M|immunoglobulin m|mesh-list
110186750|NCT04902911|Immunologic Factors|immunologic factors|mesh-ancestor
110186751|NCT04902911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110186752|NCT04864366|Tenofovir|tenofovir|mesh-list
110186753|NCT04864366|Antiviral Agents|antiviral agents|mesh-ancestor
110186754|NCT04864366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110186755|NCT04864366|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110186756|NCT04864366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110186757|NCT04864366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110186758|NCT04864366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186759|NCT04864366|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110186760|NCT04864366|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110186761|NCT04859296|Dronabinol|dronabinol|mesh-list
110186762|NCT04859296|Hallucinogens|hallucinogens|mesh-ancestor
110186763|NCT04859296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110186764|NCT04859296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110186765|NCT04859296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110186766|NCT04859296|Analgesics|analgesics|mesh-ancestor
110186767|NCT04859296|Sensory System Agents|sensory system agents|mesh-ancestor
110186768|NCT04859296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110186769|NCT04859296|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110186770|NCT04859296|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110186771|NCT04859296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110186772|NCT04859296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186773|NCT04859296|Hormones|hormones|mesh-ancestor
110094942|NCT01711749|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110186774|NCT04859296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110186775|NCT04857684|Bevacizumab|bevacizumab|mesh-list
110186776|NCT04857684|Atezolizumab|atezolizumab|mesh-list
110186777|NCT04857684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110186778|NCT04857684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110186779|NCT04857684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110186780|NCT04857684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110186781|NCT04857684|Growth Substances|growth substances|mesh-ancestor
110186782|NCT04857684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110186784|NCT04857684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110186785|NCT04857684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186786|NCT04854811|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-list
110186787|NCT04854811|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110186788|NCT04854811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110186789|NCT04854811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186790|NCT04846348|Diphenhydramine|diphenhydramine|mesh-list
110186791|NCT04846348|Promethazine|promethazine|mesh-list
110186792|NCT04846348|Cromolyn Sodium|cromolyn sodium|mesh-list
110186793|NCT04846348|Salicylates|salicylates|mesh-list
110186794|NCT04846348|Emollients|emollients|mesh-list
110186795|NCT04846348|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110186796|NCT04846348|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110186797|NCT04846348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110186798|NCT04846348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110186799|NCT04846348|Anesthetics, Local|anesthetics, local|mesh-ancestor
110186800|NCT04846348|Anesthetics|anesthetics|mesh-ancestor
110186801|NCT04846348|Sensory System Agents|sensory system agents|mesh-ancestor
110186802|NCT04846348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110296322|NCT00234962|Ritonavir|ritonavir|mesh-list
110186804|NCT04846348|Autonomic Agents|autonomic agents|mesh-ancestor
110186805|NCT04846348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110186806|NCT04846348|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110186807|NCT04846348|Histamine Antagonists|histamine antagonists|mesh-ancestor
110186808|NCT04846348|Histamine Agents|histamine agents|mesh-ancestor
110186809|NCT04846348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110186810|NCT04846348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186811|NCT04846348|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110186812|NCT04846348|Antipruritics|antipruritics|mesh-ancestor
110186813|NCT04846348|Dermatologic Agents|dermatologic agents|mesh-ancestor
110186814|NCT04846348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110186815|NCT04846348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110186817|NCT04846348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110186818|NCT04846348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110186819|NCT04846348|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110186820|NCT04846348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110186821|NCT04846348|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
110186822|NCT04846348|Immunologic Factors|immunologic factors|mesh-ancestor
110186823|NCT04846348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110186824|NCT04846348|Respiratory System Agents|respiratory system agents|mesh-ancestor
110186825|NCT04771520|Piperazine|piperazine|mesh-list
110186826|NCT04771520|Mebendazole|mebendazole|mesh-list
110186827|NCT04771520|Piperazine citrate|piperazine citrate|mesh-list
110186828|NCT04771520|DMP 777|dmp 777|mesh-list
110186829|NCT04771520|Antinematodal Agents|antinematodal agents|mesh-ancestor
110186830|NCT04771520|Anthelmintics|anthelmintics|mesh-ancestor
110186831|NCT04771520|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110186832|NCT04771520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110186833|NCT04771520|Tubulin Modulators|tubulin modulators|mesh-ancestor
110186834|NCT04771520|Antimitotic Agents|antimitotic agents|mesh-ancestor
110186835|NCT04771520|Mitosis Modulators|mitosis modulators|mesh-ancestor
110186836|NCT04771520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186837|NCT04771520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110186838|NCT04771520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110186839|NCT04769453|Hyaluronic Acid|hyaluronic acid|mesh-list
110186840|NCT04769453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110186841|NCT04769453|Immunologic Factors|immunologic factors|mesh-ancestor
110186842|NCT04769453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110186843|NCT04769453|Viscosupplements|viscosupplements|mesh-ancestor
110186844|NCT04769453|Protective Agents|protective agents|mesh-ancestor
110186845|NCT04765709|Carboplatin|carboplatin|mesh-list
110186847|NCT04765709|Durvalumab|durvalumab|mesh-list
110186849|NCT04765709|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110186850|NCT04765709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110186851|NCT04765709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110186852|NCT04765709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186853|NCT04765709|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110186854|NCT04765709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110186855|NCT04765709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110186856|NCT04765709|Immunologic Factors|immunologic factors|mesh-ancestor
110186857|NCT04765709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110186858|NCT04765709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110186859|NCT04765709|Tubulin Modulators|tubulin modulators|mesh-ancestor
110186860|NCT04765709|Antimitotic Agents|antimitotic agents|mesh-ancestor
110186861|NCT04765709|Mitosis Modulators|mitosis modulators|mesh-ancestor
110186862|NCT04742699|Lemborexant|lemborexant|mesh-list
110186863|NCT04742699|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
110186864|NCT04742699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110186865|NCT04742699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186866|NCT04742699|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110186867|NCT04742699|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110186868|NCT04742699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110186869|NCT04742699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110186871|NCT04654689|Resveratrol|resveratrol|mesh-list
110186872|NCT04654689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110186873|NCT04654689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110186874|NCT04654689|Analgesics|analgesics|mesh-ancestor
110186875|NCT04654689|Sensory System Agents|sensory system agents|mesh-ancestor
110186876|NCT04654689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110186877|NCT04654689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110186878|NCT04654689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110186879|NCT04654689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110186880|NCT04654689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110186881|NCT04654689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110186882|NCT04654689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186883|NCT04654689|Antioxidants|antioxidants|mesh-ancestor
110186884|NCT04654689|Protective Agents|protective agents|mesh-ancestor
110186885|NCT04654689|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110186886|NCT04634838|Copper|copper|mesh-list
110186887|NCT04634838|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110186888|NCT04634838|Trace Elements|trace elements|mesh-ancestor
110186889|NCT04634838|Micronutrients|micronutrients|mesh-ancestor
110186890|NCT04634838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110186891|NCT04634838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110186892|NCT04629534|Cholecalciferol|cholecalciferol|mesh-list
110186893|NCT04629534|Vitamin D|vitamin d|mesh-list
110186894|NCT04629534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110186895|NCT04629534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110186896|NCT04629534|Vitamins|vitamins|mesh-ancestor
110186897|NCT04629534|Micronutrients|micronutrients|mesh-ancestor
110186898|NCT04629534|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110186899|NCT04602065|Antibodies|antibodies|mesh-list
110186900|NCT04602065|Antibodies, Bispecific|antibodies, bispecific|mesh-list
110186901|NCT04602065|Immunologic Factors|immunologic factors|mesh-ancestor
110186902|NCT04602065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110186903|NCT04598815|Sirolimus|sirolimus|mesh-list
110186904|NCT04598815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110186905|NCT04598815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110186906|NCT04598815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110186907|NCT04598815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110186909|NCT04598815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110186910|NCT04598815|Immunologic Factors|immunologic factors|mesh-ancestor
110186911|NCT04598815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110186912|NCT04584112|Paclitaxel|paclitaxel|mesh-list
110186913|NCT04584112|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110186914|NCT04584112|Cyclophosphamide|cyclophosphamide|mesh-list
110186915|NCT04584112|Carboplatin|carboplatin|mesh-list
110186916|NCT04584112|Doxorubicin|doxorubicin|mesh-list
110186917|NCT04584112|Atezolizumab|atezolizumab|mesh-list
110186918|NCT04584112|Molgramostim|molgramostim|mesh-list
110186919|NCT04584112|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110186920|NCT04584112|Lenograstim|lenograstim|mesh-list
110186921|NCT04584112|Sargramostim|sargramostim|mesh-list
110186922|NCT04584112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110186923|NCT04584112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110186924|NCT04584112|Tubulin Modulators|tubulin modulators|mesh-ancestor
110186925|NCT04584112|Antimitotic Agents|antimitotic agents|mesh-ancestor
110186926|NCT04584112|Mitosis Modulators|mitosis modulators|mesh-ancestor
110186927|NCT04584112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186928|NCT04584112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110186929|NCT04584112|Immunologic Factors|immunologic factors|mesh-ancestor
110186930|NCT04584112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110186931|NCT04584112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110186932|NCT04584112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110186933|NCT04584112|Alkylating Agents|alkylating agents|mesh-ancestor
110186934|NCT04584112|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110186935|NCT04584112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110186936|NCT04584112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110186937|NCT04584112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110186938|NCT04584112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110186939|NCT04584112|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110186940|NCT04584112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110186941|NCT04584112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110186943|NCT04573777|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110186944|NCT04573777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110186945|NCT04573777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110186946|NCT04573777|Antimetabolites|antimetabolites|mesh-ancestor
110186947|NCT04573777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186948|NCT04573777|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110186949|NCT04573777|Protease Inhibitors|protease inhibitors|mesh-ancestor
110186950|NCT04573777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110186951|NCT04573777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110186952|NCT04507711|Palonosetron|palonosetron|mesh-list
110186953|NCT04507711|Antiemetics|antiemetics|mesh-ancestor
110186954|NCT04507711|Autonomic Agents|autonomic agents|mesh-ancestor
110186955|NCT04507711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110186956|NCT04507711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110186957|NCT04507711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110186958|NCT04507711|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110186960|NCT04507711|Serotonin Agents|serotonin agents|mesh-ancestor
110186961|NCT04507711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110186962|NCT04507711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186963|NCT04499274|Ondansetron|ondansetron|mesh-list
110186964|NCT04499274|Antiemetics|antiemetics|mesh-ancestor
110186965|NCT04499274|Autonomic Agents|autonomic agents|mesh-ancestor
110186966|NCT04499274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110186967|NCT04499274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110186968|NCT04499274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110186969|NCT04499274|Antipruritics|antipruritics|mesh-ancestor
110186970|NCT04499274|Dermatologic Agents|dermatologic agents|mesh-ancestor
110186971|NCT04499274|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110186972|NCT04499274|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110186973|NCT04499274|Serotonin Agents|serotonin agents|mesh-ancestor
110186974|NCT04499274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110186975|NCT04499274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186976|NCT04488159|Leucovorin|leucovorin|mesh-list
110186977|NCT04488159|Fluorouracil|fluorouracil|mesh-list
110186978|NCT04488159|Capecitabine|capecitabine|mesh-list
110186979|NCT04488159|Oxaliplatin|oxaliplatin|mesh-list
110186980|NCT04488159|Antimetabolites|antimetabolites|mesh-ancestor
110186981|NCT04488159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186982|NCT04488159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110186983|NCT04488159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110186984|NCT04488159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110186985|NCT04488159|Immunologic Factors|immunologic factors|mesh-ancestor
110186986|NCT04488159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110186987|NCT04488159|Antidotes|antidotes|mesh-ancestor
110186988|NCT04488159|Protective Agents|protective agents|mesh-ancestor
110186989|NCT04488159|Vitamin B Complex|vitamin b complex|mesh-ancestor
110186990|NCT04488159|Vitamins|vitamins|mesh-ancestor
110186992|NCT04376827|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110186993|NCT04376827|Immunologic Factors|immunologic factors|mesh-ancestor
110186994|NCT04376827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110186995|NCT04315948|Interferons|interferons|mesh-list
110186996|NCT04315948|Ritonavir|ritonavir|mesh-list
110186997|NCT04315948|Lopinavir|lopinavir|mesh-list
110186998|NCT04315948|Interferon-beta|interferon-beta|mesh-list
110186999|NCT04315948|Interferon beta-1a|interferon beta-1a|mesh-list
110187000|NCT04315948|Remdesivir|remdesivir|mesh-list
110187001|NCT04315948|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
110187002|NCT04315948|Hydroxychloroquine|hydroxychloroquine|mesh-list
110187003|NCT04315948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110187004|NCT04315948|Antiviral Agents|antiviral agents|mesh-ancestor
110187005|NCT04315948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110187006|NCT04315948|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110187007|NCT04315948|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110187008|NCT04315948|Protease Inhibitors|protease inhibitors|mesh-ancestor
110187009|NCT04315948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110187010|NCT04315948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110187011|NCT04315948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110187012|NCT04315948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110187013|NCT04315948|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110187014|NCT04315948|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110187016|NCT04315948|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110187017|NCT04315948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110187018|NCT04315948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110187019|NCT04315948|Immunologic Factors|immunologic factors|mesh-ancestor
110187020|NCT04315948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110187021|NCT04315948|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110187022|NCT04315948|Antimetabolites|antimetabolites|mesh-ancestor
110187024|NCT04300127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110187025|NCT04300127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110187026|NCT04266236|Ropivacaine|ropivacaine|mesh-list
110187027|NCT04266236|Anesthetics|anesthetics|mesh-ancestor
110187028|NCT04266236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110187029|NCT04266236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110187030|NCT04266236|Anesthetics, Local|anesthetics, local|mesh-ancestor
110187031|NCT04266236|Sensory System Agents|sensory system agents|mesh-ancestor
110187032|NCT04266236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110187033|NCT04256343|Deuterium Oxide|deuterium oxide|mesh-list
110187034|NCT04256343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110187035|NCT04256343|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110187036|NCT04256343|Protective Agents|protective agents|mesh-ancestor
110187037|NCT04256343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296496|NCT00268398|Antidotes|antidotes|mesh-ancestor
110187039|NCT04243629|Insulin, Short-Acting|insulin, short-acting|mesh-list
110187040|NCT04243629|Pancrelipase|pancrelipase|mesh-list
110187041|NCT04243629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110187042|NCT04243629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110187043|NCT04243629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110187044|NCT04202835|Cyclophosphamide|cyclophosphamide|mesh-list
110187046|NCT04202835|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110187047|NCT04202835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110187048|NCT04202835|Immunologic Factors|immunologic factors|mesh-ancestor
110187049|NCT04202835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110187050|NCT04202835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110187051|NCT04202835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110187052|NCT04202835|Alkylating Agents|alkylating agents|mesh-ancestor
110187053|NCT04202835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110187054|NCT04202835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110187055|NCT04202835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110187057|NCT04199026|Doxorubicin|doxorubicin|mesh-list
110187058|NCT04199026|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110187059|NCT04199026|Daunorubicin|daunorubicin|mesh-list
110187060|NCT04199026|Irinotecan|irinotecan|mesh-list
110187061|NCT04199026|Vincristine|vincristine|mesh-list
110187062|NCT04199026|Everolimus|everolimus|mesh-list
110187063|NCT04199026|Temozolomide|temozolomide|mesh-list
110187064|NCT04199026|Temsirolimus|temsirolimus|mesh-list
110187065|NCT04199026|Ifosfamide|ifosfamide|mesh-list
110187066|NCT04199026|Isophosphamide mustard|isophosphamide mustard|mesh-list
110187067|NCT04199026|MTOR Inhibitors|mtor inhibitors|mesh-list
110187068|NCT04199026|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110187069|NCT04199026|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110187070|NCT04199026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110187071|NCT04199026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110187072|NCT04199026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110187073|NCT04199026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110187074|NCT04199026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110187075|NCT04199026|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110187076|NCT04199026|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110187077|NCT04199026|Tubulin Modulators|tubulin modulators|mesh-ancestor
110187078|NCT04199026|Antimitotic Agents|antimitotic agents|mesh-ancestor
110187079|NCT04199026|Mitosis Modulators|mitosis modulators|mesh-ancestor
110187080|NCT04199026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110187081|NCT04199026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110187082|NCT04199026|Immunologic Factors|immunologic factors|mesh-ancestor
110187083|NCT04199026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110278904|NCT00587470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110278905|NCT00587470|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110278906|NCT00587470|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110278907|NCT00587470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110278908|NCT00209703|Leucovorin|leucovorin|mesh-list
110278909|NCT00209703|Fluorouracil|fluorouracil|mesh-list
110278910|NCT00209703|Oxaliplatin|oxaliplatin|mesh-list
110278911|NCT00209703|Levoleucovorin|levoleucovorin|mesh-list
110187084|NCT04199026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110187086|NCT04199026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110187087|NCT04199026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110187088|NCT04199026|Antifungal Agents|antifungal agents|mesh-ancestor
110187089|NCT04182997|Dexamethasone|dexamethasone|mesh-list
110187090|NCT04182997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110187091|NCT04182997|Antiemetics|antiemetics|mesh-ancestor
110187092|NCT04182997|Autonomic Agents|autonomic agents|mesh-ancestor
110187093|NCT04182997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110187094|NCT04182997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110187095|NCT04182997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110187096|NCT04182997|Glucocorticoids|glucocorticoids|mesh-ancestor
110187097|NCT04182997|Hormones|hormones|mesh-ancestor
110187098|NCT04182997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110187099|NCT04182997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110187101|NCT04167163|Abaloparatide|abaloparatide|mesh-list
110187102|NCT04167163|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110187103|NCT04167163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110187104|NCT04134936|Lenalidomide|lenalidomide|mesh-list
110187105|NCT04134936|Immunologic Factors|immunologic factors|mesh-ancestor
110187106|NCT04134936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110187107|NCT04134936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110187108|NCT04134936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110187109|NCT04134936|Growth Substances|growth substances|mesh-ancestor
110187110|NCT04134936|Growth Inhibitors|growth inhibitors|mesh-ancestor
110218024|NCT00274573|Bromides|bromides|mesh-list
110187111|NCT04134936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110187113|NCT04115111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110296527|NCT00235508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110296528|NCT00235508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296529|NCT00268515|Cyclosporine|cyclosporine|mesh-list
110296530|NCT00268515|Prednisone|prednisone|mesh-list
110296531|NCT00268515|Azathioprine|azathioprine|mesh-list
110296532|NCT00268515|Tacrolimus|tacrolimus|mesh-list
110296533|NCT00268515|Cyclosporins|cyclosporins|mesh-list
110187114|NCT04115111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110187115|NCT04113109|Icatibant|icatibant|mesh-list
110187116|NCT04113109|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110187117|NCT04113109|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110187118|NCT04113109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110187119|NCT04113109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110187120|NCT04113109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110187121|NCT04113109|Analgesics|analgesics|mesh-ancestor
110187122|NCT04113109|Sensory System Agents|sensory system agents|mesh-ancestor
110187123|NCT04113109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110187124|NCT04113109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110187125|NCT04113109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110187126|NCT04113109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110187127|NCT04113109|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
110187128|NCT04113109|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
110187129|NCT04113109|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110187130|NCT04113109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110187131|NCT04113109|Immunologic Factors|immunologic factors|mesh-ancestor
110187132|NCT04107038|Anesthetics|anesthetics|mesh-list
110187133|NCT04107038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110187134|NCT04107038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110187136|NCT04042233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110187137|NCT04042233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110187138|NCT03982693|Edetic Acid|edetic acid|mesh-list
110187139|NCT03982693|Pentetic Acid|pentetic acid|mesh-list
110187140|NCT03982693|Anticoagulants|anticoagulants|mesh-ancestor
110187141|NCT03982693|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110187142|NCT03982693|Chelating Agents|chelating agents|mesh-ancestor
110187143|NCT03982693|Sequestering Agents|sequestering agents|mesh-ancestor
110187144|NCT03982693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110187145|NCT03982693|Antidotes|antidotes|mesh-ancestor
110187146|NCT03982693|Protective Agents|protective agents|mesh-ancestor
110187147|NCT03982693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110187148|NCT03982693|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110187149|NCT03965195|Vaccines|vaccines|mesh-list
110187150|NCT03965195|Immunologic Factors|immunologic factors|mesh-ancestor
110187151|NCT03965195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110187152|NCT03942653|Pembrolizumab|pembrolizumab|mesh-list
110187153|NCT03942653|Goserelin|goserelin|mesh-list
110187154|NCT03942653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110187155|NCT03942653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110296607|NCT02212561|Antiviral Agents|antiviral agents|mesh-ancestor
110296608|NCT02212561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110296609|NCT02212561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110296610|NCT00268554|Dipyridamole|dipyridamole|mesh-list
110296611|NCT00268554|Caffeine|caffeine|mesh-list
110296612|NCT00268554|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110296613|NCT00268554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296614|NCT00268554|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110296615|NCT00268554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110187156|NCT03942653|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110187157|NCT03942653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110187158|NCT03942653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110187159|NCT03928314|Paclitaxel|paclitaxel|mesh-list
110187160|NCT03928314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110187161|NCT03928314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110187162|NCT03928314|Tubulin Modulators|tubulin modulators|mesh-ancestor
110187163|NCT03928314|Antimitotic Agents|antimitotic agents|mesh-ancestor
110187164|NCT03928314|Mitosis Modulators|mitosis modulators|mesh-ancestor
110187165|NCT03928314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110187166|NCT03878082|Acetaminophen|acetaminophen|mesh-list
110187167|NCT03878082|Propacetamol|propacetamol|mesh-list
110187168|NCT03878082|Analgesics|analgesics|mesh-ancestor
110218038|NCT00274612|Telmisartan|telmisartan|mesh-list
110187169|NCT03878082|Sensory System Agents|sensory system agents|mesh-ancestor
110187170|NCT03878082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110187171|NCT03878082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110187172|NCT03878082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110187174|NCT03878082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110187176|NCT03878082|Antipyretics|antipyretics|mesh-ancestor
110187177|NCT03862859|Warfarin|warfarin|mesh-list
110187178|NCT03862859|Anticoagulants|anticoagulants|mesh-ancestor
110187179|NCT03848689|Fluoroquinolones|fluoroquinolones|mesh-list
110187180|NCT03848689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110187181|NCT03848689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110187182|NCT03848689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110187183|NCT03848689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110187184|NCT03848689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110187185|NCT03814941|Anesthetics|anesthetics|mesh-list
110187186|NCT03814941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110187187|NCT03814941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110187188|NCT03759938|Rivaroxaban|rivaroxaban|mesh-list
110187189|NCT03759938|Apixaban|apixaban|mesh-list
110187190|NCT03759938|Edoxaban|edoxaban|mesh-list
110187191|NCT03759938|Dabigatran|dabigatran|mesh-list
110187192|NCT03759938|Anticoagulants|anticoagulants|mesh-list
110187193|NCT03759938|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110187194|NCT03759938|Antithrombins|antithrombins|mesh-ancestor
110187195|NCT03759938|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110187196|NCT03759938|Protease Inhibitors|protease inhibitors|mesh-ancestor
110187197|NCT03759938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110187198|NCT03759938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110187199|NCT03732950|Pembrolizumab|pembrolizumab|mesh-list
110187200|NCT03732950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110187201|NCT03732950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110187202|NCT03732950|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110187203|NCT03732950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110187204|NCT03596164|Teduglutide|teduglutide|mesh-list
110187205|NCT03596164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110187206|NCT03596164|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110187207|NCT03596164|Protective Agents|protective agents|mesh-ancestor
110187208|NCT03596164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110187209|NCT03525873|Methylphenidate|methylphenidate|mesh-list
110187210|NCT03525873|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110187211|NCT03525873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110187212|NCT03525873|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110187213|NCT03525873|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110296679|NCT04554589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110296680|NCT04554589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110296681|NCT04554589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296682|NCT00268671|Docetaxel|docetaxel|mesh-list
110296683|NCT00268671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110278970|NCT00216645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110278971|NCT00216645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110278972|NCT00216645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110278973|NCT00216645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110278974|NCT00216645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110278975|NCT00216645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110278976|NCT00588016|Itraconazole|itraconazole|mesh-list
110187214|NCT03525873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110187215|NCT03525873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110187216|NCT03525873|Dopamine Agents|dopamine agents|mesh-ancestor
110187218|NCT03492125|Rituximab|rituximab|mesh-list
110187219|NCT03492125|Obinutuzumab|obinutuzumab|mesh-list
110187220|NCT03492125|Venetoclax|venetoclax|mesh-list
110187221|NCT03492125|Acalabrutinib|acalabrutinib|mesh-list
110187222|NCT03492125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110187223|NCT03492125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110187224|NCT03492125|Immunologic Factors|immunologic factors|mesh-ancestor
110187225|NCT03492125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110187226|NCT03492125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110187227|NCT03427463|Morphine|morphine|mesh-list
110187228|NCT03427463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110187229|NCT03427463|Narcotics|narcotics|mesh-ancestor
110187230|NCT03427463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110187231|NCT03427463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110187232|NCT03427463|Analgesics|analgesics|mesh-ancestor
110187233|NCT03427463|Sensory System Agents|sensory system agents|mesh-ancestor
110187234|NCT03427463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110187235|NCT03356873|Vitamin D|vitamin d|mesh-list
110187237|NCT03356873|Cholecalciferol|cholecalciferol|mesh-list
110187238|NCT03356873|Vitamins|vitamins|mesh-list
110187239|NCT03356873|Micronutrients|micronutrients|mesh-ancestor
110187240|NCT03356873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110187241|NCT03356873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110187242|NCT03356873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110187243|NCT03308578|Atorvastatin|atorvastatin|mesh-list
110187244|NCT03308578|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110187245|NCT03308578|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110187246|NCT03308578|Antimetabolites|antimetabolites|mesh-ancestor
110187247|NCT03308578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110187249|NCT03308578|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110187250|NCT03308578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110187251|NCT03305341|Molgramostim|molgramostim|mesh-list
110187252|NCT03305341|Sargramostim|sargramostim|mesh-list
110187253|NCT03305341|Immunologic Factors|immunologic factors|mesh-ancestor
110187254|NCT03305341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110187255|NCT03305341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110187256|NCT03255473|Dexamethasone|dexamethasone|mesh-list
110187258|NCT03255473|Prednisone|prednisone|mesh-list
110187259|NCT03255473|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
110187260|NCT03255473|BB 1101|bb 1101|mesh-list
110187261|NCT03255473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110187262|NCT03255473|Antiemetics|antiemetics|mesh-ancestor
110187263|NCT03255473|Autonomic Agents|autonomic agents|mesh-ancestor
110187264|NCT03255473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110187265|NCT03255473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110187266|NCT03255473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110187268|NCT03255473|Hormones|hormones|mesh-ancestor
110187269|NCT03255473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110187270|NCT03255473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110278990|NCT00216684|Narcotics|narcotics|mesh-ancestor
110187271|NCT03255473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110187273|NCT03255473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110187274|NCT03255473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110187275|NCT03176277|Venetoclax|venetoclax|mesh-list
110187276|NCT03176277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110187277|NCT03098225|Methylprednisolone|methylprednisolone|mesh-list
110187278|NCT03098225|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110187279|NCT03098225|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110187280|NCT03098225|Prednisolone|prednisolone|mesh-list
110187281|NCT03098225|Prednisolone acetate|prednisolone acetate|mesh-list
110187282|NCT03098225|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110187283|NCT03098225|Prednisolone phosphate|prednisolone phosphate|mesh-list
110187284|NCT03098225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110187286|NCT03098225|Autonomic Agents|autonomic agents|mesh-ancestor
110187287|NCT03098225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110187288|NCT03098225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110187290|NCT03098225|Glucocorticoids|glucocorticoids|mesh-ancestor
110187291|NCT03098225|Hormones|hormones|mesh-ancestor
110187292|NCT03098225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110187293|NCT03098225|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110187294|NCT03098225|Protective Agents|protective agents|mesh-ancestor
110187295|NCT03098225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110187296|NCT03098225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110187297|NCT03017131|Aldesleukin|aldesleukin|mesh-list
110187298|NCT03017131|Cyclophosphamide|cyclophosphamide|mesh-list
110187299|NCT03017131|Decitabine|decitabine|mesh-list
110187300|NCT03017131|Interleukin-2|interleukin-2|mesh-list
110187301|NCT03017131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110187302|NCT03017131|Immunologic Factors|immunologic factors|mesh-ancestor
110187303|NCT03017131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110187304|NCT03017131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110187305|NCT03017131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110187307|NCT03017131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110187309|NCT03017131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110187310|NCT03017131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110187311|NCT03017131|Antimetabolites|antimetabolites|mesh-ancestor
110187312|NCT03017131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110187313|NCT03017131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110187314|NCT03017131|Analgesics|analgesics|mesh-ancestor
110187315|NCT03017131|Sensory System Agents|sensory system agents|mesh-ancestor
110187316|NCT03017131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110187317|NCT03017131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110187318|NCT03017131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110187319|NCT03017131|Antiviral Agents|antiviral agents|mesh-ancestor
110187320|NCT03017131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110279007|NCT00588172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110187321|NCT02990468|Cisplatin|cisplatin|mesh-list
110187322|NCT02990468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110187323|NCT02882100|Vaccines|vaccines|mesh-list
110187324|NCT02882100|Immunologic Factors|immunologic factors|mesh-ancestor
110187325|NCT02882100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110187326|NCT02855944|Paclitaxel|paclitaxel|mesh-list
110187327|NCT02855944|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110187328|NCT02855944|Cisplatin|cisplatin|mesh-list
110187329|NCT02855944|Carboplatin|carboplatin|mesh-list
110187330|NCT02855944|Gemcitabine|gemcitabine|mesh-list
110187331|NCT02855944|Rucaparib|rucaparib|mesh-list
110187332|NCT02855944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110187333|NCT02855944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110187334|NCT02855944|Tubulin Modulators|tubulin modulators|mesh-ancestor
110187335|NCT02855944|Antimitotic Agents|antimitotic agents|mesh-ancestor
110187336|NCT02855944|Mitosis Modulators|mitosis modulators|mesh-ancestor
110187337|NCT02855944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110187338|NCT02855944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110187339|NCT02855944|Antimetabolites|antimetabolites|mesh-ancestor
110187340|NCT02855944|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110187341|NCT02855944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110187342|NCT02603848|Ibuprofen|ibuprofen|mesh-list
110187343|NCT02603848|Morphine|morphine|mesh-list
110187344|NCT02603848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110187345|NCT02603848|Narcotics|narcotics|mesh-ancestor
110187346|NCT02603848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110187347|NCT02603848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110187348|NCT02603848|Analgesics|analgesics|mesh-ancestor
110187349|NCT02603848|Sensory System Agents|sensory system agents|mesh-ancestor
110187350|NCT02603848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110187351|NCT02603848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110187352|NCT02603848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110187353|NCT02603848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110187354|NCT02603848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110187355|NCT02603848|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110187356|NCT02603848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110187357|NCT02603848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110187358|NCT02512887|Anesthetics|anesthetics|mesh-list
110187359|NCT02512887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110187360|NCT02512887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110187361|NCT02484261|Bortezomib|bortezomib|mesh-list
110187362|NCT02484261|Pravastatin|pravastatin|mesh-list
110187363|NCT02484261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110187364|NCT02484261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110187365|NCT02484261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110187367|NCT02484261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110187368|NCT02484261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110218062|NCT00274807|Cytarabine|cytarabine|mesh-list
110187369|NCT02484261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110187370|NCT02484261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110187371|NCT02471430|Interferons|interferons|mesh-list
110187372|NCT02471430|Interferon-alpha|interferon-alpha|mesh-list
110187373|NCT02471430|Interferon alpha-2|interferon alpha-2|mesh-list
110187374|NCT02471430|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110279028|NCT00209742|Levoleucovorin|levoleucovorin|mesh-list
110279029|NCT00209742|Antidotes|antidotes|mesh-ancestor
110279030|NCT00209742|Protective Agents|protective agents|mesh-ancestor
110279031|NCT00209742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110279032|NCT00209742|Vitamin B Complex|vitamin b complex|mesh-ancestor
110187380|NCT02471430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110187381|NCT02471430|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110187382|NCT02471430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110187383|NCT02471430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110187384|NCT02438007|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene|mesh-list
110187386|NCT02438007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110187387|NCT02409342|Carboplatin|carboplatin|mesh-list
110187388|NCT02409342|Gemcitabine|gemcitabine|mesh-list
110187389|NCT02409342|Pemetrexed|pemetrexed|mesh-list
110187390|NCT02409342|Atezolizumab|atezolizumab|mesh-list
110187391|NCT02409342|Antibodies|antibodies|mesh-list
110187392|NCT02409342|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110187393|NCT02409342|Immunologic Factors|immunologic factors|mesh-ancestor
110187394|NCT02409342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110187395|NCT02409342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110187396|NCT02409342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110187397|NCT02409342|Antimetabolites|antimetabolites|mesh-ancestor
110187398|NCT02409342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110187399|NCT02409342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110187400|NCT02409342|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110187401|NCT02409342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110187402|NCT02409342|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110187403|NCT02409342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110187404|NCT02399085|Lenalidomide|lenalidomide|mesh-list
110187405|NCT02399085|Immunologic Factors|immunologic factors|mesh-ancestor
110187406|NCT02399085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110187407|NCT02399085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110187408|NCT02399085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110187409|NCT02399085|Growth Substances|growth substances|mesh-ancestor
110187410|NCT02399085|Growth Inhibitors|growth inhibitors|mesh-ancestor
110187411|NCT02399085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110187412|NCT02255409|Vaccines|vaccines|mesh-list
110187413|NCT02255409|Immunologic Factors|immunologic factors|mesh-ancestor
110187414|NCT02255409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110187415|NCT02213757|Estrogens|estrogens|mesh-list
110187416|NCT02213757|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110187417|NCT02213757|Hormones|hormones|mesh-ancestor
110187418|NCT02213757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110187419|NCT02213757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110279041|NCT00209742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110279042|NCT00209742|Antiviral Agents|antiviral agents|mesh-ancestor
110279043|NCT00209742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110279044|NCT00209742|Interferon Inducers|interferon inducers|mesh-ancestor
110279045|NCT00209742|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110279046|NCT00216723|Aripiprazole|aripiprazole|mesh-list
110279047|NCT00216723|Antidepressive Agents|antidepressive agents|mesh-ancestor
110279048|NCT00216723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110279049|NCT00216723|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110279050|NCT00216723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110187420|NCT02102243|Insulin|insulin|mesh-list
110187421|NCT02102243|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110187422|NCT02102243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110187423|NCT02102243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110187424|NCT01969227|Ketamine|ketamine|mesh-list
110187425|NCT01969227|Analgesics|analgesics|mesh-ancestor
110187426|NCT01969227|Sensory System Agents|sensory system agents|mesh-ancestor
110187427|NCT01969227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110187428|NCT01969227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110187429|NCT01969227|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110187430|NCT01969227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110187431|NCT01969227|Anesthetics, General|anesthetics, general|mesh-ancestor
110187432|NCT01969227|Anesthetics|anesthetics|mesh-ancestor
110187433|NCT01969227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110187434|NCT01969227|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110187435|NCT01969227|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110187436|NCT01969227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110187437|NCT01969227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110187439|NCT01885949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110187440|NCT01885949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110187441|NCT01885949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110187442|NCT01709734|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene|mesh-list
110187443|NCT01709734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110187444|NCT01709734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110187447|NCT01604135|Vitamin B Complex|vitamin b complex|mesh-ancestor
110187448|NCT01604135|Vitamins|vitamins|mesh-ancestor
110279051|NCT00216723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110279052|NCT00216723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110279053|NCT00216723|Dopamine Agonists|dopamine agonists|mesh-ancestor
110279054|NCT00216723|Dopamine Agents|dopamine agents|mesh-ancestor
110279055|NCT00216723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110279056|NCT00216723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110279057|NCT00216723|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110279058|NCT00216723|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110279059|NCT00216723|Serotonin Agents|serotonin agents|mesh-ancestor
110279060|NCT00216723|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110279061|NCT00216723|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110279062|NCT00216723|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110279063|NCT00216723|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110279064|NCT00209781|Pyrimethamine|pyrimethamine|mesh-list
110279065|NCT00209781|Sulfadoxine|sulfadoxine|mesh-list
110187450|NCT01604135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110187451|NCT01604135|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110187452|NCT01604135|Dermatologic Agents|dermatologic agents|mesh-ancestor
110187453|NCT01604135|Anticoagulants|anticoagulants|mesh-ancestor
110187454|NCT01604135|Plasma Substitutes|plasma substitutes|mesh-ancestor
110187455|NCT01604135|Blood Substitutes|blood substitutes|mesh-ancestor
110187456|NCT00644189|Clofarabine|clofarabine|mesh-list
110187457|NCT00644189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110187458|NCT00644189|Antimetabolites|antimetabolites|mesh-ancestor
110187459|NCT00644189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110187460|NCT00644189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110187461|NCT00630032|Cyclophosphamide|cyclophosphamide|mesh-list
110187462|NCT00630032|Docetaxel|docetaxel|mesh-list
110187463|NCT00630032|Fluorouracil|fluorouracil|mesh-list
110187464|NCT00630032|Epirubicin|epirubicin|mesh-list
110187465|NCT00630032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110187466|NCT00630032|Immunologic Factors|immunologic factors|mesh-ancestor
110187467|NCT00630032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110187468|NCT00630032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110187469|NCT00630032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110187470|NCT00630032|Alkylating Agents|alkylating agents|mesh-ancestor
110187471|NCT00630032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110187472|NCT00630032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110187473|NCT00630032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110187474|NCT00630032|Tubulin Modulators|tubulin modulators|mesh-ancestor
110187475|NCT00630032|Antimitotic Agents|antimitotic agents|mesh-ancestor
110187476|NCT00630032|Mitosis Modulators|mitosis modulators|mesh-ancestor
110187477|NCT00630032|Antimetabolites|antimetabolites|mesh-ancestor
110187478|NCT00630032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110187479|NCT00630032|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110187480|NCT00630032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110187481|NCT00630032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110187482|NCT00630032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110187483|NCT00465517|Ganaxolone|ganaxolone|mesh-list
110187484|NCT00465517|Neurosteroids|neurosteroids|mesh-ancestor
110187485|NCT00465517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110187486|NCT00465517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110187487|NCT00465517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110187488|NCT00465517|GABA Modulators|gaba modulators|mesh-ancestor
110187489|NCT00465517|GABA Agents|gaba agents|mesh-ancestor
110187490|NCT00289952|Valproic Acid|valproic acid|mesh-list
110279066|NCT00209781|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110279067|NCT00209781|Antimalarials|antimalarials|mesh-ancestor
110279068|NCT00209781|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110279069|NCT00209781|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110279070|NCT00209781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110279071|NCT00209781|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110279072|NCT00209781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110279073|NCT00209781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110279074|NCT00209781|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110279075|NCT00182663|Clarithromycin|clarithromycin|mesh-list
110279076|NCT00182663|Thalidomide|thalidomide|mesh-list
110187491|NCT00289952|Anticonvulsants|anticonvulsants|mesh-ancestor
110187492|NCT00289952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110187493|NCT00289952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110187494|NCT00289952|GABA Agents|gaba agents|mesh-ancestor
110187495|NCT00289952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110187496|NCT00289952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110187497|NCT00289952|Antimanic Agents|antimanic agents|mesh-ancestor
110187498|NCT00289952|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110187499|NCT00289952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110187500|NCT00289952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110187501|NCT05772832|Dexmedetomidine|dexmedetomidine|mesh-list
110187502|NCT05772832|Remifentanil|remifentanil|mesh-list
110187503|NCT05772832|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110187504|NCT05772832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110187505|NCT05772832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110187506|NCT05772832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110187507|NCT05772832|Analgesics|analgesics|mesh-ancestor
110187508|NCT05772832|Sensory System Agents|sensory system agents|mesh-ancestor
110187509|NCT05772832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110187510|NCT05772832|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110187511|NCT05772832|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110187512|NCT05772832|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110187513|NCT05772832|Adrenergic Agents|adrenergic agents|mesh-ancestor
110187514|NCT05772832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110187515|NCT05772832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110187516|NCT05772832|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110187517|NCT05772832|Narcotics|narcotics|mesh-ancestor
110187518|NCT05772728|Azacitidine|azacitidine|mesh-list
110187519|NCT05772728|Mitoxantrone|mitoxantrone|mesh-list
110187520|NCT05772728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110187521|NCT05772728|Antimetabolites|antimetabolites|mesh-ancestor
110187522|NCT05772728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110187523|NCT05772728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110187524|NCT05772728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110187525|NCT05772728|Analgesics|analgesics|mesh-ancestor
110187526|NCT05772728|Sensory System Agents|sensory system agents|mesh-ancestor
110187527|NCT05772728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110187528|NCT05772728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110187529|NCT05772728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110187530|NCT05772728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110187531|NCT05772676|Aprepitant|aprepitant|mesh-list
110187532|NCT05772676|Antiemetics|antiemetics|mesh-ancestor
110279087|NCT00182663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110279088|NCT00182663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110279089|NCT00182663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110279090|NCT00182663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110279091|NCT00182663|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110279092|NCT00182663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110279093|NCT00182663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110279094|NCT00182663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110279095|NCT00182663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110279096|NCT00182663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110187533|NCT05772676|Autonomic Agents|autonomic agents|mesh-ancestor
110187534|NCT05772676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110187535|NCT05772676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110187536|NCT05772676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110187537|NCT05772676|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110187538|NCT05772676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110187539|NCT05772676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110187540|NCT05772624|Nivolumab|nivolumab|mesh-list
110187541|NCT05772624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110187542|NCT05772624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110187543|NCT05772624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110187544|NCT05772624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110187545|NCT05772546|Maleic acid|maleic acid|mesh-list
110187546|NCT05772546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110187547|NCT05772546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110187548|NCT05772377|Carboplatin|carboplatin|mesh-list
110187549|NCT05772377|Cisplatin|cisplatin|mesh-list
110187550|NCT05772377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110187551|NCT05772208|Nimotuzumab|nimotuzumab|mesh-list
110187552|NCT05772208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110187553|NCT05772208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110187554|NCT05772039|Listerine|listerine|mesh-list
110187555|NCT05772039|Fluorides|fluorides|mesh-list
110296697|NCT04721054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110296698|NCT04721054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296699|NCT04721054|Sensory System Agents|sensory system agents|mesh-ancestor
110296700|NCT04721054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110296701|NCT04721054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110296702|NCT04721054|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110296712|NCT02212639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296714|NCT02212756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110279100|NCT00182663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110279101|NCT00182663|Growth Substances|growth substances|mesh-ancestor
110279102|NCT00182663|Growth Inhibitors|growth inhibitors|mesh-ancestor
110279103|NCT00216762|Rituximab|rituximab|mesh-list
110279104|NCT00216762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110279105|NCT00216762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110279109|NCT00182702|Epothilones|epothilones|mesh-list
110187556|NCT05772039|Sodium Fluoride|sodium fluoride|mesh-list
110187557|NCT05772039|Cariostatic Agents|cariostatic agents|mesh-ancestor
110187558|NCT05772039|Protective Agents|protective agents|mesh-ancestor
110187559|NCT05772039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110187560|NCT05772039|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110187561|NCT05772039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110187562|NCT05772013|Azithromycin|azithromycin|mesh-list
110187563|NCT05772013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110187564|NCT05772013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110187565|NCT05771675|Simvastatin|simvastatin|mesh-list
110187566|NCT05771675|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110187567|NCT05771675|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110187568|NCT05771675|Antimetabolites|antimetabolites|mesh-ancestor
110187569|NCT05771675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110187570|NCT05771675|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110187571|NCT05771675|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110187573|NCT05771194|Lubricant Eye Drops|lubricant eye drops|mesh-list
110187574|NCT05771194|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110296726|NCT02212795|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110279115|NCT00182702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110279116|NCT00588835|Dexamethasone|dexamethasone|mesh-list
110279117|NCT00588835|Ondansetron|ondansetron|mesh-list
110279118|NCT00588835|Aprepitant|aprepitant|mesh-list
110279119|NCT00588835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110279120|NCT00588835|Antiemetics|antiemetics|mesh-ancestor
110279121|NCT00588835|Autonomic Agents|autonomic agents|mesh-ancestor
110279122|NCT00588835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110279123|NCT00588835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110279124|NCT00588835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110279125|NCT00588835|Glucocorticoids|glucocorticoids|mesh-ancestor
110279126|NCT00588835|Hormones|hormones|mesh-ancestor
110279128|NCT00588835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110187576|NCT05771181|Vitamin E|vitamin e|mesh-list
110187577|NCT05771181|Tislelizumab|tislelizumab|mesh-list
110187578|NCT05771181|Vitamins|vitamins|mesh-ancestor
110187579|NCT05771181|Micronutrients|micronutrients|mesh-ancestor
110187580|NCT05771181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110187581|NCT05771181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110187582|NCT05771181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110187583|NCT05771181|Antioxidants|antioxidants|mesh-ancestor
110187584|NCT05771181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110187585|NCT05771181|Protective Agents|protective agents|mesh-ancestor
110187586|NCT05771038|Alendronate|alendronate|mesh-list
110187587|NCT05771038|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110187588|NCT05771038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110187590|NCT05771012|Cyclosporins|cyclosporins|mesh-list
110187591|NCT05771012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110187592|NCT05771012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110187593|NCT05771012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110187594|NCT05771012|Immunologic Factors|immunologic factors|mesh-ancestor
110279138|NCT00209859|Cyclosporine|cyclosporine|mesh-list
110279139|NCT00209859|Betamethasone|betamethasone|mesh-list
110279140|NCT00209859|Methotrexate|methotrexate|mesh-list
110279141|NCT00209859|Cyclosporins|cyclosporins|mesh-list
110279142|NCT00209859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110279143|NCT00209859|Abortifacient Agents|abortifacient agents|mesh-ancestor
110279144|NCT00209859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110279145|NCT00209859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110279146|NCT00209859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110279147|NCT00209859|Antimetabolites|antimetabolites|mesh-ancestor
110279148|NCT00209859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110279149|NCT00209859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110279150|NCT00209859|Dermatologic Agents|dermatologic agents|mesh-ancestor
110279151|NCT00209859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110279152|NCT00209859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110279153|NCT00209859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110279154|NCT00209859|Immunologic Factors|immunologic factors|mesh-ancestor
110279155|NCT00209859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110279156|NCT00209859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110279157|NCT00209859|Antifungal Agents|antifungal agents|mesh-ancestor
110279158|NCT00209859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110279159|NCT00209859|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110279160|NCT00209859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110279161|NCT00209859|Glucocorticoids|glucocorticoids|mesh-ancestor
110279163|NCT00209859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110279164|NCT00209859|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110279165|NCT00209859|Respiratory System Agents|respiratory system agents|mesh-ancestor
110187595|NCT05771012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110187596|NCT05771012|Antifungal Agents|antifungal agents|mesh-ancestor
110187597|NCT05771012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110187598|NCT05771012|Dermatologic Agents|dermatologic agents|mesh-ancestor
110187599|NCT05771012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110187600|NCT05771012|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110187602|NCT05770960|Naloxegol|naloxegol|mesh-list
110187603|NCT05770960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110187604|NCT05770960|Narcotics|narcotics|mesh-ancestor
110187605|NCT05770960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110187606|NCT05770960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110187607|NCT05770960|Analgesics|analgesics|mesh-ancestor
110187608|NCT05770960|Sensory System Agents|sensory system agents|mesh-ancestor
110187609|NCT05770960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110187610|NCT05770960|Antitussive Agents|antitussive agents|mesh-ancestor
110187611|NCT05770960|Respiratory System Agents|respiratory system agents|mesh-ancestor
110187612|NCT05770960|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110187613|NCT05769946|Hemay005|hemay005|mesh-list
110187614|NCT05769946|Dermatologic Agents|dermatologic agents|mesh-ancestor
110187615|NCT05769946|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110187616|NCT05769946|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110187617|NCT05769946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110187618|NCT05769946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110187619|NCT05768282|Prednisolone|prednisolone|mesh-list
110187620|NCT05768282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110187621|NCT05768282|Glucocorticoids|glucocorticoids|mesh-ancestor
110187622|NCT05768282|Hormones|hormones|mesh-ancestor
110279166|NCT00588913|Zoledronic Acid|zoledronic acid|mesh-list
110279167|NCT00588913|Aldesleukin|aldesleukin|mesh-list
110279168|NCT00588913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110279169|NCT00588913|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110279170|NCT00588913|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110279171|NCT00588913|Antiviral Agents|antiviral agents|mesh-ancestor
110279172|NCT00588913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110279173|NCT00588913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110279174|NCT00588913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110279175|NCT00182741|Calcitriol|calcitriol|mesh-list
110279176|NCT00182741|Prednisone|prednisone|mesh-list
110187623|NCT05768282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110187624|NCT05768282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110187625|NCT05768282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110187626|NCT05768282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110187627|NCT05766800|Paclitaxel|paclitaxel|mesh-list
110187628|NCT05766800|Carboplatin|carboplatin|mesh-list
110187629|NCT05766800|Pemetrexed|pemetrexed|mesh-list
110187630|NCT05766800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110187631|NCT05766800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110187632|NCT05766800|Tubulin Modulators|tubulin modulators|mesh-ancestor
110187633|NCT05766800|Antimitotic Agents|antimitotic agents|mesh-ancestor
110187634|NCT05766800|Mitosis Modulators|mitosis modulators|mesh-ancestor
110187635|NCT05766800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110187636|NCT05766800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110187637|NCT05766800|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110187638|NCT05766800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110187639|NCT05766410|Letrozole|letrozole|mesh-list
110187640|NCT05766410|Palbociclib|palbociclib|mesh-list
110187641|NCT05766410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110187642|NCT05766410|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110187643|NCT05766410|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110187644|NCT05766410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110187645|NCT05766410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110187646|NCT05766410|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110187647|NCT05766410|Hormone Antagonists|hormone antagonists|mesh-ancestor
110187648|NCT05766410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110187649|NCT05766410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110187650|NCT05766410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110187652|NCT05757011|Anesthetics, Local|anesthetics, local|mesh-ancestor
110187653|NCT05757011|Anesthetics|anesthetics|mesh-ancestor
110187654|NCT05757011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110187655|NCT05757011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110187656|NCT05757011|Sensory System Agents|sensory system agents|mesh-ancestor
110187657|NCT05757011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110187658|NCT05750875|Loratadine|loratadine|mesh-list
110187659|NCT05750875|Gabapentin|gabapentin|mesh-list
110187660|NCT05750875|Analgesics|analgesics|mesh-ancestor
110187661|NCT05750875|Sensory System Agents|sensory system agents|mesh-ancestor
110187662|NCT05750875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110187663|NCT05750875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110187665|NCT05750875|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110187666|NCT05750875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110187667|NCT05750875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110187668|NCT05750875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110187669|NCT05750875|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110187670|NCT05750875|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110187671|NCT05750875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110187672|NCT05750875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110187673|NCT05750875|Antimanic Agents|antimanic agents|mesh-ancestor
110187674|NCT05750875|Antipruritics|antipruritics|mesh-ancestor
110187675|NCT05750875|Dermatologic Agents|dermatologic agents|mesh-ancestor
110187676|NCT05750875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110187683|NCT05715073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110187684|NCT05715073|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110187685|NCT05715073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110052935|NCT01482936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110187686|NCT05715073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110187687|NCT05715073|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110187688|NCT05715073|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110187689|NCT05715073|Purinergic Agents|purinergic agents|mesh-ancestor
110187690|NCT05715073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110187691|NCT05702463|Aspirin|aspirin|mesh-list
110187692|NCT05702463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110187693|NCT05702463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110187694|NCT05702463|Analgesics|analgesics|mesh-ancestor
110187695|NCT05702463|Sensory System Agents|sensory system agents|mesh-ancestor
110187696|NCT05702463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110187697|NCT05702463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110187698|NCT05702463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110187699|NCT05702463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110187700|NCT05702463|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110187701|NCT05702463|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110187702|NCT05702463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110187703|NCT05702463|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110187704|NCT05702463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110187705|NCT05702463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110187706|NCT05702463|Antipyretics|antipyretics|mesh-ancestor
110187707|NCT05680584|Melatonin|melatonin|mesh-list
110187708|NCT05680584|Hydroxyzine|hydroxyzine|mesh-list
110187709|NCT05680584|Antioxidants|antioxidants|mesh-ancestor
110187710|NCT05680584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110187711|NCT05680584|Protective Agents|protective agents|mesh-ancestor
110187712|NCT05680584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110187713|NCT05680584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110187714|NCT05680584|Antipruritics|antipruritics|mesh-ancestor
110187715|NCT05680584|Dermatologic Agents|dermatologic agents|mesh-ancestor
110187716|NCT05680584|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110187717|NCT05680584|Histamine Antagonists|histamine antagonists|mesh-ancestor
110187718|NCT05680584|Histamine Agents|histamine agents|mesh-ancestor
110187719|NCT05680584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110187721|NCT05646992|Tacrolimus|tacrolimus|mesh-list
110187722|NCT05646992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110187723|NCT05646992|Immunologic Factors|immunologic factors|mesh-ancestor
110187724|NCT05646992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110187726|NCT05646992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110187727|NCT05646992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110187728|NCT05646992|Antimetabolites|antimetabolites|mesh-ancestor
110187729|NCT05646992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110187730|NCT05646992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110187731|NCT05646992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110094943|NCT01711749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110187771|NCT05533684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110187772|NCT05533684|Antimanic Agents|antimanic agents|mesh-ancestor
110187773|NCT05458479|Fluoxetine|fluoxetine|mesh-list
110187774|NCT05458479|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110187775|NCT05458479|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110187776|NCT05458479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110187777|NCT05458479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110187778|NCT05458479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110187780|NCT05458479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110187781|NCT05458479|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110187782|NCT05458479|Antidepressive Agents|antidepressive agents|mesh-ancestor
110187783|NCT05458479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110187784|NCT05458479|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110187785|NCT05458479|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110187786|NCT05458479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110187787|NCT05423769|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
110187788|NCT05423769|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110187789|NCT05423769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110187790|NCT05423769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110187791|NCT05423769|Immunologic Factors|immunologic factors|mesh-ancestor
110187792|NCT05423769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110187793|NCT05408247|Acetylcysteine|acetylcysteine|mesh-list
110296984|NCT00261612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110187797|NCT05408247|Expectorants|expectorants|mesh-ancestor
110187798|NCT05408247|Respiratory System Agents|respiratory system agents|mesh-ancestor
110187799|NCT05408247|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110187800|NCT05408247|Antioxidants|antioxidants|mesh-ancestor
110187801|NCT05408247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110187802|NCT05408247|Protective Agents|protective agents|mesh-ancestor
110187803|NCT05408247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110187804|NCT05408247|Antidotes|antidotes|mesh-ancestor
110187806|NCT05375942|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110187807|NCT05375942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110187808|NCT05375942|Dermatologic Agents|dermatologic agents|mesh-ancestor
110187809|NCT05375942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110187810|NCT05375942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110187812|NCT05209308|Venetoclax|venetoclax|mesh-list
110187813|NCT05209308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110187814|NCT05209308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110187815|NCT05209308|Immunologic Factors|immunologic factors|mesh-ancestor
110187816|NCT05209308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110187817|NCT05209308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110187818|NCT05153317|Ivacaftor|ivacaftor|mesh-list
110187819|NCT05153317|Elexacaftor|elexacaftor|mesh-list
110187820|NCT05153317|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110187821|NCT05153317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110187822|NCT05153317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110187823|NCT05150015|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110036486|NCT01411930|Olanzapine|olanzapine|mesh-list
110187824|NCT05150015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110187826|NCT05112848|Immunologic Factors|immunologic factors|mesh-ancestor
110187827|NCT05112848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110187828|NCT05029622|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110187829|NCT05029622|Luteolytic Agents|luteolytic agents|mesh-ancestor
110187830|NCT05029622|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110187831|NCT05029622|Contraceptive Agents|contraceptive agents|mesh-ancestor
110187832|NCT05029622|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110187833|NCT05029622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110187834|NCT05029622|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110187835|NCT05029622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110187836|NCT05029622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110187837|NCT04916418|Ropivacaine|ropivacaine|mesh-list
110187838|NCT04916418|Anesthetics, Local|anesthetics, local|mesh-ancestor
110187839|NCT04916418|Anesthetics|anesthetics|mesh-ancestor
110297055|NCT00236327|Fentanyl|fentanyl|mesh-list
110187840|NCT04916418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110187841|NCT04916418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110187842|NCT04916418|Sensory System Agents|sensory system agents|mesh-ancestor
110187843|NCT04916418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110187844|NCT04899518|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110187845|NCT04899518|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110036758|NCT01414140|Levonorgestrel|levonorgestrel|mesh-list
110187851|NCT04892511|Labetalol|labetalol|mesh-list
110187852|NCT04892511|Urapidil|urapidil|mesh-list
110187853|NCT04892511|Phenylephrine|phenylephrine|mesh-list
110187854|NCT04892511|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110187855|NCT04892511|Mydriatics|mydriatics|mesh-ancestor
110187856|NCT04892511|Autonomic Agents|autonomic agents|mesh-ancestor
110187857|NCT04892511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110187858|NCT04892511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110187859|NCT04892511|Sympathomimetics|sympathomimetics|mesh-ancestor
110187860|NCT04892511|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110187861|NCT04892511|Nasal Decongestants|nasal decongestants|mesh-ancestor
110187862|NCT04892511|Respiratory System Agents|respiratory system agents|mesh-ancestor
110187863|NCT04892511|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110187864|NCT04892511|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110187865|NCT04892511|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110187866|NCT04892511|Adrenergic Agents|adrenergic agents|mesh-ancestor
110187867|NCT04892511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110187868|NCT04892511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110187869|NCT04892511|Protective Agents|protective agents|mesh-ancestor
110187870|NCT04892511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110187871|NCT04892511|Vasodilator Agents|vasodilator agents|mesh-ancestor
110187872|NCT04892511|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110187873|NCT04892511|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110187874|NCT04892511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110187875|NCT04892511|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110187876|NCT04892511|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110187877|NCT04892511|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110187878|NCT04892511|Serotonin Agents|serotonin agents|mesh-ancestor
110187879|NCT04857333|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110187880|NCT04857333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110187882|NCT04855695|Obinutuzumab|obinutuzumab|mesh-list
110187883|NCT04855695|Acalabrutinib|acalabrutinib|mesh-list
110187884|NCT04855695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110187885|NCT04855695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110187886|NCT04785118|Scopolamine|scopolamine|mesh-list
110187887|NCT04785118|Ondansetron|ondansetron|mesh-list
110187888|NCT04785118|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
110187889|NCT04785118|Antiemetics|antiemetics|mesh-ancestor
110187890|NCT04785118|Autonomic Agents|autonomic agents|mesh-ancestor
110094944|NCT01711814|Peficitinib|peficitinib|mesh-list
110187891|NCT04785118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110187892|NCT04785118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110187893|NCT04785118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110187894|NCT04785118|Antipruritics|antipruritics|mesh-ancestor
110187895|NCT04785118|Dermatologic Agents|dermatologic agents|mesh-ancestor
110187896|NCT04785118|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110187897|NCT04785118|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110187898|NCT04785118|Serotonin Agents|serotonin agents|mesh-ancestor
110187899|NCT04785118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110187900|NCT04785118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110187901|NCT04785118|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110187902|NCT04785118|Mydriatics|mydriatics|mesh-ancestor
110187903|NCT04785118|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110187904|NCT04785118|Cholinergic Agents|cholinergic agents|mesh-ancestor
110187905|NCT04785118|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110187906|NCT04785118|Parasympatholytics|parasympatholytics|mesh-ancestor
110187907|NCT04752163|Leucovorin|leucovorin|mesh-list
110187908|NCT04752163|Cytarabine|cytarabine|mesh-list
110187909|NCT04752163|Voriconazole|voriconazole|mesh-list
110187910|NCT04752163|Posaconazole|posaconazole|mesh-list
110187911|NCT04752163|Dexamethasone|dexamethasone|mesh-list
110187912|NCT04752163|Dexamethasone acetate|dexamethasone acetate|mesh-list
110187913|NCT04752163|Prednisone|prednisone|mesh-list
110187915|NCT04752163|Cyclophosphamide|cyclophosphamide|mesh-list
110187916|NCT04752163|Rituximab|rituximab|mesh-list
110187917|NCT04752163|Methotrexate|methotrexate|mesh-list
110187918|NCT04752163|Vincristine|vincristine|mesh-list
110187919|NCT04752163|Azacitidine|azacitidine|mesh-list
110187920|NCT04752163|Venetoclax|venetoclax|mesh-list
110187921|NCT04752163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110187922|NCT04752163|Antibodies|antibodies|mesh-list
110187923|NCT04752163|Immunoglobulins|immunoglobulins|mesh-list
110187924|NCT04752163|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110187925|NCT04752163|Lenograstim|lenograstim|mesh-list
110187926|NCT04752163|BB 1101|bb 1101|mesh-list
110187927|NCT04752163|Mesna|mesna|mesh-list
110187928|NCT04752163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110187929|NCT04752163|Immunologic Factors|immunologic factors|mesh-ancestor
110187930|NCT04752163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110187931|NCT04752163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110187932|NCT04752163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110187933|NCT04752163|Alkylating Agents|alkylating agents|mesh-ancestor
110187934|NCT04752163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110187935|NCT04752163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110187936|NCT04752163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110187937|NCT04752163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110187938|NCT04752163|Antiemetics|antiemetics|mesh-ancestor
110187939|NCT04752163|Autonomic Agents|autonomic agents|mesh-ancestor
110187940|NCT04752163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110187941|NCT04752163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110187942|NCT04752163|Glucocorticoids|glucocorticoids|mesh-ancestor
110187943|NCT04752163|Hormones|hormones|mesh-ancestor
110187944|NCT04752163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110187945|NCT04752163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110187946|NCT04752163|Protease Inhibitors|protease inhibitors|mesh-ancestor
110187947|NCT04752163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110187948|NCT04752163|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110187949|NCT04752163|Abortifacient Agents|abortifacient agents|mesh-ancestor
110187950|NCT04752163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110187951|NCT04752163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110187953|NCT04752163|Dermatologic Agents|dermatologic agents|mesh-ancestor
110187954|NCT04752163|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110187955|NCT04752163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110187956|NCT04752163|Antiviral Agents|antiviral agents|mesh-ancestor
110187957|NCT04752163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110187958|NCT04752163|Antidotes|antidotes|mesh-ancestor
110187959|NCT04752163|Protective Agents|protective agents|mesh-ancestor
110187960|NCT04752163|Vitamin B Complex|vitamin b complex|mesh-ancestor
110187962|NCT04752163|Micronutrients|micronutrients|mesh-ancestor
110187963|NCT04752163|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110187964|NCT04752163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110187965|NCT04752163|Tubulin Modulators|tubulin modulators|mesh-ancestor
110187966|NCT04752163|Antimitotic Agents|antimitotic agents|mesh-ancestor
110187968|NCT04752163|Antifungal Agents|antifungal agents|mesh-ancestor
110187969|NCT04752163|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110187970|NCT04752163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110187971|NCT04752163|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110187972|NCT04752163|Hormone Antagonists|hormone antagonists|mesh-ancestor
110187973|NCT04752163|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110187974|NCT04752163|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110187975|NCT04752163|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110187976|NCT04752163|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110187977|NCT04720768|Palbociclib|palbociclib|mesh-list
110187978|NCT04720768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110037541|NCT01419041|Crizotinib|crizotinib|mesh-list
110187979|NCT04720768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110187980|NCT04720768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110187981|NCT04720768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110187982|NCT04702256|Mycophenolic Acid|mycophenolic acid|mesh-list
110187983|NCT04702256|Prednisone|prednisone|mesh-list
110187984|NCT04702256|Methylprednisolone|methylprednisolone|mesh-list
110187985|NCT04702256|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110187986|NCT04702256|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110187987|NCT04702256|Prednisolone|prednisolone|mesh-list
110187988|NCT04702256|Prednisolone acetate|prednisolone acetate|mesh-list
110187989|NCT04702256|Obinutuzumab|obinutuzumab|mesh-list
110187990|NCT04702256|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110187991|NCT04702256|Prednisolone phosphate|prednisolone phosphate|mesh-list
110187992|NCT04702256|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
110187993|NCT04702256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110187994|NCT04702256|Glucocorticoids|glucocorticoids|mesh-ancestor
110187995|NCT04702256|Hormones|hormones|mesh-ancestor
110187996|NCT04702256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110187997|NCT04702256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110187998|NCT04702256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110187999|NCT04702256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110188000|NCT04702256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110188001|NCT04702256|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110188002|NCT04702256|Antitubercular Agents|antitubercular agents|mesh-ancestor
110188003|NCT04702256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110188004|NCT04702256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110188006|NCT04702256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110188007|NCT04702256|Antiemetics|antiemetics|mesh-ancestor
110188008|NCT04702256|Autonomic Agents|autonomic agents|mesh-ancestor
110188009|NCT04702256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110188010|NCT04702256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110188011|NCT04702256|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110188012|NCT04702256|Protective Agents|protective agents|mesh-ancestor
110188013|NCT04702256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110188014|NCT04702256|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110188015|NCT04702256|Histamine Antagonists|histamine antagonists|mesh-ancestor
110188016|NCT04702256|Histamine Agents|histamine agents|mesh-ancestor
110297384|NCT00269607|Naltrexone|naltrexone|mesh-list
110188017|NCT04702256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110188020|NCT04671966|Estrogens|estrogens|mesh-ancestor
110188021|NCT04671966|Hormones|hormones|mesh-ancestor
110037853|NCT01421173|Glucocorticoids|glucocorticoids|mesh-ancestor
110188022|NCT04671966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110188023|NCT04671966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110188024|NCT04671966|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110188025|NCT04671966|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110188026|NCT04671966|Fertility Agents|fertility agents|mesh-ancestor
110188027|NCT04671966|Hormone Antagonists|hormone antagonists|mesh-ancestor
110188028|NCT04641702|Atropine|atropine|mesh-list
110188029|NCT04641702|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110188030|NCT04641702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110188031|NCT04641702|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110188032|NCT04641702|Autonomic Agents|autonomic agents|mesh-ancestor
110188033|NCT04641702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110188034|NCT04641702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110188035|NCT04641702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110188036|NCT04641702|Respiratory System Agents|respiratory system agents|mesh-ancestor
110188037|NCT04641702|Mydriatics|mydriatics|mesh-ancestor
110188038|NCT04641702|Parasympatholytics|parasympatholytics|mesh-ancestor
110188039|NCT04641702|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110188040|NCT04641702|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110188041|NCT04641702|Cholinergic Agents|cholinergic agents|mesh-ancestor
110188042|NCT04641702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110188043|NCT04641702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110188045|NCT04624750|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110188046|NCT04624750|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110188047|NCT04624750|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110188048|NCT04624750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110038048|NCT01422330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110188049|NCT04624750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110188050|NCT04622553|Mexiletine|mexiletine|mesh-list
110188051|NCT04622553|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110188052|NCT04622553|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110188053|NCT04622553|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110188054|NCT04622553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110188055|NCT04622553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110188056|NCT04616807|Mexiletine|mexiletine|mesh-list
110188057|NCT04616807|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110279377|NCT00476593|Lactitol|lactitol|mesh-list
110188058|NCT04616807|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110188059|NCT04616807|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110188060|NCT04616807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110188061|NCT04616807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110188062|NCT04608630|Zoledronic Acid|zoledronic acid|mesh-list
110188063|NCT04608630|Denosumab|denosumab|mesh-list
110188064|NCT04608630|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110188065|NCT04608630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110188066|NCT04603183|Paclitaxel|paclitaxel|mesh-list
110188067|NCT04603183|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110188068|NCT04603183|Letrozole|letrozole|mesh-list
110188069|NCT04603183|Fulvestrant|fulvestrant|mesh-list
110188070|NCT04603183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110188071|NCT04603183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110188072|NCT04603183|Tubulin Modulators|tubulin modulators|mesh-ancestor
110188073|NCT04603183|Antimitotic Agents|antimitotic agents|mesh-ancestor
110188074|NCT04603183|Mitosis Modulators|mitosis modulators|mesh-ancestor
110188075|NCT04603183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110188076|NCT04603183|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110188077|NCT04603183|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110188078|NCT04603183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110188079|NCT04603183|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110188080|NCT04603183|Hormone Antagonists|hormone antagonists|mesh-ancestor
110188081|NCT04603183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110188082|NCT04603183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110188083|NCT04603183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110188084|NCT04603183|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110188086|NCT04580134|Clozapine|clozapine|mesh-list
110188087|NCT04580134|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110188088|NCT04580134|Serotonin Agents|serotonin agents|mesh-ancestor
110188089|NCT04580134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110188090|NCT04580134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110188091|NCT04580134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110188092|NCT04580134|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110188093|NCT04580134|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110188094|NCT04580134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110188095|NCT04580134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110188096|NCT04580134|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110188097|NCT04580134|Dopamine Agents|dopamine agents|mesh-ancestor
110188098|NCT04580134|GABA Antagonists|gaba antagonists|mesh-ancestor
110188099|NCT04580134|GABA Agents|gaba agents|mesh-ancestor
110188100|NCT04541108|Pembrolizumab|pembrolizumab|mesh-list
110188101|NCT04541108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110188102|NCT04541108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110188103|NCT04541108|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110094945|NCT01711814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110279407|NCT00183404|Olanzapine|olanzapine|mesh-list
110188104|NCT04541108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110188105|NCT04529954|Valproic Acid|valproic acid|mesh-list
110188106|NCT04529954|Anticonvulsants|anticonvulsants|mesh-ancestor
110188107|NCT04529954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110188108|NCT04529954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110188109|NCT04529954|GABA Agents|gaba agents|mesh-ancestor
110188110|NCT04529954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110188111|NCT04529954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110188112|NCT04529954|Antimanic Agents|antimanic agents|mesh-ancestor
110188113|NCT04529954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110188114|NCT04529954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110188115|NCT04529954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110188116|NCT04525755|Nicotine|nicotine|mesh-list
110297562|NCT04539418|Vitamins|vitamins|mesh-ancestor
110188117|NCT04525755|Varenicline|varenicline|mesh-list
110188118|NCT04525755|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110188119|NCT04525755|Autonomic Agents|autonomic agents|mesh-ancestor
110188120|NCT04525755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110188121|NCT04525755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110188122|NCT04525755|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110188123|NCT04525755|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110188124|NCT04525755|Cholinergic Agents|cholinergic agents|mesh-ancestor
110188125|NCT04525755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110188126|NCT04525755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110188127|NCT04512079|Enoxaparin|enoxaparin|mesh-list
110188128|NCT04512079|Apixaban|apixaban|mesh-list
110188129|NCT04512079|Anticoagulants|anticoagulants|mesh-ancestor
110188130|NCT04512079|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110188131|NCT04512079|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110188132|NCT04512079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110188134|NCT04512079|Antithrombins|antithrombins|mesh-ancestor
110188135|NCT04512079|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110188137|NCT04512079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110188138|NCT04437485|Norepinephrine|norepinephrine|mesh-list
110188139|NCT04437485|Bupropion|bupropion|mesh-list
110279436|NCT00217152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110188140|NCT04437485|Antidepressive Agents|antidepressive agents|mesh-list
110188141|NCT04437485|Serotonin|serotonin|mesh-list
110188142|NCT04437485|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
110188143|NCT04437485|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110188145|NCT04437485|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110188146|NCT04437485|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110188147|NCT04437485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110188148|NCT04437485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110188149|NCT04437485|Dopamine Agents|dopamine agents|mesh-ancestor
110188150|NCT04437485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110188151|NCT04437485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110188152|NCT04437485|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110188153|NCT04437485|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110188154|NCT04437485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110188155|NCT04437485|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110188156|NCT04437485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110188157|NCT04437485|Adrenergic Agents|adrenergic agents|mesh-ancestor
110188158|NCT04437485|Sympathomimetics|sympathomimetics|mesh-ancestor
110188159|NCT04437485|Autonomic Agents|autonomic agents|mesh-ancestor
110188160|NCT04437485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110038460|NCT01424449|Serotonin Agents|serotonin agents|mesh-ancestor
110188161|NCT04437485|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110188162|NCT04437485|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110188164|NCT04421560|Rituximab|rituximab|mesh-list
110188165|NCT04421560|Pembrolizumab|pembrolizumab|mesh-list
110188166|NCT04421560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110188167|NCT04421560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110188168|NCT04421560|Immunologic Factors|immunologic factors|mesh-ancestor
110188169|NCT04421560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110188170|NCT04421560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110188171|NCT04421560|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110188172|NCT04421560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110188173|NCT04332341|Niacinamide|niacinamide|mesh-list
110188174|NCT04332341|Niacin|niacin|mesh-list
110188175|NCT04332341|Nicotinic Acids|nicotinic acids|mesh-list
110188176|NCT04332341|Vitamin B Complex|vitamin b complex|mesh-ancestor
110188177|NCT04332341|Vitamins|vitamins|mesh-ancestor
110188178|NCT04332341|Micronutrients|micronutrients|mesh-ancestor
110188179|NCT04332341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110188180|NCT04332341|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110188181|NCT04332341|Antimetabolites|antimetabolites|mesh-ancestor
110297697|NCT04538365|Antimetabolites|antimetabolites|mesh-ancestor
110188182|NCT04332341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110188184|NCT04332341|Vasodilator Agents|vasodilator agents|mesh-ancestor
110188185|NCT04323657|Cyclophosphamide|cyclophosphamide|mesh-list
110188186|NCT04323657|Fludarabine|fludarabine|mesh-list
110188187|NCT04323657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110188188|NCT04323657|Immunologic Factors|immunologic factors|mesh-ancestor
110188189|NCT04323657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110188190|NCT04323657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110188191|NCT04323657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110188192|NCT04323657|Alkylating Agents|alkylating agents|mesh-ancestor
110188193|NCT04323657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110188194|NCT04323657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110188195|NCT04323657|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110188197|NCT04318691|Chelating Agents|chelating agents|mesh-ancestor
110038585|NCT01425216|Sorafenib|sorafenib|mesh-list
110188198|NCT04318691|Sequestering Agents|sequestering agents|mesh-ancestor
110188199|NCT04318691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110188200|NCT04278092|Paclitaxel|paclitaxel|mesh-list
110188201|NCT04278092|Cetuximab|cetuximab|mesh-list
110188202|NCT04278092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110188203|NCT04278092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110188204|NCT04278092|Tubulin Modulators|tubulin modulators|mesh-ancestor
110297745|NCT00237731|Analgesics|analgesics|mesh-ancestor
110188205|NCT04278092|Antimitotic Agents|antimitotic agents|mesh-ancestor
110188206|NCT04278092|Mitosis Modulators|mitosis modulators|mesh-ancestor
110188207|NCT04278092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110188208|NCT04278092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110188209|NCT04240106|Niraparib|niraparib|mesh-list
110188210|NCT04240106|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110188211|NCT04240106|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110188212|NCT04240106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110188213|NCT04240106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110188214|NCT04240106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110188215|NCT04240106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110188216|NCT04240106|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110188217|NCT04240106|Hormone Antagonists|hormone antagonists|mesh-ancestor
110038627|NCT01425411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110188218|NCT04240106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110188219|NCT04240106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110188220|NCT04220489|Ketamine|ketamine|mesh-list
110188221|NCT04220489|Analgesics|analgesics|mesh-ancestor
110188222|NCT04220489|Sensory System Agents|sensory system agents|mesh-ancestor
110188223|NCT04220489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110188224|NCT04220489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110188225|NCT04220489|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110188226|NCT04220489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110188227|NCT04220489|Anesthetics, General|anesthetics, general|mesh-ancestor
110188228|NCT04220489|Anesthetics|anesthetics|mesh-ancestor
110188229|NCT04220489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110188230|NCT04220489|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110188231|NCT04220489|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110188232|NCT04220489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110188233|NCT04220489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110188234|NCT04189107|Dexamethasone|dexamethasone|mesh-list
110188235|NCT04189107|Dexamethasone acetate|dexamethasone acetate|mesh-list
110188236|NCT04189107|BB 1101|bb 1101|mesh-list
110188237|NCT04189107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110188238|NCT04189107|Antiemetics|antiemetics|mesh-ancestor
110188239|NCT04189107|Autonomic Agents|autonomic agents|mesh-ancestor
110188240|NCT04189107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110188241|NCT04189107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110188242|NCT04189107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110188243|NCT04189107|Glucocorticoids|glucocorticoids|mesh-ancestor
110188244|NCT04189107|Hormones|hormones|mesh-ancestor
110188245|NCT04189107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110188246|NCT04189107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110188247|NCT04189107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110188248|NCT04189107|Protease Inhibitors|protease inhibitors|mesh-ancestor
110188249|NCT04189107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110188250|NCT04189107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110188252|NCT04124991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110188253|NCT04124991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110188254|NCT04115267|Antineoplastic Agents|antineoplastic agents|mesh-list
110188255|NCT04004221|Tislelizumab|tislelizumab|mesh-list
110188256|NCT04004221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110188257|NCT04004221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110188258|NCT03934567|Abexinostat|abexinostat|mesh-list
110188259|NCT03934567|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110188260|NCT03934567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110297835|NCT04536961|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110188261|NCT03934567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110188263|NCT03865940|Guanfacine|guanfacine|mesh-list
110188264|NCT03865940|Anesthetics, Local|anesthetics, local|mesh-ancestor
110188265|NCT03865940|Anesthetics|anesthetics|mesh-ancestor
110188266|NCT03865940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110188267|NCT03865940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110188268|NCT03865940|Sensory System Agents|sensory system agents|mesh-ancestor
110188269|NCT03865940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110188270|NCT03865940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110188271|NCT03865940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110188272|NCT03865940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110188273|NCT03865940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110297883|NCT04536415|Oseltamivir|oseltamivir|mesh-list
110188274|NCT03865940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110038795|NCT05385900|Oxaliplatin|oxaliplatin|mesh-list
110188275|NCT03865940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110188276|NCT03865940|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110188277|NCT03865940|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110188278|NCT03865940|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110188279|NCT03865940|Adrenergic Agents|adrenergic agents|mesh-ancestor
110188280|NCT03865940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110188281|NCT03844997|Palbociclib|palbociclib|mesh-list
110188282|NCT03844997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110188283|NCT03844997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110188284|NCT03844997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110188285|NCT03844997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110038845|NCT05385029|Carbimazole|carbimazole|mesh-list
110188286|NCT03826199|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110188287|NCT03826199|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110188288|NCT03826199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110188289|NCT03826199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110188290|NCT03826199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110188291|NCT03826199|Antiviral Agents|antiviral agents|mesh-ancestor
110188292|NCT03826199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110188293|NCT03826199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110188294|NCT03826199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110188295|NCT03671811|Megestrol|megestrol|mesh-list
110188296|NCT03671811|Megestrol Acetate|megestrol acetate|mesh-list
110188297|NCT03671811|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110188298|NCT03671811|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110188299|NCT03671811|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110188300|NCT03671811|Contraceptive Agents|contraceptive agents|mesh-ancestor
110188301|NCT03671811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110188302|NCT03671811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110188303|NCT03671811|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110297975|NCT00238277|Temozolomide|temozolomide|mesh-list
110188304|NCT03671811|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110188305|NCT03671811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110188306|NCT03671811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110188308|NCT03671811|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110188309|NCT03589729|Cytarabine|cytarabine|mesh-list
110188310|NCT03589729|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
110188311|NCT03589729|Idarubicin|idarubicin|mesh-list
110188312|NCT03589729|Cladribine|cladribine|mesh-list
110188313|NCT03589729|Gemtuzumab|gemtuzumab|mesh-list
110188314|NCT03589729|Dexrazoxane|dexrazoxane|mesh-list
110188317|NCT03589729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110188318|NCT03589729|Antimetabolites|antimetabolites|mesh-ancestor
110188319|NCT03589729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110188320|NCT03589729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110188321|NCT03589729|Antiviral Agents|antiviral agents|mesh-ancestor
110188322|NCT03589729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110188323|NCT03589729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110188324|NCT03589729|Immunologic Factors|immunologic factors|mesh-ancestor
110188325|NCT03589729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110188326|NCT03589729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110188327|NCT03589729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110188328|NCT03589729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110188329|NCT03589729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110039042|NCT04311762|Cisplatin|cisplatin|mesh-list
110188330|NCT03589729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110188331|NCT03589729|Immunotoxins|immunotoxins|mesh-ancestor
110188332|NCT03589729|Immunoconjugates|immunoconjugates|mesh-ancestor
110279552|NCT00412191|Lamotrigine|lamotrigine|mesh-list
110188333|NCT03589729|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110188334|NCT03589729|Protective Agents|protective agents|mesh-ancestor
110188335|NCT03589729|Antimitotic Agents|antimitotic agents|mesh-ancestor
110188336|NCT03589729|Mitosis Modulators|mitosis modulators|mesh-ancestor
110188337|NCT03585686|Cytarabine|cytarabine|mesh-list
110188338|NCT03585686|Vemurafenib|vemurafenib|mesh-list
110188339|NCT03585686|Cladribine|cladribine|mesh-list
110188340|NCT03585686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110188341|NCT03585686|Antimetabolites|antimetabolites|mesh-ancestor
110188342|NCT03585686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110188343|NCT03585686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110188344|NCT03585686|Antiviral Agents|antiviral agents|mesh-ancestor
110188345|NCT03585686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110188346|NCT03585686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110188347|NCT03585686|Immunologic Factors|immunologic factors|mesh-ancestor
110188348|NCT03585686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110188349|NCT03585686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110188350|NCT03585686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110188352|NCT03479307|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110188353|NCT03479307|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110188354|NCT03479307|Antipruritics|antipruritics|mesh-ancestor
110188355|NCT03479307|Dermatologic Agents|dermatologic agents|mesh-ancestor
110188356|NCT03479307|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110188357|NCT03479307|Histamine Antagonists|histamine antagonists|mesh-ancestor
110188358|NCT03479307|Histamine Agents|histamine agents|mesh-ancestor
110188359|NCT03479307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110188360|NCT03479307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110188361|NCT03479307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110188362|NCT03479307|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110188363|NCT03467867|Rituximab|rituximab|mesh-list
110188364|NCT03467867|Venetoclax|venetoclax|mesh-list
110188365|NCT03467867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110039148|NCT02767882|Hormones|hormones|mesh-ancestor
110188366|NCT03467867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110188367|NCT03467867|Immunologic Factors|immunologic factors|mesh-ancestor
110188368|NCT03467867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110188369|NCT03467867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110188370|NCT03390933|Fluoxetine|fluoxetine|mesh-list
110188371|NCT03390933|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110188372|NCT03390933|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110188373|NCT03390933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110188374|NCT03390933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110188375|NCT03390933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110188376|NCT03390933|Serotonin Agents|serotonin agents|mesh-ancestor
110188377|NCT03390933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110188378|NCT03390933|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110188379|NCT03390933|Antidepressive Agents|antidepressive agents|mesh-ancestor
110188380|NCT03390933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110188381|NCT03390933|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110188382|NCT03390933|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110188383|NCT03390933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110188384|NCT03387787|Insulin|insulin|mesh-list
110188385|NCT03387787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110188386|NCT03387787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110188387|NCT03364036|Cladribine|cladribine|mesh-list
110188388|NCT03364036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110188389|NCT03364036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110188390|NCT03364036|Immunologic Factors|immunologic factors|mesh-ancestor
110188391|NCT03364036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110188394|NCT03338790|Nivolumab|nivolumab|mesh-list
110188395|NCT03338790|Rucaparib|rucaparib|mesh-list
110188396|NCT03338790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110188397|NCT03338790|Tubulin Modulators|tubulin modulators|mesh-ancestor
110298135|NCT04534231|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110188398|NCT03338790|Antimitotic Agents|antimitotic agents|mesh-ancestor
110188399|NCT03338790|Mitosis Modulators|mitosis modulators|mesh-ancestor
110188400|NCT03338790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110188401|NCT03338790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110188402|NCT03338790|Glucocorticoids|glucocorticoids|mesh-ancestor
110188403|NCT03338790|Hormones|hormones|mesh-ancestor
110188404|NCT03338790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110188405|NCT03338790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110188406|NCT03338790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110188407|NCT03338790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110188408|NCT03338790|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110188409|NCT03338790|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110188410|NCT03338790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110188411|NCT03315897|Epoetin Alfa|epoetin alfa|mesh-list
110188412|NCT03315897|Hematinics|hematinics|mesh-ancestor
110188413|NCT03299660|Fluorouracil|fluorouracil|mesh-list
110188414|NCT03299660|Capecitabine|capecitabine|mesh-list
110188415|NCT03299660|Avelumab|avelumab|mesh-list
110188416|NCT03299660|Antimetabolites|antimetabolites|mesh-ancestor
110188417|NCT03299660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110188418|NCT03299660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110188419|NCT03299660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110188420|NCT03299660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110188421|NCT03299660|Immunologic Factors|immunologic factors|mesh-ancestor
110188422|NCT03299660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110188423|NCT03299660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110188424|NCT03292458|Sodium Oxybate|sodium oxybate|mesh-list
110188425|NCT03292458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110188426|NCT03292458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110188427|NCT03292458|Anesthetics, General|anesthetics, general|mesh-ancestor
110188428|NCT03292458|Anesthetics|anesthetics|mesh-ancestor
110188429|NCT03292458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110188430|NCT03292458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110188431|NCT03140358|Atropine|atropine|mesh-list
110188432|NCT03140358|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110188433|NCT03140358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110188434|NCT03140358|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110188435|NCT03140358|Autonomic Agents|autonomic agents|mesh-ancestor
110188436|NCT03140358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110188437|NCT03140358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110188438|NCT03140358|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110188439|NCT03140358|Respiratory System Agents|respiratory system agents|mesh-ancestor
110188440|NCT03140358|Mydriatics|mydriatics|mesh-ancestor
110188441|NCT03140358|Parasympatholytics|parasympatholytics|mesh-ancestor
110188442|NCT03140358|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110188443|NCT03140358|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110188444|NCT03140358|Cholinergic Agents|cholinergic agents|mesh-ancestor
110188445|NCT03140358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110188446|NCT03140358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110188447|NCT02954536|Pembrolizumab|pembrolizumab|mesh-list
110188448|NCT02954536|Fluorouracil|fluorouracil|mesh-list
110188449|NCT02954536|Capecitabine|capecitabine|mesh-list
110188450|NCT02954536|Oxaliplatin|oxaliplatin|mesh-list
110188451|NCT02954536|Trastuzumab|trastuzumab|mesh-list
110188452|NCT02954536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110188453|NCT02954536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110188454|NCT02954536|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110218249|NCT00278278|Vincristine|vincristine|mesh-list
110188455|NCT02954536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110188456|NCT02954536|Antimetabolites|antimetabolites|mesh-ancestor
110188457|NCT02954536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110188458|NCT02954536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110188459|NCT02954536|Immunologic Factors|immunologic factors|mesh-ancestor
110188460|NCT02954536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110188462|NCT02899611|Anticonvulsants|anticonvulsants|mesh-ancestor
110188463|NCT02899611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110039270|NCT01426126|Mitosis Modulators|mitosis modulators|mesh-ancestor
110188464|NCT02899611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110188465|NCT02899611|GABA Agents|gaba agents|mesh-ancestor
110188466|NCT02899611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110188467|NCT02899611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110188469|NCT02899611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110188470|NCT02899611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110188471|NCT02899611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110188472|NCT02750202|Vaccines|vaccines|mesh-list
110188473|NCT02750202|Immunologic Factors|immunologic factors|mesh-ancestor
110188474|NCT02750202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110188475|NCT02645266|Aflibercept|aflibercept|mesh-list
110188476|NCT02645266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110188477|NCT02645266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110188478|NCT02645266|Growth Substances|growth substances|mesh-ancestor
110188479|NCT02645266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110188480|NCT02645266|Growth Inhibitors|growth inhibitors|mesh-ancestor
110188481|NCT02645266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110188482|NCT02634294|Interferons|interferons|mesh-list
110188483|NCT02634294|Interferon-alpha|interferon-alpha|mesh-list
110188484|NCT02634294|Interferon alpha-2|interferon alpha-2|mesh-list
110188485|NCT02634294|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110188486|NCT02634294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110188487|NCT02634294|Antiviral Agents|antiviral agents|mesh-ancestor
110188488|NCT02634294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110188489|NCT02634294|Immunologic Factors|immunologic factors|mesh-ancestor
110188490|NCT02634294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110188491|NCT02575677|Oxycodone|oxycodone|mesh-list
110188492|NCT02575677|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110188493|NCT02575677|Narcotics|narcotics|mesh-ancestor
110188494|NCT02575677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110188495|NCT02575677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110188496|NCT02575677|Analgesics|analgesics|mesh-ancestor
110188497|NCT02575677|Sensory System Agents|sensory system agents|mesh-ancestor
110188498|NCT02575677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110188500|NCT02573831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110188502|NCT02573831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110188503|NCT02573831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110188504|NCT02573831|Analgesics|analgesics|mesh-ancestor
110188505|NCT02573831|Sensory System Agents|sensory system agents|mesh-ancestor
110188506|NCT02573831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110188507|NCT02571881|Oxycodone|oxycodone|mesh-list
110188508|NCT02571881|Naloxone|naloxone|mesh-list
110188509|NCT02571881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110188510|NCT02571881|Narcotics|narcotics|mesh-ancestor
110188511|NCT02571881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110188512|NCT02571881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110188513|NCT02571881|Analgesics|analgesics|mesh-ancestor
110188514|NCT02571881|Sensory System Agents|sensory system agents|mesh-ancestor
110188515|NCT02571881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110188516|NCT02571881|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110188517|NCT02571179|Fentanyl|fentanyl|mesh-list
110188518|NCT02571179|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110188519|NCT02571179|Narcotics|narcotics|mesh-ancestor
110298326|NCT05896800|Protective Agents|protective agents|mesh-ancestor
110298327|NCT05896787|Paclitaxel|paclitaxel|mesh-list
110188520|NCT02571179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110188521|NCT02571179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110188522|NCT02571179|Analgesics|analgesics|mesh-ancestor
110188523|NCT02571179|Sensory System Agents|sensory system agents|mesh-ancestor
110188524|NCT02571179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110188525|NCT02571179|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110188526|NCT02571179|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110188527|NCT02571179|Anesthetics, General|anesthetics, general|mesh-ancestor
110188528|NCT02571179|Anesthetics|anesthetics|mesh-ancestor
110188529|NCT02511418|Simvastatin|simvastatin|mesh-list
110188530|NCT02511418|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110188531|NCT02511418|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110188532|NCT02511418|Antimetabolites|antimetabolites|mesh-ancestor
110188533|NCT02511418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110188534|NCT02511418|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110039418|NCT01426984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110188535|NCT02511418|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110188537|NCT02278250|Carboplatin|carboplatin|mesh-list
110188538|NCT02278250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110188540|NCT02250326|Azacitidine|azacitidine|mesh-list
110188541|NCT02250326|Cc-486|cc-486|mesh-list
110188542|NCT02250326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110188543|NCT02250326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110188544|NCT02250326|Tubulin Modulators|tubulin modulators|mesh-ancestor
110298378|NCT05896319|Immunologic Factors|immunologic factors|mesh-ancestor
110298379|NCT05896319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110298380|NCT05896319|Viscosupplements|viscosupplements|mesh-ancestor
110188545|NCT02250326|Antimitotic Agents|antimitotic agents|mesh-ancestor
110188546|NCT02250326|Mitosis Modulators|mitosis modulators|mesh-ancestor
110188547|NCT02250326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110188548|NCT02250326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110188549|NCT02250326|Antimetabolites|antimetabolites|mesh-ancestor
110052945|NCT01483053|Escitalopram|escitalopram|mesh-list
110188550|NCT02250326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110188552|NCT02225600|Oxytocics|oxytocics|mesh-ancestor
110188553|NCT02225600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110188554|NCT02225600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110188555|NCT02211742|Dapagliflozin|dapagliflozin|mesh-list
110188556|NCT02211742|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110188557|NCT02211742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110188558|NCT02211742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110188559|NCT02211742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110188560|NCT02101905|Lapatinib|lapatinib|mesh-list
110188561|NCT02101905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110188562|NCT02101905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110188563|NCT02101905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110188564|NCT02101905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110188565|NCT02081404|Esomeprazole|esomeprazole|mesh-list
110188566|NCT02081404|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110188567|NCT02081404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110188568|NCT02081404|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110188569|NCT02081404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110188570|NCT02081404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110188571|NCT01526603|Carboplatin|carboplatin|mesh-list
110188572|NCT01526603|Etoposide|etoposide|mesh-list
110188573|NCT01526603|Melphalan|melphalan|mesh-list
110188574|NCT01526603|Tretinoin|tretinoin|mesh-list
110188575|NCT01526603|Isotretinoin|isotretinoin|mesh-list
110188576|NCT01526603|Lenograstim|lenograstim|mesh-list
110188577|NCT01526603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110188578|NCT01526603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110188579|NCT01526603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110188580|NCT01526603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110188581|NCT01526603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110188582|NCT01526603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110188583|NCT01526603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110188584|NCT01526603|Alkylating Agents|alkylating agents|mesh-ancestor
110188585|NCT01526603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110188586|NCT01526603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110188587|NCT01526603|Immunologic Factors|immunologic factors|mesh-ancestor
110188588|NCT01526603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110188589|NCT01526603|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110188590|NCT01526603|Keratolytic Agents|keratolytic agents|mesh-ancestor
110188591|NCT01526603|Dermatologic Agents|dermatologic agents|mesh-ancestor
110188592|NCT00038766|Semapimod|semapimod|mesh-list
110298477|NCT05694533|Midazolam|midazolam|mesh-list
110188593|NCT00038766|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110188594|NCT00038766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110188595|NCT00038766|Analgesics|analgesics|mesh-ancestor
110188596|NCT00038766|Sensory System Agents|sensory system agents|mesh-ancestor
110188597|NCT00038766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110188598|NCT00038766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110188599|NCT00038766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110188600|NCT00038766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110188601|NCT00038766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110188602|NCT00038766|Immunologic Factors|immunologic factors|mesh-ancestor
110188603|NCT00070070|Sargramostim|sargramostim|mesh-list
110188604|NCT00070070|BCG Vaccine|bcg vaccine|mesh-list
110188605|NCT00070070|Immunologic Factors|immunologic factors|mesh-ancestor
110188606|NCT00070070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110188607|NCT00070070|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110188608|NCT02573909|Oxycodone|oxycodone|mesh-list
110188609|NCT02573909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110188610|NCT02573909|Narcotics|narcotics|mesh-ancestor
110188611|NCT02573909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110188612|NCT02573909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110188613|NCT02573909|Analgesics|analgesics|mesh-ancestor
110188614|NCT02573909|Sensory System Agents|sensory system agents|mesh-ancestor
110188615|NCT02573909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110188616|NCT00042315|Vinorelbine|vinorelbine|mesh-list
110188617|NCT00042315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110188618|NCT00042315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110188619|NCT00042315|Tubulin Modulators|tubulin modulators|mesh-ancestor
110298493|NCT05681390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110298494|NCT05681390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110298495|NCT05669547|Hormones|hormones|mesh-list
110298496|NCT05669547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110298497|NCT05669547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110298498|NCT05669079|Decitabine|decitabine|mesh-list
110298499|NCT05669079|Epoetin Alfa|epoetin alfa|mesh-list
110298500|NCT05669079|Lenograstim|lenograstim|mesh-list
110298501|NCT05669079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110298502|NCT05669079|Antimetabolites|antimetabolites|mesh-ancestor
110298503|NCT05669079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110298504|NCT05669079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110298505|NCT05669079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110298506|NCT05669079|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110188620|NCT00042315|Antimitotic Agents|antimitotic agents|mesh-ancestor
110188621|NCT00042315|Mitosis Modulators|mitosis modulators|mesh-ancestor
110188622|NCT00042315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110188623|NCT00018668|Olanzapine|olanzapine|mesh-list
110188624|NCT00018668|Risperidone|risperidone|mesh-list
110188625|NCT00018668|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110188626|NCT00018668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110188627|NCT00018668|Serotonin Agents|serotonin agents|mesh-ancestor
110188628|NCT00018668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110188629|NCT00018668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110188630|NCT00018668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110188631|NCT00018668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110188632|NCT00018668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110188633|NCT00018668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110188634|NCT00018668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110188635|NCT00018668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110188637|NCT00018668|Antiemetics|antiemetics|mesh-ancestor
110188638|NCT00018668|Autonomic Agents|autonomic agents|mesh-ancestor
110298528|NCT05586373|Dipyrone|dipyrone|mesh-list
110188640|NCT00018668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110188641|NCT00018668|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110188642|NCT00018668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110188643|NCT00018668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110188644|NCT00018668|Antidepressive Agents|antidepressive agents|mesh-ancestor
110188645|NCT00042354|Clofarabine|clofarabine|mesh-list
110188646|NCT00042354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110188647|NCT00042354|Antimetabolites|antimetabolites|mesh-ancestor
110039611|NCT01428180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110188648|NCT00042354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110188649|NCT00042354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110188650|NCT00042393|Adefovir|adefovir|mesh-list
110188651|NCT00042393|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
110188652|NCT00042393|Antiviral Agents|antiviral agents|mesh-ancestor
110188653|NCT00042393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110188654|NCT00042393|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110188655|NCT00042393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110188656|NCT00042393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110188657|NCT00042393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110188659|NCT00042471|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
110188660|NCT00042471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110188661|NCT00042471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110188662|NCT00042471|Appetite Depressants|appetite depressants|mesh-ancestor
110188663|NCT00042471|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110188664|NCT00042471|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
110039670|NCT01428492|Dexamethasone|dexamethasone|mesh-list
110188665|NCT00042471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110188666|NCT00042549|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
110188667|NCT00042549|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110188668|NCT00042549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110188669|NCT00042588|Antibodies|antibodies|mesh-list
110188670|NCT00042588|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110298701|NCT04716881|Naltrexone|naltrexone|mesh-list
110188671|NCT00042588|Immunologic Factors|immunologic factors|mesh-ancestor
110188672|NCT00042588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110188673|NCT00038805|Gemtuzumab|gemtuzumab|mesh-list
110188674|NCT00038805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110188675|NCT00038805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110188676|NCT00038805|Immunotoxins|immunotoxins|mesh-ancestor
110188677|NCT00038805|Immunoconjugates|immunoconjugates|mesh-ancestor
110188678|NCT00038805|Immunologic Factors|immunologic factors|mesh-ancestor
110188679|NCT00038805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110188681|NCT00018824|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110298758|NCT04452877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110188682|NCT00018824|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110188683|NCT00018824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110188684|NCT00018824|Sensory System Agents|sensory system agents|mesh-ancestor
110188685|NCT00018824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110188686|NCT00038844|Cyclophosphamide|cyclophosphamide|mesh-list
110188687|NCT00038844|Rituximab|rituximab|mesh-list
110188688|NCT00038844|Fludarabine|fludarabine|mesh-list
110188689|NCT00038844|Fludarabine phosphate|fludarabine phosphate|mesh-list
110188690|NCT00038844|Alemtuzumab|alemtuzumab|mesh-list
110188691|NCT00038844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110188692|NCT00038844|Immunologic Factors|immunologic factors|mesh-ancestor
110188693|NCT00038844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110188694|NCT00038844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110039787|NCT01429337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110188695|NCT00038844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110188696|NCT00038844|Alkylating Agents|alkylating agents|mesh-ancestor
110188697|NCT00038844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110188698|NCT00038844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110279780|NCT00210717|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110188699|NCT00038844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110188700|NCT00038844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110188701|NCT00038844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110188702|NCT00038844|Antimetabolites|antimetabolites|mesh-ancestor
110188703|NCT00018863|Methylphenidate|methylphenidate|mesh-list
110188704|NCT00018863|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110188705|NCT00018863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110188706|NCT00018863|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110188707|NCT00018863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110188708|NCT00018863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110188709|NCT00018863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110188711|NCT00018863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110188712|NCT00038883|Alemtuzumab|alemtuzumab|mesh-list
110188713|NCT00038883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110188714|NCT00038883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110188716|NCT00018902|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110188717|NCT00018902|Citalopram|citalopram|mesh-list
110188718|NCT00018902|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110188719|NCT00018902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110188720|NCT00018902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110188721|NCT00018902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110188722|NCT00018902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110188723|NCT00018902|Serotonin Agents|serotonin agents|mesh-ancestor
110188724|NCT00018902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110188725|NCT00018902|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110188726|NCT00018902|Antidepressive Agents|antidepressive agents|mesh-ancestor
110039971|NCT01430078|Vitamins|vitamins|mesh-ancestor
110188727|NCT00018902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110188728|NCT00018902|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110188729|NCT00018902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110188730|NCT00018902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110188731|NCT00018902|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110188732|NCT00038922|Oprelvekin|oprelvekin|mesh-list
110188733|NCT00038922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110188734|NCT00018941|Aldesleukin|aldesleukin|mesh-list
110188735|NCT00018941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110188736|NCT00018941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110188737|NCT00018941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110188738|NCT00018941|Antiviral Agents|antiviral agents|mesh-ancestor
110188739|NCT00018941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110188740|NCT00038961|PENTA|penta|mesh-list
110188741|NCT00038961|Fondaparinux|fondaparinux|mesh-list
110188742|NCT00038961|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110188743|NCT00038961|Antithrombins|antithrombins|mesh-ancestor
110188744|NCT00038961|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110188745|NCT00038961|Protease Inhibitors|protease inhibitors|mesh-ancestor
110188746|NCT00038961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110188747|NCT00038961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110188748|NCT00038961|Anticoagulants|anticoagulants|mesh-ancestor
110188749|NCT00038961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110188750|NCT00038961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110188751|NCT00019019|Paclitaxel|paclitaxel|mesh-list
110188752|NCT00019019|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
110188753|NCT00019019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110188754|NCT00019019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110298881|NCT03875287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110188755|NCT00019019|Tubulin Modulators|tubulin modulators|mesh-ancestor
110188756|NCT00019019|Antimitotic Agents|antimitotic agents|mesh-ancestor
110040163|NCT01431729|Propolis|propolis|mesh-list
110188757|NCT00019019|Mitosis Modulators|mitosis modulators|mesh-ancestor
110188758|NCT00019019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110188759|NCT00019019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110188760|NCT00019019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110188761|NCT00019019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110188762|NCT00019019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110188763|NCT00019058|Hydroxyurea|hydroxyurea|mesh-list
110188764|NCT00019058|Pentoxifylline|pentoxifylline|mesh-list
110188765|NCT00019058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110188766|NCT00019058|Antisickling Agents|antisickling agents|mesh-ancestor
110188767|NCT00019058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110188768|NCT00019058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110188769|NCT00019058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110188771|NCT00019058|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110188772|NCT00019058|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110188773|NCT00019058|Protective Agents|protective agents|mesh-ancestor
110188774|NCT00019058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110188775|NCT00019058|Vasodilator Agents|vasodilator agents|mesh-ancestor
110188776|NCT00019058|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110188777|NCT00019058|Antioxidants|antioxidants|mesh-ancestor
110188778|NCT00039039|Paclitaxel|paclitaxel|mesh-list
110188779|NCT00039039|Carboplatin|carboplatin|mesh-list
110188780|NCT00039039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110188781|NCT00039039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110188782|NCT00039039|Tubulin Modulators|tubulin modulators|mesh-ancestor
110188783|NCT00039039|Antimitotic Agents|antimitotic agents|mesh-ancestor
110188784|NCT00039039|Mitosis Modulators|mitosis modulators|mesh-ancestor
110040353|NCT01432782|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110188785|NCT00039039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110188786|NCT00019097|Melphalan|melphalan|mesh-list
110188787|NCT00019097|Sargramostim|sargramostim|mesh-list
110188788|NCT00019097|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
110188789|NCT00019097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110188790|NCT00019097|Alkylating Agents|alkylating agents|mesh-ancestor
110188791|NCT00019097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110188792|NCT00019097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110188793|NCT00019097|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110188794|NCT00019097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110188795|NCT00019097|Immunologic Factors|immunologic factors|mesh-ancestor
110188796|NCT00019097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110188797|NCT00019097|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110188798|NCT00019136|Aldesleukin|aldesleukin|mesh-list
110188799|NCT00019136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110188800|NCT00019136|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110188801|NCT00019136|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110188802|NCT00019136|Antiviral Agents|antiviral agents|mesh-ancestor
110188803|NCT00019136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110188804|NCT00039117|Cytarabine|cytarabine|mesh-list
110188805|NCT00039117|Daunorubicin|daunorubicin|mesh-list
110298915|NCT03598426|Hormones|hormones|mesh-ancestor
110188807|NCT00039117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110188808|NCT00039117|Antimetabolites|antimetabolites|mesh-ancestor
110188809|NCT00039117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110188810|NCT00039117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110188811|NCT00039117|Antiviral Agents|antiviral agents|mesh-ancestor
110188812|NCT00039117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110188813|NCT00039117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110188814|NCT00039117|Immunologic Factors|immunologic factors|mesh-ancestor
110188815|NCT00039117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110188816|NCT00039117|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110188817|NCT00039117|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110188818|NCT00039117|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110188819|NCT00039117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110188821|NCT00019175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110188822|NCT00019175|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110188823|NCT00019175|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110188824|NCT00019175|Antiviral Agents|antiviral agents|mesh-ancestor
110188825|NCT00019175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110188827|NCT00039156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110188828|NCT00019214|Aldesleukin|aldesleukin|mesh-list
110188829|NCT00019214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110188830|NCT00019214|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110188831|NCT00019214|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110188832|NCT00019214|Antiviral Agents|antiviral agents|mesh-ancestor
110188833|NCT00019214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110188834|NCT00039234|Aldesleukin|aldesleukin|mesh-list
110188835|NCT00039234|Histamine|histamine|mesh-list
110188836|NCT00039234|Histamine phosphate|histamine phosphate|mesh-list
110188837|NCT00039234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110188838|NCT00039234|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110188839|NCT00039234|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110188840|NCT00039234|Antiviral Agents|antiviral agents|mesh-ancestor
110188841|NCT00039234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110188842|NCT00039234|Histamine Agonists|histamine agonists|mesh-ancestor
110188843|NCT00039234|Histamine Agents|histamine agents|mesh-ancestor
110188844|NCT00039234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110188845|NCT00039234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110188846|NCT00039234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110279846|NCT00217815|Mitosis Modulators|mitosis modulators|mesh-ancestor
110279852|NCT04722471|Hormones|hormones|mesh-ancestor
110188847|NCT00019331|Aldesleukin|aldesleukin|mesh-list
110188848|NCT00019331|Sargramostim|sargramostim|mesh-list
110188849|NCT00019331|Immunologic Factors|immunologic factors|mesh-ancestor
110188850|NCT00019331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110188851|NCT00019331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110188852|NCT00019331|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110188853|NCT00019331|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110188854|NCT00019331|Antiviral Agents|antiviral agents|mesh-ancestor
110188855|NCT00019331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110188856|NCT00039273|Panitumumab|panitumumab|mesh-list
110188857|NCT00039273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110188858|NCT00039273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110188859|NCT00019409|Cytarabine|cytarabine|mesh-list
110188860|NCT00019409|Prednisone|prednisone|mesh-list
110188861|NCT00019409|Hydrocortisone|hydrocortisone|mesh-list
110188862|NCT00019409|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110188863|NCT00019409|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110188864|NCT00019409|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110188865|NCT00019409|Cyclophosphamide|cyclophosphamide|mesh-list
110188866|NCT00019409|Methotrexate|methotrexate|mesh-list
110188867|NCT00019409|Vincristine|vincristine|mesh-list
110188868|NCT00019409|Daunorubicin|daunorubicin|mesh-list
110188869|NCT00019409|Asparaginase|asparaginase|mesh-list
110188870|NCT00019409|Mercaptopurine|mercaptopurine|mesh-list
110188871|NCT00019409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110188872|NCT00019409|Immunologic Factors|immunologic factors|mesh-ancestor
110188873|NCT00019409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110188874|NCT00019409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110188875|NCT00019409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110188876|NCT00019409|Alkylating Agents|alkylating agents|mesh-ancestor
110040598|NCT01434212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110188877|NCT00019409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110188878|NCT00019409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110188879|NCT00019409|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110188880|NCT00019409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110188881|NCT00019409|Glucocorticoids|glucocorticoids|mesh-ancestor
110188883|NCT00019409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110188884|NCT00019409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110188885|NCT00019409|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110188887|NCT00019409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110188888|NCT00019409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110188890|NCT00019409|Dermatologic Agents|dermatologic agents|mesh-ancestor
110188891|NCT00019409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110188892|NCT00019409|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110188893|NCT00019409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110188895|NCT00019409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110188896|NCT00019409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110188897|NCT00019409|Tubulin Modulators|tubulin modulators|mesh-ancestor
110040775|NCT01435486|Caffeine|caffeine|mesh-list
110188898|NCT00019409|Antimitotic Agents|antimitotic agents|mesh-ancestor
110188899|NCT00019409|Mitosis Modulators|mitosis modulators|mesh-ancestor
110188900|NCT00019409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110188901|NCT00019409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110188902|NCT00019409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110188904|NCT00019448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110188905|NCT00019448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110188906|NCT00019448|Analgesics|analgesics|mesh-ancestor
110188907|NCT00019448|Sensory System Agents|sensory system agents|mesh-ancestor
110188908|NCT00019448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110188909|NCT00019448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110188910|NCT00019487|Aldesleukin|aldesleukin|mesh-list
110188911|NCT00019487|Freund's Adjuvant|freund's adjuvant|mesh-list
110188912|NCT00019487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110188913|NCT00019487|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110188914|NCT00019487|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110188915|NCT00019487|Antiviral Agents|antiviral agents|mesh-ancestor
110188916|NCT00019487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110188917|NCT00019487|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110188918|NCT00019487|Immunologic Factors|immunologic factors|mesh-ancestor
110188919|NCT00019487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110188920|NCT00039351|Prednisone|prednisone|mesh-list
110188921|NCT00039351|Cyclophosphamide|cyclophosphamide|mesh-list
110188922|NCT00039351|Vincristine|vincristine|mesh-list
110188923|NCT00039351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110040967|NCT01437007|TKM-080301|tkm-080301|mesh-list
110188924|NCT00039351|Immunologic Factors|immunologic factors|mesh-ancestor
110188925|NCT00039351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110188926|NCT00039351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110188927|NCT00039351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110188928|NCT00039351|Alkylating Agents|alkylating agents|mesh-ancestor
110188929|NCT00039351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110188930|NCT00039351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110188931|NCT00039351|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110188932|NCT00039351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110188933|NCT00039351|Glucocorticoids|glucocorticoids|mesh-ancestor
110188935|NCT00039351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110188936|NCT00039351|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110188937|NCT00039351|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110188939|NCT00039351|Antimitotic Agents|antimitotic agents|mesh-ancestor
110188940|NCT00039351|Mitosis Modulators|mitosis modulators|mesh-ancestor
110188941|NCT00019565|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110188943|NCT00019565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110188944|NCT00039390|Capecitabine|capecitabine|mesh-list
110188945|NCT00039390|Gefitinib|gefitinib|mesh-list
110188946|NCT00039390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110188947|NCT00039390|Antimetabolites|antimetabolites|mesh-ancestor
110188948|NCT00039390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110188949|NCT00039390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110188950|NCT00039390|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110188951|NCT00039390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110188953|NCT00019721|Freund's Adjuvant|freund's adjuvant|mesh-list
110188954|NCT00019721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110188955|NCT00019721|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110188956|NCT00019721|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110188957|NCT00019721|Antiviral Agents|antiviral agents|mesh-ancestor
110188958|NCT00019721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110188959|NCT00019721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110188960|NCT00019721|Immunologic Factors|immunologic factors|mesh-ancestor
110188961|NCT00019721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110188962|NCT00019760|Leucovorin|leucovorin|mesh-list
110188963|NCT00019760|Melphalan|melphalan|mesh-list
110188964|NCT00019760|Floxuridine|floxuridine|mesh-list
110188965|NCT00019760|Calcium|calcium|mesh-list
110188966|NCT00019760|Levoleucovorin|levoleucovorin|mesh-list
110188967|NCT00019760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110188968|NCT00019760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110188969|NCT00019760|Antidotes|antidotes|mesh-ancestor
110188970|NCT00019760|Protective Agents|protective agents|mesh-ancestor
110188971|NCT00019760|Vitamin B Complex|vitamin b complex|mesh-ancestor
110188973|NCT00019760|Micronutrients|micronutrients|mesh-ancestor
110218334|NCT00108849|Estrogens|estrogens|mesh-ancestor
110188974|NCT00019760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110188975|NCT00019760|Alkylating Agents|alkylating agents|mesh-ancestor
110299045|NCT03290794|Aflibercept|aflibercept|mesh-list
110299046|NCT03290794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110188976|NCT00019760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110188978|NCT00019760|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110188979|NCT00019760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110188980|NCT00019760|Immunologic Factors|immunologic factors|mesh-ancestor
110188981|NCT00019760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110188982|NCT00019760|Antimetabolites|antimetabolites|mesh-ancestor
110188983|NCT00039468|Thalidomide|thalidomide|mesh-list
110188984|NCT00039468|Irinotecan|irinotecan|mesh-list
110188985|NCT00039468|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110188986|NCT00039468|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110188987|NCT00039468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110188988|NCT00039468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110188989|NCT00039468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110188990|NCT00039468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110188991|NCT00039468|Immunologic Factors|immunologic factors|mesh-ancestor
110188992|NCT00039468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110188993|NCT00039468|Leprostatic Agents|leprostatic agents|mesh-ancestor
110188994|NCT00039468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110188995|NCT00039468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110188996|NCT00039468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110188997|NCT00039468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110188998|NCT00039468|Growth Substances|growth substances|mesh-ancestor
110041491|NCT04597372|Tamsulosin|tamsulosin|mesh-list
110188999|NCT00039468|Growth Inhibitors|growth inhibitors|mesh-ancestor
110189001|NCT00019838|Fludarabine phosphate|fludarabine phosphate|mesh-list
110189002|NCT00019838|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
110189003|NCT00019838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110189004|NCT00019838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110189005|NCT00019838|Antimetabolites|antimetabolites|mesh-ancestor
110189006|NCT00019838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110189008|NCT00019838|Immunologic Factors|immunologic factors|mesh-ancestor
110189009|NCT00019838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110189010|NCT00019838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110189011|NCT00019838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110189012|NCT00019916|Aldesleukin|aldesleukin|mesh-list
110189013|NCT00019916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110189014|NCT00019916|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110189015|NCT00019916|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110189016|NCT00019916|Antiviral Agents|antiviral agents|mesh-ancestor
110189017|NCT00019916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110189018|NCT00039546|Paclitaxel|paclitaxel|mesh-list
110189019|NCT00039546|Cyclophosphamide|cyclophosphamide|mesh-list
110189020|NCT00039546|Gemcitabine|gemcitabine|mesh-list
110189021|NCT00039546|Epirubicin|epirubicin|mesh-list
110189022|NCT00039546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110189023|NCT00039546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110189024|NCT00039546|Tubulin Modulators|tubulin modulators|mesh-ancestor
110189025|NCT00039546|Antimitotic Agents|antimitotic agents|mesh-ancestor
110189026|NCT00039546|Mitosis Modulators|mitosis modulators|mesh-ancestor
110189027|NCT00039546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110189028|NCT00039546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110189029|NCT00039546|Immunologic Factors|immunologic factors|mesh-ancestor
110189030|NCT00039546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110189031|NCT00039546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110189032|NCT00039546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110189033|NCT00039546|Alkylating Agents|alkylating agents|mesh-ancestor
110189034|NCT00039546|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110041674|NCT02986334|Analgesics|analgesics|mesh-ancestor
110189035|NCT00039546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110189037|NCT00039546|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110189038|NCT00039546|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110189039|NCT00039546|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110189040|NCT00039546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110189041|NCT00039585|Imatinib Mesylate|imatinib mesylate|mesh-list
110041744|NCT02067182|Dabigatran|dabigatran|mesh-list
110189042|NCT00039585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110189043|NCT00039585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110189044|NCT00039585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110041809|NCT00330759|Zoledronic Acid|zoledronic acid|mesh-list
110189045|NCT00039585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110189047|NCT00019994|Freund's Adjuvant|freund's adjuvant|mesh-list
110189048|NCT00019994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110189049|NCT00019994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110189050|NCT00019994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110189051|NCT00019994|Antiviral Agents|antiviral agents|mesh-ancestor
110189052|NCT00019994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110189053|NCT00019994|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110189054|NCT00019994|Immunologic Factors|immunologic factors|mesh-ancestor
110041881|NCT01438580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110189055|NCT00019994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110189057|NCT00039663|Pravastatin|pravastatin|mesh-list
110189058|NCT00039663|Gemfibrozil|gemfibrozil|mesh-list
110189059|NCT00039663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110189060|NCT00039663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110189061|NCT00039663|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110189062|NCT00039663|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110189063|NCT00039663|Antimetabolites|antimetabolites|mesh-ancestor
110189064|NCT00039663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110189065|NCT00039663|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110189066|NCT00039663|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110189067|NCT00039663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110189068|NCT00039663|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110189069|NCT00039663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110189070|NCT00020111|Arsenic Trioxide|arsenic trioxide|mesh-list
110189071|NCT00020111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110189072|NCT00020150|Temozolomide|temozolomide|mesh-list
110189073|NCT00020150|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
110189074|NCT00020150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110189075|NCT00020150|Alkylating Agents|alkylating agents|mesh-ancestor
110189076|NCT00020150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110189077|NCT00020150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110189078|NCT00020150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110189080|NCT00039858|Antithrombins|antithrombins|mesh-ancestor
110189081|NCT00039858|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110189082|NCT00039858|Protease Inhibitors|protease inhibitors|mesh-ancestor
110189083|NCT00039858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110189084|NCT00039858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110189085|NCT00039858|Anticoagulants|anticoagulants|mesh-ancestor
110189086|NCT00039858|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110189088|NCT00020189|Alvocidib|alvocidib|mesh-list
110189089|NCT00020189|Clopidogrel|clopidogrel|mesh-list
110189090|NCT00020189|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110189091|NCT00020189|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110189092|NCT00020189|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110189093|NCT00020189|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110189094|NCT00020189|Purinergic Agents|purinergic agents|mesh-ancestor
110189095|NCT00020189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110189096|NCT00020189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110189097|NCT00020189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110189098|NCT00020189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110189099|NCT00020189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110189100|NCT00020189|Analgesics|analgesics|mesh-ancestor
110189101|NCT00020189|Sensory System Agents|sensory system agents|mesh-ancestor
110189102|NCT00020189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110189103|NCT00020189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110218355|NCT00109044|Escitalopram|escitalopram|mesh-list
110189104|NCT00020189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110189105|NCT00020189|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110189106|NCT00020189|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110189107|NCT00020189|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110189108|NCT00020189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110189110|NCT00020189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110189111|NCT00020189|Growth Inhibitors|growth inhibitors|mesh-ancestor
110189112|NCT00020189|Growth Substances|growth substances|mesh-ancestor
110189113|NCT00020189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110189115|NCT00039975|Indinavir|indinavir|mesh-list
110189116|NCT00039975|Amlodipine|amlodipine|mesh-list
110189117|NCT00039975|Diltiazem|diltiazem|mesh-list
110189118|NCT00039975|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110189119|NCT00039975|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110189120|NCT00039975|Protease Inhibitors|protease inhibitors|mesh-ancestor
110189121|NCT00039975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110189122|NCT00039975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110189123|NCT00039975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110189124|NCT00039975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110189125|NCT00039975|Antiviral Agents|antiviral agents|mesh-ancestor
110189126|NCT00039975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110189127|NCT00039975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110189128|NCT00039975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110189129|NCT00039975|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110189130|NCT00039975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110189131|NCT00039975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110189132|NCT00039975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110189133|NCT00039975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110189134|NCT00039975|Vasodilator Agents|vasodilator agents|mesh-ancestor
110189135|NCT00020267|Interleukin-2|interleukin-2|mesh-list
110189137|NCT00020267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110189138|NCT00020267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110189139|NCT00020267|Analgesics|analgesics|mesh-ancestor
110189140|NCT00020267|Sensory System Agents|sensory system agents|mesh-ancestor
110189141|NCT00020267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110189142|NCT00020267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110189143|NCT00020267|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110189144|NCT00020267|Immunologic Factors|immunologic factors|mesh-ancestor
110189145|NCT00040014|Exemestane|exemestane|mesh-list
110189146|NCT00040014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110189147|NCT00040014|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110189148|NCT00040014|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110189149|NCT00040014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110189150|NCT00040014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110189151|NCT00040014|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110189152|NCT00040014|Hormone Antagonists|hormone antagonists|mesh-ancestor
110189153|NCT00040014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110189154|NCT00040014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110189155|NCT00020345|Gemcitabine|gemcitabine|mesh-list
110189156|NCT00020345|Fluorouracil|fluorouracil|mesh-list
110189157|NCT00020345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110189158|NCT00020345|Antimetabolites|antimetabolites|mesh-ancestor
110189159|NCT00020345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110189160|NCT00020345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110189161|NCT00020345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110189162|NCT00020345|Immunologic Factors|immunologic factors|mesh-ancestor
110189163|NCT00020345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110189164|NCT00040053|Ondansetron|ondansetron|mesh-list
110189165|NCT00040053|Antiemetics|antiemetics|mesh-ancestor
110189166|NCT00040053|Autonomic Agents|autonomic agents|mesh-ancestor
110189167|NCT00040053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110189168|NCT00040053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110189169|NCT00040053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110189170|NCT00040053|Antipruritics|antipruritics|mesh-ancestor
110189171|NCT00040053|Dermatologic Agents|dermatologic agents|mesh-ancestor
110189172|NCT00040053|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110189173|NCT00040053|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110189175|NCT00040053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110189176|NCT00040053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110189177|NCT00020462|Aldesleukin|aldesleukin|mesh-list
110189178|NCT00020462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110189179|NCT00020462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110189180|NCT00020462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110189181|NCT00020462|Antiviral Agents|antiviral agents|mesh-ancestor
110189182|NCT00020462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110189183|NCT00020501|Leucovorin|leucovorin|mesh-list
110189184|NCT00020501|Fluorouracil|fluorouracil|mesh-list
110189185|NCT00020501|Floxuridine|floxuridine|mesh-list
110189186|NCT00020501|Irinotecan|irinotecan|mesh-list
110189188|NCT00020501|Calcium|calcium|mesh-list
110189189|NCT00020501|Levoleucovorin|levoleucovorin|mesh-list
110189190|NCT00020501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110189191|NCT00020501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110189192|NCT00020501|Antimetabolites|antimetabolites|mesh-ancestor
110189193|NCT00020501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110189194|NCT00020501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110189195|NCT00020501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110042482|NCT01442532|Anesthetics|anesthetics|mesh-ancestor
110280005|NCT00211146|Hematinics|hematinics|mesh-ancestor
110189196|NCT00020501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110189197|NCT00020501|Immunologic Factors|immunologic factors|mesh-ancestor
110189198|NCT00020501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110189199|NCT00020501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110189200|NCT00020501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110189201|NCT00020501|Antidotes|antidotes|mesh-ancestor
110189202|NCT00020501|Protective Agents|protective agents|mesh-ancestor
110189203|NCT00020501|Vitamin B Complex|vitamin b complex|mesh-ancestor
110189204|NCT00020501|Vitamins|vitamins|mesh-ancestor
110189205|NCT00020501|Micronutrients|micronutrients|mesh-ancestor
110189206|NCT00020501|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110189207|NCT00020501|Alkylating Agents|alkylating agents|mesh-ancestor
110189208|NCT00020501|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110189209|NCT00020540|Flt3 ligand protein|flt3 ligand protein|mesh-list
110189210|NCT00020540|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110189211|NCT00020540|Immunologic Factors|immunologic factors|mesh-ancestor
110189212|NCT00020540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110189213|NCT00020540|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110189214|NCT00020540|Protective Agents|protective agents|mesh-ancestor
110189216|NCT00020579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110189217|NCT00020579|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110189218|NCT00020579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110189219|NCT00020579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110189220|NCT00040209|Levodopa|levodopa|mesh-list
110189221|NCT00040209|Apomorphine|apomorphine|mesh-list
110189222|NCT00040209|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110189223|NCT00040209|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110189224|NCT00040209|Dopamine Agents|dopamine agents|mesh-ancestor
110189225|NCT00040209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110189226|NCT00040209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110189227|NCT00040209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110189229|NCT00040209|Autonomic Agents|autonomic agents|mesh-ancestor
110189230|NCT00040209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110189231|NCT00040209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110189232|NCT00040209|Dopamine Agonists|dopamine agonists|mesh-ancestor
110189233|NCT00040248|Daclizumab|daclizumab|mesh-list
110189234|NCT00040248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110189235|NCT00040248|Immunologic Factors|immunologic factors|mesh-ancestor
110189236|NCT00040248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110189238|NCT00020618|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110189239|NCT00020618|Narcotics|narcotics|mesh-ancestor
110189240|NCT00020618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110299238|NCT00915837|Glucocorticoids|glucocorticoids|mesh-ancestor
110189241|NCT00020618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110189242|NCT00020618|Analgesics|analgesics|mesh-ancestor
110189243|NCT00020618|Sensory System Agents|sensory system agents|mesh-ancestor
110189244|NCT00020618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110189245|NCT00020657|Ondansetron|ondansetron|mesh-list
110189246|NCT00020657|Granisetron|granisetron|mesh-list
110189247|NCT00020657|Prochlorperazine|prochlorperazine|mesh-list
110189248|NCT00020657|Dolasetron|dolasetron|mesh-list
110189249|NCT00020657|Antiemetics|antiemetics|mesh-ancestor
110189250|NCT00020657|Autonomic Agents|autonomic agents|mesh-ancestor
110189251|NCT00020657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110189252|NCT00020657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110189253|NCT00020657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110189254|NCT00020657|Antipruritics|antipruritics|mesh-ancestor
110189255|NCT00020657|Dermatologic Agents|dermatologic agents|mesh-ancestor
110189256|NCT00020657|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110189257|NCT00020657|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110189258|NCT00020657|Serotonin Agents|serotonin agents|mesh-ancestor
110189259|NCT00020657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110189260|NCT00020657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110189261|NCT00020657|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110189262|NCT00020657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110189263|NCT00020657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110189264|NCT00020657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110189265|NCT00020657|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110189266|NCT00020657|Dopamine Agents|dopamine agents|mesh-ancestor
110189267|NCT00040326|Anticonvulsants|anticonvulsants|mesh-list
110189268|NCT00020696|Tirapazamine|tirapazamine|mesh-list
110189269|NCT00020696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110189270|NCT02970630|Everolimus|everolimus|mesh-list
110189271|NCT02970630|Tacrolimus|tacrolimus|mesh-list
110189272|NCT02970630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110189273|NCT02970630|Immunologic Factors|immunologic factors|mesh-ancestor
110189274|NCT02970630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110189275|NCT02970630|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110189276|NCT02970630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110189277|NCT02970630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110189278|NCT02970630|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110189279|NCT02970630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110189280|NCT02970630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110189281|NCT00020735|Toremifene|toremifene|mesh-list
110189282|NCT00020735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110189283|NCT00020735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110189284|NCT00020735|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110043270|NCT01446926|Immunologic Factors|immunologic factors|mesh-ancestor
110189286|NCT00020735|Hormone Antagonists|hormone antagonists|mesh-ancestor
110189287|NCT00020735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110189288|NCT00020735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110189289|NCT00020735|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110189290|NCT00040482|Cyclophosphamide|cyclophosphamide|mesh-list
110189291|NCT00040482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110189292|NCT00040482|Immunologic Factors|immunologic factors|mesh-ancestor
110043340|NCT01447394|Interferons|interferons|mesh-list
110189293|NCT00040482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110189294|NCT00040482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110189295|NCT00040482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110189296|NCT00040482|Alkylating Agents|alkylating agents|mesh-ancestor
110043403|NCT01447875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110189297|NCT00040482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110189298|NCT00040482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110189299|NCT00040482|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110189300|NCT00020774|Gemcitabine|gemcitabine|mesh-list
110189301|NCT00020774|Lonafarnib|lonafarnib|mesh-list
110189302|NCT00020774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110189303|NCT00020774|Antimetabolites|antimetabolites|mesh-ancestor
110189304|NCT00020774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110043480|NCT01448317|Alirocumab|alirocumab|mesh-list
110189306|NCT00020774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110189307|NCT00040521|Oprelvekin|oprelvekin|mesh-list
110189308|NCT00040521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110189309|NCT00040599|Labetuzumab|labetuzumab|mesh-list
110189310|NCT00040599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110189311|NCT00040599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110189312|NCT00020930|Cetuximab|cetuximab|mesh-list
110280047|NCT00185510|Prednisolone phosphate|prednisolone phosphate|mesh-list
110189313|NCT00020930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110189314|NCT00020930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110189315|NCT00020969|Arsenic Trioxide|arsenic trioxide|mesh-list
110189316|NCT00020969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110189317|NCT00040794|Paclitaxel|paclitaxel|mesh-list
110189318|NCT00040794|Carboplatin|carboplatin|mesh-list
110189319|NCT00040794|Gefitinib|gefitinib|mesh-list
110189320|NCT00040794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110189321|NCT00040794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110189322|NCT00040794|Tubulin Modulators|tubulin modulators|mesh-ancestor
110189323|NCT00040794|Antimitotic Agents|antimitotic agents|mesh-ancestor
110189324|NCT00040794|Mitosis Modulators|mitosis modulators|mesh-ancestor
110189325|NCT00040794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110189326|NCT00040794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110189327|NCT00040794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110189328|NCT00021047|Carboplatin|carboplatin|mesh-list
110189329|NCT00021047|Capecitabine|capecitabine|mesh-list
110189330|NCT00021047|Epirubicin|epirubicin|mesh-list
110189331|NCT00021047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110189332|NCT00021047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110189333|NCT00021047|Antimetabolites|antimetabolites|mesh-ancestor
110189334|NCT00021047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110189335|NCT00021047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110189336|NCT00021047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110299313|NCT04531228|Lenvatinib|lenvatinib|mesh-list
110189337|NCT00021047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110189339|NCT00021164|Aldesleukin|aldesleukin|mesh-list
110189340|NCT00021164|Freund's Adjuvant|freund's adjuvant|mesh-list
110189341|NCT00021164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110189342|NCT00021164|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110189343|NCT00021164|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110189344|NCT00021164|Antiviral Agents|antiviral agents|mesh-ancestor
110189345|NCT00021164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110189346|NCT00021164|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110189347|NCT00021164|Immunologic Factors|immunologic factors|mesh-ancestor
110189348|NCT00021164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110189349|NCT00040872|Cyclophosphamide|cyclophosphamide|mesh-list
110189350|NCT00040872|Thiotepa|thiotepa|mesh-list
110189351|NCT00040872|Carboplatin|carboplatin|mesh-list
110189352|NCT00040872|Doxorubicin|doxorubicin|mesh-list
110189353|NCT00040872|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110189354|NCT00040872|Etoposide|etoposide|mesh-list
110189355|NCT00040872|Vincristine|vincristine|mesh-list
110189356|NCT00040872|Topotecan|topotecan|mesh-list
110189357|NCT00040872|Isotretinoin|isotretinoin|mesh-list
110189358|NCT00040872|Antibodies|antibodies|mesh-list
110189359|NCT00040872|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110189360|NCT00040872|Sargramostim|sargramostim|mesh-list
110189361|NCT00040872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110043597|NCT01448772|Hormones|hormones|mesh-ancestor
110189362|NCT00040872|Immunologic Factors|immunologic factors|mesh-ancestor
110189363|NCT00040872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110189364|NCT00040872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110189365|NCT00040872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110189366|NCT00040872|Alkylating Agents|alkylating agents|mesh-ancestor
110189367|NCT00040872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110189368|NCT00040872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110189369|NCT00040872|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110189370|NCT00040872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110189371|NCT00040872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110189372|NCT00040872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110189374|NCT00040872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110189375|NCT00040872|Tubulin Modulators|tubulin modulators|mesh-ancestor
110189376|NCT00040872|Antimitotic Agents|antimitotic agents|mesh-ancestor
110189377|NCT00040872|Mitosis Modulators|mitosis modulators|mesh-ancestor
110189378|NCT00040872|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110189379|NCT00040872|Dermatologic Agents|dermatologic agents|mesh-ancestor
110189380|NCT00021242|Docetaxel|docetaxel|mesh-list
110189381|NCT00021242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110189382|NCT00021242|Tubulin Modulators|tubulin modulators|mesh-ancestor
110189383|NCT00021242|Antimitotic Agents|antimitotic agents|mesh-ancestor
110189384|NCT00021242|Mitosis Modulators|mitosis modulators|mesh-ancestor
110189385|NCT00021242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110189386|NCT00040950|Rituximab|rituximab|mesh-list
110189387|NCT00040950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110189388|NCT00040950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110189389|NCT00040950|Immunologic Factors|immunologic factors|mesh-ancestor
110189390|NCT00040950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110189391|NCT00040950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110189392|NCT00040989|Enzyme Inhibitors|enzyme inhibitors|mesh-list
110189393|NCT00040989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110189394|NCT00021281|Leucovorin|leucovorin|mesh-list
110189395|NCT00021281|Fluorouracil|fluorouracil|mesh-list
110189396|NCT00021281|Irinotecan|irinotecan|mesh-list
110189397|NCT00021281|Calcium|calcium|mesh-list
110189398|NCT00021281|Levoleucovorin|levoleucovorin|mesh-list
110189399|NCT00021281|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110189400|NCT00021281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110189401|NCT00021281|Antimetabolites|antimetabolites|mesh-ancestor
110189402|NCT00021281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110189403|NCT00021281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110189404|NCT00021281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110189405|NCT00021281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110189406|NCT00021281|Immunologic Factors|immunologic factors|mesh-ancestor
110189407|NCT00021281|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110189408|NCT00021281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110189409|NCT00021281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110189410|NCT00021281|Antidotes|antidotes|mesh-ancestor
110189411|NCT00021281|Protective Agents|protective agents|mesh-ancestor
110189412|NCT00021281|Vitamin B Complex|vitamin b complex|mesh-ancestor
110189414|NCT00021281|Micronutrients|micronutrients|mesh-ancestor
110189415|NCT00041106|Gemcitabine|gemcitabine|mesh-list
110189416|NCT00041106|Gefitinib|gefitinib|mesh-list
110189417|NCT00041106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110189418|NCT00041106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110189419|NCT00041106|Antimetabolites|antimetabolites|mesh-ancestor
110189420|NCT00041106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110189421|NCT00041106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110189422|NCT00041106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110189423|NCT00021320|Paclitaxel|paclitaxel|mesh-list
110189424|NCT00021320|Fluorouracil|fluorouracil|mesh-list
110189425|NCT00021320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110189426|NCT00021320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110189427|NCT00021320|Tubulin Modulators|tubulin modulators|mesh-ancestor
110189428|NCT00021320|Antimitotic Agents|antimitotic agents|mesh-ancestor
110189429|NCT00021320|Mitosis Modulators|mitosis modulators|mesh-ancestor
110189430|NCT00021320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110189431|NCT00021320|Antimetabolites|antimetabolites|mesh-ancestor
110189432|NCT00021320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110189433|NCT00021320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110189434|NCT00021320|Immunologic Factors|immunologic factors|mesh-ancestor
110189435|NCT00021320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110189436|NCT00041223|Proanthocyanidin|proanthocyanidin|mesh-list
110189437|NCT00041223|Procyanidin|procyanidin|mesh-list
110044024|NCT05963204|Mannitol|mannitol|mesh-list
110189438|NCT00041223|Antioxidants|antioxidants|mesh-ancestor
110189439|NCT00041223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110189440|NCT00041223|Protective Agents|protective agents|mesh-ancestor
110189441|NCT00041223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110189442|NCT00041223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110189443|NCT00041223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110189444|NCT00041223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110189445|NCT00021359|Dexamethasone|dexamethasone|mesh-list
110189446|NCT00021359|Isotretinoin|isotretinoin|mesh-list
110189447|NCT00021359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110189448|NCT00021359|Antiemetics|antiemetics|mesh-ancestor
110189449|NCT00021359|Autonomic Agents|autonomic agents|mesh-ancestor
110189450|NCT00021359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110189451|NCT00021359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110189452|NCT00021359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110189454|NCT00021359|Hormones|hormones|mesh-ancestor
110189455|NCT00021359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110189456|NCT00021359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110189457|NCT00021359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110189458|NCT00021359|Dermatologic Agents|dermatologic agents|mesh-ancestor
110189459|NCT00041262|Fluorouracil|fluorouracil|mesh-list
110189460|NCT00041262|Epirubicin|epirubicin|mesh-list
110189461|NCT00041262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110189462|NCT00041262|Antimetabolites|antimetabolites|mesh-ancestor
110189463|NCT00041262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110189464|NCT00041262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110189465|NCT00041262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110189466|NCT00041262|Immunologic Factors|immunologic factors|mesh-ancestor
110189467|NCT00041262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110189468|NCT00041262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110189469|NCT00041262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110189470|NCT00041262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110189471|NCT00041262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110189472|NCT00021398|Leucovorin|leucovorin|mesh-list
110189473|NCT00021398|Fluorouracil|fluorouracil|mesh-list
110189474|NCT00021398|Calcium|calcium|mesh-list
110189475|NCT00021398|Levoleucovorin|levoleucovorin|mesh-list
110189476|NCT00021398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110189477|NCT00021398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110189478|NCT00021398|Antimetabolites|antimetabolites|mesh-ancestor
110189479|NCT00021398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110189480|NCT00021398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110189481|NCT00021398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110189482|NCT00021398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110189483|NCT00021398|Immunologic Factors|immunologic factors|mesh-ancestor
110189484|NCT00021398|Antidotes|antidotes|mesh-ancestor
110189485|NCT00021398|Protective Agents|protective agents|mesh-ancestor
110189486|NCT00021398|Vitamin B Complex|vitamin b complex|mesh-ancestor
110189487|NCT00021398|Vitamins|vitamins|mesh-ancestor
110189488|NCT00021398|Micronutrients|micronutrients|mesh-ancestor
110189489|NCT00048945|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110189490|NCT00048945|Antiviral Agents|antiviral agents|mesh-ancestor
110189491|NCT00048945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110189492|NCT00021554|Enfuvirtide|enfuvirtide|mesh-list
110189493|NCT00021554|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110189494|NCT00021554|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110189495|NCT00021554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110189496|NCT00021554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110189497|NCT00021554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110189498|NCT00021554|Antiviral Agents|antiviral agents|mesh-ancestor
110189499|NCT00021554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110189500|NCT00049023|Octreotide|octreotide|mesh-list
110189501|NCT00049023|Edotreotide|edotreotide|mesh-list
110189502|NCT00049023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110189503|NCT00049023|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110189504|NCT00049023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110189505|NCT00049023|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110189506|NCT00049023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110189508|NCT00021671|Nevirapine|nevirapine|mesh-list
110189510|NCT00021671|Erythromycin Estolate|erythromycin estolate|mesh-list
110189511|NCT00021671|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
110189512|NCT00021671|Erythromycin stearate|erythromycin stearate|mesh-list
110189513|NCT00021671|Ampicillin|ampicillin|mesh-list
110189514|NCT00021671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110189515|NCT00021671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110189516|NCT00021671|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110189517|NCT00021671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110189518|NCT00021671|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110189519|NCT00021671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110189520|NCT00021671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110189521|NCT00021671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110189522|NCT00021671|Antiviral Agents|antiviral agents|mesh-ancestor
110189524|NCT00021671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110189525|NCT00021671|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110189526|NCT00021671|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110189527|NCT00021671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110189528|NCT00021671|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110189529|NCT00049062|Gefitinib|gefitinib|mesh-list
110189530|NCT00049062|Anastrozole|anastrozole|mesh-list
110189531|NCT00049062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110189532|NCT00049062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110189533|NCT00049062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110189534|NCT00049062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110189535|NCT00049062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110189536|NCT00049062|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110189537|NCT00049062|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110189538|NCT00049062|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110189539|NCT00049062|Hormone Antagonists|hormone antagonists|mesh-ancestor
110189540|NCT00049062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110189541|NCT00049062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110189543|NCT00049101|Fluorouracil|fluorouracil|mesh-list
110189544|NCT00049101|Oxaliplatin|oxaliplatin|mesh-list
110189545|NCT00049101|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110189546|NCT00049101|Calcium|calcium|mesh-list
110189548|NCT00049101|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110189549|NCT00049101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110189550|NCT00049101|Antimetabolites|antimetabolites|mesh-ancestor
110189551|NCT00049101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110189552|NCT00049101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110189553|NCT00049101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110189554|NCT00049101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110189555|NCT00049101|Immunologic Factors|immunologic factors|mesh-ancestor
110189556|NCT00049101|Antidotes|antidotes|mesh-ancestor
110189557|NCT00049101|Protective Agents|protective agents|mesh-ancestor
110189558|NCT00049101|Vitamin B Complex|vitamin b complex|mesh-ancestor
110189559|NCT00049101|Vitamins|vitamins|mesh-ancestor
110189560|NCT00049101|Micronutrients|micronutrients|mesh-ancestor
110189561|NCT00049101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110189562|NCT00049101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110189563|NCT00394628|Temozolomide|temozolomide|mesh-list
110189564|NCT00394628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110189565|NCT00394628|Alkylating Agents|alkylating agents|mesh-ancestor
110189566|NCT00394628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110189567|NCT00394628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110189568|NCT00049179|Cytarabine|cytarabine|mesh-list
110189569|NCT00049179|Gemtuzumab|gemtuzumab|mesh-list
110189570|NCT00049179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110189571|NCT00049179|Antimetabolites|antimetabolites|mesh-ancestor
110189572|NCT00049179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110189573|NCT00049179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110189574|NCT00049179|Antiviral Agents|antiviral agents|mesh-ancestor
110189575|NCT00049179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110189576|NCT00049179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110189577|NCT00049179|Immunologic Factors|immunologic factors|mesh-ancestor
110189578|NCT00049179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110189579|NCT00049179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110189580|NCT00049179|Immunotoxins|immunotoxins|mesh-ancestor
110189581|NCT00049179|Immunoconjugates|immunoconjugates|mesh-ancestor
110189582|NCT00394745|Valsartan|valsartan|mesh-list
110189583|NCT00394745|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110189584|NCT00394745|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110189585|NCT00394745|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110189586|NCT00394745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110189587|NCT00049218|Carboplatin|carboplatin|mesh-list
110189588|NCT00049218|Etoposide|etoposide|mesh-list
110189589|NCT00049218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110189590|NCT00049218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110189591|NCT00049218|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110189592|NCT00049218|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110189593|NCT00049218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110280164|NCT00218517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110189594|NCT00049218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110189596|NCT00049296|Docetaxel|docetaxel|mesh-list
110189597|NCT00049296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110189598|NCT00049296|Tubulin Modulators|tubulin modulators|mesh-ancestor
110189599|NCT00049296|Antimitotic Agents|antimitotic agents|mesh-ancestor
110189600|NCT00049296|Mitosis Modulators|mitosis modulators|mesh-ancestor
110044821|NCT05351801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110189601|NCT00049296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110189602|NCT00049296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110189604|NCT00049296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110189605|NCT00049296|Leprostatic Agents|leprostatic agents|mesh-ancestor
110189606|NCT00049296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110189607|NCT00049296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110189608|NCT00049296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110189609|NCT00049296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110189610|NCT00049296|Growth Substances|growth substances|mesh-ancestor
110189611|NCT00049296|Growth Inhibitors|growth inhibitors|mesh-ancestor
110189613|NCT00021827|Parathyroid Hormone|parathyroid hormone|mesh-list
110189614|NCT00021827|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
110189615|NCT00021827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110044941|NCT05179512|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110189616|NCT00021827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110189617|NCT00021827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110189618|NCT00049335|Capecitabine|capecitabine|mesh-list
110189619|NCT00049335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110189620|NCT00049335|Antimetabolites|antimetabolites|mesh-ancestor
110189621|NCT00049335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110189622|NCT00049335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110189623|NCT00049374|Thalidomide|thalidomide|mesh-list
110045015|NCT05086081|Ticagrelor|ticagrelor|mesh-list
110189624|NCT00049374|Dexamethasone|dexamethasone|mesh-list
110189625|NCT00049374|Oblimersen|oblimersen|mesh-list
110189626|NCT00049374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110189627|NCT00049374|Antiemetics|antiemetics|mesh-ancestor
110189628|NCT00049374|Autonomic Agents|autonomic agents|mesh-ancestor
110189629|NCT00049374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110189630|NCT00049374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110189631|NCT00049374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110189632|NCT00049374|Glucocorticoids|glucocorticoids|mesh-ancestor
110189633|NCT00049374|Hormones|hormones|mesh-ancestor
110191435|NCT00027989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110189634|NCT00049374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110189635|NCT00049374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110189636|NCT00049374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110189637|NCT00049374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110189638|NCT00049374|Immunologic Factors|immunologic factors|mesh-ancestor
110189639|NCT00049374|Leprostatic Agents|leprostatic agents|mesh-ancestor
110189640|NCT00049374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110189641|NCT00049374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110189642|NCT00049374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110189643|NCT00049374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110189644|NCT00049374|Growth Substances|growth substances|mesh-ancestor
110189645|NCT00049374|Growth Inhibitors|growth inhibitors|mesh-ancestor
110189647|NCT00021983|Immunoconjugates|immunoconjugates|mesh-ancestor
110189648|NCT00021983|Immunologic Factors|immunologic factors|mesh-ancestor
110189649|NCT00021983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110189651|NCT00049413|Rituximab|rituximab|mesh-list
110189652|NCT00049413|Pentostatin|pentostatin|mesh-list
110189653|NCT00049413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110189654|NCT00049413|Immunologic Factors|immunologic factors|mesh-ancestor
110045276|NCT04892732|Budesonide|budesonide|mesh-list
110189655|NCT00049413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110189657|NCT00049413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110189658|NCT00049413|Alkylating Agents|alkylating agents|mesh-ancestor
110189659|NCT00049413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110189660|NCT00049413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110189661|NCT00049413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110189662|NCT00049413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110189663|NCT00049413|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
110189664|NCT00049413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110189665|NCT00022022|Docetaxel|docetaxel|mesh-list
110189666|NCT00022022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110189667|NCT00022022|Tubulin Modulators|tubulin modulators|mesh-ancestor
110189668|NCT00022022|Antimitotic Agents|antimitotic agents|mesh-ancestor
110189669|NCT00022022|Mitosis Modulators|mitosis modulators|mesh-ancestor
110189670|NCT00022022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110189671|NCT00049452|Zoledronic Acid|zoledronic acid|mesh-list
110189672|NCT00049452|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110189673|NCT00049452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110189674|NCT00022139|Paclitaxel|paclitaxel|mesh-list
110189675|NCT00022139|Carboplatin|carboplatin|mesh-list
110189676|NCT00022139|Fluorouracil|fluorouracil|mesh-list
110189677|NCT00022139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110045405|NCT06040424|Cholinergic Agents|cholinergic agents|mesh-ancestor
110189678|NCT00022139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110189679|NCT00022139|Tubulin Modulators|tubulin modulators|mesh-ancestor
110189680|NCT00022139|Antimitotic Agents|antimitotic agents|mesh-ancestor
110189681|NCT00022139|Mitosis Modulators|mitosis modulators|mesh-ancestor
110189682|NCT00022139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110189684|NCT00022139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110189685|NCT00022139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110189686|NCT00022139|Immunologic Factors|immunologic factors|mesh-ancestor
110189687|NCT00022139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110189692|NCT00049569|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110189694|NCT00049569|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110189695|NCT00049569|Cyclophosphamide|cyclophosphamide|mesh-list
110189696|NCT00049569|Doxorubicin|doxorubicin|mesh-list
110189697|NCT00049569|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110189698|NCT00049569|Methotrexate|methotrexate|mesh-list
110189699|NCT00049569|Etoposide|etoposide|mesh-list
110189700|NCT00049569|Vincristine|vincristine|mesh-list
110189701|NCT00049569|Imatinib Mesylate|imatinib mesylate|mesh-list
110189702|NCT00049569|Asparaginase|asparaginase|mesh-list
110189703|NCT00049569|Pegaspargase|pegaspargase|mesh-list
110045605|NCT06039540|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110189704|NCT00049569|Levoleucovorin|levoleucovorin|mesh-list
110189705|NCT00049569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110189706|NCT00049569|Immunologic Factors|immunologic factors|mesh-ancestor
110280205|NCT00186797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280206|NCT00186797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110280207|NCT00186797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110280208|NCT00186797|Alkylating Agents|alkylating agents|mesh-ancestor
110280209|NCT00186797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280210|NCT00186797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110189707|NCT00049569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110189708|NCT00049569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110189709|NCT00049569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110189710|NCT00049569|Alkylating Agents|alkylating agents|mesh-ancestor
110189711|NCT00049569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110189712|NCT00049569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110189713|NCT00049569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110189714|NCT00049569|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110189715|NCT00049569|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110189716|NCT00049569|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110189717|NCT00049569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110189718|NCT00049569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110189721|NCT00049569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110189722|NCT00049569|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110189723|NCT00049569|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110189724|NCT00049569|Abortifacient Agents|abortifacient agents|mesh-ancestor
110189725|NCT00049569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110189726|NCT00049569|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110045732|NCT06038968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110189727|NCT00049569|Antimetabolites|antimetabolites|mesh-ancestor
110189728|NCT00049569|Dermatologic Agents|dermatologic agents|mesh-ancestor
110189729|NCT00049569|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110189730|NCT00049569|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110189731|NCT00049569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110189732|NCT00049569|Antiviral Agents|antiviral agents|mesh-ancestor
110189733|NCT00049569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110189734|NCT00049569|Antidotes|antidotes|mesh-ancestor
110189735|NCT00049569|Protective Agents|protective agents|mesh-ancestor
110189736|NCT00049569|Vitamin B Complex|vitamin b complex|mesh-ancestor
110189738|NCT00049569|Micronutrients|micronutrients|mesh-ancestor
110045791|NCT06037434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110045792|NCT06037434|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110045793|NCT06037434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110045805|NCT06035523|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110045806|NCT06035523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110045807|NCT06031740|Polidocanol|polidocanol|mesh-list
110045808|NCT06031740|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
110045809|NCT06031740|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110045832|NCT06019728|Diphenhydramine|diphenhydramine|mesh-list
110045833|NCT06019728|Promethazine|promethazine|mesh-list
110045834|NCT06019728|Dexamethasone|dexamethasone|mesh-list
110045835|NCT06019728|Montelukast|montelukast|mesh-list
110045836|NCT06019728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110045837|NCT06019728|Antiemetics|antiemetics|mesh-ancestor
110045838|NCT06019728|Autonomic Agents|autonomic agents|mesh-ancestor
110045839|NCT06019728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110045840|NCT06019728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110045841|NCT06019728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110045842|NCT06019728|Glucocorticoids|glucocorticoids|mesh-ancestor
110045843|NCT06019728|Hormones|hormones|mesh-ancestor
110045844|NCT06019728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110045845|NCT06019728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110045846|NCT06019728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110045847|NCT06019728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110045848|NCT06019728|Analgesics|analgesics|mesh-ancestor
110045849|NCT06019728|Sensory System Agents|sensory system agents|mesh-ancestor
110045850|NCT06019728|Antipyretics|antipyretics|mesh-ancestor
110189739|NCT00049569|Tubulin Modulators|tubulin modulators|mesh-ancestor
110189741|NCT00049569|Mitosis Modulators|mitosis modulators|mesh-ancestor
110189742|NCT00049569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110189743|NCT00022178|Cyclophosphamide|cyclophosphamide|mesh-list
110189744|NCT00022178|Doxorubicin|doxorubicin|mesh-list
110189745|NCT00022178|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110189746|NCT00022178|Fluorouracil|fluorouracil|mesh-list
110189747|NCT00022178|Vincristine|vincristine|mesh-list
110189748|NCT00022178|Epirubicin|epirubicin|mesh-list
110189749|NCT00022178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110189750|NCT00022178|Immunologic Factors|immunologic factors|mesh-ancestor
110189751|NCT00022178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110189752|NCT00022178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110189753|NCT00022178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110189754|NCT00022178|Alkylating Agents|alkylating agents|mesh-ancestor
110189755|NCT00022178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110045854|NCT06019728|Hormone Antagonists|hormone antagonists|mesh-ancestor
110189756|NCT00022178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110189757|NCT00022178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110189758|NCT00022178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110189759|NCT00022178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110189760|NCT00022178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110189761|NCT00022178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110189762|NCT00022178|Antimetabolites|antimetabolites|mesh-ancestor
110189763|NCT00022178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110189764|NCT00022178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110189765|NCT00022178|Tubulin Modulators|tubulin modulators|mesh-ancestor
110189766|NCT00022178|Antimitotic Agents|antimitotic agents|mesh-ancestor
110189767|NCT00022178|Mitosis Modulators|mitosis modulators|mesh-ancestor
110189768|NCT00049608|Gemcitabine|gemcitabine|mesh-list
110189769|NCT00049608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110189770|NCT00049608|Antimetabolites|antimetabolites|mesh-ancestor
110189771|NCT00049608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110189772|NCT00049608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110189773|NCT00022217|Paclitaxel|paclitaxel|mesh-list
110189774|NCT00022217|Carboplatin|carboplatin|mesh-list
110189775|NCT00022217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110189776|NCT00022217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110189777|NCT00022217|Tubulin Modulators|tubulin modulators|mesh-ancestor
110189778|NCT00022217|Antimitotic Agents|antimitotic agents|mesh-ancestor
110189779|NCT00022217|Mitosis Modulators|mitosis modulators|mesh-ancestor
110189780|NCT00022217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110189781|NCT00022256|Motexafin gadolinium|motexafin gadolinium|mesh-list
110280246|NCT00187070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110189782|NCT00022256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110189783|NCT00022256|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110189784|NCT00022256|Dermatologic Agents|dermatologic agents|mesh-ancestor
110189785|NCT00049725|Daclizumab|daclizumab|mesh-list
110189786|NCT00049725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110189787|NCT00049725|Immunologic Factors|immunologic factors|mesh-ancestor
110189788|NCT00049725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110189789|NCT00049764|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
110189790|NCT00049764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110189791|NCT00049803|Sodium Oxybate|sodium oxybate|mesh-list
110045961|NCT05837091|Anesthetics|anesthetics|mesh-ancestor
110189792|NCT00049803|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110218467|NCT00416767|Protective Agents|protective agents|mesh-ancestor
110189794|NCT00049803|Anesthetics, General|anesthetics, general|mesh-ancestor
110189795|NCT00049803|Anesthetics|anesthetics|mesh-ancestor
110189796|NCT00049803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110189797|NCT00049803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110189798|NCT00397761|Paclitaxel|paclitaxel|mesh-list
110189799|NCT00397761|Capecitabine|capecitabine|mesh-list
110189800|NCT00397761|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110189801|NCT00397761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110189802|NCT00397761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110189803|NCT00397761|Tubulin Modulators|tubulin modulators|mesh-ancestor
110189804|NCT00397761|Antimitotic Agents|antimitotic agents|mesh-ancestor
110189805|NCT00397761|Mitosis Modulators|mitosis modulators|mesh-ancestor
110189806|NCT00397761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110189807|NCT00397761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110189809|NCT00022412|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
110189810|NCT00022412|Vitamins|vitamins|mesh-ancestor
110189811|NCT00022412|Micronutrients|micronutrients|mesh-ancestor
110189812|NCT00022412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110189813|NCT00022412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110189815|NCT00397800|Rituximab|rituximab|mesh-list
110189816|NCT00397800|Fludarabine|fludarabine|mesh-list
110189817|NCT00397800|Fludarabine phosphate|fludarabine phosphate|mesh-list
110189818|NCT00397800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110189819|NCT00397800|Immunologic Factors|immunologic factors|mesh-ancestor
110189820|NCT00397800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110189821|NCT00397800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110189822|NCT00397800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110189823|NCT00397800|Alkylating Agents|alkylating agents|mesh-ancestor
110189824|NCT00397800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110189825|NCT00397800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110189826|NCT00397800|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110189827|NCT00397800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110189828|NCT00397800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110189829|NCT00397800|Antimetabolites|antimetabolites|mesh-ancestor
110189830|NCT00022451|Tipifarnib|tipifarnib|mesh-list
110046082|NCT05729568|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110189831|NCT00022451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110189832|NCT00022529|Trastuzumab|trastuzumab|mesh-list
110189833|NCT00022529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110189834|NCT00022529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110189835|NCT00022607|Thalidomide|thalidomide|mesh-list
110189836|NCT00022607|Bevacizumab|bevacizumab|mesh-list
110189837|NCT00022607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110189838|NCT00022607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110189839|NCT00022607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110046139|NCT05646862|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110189840|NCT00022607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110189841|NCT00022607|Growth Substances|growth substances|mesh-ancestor
110189842|NCT00022607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110189843|NCT00022607|Growth Inhibitors|growth inhibitors|mesh-ancestor
110189844|NCT00022607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110189845|NCT00022607|Immunologic Factors|immunologic factors|mesh-ancestor
110189846|NCT00022607|Leprostatic Agents|leprostatic agents|mesh-ancestor
110189847|NCT00022607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110189848|NCT00022607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110189850|NCT00049998|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110189851|NCT00049998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110189852|NCT00049998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110189853|NCT00049998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110189854|NCT00049998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110189855|NCT00022646|Gemcitabine|gemcitabine|mesh-list
110189856|NCT00022646|Pemetrexed|pemetrexed|mesh-list
110046205|NCT05548985|Dopamine Agents|dopamine agents|mesh-ancestor
110218483|NCT00109239|Bevacizumab|bevacizumab|mesh-list
110189857|NCT00022646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110189858|NCT00022646|Antimetabolites|antimetabolites|mesh-ancestor
110189859|NCT00022646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110189860|NCT00022646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110189861|NCT00022646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110189862|NCT00022646|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110280338|NCT00212199|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110189863|NCT00022646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110189864|NCT00022685|Epratuzumab|epratuzumab|mesh-list
110189865|NCT00022685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110189866|NCT00022685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110189867|NCT00022724|Sirolimus|sirolimus|mesh-list
110189868|NCT00022724|Temsirolimus|temsirolimus|mesh-list
110189869|NCT00022724|MTOR Inhibitors|mtor inhibitors|mesh-list
110189870|NCT00022724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110046260|NCT05435053|Nivolumab|nivolumab|mesh-list
110189871|NCT00022724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110189872|NCT00022724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110189873|NCT00022724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110189874|NCT00022724|Immunologic Factors|immunologic factors|mesh-ancestor
110189875|NCT00022724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110189876|NCT00022724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110189877|NCT00022724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110189878|NCT00022724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110189879|NCT00022724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110189880|NCT00022724|Antifungal Agents|antifungal agents|mesh-ancestor
110189881|NCT00050154|Tipifarnib|tipifarnib|mesh-list
110189882|NCT00050154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110189883|NCT00022841|Pamidronate|pamidronate|mesh-list
110189884|NCT00022841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110189885|NCT00022841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110189886|NCT00022880|Tositumomab I-131|tositumomab i-131|mesh-list
110189887|NCT00022880|Antibodies|antibodies|mesh-list
110189888|NCT00022880|Immunologic Factors|immunologic factors|mesh-ancestor
110189889|NCT00022880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110189890|NCT00022880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110189892|NCT00050271|Vitamin B Complex|vitamin b complex|mesh-ancestor
110189893|NCT00050271|Vitamins|vitamins|mesh-ancestor
110189894|NCT00050271|Micronutrients|micronutrients|mesh-ancestor
110189895|NCT00050271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110189896|NCT00050271|Nootropic Agents|nootropic agents|mesh-ancestor
110189897|NCT00022958|Tositumomab I-131|tositumomab i-131|mesh-list
110189898|NCT00022958|Antibodies|antibodies|mesh-list
110189899|NCT00022958|Immunologic Factors|immunologic factors|mesh-ancestor
110189900|NCT00022958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110189901|NCT00022958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110189902|NCT00050349|Epothilones|epothilones|mesh-list
110189903|NCT00050349|Epothilone B|epothilone b|mesh-list
110189904|NCT00050349|Tubulin Modulators|tubulin modulators|mesh-ancestor
110189905|NCT00050349|Antimitotic Agents|antimitotic agents|mesh-ancestor
110189906|NCT00050349|Mitosis Modulators|mitosis modulators|mesh-ancestor
110189907|NCT00050349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110189908|NCT00050349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110189909|NCT00050427|Trabectedin|trabectedin|mesh-list
110189910|NCT00050427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110189911|NCT00050427|Alkylating Agents|alkylating agents|mesh-ancestor
110189912|NCT00050427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110189913|NCT00050427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110189914|NCT00023153|Adefovir|adefovir|mesh-list
110189915|NCT00023153|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
110189916|NCT00023153|Antiviral Agents|antiviral agents|mesh-ancestor
110189917|NCT00023153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110189918|NCT00023153|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110189919|NCT00023153|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110189920|NCT00023153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110189921|NCT00023153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110189922|NCT00050505|Vaccines|vaccines|mesh-list
110189923|NCT00050505|Immunologic Factors|immunologic factors|mesh-ancestor
110189924|NCT00050505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110189925|NCT00050661|Daclizumab|daclizumab|mesh-list
110189926|NCT00050661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110189927|NCT00050661|Immunologic Factors|immunologic factors|mesh-ancestor
110189928|NCT00050661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110189929|NCT00050817|Clopidogrel|clopidogrel|mesh-list
110280383|NCT00219375|Glycine|glycine|mesh-list
110189930|NCT00050817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110189931|NCT00050817|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110189932|NCT00050817|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110046593|NCT05150704|Hormones|hormones|mesh-ancestor
110189933|NCT00050817|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110189934|NCT00050817|Purinergic Agents|purinergic agents|mesh-ancestor
110189935|NCT00050817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110189936|NCT00050817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110189937|NCT00050817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110189938|NCT00023231|Mycophenolic Acid|mycophenolic acid|mesh-list
110189939|NCT00023231|Sirolimus|sirolimus|mesh-list
110189940|NCT00023231|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110189941|NCT00023231|Ganciclovir|ganciclovir|mesh-list
110189942|NCT00023231|Prednisone|prednisone|mesh-list
110189943|NCT00023231|Methylprednisolone|methylprednisolone|mesh-list
110280394|NCT00188396|Citalopram|citalopram|mesh-list
110189944|NCT00023231|Atorvastatin|atorvastatin|mesh-list
110189945|NCT00023231|Daclizumab|daclizumab|mesh-list
110189946|NCT00023231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110189947|NCT00023231|Glucocorticoids|glucocorticoids|mesh-ancestor
110189948|NCT00023231|Hormones|hormones|mesh-ancestor
110189949|NCT00023231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110046708|NCT05039619|Antitubercular Agents|antitubercular agents|mesh-ancestor
110046713|NCT05039619|Antiemetics|antiemetics|mesh-ancestor
110189950|NCT00023231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110300181|NCT04708821|Hormones|hormones|mesh-ancestor
110189951|NCT00023231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110189952|NCT00023231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110189953|NCT00023231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110189954|NCT00023231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110189955|NCT00023231|Antitubercular Agents|antitubercular agents|mesh-ancestor
110189956|NCT00023231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110189957|NCT00023231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110046773|NCT04975997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110046775|NCT04975308|Exemestane|exemestane|mesh-list
110046776|NCT04975308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110046777|NCT04975308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110300219|NCT00240812|Sympathomimetics|sympathomimetics|mesh-ancestor
110046778|NCT04975308|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110046780|NCT04975308|Hormone Antagonists|hormone antagonists|mesh-ancestor
110189958|NCT00023231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110189959|NCT00023231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110189960|NCT00023231|Antifungal Agents|antifungal agents|mesh-ancestor
110189961|NCT00023231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110189962|NCT00023231|Immunologic Factors|immunologic factors|mesh-ancestor
110189963|NCT00023231|Antiemetics|antiemetics|mesh-ancestor
110189964|NCT00023231|Autonomic Agents|autonomic agents|mesh-ancestor
110189965|NCT00023231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110046841|NCT04963296|Histamine Antagonists|histamine antagonists|mesh-ancestor
110046842|NCT04963296|Histamine Agents|histamine agents|mesh-ancestor
110300272|NCT01688947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110189972|NCT00023231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110189973|NCT00023231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110046907|NCT04826900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110046908|NCT04826900|Cholinergic Agents|cholinergic agents|mesh-ancestor
110046909|NCT04826900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110046911|NCT04819906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110046912|NCT04819906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110189974|NCT00023231|Antiviral Agents|antiviral agents|mesh-ancestor
110189975|NCT00023231|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110189976|NCT00023231|Antimalarials|antimalarials|mesh-ancestor
110189977|NCT00023231|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110189978|NCT00023231|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110189979|NCT00050856|Enfuvirtide|enfuvirtide|mesh-list
110189980|NCT00050856|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110189981|NCT00050856|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110189982|NCT00050856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110189983|NCT00050856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110046989|NCT04735926|Calcifediol|calcifediol|mesh-list
110046990|NCT04735926|Vitamins|vitamins|mesh-ancestor
110046991|NCT04735926|Micronutrients|micronutrients|mesh-ancestor
110046992|NCT04735926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110046993|NCT04735926|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110046994|NCT04711252|Palbociclib|palbociclib|mesh-list
110189984|NCT00050856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110189985|NCT00050856|Antiviral Agents|antiviral agents|mesh-ancestor
110300381|NCT01685359|Epoetin Alfa|epoetin alfa|mesh-list
110300386|NCT02278978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110300387|NCT02278978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110300388|NCT02218762|Fluticasone|fluticasone|mesh-list
110300389|NCT02218762|Xhance|xhance|mesh-list
110031324|NCT01391377|Niacin|niacin|mesh-list
110300390|NCT02218762|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110300391|NCT02218762|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110300392|NCT02218762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110300393|NCT02218762|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110300395|NCT02218762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110280455|NCT00188669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280456|NCT00188669|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110280457|NCT00188669|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110280458|NCT00188669|Protective Agents|protective agents|mesh-ancestor
110189987|NCT00023348|Isoniazid|isoniazid|mesh-list
110189988|NCT00023348|Rifabutin|rifabutin|mesh-list
110189989|NCT00023348|Antitubercular Agents|antitubercular agents|mesh-ancestor
110189990|NCT00023348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110189991|NCT00023348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110047038|NCT04684368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110189992|NCT00023348|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110189994|NCT00023348|Antimetabolites|antimetabolites|mesh-ancestor
110189995|NCT00023348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110189996|NCT00023348|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110189998|NCT00050895|Ritonavir|ritonavir|mesh-list
110189999|NCT00050895|Lopinavir|lopinavir|mesh-list
110190000|NCT00050895|Tenofovir|tenofovir|mesh-list
110190001|NCT00050895|Lamivudine|lamivudine|mesh-list
110190002|NCT00050895|Zidovudine|zidovudine|mesh-list
110190003|NCT00050895|Stavudine|stavudine|mesh-list
110190004|NCT00050895|Efavirenz|efavirenz|mesh-list
110190005|NCT00050895|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110190006|NCT00050895|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110190007|NCT00050895|Protease Inhibitors|protease inhibitors|mesh-ancestor
110190008|NCT00050895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110190009|NCT00050895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110190010|NCT00050895|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110190011|NCT00050895|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110190012|NCT00050895|Antiviral Agents|antiviral agents|mesh-ancestor
110190013|NCT00050895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110190014|NCT00050895|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110190015|NCT00050895|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110190016|NCT00050895|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110190017|NCT00050895|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110190018|NCT00050895|Antimetabolites|antimetabolites|mesh-ancestor
110190019|NCT00050895|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110190020|NCT00050895|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110190021|NCT00050895|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110190022|NCT00050895|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110190023|NCT00050895|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110190025|NCT00023387|Rifapentine|rifapentine|mesh-list
110190026|NCT00023387|Rifampin|rifampin|mesh-list
110190027|NCT00023387|Antitubercular Agents|antitubercular agents|mesh-ancestor
110190028|NCT00023387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110190029|NCT00023387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110190030|NCT00023387|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110190031|NCT00023387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110190032|NCT00023387|Antimetabolites|antimetabolites|mesh-ancestor
110190033|NCT00023387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110190034|NCT00023387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110280500|NCT00219765|Imatinib Mesylate|imatinib mesylate|mesh-list
110190036|NCT00023387|Leprostatic Agents|leprostatic agents|mesh-ancestor
110190037|NCT00023387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110190038|NCT00023387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110190039|NCT00023387|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110047298|NCT04294264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110190040|NCT00023387|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110190041|NCT00023387|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110190042|NCT00023387|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110190043|NCT00023387|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110190044|NCT00023387|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110190046|NCT00050934|Anticonvulsants|anticonvulsants|mesh-ancestor
110190047|NCT00050934|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110190048|NCT00050934|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110190049|NCT00050934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110190050|NCT00050934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110190051|NCT00050934|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110190052|NCT00050934|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110190053|NCT00023426|Rifapentine|rifapentine|mesh-list
110190054|NCT00023426|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110300569|NCT00241982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110300570|NCT00241982|Glucocorticoids|glucocorticoids|mesh-ancestor
110190055|NCT00023426|Antitubercular Agents|antitubercular agents|mesh-ancestor
110190056|NCT00023426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110190057|NCT00023426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110190058|NCT00023426|Leprostatic Agents|leprostatic agents|mesh-ancestor
110190059|NCT00050973|Bexarotene|bexarotene|mesh-list
110190060|NCT00050973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110190061|NCT00023504|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110190062|NCT00023504|Immunologic Factors|immunologic factors|mesh-ancestor
110190063|NCT00023504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110190064|NCT00051051|Canertinib dihydrochloride|canertinib dihydrochloride|mesh-list
110190065|NCT00051051|Anesthetics, Local|anesthetics, local|mesh-ancestor
110190066|NCT00051051|Anesthetics|anesthetics|mesh-ancestor
110190067|NCT00051051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110190068|NCT00051051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110190069|NCT00051051|Sensory System Agents|sensory system agents|mesh-ancestor
110300616|NCT00272805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110190070|NCT00051051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110047424|NCT04007029|Fludarabine phosphate|fludarabine phosphate|mesh-list
110190071|NCT00051051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110190072|NCT00051051|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110190073|NCT00051051|Protective Agents|protective agents|mesh-ancestor
110190077|NCT00051090|Didanosine|didanosine|mesh-list
110190078|NCT00051090|Telbivudine|telbivudine|mesh-list
110190079|NCT00051090|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110190080|NCT00051090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110190081|NCT00051090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110190082|NCT00051090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110190083|NCT00051090|Antiviral Agents|antiviral agents|mesh-ancestor
110190084|NCT00051090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110047474|NCT03887650|Respiratory System Agents|respiratory system agents|mesh-ancestor
110047484|NCT03794349|Irinotecan|irinotecan|mesh-list
110190085|NCT00051090|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110190086|NCT00051090|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110190087|NCT00051090|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110190088|NCT00051090|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110190089|NCT00051090|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110190090|NCT00051090|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110190091|NCT00051090|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110190092|NCT00051090|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110190093|NCT00051090|Antimetabolites|antimetabolites|mesh-ancestor
110190095|NCT00023621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110190096|NCT00023621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110190097|NCT00023621|Analgesics|analgesics|mesh-ancestor
110190098|NCT00023621|Sensory System Agents|sensory system agents|mesh-ancestor
110190099|NCT00023621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110190100|NCT00023621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110190101|NCT00023621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110190102|NCT00023621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110190103|NCT00023621|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110190104|NCT00023621|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110047598|NCT03522246|Rucaparib|rucaparib|mesh-list
110190105|NCT00023621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110190106|NCT00023621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110190107|NCT00023660|Celecoxib|celecoxib|mesh-list
110300730|NCT00242879|Protease Inhibitors|protease inhibitors|mesh-ancestor
110190108|NCT00023660|Fluorouracil|fluorouracil|mesh-list
110190109|NCT00023660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110190110|NCT00023660|Antimetabolites|antimetabolites|mesh-ancestor
110190111|NCT00023660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110190112|NCT00023660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110190113|NCT00023660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110190114|NCT00023660|Immunologic Factors|immunologic factors|mesh-ancestor
110190115|NCT00023660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110190116|NCT00023660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110190117|NCT00023660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110190118|NCT00023660|Analgesics|analgesics|mesh-ancestor
110190119|NCT00023660|Sensory System Agents|sensory system agents|mesh-ancestor
110190120|NCT00023660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110190121|NCT00023660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110190122|NCT00023660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110190123|NCT00023660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110190124|NCT00023660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110190125|NCT00023660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110190126|NCT00051285|Enoximone|enoximone|mesh-list
110190127|NCT00051285|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110190128|NCT00051285|Vasodilator Agents|vasodilator agents|mesh-ancestor
110190129|NCT00051285|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110190130|NCT00051285|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110190131|NCT00051285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110300849|NCT00273546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110300850|NCT00283101|Dacetuzumab|dacetuzumab|mesh-list
110190132|NCT00051285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110190133|NCT00051285|Protective Agents|protective agents|mesh-ancestor
110190134|NCT00051285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110190135|NCT00023699|Gefitinib|gefitinib|mesh-list
110190136|NCT00023699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110190137|NCT00023699|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110218542|NCT00280540|Valsartan|valsartan|mesh-list
110190138|NCT00023699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110191436|NCT00027989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110190139|NCT00023699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110300901|NCT00283179|Antidepressive Agents|antidepressive agents|mesh-ancestor
110190141|NCT00051441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110190142|NCT00023738|Doxorubicin|doxorubicin|mesh-list
110190143|NCT00023738|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110190144|NCT00023738|Ifosfamide|ifosfamide|mesh-list
110190145|NCT00023738|Dacarbazine|dacarbazine|mesh-list
110190146|NCT00023738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110190147|NCT00023738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110190148|NCT00023738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110190149|NCT00023738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110190150|NCT00023738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110190151|NCT00023738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110190152|NCT00023738|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110190153|NCT00023738|Alkylating Agents|alkylating agents|mesh-ancestor
110190154|NCT00397917|Folic Acid|folic acid|mesh-list
110190155|NCT00397917|Hematinics|hematinics|mesh-ancestor
110190156|NCT00397917|Vitamin B Complex|vitamin b complex|mesh-ancestor
110190157|NCT00397917|Vitamins|vitamins|mesh-ancestor
110190158|NCT00397917|Micronutrients|micronutrients|mesh-ancestor
110190159|NCT00397917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110190160|NCT00397956|Ertapenem|ertapenem|mesh-list
110190161|NCT00397956|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110190162|NCT00397956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110190163|NCT00023777|Cytarabine|cytarabine|mesh-list
110190164|NCT00023777|Daunorubicin|daunorubicin|mesh-list
110190165|NCT00023777|Sargramostim|sargramostim|mesh-list
110190166|NCT00023777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110190167|NCT00023777|Antimetabolites|antimetabolites|mesh-ancestor
110190168|NCT00023777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110190169|NCT00023777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110190170|NCT00023777|Antiviral Agents|antiviral agents|mesh-ancestor
110190171|NCT00023777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110190172|NCT00023777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110190173|NCT00023777|Immunologic Factors|immunologic factors|mesh-ancestor
110190174|NCT00023777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110190175|NCT00023777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110190176|NCT00023777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110190177|NCT00023777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110190178|NCT00023777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110190179|NCT00023816|Carbendazim|carbendazim|mesh-list
110190180|NCT00023816|Antinematodal Agents|antinematodal agents|mesh-ancestor
110190181|NCT00023816|Anthelmintics|anthelmintics|mesh-ancestor
110190182|NCT00023816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110190183|NCT00023816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110190184|NCT00398034|Testosterone|testosterone|mesh-list
110190185|NCT00398034|Androgens|androgens|mesh-ancestor
110190187|NCT00398034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110190188|NCT00398034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110190189|NCT00023855|Doxorubicin|doxorubicin|mesh-list
110190190|NCT00023855|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110190191|NCT00023855|Bortezomib|bortezomib|mesh-list
110190192|NCT00023855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110190193|NCT00023855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110047975|NCT02719613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110190194|NCT00023855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110190195|NCT00023855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110190196|NCT00023855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110190197|NCT00023855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110190199|NCT00023894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110190200|NCT00023894|Growth Inhibitors|growth inhibitors|mesh-ancestor
110190201|NCT00023894|Growth Substances|growth substances|mesh-ancestor
110190202|NCT00023894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110190203|NCT00023894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110190204|NCT00023894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110190205|NCT00023894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110190206|NCT00023933|Antibodies|antibodies|mesh-list
110190207|NCT00023933|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110190208|NCT00023933|Immunologic Factors|immunologic factors|mesh-ancestor
110190209|NCT00023933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110190210|NCT00051597|Antibodies|antibodies|mesh-list
110190211|NCT00051597|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110190212|NCT00051597|Immunologic Factors|immunologic factors|mesh-ancestor
110190213|NCT00051597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110190214|NCT00023972|Gemcitabine|gemcitabine|mesh-list
110190215|NCT00023972|Exatecan|exatecan|mesh-list
110190216|NCT00023972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110190217|NCT00023972|Antimetabolites|antimetabolites|mesh-ancestor
110190218|NCT00023972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110190219|NCT00023972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110190220|NCT00023972|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110190221|NCT00023972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110190222|NCT00023972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110190224|NCT00024011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110190225|NCT00051753|Amoxicillin|amoxicillin|mesh-list
110190226|NCT00051753|Levofloxacin|levofloxacin|mesh-list
110190227|NCT00051753|Clavulanic Acid|clavulanic acid|mesh-list
110190228|NCT00051753|Clavulanic Acids|clavulanic acids|mesh-list
110190229|NCT00051753|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110190230|NCT00051753|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110190231|NCT00051753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110190232|NCT00051753|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110190233|NCT00051753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110190234|NCT00051753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110190235|NCT00051753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110190236|NCT00051753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110190237|NCT00051753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110190238|NCT00051753|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110190239|NCT00051753|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110190240|NCT00051753|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110190242|NCT00024050|Cyclophosphamide|cyclophosphamide|mesh-list
110190243|NCT00024050|Busulfan|busulfan|mesh-list
110190244|NCT00024050|Methotrexate|methotrexate|mesh-list
110190245|NCT00024050|Cyclosporins|cyclosporins|mesh-list
110190246|NCT00024050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110190247|NCT00024050|Immunologic Factors|immunologic factors|mesh-ancestor
110190248|NCT00024050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110190249|NCT00024050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110048125|NCT02265770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110190250|NCT00024050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110190251|NCT00024050|Alkylating Agents|alkylating agents|mesh-ancestor
110190252|NCT00024050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110190253|NCT00024050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110190254|NCT00024050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110190255|NCT00024050|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110190256|NCT00024050|Abortifacient Agents|abortifacient agents|mesh-ancestor
110301219|NCT00416637|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110190257|NCT00024050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110190258|NCT00024050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110190259|NCT00024050|Antimetabolites|antimetabolites|mesh-ancestor
110190260|NCT00024050|Dermatologic Agents|dermatologic agents|mesh-ancestor
110190261|NCT00024050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110190262|NCT00024050|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110190263|NCT00024050|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110190264|NCT00024050|Antifungal Agents|antifungal agents|mesh-ancestor
110190265|NCT00024050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110190266|NCT00024050|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110190268|NCT00024089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110190269|NCT00024089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110190270|NCT00024089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110190271|NCT00024089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110190272|NCT00051831|Ritonavir|ritonavir|mesh-list
110190273|NCT00051831|Saquinavir|saquinavir|mesh-list
110190274|NCT00051831|Tenofovir|tenofovir|mesh-list
110190275|NCT00051831|Emtricitabine|emtricitabine|mesh-list
110190276|NCT00051831|Enfuvirtide|enfuvirtide|mesh-list
110190277|NCT00051831|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110190278|NCT00051831|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110190279|NCT00051831|Protease Inhibitors|protease inhibitors|mesh-ancestor
110301269|NCT00274521|Tiotropium Bromide|tiotropium bromide|mesh-list
110190280|NCT00051831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110190281|NCT00051831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110190282|NCT00051831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110190283|NCT00051831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110190284|NCT00051831|Antiviral Agents|antiviral agents|mesh-ancestor
110190285|NCT00051831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110190286|NCT00051831|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110190287|NCT00051831|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110190288|NCT00051831|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110190289|NCT00051831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110301308|NCT00245609|Pregabalin|pregabalin|mesh-list
110190290|NCT00051831|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110190291|NCT00051831|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110190292|NCT00024128|Cyclosporine|cyclosporine|mesh-list
110190293|NCT00024128|Cyclophosphamide|cyclophosphamide|mesh-list
110190294|NCT00024128|Cyclosporins|cyclosporins|mesh-list
110190295|NCT00024128|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110190296|NCT00024128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110190297|NCT00024128|Immunologic Factors|immunologic factors|mesh-ancestor
110190298|NCT00024128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110190299|NCT00024128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110048235|NCT01371630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110048236|NCT01371630|Tubulin Modulators|tubulin modulators|mesh-ancestor
110048237|NCT01371630|Antimitotic Agents|antimitotic agents|mesh-ancestor
110048238|NCT01371630|Mitosis Modulators|mitosis modulators|mesh-ancestor
110048239|NCT01371630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110048240|NCT01371630|Immunotoxins|immunotoxins|mesh-ancestor
110048241|NCT01371630|Immunoconjugates|immunoconjugates|mesh-ancestor
110190300|NCT00024128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110190301|NCT00024128|Alkylating Agents|alkylating agents|mesh-ancestor
110190302|NCT00024128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110190303|NCT00024128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110190304|NCT00024128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110190305|NCT00024128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110190306|NCT00024128|Antifungal Agents|antifungal agents|mesh-ancestor
110190307|NCT00024128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110190308|NCT00024128|Dermatologic Agents|dermatologic agents|mesh-ancestor
110218583|NCT00280774|Memantine|memantine|mesh-list
110190309|NCT00024128|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110190310|NCT00024206|Orantinib|orantinib|mesh-list
110190311|NCT00024206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110190312|NCT00024206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110190313|NCT00024206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110190314|NCT00024245|Probenecid|probenecid|mesh-list
110190315|NCT00024245|Uricosuric Agents|uricosuric agents|mesh-ancestor
110190316|NCT00024245|Gout Suppressants|gout suppressants|mesh-ancestor
110190317|NCT00024245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110190318|NCT00051987|Bortezomib|bortezomib|mesh-list
110190319|NCT00051987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110190320|NCT00024284|Carboplatin|carboplatin|mesh-list
110190321|NCT00024284|Irinotecan|irinotecan|mesh-list
110190322|NCT00024284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110190323|NCT00024284|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110190324|NCT00024284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110190325|NCT00024284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110190326|NCT00024284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110190327|NCT00052026|Carvedilol|carvedilol|mesh-list
110190328|NCT00052026|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110190329|NCT00052026|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110190330|NCT00052026|Adrenergic Agents|adrenergic agents|mesh-ancestor
110190331|NCT00052026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110190332|NCT00052026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110190333|NCT00052026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110190334|NCT00052026|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110190336|NCT00052026|Protective Agents|protective agents|mesh-ancestor
110190337|NCT00052026|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110190338|NCT00052026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110190339|NCT00052026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110190340|NCT00052026|Vasodilator Agents|vasodilator agents|mesh-ancestor
110190341|NCT00052026|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110190342|NCT00052026|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110190344|NCT00024323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110190345|NCT00024362|BBR 3464|bbr 3464|mesh-list
110190346|NCT00024362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110190347|NCT00024401|Paclitaxel|paclitaxel|mesh-list
110190348|NCT00024401|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110190349|NCT00024401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110190350|NCT00024401|Tubulin Modulators|tubulin modulators|mesh-ancestor
110190351|NCT00024401|Antimitotic Agents|antimitotic agents|mesh-ancestor
110190352|NCT00024401|Mitosis Modulators|mitosis modulators|mesh-ancestor
110301488|NCT00246389|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110190353|NCT00024401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110190354|NCT00024440|Cyclophosphamide|cyclophosphamide|mesh-list
110190356|NCT00024440|Fludarabine phosphate|fludarabine phosphate|mesh-list
110190358|NCT00024440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110190359|NCT00024440|Immunologic Factors|immunologic factors|mesh-ancestor
110190360|NCT00024440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110190361|NCT00024440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110190362|NCT00024440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110190363|NCT00024440|Alkylating Agents|alkylating agents|mesh-ancestor
110190364|NCT00024440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110048626|NCT04237922|Clopidogrel|clopidogrel|mesh-list
110190366|NCT00024440|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110190367|NCT00024440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110190368|NCT00024440|Antimetabolites|antimetabolites|mesh-ancestor
110190369|NCT00024518|Interferons|interferons|mesh-list
110190370|NCT00024518|Interferon-alpha|interferon-alpha|mesh-list
110190371|NCT00024518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110190372|NCT00024518|Antiviral Agents|antiviral agents|mesh-ancestor
110190373|NCT00024518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110190374|NCT00024518|Immunologic Factors|immunologic factors|mesh-ancestor
110190375|NCT00024518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110190376|NCT00052221|Epoetin Alfa|epoetin alfa|mesh-list
110190377|NCT00052221|Hematinics|hematinics|mesh-ancestor
110048747|NCT04120987|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110190378|NCT00024557|Pseudomonas aeruginosa exotoxin A|pseudomonas aeruginosa exotoxin a|mesh-list
110190379|NCT00024557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110190380|NCT00052299|Cytarabine|cytarabine|mesh-list
110190381|NCT00052299|Etoposide|etoposide|mesh-list
110190382|NCT00052299|Mitoxantrone|mitoxantrone|mesh-list
110190383|NCT00052299|Idarubicin|idarubicin|mesh-list
110190384|NCT00052299|Gemtuzumab|gemtuzumab|mesh-list
110190385|NCT00052299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110190386|NCT00052299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110190387|NCT00052299|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110190388|NCT00052299|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110190389|NCT00052299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110190390|NCT00052299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110190391|NCT00052299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110190392|NCT00052299|Antimetabolites|antimetabolites|mesh-ancestor
110190393|NCT00052299|Antiviral Agents|antiviral agents|mesh-ancestor
110190394|NCT00052299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110190395|NCT00052299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110190396|NCT00052299|Immunologic Factors|immunologic factors|mesh-ancestor
110190397|NCT00052299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110190398|NCT00052299|Analgesics|analgesics|mesh-ancestor
110190399|NCT00052299|Sensory System Agents|sensory system agents|mesh-ancestor
110190400|NCT00052299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110190401|NCT00052299|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110190402|NCT00052299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110190403|NCT00052299|Immunotoxins|immunotoxins|mesh-ancestor
110190404|NCT00052299|Immunoconjugates|immunoconjugates|mesh-ancestor
110190405|NCT00052338|Carboplatin|carboplatin|mesh-list
110190406|NCT00052338|Gemcitabine|gemcitabine|mesh-list
110190408|NCT00052338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110190409|NCT00052338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110190410|NCT00052338|Antimetabolites|antimetabolites|mesh-ancestor
110190411|NCT00052338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110190412|NCT04733066|Teduglutide|teduglutide|mesh-list
110190413|NCT04733066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110190414|NCT04733066|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110190415|NCT04733066|Protective Agents|protective agents|mesh-ancestor
110190416|NCT04733066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110190417|NCT00052377|Aldesleukin|aldesleukin|mesh-list
110190418|NCT00052377|Interleukin-2|interleukin-2|mesh-list
110190419|NCT00052377|Interleukin-12|interleukin-12|mesh-list
110190420|NCT00052377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110190421|NCT00052377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110190422|NCT00052377|Analgesics|analgesics|mesh-ancestor
110190423|NCT00052377|Sensory System Agents|sensory system agents|mesh-ancestor
110190424|NCT00052377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110190425|NCT00052377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110190426|NCT00052377|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110190427|NCT00052377|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110190428|NCT00052377|Antiviral Agents|antiviral agents|mesh-ancestor
110190429|NCT00052377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110190430|NCT00052377|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110190431|NCT00052377|Immunologic Factors|immunologic factors|mesh-ancestor
110190432|NCT00052377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110190433|NCT00052377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110190434|NCT00052377|Growth Substances|growth substances|mesh-ancestor
110190435|NCT00052377|Growth Inhibitors|growth inhibitors|mesh-ancestor
110190436|NCT00052416|Thalidomide|thalidomide|mesh-list
110190437|NCT00052416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110190438|NCT00052416|Immunologic Factors|immunologic factors|mesh-ancestor
110190439|NCT00052416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110190440|NCT00052416|Leprostatic Agents|leprostatic agents|mesh-ancestor
110301642|NCT00284778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110190441|NCT00052416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110190442|NCT00052416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110190443|NCT00052416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110190444|NCT00052416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110190445|NCT00052416|Growth Substances|growth substances|mesh-ancestor
110190446|NCT00052416|Growth Inhibitors|growth inhibitors|mesh-ancestor
110190447|NCT00052416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110190448|NCT00052455|Vincristine|vincristine|mesh-list
110190449|NCT00052455|Temozolomide|temozolomide|mesh-list
110190451|NCT00052455|Procarbazine|procarbazine|mesh-list
110190452|NCT00052455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110190453|NCT00052455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110190454|NCT00052455|Tubulin Modulators|tubulin modulators|mesh-ancestor
110190455|NCT00052455|Antimitotic Agents|antimitotic agents|mesh-ancestor
110190456|NCT00052455|Mitosis Modulators|mitosis modulators|mesh-ancestor
110190457|NCT00052455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110190458|NCT00052455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110301666|NCT00277758|Analgesics|analgesics|mesh-ancestor
110190459|NCT00052455|Alkylating Agents|alkylating agents|mesh-ancestor
110190460|NCT00052494|Irinotecan|irinotecan|mesh-list
110190461|NCT00052494|Imatinib Mesylate|imatinib mesylate|mesh-list
110190462|NCT00052494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110190463|NCT00052494|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110190464|NCT00052494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110190465|NCT00052494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110190466|NCT00052494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110190467|NCT00052494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110190469|NCT00395174|Agglutinins|agglutinins|mesh-ancestor
110190470|NCT00395174|Immunologic Factors|immunologic factors|mesh-ancestor
110280795|NCT00189917|Antiviral Agents|antiviral agents|mesh-ancestor
110190471|NCT00395174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110190472|NCT00395174|Coagulants|coagulants|mesh-ancestor
110190473|NCT00395213|Norepinephrine|norepinephrine|mesh-list
110190474|NCT00395213|Serotonin|serotonin|mesh-list
110190475|NCT00395213|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
110190476|NCT00395213|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110190477|NCT00395213|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110190478|NCT00395213|Adrenergic Agents|adrenergic agents|mesh-ancestor
110049187|NCT03335488|Glycerol|glycerol|mesh-list
110190479|NCT00395213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110190480|NCT00395213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110190481|NCT00395213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110190482|NCT00395213|Sympathomimetics|sympathomimetics|mesh-ancestor
110190483|NCT00395213|Autonomic Agents|autonomic agents|mesh-ancestor
110190484|NCT00395213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110190485|NCT00395213|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110190486|NCT00395213|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110190487|NCT00395213|Serotonin Agents|serotonin agents|mesh-ancestor
110190488|NCT00395213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110280805|NCT00213252|Montelukast|montelukast|mesh-list
110190489|NCT00395213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110190491|NCT00052611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110190492|NCT00052611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110190494|NCT00052611|Sensory System Agents|sensory system agents|mesh-ancestor
110190495|NCT00052611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110190496|NCT00052611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110190497|NCT00052611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110190498|NCT00052611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110190499|NCT00052611|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110190500|NCT00052611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110190501|NCT00052611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110049377|NCT02586831|Hormones|hormones|mesh-ancestor
110190502|NCT00052611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110190504|NCT00395252|Cetuximab|cetuximab|mesh-list
110190505|NCT00395252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110190506|NCT00395252|Antimetabolites|antimetabolites|mesh-ancestor
110190507|NCT00395252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110190509|NCT00395252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110190510|NCT00052689|Gemcitabine|gemcitabine|mesh-list
110190512|NCT00052689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110190513|NCT00052689|Antimetabolites|antimetabolites|mesh-ancestor
110190514|NCT00052689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110190515|NCT00052689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110190516|NCT00052728|Tamoxifen|tamoxifen|mesh-list
110190517|NCT00052728|Tipifarnib|tipifarnib|mesh-list
110190518|NCT00052728|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110190519|NCT00052728|Hormone Antagonists|hormone antagonists|mesh-ancestor
110190520|NCT00052728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110190521|NCT00052728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110190522|NCT00052728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110190523|NCT00052728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110190524|NCT00052728|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110190525|NCT00052728|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110301888|NCT00278421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110190526|NCT00052728|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110190527|NCT00395369|Aprotinin|aprotinin|mesh-list
110190528|NCT00395369|Hemostatics|hemostatics|mesh-ancestor
110190529|NCT00395369|Coagulants|coagulants|mesh-ancestor
110190530|NCT00395369|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110190531|NCT00395369|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110190532|NCT00395369|Protease Inhibitors|protease inhibitors|mesh-ancestor
110190533|NCT00395369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110190534|NCT00395369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110190535|NCT00052845|Sulindac sulfone|sulindac sulfone|mesh-list
110190536|NCT00052845|Docetaxel|docetaxel|mesh-list
110190537|NCT00052845|Estramustine|estramustine|mesh-list
110190538|NCT00052845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110190539|NCT00052845|Tubulin Modulators|tubulin modulators|mesh-ancestor
110190540|NCT00052845|Antimitotic Agents|antimitotic agents|mesh-ancestor
110190541|NCT00052845|Mitosis Modulators|mitosis modulators|mesh-ancestor
110190542|NCT00052845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110049703|NCT01042379|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110190543|NCT00052845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110190544|NCT00052845|Alkylating Agents|alkylating agents|mesh-ancestor
110190545|NCT00052845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110190546|NCT00052845|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110190547|NCT00052845|Protective Agents|protective agents|mesh-ancestor
110190548|NCT00052845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110190549|NCT00052845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110190550|NCT00052845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110190551|NCT00052845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110190552|NCT00052845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110190553|NCT00052845|Analgesics|analgesics|mesh-ancestor
110190554|NCT00052845|Sensory System Agents|sensory system agents|mesh-ancestor
110190555|NCT00052845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110190556|NCT00052845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110190557|NCT00052845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110301991|NCT00249119|Serotonin Agents|serotonin agents|mesh-ancestor
110190559|NCT00024986|Antiviral Agents|antiviral agents|mesh-ancestor
110190560|NCT00024986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110190561|NCT00024986|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110190562|NCT00024986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110190563|NCT00024986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110190564|NCT00024986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110190565|NCT00024986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110190566|NCT00024986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110190567|NCT00052923|Cyclophosphamide|cyclophosphamide|mesh-list
110190568|NCT00052923|Carmustine|carmustine|mesh-list
110190569|NCT00052923|Rituximab|rituximab|mesh-list
110190570|NCT00052923|Etoposide|etoposide|mesh-list
110190571|NCT00052923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110190572|NCT00052923|Immunologic Factors|immunologic factors|mesh-ancestor
110190573|NCT00052923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110190574|NCT00052923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110190575|NCT00052923|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110190576|NCT00052923|Alkylating Agents|alkylating agents|mesh-ancestor
110190577|NCT00052923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110190578|NCT00052923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110302046|NCT00249236|Dopamine Agents|dopamine agents|mesh-ancestor
110190579|NCT00052923|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110190580|NCT00052923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110190581|NCT00052923|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110190582|NCT00052923|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110190583|NCT00052923|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110190584|NCT00052923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110190586|NCT00025064|Doxorubicin|doxorubicin|mesh-list
110190587|NCT00025064|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110190588|NCT00025064|Etoposide|etoposide|mesh-list
110190589|NCT00025064|Vincristine|vincristine|mesh-list
110190591|NCT00025064|Ifosfamide|ifosfamide|mesh-list
110190592|NCT00025064|Dacarbazine|dacarbazine|mesh-list
110190593|NCT00025064|Bleomycin|bleomycin|mesh-list
110190594|NCT00025064|Vinblastine|vinblastine|mesh-list
110190595|NCT00025064|Procarbazine|procarbazine|mesh-list
110190596|NCT00025064|Chlorambucil|chlorambucil|mesh-list
110190597|NCT00025064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110190599|NCT00025064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110190600|NCT00025064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110190602|NCT00025064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110190603|NCT00025064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110190604|NCT00025064|Tubulin Modulators|tubulin modulators|mesh-ancestor
110190605|NCT00025064|Antimitotic Agents|antimitotic agents|mesh-ancestor
110190606|NCT00025064|Mitosis Modulators|mitosis modulators|mesh-ancestor
110190607|NCT00025064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110190608|NCT00025064|Alkylating Agents|alkylating agents|mesh-ancestor
110280932|NCT00190307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110190610|NCT00025064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110190611|NCT00025064|Immunologic Factors|immunologic factors|mesh-ancestor
110190612|NCT00025064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110190613|NCT00025064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110190614|NCT00025064|Glucocorticoids|glucocorticoids|mesh-ancestor
110190615|NCT00025064|Hormones|hormones|mesh-ancestor
110191437|NCT00027989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110190616|NCT00025064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110190617|NCT00025064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110190618|NCT00053001|Thalidomide|thalidomide|mesh-list
110190619|NCT00053001|Epoetin Alfa|epoetin alfa|mesh-list
110190621|NCT00053001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110190622|NCT00053001|Immunologic Factors|immunologic factors|mesh-ancestor
110190623|NCT00053001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110190624|NCT00053001|Leprostatic Agents|leprostatic agents|mesh-ancestor
110190625|NCT00053001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110190626|NCT00053001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110190627|NCT00053001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110190628|NCT00053001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110190629|NCT00053001|Growth Substances|growth substances|mesh-ancestor
110190630|NCT00053001|Growth Inhibitors|growth inhibitors|mesh-ancestor
110190631|NCT00053001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110190632|NCT00025103|Dactinomycin|dactinomycin|mesh-list
110190633|NCT00025103|Cyclophosphamide|cyclophosphamide|mesh-list
110190635|NCT00025103|Carboplatin|carboplatin|mesh-list
110190636|NCT00025103|Doxorubicin|doxorubicin|mesh-list
110190637|NCT00025103|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110190639|NCT00025103|Vincristine|vincristine|mesh-list
110190640|NCT00025103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110190641|NCT00025103|Immunologic Factors|immunologic factors|mesh-ancestor
110190642|NCT00025103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110190643|NCT00025103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110190644|NCT00025103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110190645|NCT00025103|Alkylating Agents|alkylating agents|mesh-ancestor
110190646|NCT00025103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110190647|NCT00025103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110190648|NCT00025103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110190649|NCT00025103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110190650|NCT00025103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110190651|NCT00025103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110190652|NCT00025103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110280948|NCT00190463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110190653|NCT00025103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110190654|NCT00025103|Tubulin Modulators|tubulin modulators|mesh-ancestor
110190655|NCT00025103|Antimitotic Agents|antimitotic agents|mesh-ancestor
110190656|NCT00025103|Mitosis Modulators|mitosis modulators|mesh-ancestor
110190657|NCT00025103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110050574|NCT01467687|Verapamil|verapamil|mesh-list
110190658|NCT00025103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110190659|NCT00025103|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110190660|NCT00025103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110190661|NCT00053040|Pseudomonas aeruginosa exotoxin A|pseudomonas aeruginosa exotoxin a|mesh-list
110190662|NCT00053040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110190663|NCT00025142|Leucovorin|leucovorin|mesh-list
110190664|NCT00025142|Fluorouracil|fluorouracil|mesh-list
110190665|NCT00025142|Oxaliplatin|oxaliplatin|mesh-list
110190666|NCT00025142|Gefitinib|gefitinib|mesh-list
110190667|NCT00025142|Calcium|calcium|mesh-list
110190668|NCT00025142|Levoleucovorin|levoleucovorin|mesh-list
110190669|NCT00025142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110190670|NCT00025142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110190671|NCT00025142|Antimetabolites|antimetabolites|mesh-ancestor
110190672|NCT00025142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110050703|NCT01468441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110190673|NCT00025142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110190674|NCT00025142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110190675|NCT00025142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110190676|NCT00025142|Immunologic Factors|immunologic factors|mesh-ancestor
110190678|NCT00025142|Protective Agents|protective agents|mesh-ancestor
110190679|NCT00025142|Vitamin B Complex|vitamin b complex|mesh-ancestor
110190681|NCT00025142|Micronutrients|micronutrients|mesh-ancestor
110190682|NCT00025142|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110190683|NCT00025142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110050844|NCT01469520|Lamivudine|lamivudine|mesh-list
110190684|NCT00053118|Carboplatin|carboplatin|mesh-list
110190685|NCT00053118|Etoposide|etoposide|mesh-list
110218650|NCT00109746|Chelating Agents|chelating agents|mesh-ancestor
110190686|NCT00053118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110190687|NCT00053118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110190688|NCT00053118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110190689|NCT00053118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110302250|NCT00250367|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110190691|NCT00053118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110190692|NCT00025181|Ipilimumab|ipilimumab|mesh-list
110190693|NCT00025181|Freund's Adjuvant|freund's adjuvant|mesh-list
110190694|NCT00025181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110190695|NCT00025181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110190696|NCT00025181|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110190697|NCT00025181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110190698|NCT00025181|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110190699|NCT00025181|Immunologic Factors|immunologic factors|mesh-ancestor
110190700|NCT00025181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110190702|NCT00025220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110190703|NCT00025220|Immunologic Factors|immunologic factors|mesh-ancestor
110190704|NCT00025220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051039|NCT01470495|Sorafenib|sorafenib|mesh-list
110190705|NCT00025220|Leprostatic Agents|leprostatic agents|mesh-ancestor
110190706|NCT00025220|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110190707|NCT00025220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110190708|NCT00025220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110190709|NCT00025220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110190710|NCT00025220|Growth Substances|growth substances|mesh-ancestor
110051105|NCT01471145|Naltrexone|naltrexone|mesh-list
110190711|NCT00025220|Growth Inhibitors|growth inhibitors|mesh-ancestor
110190712|NCT00025220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110190713|NCT00053157|Sargramostim|sargramostim|mesh-list
110190714|NCT00053157|Immunologic Factors|immunologic factors|mesh-ancestor
110190715|NCT00053157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110190716|NCT00025298|Paclitaxel|paclitaxel|mesh-list
110190717|NCT00025298|Carboplatin|carboplatin|mesh-list
110190718|NCT00025298|Amifostine|amifostine|mesh-list
110190719|NCT00025298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110302291|NCT00250640|Iloprost|iloprost|mesh-list
110190720|NCT00025298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110190721|NCT00025298|Tubulin Modulators|tubulin modulators|mesh-ancestor
110190722|NCT00025298|Antimitotic Agents|antimitotic agents|mesh-ancestor
110190723|NCT00025298|Mitosis Modulators|mitosis modulators|mesh-ancestor
110190724|NCT00025298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110190725|NCT00025298|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110190726|NCT00025298|Protective Agents|protective agents|mesh-ancestor
110190727|NCT00025298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110190728|NCT00053196|Mycophenolic Acid|mycophenolic acid|mesh-list
110190729|NCT00053196|Methotrexate|methotrexate|mesh-list
110190730|NCT00053196|Fludarabine phosphate|fludarabine phosphate|mesh-list
110190731|NCT00053196|Fludarabine|fludarabine|mesh-list
110190732|NCT00053196|Busulfan|busulfan|mesh-list
110190733|NCT00053196|Allopurinol|allopurinol|mesh-list
110190735|NCT00053196|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110190736|NCT00053196|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110190738|NCT00053196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110190739|NCT00053196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110190740|NCT00053196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110190741|NCT00053196|Antimetabolites|antimetabolites|mesh-ancestor
110190742|NCT00053196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110190743|NCT00053196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110190745|NCT00053196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110190746|NCT00053196|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110190747|NCT00053196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110190748|NCT00053196|Immunologic Factors|immunologic factors|mesh-ancestor
110190749|NCT00053196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110190750|NCT00053196|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110190751|NCT00053196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110190752|NCT00053196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110218673|NCT00399269|Epoetin Alfa|epoetin alfa|mesh-list
110190754|NCT00053196|Antitubercular Agents|antitubercular agents|mesh-ancestor
110190755|NCT00053196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110190756|NCT00053196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110190757|NCT00053196|Alkylating Agents|alkylating agents|mesh-ancestor
110190758|NCT00053196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110190759|NCT00053196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110190760|NCT00053196|Gout Suppressants|gout suppressants|mesh-ancestor
110190761|NCT00053196|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110190762|NCT00053196|Antioxidants|antioxidants|mesh-ancestor
110190763|NCT00053196|Protective Agents|protective agents|mesh-ancestor
110190764|NCT00025337|Leucovorin|leucovorin|mesh-list
110190765|NCT00025337|Bevacizumab|bevacizumab|mesh-list
110190766|NCT00025337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110190767|NCT00025337|Fluorouracil|fluorouracil|mesh-list
110190768|NCT00025337|Oxaliplatin|oxaliplatin|mesh-list
110190769|NCT00025337|Antibodies|antibodies|mesh-list
110190770|NCT00025337|Immunoglobulins|immunoglobulins|mesh-list
110190771|NCT00025337|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110190772|NCT00025337|Levoleucovorin|levoleucovorin|mesh-list
110302323|NCT00250874|Antimitotic Agents|antimitotic agents|mesh-ancestor
110190773|NCT00025337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110190774|NCT00025337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110190775|NCT00025337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110190776|NCT00025337|Growth Substances|growth substances|mesh-ancestor
110190777|NCT00025337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110190778|NCT00025337|Growth Inhibitors|growth inhibitors|mesh-ancestor
110190779|NCT00025337|Immunologic Factors|immunologic factors|mesh-ancestor
110190780|NCT00025337|Antimetabolites|antimetabolites|mesh-ancestor
110190781|NCT00025337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110190782|NCT00025337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110190783|NCT00025337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110190784|NCT00025337|Antidotes|antidotes|mesh-ancestor
110051637|NCT01475227|Zinc Sulfate|zinc sulfate|mesh-list
110190785|NCT00025337|Protective Agents|protective agents|mesh-ancestor
110190786|NCT00025337|Vitamin B Complex|vitamin b complex|mesh-ancestor
110190787|NCT00025337|Vitamins|vitamins|mesh-ancestor
110190788|NCT00025337|Micronutrients|micronutrients|mesh-ancestor
110190789|NCT00025376|Bortezomib|bortezomib|mesh-list
110190790|NCT00025376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110190791|NCT00025415|Imatinib Mesylate|imatinib mesylate|mesh-list
110190792|NCT00025415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110190793|NCT00025415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110190794|NCT00025415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110190795|NCT00025415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110190796|NCT00025454|Tipifarnib|tipifarnib|mesh-list
110190797|NCT00025454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110190798|NCT00025493|Docetaxel|docetaxel|mesh-list
110190799|NCT00025493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110190800|NCT00025493|Tubulin Modulators|tubulin modulators|mesh-ancestor
110190801|NCT00025493|Antimitotic Agents|antimitotic agents|mesh-ancestor
110190803|NCT00025493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110190804|NCT00025532|Antibodies|antibodies|mesh-list
110190805|NCT00025532|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110190806|NCT00025532|Immunologic Factors|immunologic factors|mesh-ancestor
110190807|NCT00025532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110190808|NCT00053430|Thalidomide|thalidomide|mesh-list
110190809|NCT00053430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110190810|NCT00053430|Immunologic Factors|immunologic factors|mesh-ancestor
110302349|NCT00250952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110190811|NCT00053430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110190812|NCT00053430|Leprostatic Agents|leprostatic agents|mesh-ancestor
110190813|NCT00053430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110190814|NCT00053430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110190815|NCT00053430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110190816|NCT00053430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110190818|NCT00053430|Growth Inhibitors|growth inhibitors|mesh-ancestor
110190819|NCT00053430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110190820|NCT00025610|Cyclophosphamide|cyclophosphamide|mesh-list
110190821|NCT00025610|Carboplatin|carboplatin|mesh-list
110190822|NCT00025610|Doxorubicin|doxorubicin|mesh-list
110190823|NCT00025610|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110190824|NCT00025610|Etoposide|etoposide|mesh-list
110190825|NCT00025610|Vincristine|vincristine|mesh-list
110190826|NCT00025610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110190827|NCT00025610|Immunologic Factors|immunologic factors|mesh-ancestor
110190828|NCT00025610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110190829|NCT00025610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110190830|NCT00025610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110190831|NCT00025610|Alkylating Agents|alkylating agents|mesh-ancestor
110302370|NCT00416832|Etoposide|etoposide|mesh-list
110190832|NCT00025610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110190833|NCT00025610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110190834|NCT00025610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110190835|NCT00025610|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110190836|NCT00025610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110190837|NCT00025610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110190838|NCT00025610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110190839|NCT00025610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110190840|NCT00025610|Tubulin Modulators|tubulin modulators|mesh-ancestor
110190841|NCT00025610|Antimitotic Agents|antimitotic agents|mesh-ancestor
110190842|NCT00025610|Mitosis Modulators|mitosis modulators|mesh-ancestor
110190843|NCT00025649|Cyclophosphamide|cyclophosphamide|mesh-list
110190846|NCT00025649|Carboplatin|carboplatin|mesh-list
110190847|NCT00025649|Doxorubicin|doxorubicin|mesh-list
110190848|NCT00025649|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110190849|NCT00025649|Etoposide|etoposide|mesh-list
110190850|NCT00025649|Vincristine|vincristine|mesh-list
110190851|NCT00025649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110190852|NCT00025649|Immunologic Factors|immunologic factors|mesh-ancestor
110190853|NCT00025649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110190854|NCT00025649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110190855|NCT00025649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110190856|NCT00025649|Alkylating Agents|alkylating agents|mesh-ancestor
110190857|NCT00025649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110190858|NCT00025649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110190859|NCT00025649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110190860|NCT00025649|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110190861|NCT00025649|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110190862|NCT00025649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110190863|NCT00025649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110190864|NCT00025649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110190865|NCT00025649|Tubulin Modulators|tubulin modulators|mesh-ancestor
110190866|NCT00025649|Antimitotic Agents|antimitotic agents|mesh-ancestor
110190867|NCT00025649|Mitosis Modulators|mitosis modulators|mesh-ancestor
110190869|NCT00025688|Carboplatin|carboplatin|mesh-list
110190870|NCT00025688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110190871|NCT00025688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110190872|NCT00025688|Tubulin Modulators|tubulin modulators|mesh-ancestor
110190873|NCT00025688|Antimitotic Agents|antimitotic agents|mesh-ancestor
110190874|NCT00025688|Mitosis Modulators|mitosis modulators|mesh-ancestor
110190875|NCT00025688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110190876|NCT00025727|Ritonavir|ritonavir|mesh-list
110190877|NCT00025727|Lopinavir|lopinavir|mesh-list
110190878|NCT00025727|Fosamprenavir|fosamprenavir|mesh-list
110190879|NCT00025727|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110190880|NCT00025727|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110190881|NCT00025727|Protease Inhibitors|protease inhibitors|mesh-ancestor
110190882|NCT00025727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110190883|NCT00025727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110190884|NCT00025727|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110190885|NCT00025727|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110190886|NCT00025727|Antiviral Agents|antiviral agents|mesh-ancestor
110052196|NCT01478490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110190887|NCT00025727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110190888|NCT00025727|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110190889|NCT00025727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110190890|NCT00053820|Interferons|interferons|mesh-list
110190891|NCT00053820|Interferon-alpha|interferon-alpha|mesh-list
110190892|NCT00053820|Aldesleukin|aldesleukin|mesh-list
110190893|NCT00053820|Fluorouracil|fluorouracil|mesh-list
110190894|NCT00053820|Antimetabolites|antimetabolites|mesh-ancestor
110190895|NCT00053820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110190896|NCT00053820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110302548|NCT01641796|Paromomycin|paromomycin|mesh-list
110190898|NCT00053820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110190900|NCT00053820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110190901|NCT00053820|Antiviral Agents|antiviral agents|mesh-ancestor
110190902|NCT00053820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110190903|NCT00053820|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110190904|NCT00053820|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110190905|NCT04731090|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110190906|NCT04731090|Fluoroquinolones|fluoroquinolones|mesh-list
110190907|NCT04731090|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110190908|NCT04731090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110190909|NCT04731090|Antitubercular Agents|antitubercular agents|mesh-ancestor
110190910|NCT04731090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110190911|NCT04731090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110190912|NCT04731090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110190913|NCT00053937|Pirfenidone|pirfenidone|mesh-list
110190914|NCT00053937|Analgesics|analgesics|mesh-ancestor
110190915|NCT00053937|Sensory System Agents|sensory system agents|mesh-ancestor
110190916|NCT00053937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110302610|NCT04823065|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110302613|NCT00280176|Bortezomib|bortezomib|mesh-list
110190917|NCT00053937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110190918|NCT00053937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110052401|NCT01479751|Anesthetics, General|anesthetics, general|mesh-ancestor
110190920|NCT00053937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110190921|NCT00053937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110190922|NCT00053937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110190923|NCT00053976|Methylprednisolone|methylprednisolone|mesh-list
110190924|NCT00053976|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110190925|NCT00053976|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110190926|NCT00053976|Prednisolone|prednisolone|mesh-list
110190927|NCT00053976|Prednisolone acetate|prednisolone acetate|mesh-list
110190928|NCT00053976|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110190929|NCT00053976|Prednisolone phosphate|prednisolone phosphate|mesh-list
110190930|NCT00053976|Daclizumab|daclizumab|mesh-list
110190931|NCT00053976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110190932|NCT00053976|Antiemetics|antiemetics|mesh-ancestor
110190933|NCT00053976|Autonomic Agents|autonomic agents|mesh-ancestor
110190934|NCT00053976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110190935|NCT00053976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110190936|NCT00053976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110190937|NCT00053976|Glucocorticoids|glucocorticoids|mesh-ancestor
110190939|NCT00053976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110190940|NCT00053976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110190941|NCT00053976|Protective Agents|protective agents|mesh-ancestor
110190942|NCT00053976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110190943|NCT00053976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110190944|NCT00053976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110190945|NCT00053976|Immunologic Factors|immunologic factors|mesh-ancestor
110190946|NCT04733573|Salicylic Acid|salicylic acid|mesh-list
110190947|NCT04733573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110190948|NCT04733573|Antifungal Agents|antifungal agents|mesh-ancestor
110190949|NCT04733573|Keratolytic Agents|keratolytic agents|mesh-ancestor
110190950|NCT04733573|Dermatologic Agents|dermatologic agents|mesh-ancestor
110190953|NCT00054054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110190954|NCT00054054|Tubulin Modulators|tubulin modulators|mesh-ancestor
110190955|NCT00054054|Antimitotic Agents|antimitotic agents|mesh-ancestor
110190956|NCT00054054|Mitosis Modulators|mitosis modulators|mesh-ancestor
110190957|NCT00054054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110190958|NCT00054054|Antimetabolites|antimetabolites|mesh-ancestor
110190959|NCT00054054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110190961|NCT00054054|Immunologic Factors|immunologic factors|mesh-ancestor
110190962|NCT00054054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110190963|NCT00026078|Docetaxel|docetaxel|mesh-list
110190964|NCT00026078|Ifosfamide|ifosfamide|mesh-list
110190965|NCT00026078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110190966|NCT00026078|Tubulin Modulators|tubulin modulators|mesh-ancestor
110190967|NCT00026078|Antimitotic Agents|antimitotic agents|mesh-ancestor
110190968|NCT00026078|Mitosis Modulators|mitosis modulators|mesh-ancestor
110190969|NCT00026078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110190970|NCT00026078|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110190972|NCT00398229|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110190973|NCT00398229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110190974|NCT00398229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110190975|NCT00026156|Docetaxel|docetaxel|mesh-list
110190976|NCT00026156|Vinorelbine|vinorelbine|mesh-list
110190977|NCT00026156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110190978|NCT00026156|Tubulin Modulators|tubulin modulators|mesh-ancestor
110190979|NCT00026156|Antimitotic Agents|antimitotic agents|mesh-ancestor
110190980|NCT00026156|Mitosis Modulators|mitosis modulators|mesh-ancestor
110190981|NCT00026156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110190982|NCT00026156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110190983|NCT00054171|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110190984|NCT00054171|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110190985|NCT00054171|Dermatologic Agents|dermatologic agents|mesh-ancestor
110190986|NCT00026195|Irinotecan|irinotecan|mesh-list
110190987|NCT00026195|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110190988|NCT00026195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110190989|NCT00026195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110302829|NCT02754154|Warfarin|warfarin|mesh-list
110190990|NCT00026195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110190991|NCT00026195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110190992|NCT00054210|Paclitaxel|paclitaxel|mesh-list
110190993|NCT00054210|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110190994|NCT00054210|Carboplatin|carboplatin|mesh-list
110190995|NCT00054210|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
110190996|NCT00054210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110190997|NCT00054210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110190998|NCT00054210|Tubulin Modulators|tubulin modulators|mesh-ancestor
110190999|NCT00054210|Antimitotic Agents|antimitotic agents|mesh-ancestor
110191000|NCT00054210|Mitosis Modulators|mitosis modulators|mesh-ancestor
110191001|NCT00054210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110191002|NCT00026234|Dexamethasone|dexamethasone|mesh-list
110191003|NCT00026234|Capecitabine|capecitabine|mesh-list
110191004|NCT00026234|Oxaliplatin|oxaliplatin|mesh-list
110191005|NCT00026234|Floxuridine|floxuridine|mesh-list
110191006|NCT00026234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110191007|NCT00026234|Antiemetics|antiemetics|mesh-ancestor
110191008|NCT00026234|Autonomic Agents|autonomic agents|mesh-ancestor
110191009|NCT00026234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110191010|NCT00026234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110191011|NCT00026234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110191012|NCT00026234|Glucocorticoids|glucocorticoids|mesh-ancestor
110191013|NCT00026234|Hormones|hormones|mesh-ancestor
110191014|NCT00026234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110191015|NCT00026234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110191016|NCT00026234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110191017|NCT00026234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110191018|NCT00026234|Antimetabolites|antimetabolites|mesh-ancestor
110053204|NCT01485445|Fluticasone|fluticasone|mesh-list
110191019|NCT00026234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110191020|NCT00054288|Gemcitabine|gemcitabine|mesh-list
110191022|NCT00054288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110191023|NCT00054288|Antimetabolites|antimetabolites|mesh-ancestor
110191024|NCT00054288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110191025|NCT00054288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110191026|NCT00054288|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110191027|NCT00054288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110191028|NCT00054288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110191030|NCT00026273|Fluorouracil|fluorouracil|mesh-list
110191031|NCT00026273|Irinotecan|irinotecan|mesh-list
110191032|NCT00026273|Calcium|calcium|mesh-list
110191033|NCT00026273|Levoleucovorin|levoleucovorin|mesh-list
110191034|NCT00026273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110191035|NCT00026273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110191036|NCT00026273|Antimetabolites|antimetabolites|mesh-ancestor
110191037|NCT00026273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110191038|NCT00026273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110191039|NCT00026273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110191040|NCT00026273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110191041|NCT00026273|Immunologic Factors|immunologic factors|mesh-ancestor
110191042|NCT00026273|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110191043|NCT00026273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110191044|NCT00026273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110191045|NCT00026273|Antidotes|antidotes|mesh-ancestor
110191046|NCT00026273|Protective Agents|protective agents|mesh-ancestor
110191047|NCT00026273|Vitamin B Complex|vitamin b complex|mesh-ancestor
110191048|NCT00026273|Vitamins|vitamins|mesh-ancestor
110191049|NCT00026273|Micronutrients|micronutrients|mesh-ancestor
110191050|NCT00054405|Aldesleukin|aldesleukin|mesh-list
110191051|NCT00054405|Interleukin-2|interleukin-2|mesh-list
110191052|NCT00054405|Interleukin-12|interleukin-12|mesh-list
110191053|NCT00054405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110191054|NCT00054405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110191055|NCT00054405|Analgesics|analgesics|mesh-ancestor
110191056|NCT00054405|Sensory System Agents|sensory system agents|mesh-ancestor
110191057|NCT00054405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110191058|NCT00054405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110191059|NCT00054405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110191060|NCT00054405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110191061|NCT00054405|Antiviral Agents|antiviral agents|mesh-ancestor
110191062|NCT00054405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110191063|NCT00054405|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110191064|NCT00054405|Immunologic Factors|immunologic factors|mesh-ancestor
110191065|NCT00054405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110191066|NCT00054405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110303071|NCT00252785|Hormones|hormones|mesh-ancestor
110191067|NCT00054405|Growth Substances|growth substances|mesh-ancestor
110191068|NCT00054405|Growth Inhibitors|growth inhibitors|mesh-ancestor
110191070|NCT00026351|Pentostatin|pentostatin|mesh-list
110191071|NCT00026351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110191072|NCT00026351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110191073|NCT00026351|Immunologic Factors|immunologic factors|mesh-ancestor
110191074|NCT00026351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110191075|NCT00026351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110191076|NCT00026351|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
110191077|NCT00026351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110191078|NCT00026351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110191080|NCT00054444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110191081|NCT00054444|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110191082|NCT00054444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110191083|NCT00054444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110191084|NCT00054444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110191085|NCT00026429|Denileukin diftitox|denileukin diftitox|mesh-list
110191086|NCT00026429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110191088|NCT00054483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110191089|NCT00026468|Sulindac sulfone|sulindac sulfone|mesh-list
110191090|NCT00026468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110191091|NCT00026468|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110191092|NCT00026468|Protective Agents|protective agents|mesh-ancestor
110191093|NCT00026468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110191094|NCT00026468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110191095|NCT00026468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110191096|NCT00026468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110191097|NCT00026468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110191098|NCT00026468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110191099|NCT00026468|Analgesics|analgesics|mesh-ancestor
110191100|NCT00026468|Sensory System Agents|sensory system agents|mesh-ancestor
110191101|NCT00026468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110191102|NCT00026468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110191103|NCT00026468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110191104|NCT00054522|Calcitriol|calcitriol|mesh-list
110191105|NCT00054522|Dexamethasone|dexamethasone|mesh-list
110191106|NCT00054522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110191107|NCT00054522|Antiemetics|antiemetics|mesh-ancestor
110191108|NCT00054522|Autonomic Agents|autonomic agents|mesh-ancestor
110303215|NCT01682161|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110191109|NCT00054522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110191110|NCT00054522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110191111|NCT00054522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110191112|NCT00054522|Glucocorticoids|glucocorticoids|mesh-ancestor
110191113|NCT00054522|Hormones|hormones|mesh-ancestor
110191114|NCT00054522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110191115|NCT00054522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110053400|NCT01486381|Insulin Aspart|insulin aspart|mesh-list
110191116|NCT00054522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110191117|NCT00054522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110191118|NCT00054522|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110191119|NCT00054522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110191120|NCT00054522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110191121|NCT00054522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110191123|NCT00054522|Micronutrients|micronutrients|mesh-ancestor
110191124|NCT00054522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110191125|NCT00026585|Tamoxifen|tamoxifen|mesh-list
110191126|NCT00026585|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110191127|NCT00026585|Hormone Antagonists|hormone antagonists|mesh-ancestor
110191128|NCT00026585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110191129|NCT00026585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110191130|NCT00026585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110191131|NCT00026585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110191132|NCT00026585|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110191133|NCT00026585|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110281190|NCT00191204|Dopamine Agents|dopamine agents|mesh-ancestor
110191134|NCT00026585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110191135|NCT00026624|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
110191136|NCT00026624|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110191137|NCT00026624|Immunologic Factors|immunologic factors|mesh-ancestor
110191138|NCT00026624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110191140|NCT00054600|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110191141|NCT00054600|Dermatologic Agents|dermatologic agents|mesh-ancestor
110191142|NCT00054795|Motexafin gadolinium|motexafin gadolinium|mesh-list
110191143|NCT00054795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110191144|NCT00054795|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110191145|NCT00054795|Dermatologic Agents|dermatologic agents|mesh-ancestor
110191147|NCT00026819|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110191148|NCT00026819|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110191149|NCT00026819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110191150|NCT00026819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110191151|NCT00026819|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110191152|NCT00026819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110191153|NCT00026819|Analgesics|analgesics|mesh-ancestor
110191154|NCT00026819|Sensory System Agents|sensory system agents|mesh-ancestor
110191155|NCT00026819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110191156|NCT00026819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110191157|NCT00026819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110191158|NCT00026819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110191159|NCT00054834|Epratuzumab|epratuzumab|mesh-list
110191160|NCT00054834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110191161|NCT00054834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110191162|NCT00054873|Fluorouracil|fluorouracil|mesh-list
110191163|NCT00054873|Tezacitabine|tezacitabine|mesh-list
110191164|NCT00054873|Antimetabolites|antimetabolites|mesh-ancestor
110191165|NCT00054873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110191166|NCT00054873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110191167|NCT00054873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110191168|NCT00054873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110191169|NCT00054873|Immunologic Factors|immunologic factors|mesh-ancestor
110191170|NCT00054873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110191171|NCT00054873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110191172|NCT00398385|Gemcitabine|gemcitabine|mesh-list
110191173|NCT00398385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110191174|NCT00398385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110191175|NCT00398385|Antimetabolites|antimetabolites|mesh-ancestor
110191176|NCT00398385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110191177|NCT00027014|Fentanyl|fentanyl|mesh-list
110191178|NCT00027014|Oxycodone|oxycodone|mesh-list
110303427|NCT00287820|Risperidone|risperidone|mesh-list
110191179|NCT00027014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110191180|NCT00027014|Narcotics|narcotics|mesh-ancestor
110191181|NCT00027014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110191182|NCT00027014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110191183|NCT00027014|Analgesics|analgesics|mesh-ancestor
110191184|NCT00027014|Sensory System Agents|sensory system agents|mesh-ancestor
110191185|NCT00027014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110191186|NCT00027014|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110191187|NCT00027014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110191188|NCT00027014|Anesthetics, General|anesthetics, general|mesh-ancestor
110191189|NCT00027014|Anesthetics|anesthetics|mesh-ancestor
110191190|NCT00398424|Cisplatin|cisplatin|mesh-list
110191191|NCT00398424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110191192|NCT00027053|Trazodone|trazodone|mesh-list
110191193|NCT00027053|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110191194|NCT00027053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110191195|NCT00027053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110191196|NCT00027053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110191197|NCT00027053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110191198|NCT00027053|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110191199|NCT00027053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110191200|NCT00027053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110191201|NCT00027053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110191202|NCT00027053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110191203|NCT00027053|Serotonin Agents|serotonin agents|mesh-ancestor
110191204|NCT00027053|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110191205|NCT00027053|Antidepressive Agents|antidepressive agents|mesh-ancestor
110191207|NCT00055107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110191208|NCT00055107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110303528|NCT01685515|Decitabine|decitabine|mesh-list
110191209|NCT00055185|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
110191210|NCT00055185|Immunologic Factors|immunologic factors|mesh-ancestor
110191211|NCT00055185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110191212|NCT00055302|Anastrozole|anastrozole|mesh-list
110191213|NCT00055302|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110191214|NCT00055302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110191216|NCT00055302|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110191217|NCT00055302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110191218|NCT00055302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110191219|NCT00055302|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110191220|NCT00055302|Hormone Antagonists|hormone antagonists|mesh-ancestor
110191221|NCT00055302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110191222|NCT00055302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110303585|NCT01686217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110303601|NCT01686529|Bevacizumab|bevacizumab|mesh-list
110191223|NCT00027248|Omiganan pentahydrochloride|omiganan pentahydrochloride|mesh-list
110191224|NCT00027248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110191225|NCT00055341|Ribavirin|ribavirin|mesh-list
110191226|NCT00055341|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110191227|NCT00055341|Antimetabolites|antimetabolites|mesh-ancestor
110191228|NCT00055341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110191229|NCT00055341|Antiviral Agents|antiviral agents|mesh-ancestor
110191230|NCT00055341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110191231|NCT00027287|Vitamin E|vitamin e|mesh-list
110191232|NCT00027287|Vitamins|vitamins|mesh-ancestor
110191233|NCT00027287|Micronutrients|micronutrients|mesh-ancestor
110191234|NCT00027287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110191235|NCT00027287|Antioxidants|antioxidants|mesh-ancestor
110303649|NCT01686802|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110191236|NCT00027287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110191237|NCT00027287|Protective Agents|protective agents|mesh-ancestor
110191238|NCT00055419|Cetuximab|cetuximab|mesh-list
110191239|NCT00055419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110191240|NCT00055419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110191241|NCT00055536|Natalizumab|natalizumab|mesh-list
110191242|NCT00055536|Immunologic Factors|immunologic factors|mesh-ancestor
110191243|NCT00055536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110191244|NCT00027443|Cyclosporine|cyclosporine|mesh-list
110191245|NCT00027443|Cyclosporins|cyclosporins|mesh-list
110191246|NCT00027443|Muromonab-CD3|muromonab-cd3|mesh-list
110191247|NCT00027443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110191248|NCT00027443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110191249|NCT00027443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110191250|NCT00027443|Immunologic Factors|immunologic factors|mesh-ancestor
110191251|NCT00027443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110191252|NCT00027443|Antifungal Agents|antifungal agents|mesh-ancestor
110191253|NCT00027443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110191254|NCT00027443|Dermatologic Agents|dermatologic agents|mesh-ancestor
110191255|NCT00027443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110054157|NCT01490229|Ezetimibe|ezetimibe|mesh-list
110191256|NCT00027443|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110191257|NCT00055614|Topotecan|topotecan|mesh-list
110191258|NCT00055614|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110191259|NCT00055614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110191260|NCT00055614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110191261|NCT00055614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110191262|NCT00055614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110191263|NCT00027521|Bleomycin|bleomycin|mesh-list
110054209|NCT01490437|Pemetrexed|pemetrexed|mesh-list
110191264|NCT00027521|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110191265|NCT00027521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110191268|NCT00027599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110303745|NCT01687894|Vasopressins|vasopressins|mesh-list
110191269|NCT00027599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110191270|NCT00027599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110191271|NCT00027599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110191272|NCT00027599|Growth Substances|growth substances|mesh-ancestor
110191273|NCT00027599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110191274|NCT00027599|Growth Inhibitors|growth inhibitors|mesh-ancestor
110191275|NCT00027599|Immunologic Factors|immunologic factors|mesh-ancestor
110191276|NCT00055653|Cyclosporine|cyclosporine|mesh-list
110191277|NCT00055653|Methylprednisolone|methylprednisolone|mesh-list
110191278|NCT00055653|Cyclophosphamide|cyclophosphamide|mesh-list
110191280|NCT00055653|Busulfan|busulfan|mesh-list
110191281|NCT00055653|Fludarabine|fludarabine|mesh-list
110191282|NCT00055653|Fludarabine phosphate|fludarabine phosphate|mesh-list
110191283|NCT00055653|Cyclosporins|cyclosporins|mesh-list
110191284|NCT00055653|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110191285|NCT00055653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110191286|NCT00055653|Immunologic Factors|immunologic factors|mesh-ancestor
110303788|NCT00288171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110191287|NCT00055653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110191288|NCT00055653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110191289|NCT00055653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110191290|NCT00055653|Alkylating Agents|alkylating agents|mesh-ancestor
110191291|NCT00055653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110191292|NCT00055653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110191293|NCT00055653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110191294|NCT00055653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110191295|NCT00055653|Antimetabolites|antimetabolites|mesh-ancestor
110191296|NCT00055653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110191297|NCT00055653|Antifungal Agents|antifungal agents|mesh-ancestor
110191298|NCT00055653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110191299|NCT00055653|Dermatologic Agents|dermatologic agents|mesh-ancestor
110191300|NCT00055653|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110191301|NCT00055653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110191302|NCT00055653|Antiemetics|antiemetics|mesh-ancestor
110303849|NCT00288444|Docetaxel|docetaxel|mesh-list
110191303|NCT00055653|Autonomic Agents|autonomic agents|mesh-ancestor
110191304|NCT00055653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110191305|NCT00055653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110191306|NCT00055653|Glucocorticoids|glucocorticoids|mesh-ancestor
110191307|NCT00055653|Hormones|hormones|mesh-ancestor
110191308|NCT00055653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110191309|NCT00055653|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110191310|NCT00055653|Protective Agents|protective agents|mesh-ancestor
110191311|NCT00055770|Docetaxel|docetaxel|mesh-list
110191312|NCT00055770|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110191313|NCT00055770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110191314|NCT00055770|Tubulin Modulators|tubulin modulators|mesh-ancestor
110191315|NCT00055770|Antimitotic Agents|antimitotic agents|mesh-ancestor
110191316|NCT00055770|Mitosis Modulators|mitosis modulators|mesh-ancestor
110191317|NCT00055770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110191318|NCT00055770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110191319|NCT00055770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110191320|NCT00027638|Thalidomide|thalidomide|mesh-list
110191321|NCT00027638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110191322|NCT00027638|Immunologic Factors|immunologic factors|mesh-ancestor
110191323|NCT00027638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110191324|NCT00027638|Leprostatic Agents|leprostatic agents|mesh-ancestor
110191325|NCT00027638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110191326|NCT00027638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110191327|NCT00027638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110191328|NCT00027638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110191329|NCT00027638|Growth Substances|growth substances|mesh-ancestor
110191330|NCT00027638|Growth Inhibitors|growth inhibitors|mesh-ancestor
110191331|NCT00027638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110191332|NCT00055809|Interferons|interferons|mesh-list
110191333|NCT00055809|Interferon-alpha|interferon-alpha|mesh-list
110191334|NCT00055809|Interferon alpha-2|interferon alpha-2|mesh-list
110191335|NCT00055809|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110191336|NCT00055809|Bevacizumab|bevacizumab|mesh-list
110191337|NCT00055809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110191338|NCT00055809|Antibodies|antibodies|mesh-list
110191339|NCT00055809|Immunoglobulins|immunoglobulins|mesh-list
110191340|NCT00055809|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110191341|NCT00055809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110191342|NCT00055809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110191343|NCT00055809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110191344|NCT00055809|Growth Substances|growth substances|mesh-ancestor
110191345|NCT00055809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110304005|NCT00254618|Mesalamine|mesalamine|mesh-list
110191346|NCT00055809|Growth Inhibitors|growth inhibitors|mesh-ancestor
110191347|NCT00055809|Immunologic Factors|immunologic factors|mesh-ancestor
110191348|NCT00055809|Antiviral Agents|antiviral agents|mesh-ancestor
110191349|NCT00055809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110191350|NCT00027677|Halofuginone|halofuginone|mesh-list
110191351|NCT00027677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110191352|NCT00027677|Coccidiostats|coccidiostats|mesh-ancestor
110191353|NCT00027677|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110191354|NCT00027677|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110191355|NCT00027677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110191356|NCT00027677|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110191357|NCT00027677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110191358|NCT00027677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110191359|NCT00027677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110191360|NCT00027677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110191361|NCT00027677|Growth Substances|growth substances|mesh-ancestor
110191362|NCT00027677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110191363|NCT00027677|Growth Inhibitors|growth inhibitors|mesh-ancestor
110191365|NCT00027716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110191366|NCT00055887|Paclitaxel|paclitaxel|mesh-list
110191367|NCT00055887|Vinorelbine|vinorelbine|mesh-list
110191368|NCT00055887|Carboplatin|carboplatin|mesh-list
110191370|NCT00055887|Efaproxiral|efaproxiral|mesh-list
110191371|NCT00055887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110191372|NCT00055887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110191373|NCT00055887|Tubulin Modulators|tubulin modulators|mesh-ancestor
110191374|NCT00055887|Antimitotic Agents|antimitotic agents|mesh-ancestor
110191375|NCT00055887|Mitosis Modulators|mitosis modulators|mesh-ancestor
110191376|NCT00055887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110191377|NCT00055887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110191378|NCT00055887|Antimetabolites|antimetabolites|mesh-ancestor
110191379|NCT00055887|Antisickling Agents|antisickling agents|mesh-ancestor
110191380|NCT00026039|Estrogens|estrogens|mesh-list
110191381|NCT00026039|Hormones|hormones|mesh-ancestor
110054534|NCT01492712|Anesthetics, General|anesthetics, general|mesh-ancestor
110191382|NCT00026039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110191383|NCT00026039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110191384|NCT00027404|Fluoxetine|fluoxetine|mesh-list
110191385|NCT00027404|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110191386|NCT00027404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110191387|NCT00027404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110191388|NCT00027404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110191389|NCT00027404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110191391|NCT00027404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110191392|NCT00027404|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110191393|NCT00027404|Antidepressive Agents|antidepressive agents|mesh-ancestor
110191394|NCT00027404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110191395|NCT00027404|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110191396|NCT00027404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110191397|NCT00027404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110191398|NCT00055965|Carboplatin|carboplatin|mesh-list
110191399|NCT00055965|Gemcitabine|gemcitabine|mesh-list
110191400|NCT00055965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110191401|NCT00055965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110191402|NCT00055965|Antimetabolites|antimetabolites|mesh-ancestor
110191403|NCT00055965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110191405|NCT00027833|Fluorouracil|fluorouracil|mesh-list
110191406|NCT00027833|Irinotecan|irinotecan|mesh-list
110191407|NCT00027833|Calcium|calcium|mesh-list
110191408|NCT00027833|Levoleucovorin|levoleucovorin|mesh-list
110191409|NCT00027833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110191410|NCT00027833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110191411|NCT00027833|Antimetabolites|antimetabolites|mesh-ancestor
110191412|NCT00027833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110191413|NCT00027833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110191414|NCT00027833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110191415|NCT00027833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110191442|NCT00056004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110191443|NCT00056004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110191444|NCT00056004|Analgesics|analgesics|mesh-ancestor
110191445|NCT00056004|Sensory System Agents|sensory system agents|mesh-ancestor
110191446|NCT00056004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110191447|NCT00056004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281386|NCT00123578|GABA Agents|gaba agents|mesh-ancestor
110191448|NCT00056004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110191449|NCT00056004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110191450|NCT00056004|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110191451|NCT00056004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110191452|NCT00056004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110191453|NCT00056004|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110191454|NCT00056004|Hormone Antagonists|hormone antagonists|mesh-ancestor
110191455|NCT00056004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110191456|NCT00028028|Sirolimus|sirolimus|mesh-list
110191457|NCT00028028|Temsirolimus|temsirolimus|mesh-list
110191458|NCT00028028|MTOR Inhibitors|mtor inhibitors|mesh-list
110191459|NCT00028028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110191460|NCT00028028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110191461|NCT00028028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110191462|NCT00028028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110191463|NCT00028028|Immunologic Factors|immunologic factors|mesh-ancestor
110191464|NCT00028028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110191465|NCT00028028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110191466|NCT00028028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110191467|NCT00028028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110191468|NCT00028028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110191469|NCT00028028|Antifungal Agents|antifungal agents|mesh-ancestor
110191470|NCT00028106|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
110191471|NCT00028106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110191472|NCT00028106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110191473|NCT00028106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110191474|NCT00028106|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110191475|NCT00056082|Celecoxib|celecoxib|mesh-list
110281545|NCT00412698|Rimonabant|rimonabant|mesh-list
110191476|NCT00056082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110191477|NCT00056082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110191479|NCT00056082|Sensory System Agents|sensory system agents|mesh-ancestor
110191480|NCT00056082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110191481|NCT00056082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110191482|NCT00056082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110191483|NCT00056082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110191484|NCT00056082|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110191485|NCT00056082|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110191486|NCT00056082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110191487|NCT00056082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110191488|NCT04730973|Evolocumab|evolocumab|mesh-list
110191489|NCT04730973|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110191490|NCT04730973|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110191491|NCT04730973|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110191492|NCT04730973|Antimetabolites|antimetabolites|mesh-ancestor
110191493|NCT04730973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110191494|NCT04730973|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110191495|NCT04730973|Protease Inhibitors|protease inhibitors|mesh-ancestor
110191496|NCT04730973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110191497|NCT04730973|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110191498|NCT00028418|Clofarabine|clofarabine|mesh-list
110191499|NCT00028418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110191500|NCT00028418|Antimetabolites|antimetabolites|mesh-ancestor
110191501|NCT00028418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110191502|NCT00028418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110191503|NCT00028496|Metronidazole|metronidazole|mesh-list
110191504|NCT00028496|Molgramostim|molgramostim|mesh-list
110191506|NCT00028496|Sargramostim|sargramostim|mesh-list
110191507|NCT00028496|Adjuvants, Vaccine|adjuvants, vaccine|mesh-list
110191508|NCT00028496|Immunologic Factors|immunologic factors|mesh-ancestor
110191509|NCT00028496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110191510|NCT00028496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110191511|NCT00028496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110191512|NCT00028496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110191513|NCT00028496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110191514|NCT00028496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110191515|NCT00028496|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110191516|NCT00028535|Paclitaxel|paclitaxel|mesh-list
110191517|NCT00028535|Trastuzumab|trastuzumab|mesh-list
110191518|NCT00028535|Interleukin-12|interleukin-12|mesh-list
110191519|NCT00028535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110191520|NCT00028535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110191521|NCT00028535|Tubulin Modulators|tubulin modulators|mesh-ancestor
110191522|NCT00028535|Antimitotic Agents|antimitotic agents|mesh-ancestor
110191523|NCT00028535|Mitosis Modulators|mitosis modulators|mesh-ancestor
110191524|NCT00028535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110191525|NCT00028535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110191526|NCT00028535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110191527|NCT00028535|Immunologic Factors|immunologic factors|mesh-ancestor
110191528|NCT00028535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110191529|NCT00028535|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110191530|NCT00028535|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110191531|NCT00028535|Growth Substances|growth substances|mesh-ancestor
110191532|NCT00028535|Growth Inhibitors|growth inhibitors|mesh-ancestor
110191534|NCT00056277|Anticonvulsants|anticonvulsants|mesh-ancestor
110191535|NCT00056277|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110191536|NCT00056277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110282520|NCT00125411|Mitosis Modulators|mitosis modulators|mesh-ancestor
110191537|NCT00056277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110055037|NCT01495520|Ranolazine|ranolazine|mesh-list
110191538|NCT00056277|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110191540|NCT00056277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110191541|NCT00056277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110191542|NCT00056277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110191543|NCT00056277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110191544|NCT00056277|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110191545|NCT00028574|Gabapentin|gabapentin|mesh-list
110191546|NCT00028574|Analgesics|analgesics|mesh-ancestor
110191547|NCT00028574|Sensory System Agents|sensory system agents|mesh-ancestor
110191548|NCT00028574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110191549|NCT00028574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110191551|NCT00028574|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110191552|NCT00028574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110191553|NCT00028574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110191554|NCT00028574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110191555|NCT00028574|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110191556|NCT00028574|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110191557|NCT00028574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110191558|NCT00028574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110191559|NCT00028574|Antimanic Agents|antimanic agents|mesh-ancestor
110191560|NCT00056433|Hydroxyurea|hydroxyurea|mesh-list
110191561|NCT00056433|Sildenafil Citrate|sildenafil citrate|mesh-list
110055259|NCT01497002|Cytarabine|cytarabine|mesh-list
110191562|NCT00056433|Vasodilator Agents|vasodilator agents|mesh-ancestor
110191563|NCT00056433|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110191564|NCT00056433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110191565|NCT00056433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110283059|NCT00195377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110191566|NCT00056433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110191567|NCT00056433|Urological Agents|urological agents|mesh-ancestor
110191568|NCT00056433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110191569|NCT00056433|Antisickling Agents|antisickling agents|mesh-ancestor
110191570|NCT00056433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110191571|NCT00028613|Antibodies|antibodies|mesh-list
110055300|NCT01497132|Vitamin D|vitamin d|mesh-list
110191572|NCT00028613|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110191573|NCT00028613|Immunologic Factors|immunologic factors|mesh-ancestor
110191574|NCT00028613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110191575|NCT00028652|Interleukin-12|interleukin-12|mesh-list
110191576|NCT00028652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110191577|NCT00028652|Immunologic Factors|immunologic factors|mesh-ancestor
110191578|NCT00028652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110191579|NCT00028652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110191580|NCT00028652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110191581|NCT00028652|Growth Substances|growth substances|mesh-ancestor
110191582|NCT00028652|Growth Inhibitors|growth inhibitors|mesh-ancestor
110191583|NCT00028652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110055361|NCT01497483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110191585|NCT00028691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110191586|NCT00028691|Alkylating Agents|alkylating agents|mesh-ancestor
110191587|NCT00028691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110191588|NCT00028691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110191589|NCT00028730|Cyclophosphamide|cyclophosphamide|mesh-list
110191590|NCT00028730|Thiotepa|thiotepa|mesh-list
110191591|NCT00028730|Fludarabine|fludarabine|mesh-list
110191592|NCT00028730|Fludarabine phosphate|fludarabine phosphate|mesh-list
110191593|NCT00028730|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110055425|NCT01497717|Adalimumab|adalimumab|mesh-list
110191594|NCT00028730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110191595|NCT00028730|Immunologic Factors|immunologic factors|mesh-ancestor
110191596|NCT00028730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110191597|NCT00028730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110191598|NCT00028730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110191599|NCT00028730|Alkylating Agents|alkylating agents|mesh-ancestor
110191600|NCT00028730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110191601|NCT00028730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110191602|NCT00028730|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110191603|NCT00028730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110191604|NCT00028730|Antimetabolites|antimetabolites|mesh-ancestor
110191606|NCT00028847|Imatinib Mesylate|imatinib mesylate|mesh-list
110191607|NCT00028847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110191608|NCT00028847|Antimetabolites|antimetabolites|mesh-ancestor
110191609|NCT00028847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110191611|NCT00028847|Antiviral Agents|antiviral agents|mesh-ancestor
110191612|NCT00028847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110191613|NCT00028847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110191614|NCT00028847|Immunologic Factors|immunologic factors|mesh-ancestor
110191615|NCT00028847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110191616|NCT00028847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110191617|NCT00028847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110191618|NCT00028886|Interferons|interferons|mesh-list
110191619|NCT00028886|Interferon-alpha|interferon-alpha|mesh-list
110191620|NCT00028886|Thalidomide|thalidomide|mesh-list
110191621|NCT00028886|Dexamethasone|dexamethasone|mesh-list
110191622|NCT00028886|Cyclophosphamide|cyclophosphamide|mesh-list
110191623|NCT00028886|Melphalan|melphalan|mesh-list
110191624|NCT00028886|Doxorubicin|doxorubicin|mesh-list
110191625|NCT00028886|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110191626|NCT00028886|Vincristine|vincristine|mesh-list
110191627|NCT00028886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110191628|NCT00028886|Immunologic Factors|immunologic factors|mesh-ancestor
110191629|NCT00028886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110191630|NCT00028886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110191631|NCT00028886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110191632|NCT00028886|Alkylating Agents|alkylating agents|mesh-ancestor
110191633|NCT00028886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110191634|NCT00028886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110191635|NCT00028886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110191636|NCT00028886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110191637|NCT00028886|Antiemetics|antiemetics|mesh-ancestor
110191638|NCT00028886|Autonomic Agents|autonomic agents|mesh-ancestor
110191639|NCT00028886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110191640|NCT00028886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110191641|NCT00028886|Glucocorticoids|glucocorticoids|mesh-ancestor
110304301|NCT00255437|Hematinics|hematinics|mesh-ancestor
110304304|NCT00255476|Gefitinib|gefitinib|mesh-list
110191643|NCT00028886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110191644|NCT00028886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110191645|NCT00028886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110191646|NCT00028886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110191647|NCT00028886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110191648|NCT00028886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110191649|NCT00028886|Antiviral Agents|antiviral agents|mesh-ancestor
110191650|NCT00028886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110191651|NCT00028886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110191652|NCT00028886|Tubulin Modulators|tubulin modulators|mesh-ancestor
110191653|NCT00028886|Antimitotic Agents|antimitotic agents|mesh-ancestor
110191654|NCT00028886|Mitosis Modulators|mitosis modulators|mesh-ancestor
110191655|NCT00028886|Leprostatic Agents|leprostatic agents|mesh-ancestor
110191656|NCT00028886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110191657|NCT00028886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110191658|NCT00028886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110191659|NCT00028886|Growth Substances|growth substances|mesh-ancestor
110191660|NCT00028886|Growth Inhibitors|growth inhibitors|mesh-ancestor
110191661|NCT00028925|Carboplatin|carboplatin|mesh-list
110191663|NCT00028925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110191664|NCT00028925|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110191665|NCT00028925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110191666|NCT00028925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110191667|NCT00028925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110191668|NCT00398463|polysaccharide-K|polysaccharide-k|mesh-list
110191669|NCT00398463|Tirofiban|tirofiban|mesh-list
110191670|NCT00398463|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110191671|NCT00398463|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110304355|NCT00255554|Escitalopram|escitalopram|mesh-list
110191672|NCT00398463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110191673|NCT00398463|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110191674|NCT00398463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110191675|NCT00398463|Immunologic Factors|immunologic factors|mesh-ancestor
110191676|NCT00398463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110191677|NCT00398463|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110191678|NCT00398463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110191679|NCT00398463|Antiviral Agents|antiviral agents|mesh-ancestor
110191680|NCT00398463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110191681|NCT00398463|Interferon Inducers|interferon inducers|mesh-ancestor
110191682|NCT00398463|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110191683|NCT00398463|Protective Agents|protective agents|mesh-ancestor
110191684|NCT00028964|Cyclophosphamide|cyclophosphamide|mesh-list
110191685|NCT00028964|Doxorubicin|doxorubicin|mesh-list
110191686|NCT00028964|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110191687|NCT00028964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110191688|NCT00028964|Immunologic Factors|immunologic factors|mesh-ancestor
110191689|NCT00028964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110191690|NCT00028964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110191691|NCT00028964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110191692|NCT00028964|Alkylating Agents|alkylating agents|mesh-ancestor
110191693|NCT00028964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110191694|NCT00028964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110191695|NCT00028964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110191696|NCT00028964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110191697|NCT00028964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110191699|NCT00028964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110191700|NCT00423501|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110191701|NCT00423501|Incretins|incretins|mesh-ancestor
110191702|NCT00423501|Hormones|hormones|mesh-ancestor
110191703|NCT00423501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110304381|NCT00255710|Fludarabine phosphate|fludarabine phosphate|mesh-list
110191704|NCT00423501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110191705|NCT00029003|Gefitinib|gefitinib|mesh-list
110191706|NCT00029003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110191707|NCT00029003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110191708|NCT00029003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110191709|NCT00029003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110191710|NCT00029042|Infliximab|infliximab|mesh-list
110191711|NCT00029042|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110191712|NCT00029042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110191713|NCT00029042|Dermatologic Agents|dermatologic agents|mesh-ancestor
110191714|NCT00029042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110191715|NCT00029042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110191716|NCT00423540|Magnesium Sulfate|magnesium sulfate|mesh-list
110191717|NCT00423540|Analgesics|analgesics|mesh-ancestor
110191718|NCT00423540|Sensory System Agents|sensory system agents|mesh-ancestor
110191719|NCT00423540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110191720|NCT00423540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110191721|NCT00423540|Anesthetics|anesthetics|mesh-ancestor
110191722|NCT00423540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110191723|NCT00423540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110191724|NCT00423540|Anticonvulsants|anticonvulsants|mesh-ancestor
110191725|NCT00423540|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110191726|NCT00423540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110191727|NCT00423540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110191728|NCT00423540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110191730|NCT00423540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110191732|NCT00029159|Androgens|androgens|mesh-list
110191733|NCT00029159|Hormones|hormones|mesh-ancestor
110191734|NCT00029159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110191735|NCT00029159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110191736|NCT00423696|Leucovorin|leucovorin|mesh-list
110191737|NCT00423696|Bevacizumab|bevacizumab|mesh-list
110056256|NCT01501890|Algestone|algestone|mesh-list
110191739|NCT00423696|Capecitabine|capecitabine|mesh-list
110191740|NCT00423696|Irinotecan|irinotecan|mesh-list
110191741|NCT00423696|Calcium|calcium|mesh-list
110191742|NCT00423696|Levoleucovorin|levoleucovorin|mesh-list
110191743|NCT00423696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110191744|NCT00423696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110191745|NCT00423696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110191746|NCT00423696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110191747|NCT00423696|Growth Substances|growth substances|mesh-ancestor
110191748|NCT00423696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110191749|NCT00423696|Growth Inhibitors|growth inhibitors|mesh-ancestor
110284142|NCT00230568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110191750|NCT00423696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110191751|NCT00423696|Antimetabolites|antimetabolites|mesh-ancestor
110191752|NCT00423696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110191753|NCT00423696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110191754|NCT00423696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110191755|NCT00423696|Immunologic Factors|immunologic factors|mesh-ancestor
110191756|NCT00423696|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110191757|NCT00423696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110191758|NCT00423696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110191759|NCT00423696|Antidotes|antidotes|mesh-ancestor
110191760|NCT00423696|Protective Agents|protective agents|mesh-ancestor
110191761|NCT00423696|Vitamin B Complex|vitamin b complex|mesh-ancestor
110191763|NCT00423696|Micronutrients|micronutrients|mesh-ancestor
110191764|NCT00029315|Plasminogen|plasminogen|mesh-list
110191765|NCT00029315|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110191766|NCT00029315|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110191767|NCT00029315|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110191768|NCT00029315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110191769|NCT00056823|Ranibizumab|ranibizumab|mesh-list
110191770|NCT00056823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110191771|NCT00056823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110191772|NCT00056823|Growth Substances|growth substances|mesh-ancestor
110191773|NCT00056823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110191774|NCT00056823|Growth Inhibitors|growth inhibitors|mesh-ancestor
110191775|NCT00056823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110191776|NCT00029627|Yohimbine|yohimbine|mesh-list
110191777|NCT00029627|Mydriatics|mydriatics|mesh-ancestor
110191778|NCT00029627|Autonomic Agents|autonomic agents|mesh-ancestor
110191779|NCT00029627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110191780|NCT00029627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110191781|NCT00029627|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110191782|NCT00029627|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110191783|NCT00029627|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110191784|NCT00029627|Adrenergic Agents|adrenergic agents|mesh-ancestor
110191785|NCT00029627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110191786|NCT00029627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110191787|NCT00029627|Urological Agents|urological agents|mesh-ancestor
110191788|NCT02970084|Vitamin K|vitamin k|mesh-list
110191789|NCT02970084|Vitamin K 2|vitamin k 2|mesh-list
110191790|NCT02970084|Vitamins|vitamins|mesh-ancestor
110191791|NCT02970084|Micronutrients|micronutrients|mesh-ancestor
110304499|NCT02488408|Cytarabine|cytarabine|mesh-list
110191792|NCT02970084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110191793|NCT02970084|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110191794|NCT02970084|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110191795|NCT02970084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110191797|NCT02970084|Coagulants|coagulants|mesh-ancestor
110191798|NCT00056979|Fludarabine|fludarabine|mesh-list
110191799|NCT00056979|Alemtuzumab|alemtuzumab|mesh-list
110191800|NCT00056979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110191801|NCT00056979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110191802|NCT00029822|Alfuzosin|alfuzosin|mesh-list
110191803|NCT00029822|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110191804|NCT00029822|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110191805|NCT00029822|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110191806|NCT00029822|Adrenergic Agents|adrenergic agents|mesh-ancestor
110191807|NCT00029822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110218857|NCT00281944|Fluorouracil|fluorouracil|mesh-list
110191808|NCT00029822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110191809|NCT00029822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110191810|NCT00029822|Urological Agents|urological agents|mesh-ancestor
110056620|NCT01503788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110191812|NCT00395681|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110191813|NCT00395681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110191814|NCT00395681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110191815|NCT00395681|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110191816|NCT00395681|Anesthetics, General|anesthetics, general|mesh-ancestor
110191817|NCT00395681|Anesthetics|anesthetics|mesh-ancestor
110191818|NCT00395720|Vaccines|vaccines|mesh-list
110191819|NCT00395720|Immunologic Factors|immunologic factors|mesh-ancestor
110191820|NCT00395720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110191821|NCT00395759|Lubricant Eye Drops|lubricant eye drops|mesh-list
110191822|NCT00395759|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110191823|NCT00395759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110191824|NCT00395915|Aripiprazole|aripiprazole|mesh-list
110191825|NCT00395915|Antidepressive Agents|antidepressive agents|mesh-ancestor
110191826|NCT00395915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110191827|NCT00395915|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110191828|NCT00395915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110191829|NCT00395915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110191830|NCT00395915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110191831|NCT00395915|Dopamine Agonists|dopamine agonists|mesh-ancestor
110191832|NCT00395915|Dopamine Agents|dopamine agents|mesh-ancestor
110191833|NCT00395915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110191834|NCT00395915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110191835|NCT00395915|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110056690|NCT01504074|Triamcinolone|triamcinolone|mesh-list
110191836|NCT00395915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110191838|NCT00395915|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110191839|NCT00395915|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110191840|NCT00395915|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110191841|NCT00395915|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110191842|NCT00029861|Rimonabant|rimonabant|mesh-list
110191843|NCT00029861|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110191844|NCT00029861|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
110191845|NCT00029861|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110191846|NCT00029861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110191847|NCT00029861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110191848|NCT00029861|Hormones|hormones|mesh-ancestor
110284193|NCT00227448|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110191849|NCT00029861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110191850|NCT00029861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110191851|NCT00057369|Dalbavancin|dalbavancin|mesh-list
110191852|NCT00057369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110191853|NCT00057369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110191854|NCT00057408|Olanzapine|olanzapine|mesh-list
110191855|NCT00057408|Antipsychotic Agents|antipsychotic agents|mesh-list
110191856|NCT00057408|Antiemetics|antiemetics|mesh-ancestor
110191857|NCT00057408|Autonomic Agents|autonomic agents|mesh-ancestor
110191858|NCT00057408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110191859|NCT00057408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110191860|NCT00057408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110191861|NCT00057408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110191862|NCT00057408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110191863|NCT00057408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110191864|NCT00057408|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110191865|NCT00057408|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110191866|NCT00057408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110218863|NCT00281944|Antimetabolites|antimetabolites|mesh-ancestor
110191867|NCT00057408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110191868|NCT00057408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110191869|NCT00057408|Serotonin Agents|serotonin agents|mesh-ancestor
110191870|NCT00030056|Molgramostim|molgramostim|mesh-list
110191871|NCT00030056|Sargramostim|sargramostim|mesh-list
110191872|NCT00030056|Immunologic Factors|immunologic factors|mesh-ancestor
110191873|NCT00030056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110191874|NCT00030056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110191875|NCT00057447|Interferons|interferons|mesh-list
110191876|NCT00057447|Interferon-gamma|interferon-gamma|mesh-list
110191877|NCT00057447|Rituximab|rituximab|mesh-list
110191878|NCT00057447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110191879|NCT00057447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110191880|NCT00057447|Immunologic Factors|immunologic factors|mesh-ancestor
110056853|NCT01504724|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110191881|NCT00057447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110191882|NCT00057447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110191883|NCT00057447|Antiviral Agents|antiviral agents|mesh-ancestor
110191884|NCT00057447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110191885|NCT00030095|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
110191886|NCT00030095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110191887|NCT00030095|Tubulin Modulators|tubulin modulators|mesh-ancestor
110191888|NCT00030095|Antimitotic Agents|antimitotic agents|mesh-ancestor
110191889|NCT00030095|Mitosis Modulators|mitosis modulators|mesh-ancestor
110191890|NCT00030095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110191892|NCT00030173|Desoxyepothilone B|desoxyepothilone b|mesh-list
110191893|NCT00030173|Tubulin Modulators|tubulin modulators|mesh-ancestor
110191894|NCT00030173|Antimitotic Agents|antimitotic agents|mesh-ancestor
110191895|NCT00030173|Mitosis Modulators|mitosis modulators|mesh-ancestor
110191896|NCT00030173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110191897|NCT00030173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110191898|NCT00057564|Thalidomide|thalidomide|mesh-list
110191899|NCT00057564|Dexamethasone|dexamethasone|mesh-list
110191900|NCT00057564|Dexamethasone acetate|dexamethasone acetate|mesh-list
110191901|NCT00057564|BB 1101|bb 1101|mesh-list
110191902|NCT00057564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110191903|NCT00057564|Antiemetics|antiemetics|mesh-ancestor
110191904|NCT00057564|Autonomic Agents|autonomic agents|mesh-ancestor
110191905|NCT00057564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110191906|NCT00057564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110191907|NCT00057564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110191908|NCT00057564|Glucocorticoids|glucocorticoids|mesh-ancestor
110191909|NCT00057564|Hormones|hormones|mesh-ancestor
110191910|NCT00057564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110191911|NCT00057564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110191912|NCT00057564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110191913|NCT00057564|Protease Inhibitors|protease inhibitors|mesh-ancestor
110191914|NCT00057564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110191915|NCT00057564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110191916|NCT00057564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110191917|NCT00057564|Immunologic Factors|immunologic factors|mesh-ancestor
110191918|NCT00057564|Leprostatic Agents|leprostatic agents|mesh-ancestor
110191919|NCT00057564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110191920|NCT00057564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110191921|NCT00057564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110191922|NCT00057564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110191923|NCT00057564|Growth Substances|growth substances|mesh-ancestor
110304820|NCT02272582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110191926|NCT00030368|Bortezomib|bortezomib|mesh-list
110191927|NCT00030368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110191928|NCT00030368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110191929|NCT00030368|Tubulin Modulators|tubulin modulators|mesh-ancestor
110191930|NCT00030368|Antimitotic Agents|antimitotic agents|mesh-ancestor
110191931|NCT00030368|Mitosis Modulators|mitosis modulators|mesh-ancestor
110191932|NCT00030368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110191933|NCT00030407|Celecoxib|celecoxib|mesh-list
110191934|NCT00030407|Docetaxel|docetaxel|mesh-list
110191935|NCT00030407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110191936|NCT00030407|Tubulin Modulators|tubulin modulators|mesh-ancestor
110191937|NCT00030407|Antimitotic Agents|antimitotic agents|mesh-ancestor
110191938|NCT00030407|Mitosis Modulators|mitosis modulators|mesh-ancestor
110191939|NCT00030407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110191940|NCT00030407|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110191941|NCT00030407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110191942|NCT00030407|Analgesics|analgesics|mesh-ancestor
110191944|NCT00030407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110191945|NCT00030407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110191946|NCT00030407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110191947|NCT00030407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110191948|NCT00030407|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110191949|NCT00030407|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110191950|NCT00030407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110191952|NCT00057642|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110191953|NCT00057642|Antidepressive Agents|antidepressive agents|mesh-ancestor
110191954|NCT00057642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110304851|NCT02272738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110191955|NCT00057642|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110191956|NCT00057642|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110191957|NCT00057642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110057149|NCT01506167|Folic Acid|folic acid|mesh-list
110191958|NCT00057642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110191959|NCT00057642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110191960|NCT00057642|Serotonin Agents|serotonin agents|mesh-ancestor
110191961|NCT00057642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110191962|NCT00057642|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110191963|NCT00057642|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110191965|NCT00030446|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110191966|NCT00030446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110191967|NCT00030446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110191968|NCT00030446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110191969|NCT00030446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110191970|NCT00030485|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110191971|NCT00030485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110191972|NCT00030485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110191973|NCT00030485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110191974|NCT00030485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110191976|NCT00057720|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110191977|NCT00057720|Topotecan|topotecan|mesh-list
110191978|NCT00057720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110191979|NCT00057720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110191980|NCT00057720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110191981|NCT00057720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110191982|NCT00057720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110191983|NCT00057720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110191984|NCT00057720|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110191985|NCT00030524|Gefitinib|gefitinib|mesh-list
110191986|NCT00030524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110191987|NCT00030524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110191988|NCT00030524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110191989|NCT00030524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110191990|NCT00030563|Irinotecan|irinotecan|mesh-list
110191991|NCT00030563|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110191992|NCT00030563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110304928|NCT00257465|Vaccines|vaccines|mesh-list
110191993|NCT00030563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110191994|NCT00030563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110191995|NCT00030563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110191996|NCT00030602|Freund's Adjuvant|freund's adjuvant|mesh-list
110191997|NCT00030602|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110191998|NCT00030602|Immunologic Factors|immunologic factors|mesh-ancestor
110191999|NCT00030602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110192000|NCT00057759|Sildenafil Citrate|sildenafil citrate|mesh-list
110192001|NCT00057759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110192002|NCT00057759|Vasodilator Agents|vasodilator agents|mesh-ancestor
110192003|NCT00057759|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110192004|NCT00057759|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110192005|NCT00057759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110192006|NCT00057759|Urological Agents|urological agents|mesh-ancestor
110192008|NCT00030641|Oblimersen|oblimersen|mesh-list
110192009|NCT00030641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110192010|NCT00030641|Tubulin Modulators|tubulin modulators|mesh-ancestor
110192011|NCT00030641|Antimitotic Agents|antimitotic agents|mesh-ancestor
110192012|NCT00030641|Mitosis Modulators|mitosis modulators|mesh-ancestor
110192013|NCT00030641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110192014|NCT00057798|Gemcitabine|gemcitabine|mesh-list
110192015|NCT00057798|Vinorelbine|vinorelbine|mesh-list
110192016|NCT00057798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110192017|NCT00057798|Antimetabolites|antimetabolites|mesh-ancestor
110192018|NCT00057798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110284287|NCT00227682|Vitamins|vitamins|mesh-ancestor
110192019|NCT00057798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110192020|NCT00057798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110192021|NCT00057798|Tubulin Modulators|tubulin modulators|mesh-ancestor
110192022|NCT00057798|Antimitotic Agents|antimitotic agents|mesh-ancestor
110192023|NCT00057798|Mitosis Modulators|mitosis modulators|mesh-ancestor
110192024|NCT02969733|Lidocaine|lidocaine|mesh-list
110192025|NCT02969733|Ketamine|ketamine|mesh-list
110192026|NCT02969733|Analgesics|analgesics|mesh-ancestor
110192027|NCT02969733|Sensory System Agents|sensory system agents|mesh-ancestor
110192028|NCT02969733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110192029|NCT02969733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110192030|NCT02969733|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110192031|NCT02969733|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110192032|NCT02969733|Anesthetics, General|anesthetics, general|mesh-ancestor
110192033|NCT02969733|Anesthetics|anesthetics|mesh-ancestor
110192034|NCT02969733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110192035|NCT02969733|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110192036|NCT02969733|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110192037|NCT02969733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110284293|NCT00230763|Adrenergic Agents|adrenergic agents|mesh-ancestor
110192038|NCT02969733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110192039|NCT02969733|Anesthetics, Local|anesthetics, local|mesh-ancestor
110192040|NCT02969733|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110057454|NCT01507428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110192041|NCT02969733|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110192042|NCT02969733|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110192043|NCT02969733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110192044|NCT00030719|Cyclophosphamide|cyclophosphamide|mesh-list
110192045|NCT00030719|Melphalan|melphalan|mesh-list
110192046|NCT00030719|Busulfan|busulfan|mesh-list
110192047|NCT00030719|Carboplatin|carboplatin|mesh-list
110192048|NCT00030719|Etoposide|etoposide|mesh-list
110192049|NCT00030719|Vincristine|vincristine|mesh-list
110192050|NCT00030719|Dinutuximab|dinutuximab|mesh-list
110192051|NCT00030719|Isotretinoin|isotretinoin|mesh-list
110192052|NCT00030719|Antibodies|antibodies|mesh-list
110192053|NCT00030719|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110192054|NCT00030719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110192055|NCT00030719|Immunologic Factors|immunologic factors|mesh-ancestor
110192056|NCT00030719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110192057|NCT00030719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110192058|NCT00030719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110192059|NCT00030719|Alkylating Agents|alkylating agents|mesh-ancestor
110192060|NCT00030719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110218899|NCT00281983|Antimetabolites|antimetabolites|mesh-ancestor
110192061|NCT00030719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110192062|NCT00030719|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110192063|NCT00030719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110192064|NCT00030719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110192065|NCT00030719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110192066|NCT00030719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110192067|NCT00030719|Tubulin Modulators|tubulin modulators|mesh-ancestor
110192068|NCT00030719|Antimitotic Agents|antimitotic agents|mesh-ancestor
110192069|NCT00030719|Mitosis Modulators|mitosis modulators|mesh-ancestor
110192070|NCT00030719|Dermatologic Agents|dermatologic agents|mesh-ancestor
110192071|NCT00030758|Lenograstim|lenograstim|mesh-list
110192072|NCT00030758|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110192073|NCT00030758|Immunologic Factors|immunologic factors|mesh-ancestor
110192074|NCT00030758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110192075|NCT04730895|Tretinoin|tretinoin|mesh-list
110192076|NCT04730895|Isotretinoin|isotretinoin|mesh-list
110192077|NCT04730895|Vaccines|vaccines|mesh-list
110192078|NCT04730895|Myeloma Proteins|myeloma proteins|mesh-list
110192079|NCT04730895|Paraproteins|paraproteins|mesh-list
110192080|NCT04730895|Immunologic Factors|immunologic factors|mesh-ancestor
110192081|NCT04730895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110192082|NCT04730895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110192083|NCT04730895|Keratolytic Agents|keratolytic agents|mesh-ancestor
110192084|NCT04730895|Dermatologic Agents|dermatologic agents|mesh-ancestor
110192086|NCT00030797|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110192087|NCT00030797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110192088|NCT00030797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110192089|NCT00030797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110192090|NCT00030797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110192092|NCT00058071|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110192093|NCT00058071|Protective Agents|protective agents|mesh-ancestor
110192094|NCT00058071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110192095|NCT00030914|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110192096|NCT00030914|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110192097|NCT00030914|Medroxyprogesterone|medroxyprogesterone|mesh-list
110192098|NCT00030914|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110192099|NCT00030914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110192100|NCT00030914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110192101|NCT00030914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110192102|NCT00030914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110192103|NCT00030914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110192104|NCT00030914|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110192105|NCT00030914|Antidepressive Agents|antidepressive agents|mesh-ancestor
110192106|NCT00030914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110192107|NCT00030914|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110192108|NCT00030914|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110192109|NCT00030914|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110192110|NCT00030914|Contraceptive Agents|contraceptive agents|mesh-ancestor
110192111|NCT00030914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110192112|NCT00030914|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110057528|NCT01507701|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110192113|NCT00030914|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110192114|NCT00030914|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110192115|NCT00030914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110192116|NCT00030914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110192117|NCT00058149|Gemcitabine|gemcitabine|mesh-list
110192118|NCT00058149|Oxaliplatin|oxaliplatin|mesh-list
110192119|NCT00058149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110192120|NCT00058149|Antimetabolites|antimetabolites|mesh-ancestor
110192121|NCT00058149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110192122|NCT00058149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110192124|NCT00058227|Fludarabine|fludarabine|mesh-list
110192125|NCT00058227|Fludarabine phosphate|fludarabine phosphate|mesh-list
110192126|NCT00058227|Alvocidib|alvocidib|mesh-list
110192127|NCT00058227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110192128|NCT00058227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110192129|NCT00058227|Immunologic Factors|immunologic factors|mesh-ancestor
110192130|NCT00058227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110192131|NCT00058227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110192132|NCT00058227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110192134|NCT00058227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110192135|NCT00058227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110192136|NCT00058227|Growth Inhibitors|growth inhibitors|mesh-ancestor
110192137|NCT00058227|Growth Substances|growth substances|mesh-ancestor
110192138|NCT00058227|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110192139|NCT00058227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110192140|NCT00031070|Cyclosporine|cyclosporine|mesh-list
110192141|NCT00031070|Lamivudine|lamivudine|mesh-list
110192142|NCT00031070|Zidovudine|zidovudine|mesh-list
110192143|NCT00031070|Efavirenz|efavirenz|mesh-list
110192144|NCT00031070|Abacavir|abacavir|mesh-list
110192145|NCT00031070|Vaccines|vaccines|mesh-list
110192146|NCT00031070|Cyclosporins|cyclosporins|mesh-list
110192147|NCT00031070|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110192148|NCT00031070|Immunologic Factors|immunologic factors|mesh-ancestor
110192149|NCT00031070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110192150|NCT00031070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110192151|NCT00031070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110192152|NCT00031070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110192153|NCT00031070|Antifungal Agents|antifungal agents|mesh-ancestor
110192154|NCT00031070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110192155|NCT00031070|Dermatologic Agents|dermatologic agents|mesh-ancestor
110192156|NCT00031070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110192157|NCT00031070|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110192158|NCT00031070|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110192159|NCT00031070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110192161|NCT00031070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110192162|NCT00031070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110192163|NCT00031070|Antimetabolites|antimetabolites|mesh-ancestor
110192164|NCT00031070|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110192165|NCT00031070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110192166|NCT00031070|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110192167|NCT00031070|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110192168|NCT00031070|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110192169|NCT00031070|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110192170|NCT00058305|Vincristine|vincristine|mesh-list
110192171|NCT00058305|Bryostatin 1|bryostatin 1|mesh-list
110192172|NCT00058305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110284361|NCT00204503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110192174|NCT00058305|Tubulin Modulators|tubulin modulators|mesh-ancestor
110192175|NCT00058305|Antimitotic Agents|antimitotic agents|mesh-ancestor
110192176|NCT00058305|Mitosis Modulators|mitosis modulators|mesh-ancestor
110192177|NCT00058305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110192178|NCT00058305|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110192179|NCT00058305|Immunologic Factors|immunologic factors|mesh-ancestor
110192180|NCT00058305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110192181|NCT00058461|Cytarabine|cytarabine|mesh-list
110192182|NCT00058461|Rituximab|rituximab|mesh-list
110192183|NCT00058461|Carboplatin|carboplatin|mesh-list
110192184|NCT00058461|Methotrexate|methotrexate|mesh-list
110192185|NCT00058461|Etoposide|etoposide|mesh-list
110192186|NCT00058461|Ifosfamide|ifosfamide|mesh-list
110192187|NCT00058461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110192188|NCT00058461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110192189|NCT00058461|Immunologic Factors|immunologic factors|mesh-ancestor
110192190|NCT00058461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110192191|NCT00058461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110192192|NCT00058461|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110192193|NCT00058461|Abortifacient Agents|abortifacient agents|mesh-ancestor
110192194|NCT00058461|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110192195|NCT00058461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110192196|NCT00058461|Antimetabolites|antimetabolites|mesh-ancestor
110192197|NCT00058461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110305339|NCT00258050|Anesthetics, General|anesthetics, general|mesh-ancestor
110192198|NCT00058461|Dermatologic Agents|dermatologic agents|mesh-ancestor
110192199|NCT00058461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110192200|NCT00058461|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110192201|NCT00058461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110192202|NCT00058461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110192203|NCT00058461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110192204|NCT00058461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110192205|NCT00058461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110192206|NCT00058461|Antiviral Agents|antiviral agents|mesh-ancestor
110192207|NCT00058461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110057665|NCT01508364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110192208|NCT00058461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110192210|NCT00058578|Cyclophosphamide|cyclophosphamide|mesh-list
110192211|NCT00058578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110057709|NCT01508494|Autonomic Agents|autonomic agents|mesh-ancestor
110192212|NCT00058578|Immunologic Factors|immunologic factors|mesh-ancestor
110192213|NCT00058578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110192214|NCT00058578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110192215|NCT00058578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110192216|NCT00058578|Alkylating Agents|alkylating agents|mesh-ancestor
110192217|NCT00058578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110192218|NCT00058578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110192219|NCT00058578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110192220|NCT04711889|Urinastatin|urinastatin|mesh-list
110192222|NCT04711889|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110192223|NCT04711889|Protease Inhibitors|protease inhibitors|mesh-ancestor
110192224|NCT04711889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110192225|NCT04711889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110192226|NCT00031109|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110192227|NCT00031109|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110192228|NCT00031109|Immunologic Factors|immunologic factors|mesh-ancestor
110192229|NCT00031109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110192230|NCT00031109|Antacids|antacids|mesh-ancestor
110192231|NCT00031109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110192232|NCT00031109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110192233|NCT00031148|Mitogens|mitogens|mesh-list
110192234|NCT00031148|Mitosis Modulators|mitosis modulators|mesh-ancestor
110192235|NCT00031148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110192236|NCT00031187|Docetaxel|docetaxel|mesh-list
110192237|NCT00031187|Doxorubicin|doxorubicin|mesh-list
110192238|NCT00031187|Immunoconjugates|immunoconjugates|mesh-list
110192239|NCT00031187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110192240|NCT00031187|Tubulin Modulators|tubulin modulators|mesh-ancestor
110192241|NCT00031187|Antimitotic Agents|antimitotic agents|mesh-ancestor
110192242|NCT00031187|Mitosis Modulators|mitosis modulators|mesh-ancestor
110192243|NCT00031187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110192244|NCT00031187|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110192245|NCT00031187|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110192246|NCT00031187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110192247|NCT00031187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110192248|NCT00031187|Immunologic Factors|immunologic factors|mesh-ancestor
110305408|NCT00258245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110192249|NCT00031187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110192250|NCT00031343|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110192251|NCT00031343|Antiviral Agents|antiviral agents|mesh-ancestor
110192252|NCT00031343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110192254|NCT00058890|Analgesics|analgesics|mesh-ancestor
110192255|NCT00058890|Sensory System Agents|sensory system agents|mesh-ancestor
110192256|NCT00058890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110192257|NCT00058890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110192258|NCT00058890|Anticonvulsants|anticonvulsants|mesh-ancestor
110192259|NCT00058890|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110192260|NCT00058890|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110192261|NCT00058890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110192262|NCT00058890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110192263|NCT00058890|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110192264|NCT00058890|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110192265|NCT00058890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110192266|NCT00058890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110192267|NCT00058890|Antimanic Agents|antimanic agents|mesh-ancestor
110192269|NCT00058929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110192270|NCT00396071|Vildagliptin|vildagliptin|mesh-list
110192271|NCT00396071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110058100|NCT01511029|Dopamine Agonists|dopamine agonists|mesh-ancestor
110192272|NCT00396071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110192273|NCT00396071|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110192274|NCT00396071|Protease Inhibitors|protease inhibitors|mesh-ancestor
110192275|NCT00396071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110192276|NCT00396071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110192277|NCT00058968|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110192278|NCT00058968|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110192279|NCT00058968|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110192280|NCT00058968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110192281|NCT00058968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110192282|NCT00058968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110192283|NCT00058968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110192285|NCT00058968|Sensory System Agents|sensory system agents|mesh-ancestor
110192286|NCT00058968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110192287|NCT00058968|Antidepressive Agents|antidepressive agents|mesh-ancestor
110192288|NCT00058968|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110192289|NCT00058968|Dopamine Agents|dopamine agents|mesh-ancestor
110192290|NCT00396227|Pioglitazone|pioglitazone|mesh-list
110192291|NCT00396227|Rosiglitazone|rosiglitazone|mesh-list
110192292|NCT00396227|Vildagliptin|vildagliptin|mesh-list
110192293|NCT00396227|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
110192294|NCT00396227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110192295|NCT00396227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110192296|NCT00396227|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110192297|NCT00396227|Protease Inhibitors|protease inhibitors|mesh-ancestor
110192298|NCT00396227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110192299|NCT00396227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110192300|NCT00396344|Hydrocortisone|hydrocortisone|mesh-list
110192301|NCT00396344|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110192302|NCT00396344|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110192303|NCT00396344|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110192305|NCT00031499|Azithromycin|azithromycin|mesh-list
110192306|NCT00031499|Doxycycline|doxycycline|mesh-list
110192307|NCT00031499|Penicillins|penicillins|mesh-list
110192308|NCT00031499|Penicillin G Benzathine|penicillin g benzathine|mesh-list
110192309|NCT00031499|Penicillin G|penicillin g|mesh-list
110192310|NCT00031499|Penicillin G Procaine|penicillin g procaine|mesh-list
110192311|NCT00031499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110192312|NCT00031499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110192313|NCT00031499|Antimalarials|antimalarials|mesh-ancestor
110192314|NCT00031499|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110192315|NCT00031499|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110192316|NCT00059358|Interferons|interferons|mesh-list
110192318|NCT00059358|Interferon-alpha|interferon-alpha|mesh-list
110192319|NCT00059358|Interferon alpha-2|interferon alpha-2|mesh-list
110192320|NCT00059358|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110192321|NCT00059358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110192322|NCT00059358|Antiviral Agents|antiviral agents|mesh-ancestor
110192323|NCT00059358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110192324|NCT00059358|Antimetabolites|antimetabolites|mesh-ancestor
110192325|NCT00059358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110192326|NCT00059358|Immunologic Factors|immunologic factors|mesh-ancestor
110192327|NCT00059358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110192328|NCT00031577|Paclitaxel|paclitaxel|mesh-list
110192329|NCT00031577|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110192330|NCT00031577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110192331|NCT00031577|Tubulin Modulators|tubulin modulators|mesh-ancestor
110192332|NCT00031577|Antimitotic Agents|antimitotic agents|mesh-ancestor
110192333|NCT00031577|Mitosis Modulators|mitosis modulators|mesh-ancestor
110192334|NCT00031577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110192335|NCT00031616|Brivudine|brivudine|mesh-list
110192336|NCT00031616|Phosphoramidic acid|phosphoramidic acid|mesh-list
110192337|NCT00031616|Antiviral Agents|antiviral agents|mesh-ancestor
110192338|NCT00031616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110192339|NCT00031616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110192340|NCT00031616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110192341|NCT02969304|Dimethyl Fumarate|dimethyl fumarate|mesh-list
110192342|NCT02969304|Dermatologic Agents|dermatologic agents|mesh-ancestor
110192343|NCT02969304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110192344|NCT02969304|Immunologic Factors|immunologic factors|mesh-ancestor
110192345|NCT02969304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110192346|NCT00031655|Cyclosporine|cyclosporine|mesh-list
110192347|NCT00031655|Mycophenolic Acid|mycophenolic acid|mesh-list
110192348|NCT00031655|Fludarabine|fludarabine|mesh-list
110192349|NCT00031655|Fludarabine phosphate|fludarabine phosphate|mesh-list
110192350|NCT00031655|Cyclosporins|cyclosporins|mesh-list
110192351|NCT00031655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110192352|NCT00031655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110192353|NCT00031655|Antimetabolites|antimetabolites|mesh-ancestor
110192354|NCT00031655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110192355|NCT00031655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110192356|NCT00031655|Immunologic Factors|immunologic factors|mesh-ancestor
110192357|NCT00031655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110192358|NCT00031655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110192359|NCT00031655|Antifungal Agents|antifungal agents|mesh-ancestor
110192360|NCT00031655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110192361|NCT00031655|Dermatologic Agents|dermatologic agents|mesh-ancestor
110192362|NCT00031655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110192363|NCT00031655|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110192364|NCT00031655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110192365|NCT00031655|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110192366|NCT00031655|Antitubercular Agents|antitubercular agents|mesh-ancestor
110192367|NCT00031655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110192368|NCT00059592|Valacyclovir|valacyclovir|mesh-list
110192369|NCT00059592|Antiviral Agents|antiviral agents|mesh-ancestor
110218965|NCT00282217|Sirolimus|sirolimus|mesh-list
110192370|NCT00059592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110192371|NCT00031733|Interleukin-12|interleukin-12|mesh-list
110192372|NCT00031733|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110192373|NCT00031733|Sargramostim|sargramostim|mesh-list
110192374|NCT00031733|Freund's Adjuvant|freund's adjuvant|mesh-list
110192375|NCT00031733|Aluminum sulfate|aluminum sulfate|mesh-list
110192376|NCT00031733|Immunologic Factors|immunologic factors|mesh-ancestor
110192377|NCT00031733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110192378|NCT00031733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110192379|NCT00031733|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110192380|NCT00031733|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110192381|NCT00031733|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110192382|NCT00031733|Growth Substances|growth substances|mesh-ancestor
110192383|NCT00031733|Growth Inhibitors|growth inhibitors|mesh-ancestor
110192384|NCT00031733|Antacids|antacids|mesh-ancestor
110192385|NCT00031733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110192386|NCT00031733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110192387|NCT02969265|Amlodipine|amlodipine|mesh-list
110192388|NCT02969265|Candesartan cilexetil|candesartan cilexetil|mesh-list
110192389|NCT02969265|Candesartan|candesartan|mesh-list
110192390|NCT02969265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110192391|NCT02969265|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110192392|NCT02969265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110192393|NCT02969265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110284501|NCT00231387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110192394|NCT02969265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110192395|NCT02969265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110192396|NCT02969265|Vasodilator Agents|vasodilator agents|mesh-ancestor
110192397|NCT02969265|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110192398|NCT02969265|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110192399|NCT00031811|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
110192400|NCT00031811|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110192401|NCT00031811|Hormone Antagonists|hormone antagonists|mesh-ancestor
110192402|NCT00031811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110192403|NCT00031811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110192404|NCT00031811|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110058280|NCT01511705|Antipruritics|antipruritics|mesh-ancestor
110192405|NCT00031811|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110192406|NCT00031811|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110192407|NCT00031850|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
110192408|NCT00031850|Goserelin|goserelin|mesh-list
110284545|NCT00198614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110192409|NCT00031850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110192410|NCT00031850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110192411|NCT00031850|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110192412|NCT00031850|Hormone Antagonists|hormone antagonists|mesh-ancestor
110192413|NCT00031850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110192414|NCT00031850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110192415|NCT00031850|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110192416|NCT00031850|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110192417|NCT00031850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110192418|NCT00059631|Bortezomib|bortezomib|mesh-list
110192419|NCT00059631|Mitoxantrone|mitoxantrone|mesh-list
110192420|NCT00059631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110192421|NCT00059631|Analgesics|analgesics|mesh-ancestor
110192422|NCT00059631|Sensory System Agents|sensory system agents|mesh-ancestor
110192423|NCT00059631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110192424|NCT00059631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110192425|NCT00059631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110192426|NCT00059631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110192427|NCT00059631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110192428|NCT00059631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110192429|NCT00031889|Exemestane|exemestane|mesh-list
110192430|NCT00031889|Bicalutamide|bicalutamide|mesh-list
110192431|NCT00031889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110192432|NCT00031889|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110218974|NCT00282451|Insulin|insulin|mesh-list
110192433|NCT00031889|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110192434|NCT00031889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110192435|NCT00031889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110192436|NCT00031889|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110192437|NCT00031889|Hormone Antagonists|hormone antagonists|mesh-ancestor
110305552|NCT04709315|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110192438|NCT00031889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110192439|NCT00031889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110192440|NCT00031889|Androgen Antagonists|androgen antagonists|mesh-ancestor
110192442|NCT00031928|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110192443|NCT00031928|Immunologic Factors|immunologic factors|mesh-ancestor
110192444|NCT00031928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110192445|NCT00031928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110192446|NCT00031967|Melatonin|melatonin|mesh-list
110192447|NCT00031967|Antioxidants|antioxidants|mesh-ancestor
110192448|NCT00031967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110192449|NCT00031967|Protective Agents|protective agents|mesh-ancestor
110192450|NCT00031967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110192451|NCT00031967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110192452|NCT00059826|Interferons|interferons|mesh-list
110192453|NCT00059826|Interferon-alpha|interferon-alpha|mesh-list
110192454|NCT00059826|Interferon alpha-2|interferon alpha-2|mesh-list
110192455|NCT00059826|Fluorouracil|fluorouracil|mesh-list
110192456|NCT00059826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110192457|NCT00059826|Antimetabolites|antimetabolites|mesh-ancestor
110192458|NCT00059826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110305599|NCT00258791|Ibuprofen|ibuprofen|mesh-list
110192459|NCT00059826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110192460|NCT00059826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110192462|NCT00059826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110192463|NCT00059826|Antiviral Agents|antiviral agents|mesh-ancestor
110192464|NCT00059826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110192465|NCT00032045|Ipilimumab|ipilimumab|mesh-list
110192466|NCT00032045|Freund's Adjuvant|freund's adjuvant|mesh-list
110192467|NCT00032045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110192468|NCT00032045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110192469|NCT00032045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110192470|NCT00032045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110192471|NCT00032045|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110192472|NCT00032045|Immunologic Factors|immunologic factors|mesh-ancestor
110192473|NCT00032045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110192474|NCT00059865|Gemcitabine|gemcitabine|mesh-list
110192475|NCT00059865|Pemetrexed|pemetrexed|mesh-list
110192476|NCT00059865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110192477|NCT00059865|Antimetabolites|antimetabolites|mesh-ancestor
110192478|NCT00059865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110192479|NCT00059865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110192480|NCT00059865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110192481|NCT00059865|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110192482|NCT00059865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110192483|NCT00032084|Bupropion|bupropion|mesh-list
110192485|NCT00032084|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110192486|NCT00032084|Autonomic Agents|autonomic agents|mesh-ancestor
110192487|NCT00032084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110192488|NCT00032084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110192489|NCT00032084|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110192490|NCT00032084|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110192491|NCT00032084|Cholinergic Agents|cholinergic agents|mesh-ancestor
110192492|NCT00032084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110192493|NCT00032084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110192494|NCT00032084|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110192495|NCT00032084|Antidepressive Agents|antidepressive agents|mesh-ancestor
110192496|NCT00032084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110192497|NCT00032084|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110192498|NCT00032084|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110192499|NCT00032084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110284669|NCT00199004|Antiviral Agents|antiviral agents|mesh-ancestor
110192500|NCT00032084|Dopamine Agents|dopamine agents|mesh-ancestor
110192501|NCT00032084|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110192502|NCT00032084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110192503|NCT00032084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110192504|NCT00059904|Aldesleukin|aldesleukin|mesh-list
110192505|NCT00059904|Rituximab|rituximab|mesh-list
110192506|NCT00059904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110192507|NCT00059904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110192508|NCT00059904|Immunologic Factors|immunologic factors|mesh-ancestor
110192509|NCT00059904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110192510|NCT00059904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110058482|NCT01512485|Clopidogrel|clopidogrel|mesh-list
110192511|NCT00059904|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110192512|NCT00059904|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110192513|NCT00059904|Antiviral Agents|antiviral agents|mesh-ancestor
110192514|NCT00059904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110192515|NCT00032123|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110192516|NCT00032123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110192517|NCT00032123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110192518|NCT00032123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110192519|NCT00032123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110192520|NCT00059943|Docetaxel|docetaxel|mesh-list
110192521|NCT00059943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110192522|NCT00059943|Tubulin Modulators|tubulin modulators|mesh-ancestor
110192523|NCT00059943|Antimitotic Agents|antimitotic agents|mesh-ancestor
110192524|NCT00059943|Mitosis Modulators|mitosis modulators|mesh-ancestor
110192525|NCT00059943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110192526|NCT00032162|Carboplatin|carboplatin|mesh-list
110192527|NCT00032162|Doxorubicin|doxorubicin|mesh-list
110192528|NCT00032162|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110192529|NCT00032162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110192530|NCT00032162|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110192531|NCT00032162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110192532|NCT00032162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110192533|NCT00032162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110192534|NCT00032162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110192535|NCT00032279|Visilizumab|visilizumab|mesh-list
110192536|NCT00032279|Immunologic Factors|immunologic factors|mesh-ancestor
110192537|NCT00032279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110192538|NCT00060138|Zoledronic Acid|zoledronic acid|mesh-list
110192539|NCT00060138|Antibodies|antibodies|mesh-list
110192540|NCT00060138|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110192541|NCT00060138|Immunologic Factors|immunologic factors|mesh-ancestor
110192542|NCT00060138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284691|NCT00204776|Antimetabolites|antimetabolites|mesh-ancestor
110192543|NCT00060138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110192545|NCT00032396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110192547|NCT00032396|Hormones|hormones|mesh-ancestor
110192548|NCT00032396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110192549|NCT00032396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110192550|NCT00060255|Cyclophosphamide|cyclophosphamide|mesh-list
110192551|NCT00060255|Melphalan|melphalan|mesh-list
110192552|NCT00060255|Busulfan|busulfan|mesh-list
110192553|NCT00060255|Thiotepa|thiotepa|mesh-list
110192554|NCT00060255|Carmustine|carmustine|mesh-list
110192555|NCT00060255|Carboplatin|carboplatin|mesh-list
110192556|NCT00060255|Etoposide|etoposide|mesh-list
110192557|NCT00060255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110192558|NCT00060255|Immunologic Factors|immunologic factors|mesh-ancestor
110192559|NCT00060255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110192560|NCT00060255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110192561|NCT00060255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110192562|NCT00060255|Alkylating Agents|alkylating agents|mesh-ancestor
110192563|NCT00060255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110192564|NCT00060255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110192565|NCT00060255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110192566|NCT00060255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110192567|NCT00060255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110192568|NCT00060255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110192569|NCT00060255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110192570|NCT00060294|Rituximab|rituximab|mesh-list
110192571|NCT00060294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110192572|NCT00060294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110192573|NCT00060294|Immunologic Factors|immunologic factors|mesh-ancestor
110192574|NCT00060294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110192575|NCT00060294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110192576|NCT00060372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110192577|NCT00060372|Ipilimumab|ipilimumab|mesh-list
110192578|NCT00060372|Antibodies|antibodies|mesh-list
110192579|NCT00060372|Immunoglobulins|immunoglobulins|mesh-list
110192580|NCT00060372|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110192581|NCT00060372|Immunologic Factors|immunologic factors|mesh-ancestor
110192582|NCT00060372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110192583|NCT00060372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110192584|NCT00060372|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110192585|NCT00060372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110192586|NCT00060411|Leucovorin|leucovorin|mesh-list
110192587|NCT00060411|Bevacizumab|bevacizumab|mesh-list
110192588|NCT00060411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110192590|NCT00060411|Oxaliplatin|oxaliplatin|mesh-list
110192591|NCT00060411|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110192592|NCT00060411|Antibodies|antibodies|mesh-list
110192593|NCT00060411|Immunoglobulins|immunoglobulins|mesh-list
110192594|NCT00060411|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110192595|NCT00060411|Levoleucovorin|levoleucovorin|mesh-list
110192596|NCT00060411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110192597|NCT00060411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110192598|NCT00060411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110192599|NCT00060411|Growth Substances|growth substances|mesh-ancestor
110192600|NCT00060411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110192601|NCT00060411|Growth Inhibitors|growth inhibitors|mesh-ancestor
110192602|NCT00060411|Immunologic Factors|immunologic factors|mesh-ancestor
110058659|NCT01513603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110192604|NCT00060411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110192605|NCT00060411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110284735|NCT00477412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110192606|NCT00060411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110192607|NCT00060411|Antidotes|antidotes|mesh-ancestor
110192608|NCT00060411|Protective Agents|protective agents|mesh-ancestor
110192609|NCT00060411|Vitamin B Complex|vitamin b complex|mesh-ancestor
110192610|NCT00060411|Vitamins|vitamins|mesh-ancestor
110192611|NCT00060411|Micronutrients|micronutrients|mesh-ancestor
110192612|NCT00060411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110192613|NCT00060411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110192614|NCT00060450|Nitric Oxide|nitric oxide|mesh-list
110192615|NCT00060450|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110192616|NCT00060450|Autonomic Agents|autonomic agents|mesh-ancestor
110192617|NCT00060450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110192618|NCT00060450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110192619|NCT00060450|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110305938|NCT00260351|Vaccines|vaccines|mesh-list
110192620|NCT00060450|Respiratory System Agents|respiratory system agents|mesh-ancestor
110058727|NCT01513941|Ribavirin|ribavirin|mesh-list
110192622|NCT00060450|Antioxidants|antioxidants|mesh-ancestor
110219009|NCT00282997|Analgesics|analgesics|mesh-ancestor
110192623|NCT00060450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110192624|NCT00060450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110192625|NCT00060450|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110192626|NCT00060450|Vasodilator Agents|vasodilator agents|mesh-ancestor
110192627|NCT00060450|Gasotransmitters|gasotransmitters|mesh-ancestor
110192628|NCT00060450|Protective Agents|protective agents|mesh-ancestor
110192629|NCT00032747|Vasopressins|vasopressins|mesh-list
110192630|NCT00032747|Arginine Vasopressin|arginine vasopressin|mesh-list
110192632|NCT00032747|Coagulants|coagulants|mesh-ancestor
110192633|NCT00032747|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110192634|NCT00032747|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110192635|NCT00032747|Natriuretic Agents|natriuretic agents|mesh-ancestor
110192636|NCT00032747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110192637|NCT00032786|Natalizumab|natalizumab|mesh-list
110192638|NCT00032786|Immunologic Factors|immunologic factors|mesh-ancestor
110192639|NCT00032786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110192640|NCT02968719|Donepezil|donepezil|mesh-list
110192641|NCT02968719|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110192642|NCT02968719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110192643|NCT02968719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110192644|NCT02968719|Cholinergic Agents|cholinergic agents|mesh-ancestor
110192645|NCT02968719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110192646|NCT02968719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110192647|NCT02968719|Nootropic Agents|nootropic agents|mesh-ancestor
110192648|NCT00060489|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110284784|NCT00204893|Calcium|calcium|mesh-list
110192649|NCT00060489|Antidepressive Agents|antidepressive agents|mesh-ancestor
110192651|NCT00060489|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110192652|NCT00060489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110192653|NCT00060489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110192654|NCT00060489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110192655|NCT00032825|Ketoconazole|ketoconazole|mesh-list
110192656|NCT00032825|Docetaxel|docetaxel|mesh-list
110192657|NCT00032825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110192658|NCT00032825|Tubulin Modulators|tubulin modulators|mesh-ancestor
110192659|NCT00032825|Antimitotic Agents|antimitotic agents|mesh-ancestor
110192660|NCT00032825|Mitosis Modulators|mitosis modulators|mesh-ancestor
110192661|NCT00032825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110192662|NCT00032825|Antifungal Agents|antifungal agents|mesh-ancestor
110192663|NCT00032825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110192664|NCT00032825|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110192665|NCT00032825|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110192666|NCT00032825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110192667|NCT00032825|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110192668|NCT00032825|Hormone Antagonists|hormone antagonists|mesh-ancestor
110192669|NCT00032825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110192670|NCT00032825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110192671|NCT00032825|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110192672|NCT00060645|Sirolimus|sirolimus|mesh-list
110192673|NCT00060645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110192674|NCT00060645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110192675|NCT00060645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110192676|NCT00060645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110192677|NCT00060645|Antifungal Agents|antifungal agents|mesh-ancestor
110192678|NCT00060645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110192679|NCT00060645|Immunologic Factors|immunologic factors|mesh-ancestor
110192680|NCT00060645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110192681|NCT00060684|Dexamethasone|dexamethasone|mesh-list
110192682|NCT00060684|Rituximab|rituximab|mesh-list
110192683|NCT00060684|Fludarabine|fludarabine|mesh-list
110192684|NCT00060684|Pixantrone|pixantrone|mesh-list
110192685|NCT00060684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110192686|NCT00060684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110192687|NCT00060684|Immunologic Factors|immunologic factors|mesh-ancestor
110192688|NCT00060684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110192689|NCT00060684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110192690|NCT00060684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110192691|NCT00060684|Antiemetics|antiemetics|mesh-ancestor
110192692|NCT00060684|Autonomic Agents|autonomic agents|mesh-ancestor
110192693|NCT00060684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110192694|NCT00060684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110192696|NCT00060684|Hormones|hormones|mesh-ancestor
110192697|NCT00060684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110192698|NCT00060684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110192699|NCT00060684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110059048|NCT01515826|BB 1101|bb 1101|mesh-list
110192700|NCT00060684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110192701|NCT00060684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110192702|NCT00060684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110192703|NCT02971475|Analgesics|analgesics|mesh-list
110192704|NCT02971475|Sensory System Agents|sensory system agents|mesh-ancestor
110192705|NCT02971475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110192706|NCT02971475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110192707|NCT00032942|Lofexidine|lofexidine|mesh-list
110192708|NCT00032942|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110192709|NCT00032942|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110192710|NCT00032942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110192711|NCT00032942|Sensory System Agents|sensory system agents|mesh-ancestor
110192712|NCT00032942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110192713|NCT00032942|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110192714|NCT00032942|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110192715|NCT00032942|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110192716|NCT00032942|Adrenergic Agents|adrenergic agents|mesh-ancestor
110059083|NCT01515839|Vitamins|vitamins|mesh-ancestor
110192717|NCT00032942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110192718|NCT00032942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110192719|NCT00033059|Tolcapone|tolcapone|mesh-list
110192720|NCT00033059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110192721|NCT00033059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110192722|NCT00033059|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
110192723|NCT00033059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110192724|NCT00033059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110192725|NCT00060918|Metoprolol|metoprolol|mesh-list
110192726|NCT00060918|Carvedilol|carvedilol|mesh-list
110192727|NCT00060918|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110192728|NCT00060918|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110192729|NCT00060918|Sympatholytics|sympatholytics|mesh-ancestor
110192730|NCT00060918|Autonomic Agents|autonomic agents|mesh-ancestor
110192731|NCT00060918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110192732|NCT00060918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110192733|NCT00060918|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110192734|NCT00060918|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110192735|NCT00060918|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110192736|NCT00060918|Adrenergic Agents|adrenergic agents|mesh-ancestor
110192737|NCT00060918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110192738|NCT00060918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110192739|NCT00060918|Antioxidants|antioxidants|mesh-ancestor
110192740|NCT00060918|Protective Agents|protective agents|mesh-ancestor
110192741|NCT00060918|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110192742|NCT00060918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110192743|NCT00060918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110192744|NCT00060918|Vasodilator Agents|vasodilator agents|mesh-ancestor
110192745|NCT00060918|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110192746|NCT00060918|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110192747|NCT00033098|Metyrapone|metyrapone|mesh-list
110192748|NCT00033098|Antimetabolites|antimetabolites|mesh-ancestor
110192749|NCT00033098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110192750|NCT00033098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110192752|NCT02968641|Lonafarnib|lonafarnib|mesh-list
110192753|NCT02968641|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110192754|NCT02968641|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110192755|NCT02968641|Protease Inhibitors|protease inhibitors|mesh-ancestor
110192756|NCT02968641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110192757|NCT02968641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110192758|NCT02968641|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110192759|NCT02968641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110192760|NCT02968641|Antiviral Agents|antiviral agents|mesh-ancestor
110192761|NCT02968641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110192762|NCT02968641|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110192763|NCT02968641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110192764|NCT00033176|Thioctic Acid|thioctic acid|mesh-list
110192765|NCT00033176|Antioxidants|antioxidants|mesh-ancestor
110192766|NCT00033176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110192767|NCT00033176|Protective Agents|protective agents|mesh-ancestor
110192768|NCT00033176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110192769|NCT00033176|Vitamin B Complex|vitamin b complex|mesh-ancestor
110192770|NCT00033176|Vitamins|vitamins|mesh-ancestor
110284833|NCT00229125|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110192773|NCT00033215|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
110192774|NCT00033215|Protease Inhibitors|protease inhibitors|mesh-ancestor
110192775|NCT00033215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110192776|NCT00033215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110192777|NCT00060957|Botulinum Toxins|botulinum toxins|mesh-list
110192778|NCT00060957|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110192779|NCT00060957|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110192780|NCT00060957|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110192781|NCT00060957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110192782|NCT00060957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110192783|NCT00060957|Cholinergic Agents|cholinergic agents|mesh-ancestor
110192784|NCT00060957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110192785|NCT00060957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110192786|NCT00060957|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110192787|NCT00060957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110192788|NCT00060996|Treprostinil|treprostinil|mesh-list
110192789|NCT00060996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110192790|NCT00033254|Thalidomide|thalidomide|mesh-list
110192791|NCT00033254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110192792|NCT00033254|Immunologic Factors|immunologic factors|mesh-ancestor
110192793|NCT00033254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110192794|NCT00033254|Leprostatic Agents|leprostatic agents|mesh-ancestor
110192795|NCT00033254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110192796|NCT00033254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110192797|NCT00033254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110192798|NCT00033254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110192799|NCT00033254|Growth Substances|growth substances|mesh-ancestor
110192801|NCT00033254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110192802|NCT00061074|Nicotine|nicotine|mesh-list
110192803|NCT00061074|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110192804|NCT00061074|Autonomic Agents|autonomic agents|mesh-ancestor
110192805|NCT00061074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110192806|NCT00061074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110192807|NCT00061074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110192808|NCT00061074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110192809|NCT00061074|Cholinergic Agents|cholinergic agents|mesh-ancestor
110192810|NCT00061074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110192811|NCT00061074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110192812|NCT00033332|Zoledronic Acid|zoledronic acid|mesh-list
110192813|NCT00033332|Pamidronate|pamidronate|mesh-list
110192814|NCT00033332|Thalidomide|thalidomide|mesh-list
110192815|NCT00033332|Dexamethasone|dexamethasone|mesh-list
110192816|NCT00033332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110192817|NCT00033332|Antiemetics|antiemetics|mesh-ancestor
110192818|NCT00033332|Autonomic Agents|autonomic agents|mesh-ancestor
110192819|NCT00033332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110192820|NCT00033332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110192821|NCT00033332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110192823|NCT00033332|Hormones|hormones|mesh-ancestor
110192824|NCT00033332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110192825|NCT00033332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110192826|NCT00033332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110192827|NCT00033332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110192828|NCT00033332|Immunologic Factors|immunologic factors|mesh-ancestor
110192829|NCT00033332|Leprostatic Agents|leprostatic agents|mesh-ancestor
110192830|NCT00033332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110192831|NCT00033332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110192832|NCT00033332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110192833|NCT00033332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110192834|NCT00033332|Growth Substances|growth substances|mesh-ancestor
110192835|NCT00033332|Growth Inhibitors|growth inhibitors|mesh-ancestor
110192836|NCT00033332|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110192837|NCT00033410|Paclitaxel|paclitaxel|mesh-list
110192838|NCT00033410|Carboplatin|carboplatin|mesh-list
110192839|NCT00033410|Tirapazamine|tirapazamine|mesh-list
110192840|NCT00033410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110192841|NCT00033410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110192842|NCT00033410|Tubulin Modulators|tubulin modulators|mesh-ancestor
110192843|NCT00033410|Antimitotic Agents|antimitotic agents|mesh-ancestor
110192844|NCT00033410|Mitosis Modulators|mitosis modulators|mesh-ancestor
110192845|NCT00033410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110192847|NCT00061113|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110192848|NCT00061113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110192849|NCT00061113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110192850|NCT00061113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110192851|NCT00061113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110192852|NCT00061113|Serotonin Agents|serotonin agents|mesh-ancestor
110192853|NCT00061113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110192854|NCT00061113|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110192855|NCT00061113|Antidepressive Agents|antidepressive agents|mesh-ancestor
110192857|NCT00061113|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110192858|NCT00061113|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110192859|NCT00061113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110192860|NCT00033449|Gefitinib|gefitinib|mesh-list
110192861|NCT00033449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110192862|NCT00033449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110192863|NCT00033449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110192864|NCT00033449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110192865|NCT00061152|Capsaicin|capsaicin|mesh-list
110192866|NCT00061152|Antipruritics|antipruritics|mesh-ancestor
110192867|NCT00061152|Dermatologic Agents|dermatologic agents|mesh-ancestor
110192868|NCT00061152|Sensory System Agents|sensory system agents|mesh-ancestor
110192869|NCT00061152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110192870|NCT00061152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110192872|NCT00033566|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
110192873|NCT00033566|Protease Inhibitors|protease inhibitors|mesh-ancestor
110306292|NCT00298974|Hydrocodone|hydrocodone|mesh-list
110192875|NCT00033566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110192876|NCT00033605|Octreotide|octreotide|mesh-list
110192877|NCT00033605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110192879|NCT00033605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110192880|NCT00033644|Doxorubicin|doxorubicin|mesh-list
110192881|NCT00033644|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110192882|NCT00033644|Mitomycins|mitomycins|mesh-list
110192883|NCT00033644|Mitomycin|mitomycin|mesh-list
110192884|NCT00033644|Dacarbazine|dacarbazine|mesh-list
110192885|NCT00033644|Sargramostim|sargramostim|mesh-list
110192886|NCT00033644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110192887|NCT00033644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110192888|NCT00033644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110192889|NCT00033644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110192890|NCT00033644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110192891|NCT00033644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110192892|NCT00033644|Immunologic Factors|immunologic factors|mesh-ancestor
110192893|NCT00033644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110192894|NCT00033644|Alkylating Agents|alkylating agents|mesh-ancestor
110192895|NCT00033644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110192896|NCT00033644|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110284949|NCT00229476|Serotonin Agents|serotonin agents|mesh-ancestor
110192898|NCT00033683|Cyclophosphamide|cyclophosphamide|mesh-list
110192899|NCT00033683|Docetaxel|docetaxel|mesh-list
110192900|NCT00033683|Fluorouracil|fluorouracil|mesh-list
110192901|NCT00033683|Methotrexate|methotrexate|mesh-list
110192902|NCT00033683|Epirubicin|epirubicin|mesh-list
110192903|NCT00033683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110192904|NCT00033683|Immunologic Factors|immunologic factors|mesh-ancestor
110192905|NCT00033683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110192906|NCT00033683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110192907|NCT00033683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110192908|NCT00033683|Alkylating Agents|alkylating agents|mesh-ancestor
110192909|NCT00033683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110192910|NCT00033683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110192911|NCT00033683|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110192912|NCT00033683|Tubulin Modulators|tubulin modulators|mesh-ancestor
110192913|NCT00033683|Antimitotic Agents|antimitotic agents|mesh-ancestor
110192914|NCT00033683|Mitosis Modulators|mitosis modulators|mesh-ancestor
110192915|NCT00033683|Antimetabolites|antimetabolites|mesh-ancestor
110192916|NCT00033683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110059490|NCT01518062|Hormones|hormones|mesh-ancestor
110192917|NCT00033683|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110192918|NCT00033683|Abortifacient Agents|abortifacient agents|mesh-ancestor
110192919|NCT00033683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110192920|NCT00033683|Dermatologic Agents|dermatologic agents|mesh-ancestor
110192921|NCT00033683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110192922|NCT00033683|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110192923|NCT00033683|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110192924|NCT00033683|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110192925|NCT00033683|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110192926|NCT00033683|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110192927|NCT00033683|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110192928|NCT00033683|Hormone Antagonists|hormone antagonists|mesh-ancestor
110192929|NCT00033683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110192930|NCT00033683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110192931|NCT00033683|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110192932|NCT00033683|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110192933|NCT00033683|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110192934|NCT00061308|Gemcitabine|gemcitabine|mesh-list
110192936|NCT00061308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110192937|NCT00061308|Antimetabolites|antimetabolites|mesh-ancestor
110284991|NCT00206024|Esomeprazole|esomeprazole|mesh-list
110192938|NCT00061308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110192939|NCT00061308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110192940|NCT00061308|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110192941|NCT00061308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110192942|NCT00061308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110192943|NCT00033722|Folic Acid|folic acid|mesh-list
110192944|NCT00033722|Lometrexol|lometrexol|mesh-list
110192945|NCT00033722|Hematinics|hematinics|mesh-ancestor
110192946|NCT00033722|Vitamin B Complex|vitamin b complex|mesh-ancestor
110192947|NCT00033722|Vitamins|vitamins|mesh-ancestor
110192948|NCT00033722|Micronutrients|micronutrients|mesh-ancestor
110192949|NCT00033722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110219045|NCT00283192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110192950|NCT00033722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110192951|NCT00033722|Antimetabolites|antimetabolites|mesh-ancestor
110192952|NCT00033722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110192953|NCT00033722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110192954|NCT00033722|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110192955|NCT00033722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110192956|NCT00061425|Epratuzumab|epratuzumab|mesh-list
110192957|NCT00061425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110192958|NCT00061425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110192959|NCT00061464|Gemcitabine|gemcitabine|mesh-list
110192960|NCT00061464|Pemetrexed|pemetrexed|mesh-list
110192961|NCT00061464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110192962|NCT00061464|Antimetabolites|antimetabolites|mesh-ancestor
110192963|NCT00061464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110192964|NCT00061464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110192965|NCT00061464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110192966|NCT00061464|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110192967|NCT00061464|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110192969|NCT00061503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110192970|NCT00061542|Timolol|timolol|mesh-list
110192971|NCT00061542|Betaxolol|betaxolol|mesh-list
110192972|NCT00061542|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110192973|NCT00061542|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110306474|NCT00262418|Ivermectin|ivermectin|mesh-list
110192974|NCT00061542|Adrenergic Agents|adrenergic agents|mesh-ancestor
110192975|NCT00061542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110192976|NCT00061542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110192977|NCT00061542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110192978|NCT00061542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110192979|NCT00061542|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110192980|NCT00061542|Sympatholytics|sympatholytics|mesh-ancestor
110192981|NCT00061542|Autonomic Agents|autonomic agents|mesh-ancestor
110192982|NCT00061542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110192983|NCT00061542|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110192984|NCT00061620|Tezacitabine|tezacitabine|mesh-list
110192985|NCT00061620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110192986|NCT00061620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110192987|NCT00061620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110192988|NCT00034151|Paclitaxel|paclitaxel|mesh-list
110192989|NCT00034151|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110192990|NCT00034151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110192991|NCT00034151|Tubulin Modulators|tubulin modulators|mesh-ancestor
110192992|NCT00034151|Antimitotic Agents|antimitotic agents|mesh-ancestor
110192993|NCT00034151|Mitosis Modulators|mitosis modulators|mesh-ancestor
110059561|NCT01518231|Anticoagulants|anticoagulants|mesh-ancestor
110192994|NCT00034151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110192995|NCT00034190|Paclitaxel|paclitaxel|mesh-list
110192996|NCT00034190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110192997|NCT00034190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110192998|NCT00034190|Tubulin Modulators|tubulin modulators|mesh-ancestor
110192999|NCT00034190|Antimitotic Agents|antimitotic agents|mesh-ancestor
110193000|NCT00034190|Mitosis Modulators|mitosis modulators|mesh-ancestor
110193001|NCT00034190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193002|NCT00034229|Felbamate|felbamate|mesh-list
110193003|NCT00034229|Anticonvulsants|anticonvulsants|mesh-ancestor
110193004|NCT00034229|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110193005|NCT00034229|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110193006|NCT00034229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110193007|NCT00034229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193008|NCT00034229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110193009|NCT00034307|Sitaxsentan|sitaxsentan|mesh-list
110193010|NCT00034307|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110219062|NCT00417157|Ganirelix|ganirelix|mesh-list
110193011|NCT00034307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193012|NCT00061776|Capsaicin|capsaicin|mesh-list
110193013|NCT00061776|Antipruritics|antipruritics|mesh-ancestor
110193014|NCT00061776|Dermatologic Agents|dermatologic agents|mesh-ancestor
110193015|NCT00061776|Sensory System Agents|sensory system agents|mesh-ancestor
110193016|NCT00061776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110193017|NCT00061776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306555|NCT00262886|Fludarabine phosphate|fludarabine phosphate|mesh-list
110193018|NCT00034346|Paclitaxel|paclitaxel|mesh-list
110193019|NCT00034346|Carboplatin|carboplatin|mesh-list
110193020|NCT00034346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110193021|NCT00034346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110193022|NCT00034346|Tubulin Modulators|tubulin modulators|mesh-ancestor
110193023|NCT00034346|Antimitotic Agents|antimitotic agents|mesh-ancestor
110193024|NCT00034346|Mitosis Modulators|mitosis modulators|mesh-ancestor
110193025|NCT00034346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193026|NCT00034385|Valganciclovir|valganciclovir|mesh-list
110193027|NCT00034385|Antiviral Agents|antiviral agents|mesh-ancestor
110193028|NCT00034385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110193029|NCT00034463|Folic Acid|folic acid|mesh-list
110193030|NCT00034463|Vitamins|vitamins|mesh-ancestor
110193031|NCT00034463|Micronutrients|micronutrients|mesh-ancestor
110193032|NCT00034463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110193033|NCT00034463|Hematinics|hematinics|mesh-ancestor
110193034|NCT00034463|Vitamin B Complex|vitamin b complex|mesh-ancestor
110193035|NCT02971397|Cytarabine|cytarabine|mesh-list
110193036|NCT02971397|Daunorubicin|daunorubicin|mesh-list
110193037|NCT02971397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110193038|NCT02971397|Antimetabolites|antimetabolites|mesh-ancestor
110193039|NCT02971397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193040|NCT02971397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110193041|NCT02971397|Antiviral Agents|antiviral agents|mesh-ancestor
110193042|NCT02971397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110193043|NCT02971397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110193044|NCT02971397|Immunologic Factors|immunologic factors|mesh-ancestor
110193045|NCT02971397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110193046|NCT02971397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110193047|NCT02971397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110193048|NCT02971397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110193049|NCT02971397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110193050|NCT00396500|Vitamin A|vitamin a|mesh-list
110193051|NCT00396500|Albendazole|albendazole|mesh-list
110193052|NCT00396500|Vitamins|vitamins|mesh-ancestor
110193053|NCT00396500|Micronutrients|micronutrients|mesh-ancestor
110193054|NCT00396500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110193055|NCT00396500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193056|NCT00396500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110193057|NCT00396500|Anthelmintics|anthelmintics|mesh-ancestor
110306596|NCT00263198|Vatalanib|vatalanib|mesh-list
110193058|NCT00396500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110193059|NCT00396500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110193060|NCT00396500|Anticestodal Agents|anticestodal agents|mesh-ancestor
110193061|NCT00396500|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110059636|NCT01518712|Metformin|metformin|mesh-list
110193062|NCT00396500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110193063|NCT00396500|Tubulin Modulators|tubulin modulators|mesh-ancestor
110193064|NCT00396500|Antimitotic Agents|antimitotic agents|mesh-ancestor
110193065|NCT00396500|Mitosis Modulators|mitosis modulators|mesh-ancestor
110193067|NCT00034502|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110193068|NCT00034502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110193069|NCT00034502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110193070|NCT00034502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193071|NCT00034502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110193072|NCT00034541|Paclitaxel|paclitaxel|mesh-list
110193073|NCT00034541|Carboplatin|carboplatin|mesh-list
110193074|NCT00034541|Cetuximab|cetuximab|mesh-list
110306630|NCT00263276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193075|NCT00034541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110193077|NCT00034541|Tubulin Modulators|tubulin modulators|mesh-ancestor
110193078|NCT00034541|Antimitotic Agents|antimitotic agents|mesh-ancestor
110193079|NCT00034541|Mitosis Modulators|mitosis modulators|mesh-ancestor
110193080|NCT00034541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193081|NCT00034541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110193083|NCT00034580|Risperidone|risperidone|mesh-list
110193084|NCT00034580|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110193085|NCT00034580|Serotonin Agents|serotonin agents|mesh-ancestor
110059686|NCT01519011|Azacitidine|azacitidine|mesh-list
110193086|NCT00034580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110193087|NCT00034580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193088|NCT00034580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110193089|NCT00034580|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110193090|NCT00034580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110306669|NCT00263393|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110193091|NCT00034580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110193092|NCT00034580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110193093|NCT00034580|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110193094|NCT00034580|Dopamine Agents|dopamine agents|mesh-ancestor
110193095|NCT00034580|Antiemetics|antiemetics|mesh-ancestor
110193096|NCT00034580|Autonomic Agents|autonomic agents|mesh-ancestor
110193097|NCT00034580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110193098|NCT00034580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110193099|NCT00034580|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110306709|NCT00263705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110193100|NCT00034580|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110193101|NCT00034580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110193102|NCT00034619|Oxaliplatin|oxaliplatin|mesh-list
110193103|NCT00034619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110193104|NCT00061815|Leucovorin|leucovorin|mesh-list
110193105|NCT00061815|Fluorouracil|fluorouracil|mesh-list
110193106|NCT00061815|Oxaliplatin|oxaliplatin|mesh-list
110193107|NCT00061815|Cetuximab|cetuximab|mesh-list
110193108|NCT00061815|Antimetabolites|antimetabolites|mesh-ancestor
110193109|NCT00061815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193110|NCT00061815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110193111|NCT00061815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110193112|NCT00061815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110193113|NCT00061815|Immunologic Factors|immunologic factors|mesh-ancestor
110193114|NCT00061815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110193115|NCT00061815|Antidotes|antidotes|mesh-ancestor
110193116|NCT00061815|Protective Agents|protective agents|mesh-ancestor
110193117|NCT00061815|Vitamin B Complex|vitamin b complex|mesh-ancestor
110193118|NCT00061815|Vitamins|vitamins|mesh-ancestor
110193119|NCT00061815|Micronutrients|micronutrients|mesh-ancestor
110193120|NCT00061815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110193121|NCT00061854|Soblidotin|soblidotin|mesh-list
110193122|NCT00061854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110193123|NCT00034658|Posaconazole|posaconazole|mesh-list
110193124|NCT00034658|Antifungal Agents|antifungal agents|mesh-ancestor
110193125|NCT00034658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110193126|NCT00034658|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110193127|NCT00034658|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110193128|NCT00034658|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110193129|NCT00034658|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110193130|NCT00034658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110193131|NCT00034658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110193132|NCT00034658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193133|NCT00034658|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110193134|NCT00034658|Hormone Antagonists|hormone antagonists|mesh-ancestor
110193135|NCT00034658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110193136|NCT00034658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110193137|NCT00398580|Methyltestosterone|methyltestosterone|mesh-list
110193138|NCT00398580|Testosterone|testosterone|mesh-list
110193139|NCT00398580|Testosterone undecanoate|testosterone undecanoate|mesh-list
110193140|NCT00398580|Testosterone enanthate|testosterone enanthate|mesh-list
110193141|NCT00398580|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110193142|NCT00398580|Dutasteride|dutasteride|mesh-list
110193143|NCT00398580|Androgens|androgens|mesh-ancestor
110193144|NCT00398580|Hormones|hormones|mesh-ancestor
110193145|NCT00398580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110193146|NCT00398580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110193147|NCT00398580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110193148|NCT00398580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110193149|NCT00398580|Anabolic Agents|anabolic agents|mesh-ancestor
110193150|NCT00398580|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110059787|NCT01519544|Temazepam|temazepam|mesh-list
110285187|NCT00206765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110193151|NCT00398580|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110193152|NCT00398580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110193153|NCT00398580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193154|NCT00398580|Hormone Antagonists|hormone antagonists|mesh-ancestor
110193155|NCT00034697|Temozolomide|temozolomide|mesh-list
110193156|NCT00034697|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110193157|NCT00034697|Alkylating Agents|alkylating agents|mesh-ancestor
110193158|NCT00034697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193159|NCT00034697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110193161|NCT00034736|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110193162|NCT00034736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110193163|NCT00034736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110193164|NCT00034736|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110193165|NCT00034736|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110193166|NCT00034736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110193167|NCT00034736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193168|NCT00034736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110193169|NCT00034736|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110193170|NCT00034736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110193171|NCT02967939|Tenofovir|tenofovir|mesh-list
110193172|NCT02967939|Antiviral Agents|antiviral agents|mesh-ancestor
110193173|NCT02967939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110193174|NCT02967939|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110193175|NCT02967939|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110193176|NCT02967939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110193177|NCT02967939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193178|NCT02967939|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110193179|NCT02967939|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110193180|NCT00034775|Risperidone|risperidone|mesh-list
110193181|NCT00034775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110193182|NCT00034775|Serotonin Agents|serotonin agents|mesh-ancestor
110193183|NCT00034775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110193184|NCT00034775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193185|NCT00034775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110193186|NCT00034775|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110193187|NCT00034775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110193188|NCT00034775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110193189|NCT00034775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110193190|NCT00034775|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110193191|NCT00034775|Dopamine Agents|dopamine agents|mesh-ancestor
110193192|NCT00062127|Thalidomide|thalidomide|mesh-list
110193193|NCT00062127|Irinotecan|irinotecan|mesh-list
110193194|NCT00062127|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110193196|NCT00062127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110193197|NCT00062127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193198|NCT00062127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110193199|NCT00062127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110193200|NCT00062127|Immunologic Factors|immunologic factors|mesh-ancestor
110193201|NCT00062127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110193202|NCT00062127|Leprostatic Agents|leprostatic agents|mesh-ancestor
110193203|NCT00062127|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110193204|NCT00062127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110193205|NCT00062127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110193206|NCT00062127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110193207|NCT00062127|Growth Substances|growth substances|mesh-ancestor
110193208|NCT00062127|Growth Inhibitors|growth inhibitors|mesh-ancestor
110193209|NCT00034853|Naproxen|naproxen|mesh-list
110193210|NCT00034853|Meloxicam|meloxicam|mesh-list
110059861|NCT01520103|Immunologic Factors|immunologic factors|mesh-ancestor
110193211|NCT00034853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110193212|NCT00034853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110193213|NCT00034853|Analgesics|analgesics|mesh-ancestor
110193214|NCT00034853|Sensory System Agents|sensory system agents|mesh-ancestor
110193215|NCT00034853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110193216|NCT00034853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110193217|NCT00034853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110193218|NCT00034853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110193219|NCT00034853|Gout Suppressants|gout suppressants|mesh-ancestor
110193220|NCT00034853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110193221|NCT00034853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110193222|NCT00034853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193223|NCT00034853|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110193225|NCT00034892|Risperidone|risperidone|mesh-list
110193226|NCT00034892|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110193227|NCT00034892|Serotonin Agents|serotonin agents|mesh-ancestor
110193228|NCT00034892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110193229|NCT00034892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193230|NCT00034892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110193231|NCT00034892|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110193232|NCT00034892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110193233|NCT00034892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110193234|NCT00034892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110193235|NCT00034892|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110193236|NCT00034892|Dopamine Agents|dopamine agents|mesh-ancestor
110193237|NCT00034892|Antiemetics|antiemetics|mesh-ancestor
110193238|NCT00034892|Autonomic Agents|autonomic agents|mesh-ancestor
110306959|NCT00294996|Doxorubicin|doxorubicin|mesh-list
110193239|NCT00034892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110193240|NCT00034892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110193241|NCT00034892|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110193242|NCT00034892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110193243|NCT00034892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110193244|NCT00062205|Imatinib Mesylate|imatinib mesylate|mesh-list
110193245|NCT00062205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110193246|NCT00062205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110193247|NCT00062205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110193248|NCT00062205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193250|NCT00062244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110193252|NCT00035009|Paroxetine|paroxetine|mesh-list
110193253|NCT00035009|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110193254|NCT00035009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110193255|NCT00035009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110193256|NCT00035009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193257|NCT00035009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110193258|NCT00035009|Serotonin Agents|serotonin agents|mesh-ancestor
110193259|NCT00035009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110193260|NCT00035009|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110193261|NCT00035009|Antidepressive Agents|antidepressive agents|mesh-ancestor
110193262|NCT00035009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110193263|NCT00035009|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110193264|NCT00035009|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110193265|NCT00035009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110193266|NCT00035009|Antiemetics|antiemetics|mesh-ancestor
110193267|NCT00035009|Autonomic Agents|autonomic agents|mesh-ancestor
110193268|NCT00035009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110193269|NCT00035009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110193270|NCT00035009|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110193272|NCT00062283|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110193273|NCT00062283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110193274|NCT00062283|Chelating Agents|chelating agents|mesh-ancestor
110193275|NCT00062283|Sequestering Agents|sequestering agents|mesh-ancestor
110193276|NCT00062283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193277|NCT00035048|Aprepitant|aprepitant|mesh-list
110193278|NCT00035048|Antiemetics|antiemetics|mesh-ancestor
110193279|NCT00035048|Autonomic Agents|autonomic agents|mesh-ancestor
110193280|NCT00035048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110193281|NCT00035048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110193282|NCT00035048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110193283|NCT00035048|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110193284|NCT00035048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110193285|NCT00035048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193286|NCT00035087|Epothilones|epothilones|mesh-list
110193287|NCT00035087|Epothilone B|epothilone b|mesh-list
110193288|NCT00035087|Tubulin Modulators|tubulin modulators|mesh-ancestor
110193289|NCT00035087|Antimitotic Agents|antimitotic agents|mesh-ancestor
110219146|NCT00284323|Adenosine|adenosine|mesh-list
110193290|NCT00035087|Mitosis Modulators|mitosis modulators|mesh-ancestor
110193291|NCT00035087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193292|NCT00035087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110193293|NCT00062322|Irinotecan|irinotecan|mesh-list
110193294|NCT00062322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110193295|NCT00062322|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110193296|NCT00062322|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110193297|NCT00062322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110193298|NCT00062322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193299|NCT00035126|Epothilones|epothilones|mesh-list
110193300|NCT00035126|Epothilone B|epothilone b|mesh-list
110193301|NCT00035126|Tubulin Modulators|tubulin modulators|mesh-ancestor
110193302|NCT00035126|Antimitotic Agents|antimitotic agents|mesh-ancestor
110193303|NCT00035126|Mitosis Modulators|mitosis modulators|mesh-ancestor
110193304|NCT00035126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193305|NCT00035126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110193307|NCT00035165|Epothilone B|epothilone b|mesh-list
110193308|NCT00035165|Tubulin Modulators|tubulin modulators|mesh-ancestor
110193309|NCT00035165|Antimitotic Agents|antimitotic agents|mesh-ancestor
110193310|NCT00035165|Mitosis Modulators|mitosis modulators|mesh-ancestor
110193311|NCT00035165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193312|NCT00035165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110193313|NCT00035204|Galantamine|galantamine|mesh-list
110060109|NCT01521767|Urological Agents|urological agents|mesh-ancestor
110193314|NCT00035204|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110193315|NCT00035204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110193316|NCT00035204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193317|NCT00035204|Cholinergic Agents|cholinergic agents|mesh-ancestor
110193318|NCT00035204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110193319|NCT00035204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110193320|NCT00035204|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110193321|NCT00035204|Autonomic Agents|autonomic agents|mesh-ancestor
110193322|NCT00035204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110193324|NCT00062478|Camptothecin|camptothecin|mesh-list
110193325|NCT00062478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110193326|NCT00062478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110193327|NCT00062478|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110193328|NCT00062478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110193329|NCT00062478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110193330|NCT00062478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193331|NCT00035243|Epothilones|epothilones|mesh-list
110193332|NCT00035243|Epothilone B|epothilone b|mesh-list
110193333|NCT00035243|Tubulin Modulators|tubulin modulators|mesh-ancestor
110193334|NCT00035243|Antimitotic Agents|antimitotic agents|mesh-ancestor
110193335|NCT00035243|Mitosis Modulators|mitosis modulators|mesh-ancestor
110193336|NCT00035243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193337|NCT00035243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110193338|NCT00035282|Aprepitant|aprepitant|mesh-list
110193339|NCT00035282|Antiemetics|antiemetics|mesh-ancestor
110193340|NCT00035282|Autonomic Agents|autonomic agents|mesh-ancestor
110193341|NCT00035282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110193342|NCT00035282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110193343|NCT00035282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110193344|NCT00035282|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110193345|NCT00035282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110193346|NCT00035282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193348|NCT00062556|Lovastatin|lovastatin|mesh-list
110193349|NCT00062556|L 647318|l 647318|mesh-list
110193350|NCT00062556|Dihydromevinolin|dihydromevinolin|mesh-list
110193351|NCT00062556|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110193352|NCT00062556|Antimetabolites|antimetabolites|mesh-ancestor
110193353|NCT00062556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193354|NCT00062556|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110193355|NCT00062556|Vasodilator Agents|vasodilator agents|mesh-ancestor
110193356|NCT00062556|Vitamin B Complex|vitamin b complex|mesh-ancestor
110193358|NCT00062556|Micronutrients|micronutrients|mesh-ancestor
110193359|NCT00062556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110193360|NCT00062556|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110193361|NCT00062556|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110193362|NCT00062556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110193363|NCT00035321|Olanzapine|olanzapine|mesh-list
110193364|NCT00035321|Fluoxetine|fluoxetine|mesh-list
110193365|NCT00035321|Antiemetics|antiemetics|mesh-ancestor
110193366|NCT00035321|Autonomic Agents|autonomic agents|mesh-ancestor
110193367|NCT00035321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110193368|NCT00035321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110193369|NCT00035321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110193370|NCT00035321|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110193371|NCT00035321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110285503|NCT00208169|Serotonin Agents|serotonin agents|mesh-ancestor
110193372|NCT00035321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110193373|NCT00035321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110193374|NCT00035321|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110193375|NCT00035321|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110193376|NCT00035321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110193377|NCT00035321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193378|NCT00035321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110193379|NCT00035321|Serotonin Agents|serotonin agents|mesh-ancestor
110193380|NCT00035321|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110193381|NCT00035321|Antidepressive Agents|antidepressive agents|mesh-ancestor
110193382|NCT00035321|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110193383|NCT00035321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110193384|NCT00035321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110193385|NCT00062595|Vitamin K 1|vitamin k 1|mesh-list
110193386|NCT00062595|Vitamin K|vitamin k|mesh-list
110193387|NCT00062595|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110193388|NCT00062595|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110193389|NCT00062595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193390|NCT00062595|Hemostatics|hemostatics|mesh-ancestor
110193391|NCT00062595|Coagulants|coagulants|mesh-ancestor
110193392|NCT00062595|Vitamins|vitamins|mesh-ancestor
110193393|NCT00062595|Micronutrients|micronutrients|mesh-ancestor
110193394|NCT00062595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110193395|NCT00035360|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110193396|NCT00035360|Antiviral Agents|antiviral agents|mesh-ancestor
110193397|NCT00035360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110193398|NCT00062673|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110193399|NCT00062673|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110193400|NCT00062673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110193401|NCT00062673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110193402|NCT00062673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193403|NCT00062673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110193404|NCT00062673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110193405|NCT00062673|Analgesics|analgesics|mesh-ancestor
110193406|NCT00062673|Sensory System Agents|sensory system agents|mesh-ancestor
110193407|NCT00062673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110193408|NCT00062673|Antidepressive Agents|antidepressive agents|mesh-ancestor
110193409|NCT00062673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110193410|NCT00062673|Dopamine Agents|dopamine agents|mesh-ancestor
110193411|NCT00035477|Azimilide|azimilide|mesh-list
110193412|NCT00035477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110193413|NCT00035477|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110193414|NCT00035477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110193415|NCT00035477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193416|NCT00035477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110193417|NCT00035477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110193418|NCT00062712|Sirolimus|sirolimus|mesh-list
110193419|NCT00062712|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110193420|NCT00062712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110193421|NCT00062712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110193422|NCT00062712|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110193423|NCT00062712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110193424|NCT00062712|Antifungal Agents|antifungal agents|mesh-ancestor
110193425|NCT00062712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110193426|NCT00062712|Immunologic Factors|immunologic factors|mesh-ancestor
110193427|NCT00062712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110193428|NCT00062790|Dutasteride|dutasteride|mesh-list
110193429|NCT00062790|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110193430|NCT00062790|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110193431|NCT00062790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110193432|NCT00062790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193433|NCT00062790|Hormone Antagonists|hormone antagonists|mesh-ancestor
110193434|NCT00062790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110193435|NCT00062790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110193436|NCT00035516|Epothilones|epothilones|mesh-list
110193437|NCT00035516|Tubulin Modulators|tubulin modulators|mesh-ancestor
110193438|NCT00035516|Antimitotic Agents|antimitotic agents|mesh-ancestor
110193439|NCT00035516|Mitosis Modulators|mitosis modulators|mesh-ancestor
110193440|NCT00035516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193441|NCT00035516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110193443|NCT00062946|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110193444|NCT00062946|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110193445|NCT00062946|Dopamine Agents|dopamine agents|mesh-ancestor
110193446|NCT00062946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110060512|NCT01523639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110193447|NCT00062946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193448|NCT00062946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110193449|NCT00063024|Calcium|calcium|mesh-list
110193450|NCT00063024|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110193451|NCT00063024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110193453|NCT00035984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110193454|NCT00035984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110193455|NCT00035984|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110193456|NCT00035984|Incretins|incretins|mesh-ancestor
110193457|NCT00035984|Hormones|hormones|mesh-ancestor
110286558|NCT00238056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110193458|NCT00035984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110193459|NCT00063141|Irinotecan|irinotecan|mesh-list
110193460|NCT00063141|Cetuximab|cetuximab|mesh-list
110193461|NCT00063141|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110193462|NCT00063141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110193463|NCT00063141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110193464|NCT00063141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193465|NCT00063141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110193466|NCT00063141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110193467|NCT00036023|Darbepoetin alfa|darbepoetin alfa|mesh-list
110193468|NCT00036023|Hematinics|hematinics|mesh-ancestor
110193469|NCT00036062|Sivelestat|sivelestat|mesh-list
110193470|NCT00036062|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110193471|NCT00036062|Protease Inhibitors|protease inhibitors|mesh-ancestor
110193472|NCT00036062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110219190|NCT00284791|Fluoxetine|fluoxetine|mesh-list
110193473|NCT00036062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193474|NCT00036101|Aripiprazole|aripiprazole|mesh-list
110193475|NCT00036101|Antidepressive Agents|antidepressive agents|mesh-ancestor
110193476|NCT00036101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110193477|NCT00036101|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110193478|NCT00036101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110287119|NCT00211952|Analgesics|analgesics|mesh-ancestor
110193479|NCT00036101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110193480|NCT00036101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110193481|NCT00036101|Dopamine Agonists|dopamine agonists|mesh-ancestor
110193482|NCT00036101|Dopamine Agents|dopamine agents|mesh-ancestor
110193483|NCT00036101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110193484|NCT00036101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193485|NCT00036101|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110193486|NCT00036101|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110193487|NCT00036101|Serotonin Agents|serotonin agents|mesh-ancestor
110193488|NCT00036101|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110193489|NCT00036101|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110193490|NCT00036101|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110193491|NCT00036101|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110193492|NCT00036179|Micafungin|micafungin|mesh-list
110193493|NCT00036179|Antifungal Agents|antifungal agents|mesh-ancestor
110193494|NCT00036179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110193495|NCT00036218|Ropinirole|ropinirole|mesh-list
110193496|NCT00036218|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110193497|NCT00036218|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110193498|NCT00036218|Dopamine Agonists|dopamine agonists|mesh-ancestor
110193499|NCT00036218|Dopamine Agents|dopamine agents|mesh-ancestor
110193500|NCT00036218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110193501|NCT00036218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193502|NCT00036218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110193503|NCT00063453|Vitamins|vitamins|mesh-list
110193505|NCT00063453|Tocopherols|tocopherols|mesh-list
110193506|NCT00063453|Tocotrienols|tocotrienols|mesh-list
110193507|NCT00063453|alpha-Tocopherol|alpha-tocopherol|mesh-list
110193508|NCT00063453|Selenium|selenium|mesh-list
110193509|NCT00063453|Micronutrients|micronutrients|mesh-ancestor
110193510|NCT00063453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110193511|NCT00063453|Antioxidants|antioxidants|mesh-ancestor
110193512|NCT00063453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193513|NCT00063453|Protective Agents|protective agents|mesh-ancestor
110193514|NCT00063453|Trace Elements|trace elements|mesh-ancestor
110193515|NCT00036335|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110193516|NCT00036335|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110193517|NCT00036335|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110193518|NCT00036335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110193519|NCT00036335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193520|NCT00036335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110193521|NCT00036335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110193522|NCT00036335|Analgesics|analgesics|mesh-ancestor
110193523|NCT00036335|Sensory System Agents|sensory system agents|mesh-ancestor
110193524|NCT00036335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110193525|NCT00036335|Antidepressive Agents|antidepressive agents|mesh-ancestor
110193526|NCT00036335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110193527|NCT00036335|Dopamine Agents|dopamine agents|mesh-ancestor
110193528|NCT00036374|Infliximab|infliximab|mesh-list
110193529|NCT00036374|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110193530|NCT00036374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110193531|NCT00036374|Dermatologic Agents|dermatologic agents|mesh-ancestor
110193532|NCT00036374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110193533|NCT00036374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110193534|NCT00036452|Ritonavir|ritonavir|mesh-list
110193535|NCT00036452|Lopinavir|lopinavir|mesh-list
110193536|NCT00036452|Tenofovir|tenofovir|mesh-list
110193537|NCT00036452|Emtricitabine|emtricitabine|mesh-list
110193538|NCT00036452|Stavudine|stavudine|mesh-list
110193539|NCT00036452|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110193540|NCT00036452|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110193541|NCT00036452|Protease Inhibitors|protease inhibitors|mesh-ancestor
110193542|NCT00036452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110193543|NCT00036452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193544|NCT00036452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110193545|NCT00036452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110193546|NCT00036452|Antiviral Agents|antiviral agents|mesh-ancestor
110193547|NCT00036452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110193548|NCT00036452|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110193549|NCT00036452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110193550|NCT00036452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110193551|NCT00036452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110193552|NCT00036452|Antimetabolites|antimetabolites|mesh-ancestor
110193553|NCT02967276|Metformin|metformin|mesh-list
110193554|NCT02967276|Dexamethasone|dexamethasone|mesh-list
110193555|NCT02967276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110193556|NCT02967276|Antiemetics|antiemetics|mesh-ancestor
110193557|NCT02967276|Autonomic Agents|autonomic agents|mesh-ancestor
110193558|NCT02967276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110193559|NCT02967276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110193560|NCT02967276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110060772|NCT06053580|Valsartan|valsartan|mesh-list
110060773|NCT06053580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110060774|NCT06053580|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110193562|NCT02967276|Hormones|hormones|mesh-ancestor
110193563|NCT02967276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110193564|NCT02967276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110193565|NCT02967276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110193566|NCT02967276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110193567|NCT00036491|Rituximab|rituximab|mesh-list
110193568|NCT00036491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110193569|NCT00036491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110193570|NCT00036491|Immunologic Factors|immunologic factors|mesh-ancestor
110193571|NCT00036491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110193572|NCT00036491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110193573|NCT00063609|Zoledronic Acid|zoledronic acid|mesh-list
110193574|NCT00063609|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110193575|NCT00063609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110193576|NCT02971319|Technetium tc-99m tetrofosmin|technetium tc-99m tetrofosmin|mesh-list
110193577|NCT02971319|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110193578|NCT02971319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193579|NCT00036647|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110193580|NCT00036647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110193581|NCT00036647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110193582|NCT00036647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110193583|NCT00036647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193588|NCT00036764|Epothilone B|epothilone b|mesh-list
110193589|NCT00036764|Tubulin Modulators|tubulin modulators|mesh-ancestor
110193590|NCT00036764|Antimitotic Agents|antimitotic agents|mesh-ancestor
110193591|NCT00036764|Mitosis Modulators|mitosis modulators|mesh-ancestor
110193592|NCT00036764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193593|NCT00036764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110193594|NCT00063726|Bortezomib|bortezomib|mesh-list
110193595|NCT00063726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110193596|NCT00036842|Arsenic Trioxide|arsenic trioxide|mesh-list
110193597|NCT00036842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110193598|NCT00036881|Zinc Sulfate|zinc sulfate|mesh-list
110193599|NCT00036881|Astringents|astringents|mesh-ancestor
110193600|NCT00036881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110193601|NCT00036881|Dermatologic Agents|dermatologic agents|mesh-ancestor
110193602|NCT00063804|Ritonavir|ritonavir|mesh-list
110060877|NCT06052995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110060878|NCT06052995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110060879|NCT06052995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110060880|NCT06052995|Dermatologic Agents|dermatologic agents|mesh-ancestor
110060881|NCT06052995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110060882|NCT06052995|Immunologic Factors|immunologic factors|mesh-ancestor
110060883|NCT06052995|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110060884|NCT06052995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110060885|NCT06052995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193603|NCT00063804|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110193604|NCT00063804|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110193605|NCT00063804|Protease Inhibitors|protease inhibitors|mesh-ancestor
110193606|NCT00063804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110193607|NCT00063804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193608|NCT00063804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110193609|NCT00063804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110193610|NCT00063804|Antiviral Agents|antiviral agents|mesh-ancestor
110193611|NCT00063804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110193612|NCT00063804|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110193613|NCT00063804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110193614|NCT02967432|Mupirocin|mupirocin|mesh-list
110193615|NCT02967432|Petrolatum|petrolatum|mesh-list
110193616|NCT02967432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110193617|NCT02967432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110193618|NCT02967432|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110193619|NCT02967432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110193620|NCT02967432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193621|NCT02967432|Emollients|emollients|mesh-ancestor
110193622|NCT02967432|Dermatologic Agents|dermatologic agents|mesh-ancestor
110193623|NCT00063960|Irinotecan|irinotecan|mesh-list
110193624|NCT00063960|Floxuridine|floxuridine|mesh-list
110193625|NCT00063960|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110193626|NCT00063960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110193627|NCT00063960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110288856|NCT00559312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110193628|NCT00063960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193629|NCT00063960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110193630|NCT00063960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110193631|NCT00063960|Antimetabolites|antimetabolites|mesh-ancestor
110193632|NCT00064116|Rituximab|rituximab|mesh-list
110193633|NCT00064116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110193634|NCT00064116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110193635|NCT00064116|Immunologic Factors|immunologic factors|mesh-ancestor
110193636|NCT00064116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110193637|NCT00064116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110193638|NCT00037037|Sargramostim|sargramostim|mesh-list
110193639|NCT00037037|Immunologic Factors|immunologic factors|mesh-ancestor
110193640|NCT00037037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110193642|NCT00064194|Selenium|selenium|mesh-list
110193643|NCT00064194|Vitamins|vitamins|mesh-ancestor
110193644|NCT00064194|Micronutrients|micronutrients|mesh-ancestor
110193645|NCT00064194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110193646|NCT00064194|Antioxidants|antioxidants|mesh-ancestor
110193647|NCT00064194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193648|NCT00064194|Protective Agents|protective agents|mesh-ancestor
110193649|NCT00064194|Trace Elements|trace elements|mesh-ancestor
110193650|NCT00064233|Dasatinib|dasatinib|mesh-list
110193651|NCT00064233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110193652|NCT00064233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110193653|NCT00064233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110193654|NCT00064233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193655|NCT02967237|Insulin Glargine|insulin glargine|mesh-list
110193656|NCT02967237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110193657|NCT02967237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110193658|NCT00037115|Interferons|interferons|mesh-list
110193660|NCT00037115|Interferon beta-1a|interferon beta-1a|mesh-list
110193661|NCT00037115|Methylprednisolone|methylprednisolone|mesh-list
110193663|NCT00037115|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110193664|NCT00037115|Abortifacient Agents|abortifacient agents|mesh-ancestor
110193665|NCT00037115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110193666|NCT00037115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110193667|NCT00037115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110193668|NCT00037115|Antimetabolites|antimetabolites|mesh-ancestor
110193669|NCT00037115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193670|NCT00037115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110193671|NCT00037115|Dermatologic Agents|dermatologic agents|mesh-ancestor
110193672|NCT00037115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110193673|NCT00037115|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110193674|NCT00037115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110193675|NCT00037115|Immunologic Factors|immunologic factors|mesh-ancestor
110193676|NCT00037115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110193677|NCT00037115|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110061099|NCT06051370|Hormones|hormones|mesh-ancestor
110193678|NCT00037115|Antiviral Agents|antiviral agents|mesh-ancestor
110193679|NCT00037115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110193680|NCT00037115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110193681|NCT00037115|Antiemetics|antiemetics|mesh-ancestor
110193682|NCT00037115|Autonomic Agents|autonomic agents|mesh-ancestor
110193683|NCT00037115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110193684|NCT00037115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110193685|NCT00037115|Glucocorticoids|glucocorticoids|mesh-ancestor
110193686|NCT00037115|Hormones|hormones|mesh-ancestor
110193687|NCT00037115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110193688|NCT00037115|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110193689|NCT00037115|Protective Agents|protective agents|mesh-ancestor
110193690|NCT00037115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110193691|NCT00037154|Saw palmetto extract|saw palmetto extract|mesh-list
110193692|NCT00037154|Urological Agents|urological agents|mesh-ancestor
110193693|NCT00064389|Albuterol|albuterol|mesh-list
110193694|NCT00064389|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110193695|NCT00064389|Autonomic Agents|autonomic agents|mesh-ancestor
110193696|NCT00064389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110193697|NCT00064389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110193698|NCT00064389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110193699|NCT00064389|Respiratory System Agents|respiratory system agents|mesh-ancestor
110061151|NCT06044935|Micronutrients|micronutrients|mesh-ancestor
110193700|NCT00064389|Tocolytic Agents|tocolytic agents|mesh-ancestor
110193701|NCT00064389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110193702|NCT00064389|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110193703|NCT00064389|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110193704|NCT00064389|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110193705|NCT00064389|Adrenergic Agents|adrenergic agents|mesh-ancestor
110193706|NCT00064389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110193707|NCT00064389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193708|NCT00064428|PENTA|penta|mesh-list
110193709|NCT00064428|Fondaparinux|fondaparinux|mesh-list
110193710|NCT00064428|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110193711|NCT00064428|Antithrombins|antithrombins|mesh-ancestor
110193712|NCT00064428|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110193713|NCT00064428|Protease Inhibitors|protease inhibitors|mesh-ancestor
110193714|NCT00064428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110061208|NCT06038539|Carboplatin|carboplatin|mesh-list
110061209|NCT06038539|Docetaxel|docetaxel|mesh-list
110061210|NCT06038539|Trastuzumab|trastuzumab|mesh-list
110061211|NCT06038539|Pertuzumab|pertuzumab|mesh-list
110061212|NCT06038539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110061213|NCT06038539|Tubulin Modulators|tubulin modulators|mesh-ancestor
110061214|NCT06038539|Antimitotic Agents|antimitotic agents|mesh-ancestor
110061215|NCT06038539|Mitosis Modulators|mitosis modulators|mesh-ancestor
110061216|NCT06038539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110061217|NCT06038539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110061239|NCT06015490|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110061240|NCT06006286|Bevacizumab|bevacizumab|mesh-list
110061241|NCT06006286|Atezolizumab|atezolizumab|mesh-list
110061242|NCT06006286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110061243|NCT06006286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110061244|NCT06006286|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110061245|NCT06006286|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110061246|NCT06006286|Growth Substances|growth substances|mesh-ancestor
110061247|NCT06006286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110061248|NCT06006286|Growth Inhibitors|growth inhibitors|mesh-ancestor
110061249|NCT06006286|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110061250|NCT06006286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110061252|NCT06005818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110061253|NCT06005818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110193715|NCT00064428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193716|NCT00064428|Anticoagulants|anticoagulants|mesh-ancestor
110193717|NCT00064428|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110193718|NCT00064428|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110193719|NCT00064467|Bupropion|bupropion|mesh-list
110193720|NCT00064467|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110193721|NCT00064467|Antidepressive Agents|antidepressive agents|mesh-ancestor
110193722|NCT00064467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110193723|NCT00064467|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110193724|NCT00064467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110193725|NCT00064467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110193726|NCT00064467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193727|NCT00064467|Dopamine Agents|dopamine agents|mesh-ancestor
110193728|NCT00064467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110061261|NCT06004830|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110061262|NCT06004830|Diuretics|diuretics|mesh-ancestor
110061263|NCT06004830|Natriuretic Agents|natriuretic agents|mesh-ancestor
110061269|NCT05973851|Ketamine|ketamine|mesh-list
110061270|NCT05973851|Antidepressive Agents|antidepressive agents|mesh-list
110061271|NCT05973851|Esketamine|esketamine|mesh-list
110061272|NCT05973851|Analgesics|analgesics|mesh-ancestor
110193729|NCT00064467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110193730|NCT00064467|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110193731|NCT00064467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110193732|NCT00064467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110193733|NCT00064623|Capsaicin|capsaicin|mesh-list
110193734|NCT00064623|Antipruritics|antipruritics|mesh-ancestor
110193735|NCT00064623|Dermatologic Agents|dermatologic agents|mesh-ancestor
110193736|NCT00064623|Sensory System Agents|sensory system agents|mesh-ancestor
110193737|NCT00064623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110193738|NCT00064623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110061321|NCT05972018|Anesthetics|anesthetics|mesh-ancestor
110022447|NCT00002832|Decitabine|decitabine|mesh-list
110061322|NCT05972018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110061323|NCT05972018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110061324|NCT05972018|Sensory System Agents|sensory system agents|mesh-ancestor
110061325|NCT05972018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110061332|NCT05958875|Antipsychotic Agents|antipsychotic agents|mesh-list
110061333|NCT05958875|Clozapine|clozapine|mesh-list
110061334|NCT05958875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110061335|NCT05958875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110061336|NCT05958875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110061337|NCT05958875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110061338|NCT05958875|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110061339|NCT05958875|Serotonin Agents|serotonin agents|mesh-ancestor
110061340|NCT05958875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110061341|NCT05958875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110061342|NCT05958875|GABA Antagonists|gaba antagonists|mesh-ancestor
110061343|NCT05958875|GABA Agents|gaba agents|mesh-ancestor
110061344|NCT05945927|Trastuzumab|trastuzumab|mesh-list
110061345|NCT05945927|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
110061346|NCT05945927|Maytansine|maytansine|mesh-list
110061347|NCT05945927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110061348|NCT05945927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110061349|NCT05945927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110061350|NCT05945927|Tubulin Modulators|tubulin modulators|mesh-ancestor
110061351|NCT05945927|Antimitotic Agents|antimitotic agents|mesh-ancestor
110061352|NCT05945927|Mitosis Modulators|mitosis modulators|mesh-ancestor
110061353|NCT05945927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110061354|NCT05945927|Immunotoxins|immunotoxins|mesh-ancestor
110061355|NCT05945927|Immunoconjugates|immunoconjugates|mesh-ancestor
110061356|NCT05945927|Immunologic Factors|immunologic factors|mesh-ancestor
110061357|NCT05945927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110193739|NCT00064779|Pseudomonas aeruginosa exotoxin A|pseudomonas aeruginosa exotoxin a|mesh-list
110193740|NCT00064779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110193741|NCT00037544|Factor VIII|factor viii|mesh-list
110193742|NCT00037544|Coagulants|coagulants|mesh-ancestor
110193743|NCT00037583|Gemtuzumab|gemtuzumab|mesh-list
110193744|NCT00037583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110193745|NCT00037583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110193746|NCT00037583|Immunotoxins|immunotoxins|mesh-ancestor
110193747|NCT00037583|Immunoconjugates|immunoconjugates|mesh-ancestor
110193748|NCT00037583|Immunologic Factors|immunologic factors|mesh-ancestor
110193749|NCT00037583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110193750|NCT00064857|Pycnogenols|pycnogenols|mesh-list
110193751|NCT00064857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110193752|NCT00064857|Immunologic Factors|immunologic factors|mesh-ancestor
110193753|NCT00064857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110193754|NCT00064857|Antioxidants|antioxidants|mesh-ancestor
110193755|NCT00064857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193756|NCT00064857|Protective Agents|protective agents|mesh-ancestor
110193757|NCT00064857|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110193758|NCT00037622|Dexelvucitabine|dexelvucitabine|mesh-list
110061401|NCT05891262|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
110061402|NCT05891262|Estradiol|estradiol|mesh-list
110061403|NCT05891262|Estrogens|estrogens|mesh-ancestor
110061404|NCT05891262|Hormones|hormones|mesh-ancestor
110061405|NCT05891262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110061406|NCT05891262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110061407|NCT05891262|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110061408|NCT05891262|Contraceptive Agents|contraceptive agents|mesh-ancestor
110061409|NCT05891262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110061410|NCT05891262|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110061411|NCT05891262|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110061412|NCT05891262|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110193760|NCT00037622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110193761|NCT00037622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110193762|NCT00037622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193763|NCT00037622|Antiviral Agents|antiviral agents|mesh-ancestor
110193764|NCT00037622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110193765|NCT00037622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110193766|NCT00037622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110193767|NCT00037661|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110193768|NCT00037661|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110193769|NCT04730622|Mitogens|mitogens|mesh-list
110193770|NCT04730622|Mitosis Modulators|mitosis modulators|mesh-ancestor
110292859|NCT00254865|Estradiol|estradiol|mesh-list
110193771|NCT04730622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193772|NCT00037700|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110193773|NCT00037700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110061438|NCT05874570|Metronidazole|metronidazole|mesh-list
110061439|NCT05874570|Doxycycline|doxycycline|mesh-list
110061440|NCT05874570|Tetracycline|tetracycline|mesh-list
110061441|NCT05874570|Potassium Citrate|potassium citrate|mesh-list
110061442|NCT05874570|Esomeprazole|esomeprazole|mesh-list
110061443|NCT05874570|Bismuth|bismuth|mesh-list
110061444|NCT05874570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110061445|NCT05874570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110061446|NCT05874570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110061447|NCT05874570|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110061448|NCT05874570|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110061449|NCT05874570|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110061450|NCT05874570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110061451|NCT05874570|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110061452|NCT05874570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110061453|NCT05874570|Antimalarials|antimalarials|mesh-ancestor
110061454|NCT05874570|Antacids|antacids|mesh-ancestor
110061455|NCT05874570|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110061456|NCT05874570|Diuretics|diuretics|mesh-ancestor
110193775|NCT00064974|Immunologic Factors|immunologic factors|mesh-ancestor
110193776|NCT00064974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110193777|NCT00064974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110193778|NCT00064974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110193779|NCT00064974|Growth Substances|growth substances|mesh-ancestor
110193780|NCT00064974|Growth Inhibitors|growth inhibitors|mesh-ancestor
110193781|NCT00064974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110193783|NCT00037817|Decitabine|decitabine|mesh-list
110193784|NCT00037817|Romidepsin|romidepsin|mesh-list
110193785|NCT00037817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110193786|NCT00037817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110193787|NCT00037817|Analgesics|analgesics|mesh-ancestor
110193788|NCT00037817|Sensory System Agents|sensory system agents|mesh-ancestor
110293251|NCT03450499|Ketamine|ketamine|mesh-list
110193789|NCT00037817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110219293|NCT00285298|Antioxidants|antioxidants|mesh-ancestor
110193790|NCT00037817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110193792|NCT00037817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110061493|NCT05840159|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110061494|NCT05840159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110061495|NCT05840159|Antimalarials|antimalarials|mesh-ancestor
110061496|NCT05840159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110061497|NCT05840159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110061498|NCT05822752|Sorafenib|sorafenib|mesh-list
110061499|NCT05822752|Lenvatinib|lenvatinib|mesh-list
110061500|NCT05822752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110061501|NCT05822752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110061502|NCT05822752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110061503|NCT05822752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110061522|NCT05808608|Axitinib|axitinib|mesh-list
110061523|NCT05808608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110061524|NCT05808608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110061525|NCT05808608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110061526|NCT05808608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110061528|NCT05781321|Levodopa|levodopa|mesh-list
110061529|NCT05781321|Fluorides|fluorides|mesh-list
110061530|NCT05781321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110061531|NCT05781321|Alkylating Agents|alkylating agents|mesh-ancestor
110061532|NCT05781321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110061533|NCT05781321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110061534|NCT05781321|Cariostatic Agents|cariostatic agents|mesh-ancestor
110061535|NCT05781321|Protective Agents|protective agents|mesh-ancestor
110061536|NCT05781321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110061537|NCT05781321|Dopamine Agents|dopamine agents|mesh-ancestor
110193793|NCT00037817|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110193794|NCT00037817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110193795|NCT00037817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110193796|NCT00037817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193797|NCT00037817|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110193798|NCT00037817|Antimetabolites|antimetabolites|mesh-ancestor
110193799|NCT00037817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110193800|NCT00037817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110193801|NCT00037817|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110193802|NCT00065130|Insulin|insulin|mesh-list
110193803|NCT00065130|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110193804|NCT00065130|Insulin Aspart|insulin aspart|mesh-list
110193805|NCT00065130|Isophane Insulin, Human|isophane insulin, human|mesh-list
110193806|NCT00065130|Insulin, Isophane|insulin, isophane|mesh-list
110193807|NCT00065130|Isophane insulin, beef|isophane insulin, beef|mesh-list
110193808|NCT00065130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110193809|NCT00065130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110193810|NCT00065169|Celecoxib|celecoxib|mesh-list
110193811|NCT00065169|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110193812|NCT00065169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110193813|NCT00065169|Analgesics|analgesics|mesh-ancestor
110193814|NCT00065169|Sensory System Agents|sensory system agents|mesh-ancestor
110193815|NCT00065169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110061553|NCT05766501|Islatravir|islatravir|mesh-list
110061554|NCT05766501|Antiviral Agents|antiviral agents|mesh-ancestor
110061555|NCT05766501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110061556|NCT05766501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110061557|NCT05766501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110061558|NCT05766501|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110061559|NCT05766501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110061560|NCT05766501|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110061561|NCT05757843|Durvalumab|durvalumab|mesh-list
110193821|NCT00065169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110193822|NCT00065169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193823|NCT00038012|Carboplatin|carboplatin|mesh-list
110193824|NCT00038012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110193825|NCT00038051|Lintuzumab|lintuzumab|mesh-list
110193826|NCT00038051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110193827|NCT00038051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110193830|NCT00038090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110193831|NCT00038090|Antiemetics|antiemetics|mesh-ancestor
110193832|NCT00038090|Autonomic Agents|autonomic agents|mesh-ancestor
110193833|NCT00038090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110193834|NCT00038090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110061606|NCT05691517|Exatecan|exatecan|mesh-list
110061607|NCT05691517|Camptothecin|camptothecin|mesh-list
110061608|NCT05691517|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110061609|NCT05691517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110061610|NCT05691517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110061611|NCT05691517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110061612|NCT05691517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110061613|NCT05691517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110061614|NCT05681715|Rozanolixizumab|rozanolixizumab|mesh-list
110061615|NCT05681715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110061616|NCT05681715|Immunologic Factors|immunologic factors|mesh-ancestor
110061617|NCT05681715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110193835|NCT00038090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110193836|NCT00038090|Glucocorticoids|glucocorticoids|mesh-ancestor
110193837|NCT00038090|Hormones|hormones|mesh-ancestor
110193838|NCT00038090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110193839|NCT00038090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110193840|NCT00038090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110193841|NCT00038090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110193842|NCT00038090|Immunologic Factors|immunologic factors|mesh-ancestor
110193843|NCT00038090|Leprostatic Agents|leprostatic agents|mesh-ancestor
110193844|NCT00038090|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110193845|NCT00038090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110193846|NCT00038090|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110193847|NCT00038090|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110193848|NCT00038090|Growth Substances|growth substances|mesh-ancestor
110193849|NCT00038090|Growth Inhibitors|growth inhibitors|mesh-ancestor
110193850|NCT00065325|Fulvestrant|fulvestrant|mesh-list
110193851|NCT00065325|Exemestane|exemestane|mesh-list
110193852|NCT00065325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110193853|NCT00065325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110193854|NCT00065325|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110193855|NCT00065325|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110193856|NCT00065325|Hormone Antagonists|hormone antagonists|mesh-ancestor
110219321|NCT00285727|Ropinirole|ropinirole|mesh-list
110193857|NCT00065325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110193858|NCT00065325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110193859|NCT00065325|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110193860|NCT00065325|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110193861|NCT00065325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110193862|NCT00065325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193863|NCT00038168|Paclitaxel|paclitaxel|mesh-list
110193864|NCT00038168|Estramustine|estramustine|mesh-list
110061657|NCT05631093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110061658|NCT05631093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110295249|NCT04560049|Phenol|phenol|mesh-list
110061659|NCT05631093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110061660|NCT05631093|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110061661|NCT05631093|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110193865|NCT00038168|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110193868|NCT00038168|Antimitotic Agents|antimitotic agents|mesh-ancestor
110193869|NCT00038168|Mitosis Modulators|mitosis modulators|mesh-ancestor
110193870|NCT00038168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193871|NCT00038168|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110193872|NCT00038168|Alkylating Agents|alkylating agents|mesh-ancestor
110193873|NCT00038168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110193874|NCT00398658|Clindamycin|clindamycin|mesh-list
110193875|NCT00398658|Clindamycin palmitate|clindamycin palmitate|mesh-list
110193876|NCT00398658|Clindamycin phosphate|clindamycin phosphate|mesh-list
110193877|NCT00398658|Gentamicins|gentamicins|mesh-list
110193878|NCT00398658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110193879|NCT00398658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110193880|NCT00398658|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110193881|NCT00398658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110193882|NCT00398658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193883|NCT00038207|Vincristine|vincristine|mesh-list
110193884|NCT00038207|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110193885|NCT00038207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110193886|NCT00038207|Tubulin Modulators|tubulin modulators|mesh-ancestor
110193887|NCT00038207|Antimitotic Agents|antimitotic agents|mesh-ancestor
110193888|NCT00038207|Mitosis Modulators|mitosis modulators|mesh-ancestor
110193889|NCT00038207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193890|NCT00398697|Gemcitabine|gemcitabine|mesh-list
110193891|NCT00398697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110193892|NCT00398697|Antimetabolites|antimetabolites|mesh-ancestor
110193893|NCT00398697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193894|NCT00398697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110193895|NCT00038246|Thalidomide|thalidomide|mesh-list
110193896|NCT00038246|Paclitaxel|paclitaxel|mesh-list
110193897|NCT00038246|Estramustine|estramustine|mesh-list
110193898|NCT00038246|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110193899|NCT00038246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110193900|NCT00038246|Tubulin Modulators|tubulin modulators|mesh-ancestor
110193901|NCT00038246|Antimitotic Agents|antimitotic agents|mesh-ancestor
110193902|NCT00038246|Mitosis Modulators|mitosis modulators|mesh-ancestor
110193903|NCT00038246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193904|NCT00038246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110193905|NCT00038246|Immunologic Factors|immunologic factors|mesh-ancestor
110193906|NCT00038246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110193907|NCT00038246|Leprostatic Agents|leprostatic agents|mesh-ancestor
110193908|NCT00038246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110193909|NCT00038246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110193910|NCT00038246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110193911|NCT00038246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110193912|NCT00038246|Growth Substances|growth substances|mesh-ancestor
110193913|NCT00038246|Growth Inhibitors|growth inhibitors|mesh-ancestor
110193914|NCT00038246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110193915|NCT00038246|Alkylating Agents|alkylating agents|mesh-ancestor
110193916|NCT00038246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110193917|NCT00398775|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110193918|NCT00398775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110193919|NCT00398814|Sorafenib|sorafenib|mesh-list
110193920|NCT00398814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110061704|NCT05605899|Hormones|hormones|mesh-ancestor
110193921|NCT00398814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110296374|NCT00424944|Vaccines|vaccines|mesh-list
110193922|NCT00398814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110193923|NCT00398814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193924|NCT00065559|Celecoxib|celecoxib|mesh-list
110193925|NCT00065559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110193926|NCT00065559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110193927|NCT00065559|Analgesics|analgesics|mesh-ancestor
110193928|NCT00065559|Sensory System Agents|sensory system agents|mesh-ancestor
110193929|NCT00065559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110193930|NCT00065559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110193931|NCT00065559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110193932|NCT00065559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110193933|NCT00065559|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110193934|NCT00065559|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110193935|NCT00065559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110193936|NCT00065559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193937|NCT00065637|Teriparatide|teriparatide|mesh-list
110193938|NCT00065637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110193939|NCT00065637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110193940|NCT00065637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110193941|NCT00396578|Vancomycin|vancomycin|mesh-list
110193942|NCT00396578|Gentamicins|gentamicins|mesh-list
110193943|NCT00396578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110193944|NCT00396578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110193945|NCT00396578|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110193946|NCT00396578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110193947|NCT00396578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193948|NCT00398853|Chromium|chromium|mesh-list
110193949|NCT00398853|Picolinic acid|picolinic acid|mesh-list
110193950|NCT00398853|Trace Elements|trace elements|mesh-ancestor
110193951|NCT00398853|Micronutrients|micronutrients|mesh-ancestor
110193952|NCT00398853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110193954|NCT00398853|Chelating Agents|chelating agents|mesh-ancestor
110193955|NCT00398853|Sequestering Agents|sequestering agents|mesh-ancestor
110193956|NCT00398853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193957|NCT05433896|Dasatinib|dasatinib|mesh-list
110193958|NCT05433896|Omeprazole|omeprazole|mesh-list
110193959|NCT05433896|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110193960|NCT05433896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110193961|NCT05433896|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110193962|NCT05433896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110193963|NCT05433896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193964|NCT05433896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110193965|NCT05433896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110193966|NCT00069888|Docetaxel|docetaxel|mesh-list
110193967|NCT00069888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110193968|NCT00069888|Tubulin Modulators|tubulin modulators|mesh-ancestor
110193969|NCT00069888|Antimitotic Agents|antimitotic agents|mesh-ancestor
110193970|NCT00069888|Mitosis Modulators|mitosis modulators|mesh-ancestor
110193971|NCT00069888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193973|NCT05433428|Lubricant Eye Drops|lubricant eye drops|mesh-list
110193974|NCT05433428|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110193975|NCT00069927|Methylphenidate|methylphenidate|mesh-list
110193976|NCT00069927|Amphetamine|amphetamine|mesh-list
110193977|NCT00069927|Adderall|adderall|mesh-list
110193978|NCT00069927|Dextroamphetamine|dextroamphetamine|mesh-list
110193979|NCT00069927|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110193980|NCT00069927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110193981|NCT00069927|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110193982|NCT00069927|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110061719|NCT05602194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110061728|NCT05600426|Cyclosporine|cyclosporine|mesh-list
110061729|NCT05600426|Cyclophosphamide|cyclophosphamide|mesh-list
110061730|NCT05600426|Methotrexate|methotrexate|mesh-list
110193983|NCT00069927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110193984|NCT00069927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193985|NCT00069927|Dopamine Agents|dopamine agents|mesh-ancestor
110193986|NCT00069927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110193987|NCT00069927|Sympathomimetics|sympathomimetics|mesh-ancestor
110193988|NCT00069927|Autonomic Agents|autonomic agents|mesh-ancestor
110193989|NCT00069927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110193990|NCT00069927|Adrenergic Agents|adrenergic agents|mesh-ancestor
110193991|NCT00069927|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110193992|NCT00069966|Cytarabine|cytarabine|mesh-list
110193993|NCT00069966|Methylprednisolone|methylprednisolone|mesh-list
110193994|NCT00069966|Rituximab|rituximab|mesh-list
110193995|NCT00069966|Pixantrone|pixantrone|mesh-list
110193996|NCT00069966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110193997|NCT00069966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110193998|NCT00069966|Immunologic Factors|immunologic factors|mesh-ancestor
110193999|NCT00069966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110194000|NCT00069966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110194001|NCT00069966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110194002|NCT00069966|Antimetabolites|antimetabolites|mesh-ancestor
110194003|NCT00069966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110194004|NCT00069966|Antiviral Agents|antiviral agents|mesh-ancestor
110194005|NCT00069966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110194006|NCT00069966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110194007|NCT00069966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110194008|NCT00069966|Antiemetics|antiemetics|mesh-ancestor
110194009|NCT00069966|Autonomic Agents|autonomic agents|mesh-ancestor
110298035|NCT00238394|Cediranib|cediranib|mesh-list
110194010|NCT00069966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110194011|NCT00069966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110194012|NCT00069966|Glucocorticoids|glucocorticoids|mesh-ancestor
110194013|NCT00069966|Hormones|hormones|mesh-ancestor
110194014|NCT00069966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110194015|NCT00069966|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110194016|NCT00069966|Protective Agents|protective agents|mesh-ancestor
110194017|NCT00069966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110194018|NCT00069966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110194019|NCT00069966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110194020|NCT00065871|Contraceptive Agents|contraceptive agents|mesh-list
110194021|NCT00065871|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110194022|NCT00065871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110194023|NCT00065949|Magnesium Sulfate|magnesium sulfate|mesh-list
110194024|NCT00065949|Analgesics|analgesics|mesh-ancestor
110194025|NCT00065949|Sensory System Agents|sensory system agents|mesh-ancestor
110194026|NCT00065949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110194027|NCT00065949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110194028|NCT00065949|Anesthetics|anesthetics|mesh-ancestor
110194029|NCT00065949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110194030|NCT00065949|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110194031|NCT00065949|Anticonvulsants|anticonvulsants|mesh-ancestor
110194032|NCT00065949|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110194033|NCT00065949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110298448|NCT05841160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110298449|NCT05815758|Ketotifen|ketotifen|mesh-list
110298450|NCT05815758|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110298461|NCT05815758|Antipruritics|antipruritics|mesh-ancestor
110194034|NCT00065949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110194035|NCT00065949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110194036|NCT00065949|Tocolytic Agents|tocolytic agents|mesh-ancestor
110194037|NCT00065949|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110194038|NCT00066027|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110194039|NCT00066027|Doxycycline|doxycycline|mesh-list
110194040|NCT00066027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110194041|NCT00066027|Antimalarials|antimalarials|mesh-ancestor
110194042|NCT00066027|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110194043|NCT00066027|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110194045|NCT00396734|Modafinil|modafinil|mesh-list
110194046|NCT00396734|Anticonvulsants|anticonvulsants|mesh-ancestor
110194047|NCT00396734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110194048|NCT00396734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110194049|NCT00396734|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110194050|NCT00396734|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110194051|NCT00396734|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110194052|NCT00396734|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110194053|NCT00396734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110194054|NCT00070083|Prednisone|prednisone|mesh-list
110194055|NCT00070083|Cyclophosphamide|cyclophosphamide|mesh-list
110194056|NCT00070083|Rituximab|rituximab|mesh-list
110194057|NCT00070083|Doxorubicin|doxorubicin|mesh-list
110194058|NCT00070083|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110194059|NCT00070083|Vincristine|vincristine|mesh-list
110194060|NCT00070083|Oblimersen|oblimersen|mesh-list
110194061|NCT00070083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110194062|NCT00070083|Immunologic Factors|immunologic factors|mesh-ancestor
110194063|NCT00070083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110194064|NCT00070083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110194065|NCT00070083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110194066|NCT00070083|Alkylating Agents|alkylating agents|mesh-ancestor
110194067|NCT00070083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110194068|NCT00070083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110194069|NCT00070083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110194070|NCT00070083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110194071|NCT00070083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110194072|NCT00070083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110194073|NCT00070083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110194074|NCT00070083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110194075|NCT00070083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110194076|NCT00070083|Glucocorticoids|glucocorticoids|mesh-ancestor
110194077|NCT00070083|Hormones|hormones|mesh-ancestor
110194078|NCT00070083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110194079|NCT00070083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110219376|NCT00110877|Darunavir|darunavir|mesh-list
110194080|NCT00070083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110194081|NCT00070083|Tubulin Modulators|tubulin modulators|mesh-ancestor
110194082|NCT00070083|Antimitotic Agents|antimitotic agents|mesh-ancestor
110194083|NCT00070083|Mitosis Modulators|mitosis modulators|mesh-ancestor
110194084|NCT00070122|Leucovorin|leucovorin|mesh-list
110194085|NCT00070122|Bevacizumab|bevacizumab|mesh-list
110194086|NCT00070122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110194087|NCT00070122|Fluorouracil|fluorouracil|mesh-list
110194088|NCT00070122|Capecitabine|capecitabine|mesh-list
110194089|NCT00070122|Oxaliplatin|oxaliplatin|mesh-list
110194090|NCT00070122|Antibodies|antibodies|mesh-list
110194091|NCT00070122|Immunoglobulins|immunoglobulins|mesh-list
110194092|NCT00070122|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110194093|NCT00070122|Levoleucovorin|levoleucovorin|mesh-list
110194094|NCT00070122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110194095|NCT00070122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110194096|NCT00070122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110194097|NCT00070122|Growth Substances|growth substances|mesh-ancestor
110194098|NCT00070122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110194099|NCT00070122|Growth Inhibitors|growth inhibitors|mesh-ancestor
110194100|NCT00070122|Immunologic Factors|immunologic factors|mesh-ancestor
110194101|NCT00070122|Antimetabolites|antimetabolites|mesh-ancestor
110194102|NCT00070122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110194103|NCT00070122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110299878|NCT01647646|Glucocorticoids|glucocorticoids|mesh-ancestor
110194104|NCT00070122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110194105|NCT00070122|Antidotes|antidotes|mesh-ancestor
110194106|NCT00070122|Protective Agents|protective agents|mesh-ancestor
110194107|NCT00070122|Vitamin B Complex|vitamin b complex|mesh-ancestor
110194109|NCT00070122|Micronutrients|micronutrients|mesh-ancestor
110194111|NCT00070161|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110194112|NCT00070161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110194113|NCT00070161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110194114|NCT00070161|Cholinergic Agents|cholinergic agents|mesh-ancestor
110194115|NCT00070161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110194116|NCT00070161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110194117|NCT00070161|Nootropic Agents|nootropic agents|mesh-ancestor
110194118|NCT00070200|Cyclophosphamide|cyclophosphamide|mesh-list
110194119|NCT00070200|Melphalan|melphalan|mesh-list
110194120|NCT00070200|Doxorubicin|doxorubicin|mesh-list
110194121|NCT00070200|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110194122|NCT00070200|Etoposide|etoposide|mesh-list
110300318|NCT00241085|Valsartan|valsartan|mesh-list
110194123|NCT00070200|Vincristine|vincristine|mesh-list
110194124|NCT00070200|Topotecan|topotecan|mesh-list
110194125|NCT00070200|Isotretinoin|isotretinoin|mesh-list
110194126|NCT00070200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110194127|NCT00070200|Immunologic Factors|immunologic factors|mesh-ancestor
110194128|NCT00070200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110194129|NCT00070200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110194130|NCT00070200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110194131|NCT00070200|Alkylating Agents|alkylating agents|mesh-ancestor
110194132|NCT00070200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110194133|NCT00070200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110194134|NCT00070200|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110194135|NCT00070200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110194136|NCT00070200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110194137|NCT00070200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110194138|NCT00070200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110194139|NCT00070200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110194140|NCT00070200|Tubulin Modulators|tubulin modulators|mesh-ancestor
110194141|NCT00070200|Antimitotic Agents|antimitotic agents|mesh-ancestor
110194142|NCT00070200|Mitosis Modulators|mitosis modulators|mesh-ancestor
110194143|NCT00070200|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110194147|NCT00066339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110194148|NCT00066339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110194149|NCT00066339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110194150|NCT00070239|Alvocidib|alvocidib|mesh-list
110194151|NCT00070239|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110194152|NCT00070239|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110194153|NCT00070239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110194154|NCT00070239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110194155|NCT00070239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110194156|NCT00070239|Growth Inhibitors|growth inhibitors|mesh-ancestor
110194157|NCT00070239|Growth Substances|growth substances|mesh-ancestor
110194158|NCT00070239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110194159|NCT00070239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110194160|NCT00070278|Paclitaxel|paclitaxel|mesh-list
110194161|NCT00070278|Cyclophosphamide|cyclophosphamide|mesh-list
110194163|NCT00070278|Epirubicin|epirubicin|mesh-list
110194164|NCT00070278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110194165|NCT00070278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110194166|NCT00070278|Tubulin Modulators|tubulin modulators|mesh-ancestor
110194167|NCT00070278|Antimitotic Agents|antimitotic agents|mesh-ancestor
110194168|NCT00070278|Mitosis Modulators|mitosis modulators|mesh-ancestor
110194169|NCT00070278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110194170|NCT00070278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110194171|NCT00070278|Immunologic Factors|immunologic factors|mesh-ancestor
110194172|NCT00070278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110194173|NCT00070278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110194174|NCT00070278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110194175|NCT00070278|Alkylating Agents|alkylating agents|mesh-ancestor
110194176|NCT00070278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110194177|NCT00070278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110194178|NCT00070278|Antimetabolites|antimetabolites|mesh-ancestor
110194179|NCT00070278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110194180|NCT00070278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110194181|NCT00070278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110194182|NCT00070278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110194184|NCT00066378|Anastrozole|anastrozole|mesh-list
110194185|NCT00066378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110194186|NCT00066378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110194187|NCT00066378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110194188|NCT00066378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110194189|NCT00066378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110194190|NCT00066378|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110194191|NCT00066378|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110194192|NCT00066378|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110194193|NCT00066378|Hormone Antagonists|hormone antagonists|mesh-ancestor
110194194|NCT00066378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110194195|NCT00066378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110194196|NCT00066417|Cyclosporine|cyclosporine|mesh-list
110194197|NCT00066417|Methylprednisolone|methylprednisolone|mesh-list
110194198|NCT00066417|Cyclophosphamide|cyclophosphamide|mesh-list
110194199|NCT00066417|Thiotepa|thiotepa|mesh-list
110194200|NCT00066417|Fludarabine|fludarabine|mesh-list
110194201|NCT00066417|Fludarabine phosphate|fludarabine phosphate|mesh-list
110194202|NCT00066417|Cyclosporins|cyclosporins|mesh-list
110194203|NCT00066417|Immunomodulating Agents|immunomodulating agents|mesh-list
110194204|NCT00066417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110194205|NCT00066417|Immunologic Factors|immunologic factors|mesh-ancestor
110194206|NCT00066417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110194207|NCT00066417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110194208|NCT00066417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110194210|NCT00066417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110194211|NCT00066417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110194212|NCT00066417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110194213|NCT00066417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110194214|NCT00066417|Antimetabolites|antimetabolites|mesh-ancestor
110194215|NCT00066417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110194216|NCT00066417|Antifungal Agents|antifungal agents|mesh-ancestor
110194217|NCT00066417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110194218|NCT00066417|Dermatologic Agents|dermatologic agents|mesh-ancestor
110194219|NCT00066417|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110194220|NCT00066417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110194221|NCT00066417|Antiemetics|antiemetics|mesh-ancestor
110194222|NCT00066417|Autonomic Agents|autonomic agents|mesh-ancestor
110194223|NCT00066417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110194224|NCT00066417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110194225|NCT00066417|Glucocorticoids|glucocorticoids|mesh-ancestor
110194227|NCT00066417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110194228|NCT00066417|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110194229|NCT00066417|Protective Agents|protective agents|mesh-ancestor
110194230|NCT00066456|Docetaxel|docetaxel|mesh-list
110194231|NCT00066456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110194232|NCT00066456|Tubulin Modulators|tubulin modulators|mesh-ancestor
110194233|NCT00066456|Antimitotic Agents|antimitotic agents|mesh-ancestor
110194234|NCT00066456|Mitosis Modulators|mitosis modulators|mesh-ancestor
110194235|NCT00066456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110194236|NCT00070434|Leucovorin|leucovorin|mesh-list
110194237|NCT00070434|Pyridoxine|pyridoxine|mesh-list
110194238|NCT00070434|Fluorouracil|fluorouracil|mesh-list
110194239|NCT00070434|Capecitabine|capecitabine|mesh-list
110194240|NCT00070434|Oxaliplatin|oxaliplatin|mesh-list
110194241|NCT00070434|Irinotecan|irinotecan|mesh-list
110194242|NCT00070434|Levoleucovorin|levoleucovorin|mesh-list
110194243|NCT00070434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110194244|NCT00070434|Antimetabolites|antimetabolites|mesh-ancestor
110194245|NCT00070434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110194246|NCT00070434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110194247|NCT00070434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110194248|NCT00070434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110194249|NCT00070434|Immunologic Factors|immunologic factors|mesh-ancestor
110194250|NCT00070434|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110194251|NCT00070434|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110194252|NCT00070434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110194253|NCT00070434|Antidotes|antidotes|mesh-ancestor
110194254|NCT00070434|Protective Agents|protective agents|mesh-ancestor
110194255|NCT00070434|Vitamin B Complex|vitamin b complex|mesh-ancestor
110194256|NCT00070434|Vitamins|vitamins|mesh-ancestor
110194257|NCT00070434|Micronutrients|micronutrients|mesh-ancestor
110194258|NCT05402891|Lithium Carbonate|lithium carbonate|mesh-list
110194259|NCT05402891|Antidepressive Agents|antidepressive agents|mesh-ancestor
110194260|NCT05402891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110194261|NCT05402891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110194262|NCT05402891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110194263|NCT05402891|Antimanic Agents|antimanic agents|mesh-ancestor
110194264|NCT05402891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110194265|NCT05402891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110194266|NCT05402891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110194267|NCT00070473|Pemetrexed|pemetrexed|mesh-list
110194268|NCT00070473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110194269|NCT00070473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110194270|NCT00070473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110194271|NCT00070473|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110194272|NCT00070473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110194273|NCT00066612|Irinotecan|irinotecan|mesh-list
110194274|NCT00066612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110194275|NCT00066612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110194276|NCT00066612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110194277|NCT00066612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110194278|NCT00066612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110194279|NCT00070551|Cytarabine|cytarabine|mesh-list
110194280|NCT00070551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110061807|NCT05554354|Fulvestrant|fulvestrant|mesh-list
110061808|NCT05554354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110061809|NCT05554354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110061810|NCT05554354|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110061811|NCT05554354|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110061812|NCT05554354|Hormone Antagonists|hormone antagonists|mesh-ancestor
110061813|NCT05554354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110194281|NCT00070551|Antimetabolites|antimetabolites|mesh-ancestor
110194282|NCT00070551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110194283|NCT00070551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110194284|NCT00070551|Antiviral Agents|antiviral agents|mesh-ancestor
110194285|NCT00070551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110194286|NCT00070551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110194287|NCT00070551|Immunologic Factors|immunologic factors|mesh-ancestor
110194288|NCT00070551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110194290|NCT00070629|Docetaxel|docetaxel|mesh-list
110194291|NCT00070629|Cisplatin|cisplatin|mesh-list
110194292|NCT00070629|Carboplatin|carboplatin|mesh-list
110194293|NCT00070629|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110303198|NCT01681966|Anesthetics|anesthetics|mesh-ancestor
110194294|NCT00070629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110194295|NCT00070629|Tubulin Modulators|tubulin modulators|mesh-ancestor
110194296|NCT00070629|Antimitotic Agents|antimitotic agents|mesh-ancestor
110194297|NCT00070629|Mitosis Modulators|mitosis modulators|mesh-ancestor
110194298|NCT00070629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110194299|NCT01349595|Bortezomib|bortezomib|mesh-list
110194300|NCT01349595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110194301|NCT05184920|Nicotine|nicotine|mesh-list
110194302|NCT05184920|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110194303|NCT05184920|Autonomic Agents|autonomic agents|mesh-ancestor
110194304|NCT05184920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110194305|NCT05184920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110194306|NCT05184920|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110194307|NCT05184920|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110194308|NCT05184920|Cholinergic Agents|cholinergic agents|mesh-ancestor
110194309|NCT05184920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110194310|NCT05184920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110194311|NCT02958501|Cholecalciferol|cholecalciferol|mesh-list
110194312|NCT02958501|Vitamin D|vitamin d|mesh-list
110194313|NCT02958501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110194314|NCT02958501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110194315|NCT02958501|Vitamins|vitamins|mesh-ancestor
110194316|NCT02958501|Micronutrients|micronutrients|mesh-ancestor
110194317|NCT02958501|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110194318|NCT00066651|Immunotoxins|immunotoxins|mesh-list
110194319|NCT00066651|Immunoconjugates|immunoconjugates|mesh-ancestor
110194320|NCT00066651|Immunologic Factors|immunologic factors|mesh-ancestor
110194321|NCT00066651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110194322|NCT00398892|Thioctic Acid|thioctic acid|mesh-list
110194323|NCT00398892|Antioxidants|antioxidants|mesh-ancestor
110194324|NCT00398892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110194325|NCT00398892|Protective Agents|protective agents|mesh-ancestor
110194326|NCT00398892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110194327|NCT00398892|Vitamin B Complex|vitamin b complex|mesh-ancestor
110194328|NCT00398892|Vitamins|vitamins|mesh-ancestor
110194329|NCT00398892|Micronutrients|micronutrients|mesh-ancestor
110194330|NCT05019794|Infigratinib|infigratinib|mesh-list
110194331|NCT05019794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110194332|NCT00066768|Suramin|suramin|mesh-list
110194333|NCT00066768|Gemcitabine|gemcitabine|mesh-list
110194334|NCT00066768|Docetaxel|docetaxel|mesh-list
110194335|NCT00066768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110194336|NCT00066768|Antimetabolites|antimetabolites|mesh-ancestor
110194337|NCT00066768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110194338|NCT00066768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110194340|NCT00066768|Antimitotic Agents|antimitotic agents|mesh-ancestor
110194341|NCT00066768|Mitosis Modulators|mitosis modulators|mesh-ancestor
110194342|NCT00066768|Antinematodal Agents|antinematodal agents|mesh-ancestor
110194343|NCT00066768|Anthelmintics|anthelmintics|mesh-ancestor
110194344|NCT00066768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110194345|NCT00066768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110194346|NCT00066768|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110194347|NCT00066768|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110194348|NCT00066846|Leucovorin|leucovorin|mesh-list
110194349|NCT00066846|Bevacizumab|bevacizumab|mesh-list
110194350|NCT00066846|Fluorouracil|fluorouracil|mesh-list
110194351|NCT00066846|Calcium|calcium|mesh-list
110194352|NCT00066846|Levoleucovorin|levoleucovorin|mesh-list
110194353|NCT00066846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110194354|NCT00066846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110194355|NCT00066846|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110194356|NCT00066846|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110194357|NCT00066846|Growth Substances|growth substances|mesh-ancestor
110194358|NCT00066846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110194359|NCT00066846|Growth Inhibitors|growth inhibitors|mesh-ancestor
110194360|NCT00066846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110194362|NCT00066846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110194363|NCT00066846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110194364|NCT00066846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110194366|NCT00066846|Antidotes|antidotes|mesh-ancestor
110194367|NCT00066846|Protective Agents|protective agents|mesh-ancestor
110194368|NCT00066846|Vitamin B Complex|vitamin b complex|mesh-ancestor
110194369|NCT00066846|Vitamins|vitamins|mesh-ancestor
110194370|NCT00066846|Micronutrients|micronutrients|mesh-ancestor
110194371|NCT00066885|Calcitriol|calcitriol|mesh-list
110194372|NCT00066885|Docetaxel|docetaxel|mesh-list
110194373|NCT00066885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110194374|NCT00066885|Tubulin Modulators|tubulin modulators|mesh-ancestor
110194375|NCT00066885|Antimitotic Agents|antimitotic agents|mesh-ancestor
110194376|NCT00066885|Mitosis Modulators|mitosis modulators|mesh-ancestor
110194377|NCT00066885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110194378|NCT00066885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110194379|NCT00066885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110194380|NCT00066885|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110194381|NCT00066885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110194382|NCT00066885|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110194383|NCT00066885|Vitamins|vitamins|mesh-ancestor
110194384|NCT00066885|Micronutrients|micronutrients|mesh-ancestor
110194385|NCT00066885|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110194386|NCT04941521|Exenatide|exenatide|mesh-list
110194387|NCT04941521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110194388|NCT04941521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110194389|NCT04941521|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110194390|NCT04941521|Incretins|incretins|mesh-ancestor
110194391|NCT04941521|Hormones|hormones|mesh-ancestor
110194392|NCT04941521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110194393|NCT02966457|Colistin|colistin|mesh-list
110194394|NCT02966457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110194395|NCT02966457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110194396|NCT00067041|Treprostinil|treprostinil|mesh-list
110194397|NCT00067041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110194398|NCT04732364|Bupivacaine|bupivacaine|mesh-list
110194399|NCT04732364|Anesthetics, Local|anesthetics, local|mesh-ancestor
110194400|NCT04732364|Anesthetics|anesthetics|mesh-ancestor
110194401|NCT04732364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110194402|NCT04732364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110194403|NCT04732364|Sensory System Agents|sensory system agents|mesh-ancestor
110194404|NCT04732364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110194406|NCT04732598|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110194408|NCT04732598|Atezolizumab|atezolizumab|mesh-list
110194409|NCT04732598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110194410|NCT04732598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110194411|NCT04732598|Tubulin Modulators|tubulin modulators|mesh-ancestor
110194412|NCT04732598|Antimitotic Agents|antimitotic agents|mesh-ancestor
110194413|NCT04732598|Mitosis Modulators|mitosis modulators|mesh-ancestor
110194414|NCT04732598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110194415|NCT04732598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110194416|NCT04732598|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110194417|NCT04732598|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110194418|NCT04732598|Growth Substances|growth substances|mesh-ancestor
110194419|NCT04732598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110194420|NCT04732598|Growth Inhibitors|growth inhibitors|mesh-ancestor
110194421|NCT04732598|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110194422|NCT00067080|Deferasirox|deferasirox|mesh-list
110194423|NCT00067080|Deferoxamine|deferoxamine|mesh-list
110194424|NCT00067080|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110194425|NCT00067080|Chelating Agents|chelating agents|mesh-ancestor
110194426|NCT00067080|Sequestering Agents|sequestering agents|mesh-ancestor
110194427|NCT00067080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110194428|NCT00067080|Siderophores|siderophores|mesh-ancestor
110194429|NCT00396851|Metformin|metformin|mesh-list
110194430|NCT00396851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110194431|NCT00396851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110194432|NCT00067119|Dipyridamole|dipyridamole|mesh-list
110194433|NCT00067119|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
110194434|NCT00067119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110194435|NCT00067119|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110194436|NCT00067119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110194437|NCT00067119|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110194438|NCT00067119|Vasodilator Agents|vasodilator agents|mesh-ancestor
110194439|NCT00396929|Paclitaxel|paclitaxel|mesh-list
110194440|NCT00396929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110194441|NCT00396929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110194442|NCT00396929|Tubulin Modulators|tubulin modulators|mesh-ancestor
110194443|NCT00396929|Antimitotic Agents|antimitotic agents|mesh-ancestor
110194444|NCT00396929|Mitosis Modulators|mitosis modulators|mesh-ancestor
110194445|NCT00396929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110194446|NCT04750772|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
110194447|NCT04750772|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110194448|NCT04750772|Chelating Agents|chelating agents|mesh-ancestor
110194449|NCT04750772|Sequestering Agents|sequestering agents|mesh-ancestor
110194450|NCT04750772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110194451|NCT04750772|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110194452|NCT00399165|Methyltestosterone|methyltestosterone|mesh-list
110194454|NCT00399165|Testosterone undecanoate|testosterone undecanoate|mesh-list
110194455|NCT00399165|Testosterone enanthate|testosterone enanthate|mesh-list
110061848|NCT05547542|Carfentanil|carfentanil|mesh-list
110061849|NCT05547542|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110061850|NCT05547542|Narcotics|narcotics|mesh-ancestor
110061851|NCT05547542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110061852|NCT05547542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110194456|NCT00399165|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110194457|NCT00399165|Dutasteride|dutasteride|mesh-list
110194458|NCT00399165|Androgens|androgens|mesh-ancestor
110194459|NCT00399165|Hormones|hormones|mesh-ancestor
110194460|NCT00399165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110194461|NCT00399165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110194462|NCT00399165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110194463|NCT00399165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110194464|NCT00399165|Anabolic Agents|anabolic agents|mesh-ancestor
110194465|NCT00399165|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110194466|NCT00399165|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110194467|NCT00399165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110194468|NCT00399165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110194469|NCT00399165|Hormone Antagonists|hormone antagonists|mesh-ancestor
110194470|NCT00067158|Nicotine|nicotine|mesh-list
110194471|NCT00067158|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110194472|NCT00067158|Autonomic Agents|autonomic agents|mesh-ancestor
110194473|NCT00067158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110194474|NCT00067158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110194475|NCT00067158|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110194476|NCT00067158|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110194477|NCT00067158|Cholinergic Agents|cholinergic agents|mesh-ancestor
110194478|NCT00067158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110194479|NCT00067158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110194480|NCT00071097|Darunavir|darunavir|mesh-list
110194481|NCT00071097|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110194482|NCT00071097|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110194483|NCT00071097|Protease Inhibitors|protease inhibitors|mesh-ancestor
110194484|NCT00071097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110194485|NCT00071097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110194486|NCT00071097|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110194487|NCT00071097|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110194488|NCT00071097|Antiviral Agents|antiviral agents|mesh-ancestor
110194489|NCT00071097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110194490|NCT00067353|Fluorides|fluorides|mesh-list
110194491|NCT00067353|Fluorides, Topical|fluorides, topical|mesh-list
110194492|NCT00067353|Cariostatic Agents|cariostatic agents|mesh-ancestor
110194493|NCT00067353|Protective Agents|protective agents|mesh-ancestor
110194494|NCT00067353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110194495|NCT00071136|Gemcitabine|gemcitabine|mesh-list
110194496|NCT00071136|Pemetrexed|pemetrexed|mesh-list
110194498|NCT00071136|Antimetabolites|antimetabolites|mesh-ancestor
110194499|NCT00071136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110194500|NCT00071136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110194501|NCT00071136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110194502|NCT00071136|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110194503|NCT00071136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110194504|NCT02970773|Rivaroxaban|rivaroxaban|mesh-list
110194505|NCT02970773|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110194506|NCT02970773|Antithrombins|antithrombins|mesh-ancestor
110194507|NCT02970773|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110194508|NCT02970773|Protease Inhibitors|protease inhibitors|mesh-ancestor
110194509|NCT02970773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110194510|NCT02970773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110194511|NCT02970773|Anticoagulants|anticoagulants|mesh-ancestor
110194512|NCT00067431|Valproic Acid|valproic acid|mesh-list
110194513|NCT00067431|Anticonvulsants|anticonvulsants|mesh-ancestor
110194514|NCT00067431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110194515|NCT00067431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110194516|NCT00067431|GABA Agents|gaba agents|mesh-ancestor
110194517|NCT00067431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110194518|NCT00067431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110194519|NCT00067431|Antimanic Agents|antimanic agents|mesh-ancestor
110194520|NCT00067431|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110194521|NCT00067431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110194524|NCT00067509|Estrogens|estrogens|mesh-list
110194525|NCT00067509|Progestins|progestins|mesh-ancestor
110194526|NCT00067509|Hormones|hormones|mesh-ancestor
110194527|NCT00067509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110194528|NCT00067509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110194529|NCT01349673|Budesonide|budesonide|mesh-list
110194530|NCT01349673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110194531|NCT01349673|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110194532|NCT01349673|Autonomic Agents|autonomic agents|mesh-ancestor
110194533|NCT01349673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110194534|NCT01349673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110194535|NCT01349673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110194536|NCT01349673|Respiratory System Agents|respiratory system agents|mesh-ancestor
110194537|NCT01349673|Glucocorticoids|glucocorticoids|mesh-ancestor
110194538|NCT01349673|Hormones|hormones|mesh-ancestor
110194539|NCT01349673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110194540|NCT00071253|Valproic Acid|valproic acid|mesh-list
110194541|NCT00071253|Olanzapine|olanzapine|mesh-list
110194542|NCT00071253|Antiemetics|antiemetics|mesh-ancestor
110194543|NCT00071253|Autonomic Agents|autonomic agents|mesh-ancestor
110194544|NCT00071253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110194545|NCT00071253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110194546|NCT00071253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110194547|NCT00071253|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110194548|NCT00071253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110194549|NCT00071253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110194550|NCT00071253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110194551|NCT00071253|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110194552|NCT00071253|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110194553|NCT00071253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110194554|NCT00071253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110194555|NCT00071253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110194556|NCT00071253|Serotonin Agents|serotonin agents|mesh-ancestor
110194557|NCT00071253|Anticonvulsants|anticonvulsants|mesh-ancestor
110194558|NCT00071253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110194559|NCT00071253|GABA Agents|gaba agents|mesh-ancestor
110194560|NCT00071253|Antimanic Agents|antimanic agents|mesh-ancestor
110194561|NCT00067548|EKB 569|ekb 569|mesh-list
110061883|NCT05491356|Plasminogen|plasminogen|mesh-list
110194562|NCT00067548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110194563|NCT00067548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110194564|NCT00067548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110194565|NCT00067548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110194566|NCT03338621|Moxifloxacin|moxifloxacin|mesh-list
110194567|NCT03338621|Rifampin|rifampin|mesh-list
110194568|NCT03338621|Isoniazid|isoniazid|mesh-list
110194569|NCT03338621|Pyrazinamide|pyrazinamide|mesh-list
110194570|NCT03338621|Ethambutol|ethambutol|mesh-list
110194571|NCT03338621|Bedaquiline|bedaquiline|mesh-list
110194572|NCT03338621|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110194573|NCT03338621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110194574|NCT03338621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110194575|NCT03338621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110194576|NCT03338621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110194577|NCT03338621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110194578|NCT03338621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110194579|NCT03338621|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110194580|NCT03338621|Antitubercular Agents|antitubercular agents|mesh-ancestor
110194581|NCT03338621|Leprostatic Agents|leprostatic agents|mesh-ancestor
110194582|NCT03338621|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110194583|NCT03338621|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110194584|NCT03338621|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110194585|NCT03338621|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110307269|NCT00295542|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110194586|NCT03338621|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110194587|NCT03338621|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110194588|NCT03338621|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110194589|NCT03338621|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110194590|NCT03338621|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110194591|NCT03338621|Antimetabolites|antimetabolites|mesh-ancestor
110194592|NCT03338621|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110194593|NCT00071331|Tolvaptan|tolvaptan|mesh-list
110194594|NCT00071331|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110194595|NCT00071331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110194596|NCT00071331|Natriuretic Agents|natriuretic agents|mesh-ancestor
110194597|NCT00071331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110194598|NCT00067626|Chromium|chromium|mesh-list
110194599|NCT00067626|Trace Elements|trace elements|mesh-ancestor
110194600|NCT00067626|Micronutrients|micronutrients|mesh-ancestor
110194601|NCT00067626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110194602|NCT00067743|Lenalidomide|lenalidomide|mesh-list
110194603|NCT00067743|Immunologic Factors|immunologic factors|mesh-ancestor
110194604|NCT00067743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110194605|NCT00067743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110194606|NCT00067743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110194607|NCT00067743|Growth Substances|growth substances|mesh-ancestor
110194608|NCT00067743|Growth Inhibitors|growth inhibitors|mesh-ancestor
110194609|NCT00067743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110194610|NCT00396968|Plerixafor|plerixafor|mesh-list
110194611|NCT00396968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110194612|NCT00396968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110194613|NCT00396968|Antiviral Agents|antiviral agents|mesh-ancestor
110194614|NCT00396968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110194615|NCT00067860|Hormones|hormones|mesh-list
110194616|NCT00067860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110061918|NCT05415397|Celecoxib|celecoxib|mesh-list
110194617|NCT00067860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110194619|NCT00071448|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110194620|NCT00071448|Insulin Aspart|insulin aspart|mesh-list
110194621|NCT00071448|Insulin Lispro|insulin lispro|mesh-list
110194622|NCT00071448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110194623|NCT00071448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110194624|NCT02599324|Paclitaxel|paclitaxel|mesh-list
110194625|NCT02599324|Docetaxel|docetaxel|mesh-list
110194626|NCT02599324|Pembrolizumab|pembrolizumab|mesh-list
110194627|NCT02599324|Cetuximab|cetuximab|mesh-list
110194628|NCT02599324|Everolimus|everolimus|mesh-list
110194629|NCT02599324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110194630|NCT02599324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110194631|NCT02599324|Tubulin Modulators|tubulin modulators|mesh-ancestor
110194632|NCT02599324|Antimitotic Agents|antimitotic agents|mesh-ancestor
110194633|NCT02599324|Mitosis Modulators|mitosis modulators|mesh-ancestor
110194634|NCT02599324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110194635|NCT02599324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110194636|NCT02599324|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110307353|NCT00266591|Topiramate|topiramate|mesh-list
110194637|NCT02599324|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110194638|NCT02599324|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110194639|NCT02599324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110194640|NCT02599324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110194641|NCT02599324|Immunologic Factors|immunologic factors|mesh-ancestor
110194642|NCT02599324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110194643|NCT00067899|Vitamins|vitamins|mesh-list
110194644|NCT00067899|Vitamin E|vitamin e|mesh-list
110194645|NCT00067899|Micronutrients|micronutrients|mesh-ancestor
110194646|NCT00067899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110194647|NCT00067899|Antioxidants|antioxidants|mesh-ancestor
110194648|NCT00067899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110194649|NCT00067899|Protective Agents|protective agents|mesh-ancestor
110194650|NCT00067938|Lamotrigine|lamotrigine|mesh-list
110194651|NCT00067938|Anticonvulsants|anticonvulsants|mesh-ancestor
110194652|NCT00067938|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110194653|NCT00067938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110194654|NCT00067938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110194655|NCT00067938|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110194656|NCT00067938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110194657|NCT00067938|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110194658|NCT00067938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110194659|NCT00067938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110194660|NCT00067938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110194661|NCT00067938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110194662|NCT02358187|Poly ICLC|poly iclc|mesh-list
110194663|NCT02358187|Interferon Inducers|interferon inducers|mesh-ancestor
110194664|NCT02358187|Immunologic Factors|immunologic factors|mesh-ancestor
110194665|NCT02358187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110194666|NCT01809808|Hormones|hormones|mesh-list
110194667|NCT01809808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110061927|NCT05415397|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110061928|NCT05415397|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110061929|NCT05415397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110194668|NCT01809808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110194669|NCT00068055|gamma-Globulins|gamma-globulins|mesh-list
110194670|NCT00068055|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110194671|NCT00068055|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110194672|NCT00068055|Immunologic Factors|immunologic factors|mesh-ancestor
110194673|NCT00068055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110194674|NCT01406197|Progesterone|progesterone|mesh-list
110194675|NCT01406197|Progestins|progestins|mesh-ancestor
110194676|NCT01406197|Hormones|hormones|mesh-ancestor
110194677|NCT01406197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110194678|NCT01406197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110194679|NCT00038402|Paclitaxel|paclitaxel|mesh-list
110194680|NCT00038402|Cyclophosphamide|cyclophosphamide|mesh-list
110194681|NCT00038402|Fluorouracil|fluorouracil|mesh-list
110194682|NCT00038402|Trastuzumab|trastuzumab|mesh-list
110194683|NCT00038402|Epirubicin|epirubicin|mesh-list
110194684|NCT00038402|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110194685|NCT00038402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110194686|NCT00038402|Tubulin Modulators|tubulin modulators|mesh-ancestor
110194687|NCT00038402|Antimitotic Agents|antimitotic agents|mesh-ancestor
110194688|NCT00038402|Mitosis Modulators|mitosis modulators|mesh-ancestor
110194689|NCT00038402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110194690|NCT00038402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110194691|NCT00038402|Immunologic Factors|immunologic factors|mesh-ancestor
110194692|NCT00038402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110194693|NCT00038402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110194694|NCT00038402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110370437|NCT04631822|Hormones|hormones|mesh-ancestor
110194695|NCT00038402|Alkylating Agents|alkylating agents|mesh-ancestor
110194696|NCT00038402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110194697|NCT00038402|Antimetabolites|antimetabolites|mesh-ancestor
110194698|NCT00038402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110194699|NCT00038402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110194700|NCT00038402|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110194701|NCT00038402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110194702|NCT00038402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110194703|NCT00038402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110194705|NCT00144703|Tacrolimus|tacrolimus|mesh-list
110194706|NCT00144703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110194707|NCT00144703|Immunologic Factors|immunologic factors|mesh-ancestor
110194708|NCT00144703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110194709|NCT00144703|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110194710|NCT00144703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110194711|NCT00144703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110194712|NCT00144703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110194713|NCT00144703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110194714|NCT00144703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110194715|NCT00144703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110194716|NCT00144703|Antifungal Agents|antifungal agents|mesh-ancestor
110194717|NCT00144820|Hyaluronic Acid|hyaluronic acid|mesh-list
110194718|NCT00144820|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110194719|NCT00144820|Immunologic Factors|immunologic factors|mesh-ancestor
110194720|NCT00144820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110194721|NCT00144820|Viscosupplements|viscosupplements|mesh-ancestor
110194722|NCT00144820|Protective Agents|protective agents|mesh-ancestor
110194723|NCT00071643|Escitalopram|escitalopram|mesh-list
110194724|NCT00071643|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110194725|NCT00071643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110307557|NCT00296127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110307558|NCT00296127|Analgesics|analgesics|mesh-ancestor
110307559|NCT00296127|Sensory System Agents|sensory system agents|mesh-ancestor
110370765|NCT04628000|Vitamin D|vitamin d|mesh-list
110307560|NCT00296127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110307561|NCT00296127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110307562|NCT00296127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110307563|NCT00296127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110307564|NCT00296127|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110370828|NCT01155583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110307565|NCT00296127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110307566|NCT00296127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110307567|NCT00296127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307568|NCT00296205|Cyclophosphamide|cyclophosphamide|mesh-list
110307569|NCT00296205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110307570|NCT00296205|Immunologic Factors|immunologic factors|mesh-ancestor
110194726|NCT00071643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110194727|NCT00071643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110194728|NCT00071643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110061953|NCT05368090|Autonomic Agents|autonomic agents|mesh-ancestor
110194730|NCT00071643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110194732|NCT00144976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110194733|NCT00144976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110194734|NCT00144976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110194735|NCT00144976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110194736|NCT00038480|Ritonavir|ritonavir|mesh-list
110194737|NCT00038480|Lopinavir|lopinavir|mesh-list
110194738|NCT00038480|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110194739|NCT00038480|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110194740|NCT00038480|Protease Inhibitors|protease inhibitors|mesh-ancestor
110194741|NCT00038480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110194742|NCT00038480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110194743|NCT00038480|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110194744|NCT00038480|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110194745|NCT00038480|Antiviral Agents|antiviral agents|mesh-ancestor
110052839|NCT01482338|Desogestrel|desogestrel|mesh-list
110194746|NCT00038480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110194747|NCT00038480|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110194748|NCT00038480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110194749|NCT00202306|Lithium Carbonate|lithium carbonate|mesh-list
110194750|NCT00202306|Antidepressive Agents|antidepressive agents|mesh-ancestor
110194751|NCT00202306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110194752|NCT00202306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110194753|NCT00202306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110194754|NCT00202306|Antimanic Agents|antimanic agents|mesh-ancestor
110194755|NCT00202306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110194756|NCT00202306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110194757|NCT00202306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110194758|NCT00038519|Ritonavir|ritonavir|mesh-list
110194759|NCT00038519|Saquinavir|saquinavir|mesh-list
110194760|NCT00038519|Amprenavir|amprenavir|mesh-list
110194761|NCT00038519|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110194762|NCT00038519|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110194763|NCT00038519|Protease Inhibitors|protease inhibitors|mesh-ancestor
110194764|NCT00038519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110194765|NCT00038519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110194766|NCT00038519|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110194767|NCT00038519|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110194768|NCT00038519|Antiviral Agents|antiviral agents|mesh-ancestor
110194769|NCT00038519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110194770|NCT00038519|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110194771|NCT00038519|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110194772|NCT00038519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110194773|NCT00038519|Antitubercular Agents|antitubercular agents|mesh-ancestor
110194774|NCT00038519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110194775|NCT00202345|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
110194776|NCT00202345|Hematinics|hematinics|mesh-ancestor
110194777|NCT00202423|Nabiximols|nabiximols|mesh-list
110194778|NCT00202423|Analgesics|analgesics|mesh-ancestor
110194779|NCT00202423|Sensory System Agents|sensory system agents|mesh-ancestor
110194780|NCT00202423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110194781|NCT00202423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110194782|NCT00202462|Testosterone|testosterone|mesh-list
110024683|NCT00005076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110194783|NCT00202462|Androgens|androgens|mesh-ancestor
110194784|NCT00202462|Hormones|hormones|mesh-ancestor
110194785|NCT00202462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110194786|NCT00202462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110194787|NCT00038558|Doxorubicin|doxorubicin|mesh-list
110194788|NCT00038558|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110194789|NCT00038558|Bleomycin|bleomycin|mesh-list
110194790|NCT00038558|Dacarbazine|dacarbazine|mesh-list
110194791|NCT00038558|Vinblastine|vinblastine|mesh-list
110194792|NCT00038558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110194793|NCT00038558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110194794|NCT00038558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110194795|NCT00038558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110194796|NCT00038558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110194797|NCT00038558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110194798|NCT00038558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110194799|NCT00038558|Alkylating Agents|alkylating agents|mesh-ancestor
110194800|NCT00038558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110194801|NCT00038558|Tubulin Modulators|tubulin modulators|mesh-ancestor
110194802|NCT00038558|Antimitotic Agents|antimitotic agents|mesh-ancestor
110194803|NCT00038558|Mitosis Modulators|mitosis modulators|mesh-ancestor
110194804|NCT00038597|Lonafarnib|lonafarnib|mesh-list
110194806|NCT00038597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110194807|NCT00202618|Amlodipine|amlodipine|mesh-list
110194808|NCT00202618|Valsartan|valsartan|mesh-list
110194809|NCT00202618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110194810|NCT00202618|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110194811|NCT00202618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110194812|NCT00202618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110194813|NCT00202618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110194814|NCT00202618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372040|NCT00571740|Fluorouracil|fluorouracil|mesh-list
110372110|NCT00563654|Alfuzosin|alfuzosin|mesh-list
110372187|NCT00572364|Olaparib|olaparib|mesh-list
110372249|NCT04611776|Paclitaxel|paclitaxel|mesh-list
110372660|NCT00577161|Vidarabine|vidarabine|mesh-list
110372786|NCT04313374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110194815|NCT00202618|Vasodilator Agents|vasodilator agents|mesh-ancestor
110194816|NCT00202618|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110194817|NCT00202618|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110194819|NCT00202696|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110194820|NCT00202696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110194821|NCT00202696|Sensory System Agents|sensory system agents|mesh-ancestor
110194822|NCT00202696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110194823|NCT00038636|Ritonavir|ritonavir|mesh-list
110194824|NCT00038636|Lopinavir|lopinavir|mesh-list
110194825|NCT00038636|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110194826|NCT00038636|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110194827|NCT00038636|Protease Inhibitors|protease inhibitors|mesh-ancestor
110194828|NCT00038636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110194829|NCT00038636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110194830|NCT00038636|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110194831|NCT00038636|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110194832|NCT00038636|Antiviral Agents|antiviral agents|mesh-ancestor
110194833|NCT00038636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110194834|NCT00038636|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110194835|NCT00038636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110194836|NCT00071838|Daclizumab|daclizumab|mesh-list
110194837|NCT00071838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110194838|NCT00071838|Immunologic Factors|immunologic factors|mesh-ancestor
110194839|NCT00071838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110194840|NCT00202852|Infliximab|infliximab|mesh-list
110194841|NCT00202852|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110194842|NCT00202852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110194843|NCT00202852|Dermatologic Agents|dermatologic agents|mesh-ancestor
110053041|NCT01484184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110368817|NCT00553943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110368819|NCT00553943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110368820|NCT00553943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110368821|NCT00563160|Carboplatin|carboplatin|mesh-list
110368822|NCT00563160|Gemcitabine|gemcitabine|mesh-list
110368823|NCT00563160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110368824|NCT00563160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110368825|NCT00563160|Antimetabolites|antimetabolites|mesh-ancestor
110194844|NCT00202852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110194845|NCT00202852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110194846|NCT00202891|Sisomicin|sisomicin|mesh-list
110194847|NCT00202891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110194848|NCT00202891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110194849|NCT00202891|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110194850|NCT00202891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110194851|NCT00202891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110194852|NCT00202969|Cisplatin|cisplatin|mesh-list
110194853|NCT00202969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110194854|NCT00203125|Rasagiline|rasagiline|mesh-list
110194855|NCT00203125|Tyramine|tyramine|mesh-list
110194856|NCT00203125|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110194857|NCT00203125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110194858|NCT00203125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110194859|NCT00203125|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110194860|NCT00203125|Protective Agents|protective agents|mesh-ancestor
110194861|NCT00203125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110194862|NCT00203125|Sympathomimetics|sympathomimetics|mesh-ancestor
110194863|NCT00203125|Autonomic Agents|autonomic agents|mesh-ancestor
110194864|NCT00203125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110194865|NCT00203125|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110194866|NCT00203125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110194867|NCT00203125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110194869|NCT00203125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110194870|NCT00203164|Rasagiline|rasagiline|mesh-list
110194871|NCT00203164|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110194872|NCT00203164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110194873|NCT00203164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110194874|NCT00203164|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110194875|NCT00203164|Protective Agents|protective agents|mesh-ancestor
110194876|NCT00203164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110194877|NCT00203281|Mycophenolic Acid|mycophenolic acid|mesh-list
110194878|NCT00203281|Tacrolimus|tacrolimus|mesh-list
110194879|NCT00203281|Daclizumab|daclizumab|mesh-list
110194880|NCT00203281|Immunoglobulins|immunoglobulins|mesh-list
110194881|NCT00203281|Antibodies|antibodies|mesh-list
110194882|NCT00203281|gamma-Globulins|gamma-globulins|mesh-list
110194883|NCT00203281|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110194884|NCT00203281|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110194885|NCT00203281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110194886|NCT00203281|Immunologic Factors|immunologic factors|mesh-ancestor
110194887|NCT00203281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110194888|NCT00203281|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110194889|NCT00203281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110194890|NCT00203281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110194891|NCT00203281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110194892|NCT00203281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110194893|NCT00203281|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110194894|NCT00203281|Antitubercular Agents|antitubercular agents|mesh-ancestor
110194895|NCT00203281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110194896|NCT00203281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110194897|NCT00203320|Etanercept|etanercept|mesh-list
110194898|NCT00203320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110194899|NCT00203320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110194900|NCT00203320|Analgesics|analgesics|mesh-ancestor
110194901|NCT00203320|Sensory System Agents|sensory system agents|mesh-ancestor
110368939|NCT04683614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110194902|NCT00203320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110194903|NCT00203320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110194904|NCT00203320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110194905|NCT00203320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110194906|NCT00203320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110194907|NCT00203320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110194908|NCT00203320|Immunologic Factors|immunologic factors|mesh-ancestor
110194909|NCT00038792|Mitogens|mitogens|mesh-list
110194910|NCT00038792|Mitosis Modulators|mitosis modulators|mesh-ancestor
110194911|NCT00038792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110194912|NCT00203359|Etanercept|etanercept|mesh-list
110062003|NCT05296564|Analgesics|analgesics|mesh-ancestor
110194913|NCT00203359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110194914|NCT00203359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110194915|NCT00203359|Analgesics|analgesics|mesh-ancestor
110194916|NCT00203359|Sensory System Agents|sensory system agents|mesh-ancestor
110194917|NCT00203359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110194918|NCT00203359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110194919|NCT00203359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110194920|NCT00203359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110194921|NCT00203359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110194922|NCT00203359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110194923|NCT00203359|Immunologic Factors|immunologic factors|mesh-ancestor
110194924|NCT00410644|Hydromorphone|hydromorphone|mesh-list
110194925|NCT00410644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110194926|NCT00410644|Narcotics|narcotics|mesh-ancestor
110194927|NCT00410644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110194928|NCT00410644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110194929|NCT00410644|Analgesics|analgesics|mesh-ancestor
110194930|NCT00410644|Sensory System Agents|sensory system agents|mesh-ancestor
110194931|NCT00410644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110194932|NCT00038831|Fludarabine|fludarabine|mesh-list
110194933|NCT00038831|Fludarabine phosphate|fludarabine phosphate|mesh-list
110194935|NCT00038831|Gemtuzumab|gemtuzumab|mesh-list
110194936|NCT00038831|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110194937|NCT00038831|Thymoglobulin|thymoglobulin|mesh-list
110194938|NCT00038831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110194939|NCT00038831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110194940|NCT00038831|Antimetabolites|antimetabolites|mesh-ancestor
110194941|NCT00038831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110194942|NCT00038831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110194943|NCT00038831|Immunologic Factors|immunologic factors|mesh-ancestor
110194944|NCT00038831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110194945|NCT00038831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110194946|NCT00038831|Alkylating Agents|alkylating agents|mesh-ancestor
110194947|NCT00038831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110194948|NCT00038831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110194949|NCT00038831|Immunotoxins|immunotoxins|mesh-ancestor
110194950|NCT00038831|Immunoconjugates|immunoconjugates|mesh-ancestor
110194951|NCT00071955|Immunoglobulins|immunoglobulins|mesh-list
110194952|NCT00071955|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110194953|NCT00071955|Antibodies|antibodies|mesh-list
110194954|NCT00071955|Sargramostim|sargramostim|mesh-list
110219555|NCT00111189|Serotonin Agents|serotonin agents|mesh-ancestor
110194955|NCT00071955|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
110194956|NCT00071955|Immunologic Factors|immunologic factors|mesh-ancestor
110194957|NCT00071955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110194958|NCT00203554|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
110194959|NCT00203554|Vasodilator Agents|vasodilator agents|mesh-ancestor
110194960|NCT00203554|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110194961|NCT00203554|Protective Agents|protective agents|mesh-ancestor
110194962|NCT00203554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110194963|NCT00203632|Rosiglitazone|rosiglitazone|mesh-list
110194964|NCT00203632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110062005|NCT05296564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110062006|NCT05296564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110062007|NCT05296564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110062008|NCT05296564|Antiviral Agents|antiviral agents|mesh-ancestor
110062009|NCT05296564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110062010|NCT05290025|Nicotine|nicotine|mesh-list
110194965|NCT00203632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110194967|NCT00071994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110194968|NCT00071994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110369102|NCT02160665|Tazarotene|tazarotene|mesh-list
110194969|NCT00071994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110194970|NCT00071994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110194972|NCT00203788|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110194973|NCT00203788|Serotonin Agents|serotonin agents|mesh-ancestor
110194974|NCT00203788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110194975|NCT00203788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110194976|NCT00203788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110194977|NCT00203788|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110194978|NCT00203788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110194979|NCT00203788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110194980|NCT00203788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110194981|NCT00203788|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110194982|NCT00203788|Dopamine Agents|dopamine agents|mesh-ancestor
110194983|NCT00072033|Docetaxel|docetaxel|mesh-list
110194984|NCT00072033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110194985|NCT00072033|Tubulin Modulators|tubulin modulators|mesh-ancestor
110194986|NCT00072033|Antimitotic Agents|antimitotic agents|mesh-ancestor
110194987|NCT00072033|Mitosis Modulators|mitosis modulators|mesh-ancestor
110194988|NCT00072033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110194989|NCT00203905|Bevacizumab|bevacizumab|mesh-list
110194990|NCT00203905|Fluorouracil|fluorouracil|mesh-list
110194991|NCT00203905|Hydroxyurea|hydroxyurea|mesh-list
110194992|NCT00203905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110194993|NCT00203905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110194994|NCT00203905|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110194995|NCT00203905|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110194996|NCT00203905|Growth Substances|growth substances|mesh-ancestor
110062029|NCT05269355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110062054|NCT05257408|Paclitaxel|paclitaxel|mesh-list
110062055|NCT05257408|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110062056|NCT05257408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110062057|NCT05257408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110062058|NCT05257408|Tubulin Modulators|tubulin modulators|mesh-ancestor
110369212|NCT00554918|Glucocorticoids|glucocorticoids|mesh-ancestor
110062059|NCT05257408|Antimitotic Agents|antimitotic agents|mesh-ancestor
110062060|NCT05257408|Mitosis Modulators|mitosis modulators|mesh-ancestor
110062061|NCT05257408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110062064|NCT05255601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110062065|NCT05255601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110062066|NCT05255601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110062067|NCT05255601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110062068|NCT05252429|Docetaxel|docetaxel|mesh-list
110062069|NCT05252429|Pembrolizumab|pembrolizumab|mesh-list
110062070|NCT05252429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110062071|NCT05252429|Tubulin Modulators|tubulin modulators|mesh-ancestor
110062072|NCT05252429|Antimitotic Agents|antimitotic agents|mesh-ancestor
110194997|NCT00203905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110194998|NCT00203905|Growth Inhibitors|growth inhibitors|mesh-ancestor
110194999|NCT00203905|Antimetabolites|antimetabolites|mesh-ancestor
110219567|NCT00111267|Vitamins|vitamins|mesh-list
110195000|NCT00203905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110195001|NCT00203905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110195002|NCT00203905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110195004|NCT00203905|Antisickling Agents|antisickling agents|mesh-ancestor
110195005|NCT00203905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110195006|NCT00203905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110195008|NCT00072072|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110195009|NCT00072072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110195010|NCT00072072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110195011|NCT00072072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110195012|NCT00072072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110195013|NCT00072072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110195014|NCT00072072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110195015|NCT00072072|Analgesics|analgesics|mesh-ancestor
110195016|NCT00072072|Sensory System Agents|sensory system agents|mesh-ancestor
110195017|NCT00072072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110195018|NCT00072072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195019|NCT00072072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110195020|NCT00072072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110164781|NCT00021385|Squalamine|squalamine|mesh-list
110195021|NCT00072072|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110195022|NCT00072072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110195023|NCT00204022|Mycophenolic Acid|mycophenolic acid|mesh-list
110195024|NCT00204022|Azathioprine|azathioprine|mesh-list
110195025|NCT00204022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110195026|NCT00204022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110195027|NCT00204022|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110195028|NCT00204022|Antitubercular Agents|antitubercular agents|mesh-ancestor
110195029|NCT00204022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110195030|NCT00204022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110195031|NCT00204022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110195032|NCT00204022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110195033|NCT00204022|Antimetabolites|antimetabolites|mesh-ancestor
110195034|NCT00204022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110195035|NCT00204022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110195036|NCT00204022|Immunologic Factors|immunologic factors|mesh-ancestor
110195037|NCT00204022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195038|NCT00204022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110195039|NCT00204061|Amisulpride|amisulpride|mesh-list
110195041|NCT00204061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110195042|NCT00204061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110195043|NCT00204061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195044|NCT00204061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110195045|NCT00204061|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110195046|NCT00204061|Dopamine Agents|dopamine agents|mesh-ancestor
110195047|NCT00204061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110195048|NCT00204061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110195049|NCT00204061|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110195050|NCT00204061|Antidepressive Agents|antidepressive agents|mesh-ancestor
110195051|NCT02966652|Methyltestosterone|methyltestosterone|mesh-list
110195052|NCT02966652|Testosterone|testosterone|mesh-list
110195053|NCT02966652|Testosterone undecanoate|testosterone undecanoate|mesh-list
110195054|NCT02966652|Testosterone enanthate|testosterone enanthate|mesh-list
110195055|NCT02966652|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110195056|NCT02966652|Androgens|androgens|mesh-ancestor
110195057|NCT02966652|Hormones|hormones|mesh-ancestor
110195058|NCT02966652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110195059|NCT02966652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110062077|NCT05249309|Ketamine|ketamine|mesh-list
110195060|NCT02966652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110195061|NCT02966652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110195062|NCT02966652|Anabolic Agents|anabolic agents|mesh-ancestor
110195064|NCT00039026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110195065|NCT00039026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195066|NCT00039026|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110195067|NCT00039026|Incretins|incretins|mesh-ancestor
110195068|NCT00039026|Hormones|hormones|mesh-ancestor
110219573|NCT00111267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195069|NCT00039026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110195070|NCT00204256|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
110195071|NCT00204256|Hematinics|hematinics|mesh-ancestor
110195072|NCT00072111|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110195073|NCT00072111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110195074|NCT00204451|Levonorgestrel|levonorgestrel|mesh-list
110195075|NCT00204451|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110195076|NCT00204451|Estradiol|estradiol|mesh-list
110195077|NCT00204451|Estrogens|estrogens|mesh-ancestor
110195078|NCT00204451|Hormones|hormones|mesh-ancestor
110195079|NCT00204451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110195080|NCT00204451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195081|NCT00204451|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110195082|NCT00204451|Contraceptive Agents|contraceptive agents|mesh-ancestor
110195083|NCT00204451|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110195084|NCT00204451|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110195085|NCT00204451|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110195086|NCT00204451|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110195087|NCT00204451|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110195088|NCT00204529|Interferons|interferons|mesh-list
110195089|NCT00204529|Interferon-alpha|interferon-alpha|mesh-list
110195090|NCT00204529|Interferon alpha-2|interferon alpha-2|mesh-list
110195091|NCT00204529|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110195092|NCT00204529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110195093|NCT00204529|Antiviral Agents|antiviral agents|mesh-ancestor
110195094|NCT00204529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110195095|NCT00204529|Immunologic Factors|immunologic factors|mesh-ancestor
110195096|NCT00204529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195097|NCT00039104|Zoledronic Acid|zoledronic acid|mesh-list
110195098|NCT00039104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110195099|NCT00039104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195100|NCT00204568|Doxorubicin|doxorubicin|mesh-list
110195101|NCT00204568|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110195102|NCT00204568|Trofosfamide|trofosfamide|mesh-list
110195103|NCT00204568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110195104|NCT00204568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110062083|NCT05249309|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110062084|NCT05249309|Anesthetics, General|anesthetics, general|mesh-ancestor
110062085|NCT05249309|Anesthetics|anesthetics|mesh-ancestor
110062086|NCT05249309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110062087|NCT05249309|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110062088|NCT05249309|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110195105|NCT00204568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110195106|NCT00204568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110195107|NCT00204568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110195108|NCT00204568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110195109|NCT00204568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110195110|NCT00204568|Immunologic Factors|immunologic factors|mesh-ancestor
110195111|NCT00204568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195112|NCT00204568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110195113|NCT00204568|Alkylating Agents|alkylating agents|mesh-ancestor
110195115|NCT00072150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110195116|NCT00204646|Carboplatin|carboplatin|mesh-list
110195117|NCT00204646|Etoposide|etoposide|mesh-list
110195118|NCT00204646|Doxorubicin|doxorubicin|mesh-list
110195119|NCT00204646|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110195120|NCT00204646|Ifosfamide|ifosfamide|mesh-list
110195121|NCT00204646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110195122|NCT00204646|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110195123|NCT00204646|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110195124|NCT00204646|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110195125|NCT00204646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110195126|NCT00204646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110195127|NCT00204646|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110195128|NCT00204646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110195130|NCT00039182|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110195131|NCT00039182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110195132|NCT00039182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110195133|NCT00039182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110195134|NCT00039182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110195135|NCT00410878|Hydromorphone|hydromorphone|mesh-list
110195136|NCT00410878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110195137|NCT00410878|Narcotics|narcotics|mesh-ancestor
110195138|NCT00410878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110195139|NCT00410878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195140|NCT00410878|Analgesics|analgesics|mesh-ancestor
110195141|NCT00410878|Sensory System Agents|sensory system agents|mesh-ancestor
110195142|NCT00410878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110195144|NCT00410995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110195145|NCT00410995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110195146|NCT00410995|Analgesics|analgesics|mesh-ancestor
110195147|NCT00410995|Sensory System Agents|sensory system agents|mesh-ancestor
110195148|NCT00410995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110195149|NCT00410995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195151|NCT00410995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110195152|NCT00410995|Gout Suppressants|gout suppressants|mesh-ancestor
110195153|NCT00410995|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110195154|NCT00410995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110195155|NCT00410995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110195156|NCT00039338|Cisplatin|cisplatin|mesh-list
110195157|NCT00039338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110195158|NCT00072228|Gemcitabine|gemcitabine|mesh-list
110195159|NCT00072228|Soblidotin|soblidotin|mesh-list
110195160|NCT00072228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110195161|NCT00072228|Antimetabolites|antimetabolites|mesh-ancestor
110195162|NCT00072228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110195163|NCT00072228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110195164|NCT00204919|Vitamin D|vitamin d|mesh-list
110195165|NCT00204919|Ergocalciferols|ergocalciferols|mesh-list
110195166|NCT00204919|Vitamins|vitamins|mesh-ancestor
110195167|NCT00204919|Micronutrients|micronutrients|mesh-ancestor
110195168|NCT00204919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195169|NCT00204919|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110195170|NCT00204919|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110195171|NCT00072267|Topotecan|topotecan|mesh-list
110195172|NCT00072267|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
110195173|NCT00072267|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110195174|NCT00072267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110195175|NCT00072267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110195176|NCT00072267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110195177|NCT00072267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110195178|NCT00072267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110195179|NCT00039416|Imatinib Mesylate|imatinib mesylate|mesh-list
110195180|NCT00039416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110195181|NCT00039416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110195182|NCT00039416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110195183|NCT00039416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110195185|NCT00072345|Temozolomide|temozolomide|mesh-list
110195186|NCT00072345|Lomustine|lomustine|mesh-list
110195187|NCT00072345|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110195188|NCT00072345|Alkylating Agents|alkylating agents|mesh-ancestor
110195189|NCT00072345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110195190|NCT00072345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110195191|NCT00072345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110195193|NCT00072345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195194|NCT00072345|Leprostatic Agents|leprostatic agents|mesh-ancestor
110195195|NCT00072345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110195196|NCT00072345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110195197|NCT00072345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110219591|NCT00287170|Calcitriol|calcitriol|mesh-list
110195198|NCT00072345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110195199|NCT00072345|Growth Substances|growth substances|mesh-ancestor
110195200|NCT00072345|Growth Inhibitors|growth inhibitors|mesh-ancestor
110195201|NCT00039455|Trastuzumab|trastuzumab|mesh-list
110195202|NCT00039455|Alvocidib|alvocidib|mesh-list
110195203|NCT00039455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110195204|NCT00039455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110195205|NCT00039455|Growth Inhibitors|growth inhibitors|mesh-ancestor
110165212|NCT00394966|Rolapitant|rolapitant|mesh-list
110195206|NCT00039455|Growth Substances|growth substances|mesh-ancestor
110195207|NCT00039455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195208|NCT00039455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110195209|NCT00039455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110195210|NCT00039455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110195212|NCT00205231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110195213|NCT00205231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110195214|NCT00205231|Analgesics|analgesics|mesh-ancestor
110195215|NCT00205231|Sensory System Agents|sensory system agents|mesh-ancestor
110195216|NCT00205231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110195217|NCT00205231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195218|NCT00205231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110195219|NCT00205231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110195220|NCT00205231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110195221|NCT00205231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110195222|NCT00205231|Immunologic Factors|immunologic factors|mesh-ancestor
110195223|NCT00072462|Tamoxifen|tamoxifen|mesh-list
110195224|NCT00072462|Anastrozole|anastrozole|mesh-list
110195225|NCT00072462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110195226|NCT00072462|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110195227|NCT00072462|Hormone Antagonists|hormone antagonists|mesh-ancestor
110195228|NCT00072462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110195229|NCT00072462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195230|NCT00072462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110195231|NCT00072462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110195232|NCT00072462|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110195233|NCT00072462|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110195234|NCT00072462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110195235|NCT00072462|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110195236|NCT00072462|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110195237|NCT00072462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110195238|NCT00205426|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
110195239|NCT00205426|Natriuretic Agents|natriuretic agents|mesh-ancestor
110195240|NCT00205426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195241|NCT00039494|Temozolomide|temozolomide|mesh-list
110195242|NCT00039494|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110195243|NCT00039494|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110195244|NCT00039494|Alkylating Agents|alkylating agents|mesh-ancestor
110195245|NCT00039494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110195246|NCT00039494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110195247|NCT00039494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110195248|NCT00039494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110195249|NCT00205738|Olanzapine|olanzapine|mesh-list
110195250|NCT00205738|Risperidone|risperidone|mesh-list
110195251|NCT00205738|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110195252|NCT00205738|Serotonin Agents|serotonin agents|mesh-ancestor
110195253|NCT00205738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110195254|NCT00205738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110195255|NCT00205738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195256|NCT00205738|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110195257|NCT00205738|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110195258|NCT00205738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110195259|NCT00205738|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110195260|NCT00205738|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110195261|NCT00205738|Dopamine Agents|dopamine agents|mesh-ancestor
110195262|NCT00205738|Antiemetics|antiemetics|mesh-ancestor
110195263|NCT00205738|Autonomic Agents|autonomic agents|mesh-ancestor
110195264|NCT00205738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110195265|NCT00205738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110195266|NCT00205738|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110195267|NCT00205738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110195268|NCT00205738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110195269|NCT00205816|Tigecycline|tigecycline|mesh-list
110195270|NCT00205816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110195271|NCT00205816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110195272|NCT00205816|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110195273|NCT00205816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110195274|NCT00205816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110195275|NCT00072540|Celecoxib|celecoxib|mesh-list
110195277|NCT00072540|Mitogens|mitogens|mesh-list
110195278|NCT00072540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110195279|NCT00072540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110195280|NCT00072540|Analgesics|analgesics|mesh-ancestor
110195281|NCT00072540|Sensory System Agents|sensory system agents|mesh-ancestor
110195282|NCT00072540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110195283|NCT00072540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195284|NCT00072540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110195285|NCT00072540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110195286|NCT00072540|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110195287|NCT00072540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110195288|NCT00072540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110195289|NCT00072540|Mitosis Modulators|mitosis modulators|mesh-ancestor
110195290|NCT00206050|Esomeprazole|esomeprazole|mesh-list
110195291|NCT00206050|Pantoprazole|pantoprazole|mesh-list
110195292|NCT00206050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110195293|NCT00206050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110195294|NCT00206050|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110195295|NCT00206050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110195296|NCT00206050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110195297|NCT00206089|Ximelagatran|ximelagatran|mesh-list
110195298|NCT00206089|Melagatran|melagatran|mesh-list
110195299|NCT00206089|Antithrombins|antithrombins|mesh-ancestor
110195300|NCT00206089|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110195301|NCT00206089|Protease Inhibitors|protease inhibitors|mesh-ancestor
110195302|NCT00206089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110195303|NCT00206089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110195304|NCT00206089|Anticoagulants|anticoagulants|mesh-ancestor
110195305|NCT00072579|Sargramostim|sargramostim|mesh-list
110195306|NCT00072579|Immunologic Factors|immunologic factors|mesh-ancestor
110195307|NCT00072579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195309|NCT04732247|Oxytocics|oxytocics|mesh-ancestor
110195310|NCT04732247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110195311|NCT04732247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195312|NCT00206128|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110195313|NCT00206128|Antidepressive Agents|antidepressive agents|mesh-ancestor
110195314|NCT00206128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110195315|NCT00206128|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110195316|NCT00206128|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110195317|NCT00206128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110195318|NCT00206128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195319|NCT00206167|Budesonide|budesonide|mesh-list
110195320|NCT00206167|Formoterol Fumarate|formoterol fumarate|mesh-list
110195321|NCT00206167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110195322|NCT00206167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110195323|NCT00206167|Autonomic Agents|autonomic agents|mesh-ancestor
110195324|NCT00206167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110165452|NCT00023920|Idarubicin|idarubicin|mesh-list
110195325|NCT00206167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195326|NCT00206167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110195327|NCT00206167|Respiratory System Agents|respiratory system agents|mesh-ancestor
110195328|NCT00206167|Glucocorticoids|glucocorticoids|mesh-ancestor
110195330|NCT00206167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110195331|NCT00206167|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110195332|NCT00206167|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110195333|NCT00206167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110195334|NCT00206167|Adrenergic Agents|adrenergic agents|mesh-ancestor
110195335|NCT00206167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110195336|NCT00206167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110195337|NCT00039611|Leucovorin|leucovorin|mesh-list
110195338|NCT00039611|Fluorouracil|fluorouracil|mesh-list
110195339|NCT00039611|Oxaliplatin|oxaliplatin|mesh-list
110195340|NCT00039611|Calcium|calcium|mesh-list
110195341|NCT00039611|Levoleucovorin|levoleucovorin|mesh-list
110195342|NCT00039611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110195343|NCT00039611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195344|NCT00039611|Antimetabolites|antimetabolites|mesh-ancestor
110195345|NCT00039611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110195346|NCT00039611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110195347|NCT00039611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110195348|NCT00039611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110195349|NCT00039611|Immunologic Factors|immunologic factors|mesh-ancestor
110195350|NCT00039611|Antidotes|antidotes|mesh-ancestor
110195351|NCT00039611|Protective Agents|protective agents|mesh-ancestor
110195352|NCT00039611|Vitamin B Complex|vitamin b complex|mesh-ancestor
110195353|NCT00039611|Vitamins|vitamins|mesh-ancestor
110195354|NCT00039611|Micronutrients|micronutrients|mesh-ancestor
110195355|NCT00068289|Bortezomib|bortezomib|mesh-list
110195356|NCT00068289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110195357|NCT00039767|Lepirudin|lepirudin|mesh-list
110195358|NCT00039767|Antithrombins|antithrombins|mesh-ancestor
110195359|NCT00039767|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110195360|NCT00039767|Protease Inhibitors|protease inhibitors|mesh-ancestor
110195361|NCT00039767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110195362|NCT00039767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110195363|NCT00039767|Anticoagulants|anticoagulants|mesh-ancestor
110195364|NCT00039767|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110195365|NCT00039767|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110195366|NCT00072618|Sulindac sulfone|sulindac sulfone|mesh-list
110195367|NCT00072618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110195368|NCT00072618|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110195369|NCT00072618|Protective Agents|protective agents|mesh-ancestor
110195370|NCT00072618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110062287|NCT04888858|Fentanyl|fentanyl|mesh-list
110062288|NCT04888858|Bupivacaine|bupivacaine|mesh-list
110062289|NCT04888858|Anesthetics, Local|anesthetics, local|mesh-ancestor
110062290|NCT04888858|Anesthetics|anesthetics|mesh-ancestor
110062291|NCT04888858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110062292|NCT04888858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110062293|NCT04888858|Sensory System Agents|sensory system agents|mesh-ancestor
110219618|NCT00287209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110062294|NCT04888858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110195371|NCT00072618|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110195372|NCT00072618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110195373|NCT00072618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110195374|NCT00072618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110195375|NCT00072618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110195376|NCT00072618|Analgesics|analgesics|mesh-ancestor
110195377|NCT00072618|Sensory System Agents|sensory system agents|mesh-ancestor
110195378|NCT00072618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110195379|NCT00072618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110195380|NCT00072618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110195381|NCT00039884|Darbepoetin alfa|darbepoetin alfa|mesh-list
110195382|NCT00039884|Hematinics|hematinics|mesh-ancestor
110195383|NCT00206401|Insulin Glargine|insulin glargine|mesh-list
110195384|NCT00206401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110195385|NCT00206401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195387|NCT00399204|Pioglitazone|pioglitazone|mesh-list
110195388|NCT00399204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110195389|NCT00399204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195390|NCT00411034|Hydromorphone|hydromorphone|mesh-list
110195391|NCT00411034|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110195392|NCT00411034|Narcotics|narcotics|mesh-ancestor
110195393|NCT00411034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110195394|NCT00411034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195395|NCT00411034|Analgesics|analgesics|mesh-ancestor
110195396|NCT00411034|Sensory System Agents|sensory system agents|mesh-ancestor
110195397|NCT00411034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110195398|NCT00411073|Darapladib|darapladib|mesh-list
110195399|NCT00411073|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
110195400|NCT00411073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110195401|NCT00411073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110195402|NCT00411190|Acetaminophen|acetaminophen|mesh-list
110195403|NCT00411190|Ibuprofen|ibuprofen|mesh-list
110195404|NCT00411190|Atorvastatin|atorvastatin|mesh-list
110195405|NCT00411190|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110195406|NCT00411190|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110195407|NCT00411190|Antimetabolites|antimetabolites|mesh-ancestor
110195408|NCT00411190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110165613|NCT00024310|Mitosis Modulators|mitosis modulators|mesh-ancestor
110195410|NCT00411190|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110195411|NCT00411190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110195412|NCT00411190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110195413|NCT00411190|Analgesics|analgesics|mesh-ancestor
110195414|NCT00411190|Sensory System Agents|sensory system agents|mesh-ancestor
110195415|NCT00411190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110195416|NCT00411190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195417|NCT00411190|Antipyretics|antipyretics|mesh-ancestor
110195418|NCT00411190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110195419|NCT00411190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110052967|NCT01483365|Progesterone|progesterone|mesh-list
110195420|NCT00411190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110195421|NCT00411190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110195422|NCT00411229|Capecitabine|capecitabine|mesh-list
110195423|NCT00411229|Oxaliplatin|oxaliplatin|mesh-list
110195424|NCT00411229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110195425|NCT00411229|Antimetabolites|antimetabolites|mesh-ancestor
110195426|NCT00411229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110195427|NCT00411229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110195428|NCT00411268|Hydromorphone|hydromorphone|mesh-list
110195429|NCT00411268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110195430|NCT00411268|Narcotics|narcotics|mesh-ancestor
110195431|NCT00411268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110195432|NCT00411268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195434|NCT00411268|Sensory System Agents|sensory system agents|mesh-ancestor
110195435|NCT00411268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110195436|NCT00039962|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110195437|NCT00039962|Thymalfasin|thymalfasin|mesh-list
110195438|NCT00039962|Antiviral Agents|antiviral agents|mesh-ancestor
110219626|NCT00077948|Sympatholytics|sympatholytics|mesh-ancestor
110195439|NCT00039962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110195440|NCT00039962|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110195441|NCT00039962|Immunologic Factors|immunologic factors|mesh-ancestor
110195442|NCT00039962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195443|NCT00424333|Insulin|insulin|mesh-list
110195444|NCT00424333|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110195445|NCT00424333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110195446|NCT00424333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195447|NCT00206557|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
110195448|NCT00206557|Estradiol|estradiol|mesh-list
110195449|NCT00206557|Estrogens|estrogens|mesh-ancestor
110195450|NCT00206557|Hormones|hormones|mesh-ancestor
110195451|NCT00206557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110195452|NCT00206557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195453|NCT00206557|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110195454|NCT00206557|Hormone Antagonists|hormone antagonists|mesh-ancestor
110195455|NCT00206557|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110195456|NCT00206557|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110195457|NCT00206557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110195458|NCT00068484|Bortezomib|bortezomib|mesh-list
110195459|NCT00068484|Topotecan|topotecan|mesh-list
110195460|NCT00068484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110195461|NCT00068484|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110195462|NCT00068484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110195463|NCT00068484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110195464|NCT00068484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110195465|NCT00206596|Sargramostim|sargramostim|mesh-list
110195466|NCT00206596|Immunologic Factors|immunologic factors|mesh-ancestor
110195467|NCT00206596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195468|NCT00206635|Interferons|interferons|mesh-list
110195469|NCT00206635|Interferon-beta|interferon-beta|mesh-list
110195470|NCT00206635|Interferon beta-1b|interferon beta-1b|mesh-list
110195471|NCT00206635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110195472|NCT00206635|Antiviral Agents|antiviral agents|mesh-ancestor
110195473|NCT00206635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110195474|NCT00206635|Immunologic Factors|immunologic factors|mesh-ancestor
110195475|NCT00206635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195476|NCT00206635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110195477|NCT00206674|Sargramostim|sargramostim|mesh-list
110195478|NCT00206674|Immunologic Factors|immunologic factors|mesh-ancestor
110195479|NCT00206674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195480|NCT00206713|Sargramostim|sargramostim|mesh-list
110195481|NCT00206713|Immunologic Factors|immunologic factors|mesh-ancestor
110195482|NCT00206713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195483|NCT00040040|Bupropion|bupropion|mesh-list
110195484|NCT00040040|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110195485|NCT00040040|Antidepressive Agents|antidepressive agents|mesh-ancestor
110195486|NCT00040040|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110195487|NCT00040040|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110383603|NCT06043336|Granisetron|granisetron|mesh-list
110195488|NCT00040040|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110195489|NCT00040040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110195490|NCT00040040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110195491|NCT00040040|Dopamine Agents|dopamine agents|mesh-ancestor
110195492|NCT00040040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110195493|NCT00040040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110052969|NCT01483365|Hormones|hormones|mesh-ancestor
110195494|NCT00040040|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110195495|NCT00040040|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110195496|NCT00040040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110195497|NCT00068523|Cyclosporine|cyclosporine|mesh-list
110195498|NCT00068523|Methylprednisolone|methylprednisolone|mesh-list
110195499|NCT00068523|Cyclophosphamide|cyclophosphamide|mesh-list
110195500|NCT00068523|Fludarabine|fludarabine|mesh-list
110195501|NCT00068523|Fludarabine phosphate|fludarabine phosphate|mesh-list
110195502|NCT00068523|Cyclosporins|cyclosporins|mesh-list
110195503|NCT00068523|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110195504|NCT00068523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110195505|NCT00068523|Immunologic Factors|immunologic factors|mesh-ancestor
110195506|NCT00068523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195507|NCT00068523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110195508|NCT00068523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110195509|NCT00068523|Alkylating Agents|alkylating agents|mesh-ancestor
110195510|NCT00068523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110195511|NCT00068523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110195512|NCT00068523|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110195513|NCT00068523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110195514|NCT00068523|Antimetabolites|antimetabolites|mesh-ancestor
110195515|NCT00068523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110195516|NCT00068523|Antifungal Agents|antifungal agents|mesh-ancestor
110195517|NCT00068523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110195518|NCT00068523|Dermatologic Agents|dermatologic agents|mesh-ancestor
110195519|NCT00068523|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110195520|NCT00068523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110195521|NCT00068523|Antiemetics|antiemetics|mesh-ancestor
110195522|NCT00068523|Autonomic Agents|autonomic agents|mesh-ancestor
110195523|NCT00068523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110195524|NCT00068523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110195525|NCT00068523|Glucocorticoids|glucocorticoids|mesh-ancestor
110195526|NCT00068523|Hormones|hormones|mesh-ancestor
110195527|NCT00068523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110195528|NCT00068523|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110195529|NCT00068523|Protective Agents|protective agents|mesh-ancestor
110195530|NCT00040157|Dexelvucitabine|dexelvucitabine|mesh-list
110195531|NCT00040157|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110195532|NCT00040157|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110195533|NCT00040157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110195534|NCT00040157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110195535|NCT00040157|Antiviral Agents|antiviral agents|mesh-ancestor
110195536|NCT00040157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110195537|NCT00040157|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110195538|NCT00040157|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110195539|NCT00206947|Ziprasidone|ziprasidone|mesh-list
110195540|NCT00206947|Donepezil|donepezil|mesh-list
110062324|NCT04837716|Bevacizumab|bevacizumab|mesh-list
110062325|NCT04837716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110062326|NCT04837716|Carboplatin|carboplatin|mesh-list
110062327|NCT04837716|Pemetrexed|pemetrexed|mesh-list
110062328|NCT04837716|Ensartinib|ensartinib|mesh-list
110195541|NCT00206947|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110195542|NCT00206947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110195543|NCT00206947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110195544|NCT00206947|Cholinergic Agents|cholinergic agents|mesh-ancestor
110195545|NCT00206947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110195546|NCT00206947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195547|NCT00206947|Nootropic Agents|nootropic agents|mesh-ancestor
110195548|NCT00206947|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110195549|NCT00206947|Serotonin Agents|serotonin agents|mesh-ancestor
110195550|NCT00206947|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110195551|NCT00206947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110195552|NCT00206947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110195553|NCT00206947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110195554|NCT00206947|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110195555|NCT00206947|Dopamine Agents|dopamine agents|mesh-ancestor
110195556|NCT00068757|Paclitaxel|paclitaxel|mesh-list
110195557|NCT00068757|Trastuzumab|trastuzumab|mesh-list
110195558|NCT00068757|Lonafarnib|lonafarnib|mesh-list
110195559|NCT00068757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110195560|NCT00068757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110195561|NCT00068757|Tubulin Modulators|tubulin modulators|mesh-ancestor
110195562|NCT00068757|Antimitotic Agents|antimitotic agents|mesh-ancestor
110195563|NCT00068757|Mitosis Modulators|mitosis modulators|mesh-ancestor
110195564|NCT00068757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110195565|NCT00068757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110195566|NCT00068757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110195567|NCT00206986|Clonidine|clonidine|mesh-list
110195568|NCT00206986|Analgesics|analgesics|mesh-ancestor
110195569|NCT00206986|Sensory System Agents|sensory system agents|mesh-ancestor
110195570|NCT00206986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110195571|NCT00206986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195572|NCT00206986|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110195573|NCT00206986|Sympatholytics|sympatholytics|mesh-ancestor
110195574|NCT00206986|Autonomic Agents|autonomic agents|mesh-ancestor
110165819|NCT00025363|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110195575|NCT00206986|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110195576|NCT00206986|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110195577|NCT00206986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110195578|NCT00206986|Adrenergic Agents|adrenergic agents|mesh-ancestor
110195579|NCT00206986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110195580|NCT00206986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110195581|NCT00207064|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110195582|NCT00207064|Antidepressive Agents|antidepressive agents|mesh-ancestor
110195583|NCT00207064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110195584|NCT00207064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110195585|NCT00207064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110195586|NCT00207064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110195587|NCT00207064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195588|NCT00040274|Dexelvucitabine|dexelvucitabine|mesh-list
110195589|NCT00040274|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110195590|NCT00040274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110195591|NCT00040274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110195592|NCT00040274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110195593|NCT00040274|Antiviral Agents|antiviral agents|mesh-ancestor
110195594|NCT00040274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110195595|NCT00040274|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110195596|NCT00040274|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110195598|NCT00072852|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110195599|NCT00072852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110195600|NCT00072852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110195601|NCT00072852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110195602|NCT00072852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110195603|NCT00207532|Folic Acid|folic acid|mesh-list
110195604|NCT00207532|Hematinics|hematinics|mesh-ancestor
110195605|NCT00207532|Vitamin B Complex|vitamin b complex|mesh-ancestor
110195606|NCT00207532|Vitamins|vitamins|mesh-ancestor
110195608|NCT00207532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195609|NCT00040391|Leucovorin|leucovorin|mesh-list
110165854|NCT00025441|Ifosfamide|ifosfamide|mesh-list
110195610|NCT00040391|Fluorouracil|fluorouracil|mesh-list
110195611|NCT00040391|Irinotecan|irinotecan|mesh-list
110195612|NCT00040391|Antimetabolites|antimetabolites|mesh-ancestor
110195613|NCT00040391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110195614|NCT00040391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110195615|NCT00040391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110195616|NCT00040391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110195617|NCT00040391|Immunologic Factors|immunologic factors|mesh-ancestor
110195618|NCT00040391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195619|NCT00040391|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110195620|NCT00040391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110195621|NCT00040391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110195622|NCT00040391|Antidotes|antidotes|mesh-ancestor
110195623|NCT00040391|Protective Agents|protective agents|mesh-ancestor
110195624|NCT00040391|Vitamin B Complex|vitamin b complex|mesh-ancestor
110195625|NCT00040391|Vitamins|vitamins|mesh-ancestor
110195626|NCT00040391|Micronutrients|micronutrients|mesh-ancestor
110195627|NCT00207688|Infliximab|infliximab|mesh-list
110195628|NCT00207688|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110195629|NCT00207688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110195630|NCT00207688|Dermatologic Agents|dermatologic agents|mesh-ancestor
110195631|NCT00207688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110195632|NCT00207688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110195634|NCT00207766|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110195635|NCT00207766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110195636|NCT00207766|Dermatologic Agents|dermatologic agents|mesh-ancestor
110195637|NCT00207766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110195638|NCT00207766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110195639|NCT00040469|Cyclophosphamide|cyclophosphamide|mesh-list
110195640|NCT00040469|Busulfan|busulfan|mesh-list
110195641|NCT00040469|Alemtuzumab|alemtuzumab|mesh-list
110195642|NCT00040469|Phenytoin|phenytoin|mesh-list
110195643|NCT00040469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110195644|NCT00040469|Immunologic Factors|immunologic factors|mesh-ancestor
110195645|NCT00040469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195646|NCT00040469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110195647|NCT00040469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110195648|NCT00040469|Alkylating Agents|alkylating agents|mesh-ancestor
110195649|NCT00040469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110195650|NCT00040469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110195651|NCT00040469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110195652|NCT00040469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110195653|NCT00040469|Anticonvulsants|anticonvulsants|mesh-ancestor
110195654|NCT00040469|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110195655|NCT00040469|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110195656|NCT00040469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110195657|NCT00040469|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110195658|NCT00040469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110195660|NCT00207844|Selenious Acid|selenious acid|mesh-list
110195661|NCT00207844|Sodium Selenite|sodium selenite|mesh-list
110195662|NCT00207844|Antioxidants|antioxidants|mesh-ancestor
110195663|NCT00207844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110195664|NCT00207844|Protective Agents|protective agents|mesh-ancestor
110195665|NCT00207844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195666|NCT00207844|Trace Elements|trace elements|mesh-ancestor
110195667|NCT00207844|Micronutrients|micronutrients|mesh-ancestor
110195668|NCT00072930|Zoledronic Acid|zoledronic acid|mesh-list
110195669|NCT00072930|Prednisone|prednisone|mesh-list
110195670|NCT00072930|Docetaxel|docetaxel|mesh-list
110195671|NCT00072930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110195672|NCT00072930|Tubulin Modulators|tubulin modulators|mesh-ancestor
110195673|NCT00072930|Antimitotic Agents|antimitotic agents|mesh-ancestor
110195674|NCT00072930|Mitosis Modulators|mitosis modulators|mesh-ancestor
110195675|NCT00072930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110195676|NCT00072930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110195677|NCT00072930|Glucocorticoids|glucocorticoids|mesh-ancestor
110195678|NCT00072930|Hormones|hormones|mesh-ancestor
110195679|NCT00072930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110195680|NCT00072930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195681|NCT00072930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110195682|NCT00072930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110195683|NCT00411307|Hydromorphone|hydromorphone|mesh-list
110195684|NCT00411307|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110195685|NCT00411307|Narcotics|narcotics|mesh-ancestor
110195686|NCT00411307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110195687|NCT00411307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195688|NCT00411307|Analgesics|analgesics|mesh-ancestor
110195689|NCT00411307|Sensory System Agents|sensory system agents|mesh-ancestor
110195690|NCT00411307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110195691|NCT00040508|Sirolimus|sirolimus|mesh-list
110195692|NCT00040508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110195693|NCT00040508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110195694|NCT00040508|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110195695|NCT00040508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110195696|NCT00040508|Antifungal Agents|antifungal agents|mesh-ancestor
110195697|NCT00040508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110195698|NCT00040508|Immunologic Factors|immunologic factors|mesh-ancestor
110195699|NCT00040508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195700|NCT00424411|Insulin|insulin|mesh-list
110195701|NCT00424411|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110195702|NCT00424411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110195703|NCT00424411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195705|NCT00072969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110195706|NCT00072969|Immunologic Factors|immunologic factors|mesh-ancestor
110195707|NCT00072969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195708|NCT00424606|Docetaxel|docetaxel|mesh-list
110195709|NCT00424606|Epirubicin|epirubicin|mesh-list
110195710|NCT00424606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110195711|NCT00424606|Tubulin Modulators|tubulin modulators|mesh-ancestor
110195712|NCT00424606|Antimitotic Agents|antimitotic agents|mesh-ancestor
110195713|NCT00424606|Mitosis Modulators|mitosis modulators|mesh-ancestor
110195714|NCT00424606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110195715|NCT00424606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110195716|NCT00424606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110195717|NCT00424606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110195718|NCT00424606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110195719|NCT00208039|Calfactant|calfactant|mesh-list
110195720|NCT00208039|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
110195721|NCT00208039|Respiratory System Agents|respiratory system agents|mesh-ancestor
110195722|NCT02962921|Insulin|insulin|mesh-list
110195723|NCT02962921|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110195724|NCT02962921|Insulin Lispro|insulin lispro|mesh-list
110195725|NCT02962921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110195726|NCT02962921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195727|NCT00040586|Interleukin-2|interleukin-2|mesh-list
110195728|NCT00040586|Antibodies|antibodies|mesh-list
110195729|NCT00040586|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110195730|NCT00040586|Immunologic Factors|immunologic factors|mesh-ancestor
110195731|NCT00040586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195732|NCT00040586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110195733|NCT00040586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110195734|NCT00040586|Analgesics|analgesics|mesh-ancestor
110195735|NCT00040586|Sensory System Agents|sensory system agents|mesh-ancestor
110195736|NCT00040586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110195737|NCT00208117|Sertraline|sertraline|mesh-list
110195738|NCT00208117|Simvastatin|simvastatin|mesh-list
110195739|NCT00208117|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110195740|NCT00208117|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110195741|NCT00208117|Antimetabolites|antimetabolites|mesh-ancestor
110195742|NCT00208117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110195743|NCT00208117|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110195744|NCT00208117|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110195745|NCT00208117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110195746|NCT00208117|Antidepressive Agents|antidepressive agents|mesh-ancestor
110195748|NCT00208117|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110195749|NCT00208117|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110195750|NCT00208117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110195751|NCT00208117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110195752|NCT00208117|Serotonin Agents|serotonin agents|mesh-ancestor
110195753|NCT00208117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195754|NCT00208156|Mifepristone|mifepristone|mesh-list
110195755|NCT00208156|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110195756|NCT00208156|Abortifacient Agents|abortifacient agents|mesh-ancestor
110195757|NCT00208156|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110195758|NCT00208156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195759|NCT00208156|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110195760|NCT00208156|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110195761|NCT00208156|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110195762|NCT00208156|Contraceptive Agents|contraceptive agents|mesh-ancestor
110195763|NCT00208156|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110195764|NCT00208156|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110195765|NCT00208156|Hormone Antagonists|hormone antagonists|mesh-ancestor
110195766|NCT00208156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110195767|NCT00208156|Luteolytic Agents|luteolytic agents|mesh-ancestor
110195768|NCT00208156|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110195769|NCT00208156|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110195770|NCT00040625|Pemetrexed|pemetrexed|mesh-list
110195771|NCT00040625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110195772|NCT00040625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110195773|NCT00040625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110195774|NCT00040625|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110195775|NCT00040625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110195776|NCT00208195|Valproic Acid|valproic acid|mesh-list
110195777|NCT00208195|Anticonvulsants|anticonvulsants|mesh-ancestor
110195778|NCT00208195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110195779|NCT00208195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110195781|NCT00208195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110195782|NCT00208195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195783|NCT00208195|Antimanic Agents|antimanic agents|mesh-ancestor
110195784|NCT00208195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110195785|NCT00208195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110195786|NCT00208195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110195787|NCT00208234|Omalizumab|omalizumab|mesh-list
110195788|NCT00208234|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110195789|NCT00208234|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110195790|NCT00208234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110195791|NCT00208234|Respiratory System Agents|respiratory system agents|mesh-ancestor
110195792|NCT00208234|Immunologic Factors|immunologic factors|mesh-ancestor
110195793|NCT00208234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195796|NCT00208273|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110195797|NCT00208273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110195798|NCT00208273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110195799|NCT00208273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110195800|NCT00208273|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110195801|NCT00208273|Hormone Antagonists|hormone antagonists|mesh-ancestor
110195802|NCT00208273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110195803|NCT00208273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195804|NCT00208312|Adenosine|adenosine|mesh-list
110195805|NCT00208312|Regadenoson|regadenoson|mesh-list
110195806|NCT00208312|Analgesics|analgesics|mesh-ancestor
110195807|NCT00208312|Sensory System Agents|sensory system agents|mesh-ancestor
110195808|NCT00208312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110195809|NCT00208312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195810|NCT00208312|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110195811|NCT00208312|Vasodilator Agents|vasodilator agents|mesh-ancestor
110195812|NCT00208312|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110195813|NCT00208312|Purinergic Agonists|purinergic agonists|mesh-ancestor
110195814|NCT00208312|Purinergic Agents|purinergic agents|mesh-ancestor
110195815|NCT00208312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110195816|NCT00208312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110195817|NCT00208312|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
110195818|NCT00040781|Gefitinib|gefitinib|mesh-list
110195819|NCT00040781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110195820|NCT00040781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110195821|NCT00040781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110195822|NCT00040781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110195824|NCT00068952|Carmustine|carmustine|mesh-list
110195825|NCT00068952|Lomustine|lomustine|mesh-list
110195826|NCT00068952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110195827|NCT00068952|Alkylating Agents|alkylating agents|mesh-ancestor
110195828|NCT00068952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110195829|NCT00068952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110195830|NCT00040820|Oxaliplatin|oxaliplatin|mesh-list
110195831|NCT00040820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110195832|NCT00208546|Bevacizumab|bevacizumab|mesh-list
110195833|NCT00208546|Cetuximab|cetuximab|mesh-list
110195834|NCT00208546|Capecitabine|capecitabine|mesh-list
110195835|NCT00208546|Oxaliplatin|oxaliplatin|mesh-list
110195836|NCT00208546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110195837|NCT00208546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110195838|NCT00208546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110195839|NCT00208546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110195840|NCT00208546|Growth Substances|growth substances|mesh-ancestor
110195841|NCT00208546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195842|NCT00208546|Growth Inhibitors|growth inhibitors|mesh-ancestor
110195843|NCT00208546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110195844|NCT00208546|Antimetabolites|antimetabolites|mesh-ancestor
110195845|NCT00208546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110195846|NCT00208585|Sertraline|sertraline|mesh-list
110195847|NCT00208585|Antidepressive Agents|antidepressive agents|mesh-ancestor
110195848|NCT00208585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110195849|NCT00208585|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110195850|NCT00208585|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110195851|NCT00208585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110195852|NCT00208585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110195853|NCT00208585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110195854|NCT00208585|Serotonin Agents|serotonin agents|mesh-ancestor
110166445|NCT00027898|Bortezomib|bortezomib|mesh-list
110195855|NCT00208585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195857|NCT00040859|Oxaliplatin|oxaliplatin|mesh-list
110195858|NCT00040859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110195859|NCT00040859|Antimetabolites|antimetabolites|mesh-ancestor
110195860|NCT00040859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110195861|NCT00040859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110195862|NCT00208702|Sertraline|sertraline|mesh-list
110195863|NCT00208702|Antidepressive Agents|antidepressive agents|mesh-ancestor
110195864|NCT00208702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110195865|NCT00208702|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110195866|NCT00208702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110195867|NCT00208702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110195868|NCT00208702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110195869|NCT00208702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110195870|NCT00208702|Serotonin Agents|serotonin agents|mesh-ancestor
110195871|NCT00208702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195872|NCT00208741|Tiagabine|tiagabine|mesh-list
110195873|NCT00208741|Anticonvulsants|anticonvulsants|mesh-ancestor
110195874|NCT00208741|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
110166495|NCT00012051|Hormones|hormones|mesh-ancestor
110195875|NCT00208741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110195876|NCT00208741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110195877|NCT00208741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110195878|NCT00208741|GABA Agents|gaba agents|mesh-ancestor
110195879|NCT00208741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110195880|NCT00208741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195881|NCT00399048|Hydromorphone|hydromorphone|mesh-list
110195882|NCT00399048|Oxycodone|oxycodone|mesh-list
110195883|NCT00399048|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110195884|NCT00399048|Narcotics|narcotics|mesh-ancestor
110195885|NCT00399048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110195886|NCT00399048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195887|NCT00399048|Analgesics|analgesics|mesh-ancestor
110195888|NCT00399048|Sensory System Agents|sensory system agents|mesh-ancestor
110219705|NCT00287560|Anesthetics, General|anesthetics, general|mesh-ancestor
110195889|NCT00399048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110195890|NCT00208819|Valproic Acid|valproic acid|mesh-list
110195891|NCT00208819|Olanzapine|olanzapine|mesh-list
110195892|NCT00208819|Risperidone|risperidone|mesh-list
110195893|NCT00208819|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110195894|NCT00208819|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110195895|NCT00208819|Serotonin Agents|serotonin agents|mesh-ancestor
110195896|NCT00208819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110195897|NCT00208819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110195898|NCT00208819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195899|NCT00208819|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110195900|NCT00208819|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110062430|NCT04685616|Immunotoxins|immunotoxins|mesh-ancestor
110195901|NCT00208819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110195902|NCT00208819|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110195903|NCT00208819|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110195904|NCT00208819|Dopamine Agents|dopamine agents|mesh-ancestor
110195905|NCT00208819|Antiemetics|antiemetics|mesh-ancestor
110195906|NCT00208819|Autonomic Agents|autonomic agents|mesh-ancestor
110195907|NCT00208819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110195908|NCT00208819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110195909|NCT00208819|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110195910|NCT00208819|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110195911|NCT00208819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110195912|NCT00208819|Antidepressive Agents|antidepressive agents|mesh-ancestor
110195913|NCT00208819|Anticonvulsants|anticonvulsants|mesh-ancestor
110195914|NCT00208819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110195915|NCT00208819|GABA Agents|gaba agents|mesh-ancestor
110195916|NCT00208819|Antimanic Agents|antimanic agents|mesh-ancestor
110195917|NCT00208858|Topiramate|topiramate|mesh-list
110195918|NCT00208858|Anticonvulsants|anticonvulsants|mesh-ancestor
110195919|NCT00208858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110195920|NCT00208858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195921|NCT00041015|Etoposide|etoposide|mesh-list
110195922|NCT00041015|Topotecan|topotecan|mesh-list
110195923|NCT00041015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110195924|NCT00041015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110195925|NCT00041015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110195926|NCT00041015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110195927|NCT00041015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110195928|NCT00041015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110195929|NCT00041015|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110195930|NCT00073047|Daclizumab|daclizumab|mesh-list
110195931|NCT00073047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110195932|NCT00073047|Immunologic Factors|immunologic factors|mesh-ancestor
110195933|NCT00073047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195934|NCT00208897|Fluoxetine|fluoxetine|mesh-list
110195935|NCT00208897|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110195936|NCT00208897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110195937|NCT00208897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110195938|NCT00208897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110195939|NCT00208897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110195940|NCT00208897|Serotonin Agents|serotonin agents|mesh-ancestor
110195941|NCT00208897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195942|NCT00208897|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110195944|NCT00208897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110195945|NCT00208897|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110195946|NCT00208897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110195947|NCT00208897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110195948|NCT00208936|Fluorouracil|fluorouracil|mesh-list
110195949|NCT00208936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110195950|NCT00208936|Antimetabolites|antimetabolites|mesh-ancestor
110195951|NCT00208936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110195952|NCT00208936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110195953|NCT00208936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110195954|NCT00208936|Immunologic Factors|immunologic factors|mesh-ancestor
110195955|NCT00208936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195956|NCT00209014|Thalidomide|thalidomide|mesh-list
110195957|NCT00209014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110195958|NCT00209014|Immunologic Factors|immunologic factors|mesh-ancestor
110195959|NCT00209014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195960|NCT00209014|Leprostatic Agents|leprostatic agents|mesh-ancestor
110062445|NCT04665570|Metformin|metformin|mesh-list
110195962|NCT00209014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110195963|NCT00209014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110195964|NCT00209014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110195966|NCT00209014|Growth Inhibitors|growth inhibitors|mesh-ancestor
110195967|NCT00209014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110195968|NCT00041054|Sulindac sulfone|sulindac sulfone|mesh-list
110195969|NCT00041054|Carboplatin|carboplatin|mesh-list
110195970|NCT00041054|Etoposide|etoposide|mesh-list
110195971|NCT00041054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110195972|NCT00041054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110195973|NCT00041054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110195974|NCT00041054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110195975|NCT00041054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110195976|NCT00041054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110195977|NCT00041054|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110195978|NCT00041054|Protective Agents|protective agents|mesh-ancestor
110195979|NCT00041054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195980|NCT00041054|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110195981|NCT00041054|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110195982|NCT00041054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110195983|NCT00041054|Analgesics|analgesics|mesh-ancestor
110195984|NCT00041054|Sensory System Agents|sensory system agents|mesh-ancestor
110195985|NCT00041054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110195986|NCT00041054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110195987|NCT00041054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110195988|NCT00209209|Interferons|interferons|mesh-list
110195989|NCT00209209|Interferon-alpha|interferon-alpha|mesh-list
110195990|NCT00209209|Interferon alpha-2|interferon alpha-2|mesh-list
110195991|NCT00209209|Prednisone|prednisone|mesh-list
110195992|NCT00209209|Cyclophosphamide|cyclophosphamide|mesh-list
110195993|NCT00209209|Rituximab|rituximab|mesh-list
110195994|NCT00209209|Doxorubicin|doxorubicin|mesh-list
110195995|NCT00209209|Fludarabine|fludarabine|mesh-list
110195996|NCT00209209|Vincristine|vincristine|mesh-list
110166751|NCT00388778|Doxycycline|doxycycline|mesh-list
110195997|NCT00209209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110195998|NCT00209209|Immunologic Factors|immunologic factors|mesh-ancestor
110195999|NCT00209209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110196000|NCT00209209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110196001|NCT00209209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110196002|NCT00209209|Alkylating Agents|alkylating agents|mesh-ancestor
110196003|NCT00209209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110196004|NCT00209209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110219732|NCT00287794|Anesthetics, General|anesthetics, general|mesh-ancestor
110196005|NCT00209209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110196006|NCT00209209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110196007|NCT00209209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110196008|NCT00209209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110196009|NCT00209209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110196011|NCT00209209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110196012|NCT00209209|Glucocorticoids|glucocorticoids|mesh-ancestor
110196013|NCT00209209|Hormones|hormones|mesh-ancestor
110196014|NCT00209209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110196015|NCT00209209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110196016|NCT00209209|Antiviral Agents|antiviral agents|mesh-ancestor
110196017|NCT00209209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110196018|NCT00209209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110196019|NCT00209209|Tubulin Modulators|tubulin modulators|mesh-ancestor
110196020|NCT00209209|Antimitotic Agents|antimitotic agents|mesh-ancestor
110196021|NCT00209209|Mitosis Modulators|mitosis modulators|mesh-ancestor
110196023|NCT00041093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110196024|NCT00041093|Tubulin Modulators|tubulin modulators|mesh-ancestor
110196025|NCT00041093|Antimitotic Agents|antimitotic agents|mesh-ancestor
110196027|NCT00041093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110196028|NCT00399087|Prednisone|prednisone|mesh-list
110196029|NCT00399087|Docetaxel|docetaxel|mesh-list
110196030|NCT00399087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110196031|NCT00399087|Tubulin Modulators|tubulin modulators|mesh-ancestor
110196032|NCT00399087|Antimitotic Agents|antimitotic agents|mesh-ancestor
110196033|NCT00399087|Mitosis Modulators|mitosis modulators|mesh-ancestor
110166865|NCT00028873|Paclitaxel|paclitaxel|mesh-list
110196034|NCT00399087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110196035|NCT00399087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110196036|NCT00399087|Glucocorticoids|glucocorticoids|mesh-ancestor
110196037|NCT00399087|Hormones|hormones|mesh-ancestor
110196038|NCT00399087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110196039|NCT00399087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110196040|NCT00399087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110196041|NCT00209482|Metformin|metformin|mesh-list
110196042|NCT00209482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110196043|NCT00209482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110196044|NCT00041171|Docetaxel|docetaxel|mesh-list
110196045|NCT00041171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110196046|NCT00041171|Tubulin Modulators|tubulin modulators|mesh-ancestor
110196047|NCT00041171|Antimitotic Agents|antimitotic agents|mesh-ancestor
110196048|NCT00041171|Mitosis Modulators|mitosis modulators|mesh-ancestor
110196049|NCT00041171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110196050|NCT00209521|Propofol|propofol|mesh-list
110196051|NCT00209521|Fospropofol|fospropofol|mesh-list
110196052|NCT00209521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110196053|NCT00209521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110196054|NCT00209521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110196055|NCT00209521|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110196056|NCT00209521|Anesthetics, General|anesthetics, general|mesh-ancestor
110196057|NCT00209521|Anesthetics|anesthetics|mesh-ancestor
110196058|NCT00209638|Irinotecan|irinotecan|mesh-list
110196059|NCT00209638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110196060|NCT00209638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110196061|NCT00209638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110196062|NCT00209638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110196063|NCT00209638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110196064|NCT00399126|Paclitaxel|paclitaxel|mesh-list
110196065|NCT00399126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110196066|NCT00399126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110196068|NCT00399126|Antimitotic Agents|antimitotic agents|mesh-ancestor
110196069|NCT00399126|Mitosis Modulators|mitosis modulators|mesh-ancestor
110196070|NCT00399126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110196071|NCT00209677|Gemcitabine|gemcitabine|mesh-list
110196072|NCT00209677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110196073|NCT00209677|Antimetabolites|antimetabolites|mesh-ancestor
110196074|NCT00209677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110196075|NCT00209677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110196077|NCT00209716|Docetaxel|docetaxel|mesh-list
110196078|NCT00209716|Fluorouracil|fluorouracil|mesh-list
110196079|NCT00209716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110196080|NCT00209716|Tubulin Modulators|tubulin modulators|mesh-ancestor
110196081|NCT00209716|Antimitotic Agents|antimitotic agents|mesh-ancestor
110196082|NCT00209716|Mitosis Modulators|mitosis modulators|mesh-ancestor
110196083|NCT00209716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110196084|NCT00209716|Antimetabolites|antimetabolites|mesh-ancestor
110196085|NCT00209716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110196086|NCT00209716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110196087|NCT00209716|Immunologic Factors|immunologic factors|mesh-ancestor
110196088|NCT00209716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110196089|NCT00209755|Ribavirin|ribavirin|mesh-list
110196090|NCT00209755|Antimetabolites|antimetabolites|mesh-ancestor
110196091|NCT00209755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110196092|NCT00209755|Antiviral Agents|antiviral agents|mesh-ancestor
110196093|NCT00209755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110196094|NCT00209794|Pyrimethamine|pyrimethamine|mesh-list
110196095|NCT00209794|Sulfadoxine|sulfadoxine|mesh-list
110196096|NCT00209794|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110196097|NCT00209794|Antimalarials|antimalarials|mesh-ancestor
110196098|NCT00209794|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110196099|NCT00209794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110196100|NCT00209794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110196101|NCT00209794|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110196102|NCT00209794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110196103|NCT00209794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110196104|NCT00209794|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110196105|NCT00209833|Cytarabine|cytarabine|mesh-list
110196106|NCT00209833|Fludarabine|fludarabine|mesh-list
110196107|NCT00209833|Etoposide|etoposide|mesh-list
110196108|NCT00209833|Idarubicin|idarubicin|mesh-list
110196109|NCT00209833|Daunorubicin|daunorubicin|mesh-list
110196110|NCT00209833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110196111|NCT00209833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110196112|NCT00209833|Antimetabolites|antimetabolites|mesh-ancestor
110196113|NCT00209833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110196114|NCT00209833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110196115|NCT00209833|Immunologic Factors|immunologic factors|mesh-ancestor
110196116|NCT00209833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110196117|NCT00209833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110196118|NCT00209833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110196119|NCT00209833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110196120|NCT00209833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110196121|NCT00209833|Antiviral Agents|antiviral agents|mesh-ancestor
110196122|NCT00209833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110196123|NCT00209833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110196124|NCT00041210|Prednisone|prednisone|mesh-list
110196126|NCT00041210|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110196127|NCT00041210|Bleomycin|bleomycin|mesh-list
110196128|NCT00041210|Etoposide|etoposide|mesh-list
110196129|NCT00041210|Vincristine|vincristine|mesh-list
110196130|NCT00041210|Dacarbazine|dacarbazine|mesh-list
110196131|NCT00041210|Vinblastine|vinblastine|mesh-list
110196132|NCT00041210|Mechlorethamine|mechlorethamine|mesh-list
110196133|NCT00041210|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110196134|NCT00041210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110196135|NCT00041210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110196136|NCT00041210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110196138|NCT00041210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110196139|NCT00041210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110196140|NCT00041210|Glucocorticoids|glucocorticoids|mesh-ancestor
110196141|NCT00041210|Hormones|hormones|mesh-ancestor
110196142|NCT00041210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110196143|NCT00041210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110196144|NCT00041210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110196145|NCT00041210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110196146|NCT00041210|Tubulin Modulators|tubulin modulators|mesh-ancestor
110196147|NCT00041210|Antimitotic Agents|antimitotic agents|mesh-ancestor
110196148|NCT00041210|Mitosis Modulators|mitosis modulators|mesh-ancestor
110196149|NCT00041210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110196150|NCT00041210|Alkylating Agents|alkylating agents|mesh-ancestor
110196151|NCT00209872|Lidocaine|lidocaine|mesh-list
110196152|NCT00209872|Ketamine|ketamine|mesh-list
110196153|NCT00209872|Gabapentin|gabapentin|mesh-list
110196154|NCT00209872|Esketamine|esketamine|mesh-list
110196155|NCT00209872|Anesthetics, Local|anesthetics, local|mesh-ancestor
110196156|NCT00209872|Anesthetics|anesthetics|mesh-ancestor
110196157|NCT00209872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110196158|NCT00209872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110196159|NCT00209872|Sensory System Agents|sensory system agents|mesh-ancestor
110196160|NCT00209872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110196161|NCT00209872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110196162|NCT00209872|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110196163|NCT00209872|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110196164|NCT00209872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110196165|NCT00209872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110196166|NCT00209872|Analgesics|analgesics|mesh-ancestor
110196167|NCT00209872|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110196168|NCT00209872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110196169|NCT00209872|Anesthetics, General|anesthetics, general|mesh-ancestor
110196170|NCT00209872|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110196171|NCT00209872|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110196172|NCT00209872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110196174|NCT00209872|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110196175|NCT00209872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110196176|NCT00209872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110196177|NCT00209872|Antimanic Agents|antimanic agents|mesh-ancestor
110196178|NCT00209872|Antidepressive Agents|antidepressive agents|mesh-ancestor
110196180|NCT00209950|Analgesics|analgesics|mesh-ancestor
110196181|NCT00209950|Sensory System Agents|sensory system agents|mesh-ancestor
110196182|NCT00209950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110196183|NCT00209950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110196184|NCT00209950|Anticonvulsants|anticonvulsants|mesh-ancestor
110196185|NCT00209950|GABA Agonists|gaba agonists|mesh-ancestor
110196186|NCT00209950|GABA Agents|gaba agents|mesh-ancestor
110196187|NCT00209950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110196188|NCT00209950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110196189|NCT00209989|Tipifarnib|tipifarnib|mesh-list
110219770|NCT00111540|Hormones|hormones|mesh-ancestor
110196190|NCT00209989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110196191|NCT00210028|Tamoxifen|tamoxifen|mesh-list
110196192|NCT00210028|Tipifarnib|tipifarnib|mesh-list
110196193|NCT00210028|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110196194|NCT00210028|Hormone Antagonists|hormone antagonists|mesh-ancestor
110196195|NCT00210028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110395566|NCT00106184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110196196|NCT00210028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110196197|NCT00210028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110196198|NCT00210028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110196199|NCT00210028|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110196200|NCT00210028|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110196201|NCT00210028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110196203|NCT00041288|Mycophenolic Acid|mycophenolic acid|mesh-list
110196204|NCT00041288|Cyclophosphamide|cyclophosphamide|mesh-list
110196205|NCT00041288|Methotrexate|methotrexate|mesh-list
110196206|NCT00041288|Fludarabine|fludarabine|mesh-list
110196207|NCT00041288|Fludarabine phosphate|fludarabine phosphate|mesh-list
110196208|NCT00041288|Tacrolimus|tacrolimus|mesh-list
110196209|NCT00041288|Cyclosporins|cyclosporins|mesh-list
110196210|NCT00041288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110196211|NCT00041288|Immunologic Factors|immunologic factors|mesh-ancestor
110196212|NCT00041288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110196213|NCT00041288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110167198|NCT00030433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110196214|NCT00041288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110196215|NCT00041288|Alkylating Agents|alkylating agents|mesh-ancestor
110196216|NCT00041288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110196217|NCT00041288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110196218|NCT00041288|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110196219|NCT00041288|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110196220|NCT00041288|Abortifacient Agents|abortifacient agents|mesh-ancestor
110196221|NCT00041288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110196222|NCT00041288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110196223|NCT00041288|Antimetabolites|antimetabolites|mesh-ancestor
110196224|NCT00041288|Dermatologic Agents|dermatologic agents|mesh-ancestor
110196225|NCT00041288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110196226|NCT00041288|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110196227|NCT00041288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110196228|NCT00041288|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110196229|NCT00041288|Antifungal Agents|antifungal agents|mesh-ancestor
110196230|NCT00041288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110196231|NCT00041288|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110196232|NCT00041288|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110196233|NCT00041288|Antitubercular Agents|antitubercular agents|mesh-ancestor
110196234|NCT00041288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110196235|NCT00073164|Valproic Acid|valproic acid|mesh-list
110196237|NCT00073164|Risperidone|risperidone|mesh-list
110196238|NCT00073164|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110196239|NCT00073164|Serotonin Agents|serotonin agents|mesh-ancestor
110167265|NCT00030745|Gemcitabine|gemcitabine|mesh-list
110196240|NCT00073164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110196241|NCT00073164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110196242|NCT00073164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110196243|NCT00073164|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110196244|NCT00073164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110196245|NCT00073164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110196246|NCT00073164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110196247|NCT00073164|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110196248|NCT00073164|Dopamine Agents|dopamine agents|mesh-ancestor
110196249|NCT00073164|Antiemetics|antiemetics|mesh-ancestor
110196250|NCT00073164|Autonomic Agents|autonomic agents|mesh-ancestor
110196251|NCT00073164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110196252|NCT00073164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110196253|NCT00073164|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110196254|NCT00073164|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110196255|NCT00073164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110196256|NCT00073164|Anticonvulsants|anticonvulsants|mesh-ancestor
110196257|NCT00073164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110196258|NCT00073164|GABA Agents|gaba agents|mesh-ancestor
110196259|NCT00073164|Antimanic Agents|antimanic agents|mesh-ancestor
110196261|NCT00210301|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110196262|NCT00210301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110196263|NCT00210301|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110196264|NCT00210301|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110196265|NCT00210301|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110196266|NCT00210301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110196267|NCT00210340|Rituximab|rituximab|mesh-list
110196268|NCT00210340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110196269|NCT00210340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110196270|NCT00210340|Immunologic Factors|immunologic factors|mesh-ancestor
110196271|NCT00210340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110196272|NCT00210340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110196274|NCT00411541|Vincristine|vincristine|mesh-list
110196275|NCT00411541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110196276|NCT00411541|Antiemetics|antiemetics|mesh-ancestor
110196277|NCT00411541|Autonomic Agents|autonomic agents|mesh-ancestor
110196278|NCT00411541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110196279|NCT00411541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110196280|NCT00411541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110196281|NCT00411541|Glucocorticoids|glucocorticoids|mesh-ancestor
110196282|NCT00411541|Hormones|hormones|mesh-ancestor
110196283|NCT00411541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110196284|NCT00411541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110196285|NCT00411541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110196286|NCT00411541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110196287|NCT00411541|Tubulin Modulators|tubulin modulators|mesh-ancestor
110196288|NCT00411541|Antimitotic Agents|antimitotic agents|mesh-ancestor
110196289|NCT00411541|Mitosis Modulators|mitosis modulators|mesh-ancestor
110167353|NCT00031135|Choline|choline|mesh-list
110196290|NCT00411541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110196292|NCT00210379|Methotrexate|methotrexate|mesh-list
110196293|NCT00210379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110196294|NCT00210379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110196295|NCT00210379|Immunologic Factors|immunologic factors|mesh-ancestor
110196296|NCT00210379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110196297|NCT00210379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110196298|NCT00210379|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110196299|NCT00210379|Abortifacient Agents|abortifacient agents|mesh-ancestor
110196300|NCT00210379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110196301|NCT00210379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110196302|NCT00210379|Antimetabolites|antimetabolites|mesh-ancestor
110196303|NCT00210379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110196304|NCT00210379|Dermatologic Agents|dermatologic agents|mesh-ancestor
110196305|NCT00210379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110196306|NCT00210379|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110196307|NCT00210379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110196308|NCT00210379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110196309|NCT00041327|Interferons|interferons|mesh-list
110196310|NCT00041327|Interferon-alpha|interferon-alpha|mesh-list
110196311|NCT00041327|Lamivudine|lamivudine|mesh-list
110196312|NCT00041327|Zidovudine|zidovudine|mesh-list
110196313|NCT00041327|Prednisone|prednisone|mesh-list
110196314|NCT00041327|Cyclophosphamide|cyclophosphamide|mesh-list
110196315|NCT00041327|Doxorubicin|doxorubicin|mesh-list
110196316|NCT00041327|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110196317|NCT00041327|Etoposide|etoposide|mesh-list
110196318|NCT00041327|Vincristine|vincristine|mesh-list
110196319|NCT00041327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110196320|NCT00041327|Immunologic Factors|immunologic factors|mesh-ancestor
110196321|NCT00041327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110196322|NCT00041327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110196323|NCT00041327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110196324|NCT00041327|Alkylating Agents|alkylating agents|mesh-ancestor
110196325|NCT00041327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110196326|NCT00041327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110196327|NCT00041327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110196328|NCT00041327|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110196329|NCT00041327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110397108|NCT01100437|Morphine|morphine|mesh-list
110196330|NCT00041327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110196331|NCT00041327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110196332|NCT00041327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110196334|NCT00041327|Hormones|hormones|mesh-ancestor
110196335|NCT00041327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110196336|NCT00041327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110196337|NCT00041327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110196338|NCT00041327|Antiviral Agents|antiviral agents|mesh-ancestor
110196339|NCT00041327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110196340|NCT00041327|Tubulin Modulators|tubulin modulators|mesh-ancestor
110196341|NCT00041327|Antimitotic Agents|antimitotic agents|mesh-ancestor
110196342|NCT00041327|Mitosis Modulators|mitosis modulators|mesh-ancestor
110196343|NCT00041327|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110196344|NCT00041327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110196345|NCT00041327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110196346|NCT00041327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110196348|NCT00210457|Lanreotide|lanreotide|mesh-list
110196349|NCT00210457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110196350|NCT00210496|Topiramate|topiramate|mesh-list
110196351|NCT00210496|Almotriptan|almotriptan|mesh-list
110196352|NCT00210496|Anticonvulsants|anticonvulsants|mesh-ancestor
110196353|NCT00210496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110196354|NCT00210496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110196355|NCT00210496|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110196356|NCT00210496|Serotonin Agents|serotonin agents|mesh-ancestor
110196357|NCT00210496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110167495|NCT00031876|Antimitotic Agents|antimitotic agents|mesh-ancestor
110196358|NCT00210496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110196360|NCT00210535|Anticonvulsants|anticonvulsants|mesh-ancestor
110196361|NCT00210535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110196362|NCT00210535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110196363|NCT00210574|Topiramate|topiramate|mesh-list
110196364|NCT00210574|Anticonvulsants|anticonvulsants|mesh-ancestor
110196365|NCT00210574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110196366|NCT00210574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110196367|NCT00210691|Risperidone|risperidone|mesh-list
110196368|NCT00210691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110196369|NCT00210691|Serotonin Agents|serotonin agents|mesh-ancestor
110196370|NCT00210691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110196371|NCT00210691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110196372|NCT00210691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110196373|NCT00210691|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110196374|NCT00210691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110196375|NCT00210691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110196376|NCT00210691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110196377|NCT00210691|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110196378|NCT00210691|Dopamine Agents|dopamine agents|mesh-ancestor
110196379|NCT00210730|Epoetin Alfa|epoetin alfa|mesh-list
110196380|NCT00210730|Hematinics|hematinics|mesh-ancestor
110196381|NCT00210769|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110196382|NCT00210769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110196383|NCT00210769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110196384|NCT00210769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110196385|NCT00210769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110196386|NCT00210769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110196387|NCT00210769|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110196388|NCT00210769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110196389|NCT00210769|Serotonin Agents|serotonin agents|mesh-ancestor
110196390|NCT00210769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110196391|NCT00210769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110196392|NCT00210769|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110196393|NCT00210769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110196394|NCT00210769|Dopamine Agents|dopamine agents|mesh-ancestor
110196395|NCT00210808|Topiramate|topiramate|mesh-list
110196396|NCT00210808|Anticonvulsants|anticonvulsants|mesh-ancestor
110196397|NCT00210808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110196398|NCT00210808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110196400|NCT00210847|Tramadol|tramadol|mesh-list
110196401|NCT00210847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110196402|NCT00210847|Analgesics|analgesics|mesh-ancestor
110196403|NCT00210847|Sensory System Agents|sensory system agents|mesh-ancestor
110196404|NCT00210847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110196405|NCT00210847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110196406|NCT00210847|Antipyretics|antipyretics|mesh-ancestor
110196407|NCT00210847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110196408|NCT00210847|Narcotics|narcotics|mesh-ancestor
110196409|NCT00210847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110196410|NCT00210886|Levofloxacin|levofloxacin|mesh-list
110196411|NCT00210886|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110196412|NCT00210886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110196413|NCT00210886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110196414|NCT00210886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110196415|NCT00210886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110196416|NCT00210886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110196417|NCT00210886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110196418|NCT00210886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110196419|NCT00210886|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110196420|NCT00210886|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110196422|NCT00210925|Anticonvulsants|anticonvulsants|mesh-ancestor
110196423|NCT00210925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110196424|NCT00210925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110196425|NCT00211003|Doripenem|doripenem|mesh-list
110196426|NCT00211003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110196427|NCT00211003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110196428|NCT00211120|Epoetin Alfa|epoetin alfa|mesh-list
110196429|NCT00211120|Hematinics|hematinics|mesh-ancestor
110196430|NCT00211198|Denileukin diftitox|denileukin diftitox|mesh-list
110196431|NCT00211198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110196432|NCT00211276|Denileukin diftitox|denileukin diftitox|mesh-list
110196433|NCT00211276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110196434|NCT00211315|Anecortave|anecortave|mesh-list
110196435|NCT00211315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110196436|NCT00211315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110196437|NCT00211315|Growth Substances|growth substances|mesh-ancestor
110196438|NCT00211315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110196439|NCT00211315|Growth Inhibitors|growth inhibitors|mesh-ancestor
110196440|NCT00211315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110196441|NCT00211354|Anecortave|anecortave|mesh-list
110196442|NCT00211354|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110196443|NCT00211354|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110196444|NCT00211354|Growth Substances|growth substances|mesh-ancestor
110196445|NCT00211354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110196446|NCT00211354|Growth Inhibitors|growth inhibitors|mesh-ancestor
110196447|NCT00211354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110196448|NCT00211393|Ketoconazole|ketoconazole|mesh-list
110196449|NCT00211393|Antifungal Agents|antifungal agents|mesh-ancestor
110196450|NCT00211393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110196451|NCT00211393|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110196452|NCT00211393|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110196453|NCT00211393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110196454|NCT00211393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110196455|NCT00211393|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110196456|NCT00211393|Hormone Antagonists|hormone antagonists|mesh-ancestor
110196457|NCT00211393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110196458|NCT00211393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110196459|NCT00211393|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110196460|NCT00211432|Anecortave|anecortave|mesh-list
110196461|NCT00211432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110196462|NCT00211432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110196463|NCT00211432|Growth Substances|growth substances|mesh-ancestor
110196464|NCT00211432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110196465|NCT00211432|Growth Inhibitors|growth inhibitors|mesh-ancestor
110196466|NCT00211432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110196467|NCT00211471|Anecortave|anecortave|mesh-list
110196468|NCT00211471|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110196469|NCT00211471|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110196470|NCT00211471|Growth Substances|growth substances|mesh-ancestor
110196471|NCT00211471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110196472|NCT00211471|Growth Inhibitors|growth inhibitors|mesh-ancestor
110196473|NCT00211471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110167841|NCT00033319|Analgesics|analgesics|mesh-ancestor
110196474|NCT00211588|Galantamine|galantamine|mesh-list
110196475|NCT00211588|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110196476|NCT00211588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110196477|NCT00211588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110196478|NCT00211588|Cholinergic Agents|cholinergic agents|mesh-ancestor
110196479|NCT00211588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110196480|NCT00211588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110196481|NCT00211588|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110196482|NCT00211588|Autonomic Agents|autonomic agents|mesh-ancestor
110196483|NCT00211588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110196484|NCT00211588|Nootropic Agents|nootropic agents|mesh-ancestor
110196485|NCT00211705|Pravastatin|pravastatin|mesh-list
110196486|NCT00211705|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110219862|NCT00288769|Vitamins|vitamins|mesh-ancestor
110196487|NCT00211705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110196488|NCT00211705|Antimetabolites|antimetabolites|mesh-ancestor
110196489|NCT00211705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110196490|NCT00211705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110196491|NCT00211705|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110196492|NCT00211705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110196493|NCT00211744|Topiramate|topiramate|mesh-list
110196494|NCT00211744|Anticonvulsants|anticonvulsants|mesh-ancestor
110196495|NCT00211744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110196496|NCT00211744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110196497|NCT00211939|Atorvastatin|atorvastatin|mesh-list
110196498|NCT00211939|Calcium|calcium|mesh-list
110196499|NCT00211939|Sevelamer|sevelamer|mesh-list
110196500|NCT00211939|Calcium acetate|calcium acetate|mesh-list
110196501|NCT00211939|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110196502|NCT00211939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110196503|NCT00211939|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110196504|NCT00211939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110196505|NCT00211939|Antimetabolites|antimetabolites|mesh-ancestor
110196506|NCT00211939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110196507|NCT00211939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110196508|NCT00211939|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110196509|NCT00211939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110196510|NCT00211939|Chelating Agents|chelating agents|mesh-ancestor
110196511|NCT00211939|Sequestering Agents|sequestering agents|mesh-ancestor
110196512|NCT00211978|Calcium|calcium|mesh-list
110196513|NCT00211978|Calcium acetate|calcium acetate|mesh-list
110196514|NCT00211978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110196515|NCT00211978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110196516|NCT00211978|Chelating Agents|chelating agents|mesh-ancestor
110196517|NCT00211978|Sequestering Agents|sequestering agents|mesh-ancestor
110196518|NCT00211978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110196519|NCT00212017|Voglibose|voglibose|mesh-list
110196520|NCT00212017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110196521|NCT00212017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110196522|NCT00212017|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110196523|NCT00212017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110196524|NCT00212017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110196525|NCT00212095|Ketoconazole|ketoconazole|mesh-list
110196526|NCT00212095|Docetaxel|docetaxel|mesh-list
110196527|NCT00212095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110196528|NCT00212095|Tubulin Modulators|tubulin modulators|mesh-ancestor
110196529|NCT00212095|Antimitotic Agents|antimitotic agents|mesh-ancestor
110196530|NCT00212095|Mitosis Modulators|mitosis modulators|mesh-ancestor
110196531|NCT00212095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110196532|NCT00212095|Antifungal Agents|antifungal agents|mesh-ancestor
110196533|NCT00212095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110196534|NCT00212095|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110219872|NCT00289042|Anticoagulants|anticoagulants|mesh-ancestor
110196535|NCT00212095|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110196536|NCT00212095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110196537|NCT00212095|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110196538|NCT00212095|Hormone Antagonists|hormone antagonists|mesh-ancestor
110196539|NCT00212095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110196540|NCT00212095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110196541|NCT00212095|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110196542|NCT00212173|Sibutramine|sibutramine|mesh-list
110196543|NCT00212173|Antidepressive Agents|antidepressive agents|mesh-ancestor
110196545|NCT00212173|Appetite Depressants|appetite depressants|mesh-ancestor
110196546|NCT00212173|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110196548|NCT00212212|Antioxidants|antioxidants|mesh-ancestor
110196549|NCT00212212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110196550|NCT00212212|Protective Agents|protective agents|mesh-ancestor
110168075|NCT00013962|Vitamins|vitamins|mesh-ancestor
110196551|NCT00212212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110196552|NCT00212212|Trace Elements|trace elements|mesh-ancestor
110196553|NCT00212212|Micronutrients|micronutrients|mesh-ancestor
110196554|NCT00212290|Pioglitazone|pioglitazone|mesh-list
110196555|NCT00212290|Nateglinide|nateglinide|mesh-list
110196556|NCT00212290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110196557|NCT00212290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110196559|NCT00073203|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110196560|NCT00073203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110196561|NCT00073203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110196562|NCT00073203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110196563|NCT00073203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110196564|NCT00073203|Serotonin Agents|serotonin agents|mesh-ancestor
110196565|NCT00073203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110168121|NCT00014001|GABA Agents|gaba agents|mesh-ancestor
110196566|NCT00073203|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110196567|NCT00073203|Antidepressive Agents|antidepressive agents|mesh-ancestor
110196569|NCT00073203|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110196570|NCT00073203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110196571|NCT00073203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110196572|NCT00411736|Azithromycin|azithromycin|mesh-list
110196573|NCT00411736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110196574|NCT00411736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110196575|NCT00212602|Aprepitant|aprepitant|mesh-list
110196576|NCT00212602|Fosaprepitant|fosaprepitant|mesh-list
110196577|NCT00212602|Antiemetics|antiemetics|mesh-ancestor
110196578|NCT00212602|Autonomic Agents|autonomic agents|mesh-ancestor
110196579|NCT00212602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110196580|NCT00212602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110196581|NCT00212602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110196582|NCT00212602|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110196583|NCT00212602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110196584|NCT00212602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110196585|NCT00212680|Landiolol|landiolol|mesh-list
110196586|NCT00212680|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110196587|NCT00212680|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110196588|NCT00212680|Adrenergic Agents|adrenergic agents|mesh-ancestor
110196589|NCT00212680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110196590|NCT00212680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110403413|NCT04873895|Antimalarials|antimalarials|mesh-ancestor
110196591|NCT00212680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110196592|NCT00212680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110196593|NCT00212875|Epoetin Alfa|epoetin alfa|mesh-list
110196594|NCT00212875|Hematinics|hematinics|mesh-ancestor
110196595|NCT00213070|Miglitol|miglitol|mesh-list
110196596|NCT00213070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110196597|NCT00213070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110196598|NCT00213070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110196599|NCT00213070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110196600|NCT00213070|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110196601|NCT00213109|Miglitol|miglitol|mesh-list
110196602|NCT00213109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110168308|NCT00034840|Telmisartan|telmisartan|mesh-list
110196603|NCT00213109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110196604|NCT00213109|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110196605|NCT00213109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110196606|NCT00213109|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110196607|NCT00213226|Dexamethasone|dexamethasone|mesh-list
110196608|NCT00213226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110196609|NCT00213226|Antiemetics|antiemetics|mesh-ancestor
110196610|NCT00213226|Autonomic Agents|autonomic agents|mesh-ancestor
110196611|NCT00213226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110196612|NCT00213226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110196613|NCT00213226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110196614|NCT00213226|Glucocorticoids|glucocorticoids|mesh-ancestor
110196615|NCT00213226|Hormones|hormones|mesh-ancestor
110196616|NCT00213226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110196617|NCT00213226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110196618|NCT00213226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110196619|NCT00213265|Vaccines|vaccines|mesh-list
110196620|NCT00213265|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110168376|NCT00014235|Cyclosporine|cyclosporine|mesh-list
110196621|NCT00213265|Immunologic Factors|immunologic factors|mesh-ancestor
110196622|NCT00213265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110196623|NCT00213538|Methotrexate|methotrexate|mesh-list
110196624|NCT00213538|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110196625|NCT00213538|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110196627|NCT00213538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110196628|NCT00213538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110196629|NCT00213538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110196630|NCT00213538|Antimetabolites|antimetabolites|mesh-ancestor
110196631|NCT00213538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110196632|NCT00213538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110196633|NCT00213538|Dermatologic Agents|dermatologic agents|mesh-ancestor
110196634|NCT00213538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110196635|NCT00213538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110196636|NCT00213538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110196637|NCT00213538|Immunologic Factors|immunologic factors|mesh-ancestor
110196638|NCT00213538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110196639|NCT00213538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110196640|NCT00213577|Botulinum Toxins|botulinum toxins|mesh-list
110196641|NCT00213577|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110196642|NCT00213577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110196643|NCT00213577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110196644|NCT00213577|Cholinergic Agents|cholinergic agents|mesh-ancestor
110196645|NCT00213577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110196646|NCT00213577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110196647|NCT00213694|Celecoxib|celecoxib|mesh-list
110196648|NCT00213694|Docetaxel|docetaxel|mesh-list
110196649|NCT00213694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110196650|NCT00213694|Tubulin Modulators|tubulin modulators|mesh-ancestor
110196651|NCT00213694|Antimitotic Agents|antimitotic agents|mesh-ancestor
110196652|NCT00213694|Mitosis Modulators|mitosis modulators|mesh-ancestor
110062652|NCT04397484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110196653|NCT00213694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110196654|NCT00213694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110196655|NCT00213694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110196657|NCT00213694|Sensory System Agents|sensory system agents|mesh-ancestor
110196658|NCT00213694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110196659|NCT00213694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110196660|NCT00213694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110196661|NCT00213694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110196662|NCT00213694|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110196663|NCT00213694|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110196664|NCT00213694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110196666|NCT00214084|Antimetabolites|antimetabolites|mesh-ancestor
110196667|NCT00214084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110196668|NCT00214084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110196669|NCT00214084|Gout Suppressants|gout suppressants|mesh-ancestor
110196670|NCT00214084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110196671|NCT00214084|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110196672|NCT00214084|Antioxidants|antioxidants|mesh-ancestor
110196673|NCT00214084|Protective Agents|protective agents|mesh-ancestor
110196674|NCT00214084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110196675|NCT00214240|Immunoglobulins|immunoglobulins|mesh-list
110196676|NCT00214240|Antibodies|antibodies|mesh-list
110168543|NCT00035191|Nootropic Agents|nootropic agents|mesh-ancestor
110196677|NCT00214240|gamma-Globulins|gamma-globulins|mesh-list
110196678|NCT00214240|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110196679|NCT00214240|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110196680|NCT00214240|Immunologic Factors|immunologic factors|mesh-ancestor
110196681|NCT00214240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110196682|NCT00214318|Metoprolol|metoprolol|mesh-list
110196683|NCT00214318|Carvedilol|carvedilol|mesh-list
110196684|NCT00214318|Terbutaline|terbutaline|mesh-list
110196685|NCT00214318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110196686|NCT00214318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110196687|NCT00214318|Sympatholytics|sympatholytics|mesh-ancestor
110196688|NCT00214318|Autonomic Agents|autonomic agents|mesh-ancestor
110196689|NCT00214318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110196690|NCT00214318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110196691|NCT00214318|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110196692|NCT00214318|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110196693|NCT00214318|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110196694|NCT00214318|Adrenergic Agents|adrenergic agents|mesh-ancestor
110196695|NCT00214318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110196696|NCT00214318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110196698|NCT00214318|Protective Agents|protective agents|mesh-ancestor
110196699|NCT00214318|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110196700|NCT00214318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110196701|NCT00214318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110196702|NCT00214318|Vasodilator Agents|vasodilator agents|mesh-ancestor
110196703|NCT00214318|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110196704|NCT00214318|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110196705|NCT00214318|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110196706|NCT00214318|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110196707|NCT00214318|Respiratory System Agents|respiratory system agents|mesh-ancestor
110196708|NCT00214318|Sympathomimetics|sympathomimetics|mesh-ancestor
110196709|NCT00214318|Tocolytic Agents|tocolytic agents|mesh-ancestor
110196710|NCT00214318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110196711|NCT00214318|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110196712|NCT00214318|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110196713|NCT00214318|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110196714|NCT00214435|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110196715|NCT00214435|Antiviral Agents|antiviral agents|mesh-ancestor
110196716|NCT00214435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110196717|NCT00214552|Rabeprazole|rabeprazole|mesh-list
110196718|NCT00214552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110196719|NCT00214552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110196721|NCT00214552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110196722|NCT00214552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110196723|NCT00069459|Bupropion|bupropion|mesh-list
110196724|NCT00069459|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110196725|NCT00069459|Antidepressive Agents|antidepressive agents|mesh-ancestor
110196726|NCT00069459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110196727|NCT00069459|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110196728|NCT00069459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110196729|NCT00069459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110196730|NCT00069459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110196731|NCT00069459|Dopamine Agents|dopamine agents|mesh-ancestor
110168780|NCT00036088|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110196732|NCT00069459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110196733|NCT00069459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110196734|NCT00069459|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110196735|NCT00069459|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110196736|NCT00069459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110196737|NCT00214630|Atorvastatin|atorvastatin|mesh-list
110196738|NCT00214630|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110196739|NCT00214630|Calcium|calcium|mesh-list
110196740|NCT00214630|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110196741|NCT00214630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110196742|NCT00214630|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110196744|NCT00214630|Antimetabolites|antimetabolites|mesh-ancestor
110196745|NCT00214630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110196746|NCT00214630|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110196747|NCT00214630|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110196748|NCT00214630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110196749|NCT00214825|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110196750|NCT00214825|Eplerenone|eplerenone|mesh-list
110196751|NCT00214825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110196752|NCT00214825|Diuretics|diuretics|mesh-ancestor
110196753|NCT00214825|Natriuretic Agents|natriuretic agents|mesh-ancestor
110196754|NCT00214825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110196755|NCT00214825|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110196756|NCT00214825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110196757|NCT00214825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110196758|NCT00214825|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110196759|NCT00214825|Hormone Antagonists|hormone antagonists|mesh-ancestor
110196760|NCT00214825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110196761|NCT00214825|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110196762|NCT00214864|Docetaxel|docetaxel|mesh-list
110196763|NCT00214864|Capecitabine|capecitabine|mesh-list
110196764|NCT00214864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110196765|NCT00214864|Tubulin Modulators|tubulin modulators|mesh-ancestor
110196766|NCT00214864|Antimitotic Agents|antimitotic agents|mesh-ancestor
110196767|NCT00214864|Mitosis Modulators|mitosis modulators|mesh-ancestor
110196768|NCT00214864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110196769|NCT00214864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110196770|NCT00214864|Antimetabolites|antimetabolites|mesh-ancestor
110196772|NCT00214942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110196773|NCT00214942|Narcotics|narcotics|mesh-ancestor
110196774|NCT00214942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110196775|NCT00214942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110196776|NCT00214942|Analgesics|analgesics|mesh-ancestor
110196777|NCT00214942|Sensory System Agents|sensory system agents|mesh-ancestor
110196778|NCT00214942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110196779|NCT00214942|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110196780|NCT00214942|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110196781|NCT00214942|Anesthetics, General|anesthetics, general|mesh-ancestor
110196782|NCT00214942|Anesthetics|anesthetics|mesh-ancestor
110196783|NCT00069498|Aminosalicylic Acid|aminosalicylic acid|mesh-list
110196784|NCT00069498|Mesalamine|mesalamine|mesh-list
110196785|NCT00069498|Antitubercular Agents|antitubercular agents|mesh-ancestor
110196786|NCT00069498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110196787|NCT00069498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110196788|NCT00069498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110196789|NCT00069498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110196790|NCT00069498|Analgesics|analgesics|mesh-ancestor
110196791|NCT00069498|Sensory System Agents|sensory system agents|mesh-ancestor
110196792|NCT00069498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110196793|NCT00069498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110196794|NCT00069498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110196795|NCT00069498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110196796|NCT00214981|Modafinil|modafinil|mesh-list
110196797|NCT00214981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110196798|NCT00214981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110196799|NCT00214981|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110196800|NCT00214981|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110196801|NCT00214981|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110196802|NCT00214981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110196803|NCT00397241|Timolol|timolol|mesh-list
110196804|NCT00397241|Dorzolamide|dorzolamide|mesh-list
110196805|NCT00397241|Latanoprost|latanoprost|mesh-list
110196806|NCT00397241|Lubricant Eye Drops|lubricant eye drops|mesh-list
110196807|NCT00397241|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110196808|NCT00397241|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110196809|NCT00397241|Adrenergic Agents|adrenergic agents|mesh-ancestor
110196810|NCT00397241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110196811|NCT00397241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110196812|NCT00397241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110196813|NCT00397241|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110196814|NCT00397241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110196815|NCT00397241|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110196816|NCT00397241|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110168999|NCT00036946|Aflibercept|aflibercept|mesh-list
110196817|NCT00397241|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110196818|NCT00397241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110196819|NCT00073320|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110196820|NCT00073320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110196821|NCT00073320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110196822|NCT00073320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110196823|NCT00073320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110196824|NCT00073320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110196825|NCT00073320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110196826|NCT00073320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110196827|NCT00073320|Serotonin Agents|serotonin agents|mesh-ancestor
110196828|NCT00073320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110169041|NCT00000869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110169042|NCT00000869|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110196829|NCT00073320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110196830|NCT00073320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110196831|NCT00073320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110196832|NCT00073320|Dopamine Agents|dopamine agents|mesh-ancestor
110196834|NCT00215176|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110196835|NCT00215176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110196836|NCT00215176|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110196837|NCT00215176|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110196838|NCT00215176|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110196839|NCT00215176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110196840|NCT00215254|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110196841|NCT00215254|Antidepressive Agents|antidepressive agents|mesh-ancestor
110196842|NCT00215254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110196843|NCT00215254|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110196844|NCT00215254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110196845|NCT00215254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110062684|NCT04393298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110062685|NCT04393298|Antidotes|antidotes|mesh-ancestor
110391626|NCT03208452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110391627|NCT03208452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110391628|NCT03208452|Anesthetics|anesthetics|mesh-ancestor
110391629|NCT03208452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110391639|NCT03190265|Nivolumab|nivolumab|mesh-list
110196846|NCT00215254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110196848|NCT00041483|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110196849|NCT00041483|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110196850|NCT00041483|Growth Substances|growth substances|mesh-ancestor
110196851|NCT00041483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110196852|NCT00041483|Growth Inhibitors|growth inhibitors|mesh-ancestor
110196853|NCT00041483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110196854|NCT00215371|Formoterol Fumarate|formoterol fumarate|mesh-list
110196855|NCT00215371|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110196856|NCT00215371|Autonomic Agents|autonomic agents|mesh-ancestor
110196857|NCT00215371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110196858|NCT00215371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110196859|NCT00215371|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110196860|NCT00215371|Respiratory System Agents|respiratory system agents|mesh-ancestor
110196861|NCT00215371|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110196862|NCT00215371|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110196863|NCT00215371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110196864|NCT00215371|Adrenergic Agents|adrenergic agents|mesh-ancestor
110196865|NCT00215371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110196866|NCT00215371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110196867|NCT00215410|Formoterol Fumarate|formoterol fumarate|mesh-list
110196868|NCT00215410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110196869|NCT00215410|Autonomic Agents|autonomic agents|mesh-ancestor
110196870|NCT00215410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110196871|NCT00215410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110196872|NCT00215410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110196873|NCT00215410|Respiratory System Agents|respiratory system agents|mesh-ancestor
110196874|NCT00215410|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110196875|NCT00215410|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110196876|NCT00215410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110196877|NCT00215410|Adrenergic Agents|adrenergic agents|mesh-ancestor
110196878|NCT00215410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110196879|NCT00215410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110196880|NCT00215449|Formoterol Fumarate|formoterol fumarate|mesh-list
110196881|NCT00215449|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110196882|NCT00215449|Autonomic Agents|autonomic agents|mesh-ancestor
110196883|NCT00215449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110196884|NCT00215449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110196885|NCT00215449|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110196886|NCT00215449|Respiratory System Agents|respiratory system agents|mesh-ancestor
110196887|NCT00215449|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110196888|NCT00215449|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110196889|NCT00215449|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110196890|NCT00215449|Adrenergic Agents|adrenergic agents|mesh-ancestor
110196891|NCT00215449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110196892|NCT00215449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110196893|NCT00215722|Cetuximab|cetuximab|mesh-list
110196894|NCT00215722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110196895|NCT00215722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110196896|NCT00215800|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
110196897|NCT00215800|Antiviral Agents|antiviral agents|mesh-ancestor
110196898|NCT00215800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110196899|NCT00215839|Ribavirin|ribavirin|mesh-list
110196900|NCT00215839|Antimetabolites|antimetabolites|mesh-ancestor
110196901|NCT00215839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110196902|NCT00215839|Antiviral Agents|antiviral agents|mesh-ancestor
110196903|NCT00215839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110196904|NCT00215956|Topotecan|topotecan|mesh-list
110196905|NCT00215956|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110196906|NCT00215956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110196907|NCT00215956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110196908|NCT00215956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110196909|NCT00215956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110196910|NCT00215995|Cisplatin|cisplatin|mesh-list
110196911|NCT00215995|Irinotecan|irinotecan|mesh-list
110196912|NCT00215995|Gefitinib|gefitinib|mesh-list
110196913|NCT00215995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110196914|NCT00215995|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110196915|NCT00215995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110196916|NCT00215995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110196917|NCT00215995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110196918|NCT00215995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110196919|NCT00216034|polysaccharide-K|polysaccharide-k|mesh-list
110196920|NCT00216034|Tegafur|tegafur|mesh-list
110196921|NCT00216034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110196922|NCT00216034|Antimetabolites|antimetabolites|mesh-ancestor
110196923|NCT00216034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110196924|NCT00216034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110196925|NCT00216034|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110196926|NCT00216034|Immunologic Factors|immunologic factors|mesh-ancestor
110196927|NCT00216034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110196928|NCT00216034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110196929|NCT00216034|Antiviral Agents|antiviral agents|mesh-ancestor
110196930|NCT00216034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110196931|NCT00216034|Interferon Inducers|interferon inducers|mesh-ancestor
110196932|NCT00216034|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110196933|NCT00216034|Protective Agents|protective agents|mesh-ancestor
110196934|NCT00216073|Capecitabine|capecitabine|mesh-list
110196935|NCT00216073|Oxaliplatin|oxaliplatin|mesh-list
110196936|NCT00216073|Trastuzumab|trastuzumab|mesh-list
110196937|NCT00216073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110196938|NCT00216073|Antimetabolites|antimetabolites|mesh-ancestor
110391821|NCT01951885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110196939|NCT00216073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110196940|NCT00216073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110196941|NCT00216073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110196942|NCT00216112|Docetaxel|docetaxel|mesh-list
110196943|NCT00216112|Imatinib Mesylate|imatinib mesylate|mesh-list
110196944|NCT00216112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110196945|NCT00216112|Tubulin Modulators|tubulin modulators|mesh-ancestor
110196946|NCT00216112|Antimitotic Agents|antimitotic agents|mesh-ancestor
110196947|NCT00216112|Mitosis Modulators|mitosis modulators|mesh-ancestor
110196948|NCT00216112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110196949|NCT00216112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110196950|NCT00216112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110196951|NCT00216151|Zoledronic Acid|zoledronic acid|mesh-list
110196952|NCT00216151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110196953|NCT00216151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110196954|NCT00216190|Midazolam|midazolam|mesh-list
110196955|NCT00216190|Dexmedetomidine|dexmedetomidine|mesh-list
110196956|NCT00216190|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110196957|NCT00216190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110196958|NCT00216190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110391886|NCT00745316|Adenosine|adenosine|mesh-list
110196959|NCT00216190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110196960|NCT00216190|Analgesics|analgesics|mesh-ancestor
110196961|NCT00216190|Sensory System Agents|sensory system agents|mesh-ancestor
110196962|NCT00216190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110196963|NCT00216190|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110196964|NCT00216190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110196965|NCT00216190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110196966|NCT00216190|Adrenergic Agents|adrenergic agents|mesh-ancestor
110196967|NCT00216190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110196968|NCT00216190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110196969|NCT00216190|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110196970|NCT00216190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110196971|NCT00216190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110196972|NCT00216190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110062709|NCT04336982|Azacitidine|azacitidine|mesh-list
110062710|NCT04336982|Venetoclax|venetoclax|mesh-list
110391940|NCT00107198|Hormones|hormones|mesh-ancestor
110062711|NCT04336982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110062713|NCT04336982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110196973|NCT00216190|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110196974|NCT00216190|Anesthetics, General|anesthetics, general|mesh-ancestor
110196976|NCT00216190|GABA Modulators|gaba modulators|mesh-ancestor
110196977|NCT00216190|GABA Agents|gaba agents|mesh-ancestor
110196978|NCT00216268|Ribavirin|ribavirin|mesh-list
110196979|NCT00216268|Antimetabolites|antimetabolites|mesh-ancestor
110196980|NCT00216268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110196981|NCT00216268|Antiviral Agents|antiviral agents|mesh-ancestor
110196982|NCT00216268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110196983|NCT00216346|Amphotericin B|amphotericin b|mesh-list
110196984|NCT00216346|Paromomycin|paromomycin|mesh-list
110052974|NCT01483508|Antioxidants|antioxidants|mesh-ancestor
110196985|NCT00216346|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110196986|NCT00216346|Amebicides|amebicides|mesh-ancestor
110196987|NCT00216346|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110196988|NCT00216346|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110196989|NCT00216346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110196991|NCT00216346|Antifungal Agents|antifungal agents|mesh-ancestor
110196992|NCT00216385|Gatifloxacin|gatifloxacin|mesh-list
110196993|NCT00216385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110196994|NCT00216385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110196995|NCT00216385|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110196996|NCT00216385|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110196997|NCT00216385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110196998|NCT00216385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110196999|NCT00216385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110197000|NCT00216385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197001|NCT00216385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110197002|NCT00216424|Capecitabine|capecitabine|mesh-list
110197003|NCT00216424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110197004|NCT00216424|Antimetabolites|antimetabolites|mesh-ancestor
110197005|NCT00216424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197006|NCT00216424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110197007|NCT00216463|Mipomersen|mipomersen|mesh-list
110197008|NCT00216463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110197009|NCT00216463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110197010|NCT00216463|Antimetabolites|antimetabolites|mesh-ancestor
110197011|NCT00216463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197012|NCT00216463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110197013|NCT00216502|Galantamine|galantamine|mesh-list
110197014|NCT00216502|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110197015|NCT00216502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110197016|NCT00216502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197017|NCT00216502|Cholinergic Agents|cholinergic agents|mesh-ancestor
110197018|NCT00216502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110197019|NCT00216502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110197020|NCT00216502|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110197021|NCT00216502|Autonomic Agents|autonomic agents|mesh-ancestor
110197022|NCT00216502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110197023|NCT00216502|Nootropic Agents|nootropic agents|mesh-ancestor
110197024|NCT00216541|Epoetin Alfa|epoetin alfa|mesh-list
110197025|NCT00216541|Hematinics|hematinics|mesh-ancestor
110197026|NCT00216580|Risperidone|risperidone|mesh-list
110197027|NCT00216580|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110197028|NCT00216580|Serotonin Agents|serotonin agents|mesh-ancestor
110197029|NCT00216580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110197030|NCT00216580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197031|NCT00216580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110197032|NCT00216580|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110197033|NCT00216580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110197034|NCT00216580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110197035|NCT00216580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110197036|NCT00216580|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110197037|NCT00216580|Dopamine Agents|dopamine agents|mesh-ancestor
110197038|NCT00041561|Nitric Oxide|nitric oxide|mesh-list
110197039|NCT00041561|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110197040|NCT00041561|Autonomic Agents|autonomic agents|mesh-ancestor
110197041|NCT00041561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110197042|NCT00041561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110197043|NCT00041561|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110197044|NCT00041561|Respiratory System Agents|respiratory system agents|mesh-ancestor
110197045|NCT00041561|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110197046|NCT00041561|Antioxidants|antioxidants|mesh-ancestor
110197047|NCT00041561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197048|NCT00041561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110197049|NCT00041561|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110197050|NCT00041561|Vasodilator Agents|vasodilator agents|mesh-ancestor
110197051|NCT00041561|Gasotransmitters|gasotransmitters|mesh-ancestor
110197052|NCT00041561|Protective Agents|protective agents|mesh-ancestor
110197053|NCT00216619|Topiramate|topiramate|mesh-list
110197054|NCT00216619|Anticonvulsants|anticonvulsants|mesh-ancestor
110197055|NCT00216619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110197056|NCT00216619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110197057|NCT00216658|Fentanyl|fentanyl|mesh-list
110197058|NCT00216658|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110197059|NCT00216658|Narcotics|narcotics|mesh-ancestor
110197060|NCT00216658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110197061|NCT00216658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110197062|NCT00216658|Analgesics|analgesics|mesh-ancestor
110197063|NCT00216658|Sensory System Agents|sensory system agents|mesh-ancestor
110197064|NCT00216658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110197065|NCT00216658|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110392135|NCT01602861|Spironolactone|spironolactone|mesh-list
110197066|NCT00216658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110197067|NCT00216658|Anesthetics, General|anesthetics, general|mesh-ancestor
110197068|NCT00216658|Anesthetics|anesthetics|mesh-ancestor
110197069|NCT00216697|Bortezomib|bortezomib|mesh-list
110197070|NCT00216697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110197071|NCT00216775|Interferons|interferons|mesh-list
110197072|NCT00216775|Ribavirin|ribavirin|mesh-list
110197073|NCT00216775|Interferon-alpha|interferon-alpha|mesh-list
110197074|NCT00216775|Interferon alpha-2|interferon alpha-2|mesh-list
110197075|NCT00216775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110197076|NCT00216775|Antiviral Agents|antiviral agents|mesh-ancestor
110197077|NCT00216775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110197078|NCT00216775|Antimetabolites|antimetabolites|mesh-ancestor
110197079|NCT00216775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197080|NCT00216775|Immunologic Factors|immunologic factors|mesh-ancestor
110197081|NCT00216775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110197082|NCT00041639|Labetuzumab|labetuzumab|mesh-list
110197083|NCT00041639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110197084|NCT00041639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110197085|NCT00216892|Betamethasone|betamethasone|mesh-list
110197086|NCT00216892|Calcipotriene|calcipotriene|mesh-list
110197087|NCT00216892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110197088|NCT00216892|Glucocorticoids|glucocorticoids|mesh-ancestor
110197089|NCT00216892|Hormones|hormones|mesh-ancestor
110197090|NCT00216892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110197091|NCT00216892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110197092|NCT00216892|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110197093|NCT00216892|Respiratory System Agents|respiratory system agents|mesh-ancestor
110197094|NCT00216892|Dermatologic Agents|dermatologic agents|mesh-ancestor
110197095|NCT00216931|Iloprost|iloprost|mesh-list
110197096|NCT00216931|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110197097|NCT00216931|Vasodilator Agents|vasodilator agents|mesh-ancestor
110197098|NCT00217009|Furocoumarins|furocoumarins|mesh-list
110197099|NCT00217009|Dermatologic Agents|dermatologic agents|mesh-ancestor
110197100|NCT00217009|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110197101|NCT00217048|Yohimbine|yohimbine|mesh-list
110197102|NCT00217048|Mydriatics|mydriatics|mesh-ancestor
110197103|NCT00217048|Autonomic Agents|autonomic agents|mesh-ancestor
110197104|NCT00217048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110197105|NCT00217048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110197106|NCT00217048|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110197107|NCT00217048|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110197108|NCT00217048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110197109|NCT00217048|Adrenergic Agents|adrenergic agents|mesh-ancestor
110197110|NCT00217048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110197111|NCT00217048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197112|NCT00217048|Urological Agents|urological agents|mesh-ancestor
110197113|NCT00217204|Pancrelipase|pancrelipase|mesh-list
110197114|NCT00217204|Pancreatin|pancreatin|mesh-list
110197115|NCT00217204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110197116|NCT00412126|Insulin|insulin|mesh-list
110197117|NCT00412126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110197119|NCT00412204|Bromides|bromides|mesh-list
110197120|NCT00412204|Tiotropium Bromide|tiotropium bromide|mesh-list
110197121|NCT00412204|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110197122|NCT00412204|Autonomic Agents|autonomic agents|mesh-ancestor
110197123|NCT00412204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110197124|NCT00412204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110197125|NCT00412204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110197126|NCT00412204|Respiratory System Agents|respiratory system agents|mesh-ancestor
110197127|NCT00412204|Parasympatholytics|parasympatholytics|mesh-ancestor
110197128|NCT00412204|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110197129|NCT00412204|Cholinergic Agents|cholinergic agents|mesh-ancestor
110197130|NCT00412204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110197131|NCT00412204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197132|NCT00412204|Anticonvulsants|anticonvulsants|mesh-ancestor
110197133|NCT00041678|Aripiprazole|aripiprazole|mesh-list
110197134|NCT00041678|Antidepressive Agents|antidepressive agents|mesh-ancestor
110197135|NCT00041678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110197136|NCT00041678|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110197137|NCT00041678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110197138|NCT00041678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110197139|NCT00041678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110197140|NCT00041678|Dopamine Agonists|dopamine agonists|mesh-ancestor
110197141|NCT00041678|Dopamine Agents|dopamine agents|mesh-ancestor
110197142|NCT00041678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110197143|NCT00041678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197144|NCT00041678|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110197145|NCT00041678|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110197146|NCT00041678|Serotonin Agents|serotonin agents|mesh-ancestor
110197147|NCT00041678|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110197148|NCT00041678|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110197149|NCT00041678|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110197150|NCT00041678|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110197151|NCT00217243|Lidocaine|lidocaine|mesh-list
110197152|NCT00217243|Anesthetics, Local|anesthetics, local|mesh-ancestor
110197153|NCT00217243|Anesthetics|anesthetics|mesh-ancestor
110197154|NCT00217243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110197155|NCT00217243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110197156|NCT00217243|Sensory System Agents|sensory system agents|mesh-ancestor
110197157|NCT00217243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110197158|NCT00217243|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110197159|NCT00217243|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110197160|NCT00217243|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110197161|NCT00217243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110197162|NCT00217243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197163|NCT00217282|Bevacizumab|bevacizumab|mesh-list
110197164|NCT00217282|Gemcitabine|gemcitabine|mesh-list
110197165|NCT00217282|Oxaliplatin|oxaliplatin|mesh-list
110197166|NCT00217282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110197167|NCT00217282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110197168|NCT00217282|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110197169|NCT00217282|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110197170|NCT00217282|Growth Substances|growth substances|mesh-ancestor
110197171|NCT00217282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110197172|NCT00217282|Growth Inhibitors|growth inhibitors|mesh-ancestor
110197173|NCT00217282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110197174|NCT00217282|Antimetabolites|antimetabolites|mesh-ancestor
110197175|NCT00217282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197176|NCT00217477|Gemcitabine|gemcitabine|mesh-list
110197177|NCT00217477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110197178|NCT00217477|Antimetabolites|antimetabolites|mesh-ancestor
110197179|NCT00217477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197180|NCT00217477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110197181|NCT00217516|Selenium|selenium|mesh-list
110197182|NCT00217516|Antioxidants|antioxidants|mesh-ancestor
110197183|NCT00217516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197184|NCT00217516|Protective Agents|protective agents|mesh-ancestor
110197185|NCT00217516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110197186|NCT00217516|Trace Elements|trace elements|mesh-ancestor
110197187|NCT00217516|Micronutrients|micronutrients|mesh-ancestor
110197188|NCT00217555|Gemcitabine|gemcitabine|mesh-list
110197189|NCT00217555|Topotecan|topotecan|mesh-list
110197190|NCT00217555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110197191|NCT00217555|Antimetabolites|antimetabolites|mesh-ancestor
110197192|NCT00217555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197193|NCT00217555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110197194|NCT00217555|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110197195|NCT00217555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110197196|NCT00217555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110197197|NCT00217711|Capecitabine|capecitabine|mesh-list
110197198|NCT00217711|Oxaliplatin|oxaliplatin|mesh-list
110197199|NCT00217711|Irinotecan|irinotecan|mesh-list
110197200|NCT00217711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110197201|NCT00217711|Antimetabolites|antimetabolites|mesh-ancestor
110197202|NCT00217711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197203|NCT00217711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110197204|NCT00217711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110197205|NCT00217711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110197206|NCT00217711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110197207|NCT00217789|Dimercaprol|dimercaprol|mesh-list
110197208|NCT00217789|Chelating Agents|chelating agents|mesh-ancestor
110197209|NCT00217789|Sequestering Agents|sequestering agents|mesh-ancestor
110197210|NCT00217789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197211|NCT00217828|Citalopram|citalopram|mesh-list
110197212|NCT00217828|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110197213|NCT00217828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110197214|NCT00217828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110197215|NCT00217828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197216|NCT00217828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110197217|NCT00217828|Serotonin Agents|serotonin agents|mesh-ancestor
110197218|NCT00217828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110197219|NCT00217828|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110197220|NCT00217828|Antidepressive Agents|antidepressive agents|mesh-ancestor
110197221|NCT00217828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110197223|NCT00041990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110197224|NCT00041990|Antimetabolites|antimetabolites|mesh-ancestor
110197225|NCT00041990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197226|NCT00041990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110197227|NCT00041990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110197228|NCT00073437|Infliximab|infliximab|mesh-list
110220053|NCT00290836|Thrombin|thrombin|mesh-list
110197229|NCT00073437|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110197230|NCT00073437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110197231|NCT00073437|Dermatologic Agents|dermatologic agents|mesh-ancestor
110197232|NCT00073437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110197233|NCT00073437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110197234|NCT00218101|Buprenorphine|buprenorphine|mesh-list
110197235|NCT00218101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110197236|NCT00218101|Narcotics|narcotics|mesh-ancestor
110197237|NCT00218101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110197238|NCT00218101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110197239|NCT00218101|Analgesics|analgesics|mesh-ancestor
110197240|NCT00218101|Sensory System Agents|sensory system agents|mesh-ancestor
110197241|NCT00218101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110197242|NCT00218101|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110197243|NCT00218140|Nicotine|nicotine|mesh-list
110197244|NCT00218140|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110197245|NCT00218140|Autonomic Agents|autonomic agents|mesh-ancestor
110197246|NCT00218140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110197247|NCT00218140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110197248|NCT00218140|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110197249|NCT00218140|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110197250|NCT00218140|Cholinergic Agents|cholinergic agents|mesh-ancestor
110197251|NCT00218140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110197252|NCT00218140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197253|NCT00042029|Aprepitant|aprepitant|mesh-list
110197254|NCT00042029|Antiemetics|antiemetics|mesh-ancestor
110197255|NCT00042029|Autonomic Agents|autonomic agents|mesh-ancestor
110197256|NCT00042029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110197257|NCT00042029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110197258|NCT00042029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110197259|NCT00042029|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110197260|NCT00042029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110197261|NCT00042029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197263|NCT00218218|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110197264|NCT00218218|Autonomic Agents|autonomic agents|mesh-ancestor
110197265|NCT00218218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110197266|NCT00218218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110197267|NCT00218218|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110197268|NCT00218218|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110197269|NCT00218218|Cholinergic Agents|cholinergic agents|mesh-ancestor
110197270|NCT00218218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110197271|NCT00218218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197272|NCT00218374|Gabapentin|gabapentin|mesh-list
110197273|NCT00218374|Analgesics|analgesics|mesh-ancestor
110197274|NCT00218374|Sensory System Agents|sensory system agents|mesh-ancestor
110197275|NCT00218374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110197276|NCT00218374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110197277|NCT00218374|Anticonvulsants|anticonvulsants|mesh-ancestor
110197278|NCT00218374|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110197279|NCT00218374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110197280|NCT00218374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110197281|NCT00218374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110197282|NCT00218374|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110197283|NCT00218374|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110197284|NCT00218374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110197285|NCT00218374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197286|NCT00218374|Antimanic Agents|antimanic agents|mesh-ancestor
110197288|NCT00218413|Immunologic Factors|immunologic factors|mesh-ancestor
110197289|NCT00218413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110197290|NCT00042068|Meloxicam|meloxicam|mesh-list
110197291|NCT00042068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110197292|NCT00042068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110197293|NCT00042068|Analgesics|analgesics|mesh-ancestor
110197294|NCT00042068|Sensory System Agents|sensory system agents|mesh-ancestor
110197295|NCT00042068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110197296|NCT00042068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110197297|NCT00042068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110197298|NCT00042068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110197299|NCT00042068|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110197300|NCT00042068|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110197301|NCT00042068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110197302|NCT00042068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197303|NCT00218530|Lofexidine|lofexidine|mesh-list
110197304|NCT00218530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110197305|NCT00218530|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110197306|NCT00218530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110197307|NCT00218530|Sensory System Agents|sensory system agents|mesh-ancestor
110392582|NCT01608984|Anesthetics, General|anesthetics, general|mesh-ancestor
110197308|NCT00218530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110197309|NCT00218530|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110197310|NCT00218530|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110197311|NCT00218530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110197312|NCT00218530|Adrenergic Agents|adrenergic agents|mesh-ancestor
110197313|NCT00218530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110197314|NCT00218530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197316|NCT00218569|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110197317|NCT00218569|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110197318|NCT00218569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110197319|NCT00218569|Sensory System Agents|sensory system agents|mesh-ancestor
110197320|NCT00218569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110197321|NCT00218608|Disulfiram|disulfiram|mesh-list
110197322|NCT00218608|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110197323|NCT00218608|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
110197324|NCT00218608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110197325|NCT00218608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197326|NCT00042146|Zolpidem|zolpidem|mesh-list
110197327|NCT00042146|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110197328|NCT00042146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110197329|NCT00042146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110197330|NCT00042146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110392628|NCT01648634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110197331|NCT00042146|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110197332|NCT00042146|GABA Agonists|gaba agonists|mesh-ancestor
110197333|NCT00042146|GABA Agents|gaba agents|mesh-ancestor
110197334|NCT00042146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110197335|NCT00042146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197337|NCT00412321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110197338|NCT00219232|Rivastigmine|rivastigmine|mesh-list
110197339|NCT00219232|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110197340|NCT00219232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110197341|NCT00219232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197342|NCT00219232|Cholinergic Agents|cholinergic agents|mesh-ancestor
110197343|NCT00219232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110197344|NCT00219232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110197345|NCT00219232|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110197346|NCT00219232|Protective Agents|protective agents|mesh-ancestor
110197347|NCT00219271|Zoledronic Acid|zoledronic acid|mesh-list
110197348|NCT00219271|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110220091|NCT00291109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110197355|NCT00219310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197356|NCT00219388|Simendan|simendan|mesh-list
110197357|NCT00219388|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110197358|NCT00219388|Vasodilator Agents|vasodilator agents|mesh-ancestor
110197359|NCT00219388|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110197360|NCT00219388|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110197361|NCT00219388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110054803|NCT01494363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110197362|NCT00219388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197363|NCT00219388|Protective Agents|protective agents|mesh-ancestor
110197364|NCT00219388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110197365|NCT00219466|Zinc|zinc|mesh-list
110197366|NCT00219466|Tocopherols|tocopherols|mesh-list
110197367|NCT00219466|Vitamin E|vitamin e|mesh-list
110197368|NCT00219466|Tocotrienols|tocotrienols|mesh-list
110197369|NCT00219466|alpha-Tocopherol|alpha-tocopherol|mesh-list
110197370|NCT00219466|Zinc Oxide|zinc oxide|mesh-list
110197371|NCT00219466|Trace Elements|trace elements|mesh-ancestor
110197372|NCT00219466|Micronutrients|micronutrients|mesh-ancestor
110197373|NCT00219466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110197374|NCT00219466|Antioxidants|antioxidants|mesh-ancestor
110197375|NCT00219466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197376|NCT00219466|Protective Agents|protective agents|mesh-ancestor
110197377|NCT00219466|Vitamins|vitamins|mesh-ancestor
110197378|NCT00219466|Dermatologic Agents|dermatologic agents|mesh-ancestor
110197379|NCT00219466|Sunscreening Agents|sunscreening agents|mesh-ancestor
110197380|NCT00219466|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110197381|NCT00042302|Paclitaxel|paclitaxel|mesh-list
110197382|NCT00042302|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110197383|NCT00042302|Carboplatin|carboplatin|mesh-list
110197384|NCT00042302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110197385|NCT00042302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110197386|NCT00042302|Tubulin Modulators|tubulin modulators|mesh-ancestor
110197387|NCT00042302|Antimitotic Agents|antimitotic agents|mesh-ancestor
110197388|NCT00042302|Mitosis Modulators|mitosis modulators|mesh-ancestor
110392681|NCT01684085|Lorazepam|lorazepam|mesh-list
110197389|NCT00042302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197390|NCT00219700|Ibuprofen|ibuprofen|mesh-list
110197391|NCT00219700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110197392|NCT00219700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110197393|NCT00219700|Analgesics|analgesics|mesh-ancestor
110197394|NCT00219700|Sensory System Agents|sensory system agents|mesh-ancestor
110197395|NCT00219700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110197396|NCT00219700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110197397|NCT00219700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110197398|NCT00219700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110197399|NCT00219700|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110197400|NCT00219700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110197401|NCT00219700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197402|NCT00219739|Interferons|interferons|mesh-list
110197403|NCT00219739|Cytarabine|cytarabine|mesh-list
110197405|NCT00219739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110197406|NCT00219739|Antiviral Agents|antiviral agents|mesh-ancestor
110197407|NCT00219739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110197408|NCT00219739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110197409|NCT00219739|Antimetabolites|antimetabolites|mesh-ancestor
110197410|NCT00219739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197411|NCT00219739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110197412|NCT00219739|Immunologic Factors|immunologic factors|mesh-ancestor
110197413|NCT00219739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110197414|NCT00219739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110197415|NCT00219739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110197417|NCT00219778|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110197418|NCT00219778|Abortifacient Agents|abortifacient agents|mesh-ancestor
110197419|NCT00219778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110197420|NCT00219778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110197421|NCT00219778|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110197422|NCT00219778|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110197423|NCT00219778|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110197424|NCT00219778|Contraceptive Agents|contraceptive agents|mesh-ancestor
110197425|NCT00219778|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110197426|NCT00219778|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110197427|NCT00219778|Hormone Antagonists|hormone antagonists|mesh-ancestor
110197428|NCT00219778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110197429|NCT00219778|Luteolytic Agents|luteolytic agents|mesh-ancestor
110197430|NCT00219778|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110197431|NCT00219778|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110197432|NCT00219856|Propofol|propofol|mesh-list
110197433|NCT00219856|Desflurane|desflurane|mesh-list
110197434|NCT00219856|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110197435|NCT00219856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110197436|NCT00219856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110197437|NCT00219856|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110197438|NCT00219856|Anesthetics, General|anesthetics, general|mesh-ancestor
110197439|NCT00219856|Anesthetics|anesthetics|mesh-ancestor
110197440|NCT00219856|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110197441|NCT00042458|Pramlintide|pramlintide|mesh-list
110197442|NCT00042458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110197443|NCT00042458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110197444|NCT00219895|Ibuprofen|ibuprofen|mesh-list
110197445|NCT00219895|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110197446|NCT00219895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110197447|NCT00219895|Analgesics|analgesics|mesh-ancestor
110197448|NCT00219895|Sensory System Agents|sensory system agents|mesh-ancestor
110197449|NCT00219895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110197450|NCT00219895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110197451|NCT00219895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110197452|NCT00219895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110197453|NCT00219895|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110197454|NCT00219895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110197455|NCT00219895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197456|NCT00077337|Romidepsin|romidepsin|mesh-list
110197457|NCT00077337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110197458|NCT00077337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110197459|NCT00077337|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110197460|NCT00077337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110197461|NCT00077337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110062821|NCT04150497|Alemtuzumab|alemtuzumab|mesh-list
110062822|NCT04150497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110062823|NCT04150497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110197462|NCT00219934|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110197464|NCT00219934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110197465|NCT00219973|Bemiparin|bemiparin|mesh-list
110197466|NCT00219973|Anticoagulants|anticoagulants|mesh-ancestor
110197467|NCT00220051|Capecitabine|capecitabine|mesh-list
110197468|NCT00220051|Oxaliplatin|oxaliplatin|mesh-list
110197469|NCT00220051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110197470|NCT00220051|Antimetabolites|antimetabolites|mesh-ancestor
110197471|NCT00220051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197472|NCT00220051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110197473|NCT00077415|Gemcitabine|gemcitabine|mesh-list
110197474|NCT00077415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110197475|NCT00077415|Antimetabolites|antimetabolites|mesh-ancestor
110197476|NCT00077415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197477|NCT00077415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110197479|NCT00042536|Yohimbine|yohimbine|mesh-list
110197480|NCT00042536|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110197481|NCT00042536|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110197482|NCT00042536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110197483|NCT00042536|Sensory System Agents|sensory system agents|mesh-ancestor
110197484|NCT00042536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110197485|NCT00042536|Mydriatics|mydriatics|mesh-ancestor
110197486|NCT00042536|Autonomic Agents|autonomic agents|mesh-ancestor
110197487|NCT00042536|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110197488|NCT00042536|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110197489|NCT00042536|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110197490|NCT00042536|Adrenergic Agents|adrenergic agents|mesh-ancestor
110197491|NCT00042536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110197492|NCT00042536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197493|NCT00042536|Urological Agents|urological agents|mesh-ancestor
110197494|NCT00220129|Capecitabine|capecitabine|mesh-list
110197495|NCT00220129|Epirubicin|epirubicin|mesh-list
110197496|NCT00220129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110197497|NCT00220129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110197498|NCT00220129|Antimetabolites|antimetabolites|mesh-ancestor
110197499|NCT00220129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197500|NCT00220129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110197501|NCT00220129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110197502|NCT00220129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110197503|NCT00220129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110197504|NCT00220168|Capecitabine|capecitabine|mesh-list
110197505|NCT00220168|Irinotecan|irinotecan|mesh-list
110197506|NCT00220168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110197507|NCT00220168|Antimetabolites|antimetabolites|mesh-ancestor
110197508|NCT00220168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197509|NCT00220168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110197510|NCT00220168|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110197511|NCT00220168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110197512|NCT00220168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110197513|NCT00042575|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110197514|NCT00042575|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110197515|NCT00042575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110197516|NCT00042575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110197517|NCT00042575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197518|NCT00042575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110197519|NCT00042575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110197520|NCT00042575|Analgesics|analgesics|mesh-ancestor
110197521|NCT00042575|Sensory System Agents|sensory system agents|mesh-ancestor
110197522|NCT00042575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110197523|NCT00042575|Antidepressive Agents|antidepressive agents|mesh-ancestor
110197524|NCT00042575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110197525|NCT00042575|Dopamine Agents|dopamine agents|mesh-ancestor
110197526|NCT00220285|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110197527|NCT00220285|Immunologic Factors|immunologic factors|mesh-ancestor
110197528|NCT00220285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110197529|NCT00077454|Temozolomide|temozolomide|mesh-list
110197530|NCT00077454|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110197531|NCT00077454|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110197532|NCT00077454|Alkylating Agents|alkylating agents|mesh-ancestor
110197533|NCT00077454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197534|NCT00077454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110197535|NCT00077454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110197536|NCT00077454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110197537|NCT00220324|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
110197538|NCT00220324|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110197539|NCT00220324|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110197540|NCT00220324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110197541|NCT00220324|Contraceptive Agents|contraceptive agents|mesh-ancestor
110197542|NCT00220324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110197543|NCT00220324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110197544|NCT00220324|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110197545|NCT00220324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110197546|NCT00220324|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110197547|NCT00220324|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
110197548|NCT00220324|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110197549|NCT00220324|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110197550|NCT00412555|Oseltamivir|oseltamivir|mesh-list
110197551|NCT00412555|Antiviral Agents|antiviral agents|mesh-ancestor
110197552|NCT00412555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110197553|NCT00412555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110197554|NCT00412555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197556|NCT00412633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110197557|NCT00042653|Cinacalcet|cinacalcet|mesh-list
110197558|NCT00042653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110197559|NCT00042653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110197560|NCT00042653|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
110197561|NCT00042653|Hormone Antagonists|hormone antagonists|mesh-ancestor
110197562|NCT00042653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110197563|NCT00073593|Heparin|heparin|mesh-list
110197564|NCT00073593|Bivalirudin|bivalirudin|mesh-list
110197565|NCT00073593|Protamines|protamines|mesh-list
110197566|NCT00073593|Anticoagulants|anticoagulants|mesh-ancestor
110197567|NCT00073593|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110197568|NCT00073593|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110197569|NCT00073593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197570|NCT00073593|Antithrombins|antithrombins|mesh-ancestor
110197571|NCT00073593|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110197572|NCT00073593|Protease Inhibitors|protease inhibitors|mesh-ancestor
110197573|NCT00073593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110197575|NCT00073593|Coagulants|coagulants|mesh-ancestor
110197576|NCT00220480|Escitalopram|escitalopram|mesh-list
110197577|NCT00220480|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110197578|NCT00220480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110197579|NCT00220480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110197580|NCT00220480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197581|NCT00220480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110197582|NCT00220480|Serotonin Agents|serotonin agents|mesh-ancestor
110197583|NCT00220480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110197584|NCT00220675|Epoetin Alfa|epoetin alfa|mesh-list
110197585|NCT00220675|Hematinics|hematinics|mesh-ancestor
110197586|NCT00042731|Lycopene|lycopene|mesh-list
110197587|NCT00042731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110062840|NCT04097561|Belimumab|belimumab|mesh-list
110062841|NCT04097561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110197588|NCT00042731|Antioxidants|antioxidants|mesh-ancestor
110197589|NCT00042731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197590|NCT00042731|Protective Agents|protective agents|mesh-ancestor
110197591|NCT00042731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110197592|NCT00042731|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110197593|NCT00042731|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110197594|NCT00042731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110197595|NCT00220714|Antipsychotic Agents|antipsychotic agents|mesh-list
110197596|NCT00220714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110197597|NCT00220714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110197598|NCT00220714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110197599|NCT00220714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110197600|NCT00077493|Antibodies|antibodies|mesh-list
110197601|NCT00077493|Immunoglobulins|immunoglobulins|mesh-list
110197602|NCT00077493|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110197603|NCT00077493|Immunotoxins|immunotoxins|mesh-list
110197604|NCT00077493|Immunoconjugates|immunoconjugates|mesh-list
110197605|NCT00077493|Immunologic Factors|immunologic factors|mesh-ancestor
110197606|NCT00077493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110197607|NCT00220831|Vitamin E|vitamin e|mesh-list
110197608|NCT00220831|Vitamins|vitamins|mesh-ancestor
110197609|NCT00220831|Micronutrients|micronutrients|mesh-ancestor
110197610|NCT00220831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110197611|NCT00220831|Antioxidants|antioxidants|mesh-ancestor
110197612|NCT00220831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197613|NCT00220831|Protective Agents|protective agents|mesh-ancestor
110197614|NCT00220909|Lansoprazole|lansoprazole|mesh-list
110197615|NCT00220909|Dexlansoprazole|dexlansoprazole|mesh-list
110197616|NCT00220909|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110197617|NCT00220909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110197618|NCT00220909|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110197619|NCT00220909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110197620|NCT00220909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197621|NCT00220987|Insulin|insulin|mesh-list
110197622|NCT00220987|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110197624|NCT00220987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110197625|NCT02966067|Anesthetics|anesthetics|mesh-list
110197626|NCT02966067|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110197627|NCT02966067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110197628|NCT02966067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110197630|NCT00221026|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110197631|NCT00221026|Dermatologic Agents|dermatologic agents|mesh-ancestor
110197632|NCT00042809|Paclitaxel|paclitaxel|mesh-list
110197633|NCT00042809|Trastuzumab|trastuzumab|mesh-list
110197634|NCT00042809|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110197635|NCT00042809|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110197636|NCT00042809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110197637|NCT00042809|Tubulin Modulators|tubulin modulators|mesh-ancestor
110197638|NCT00042809|Antimitotic Agents|antimitotic agents|mesh-ancestor
110197639|NCT00042809|Mitosis Modulators|mitosis modulators|mesh-ancestor
110197640|NCT00042809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110393282|NCT01687439|Endostar protein|endostar protein|mesh-list
110197641|NCT00042809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110197642|NCT00042809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110197643|NCT00042809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110197644|NCT00073710|Calcitriol|calcitriol|mesh-list
110197645|NCT00073710|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110197646|NCT00073710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110197647|NCT00073710|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110197648|NCT00073710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110197649|NCT00073710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197650|NCT00073710|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110197651|NCT00073710|Vitamins|vitamins|mesh-ancestor
110197652|NCT00073710|Micronutrients|micronutrients|mesh-ancestor
110197653|NCT00073710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110197654|NCT00042848|Modafinil|modafinil|mesh-list
110197655|NCT00042848|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110197656|NCT00042848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110197657|NCT00042848|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110197658|NCT00042848|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110197659|NCT00042848|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110220146|NCT00112476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110197660|NCT00042848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197661|NCT00221260|Anesthetics|anesthetics|mesh-list
110197662|NCT00221260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110197663|NCT00221260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110197664|NCT00402259|Esomeprazole|esomeprazole|mesh-list
110197665|NCT00402259|Omeprazole|omeprazole|mesh-list
110197666|NCT00402259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110197667|NCT00402259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110197669|NCT00402259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110197670|NCT00402259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197671|NCT02965677|Paclitaxel|paclitaxel|mesh-list
110197672|NCT02965677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110197673|NCT02965677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110197674|NCT02965677|Tubulin Modulators|tubulin modulators|mesh-ancestor
110197675|NCT02965677|Antimitotic Agents|antimitotic agents|mesh-ancestor
110197676|NCT02965677|Mitosis Modulators|mitosis modulators|mesh-ancestor
110197677|NCT02965677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197678|NCT00402376|Carvedilol|carvedilol|mesh-list
110197679|NCT00402376|Perindopril|perindopril|mesh-list
110197680|NCT00402376|Pravastatin|pravastatin|mesh-list
110197681|NCT00402376|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110197682|NCT00402376|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110197683|NCT00402376|Adrenergic Agents|adrenergic agents|mesh-ancestor
110197684|NCT00402376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110197685|NCT00402376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197686|NCT00402376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110197687|NCT00402376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110197688|NCT00402376|Antioxidants|antioxidants|mesh-ancestor
110197689|NCT00402376|Protective Agents|protective agents|mesh-ancestor
110197690|NCT00402376|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110197691|NCT00402376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110197692|NCT00402376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110197693|NCT00402376|Vasodilator Agents|vasodilator agents|mesh-ancestor
110197694|NCT00402376|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110197695|NCT00402376|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110197696|NCT00402376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110197697|NCT00402376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110197698|NCT00402376|Antimetabolites|antimetabolites|mesh-ancestor
110197699|NCT00402376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110197700|NCT00402376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110197701|NCT00402376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110197702|NCT00402376|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110197703|NCT00402376|Protease Inhibitors|protease inhibitors|mesh-ancestor
110197704|NCT00042887|Mitomycins|mitomycins|mesh-list
110197705|NCT00042887|Mitomycin|mitomycin|mesh-list
110197706|NCT00042887|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110197707|NCT00042887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110197708|NCT00042887|Alkylating Agents|alkylating agents|mesh-ancestor
110197709|NCT00042887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110062864|NCT04074746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110062865|NCT04074746|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110197710|NCT00042887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110197711|NCT00042887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110197712|NCT00122746|Cisplatin|cisplatin|mesh-list
110197713|NCT00122746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110197714|NCT00122785|Dexamethasone|dexamethasone|mesh-list
110197715|NCT00122785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110393506|NCT03558854|Aspirin|aspirin|mesh-list
110197716|NCT00122785|Antiemetics|antiemetics|mesh-ancestor
110197717|NCT00122785|Autonomic Agents|autonomic agents|mesh-ancestor
110197718|NCT00122785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110197719|NCT00122785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110197720|NCT00122785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110197721|NCT00122785|Glucocorticoids|glucocorticoids|mesh-ancestor
110197722|NCT00122785|Hormones|hormones|mesh-ancestor
110197723|NCT00122785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110197724|NCT00122785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110197725|NCT00122785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110197726|NCT00122824|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110197727|NCT00122824|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110197728|NCT00122824|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110197729|NCT00122824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110197730|NCT00122824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197731|NCT00122824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110197732|NCT00122824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110197733|NCT00122824|Analgesics|analgesics|mesh-ancestor
110197734|NCT00122824|Sensory System Agents|sensory system agents|mesh-ancestor
110197735|NCT00122824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110197736|NCT00122824|Antidepressive Agents|antidepressive agents|mesh-ancestor
110393555|NCT01335399|Glucocorticoids|glucocorticoids|mesh-ancestor
110197737|NCT00122824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110197738|NCT00122824|Dopamine Agents|dopamine agents|mesh-ancestor
110197739|NCT00077532|Ipilimumab|ipilimumab|mesh-list
110197740|NCT00077532|Freund's Adjuvant|freund's adjuvant|mesh-list
110197741|NCT00077532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110197742|NCT00077532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110197743|NCT00077532|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110197744|NCT00077532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197745|NCT00077532|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110197746|NCT00077532|Immunologic Factors|immunologic factors|mesh-ancestor
110197747|NCT00077532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110197748|NCT00122863|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110197749|NCT00122863|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110197750|NCT00122863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110197751|NCT00122863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110197752|NCT00122863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197753|NCT00122863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110197754|NCT00122863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110197756|NCT00122863|Sensory System Agents|sensory system agents|mesh-ancestor
110197757|NCT00122863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110197758|NCT00122863|Antidepressive Agents|antidepressive agents|mesh-ancestor
110197759|NCT00122863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110197760|NCT00122863|Dopamine Agents|dopamine agents|mesh-ancestor
110197761|NCT00042926|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
110197762|NCT00042926|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110197763|NCT00042926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197764|NCT00122941|Micronutrients|micronutrients|mesh-list
110197765|NCT00122941|Trace Elements|trace elements|mesh-list
110052796|NCT01482117|Cilostazol|cilostazol|mesh-list
110197766|NCT00122941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110197768|NCT00077688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110197769|NCT00077688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110197770|NCT00077688|Tubulin Modulators|tubulin modulators|mesh-ancestor
110197771|NCT00077688|Antimitotic Agents|antimitotic agents|mesh-ancestor
110197772|NCT00077688|Mitosis Modulators|mitosis modulators|mesh-ancestor
110197773|NCT00077688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197775|NCT00397319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110197776|NCT00397319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110197777|NCT02965443|Dapagliflozin|dapagliflozin|mesh-list
110197778|NCT02965443|Saxagliptin|saxagliptin|mesh-list
110220171|NCT00078572|Antimetabolites|antimetabolites|mesh-ancestor
110197779|NCT02965443|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110197780|NCT02965443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197781|NCT02965443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110197782|NCT02965443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110197783|NCT02965443|Incretins|incretins|mesh-ancestor
110197784|NCT02965443|Hormones|hormones|mesh-ancestor
110393653|NCT01357980|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110197785|NCT02965443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110197786|NCT02965443|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110197787|NCT02965443|Protease Inhibitors|protease inhibitors|mesh-ancestor
110197788|NCT02965443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110197789|NCT00042965|Gemcitabine|gemcitabine|mesh-list
110197790|NCT00042965|Capecitabine|capecitabine|mesh-list
110197791|NCT00042965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110197792|NCT00042965|Antimetabolites|antimetabolites|mesh-ancestor
110197793|NCT00042965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197794|NCT00042965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110197795|NCT00123175|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110197796|NCT00123175|Medroxyprogesterone|medroxyprogesterone|mesh-list
110197797|NCT00123175|Progestins|progestins|mesh-list
110197798|NCT00123175|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110197799|NCT00123175|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110197800|NCT00123175|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110197801|NCT00123175|Contraceptive Agents|contraceptive agents|mesh-ancestor
110197802|NCT00123175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110197803|NCT00123175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110197804|NCT00123175|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110197805|NCT00123175|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110197806|NCT00123175|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110197807|NCT00123175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110197808|NCT00123175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110197809|NCT00123175|Hormones|hormones|mesh-ancestor
110197810|NCT00123175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110197811|NCT00077727|Galantamine|galantamine|mesh-list
110197813|NCT00077727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110393706|NCT01331109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110197814|NCT00077727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197815|NCT00077727|Cholinergic Agents|cholinergic agents|mesh-ancestor
110197816|NCT00077727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110197817|NCT00077727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110197818|NCT00077727|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110197819|NCT00077727|Autonomic Agents|autonomic agents|mesh-ancestor
110197820|NCT00077727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110197821|NCT00077727|Nootropic Agents|nootropic agents|mesh-ancestor
110197822|NCT00123292|Plasminogen|plasminogen|mesh-list
110197823|NCT00123292|Fibrinolysin|fibrinolysin|mesh-list
110197824|NCT00123292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110197825|NCT00123292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110197826|NCT00123292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197827|NCT00043004|Leucovorin|leucovorin|mesh-list
110197828|NCT00043004|Bevacizumab|bevacizumab|mesh-list
110197829|NCT00043004|Fluorouracil|fluorouracil|mesh-list
110197830|NCT00043004|Oxaliplatin|oxaliplatin|mesh-list
110197831|NCT00043004|Calcium|calcium|mesh-list
110197832|NCT00043004|Levoleucovorin|levoleucovorin|mesh-list
110197833|NCT00043004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110062887|NCT03951831|Docetaxel|docetaxel|mesh-list
110197834|NCT00043004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110197835|NCT00043004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110197836|NCT00043004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110197837|NCT00043004|Growth Substances|growth substances|mesh-ancestor
110197838|NCT00043004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110197839|NCT00043004|Growth Inhibitors|growth inhibitors|mesh-ancestor
110393754|NCT01348542|Trazodone|trazodone|mesh-list
110197840|NCT00043004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110197841|NCT00043004|Antimetabolites|antimetabolites|mesh-ancestor
110197842|NCT00043004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197843|NCT00043004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110197844|NCT00043004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110197846|NCT00043004|Antidotes|antidotes|mesh-ancestor
110197847|NCT00043004|Protective Agents|protective agents|mesh-ancestor
110197848|NCT00043004|Vitamin B Complex|vitamin b complex|mesh-ancestor
110197850|NCT00043004|Micronutrients|micronutrients|mesh-ancestor
110197851|NCT00123331|Cyclosporine|cyclosporine|mesh-list
110197852|NCT00123331|Sirolimus|sirolimus|mesh-list
110197853|NCT00123331|Cyclosporins|cyclosporins|mesh-list
110197854|NCT00123331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110197855|NCT00123331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197856|NCT00123331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110197857|NCT00123331|Immunologic Factors|immunologic factors|mesh-ancestor
110197858|NCT00123331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110197859|NCT00123331|Antifungal Agents|antifungal agents|mesh-ancestor
110197860|NCT00123331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110393801|NCT01342887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110197861|NCT00123331|Dermatologic Agents|dermatologic agents|mesh-ancestor
110197862|NCT00123331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110197863|NCT00123331|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110197864|NCT00123331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110197865|NCT00123331|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110197866|NCT00123331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110197867|NCT00123370|Modafinil|modafinil|mesh-list
110197868|NCT00123370|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110197869|NCT00123370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110197870|NCT00123370|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110197871|NCT00123370|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110197872|NCT00123370|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110197873|NCT00123370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197874|NCT00043043|Celecoxib|celecoxib|mesh-list
110197875|NCT00043043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110197876|NCT00043043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110197877|NCT00043043|Analgesics|analgesics|mesh-ancestor
110197878|NCT00043043|Sensory System Agents|sensory system agents|mesh-ancestor
110197879|NCT00043043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110197880|NCT00043043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110197881|NCT00043043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110393864|NCT04328493|Analgesics|analgesics|mesh-ancestor
110197882|NCT00043043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110197883|NCT00043043|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110197884|NCT00043043|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110197885|NCT00043043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110197886|NCT00043043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197888|NCT00077805|Enoxaparin sodium|enoxaparin sodium|mesh-list
110197889|NCT00077805|Anticoagulants|anticoagulants|mesh-ancestor
110197890|NCT00077805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110197891|NCT00077805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110197892|NCT00077805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197893|NCT00043082|Carboplatin|carboplatin|mesh-list
110197894|NCT00043082|Doxorubicin|doxorubicin|mesh-list
110197895|NCT00043082|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110197896|NCT00043082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110197897|NCT00043082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110197898|NCT00043082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110197899|NCT00043082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110197900|NCT00043082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110197901|NCT00043082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197902|NCT00123877|Esorubicin|esorubicin|mesh-list
110197903|NCT00123877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110197904|NCT00123877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110197905|NCT00123916|Benzonidazole|benzonidazole|mesh-list
110197906|NCT00123916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110197908|NCT00123916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110197909|NCT00123916|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110197910|NCT00123916|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110197911|NCT00123916|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110197912|NCT00123916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110197914|NCT00073827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110197915|NCT00073827|Autonomic Agents|autonomic agents|mesh-ancestor
110197916|NCT00073827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110197917|NCT00073827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110197918|NCT00073827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110197919|NCT00073827|Respiratory System Agents|respiratory system agents|mesh-ancestor
110197920|NCT00073827|Tocolytic Agents|tocolytic agents|mesh-ancestor
110197921|NCT00073827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110197922|NCT00073827|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110197923|NCT00073827|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110197924|NCT00073827|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110197925|NCT00073827|Adrenergic Agents|adrenergic agents|mesh-ancestor
110197926|NCT00073827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110197927|NCT00073827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197928|NCT02970539|Paclitaxel|paclitaxel|mesh-list
110197929|NCT02970539|Ramucirumab|ramucirumab|mesh-list
110197930|NCT02970539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110197931|NCT02970539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110197932|NCT02970539|Tubulin Modulators|tubulin modulators|mesh-ancestor
110197933|NCT02970539|Antimitotic Agents|antimitotic agents|mesh-ancestor
110197934|NCT02970539|Mitosis Modulators|mitosis modulators|mesh-ancestor
110197935|NCT02970539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197936|NCT00124111|Cyclophosphamide|cyclophosphamide|mesh-list
110197937|NCT00124111|Fluorouracil|fluorouracil|mesh-list
110197938|NCT00124111|Methotrexate|methotrexate|mesh-list
110197939|NCT00124111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110197940|NCT00124111|Immunologic Factors|immunologic factors|mesh-ancestor
110197941|NCT00124111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110197942|NCT00124111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110197943|NCT00124111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110197944|NCT00124111|Alkylating Agents|alkylating agents|mesh-ancestor
110197945|NCT00124111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197946|NCT00124111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110197947|NCT00124111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110197948|NCT00124111|Antimetabolites|antimetabolites|mesh-ancestor
110197949|NCT00124111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110197950|NCT00124111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110197951|NCT00124111|Abortifacient Agents|abortifacient agents|mesh-ancestor
110197952|NCT00124111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110197953|NCT00124111|Dermatologic Agents|dermatologic agents|mesh-ancestor
110197954|NCT00124111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110197955|NCT00124111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110197956|NCT00124111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110197957|NCT00124150|Magnesium Sulfate|magnesium sulfate|mesh-list
110197958|NCT00124150|Analgesics|analgesics|mesh-ancestor
110197959|NCT00124150|Sensory System Agents|sensory system agents|mesh-ancestor
110197960|NCT00124150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110197961|NCT00124150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110197962|NCT00124150|Anesthetics|anesthetics|mesh-ancestor
110197963|NCT00124150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110197964|NCT00124150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110197965|NCT00124150|Anticonvulsants|anticonvulsants|mesh-ancestor
110197966|NCT00124150|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110197967|NCT00124150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110197968|NCT00124150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197969|NCT00124150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110197970|NCT00124150|Tocolytic Agents|tocolytic agents|mesh-ancestor
110197971|NCT00124150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110197972|NCT02958046|Domperidone|domperidone|mesh-list
110197973|NCT02958046|Lansoprazole|lansoprazole|mesh-list
110197974|NCT02958046|Dexlansoprazole|dexlansoprazole|mesh-list
110197975|NCT02958046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110197976|NCT02958046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110197977|NCT02958046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110197978|NCT02958046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110197979|NCT02958046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197980|NCT02958046|Antiemetics|antiemetics|mesh-ancestor
110197981|NCT02958046|Autonomic Agents|autonomic agents|mesh-ancestor
110197983|NCT02958046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110197984|NCT02958046|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110197985|NCT02958046|Dopamine Agents|dopamine agents|mesh-ancestor
110197986|NCT02958046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110197987|NCT00073905|Gemcitabine|gemcitabine|mesh-list
110197988|NCT00073905|Capecitabine|capecitabine|mesh-list
110197989|NCT00073905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110197990|NCT00073905|Antimetabolites|antimetabolites|mesh-ancestor
110197991|NCT00073905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110197992|NCT00073905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110197993|NCT00124267|Quinine|quinine|mesh-list
110197994|NCT00124267|Antimalarials|antimalarials|mesh-ancestor
110197995|NCT00124267|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110197996|NCT00124267|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110197997|NCT00124267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110197998|NCT00124267|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110197999|NCT00124267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110198000|NCT00124267|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110198001|NCT00124267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110198002|NCT00124267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110198003|NCT00124267|Analgesics|analgesics|mesh-ancestor
110198004|NCT00124267|Sensory System Agents|sensory system agents|mesh-ancestor
110198005|NCT00077844|Enoxaparin|enoxaparin|mesh-list
110198006|NCT00077844|Enoxaparin sodium|enoxaparin sodium|mesh-list
110198007|NCT00077844|Anticoagulants|anticoagulants|mesh-ancestor
110198008|NCT00077844|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110198009|NCT00077844|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110198010|NCT00077844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110198011|NCT00043121|Leucovorin|leucovorin|mesh-list
110198012|NCT00043121|Fluorouracil|fluorouracil|mesh-list
110198013|NCT00043121|Capecitabine|capecitabine|mesh-list
110198014|NCT00043121|Oxaliplatin|oxaliplatin|mesh-list
110198015|NCT00043121|Calcium|calcium|mesh-list
110198016|NCT00043121|Levoleucovorin|levoleucovorin|mesh-list
110198017|NCT00043121|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110198018|NCT00043121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110198019|NCT00043121|Antimetabolites|antimetabolites|mesh-ancestor
110198020|NCT00043121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110198021|NCT00043121|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110198022|NCT00043121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110198023|NCT00043121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110198024|NCT00043121|Immunologic Factors|immunologic factors|mesh-ancestor
110198025|NCT00043121|Antidotes|antidotes|mesh-ancestor
110198026|NCT00043121|Protective Agents|protective agents|mesh-ancestor
110198027|NCT00043121|Vitamin B Complex|vitamin b complex|mesh-ancestor
110198028|NCT00043121|Vitamins|vitamins|mesh-ancestor
110198029|NCT00043121|Micronutrients|micronutrients|mesh-ancestor
110198030|NCT00402415|Sirolimus|sirolimus|mesh-list
110198031|NCT00402415|Sunitinib|sunitinib|mesh-list
110198032|NCT00402415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110198033|NCT00402415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110198034|NCT00402415|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110198035|NCT00402415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110198036|NCT00402415|Antifungal Agents|antifungal agents|mesh-ancestor
110198037|NCT00402415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110198038|NCT00402415|Immunologic Factors|immunologic factors|mesh-ancestor
110198040|NCT00402415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110198041|NCT00402415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110198042|NCT00402415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110198043|NCT00402415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110198044|NCT00402415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110198045|NCT00402415|Growth Substances|growth substances|mesh-ancestor
110198046|NCT00402415|Growth Inhibitors|growth inhibitors|mesh-ancestor
110198047|NCT04727476|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
110198048|NCT04727476|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110198049|NCT04727476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110198050|NCT04727476|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110198051|NCT04727476|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110198052|NCT04727476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110198053|NCT04727476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110198054|NCT04727476|Dopamine Agents|dopamine agents|mesh-ancestor
110198055|NCT04727476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110198056|NCT00124306|Amitriptyline|amitriptyline|mesh-list
110198057|NCT00124306|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110198058|NCT00124306|Antidepressive Agents|antidepressive agents|mesh-ancestor
110198059|NCT00124306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110198060|NCT00124306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110198061|NCT00124306|Analgesics|analgesics|mesh-ancestor
110198062|NCT00124306|Sensory System Agents|sensory system agents|mesh-ancestor
110198063|NCT00124306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110198064|NCT00124306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110198065|NCT00124306|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110198066|NCT00124306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110198067|NCT00124306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110198068|NCT00124306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110198069|NCT00124306|Adrenergic Agents|adrenergic agents|mesh-ancestor
110198070|NCT00124306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110198071|NCT00043199|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(II)|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii)|mesh-list
110198072|NCT00043199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110198074|NCT00124384|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110198075|NCT00124384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110198076|NCT00124384|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110198077|NCT00124384|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110198078|NCT00124384|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110198079|NCT00124384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110198081|NCT00077883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110198082|NCT00124540|Misoprostol|misoprostol|mesh-list
110198083|NCT00124540|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110198084|NCT00124540|Abortifacient Agents|abortifacient agents|mesh-ancestor
110198085|NCT00124540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110198086|NCT00124540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110198087|NCT00124540|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110198088|NCT00124540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110198089|NCT00124540|Oxytocics|oxytocics|mesh-ancestor
110198090|NCT00124696|Cocaethylene|cocaethylene|mesh-list
110198091|NCT00124696|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110198092|NCT00124696|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110220219|NCT04718311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110198093|NCT00124696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110198094|NCT00124696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110198096|NCT00124696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110198097|NCT00124696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110198098|NCT00043277|Bivalirudin|bivalirudin|mesh-list
110198099|NCT00043277|Antithrombins|antithrombins|mesh-ancestor
110198100|NCT00043277|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110198101|NCT00043277|Protease Inhibitors|protease inhibitors|mesh-ancestor
110198102|NCT00043277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110198103|NCT00043277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110198104|NCT00043277|Anticoagulants|anticoagulants|mesh-ancestor
110198105|NCT00074022|Docetaxel|docetaxel|mesh-list
110198106|NCT00074022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110198107|NCT00074022|Tubulin Modulators|tubulin modulators|mesh-ancestor
110198108|NCT00074022|Antimitotic Agents|antimitotic agents|mesh-ancestor
110198109|NCT00074022|Mitosis Modulators|mitosis modulators|mesh-ancestor
110198110|NCT00074022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110198111|NCT00124813|Thalidomide|thalidomide|mesh-list
110198112|NCT00124813|Idarubicin|idarubicin|mesh-list
110198113|NCT00124813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110198114|NCT00124813|Immunologic Factors|immunologic factors|mesh-ancestor
110198115|NCT00124813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110198116|NCT00124813|Leprostatic Agents|leprostatic agents|mesh-ancestor
110198117|NCT00124813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110198118|NCT00124813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110198119|NCT00124813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110198120|NCT00124813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110198121|NCT00124813|Growth Substances|growth substances|mesh-ancestor
110198122|NCT00124813|Growth Inhibitors|growth inhibitors|mesh-ancestor
110198123|NCT00124813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110198124|NCT00124813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110394292|NCT02273765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110198125|NCT00124813|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110198126|NCT00124813|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110198127|NCT00124813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110198128|NCT00124813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110198129|NCT00124930|Olanzapine|olanzapine|mesh-list
110198130|NCT00124930|Antiemetics|antiemetics|mesh-ancestor
110198131|NCT00124930|Autonomic Agents|autonomic agents|mesh-ancestor
110198132|NCT00124930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110198133|NCT00124930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110198134|NCT00124930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110198135|NCT00124930|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110198136|NCT00124930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110198137|NCT00124930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110198138|NCT00124930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110198139|NCT00124930|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110198140|NCT00124930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110198141|NCT00124930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110220238|NCT00275275|Pramipexole|pramipexole|mesh-list
110198142|NCT00124930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110198143|NCT00124930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110198144|NCT00124930|Serotonin Agents|serotonin agents|mesh-ancestor
110198145|NCT00124969|Amlodipine|amlodipine|mesh-list
110198146|NCT00124969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110198147|NCT00124969|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110198148|NCT00124969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110198149|NCT00124969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110198150|NCT00124969|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110198151|NCT00124969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110198152|NCT00124969|Vasodilator Agents|vasodilator agents|mesh-ancestor
110198153|NCT00043316|Interferons|interferons|mesh-list
110198154|NCT00043316|Interferon-gamma|interferon-gamma|mesh-list
110198155|NCT00043316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110198156|NCT00043316|Antiviral Agents|antiviral agents|mesh-ancestor
110198157|NCT00043316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110198158|NCT00077961|Alemtuzumab|alemtuzumab|mesh-list
110198159|NCT00077961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110198160|NCT00077961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110198161|NCT00125008|Vaccines|vaccines|mesh-list
110198162|NCT00125008|Immunologic Factors|immunologic factors|mesh-ancestor
110198163|NCT00125008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110198164|NCT00125047|Vaccines|vaccines|mesh-list
110198165|NCT00125047|Immunologic Factors|immunologic factors|mesh-ancestor
110198166|NCT00125047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110198167|NCT00078000|Sunitinib|sunitinib|mesh-list
110198168|NCT00078000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110198169|NCT00078000|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110198170|NCT00078000|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110198171|NCT00078000|Growth Substances|growth substances|mesh-ancestor
110198172|NCT00078000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110198173|NCT00078000|Growth Inhibitors|growth inhibitors|mesh-ancestor
110198174|NCT00078000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110198175|NCT00078000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110198176|NCT00078000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110198177|NCT00125203|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
110198179|NCT00125203|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110198180|NCT00125203|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110198181|NCT00125203|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110198182|NCT00125203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110062999|NCT03884972|Venetoclax|venetoclax|mesh-list
110063000|NCT03884972|Trabectedin|trabectedin|mesh-list
110394380|NCT01601327|Androgens|androgens|mesh-ancestor
110063001|NCT03884972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110198183|NCT00125203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110198184|NCT00125203|Cholinergic Agents|cholinergic agents|mesh-ancestor
110198185|NCT00125203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110198186|NCT00125203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110198187|NCT00125203|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110198188|NCT00125203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110198189|NCT00125203|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110198190|NCT00043355|Interferons|interferons|mesh-list
110198191|NCT00043355|Interferon-gamma|interferon-gamma|mesh-list
110198192|NCT00043355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110198193|NCT00043355|Antiviral Agents|antiviral agents|mesh-ancestor
110198194|NCT00043355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110198195|NCT00125398|Fospropofol|fospropofol|mesh-list
110198196|NCT00125398|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110198197|NCT00125398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110198198|NCT00125398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110198199|NCT04729998|Rivaroxaban|rivaroxaban|mesh-list
110198200|NCT04729998|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110198201|NCT04729998|Antithrombins|antithrombins|mesh-ancestor
110220271|NCT00275119|Gemcitabine|gemcitabine|mesh-list
110394446|NCT01607996|Anesthetics|anesthetics|mesh-list
110198202|NCT04729998|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110198203|NCT04729998|Protease Inhibitors|protease inhibitors|mesh-ancestor
110198204|NCT04729998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110198205|NCT04729998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110198206|NCT04729998|Anticoagulants|anticoagulants|mesh-ancestor
110198207|NCT00125437|Spironolactone|spironolactone|mesh-list
110198208|NCT00125437|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110198209|NCT00125437|Hormone Antagonists|hormone antagonists|mesh-ancestor
110198210|NCT00125437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110198211|NCT00125437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110198212|NCT00125437|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110198213|NCT00125437|Diuretics|diuretics|mesh-ancestor
110198214|NCT00125437|Natriuretic Agents|natriuretic agents|mesh-ancestor
110198216|NCT00125554|Antimetabolites|antimetabolites|mesh-ancestor
110198217|NCT00125554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110198218|NCT00125554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110198219|NCT00043394|Trastuzumab|trastuzumab|mesh-list
110198220|NCT00043394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110198221|NCT00043394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110198222|NCT00125671|Warfarin|warfarin|mesh-list
110198223|NCT00125671|Anticoagulants|anticoagulants|mesh-ancestor
110198224|NCT00125827|Clofarabine|clofarabine|mesh-list
110198225|NCT00125827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110198226|NCT00125827|Antimetabolites|antimetabolites|mesh-ancestor
110198227|NCT00125827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110198228|NCT00125827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110198229|NCT00078039|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110198230|NCT00078039|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110198231|NCT00078039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110198232|NCT00078039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110198233|NCT00078039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110198234|NCT00078039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110394492|NCT01111825|Immunologic Factors|immunologic factors|mesh-ancestor
110198235|NCT00078039|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110198236|NCT00078039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110198237|NCT00078039|Serotonin Agents|serotonin agents|mesh-ancestor
110198238|NCT00078039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110198239|NCT00078039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110198240|NCT00078039|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110198241|NCT00078039|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110198242|NCT00078039|Dopamine Agents|dopamine agents|mesh-ancestor
110063002|NCT03884972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110063003|NCT03884972|Alkylating Agents|alkylating agents|mesh-ancestor
110063004|NCT03884972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110063013|NCT03819517|Resveratrol|resveratrol|mesh-list
110063014|NCT03819517|Antioxidants|antioxidants|mesh-ancestor
110063015|NCT03819517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110198243|NCT00125905|Bupropion|bupropion|mesh-list
110198244|NCT00125905|Nicotine|nicotine|mesh-list
110198245|NCT00125905|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110198246|NCT00125905|Autonomic Agents|autonomic agents|mesh-ancestor
110198247|NCT00125905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110198248|NCT00125905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110198249|NCT00125905|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110198250|NCT00125905|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110198251|NCT00125905|Cholinergic Agents|cholinergic agents|mesh-ancestor
110198252|NCT00125905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110198253|NCT00125905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110198254|NCT00125905|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110198255|NCT00125905|Antidepressive Agents|antidepressive agents|mesh-ancestor
110198256|NCT00125905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110198257|NCT00125905|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110220275|NCT00275119|Antimetabolites|antimetabolites|mesh-ancestor
110198258|NCT00125905|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110198259|NCT00125905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110198260|NCT00125905|Dopamine Agents|dopamine agents|mesh-ancestor
110198261|NCT00125905|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110198262|NCT00125905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110198263|NCT00125905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110198264|NCT00078117|Buprenorphine|buprenorphine|mesh-list
110198265|NCT00078117|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110198266|NCT00078117|Narcotics|narcotics|mesh-ancestor
110198267|NCT00078117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110198268|NCT00078117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110198269|NCT00078117|Analgesics|analgesics|mesh-ancestor
110198270|NCT00078117|Sensory System Agents|sensory system agents|mesh-ancestor
110198271|NCT00078117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110198272|NCT00078117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110198274|NCT00125983|Lopinavir|lopinavir|mesh-list
110198275|NCT00125983|Norinyl|norinyl|mesh-list
110198276|NCT00125983|Ortho Evra|ortho evra|mesh-list
110198277|NCT00125983|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110198278|NCT00125983|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110198279|NCT00125983|Protease Inhibitors|protease inhibitors|mesh-ancestor
110198280|NCT00125983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110394592|NCT01608347|Hematinics|hematinics|mesh-ancestor
110198281|NCT00125983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110198282|NCT00125983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110198283|NCT00125983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110198284|NCT00125983|Antiviral Agents|antiviral agents|mesh-ancestor
110198285|NCT00125983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110198286|NCT00125983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110198287|NCT00125983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110198288|NCT00125983|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110198289|NCT00125983|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110198290|NCT00125983|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110198291|NCT00125983|Contraceptive Agents|contraceptive agents|mesh-ancestor
110198292|NCT00125983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110198293|NCT00125983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110198294|NCT00125983|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110198295|NCT00125983|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110198296|NCT00126022|Tedisamil|tedisamil|mesh-list
110198297|NCT00126022|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110394654|NCT01174186|Adalimumab|adalimumab|mesh-list
110198298|NCT00126022|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110198299|NCT00126022|Protective Agents|protective agents|mesh-ancestor
110198300|NCT00126022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110198301|NCT00402454|Rifampin|rifampin|mesh-list
110198302|NCT00402454|Isoniazid|isoniazid|mesh-list
110198303|NCT00402454|Pyrazinamide|pyrazinamide|mesh-list
110198304|NCT00402454|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110198305|NCT00402454|Antitubercular Agents|antitubercular agents|mesh-ancestor
110198306|NCT00402454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110063020|NCT03819296|Prednisone|prednisone|mesh-list
110198307|NCT00402454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110198308|NCT00402454|Leprostatic Agents|leprostatic agents|mesh-ancestor
110198309|NCT00402454|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110198310|NCT00402454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110198311|NCT00402454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110198312|NCT00402454|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110198313|NCT00402454|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110198314|NCT00402454|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110198315|NCT00402454|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110198316|NCT00402454|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110198317|NCT00402454|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110198318|NCT00402454|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110198319|NCT00402454|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110198320|NCT00402454|Antimetabolites|antimetabolites|mesh-ancestor
110198321|NCT00402454|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110198322|NCT00402493|Ibuprofen|ibuprofen|mesh-list
110198323|NCT00402493|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110198324|NCT00402493|Latanoprost|latanoprost|mesh-list
110198325|NCT00402493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110198326|NCT00402493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110198327|NCT00402493|Analgesics|analgesics|mesh-ancestor
110198328|NCT00402493|Sensory System Agents|sensory system agents|mesh-ancestor
110198329|NCT00402493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110198330|NCT00402493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110198331|NCT00402493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110198332|NCT00402493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110198333|NCT00402493|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110198334|NCT00402493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110198335|NCT00402493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110198336|NCT00402493|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110198337|NCT00402493|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110198338|NCT00402493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110198339|NCT00402493|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110198340|NCT00402493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110198341|NCT00402493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110198342|NCT00402493|Adrenergic Agents|adrenergic agents|mesh-ancestor
110198343|NCT00402493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110198344|NCT00402532|Everolimus|everolimus|mesh-list
110198345|NCT00402532|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110198346|NCT00402532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110198347|NCT00402532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110198348|NCT00402532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110198349|NCT00402532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110198350|NCT00402532|Immunologic Factors|immunologic factors|mesh-ancestor
110198351|NCT00402532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110198352|NCT00402532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110198353|NCT00126061|Tedisamil|tedisamil|mesh-list
110198354|NCT00126061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110198355|NCT00126061|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110198356|NCT00126061|Protective Agents|protective agents|mesh-ancestor
110198357|NCT00126061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110198358|NCT00043589|Donepezil|donepezil|mesh-list
110198359|NCT00043589|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110198360|NCT00043589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110198361|NCT00043589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220304|NCT00274963|Mitoxantrone|mitoxantrone|mesh-list
110198363|NCT00043589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110198364|NCT00043589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110198365|NCT00043589|Nootropic Agents|nootropic agents|mesh-ancestor
110198366|NCT00399399|Cyclophosphamide|cyclophosphamide|mesh-list
110198367|NCT00399399|Azathioprine|azathioprine|mesh-list
110198368|NCT00399399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110198369|NCT00399399|Immunologic Factors|immunologic factors|mesh-ancestor
110198370|NCT00399399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110198371|NCT00399399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110198372|NCT00399399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110198373|NCT00399399|Alkylating Agents|alkylating agents|mesh-ancestor
110198374|NCT00399399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110198375|NCT00399399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110198376|NCT00399399|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110198377|NCT00399399|Antimetabolites|antimetabolites|mesh-ancestor
110198378|NCT00399399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110198379|NCT00126100|Lenograstim|lenograstim|mesh-list
110198380|NCT00126100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110198381|NCT00126100|Immunologic Factors|immunologic factors|mesh-ancestor
110198382|NCT00126100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110198383|NCT00123253|Tesamorelin|tesamorelin|mesh-list
110198384|NCT00123253|Growth Substances|growth substances|mesh-ancestor
110198385|NCT00123253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110198386|NCT00126139|Abciximab|abciximab|mesh-list
110198387|NCT00126139|Anticoagulants|anticoagulants|mesh-ancestor
110198388|NCT00126139|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110198389|NCT00074100|Amonafide|amonafide|mesh-list
110198390|NCT00074100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110198391|NCT00074100|Antiviral Agents|antiviral agents|mesh-ancestor
110198392|NCT00074100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110198393|NCT00074100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110198394|NCT00074100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110198395|NCT00126256|Leucovorin|leucovorin|mesh-list
110198396|NCT00126256|Fluorouracil|fluorouracil|mesh-list
110198397|NCT00126256|Oxaliplatin|oxaliplatin|mesh-list
110198398|NCT00126256|Irinotecan|irinotecan|mesh-list
110198399|NCT00126256|Antimetabolites|antimetabolites|mesh-ancestor
110394840|NCT00593580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110198400|NCT00126256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110198401|NCT00126256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110198402|NCT00126256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110198403|NCT00126256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110198405|NCT00126256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110198406|NCT00126256|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110198407|NCT00126256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110198408|NCT00126256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110198409|NCT00126256|Antidotes|antidotes|mesh-ancestor
110198410|NCT00126256|Protective Agents|protective agents|mesh-ancestor
110198411|NCT00126256|Vitamin B Complex|vitamin b complex|mesh-ancestor
110198412|NCT00126256|Vitamins|vitamins|mesh-ancestor
110198413|NCT00126256|Micronutrients|micronutrients|mesh-ancestor
110198414|NCT00043667|Daclizumab|daclizumab|mesh-list
110198415|NCT00043667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110198416|NCT00043667|Immunologic Factors|immunologic factors|mesh-ancestor
110198417|NCT00043667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110198418|NCT00074139|Cyclophosphamide|cyclophosphamide|mesh-list
110198419|NCT00074139|Docetaxel|docetaxel|mesh-list
110198420|NCT00074139|Doxorubicin|doxorubicin|mesh-list
110198421|NCT00074139|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110198422|NCT00074139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110198423|NCT00074139|Immunologic Factors|immunologic factors|mesh-ancestor
110198424|NCT00074139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110198425|NCT00074139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110198426|NCT00074139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110198427|NCT00074139|Alkylating Agents|alkylating agents|mesh-ancestor
110198428|NCT00074139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110198429|NCT00074139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110198430|NCT00074139|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110198431|NCT00074139|Tubulin Modulators|tubulin modulators|mesh-ancestor
110198432|NCT00074139|Antimitotic Agents|antimitotic agents|mesh-ancestor
110198433|NCT00074139|Mitosis Modulators|mitosis modulators|mesh-ancestor
110198434|NCT00074139|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110198435|NCT00074139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110198436|NCT00074139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110198437|NCT00074139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110198439|NCT00126373|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110198440|NCT00126373|Antidepressive Agents|antidepressive agents|mesh-ancestor
110198441|NCT00126373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110198442|NCT00126373|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110198443|NCT00126373|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110198444|NCT00126373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110198445|NCT00126373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110198446|NCT00126373|Dopamine Agents|dopamine agents|mesh-ancestor
110198447|NCT00126373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110198448|NCT00126373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110198449|NCT00126373|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110198450|NCT00126373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110198451|NCT00126373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110198452|NCT00126412|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
110198453|NCT00126412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110198454|NCT00126412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110198455|NCT00126412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110198456|NCT00126412|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110198457|NCT00043706|Antibodies|antibodies|mesh-list
110198458|NCT00043706|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110198459|NCT00043706|Mitogens|mitogens|mesh-list
110198460|NCT00043706|Immunologic Factors|immunologic factors|mesh-ancestor
110198461|NCT00043706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110198462|NCT00043706|Mitosis Modulators|mitosis modulators|mesh-ancestor
110198463|NCT00043706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110198464|NCT00126451|Vorinostat|vorinostat|mesh-list
110198465|NCT00126451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110198466|NCT00126451|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110198467|NCT00126451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110198468|NCT00126451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110198469|NCT00126607|Trastuzumab|trastuzumab|mesh-list
110198470|NCT00126607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110198471|NCT00126607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110198472|NCT00074178|Cytarabine|cytarabine|mesh-list
110198473|NCT00074178|Dexamethasone|dexamethasone|mesh-list
110198474|NCT00074178|Cyclophosphamide|cyclophosphamide|mesh-list
110198475|NCT00074178|Methotrexate|methotrexate|mesh-list
110198476|NCT00074178|Etoposide|etoposide|mesh-list
110198477|NCT00074178|Etoposide phosphate|etoposide phosphate|mesh-list
110198478|NCT00074178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110198479|NCT00074178|Immunologic Factors|immunologic factors|mesh-ancestor
110198480|NCT00074178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110198481|NCT00074178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110198482|NCT00074178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110198483|NCT00074178|Alkylating Agents|alkylating agents|mesh-ancestor
110198484|NCT00074178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110198485|NCT00074178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110198486|NCT00074178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110198487|NCT00074178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110198488|NCT00074178|Antiemetics|antiemetics|mesh-ancestor
110198489|NCT00074178|Autonomic Agents|autonomic agents|mesh-ancestor
110198490|NCT00074178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110198491|NCT00074178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110198492|NCT00074178|Glucocorticoids|glucocorticoids|mesh-ancestor
110198494|NCT00074178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110198495|NCT00074178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110395123|NCT00595140|Somatostatin|somatostatin|mesh-list
110395147|NCT01606358|Carboplatin|carboplatin|mesh-list
110198496|NCT00074178|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110198498|NCT00074178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110198499|NCT00074178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110198500|NCT00074178|Antimetabolites|antimetabolites|mesh-ancestor
110198501|NCT00074178|Dermatologic Agents|dermatologic agents|mesh-ancestor
110198502|NCT00074178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110198503|NCT00074178|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110198504|NCT00074178|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110198505|NCT00074178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110198506|NCT00074178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110198507|NCT00074178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110198508|NCT00074178|Antiviral Agents|antiviral agents|mesh-ancestor
110198509|NCT00074178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110198510|NCT00126646|Antibodies|antibodies|mesh-list
110198511|NCT00126646|Immunotoxins|immunotoxins|mesh-list
110198512|NCT00126646|Immunoconjugates|immunoconjugates|mesh-list
110198513|NCT00126646|Immunologic Factors|immunologic factors|mesh-ancestor
110198514|NCT00126646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110198515|NCT00126763|Fentanyl|fentanyl|mesh-list
110395182|NCT01172938|Analgesics|analgesics|mesh-ancestor
110198516|NCT00126763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110198517|NCT00126763|Narcotics|narcotics|mesh-ancestor
110198518|NCT00126763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110198519|NCT00126763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110198520|NCT00126763|Analgesics|analgesics|mesh-ancestor
110198521|NCT00126763|Sensory System Agents|sensory system agents|mesh-ancestor
110198522|NCT00126763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110198523|NCT00126763|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110198524|NCT00126763|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110198525|NCT00126763|Anesthetics, General|anesthetics, general|mesh-ancestor
110198526|NCT00126763|Anesthetics|anesthetics|mesh-ancestor
110198527|NCT00402571|Acetaminophen|acetaminophen|mesh-list
110198528|NCT00402571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110198529|NCT00402571|Analgesics|analgesics|mesh-ancestor
110198530|NCT00402571|Sensory System Agents|sensory system agents|mesh-ancestor
110198531|NCT00402571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110198532|NCT00402571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110198533|NCT00402571|Antipyretics|antipyretics|mesh-ancestor
110198534|NCT00126880|Lamivudine|lamivudine|mesh-list
110198535|NCT00126880|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110198536|NCT00126880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110198537|NCT00126880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110198538|NCT00126880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110198539|NCT00126880|Antiviral Agents|antiviral agents|mesh-ancestor
110198540|NCT00126880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110198541|NCT00126880|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110198542|NCT00126880|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110198543|NCT02965911|Fenofibrate|fenofibrate|mesh-list
110198544|NCT02965911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110198545|NCT02965911|Antimetabolites|antimetabolites|mesh-ancestor
110198546|NCT02965911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110198547|NCT02965911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110198549|NCT00127075|Estrogens|estrogens|mesh-ancestor
110198550|NCT00127075|Hormones|hormones|mesh-ancestor
110220349|NCT00130312|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110198551|NCT00127075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110198552|NCT00127075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110198554|NCT00127114|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110198555|NCT00127114|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110198556|NCT00127114|Antiviral Agents|antiviral agents|mesh-ancestor
110198557|NCT00127114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110198558|NCT00127114|Dopamine Agents|dopamine agents|mesh-ancestor
110198559|NCT00127114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110198560|NCT00127114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110198561|NCT00127114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110198562|NCT00127114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110198564|NCT00127114|Sensory System Agents|sensory system agents|mesh-ancestor
110198565|NCT00127114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110198567|NCT00043784|Anticoagulants|anticoagulants|mesh-ancestor
110198568|NCT00043784|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110198569|NCT00043784|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110198570|NCT00043784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110198571|NCT00127153|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110198572|NCT00127153|Immunologic Factors|immunologic factors|mesh-ancestor
110198573|NCT00127153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110198574|NCT00399477|Levodopa|levodopa|mesh-list
110198575|NCT00399477|Pramipexole|pramipexole|mesh-list
110198576|NCT00399477|Rasagiline|rasagiline|mesh-list
110198577|NCT00399477|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110198578|NCT00399477|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110198579|NCT00399477|Dopamine Agents|dopamine agents|mesh-ancestor
110198580|NCT00399477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110198581|NCT00399477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110198582|NCT00399477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110198583|NCT00399477|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110198584|NCT00399477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110198585|NCT00399477|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110198586|NCT00399477|Protective Agents|protective agents|mesh-ancestor
110198587|NCT00399477|Antioxidants|antioxidants|mesh-ancestor
110198588|NCT00399477|Dopamine Agonists|dopamine agonists|mesh-ancestor
110198589|NCT00127270|Darifenacin|darifenacin|mesh-list
110198590|NCT00127270|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110198591|NCT00127270|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110198592|NCT00127270|Cholinergic Agents|cholinergic agents|mesh-ancestor
110395421|NCT02273258|Insulin|insulin|mesh-list
110198593|NCT00127270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110198594|NCT00127270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110198595|NCT00127270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110198596|NCT00127270|Urological Agents|urological agents|mesh-ancestor
110198597|NCT00043823|Bevacizumab|bevacizumab|mesh-list
110198598|NCT00043823|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110198599|NCT00043823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110198600|NCT00043823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110198601|NCT00043823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110198602|NCT00043823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110198603|NCT00043823|Growth Substances|growth substances|mesh-ancestor
110198604|NCT00043823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110198605|NCT00043823|Growth Inhibitors|growth inhibitors|mesh-ancestor
110198606|NCT00043823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110198607|NCT00043823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110198608|NCT00043823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110198609|NCT00074334|Immunotoxins|immunotoxins|mesh-list
110198610|NCT00074334|Immunoconjugates|immunoconjugates|mesh-ancestor
110198611|NCT00074334|Immunologic Factors|immunologic factors|mesh-ancestor
110198612|NCT00074334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110063081|NCT03772834|Dopamine Agents|dopamine agents|mesh-ancestor
110395462|NCT01107925|Clopidogrel|clopidogrel|mesh-list
110198614|NCT00127387|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110198617|NCT00127387|Sensory System Agents|sensory system agents|mesh-ancestor
110198618|NCT00127387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110198619|NCT00127387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110198620|NCT00127387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110198621|NCT00127387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110198622|NCT00127387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110198623|NCT00127387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110198624|NCT00127387|Immunologic Factors|immunologic factors|mesh-ancestor
110198625|NCT00043862|Topotecan|topotecan|mesh-list
110198626|NCT00043862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110198627|NCT00043862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110198628|NCT00043862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110198629|NCT00043862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110198630|NCT00043862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110198631|NCT00127504|Azithromycin|azithromycin|mesh-list
110198632|NCT00127504|Rifampin|rifampin|mesh-list
110198633|NCT00127504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110198634|NCT00127504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110198635|NCT00127504|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110198636|NCT00127504|Antitubercular Agents|antitubercular agents|mesh-ancestor
110198637|NCT00127504|Leprostatic Agents|leprostatic agents|mesh-ancestor
110198638|NCT00127504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110198639|NCT00127504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110198640|NCT00127504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110198641|NCT00127504|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110198642|NCT00127504|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110198643|NCT00127504|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110198644|NCT00127504|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110198645|NCT00127504|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110198646|NCT00127504|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110198647|NCT00043901|Lamotrigine|lamotrigine|mesh-list
110198648|NCT00043901|Anticonvulsants|anticonvulsants|mesh-ancestor
110198649|NCT00043901|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110198650|NCT00043901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110198651|NCT00043901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110198652|NCT00043901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110198653|NCT00043901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110198654|NCT00043901|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110198655|NCT00043901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110198656|NCT00043901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110198657|NCT00043901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110198658|NCT00043901|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110198659|NCT00127777|Amantadine|amantadine|mesh-list
110198660|NCT00127777|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110198661|NCT00127777|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110198662|NCT00127777|Antiviral Agents|antiviral agents|mesh-ancestor
110198663|NCT00127777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110198664|NCT00127777|Dopamine Agents|dopamine agents|mesh-ancestor
110063104|NCT03726879|Paclitaxel|paclitaxel|mesh-list
110063105|NCT03726879|Maytansine|maytansine|mesh-list
110063106|NCT03726879|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
110063107|NCT03726879|Cyclophosphamide|cyclophosphamide|mesh-list
110063108|NCT03726879|Doxorubicin|doxorubicin|mesh-list
110063109|NCT03726879|Trastuzumab|trastuzumab|mesh-list
110063110|NCT03726879|Atezolizumab|atezolizumab|mesh-list
110063111|NCT03726879|Pertuzumab|pertuzumab|mesh-list
110063112|NCT03726879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110063113|NCT03726879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110198666|NCT00127777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110198667|NCT00127777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110198668|NCT00127777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110198669|NCT00127777|Analgesics|analgesics|mesh-ancestor
110198670|NCT00127777|Sensory System Agents|sensory system agents|mesh-ancestor
110198671|NCT00127777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110198672|NCT00399633|Sumatriptan|sumatriptan|mesh-list
110198673|NCT00399633|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110198674|NCT00399633|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110198675|NCT00399633|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110198676|NCT00399633|Serotonin Agents|serotonin agents|mesh-ancestor
110198677|NCT00399633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110198678|NCT00399633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110198679|NCT00399633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110198680|NCT04727008|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
110198681|NCT04727008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110198682|NCT04727008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110198683|NCT04726657|Insulin|insulin|mesh-list
110198684|NCT04726657|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110198685|NCT04726657|Insulin, Isophane|insulin, isophane|mesh-list
110198686|NCT04726657|Isophane Insulin, Human|isophane insulin, human|mesh-list
110198687|NCT04726657|Isophane insulin, beef|isophane insulin, beef|mesh-list
110198688|NCT04726657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110198689|NCT04726657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110198691|NCT00402610|Isoniazid|isoniazid|mesh-list
110198692|NCT00402610|Pyrazinamide|pyrazinamide|mesh-list
110198693|NCT00402610|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110198694|NCT00402610|Antitubercular Agents|antitubercular agents|mesh-ancestor
110198695|NCT00402610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110198696|NCT00402610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110198697|NCT00402610|Leprostatic Agents|leprostatic agents|mesh-ancestor
110198698|NCT00402610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110198699|NCT00402610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110198700|NCT00402610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110198701|NCT00402610|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110198702|NCT00402610|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110198703|NCT00402610|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110198704|NCT00402610|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110198705|NCT00402610|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110198706|NCT00402610|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110198707|NCT00402610|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110198708|NCT00402610|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110198709|NCT00402610|Antimetabolites|antimetabolites|mesh-ancestor
110198710|NCT00402610|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110198711|NCT00402766|Dexamethasone|dexamethasone|mesh-list
110198712|NCT00402766|Cisplatin|cisplatin|mesh-list
110198713|NCT00402766|Pemetrexed|pemetrexed|mesh-list
110198714|NCT00402766|Imatinib Mesylate|imatinib mesylate|mesh-list
110198715|NCT00402766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110198716|NCT00402766|Antiemetics|antiemetics|mesh-ancestor
110198717|NCT00402766|Autonomic Agents|autonomic agents|mesh-ancestor
110198718|NCT00402766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110198719|NCT00402766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110198720|NCT00402766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110198721|NCT00402766|Glucocorticoids|glucocorticoids|mesh-ancestor
110198723|NCT00402766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110198724|NCT00402766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110198725|NCT00402766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110198726|NCT00402766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110198727|NCT00402766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220394|NCT00130195|Cytarabine|cytarabine|mesh-list
110198728|NCT00402766|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110198729|NCT00402766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110198730|NCT00402766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110198731|NCT00127972|Lamivudine|lamivudine|mesh-list
110198732|NCT00127972|Efavirenz|efavirenz|mesh-list
110198733|NCT00127972|Nevirapine|nevirapine|mesh-list
110198734|NCT00127972|Stavudine|stavudine|mesh-list
110198735|NCT00127972|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110198736|NCT00127972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110198737|NCT00127972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110198738|NCT00127972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110198739|NCT00127972|Antiviral Agents|antiviral agents|mesh-ancestor
110198740|NCT00127972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110198741|NCT00127972|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110198742|NCT00127972|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110198743|NCT00127972|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110198744|NCT00127972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110198745|NCT00127972|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110198746|NCT00127972|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110198747|NCT00127972|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110198748|NCT00127972|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110198749|NCT00127972|Antimetabolites|antimetabolites|mesh-ancestor
110198750|NCT00043940|Bivalirudin|bivalirudin|mesh-list
110198751|NCT00043940|Antithrombins|antithrombins|mesh-ancestor
110198752|NCT00043940|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110198753|NCT00043940|Protease Inhibitors|protease inhibitors|mesh-ancestor
110198754|NCT00043940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110198755|NCT00043940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110198756|NCT00043940|Anticoagulants|anticoagulants|mesh-ancestor
110198757|NCT04711434|Antibodies|antibodies|mesh-list
110198758|NCT04711434|Immunologic Factors|immunologic factors|mesh-ancestor
110198759|NCT04711434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110198760|NCT00128245|Pimecrolimus|pimecrolimus|mesh-list
110198761|NCT00128245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110198762|NCT00128245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110198763|NCT00128245|Analgesics|analgesics|mesh-ancestor
110198764|NCT00128245|Sensory System Agents|sensory system agents|mesh-ancestor
110198765|NCT00128245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110198766|NCT00128245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110198767|NCT00128245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110198768|NCT00128245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110198769|NCT00128245|Dermatologic Agents|dermatologic agents|mesh-ancestor
110198770|NCT00128245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110198771|NCT00128245|Immunologic Factors|immunologic factors|mesh-ancestor
110198772|NCT00128245|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110198773|NCT00128245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110198774|NCT00128245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110198775|NCT00044057|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110198776|NCT00044057|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110198777|NCT00044057|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110198778|NCT00044057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110198780|NCT00044135|Antiviral Agents|antiviral agents|mesh-ancestor
110198781|NCT00044135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110198782|NCT05561725|Dexamethasone|dexamethasone|mesh-list
110198783|NCT05561725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110198784|NCT05561725|Antiemetics|antiemetics|mesh-ancestor
110063131|NCT03726879|Immunotoxins|immunotoxins|mesh-ancestor
110198785|NCT05561725|Autonomic Agents|autonomic agents|mesh-ancestor
110198786|NCT05561725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110198787|NCT05561725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110198788|NCT05561725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110198789|NCT05561725|Glucocorticoids|glucocorticoids|mesh-ancestor
110198791|NCT05561725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110198792|NCT05561725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110198793|NCT05561725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110198794|NCT00078195|Omalizumab|omalizumab|mesh-list
110198795|NCT00078195|Immunoglobulins|immunoglobulins|mesh-list
110198796|NCT00078195|Immunologic Factors|immunologic factors|mesh-list
110198797|NCT00078195|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110198798|NCT00078195|Immunomodulating Agents|immunomodulating agents|mesh-list
110198799|NCT00078195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110198800|NCT00078195|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110198801|NCT00078195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110198802|NCT00078195|Respiratory System Agents|respiratory system agents|mesh-ancestor
110198803|NCT00044291|Toremifene|toremifene|mesh-list
110198804|NCT00044291|Letrozole|letrozole|mesh-list
110198805|NCT00044291|Hormones|hormones|mesh-list
110198806|NCT00044291|Atamestane|atamestane|mesh-list
110198807|NCT00044291|Estrogen Antagonists|estrogen antagonists|mesh-list
110198808|NCT00044291|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-list
110198809|NCT00044291|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-list
110198810|NCT00044291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110198811|NCT00044291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110198812|NCT00044291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110198813|NCT00044291|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110198814|NCT00044291|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110198815|NCT00044291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110198816|NCT00044291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110198817|NCT00044291|Hormone Antagonists|hormone antagonists|mesh-ancestor
110198818|NCT00044291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110198819|NCT00044291|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110198820|NCT00044291|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110198821|NCT00078234|Rituximab|rituximab|mesh-list
110198822|NCT00078234|Fludarabine|fludarabine|mesh-list
110198823|NCT00078234|Oblimersen|oblimersen|mesh-list
110198824|NCT00078234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110198825|NCT00078234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110198826|NCT00078234|Immunologic Factors|immunologic factors|mesh-ancestor
110198827|NCT00078234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110198828|NCT00078234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110198830|NCT00044408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110198831|NCT00044408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110198832|NCT00078351|Hylan|hylan|mesh-list
110198833|NCT00078351|Viscosupplements|viscosupplements|mesh-ancestor
110198834|NCT00078351|Protective Agents|protective agents|mesh-ancestor
110198835|NCT00078351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110198836|NCT00044447|Glimepiride|glimepiride|mesh-list
110198837|NCT00044447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110198838|NCT00044447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110198839|NCT00044447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110198840|NCT00044447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110198841|NCT00044447|Immunologic Factors|immunologic factors|mesh-ancestor
110198842|NCT00397358|Icodextrin|icodextrin|mesh-list
110198843|NCT00397358|Dialysis Solutions|dialysis solutions|mesh-list
110198844|NCT00397358|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110198845|NCT05519917|Afatinib|afatinib|mesh-list
110198846|NCT05519917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110198847|NCT05519917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110063148|NCT03634241|Pembrolizumab|pembrolizumab|mesh-list
110198849|NCT05519917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110198850|NCT00078390|S 3304|s 3304|mesh-list
110198851|NCT00078390|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
110198852|NCT00078390|Protease Inhibitors|protease inhibitors|mesh-ancestor
110198853|NCT00078390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110396030|NCT01326546|Antiviral Agents|antiviral agents|mesh-ancestor
110198854|NCT00078390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110198855|NCT00044486|Posaconazole|posaconazole|mesh-list
110198856|NCT00044486|Antifungal Agents|antifungal agents|mesh-ancestor
110198857|NCT00044486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110198858|NCT00044486|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110198859|NCT00044486|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110198860|NCT00044486|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110198862|NCT00044486|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110198863|NCT00044486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110198864|NCT00044486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110198865|NCT00044486|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110198866|NCT00044486|Hormone Antagonists|hormone antagonists|mesh-ancestor
110198867|NCT00044486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110198868|NCT00044486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110198869|NCT05497336|Cetuximab|cetuximab|mesh-list
110198870|NCT05497336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110198871|NCT05497336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110198872|NCT00044525|Taxane|taxane|mesh-list
110198873|NCT00044525|IDN 5109|idn 5109|mesh-list
110198874|NCT00044525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110198875|NCT00074607|Gemcitabine|gemcitabine|mesh-list
110198876|NCT00074607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110198877|NCT00074607|Antimetabolites|antimetabolites|mesh-ancestor
110198878|NCT00074607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110198879|NCT00074607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110198880|NCT05305885|Pemetrexed|pemetrexed|mesh-list
110198881|NCT05305885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110198882|NCT05305885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110198883|NCT05305885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110198884|NCT05305885|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110198885|NCT05305885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110198886|NCT00044564|IDN 5109|idn 5109|mesh-list
110198887|NCT00044564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110198888|NCT00078546|Antibodies|antibodies|mesh-list
110198889|NCT00078546|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110198890|NCT00078546|Immunologic Factors|immunologic factors|mesh-ancestor
110198891|NCT00078546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110198892|NCT00044642|Lorazepam|lorazepam|mesh-list
110198893|NCT00044642|Anticonvulsants|anticonvulsants|mesh-ancestor
110198894|NCT00044642|Antiemetics|antiemetics|mesh-ancestor
110198895|NCT00044642|Autonomic Agents|autonomic agents|mesh-ancestor
110198896|NCT00044642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110198897|NCT00044642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110198898|NCT00044642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110198899|NCT00044642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110198900|NCT00044642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110198901|NCT00044642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110198903|NCT00044642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110198904|NCT00044642|GABA Modulators|gaba modulators|mesh-ancestor
110198905|NCT00044642|GABA Agents|gaba agents|mesh-ancestor
110198906|NCT00044642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110198907|NCT00044642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110198908|NCT00044681|Risperidone|risperidone|mesh-list
110198909|NCT00044681|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110198910|NCT00044681|Serotonin Agents|serotonin agents|mesh-ancestor
110198911|NCT00044681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110198912|NCT00044681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110198913|NCT00044681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110198914|NCT00044681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110198915|NCT00044681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110198916|NCT00044681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110198917|NCT00044681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110198918|NCT00044681|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110198919|NCT00044681|Dopamine Agents|dopamine agents|mesh-ancestor
110198920|NCT00044720|Sirolimus|sirolimus|mesh-list
110198921|NCT00044720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110198922|NCT00044720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110198923|NCT00044720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110198924|NCT00044720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110198925|NCT00044720|Antifungal Agents|antifungal agents|mesh-ancestor
110198926|NCT00044720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110198927|NCT00044720|Immunologic Factors|immunologic factors|mesh-ancestor
110198928|NCT00044720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110198929|NCT00403000|Dutasteride|dutasteride|mesh-list
110198930|NCT00403000|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110198931|NCT00403000|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110198932|NCT00403000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110198933|NCT00403000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110198934|NCT00403000|Hormone Antagonists|hormone antagonists|mesh-ancestor
110198935|NCT00403000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110198936|NCT00403000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110198937|NCT00397553|Insulin glulisine|insulin glulisine|mesh-list
110198938|NCT00397553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110198939|NCT00397553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110198940|NCT00403039|Ranibizumab|ranibizumab|mesh-list
110198941|NCT00403039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110198942|NCT00403039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110198943|NCT00403039|Growth Substances|growth substances|mesh-ancestor
110198944|NCT00403039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110198945|NCT00403039|Growth Inhibitors|growth inhibitors|mesh-ancestor
110198946|NCT00403039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110198947|NCT00078858|Cyclosporine|cyclosporine|mesh-list
110198948|NCT00078858|Mycophenolic Acid|mycophenolic acid|mesh-list
110198949|NCT00078858|Fludarabine|fludarabine|mesh-list
110198950|NCT00078858|Fludarabine phosphate|fludarabine phosphate|mesh-list
110198951|NCT00078858|Cyclosporins|cyclosporins|mesh-list
110198952|NCT00078858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110198953|NCT00078858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110198954|NCT00078858|Antimetabolites|antimetabolites|mesh-ancestor
110198955|NCT00078858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110198956|NCT00078858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110198957|NCT00078858|Immunologic Factors|immunologic factors|mesh-ancestor
110198958|NCT00078858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110198959|NCT00078858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110198960|NCT00078858|Antifungal Agents|antifungal agents|mesh-ancestor
110198961|NCT00078858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110198962|NCT00078858|Dermatologic Agents|dermatologic agents|mesh-ancestor
110198963|NCT00078858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110198964|NCT00078858|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110198965|NCT00078858|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110198966|NCT00078858|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110198967|NCT00078858|Antitubercular Agents|antitubercular agents|mesh-ancestor
110198968|NCT00078858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110198969|NCT00044759|Tazobactam|tazobactam|mesh-list
110198970|NCT00044759|Piperacillin|piperacillin|mesh-list
110198971|NCT00044759|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
110198972|NCT00044759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110198973|NCT00044759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110198974|NCT00044759|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110198975|NCT00044759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110198976|NCT00044759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110198977|NCT00044798|Citalopram|citalopram|mesh-list
110198978|NCT00044798|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110198979|NCT00044798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110198980|NCT00044798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110198981|NCT00044798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110198982|NCT00044798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110198983|NCT00044798|Serotonin Agents|serotonin agents|mesh-ancestor
110198984|NCT00044798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110198985|NCT00044798|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110198986|NCT00044798|Antidepressive Agents|antidepressive agents|mesh-ancestor
110198987|NCT00044798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110198989|NCT00074841|Chloroquine|chloroquine|mesh-list
110198990|NCT00074841|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
110198991|NCT00074841|Pyrimethamine|pyrimethamine|mesh-list
110198992|NCT00074841|Sulfadoxine|sulfadoxine|mesh-list
110198993|NCT00074841|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110220417|NCT00130195|Hormones|hormones|mesh-ancestor
110198994|NCT00074841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110198995|NCT00074841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110198996|NCT00074841|Amebicides|amebicides|mesh-ancestor
110198997|NCT00074841|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110198998|NCT00074841|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110198999|NCT00074841|Antimalarials|antimalarials|mesh-ancestor
110199000|NCT00074841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110199001|NCT00074841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110199002|NCT00074841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110199004|NCT00074841|Sensory System Agents|sensory system agents|mesh-ancestor
110199005|NCT00074841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110199006|NCT00074841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110199007|NCT00074841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110199008|NCT00074841|Filaricides|filaricides|mesh-ancestor
110199009|NCT00074841|Antinematodal Agents|antinematodal agents|mesh-ancestor
110199010|NCT00074841|Anthelmintics|anthelmintics|mesh-ancestor
110199011|NCT00074841|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110199012|NCT00074841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110199013|NCT00074841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110199014|NCT00074841|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110199015|NCT00078975|Gemcitabine|gemcitabine|mesh-list
110199016|NCT00078975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110199017|NCT00078975|Antimetabolites|antimetabolites|mesh-ancestor
110199018|NCT00078975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110199019|NCT00078975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110396549|NCT00600158|Lidocaine|lidocaine|mesh-list
110199020|NCT00044837|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110199021|NCT00044837|Medroxyprogesterone|medroxyprogesterone|mesh-list
110199023|NCT00044837|Estrogens|estrogens|mesh-ancestor
110199025|NCT00044837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110199026|NCT00044837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110199027|NCT00044837|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110199028|NCT00044837|Contraceptive Agents|contraceptive agents|mesh-ancestor
110199029|NCT00044837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110199030|NCT00044837|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110199031|NCT00044837|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110199032|NCT00044837|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110199033|NCT00044837|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110199034|NCT00044837|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110199035|NCT00044837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110199036|NCT00044837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110199037|NCT04457557|Ropivacaine|ropivacaine|mesh-list
110199038|NCT04457557|Anesthetics, Local|anesthetics, local|mesh-list
110199039|NCT04457557|Anesthetics|anesthetics|mesh-list
110199040|NCT04457557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110199041|NCT04457557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110199042|NCT04457557|Sensory System Agents|sensory system agents|mesh-ancestor
110199043|NCT04457557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110199045|NCT00044876|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110199046|NCT00044876|Contraceptive Agents|contraceptive agents|mesh-ancestor
110199047|NCT00044876|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110199048|NCT00044876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110199049|NCT00044876|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110199050|NCT00079014|Doxorubicin|doxorubicin|mesh-list
110199051|NCT00079014|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110199052|NCT00079014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110199053|NCT00079014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110199054|NCT00079014|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110199055|NCT00079014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110199056|NCT00079014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110199057|NCT00079014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110199058|NCT00397475|Cholecalciferol|cholecalciferol|mesh-list
110199060|NCT00397475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110199061|NCT00397475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110199063|NCT00397475|Micronutrients|micronutrients|mesh-ancestor
110199064|NCT00397475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110199065|NCT04731740|Pembrolizumab|pembrolizumab|mesh-list
110199066|NCT04731740|Lenvatinib|lenvatinib|mesh-list
110199067|NCT04731740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110199068|NCT04731740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110199069|NCT04731740|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110199070|NCT04731740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110199071|NCT04731740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110199072|NCT04731740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110199073|NCT00044915|Repinotan hydrochloride|repinotan hydrochloride|mesh-list
110199074|NCT00044915|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110199075|NCT00044915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110199076|NCT00044915|Serotonin Agents|serotonin agents|mesh-ancestor
110199077|NCT00044915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110199078|NCT00044915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110199079|NCT00044915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110199080|NCT04263298|Capecitabine|capecitabine|mesh-list
110199081|NCT04263298|Fulvestrant|fulvestrant|mesh-list
110199082|NCT04263298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110199083|NCT04263298|Antimetabolites|antimetabolites|mesh-ancestor
110199084|NCT04263298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110199085|NCT04263298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110199086|NCT04263298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110199087|NCT04263298|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110199088|NCT04263298|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110199089|NCT04263298|Hormone Antagonists|hormone antagonists|mesh-ancestor
110199090|NCT04263298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110199091|NCT04263298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110199092|NCT00044954|Cyclosporine|cyclosporine|mesh-list
110199093|NCT00044954|Mycophenolic Acid|mycophenolic acid|mesh-list
110199094|NCT00044954|Fludarabine|fludarabine|mesh-list
110199095|NCT00044954|Fludarabine phosphate|fludarabine phosphate|mesh-list
110199096|NCT00044954|Cyclosporins|cyclosporins|mesh-list
110396745|NCT01324232|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110199097|NCT00044954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110199098|NCT00044954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110199099|NCT00044954|Antimetabolites|antimetabolites|mesh-ancestor
110199100|NCT00044954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110199101|NCT00044954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110063187|NCT03471260|Antimetabolites|antimetabolites|mesh-ancestor
110063188|NCT03471260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110063189|NCT03471260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110063190|NCT03471260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110199102|NCT00044954|Immunologic Factors|immunologic factors|mesh-ancestor
110199103|NCT00044954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110199104|NCT00044954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110199105|NCT00044954|Antifungal Agents|antifungal agents|mesh-ancestor
110199106|NCT00044954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110199107|NCT00044954|Dermatologic Agents|dermatologic agents|mesh-ancestor
110199108|NCT00044954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110199109|NCT00044954|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110199110|NCT00044954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110199111|NCT00044954|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110199112|NCT00044954|Antitubercular Agents|antitubercular agents|mesh-ancestor
110396802|NCT00598377|Hormones|hormones|mesh-ancestor
110199113|NCT00044954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110199115|NCT00079092|Procarbazine|procarbazine|mesh-list
110199116|NCT00079092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110199117|NCT00079092|Immunologic Factors|immunologic factors|mesh-ancestor
110199118|NCT00079092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110199119|NCT00079092|Leprostatic Agents|leprostatic agents|mesh-ancestor
110199120|NCT00079092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110199121|NCT00079092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110199122|NCT00079092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110199123|NCT00079092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110199124|NCT00079092|Growth Substances|growth substances|mesh-ancestor
110396862|NCT00600405|Narcotics|narcotics|mesh-ancestor
110199125|NCT00079092|Growth Inhibitors|growth inhibitors|mesh-ancestor
110199126|NCT00079092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110199128|NCT00044993|Doxorubicin|doxorubicin|mesh-list
110199129|NCT00044993|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110199130|NCT00044993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110199131|NCT00044993|Tubulin Modulators|tubulin modulators|mesh-ancestor
110199132|NCT00044993|Antimitotic Agents|antimitotic agents|mesh-ancestor
110199133|NCT00044993|Mitosis Modulators|mitosis modulators|mesh-ancestor
110199134|NCT00044993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110199135|NCT00044993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110199136|NCT00044993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110199137|NCT00044993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110199138|NCT00044993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110199139|NCT04162210|Dexamethasone|dexamethasone|mesh-list
110199140|NCT04162210|Pomalidomide|pomalidomide|mesh-list
110199141|NCT04162210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110199142|NCT04162210|Antiemetics|antiemetics|mesh-ancestor
110199143|NCT04162210|Autonomic Agents|autonomic agents|mesh-ancestor
110199144|NCT04162210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110199145|NCT04162210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110199146|NCT04162210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110199147|NCT04162210|Glucocorticoids|glucocorticoids|mesh-ancestor
110199148|NCT04162210|Hormones|hormones|mesh-ancestor
110199149|NCT04162210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110199150|NCT04162210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110199151|NCT04162210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110199152|NCT04162210|Immunologic Factors|immunologic factors|mesh-ancestor
110199153|NCT04162210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110199154|NCT04162210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110199156|NCT04162210|Growth Inhibitors|growth inhibitors|mesh-ancestor
110199157|NCT00079131|Oblimersen|oblimersen|mesh-list
110199158|NCT00079131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110199160|NCT00045149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110199161|NCT00045149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110199162|NCT00045149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110199163|NCT00045149|Antiviral Agents|antiviral agents|mesh-ancestor
110199164|NCT00045149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110199165|NCT00045188|Imatinib Mesylate|imatinib mesylate|mesh-list
110199166|NCT00045188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110199167|NCT00045188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110199168|NCT00045188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110199169|NCT00045188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110199171|NCT00403156|Imatinib Mesylate|imatinib mesylate|mesh-list
110199172|NCT00403156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110199173|NCT00403156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110199174|NCT00403156|Growth Substances|growth substances|mesh-ancestor
110199175|NCT00403156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110199176|NCT00403156|Growth Inhibitors|growth inhibitors|mesh-ancestor
110199177|NCT00403156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110199178|NCT00403156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110199179|NCT00403156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110397030|NCT01323582|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
110199180|NCT00403156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110199182|NCT00045227|Vaccines|vaccines|mesh-list
110199183|NCT00045227|Sargramostim|sargramostim|mesh-list
110199184|NCT00045227|Immunologic Factors|immunologic factors|mesh-ancestor
110199185|NCT00045227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110199186|NCT00045227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110199187|NCT00045227|Tubulin Modulators|tubulin modulators|mesh-ancestor
110199188|NCT00045227|Antimitotic Agents|antimitotic agents|mesh-ancestor
110199189|NCT00045227|Mitosis Modulators|mitosis modulators|mesh-ancestor
110199190|NCT00045227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110199191|NCT00075075|Infliximab|infliximab|mesh-list
110199192|NCT00075075|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110199193|NCT00075075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110199194|NCT00075075|Dermatologic Agents|dermatologic agents|mesh-ancestor
110199195|NCT00075075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110199196|NCT00075075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110199197|NCT04065451|Epinephrine|epinephrine|mesh-list
110199198|NCT04065451|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110199199|NCT04065451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110199200|NCT04065451|Adrenergic Agents|adrenergic agents|mesh-ancestor
110199201|NCT04065451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110199202|NCT04065451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110199203|NCT04065451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110199204|NCT04065451|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110199205|NCT04065451|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110199206|NCT04065451|Autonomic Agents|autonomic agents|mesh-ancestor
110199207|NCT04065451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110199208|NCT04065451|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110199209|NCT04065451|Respiratory System Agents|respiratory system agents|mesh-ancestor
110199210|NCT04065451|Mydriatics|mydriatics|mesh-ancestor
110199211|NCT04065451|Sympathomimetics|sympathomimetics|mesh-ancestor
110199212|NCT04065451|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110199213|NCT00045266|Aflibercept|aflibercept|mesh-list
110199214|NCT00045266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110199215|NCT00045266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110199216|NCT00045266|Growth Substances|growth substances|mesh-ancestor
110199217|NCT00045266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110199218|NCT00045266|Growth Inhibitors|growth inhibitors|mesh-ancestor
110199219|NCT00045266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110199220|NCT03948568|Tamoxifen|tamoxifen|mesh-list
110199221|NCT03948568|Letrozole|letrozole|mesh-list
110199222|NCT03948568|Anastrozole|anastrozole|mesh-list
110199223|NCT03948568|Exemestane|exemestane|mesh-list
110199224|NCT03948568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110199225|NCT03948568|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110199226|NCT03948568|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110199227|NCT03948568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110199228|NCT03948568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110199229|NCT03948568|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110199230|NCT03948568|Hormone Antagonists|hormone antagonists|mesh-ancestor
110063211|NCT03364868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110063212|NCT03364868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110063213|NCT03361735|Leuprolide|leuprolide|mesh-list
110199231|NCT03948568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110199232|NCT03948568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110199233|NCT03948568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110199234|NCT03948568|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110199235|NCT03948568|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110199236|NCT03948568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110199237|NCT03928366|Remifentanil|remifentanil|mesh-list
110199238|NCT03928366|Propofol|propofol|mesh-list
110199239|NCT03928366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110199240|NCT03928366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110199241|NCT03928366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110199242|NCT03928366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110199243|NCT03928366|Anesthetics, General|anesthetics, general|mesh-ancestor
110199244|NCT03928366|Anesthetics|anesthetics|mesh-ancestor
110199245|NCT03928366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110199246|NCT03928366|Narcotics|narcotics|mesh-ancestor
110199247|NCT03928366|Analgesics|analgesics|mesh-ancestor
110199248|NCT03928366|Sensory System Agents|sensory system agents|mesh-ancestor
110199249|NCT03928366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110199250|NCT00045422|Interferons|interferons|mesh-list
110199251|NCT00045422|Interferon-alpha|interferon-alpha|mesh-list
110199252|NCT00045422|Imatinib Mesylate|imatinib mesylate|mesh-list
110051334|NCT01472497|Pioglitazone|pioglitazone|mesh-list
110199253|NCT00045422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110199254|NCT00045422|Antiviral Agents|antiviral agents|mesh-ancestor
110199255|NCT00045422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110199256|NCT00045422|Immunologic Factors|immunologic factors|mesh-ancestor
110199257|NCT00045422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110199258|NCT00045422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110199259|NCT00045422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110199260|NCT00045422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110199261|NCT00075192|Leuprolide|leuprolide|mesh-list
110199262|NCT00075192|Bicalutamide|bicalutamide|mesh-list
110199263|NCT00075192|Tremelimumab|tremelimumab|mesh-list
110199264|NCT00075192|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110199265|NCT00075192|Fertility Agents|fertility agents|mesh-ancestor
110199266|NCT00075192|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110199267|NCT00075192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110199268|NCT00075192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110199269|NCT00075192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110199270|NCT00075192|Androgen Antagonists|androgen antagonists|mesh-ancestor
110199271|NCT00075192|Hormone Antagonists|hormone antagonists|mesh-ancestor
110199272|NCT00075192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110199274|NCT03739411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110199275|NCT03739411|Alkylating Agents|alkylating agents|mesh-ancestor
110199276|NCT03739411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110199277|NCT03739411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110199278|NCT00045461|Carboplatin|carboplatin|mesh-list
110199279|NCT00045461|Ifosfamide|ifosfamide|mesh-list
110199280|NCT00045461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110199281|NCT00045461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110199282|NCT00045461|Alkylating Agents|alkylating agents|mesh-ancestor
110199283|NCT00045461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110199284|NCT00075231|Ritonavir|ritonavir|mesh-list
110199285|NCT00075231|Lopinavir|lopinavir|mesh-list
110199286|NCT00075231|Lamivudine|lamivudine|mesh-list
110199287|NCT00075231|Zidovudine|zidovudine|mesh-list
110199288|NCT00075231|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
110199289|NCT00075231|Efavirenz|efavirenz|mesh-list
110199290|NCT00075231|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110220451|NCT00119340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110199291|NCT00075231|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110199292|NCT00075231|Protease Inhibitors|protease inhibitors|mesh-ancestor
110199293|NCT00075231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110199294|NCT00075231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110199295|NCT00075231|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110063224|NCT03354897|Torsemide|torsemide|mesh-list
110199296|NCT00075231|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110199297|NCT00075231|Antiviral Agents|antiviral agents|mesh-ancestor
110199298|NCT00075231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110199299|NCT00075231|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110199300|NCT00075231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110199301|NCT00075231|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110199302|NCT00075231|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110199304|NCT00075231|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110199305|NCT00075231|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110199306|NCT00075231|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110199307|NCT00075231|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110199308|NCT00075231|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110199310|NCT00403312|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110199311|NCT00403312|Autonomic Agents|autonomic agents|mesh-ancestor
110199312|NCT00403312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110199313|NCT00403312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110199314|NCT00403312|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110199315|NCT00403312|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110199316|NCT00403312|Cholinergic Agents|cholinergic agents|mesh-ancestor
110199317|NCT00403312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110199318|NCT00403312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110199319|NCT00079170|Docetaxel|docetaxel|mesh-list
110397420|NCT01075243|Acetaminophen|acetaminophen|mesh-list
110199320|NCT00079170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110199321|NCT00079170|Tubulin Modulators|tubulin modulators|mesh-ancestor
110199322|NCT00079170|Antimitotic Agents|antimitotic agents|mesh-ancestor
110199323|NCT00079170|Mitosis Modulators|mitosis modulators|mesh-ancestor
110199324|NCT00079170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110199325|NCT00045500|Prednisone|prednisone|mesh-list
110199326|NCT00045500|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
110199327|NCT00045500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110199328|NCT00045500|Glucocorticoids|glucocorticoids|mesh-ancestor
110199329|NCT00045500|Hormones|hormones|mesh-ancestor
110199330|NCT00045500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110199331|NCT00045500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110199332|NCT00045500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110199333|NCT00045500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110199334|NCT00045500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110199335|NCT00045500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110199336|NCT00045500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110199337|NCT00045539|Leucovorin|leucovorin|mesh-list
110199338|NCT00045539|Methotrexate|methotrexate|mesh-list
110199339|NCT00045539|Thiotepa|thiotepa|mesh-list
110199341|NCT00045539|Levoleucovorin|levoleucovorin|mesh-list
110199342|NCT00045539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110199343|NCT00045539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110199344|NCT00045539|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110199345|NCT00045539|Abortifacient Agents|abortifacient agents|mesh-ancestor
110199346|NCT00045539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110199347|NCT00045539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110199348|NCT00045539|Antimetabolites|antimetabolites|mesh-ancestor
110199349|NCT00045539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110199350|NCT00045539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110199351|NCT00045539|Dermatologic Agents|dermatologic agents|mesh-ancestor
110199352|NCT00045539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110199353|NCT00045539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110199355|NCT00045539|Immunologic Factors|immunologic factors|mesh-ancestor
110199356|NCT00045539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110199357|NCT00045539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110199359|NCT00045539|Protective Agents|protective agents|mesh-ancestor
110199360|NCT00045539|Vitamin B Complex|vitamin b complex|mesh-ancestor
110199361|NCT00045539|Vitamins|vitamins|mesh-ancestor
110199362|NCT00045539|Micronutrients|micronutrients|mesh-ancestor
110199363|NCT00045539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110199364|NCT00045539|Alkylating Agents|alkylating agents|mesh-ancestor
110199365|NCT00045539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110199366|NCT00079248|Progesterone|progesterone|mesh-list
110199367|NCT00079248|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110199368|NCT00079248|Estrogens|estrogens|mesh-list
110199369|NCT00079248|Progestins|progestins|mesh-ancestor
110199371|NCT00079248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110199372|NCT00079248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110199373|NCT00045617|Etoposide|etoposide|mesh-list
110199374|NCT00045617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110199375|NCT00045617|Vaccines|vaccines|mesh-list
110199376|NCT00045617|Antibodies|antibodies|mesh-list
110199377|NCT00045617|Immunoglobulins|immunoglobulins|mesh-list
110199378|NCT00045617|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110199379|NCT00045617|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
110199380|NCT00045617|Immunologic Factors|immunologic factors|mesh-ancestor
110199381|NCT00045617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110199382|NCT00045617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110199383|NCT00045617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110199384|NCT00045617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110199385|NCT00045617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110199386|NCT00045617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110199387|NCT00045617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110199388|NCT03442309|Fluorides|fluorides|mesh-list
110199389|NCT03442309|Fluorides, Topical|fluorides, topical|mesh-list
110199390|NCT03442309|Cariostatic Agents|cariostatic agents|mesh-ancestor
110199391|NCT03442309|Protective Agents|protective agents|mesh-ancestor
110199392|NCT03442309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110199393|NCT03399838|Midazolam|midazolam|mesh-list
110199394|NCT03399838|Dexmedetomidine|dexmedetomidine|mesh-list
110199395|NCT03399838|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110199396|NCT03399838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110397577|NCT04306081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110397579|NCT01074307|Bisoprolol|bisoprolol|mesh-list
110199397|NCT03399838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110199398|NCT03399838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110199399|NCT03399838|Analgesics|analgesics|mesh-ancestor
110199400|NCT03399838|Sensory System Agents|sensory system agents|mesh-ancestor
110199401|NCT03399838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110199402|NCT03399838|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110199403|NCT03399838|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110199404|NCT03399838|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110199405|NCT03399838|Adrenergic Agents|adrenergic agents|mesh-ancestor
110199406|NCT03399838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110199407|NCT03399838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110199408|NCT03399838|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110199409|NCT03399838|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110199410|NCT03399838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110199411|NCT03399838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110199412|NCT03399838|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110199413|NCT03399838|Anesthetics, General|anesthetics, general|mesh-ancestor
110199414|NCT03399838|Anesthetics|anesthetics|mesh-ancestor
110199415|NCT03399838|GABA Modulators|gaba modulators|mesh-ancestor
110199416|NCT03399838|GABA Agents|gaba agents|mesh-ancestor
110199417|NCT00079287|Paclitaxel|paclitaxel|mesh-list
110199418|NCT00079287|Vinorelbine|vinorelbine|mesh-list
110199419|NCT00079287|Docetaxel|docetaxel|mesh-list
110199420|NCT00079287|Carboplatin|carboplatin|mesh-list
110199421|NCT00079287|Gemcitabine|gemcitabine|mesh-list
110199422|NCT00079287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110199423|NCT00079287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110199424|NCT00079287|Tubulin Modulators|tubulin modulators|mesh-ancestor
110220485|NCT00130000|Eculizumab|eculizumab|mesh-list
110199425|NCT00079287|Antimitotic Agents|antimitotic agents|mesh-ancestor
110199426|NCT00079287|Mitosis Modulators|mitosis modulators|mesh-ancestor
110199427|NCT00079287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110199428|NCT00079287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110199430|NCT00045695|Bortezomib|bortezomib|mesh-list
110199431|NCT00045695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110199432|NCT00079365|Gemcitabine|gemcitabine|mesh-list
110199433|NCT00079365|Fluorouracil|fluorouracil|mesh-list
110199434|NCT00079365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110199435|NCT00079365|Antimetabolites|antimetabolites|mesh-ancestor
110199436|NCT00079365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110199437|NCT00079365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110199438|NCT00079365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110199439|NCT00079365|Immunologic Factors|immunologic factors|mesh-ancestor
110199440|NCT00079365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110199442|NCT00045773|Antidepressive Agents|antidepressive agents|mesh-ancestor
110199443|NCT00045773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110199444|NCT00045773|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110199445|NCT00045773|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110199446|NCT00045773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110199447|NCT00045773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110199448|NCT00045773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110199449|NCT00045773|Serotonin Agents|serotonin agents|mesh-ancestor
110199450|NCT00045773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110199451|NCT02839915|Leucovorin|leucovorin|mesh-list
110199452|NCT02839915|Folic Acid|folic acid|mesh-list
110199453|NCT02839915|Levoleucovorin|levoleucovorin|mesh-list
110199454|NCT02839915|Antidotes|antidotes|mesh-ancestor
110199455|NCT02839915|Protective Agents|protective agents|mesh-ancestor
110199456|NCT02839915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110199457|NCT02839915|Vitamin B Complex|vitamin b complex|mesh-ancestor
110199458|NCT02839915|Vitamins|vitamins|mesh-ancestor
110199459|NCT02839915|Micronutrients|micronutrients|mesh-ancestor
110199460|NCT02839915|Hematinics|hematinics|mesh-ancestor
110199461|NCT00045812|Ezetimibe|ezetimibe|mesh-list
110199462|NCT00045812|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110199463|NCT00045812|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110199464|NCT00045812|Antimetabolites|antimetabolites|mesh-ancestor
110199465|NCT00045812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110199466|NCT00045812|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110199467|NCT00079443|Rituximab|rituximab|mesh-list
110199468|NCT00079443|Fludarabine|fludarabine|mesh-list
110199469|NCT00079443|Fludarabine phosphate|fludarabine phosphate|mesh-list
110199470|NCT00079443|Romidepsin|romidepsin|mesh-list
110199471|NCT00079443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110199472|NCT00079443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110199473|NCT00079443|Immunologic Factors|immunologic factors|mesh-ancestor
110199475|NCT00079443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110199476|NCT00079443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110199477|NCT00079443|Antimetabolites|antimetabolites|mesh-ancestor
110199478|NCT00079443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110199479|NCT00079443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110199480|NCT00079443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110199481|NCT00079443|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110199482|NCT00079443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110199483|NCT02599363|Paclitaxel|paclitaxel|mesh-list
110199484|NCT02599363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110199485|NCT02599363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110199486|NCT02599363|Tubulin Modulators|tubulin modulators|mesh-ancestor
110199487|NCT02599363|Antimitotic Agents|antimitotic agents|mesh-ancestor
110199488|NCT02599363|Mitosis Modulators|mitosis modulators|mesh-ancestor
110199489|NCT02599363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110199490|NCT02580838|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110199491|NCT02580838|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110199492|NCT02580838|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110199493|NCT02580838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110199494|NCT02580838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110199495|NCT02580838|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110199496|NCT02580838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110199497|NCT02580838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110199498|NCT02580838|Cholinergic Agents|cholinergic agents|mesh-ancestor
110199499|NCT02580838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110199500|NCT00403429|Capecitabine|capecitabine|mesh-list
110199501|NCT00403429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110199502|NCT00403429|Antimetabolites|antimetabolites|mesh-ancestor
110199503|NCT00403429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110199504|NCT00403429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110199505|NCT00403624|Oxaliplatin|oxaliplatin|mesh-list
110199506|NCT00403624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110199508|NCT00079560|Hallucinogens|hallucinogens|mesh-ancestor
110199509|NCT00079560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110199510|NCT00079560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110199511|NCT00079560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110199512|NCT00079560|Analgesics|analgesics|mesh-ancestor
110199513|NCT00079560|Sensory System Agents|sensory system agents|mesh-ancestor
110199514|NCT00079560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110199515|NCT00079560|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110199516|NCT00079560|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110199517|NCT00079560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110199518|NCT00079560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110199519|NCT00079560|Hormones|hormones|mesh-ancestor
110199520|NCT00079560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110199521|NCT00046163|Midodrine|midodrine|mesh-list
110199522|NCT00046163|Sympathomimetics|sympathomimetics|mesh-ancestor
110199523|NCT00046163|Autonomic Agents|autonomic agents|mesh-ancestor
110199524|NCT00046163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110199525|NCT00046163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110199526|NCT00046163|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110199527|NCT00046163|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110063277|NCT03214562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110063278|NCT03214562|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110063279|NCT03214562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110063280|NCT03214562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110063286|NCT03199612|Sildenafil Citrate|sildenafil citrate|mesh-list
110199528|NCT00046163|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110199529|NCT00046163|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110199530|NCT00046163|Adrenergic Agents|adrenergic agents|mesh-ancestor
110199531|NCT00046163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110199532|NCT00046163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110199533|NCT01409161|Vitamins|vitamins|mesh-list
110199534|NCT01409161|Vitamin A|vitamin a|mesh-list
110199535|NCT01409161|Tretinoin|tretinoin|mesh-list
110199536|NCT01409161|Retinol palmitate|retinol palmitate|mesh-list
110199537|NCT01409161|Arsenic Trioxide|arsenic trioxide|mesh-list
110199538|NCT01409161|Gemtuzumab|gemtuzumab|mesh-list
110199539|NCT01409161|Calicheamicins|calicheamicins|mesh-list
110199540|NCT01409161|Micronutrients|micronutrients|mesh-ancestor
110199541|NCT01409161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110199542|NCT01409161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110199543|NCT01409161|Keratolytic Agents|keratolytic agents|mesh-ancestor
110199544|NCT01409161|Dermatologic Agents|dermatologic agents|mesh-ancestor
110199545|NCT01409161|Antioxidants|antioxidants|mesh-ancestor
110199546|NCT01409161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220508|NCT00129805|Aspirin|aspirin|mesh-list
110199547|NCT01409161|Protective Agents|protective agents|mesh-ancestor
110199548|NCT01409161|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110199549|NCT01409161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110199551|NCT01409161|Immunoconjugates|immunoconjugates|mesh-ancestor
110199552|NCT01409161|Immunologic Factors|immunologic factors|mesh-ancestor
110199553|NCT01409161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110199555|NCT00079638|Atorvastatin|atorvastatin|mesh-list
110199556|NCT00079638|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110199557|NCT00079638|Simvastatin|simvastatin|mesh-list
110199559|NCT00079638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110199560|NCT00079638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110199561|NCT00079638|Antimetabolites|antimetabolites|mesh-ancestor
110199562|NCT00079638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110199563|NCT00079638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110199564|NCT00079638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110199565|NCT00079638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110199566|NCT00079638|Vasodilator Agents|vasodilator agents|mesh-ancestor
110199567|NCT00079638|Vitamin B Complex|vitamin b complex|mesh-ancestor
110199568|NCT00079638|Vitamins|vitamins|mesh-ancestor
110199569|NCT00079638|Micronutrients|micronutrients|mesh-ancestor
110199570|NCT00079638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110199571|NCT00046241|Bupropion|bupropion|mesh-list
110199572|NCT00046241|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110199573|NCT00046241|Antidepressive Agents|antidepressive agents|mesh-ancestor
110199574|NCT00046241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110199575|NCT00046241|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110199576|NCT00046241|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110199577|NCT00046241|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110022410|NCT00002802|Carboplatin|carboplatin|mesh-list
110199578|NCT00046241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110199579|NCT00046241|Dopamine Agents|dopamine agents|mesh-ancestor
110199580|NCT00046241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110199581|NCT00046241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110199582|NCT00046241|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110199583|NCT00046241|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110199584|NCT00046241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110199585|NCT00079716|Dacetuzumab|dacetuzumab|mesh-list
110199586|NCT00079716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110199587|NCT00079716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110199588|NCT00130468|Hyaluronic Acid|hyaluronic acid|mesh-list
110199589|NCT00130468|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110199590|NCT00130468|Immunologic Factors|immunologic factors|mesh-ancestor
110398032|NCT00593099|Dopamine Agents|dopamine agents|mesh-ancestor
110199591|NCT00130468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110199592|NCT00130468|Viscosupplements|viscosupplements|mesh-ancestor
110199595|NCT00130507|Trastuzumab|trastuzumab|mesh-list
110199596|NCT00130507|Vinorelbine|vinorelbine|mesh-list
110199597|NCT00130507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110199598|NCT00130507|Antimetabolites|antimetabolites|mesh-ancestor
110199599|NCT00130507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110199600|NCT00130507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110199601|NCT00130507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110199602|NCT00130507|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110199603|NCT00130507|Tubulin Modulators|tubulin modulators|mesh-ancestor
110199604|NCT00130507|Antimitotic Agents|antimitotic agents|mesh-ancestor
110199605|NCT00130507|Mitosis Modulators|mitosis modulators|mesh-ancestor
110199607|NCT00130546|Paclitaxel|paclitaxel|mesh-list
110199608|NCT00130546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110199609|NCT00130546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110220509|NCT00129805|Sarpogrelate|sarpogrelate|mesh-list
110199614|NCT00130546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110398085|NCT00594269|Dopamine Agents|dopamine agents|mesh-ancestor
110199616|NCT00130546|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110199617|NCT00130546|Antifungal Agents|antifungal agents|mesh-ancestor
110199618|NCT00130546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110199619|NCT00130546|Immunologic Factors|immunologic factors|mesh-ancestor
110199620|NCT00130546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110199621|NCT00130585|Folic Acid|folic acid|mesh-list
110199622|NCT00130585|Vitamin B Complex|vitamin b complex|mesh-list
110199623|NCT00130585|Hematinics|hematinics|mesh-ancestor
110199624|NCT00130585|Vitamins|vitamins|mesh-ancestor
110199625|NCT00130585|Micronutrients|micronutrients|mesh-ancestor
110199626|NCT00130585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110199627|NCT00079755|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110199628|NCT00079755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110199629|NCT00079755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110199630|NCT00079755|Immunotoxins|immunotoxins|mesh-ancestor
110199631|NCT00079755|Immunoconjugates|immunoconjugates|mesh-ancestor
110199632|NCT00079755|Immunologic Factors|immunologic factors|mesh-ancestor
110199633|NCT00079755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110199634|NCT00130702|Gefitinib|gefitinib|mesh-list
110199635|NCT00130702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110199636|NCT00130702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110199637|NCT00130702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110199638|NCT00130702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110199639|NCT00130819|Buprenorphine|buprenorphine|mesh-list
110199640|NCT00130819|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110199641|NCT00130819|Narcotics|narcotics|mesh-ancestor
110063329|NCT03140423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110063330|NCT03140423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110063331|NCT03140423|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110063332|NCT03140423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110199642|NCT00130819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110199643|NCT00130819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110199644|NCT00130819|Analgesics|analgesics|mesh-ancestor
110199645|NCT00130819|Sensory System Agents|sensory system agents|mesh-ancestor
110199646|NCT00130819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110199647|NCT00130819|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110199648|NCT00130858|Carboplatin|carboplatin|mesh-list
110199649|NCT00130858|Topotecan|topotecan|mesh-list
110199650|NCT00130858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110199651|NCT00130858|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110199652|NCT00130858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110199653|NCT00130858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110199654|NCT00130858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110199656|NCT00130897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110199657|NCT00130897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110199658|NCT00130897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110199659|NCT00130897|Growth Substances|growth substances|mesh-ancestor
110199660|NCT00130897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110199661|NCT00130897|Growth Inhibitors|growth inhibitors|mesh-ancestor
110199662|NCT00130897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110199663|NCT00130897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110199664|NCT00130897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110199665|NCT00046319|Ambrisentan|ambrisentan|mesh-list
110398263|NCT00598169|Rituximab|rituximab|mesh-list
110199666|NCT00046319|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110199667|NCT00079833|Esomeprazole|esomeprazole|mesh-list
110199668|NCT00079833|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110199669|NCT00079833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110199670|NCT00079833|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110199671|NCT00079833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110199672|NCT00079833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110199673|NCT00079872|Pemetrexed|pemetrexed|mesh-list
110199674|NCT00079872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110199675|NCT00079872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110199676|NCT00079872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110199677|NCT00079872|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110199678|NCT00079872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110199679|NCT00046358|Ibuprofen|ibuprofen|mesh-list
110199680|NCT00046358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110199681|NCT00046358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110199682|NCT00046358|Analgesics|analgesics|mesh-ancestor
110199683|NCT00046358|Sensory System Agents|sensory system agents|mesh-ancestor
110199684|NCT00046358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110199685|NCT00046358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110199686|NCT00046358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110199687|NCT00046358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110199688|NCT00046358|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110063334|NCT03077542|Sirolimus|sirolimus|mesh-list
110199689|NCT00046358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110199690|NCT00046358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110199691|NCT00130936|Carboplatin|carboplatin|mesh-list
110199692|NCT00130936|Capecitabine|capecitabine|mesh-list
110199693|NCT00130936|Epirubicin|epirubicin|mesh-list
110199694|NCT00130936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110199695|NCT00130936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110199696|NCT00130936|Antimetabolites|antimetabolites|mesh-ancestor
110199697|NCT00130936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110199698|NCT00130936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110199699|NCT00130936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110199700|NCT00130936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110199701|NCT00130936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110199702|NCT00130975|Candesartan|candesartan|mesh-list
110199703|NCT00130975|Candesartan cilexetil|candesartan cilexetil|mesh-list
110199704|NCT00130975|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110199705|NCT00130975|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110199706|NCT00130975|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110199707|NCT00130975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110199708|NCT00131053|Cytarabine|cytarabine|mesh-list
110199709|NCT00131053|Dexamethasone|dexamethasone|mesh-list
110199710|NCT00131053|Prednisolone|prednisolone|mesh-list
110199711|NCT00131053|Hydrocortisone|hydrocortisone|mesh-list
110199712|NCT00131053|Cyclophosphamide|cyclophosphamide|mesh-list
110199713|NCT00131053|Methotrexate|methotrexate|mesh-list
110199714|NCT00131053|Vincristine|vincristine|mesh-list
110199715|NCT00131053|Asparaginase|asparaginase|mesh-list
110199716|NCT00131053|Mercaptopurine|mercaptopurine|mesh-list
110199717|NCT00131053|Pirarubicin|pirarubicin|mesh-list
110199718|NCT00131053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110199719|NCT00131053|Immunologic Factors|immunologic factors|mesh-ancestor
110199720|NCT00131053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110199721|NCT00131053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110199722|NCT00131053|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110199723|NCT00131053|Alkylating Agents|alkylating agents|mesh-ancestor
110199724|NCT00131053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110199725|NCT00131053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110220543|NCT00129688|Amikacin|amikacin|mesh-list
110199726|NCT00131053|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110199727|NCT00131053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110199728|NCT00131053|Antiemetics|antiemetics|mesh-ancestor
110199729|NCT00131053|Autonomic Agents|autonomic agents|mesh-ancestor
110199730|NCT00131053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110199731|NCT00131053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110199732|NCT00131053|Glucocorticoids|glucocorticoids|mesh-ancestor
110199733|NCT00131053|Hormones|hormones|mesh-ancestor
110398489|NCT00601991|Aflibercept|aflibercept|mesh-list
110199734|NCT00131053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110199735|NCT00131053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110199736|NCT00131053|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110199737|NCT00131053|Abortifacient Agents|abortifacient agents|mesh-ancestor
110199738|NCT00131053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110199739|NCT00131053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110199740|NCT00131053|Antimetabolites|antimetabolites|mesh-ancestor
110199741|NCT00131053|Dermatologic Agents|dermatologic agents|mesh-ancestor
110199742|NCT00131053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110199743|NCT00131053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110199744|NCT00131053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110199745|NCT00131053|Antiviral Agents|antiviral agents|mesh-ancestor
110199746|NCT00131053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110199747|NCT00131053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110063359|NCT03049462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110063360|NCT03049462|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110199748|NCT00131053|Tubulin Modulators|tubulin modulators|mesh-ancestor
110199749|NCT00131053|Antimitotic Agents|antimitotic agents|mesh-ancestor
110199750|NCT00131053|Mitosis Modulators|mitosis modulators|mesh-ancestor
110199751|NCT00079911|Valacyclovir|valacyclovir|mesh-list
110199752|NCT00079911|Antiviral Agents|antiviral agents|mesh-ancestor
110199753|NCT00079911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110199754|NCT00397592|Hormones|hormones|mesh-list
110199755|NCT00397592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110199756|NCT00397592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110199757|NCT00131326|Hylan|hylan|mesh-list
110199758|NCT00131326|Viscosupplements|viscosupplements|mesh-ancestor
110199759|NCT00131326|Protective Agents|protective agents|mesh-ancestor
110199760|NCT00131326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368620|NCT05419583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110368621|NCT05419583|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110199761|NCT00131404|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
110199762|NCT00131404|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110199763|NCT00131404|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110199764|NCT00131404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110199765|NCT00131404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110199767|NCT00131404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110199768|NCT00131404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110199769|NCT00131443|Topiramate|topiramate|mesh-list
110199770|NCT00131443|Anticonvulsants|anticonvulsants|mesh-ancestor
110199771|NCT00131443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110199772|NCT00131443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110199773|NCT00079989|Tigecycline|tigecycline|mesh-list
110199774|NCT00079989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110199775|NCT00079989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110199776|NCT00079989|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110199777|NCT00079989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110199778|NCT00079989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110199779|NCT00131482|Thrombin|thrombin|mesh-list
110199780|NCT00131482|Hemostatics|hemostatics|mesh-ancestor
110199781|NCT00131482|Coagulants|coagulants|mesh-ancestor
110199782|NCT00397709|Rifampin|rifampin|mesh-list
110199783|NCT00397709|Isoniazid|isoniazid|mesh-list
110199784|NCT00397709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110063384|NCT03008408|Letrozole|letrozole|mesh-list
110063386|NCT03008408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110063387|NCT03008408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110063388|NCT03008408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110063389|NCT03008408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110063390|NCT03008408|Immunologic Factors|immunologic factors|mesh-ancestor
110199785|NCT00397709|Antitubercular Agents|antitubercular agents|mesh-ancestor
110199786|NCT00397709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110199787|NCT00397709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110199789|NCT00397709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110199790|NCT00397709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110199791|NCT00397709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110199792|NCT00397709|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110199793|NCT00397709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110199794|NCT00397709|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110199795|NCT00397709|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110199796|NCT00397709|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110199797|NCT00397709|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110199798|NCT00397709|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110199799|NCT00397709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110199800|NCT00397709|Antimetabolites|antimetabolites|mesh-ancestor
110199801|NCT00397709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110199802|NCT00131521|Acetylcysteine|acetylcysteine|mesh-list
110199803|NCT00131521|Antiviral Agents|antiviral agents|mesh-ancestor
110199804|NCT00131521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110199805|NCT00131521|Expectorants|expectorants|mesh-ancestor
110199806|NCT00131521|Respiratory System Agents|respiratory system agents|mesh-ancestor
110199807|NCT00131521|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110199808|NCT00131521|Antioxidants|antioxidants|mesh-ancestor
110199809|NCT00131521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110199810|NCT00131521|Protective Agents|protective agents|mesh-ancestor
110199811|NCT00131521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110199812|NCT00080028|Motexafin gadolinium|motexafin gadolinium|mesh-list
110199813|NCT00080028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110199814|NCT00080028|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110199815|NCT00080028|Dermatologic Agents|dermatologic agents|mesh-ancestor
110199816|NCT00131716|Pyrimethamine|pyrimethamine|mesh-list
110199817|NCT00131716|Sulfadoxine|sulfadoxine|mesh-list
110199818|NCT00131716|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110199819|NCT00131716|Antimalarials|antimalarials|mesh-ancestor
110199820|NCT00131716|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110199821|NCT00131716|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110199822|NCT00131716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110199823|NCT00131716|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110199824|NCT00131716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110199825|NCT00131716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110199826|NCT00131716|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110199827|NCT00080145|Risperidone|risperidone|mesh-list
110199828|NCT00080145|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110199829|NCT00080145|Serotonin Agents|serotonin agents|mesh-ancestor
110199830|NCT00080145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110199831|NCT00080145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110199832|NCT00080145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110199833|NCT00080145|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110199834|NCT00080145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110199835|NCT00080145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110199836|NCT00080145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110199837|NCT00080145|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110199838|NCT00080145|Dopamine Agents|dopamine agents|mesh-ancestor
110199841|NCT00403663|Bupivacaine|bupivacaine|mesh-list
110199842|NCT00403663|Anesthetics, Local|anesthetics, local|mesh-ancestor
110199843|NCT00403663|Anesthetics|anesthetics|mesh-ancestor
110199844|NCT00403663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110199845|NCT00403663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110199846|NCT00403663|Sensory System Agents|sensory system agents|mesh-ancestor
110199847|NCT00403663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110199849|NCT00403663|Narcotics|narcotics|mesh-ancestor
110199850|NCT00403663|Analgesics|analgesics|mesh-ancestor
110199851|NCT00403663|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110199852|NCT00403663|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110199853|NCT00403663|Anesthetics, General|anesthetics, general|mesh-ancestor
110199854|NCT00403780|Pregabalin|pregabalin|mesh-list
110199855|NCT00403780|Analgesics|analgesics|mesh-ancestor
110199856|NCT00403780|Sensory System Agents|sensory system agents|mesh-ancestor
110199857|NCT00403780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110199858|NCT00403780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110199859|NCT00403780|Anticonvulsants|anticonvulsants|mesh-ancestor
110199860|NCT00403780|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110199861|NCT00403780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110199862|NCT00403780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110199863|NCT00403780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110199864|NCT00403780|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110199865|NCT00403780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110199866|NCT00403780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110199867|NCT00403780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110199868|NCT00046514|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110199869|NCT00046514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110199870|NCT00403819|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
110399004|NCT01313273|Vitamins|vitamins|mesh-ancestor
110199871|NCT00403819|Laxatives|laxatives|mesh-ancestor
110199872|NCT00403819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110199873|NCT00403858|Lactulose|lactulose|mesh-list
110199874|NCT00403858|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
110199875|NCT00403858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110199876|NCT00403858|Laxatives|laxatives|mesh-ancestor
110199877|NCT00046553|Mifepristone|mifepristone|mesh-list
110199878|NCT00046553|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110199879|NCT00046553|Abortifacient Agents|abortifacient agents|mesh-ancestor
110199880|NCT00046553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110199881|NCT00046553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110199882|NCT00046553|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110199883|NCT00046553|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110199884|NCT00046553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110199885|NCT00046553|Contraceptive Agents|contraceptive agents|mesh-ancestor
110199886|NCT00046553|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110199887|NCT00046553|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110199888|NCT00046553|Hormone Antagonists|hormone antagonists|mesh-ancestor
110199889|NCT00046553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110199890|NCT00046553|Luteolytic Agents|luteolytic agents|mesh-ancestor
110199891|NCT00046553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110199892|NCT00046553|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110199893|NCT00131989|Sorafenib|sorafenib|mesh-list
110199894|NCT00131989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110199895|NCT00131989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110199896|NCT00131989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110063429|NCT02975934|Abiraterone Acetate|abiraterone acetate|mesh-list
110199897|NCT00131989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110199898|NCT00132067|Vorinostat|vorinostat|mesh-list
110199899|NCT00132067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110199900|NCT00132067|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110199901|NCT00132067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110199902|NCT00132067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110199904|NCT00132106|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110199905|NCT00132106|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110199906|NCT00132106|Adrenergic Agents|adrenergic agents|mesh-ancestor
110399193|NCT01056289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110199907|NCT00132106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110199908|NCT00132106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110199909|NCT00132106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110199910|NCT00132106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110199911|NCT00080340|Gefitinib|gefitinib|mesh-list
110199912|NCT00080340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110199913|NCT00080340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110199914|NCT00080340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110199915|NCT00080340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110199916|NCT00132184|Vitamin D|vitamin d|mesh-list
110199917|NCT00132184|Vitamins|vitamins|mesh-ancestor
110199918|NCT00132184|Micronutrients|micronutrients|mesh-ancestor
110199919|NCT00132184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399253|NCT01096186|Carbidopa|carbidopa|mesh-list
110199920|NCT00132184|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110199921|NCT00132379|Docetaxel|docetaxel|mesh-list
110199922|NCT00132379|Naptumomab estafenatox|naptumomab estafenatox|mesh-list
110199923|NCT00132379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110199924|NCT00132379|Tubulin Modulators|tubulin modulators|mesh-ancestor
110199925|NCT00132379|Antimitotic Agents|antimitotic agents|mesh-ancestor
110199926|NCT00132379|Mitosis Modulators|mitosis modulators|mesh-ancestor
110199927|NCT00132379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110199928|NCT00132379|Immunoconjugates|immunoconjugates|mesh-ancestor
110199929|NCT00132379|Immunologic Factors|immunologic factors|mesh-ancestor
110199930|NCT00132379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110199931|NCT00132418|Etanercept|etanercept|mesh-list
110199932|NCT00132418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110199933|NCT00132418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110199934|NCT00132418|Analgesics|analgesics|mesh-ancestor
110199935|NCT00132418|Sensory System Agents|sensory system agents|mesh-ancestor
110199936|NCT00132418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110399311|NCT01095796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110199937|NCT00132418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110199938|NCT00132418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110199940|NCT00132418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110199941|NCT00132418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110199942|NCT00132418|Immunologic Factors|immunologic factors|mesh-ancestor
110199943|NCT00132535|Chloroquine|chloroquine|mesh-list
110199944|NCT00132535|Pyrimethamine|pyrimethamine|mesh-list
110199945|NCT00132535|Sulfadoxine|sulfadoxine|mesh-list
110199946|NCT00132535|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110063455|NCT02876302|Paclitaxel|paclitaxel|mesh-list
110199947|NCT00132535|Amebicides|amebicides|mesh-ancestor
110199948|NCT00132535|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110199949|NCT00132535|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110199950|NCT00132535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110199951|NCT00132535|Antimalarials|antimalarials|mesh-ancestor
110199952|NCT00132535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110199953|NCT00132535|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110199954|NCT00132535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110199955|NCT00132535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110199956|NCT00132535|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110199957|NCT00132613|Bleomycin|bleomycin|mesh-list
110199958|NCT00132613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110199959|NCT00132613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110199960|NCT00132652|Lamivudine|lamivudine|mesh-list
110199961|NCT00132652|Telbivudine|telbivudine|mesh-list
110199962|NCT00132652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110199963|NCT00132652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110199964|NCT00132652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110199965|NCT00132652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110199966|NCT00132652|Antiviral Agents|antiviral agents|mesh-ancestor
110199967|NCT00132652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110199968|NCT00132652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110199969|NCT00132652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110199971|NCT00046748|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110199972|NCT00046748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110199973|NCT00046748|Respiratory System Agents|respiratory system agents|mesh-ancestor
110199974|NCT00132886|Tolvaptan|tolvaptan|mesh-list
110199975|NCT00132886|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110199976|NCT00132886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110199978|NCT00132886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110199979|NCT00080418|Paclitaxel|paclitaxel|mesh-list
110199980|NCT00080418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110199981|NCT00080418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110199982|NCT00080418|Tubulin Modulators|tubulin modulators|mesh-ancestor
110199983|NCT00080418|Antimitotic Agents|antimitotic agents|mesh-ancestor
110199984|NCT00080418|Mitosis Modulators|mitosis modulators|mesh-ancestor
110199985|NCT00080418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110199987|NCT00132925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110199988|NCT00132925|Glucocorticoids|glucocorticoids|mesh-ancestor
110199990|NCT00132925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110199991|NCT00132925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110199992|NCT00133003|Abciximab|abciximab|mesh-list
110199993|NCT00133003|Anticoagulants|anticoagulants|mesh-ancestor
110199994|NCT00133003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110199995|NCT00046787|Lurtotecan|lurtotecan|mesh-list
110199996|NCT00046787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110199997|NCT00133042|Omalizumab|omalizumab|mesh-list
110199998|NCT00133042|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110199999|NCT00133042|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110200000|NCT00133042|Respiratory System Agents|respiratory system agents|mesh-ancestor
110200001|NCT00080457|Sitaxsentan|sitaxsentan|mesh-list
110200002|NCT00080457|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110200003|NCT00080457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110200004|NCT00133081|Anticonvulsants|anticonvulsants|mesh-list
110200005|NCT00133198|Pramipexole|pramipexole|mesh-list
110200006|NCT00133198|Antioxidants|antioxidants|mesh-ancestor
110200007|NCT00133198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110200008|NCT00133198|Protective Agents|protective agents|mesh-ancestor
110200009|NCT00133198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110200010|NCT00133198|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110200011|NCT00133198|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110200012|NCT00133198|Dopamine Agonists|dopamine agonists|mesh-ancestor
110200013|NCT00133198|Dopamine Agents|dopamine agents|mesh-ancestor
110200014|NCT00133198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110200015|NCT00046826|Thalidomide|thalidomide|mesh-list
110200016|NCT00046826|Docetaxel|docetaxel|mesh-list
110200017|NCT00046826|Estramustine|estramustine|mesh-list
110200018|NCT00046826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110200019|NCT00046826|Tubulin Modulators|tubulin modulators|mesh-ancestor
110200020|NCT00046826|Antimitotic Agents|antimitotic agents|mesh-ancestor
110200021|NCT00046826|Mitosis Modulators|mitosis modulators|mesh-ancestor
110200022|NCT00046826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110200023|NCT00046826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110200024|NCT00046826|Immunologic Factors|immunologic factors|mesh-ancestor
110200025|NCT00046826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110200026|NCT00046826|Leprostatic Agents|leprostatic agents|mesh-ancestor
110200027|NCT00046826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110200028|NCT00046826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110200029|NCT00046826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110220588|NCT00298324|Cyclosporine|cyclosporine|mesh-list
110200030|NCT00046826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110200031|NCT00046826|Growth Substances|growth substances|mesh-ancestor
110200032|NCT00046826|Growth Inhibitors|growth inhibitors|mesh-ancestor
110200033|NCT00046826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110200034|NCT00046826|Alkylating Agents|alkylating agents|mesh-ancestor
110200035|NCT00046826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110200036|NCT00133237|Sirolimus|sirolimus|mesh-list
110200037|NCT00133237|Paclitaxel|paclitaxel|mesh-list
110200038|NCT00133237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110200039|NCT00133237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110200040|NCT00133237|Tubulin Modulators|tubulin modulators|mesh-ancestor
110200041|NCT00133237|Antimitotic Agents|antimitotic agents|mesh-ancestor
110200042|NCT00133237|Mitosis Modulators|mitosis modulators|mesh-ancestor
110200043|NCT00133237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110200044|NCT00133237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110200045|NCT00133237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110200046|NCT00133237|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110200047|NCT00133237|Antifungal Agents|antifungal agents|mesh-ancestor
110200048|NCT00133237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110200049|NCT00133237|Immunologic Factors|immunologic factors|mesh-ancestor
110200050|NCT00133237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110200051|NCT00399672|Interferons|interferons|mesh-list
110200052|NCT00399672|Ribavirin|ribavirin|mesh-list
110200053|NCT00399672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110200054|NCT00399672|Antiviral Agents|antiviral agents|mesh-ancestor
110200055|NCT00399672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110200056|NCT00399672|Antimetabolites|antimetabolites|mesh-ancestor
110063486|NCT02803437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110200057|NCT00399672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110200058|NCT00133276|Escitalopram|escitalopram|mesh-list
110368622|NCT05419583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110200059|NCT00133276|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110200060|NCT00133276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110200061|NCT00133276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110200062|NCT00133276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110200063|NCT00133276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110200064|NCT00133276|Serotonin Agents|serotonin agents|mesh-ancestor
110200065|NCT00133276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110200067|NCT00131755|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110200068|NCT00131755|Vasodilator Agents|vasodilator agents|mesh-ancestor
110200069|NCT00133315|Adalimumab|adalimumab|mesh-list
110200070|NCT00133315|Infliximab|infliximab|mesh-list
110200071|NCT00133315|Etanercept|etanercept|mesh-list
110200072|NCT00133315|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110200073|NCT00133315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110200074|NCT00133315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110200075|NCT00133315|Dermatologic Agents|dermatologic agents|mesh-ancestor
110200076|NCT00133315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110200077|NCT00133315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110200078|NCT00133315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110200079|NCT00133315|Analgesics|analgesics|mesh-ancestor
110200080|NCT00133315|Sensory System Agents|sensory system agents|mesh-ancestor
110200081|NCT00133315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110200082|NCT00133315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110200083|NCT00133315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110200084|NCT00133315|Immunologic Factors|immunologic factors|mesh-ancestor
110200085|NCT00080496|Imipenem|imipenem|mesh-list
110200086|NCT00080496|Tigecycline|tigecycline|mesh-list
110200087|NCT00080496|Cilastatin|cilastatin|mesh-list
110200088|NCT00080496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110200089|NCT00080496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110200090|NCT00080496|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110200091|NCT00080496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110200092|NCT00080496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110200093|NCT00080496|Protease Inhibitors|protease inhibitors|mesh-ancestor
110200095|NCT00133354|Hormones|hormones|mesh-list
110200096|NCT00133354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110200097|NCT00133354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110200098|NCT00133354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110200099|NCT00133354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110200100|NCT00133354|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110200101|NCT00133354|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110200102|NCT00133354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110200103|NCT00133354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110200104|NCT00133354|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110200105|NCT00133354|Hormone Antagonists|hormone antagonists|mesh-ancestor
110200106|NCT00133393|Pentoxifylline|pentoxifylline|mesh-list
110200107|NCT00133393|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110200108|NCT00133393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110200109|NCT00133393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110200110|NCT00133393|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110200111|NCT00133393|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110200112|NCT00133393|Protective Agents|protective agents|mesh-ancestor
110200113|NCT00133393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110200114|NCT00133393|Vasodilator Agents|vasodilator agents|mesh-ancestor
110200115|NCT00133393|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110200116|NCT00133393|Antioxidants|antioxidants|mesh-ancestor
110200117|NCT00046904|Etanercept|etanercept|mesh-list
110200118|NCT00046904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110200119|NCT00046904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110200120|NCT00046904|Analgesics|analgesics|mesh-ancestor
110200121|NCT00046904|Sensory System Agents|sensory system agents|mesh-ancestor
110200122|NCT00046904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110200123|NCT00046904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110200124|NCT00046904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110200125|NCT00046904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110200126|NCT00046904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110200127|NCT00046904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110200128|NCT00046904|Immunologic Factors|immunologic factors|mesh-ancestor
110200129|NCT00403897|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
110200130|NCT00403897|Laxatives|laxatives|mesh-ancestor
110200131|NCT00403897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110200132|NCT00403975|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110200133|NCT00403975|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110200135|NCT00046943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110200136|NCT00046943|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
110200137|NCT00046943|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110200138|NCT00046943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110200139|NCT00133549|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110200140|NCT00133549|Immunologic Factors|immunologic factors|mesh-ancestor
110200141|NCT00133549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110200142|NCT00080613|Exemestane|exemestane|mesh-list
110200143|NCT00080613|Hormones|hormones|mesh-list
110200144|NCT00080613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110200145|NCT00080613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110200146|NCT00080613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110200147|NCT00080613|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110200148|NCT00080613|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110200149|NCT00080613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110200150|NCT00080613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110200151|NCT00080613|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110200152|NCT00080613|Hormone Antagonists|hormone antagonists|mesh-ancestor
110200153|NCT00047021|Cytarabine|cytarabine|mesh-list
110200154|NCT00047021|Mitoxantrone|mitoxantrone|mesh-list
110200155|NCT00047021|Sargramostim|sargramostim|mesh-list
110200156|NCT00047021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110200157|NCT00047021|Antimetabolites|antimetabolites|mesh-ancestor
110200158|NCT00047021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110200159|NCT00047021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110200160|NCT00047021|Antiviral Agents|antiviral agents|mesh-ancestor
110200161|NCT00047021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110200162|NCT00047021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110200163|NCT00047021|Immunologic Factors|immunologic factors|mesh-ancestor
110200164|NCT00047021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110063519|NCT02639065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110200165|NCT00047021|Analgesics|analgesics|mesh-ancestor
110200166|NCT00047021|Sensory System Agents|sensory system agents|mesh-ancestor
110200167|NCT00047021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110200168|NCT00047021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110200169|NCT00047021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110200170|NCT00047021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110200171|NCT00133627|Ketotifen|ketotifen|mesh-list
110200172|NCT00133627|Antipruritics|antipruritics|mesh-ancestor
110200173|NCT00133627|Dermatologic Agents|dermatologic agents|mesh-ancestor
110200174|NCT00133627|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110200175|NCT00133627|Histamine Antagonists|histamine antagonists|mesh-ancestor
110200176|NCT00133627|Histamine Agents|histamine agents|mesh-ancestor
110200177|NCT00133627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110200178|NCT00133627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110200179|NCT00133627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110200180|NCT00133627|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110200182|NCT00133744|Vitamin B Complex|vitamin b complex|mesh-list
110200183|NCT00133744|Vitamins|vitamins|mesh-ancestor
110200184|NCT00133744|Micronutrients|micronutrients|mesh-ancestor
110200185|NCT00133744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110200186|NCT00133744|Hematinics|hematinics|mesh-ancestor
110200187|NCT00080808|Phentolamine|phentolamine|mesh-list
110200188|NCT00080808|Sildenafil Citrate|sildenafil citrate|mesh-list
110200189|NCT00080808|Alprostadil|alprostadil|mesh-list
110200190|NCT00080808|Papaverine|papaverine|mesh-list
110200191|NCT00080808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110200192|NCT00080808|Vasodilator Agents|vasodilator agents|mesh-ancestor
110200193|NCT00080808|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110200194|NCT00080808|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110200195|NCT00080808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110200196|NCT00080808|Urological Agents|urological agents|mesh-ancestor
110200197|NCT00080808|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110200198|NCT00080808|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110200199|NCT00080808|Adrenergic Agents|adrenergic agents|mesh-ancestor
110200200|NCT00080808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110400167|NCT02889549|Ticagrelor|ticagrelor|mesh-list
110200201|NCT00080808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110200202|NCT00080808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110200203|NCT00080808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110200204|NCT00047099|Tamoxifen|tamoxifen|mesh-list
110200205|NCT00047099|Cyclophosphamide|cyclophosphamide|mesh-list
110200206|NCT00047099|Docetaxel|docetaxel|mesh-list
110200207|NCT00047099|Fluorouracil|fluorouracil|mesh-list
110200208|NCT00047099|Epirubicin|epirubicin|mesh-list
110200210|NCT00047099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110200211|NCT00047099|Immunologic Factors|immunologic factors|mesh-ancestor
110200212|NCT00047099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110200213|NCT00047099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110200214|NCT00047099|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110200215|NCT00047099|Alkylating Agents|alkylating agents|mesh-ancestor
110200216|NCT00047099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110200217|NCT00047099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110200218|NCT00047099|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110200220|NCT00047099|Antimitotic Agents|antimitotic agents|mesh-ancestor
110200221|NCT00047099|Mitosis Modulators|mitosis modulators|mesh-ancestor
110200222|NCT00047099|Antimetabolites|antimetabolites|mesh-ancestor
110200223|NCT00047099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110200224|NCT00047099|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110200225|NCT00047099|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110200226|NCT00047099|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110200227|NCT00047099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110200228|NCT00047099|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110200229|NCT00047099|Hormone Antagonists|hormone antagonists|mesh-ancestor
110063548|NCT02451943|Doxorubicin|doxorubicin|mesh-list
110063549|NCT02451943|Olaratumab|olaratumab|mesh-list
110063550|NCT02451943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110063551|NCT02451943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110063552|NCT02451943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110063553|NCT02451943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110200230|NCT00047099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110200231|NCT00047099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110200232|NCT00047099|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110200233|NCT00047099|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110200234|NCT00047099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110200235|NCT00133822|Risperidone|risperidone|mesh-list
110200236|NCT00133822|Sertraline|sertraline|mesh-list
110200237|NCT00133822|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110200238|NCT00133822|Serotonin Agents|serotonin agents|mesh-ancestor
110200239|NCT00133822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110200240|NCT00133822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110200241|NCT00133822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110200242|NCT00133822|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110400357|NCT01003639|Anticonvulsants|anticonvulsants|mesh-ancestor
110200243|NCT00133822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110200244|NCT00133822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110200245|NCT00133822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110200246|NCT00133822|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110200247|NCT00133822|Dopamine Agents|dopamine agents|mesh-ancestor
110200248|NCT00133822|Antidepressive Agents|antidepressive agents|mesh-ancestor
110200249|NCT00133822|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110200250|NCT00133822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110200251|NCT00133822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110200252|NCT00133861|Botulinum Toxins|botulinum toxins|mesh-list
110200253|NCT00133861|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110200254|NCT00133861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110200255|NCT00133861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110200256|NCT00133861|Cholinergic Agents|cholinergic agents|mesh-ancestor
110200257|NCT00133861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110200258|NCT00133861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110200259|NCT00134095|Irinotecan|irinotecan|mesh-list
110200260|NCT00134095|Tegafur|tegafur|mesh-list
110200261|NCT00134095|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110200262|NCT00134095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110200263|NCT00134095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110200264|NCT00134095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110200265|NCT00134095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110200266|NCT00134095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110200267|NCT00134095|Antimetabolites|antimetabolites|mesh-ancestor
110200268|NCT00047138|Dactinomycin|dactinomycin|mesh-list
110200269|NCT00047138|Cyclophosphamide|cyclophosphamide|mesh-list
110200270|NCT00047138|Carboplatin|carboplatin|mesh-list
110200271|NCT00047138|Doxorubicin|doxorubicin|mesh-list
110200272|NCT00047138|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110200273|NCT00047138|Etoposide|etoposide|mesh-list
110200274|NCT00047138|Vincristine|vincristine|mesh-list
110200275|NCT00047138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110200276|NCT00047138|Immunologic Factors|immunologic factors|mesh-ancestor
110200277|NCT00047138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110200278|NCT00047138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110200279|NCT00047138|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110200280|NCT00047138|Alkylating Agents|alkylating agents|mesh-ancestor
110200281|NCT00047138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110200282|NCT00047138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110200283|NCT00047138|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110200284|NCT00047138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110200285|NCT00047138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110200286|NCT00047138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110200287|NCT00047138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110200288|NCT00047138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110200289|NCT00047138|Tubulin Modulators|tubulin modulators|mesh-ancestor
110200290|NCT00047138|Antimitotic Agents|antimitotic agents|mesh-ancestor
110200291|NCT00047138|Mitosis Modulators|mitosis modulators|mesh-ancestor
110063557|NCT02420860|Elotuzumab|elotuzumab|mesh-list
110200292|NCT00047138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110200293|NCT00047138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110200294|NCT00047138|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110200295|NCT00047138|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110200296|NCT00080847|Prednisone|prednisone|mesh-list
110200297|NCT00080847|Cyclophosphamide|cyclophosphamide|mesh-list
110200298|NCT00080847|Rituximab|rituximab|mesh-list
110200299|NCT00080847|Doxorubicin|doxorubicin|mesh-list
110200300|NCT00080847|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110200301|NCT00080847|Vincristine|vincristine|mesh-list
110200302|NCT00080847|Oblimersen|oblimersen|mesh-list
110200303|NCT00080847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110200304|NCT00080847|Immunologic Factors|immunologic factors|mesh-ancestor
110200305|NCT00080847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110200306|NCT00080847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110200307|NCT00080847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110200308|NCT00080847|Alkylating Agents|alkylating agents|mesh-ancestor
110200309|NCT00080847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110200310|NCT00080847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110200311|NCT00080847|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110200312|NCT00080847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110200313|NCT00080847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110200314|NCT00080847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110200315|NCT00080847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110200316|NCT00080847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110200317|NCT00080847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110200318|NCT00080847|Glucocorticoids|glucocorticoids|mesh-ancestor
110200319|NCT00080847|Hormones|hormones|mesh-ancestor
110200320|NCT00080847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110200321|NCT00080847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110200322|NCT00080847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110200324|NCT00080847|Antimitotic Agents|antimitotic agents|mesh-ancestor
110200325|NCT00080847|Mitosis Modulators|mitosis modulators|mesh-ancestor
110200326|NCT00134173|Atorvastatin|atorvastatin|mesh-list
110200327|NCT00134173|Torcetrapib|torcetrapib|mesh-list
110200328|NCT00134173|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110200329|NCT00134173|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110200330|NCT00134173|Antimetabolites|antimetabolites|mesh-ancestor
110200331|NCT00134173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110200332|NCT00134173|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110200333|NCT00134173|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110200334|NCT00134173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110200335|NCT00047177|Oxaliplatin|oxaliplatin|mesh-list
110200336|NCT00047177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110200338|NCT00080886|Rituximab|rituximab|mesh-list
110200339|NCT00080886|Etoposide|etoposide|mesh-list
110200340|NCT00080886|Melphalan|melphalan|mesh-list
110200341|NCT00080886|Carmustine|carmustine|mesh-list
110200342|NCT00080886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110200343|NCT00080886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110200344|NCT00080886|Immunologic Factors|immunologic factors|mesh-ancestor
110200345|NCT00080886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110200346|NCT00080886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110200347|NCT00080886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110200348|NCT00080886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110200349|NCT00080886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110200350|NCT00080886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110200351|NCT00080886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110200352|NCT00080886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110200353|NCT00080886|Antimetabolites|antimetabolites|mesh-ancestor
110200354|NCT00080886|Antiviral Agents|antiviral agents|mesh-ancestor
110200355|NCT00080886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110200356|NCT00080886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110200357|NCT00080886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110200358|NCT00080886|Alkylating Agents|alkylating agents|mesh-ancestor
110200359|NCT00080886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110200360|NCT00134212|Epinephrine|epinephrine|mesh-list
110200361|NCT00134212|Norepinephrine|norepinephrine|mesh-list
110200362|NCT00134212|Dopexamine|dopexamine|mesh-list
110200363|NCT00134212|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110200364|NCT00134212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110200365|NCT00134212|Adrenergic Agents|adrenergic agents|mesh-ancestor
110200366|NCT00134212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110200367|NCT00134212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110200368|NCT00134212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110200369|NCT00134212|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110200370|NCT00134212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110200371|NCT00134212|Autonomic Agents|autonomic agents|mesh-ancestor
110200372|NCT00134212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110200374|NCT00134212|Respiratory System Agents|respiratory system agents|mesh-ancestor
110200375|NCT00134212|Mydriatics|mydriatics|mesh-ancestor
110200376|NCT00134212|Sympathomimetics|sympathomimetics|mesh-ancestor
110200377|NCT00134212|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110200378|NCT00134212|Vasodilator Agents|vasodilator agents|mesh-ancestor
110200379|NCT00134212|Dopamine Agonists|dopamine agonists|mesh-ancestor
110200380|NCT00134212|Dopamine Agents|dopamine agents|mesh-ancestor
110200381|NCT00134290|Metformin|metformin|mesh-list
110200382|NCT00134290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110200383|NCT00134290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110200384|NCT00047216|Tipifarnib|tipifarnib|mesh-list
110200385|NCT00047216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110200386|NCT00080925|Cytarabine|cytarabine|mesh-list
110200387|NCT00080925|Cyclosporine|cyclosporine|mesh-list
110200388|NCT00080925|Prednisone|prednisone|mesh-list
110200389|NCT00080925|Cyclophosphamide|cyclophosphamide|mesh-list
110200390|NCT00080925|Rituximab|rituximab|mesh-list
110200391|NCT00080925|Doxorubicin|doxorubicin|mesh-list
110200392|NCT00080925|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110200393|NCT00080925|Fludarabine|fludarabine|mesh-list
110200394|NCT00080925|Fludarabine phosphate|fludarabine phosphate|mesh-list
110200395|NCT00080925|Etoposide|etoposide|mesh-list
110200396|NCT00080925|Vincristine|vincristine|mesh-list
110200397|NCT00080925|Cyclosporins|cyclosporins|mesh-list
110200398|NCT00080925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110200400|NCT00080925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110200401|NCT00080925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110200402|NCT00080925|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110200403|NCT00080925|Alkylating Agents|alkylating agents|mesh-ancestor
110200404|NCT00080925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110200405|NCT00080925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110200406|NCT00080925|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110200407|NCT00080925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110200408|NCT00080925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110200409|NCT00080925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110200410|NCT00080925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110200411|NCT00080925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110200412|NCT00080925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110200414|NCT00080925|Hormones|hormones|mesh-ancestor
110200415|NCT00080925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110200416|NCT00080925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110400952|NCT01293006|Suvorexant|suvorexant|mesh-list
110200417|NCT00080925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110200419|NCT00080925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110200420|NCT00080925|Antiviral Agents|antiviral agents|mesh-ancestor
110200421|NCT00080925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110200422|NCT00080925|Tubulin Modulators|tubulin modulators|mesh-ancestor
110200423|NCT00080925|Antimitotic Agents|antimitotic agents|mesh-ancestor
110200424|NCT00080925|Mitosis Modulators|mitosis modulators|mesh-ancestor
110200425|NCT00080925|Antifungal Agents|antifungal agents|mesh-ancestor
110200426|NCT00080925|Dermatologic Agents|dermatologic agents|mesh-ancestor
110200427|NCT00080925|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110200428|NCT04705831|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
110200429|NCT04705831|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110200430|NCT04705831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110200431|NCT04705831|Immunologic Factors|immunologic factors|mesh-ancestor
110200432|NCT04705831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110200433|NCT00047255|Carboplatin|carboplatin|mesh-list
110200434|NCT00047255|Docetaxel|docetaxel|mesh-list
110200435|NCT00047255|Trastuzumab|trastuzumab|mesh-list
110200436|NCT00047255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110200437|NCT00047255|Tubulin Modulators|tubulin modulators|mesh-ancestor
110200438|NCT00047255|Antimitotic Agents|antimitotic agents|mesh-ancestor
110200439|NCT00047255|Mitosis Modulators|mitosis modulators|mesh-ancestor
110200440|NCT00047255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110200441|NCT00047255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110200442|NCT00134368|Etanercept|etanercept|mesh-list
110200443|NCT00134368|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110200444|NCT00134368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110200445|NCT00134368|Analgesics|analgesics|mesh-ancestor
110400999|NCT01075048|Irinotecan|irinotecan|mesh-list
110200446|NCT00134368|Sensory System Agents|sensory system agents|mesh-ancestor
110200447|NCT00134368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110200448|NCT00134368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110200449|NCT00134368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110200450|NCT00134368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110200451|NCT00134368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110200452|NCT00134368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110200453|NCT00134368|Immunologic Factors|immunologic factors|mesh-ancestor
110200454|NCT00134485|Atorvastatin|atorvastatin|mesh-list
110200455|NCT00134485|Torcetrapib|torcetrapib|mesh-list
110200456|NCT00134485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110200457|NCT00134485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110200458|NCT00134485|Antimetabolites|antimetabolites|mesh-ancestor
110200459|NCT00134485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110200460|NCT00134485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110200461|NCT00134485|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110200462|NCT00134485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110200463|NCT00047294|Thalidomide|thalidomide|mesh-list
110200464|NCT00047294|Celecoxib|celecoxib|mesh-list
110200465|NCT00047294|Temozolomide|temozolomide|mesh-list
110200466|NCT00047294|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110200467|NCT00047294|Alkylating Agents|alkylating agents|mesh-ancestor
110200468|NCT00047294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110200469|NCT00047294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110200470|NCT00047294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110200471|NCT00047294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110200472|NCT00047294|Analgesics|analgesics|mesh-ancestor
110200473|NCT00047294|Sensory System Agents|sensory system agents|mesh-ancestor
110200474|NCT00047294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110063599|NCT02357797|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110200476|NCT00047294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110200477|NCT00047294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110200478|NCT00047294|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110200479|NCT00047294|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110200480|NCT00047294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110200481|NCT00047294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110200482|NCT00047294|Immunologic Factors|immunologic factors|mesh-ancestor
110200483|NCT00047294|Leprostatic Agents|leprostatic agents|mesh-ancestor
110200484|NCT00047294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110200485|NCT00047294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110200486|NCT00047294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110200487|NCT00047294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110200488|NCT00047294|Growth Substances|growth substances|mesh-ancestor
110200489|NCT00047294|Growth Inhibitors|growth inhibitors|mesh-ancestor
110200491|NCT00042822|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110200492|NCT00042822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110200493|NCT00042822|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110200494|NCT00042822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110200495|NCT00042822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110200497|NCT00134641|Vinorelbine|vinorelbine|mesh-list
110200498|NCT00134641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110200499|NCT00134641|Antimetabolites|antimetabolites|mesh-ancestor
110200500|NCT00134641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110200501|NCT00134641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110200502|NCT00134641|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110200503|NCT00134641|Tubulin Modulators|tubulin modulators|mesh-ancestor
110200504|NCT00134641|Antimitotic Agents|antimitotic agents|mesh-ancestor
110200505|NCT00134641|Mitosis Modulators|mitosis modulators|mesh-ancestor
110200506|NCT00134680|Trastuzumab|trastuzumab|mesh-list
110200507|NCT00134680|Letrozole|letrozole|mesh-list
110200508|NCT00134680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110200509|NCT00134680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110200510|NCT00134680|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110200511|NCT00134680|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110200512|NCT00134680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110368623|NCT05419583|Antipyretics|antipyretics|mesh-ancestor
110200513|NCT00134680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110200514|NCT00134680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110200515|NCT00134680|Hormone Antagonists|hormone antagonists|mesh-ancestor
110200516|NCT00134680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110200517|NCT00134680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110200518|NCT00134758|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
110200519|NCT00134758|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110200520|NCT00134758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110200522|NCT00081042|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110200523|NCT00081042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110200524|NCT00081042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110200525|NCT00081042|Tubulin Modulators|tubulin modulators|mesh-ancestor
110200526|NCT00081042|Antimitotic Agents|antimitotic agents|mesh-ancestor
110200527|NCT00081042|Mitosis Modulators|mitosis modulators|mesh-ancestor
110200528|NCT00081042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110200529|NCT00047333|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110200530|NCT00047333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110063624|NCT02169310|Raclopride|raclopride|mesh-list
110063625|NCT02169310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110063626|NCT02169310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110063627|NCT02169310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110200531|NCT00047333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110200532|NCT00047333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110200533|NCT00047333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110200534|NCT00134875|Buprenorphine|buprenorphine|mesh-list
110200535|NCT00134875|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
110200536|NCT00134875|Naloxone|naloxone|mesh-list
110200537|NCT00134875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110200538|NCT00134875|Narcotics|narcotics|mesh-ancestor
110200539|NCT00134875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110200540|NCT00134875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110200541|NCT00134875|Analgesics|analgesics|mesh-ancestor
110200542|NCT00134875|Sensory System Agents|sensory system agents|mesh-ancestor
110200543|NCT00134875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110200544|NCT00134875|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110200545|NCT00134914|Buprenorphine|buprenorphine|mesh-list
110200546|NCT00134914|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110200547|NCT00134914|Narcotics|narcotics|mesh-ancestor
110200548|NCT00134914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110200549|NCT00134914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110200551|NCT00134914|Sensory System Agents|sensory system agents|mesh-ancestor
110200552|NCT00134914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110200553|NCT00134914|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110200554|NCT00134953|Rivastigmine|rivastigmine|mesh-list
110200555|NCT00134953|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110200556|NCT00134953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110200557|NCT00134953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110200558|NCT00134953|Cholinergic Agents|cholinergic agents|mesh-ancestor
110200559|NCT00134953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110200560|NCT00134953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110200561|NCT00134953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110200562|NCT00134953|Protective Agents|protective agents|mesh-ancestor
110200564|NCT00042861|Fluorouracil|fluorouracil|mesh-list
110200565|NCT00042861|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
110200566|NCT00042861|Calcium|calcium|mesh-list
110200567|NCT00042861|Levoleucovorin|levoleucovorin|mesh-list
110200568|NCT00042861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110200569|NCT00042861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110200570|NCT00042861|Antimetabolites|antimetabolites|mesh-ancestor
110200571|NCT00042861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110200572|NCT00042861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110200573|NCT00042861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110200574|NCT00042861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110200575|NCT00042861|Immunologic Factors|immunologic factors|mesh-ancestor
110200576|NCT00042861|Antidotes|antidotes|mesh-ancestor
110200577|NCT00042861|Protective Agents|protective agents|mesh-ancestor
110200578|NCT00042861|Vitamin B Complex|vitamin b complex|mesh-ancestor
110200579|NCT00042861|Vitamins|vitamins|mesh-ancestor
110200580|NCT00042861|Micronutrients|micronutrients|mesh-ancestor
110200581|NCT00042861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110200582|NCT00042861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110200583|NCT00134992|Prednisolone|prednisolone|mesh-list
110200584|NCT00134992|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110200585|NCT00134992|Methylprednisolone|methylprednisolone|mesh-list
110200586|NCT00134992|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110200587|NCT00134992|Prednisolone acetate|prednisolone acetate|mesh-list
110200588|NCT00134992|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110200589|NCT00134992|Prednisolone phosphate|prednisolone phosphate|mesh-list
110200590|NCT00134992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110200591|NCT00134992|Glucocorticoids|glucocorticoids|mesh-ancestor
110200592|NCT00134992|Hormones|hormones|mesh-ancestor
110200593|NCT00134992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110200594|NCT00134992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110200595|NCT00134992|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110200596|NCT00134992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110200597|NCT00134992|Antiemetics|antiemetics|mesh-ancestor
110200598|NCT00134992|Autonomic Agents|autonomic agents|mesh-ancestor
110200599|NCT00134992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110200600|NCT00134992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110200601|NCT00134992|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110200602|NCT00134992|Protective Agents|protective agents|mesh-ancestor
110200603|NCT00135070|Insulin Detemir|insulin detemir|mesh-list
110200604|NCT00135070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110200605|NCT00135070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110200606|NCT00135187|Dexamethasone|dexamethasone|mesh-list
110200607|NCT00135187|Bortezomib|bortezomib|mesh-list
110200608|NCT00135187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110200609|NCT00135187|Antiemetics|antiemetics|mesh-ancestor
110200610|NCT00135187|Autonomic Agents|autonomic agents|mesh-ancestor
110200611|NCT00135187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110200612|NCT00135187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110200613|NCT00135187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110200614|NCT00135187|Glucocorticoids|glucocorticoids|mesh-ancestor
110200615|NCT00135187|Hormones|hormones|mesh-ancestor
110200616|NCT00135187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110200617|NCT00135187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110200618|NCT00135187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110200619|NCT00145093|Chromium|chromium|mesh-list
110200620|NCT00145093|Trace Elements|trace elements|mesh-ancestor
110200621|NCT00145093|Micronutrients|micronutrients|mesh-ancestor
110200622|NCT00145093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110200623|NCT00047450|Citalopram|citalopram|mesh-list
110200624|NCT00047450|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110200625|NCT00047450|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110200626|NCT00047450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110220732|NCT00299065|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110200628|NCT00047450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110200630|NCT00047450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110200631|NCT00047450|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110200632|NCT00047450|Antidepressive Agents|antidepressive agents|mesh-ancestor
110200633|NCT00047450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110200634|NCT00081237|Oxaliplatin|oxaliplatin|mesh-list
110200635|NCT00081237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110200636|NCT00145171|Apomorphine|apomorphine|mesh-list
110200637|NCT00145171|Emetics|emetics|mesh-ancestor
110200638|NCT00145171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110401564|NCT01264770|Adalimumab|adalimumab|mesh-list
110200639|NCT00145171|Autonomic Agents|autonomic agents|mesh-ancestor
110200640|NCT00145171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110200641|NCT00145171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110200642|NCT00145171|Dopamine Agonists|dopamine agonists|mesh-ancestor
110200643|NCT00145171|Dopamine Agents|dopamine agents|mesh-ancestor
110200644|NCT00145171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110200645|NCT00145171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110200646|NCT00145210|Atenolol|atenolol|mesh-list
110200647|NCT00145210|Nebivolol|nebivolol|mesh-list
110200648|NCT00145210|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110200649|NCT00145210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110200650|NCT00145210|Sympatholytics|sympatholytics|mesh-ancestor
110200651|NCT00145210|Autonomic Agents|autonomic agents|mesh-ancestor
110200652|NCT00145210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110200653|NCT00145210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110200654|NCT00145210|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110200655|NCT00145210|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110200656|NCT00145210|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110200657|NCT00145210|Adrenergic Agents|adrenergic agents|mesh-ancestor
110200658|NCT00145210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110200659|NCT00145210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110200660|NCT00145210|Vasodilator Agents|vasodilator agents|mesh-ancestor
110200661|NCT00145210|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110200662|NCT00145210|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110200663|NCT00145210|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110200665|NCT00081276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110200666|NCT00145405|Octreotide|octreotide|mesh-list
110200667|NCT00145405|Lanreotide|lanreotide|mesh-list
110200668|NCT00145405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110200669|NCT00145405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110200670|NCT00145405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110200671|NCT00145444|Olanzapine|olanzapine|mesh-list
110200672|NCT00145444|Ziprasidone|ziprasidone|mesh-list
110200673|NCT00145444|Antiemetics|antiemetics|mesh-ancestor
110200674|NCT00145444|Autonomic Agents|autonomic agents|mesh-ancestor
110200675|NCT00145444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110200676|NCT00145444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110200677|NCT00145444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110200678|NCT00145444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110200679|NCT00145444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110200680|NCT00145444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110200681|NCT00145444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110200682|NCT00145444|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110200683|NCT00145444|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110200684|NCT00145444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110200685|NCT00145444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110200686|NCT00145444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110200687|NCT00145444|Serotonin Agents|serotonin agents|mesh-ancestor
110063651|NCT01896999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110063652|NCT01896999|Nivolumab|nivolumab|mesh-list
110063653|NCT01896999|Ipilimumab|ipilimumab|mesh-list
110063654|NCT01896999|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110063655|NCT01896999|Antibodies|antibodies|mesh-list
110063656|NCT01896999|Immunoglobulins|immunoglobulins|mesh-list
110063657|NCT01896999|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110063658|NCT01896999|Immunoconjugates|immunoconjugates|mesh-list
110200688|NCT00145444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110200689|NCT00145444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110200690|NCT00145444|Dopamine Agents|dopamine agents|mesh-ancestor
110200691|NCT00145483|Sildenafil Citrate|sildenafil citrate|mesh-list
110200692|NCT00145483|Vasodilator Agents|vasodilator agents|mesh-ancestor
110200693|NCT00145483|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110200694|NCT00145483|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110200695|NCT00145483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110200696|NCT00145483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110200697|NCT00145483|Urological Agents|urological agents|mesh-ancestor
110200699|NCT00145522|Estradiol|estradiol|mesh-list
110200701|NCT00145522|Estrogens|estrogens|mesh-ancestor
110200702|NCT00145522|Hormones|hormones|mesh-ancestor
110200703|NCT00145522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110200704|NCT00145522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110200705|NCT00145522|Progestins|progestins|mesh-ancestor
110200706|NCT00145522|Androgen Antagonists|androgen antagonists|mesh-ancestor
110200707|NCT00145522|Hormone Antagonists|hormone antagonists|mesh-ancestor
110200708|NCT00145522|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110200709|NCT00145522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110200710|NCT00145522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110200711|NCT00145522|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110200712|NCT00145522|Anabolic Agents|anabolic agents|mesh-ancestor
110200713|NCT00081315|Amifostine|amifostine|mesh-list
110200715|NCT00081315|Protective Agents|protective agents|mesh-ancestor
110200716|NCT00081315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110200717|NCT00145561|Ritonavir|ritonavir|mesh-list
110200718|NCT00145561|Saquinavir|saquinavir|mesh-list
110200719|NCT00145561|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110200720|NCT00145561|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110200721|NCT00145561|Protease Inhibitors|protease inhibitors|mesh-ancestor
110200722|NCT00145561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110200723|NCT00145561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110200724|NCT00145561|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110200725|NCT00145561|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110200726|NCT00145561|Antiviral Agents|antiviral agents|mesh-ancestor
110200727|NCT00145561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110200728|NCT00145561|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110200729|NCT00145561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110200730|NCT00145639|Carboplatin|carboplatin|mesh-list
110200731|NCT00145639|Doxorubicin|doxorubicin|mesh-list
110200732|NCT00145639|Ifosfamide|ifosfamide|mesh-list
110200733|NCT00145639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110200734|NCT00145639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110200735|NCT00145639|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110200736|NCT00145639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110200737|NCT00145639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110200738|NCT00145639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110200739|NCT00145639|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110200740|NCT00145639|Alkylating Agents|alkylating agents|mesh-ancestor
110200741|NCT00047567|Zonisamide|zonisamide|mesh-list
110200742|NCT00047567|Anticonvulsants|anticonvulsants|mesh-ancestor
110200743|NCT00047567|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110200744|NCT00047567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110200745|NCT00047567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110200746|NCT00047567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110200747|NCT00047567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110200748|NCT00145873|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
110200749|NCT00145873|Natriuretic Agents|natriuretic agents|mesh-ancestor
110200750|NCT00145873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110200751|NCT00145990|Methacholine Chloride|methacholine chloride|mesh-list
110200753|NCT00145990|Autonomic Agents|autonomic agents|mesh-ancestor
110200754|NCT00145990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110200755|NCT00145990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110200756|NCT00145990|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110200757|NCT00145990|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
110200758|NCT00145990|Respiratory System Agents|respiratory system agents|mesh-ancestor
110200759|NCT00145990|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110200760|NCT00145990|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110200761|NCT00145990|Cholinergic Agents|cholinergic agents|mesh-ancestor
110200762|NCT00145990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110200763|NCT00145990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110200764|NCT00146068|Interferon beta-1a|interferon beta-1a|mesh-list
110401961|NCT06054113|Blinatumomab|blinatumomab|mesh-list
110200765|NCT00146068|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110200766|NCT00146068|Immunologic Factors|immunologic factors|mesh-ancestor
110200767|NCT00146068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110200768|NCT00146068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110200769|NCT00146068|Antiviral Agents|antiviral agents|mesh-ancestor
110200770|NCT00146068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110200771|NCT00081471|Darbepoetin alfa|darbepoetin alfa|mesh-list
110200773|NCT00047645|Interferons|interferons|mesh-list
110200774|NCT00047645|Interferon-gamma|interferon-gamma|mesh-list
110200775|NCT00047645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110200776|NCT00047645|Antiviral Agents|antiviral agents|mesh-ancestor
110200777|NCT00047645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110200778|NCT00146146|Letrozole|letrozole|mesh-list
110402055|NCT06036823|Albuterol|albuterol|mesh-list
110200779|NCT00146146|Methyltestosterone|methyltestosterone|mesh-list
110200780|NCT00146146|Dutasteride|dutasteride|mesh-list
110200781|NCT00146146|Testosterone|testosterone|mesh-list
110200782|NCT00146146|Testosterone undecanoate|testosterone undecanoate|mesh-list
110200783|NCT00146146|Testosterone enanthate|testosterone enanthate|mesh-list
110200784|NCT00146146|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110200785|NCT00146146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110200786|NCT00146146|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110200787|NCT00146146|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110200788|NCT00146146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110200789|NCT00146146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110200790|NCT00146146|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110200791|NCT00146146|Hormone Antagonists|hormone antagonists|mesh-ancestor
110200792|NCT00146146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110200793|NCT00146146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110200794|NCT00146146|Androgens|androgens|mesh-ancestor
110200795|NCT00146146|Hormones|hormones|mesh-ancestor
110200796|NCT00146146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110200797|NCT00146146|Anabolic Agents|anabolic agents|mesh-ancestor
110200798|NCT00146146|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110200799|NCT00146224|Epoetin Alfa|epoetin alfa|mesh-list
110200800|NCT00146224|Hematinics|hematinics|mesh-ancestor
110200801|NCT00081549|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(II)|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii)|mesh-list
110200802|NCT00081549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110200803|NCT00146341|Telmisartan|telmisartan|mesh-list
110200804|NCT00146341|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110200805|NCT00146341|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110200807|NCT00146341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110200808|NCT00146380|Lamivudine|lamivudine|mesh-list
110200809|NCT00146380|Zidovudine|zidovudine|mesh-list
110200810|NCT00146380|Nevirapine|nevirapine|mesh-list
110200811|NCT00146380|Nelfinavir|nelfinavir|mesh-list
110200812|NCT00146380|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110200813|NCT00146380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110200814|NCT00146380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110200815|NCT00146380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110200816|NCT00146380|Antiviral Agents|antiviral agents|mesh-ancestor
110402209|NCT05943691|Glucocorticoids|glucocorticoids|mesh-ancestor
110200817|NCT00146380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110200818|NCT00146380|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110200819|NCT00146380|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110200820|NCT00146380|Antimetabolites|antimetabolites|mesh-ancestor
110200821|NCT00146380|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110200822|NCT00146380|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110200823|NCT00146380|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110200824|NCT00146380|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110200825|NCT00146380|Protease Inhibitors|protease inhibitors|mesh-ancestor
110200826|NCT00081588|Darunavir|darunavir|mesh-list
110200827|NCT00081588|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110200828|NCT00081588|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110200829|NCT00081588|Protease Inhibitors|protease inhibitors|mesh-ancestor
110200830|NCT00081588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110200831|NCT00081588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110200832|NCT00081588|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110200833|NCT00081588|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110200834|NCT00081588|Antiviral Agents|antiviral agents|mesh-ancestor
110200835|NCT00081588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110200836|NCT00146458|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110200837|NCT00146458|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110200838|NCT00146458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110200839|NCT00047723|Minocycline|minocycline|mesh-list
110200840|NCT00047723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110200841|NCT00047723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110200842|NCT00146497|Budesonide|budesonide|mesh-list
110200843|NCT00146497|Pulmonary Surfactants|pulmonary surfactants|mesh-list
110200844|NCT00146497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110200845|NCT00146497|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110200846|NCT00146497|Autonomic Agents|autonomic agents|mesh-ancestor
110200847|NCT00146497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110200848|NCT00146497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110200849|NCT00146497|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110200850|NCT00146497|Respiratory System Agents|respiratory system agents|mesh-ancestor
110200851|NCT00146497|Glucocorticoids|glucocorticoids|mesh-ancestor
110200852|NCT00146497|Hormones|hormones|mesh-ancestor
110200853|NCT00146497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110200854|NCT02957890|Vaccines|vaccines|mesh-list
110200855|NCT02957890|Immunologic Factors|immunologic factors|mesh-ancestor
110200856|NCT02957890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110200857|NCT00146575|Sirolimus|sirolimus|mesh-list
110200858|NCT00146575|Paclitaxel|paclitaxel|mesh-list
110200859|NCT00146575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110200860|NCT00146575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110200861|NCT00146575|Tubulin Modulators|tubulin modulators|mesh-ancestor
110200862|NCT00146575|Antimitotic Agents|antimitotic agents|mesh-ancestor
110200863|NCT00146575|Mitosis Modulators|mitosis modulators|mesh-ancestor
110200864|NCT00146575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110063721|NCT01415882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110063731|NCT01303341|Sorafenib|sorafenib|mesh-list
110063732|NCT01303341|Riluzole|riluzole|mesh-list
110063734|NCT01303341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110063735|NCT01303341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110063736|NCT01303341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110200865|NCT00146575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110200866|NCT00146575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110200867|NCT00146575|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110200869|NCT00146575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110200870|NCT00146575|Immunologic Factors|immunologic factors|mesh-ancestor
110200871|NCT00146575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110200872|NCT00146614|Sirolimus|sirolimus|mesh-list
110200874|NCT00146614|Tacrolimus|tacrolimus|mesh-list
110200875|NCT00146614|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110200876|NCT00146614|Abortifacient Agents|abortifacient agents|mesh-ancestor
110200877|NCT00146614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110200878|NCT00146614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110200879|NCT00146614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110200880|NCT00146614|Antimetabolites|antimetabolites|mesh-ancestor
110200881|NCT00146614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110200882|NCT00146614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110200883|NCT00146614|Dermatologic Agents|dermatologic agents|mesh-ancestor
110402559|NCT05793060|Hormones|hormones|mesh-ancestor
110200884|NCT00146614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110200885|NCT00146614|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110200886|NCT00146614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110200887|NCT00146614|Immunologic Factors|immunologic factors|mesh-ancestor
110200889|NCT00146614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110200890|NCT00146614|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110200891|NCT00146614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110200892|NCT00146614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110200893|NCT00146614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110200894|NCT00146614|Antifungal Agents|antifungal agents|mesh-ancestor
110200895|NCT00047762|Bevacizumab|bevacizumab|mesh-list
110200896|NCT00047762|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110200897|NCT00047762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110200898|NCT00047762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110200899|NCT00047762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110200900|NCT00047762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110200901|NCT00047762|Growth Substances|growth substances|mesh-ancestor
110200902|NCT00047762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110200903|NCT00047762|Growth Inhibitors|growth inhibitors|mesh-ancestor
110200904|NCT00047762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110200905|NCT00047762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110200906|NCT00047762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110200907|NCT00042978|Carboplatin|carboplatin|mesh-list
110200908|NCT00042978|Etoposide|etoposide|mesh-list
110200909|NCT00042978|Etoposide phosphate|etoposide phosphate|mesh-list
110200910|NCT00042978|Oblimersen|oblimersen|mesh-list
110200911|NCT00042978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110200912|NCT00042978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110200913|NCT00042978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110200914|NCT00042978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110200915|NCT00042978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110200916|NCT00042978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110200917|NCT00405730|Ketorolac|ketorolac|mesh-list
110200918|NCT00405730|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110200919|NCT00405730|Nepafenac|nepafenac|mesh-list
110200920|NCT00405730|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110200921|NCT00405730|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110200922|NCT00405730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110200923|NCT00405730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110200924|NCT00405730|Analgesics|analgesics|mesh-ancestor
110200925|NCT00405730|Sensory System Agents|sensory system agents|mesh-ancestor
110200926|NCT00405730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110402737|NCT05628038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110402738|NCT05628038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110402739|NCT05628038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110402740|NCT05628038|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110402741|NCT05628038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110402742|NCT05628038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110402743|NCT05628038|Antidotes|antidotes|mesh-ancestor
110402744|NCT05628038|Protective Agents|protective agents|mesh-ancestor
110402745|NCT05628038|Vitamin B Complex|vitamin b complex|mesh-ancestor
110200927|NCT00405730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110200929|NCT00405730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110200930|NCT00405730|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110200931|NCT00405730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110200932|NCT00405730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110200933|NCT00405769|Red yeast rice|red yeast rice|mesh-list
110200934|NCT00405769|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110200935|NCT00405769|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110200936|NCT00405769|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110200937|NCT00405769|Antimetabolites|antimetabolites|mesh-ancestor
110200938|NCT00405769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110200939|NCT00405769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110200940|NCT00405769|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110200942|NCT00047801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110200943|NCT00047801|Tubulin Modulators|tubulin modulators|mesh-ancestor
110200944|NCT00047801|Antimitotic Agents|antimitotic agents|mesh-ancestor
110200945|NCT00047801|Mitosis Modulators|mitosis modulators|mesh-ancestor
110200946|NCT00047801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110200947|NCT00146731|Artesunate|artesunate|mesh-list
110200948|NCT00146731|Amodiaquine|amodiaquine|mesh-list
110200949|NCT00146731|Dapsone|dapsone|mesh-list
110200950|NCT00146731|Chlorproguanil|chlorproguanil|mesh-list
110200951|NCT00146731|Antimalarials|antimalarials|mesh-ancestor
110200952|NCT00146731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110200953|NCT00146731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110200954|NCT00146731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110200955|NCT00146731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110200956|NCT00146731|Antiviral Agents|antiviral agents|mesh-ancestor
110200957|NCT00146731|Schistosomicides|schistosomicides|mesh-ancestor
110200958|NCT00146731|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110200959|NCT00146731|Anthelmintics|anthelmintics|mesh-ancestor
110200960|NCT00146731|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110200961|NCT00146731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110200962|NCT00146731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110200963|NCT00146731|Leprostatic Agents|leprostatic agents|mesh-ancestor
110200964|NCT00146731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110200965|NCT00047840|Docetaxel|docetaxel|mesh-list
110200966|NCT00047840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110200967|NCT00047840|Tubulin Modulators|tubulin modulators|mesh-ancestor
110200968|NCT00047840|Antimitotic Agents|antimitotic agents|mesh-ancestor
110200969|NCT00047840|Mitosis Modulators|mitosis modulators|mesh-ancestor
110200970|NCT00047840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110200971|NCT00146926|Lidocaine|lidocaine|mesh-list
110200972|NCT00146926|Ephedrine|ephedrine|mesh-list
110200973|NCT00146926|Ketamine|ketamine|mesh-list
110200974|NCT00146926|Anesthetics, Local|anesthetics, local|mesh-ancestor
110200975|NCT00146926|Anesthetics|anesthetics|mesh-ancestor
110200976|NCT00146926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110200977|NCT00146926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110200978|NCT00146926|Sensory System Agents|sensory system agents|mesh-ancestor
110200979|NCT00146926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110200980|NCT00146926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110200981|NCT00146926|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110200982|NCT00146926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110200983|NCT00146926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110200984|NCT00146926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110200986|NCT00146926|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110200987|NCT00146926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110200988|NCT00146926|Anesthetics, General|anesthetics, general|mesh-ancestor
110200989|NCT00146926|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110200990|NCT00146926|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110200991|NCT00146926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110200992|NCT00146926|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110200993|NCT00146926|Sympathomimetics|sympathomimetics|mesh-ancestor
110200994|NCT00146926|Autonomic Agents|autonomic agents|mesh-ancestor
110200995|NCT00146926|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110200996|NCT00146926|Adrenergic Agents|adrenergic agents|mesh-ancestor
110200997|NCT00147004|Hydrocortisone|hydrocortisone|mesh-list
110200998|NCT00147004|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110200999|NCT00147004|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110201000|NCT00147004|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110201001|NCT00147004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110201002|NCT00147121|Rituximab|rituximab|mesh-list
110201003|NCT00147121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110201004|NCT00147121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110220799|NCT04727853|Irinotecan|irinotecan|mesh-list
110201005|NCT00147121|Immunologic Factors|immunologic factors|mesh-ancestor
110201006|NCT00147121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110201007|NCT00147121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110201008|NCT00147160|Temozolomide|temozolomide|mesh-list
110201010|NCT00147160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110201011|NCT00147160|Alkylating Agents|alkylating agents|mesh-ancestor
110201012|NCT00147160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201013|NCT00147160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110201014|NCT04732104|Lidocaine|lidocaine|mesh-list
110201015|NCT04732104|Xylometazoline|xylometazoline|mesh-list
110201016|NCT04732104|Nasal Decongestants|nasal decongestants|mesh-list
110201017|NCT04732104|Anesthetics, Local|anesthetics, local|mesh-ancestor
110201018|NCT04732104|Anesthetics|anesthetics|mesh-ancestor
110201019|NCT04732104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110201020|NCT04732104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110201021|NCT04732104|Sensory System Agents|sensory system agents|mesh-ancestor
110201022|NCT04732104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110201023|NCT04732104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110201024|NCT04732104|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110201025|NCT04732104|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110201026|NCT04732104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110403273|NCT05064280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110201027|NCT04732104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201028|NCT04732104|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110201029|NCT04732104|Respiratory System Agents|respiratory system agents|mesh-ancestor
110201032|NCT00147355|Codeine|codeine|mesh-list
110201033|NCT00147355|Ondansetron|ondansetron|mesh-list
110201034|NCT00147355|Metoclopramide|metoclopramide|mesh-list
110201035|NCT00147355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110201036|NCT00147355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110201037|NCT00147355|Analgesics|analgesics|mesh-ancestor
110201038|NCT00147355|Sensory System Agents|sensory system agents|mesh-ancestor
110201039|NCT00147355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110201040|NCT00147355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110201041|NCT00147355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110201042|NCT00147355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110201043|NCT00147355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110201044|NCT00147355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110201045|NCT00147355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201046|NCT00147355|Antipyretics|antipyretics|mesh-ancestor
110201047|NCT00147355|Antiemetics|antiemetics|mesh-ancestor
110201048|NCT00147355|Autonomic Agents|autonomic agents|mesh-ancestor
110403355|NCT04973254|Antiviral Agents|antiviral agents|mesh-ancestor
110403356|NCT04973254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110403357|NCT04973254|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110403358|NCT04973254|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110403361|NCT04964505|Azacitidine|azacitidine|mesh-list
110201049|NCT00147355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110201050|NCT00147355|Antipruritics|antipruritics|mesh-ancestor
110201051|NCT00147355|Dermatologic Agents|dermatologic agents|mesh-ancestor
110063759|NCT00750841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110201052|NCT00147355|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110201053|NCT00147355|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110201055|NCT00147355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110201056|NCT00147355|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110201057|NCT00147355|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110201058|NCT00147355|Dopamine Agents|dopamine agents|mesh-ancestor
110201059|NCT00147355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110201060|NCT00147355|Narcotics|narcotics|mesh-ancestor
110201061|NCT00147355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110201062|NCT00147355|Antitussive Agents|antitussive agents|mesh-ancestor
110201063|NCT00147355|Respiratory System Agents|respiratory system agents|mesh-ancestor
110201064|NCT00048152|Mycophenolic Acid|mycophenolic acid|mesh-list
110201065|NCT00048152|Cyclosporine|cyclosporine|mesh-list
110201066|NCT00048152|Cyclosporins|cyclosporins|mesh-list
110201067|NCT00048152|Daclizumab|daclizumab|mesh-list
110201068|NCT00048152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110201069|NCT00048152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110201070|NCT00048152|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110201071|NCT00048152|Antitubercular Agents|antitubercular agents|mesh-ancestor
110201072|NCT00048152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110201073|NCT00048152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110201074|NCT00048152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110201075|NCT00048152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201076|NCT00048152|Antifungal Agents|antifungal agents|mesh-ancestor
110201077|NCT00048152|Dermatologic Agents|dermatologic agents|mesh-ancestor
110201078|NCT00048152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110201079|NCT00048152|Immunologic Factors|immunologic factors|mesh-ancestor
110201080|NCT00048152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110201081|NCT00048152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110201082|NCT00048152|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110201083|NCT00147394|Risperidone|risperidone|mesh-list
110201084|NCT00147394|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110201085|NCT00147394|Serotonin Agents|serotonin agents|mesh-ancestor
110201086|NCT00147394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110201087|NCT00147394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201088|NCT00147394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110201090|NCT00147394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110201091|NCT00147394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110201092|NCT00147394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110201093|NCT00147394|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110201094|NCT00147394|Dopamine Agents|dopamine agents|mesh-ancestor
110201095|NCT04725682|Tacrolimus|tacrolimus|mesh-list
110201096|NCT04725682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110201097|NCT04725682|Immunologic Factors|immunologic factors|mesh-ancestor
110201098|NCT04725682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110201099|NCT04725682|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110201100|NCT04725682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110201101|NCT04725682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201102|NCT00147511|Linezolid|linezolid|mesh-list
110201103|NCT00147511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110201104|NCT00147511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110201105|NCT00147511|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110201106|NCT00147511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110201107|NCT00147511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201108|NCT00043095|Gemcitabine|gemcitabine|mesh-list
110201109|NCT00043095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110201110|NCT00043095|Antimetabolites|antimetabolites|mesh-ancestor
110201111|NCT00043095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201112|NCT00043095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110201114|NCT00048230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110201115|NCT00147589|Eplerenone|eplerenone|mesh-list
110368624|NCT05419583|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110201116|NCT00147589|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110201117|NCT00147589|Hormone Antagonists|hormone antagonists|mesh-ancestor
110201118|NCT00147589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110403798|NCT04298567|Antithrombins|antithrombins|mesh-ancestor
110201119|NCT00147589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110201120|NCT00147589|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110201121|NCT00147589|Diuretics|diuretics|mesh-ancestor
110201122|NCT00147589|Natriuretic Agents|natriuretic agents|mesh-ancestor
110201123|NCT00147589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110201125|NCT00397332|Dermatologic Agents|dermatologic agents|mesh-ancestor
110201126|NCT00397332|Immunologic Factors|immunologic factors|mesh-ancestor
110053003|NCT01483781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110201127|NCT00397332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110201128|NCT00147628|Sildenafil Citrate|sildenafil citrate|mesh-list
110201129|NCT00147628|Citric Acid|citric acid|mesh-list
110201130|NCT00147628|Sodium Citrate|sodium citrate|mesh-list
110201132|NCT00147628|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110201133|NCT00147628|Chelating Agents|chelating agents|mesh-ancestor
110201134|NCT00147628|Sequestering Agents|sequestering agents|mesh-ancestor
110201135|NCT00147628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201136|NCT00147628|Vasodilator Agents|vasodilator agents|mesh-ancestor
110201137|NCT00147628|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110201138|NCT00147628|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110201139|NCT00147628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110201140|NCT00147628|Urological Agents|urological agents|mesh-ancestor
110201141|NCT00147667|Erythromycin|erythromycin|mesh-list
110201142|NCT00147667|Erythromycin Estolate|erythromycin estolate|mesh-list
110201143|NCT00147667|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
110201144|NCT00147667|Erythromycin stearate|erythromycin stearate|mesh-list
110201145|NCT00147667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110201146|NCT00147667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110201147|NCT00147667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110201148|NCT00147667|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110201149|NCT00147667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110201150|NCT00147667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201151|NCT00147784|Interferons|interferons|mesh-list
110201152|NCT00147784|Ribavirin|ribavirin|mesh-list
110201153|NCT00147784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110201154|NCT00147784|Antiviral Agents|antiviral agents|mesh-ancestor
110201155|NCT00147784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110201156|NCT00147784|Antimetabolites|antimetabolites|mesh-ancestor
110201157|NCT00147784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201158|NCT00081744|Tigecycline|tigecycline|mesh-list
110201159|NCT00081744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110201160|NCT00081744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110201161|NCT00081744|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110201162|NCT00081744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110201163|NCT00081744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201164|NCT00147862|Tranexamic Acid|tranexamic acid|mesh-list
110201165|NCT00147862|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110201166|NCT00147862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110201167|NCT00147862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201168|NCT00147862|Hemostatics|hemostatics|mesh-ancestor
110201169|NCT00147862|Coagulants|coagulants|mesh-ancestor
110201170|NCT00147901|Cyclophosphamide|cyclophosphamide|mesh-list
110201171|NCT00147901|Fludarabine|fludarabine|mesh-list
110201172|NCT00147901|Alemtuzumab|alemtuzumab|mesh-list
110201173|NCT00147901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110201174|NCT00147901|Immunologic Factors|immunologic factors|mesh-ancestor
110201175|NCT00147901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110201176|NCT00147901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110201177|NCT00147901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110201178|NCT00147901|Alkylating Agents|alkylating agents|mesh-ancestor
110201179|NCT00147901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201180|NCT00147901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110201181|NCT00147901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110201182|NCT00147901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110201184|NCT02957851|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110201185|NCT02957851|Anesthetics, General|anesthetics, general|mesh-ancestor
110404190|NCT03911739|Buprenorphine|buprenorphine|mesh-list
110404191|NCT03911739|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110201186|NCT02957851|Anesthetics|anesthetics|mesh-ancestor
110201187|NCT02957851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110201188|NCT02957851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110201189|NCT02957851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110201190|NCT02957851|Analgesics|analgesics|mesh-ancestor
110201191|NCT02957851|Sensory System Agents|sensory system agents|mesh-ancestor
110201192|NCT02957851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110201194|NCT00147979|Calcium heparin|calcium heparin|mesh-list
110201195|NCT00147979|Anticoagulants|anticoagulants|mesh-ancestor
110201196|NCT00147979|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110201197|NCT00147979|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110201198|NCT00147979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201199|NCT00148018|Dexamethasone|dexamethasone|mesh-list
110201200|NCT00148018|Bortezomib|bortezomib|mesh-list
110201201|NCT00148018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110201202|NCT00148018|Antiemetics|antiemetics|mesh-ancestor
110201203|NCT00148018|Autonomic Agents|autonomic agents|mesh-ancestor
110201204|NCT00148018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110201205|NCT00148018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110201206|NCT00148018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110201207|NCT00148018|Glucocorticoids|glucocorticoids|mesh-ancestor
110201209|NCT00148018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110201210|NCT00148018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110201211|NCT00148018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110201212|NCT00081822|Cytarabine|cytarabine|mesh-list
110404374|NCT03678129|GABA Agonists|gaba agonists|mesh-ancestor
110404382|NCT03661684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110404383|NCT03661684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110404384|NCT03661684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110404385|NCT03661684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110404386|NCT03660826|Durvalumab|durvalumab|mesh-list
110404387|NCT03660826|Olaparib|olaparib|mesh-list
110404388|NCT03660826|Cediranib|cediranib|mesh-list
110201213|NCT00081822|Clofarabine|clofarabine|mesh-list
110201214|NCT00081822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110201215|NCT00081822|Antimetabolites|antimetabolites|mesh-ancestor
110201216|NCT00081822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201217|NCT00081822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110201218|NCT00081822|Antiviral Agents|antiviral agents|mesh-ancestor
110201219|NCT00081822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110201220|NCT00081822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110201221|NCT00081822|Immunologic Factors|immunologic factors|mesh-ancestor
110201222|NCT00081822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110201223|NCT00048425|Simendan|simendan|mesh-list
110201224|NCT00048425|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110201225|NCT00048425|Vasodilator Agents|vasodilator agents|mesh-ancestor
110201226|NCT00048425|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110201227|NCT00048425|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110201228|NCT00048425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110201229|NCT00048425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201230|NCT00048425|Protective Agents|protective agents|mesh-ancestor
110201231|NCT00048425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110201233|NCT00148135|Gemcitabine|gemcitabine|mesh-list
110201234|NCT00148135|Capecitabine|capecitabine|mesh-list
110404465|NCT03564691|Paclitaxel|paclitaxel|mesh-list
110201235|NCT00148135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110201236|NCT00148135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110201237|NCT00148135|Antimetabolites|antimetabolites|mesh-ancestor
110201238|NCT00148135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201241|NCT00399711|Repaglinide|repaglinide|mesh-list
110201242|NCT00399711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110201243|NCT00399711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110201244|NCT00148252|Mycophenolic Acid|mycophenolic acid|mesh-list
110201245|NCT00148252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110201246|NCT00148252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110201247|NCT00148252|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110201248|NCT00148252|Antitubercular Agents|antitubercular agents|mesh-ancestor
110201249|NCT00148252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110404508|NCT03539744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110404509|NCT03539744|Growth Substances|growth substances|mesh-ancestor
110404510|NCT03539744|Growth Inhibitors|growth inhibitors|mesh-ancestor
110404511|NCT03528642|Temozolomide|temozolomide|mesh-list
110404512|NCT03528642|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110404513|NCT03528642|Alkylating Agents|alkylating agents|mesh-ancestor
110404515|NCT03528642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110201250|NCT00148252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110201251|NCT00148252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110201252|NCT00148252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201254|NCT00148291|Vinorelbine|vinorelbine|mesh-list
110201255|NCT00148291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110201256|NCT00148291|Tubulin Modulators|tubulin modulators|mesh-ancestor
110201257|NCT00148291|Antimitotic Agents|antimitotic agents|mesh-ancestor
110201258|NCT00148291|Mitosis Modulators|mitosis modulators|mesh-ancestor
110201259|NCT00148291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201260|NCT00148291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110201261|NCT00148330|Triamcinolone|triamcinolone|mesh-list
110404580|NCT03376672|Dexamethasone|dexamethasone|mesh-list
110404581|NCT03376672|Lenalidomide|lenalidomide|mesh-list
110404582|NCT03376672|Ixazomib|ixazomib|mesh-list
110404583|NCT03376672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110404584|NCT03376672|Antiemetics|antiemetics|mesh-ancestor
110404585|NCT03376672|Autonomic Agents|autonomic agents|mesh-ancestor
110404586|NCT03376672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110404587|NCT03376672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110404588|NCT03376672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110404589|NCT03376672|Glucocorticoids|glucocorticoids|mesh-ancestor
110404590|NCT03376672|Hormones|hormones|mesh-ancestor
110404591|NCT03376672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110404592|NCT03376672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110201262|NCT00148330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110201264|NCT00148330|Hormones|hormones|mesh-ancestor
110201265|NCT00148330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110201266|NCT00148330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110201267|NCT00405808|Rimonabant|rimonabant|mesh-list
110201268|NCT00405808|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110201269|NCT00405808|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
110201270|NCT00405808|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110201271|NCT00405808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110201272|NCT00405808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201273|NCT00405808|Hormones|hormones|mesh-ancestor
110201274|NCT00405808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110201275|NCT00405808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110201276|NCT00081900|N(1),N(11)-diethylnorspermine|n(1),n(11)-diethylnorspermine|mesh-list
110404632|NCT03290937|Camptothecin|camptothecin|mesh-list
110201277|NCT00081900|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110201278|NCT00081900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110201280|NCT00405847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110201281|NCT00405847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110201282|NCT00405847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110201283|NCT00405847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110201284|NCT00405847|Analgesics|analgesics|mesh-ancestor
110201285|NCT00405847|Sensory System Agents|sensory system agents|mesh-ancestor
110201286|NCT00405847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110201287|NCT00405847|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110201288|NCT00405847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110201289|NCT00405847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110201290|NCT00405847|Adrenergic Agents|adrenergic agents|mesh-ancestor
110201291|NCT00405847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110201292|NCT00405847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201293|NCT00148408|Montelukast|montelukast|mesh-list
110201294|NCT00148408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110201295|NCT00148408|Respiratory System Agents|respiratory system agents|mesh-ancestor
110201296|NCT00148408|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110201297|NCT00148408|Hormone Antagonists|hormone antagonists|mesh-ancestor
110201298|NCT00148408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110201299|NCT00148408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110201300|NCT00148408|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110404698|NCT03218137|Adenosine|adenosine|mesh-list
110201301|NCT00148408|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110201302|NCT00148408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201303|NCT00048503|Tipifarnib|tipifarnib|mesh-list
110201304|NCT00048503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110201305|NCT00148447|Escitalopram|escitalopram|mesh-list
110201306|NCT00148447|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110201307|NCT00148447|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110201308|NCT00148447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110201309|NCT00148447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201310|NCT00148447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110201311|NCT00148447|Serotonin Agents|serotonin agents|mesh-ancestor
110201312|NCT00148447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110201313|NCT00043134|Decitabine|decitabine|mesh-list
110201314|NCT00043134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110201316|NCT00043134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201317|NCT00043134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110201318|NCT00043134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110201319|NCT00148564|Olanzapine|olanzapine|mesh-list
110201321|NCT00148564|Antiemetics|antiemetics|mesh-ancestor
110201322|NCT00148564|Autonomic Agents|autonomic agents|mesh-ancestor
110201323|NCT00148564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110201324|NCT00148564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110201325|NCT00148564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110201326|NCT00148564|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110201327|NCT00148564|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110404838|NCT03038672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110404840|NCT03038672|Immunologic Factors|immunologic factors|mesh-ancestor
110201328|NCT00148564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110201329|NCT00148564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110201330|NCT00148564|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110201331|NCT00148564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110201332|NCT00148564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110201333|NCT00148564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201334|NCT00148564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110201336|NCT00148564|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110201337|NCT00148564|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110201338|NCT00148564|Dopamine Agents|dopamine agents|mesh-ancestor
110201339|NCT00148603|Montelukast|montelukast|mesh-list
110201340|NCT00148603|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110201341|NCT00148603|Respiratory System Agents|respiratory system agents|mesh-ancestor
110201342|NCT00148603|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110201343|NCT00148603|Hormone Antagonists|hormone antagonists|mesh-ancestor
110225490|NCT05952713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201344|NCT00148603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110201345|NCT00148603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110201346|NCT00148603|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110201347|NCT00148603|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110201348|NCT00148603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201349|NCT00048659|N-(6-methoxy-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl)-2-phenylethenesulfonamide|n-(6-methoxy-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl)-2-phenylethenesulfonamide|mesh-list
110201350|NCT00048659|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110201351|NCT00048659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201353|NCT00148681|Vinorelbine|vinorelbine|mesh-list
110201355|NCT00148681|Doxorubicin|doxorubicin|mesh-list
110201357|NCT00148681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110201358|NCT00148681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110201359|NCT00148681|Tubulin Modulators|tubulin modulators|mesh-ancestor
110201360|NCT00148681|Antimitotic Agents|antimitotic agents|mesh-ancestor
110404974|NCT02839707|Bevacizumab|bevacizumab|mesh-list
110201362|NCT00148681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201363|NCT00148681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110201364|NCT00148681|Immunologic Factors|immunologic factors|mesh-ancestor
110201365|NCT00148681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110201366|NCT00148681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110201367|NCT00148681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110201368|NCT00148681|Alkylating Agents|alkylating agents|mesh-ancestor
110201369|NCT00148681|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110201370|NCT00148681|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110201371|NCT00148681|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110201372|NCT00148681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110201373|NCT00148681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110405083|NCT02631733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110201374|NCT00148681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110201375|NCT00148720|Capecitabine|capecitabine|mesh-list
110201376|NCT00148720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110201377|NCT00148720|Antimetabolites|antimetabolites|mesh-ancestor
110201378|NCT00148720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201379|NCT00148720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110201380|NCT00148837|Interferons|interferons|mesh-list
110201382|NCT00148837|Interferon-alpha|interferon-alpha|mesh-list
110201383|NCT00148837|Interferon alpha-2|interferon alpha-2|mesh-list
110201384|NCT00148837|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110201385|NCT00148837|Prazosin|prazosin|mesh-list
110201386|NCT00148837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110201387|NCT00148837|Antiviral Agents|antiviral agents|mesh-ancestor
110201388|NCT00148837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110201389|NCT00148837|Antimetabolites|antimetabolites|mesh-ancestor
110201390|NCT00148837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201391|NCT00148837|Immunologic Factors|immunologic factors|mesh-ancestor
110201392|NCT00148837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110201393|NCT00148837|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110201394|NCT00148837|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110201395|NCT00148837|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110201396|NCT00148837|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110201397|NCT00148837|Adrenergic Agents|adrenergic agents|mesh-ancestor
110201398|NCT00148837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110201399|NCT00148876|Capecitabine|capecitabine|mesh-list
110201400|NCT00148876|Trastuzumab|trastuzumab|mesh-list
110201401|NCT00148876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110201402|NCT00148876|Antimetabolites|antimetabolites|mesh-ancestor
110405203|NCT02400216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110201403|NCT00148876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201404|NCT00148876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110201405|NCT00148876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110201406|NCT00148915|Ibandronic Acid|ibandronic acid|mesh-list
110201407|NCT00148915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110201408|NCT00148915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110201409|NCT00149110|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110201410|NCT00149110|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110201411|NCT00149110|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110201412|NCT00149110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110201413|NCT00149110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201414|NCT00149110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110201415|NCT00149110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110201416|NCT00149110|Analgesics|analgesics|mesh-ancestor
110201417|NCT00149110|Sensory System Agents|sensory system agents|mesh-ancestor
110201418|NCT00149110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110201419|NCT00149110|Antidepressive Agents|antidepressive agents|mesh-ancestor
110201420|NCT00149110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110201421|NCT00149110|Dopamine Agents|dopamine agents|mesh-ancestor
110201423|NCT00149149|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110201424|NCT00149149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110201426|NCT00149188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110201427|NCT00043212|Immunomodulating Agents|immunomodulating agents|mesh-list
110201428|NCT00043212|Immunologic Factors|immunologic factors|mesh-ancestor
110201429|NCT00043212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110201431|NCT00048776|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110201433|NCT00048776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110201434|NCT00048776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110201435|NCT00048776|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110201436|NCT00048776|Respiratory System Agents|respiratory system agents|mesh-ancestor
110201437|NCT00048776|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110201438|NCT00048776|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110201439|NCT00048776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201440|NCT00048776|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110201441|NCT00048776|Vasodilator Agents|vasodilator agents|mesh-ancestor
110201442|NCT00048776|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110201443|NCT00048776|Protective Agents|protective agents|mesh-ancestor
110201444|NCT00048776|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110201445|NCT00048776|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110201447|NCT00149383|Rosiglitazone|rosiglitazone|mesh-list
110201448|NCT00149383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110201449|NCT00149383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110201450|NCT00048854|Sertraline|sertraline|mesh-list
110201451|NCT00048854|Antidepressive Agents|antidepressive agents|mesh-ancestor
110201452|NCT00048854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110201453|NCT00048854|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110201454|NCT00048854|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110201455|NCT00048854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110201456|NCT00048854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201457|NCT00048854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110201458|NCT00048854|Serotonin Agents|serotonin agents|mesh-ancestor
110405502|NCT01712620|Diuretics|diuretics|mesh-ancestor
110201459|NCT00048854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110201460|NCT00081978|Etravirine|etravirine|mesh-list
110201461|NCT00081978|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110201462|NCT00081978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110201463|NCT00081978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110201464|NCT00081978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201465|NCT00081978|Antiviral Agents|antiviral agents|mesh-ancestor
110201466|NCT00081978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110201468|NCT00149539|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
110201469|NCT00149539|Naloxone|naloxone|mesh-list
110201470|NCT00149539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110201471|NCT00149539|Narcotics|narcotics|mesh-ancestor
110201472|NCT00149539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110201473|NCT00149539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110201475|NCT00149539|Sensory System Agents|sensory system agents|mesh-ancestor
110201476|NCT00149539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110405564|NCT00788671|Contraceptive Agents|contraceptive agents|mesh-ancestor
110405565|NCT00788671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110405566|NCT00788671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110405567|NCT00788671|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110201477|NCT00149539|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110201478|NCT00149578|Leucovorin|leucovorin|mesh-list
110201479|NCT00149578|Gemcitabine|gemcitabine|mesh-list
110201480|NCT00149578|Oxaliplatin|oxaliplatin|mesh-list
110201481|NCT00149578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110201482|NCT00149578|Antimetabolites|antimetabolites|mesh-ancestor
110201483|NCT00149578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110063852|NCT00336024|Abortifacient Agents|abortifacient agents|mesh-ancestor
110201484|NCT00149578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110201485|NCT00149578|Antidotes|antidotes|mesh-ancestor
110201486|NCT00149578|Protective Agents|protective agents|mesh-ancestor
110201487|NCT00149578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110201488|NCT00149578|Vitamin B Complex|vitamin b complex|mesh-ancestor
110201489|NCT00149578|Vitamins|vitamins|mesh-ancestor
110201490|NCT00149578|Micronutrients|micronutrients|mesh-ancestor
110201491|NCT00149617|Buspirone|buspirone|mesh-list
110201492|NCT00149617|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110405619|NCT00006721|Tubulin Modulators|tubulin modulators|mesh-ancestor
110405620|NCT00006721|Antimitotic Agents|antimitotic agents|mesh-ancestor
110405638|NCT00001379|Interferons|interferons|mesh-list
110405639|NCT00001379|Rituximab|rituximab|mesh-list
110405640|NCT00001379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110405641|NCT00001379|Antiviral Agents|antiviral agents|mesh-ancestor
110405642|NCT00001379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110405643|NCT00001379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110405644|NCT00001379|Immunologic Factors|immunologic factors|mesh-ancestor
110405645|NCT00001379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110405646|NCT00001379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110405647|NCT00001337|Rituximab|rituximab|mesh-list
110405648|NCT00001337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110405649|NCT00001337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110405650|NCT00001337|Immunologic Factors|immunologic factors|mesh-ancestor
110405651|NCT00001337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110201493|NCT00149617|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110201494|NCT00149617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110201495|NCT00149617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110201496|NCT00149617|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110201497|NCT00149617|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110201498|NCT00149617|Serotonin Agents|serotonin agents|mesh-ancestor
110201499|NCT00149617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110201500|NCT00149617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201501|NCT00043329|Interferon-gamma|interferon-gamma|mesh-list
110201502|NCT00043329|Antiviral Agents|antiviral agents|mesh-ancestor
110201503|NCT00043329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110201505|NCT00149656|Antioxidants|antioxidants|mesh-ancestor
110201506|NCT00149656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201507|NCT00149656|Protective Agents|protective agents|mesh-ancestor
110201508|NCT00149656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110201509|NCT00149656|Trace Elements|trace elements|mesh-ancestor
110201510|NCT00149656|Micronutrients|micronutrients|mesh-ancestor
110201511|NCT00082095|Doxorubicin|doxorubicin|mesh-list
110201512|NCT00082095|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110201513|NCT00082095|Capecitabine|capecitabine|mesh-list
110201514|NCT00082095|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110201515|NCT00082095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110201516|NCT00082095|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110201517|NCT00082095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110201518|NCT00082095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110201519|NCT00082095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201520|NCT00082095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110201521|NCT00082095|Antimetabolites|antimetabolites|mesh-ancestor
110201522|NCT00149851|Tegaserod|tegaserod|mesh-list
110201523|NCT00149851|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110201524|NCT00149851|Serotonin Agents|serotonin agents|mesh-ancestor
110201525|NCT00149851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110201526|NCT00149851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201527|NCT00149851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110201528|NCT00149929|Mycophenolic Acid|mycophenolic acid|mesh-list
110018893|NCT01483872|Anticoagulants|anticoagulants|mesh-list
110201529|NCT00149929|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110201530|NCT00149929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110201531|NCT00149929|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110201532|NCT00149929|Antitubercular Agents|antitubercular agents|mesh-ancestor
110201533|NCT00149929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110201534|NCT00149929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110201535|NCT00149929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110201536|NCT00149929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201538|NCT00049088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110201540|NCT00049088|Antibodies|antibodies|mesh-list
110201541|NCT00049088|Immunoglobulins|immunoglobulins|mesh-list
110201542|NCT00049088|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110201543|NCT00049088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110201544|NCT00049088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110201545|NCT00049088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110201546|NCT00049088|Growth Substances|growth substances|mesh-ancestor
110201547|NCT00049088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110201548|NCT00049088|Growth Inhibitors|growth inhibitors|mesh-ancestor
110201549|NCT00049088|Immunologic Factors|immunologic factors|mesh-ancestor
110201550|NCT00049088|Tubulin Modulators|tubulin modulators|mesh-ancestor
110201551|NCT00049088|Antimitotic Agents|antimitotic agents|mesh-ancestor
110201552|NCT00049088|Mitosis Modulators|mitosis modulators|mesh-ancestor
110201553|NCT00049088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201554|NCT00149968|Mycophenolic Acid|mycophenolic acid|mesh-list
110201555|NCT00149968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110201556|NCT00149968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110201557|NCT00149968|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110201558|NCT00149968|Antitubercular Agents|antitubercular agents|mesh-ancestor
110201559|NCT00149968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110201560|NCT00149968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110201561|NCT00149968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110201562|NCT00149968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201564|NCT04725448|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110201565|NCT04725448|Bevacizumab|bevacizumab|mesh-list
110201566|NCT04725448|Carboplatin|carboplatin|mesh-list
110201567|NCT04725448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110201568|NCT04725448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110201569|NCT04725448|Tubulin Modulators|tubulin modulators|mesh-ancestor
110201570|NCT04725448|Antimitotic Agents|antimitotic agents|mesh-ancestor
110201571|NCT04725448|Mitosis Modulators|mitosis modulators|mesh-ancestor
110201572|NCT04725448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201573|NCT04725448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110201574|NCT04725448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110201575|NCT04725448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110201576|NCT04725448|Growth Substances|growth substances|mesh-ancestor
110201577|NCT04725448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110201578|NCT04725448|Growth Inhibitors|growth inhibitors|mesh-ancestor
110201579|NCT00405925|Lamivudine|lamivudine|mesh-list
110201580|NCT00405925|Zidovudine|zidovudine|mesh-list
110201581|NCT00405925|Abacavir|abacavir|mesh-list
110201582|NCT00405925|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110201583|NCT00405925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110201584|NCT00405925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110201585|NCT00405925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201586|NCT00405925|Antiviral Agents|antiviral agents|mesh-ancestor
110201587|NCT00405925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110201588|NCT00405925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110201589|NCT00405925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110201590|NCT00405925|Antimetabolites|antimetabolites|mesh-ancestor
110201591|NCT00049166|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110201592|NCT00049166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110201593|NCT00049166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110201595|NCT00049166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201596|NCT00082212|Cetuximab|cetuximab|mesh-list
110201597|NCT00082212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110201598|NCT00082212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110201599|NCT00150007|Mycophenolic Acid|mycophenolic acid|mesh-list
110201600|NCT00150007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110201601|NCT00150007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110201602|NCT00150007|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110201603|NCT00150007|Antitubercular Agents|antitubercular agents|mesh-ancestor
110201604|NCT00150007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110201605|NCT00150007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110201606|NCT00150007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110201607|NCT00150007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201609|NCT00150046|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110201610|NCT00150046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110201611|NCT00150046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110201612|NCT00150046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201613|NCT00150046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110201614|NCT00150046|Immunologic Factors|immunologic factors|mesh-ancestor
110201615|NCT00150046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110201616|NCT00150046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110201618|NCT00150085|Cyclosporins|cyclosporins|mesh-list
110201619|NCT00150085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110201620|NCT00150085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201621|NCT00150085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110201622|NCT00150085|Immunologic Factors|immunologic factors|mesh-ancestor
110201623|NCT00150085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110201624|NCT00150085|Antifungal Agents|antifungal agents|mesh-ancestor
110201625|NCT00150085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110201626|NCT00150085|Dermatologic Agents|dermatologic agents|mesh-ancestor
110201628|NCT00150085|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110201629|NCT00082251|Niacin|niacin|mesh-list
110201630|NCT00082251|Simvastatin|simvastatin|mesh-list
110201631|NCT00082251|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110201632|NCT00082251|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110201633|NCT00082251|Antimetabolites|antimetabolites|mesh-ancestor
110201634|NCT00082251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201635|NCT00082251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110201636|NCT00082251|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110201637|NCT00082251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110201638|NCT00082251|Vasodilator Agents|vasodilator agents|mesh-ancestor
110201639|NCT00082251|Vitamin B Complex|vitamin b complex|mesh-ancestor
110201640|NCT00082251|Vitamins|vitamins|mesh-ancestor
110201641|NCT00082251|Micronutrients|micronutrients|mesh-ancestor
110201642|NCT00082251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110201643|NCT00049244|Capecitabine|capecitabine|mesh-list
110201644|NCT00049244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110201645|NCT00049244|Antimetabolites|antimetabolites|mesh-ancestor
110201646|NCT00049244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201648|NCT00150124|Methimazole|methimazole|mesh-list
110201649|NCT00150124|Antithyroid Agents|antithyroid agents|mesh-ancestor
110201650|NCT00150124|Hormone Antagonists|hormone antagonists|mesh-ancestor
110201651|NCT00150124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110201652|NCT00150124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110201653|NCT00049283|Docetaxel|docetaxel|mesh-list
110201654|NCT00049283|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110201655|NCT00049283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110201656|NCT00049283|Tubulin Modulators|tubulin modulators|mesh-ancestor
110201657|NCT00049283|Antimitotic Agents|antimitotic agents|mesh-ancestor
110201658|NCT00049283|Mitosis Modulators|mitosis modulators|mesh-ancestor
110201659|NCT00049283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201660|NCT00049283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110201661|NCT00049283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110201662|NCT00150241|Varenicline|varenicline|mesh-list
110201663|NCT00150241|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110201664|NCT00150241|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110201665|NCT00150241|Cholinergic Agents|cholinergic agents|mesh-ancestor
110201666|NCT00150241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110201667|NCT00150241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201668|NCT00150241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110201669|NCT00150280|Ibuprofen|ibuprofen|mesh-list
110201670|NCT00150280|Celecoxib|celecoxib|mesh-list
110201671|NCT00150280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110201672|NCT00150280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110201673|NCT00150280|Analgesics|analgesics|mesh-ancestor
110201674|NCT00150280|Sensory System Agents|sensory system agents|mesh-ancestor
110201675|NCT00150280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110201676|NCT00150280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110201677|NCT00150280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110201678|NCT00150280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110201679|NCT00150280|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110201680|NCT00150280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110201681|NCT00150280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201682|NCT00150280|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110201683|NCT00150358|Sildenafil Citrate|sildenafil citrate|mesh-list
110201684|NCT00150358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201685|NCT00150358|Vasodilator Agents|vasodilator agents|mesh-ancestor
110201686|NCT00150358|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110201687|NCT00150358|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110201688|NCT00150358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110201689|NCT00150358|Urological Agents|urological agents|mesh-ancestor
110201691|NCT00049361|Temozolomide|temozolomide|mesh-list
110201692|NCT00049361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110201693|NCT00049361|Alkylating Agents|alkylating agents|mesh-ancestor
110201694|NCT00049361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201695|NCT00049361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110201696|NCT00049361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110201697|NCT00049361|Immunologic Factors|immunologic factors|mesh-ancestor
110201698|NCT00049361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110201699|NCT00049361|Leprostatic Agents|leprostatic agents|mesh-ancestor
110201700|NCT00049361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110201701|NCT00049361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110201702|NCT00049361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110201703|NCT00049361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110201704|NCT00049361|Growth Substances|growth substances|mesh-ancestor
110201705|NCT00049361|Growth Inhibitors|growth inhibitors|mesh-ancestor
110201706|NCT00150436|Pregabalin|pregabalin|mesh-list
110201707|NCT00150436|Analgesics|analgesics|mesh-ancestor
110063923|NCT00092222|Antiviral Agents|antiviral agents|mesh-ancestor
110201708|NCT00150436|Sensory System Agents|sensory system agents|mesh-ancestor
110201709|NCT00150436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110201710|NCT00150436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110201711|NCT00150436|Anticonvulsants|anticonvulsants|mesh-ancestor
110201712|NCT00150436|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110201713|NCT00150436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110201714|NCT00150436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201715|NCT00150436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110201716|NCT00150436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110201717|NCT00150436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110201718|NCT00150436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110201719|NCT00150436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110201720|NCT00150553|Carbamazepine|carbamazepine|mesh-list
110201721|NCT00150553|Anticonvulsants|anticonvulsants|mesh-ancestor
110201722|NCT00150553|Antimanic Agents|antimanic agents|mesh-ancestor
110201723|NCT00150553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110201724|NCT00150553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110201725|NCT00150553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110201726|NCT00150553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110201727|NCT00150553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110201728|NCT00150553|Analgesics|analgesics|mesh-ancestor
110201729|NCT00150553|Sensory System Agents|sensory system agents|mesh-ancestor
110201730|NCT00150553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110201731|NCT00150553|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110201732|NCT00150553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110201733|NCT00150553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201734|NCT00150553|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110201735|NCT00150553|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110201736|NCT00150631|Candesartan|candesartan|mesh-list
110201737|NCT00150631|Candesartan cilexetil|candesartan cilexetil|mesh-list
110201738|NCT00150631|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110201739|NCT00150631|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110201740|NCT00150631|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110201741|NCT00150631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201742|NCT00082446|Vaccines|vaccines|mesh-list
110201743|NCT00082446|Immunologic Factors|immunologic factors|mesh-ancestor
110201744|NCT00082446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110201745|NCT00049439|Cyclophosphamide|cyclophosphamide|mesh-list
110201746|NCT00049439|Lomustine|lomustine|mesh-list
110201747|NCT00049439|Etoposide|etoposide|mesh-list
110201748|NCT00049439|Procarbazine|procarbazine|mesh-list
110201749|NCT00049439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110201750|NCT00049439|Immunologic Factors|immunologic factors|mesh-ancestor
110201751|NCT00049439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110201752|NCT00049439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110201753|NCT00049439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110201754|NCT00049439|Alkylating Agents|alkylating agents|mesh-ancestor
110201755|NCT00049439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201756|NCT00049439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110201757|NCT00049439|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110201758|NCT00049439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110201759|NCT00049439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110201760|NCT00049439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110201761|NCT00049439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110201762|NCT00150670|Cisplatin|cisplatin|mesh-list
110201763|NCT00150670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110201764|NCT00150709|Levetiracetam|levetiracetam|mesh-list
110201765|NCT00150709|Anticonvulsants|anticonvulsants|mesh-ancestor
110201766|NCT00150709|Nootropic Agents|nootropic agents|mesh-ancestor
110201767|NCT00150748|Levetiracetam|levetiracetam|mesh-list
110201768|NCT00150748|Anticonvulsants|anticonvulsants|mesh-ancestor
110201769|NCT00150748|Nootropic Agents|nootropic agents|mesh-ancestor
110201770|NCT00150787|Levetiracetam|levetiracetam|mesh-list
110063940|NCT00025935|Lithium Carbonate|lithium carbonate|mesh-list
110063941|NCT00025935|Antidepressive Agents|antidepressive agents|mesh-ancestor
110063942|NCT00025935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110063943|NCT00025935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110063945|NCT00025935|Antimanic Agents|antimanic agents|mesh-ancestor
110201771|NCT00150787|Anticonvulsants|anticonvulsants|mesh-ancestor
110201772|NCT00150787|Nootropic Agents|nootropic agents|mesh-ancestor
110201773|NCT00150826|Quinapril|quinapril|mesh-list
110201774|NCT00150826|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110201775|NCT00150826|Protease Inhibitors|protease inhibitors|mesh-ancestor
110201776|NCT00150826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110201777|NCT00150826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201778|NCT00150826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110201779|NCT00150865|Ropivacaine|ropivacaine|mesh-list
110201780|NCT00150865|Anesthetics, Local|anesthetics, local|mesh-ancestor
110201781|NCT00150865|Anesthetics|anesthetics|mesh-ancestor
110201782|NCT00150865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110201783|NCT00150865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110201784|NCT00150865|Sensory System Agents|sensory system agents|mesh-ancestor
110201785|NCT00150865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110201786|NCT00049556|Gefitinib|gefitinib|mesh-list
110201787|NCT00049556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110201788|NCT00049556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110201789|NCT00049556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110201790|NCT00049556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201791|NCT00150982|Alefacept|alefacept|mesh-list
110201792|NCT00150982|Dermatologic Agents|dermatologic agents|mesh-ancestor
110201793|NCT00150982|Immunologic Factors|immunologic factors|mesh-ancestor
110201794|NCT00150982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110201795|NCT00049634|Cyclosporine|cyclosporine|mesh-list
110201796|NCT00049634|Cyclophosphamide|cyclophosphamide|mesh-list
110201797|NCT00049634|Busulfan|busulfan|mesh-list
110201798|NCT00049634|Methotrexate|methotrexate|mesh-list
110201799|NCT00049634|Cyclosporins|cyclosporins|mesh-list
110201800|NCT00049634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110201801|NCT00049634|Immunologic Factors|immunologic factors|mesh-ancestor
110201802|NCT00049634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110201803|NCT00049634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110201804|NCT00049634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110201805|NCT00049634|Alkylating Agents|alkylating agents|mesh-ancestor
110201806|NCT00049634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201807|NCT00049634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110201808|NCT00049634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110201809|NCT00049634|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110201810|NCT00049634|Abortifacient Agents|abortifacient agents|mesh-ancestor
110201811|NCT00049634|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110201812|NCT00049634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110201813|NCT00049634|Antimetabolites|antimetabolites|mesh-ancestor
110201814|NCT00049634|Dermatologic Agents|dermatologic agents|mesh-ancestor
110201815|NCT00049634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110201816|NCT00049634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110201817|NCT00049634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110201818|NCT00049634|Antifungal Agents|antifungal agents|mesh-ancestor
110201819|NCT00049634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110201820|NCT00049634|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110201822|NCT00151060|Etoposide|etoposide|mesh-list
110201823|NCT00151060|Estramustine|estramustine|mesh-list
110201824|NCT00151060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110201825|NCT00151060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110201826|NCT00151060|Tubulin Modulators|tubulin modulators|mesh-ancestor
110201827|NCT00151060|Antimitotic Agents|antimitotic agents|mesh-ancestor
110201828|NCT00151060|Mitosis Modulators|mitosis modulators|mesh-ancestor
110201829|NCT00151060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201830|NCT00151060|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110201831|NCT00151060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110201832|NCT00151060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110201833|NCT00151060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110220921|NCT00119730|Rituximab|rituximab|mesh-list
110201835|NCT00151060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110201836|NCT00151138|Atenolol|atenolol|mesh-list
110063946|NCT00025935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110063947|NCT00025935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110063948|NCT00025935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110201837|NCT00151138|Lisinopril|lisinopril|mesh-list
110201838|NCT00151138|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110201839|NCT00151138|Protease Inhibitors|protease inhibitors|mesh-ancestor
110201840|NCT00151138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110201841|NCT00151138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201842|NCT00151138|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110201843|NCT00151138|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110201844|NCT00151138|Protective Agents|protective agents|mesh-ancestor
110201845|NCT00151138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110201846|NCT00151138|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110201847|NCT00151138|Sympatholytics|sympatholytics|mesh-ancestor
110201848|NCT00151138|Autonomic Agents|autonomic agents|mesh-ancestor
110201849|NCT00151138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110201850|NCT00151138|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110201851|NCT00151138|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110201852|NCT00151138|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110201853|NCT00151138|Adrenergic Agents|adrenergic agents|mesh-ancestor
110201854|NCT00151138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110201856|NCT00082485|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110201857|NCT00082485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110201858|NCT00082485|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110368625|NCT05419583|Antithrombins|antithrombins|mesh-ancestor
110201859|NCT00082485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110201860|NCT00082485|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110201861|NCT00082485|GABA Agonists|gaba agonists|mesh-ancestor
110201862|NCT00082485|GABA Agents|gaba agents|mesh-ancestor
110201863|NCT00082485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110201864|NCT00082485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201865|NCT00151255|Cytarabine|cytarabine|mesh-list
110201866|NCT00151255|Mitoxantrone|mitoxantrone|mesh-list
110201867|NCT00151255|Idarubicin|idarubicin|mesh-list
110201868|NCT00151255|Tretinoin|tretinoin|mesh-list
110201869|NCT00151255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110201871|NCT00151255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201872|NCT00151255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110201873|NCT00151255|Antiviral Agents|antiviral agents|mesh-ancestor
110201874|NCT00151255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110201875|NCT00151255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110201876|NCT00151255|Immunologic Factors|immunologic factors|mesh-ancestor
110201877|NCT00151255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110201878|NCT00151255|Analgesics|analgesics|mesh-ancestor
110201879|NCT00151255|Sensory System Agents|sensory system agents|mesh-ancestor
110201880|NCT00151255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110201881|NCT00151255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110201882|NCT00151255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110201883|NCT00151255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110201884|NCT00151255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110201885|NCT00151255|Keratolytic Agents|keratolytic agents|mesh-ancestor
110201886|NCT00151255|Dermatologic Agents|dermatologic agents|mesh-ancestor
110201888|NCT00049751|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110201889|NCT00049751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110201890|NCT00049751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110201891|NCT00151294|Dexetimide|dexetimide|mesh-list
110201892|NCT00151294|Citalopram|citalopram|mesh-list
110201893|NCT00151294|Antidepressive Agents|antidepressive agents|mesh-list
110201894|NCT00151294|Escitalopram|escitalopram|mesh-list
110201895|NCT00151294|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110220925|NCT00119730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110201896|NCT00151294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110201897|NCT00151294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110201898|NCT00151294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201899|NCT00151294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110201900|NCT00151294|Serotonin Agents|serotonin agents|mesh-ancestor
110201901|NCT00151294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110201902|NCT00151294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110201903|NCT00151294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110201904|NCT00151294|Parasympatholytics|parasympatholytics|mesh-ancestor
110201905|NCT00151294|Autonomic Agents|autonomic agents|mesh-ancestor
110201906|NCT00151294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110201907|NCT00151294|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110201908|NCT00151294|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110201909|NCT00151294|Cholinergic Agents|cholinergic agents|mesh-ancestor
110201910|NCT00151294|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110201911|NCT00151294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110201913|NCT00151450|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110201914|NCT00151450|Analgesics|analgesics|mesh-ancestor
110201915|NCT00151450|Sensory System Agents|sensory system agents|mesh-ancestor
110201916|NCT00151450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110201917|NCT00151450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110201918|NCT00151450|Anticonvulsants|anticonvulsants|mesh-ancestor
110201919|NCT00151450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110201920|NCT00151450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110201921|NCT00151450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201922|NCT00151450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110201923|NCT00151450|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110201924|NCT00151450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110201925|NCT00151450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110201926|NCT00151450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110201927|NCT00151450|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110201928|NCT00151450|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110201929|NCT00151450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110201930|NCT00151450|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110201931|NCT00151450|Antidepressive Agents|antidepressive agents|mesh-ancestor
110201933|NCT00151489|Analgesics|analgesics|mesh-ancestor
110201934|NCT00151489|Sensory System Agents|sensory system agents|mesh-ancestor
110201935|NCT00151489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110201936|NCT00151489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110201937|NCT00151489|Anticonvulsants|anticonvulsants|mesh-ancestor
110201938|NCT00151489|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110201939|NCT00151489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110201940|NCT00151489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201941|NCT00151489|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110201942|NCT00151489|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110201943|NCT00151489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110201944|NCT00151489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110201945|NCT00151489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110201947|NCT00049790|Carboplatin|carboplatin|mesh-list
110201948|NCT00049790|Angiostatins|angiostatins|mesh-list
110201955|NCT00049790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110201956|NCT00049790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110201957|NCT00049790|Growth Substances|growth substances|mesh-ancestor
110201958|NCT00049790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110201959|NCT00049790|Growth Inhibitors|growth inhibitors|mesh-ancestor
110201960|NCT00082524|Caspofungin|caspofungin|mesh-list
110201961|NCT00082524|Antifungal Agents|antifungal agents|mesh-ancestor
110201962|NCT00082524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110201963|NCT00082524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110201964|NCT00082524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201965|NCT00406003|Paroxetine|paroxetine|mesh-list
110201966|NCT00406003|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110201967|NCT00406003|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110201968|NCT00406003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110201969|NCT00406003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201970|NCT00406003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110201971|NCT00406003|Serotonin Agents|serotonin agents|mesh-ancestor
110201972|NCT00406003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110201973|NCT00406003|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110201974|NCT00406003|Antidepressive Agents|antidepressive agents|mesh-ancestor
110201975|NCT00406003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110019016|NCT01031550|Propofol|propofol|mesh-list
110201976|NCT00406003|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110201977|NCT00406003|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110201978|NCT00406003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110201979|NCT00049829|Zoledronic Acid|zoledronic acid|mesh-list
110201980|NCT00049829|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110201981|NCT00049829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110201982|NCT00406042|Prednisolone|prednisolone|mesh-list
110201983|NCT00406042|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110201984|NCT00406042|Methylprednisolone|methylprednisolone|mesh-list
110201985|NCT00406042|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110201986|NCT00406042|Prednisolone acetate|prednisolone acetate|mesh-list
110201987|NCT00406042|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110201988|NCT00406042|Prednisolone phosphate|prednisolone phosphate|mesh-list
110201989|NCT00406042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110201990|NCT00406042|Glucocorticoids|glucocorticoids|mesh-ancestor
110201992|NCT00406042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110201993|NCT00406042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110201994|NCT00406042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110201995|NCT00406042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110201996|NCT00406042|Antiemetics|antiemetics|mesh-ancestor
110201997|NCT00406042|Autonomic Agents|autonomic agents|mesh-ancestor
110201998|NCT00406042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110201999|NCT00406042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110202000|NCT00406042|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110202001|NCT00406042|Protective Agents|protective agents|mesh-ancestor
110202002|NCT00082563|Azithromycin|azithromycin|mesh-list
110202003|NCT00082563|Chloroquine|chloroquine|mesh-list
110202004|NCT00082563|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
110202005|NCT00082563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110202006|NCT00082563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110202007|NCT00082563|Amebicides|amebicides|mesh-ancestor
110202008|NCT00082563|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110202009|NCT00082563|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110202010|NCT00082563|Antimalarials|antimalarials|mesh-ancestor
110202011|NCT00082563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110202012|NCT00082563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110202013|NCT00082563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110202014|NCT00082563|Analgesics|analgesics|mesh-ancestor
110202015|NCT00082563|Sensory System Agents|sensory system agents|mesh-ancestor
110202016|NCT00082563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110202017|NCT00082563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110202018|NCT00082563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110202019|NCT00082563|Filaricides|filaricides|mesh-ancestor
110202020|NCT00082563|Antinematodal Agents|antinematodal agents|mesh-ancestor
110202021|NCT00082563|Anthelmintics|anthelmintics|mesh-ancestor
110202022|NCT00151528|Pregabalin|pregabalin|mesh-list
110202023|NCT00151528|Analgesics|analgesics|mesh-ancestor
110202024|NCT00151528|Sensory System Agents|sensory system agents|mesh-ancestor
110202025|NCT00151528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110202026|NCT00151528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110202027|NCT00151528|Anticonvulsants|anticonvulsants|mesh-ancestor
110202028|NCT00151528|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110202029|NCT00151528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110202030|NCT00151528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110202031|NCT00151528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110202032|NCT00151528|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110202033|NCT00151528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110202034|NCT00151528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110202035|NCT00151528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110202037|NCT00397787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110202038|NCT00397787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110202039|NCT00397787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110202040|NCT00397787|Growth Substances|growth substances|mesh-ancestor
110202041|NCT00397787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110202042|NCT00397787|Growth Inhibitors|growth inhibitors|mesh-ancestor
110202043|NCT00397787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110202044|NCT00397787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110202045|NCT00397787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110202046|NCT00082602|Galantamine|galantamine|mesh-list
110202047|NCT00082602|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110202048|NCT00082602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110202049|NCT00082602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110202050|NCT00082602|Cholinergic Agents|cholinergic agents|mesh-ancestor
110202051|NCT00082602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110202052|NCT00082602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110202053|NCT00082602|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110202055|NCT00082602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110202056|NCT00082602|Nootropic Agents|nootropic agents|mesh-ancestor
110202057|NCT00151567|Tamsulosin|tamsulosin|mesh-list
110202058|NCT00151567|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110202059|NCT00151567|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110202060|NCT00151567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110202061|NCT00151567|Adrenergic Agents|adrenergic agents|mesh-ancestor
110202063|NCT00151567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110202064|NCT00151567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110202065|NCT00151567|Urological Agents|urological agents|mesh-ancestor
110202066|NCT00397826|Simvastatin|simvastatin|mesh-list
110202067|NCT00397826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110202068|NCT00397826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110202069|NCT00397826|Antimetabolites|antimetabolites|mesh-ancestor
110202070|NCT00397826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110202071|NCT00397826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110202072|NCT00397826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110202073|NCT00397826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110202075|NCT00151684|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110202076|NCT00151684|Vasodilator Agents|vasodilator agents|mesh-ancestor
110202077|NCT00151762|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
110202078|NCT00151762|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110202079|NCT00151762|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110202080|NCT00151762|Antimetabolites|antimetabolites|mesh-ancestor
110202081|NCT00151762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110202082|NCT00151762|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110202084|NCT00151801|Interferon-beta|interferon-beta|mesh-list
110202085|NCT00151801|Interferon beta-1a|interferon beta-1a|mesh-list
110202086|NCT00151801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110202087|NCT00151801|Antiviral Agents|antiviral agents|mesh-ancestor
110202088|NCT00151801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110202089|NCT00151801|Immunologic Factors|immunologic factors|mesh-ancestor
110202090|NCT00151801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110202091|NCT00151801|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110202092|NCT04725253|Niacinamide|niacinamide|mesh-list
110202093|NCT04725253|Niacin|niacin|mesh-list
110202094|NCT04725253|Nicotinic Acids|nicotinic acids|mesh-list
110202095|NCT04725253|Vitamin B Complex|vitamin b complex|mesh-ancestor
110202096|NCT04725253|Vitamins|vitamins|mesh-ancestor
110202097|NCT04725253|Micronutrients|micronutrients|mesh-ancestor
110202098|NCT04725253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110202099|NCT04725253|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110202100|NCT04725253|Antimetabolites|antimetabolites|mesh-ancestor
110202101|NCT04725253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110202102|NCT04725253|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110202103|NCT04725253|Vasodilator Agents|vasodilator agents|mesh-ancestor
110202104|NCT00082719|Interferons|interferons|mesh-list
110202105|NCT00082719|Interferon-alpha|interferon-alpha|mesh-list
110202106|NCT00082719|Interferon alpha-2|interferon alpha-2|mesh-list
110202107|NCT00082719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110202108|NCT00082719|Antiviral Agents|antiviral agents|mesh-ancestor
110202109|NCT00082719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110202110|NCT00082719|Immunologic Factors|immunologic factors|mesh-ancestor
110202111|NCT00082719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110202112|NCT00151957|Methylphenidate|methylphenidate|mesh-list
110202113|NCT00151957|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110202114|NCT00151957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110202115|NCT00151957|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110202116|NCT00151957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110202117|NCT00151957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110202118|NCT00151957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110202119|NCT00151957|Dopamine Agents|dopamine agents|mesh-ancestor
110202120|NCT00151957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110202122|NCT00049946|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110202123|NCT00049946|Serotonin Agents|serotonin agents|mesh-ancestor
110202124|NCT00049946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110202125|NCT00049946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110202126|NCT00049946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110202127|NCT00049946|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110202128|NCT00049946|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110202129|NCT00049946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110202130|NCT00049946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110202131|NCT00049946|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110202132|NCT00049946|Dopamine Agents|dopamine agents|mesh-ancestor
110202133|NCT00152035|Amphetamine|amphetamine|mesh-list
110202134|NCT00152035|Dextroamphetamine|dextroamphetamine|mesh-list
110202135|NCT00152035|Adderall|adderall|mesh-list
110202136|NCT00152035|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110202137|NCT00152035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110202138|NCT00152035|Sympathomimetics|sympathomimetics|mesh-ancestor
110202139|NCT00152035|Autonomic Agents|autonomic agents|mesh-ancestor
110202140|NCT00152035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110202141|NCT00152035|Dopamine Agents|dopamine agents|mesh-ancestor
110202142|NCT00152035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110202143|NCT00152035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110202144|NCT00152035|Adrenergic Agents|adrenergic agents|mesh-ancestor
110202145|NCT00152035|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110202146|NCT00152035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110202147|NCT00152035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110202148|NCT00152035|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110202149|NCT00049985|Darbepoetin alfa|darbepoetin alfa|mesh-list
110202150|NCT00049985|Hematinics|hematinics|mesh-ancestor
110202151|NCT00152191|Cyclophosphamide|cyclophosphamide|mesh-list
110202152|NCT00152191|Fluorouracil|fluorouracil|mesh-list
110202153|NCT00152191|Methotrexate|methotrexate|mesh-list
110202154|NCT00152191|Tegafur|tegafur|mesh-list
110202155|NCT00152191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110202156|NCT00152191|Immunologic Factors|immunologic factors|mesh-ancestor
110202157|NCT00152191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110202158|NCT00152191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110202159|NCT00152191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110202160|NCT00152191|Alkylating Agents|alkylating agents|mesh-ancestor
110202161|NCT00152191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110202162|NCT00152191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110202163|NCT00152191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110202164|NCT00152191|Antimetabolites|antimetabolites|mesh-ancestor
110202165|NCT00152191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110202166|NCT00152191|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110202167|NCT00152191|Abortifacient Agents|abortifacient agents|mesh-ancestor
110202168|NCT00152191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110202169|NCT00152191|Dermatologic Agents|dermatologic agents|mesh-ancestor
110202170|NCT00152191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110202171|NCT00152191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110202172|NCT00152191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110202174|NCT00152230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110202175|NCT00152230|Antimetabolites|antimetabolites|mesh-ancestor
110202176|NCT00152230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110202178|NCT00152308|Sirolimus|sirolimus|mesh-list
110202179|NCT00152308|Ethanol|ethanol|mesh-list
110202180|NCT00152308|Temsirolimus|temsirolimus|mesh-list
110202181|NCT00152308|MTOR Inhibitors|mtor inhibitors|mesh-list
110202182|NCT00152308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110202183|NCT00152308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110202184|NCT00152308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110202185|NCT00152308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110202186|NCT00152308|Antifungal Agents|antifungal agents|mesh-ancestor
110202187|NCT00152308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110202188|NCT00152308|Immunologic Factors|immunologic factors|mesh-ancestor
110202189|NCT00152308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110202190|NCT00152308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110202191|NCT00152308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110202192|NCT00152308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110202193|NCT00152308|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110202194|NCT00152308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110202195|NCT00152386|Certolizumab Pegol|certolizumab pegol|mesh-list
110202196|NCT00152386|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110202197|NCT00152386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110202198|NCT00152386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110202199|NCT00152386|Immunologic Factors|immunologic factors|mesh-ancestor
110202200|NCT00152386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110202201|NCT00152386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110202203|NCT00082836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110202204|NCT00082836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110202205|NCT00082836|Immunologic Factors|immunologic factors|mesh-ancestor
110202206|NCT00082836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110202207|NCT00082836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110202208|NCT00152425|Certolizumab Pegol|certolizumab pegol|mesh-list
110202209|NCT00152425|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110202210|NCT00152425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110202211|NCT00152425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110202212|NCT00152425|Immunologic Factors|immunologic factors|mesh-ancestor
110202213|NCT00152425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110202214|NCT00152425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110202215|NCT00152542|Nitric Oxide|nitric oxide|mesh-list
110202216|NCT00152542|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110202217|NCT00152542|Autonomic Agents|autonomic agents|mesh-ancestor
110202218|NCT00152542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110202219|NCT00152542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110202220|NCT00152542|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110202221|NCT00152542|Respiratory System Agents|respiratory system agents|mesh-ancestor
110202222|NCT00152542|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110202224|NCT00152542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110202225|NCT00152542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110202226|NCT00152542|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110202227|NCT00152542|Vasodilator Agents|vasodilator agents|mesh-ancestor
110202228|NCT00152542|Gasotransmitters|gasotransmitters|mesh-ancestor
110202229|NCT00152542|Protective Agents|protective agents|mesh-ancestor
110202230|NCT00043680|Celecoxib|celecoxib|mesh-list
110202231|NCT00043680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110202232|NCT00043680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110202233|NCT00043680|Analgesics|analgesics|mesh-ancestor
110202234|NCT00043680|Sensory System Agents|sensory system agents|mesh-ancestor
110202235|NCT00043680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110202236|NCT00043680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110202237|NCT00043680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110202238|NCT00043680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110202239|NCT00043680|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110202240|NCT00043680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110202241|NCT00043680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110202242|NCT00043680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110202243|NCT00152581|Interferons|interferons|mesh-list
110202244|NCT00152581|Ribavirin|ribavirin|mesh-list
110202245|NCT00152581|Interferon-alpha|interferon-alpha|mesh-list
110202246|NCT00152581|Interferon alpha-2|interferon alpha-2|mesh-list
110202247|NCT00152581|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110202248|NCT00152581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110202249|NCT00152581|Antiviral Agents|antiviral agents|mesh-ancestor
110202250|NCT00152581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110202251|NCT00152581|Antimetabolites|antimetabolites|mesh-ancestor
110202252|NCT00152581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110202253|NCT00152581|Immunologic Factors|immunologic factors|mesh-ancestor
110202254|NCT00152581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110202255|NCT00152620|Dexamethasone|dexamethasone|mesh-list
110202257|NCT00152620|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110202258|NCT00152620|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110202259|NCT00152620|Prednisolone|prednisolone|mesh-list
110202260|NCT00152620|Prednisolone acetate|prednisolone acetate|mesh-list
110202261|NCT00152620|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110202262|NCT00152620|Prednisolone phosphate|prednisolone phosphate|mesh-list
110202263|NCT00152620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110202264|NCT00152620|Antiemetics|antiemetics|mesh-ancestor
110202265|NCT00152620|Autonomic Agents|autonomic agents|mesh-ancestor
110202266|NCT00152620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110202267|NCT00152620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110202268|NCT00152620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110202269|NCT00152620|Glucocorticoids|glucocorticoids|mesh-ancestor
110202270|NCT00152620|Hormones|hormones|mesh-ancestor
110202271|NCT00152620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110202272|NCT00152620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110202273|NCT00152620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110202274|NCT00152620|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110202275|NCT00152620|Protective Agents|protective agents|mesh-ancestor
110202276|NCT00050141|Tipifarnib|tipifarnib|mesh-list
110202277|NCT00050141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110202278|NCT04725214|Temozolomide|temozolomide|mesh-list
110202279|NCT04725214|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110202281|NCT04725214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110202282|NCT04725214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110202284|NCT00050180|Saquinavir|saquinavir|mesh-list
110202285|NCT00050180|Midazolam|midazolam|mesh-list
110202286|NCT00050180|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110202287|NCT00050180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110202288|NCT00050180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110202289|NCT00050180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110202290|NCT00050180|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110202291|NCT00050180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110202292|NCT00050180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110202293|NCT00050180|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110202294|NCT00050180|Anesthetics, General|anesthetics, general|mesh-ancestor
110202295|NCT00050180|Anesthetics|anesthetics|mesh-ancestor
110202296|NCT00050180|GABA Modulators|gaba modulators|mesh-ancestor
110202297|NCT00050180|GABA Agents|gaba agents|mesh-ancestor
110202298|NCT00050180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110202299|NCT00050180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110202300|NCT00050180|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110202301|NCT00050180|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110202302|NCT00050180|Protease Inhibitors|protease inhibitors|mesh-ancestor
110202303|NCT00050180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110202304|NCT00050180|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110202305|NCT00050180|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110202306|NCT00050180|Antiviral Agents|antiviral agents|mesh-ancestor
110202307|NCT00050180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110202308|NCT00050180|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110202309|NCT00050180|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110202310|NCT00082914|Denileukin diftitox|denileukin diftitox|mesh-list
110202311|NCT00082914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110202313|NCT00152815|Antioxidants|antioxidants|mesh-list
110202314|NCT00152815|Vitamins|vitamins|mesh-ancestor
110202315|NCT00152815|Micronutrients|micronutrients|mesh-ancestor
110202316|NCT00152815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110202317|NCT00152815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110202318|NCT00152815|Protective Agents|protective agents|mesh-ancestor
110202320|NCT00043719|Nitroglycerin|nitroglycerin|mesh-list
110202321|NCT00043719|Calcium|calcium|mesh-list
110202322|NCT00043719|Vitamins|vitamins|mesh-ancestor
110202323|NCT00043719|Micronutrients|micronutrients|mesh-ancestor
110202324|NCT00043719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110202325|NCT00043719|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110202326|NCT00043719|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110202327|NCT00043719|Vasodilator Agents|vasodilator agents|mesh-ancestor
110202328|NCT00152854|Acetaminophen|acetaminophen|mesh-list
110202329|NCT00152854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110202330|NCT00152854|Analgesics|analgesics|mesh-ancestor
110202331|NCT00152854|Sensory System Agents|sensory system agents|mesh-ancestor
110202332|NCT00152854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110202333|NCT00152854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110202334|NCT00152854|Antipyretics|antipyretics|mesh-ancestor
110202335|NCT00050297|N-(6-methoxy-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl)-2-phenylethenesulfonamide|n-(6-methoxy-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl)-2-phenylethenesulfonamide|mesh-list
110202336|NCT00050297|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110202337|NCT00050297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110202338|NCT00152893|Chromium|chromium|mesh-list
110202339|NCT00152893|Niacin|niacin|mesh-list
110202340|NCT00152893|Trace Elements|trace elements|mesh-ancestor
110220975|NCT00086463|Iloprost|iloprost|mesh-list
110202342|NCT00152893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110202343|NCT00152893|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110202344|NCT00152893|Antimetabolites|antimetabolites|mesh-ancestor
110202345|NCT00152893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110202346|NCT00152893|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110202347|NCT00152893|Vasodilator Agents|vasodilator agents|mesh-ancestor
110202348|NCT00152893|Vitamin B Complex|vitamin b complex|mesh-ancestor
110202349|NCT00152893|Vitamins|vitamins|mesh-ancestor
110202350|NCT00152932|Dorzolamide|dorzolamide|mesh-list
110202351|NCT00152932|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110202352|NCT00152932|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110202353|NCT00152932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110202354|NCT00152932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110202355|NCT00083031|Cyclophosphamide|cyclophosphamide|mesh-list
110202356|NCT00083031|Bevacizumab|bevacizumab|mesh-list
110202357|NCT00083031|Methotrexate|methotrexate|mesh-list
110202358|NCT00083031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110202359|NCT00083031|Immunologic Factors|immunologic factors|mesh-ancestor
110202360|NCT00083031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110202361|NCT00083031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110202362|NCT00083031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110202363|NCT00083031|Alkylating Agents|alkylating agents|mesh-ancestor
110202364|NCT00083031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110202365|NCT00083031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110202366|NCT00083031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110202367|NCT00083031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110202368|NCT00083031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110202369|NCT00083031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110202370|NCT00083031|Growth Substances|growth substances|mesh-ancestor
110202371|NCT00083031|Growth Inhibitors|growth inhibitors|mesh-ancestor
110202372|NCT00083031|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110202373|NCT00083031|Abortifacient Agents|abortifacient agents|mesh-ancestor
110202374|NCT00083031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110202375|NCT00083031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110202376|NCT00083031|Antimetabolites|antimetabolites|mesh-ancestor
110202377|NCT00083031|Dermatologic Agents|dermatologic agents|mesh-ancestor
110202378|NCT00083031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110202379|NCT00083031|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110202380|NCT00083031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110202381|NCT00050336|Lonafarnib|lonafarnib|mesh-list
110202382|NCT00050336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110202383|NCT00050336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110202385|NCT00043758|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110202386|NCT00043758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110202387|NCT00043758|Natriuretic Agents|natriuretic agents|mesh-ancestor
110202388|NCT00043758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110202389|NCT00050375|Oregovomab|oregovomab|mesh-list
110202390|NCT00050375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110202391|NCT00050375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110202392|NCT00153049|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110202393|NCT00153049|Telmisartan|telmisartan|mesh-list
110202394|NCT00153049|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
110202395|NCT00153049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110202396|NCT00153049|Diuretics|diuretics|mesh-ancestor
110202397|NCT00153049|Natriuretic Agents|natriuretic agents|mesh-ancestor
110202398|NCT00153049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110202399|NCT00153049|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110202400|NCT00153049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110202401|NCT00153049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110202402|NCT00153049|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110202403|NCT00153049|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110202404|NCT00153088|Telmisartan|telmisartan|mesh-list
110202405|NCT00153088|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110202406|NCT00153088|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110202407|NCT00153088|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110202408|NCT00153088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110202409|NCT00083070|Temozolomide|temozolomide|mesh-list
110202410|NCT00083070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110202411|NCT00083070|Alkylating Agents|alkylating agents|mesh-ancestor
110202412|NCT00083070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110202413|NCT00083070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110202414|NCT00050414|Dexamethasone|dexamethasone|mesh-list
110202415|NCT00050414|Trabectedin|trabectedin|mesh-list
110202416|NCT00050414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110202417|NCT00050414|Antiemetics|antiemetics|mesh-ancestor
110202418|NCT00050414|Autonomic Agents|autonomic agents|mesh-ancestor
110202419|NCT00050414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110202420|NCT00050414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110202421|NCT00050414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110202422|NCT00050414|Glucocorticoids|glucocorticoids|mesh-ancestor
110202424|NCT00050414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110202425|NCT00050414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110202426|NCT00050414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110202427|NCT00050414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110202428|NCT00050414|Alkylating Agents|alkylating agents|mesh-ancestor
110202429|NCT00050414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110202430|NCT00153127|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
110202431|NCT00153127|Laxatives|laxatives|mesh-ancestor
110202432|NCT00153127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110202433|NCT00083109|Suramin|suramin|mesh-list
110202434|NCT00083109|Fluorouracil|fluorouracil|mesh-list
110202435|NCT00083109|Antimetabolites|antimetabolites|mesh-ancestor
110202436|NCT00083109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110202437|NCT00083109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110202438|NCT00083109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110202439|NCT00083109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110202440|NCT00083109|Immunologic Factors|immunologic factors|mesh-ancestor
110202441|NCT00083109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110202443|NCT00083109|Anthelmintics|anthelmintics|mesh-ancestor
110202444|NCT00083109|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110202445|NCT00083109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110202446|NCT00083109|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110202447|NCT00083109|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110202448|NCT00153244|Lamotrigine|lamotrigine|mesh-list
110202449|NCT00153244|Anticonvulsants|anticonvulsants|mesh-ancestor
110202450|NCT00153244|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110202451|NCT00153244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110202452|NCT00153244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110202453|NCT00153244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110202454|NCT00153244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110202455|NCT00153244|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110202456|NCT00153244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110202457|NCT00153244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110202458|NCT00153244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110202459|NCT00153244|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110202460|NCT00153283|Gabapentin|gabapentin|mesh-list
110202461|NCT00153283|Analgesics|analgesics|mesh-ancestor
110221006|NCT00300586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110202462|NCT00153283|Sensory System Agents|sensory system agents|mesh-ancestor
110202463|NCT00153283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110202464|NCT00153283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110202466|NCT00153283|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110202467|NCT00153283|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110202468|NCT00153283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110202469|NCT00153283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110202470|NCT00153283|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110202471|NCT00153283|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110202472|NCT00153283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110202473|NCT00153283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110202474|NCT00153283|Antimanic Agents|antimanic agents|mesh-ancestor
110202476|NCT00050531|Interferon-alpha|interferon-alpha|mesh-list
110202477|NCT00050531|Interferon alpha-2|interferon alpha-2|mesh-list
110202478|NCT00050531|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110202479|NCT00050531|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
110202480|NCT00050531|Imatinib Mesylate|imatinib mesylate|mesh-list
110202481|NCT00050531|Molgramostim|molgramostim|mesh-list
110202482|NCT00050531|Sargramostim|sargramostim|mesh-list
110202483|NCT00050531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110202485|NCT00050531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110202486|NCT00050531|Immunologic Factors|immunologic factors|mesh-ancestor
110202487|NCT00050531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110202488|NCT00050531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110202489|NCT00050531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110202490|NCT00050531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110202491|NCT00083148|Capecitabine|capecitabine|mesh-list
110202492|NCT00083148|Irinotecan|irinotecan|mesh-list
110202493|NCT00083148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110202494|NCT00083148|Antimetabolites|antimetabolites|mesh-ancestor
110202495|NCT00083148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110202496|NCT00083148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110202498|NCT00083148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110202499|NCT00083148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110202501|NCT00153517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110202502|NCT00153517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110202503|NCT00153517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110202505|NCT00153556|Vaccines|vaccines|mesh-list
110202506|NCT00153556|Immunologic Factors|immunologic factors|mesh-ancestor
110202507|NCT00153556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110202508|NCT00083187|Hydroxyurea|hydroxyurea|mesh-list
110202509|NCT00083187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110202510|NCT00083187|Antisickling Agents|antisickling agents|mesh-ancestor
110202511|NCT00083187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110202512|NCT00083187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110202513|NCT00083187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110202515|NCT00153634|Ciprofloxacin|ciprofloxacin|mesh-list
110202516|NCT00153634|Meropenem|meropenem|mesh-list
110202517|NCT00153634|Tazobactam|tazobactam|mesh-list
110202518|NCT00153634|Piperacillin|piperacillin|mesh-list
110202519|NCT00153634|Tobramycin|tobramycin|mesh-list
110202520|NCT00153634|Clavulanic Acid|clavulanic acid|mesh-list
110202521|NCT00153634|Amikacin|amikacin|mesh-list
110202522|NCT00153634|Ceftazidime|ceftazidime|mesh-list
110202523|NCT00153634|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
110202524|NCT00153634|Ticarcillin|ticarcillin|mesh-list
110202525|NCT00153634|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
110202526|NCT00153634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110202527|NCT00153634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110202528|NCT00153634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110202529|NCT00153634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110202530|NCT00153634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110202531|NCT00153634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110202532|NCT00153634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110202533|NCT00153634|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110202534|NCT00153634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110202535|NCT00153634|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110202536|NCT00050609|Tadalafil|tadalafil|mesh-list
110202537|NCT00050609|Vasodilator Agents|vasodilator agents|mesh-ancestor
110202538|NCT00050609|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110202539|NCT00050609|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110202540|NCT00050609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110202541|NCT00050609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110202542|NCT00050609|Urological Agents|urological agents|mesh-ancestor
110202544|NCT00153673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110202545|NCT00153673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110202546|NCT00153673|Analgesics|analgesics|mesh-ancestor
110202547|NCT00153673|Sensory System Agents|sensory system agents|mesh-ancestor
110202548|NCT00153673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110202549|NCT00153673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110202550|NCT00153673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110202551|NCT00153673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110202552|NCT00153673|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110202553|NCT00153673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110202554|NCT00153673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110202555|NCT00153673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110202556|NCT00050648|Cyclosporine|cyclosporine|mesh-list
110202557|NCT00050648|Cyclosporins|cyclosporins|mesh-list
110202558|NCT00050648|Daclizumab|daclizumab|mesh-list
110202559|NCT00050648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110202560|NCT00050648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110202561|NCT00050648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110202562|NCT00050648|Immunologic Factors|immunologic factors|mesh-ancestor
110202563|NCT00050648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110202564|NCT00050648|Antifungal Agents|antifungal agents|mesh-ancestor
110202565|NCT00050648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110202566|NCT00050648|Dermatologic Agents|dermatologic agents|mesh-ancestor
110202567|NCT00050648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110202568|NCT00050648|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110202569|NCT00153868|Darbepoetin alfa|darbepoetin alfa|mesh-list
110202570|NCT00153868|Hematinics|hematinics|mesh-ancestor
110202571|NCT00153907|Capecitabine|capecitabine|mesh-list
110202572|NCT00153907|Vinorelbine|vinorelbine|mesh-list
110202573|NCT00153907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110202574|NCT00153907|Antimetabolites|antimetabolites|mesh-ancestor
110202575|NCT00153907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110202576|NCT00153907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110202577|NCT00153907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110202578|NCT00153907|Tubulin Modulators|tubulin modulators|mesh-ancestor
110202579|NCT00153907|Antimitotic Agents|antimitotic agents|mesh-ancestor
110202580|NCT00153907|Mitosis Modulators|mitosis modulators|mesh-ancestor
110202581|NCT00050726|Interleukin-2|interleukin-2|mesh-list
110202582|NCT00050726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110202583|NCT00050726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110202584|NCT00050726|Analgesics|analgesics|mesh-ancestor
110202585|NCT00050726|Sensory System Agents|sensory system agents|mesh-ancestor
110202586|NCT00050726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110202587|NCT00050726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110202588|NCT00153946|Edaravone|edaravone|mesh-list
110202589|NCT00153946|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110202590|NCT00153946|Antioxidants|antioxidants|mesh-ancestor
110202591|NCT00153946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110202592|NCT00153946|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110202593|NCT00153946|Protective Agents|protective agents|mesh-ancestor
110202594|NCT00153946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110202596|NCT00154024|Atorvastatin|atorvastatin|mesh-list
110202597|NCT00154024|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110202598|NCT00154024|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110202599|NCT00154024|Antimetabolites|antimetabolites|mesh-ancestor
110202600|NCT00154024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110202601|NCT00154024|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110202602|NCT00154024|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110202603|NCT00154024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110202604|NCT00154024|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110202605|NCT00154024|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110202606|NCT00154024|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110202607|NCT00154141|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110202608|NCT00154141|Hemostatics|hemostatics|mesh-ancestor
110202609|NCT00154141|Coagulants|coagulants|mesh-ancestor
110202610|NCT00154180|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110202611|NCT00154180|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110202612|NCT00154180|Estradiol|estradiol|mesh-list
110202613|NCT00154180|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110202614|NCT00154180|Estrogens|estrogens|mesh-list
110202615|NCT00154180|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110202616|NCT00154180|Progesterone|progesterone|mesh-list
110202617|NCT00154180|Hormones|hormones|mesh-ancestor
110202618|NCT00154180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110202619|NCT00154180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110202620|NCT00154180|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110202621|NCT00154180|Contraceptive Agents|contraceptive agents|mesh-ancestor
110202622|NCT00154180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110202623|NCT00154180|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110202624|NCT00154180|Progestins|progestins|mesh-ancestor
110202625|NCT00154219|Lumiracoxib|lumiracoxib|mesh-list
110202626|NCT00154219|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110202627|NCT00154219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110202628|NCT00154219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110202629|NCT00154219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110202631|NCT00154219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110202632|NCT00154219|Analgesics|analgesics|mesh-ancestor
110202633|NCT00154219|Sensory System Agents|sensory system agents|mesh-ancestor
110202634|NCT00154219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110202635|NCT00154219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110202636|NCT00154219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110202637|NCT00154219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110202638|NCT00043875|Lamotrigine|lamotrigine|mesh-list
110202639|NCT00043875|Anticonvulsants|anticonvulsants|mesh-ancestor
110202640|NCT00043875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110202641|NCT00043875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110202642|NCT00043875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110202643|NCT00043875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110202644|NCT00043875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110202645|NCT00043875|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110202646|NCT00043875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110202647|NCT00043875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110202648|NCT00043875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110202649|NCT00043875|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110202651|NCT00154258|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110202652|NCT00154258|Serotonin Agents|serotonin agents|mesh-ancestor
110202653|NCT00154258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110202654|NCT00154258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110202655|NCT00154258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110202656|NCT00154258|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110202657|NCT00154258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110202658|NCT00154258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110202659|NCT00154258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110202660|NCT00154258|GABA Antagonists|gaba antagonists|mesh-ancestor
110202661|NCT00154258|GABA Agents|gaba agents|mesh-ancestor
110202662|NCT00154336|Methotrexate|methotrexate|mesh-list
110202663|NCT00154336|Imatinib Mesylate|imatinib mesylate|mesh-list
110202664|NCT00154336|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110202665|NCT00154336|Abortifacient Agents|abortifacient agents|mesh-ancestor
110202666|NCT00154336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110202667|NCT00154336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110202668|NCT00154336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110202670|NCT00154336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110202671|NCT00154336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110202672|NCT00154336|Dermatologic Agents|dermatologic agents|mesh-ancestor
110202673|NCT00154336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110202674|NCT00154336|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110202675|NCT00154336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110202676|NCT00154336|Immunologic Factors|immunologic factors|mesh-ancestor
110202677|NCT00154336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110202678|NCT00154336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110202679|NCT00154336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110202680|NCT00050804|Sertraline|sertraline|mesh-list
110202681|NCT00050804|Antidepressive Agents|antidepressive agents|mesh-ancestor
110202682|NCT00050804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110202683|NCT00050804|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110202685|NCT00050804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110202686|NCT00050804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110202687|NCT00050804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110202688|NCT00050804|Serotonin Agents|serotonin agents|mesh-ancestor
110202689|NCT00050804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110202691|NCT00043914|Anticonvulsants|anticonvulsants|mesh-ancestor
110202692|NCT00043914|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110202693|NCT00043914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110202694|NCT00043914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110202695|NCT00043914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110202696|NCT00043914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110202697|NCT00043914|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110202698|NCT00043914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110202699|NCT00043914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110202700|NCT00043914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110202701|NCT00043914|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110202703|NCT04705987|Gout Suppressants|gout suppressants|mesh-ancestor
110202704|NCT04705987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110202705|NCT04705987|Tubulin Modulators|tubulin modulators|mesh-ancestor
110202706|NCT04705987|Antimitotic Agents|antimitotic agents|mesh-ancestor
110202707|NCT04705987|Mitosis Modulators|mitosis modulators|mesh-ancestor
110202708|NCT04705987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110202709|NCT04705987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110202710|NCT04705909|Pitavastatin|pitavastatin|mesh-list
110202711|NCT04705909|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
110202712|NCT04705909|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110202713|NCT04705909|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110202714|NCT04705909|Antimetabolites|antimetabolites|mesh-ancestor
110202715|NCT04705909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110202716|NCT04705909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110202717|NCT04705909|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110202718|NCT00083304|Efaproxiral|efaproxiral|mesh-list
110202719|NCT00083304|Antisickling Agents|antisickling agents|mesh-ancestor
110202720|NCT00050843|Thalidomide|thalidomide|mesh-list
110202721|NCT00050843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110202722|NCT00050843|Immunologic Factors|immunologic factors|mesh-ancestor
110202723|NCT00050843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110202724|NCT00050843|Leprostatic Agents|leprostatic agents|mesh-ancestor
110202725|NCT00050843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110202726|NCT00050843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110202727|NCT00050843|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110202728|NCT00050843|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110202729|NCT00050843|Growth Substances|growth substances|mesh-ancestor
110202730|NCT00050843|Growth Inhibitors|growth inhibitors|mesh-ancestor
110202731|NCT00050843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110202732|NCT00406237|Tigecycline|tigecycline|mesh-list
110202733|NCT00406237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110202734|NCT00406237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110202735|NCT00406237|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110202736|NCT00406237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110202737|NCT00406237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110202739|NCT00406432|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110202740|NCT00406432|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110202741|NCT00406432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110202742|NCT00406432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110202743|NCT00406432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110202745|NCT00406432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110202746|NCT00406432|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110202747|NCT00406432|Antidepressive Agents|antidepressive agents|mesh-ancestor
110202748|NCT00406432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110202749|NCT00406432|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110202750|NCT00406432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110202751|NCT00406432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110202753|NCT00083343|Antifungal Agents|antifungal agents|mesh-ancestor
110202754|NCT00083343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110202755|NCT00083343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110202756|NCT00083343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110202758|NCT00406471|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110202759|NCT00406471|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110202760|NCT00406471|Growth Substances|growth substances|mesh-ancestor
110202761|NCT00406471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110202762|NCT00406471|Growth Inhibitors|growth inhibitors|mesh-ancestor
110202763|NCT00406471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110202764|NCT00050921|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
110202765|NCT00050921|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110202766|NCT00050921|Immunologic Factors|immunologic factors|mesh-ancestor
110202767|NCT00050921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110202768|NCT00154687|Paclitaxel|paclitaxel|mesh-list
110202769|NCT00154687|Fluorouracil|fluorouracil|mesh-list
110202770|NCT00154687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110202771|NCT00154687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110202772|NCT00154687|Tubulin Modulators|tubulin modulators|mesh-ancestor
110202773|NCT00154687|Antimitotic Agents|antimitotic agents|mesh-ancestor
110202774|NCT00154687|Mitosis Modulators|mitosis modulators|mesh-ancestor
110202775|NCT00154687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110202776|NCT00154687|Antimetabolites|antimetabolites|mesh-ancestor
110202777|NCT00154687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110202778|NCT00154687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110202779|NCT00154687|Immunologic Factors|immunologic factors|mesh-ancestor
110202780|NCT00154687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110202781|NCT00083460|Thalidomide|thalidomide|mesh-list
110202783|NCT00083460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110202784|NCT00083460|Antiemetics|antiemetics|mesh-ancestor
110202785|NCT00083460|Autonomic Agents|autonomic agents|mesh-ancestor
110202786|NCT00083460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110202787|NCT00083460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110202788|NCT00083460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110202789|NCT00083460|Glucocorticoids|glucocorticoids|mesh-ancestor
110202790|NCT00083460|Hormones|hormones|mesh-ancestor
110202791|NCT00083460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110202792|NCT00083460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110202793|NCT00083460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110202794|NCT00083460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110202795|NCT00083460|Immunologic Factors|immunologic factors|mesh-ancestor
110202796|NCT00083460|Leprostatic Agents|leprostatic agents|mesh-ancestor
110202797|NCT00083460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110202798|NCT00083460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110202799|NCT00083460|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110202800|NCT00083460|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110202801|NCT00083460|Growth Substances|growth substances|mesh-ancestor
110202802|NCT00083460|Growth Inhibitors|growth inhibitors|mesh-ancestor
110202804|NCT00154726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110202805|NCT00154726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110202806|NCT00154726|Tubulin Modulators|tubulin modulators|mesh-ancestor
110202807|NCT00154726|Antimitotic Agents|antimitotic agents|mesh-ancestor
110202808|NCT00154726|Mitosis Modulators|mitosis modulators|mesh-ancestor
110202809|NCT00154726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110202810|NCT00154804|Paclitaxel|paclitaxel|mesh-list
110202811|NCT00154804|Cisplatin|cisplatin|mesh-list
110202812|NCT00154804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110202813|NCT00154804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110202814|NCT00154804|Tubulin Modulators|tubulin modulators|mesh-ancestor
110202815|NCT00154804|Antimitotic Agents|antimitotic agents|mesh-ancestor
110202816|NCT00154804|Mitosis Modulators|mitosis modulators|mesh-ancestor
110202817|NCT00154804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110202818|NCT00154843|Lycopene|lycopene|mesh-list
110202819|NCT00154843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110202820|NCT00154843|Antioxidants|antioxidants|mesh-ancestor
110202821|NCT00154843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110202822|NCT00154843|Protective Agents|protective agents|mesh-ancestor
110202823|NCT00154843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110202824|NCT00154843|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110202825|NCT00154843|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110202826|NCT00154843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110202827|NCT00043953|Ritonavir|ritonavir|mesh-list
110202828|NCT00043953|Lopinavir|lopinavir|mesh-list
110202829|NCT00043953|Saquinavir|saquinavir|mesh-list
110202830|NCT00043953|Lamivudine|lamivudine|mesh-list
110202831|NCT00043953|Zidovudine|zidovudine|mesh-list
110202832|NCT00043953|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
110202833|NCT00043953|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110202834|NCT00043953|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110202835|NCT00043953|Protease Inhibitors|protease inhibitors|mesh-ancestor
110202836|NCT00043953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110202837|NCT00043953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110202838|NCT00043953|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110202839|NCT00043953|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110202840|NCT00043953|Antiviral Agents|antiviral agents|mesh-ancestor
110202841|NCT00043953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110202842|NCT00043953|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110202843|NCT00043953|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110202844|NCT00043953|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110202845|NCT00043953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110202847|NCT00154882|Paclitaxel|paclitaxel|mesh-list
110202848|NCT00154882|Cisplatin|cisplatin|mesh-list
110202849|NCT00154882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110202850|NCT00154882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110202851|NCT00154882|Tubulin Modulators|tubulin modulators|mesh-ancestor
110202852|NCT00154882|Antimitotic Agents|antimitotic agents|mesh-ancestor
110202853|NCT00154882|Mitosis Modulators|mitosis modulators|mesh-ancestor
110202854|NCT00154882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110202855|NCT00051077|Ribavirin|ribavirin|mesh-list
110202856|NCT00051077|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110202857|NCT00051077|Adefovir|adefovir|mesh-list
110202858|NCT00051077|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
110202859|NCT00051077|Antimetabolites|antimetabolites|mesh-ancestor
110202860|NCT00051077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110202861|NCT00051077|Antiviral Agents|antiviral agents|mesh-ancestor
110202862|NCT00051077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110202863|NCT00051077|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110202864|NCT00051077|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110202865|NCT00051077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110202866|NCT00155233|Morphine|morphine|mesh-list
110202867|NCT00155233|Nalbuphine|nalbuphine|mesh-list
110202868|NCT00155233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110202869|NCT00155233|Narcotics|narcotics|mesh-ancestor
110202870|NCT00155233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110202871|NCT00155233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110202872|NCT00155233|Analgesics|analgesics|mesh-ancestor
110202873|NCT00155233|Sensory System Agents|sensory system agents|mesh-ancestor
110202874|NCT00155233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110202875|NCT00051116|Lenalidomide|lenalidomide|mesh-list
110202876|NCT00051116|Immunologic Factors|immunologic factors|mesh-ancestor
110202877|NCT00051116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110202878|NCT00051116|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110202879|NCT00051116|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110202880|NCT00051116|Growth Substances|growth substances|mesh-ancestor
110202881|NCT00051116|Growth Inhibitors|growth inhibitors|mesh-ancestor
110202882|NCT00051116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110202883|NCT00155272|Thalidomide|thalidomide|mesh-list
110202884|NCT00155272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110202885|NCT00155272|Immunologic Factors|immunologic factors|mesh-ancestor
110202886|NCT00155272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110202887|NCT00155272|Leprostatic Agents|leprostatic agents|mesh-ancestor
110202888|NCT00155272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110202889|NCT00155272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110202890|NCT00155272|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110202891|NCT00155272|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110202892|NCT00155272|Growth Substances|growth substances|mesh-ancestor
110202893|NCT00155272|Growth Inhibitors|growth inhibitors|mesh-ancestor
110202894|NCT00155272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110202895|NCT00155350|Pioglitazone|pioglitazone|mesh-list
110202896|NCT00155350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110202897|NCT00155350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110202898|NCT00051155|Timolol|timolol|mesh-list
110202899|NCT00051155|Travoprost|travoprost|mesh-list
110202900|NCT00051155|Latanoprost|latanoprost|mesh-list
110202901|NCT00051155|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110202902|NCT00051155|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110202903|NCT00051155|Adrenergic Agents|adrenergic agents|mesh-ancestor
110202904|NCT00051155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110202905|NCT00051155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110202906|NCT00051155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110202907|NCT00051155|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110202908|NCT00051155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110202909|NCT00051155|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110202910|NCT00051155|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110202911|NCT00083538|Thalidomide|thalidomide|mesh-list
110202912|NCT00083538|Dexamethasone|dexamethasone|mesh-list
110202913|NCT00083538|Cyclophosphamide|cyclophosphamide|mesh-list
110202915|NCT00083538|Doxorubicin|doxorubicin|mesh-list
110202916|NCT00083538|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110202917|NCT00083538|Cisplatin|cisplatin|mesh-list
110202918|NCT00083538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110202919|NCT00083538|Immunologic Factors|immunologic factors|mesh-ancestor
110202920|NCT00083538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110202921|NCT00083538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110202922|NCT00083538|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110202923|NCT00083538|Alkylating Agents|alkylating agents|mesh-ancestor
110202924|NCT00083538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110202925|NCT00083538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110202926|NCT00083538|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110202927|NCT00083538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110202929|NCT00083538|Autonomic Agents|autonomic agents|mesh-ancestor
110202930|NCT00083538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110202931|NCT00083538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110202932|NCT00083538|Glucocorticoids|glucocorticoids|mesh-ancestor
110202933|NCT00083538|Hormones|hormones|mesh-ancestor
110202934|NCT00083538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110202935|NCT00083538|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110202936|NCT00083538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110202937|NCT00083538|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110202938|NCT00083538|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110202939|NCT00083538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110202940|NCT00083538|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110202941|NCT00083538|Leprostatic Agents|leprostatic agents|mesh-ancestor
110202942|NCT00083538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110202943|NCT00083538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110202944|NCT00083538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110202945|NCT00083538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110202946|NCT00083538|Growth Substances|growth substances|mesh-ancestor
110202947|NCT00083538|Growth Inhibitors|growth inhibitors|mesh-ancestor
110202948|NCT00083577|Thalidomide|thalidomide|mesh-list
110202949|NCT00083577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110202950|NCT00083577|Immunologic Factors|immunologic factors|mesh-ancestor
110202951|NCT00083577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110202952|NCT00083577|Leprostatic Agents|leprostatic agents|mesh-ancestor
110202953|NCT00083577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110202954|NCT00083577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110202955|NCT00083577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110202956|NCT00083577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110202957|NCT00083577|Growth Substances|growth substances|mesh-ancestor
110202958|NCT00083577|Growth Inhibitors|growth inhibitors|mesh-ancestor
110202959|NCT00083577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110202960|NCT00154414|Liraglutide|liraglutide|mesh-list
110202961|NCT00154414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110202962|NCT00154414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110202964|NCT00154414|Hormones|hormones|mesh-ancestor
110202965|NCT00154414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110202966|NCT00406744|Bevacizumab|bevacizumab|mesh-list
110202967|NCT00406744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110202968|NCT00406744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110202969|NCT00406744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110202970|NCT00406744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110202971|NCT00406744|Growth Substances|growth substances|mesh-ancestor
110202972|NCT00406744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110202973|NCT00406744|Growth Inhibitors|growth inhibitors|mesh-ancestor
110202975|NCT00399750|Oxaliplatin|oxaliplatin|mesh-list
110202976|NCT00399750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110202977|NCT00399750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110202978|NCT00399750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110202979|NCT00399750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110202980|NCT00399750|Growth Substances|growth substances|mesh-ancestor
110202981|NCT00399750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110202982|NCT00399750|Growth Inhibitors|growth inhibitors|mesh-ancestor
110202983|NCT00044148|Ruboxistaurin|ruboxistaurin|mesh-list
110202984|NCT00044148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110202985|NCT00044148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110202986|NCT00156286|Imatinib Mesylate|imatinib mesylate|mesh-list
110202987|NCT00156286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110202988|NCT00156286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110202989|NCT00156286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110202990|NCT00156286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110202991|NCT00156325|Escitalopram|escitalopram|mesh-list
110202992|NCT00156325|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110202993|NCT00156325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110202994|NCT00156325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110202995|NCT00156325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110202996|NCT00156325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110202997|NCT00156325|Serotonin Agents|serotonin agents|mesh-ancestor
110202998|NCT00156325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110203000|NCT00156403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110203001|NCT00156403|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110203002|NCT00156403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110203003|NCT00156403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110203004|NCT00156403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110203005|NCT00156403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110203006|NCT00156403|Vasodilator Agents|vasodilator agents|mesh-ancestor
110203007|NCT00051272|Bupropion|bupropion|mesh-list
110203008|NCT00051272|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110203009|NCT00051272|Antidepressive Agents|antidepressive agents|mesh-ancestor
110203010|NCT00051272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110203011|NCT00051272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110203012|NCT00051272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110203013|NCT00051272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110203014|NCT00051272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110203015|NCT00051272|Dopamine Agents|dopamine agents|mesh-ancestor
110203016|NCT00051272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110203017|NCT00051272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110203018|NCT00051272|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110203019|NCT00051272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110203020|NCT00051272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110203021|NCT00044187|Sibutramine|sibutramine|mesh-list
110203022|NCT00044187|Antidepressive Agents|antidepressive agents|mesh-ancestor
110203024|NCT00044187|Appetite Depressants|appetite depressants|mesh-ancestor
110203026|NCT00156520|Aminocaproic Acid|aminocaproic acid|mesh-list
110203027|NCT00156520|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110203028|NCT00156520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110203029|NCT00156520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110203030|NCT00156520|Hemostatics|hemostatics|mesh-ancestor
110203031|NCT00156520|Coagulants|coagulants|mesh-ancestor
110203032|NCT00083694|Thalidomide|thalidomide|mesh-list
110203033|NCT00083694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110203034|NCT00083694|Immunologic Factors|immunologic factors|mesh-ancestor
110203035|NCT00083694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110203036|NCT00083694|Leprostatic Agents|leprostatic agents|mesh-ancestor
110203037|NCT00083694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110203038|NCT00083694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110203039|NCT00083694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110203040|NCT00083694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110203041|NCT00083694|Growth Substances|growth substances|mesh-ancestor
110203042|NCT00083694|Growth Inhibitors|growth inhibitors|mesh-ancestor
110203043|NCT00083694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110203045|NCT00051389|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110203046|NCT00051389|Protease Inhibitors|protease inhibitors|mesh-ancestor
110203047|NCT00051389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110203048|NCT00051389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110203049|NCT00051389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110203050|NCT00156949|Epoetin Alfa|epoetin alfa|mesh-list
110203051|NCT00156949|Hematinics|hematinics|mesh-ancestor
110203052|NCT00156988|Sulfadiazine|sulfadiazine|mesh-list
110203053|NCT00156988|Silver Sulfadiazine|silver sulfadiazine|mesh-list
110203054|NCT00156988|Cerium nitrate|cerium nitrate|mesh-list
110203055|NCT00156988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110203056|NCT00156988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110203057|NCT00156988|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110203058|NCT00156988|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110203059|NCT00156988|Coccidiostats|coccidiostats|mesh-ancestor
110203060|NCT00156988|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110203061|NCT00157066|Ergocalciferols|ergocalciferols|mesh-list
110203063|NCT00157066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110203064|NCT00157066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110203065|NCT00157066|Vitamins|vitamins|mesh-ancestor
110203066|NCT00157066|Micronutrients|micronutrients|mesh-ancestor
110203067|NCT00157066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110203068|NCT00157105|Factor VIII|factor viii|mesh-list
110203069|NCT00157105|Coagulants|coagulants|mesh-ancestor
110203070|NCT00083772|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
110203071|NCT00083772|Natriuretic Agents|natriuretic agents|mesh-ancestor
110203072|NCT00083772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110203073|NCT00157261|Tenecteplase|tenecteplase|mesh-list
110203074|NCT00157261|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110203075|NCT00157261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110203076|NCT00157261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110203077|NCT00157300|Epoetin Alfa|epoetin alfa|mesh-list
110203078|NCT00157300|Hematinics|hematinics|mesh-ancestor
110203079|NCT00157378|Haloperidol|haloperidol|mesh-list
110203080|NCT00157378|Risperidone|risperidone|mesh-list
110203081|NCT00157378|Haloperidol decanoate|haloperidol decanoate|mesh-list
110203082|NCT00157378|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110203083|NCT00157378|Serotonin Agents|serotonin agents|mesh-ancestor
110203084|NCT00157378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110203085|NCT00157378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110203086|NCT00157378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110203087|NCT00157378|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110203088|NCT00157378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110221129|NCT00301483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110203089|NCT00157378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110203090|NCT00157378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110203091|NCT00157378|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110203093|NCT00157378|Antiemetics|antiemetics|mesh-ancestor
110203094|NCT00157378|Autonomic Agents|autonomic agents|mesh-ancestor
110203095|NCT00157378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110203096|NCT00157378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110203097|NCT00157378|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110203098|NCT00406861|Montelukast|montelukast|mesh-list
110203099|NCT00406861|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110203100|NCT00406861|Respiratory System Agents|respiratory system agents|mesh-ancestor
110203102|NCT00406861|Hormone Antagonists|hormone antagonists|mesh-ancestor
110203103|NCT00406861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110203104|NCT00406861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110203105|NCT00406861|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110203106|NCT00406861|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110203107|NCT00406861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110203108|NCT00044265|Ramipril|ramipril|mesh-list
110203109|NCT00044265|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110203110|NCT00044265|Protease Inhibitors|protease inhibitors|mesh-ancestor
110203111|NCT00044265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110203112|NCT00044265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110203113|NCT00044265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110203114|NCT00398099|Ertapenem|ertapenem|mesh-list
110203115|NCT00398099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110203116|NCT00398099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110203117|NCT00406978|Thalidomide|thalidomide|mesh-list
110203118|NCT00406978|Prednisone|prednisone|mesh-list
110203119|NCT00406978|Melphalan|melphalan|mesh-list
110203120|NCT00406978|Defibrotide|defibrotide|mesh-list
110203121|NCT00406978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110203122|NCT00406978|Glucocorticoids|glucocorticoids|mesh-ancestor
110203123|NCT00406978|Hormones|hormones|mesh-ancestor
110203124|NCT00406978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110203125|NCT00406978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110203126|NCT00406978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110203127|NCT00406978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110203128|NCT00406978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110203129|NCT00406978|Alkylating Agents|alkylating agents|mesh-ancestor
110020903|NCT00002322|Antimetabolites|antimetabolites|mesh-ancestor
110203130|NCT00406978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110203131|NCT00406978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110203132|NCT00406978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110203133|NCT00406978|Immunologic Factors|immunologic factors|mesh-ancestor
110203134|NCT00406978|Leprostatic Agents|leprostatic agents|mesh-ancestor
110203135|NCT00406978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110203136|NCT00406978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110203137|NCT00406978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110203138|NCT00406978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110203139|NCT00406978|Growth Substances|growth substances|mesh-ancestor
110203140|NCT00406978|Growth Inhibitors|growth inhibitors|mesh-ancestor
110203141|NCT00406978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110203142|NCT00406978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110203143|NCT00406978|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110203145|NCT00157651|Anticoagulants|anticoagulants|mesh-ancestor
110203147|NCT00044343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110203148|NCT00044343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110203149|NCT00044343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110203150|NCT00044343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110203151|NCT00157690|Alendronate|alendronate|mesh-list
110203152|NCT00157690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110203153|NCT00157690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110203154|NCT00051506|Carboplatin|carboplatin|mesh-list
110203155|NCT00051506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110203156|NCT00157729|Pyridoxal|pyridoxal|mesh-list
110203157|NCT00157729|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
110203158|NCT00157729|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110203159|NCT00157729|Protease Inhibitors|protease inhibitors|mesh-ancestor
110203160|NCT00157729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110203161|NCT00157729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110203162|NCT00157729|Vitamin B Complex|vitamin b complex|mesh-ancestor
110203163|NCT00157729|Vitamins|vitamins|mesh-ancestor
110203164|NCT00157729|Micronutrients|micronutrients|mesh-ancestor
110203165|NCT00157729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110203166|NCT00051545|Seocalcitol|seocalcitol|mesh-list
110203167|NCT00051545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110203168|NCT00051545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110203169|NCT00051545|Immunologic Factors|immunologic factors|mesh-ancestor
110203170|NCT00051545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110203171|NCT00157885|Artesunate|artesunate|mesh-list
110203172|NCT00157885|Amodiaquine|amodiaquine|mesh-list
110203173|NCT00157885|Antimalarials|antimalarials|mesh-ancestor
110203174|NCT00157885|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110203175|NCT00157885|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110203177|NCT00157885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110203178|NCT00157885|Antiviral Agents|antiviral agents|mesh-ancestor
110203179|NCT00157885|Schistosomicides|schistosomicides|mesh-ancestor
110203180|NCT00157885|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110203181|NCT00157885|Anthelmintics|anthelmintics|mesh-ancestor
110203182|NCT00158002|Topiramate|topiramate|mesh-list
110203183|NCT00158002|Anticonvulsants|anticonvulsants|mesh-ancestor
110203184|NCT00158002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110203185|NCT00158002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110203186|NCT00158041|Amifostine|amifostine|mesh-list
110203187|NCT00158041|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110203188|NCT00158041|Protective Agents|protective agents|mesh-ancestor
110203189|NCT00158041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110203190|NCT00051584|Gemcitabine|gemcitabine|mesh-list
110203191|NCT00051584|Doxorubicin|doxorubicin|mesh-list
110203192|NCT00051584|Immunoconjugates|immunoconjugates|mesh-list
110203193|NCT00051584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110203194|NCT00051584|Antimetabolites|antimetabolites|mesh-ancestor
110203195|NCT00051584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110203196|NCT00051584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110203197|NCT00051584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110203198|NCT00051584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110203199|NCT00051584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110203200|NCT00051584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110203201|NCT00051584|Immunologic Factors|immunologic factors|mesh-ancestor
110203202|NCT00051584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110203203|NCT00044382|Lenalidomide|lenalidomide|mesh-list
110203204|NCT00044382|Immunologic Factors|immunologic factors|mesh-ancestor
110203205|NCT00044382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110203206|NCT00044382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110203207|NCT00044382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110203208|NCT00044382|Growth Substances|growth substances|mesh-ancestor
110203209|NCT00044382|Growth Inhibitors|growth inhibitors|mesh-ancestor
110203210|NCT00044382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110203212|NCT00158158|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110203213|NCT00158158|Autonomic Agents|autonomic agents|mesh-ancestor
110203214|NCT00158158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110203215|NCT00158158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110203216|NCT00158158|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110203217|NCT00158158|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110203218|NCT00158158|Cholinergic Agents|cholinergic agents|mesh-ancestor
110203219|NCT00158158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110203220|NCT00158158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110203221|NCT00051623|Infliximab|infliximab|mesh-list
110203222|NCT00051623|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110203223|NCT00051623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110203224|NCT00051623|Dermatologic Agents|dermatologic agents|mesh-ancestor
110203225|NCT00051623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110203226|NCT00051623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110203227|NCT00158236|Buprenorphine|buprenorphine|mesh-list
110203228|NCT00158236|Hydromorphone|hydromorphone|mesh-list
110203229|NCT00158236|Naloxone|naloxone|mesh-list
110203230|NCT00158236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110203231|NCT00158236|Narcotics|narcotics|mesh-ancestor
110203232|NCT00158236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110203233|NCT00158236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110203234|NCT00158236|Analgesics|analgesics|mesh-ancestor
110203235|NCT00158236|Sensory System Agents|sensory system agents|mesh-ancestor
110203236|NCT00158236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110203237|NCT00158236|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110203238|NCT00158275|Antidepressive Agents|antidepressive agents|mesh-list
110203239|NCT00158275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110203240|NCT00044421|Ruboxistaurin|ruboxistaurin|mesh-list
110203241|NCT00044421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110203242|NCT00044421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110203243|NCT00051701|Alemtuzumab|alemtuzumab|mesh-list
110203244|NCT00051701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110203245|NCT00051701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110203246|NCT00158470|Lamivudine|lamivudine|mesh-list
110203247|NCT00158470|Efavirenz|efavirenz|mesh-list
110203248|NCT00158470|Didanosine|didanosine|mesh-list
110203249|NCT00158470|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110203250|NCT00158470|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110203251|NCT00158470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110203252|NCT00158470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110203253|NCT00158470|Antiviral Agents|antiviral agents|mesh-ancestor
110203254|NCT00158470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110203255|NCT00158470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110203256|NCT00158470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110203257|NCT00158470|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110203258|NCT00158470|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110203259|NCT00158470|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110203260|NCT00158470|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110203261|NCT00158470|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110203262|NCT00158470|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110203263|NCT00158470|Antimetabolites|antimetabolites|mesh-ancestor
110203264|NCT00158509|Valacyclovir|valacyclovir|mesh-list
110203265|NCT00158509|Antiviral Agents|antiviral agents|mesh-ancestor
110203266|NCT00158509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110203267|NCT00158548|Artesunate|artesunate|mesh-list
110203268|NCT00158548|Chloroquine|chloroquine|mesh-list
110203269|NCT00158548|Primaquine|primaquine|mesh-list
110203270|NCT00158548|Amodiaquine|amodiaquine|mesh-list
110203271|NCT00158548|Antimalarials|antimalarials|mesh-ancestor
110203272|NCT00158548|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110203273|NCT00158548|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110203274|NCT00158548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110203275|NCT00158548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110203276|NCT00158548|Antiviral Agents|antiviral agents|mesh-ancestor
110203277|NCT00158548|Schistosomicides|schistosomicides|mesh-ancestor
110203278|NCT00158548|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110203279|NCT00158548|Anthelmintics|anthelmintics|mesh-ancestor
110203280|NCT00158548|Amebicides|amebicides|mesh-ancestor
110203281|NCT00158548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110203282|NCT00158587|Primaquine|primaquine|mesh-list
110203283|NCT00158587|Antimalarials|antimalarials|mesh-ancestor
110203284|NCT00158587|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110203285|NCT00158587|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110203286|NCT00158587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110203287|NCT00158704|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
110203288|NCT00158704|Antiviral Agents|antiviral agents|mesh-ancestor
110203289|NCT00158704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110203290|NCT00158704|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110203291|NCT00158704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110203292|NCT00158704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110203293|NCT00158704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110203294|NCT00158782|Lapatinib|lapatinib|mesh-list
110203295|NCT00158782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110203296|NCT00158782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110203297|NCT00158782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110203298|NCT00158782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110203300|NCT00158821|Lamivudine|lamivudine|mesh-list
110203301|NCT00158821|Efavirenz|efavirenz|mesh-list
110203302|NCT00158821|Stavudine|stavudine|mesh-list
110203303|NCT00158821|Antiviral Agents|antiviral agents|mesh-ancestor
110203304|NCT00158821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110203305|NCT00158821|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110203306|NCT00158821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110203307|NCT00158821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110203308|NCT00158821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110203309|NCT00158821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110203310|NCT00158821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110203311|NCT00158821|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110203312|NCT00158821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110203313|NCT00158821|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110203314|NCT00158821|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110203315|NCT00158821|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110203316|NCT00158821|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110203317|NCT00158821|Antimetabolites|antimetabolites|mesh-ancestor
110203318|NCT05568147|Aspirin|aspirin|mesh-list
110203319|NCT05568147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110203320|NCT05568147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110203321|NCT05568147|Analgesics|analgesics|mesh-ancestor
110203322|NCT05568147|Sensory System Agents|sensory system agents|mesh-ancestor
110203323|NCT05568147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110203324|NCT05568147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110203325|NCT05568147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110203326|NCT05568147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110203327|NCT05568147|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110203328|NCT05568147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110203329|NCT05568147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110203330|NCT05568147|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110203331|NCT05568147|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110203332|NCT05568147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110203333|NCT05568147|Antipyretics|antipyretics|mesh-ancestor
110203334|NCT00051896|Vanoxerine|vanoxerine|mesh-list
110203335|NCT00051896|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110203336|NCT00051896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110203337|NCT00051896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110203338|NCT00051896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110203339|NCT00051896|Dopamine Agents|dopamine agents|mesh-ancestor
110203340|NCT00051896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110203341|NCT00051896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110203342|NCT04724473|Tretinoin|tretinoin|mesh-list
110203343|NCT04724473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110203344|NCT04724473|Keratolytic Agents|keratolytic agents|mesh-ancestor
110203345|NCT04724473|Dermatologic Agents|dermatologic agents|mesh-ancestor
110203346|NCT00159016|Imatinib Mesylate|imatinib mesylate|mesh-list
110203347|NCT00159016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110203348|NCT00159016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110203349|NCT00159016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110203350|NCT00159016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110203351|NCT00159094|Vinorelbine|vinorelbine|mesh-list
110203352|NCT00159094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110203353|NCT00159094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110203354|NCT00159094|Tubulin Modulators|tubulin modulators|mesh-ancestor
110203355|NCT00159094|Antimitotic Agents|antimitotic agents|mesh-ancestor
110203356|NCT00159094|Mitosis Modulators|mitosis modulators|mesh-ancestor
110203357|NCT00159094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110203359|NCT02965053|Chelating Agents|chelating agents|mesh-ancestor
110203360|NCT02965053|Sequestering Agents|sequestering agents|mesh-ancestor
110203361|NCT02965053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110203362|NCT00159133|Lorazepam|lorazepam|mesh-list
110203363|NCT00159133|Antipsychotic Agents|antipsychotic agents|mesh-list
110203364|NCT00159133|Anticonvulsants|anticonvulsants|mesh-ancestor
110203365|NCT00159133|Antiemetics|antiemetics|mesh-ancestor
110203366|NCT00159133|Autonomic Agents|autonomic agents|mesh-ancestor
110203367|NCT00159133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110203368|NCT00159133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110203369|NCT00159133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110203370|NCT00159133|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110203371|NCT00159133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110203372|NCT00159133|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110203373|NCT00159133|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110203374|NCT00159133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110203375|NCT00159133|GABA Modulators|gaba modulators|mesh-ancestor
110203376|NCT00159133|GABA Agents|gaba agents|mesh-ancestor
110203377|NCT00159133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110203378|NCT00159133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110203379|NCT00051974|Bortezomib|bortezomib|mesh-list
110203380|NCT00051974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110203381|NCT00159211|Pioglitazone|pioglitazone|mesh-list
110203382|NCT00159211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110203383|NCT00159211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110203385|NCT05567718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110203386|NCT05567718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110203387|NCT00052013|Vatalanib|vatalanib|mesh-list
110203388|NCT00052013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110203389|NCT00052013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110203390|NCT00052013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110203391|NCT00159445|Gemcitabine|gemcitabine|mesh-list
110203392|NCT00159445|Capecitabine|capecitabine|mesh-list
110203393|NCT00159445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110203394|NCT00159445|Antimetabolites|antimetabolites|mesh-ancestor
110203395|NCT00159445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110203396|NCT00159445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110203397|NCT00044460|Rosiglitazone|rosiglitazone|mesh-list
110203398|NCT00044460|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110203399|NCT00044460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110203400|NCT00159484|Celecoxib|celecoxib|mesh-list
110203401|NCT00159484|Epothilone B|epothilone b|mesh-list
110203402|NCT00159484|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110203403|NCT00159484|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110203404|NCT00159484|Analgesics|analgesics|mesh-ancestor
110203405|NCT00159484|Sensory System Agents|sensory system agents|mesh-ancestor
110203406|NCT00159484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110203407|NCT00159484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110203408|NCT00159484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110203409|NCT00159484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110203410|NCT00159484|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110203411|NCT00159484|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110203412|NCT00159484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110203413|NCT00159484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110203414|NCT00159484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110203415|NCT00159484|Tubulin Modulators|tubulin modulators|mesh-ancestor
110203416|NCT00159484|Antimitotic Agents|antimitotic agents|mesh-ancestor
110203417|NCT00159484|Mitosis Modulators|mitosis modulators|mesh-ancestor
110203419|NCT00052052|Interferon-gamma|interferon-gamma|mesh-list
110203420|NCT00052052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110203421|NCT00052052|Antiviral Agents|antiviral agents|mesh-ancestor
110203422|NCT00052052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110203423|NCT00159679|Pregabalin|pregabalin|mesh-list
110203424|NCT00159679|Analgesics|analgesics|mesh-ancestor
110203425|NCT00159679|Sensory System Agents|sensory system agents|mesh-ancestor
110203426|NCT00159679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110203427|NCT00159679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110203428|NCT00159679|Anticonvulsants|anticonvulsants|mesh-ancestor
110203429|NCT00159679|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110203430|NCT00159679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110203431|NCT00159679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110203432|NCT00159679|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110203433|NCT00159679|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110203434|NCT00159679|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110203435|NCT00159679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110203436|NCT00159679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110203438|NCT00159718|Atorvastatin|atorvastatin|mesh-list
110203439|NCT00159718|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110203440|NCT00159718|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110203441|NCT00159718|Antimetabolites|antimetabolites|mesh-ancestor
110203442|NCT00159718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110203443|NCT00159718|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110203444|NCT00159718|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110203445|NCT00159718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110203446|NCT00159718|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110203447|NCT00159718|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110203448|NCT00159718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110203449|NCT00159718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110203450|NCT00159718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110203451|NCT00159718|Vasodilator Agents|vasodilator agents|mesh-ancestor
110203453|NCT00159757|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110203454|NCT00159757|Serotonin Agents|serotonin agents|mesh-ancestor
110203455|NCT00159757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110203456|NCT00159757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110203457|NCT00159757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110203458|NCT00159757|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110203459|NCT00159757|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110203460|NCT00159757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110203461|NCT00159757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110203462|NCT00159757|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110203463|NCT00159757|Dopamine Agents|dopamine agents|mesh-ancestor
110203464|NCT00159835|Atorvastatin|atorvastatin|mesh-list
110203465|NCT00159835|Simvastatin|simvastatin|mesh-list
110203466|NCT00159835|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110203467|NCT00159835|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110203468|NCT00159835|Antimetabolites|antimetabolites|mesh-ancestor
110203469|NCT00159835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110203470|NCT00159835|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110203471|NCT00159835|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110203472|NCT00159835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110203473|NCT00052169|Docetaxel|docetaxel|mesh-list
110203474|NCT00052169|Gefitinib|gefitinib|mesh-list
110203475|NCT00052169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110203476|NCT00052169|Tubulin Modulators|tubulin modulators|mesh-ancestor
110203477|NCT00052169|Antimitotic Agents|antimitotic agents|mesh-ancestor
110203478|NCT00052169|Mitosis Modulators|mitosis modulators|mesh-ancestor
110203479|NCT00052169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110203480|NCT00052169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110203481|NCT00052169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110203483|NCT00159952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110203484|NCT00159952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110203485|NCT00052208|Gefitinib|gefitinib|mesh-list
110203486|NCT00052208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110203487|NCT00052208|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110203488|NCT00052208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110203489|NCT00052208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110203490|NCT00407017|Moxifloxacin|moxifloxacin|mesh-list
110203491|NCT00407017|Gatifloxacin|gatifloxacin|mesh-list
110203492|NCT00407017|Ketorolac|ketorolac|mesh-list
110203493|NCT00407017|Nepafenac|nepafenac|mesh-list
110203494|NCT00407017|Prednisolone acetate|prednisolone acetate|mesh-list
110203495|NCT00407017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110203496|NCT00407017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110203497|NCT00407017|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110203498|NCT00407017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110203499|NCT00407017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110203500|NCT00407017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110203501|NCT00407017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110203502|NCT00407017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110203503|NCT00407017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110203504|NCT00407017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110203505|NCT00407017|Analgesics|analgesics|mesh-ancestor
110203506|NCT00407017|Sensory System Agents|sensory system agents|mesh-ancestor
110203507|NCT00407017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110203508|NCT00407017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110203509|NCT00407017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110203510|NCT00407017|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110203511|NCT00407017|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110203512|NCT00407017|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110203513|NCT00160030|Cisplatin|cisplatin|mesh-list
110203514|NCT00160030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110203515|NCT00160069|Sagopilone|sagopilone|mesh-list
110203516|NCT00160069|Epothilones|epothilones|mesh-list
110203517|NCT00160069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110203518|NCT00160069|Tubulin Modulators|tubulin modulators|mesh-ancestor
110203519|NCT00160069|Antimitotic Agents|antimitotic agents|mesh-ancestor
110203520|NCT00160069|Mitosis Modulators|mitosis modulators|mesh-ancestor
110203521|NCT00160069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110203522|NCT00052286|Modafinil|modafinil|mesh-list
110203523|NCT00052286|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110203524|NCT00052286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110203525|NCT00052286|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110203526|NCT00052286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110221224|NCT00080522|Antimetabolites|antimetabolites|mesh-ancestor
110203527|NCT00052286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110203528|NCT00052286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110203530|NCT00160186|Pancrelipase|pancrelipase|mesh-list
110203531|NCT00160186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110203532|NCT05567484|Itraconazole|itraconazole|mesh-list
110203533|NCT05567484|Antifungal Agents|antifungal agents|mesh-ancestor
110203534|NCT05567484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110203535|NCT05567484|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110203536|NCT05567484|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110203537|NCT05567484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110203538|NCT05567484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110203539|NCT05567484|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110203540|NCT05567484|Hormone Antagonists|hormone antagonists|mesh-ancestor
110203541|NCT05567484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110203542|NCT05567484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110203543|NCT05567484|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110203544|NCT00160264|Vitamin D|vitamin d|mesh-list
110203545|NCT00160264|Lactulose|lactulose|mesh-list
110203546|NCT00160264|Calcium|calcium|mesh-list
110203547|NCT00160264|Vitamins|vitamins|mesh-ancestor
110203548|NCT00160264|Micronutrients|micronutrients|mesh-ancestor
110203549|NCT00160264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110203550|NCT00160264|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110203551|NCT00160264|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110203552|NCT00160264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110203553|NCT00160342|Methyltestosterone|methyltestosterone|mesh-list
110203554|NCT00160342|Estrogens|estrogens|mesh-list
110203555|NCT00160342|Estrogens, Esterified (USP)|estrogens, esterified (usp)|mesh-list
110203556|NCT00160342|Estrone|estrone|mesh-list
110203557|NCT00160342|Testosterone|testosterone|mesh-list
110203558|NCT00160342|Testosterone undecanoate|testosterone undecanoate|mesh-list
110203559|NCT00160342|Testosterone enanthate|testosterone enanthate|mesh-list
110203560|NCT00160342|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110203561|NCT00160342|Hormones|hormones|mesh-ancestor
110203562|NCT00160342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110203563|NCT00160342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110203564|NCT00160342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110203565|NCT00160342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110203566|NCT00160342|Anabolic Agents|anabolic agents|mesh-ancestor
110203567|NCT00160342|Androgens|androgens|mesh-ancestor
110203568|NCT00052364|Oxaliplatin|oxaliplatin|mesh-list
110203569|NCT00052364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110203570|NCT00052403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110203571|NCT00052403|Antibodies|antibodies|mesh-list
110203572|NCT00052403|Immunoglobulins|immunoglobulins|mesh-list
110203573|NCT00052403|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110203574|NCT00052403|Antibodies, Anti-Idiotypic|antibodies, anti-idiotypic|mesh-list
110203575|NCT00052403|Immunologic Factors|immunologic factors|mesh-list
110203576|NCT00052403|Mitogens|mitogens|mesh-list
110203577|NCT00052403|Immunomodulating Agents|immunomodulating agents|mesh-list
110203578|NCT00052403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110203579|NCT00052403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110203580|NCT00052403|Mitosis Modulators|mitosis modulators|mesh-ancestor
110203581|NCT00052403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110203582|NCT00160498|Lercanidipine|lercanidipine|mesh-list
110203583|NCT00160498|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110203584|NCT00160498|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110203585|NCT00160498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110203586|NCT00160498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221232|NCT00086775|Fludarabine|fludarabine|mesh-list
110203587|NCT00160498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110203588|NCT00160498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110203590|NCT00160537|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110203591|NCT00160537|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110203592|NCT00160537|Histamine Antagonists|histamine antagonists|mesh-ancestor
110203593|NCT00160537|Histamine Agents|histamine agents|mesh-ancestor
110203594|NCT00160537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110203595|NCT00160537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110203596|NCT00160537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110203597|NCT00160576|Levetiracetam|levetiracetam|mesh-list
110203598|NCT00160576|Anticonvulsants|anticonvulsants|mesh-ancestor
110203601|NCT00160849|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110203602|NCT00160849|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110203603|NCT00160849|Protease Inhibitors|protease inhibitors|mesh-ancestor
110203604|NCT00160849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110203605|NCT00160849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110203606|NCT00160849|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110203607|NCT00160849|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110203608|NCT00160849|Antiviral Agents|antiviral agents|mesh-ancestor
110203609|NCT00160849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110203610|NCT00160849|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110203611|NCT00160849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110203612|NCT00160888|Nitroprusside|nitroprusside|mesh-list
110203613|NCT00160888|Acetylcholine|acetylcholine|mesh-list
110203614|NCT00160888|Bradykinin|bradykinin|mesh-list
110203615|NCT00160888|Kininogens|kininogens|mesh-list
110203616|NCT00160888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110203617|NCT00160888|Vasodilator Agents|vasodilator agents|mesh-ancestor
110203618|NCT00160888|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110203619|NCT00160888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110203620|NCT00160888|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110203621|NCT00160888|Cholinergic Agents|cholinergic agents|mesh-ancestor
110203622|NCT00160888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110203623|NCT00160888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110203624|NCT00160888|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
110203625|NCT00160888|Protease Inhibitors|protease inhibitors|mesh-ancestor
110203626|NCT00160888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110203627|NCT00160927|Nitroprusside|nitroprusside|mesh-list
110203628|NCT00160927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110203629|NCT00160927|Vasodilator Agents|vasodilator agents|mesh-ancestor
110203630|NCT00160927|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110203631|NCT00160927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110203632|NCT00160966|Cyclosporine|cyclosporine|mesh-list
110203633|NCT00160966|Mycophenolic Acid|mycophenolic acid|mesh-list
110203634|NCT00160966|Everolimus|everolimus|mesh-list
110203635|NCT00160966|Tacrolimus|tacrolimus|mesh-list
110203636|NCT00160966|Cyclosporins|cyclosporins|mesh-list
110203637|NCT00160966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110203638|NCT00160966|Immunologic Factors|immunologic factors|mesh-ancestor
110203639|NCT00160966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110203640|NCT00160966|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110203641|NCT00160966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110203642|NCT00160966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110203643|NCT00160966|Antifungal Agents|antifungal agents|mesh-ancestor
110203644|NCT00160966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110203645|NCT00160966|Dermatologic Agents|dermatologic agents|mesh-ancestor
110203646|NCT00160966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110203647|NCT00160966|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110203648|NCT00160966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110203649|NCT00160966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110203650|NCT00160966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110203651|NCT00160966|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110203652|NCT00160966|Antitubercular Agents|antitubercular agents|mesh-ancestor
110203653|NCT00160966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110203654|NCT00052559|Bevacizumab|bevacizumab|mesh-list
110221247|NCT00292708|Cefmetazole|cefmetazole|mesh-list
110203655|NCT00052559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110203657|NCT00052559|Antibodies|antibodies|mesh-list
110203658|NCT00052559|Immunoglobulins|immunoglobulins|mesh-list
110203659|NCT00052559|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110203660|NCT00052559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110203661|NCT00052559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110203662|NCT00052559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110203663|NCT00052559|Growth Substances|growth substances|mesh-ancestor
110203664|NCT00052559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110203665|NCT00052559|Growth Inhibitors|growth inhibitors|mesh-ancestor
110203666|NCT00052559|Immunologic Factors|immunologic factors|mesh-ancestor
110203667|NCT00052559|Antimetabolites|antimetabolites|mesh-ancestor
110203668|NCT00052559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110203669|NCT00052559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110203670|NCT00052559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110203671|NCT00161083|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
110203672|NCT00161083|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110203673|NCT00161083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110203677|NCT00044577|Dideoxynucleosides|dideoxynucleosides|mesh-list
110203678|NCT00044577|Antiviral Agents|antiviral agents|mesh-ancestor
110203679|NCT00044577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110203680|NCT00044577|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110203681|NCT00044577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110203682|NCT00044577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110203683|NCT00044577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110203684|NCT00044577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110203685|NCT00044577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110203686|NCT00044577|Antimetabolites|antimetabolites|mesh-ancestor
110203687|NCT00161122|Vaccines|vaccines|mesh-list
110203688|NCT00161122|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110203689|NCT00161122|Immunologic Factors|immunologic factors|mesh-ancestor
110203690|NCT00161122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110203691|NCT00161200|Pantoprazole|pantoprazole|mesh-list
110203692|NCT00161200|Ranitidine|ranitidine|mesh-list
110203693|NCT00161200|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
110203694|NCT00161200|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110203695|NCT00161200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110203696|NCT00161200|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110203697|NCT00161200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110203698|NCT00161200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110203699|NCT00161200|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110203700|NCT00161200|Histamine Antagonists|histamine antagonists|mesh-ancestor
110203701|NCT00161200|Histamine Agents|histamine agents|mesh-ancestor
110203702|NCT00161200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110203703|NCT00161200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110203705|NCT00161239|Methotrexate|methotrexate|mesh-list
110203706|NCT00161239|Asparaginase|asparaginase|mesh-list
110203707|NCT00161239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110203708|NCT00161239|Glucocorticoids|glucocorticoids|mesh-ancestor
110203709|NCT00161239|Hormones|hormones|mesh-ancestor
110203710|NCT00161239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110203711|NCT00161239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110203712|NCT00161239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110203713|NCT00161239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110203714|NCT00161239|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110203715|NCT00161239|Abortifacient Agents|abortifacient agents|mesh-ancestor
110203716|NCT00161239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110203717|NCT00161239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110203718|NCT00161239|Antimetabolites|antimetabolites|mesh-ancestor
110203719|NCT00161239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110203720|NCT00161239|Dermatologic Agents|dermatologic agents|mesh-ancestor
110203721|NCT00161239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110203722|NCT00161239|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110203723|NCT00161239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110203724|NCT00161239|Immunologic Factors|immunologic factors|mesh-ancestor
110203725|NCT00161239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110203726|NCT00161239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110203727|NCT00161278|Paclitaxel|paclitaxel|mesh-list
110203728|NCT00161278|Carboplatin|carboplatin|mesh-list
110203729|NCT00161278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110203730|NCT00161278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110203731|NCT00161278|Tubulin Modulators|tubulin modulators|mesh-ancestor
110203732|NCT00161278|Antimitotic Agents|antimitotic agents|mesh-ancestor
110203733|NCT00161278|Mitosis Modulators|mitosis modulators|mesh-ancestor
110203734|NCT00161278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110203736|NCT00044616|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110203737|NCT00044616|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110203738|NCT00044616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110203739|NCT00044616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110203741|NCT00044616|Serotonin Agents|serotonin agents|mesh-ancestor
110203742|NCT00044616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110203743|NCT00044616|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110203744|NCT00044616|Antidepressive Agents|antidepressive agents|mesh-ancestor
110203745|NCT00044616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110203746|NCT00044616|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110203747|NCT00044616|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110203748|NCT00044616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110203749|NCT00161356|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110203750|NCT00161356|Antifungal Agents|antifungal agents|mesh-ancestor
110203751|NCT00161356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110203752|NCT00161356|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110203753|NCT00161356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110203754|NCT00052676|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
110203755|NCT00052676|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110203756|NCT00052676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110203757|NCT00161434|Valacyclovir|valacyclovir|mesh-list
110203758|NCT00161434|Antiviral Agents|antiviral agents|mesh-ancestor
110203759|NCT00161434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110203761|NCT00044694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110203762|NCT00044694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110203763|NCT00044694|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110203764|NCT00044694|Incretins|incretins|mesh-ancestor
110203765|NCT00044694|Hormones|hormones|mesh-ancestor
110203766|NCT00044694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110203767|NCT00052754|Gefitinib|gefitinib|mesh-list
110203768|NCT00052754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110203769|NCT00052754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110203770|NCT00052754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110203771|NCT00052754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110203772|NCT00161590|Alemtuzumab|alemtuzumab|mesh-list
110203773|NCT00161590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110203774|NCT00161590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110203775|NCT00161668|Gemtuzumab|gemtuzumab|mesh-list
110203776|NCT00161668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110203777|NCT00161668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110203778|NCT00161668|Immunotoxins|immunotoxins|mesh-ancestor
110203779|NCT00161668|Immunoconjugates|immunoconjugates|mesh-ancestor
110203780|NCT00161668|Immunologic Factors|immunologic factors|mesh-ancestor
110203781|NCT00161668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110203782|NCT00052832|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
110203783|NCT00052832|Vitamins|vitamins|mesh-ancestor
110203784|NCT00052832|Micronutrients|micronutrients|mesh-ancestor
110203785|NCT00052832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110203786|NCT00052832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110203787|NCT00161707|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
110203788|NCT00161707|Protein C Inhibitor|protein c inhibitor|mesh-list
110203789|NCT00161707|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110203790|NCT00161707|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110203791|NCT00161707|Protease Inhibitors|protease inhibitors|mesh-ancestor
110203792|NCT00161707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110203793|NCT00161707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110203794|NCT00044538|Taxane|taxane|mesh-list
110203795|NCT00044538|IDN 5109|idn 5109|mesh-list
110203796|NCT00044538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110203797|NCT00044733|Gemtuzumab|gemtuzumab|mesh-list
110203798|NCT00044733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110203799|NCT00044733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110203800|NCT00044733|Immunotoxins|immunotoxins|mesh-ancestor
110203801|NCT00044733|Immunoconjugates|immunoconjugates|mesh-ancestor
110203802|NCT00044733|Immunologic Factors|immunologic factors|mesh-ancestor
110203803|NCT00044733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110203804|NCT00052949|Imatinib Mesylate|imatinib mesylate|mesh-list
110203805|NCT00052949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110203806|NCT00052949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110203807|NCT00052949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110203808|NCT00052949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110203809|NCT00161902|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110203810|NCT00161902|Hemostatics|hemostatics|mesh-ancestor
110203811|NCT00161902|Coagulants|coagulants|mesh-ancestor
110203812|NCT00053027|Rituximab|rituximab|mesh-list
110203813|NCT00053027|Cladribine|cladribine|mesh-list
110203814|NCT00053027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110203815|NCT00053027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110203816|NCT00053027|Immunologic Factors|immunologic factors|mesh-ancestor
110203817|NCT00053027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110203818|NCT00053027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110203819|NCT00053027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110203820|NCT00161980|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110203821|NCT00161980|Hemostatics|hemostatics|mesh-ancestor
110203822|NCT00161980|Coagulants|coagulants|mesh-ancestor
110203823|NCT00162019|Factor VIII|factor viii|mesh-list
110203824|NCT00162019|Coagulants|coagulants|mesh-ancestor
110203825|NCT00162214|Ketoconazole|ketoconazole|mesh-list
110203827|NCT00162214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110203828|NCT00162214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110203829|NCT00162214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110203830|NCT00162214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110203831|NCT00162214|Antifungal Agents|antifungal agents|mesh-ancestor
110203832|NCT00162214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110203833|NCT00162214|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110203834|NCT00162214|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110203835|NCT00162214|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110203836|NCT00162214|Hormone Antagonists|hormone antagonists|mesh-ancestor
110203837|NCT00162214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110203838|NCT00162214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110203839|NCT00162214|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110203840|NCT04731116|Cannabidiol|cannabidiol|mesh-list
110203841|NCT04731116|Anticonvulsants|anticonvulsants|mesh-ancestor
110203842|NCT00407056|Difluprednate|difluprednate|mesh-list
110203843|NCT00407056|Glucocorticoids|glucocorticoids|mesh-ancestor
110203845|NCT00407056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110203846|NCT00407056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110203847|NCT00405457|Cyclosporine|cyclosporine|mesh-list
110203848|NCT00405457|Cyclosporins|cyclosporins|mesh-list
110203849|NCT00405457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110203850|NCT00405457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110203851|NCT00405457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110203852|NCT00405457|Immunologic Factors|immunologic factors|mesh-ancestor
110221462|NCT00087087|Pemetrexed|pemetrexed|mesh-list
110203853|NCT00405457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110203854|NCT00405457|Antifungal Agents|antifungal agents|mesh-ancestor
110203855|NCT00405457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110203856|NCT00405457|Dermatologic Agents|dermatologic agents|mesh-ancestor
110203857|NCT00405457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110203858|NCT00405457|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110203859|NCT00053105|Cytarabine|cytarabine|mesh-list
110203860|NCT00053105|Methylprednisolone|methylprednisolone|mesh-list
110203861|NCT00053105|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110203862|NCT00053105|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110203864|NCT00053105|Prednisolone acetate|prednisolone acetate|mesh-list
110203865|NCT00053105|Pixantrone|pixantrone|mesh-list
110203866|NCT00053105|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110203867|NCT00053105|Prednisolone phosphate|prednisolone phosphate|mesh-list
110203868|NCT00053105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110203869|NCT00053105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110203870|NCT00053105|Antimetabolites|antimetabolites|mesh-ancestor
110203871|NCT00053105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110203872|NCT00053105|Antiviral Agents|antiviral agents|mesh-ancestor
110203873|NCT00053105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110203874|NCT00053105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110203875|NCT00053105|Immunologic Factors|immunologic factors|mesh-ancestor
110203876|NCT00053105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110203877|NCT00053105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110203878|NCT00053105|Antiemetics|antiemetics|mesh-ancestor
110203879|NCT00053105|Autonomic Agents|autonomic agents|mesh-ancestor
110203880|NCT00053105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110203881|NCT00053105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110203882|NCT00053105|Glucocorticoids|glucocorticoids|mesh-ancestor
110203883|NCT00053105|Hormones|hormones|mesh-ancestor
110203884|NCT00053105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110203885|NCT00053105|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110203886|NCT00053105|Protective Agents|protective agents|mesh-ancestor
110203887|NCT00053105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110203888|NCT00053105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110203890|NCT00053105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110203891|NCT00162331|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
110203892|NCT00162331|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110203893|NCT00162331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110203894|NCT00162409|Folic Acid|folic acid|mesh-list
110203895|NCT00162409|Hematinics|hematinics|mesh-ancestor
110203896|NCT00162409|Vitamin B Complex|vitamin b complex|mesh-ancestor
110203897|NCT00162409|Vitamins|vitamins|mesh-ancestor
110203898|NCT00162409|Micronutrients|micronutrients|mesh-ancestor
110203899|NCT00162409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110203900|NCT00053144|Cytarabine|cytarabine|mesh-list
110203901|NCT00053144|Irinotecan|irinotecan|mesh-list
110203902|NCT00053144|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110203903|NCT00053144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110203904|NCT00053144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110203905|NCT00053144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110203906|NCT00053144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110203907|NCT00053144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110203908|NCT00053144|Antimetabolites|antimetabolites|mesh-ancestor
110203909|NCT00053144|Antiviral Agents|antiviral agents|mesh-ancestor
110203910|NCT00053144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110203911|NCT00053144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110203912|NCT00053144|Immunologic Factors|immunologic factors|mesh-ancestor
110203913|NCT00053144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110203915|NCT00162487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110203916|NCT00162487|Autonomic Agents|autonomic agents|mesh-ancestor
110203917|NCT00162487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110203918|NCT00162487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110203919|NCT00162487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110203920|NCT00162487|Respiratory System Agents|respiratory system agents|mesh-ancestor
110203921|NCT00162487|Tocolytic Agents|tocolytic agents|mesh-ancestor
110203922|NCT00162487|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110203923|NCT00162487|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110203924|NCT00162487|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110203925|NCT00162487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110203926|NCT00162487|Adrenergic Agents|adrenergic agents|mesh-ancestor
110203927|NCT00162487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110203928|NCT00162487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110203930|NCT00162526|Vitamin E|vitamin e|mesh-list
110203931|NCT00162526|Tocotrienols|tocotrienols|mesh-list
110203932|NCT00162526|alpha-Tocopherol|alpha-tocopherol|mesh-list
110203933|NCT00162526|Antioxidants|antioxidants|mesh-ancestor
110203934|NCT00162526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110203935|NCT00162526|Protective Agents|protective agents|mesh-ancestor
110203936|NCT00162526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110203937|NCT00162526|Vitamins|vitamins|mesh-ancestor
110203938|NCT00162526|Micronutrients|micronutrients|mesh-ancestor
110203939|NCT00162565|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110203940|NCT00162565|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110203941|NCT00162565|Adrenergic Agents|adrenergic agents|mesh-ancestor
110203942|NCT00162565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110203943|NCT00162565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110203944|NCT00162565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110203945|NCT00162604|Cefuroxime|cefuroxime|mesh-list
110203946|NCT00162604|Cefuroxime axetil|cefuroxime axetil|mesh-list
110203947|NCT00162604|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110203948|NCT00162604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110203949|NCT00162643|Ritonavir|ritonavir|mesh-list
110203950|NCT00162643|Lopinavir|lopinavir|mesh-list
110203952|NCT00162643|Zidovudine|zidovudine|mesh-list
110203953|NCT00162643|Efavirenz|efavirenz|mesh-list
110203954|NCT00162643|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110203955|NCT00162643|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110203956|NCT00162643|Protease Inhibitors|protease inhibitors|mesh-ancestor
110203957|NCT00162643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110203958|NCT00162643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110203959|NCT00162643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110203960|NCT00162643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110203961|NCT00162643|Antiviral Agents|antiviral agents|mesh-ancestor
110203962|NCT00162643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110203963|NCT00162643|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110203964|NCT00162643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110203965|NCT00162643|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110203966|NCT00162643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110203967|NCT00162643|Antimetabolites|antimetabolites|mesh-ancestor
110203968|NCT00162643|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110203969|NCT00162643|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110221941|NCT00304018|Antimetabolites|antimetabolites|mesh-ancestor
110203970|NCT00162643|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110203971|NCT00162643|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110203972|NCT00162643|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110203973|NCT00162682|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110203974|NCT00162682|Antiviral Agents|antiviral agents|mesh-ancestor
110203975|NCT00162682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110203976|NCT00044772|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110203977|NCT00044772|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110203978|NCT00044772|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110203979|NCT00044772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110203980|NCT00044772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110203981|NCT00044772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110221992|NCT00082043|Hormone Antagonists|hormone antagonists|mesh-ancestor
110203982|NCT00044772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110203983|NCT00044772|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110203984|NCT00044772|Antidepressive Agents|antidepressive agents|mesh-ancestor
110203985|NCT00044772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110203987|NCT00162721|Ifosfamide|ifosfamide|mesh-list
110203988|NCT00162721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110203989|NCT00162721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110203990|NCT00162721|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110203991|NCT00162721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110203992|NCT00162721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110203993|NCT00162721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110203994|NCT00162721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110203995|NCT00162721|Alkylating Agents|alkylating agents|mesh-ancestor
110203996|NCT00053222|Arsenic Trioxide|arsenic trioxide|mesh-list
110203997|NCT00053222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110203998|NCT00162760|Thalidomide|thalidomide|mesh-list
110203999|NCT00162760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110204000|NCT00162760|Immunologic Factors|immunologic factors|mesh-ancestor
110204001|NCT00162760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110204002|NCT00162760|Leprostatic Agents|leprostatic agents|mesh-ancestor
110204003|NCT00162760|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110204004|NCT00162760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110204005|NCT00162760|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110204006|NCT00162760|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110204007|NCT00162760|Growth Substances|growth substances|mesh-ancestor
110204008|NCT00162760|Growth Inhibitors|growth inhibitors|mesh-ancestor
110204009|NCT00162760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110204011|NCT00162799|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110204013|NCT00044811|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110204014|NCT00044811|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110204016|NCT00044811|Histamine Antagonists|histamine antagonists|mesh-ancestor
110204017|NCT00044811|Histamine Agents|histamine agents|mesh-ancestor
110204018|NCT00044811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110222245|NCT00082667|Gefitinib|gefitinib|mesh-list
110204019|NCT00044811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204020|NCT00044811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110204021|NCT00162877|Esomeprazole|esomeprazole|mesh-list
110204022|NCT00162877|Rabeprazole|rabeprazole|mesh-list
110204023|NCT00162877|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110204024|NCT00162877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110204025|NCT00162877|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110204026|NCT00162877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110204027|NCT00162877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204029|NCT00162916|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110204030|NCT00162916|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110204031|NCT00162916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110204032|NCT00162916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204033|NCT00162916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110204034|NCT00162916|Serotonin Agents|serotonin agents|mesh-ancestor
110204035|NCT00162916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110204036|NCT00162916|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110204037|NCT00162916|Antidepressive Agents|antidepressive agents|mesh-ancestor
110204038|NCT00162916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110204039|NCT00163072|Megestrol Acetate|megestrol acetate|mesh-list
110204040|NCT00163072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110204042|NCT00163072|Appetite Stimulants|appetite stimulants|mesh-ancestor
110204043|NCT00163072|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110204044|NCT00163072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110204045|NCT00163111|Amphotericin B|amphotericin b|mesh-list
110204046|NCT00163111|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110204047|NCT00163111|Fluconazole|fluconazole|mesh-list
110204048|NCT00163111|Amebicides|amebicides|mesh-ancestor
110204049|NCT00163111|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110204050|NCT00163111|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110204051|NCT00163111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110204052|NCT00163111|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110204053|NCT00163111|Antifungal Agents|antifungal agents|mesh-ancestor
110204054|NCT00163111|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110204055|NCT00163111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110204056|NCT00163111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110204057|NCT00163111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204058|NCT00163111|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110204059|NCT00163111|Hormone Antagonists|hormone antagonists|mesh-ancestor
110204060|NCT00163111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110204061|NCT00163111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110204062|NCT00163111|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110204063|NCT00163111|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110204064|NCT00163150|Atorvastatin|atorvastatin|mesh-list
110204065|NCT00163150|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110204066|NCT00163150|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110204067|NCT00163150|Antimetabolites|antimetabolites|mesh-ancestor
110204068|NCT00163150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204069|NCT00163150|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110204070|NCT00163150|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110204072|NCT00163267|Clopidogrel|clopidogrel|mesh-list
110204073|NCT00163267|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110222583|NCT00083408|Growth Substances|growth substances|mesh-ancestor
110204074|NCT00163267|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110204075|NCT00163267|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110204076|NCT00163267|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110204077|NCT00163267|Purinergic Agents|purinergic agents|mesh-ancestor
110204078|NCT00163267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110204079|NCT00163267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204080|NCT00163267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110204081|NCT00163306|Pantoprazole|pantoprazole|mesh-list
110204082|NCT00163306|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110204083|NCT00163306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110204084|NCT00163306|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110204085|NCT00163306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110204086|NCT00163306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204088|NCT00044889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110204089|NCT00044889|Antimetabolites|antimetabolites|mesh-ancestor
110204090|NCT00044889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204091|NCT00044889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110204092|NCT00163345|Ciclesonide|ciclesonide|mesh-list
110204093|NCT00163345|Glucocorticoids|glucocorticoids|mesh-ancestor
110204094|NCT00163345|Hormones|hormones|mesh-ancestor
110222773|NCT00309790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110204095|NCT00163345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110204096|NCT00163345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110204097|NCT00163345|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110204098|NCT00163384|Ciclesonide|ciclesonide|mesh-list
110204099|NCT00163384|Glucocorticoids|glucocorticoids|mesh-ancestor
110204100|NCT00163384|Hormones|hormones|mesh-ancestor
110204101|NCT00163384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110204102|NCT00163384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110204103|NCT00163384|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110204104|NCT00163423|Ciclesonide|ciclesonide|mesh-list
110204105|NCT00163423|Glucocorticoids|glucocorticoids|mesh-ancestor
110204106|NCT00163423|Hormones|hormones|mesh-ancestor
110204107|NCT00163423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110204108|NCT00163423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110204109|NCT00163423|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110204110|NCT04731038|Paclitaxel|paclitaxel|mesh-list
110204111|NCT04731038|Carboplatin|carboplatin|mesh-list
110204112|NCT04731038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110204113|NCT04731038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110204114|NCT04731038|Tubulin Modulators|tubulin modulators|mesh-ancestor
110204115|NCT04731038|Antimitotic Agents|antimitotic agents|mesh-ancestor
110204116|NCT04731038|Mitosis Modulators|mitosis modulators|mesh-ancestor
110204117|NCT04731038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204119|NCT00163462|Glucocorticoids|glucocorticoids|mesh-ancestor
110204120|NCT00163462|Hormones|hormones|mesh-ancestor
110204121|NCT00163462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110204122|NCT00163462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110204124|NCT00053300|Thalidomide|thalidomide|mesh-list
110204125|NCT00053300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110204126|NCT00053300|Immunologic Factors|immunologic factors|mesh-ancestor
110204127|NCT00053300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110204128|NCT00053300|Leprostatic Agents|leprostatic agents|mesh-ancestor
110204130|NCT00053300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110204131|NCT00053300|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110204132|NCT00053300|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110204134|NCT00053300|Growth Inhibitors|growth inhibitors|mesh-ancestor
110204135|NCT00053300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110204136|NCT00163501|Ciclesonide|ciclesonide|mesh-list
110204137|NCT00163501|Glucocorticoids|glucocorticoids|mesh-ancestor
110204138|NCT00163501|Hormones|hormones|mesh-ancestor
110223100|NCT00311857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204139|NCT00163501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110204140|NCT00163501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110204141|NCT00163501|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110204143|NCT00163540|Disinfectants|disinfectants|mesh-ancestor
110204144|NCT00163540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110204146|NCT00053339|Trastuzumab|trastuzumab|mesh-list
110204147|NCT00053339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110204148|NCT00053339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110204149|NCT00053339|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110204150|NCT00053339|Hormone Antagonists|hormone antagonists|mesh-ancestor
110223241|NCT00293176|Cholinergic Agents|cholinergic agents|mesh-ancestor
110204151|NCT00053339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110204152|NCT00053339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110204153|NCT00053339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110204154|NCT00053339|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110204155|NCT00053339|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110204156|NCT00053339|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110204157|NCT00163618|Formaldehyde|formaldehyde|mesh-list
110204158|NCT00163618|Disinfectants|disinfectants|mesh-ancestor
110223316|NCT00293371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110204159|NCT00163618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110204160|NCT00053378|Calcium|calcium|mesh-list
110204161|NCT00053378|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110204162|NCT00053378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110204164|NCT02970383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110204165|NCT02970383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110204166|NCT02970383|Analgesics|analgesics|mesh-ancestor
110204167|NCT02970383|Sensory System Agents|sensory system agents|mesh-ancestor
110204168|NCT02970383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110204169|NCT05502900|Melatonin|melatonin|mesh-list
110204170|NCT05502900|Antioxidants|antioxidants|mesh-ancestor
110204171|NCT05502900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204172|NCT05502900|Protective Agents|protective agents|mesh-ancestor
110204173|NCT05502900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110204174|NCT05502900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110204175|NCT00163969|Ketamine|ketamine|mesh-list
110204176|NCT00163969|Analgesics|analgesics|mesh-ancestor
110204177|NCT00163969|Sensory System Agents|sensory system agents|mesh-ancestor
110204178|NCT00163969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110204179|NCT00163969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110204180|NCT00163969|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110204181|NCT00163969|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110204182|NCT00163969|Anesthetics, General|anesthetics, general|mesh-ancestor
110204183|NCT00163969|Anesthetics|anesthetics|mesh-ancestor
110204184|NCT00163969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110204185|NCT00163969|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110204186|NCT00163969|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110204187|NCT00163969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110204188|NCT00163969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204189|NCT00164008|Zoledronic Acid|zoledronic acid|mesh-list
110204190|NCT00164008|Pamidronate|pamidronate|mesh-list
110204191|NCT00164008|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110204192|NCT00164008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110204193|NCT00164047|Nitrous Oxide|nitrous oxide|mesh-list
110204194|NCT00164047|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110204195|NCT00164047|Anesthetics, General|anesthetics, general|mesh-ancestor
110204196|NCT00164047|Anesthetics|anesthetics|mesh-ancestor
110204197|NCT00164047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110204198|NCT00164047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110204199|NCT00164047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110204200|NCT00164047|Analgesics|analgesics|mesh-ancestor
110204201|NCT00164047|Sensory System Agents|sensory system agents|mesh-ancestor
110204202|NCT00164047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110204203|NCT00164086|Atorvastatin|atorvastatin|mesh-list
110204204|NCT00164086|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110204205|NCT00164086|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110204206|NCT00164086|Antimetabolites|antimetabolites|mesh-ancestor
110204207|NCT00164086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204208|NCT00164086|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110223777|NCT00089856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110204209|NCT00164086|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110204211|NCT00164125|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
110204212|NCT00164125|Laxatives|laxatives|mesh-ancestor
110204213|NCT00164125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110204214|NCT00164164|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
110204215|NCT00164164|Laxatives|laxatives|mesh-ancestor
110204216|NCT00164164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110204217|NCT00164242|Galantamine|galantamine|mesh-list
110204218|NCT00164242|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110204220|NCT00164242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204221|NCT00164242|Cholinergic Agents|cholinergic agents|mesh-ancestor
110204222|NCT00164242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110204223|NCT00164242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110204224|NCT00164242|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110204225|NCT00164242|Autonomic Agents|autonomic agents|mesh-ancestor
110204226|NCT00164242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110204228|NCT00162955|Valsartan|valsartan|mesh-list
110204229|NCT00162955|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110204230|NCT00162955|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110204231|NCT00162955|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110204232|NCT00162955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204233|NCT00164281|Isoniazid|isoniazid|mesh-list
110204234|NCT00164281|Antitubercular Agents|antitubercular agents|mesh-ancestor
110223968|NCT00090207|Antipruritics|antipruritics|mesh-ancestor
110204235|NCT00164281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110204236|NCT00164281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110204237|NCT00164281|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110204238|NCT00164281|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110204239|NCT00164281|Antimetabolites|antimetabolites|mesh-ancestor
110204240|NCT00164281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204241|NCT00164281|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110204242|NCT00044928|Tazobactam|tazobactam|mesh-list
110204243|NCT00044928|Piperacillin|piperacillin|mesh-list
110204244|NCT00044928|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
110204245|NCT00044928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110204246|NCT00044928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110204247|NCT00044928|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110204248|NCT00044928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110204249|NCT00044928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204250|NCT00164359|Artesunate|artesunate|mesh-list
110204251|NCT00164359|Amodiaquine|amodiaquine|mesh-list
110204252|NCT00164359|Dapsone|dapsone|mesh-list
110204253|NCT00164359|Chlorproguanil|chlorproguanil|mesh-list
110204254|NCT00164359|Antimalarials|antimalarials|mesh-ancestor
110204255|NCT00164359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110204256|NCT00164359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110204257|NCT00164359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110204258|NCT00164359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110204260|NCT00164359|Schistosomicides|schistosomicides|mesh-ancestor
110204261|NCT00164359|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110204264|NCT00164359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110204265|NCT00164359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204266|NCT00164359|Leprostatic Agents|leprostatic agents|mesh-ancestor
110204267|NCT00164359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110204268|NCT00053612|Vitamin A|vitamin a|mesh-list
110204269|NCT00053612|Vitamins|vitamins|mesh-ancestor
110204270|NCT00053612|Micronutrients|micronutrients|mesh-ancestor
110204271|NCT00053612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110204272|NCT00045006|Vorinostat|vorinostat|mesh-list
110224242|NCT00323323|Hormones|hormones|mesh-ancestor
110204273|NCT00045006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110204274|NCT00045006|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110204275|NCT00045006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110204276|NCT00045006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204278|NCT00164710|Lumefantrine|lumefantrine|mesh-list
110204279|NCT00164710|Artemether|artemether|mesh-list
110204280|NCT00164710|Pyrimethamine|pyrimethamine|mesh-list
110204281|NCT00164710|Sulfadoxine|sulfadoxine|mesh-list
110204282|NCT00164710|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110204283|NCT00164710|Amodiaquine|amodiaquine|mesh-list
110204284|NCT00164710|Dapsone|dapsone|mesh-list
110204285|NCT00164710|Chlorproguanil|chlorproguanil|mesh-list
110204286|NCT00164710|Antimalarials|antimalarials|mesh-ancestor
110204287|NCT00164710|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110204288|NCT00164710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110204289|NCT00164710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110224372|NCT06003049|Cholinergic Agents|cholinergic agents|mesh-ancestor
110204290|NCT00164710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110204291|NCT00164710|Antiviral Agents|antiviral agents|mesh-ancestor
110204292|NCT00164710|Schistosomicides|schistosomicides|mesh-ancestor
110204293|NCT00164710|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110204295|NCT00164710|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110204296|NCT00164710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110204297|NCT00164710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204298|NCT00164710|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110204299|NCT00164710|Leprostatic Agents|leprostatic agents|mesh-ancestor
110204300|NCT00164710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110204301|NCT00045045|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110204302|NCT00045045|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110204303|NCT00045045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204305|NCT00164749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110204306|NCT00164749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110204308|NCT00164749|Sensory System Agents|sensory system agents|mesh-ancestor
110204309|NCT00164749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110204310|NCT00164749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110204311|NCT00164749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110204312|NCT00164749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110204313|NCT00164749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110204314|NCT00164749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110204315|NCT00164749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204316|NCT00164788|Esomeprazole|esomeprazole|mesh-list
110204317|NCT00164788|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110204318|NCT00164788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110204319|NCT00164788|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110224640|NCT06000423|Hemostatics|hemostatics|mesh-ancestor
110204321|NCT00164788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204322|NCT00053768|Prednisone|prednisone|mesh-list
110204323|NCT00053768|Cyclophosphamide|cyclophosphamide|mesh-list
110204324|NCT00053768|Doxorubicin|doxorubicin|mesh-list
110204325|NCT00053768|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110204326|NCT00053768|Etoposide|etoposide|mesh-list
110204327|NCT00053768|Vincristine|vincristine|mesh-list
110204328|NCT00053768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110204329|NCT00053768|Immunologic Factors|immunologic factors|mesh-ancestor
110204330|NCT00053768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110204331|NCT00053768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110204332|NCT00053768|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110204333|NCT00053768|Alkylating Agents|alkylating agents|mesh-ancestor
110204334|NCT00053768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204335|NCT00053768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110204336|NCT00053768|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110204337|NCT00053768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110204338|NCT00053768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110204339|NCT00053768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110204340|NCT00053768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110204341|NCT00053768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110204342|NCT00053768|Glucocorticoids|glucocorticoids|mesh-ancestor
110204343|NCT00053768|Hormones|hormones|mesh-ancestor
110204344|NCT00053768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110204345|NCT00053768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110204346|NCT00053768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110204347|NCT00053768|Tubulin Modulators|tubulin modulators|mesh-ancestor
110204348|NCT00053768|Antimitotic Agents|antimitotic agents|mesh-ancestor
110204349|NCT00053768|Mitosis Modulators|mitosis modulators|mesh-ancestor
110204350|NCT00045123|Tarenflurbil|tarenflurbil|mesh-list
110204351|NCT00045123|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
110224983|NCT05998096|Caffeine|caffeine|mesh-list
110204352|NCT00045123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110204353|NCT00045123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204354|NCT00164866|Omeprazole|omeprazole|mesh-list
110204357|NCT00164866|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110204358|NCT00164866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110204359|NCT00164866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204360|NCT00407212|Maleic acid|maleic acid|mesh-list
110204361|NCT00407212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110204362|NCT00407212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204365|NCT00165139|Ifosfamide|ifosfamide|mesh-list
110204366|NCT00165139|Carboplatin|carboplatin|mesh-list
110204367|NCT00165139|Etoposide|etoposide|mesh-list
110204368|NCT00165139|Vincristine|vincristine|mesh-list
110204369|NCT00165139|Doxorubicin|doxorubicin|mesh-list
110204370|NCT00165139|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110204371|NCT00165139|Lenograstim|lenograstim|mesh-list
110204372|NCT00165139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110204373|NCT00165139|Immunologic Factors|immunologic factors|mesh-ancestor
110204374|NCT00165139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110204375|NCT00165139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110204376|NCT00165139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110204377|NCT00165139|Alkylating Agents|alkylating agents|mesh-ancestor
110204378|NCT00165139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204379|NCT00165139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110204380|NCT00165139|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110204381|NCT00165139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110204382|NCT00165139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110204383|NCT00165139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110204384|NCT00165139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110204385|NCT00165139|Tubulin Modulators|tubulin modulators|mesh-ancestor
110204386|NCT00165139|Antimitotic Agents|antimitotic agents|mesh-ancestor
110204387|NCT00165139|Mitosis Modulators|mitosis modulators|mesh-ancestor
110204388|NCT00165139|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110204389|NCT00165139|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110204390|NCT00053807|Interferons|interferons|mesh-list
110204391|NCT00053807|Interferon-alpha|interferon-alpha|mesh-list
110204392|NCT00053807|Aldesleukin|aldesleukin|mesh-list
110204393|NCT00053807|Fluorouracil|fluorouracil|mesh-list
110204394|NCT00053807|Antimetabolites|antimetabolites|mesh-ancestor
110204395|NCT00053807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204396|NCT00053807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110204397|NCT00053807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110204398|NCT00053807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110204399|NCT00053807|Immunologic Factors|immunologic factors|mesh-ancestor
110204400|NCT00053807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110204401|NCT00053807|Antiviral Agents|antiviral agents|mesh-ancestor
110204402|NCT00053807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110204403|NCT00053807|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110204404|NCT00053807|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110204406|NCT00165178|Cytarabine|cytarabine|mesh-list
110204407|NCT00165178|Dexamethasone|dexamethasone|mesh-list
110204408|NCT00165178|Prednisone|prednisone|mesh-list
110204409|NCT00165178|Hydrocortisone|hydrocortisone|mesh-list
110204410|NCT00165178|Doxorubicin|doxorubicin|mesh-list
110204411|NCT00165178|Methotrexate|methotrexate|mesh-list
110204412|NCT00165178|Vincristine|vincristine|mesh-list
110204414|NCT00165178|Dexrazoxane|dexrazoxane|mesh-list
110204415|NCT00165178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110204416|NCT00165178|Antiemetics|antiemetics|mesh-ancestor
110204417|NCT00165178|Autonomic Agents|autonomic agents|mesh-ancestor
110204418|NCT00165178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110204419|NCT00165178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110204421|NCT00165178|Glucocorticoids|glucocorticoids|mesh-ancestor
110204422|NCT00165178|Hormones|hormones|mesh-ancestor
110204423|NCT00165178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110204424|NCT00165178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110204425|NCT00165178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110225446|NCT05966194|Cisplatin|cisplatin|mesh-list
110204426|NCT00165178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110204427|NCT00165178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110204428|NCT00165178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110204430|NCT00165178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204431|NCT00165178|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110204432|NCT00165178|Abortifacient Agents|abortifacient agents|mesh-ancestor
110204433|NCT00165178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110204434|NCT00165178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110204435|NCT00165178|Antimetabolites|antimetabolites|mesh-ancestor
110204436|NCT00165178|Dermatologic Agents|dermatologic agents|mesh-ancestor
110204437|NCT00165178|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110204438|NCT00165178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110204439|NCT00165178|Immunologic Factors|immunologic factors|mesh-ancestor
110204440|NCT00165178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110225498|NCT05952713|Analgesics|analgesics|mesh-ancestor
110204441|NCT00165178|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110204442|NCT00165178|Antiviral Agents|antiviral agents|mesh-ancestor
110204443|NCT00165178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110204444|NCT00165178|Antidotes|antidotes|mesh-ancestor
110204445|NCT00165178|Protective Agents|protective agents|mesh-ancestor
110204446|NCT00165178|Vitamin B Complex|vitamin b complex|mesh-ancestor
110204447|NCT00165178|Vitamins|vitamins|mesh-ancestor
110204448|NCT00165178|Micronutrients|micronutrients|mesh-ancestor
110204449|NCT00165178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110204450|NCT00165178|Tubulin Modulators|tubulin modulators|mesh-ancestor
110204451|NCT00165178|Antimitotic Agents|antimitotic agents|mesh-ancestor
110225555|NCT05905419|Narcotics|narcotics|mesh-ancestor
110204452|NCT00165178|Mitosis Modulators|mitosis modulators|mesh-ancestor
110204453|NCT00165178|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110204454|NCT00165217|Thalidomide|thalidomide|mesh-list
110204455|NCT00165217|Capecitabine|capecitabine|mesh-list
110204456|NCT00165217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110204457|NCT00165217|Antimetabolites|antimetabolites|mesh-ancestor
110204458|NCT00165217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204459|NCT00165217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110225621|NCT05894928|Antimetabolites|antimetabolites|mesh-ancestor
110204460|NCT00165217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110204461|NCT00165217|Immunologic Factors|immunologic factors|mesh-ancestor
110204462|NCT00165217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110204463|NCT00165217|Leprostatic Agents|leprostatic agents|mesh-ancestor
110204464|NCT00165217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110204465|NCT00165217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110204466|NCT00165217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110204467|NCT00165217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110204469|NCT00165217|Growth Inhibitors|growth inhibitors|mesh-ancestor
110204470|NCT00165295|Sildenafil Citrate|sildenafil citrate|mesh-list
110204471|NCT00165295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204472|NCT00165295|Vasodilator Agents|vasodilator agents|mesh-ancestor
110204473|NCT00165295|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110204474|NCT00165295|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110204475|NCT00165295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110204476|NCT00165295|Urological Agents|urological agents|mesh-ancestor
110204478|NCT00053885|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110204479|NCT00053885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110204480|NCT00053885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204481|NCT00165334|Cetuximab|cetuximab|mesh-list
110204482|NCT00165334|Vinorelbine|vinorelbine|mesh-list
110204483|NCT00165334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110204485|NCT00165334|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110204487|NCT00165334|Antimitotic Agents|antimitotic agents|mesh-ancestor
110204488|NCT00165334|Mitosis Modulators|mitosis modulators|mesh-ancestor
110225817|NCT05826574|Leprostatic Agents|leprostatic agents|mesh-ancestor
110204489|NCT00165334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204490|NCT00165373|Endostatins|endostatins|mesh-list
110204491|NCT00165373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110204492|NCT00165373|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110204493|NCT00165373|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110204494|NCT00165373|Growth Substances|growth substances|mesh-ancestor
110204495|NCT00165373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110204496|NCT00165373|Growth Inhibitors|growth inhibitors|mesh-ancestor
110204497|NCT00165451|Thalidomide|thalidomide|mesh-list
110204498|NCT00165451|Celecoxib|celecoxib|mesh-list
110204499|NCT00165451|Cyclophosphamide|cyclophosphamide|mesh-list
110204500|NCT00165451|Etoposide|etoposide|mesh-list
110204501|NCT00165451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110204502|NCT00165451|Immunologic Factors|immunologic factors|mesh-ancestor
110204503|NCT00165451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110204504|NCT00165451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110204505|NCT00165451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110204506|NCT00165451|Alkylating Agents|alkylating agents|mesh-ancestor
110204507|NCT00165451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204508|NCT00165451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110204509|NCT00165451|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110204510|NCT00165451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110204511|NCT00165451|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110204512|NCT00165451|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110204513|NCT00165451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110204514|NCT00165451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110204515|NCT00165451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110204516|NCT00165451|Analgesics|analgesics|mesh-ancestor
110204517|NCT00165451|Sensory System Agents|sensory system agents|mesh-ancestor
110204518|NCT00165451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110204519|NCT00165451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110204520|NCT00165451|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110204521|NCT00165451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110204522|NCT00165451|Leprostatic Agents|leprostatic agents|mesh-ancestor
110204523|NCT00165451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110204524|NCT00165451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110204525|NCT00165451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110204526|NCT00165451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110204527|NCT00165451|Growth Substances|growth substances|mesh-ancestor
110204528|NCT00165451|Growth Inhibitors|growth inhibitors|mesh-ancestor
110204530|NCT00165490|Cetuximab|cetuximab|mesh-list
110204531|NCT00165490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110204532|NCT00165490|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110204533|NCT00165490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110204534|NCT00165490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110204535|NCT00165490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204536|NCT00165490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110204538|NCT00165568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110204539|NCT00165568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110204540|NCT00165568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110204541|NCT00165568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110204542|NCT00165568|Growth Substances|growth substances|mesh-ancestor
110204543|NCT00165568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110204544|NCT00165568|Growth Inhibitors|growth inhibitors|mesh-ancestor
110204545|NCT00165685|Sibutramine|sibutramine|mesh-list
110204546|NCT00165685|Antidepressive Agents|antidepressive agents|mesh-ancestor
110204547|NCT00165685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110204548|NCT00165685|Appetite Depressants|appetite depressants|mesh-ancestor
110204549|NCT00165685|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110204550|NCT00045279|Interferons|interferons|mesh-list
110204552|NCT00045279|Interferon alpha-2|interferon alpha-2|mesh-list
110204553|NCT00045279|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110204554|NCT00045279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110204555|NCT00045279|Antiviral Agents|antiviral agents|mesh-ancestor
110204556|NCT00045279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110204557|NCT00045279|Immunologic Factors|immunologic factors|mesh-ancestor
110204558|NCT00045279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110204559|NCT00053963|Romidepsin|romidepsin|mesh-list
110204560|NCT00053963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110204561|NCT00053963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110204562|NCT00053963|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110204563|NCT00053963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110204564|NCT00053963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204565|NCT00165763|Donepezil|donepezil|mesh-list
110204566|NCT00165763|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110204567|NCT00165763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110204568|NCT00165763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204569|NCT00165763|Cholinergic Agents|cholinergic agents|mesh-ancestor
110204570|NCT00165763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110204571|NCT00165763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110204572|NCT00165763|Nootropic Agents|nootropic agents|mesh-ancestor
110204573|NCT00165880|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
110204574|NCT00165880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110204575|NCT00165880|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110204576|NCT00165880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110204577|NCT00165880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204579|NCT00045318|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110204580|NCT00045318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110204581|NCT00045318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110204582|NCT00045318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204583|NCT00045318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110226327|NCT05561751|Propranolol|propranolol|mesh-list
110204584|NCT00054002|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
110204586|NCT00054002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110204587|NCT00054002|Dermatologic Agents|dermatologic agents|mesh-ancestor
110204588|NCT00054002|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110204589|NCT00054041|Vaccines|vaccines|mesh-list
110204590|NCT00054041|Immunologic Factors|immunologic factors|mesh-ancestor
110204591|NCT00054041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110204592|NCT00166153|Mycophenolic Acid|mycophenolic acid|mesh-list
110204593|NCT00166153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110204594|NCT00166153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110204595|NCT00166153|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110204596|NCT00166153|Antitubercular Agents|antitubercular agents|mesh-ancestor
110204597|NCT00166153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110204598|NCT00166153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110226450|NCT05491317|Pembrolizumab|pembrolizumab|mesh-list
110204599|NCT00166153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110204600|NCT00166153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204601|NCT00054197|Paclitaxel|paclitaxel|mesh-list
110204602|NCT00054197|Vinorelbine|vinorelbine|mesh-list
110204603|NCT00054197|Gemcitabine|gemcitabine|mesh-list
110204604|NCT00054197|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
110226513|NCT05467670|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110204605|NCT00054197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110204606|NCT00054197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110204608|NCT00054197|Antimitotic Agents|antimitotic agents|mesh-ancestor
110204609|NCT00054197|Mitosis Modulators|mitosis modulators|mesh-ancestor
110204610|NCT00054197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204611|NCT00054197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110204612|NCT00054197|Antimetabolites|antimetabolites|mesh-ancestor
110204613|NCT00045396|Tipifarnib|tipifarnib|mesh-list
110204614|NCT00045396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110204615|NCT00166426|Sulindac sulfone|sulindac sulfone|mesh-list
110204616|NCT00166426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110204617|NCT00166426|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110204618|NCT00166426|Protective Agents|protective agents|mesh-ancestor
110204619|NCT00166426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110204620|NCT00166426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110204621|NCT00166426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110204622|NCT00166426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204623|NCT00166426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110204624|NCT00166426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110204626|NCT00166426|Sensory System Agents|sensory system agents|mesh-ancestor
110204627|NCT00166426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110204629|NCT00166426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110204630|NCT00166465|Leucovorin|leucovorin|mesh-list
110204631|NCT00166465|Fluorouracil|fluorouracil|mesh-list
110204632|NCT00166465|Oxaliplatin|oxaliplatin|mesh-list
110204633|NCT00166465|Antimetabolites|antimetabolites|mesh-ancestor
110204634|NCT00166465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204635|NCT00166465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110204636|NCT00166465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110204637|NCT00166465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110204638|NCT00166465|Immunologic Factors|immunologic factors|mesh-ancestor
110204639|NCT00166465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110204641|NCT00166465|Protective Agents|protective agents|mesh-ancestor
110204642|NCT00166465|Vitamin B Complex|vitamin b complex|mesh-ancestor
110204644|NCT00166465|Micronutrients|micronutrients|mesh-ancestor
110204645|NCT00166621|Buspirone|buspirone|mesh-list
110204646|NCT00166621|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110204647|NCT00166621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110204648|NCT00166621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110204649|NCT00166621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110204650|NCT00166621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110204651|NCT00166621|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110204653|NCT00166621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110204654|NCT00166621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204656|NCT00054236|Cyclophosphamide|cyclophosphamide|mesh-list
110204658|NCT00054236|Fludarabine phosphate|fludarabine phosphate|mesh-list
110227003|NCT05068791|Psilocybin|psilocybin|mesh-list
110204659|NCT00054236|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110204660|NCT00054236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110204661|NCT00054236|Immunologic Factors|immunologic factors|mesh-ancestor
110204662|NCT00054236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110204663|NCT00054236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110204664|NCT00054236|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110204665|NCT00054236|Alkylating Agents|alkylating agents|mesh-ancestor
110204666|NCT00054236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204667|NCT00054236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110204668|NCT00054236|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110204669|NCT00054236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110204670|NCT00054236|Antimetabolites|antimetabolites|mesh-ancestor
110204671|NCT00054236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110204672|NCT00054236|Antiemetics|antiemetics|mesh-ancestor
110204673|NCT00054236|Autonomic Agents|autonomic agents|mesh-ancestor
110204674|NCT00054236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110204675|NCT00054236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110204676|NCT00054236|Glucocorticoids|glucocorticoids|mesh-ancestor
110204677|NCT00054236|Hormones|hormones|mesh-ancestor
110204678|NCT00054236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110204679|NCT00054236|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110204680|NCT00054236|Protective Agents|protective agents|mesh-ancestor
110204681|NCT00054392|Paclitaxel|paclitaxel|mesh-list
110204682|NCT00054392|Carboplatin|carboplatin|mesh-list
110204683|NCT00054392|Gemcitabine|gemcitabine|mesh-list
110204684|NCT00054392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110204685|NCT00054392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110204686|NCT00054392|Tubulin Modulators|tubulin modulators|mesh-ancestor
110204687|NCT00054392|Antimitotic Agents|antimitotic agents|mesh-ancestor
110204688|NCT00054392|Mitosis Modulators|mitosis modulators|mesh-ancestor
110204689|NCT00054392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204690|NCT00054392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110204691|NCT00054392|Antimetabolites|antimetabolites|mesh-ancestor
110204692|NCT00166816|Cyclosporine|cyclosporine|mesh-list
110204694|NCT00166816|Tacrolimus|tacrolimus|mesh-list
110204695|NCT00166816|Cyclosporins|cyclosporins|mesh-list
110204696|NCT00166816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110204697|NCT00166816|Immunologic Factors|immunologic factors|mesh-ancestor
110204698|NCT00166816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110204699|NCT00166816|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110227095|NCT05035407|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110204701|NCT00166816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204702|NCT00166816|Antifungal Agents|antifungal agents|mesh-ancestor
110227175|NCT04926181|Androgens|androgens|mesh-list
110204703|NCT00166816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110204704|NCT00166816|Dermatologic Agents|dermatologic agents|mesh-ancestor
110204705|NCT00166816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110204706|NCT00166816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110204707|NCT00166816|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110227246|NCT04885530|Serotonin Agents|serotonin agents|mesh-ancestor
110204708|NCT00166816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110204709|NCT04723732|Chlorhexidine|chlorhexidine|mesh-list
110204710|NCT04723732|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110204711|NCT04723732|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110204712|NCT04723732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110204713|NCT04723732|Disinfectants|disinfectants|mesh-ancestor
110204714|NCT04723732|Dermatologic Agents|dermatologic agents|mesh-ancestor
110204715|NCT00054431|Imatinib Mesylate|imatinib mesylate|mesh-list
110204716|NCT00054431|Decitabine|decitabine|mesh-list
110204717|NCT00054431|Azacitidine|azacitidine|mesh-list
110204718|NCT00054431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110204719|NCT00054431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110204720|NCT00054431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110204721|NCT00054431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204723|NCT00054431|Antimetabolites|antimetabolites|mesh-ancestor
110204725|NCT00054470|Tipifarnib|tipifarnib|mesh-list
110204726|NCT00054470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110204727|NCT00054470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110204728|NCT00054548|Paclitaxel|paclitaxel|mesh-list
110204729|NCT00054548|Oblimersen|oblimersen|mesh-list
110204730|NCT00054548|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110204731|NCT00054548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110204732|NCT00054548|Tubulin Modulators|tubulin modulators|mesh-ancestor
110204733|NCT00054548|Antimitotic Agents|antimitotic agents|mesh-ancestor
110204734|NCT00054548|Mitosis Modulators|mitosis modulators|mesh-ancestor
110204735|NCT00054548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204737|NCT00045513|Fludarabine phosphate|fludarabine phosphate|mesh-list
110204738|NCT00045513|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
110204739|NCT00045513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110204740|NCT00045513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110204742|NCT00045513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204743|NCT00045513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110204744|NCT00045513|Immunologic Factors|immunologic factors|mesh-ancestor
110204745|NCT00045513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110204746|NCT00045513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110204747|NCT00045513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110204748|NCT00167401|Docetaxel|docetaxel|mesh-list
110204749|NCT00167401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110204750|NCT00167401|Tubulin Modulators|tubulin modulators|mesh-ancestor
110204751|NCT00167401|Antimitotic Agents|antimitotic agents|mesh-ancestor
110204752|NCT00167401|Mitosis Modulators|mitosis modulators|mesh-ancestor
110204753|NCT00167401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204754|NCT00167479|Risperidone|risperidone|mesh-list
110204756|NCT00167479|Serotonin Agents|serotonin agents|mesh-ancestor
110204757|NCT00167479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110204758|NCT00167479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204759|NCT00167479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110204760|NCT00167479|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110204761|NCT00167479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110204762|NCT00167479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110204763|NCT00167479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110204764|NCT00167479|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110204765|NCT00167479|Dopamine Agents|dopamine agents|mesh-ancestor
110204766|NCT00054587|Cyclophosphamide|cyclophosphamide|mesh-list
110204767|NCT00054587|Docetaxel|docetaxel|mesh-list
110204768|NCT00054587|Fluorouracil|fluorouracil|mesh-list
110204769|NCT00054587|Trastuzumab|trastuzumab|mesh-list
110204770|NCT00054587|Epirubicin|epirubicin|mesh-list
110204771|NCT00054587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110204772|NCT00054587|Immunologic Factors|immunologic factors|mesh-ancestor
110204773|NCT00054587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110204775|NCT00054587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110227560|NCT04574778|Acetaminophen|acetaminophen|mesh-list
110204776|NCT00054587|Alkylating Agents|alkylating agents|mesh-ancestor
110204777|NCT00054587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204778|NCT00054587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110204779|NCT00054587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110204780|NCT00054587|Tubulin Modulators|tubulin modulators|mesh-ancestor
110204781|NCT00054587|Antimitotic Agents|antimitotic agents|mesh-ancestor
110204782|NCT00054587|Mitosis Modulators|mitosis modulators|mesh-ancestor
110204783|NCT00054587|Antimetabolites|antimetabolites|mesh-ancestor
110204784|NCT00054587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110204785|NCT00054587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110204786|NCT00054587|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110204787|NCT00054587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110204788|NCT00054587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110204789|NCT00054587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110204790|NCT00167518|Triamcinolone|triamcinolone|mesh-list
110204791|NCT00167518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110204792|NCT00167518|Glucocorticoids|glucocorticoids|mesh-ancestor
110204794|NCT00167518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110227683|NCT04447027|Cc-486|cc-486|mesh-list
110204795|NCT00167518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110204796|NCT00167557|Interferons|interferons|mesh-list
110204797|NCT00167557|Ribavirin|ribavirin|mesh-list
110204798|NCT00167557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110204800|NCT00167557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110204801|NCT00167557|Antimetabolites|antimetabolites|mesh-ancestor
110204802|NCT00167557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204803|NCT00167674|Zidovudine|zidovudine|mesh-list
110204804|NCT00167674|Nevirapine|nevirapine|mesh-list
110204805|NCT00167674|Antimetabolites|antimetabolites|mesh-ancestor
110204806|NCT00167674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204807|NCT00167674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110204808|NCT00167674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110204809|NCT00167674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110204810|NCT00167674|Antiviral Agents|antiviral agents|mesh-ancestor
110204811|NCT00167674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110204812|NCT00167674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110204813|NCT00167674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110204814|NCT00167674|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110204815|NCT00167674|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110204816|NCT00054626|Gemcitabine|gemcitabine|mesh-list
110204817|NCT00054626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110204818|NCT00054626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110204819|NCT00054626|Antimetabolites|antimetabolites|mesh-ancestor
110204820|NCT00054626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204821|NCT00167713|Ibuprofen|ibuprofen|mesh-list
110204822|NCT00167713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110204823|NCT00167713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110204824|NCT00167713|Analgesics|analgesics|mesh-ancestor
110204826|NCT00167713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110204827|NCT00167713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110204828|NCT00167713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110204829|NCT00167713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110204830|NCT00167713|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110204831|NCT00167713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110204832|NCT00167713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204833|NCT00167791|Rituximab|rituximab|mesh-list
110204834|NCT00167791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110204835|NCT00167791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110204836|NCT00167791|Immunologic Factors|immunologic factors|mesh-ancestor
110204837|NCT00167791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110204838|NCT00167791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110204840|NCT00045591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110204841|NCT00045591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110204842|NCT00045591|Analgesics|analgesics|mesh-ancestor
110227883|NCT04240002|Cytarabine|cytarabine|mesh-list
110204843|NCT00045591|Sensory System Agents|sensory system agents|mesh-ancestor
110204844|NCT00045591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110204845|NCT00045591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110204846|NCT00045591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110204847|NCT00045591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110204848|NCT00045591|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110204849|NCT00045591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110204850|NCT00045591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110204851|NCT00045591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204852|NCT00167908|Amifostine|amifostine|mesh-list
110204853|NCT00167908|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110204854|NCT00167908|Protective Agents|protective agents|mesh-ancestor
110204855|NCT00167908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110204856|NCT00167947|Cyclosporine|cyclosporine|mesh-list
110204857|NCT00167947|Sirolimus|sirolimus|mesh-list
110204858|NCT00167947|Cyclosporins|cyclosporins|mesh-list
110204859|NCT00167947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110204860|NCT00167947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204861|NCT00167947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110204862|NCT00167947|Immunologic Factors|immunologic factors|mesh-ancestor
110204863|NCT00167947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110204864|NCT00167947|Antifungal Agents|antifungal agents|mesh-ancestor
110204865|NCT00167947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110204866|NCT00167947|Dermatologic Agents|dermatologic agents|mesh-ancestor
110204867|NCT00167947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110204868|NCT00167947|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110204869|NCT00167947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110204870|NCT00167947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110204871|NCT00167947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110204873|NCT00167986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110204874|NCT00167986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110204875|NCT00168025|Immunoglobulins|immunoglobulins|mesh-list
110204876|NCT00168025|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110204877|NCT00168025|Antibodies|antibodies|mesh-list
110204878|NCT00168025|Immunologic Factors|immunologic factors|mesh-ancestor
110204879|NCT00168025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110204880|NCT00168181|Pilocarpine|pilocarpine|mesh-list
110204881|NCT00168181|Miotics|miotics|mesh-ancestor
110204882|NCT00168181|Autonomic Agents|autonomic agents|mesh-ancestor
110204883|NCT00168181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110204884|NCT00168181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110204885|NCT00168181|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110204886|NCT00168181|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110204887|NCT00168181|Cholinergic Agents|cholinergic agents|mesh-ancestor
110204888|NCT00168181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110228186|NCT04029038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110204889|NCT00168181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204891|NCT00407251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110204892|NCT00407251|Tubulin Modulators|tubulin modulators|mesh-ancestor
110204893|NCT00407251|Antimitotic Agents|antimitotic agents|mesh-ancestor
110204894|NCT00407251|Mitosis Modulators|mitosis modulators|mesh-ancestor
110204895|NCT00407251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204896|NCT00045669|Imatinib Mesylate|imatinib mesylate|mesh-list
110204897|NCT00045669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110204898|NCT00045669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110204899|NCT00045669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110204900|NCT00045669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204901|NCT00407290|Neostigmine|neostigmine|mesh-list
110204902|NCT00407290|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110204903|NCT00407290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110204904|NCT00407290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204905|NCT00407290|Cholinergic Agents|cholinergic agents|mesh-ancestor
110204906|NCT00407290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110204907|NCT00407290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110204908|NCT00407290|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110204909|NCT00407290|Autonomic Agents|autonomic agents|mesh-ancestor
110204910|NCT00407290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110204913|NCT00407407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110204915|NCT00407446|Vasodilator Agents|vasodilator agents|mesh-ancestor
110204916|NCT00407446|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110204917|NCT00407446|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110204918|NCT00407446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110204919|NCT00407446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204920|NCT00407446|Urological Agents|urological agents|mesh-ancestor
110204921|NCT00168415|Botulinum Toxins|botulinum toxins|mesh-list
110204922|NCT00168415|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110204923|NCT00168415|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110204924|NCT00168415|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110204925|NCT00168415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110204926|NCT00168415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204927|NCT00168415|Cholinergic Agents|cholinergic agents|mesh-ancestor
110204928|NCT00168415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110204929|NCT00168415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110204930|NCT00168415|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110204931|NCT00168415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110204932|NCT00168493|Antidepressive Agents|antidepressive agents|mesh-list
110204933|NCT00168493|Serotonin|serotonin|mesh-list
110204934|NCT00168493|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
110204935|NCT00168493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110204936|NCT00168493|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110204937|NCT00168493|Serotonin Agents|serotonin agents|mesh-ancestor
110204938|NCT00168493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110204939|NCT00168493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204940|NCT00168493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110204941|NCT00168493|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110204942|NCT00168493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110204943|NCT00168532|Trimethoprim|trimethoprim|mesh-list
110204944|NCT00168532|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110204945|NCT00168532|Sulfamethoxazole|sulfamethoxazole|mesh-list
110204946|NCT00168532|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110204947|NCT00168532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110204948|NCT00168532|Antimalarials|antimalarials|mesh-ancestor
110204949|NCT00168532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110204950|NCT00168532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110204951|NCT00168532|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110204952|NCT00168532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110204953|NCT00168532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204954|NCT00168532|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110204955|NCT00168532|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110204956|NCT00168532|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110204957|NCT00168532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110204958|NCT00168610|Vitamin A|vitamin a|mesh-list
110204959|NCT00168610|Vitamins|vitamins|mesh-ancestor
110204960|NCT00168610|Micronutrients|micronutrients|mesh-ancestor
110204961|NCT00168610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110204962|NCT04731948|Vitamins|vitamins|mesh-list
110204963|NCT04731948|Folic Acid|folic acid|mesh-list
110204964|NCT04731948|Hydroxocobalamin|hydroxocobalamin|mesh-list
110204965|NCT04731948|Vitamin B 12|vitamin b 12|mesh-list
110204966|NCT04731948|Vitamin B Complex|vitamin b complex|mesh-list
110204967|NCT04731948|Micronutrients|micronutrients|mesh-ancestor
110204968|NCT04731948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110204969|NCT04731948|Hematinics|hematinics|mesh-ancestor
110204970|NCT00168649|Vitamin A|vitamin a|mesh-list
110204971|NCT00168649|Vitamins|vitamins|mesh-ancestor
110204972|NCT00168649|Micronutrients|micronutrients|mesh-ancestor
110204973|NCT00168649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110204974|NCT00168688|Micronutrients|micronutrients|mesh-list
110204975|NCT00168688|Trace Elements|trace elements|mesh-list
110204976|NCT00168688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110204977|NCT00168766|Interferons|interferons|mesh-list
110204978|NCT00168766|Interferon-beta|interferon-beta|mesh-list
110204979|NCT00168766|Interferon beta-1a|interferon beta-1a|mesh-list
110204980|NCT00168766|Methylprednisolone|methylprednisolone|mesh-list
110204982|NCT00168766|Antiviral Agents|antiviral agents|mesh-ancestor
110204983|NCT00168766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110204984|NCT00168766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110204985|NCT00168766|Antiemetics|antiemetics|mesh-ancestor
110204986|NCT00168766|Autonomic Agents|autonomic agents|mesh-ancestor
110204987|NCT00168766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110204988|NCT00168766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110204989|NCT00168766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110204990|NCT00168766|Glucocorticoids|glucocorticoids|mesh-ancestor
110204991|NCT00168766|Hormones|hormones|mesh-ancestor
110204992|NCT00168766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110204993|NCT00168766|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110204994|NCT00168766|Protective Agents|protective agents|mesh-ancestor
110204995|NCT00168766|Immunologic Factors|immunologic factors|mesh-ancestor
110204996|NCT00168766|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110204998|NCT00168883|Vinorelbine|vinorelbine|mesh-list
110204999|NCT00168883|Carboplatin|carboplatin|mesh-list
110228824|NCT03182244|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110205000|NCT00168883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110205001|NCT00168883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110205002|NCT00168883|Tubulin Modulators|tubulin modulators|mesh-ancestor
110205003|NCT00168883|Antimitotic Agents|antimitotic agents|mesh-ancestor
110205004|NCT00168883|Mitosis Modulators|mitosis modulators|mesh-ancestor
110205005|NCT00168883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205007|NCT04731909|Carboplatin|carboplatin|mesh-list
110205008|NCT04731909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110205009|NCT00168922|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110205010|NCT00168922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110205011|NCT00168922|Alkylating Agents|alkylating agents|mesh-ancestor
110205012|NCT00168922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205013|NCT00168922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110205014|NCT00054938|Aspirin|aspirin|mesh-list
110205015|NCT00054938|Ramipril|ramipril|mesh-list
110205016|NCT00054938|Pravastatin|pravastatin|mesh-list
110205017|NCT00054938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110205018|NCT00054938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110205019|NCT00054938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110205020|NCT00054938|Analgesics|analgesics|mesh-ancestor
110228959|NCT02741323|Maraviroc|maraviroc|mesh-list
110205021|NCT00054938|Sensory System Agents|sensory system agents|mesh-ancestor
110205022|NCT00054938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110205023|NCT00054938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110205024|NCT00054938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110205025|NCT00054938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110205026|NCT00054938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110205027|NCT00054938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205028|NCT00054938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110205029|NCT00054938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110205030|NCT00054938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110205031|NCT00054938|Antipyretics|antipyretics|mesh-ancestor
110205032|NCT00054938|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110205033|NCT00054938|Protease Inhibitors|protease inhibitors|mesh-ancestor
110205034|NCT00054938|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110205035|NCT00054938|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110205036|NCT00054938|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110205037|NCT00054938|Antimetabolites|antimetabolites|mesh-ancestor
110205038|NCT00054938|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110205039|NCT00054938|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110205040|NCT00169000|Docetaxel|docetaxel|mesh-list
110205041|NCT00169000|Capecitabine|capecitabine|mesh-list
110205042|NCT00169000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110205043|NCT00169000|Tubulin Modulators|tubulin modulators|mesh-ancestor
110205044|NCT00169000|Antimitotic Agents|antimitotic agents|mesh-ancestor
110205045|NCT00169000|Mitosis Modulators|mitosis modulators|mesh-ancestor
110205046|NCT00169000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205047|NCT00169000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110205048|NCT00169000|Antimetabolites|antimetabolites|mesh-ancestor
110205049|NCT00045747|Fluorouracil|fluorouracil|mesh-list
110205050|NCT00045747|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
110205051|NCT00045747|Antimetabolites|antimetabolites|mesh-ancestor
110205052|NCT00045747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205053|NCT00045747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110205055|NCT00045747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110205056|NCT00045747|Immunologic Factors|immunologic factors|mesh-ancestor
110205057|NCT00045747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110205058|NCT00045747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110205059|NCT00045747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110205060|NCT00169039|Chlorpromazine|chlorpromazine|mesh-list
110205061|NCT00169039|Clozapine|clozapine|mesh-list
110205062|NCT00169039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110205063|NCT00169039|Serotonin Agents|serotonin agents|mesh-ancestor
110205064|NCT00169039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110205065|NCT00169039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110229217|NCT01861106|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110205066|NCT00169039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110205067|NCT00169039|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110205068|NCT00169039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110205069|NCT00169039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110205070|NCT00169039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110205071|NCT00169039|GABA Antagonists|gaba antagonists|mesh-ancestor
110205072|NCT00169039|GABA Agents|gaba agents|mesh-ancestor
110205073|NCT00169039|Antiemetics|antiemetics|mesh-ancestor
110205074|NCT00169039|Autonomic Agents|autonomic agents|mesh-ancestor
110205075|NCT00169039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110205076|NCT00169039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110205077|NCT00169039|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110205078|NCT00169039|Dopamine Agents|dopamine agents|mesh-ancestor
110205079|NCT00169078|Chloroquine|chloroquine|mesh-list
110205080|NCT00169078|Amebicides|amebicides|mesh-ancestor
110205081|NCT00169078|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110205082|NCT00169078|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110205083|NCT00169078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110205084|NCT00169078|Antimalarials|antimalarials|mesh-ancestor
110205085|NCT00169078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110205086|NCT00054977|Fluorouracil|fluorouracil|mesh-list
110205087|NCT00054977|Antimetabolites|antimetabolites|mesh-ancestor
110229331|NCT01199575|Lenalidomide|lenalidomide|mesh-list
110205088|NCT00054977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205089|NCT00054977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110205090|NCT00054977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110205091|NCT00054977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110205092|NCT00054977|Immunologic Factors|immunologic factors|mesh-ancestor
110205093|NCT00054977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110205095|NCT00169156|Cyclophosphamide|cyclophosphamide|mesh-list
110205096|NCT00169156|Rituximab|rituximab|mesh-list
110205097|NCT00169156|Doxorubicin|doxorubicin|mesh-list
110205098|NCT00169156|Vincristine|vincristine|mesh-list
110205099|NCT00169156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110205100|NCT00169156|Immunologic Factors|immunologic factors|mesh-ancestor
110205101|NCT00169156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110205102|NCT00169156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110205103|NCT00169156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110205104|NCT00169156|Alkylating Agents|alkylating agents|mesh-ancestor
110205105|NCT00169156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205106|NCT00169156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110205107|NCT00169156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110205108|NCT00169156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110205109|NCT00169156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110205110|NCT00169156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110205111|NCT00169156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110205112|NCT00169156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110205113|NCT00169156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110205116|NCT00169156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110205117|NCT00169156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110205118|NCT00169156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110205119|NCT00169156|Tubulin Modulators|tubulin modulators|mesh-ancestor
110205120|NCT00169156|Antimitotic Agents|antimitotic agents|mesh-ancestor
110205121|NCT00169156|Mitosis Modulators|mitosis modulators|mesh-ancestor
110205122|NCT00169195|Rituximab|rituximab|mesh-list
110205123|NCT00169195|Gemcitabine|gemcitabine|mesh-list
110205124|NCT00169195|Oxaliplatin|oxaliplatin|mesh-list
110205125|NCT00169195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110205126|NCT00169195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110025338|NCT00363090|Prednisone|prednisone|mesh-list
110205127|NCT00169195|Immunologic Factors|immunologic factors|mesh-ancestor
110205128|NCT00169195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110205129|NCT00169195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110205130|NCT00169195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110205131|NCT00169195|Antimetabolites|antimetabolites|mesh-ancestor
110205132|NCT00169195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205133|NCT00169234|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110205134|NCT00169234|Immunologic Factors|immunologic factors|mesh-ancestor
110205135|NCT00169234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110205136|NCT00169468|Rituximab|rituximab|mesh-list
110205137|NCT00169468|Bortezomib|bortezomib|mesh-list
110205138|NCT00169468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110205139|NCT00169468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110205140|NCT00169468|Immunologic Factors|immunologic factors|mesh-ancestor
110205141|NCT00169468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110205142|NCT00169468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110205143|NCT00169546|Fluticasone|fluticasone|mesh-list
110205144|NCT00169546|Xhance|xhance|mesh-list
110205145|NCT00169546|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110205146|NCT00169546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110205147|NCT00169546|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110205148|NCT00169546|Autonomic Agents|autonomic agents|mesh-ancestor
110205149|NCT00169546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110205150|NCT00169546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110205151|NCT00169546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110205152|NCT00169546|Respiratory System Agents|respiratory system agents|mesh-ancestor
110205153|NCT00169546|Dermatologic Agents|dermatologic agents|mesh-ancestor
110205154|NCT00169546|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110205155|NCT00169546|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110205156|NCT00169546|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110205157|NCT00169546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110205158|NCT00169546|Adrenergic Agents|adrenergic agents|mesh-ancestor
110205159|NCT00169546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110205160|NCT00169546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205161|NCT00398372|Rituximab|rituximab|mesh-list
110205162|NCT00398372|Epratuzumab|epratuzumab|mesh-list
110205163|NCT00398372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110205164|NCT00398372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110205165|NCT00398372|Immunologic Factors|immunologic factors|mesh-ancestor
110205166|NCT00398372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110205167|NCT00398372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110205168|NCT00169585|Levofloxacin|levofloxacin|mesh-list
110205169|NCT00169585|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110205170|NCT00169585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110205171|NCT00169585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110205172|NCT00169585|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110205173|NCT00169585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110205174|NCT00169585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110205175|NCT00169585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205176|NCT00169585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110205177|NCT00169585|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110205178|NCT00169585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110205179|NCT00169624|Metformin|metformin|mesh-list
110205180|NCT00169624|Gliclazide|gliclazide|mesh-list
110205181|NCT00169624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110205182|NCT00169624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110205183|NCT00407641|Heparin|heparin|mesh-list
110205184|NCT00407641|Tinzaparin|tinzaparin|mesh-list
110205185|NCT00407641|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110205186|NCT00407641|Dalteparin|dalteparin|mesh-list
110205187|NCT00407641|Anticoagulants|anticoagulants|mesh-ancestor
110205188|NCT00407641|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110205189|NCT00407641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110205190|NCT00407641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205192|NCT00407680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110205193|NCT00407680|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110205194|NCT00407680|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110205195|NCT00407680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205196|NCT00169819|Abciximab|abciximab|mesh-list
110205197|NCT00169819|Anticoagulants|anticoagulants|mesh-ancestor
110205198|NCT00169819|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110205199|NCT00055133|Paclitaxel|paclitaxel|mesh-list
110205200|NCT00055133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110205201|NCT00055133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110205202|NCT00055133|Tubulin Modulators|tubulin modulators|mesh-ancestor
110205203|NCT00055133|Antimitotic Agents|antimitotic agents|mesh-ancestor
110205204|NCT00055133|Mitosis Modulators|mitosis modulators|mesh-ancestor
110205205|NCT00055133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205207|NCT00170053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110205208|NCT00170053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110205209|NCT00170053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110205210|NCT00170053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110205211|NCT00170053|Antifungal Agents|antifungal agents|mesh-ancestor
110205212|NCT00170053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110205213|NCT00170053|Immunologic Factors|immunologic factors|mesh-ancestor
110229827|NCT00313885|Serotonin Agents|serotonin agents|mesh-ancestor
110205214|NCT00170053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110205215|NCT00055250|Gemcitabine|gemcitabine|mesh-list
110205216|NCT00055250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110205217|NCT00055250|Antimetabolites|antimetabolites|mesh-ancestor
110205218|NCT00055250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205219|NCT00055250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110205220|NCT00170209|Rifampin|rifampin|mesh-list
110205221|NCT00170209|Isoniazid|isoniazid|mesh-list
110205222|NCT00170209|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110205223|NCT00170209|Antitubercular Agents|antitubercular agents|mesh-ancestor
110205224|NCT00170209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110205225|NCT00170209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110205226|NCT00170209|Leprostatic Agents|leprostatic agents|mesh-ancestor
110205227|NCT00170209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110205228|NCT00170209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110205229|NCT00170209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205230|NCT00170209|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110205231|NCT00170209|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110205232|NCT00170209|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110205233|NCT00170209|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110205234|NCT00170209|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110205235|NCT00170209|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110205236|NCT00170209|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110205237|NCT00170209|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110205238|NCT00170209|Antimetabolites|antimetabolites|mesh-ancestor
110205239|NCT00170209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110205241|NCT02964091|Ledipasvir|ledipasvir|mesh-list
110230000|NCT00314977|Docetaxel|docetaxel|mesh-list
110205242|NCT02964091|Antiviral Agents|antiviral agents|mesh-ancestor
110205243|NCT02964091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110205244|NCT00170404|Vitamins|vitamins|mesh-list
110205245|NCT00170404|Folic Acid|folic acid|mesh-list
110205246|NCT00170404|Vitamin A|vitamin a|mesh-list
110205247|NCT00170404|Thiamine|thiamine|mesh-list
110205248|NCT00170404|Selenium|selenium|mesh-list
110205249|NCT00170404|Micronutrients|micronutrients|mesh-list
110205250|NCT00170404|Trace Elements|trace elements|mesh-list
110205251|NCT00170404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110205253|NCT00170404|Vitamin B Complex|vitamin b complex|mesh-ancestor
110205254|NCT00170404|Antioxidants|antioxidants|mesh-ancestor
110205255|NCT00170404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205256|NCT00170404|Protective Agents|protective agents|mesh-ancestor
110205257|NCT00055367|Natalizumab|natalizumab|mesh-list
110205258|NCT00055367|Immunologic Factors|immunologic factors|mesh-ancestor
110205259|NCT00055367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110205260|NCT00170677|Topotecan|topotecan|mesh-list
110205261|NCT00170677|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110205262|NCT00170677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110205263|NCT00170677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110205264|NCT00170677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205265|NCT00170677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110205266|NCT00170755|Darifenacin|darifenacin|mesh-list
110205267|NCT00170755|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110205268|NCT00170755|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110205269|NCT00170755|Cholinergic Agents|cholinergic agents|mesh-ancestor
110205270|NCT00170755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110205271|NCT00170755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205272|NCT00170755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110205273|NCT00170755|Urological Agents|urological agents|mesh-ancestor
110205274|NCT00170794|Everolimus|everolimus|mesh-list
110205275|NCT00170794|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110205276|NCT00170794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110205277|NCT00170794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110205278|NCT00170794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205279|NCT00170794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110205280|NCT00170794|Immunologic Factors|immunologic factors|mesh-ancestor
110205281|NCT00170794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110205282|NCT00170794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110205283|NCT00170833|Everolimus|everolimus|mesh-list
110205284|NCT00170833|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110205285|NCT00170833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110205286|NCT00170833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110205287|NCT00170833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205288|NCT00170833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110205289|NCT00170833|Immunologic Factors|immunologic factors|mesh-ancestor
110205290|NCT00170833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110205291|NCT00170833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110205292|NCT00170872|Lumiracoxib|lumiracoxib|mesh-list
110205293|NCT00170872|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110205295|NCT00170872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110205296|NCT00170872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205297|NCT00170872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110205298|NCT00170872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110205299|NCT00170872|Analgesics|analgesics|mesh-ancestor
110205300|NCT00170872|Sensory System Agents|sensory system agents|mesh-ancestor
110205301|NCT00170872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110205302|NCT00170872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110205303|NCT00170872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110205304|NCT00170872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110205306|NCT00170989|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110205307|NCT00170989|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110205308|NCT00170989|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110205309|NCT00170989|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110205310|NCT00170989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205311|NCT00170989|Diuretics|diuretics|mesh-ancestor
110205312|NCT00170989|Natriuretic Agents|natriuretic agents|mesh-ancestor
110205313|NCT00170989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110205314|NCT00170989|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110205315|NCT00170989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110205316|NCT00171028|Valsartan|valsartan|mesh-list
110205317|NCT00171028|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110205318|NCT00171028|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110205319|NCT00171028|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110205320|NCT00171028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205322|NCT00055484|Anticonvulsants|anticonvulsants|mesh-ancestor
110205323|NCT00055484|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110205324|NCT00055484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110205325|NCT00055484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205326|NCT00055484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110205327|NCT00055484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110205328|NCT00171067|Valsartan|valsartan|mesh-list
110205329|NCT00171067|Lisinopril|lisinopril|mesh-list
110205330|NCT00171067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110205331|NCT00171067|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110205332|NCT00171067|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110205333|NCT00171067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205334|NCT00171067|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110205335|NCT00171067|Protease Inhibitors|protease inhibitors|mesh-ancestor
110205336|NCT00171067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110205337|NCT00171067|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110205338|NCT00171067|Protective Agents|protective agents|mesh-ancestor
110205339|NCT00171067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110205340|NCT00171106|Valsartan|valsartan|mesh-list
110205341|NCT00171106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110205342|NCT00171106|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110205343|NCT00171106|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110205344|NCT00171106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205345|NCT00171145|Darifenacin|darifenacin|mesh-list
110205346|NCT00171145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110205347|NCT00171145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110205348|NCT00171145|Cholinergic Agents|cholinergic agents|mesh-ancestor
110205349|NCT00171145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110026033|NCT00381732|Tadalafil|tadalafil|mesh-list
110205350|NCT00171145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205351|NCT00171145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110205352|NCT00171145|Urological Agents|urological agents|mesh-ancestor
110205353|NCT00171184|Darifenacin|darifenacin|mesh-list
110205354|NCT00171184|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110205355|NCT00171184|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110205356|NCT00171184|Cholinergic Agents|cholinergic agents|mesh-ancestor
110205357|NCT00171184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110205358|NCT00171184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205359|NCT00171184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110205360|NCT00171184|Urological Agents|urological agents|mesh-ancestor
110205361|NCT00055523|Adalimumab|adalimumab|mesh-list
110205362|NCT00055523|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110205364|NCT00055523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110205365|NCT00171379|Mycophenolic Acid|mycophenolic acid|mesh-list
110205366|NCT00171379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110205367|NCT00171379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110205368|NCT00171379|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110205369|NCT00171379|Antitubercular Agents|antitubercular agents|mesh-ancestor
110205370|NCT00171379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110205371|NCT00171379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110205372|NCT00171379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110205373|NCT00171379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205374|NCT00171418|Tegaserod|tegaserod|mesh-list
110205375|NCT00171418|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110205376|NCT00171418|Serotonin Agents|serotonin agents|mesh-ancestor
110205377|NCT00171418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110205378|NCT00171418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205379|NCT00171418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110205380|NCT00171457|Tegaserod|tegaserod|mesh-list
110205381|NCT00171457|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110205382|NCT00171457|Serotonin Agents|serotonin agents|mesh-ancestor
110205384|NCT00171457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205385|NCT00171457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110205386|NCT00055562|Lenalidomide|lenalidomide|mesh-list
110205387|NCT00055562|Immunologic Factors|immunologic factors|mesh-ancestor
110205388|NCT00055562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110205389|NCT00055562|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110205390|NCT00055562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110205391|NCT00055562|Growth Substances|growth substances|mesh-ancestor
110205392|NCT00055562|Growth Inhibitors|growth inhibitors|mesh-ancestor
110205393|NCT00055562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110205395|NCT00171496|Tacrolimus|tacrolimus|mesh-list
110205396|NCT00171496|Cyclosporins|cyclosporins|mesh-list
110205397|NCT00171496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110205398|NCT00171496|Immunologic Factors|immunologic factors|mesh-ancestor
110205399|NCT00171496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110205400|NCT00171496|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110205401|NCT00171496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110205402|NCT00171496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205403|NCT00171496|Antifungal Agents|antifungal agents|mesh-ancestor
110205404|NCT00171496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110205406|NCT00171496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110205408|NCT00171535|Valsartan|valsartan|mesh-list
110205409|NCT00171535|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110205410|NCT00171535|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110205411|NCT00171535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110205412|NCT00171535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205413|NCT00171535|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110205414|NCT00171535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110205415|NCT00171535|Vasodilator Agents|vasodilator agents|mesh-ancestor
110230675|NCT01821833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110205416|NCT00171535|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110205417|NCT00171535|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110205420|NCT00171574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110205421|NCT00171574|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110205422|NCT00171574|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110205423|NCT00171574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205424|NCT00171574|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110205425|NCT00171574|Protease Inhibitors|protease inhibitors|mesh-ancestor
110205426|NCT00171574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110205427|NCT00171574|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110205428|NCT00171574|Protective Agents|protective agents|mesh-ancestor
110205429|NCT00171574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110205431|NCT00171613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110205432|NCT00171613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110205433|NCT00171613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110205434|NCT04920981|Atezolizumab|atezolizumab|mesh-list
110205435|NCT04920981|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110205436|NCT04920981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205437|NCT04920981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110205438|NCT04920981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110205439|NCT00055640|Prednisone|prednisone|mesh-list
110205440|NCT00055640|Cyclophosphamide|cyclophosphamide|mesh-list
110205441|NCT00055640|Rituximab|rituximab|mesh-list
110205442|NCT00055640|Doxorubicin|doxorubicin|mesh-list
110205443|NCT00055640|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110205444|NCT00055640|Vincristine|vincristine|mesh-list
110205445|NCT00055640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110205446|NCT00055640|Immunologic Factors|immunologic factors|mesh-ancestor
110205447|NCT00055640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110205448|NCT00055640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110205449|NCT00055640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110205450|NCT00055640|Alkylating Agents|alkylating agents|mesh-ancestor
110205451|NCT00055640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205453|NCT00055640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110205454|NCT00055640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110205455|NCT00055640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110205456|NCT00055640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110205457|NCT00055640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110205458|NCT00055640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110205459|NCT00055640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110205460|NCT00055640|Glucocorticoids|glucocorticoids|mesh-ancestor
110205461|NCT00055640|Hormones|hormones|mesh-ancestor
110205462|NCT00055640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110205463|NCT00055640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110205464|NCT00055640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110205465|NCT00055640|Tubulin Modulators|tubulin modulators|mesh-ancestor
110205466|NCT00055640|Antimitotic Agents|antimitotic agents|mesh-ancestor
110205467|NCT00055640|Mitosis Modulators|mitosis modulators|mesh-ancestor
110205468|NCT00171652|Diclofenac|diclofenac|mesh-list
110368626|NCT05419583|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110205469|NCT00171652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110205470|NCT00171652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110205471|NCT00171652|Analgesics|analgesics|mesh-ancestor
110205472|NCT00171652|Sensory System Agents|sensory system agents|mesh-ancestor
110205473|NCT00171652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110205474|NCT00171652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110205476|NCT00171652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110205477|NCT00171652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110205478|NCT00171652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110205479|NCT00171652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205481|NCT00171691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110205482|NCT00171691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110205483|NCT00171691|Analgesics|analgesics|mesh-ancestor
110205484|NCT00171691|Sensory System Agents|sensory system agents|mesh-ancestor
110205485|NCT00171691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110205486|NCT00171691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110205487|NCT00171691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110205488|NCT00171691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110205489|NCT00171691|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110205490|NCT00171691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110205491|NCT00171691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205492|NCT00171769|Certoparin|certoparin|mesh-list
110205493|NCT00171769|Anticoagulants|anticoagulants|mesh-ancestor
110205494|NCT00171808|Letrozole|letrozole|mesh-list
110205495|NCT00171808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110205496|NCT00171808|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110205497|NCT00171808|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110205498|NCT00171808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110231115|NCT00093288|Bupropion|bupropion|mesh-list
110205499|NCT00171808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205501|NCT00171808|Hormone Antagonists|hormone antagonists|mesh-ancestor
110231166|NCT00093366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110205502|NCT00171808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110205503|NCT00171808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110205505|NCT00171847|Letrozole|letrozole|mesh-list
110231235|NCT00325000|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110205506|NCT00171847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110205507|NCT00171847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110205508|NCT00171847|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110205509|NCT00171847|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110205510|NCT00171847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110205511|NCT00171847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205512|NCT00171847|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110205513|NCT00171847|Hormone Antagonists|hormone antagonists|mesh-ancestor
110205514|NCT00171847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110205515|NCT00171847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110205516|NCT00055679|Cyclophosphamide|cyclophosphamide|mesh-list
110205517|NCT00055679|Fluorouracil|fluorouracil|mesh-list
110205518|NCT00055679|Epirubicin|epirubicin|mesh-list
110205519|NCT00055679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110205520|NCT00055679|Immunologic Factors|immunologic factors|mesh-ancestor
110205521|NCT00055679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110205522|NCT00055679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110205523|NCT00055679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110205526|NCT00055679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110205527|NCT00055679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110205528|NCT00055679|Antimetabolites|antimetabolites|mesh-ancestor
110205529|NCT00055679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110205530|NCT00055679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110205531|NCT00055679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110205532|NCT00055679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110205533|NCT00055679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110205535|NCT00171886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110205536|NCT00171886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110205537|NCT00171886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110205538|NCT00171964|Zoledronic Acid|zoledronic acid|mesh-list
110205539|NCT00171964|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110205540|NCT00171964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110205541|NCT00172003|Zoledronic Acid|zoledronic acid|mesh-list
110205542|NCT00172003|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110205543|NCT00172003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110205544|NCT00055718|Silymarin|silymarin|mesh-list
110205545|NCT00055718|Antioxidants|antioxidants|mesh-ancestor
110205546|NCT00055718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205547|NCT00055718|Protective Agents|protective agents|mesh-ancestor
110205548|NCT00055718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110205549|NCT00055757|Gemcitabine|gemcitabine|mesh-list
110205550|NCT00055757|Tipifarnib|tipifarnib|mesh-list
110205551|NCT00055757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110205552|NCT00055757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110205553|NCT00055757|Antimetabolites|antimetabolites|mesh-ancestor
110205554|NCT00055757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205555|NCT00399867|Simvastatin|simvastatin|mesh-list
110205556|NCT00399867|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110205557|NCT00399867|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110205558|NCT00399867|Antimetabolites|antimetabolites|mesh-ancestor
110205559|NCT00399867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205560|NCT00399867|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110205561|NCT00399867|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110205562|NCT00399867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110205564|NCT00055835|Carboplatin|carboplatin|mesh-list
110205565|NCT00055835|Gemcitabine|gemcitabine|mesh-list
110231835|NCT00085943|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110205566|NCT00055835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110205567|NCT00055835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110205568|NCT00055835|Tubulin Modulators|tubulin modulators|mesh-ancestor
110205569|NCT00055835|Antimitotic Agents|antimitotic agents|mesh-ancestor
110205570|NCT00055835|Mitosis Modulators|mitosis modulators|mesh-ancestor
110231906|NCT00320632|Antidepressive Agents|antidepressive agents|mesh-ancestor
110205571|NCT00055835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205573|NCT00055835|Antimetabolites|antimetabolites|mesh-ancestor
110205575|NCT00172354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110205576|NCT00055874|Interferons|interferons|mesh-list
110205577|NCT00055874|Cytarabine|cytarabine|mesh-list
110205578|NCT00055874|Interferon-alpha|interferon-alpha|mesh-list
110205579|NCT00055874|Imatinib Mesylate|imatinib mesylate|mesh-list
110205580|NCT00055874|Hydroxyurea|hydroxyurea|mesh-list
110205581|NCT00055874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110205582|NCT00055874|Antiviral Agents|antiviral agents|mesh-ancestor
110231974|NCT05458492|Sirolimus|sirolimus|mesh-list
110205583|NCT00055874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110205584|NCT00055874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110205585|NCT00055874|Antimetabolites|antimetabolites|mesh-ancestor
110205586|NCT00055874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205587|NCT00055874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110205588|NCT00055874|Immunologic Factors|immunologic factors|mesh-ancestor
110205589|NCT00055874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110205590|NCT00055874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110205591|NCT00055874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110205592|NCT00055874|Antisickling Agents|antisickling agents|mesh-ancestor
110205593|NCT00055874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110205595|NCT00407719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110205596|NCT00407719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110205597|NCT00407719|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110205598|NCT00407719|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110205599|NCT00407719|Growth Substances|growth substances|mesh-ancestor
110205600|NCT00407719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110205601|NCT00407719|Growth Inhibitors|growth inhibitors|mesh-ancestor
110205603|NCT00055913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110205604|NCT00055913|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110205605|NCT00055913|Antibodies|antibodies|mesh-list
110205606|NCT00055913|Immunoglobulins|immunoglobulins|mesh-list
110205607|NCT00055913|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110205608|NCT00055913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110205609|NCT00055913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110205610|NCT00055913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110205611|NCT00055913|Growth Substances|growth substances|mesh-ancestor
110205612|NCT00055913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110205613|NCT00055913|Growth Inhibitors|growth inhibitors|mesh-ancestor
110205615|NCT00055913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110205616|NCT00055913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110205617|NCT00055913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205618|NCT00045864|Aldesleukin|aldesleukin|mesh-list
110205619|NCT00045864|Rituximab|rituximab|mesh-list
110205620|NCT00045864|Interleukin-2|interleukin-2|mesh-list
110205621|NCT00045864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110205622|NCT00045864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110205623|NCT00045864|Immunologic Factors|immunologic factors|mesh-ancestor
110205624|NCT00045864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110205625|NCT00045864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110205626|NCT00045864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110205627|NCT00045864|Analgesics|analgesics|mesh-ancestor
110205628|NCT00045864|Sensory System Agents|sensory system agents|mesh-ancestor
110205629|NCT00045864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110205630|NCT00045864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110205631|NCT00045864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110205632|NCT00045864|Antiviral Agents|antiviral agents|mesh-ancestor
110205633|NCT00045864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110205634|NCT00055952|Exatecan|exatecan|mesh-list
110205635|NCT00055952|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110205636|NCT00055952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110205637|NCT00055952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110205638|NCT00055952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205639|NCT00055952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110205640|NCT00055991|Bexarotene|bexarotene|mesh-list
110205641|NCT00055991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110205642|NCT04631484|Niacinamide|niacinamide|mesh-list
110205644|NCT04631484|Nicotinic Acids|nicotinic acids|mesh-list
110205646|NCT04631484|Vitamin B Complex|vitamin b complex|mesh-ancestor
110205647|NCT04631484|Vitamins|vitamins|mesh-ancestor
110205648|NCT04631484|Micronutrients|micronutrients|mesh-ancestor
110205649|NCT04631484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110205650|NCT04631484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110205651|NCT04631484|Antimetabolites|antimetabolites|mesh-ancestor
110205652|NCT04631484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205653|NCT04631484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110205654|NCT04631484|Vasodilator Agents|vasodilator agents|mesh-ancestor
110205655|NCT04631484|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110205656|NCT04631484|Dermatologic Agents|dermatologic agents|mesh-ancestor
110205657|NCT00056030|Leucovorin|leucovorin|mesh-list
110205658|NCT00056030|Fluorouracil|fluorouracil|mesh-list
110205659|NCT00056030|Oxaliplatin|oxaliplatin|mesh-list
110205660|NCT00056030|Cetuximab|cetuximab|mesh-list
110205661|NCT00056030|Calcium|calcium|mesh-list
110205662|NCT00056030|Levoleucovorin|levoleucovorin|mesh-list
110205663|NCT00056030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110205664|NCT00056030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110205665|NCT00056030|Antimetabolites|antimetabolites|mesh-ancestor
110205666|NCT00056030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205667|NCT00056030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110205668|NCT00056030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110205669|NCT00056030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110205670|NCT00056030|Immunologic Factors|immunologic factors|mesh-ancestor
110205671|NCT00056030|Antidotes|antidotes|mesh-ancestor
110205672|NCT00056030|Protective Agents|protective agents|mesh-ancestor
110205673|NCT00056030|Vitamin B Complex|vitamin b complex|mesh-ancestor
110205674|NCT00056030|Vitamins|vitamins|mesh-ancestor
110205675|NCT00056030|Micronutrients|micronutrients|mesh-ancestor
110205676|NCT00056030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110232415|NCT00124839|Naltrexone|naltrexone|mesh-list
110205677|NCT00046020|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110205678|NCT00046020|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110205679|NCT00046020|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110205680|NCT00046020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110205681|NCT00046020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205682|NCT00046020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110205683|NCT00046020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110205684|NCT00046020|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110205685|NCT00046020|Antidepressive Agents|antidepressive agents|mesh-ancestor
110205686|NCT00046020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110205687|NCT00173875|Gefitinib|gefitinib|mesh-list
110205688|NCT00173875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110205689|NCT00173875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110205690|NCT00173875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110205691|NCT00173875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205692|NCT00174226|Buspirone|buspirone|mesh-list
110205693|NCT00174226|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110205694|NCT00174226|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110205695|NCT00174226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110205696|NCT00174226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110205697|NCT00174226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205698|NCT00174226|Adrenergic Agents|adrenergic agents|mesh-ancestor
110205699|NCT00174226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110205700|NCT00174226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110205702|NCT00174226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110205703|NCT00174226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110205705|NCT00174226|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110205706|NCT00174226|Serotonin Agents|serotonin agents|mesh-ancestor
110205708|NCT00174304|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
110205709|NCT00174304|Atorvastatin|atorvastatin|mesh-list
110205710|NCT00174304|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110205711|NCT00174304|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110205712|NCT00174304|Antimetabolites|antimetabolites|mesh-ancestor
110205713|NCT00174304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205715|NCT00174304|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110205716|NCT00174304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110205717|NCT00174304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110205718|NCT00174304|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110205719|NCT00174304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110205720|NCT00174304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110205721|NCT00174304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110205722|NCT00174304|Vasodilator Agents|vasodilator agents|mesh-ancestor
110205723|NCT00174343|Exemestane|exemestane|mesh-list
110205724|NCT00174343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110205725|NCT00174343|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110205726|NCT00174343|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110205727|NCT00174343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110205728|NCT00174343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205729|NCT00174343|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110205730|NCT00174343|Hormone Antagonists|hormone antagonists|mesh-ancestor
110205731|NCT00174343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110205732|NCT00174343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110205733|NCT00174499|Nicotine|nicotine|mesh-list
110053021|NCT01484145|Terbinafine|terbinafine|mesh-list
110205734|NCT00174499|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110205735|NCT00174499|Autonomic Agents|autonomic agents|mesh-ancestor
110205736|NCT00174499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110205737|NCT00174499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110205738|NCT00174499|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110205739|NCT00174499|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110205740|NCT00174499|Cholinergic Agents|cholinergic agents|mesh-ancestor
110205741|NCT00174499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110205742|NCT00174499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205743|NCT00174538|Codeine|codeine|mesh-list
110205744|NCT00174538|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110205745|NCT00174538|Narcotics|narcotics|mesh-ancestor
110205746|NCT00174538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110205747|NCT00174538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110205748|NCT00174538|Analgesics|analgesics|mesh-ancestor
110205749|NCT00174538|Sensory System Agents|sensory system agents|mesh-ancestor
110205750|NCT00174538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110205751|NCT00174538|Antitussive Agents|antitussive agents|mesh-ancestor
110205752|NCT00174538|Respiratory System Agents|respiratory system agents|mesh-ancestor
110205753|NCT00174577|Risperidone|risperidone|mesh-list
110205754|NCT00174577|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110205755|NCT00174577|Serotonin Agents|serotonin agents|mesh-ancestor
110205756|NCT00174577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110205757|NCT00174577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205758|NCT00174577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110205759|NCT00174577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110205760|NCT00174577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110205761|NCT00174577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110205762|NCT00174577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110205763|NCT00174577|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110205764|NCT00174577|Dopamine Agents|dopamine agents|mesh-ancestor
110205765|NCT00046137|Teriparatide|teriparatide|mesh-list
110205766|NCT00046137|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
110232979|NCT05828758|Amoxicillin|amoxicillin|mesh-list
110205767|NCT00046137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110205768|NCT00046137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110205769|NCT00046137|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110205770|NCT00046137|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110205771|NCT00046137|Hormone Antagonists|hormone antagonists|mesh-ancestor
110205772|NCT00046137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110233116|NCT05413330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110205773|NCT00046137|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110205774|NCT00046137|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110205776|NCT00056225|Vitamin B 12|vitamin b 12|mesh-list
110205777|NCT00056225|Vitamin B 6|vitamin b 6|mesh-list
110205778|NCT00056225|Pyridoxal|pyridoxal|mesh-list
110205779|NCT00056225|Pyridoxine|pyridoxine|mesh-list
110205780|NCT00056225|Vitamin B Complex|vitamin b complex|mesh-list
110205781|NCT00056225|Micronutrients|micronutrients|mesh-ancestor
110205782|NCT00056225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110205783|NCT00174616|Capecitabine|capecitabine|mesh-list
110205784|NCT00174616|Oxaliplatin|oxaliplatin|mesh-list
110205785|NCT00174616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110205786|NCT00174616|Antimetabolites|antimetabolites|mesh-ancestor
110205787|NCT00174616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205788|NCT00174616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110205789|NCT00174655|Cyclophosphamide|cyclophosphamide|mesh-list
110205790|NCT00174655|Docetaxel|docetaxel|mesh-list
110205792|NCT00174655|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110205794|NCT00174655|Immunologic Factors|immunologic factors|mesh-ancestor
110205795|NCT00174655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110205796|NCT00174655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110205797|NCT00174655|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110205798|NCT00174655|Alkylating Agents|alkylating agents|mesh-ancestor
110205799|NCT00174655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205800|NCT00174655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110205801|NCT00174655|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110205802|NCT00174655|Tubulin Modulators|tubulin modulators|mesh-ancestor
110205803|NCT00174655|Antimitotic Agents|antimitotic agents|mesh-ancestor
110205804|NCT00174655|Mitosis Modulators|mitosis modulators|mesh-ancestor
110205805|NCT00174655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110205806|NCT00174655|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110205807|NCT00174655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110205808|NCT00174655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110205809|NCT00174694|Telithromycin|telithromycin|mesh-list
110205810|NCT00174694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110205811|NCT00174694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110205812|NCT00174733|Ciclesonide|ciclesonide|mesh-list
110233244|NCT05037032|Naltrexone|naltrexone|mesh-list
110205813|NCT00174733|Glucocorticoids|glucocorticoids|mesh-ancestor
110205814|NCT00174733|Hormones|hormones|mesh-ancestor
110205815|NCT00174733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110205816|NCT00174733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110205817|NCT00174733|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110205818|NCT00056264|Infliximab|infliximab|mesh-list
110205819|NCT00056264|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110205820|NCT00056264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110205821|NCT00056264|Dermatologic Agents|dermatologic agents|mesh-ancestor
110205822|NCT00056264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110205823|NCT00056264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110205824|NCT00174772|Cisplatin|cisplatin|mesh-list
110205825|NCT00174772|Docetaxel|docetaxel|mesh-list
110205826|NCT00174772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110205827|NCT00174772|Tubulin Modulators|tubulin modulators|mesh-ancestor
110205828|NCT00174772|Antimitotic Agents|antimitotic agents|mesh-ancestor
110205829|NCT00174772|Mitosis Modulators|mitosis modulators|mesh-ancestor
110205830|NCT00174772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205831|NCT00174811|Telithromycin|telithromycin|mesh-list
110205832|NCT00174811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110205833|NCT00174811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110205834|NCT02963779|Apremilast|apremilast|mesh-list
110205835|NCT02963779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110205836|NCT02963779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110205837|NCT02963779|Analgesics|analgesics|mesh-ancestor
110205838|NCT02963779|Sensory System Agents|sensory system agents|mesh-ancestor
110205839|NCT02963779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110205840|NCT02963779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110205842|NCT02963779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110205843|NCT02963779|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110205844|NCT02963779|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110205845|NCT02963779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110205846|NCT02963779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205847|NCT00046176|Lamivudine|lamivudine|mesh-list
110205848|NCT00046176|Abacavir|abacavir|mesh-list
110205849|NCT00046176|Dideoxynucleosides|dideoxynucleosides|mesh-list
110205850|NCT00046176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110205851|NCT00046176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110205852|NCT00046176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110205853|NCT00046176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205855|NCT00046176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110205857|NCT00046176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110205858|NCT00046176|Antimetabolites|antimetabolites|mesh-ancestor
110205859|NCT00174928|Lansoprazole|lansoprazole|mesh-list
110205860|NCT00174928|Dexlansoprazole|dexlansoprazole|mesh-list
110205861|NCT00174928|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110205862|NCT00174928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110205863|NCT00174928|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110205864|NCT00174928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110205865|NCT00174928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205866|NCT00175045|Lansoprazole|lansoprazole|mesh-list
110205867|NCT00175045|Dexlansoprazole|dexlansoprazole|mesh-list
110205868|NCT00175045|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110205869|NCT00175045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110205870|NCT00175045|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110205871|NCT00175045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110205872|NCT00175045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205873|NCT00056381|Anidulafungin|anidulafungin|mesh-list
110205874|NCT00056381|Antifungal Agents|antifungal agents|mesh-ancestor
110205875|NCT00056381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110205876|NCT00175123|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110205877|NCT00175123|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110205878|NCT00175123|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110205879|NCT00175123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110205880|NCT00175123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110205881|NCT00175123|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110205882|NCT00175123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110205883|NCT00175123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205884|NCT00175123|Cholinergic Agents|cholinergic agents|mesh-ancestor
110205885|NCT00175123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110205887|NCT00175357|Heroin|heroin|mesh-list
110205888|NCT00175357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110205889|NCT00175357|Narcotics|narcotics|mesh-ancestor
110205890|NCT00175357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110205891|NCT00175357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110205892|NCT00175357|Analgesics|analgesics|mesh-ancestor
110205893|NCT00175357|Sensory System Agents|sensory system agents|mesh-ancestor
110205894|NCT00175357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110205895|NCT00175357|Antitussive Agents|antitussive agents|mesh-ancestor
110205896|NCT00175357|Respiratory System Agents|respiratory system agents|mesh-ancestor
110205897|NCT00046254|Zoledronic Acid|zoledronic acid|mesh-list
110205898|NCT00046254|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110205899|NCT00046254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110205900|NCT00175396|Ascorbic Acid|ascorbic acid|mesh-list
110205901|NCT00175396|Leuprolide|leuprolide|mesh-list
110205902|NCT00175396|Methyltestosterone|methyltestosterone|mesh-list
110205903|NCT00175396|Flutamide|flutamide|mesh-list
110205904|NCT00175396|Bicalutamide|bicalutamide|mesh-list
110205905|NCT00175396|Nilutamide|nilutamide|mesh-list
110205906|NCT00175396|Buserelin|buserelin|mesh-list
110205907|NCT00175396|Androgens|androgens|mesh-list
110205908|NCT00175396|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110233604|NCT03123978|Niclosamide|niclosamide|mesh-list
110205909|NCT00175396|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110205910|NCT00175396|Fertility Agents|fertility agents|mesh-ancestor
110205911|NCT00175396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110205912|NCT00175396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110205913|NCT00175396|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110205914|NCT00175396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110205915|NCT00175396|Hormones|hormones|mesh-ancestor
110205916|NCT00175396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110205917|NCT00175396|Antioxidants|antioxidants|mesh-ancestor
110205918|NCT00175396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205919|NCT00175396|Protective Agents|protective agents|mesh-ancestor
110205920|NCT00175396|Vitamins|vitamins|mesh-ancestor
110205921|NCT00175396|Micronutrients|micronutrients|mesh-ancestor
110205922|NCT00175396|Estrogens|estrogens|mesh-ancestor
110205923|NCT00175396|Anabolic Agents|anabolic agents|mesh-ancestor
110205924|NCT00175396|Androgen Antagonists|androgen antagonists|mesh-ancestor
110205925|NCT00175396|Hormone Antagonists|hormone antagonists|mesh-ancestor
110205926|NCT00056459|Vatalanib|vatalanib|mesh-list
110205927|NCT00056459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110205928|NCT00056459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110205929|NCT00056459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205930|NCT00175435|Vaccines|vaccines|mesh-list
110205931|NCT00175435|Immunologic Factors|immunologic factors|mesh-ancestor
110205932|NCT00175435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110205933|NCT00175513|Valacyclovir|valacyclovir|mesh-list
110205934|NCT00175513|Antiviral Agents|antiviral agents|mesh-ancestor
110205935|NCT00175513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110205936|NCT00175591|Bupivacaine|bupivacaine|mesh-list
110205937|NCT00175591|Anesthetics, Local|anesthetics, local|mesh-ancestor
110205938|NCT00175591|Anesthetics|anesthetics|mesh-ancestor
110205939|NCT00175591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110205940|NCT00175591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110205941|NCT00175591|Sensory System Agents|sensory system agents|mesh-ancestor
110205942|NCT00175591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110205943|NCT00175630|Bupivacaine|bupivacaine|mesh-list
110205944|NCT00175630|Anesthetics, Local|anesthetics, local|mesh-ancestor
110205945|NCT00175630|Anesthetics|anesthetics|mesh-ancestor
110205946|NCT00175630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110205947|NCT00175630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110205948|NCT00175630|Sensory System Agents|sensory system agents|mesh-ancestor
110205949|NCT00175630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110205950|NCT00056537|Naptumomab estafenatox|naptumomab estafenatox|mesh-list
110205952|NCT00056537|Immunologic Factors|immunologic factors|mesh-ancestor
110205953|NCT00056537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110205954|NCT00408031|Cycloserine|cycloserine|mesh-list
110205955|NCT00408031|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110205956|NCT00408031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110205957|NCT00408031|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110205958|NCT00408031|Antitubercular Agents|antitubercular agents|mesh-ancestor
110205959|NCT00408031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110205960|NCT00408031|Antimetabolites|antimetabolites|mesh-ancestor
110205961|NCT00408031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205962|NCT00175747|Budesonide|budesonide|mesh-list
110205963|NCT00175747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110205964|NCT00175747|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110205965|NCT00175747|Autonomic Agents|autonomic agents|mesh-ancestor
110205966|NCT00175747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110205967|NCT00175747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110205968|NCT00175747|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110205969|NCT00175747|Respiratory System Agents|respiratory system agents|mesh-ancestor
110205970|NCT00175747|Glucocorticoids|glucocorticoids|mesh-ancestor
110205971|NCT00175747|Hormones|hormones|mesh-ancestor
110205972|NCT00175747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110205973|NCT04493619|Carboplatin|carboplatin|mesh-list
110205974|NCT04493619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110205975|NCT00056576|Zonisamide|zonisamide|mesh-list
110205976|NCT00056576|Anticonvulsants|anticonvulsants|mesh-ancestor
110205977|NCT00056576|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110205978|NCT00056576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110205979|NCT00056576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205980|NCT00056576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110205981|NCT00056576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110205982|NCT00175903|Carbamazepine|carbamazepine|mesh-list
110234065|NCT05951959|Rituximab|rituximab|mesh-list
110205984|NCT00175903|Valproic Acid|valproic acid|mesh-list
110205985|NCT00175903|Anticonvulsants|anticonvulsants|mesh-ancestor
110205986|NCT00175903|Nootropic Agents|nootropic agents|mesh-ancestor
110205987|NCT00175903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110205988|NCT00175903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205989|NCT00175903|GABA Agents|gaba agents|mesh-ancestor
110205990|NCT00175903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110205991|NCT00175903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110205992|NCT00175903|Antimanic Agents|antimanic agents|mesh-ancestor
110205993|NCT00175903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110205994|NCT00175903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110205995|NCT00175903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110205996|NCT00175903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110205998|NCT00175903|Sensory System Agents|sensory system agents|mesh-ancestor
110205999|NCT00175903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110206000|NCT00175903|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110206001|NCT00175903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110206002|NCT00175903|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110206003|NCT00175903|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110206005|NCT00056654|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110206006|NCT00056654|Fertility Agents|fertility agents|mesh-ancestor
110206007|NCT00056654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110206008|NCT00056654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110206009|NCT00056654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110206010|NCT00056654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110206011|NCT00175981|Sildenafil Citrate|sildenafil citrate|mesh-list
110206012|NCT00175981|Fluvoxamine|fluvoxamine|mesh-list
110206014|NCT00175981|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110206015|NCT00175981|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110206016|NCT00175981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110206017|NCT00175981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110206018|NCT00175981|Urological Agents|urological agents|mesh-ancestor
110206019|NCT00175981|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110206020|NCT00175981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110206021|NCT00175981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110206022|NCT00175981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110206023|NCT00175981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110206024|NCT00175981|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110206025|NCT00175981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110206026|NCT00175981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110206027|NCT00175981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110206029|NCT00175981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110206030|NCT00175981|Antidepressive Agents|antidepressive agents|mesh-ancestor
110206031|NCT00175981|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110206032|NCT00175981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110206033|NCT00175981|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110206034|NCT04420533|Mirabegron|mirabegron|mesh-list
110206035|NCT04420533|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110206036|NCT04420533|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110206037|NCT04420533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110206038|NCT04420533|Adrenergic Agents|adrenergic agents|mesh-ancestor
110206039|NCT04420533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110206040|NCT04420533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110206041|NCT04420533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110206042|NCT04420533|Urological Agents|urological agents|mesh-ancestor
110206043|NCT00176020|Nicotinic Acids|nicotinic acids|mesh-list
110206045|NCT00176020|Niacinamide|niacinamide|mesh-list
110206046|NCT00176020|Vitamin B Complex|vitamin b complex|mesh-ancestor
110206047|NCT00176020|Vitamins|vitamins|mesh-ancestor
110206048|NCT00176020|Micronutrients|micronutrients|mesh-ancestor
110206050|NCT00176020|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110206051|NCT00176020|Antimetabolites|antimetabolites|mesh-ancestor
110206052|NCT00176020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110206053|NCT00176020|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110206054|NCT00176020|Vasodilator Agents|vasodilator agents|mesh-ancestor
110206055|NCT00176059|Immunoglobulins|immunoglobulins|mesh-list
110206056|NCT00176059|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110206057|NCT00176059|Antibodies|antibodies|mesh-list
110206058|NCT00176059|gamma-Globulins|gamma-globulins|mesh-list
110206059|NCT00176059|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110206060|NCT00176059|Immunologic Factors|immunologic factors|mesh-ancestor
110206061|NCT00176059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110206063|NCT00176098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110206064|NCT00176098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110206065|NCT00176293|Dexamethasone|dexamethasone|mesh-list
110206066|NCT00176293|Doxorubicin|doxorubicin|mesh-list
110206067|NCT00176293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110206068|NCT00176293|Antiemetics|antiemetics|mesh-ancestor
110206069|NCT00176293|Autonomic Agents|autonomic agents|mesh-ancestor
110206070|NCT00176293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110206071|NCT00176293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110206072|NCT00176293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110206073|NCT00176293|Glucocorticoids|glucocorticoids|mesh-ancestor
110234303|NCT05819892|Paclitaxel|paclitaxel|mesh-list
110206077|NCT00176293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110206078|NCT00176293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110206079|NCT00176293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110206080|NCT00176293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110206081|NCT00176293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110206082|NCT00176293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110206084|NCT00056693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110206085|NCT00056693|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110206086|NCT00056693|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110206087|NCT00056693|Growth Substances|growth substances|mesh-ancestor
110206088|NCT00056693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110206089|NCT00056693|Growth Inhibitors|growth inhibitors|mesh-ancestor
110206090|NCT00056693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110206091|NCT00056693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110206092|NCT00056693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110206093|NCT00176332|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110206094|NCT00176332|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110206095|NCT00176332|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110206096|NCT00176332|Antimetabolites|antimetabolites|mesh-ancestor
110206097|NCT00176332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110206098|NCT00176332|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110206099|NCT00176332|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110206100|NCT00176332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110206102|NCT00176449|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110206103|NCT00176449|Antidepressive Agents|antidepressive agents|mesh-ancestor
110206104|NCT00176449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110206106|NCT00176449|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110206107|NCT00176449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110206108|NCT00176449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110206109|NCT00176449|Dopamine Agents|dopamine agents|mesh-ancestor
110206110|NCT00176449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110206111|NCT00176449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110206112|NCT00176449|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110206113|NCT00176449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110206114|NCT00176449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110206115|NCT00398450|Interferons|interferons|mesh-list
110206116|NCT00398450|Interferon-alpha|interferon-alpha|mesh-list
110206117|NCT00398450|Interferon alpha-2|interferon alpha-2|mesh-list
110206118|NCT00398450|Azacitidine|azacitidine|mesh-list
110206119|NCT00398450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110206120|NCT00398450|Antiviral Agents|antiviral agents|mesh-ancestor
110206121|NCT00398450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110206122|NCT00398450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110206123|NCT00398450|Antimetabolites|antimetabolites|mesh-ancestor
110206124|NCT00398450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110206125|NCT00398450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110206126|NCT00398450|Immunologic Factors|immunologic factors|mesh-ancestor
110206127|NCT00398450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110206128|NCT00046293|Abciximab|abciximab|mesh-list
110206129|NCT00046293|Anticoagulants|anticoagulants|mesh-ancestor
110206130|NCT00046293|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110206131|NCT00176527|Interferons|interferons|mesh-list
110206133|NCT00176527|Interferon alpha-2|interferon alpha-2|mesh-list
110206134|NCT00176527|Docetaxel|docetaxel|mesh-list
110206135|NCT00176527|Estramustine|estramustine|mesh-list
110206136|NCT00176527|Isotretinoin|isotretinoin|mesh-list
110206137|NCT00176527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110206138|NCT00176527|Tubulin Modulators|tubulin modulators|mesh-ancestor
110206139|NCT00176527|Antimitotic Agents|antimitotic agents|mesh-ancestor
110206140|NCT00176527|Mitosis Modulators|mitosis modulators|mesh-ancestor
110206141|NCT00176527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110206142|NCT00176527|Antiviral Agents|antiviral agents|mesh-ancestor
110206143|NCT00176527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110206144|NCT00176527|Immunologic Factors|immunologic factors|mesh-ancestor
110206145|NCT00176527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110206146|NCT00176527|Dermatologic Agents|dermatologic agents|mesh-ancestor
110206147|NCT00176527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110206148|NCT00176527|Alkylating Agents|alkylating agents|mesh-ancestor
110206149|NCT00176527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110206150|NCT00398489|Tamoxifen|tamoxifen|mesh-list
110206151|NCT00398489|Cyclophosphamide|cyclophosphamide|mesh-list
110206152|NCT00398489|Docetaxel|docetaxel|mesh-list
110206153|NCT00398489|Trastuzumab|trastuzumab|mesh-list
110206154|NCT00398489|Epirubicin|epirubicin|mesh-list
110206155|NCT00398489|Anastrozole|anastrozole|mesh-list
110206156|NCT00398489|Goserelin|goserelin|mesh-list
110206157|NCT00398489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110206158|NCT00398489|Immunologic Factors|immunologic factors|mesh-ancestor
110206159|NCT00398489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110206160|NCT00398489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110206161|NCT00398489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110206162|NCT00398489|Alkylating Agents|alkylating agents|mesh-ancestor
110206163|NCT00398489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110206164|NCT00398489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110206165|NCT00398489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110206166|NCT00398489|Tubulin Modulators|tubulin modulators|mesh-ancestor
110206167|NCT00398489|Antimitotic Agents|antimitotic agents|mesh-ancestor
110206168|NCT00398489|Mitosis Modulators|mitosis modulators|mesh-ancestor
110206169|NCT00398489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110206170|NCT00398489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110206171|NCT00398489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110206172|NCT00398489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110206173|NCT00398489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110206174|NCT00398489|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110206175|NCT00398489|Hormone Antagonists|hormone antagonists|mesh-ancestor
110206176|NCT00398489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110206177|NCT00398489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110206178|NCT00398489|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110206179|NCT00398489|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110206180|NCT00398489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110206181|NCT00398489|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110206182|NCT00398489|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110206183|NCT00176761|Interleukin-2|interleukin-2|mesh-list
110206184|NCT00176761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110206185|NCT00176761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110206186|NCT00176761|Analgesics|analgesics|mesh-ancestor
110206187|NCT00176761|Sensory System Agents|sensory system agents|mesh-ancestor
110206188|NCT00176761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110206191|NCT00176995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110206192|NCT00176995|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110206193|NCT00176995|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110206194|NCT00176995|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110206195|NCT00176995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110206196|NCT00176995|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
110206197|NCT00176995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110206198|NCT00176995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110206200|NCT00423527|Anticonvulsants|anticonvulsants|mesh-ancestor
110206201|NCT00423527|Nootropic Agents|nootropic agents|mesh-ancestor
110206202|NCT00408148|Rimonabant|rimonabant|mesh-list
110206203|NCT00408148|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110206204|NCT00408148|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
110206205|NCT00408148|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110206206|NCT00408148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110206207|NCT00408148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110206208|NCT00408148|Hormones|hormones|mesh-ancestor
110206209|NCT00408148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110206210|NCT00408148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110206211|NCT00397566|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-list
110206212|NCT00397566|BMS-707035|bms-707035|mesh-list
110206213|NCT00397566|Integrase Inhibitors|integrase inhibitors|mesh-list
110206214|NCT00397566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110206215|NCT00397566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110206216|NCT00397566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110206217|NCT00397566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110206218|NCT00397566|Antiviral Agents|antiviral agents|mesh-ancestor
110206219|NCT00397566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110206220|NCT00177424|Sertraline|sertraline|mesh-list
110206221|NCT00177424|Antidepressive Agents|antidepressive agents|mesh-ancestor
110206222|NCT00177424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110206223|NCT00177424|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110206224|NCT00177424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110206225|NCT00177424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110206226|NCT00177424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110206227|NCT00177424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110206228|NCT00177424|Serotonin Agents|serotonin agents|mesh-ancestor
110206229|NCT00177424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110206230|NCT00177580|Pravastatin|pravastatin|mesh-list
110206231|NCT00177580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110206232|NCT00177580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110206233|NCT00177580|Antimetabolites|antimetabolites|mesh-ancestor
110206234|NCT00177580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110206235|NCT00177580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110206236|NCT00177580|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110206237|NCT00177580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110206238|NCT04723342|Blinatumomab|blinatumomab|mesh-list
110206239|NCT04723342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110206240|NCT00177619|Alendronate|alendronate|mesh-list
110206241|NCT00177619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110206242|NCT00177619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110206243|NCT00056810|4-Aminopyridine|4-aminopyridine|mesh-list
110206244|NCT00056810|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110206245|NCT00056810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110206246|NCT00056810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110206247|NCT00177853|Celecoxib|celecoxib|mesh-list
110206248|NCT00177853|Irinotecan|irinotecan|mesh-list
110206249|NCT00177853|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110206250|NCT00177853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110206257|NCT00177853|Sensory System Agents|sensory system agents|mesh-ancestor
110206258|NCT00177853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110206259|NCT00177853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110206260|NCT00177853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110206261|NCT00177853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110206262|NCT00177853|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110206263|NCT00177853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110206264|NCT00178048|Paroxetine|paroxetine|mesh-list
110206265|NCT00178048|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110206266|NCT00178048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110206267|NCT00178048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110206268|NCT00178048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110206269|NCT00178048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110206271|NCT00178048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110206272|NCT00178048|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110206273|NCT00178048|Antidepressive Agents|antidepressive agents|mesh-ancestor
110206274|NCT00178048|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110206275|NCT00178048|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110206276|NCT00178048|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110206277|NCT00178048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110206279|NCT00056966|Alemtuzumab|alemtuzumab|mesh-list
110206280|NCT00056966|Tacrolimus|tacrolimus|mesh-list
110206281|NCT00056966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110206282|NCT00056966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110206283|NCT00056966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110206284|NCT00056966|Immunologic Factors|immunologic factors|mesh-ancestor
110206285|NCT00056966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110206286|NCT00056966|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110206287|NCT00056966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110206288|NCT00056966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110206289|NCT00178828|Bupropion|bupropion|mesh-list
110206291|NCT00178828|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110206292|NCT00178828|Antidepressive Agents|antidepressive agents|mesh-ancestor
110206293|NCT00178828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110206294|NCT00178828|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110206295|NCT00178828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110206296|NCT00178828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110206297|NCT00178828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110206298|NCT00178828|Dopamine Agents|dopamine agents|mesh-ancestor
110206299|NCT00178828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110206300|NCT00178828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110206301|NCT00178828|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110206302|NCT00178828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110206303|NCT00178828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110206304|NCT00178828|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110206305|NCT00178828|Serotonin Agents|serotonin agents|mesh-ancestor
110206306|NCT00408187|Cyclosporine|cyclosporine|mesh-list
110206307|NCT00408187|Cyclosporins|cyclosporins|mesh-list
110206308|NCT00408187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110206309|NCT00408187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110206310|NCT00408187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110206311|NCT00408187|Immunologic Factors|immunologic factors|mesh-ancestor
110206312|NCT00408187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110206313|NCT00408187|Antifungal Agents|antifungal agents|mesh-ancestor
110206314|NCT00408187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110206315|NCT00408187|Dermatologic Agents|dermatologic agents|mesh-ancestor
110206316|NCT00408187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110206317|NCT00408187|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110206319|NCT00408226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110206320|NCT00408226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110206321|NCT00408226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110206322|NCT00408226|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110206323|NCT00408226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110206324|NCT02963896|Gentamicins|gentamicins|mesh-list
110206325|NCT02963896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110206326|NCT02963896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110206327|NCT02963896|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110206328|NCT02963896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110206329|NCT02963896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110206330|NCT00178945|Botulinum Toxins|botulinum toxins|mesh-list
110206331|NCT00178945|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110206332|NCT00178945|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110206333|NCT00178945|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110206334|NCT00178945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110206335|NCT00178945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110206336|NCT00178945|Cholinergic Agents|cholinergic agents|mesh-ancestor
110206337|NCT00178945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110206338|NCT00178945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110206339|NCT00178945|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110206340|NCT00178945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110206341|NCT00397722|Paroxetine|paroxetine|mesh-list
110206342|NCT00397722|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110206343|NCT00397722|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110206344|NCT00397722|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110206345|NCT00397722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110206346|NCT00397722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110206347|NCT00397722|Serotonin Agents|serotonin agents|mesh-ancestor
110206348|NCT00397722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110206349|NCT00397722|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110206358|NCT00179023|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
110206359|NCT00179023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110206360|NCT00179023|Autonomic Agents|autonomic agents|mesh-ancestor
110206361|NCT00179023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110206362|NCT00179023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110206363|NCT00179023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110206364|NCT00179023|Respiratory System Agents|respiratory system agents|mesh-ancestor
110206365|NCT00179023|Nasal Decongestants|nasal decongestants|mesh-ancestor
110206366|NCT00179023|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110206367|NCT00179023|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110206368|NCT00179023|Sympathomimetics|sympathomimetics|mesh-ancestor
110206369|NCT00179023|Adrenergic Agents|adrenergic agents|mesh-ancestor
110206370|NCT00179023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110206371|NCT00179023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110206372|NCT00179023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110206373|NCT00179023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110206374|NCT00179023|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
110206375|NCT00179023|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
110206376|NCT00179023|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110206377|NCT00179023|Cholinergic Agents|cholinergic agents|mesh-ancestor
110206378|NCT00179023|Vasodilator Agents|vasodilator agents|mesh-ancestor
110206379|NCT00057005|Cyclophosphamide|cyclophosphamide|mesh-list
110206380|NCT00057005|Alemtuzumab|alemtuzumab|mesh-list
110206381|NCT00057005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110206382|NCT00057005|Immunologic Factors|immunologic factors|mesh-ancestor
110206383|NCT00057005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110206384|NCT00057005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110206385|NCT00057005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110206386|NCT00057005|Alkylating Agents|alkylating agents|mesh-ancestor
110206387|NCT00057005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110206388|NCT00057005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110206389|NCT00057005|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110206390|NCT00057005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110206392|NCT00179062|Risperidone|risperidone|mesh-list
110206393|NCT00179062|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110206394|NCT00179062|Serotonin Agents|serotonin agents|mesh-ancestor
110206395|NCT00179062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110206396|NCT00179062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110206397|NCT00179062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110206398|NCT00179062|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110206399|NCT00179062|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110206400|NCT00179062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110206401|NCT00179062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110206402|NCT00179062|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110206404|NCT00179062|Antiemetics|antiemetics|mesh-ancestor
110206405|NCT00179062|Autonomic Agents|autonomic agents|mesh-ancestor
110206406|NCT00179062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110206407|NCT00179062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110206408|NCT00179062|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110206409|NCT00179062|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110206410|NCT00179062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110206411|NCT04723459|Ivermectin|ivermectin|mesh-list
110206412|NCT04723459|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110206413|NCT04723459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110206415|NCT00179257|Antidepressive Agents|antidepressive agents|mesh-ancestor
110206416|NCT00179257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110206417|NCT00179257|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110206418|NCT00179257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110206419|NCT00179257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110206420|NCT00179257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110206421|NCT00179257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110206422|NCT00179257|Serotonin Agents|serotonin agents|mesh-ancestor
110206423|NCT00179257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110206424|NCT00408382|Atorvastatin|atorvastatin|mesh-list
110206425|NCT00408382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110206426|NCT00408382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110206427|NCT00408382|Antimetabolites|antimetabolites|mesh-ancestor
110206428|NCT00408382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110206429|NCT00408382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110206430|NCT00408382|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110206431|NCT00408382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110206432|NCT00057122|Rifampin|rifampin|mesh-list
110206433|NCT00057122|Rifapentine|rifapentine|mesh-list
110206434|NCT00057122|Isoniazid|isoniazid|mesh-list
110206435|NCT00057122|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110206436|NCT00057122|Antitubercular Agents|antitubercular agents|mesh-ancestor
110206437|NCT00057122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110206438|NCT00057122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110206439|NCT00057122|Leprostatic Agents|leprostatic agents|mesh-ancestor
110206440|NCT00057122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110206441|NCT00057122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110206442|NCT00057122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110206443|NCT00057122|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110206444|NCT00057122|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110206445|NCT00057122|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110206446|NCT00057122|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110206447|NCT00057122|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110206448|NCT00057122|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110206449|NCT00057122|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110206450|NCT00057122|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110206451|NCT00057122|Antimetabolites|antimetabolites|mesh-ancestor
110206452|NCT00057122|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110206454|NCT00179608|Immunologic Factors|immunologic factors|mesh-ancestor
110206459|NCT00179608|Growth Inhibitors|growth inhibitors|mesh-ancestor
110206460|NCT00179608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110206461|NCT00179686|Lenalidomide|lenalidomide|mesh-list
110206462|NCT00179686|Immunologic Factors|immunologic factors|mesh-ancestor
110206463|NCT00179686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110206464|NCT00179686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110206465|NCT00179686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110206466|NCT00179686|Growth Substances|growth substances|mesh-ancestor
110206467|NCT00179686|Growth Inhibitors|growth inhibitors|mesh-ancestor
110206468|NCT00179686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110206469|NCT00179725|Doxorubicin|doxorubicin|mesh-list
110206470|NCT00179725|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110206471|NCT00179725|Lenalidomide|lenalidomide|mesh-list
110206472|NCT00179725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110206473|NCT00179725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110206474|NCT00179725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110206475|NCT00179725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110206477|NCT00179725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110206478|NCT00179725|Immunologic Factors|immunologic factors|mesh-ancestor
110206479|NCT00179725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110206480|NCT00179725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110206481|NCT00179725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110206482|NCT00179725|Growth Substances|growth substances|mesh-ancestor
110206483|NCT00179725|Growth Inhibitors|growth inhibitors|mesh-ancestor
110206484|NCT00179764|Busulfan|busulfan|mesh-list
110206485|NCT00179764|Alkylating Agents|alkylating agents|mesh-ancestor
110206486|NCT00179764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110206487|NCT00179764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110206488|NCT00179764|Immunologic Factors|immunologic factors|mesh-ancestor
110206489|NCT00179764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110206490|NCT00179764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110206491|NCT00179764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110206492|NCT00179764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110206494|NCT00179881|Carboplatin|carboplatin|mesh-list
110206495|NCT00179881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110206496|NCT00179881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110206497|NCT00179881|Immunologic Factors|immunologic factors|mesh-ancestor
110206498|NCT00179881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110206499|NCT00179881|Leprostatic Agents|leprostatic agents|mesh-ancestor
110206500|NCT00179881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110206501|NCT00179881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110206502|NCT00179881|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110206503|NCT00179881|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110206504|NCT00179881|Growth Substances|growth substances|mesh-ancestor
110206505|NCT00179881|Growth Inhibitors|growth inhibitors|mesh-ancestor
110206507|NCT00179920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110206509|NCT00180037|Coenzyme Q10|coenzyme q10|mesh-list
110206510|NCT00180037|Micronutrients|micronutrients|mesh-ancestor
110206511|NCT00180037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110206512|NCT00180037|Vitamins|vitamins|mesh-ancestor
110206514|NCT00180076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110206515|NCT00180076|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110206516|NCT00180076|Autonomic Agents|autonomic agents|mesh-ancestor
110206517|NCT00180076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110206518|NCT00180076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110206519|NCT00180076|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110206520|NCT00180076|Respiratory System Agents|respiratory system agents|mesh-ancestor
110206521|NCT00180076|Glucocorticoids|glucocorticoids|mesh-ancestor
110206522|NCT00180076|Hormones|hormones|mesh-ancestor
110206523|NCT00180076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110206524|NCT00180115|Cytarabine|cytarabine|mesh-list
110206525|NCT00180115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110206526|NCT00180115|Antimetabolites|antimetabolites|mesh-ancestor
110206532|NCT00180115|Immunologic Factors|immunologic factors|mesh-ancestor
110206538|NCT00180310|Everolimus|everolimus|mesh-list
110206539|NCT00180310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110206540|NCT00180310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110206541|NCT00180310|Tubulin Modulators|tubulin modulators|mesh-ancestor
110206542|NCT00180310|Antimitotic Agents|antimitotic agents|mesh-ancestor
110206543|NCT00180310|Mitosis Modulators|mitosis modulators|mesh-ancestor
110206544|NCT00180310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110206545|NCT00180310|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110206546|NCT00180310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110206547|NCT00180310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110206548|NCT00180310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110206549|NCT00180310|Immunologic Factors|immunologic factors|mesh-ancestor
110206550|NCT00180310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110206552|NCT00057278|Analgesics|analgesics|mesh-ancestor
110206553|NCT00057278|Sensory System Agents|sensory system agents|mesh-ancestor
110206554|NCT00057278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110206555|NCT00057278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110206556|NCT00057278|Anticonvulsants|anticonvulsants|mesh-ancestor
110206557|NCT00057278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110206558|NCT00057278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110206559|NCT00057278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110206560|NCT00057278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110206561|NCT00057278|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110206562|NCT00057278|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110206563|NCT00057278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110206564|NCT00057278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110206565|NCT00057278|Antimanic Agents|antimanic agents|mesh-ancestor
110206566|NCT00180622|Nitric Oxide|nitric oxide|mesh-list
110206567|NCT00180622|Carbon Monoxide|carbon monoxide|mesh-list
110206568|NCT00180622|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110206569|NCT00180622|Autonomic Agents|autonomic agents|mesh-ancestor
110206570|NCT00180622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110206571|NCT00180622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110206572|NCT00180622|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110206573|NCT00180622|Respiratory System Agents|respiratory system agents|mesh-ancestor
110206574|NCT00180622|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110206575|NCT00180622|Antioxidants|antioxidants|mesh-ancestor
110206576|NCT00180622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110206577|NCT00180622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110206578|NCT00180622|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110206579|NCT00180622|Vasodilator Agents|vasodilator agents|mesh-ancestor
110206580|NCT00180622|Gasotransmitters|gasotransmitters|mesh-ancestor
110206581|NCT00180622|Protective Agents|protective agents|mesh-ancestor
110206582|NCT00180622|Antimetabolites|antimetabolites|mesh-ancestor
110206584|NCT00180895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110206585|NCT00180895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110206586|NCT00180895|Immunologic Factors|immunologic factors|mesh-ancestor
110206587|NCT00180895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110206588|NCT00180895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110206589|NCT00180973|Hydroxyurea|hydroxyurea|mesh-list
110206590|NCT00180973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110206591|NCT00180973|Antisickling Agents|antisickling agents|mesh-ancestor
110206592|NCT00180973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110206593|NCT00180973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110206594|NCT00180973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110206595|NCT04729491|Azithromycin|azithromycin|mesh-list
110206596|NCT04729491|Nitazoxanide|nitazoxanide|mesh-list
110206597|NCT04729491|Dutasteride|dutasteride|mesh-list
110206598|NCT04729491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110206599|NCT04729491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110206600|NCT04729491|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110206601|NCT04729491|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110206602|NCT04729491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110206603|NCT04729491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110206604|NCT04729491|Hormone Antagonists|hormone antagonists|mesh-ancestor
110206605|NCT04729491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110206606|NCT04729491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110206607|NCT04729491|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110206609|NCT00057356|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110206610|NCT00057356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110206611|NCT00057356|Natriuretic Agents|natriuretic agents|mesh-ancestor
110206612|NCT00057356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110206613|NCT00181012|Lidocaine|lidocaine|mesh-list
110206614|NCT00181012|Anesthetics, Local|anesthetics, local|mesh-ancestor
110206615|NCT00181012|Anesthetics|anesthetics|mesh-ancestor
110206616|NCT00181012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110206617|NCT00181012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110206618|NCT00181012|Sensory System Agents|sensory system agents|mesh-ancestor
110206619|NCT00181012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110206620|NCT00181012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110206621|NCT00181012|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110206622|NCT00181012|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110206623|NCT00181012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110234478|NCT05635370|Antioxidants|antioxidants|mesh-ancestor
110206624|NCT00181012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110206625|NCT00181246|Fentanyl|fentanyl|mesh-list
110206626|NCT00181246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110206627|NCT00181246|Narcotics|narcotics|mesh-ancestor
110206628|NCT00181246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110206629|NCT00181246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110206630|NCT00181246|Analgesics|analgesics|mesh-ancestor
110206631|NCT00181246|Sensory System Agents|sensory system agents|mesh-ancestor
110206632|NCT00181246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110206633|NCT00181246|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110206634|NCT00181246|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110206635|NCT00181246|Anesthetics, General|anesthetics, general|mesh-ancestor
110206636|NCT00181246|Anesthetics|anesthetics|mesh-ancestor
110206637|NCT00181558|Zoledronic Acid|zoledronic acid|mesh-list
110206638|NCT00181558|Atrasentan|atrasentan|mesh-list
110206639|NCT00181558|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110206640|NCT00181558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110206641|NCT00181558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110206642|NCT00181558|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
110206643|NCT00181558|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110206644|NCT00181558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110206645|NCT00181597|Hydrocortisone|hydrocortisone|mesh-list
110206646|NCT00181597|Trilostane|trilostane|mesh-list
110206647|NCT00181597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110206648|NCT00181597|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110206649|NCT00181597|Abortifacient Agents|abortifacient agents|mesh-ancestor
110206650|NCT00181597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110206651|NCT00181597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110206652|NCT00181597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110206653|NCT00181597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110206654|NCT00181597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110206656|NCT00181636|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110206657|NCT00181636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110206658|NCT00181636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110206659|NCT00181636|Cholinergic Agents|cholinergic agents|mesh-ancestor
110206660|NCT00181636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110206661|NCT00181636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110206662|NCT00181636|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110206663|NCT00181636|Autonomic Agents|autonomic agents|mesh-ancestor
110206664|NCT00181636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110206666|NCT00181675|Galantamine|galantamine|mesh-list
110206667|NCT00181675|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110206668|NCT00181675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110206669|NCT00181675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110206670|NCT00181675|Cholinergic Agents|cholinergic agents|mesh-ancestor
110206671|NCT00181675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110206672|NCT00181675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110206673|NCT00181675|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110206674|NCT00181675|Autonomic Agents|autonomic agents|mesh-ancestor
110206675|NCT00181675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110206677|NCT00181870|Carbamazepine|carbamazepine|mesh-list
110206678|NCT00181870|Anticonvulsants|anticonvulsants|mesh-ancestor
110206679|NCT00181870|Antimanic Agents|antimanic agents|mesh-ancestor
110206680|NCT00181870|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110206681|NCT00181870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110206682|NCT00181870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110206683|NCT00181870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110206684|NCT00181870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110206685|NCT00181870|Analgesics|analgesics|mesh-ancestor
110206686|NCT00181870|Sensory System Agents|sensory system agents|mesh-ancestor
110206687|NCT00181870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110206688|NCT00181870|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110206689|NCT00181870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110206690|NCT00181870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110206691|NCT00181870|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110206692|NCT00181870|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110206693|NCT00181948|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110206694|NCT00181948|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110206695|NCT00181948|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110206696|NCT00181948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110206703|NCT00181987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110206704|NCT00181987|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110206705|NCT00181987|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110206706|NCT00181987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110206707|NCT00181987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110206708|NCT00181987|Dopamine Agents|dopamine agents|mesh-ancestor
110206709|NCT00181987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110206710|NCT00182104|Warfarin|warfarin|mesh-list
110206711|NCT00182104|Anticoagulants|anticoagulants|mesh-ancestor
110206712|NCT00182143|Heparin|heparin|mesh-list
110206713|NCT00182143|Calcium heparin|calcium heparin|mesh-list
110206714|NCT00182143|Dalteparin|dalteparin|mesh-list
110206715|NCT00182143|Tinzaparin|tinzaparin|mesh-list
110206716|NCT00182143|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110206717|NCT00182143|Anticoagulants|anticoagulants|mesh-ancestor
110206718|NCT00182143|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110206719|NCT00182143|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110206720|NCT00182143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110206721|NCT00182221|Fibrin fragment D|fibrin fragment d|mesh-list
110206722|NCT00182221|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110206723|NCT00182221|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110206724|NCT00182221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110206725|NCT00182221|Hemostatics|hemostatics|mesh-ancestor
110206726|NCT00182221|Coagulants|coagulants|mesh-ancestor
110206727|NCT00182260|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
110206729|NCT00182260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110206730|NCT00408538|UC-781|uc-781|mesh-list
110206731|NCT00408538|Anti-Infective Agents|anti-infective agents|mesh-list
110206732|NCT00408538|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110206733|NCT00408538|Antiviral Agents|antiviral agents|mesh-ancestor
110206734|NCT00408655|Sirolimus|sirolimus|mesh-list
110206735|NCT00408655|Paclitaxel|paclitaxel|mesh-list
110206736|NCT00408655|Carboplatin|carboplatin|mesh-list
110206737|NCT00408655|Temsirolimus|temsirolimus|mesh-list
110206738|NCT00408655|MTOR Inhibitors|mtor inhibitors|mesh-list
110206739|NCT00408655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110206740|NCT00408655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110206741|NCT00408655|Tubulin Modulators|tubulin modulators|mesh-ancestor
110206743|NCT00408655|Mitosis Modulators|mitosis modulators|mesh-ancestor
110206744|NCT00408655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110206745|NCT00408655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110206746|NCT00408655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110206747|NCT00408655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110206748|NCT00408655|Immunologic Factors|immunologic factors|mesh-ancestor
110206749|NCT00408655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110206753|NCT00408655|Antifungal Agents|antifungal agents|mesh-ancestor
110206754|NCT00182377|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
110206755|NCT00182377|Plasma Substitutes|plasma substitutes|mesh-ancestor
110206756|NCT00182377|Blood Substitutes|blood substitutes|mesh-ancestor
110206758|NCT00182455|Anticonvulsants|anticonvulsants|mesh-ancestor
110206759|NCT00182455|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110206760|NCT00182455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110206762|NCT00182494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110206763|NCT00182494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110206764|NCT00182533|Sertraline|sertraline|mesh-list
110206765|NCT00182533|Antidepressive Agents|antidepressive agents|mesh-ancestor
110206766|NCT00182533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110206767|NCT00182533|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110206768|NCT00182533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110206769|NCT00182533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110225491|NCT05952713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110206770|NCT00182533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110206771|NCT00182533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110206772|NCT00182533|Serotonin Agents|serotonin agents|mesh-ancestor
110206773|NCT00182533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110206774|NCT00182572|Naltrexone|naltrexone|mesh-list
110206775|NCT00182572|Buprenorphine|buprenorphine|mesh-list
110206776|NCT00182572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110206777|NCT00182572|Narcotics|narcotics|mesh-ancestor
110206778|NCT00182572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110206779|NCT00182572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110206780|NCT00182572|Analgesics|analgesics|mesh-ancestor
110206781|NCT00182572|Sensory System Agents|sensory system agents|mesh-ancestor
110206782|NCT00182572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110206783|NCT00182572|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110206784|NCT00182572|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110206785|NCT00182611|Tegafur|tegafur|mesh-list
110206786|NCT00182611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110206787|NCT00182611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110206788|NCT00182611|Antimetabolites|antimetabolites|mesh-ancestor
110206789|NCT00182611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110206790|NCT00182650|Aldesleukin|aldesleukin|mesh-list
110206791|NCT00182650|Rituximab|rituximab|mesh-list
110206792|NCT00182650|Fludarabine|fludarabine|mesh-list
110206793|NCT00182650|Fludarabine phosphate|fludarabine phosphate|mesh-list
110234504|NCT05614089|Insulin|insulin|mesh-list
110206794|NCT00182650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110206795|NCT00182650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110206797|NCT00182650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110206798|NCT00182650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110225492|NCT05952713|Serotonin Agents|serotonin agents|mesh-ancestor
110206800|NCT00182650|Antimetabolites|antimetabolites|mesh-ancestor
110206801|NCT00182650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110206802|NCT00182650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110206803|NCT00182650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110206804|NCT00182650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110206805|NCT00182650|Antiviral Agents|antiviral agents|mesh-ancestor
110206806|NCT00182650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110206807|NCT00182806|Gemcitabine|gemcitabine|mesh-list
110206808|NCT00182806|Irinotecan|irinotecan|mesh-list
110206809|NCT00182806|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110206810|NCT00182806|Antimetabolites|antimetabolites|mesh-ancestor
110206811|NCT00182806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110206812|NCT00182806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110206813|NCT00182806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110206814|NCT00182806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110206815|NCT00182806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110206816|NCT00182845|Donepezil|donepezil|mesh-list
110206817|NCT00182845|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110206818|NCT00182845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110206819|NCT00182845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110206820|NCT00182845|Cholinergic Agents|cholinergic agents|mesh-ancestor
110206821|NCT00182845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110206822|NCT00182845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110206823|NCT00182845|Nootropic Agents|nootropic agents|mesh-ancestor
110206824|NCT00182884|Donepezil|donepezil|mesh-list
110206825|NCT00182884|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110206826|NCT00182884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110206827|NCT00182884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110206828|NCT00182884|Cholinergic Agents|cholinergic agents|mesh-ancestor
110206829|NCT00182884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110206830|NCT00182884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110206831|NCT00182884|Nootropic Agents|nootropic agents|mesh-ancestor
110206832|NCT00183001|Vitamin K|vitamin k|mesh-list
110206833|NCT00183001|Vitamins|vitamins|mesh-ancestor
110206834|NCT00183001|Micronutrients|micronutrients|mesh-ancestor
110206835|NCT00183001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110206836|NCT00183001|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110206837|NCT00183001|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110206838|NCT00183001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110206839|NCT00183001|Hemostatics|hemostatics|mesh-ancestor
110206840|NCT00183001|Coagulants|coagulants|mesh-ancestor
110206841|NCT00183040|Hormones|hormones|mesh-list
110206842|NCT00183040|Testosterone|testosterone|mesh-list
110206843|NCT00183040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110206844|NCT00183040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110206845|NCT00183040|Androgens|androgens|mesh-ancestor
110206846|NCT00057395|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(II)|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii)|mesh-list
110206847|NCT00057395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110206848|NCT00183235|Aripiprazole|aripiprazole|mesh-list
110206849|NCT00183235|Antidepressive Agents|antidepressive agents|mesh-ancestor
110206850|NCT00183235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110206851|NCT00183235|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110206852|NCT00183235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110206853|NCT00183235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110206854|NCT00183235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110206855|NCT00183235|Dopamine Agonists|dopamine agonists|mesh-ancestor
110206857|NCT00183235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110206858|NCT00183235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110206859|NCT00183235|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110206861|NCT00183235|Serotonin Agents|serotonin agents|mesh-ancestor
110206862|NCT00183235|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110206863|NCT00183235|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110206864|NCT00183235|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110206865|NCT00183235|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110206867|NCT00057512|Antioxidants|antioxidants|mesh-ancestor
110206868|NCT00057512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110206869|NCT00057512|Protective Agents|protective agents|mesh-ancestor
110206870|NCT00057512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110206871|NCT00057512|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110206872|NCT00057512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110206873|NCT00057512|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110206874|NCT00057512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110206875|NCT00057512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110206876|NCT00057512|Analgesics|analgesics|mesh-ancestor
110206877|NCT00057512|Sensory System Agents|sensory system agents|mesh-ancestor
110206878|NCT00057512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110206880|NCT00057512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110206881|NCT00183742|Docetaxel|docetaxel|mesh-list
110206882|NCT00183742|Doxorubicin|doxorubicin|mesh-list
110206883|NCT00183742|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110206884|NCT00183742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110206885|NCT00183742|Tubulin Modulators|tubulin modulators|mesh-ancestor
110206886|NCT00183742|Antimitotic Agents|antimitotic agents|mesh-ancestor
110206887|NCT00183742|Mitosis Modulators|mitosis modulators|mesh-ancestor
110206888|NCT00183742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110206889|NCT00183742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110206890|NCT00183742|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110206891|NCT00183742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110206892|NCT00183742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110206893|NCT02965248|Calcium, Dietary|calcium, dietary|mesh-list
110206894|NCT02965248|Leucovorin|leucovorin|mesh-list
110206895|NCT02965248|Capecitabine|capecitabine|mesh-list
110206896|NCT02965248|Raltitrexed|raltitrexed|mesh-list
110206897|NCT02965248|Oxaliplatin|oxaliplatin|mesh-list
110206898|NCT02965248|Calcium|calcium|mesh-list
110206899|NCT02965248|Levoleucovorin|levoleucovorin|mesh-list
110206900|NCT02965248|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110206901|NCT02965248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110206902|NCT02965248|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110206903|NCT02965248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110206904|NCT02965248|Antimetabolites|antimetabolites|mesh-ancestor
110206905|NCT02965248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110206906|NCT02965248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110206907|NCT02965248|Antidotes|antidotes|mesh-ancestor
110206908|NCT02965248|Protective Agents|protective agents|mesh-ancestor
110206909|NCT02965248|Vitamin B Complex|vitamin b complex|mesh-ancestor
110206910|NCT02965248|Vitamins|vitamins|mesh-ancestor
110206911|NCT02965248|Micronutrients|micronutrients|mesh-ancestor
110206912|NCT02965248|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110206913|NCT02965248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110206915|NCT00183820|Gemcitabine|gemcitabine|mesh-list
110206916|NCT00183820|Oxaliplatin|oxaliplatin|mesh-list
110206917|NCT00183820|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110206918|NCT00183820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110206919|NCT00183820|Tubulin Modulators|tubulin modulators|mesh-ancestor
110206920|NCT00183820|Antimitotic Agents|antimitotic agents|mesh-ancestor
110206921|NCT00183820|Mitosis Modulators|mitosis modulators|mesh-ancestor
110206922|NCT00183820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110206923|NCT00183820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110206924|NCT00183820|Antimetabolites|antimetabolites|mesh-ancestor
110206925|NCT02969720|Titanium dioxide|titanium dioxide|mesh-list
110206926|NCT02969720|Sunscreening Agents|sunscreening agents|mesh-ancestor
110206927|NCT02969720|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110206928|NCT02969720|Protective Agents|protective agents|mesh-ancestor
110206929|NCT02969720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110206930|NCT02969720|Dermatologic Agents|dermatologic agents|mesh-ancestor
110206931|NCT02969720|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110206932|NCT00183859|Irinotecan|irinotecan|mesh-list
110206933|NCT00183859|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110206934|NCT00183859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110206935|NCT00183859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110206936|NCT00183859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110206937|NCT00183859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110206938|NCT00183898|Capecitabine|capecitabine|mesh-list
110206939|NCT00183898|Oxaliplatin|oxaliplatin|mesh-list
110206940|NCT00183898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110206941|NCT00183898|Antimetabolites|antimetabolites|mesh-ancestor
110206942|NCT00183898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110206943|NCT00183898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110206944|NCT04730765|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110206945|NCT04730765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110206947|NCT00183937|Bortezomib|bortezomib|mesh-list
110206948|NCT00183937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110206949|NCT00183937|Tubulin Modulators|tubulin modulators|mesh-ancestor
110206950|NCT00183937|Antimitotic Agents|antimitotic agents|mesh-ancestor
110206951|NCT00183937|Mitosis Modulators|mitosis modulators|mesh-ancestor
110206952|NCT00183937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110206954|NCT00408772|Capecitabine|capecitabine|mesh-list
110206955|NCT00408772|Oxaliplatin|oxaliplatin|mesh-list
110206956|NCT00408772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110206957|NCT00408772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110206958|NCT00408772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110206959|NCT00408772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110206960|NCT00408772|Growth Substances|growth substances|mesh-ancestor
110206961|NCT00408772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110206962|NCT00408772|Growth Inhibitors|growth inhibitors|mesh-ancestor
110206963|NCT00408772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110206964|NCT00408772|Antimetabolites|antimetabolites|mesh-ancestor
110206965|NCT00408772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110206966|NCT00408850|Pioglitazone|pioglitazone|mesh-list
110206967|NCT00408850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110206968|NCT00408850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110206969|NCT00183976|Rituximab|rituximab|mesh-list
110206970|NCT00183976|Doxorubicin|doxorubicin|mesh-list
110206971|NCT00183976|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110206972|NCT00183976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110206973|NCT00183976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110206974|NCT00183976|Immunologic Factors|immunologic factors|mesh-ancestor
110206975|NCT00183976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110206976|NCT00183976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110206977|NCT00183976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110206978|NCT00183976|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110206979|NCT00183976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110206980|NCT00183976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110206981|NCT00183976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110206982|NCT00046683|Alemtuzumab|alemtuzumab|mesh-list
110206983|NCT00046683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110206984|NCT00046683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110206985|NCT00184015|Bevacizumab|bevacizumab|mesh-list
110206986|NCT00184015|Bortezomib|bortezomib|mesh-list
110206987|NCT00184015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110206988|NCT00184015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110206989|NCT00184015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110206990|NCT00184015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110206991|NCT00184015|Growth Substances|growth substances|mesh-ancestor
110206993|NCT00184015|Growth Inhibitors|growth inhibitors|mesh-ancestor
110206994|NCT00184171|Budesonide|budesonide|mesh-list
110206995|NCT00184171|Bismuth|bismuth|mesh-list
110206996|NCT00184171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110206997|NCT00184171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110206998|NCT00184171|Autonomic Agents|autonomic agents|mesh-ancestor
110206999|NCT00184171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110207000|NCT00184171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207001|NCT00184171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110207002|NCT00184171|Respiratory System Agents|respiratory system agents|mesh-ancestor
110207003|NCT00184171|Glucocorticoids|glucocorticoids|mesh-ancestor
110207004|NCT00184171|Hormones|hormones|mesh-ancestor
110207005|NCT00184171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110207007|NCT00184171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207008|NCT00184171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110207009|NCT00057707|Modafinil|modafinil|mesh-list
110207010|NCT00057707|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110207011|NCT00057707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207012|NCT00057707|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110207013|NCT00057707|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110207014|NCT00057707|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110207015|NCT00057707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207016|NCT00184522|Esomeprazole|esomeprazole|mesh-list
110207017|NCT00184522|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110207018|NCT00184522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110207019|NCT00184522|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110207020|NCT00184522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110207021|NCT00184522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207022|NCT00184561|Insulin Aspart|insulin aspart|mesh-list
110207023|NCT00184561|Biphasic Insulins|biphasic insulins|mesh-list
110207024|NCT00184561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110207025|NCT00184561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207026|NCT00184639|Insulin Detemir|insulin detemir|mesh-list
110207027|NCT00184639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110207028|NCT00184639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207029|NCT00058097|Tipifarnib|tipifarnib|mesh-list
110207030|NCT00058097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110207031|NCT00184795|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110207032|NCT00184795|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110207033|NCT00184795|Norethindrone|norethindrone|mesh-list
110207034|NCT00184795|Norethindrone Acetate|norethindrone acetate|mesh-list
110207035|NCT00184795|Estradiol|estradiol|mesh-list
110207036|NCT00184795|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110207037|NCT00184795|Estrogens|estrogens|mesh-ancestor
110207038|NCT00184795|Hormones|hormones|mesh-ancestor
110225493|NCT05952713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207039|NCT00184795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110207040|NCT00184795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207041|NCT00184795|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110207042|NCT00184795|Contraceptive Agents|contraceptive agents|mesh-ancestor
110207043|NCT00184795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110207044|NCT00184795|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110207045|NCT00184795|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110207046|NCT00184795|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110207047|NCT00184795|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110207048|NCT00058253|Docetaxel|docetaxel|mesh-list
110207049|NCT00058253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110207050|NCT00058253|Tubulin Modulators|tubulin modulators|mesh-ancestor
110207051|NCT00058253|Antimitotic Agents|antimitotic agents|mesh-ancestor
110234548|NCT05457855|Autonomic Agents|autonomic agents|mesh-ancestor
110207052|NCT00058253|Mitosis Modulators|mitosis modulators|mesh-ancestor
110207053|NCT00058253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207054|NCT00046800|Lurtotecan|lurtotecan|mesh-list
110207055|NCT00046800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110207056|NCT00058292|Cytarabine|cytarabine|mesh-list
110207057|NCT00058292|Rituximab|rituximab|mesh-list
110207058|NCT00058292|Etoposide|etoposide|mesh-list
110207059|NCT00058292|Etoposide phosphate|etoposide phosphate|mesh-list
110207061|NCT00058292|Carmustine|carmustine|mesh-list
110207062|NCT00058292|Lenograstim|lenograstim|mesh-list
110207063|NCT00058292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110207064|NCT00058292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110207065|NCT00058292|Immunologic Factors|immunologic factors|mesh-ancestor
110207066|NCT00058292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207067|NCT00058292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110207068|NCT00058292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110207069|NCT00058292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110207070|NCT00058292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110207071|NCT00058292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110207072|NCT00058292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207073|NCT00058292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110207075|NCT00058292|Antiviral Agents|antiviral agents|mesh-ancestor
110207076|NCT00058292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110207077|NCT00058292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110207078|NCT00058292|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110207079|NCT00058292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110053026|NCT01484171|Idarubicin|idarubicin|mesh-list
110207080|NCT00058292|Alkylating Agents|alkylating agents|mesh-ancestor
110207081|NCT00058292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110207083|NCT03816774|Antifoaming Agents|antifoaming agents|mesh-ancestor
110225494|NCT05952713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110207084|NCT03816774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207085|NCT03816774|Emollients|emollients|mesh-ancestor
110207086|NCT03816774|Dermatologic Agents|dermatologic agents|mesh-ancestor
110207087|NCT00184912|Caffeine|caffeine|mesh-list
110207088|NCT00184912|Annexin A5|annexin a5|mesh-list
110207089|NCT00184912|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110207090|NCT00184912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207091|NCT00184912|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110207092|NCT00184912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110207093|NCT00184912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207094|NCT00184912|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110207095|NCT00184912|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110207096|NCT00184912|Purinergic Agents|purinergic agents|mesh-ancestor
110207097|NCT00184912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110207098|NCT00184951|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110207099|NCT00184951|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110207100|NCT00184951|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110207101|NCT00184951|Antimetabolites|antimetabolites|mesh-ancestor
110207102|NCT00184951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207103|NCT00184951|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110207104|NCT00184951|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110207105|NCT00184951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110207107|NCT00184990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110207108|NCT00184990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207109|NCT00058331|Epoetin Alfa|epoetin alfa|mesh-list
110207110|NCT00058331|Hematinics|hematinics|mesh-ancestor
110207111|NCT00185068|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110207112|NCT00185068|Olmesartan|olmesartan|mesh-list
110207113|NCT00185068|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110207114|NCT00185068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110207115|NCT00185068|Diuretics|diuretics|mesh-ancestor
110207116|NCT00185068|Natriuretic Agents|natriuretic agents|mesh-ancestor
110207117|NCT00185068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207118|NCT00185068|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110207119|NCT00185068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110207120|NCT00185068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207121|NCT00185068|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110207122|NCT00185068|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110207123|NCT00185107|Simvastatin|simvastatin|mesh-list
110207125|NCT00185107|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
110207126|NCT00185107|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110207127|NCT00185107|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110207128|NCT00185107|Antimetabolites|antimetabolites|mesh-ancestor
110207129|NCT00185107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207130|NCT00185107|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110207131|NCT00185107|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110207132|NCT00185107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110207133|NCT00058448|Docetaxel|docetaxel|mesh-list
110207134|NCT00058448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110207135|NCT00058448|Tubulin Modulators|tubulin modulators|mesh-ancestor
110207136|NCT00058448|Antimitotic Agents|antimitotic agents|mesh-ancestor
110207137|NCT00058448|Mitosis Modulators|mitosis modulators|mesh-ancestor
110207138|NCT00058448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207139|NCT00185185|Atenolol|atenolol|mesh-list
110207140|NCT00185185|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110207141|NCT00185185|Olmesartan|olmesartan|mesh-list
110207142|NCT00185185|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110207143|NCT00185185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110207144|NCT00185185|Diuretics|diuretics|mesh-ancestor
110207145|NCT00185185|Natriuretic Agents|natriuretic agents|mesh-ancestor
110207146|NCT00185185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207147|NCT00185185|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110207148|NCT00185185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110207149|NCT00185185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207150|NCT00185185|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110207151|NCT00185185|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110207152|NCT00185185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110207153|NCT00185185|Sympatholytics|sympatholytics|mesh-ancestor
110207154|NCT00185185|Autonomic Agents|autonomic agents|mesh-ancestor
110207155|NCT00185185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110207156|NCT00185185|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110207157|NCT00185185|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110207158|NCT00185185|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110207159|NCT00185185|Adrenergic Agents|adrenergic agents|mesh-ancestor
110207160|NCT00185185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110207161|NCT00185224|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
110207162|NCT00185224|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110207163|NCT00185224|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110207164|NCT00185224|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110207165|NCT00185224|Contraceptive Agents|contraceptive agents|mesh-ancestor
110207166|NCT00185224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110207167|NCT00185224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207168|NCT00185224|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110207169|NCT00185224|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110207170|NCT00185224|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110207171|NCT00185224|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
110207172|NCT00185224|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110207173|NCT00185224|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110207175|NCT00185302|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
110207176|NCT00185302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110207177|NCT00185302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110207178|NCT00185302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207179|NCT03784014|Durvalumab|durvalumab|mesh-list
110207180|NCT03784014|Olaparib|olaparib|mesh-list
110207181|NCT03784014|Palbociclib|palbociclib|mesh-list
110207182|NCT03784014|Lapatinib|lapatinib|mesh-list
110207183|NCT03784014|Trametinib|trametinib|mesh-list
110207184|NCT03784014|Dabrafenib|dabrafenib|mesh-list
110207185|NCT03784014|Ceritinib|ceritinib|mesh-list
110207186|NCT03784014|Futibatinib|futibatinib|mesh-list
110207187|NCT03784014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110207188|NCT03784014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110207189|NCT03784014|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110207190|NCT03784014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110207191|NCT03784014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207192|NCT03784014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110207193|NCT00058487|Thalidomide|thalidomide|mesh-list
110207194|NCT00058487|Epirubicin|epirubicin|mesh-list
110207195|NCT00058487|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110207196|NCT00058487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110207197|NCT00058487|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110207198|NCT00058487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110207199|NCT00058487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110207200|NCT00058487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207201|NCT00058487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110207202|NCT00058487|Immunologic Factors|immunologic factors|mesh-ancestor
110207203|NCT00058487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207204|NCT00058487|Leprostatic Agents|leprostatic agents|mesh-ancestor
110207205|NCT00058487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110207206|NCT00058487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110207207|NCT00058487|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110207208|NCT00058487|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110207209|NCT00058487|Growth Substances|growth substances|mesh-ancestor
110207210|NCT00058487|Growth Inhibitors|growth inhibitors|mesh-ancestor
110207211|NCT00185419|Desogestrel|desogestrel|mesh-list
110207212|NCT00185419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110207213|NCT00185419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207214|NCT00185419|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110207215|NCT00185419|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110207216|NCT00185419|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110207217|NCT00185419|Contraceptive Agents|contraceptive agents|mesh-ancestor
110207218|NCT00185419|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110207219|NCT00185419|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110207220|NCT00185419|Progestins|progestins|mesh-ancestor
110207221|NCT00185419|Hormones|hormones|mesh-ancestor
110207222|NCT00185419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110207223|NCT00185575|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110207224|NCT00185575|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110207225|NCT00185575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110207226|NCT00185575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110207227|NCT00185575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207228|NCT00185575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110207229|NCT00185575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207231|NCT00185575|Sensory System Agents|sensory system agents|mesh-ancestor
110207232|NCT00185575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110207233|NCT00185575|Antidepressive Agents|antidepressive agents|mesh-ancestor
110207234|NCT00185575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110207235|NCT00185575|Dopamine Agents|dopamine agents|mesh-ancestor
110207236|NCT03731832|Dexamethasone|dexamethasone|mesh-list
110207237|NCT03731832|Cyclophosphamide|cyclophosphamide|mesh-list
110207238|NCT03731832|Pomalidomide|pomalidomide|mesh-list
110207240|NCT03731832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110207241|NCT03731832|Immunologic Factors|immunologic factors|mesh-ancestor
110207242|NCT03731832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207243|NCT03731832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110207244|NCT03731832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110207245|NCT03731832|Alkylating Agents|alkylating agents|mesh-ancestor
110207246|NCT03731832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207247|NCT03731832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110207248|NCT03731832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110207249|NCT03731832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110207250|NCT03731832|Antiemetics|antiemetics|mesh-ancestor
110207251|NCT03731832|Autonomic Agents|autonomic agents|mesh-ancestor
110207252|NCT03731832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110207253|NCT03731832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110207254|NCT03731832|Glucocorticoids|glucocorticoids|mesh-ancestor
110207255|NCT03731832|Hormones|hormones|mesh-ancestor
110207256|NCT03731832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110207257|NCT03731832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110207258|NCT03731832|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110207259|NCT03731832|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110207260|NCT03731832|Growth Substances|growth substances|mesh-ancestor
110207261|NCT03731832|Growth Inhibitors|growth inhibitors|mesh-ancestor
110207262|NCT03731832|Protease Inhibitors|protease inhibitors|mesh-ancestor
110207263|NCT03731832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110207265|NCT00185887|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110207266|NCT00185887|Autonomic Agents|autonomic agents|mesh-ancestor
110207267|NCT00185887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110207268|NCT00185887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207269|NCT00185887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110207270|NCT00185887|Respiratory System Agents|respiratory system agents|mesh-ancestor
110207272|NCT00185887|Tocolytic Agents|tocolytic agents|mesh-ancestor
110207273|NCT00185887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110207274|NCT00185887|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110207275|NCT00185887|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110207276|NCT00185887|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110207277|NCT00185887|Adrenergic Agents|adrenergic agents|mesh-ancestor
110207278|NCT00185887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110207279|NCT00185887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207280|NCT00186082|Cefoxitin|cefoxitin|mesh-list
110207281|NCT00186082|Cefotetan|cefotetan|mesh-list
110207282|NCT00186082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110207283|NCT00186082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110207284|NCT00186277|Docetaxel|docetaxel|mesh-list
110207285|NCT00186277|Oxaliplatin|oxaliplatin|mesh-list
110207286|NCT00186277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110207287|NCT00186277|Tubulin Modulators|tubulin modulators|mesh-ancestor
110207288|NCT00186277|Antimitotic Agents|antimitotic agents|mesh-ancestor
110207289|NCT00186277|Mitosis Modulators|mitosis modulators|mesh-ancestor
110207290|NCT00186277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207291|NCT00186316|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
110207292|NCT00186316|Immunologic Factors|immunologic factors|mesh-ancestor
110207293|NCT00186316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207295|NCT00058682|Antifungal Agents|antifungal agents|mesh-ancestor
110207296|NCT00058682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110207297|NCT00186589|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110207298|NCT00186589|Immunologic Factors|immunologic factors|mesh-ancestor
110207299|NCT00186589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207300|NCT00186706|Selenium|selenium|mesh-list
110207301|NCT00186706|Antioxidants|antioxidants|mesh-ancestor
110207302|NCT00186706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207303|NCT00186706|Protective Agents|protective agents|mesh-ancestor
110207304|NCT00186706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207305|NCT00186706|Trace Elements|trace elements|mesh-ancestor
110207306|NCT00186706|Micronutrients|micronutrients|mesh-ancestor
110207307|NCT00409201|Reboxetine|reboxetine|mesh-list
110207308|NCT00409201|Antidepressive Agents|antidepressive agents|mesh-ancestor
110207309|NCT00409201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110207310|NCT00409201|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110207311|NCT00409201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110207312|NCT00409201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110207313|NCT00409201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207314|NCT00409201|Adrenergic Agents|adrenergic agents|mesh-ancestor
110207315|NCT00409201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110207316|NCT00409201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207317|NCT00046878|Carmustine|carmustine|mesh-list
110207318|NCT00046878|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
110207319|NCT00046878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110207320|NCT00046878|Alkylating Agents|alkylating agents|mesh-ancestor
110207321|NCT00046878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207322|NCT00046878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110207323|NCT00046878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110207325|NCT00186745|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110207326|NCT00186745|Dalteparin|dalteparin|mesh-list
110207327|NCT00186745|Anticoagulants|anticoagulants|mesh-ancestor
110207328|NCT00186745|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110207329|NCT00186745|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110207330|NCT00186745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207331|NCT00186823|Antibodies|antibodies|mesh-list
110207332|NCT00186823|Immunologic Factors|immunologic factors|mesh-ancestor
110207333|NCT00186823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207334|NCT00186862|Interleukin-2|interleukin-2|mesh-list
110207335|NCT00186862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207336|NCT00186862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110207337|NCT00186862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110207338|NCT00186862|Analgesics|analgesics|mesh-ancestor
110207339|NCT00186862|Sensory System Agents|sensory system agents|mesh-ancestor
110207340|NCT00186862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110207341|NCT00186940|Rasburicase|rasburicase|mesh-list
110207342|NCT00186940|Gout Suppressants|gout suppressants|mesh-ancestor
110207343|NCT00186940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110207345|NCT00186979|Cefpodoxime|cefpodoxime|mesh-list
110207346|NCT00186979|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
110207347|NCT00186979|Irinotecan|irinotecan|mesh-list
110207348|NCT00186979|Vincristine|vincristine|mesh-list
110207349|NCT00186979|Gefitinib|gefitinib|mesh-list
110207350|NCT00186979|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110207351|NCT00186979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110207352|NCT00186979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110207353|NCT00186979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207355|NCT00186979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110207356|NCT00186979|Tubulin Modulators|tubulin modulators|mesh-ancestor
110207357|NCT00186979|Antimitotic Agents|antimitotic agents|mesh-ancestor
110207358|NCT00186979|Mitosis Modulators|mitosis modulators|mesh-ancestor
110207359|NCT00186979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110207360|NCT00186979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110207361|NCT00186979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110207362|NCT00187057|Cytarabine|cytarabine|mesh-list
110207363|NCT00187057|Dexamethasone|dexamethasone|mesh-list
110207364|NCT00187057|Prednisone|prednisone|mesh-list
110207365|NCT00187057|Cyclophosphamide|cyclophosphamide|mesh-list
110207366|NCT00187057|Doxorubicin|doxorubicin|mesh-list
110207367|NCT00187057|Methotrexate|methotrexate|mesh-list
110207368|NCT00187057|Etoposide|etoposide|mesh-list
110207369|NCT00187057|Vincristine|vincristine|mesh-list
110207370|NCT00187057|Daunorubicin|daunorubicin|mesh-list
110207371|NCT00187057|Asparaginase|asparaginase|mesh-list
110207372|NCT00187057|Mercaptopurine|mercaptopurine|mesh-list
110207373|NCT00187057|Vinblastine|vinblastine|mesh-list
110207374|NCT00187057|Procarbazine|procarbazine|mesh-list
110207375|NCT00187057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110207376|NCT00187057|Immunologic Factors|immunologic factors|mesh-ancestor
110207377|NCT00187057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207378|NCT00187057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110207379|NCT00187057|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110207380|NCT00187057|Alkylating Agents|alkylating agents|mesh-ancestor
110207381|NCT00187057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207382|NCT00187057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110207383|NCT00187057|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110207384|NCT00187057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110207385|NCT00187057|Antiemetics|antiemetics|mesh-ancestor
110207386|NCT00187057|Autonomic Agents|autonomic agents|mesh-ancestor
110207387|NCT00187057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110207388|NCT00187057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110207389|NCT00187057|Glucocorticoids|glucocorticoids|mesh-ancestor
110207390|NCT00187057|Hormones|hormones|mesh-ancestor
110207391|NCT00187057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110207392|NCT00187057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110207393|NCT00187057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110207394|NCT00187057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110207395|NCT00187057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110207396|NCT00187057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110207397|NCT00187057|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110207398|NCT00187057|Abortifacient Agents|abortifacient agents|mesh-ancestor
110207399|NCT00187057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110207400|NCT00187057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110207401|NCT00187057|Antimetabolites|antimetabolites|mesh-ancestor
110207402|NCT00187057|Dermatologic Agents|dermatologic agents|mesh-ancestor
110207403|NCT00187057|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110207404|NCT00187057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110207405|NCT00187057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110207406|NCT00187057|Antiviral Agents|antiviral agents|mesh-ancestor
110207407|NCT00187057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110207408|NCT00187057|Tubulin Modulators|tubulin modulators|mesh-ancestor
110207409|NCT00187057|Antimitotic Agents|antimitotic agents|mesh-ancestor
110207410|NCT00187057|Mitosis Modulators|mitosis modulators|mesh-ancestor
110207411|NCT00046917|Irinotecan|irinotecan|mesh-list
110207412|NCT00046917|Alvocidib|alvocidib|mesh-list
110207413|NCT00046917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110207414|NCT00046917|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110207415|NCT00046917|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110207416|NCT00046917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110207417|NCT00046917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207418|NCT00046917|Growth Inhibitors|growth inhibitors|mesh-ancestor
110207419|NCT00046917|Growth Substances|growth substances|mesh-ancestor
110207420|NCT00046917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207421|NCT00046917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110207422|NCT00187174|Everolimus|everolimus|mesh-list
110207423|NCT00187174|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110207424|NCT00187174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110207425|NCT00187174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110207426|NCT00187174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207427|NCT00187174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110207428|NCT00187174|Immunologic Factors|immunologic factors|mesh-ancestor
110207429|NCT00187174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207430|NCT00187174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110207431|NCT00187330|Acetylcysteine|acetylcysteine|mesh-list
110207432|NCT00187330|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110207433|NCT00187330|Antiviral Agents|antiviral agents|mesh-ancestor
110207434|NCT00187330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110207435|NCT00187330|Expectorants|expectorants|mesh-ancestor
110207436|NCT00187330|Respiratory System Agents|respiratory system agents|mesh-ancestor
110207437|NCT00187330|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110207438|NCT00187330|Antioxidants|antioxidants|mesh-ancestor
110207439|NCT00187330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207440|NCT00187330|Protective Agents|protective agents|mesh-ancestor
110207441|NCT00187330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207442|NCT00187330|Antidotes|antidotes|mesh-ancestor
110207443|NCT00187408|Heparin|heparin|mesh-list
110207444|NCT00187408|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110207446|NCT00187408|Dalteparin|dalteparin|mesh-list
110207447|NCT00187408|Anticoagulants|anticoagulants|mesh-ancestor
110207448|NCT00187408|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110207449|NCT00187408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110207450|NCT00187408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207451|NCT00187447|Indomethacin|indomethacin|mesh-list
110207452|NCT00187447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110207453|NCT00187447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110207454|NCT00187447|Analgesics|analgesics|mesh-ancestor
110207455|NCT00187447|Sensory System Agents|sensory system agents|mesh-ancestor
110207456|NCT00187447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110207457|NCT00187447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207458|NCT00187447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110207459|NCT00187447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110207460|NCT00187447|Gout Suppressants|gout suppressants|mesh-ancestor
110207461|NCT00187447|Tocolytic Agents|tocolytic agents|mesh-ancestor
110207462|NCT00187447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110207463|NCT00187447|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110207464|NCT00187447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110207465|NCT00187447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207466|NCT02969564|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
110207467|NCT02969564|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110207468|NCT02969564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207470|NCT00187525|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110207471|NCT00187525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110207472|NCT00187525|Dopamine Agents|dopamine agents|mesh-ancestor
110207473|NCT00187525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110207474|NCT00187525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207475|NCT00187525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207476|NCT00187525|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110207477|NCT00187525|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110207478|NCT00187564|Thioctic Acid|thioctic acid|mesh-list
110207479|NCT00187564|Antioxidants|antioxidants|mesh-ancestor
110207480|NCT00187564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207481|NCT00187564|Protective Agents|protective agents|mesh-ancestor
110207482|NCT00187564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207483|NCT00187564|Vitamin B Complex|vitamin b complex|mesh-ancestor
110207484|NCT00187564|Vitamins|vitamins|mesh-ancestor
110207485|NCT00187564|Micronutrients|micronutrients|mesh-ancestor
110207486|NCT00046995|Leucovorin|leucovorin|mesh-list
110207487|NCT00046995|Carboplatin|carboplatin|mesh-list
110207488|NCT00046995|Fluorouracil|fluorouracil|mesh-list
110207489|NCT00046995|Calcium|calcium|mesh-list
110207490|NCT00046995|Levoleucovorin|levoleucovorin|mesh-list
110207491|NCT00046995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110234627|NCT05253833|Antioxidants|antioxidants|mesh-ancestor
110207492|NCT00046995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110207493|NCT00046995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207494|NCT00046995|Antimetabolites|antimetabolites|mesh-ancestor
110207495|NCT00046995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207496|NCT00046995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110207497|NCT00046995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110207498|NCT00046995|Immunologic Factors|immunologic factors|mesh-ancestor
110207499|NCT00046995|Antidotes|antidotes|mesh-ancestor
110207500|NCT00046995|Protective Agents|protective agents|mesh-ancestor
110207501|NCT00046995|Vitamin B Complex|vitamin b complex|mesh-ancestor
110207502|NCT00046995|Vitamins|vitamins|mesh-ancestor
110207503|NCT00046995|Micronutrients|micronutrients|mesh-ancestor
110207504|NCT00058955|Sodium Oxybate|sodium oxybate|mesh-list
110207505|NCT00058955|Triazolam|triazolam|mesh-list
110207506|NCT00058955|Pentobarbital|pentobarbital|mesh-list
110207507|NCT00058955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110207508|NCT00058955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110207509|NCT00058955|Anesthetics, General|anesthetics, general|mesh-ancestor
110207510|NCT00058955|Anesthetics|anesthetics|mesh-ancestor
110207511|NCT00058955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110207512|NCT00058955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207513|NCT00058955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110207514|NCT00058955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110207515|NCT00058955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110207516|NCT00058955|GABA Modulators|gaba modulators|mesh-ancestor
110207517|NCT00058955|GABA Agents|gaba agents|mesh-ancestor
110207518|NCT00058955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110207519|NCT00058955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207520|NCT00058955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110207521|NCT00187759|Cephalexin|cephalexin|mesh-list
110207522|NCT00187759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110207523|NCT00187759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110207524|NCT00187798|Metformin|metformin|mesh-list
110207525|NCT00187798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110207526|NCT00187798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207527|NCT00058994|Anecortave|anecortave|mesh-list
110207528|NCT00058994|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110207529|NCT00058994|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110207530|NCT00058994|Growth Substances|growth substances|mesh-ancestor
110207531|NCT00058994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207532|NCT00058994|Growth Inhibitors|growth inhibitors|mesh-ancestor
110207533|NCT00058994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110207534|NCT00187915|Cyclosporine|cyclosporine|mesh-list
110207535|NCT00187915|Mycophenolic Acid|mycophenolic acid|mesh-list
110207536|NCT00187915|Tacrolimus|tacrolimus|mesh-list
110207537|NCT00187915|Cyclosporins|cyclosporins|mesh-list
110207538|NCT00187915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110207539|NCT00187915|Immunologic Factors|immunologic factors|mesh-ancestor
110207540|NCT00187915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207541|NCT00187915|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110207542|NCT00187915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110207543|NCT00187915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207544|NCT00187915|Antifungal Agents|antifungal agents|mesh-ancestor
110207545|NCT00187915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110207546|NCT00187915|Dermatologic Agents|dermatologic agents|mesh-ancestor
110207547|NCT00187915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110207548|NCT00187915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110207549|NCT00187915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110207550|NCT00187915|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110207551|NCT00187915|Antitubercular Agents|antitubercular agents|mesh-ancestor
110207552|NCT00187915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110207554|NCT00187993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110207555|NCT00187993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207556|NCT00188071|Acetaminophen|acetaminophen|mesh-list
110207557|NCT00188071|Ketoprofen|ketoprofen|mesh-list
110207558|NCT00188071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110207559|NCT00188071|Analgesics|analgesics|mesh-ancestor
110234643|NCT05170893|Vitamins|vitamins|mesh-ancestor
110207560|NCT00188071|Sensory System Agents|sensory system agents|mesh-ancestor
110207561|NCT00188071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110207562|NCT00188071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207564|NCT00188071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110207565|NCT00188071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110207566|NCT00188071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110207567|NCT00188071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110207568|NCT00188071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110207569|NCT00188071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207571|NCT00188227|Pirinitramide|pirinitramide|mesh-list
110207572|NCT00188227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
110207573|NCT00188227|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110207574|NCT00188227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110207575|NCT00188227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207576|NCT00188227|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110207577|NCT00188227|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110207578|NCT00188227|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110207579|NCT00188227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110207580|NCT00188227|Anesthetics, General|anesthetics, general|mesh-ancestor
110207581|NCT00188227|Anesthetics|anesthetics|mesh-ancestor
110207582|NCT00188227|GABA Modulators|gaba modulators|mesh-ancestor
110207583|NCT00188227|GABA Agents|gaba agents|mesh-ancestor
110207584|NCT00188227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110207585|NCT00188227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207586|NCT00188227|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110207587|NCT00188227|Narcotics|narcotics|mesh-ancestor
110207588|NCT00188227|Analgesics|analgesics|mesh-ancestor
110207589|NCT00188227|Sensory System Agents|sensory system agents|mesh-ancestor
110207590|NCT00188227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110207591|NCT00188266|Fluorouracil|fluorouracil|mesh-list
110207592|NCT00188266|Cisplatin|cisplatin|mesh-list
110207593|NCT00188266|Antimetabolites|antimetabolites|mesh-ancestor
110207594|NCT00188266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207595|NCT00188266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110207596|NCT00188266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110207597|NCT00188266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110207598|NCT00188266|Immunologic Factors|immunologic factors|mesh-ancestor
110207599|NCT00188266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207601|NCT00047073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110207602|NCT00047073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110207603|NCT00047073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110207604|NCT00047073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110207606|NCT00047073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110207607|NCT00047073|Immunologic Factors|immunologic factors|mesh-ancestor
110207608|NCT00047073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207609|NCT00188383|Amantadine|amantadine|mesh-list
110207610|NCT00188383|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110207611|NCT00188383|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110207612|NCT00188383|Antiviral Agents|antiviral agents|mesh-ancestor
110207613|NCT00188383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110207614|NCT00188383|Dopamine Agents|dopamine agents|mesh-ancestor
110207615|NCT00188383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110207616|NCT00188383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207617|NCT00188383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207618|NCT00188383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110207619|NCT00188383|Analgesics|analgesics|mesh-ancestor
110207620|NCT00188383|Sensory System Agents|sensory system agents|mesh-ancestor
110207621|NCT00188383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110207622|NCT02969447|Oxytocin|oxytocin|mesh-list
110207623|NCT02969447|Oxytocics|oxytocics|mesh-ancestor
110207624|NCT02969447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110207625|NCT02969447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207626|NCT00188617|Gefitinib|gefitinib|mesh-list
110207627|NCT00188617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110207628|NCT00188617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110207629|NCT00188617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110207630|NCT00188617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207631|NCT00047112|Fluorouracil|fluorouracil|mesh-list
110207632|NCT00047112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110207633|NCT00047112|Antimetabolites|antimetabolites|mesh-ancestor
110207634|NCT00047112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207635|NCT00047112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110207636|NCT00047112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110207637|NCT00047112|Immunologic Factors|immunologic factors|mesh-ancestor
110207638|NCT00047112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207639|NCT00409318|Etanercept|etanercept|mesh-list
110207640|NCT00409318|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110207641|NCT00409318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110207642|NCT00409318|Analgesics|analgesics|mesh-ancestor
110207643|NCT00409318|Sensory System Agents|sensory system agents|mesh-ancestor
110207644|NCT00409318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110207645|NCT00409318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207647|NCT00409318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110207648|NCT00409318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110207649|NCT00409318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110207650|NCT00409318|Immunologic Factors|immunologic factors|mesh-ancestor
110207651|NCT00409357|Alfuzosin|alfuzosin|mesh-list
110207652|NCT00409357|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110207653|NCT00409357|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110207654|NCT00409357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110207655|NCT00409357|Adrenergic Agents|adrenergic agents|mesh-ancestor
110207656|NCT00409357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110207657|NCT00409357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207658|NCT00409357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207659|NCT00409357|Urological Agents|urological agents|mesh-ancestor
110207660|NCT00059267|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
110207661|NCT00059267|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110207662|NCT00059267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110207663|NCT00059267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110207664|NCT00059267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207665|NCT00059267|Antiviral Agents|antiviral agents|mesh-ancestor
110207666|NCT00059267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110207667|NCT00188773|Acetylcysteine|acetylcysteine|mesh-list
110207668|NCT00188773|Heparin|heparin|mesh-list
110207669|NCT00188773|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
110207670|NCT00188773|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110207671|NCT00188773|Anticoagulants|anticoagulants|mesh-ancestor
110207672|NCT00188773|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110207674|NCT00188773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207675|NCT00188773|Antiviral Agents|antiviral agents|mesh-ancestor
110207676|NCT00188773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110207677|NCT00188773|Expectorants|expectorants|mesh-ancestor
110207678|NCT00188773|Respiratory System Agents|respiratory system agents|mesh-ancestor
110207679|NCT00188773|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110207680|NCT00188773|Antioxidants|antioxidants|mesh-ancestor
110207682|NCT00188773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207683|NCT00188773|Antidotes|antidotes|mesh-ancestor
110207684|NCT00188773|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
110207685|NCT00188773|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110207686|NCT00188773|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110207687|NCT00188812|Donepezil|donepezil|mesh-list
110207688|NCT00188812|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110207689|NCT00188812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110207690|NCT00188812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207691|NCT00188812|Cholinergic Agents|cholinergic agents|mesh-ancestor
110207692|NCT00188812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110054814|NCT01494402|Aspirin|aspirin|mesh-list
110207693|NCT00188812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207694|NCT00188812|Nootropic Agents|nootropic agents|mesh-ancestor
110207695|NCT02963194|Oxytocin|oxytocin|mesh-list
110207696|NCT02963194|Oxytocics|oxytocics|mesh-ancestor
110207697|NCT02963194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110207698|NCT02963194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207699|NCT00059306|Aspirin|aspirin|mesh-list
110207700|NCT00059306|Clopidogrel|clopidogrel|mesh-list
110207701|NCT00059306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110207702|NCT00059306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110207703|NCT00059306|Analgesics|analgesics|mesh-ancestor
110207704|NCT00059306|Sensory System Agents|sensory system agents|mesh-ancestor
110207705|NCT00059306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110207706|NCT00059306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207707|NCT00059306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110207708|NCT00059306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110207709|NCT00059306|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110207710|NCT00059306|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110207711|NCT00059306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207712|NCT00059306|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110207713|NCT00059306|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110207714|NCT00059306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110207715|NCT00059306|Antipyretics|antipyretics|mesh-ancestor
110207716|NCT00059306|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110207717|NCT00059306|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110207718|NCT00059306|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110207719|NCT00059306|Purinergic Agents|purinergic agents|mesh-ancestor
110207720|NCT00059306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110207721|NCT00188929|Deoxyglucose|deoxyglucose|mesh-list
110207722|NCT00188929|Antimetabolites|antimetabolites|mesh-ancestor
110207723|NCT00188929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207724|NCT00188929|Antiviral Agents|antiviral agents|mesh-ancestor
110207725|NCT00188929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110207726|NCT03428373|Rivaroxaban|rivaroxaban|mesh-list
110207727|NCT03428373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207728|NCT03428373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110207729|NCT03428373|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110207730|NCT03428373|Antithrombins|antithrombins|mesh-ancestor
110207731|NCT03428373|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110207732|NCT03428373|Protease Inhibitors|protease inhibitors|mesh-ancestor
110207733|NCT03428373|Anticoagulants|anticoagulants|mesh-ancestor
110207734|NCT00189007|Allopurinol|allopurinol|mesh-list
110207736|NCT00189007|Antimetabolites|antimetabolites|mesh-ancestor
110207737|NCT00189007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207738|NCT00189007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110207739|NCT00189007|Gout Suppressants|gout suppressants|mesh-ancestor
110207740|NCT00189007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110207741|NCT00189007|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110207742|NCT00189007|Antioxidants|antioxidants|mesh-ancestor
110207743|NCT00189007|Protective Agents|protective agents|mesh-ancestor
110207744|NCT00189007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207745|NCT00189007|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110207746|NCT00189007|Diuretics|diuretics|mesh-ancestor
110207747|NCT00189007|Natriuretic Agents|natriuretic agents|mesh-ancestor
110207749|NCT00399945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110207750|NCT00399945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110207751|NCT00189085|Simvastatin|simvastatin|mesh-list
110207752|NCT00189085|Ezetimibe|ezetimibe|mesh-list
110207753|NCT00189085|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
110207754|NCT00189085|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110207755|NCT00189085|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110207756|NCT00189085|Antimetabolites|antimetabolites|mesh-ancestor
110207757|NCT00189085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207758|NCT00189085|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110207759|NCT00189085|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110207760|NCT00189085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110207761|NCT00189124|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
110207762|NCT00189124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110207763|NCT00189124|Immunologic Factors|immunologic factors|mesh-ancestor
110207764|NCT00189124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207765|NCT00189163|Pioglitazone|pioglitazone|mesh-list
110207766|NCT00189163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110207767|NCT00189163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207768|NCT00189358|Tamoxifen|tamoxifen|mesh-list
110207769|NCT00189358|Gefitinib|gefitinib|mesh-list
110207770|NCT00189358|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110207771|NCT00189358|Hormone Antagonists|hormone antagonists|mesh-ancestor
110207772|NCT00189358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110207773|NCT00189358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207774|NCT00189358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110207775|NCT00189358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110207776|NCT00189358|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110207778|NCT00189358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110207779|NCT00189358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110207780|NCT00189358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110207781|NCT00189358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207782|NCT00189397|Azathioprine|azathioprine|mesh-list
110207783|NCT00189397|Antimetabolites|antimetabolites|mesh-ancestor
110207784|NCT00189397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207785|NCT00189397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110207786|NCT00189397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110207787|NCT00189397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110207788|NCT00189397|Immunologic Factors|immunologic factors|mesh-ancestor
110207789|NCT00189397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207790|NCT00189397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110207791|NCT00189514|Pramlintide|pramlintide|mesh-list
110207792|NCT00189514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110207793|NCT00189514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207794|NCT00189553|Paclitaxel|paclitaxel|mesh-list
110207795|NCT00189553|Carboplatin|carboplatin|mesh-list
110207796|NCT00189553|Doxorubicin|doxorubicin|mesh-list
110207797|NCT00189553|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110207798|NCT00189553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110207799|NCT00189553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110207800|NCT00189553|Tubulin Modulators|tubulin modulators|mesh-ancestor
110207801|NCT00189553|Antimitotic Agents|antimitotic agents|mesh-ancestor
110207802|NCT00189553|Mitosis Modulators|mitosis modulators|mesh-ancestor
110207803|NCT00189553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207804|NCT00189553|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110207805|NCT00189553|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110207806|NCT00189553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110207807|NCT00189553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110207808|NCT00189709|Fluconazole|fluconazole|mesh-list
110207809|NCT00189709|Micafungin|micafungin|mesh-list
110207810|NCT00189709|Antifungal Agents|antifungal agents|mesh-ancestor
110207811|NCT00189709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110207812|NCT00189709|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110207813|NCT00189709|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110207814|NCT00189709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110207815|NCT00189709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207816|NCT00189709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110207818|NCT00189709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110207819|NCT00189709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207820|NCT00189709|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110207821|NCT00189709|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110207822|NCT04722796|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110207824|NCT00189748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110207825|NCT00189748|Immunologic Factors|immunologic factors|mesh-ancestor
110207826|NCT00189748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207827|NCT00189748|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110207828|NCT00189748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110207829|NCT00189748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207831|NCT00189787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110207832|NCT00189787|Immunologic Factors|immunologic factors|mesh-ancestor
110207833|NCT00189787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207834|NCT00189787|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110207835|NCT00189787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110207836|NCT00189787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207837|NCT00059462|Interleukin-2|interleukin-2|mesh-list
110207838|NCT00059462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110207839|NCT00059462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110207840|NCT00059462|Analgesics|analgesics|mesh-ancestor
110207841|NCT00059462|Sensory System Agents|sensory system agents|mesh-ancestor
110207842|NCT00059462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110207843|NCT00059462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207844|NCT00189826|Tacrolimus|tacrolimus|mesh-list
110207845|NCT00189826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110207846|NCT00189826|Immunologic Factors|immunologic factors|mesh-ancestor
110207847|NCT00189826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207848|NCT00189826|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110207849|NCT00189826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110207850|NCT00189826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207851|NCT00047190|Tipifarnib|tipifarnib|mesh-list
110207852|NCT00047190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110207853|NCT00189904|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
110207854|NCT00189904|Antiviral Agents|antiviral agents|mesh-ancestor
110207855|NCT00189904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110207856|NCT00189943|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
110207857|NCT00189943|Antiviral Agents|antiviral agents|mesh-ancestor
110207858|NCT00189943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110207859|NCT00189982|Factor VIII|factor viii|mesh-list
110207860|NCT00189982|Coagulants|coagulants|mesh-ancestor
110207861|NCT00190021|Donepezil|donepezil|mesh-list
110207862|NCT00190021|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110207863|NCT00190021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110207864|NCT00190021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207865|NCT00190021|Cholinergic Agents|cholinergic agents|mesh-ancestor
110207866|NCT00190021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110207867|NCT00190021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207868|NCT00190021|Nootropic Agents|nootropic agents|mesh-ancestor
110207869|NCT00190060|Testosterone|testosterone|mesh-list
110207870|NCT00190060|Androgens|androgens|mesh-ancestor
110207871|NCT00190060|Hormones|hormones|mesh-ancestor
110207872|NCT00190060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110207873|NCT00190060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207874|NCT00047229|Doxorubicin|doxorubicin|mesh-list
110207875|NCT00047229|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110207876|NCT00047229|Oblimersen|oblimersen|mesh-list
110207877|NCT00047229|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110207878|NCT00047229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110207879|NCT00047229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110207880|NCT00047229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110207881|NCT00047229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110207882|NCT00047229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207883|NCT00190099|Dexamethasone|dexamethasone|mesh-list
110207884|NCT00190099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110207885|NCT00190099|Antiemetics|antiemetics|mesh-ancestor
110207886|NCT00190099|Autonomic Agents|autonomic agents|mesh-ancestor
110207887|NCT00190099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110207888|NCT00190099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207889|NCT00190099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110207890|NCT00190099|Glucocorticoids|glucocorticoids|mesh-ancestor
110207891|NCT00190099|Hormones|hormones|mesh-ancestor
110207892|NCT00190099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110207893|NCT00190099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110207894|NCT00190099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110207895|NCT02963077|Cholestyramine Resin|cholestyramine resin|mesh-list
110207896|NCT02963077|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110207897|NCT02963077|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110207898|NCT02963077|Antimetabolites|antimetabolites|mesh-ancestor
110207899|NCT02963077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207900|NCT02963077|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110207901|NCT00047268|Cytarabine|cytarabine|mesh-list
110207902|NCT00047268|Mercaptopurine|mercaptopurine|mesh-list
110207903|NCT00047268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110207904|NCT00047268|Antimetabolites|antimetabolites|mesh-ancestor
110207905|NCT00047268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207906|NCT00047268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110207907|NCT00047268|Antiviral Agents|antiviral agents|mesh-ancestor
110207908|NCT00047268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110207909|NCT00047268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110207910|NCT00047268|Immunologic Factors|immunologic factors|mesh-ancestor
110207911|NCT00047268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207912|NCT00047268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110207913|NCT00047268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110207914|NCT00190294|Misoprostol|misoprostol|mesh-list
110207916|NCT00190294|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110207917|NCT00190294|Abortifacient Agents|abortifacient agents|mesh-ancestor
110207918|NCT00190294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110207919|NCT00190294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207920|NCT00190294|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110207921|NCT00190294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110207922|NCT00190294|Oxytocics|oxytocics|mesh-ancestor
110207923|NCT00190294|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110207924|NCT00190294|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110207925|NCT00190294|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110207926|NCT00190294|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110207927|NCT00190294|Contraceptive Agents|contraceptive agents|mesh-ancestor
110207928|NCT00190294|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110207929|NCT00190294|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110207930|NCT00190294|Hormone Antagonists|hormone antagonists|mesh-ancestor
110207931|NCT00190294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110207932|NCT00190294|Luteolytic Agents|luteolytic agents|mesh-ancestor
110207933|NCT00190294|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110207934|NCT00190294|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110207935|NCT03238365|Nivolumab|nivolumab|mesh-list
110207936|NCT03238365|Tadalafil|tadalafil|mesh-list
110207937|NCT03238365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110207938|NCT03238365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110207939|NCT03238365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110207940|NCT03238365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207941|NCT03238365|Vasodilator Agents|vasodilator agents|mesh-ancestor
110207942|NCT03238365|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110207943|NCT03238365|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110207944|NCT03238365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110207945|NCT03238365|Urological Agents|urological agents|mesh-ancestor
110207946|NCT00059618|Carboplatin|carboplatin|mesh-list
110207947|NCT00059618|Bortezomib|bortezomib|mesh-list
110207948|NCT00059618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110207949|NCT00190333|Escitalopram|escitalopram|mesh-list
110207950|NCT00190333|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110207951|NCT00190333|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110207952|NCT00190333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110207953|NCT00190333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207954|NCT00190333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110207956|NCT00190333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207957|NCT00190372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
110207958|NCT00190372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110207959|NCT00190372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207960|NCT00190411|Celiprolol|celiprolol|mesh-list
110207961|NCT00190411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110207962|NCT00190411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110207963|NCT00190411|Sympathomimetics|sympathomimetics|mesh-ancestor
110207964|NCT00190411|Autonomic Agents|autonomic agents|mesh-ancestor
110207965|NCT00190411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110207966|NCT00190411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207967|NCT00190411|Vasodilator Agents|vasodilator agents|mesh-ancestor
110207968|NCT00190411|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110207969|NCT00190411|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110207970|NCT00190411|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110207971|NCT00190411|Adrenergic Agents|adrenergic agents|mesh-ancestor
110207972|NCT00190411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110207973|NCT00190411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207974|NCT00047307|Gemcitabine|gemcitabine|mesh-list
110207975|NCT00047307|Alvocidib|alvocidib|mesh-list
110207976|NCT00047307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110207977|NCT00047307|Antimetabolites|antimetabolites|mesh-ancestor
110207978|NCT00047307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207979|NCT00047307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110207980|NCT00047307|Growth Inhibitors|growth inhibitors|mesh-ancestor
110207981|NCT00047307|Growth Substances|growth substances|mesh-ancestor
110207982|NCT00047307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207983|NCT00047307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110207984|NCT00047307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110207985|NCT00190489|Docetaxel|docetaxel|mesh-list
110207986|NCT00190489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110207987|NCT00190489|Tubulin Modulators|tubulin modulators|mesh-ancestor
110207988|NCT00190489|Antimitotic Agents|antimitotic agents|mesh-ancestor
110207989|NCT00190489|Mitosis Modulators|mitosis modulators|mesh-ancestor
110207990|NCT00190489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207991|NCT00190567|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110207992|NCT00190567|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110207993|NCT00190567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110207994|NCT00190567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110207995|NCT00190567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207996|NCT00190567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110207997|NCT00190567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207998|NCT00190567|Analgesics|analgesics|mesh-ancestor
110207999|NCT00190567|Sensory System Agents|sensory system agents|mesh-ancestor
110208000|NCT00190567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110208001|NCT00190567|Antidepressive Agents|antidepressive agents|mesh-ancestor
110208002|NCT00190567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110208003|NCT00190567|Dopamine Agents|dopamine agents|mesh-ancestor
110208004|NCT02969252|Rifamycins|rifamycins|mesh-list
110208005|NCT02969252|Rifamycin SV|rifamycin sv|mesh-list
110208006|NCT02969252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110208007|NCT02969252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110208008|NCT02969252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110208009|NCT00190606|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110208010|NCT00190606|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110208011|NCT00190606|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110368627|NCT05419583|Protease Inhibitors|protease inhibitors|mesh-ancestor
110208012|NCT00190606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110208013|NCT00190606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208014|NCT00190606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110208015|NCT00190606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110208017|NCT00190606|Sensory System Agents|sensory system agents|mesh-ancestor
110208018|NCT00190606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110208019|NCT00190606|Antidepressive Agents|antidepressive agents|mesh-ancestor
110208020|NCT00190606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110208021|NCT00190606|Dopamine Agents|dopamine agents|mesh-ancestor
110208022|NCT00190645|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110208023|NCT00190645|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110208025|NCT00190645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110208026|NCT00190645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208027|NCT00190645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110208028|NCT00190645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110208029|NCT00190645|Analgesics|analgesics|mesh-ancestor
110208030|NCT00190645|Sensory System Agents|sensory system agents|mesh-ancestor
110208031|NCT00190645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110208032|NCT00190645|Antidepressive Agents|antidepressive agents|mesh-ancestor
110208033|NCT00190645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110208034|NCT00190645|Dopamine Agents|dopamine agents|mesh-ancestor
110208036|NCT00190762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110208037|NCT00190762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110208038|NCT00190762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208039|NCT00190762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110208040|NCT00190762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110208041|NCT00190801|Pemetrexed|pemetrexed|mesh-list
110208042|NCT00190801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110208043|NCT00190801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110208044|NCT00190801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208045|NCT00190801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110208046|NCT00190801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110208047|NCT00047346|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110208048|NCT00047346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110208049|NCT00047346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110208050|NCT00047346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110208051|NCT00047346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208052|NCT00190840|Pemetrexed|pemetrexed|mesh-list
110208053|NCT00190840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110208054|NCT00190840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110208055|NCT00190840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208056|NCT00190840|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110208057|NCT00190840|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110208058|NCT00190879|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110208059|NCT00190879|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110208060|NCT00190879|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110208061|NCT00190879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110208062|NCT00190879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208063|NCT00190879|Adrenergic Agents|adrenergic agents|mesh-ancestor
110208064|NCT00190879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110208065|NCT00190879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110208067|NCT00190918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110208068|NCT00190918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110208069|NCT00190918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208070|NCT00190918|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110208071|NCT00190918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110208072|NCT00190957|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110208073|NCT00190957|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110208074|NCT00190957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110208075|NCT00190957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110208076|NCT00190957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208077|NCT00190957|Adrenergic Agents|adrenergic agents|mesh-ancestor
110208078|NCT00190957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110208079|NCT00190957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110208080|NCT00190996|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110208081|NCT00190996|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110208082|NCT00190996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110208083|NCT00190996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110208084|NCT00190996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208085|NCT00190996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110208086|NCT00190996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110208088|NCT00190996|Sensory System Agents|sensory system agents|mesh-ancestor
110208089|NCT00190996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110208090|NCT00190996|Antidepressive Agents|antidepressive agents|mesh-ancestor
110208091|NCT00190996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110208092|NCT00190996|Dopamine Agents|dopamine agents|mesh-ancestor
110208093|NCT00191035|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110208094|NCT00191035|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110208095|NCT00191035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110208096|NCT00191035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110208097|NCT00191035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208098|NCT00191035|Adrenergic Agents|adrenergic agents|mesh-ancestor
110208099|NCT00191035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110208100|NCT00191035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110208101|NCT02922894|Trazodone|trazodone|mesh-list
110208102|NCT02922894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110208103|NCT02922894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110208104|NCT02922894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110208105|NCT02922894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110208106|NCT02922894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110208107|NCT02922894|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110208108|NCT02922894|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110208109|NCT02922894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110208110|NCT02922894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208111|NCT02922894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110208113|NCT02922894|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110208114|NCT02922894|Antidepressive Agents|antidepressive agents|mesh-ancestor
110208115|NCT00191230|Carboplatin|carboplatin|mesh-list
110208116|NCT00191230|Gemcitabine|gemcitabine|mesh-list
110208117|NCT00191230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110208118|NCT00191230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110208119|NCT00191230|Antimetabolites|antimetabolites|mesh-ancestor
110234738|NCT04977986|Cannabidiol|cannabidiol|mesh-list
110208120|NCT00191230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208121|NCT00191347|Gemcitabine|gemcitabine|mesh-list
110208123|NCT00191347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110208124|NCT00191347|Antimetabolites|antimetabolites|mesh-ancestor
110208125|NCT00191347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208126|NCT00191347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110208127|NCT00191347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110208128|NCT00191347|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110208129|NCT00191347|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110208130|NCT00191425|Teriparatide|teriparatide|mesh-list
110208131|NCT00191425|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
110208132|NCT00191425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110208133|NCT00191425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110208134|NCT00191425|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110208135|NCT00191425|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110208136|NCT00191425|Hormone Antagonists|hormone antagonists|mesh-ancestor
110208137|NCT00191425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110208138|NCT00191425|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110208139|NCT00191425|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110208140|NCT00191464|Insulin|insulin|mesh-list
110208141|NCT00191464|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110208142|NCT00191464|Metformin|metformin|mesh-list
110208143|NCT00191464|Insulin Glargine|insulin glargine|mesh-list
110208144|NCT00191464|Insulin Lispro|insulin lispro|mesh-list
110208145|NCT00191464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110208146|NCT00191464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110208147|NCT04723030|Paclitaxel|paclitaxel|mesh-list
110208148|NCT04723030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110208149|NCT04723030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110208150|NCT04723030|Tubulin Modulators|tubulin modulators|mesh-ancestor
110208151|NCT04723030|Antimitotic Agents|antimitotic agents|mesh-ancestor
110208152|NCT04723030|Mitosis Modulators|mitosis modulators|mesh-ancestor
110208153|NCT04723030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208154|NCT00191503|Gemcitabine|gemcitabine|mesh-list
110208155|NCT00191503|Pemetrexed|pemetrexed|mesh-list
110208156|NCT00191503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110208157|NCT00191503|Antimetabolites|antimetabolites|mesh-ancestor
110208158|NCT00191503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208159|NCT00191503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110208160|NCT00191503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110208161|NCT00191503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110208162|NCT00191503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110208163|NCT00191542|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110208164|NCT00191542|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110208165|NCT00191542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110208166|NCT00191542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110208167|NCT00191542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208168|NCT00191542|Adrenergic Agents|adrenergic agents|mesh-ancestor
110208169|NCT00191542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110208170|NCT00191542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110208171|NCT00059735|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
110208172|NCT00059735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110208173|NCT00059735|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110208174|NCT00059735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110208175|NCT00059735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208176|NCT00191581|Insulin|insulin|mesh-list
110208177|NCT00191581|Insulin Lispro|insulin lispro|mesh-list
110208178|NCT00191581|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110208179|NCT00191581|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
110208180|NCT00191581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110208181|NCT00191581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110208182|NCT00191620|Gemcitabine|gemcitabine|mesh-list
110208183|NCT00191620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110208184|NCT00191620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110208185|NCT00191620|Antimetabolites|antimetabolites|mesh-ancestor
110208186|NCT00191620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208187|NCT00191659|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110208188|NCT00191659|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110208189|NCT00191659|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110208190|NCT00191659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110208191|NCT00191659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208192|NCT00191659|Adrenergic Agents|adrenergic agents|mesh-ancestor
110208193|NCT00191659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110208194|NCT00191659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110208195|NCT00191698|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110208196|NCT00191698|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110208197|NCT00191698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110208198|NCT00191698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110208199|NCT00191698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208200|NCT00191698|Adrenergic Agents|adrenergic agents|mesh-ancestor
110208201|NCT00191698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110208202|NCT00191698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110208204|NCT02470299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110208205|NCT02470299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110208206|NCT02470299|Analgesics|analgesics|mesh-ancestor
110208207|NCT02470299|Sensory System Agents|sensory system agents|mesh-ancestor
110208208|NCT02470299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110208209|NCT02470299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110208210|NCT02470299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110208211|NCT02470299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110208212|NCT02470299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110208213|NCT02470299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110208214|NCT02470299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208215|NCT00191737|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110208216|NCT00191737|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110208217|NCT00191737|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110208218|NCT00191737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110208219|NCT00191737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208220|NCT00191737|Adrenergic Agents|adrenergic agents|mesh-ancestor
110208221|NCT00191737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110208222|NCT00191737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110208224|NCT00191893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110208225|NCT00191893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110208226|NCT00191893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110208227|NCT00191932|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110208228|NCT00191932|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110208229|NCT00191932|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110208230|NCT00191932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110208231|NCT00191932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208232|NCT00191932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110208233|NCT00191932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110208234|NCT00191932|Analgesics|analgesics|mesh-ancestor
110208235|NCT00191932|Sensory System Agents|sensory system agents|mesh-ancestor
110208236|NCT00191932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110208237|NCT00191932|Antidepressive Agents|antidepressive agents|mesh-ancestor
110208238|NCT00191932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110208239|NCT00191932|Dopamine Agents|dopamine agents|mesh-ancestor
110208240|NCT00059813|Interferons|interferons|mesh-list
110208241|NCT00059813|Interferon-alpha|interferon-alpha|mesh-list
110208242|NCT00059813|Interferon alpha-2|interferon alpha-2|mesh-list
110208244|NCT00059813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110208245|NCT00059813|Antiviral Agents|antiviral agents|mesh-ancestor
110208246|NCT00059813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110208247|NCT00059813|Immunologic Factors|immunologic factors|mesh-ancestor
110208248|NCT00059813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110208249|NCT00191971|Gemcitabine|gemcitabine|mesh-list
110208250|NCT00191971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110208251|NCT00191971|Antimetabolites|antimetabolites|mesh-ancestor
110208252|NCT00191971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208253|NCT00191971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110208254|NCT00047502|Imatinib Mesylate|imatinib mesylate|mesh-list
110208255|NCT00047502|Lonafarnib|lonafarnib|mesh-list
110208256|NCT00047502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110208257|NCT00047502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110208258|NCT00047502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110208259|NCT00047502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208260|NCT00192049|Gemcitabine|gemcitabine|mesh-list
110208261|NCT00192049|Mitomycins|mitomycins|mesh-list
110208262|NCT00192049|Mitomycin|mitomycin|mesh-list
110208263|NCT00192049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110208264|NCT00192049|Antimetabolites|antimetabolites|mesh-ancestor
110208265|NCT00192049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208266|NCT00192049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110208267|NCT00192049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110208268|NCT00192049|Alkylating Agents|alkylating agents|mesh-ancestor
110208269|NCT00192049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110208270|NCT00192049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110208272|NCT00192088|Pemetrexed|pemetrexed|mesh-list
110208273|NCT00192088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110208274|NCT00192088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110208275|NCT00192088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208276|NCT00192088|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110208277|NCT00192088|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110208278|NCT00059852|Gemcitabine|gemcitabine|mesh-list
110208279|NCT00059852|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110208280|NCT00059852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110208281|NCT00059852|Antimetabolites|antimetabolites|mesh-ancestor
110208282|NCT00059852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208283|NCT00059852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110208284|NCT00059852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110208285|NCT00059852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110208286|NCT00047580|Tizanidine|tizanidine|mesh-list
110208287|NCT00047580|Analgesics|analgesics|mesh-ancestor
110208288|NCT00047580|Sensory System Agents|sensory system agents|mesh-ancestor
110208289|NCT00047580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110208290|NCT00047580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110208291|NCT00047580|Anticonvulsants|anticonvulsants|mesh-ancestor
110208292|NCT00047580|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110208293|NCT00047580|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110208294|NCT00047580|Parasympatholytics|parasympatholytics|mesh-ancestor
110208295|NCT00047580|Autonomic Agents|autonomic agents|mesh-ancestor
110208296|NCT00047580|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110208297|NCT00047580|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110208298|NCT00047580|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110208299|NCT00047580|Adrenergic Agents|adrenergic agents|mesh-ancestor
110208300|NCT00047580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110208301|NCT00047580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208303|NCT02968901|Macitentan|macitentan|mesh-list
110208304|NCT02968901|Vasodilator Agents|vasodilator agents|mesh-ancestor
110208305|NCT02968901|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110208306|NCT02968901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110208307|NCT02968901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110208308|NCT02968901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208309|NCT02968901|Urological Agents|urological agents|mesh-ancestor
110208310|NCT02968901|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
110208311|NCT02968901|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110208312|NCT02968901|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
110208314|NCT00192595|Lamivudine|lamivudine|mesh-list
110208315|NCT00192595|Zidovudine|zidovudine|mesh-list
110208316|NCT00192595|Efavirenz|efavirenz|mesh-list
110208317|NCT00192595|Antiviral Agents|antiviral agents|mesh-ancestor
110208318|NCT00192595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110208319|NCT00192595|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110208320|NCT00192595|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110208321|NCT00192595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110208322|NCT00192595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208323|NCT00192595|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110208324|NCT00192595|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110208325|NCT00192595|Antimetabolites|antimetabolites|mesh-ancestor
110208326|NCT00192595|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110208327|NCT00192595|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110208328|NCT00192595|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110208329|NCT00192595|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110208331|NCT00192595|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110208332|NCT00192634|Tenofovir|tenofovir|mesh-list
110208333|NCT00192634|Lamivudine|lamivudine|mesh-list
110208334|NCT00192634|Emtricitabine|emtricitabine|mesh-list
110208335|NCT00192634|Abacavir|abacavir|mesh-list
110208336|NCT00192634|Antiviral Agents|antiviral agents|mesh-ancestor
110208337|NCT00192634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110208338|NCT00192634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110208339|NCT00192634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110208340|NCT00192634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110208341|NCT00192634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208342|NCT00192634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110208343|NCT00192634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110208344|NCT00192673|Asparaginase|asparaginase|mesh-list
110208345|NCT00192673|Pegaspargase|pegaspargase|mesh-list
110208346|NCT00192673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110208347|NCT00192712|Gemcitabine|gemcitabine|mesh-list
110208348|NCT00192712|Irinotecan|irinotecan|mesh-list
110208349|NCT00192712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110208350|NCT00192712|Antimetabolites|antimetabolites|mesh-ancestor
110208351|NCT00192712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208352|NCT00192712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110208353|NCT00192712|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110208354|NCT00192712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110208355|NCT00192712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110208356|NCT00047658|Interferons|interferons|mesh-list
110208357|NCT00047658|Interferon-gamma|interferon-gamma|mesh-list
110208358|NCT00047658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110208359|NCT00047658|Antiviral Agents|antiviral agents|mesh-ancestor
110208360|NCT00047658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110208361|NCT00193024|Docetaxel|docetaxel|mesh-list
110208362|NCT00193024|Epirubicin|epirubicin|mesh-list
110208363|NCT00193024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110208364|NCT00193024|Tubulin Modulators|tubulin modulators|mesh-ancestor
110208365|NCT00193024|Antimitotic Agents|antimitotic agents|mesh-ancestor
110208366|NCT00193024|Mitosis Modulators|mitosis modulators|mesh-ancestor
110208367|NCT00193024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208368|NCT00193024|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110208369|NCT00193024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110208370|NCT00193024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110208371|NCT00193024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110208372|NCT00193102|Thalidomide|thalidomide|mesh-list
110208373|NCT00193102|Capecitabine|capecitabine|mesh-list
110208374|NCT00193102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110208375|NCT00193102|Antimetabolites|antimetabolites|mesh-ancestor
110208376|NCT00193102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208377|NCT00193102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110208378|NCT00193102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110208379|NCT00193102|Immunologic Factors|immunologic factors|mesh-ancestor
110208380|NCT00193102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110208382|NCT00193102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110208383|NCT00193102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110208384|NCT00193102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110208385|NCT00193102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110208386|NCT00193102|Growth Substances|growth substances|mesh-ancestor
110208387|NCT00193102|Growth Inhibitors|growth inhibitors|mesh-ancestor
110208388|NCT00193141|Paclitaxel|paclitaxel|mesh-list
110208389|NCT00193141|Carboplatin|carboplatin|mesh-list
110208390|NCT00193141|Fluorouracil|fluorouracil|mesh-list
110208391|NCT00193141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110208392|NCT00193141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110208393|NCT00193141|Tubulin Modulators|tubulin modulators|mesh-ancestor
110208394|NCT00193141|Antimitotic Agents|antimitotic agents|mesh-ancestor
110208395|NCT00193141|Mitosis Modulators|mitosis modulators|mesh-ancestor
110208396|NCT00193141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208397|NCT00193141|Antimetabolites|antimetabolites|mesh-ancestor
110208398|NCT00193141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110208399|NCT00193141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110208400|NCT00193141|Immunologic Factors|immunologic factors|mesh-ancestor
110208401|NCT00193141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110208402|NCT00193297|Paclitaxel|paclitaxel|mesh-list
110208403|NCT00193297|Carboplatin|carboplatin|mesh-list
110208404|NCT00193297|Topotecan|topotecan|mesh-list
110208405|NCT00193297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110208406|NCT00193297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110208407|NCT00193297|Tubulin Modulators|tubulin modulators|mesh-ancestor
110208408|NCT00193297|Antimitotic Agents|antimitotic agents|mesh-ancestor
110208409|NCT00193297|Mitosis Modulators|mitosis modulators|mesh-ancestor
110208410|NCT00193297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208411|NCT00193297|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110208412|NCT00193297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110208413|NCT00193297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110208414|NCT00193336|Gefitinib|gefitinib|mesh-list
110208415|NCT00193336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110208416|NCT00193336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110208417|NCT00193336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110208418|NCT00193336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208419|NCT00193531|Paclitaxel|paclitaxel|mesh-list
110208420|NCT00193531|Etoposide|etoposide|mesh-list
110208421|NCT00193531|Carboplatin|carboplatin|mesh-list
110208422|NCT00193531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110208423|NCT00193531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110208424|NCT00193531|Tubulin Modulators|tubulin modulators|mesh-ancestor
110208425|NCT00193531|Antimitotic Agents|antimitotic agents|mesh-ancestor
110208426|NCT00193531|Mitosis Modulators|mitosis modulators|mesh-ancestor
110208427|NCT00193531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208428|NCT00193531|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110208429|NCT00193531|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110208430|NCT00193531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110208431|NCT00193570|Docetaxel|docetaxel|mesh-list
110208433|NCT00193570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110208434|NCT00193570|Tubulin Modulators|tubulin modulators|mesh-ancestor
110208435|NCT00193570|Antimitotic Agents|antimitotic agents|mesh-ancestor
110208436|NCT00193570|Mitosis Modulators|mitosis modulators|mesh-ancestor
110208437|NCT00193570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208438|NCT00193570|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110208439|NCT00193570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110208440|NCT00193570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110208441|NCT00047736|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110208442|NCT00047736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110208443|NCT00047736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110208444|NCT00047736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110234786|NCT04784715|Taxane|taxane|mesh-list
110208445|NCT00047736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208446|NCT00409591|Ritonavir|ritonavir|mesh-list
110208447|NCT00409591|Lopinavir|lopinavir|mesh-list
110208448|NCT00409591|Zidovudine|zidovudine|mesh-list
110208449|NCT00409591|Nevirapine|nevirapine|mesh-list
110208450|NCT00409591|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110208451|NCT00409591|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110208452|NCT00409591|Protease Inhibitors|protease inhibitors|mesh-ancestor
110208453|NCT00409591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110208454|NCT00409591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208455|NCT00409591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110208456|NCT00409591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110208457|NCT00409591|Antiviral Agents|antiviral agents|mesh-ancestor
110208458|NCT00409591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110208459|NCT00409591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110208460|NCT00409591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110208461|NCT00409591|Antimetabolites|antimetabolites|mesh-ancestor
110208462|NCT00409591|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110208463|NCT00409591|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110208464|NCT00409591|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110208465|NCT00409591|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110208466|NCT00409630|Fluticasone|fluticasone|mesh-list
110208467|NCT00409630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110208468|NCT00409630|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110208469|NCT00409630|Autonomic Agents|autonomic agents|mesh-ancestor
110208470|NCT00409630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110208471|NCT00409630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110208472|NCT00409630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110208473|NCT00409630|Respiratory System Agents|respiratory system agents|mesh-ancestor
110208474|NCT00409630|Dermatologic Agents|dermatologic agents|mesh-ancestor
110208475|NCT00409630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110208476|NCT00060125|Tipifarnib|tipifarnib|mesh-list
110208477|NCT00060125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110208478|NCT00193648|Rosiglitazone|rosiglitazone|mesh-list
110208479|NCT00193648|Adalimumab|adalimumab|mesh-list
110208480|NCT00193648|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110208481|NCT00193648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110208482|NCT00193648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110208483|NCT00193648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110208484|NCT00193648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110208485|NCT00193726|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110208486|NCT00193726|Estradiol|estradiol|mesh-list
110208487|NCT00193726|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110208488|NCT00193726|Estrogens|estrogens|mesh-ancestor
110208489|NCT00193726|Hormones|hormones|mesh-ancestor
110208490|NCT00193726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110208491|NCT00193726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110208492|NCT00193726|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110208493|NCT00193726|Contraceptive Agents|contraceptive agents|mesh-ancestor
110208494|NCT00193726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110208495|NCT00193726|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110208496|NCT00193726|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110208497|NCT00193726|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110208498|NCT00193882|Cisplatin|cisplatin|mesh-list
110208499|NCT00193882|Fluorouracil|fluorouracil|mesh-list
110208500|NCT00193882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110208501|NCT00193882|Antimetabolites|antimetabolites|mesh-ancestor
110208502|NCT00193882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208503|NCT00193882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110208504|NCT00193882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110208505|NCT00193882|Immunologic Factors|immunologic factors|mesh-ancestor
110208506|NCT00193882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110208507|NCT00060242|Fosbretabulin|fosbretabulin|mesh-list
110208508|NCT00060242|Combretastatin|combretastatin|mesh-list
110208509|NCT00060242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110208510|NCT00060242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110208511|NCT00060242|Tubulin Modulators|tubulin modulators|mesh-ancestor
110208512|NCT00060242|Antimitotic Agents|antimitotic agents|mesh-ancestor
110208513|NCT00060242|Mitosis Modulators|mitosis modulators|mesh-ancestor
110208514|NCT00060242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208515|NCT00193921|Cisplatin|cisplatin|mesh-list
110208516|NCT00193921|Gemcitabine|gemcitabine|mesh-list
110208517|NCT00193921|Vinorelbine|vinorelbine|mesh-list
110208518|NCT00193921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110208519|NCT00193921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110208520|NCT00193921|Antimetabolites|antimetabolites|mesh-ancestor
110208521|NCT00193921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208522|NCT00193921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110208523|NCT00193921|Tubulin Modulators|tubulin modulators|mesh-ancestor
110208524|NCT00193921|Antimitotic Agents|antimitotic agents|mesh-ancestor
110208525|NCT00193921|Mitosis Modulators|mitosis modulators|mesh-ancestor
110208526|NCT00194038|Aripiprazole|aripiprazole|mesh-list
110208527|NCT00194038|Antidepressive Agents|antidepressive agents|mesh-ancestor
110208528|NCT00194038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110208529|NCT00194038|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110208530|NCT00194038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110208531|NCT00194038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110208533|NCT00194038|Dopamine Agonists|dopamine agonists|mesh-ancestor
110208534|NCT00194038|Dopamine Agents|dopamine agents|mesh-ancestor
110208535|NCT00194038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110208536|NCT00194038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208537|NCT00194038|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110208538|NCT00194038|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110208539|NCT00194038|Serotonin Agents|serotonin agents|mesh-ancestor
110208540|NCT00194038|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110208541|NCT00194038|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110208542|NCT00194038|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110208543|NCT00194038|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110208544|NCT00060359|Paclitaxel|paclitaxel|mesh-list
110208545|NCT00060359|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110208546|NCT00060359|Carboplatin|carboplatin|mesh-list
110208547|NCT00060359|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
110208548|NCT00060359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110208549|NCT00060359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110208550|NCT00060359|Tubulin Modulators|tubulin modulators|mesh-ancestor
110208551|NCT00060359|Antimitotic Agents|antimitotic agents|mesh-ancestor
110208552|NCT00060359|Mitosis Modulators|mitosis modulators|mesh-ancestor
110208553|NCT00060359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208554|NCT00194272|Methotrexate|methotrexate|mesh-list
110208555|NCT00194272|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110208556|NCT00194272|Abortifacient Agents|abortifacient agents|mesh-ancestor
110208557|NCT00194272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110208558|NCT00194272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110208559|NCT00194272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110208560|NCT00194272|Antimetabolites|antimetabolites|mesh-ancestor
110208561|NCT00194272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208562|NCT00194272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110208563|NCT00194272|Dermatologic Agents|dermatologic agents|mesh-ancestor
110208564|NCT00194272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110208565|NCT00194272|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110208566|NCT00194272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110208567|NCT00194272|Immunologic Factors|immunologic factors|mesh-ancestor
110208568|NCT00194272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110208569|NCT00194272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110208570|NCT00398528|Glatiramer Acetate|glatiramer acetate|mesh-list
110208572|NCT00398528|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110208573|NCT00398528|Immunologic Factors|immunologic factors|mesh-ancestor
110208574|NCT00398528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110208575|NCT00398528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110208576|NCT00398528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110208577|NCT00194467|Valganciclovir|valganciclovir|mesh-list
110208578|NCT00194467|Antiviral Agents|antiviral agents|mesh-ancestor
110208579|NCT00194467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110208580|NCT00194623|Botulinum Toxins|botulinum toxins|mesh-list
110208581|NCT00194623|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110208582|NCT00194623|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110208583|NCT00194623|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110208584|NCT00194623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110208585|NCT00194623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208586|NCT00194623|Cholinergic Agents|cholinergic agents|mesh-ancestor
110208587|NCT00194623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110208588|NCT00194623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110208589|NCT00194623|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110208590|NCT00194623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110208591|NCT00194740|Docetaxel|docetaxel|mesh-list
110208592|NCT00194740|Vinorelbine|vinorelbine|mesh-list
110208593|NCT00194740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110208594|NCT00194740|Tubulin Modulators|tubulin modulators|mesh-ancestor
110208595|NCT00194740|Antimitotic Agents|antimitotic agents|mesh-ancestor
110208596|NCT00194740|Mitosis Modulators|mitosis modulators|mesh-ancestor
110208597|NCT00194740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208598|NCT00194740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110208600|NCT00194818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110208601|NCT00194818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110208602|NCT00194818|Analgesics|analgesics|mesh-ancestor
110208603|NCT00194818|Sensory System Agents|sensory system agents|mesh-ancestor
110208604|NCT00194818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110208605|NCT00194818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110208606|NCT00194818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110208607|NCT00194818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110208608|NCT00194857|Epoetin Alfa|epoetin alfa|mesh-list
110208609|NCT00194857|Hematinics|hematinics|mesh-ancestor
110208610|NCT00194935|Topotecan|topotecan|mesh-list
110208611|NCT00194935|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110208612|NCT00194935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110208613|NCT00194935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110208614|NCT00194935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208615|NCT00194935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110208616|NCT00194974|Clonidine|clonidine|mesh-list
110208617|NCT00194974|Labetalol|labetalol|mesh-list
110208618|NCT00194974|Methyldopa|methyldopa|mesh-list
110208619|NCT00194974|Nifedipine|nifedipine|mesh-list
110208620|NCT00194974|Analgesics|analgesics|mesh-ancestor
110208621|NCT00194974|Sensory System Agents|sensory system agents|mesh-ancestor
110208622|NCT00194974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110208623|NCT00194974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110208624|NCT00194974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110208625|NCT00194974|Sympatholytics|sympatholytics|mesh-ancestor
110208626|NCT00194974|Autonomic Agents|autonomic agents|mesh-ancestor
110208627|NCT00194974|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110208628|NCT00194974|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110208629|NCT00194974|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110208630|NCT00194974|Adrenergic Agents|adrenergic agents|mesh-ancestor
110208631|NCT00194974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110208632|NCT00194974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208633|NCT00194974|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110208634|NCT00194974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110208635|NCT00194974|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110208636|NCT00194974|Vasodilator Agents|vasodilator agents|mesh-ancestor
110234826|NCT04635189|Hormones|hormones|mesh-ancestor
110208638|NCT00194974|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110208639|NCT00194974|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110208640|NCT00194974|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110208641|NCT00194974|Sympathomimetics|sympathomimetics|mesh-ancestor
110208642|NCT00194974|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110208643|NCT00194974|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110208644|NCT00195208|Pantoprazole|pantoprazole|mesh-list
110208645|NCT00195208|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110208646|NCT00195208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110208647|NCT00195208|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110208648|NCT00195208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110208649|NCT00195208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208650|NCT02963116|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110208651|NCT02963116|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110208652|NCT02963116|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110208653|NCT02963116|Antimetabolites|antimetabolites|mesh-ancestor
110208654|NCT02963116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208655|NCT02963116|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110208656|NCT02963116|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110208657|NCT02963116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110208659|NCT00195286|Piperacillin|piperacillin|mesh-list
110208660|NCT00195286|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
110208661|NCT00195286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110208662|NCT00195286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110208663|NCT00195286|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110208664|NCT00195286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110208665|NCT00195286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208666|NCT00084201|Amoxicillin|amoxicillin|mesh-list
110208667|NCT00084201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110208668|NCT00084201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110208669|NCT00195364|Etanercept|etanercept|mesh-list
110208670|NCT00195364|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110208671|NCT00195364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110208672|NCT00195364|Analgesics|analgesics|mesh-ancestor
110208673|NCT00195364|Sensory System Agents|sensory system agents|mesh-ancestor
110208674|NCT00195364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110208675|NCT00195364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110208676|NCT00195364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110208677|NCT00195364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110208678|NCT00195364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110208679|NCT00195364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110208680|NCT00195364|Immunologic Factors|immunologic factors|mesh-ancestor
110208681|NCT00195481|Sirolimus|sirolimus|mesh-list
110208682|NCT00195481|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110208683|NCT00195481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110208684|NCT00195481|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110208685|NCT00195481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110208686|NCT00195481|Antifungal Agents|antifungal agents|mesh-ancestor
110208687|NCT00195481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110208688|NCT00195481|Immunologic Factors|immunologic factors|mesh-ancestor
110208689|NCT00195481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110208690|NCT00195559|Levonorgestrel|levonorgestrel|mesh-list
110208691|NCT00195559|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110208692|NCT00195559|Estradiol|estradiol|mesh-list
110208693|NCT00195559|Estrogens|estrogens|mesh-ancestor
110208694|NCT00195559|Hormones|hormones|mesh-ancestor
110208695|NCT00195559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110208696|NCT00195559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110208697|NCT00195559|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110208698|NCT00195559|Contraceptive Agents|contraceptive agents|mesh-ancestor
110208699|NCT00195559|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110208700|NCT00195559|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110208701|NCT00195559|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110208702|NCT00195559|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110208703|NCT00195559|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110208704|NCT00084240|Azithromycin|azithromycin|mesh-list
110208705|NCT00084240|Chloroquine|chloroquine|mesh-list
110208706|NCT00084240|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
110208707|NCT00084240|Pyrimethamine|pyrimethamine|mesh-list
110208708|NCT00084240|Sulfadoxine|sulfadoxine|mesh-list
110208709|NCT00084240|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110208710|NCT00084240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110208711|NCT00084240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110208712|NCT00084240|Amebicides|amebicides|mesh-ancestor
110208713|NCT00084240|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110208714|NCT00084240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110208715|NCT00084240|Antimalarials|antimalarials|mesh-ancestor
110208716|NCT00084240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110208717|NCT00084240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110208718|NCT00084240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110208719|NCT00084240|Analgesics|analgesics|mesh-ancestor
110208720|NCT00084240|Sensory System Agents|sensory system agents|mesh-ancestor
110208721|NCT00084240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110208722|NCT00084240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110208723|NCT00084240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110208724|NCT00084240|Filaricides|filaricides|mesh-ancestor
110208725|NCT00084240|Antinematodal Agents|antinematodal agents|mesh-ancestor
110208726|NCT00084240|Anthelmintics|anthelmintics|mesh-ancestor
110208727|NCT00084240|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110208728|NCT00084240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110208729|NCT00084240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208730|NCT00084240|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110208731|NCT00195598|Paroxetine|paroxetine|mesh-list
110208732|NCT00195598|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110208733|NCT00195598|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110208734|NCT00195598|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110208735|NCT00195598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110208736|NCT00195598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208737|NCT00195598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110208738|NCT00195598|Serotonin Agents|serotonin agents|mesh-ancestor
110208739|NCT00195598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110208740|NCT00195598|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110208741|NCT00195598|Antidepressive Agents|antidepressive agents|mesh-ancestor
110208742|NCT00195598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110208743|NCT00195598|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110208744|NCT00195598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110208745|NCT00195598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110208746|NCT00195598|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110208747|NCT00195637|Immunoglobulins|immunoglobulins|mesh-list
110208749|NCT00195637|gamma-Globulins|gamma-globulins|mesh-list
110208750|NCT00195637|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110208751|NCT00195637|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110208752|NCT00195637|Immunologic Factors|immunologic factors|mesh-ancestor
110208753|NCT00195637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110208754|NCT00195754|Valproic Acid|valproic acid|mesh-list
110208755|NCT00195754|Anticonvulsants|anticonvulsants|mesh-ancestor
110208756|NCT00195754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110208757|NCT00195754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208758|NCT00195754|GABA Agents|gaba agents|mesh-ancestor
110208759|NCT00195754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110208760|NCT00195754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110208761|NCT00195754|Antimanic Agents|antimanic agents|mesh-ancestor
110208762|NCT00195754|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110208763|NCT00195754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110208764|NCT00195754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110208765|NCT00195793|Atorvastatin|atorvastatin|mesh-list
110208766|NCT00195793|Ezetimibe|ezetimibe|mesh-list
110208767|NCT00195793|Fenofibrate|fenofibrate|mesh-list
110208768|NCT00195793|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110208769|NCT00195793|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110208770|NCT00195793|Antimetabolites|antimetabolites|mesh-ancestor
110208771|NCT00195793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208773|NCT00195793|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110208774|NCT00195793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110208776|NCT00195871|Prednisone|prednisone|mesh-list
110208777|NCT00195871|Cyclophosphamide|cyclophosphamide|mesh-list
110208778|NCT00195871|Methotrexate|methotrexate|mesh-list
110208779|NCT00195871|Etoposide|etoposide|mesh-list
110208780|NCT00195871|Vincristine|vincristine|mesh-list
110208781|NCT00195871|Daunorubicin|daunorubicin|mesh-list
110208782|NCT00195871|Asparaginase|asparaginase|mesh-list
110208783|NCT00195871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110208784|NCT00195871|Immunologic Factors|immunologic factors|mesh-ancestor
110208785|NCT00195871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110208786|NCT00195871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110208787|NCT00195871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110208788|NCT00195871|Alkylating Agents|alkylating agents|mesh-ancestor
110208789|NCT00195871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208790|NCT00195871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110208791|NCT00195871|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110208792|NCT00195871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110208794|NCT00195871|Hormones|hormones|mesh-ancestor
110208795|NCT00195871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110208796|NCT00195871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110208797|NCT00195871|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110208798|NCT00195871|Abortifacient Agents|abortifacient agents|mesh-ancestor
110208799|NCT00195871|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110208800|NCT00195871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110208801|NCT00195871|Antimetabolites|antimetabolites|mesh-ancestor
110208802|NCT00195871|Dermatologic Agents|dermatologic agents|mesh-ancestor
110208803|NCT00195871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110208804|NCT00195871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110208805|NCT00195871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110208806|NCT00195871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110208807|NCT00195871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110208808|NCT00195871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110208809|NCT00195871|Tubulin Modulators|tubulin modulators|mesh-ancestor
110208810|NCT00195871|Antimitotic Agents|antimitotic agents|mesh-ancestor
110208811|NCT00195871|Mitosis Modulators|mitosis modulators|mesh-ancestor
110208812|NCT00195871|Antiviral Agents|antiviral agents|mesh-ancestor
110208813|NCT00195871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110208814|NCT00195871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110208815|NCT00195910|Morphine|morphine|mesh-list
110208816|NCT00195910|Hydromorphone|hydromorphone|mesh-list
110208817|NCT00195910|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110208818|NCT00195910|Narcotics|narcotics|mesh-ancestor
110208819|NCT00195910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110208820|NCT00195910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110208821|NCT00195910|Analgesics|analgesics|mesh-ancestor
110208822|NCT00195910|Sensory System Agents|sensory system agents|mesh-ancestor
110208823|NCT00195910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110208824|NCT00195988|Mycophenolic Acid|mycophenolic acid|mesh-list
110208825|NCT00195988|Tacrolimus|tacrolimus|mesh-list
110208826|NCT00195988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110208827|NCT00195988|Immunologic Factors|immunologic factors|mesh-ancestor
110208828|NCT00195988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110208829|NCT00195988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110208830|NCT00195988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110208831|NCT00195988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208832|NCT00195988|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110208833|NCT00195988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110208834|NCT00195988|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110208835|NCT00195988|Antitubercular Agents|antitubercular agents|mesh-ancestor
110208836|NCT00195988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110208837|NCT00195988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110208839|NCT00060476|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110208840|NCT00060476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110208841|NCT00060476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110208842|NCT00060476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208843|NCT00060476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110208844|NCT00060476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110208846|NCT00060476|Sensory System Agents|sensory system agents|mesh-ancestor
110208847|NCT00060476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110208848|NCT00060476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110208849|NCT00060476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110208850|NCT00060476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110208851|NCT00084279|Interferons|interferons|mesh-list
110208852|NCT00084279|Ribavirin|ribavirin|mesh-list
110208853|NCT00084279|Interferon-alpha|interferon-alpha|mesh-list
110208854|NCT00084279|Interferon-gamma|interferon-gamma|mesh-list
110208855|NCT00084279|Interferon alfacon-1|interferon alfacon-1|mesh-list
110208856|NCT00084279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110208857|NCT00084279|Antiviral Agents|antiviral agents|mesh-ancestor
110208858|NCT00084279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110208859|NCT00084279|Antimetabolites|antimetabolites|mesh-ancestor
110208860|NCT00084279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208861|NCT00084279|Immunologic Factors|immunologic factors|mesh-ancestor
110208862|NCT00084279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110208863|NCT00196378|Estrogens|estrogens|mesh-list
110208864|NCT00196378|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110208865|NCT00196378|Estrogens, conjugated synthetic A|estrogens, conjugated synthetic a|mesh-list
110208866|NCT00196378|Estrogens, conjugated synthetic B|estrogens, conjugated synthetic b|mesh-list
110208867|NCT00196378|Hormones|hormones|mesh-ancestor
110208868|NCT00196378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110208869|NCT00196378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110208870|NCT00196417|Heparin|heparin|mesh-list
110208871|NCT00196417|Certoparin|certoparin|mesh-list
110208872|NCT00196417|Anticoagulants|anticoagulants|mesh-ancestor
110208873|NCT00196417|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110208874|NCT00196417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110208875|NCT00196417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208876|NCT00060554|Heparin|heparin|mesh-list
110208877|NCT00060554|PENTA|penta|mesh-list
110208878|NCT00060554|Fondaparinux|fondaparinux|mesh-list
110208879|NCT00060554|Anticoagulants|anticoagulants|mesh-ancestor
110208880|NCT00060554|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110208881|NCT00060554|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110208882|NCT00060554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208883|NCT00060554|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110208884|NCT00060554|Antithrombins|antithrombins|mesh-ancestor
110208885|NCT00060554|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110208886|NCT00060554|Protease Inhibitors|protease inhibitors|mesh-ancestor
110208887|NCT00060554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110208888|NCT00048087|Docetaxel|docetaxel|mesh-list
110208889|NCT00048087|Gefitinib|gefitinib|mesh-list
110208890|NCT00048087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110208891|NCT00048087|Tubulin Modulators|tubulin modulators|mesh-ancestor
110208892|NCT00048087|Antimitotic Agents|antimitotic agents|mesh-ancestor
110208893|NCT00048087|Mitosis Modulators|mitosis modulators|mesh-ancestor
110208894|NCT00048087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208895|NCT00048087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110208896|NCT00048087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110208897|NCT00196534|Thrombin|thrombin|mesh-list
110208898|NCT00196534|Hemostatics|hemostatics|mesh-ancestor
110208899|NCT00196534|Coagulants|coagulants|mesh-ancestor
110208900|NCT00048126|Capecitabine|capecitabine|mesh-list
110208901|NCT00048126|Irinotecan|irinotecan|mesh-list
110208902|NCT00048126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110208903|NCT00048126|Antimetabolites|antimetabolites|mesh-ancestor
110208904|NCT00048126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208905|NCT00048126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110208906|NCT00048126|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110208907|NCT00048126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110208908|NCT00048126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110208911|NCT00196612|Didanosine|didanosine|mesh-list
110208912|NCT00196612|Antiviral Agents|antiviral agents|mesh-ancestor
110208913|NCT00196612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110208914|NCT00196612|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110208915|NCT00196612|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110208916|NCT00196612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110208917|NCT00196612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208918|NCT00196612|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110208919|NCT00196612|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110208920|NCT00196612|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110208921|NCT00196612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110208922|NCT00196612|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110208923|NCT00196612|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110208924|NCT00196612|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110208925|NCT00196612|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110208926|NCT00196612|Antimetabolites|antimetabolites|mesh-ancestor
110208927|NCT00196690|Donepezil|donepezil|mesh-list
110208928|NCT00196690|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110208929|NCT00196690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110208930|NCT00196690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208931|NCT00196690|Cholinergic Agents|cholinergic agents|mesh-ancestor
110208932|NCT00196690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110208933|NCT00196690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110208934|NCT00196690|Nootropic Agents|nootropic agents|mesh-ancestor
110208935|NCT00196768|Arsenic Trioxide|arsenic trioxide|mesh-list
110208936|NCT00196768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110208937|NCT00084396|Letrozole|letrozole|mesh-list
110208938|NCT00084396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110208939|NCT00084396|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110208940|NCT00084396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110208941|NCT00084396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110208942|NCT00084396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208943|NCT00084396|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110208944|NCT00084396|Hormone Antagonists|hormone antagonists|mesh-ancestor
110208945|NCT00084396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110208946|NCT00084396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110208947|NCT00196846|Goserelin|goserelin|mesh-list
110208948|NCT00196846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110208949|NCT00196846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110208950|NCT00060632|Sirolimus|sirolimus|mesh-list
110208951|NCT00060632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110208952|NCT00060632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110208953|NCT00060632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110208954|NCT00060632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110208955|NCT00060632|Antifungal Agents|antifungal agents|mesh-ancestor
110208956|NCT00060632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110208957|NCT00060632|Immunologic Factors|immunologic factors|mesh-ancestor
110208958|NCT00060632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110208959|NCT00196885|Acetylcysteine|acetylcysteine|mesh-list
110208960|NCT00196885|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110208961|NCT00196885|Antiviral Agents|antiviral agents|mesh-ancestor
110208962|NCT00196885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110208963|NCT00196885|Expectorants|expectorants|mesh-ancestor
110208964|NCT00196885|Respiratory System Agents|respiratory system agents|mesh-ancestor
110208965|NCT00196885|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110208966|NCT00196885|Antioxidants|antioxidants|mesh-ancestor
110208967|NCT00196885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208968|NCT00196885|Protective Agents|protective agents|mesh-ancestor
110208969|NCT00196885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110208970|NCT00196885|Antidotes|antidotes|mesh-ancestor
110208971|NCT00048204|Paroxetine|paroxetine|mesh-list
110208972|NCT00048204|Vestipitant|vestipitant|mesh-list
110208973|NCT00048204|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110208974|NCT00048204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110208975|NCT00048204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110208976|NCT00048204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208977|NCT00048204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110208979|NCT00048204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110208980|NCT00048204|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110208981|NCT00048204|Antidepressive Agents|antidepressive agents|mesh-ancestor
110208982|NCT00048204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110208983|NCT00048204|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110208984|NCT00048204|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110208985|NCT00048204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110208986|NCT00048204|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110208987|NCT00197080|Ropinirole|ropinirole|mesh-list
110208988|NCT00197080|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110208989|NCT00197080|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110208990|NCT00197080|Dopamine Agonists|dopamine agonists|mesh-ancestor
110208991|NCT00197080|Dopamine Agents|dopamine agents|mesh-ancestor
110208992|NCT00197080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110208993|NCT00197080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208994|NCT00197080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110208995|NCT00060671|Rituximab|rituximab|mesh-list
110208996|NCT00060671|Pixantrone|pixantrone|mesh-list
110208997|NCT00060671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110208998|NCT00060671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110208999|NCT00060671|Immunologic Factors|immunologic factors|mesh-ancestor
110209000|NCT00060671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110209001|NCT00060671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110209002|NCT00060671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110209003|NCT00060671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110209004|NCT00060671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110209005|NCT00060671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209006|NCT00197197|Aplaviroc|aplaviroc|mesh-list
110209007|NCT00197197|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110209008|NCT00197197|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110209009|NCT00197197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209010|NCT00197197|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110209011|NCT00197197|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110209012|NCT00197197|Antiviral Agents|antiviral agents|mesh-ancestor
110209013|NCT00197197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110209014|NCT00409903|Eprosartan|eprosartan|mesh-list
110209015|NCT00409903|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110209016|NCT00409903|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
110209017|NCT00409903|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110209018|NCT00409903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209020|NCT00084435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110209021|NCT00084435|Tubulin Modulators|tubulin modulators|mesh-ancestor
110209022|NCT00084435|Antimitotic Agents|antimitotic agents|mesh-ancestor
110209023|NCT00084435|Mitosis Modulators|mitosis modulators|mesh-ancestor
110209024|NCT00084435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209025|NCT00197353|Bupivacaine|bupivacaine|mesh-list
110209026|NCT00197353|Anesthetics, Local|anesthetics, local|mesh-ancestor
110209027|NCT00197353|Anesthetics|anesthetics|mesh-ancestor
110209028|NCT00197353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110209029|NCT00197353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110209030|NCT00197353|Sensory System Agents|sensory system agents|mesh-ancestor
110209031|NCT00197353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110209032|NCT02962999|Ketamine|ketamine|mesh-list
110209033|NCT02962999|Analgesics|analgesics|mesh-ancestor
110209034|NCT02962999|Sensory System Agents|sensory system agents|mesh-ancestor
110209035|NCT02962999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110209036|NCT02962999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110209037|NCT02962999|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110209038|NCT02962999|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110209039|NCT02962999|Anesthetics, General|anesthetics, general|mesh-ancestor
110209040|NCT02962999|Anesthetics|anesthetics|mesh-ancestor
110209041|NCT02962999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110209042|NCT02962999|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110209043|NCT02962999|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110209044|NCT02962999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110209045|NCT02962999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209046|NCT00084513|Trastuzumab|trastuzumab|mesh-list
110209047|NCT00084513|Imatinib Mesylate|imatinib mesylate|mesh-list
110209048|NCT00084513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110209049|NCT00084513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110209050|NCT00084513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110209051|NCT00084513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110209052|NCT00084513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209054|NCT00084591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110209055|NCT00084591|Antimetabolites|antimetabolites|mesh-ancestor
110209056|NCT00084591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209057|NCT00084591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110209058|NCT00197548|Folic Acid|folic acid|mesh-list
110209059|NCT00197548|Vitamin B Complex|vitamin b complex|mesh-list
110209060|NCT00197548|Vitamins|vitamins|mesh-ancestor
110209061|NCT00197548|Micronutrients|micronutrients|mesh-ancestor
110209062|NCT00197548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110209063|NCT00197548|Hematinics|hematinics|mesh-ancestor
110209064|NCT00197587|Nevirapine|nevirapine|mesh-list
110209065|NCT00197587|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110209066|NCT00197587|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110209067|NCT00197587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110234911|NCT04293393|Paclitaxel|paclitaxel|mesh-list
110209068|NCT00197587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209069|NCT00197587|Antiviral Agents|antiviral agents|mesh-ancestor
110209070|NCT00197587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110209071|NCT00197587|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110209072|NCT00197587|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110209073|NCT00197587|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110209074|NCT00197587|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110209075|NCT00197743|Vitamin A|vitamin a|mesh-list
110209076|NCT00197743|Beta Carotene|beta carotene|mesh-list
110209077|NCT00197743|Carotenoids|carotenoids|mesh-list
110209078|NCT00197743|Vitamins|vitamins|mesh-ancestor
110209079|NCT00197743|Micronutrients|micronutrients|mesh-ancestor
110209080|NCT00197743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110209081|NCT00197743|Antioxidants|antioxidants|mesh-ancestor
110209082|NCT00197743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209083|NCT00197743|Protective Agents|protective agents|mesh-ancestor
110209084|NCT00197743|Provitamins|provitamins|mesh-ancestor
110209085|NCT00084630|Imatinib Mesylate|imatinib mesylate|mesh-list
110209086|NCT00084630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110209087|NCT00084630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110209088|NCT00084630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110209089|NCT00084630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209090|NCT00197821|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110209091|NCT00197821|Immunologic Factors|immunologic factors|mesh-ancestor
110209092|NCT00197821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110209093|NCT00084669|Zolpidem|zolpidem|mesh-list
110209094|NCT00084669|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110209095|NCT00084669|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110209096|NCT00084669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110209097|NCT00084669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110209098|NCT00084669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209099|NCT00084669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110209100|NCT00084669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110209101|NCT00084669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110209102|NCT00084669|Antidepressive Agents|antidepressive agents|mesh-ancestor
110209103|NCT00084669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110209104|NCT00084669|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110209105|NCT00084669|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110209106|NCT00084669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110209107|NCT00084669|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110209108|NCT00084669|GABA Agonists|gaba agonists|mesh-ancestor
110209109|NCT00084669|GABA Agents|gaba agents|mesh-ancestor
110209110|NCT00060866|Propranolol|propranolol|mesh-list
110209111|NCT00060866|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110209112|NCT00060866|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110209113|NCT00060866|Adrenergic Agents|adrenergic agents|mesh-ancestor
110209114|NCT00060866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110209115|NCT00060866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209116|NCT00060866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110209117|NCT00060866|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110209118|NCT00060866|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110209120|NCT00048360|Bupropion|bupropion|mesh-list
110209121|NCT00048360|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110209122|NCT00048360|Antidepressive Agents|antidepressive agents|mesh-ancestor
110209123|NCT00048360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110209124|NCT00048360|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110209125|NCT00048360|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110209126|NCT00048360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110209127|NCT00048360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209128|NCT00048360|Dopamine Agents|dopamine agents|mesh-ancestor
110209129|NCT00048360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110209130|NCT00048360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110209131|NCT00048360|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110209132|NCT00048360|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110209133|NCT00048360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110209134|NCT00198055|Aripiprazole|aripiprazole|mesh-list
110209135|NCT00198055|Antidepressive Agents|antidepressive agents|mesh-ancestor
110209136|NCT00198055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110209137|NCT00198055|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110209138|NCT00198055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110209139|NCT00198055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110209140|NCT00198055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110209141|NCT00198055|Dopamine Agonists|dopamine agonists|mesh-ancestor
110209142|NCT00198055|Dopamine Agents|dopamine agents|mesh-ancestor
110209143|NCT00198055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110209144|NCT00198055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209145|NCT00198055|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110209146|NCT00198055|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110209147|NCT00198055|Serotonin Agents|serotonin agents|mesh-ancestor
110209148|NCT00198055|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110209149|NCT00198055|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110209150|NCT00198055|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110209151|NCT00198055|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110209153|NCT00198094|Sertraline|sertraline|mesh-list
110209154|NCT00198094|Antidepressive Agents|antidepressive agents|mesh-ancestor
110209155|NCT00198094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110209156|NCT00198094|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110209157|NCT00198094|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110209158|NCT00198094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110209159|NCT00198094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209160|NCT00198094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110209161|NCT00198094|Serotonin Agents|serotonin agents|mesh-ancestor
110209162|NCT00198094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110209163|NCT00198094|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110209164|NCT00198094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110209165|NCT00198094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110209166|NCT00198094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110209167|NCT00198094|GABA Modulators|gaba modulators|mesh-ancestor
110209168|NCT00198094|GABA Agents|gaba agents|mesh-ancestor
110209169|NCT00198172|Epirubicin|epirubicin|mesh-list
110209170|NCT00198172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110209171|NCT00198172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110209172|NCT00198172|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110209173|NCT00198172|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110209174|NCT00198172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110209175|NCT00198172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209176|NCT00198250|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110209177|NCT00198250|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110209178|NCT00198250|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110209179|NCT00198250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110209180|NCT00198250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209181|NCT00198250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110209182|NCT00198250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110209183|NCT00198250|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110209184|NCT00198250|Antidepressive Agents|antidepressive agents|mesh-ancestor
110209185|NCT00198250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110209187|NCT00084708|Dexamethasone|dexamethasone|mesh-list
110209188|NCT00084708|Gefitinib|gefitinib|mesh-list
110209189|NCT00084708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110209190|NCT00084708|Antiemetics|antiemetics|mesh-ancestor
110209191|NCT00084708|Autonomic Agents|autonomic agents|mesh-ancestor
110209192|NCT00084708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110209193|NCT00084708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110209194|NCT00084708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110209195|NCT00084708|Glucocorticoids|glucocorticoids|mesh-ancestor
110209196|NCT00084708|Hormones|hormones|mesh-ancestor
110209197|NCT00084708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110209198|NCT00084708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110209199|NCT00084708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110209200|NCT00084708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110209201|NCT00084708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110209202|NCT00084708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209203|NCT00084708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110209204|NCT00084708|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110209205|NCT00084708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110209206|NCT00084708|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110209207|NCT00084708|Vitamins|vitamins|mesh-ancestor
110209208|NCT00084708|Micronutrients|micronutrients|mesh-ancestor
110209209|NCT00084708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110209210|NCT00198367|Cisplatin|cisplatin|mesh-list
110209212|NCT00198367|Vinorelbine|vinorelbine|mesh-list
110209213|NCT00198367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110209214|NCT00198367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209215|NCT00198367|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110209216|NCT00198367|Tubulin Modulators|tubulin modulators|mesh-ancestor
110209217|NCT00198367|Antimitotic Agents|antimitotic agents|mesh-ancestor
110209218|NCT00198367|Mitosis Modulators|mitosis modulators|mesh-ancestor
110209219|NCT00198445|Bromfenac|bromfenac|mesh-list
110209220|NCT00198445|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110209221|NCT00198445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110209222|NCT00198445|Analgesics|analgesics|mesh-ancestor
110209223|NCT00198445|Sensory System Agents|sensory system agents|mesh-ancestor
110209224|NCT00198445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110209225|NCT00198445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110209226|NCT00198445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110209227|NCT00198445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110209228|NCT00048399|Fludarabine|fludarabine|mesh-list
110209229|NCT00048399|Alemtuzumab|alemtuzumab|mesh-list
110209230|NCT00048399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110209231|NCT00048399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110209232|NCT00060905|Valproic Acid|valproic acid|mesh-list
110209233|NCT00060905|Anticonvulsants|anticonvulsants|mesh-ancestor
110209234|NCT00060905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110209235|NCT00060905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209236|NCT00060905|GABA Agents|gaba agents|mesh-ancestor
110209237|NCT00060905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110209238|NCT00060905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110209239|NCT00060905|Antimanic Agents|antimanic agents|mesh-ancestor
110209240|NCT00060905|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110209241|NCT00060905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110209242|NCT00060905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110209243|NCT00198523|Tobramycin|tobramycin|mesh-list
110209244|NCT00198523|Prednisolone|prednisolone|mesh-list
110209245|NCT00198523|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110209246|NCT00198523|Methylprednisolone|methylprednisolone|mesh-list
110209247|NCT00198523|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110209248|NCT00198523|Prednisolone acetate|prednisolone acetate|mesh-list
110209249|NCT00198523|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110209250|NCT00198523|Prednisolone phosphate|prednisolone phosphate|mesh-list
110209251|NCT00198523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110209252|NCT00198523|Glucocorticoids|glucocorticoids|mesh-ancestor
110209253|NCT00198523|Hormones|hormones|mesh-ancestor
110209254|NCT00198523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110209255|NCT00198523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110209256|NCT00198523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110209257|NCT00198523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110209258|NCT00198523|Antiemetics|antiemetics|mesh-ancestor
110209259|NCT00198523|Autonomic Agents|autonomic agents|mesh-ancestor
110209260|NCT00198523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110209261|NCT00198523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110209262|NCT00198523|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110209263|NCT00198523|Protective Agents|protective agents|mesh-ancestor
110209264|NCT00198523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110209265|NCT00198523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110209266|NCT00198562|Losartan|losartan|mesh-list
110209267|NCT00198562|Amlodipine|amlodipine|mesh-list
110209268|NCT00198562|Antihypertensive Agents|antihypertensive agents|mesh-list
110209269|NCT00198562|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110209270|NCT00198562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110209271|NCT00198562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209272|NCT00198562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110209273|NCT00198562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110209274|NCT00198562|Vasodilator Agents|vasodilator agents|mesh-ancestor
110209275|NCT00198562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110209276|NCT00198562|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110209277|NCT00198562|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110209279|NCT00409942|Furosemide|furosemide|mesh-list
110209280|NCT00409942|Diuretics|diuretics|mesh-ancestor
110209281|NCT00409942|Natriuretic Agents|natriuretic agents|mesh-ancestor
110209282|NCT00409942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110209283|NCT00409942|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110209284|NCT00409942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110209285|NCT00409942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209286|NCT00409942|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110209287|NCT00084786|Docetaxel|docetaxel|mesh-list
110209288|NCT00084786|Gefitinib|gefitinib|mesh-list
110209289|NCT00084786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110209290|NCT00084786|Tubulin Modulators|tubulin modulators|mesh-ancestor
110209291|NCT00084786|Antimitotic Agents|antimitotic agents|mesh-ancestor
110209292|NCT00084786|Mitosis Modulators|mitosis modulators|mesh-ancestor
110209293|NCT00084786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209294|NCT00084786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110209295|NCT00084786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110209296|NCT00409981|Paclitaxel|paclitaxel|mesh-list
110209297|NCT00409981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110209298|NCT00409981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110209299|NCT00409981|Tubulin Modulators|tubulin modulators|mesh-ancestor
110209300|NCT00409981|Antimitotic Agents|antimitotic agents|mesh-ancestor
110209301|NCT00409981|Mitosis Modulators|mitosis modulators|mesh-ancestor
110209302|NCT00409981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209303|NCT00198601|Gentamicins|gentamicins|mesh-list
110209304|NCT00198601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110209305|NCT00198601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110209306|NCT00198601|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110209307|NCT00198601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110209308|NCT00198601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209309|NCT00198640|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110209310|NCT00198640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110209311|NCT00198679|Chlorhexidine|chlorhexidine|mesh-list
110209312|NCT00198679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110209313|NCT00198679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110209314|NCT00198679|Disinfectants|disinfectants|mesh-ancestor
110209315|NCT00084825|Docetaxel|docetaxel|mesh-list
110209316|NCT00084825|Imatinib Mesylate|imatinib mesylate|mesh-list
110209317|NCT00084825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110209318|NCT00084825|Tubulin Modulators|tubulin modulators|mesh-ancestor
110209319|NCT00084825|Antimitotic Agents|antimitotic agents|mesh-ancestor
110209320|NCT00084825|Mitosis Modulators|mitosis modulators|mesh-ancestor
110209321|NCT00084825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209322|NCT00084825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110209323|NCT00084825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110209324|NCT00048477|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
110209325|NCT00048477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110209326|NCT00048477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209327|NCT00199147|Cytarabine|cytarabine|mesh-list
110209328|NCT00199147|Fludarabine|fludarabine|mesh-list
110209329|NCT00199147|Etoposide|etoposide|mesh-list
110209330|NCT00199147|Idarubicin|idarubicin|mesh-list
110209331|NCT00199147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110209332|NCT00199147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110209333|NCT00199147|Antimetabolites|antimetabolites|mesh-ancestor
110209334|NCT00199147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209335|NCT00199147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110209336|NCT00199147|Immunologic Factors|immunologic factors|mesh-ancestor
110209337|NCT00199147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110209338|NCT00199147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110209339|NCT00199147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110209340|NCT00199147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110209341|NCT00199147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110209342|NCT00199147|Antiviral Agents|antiviral agents|mesh-ancestor
110209343|NCT00199147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110209345|NCT00199186|Cytarabine|cytarabine|mesh-list
110209346|NCT00199186|Dexamethasone|dexamethasone|mesh-list
110209347|NCT00199186|Dexamethasone acetate|dexamethasone acetate|mesh-list
110209348|NCT00199186|Cyclophosphamide|cyclophosphamide|mesh-list
110209349|NCT00199186|Methotrexate|methotrexate|mesh-list
110209350|NCT00199186|Vincristine|vincristine|mesh-list
110209351|NCT00199186|Imatinib Mesylate|imatinib mesylate|mesh-list
110209352|NCT00199186|Idarubicin|idarubicin|mesh-list
110209353|NCT00199186|BB 1101|bb 1101|mesh-list
110209354|NCT00199186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110209355|NCT00199186|Immunologic Factors|immunologic factors|mesh-ancestor
110209356|NCT00199186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110209357|NCT00199186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110209358|NCT00199186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110209359|NCT00199186|Alkylating Agents|alkylating agents|mesh-ancestor
110209360|NCT00199186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209361|NCT00199186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110209362|NCT00199186|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110209363|NCT00199186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110209364|NCT00199186|Antiemetics|antiemetics|mesh-ancestor
110209365|NCT00199186|Autonomic Agents|autonomic agents|mesh-ancestor
110209366|NCT00199186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110209367|NCT00199186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110209368|NCT00199186|Glucocorticoids|glucocorticoids|mesh-ancestor
110209369|NCT00199186|Hormones|hormones|mesh-ancestor
110209370|NCT00199186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110209371|NCT00199186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110209372|NCT00199186|Protease Inhibitors|protease inhibitors|mesh-ancestor
110209373|NCT00199186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110209374|NCT00199186|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110209375|NCT00199186|Abortifacient Agents|abortifacient agents|mesh-ancestor
110209376|NCT00199186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110209377|NCT00199186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110209378|NCT00199186|Antimetabolites|antimetabolites|mesh-ancestor
110209379|NCT00199186|Dermatologic Agents|dermatologic agents|mesh-ancestor
110209380|NCT00199186|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110209381|NCT00199186|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110209382|NCT00199186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110209383|NCT00199186|Tubulin Modulators|tubulin modulators|mesh-ancestor
110209384|NCT00199186|Antimitotic Agents|antimitotic agents|mesh-ancestor
110209385|NCT00199186|Mitosis Modulators|mitosis modulators|mesh-ancestor
110209386|NCT00199186|Antiviral Agents|antiviral agents|mesh-ancestor
110209387|NCT00199186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110209388|NCT00199186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110209389|NCT00199186|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110209390|NCT00199186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110209391|NCT00199186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110209392|NCT00199225|Moxifloxacin|moxifloxacin|mesh-list
110209393|NCT00199225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110209394|NCT00199225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110209395|NCT00199225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110209396|NCT00199225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110209397|NCT00199225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110209398|NCT00199225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209399|NCT00199225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110209400|NCT00061022|Disufenton sodium|disufenton sodium|mesh-list
110209401|NCT00061022|Antioxidants|antioxidants|mesh-ancestor
110209402|NCT00061022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209403|NCT00061022|Protective Agents|protective agents|mesh-ancestor
110209404|NCT00061022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110209405|NCT00199264|Albaconazole|albaconazole|mesh-list
110209406|NCT00199264|Antifungal Agents|antifungal agents|mesh-ancestor
110209407|NCT00199264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110209408|NCT00199342|Ecromeximab|ecromeximab|mesh-list
110209409|NCT00199342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110209410|NCT00199342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110209411|NCT00199420|Istradefylline|istradefylline|mesh-list
110209412|NCT00199420|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
110209413|NCT00199420|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110209414|NCT00199420|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110209415|NCT00199420|Purinergic Agents|purinergic agents|mesh-ancestor
110209416|NCT00199420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110209417|NCT00199420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209418|NCT00199420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110209420|NCT00199576|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110209421|NCT00199576|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110209422|NCT00199576|Prednisolone|prednisolone|mesh-list
110209423|NCT00199576|Prednisolone acetate|prednisolone acetate|mesh-list
110209424|NCT00199576|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110209425|NCT00199576|Prednisolone phosphate|prednisolone phosphate|mesh-list
110209426|NCT00199576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110209427|NCT00199576|Antiemetics|antiemetics|mesh-ancestor
110209428|NCT00199576|Autonomic Agents|autonomic agents|mesh-ancestor
110209429|NCT00199576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110209430|NCT00199576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110209431|NCT00199576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110209432|NCT00199576|Glucocorticoids|glucocorticoids|mesh-ancestor
110209433|NCT00199576|Hormones|hormones|mesh-ancestor
110209434|NCT00199576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110209435|NCT00199576|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110209436|NCT00199576|Protective Agents|protective agents|mesh-ancestor
110209437|NCT00199576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110209438|NCT00199576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110209439|NCT00084942|Gemcitabine|gemcitabine|mesh-list
110209440|NCT00084942|Capecitabine|capecitabine|mesh-list
110209441|NCT00084942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110209442|NCT00084942|Antimetabolites|antimetabolites|mesh-ancestor
110209443|NCT00084942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209444|NCT00084942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110209445|NCT02968394|Omalizumab|omalizumab|mesh-list
110209446|NCT02968394|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110209447|NCT02968394|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110209448|NCT02968394|Respiratory System Agents|respiratory system agents|mesh-ancestor
110209449|NCT00199771|Dextrans|dextrans|mesh-list
110209450|NCT00199771|Anticoagulants|anticoagulants|mesh-ancestor
110209451|NCT00199771|Plasma Substitutes|plasma substitutes|mesh-ancestor
110209453|NCT00084981|Decitabine|decitabine|mesh-list
110209454|NCT00084981|Azacitidine|azacitidine|mesh-list
110209455|NCT00084981|Valproic Acid|valproic acid|mesh-list
110209456|NCT00084981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110209457|NCT00084981|Antimetabolites|antimetabolites|mesh-ancestor
110209458|NCT00084981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209459|NCT00084981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110209460|NCT00084981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110209461|NCT00084981|Anticonvulsants|anticonvulsants|mesh-ancestor
110209462|NCT00084981|GABA Agents|gaba agents|mesh-ancestor
110209463|NCT00084981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110209464|NCT00084981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110209465|NCT00084981|Antimanic Agents|antimanic agents|mesh-ancestor
110209466|NCT00084981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110209467|NCT00084981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110209468|NCT00084981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110209469|NCT00199966|Valproic Acid|valproic acid|mesh-list
110209470|NCT00199966|Anticonvulsants|anticonvulsants|mesh-ancestor
110209471|NCT00199966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110209472|NCT00199966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209473|NCT00199966|GABA Agents|gaba agents|mesh-ancestor
110209474|NCT00199966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110209475|NCT00199966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110209476|NCT00199966|Antimanic Agents|antimanic agents|mesh-ancestor
110209477|NCT00199966|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110209478|NCT00199966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110209479|NCT00199966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110209480|NCT00085020|Trastuzumab|trastuzumab|mesh-list
110209481|NCT00085020|Lapatinib|lapatinib|mesh-list
110209482|NCT00085020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110209483|NCT00085020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110209484|NCT00085020|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110209485|NCT00085020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110209486|NCT00085020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209487|NCT00410215|Bisacodyl|bisacodyl|mesh-list
110209488|NCT00410215|Cathartics|cathartics|mesh-ancestor
110235023|NCT03800134|Paclitaxel|paclitaxel|mesh-list
110209489|NCT00410215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110209490|NCT00410215|Laxatives|laxatives|mesh-ancestor
110209492|NCT00410254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110209493|NCT00410254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110209494|NCT00410254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110209495|NCT00410254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110209496|NCT00410254|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110209497|NCT00410254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110209498|NCT00410254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110209499|NCT00410254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110209500|NCT00410254|Anesthetics, General|anesthetics, general|mesh-ancestor
110209502|NCT00410254|GABA Modulators|gaba modulators|mesh-ancestor
110209503|NCT00410254|GABA Agents|gaba agents|mesh-ancestor
110209504|NCT00410254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110209505|NCT00410254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209506|NCT00061178|Bevacizumab|bevacizumab|mesh-list
110209507|NCT00061178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110209508|NCT00061178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110209509|NCT00061178|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110209510|NCT00061178|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110209511|NCT00061178|Growth Substances|growth substances|mesh-ancestor
110209512|NCT00061178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110209513|NCT00061178|Growth Inhibitors|growth inhibitors|mesh-ancestor
110209514|NCT00200395|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110209515|NCT00200395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110209516|NCT00200395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110209517|NCT00200395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110209518|NCT00200395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209519|NCT00200434|Nebivolol|nebivolol|mesh-list
110209520|NCT00200434|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110209521|NCT00200434|Vasodilator Agents|vasodilator agents|mesh-ancestor
110020044|NCT00000918|Ritonavir|ritonavir|mesh-list
110209522|NCT00200434|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110209523|NCT00200434|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110209524|NCT00200434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110209525|NCT00200434|Adrenergic Agents|adrenergic agents|mesh-ancestor
110209526|NCT00200434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110209527|NCT00200434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209528|NCT00200434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110209529|NCT00200473|Nebivolol|nebivolol|mesh-list
110209530|NCT00200473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110209531|NCT00200473|Vasodilator Agents|vasodilator agents|mesh-ancestor
110209532|NCT00200473|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110209533|NCT00200473|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110209534|NCT00200473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110209535|NCT00200473|Adrenergic Agents|adrenergic agents|mesh-ancestor
110209536|NCT00200473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110209537|NCT00200473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209538|NCT00200473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110209539|NCT02962804|Nivolumab|nivolumab|mesh-list
110209540|NCT02962804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110209541|NCT02962804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110209542|NCT02962804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110209543|NCT02962804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209544|NCT00048555|Galiximab|galiximab|mesh-list
110209545|NCT00048555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110209546|NCT00048555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110209547|NCT00200512|Apomorphine|apomorphine|mesh-list
110209548|NCT00200512|Emetics|emetics|mesh-ancestor
110209549|NCT00200512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110209550|NCT00200512|Autonomic Agents|autonomic agents|mesh-ancestor
110209551|NCT00200512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110209552|NCT00200512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110209554|NCT00200512|Dopamine Agents|dopamine agents|mesh-ancestor
110235041|NCT03774810|Zolpidem|zolpidem|mesh-list
110209555|NCT00200512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110209556|NCT00200512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209557|NCT00200551|Cyclosporine|cyclosporine|mesh-list
110209558|NCT00200551|Mycophenolic Acid|mycophenolic acid|mesh-list
110209559|NCT00200551|Cyclosporins|cyclosporins|mesh-list
110209560|NCT00200551|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110209561|NCT00200551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110209562|NCT00200551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209563|NCT00200551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110209564|NCT00200551|Immunologic Factors|immunologic factors|mesh-ancestor
110209565|NCT00200551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110209566|NCT00200551|Antifungal Agents|antifungal agents|mesh-ancestor
110209567|NCT00200551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110209568|NCT00200551|Dermatologic Agents|dermatologic agents|mesh-ancestor
110209569|NCT00200551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110209570|NCT00200551|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110209571|NCT00200551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110209572|NCT00200551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110209573|NCT00200551|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110209574|NCT00200551|Antitubercular Agents|antitubercular agents|mesh-ancestor
110209575|NCT00200551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110209576|NCT00061256|Vitamin D|vitamin d|mesh-list
110209577|NCT00061256|Alendronate|alendronate|mesh-list
110209578|NCT00061256|Calcium Carbonate|calcium carbonate|mesh-list
110209579|NCT00061256|Calcium|calcium|mesh-list
110209580|NCT00061256|Vitamins|vitamins|mesh-ancestor
110209581|NCT00061256|Micronutrients|micronutrients|mesh-ancestor
110209582|NCT00061256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110209583|NCT00061256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110209584|NCT00061256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110209585|NCT00061256|Antacids|antacids|mesh-ancestor
110209586|NCT00061256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209587|NCT00061256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110209588|NCT00200590|Acetaminophen|acetaminophen|mesh-list
110209589|NCT00200590|Morphine|morphine|mesh-list
110209590|NCT00200590|Nalbuphine|nalbuphine|mesh-list
110209591|NCT00200590|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110209592|NCT00200590|Narcotics|narcotics|mesh-ancestor
110209593|NCT00200590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110209594|NCT00200590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110209595|NCT00200590|Analgesics|analgesics|mesh-ancestor
110209596|NCT00200590|Sensory System Agents|sensory system agents|mesh-ancestor
110209597|NCT00200590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110209598|NCT00200590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110209599|NCT00200590|Antipyretics|antipyretics|mesh-ancestor
110209600|NCT00200629|Adenosine|adenosine|mesh-list
110209601|NCT00200629|Analgesics|analgesics|mesh-ancestor
110209602|NCT00200629|Sensory System Agents|sensory system agents|mesh-ancestor
110209603|NCT00200629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110209604|NCT00200629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110209605|NCT00200629|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110209606|NCT00200629|Vasodilator Agents|vasodilator agents|mesh-ancestor
110209607|NCT00200629|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110209608|NCT00200629|Purinergic Agonists|purinergic agonists|mesh-ancestor
110209609|NCT00200629|Purinergic Agents|purinergic agents|mesh-ancestor
110209610|NCT00200629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110209611|NCT00200629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209612|NCT00200668|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110209613|NCT00200668|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110209614|NCT00200668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209615|NCT00048594|Aprepitant|aprepitant|mesh-list
110209616|NCT00048594|Antiemetics|antiemetics|mesh-ancestor
110209617|NCT00048594|Autonomic Agents|autonomic agents|mesh-ancestor
110209618|NCT00048594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110209619|NCT00048594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110209620|NCT00048594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110209621|NCT00048594|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110209622|NCT00048594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110209623|NCT00048594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209624|NCT00200941|Topiramate|topiramate|mesh-list
110209625|NCT00200941|Anticonvulsants|anticonvulsants|mesh-ancestor
110209626|NCT00200941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110209627|NCT00200941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110209628|NCT00201253|Dimercaprol|dimercaprol|mesh-list
110209629|NCT00201253|Chelating Agents|chelating agents|mesh-ancestor
110209630|NCT00201253|Sequestering Agents|sequestering agents|mesh-ancestor
110209631|NCT00201253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209632|NCT00201331|Leucovorin|leucovorin|mesh-list
110209633|NCT00201331|Antidotes|antidotes|mesh-ancestor
110209634|NCT00201331|Protective Agents|protective agents|mesh-ancestor
110209635|NCT00201331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110209636|NCT00201331|Vitamin B Complex|vitamin b complex|mesh-ancestor
110209637|NCT00201331|Vitamins|vitamins|mesh-ancestor
110209638|NCT00201331|Micronutrients|micronutrients|mesh-ancestor
110209639|NCT00048672|Imatinib Mesylate|imatinib mesylate|mesh-list
110209640|NCT00048672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110209641|NCT00048672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110209642|NCT00048672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110209643|NCT00048672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209644|NCT00201682|Etanercept|etanercept|mesh-list
110209645|NCT00201682|Rituximab|rituximab|mesh-list
110209646|NCT00201682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110209647|NCT00201682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110209648|NCT00201682|Immunologic Factors|immunologic factors|mesh-ancestor
110209649|NCT00201682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110209650|NCT00201682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110209651|NCT00201682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110209652|NCT00201682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110209653|NCT00201682|Analgesics|analgesics|mesh-ancestor
110209654|NCT00201682|Sensory System Agents|sensory system agents|mesh-ancestor
110209655|NCT00201682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110209656|NCT00201682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110209657|NCT00201682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110209658|NCT00201682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110209659|NCT00410371|Lamotrigine|lamotrigine|mesh-list
110209660|NCT00410371|Anticonvulsants|anticonvulsants|mesh-ancestor
110209661|NCT00410371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110209662|NCT00410371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110209663|NCT00410371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209664|NCT00410371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110209665|NCT00410371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110209666|NCT00410371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110209667|NCT00410371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110209668|NCT00410371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110209670|NCT00410371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110209671|NCT00410449|Tocopherols|tocopherols|mesh-list
110209672|NCT00410449|Vitamin E|vitamin e|mesh-list
110209673|NCT00410449|Tocotrienols|tocotrienols|mesh-list
110209674|NCT00410449|alpha-Tocopherol|alpha-tocopherol|mesh-list
110209675|NCT00410449|Antioxidants|antioxidants|mesh-ancestor
110209676|NCT00410449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209677|NCT00410449|Protective Agents|protective agents|mesh-ancestor
110209678|NCT00410449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110209679|NCT00410449|Vitamins|vitamins|mesh-ancestor
110209680|NCT00410449|Micronutrients|micronutrients|mesh-ancestor
110209681|NCT00061451|Gemcitabine|gemcitabine|mesh-list
110209682|NCT00061451|Pemetrexed|pemetrexed|mesh-list
110209683|NCT00061451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110209684|NCT00061451|Antimetabolites|antimetabolites|mesh-ancestor
110209685|NCT00061451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209686|NCT00061451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110209687|NCT00061451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110209688|NCT00061451|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110209689|NCT00061451|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110209690|NCT00410527|Meropenem|meropenem|mesh-list
110209691|NCT00410527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110209692|NCT00410527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110209693|NCT00048750|Micafungin|micafungin|mesh-list
110209694|NCT00048750|Antifungal Agents|antifungal agents|mesh-ancestor
110209695|NCT00048750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110209696|NCT00221416|Aripiprazole|aripiprazole|mesh-list
110209697|NCT00221416|Antidepressive Agents|antidepressive agents|mesh-ancestor
110209698|NCT00221416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110209699|NCT00221416|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110209700|NCT00221416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110209701|NCT00221416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110209702|NCT00221416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110209703|NCT00221416|Dopamine Agonists|dopamine agonists|mesh-ancestor
110209704|NCT00221416|Dopamine Agents|dopamine agents|mesh-ancestor
110209705|NCT00221416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110209706|NCT00221416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209707|NCT00221416|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110209708|NCT00221416|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110209709|NCT00221416|Serotonin Agents|serotonin agents|mesh-ancestor
110209710|NCT00221416|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110209711|NCT00221416|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110209712|NCT00221416|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110209713|NCT00221416|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110209714|NCT00221494|Pindolol|pindolol|mesh-list
110209715|NCT00221494|Citalopram|citalopram|mesh-list
110209716|NCT00221494|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110209717|NCT00221494|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110209718|NCT00221494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110209719|NCT00221494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209720|NCT00221494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110209722|NCT00221494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110209723|NCT00221494|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110209724|NCT00221494|Antidepressive Agents|antidepressive agents|mesh-ancestor
110209725|NCT00221494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110209726|NCT00221494|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110209727|NCT00221494|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110209728|NCT00221494|Adrenergic Agents|adrenergic agents|mesh-ancestor
110209729|NCT00221494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110209730|NCT00221494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110209731|NCT00221494|Vasodilator Agents|vasodilator agents|mesh-ancestor
110209732|NCT00221611|Baclofen|baclofen|mesh-list
110209733|NCT00221611|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110209734|NCT00221611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110209735|NCT00221611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110209736|NCT00221611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110209737|NCT00221611|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110209738|NCT00221611|GABA Agonists|gaba agonists|mesh-ancestor
110209739|NCT00221611|GABA Agents|gaba agents|mesh-ancestor
110209740|NCT00221611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110209741|NCT00221611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209742|NCT00221650|Ribavirin|ribavirin|mesh-list
110209743|NCT00221650|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110209744|NCT00221650|Antimetabolites|antimetabolites|mesh-ancestor
110209745|NCT00221650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209746|NCT00221650|Antiviral Agents|antiviral agents|mesh-ancestor
110209747|NCT00221650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110209748|NCT00221689|Baclofen|baclofen|mesh-list
110209749|NCT00221689|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110209750|NCT00221689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110209751|NCT00221689|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110209752|NCT00221689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110209753|NCT00221689|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110209754|NCT00221689|GABA Agonists|gaba agonists|mesh-ancestor
110209755|NCT00221689|GABA Agents|gaba agents|mesh-ancestor
110209756|NCT00221689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110209757|NCT00221689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209758|NCT02968121|Brexpiprazole|brexpiprazole|mesh-list
110209759|NCT02968121|Serotonin Agents|serotonin agents|mesh-ancestor
110209760|NCT02968121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110209761|NCT02968121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209762|NCT02968121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110209763|NCT02968121|Dopamine Agonists|dopamine agonists|mesh-ancestor
110209764|NCT02968121|Dopamine Agents|dopamine agents|mesh-ancestor
110209765|NCT00412789|Epothilone B|epothilone b|mesh-list
110209766|NCT00412789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110209767|NCT00412789|Tubulin Modulators|tubulin modulators|mesh-ancestor
110209768|NCT00412789|Antimitotic Agents|antimitotic agents|mesh-ancestor
110209769|NCT00412789|Mitosis Modulators|mitosis modulators|mesh-ancestor
110209770|NCT00412789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209771|NCT00048828|Olanzapine|olanzapine|mesh-list
110209772|NCT00048828|Clozapine|clozapine|mesh-list
110209773|NCT00048828|Antiemetics|antiemetics|mesh-ancestor
110209774|NCT00048828|Autonomic Agents|autonomic agents|mesh-ancestor
110209775|NCT00048828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110209776|NCT00048828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110209777|NCT00048828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110209778|NCT00048828|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110209779|NCT00048828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110209780|NCT00048828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110209781|NCT00048828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110209782|NCT00048828|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110209783|NCT00048828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110209784|NCT00048828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110209785|NCT00048828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209786|NCT00048828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110209788|NCT00048828|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110209789|NCT00048828|GABA Antagonists|gaba antagonists|mesh-ancestor
110209790|NCT00048828|GABA Agents|gaba agents|mesh-ancestor
110209791|NCT00061529|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110209792|NCT00061529|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110209793|NCT00061529|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110209794|NCT00061529|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110209795|NCT00061529|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110209796|NCT00061529|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110209797|NCT00061529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110209798|NCT00061529|Adrenergic Agents|adrenergic agents|mesh-ancestor
110209799|NCT00061529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110209800|NCT00061529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209801|NCT00061529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110209802|NCT00221845|Telmisartan|telmisartan|mesh-list
110209803|NCT00221845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110209804|NCT00221845|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110209805|NCT00221845|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110209806|NCT00221845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209808|NCT00085761|Antipruritics|antipruritics|mesh-ancestor
110209809|NCT00085761|Dermatologic Agents|dermatologic agents|mesh-ancestor
110209810|NCT00085761|Sensory System Agents|sensory system agents|mesh-ancestor
110209811|NCT00085761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110209812|NCT00085761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110209813|NCT00221962|Aripiprazole|aripiprazole|mesh-list
110209814|NCT00221962|Antidepressive Agents|antidepressive agents|mesh-ancestor
110209815|NCT00221962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110209816|NCT00221962|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110209817|NCT00221962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110209818|NCT00221962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110209819|NCT00221962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110209820|NCT00221962|Dopamine Agonists|dopamine agonists|mesh-ancestor
110209821|NCT00221962|Dopamine Agents|dopamine agents|mesh-ancestor
110209822|NCT00221962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110209823|NCT00221962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209824|NCT00221962|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110209825|NCT00221962|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110209826|NCT00221962|Serotonin Agents|serotonin agents|mesh-ancestor
110209827|NCT00221962|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110209828|NCT00221962|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110209829|NCT00221962|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110209830|NCT00221962|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110209831|NCT02968160|Telmisartan|telmisartan|mesh-list
110209832|NCT02968160|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110209833|NCT02968160|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110209834|NCT02968160|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110209835|NCT02968160|Antimetabolites|antimetabolites|mesh-ancestor
110209836|NCT02968160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209837|NCT02968160|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110209838|NCT02968160|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110209839|NCT02968160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110209840|NCT02968160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110209841|NCT02968160|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110209842|NCT02968160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110209843|NCT00222079|Esomeprazole|esomeprazole|mesh-list
110209844|NCT00222079|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110209845|NCT00222079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110209846|NCT00222079|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110209847|NCT00222079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110209848|NCT00222079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209850|NCT00222235|Glycine|glycine|mesh-list
110209851|NCT00222235|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110209852|NCT00222235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110209853|NCT00222235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110209854|NCT00222235|Antitubercular Agents|antitubercular agents|mesh-ancestor
110209855|NCT00222235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110209856|NCT00222235|Antimetabolites|antimetabolites|mesh-ancestor
110209857|NCT00222235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209858|NCT00222235|Glycine Agents|glycine agents|mesh-ancestor
110209859|NCT00222235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110209860|NCT00222235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110209861|NCT00061646|Carboplatin|carboplatin|mesh-list
110209862|NCT00061646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110209863|NCT00222469|Bevacizumab|bevacizumab|mesh-list
110209864|NCT00222469|Gemcitabine|gemcitabine|mesh-list
110209865|NCT00222469|Oxaliplatin|oxaliplatin|mesh-list
110209866|NCT00222469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110209867|NCT00222469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110209868|NCT00222469|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110209869|NCT00222469|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110209870|NCT00222469|Growth Substances|growth substances|mesh-ancestor
110209871|NCT00222469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110209872|NCT00222469|Growth Inhibitors|growth inhibitors|mesh-ancestor
110209873|NCT00222469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110209874|NCT00222469|Antimetabolites|antimetabolites|mesh-ancestor
110209875|NCT00222469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209876|NCT00222547|Vitamin A|vitamin a|mesh-list
110209877|NCT00222547|Albendazole|albendazole|mesh-list
110209878|NCT00222547|Vitamins|vitamins|mesh-ancestor
110209879|NCT00222547|Micronutrients|micronutrients|mesh-ancestor
110209880|NCT00222547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110209881|NCT00222547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209882|NCT00222547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110209883|NCT00222547|Anthelmintics|anthelmintics|mesh-ancestor
110209884|NCT00222547|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110209885|NCT00222547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110209886|NCT00222547|Anticestodal Agents|anticestodal agents|mesh-ancestor
110209887|NCT00222547|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110209888|NCT00222547|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110209889|NCT00222547|Tubulin Modulators|tubulin modulators|mesh-ancestor
110209890|NCT00222547|Antimitotic Agents|antimitotic agents|mesh-ancestor
110209891|NCT00222547|Mitosis Modulators|mitosis modulators|mesh-ancestor
110209892|NCT00086034|Motexafin gadolinium|motexafin gadolinium|mesh-list
110209893|NCT00086034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110209894|NCT00086034|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110209895|NCT00086034|Dermatologic Agents|dermatologic agents|mesh-ancestor
110209896|NCT02968082|Scopolamine|scopolamine|mesh-list
110209897|NCT02968082|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
110209898|NCT02968082|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110209899|NCT02968082|Antiemetics|antiemetics|mesh-ancestor
110209900|NCT02968082|Autonomic Agents|autonomic agents|mesh-ancestor
110209901|NCT02968082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110209902|NCT02968082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110209903|NCT02968082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110209905|NCT02968082|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110209906|NCT02968082|Cholinergic Agents|cholinergic agents|mesh-ancestor
110209907|NCT02968082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110209908|NCT02968082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209909|NCT02968082|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110209910|NCT02968082|Parasympatholytics|parasympatholytics|mesh-ancestor
110209911|NCT00222820|Escitalopram|escitalopram|mesh-list
110209912|NCT00222820|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110209913|NCT00222820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110209914|NCT00222820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110209915|NCT00222820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209916|NCT00222820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110209917|NCT00222820|Serotonin Agents|serotonin agents|mesh-ancestor
110209918|NCT00222820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110209920|NCT00085332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110209921|NCT00085332|Tubulin Modulators|tubulin modulators|mesh-ancestor
110209922|NCT00085332|Antimitotic Agents|antimitotic agents|mesh-ancestor
110209923|NCT00085332|Mitosis Modulators|mitosis modulators|mesh-ancestor
110209924|NCT00085332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209925|NCT00222976|Naproxen|naproxen|mesh-list
110209926|NCT00222976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110209927|NCT00222976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110209928|NCT00222976|Analgesics|analgesics|mesh-ancestor
110209929|NCT00222976|Sensory System Agents|sensory system agents|mesh-ancestor
110209930|NCT00222976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110209931|NCT00222976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110209932|NCT00222976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110209933|NCT00222976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110209934|NCT00222976|Gout Suppressants|gout suppressants|mesh-ancestor
110209935|NCT00222976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110209936|NCT00222976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110209937|NCT00222976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209938|NCT00223015|Tacrolimus|tacrolimus|mesh-list
110209939|NCT00223015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110209940|NCT00223015|Immunologic Factors|immunologic factors|mesh-ancestor
110209941|NCT00223015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110209942|NCT00223015|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110209943|NCT00223015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110209944|NCT00223015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209945|NCT00061763|Deferasirox|deferasirox|mesh-list
110209946|NCT00061763|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110209947|NCT00061763|Chelating Agents|chelating agents|mesh-ancestor
110209948|NCT00061763|Sequestering Agents|sequestering agents|mesh-ancestor
110209949|NCT00061763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209950|NCT00223054|Cyclosporine|cyclosporine|mesh-list
110209951|NCT00223054|Sirolimus|sirolimus|mesh-list
110209952|NCT00223054|Everolimus|everolimus|mesh-list
110209953|NCT00223054|Tacrolimus|tacrolimus|mesh-list
110209954|NCT00223054|Cyclosporins|cyclosporins|mesh-list
110209955|NCT00223054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110209956|NCT00223054|Immunologic Factors|immunologic factors|mesh-ancestor
110209957|NCT00223054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110209958|NCT00223054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110209959|NCT00223054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110209960|NCT00223054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209961|NCT00223054|Antifungal Agents|antifungal agents|mesh-ancestor
110209962|NCT00223054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110209963|NCT00223054|Dermatologic Agents|dermatologic agents|mesh-ancestor
110209964|NCT00223054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110209965|NCT00223054|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110209966|NCT00223054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110209967|NCT00223054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110209968|NCT00223054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110209969|NCT00223054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110209970|NCT00223210|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110209971|NCT00223210|Antidepressive Agents|antidepressive agents|mesh-ancestor
110209972|NCT00223210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110209973|NCT00223210|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110209974|NCT00223210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110209975|NCT00223210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110209976|NCT00223210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110209977|NCT00061802|Risperidone|risperidone|mesh-list
110209978|NCT00061802|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110209979|NCT00061802|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110209980|NCT00061802|Serotonin Agents|serotonin agents|mesh-ancestor
110209981|NCT00061802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110209982|NCT00061802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110209983|NCT00061802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110209984|NCT00061802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110209985|NCT00061802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110209986|NCT00061802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110209987|NCT00061802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110209988|NCT00061802|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110209989|NCT00061802|Dopamine Agents|dopamine agents|mesh-ancestor
110209990|NCT00061802|Antidepressive Agents|antidepressive agents|mesh-ancestor
110209991|NCT00223249|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110209992|NCT00223249|Antidepressive Agents|antidepressive agents|mesh-ancestor
110209993|NCT00223249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110209994|NCT00223249|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110209995|NCT00223249|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110209996|NCT00223249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110209997|NCT00223249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110209998|NCT00223288|Escitalopram|escitalopram|mesh-list
110209999|NCT00223288|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110210000|NCT00223288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110210001|NCT00223288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110235116|NCT03464942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110210002|NCT00223288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110210003|NCT00223288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110210004|NCT00223288|Serotonin Agents|serotonin agents|mesh-ancestor
110210005|NCT00223288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110210006|NCT00085449|Cyclosporine|cyclosporine|mesh-list
110210007|NCT00085449|Mycophenolic Acid|mycophenolic acid|mesh-list
110210008|NCT00085449|Fludarabine|fludarabine|mesh-list
110210009|NCT00085449|Fludarabine phosphate|fludarabine phosphate|mesh-list
110210010|NCT00085449|Melphalan|melphalan|mesh-list
110210011|NCT00085449|Alemtuzumab|alemtuzumab|mesh-list
110210012|NCT00085449|Cyclosporins|cyclosporins|mesh-list
110210013|NCT00085449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110210014|NCT00085449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110210015|NCT00085449|Antimetabolites|antimetabolites|mesh-ancestor
110210016|NCT00085449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110210017|NCT00085449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110210018|NCT00085449|Immunologic Factors|immunologic factors|mesh-ancestor
110210019|NCT00085449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110210020|NCT00085449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110210021|NCT00085449|Antifungal Agents|antifungal agents|mesh-ancestor
110210022|NCT00085449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110210023|NCT00085449|Dermatologic Agents|dermatologic agents|mesh-ancestor
110210024|NCT00085449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110210025|NCT00085449|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110210026|NCT00085449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110210027|NCT00085449|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110210028|NCT00085449|Antitubercular Agents|antitubercular agents|mesh-ancestor
110210029|NCT00085449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110210030|NCT00085449|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110210031|NCT00085449|Alkylating Agents|alkylating agents|mesh-ancestor
110210032|NCT00085449|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110210033|NCT00085449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110210034|NCT00223561|Methylphenidate|methylphenidate|mesh-list
110210035|NCT00223561|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110210036|NCT00223561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110210037|NCT00223561|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110210038|NCT00223561|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110210039|NCT00223561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110210040|NCT00223561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110210041|NCT00223561|Dopamine Agents|dopamine agents|mesh-ancestor
110210042|NCT00223561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110210043|NCT00223639|Topiramate|topiramate|mesh-list
110210044|NCT00223639|Anticonvulsants|anticonvulsants|mesh-ancestor
110210045|NCT00223639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110210046|NCT00223639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110210047|NCT00223717|Aspirin|aspirin|mesh-list
110210048|NCT00223717|Losartan|losartan|mesh-list
110210049|NCT00223717|Metoprolol|metoprolol|mesh-list
110210050|NCT00223717|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110210051|NCT00223717|Clonidine|clonidine|mesh-list
110210052|NCT00223717|Eplerenone|eplerenone|mesh-list
110210053|NCT00223717|Nebivolol|nebivolol|mesh-list
110210054|NCT00223717|Bosentan|bosentan|mesh-list
110210055|NCT00223717|Diltiazem|diltiazem|mesh-list
110210056|NCT00223717|Guanfacine|guanfacine|mesh-list
110210057|NCT00223717|Prazosin|prazosin|mesh-list
110210058|NCT00223717|Captopril|captopril|mesh-list
110210059|NCT00223717|Hydralazine|hydralazine|mesh-list
110210060|NCT00223717|Nifedipine|nifedipine|mesh-list
110210061|NCT00223717|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
110210062|NCT00223717|Sildenafil Citrate|sildenafil citrate|mesh-list
110210063|NCT00223717|Nitroglycerin|nitroglycerin|mesh-list
110210064|NCT00223717|Dipyridamole|dipyridamole|mesh-list
110210065|NCT00223717|Carbidopa|carbidopa|mesh-list
110210066|NCT00223717|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
110210067|NCT00223717|Tamsulosin|tamsulosin|mesh-list
110210068|NCT00223717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110210069|NCT00223717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110210070|NCT00223717|Analgesics|analgesics|mesh-ancestor
110210071|NCT00223717|Sensory System Agents|sensory system agents|mesh-ancestor
110210072|NCT00223717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110210073|NCT00223717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110210074|NCT00223717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110210075|NCT00223717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110210076|NCT00223717|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110210077|NCT00223717|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110210078|NCT00223717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110210079|NCT00223717|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110210080|NCT00223717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110210081|NCT00223717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110210082|NCT00223717|Antipyretics|antipyretics|mesh-ancestor
110210083|NCT00223717|Vasodilator Agents|vasodilator agents|mesh-ancestor
110210084|NCT00223717|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110210085|NCT00223717|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110210086|NCT00223717|Urological Agents|urological agents|mesh-ancestor
110210087|NCT00223717|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110210088|NCT00223717|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110210089|NCT00223717|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110210090|NCT00223717|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110210091|NCT00223717|Diuretics|diuretics|mesh-ancestor
110210092|NCT00223717|Natriuretic Agents|natriuretic agents|mesh-ancestor
110210093|NCT00223717|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110210094|NCT00223717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110210095|NCT00223717|Sympatholytics|sympatholytics|mesh-ancestor
110210096|NCT00223717|Autonomic Agents|autonomic agents|mesh-ancestor
110210097|NCT00223717|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110210098|NCT00223717|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110210099|NCT00223717|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110210100|NCT00223717|Adrenergic Agents|adrenergic agents|mesh-ancestor
110210101|NCT00223717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110210102|NCT00223717|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110210103|NCT00223717|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110210104|NCT00223717|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110210105|NCT00223717|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110210106|NCT00223717|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110210108|NCT00223717|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110210110|NCT00223717|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110210111|NCT00223717|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110210112|NCT00223717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110210113|NCT00223717|Tocolytic Agents|tocolytic agents|mesh-ancestor
110210114|NCT00223717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110210115|NCT00223717|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110210116|NCT00223717|Hormone Antagonists|hormone antagonists|mesh-ancestor
110210117|NCT00223717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110210118|NCT00223717|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110210119|NCT00223717|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110210120|NCT00223717|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110210121|NCT00223717|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110210122|NCT00223717|Hemostatics|hemostatics|mesh-ancestor
110210123|NCT00223717|Coagulants|coagulants|mesh-ancestor
110210124|NCT00223717|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110210125|NCT00223717|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110210126|NCT00223717|Protease Inhibitors|protease inhibitors|mesh-ancestor
110210127|NCT00061919|Thalidomide|thalidomide|mesh-list
110210128|NCT00061919|Carboplatin|carboplatin|mesh-list
110210129|NCT00061919|Etoposide|etoposide|mesh-list
110210130|NCT00061919|Etoposide phosphate|etoposide phosphate|mesh-list
110210131|NCT00061919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110210132|NCT00061919|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110210133|NCT00061919|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110210134|NCT00061919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110210135|NCT00061919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110210136|NCT00061919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110210137|NCT00061919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110210138|NCT00061919|Immunologic Factors|immunologic factors|mesh-ancestor
110210139|NCT00061919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110210140|NCT00061919|Leprostatic Agents|leprostatic agents|mesh-ancestor
110210141|NCT00061919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110210142|NCT00061919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110210143|NCT00061919|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110210144|NCT00061919|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110210145|NCT00061919|Growth Substances|growth substances|mesh-ancestor
110210146|NCT00061919|Growth Inhibitors|growth inhibitors|mesh-ancestor
110210147|NCT00085527|Romidepsin|romidepsin|mesh-list
110210148|NCT00085527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110210149|NCT00085527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110210150|NCT00085527|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110210151|NCT00085527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110210152|NCT00085527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110210153|NCT00061958|Arsenic Trioxide|arsenic trioxide|mesh-list
110210154|NCT00061958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110210155|NCT00224068|Ferric gluconate|ferric gluconate|mesh-list
110210156|NCT00224068|Hematinics|hematinics|mesh-ancestor
110210157|NCT00224146|Oxybutynin|oxybutynin|mesh-list
110210158|NCT00224146|Parasympatholytics|parasympatholytics|mesh-ancestor
110210159|NCT00224146|Autonomic Agents|autonomic agents|mesh-ancestor
110210160|NCT00224146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110210161|NCT00224146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110210162|NCT00224146|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110210163|NCT00224146|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110210164|NCT00224146|Cholinergic Agents|cholinergic agents|mesh-ancestor
110210166|NCT00224146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110210167|NCT00224146|Urological Agents|urological agents|mesh-ancestor
110210168|NCT00061997|Inositol|inositol|mesh-list
110210170|NCT00061997|Vitamins|vitamins|mesh-ancestor
110210171|NCT00061997|Micronutrients|micronutrients|mesh-ancestor
110210172|NCT00061997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110210174|NCT00224185|Chelating Agents|chelating agents|mesh-ancestor
110210175|NCT00224185|Sequestering Agents|sequestering agents|mesh-ancestor
110210176|NCT00224185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110210177|NCT00062036|Aldesleukin|aldesleukin|mesh-list
110210178|NCT00062036|Cyclophosphamide|cyclophosphamide|mesh-list
110210179|NCT00062036|Fludarabine|fludarabine|mesh-list
110210180|NCT00062036|Fludarabine phosphate|fludarabine phosphate|mesh-list
110210181|NCT00062036|Interleukin-2|interleukin-2|mesh-list
110210182|NCT00062036|Freund's Adjuvant|freund's adjuvant|mesh-list
110210183|NCT00062036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110210184|NCT00062036|Immunologic Factors|immunologic factors|mesh-ancestor
110210185|NCT00062036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110210186|NCT00062036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110210187|NCT00062036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110210188|NCT00062036|Alkylating Agents|alkylating agents|mesh-ancestor
110210189|NCT00062036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110210190|NCT00062036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110210191|NCT00062036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110210192|NCT00062036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110210193|NCT00062036|Antimetabolites|antimetabolites|mesh-ancestor
110210194|NCT00062036|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110210195|NCT00062036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110210196|NCT00062036|Analgesics|analgesics|mesh-ancestor
110210197|NCT00062036|Sensory System Agents|sensory system agents|mesh-ancestor
110210198|NCT00062036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110210199|NCT00062036|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110210200|NCT00062036|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110210201|NCT00062036|Antiviral Agents|antiviral agents|mesh-ancestor
110210202|NCT00062036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110210203|NCT00224302|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110210204|NCT00224302|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110210205|NCT00224302|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110210206|NCT00224302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110210207|NCT00224302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110210208|NCT00224302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110210209|NCT00224302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110210210|NCT00224302|Analgesics|analgesics|mesh-ancestor
110210211|NCT00224302|Sensory System Agents|sensory system agents|mesh-ancestor
110210212|NCT00224302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110210213|NCT00224302|Antidepressive Agents|antidepressive agents|mesh-ancestor
110210214|NCT00224302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110210215|NCT00224302|Dopamine Agents|dopamine agents|mesh-ancestor
110210216|NCT00062075|Romidepsin|romidepsin|mesh-list
110210217|NCT00062075|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110210218|NCT00062075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110210219|NCT00062075|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110210220|NCT00062075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110210221|NCT00062075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110210222|NCT00224419|Nicotine|nicotine|mesh-list
110210223|NCT00224419|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110210224|NCT00224419|Autonomic Agents|autonomic agents|mesh-ancestor
110210225|NCT00224419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110210226|NCT00224419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110210227|NCT00224419|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110210228|NCT00224419|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110210229|NCT00224419|Cholinergic Agents|cholinergic agents|mesh-ancestor
110210230|NCT00224419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110210231|NCT00224419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110210233|NCT00224458|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110210234|NCT00224458|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110210235|NCT00224458|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110210236|NCT00224458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110210237|NCT00224458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110210239|NCT00224458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110210240|NCT00224458|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110210241|NCT00224458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110210242|NCT00224458|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110210243|NCT00224458|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110210244|NCT00224458|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110210245|NCT00224458|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110210247|NCT00224458|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110210248|NCT00062114|Rituximab|rituximab|mesh-list
110210249|NCT00062114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110210250|NCT00062114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110210251|NCT00062114|Immunologic Factors|immunologic factors|mesh-ancestor
110210252|NCT00062114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110210253|NCT00062114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110210254|NCT00095043|Gaboxadol|gaboxadol|mesh-list
110210255|NCT00095043|Analgesics|analgesics|mesh-ancestor
110210256|NCT00095043|Sensory System Agents|sensory system agents|mesh-ancestor
110210257|NCT00095043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110210258|NCT00095043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110210259|NCT00095043|Anticonvulsants|anticonvulsants|mesh-ancestor
110210260|NCT00095043|GABA Agonists|gaba agonists|mesh-ancestor
110210261|NCT00095043|GABA Agents|gaba agents|mesh-ancestor
110210262|NCT00095043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110210263|NCT00095043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110210264|NCT00095082|Insulin|insulin|mesh-list
110210265|NCT00095082|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110210266|NCT00095082|Insulin Glargine|insulin glargine|mesh-list
110210267|NCT00095082|Insulin Aspart|insulin aspart|mesh-list
110210268|NCT00095082|Insulin Detemir|insulin detemir|mesh-list
110210269|NCT00095082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110210270|NCT00095082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110210271|NCT00062231|Amoxicillin|amoxicillin|mesh-list
110210272|NCT00062231|Moxifloxacin|moxifloxacin|mesh-list
110210273|NCT00062231|Ciprofloxacin|ciprofloxacin|mesh-list
110210274|NCT00062231|Clavulanic Acid|clavulanic acid|mesh-list
110210275|NCT00062231|Clavulanic Acids|clavulanic acids|mesh-list
110210276|NCT00062231|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110210277|NCT00062231|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110210278|NCT00062231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110210279|NCT00062231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110210280|NCT00062231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110210281|NCT00062231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110210282|NCT00062231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110210283|NCT00062231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110210284|NCT00062231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110210285|NCT00062231|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110210286|NCT00062231|Contraceptive Agents|contraceptive agents|mesh-ancestor
110210287|NCT00062231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110210288|NCT00062231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110210289|NCT00062231|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110210290|NCT00062231|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110210291|NCT00062231|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110210292|NCT00062231|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110210293|NCT00062231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110210294|NCT00062231|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110210295|NCT00224692|Ketamine|ketamine|mesh-list
110210296|NCT00224692|Analgesics|analgesics|mesh-ancestor
110210297|NCT00224692|Sensory System Agents|sensory system agents|mesh-ancestor
110210298|NCT00224692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110210299|NCT00224692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110210300|NCT00224692|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110210301|NCT00224692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110210302|NCT00224692|Anesthetics, General|anesthetics, general|mesh-ancestor
110210303|NCT00224692|Anesthetics|anesthetics|mesh-ancestor
110210304|NCT00224692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110210305|NCT00224692|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110210306|NCT00224692|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110210307|NCT00224692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110210308|NCT00224692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110210309|NCT00224809|Aspirin|aspirin|mesh-list
110210315|NCT00224809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110210316|NCT00224809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110210317|NCT00224809|Analgesics|analgesics|mesh-ancestor
110210318|NCT00224809|Sensory System Agents|sensory system agents|mesh-ancestor
110210319|NCT00224809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110210320|NCT00224809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110210321|NCT00224809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110210322|NCT00224809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110210323|NCT00224809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110210324|NCT00224809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110210325|NCT00224809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110210326|NCT00224809|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110210327|NCT00224809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110210329|NCT00224809|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110210330|NCT00224809|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110210331|NCT00224809|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110210332|NCT00224809|Purinergic Agents|purinergic agents|mesh-ancestor
110210333|NCT00224809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110210334|NCT00224809|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110210335|NCT00224809|Hormone Antagonists|hormone antagonists|mesh-ancestor
110210336|NCT00224809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110210337|NCT00224809|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110210338|NCT00224809|Diuretics|diuretics|mesh-ancestor
110210339|NCT00224809|Natriuretic Agents|natriuretic agents|mesh-ancestor
110210340|NCT00224809|Protease Inhibitors|protease inhibitors|mesh-ancestor
110210341|NCT00062270|Gemcitabine|gemcitabine|mesh-list
110210342|NCT00062270|Docetaxel|docetaxel|mesh-list
110210343|NCT00062270|Gefitinib|gefitinib|mesh-list
110210344|NCT00062270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110210345|NCT00062270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110210346|NCT00062270|Antimetabolites|antimetabolites|mesh-ancestor
110210347|NCT00062270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110210348|NCT00062270|Tubulin Modulators|tubulin modulators|mesh-ancestor
110210349|NCT00062270|Antimitotic Agents|antimitotic agents|mesh-ancestor
110210350|NCT00062270|Mitosis Modulators|mitosis modulators|mesh-ancestor
110210351|NCT00062270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110210352|NCT00062270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110210353|NCT00413023|Casopitant|casopitant|mesh-list
110210354|NCT00413023|Antiemetics|antiemetics|mesh-ancestor
110210355|NCT00413023|Autonomic Agents|autonomic agents|mesh-ancestor
110210356|NCT00413023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110210357|NCT00413023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110210358|NCT00413023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110210359|NCT00413023|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110210360|NCT00413023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110210361|NCT00413023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110210362|NCT00095277|Darbepoetin alfa|darbepoetin alfa|mesh-list
110210363|NCT00095277|Hematinics|hematinics|mesh-ancestor
110210364|NCT00413101|Epoetin Alfa|epoetin alfa|mesh-list
110210365|NCT00413101|Hematinics|hematinics|mesh-ancestor
110210366|NCT00413179|Metformin|metformin|mesh-list
110210367|NCT00413179|Clomiphene|clomiphene|mesh-list
110210368|NCT00413179|Enclomiphene|enclomiphene|mesh-list
110210369|NCT00413179|Zuclomiphene|zuclomiphene|mesh-list
110210370|NCT00413179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110210371|NCT00413179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110210372|NCT00413179|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110210373|NCT00413179|Hormone Antagonists|hormone antagonists|mesh-ancestor
110210374|NCT00413179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110210375|NCT00413179|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110210376|NCT00413179|Fertility Agents|fertility agents|mesh-ancestor
110210377|NCT00413179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110210378|NCT00413179|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110210379|NCT00413179|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110210381|NCT00413257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110210382|NCT00413257|Analgesics|analgesics|mesh-ancestor
110210383|NCT00413257|Sensory System Agents|sensory system agents|mesh-ancestor
110210384|NCT00413257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110210385|NCT00413257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110210386|NCT00095316|Caspofungin|caspofungin|mesh-list
110210387|NCT00095316|Antifungal Agents|antifungal agents|mesh-ancestor
110210388|NCT00095316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110210389|NCT00095316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110210390|NCT00095316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110210391|NCT00225043|Phenylephrine|phenylephrine|mesh-list
110210392|NCT00225043|Epinephrine|epinephrine|mesh-list
110210393|NCT00225043|Oxymetazoline|oxymetazoline|mesh-list
110210394|NCT00225043|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110210395|NCT00225043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110210396|NCT00225043|Adrenergic Agents|adrenergic agents|mesh-ancestor
110210397|NCT00225043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110210398|NCT00225043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110210399|NCT00225043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110210400|NCT00225043|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110210401|NCT00225043|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110210402|NCT00225043|Autonomic Agents|autonomic agents|mesh-ancestor
110210403|NCT00225043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110210404|NCT00225043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110210405|NCT00225043|Respiratory System Agents|respiratory system agents|mesh-ancestor
110210406|NCT00225043|Mydriatics|mydriatics|mesh-ancestor
110210407|NCT00225043|Sympathomimetics|sympathomimetics|mesh-ancestor
110210408|NCT00225043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110210409|NCT00225043|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110210410|NCT00225043|Nasal Decongestants|nasal decongestants|mesh-ancestor
110210411|NCT00225043|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110210412|NCT00225043|Protective Agents|protective agents|mesh-ancestor
110210413|NCT00095355|Valproic Acid|valproic acid|mesh-list
110210414|NCT00095355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110210415|NCT00095355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110210416|NCT00095355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110210417|NCT00095355|Antimanic Agents|antimanic agents|mesh-ancestor
110210418|NCT00095355|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110210419|NCT00095355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110210420|NCT00095355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110210421|NCT00095355|Anticonvulsants|anticonvulsants|mesh-ancestor
110210422|NCT00095355|GABA Agents|gaba agents|mesh-ancestor
110210423|NCT00095355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110210424|NCT00225160|Acetylcarnitine|acetylcarnitine|mesh-list
110210425|NCT00225160|Vitamin B Complex|vitamin b complex|mesh-ancestor
110210426|NCT00225160|Vitamins|vitamins|mesh-ancestor
110210427|NCT00225160|Micronutrients|micronutrients|mesh-ancestor
110210428|NCT00225160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110210429|NCT00225160|Nootropic Agents|nootropic agents|mesh-ancestor
110210430|NCT00225238|Esomeprazole|esomeprazole|mesh-list
110210431|NCT00225238|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110210432|NCT00225238|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110210433|NCT00225238|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110210434|NCT00225238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110210435|NCT00225238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110210436|NCT00062426|Leucovorin|leucovorin|mesh-list
110210437|NCT00062426|Bevacizumab|bevacizumab|mesh-list
110210438|NCT00062426|Fluorouracil|fluorouracil|mesh-list
110210439|NCT00062426|Capecitabine|capecitabine|mesh-list
110210440|NCT00062426|Oxaliplatin|oxaliplatin|mesh-list
110210441|NCT00062426|Calcium|calcium|mesh-list
110210442|NCT00062426|Levoleucovorin|levoleucovorin|mesh-list
110210443|NCT00062426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110210444|NCT00062426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110210445|NCT00062426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110210446|NCT00062426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110210447|NCT00062426|Growth Substances|growth substances|mesh-ancestor
110210448|NCT00062426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110210449|NCT00062426|Growth Inhibitors|growth inhibitors|mesh-ancestor
110210450|NCT00062426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110210451|NCT00062426|Antimetabolites|antimetabolites|mesh-ancestor
110210452|NCT00062426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110210453|NCT00062426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110210454|NCT00062426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110210455|NCT00062426|Immunologic Factors|immunologic factors|mesh-ancestor
110210456|NCT00062426|Antidotes|antidotes|mesh-ancestor
110210457|NCT00062426|Protective Agents|protective agents|mesh-ancestor
110210458|NCT00062426|Vitamin B Complex|vitamin b complex|mesh-ancestor
110210459|NCT00062426|Vitamins|vitamins|mesh-ancestor
110210460|NCT00062426|Micronutrients|micronutrients|mesh-ancestor
110210461|NCT00095433|Ranibizumab|ranibizumab|mesh-list
110210462|NCT00095433|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110210463|NCT00095433|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110210464|NCT00095433|Growth Substances|growth substances|mesh-ancestor
110210465|NCT00095433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110210466|NCT00095433|Growth Inhibitors|growth inhibitors|mesh-ancestor
110210467|NCT00095433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110210468|NCT00225355|Rosiglitazone|rosiglitazone|mesh-list
110210469|NCT00225355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110210470|NCT00225355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110210471|NCT00225433|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110210473|NCT00225433|Hormones|hormones|mesh-ancestor
110210474|NCT00225433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110210475|NCT00225433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110210476|NCT00225433|Hormone Antagonists|hormone antagonists|mesh-ancestor
110210477|NCT00095472|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
110210478|NCT00095472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110210479|NCT00095472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110210480|NCT02962258|Amlodipine|amlodipine|mesh-list
110210481|NCT02962258|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110210482|NCT02962258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110210483|NCT02962258|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110210484|NCT02962258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110210485|NCT02962258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110210486|NCT02962258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110210487|NCT02962258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110210488|NCT02962258|Vasodilator Agents|vasodilator agents|mesh-ancestor
110210489|NCT02962258|Diuretics|diuretics|mesh-ancestor
110210490|NCT02962258|Natriuretic Agents|natriuretic agents|mesh-ancestor
110210491|NCT02962258|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110210492|NCT00225511|Milnacipran|milnacipran|mesh-list
110210493|NCT00225511|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110210494|NCT00225511|Levomilnacipran|levomilnacipran|mesh-list
110210495|NCT00225511|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110210496|NCT00225511|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110210497|NCT00225511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110210498|NCT00225511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110210499|NCT00225511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110210500|NCT00225511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110210501|NCT00225511|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110210502|NCT00225511|Antidepressive Agents|antidepressive agents|mesh-ancestor
110210503|NCT00225511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110210504|NCT00225511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110210505|NCT00225511|Analgesics|analgesics|mesh-ancestor
110210506|NCT00225511|Sensory System Agents|sensory system agents|mesh-ancestor
110210507|NCT00225511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110210509|NCT00095511|Antidepressive Agents|antidepressive agents|mesh-ancestor
110210510|NCT00095511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110210511|NCT00095511|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110210512|NCT00095511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110210513|NCT00095511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110210514|NCT00095511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110210515|NCT00095511|Dopamine Agonists|dopamine agonists|mesh-ancestor
110210516|NCT00095511|Dopamine Agents|dopamine agents|mesh-ancestor
110210517|NCT00095511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110210518|NCT00095511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110210519|NCT00095511|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110210520|NCT00095511|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110210521|NCT00095511|Serotonin Agents|serotonin agents|mesh-ancestor
110210522|NCT00095511|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110210523|NCT00095511|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110210524|NCT00095511|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110210525|NCT00095511|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110210526|NCT00225589|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110210527|NCT00225589|Calcium|calcium|mesh-list
110210528|NCT00225589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110210529|NCT00225589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110210530|NCT00225589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110210531|NCT00225589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110210532|NCT00225589|Antimetabolites|antimetabolites|mesh-ancestor
110210533|NCT00225589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110210534|NCT00225589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110210535|NCT00225589|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110210536|NCT00225589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110210537|NCT02967887|Fluorouracil|fluorouracil|mesh-list
110210538|NCT02967887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110210539|NCT02967887|Antimetabolites|antimetabolites|mesh-ancestor
110210540|NCT02967887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110210541|NCT02967887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110210542|NCT02967887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110210543|NCT02967887|Immunologic Factors|immunologic factors|mesh-ancestor
110210544|NCT02967887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110210545|NCT00225667|Irbesartan|irbesartan|mesh-list
110210546|NCT00225667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110210547|NCT00225667|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110210548|NCT00225667|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110210549|NCT00225667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110210550|NCT00225706|Ibuprofen|ibuprofen|mesh-list
110210551|NCT00225706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110210552|NCT00225706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110210553|NCT00225706|Analgesics|analgesics|mesh-ancestor
110210554|NCT00225706|Sensory System Agents|sensory system agents|mesh-ancestor
110210555|NCT00225706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110210556|NCT00225706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110210557|NCT00225706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110210558|NCT00225706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110210559|NCT00225706|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110210560|NCT00225706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110210561|NCT00225706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110210562|NCT00095667|Lapatinib|lapatinib|mesh-list
110210563|NCT00095667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110210564|NCT00095667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110210565|NCT00095667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110210566|NCT00095667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110210567|NCT00225862|Ropinirole|ropinirole|mesh-list
110210568|NCT00225862|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110210569|NCT00225862|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110210570|NCT00225862|Dopamine Agonists|dopamine agonists|mesh-ancestor
110210571|NCT00225862|Dopamine Agents|dopamine agents|mesh-ancestor
110210572|NCT00225862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110210573|NCT00225862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110210574|NCT00225862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110210575|NCT00095706|Bevacizumab|bevacizumab|mesh-list
110210576|NCT00095706|Trastuzumab|trastuzumab|mesh-list
110210577|NCT00095706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110210578|NCT00095706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110210579|NCT00095706|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110210580|NCT00095706|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110210581|NCT00095706|Growth Substances|growth substances|mesh-ancestor
110210582|NCT00095706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110210583|NCT00095706|Growth Inhibitors|growth inhibitors|mesh-ancestor
110210584|NCT00225901|Mitogens|mitogens|mesh-list
110210585|NCT00225901|Mitosis Modulators|mitosis modulators|mesh-ancestor
110210586|NCT00225901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110210587|NCT00225979|Octreotide|octreotide|mesh-list
110210588|NCT00225979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110210589|NCT00225979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110210590|NCT00225979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110210591|NCT02967731|Mometasone Furoate|mometasone furoate|mesh-list
110210592|NCT02967731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110210593|NCT02967731|Dermatologic Agents|dermatologic agents|mesh-ancestor
110210594|NCT02967731|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110210595|NCT00095745|Aripiprazole|aripiprazole|mesh-list
110210596|NCT00095745|Antidepressive Agents|antidepressive agents|mesh-list
110210597|NCT00095745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110210598|NCT00095745|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110210599|NCT00095745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110210600|NCT00095745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110210601|NCT00095745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110210602|NCT00095745|Dopamine Agonists|dopamine agonists|mesh-ancestor
110210603|NCT00095745|Dopamine Agents|dopamine agents|mesh-ancestor
110210604|NCT00095745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110210605|NCT00095745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110210606|NCT00095745|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110210607|NCT00095745|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110210608|NCT00095745|Serotonin Agents|serotonin agents|mesh-ancestor
110210609|NCT00095745|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110210610|NCT00095745|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110210611|NCT00095745|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110210612|NCT00095745|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110210613|NCT00226096|Metoprolol|metoprolol|mesh-list
110210614|NCT00226096|Clonidine|clonidine|mesh-list
110210615|NCT00226096|Nitroprusside|nitroprusside|mesh-list
110210616|NCT00226096|Labetalol|labetalol|mesh-list
110210617|NCT00226096|Hydralazine|hydralazine|mesh-list
110210618|NCT00226096|Nicardipine|nicardipine|mesh-list
110210619|NCT00226096|Phentolamine|phentolamine|mesh-list
110210620|NCT00226096|Urapidil|urapidil|mesh-list
110210621|NCT00226096|Enalaprilat|enalaprilat|mesh-list
110210622|NCT00226096|Nitroglycerin|nitroglycerin|mesh-list
110210623|NCT00226096|Esmolol|esmolol|mesh-list
110210624|NCT00226096|Glycerol|glycerol|mesh-list
110210625|NCT00226096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110210626|NCT00226096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110210627|NCT00226096|Sympatholytics|sympatholytics|mesh-ancestor
110210628|NCT00226096|Autonomic Agents|autonomic agents|mesh-ancestor
110210629|NCT00226096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110210630|NCT00226096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110210631|NCT00226096|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110210632|NCT00226096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110210633|NCT00226096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110210634|NCT00226096|Adrenergic Agents|adrenergic agents|mesh-ancestor
110210635|NCT00226096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110210636|NCT00226096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110210637|NCT00226096|Analgesics|analgesics|mesh-ancestor
110210638|NCT00226096|Sensory System Agents|sensory system agents|mesh-ancestor
110210639|NCT00226096|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110210640|NCT00226096|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110210641|NCT00226096|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110210642|NCT00226096|Vasodilator Agents|vasodilator agents|mesh-ancestor
110210643|NCT00226096|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110210644|NCT00226096|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110210645|NCT00226096|Protective Agents|protective agents|mesh-ancestor
110210646|NCT00226096|Sympathomimetics|sympathomimetics|mesh-ancestor
110210647|NCT00226096|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110210648|NCT00226096|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110210649|NCT00226096|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110210650|NCT00226096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110210651|NCT00226096|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110210652|NCT00226096|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110210653|NCT00226096|Serotonin Agents|serotonin agents|mesh-ancestor
110210654|NCT00226096|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110210655|NCT00226096|Protease Inhibitors|protease inhibitors|mesh-ancestor
110210656|NCT00226096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110210657|NCT00226135|Lamotrigine|lamotrigine|mesh-list
110210658|NCT00226135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110210659|NCT00226135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110210660|NCT00226135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110210661|NCT00226135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110210662|NCT00226135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110210663|NCT00226135|Anticonvulsants|anticonvulsants|mesh-ancestor
110210664|NCT00226135|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110210665|NCT00226135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110210666|NCT00226135|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110210667|NCT00226135|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110210668|NCT00226135|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110210669|NCT00400374|Celecoxib|celecoxib|mesh-list
110210670|NCT00400374|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110210671|NCT00400374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110210672|NCT00400374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110210673|NCT00400374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110210674|NCT00400374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110210675|NCT00400374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110210676|NCT00400374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110210677|NCT00400374|Analgesics|analgesics|mesh-ancestor
110210678|NCT00400374|Sensory System Agents|sensory system agents|mesh-ancestor
110210679|NCT00400374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110210680|NCT00400374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110210681|NCT00400374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110210682|NCT00400374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110210683|NCT00400374|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110235239|NCT02849639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110210684|NCT00400374|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110210686|NCT00226330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110210687|NCT00226330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110210688|NCT00075426|Arsenic Trioxide|arsenic trioxide|mesh-list
110210689|NCT00075426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110210690|NCT00226408|Interferons|interferons|mesh-list
110210691|NCT00226408|Interferon-alpha|interferon-alpha|mesh-list
110210692|NCT00226408|Interferon alpha-2|interferon alpha-2|mesh-list
110210693|NCT00226408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110210694|NCT00226408|Antiviral Agents|antiviral agents|mesh-ancestor
110210695|NCT00226408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110210696|NCT00226408|Immunologic Factors|immunologic factors|mesh-ancestor
110210697|NCT00226408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110210698|NCT00226447|Interferons|interferons|mesh-list
110210699|NCT00226447|Lamivudine|lamivudine|mesh-list
110210700|NCT00226447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110210701|NCT00226447|Antiviral Agents|antiviral agents|mesh-ancestor
110210702|NCT00226447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110210703|NCT00226447|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110210704|NCT00226447|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110210705|NCT00226447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110210706|NCT00226447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110210707|NCT00226447|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110210708|NCT00226447|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110210709|NCT00062660|Tipranavir|tipranavir|mesh-list
110210710|NCT00062660|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110210711|NCT00062660|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110210712|NCT00062660|Antiviral Agents|antiviral agents|mesh-ancestor
110210713|NCT00062660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110210714|NCT00413296|Levetiracetam|levetiracetam|mesh-list
110210715|NCT00413296|Anticonvulsants|anticonvulsants|mesh-ancestor
110210716|NCT00413296|Nootropic Agents|nootropic agents|mesh-ancestor
110210717|NCT00413452|Etanercept|etanercept|mesh-list
110210718|NCT00413452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110210719|NCT00413452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110210720|NCT00413452|Analgesics|analgesics|mesh-ancestor
110210721|NCT00413452|Sensory System Agents|sensory system agents|mesh-ancestor
110210722|NCT00413452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110210723|NCT00413452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110210724|NCT00413452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110210725|NCT00413452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110210726|NCT00413452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110210727|NCT00413452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110210728|NCT00413452|Immunologic Factors|immunologic factors|mesh-ancestor
110210729|NCT00095823|Aripiprazole|aripiprazole|mesh-list
110210730|NCT00095823|Antidepressive Agents|antidepressive agents|mesh-list
110210731|NCT00095823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110210732|NCT00095823|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110210733|NCT00095823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110210734|NCT00095823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110210735|NCT00095823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110210736|NCT00095823|Dopamine Agonists|dopamine agonists|mesh-ancestor
110210737|NCT00095823|Dopamine Agents|dopamine agents|mesh-ancestor
110210738|NCT00095823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110210739|NCT00095823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110210740|NCT00095823|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110210741|NCT00095823|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110210742|NCT00095823|Serotonin Agents|serotonin agents|mesh-ancestor
110210743|NCT00095823|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110210744|NCT00095823|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110210745|NCT00095823|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110210746|NCT00095823|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110210747|NCT00226564|Alfentanil|alfentanil|mesh-list
110210748|NCT00226564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110210750|NCT00226564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110210751|NCT00226564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110210752|NCT00226564|Analgesics|analgesics|mesh-ancestor
110210753|NCT00226564|Sensory System Agents|sensory system agents|mesh-ancestor
110210754|NCT00226564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110210755|NCT00226564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110210756|NCT00226564|Anesthetics, General|anesthetics, general|mesh-ancestor
110210757|NCT00226564|Anesthetics|anesthetics|mesh-ancestor
110210758|NCT00062699|Calcitriol|calcitriol|mesh-list
110210759|NCT00062699|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110210760|NCT00062699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110210761|NCT00062699|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110210762|NCT00062699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110210763|NCT00062699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110210764|NCT00062699|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110210765|NCT00062699|Vitamins|vitamins|mesh-ancestor
110210766|NCT00062699|Micronutrients|micronutrients|mesh-ancestor
110210767|NCT00062699|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110210768|NCT00226798|Capecitabine|capecitabine|mesh-list
110210769|NCT00226798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110210770|NCT00226798|Antimetabolites|antimetabolites|mesh-ancestor
110210771|NCT00226798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110210772|NCT00226798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110210773|NCT00399243|Sumatriptan|sumatriptan|mesh-list
110210774|NCT00399243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110210775|NCT00399243|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110210776|NCT00399243|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110210777|NCT00399243|Serotonin Agents|serotonin agents|mesh-ancestor
110210778|NCT00399243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110210779|NCT00399243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110210780|NCT00399243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110210781|NCT00226837|Nitrous Oxide|nitrous oxide|mesh-list
110210782|NCT00226837|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110210783|NCT00226837|Anesthetics, General|anesthetics, general|mesh-ancestor
110210784|NCT00226837|Anesthetics|anesthetics|mesh-ancestor
110210785|NCT00226837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110210786|NCT00226837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110210787|NCT00226837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110210788|NCT00226837|Analgesics|analgesics|mesh-ancestor
110210789|NCT00226837|Sensory System Agents|sensory system agents|mesh-ancestor
110210790|NCT00226837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110210791|NCT00226915|Paclitaxel|paclitaxel|mesh-list
110210792|NCT00226915|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110210793|NCT00226915|Carboplatin|carboplatin|mesh-list
110210794|NCT00226915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110210795|NCT00226915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110210796|NCT00226915|Tubulin Modulators|tubulin modulators|mesh-ancestor
110210797|NCT00226915|Antimitotic Agents|antimitotic agents|mesh-ancestor
110210798|NCT00226915|Mitosis Modulators|mitosis modulators|mesh-ancestor
110210799|NCT00226915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110210800|NCT00095862|Interferons|interferons|mesh-list
110210801|NCT00095862|Interferon-alpha|interferon-alpha|mesh-list
110210802|NCT00095862|Cyclophosphamide|cyclophosphamide|mesh-list
110210803|NCT00095862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110021348|NCT00002556|Prednisone|prednisone|mesh-list
110210804|NCT00095862|Immunologic Factors|immunologic factors|mesh-ancestor
110210805|NCT00095862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110210806|NCT00095862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110210807|NCT00095862|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110210808|NCT00095862|Alkylating Agents|alkylating agents|mesh-ancestor
110210809|NCT00095862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110210810|NCT00095862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110210811|NCT00095862|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110210812|NCT00095862|Antiviral Agents|antiviral agents|mesh-ancestor
110210813|NCT00095862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110210814|NCT00226954|Zoledronic Acid|zoledronic acid|mesh-list
110210815|NCT00226954|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110210816|NCT00226954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110210818|NCT00227032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110210819|NCT00227032|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110210820|NCT00227032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110210821|NCT00227032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110210823|NCT00095901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110210824|NCT00095901|Antimetabolites|antimetabolites|mesh-ancestor
110210825|NCT00095901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110210826|NCT00095901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110210827|NCT00227110|Pioglitazone|pioglitazone|mesh-list
110210828|NCT00227110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110210829|NCT00227110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110210830|NCT00062894|Tositumomab I-131|tositumomab i-131|mesh-list
110210831|NCT00062894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110210832|NCT00227188|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110210833|NCT00227188|Immunologic Factors|immunologic factors|mesh-ancestor
110210834|NCT00227188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110210835|NCT00096057|Antibodies|antibodies|mesh-list
110210836|NCT00096057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110210837|NCT00096057|Immunologic Factors|immunologic factors|mesh-ancestor
110210838|NCT00096057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110210839|NCT00227461|Levetiracetam|levetiracetam|mesh-list
110210840|NCT00227461|Anticonvulsants|anticonvulsants|mesh-ancestor
110210841|NCT00227461|Nootropic Agents|nootropic agents|mesh-ancestor
110210842|NCT00227500|Pravastatin|pravastatin|mesh-list
110210843|NCT00227500|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110210844|NCT00227500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110210845|NCT00227500|Antimetabolites|antimetabolites|mesh-ancestor
110210846|NCT00227500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110210847|NCT00227500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110210848|NCT00227500|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110210849|NCT00227500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110210850|NCT00096096|Mycophenolic Acid|mycophenolic acid|mesh-list
110210851|NCT00096096|Tacrolimus|tacrolimus|mesh-list
110210852|NCT00096096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110210853|NCT00096096|Immunologic Factors|immunologic factors|mesh-ancestor
110210854|NCT00096096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110210855|NCT00096096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110210856|NCT00096096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110210857|NCT00096096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110210858|NCT00096096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110210859|NCT00096096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110210860|NCT00096096|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110210861|NCT00096096|Antitubercular Agents|antitubercular agents|mesh-ancestor
110210862|NCT00096096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110210863|NCT00096096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110210864|NCT04721899|Vitamin D|vitamin d|mesh-list
110210865|NCT04721899|Vitamins|vitamins|mesh-ancestor
110210866|NCT04721899|Micronutrients|micronutrients|mesh-ancestor
110210867|NCT04721899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110210868|NCT04721899|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110210870|NCT00062972|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110210871|NCT00062972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110210872|NCT00062972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110210873|NCT00062972|Cholinergic Agents|cholinergic agents|mesh-ancestor
110210874|NCT00062972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110210875|NCT00062972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110210876|NCT00062972|Nootropic Agents|nootropic agents|mesh-ancestor
110210878|NCT00227656|Interferon-alpha|interferon-alpha|mesh-list
110210879|NCT00227656|Interferon alpha-2|interferon alpha-2|mesh-list
110210880|NCT00227656|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110210881|NCT00227656|Capecitabine|capecitabine|mesh-list
110210882|NCT00227656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110210883|NCT00227656|Antimetabolites|antimetabolites|mesh-ancestor
110210884|NCT00227656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110210885|NCT00227656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110210886|NCT00227656|Antiviral Agents|antiviral agents|mesh-ancestor
110210887|NCT00227656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110210888|NCT00227656|Immunologic Factors|immunologic factors|mesh-ancestor
110210889|NCT00227656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110210890|NCT00227695|Rituximab|rituximab|mesh-list
110210891|NCT00227695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110210892|NCT00227695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110210893|NCT00227695|Immunologic Factors|immunologic factors|mesh-ancestor
110210894|NCT00227695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110210895|NCT00227695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110210896|NCT00227734|Capecitabine|capecitabine|mesh-list
110210897|NCT00227734|Oxaliplatin|oxaliplatin|mesh-list
110210898|NCT00227734|Cetuximab|cetuximab|mesh-list
110210899|NCT00227734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110210900|NCT00227734|Antimetabolites|antimetabolites|mesh-ancestor
110210901|NCT00227734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110210902|NCT00227734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110210903|NCT00227734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110210904|NCT00063011|Calcium|calcium|mesh-list
110210905|NCT00063011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110210906|NCT00063011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110210907|NCT00227773|Octreotide|octreotide|mesh-list
110210908|NCT00227773|Hormones|hormones|mesh-list
110210909|NCT00227773|Somatostatin|somatostatin|mesh-list
110210910|NCT00227773|Mitogens|mitogens|mesh-list
110210911|NCT00227773|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
110210912|NCT00227773|Enzyme Inhibitors|enzyme inhibitors|mesh-list
110210913|NCT00227773|Vatalanib|vatalanib|mesh-list
110210914|NCT00227773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110210915|NCT00227773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110210916|NCT00227773|Mitosis Modulators|mitosis modulators|mesh-ancestor
110210917|NCT00227773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110210918|NCT00227773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110210919|NCT00227773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110210920|NCT00227773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110210921|NCT00227773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110210922|NCT00227812|Bupropion|bupropion|mesh-list
110210923|NCT00227812|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110210924|NCT00227812|Antidepressive Agents|antidepressive agents|mesh-ancestor
110210925|NCT00227812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110210926|NCT00227812|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110210927|NCT00227812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110210928|NCT00227812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110235293|NCT01952782|Naloxone|naloxone|mesh-list
110210929|NCT00227812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110210930|NCT00227812|Dopamine Agents|dopamine agents|mesh-ancestor
110210931|NCT00227812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110210932|NCT00227812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110210933|NCT00227812|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110210934|NCT00227812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110210935|NCT00227812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110210936|NCT00096291|Paclitaxel|paclitaxel|mesh-list
110210937|NCT00096291|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110210938|NCT00096291|Doxorubicin|doxorubicin|mesh-list
110210939|NCT00096291|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110210940|NCT00096291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110210941|NCT00096291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110210942|NCT00096291|Tubulin Modulators|tubulin modulators|mesh-ancestor
110210943|NCT00096291|Antimitotic Agents|antimitotic agents|mesh-ancestor
110210944|NCT00096291|Mitosis Modulators|mitosis modulators|mesh-ancestor
110210945|NCT00096291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110210946|NCT00096291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110210947|NCT00096291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110210948|NCT00096291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110210949|NCT00096291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110210950|NCT02967302|Triamcinolone|triamcinolone|mesh-list
110210951|NCT02967302|Morphine|morphine|mesh-list
110210952|NCT02967302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110210953|NCT02967302|Narcotics|narcotics|mesh-ancestor
110210954|NCT02967302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110210955|NCT02967302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110210956|NCT02967302|Analgesics|analgesics|mesh-ancestor
110210957|NCT02967302|Sensory System Agents|sensory system agents|mesh-ancestor
110210958|NCT02967302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110210959|NCT02967302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110210960|NCT02967302|Glucocorticoids|glucocorticoids|mesh-ancestor
110210961|NCT02967302|Hormones|hormones|mesh-ancestor
110210962|NCT02967302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110210963|NCT00096330|Folic Acid|folic acid|mesh-list
110210964|NCT00096330|Hematinics|hematinics|mesh-ancestor
110210965|NCT00096330|Vitamin B Complex|vitamin b complex|mesh-ancestor
110210966|NCT00096330|Vitamins|vitamins|mesh-ancestor
110210967|NCT00096330|Micronutrients|micronutrients|mesh-ancestor
110210968|NCT00096330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110210969|NCT02962492|Dapagliflozin|dapagliflozin|mesh-list
110210970|NCT02962492|Exenatide|exenatide|mesh-list
110210971|NCT02962492|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110210972|NCT02962492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110210973|NCT02962492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110210974|NCT02962492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110210975|NCT02962492|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110210976|NCT02962492|Incretins|incretins|mesh-ancestor
110210977|NCT02962492|Hormones|hormones|mesh-ancestor
110210978|NCT02962492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110210979|NCT00096369|Tamoxifen|tamoxifen|mesh-list
110210980|NCT00096369|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110210981|NCT00096369|Hormone Antagonists|hormone antagonists|mesh-ancestor
110210982|NCT00096369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110210983|NCT00096369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110210984|NCT00096369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110210985|NCT00096369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110210986|NCT00096369|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110210987|NCT00096369|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110210988|NCT00096369|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110210989|NCT00228007|Antidepressive Agents|antidepressive agents|mesh-list
110210990|NCT00228007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110210991|NCT00228046|Valproic Acid|valproic acid|mesh-list
110210992|NCT00228046|Methylphenidate|methylphenidate|mesh-list
110210993|NCT00228046|Amphetamine|amphetamine|mesh-list
110210994|NCT00228046|Dextroamphetamine|dextroamphetamine|mesh-list
110210995|NCT00228046|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110210996|NCT00228046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110210997|NCT00228046|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110210998|NCT00228046|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110210999|NCT00228046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110211000|NCT00228046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110211001|NCT00228046|Dopamine Agents|dopamine agents|mesh-ancestor
110211002|NCT00228046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110211003|NCT00228046|Sympathomimetics|sympathomimetics|mesh-ancestor
110211004|NCT00228046|Autonomic Agents|autonomic agents|mesh-ancestor
110211005|NCT00228046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110211006|NCT00228046|Adrenergic Agents|adrenergic agents|mesh-ancestor
110211007|NCT00228046|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110211008|NCT00228046|Anticonvulsants|anticonvulsants|mesh-ancestor
110211010|NCT00228046|GABA Agents|gaba agents|mesh-ancestor
110211011|NCT00228046|Antimanic Agents|antimanic agents|mesh-ancestor
110211012|NCT00228046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110211013|NCT00228046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110211014|NCT00228046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110211015|NCT00063089|Immunoglobulins|immunoglobulins|mesh-list
110211016|NCT00063089|Antibodies|antibodies|mesh-list
110211017|NCT00063089|gamma-Globulins|gamma-globulins|mesh-list
110211018|NCT00063089|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110211019|NCT00063089|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110211020|NCT00063089|Immunologic Factors|immunologic factors|mesh-ancestor
110211021|NCT00063089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211022|NCT00228163|Teriflunomide|teriflunomide|mesh-list
110211023|NCT00228163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110211024|NCT00228163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110211025|NCT00228163|Analgesics|analgesics|mesh-ancestor
110211026|NCT00228163|Sensory System Agents|sensory system agents|mesh-ancestor
110211027|NCT00228163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110211028|NCT00228163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211029|NCT00228163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110211030|NCT00228163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110211031|NCT00228163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110211032|NCT00228163|Immunologic Factors|immunologic factors|mesh-ancestor
110211033|NCT00063128|Insulin|insulin|mesh-list
110211034|NCT00063128|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110211035|NCT00063128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110211036|NCT00063128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211037|NCT00075465|Docetaxel|docetaxel|mesh-list
110211038|NCT00075465|Epirubicin|epirubicin|mesh-list
110211039|NCT00075465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110211040|NCT00075465|Tubulin Modulators|tubulin modulators|mesh-ancestor
110211041|NCT00075465|Antimitotic Agents|antimitotic agents|mesh-ancestor
110211042|NCT00075465|Mitosis Modulators|mitosis modulators|mesh-ancestor
110211043|NCT00075465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110211044|NCT00075465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110211045|NCT00075465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110211046|NCT00075465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110211047|NCT00075465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110211048|NCT00228319|Vitamins|vitamins|mesh-list
110211049|NCT00228319|Ascorbic Acid|ascorbic acid|mesh-list
110211050|NCT00228319|Vitamin E|vitamin e|mesh-list
110211051|NCT00228319|Vitamin A|vitamin a|mesh-list
110211052|NCT00228319|Carboplatin|carboplatin|mesh-list
110211053|NCT00228319|Carotenoids|carotenoids|mesh-list
110211054|NCT00228319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110211055|NCT00228319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110211056|NCT00228319|Micronutrients|micronutrients|mesh-ancestor
110211057|NCT00228319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211058|NCT00228319|Antioxidants|antioxidants|mesh-ancestor
110211059|NCT00228319|Protective Agents|protective agents|mesh-ancestor
110211060|NCT00096525|Lenalidomide|lenalidomide|mesh-list
110211061|NCT00096525|Immunologic Factors|immunologic factors|mesh-ancestor
110211062|NCT00096525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211063|NCT00096525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110211064|NCT00096525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110211065|NCT00096525|Growth Substances|growth substances|mesh-ancestor
110211066|NCT00096525|Growth Inhibitors|growth inhibitors|mesh-ancestor
110211067|NCT00096525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110211068|NCT00228358|Cyclophosphamide|cyclophosphamide|mesh-list
110211069|NCT00228358|Interleukin-2|interleukin-2|mesh-list
110211070|NCT00228358|Denileukin diftitox|denileukin diftitox|mesh-list
110211071|NCT00228358|Immunotoxins|immunotoxins|mesh-list
110211072|NCT00228358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110211073|NCT00228358|Immunologic Factors|immunologic factors|mesh-ancestor
110211074|NCT00228358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211075|NCT00228358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110211076|NCT00228358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110211077|NCT00228358|Alkylating Agents|alkylating agents|mesh-ancestor
110211078|NCT00228358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110211079|NCT00228358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110211080|NCT00228358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110211081|NCT00228358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110211083|NCT00228358|Sensory System Agents|sensory system agents|mesh-ancestor
110211084|NCT00228358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110211085|NCT00228358|Immunoconjugates|immunoconjugates|mesh-ancestor
110211086|NCT00228397|Temsirolimus|temsirolimus|mesh-list
110211087|NCT00228397|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110211088|NCT00228397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110211089|NCT00228397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110211090|NCT00228397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110211091|NCT00228397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110211092|NCT00228397|Immunologic Factors|immunologic factors|mesh-ancestor
110211093|NCT00228397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211094|NCT00228397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110211095|NCT00075543|Docetaxel|docetaxel|mesh-list
110211096|NCT00075543|Oxaliplatin|oxaliplatin|mesh-list
110211097|NCT00075543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110211098|NCT00075543|Tubulin Modulators|tubulin modulators|mesh-ancestor
110211099|NCT00075543|Antimitotic Agents|antimitotic agents|mesh-ancestor
110211100|NCT00075543|Mitosis Modulators|mitosis modulators|mesh-ancestor
110211101|NCT00075543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110211102|NCT00228475|Budesonide|budesonide|mesh-list
110211103|NCT00228475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110211104|NCT00228475|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110211105|NCT00228475|Autonomic Agents|autonomic agents|mesh-ancestor
110211106|NCT00228475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110211107|NCT00228475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211108|NCT00228475|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110211109|NCT00228475|Respiratory System Agents|respiratory system agents|mesh-ancestor
110211110|NCT00228475|Glucocorticoids|glucocorticoids|mesh-ancestor
110211111|NCT00228475|Hormones|hormones|mesh-ancestor
110211112|NCT00228475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110211113|NCT00228514|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110211114|NCT00228514|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110211115|NCT00228514|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110211116|NCT00228514|Antimetabolites|antimetabolites|mesh-ancestor
110211117|NCT00228514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110211118|NCT00228514|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110211119|NCT00228514|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110211120|NCT00228514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110211121|NCT00228592|Immunoglobulins|immunoglobulins|mesh-list
110211122|NCT00228592|Antibodies|antibodies|mesh-list
110211124|NCT00228592|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110211125|NCT00228592|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110211126|NCT00228592|Immunologic Factors|immunologic factors|mesh-ancestor
110211127|NCT00228592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211128|NCT00075621|Melphalan|melphalan|mesh-list
110211129|NCT00075621|Immunologic Factors|immunologic factors|mesh-ancestor
110211130|NCT00075621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211131|NCT00075621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110211132|NCT00075621|Alkylating Agents|alkylating agents|mesh-ancestor
110211133|NCT00075621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110211134|NCT00075621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110211135|NCT00075621|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110211136|NCT00075621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110211137|NCT00228865|Insulin|insulin|mesh-list
110211138|NCT00228865|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110211139|NCT00228865|Insulin, Isophane|insulin, isophane|mesh-list
110211140|NCT00228865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110211141|NCT00228865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211142|NCT00228904|Insulin|insulin|mesh-list
110211143|NCT00228904|Insulin Lispro|insulin lispro|mesh-list
110211144|NCT00228904|Insulin Aspart|insulin aspart|mesh-list
110211145|NCT00228904|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110211146|NCT00228904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110211147|NCT00228904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211148|NCT00228982|Vancomycin|vancomycin|mesh-list
110211149|NCT00228982|Ceftobiprole|ceftobiprole|mesh-list
110211150|NCT00228982|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
110211151|NCT00228982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110211152|NCT00228982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110211153|NCT00229060|Doripenem|doripenem|mesh-list
110211154|NCT00229060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110211155|NCT00229060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110211156|NCT00229138|Tacrolimus|tacrolimus|mesh-list
110211157|NCT00229138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110211158|NCT00229138|Immunologic Factors|immunologic factors|mesh-ancestor
110211159|NCT00229138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211160|NCT00229138|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110211161|NCT00229138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110211162|NCT00229138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110211163|NCT00063323|Bupropion|bupropion|mesh-list
110211164|NCT00063323|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110211165|NCT00063323|Antidepressive Agents|antidepressive agents|mesh-ancestor
110211166|NCT00063323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110211167|NCT00063323|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110211168|NCT00063323|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110211169|NCT00063323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110211170|NCT00063323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110211171|NCT00063323|Dopamine Agents|dopamine agents|mesh-ancestor
110211172|NCT00063323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110211173|NCT00063323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211174|NCT00063323|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110211175|NCT00063323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110211176|NCT00063323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110211177|NCT00229216|Tinidazole|tinidazole|mesh-list
110211178|NCT00229216|Alkylating Agents|alkylating agents|mesh-ancestor
110211179|NCT00229216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110211180|NCT00229216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110211181|NCT00229216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110211182|NCT00229216|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
110211183|NCT00229216|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110211184|NCT00229216|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110211185|NCT02967653|Atorvastatin|atorvastatin|mesh-list
110211186|NCT02967653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110211187|NCT02967653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110211188|NCT02967653|Antimetabolites|antimetabolites|mesh-ancestor
110211189|NCT02967653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110211190|NCT02967653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110211191|NCT02967653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110211192|NCT02967653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110211193|NCT00229333|Escitalopram|escitalopram|mesh-list
110211194|NCT00229333|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110211195|NCT00229333|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110211196|NCT00229333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110211197|NCT00229333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110211198|NCT00229333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110211200|NCT00229333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211201|NCT00229450|Estrogens|estrogens|mesh-list
110211202|NCT00229450|Hormones|hormones|mesh-ancestor
110211203|NCT00229450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110211204|NCT00229450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211205|NCT00229528|Paroxetine|paroxetine|mesh-list
110211206|NCT00229528|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110211207|NCT00229528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110211208|NCT00229528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110211209|NCT00229528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110211210|NCT00229528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110211211|NCT00229528|Serotonin Agents|serotonin agents|mesh-ancestor
110211212|NCT00229528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211213|NCT00229528|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110211214|NCT00229528|Antidepressive Agents|antidepressive agents|mesh-ancestor
110211215|NCT00229528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110211216|NCT00229528|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110211217|NCT00229528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110211218|NCT00229528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110211219|NCT00075699|Vincristine|vincristine|mesh-list
110211220|NCT00075699|Vinorelbine|vinorelbine|mesh-list
110211222|NCT00075699|Mitomycin|mitomycin|mesh-list
110211223|NCT00075699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110211224|NCT00075699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110211225|NCT00075699|Tubulin Modulators|tubulin modulators|mesh-ancestor
110211226|NCT00075699|Antimitotic Agents|antimitotic agents|mesh-ancestor
110211227|NCT00075699|Mitosis Modulators|mitosis modulators|mesh-ancestor
110211228|NCT00075699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110211229|NCT00075699|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110211230|NCT00075699|Alkylating Agents|alkylating agents|mesh-ancestor
110211231|NCT00075699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110211232|NCT00075699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110211233|NCT00229567|Lidocaine|lidocaine|mesh-list
110211234|NCT00229567|Ketamine|ketamine|mesh-list
110211235|NCT00229567|Anesthetics, Local|anesthetics, local|mesh-ancestor
110211236|NCT00229567|Anesthetics|anesthetics|mesh-ancestor
110211237|NCT00229567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110211238|NCT00229567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211239|NCT00229567|Sensory System Agents|sensory system agents|mesh-ancestor
110211240|NCT00229567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110211241|NCT00229567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110211242|NCT00229567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110211243|NCT00229567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110211244|NCT00229567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110211245|NCT00229567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110211246|NCT00229567|Analgesics|analgesics|mesh-ancestor
110211247|NCT00229567|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110211248|NCT00229567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110211249|NCT00229567|Anesthetics, General|anesthetics, general|mesh-ancestor
110211250|NCT00229567|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110211251|NCT00229567|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110211252|NCT00229567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110211253|NCT00229645|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110211254|NCT00229645|Antidepressive Agents|antidepressive agents|mesh-ancestor
110211255|NCT00229645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110211256|NCT00229645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110211257|NCT00229645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110211258|NCT00229645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110211259|NCT00229645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211260|NCT02967341|Ciprofloxacin|ciprofloxacin|mesh-list
110211261|NCT02967341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110211262|NCT02967341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110211263|NCT02967341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110211264|NCT02967341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110211265|NCT02967341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110211266|NCT02967341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110211267|NCT02967341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110211268|NCT02967341|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110211269|NCT02967341|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110211270|NCT00229684|Pioglitazone|pioglitazone|mesh-list
110211271|NCT00229684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110211272|NCT00229684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211273|NCT00096720|Levodopa|levodopa|mesh-list
110211274|NCT00096720|Pramipexole|pramipexole|mesh-list
110211275|NCT00096720|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110211276|NCT00096720|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110211277|NCT00096720|Dopamine Agents|dopamine agents|mesh-ancestor
110211278|NCT00096720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110211279|NCT00096720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110211280|NCT00096720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211281|NCT00096720|Antioxidants|antioxidants|mesh-ancestor
110211282|NCT00096720|Protective Agents|protective agents|mesh-ancestor
110211283|NCT00096720|Dopamine Agonists|dopamine agonists|mesh-ancestor
110211284|NCT00413608|Clopidogrel|clopidogrel|mesh-list
110211285|NCT00413608|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110211286|NCT00413608|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110211287|NCT00413608|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110211288|NCT00413608|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110211289|NCT00413608|Purinergic Agents|purinergic agents|mesh-ancestor
110211290|NCT00413608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110211291|NCT00413608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110211292|NCT00413608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368628|NCT05419583|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110368629|NCT05419583|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110368631|NCT05419583|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110368632|NCT05387408|Analgesics, Opioid|analgesics, opioid|mesh-list
110368633|NCT05387408|Narcotics|narcotics|mesh-ancestor
110368634|NCT05387408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110368635|NCT05387408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368636|NCT05387408|Analgesics|analgesics|mesh-ancestor
110368637|NCT05387408|Sensory System Agents|sensory system agents|mesh-ancestor
110368638|NCT05387408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110368639|NCT05376761|Dexmedetomidine|dexmedetomidine|mesh-list
110368640|NCT05376761|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110368641|NCT05376761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110368642|NCT05376761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368643|NCT05376761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110368644|NCT05376761|Analgesics|analgesics|mesh-ancestor
110368645|NCT05376761|Sensory System Agents|sensory system agents|mesh-ancestor
110368646|NCT05376761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110368647|NCT05376761|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110368648|NCT05376761|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110368649|NCT05376761|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110368650|NCT05376761|Adrenergic Agents|adrenergic agents|mesh-ancestor
110368651|NCT05376761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110368652|NCT05376761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110368653|NCT04617561|Methylprednisolone|methylprednisolone|mesh-list
110368654|NCT04617561|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110368655|NCT04617561|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110368656|NCT04617561|Prednisolone|prednisolone|mesh-list
110368657|NCT04617561|Prednisolone acetate|prednisolone acetate|mesh-list
110368658|NCT04617561|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
110368659|NCT04617561|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110368660|NCT04617561|Prednisolone phosphate|prednisolone phosphate|mesh-list
110368661|NCT04617561|Glucocorticoids|glucocorticoids|mesh-list
110368662|NCT04617561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110368663|NCT04617561|Antiemetics|antiemetics|mesh-ancestor
110368664|NCT04617561|Autonomic Agents|autonomic agents|mesh-ancestor
110368665|NCT04617561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110368666|NCT04617561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368667|NCT04617561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110368668|NCT04617561|Hormones|hormones|mesh-ancestor
110368669|NCT04617561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110368670|NCT04617561|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110368671|NCT04617561|Protective Agents|protective agents|mesh-ancestor
110368672|NCT04617561|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110368673|NCT04617561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110368674|NCT04617561|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110368675|NCT04617483|Vaccines|vaccines|mesh-list
110368676|NCT04617483|Immunologic Factors|immunologic factors|mesh-ancestor
110368677|NCT04617483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368678|NCT04617249|Anesthetics|anesthetics|mesh-list
110368679|NCT04617249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110368680|NCT04617249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368681|NCT05349383|Antineoplastic Agents|antineoplastic agents|mesh-list
110368682|NCT05349383|Antibodies|antibodies|mesh-list
110368683|NCT05349383|Immunoglobulins|immunoglobulins|mesh-list
110368684|NCT05349383|Immunoconjugates|immunoconjugates|mesh-list
110368685|NCT05349383|Immunomodulating Agents|immunomodulating agents|mesh-list
110368686|NCT05349383|Immunologic Factors|immunologic factors|mesh-ancestor
110368687|NCT05349383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368688|NCT04617171|Benralizumab|benralizumab|mesh-list
110368689|NCT04617171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110235378|NCT00856947|Cholecalciferol|cholecalciferol|mesh-list
110368690|NCT04617171|Respiratory System Agents|respiratory system agents|mesh-ancestor
110368691|NCT00557934|Dobutamine|dobutamine|mesh-list
110368692|NCT00557934|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110368693|NCT00557934|Sympathomimetics|sympathomimetics|mesh-ancestor
110368694|NCT00557934|Autonomic Agents|autonomic agents|mesh-ancestor
110368695|NCT00557934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110368696|NCT00557934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368697|NCT00557934|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110368698|NCT00557934|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110368699|NCT00557934|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110211293|NCT00229918|Triamcinolone|triamcinolone|mesh-list
110211294|NCT00229918|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110211295|NCT00229918|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110211296|NCT00229918|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110211297|NCT00229918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110211298|NCT00229918|Glucocorticoids|glucocorticoids|mesh-ancestor
110211299|NCT00229918|Hormones|hormones|mesh-ancestor
110211300|NCT00229918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110211301|NCT00229918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211302|NCT00229918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110211303|NCT00229918|Immunologic Factors|immunologic factors|mesh-ancestor
110211304|NCT00229918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110211305|NCT00229918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110211306|NCT00096798|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
110211307|NCT00096798|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110211308|NCT00096798|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110211309|NCT00229996|Leuprolide|leuprolide|mesh-list
110211310|NCT00229996|Norethindrone|norethindrone|mesh-list
110211311|NCT00229996|Norethindrone Acetate|norethindrone acetate|mesh-list
110211312|NCT00229996|Contraceptive Agents|contraceptive agents|mesh-list
110211313|NCT00229996|Contraceptives, Oral|contraceptives, oral|mesh-list
110211314|NCT00229996|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110211315|NCT00229996|Fertility Agents|fertility agents|mesh-ancestor
110211316|NCT00229996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110211317|NCT00229996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211318|NCT00229996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110211319|NCT00229996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110211320|NCT00229996|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110211321|NCT00229996|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110211322|NCT00229996|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110211323|NCT00229996|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110211324|NCT00230035|Mycophenolic Acid|mycophenolic acid|mesh-list
110211325|NCT00230035|Methylprednisolone|methylprednisolone|mesh-list
110211326|NCT00230035|Rituximab|rituximab|mesh-list
110211327|NCT00230035|Methotrexate|methotrexate|mesh-list
110211328|NCT00230035|Azathioprine|azathioprine|mesh-list
110211329|NCT00230035|Immunoglobulins|immunoglobulins|mesh-list
110211330|NCT00230035|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110211331|NCT00230035|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110211332|NCT00230035|gamma-Globulins|gamma-globulins|mesh-list
110211333|NCT00230035|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110211334|NCT00230035|Leflunomide|leflunomide|mesh-list
110211335|NCT00230035|Thymoglobulin|thymoglobulin|mesh-list
110211336|NCT00230035|Immunosuppressive Agents|immunosuppressive agents|mesh-list
110211337|NCT00230035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110211338|NCT00230035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110211339|NCT00230035|Immunologic Factors|immunologic factors|mesh-ancestor
110211340|NCT00230035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211341|NCT00230035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110211342|NCT00230035|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110211343|NCT00230035|Abortifacient Agents|abortifacient agents|mesh-ancestor
110211344|NCT00230035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110211345|NCT00230035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110211347|NCT00230035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110211348|NCT00230035|Dermatologic Agents|dermatologic agents|mesh-ancestor
110211349|NCT00230035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110211350|NCT00230035|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110211351|NCT00230035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110211352|NCT00230035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110211353|NCT00230035|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110211354|NCT00230035|Antitubercular Agents|antitubercular agents|mesh-ancestor
110211355|NCT00230035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110211356|NCT00230035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110211357|NCT00230035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110211359|NCT00230035|Autonomic Agents|autonomic agents|mesh-ancestor
110211360|NCT00230035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110211361|NCT00230035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110211362|NCT00230035|Glucocorticoids|glucocorticoids|mesh-ancestor
110211363|NCT00230035|Hormones|hormones|mesh-ancestor
110211364|NCT00230035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110211365|NCT00230035|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110211366|NCT00230035|Protective Agents|protective agents|mesh-ancestor
110211367|NCT00063401|Paclitaxel|paclitaxel|mesh-list
110211368|NCT00063401|Carboplatin|carboplatin|mesh-list
110211369|NCT00063401|Cetuximab|cetuximab|mesh-list
110211370|NCT00063401|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110211371|NCT00063401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110211372|NCT00063401|Tubulin Modulators|tubulin modulators|mesh-ancestor
110211373|NCT00063401|Antimitotic Agents|antimitotic agents|mesh-ancestor
110211374|NCT00063401|Mitosis Modulators|mitosis modulators|mesh-ancestor
110211375|NCT00063401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110211376|NCT00063401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110211377|NCT00096837|Motexafin gadolinium|motexafin gadolinium|mesh-list
110211378|NCT00096837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110211379|NCT00096837|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110211380|NCT00096837|Dermatologic Agents|dermatologic agents|mesh-ancestor
110211381|NCT00230464|Vildagliptin|vildagliptin|mesh-list
110211382|NCT00230464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110211383|NCT00230464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211384|NCT00230464|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110211385|NCT00230464|Protease Inhibitors|protease inhibitors|mesh-ancestor
110211386|NCT00230464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110211387|NCT00230464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110211388|NCT00096915|Darbepoetin alfa|darbepoetin alfa|mesh-list
110211389|NCT00096915|Hematinics|hematinics|mesh-ancestor
110211390|NCT00230503|Adefovir|adefovir|mesh-list
110211391|NCT00230503|Pradefovir|pradefovir|mesh-list
110211392|NCT00230503|Antiviral Agents|antiviral agents|mesh-ancestor
110211393|NCT00230503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110211394|NCT00230503|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110211395|NCT00230503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110211396|NCT00230503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110211397|NCT00230503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110211398|NCT00230503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110211399|NCT00424723|Pemetrexed|pemetrexed|mesh-list
110211400|NCT00424723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110211401|NCT00424723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110026519|NCT02995746|Hormones|hormones|mesh-ancestor
110211402|NCT00424723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110211403|NCT00424723|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110211404|NCT00424723|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110211405|NCT00230542|Carboplatin|carboplatin|mesh-list
110211406|NCT00230542|Pemetrexed|pemetrexed|mesh-list
110211407|NCT00230542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110211408|NCT00230542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110211409|NCT00230542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110211410|NCT00230542|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110211411|NCT00230542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110211413|NCT00063479|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110211414|NCT00063479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211415|NCT00097032|Risperidone|risperidone|mesh-list
110211416|NCT00097032|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110211417|NCT00097032|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110211418|NCT00097032|Serotonin Agents|serotonin agents|mesh-ancestor
110211419|NCT00097032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110211420|NCT00097032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110211421|NCT00097032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211422|NCT00097032|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110211423|NCT00097032|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110211424|NCT00097032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110211425|NCT00097032|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110211426|NCT00097032|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110211427|NCT00097032|Dopamine Agents|dopamine agents|mesh-ancestor
110211428|NCT00097032|Antidepressive Agents|antidepressive agents|mesh-ancestor
110211429|NCT02962336|Amlodipine|amlodipine|mesh-list
110211430|NCT02962336|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110211431|NCT02962336|Olmesartan|olmesartan|mesh-list
110211432|NCT02962336|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110211433|NCT02962336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110211434|NCT02962336|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110211435|NCT02962336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110211436|NCT02962336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110211437|NCT02962336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110211438|NCT02962336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211439|NCT02962336|Vasodilator Agents|vasodilator agents|mesh-ancestor
110211440|NCT02962336|Diuretics|diuretics|mesh-ancestor
110211441|NCT02962336|Natriuretic Agents|natriuretic agents|mesh-ancestor
110368700|NCT00557934|Adrenergic Agents|adrenergic agents|mesh-ancestor
110211442|NCT02962336|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110211443|NCT02962336|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110211444|NCT02962336|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110211445|NCT00075738|Leucovorin|leucovorin|mesh-list
110211446|NCT00075738|Fluorouracil|fluorouracil|mesh-list
110211447|NCT00075738|Irinotecan|irinotecan|mesh-list
110211448|NCT00075738|Calcium|calcium|mesh-list
110211449|NCT00075738|Levoleucovorin|levoleucovorin|mesh-list
110211450|NCT00075738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110211451|NCT00075738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110211452|NCT00075738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211453|NCT00075738|Antimetabolites|antimetabolites|mesh-ancestor
110211454|NCT00075738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110211455|NCT00075738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110211456|NCT00075738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110211457|NCT00075738|Immunologic Factors|immunologic factors|mesh-ancestor
110211458|NCT00075738|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110211459|NCT00075738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110211460|NCT00075738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110211461|NCT00075738|Antidotes|antidotes|mesh-ancestor
110211462|NCT00075738|Protective Agents|protective agents|mesh-ancestor
110211463|NCT00075738|Vitamin B Complex|vitamin b complex|mesh-ancestor
110211464|NCT00075738|Vitamins|vitamins|mesh-ancestor
110211465|NCT00075738|Micronutrients|micronutrients|mesh-ancestor
110211466|NCT00230698|Topiramate|topiramate|mesh-list
110211467|NCT00230698|Anticonvulsants|anticonvulsants|mesh-ancestor
110211468|NCT00230698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110211469|NCT00230698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211470|NCT00230776|Pregabalin|pregabalin|mesh-list
110211471|NCT00230776|Analgesics|analgesics|mesh-ancestor
110211472|NCT00230776|Sensory System Agents|sensory system agents|mesh-ancestor
110211473|NCT00230776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110211474|NCT00230776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211475|NCT00230776|Anticonvulsants|anticonvulsants|mesh-ancestor
110211476|NCT00230776|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110211477|NCT00230776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110211478|NCT00230776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110211479|NCT00230776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110211480|NCT00230776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110211481|NCT00230776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110211482|NCT00230776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110211483|NCT00230776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110211484|NCT00075777|Valproic Acid|valproic acid|mesh-list
110211485|NCT00075777|Anticonvulsants|anticonvulsants|mesh-ancestor
110211486|NCT00075777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110211487|NCT00075777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110211488|NCT00075777|GABA Agents|gaba agents|mesh-ancestor
110211489|NCT00075777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110211490|NCT00075777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211491|NCT00075777|Antimanic Agents|antimanic agents|mesh-ancestor
110211492|NCT00075777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110211493|NCT00075777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110211494|NCT00075777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110211495|NCT02967614|Timolol|timolol|mesh-list
110211496|NCT02967614|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110211497|NCT02967614|Dorzolamide|dorzolamide|mesh-list
110211498|NCT02967614|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110211499|NCT02967614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110211500|NCT02967614|Adrenergic Agents|adrenergic agents|mesh-ancestor
110211501|NCT02967614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110211502|NCT02967614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110211503|NCT02967614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211504|NCT02967614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110211505|NCT02967614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110211506|NCT02967614|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110211507|NCT02967614|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110211508|NCT02967614|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110211509|NCT02967614|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110211510|NCT02967614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110211511|NCT00230815|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110211512|NCT00230815|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110211513|NCT00230815|Hormones|hormones|mesh-ancestor
110211514|NCT00230815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110211515|NCT00230815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211516|NCT00230815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110211517|NCT00097071|Insulin|insulin|mesh-list
110211518|NCT00097071|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110211519|NCT00097071|Insulin Aspart|insulin aspart|mesh-list
110211521|NCT00097071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110211522|NCT00097071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211524|NCT02967380|Antidotes|antidotes|mesh-ancestor
110211525|NCT02967380|Protective Agents|protective agents|mesh-ancestor
110211526|NCT02967380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211527|NCT02967380|Chelating Agents|chelating agents|mesh-ancestor
110211528|NCT02967380|Sequestering Agents|sequestering agents|mesh-ancestor
110211529|NCT02967380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110211530|NCT02967380|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110211531|NCT00075855|Testosterone|testosterone|mesh-list
110211532|NCT00075855|Androgens|androgens|mesh-ancestor
110211533|NCT00075855|Hormones|hormones|mesh-ancestor
110211534|NCT00075855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110211535|NCT00075855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211536|NCT00063596|Vitamin A|vitamin a|mesh-list
110211537|NCT00063596|Vitamins|vitamins|mesh-ancestor
110211538|NCT00063596|Micronutrients|micronutrients|mesh-ancestor
110211539|NCT00063596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211540|NCT00231244|Sirolimus|sirolimus|mesh-list
110211541|NCT00231244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110211542|NCT00231244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110211543|NCT00231244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110211544|NCT00231244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110211545|NCT00231244|Antifungal Agents|antifungal agents|mesh-ancestor
110211546|NCT00231244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110211547|NCT00231244|Immunologic Factors|immunologic factors|mesh-ancestor
110211548|NCT00231244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211549|NCT00231322|Praziquantel|praziquantel|mesh-list
110211550|NCT00231322|Anthelmintics|anthelmintics|mesh-ancestor
110211551|NCT00231322|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110211552|NCT00231322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110211553|NCT00231517|Morphine|morphine|mesh-list
110211554|NCT00231517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110211555|NCT00231517|Narcotics|narcotics|mesh-ancestor
110211556|NCT00231517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110211557|NCT00231517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211558|NCT00231517|Analgesics|analgesics|mesh-ancestor
110211559|NCT00231517|Sensory System Agents|sensory system agents|mesh-ancestor
110211560|NCT00231517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110211561|NCT00075894|Alanosine|alanosine|mesh-list
110211562|NCT00075894|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110211563|NCT00075894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110211564|NCT00075894|Chelating Agents|chelating agents|mesh-ancestor
110211565|NCT00075894|Sequestering Agents|sequestering agents|mesh-ancestor
110211566|NCT00075894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110211567|NCT00231556|Topiramate|topiramate|mesh-list
110211568|NCT00231556|Anticonvulsants|anticonvulsants|mesh-ancestor
110211569|NCT00231556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110211570|NCT00231556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211571|NCT00231595|Topiramate|topiramate|mesh-list
110211572|NCT00231595|Anticonvulsants|anticonvulsants|mesh-ancestor
110211573|NCT00231595|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110211574|NCT00231595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211575|NCT00231634|Topiramate|topiramate|mesh-list
110211576|NCT00231634|Anticonvulsants|anticonvulsants|mesh-ancestor
110211577|NCT00231634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110211578|NCT00231634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211579|NCT00231673|Topiramate|topiramate|mesh-list
110211580|NCT00231673|Anticonvulsants|anticonvulsants|mesh-ancestor
110211581|NCT00231673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110211582|NCT00231673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211583|NCT00097188|Rituximab|rituximab|mesh-list
110211584|NCT00097188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110211585|NCT00097188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110211586|NCT00097188|Immunologic Factors|immunologic factors|mesh-ancestor
110211587|NCT00097188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211588|NCT00097188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110211589|NCT00231829|Celecoxib|celecoxib|mesh-list
110211590|NCT00231829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110211592|NCT00231829|Analgesics|analgesics|mesh-ancestor
110211593|NCT00231829|Sensory System Agents|sensory system agents|mesh-ancestor
110211594|NCT00231829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110211595|NCT00231829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211596|NCT00231829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110211597|NCT00231829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110211598|NCT00231829|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110211599|NCT00231829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110211600|NCT00231829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110211601|NCT00231829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110211602|NCT00075933|Beta-lapachone|beta-lapachone|mesh-list
110211603|NCT00075933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110211604|NCT00075933|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110211605|NCT00075933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110211606|NCT00075933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110211607|NCT00075933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110211608|NCT00075933|Antiviral Agents|antiviral agents|mesh-ancestor
110211610|NCT00063713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110211612|NCT00232024|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110211613|NCT00232024|Serotonin Agents|serotonin agents|mesh-ancestor
110211614|NCT00232024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110211615|NCT00232024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110211616|NCT00232024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211617|NCT00232063|Cyclosporine|cyclosporine|mesh-list
110211618|NCT00232063|Cyclosporins|cyclosporins|mesh-list
110211619|NCT00232063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110211620|NCT00232063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110211621|NCT00232063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110211622|NCT00232063|Immunologic Factors|immunologic factors|mesh-ancestor
110211623|NCT00232063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211624|NCT00232063|Antifungal Agents|antifungal agents|mesh-ancestor
110211625|NCT00232063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110211626|NCT00232063|Dermatologic Agents|dermatologic agents|mesh-ancestor
110211627|NCT00232063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110211628|NCT00232063|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110211629|NCT00232102|Tegaserod|tegaserod|mesh-list
110211630|NCT00232102|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110211631|NCT00232102|Serotonin Agents|serotonin agents|mesh-ancestor
110211632|NCT00232102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110211633|NCT00232102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110211634|NCT00232102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211635|NCT00097227|Paclitaxel|paclitaxel|mesh-list
110211636|NCT00097227|Carboplatin|carboplatin|mesh-list
110211637|NCT00097227|Cetuximab|cetuximab|mesh-list
110211638|NCT00097227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110211639|NCT00097227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110211641|NCT00097227|Antimitotic Agents|antimitotic agents|mesh-ancestor
110211642|NCT00097227|Mitosis Modulators|mitosis modulators|mesh-ancestor
110211643|NCT00097227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110211644|NCT00097227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110211645|NCT00232336|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110211646|NCT00232336|Antidepressive Agents|antidepressive agents|mesh-ancestor
110211647|NCT00232336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110211648|NCT00232336|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110211649|NCT00232336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110211650|NCT00232336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110211651|NCT00232336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211652|NCT00232375|Insulin|insulin|mesh-list
110211653|NCT00232375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110211654|NCT00232375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211655|NCT00063791|Bortezomib|bortezomib|mesh-list
110211656|NCT00063791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110211657|NCT00232414|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110211658|NCT00232414|Antidepressive Agents|antidepressive agents|mesh-ancestor
110211659|NCT00232414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110211660|NCT00232414|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110211661|NCT00232414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110211662|NCT00232414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110211663|NCT00232414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211664|NCT00232492|Ketamine|ketamine|mesh-list
110211665|NCT00232492|Analgesics|analgesics|mesh-ancestor
110211666|NCT00232492|Sensory System Agents|sensory system agents|mesh-ancestor
110211667|NCT00232492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110211668|NCT00232492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211669|NCT00232492|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110211670|NCT00232492|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110211671|NCT00232492|Anesthetics, General|anesthetics, general|mesh-ancestor
110211673|NCT00232492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110211674|NCT00232492|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110211675|NCT00232492|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110211676|NCT00232492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110211677|NCT00232492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110211678|NCT00075972|Nicotine|nicotine|mesh-list
110211679|NCT00075972|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110211680|NCT00075972|Autonomic Agents|autonomic agents|mesh-ancestor
110211681|NCT00075972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110211682|NCT00075972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211683|NCT00075972|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110211684|NCT00075972|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110211685|NCT00075972|Cholinergic Agents|cholinergic agents|mesh-ancestor
110211686|NCT00075972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110211687|NCT00075972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110211688|NCT00063869|Etanercept|etanercept|mesh-list
110211689|NCT00063869|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110211690|NCT00063869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110211691|NCT00063869|Analgesics|analgesics|mesh-ancestor
110211692|NCT00063869|Sensory System Agents|sensory system agents|mesh-ancestor
110211693|NCT00063869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110211694|NCT00063869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211695|NCT00063869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110211696|NCT00063869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110235495|NCT00127023|Vaccines|vaccines|mesh-list
110211697|NCT00063869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110211698|NCT00063869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110211699|NCT00063869|Immunologic Factors|immunologic factors|mesh-ancestor
110211701|NCT00232531|Nicotinic Acids|nicotinic acids|mesh-list
110211702|NCT00232531|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110211703|NCT00232531|Antimetabolites|antimetabolites|mesh-ancestor
110211704|NCT00232531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110211705|NCT00232531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110211706|NCT00232531|Vasodilator Agents|vasodilator agents|mesh-ancestor
110211707|NCT00232531|Vitamin B Complex|vitamin b complex|mesh-ancestor
110211708|NCT00232531|Vitamins|vitamins|mesh-ancestor
110211709|NCT00232531|Micronutrients|micronutrients|mesh-ancestor
110211710|NCT00232531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211711|NCT00232570|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110211712|NCT00232570|Antidepressive Agents|antidepressive agents|mesh-ancestor
110211713|NCT00232570|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110211714|NCT00232570|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110211715|NCT00232570|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110211716|NCT00232570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110211717|NCT00232570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211718|NCT00097266|Haloperidol|haloperidol|mesh-list
110211719|NCT00097266|Aripiprazole|aripiprazole|mesh-list
110211720|NCT00097266|Haloperidol decanoate|haloperidol decanoate|mesh-list
110211721|NCT00097266|Antidepressive Agents|antidepressive agents|mesh-ancestor
110211722|NCT00097266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110211723|NCT00097266|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110211724|NCT00097266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110211725|NCT00097266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110211726|NCT00097266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211727|NCT00097266|Dopamine Agonists|dopamine agonists|mesh-ancestor
110211728|NCT00097266|Dopamine Agents|dopamine agents|mesh-ancestor
110211729|NCT00097266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110211730|NCT00097266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110211731|NCT00097266|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110211732|NCT00097266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110211733|NCT00097266|Serotonin Agents|serotonin agents|mesh-ancestor
110211734|NCT00097266|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110211735|NCT00097266|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110211736|NCT00097266|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110211737|NCT00097266|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110211738|NCT00097266|Antiemetics|antiemetics|mesh-ancestor
110211739|NCT00097266|Autonomic Agents|autonomic agents|mesh-ancestor
110211740|NCT00097266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110211741|NCT00097266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110211743|NCT00063947|Gemcitabine|gemcitabine|mesh-list
110211744|NCT00063947|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110211745|NCT00063947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110211746|NCT00063947|Antimetabolites|antimetabolites|mesh-ancestor
110211747|NCT00063947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110211748|NCT00063947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110211749|NCT00063947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110211750|NCT00063947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110211751|NCT00232648|Budesonide|budesonide|mesh-list
110211752|NCT00232648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110211753|NCT00232648|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110211754|NCT00232648|Autonomic Agents|autonomic agents|mesh-ancestor
110211755|NCT00232648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110211756|NCT00232648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211757|NCT00232648|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110211758|NCT00232648|Respiratory System Agents|respiratory system agents|mesh-ancestor
110211759|NCT00232648|Glucocorticoids|glucocorticoids|mesh-ancestor
110211760|NCT00232648|Hormones|hormones|mesh-ancestor
110211761|NCT00232648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110211762|NCT00232687|Aripiprazole|aripiprazole|mesh-list
110211763|NCT00232687|Antidepressive Agents|antidepressive agents|mesh-ancestor
110211764|NCT00232687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110211765|NCT00232687|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110211766|NCT00232687|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110211767|NCT00232687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110211768|NCT00232687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211769|NCT00232687|Dopamine Agonists|dopamine agonists|mesh-ancestor
110211770|NCT00232687|Dopamine Agents|dopamine agents|mesh-ancestor
110211771|NCT00232687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110211772|NCT00232687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110211773|NCT00232687|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110211774|NCT00232687|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110211775|NCT00232687|Serotonin Agents|serotonin agents|mesh-ancestor
110211776|NCT00232687|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110211777|NCT00232687|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110211778|NCT00232687|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110211779|NCT00232687|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110211780|NCT00232765|Sirolimus|sirolimus|mesh-list
110211781|NCT00232765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110211782|NCT00232765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110211783|NCT00232765|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110211784|NCT00232765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110211785|NCT00232765|Antifungal Agents|antifungal agents|mesh-ancestor
110211786|NCT00232765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110211787|NCT00232765|Immunologic Factors|immunologic factors|mesh-ancestor
110211788|NCT00232765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211789|NCT02958566|Acetaminophen|acetaminophen|mesh-list
110211790|NCT02958566|Ketorolac|ketorolac|mesh-list
110211791|NCT02958566|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
110211792|NCT02958566|Lidocaine|lidocaine|mesh-list
110211793|NCT02958566|Fentanyl|fentanyl|mesh-list
110211794|NCT02958566|Ketamine|ketamine|mesh-list
110211795|NCT02958566|Morphine|morphine|mesh-list
110211796|NCT02958566|Gabapentin|gabapentin|mesh-list
110211797|NCT02958566|Tramadol|tramadol|mesh-list
110211798|NCT02958566|Methadone|methadone|mesh-list
110211799|NCT02958566|Hydrocodone|hydrocodone|mesh-list
110211800|NCT02958566|Hydromorphone|hydromorphone|mesh-list
110211801|NCT02958566|Orphenadrine|orphenadrine|mesh-list
110211802|NCT02958566|Bupivacaine|bupivacaine|mesh-list
110211803|NCT02958566|Anesthetics, Local|anesthetics, local|mesh-ancestor
110211804|NCT02958566|Anesthetics|anesthetics|mesh-ancestor
110211805|NCT02958566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110211806|NCT02958566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211807|NCT02958566|Sensory System Agents|sensory system agents|mesh-ancestor
110211808|NCT02958566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110211809|NCT02958566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110211810|NCT02958566|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110211811|NCT02958566|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110211812|NCT02958566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110211813|NCT02958566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110211814|NCT02958566|Analgesics|analgesics|mesh-ancestor
110211815|NCT02958566|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110211816|NCT02958566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110211817|NCT02958566|Anesthetics, General|anesthetics, general|mesh-ancestor
110211818|NCT02958566|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110211819|NCT02958566|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110211820|NCT02958566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110211821|NCT02958566|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110211823|NCT02958566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110211824|NCT02958566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110211825|NCT02958566|Antipyretics|antipyretics|mesh-ancestor
110211826|NCT02958566|Anticonvulsants|anticonvulsants|mesh-ancestor
110211827|NCT02958566|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110211828|NCT02958566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110211829|NCT02958566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110211830|NCT02958566|Antimanic Agents|antimanic agents|mesh-ancestor
110211831|NCT02958566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110211832|NCT02958566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110211833|NCT02958566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110211834|NCT02958566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110211835|NCT02958566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110211836|NCT02958566|Antitussive Agents|antitussive agents|mesh-ancestor
110211837|NCT02958566|Respiratory System Agents|respiratory system agents|mesh-ancestor
110211838|NCT02958566|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110211839|NCT02958566|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110211840|NCT02958566|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110211841|NCT02958566|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110211842|NCT02958566|Parasympatholytics|parasympatholytics|mesh-ancestor
110211843|NCT02958566|Autonomic Agents|autonomic agents|mesh-ancestor
110211844|NCT02958566|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110211845|NCT02958566|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110211846|NCT02958566|Cholinergic Agents|cholinergic agents|mesh-ancestor
110211847|NCT02958566|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
110211848|NCT02958566|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110211849|NCT00097344|Toremifene|toremifene|mesh-list
110211850|NCT00097344|Letrozole|letrozole|mesh-list
110211851|NCT00097344|Hormones|hormones|mesh-list
110211852|NCT00097344|Atamestane|atamestane|mesh-list
110211853|NCT00097344|Estrogen Antagonists|estrogen antagonists|mesh-list
110211855|NCT00097344|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-list
110211856|NCT00097344|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-list
110211857|NCT00097344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110211858|NCT00097344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211859|NCT00097344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110211860|NCT00097344|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110211861|NCT00097344|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110211862|NCT00097344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110211863|NCT00097344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110211864|NCT00097344|Hormone Antagonists|hormone antagonists|mesh-ancestor
110211865|NCT00097344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110211866|NCT00097344|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110211867|NCT00097344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110211868|NCT00232882|Atenolol|atenolol|mesh-list
110211869|NCT00232882|Candesartan|candesartan|mesh-list
110211870|NCT00232882|Candesartan cilexetil|candesartan cilexetil|mesh-list
110211871|NCT00232882|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
110211872|NCT00232882|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110211873|NCT00232882|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110211874|NCT00232882|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110211875|NCT00232882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110211876|NCT00232882|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110211877|NCT00232882|Sympatholytics|sympatholytics|mesh-ancestor
110211878|NCT00232882|Autonomic Agents|autonomic agents|mesh-ancestor
110211879|NCT00232882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110211880|NCT00232882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211881|NCT00232882|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110211882|NCT00232882|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110211883|NCT00232882|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110211884|NCT00232882|Adrenergic Agents|adrenergic agents|mesh-ancestor
110211885|NCT00232882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110211886|NCT00232882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110211887|NCT00232882|Diuretics|diuretics|mesh-ancestor
110211888|NCT00232882|Natriuretic Agents|natriuretic agents|mesh-ancestor
110211889|NCT00064064|Gemcitabine|gemcitabine|mesh-list
110211890|NCT00064064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110022533|NCT00002904|Trabectedin|trabectedin|mesh-list
110211891|NCT00064064|Antimetabolites|antimetabolites|mesh-ancestor
110211892|NCT00064064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110211893|NCT00064064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110211894|NCT00413686|Gemcitabine|gemcitabine|mesh-list
110211895|NCT00413686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110211896|NCT00413686|Antimetabolites|antimetabolites|mesh-ancestor
110211897|NCT00413686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110211898|NCT00413686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110211899|NCT00233038|Ethanol|ethanol|mesh-list
110211900|NCT00233038|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110211901|NCT00233038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110211902|NCT00233038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110211903|NCT00233038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211904|NCT00097383|Epirubicin|epirubicin|mesh-list
110211905|NCT00097383|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110211906|NCT00097383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110211907|NCT00097383|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110211908|NCT00097383|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110211909|NCT00097383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110211910|NCT00097383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110211911|NCT00233155|Capsaicin|capsaicin|mesh-list
110211912|NCT00233155|Antipruritics|antipruritics|mesh-ancestor
110211913|NCT00233155|Dermatologic Agents|dermatologic agents|mesh-ancestor
110211914|NCT00233155|Sensory System Agents|sensory system agents|mesh-ancestor
110211915|NCT00233155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110211916|NCT00233155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211918|NCT00064142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110211920|NCT00064142|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110211921|NCT00064142|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110211922|NCT00064142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110211923|NCT00064142|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110211924|NCT00064142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110211925|NCT00064142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110211926|NCT00064142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110211927|NCT00064142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110211928|NCT00064142|Growth Substances|growth substances|mesh-ancestor
110211929|NCT00064142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211930|NCT00064142|Growth Inhibitors|growth inhibitors|mesh-ancestor
110211931|NCT00064181|Leucovorin|leucovorin|mesh-list
110211932|NCT00064181|Celecoxib|celecoxib|mesh-list
110211933|NCT00064181|Fluorouracil|fluorouracil|mesh-list
110211934|NCT00064181|Capecitabine|capecitabine|mesh-list
110211935|NCT00064181|Irinotecan|irinotecan|mesh-list
110211936|NCT00064181|Calcium|calcium|mesh-list
110211937|NCT00064181|Levoleucovorin|levoleucovorin|mesh-list
110211938|NCT00064181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110211939|NCT00064181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211940|NCT00064181|Antimetabolites|antimetabolites|mesh-ancestor
110211941|NCT00064181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110211942|NCT00064181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110211943|NCT00064181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110211944|NCT00064181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110211945|NCT00064181|Immunologic Factors|immunologic factors|mesh-ancestor
110211946|NCT00064181|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110211947|NCT00064181|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110211948|NCT00064181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110211949|NCT00064181|Antidotes|antidotes|mesh-ancestor
110211950|NCT00064181|Protective Agents|protective agents|mesh-ancestor
110211951|NCT00064181|Vitamin B Complex|vitamin b complex|mesh-ancestor
110211952|NCT00064181|Vitamins|vitamins|mesh-ancestor
110211953|NCT00064181|Micronutrients|micronutrients|mesh-ancestor
110211954|NCT00064181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110211955|NCT00064181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110211956|NCT00064181|Analgesics|analgesics|mesh-ancestor
110211957|NCT00064181|Sensory System Agents|sensory system agents|mesh-ancestor
110211958|NCT00064181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110211959|NCT00064181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110211960|NCT00064181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110211961|NCT00064181|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110211962|NCT00064181|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110211963|NCT00233545|Miltefosine|miltefosine|mesh-list
110211964|NCT00233545|Antifungal Agents|antifungal agents|mesh-ancestor
110211965|NCT00233545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110211966|NCT00233545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110211967|NCT00233545|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110211968|NCT00233545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110211969|NCT00233584|Budesonide|budesonide|mesh-list
110211970|NCT00233584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110211971|NCT00233584|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110211972|NCT00233584|Autonomic Agents|autonomic agents|mesh-ancestor
110211973|NCT00233584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110211974|NCT00233584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211975|NCT00233584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110211976|NCT00233584|Respiratory System Agents|respiratory system agents|mesh-ancestor
110211977|NCT00233584|Glucocorticoids|glucocorticoids|mesh-ancestor
110211978|NCT00233584|Hormones|hormones|mesh-ancestor
110211979|NCT00233584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110211980|NCT00233623|Leucovorin|leucovorin|mesh-list
110211981|NCT00233623|Fluorouracil|fluorouracil|mesh-list
110211982|NCT00233623|Irinotecan|irinotecan|mesh-list
110211983|NCT00233623|Gefitinib|gefitinib|mesh-list
110211984|NCT00233623|Antimetabolites|antimetabolites|mesh-ancestor
110211985|NCT00233623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110211986|NCT00233623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110211987|NCT00233623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110211988|NCT00233623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110211989|NCT00233623|Immunologic Factors|immunologic factors|mesh-ancestor
110211990|NCT00233623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211991|NCT00233623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110211992|NCT00233623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110211993|NCT00233623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110211994|NCT00233623|Antidotes|antidotes|mesh-ancestor
110211995|NCT00233623|Protective Agents|protective agents|mesh-ancestor
110211996|NCT00233623|Vitamin B Complex|vitamin b complex|mesh-ancestor
110211997|NCT00233623|Vitamins|vitamins|mesh-ancestor
110211998|NCT00233623|Micronutrients|micronutrients|mesh-ancestor
110211999|NCT00233623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110212000|NCT00064220|Soblidotin|soblidotin|mesh-list
110212001|NCT00064220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110212002|NCT00233779|Sirolimus|sirolimus|mesh-list
110212003|NCT00233779|Heparin|heparin|mesh-list
110212004|NCT00233779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110212005|NCT00233779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110212006|NCT00233779|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110212007|NCT00233779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110212008|NCT00233779|Antifungal Agents|antifungal agents|mesh-ancestor
110212009|NCT00233779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110212010|NCT00233779|Immunologic Factors|immunologic factors|mesh-ancestor
110212011|NCT00233779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110212012|NCT00233779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110212013|NCT00233779|Anticoagulants|anticoagulants|mesh-ancestor
110212014|NCT00233779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110212015|NCT00233779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110212016|NCT00233818|Sirolimus|sirolimus|mesh-list
110212017|NCT00233818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110212018|NCT00233818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110212019|NCT00233818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110212020|NCT00233818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110212021|NCT00233818|Antifungal Agents|antifungal agents|mesh-ancestor
110212022|NCT00233818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110212023|NCT00233818|Immunologic Factors|immunologic factors|mesh-ancestor
110212024|NCT00233818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110212025|NCT00076206|Temsirolimus|temsirolimus|mesh-list
110212026|NCT00076206|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110212027|NCT00076206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110212028|NCT00076206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110212029|NCT00076206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110212030|NCT00076206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110212031|NCT00076206|Immunologic Factors|immunologic factors|mesh-ancestor
110212032|NCT00076206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110212033|NCT00076206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110212034|NCT00233896|Beclomethasone|beclomethasone|mesh-list
110212035|NCT00233896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110212036|NCT00233896|Glucocorticoids|glucocorticoids|mesh-ancestor
110212037|NCT00233896|Hormones|hormones|mesh-ancestor
110212038|NCT00233896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110212039|NCT00233896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110212040|NCT00233896|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110212041|NCT00233896|Respiratory System Agents|respiratory system agents|mesh-ancestor
110212042|NCT00233935|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
110212043|NCT00233935|Antioxidants|antioxidants|mesh-ancestor
110212044|NCT00233935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110235600|NCT00125424|Anesthetics|anesthetics|mesh-ancestor
110212045|NCT00233935|Protective Agents|protective agents|mesh-ancestor
110212046|NCT00233935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110212047|NCT00233935|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110212048|NCT00233935|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110212049|NCT00233935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110212050|NCT00233935|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110212051|NCT00234091|Ritonavir|ritonavir|mesh-list
110212052|NCT00234091|Lopinavir|lopinavir|mesh-list
110212053|NCT00234091|Nelfinavir|nelfinavir|mesh-list
110212054|NCT00234091|Lamivudine|lamivudine|mesh-list
110212055|NCT00234091|Zidovudine|zidovudine|mesh-list
110212056|NCT00234091|Nevirapine|nevirapine|mesh-list
110212057|NCT00234091|Abacavir|abacavir|mesh-list
110212058|NCT00234091|Efavirenz|efavirenz|mesh-list
110212059|NCT00234091|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110212060|NCT00234091|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110212061|NCT00234091|Protease Inhibitors|protease inhibitors|mesh-ancestor
110212062|NCT00234091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110212063|NCT00234091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110212064|NCT00234091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110212065|NCT00234091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110212066|NCT00234091|Antiviral Agents|antiviral agents|mesh-ancestor
110212067|NCT00234091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110212068|NCT00234091|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110212069|NCT00234091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110212070|NCT00234091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110212071|NCT00234091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110212072|NCT00234091|Antimetabolites|antimetabolites|mesh-ancestor
110212073|NCT00234091|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110212074|NCT00234091|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110212075|NCT00234091|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110212076|NCT00234091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110212077|NCT00234091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110212078|NCT04721704|Amoxicillin|amoxicillin|mesh-list
110212079|NCT04721704|Metronidazole|metronidazole|mesh-list
110212080|NCT04721704|Clarithromycin|clarithromycin|mesh-list
110212081|NCT04721704|Omeprazole|omeprazole|mesh-list
110212082|NCT04721704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110212083|NCT04721704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110212084|NCT04721704|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110212085|NCT04721704|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110212086|NCT04721704|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110212087|NCT04721704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110212088|NCT04721704|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110212089|NCT04721704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110212090|NCT04721704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110212091|NCT04721704|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110212092|NCT04721704|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110212093|NCT04721704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110212095|NCT00076284|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110212096|NCT00076284|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110212097|NCT00076284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110212098|NCT00076284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110212099|NCT00076284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110212100|NCT00076284|Antiviral Agents|antiviral agents|mesh-ancestor
110212101|NCT00076284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110212102|NCT00234403|Fulvestrant|fulvestrant|mesh-list
110212103|NCT00234403|Gefitinib|gefitinib|mesh-list
110212104|NCT00234403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110212105|NCT00234403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110212106|NCT00234403|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110212107|NCT00234403|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110235613|NCT00333385|Ceftazidime|ceftazidime|mesh-list
110212108|NCT00234403|Hormone Antagonists|hormone antagonists|mesh-ancestor
110212109|NCT00234403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110212110|NCT00234403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110212111|NCT00234403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110212112|NCT00234403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110212113|NCT00234403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110212114|NCT00064415|Formoterol Fumarate|formoterol fumarate|mesh-list
110212115|NCT00064415|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110212116|NCT00064415|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110212118|NCT00064415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110212119|NCT00064415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110212120|NCT00064415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110212121|NCT00064415|Respiratory System Agents|respiratory system agents|mesh-ancestor
110212122|NCT00064415|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110212123|NCT00064415|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110212124|NCT00064415|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110212125|NCT00064415|Adrenergic Agents|adrenergic agents|mesh-ancestor
110212126|NCT00064415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110212127|NCT00064415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110212128|NCT00234442|Gefitinib|gefitinib|mesh-list
110212129|NCT00234442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110212130|NCT00234442|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110212131|NCT00234442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110212132|NCT00234442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110212133|NCT00076323|Primaquine|primaquine|mesh-list
110212134|NCT00076323|Antimalarials|antimalarials|mesh-ancestor
110212135|NCT00076323|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110212136|NCT00076323|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110212137|NCT00076323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110212138|NCT00234598|Chlorhexidine|chlorhexidine|mesh-list
110212139|NCT00234598|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110212140|NCT00234598|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110212141|NCT00234598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110212142|NCT00234598|Disinfectants|disinfectants|mesh-ancestor
110212143|NCT00234598|Dermatologic Agents|dermatologic agents|mesh-ancestor
110212144|NCT00234637|Memantine|memantine|mesh-list
110212145|NCT00234637|Rivastigmine|rivastigmine|mesh-list
110212146|NCT00234637|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110212147|NCT00234637|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110212148|NCT00234637|Dopamine Agents|dopamine agents|mesh-ancestor
110212149|NCT00234637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110212150|NCT00234637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110212151|NCT00234637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110212152|NCT00234637|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110212153|NCT00234637|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110212154|NCT00234637|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110212155|NCT00234637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110212156|NCT00234637|Cholinergic Agents|cholinergic agents|mesh-ancestor
110212157|NCT00234637|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110212158|NCT00234637|Protective Agents|protective agents|mesh-ancestor
110212159|NCT00234676|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110212160|NCT00234676|Estrogens|estrogens|mesh-ancestor
110212162|NCT00234676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110212163|NCT00234676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110212164|NCT00076362|Octreotide|octreotide|mesh-list
110212165|NCT00076362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110212166|NCT00076362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110212167|NCT00076362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110212168|NCT00234871|Verapamil|verapamil|mesh-list
110212169|NCT00234871|Amlodipine|amlodipine|mesh-list
110212170|NCT00234871|Benazepril|benazepril|mesh-list
110212171|NCT00234871|Trandolapril|trandolapril|mesh-list
110212172|NCT00234871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110212173|NCT00234871|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110212174|NCT00234871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110212175|NCT00234871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110212176|NCT00234871|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110212177|NCT00234871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110212179|NCT00234871|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110212180|NCT00234871|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110212181|NCT00234871|Protease Inhibitors|protease inhibitors|mesh-ancestor
110212182|NCT00234871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110212183|NCT00234910|Ritonavir|ritonavir|mesh-list
110212184|NCT00234910|Lopinavir|lopinavir|mesh-list
110212185|NCT00234910|Tenofovir|tenofovir|mesh-list
110212186|NCT00234910|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110212187|NCT00234910|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110212188|NCT00234910|Protease Inhibitors|protease inhibitors|mesh-ancestor
110212189|NCT00234910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110212190|NCT00234910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110212191|NCT00234910|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110212192|NCT00234910|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110212193|NCT00234910|Antiviral Agents|antiviral agents|mesh-ancestor
110212194|NCT00234910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110212195|NCT00234910|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110212196|NCT00234910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110212197|NCT00234910|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110212198|NCT00234910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110212199|NCT00234949|Cephalexin|cephalexin|mesh-list
110212200|NCT00234949|Cefdinir|cefdinir|mesh-list
110212201|NCT00234949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110212202|NCT00234949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110212203|NCT00234988|Sibutramine|sibutramine|mesh-list
110212204|NCT00234988|Antidepressive Agents|antidepressive agents|mesh-ancestor
110212205|NCT00234988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110212206|NCT00234988|Appetite Depressants|appetite depressants|mesh-ancestor
110212207|NCT00234988|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110212208|NCT00400491|Vitamin D|vitamin d|mesh-list
110212209|NCT00400491|Ergocalciferols|ergocalciferols|mesh-list
110212210|NCT00400491|Cholecalciferol|cholecalciferol|mesh-list
110212211|NCT00400491|Vitamins|vitamins|mesh-list
110212212|NCT00400491|Micronutrients|micronutrients|mesh-ancestor
110212213|NCT00400491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110212214|NCT00400491|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110212215|NCT00400491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110212216|NCT00235105|Adalimumab|adalimumab|mesh-list
110212217|NCT00235105|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110212218|NCT00235105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110212219|NCT00235105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110212220|NCT00235144|Sirolimus|sirolimus|mesh-list
110212221|NCT00235144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110212222|NCT00235144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110212223|NCT00235144|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110212224|NCT00235144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110212225|NCT00235144|Antifungal Agents|antifungal agents|mesh-ancestor
110212226|NCT00235144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110212227|NCT00235144|Immunologic Factors|immunologic factors|mesh-ancestor
110212228|NCT00235144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110212229|NCT00400530|Alendronate|alendronate|mesh-list
110212230|NCT00400530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110212231|NCT00400530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110212232|NCT00064610|Bortezomib|bortezomib|mesh-list
110212233|NCT00064610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110212234|NCT00235222|Stavudine|stavudine|mesh-list
110212235|NCT00235222|Antimetabolites|antimetabolites|mesh-ancestor
110212236|NCT00235222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110212237|NCT00235222|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110235635|NCT00127257|GABA Agents|gaba agents|mesh-ancestor
110212238|NCT00235222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110212240|NCT00235222|Antiviral Agents|antiviral agents|mesh-ancestor
110212241|NCT00235222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110212242|NCT00235222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110212243|NCT00235222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110212245|NCT00235261|Pregabalin|pregabalin|mesh-list
110212246|NCT00235261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110212247|NCT00235261|Antiemetics|antiemetics|mesh-ancestor
110212248|NCT00235261|Autonomic Agents|autonomic agents|mesh-ancestor
110212249|NCT00235261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110212250|NCT00235261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110212251|NCT00235261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110212252|NCT00235261|Glucocorticoids|glucocorticoids|mesh-ancestor
110212253|NCT00235261|Hormones|hormones|mesh-ancestor
110212254|NCT00235261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110212255|NCT00235261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110212256|NCT00235261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110212257|NCT00235261|Analgesics|analgesics|mesh-ancestor
110212258|NCT00235261|Sensory System Agents|sensory system agents|mesh-ancestor
110212259|NCT00235261|Anticonvulsants|anticonvulsants|mesh-ancestor
110212261|NCT00235261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110212262|NCT00235261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110212263|NCT00235261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110212264|NCT00235261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110212265|NCT00235261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110212266|NCT00235261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110212267|NCT00235261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110212268|NCT00235300|Thymoglobulin|thymoglobulin|mesh-list
110212269|NCT00235300|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110212270|NCT00235300|Basiliximab|basiliximab|mesh-list
110212271|NCT00235300|Immunologic Factors|immunologic factors|mesh-ancestor
110212272|NCT00235300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110212273|NCT00235300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110212274|NCT00064649|Finasteride|finasteride|mesh-list
110212275|NCT00064649|Alfuzosin|alfuzosin|mesh-list
110212276|NCT00064649|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110212277|NCT00064649|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110212278|NCT00064649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110212279|NCT00064649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110212280|NCT00064649|Hormone Antagonists|hormone antagonists|mesh-ancestor
110212281|NCT00064649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110212282|NCT00064649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110212283|NCT00064649|Urological Agents|urological agents|mesh-ancestor
110212284|NCT00064649|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110212285|NCT00064649|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110212286|NCT00064649|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110212287|NCT00064649|Adrenergic Agents|adrenergic agents|mesh-ancestor
110212288|NCT00064649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110212289|NCT00097734|Ertapenem|ertapenem|mesh-list
110212290|NCT00097734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110212291|NCT00097734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110212292|NCT00064727|Rosiglitazone|rosiglitazone|mesh-list
110212293|NCT00064727|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110212294|NCT00064727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110212295|NCT00235651|Amphotericin B|amphotericin b|mesh-list
110212296|NCT00235651|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110212298|NCT00235651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110212299|NCT00235651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110212300|NCT00235651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110212301|NCT00235651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110212302|NCT00235651|Antifungal Agents|antifungal agents|mesh-ancestor
110212303|NCT00097812|Zoledronic Acid|zoledronic acid|mesh-list
110212304|NCT00097812|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110212305|NCT00097812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110212306|NCT00064766|Doxycycline|doxycycline|mesh-list
110212307|NCT00064766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110212308|NCT00064766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110212309|NCT00064766|Antimalarials|antimalarials|mesh-ancestor
110212310|NCT00064766|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110212311|NCT00064766|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110212312|NCT00235729|Lofexidine|lofexidine|mesh-list
110212313|NCT00235729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110212314|NCT00235729|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110212315|NCT00235729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110212316|NCT00235729|Sensory System Agents|sensory system agents|mesh-ancestor
110212317|NCT00235729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110212318|NCT00235729|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110212319|NCT00235729|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110212320|NCT00235729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110212321|NCT00235729|Adrenergic Agents|adrenergic agents|mesh-ancestor
110212322|NCT00235729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110212323|NCT00235729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110212324|NCT00235885|Adalimumab|adalimumab|mesh-list
110212325|NCT00235885|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110212326|NCT00235885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110212327|NCT00235885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110212328|NCT04728750|Pancrelipase|pancrelipase|mesh-list
110212329|NCT04728750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110212330|NCT00235963|Simvastatin|simvastatin|mesh-list
110212331|NCT00235963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110212332|NCT00235963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110212333|NCT00235963|Antimetabolites|antimetabolites|mesh-ancestor
110212334|NCT00235963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110212335|NCT00235963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110212336|NCT00235963|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110212337|NCT00235963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110212338|NCT00236002|Alendronate|alendronate|mesh-list
110212339|NCT00236002|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110212340|NCT00236002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110212341|NCT00414037|Eszopiclone|eszopiclone|mesh-list
110212342|NCT00414037|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110212343|NCT00414037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110212344|NCT00414037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110212345|NCT00236275|Telbivudine|telbivudine|mesh-list
110212346|NCT00236275|Antiviral Agents|antiviral agents|mesh-ancestor
110212347|NCT00236275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110212348|NCT00236275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110212349|NCT00236275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110212350|NCT00236275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110212351|NCT00236353|Risperidone|risperidone|mesh-list
110212352|NCT00236353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110212353|NCT00236353|Serotonin Agents|serotonin agents|mesh-ancestor
110212354|NCT00236353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110212355|NCT00236353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110212356|NCT00236353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110212357|NCT00236353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110212358|NCT00236353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110212359|NCT00236353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110212360|NCT00236353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110212361|NCT00236353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110212362|NCT00236353|Dopamine Agents|dopamine agents|mesh-ancestor
110212364|NCT00236392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110212365|NCT00236392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110212366|NCT00236392|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110212368|NCT00236392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110212369|NCT00236431|Galantamine|galantamine|mesh-list
110212370|NCT00236431|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110212371|NCT00236431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110212372|NCT00236431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110212373|NCT00236431|Cholinergic Agents|cholinergic agents|mesh-ancestor
110212374|NCT00236431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110212375|NCT00236431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110212376|NCT00236431|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110212377|NCT00236431|Autonomic Agents|autonomic agents|mesh-ancestor
110212378|NCT00236431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110212379|NCT00236431|Nootropic Agents|nootropic agents|mesh-ancestor
110212380|NCT00097929|Vorinostat|vorinostat|mesh-list
110212381|NCT00097929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110212382|NCT00097929|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110212383|NCT00097929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110212384|NCT00097929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110212385|NCT00236470|Risperidone|risperidone|mesh-list
110212386|NCT00236470|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110212387|NCT00236470|Serotonin Agents|serotonin agents|mesh-ancestor
110212388|NCT00236470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110212389|NCT00236470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110212390|NCT00236470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110212391|NCT00236470|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110212392|NCT00236470|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110212393|NCT00236470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110212394|NCT00236470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110212395|NCT00236470|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110212396|NCT00236470|Dopamine Agents|dopamine agents|mesh-ancestor
110212397|NCT00236509|Topiramate|topiramate|mesh-list
110212398|NCT00236509|Anticonvulsants|anticonvulsants|mesh-ancestor
110212399|NCT00236509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110212400|NCT00236509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110212401|NCT02962141|Paclitaxel|paclitaxel|mesh-list
110212402|NCT02962141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110212403|NCT02962141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110212404|NCT02962141|Tubulin Modulators|tubulin modulators|mesh-ancestor
110212405|NCT02962141|Antimitotic Agents|antimitotic agents|mesh-ancestor
110212406|NCT02962141|Mitosis Modulators|mitosis modulators|mesh-ancestor
110212407|NCT02962141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110212408|NCT00076401|Motexafin gadolinium|motexafin gadolinium|mesh-list
110212409|NCT00076401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110212410|NCT00076401|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110212411|NCT00076401|Dermatologic Agents|dermatologic agents|mesh-ancestor
110212412|NCT00236548|Risperidone|risperidone|mesh-list
110212413|NCT00236548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110212414|NCT00236548|Serotonin Agents|serotonin agents|mesh-ancestor
110212415|NCT00236548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110212416|NCT00236548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110212417|NCT00236548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110212418|NCT00236548|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110212419|NCT00236548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110212420|NCT00236548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110212421|NCT00236548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110212423|NCT00236548|Dopamine Agents|dopamine agents|mesh-ancestor
110212424|NCT00236587|Risperidone|risperidone|mesh-list
110212425|NCT00236587|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110212426|NCT00236587|Serotonin Agents|serotonin agents|mesh-ancestor
110212427|NCT00236587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110212428|NCT00236587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110212429|NCT00236587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110212430|NCT00236587|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110212431|NCT00236587|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110212432|NCT00236587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110212433|NCT00236587|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110212434|NCT00236587|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110212435|NCT00236587|Dopamine Agents|dopamine agents|mesh-ancestor
110212436|NCT00236626|Topiramate|topiramate|mesh-list
110212437|NCT00236626|Anticonvulsants|anticonvulsants|mesh-ancestor
110212438|NCT00236626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110212439|NCT00236626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110212440|NCT00236665|Topiramate|topiramate|mesh-list
110212441|NCT00236665|Anticonvulsants|anticonvulsants|mesh-ancestor
110212442|NCT00236665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110212443|NCT00236665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110212444|NCT00399282|Vitamin E|vitamin e|mesh-list
110212445|NCT00399282|Vitamins|vitamins|mesh-ancestor
110212446|NCT00399282|Micronutrients|micronutrients|mesh-ancestor
110212447|NCT00399282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110212448|NCT00399282|Antioxidants|antioxidants|mesh-ancestor
110212449|NCT00399282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110212450|NCT00399282|Protective Agents|protective agents|mesh-ancestor
110212451|NCT00236704|Topiramate|topiramate|mesh-list
110212452|NCT00236704|Anticonvulsants|anticonvulsants|mesh-ancestor
110212453|NCT00236704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110212454|NCT00236704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110212455|NCT00236743|Topiramate|topiramate|mesh-list
110212456|NCT00236743|Anticonvulsants|anticonvulsants|mesh-ancestor
110212457|NCT00236743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110212458|NCT00236743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110212459|NCT00236782|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110212460|NCT00236782|Norelgestromin|norelgestromin|mesh-list
110212461|NCT00236782|Estradiol|estradiol|mesh-list
110212462|NCT00236782|Estrogens|estrogens|mesh-ancestor
110212463|NCT00236782|Hormones|hormones|mesh-ancestor
110212464|NCT00236782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110212465|NCT00236782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110212466|NCT00236782|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110212467|NCT00236782|Contraceptive Agents|contraceptive agents|mesh-ancestor
110212468|NCT00236782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110212469|NCT00236782|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110212470|NCT00236782|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110212471|NCT00236782|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110212472|NCT00097968|Everolimus|everolimus|mesh-list
110212473|NCT00097968|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110212474|NCT00097968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110212475|NCT00097968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110212476|NCT00097968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110212477|NCT00097968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110212478|NCT00097968|Immunologic Factors|immunologic factors|mesh-ancestor
110212479|NCT00097968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110212480|NCT00097968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110212481|NCT00236821|Levofloxacin|levofloxacin|mesh-list
110212482|NCT00236821|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110212483|NCT00236821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110212484|NCT00236821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110212485|NCT00236821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110212486|NCT00236821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110212487|NCT00236821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110212488|NCT00236821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110212489|NCT00236821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110212490|NCT00236821|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110212491|NCT00236821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110212492|NCT00236860|Topiramate|topiramate|mesh-list
110212493|NCT00236860|Anticonvulsants|anticonvulsants|mesh-ancestor
110212494|NCT00236860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110212495|NCT00236860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110212497|NCT00065117|Fluorouracil|fluorouracil|mesh-list
110212498|NCT00065117|Oxaliplatin|oxaliplatin|mesh-list
110212499|NCT00065117|Antimetabolites|antimetabolites|mesh-ancestor
110212500|NCT00065117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110212501|NCT00065117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110212502|NCT00065117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110212503|NCT00065117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110212504|NCT00065117|Immunologic Factors|immunologic factors|mesh-ancestor
110212505|NCT00065117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110212506|NCT00065117|Antidotes|antidotes|mesh-ancestor
110212507|NCT00065117|Protective Agents|protective agents|mesh-ancestor
110212508|NCT00065117|Vitamin B Complex|vitamin b complex|mesh-ancestor
110212509|NCT00065117|Vitamins|vitamins|mesh-ancestor
110212510|NCT00065117|Micronutrients|micronutrients|mesh-ancestor
110212511|NCT00237016|Doxycycline|doxycycline|mesh-list
110212512|NCT00237016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110212513|NCT00237016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110212514|NCT00237016|Antimalarials|antimalarials|mesh-ancestor
110212515|NCT00237016|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110212516|NCT00237016|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110212517|NCT00237133|Letrozole|letrozole|mesh-list
110212518|NCT00237133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110212519|NCT00237133|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110212520|NCT00237133|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110212521|NCT00237133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110212522|NCT00237133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110212523|NCT00237133|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110212524|NCT00237133|Hormone Antagonists|hormone antagonists|mesh-ancestor
110212525|NCT00237133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110212526|NCT00237133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110212527|NCT00237172|Imatinib Mesylate|imatinib mesylate|mesh-list
110212528|NCT00237172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110212529|NCT00237172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110212530|NCT00237172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110212531|NCT00237172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110212532|NCT00237211|Letrozole|letrozole|mesh-list
110212533|NCT00237211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110212534|NCT00237211|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110212535|NCT00237211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110212536|NCT00237211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110212537|NCT00237211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110212538|NCT00237211|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110212539|NCT00237211|Hormone Antagonists|hormone antagonists|mesh-ancestor
110212540|NCT00237211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110212541|NCT00237211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110212542|NCT00098007|Everolimus|everolimus|mesh-list
110212543|NCT00098007|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110212544|NCT00098007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110212545|NCT00098007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110212546|NCT00098007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110212547|NCT00098007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110212548|NCT00098007|Immunologic Factors|immunologic factors|mesh-ancestor
110235705|NCT00089219|Sargramostim|sargramostim|mesh-list
110212549|NCT00098007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110212550|NCT00098007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110212552|NCT00237250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110212553|NCT00237250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110212554|NCT00237250|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110212555|NCT00237250|Protease Inhibitors|protease inhibitors|mesh-ancestor
110212556|NCT00237250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110212557|NCT00237250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110212558|NCT00237289|Topiramate|topiramate|mesh-list
110212559|NCT00237289|Anticonvulsants|anticonvulsants|mesh-ancestor
110212560|NCT00237289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110212561|NCT00237289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110212562|NCT00237328|Heparin|heparin|mesh-list
110212563|NCT00237328|Anticoagulants|anticoagulants|mesh-ancestor
110212564|NCT00237328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110212565|NCT00237328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110212566|NCT00237328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110212568|NCT00237367|Pantoprazole|pantoprazole|mesh-list
110212569|NCT00237367|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110212570|NCT00237367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110212571|NCT00237367|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110212572|NCT00237367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110212573|NCT00237367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110212574|NCT00098046|Famciclovir|famciclovir|mesh-list
110212575|NCT00098046|Antiviral Agents|antiviral agents|mesh-ancestor
110212576|NCT00098046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110212577|NCT00098046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110212578|NCT00098046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110212579|NCT00098046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110212581|NCT00065273|Risperidone|risperidone|mesh-list
110212582|NCT00065273|Clozapine|clozapine|mesh-list
110212583|NCT00065273|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110212584|NCT00065273|Serotonin Agents|serotonin agents|mesh-ancestor
110212585|NCT00065273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110212586|NCT00065273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110212587|NCT00065273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110212588|NCT00065273|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110212589|NCT00065273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110212590|NCT00065273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110212591|NCT00065273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110212592|NCT00065273|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110212593|NCT00065273|Dopamine Agents|dopamine agents|mesh-ancestor
110212594|NCT00065273|Antiemetics|antiemetics|mesh-ancestor
110212595|NCT00065273|Autonomic Agents|autonomic agents|mesh-ancestor
110212596|NCT00065273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110212597|NCT00065273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110212598|NCT00065273|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110212599|NCT00065273|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110212600|NCT00065273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110212601|NCT00065273|GABA Antagonists|gaba antagonists|mesh-ancestor
110212602|NCT00065273|GABA Agents|gaba agents|mesh-ancestor
110212603|NCT00237445|Azithromycin|azithromycin|mesh-list
110212604|NCT00237445|Telithromycin|telithromycin|mesh-list
110212605|NCT00237445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110212606|NCT00237445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110212608|NCT00237484|Ribavirin|ribavirin|mesh-list
110212609|NCT00237484|Interferon-alpha|interferon-alpha|mesh-list
110212610|NCT00237484|Interferon alpha-2|interferon alpha-2|mesh-list
110212611|NCT00237484|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110212612|NCT00237484|Infliximab|infliximab|mesh-list
110212613|NCT00237484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110212614|NCT00237484|Antiviral Agents|antiviral agents|mesh-ancestor
110212615|NCT00237484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110212616|NCT00237484|Antimetabolites|antimetabolites|mesh-ancestor
110235713|NCT00334321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110212617|NCT00237484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110212618|NCT00237484|Immunologic Factors|immunologic factors|mesh-ancestor
110212619|NCT00237484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110212620|NCT00237484|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110212621|NCT00237484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110212622|NCT00237484|Dermatologic Agents|dermatologic agents|mesh-ancestor
110212623|NCT00237484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110212624|NCT00237484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110212625|NCT00237523|Iodine|iodine|mesh-list
110212626|NCT00237523|Cadexomer iodine|cadexomer iodine|mesh-list
110212627|NCT00237523|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110212628|NCT00237523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110212629|NCT00237523|Trace Elements|trace elements|mesh-ancestor
110212630|NCT00237523|Micronutrients|micronutrients|mesh-ancestor
110212631|NCT00237523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110212632|NCT00098124|Milnacipran|milnacipran|mesh-list
110212633|NCT00098124|Levomilnacipran|levomilnacipran|mesh-list
110212634|NCT00098124|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110212635|NCT00098124|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110212636|NCT00098124|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110212637|NCT00098124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110212638|NCT00098124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110212639|NCT00098124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110212640|NCT00098124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110212641|NCT00098124|Analgesics|analgesics|mesh-ancestor
110212642|NCT00098124|Sensory System Agents|sensory system agents|mesh-ancestor
110212643|NCT00098124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110212644|NCT00098124|Antidepressive Agents|antidepressive agents|mesh-ancestor
110212645|NCT00098124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110212646|NCT04710160|Calcium|calcium|mesh-list
110212647|NCT04710160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110212648|NCT04710160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110212649|NCT00065351|Lenalidomide|lenalidomide|mesh-list
110212650|NCT00065351|Immunologic Factors|immunologic factors|mesh-ancestor
110212651|NCT00065351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110212652|NCT00065351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110212653|NCT00065351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110212654|NCT00065351|Growth Substances|growth substances|mesh-ancestor
110212655|NCT00065351|Growth Inhibitors|growth inhibitors|mesh-ancestor
110212656|NCT00065351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110212657|NCT04709770|Simethicone|simethicone|mesh-list
110212658|NCT04709770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110212659|NCT04709770|Antifoaming Agents|antifoaming agents|mesh-ancestor
110212660|NCT04709770|Emollients|emollients|mesh-ancestor
110212661|NCT04709770|Dermatologic Agents|dermatologic agents|mesh-ancestor
110212662|NCT04709731|Ponatinib|ponatinib|mesh-list
110212663|NCT04709731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110212664|NCT04709731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110212665|NCT04709731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110212666|NCT04709731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110212667|NCT00398684|Nevirapine|nevirapine|mesh-list
110212668|NCT00398684|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110212669|NCT00398684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110212670|NCT00398684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110212671|NCT00398684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110212672|NCT00398684|Antiviral Agents|antiviral agents|mesh-ancestor
110212673|NCT00398684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110212674|NCT00398684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110212675|NCT00398684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110212676|NCT00398684|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110212677|NCT00398684|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110212678|NCT00076440|Leuprolide|leuprolide|mesh-list
110212679|NCT00076440|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110212680|NCT00076440|Fertility Agents|fertility agents|mesh-ancestor
110212681|NCT00076440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110212682|NCT00076440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110212683|NCT00076440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110212684|NCT00076440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110212685|NCT00237874|Aripiprazole|aripiprazole|mesh-list
110212686|NCT00237874|Antidepressive Agents|antidepressive agents|mesh-ancestor
110212687|NCT00237874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110212688|NCT00237874|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110212689|NCT00237874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110212690|NCT00237874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110212691|NCT00237874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110212692|NCT00237874|Dopamine Agonists|dopamine agonists|mesh-ancestor
110212693|NCT00237874|Dopamine Agents|dopamine agents|mesh-ancestor
110212694|NCT00237874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110212695|NCT00237874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110212696|NCT00237874|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110212697|NCT00237874|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110212698|NCT00237874|Serotonin Agents|serotonin agents|mesh-ancestor
110212699|NCT00237874|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110212700|NCT00237874|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110212701|NCT00237874|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110212702|NCT00237874|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110212704|NCT00237913|Risperidone|risperidone|mesh-list
110212705|NCT00237913|Aripiprazole|aripiprazole|mesh-list
110212706|NCT00237913|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110212707|NCT00237913|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110212708|NCT00237913|Serotonin Agents|serotonin agents|mesh-ancestor
110212709|NCT00237913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110212710|NCT00237913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110212711|NCT00237913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110212712|NCT00237913|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110212713|NCT00237913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110212714|NCT00237913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110212715|NCT00237913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110212716|NCT00237913|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110212717|NCT00237913|Dopamine Agents|dopamine agents|mesh-ancestor
110212718|NCT00237913|Antiemetics|antiemetics|mesh-ancestor
110212719|NCT00237913|Autonomic Agents|autonomic agents|mesh-ancestor
110212720|NCT00237913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110212721|NCT00237913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110212722|NCT00237913|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110212723|NCT00237913|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110212724|NCT00237913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110212725|NCT00237913|Antidepressive Agents|antidepressive agents|mesh-ancestor
110212726|NCT00237913|Dopamine Agonists|dopamine agonists|mesh-ancestor
110212727|NCT00237913|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110212728|NCT00237913|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110212729|NCT00237913|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110212730|NCT00237913|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110212731|NCT00237952|Chelating Agents|chelating agents|mesh-list
110212732|NCT00237952|Sequestering Agents|sequestering agents|mesh-ancestor
110212733|NCT00237952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110212734|NCT00098241|Everolimus|everolimus|mesh-list
110212735|NCT00098241|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110212736|NCT00098241|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110212737|NCT00098241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110212738|NCT00098241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110212739|NCT00098241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110212740|NCT00098241|Immunologic Factors|immunologic factors|mesh-ancestor
110212741|NCT00098241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110212742|NCT00098241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110212744|NCT04721119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110212745|NCT04721119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110212746|NCT00238147|Carboplatin|carboplatin|mesh-list
110212747|NCT00238147|Docetaxel|docetaxel|mesh-list
110212748|NCT00238147|Capecitabine|capecitabine|mesh-list
110212749|NCT00238147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110212750|NCT00238147|Tubulin Modulators|tubulin modulators|mesh-ancestor
110212751|NCT00238147|Antimitotic Agents|antimitotic agents|mesh-ancestor
110212752|NCT00238147|Mitosis Modulators|mitosis modulators|mesh-ancestor
110212753|NCT00238147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110212754|NCT00238147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110212755|NCT00238147|Antimetabolites|antimetabolites|mesh-ancestor
110212756|NCT00065390|Pyrimethamine|pyrimethamine|mesh-list
110212757|NCT00065390|Antimalarials|antimalarials|mesh-ancestor
110212758|NCT00065390|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110212759|NCT00065390|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110212760|NCT00065390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110212761|NCT00065390|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110212762|NCT00065390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110212763|NCT00065390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110212764|NCT00238225|Calcitriol|calcitriol|mesh-list
110212765|NCT00238225|Ketoconazole|ketoconazole|mesh-list
110212766|NCT00238225|Dexamethasone|dexamethasone|mesh-list
110212767|NCT00238225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110212768|NCT00238225|Antiemetics|antiemetics|mesh-ancestor
110212769|NCT00238225|Autonomic Agents|autonomic agents|mesh-ancestor
110212770|NCT00238225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110212771|NCT00238225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110212772|NCT00238225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110212773|NCT00238225|Glucocorticoids|glucocorticoids|mesh-ancestor
110212774|NCT00238225|Hormones|hormones|mesh-ancestor
110212775|NCT00238225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110212776|NCT00238225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110212777|NCT00238225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110212778|NCT00238225|Antifungal Agents|antifungal agents|mesh-ancestor
110212779|NCT00238225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110212780|NCT00238225|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110212781|NCT00238225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110212782|NCT00238225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110212783|NCT00238225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110212784|NCT00238225|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110212785|NCT00238225|Hormone Antagonists|hormone antagonists|mesh-ancestor
110212786|NCT00238225|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110212787|NCT00238225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110212788|NCT00238225|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110212789|NCT00238225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110212790|NCT00238225|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110212791|NCT00238225|Vitamins|vitamins|mesh-ancestor
110212792|NCT00238225|Micronutrients|micronutrients|mesh-ancestor
110212793|NCT00238225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110212794|NCT00076518|Fenofibrate|fenofibrate|mesh-list
110212795|NCT00076518|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110212796|NCT00076518|Antimetabolites|antimetabolites|mesh-ancestor
110212797|NCT00076518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110212798|NCT00076518|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110212799|NCT00065546|Choline|choline|mesh-list
110212800|NCT00065546|Estrogens|estrogens|mesh-list
110212801|NCT00065546|Hormones|hormones|mesh-ancestor
110212802|NCT00065546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110212803|NCT00065546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110212804|NCT00065546|Lipotropic Agents|lipotropic agents|mesh-ancestor
110212805|NCT00065546|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110212806|NCT00065546|Antimetabolites|antimetabolites|mesh-ancestor
110212807|NCT00065546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110212808|NCT00065546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110212809|NCT00065546|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110212810|NCT00065546|Nootropic Agents|nootropic agents|mesh-ancestor
110212811|NCT00098280|Eculizumab|eculizumab|mesh-list
110212812|NCT00098280|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110212813|NCT00098280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110212814|NCT00098280|Immunologic Factors|immunologic factors|mesh-ancestor
110212815|NCT00098280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110212816|NCT00238459|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110212817|NCT00238459|Vaccines|vaccines|mesh-list
110212818|NCT00238459|Immunologic Factors|immunologic factors|mesh-ancestor
110212819|NCT00238459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110212820|NCT00238459|Antiviral Agents|antiviral agents|mesh-ancestor
110212821|NCT00238459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110212822|NCT00238498|Vildagliptin|vildagliptin|mesh-list
110212823|NCT00238498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110212824|NCT00238498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110212825|NCT00238498|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110212826|NCT00238498|Protease Inhibitors|protease inhibitors|mesh-ancestor
110212827|NCT00238498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110212828|NCT00238498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110212829|NCT00238537|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110212830|NCT00238537|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110212831|NCT00238537|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110212832|NCT00238537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110212833|NCT00098319|Folic Acid|folic acid|mesh-list
110212834|NCT00098319|Hematinics|hematinics|mesh-ancestor
110212835|NCT00098319|Vitamin B Complex|vitamin b complex|mesh-ancestor
110212836|NCT00098319|Vitamins|vitamins|mesh-ancestor
110212837|NCT00098319|Micronutrients|micronutrients|mesh-ancestor
110212838|NCT00098319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110212839|NCT00238732|Bazedoxifene|bazedoxifene|mesh-list
110212840|NCT00238732|Estrogens|estrogens|mesh-list
110212841|NCT00238732|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110212842|NCT00238732|Hormones|hormones|mesh-ancestor
110212843|NCT00238732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110212844|NCT00238732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110212845|NCT00238732|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110212846|NCT00238732|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110212847|NCT00238732|Hormone Antagonists|hormone antagonists|mesh-ancestor
110212848|NCT00238732|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110212849|NCT00238849|Oxaliplatin|oxaliplatin|mesh-list
110212850|NCT00238849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110212851|NCT00238927|Fluticasone|fluticasone|mesh-list
110212852|NCT00238927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110212853|NCT00238927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110212854|NCT00238927|Autonomic Agents|autonomic agents|mesh-ancestor
110212855|NCT00238927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110212856|NCT00238927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110212857|NCT00238927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110212858|NCT00238927|Respiratory System Agents|respiratory system agents|mesh-ancestor
110212859|NCT00238927|Dermatologic Agents|dermatologic agents|mesh-ancestor
110212860|NCT00238927|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110212861|NCT00065624|Thioctic Acid|thioctic acid|mesh-list
110212862|NCT00065624|Antioxidants|antioxidants|mesh-ancestor
110212863|NCT00065624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110212864|NCT00065624|Protective Agents|protective agents|mesh-ancestor
110212865|NCT00065624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110212866|NCT00065624|Vitamin B Complex|vitamin b complex|mesh-ancestor
110212868|NCT00065624|Micronutrients|micronutrients|mesh-ancestor
110212869|NCT00238966|Mycophenolic Acid|mycophenolic acid|mesh-list
110212870|NCT00238966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110212871|NCT00238966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110212872|NCT00238966|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110212873|NCT00238966|Antitubercular Agents|antitubercular agents|mesh-ancestor
110212874|NCT00238966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110212875|NCT00238966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110212876|NCT00238966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110212877|NCT00238966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110212879|NCT00239044|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110212880|NCT00239044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110212881|NCT00239044|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110212882|NCT00239044|Antitubercular Agents|antitubercular agents|mesh-ancestor
110212883|NCT00239044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110212884|NCT00239044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110212885|NCT00239044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110212886|NCT00239044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110212888|NCT00098358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110212889|NCT00098358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110212890|NCT00098358|Analgesics|analgesics|mesh-ancestor
110212891|NCT00098358|Sensory System Agents|sensory system agents|mesh-ancestor
110212892|NCT00098358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110212893|NCT00098358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110212894|NCT00098358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110212895|NCT00098358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110212896|NCT00098358|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110212897|NCT00098358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110212898|NCT00098358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110212899|NCT00098358|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110212900|NCT00098358|Hormone Antagonists|hormone antagonists|mesh-ancestor
110212901|NCT00098358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110212902|NCT00239083|Mycophenolic Acid|mycophenolic acid|mesh-list
110212903|NCT00239083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110212904|NCT00239083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110212905|NCT00239083|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110212906|NCT00239083|Antitubercular Agents|antitubercular agents|mesh-ancestor
110212907|NCT00239083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110212908|NCT00239083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110212909|NCT00239083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110212910|NCT00239083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110212912|NCT00239161|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110212913|NCT00239161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110212914|NCT00239161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110212915|NCT00239161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110212916|NCT00239161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110212917|NCT00239161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110235775|NCT00089258|Isotretinoin|isotretinoin|mesh-list
110212918|NCT00239161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110212919|NCT00239161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110212920|NCT00239161|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110212921|NCT00239161|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110212923|NCT00239200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110212924|NCT00239200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110212925|NCT00239200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110212926|NCT00239200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110212927|NCT02961829|Niacinamide|niacinamide|mesh-list
110212928|NCT02961829|Dolutegravir|dolutegravir|mesh-list
110212929|NCT02961829|Maraviroc|maraviroc|mesh-list
110212930|NCT02961829|Auranofin|auranofin|mesh-list
110212931|NCT02961829|Vaccines|vaccines|mesh-list
110212932|NCT02961829|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
110212933|NCT02961829|Immunologic Factors|immunologic factors|mesh-ancestor
110212934|NCT02961829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110212935|NCT02961829|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110212936|NCT02961829|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110212937|NCT02961829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110212938|NCT02961829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110212939|NCT02961829|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110212940|NCT02961829|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110212941|NCT02961829|Antiviral Agents|antiviral agents|mesh-ancestor
110212942|NCT02961829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110212943|NCT02961829|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110212944|NCT02961829|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110212945|NCT02961829|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110212946|NCT02961829|Vitamin B Complex|vitamin b complex|mesh-ancestor
110212947|NCT02961829|Vitamins|vitamins|mesh-ancestor
110212948|NCT02961829|Micronutrients|micronutrients|mesh-ancestor
110212949|NCT02961829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110212950|NCT00239239|Darbepoetin alfa|darbepoetin alfa|mesh-list
110212951|NCT00239239|Hematinics|hematinics|mesh-ancestor
110212952|NCT00414349|Analgesics|analgesics|mesh-list
110212953|NCT00414349|Sensory System Agents|sensory system agents|mesh-ancestor
110212954|NCT00414349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110212955|NCT00414349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110212956|NCT00065741|Silymarin|silymarin|mesh-list
110212957|NCT00065741|Antioxidants|antioxidants|mesh-ancestor
110212958|NCT00065741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110212959|NCT00065741|Protective Agents|protective agents|mesh-ancestor
110212960|NCT00065741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110212961|NCT00098397|Romidepsin|romidepsin|mesh-list
110212962|NCT00098397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110212963|NCT00098397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110212964|NCT00098397|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110212965|NCT00098397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110212966|NCT00098397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110212967|NCT00239278|Prednisolone|prednisolone|mesh-list
110212968|NCT00239278|Budesonide|budesonide|mesh-list
110212969|NCT00239278|Formoterol Fumarate|formoterol fumarate|mesh-list
110212970|NCT00239278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110212971|NCT00239278|Glucocorticoids|glucocorticoids|mesh-ancestor
110212972|NCT00239278|Hormones|hormones|mesh-ancestor
110212973|NCT00239278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110212974|NCT00239278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110212975|NCT00239278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110212976|NCT00239278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110212977|NCT00239278|Autonomic Agents|autonomic agents|mesh-ancestor
110212978|NCT00239278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110212979|NCT00239278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110212980|NCT00239278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110212981|NCT00239278|Respiratory System Agents|respiratory system agents|mesh-ancestor
110212982|NCT00239278|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110212983|NCT00239278|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110212984|NCT00239278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110212986|NCT00239278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110212987|NCT00239278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110212988|NCT00239395|Meloxicam|meloxicam|mesh-list
110212989|NCT00239395|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110212990|NCT00239395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110212991|NCT00239395|Analgesics|analgesics|mesh-ancestor
110212992|NCT00239395|Sensory System Agents|sensory system agents|mesh-ancestor
110212993|NCT00239395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110212994|NCT00239395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110212995|NCT00239395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110212996|NCT00239395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110212997|NCT00239395|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110212998|NCT00239395|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110212999|NCT00239395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110213000|NCT00239395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213001|NCT00076635|Interferons|interferons|mesh-list
110213002|NCT00076635|Interferon-gamma|interferon-gamma|mesh-list
110213003|NCT00076635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110213004|NCT00076635|Antiviral Agents|antiviral agents|mesh-ancestor
110213005|NCT00076635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110213006|NCT00239434|Bromides|bromides|mesh-list
110213007|NCT00239434|Tiotropium Bromide|tiotropium bromide|mesh-list
110213008|NCT00239434|Ipratropium|ipratropium|mesh-list
110213009|NCT00239434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110213010|NCT00239434|Autonomic Agents|autonomic agents|mesh-ancestor
110213011|NCT00239434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110213012|NCT00239434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213013|NCT00239434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110213014|NCT00239434|Respiratory System Agents|respiratory system agents|mesh-ancestor
110213015|NCT00239434|Parasympatholytics|parasympatholytics|mesh-ancestor
110213016|NCT00239434|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110213017|NCT00239434|Cholinergic Agents|cholinergic agents|mesh-ancestor
110213018|NCT00239434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110213019|NCT00239434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213020|NCT00239434|Anticonvulsants|anticonvulsants|mesh-ancestor
110213021|NCT00239473|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110213022|NCT00239473|Tiotropium Bromide|tiotropium bromide|mesh-list
110213023|NCT00239473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110213024|NCT00239473|Autonomic Agents|autonomic agents|mesh-ancestor
110213025|NCT00239473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110213026|NCT00239473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213027|NCT00239473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110213028|NCT00239473|Respiratory System Agents|respiratory system agents|mesh-ancestor
110213029|NCT00239473|Parasympatholytics|parasympatholytics|mesh-ancestor
110213030|NCT00239473|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110213031|NCT00239473|Cholinergic Agents|cholinergic agents|mesh-ancestor
110213032|NCT00239473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110213033|NCT00239473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213034|NCT00239512|Ibuprofen|ibuprofen|mesh-list
110213035|NCT00239512|Indomethacin|indomethacin|mesh-list
110213036|NCT00239512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110213037|NCT00239512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110213038|NCT00239512|Analgesics|analgesics|mesh-ancestor
110213039|NCT00239512|Sensory System Agents|sensory system agents|mesh-ancestor
110213040|NCT00239512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110213041|NCT00239512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213042|NCT00239512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110213043|NCT00239512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110213044|NCT00239512|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110213045|NCT00239512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110213046|NCT00239512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213047|NCT00239512|Gout Suppressants|gout suppressants|mesh-ancestor
110213048|NCT00239512|Tocolytic Agents|tocolytic agents|mesh-ancestor
110213049|NCT00239512|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110213050|NCT00076674|Levodopa|levodopa|mesh-list
110213051|NCT00076674|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110213052|NCT00076674|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110213053|NCT00076674|Dopamine Agents|dopamine agents|mesh-ancestor
110213054|NCT00076674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110213055|NCT00076674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213056|NCT00076674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213057|NCT00239551|Lansoprazole|lansoprazole|mesh-list
110213058|NCT00239551|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110213059|NCT00239551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110213060|NCT00239551|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110213061|NCT00239551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110213062|NCT00239551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213063|NCT00239629|Teriparatide|teriparatide|mesh-list
110213064|NCT00239629|Strontium ranelate|strontium ranelate|mesh-list
110213065|NCT00239629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110213066|NCT00239629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213067|NCT00239629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110213068|NCT00098436|Temozolomide|temozolomide|mesh-list
110213069|NCT00098436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110213070|NCT00098436|Alkylating Agents|alkylating agents|mesh-ancestor
110213071|NCT00098436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213072|NCT00098436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110213073|NCT00239707|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
110213074|NCT00239707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110213075|NCT00239707|Incretins|incretins|mesh-ancestor
110213076|NCT00239707|Hormones|hormones|mesh-ancestor
110213077|NCT00239707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110213078|NCT00239707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213079|NCT00239746|Ibuprofen|ibuprofen|mesh-list
110213080|NCT00239746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110213081|NCT00239746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110213082|NCT00239746|Analgesics|analgesics|mesh-ancestor
110213083|NCT00239746|Sensory System Agents|sensory system agents|mesh-ancestor
110213084|NCT00239746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110213085|NCT00239746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213086|NCT00239746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110213087|NCT00239746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110213088|NCT00239746|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110213089|NCT00239746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110213090|NCT00239746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213091|NCT00239785|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
110213092|NCT00239785|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110213093|NCT00239785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213094|NCT00239785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110213095|NCT00239785|Immunologic Factors|immunologic factors|mesh-ancestor
110213096|NCT00239785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213097|NCT00239863|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
110213098|NCT00239863|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110213099|NCT00239863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213100|NCT00239863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110213101|NCT00239863|Immunologic Factors|immunologic factors|mesh-ancestor
110213102|NCT00239863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213103|NCT00239902|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
110213104|NCT00239902|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110213105|NCT00239902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213106|NCT00239902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110213107|NCT00239902|Immunologic Factors|immunologic factors|mesh-ancestor
110213108|NCT00239902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213109|NCT00239980|Dalteparin|dalteparin|mesh-list
110213111|NCT00239980|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110213112|NCT00239980|Anticoagulants|anticoagulants|mesh-ancestor
110213113|NCT00239980|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110213114|NCT00239980|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110213115|NCT00239980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213116|NCT00240019|Furosemide|furosemide|mesh-list
110213117|NCT00240019|Diuretics|diuretics|mesh-ancestor
110213118|NCT00240019|Natriuretic Agents|natriuretic agents|mesh-ancestor
110213119|NCT00240019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213120|NCT00240019|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110213121|NCT00240019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110213122|NCT00240019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213123|NCT00240058|Phenylephrine|phenylephrine|mesh-list
110213124|NCT00240058|Oxymetazoline|oxymetazoline|mesh-list
110213125|NCT00240058|Nitric Oxide|nitric oxide|mesh-list
110213126|NCT00240058|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110213127|NCT00240058|Mydriatics|mydriatics|mesh-ancestor
110213128|NCT00240058|Autonomic Agents|autonomic agents|mesh-ancestor
110213129|NCT00240058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110213130|NCT00240058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213131|NCT00240058|Sympathomimetics|sympathomimetics|mesh-ancestor
110213132|NCT00240058|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110213133|NCT00240058|Nasal Decongestants|nasal decongestants|mesh-ancestor
110213134|NCT00240058|Respiratory System Agents|respiratory system agents|mesh-ancestor
110213135|NCT00240058|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110213136|NCT00240058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110213137|NCT00240058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110213138|NCT00240058|Adrenergic Agents|adrenergic agents|mesh-ancestor
110213139|NCT00240058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110213140|NCT00240058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213141|NCT00240058|Protective Agents|protective agents|mesh-ancestor
110213142|NCT00240058|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110213143|NCT00240058|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110213144|NCT00240058|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110213145|NCT00240058|Antioxidants|antioxidants|mesh-ancestor
110213146|NCT00240058|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110213147|NCT00240058|Vasodilator Agents|vasodilator agents|mesh-ancestor
110213148|NCT00240058|Gasotransmitters|gasotransmitters|mesh-ancestor
110213149|NCT00098553|Everolimus|everolimus|mesh-list
110213150|NCT00098553|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110213151|NCT00098553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110213152|NCT00098553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110213153|NCT00098553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213154|NCT00098553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110213155|NCT00098553|Immunologic Factors|immunologic factors|mesh-ancestor
110213156|NCT00098553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213157|NCT00098553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110213158|NCT00240214|Sirolimus|sirolimus|mesh-list
110213159|NCT00240214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110213160|NCT00240214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110213161|NCT00240214|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110213162|NCT00240214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110213163|NCT00240214|Antifungal Agents|antifungal agents|mesh-ancestor
110213164|NCT00240214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110213165|NCT00240214|Immunologic Factors|immunologic factors|mesh-ancestor
110213166|NCT00240214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213167|NCT00240253|Pramlintide|pramlintide|mesh-list
110213168|NCT00240253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110213169|NCT00240253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213170|NCT00065936|Naltrexone|naltrexone|mesh-list
110213171|NCT00065936|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110213172|NCT00065936|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110213173|NCT00065936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213174|NCT00065936|Sensory System Agents|sensory system agents|mesh-ancestor
110213175|NCT00065936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110213176|NCT00240292|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110213177|NCT00240292|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110213178|NCT00240292|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110213179|NCT00240292|Antimetabolites|antimetabolites|mesh-ancestor
110213180|NCT00240292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213181|NCT00240292|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110213182|NCT00240292|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110213183|NCT00240292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110213184|NCT00240409|Pramipexole|pramipexole|mesh-list
110213185|NCT00240409|Bromocriptine|bromocriptine|mesh-list
110213186|NCT00240409|Antioxidants|antioxidants|mesh-ancestor
110213187|NCT00240409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213188|NCT00240409|Protective Agents|protective agents|mesh-ancestor
110213189|NCT00240409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213190|NCT00240409|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110213191|NCT00240409|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110213192|NCT00240409|Dopamine Agonists|dopamine agonists|mesh-ancestor
110213193|NCT00240409|Dopamine Agents|dopamine agents|mesh-ancestor
110213194|NCT00240409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110213195|NCT00240409|Hormone Antagonists|hormone antagonists|mesh-ancestor
110213196|NCT00240409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110213198|NCT00240448|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110213200|NCT00240448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110213201|NCT00240448|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110213202|NCT00240448|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110213203|NCT00240448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213204|NCT00240448|Diuretics|diuretics|mesh-ancestor
110213205|NCT00240448|Natriuretic Agents|natriuretic agents|mesh-ancestor
110213206|NCT00240448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213207|NCT00240448|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110213208|NCT00240448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110213210|NCT00098631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110213211|NCT00098631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110213212|NCT00098631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110213213|NCT00098631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213214|NCT00240604|Rosiglitazone|rosiglitazone|mesh-list
110213215|NCT00240604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110213216|NCT00240604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213217|NCT00076791|Tenofovir|tenofovir|mesh-list
110213218|NCT00076791|Emtricitabine|emtricitabine|mesh-list
110213219|NCT00076791|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110213220|NCT00076791|Antiviral Agents|antiviral agents|mesh-ancestor
110213221|NCT00076791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110213222|NCT00076791|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110213223|NCT00076791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110213224|NCT00076791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110213225|NCT00076791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213226|NCT00076791|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110213227|NCT00076791|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110213228|NCT00240682|Cetuximab|cetuximab|mesh-list
110213229|NCT00240682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110213230|NCT00240682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110213231|NCT00240721|Topiramate|topiramate|mesh-list
110213232|NCT00240721|Anticonvulsants|anticonvulsants|mesh-ancestor
110213233|NCT00240721|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110213234|NCT00240721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213235|NCT00240760|Memantine|memantine|mesh-list
110213236|NCT00240760|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110213237|NCT00240760|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110213238|NCT00240760|Dopamine Agents|dopamine agents|mesh-ancestor
110213239|NCT00240760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110213240|NCT00240760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213241|NCT00240760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213242|NCT00240760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110213243|NCT00240760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110213244|NCT00066092|Lenograstim|lenograstim|mesh-list
110213245|NCT00066092|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110213246|NCT00066092|Immunologic Factors|immunologic factors|mesh-ancestor
110213247|NCT00066092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213248|NCT04720807|Letrozole|letrozole|mesh-list
110213249|NCT04720807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110213250|NCT04720807|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110213251|NCT04720807|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110213252|NCT04720807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110213253|NCT04720807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213254|NCT04720807|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110213255|NCT04720807|Hormone Antagonists|hormone antagonists|mesh-ancestor
110213256|NCT04720807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110235882|NCT00334789|Vitamin A|vitamin a|mesh-list
110213257|NCT04720807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213258|NCT00240799|Acetaminophen|acetaminophen|mesh-list
110213259|NCT00240799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110213260|NCT00240799|Analgesics|analgesics|mesh-ancestor
110213261|NCT00240799|Sensory System Agents|sensory system agents|mesh-ancestor
110213262|NCT00240799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110213263|NCT00240799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213264|NCT00240799|Antipyretics|antipyretics|mesh-ancestor
110213265|NCT00240838|Acetaminophen|acetaminophen|mesh-list
110213266|NCT00240838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110213267|NCT00240838|Analgesics|analgesics|mesh-ancestor
110213268|NCT00240838|Sensory System Agents|sensory system agents|mesh-ancestor
110213269|NCT00240838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110213270|NCT00240838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213271|NCT00240838|Antipyretics|antipyretics|mesh-ancestor
110213272|NCT02965404|Vaccines|vaccines|mesh-list
110213273|NCT02965404|Immunologic Factors|immunologic factors|mesh-ancestor
110213274|NCT02965404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213275|NCT00240955|Mycophenolic Acid|mycophenolic acid|mesh-list
110213276|NCT00240955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110213277|NCT00240955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110213278|NCT00240955|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110213279|NCT00240955|Antitubercular Agents|antitubercular agents|mesh-ancestor
110213280|NCT00240955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110213281|NCT00240955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110213282|NCT00240955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110213283|NCT00240955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213284|NCT00241072|Valsartan|valsartan|mesh-list
110213285|NCT00241072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110213286|NCT00241072|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110213287|NCT00241072|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110213288|NCT00241072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213289|NCT00241111|Zoledronic Acid|zoledronic acid|mesh-list
110213290|NCT00241111|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110213291|NCT00241111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213292|NCT00241150|Valsartan|valsartan|mesh-list
110213293|NCT00241150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110213294|NCT00241150|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110213295|NCT00241150|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110213296|NCT00241150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213297|NCT00076869|Amphotericin B|amphotericin b|mesh-list
110213298|NCT00076869|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110213299|NCT00076869|Caspofungin|caspofungin|mesh-list
110213300|NCT00076869|Amebicides|amebicides|mesh-ancestor
110213301|NCT00076869|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110213302|NCT00076869|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110213303|NCT00076869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110213304|NCT00076869|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110213305|NCT00076869|Antifungal Agents|antifungal agents|mesh-ancestor
110213306|NCT00076869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110213307|NCT00076869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213308|NCT00066248|Cyproheptadine|cyproheptadine|mesh-list
110213309|NCT00066248|Megestrol|megestrol|mesh-list
110213310|NCT00066248|Megestrol Acetate|megestrol acetate|mesh-list
110213311|NCT00066248|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110213312|NCT00066248|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110213313|NCT00066248|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110213314|NCT00066248|Contraceptive Agents|contraceptive agents|mesh-ancestor
110213315|NCT00066248|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110213316|NCT00066248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213317|NCT00066248|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110213318|NCT00066248|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110213319|NCT00066248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110213320|NCT00066248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110213321|NCT00066248|Appetite Stimulants|appetite stimulants|mesh-ancestor
110213322|NCT00066248|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110213323|NCT00066248|Antipruritics|antipruritics|mesh-ancestor
110213324|NCT00066248|Dermatologic Agents|dermatologic agents|mesh-ancestor
110213325|NCT00066248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110213326|NCT00066248|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110213327|NCT00066248|Histamine Antagonists|histamine antagonists|mesh-ancestor
110213328|NCT00066248|Histamine Agents|histamine agents|mesh-ancestor
110213329|NCT00066248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110213330|NCT00066248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213331|NCT00066248|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110213332|NCT00066248|Serotonin Agents|serotonin agents|mesh-ancestor
110213333|NCT00066248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110213335|NCT00241189|Methotrexate|methotrexate|mesh-list
110213336|NCT00241189|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110213337|NCT00241189|Abortifacient Agents|abortifacient agents|mesh-ancestor
110213338|NCT00241189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110213339|NCT00241189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213340|NCT00241189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110213341|NCT00241189|Antimetabolites|antimetabolites|mesh-ancestor
110213342|NCT00241189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213343|NCT00241189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110213344|NCT00241189|Dermatologic Agents|dermatologic agents|mesh-ancestor
110213346|NCT00241189|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110213347|NCT00241189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110213348|NCT00241189|Immunologic Factors|immunologic factors|mesh-ancestor
110213349|NCT00241189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110213350|NCT00241189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110213351|NCT00241189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110213352|NCT00241189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110213353|NCT00241189|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110213354|NCT00241189|Antifungal Agents|antifungal agents|mesh-ancestor
110213355|NCT00066326|Imatinib Mesylate|imatinib mesylate|mesh-list
110213356|NCT00066326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110213357|NCT00066326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110213358|NCT00066326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110213359|NCT00066326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213360|NCT00241345|Valganciclovir|valganciclovir|mesh-list
110213361|NCT00241345|Ganciclovir|ganciclovir|mesh-list
110213362|NCT00241345|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
110213363|NCT00241345|Antiviral Agents|antiviral agents|mesh-ancestor
110213364|NCT00241345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110213365|NCT00241345|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110213366|NCT00241345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110213367|NCT00241345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213368|NCT00241423|Exenatide|exenatide|mesh-list
110213369|NCT00241423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110213370|NCT00241423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213371|NCT00241423|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110213372|NCT00241423|Incretins|incretins|mesh-ancestor
110213373|NCT00241423|Hormones|hormones|mesh-ancestor
110213374|NCT00241423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110213375|NCT00241501|Esomeprazole|esomeprazole|mesh-list
110213376|NCT00241501|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110213377|NCT00241501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110213378|NCT00241501|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110213379|NCT00241501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110213380|NCT00241501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213382|NCT00076986|Pseudomonas aeruginosa exotoxin A|pseudomonas aeruginosa exotoxin a|mesh-list
110213383|NCT00076986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110213384|NCT00076986|Alkylating Agents|alkylating agents|mesh-ancestor
110213385|NCT00076986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213386|NCT00076986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110213387|NCT00241540|Esomeprazole|esomeprazole|mesh-list
110213388|NCT00241540|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110213389|NCT00241540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110213390|NCT00241540|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110213391|NCT00241540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110213392|NCT00241540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213395|NCT00098982|Oxaliplatin|oxaliplatin|mesh-list
110213396|NCT00098982|Bortezomib|bortezomib|mesh-list
110213397|NCT00098982|Calcium|calcium|mesh-list
110213398|NCT00098982|Levoleucovorin|levoleucovorin|mesh-list
110213399|NCT00098982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110213400|NCT00098982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213401|NCT00098982|Antimetabolites|antimetabolites|mesh-ancestor
110213402|NCT00098982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213403|NCT00098982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110213404|NCT00098982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110213405|NCT00098982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110213407|NCT00098982|Antidotes|antidotes|mesh-ancestor
110213408|NCT00098982|Protective Agents|protective agents|mesh-ancestor
110213409|NCT00098982|Vitamin B Complex|vitamin b complex|mesh-ancestor
110213410|NCT00098982|Vitamins|vitamins|mesh-ancestor
110213411|NCT00098982|Micronutrients|micronutrients|mesh-ancestor
110213412|NCT00241618|Interferons|interferons|mesh-list
110213413|NCT00241618|Ribavirin|ribavirin|mesh-list
110213414|NCT00241618|Interferon-alpha|interferon-alpha|mesh-list
110213415|NCT00241618|Interferon alpha-2|interferon alpha-2|mesh-list
110213416|NCT00241618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110213417|NCT00241618|Antiviral Agents|antiviral agents|mesh-ancestor
110213418|NCT00241618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110213419|NCT00241618|Antimetabolites|antimetabolites|mesh-ancestor
110213420|NCT00241618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213421|NCT00241618|Immunologic Factors|immunologic factors|mesh-ancestor
110213422|NCT00241618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213423|NCT00066482|Cyclophosphamide|cyclophosphamide|mesh-list
110213424|NCT00066482|Cisplatin|cisplatin|mesh-list
110213425|NCT00066482|Etoposide|etoposide|mesh-list
110213426|NCT00066482|Bleomycin|bleomycin|mesh-list
110213427|NCT00066482|Lenograstim|lenograstim|mesh-list
110213428|NCT00066482|Mesna|mesna|mesh-list
110213429|NCT00066482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110213430|NCT00066482|Immunologic Factors|immunologic factors|mesh-ancestor
110213431|NCT00066482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213432|NCT00066482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110213433|NCT00066482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110213434|NCT00066482|Alkylating Agents|alkylating agents|mesh-ancestor
110213435|NCT00066482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213436|NCT00066482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110213437|NCT00066482|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110213438|NCT00066482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110213439|NCT00066482|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110213440|NCT00066482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110213442|NCT00066482|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110213443|NCT00066482|Protective Agents|protective agents|mesh-ancestor
110213444|NCT00066482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110213445|NCT00099060|Lapatinib|lapatinib|mesh-list
110213446|NCT00099060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110213447|NCT00099060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110213448|NCT00099060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110213449|NCT00099060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213450|NCT00066599|Voriconazole|voriconazole|mesh-list
110213451|NCT00066599|Antifungal Agents|antifungal agents|mesh-ancestor
110213452|NCT00066599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110213453|NCT00066599|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110213454|NCT00066599|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110213455|NCT00066599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110213456|NCT00066599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213457|NCT00066599|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110213458|NCT00066599|Hormone Antagonists|hormone antagonists|mesh-ancestor
110213459|NCT00066599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110213460|NCT00066599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213461|NCT00066599|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110213462|NCT00242008|Rotigotine|rotigotine|mesh-list
110213463|NCT00242008|Dopamine Agonists|dopamine agonists|mesh-ancestor
110213464|NCT00242008|Dopamine Agents|dopamine agents|mesh-ancestor
110213465|NCT00242008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110213466|NCT00242008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213467|NCT00242008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213468|NCT00242164|Dialysis Solutions|dialysis solutions|mesh-list
110213469|NCT00242164|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110213470|NCT00099177|Zoledronic Acid|zoledronic acid|mesh-list
110213471|NCT00099177|Ibandronic Acid|ibandronic acid|mesh-list
110213472|NCT00099177|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110213473|NCT00099177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213475|NCT02962024|Bupivacaine|bupivacaine|mesh-list
110213476|NCT02962024|Anesthetics, Local|anesthetics, local|mesh-ancestor
110213477|NCT02962024|Anesthetics|anesthetics|mesh-ancestor
110213478|NCT02962024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110213479|NCT02962024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213480|NCT02962024|Sensory System Agents|sensory system agents|mesh-ancestor
110213481|NCT02962024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110213482|NCT02962024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110213483|NCT02962024|Narcotics|narcotics|mesh-ancestor
110213484|NCT02962024|Analgesics|analgesics|mesh-ancestor
110213485|NCT00066638|Romidepsin|romidepsin|mesh-list
110213486|NCT00066638|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110213487|NCT00066638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110213488|NCT00066638|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110213489|NCT00066638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110213490|NCT00066638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213491|NCT00242203|Zoledronic Acid|zoledronic acid|mesh-list
110213492|NCT00242203|Docetaxel|docetaxel|mesh-list
110213493|NCT00242203|Trastuzumab|trastuzumab|mesh-list
110213494|NCT00242203|Epirubicin|epirubicin|mesh-list
110213495|NCT00242203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110213496|NCT00242203|Tubulin Modulators|tubulin modulators|mesh-ancestor
110213497|NCT00242203|Antimitotic Agents|antimitotic agents|mesh-ancestor
110213498|NCT00242203|Mitosis Modulators|mitosis modulators|mesh-ancestor
110213499|NCT00242203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213500|NCT00242203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110213501|NCT00242203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110213502|NCT00242203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110213503|NCT00242203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110213504|NCT00242203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110213505|NCT00242203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110213506|NCT00242203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213507|NCT00077025|Gefitinib|gefitinib|mesh-list
110213508|NCT00077025|Anastrozole|anastrozole|mesh-list
110213509|NCT00077025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110213510|NCT00077025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110213511|NCT00077025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110213512|NCT00077025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213513|NCT00077025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110213514|NCT00077025|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110213515|NCT00077025|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110213516|NCT00077025|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110213517|NCT00077025|Hormone Antagonists|hormone antagonists|mesh-ancestor
110213518|NCT00077025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110213519|NCT00077025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213520|NCT00242359|Omalizumab|omalizumab|mesh-list
110213521|NCT00242359|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110213522|NCT00242359|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110213523|NCT00242359|Respiratory System Agents|respiratory system agents|mesh-ancestor
110213524|NCT00066716|Celecoxib|celecoxib|mesh-list
110213525|NCT00066716|Paclitaxel|paclitaxel|mesh-list
110213526|NCT00066716|Carboplatin|carboplatin|mesh-list
110213527|NCT00066716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110213528|NCT00066716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110213529|NCT00066716|Tubulin Modulators|tubulin modulators|mesh-ancestor
110213530|NCT00066716|Antimitotic Agents|antimitotic agents|mesh-ancestor
110213531|NCT00066716|Mitosis Modulators|mitosis modulators|mesh-ancestor
110213532|NCT00066716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213533|NCT00066716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110213534|NCT00066716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110213535|NCT00066716|Analgesics|analgesics|mesh-ancestor
110213536|NCT00066716|Sensory System Agents|sensory system agents|mesh-ancestor
110213537|NCT00066716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110213538|NCT00066716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213539|NCT00066716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110213540|NCT00066716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110213541|NCT00066716|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110213542|NCT00066716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110213543|NCT00066716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110213544|NCT00077103|Doxorubicin|doxorubicin|mesh-list
110213545|NCT00077103|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110213546|NCT00077103|Fosbretabulin|fosbretabulin|mesh-list
110213547|NCT00077103|Combretastatin|combretastatin|mesh-list
110213548|NCT00077103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110213549|NCT00077103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110213550|NCT00077103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110213551|NCT00077103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110213552|NCT00077103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110213553|NCT00077103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213554|NCT00077103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110213555|NCT00077103|Tubulin Modulators|tubulin modulators|mesh-ancestor
110213556|NCT00077103|Antimitotic Agents|antimitotic agents|mesh-ancestor
110213557|NCT00077103|Mitosis Modulators|mitosis modulators|mesh-ancestor
110213558|NCT00242437|Thrombin|thrombin|mesh-list
110213559|NCT00242437|Hemostatics|hemostatics|mesh-list
110213560|NCT00242437|Coagulants|coagulants|mesh-ancestor
110213561|NCT00066794|Cytarabine|cytarabine|mesh-list
110213562|NCT00066794|Cyclosporine|cyclosporine|mesh-list
110213563|NCT00066794|Daunorubicin|daunorubicin|mesh-list
110213564|NCT00066794|Cyclosporins|cyclosporins|mesh-list
110213565|NCT00066794|Sargramostim|sargramostim|mesh-list
110213566|NCT00066794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110213567|NCT00066794|Antimetabolites|antimetabolites|mesh-ancestor
110213568|NCT00066794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213569|NCT00066794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110213570|NCT00066794|Antiviral Agents|antiviral agents|mesh-ancestor
110213571|NCT00066794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110213572|NCT00066794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110213573|NCT00066794|Immunologic Factors|immunologic factors|mesh-ancestor
110213574|NCT00066794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213575|NCT00066794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110213576|NCT00066794|Antifungal Agents|antifungal agents|mesh-ancestor
110213577|NCT00066794|Dermatologic Agents|dermatologic agents|mesh-ancestor
110213578|NCT00066794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110213579|NCT00066794|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110213580|NCT00066794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110213581|NCT00066794|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110213582|NCT00066794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110213583|NCT00242554|Zoledronic Acid|zoledronic acid|mesh-list
110213584|NCT00242554|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110213585|NCT00242554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213586|NCT00242593|Rosiglitazone|rosiglitazone|mesh-list
110213587|NCT00242593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110213588|NCT00242593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213589|NCT00242749|Gefitinib|gefitinib|mesh-list
110213590|NCT00242749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110213591|NCT00242749|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110213592|NCT00242749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110213593|NCT00242749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213594|NCT00242788|Capecitabine|capecitabine|mesh-list
110213595|NCT00242788|Gefitinib|gefitinib|mesh-list
110213596|NCT00242788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110213597|NCT00242788|Antimetabolites|antimetabolites|mesh-ancestor
110213598|NCT00242788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213599|NCT00242788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110213600|NCT00242788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110213601|NCT00242788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110213602|NCT00066872|Imiquimod|imiquimod|mesh-list
110213603|NCT00066872|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110213604|NCT00066872|Immunologic Factors|immunologic factors|mesh-ancestor
110213605|NCT00066872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213606|NCT00066872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110213607|NCT00066872|Interferon Inducers|interferon inducers|mesh-ancestor
110213608|NCT00242944|Atorvastatin|atorvastatin|mesh-list
110213609|NCT00242944|Pitavastatin|pitavastatin|mesh-list
110213610|NCT00242944|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110213611|NCT00242944|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110213612|NCT00242944|Antimetabolites|antimetabolites|mesh-ancestor
110213613|NCT00242944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213614|NCT00242944|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110213615|NCT00242944|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110213616|NCT00242944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110213617|NCT00243100|Gemcitabine|gemcitabine|mesh-list
110213618|NCT00243100|Vorinostat|vorinostat|mesh-list
110213619|NCT00243100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110213620|NCT00243100|Antimetabolites|antimetabolites|mesh-ancestor
110213621|NCT00243100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213622|NCT00243100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110213623|NCT00243100|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110213624|NCT00243100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110213626|NCT00099216|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110213627|NCT00099216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110213628|NCT00099216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213629|NCT00099216|Cholinergic Agents|cholinergic agents|mesh-ancestor
110213630|NCT00099216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110213631|NCT00099216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213632|NCT00099216|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110213633|NCT00099216|Protective Agents|protective agents|mesh-ancestor
110213634|NCT00066989|Immunoglobulins|immunoglobulins|mesh-list
110213635|NCT00066989|Antibodies|antibodies|mesh-list
110213636|NCT00066989|gamma-Globulins|gamma-globulins|mesh-list
110213637|NCT00066989|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110213638|NCT00066989|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110213639|NCT00066989|Immunologic Factors|immunologic factors|mesh-ancestor
110213640|NCT00066989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213641|NCT00243178|Clopidogrel|clopidogrel|mesh-list
110213642|NCT00243178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110213643|NCT00243178|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110213644|NCT00243178|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110213645|NCT00243178|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110213646|NCT00243178|Purinergic Agents|purinergic agents|mesh-ancestor
110213647|NCT00243178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110213648|NCT00243178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213649|NCT00243178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213650|NCT00243256|Cholecalciferol|cholecalciferol|mesh-list
110213651|NCT00243256|Vitamin D|vitamin d|mesh-list
110213652|NCT00243256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110213653|NCT00243256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213654|NCT00243256|Vitamins|vitamins|mesh-ancestor
110213655|NCT00243256|Micronutrients|micronutrients|mesh-ancestor
110213656|NCT00243256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110213657|NCT00243646|Bicalutamide|bicalutamide|mesh-list
110213658|NCT00243646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213659|NCT00243646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110213660|NCT00243646|Androgen Antagonists|androgen antagonists|mesh-ancestor
110213661|NCT00243646|Hormone Antagonists|hormone antagonists|mesh-ancestor
110213662|NCT00243646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110213663|NCT00099333|Exenatide|exenatide|mesh-list
110213664|NCT00099333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110213665|NCT00099333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213666|NCT00099333|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110213667|NCT00099333|Incretins|incretins|mesh-ancestor
110213668|NCT00099333|Hormones|hormones|mesh-ancestor
110213669|NCT00099333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110213670|NCT00243724|Esomeprazole|esomeprazole|mesh-list
110213671|NCT00243724|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110213672|NCT00243724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110213673|NCT00243724|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110213674|NCT00243724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110213675|NCT00243724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213676|NCT00243880|Lovastatin|lovastatin|mesh-list
110213677|NCT00243880|L 647318|l 647318|mesh-list
110213678|NCT00243880|Dihydromevinolin|dihydromevinolin|mesh-list
110213679|NCT00243880|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110213680|NCT00243880|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110213681|NCT00243880|Antimetabolites|antimetabolites|mesh-ancestor
110213682|NCT00243880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213683|NCT00243880|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110026665|NCT01273974|Vaccines|vaccines|mesh-list
110026680|NCT01276548|genexol-PM|genexol-pm|mesh-list
110213684|NCT00243880|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110213685|NCT00243880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110213686|NCT00244075|Hormones|hormones|mesh-list
110213687|NCT00244075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110213688|NCT00244075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213689|NCT00244153|Dexamethasone|dexamethasone|mesh-list
110213690|NCT00244153|Morphine|morphine|mesh-list
110213691|NCT00244153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110213692|NCT00244153|Antiemetics|antiemetics|mesh-ancestor
110213693|NCT00244153|Autonomic Agents|autonomic agents|mesh-ancestor
110213694|NCT00244153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110236102|NCT00343486|Solabegron|solabegron|mesh-list
110213695|NCT00244153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213696|NCT00244153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110213697|NCT00244153|Glucocorticoids|glucocorticoids|mesh-ancestor
110213698|NCT00244153|Hormones|hormones|mesh-ancestor
110213699|NCT00244153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110213701|NCT00244153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110213702|NCT00244153|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110213703|NCT00244153|Narcotics|narcotics|mesh-ancestor
110213704|NCT00244153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110213705|NCT00244153|Analgesics|analgesics|mesh-ancestor
110213706|NCT00244153|Sensory System Agents|sensory system agents|mesh-ancestor
110213707|NCT02967029|Remifentanil|remifentanil|mesh-list
110213708|NCT02967029|Esmolol|esmolol|mesh-list
110213709|NCT02967029|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110213710|NCT02967029|Narcotics|narcotics|mesh-ancestor
110213711|NCT02967029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110213712|NCT02967029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213713|NCT02967029|Analgesics|analgesics|mesh-ancestor
110213714|NCT02967029|Sensory System Agents|sensory system agents|mesh-ancestor
110213715|NCT02967029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110213716|NCT02967029|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110213717|NCT02967029|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110213718|NCT02967029|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110213719|NCT02967029|Adrenergic Agents|adrenergic agents|mesh-ancestor
110213720|NCT02967029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110213721|NCT02967029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213722|NCT00244192|Infliximab|infliximab|mesh-list
110213723|NCT00244192|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110213724|NCT00244192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110213725|NCT00244192|Dermatologic Agents|dermatologic agents|mesh-ancestor
110213726|NCT00244192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110213727|NCT00244192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110213728|NCT00077181|Cytarabine|cytarabine|mesh-list
110213729|NCT00077181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110213730|NCT00077181|Antimetabolites|antimetabolites|mesh-ancestor
110213731|NCT00077181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213732|NCT00077181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110213733|NCT00077181|Antiviral Agents|antiviral agents|mesh-ancestor
110213734|NCT00077181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110213735|NCT00077181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110213736|NCT00077181|Immunologic Factors|immunologic factors|mesh-ancestor
110213737|NCT00077181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213738|NCT00244309|Tamsulosin|tamsulosin|mesh-list
110213739|NCT00244309|Dutasteride|dutasteride|mesh-list
110213740|NCT00244309|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110213741|NCT00244309|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110213742|NCT00244309|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110213743|NCT00244309|Adrenergic Agents|adrenergic agents|mesh-ancestor
110213744|NCT00244309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110213745|NCT00244309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213746|NCT00244309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213747|NCT00244309|Urological Agents|urological agents|mesh-ancestor
110213748|NCT00244309|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110213749|NCT00244309|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110213751|NCT00244309|Hormone Antagonists|hormone antagonists|mesh-ancestor
110213752|NCT00244309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110213753|NCT00244348|Fluorouracil|fluorouracil|mesh-list
110213754|NCT00244348|Oxaliplatin|oxaliplatin|mesh-list
110213755|NCT00244348|Antimetabolites|antimetabolites|mesh-ancestor
110213756|NCT00244348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213757|NCT00244348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110213758|NCT00244348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110213759|NCT00244348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110213760|NCT00244348|Immunologic Factors|immunologic factors|mesh-ancestor
110213761|NCT00244348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213763|NCT00077220|Carboplatin|carboplatin|mesh-list
110213764|NCT00077220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110213765|NCT00077220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110213766|NCT00077220|Tubulin Modulators|tubulin modulators|mesh-ancestor
110213767|NCT00077220|Antimitotic Agents|antimitotic agents|mesh-ancestor
110213768|NCT00077220|Mitosis Modulators|mitosis modulators|mesh-ancestor
110213769|NCT00077220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213770|NCT00244426|Aspirin|aspirin|mesh-list
110213771|NCT00244426|Indobufen|indobufen|mesh-list
110213772|NCT00244426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110213773|NCT00244426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110213775|NCT00244426|Sensory System Agents|sensory system agents|mesh-ancestor
110213776|NCT00244426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110213777|NCT00244426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213778|NCT00244426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110213779|NCT00244426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110213780|NCT00244426|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110213781|NCT00244426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110213782|NCT00244426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213783|NCT00244426|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110213784|NCT00244426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110213785|NCT00244426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110213786|NCT00244426|Antipyretics|antipyretics|mesh-ancestor
110213787|NCT00398957|Naltrexone|naltrexone|mesh-list
110213788|NCT00398957|Hydromorphone|hydromorphone|mesh-list
110213789|NCT00398957|Narcotic Antagonists|narcotic antagonists|mesh-list
110213790|NCT00398957|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110213791|NCT00398957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213792|NCT00398957|Sensory System Agents|sensory system agents|mesh-ancestor
110213793|NCT00398957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110213794|NCT00398957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110213796|NCT00398957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110213797|NCT00398957|Analgesics|analgesics|mesh-ancestor
110213798|NCT00099450|INS 50589|ins 50589|mesh-list
110213799|NCT00099450|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110213800|NCT00099450|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110213801|NCT00099450|Purinergic Agents|purinergic agents|mesh-ancestor
110213802|NCT00099450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110213803|NCT00099450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213804|NCT00099450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213805|NCT00244504|Moxonidine|moxonidine|mesh-list
110213806|NCT00244504|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110213807|NCT00099489|Interferons|interferons|mesh-list
110213808|NCT00099489|Interferon-beta|interferon-beta|mesh-list
110213809|NCT00099489|Interferon beta-1a|interferon beta-1a|mesh-list
110213810|NCT00099489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110213811|NCT00099489|Antiviral Agents|antiviral agents|mesh-ancestor
110213812|NCT00099489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110213813|NCT00099489|Immunologic Factors|immunologic factors|mesh-ancestor
110213814|NCT00099489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213815|NCT00099489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110213816|NCT00067262|Valproic Acid|valproic acid|mesh-list
110213817|NCT00067262|Anticonvulsants|anticonvulsants|mesh-ancestor
110213818|NCT00067262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110213819|NCT00067262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213820|NCT00067262|GABA Agents|gaba agents|mesh-ancestor
110213821|NCT00067262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110213822|NCT00067262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213823|NCT00067262|Antimanic Agents|antimanic agents|mesh-ancestor
110213824|NCT00067262|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110213825|NCT00067262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110213826|NCT00067262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110213827|NCT00244738|Castor Oil|castor oil|mesh-list
110213828|NCT00244738|Cathartics|cathartics|mesh-ancestor
110213829|NCT00244738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110213830|NCT00077259|Epothilones|epothilones|mesh-list
110213831|NCT00077259|Desoxyepothilone B|desoxyepothilone b|mesh-list
110213832|NCT00077259|Tubulin Modulators|tubulin modulators|mesh-ancestor
110213833|NCT00077259|Antimitotic Agents|antimitotic agents|mesh-ancestor
110213834|NCT00077259|Mitosis Modulators|mitosis modulators|mesh-ancestor
110213835|NCT00077259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213836|NCT00077259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110213837|NCT00067301|Citalopram|citalopram|mesh-list
110213838|NCT00067301|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110213839|NCT00067301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110213840|NCT00067301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110213841|NCT00067301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213842|NCT00067301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110213843|NCT00067301|Serotonin Agents|serotonin agents|mesh-ancestor
110213844|NCT00067301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213845|NCT00067301|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110213846|NCT00067301|Antidepressive Agents|antidepressive agents|mesh-ancestor
110213847|NCT00067301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110213849|NCT00244972|Tipifarnib|tipifarnib|mesh-list
110213850|NCT00244972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110213851|NCT00244972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110213852|NCT00244972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110213853|NCT00244972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213854|NCT00245089|Dactinomycin|dactinomycin|mesh-list
110213855|NCT00245089|Cyclophosphamide|cyclophosphamide|mesh-list
110213856|NCT00245089|Vincristine|vincristine|mesh-list
110213857|NCT00245089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110213858|NCT00245089|Immunologic Factors|immunologic factors|mesh-ancestor
110213859|NCT00245089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213860|NCT00245089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110213861|NCT00245089|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110213862|NCT00245089|Alkylating Agents|alkylating agents|mesh-ancestor
110213863|NCT00245089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213864|NCT00245089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110213865|NCT00245089|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110236169|NCT00343876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110213867|NCT00245089|Tubulin Modulators|tubulin modulators|mesh-ancestor
110213868|NCT00245089|Antimitotic Agents|antimitotic agents|mesh-ancestor
110213869|NCT00245089|Mitosis Modulators|mitosis modulators|mesh-ancestor
110213870|NCT00245089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110213871|NCT00245089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110213872|NCT00245089|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110213873|NCT00245089|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110213874|NCT00245089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110213875|NCT00245089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110213876|NCT00067340|Chlorhexidine|chlorhexidine|mesh-list
110213877|NCT00067340|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110213878|NCT00067340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110213879|NCT00067340|Disinfectants|disinfectants|mesh-ancestor
110213880|NCT00245206|Olanzapine|olanzapine|mesh-list
110213881|NCT00245206|Risperidone|risperidone|mesh-list
110213882|NCT00245206|Aripiprazole|aripiprazole|mesh-list
110213883|NCT00245206|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110213884|NCT00245206|Serotonin Agents|serotonin agents|mesh-ancestor
110213885|NCT00245206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110213886|NCT00245206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213887|NCT00245206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213888|NCT00245206|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110213889|NCT00245206|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110213890|NCT00245206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110213891|NCT00245206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110213892|NCT00245206|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110213893|NCT00245206|Dopamine Agents|dopamine agents|mesh-ancestor
110213894|NCT00245206|Antiemetics|antiemetics|mesh-ancestor
110213895|NCT00245206|Autonomic Agents|autonomic agents|mesh-ancestor
110213896|NCT00245206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110213897|NCT00245206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110213898|NCT00245206|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110213899|NCT00245206|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110213900|NCT00245206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110213901|NCT00245206|Antidepressive Agents|antidepressive agents|mesh-ancestor
110213902|NCT00245206|Dopamine Agonists|dopamine agonists|mesh-ancestor
110213903|NCT00245206|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110213904|NCT00245206|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110213905|NCT00245206|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110213906|NCT00245206|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110213908|NCT00245245|Coagulants|coagulants|mesh-ancestor
110213909|NCT00077298|Bevacizumab|bevacizumab|mesh-list
110213910|NCT00077298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110213911|NCT00077298|Cetuximab|cetuximab|mesh-list
110213912|NCT00077298|Irinotecan|irinotecan|mesh-list
110213913|NCT00077298|Antibodies|antibodies|mesh-list
110213914|NCT00077298|Immunoglobulins|immunoglobulins|mesh-list
110213915|NCT00077298|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110213916|NCT00077298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110213917|NCT00077298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110213918|NCT00077298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110213919|NCT00077298|Growth Substances|growth substances|mesh-ancestor
110213920|NCT00077298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213921|NCT00077298|Growth Inhibitors|growth inhibitors|mesh-ancestor
110213922|NCT00077298|Immunologic Factors|immunologic factors|mesh-ancestor
110213923|NCT00077298|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110213924|NCT00077298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110213925|NCT00077298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110213926|NCT00077298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213928|NCT00245401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110213929|NCT00245401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110213930|NCT00245401|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110213931|NCT00245401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110213932|NCT00245401|Antifungal Agents|antifungal agents|mesh-ancestor
110213933|NCT00245401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110213934|NCT00245401|Immunologic Factors|immunologic factors|mesh-ancestor
110213935|NCT00245401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213936|NCT00245440|Azithromycin|azithromycin|mesh-list
110213937|NCT00245440|Telithromycin|telithromycin|mesh-list
110213938|NCT00245440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110213939|NCT00245440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110213940|NCT00400608|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110213941|NCT00400608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110213942|NCT00400608|Autonomic Agents|autonomic agents|mesh-ancestor
110213943|NCT00400608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110213944|NCT00400608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213945|NCT00400608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110213946|NCT00400608|Respiratory System Agents|respiratory system agents|mesh-ancestor
110213947|NCT00400608|Glucocorticoids|glucocorticoids|mesh-ancestor
110213948|NCT00400608|Hormones|hormones|mesh-ancestor
110213949|NCT00400608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110213950|NCT00400608|Sympathomimetics|sympathomimetics|mesh-ancestor
110213951|NCT00245596|Sildenafil Citrate|sildenafil citrate|mesh-list
110213952|NCT00245596|Vasodilator Agents|vasodilator agents|mesh-ancestor
110213953|NCT00245596|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110213954|NCT00245596|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110213955|NCT00245596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110213956|NCT00245596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213957|NCT00245596|Urological Agents|urological agents|mesh-ancestor
110213958|NCT00245674|Amisulpride|amisulpride|mesh-list
110213959|NCT00245674|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110213960|NCT00245674|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110213961|NCT00245674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110213962|NCT00245674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213963|NCT00245674|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110213964|NCT00245674|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110213965|NCT00245674|Dopamine Agents|dopamine agents|mesh-ancestor
110213966|NCT00245674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110213967|NCT00245674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213968|NCT00245674|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110213969|NCT00245674|Antidepressive Agents|antidepressive agents|mesh-ancestor
110213970|NCT00245713|Levetiracetam|levetiracetam|mesh-list
110213971|NCT00245713|Anticonvulsants|anticonvulsants|mesh-ancestor
110213972|NCT00245713|Nootropic Agents|nootropic agents|mesh-ancestor
110213973|NCT00067457|Alosetron|alosetron|mesh-list
110213974|NCT00067457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110213975|NCT00067457|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110213976|NCT00067457|Serotonin Agents|serotonin agents|mesh-ancestor
110213977|NCT00067457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110213978|NCT00067457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213979|NCT00067457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213980|NCT00102843|Folic Acid|folic acid|mesh-list
110213981|NCT00102843|Betaine|betaine|mesh-list
110213982|NCT00102843|Hematinics|hematinics|mesh-ancestor
110213983|NCT00102843|Vitamin B Complex|vitamin b complex|mesh-ancestor
110213985|NCT00102843|Micronutrients|micronutrients|mesh-ancestor
110213986|NCT00102843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213987|NCT00102843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110213988|NCT00102843|Lipotropic Agents|lipotropic agents|mesh-ancestor
110213989|NCT00102843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110213990|NCT00102843|Antimetabolites|antimetabolites|mesh-ancestor
110213991|NCT00102843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110213992|NCT00102843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110213993|NCT00245791|Levofloxacin|levofloxacin|mesh-list
110213994|NCT00245791|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110213995|NCT00245791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110213996|NCT00245791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110213997|NCT00245791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110213998|NCT00245791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110213999|NCT00245791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110214000|NCT00245791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214001|NCT00245791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110214002|NCT00245791|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110214003|NCT00245791|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110214004|NCT00400647|Mycophenolic Acid|mycophenolic acid|mesh-list
110214005|NCT00400647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110214006|NCT00400647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110214007|NCT00400647|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110214008|NCT00400647|Antitubercular Agents|antitubercular agents|mesh-ancestor
110214009|NCT00400647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110214010|NCT00400647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110214011|NCT00400647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110214012|NCT00400647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214013|NCT00245908|Azithromycin|azithromycin|mesh-list
110214014|NCT00245908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110214015|NCT00245908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110214016|NCT00067496|Modafinil|modafinil|mesh-list
110214017|NCT00067496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110214018|NCT00067496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214019|NCT00067496|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110214020|NCT00067496|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110214021|NCT00067496|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110214022|NCT00067496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214024|NCT00246064|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110214025|NCT00246064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110214026|NCT00246064|Dermatologic Agents|dermatologic agents|mesh-ancestor
110214027|NCT00246064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110214028|NCT00246064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110214029|NCT00246103|Cyclophosphamide|cyclophosphamide|mesh-list
110214030|NCT00246103|Fluorouracil|fluorouracil|mesh-list
110214031|NCT00246103|Epirubicin|epirubicin|mesh-list
110214032|NCT00246103|Valproic Acid|valproic acid|mesh-list
110214033|NCT00246103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110214034|NCT00246103|Immunologic Factors|immunologic factors|mesh-ancestor
110214035|NCT00246103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214036|NCT00246103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110214037|NCT00246103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110214038|NCT00246103|Alkylating Agents|alkylating agents|mesh-ancestor
110214039|NCT00246103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214040|NCT00246103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110214041|NCT00246103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110214042|NCT00246103|Antimetabolites|antimetabolites|mesh-ancestor
110214043|NCT00246103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110214044|NCT00246103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110214045|NCT00246103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110214046|NCT00246103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110214047|NCT00246103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110214048|NCT00246103|Anticonvulsants|anticonvulsants|mesh-ancestor
110214049|NCT00246103|GABA Agents|gaba agents|mesh-ancestor
110214050|NCT00246103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110214051|NCT00246103|Antimanic Agents|antimanic agents|mesh-ancestor
110214052|NCT00246103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110214053|NCT00246103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110214054|NCT00246103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110214055|NCT00246142|Botulinum Toxins|botulinum toxins|mesh-list
110214056|NCT00246142|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110214057|NCT00246142|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110214058|NCT00246142|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110214059|NCT00246142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110214060|NCT00246142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214061|NCT00246142|Cholinergic Agents|cholinergic agents|mesh-ancestor
110214062|NCT00246142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110214063|NCT00246142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026781|NCT01275144|Lorazepam|lorazepam|mesh-list
110214064|NCT00246142|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110214065|NCT00246142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110214067|NCT00067535|Anesthetics, Local|anesthetics, local|mesh-ancestor
110214069|NCT00067535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110214070|NCT00067535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214071|NCT00067535|Sensory System Agents|sensory system agents|mesh-ancestor
110214072|NCT00067535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110214073|NCT00067535|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110214074|NCT00067535|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110214075|NCT00067535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110214076|NCT00067535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110214077|NCT00067535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214078|NCT00067535|Dopamine Agents|dopamine agents|mesh-ancestor
110214079|NCT00067535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110214080|NCT00102882|Fluticasone|fluticasone|mesh-list
110214081|NCT00102882|Xhance|xhance|mesh-list
110214082|NCT00102882|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110214083|NCT00102882|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110214084|NCT00102882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110214085|NCT00102882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110214086|NCT00102882|Autonomic Agents|autonomic agents|mesh-ancestor
110214087|NCT00102882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110214088|NCT00102882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214089|NCT00102882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110214090|NCT00102882|Respiratory System Agents|respiratory system agents|mesh-ancestor
110214091|NCT00102882|Dermatologic Agents|dermatologic agents|mesh-ancestor
110214092|NCT00102882|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110214093|NCT00102882|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110214094|NCT00102882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110214095|NCT00102882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110214096|NCT00102882|Adrenergic Agents|adrenergic agents|mesh-ancestor
110214097|NCT00102882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110214098|NCT00102882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214099|NCT00102882|Glucocorticoids|glucocorticoids|mesh-ancestor
110214101|NCT00102882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110214102|NCT00102882|Sympathomimetics|sympathomimetics|mesh-ancestor
110214103|NCT00246220|Methylphenidate|methylphenidate|mesh-list
110214104|NCT00246220|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110214105|NCT00246220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214106|NCT00246220|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110214107|NCT00246220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110214108|NCT00246220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110214109|NCT00246220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214110|NCT00246220|Dopamine Agents|dopamine agents|mesh-ancestor
110214111|NCT00246220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110214112|NCT00424801|Nicorandil|nicorandil|mesh-list
110214113|NCT00424801|Valsartan|valsartan|mesh-list
110214114|NCT00424801|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110214115|NCT00424801|Doxazosin|doxazosin|mesh-list
110214116|NCT00424801|Lercanidipine|lercanidipine|mesh-list
110214117|NCT00424801|Pindolol|pindolol|mesh-list
110214118|NCT00424801|Moxonidine|moxonidine|mesh-list
110214119|NCT00424801|Amiloride|amiloride|mesh-list
110214120|NCT00424801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110214121|NCT00424801|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110214122|NCT00424801|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110214123|NCT00424801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214124|NCT00424801|Diuretics|diuretics|mesh-ancestor
110214125|NCT00424801|Natriuretic Agents|natriuretic agents|mesh-ancestor
110214126|NCT00424801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214127|NCT00424801|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110214128|NCT00424801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110214129|NCT00424801|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
110214130|NCT00424801|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110214131|NCT00424801|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
110214132|NCT00424801|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110214133|NCT00424801|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110214134|NCT00424801|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110214135|NCT00424801|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110214136|NCT00424801|Adrenergic Agents|adrenergic agents|mesh-ancestor
110214137|NCT00424801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110214138|NCT00424801|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110214139|NCT00424801|Vasodilator Agents|vasodilator agents|mesh-ancestor
110214140|NCT00424801|Vitamin B Complex|vitamin b complex|mesh-ancestor
110214142|NCT00424801|Micronutrients|micronutrients|mesh-ancestor
110214143|NCT00424801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110214144|NCT00424801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110214145|NCT00424801|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110214146|NCT00424801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110214147|NCT00424801|Serotonin Agents|serotonin agents|mesh-ancestor
110214148|NCT00246298|Epoetin Alfa|epoetin alfa|mesh-list
110214149|NCT00246298|Hematinics|hematinics|mesh-ancestor
110214150|NCT00246415|Memantine|memantine|mesh-list
110214151|NCT00246415|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110214152|NCT00246415|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110214153|NCT00246415|Dopamine Agents|dopamine agents|mesh-ancestor
110214154|NCT00246415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110214155|NCT00246415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214156|NCT00246415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214157|NCT00246415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110214158|NCT00246415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110214159|NCT00246532|Morphine|morphine|mesh-list
110214160|NCT00246532|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110214161|NCT00246532|Narcotics|narcotics|mesh-ancestor
110214162|NCT00246532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110214163|NCT00246532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214164|NCT00246532|Analgesics|analgesics|mesh-ancestor
110214165|NCT00246532|Sensory System Agents|sensory system agents|mesh-ancestor
110214166|NCT00246532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110214167|NCT00246610|Nelfinavir|nelfinavir|mesh-list
110214168|NCT00246610|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110214169|NCT00246610|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110214170|NCT00246610|Protease Inhibitors|protease inhibitors|mesh-ancestor
110214171|NCT00246610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110214172|NCT00246610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214173|NCT00246610|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110214174|NCT00246610|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110214175|NCT00246610|Antiviral Agents|antiviral agents|mesh-ancestor
110214176|NCT00246610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110214177|NCT00246688|Sagopilone|sagopilone|mesh-list
110214178|NCT00246688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110214179|NCT04728516|Amoxicillin|amoxicillin|mesh-list
110214180|NCT04728516|Pantoprazole|pantoprazole|mesh-list
110236316|NCT00127998|Artesunate|artesunate|mesh-list
110214181|NCT04728516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110214182|NCT04728516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110214183|NCT04728516|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110214184|NCT04728516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110214185|NCT04728516|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110214186|NCT04728516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110214187|NCT04728516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214188|NCT00400998|Fluticasone|fluticasone|mesh-list
110214189|NCT00400998|Xhance|xhance|mesh-list
110214190|NCT00400998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110214191|NCT00400998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110214192|NCT00400998|Autonomic Agents|autonomic agents|mesh-ancestor
110214193|NCT00400998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110214194|NCT00400998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214195|NCT00400998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110214196|NCT00400998|Respiratory System Agents|respiratory system agents|mesh-ancestor
110214197|NCT00400998|Dermatologic Agents|dermatologic agents|mesh-ancestor
110214199|NCT00247078|Antivenins|antivenins|mesh-list
110214200|NCT00247078|Immunologic Factors|immunologic factors|mesh-ancestor
110214201|NCT00247078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214202|NCT00247117|Metformin|metformin|mesh-list
110214203|NCT00247117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110214204|NCT00247117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214205|NCT00099606|Dasatinib|dasatinib|mesh-list
110214206|NCT00099606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110214207|NCT00099606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110214208|NCT00099606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110214209|NCT00099606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214210|NCT00247507|Acetylcysteine|acetylcysteine|mesh-list
110214211|NCT00247507|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110214212|NCT00247507|Antiviral Agents|antiviral agents|mesh-ancestor
110214213|NCT00247507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110214214|NCT00247507|Expectorants|expectorants|mesh-ancestor
110214215|NCT00247507|Respiratory System Agents|respiratory system agents|mesh-ancestor
110214216|NCT00247507|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110214217|NCT00247507|Antioxidants|antioxidants|mesh-ancestor
110214218|NCT00247507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214219|NCT00247507|Protective Agents|protective agents|mesh-ancestor
110214220|NCT00247507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214221|NCT00247507|Antidotes|antidotes|mesh-ancestor
110214222|NCT00247585|Ethanol|ethanol|mesh-list
110214223|NCT00247585|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110214224|NCT00247585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110214225|NCT00247585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110214226|NCT00247585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214227|NCT00099645|Mifepristone|mifepristone|mesh-list
110214228|NCT00099645|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110214229|NCT00099645|Abortifacient Agents|abortifacient agents|mesh-ancestor
110214230|NCT00099645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110214231|NCT00099645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214232|NCT00099645|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110214233|NCT00099645|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110214234|NCT00099645|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110236318|NCT00127998|Lumefantrine|lumefantrine|mesh-list
110214235|NCT00099645|Contraceptive Agents|contraceptive agents|mesh-ancestor
110214236|NCT00099645|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110214237|NCT00099645|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110214238|NCT00099645|Hormone Antagonists|hormone antagonists|mesh-ancestor
110214239|NCT00099645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110214240|NCT00099645|Luteolytic Agents|luteolytic agents|mesh-ancestor
110214241|NCT00099645|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110214242|NCT00099645|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110214244|NCT00247663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110214245|NCT00247663|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110214246|NCT00247663|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110214247|NCT00247663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110214248|NCT00247663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214249|NCT00247663|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110214250|NCT00247663|Hormone Antagonists|hormone antagonists|mesh-ancestor
110214251|NCT00247663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110214252|NCT00247663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214253|NCT00247702|Warfarin|warfarin|mesh-list
110214254|NCT00247702|Anticoagulants|anticoagulants|mesh-ancestor
110214255|NCT01349660|Bevacizumab|bevacizumab|mesh-list
110214256|NCT01349660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110214257|NCT01349660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110214258|NCT01349660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110214259|NCT01349660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110214260|NCT01349660|Growth Substances|growth substances|mesh-ancestor
110214261|NCT01349660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214262|NCT01349660|Growth Inhibitors|growth inhibitors|mesh-ancestor
110214264|NCT00247741|Carticaine|carticaine|mesh-list
110214265|NCT00247741|Anesthetics, Local|anesthetics, local|mesh-ancestor
110214266|NCT00247741|Anesthetics|anesthetics|mesh-ancestor
110214267|NCT00247741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110214268|NCT00247741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214269|NCT00247741|Sensory System Agents|sensory system agents|mesh-ancestor
110214270|NCT00247741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110214271|NCT00247741|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110214272|NCT00247741|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110214273|NCT00247741|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110214274|NCT00247741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110214275|NCT00247741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214276|NCT00099684|Ezetimibe|ezetimibe|mesh-list
110214277|NCT00099684|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110214278|NCT00099684|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110214279|NCT00099684|Antimetabolites|antimetabolites|mesh-ancestor
110214280|NCT00099684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214281|NCT00099684|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110214282|NCT00067730|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
110214283|NCT00067730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110214284|NCT00248053|Curcumin|curcumin|mesh-list
110214285|NCT00248053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110214286|NCT00248053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110214287|NCT00248053|Analgesics|analgesics|mesh-ancestor
110214288|NCT00248053|Sensory System Agents|sensory system agents|mesh-ancestor
110214289|NCT00248053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110026828|NCT01279590|Antimetabolites|antimetabolites|mesh-ancestor
110214290|NCT00248053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214291|NCT00248053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110214292|NCT00248053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110214293|NCT00248053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110214294|NCT00248053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110214295|NCT00248053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214296|NCT00248092|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
110214297|NCT00248092|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110214298|NCT00248092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214299|NCT00248092|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110214300|NCT00248092|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110214301|NCT00248092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110214302|NCT00248092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214303|NCT00248092|Dopamine Agents|dopamine agents|mesh-ancestor
110214304|NCT00248092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110214306|NCT00248131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110214307|NCT00248131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110214308|NCT00248131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110214309|NCT00248209|Bupropion|bupropion|mesh-list
110214310|NCT00248209|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110214311|NCT00248209|Antidepressive Agents|antidepressive agents|mesh-ancestor
110214312|NCT00248209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110214313|NCT00248209|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110214314|NCT00248209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110214315|NCT00248209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110214316|NCT00248209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214317|NCT00248209|Dopamine Agents|dopamine agents|mesh-ancestor
110214318|NCT00248209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110214319|NCT00248209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214320|NCT00248209|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110214321|NCT00248209|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110214322|NCT00248209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110214323|NCT00248248|Doxorubicin|doxorubicin|mesh-list
110214324|NCT00248248|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110214325|NCT00248248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110214326|NCT00248248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110214327|NCT00248248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110214328|NCT00248248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110214329|NCT00248248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110214330|NCT00248248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214332|NCT00248443|Chelating Agents|chelating agents|mesh-ancestor
110214333|NCT00248443|Sequestering Agents|sequestering agents|mesh-ancestor
110214334|NCT00248443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214336|NCT00248482|Irinotecan|irinotecan|mesh-list
110214337|NCT00248482|Imatinib Mesylate|imatinib mesylate|mesh-list
110214338|NCT00248482|Camptothecin|camptothecin|mesh-list
110214339|NCT00248482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110214340|NCT00248482|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110214341|NCT00248482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110214342|NCT00248482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110214343|NCT00248482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214344|NCT00248482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110214345|NCT00248482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110214346|NCT00103233|Trastuzumab|trastuzumab|mesh-list
110214347|NCT00103233|Vinorelbine|vinorelbine|mesh-list
110214348|NCT00103233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110214349|NCT00103233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110214350|NCT00103233|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110214351|NCT00103233|Tubulin Modulators|tubulin modulators|mesh-ancestor
110214352|NCT00103233|Antimitotic Agents|antimitotic agents|mesh-ancestor
110214353|NCT00103233|Mitosis Modulators|mitosis modulators|mesh-ancestor
110214354|NCT00103233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214355|NCT00248716|Ferrous gluconate|ferrous gluconate|mesh-list
110214357|NCT00067925|Calcium|calcium|mesh-list
110214358|NCT00067925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110214359|NCT00067925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214360|NCT00103272|Bortezomib|bortezomib|mesh-list
110214361|NCT00103272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110214362|NCT00248989|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
110214363|NCT00248989|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110214364|NCT00248989|Immunologic Factors|immunologic factors|mesh-ancestor
110214365|NCT00248989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214366|NCT00249106|Vaccines|vaccines|mesh-list
110214367|NCT00249106|Immunologic Factors|immunologic factors|mesh-ancestor
110214368|NCT00249106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214369|NCT00068042|Octreotide|octreotide|mesh-list
110214370|NCT00068042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110214371|NCT00068042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110214372|NCT00068042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110214373|NCT00249145|Risperidone|risperidone|mesh-list
110214374|NCT00249145|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110214375|NCT00249145|Serotonin Agents|serotonin agents|mesh-ancestor
110214376|NCT00249145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110214377|NCT00249145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214378|NCT00249145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214379|NCT00249145|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110214380|NCT00249145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110214381|NCT00249145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110214382|NCT00249145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110214383|NCT00249145|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110214384|NCT00249145|Dopamine Agents|dopamine agents|mesh-ancestor
110214385|NCT00099801|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
110214386|NCT00099801|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110214387|NCT00099801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214388|NCT00099801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110214389|NCT00099801|Immunologic Factors|immunologic factors|mesh-ancestor
110214390|NCT00099801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214391|NCT00414739|Benzalkonium Compounds|benzalkonium compounds|mesh-list
110214392|NCT00414739|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110214393|NCT00414739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110214394|NCT00068081|Capsaicin|capsaicin|mesh-list
110214395|NCT00068081|Antipruritics|antipruritics|mesh-ancestor
110214396|NCT00068081|Dermatologic Agents|dermatologic agents|mesh-ancestor
110214397|NCT00068081|Sensory System Agents|sensory system agents|mesh-ancestor
110214398|NCT00068081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110214399|NCT00068081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214400|NCT00249223|Risperidone|risperidone|mesh-list
110214401|NCT00249223|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110214402|NCT00249223|Serotonin Agents|serotonin agents|mesh-ancestor
110214403|NCT00249223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110214404|NCT00249223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214405|NCT00249223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214406|NCT00249223|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110214407|NCT00249223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110214408|NCT00249223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110214409|NCT00249223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110214410|NCT00249223|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110214411|NCT00249223|Dopamine Agents|dopamine agents|mesh-ancestor
110214412|NCT00099840|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110214413|NCT00099840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110214414|NCT02967224|Insulin|insulin|mesh-list
110214415|NCT02967224|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110214416|NCT02967224|Insulin Glargine|insulin glargine|mesh-list
110214418|NCT02967224|Insulin, Isophane|insulin, isophane|mesh-list
110214419|NCT02967224|Isophane Insulin, Human|isophane insulin, human|mesh-list
110214420|NCT02967224|Isophane insulin, beef|isophane insulin, beef|mesh-list
110214421|NCT02967224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110214422|NCT02967224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214423|NCT00099918|Vildagliptin|vildagliptin|mesh-list
110214424|NCT00099918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110214425|NCT00099918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214426|NCT00099918|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110214427|NCT00099918|Protease Inhibitors|protease inhibitors|mesh-ancestor
110214428|NCT00099918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110214429|NCT00099918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214430|NCT00249574|Buprenorphine|buprenorphine|mesh-list
110214431|NCT00249574|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
110214432|NCT00249574|Naloxone|naloxone|mesh-list
110214433|NCT00249574|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110214434|NCT00249574|Narcotics|narcotics|mesh-ancestor
110214435|NCT00249574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110214436|NCT00249574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214437|NCT00249574|Analgesics|analgesics|mesh-ancestor
110214438|NCT00249574|Sensory System Agents|sensory system agents|mesh-ancestor
110214439|NCT00249574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110214440|NCT00249574|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110214441|NCT00249691|Topiramate|topiramate|mesh-list
110214442|NCT00249691|Anticonvulsants|anticonvulsants|mesh-ancestor
110214443|NCT00249691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110214444|NCT00249691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214445|NCT00249730|Sildenafil Citrate|sildenafil citrate|mesh-list
110214446|NCT00249730|Vasodilator Agents|vasodilator agents|mesh-ancestor
110214447|NCT00249730|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110214448|NCT00249730|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110214449|NCT00249730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110214450|NCT00249730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214451|NCT00249730|Urological Agents|urological agents|mesh-ancestor
110214452|NCT00249847|Paroxetine|paroxetine|mesh-list
110214453|NCT00249847|Estrogens|estrogens|mesh-list
110214454|NCT00249847|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110214455|NCT00249847|Hormones|hormones|mesh-ancestor
110214456|NCT00249847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110214457|NCT00249847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214458|NCT00249847|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110214459|NCT00249847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110214460|NCT00249847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110214461|NCT00249847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214462|NCT00249847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110214463|NCT00249847|Serotonin Agents|serotonin agents|mesh-ancestor
110214464|NCT00249847|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110214465|NCT00249847|Antidepressive Agents|antidepressive agents|mesh-ancestor
110214466|NCT00249847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110214467|NCT00249847|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110214468|NCT00249847|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110214469|NCT00249847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110214471|NCT00249886|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110214472|NCT00249886|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110214473|NCT00249886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110214474|NCT00249886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214475|NCT00249886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110214476|NCT00249886|Serotonin Agents|serotonin agents|mesh-ancestor
110214477|NCT00249886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236382|NCT00344812|Narcotics|narcotics|mesh-ancestor
110214478|NCT00249886|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110214479|NCT00249886|Antidepressive Agents|antidepressive agents|mesh-ancestor
110214480|NCT00249886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110214481|NCT00249964|Paclitaxel|paclitaxel|mesh-list
110214482|NCT00249964|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110214483|NCT00249964|Carboplatin|carboplatin|mesh-list
110214484|NCT00249964|Temozolomide|temozolomide|mesh-list
110214485|NCT00249964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110214486|NCT00249964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110214487|NCT00249964|Tubulin Modulators|tubulin modulators|mesh-ancestor
110214488|NCT00249964|Antimitotic Agents|antimitotic agents|mesh-ancestor
110214489|NCT00249964|Mitosis Modulators|mitosis modulators|mesh-ancestor
110214490|NCT00249964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214491|NCT00249964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110214492|NCT00249964|Alkylating Agents|alkylating agents|mesh-ancestor
110214493|NCT00068276|Cholecalciferol|cholecalciferol|mesh-list
110214495|NCT00068276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110214496|NCT00068276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214497|NCT00068276|Vitamins|vitamins|mesh-ancestor
110214498|NCT00068276|Micronutrients|micronutrients|mesh-ancestor
110214499|NCT00068276|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110214500|NCT00250042|Imatinib Mesylate|imatinib mesylate|mesh-list
110214501|NCT00250042|Arsenic Trioxide|arsenic trioxide|mesh-list
110214502|NCT00250042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110214503|NCT00250042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110214504|NCT00250042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110214505|NCT00250042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214506|NCT00068315|Rituximab|rituximab|mesh-list
110214507|NCT00068315|Fludarabine|fludarabine|mesh-list
110214508|NCT00068315|Fludarabine phosphate|fludarabine phosphate|mesh-list
110214509|NCT00068315|Bortezomib|bortezomib|mesh-list
110214510|NCT00068315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110214511|NCT00068315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110214512|NCT00068315|Immunologic Factors|immunologic factors|mesh-ancestor
110214513|NCT00068315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214514|NCT00068315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110026905|NCT00247962|Sulfasalazine|sulfasalazine|mesh-list
110214515|NCT00068315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110214516|NCT00068315|Antimetabolites|antimetabolites|mesh-ancestor
110214517|NCT00068315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214518|NCT00068315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110214519|NCT00250081|Botulinum Toxins|botulinum toxins|mesh-list
110214520|NCT00250081|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110214521|NCT00250081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110214522|NCT00250081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214523|NCT00250081|Cholinergic Agents|cholinergic agents|mesh-ancestor
110214524|NCT00250081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110214525|NCT00250081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214526|NCT00250120|Camptothecin|camptothecin|mesh-list
110214528|NCT00250120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110214529|NCT00250120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110214530|NCT00250120|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110214531|NCT00250120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110214532|NCT00250120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110214533|NCT00250120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214534|NCT04720573|Neostigmine|neostigmine|mesh-list
110214535|NCT04720573|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110214536|NCT04720573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110214537|NCT04720573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214538|NCT04720573|Cholinergic Agents|cholinergic agents|mesh-ancestor
110214539|NCT04720573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110214540|NCT04720573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214541|NCT04720573|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110214542|NCT04720573|Autonomic Agents|autonomic agents|mesh-ancestor
110214543|NCT04720573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110214544|NCT00103545|Abagovomab|abagovomab|mesh-list
110214545|NCT00103545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110214546|NCT00103545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110214547|NCT00068432|Celecoxib|celecoxib|mesh-list
110214548|NCT00068432|Gemcitabine|gemcitabine|mesh-list
110214549|NCT00068432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110214550|NCT00068432|Antimetabolites|antimetabolites|mesh-ancestor
110214551|NCT00068432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214552|NCT00068432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110214553|NCT00068432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110214554|NCT00068432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110214555|NCT00068432|Analgesics|analgesics|mesh-ancestor
110214556|NCT00068432|Sensory System Agents|sensory system agents|mesh-ancestor
110214557|NCT00068432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110214558|NCT00068432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214559|NCT00068432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110214560|NCT00068432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110214561|NCT00068432|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110214562|NCT00068432|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110214563|NCT00068432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110214564|NCT00250237|Haloperidol|haloperidol|mesh-list
110214565|NCT00250237|Haloperidol decanoate|haloperidol decanoate|mesh-list
110214566|NCT00250237|Antiemetics|antiemetics|mesh-ancestor
110214567|NCT00250237|Autonomic Agents|autonomic agents|mesh-ancestor
110214568|NCT00250237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110214569|NCT00250237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214570|NCT00250237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110214571|NCT00250237|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110214572|NCT00250237|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110214573|NCT00250237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110214574|NCT00250237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110214575|NCT00250237|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110214576|NCT00250237|Dopamine Agents|dopamine agents|mesh-ancestor
110214577|NCT00250237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110214578|NCT00250237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214579|NCT00250237|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110214580|NCT00099957|Vildagliptin|vildagliptin|mesh-list
110214581|NCT00099957|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110214582|NCT00099957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214583|NCT00099957|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110214584|NCT00099957|Protease Inhibitors|protease inhibitors|mesh-ancestor
110214585|NCT00099957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110214586|NCT00099957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214587|NCT00250315|Dobutamine|dobutamine|mesh-list
110214588|NCT00250315|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110214589|NCT00250315|Sympathomimetics|sympathomimetics|mesh-ancestor
110214590|NCT00250315|Autonomic Agents|autonomic agents|mesh-ancestor
110214591|NCT00250315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110214592|NCT00250315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214593|NCT00250315|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110214594|NCT00250315|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110214595|NCT00250315|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110214596|NCT00250315|Adrenergic Agents|adrenergic agents|mesh-ancestor
110214597|NCT00250315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110214598|NCT00250315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214599|NCT00250315|Protective Agents|protective agents|mesh-ancestor
110214601|NCT00068471|Antifungal Agents|antifungal agents|mesh-ancestor
110214602|NCT00068471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110214603|NCT00250354|Risperidone|risperidone|mesh-list
110236400|NCT00090155|Aprepitant|aprepitant|mesh-list
110214604|NCT00250354|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110214605|NCT00250354|Serotonin Agents|serotonin agents|mesh-ancestor
110214606|NCT00250354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110214607|NCT00250354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214608|NCT00250354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214609|NCT00250354|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110214610|NCT00250354|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110214611|NCT00250354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110214612|NCT00250354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110214613|NCT00250354|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110214615|NCT00250393|Istradefylline|istradefylline|mesh-list
110214616|NCT00250393|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
110214617|NCT00250393|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110214618|NCT00250393|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110214619|NCT00250393|Purinergic Agents|purinergic agents|mesh-ancestor
110214620|NCT00250393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110214621|NCT00250393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214622|NCT00250393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214623|NCT02961634|Ciclopirox|ciclopirox|mesh-list
110214624|NCT02961634|Antifungal Agents|antifungal agents|mesh-ancestor
110214625|NCT02961634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110214626|NCT02966717|Rituximab|rituximab|mesh-list
110214627|NCT02966717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110214628|NCT02966717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110214629|NCT02966717|Immunologic Factors|immunologic factors|mesh-ancestor
110214630|NCT02966717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214631|NCT02966717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110214632|NCT00099996|Ezetimibe|ezetimibe|mesh-list
110214633|NCT00099996|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110214634|NCT00099996|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110214635|NCT00099996|Antimetabolites|antimetabolites|mesh-ancestor
110214636|NCT00099996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214637|NCT00099996|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110214638|NCT00250744|Gabapentin|gabapentin|mesh-list
110214639|NCT00250744|Aprepitant|aprepitant|mesh-list
110214640|NCT00250744|Fosaprepitant|fosaprepitant|mesh-list
110214641|NCT00250744|Analgesics|analgesics|mesh-ancestor
110214642|NCT00250744|Sensory System Agents|sensory system agents|mesh-ancestor
110214643|NCT00250744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110214644|NCT00250744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214645|NCT00250744|Anticonvulsants|anticonvulsants|mesh-ancestor
110214646|NCT00250744|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110214647|NCT00250744|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110214648|NCT00250744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110214649|NCT00250744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110214650|NCT00250744|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110214651|NCT00250744|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110214652|NCT00250744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110214653|NCT00250744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214654|NCT00250744|Antimanic Agents|antimanic agents|mesh-ancestor
110214655|NCT00250744|Antiemetics|antiemetics|mesh-ancestor
110214656|NCT00250744|Autonomic Agents|autonomic agents|mesh-ancestor
110214657|NCT00250744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110214658|NCT00250744|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110214659|NCT00103623|Abarelix|abarelix|mesh-list
110214660|NCT00103623|Hormone Antagonists|hormone antagonists|mesh-ancestor
110214661|NCT00103623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110214662|NCT00103623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214664|NCT00250861|Rituximab|rituximab|mesh-list
110214665|NCT00250861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110214666|NCT00250861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110214667|NCT00250861|Immunologic Factors|immunologic factors|mesh-ancestor
110214668|NCT00250861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214669|NCT00250861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110214670|NCT00250861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110214671|NCT00250861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110214673|NCT00250861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110214674|NCT00068549|Gemcitabine|gemcitabine|mesh-list
110214675|NCT00068549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110214676|NCT00068549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110214677|NCT00068549|Antimetabolites|antimetabolites|mesh-ancestor
110214678|NCT00068549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214679|NCT04720183|Sulfasalazine|sulfasalazine|mesh-list
110214680|NCT04720183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110214681|NCT04720183|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110214682|NCT04720183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110214683|NCT04720183|Analgesics|analgesics|mesh-ancestor
110214684|NCT04720183|Sensory System Agents|sensory system agents|mesh-ancestor
110214685|NCT04720183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110214686|NCT04720183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214687|NCT04720183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110214688|NCT04720183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110214689|NCT04720183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110214690|NCT00250978|Bevacizumab|bevacizumab|mesh-list
110214691|NCT00250978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110214692|NCT00250978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110214693|NCT00250978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110214694|NCT00250978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110214695|NCT00250978|Growth Substances|growth substances|mesh-ancestor
110214696|NCT00250978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214697|NCT00250978|Growth Inhibitors|growth inhibitors|mesh-ancestor
110214698|NCT00068666|Temozolomide|temozolomide|mesh-list
110214699|NCT00068666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110214700|NCT00068666|Alkylating Agents|alkylating agents|mesh-ancestor
110214701|NCT00068666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214702|NCT00068666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110214703|NCT00103701|Dasatinib|dasatinib|mesh-list
110214704|NCT00103701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110214705|NCT00103701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110214706|NCT00103701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110214707|NCT00103701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214708|NCT00251017|Vancomycin|vancomycin|mesh-list
110214709|NCT00251017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110214710|NCT00251017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110214711|NCT00251056|Mannitol|mannitol|mesh-list
110214712|NCT00251056|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110214713|NCT00251056|Diuretics|diuretics|mesh-ancestor
110214714|NCT00251056|Natriuretic Agents|natriuretic agents|mesh-ancestor
110214715|NCT00251056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214716|NCT00251095|Paclitaxel|paclitaxel|mesh-list
110214717|NCT00251095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110214718|NCT00251095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110214719|NCT00251095|Tubulin Modulators|tubulin modulators|mesh-ancestor
110214720|NCT00251095|Antimitotic Agents|antimitotic agents|mesh-ancestor
110214721|NCT00251095|Mitosis Modulators|mitosis modulators|mesh-ancestor
110214722|NCT00251095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214723|NCT00100074|Lobeline|lobeline|mesh-list
110214724|NCT00100074|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110214725|NCT00100074|Autonomic Agents|autonomic agents|mesh-ancestor
110214726|NCT00100074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110214727|NCT00100074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214728|NCT00100074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110214729|NCT00100074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110214730|NCT00100074|Cholinergic Agents|cholinergic agents|mesh-ancestor
110236421|NCT00335413|Natriuretic Agents|natriuretic agents|mesh-ancestor
110214731|NCT00100074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110214732|NCT00100074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214733|NCT00100074|Respiratory System Agents|respiratory system agents|mesh-ancestor
110214734|NCT00068744|Fluorouracil|fluorouracil|mesh-list
110214735|NCT00068744|Mitomycins|mitomycins|mesh-list
110214736|NCT00068744|Mitomycin|mitomycin|mesh-list
110214737|NCT00068744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110214738|NCT00068744|Antimetabolites|antimetabolites|mesh-ancestor
110026965|NCT00242580|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110214739|NCT00068744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214740|NCT00068744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110214741|NCT00068744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110214742|NCT00068744|Immunologic Factors|immunologic factors|mesh-ancestor
110214743|NCT00068744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214744|NCT00068744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110214745|NCT00068744|Alkylating Agents|alkylating agents|mesh-ancestor
110214746|NCT00068744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110214747|NCT00068744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110214748|NCT00100113|Vanoxerine|vanoxerine|mesh-list
110214749|NCT00100113|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110214750|NCT00100113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110214751|NCT00100113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110214752|NCT00100113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214753|NCT00100113|Dopamine Agents|dopamine agents|mesh-ancestor
110214754|NCT00100113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110214755|NCT00100113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214756|NCT00068783|Imatinib Mesylate|imatinib mesylate|mesh-list
110214757|NCT00068783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110214758|NCT00068783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110214759|NCT00068783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110214760|NCT00068783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214761|NCT00251368|9-aminocamptothecin|9-aminocamptothecin|mesh-list
110214762|NCT00251368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110214763|NCT00103779|Dacetuzumab|dacetuzumab|mesh-list
110214764|NCT00103779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110214765|NCT00103779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110214766|NCT00251407|Docetaxel|docetaxel|mesh-list
110214767|NCT00251407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110214768|NCT00251407|Tubulin Modulators|tubulin modulators|mesh-ancestor
110214769|NCT00251407|Antimitotic Agents|antimitotic agents|mesh-ancestor
110214770|NCT00251407|Mitosis Modulators|mitosis modulators|mesh-ancestor
110214771|NCT00251407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214772|NCT02966522|Thalidomide|thalidomide|mesh-list
110214773|NCT02966522|Dexamethasone|dexamethasone|mesh-list
110214774|NCT02966522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110214775|NCT02966522|Antiemetics|antiemetics|mesh-ancestor
110214776|NCT02966522|Autonomic Agents|autonomic agents|mesh-ancestor
110214777|NCT02966522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110214778|NCT02966522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214779|NCT02966522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110214780|NCT02966522|Glucocorticoids|glucocorticoids|mesh-ancestor
110214781|NCT02966522|Hormones|hormones|mesh-ancestor
110214782|NCT02966522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110214783|NCT02966522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110214784|NCT02966522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110214785|NCT02966522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110214786|NCT02966522|Immunologic Factors|immunologic factors|mesh-ancestor
110214787|NCT02966522|Leprostatic Agents|leprostatic agents|mesh-ancestor
110214788|NCT02966522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110214789|NCT02966522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110214790|NCT02966522|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110214791|NCT02966522|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110214792|NCT02966522|Growth Substances|growth substances|mesh-ancestor
110214793|NCT02966522|Growth Inhibitors|growth inhibitors|mesh-ancestor
110214794|NCT00251485|Cetuximab|cetuximab|mesh-list
110214795|NCT00251485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110214796|NCT00251485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110214797|NCT00100152|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|mesh-list
110214798|NCT00100152|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
110214799|NCT00100152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110214800|NCT00100152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214801|NCT00251524|Bevacizumab|bevacizumab|mesh-list
110214802|NCT00251524|Oxaliplatin|oxaliplatin|mesh-list
110214804|NCT00251524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110214805|NCT00251524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110214806|NCT00251524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110214807|NCT00251524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110214808|NCT00251524|Growth Substances|growth substances|mesh-ancestor
110214809|NCT00251524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214810|NCT00251524|Growth Inhibitors|growth inhibitors|mesh-ancestor
110214811|NCT00251524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110214812|NCT00251524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214813|NCT00251524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110214814|NCT00251524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110214816|NCT00068861|Clomiphene|clomiphene|mesh-list
110214817|NCT00068861|Enclomiphene|enclomiphene|mesh-list
110214818|NCT00068861|Zuclomiphene|zuclomiphene|mesh-list
110214819|NCT00068861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110214820|NCT00068861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214821|NCT00068861|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110214822|NCT00068861|Hormone Antagonists|hormone antagonists|mesh-ancestor
110214823|NCT00068861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110214824|NCT00068861|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110214825|NCT00068861|Fertility Agents|fertility agents|mesh-ancestor
110214826|NCT00068861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110214827|NCT00068861|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110214828|NCT00068861|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110214829|NCT00251602|Propranolol|propranolol|mesh-list
110214830|NCT00251602|Atropine|atropine|mesh-list
110214831|NCT00251602|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110214832|NCT00251602|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110214833|NCT00251602|Adrenergic Agents|adrenergic agents|mesh-ancestor
110214834|NCT00251602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110214835|NCT00251602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214836|NCT00251602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214837|NCT00251602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110214838|NCT00251602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110214839|NCT00251602|Vasodilator Agents|vasodilator agents|mesh-ancestor
110214840|NCT00251602|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110214841|NCT00251602|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110214842|NCT00251602|Autonomic Agents|autonomic agents|mesh-ancestor
110214843|NCT00251602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110214844|NCT00251602|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110214845|NCT00251602|Respiratory System Agents|respiratory system agents|mesh-ancestor
110214846|NCT00251602|Mydriatics|mydriatics|mesh-ancestor
110214847|NCT00251602|Parasympatholytics|parasympatholytics|mesh-ancestor
110214848|NCT00251602|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110214849|NCT00251602|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110214850|NCT00251602|Cholinergic Agents|cholinergic agents|mesh-ancestor
110214851|NCT02961166|Immunoglobulins|immunoglobulins|mesh-list
110214852|NCT02961166|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110214853|NCT02961166|Antibodies|antibodies|mesh-list
110214854|NCT02961166|Immunologic Factors|immunologic factors|mesh-ancestor
110214855|NCT02961166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214856|NCT00103818|Gaboxadol|gaboxadol|mesh-list
110214857|NCT00103818|Analgesics|analgesics|mesh-ancestor
110214858|NCT00103818|Sensory System Agents|sensory system agents|mesh-ancestor
110214859|NCT00103818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110214860|NCT00103818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214861|NCT00103818|Anticonvulsants|anticonvulsants|mesh-ancestor
110214862|NCT00103818|GABA Agonists|gaba agonists|mesh-ancestor
110214863|NCT00103818|GABA Agents|gaba agents|mesh-ancestor
110214864|NCT00103818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110214865|NCT00103818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214866|NCT00251680|Atorvastatin|atorvastatin|mesh-list
110214867|NCT00251680|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110214868|NCT00251680|Simvastatin|simvastatin|mesh-list
110214869|NCT00251680|Fenofibrate|fenofibrate|mesh-list
110214870|NCT00251680|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110214871|NCT00251680|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110214872|NCT00251680|Antimetabolites|antimetabolites|mesh-ancestor
110214873|NCT00251680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214874|NCT00251680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110214875|NCT00251680|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110214876|NCT00251680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110214877|NCT00251797|Thalidomide|thalidomide|mesh-list
110214878|NCT00251797|Irinotecan|irinotecan|mesh-list
110214879|NCT00251797|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110214880|NCT00251797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110214881|NCT00251797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110214882|NCT00251797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214883|NCT00251797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110214884|NCT00251797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110214885|NCT00251797|Immunologic Factors|immunologic factors|mesh-ancestor
110214886|NCT00251797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214887|NCT00251797|Leprostatic Agents|leprostatic agents|mesh-ancestor
110214888|NCT00251797|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110214889|NCT00251797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110214890|NCT00251797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110214891|NCT00251797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110214892|NCT00251797|Growth Substances|growth substances|mesh-ancestor
110214893|NCT00251797|Growth Inhibitors|growth inhibitors|mesh-ancestor
110214894|NCT00251914|Esomeprazole|esomeprazole|mesh-list
110214895|NCT00251914|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110214896|NCT00251914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110214897|NCT00251914|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110214898|NCT00251914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110214899|NCT00251914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214900|NCT00100269|Antioxidants|antioxidants|mesh-list
110214901|NCT00100269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214902|NCT00100269|Protective Agents|protective agents|mesh-ancestor
110214903|NCT00100269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214904|NCT00399074|Pyrimethamine|pyrimethamine|mesh-list
110214905|NCT00399074|Sulfadoxine|sulfadoxine|mesh-list
110214906|NCT00399074|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110214907|NCT00399074|Antimalarials|antimalarials|mesh-ancestor
110214908|NCT00399074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110214909|NCT00399074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110214910|NCT00399074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110214911|NCT00399074|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110214912|NCT00399074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110214913|NCT00399074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214914|NCT00399074|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110214915|NCT00100308|Heparin|heparin|mesh-list
110214916|NCT00100308|Anticoagulants|anticoagulants|mesh-ancestor
110214917|NCT00100308|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110214918|NCT00100308|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110236458|NCT00335647|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110214919|NCT00100308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214920|NCT00251953|Metformin|metformin|mesh-list
110214921|NCT00251953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110214922|NCT00251953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214923|NCT00251992|Esomeprazole|esomeprazole|mesh-list
110214924|NCT00251992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110214925|NCT00251992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110214926|NCT00251992|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110214927|NCT00251992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110214928|NCT00251992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214929|NCT00103935|Exenatide|exenatide|mesh-list
110214930|NCT00103935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110214931|NCT00103935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214932|NCT00103935|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110214934|NCT00103935|Hormones|hormones|mesh-ancestor
110214935|NCT00103935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110214936|NCT00399152|Sunitinib|sunitinib|mesh-list
110214937|NCT00399152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110214938|NCT00399152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110214939|NCT00399152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110214940|NCT00399152|Growth Substances|growth substances|mesh-ancestor
110214941|NCT00399152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214942|NCT00399152|Growth Inhibitors|growth inhibitors|mesh-ancestor
110025635|NCT00370656|Pregabalin|pregabalin|mesh-list
110214943|NCT00399152|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110214944|NCT00399152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110214945|NCT00399152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214946|NCT00104013|Xaliproden|xaliproden|mesh-list
110214947|NCT00104013|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110214948|NCT00104013|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110214949|NCT00104013|Serotonin Agents|serotonin agents|mesh-ancestor
110214950|NCT00104013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110214951|NCT00104013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214952|NCT00104013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214953|NCT04719715|Antibodies|antibodies|mesh-list
110214954|NCT04719715|Immunologic Factors|immunologic factors|mesh-ancestor
110214955|NCT04719715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214956|NCT00252226|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110214957|NCT00252226|Antidepressive Agents|antidepressive agents|mesh-ancestor
110214958|NCT00252226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110214959|NCT00252226|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110214960|NCT00252226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110214961|NCT00252226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110214962|NCT00252226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214963|NCT00252304|Zinc Sulfate|zinc sulfate|mesh-list
110214964|NCT00252304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214965|NCT00252304|Astringents|astringents|mesh-ancestor
110214966|NCT00252304|Dermatologic Agents|dermatologic agents|mesh-ancestor
110214967|NCT00252343|Amibegron|amibegron|mesh-list
110214968|NCT00252343|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
110214969|NCT00252343|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110214970|NCT00252343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110214971|NCT00252343|Adrenergic Agents|adrenergic agents|mesh-ancestor
110214972|NCT00252343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110214973|NCT00252343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214974|NCT00252343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214975|NCT00252343|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110214976|NCT00252421|Nitroglycerin|nitroglycerin|mesh-list
110214977|NCT00252421|Vasodilator Agents|vasodilator agents|mesh-ancestor
110214978|NCT00252655|Sirolimus|sirolimus|mesh-list
110214979|NCT00252655|Tacrolimus|tacrolimus|mesh-list
110214980|NCT00252655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110214981|NCT00252655|Immunologic Factors|immunologic factors|mesh-ancestor
110214982|NCT00252655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214983|NCT00252655|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110214984|NCT00252655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110214985|NCT00252655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214986|NCT00252655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110214987|NCT00252655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110214988|NCT00252655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110214989|NCT00252655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110214990|NCT00252655|Antifungal Agents|antifungal agents|mesh-ancestor
110214992|NCT00252811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110214993|NCT00252811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110214994|NCT00252811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110214995|NCT00252811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110214996|NCT00069251|Bupropion|bupropion|mesh-list
110214997|NCT00069251|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110214998|NCT00069251|Antidepressive Agents|antidepressive agents|mesh-ancestor
110214999|NCT00069251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110215000|NCT00069251|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110215001|NCT00069251|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110215002|NCT00069251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110215003|NCT00069251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110215004|NCT00069251|Dopamine Agents|dopamine agents|mesh-ancestor
110215005|NCT00069251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110215006|NCT00069251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110215007|NCT00069251|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110215008|NCT00069251|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110215009|NCT00069251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110215010|NCT00252889|Doxorubicin|doxorubicin|mesh-list
110215011|NCT00252889|Topotecan|topotecan|mesh-list
110215012|NCT00252889|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-list
110215013|NCT00252889|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110215014|NCT00252889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110215015|NCT00252889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110215016|NCT00252889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110215017|NCT00252889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110215018|NCT00252889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110215019|NCT00252928|Troclosene|troclosene|mesh-list
110215020|NCT00252928|Antifungal Agents|antifungal agents|mesh-ancestor
110215021|NCT00252928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110215022|NCT00252928|Antiviral Agents|antiviral agents|mesh-ancestor
110215023|NCT00252928|Disinfectants|disinfectants|mesh-ancestor
110215024|NCT00253123|Risperidone|risperidone|mesh-list
110215025|NCT00253123|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110215026|NCT00253123|Serotonin Agents|serotonin agents|mesh-ancestor
110215027|NCT00253123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110215028|NCT00253123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110215029|NCT00253123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110215030|NCT00253123|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110215031|NCT00253123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110215032|NCT00253123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110215033|NCT00253123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110215034|NCT00253123|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110215035|NCT00253123|Dopamine Agents|dopamine agents|mesh-ancestor
110215036|NCT00253162|Risperidone|risperidone|mesh-list
110215037|NCT00253162|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110215038|NCT00253162|Serotonin Agents|serotonin agents|mesh-ancestor
110215039|NCT00253162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110215040|NCT00253162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110215041|NCT00253162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110215042|NCT00253162|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110215043|NCT00253162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110215044|NCT00253162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110215045|NCT00253162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110215046|NCT00253162|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110215047|NCT00253162|Dopamine Agents|dopamine agents|mesh-ancestor
110215048|NCT00253201|Galantamine|galantamine|mesh-list
110215049|NCT00253201|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110215050|NCT00253201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110215051|NCT00253201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110215052|NCT00253201|Cholinergic Agents|cholinergic agents|mesh-ancestor
110215053|NCT00253201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110215054|NCT00253201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110215055|NCT00253201|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110215056|NCT00253201|Autonomic Agents|autonomic agents|mesh-ancestor
110215057|NCT00253201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110215058|NCT00253201|Nootropic Agents|nootropic agents|mesh-ancestor
110215059|NCT00253318|Dexamethasone|dexamethasone|mesh-list
110215061|NCT00253318|Everolimus|everolimus|mesh-list
110215062|NCT00253318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110215063|NCT00253318|Antiemetics|antiemetics|mesh-ancestor
110215064|NCT00253318|Autonomic Agents|autonomic agents|mesh-ancestor
110215065|NCT00253318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110215066|NCT00253318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110215067|NCT00253318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110215068|NCT00253318|Glucocorticoids|glucocorticoids|mesh-ancestor
110215069|NCT00253318|Hormones|hormones|mesh-ancestor
110215070|NCT00253318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110215071|NCT00253318|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110215072|NCT00253318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110215073|NCT00253318|Tubulin Modulators|tubulin modulators|mesh-ancestor
110215074|NCT00253318|Antimitotic Agents|antimitotic agents|mesh-ancestor
110215075|NCT00253318|Mitosis Modulators|mitosis modulators|mesh-ancestor
110215076|NCT00253318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110215077|NCT00253318|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110215078|NCT00253318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110215079|NCT00253318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110215080|NCT00253318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110215081|NCT00253318|Immunologic Factors|immunologic factors|mesh-ancestor
110215082|NCT00100464|Paroxetine|paroxetine|mesh-list
110215083|NCT00100464|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110215084|NCT00100464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110215085|NCT00100464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110215086|NCT00100464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110215087|NCT00100464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110215088|NCT00100464|Serotonin Agents|serotonin agents|mesh-ancestor
110215089|NCT00100464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110215090|NCT00100464|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110215091|NCT00100464|Antidepressive Agents|antidepressive agents|mesh-ancestor
110215092|NCT00100464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110215093|NCT00100464|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110215094|NCT00100464|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110215095|NCT00100464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110215096|NCT00253396|Heparin|heparin|mesh-list
110215097|NCT00253396|Enoxaparin|enoxaparin|mesh-list
110215098|NCT00253396|Calcium heparin|calcium heparin|mesh-list
110215099|NCT00253396|Anticoagulants|anticoagulants|mesh-ancestor
110215100|NCT00253396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110215101|NCT00253396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110215102|NCT00253396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110215103|NCT00253474|Interferons|interferons|mesh-list
110215104|NCT00253474|Interferon-alpha|interferon-alpha|mesh-list
110215105|NCT00253474|Interferon alpha-2|interferon alpha-2|mesh-list
110215106|NCT00253474|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110215107|NCT00253474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110215108|NCT00253474|Antiviral Agents|antiviral agents|mesh-ancestor
110215109|NCT00253474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110215110|NCT00253474|Immunologic Factors|immunologic factors|mesh-ancestor
110215111|NCT00253474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110215112|NCT00253552|Cyclosporine|cyclosporine|mesh-list
110215113|NCT00253552|Cyclophosphamide|cyclophosphamide|mesh-list
110215114|NCT00253552|Busulfan|busulfan|mesh-list
110236488|NCT00128232|Octreotide|octreotide|mesh-list
110215115|NCT00253552|Methotrexate|methotrexate|mesh-list
110215116|NCT00253552|Etoposide|etoposide|mesh-list
110215117|NCT00253552|Cyclosporins|cyclosporins|mesh-list
110215118|NCT00253552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110215119|NCT00253552|Immunologic Factors|immunologic factors|mesh-ancestor
110215120|NCT00253552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110215121|NCT00253552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110215122|NCT00253552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110215123|NCT00253552|Alkylating Agents|alkylating agents|mesh-ancestor
110215124|NCT00253552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110215125|NCT00253552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110215126|NCT00253552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110215127|NCT00253552|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110215128|NCT00253552|Abortifacient Agents|abortifacient agents|mesh-ancestor
110215129|NCT00253552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110215130|NCT00253552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110215131|NCT00253552|Antimetabolites|antimetabolites|mesh-ancestor
110215132|NCT00253552|Dermatologic Agents|dermatologic agents|mesh-ancestor
110215133|NCT00253552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110215134|NCT00253552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110215135|NCT00253552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110215136|NCT00253552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110215137|NCT00253552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110215138|NCT00253552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110215139|NCT00253552|Antifungal Agents|antifungal agents|mesh-ancestor
110215140|NCT00253552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110215141|NCT00253552|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110215142|NCT00253591|Vinorelbine|vinorelbine|mesh-list
110215143|NCT00253591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110215144|NCT00253591|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110215145|NCT00253591|Tubulin Modulators|tubulin modulators|mesh-ancestor
110215146|NCT00253591|Antimitotic Agents|antimitotic agents|mesh-ancestor
110215147|NCT00253591|Mitosis Modulators|mitosis modulators|mesh-ancestor
110215148|NCT00253591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110215149|NCT04719481|Pravastatin|pravastatin|mesh-list
110215150|NCT04719481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110215151|NCT04719481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110215152|NCT04719481|Antimetabolites|antimetabolites|mesh-ancestor
110215153|NCT04719481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110215154|NCT04719481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110215155|NCT04719481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110215156|NCT04719481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110215157|NCT00253903|SR 46349B|sr 46349b|mesh-list
110215158|NCT00253903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110215159|NCT00253903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110215160|NCT00253903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110215161|NCT00253903|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110215162|NCT00253903|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110215163|NCT00253903|Serotonin Agents|serotonin agents|mesh-ancestor
110215164|NCT00253903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110215165|NCT00253903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110215166|NCT00104130|Desoxyepothilone B|desoxyepothilone b|mesh-list
110215167|NCT00104130|Tubulin Modulators|tubulin modulators|mesh-ancestor
110215168|NCT00104130|Antimitotic Agents|antimitotic agents|mesh-ancestor
110215169|NCT00104130|Mitosis Modulators|mitosis modulators|mesh-ancestor
110215170|NCT00104130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110215171|NCT00104130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110215172|NCT00254020|Citalopram|citalopram|mesh-list
110215173|NCT00254020|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110215174|NCT00254020|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110215175|NCT00254020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110215176|NCT00254020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110215177|NCT00254020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110215178|NCT00254020|Serotonin Agents|serotonin agents|mesh-ancestor
110215179|NCT00254020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110215180|NCT00254020|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110215181|NCT00254020|Antidepressive Agents|antidepressive agents|mesh-ancestor
110215182|NCT00254020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110215183|NCT00254137|Capecitabine|capecitabine|mesh-list
110215184|NCT00254137|Oxaliplatin|oxaliplatin|mesh-list
110215185|NCT00254137|Irinotecan|irinotecan|mesh-list
110215186|NCT00254137|Cetuximab|cetuximab|mesh-list
110215187|NCT00254137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110215188|NCT00254137|Antimetabolites|antimetabolites|mesh-ancestor
110215189|NCT00254137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110215190|NCT00254137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110215191|NCT00254137|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110215192|NCT00254137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110215193|NCT00254137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110215194|NCT00254137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110215195|NCT00104169|Epoetin Alfa|epoetin alfa|mesh-list
110215196|NCT00104169|Hematinics|hematinics|mesh-ancestor
110215197|NCT00415090|Nevirapine|nevirapine|mesh-list
110215198|NCT00415090|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110215199|NCT00415090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110215200|NCT00415090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110215201|NCT00415090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110215202|NCT00415090|Antiviral Agents|antiviral agents|mesh-ancestor
110215203|NCT00415090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110215204|NCT00415090|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110215205|NCT00415090|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110215206|NCT00415090|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110215207|NCT00415090|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110215208|NCT00254176|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
110215209|NCT00254176|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110215210|NCT00254176|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110215211|NCT00254254|Exenatide|exenatide|mesh-list
110215212|NCT00254254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110215213|NCT00254254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110215214|NCT00254254|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110215215|NCT00254254|Incretins|incretins|mesh-ancestor
110215216|NCT00254254|Hormones|hormones|mesh-ancestor
110215217|NCT00254254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110215218|NCT00254371|Androgens|androgens|mesh-list
110215219|NCT00254371|Hormones|hormones|mesh-ancestor
110215220|NCT00254371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110215221|NCT00254371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110215222|NCT00254449|Capsaicin|capsaicin|mesh-list
110215223|NCT00254449|Antipruritics|antipruritics|mesh-ancestor
110215224|NCT00254449|Dermatologic Agents|dermatologic agents|mesh-ancestor
110215225|NCT00254449|Sensory System Agents|sensory system agents|mesh-ancestor
110215226|NCT00254449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110215227|NCT00254449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110215228|NCT00104286|Troxacitabine|troxacitabine|mesh-list
110215229|NCT00104286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110215230|NCT00104286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110215231|NCT00104286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110215232|NCT00104286|Antiviral Agents|antiviral agents|mesh-ancestor
110215233|NCT00104286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110215234|NCT00254800|Exenatide|exenatide|mesh-list
110215235|NCT00254800|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110215236|NCT00254800|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110215237|NCT00254800|Levonorgestrel|levonorgestrel|mesh-list
110215238|NCT00254800|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110215239|NCT00254800|Estradiol|estradiol|mesh-list
110215240|NCT00254800|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110215241|NCT00254800|Estrogens|estrogens|mesh-ancestor
110215242|NCT00254800|Hormones|hormones|mesh-ancestor
110215243|NCT00254800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110215244|NCT00254800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110215245|NCT00254800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110215246|NCT00254800|Contraceptive Agents|contraceptive agents|mesh-ancestor
110215247|NCT00254800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110215248|NCT00254800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110215249|NCT00254800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110215250|NCT00254800|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110215251|NCT00254800|Incretins|incretins|mesh-ancestor
110215252|NCT00254800|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110215253|NCT00254800|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110215254|NCT00254800|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110215255|NCT00104403|Dexamethasone|dexamethasone|mesh-list
110215256|NCT00104403|Dexamethasone acetate|dexamethasone acetate|mesh-list
110215257|NCT00104403|Ondansetron|ondansetron|mesh-list
110215258|NCT00104403|Casopitant|casopitant|mesh-list
110215259|NCT00104403|BB 1101|bb 1101|mesh-list
110215260|NCT00104403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110215261|NCT00104403|Antiemetics|antiemetics|mesh-ancestor
110215262|NCT00104403|Autonomic Agents|autonomic agents|mesh-ancestor
110215263|NCT00104403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110215264|NCT00104403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110215265|NCT00104403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110215266|NCT00104403|Glucocorticoids|glucocorticoids|mesh-ancestor
110215267|NCT00104403|Hormones|hormones|mesh-ancestor
110215268|NCT00104403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110215269|NCT00104403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110215270|NCT00104403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110215271|NCT00104403|Protease Inhibitors|protease inhibitors|mesh-ancestor
110215272|NCT00104403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110215273|NCT00104403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110215274|NCT00104403|Antipruritics|antipruritics|mesh-ancestor
110215275|NCT00104403|Dermatologic Agents|dermatologic agents|mesh-ancestor
110215276|NCT00104403|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110215277|NCT00104403|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110215278|NCT00104403|Serotonin Agents|serotonin agents|mesh-ancestor
110215279|NCT00104403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110215280|NCT00104403|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110215281|NCT00069836|Metformin|metformin|mesh-list
110215282|NCT00069836|Rosiglitazone|rosiglitazone|mesh-list
110215283|NCT00069836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110025966|NCT00380484|Budesonide|budesonide|mesh-list
110215284|NCT00069836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110215285|NCT00254878|Methylphenidate|methylphenidate|mesh-list
110215286|NCT00254878|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110215287|NCT00254878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110215288|NCT00254878|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110215289|NCT00254878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110215290|NCT00254878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110215291|NCT00254878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110215292|NCT00254878|Dopamine Agents|dopamine agents|mesh-ancestor
110215293|NCT00254878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110215295|NCT00254917|Immunologic Factors|immunologic factors|mesh-ancestor
110215296|NCT00254917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110215298|NCT00254956|Glucocorticoids|glucocorticoids|mesh-ancestor
110215299|NCT00254956|Hormones|hormones|mesh-ancestor
110215300|NCT00254956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110215302|NCT00254956|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110215303|NCT00255073|Baclofen|baclofen|mesh-list
110215304|NCT00255073|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110215305|NCT00255073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110215306|NCT00255073|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110215307|NCT00255073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110215308|NCT00255073|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110215309|NCT00255073|GABA Agonists|gaba agonists|mesh-ancestor
110215310|NCT00255073|GABA Agents|gaba agents|mesh-ancestor
110215311|NCT00255073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110215312|NCT00255073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110215313|NCT00069875|Gemcitabine|gemcitabine|mesh-list
110215314|NCT00069875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110215315|NCT00069875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110215316|NCT00069875|Antimetabolites|antimetabolites|mesh-ancestor
110215317|NCT00069875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110215318|NCT00255268|Goserelin|goserelin|mesh-list
110215319|NCT00255268|Bicalutamide|bicalutamide|mesh-list
110215320|NCT00255268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110215321|NCT00255268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110215322|NCT00255268|Androgen Antagonists|androgen antagonists|mesh-ancestor
110215323|NCT00255268|Hormone Antagonists|hormone antagonists|mesh-ancestor
110215324|NCT00255268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110215325|NCT00255268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110215326|NCT00104442|Rivastigmine|rivastigmine|mesh-list
110215327|NCT00104442|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110215328|NCT00104442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110215329|NCT00104442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110215330|NCT00104442|Cholinergic Agents|cholinergic agents|mesh-ancestor
110215331|NCT00104442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110215332|NCT00104442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110215333|NCT00104442|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110215334|NCT00104442|Protective Agents|protective agents|mesh-ancestor
110215335|NCT00255385|Micronutrients|micronutrients|mesh-list
110215336|NCT00255385|Trace Elements|trace elements|mesh-list
110215337|NCT00255385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110215338|NCT00255424|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
110215339|NCT00255424|Hematinics|hematinics|mesh-ancestor
110215340|NCT00255424|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110215341|NCT00255424|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110215342|NCT00069992|Fludarabine|fludarabine|mesh-list
110215343|NCT00069992|Alemtuzumab|alemtuzumab|mesh-list
110215344|NCT00069992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110215345|NCT00069992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110215346|NCT00255463|Gefitinib|gefitinib|mesh-list
110215347|NCT00255463|Anastrozole|anastrozole|mesh-list
110215348|NCT00255463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110215349|NCT00255463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110215350|NCT00255463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110215351|NCT00255463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110215352|NCT00255463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110215353|NCT00255463|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110215354|NCT00255463|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110215355|NCT00255463|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110215356|NCT00255463|Hormone Antagonists|hormone antagonists|mesh-ancestor
110215357|NCT00255463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110215358|NCT00255463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110215359|NCT00255502|Metoprolol|metoprolol|mesh-list
110215360|NCT00255502|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110215361|NCT00255502|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110215362|NCT00255502|Sympatholytics|sympatholytics|mesh-ancestor
110215363|NCT00255502|Autonomic Agents|autonomic agents|mesh-ancestor
110215364|NCT00255502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110215365|NCT00255502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110215366|NCT00255502|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110215367|NCT00255502|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110215368|NCT00255502|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110215369|NCT00255502|Adrenergic Agents|adrenergic agents|mesh-ancestor
110215370|NCT00255502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110215371|NCT00255502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110215372|NCT00255541|Glyburide|glyburide|mesh-list
110215373|NCT00255541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110215374|NCT00255541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110215375|NCT00255658|Sirolimus|sirolimus|mesh-list
110215376|NCT00255658|Sorafenib|sorafenib|mesh-list
110215377|NCT00255658|Temsirolimus|temsirolimus|mesh-list
110215378|NCT00255658|MTOR Inhibitors|mtor inhibitors|mesh-list
110215379|NCT00255658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110215380|NCT00255658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110215381|NCT00255658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110215382|NCT00255658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110215383|NCT00255658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110215384|NCT00255658|Immunologic Factors|immunologic factors|mesh-ancestor
110215385|NCT00255658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110215386|NCT00255658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110215387|NCT00255658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110215388|NCT00255658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110215389|NCT00255658|Antifungal Agents|antifungal agents|mesh-ancestor
110215390|NCT00070148|Megestrol|megestrol|mesh-list
110215391|NCT00070148|Megestrol Acetate|megestrol acetate|mesh-list
110215392|NCT00070148|Oxandrolone|oxandrolone|mesh-list
110215393|NCT00070148|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110215394|NCT00070148|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110215395|NCT00070148|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110215396|NCT00070148|Contraceptive Agents|contraceptive agents|mesh-ancestor
110215397|NCT00070148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110215398|NCT00070148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110215399|NCT00070148|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110215400|NCT00070148|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110215401|NCT00070148|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110215402|NCT00070148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110215403|NCT00070148|Appetite Stimulants|appetite stimulants|mesh-ancestor
110215404|NCT00070148|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110215406|NCT00070148|Hormones|hormones|mesh-ancestor
110215407|NCT00070148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110215408|NCT00070148|Anabolic Agents|anabolic agents|mesh-ancestor
110215409|NCT00100581|Interferons|interferons|mesh-list
110215410|NCT00100581|Ritonavir|ritonavir|mesh-list
110215411|NCT00100581|Tenofovir|tenofovir|mesh-list
110215412|NCT00100581|Ribavirin|ribavirin|mesh-list
110215413|NCT00100581|Interferon-alpha|interferon-alpha|mesh-list
110215414|NCT00100581|Lamivudine|lamivudine|mesh-list
110215415|NCT00100581|Interferon alpha-2|interferon alpha-2|mesh-list
110215416|NCT00100581|Efavirenz|efavirenz|mesh-list
110215417|NCT00100581|Lopinavir|lopinavir|mesh-list
110215418|NCT00100581|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110215419|NCT00100581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110215420|NCT00100581|Antiviral Agents|antiviral agents|mesh-ancestor
110215421|NCT00100581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110215422|NCT00100581|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110215423|NCT00100581|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110215424|NCT00100581|Protease Inhibitors|protease inhibitors|mesh-ancestor
110215425|NCT00100581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110215426|NCT00100581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110215428|NCT00100581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110215429|NCT00100581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110215430|NCT00100581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110215431|NCT00100581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110215432|NCT00100581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110215433|NCT00100581|Antimetabolites|antimetabolites|mesh-ancestor
110215434|NCT00100581|Immunologic Factors|immunologic factors|mesh-ancestor
110215435|NCT00100581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110215436|NCT00100581|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110215437|NCT00100581|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110215438|NCT00100581|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110215439|NCT00100581|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110215440|NCT00100581|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110215442|NCT00070187|Cytarabine|cytarabine|mesh-list
110215443|NCT00070187|Aldesleukin|aldesleukin|mesh-list
110215444|NCT00070187|Interferon-gamma|interferon-gamma|mesh-list
110215445|NCT00070187|Cyclosporine|cyclosporine|mesh-list
110215446|NCT00070187|Etoposide|etoposide|mesh-list
110215447|NCT00070187|Melphalan|melphalan|mesh-list
110215448|NCT00070187|Interleukin-2|interleukin-2|mesh-list
110215449|NCT00070187|Carmustine|carmustine|mesh-list
110215450|NCT00070187|Cyclosporins|cyclosporins|mesh-list
110215451|NCT00070187|Lenograstim|lenograstim|mesh-list
110215452|NCT00070187|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110215453|NCT00070187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110215454|NCT00070187|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110215455|NCT00070187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110215457|NCT00070187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110215458|NCT00070187|Antiviral Agents|antiviral agents|mesh-ancestor
110215459|NCT00070187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110215460|NCT00070187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110215461|NCT00070187|Antimetabolites|antimetabolites|mesh-ancestor
110215462|NCT00070187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110215463|NCT00070187|Immunologic Factors|immunologic factors|mesh-ancestor
110215464|NCT00070187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110215465|NCT00070187|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110215466|NCT00070187|Antifungal Agents|antifungal agents|mesh-ancestor
110215467|NCT00070187|Dermatologic Agents|dermatologic agents|mesh-ancestor
110215468|NCT00070187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110215469|NCT00070187|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110215470|NCT00070187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110215471|NCT00070187|Alkylating Agents|alkylating agents|mesh-ancestor
110215472|NCT00070187|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110215473|NCT00070187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110215474|NCT00070187|Analgesics|analgesics|mesh-ancestor
110215475|NCT00070187|Sensory System Agents|sensory system agents|mesh-ancestor
110215476|NCT00070187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110215477|NCT00070187|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110215478|NCT00070187|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110215479|NCT00415246|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110215480|NCT00415246|Luteolytic Agents|luteolytic agents|mesh-ancestor
110215481|NCT00415246|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110215482|NCT00415246|Contraceptive Agents|contraceptive agents|mesh-ancestor
110215483|NCT00415246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110215484|NCT00415246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110215485|NCT00415246|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110215486|NCT00415246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110215487|NCT00415246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110215488|NCT00415285|Docetaxel|docetaxel|mesh-list
110215490|NCT00415285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110215491|NCT00415285|Tubulin Modulators|tubulin modulators|mesh-ancestor
110215492|NCT00415285|Antimitotic Agents|antimitotic agents|mesh-ancestor
110215493|NCT00415285|Mitosis Modulators|mitosis modulators|mesh-ancestor
110215494|NCT00415285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110215495|NCT00415285|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110027137|NCT05311722|Ketamine|ketamine|mesh-list
110215496|NCT00415285|Antimetabolites|antimetabolites|mesh-ancestor
110215497|NCT00256009|Misoprostol|misoprostol|mesh-list
110215498|NCT00256009|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110215499|NCT00256009|Abortifacient Agents|abortifacient agents|mesh-ancestor
110215500|NCT00256009|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110215501|NCT00256009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110215502|NCT00256009|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110215503|NCT00256009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110052837|NCT01482299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110215504|NCT00256009|Oxytocics|oxytocics|mesh-ancestor
110215505|NCT00100620|Zoledronic Acid|zoledronic acid|mesh-list
110215506|NCT00100620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110215507|NCT00100620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110215508|NCT00070265|Capecitabine|capecitabine|mesh-list
110215509|NCT00070265|Oxaliplatin|oxaliplatin|mesh-list
110215510|NCT00070265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110215511|NCT00070265|Antimetabolites|antimetabolites|mesh-ancestor
110215512|NCT00070265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110215513|NCT00070265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110215515|NCT00104598|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110215516|NCT00104598|Antidepressive Agents|antidepressive agents|mesh-ancestor
110215517|NCT00104598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110215518|NCT00104598|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110215519|NCT00104598|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110215520|NCT00104598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110215521|NCT00104598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110215522|NCT00104598|Dopamine Agents|dopamine agents|mesh-ancestor
110215523|NCT00104598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110215524|NCT00104598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110215525|NCT00104598|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110215526|NCT00104598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110215527|NCT00104598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110215528|NCT00256321|Celecoxib|celecoxib|mesh-list
110215529|NCT00256321|Capecitabine|capecitabine|mesh-list
110215530|NCT00256321|Oxaliplatin|oxaliplatin|mesh-list
110215531|NCT00256321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110215532|NCT00256321|Antimetabolites|antimetabolites|mesh-ancestor
110215533|NCT00256321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110215534|NCT00256321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110215535|NCT00256321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110215536|NCT00256321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110215537|NCT00256321|Analgesics|analgesics|mesh-ancestor
110215538|NCT00256321|Sensory System Agents|sensory system agents|mesh-ancestor
110215539|NCT00256321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110215540|NCT00256321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110215541|NCT00256321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110215542|NCT00256321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110215543|NCT00256321|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110215544|NCT00256321|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110215545|NCT00256321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110215546|NCT00070304|Gemcitabine|gemcitabine|mesh-list
110215547|NCT00070304|Vinorelbine|vinorelbine|mesh-list
110215548|NCT00070304|Lenograstim|lenograstim|mesh-list
110215549|NCT00070304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110215550|NCT00070304|Antimetabolites|antimetabolites|mesh-ancestor
110215551|NCT00070304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110215552|NCT00070304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110215553|NCT00070304|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110215554|NCT00070304|Immunologic Factors|immunologic factors|mesh-ancestor
110215555|NCT00070304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110215556|NCT00070304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110215557|NCT00070304|Tubulin Modulators|tubulin modulators|mesh-ancestor
110215558|NCT00070304|Antimitotic Agents|antimitotic agents|mesh-ancestor
110215559|NCT00070304|Mitosis Modulators|mitosis modulators|mesh-ancestor
110215560|NCT00100737|Rituximab|rituximab|mesh-list
110215561|NCT00100737|Interleukin-2|interleukin-2|mesh-list
110215562|NCT00100737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110215564|NCT00100737|Immunologic Factors|immunologic factors|mesh-ancestor
110215565|NCT00100737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110215566|NCT00100737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110215567|NCT00100737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110215568|NCT00100737|Analgesics|analgesics|mesh-ancestor
110215569|NCT00100737|Sensory System Agents|sensory system agents|mesh-ancestor
110215570|NCT00100737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110215571|NCT00070343|Dacarbazine|dacarbazine|mesh-list
110215572|NCT00070343|Oblimersen|oblimersen|mesh-list
110215573|NCT00070343|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110215574|NCT00070343|Alkylating Agents|alkylating agents|mesh-ancestor
110215575|NCT00070343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110215576|NCT00070343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110215577|NCT00104715|Docetaxel|docetaxel|mesh-list
110215578|NCT00104715|Goserelin|goserelin|mesh-list
110215579|NCT00104715|Androgen Antagonists|androgen antagonists|mesh-list
110215580|NCT00104715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110215581|NCT00104715|Tubulin Modulators|tubulin modulators|mesh-ancestor
110215583|NCT00104715|Mitosis Modulators|mitosis modulators|mesh-ancestor
110215584|NCT00104715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110215585|NCT00104715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110215586|NCT00104715|Hormone Antagonists|hormone antagonists|mesh-ancestor
110215587|NCT00104715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110215588|NCT00104715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110215589|NCT00256711|Vinorelbine|vinorelbine|mesh-list
110215590|NCT00256711|Gefitinib|gefitinib|mesh-list
110215591|NCT00256711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110215592|NCT00256711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110215593|NCT00256711|Tubulin Modulators|tubulin modulators|mesh-ancestor
110215594|NCT00256711|Antimitotic Agents|antimitotic agents|mesh-ancestor
110215595|NCT00256711|Mitosis Modulators|mitosis modulators|mesh-ancestor
110215596|NCT00256711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110215597|NCT00256711|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110215598|NCT00256711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110215599|NCT00070382|Epoetin Alfa|epoetin alfa|mesh-list
110215600|NCT00070382|Darbepoetin alfa|darbepoetin alfa|mesh-list
110215601|NCT00070382|Hematinics|hematinics|mesh-ancestor
110215602|NCT00256828|Lamivudine|lamivudine|mesh-list
110215603|NCT00256828|Efavirenz|efavirenz|mesh-list
110215604|NCT00256828|Didanosine|didanosine|mesh-list
110215605|NCT00256828|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110215606|NCT00256828|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110215607|NCT00256828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110215608|NCT00256828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110215609|NCT00256828|Antiviral Agents|antiviral agents|mesh-ancestor
110215610|NCT00256828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110236602|NCT00346567|Tenofovir|tenofovir|mesh-list
110215611|NCT00256828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110215612|NCT00256828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110215613|NCT00256828|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110215614|NCT00256828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110215615|NCT00256828|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110215616|NCT00256828|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110215617|NCT00256828|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110215618|NCT00256828|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110215619|NCT00256828|Antimetabolites|antimetabolites|mesh-ancestor
110215620|NCT00100776|Olanzapine|olanzapine|mesh-list
110215621|NCT00100776|Antiemetics|antiemetics|mesh-ancestor
110215622|NCT00100776|Autonomic Agents|autonomic agents|mesh-ancestor
110215623|NCT00100776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110215624|NCT00100776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110215625|NCT00100776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110215626|NCT00100776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110215627|NCT00100776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110215629|NCT00100776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110215630|NCT00100776|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110215631|NCT00100776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110215632|NCT00100776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110215633|NCT00100776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110215634|NCT00100776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110215635|NCT00100776|Serotonin Agents|serotonin agents|mesh-ancestor
110215636|NCT00070538|Cytarabine|cytarabine|mesh-list
110215637|NCT00070538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110215638|NCT00070538|Antimetabolites|antimetabolites|mesh-ancestor
110215639|NCT00070538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110215640|NCT00070538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110215641|NCT00070538|Antiviral Agents|antiviral agents|mesh-ancestor
110215642|NCT00070538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110215643|NCT00070538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110215644|NCT00070538|Immunologic Factors|immunologic factors|mesh-ancestor
110215645|NCT00070538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110215646|NCT00257023|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110215647|NCT00257023|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110215648|NCT00257023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110215649|NCT00257023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110215650|NCT00257023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110215651|NCT00257023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110215652|NCT00257023|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110215653|NCT00257023|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110215654|NCT00257023|Serotonin Agents|serotonin agents|mesh-ancestor
110215655|NCT00257023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110215656|NCT00257023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110215657|NCT00257023|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110215660|NCT00257062|Levofloxacin|levofloxacin|mesh-list
110215661|NCT00257062|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110215662|NCT00257062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110215663|NCT00257062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110215664|NCT00257062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110215665|NCT00257062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110215666|NCT00257062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110215667|NCT00257062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110215668|NCT00257062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110215669|NCT00257062|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110215670|NCT00257062|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110215671|NCT00100854|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110215672|NCT00100854|Fulvestrant|fulvestrant|mesh-list
110215673|NCT00100854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110215674|NCT00100854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110215675|NCT00100854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110215676|NCT00100854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110215677|NCT00100854|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110215678|NCT00100854|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110215680|NCT00100854|Hormone Antagonists|hormone antagonists|mesh-ancestor
110215681|NCT00100854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110215682|NCT00100854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110215683|NCT00257140|Levofloxacin|levofloxacin|mesh-list
110215684|NCT00257140|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110215685|NCT00257140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110215686|NCT00257140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110215687|NCT00257140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110215688|NCT00257140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110215689|NCT00257140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110215690|NCT00257140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110215691|NCT00257140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110215692|NCT00257140|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110215693|NCT00257140|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110215694|NCT00257257|Rimonabant|rimonabant|mesh-list
110215695|NCT00257257|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110215696|NCT00257257|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
110215697|NCT00257257|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110215698|NCT00257257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110215699|NCT00257257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110215700|NCT00257257|Hormones|hormones|mesh-ancestor
110215701|NCT00257257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110215702|NCT00257257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110215703|NCT00257452|Moxifloxacin|moxifloxacin|mesh-list
110215704|NCT00257452|Tiotropium Bromide|tiotropium bromide|mesh-list
110215705|NCT00257452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110215706|NCT00257452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110215707|NCT00257452|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110215708|NCT00257452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110215709|NCT00257452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110215710|NCT00257452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110215711|NCT00257452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110215712|NCT00257452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110215713|NCT00257452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110215714|NCT00257452|Autonomic Agents|autonomic agents|mesh-ancestor
110215715|NCT00257452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110215716|NCT00257452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110215717|NCT00257452|Respiratory System Agents|respiratory system agents|mesh-ancestor
110215718|NCT00257452|Parasympatholytics|parasympatholytics|mesh-ancestor
110236624|NCT02957994|Tenofovir|tenofovir|mesh-list
110215719|NCT00257452|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110215720|NCT00257452|Cholinergic Agents|cholinergic agents|mesh-ancestor
110215721|NCT00257452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110215723|NCT00257491|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110215724|NCT00257491|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110215725|NCT00257491|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110215726|NCT00257491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110215727|NCT00104793|Carboplatin|carboplatin|mesh-list
110215728|NCT00104793|Irinotecan|irinotecan|mesh-list
110215729|NCT00104793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110215730|NCT00104793|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110215731|NCT00104793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110215732|NCT00104793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110215733|NCT00104793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110215735|NCT00070655|Warfarin|warfarin|mesh-list
110215736|NCT00070655|Acenocoumarol|acenocoumarol|mesh-list
110215737|NCT00070655|Idraparinux|idraparinux|mesh-list
110215738|NCT00070655|Vitamins|vitamins|mesh-ancestor
110215739|NCT00070655|Micronutrients|micronutrients|mesh-ancestor
110215740|NCT00070655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110215741|NCT00070655|Anticoagulants|anticoagulants|mesh-ancestor
110215742|NCT00070655|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110215743|NCT00070655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110215744|NCT00070655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110215745|NCT00070655|Hemostatics|hemostatics|mesh-ancestor
110215746|NCT00070655|Coagulants|coagulants|mesh-ancestor
110215747|NCT00070655|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110215748|NCT00070655|Antithrombins|antithrombins|mesh-ancestor
110215749|NCT00070655|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110215750|NCT00070655|Protease Inhibitors|protease inhibitors|mesh-ancestor
110215751|NCT00070655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110215752|NCT00257530|Imiquimod|imiquimod|mesh-list
110215753|NCT00257530|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110215754|NCT00257530|Immunologic Factors|immunologic factors|mesh-ancestor
110215755|NCT00257530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110215756|NCT00257530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110215757|NCT00257530|Interferon Inducers|interferon inducers|mesh-ancestor
110215758|NCT00257569|Cetirizine|cetirizine|mesh-list
110215759|NCT00257569|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110215760|NCT00257569|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110215761|NCT00257569|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110215762|NCT00257569|Histamine Antagonists|histamine antagonists|mesh-ancestor
110215763|NCT00257569|Histamine Agents|histamine agents|mesh-ancestor
110215764|NCT00257569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110215765|NCT00257569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110215766|NCT00257569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110215767|NCT00100893|Proanthocyanidin|proanthocyanidin|mesh-list
110215768|NCT00100893|Procyanidin|procyanidin|mesh-list
110215769|NCT00100893|Antioxidants|antioxidants|mesh-ancestor
110215770|NCT00100893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110215771|NCT00100893|Protective Agents|protective agents|mesh-ancestor
110215772|NCT00100893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110215773|NCT00100893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110215774|NCT00100893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110215775|NCT00100893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110215776|NCT00257803|Oxytocin|oxytocin|mesh-list
110215777|NCT00257803|Oxytocics|oxytocics|mesh-ancestor
110215778|NCT00257803|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110215779|NCT00257803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110215781|NCT00401115|Temsirolimus|temsirolimus|mesh-list
110215782|NCT00401115|MTOR Inhibitors|mtor inhibitors|mesh-list
110215783|NCT00401115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110215784|NCT00401115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110215785|NCT00401115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110215786|NCT00401115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110215787|NCT00401115|Antifungal Agents|antifungal agents|mesh-ancestor
110215788|NCT00401115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110215789|NCT00401115|Immunologic Factors|immunologic factors|mesh-ancestor
110215790|NCT00401115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110215791|NCT00401115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110215792|NCT00401115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110215793|NCT00401115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110215794|NCT00257959|Amiodarone|amiodarone|mesh-list
110215795|NCT00257959|Sotalol|sotalol|mesh-list
110215796|NCT00257959|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110215797|NCT00257959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110215798|NCT00257959|Adrenergic Agents|adrenergic agents|mesh-ancestor
110215799|NCT00257959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110215800|NCT00257959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110215801|NCT00257959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110215802|NCT00257959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110215803|NCT00257959|Vasodilator Agents|vasodilator agents|mesh-ancestor
110215804|NCT00257959|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110215805|NCT00257959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110215806|NCT00257959|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110215807|NCT00257959|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110215808|NCT00257959|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110215809|NCT00257959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110215810|NCT00257959|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110215811|NCT00257959|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110215812|NCT00257959|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110215813|NCT00257959|Sympatholytics|sympatholytics|mesh-ancestor
110215814|NCT00257959|Autonomic Agents|autonomic agents|mesh-ancestor
110215815|NCT00257959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110215816|NCT00070733|Methyltestosterone|methyltestosterone|mesh-list
110215817|NCT00070733|Testosterone|testosterone|mesh-list
110215818|NCT00070733|Testosterone undecanoate|testosterone undecanoate|mesh-list
110215819|NCT00070733|Testosterone enanthate|testosterone enanthate|mesh-list
110215820|NCT00070733|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110215821|NCT00070733|Androgens|androgens|mesh-ancestor
110215822|NCT00070733|Hormones|hormones|mesh-ancestor
110215823|NCT00070733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110215824|NCT00070733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110215825|NCT00070733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110215826|NCT00070733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110215827|NCT00070733|Anabolic Agents|anabolic agents|mesh-ancestor
110215828|NCT00258076|Contraceptive Agents|contraceptive agents|mesh-list
110215829|NCT00258076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110215830|NCT00258076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110215831|NCT00258115|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
110215832|NCT00258115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110215834|NCT00258115|Analgesics|analgesics|mesh-ancestor
110215835|NCT00258115|Sensory System Agents|sensory system agents|mesh-ancestor
110215836|NCT00258115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110215837|NCT00258115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110215838|NCT00258115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110215841|NCT00258193|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
110215842|NCT00258193|Enzyme Activators|enzyme activators|mesh-ancestor
110215843|NCT00258193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110215844|NCT00258193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110215846|NCT00100971|Immunologic Factors|immunologic factors|mesh-ancestor
110215847|NCT00100971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110215848|NCT00258232|Celecoxib|celecoxib|mesh-list
110215849|NCT00258232|Capecitabine|capecitabine|mesh-list
110215850|NCT00258232|Irinotecan|irinotecan|mesh-list
110215851|NCT00258232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110215852|NCT00258232|Antimetabolites|antimetabolites|mesh-ancestor
110215853|NCT00258232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110215854|NCT00258232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110215855|NCT00258232|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110215856|NCT00258232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110215857|NCT00258232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110215858|NCT00258232|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110215859|NCT00258232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110215860|NCT00258232|Analgesics|analgesics|mesh-ancestor
110215861|NCT00258232|Sensory System Agents|sensory system agents|mesh-ancestor
110215862|NCT00258232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110215863|NCT00258232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110215865|NCT00258232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110215866|NCT00258232|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110215867|NCT00258232|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110215868|NCT00258271|Cytarabine|cytarabine|mesh-list
110215869|NCT00258271|Imatinib Mesylate|imatinib mesylate|mesh-list
110215870|NCT00258271|Cladribine|cladribine|mesh-list
110215871|NCT00258271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110215872|NCT00258271|Antimetabolites|antimetabolites|mesh-ancestor
110215873|NCT00258271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110215874|NCT00258271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110215875|NCT00258271|Antiviral Agents|antiviral agents|mesh-ancestor
110215876|NCT00258271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110215878|NCT00258271|Immunologic Factors|immunologic factors|mesh-ancestor
110215879|NCT00258271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110215880|NCT00258271|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110215881|NCT00258271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110215882|NCT00101088|Sirolimus|sirolimus|mesh-list
110215883|NCT00101088|Imatinib Mesylate|imatinib mesylate|mesh-list
110215884|NCT00101088|Temsirolimus|temsirolimus|mesh-list
110215885|NCT00101088|MTOR Inhibitors|mtor inhibitors|mesh-list
110215886|NCT00101088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110215887|NCT00101088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110215888|NCT00101088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110215889|NCT00101088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110215890|NCT00101088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110215891|NCT00101088|Immunologic Factors|immunologic factors|mesh-ancestor
110215892|NCT00101088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110215893|NCT00101088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110215894|NCT00101088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110215895|NCT00101088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110215896|NCT00101088|Antifungal Agents|antifungal agents|mesh-ancestor
110215897|NCT00258622|Lidocaine|lidocaine|mesh-list
110215898|NCT00258622|Anesthetics, Local|anesthetics, local|mesh-ancestor
110215899|NCT00258622|Anesthetics|anesthetics|mesh-ancestor
110215900|NCT00258622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110215901|NCT00258622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110215902|NCT00258622|Sensory System Agents|sensory system agents|mesh-ancestor
110215903|NCT00258622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110215904|NCT00258622|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110215905|NCT00258622|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110215906|NCT00258622|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110215907|NCT00258622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110215908|NCT00258622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110215910|NCT00423761|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110215911|NCT00423761|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110215912|NCT00423761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110215913|NCT00423761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110215914|NCT00423761|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110215915|NCT00423761|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110215916|NCT00423761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110215917|NCT00423761|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110215918|NCT00423761|Anesthetics, General|anesthetics, general|mesh-ancestor
110215919|NCT00423761|Anesthetics|anesthetics|mesh-ancestor
110215920|NCT00423761|GABA Modulators|gaba modulators|mesh-ancestor
110215921|NCT00423761|GABA Agents|gaba agents|mesh-ancestor
110215922|NCT00423761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110215923|NCT00423761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110215925|NCT00104910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110215926|NCT00104910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110215927|NCT00415324|Cisplatin|cisplatin|mesh-list
110215928|NCT00415324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110215929|NCT00258739|Carboplatin|carboplatin|mesh-list
110215930|NCT00258739|Gemcitabine|gemcitabine|mesh-list
110215931|NCT00258739|Docetaxel|docetaxel|mesh-list
110215932|NCT00258739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110215933|NCT00258739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110215934|NCT00258739|Antimetabolites|antimetabolites|mesh-ancestor
110215935|NCT00258739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110215936|NCT00258739|Tubulin Modulators|tubulin modulators|mesh-ancestor
110215937|NCT00258739|Antimitotic Agents|antimitotic agents|mesh-ancestor
110215938|NCT00258739|Mitosis Modulators|mitosis modulators|mesh-ancestor
110215939|NCT00104949|Trastuzumab|trastuzumab|mesh-list
110215940|NCT00104949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110215941|NCT00104949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110215942|NCT00101127|Gemcitabine|gemcitabine|mesh-list
110215943|NCT00101127|Docetaxel|docetaxel|mesh-list
110215944|NCT00101127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110215945|NCT00101127|Antimetabolites|antimetabolites|mesh-ancestor
110215946|NCT00101127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110215947|NCT00101127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110215948|NCT00101127|Tubulin Modulators|tubulin modulators|mesh-ancestor
110215949|NCT00101127|Antimitotic Agents|antimitotic agents|mesh-ancestor
110215950|NCT00101127|Mitosis Modulators|mitosis modulators|mesh-ancestor
110215951|NCT00259051|Omeprazole|omeprazole|mesh-list
110215952|NCT00259051|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110215953|NCT00259051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110215954|NCT00259051|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110215955|NCT00259051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110215956|NCT00259051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110215957|NCT00259129|Sorafenib|sorafenib|mesh-list
110215958|NCT00259129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110215959|NCT00259129|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110215960|NCT00259129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110215961|NCT00259129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110215962|NCT00259168|Nateglinide|nateglinide|mesh-list
110215963|NCT00259168|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110215964|NCT00259168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110215966|NCT00259363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110215967|NCT00104988|Thalidomide|thalidomide|mesh-list
110215968|NCT00104988|Temozolomide|temozolomide|mesh-list
110215969|NCT00104988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110215970|NCT00104988|Alkylating Agents|alkylating agents|mesh-ancestor
110236673|NCT00346801|Analgesics|analgesics|mesh-ancestor
110215971|NCT00104988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110215972|NCT00104988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110215973|NCT00104988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110215974|NCT00104988|Immunologic Factors|immunologic factors|mesh-ancestor
110215975|NCT00104988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110215976|NCT00104988|Leprostatic Agents|leprostatic agents|mesh-ancestor
110215977|NCT00104988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110215979|NCT00104988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110215980|NCT00104988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110215981|NCT00104988|Growth Substances|growth substances|mesh-ancestor
110215982|NCT00104988|Growth Inhibitors|growth inhibitors|mesh-ancestor
110215983|NCT00415402|Vitamin D|vitamin d|mesh-list
110215984|NCT00415402|Cholecalciferol|cholecalciferol|mesh-list
110215985|NCT00415402|Vitamins|vitamins|mesh-ancestor
110215986|NCT00415402|Micronutrients|micronutrients|mesh-ancestor
110215987|NCT00415402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110215988|NCT00415402|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110215989|NCT00415402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110215990|NCT00259402|Fluorouracil|fluorouracil|mesh-list
110215991|NCT00259402|Oxaliplatin|oxaliplatin|mesh-list
110215992|NCT00259402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110215993|NCT00259402|Antimetabolites|antimetabolites|mesh-ancestor
110215994|NCT00259402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110215995|NCT00259402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110215996|NCT00259402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110215997|NCT00259402|Immunologic Factors|immunologic factors|mesh-ancestor
110215998|NCT00259402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110215999|NCT00259441|Simvastatin|simvastatin|mesh-list
110216000|NCT00259441|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110216001|NCT00259441|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110216002|NCT00259441|Antimetabolites|antimetabolites|mesh-ancestor
110216003|NCT00259441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110216004|NCT00259441|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110216005|NCT00259441|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110216006|NCT00259441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110216007|NCT00071201|Adefovir|adefovir|mesh-list
110216008|NCT00071201|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
110216009|NCT00071201|Antiviral Agents|antiviral agents|mesh-ancestor
110216010|NCT00071201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110216011|NCT00071201|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110216012|NCT00071201|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110216013|NCT00071201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110216014|NCT00071201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110216015|NCT00259636|Zonisamide|zonisamide|mesh-list
110216016|NCT00259636|Anticonvulsants|anticonvulsants|mesh-ancestor
110216017|NCT00259636|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110216018|NCT00259636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110216019|NCT00259636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110216020|NCT00259636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110216021|NCT00259636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216022|NCT00259675|Carboplatin|carboplatin|mesh-list
110216023|NCT00259675|Gemcitabine|gemcitabine|mesh-list
110216024|NCT00259675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110216025|NCT00259675|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110216026|NCT00259675|Antimetabolites|antimetabolites|mesh-ancestor
110216027|NCT00259675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110216028|NCT00105105|Mifepristone|mifepristone|mesh-list
110027498|NCT01838772|Ribavirin|ribavirin|mesh-list
110216029|NCT00105105|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110216030|NCT00105105|Abortifacient Agents|abortifacient agents|mesh-ancestor
110216031|NCT00105105|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110216032|NCT00105105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216033|NCT00105105|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110216034|NCT00105105|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110216035|NCT00105105|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110216036|NCT00105105|Contraceptive Agents|contraceptive agents|mesh-ancestor
110216037|NCT00105105|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110216038|NCT00105105|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110216039|NCT00105105|Hormone Antagonists|hormone antagonists|mesh-ancestor
110216040|NCT00105105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110216042|NCT00105105|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110216043|NCT00105105|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110216044|NCT00259714|Dialysis Solutions|dialysis solutions|mesh-list
110216045|NCT00259714|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110216046|NCT00071240|Hormones|hormones|mesh-list
110216047|NCT00071240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110216048|NCT00071240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216049|NCT00259792|Budesonide|budesonide|mesh-list
110216050|NCT00259792|Formoterol Fumarate|formoterol fumarate|mesh-list
110216051|NCT00259792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110216052|NCT00259792|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110216053|NCT00259792|Autonomic Agents|autonomic agents|mesh-ancestor
110216054|NCT00259792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110216055|NCT00259792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216057|NCT00259792|Respiratory System Agents|respiratory system agents|mesh-ancestor
110216058|NCT00259792|Glucocorticoids|glucocorticoids|mesh-ancestor
110216059|NCT00259792|Hormones|hormones|mesh-ancestor
110216060|NCT00259792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110216061|NCT00259792|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110216062|NCT00259792|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110216063|NCT00259792|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110216064|NCT00259792|Adrenergic Agents|adrenergic agents|mesh-ancestor
110216065|NCT00259792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110216066|NCT00259792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110216067|NCT00105144|Caspofungin|caspofungin|mesh-list
110216068|NCT00105144|Micafungin|micafungin|mesh-list
110216069|NCT00105144|Antifungal Agents|antifungal agents|mesh-ancestor
110216070|NCT00105144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110216071|NCT00105144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110216072|NCT00105144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110216073|NCT00259870|Olanzapine|olanzapine|mesh-list
110216074|NCT00259870|Antiemetics|antiemetics|mesh-ancestor
110216075|NCT00259870|Autonomic Agents|autonomic agents|mesh-ancestor
110216076|NCT00259870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110216077|NCT00259870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216078|NCT00259870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110216079|NCT00259870|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110216080|NCT00259870|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110216081|NCT00259870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110216082|NCT00259870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110216083|NCT00259870|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110216084|NCT00259870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110216085|NCT00259870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110216086|NCT00259870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110216087|NCT00259870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110216088|NCT00259870|Serotonin Agents|serotonin agents|mesh-ancestor
110216089|NCT00071279|Idraparinux|idraparinux|mesh-list
110216090|NCT00071279|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110216091|NCT00071279|Antithrombins|antithrombins|mesh-ancestor
110216092|NCT00071279|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110216093|NCT00071279|Protease Inhibitors|protease inhibitors|mesh-ancestor
110216094|NCT00071279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110216095|NCT00071279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110216096|NCT00071279|Anticoagulants|anticoagulants|mesh-ancestor
110216097|NCT00259987|Lapatinib|lapatinib|mesh-list
110216098|NCT00259987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110216099|NCT00259987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110216100|NCT00259987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110216101|NCT00259987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110216102|NCT00260026|Docetaxel|docetaxel|mesh-list
110216103|NCT00260026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110216104|NCT00260026|Tubulin Modulators|tubulin modulators|mesh-ancestor
110216105|NCT00260026|Antimitotic Agents|antimitotic agents|mesh-ancestor
110216107|NCT00260026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110216108|NCT00260143|Methyltestosterone|methyltestosterone|mesh-list
110216109|NCT00260143|Testosterone|testosterone|mesh-list
110216110|NCT00260143|Testosterone undecanoate|testosterone undecanoate|mesh-list
110216111|NCT00260143|Testosterone enanthate|testosterone enanthate|mesh-list
110216112|NCT00260143|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110216113|NCT00260143|Androgens|androgens|mesh-ancestor
110216114|NCT00260143|Hormones|hormones|mesh-ancestor
110216115|NCT00260143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110216116|NCT00260143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216117|NCT00260143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110216118|NCT00260143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110216119|NCT00260143|Anabolic Agents|anabolic agents|mesh-ancestor
110216120|NCT00260260|Oxycodone|oxycodone|mesh-list
110216121|NCT00260260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110216122|NCT00260260|Narcotics|narcotics|mesh-ancestor
110216123|NCT00260260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110216124|NCT00260260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216125|NCT00260260|Analgesics|analgesics|mesh-ancestor
110216126|NCT00260260|Sensory System Agents|sensory system agents|mesh-ancestor
110216127|NCT00260260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110216128|NCT00105300|Adalimumab|adalimumab|mesh-list
110216129|NCT00105300|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110216130|NCT00105300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110216131|NCT00105300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110216132|NCT00260416|Abciximab|abciximab|mesh-list
110216133|NCT00260416|Anticoagulants|anticoagulants|mesh-ancestor
110216134|NCT00260416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110216135|NCT00260611|Docetaxel|docetaxel|mesh-list
110216136|NCT00260611|Oxaliplatin|oxaliplatin|mesh-list
110216137|NCT00260611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110216138|NCT00260611|Tubulin Modulators|tubulin modulators|mesh-ancestor
110216139|NCT00260611|Antimitotic Agents|antimitotic agents|mesh-ancestor
110216140|NCT00260611|Mitosis Modulators|mitosis modulators|mesh-ancestor
110216141|NCT00260611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110216142|NCT00424086|Vaccines|vaccines|mesh-list
110216143|NCT00424086|Immunologic Factors|immunologic factors|mesh-ancestor
110216144|NCT00424086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216145|NCT00101205|Oxaliplatin|oxaliplatin|mesh-list
110216146|NCT00101205|Etoposide|etoposide|mesh-list
110216147|NCT00101205|Etoposide phosphate|etoposide phosphate|mesh-list
110216148|NCT00101205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110216149|NCT00101205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110216150|NCT00101205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110216151|NCT00101205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110216153|NCT00101205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110216154|NCT00261079|Fexofenadine|fexofenadine|mesh-list
110216155|NCT00261079|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110216156|NCT00261079|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110216157|NCT00261079|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110216158|NCT00261079|Histamine Antagonists|histamine antagonists|mesh-ancestor
110216159|NCT00261079|Histamine Agents|histamine agents|mesh-ancestor
110216160|NCT00261079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110216161|NCT00261079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110216162|NCT00261079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216163|NCT00261118|Rituximab|rituximab|mesh-list
110216164|NCT00261118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110216165|NCT00261118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110216166|NCT00261118|Immunologic Factors|immunologic factors|mesh-ancestor
110216167|NCT00261118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216168|NCT00261118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110216169|NCT00071747|Lamotrigine|lamotrigine|mesh-list
110216170|NCT00071747|Anticonvulsants|anticonvulsants|mesh-ancestor
110216171|NCT00071747|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110216172|NCT00071747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110216173|NCT00071747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110216174|NCT00071747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110216175|NCT00071747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216177|NCT00071747|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110216178|NCT00071747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110216179|NCT00071747|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110216180|NCT00071747|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110216181|NCT00261313|Darbepoetin alfa|darbepoetin alfa|mesh-list
110216182|NCT00261313|Hematinics|hematinics|mesh-ancestor
110216183|NCT00261352|Metformin|metformin|mesh-list
110216184|NCT00261352|Fenofibrate|fenofibrate|mesh-list
110216185|NCT00261352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110216186|NCT00261352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216187|NCT00261352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110216188|NCT00261352|Antimetabolites|antimetabolites|mesh-ancestor
110216189|NCT00261352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110216190|NCT00261352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110216191|NCT00261391|Marimastat|marimastat|mesh-list
110216192|NCT00261391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110216193|NCT00261391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110216194|NCT00071942|Metronidazole|metronidazole|mesh-list
110216195|NCT00071942|Vaccines|vaccines|mesh-list
110216196|NCT00071942|Immunologic Factors|immunologic factors|mesh-ancestor
110216197|NCT00071942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216198|NCT00071942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110216199|NCT00071942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110216200|NCT00071942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110216201|NCT00071942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110216202|NCT00261469|Topiramate|topiramate|mesh-list
110216203|NCT00261469|Anticonvulsants|anticonvulsants|mesh-ancestor
110216204|NCT00261469|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110216205|NCT00261469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216206|NCT00261508|Risperidone|risperidone|mesh-list
110216207|NCT00261508|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110216208|NCT00261508|Serotonin Agents|serotonin agents|mesh-ancestor
110216209|NCT00261508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110216210|NCT00261508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110216211|NCT00261508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216212|NCT00261508|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110216213|NCT00261508|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110216214|NCT00261508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110216215|NCT00261508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110216216|NCT00261508|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110216217|NCT00261508|Dopamine Agents|dopamine agents|mesh-ancestor
110216218|NCT00261547|Rituximab|rituximab|mesh-list
110216219|NCT00261547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110216220|NCT00261547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110216221|NCT00261547|Immunologic Factors|immunologic factors|mesh-ancestor
110216222|NCT00261547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216223|NCT00261547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110216224|NCT00261586|Aspirin|aspirin|mesh-list
110216225|NCT00261586|Acetaminophen|acetaminophen|mesh-list
110216226|NCT00261586|Ibuprofen|ibuprofen|mesh-list
110216227|NCT00261586|Celecoxib|celecoxib|mesh-list
110216228|NCT00261586|Naproxen|naproxen|mesh-list
110216229|NCT00261586|Rofecoxib|rofecoxib|mesh-list
110216230|NCT00261586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110216231|NCT00261586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110216232|NCT00261586|Analgesics|analgesics|mesh-ancestor
110216233|NCT00261586|Sensory System Agents|sensory system agents|mesh-ancestor
110216234|NCT00261586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110216235|NCT00261586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216236|NCT00261586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110216237|NCT00261586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110216238|NCT00261586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110216239|NCT00261586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110216240|NCT00261586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110216241|NCT00261586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110216242|NCT00261586|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110216243|NCT00261586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110216244|NCT00261586|Antipyretics|antipyretics|mesh-ancestor
110216245|NCT00261586|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110216246|NCT00261586|Gout Suppressants|gout suppressants|mesh-ancestor
110216247|NCT00072020|Zoledronic Acid|zoledronic acid|mesh-list
110216248|NCT00072020|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110216249|NCT00072020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216250|NCT00261625|Alendronate|alendronate|mesh-list
110216251|NCT00261625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110216252|NCT00261625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216253|NCT00261703|Cisplatin|cisplatin|mesh-list
110216254|NCT00261703|Docetaxel|docetaxel|mesh-list
110216255|NCT00261703|Fluorouracil|fluorouracil|mesh-list
110216256|NCT00261703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110216257|NCT00261703|Tubulin Modulators|tubulin modulators|mesh-ancestor
110216258|NCT00261703|Antimitotic Agents|antimitotic agents|mesh-ancestor
110216259|NCT00261703|Mitosis Modulators|mitosis modulators|mesh-ancestor
110216260|NCT00261703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110216261|NCT00261703|Antimetabolites|antimetabolites|mesh-ancestor
110216262|NCT00261703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110216263|NCT00261703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110216264|NCT00261703|Immunologic Factors|immunologic factors|mesh-ancestor
110216265|NCT00261703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216266|NCT00261742|Penicillins|penicillins|mesh-list
110216267|NCT00261742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110216268|NCT00261742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110216269|NCT00072059|Epoetin Alfa|epoetin alfa|mesh-list
110216270|NCT00072059|Hematinics|hematinics|mesh-ancestor
110216271|NCT00261820|Mycophenolic Acid|mycophenolic acid|mesh-list
110216272|NCT00261820|Sirolimus|sirolimus|mesh-list
110216273|NCT00261820|Methylprednisolone|methylprednisolone|mesh-list
110216274|NCT00261820|Prednisolone|prednisolone|mesh-list
110216275|NCT00261820|Tacrolimus|tacrolimus|mesh-list
110216276|NCT00261820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110216277|NCT00261820|Immunologic Factors|immunologic factors|mesh-ancestor
110216278|NCT00261820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216279|NCT00261820|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110216280|NCT00261820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110216281|NCT00261820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110216282|NCT00261820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110216283|NCT00261820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110216284|NCT00261820|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110216285|NCT00261820|Antitubercular Agents|antitubercular agents|mesh-ancestor
110216287|NCT00261820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110216288|NCT00261820|Antifungal Agents|antifungal agents|mesh-ancestor
110216289|NCT00261820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110216290|NCT00261820|Antiemetics|antiemetics|mesh-ancestor
110216291|NCT00261820|Autonomic Agents|autonomic agents|mesh-ancestor
110216292|NCT00261820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110216293|NCT00261820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110216294|NCT00261820|Glucocorticoids|glucocorticoids|mesh-ancestor
110216295|NCT00261820|Hormones|hormones|mesh-ancestor
110216296|NCT00261820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110216297|NCT00261820|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110216298|NCT00261820|Protective Agents|protective agents|mesh-ancestor
110216299|NCT00261820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110216300|NCT00072098|Interleukin-12|interleukin-12|mesh-list
110216301|NCT00072098|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110216302|NCT00072098|Immunologic Factors|immunologic factors|mesh-ancestor
110216303|NCT00072098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216304|NCT00072098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110216305|NCT00072098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110216306|NCT00072098|Growth Substances|growth substances|mesh-ancestor
110216307|NCT00072098|Growth Inhibitors|growth inhibitors|mesh-ancestor
110216308|NCT00072098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110216309|NCT00261937|Furosemide|furosemide|mesh-list
110216310|NCT00261937|Diuretics|diuretics|mesh-ancestor
110216311|NCT00261937|Natriuretic Agents|natriuretic agents|mesh-ancestor
110216312|NCT00261937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216313|NCT00261937|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110216314|NCT00261937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110216315|NCT00261937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110216316|NCT00105495|Deferiprone|deferiprone|mesh-list
110216317|NCT00105495|Deferoxamine|deferoxamine|mesh-list
110216318|NCT00105495|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110216319|NCT00105495|Chelating Agents|chelating agents|mesh-ancestor
110216320|NCT00105495|Sequestering Agents|sequestering agents|mesh-ancestor
110216321|NCT00105495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110216322|NCT00105495|Siderophores|siderophores|mesh-ancestor
110216323|NCT00261976|Infliximab|infliximab|mesh-list
110216324|NCT00261976|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110216325|NCT00261976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110216326|NCT00261976|Dermatologic Agents|dermatologic agents|mesh-ancestor
110216327|NCT00261976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110216328|NCT00261976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110216329|NCT00072137|Metronidazole|metronidazole|mesh-list
110216330|NCT00072137|Molgramostim|molgramostim|mesh-list
110216331|NCT00072137|Vaccines|vaccines|mesh-list
110216332|NCT00072137|Sargramostim|sargramostim|mesh-list
110216333|NCT00072137|Adjuvants, Vaccine|adjuvants, vaccine|mesh-list
110216334|NCT00072137|Immunologic Factors|immunologic factors|mesh-ancestor
110216335|NCT00072137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216336|NCT00072137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110216337|NCT00072137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110216338|NCT00072137|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110216339|NCT00072137|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110216340|NCT00072137|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110216341|NCT00072137|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110216342|NCT00262015|Vaccines|vaccines|mesh-list
110216343|NCT00262015|Immunologic Factors|immunologic factors|mesh-ancestor
110216344|NCT00262015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216345|NCT00262054|Heparin|heparin|mesh-list
110216347|NCT00262054|Bivalirudin|bivalirudin|mesh-list
110216348|NCT00262054|Anticoagulants|anticoagulants|mesh-ancestor
110216349|NCT00262054|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110216350|NCT00262054|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110216351|NCT00262054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110216352|NCT00262054|Antithrombins|antithrombins|mesh-ancestor
110216353|NCT00262054|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110216354|NCT00262054|Protease Inhibitors|protease inhibitors|mesh-ancestor
110216355|NCT00262054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110216356|NCT00262132|Mycophenolic Acid|mycophenolic acid|mesh-list
110216357|NCT00262132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110216358|NCT00262132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110216361|NCT00262132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110216362|NCT00262132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110216363|NCT00262132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110216364|NCT00262132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110216365|NCT00262210|Prednisolone|prednisolone|mesh-list
110216366|NCT00262210|Cyclophosphamide|cyclophosphamide|mesh-list
110216367|NCT00262210|Etoposide|etoposide|mesh-list
110216368|NCT00262210|Epirubicin|epirubicin|mesh-list
110216369|NCT00262210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110216370|NCT00262210|Immunologic Factors|immunologic factors|mesh-ancestor
110216371|NCT00262210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216373|NCT00262210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110216374|NCT00262210|Alkylating Agents|alkylating agents|mesh-ancestor
110216375|NCT00262210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110216376|NCT00262210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110216377|NCT00262210|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110216378|NCT00262210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110216379|NCT00262210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110216380|NCT00262210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110216381|NCT00262210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110216382|NCT00262210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110216383|NCT00262210|Glucocorticoids|glucocorticoids|mesh-ancestor
110216384|NCT00262210|Hormones|hormones|mesh-ancestor
110216385|NCT00262210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110216386|NCT00262210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110216387|NCT00262210|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110216388|NCT00262288|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
110216389|NCT00262288|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110216390|NCT00262288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110216391|NCT00262288|Immunologic Factors|immunologic factors|mesh-ancestor
110216392|NCT00262288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216393|NCT00262327|Endostatins|endostatins|mesh-list
110216394|NCT00262327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110216395|NCT00262327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110216396|NCT00262327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110216397|NCT00262327|Growth Substances|growth substances|mesh-ancestor
110216398|NCT00262327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216399|NCT00262327|Growth Inhibitors|growth inhibitors|mesh-ancestor
110216401|NCT02966288|Ketorolac|ketorolac|mesh-list
110216402|NCT02966288|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110216403|NCT02966288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110216404|NCT02966288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110216405|NCT02966288|Analgesics|analgesics|mesh-ancestor
110216406|NCT02966288|Sensory System Agents|sensory system agents|mesh-ancestor
110216407|NCT02966288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110216408|NCT02966288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216409|NCT02966288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110216410|NCT02966288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110216411|NCT02966288|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110216412|NCT02966288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110216413|NCT02966288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110216415|NCT00262405|Zileuton|zileuton|mesh-list
110216416|NCT00262405|Azathioprine|azathioprine|mesh-list
110216417|NCT00262405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110216419|NCT00262405|Hormones|hormones|mesh-ancestor
110216420|NCT00262405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110216421|NCT00262405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216422|NCT00262405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110216423|NCT00262405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110216424|NCT00262405|Antimetabolites|antimetabolites|mesh-ancestor
110216425|NCT00262405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110216426|NCT00262405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110216427|NCT00262405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110216429|NCT00262405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110216430|NCT00262405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110216431|NCT00262405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110216432|NCT00262405|Analgesics|analgesics|mesh-ancestor
110216433|NCT00262405|Sensory System Agents|sensory system agents|mesh-ancestor
110216434|NCT00262405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110216435|NCT00262405|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110216436|NCT00262405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110216437|NCT00262405|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110216438|NCT00262405|Hormone Antagonists|hormone antagonists|mesh-ancestor
110216439|NCT00262483|Ribavirin|ribavirin|mesh-list
110216440|NCT00262483|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110216441|NCT00262483|Antimetabolites|antimetabolites|mesh-ancestor
110216442|NCT00262483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110216443|NCT00262483|Antiviral Agents|antiviral agents|mesh-ancestor
110216444|NCT00262483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110216445|NCT00262561|Aspirin|aspirin|mesh-list
110216446|NCT00262561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110216447|NCT00262561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110216448|NCT00262561|Analgesics|analgesics|mesh-ancestor
110216449|NCT00262561|Sensory System Agents|sensory system agents|mesh-ancestor
110216450|NCT00262561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110216451|NCT00262561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216452|NCT00262561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110216453|NCT00262561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110216454|NCT00262561|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110216455|NCT00262561|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110216456|NCT00262561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110216457|NCT00262561|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110216458|NCT00262561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110216459|NCT00262561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110216460|NCT00262561|Antipyretics|antipyretics|mesh-ancestor
110216461|NCT00072215|Paclitaxel|paclitaxel|mesh-list
110216462|NCT00072215|Vinblastine|vinblastine|mesh-list
110216463|NCT00072215|Ifosfamide|ifosfamide|mesh-list
110216464|NCT00072215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110216465|NCT00072215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110216466|NCT00072215|Tubulin Modulators|tubulin modulators|mesh-ancestor
110216467|NCT00072215|Antimitotic Agents|antimitotic agents|mesh-ancestor
110216468|NCT00072215|Mitosis Modulators|mitosis modulators|mesh-ancestor
110216469|NCT00072215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110216470|NCT00072215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110216471|NCT00072215|Alkylating Agents|alkylating agents|mesh-ancestor
110216472|NCT00262795|Fludarabine|fludarabine|mesh-list
110216473|NCT00262795|Chlorambucil|chlorambucil|mesh-list
110216474|NCT00262795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110216475|NCT00262795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110216476|NCT00262795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110216477|NCT00262795|Alkylating Agents|alkylating agents|mesh-ancestor
110216478|NCT00072332|Cisplatin|cisplatin|mesh-list
110216479|NCT00072332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110216480|NCT00263029|Capecitabine|capecitabine|mesh-list
110216481|NCT00263029|Oxaliplatin|oxaliplatin|mesh-list
110216482|NCT00263029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110216483|NCT00263029|Antimetabolites|antimetabolites|mesh-ancestor
110216484|NCT00263029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110216485|NCT00263029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110216486|NCT00263068|Rotigotine|rotigotine|mesh-list
110216487|NCT00263068|Dopamine Agonists|dopamine agonists|mesh-ancestor
110216488|NCT00263068|Dopamine Agents|dopamine agents|mesh-ancestor
110216489|NCT00263068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110216491|NCT00263068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216492|NCT00101634|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110216493|NCT00101634|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110216494|NCT00101634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110216495|NCT00101634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110216496|NCT00101634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216497|NCT00101634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110216498|NCT00101634|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110216499|NCT00101634|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110216500|NCT00101634|Serotonin Agents|serotonin agents|mesh-ancestor
110216501|NCT00101634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110216502|NCT00101634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110216503|NCT00101634|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110216504|NCT00101634|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110216505|NCT00101634|Dopamine Agents|dopamine agents|mesh-ancestor
110216507|NCT00263185|Ergocalciferols|ergocalciferols|mesh-list
110216508|NCT00263185|Cholecalciferol|cholecalciferol|mesh-list
110216509|NCT00263185|Vitamins|vitamins|mesh-list
110216510|NCT00263185|Calcium Carbonate|calcium carbonate|mesh-list
110216511|NCT00263185|Micronutrients|micronutrients|mesh-ancestor
110216512|NCT00263185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216513|NCT00263185|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110216514|NCT00263185|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110216515|NCT00263185|Antacids|antacids|mesh-ancestor
110216516|NCT00263185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110216517|NCT00263185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110216518|NCT00263263|Sirolimus|sirolimus|mesh-list
110216519|NCT00263263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110216520|NCT00263263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110216521|NCT00263263|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110216522|NCT00263263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110216523|NCT00263263|Antifungal Agents|antifungal agents|mesh-ancestor
110216524|NCT00263263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110216525|NCT00263263|Immunologic Factors|immunologic factors|mesh-ancestor
110216526|NCT00263263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216527|NCT00101673|Vildagliptin|vildagliptin|mesh-list
110216528|NCT00101673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110216529|NCT00101673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216530|NCT00101673|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110216531|NCT00101673|Protease Inhibitors|protease inhibitors|mesh-ancestor
110216532|NCT00101673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110216533|NCT00101673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110216534|NCT00263302|Dexamethasone|dexamethasone|mesh-list
110216535|NCT00263302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110216536|NCT00263302|Antiemetics|antiemetics|mesh-ancestor
110216537|NCT00263302|Autonomic Agents|autonomic agents|mesh-ancestor
110216538|NCT00263302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110216539|NCT00263302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216540|NCT00263302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110216541|NCT00263302|Glucocorticoids|glucocorticoids|mesh-ancestor
110216542|NCT00263302|Hormones|hormones|mesh-ancestor
110216543|NCT00263302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110216544|NCT00263302|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110216545|NCT00263302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110216547|NCT00263458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110216548|NCT00263458|Narcotics|narcotics|mesh-ancestor
110216549|NCT00263458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110216550|NCT00263458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216553|NCT00263458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110216555|NCT00101712|Vildagliptin|vildagliptin|mesh-list
110216556|NCT00101712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110216557|NCT00101712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216558|NCT00101712|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110216559|NCT00101712|Protease Inhibitors|protease inhibitors|mesh-ancestor
110216560|NCT00101712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110216561|NCT00101712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110216562|NCT00072527|Carboplatin|carboplatin|mesh-list
110216563|NCT00072527|Irinotecan|irinotecan|mesh-list
110216564|NCT00072527|Etoposide|etoposide|mesh-list
110216565|NCT00072527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110216566|NCT00072527|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110216567|NCT00072527|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110216568|NCT00072527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110216569|NCT00072527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110216570|NCT00072527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110216571|NCT00072527|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110216572|NCT00101751|Insulin Aspart|insulin aspart|mesh-list
110216573|NCT00101751|Biphasic Insulins|biphasic insulins|mesh-list
110216574|NCT00101751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110216575|NCT00101751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216577|NCT00263965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110216578|NCT00263965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216579|NCT00264082|Zoledronic Acid|zoledronic acid|mesh-list
110216580|NCT00264082|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110216581|NCT00264082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216582|NCT00072683|Tolvaptan|tolvaptan|mesh-list
110216583|NCT00072683|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110216584|NCT00072683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110216585|NCT00072683|Natriuretic Agents|natriuretic agents|mesh-ancestor
110216586|NCT00072683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216587|NCT00101790|Pamidronate|pamidronate|mesh-list
110216588|NCT00101790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110216589|NCT00101790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216590|NCT00264277|Vitamin K|vitamin k|mesh-list
110216591|NCT00264277|Anticoagulants|anticoagulants|mesh-list
110216592|NCT00264277|Vitamins|vitamins|mesh-ancestor
110216594|NCT00264277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216595|NCT00264277|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110216596|NCT00264277|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110216597|NCT00264277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110216598|NCT00264277|Hemostatics|hemostatics|mesh-ancestor
110216599|NCT00264277|Coagulants|coagulants|mesh-ancestor
110216600|NCT00415753|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110216601|NCT00415753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110216603|NCT04709029|Dexamethasone acetate|dexamethasone acetate|mesh-list
110216604|NCT04709029|BB 1101|bb 1101|mesh-list
110216605|NCT04709029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110216606|NCT04709029|Antiemetics|antiemetics|mesh-ancestor
110216607|NCT04709029|Autonomic Agents|autonomic agents|mesh-ancestor
110216608|NCT04709029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110216609|NCT04709029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216610|NCT04709029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110216611|NCT04709029|Glucocorticoids|glucocorticoids|mesh-ancestor
110216612|NCT04709029|Hormones|hormones|mesh-ancestor
110216613|NCT04709029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110216614|NCT04709029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110216615|NCT04709029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110216616|NCT04709029|Protease Inhibitors|protease inhibitors|mesh-ancestor
110216617|NCT04709029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110216618|NCT04709029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110216619|NCT00072722|Pomalidomide|pomalidomide|mesh-list
110216620|NCT00072722|Immunologic Factors|immunologic factors|mesh-ancestor
110216621|NCT00072722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216622|NCT00072722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110216623|NCT00072722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110216624|NCT00072722|Growth Substances|growth substances|mesh-ancestor
110216625|NCT00072722|Growth Inhibitors|growth inhibitors|mesh-ancestor
110216626|NCT00072722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110216627|NCT00264355|Cyclosporine|cyclosporine|mesh-list
110216628|NCT00264355|Cyclosporins|cyclosporins|mesh-list
110216629|NCT00264355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110216630|NCT00264355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110216631|NCT00264355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110216632|NCT00264355|Immunologic Factors|immunologic factors|mesh-ancestor
110216633|NCT00264355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216634|NCT00264355|Antifungal Agents|antifungal agents|mesh-ancestor
110216635|NCT00264355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110216636|NCT00264355|Dermatologic Agents|dermatologic agents|mesh-ancestor
110216637|NCT00264355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110216638|NCT00264355|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110216639|NCT00264472|Eniluracil|eniluracil|mesh-list
110216640|NCT00264472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110216641|NCT00264472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110216642|NCT00101829|Rituximab|rituximab|mesh-list
110216643|NCT00101829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110216644|NCT00101829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110216645|NCT00101829|Immunologic Factors|immunologic factors|mesh-ancestor
110216646|NCT00101829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216647|NCT00101829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110216648|NCT00072839|Teduglutide|teduglutide|mesh-list
110216649|NCT00072839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110216650|NCT00072839|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110216651|NCT00072839|Protective Agents|protective agents|mesh-ancestor
110216652|NCT00072839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216654|NCT00264628|Antiemetics|antiemetics|mesh-ancestor
110216655|NCT00264628|Autonomic Agents|autonomic agents|mesh-ancestor
110216656|NCT00264628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110216657|NCT00264628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216658|NCT00264628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110216659|NCT00264628|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110216661|NCT00264628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110216662|NCT00264901|Insulin Detemir|insulin detemir|mesh-list
110216663|NCT00264901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110216664|NCT00264901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216665|NCT00265018|Doxorubicin|doxorubicin|mesh-list
110216666|NCT00265018|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110216667|NCT00265018|Bleomycin|bleomycin|mesh-list
110216668|NCT00265018|Vinblastine|vinblastine|mesh-list
110216669|NCT00265018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110216670|NCT00265018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110216671|NCT00265018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110216672|NCT00265018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110216673|NCT00265018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110216674|NCT00265018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110216675|NCT00265018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110216676|NCT00265018|Tubulin Modulators|tubulin modulators|mesh-ancestor
110216677|NCT00265018|Antimitotic Agents|antimitotic agents|mesh-ancestor
110216678|NCT00265018|Mitosis Modulators|mitosis modulators|mesh-ancestor
110216680|NCT00265135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110216681|NCT00106197|Bupropion|bupropion|mesh-list
110216682|NCT00106197|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110216683|NCT00106197|Antidepressive Agents|antidepressive agents|mesh-ancestor
110216685|NCT00106197|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110216686|NCT00106197|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110216687|NCT00106197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110216688|NCT00106197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110216689|NCT00106197|Dopamine Agents|dopamine agents|mesh-ancestor
110216690|NCT00106197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110216691|NCT00106197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216692|NCT00106197|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110216693|NCT00106197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110216694|NCT00106197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110216695|NCT00265252|Alendronate|alendronate|mesh-list
110216696|NCT00265252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110216697|NCT00265252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216699|NCT00265291|Desipramine|desipramine|mesh-list
110216700|NCT00265291|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110216701|NCT00265291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110216702|NCT00265291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110216703|NCT00265291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110216704|NCT00265291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110216705|NCT00265291|Serotonin Agents|serotonin agents|mesh-ancestor
110216706|NCT00265291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216707|NCT00265291|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110216708|NCT00265291|Antidepressive Agents|antidepressive agents|mesh-ancestor
110216709|NCT00265291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110236836|NCT00347425|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110216710|NCT00265291|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110216711|NCT00265291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110216712|NCT00265291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110216714|NCT00265291|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110216715|NCT00265291|Adrenergic Agents|adrenergic agents|mesh-ancestor
110216716|NCT00265408|Aspirin|aspirin|mesh-list
110216717|NCT00265408|Warfarin|warfarin|mesh-list
110216718|NCT00265408|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110216719|NCT00265408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110216720|NCT00265408|Analgesics|analgesics|mesh-ancestor
110216721|NCT00265408|Sensory System Agents|sensory system agents|mesh-ancestor
110216722|NCT00265408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110216723|NCT00265408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216724|NCT00265408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110216725|NCT00265408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110216726|NCT00265408|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110216727|NCT00265408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110216728|NCT00265408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110216729|NCT00265408|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110216730|NCT00265408|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110216731|NCT00265408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110216732|NCT00265408|Antipyretics|antipyretics|mesh-ancestor
110216733|NCT00265408|Anticoagulants|anticoagulants|mesh-ancestor
110216734|NCT00265486|Epoetin Alfa|epoetin alfa|mesh-list
110216735|NCT00265486|Hematinics|hematinics|mesh-ancestor
110216737|NCT00265642|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110216738|NCT00265642|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110216739|NCT00265642|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110216741|NCT00265915|Rituximab|rituximab|mesh-list
110216742|NCT00265915|Sargramostim|sargramostim|mesh-list
110216743|NCT00265915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110216744|NCT00265915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110216745|NCT00265915|Immunologic Factors|immunologic factors|mesh-ancestor
110216746|NCT00265915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216747|NCT00265915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110216748|NCT00265993|Enoxaparin|enoxaparin|mesh-list
110216749|NCT00265993|Anticoagulants|anticoagulants|mesh-ancestor
110216750|NCT00265993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110216751|NCT00265993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110216752|NCT00265993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110216753|NCT00266149|Lamotrigine|lamotrigine|mesh-list
110216754|NCT00266149|Anticonvulsants|anticonvulsants|mesh-ancestor
110216755|NCT00266149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110216756|NCT00266149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110216757|NCT00266149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110216758|NCT00266149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110216759|NCT00266149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216760|NCT00266149|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110216761|NCT00266149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110216762|NCT00266149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110216763|NCT00266149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110216764|NCT00266149|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110216765|NCT00106314|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
110216766|NCT00106314|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110216767|NCT00106314|Immunologic Factors|immunologic factors|mesh-ancestor
110216768|NCT00106314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216769|NCT00415792|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110216770|NCT00415792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110216771|NCT00415792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216774|NCT00415831|Entacapone|entacapone|mesh-list
110216775|NCT00415831|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110216776|NCT00415831|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110216777|NCT00415831|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110216778|NCT00415831|Dopamine Agents|dopamine agents|mesh-ancestor
110216779|NCT00415831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110216780|NCT00415831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110216781|NCT00415831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216782|NCT00415831|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110216783|NCT00415831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110216784|NCT00415831|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
110216785|NCT00415831|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110216787|NCT00415831|Dopamine Agonists|dopamine agonists|mesh-ancestor
110216788|NCT00102141|Drospirenone|drospirenone|mesh-list
110216789|NCT00102141|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110216790|NCT00102141|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110216791|NCT00102141|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110216792|NCT00102141|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
110216793|NCT00102141|Estradiol|estradiol|mesh-list
110216794|NCT00102141|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110216795|NCT00102141|Estrogens|estrogens|mesh-ancestor
110216796|NCT00102141|Hormones|hormones|mesh-ancestor
110216797|NCT00102141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110216798|NCT00102141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216799|NCT00102141|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110216800|NCT00102141|Contraceptive Agents|contraceptive agents|mesh-ancestor
110216801|NCT00102141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110216802|NCT00102141|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110216803|NCT00102141|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110216804|NCT00102141|Hormone Antagonists|hormone antagonists|mesh-ancestor
110216805|NCT00102141|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110216807|NCT00102141|Natriuretic Agents|natriuretic agents|mesh-ancestor
110216808|NCT00102141|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110216809|NCT00102141|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110216810|NCT00266344|Gaboxadol|gaboxadol|mesh-list
110216811|NCT00266344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110216812|NCT00266344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110216813|NCT00266344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216816|NCT00266344|Sensory System Agents|sensory system agents|mesh-ancestor
110216817|NCT00266344|Anticonvulsants|anticonvulsants|mesh-ancestor
110216818|NCT00266344|GABA Agonists|gaba agonists|mesh-ancestor
110216819|NCT00266344|GABA Agents|gaba agents|mesh-ancestor
110216820|NCT00266539|Fentanyl|fentanyl|mesh-list
110216821|NCT00266539|Morphine|morphine|mesh-list
110216822|NCT00266539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110216823|NCT00266539|Narcotics|narcotics|mesh-ancestor
110216824|NCT00266539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110216826|NCT00266539|Analgesics|analgesics|mesh-ancestor
110216827|NCT00266539|Sensory System Agents|sensory system agents|mesh-ancestor
110216828|NCT00266539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110216829|NCT00266539|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110216830|NCT00266539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110216831|NCT00266539|Anesthetics, General|anesthetics, general|mesh-ancestor
110216832|NCT00266539|Anesthetics|anesthetics|mesh-ancestor
110216833|NCT00266578|Fluticasone|fluticasone|mesh-list
110216835|NCT00266578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110216836|NCT00266578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110216837|NCT00266578|Autonomic Agents|autonomic agents|mesh-ancestor
110216838|NCT00266578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110216839|NCT00266578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216840|NCT00266578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110216841|NCT00266578|Respiratory System Agents|respiratory system agents|mesh-ancestor
110216842|NCT00266578|Dermatologic Agents|dermatologic agents|mesh-ancestor
110216843|NCT00266578|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110216844|NCT00266617|Epoetin Alfa|epoetin alfa|mesh-list
110216845|NCT00266617|Hematinics|hematinics|mesh-ancestor
110216846|NCT00102219|Doxorubicin|doxorubicin|mesh-list
110216848|NCT00102219|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110216849|NCT00102219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110216850|NCT00102219|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110216851|NCT00102219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110216852|NCT00102219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110216853|NCT00102219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110216854|NCT00102219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110216855|NCT00102219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110216856|NCT01349569|Lenalidomide|lenalidomide|mesh-list
110216857|NCT01349569|Vaccines|vaccines|mesh-list
110216858|NCT01349569|Immunologic Factors|immunologic factors|mesh-ancestor
110216859|NCT01349569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216860|NCT01349569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110216861|NCT01349569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110216862|NCT01349569|Growth Substances|growth substances|mesh-ancestor
110216863|NCT01349569|Growth Inhibitors|growth inhibitors|mesh-ancestor
110216864|NCT01349569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110216865|NCT00267163|Donepezil|donepezil|mesh-list
110216866|NCT00267163|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110216867|NCT00267163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110216868|NCT00267163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110216869|NCT00267163|Cholinergic Agents|cholinergic agents|mesh-ancestor
110216870|NCT00267163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110216871|NCT00267163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216872|NCT00267163|Nootropic Agents|nootropic agents|mesh-ancestor
110216874|NCT00267319|(T,G)-A-L|(t,g)-a-l|mesh-list
110216875|NCT00267319|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110216876|NCT00267319|Immunologic Factors|immunologic factors|mesh-ancestor
110216877|NCT00267319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216878|NCT00267319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110216879|NCT00267319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110216880|NCT00073385|Docetaxel|docetaxel|mesh-list
110216881|NCT00073385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110216882|NCT00073385|Tubulin Modulators|tubulin modulators|mesh-ancestor
110216883|NCT00073385|Antimitotic Agents|antimitotic agents|mesh-ancestor
110216885|NCT00073385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110216886|NCT00102258|Hormones|hormones|mesh-list
110216887|NCT00102258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110216888|NCT00102258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216889|NCT00267514|Sevelamer|sevelamer|mesh-list
110216890|NCT00267514|Chelating Agents|chelating agents|mesh-ancestor
110216891|NCT00267514|Sequestering Agents|sequestering agents|mesh-ancestor
110216892|NCT00267514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110216893|NCT00267553|Toremifene|toremifene|mesh-list
110216894|NCT00267553|Letrozole|letrozole|mesh-list
110216895|NCT00267553|Atamestane|atamestane|mesh-list
110216896|NCT00267553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110216897|NCT00267553|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110216898|NCT00267553|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110216900|NCT00267553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110216901|NCT00267553|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110216902|NCT00267553|Hormone Antagonists|hormone antagonists|mesh-ancestor
110216903|NCT00267553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110216904|NCT00267553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216905|NCT00267553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110236869|NCT00126087|Dopamine Agents|dopamine agents|mesh-ancestor
110216906|NCT00267553|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110216907|NCT00267553|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110216908|NCT00267553|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110216909|NCT00106548|Methotrexate|methotrexate|mesh-list
110216910|NCT00106548|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110216911|NCT00106548|Abortifacient Agents|abortifacient agents|mesh-ancestor
110216912|NCT00106548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110216914|NCT00106548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110216915|NCT00106548|Antimetabolites|antimetabolites|mesh-ancestor
110216916|NCT00106548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110216917|NCT00106548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110216919|NCT00106548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110216920|NCT00106548|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110216921|NCT00106548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110216923|NCT00106548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110216924|NCT00106548|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110216925|NCT00267709|Visilizumab|visilizumab|mesh-list
110216926|NCT00267709|Immunologic Factors|immunologic factors|mesh-ancestor
110216927|NCT00267709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216928|NCT00267826|Rituximab|rituximab|mesh-list
110216929|NCT00267826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110216930|NCT00267826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110216931|NCT00267826|Immunologic Factors|immunologic factors|mesh-ancestor
110216932|NCT00267826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216935|NCT00425620|Amebicides|amebicides|mesh-ancestor
110216936|NCT00425620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110216937|NCT00425620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110216938|NCT00425620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110216939|NCT00425620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110216940|NCT00425620|Antifungal Agents|antifungal agents|mesh-ancestor
110216941|NCT00267943|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110216942|NCT00267943|Telmisartan|telmisartan|mesh-list
110216943|NCT00267943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110216944|NCT00267943|Diuretics|diuretics|mesh-ancestor
110216945|NCT00267943|Natriuretic Agents|natriuretic agents|mesh-ancestor
110216946|NCT00267943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216947|NCT00267943|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110216948|NCT00267943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110216949|NCT00267943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110216950|NCT00267943|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110216951|NCT00267943|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110216952|NCT04711265|Vaccines|vaccines|mesh-list
110216953|NCT04711265|Immunologic Factors|immunologic factors|mesh-ancestor
110216954|NCT04711265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216955|NCT00268138|Fluorides|fluorides|mesh-list
110216956|NCT00268138|Cariostatic Agents|cariostatic agents|mesh-ancestor
110216957|NCT00268138|Protective Agents|protective agents|mesh-ancestor
110216958|NCT00268138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216959|NCT00102375|Topotecan|topotecan|mesh-list
110216960|NCT00102375|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110216961|NCT00102375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110216962|NCT00102375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110216963|NCT00102375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110216964|NCT00102375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110216965|NCT00268177|Fluticasone|fluticasone|mesh-list
110216967|NCT00268177|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110216968|NCT00268177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110216969|NCT00268177|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110216970|NCT00268177|Autonomic Agents|autonomic agents|mesh-ancestor
110216971|NCT00268177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110027646|NCT01721616|Azithromycin|azithromycin|mesh-list
110216972|NCT00268177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216973|NCT00268177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110216974|NCT00268177|Respiratory System Agents|respiratory system agents|mesh-ancestor
110216975|NCT00268177|Dermatologic Agents|dermatologic agents|mesh-ancestor
110216976|NCT00268177|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110216977|NCT00268177|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110216978|NCT00268177|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110216979|NCT00268177|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110216980|NCT00268177|Adrenergic Agents|adrenergic agents|mesh-ancestor
110216981|NCT00268177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110216982|NCT00268177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110216984|NCT00268216|Xhance|xhance|mesh-list
110216985|NCT00268216|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110216986|NCT00268216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110216987|NCT00268216|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110216988|NCT00268216|Autonomic Agents|autonomic agents|mesh-ancestor
110216989|NCT00268216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110216990|NCT00268216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216991|NCT00268216|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110216992|NCT00268216|Respiratory System Agents|respiratory system agents|mesh-ancestor
110216993|NCT00268216|Dermatologic Agents|dermatologic agents|mesh-ancestor
110216995|NCT00268216|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110216996|NCT00268216|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110216997|NCT00268216|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110216998|NCT00268216|Adrenergic Agents|adrenergic agents|mesh-ancestor
110216999|NCT00268216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110217000|NCT00268216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217001|NCT00073580|Hirudins|hirudins|mesh-list
110217002|NCT00073580|Anticoagulants|anticoagulants|mesh-list
110217003|NCT00073580|Bivalirudin|bivalirudin|mesh-list
110217004|NCT00073580|Antithrombins|antithrombins|mesh-ancestor
110217005|NCT00073580|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110217006|NCT00073580|Protease Inhibitors|protease inhibitors|mesh-ancestor
110217007|NCT00073580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110217008|NCT00073580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217009|NCT00073580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110217010|NCT00073580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110217011|NCT00073658|Risperidone|risperidone|mesh-list
110217013|NCT00073658|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110217014|NCT00073658|Serotonin Agents|serotonin agents|mesh-ancestor
110217015|NCT00073658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110217016|NCT00073658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217017|NCT00073658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110217018|NCT00073658|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110217019|NCT00073658|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110217020|NCT00073658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110217021|NCT00073658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110217022|NCT00073658|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110217023|NCT00073658|Dopamine Agents|dopamine agents|mesh-ancestor
110217024|NCT00073658|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110217025|NCT00073658|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110217026|NCT00073658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110217027|NCT00073658|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110217029|NCT00268255|Gefitinib|gefitinib|mesh-list
110217030|NCT00268255|Enzyme Inhibitors|enzyme inhibitors|mesh-list
110217031|NCT00268255|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
110217032|NCT00268255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110217033|NCT00268255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110217034|NCT00268255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217035|NCT00102414|Gemcitabine|gemcitabine|mesh-list
110217036|NCT00102414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110217037|NCT00102414|Antimetabolites|antimetabolites|mesh-ancestor
110217038|NCT00102414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217039|NCT00102414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110217040|NCT00268333|Leucovorin|leucovorin|mesh-list
110217041|NCT00268333|Fluorouracil|fluorouracil|mesh-list
110217042|NCT00268333|Oxaliplatin|oxaliplatin|mesh-list
110217043|NCT00268333|Calcium|calcium|mesh-list
110217044|NCT00268333|Levoleucovorin|levoleucovorin|mesh-list
110217045|NCT00268333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110217046|NCT00268333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110217047|NCT00268333|Antimetabolites|antimetabolites|mesh-ancestor
110217048|NCT00268333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217049|NCT00268333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110217050|NCT00268333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110217051|NCT00268333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110217052|NCT00268333|Immunologic Factors|immunologic factors|mesh-ancestor
110217053|NCT00268333|Antidotes|antidotes|mesh-ancestor
110217054|NCT00268333|Protective Agents|protective agents|mesh-ancestor
110217055|NCT00268333|Vitamin B Complex|vitamin b complex|mesh-ancestor
110217057|NCT00268333|Micronutrients|micronutrients|mesh-ancestor
110217058|NCT00073697|Dexetimide|dexetimide|mesh-list
110217059|NCT00073697|Citalopram|citalopram|mesh-list
110217060|NCT00073697|Escitalopram|escitalopram|mesh-list
110217061|NCT00073697|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110217062|NCT00073697|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110217063|NCT00073697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110217064|NCT00073697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217066|NCT00073697|Serotonin Agents|serotonin agents|mesh-ancestor
110217067|NCT00073697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110217068|NCT00073697|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110217069|NCT00073697|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110217070|NCT00073697|Parasympatholytics|parasympatholytics|mesh-ancestor
110217071|NCT00073697|Autonomic Agents|autonomic agents|mesh-ancestor
110217072|NCT00073697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110217073|NCT00073697|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110217074|NCT00073697|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110217075|NCT00073697|Cholinergic Agents|cholinergic agents|mesh-ancestor
110217076|NCT00073697|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110217077|NCT00073697|Antidepressive Agents|antidepressive agents|mesh-ancestor
110217078|NCT00073697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110217081|NCT00268372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110217082|NCT00268372|Tubulin Modulators|tubulin modulators|mesh-ancestor
110217083|NCT00268372|Antimitotic Agents|antimitotic agents|mesh-ancestor
110217084|NCT00268372|Mitosis Modulators|mitosis modulators|mesh-ancestor
110217085|NCT00268372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217086|NCT00268372|Antimetabolites|antimetabolites|mesh-ancestor
110217087|NCT00268372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110217088|NCT00268372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110217089|NCT00268372|Immunologic Factors|immunologic factors|mesh-ancestor
110217090|NCT00268372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110217091|NCT00268411|Gemcitabine|gemcitabine|mesh-list
110217092|NCT00268411|Oxaliplatin|oxaliplatin|mesh-list
110217093|NCT00268411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110217094|NCT00268411|Antimetabolites|antimetabolites|mesh-ancestor
110217095|NCT00268411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217096|NCT00268411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110217098|NCT00073736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110217099|NCT00073736|Antimetabolites|antimetabolites|mesh-ancestor
110217100|NCT00073736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217101|NCT00073736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110217102|NCT00073736|Antiviral Agents|antiviral agents|mesh-ancestor
110217103|NCT00073736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110217104|NCT00073736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110217105|NCT00073736|Immunologic Factors|immunologic factors|mesh-ancestor
110217106|NCT00073736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110217108|NCT00268489|Pemetrexed|pemetrexed|mesh-list
110217109|NCT00268489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110217110|NCT00268489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110217111|NCT00268489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110217112|NCT00268489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110217113|NCT00268489|Growth Substances|growth substances|mesh-ancestor
110217114|NCT00268489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110217115|NCT00268489|Growth Inhibitors|growth inhibitors|mesh-ancestor
110217116|NCT00268489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110217117|NCT00268489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217118|NCT00268489|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110217119|NCT00268489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110217120|NCT00268528|Methotrexate|methotrexate|mesh-list
110217121|NCT00268528|Mercaptopurine|mercaptopurine|mesh-list
110217122|NCT00268528|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110217123|NCT00268528|Abortifacient Agents|abortifacient agents|mesh-ancestor
110217124|NCT00268528|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110217125|NCT00268528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110217126|NCT00268528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110217127|NCT00268528|Antimetabolites|antimetabolites|mesh-ancestor
110217128|NCT00268528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217129|NCT00268528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110217130|NCT00268528|Dermatologic Agents|dermatologic agents|mesh-ancestor
110217131|NCT00268528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110217133|NCT00268528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110217134|NCT00268528|Immunologic Factors|immunologic factors|mesh-ancestor
110217135|NCT00268528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110217136|NCT00268528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110217137|NCT00073814|Albuterol|albuterol|mesh-list
110217139|NCT00073814|Autonomic Agents|autonomic agents|mesh-ancestor
110217140|NCT00073814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110217141|NCT00073814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110217142|NCT00073814|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110217143|NCT00073814|Respiratory System Agents|respiratory system agents|mesh-ancestor
110217144|NCT00073814|Tocolytic Agents|tocolytic agents|mesh-ancestor
110217145|NCT00073814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110217146|NCT00073814|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110217147|NCT00073814|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110217148|NCT00073814|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110217149|NCT00073814|Adrenergic Agents|adrenergic agents|mesh-ancestor
110217150|NCT00073814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110217151|NCT00073814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217152|NCT00102453|Pentoxifylline|pentoxifylline|mesh-list
110217153|NCT00102453|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110217154|NCT00102453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110217155|NCT00102453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217156|NCT00102453|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110217157|NCT00102453|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110217158|NCT00102453|Protective Agents|protective agents|mesh-ancestor
110217159|NCT00102453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236908|NCT00421252|Clopidogrel|clopidogrel|mesh-list
110217160|NCT00102453|Vasodilator Agents|vasodilator agents|mesh-ancestor
110217161|NCT00102453|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110217164|NCT00268567|Leflunomide|leflunomide|mesh-list
110217165|NCT00268567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110217168|NCT00268567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110217170|NCT00268567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110217171|NCT00268567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110217172|NCT00268567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110217173|NCT00268567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217174|NCT00268567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110217175|NCT00268567|Immunologic Factors|immunologic factors|mesh-ancestor
110217176|NCT00268645|Insulin Glargine|insulin glargine|mesh-list
110217177|NCT00268645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110217178|NCT00268645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110217180|NCT00268684|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110217181|NCT00268684|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110217182|NCT00268684|Alkylating Agents|alkylating agents|mesh-ancestor
110217183|NCT00268684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217184|NCT00268684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110217185|NCT00268684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110217186|NCT00268684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110217187|NCT00106821|Bromides|bromides|mesh-list
110217188|NCT00106821|Tiotropium Bromide|tiotropium bromide|mesh-list
110217189|NCT00106821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110217190|NCT00106821|Autonomic Agents|autonomic agents|mesh-ancestor
110217191|NCT00106821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110217192|NCT00106821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110217193|NCT00106821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110217194|NCT00106821|Respiratory System Agents|respiratory system agents|mesh-ancestor
110217195|NCT00106821|Parasympatholytics|parasympatholytics|mesh-ancestor
110217196|NCT00106821|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110217197|NCT00106821|Cholinergic Agents|cholinergic agents|mesh-ancestor
110217198|NCT00106821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110217201|NCT00073931|Tositumomab I-131|tositumomab i-131|mesh-list
110217202|NCT00073931|Sargramostim|sargramostim|mesh-list
110217203|NCT00073931|Immunologic Factors|immunologic factors|mesh-ancestor
110217204|NCT00073931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110217205|NCT00073931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110217207|NCT00268723|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110217208|NCT00268723|Autonomic Agents|autonomic agents|mesh-ancestor
110217209|NCT00268723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110217210|NCT00268723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110217211|NCT00268723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110217212|NCT00268723|Respiratory System Agents|respiratory system agents|mesh-ancestor
110217213|NCT00268723|Tocolytic Agents|tocolytic agents|mesh-ancestor
110217214|NCT00268723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110217215|NCT00268723|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110217216|NCT00268723|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110217217|NCT00268723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110217218|NCT00268723|Adrenergic Agents|adrenergic agents|mesh-ancestor
110217219|NCT00268723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110217220|NCT00268723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217221|NCT00268840|Gemcitabine|gemcitabine|mesh-list
110217222|NCT00268840|Docetaxel|docetaxel|mesh-list
110217223|NCT00268840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110217224|NCT00268840|Antimetabolites|antimetabolites|mesh-ancestor
110217225|NCT00268840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217226|NCT00268840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110217227|NCT00268840|Tubulin Modulators|tubulin modulators|mesh-ancestor
110217228|NCT00268840|Antimitotic Agents|antimitotic agents|mesh-ancestor
110217229|NCT00268840|Mitosis Modulators|mitosis modulators|mesh-ancestor
110217230|NCT00268879|Renzapride|renzapride|mesh-list
110217231|NCT00268879|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110217232|NCT00268879|Serotonin Agents|serotonin agents|mesh-ancestor
110217233|NCT00268879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110217234|NCT00268879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217235|NCT00268879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110217237|NCT00268918|Vatalanib|vatalanib|mesh-list
110217238|NCT00268918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110217239|NCT00268918|Tubulin Modulators|tubulin modulators|mesh-ancestor
110217240|NCT00268918|Antimitotic Agents|antimitotic agents|mesh-ancestor
110217241|NCT00268918|Mitosis Modulators|mitosis modulators|mesh-ancestor
110217242|NCT00268918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217243|NCT00268918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110217244|NCT00268918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110217245|NCT00268957|Sevelamer|sevelamer|mesh-list
110217246|NCT00268957|Chelating Agents|chelating agents|mesh-ancestor
110217247|NCT00268957|Sequestering Agents|sequestering agents|mesh-ancestor
110217248|NCT00268957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217249|NCT00073970|Celecoxib|celecoxib|mesh-list
110217250|NCT00073970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110217251|NCT00073970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110217252|NCT00073970|Analgesics|analgesics|mesh-ancestor
110217253|NCT00073970|Sensory System Agents|sensory system agents|mesh-ancestor
110217254|NCT00073970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110217255|NCT00073970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110217256|NCT00073970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110217257|NCT00073970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110217258|NCT00073970|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110217259|NCT00073970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110217260|NCT00073970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110217261|NCT00073970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217262|NCT00102492|Casopitant|casopitant|mesh-list
110217263|NCT00102492|Antiemetics|antiemetics|mesh-ancestor
110217264|NCT00102492|Autonomic Agents|autonomic agents|mesh-ancestor
110217266|NCT00102492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110217267|NCT00102492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110217268|NCT00102492|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110217269|NCT00102492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110217270|NCT00102492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217271|NCT00269035|Risperidone|risperidone|mesh-list
110217272|NCT00269035|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110217273|NCT00269035|Serotonin Agents|serotonin agents|mesh-ancestor
110217275|NCT00269035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217276|NCT00269035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110217277|NCT00269035|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110217278|NCT00269035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110217279|NCT00269035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110217280|NCT00269035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110217281|NCT00269035|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110217282|NCT00269035|Dopamine Agents|dopamine agents|mesh-ancestor
110217284|NCT00074009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110217285|NCT00269269|Antihypertensive Agents|antihypertensive agents|mesh-list
110217286|NCT00269386|Clarithromycin|clarithromycin|mesh-list
110217287|NCT00269386|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110236931|NCT00126243|Rituximab|rituximab|mesh-list
110217288|NCT00269386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110217289|NCT00269386|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110217291|NCT00269386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217292|NCT00269386|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110217293|NCT00269386|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110217295|NCT00074087|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110217296|NCT00074087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110217297|NCT00074087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110217298|NCT00074087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110217299|NCT00074087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110217300|NCT00074087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110217301|NCT00074087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217305|NCT00269542|Trace Elements|trace elements|mesh-ancestor
110217306|NCT00269542|Micronutrients|micronutrients|mesh-ancestor
110217307|NCT00269542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110217308|NCT00269542|Hematinics|hematinics|mesh-ancestor
110217309|NCT00269542|Vitamins|vitamins|mesh-ancestor
110217310|NCT00269620|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110217311|NCT00269620|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110217312|NCT00269620|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110217313|NCT00269620|Etonogestrel|etonogestrel|mesh-list
110217314|NCT00269620|NuvaRing|nuvaring|mesh-list
110217315|NCT00269620|Norelgestromin|norelgestromin|mesh-list
110217316|NCT00269620|Ortho Evra|ortho evra|mesh-list
110217317|NCT00269620|Contraceptive Agents|contraceptive agents|mesh-list
110217318|NCT00269620|Estradiol|estradiol|mesh-list
110217319|NCT00269620|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110217320|NCT00269620|Estrogens|estrogens|mesh-ancestor
110217321|NCT00269620|Hormones|hormones|mesh-ancestor
110217322|NCT00269620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110217323|NCT00269620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110217324|NCT00269620|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110217325|NCT00269620|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110217326|NCT00269620|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110217327|NCT00269620|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110217328|NCT00269620|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110217329|NCT00074204|Carboplatin|carboplatin|mesh-list
110217330|NCT00074204|Gemcitabine|gemcitabine|mesh-list
110217331|NCT00074204|Docetaxel|docetaxel|mesh-list
110217332|NCT00074204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110217333|NCT00074204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110217334|NCT00074204|Antimetabolites|antimetabolites|mesh-ancestor
110217335|NCT00074204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217336|NCT00074204|Tubulin Modulators|tubulin modulators|mesh-ancestor
110217337|NCT00074204|Antimitotic Agents|antimitotic agents|mesh-ancestor
110217338|NCT00074204|Mitosis Modulators|mitosis modulators|mesh-ancestor
110217339|NCT00416143|Prednisone|prednisone|mesh-list
110217340|NCT00416143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110217341|NCT00416143|Glucocorticoids|glucocorticoids|mesh-ancestor
110217342|NCT00416143|Hormones|hormones|mesh-ancestor
110217343|NCT00416143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110217344|NCT00416143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110217345|NCT00416143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110217346|NCT00416143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110217349|NCT00416221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110217350|NCT00416221|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110217351|NCT00416221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110217352|NCT00416221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110217353|NCT00416221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217354|NCT00416221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110217355|NCT00416221|Serotonin Agents|serotonin agents|mesh-ancestor
110217356|NCT00416221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110217358|NCT00269737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110217360|NCT00269737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110217361|NCT00269737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110217362|NCT00269737|Analgesics|analgesics|mesh-ancestor
110217363|NCT00269737|Sensory System Agents|sensory system agents|mesh-ancestor
110217364|NCT00269737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110217365|NCT00269737|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110217366|NCT00269737|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110217367|NCT00269737|Anesthetics, General|anesthetics, general|mesh-ancestor
110217368|NCT00269737|Anesthetics|anesthetics|mesh-ancestor
110217369|NCT00269776|Methylphenidate|methylphenidate|mesh-list
110217370|NCT00269776|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110217371|NCT00269776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110217372|NCT00269776|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110217373|NCT00269776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110217374|NCT00269776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110217375|NCT00269776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217376|NCT00269776|Dopamine Agents|dopamine agents|mesh-ancestor
110217377|NCT00269776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110217378|NCT00269815|Methylphenidate|methylphenidate|mesh-list
110217379|NCT00269815|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110217380|NCT00269815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110217381|NCT00269815|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110217382|NCT00269815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110217383|NCT00269815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110217384|NCT00269815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217386|NCT00269815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110217387|NCT00269854|Infliximab|infliximab|mesh-list
110217388|NCT00269854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110217389|NCT00269854|Antibodies|antibodies|mesh-list
110217390|NCT00269854|Immunoglobulins|immunoglobulins|mesh-list
110217391|NCT00269854|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110217392|NCT00269854|Immunologic Factors|immunologic factors|mesh-ancestor
110217393|NCT00269854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110217394|NCT00269854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110217395|NCT00269854|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110217396|NCT00269854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110217397|NCT00269854|Dermatologic Agents|dermatologic agents|mesh-ancestor
110217398|NCT00269854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110217399|NCT00269854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110217400|NCT00269893|Abciximab|abciximab|mesh-list
110217401|NCT00269893|Anticoagulants|anticoagulants|mesh-ancestor
110217402|NCT00269893|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110217403|NCT00074321|Capecitabine|capecitabine|mesh-list
110217404|NCT00074321|Oxaliplatin|oxaliplatin|mesh-list
110217405|NCT00074321|Irinotecan|irinotecan|mesh-list
110217406|NCT00074321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110217407|NCT00074321|Antimetabolites|antimetabolites|mesh-ancestor
110217408|NCT00074321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217409|NCT00074321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110217410|NCT00074321|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110217412|NCT00074321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110217414|NCT00102609|Doxorubicin|doxorubicin|mesh-list
110217415|NCT00102609|Trabectedin|trabectedin|mesh-list
110217416|NCT00102609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110217417|NCT00102609|Antiemetics|antiemetics|mesh-ancestor
110217419|NCT00102609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110217420|NCT00102609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110217421|NCT00102609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110217422|NCT00102609|Glucocorticoids|glucocorticoids|mesh-ancestor
110217423|NCT00102609|Hormones|hormones|mesh-ancestor
110217424|NCT00102609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110217425|NCT00102609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110217426|NCT00102609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110217427|NCT00102609|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110217428|NCT00102609|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110217429|NCT00102609|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110217430|NCT00102609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110217431|NCT00102609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217432|NCT00102609|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110217433|NCT00102609|Alkylating Agents|alkylating agents|mesh-ancestor
110217434|NCT00269932|Levofloxacin|levofloxacin|mesh-list
110217435|NCT00269932|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110217436|NCT00269932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110217437|NCT00269932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110217438|NCT00269932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110217439|NCT00269932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110217440|NCT00269932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110217441|NCT00269932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217442|NCT00269932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110217443|NCT00269932|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110217444|NCT00269932|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110217446|NCT00269971|Hematinics|hematinics|mesh-ancestor
110217447|NCT00270010|Epoetin Alfa|epoetin alfa|mesh-list
110217448|NCT00270010|Hematinics|hematinics|mesh-ancestor
110217449|NCT00270049|Epoetin Alfa|epoetin alfa|mesh-list
110217450|NCT00270049|Hematinics|hematinics|mesh-ancestor
110217452|NCT00107016|Everolimus|everolimus|mesh-list
110217453|NCT00107016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110217454|NCT00107016|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110217455|NCT00107016|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110217456|NCT00107016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110217457|NCT00107016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217458|NCT00107016|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110217459|NCT00107016|Hormone Antagonists|hormone antagonists|mesh-ancestor
110217460|NCT00107016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110217462|NCT00107016|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110217463|NCT00107016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110217464|NCT00107016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110217465|NCT00107016|Immunologic Factors|immunologic factors|mesh-ancestor
110217467|NCT00270088|Hematinics|hematinics|mesh-ancestor
110217468|NCT00270127|Epoetin Alfa|epoetin alfa|mesh-list
110217469|NCT00270127|Hematinics|hematinics|mesh-ancestor
110217470|NCT00270166|Epoetin Alfa|epoetin alfa|mesh-list
110217471|NCT00270166|Hematinics|hematinics|mesh-ancestor
110217472|NCT00074399|Nevirapine|nevirapine|mesh-list
110217473|NCT00074399|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110217474|NCT00074399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110217475|NCT00074399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110217476|NCT00074399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217477|NCT00074399|Antiviral Agents|antiviral agents|mesh-ancestor
110217478|NCT00074399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110217479|NCT00074399|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110217480|NCT00074399|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110217481|NCT00074399|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110217482|NCT00074399|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110217483|NCT00270283|Epoetin Alfa|epoetin alfa|mesh-list
110217484|NCT00270283|Hematinics|hematinics|mesh-ancestor
110217486|NCT00270322|Morphine|morphine|mesh-list
110217487|NCT00270322|Bupivacaine|bupivacaine|mesh-list
110217488|NCT00270322|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110217489|NCT00270322|Narcotics|narcotics|mesh-ancestor
110217490|NCT00270322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110217491|NCT00270322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110217492|NCT00270322|Analgesics|analgesics|mesh-ancestor
110217493|NCT00270322|Sensory System Agents|sensory system agents|mesh-ancestor
110217494|NCT00270322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110217495|NCT00270322|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110217496|NCT00270322|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110217498|NCT00270322|Anesthetics|anesthetics|mesh-ancestor
110217499|NCT00270322|Anesthetics, Local|anesthetics, local|mesh-ancestor
110217500|NCT00270361|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
110217501|NCT00270361|Natriuretic Agents|natriuretic agents|mesh-ancestor
110217502|NCT00270361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110217503|NCT02966249|Levobupivacaine|levobupivacaine|mesh-list
110217504|NCT02966249|Anesthetics, Local|anesthetics, local|mesh-ancestor
110217505|NCT02966249|Anesthetics|anesthetics|mesh-ancestor
110217506|NCT02966249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110217507|NCT02966249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110217508|NCT02966249|Sensory System Agents|sensory system agents|mesh-ancestor
110217509|NCT02966249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110217510|NCT00270400|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
110217511|NCT00270400|Natriuretic Agents|natriuretic agents|mesh-ancestor
110217512|NCT00270400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110217513|NCT00107094|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110217514|NCT00107094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110217515|NCT00270478|Hydroxyurea|hydroxyurea|mesh-list
110217516|NCT00270478|Epoetin Alfa|epoetin alfa|mesh-list
110217517|NCT00270478|Hematinics|hematinics|mesh-ancestor
110217518|NCT00270478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110217519|NCT00270478|Antisickling Agents|antisickling agents|mesh-ancestor
110217520|NCT00270478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110217521|NCT00270478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217522|NCT00270478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110217523|NCT00270517|Telithromycin|telithromycin|mesh-list
110217524|NCT00270517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110217525|NCT00270517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110217526|NCT00270556|Tenofovir|tenofovir|mesh-list
110217527|NCT00270556|Abacavir|abacavir|mesh-list
110217528|NCT00270556|Antiviral Agents|antiviral agents|mesh-ancestor
110217529|NCT00270556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110217530|NCT00270556|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110217531|NCT00270556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110217532|NCT00270556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110217533|NCT00270556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217534|NCT00270556|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110217535|NCT00270556|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110217536|NCT00074438|Rituximab|rituximab|mesh-list
110217537|NCT00074438|Methotrexate|methotrexate|mesh-list
110217538|NCT00074438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110217539|NCT00074438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110217540|NCT00074438|Immunologic Factors|immunologic factors|mesh-ancestor
110217541|NCT00074438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110217542|NCT00074438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110217543|NCT00074438|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110217544|NCT00074438|Abortifacient Agents|abortifacient agents|mesh-ancestor
110217545|NCT00074438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110217546|NCT00074438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110217547|NCT00074438|Antimetabolites|antimetabolites|mesh-ancestor
110217548|NCT00074438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217549|NCT00074438|Dermatologic Agents|dermatologic agents|mesh-ancestor
110217550|NCT00074438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110217551|NCT00074438|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110217552|NCT00074438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110217553|NCT00074438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110217555|NCT00270751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110217556|NCT00270751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110217557|NCT00270829|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
110217559|NCT00270829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110217560|NCT04730375|Dexmedetomidine|dexmedetomidine|mesh-list
110217561|NCT04730375|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110217562|NCT04730375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110217563|NCT04730375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110217564|NCT04730375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110217565|NCT04730375|Analgesics|analgesics|mesh-ancestor
110217566|NCT04730375|Sensory System Agents|sensory system agents|mesh-ancestor
110217567|NCT04730375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110217568|NCT04730375|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110217569|NCT04730375|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110217570|NCT04730375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110217571|NCT04730375|Adrenergic Agents|adrenergic agents|mesh-ancestor
110217572|NCT04730375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110217573|NCT04730375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217574|NCT00270907|Gemcitabine|gemcitabine|mesh-list
110217575|NCT00270907|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
110217576|NCT00270907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110217577|NCT00270907|Antimetabolites|antimetabolites|mesh-ancestor
110217578|NCT00270907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217579|NCT00270907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110217580|NCT00271063|Annamycin|annamycin|mesh-list
110217581|NCT00271063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110217582|NCT00271063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110217583|NCT00107523|Cytarabine|cytarabine|mesh-list
110217584|NCT00107523|Idarubicin|idarubicin|mesh-list
110217585|NCT00107523|Pravastatin|pravastatin|mesh-list
110217586|NCT00107523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110217587|NCT00107523|Antimetabolites|antimetabolites|mesh-ancestor
110217588|NCT00107523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217589|NCT00107523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110217590|NCT00107523|Antiviral Agents|antiviral agents|mesh-ancestor
110217591|NCT00107523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110217592|NCT00107523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110217593|NCT00107523|Immunologic Factors|immunologic factors|mesh-ancestor
110217594|NCT00107523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110217595|NCT00107523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110217596|NCT00107523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110217597|NCT00107523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110217598|NCT00107523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110217599|NCT00107523|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110217600|NCT00107523|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110217601|NCT00107523|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110217602|NCT00107523|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110217603|NCT00416377|Prednisolone|prednisolone|mesh-list
110217604|NCT00416377|Doxorubicin|doxorubicin|mesh-list
110217605|NCT00416377|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110217606|NCT00416377|Bleomycin|bleomycin|mesh-list
110217607|NCT00416377|Vincristine|vincristine|mesh-list
110217608|NCT00416377|Dacarbazine|dacarbazine|mesh-list
110217609|NCT00416377|Vinblastine|vinblastine|mesh-list
110217610|NCT00416377|Procarbazine|procarbazine|mesh-list
110236991|NCT00126321|Cladribine|cladribine|mesh-list
110217611|NCT00416377|Chlorambucil|chlorambucil|mesh-list
110217612|NCT00416377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110217613|NCT00416377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110217614|NCT00416377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110217615|NCT00416377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110217616|NCT00416377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110217618|NCT00416377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110217619|NCT00416377|Tubulin Modulators|tubulin modulators|mesh-ancestor
110217620|NCT00416377|Antimitotic Agents|antimitotic agents|mesh-ancestor
110217621|NCT00416377|Mitosis Modulators|mitosis modulators|mesh-ancestor
110217622|NCT00416377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110217623|NCT00416377|Glucocorticoids|glucocorticoids|mesh-ancestor
110217624|NCT00416377|Hormones|hormones|mesh-ancestor
110217625|NCT00416377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110217626|NCT00416377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110217627|NCT00416377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110217628|NCT00416377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110217629|NCT00416377|Alkylating Agents|alkylating agents|mesh-ancestor
110217630|NCT02965859|Adefovir|adefovir|mesh-list
110217631|NCT02965859|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
110217632|NCT02965859|Antiviral Agents|antiviral agents|mesh-ancestor
110217633|NCT02965859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110217634|NCT02965859|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110217635|NCT02965859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110217636|NCT02965859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110217637|NCT02965859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217638|NCT00271336|Pentoxifylline|pentoxifylline|mesh-list
110217639|NCT00271336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110217640|NCT00271336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110217641|NCT00271336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217643|NCT00271336|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110217644|NCT00271336|Protective Agents|protective agents|mesh-ancestor
110217645|NCT00271336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110217646|NCT00271336|Vasodilator Agents|vasodilator agents|mesh-ancestor
110217647|NCT00271336|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110217648|NCT00271336|Antioxidants|antioxidants|mesh-ancestor
110217649|NCT00271414|Fentanyl|fentanyl|mesh-list
110217650|NCT00271414|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110217652|NCT00271414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110217653|NCT00271414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110217654|NCT00271414|Analgesics|analgesics|mesh-ancestor
110217655|NCT00271414|Sensory System Agents|sensory system agents|mesh-ancestor
110217656|NCT00271414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110217657|NCT00271414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110217658|NCT00271414|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110217659|NCT00271414|Anesthetics, General|anesthetics, general|mesh-ancestor
110217661|NCT00271453|Fentanyl|fentanyl|mesh-list
110217662|NCT00271453|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110217663|NCT00271453|Narcotics|narcotics|mesh-ancestor
110217664|NCT00271453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110217665|NCT00271453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110217666|NCT00271453|Analgesics|analgesics|mesh-ancestor
110217667|NCT00271453|Sensory System Agents|sensory system agents|mesh-ancestor
110217668|NCT00271453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110217669|NCT00271453|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110217670|NCT00271453|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110217671|NCT00271453|Anesthetics, General|anesthetics, general|mesh-ancestor
110217672|NCT00271453|Anesthetics|anesthetics|mesh-ancestor
110217674|NCT00271492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110217675|NCT00271492|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
110217676|NCT00271492|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110217677|NCT00271492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217679|NCT00271804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110217680|NCT00107601|Insulin|insulin|mesh-list
110217681|NCT00107601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110217682|NCT00107601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110217683|NCT00272077|Insulin Glargine|insulin glargine|mesh-list
110217684|NCT00272077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110217685|NCT00272077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110217686|NCT00272116|Vitamins|vitamins|mesh-list
110217687|NCT00272116|Vitamin A|vitamin a|mesh-list
110217688|NCT00272116|Retinol palmitate|retinol palmitate|mesh-list
110217689|NCT00272116|Micronutrients|micronutrients|mesh-ancestor
110027791|NCT01726530|Fentanyl|fentanyl|mesh-list
110217690|NCT00272116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110217691|NCT00272116|Antioxidants|antioxidants|mesh-ancestor
110217692|NCT00272116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217693|NCT00272116|Protective Agents|protective agents|mesh-ancestor
110217694|NCT00272116|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110217695|NCT00272116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110217696|NCT00272428|Ascorbic Acid|ascorbic acid|mesh-list
110217697|NCT00272428|Vitamin E|vitamin e|mesh-list
110217698|NCT00272428|Beta Carotene|beta carotene|mesh-list
110217699|NCT00272428|Selenium|selenium|mesh-list
110217700|NCT00272428|Carotenoids|carotenoids|mesh-list
110217701|NCT00272428|Vitamins|vitamins|mesh-ancestor
110217702|NCT00272428|Micronutrients|micronutrients|mesh-ancestor
110217703|NCT00272428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110217704|NCT00272428|Antioxidants|antioxidants|mesh-ancestor
110217705|NCT00272428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217706|NCT00272428|Protective Agents|protective agents|mesh-ancestor
110217707|NCT00272428|Trace Elements|trace elements|mesh-ancestor
110217708|NCT00272428|Provitamins|provitamins|mesh-ancestor
110217709|NCT00272467|Omeprazole|omeprazole|mesh-list
110217710|NCT00272467|Rebamipide|rebamipide|mesh-list
110217711|NCT00272467|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110217712|NCT00272467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110217713|NCT00272467|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110217714|NCT00272467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110217715|NCT00272467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217716|NCT00272467|Antioxidants|antioxidants|mesh-ancestor
110217717|NCT00272467|Protective Agents|protective agents|mesh-ancestor
110217718|NCT00272467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110217719|NCT00272584|Risperidone|risperidone|mesh-list
110217720|NCT00272584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110217721|NCT00272584|Serotonin Agents|serotonin agents|mesh-ancestor
110217723|NCT00272584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217724|NCT00272584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110217725|NCT00272584|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110217726|NCT00272584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110217727|NCT00272584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110217728|NCT00272584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110217729|NCT00272584|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110217730|NCT00272584|Dopamine Agents|dopamine agents|mesh-ancestor
110217731|NCT00272701|Esomeprazole|esomeprazole|mesh-list
110217732|NCT00272701|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110217733|NCT00272701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110217734|NCT00272701|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110217736|NCT00272701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217737|NCT00272740|Fulvestrant|fulvestrant|mesh-list
110217738|NCT00272740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110217739|NCT00272740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110217740|NCT00272740|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110217741|NCT00272740|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110217742|NCT00272740|Hormone Antagonists|hormone antagonists|mesh-ancestor
110217743|NCT00272740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110217744|NCT00272740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110217745|NCT00074750|Molgramostim|molgramostim|mesh-list
110217746|NCT00074750|Sargramostim|sargramostim|mesh-list
110217747|NCT00074750|Immunologic Factors|immunologic factors|mesh-ancestor
110217748|NCT00074750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110217749|NCT00074750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110217750|NCT00416533|Prednisone|prednisone|mesh-list
110217751|NCT00416533|Docetaxel|docetaxel|mesh-list
110217752|NCT00416533|Doxorubicin|doxorubicin|mesh-list
110217753|NCT00416533|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110217754|NCT00416533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110217755|NCT00416533|Tubulin Modulators|tubulin modulators|mesh-ancestor
110217756|NCT00416533|Antimitotic Agents|antimitotic agents|mesh-ancestor
110217757|NCT00416533|Mitosis Modulators|mitosis modulators|mesh-ancestor
110217758|NCT00416533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217759|NCT00416533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110217760|NCT00416533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110217761|NCT00416533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110217762|NCT00416533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110217763|NCT00416533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110217764|NCT00416533|Glucocorticoids|glucocorticoids|mesh-ancestor
110217766|NCT00416533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110217767|NCT00416533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110217768|NCT00416533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110217769|NCT00107796|Modafinil|modafinil|mesh-list
110217770|NCT00107796|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110217771|NCT00107796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110217772|NCT00107796|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110217773|NCT00107796|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110217774|NCT00107796|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110217775|NCT00107796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217777|NCT00272896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110217778|NCT00272896|Vasodilator Agents|vasodilator agents|mesh-ancestor
110217779|NCT00272896|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110217780|NCT00272896|Protective Agents|protective agents|mesh-ancestor
110217781|NCT00272896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110217782|NCT00272935|Estrogens|estrogens|mesh-list
110217783|NCT00272935|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110217784|NCT00272935|Estrogens, conjugated synthetic A|estrogens, conjugated synthetic a|mesh-list
110217785|NCT00272935|Hormones|hormones|mesh-ancestor
110217786|NCT00272935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110217787|NCT00272935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110217788|NCT00273013|Montelukast|montelukast|mesh-list
110217789|NCT00273013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110217790|NCT00273013|Respiratory System Agents|respiratory system agents|mesh-ancestor
110217791|NCT00273013|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110217793|NCT00273013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110217794|NCT00273013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110217795|NCT00273013|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110217796|NCT00273013|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110217797|NCT00273013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217798|NCT00107835|Lidocaine|lidocaine|mesh-list
110217799|NCT00107835|Tetracaine|tetracaine|mesh-list
110217800|NCT00107835|Anesthetics, Local|anesthetics, local|mesh-ancestor
110217801|NCT00107835|Anesthetics|anesthetics|mesh-ancestor
110217802|NCT00107835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110217803|NCT00107835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110217804|NCT00107835|Sensory System Agents|sensory system agents|mesh-ancestor
110217805|NCT00107835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110217807|NCT00107835|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110217808|NCT00107835|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110217809|NCT00107835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110217810|NCT00107835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217812|NCT00107874|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110217813|NCT00107874|Abortifacient Agents|abortifacient agents|mesh-ancestor
110217814|NCT00107874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110217815|NCT00107874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110217816|NCT00107874|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110217817|NCT00107874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110217818|NCT00107874|Oxytocics|oxytocics|mesh-ancestor
110217819|NCT00074828|Enoxaparin|enoxaparin|mesh-list
110217820|NCT00074828|Anticoagulants|anticoagulants|mesh-ancestor
110217821|NCT00074828|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110217822|NCT00074828|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110217823|NCT00074828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217824|NCT00273247|Interferons|interferons|mesh-list
110217825|NCT00273247|Interferon-alpha|interferon-alpha|mesh-list
110217826|NCT00273247|Interferon alpha-2|interferon alpha-2|mesh-list
110217827|NCT00273247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110217828|NCT00273247|Antiviral Agents|antiviral agents|mesh-ancestor
110217829|NCT00273247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110217830|NCT00273247|Immunologic Factors|immunologic factors|mesh-ancestor
110217831|NCT00273247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110217834|NCT00273442|Maleic acid|maleic acid|mesh-list
110217835|NCT00273442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110217836|NCT00273442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217838|NCT00273442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110217839|NCT00273442|Adrenergic Agents|adrenergic agents|mesh-ancestor
110217840|NCT00273442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110217841|NCT00273442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110217842|NCT00273442|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110217843|NCT00273442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110217844|NCT00273442|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110217846|NCT00401427|Vinorelbine|vinorelbine|mesh-list
110217847|NCT00401427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110217848|NCT00401427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110217849|NCT00401427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110217850|NCT00401427|Tubulin Modulators|tubulin modulators|mesh-ancestor
110217851|NCT00401427|Antimitotic Agents|antimitotic agents|mesh-ancestor
110217852|NCT00401427|Mitosis Modulators|mitosis modulators|mesh-ancestor
110217853|NCT00401427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217855|NCT00273481|Dorzolamide|dorzolamide|mesh-list
110217856|NCT00273481|Latanoprost|latanoprost|mesh-list
110217857|NCT00273481|Maleic acid|maleic acid|mesh-list
110217858|NCT00273481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110217859|NCT00273481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217860|NCT00273481|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110217861|NCT00273481|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110217862|NCT00273481|Adrenergic Agents|adrenergic agents|mesh-ancestor
110217863|NCT00273481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110217864|NCT00273481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110217865|NCT00273481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110217866|NCT00273481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110217867|NCT00273481|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110217868|NCT00273481|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110217869|NCT00273481|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110217870|NCT00273520|Telithromycin|telithromycin|mesh-list
110217871|NCT00273520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110217872|NCT00273520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110217873|NCT00273559|Prednisone|prednisone|mesh-list
110217874|NCT00273559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110217875|NCT00273559|Glucocorticoids|glucocorticoids|mesh-ancestor
110217876|NCT00273559|Hormones|hormones|mesh-ancestor
110217877|NCT00273559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110217878|NCT00273559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110217879|NCT00273559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110217880|NCT00273559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110217881|NCT00273676|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110217882|NCT00273676|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110217883|NCT00273676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110217884|NCT00273676|Antitubercular Agents|antitubercular agents|mesh-ancestor
110217885|NCT00273871|Cyclosporine|cyclosporine|mesh-list
110217886|NCT00273871|Tacrolimus|tacrolimus|mesh-list
110217887|NCT00273871|Cyclosporins|cyclosporins|mesh-list
110217888|NCT00273871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110217889|NCT00273871|Immunologic Factors|immunologic factors|mesh-ancestor
110217890|NCT00273871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110217891|NCT00273871|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110217892|NCT00273871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110217893|NCT00273871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217894|NCT00273871|Antifungal Agents|antifungal agents|mesh-ancestor
110217895|NCT00273871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110217896|NCT00273871|Dermatologic Agents|dermatologic agents|mesh-ancestor
110217897|NCT00273871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110217898|NCT00273949|Lactulose|lactulose|mesh-list
110217899|NCT00273949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110217900|NCT00273988|Nevirapine|nevirapine|mesh-list
110217901|NCT00273988|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110217902|NCT00273988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110217903|NCT00273988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110217904|NCT00273988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217905|NCT00273988|Antiviral Agents|antiviral agents|mesh-ancestor
110217906|NCT00273988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110217907|NCT00273988|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110217908|NCT00273988|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110217909|NCT00273988|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110217910|NCT00273988|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110217912|NCT00274027|Tiotropium Bromide|tiotropium bromide|mesh-list
110217913|NCT00274027|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110217914|NCT00274027|Autonomic Agents|autonomic agents|mesh-ancestor
110217915|NCT00274027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110217916|NCT00274027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110217917|NCT00274027|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110217918|NCT00274027|Respiratory System Agents|respiratory system agents|mesh-ancestor
110217919|NCT00274027|Parasympatholytics|parasympatholytics|mesh-ancestor
110217920|NCT00274027|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110217921|NCT00274027|Cholinergic Agents|cholinergic agents|mesh-ancestor
110217922|NCT00274027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110217923|NCT00274027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217924|NCT00274027|Anticonvulsants|anticonvulsants|mesh-ancestor
110217925|NCT00075101|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
110217926|NCT00075101|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110217927|NCT00075101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110217928|NCT00075101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217929|NCT00075101|Cholinergic Agents|cholinergic agents|mesh-ancestor
110217930|NCT00075101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110217931|NCT00075101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110217932|NCT00274066|Fenoterol|fenoterol|mesh-list
110217933|NCT00274066|Tiotropium Bromide|tiotropium bromide|mesh-list
110217934|NCT00274066|Ipratropium|ipratropium|mesh-list
110217935|NCT00274066|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110217936|NCT00274066|Autonomic Agents|autonomic agents|mesh-ancestor
110217937|NCT00274066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110217938|NCT00274066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110217939|NCT00274066|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110217940|NCT00274066|Respiratory System Agents|respiratory system agents|mesh-ancestor
110217941|NCT00274066|Parasympatholytics|parasympatholytics|mesh-ancestor
110217942|NCT00274066|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110217943|NCT00274066|Cholinergic Agents|cholinergic agents|mesh-ancestor
110217944|NCT00274066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110217945|NCT00274066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217946|NCT00274066|Sympathomimetics|sympathomimetics|mesh-ancestor
110217947|NCT00274066|Tocolytic Agents|tocolytic agents|mesh-ancestor
110217948|NCT00274066|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110217949|NCT00274066|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110217950|NCT00274066|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110217951|NCT00274066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110217952|NCT00274066|Adrenergic Agents|adrenergic agents|mesh-ancestor
110217953|NCT00274105|Telmisartan|telmisartan|mesh-list
110217954|NCT00274105|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110237073|NCT00126516|Protease Inhibitors|protease inhibitors|mesh-ancestor
110217955|NCT00274105|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110217956|NCT00274105|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110217957|NCT00274105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217958|NCT00274144|Telmisartan|telmisartan|mesh-list
110217959|NCT00274144|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110368701|NCT00557934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110217961|NCT00274144|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110217962|NCT00274144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217964|NCT00108186|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110217965|NCT00108186|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110217966|NCT00108186|Analgesics|analgesics|mesh-ancestor
110217967|NCT00108186|Sensory System Agents|sensory system agents|mesh-ancestor
110217968|NCT00108186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110217969|NCT00108186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110217970|NCT00108186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110217971|NCT00108186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110217972|NCT00108186|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110217973|NCT00108186|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110217974|NCT00108186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110217975|NCT00108186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217976|NCT00274339|Lansoprazole|lansoprazole|mesh-list
110217977|NCT00274339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110217978|NCT00274339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110217979|NCT00274339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110217980|NCT00274339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110217981|NCT00274339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217982|NCT00075179|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
110217983|NCT00075179|Natriuretic Agents|natriuretic agents|mesh-ancestor
110217984|NCT00075179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110217985|NCT00416650|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110217986|NCT00416650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110217987|NCT00416650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110217988|NCT00416650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110217989|NCT00416650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217991|NCT00274417|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110217992|NCT00274417|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110217993|NCT00274417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110217994|NCT00274417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217995|NCT00274417|Hormone Antagonists|hormone antagonists|mesh-ancestor
110217996|NCT00274417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110217997|NCT00274417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110217999|NCT00274495|Ribavirin|ribavirin|mesh-list
110218000|NCT00274495|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110218001|NCT00274495|Antimetabolites|antimetabolites|mesh-ancestor
110218002|NCT00274495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110218003|NCT00274495|Antiviral Agents|antiviral agents|mesh-ancestor
110218004|NCT00274495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110218005|NCT00274495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110218006|NCT00274495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218008|NCT00274534|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110218009|NCT00274534|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110218010|NCT00274534|Autonomic Agents|autonomic agents|mesh-ancestor
110218011|NCT00274534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110218012|NCT00274534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218013|NCT00274534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110218014|NCT00274534|Respiratory System Agents|respiratory system agents|mesh-ancestor
110218015|NCT00274534|Parasympatholytics|parasympatholytics|mesh-ancestor
110218016|NCT00274534|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110218017|NCT00274534|Cholinergic Agents|cholinergic agents|mesh-ancestor
110218018|NCT00274534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110218019|NCT00274534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110218020|NCT00274534|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110218021|NCT00274534|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110218022|NCT00274534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110218023|NCT00274534|Adrenergic Agents|adrenergic agents|mesh-ancestor
110218025|NCT00274573|Tiotropium Bromide|tiotropium bromide|mesh-list
110218026|NCT00274573|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110218027|NCT00274573|Autonomic Agents|autonomic agents|mesh-ancestor
110218028|NCT00274573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110218029|NCT00274573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218030|NCT00274573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110218031|NCT00274573|Respiratory System Agents|respiratory system agents|mesh-ancestor
110218033|NCT00274573|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110218036|NCT00274573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110218037|NCT00274573|Anticonvulsants|anticonvulsants|mesh-ancestor
110218039|NCT00274612|Ramipril|ramipril|mesh-list
110218040|NCT00274612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110218041|NCT00274612|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110218042|NCT00274612|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110218043|NCT00274612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110218044|NCT00274612|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110218045|NCT00274612|Protease Inhibitors|protease inhibitors|mesh-ancestor
110218046|NCT00274612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110218047|NCT00075374|Docetaxel|docetaxel|mesh-list
110218048|NCT00075374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110218049|NCT00075374|Tubulin Modulators|tubulin modulators|mesh-ancestor
110218050|NCT00075374|Antimitotic Agents|antimitotic agents|mesh-ancestor
110218051|NCT00075374|Mitosis Modulators|mitosis modulators|mesh-ancestor
110218052|NCT00075374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110218054|NCT00274690|Antiemetics|antiemetics|mesh-ancestor
110218055|NCT00274690|Autonomic Agents|autonomic agents|mesh-ancestor
110218056|NCT00274690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110218057|NCT00274690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218058|NCT00274690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110218059|NCT00274690|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110218060|NCT00274690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110218061|NCT00274690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110218063|NCT00274807|Etoposide|etoposide|mesh-list
110218064|NCT00274807|Mitoxantrone|mitoxantrone|mesh-list
110218065|NCT00274807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110218066|NCT00274807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110218067|NCT00274807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110218068|NCT00274807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110218069|NCT00274807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110218070|NCT00274807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110218071|NCT00274807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110218072|NCT00274807|Antimetabolites|antimetabolites|mesh-ancestor
110218073|NCT00274807|Antiviral Agents|antiviral agents|mesh-ancestor
110218074|NCT00274807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110218075|NCT00274807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110218076|NCT00274807|Immunologic Factors|immunologic factors|mesh-ancestor
110218077|NCT00274807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218078|NCT00274807|Analgesics|analgesics|mesh-ancestor
110218079|NCT00274807|Sensory System Agents|sensory system agents|mesh-ancestor
110218080|NCT00274807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110218081|NCT00274885|Oxaliplatin|oxaliplatin|mesh-list
110218082|NCT00274885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110218083|NCT00277225|Abatacept|abatacept|mesh-list
110218084|NCT00277225|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110218085|NCT00277225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110218086|NCT00277225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110218087|NCT00277225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110218088|NCT00277225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110218089|NCT00277225|Immunologic Factors|immunologic factors|mesh-ancestor
110218090|NCT00277225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218091|NCT00277225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110218092|NCT00277264|Tiotropium Bromide|tiotropium bromide|mesh-list
110218093|NCT00277264|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110218094|NCT00277264|Autonomic Agents|autonomic agents|mesh-ancestor
110218095|NCT00277264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110218096|NCT00277264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218097|NCT00277264|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110218098|NCT00277264|Respiratory System Agents|respiratory system agents|mesh-ancestor
110218099|NCT00277264|Parasympatholytics|parasympatholytics|mesh-ancestor
110218101|NCT00277264|Cholinergic Agents|cholinergic agents|mesh-ancestor
110218102|NCT00277264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110218103|NCT00277264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110218104|NCT00108420|Prazosin|prazosin|mesh-list
110218105|NCT00108420|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110218106|NCT00108420|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110218107|NCT00108420|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110218108|NCT00108420|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110218109|NCT00108420|Adrenergic Agents|adrenergic agents|mesh-ancestor
110218110|NCT00108420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110218111|NCT00108420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110218112|NCT00108420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218113|NCT00075413|Arsenic Trioxide|arsenic trioxide|mesh-list
110218114|NCT00075413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110218115|NCT00277342|Insulin|insulin|mesh-list
110218116|NCT00277342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110218117|NCT00277342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218118|NCT00277498|Timolol|timolol|mesh-list
110218119|NCT00277498|Latanoprost|latanoprost|mesh-list
110218120|NCT00277498|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110218121|NCT00277498|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110218122|NCT00277498|Adrenergic Agents|adrenergic agents|mesh-ancestor
110218123|NCT00277498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110218124|NCT00277498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110218125|NCT00277498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218126|NCT00277498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110218127|NCT00277498|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110218128|NCT00277498|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110218129|NCT00277498|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110218130|NCT00108498|Mirtazapine|mirtazapine|mesh-list
110218131|NCT00108498|Antidepressive Agents|antidepressive agents|mesh-ancestor
110218132|NCT00108498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110218133|NCT00108498|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110218134|NCT00108498|Histamine Antagonists|histamine antagonists|mesh-ancestor
110218135|NCT00108498|Histamine Agents|histamine agents|mesh-ancestor
110218136|NCT00108498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110237126|NCT00426985|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110218137|NCT00108498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110218138|NCT00108498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218139|NCT00108498|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110218140|NCT00108498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110218141|NCT00108498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110218142|NCT00108498|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110218143|NCT00108498|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110218144|NCT00108498|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110218145|NCT00108498|Adrenergic Agents|adrenergic agents|mesh-ancestor
110218146|NCT00108498|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110218147|NCT00108498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110218148|NCT00108498|Serotonin Agents|serotonin agents|mesh-ancestor
110218149|NCT00108498|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110218150|NCT00277537|Mannitol|mannitol|mesh-list
110218151|NCT00277537|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110218152|NCT00277537|Diuretics|diuretics|mesh-ancestor
110218153|NCT00277537|Natriuretic Agents|natriuretic agents|mesh-ancestor
110218154|NCT00277537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218156|NCT00075452|Oxaliplatin|oxaliplatin|mesh-list
110218157|NCT00075452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110218160|NCT00075452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110218161|NCT00108537|Bupropion|bupropion|mesh-list
110218162|NCT00108537|Nicotine|nicotine|mesh-list
110218163|NCT00108537|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110218164|NCT00108537|Autonomic Agents|autonomic agents|mesh-ancestor
110218165|NCT00108537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110218166|NCT00108537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218167|NCT00108537|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110218168|NCT00108537|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110218169|NCT00108537|Cholinergic Agents|cholinergic agents|mesh-ancestor
110218170|NCT00108537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110218171|NCT00108537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110218172|NCT00108537|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110218173|NCT00108537|Antidepressive Agents|antidepressive agents|mesh-ancestor
110218174|NCT00108537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110218175|NCT00108537|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110218176|NCT00108537|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110218177|NCT00108537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110218178|NCT00108537|Dopamine Agents|dopamine agents|mesh-ancestor
110218179|NCT00108537|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110218180|NCT00108537|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110218181|NCT00108537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110218182|NCT00277654|Risperidone|risperidone|mesh-list
110218183|NCT00277654|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110218184|NCT00277654|Serotonin Agents|serotonin agents|mesh-ancestor
110218185|NCT00277654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110218186|NCT00277654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110218187|NCT00277654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218188|NCT00277654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110218190|NCT00277654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110218191|NCT00277654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110218192|NCT00277654|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110218193|NCT00277654|Dopamine Agents|dopamine agents|mesh-ancestor
110218194|NCT00277693|Spironolactone|spironolactone|mesh-list
110218195|NCT00277693|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110218196|NCT00277693|Hormone Antagonists|hormone antagonists|mesh-ancestor
110218197|NCT00277693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110218198|NCT00277693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218199|NCT00277693|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110218200|NCT00277693|Diuretics|diuretics|mesh-ancestor
110218201|NCT00277693|Natriuretic Agents|natriuretic agents|mesh-ancestor
110218202|NCT00108576|Valproic Acid|valproic acid|mesh-list
110218203|NCT00108576|Anticonvulsants|anticonvulsants|mesh-ancestor
110218204|NCT00108576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110218205|NCT00108576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110218206|NCT00108576|GABA Agents|gaba agents|mesh-ancestor
110218207|NCT00108576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110218208|NCT00108576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218210|NCT00108576|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110218211|NCT00108576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110218212|NCT00108576|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110218213|NCT00075491|Fenretinide|fenretinide|mesh-list
110218214|NCT00075491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110218215|NCT00075491|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110218216|NCT00075491|Protective Agents|protective agents|mesh-ancestor
110218217|NCT00075491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218219|NCT00108615|Pioglitazone|pioglitazone|mesh-list
110218220|NCT00108615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110218221|NCT00108615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218222|NCT00278122|Paclitaxel|paclitaxel|mesh-list
110218223|NCT00278122|Sargramostim|sargramostim|mesh-list
110218224|NCT00278122|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110218225|NCT00278122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110218226|NCT00278122|Tubulin Modulators|tubulin modulators|mesh-ancestor
110218227|NCT00278122|Antimitotic Agents|antimitotic agents|mesh-ancestor
110218228|NCT00278122|Mitosis Modulators|mitosis modulators|mesh-ancestor
110218229|NCT00278122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110218230|NCT00278122|Immunologic Factors|immunologic factors|mesh-ancestor
110218231|NCT00278122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218232|NCT00075647|Sirolimus|sirolimus|mesh-list
110218233|NCT00075647|Temsirolimus|temsirolimus|mesh-list
110218234|NCT00075647|MTOR Inhibitors|mtor inhibitors|mesh-list
110218235|NCT00075647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110218236|NCT00075647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110218237|NCT00075647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110218238|NCT00075647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110218239|NCT00075647|Immunologic Factors|immunologic factors|mesh-ancestor
110218240|NCT00075647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218241|NCT00075647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110218242|NCT00075647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110218243|NCT00075647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110218244|NCT00075647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110218245|NCT00075647|Antifungal Agents|antifungal agents|mesh-ancestor
110218247|NCT00278278|Methotrexate|methotrexate|mesh-list
110218248|NCT00278278|Etoposide|etoposide|mesh-list
110218250|NCT00278278|Ifosfamide|ifosfamide|mesh-list
110218251|NCT00278278|Lomustine|lomustine|mesh-list
110218252|NCT00278278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110218253|NCT00278278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110218254|NCT00278278|Glucocorticoids|glucocorticoids|mesh-ancestor
110218255|NCT00278278|Hormones|hormones|mesh-ancestor
110218256|NCT00278278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110218257|NCT00278278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218258|NCT00278278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110218259|NCT00278278|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110218261|NCT00278278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110218264|NCT00278278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110218265|NCT00278278|Dermatologic Agents|dermatologic agents|mesh-ancestor
110218266|NCT00278278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110218267|NCT00278278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110218268|NCT00278278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110218269|NCT00278278|Immunologic Factors|immunologic factors|mesh-ancestor
110218271|NCT00278278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110218272|NCT00278278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110218273|NCT00278278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110218274|NCT00278278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110218276|NCT00278278|Antimitotic Agents|antimitotic agents|mesh-ancestor
110218277|NCT00278278|Mitosis Modulators|mitosis modulators|mesh-ancestor
110218278|NCT00278278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110218279|NCT00278278|Alkylating Agents|alkylating agents|mesh-ancestor
110218281|NCT00108771|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110218282|NCT00108771|Narcotics|narcotics|mesh-ancestor
110218283|NCT00108771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110218284|NCT00108771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218285|NCT00108771|Analgesics|analgesics|mesh-ancestor
110218286|NCT00108771|Sensory System Agents|sensory system agents|mesh-ancestor
110218287|NCT00108771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110218288|NCT00108771|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110218289|NCT00108771|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110218290|NCT00108771|Anesthetics, General|anesthetics, general|mesh-ancestor
110218291|NCT00108771|Anesthetics|anesthetics|mesh-ancestor
110218293|NCT00278434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110218294|NCT00278434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218295|NCT00075686|Gemcitabine|gemcitabine|mesh-list
110218296|NCT00075686|Cetuximab|cetuximab|mesh-list
110218297|NCT00075686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110218298|NCT00075686|Antimetabolites|antimetabolites|mesh-ancestor
110218299|NCT00075686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110218301|NCT00075686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110218302|NCT00278824|Fentanyl|fentanyl|mesh-list
110218303|NCT00278824|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110218304|NCT00278824|Narcotics|narcotics|mesh-ancestor
110218305|NCT00278824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110218306|NCT00278824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218308|NCT00278824|Sensory System Agents|sensory system agents|mesh-ancestor
110218309|NCT00278824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110218310|NCT00278824|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110218311|NCT00278824|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110218312|NCT00278824|Anesthetics, General|anesthetics, general|mesh-ancestor
110218324|NCT00279019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110218325|NCT00279019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218326|NCT00279019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110218327|NCT00279019|Respiratory System Agents|respiratory system agents|mesh-ancestor
110218328|NCT00279019|Parasympatholytics|parasympatholytics|mesh-ancestor
110218329|NCT00279019|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110218330|NCT00279019|Cholinergic Agents|cholinergic agents|mesh-ancestor
110218331|NCT00279019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110218332|NCT00279019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110218335|NCT00108849|Hormones|hormones|mesh-ancestor
110218336|NCT00108849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110218337|NCT00108849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218338|NCT00279058|Immunomodulating Agents|immunomodulating agents|mesh-list
110218339|NCT00279058|Immunologic Factors|immunologic factors|mesh-ancestor
110218340|NCT00279058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218341|NCT00279253|Clonidine|clonidine|mesh-list
110218342|NCT00279253|Analgesics|analgesics|mesh-ancestor
110218343|NCT00279253|Sensory System Agents|sensory system agents|mesh-ancestor
110218344|NCT00279253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110218345|NCT00279253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218346|NCT00279253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110218347|NCT00279253|Sympatholytics|sympatholytics|mesh-ancestor
110218348|NCT00279253|Autonomic Agents|autonomic agents|mesh-ancestor
110218349|NCT00279253|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110218350|NCT00279253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110218351|NCT00279253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110218352|NCT00279253|Adrenergic Agents|adrenergic agents|mesh-ancestor
110218353|NCT00279253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110218354|NCT00279253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110218357|NCT00109044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110218358|NCT00109044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110218359|NCT00109044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110218361|NCT00109044|Serotonin Agents|serotonin agents|mesh-ancestor
110218362|NCT00109044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218363|NCT00279448|Tamoxifen|tamoxifen|mesh-list
110218364|NCT00279448|Exemestane|exemestane|mesh-list
110218365|NCT00279448|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110218366|NCT00279448|Hormone Antagonists|hormone antagonists|mesh-ancestor
110218367|NCT00279448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110218368|NCT00279448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218369|NCT00279448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110218370|NCT00279448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110218371|NCT00279448|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110218372|NCT00279448|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110218373|NCT00279448|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110218374|NCT00279448|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110218375|NCT00279448|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110218376|NCT00279448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110218377|NCT00279448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110218379|NCT00075959|Antioxidants|antioxidants|mesh-ancestor
110218380|NCT00075959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110218381|NCT00075959|Protective Agents|protective agents|mesh-ancestor
110218382|NCT00075959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218384|NCT00279487|Analgesics|analgesics|mesh-ancestor
110218385|NCT00279487|Sensory System Agents|sensory system agents|mesh-ancestor
110218386|NCT00279487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110218387|NCT00279487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218388|NCT00279487|Anticonvulsants|anticonvulsants|mesh-ancestor
110218389|NCT00279487|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110218390|NCT00279487|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110218391|NCT00279487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110218392|NCT00279487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110218393|NCT00279487|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110218395|NCT00279487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110218396|NCT00279487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110218397|NCT00279487|Antimanic Agents|antimanic agents|mesh-ancestor
110218398|NCT00279565|Interferons|interferons|mesh-list
110218399|NCT00279565|Ribavirin|ribavirin|mesh-list
110218400|NCT00279565|Interferon-alpha|interferon-alpha|mesh-list
110218401|NCT00279565|Interferon alpha-2|interferon alpha-2|mesh-list
110218402|NCT00279565|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110218404|NCT00279565|Methadone|methadone|mesh-list
110218406|NCT00279565|Antiviral Agents|antiviral agents|mesh-ancestor
110218407|NCT00279565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110218408|NCT00279565|Antimetabolites|antimetabolites|mesh-ancestor
110218409|NCT00279565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110218410|NCT00279565|Immunologic Factors|immunologic factors|mesh-ancestor
110218411|NCT00279565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218412|NCT00279565|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110218413|NCT00279565|Narcotics|narcotics|mesh-ancestor
110218414|NCT00279565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110218416|NCT00279565|Sensory System Agents|sensory system agents|mesh-ancestor
110218417|NCT00279565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110218419|NCT00279565|Antitussive Agents|antitussive agents|mesh-ancestor
110237197|NCT04704622|Midazolam|midazolam|mesh-list
110218420|NCT00279565|Respiratory System Agents|respiratory system agents|mesh-ancestor
110218422|NCT00075998|Interferon-gamma|interferon-gamma|mesh-list
110218423|NCT00075998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110218424|NCT00075998|Antiviral Agents|antiviral agents|mesh-ancestor
110218425|NCT00075998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110218426|NCT00109161|Antibodies|antibodies|mesh-list
110218428|NCT00109161|Daclizumab|daclizumab|mesh-list
110218429|NCT00109161|Immunologic Factors|immunologic factors|mesh-ancestor
110218430|NCT00109161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218431|NCT00109161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110218432|NCT00279760|Abatacept|abatacept|mesh-list
110218433|NCT00279760|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110218434|NCT00279760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110218435|NCT00279760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110218436|NCT00279760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110218437|NCT00279760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110218438|NCT00279760|Immunologic Factors|immunologic factors|mesh-ancestor
110218439|NCT00279760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218440|NCT00279760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110218441|NCT00109200|Omalizumab|omalizumab|mesh-list
110218442|NCT00109200|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110218443|NCT00109200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110218444|NCT00109200|Respiratory System Agents|respiratory system agents|mesh-ancestor
110218446|NCT00416728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110218447|NCT00416728|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110218448|NCT00416728|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110218449|NCT00416728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110218450|NCT00416767|Leucovorin|leucovorin|mesh-list
110218451|NCT00416767|Fluorouracil|fluorouracil|mesh-list
110218452|NCT00416767|Irinotecan|irinotecan|mesh-list
110218453|NCT00416767|Calcium|calcium|mesh-list
110218454|NCT00416767|Levoleucovorin|levoleucovorin|mesh-list
110218455|NCT00416767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110218456|NCT00416767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218457|NCT00416767|Antimetabolites|antimetabolites|mesh-ancestor
110218458|NCT00416767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110218459|NCT00416767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110218461|NCT00416767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110218462|NCT00416767|Immunologic Factors|immunologic factors|mesh-ancestor
110218463|NCT00416767|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110218464|NCT00416767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110218465|NCT00416767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110218466|NCT00416767|Antidotes|antidotes|mesh-ancestor
110218468|NCT00416767|Vitamin B Complex|vitamin b complex|mesh-ancestor
110218469|NCT00416767|Vitamins|vitamins|mesh-ancestor
110218470|NCT00416767|Micronutrients|micronutrients|mesh-ancestor
110218471|NCT00076115|Risperidone|risperidone|mesh-list
110218472|NCT00076115|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110218473|NCT00076115|Serotonin Agents|serotonin agents|mesh-ancestor
110218474|NCT00076115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110218475|NCT00076115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110218476|NCT00076115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218477|NCT00076115|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110218479|NCT00076115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110218481|NCT00076115|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110218482|NCT00076115|Dopamine Agents|dopamine agents|mesh-ancestor
110218484|NCT00109239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110218485|NCT00109239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110218486|NCT00109239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110218487|NCT00109239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110218488|NCT00109239|Growth Substances|growth substances|mesh-ancestor
110218489|NCT00109239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218490|NCT00109239|Growth Inhibitors|growth inhibitors|mesh-ancestor
110218491|NCT00280033|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110218492|NCT00280033|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110218493|NCT00280033|Immunologic Factors|immunologic factors|mesh-ancestor
110218494|NCT00280033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218495|NCT00280033|Antacids|antacids|mesh-ancestor
110027978|NCT01042158|Tadalafil|tadalafil|mesh-list
110218496|NCT00280033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110218497|NCT00280033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110218498|NCT00109278|Vaccines|vaccines|mesh-list
110218499|NCT00109278|Immunologic Factors|immunologic factors|mesh-ancestor
110218500|NCT00109278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218501|NCT00280267|Testosterone|testosterone|mesh-list
110218502|NCT00280267|Androgens|androgens|mesh-ancestor
110218503|NCT00280267|Hormones|hormones|mesh-ancestor
110218504|NCT00280267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110218505|NCT00280267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218507|NCT00076232|Antiviral Agents|antiviral agents|mesh-ancestor
110218508|NCT00076232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110218509|NCT00280423|Casopitant|casopitant|mesh-list
110218510|NCT00280423|Antiemetics|antiemetics|mesh-ancestor
110218511|NCT00280423|Autonomic Agents|autonomic agents|mesh-ancestor
110218512|NCT00280423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110218513|NCT00280423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218514|NCT00280423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110218515|NCT00280423|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110218517|NCT00280423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110218519|NCT00109356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110218520|NCT00280462|Nifedipine|nifedipine|mesh-list
110218521|NCT00280462|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110218522|NCT00280462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110237243|NCT00092183|Dermatologic Agents|dermatologic agents|mesh-ancestor
110218523|NCT00280462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110218524|NCT00280462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110218525|NCT00280462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218526|NCT00280462|Vasodilator Agents|vasodilator agents|mesh-ancestor
110218527|NCT00280462|Tocolytic Agents|tocolytic agents|mesh-ancestor
110218528|NCT00280462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110218529|NCT00280501|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110218530|NCT00280501|Sulpiride|sulpiride|mesh-list
110218531|NCT00280501|Antidepressive Agents|antidepressive agents|mesh-ancestor
110218532|NCT00280501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110218533|NCT00280501|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110218534|NCT00280501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110218535|NCT00280501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110218536|NCT00280501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218537|NCT00280501|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110218538|NCT00280501|Dopamine Agents|dopamine agents|mesh-ancestor
110218539|NCT00280501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110218540|NCT00280501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110218541|NCT00280501|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110218543|NCT00280540|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110218544|NCT00280540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110218545|NCT00280540|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110218546|NCT00280540|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110218547|NCT00280540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110218548|NCT00280540|Diuretics|diuretics|mesh-ancestor
110218549|NCT00280540|Natriuretic Agents|natriuretic agents|mesh-ancestor
110218550|NCT00280540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218551|NCT00280540|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110218552|NCT00280540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110218553|NCT00076349|Rituximab|rituximab|mesh-list
110218554|NCT00076349|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110218556|NCT00076349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110218557|NCT00076349|Immunologic Factors|immunologic factors|mesh-ancestor
110218558|NCT00076349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218559|NCT00076349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110218560|NCT00076349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110218561|NCT00076349|Alkylating Agents|alkylating agents|mesh-ancestor
110218562|NCT00076349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110218563|NCT00280618|Oxaliplatin|oxaliplatin|mesh-list
110218564|NCT00280618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110218565|NCT00416845|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
110218566|NCT00416845|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110218567|NCT00416845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110218568|NCT00416845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110218569|NCT00416845|Immunologic Factors|immunologic factors|mesh-ancestor
110218570|NCT00416845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218572|NCT00280696|Anticonvulsants|anticonvulsants|mesh-ancestor
110218573|NCT00280696|Nootropic Agents|nootropic agents|mesh-ancestor
110218575|NCT00076388|Gefitinib|gefitinib|mesh-list
110218576|NCT00076388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110218577|NCT00076388|Tubulin Modulators|tubulin modulators|mesh-ancestor
110218578|NCT00076388|Antimitotic Agents|antimitotic agents|mesh-ancestor
110218579|NCT00076388|Mitosis Modulators|mitosis modulators|mesh-ancestor
110218580|NCT00076388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110218581|NCT00076388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110218582|NCT00076388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110218584|NCT00280774|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110218585|NCT00280774|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110218586|NCT00280774|Dopamine Agents|dopamine agents|mesh-ancestor
110218587|NCT00280774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110218588|NCT00280774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110218589|NCT00280774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218590|NCT00280774|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110218591|NCT00280774|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110218593|NCT00109551|Zinc Sulfate|zinc sulfate|mesh-list
110218594|NCT00109551|Hematinics|hematinics|mesh-ancestor
110218595|NCT00109551|Vitamin B Complex|vitamin b complex|mesh-ancestor
110218596|NCT00109551|Vitamins|vitamins|mesh-ancestor
110218597|NCT00109551|Micronutrients|micronutrients|mesh-ancestor
110218598|NCT00109551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218599|NCT00109551|Astringents|astringents|mesh-ancestor
110218600|NCT00109551|Dermatologic Agents|dermatologic agents|mesh-ancestor
110218601|NCT00280930|Letrozole|letrozole|mesh-list
110218602|NCT00280930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110218603|NCT00280930|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110218604|NCT00280930|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110218605|NCT00280930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110218606|NCT00280930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110218607|NCT00280930|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110218608|NCT00280930|Hormone Antagonists|hormone antagonists|mesh-ancestor
110218609|NCT00280930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110218610|NCT00280930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218611|NCT00280969|Efavirenz|efavirenz|mesh-list
110218612|NCT00280969|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110218613|NCT00280969|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110218614|NCT00280969|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110218615|NCT00280969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110218616|NCT00280969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110218617|NCT00280969|Antiviral Agents|antiviral agents|mesh-ancestor
110218618|NCT00280969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110218619|NCT00280969|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110218620|NCT00280969|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110218621|NCT00280969|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110218622|NCT00280969|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110218623|NCT00280969|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110218624|NCT00280969|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110218625|NCT00280969|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110218626|NCT00280969|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110218627|NCT00280969|Protease Inhibitors|protease inhibitors|mesh-ancestor
110218628|NCT00280969|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110218629|NCT00280969|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110218630|NCT00281008|Mipomersen|mipomersen|mesh-list
110218631|NCT00281008|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110218632|NCT00281008|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110218633|NCT00281008|Antimetabolites|antimetabolites|mesh-ancestor
110218634|NCT00281008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110218635|NCT00281008|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110218636|NCT00281125|Pemetrexed|pemetrexed|mesh-list
110218637|NCT00281125|Vatalanib|vatalanib|mesh-list
110218638|NCT00281125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110218639|NCT00281125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110218640|NCT00281125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110218641|NCT00281125|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110218642|NCT00281125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110218643|NCT00281125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110218644|NCT00109746|Chromium|chromium|mesh-list
110218645|NCT00109746|Picolinic acid|picolinic acid|mesh-list
110218646|NCT00109746|Trace Elements|trace elements|mesh-ancestor
110218647|NCT00109746|Micronutrients|micronutrients|mesh-ancestor
110218648|NCT00109746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218649|NCT00109746|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110218651|NCT00109746|Sequestering Agents|sequestering agents|mesh-ancestor
110218652|NCT00109746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110218653|NCT04730297|Acetaminophen|acetaminophen|mesh-list
110218654|NCT04730297|Ibuprofen|ibuprofen|mesh-list
110218655|NCT04730297|Codeine|codeine|mesh-list
110218656|NCT04730297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110218657|NCT04730297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110218658|NCT04730297|Analgesics|analgesics|mesh-ancestor
110218659|NCT04730297|Sensory System Agents|sensory system agents|mesh-ancestor
110218660|NCT04730297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110218661|NCT04730297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218662|NCT04730297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110218663|NCT04730297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110218664|NCT04730297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110218665|NCT04730297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110218666|NCT04730297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110218667|NCT04730297|Antipyretics|antipyretics|mesh-ancestor
110218668|NCT04730297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110218669|NCT04730297|Narcotics|narcotics|mesh-ancestor
110218670|NCT04730297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110218671|NCT04730297|Antitussive Agents|antitussive agents|mesh-ancestor
110218672|NCT04730297|Respiratory System Agents|respiratory system agents|mesh-ancestor
110218674|NCT00399269|Hematinics|hematinics|mesh-ancestor
110218675|NCT00281281|Vancomycin|vancomycin|mesh-list
110218676|NCT00281281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110218677|NCT00281281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110218678|NCT00109785|Idoxuridine|idoxuridine|mesh-list
110218679|NCT00109785|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110218680|NCT00109785|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110218681|NCT00109785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110218682|NCT00109785|Antiviral Agents|antiviral agents|mesh-ancestor
110218683|NCT00109785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110218684|NCT00109785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110218685|NCT00109785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110218686|NCT00281476|Simvastatin|simvastatin|mesh-list
110218687|NCT00281476|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110218688|NCT00281476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110218689|NCT00281476|Antimetabolites|antimetabolites|mesh-ancestor
110218691|NCT00281476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110218692|NCT00281476|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110218693|NCT00281476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110218694|NCT00416923|Rituximab|rituximab|mesh-list
110218695|NCT00416923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110218696|NCT00416923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110218698|NCT00416923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218699|NCT00416923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110218700|NCT00416962|Oseltamivir|oseltamivir|mesh-list
110218701|NCT00416962|Amantadine|amantadine|mesh-list
110218702|NCT00416962|Antiviral Agents|antiviral agents|mesh-ancestor
110218703|NCT00416962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110218704|NCT00416962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110218705|NCT00416962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110218706|NCT00416962|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110218707|NCT00416962|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110218708|NCT00416962|Dopamine Agents|dopamine agents|mesh-ancestor
110218709|NCT00416962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110218710|NCT00416962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218711|NCT00416962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110218712|NCT00416962|Analgesics|analgesics|mesh-ancestor
110218713|NCT00416962|Sensory System Agents|sensory system agents|mesh-ancestor
110218714|NCT00416962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110218715|NCT00109824|Decitabine|decitabine|mesh-list
110218716|NCT00109824|Azacitidine|azacitidine|mesh-list
110218717|NCT00109824|Valproic Acid|valproic acid|mesh-list
110218718|NCT00109824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110218719|NCT00109824|Antimetabolites|antimetabolites|mesh-ancestor
110218720|NCT00109824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110218721|NCT00109824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110218722|NCT00109824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110218723|NCT00109824|Anticonvulsants|anticonvulsants|mesh-ancestor
110218726|NCT00109824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218727|NCT00109824|Antimanic Agents|antimanic agents|mesh-ancestor
110218728|NCT00109824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110218729|NCT00109824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110218730|NCT00109824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110218731|NCT00281515|Lonafarnib|lonafarnib|mesh-list
110218732|NCT00281515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110218733|NCT00281515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110218734|NCT00109941|Analgesics, Opioid|analgesics, opioid|mesh-list
110218735|NCT00109941|Mitogens|mitogens|mesh-list
110218736|NCT00109941|Enkephalin, Methionine|enkephalin, methionine|mesh-list
110218737|NCT00109941|Narcotics|narcotics|mesh-ancestor
110218739|NCT00109941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218740|NCT00109941|Analgesics|analgesics|mesh-ancestor
110218741|NCT00109941|Sensory System Agents|sensory system agents|mesh-ancestor
110218742|NCT00109941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110218743|NCT00109941|Mitosis Modulators|mitosis modulators|mesh-ancestor
110218744|NCT00109941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110218746|NCT00281593|Telmisartan|telmisartan|mesh-list
110218747|NCT00281593|Ramipril|ramipril|mesh-list
110218748|NCT00281593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110218749|NCT00281593|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110218750|NCT00281593|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110218751|NCT00281593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110218752|NCT00281593|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110218753|NCT00281593|Protease Inhibitors|protease inhibitors|mesh-ancestor
110218754|NCT00281593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110218756|NCT00281710|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110218757|NCT00281710|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110218758|NCT00281710|Prednisolone|prednisolone|mesh-list
110218759|NCT00281710|Prednisolone acetate|prednisolone acetate|mesh-list
110218760|NCT00281710|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110218761|NCT00281710|Prednisolone phosphate|prednisolone phosphate|mesh-list
110218762|NCT00281710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110218763|NCT00281710|Antiemetics|antiemetics|mesh-ancestor
110218764|NCT00281710|Autonomic Agents|autonomic agents|mesh-ancestor
110218765|NCT00281710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110218766|NCT00281710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218767|NCT00281710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110218768|NCT00281710|Glucocorticoids|glucocorticoids|mesh-ancestor
110218769|NCT00281710|Hormones|hormones|mesh-ancestor
110218770|NCT00281710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110218772|NCT00281710|Protective Agents|protective agents|mesh-ancestor
110218773|NCT00281710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110218774|NCT00281710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110218775|NCT00076544|Ziconotide|ziconotide|mesh-list
110218776|NCT00076544|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110218777|NCT00076544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110218778|NCT00076544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110218779|NCT00076544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110218780|NCT00076544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218781|NCT00076544|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110218782|NCT00076544|Protective Agents|protective agents|mesh-ancestor
110218783|NCT00076544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110218784|NCT00076544|Analgesics|analgesics|mesh-ancestor
110218785|NCT00076544|Sensory System Agents|sensory system agents|mesh-ancestor
110218786|NCT00076544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110218787|NCT00281788|Paclitaxel|paclitaxel|mesh-list
110218788|NCT00281788|Carboplatin|carboplatin|mesh-list
110218789|NCT00281788|Capecitabine|capecitabine|mesh-list
110218790|NCT00281788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110218791|NCT00281788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110218792|NCT00281788|Tubulin Modulators|tubulin modulators|mesh-ancestor
110218793|NCT00281788|Antimitotic Agents|antimitotic agents|mesh-ancestor
110218795|NCT00281788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110218796|NCT00281788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110218797|NCT00281788|Antimetabolites|antimetabolites|mesh-ancestor
110218798|NCT00281866|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110218799|NCT00281866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110218800|NCT00281866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110218801|NCT00281866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110218802|NCT00281866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110218803|NCT00281905|Cyclophosphamide|cyclophosphamide|mesh-list
110218804|NCT00281905|Carboplatin|carboplatin|mesh-list
110218805|NCT00281905|Methotrexate|methotrexate|mesh-list
110218806|NCT00281905|Vincristine|vincristine|mesh-list
110218807|NCT00281905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110218808|NCT00281905|Immunologic Factors|immunologic factors|mesh-ancestor
110218809|NCT00281905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218810|NCT00281905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110218811|NCT00281905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110218812|NCT00281905|Alkylating Agents|alkylating agents|mesh-ancestor
110218813|NCT00281905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110218814|NCT00281905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110218815|NCT00281905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110218816|NCT00281905|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110218817|NCT00281905|Abortifacient Agents|abortifacient agents|mesh-ancestor
110218818|NCT00281905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110218819|NCT00281905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110218820|NCT00281905|Antimetabolites|antimetabolites|mesh-ancestor
110218821|NCT00281905|Dermatologic Agents|dermatologic agents|mesh-ancestor
110218822|NCT00281905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110218823|NCT00281905|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110218824|NCT00281905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110218825|NCT00281905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110218826|NCT00281905|Tubulin Modulators|tubulin modulators|mesh-ancestor
110218827|NCT00281905|Antimitotic Agents|antimitotic agents|mesh-ancestor
110218828|NCT00281905|Mitosis Modulators|mitosis modulators|mesh-ancestor
110218829|NCT00110058|Interferons|interferons|mesh-list
110218831|NCT00110058|Cyclosporine|cyclosporine|mesh-list
110218832|NCT00110058|Mycophenolic Acid|mycophenolic acid|mesh-list
110218833|NCT00110058|Fludarabine|fludarabine|mesh-list
110218834|NCT00110058|Fludarabine phosphate|fludarabine phosphate|mesh-list
110218835|NCT00110058|Imatinib Mesylate|imatinib mesylate|mesh-list
110218836|NCT00110058|Cyclosporins|cyclosporins|mesh-list
110218837|NCT00110058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110218838|NCT00110058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110218839|NCT00110058|Antimetabolites|antimetabolites|mesh-ancestor
110218840|NCT00110058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110218842|NCT00110058|Immunologic Factors|immunologic factors|mesh-ancestor
110218843|NCT00110058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218846|NCT00110058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110218847|NCT00110058|Antifungal Agents|antifungal agents|mesh-ancestor
110218848|NCT00110058|Dermatologic Agents|dermatologic agents|mesh-ancestor
110218849|NCT00110058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110218850|NCT00110058|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110218851|NCT00110058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110218852|NCT00110058|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110218853|NCT00110058|Antitubercular Agents|antitubercular agents|mesh-ancestor
110218854|NCT00110058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110218855|NCT00110058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110218858|NCT00281944|Oxaliplatin|oxaliplatin|mesh-list
110218859|NCT00281944|Calcium|calcium|mesh-list
110218860|NCT00281944|Levoleucovorin|levoleucovorin|mesh-list
110218861|NCT00281944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110218862|NCT00281944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218864|NCT00281944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110218865|NCT00281944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110218866|NCT00281944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110218867|NCT00281944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110218868|NCT00281944|Immunologic Factors|immunologic factors|mesh-ancestor
110218869|NCT00281944|Antidotes|antidotes|mesh-ancestor
110218870|NCT00281944|Protective Agents|protective agents|mesh-ancestor
110218871|NCT00281944|Vitamin B Complex|vitamin b complex|mesh-ancestor
110218872|NCT00281944|Vitamins|vitamins|mesh-ancestor
110218873|NCT00281944|Micronutrients|micronutrients|mesh-ancestor
110218874|NCT00281983|Cyclosporine|cyclosporine|mesh-list
110218875|NCT00281983|Mycophenolic Acid|mycophenolic acid|mesh-list
110218876|NCT00281983|Cyclophosphamide|cyclophosphamide|mesh-list
110218877|NCT00281983|Busulfan|busulfan|mesh-list
110218878|NCT00281983|Rituximab|rituximab|mesh-list
110218880|NCT00281983|Fludarabine|fludarabine|mesh-list
110218881|NCT00281983|Fludarabine phosphate|fludarabine phosphate|mesh-list
110218882|NCT00281983|Alemtuzumab|alemtuzumab|mesh-list
110218883|NCT00281983|Cyclosporins|cyclosporins|mesh-list
110218884|NCT00281983|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110218885|NCT00281983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110218886|NCT00281983|Immunologic Factors|immunologic factors|mesh-ancestor
110218887|NCT00281983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218888|NCT00281983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110218889|NCT00281983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110218890|NCT00281983|Alkylating Agents|alkylating agents|mesh-ancestor
110218891|NCT00281983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110218892|NCT00281983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110218893|NCT00281983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110218894|NCT00281983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110218895|NCT00281983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110218896|NCT00281983|Abortifacient Agents|abortifacient agents|mesh-ancestor
110218897|NCT00281983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110218898|NCT00281983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110218900|NCT00281983|Dermatologic Agents|dermatologic agents|mesh-ancestor
110218901|NCT00281983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110218902|NCT00281983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110218903|NCT00281983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110218904|NCT00281983|Antifungal Agents|antifungal agents|mesh-ancestor
110218905|NCT00281983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110218906|NCT00281983|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110218907|NCT00281983|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110218909|NCT00281983|Antitubercular Agents|antitubercular agents|mesh-ancestor
110218910|NCT00281983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110218911|NCT00282061|Melatonin|melatonin|mesh-list
110218912|NCT00282061|Antioxidants|antioxidants|mesh-ancestor
110218913|NCT00282061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110218914|NCT00282061|Protective Agents|protective agents|mesh-ancestor
110218915|NCT00282061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218916|NCT00282061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110218917|NCT00282100|Gefitinib|gefitinib|mesh-list
110218918|NCT00282100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110218919|NCT00282100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110218920|NCT00282100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110218921|NCT00282100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110218922|NCT00282139|Aripiprazole|aripiprazole|mesh-list
110218924|NCT00282139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110218925|NCT00282139|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110218926|NCT00282139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110218927|NCT00282139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110218928|NCT00282139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218929|NCT00282139|Dopamine Agonists|dopamine agonists|mesh-ancestor
110218930|NCT00282139|Dopamine Agents|dopamine agents|mesh-ancestor
110218931|NCT00282139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110218932|NCT00282139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110218933|NCT00282139|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110218934|NCT00282139|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110218935|NCT00282139|Serotonin Agents|serotonin agents|mesh-ancestor
110218937|NCT00282139|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110218938|NCT00282139|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110218939|NCT00282139|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110218940|NCT00110253|Lidocaine|lidocaine|mesh-list
110218941|NCT00110253|Tetracaine|tetracaine|mesh-list
110218942|NCT00110253|Anesthetics, Local|anesthetics, local|mesh-ancestor
110218943|NCT00110253|Anesthetics|anesthetics|mesh-ancestor
110218944|NCT00110253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110218945|NCT00110253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218946|NCT00110253|Sensory System Agents|sensory system agents|mesh-ancestor
110218947|NCT00110253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110218948|NCT00110253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110218949|NCT00110253|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110218951|NCT00110253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110218952|NCT00110253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110218953|NCT00282178|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110218954|NCT00282178|Candesartan|candesartan|mesh-list
110218955|NCT00282178|Candesartan cilexetil|candesartan cilexetil|mesh-list
110218956|NCT00282178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110218957|NCT00282178|Diuretics|diuretics|mesh-ancestor
110218958|NCT00282178|Natriuretic Agents|natriuretic agents|mesh-ancestor
110218959|NCT00282178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110237402|NCT05561049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110218960|NCT00282178|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110218961|NCT00282178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110218962|NCT00282178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110218963|NCT00282178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110218964|NCT00282178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110218966|NCT00282217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110218967|NCT00282217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110218968|NCT00282217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110218969|NCT00282217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110218971|NCT00282217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110218972|NCT00282217|Immunologic Factors|immunologic factors|mesh-ancestor
110218973|NCT00282217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218975|NCT00282451|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110218976|NCT00282451|Insulin Aspart|insulin aspart|mesh-list
110218977|NCT00282451|Insulin, Long-Acting|insulin, long-acting|mesh-list
110218978|NCT00282451|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110218979|NCT00282451|Biphasic Insulins|biphasic insulins|mesh-list
110218980|NCT00282451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110218981|NCT00282451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218982|NCT00282607|Udenafil|udenafil|mesh-list
110218983|NCT00282607|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110218984|NCT00282607|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110218985|NCT00282607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110218986|NCT00282607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110218987|NCT00282724|Liarozole|liarozole|mesh-list
110218988|NCT00282724|Androgen Antagonists|androgen antagonists|mesh-ancestor
110218989|NCT00282724|Hormone Antagonists|hormone antagonists|mesh-ancestor
110218990|NCT00282724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110218991|NCT00282724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218992|NCT00282724|Dermatologic Agents|dermatologic agents|mesh-ancestor
110218993|NCT00282724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110218994|NCT00282724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110218995|NCT00282724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110218996|NCT00282724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110218997|NCT00282958|Botulinum Toxins|botulinum toxins|mesh-list
110218998|NCT00282958|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110218999|NCT00282958|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110219000|NCT00282958|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110219001|NCT00282958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110219002|NCT00282958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219003|NCT00282958|Cholinergic Agents|cholinergic agents|mesh-ancestor
110219004|NCT00282958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110219005|NCT00282958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110219006|NCT00282958|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110219007|NCT00282958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110219010|NCT00282997|Sensory System Agents|sensory system agents|mesh-ancestor
110219011|NCT00282997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110219012|NCT00282997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110219013|NCT00282997|Anticonvulsants|anticonvulsants|mesh-ancestor
110219014|NCT00282997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110219015|NCT00282997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110219016|NCT00282997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219017|NCT00282997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110219018|NCT00282997|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110219019|NCT00282997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110219020|NCT00282997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110219021|NCT00282997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110219022|NCT00283036|Irbesartan|irbesartan|mesh-list
110219023|NCT00283036|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110219024|NCT00283036|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110219025|NCT00283036|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110219026|NCT00283036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219027|NCT00110370|Insulin Glargine|insulin glargine|mesh-list
110219028|NCT00110370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110219029|NCT00110370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110219030|NCT00283114|Lintuzumab|lintuzumab|mesh-list
110219031|NCT00283114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110219032|NCT00283114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110219033|NCT00076856|Temozolomide|temozolomide|mesh-list
110219034|NCT00076856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110219035|NCT00076856|Alkylating Agents|alkylating agents|mesh-ancestor
110219036|NCT00076856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219037|NCT00076856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110219038|NCT00283192|Sertraline|sertraline|mesh-list
110219039|NCT00283192|Antidepressive Agents|antidepressive agents|mesh-ancestor
110219040|NCT00283192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110219041|NCT00283192|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110219042|NCT00283192|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110219043|NCT00283192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110219044|NCT00283192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219046|NCT00283192|Serotonin Agents|serotonin agents|mesh-ancestor
110219047|NCT00283192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110219048|NCT00283309|Riluzole|riluzole|mesh-list
110219049|NCT00283309|Memantine|memantine|mesh-list
110219050|NCT00283309|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110219052|NCT00283309|Dopamine Agents|dopamine agents|mesh-ancestor
110219053|NCT00283309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110219054|NCT00283309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219055|NCT00283309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110219056|NCT00283309|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110219057|NCT00283309|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110219058|NCT00283309|Anticonvulsants|anticonvulsants|mesh-ancestor
110219059|NCT00283309|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110219060|NCT00283309|Protective Agents|protective agents|mesh-ancestor
110219061|NCT00417157|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110219063|NCT00417157|Hormone Antagonists|hormone antagonists|mesh-ancestor
110219064|NCT00417157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110219065|NCT00417157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110219066|NCT00417157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110219067|NCT00283465|Epoetin Alfa|epoetin alfa|mesh-list
110219068|NCT00283465|Hematinics|hematinics|mesh-ancestor
110219069|NCT00283543|Temozolomide|temozolomide|mesh-list
110219070|NCT00283543|Carmustine|carmustine|mesh-list
110219071|NCT00283543|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110219072|NCT00283543|Alkylating Agents|alkylating agents|mesh-ancestor
110219073|NCT00283543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219074|NCT00283543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110219075|NCT00283621|Doxorubicin|doxorubicin|mesh-list
110219076|NCT00283621|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110219078|NCT00283621|Darbepoetin alfa|darbepoetin alfa|mesh-list
110219079|NCT00283621|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110219080|NCT00283621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110219081|NCT00283621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110219082|NCT00283621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110219083|NCT00283621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110219084|NCT00283621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219085|NCT00283621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110219086|NCT00283621|Alkylating Agents|alkylating agents|mesh-ancestor
110219087|NCT00283621|Hematinics|hematinics|mesh-ancestor
110219089|NCT00283660|Dermatologic Agents|dermatologic agents|mesh-ancestor
110219090|NCT00283660|Sunscreening Agents|sunscreening agents|mesh-ancestor
110219091|NCT00283660|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110219092|NCT00283660|Protective Agents|protective agents|mesh-ancestor
110219093|NCT00283660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110219094|NCT00077051|Tetrahydrouridine|tetrahydrouridine|mesh-list
110219095|NCT00077051|Antimetabolites|antimetabolites|mesh-ancestor
110219096|NCT00077051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219097|NCT00283699|Albendazole|albendazole|mesh-list
110219098|NCT00283699|Anthelmintics|anthelmintics|mesh-ancestor
110219099|NCT00283699|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110219100|NCT00283699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110219101|NCT00283699|Anticestodal Agents|anticestodal agents|mesh-ancestor
110219102|NCT00283699|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110219103|NCT00283699|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110219104|NCT00283699|Tubulin Modulators|tubulin modulators|mesh-ancestor
110219105|NCT00283699|Antimitotic Agents|antimitotic agents|mesh-ancestor
110219106|NCT00283699|Mitosis Modulators|mitosis modulators|mesh-ancestor
110219107|NCT00283699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219108|NCT00283699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110219109|NCT00283777|Chromium|chromium|mesh-list
110219110|NCT00283777|Picolinic acid|picolinic acid|mesh-list
110219111|NCT00283777|Trace Elements|trace elements|mesh-ancestor
110219112|NCT00283777|Micronutrients|micronutrients|mesh-ancestor
110219113|NCT00283777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110219114|NCT00283777|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110219115|NCT00283777|Chelating Agents|chelating agents|mesh-ancestor
110219116|NCT00283777|Sequestering Agents|sequestering agents|mesh-ancestor
110219117|NCT00283777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219118|NCT00110448|Aspirin|aspirin|mesh-list
110219119|NCT00110448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110219120|NCT00110448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110219121|NCT00110448|Analgesics|analgesics|mesh-ancestor
110219122|NCT00110448|Sensory System Agents|sensory system agents|mesh-ancestor
110219123|NCT00110448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110219124|NCT00110448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110219125|NCT00110448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110219126|NCT00110448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110219127|NCT00110448|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110219128|NCT00110448|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110219129|NCT00110448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219130|NCT00110448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110219131|NCT00110448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110219133|NCT00110448|Antipyretics|antipyretics|mesh-ancestor
110219134|NCT00284206|Risperidone|risperidone|mesh-list
110219135|NCT00284206|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110219136|NCT00284206|Serotonin Agents|serotonin agents|mesh-ancestor
110219137|NCT00284206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110219138|NCT00284206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219139|NCT00284206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110237441|NCT00093509|Ifosfamide|ifosfamide|mesh-list
110219140|NCT00284206|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110219141|NCT00284206|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110219142|NCT00284206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110219143|NCT00284206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110219144|NCT00284206|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110219145|NCT00284206|Dopamine Agents|dopamine agents|mesh-ancestor
110219147|NCT00284323|Analgesics|analgesics|mesh-ancestor
110219148|NCT00284323|Sensory System Agents|sensory system agents|mesh-ancestor
110219149|NCT00284323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110219150|NCT00284323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110219151|NCT00284323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110219152|NCT00284323|Vasodilator Agents|vasodilator agents|mesh-ancestor
110219153|NCT00284323|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110219154|NCT00284323|Purinergic Agonists|purinergic agonists|mesh-ancestor
110219155|NCT00284323|Purinergic Agents|purinergic agents|mesh-ancestor
110219156|NCT00284323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110219157|NCT00284323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219159|NCT04718701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110219160|NCT04718701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110219161|NCT04718701|Tubulin Modulators|tubulin modulators|mesh-ancestor
110219162|NCT04718701|Antimitotic Agents|antimitotic agents|mesh-ancestor
110219163|NCT04718701|Mitosis Modulators|mitosis modulators|mesh-ancestor
110219164|NCT04718701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219165|NCT00077168|Tamoxifen|tamoxifen|mesh-list
110219166|NCT00077168|Anastrozole|anastrozole|mesh-list
110219167|NCT00077168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219168|NCT00077168|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110219169|NCT00077168|Hormone Antagonists|hormone antagonists|mesh-ancestor
110219170|NCT00077168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110219171|NCT00077168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110219172|NCT00077168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110219173|NCT00077168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110219174|NCT00077168|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110219175|NCT00077168|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110219176|NCT00077168|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110219177|NCT00077168|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110219178|NCT00077168|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110219179|NCT00077168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110219180|NCT00110604|Folic Acid|folic acid|mesh-list
110219181|NCT00110604|Hematinics|hematinics|mesh-ancestor
110219182|NCT00110604|Vitamin B Complex|vitamin b complex|mesh-ancestor
110219183|NCT00110604|Vitamins|vitamins|mesh-ancestor
110219184|NCT00110604|Micronutrients|micronutrients|mesh-ancestor
110219185|NCT00110604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110219186|NCT00284752|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110219187|NCT00284752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110219188|NCT00284791|Lamotrigine|lamotrigine|mesh-list
110219189|NCT00284791|Sertraline|sertraline|mesh-list
110219191|NCT00284791|Antidepressive Agents|antidepressive agents|mesh-ancestor
110219192|NCT00284791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110219193|NCT00284791|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110219194|NCT00284791|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110219195|NCT00284791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110219196|NCT00284791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219197|NCT00284791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110219198|NCT00284791|Serotonin Agents|serotonin agents|mesh-ancestor
110219199|NCT00284791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110219200|NCT00284791|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110219201|NCT00284791|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110219202|NCT00284791|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110219203|NCT00284791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110219204|NCT00284791|Anticonvulsants|anticonvulsants|mesh-ancestor
110219205|NCT00284791|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110219206|NCT00284791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110219207|NCT00284791|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110219208|NCT00284791|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110219209|NCT00284791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110219210|NCT00284791|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110219211|NCT00284947|Prednisone|prednisone|mesh-list
110219212|NCT00284947|Prednisolone|prednisolone|mesh-list
110219213|NCT00284947|Methylprednisolone|methylprednisolone|mesh-list
110219215|NCT00284947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110219216|NCT00284947|Glucocorticoids|glucocorticoids|mesh-ancestor
110219217|NCT00284947|Hormones|hormones|mesh-ancestor
110219218|NCT00284947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110219219|NCT00284947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110219220|NCT00284947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110219221|NCT00284947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110219224|NCT00284947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110219226|NCT00284947|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110219227|NCT00284947|Protective Agents|protective agents|mesh-ancestor
110219228|NCT00284947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110219229|NCT00284947|Immunologic Factors|immunologic factors|mesh-ancestor
110219230|NCT00110682|Imiquimod|imiquimod|mesh-list
110219231|NCT00110682|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110219232|NCT00110682|Immunologic Factors|immunologic factors|mesh-ancestor
110219233|NCT00110682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110219234|NCT00110682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110219236|NCT00077246|Paclitaxel|paclitaxel|mesh-list
110219237|NCT00077246|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110219238|NCT00077246|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110219239|NCT00077246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110219240|NCT00077246|Tubulin Modulators|tubulin modulators|mesh-ancestor
110219241|NCT00077246|Antimitotic Agents|antimitotic agents|mesh-ancestor
110219242|NCT00077246|Mitosis Modulators|mitosis modulators|mesh-ancestor
110219243|NCT00077246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219244|NCT00110721|Fluorouracil|fluorouracil|mesh-list
110219245|NCT00110721|Antimetabolites|antimetabolites|mesh-ancestor
110219246|NCT00110721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219247|NCT00110721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110219248|NCT00110721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110219249|NCT00110721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110219250|NCT00110721|Immunologic Factors|immunologic factors|mesh-ancestor
110219251|NCT00110721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110219252|NCT00417235|Chlorhexidine|chlorhexidine|mesh-list
110219253|NCT00417235|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110219254|NCT00417235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110219255|NCT00417235|Disinfectants|disinfectants|mesh-ancestor
110219256|NCT00425035|Panitumumab|panitumumab|mesh-list
110219257|NCT00425035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110219258|NCT00425035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110219259|NCT00110760|Lidocaine|lidocaine|mesh-list
110219260|NCT00110760|Tetracaine|tetracaine|mesh-list
110219261|NCT00110760|Anesthetics, Local|anesthetics, local|mesh-ancestor
110219262|NCT00110760|Anesthetics|anesthetics|mesh-ancestor
110219263|NCT00110760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110219264|NCT00110760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110237469|NCT05549895|Hormones|hormones|mesh-ancestor
110219266|NCT00110760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110219267|NCT00110760|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110219268|NCT00110760|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110219269|NCT00110760|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110219270|NCT00110760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110219271|NCT00110760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219272|NCT00285142|Rosiglitazone|rosiglitazone|mesh-list
110219273|NCT00285142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110219274|NCT00285142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110219275|NCT00285181|Simvastatin|simvastatin|mesh-list
110219276|NCT00285181|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110219277|NCT00285181|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110219278|NCT00285181|Antimetabolites|antimetabolites|mesh-ancestor
110219279|NCT00285181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219280|NCT00285181|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110219281|NCT00285181|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110219282|NCT00285181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110219283|NCT00285298|Pentoxifylline|pentoxifylline|mesh-list
110219284|NCT00285298|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110219285|NCT00285298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110219286|NCT00285298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219287|NCT00285298|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110219288|NCT00285298|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110219289|NCT00285298|Protective Agents|protective agents|mesh-ancestor
110219290|NCT00285298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110219291|NCT00285298|Vasodilator Agents|vasodilator agents|mesh-ancestor
110219294|NCT00285376|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
110219295|NCT00285376|Antidepressive Agents|antidepressive agents|mesh-ancestor
110219296|NCT00285376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110219297|NCT00285376|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110219298|NCT00285376|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110219299|NCT00285376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110219300|NCT00285376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219301|NCT00285376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110219302|NCT00285376|Serotonin Agents|serotonin agents|mesh-ancestor
110219303|NCT00285376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110219304|NCT00285376|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110219305|NCT00285376|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110219306|NCT00077363|Capecitabine|capecitabine|mesh-list
110219308|NCT00077363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110219309|NCT00077363|Antimetabolites|antimetabolites|mesh-ancestor
110219310|NCT00077363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219311|NCT00077363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110219312|NCT00285415|Carboplatin|carboplatin|mesh-list
110219313|NCT00285415|Docetaxel|docetaxel|mesh-list
110219314|NCT00285415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110219315|NCT00285415|Tubulin Modulators|tubulin modulators|mesh-ancestor
110219316|NCT00285415|Antimitotic Agents|antimitotic agents|mesh-ancestor
110219317|NCT00285415|Mitosis Modulators|mitosis modulators|mesh-ancestor
110219318|NCT00285415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219319|NCT00285493|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110219320|NCT00285493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110219322|NCT00285727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110219323|NCT00285727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110219324|NCT00285727|Dopamine Agonists|dopamine agonists|mesh-ancestor
110219325|NCT00285727|Dopamine Agents|dopamine agents|mesh-ancestor
110219326|NCT00285727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110219327|NCT00285727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219328|NCT00285727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110219329|NCT00077402|Fenretinide|fenretinide|mesh-list
110219330|NCT00077402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110219331|NCT00077402|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110219332|NCT00077402|Protective Agents|protective agents|mesh-ancestor
110219333|NCT00077402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110219334|NCT00285766|Selegiline|selegiline|mesh-list
110219335|NCT00285766|Antidepressive Agents|antidepressive agents|mesh-ancestor
110219336|NCT00285766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110219337|NCT00285766|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110219338|NCT00285766|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110219339|NCT00285766|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110219340|NCT00285766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110219341|NCT00285766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219342|NCT00285766|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110219343|NCT00285766|Protective Agents|protective agents|mesh-ancestor
110219344|NCT00285766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110219345|NCT00285805|Rosiglitazone|rosiglitazone|mesh-list
110219347|NCT00285805|Furosemide|furosemide|mesh-list
110219348|NCT00285805|Diuretics|diuretics|mesh-ancestor
110219349|NCT00285805|Natriuretic Agents|natriuretic agents|mesh-ancestor
110219350|NCT00285805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110219351|NCT00285805|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110219352|NCT00285805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110219353|NCT00285805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219354|NCT00285805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110219355|NCT00285805|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
110219356|NCT00285805|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110219357|NCT00285805|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
110219358|NCT00285805|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110219359|NCT00285844|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
110219360|NCT00285844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110219361|NCT00285844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110219362|NCT00077441|Bortezomib|bortezomib|mesh-list
110219366|NCT00285883|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110219367|NCT00285883|Protease Inhibitors|protease inhibitors|mesh-ancestor
110219368|NCT00285883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110219369|NCT00285883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219370|NCT00285883|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110219371|NCT00285883|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110219372|NCT00285883|Antiviral Agents|antiviral agents|mesh-ancestor
110219373|NCT00285883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110219374|NCT00285883|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110219375|NCT00285883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110219377|NCT00110877|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110219378|NCT00110877|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110219379|NCT00110877|Protease Inhibitors|protease inhibitors|mesh-ancestor
110219380|NCT00110877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110219381|NCT00110877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219382|NCT00110877|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110219383|NCT00110877|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110219384|NCT00110877|Antiviral Agents|antiviral agents|mesh-ancestor
110219385|NCT00110877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110219386|NCT00077519|Tipifarnib|tipifarnib|mesh-list
110219387|NCT00077519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110219388|NCT00286117|Tamoxifen|tamoxifen|mesh-list
110219389|NCT00286117|Anastrozole|anastrozole|mesh-list
110219390|NCT00286117|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110219392|NCT00286117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110219393|NCT00286117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110219394|NCT00286117|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110219395|NCT00286117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110219396|NCT00286117|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110219397|NCT00286117|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110219398|NCT00286117|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110219399|NCT00286117|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110219400|NCT00286117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110219401|NCT00286117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110219402|NCT00286117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219403|NCT00110916|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110219404|NCT00110916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110219406|NCT00077558|Fludarabine phosphate|fludarabine phosphate|mesh-list
110219407|NCT00077558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110219408|NCT00077558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110219409|NCT00077558|Antimetabolites|antimetabolites|mesh-ancestor
110219410|NCT00077558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219411|NCT00077558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110219412|NCT00077558|Immunologic Factors|immunologic factors|mesh-ancestor
110219413|NCT00077558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110219414|NCT00286273|Heparin|heparin|mesh-list
110219415|NCT00286273|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110219416|NCT00286273|Tinzaparin|tinzaparin|mesh-list
110219417|NCT00286273|Dalteparin|dalteparin|mesh-list
110219418|NCT00286273|Nadroparin|nadroparin|mesh-list
110219419|NCT00286273|Citric Acid|citric acid|mesh-list
110219420|NCT00286273|Sodium Citrate|sodium citrate|mesh-list
110219421|NCT00286273|Anticoagulants|anticoagulants|mesh-ancestor
110219422|NCT00286273|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110219423|NCT00286273|Chelating Agents|chelating agents|mesh-ancestor
110219424|NCT00286273|Sequestering Agents|sequestering agents|mesh-ancestor
110219425|NCT00286273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219426|NCT00286273|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110219427|NCT00286273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110219428|NCT00286312|Atorvastatin|atorvastatin|mesh-list
110219429|NCT00286312|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110219430|NCT00286312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110219431|NCT00286312|Antimetabolites|antimetabolites|mesh-ancestor
110219432|NCT00286312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219433|NCT00286312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110219434|NCT00286312|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110219435|NCT00286312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110219436|NCT00286351|Goserelin|goserelin|mesh-list
110219437|NCT00286351|Anastrozole|anastrozole|mesh-list
110219438|NCT00286351|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110219439|NCT00286351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110219440|NCT00286351|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110219441|NCT00286351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110219442|NCT00286351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110219443|NCT00286351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219444|NCT00286351|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110219445|NCT00286351|Hormone Antagonists|hormone antagonists|mesh-ancestor
110219446|NCT00286351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110219447|NCT00286351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110219448|NCT00110955|Darbepoetin alfa|darbepoetin alfa|mesh-list
110219449|NCT00110955|Hematinics|hematinics|mesh-ancestor
110219450|NCT00286585|Propofol|propofol|mesh-list
110219451|NCT00286585|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
110219452|NCT00286585|Anesthetics|anesthetics|mesh-list
110219453|NCT00286585|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110219454|NCT00286585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110219455|NCT00286585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110219456|NCT00286585|Anesthetics, General|anesthetics, general|mesh-ancestor
110219457|NCT00111072|Dexamethasone|dexamethasone|mesh-list
110219458|NCT00111072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110219459|NCT00111072|Antiemetics|antiemetics|mesh-ancestor
110219460|NCT00111072|Autonomic Agents|autonomic agents|mesh-ancestor
110219461|NCT00111072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110219462|NCT00111072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110219463|NCT00111072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110219466|NCT00111072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110219467|NCT00111072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110219468|NCT00111072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110219469|NCT00286624|Cyclosporine|cyclosporine|mesh-list
110219470|NCT00286624|Everolimus|everolimus|mesh-list
110219471|NCT00286624|Cyclosporins|cyclosporins|mesh-list
110219472|NCT00286624|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110219473|NCT00286624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110219474|NCT00286624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219475|NCT00286624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110219476|NCT00286624|Immunologic Factors|immunologic factors|mesh-ancestor
110219477|NCT00286624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110219478|NCT00286624|Antifungal Agents|antifungal agents|mesh-ancestor
110219479|NCT00286624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110219480|NCT00286624|Dermatologic Agents|dermatologic agents|mesh-ancestor
110219481|NCT00286624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110219482|NCT00286624|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110219483|NCT00286624|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110219484|NCT00286624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110219485|NCT00286624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110219486|NCT00077597|Epoetin Alfa|epoetin alfa|mesh-list
110219487|NCT00077597|Hematinics|hematinics|mesh-ancestor
110219488|NCT00286780|Gossypol acetic acid|gossypol acetic acid|mesh-list
110219489|NCT00286780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110219490|NCT00286780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110219491|NCT00286780|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110219492|NCT00286780|Contraceptive Agents|contraceptive agents|mesh-ancestor
110219494|NCT00286780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110219495|NCT00286780|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
110219496|NCT00286780|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
110219497|NCT00286780|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110219498|NCT00111111|Etanercept|etanercept|mesh-list
110219499|NCT00111111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110219500|NCT00111111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110219501|NCT00111111|Analgesics|analgesics|mesh-ancestor
110219502|NCT00111111|Sensory System Agents|sensory system agents|mesh-ancestor
110219503|NCT00111111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110219504|NCT00111111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110219505|NCT00111111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110219506|NCT00111111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110219507|NCT00111111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110219508|NCT00111111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110219509|NCT00111111|Immunologic Factors|immunologic factors|mesh-ancestor
110219510|NCT00077714|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110219511|NCT00077714|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110219512|NCT00077714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110219513|NCT00077714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110219514|NCT00077714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110219515|NCT00077714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110219516|NCT00077714|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110219517|NCT00077714|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110219518|NCT00077714|Serotonin Agents|serotonin agents|mesh-ancestor
110219520|NCT00077714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219521|NCT00077714|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110219522|NCT00077714|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110219523|NCT00077714|Dopamine Agents|dopamine agents|mesh-ancestor
110219524|NCT00111150|Tenofovir|tenofovir|mesh-list
110219525|NCT00111150|Antiviral Agents|antiviral agents|mesh-ancestor
110219526|NCT00111150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110219527|NCT00111150|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110219528|NCT00111150|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110219529|NCT00111150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110219530|NCT00111150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219531|NCT00111150|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110219532|NCT00111150|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110219533|NCT00417430|Fulvestrant|fulvestrant|mesh-list
110219534|NCT00417430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110219535|NCT00417430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110219536|NCT00417430|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110219537|NCT00417430|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110219538|NCT00417430|Hormone Antagonists|hormone antagonists|mesh-ancestor
110219539|NCT00417430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110219540|NCT00417430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110219542|NCT00077753|Enoxaparin sodium|enoxaparin sodium|mesh-list
110219543|NCT00077753|Anticoagulants|anticoagulants|mesh-ancestor
110219544|NCT00077753|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110219545|NCT00077753|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110219546|NCT00077753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219547|NCT00111189|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110219548|NCT00111189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110219549|NCT00111189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110219550|NCT00111189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110219551|NCT00111189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110219552|NCT00111189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110219553|NCT00111189|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110219554|NCT00111189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110219556|NCT00111189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110219557|NCT00111189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219558|NCT00111189|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110219559|NCT00111189|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110219560|NCT00111189|Dopamine Agents|dopamine agents|mesh-ancestor
110219561|NCT00077792|Enoxaparin|enoxaparin|mesh-list
110219562|NCT00077792|Enoxaparin sodium|enoxaparin sodium|mesh-list
110219563|NCT00077792|Anticoagulants|anticoagulants|mesh-ancestor
110219564|NCT00077792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110219565|NCT00077792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110219566|NCT00077792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219568|NCT00111267|Folic Acid|folic acid|mesh-list
110219569|NCT00111267|Hydroxocobalamin|hydroxocobalamin|mesh-list
110219570|NCT00111267|Vitamin B 12|vitamin b 12|mesh-list
110219571|NCT00111267|Vitamin B Complex|vitamin b complex|mesh-list
110219572|NCT00111267|Micronutrients|micronutrients|mesh-ancestor
110219574|NCT00111267|Hematinics|hematinics|mesh-ancestor
110219575|NCT00286936|Zolpidem|zolpidem|mesh-list
110219576|NCT00286936|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110219577|NCT00286936|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110219578|NCT00286936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110219579|NCT00286936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110219580|NCT00286936|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110219581|NCT00286936|GABA Agonists|gaba agonists|mesh-ancestor
110219582|NCT00286936|GABA Agents|gaba agents|mesh-ancestor
110219583|NCT00286936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110219584|NCT00286936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219585|NCT00111306|Epratuzumab|epratuzumab|mesh-list
110219586|NCT00111306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110219587|NCT00111306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110219588|NCT00077870|Ocrelizumab|ocrelizumab|mesh-list
110219592|NCT00287170|Mercaptopurine|mercaptopurine|mesh-list
110219593|NCT00287170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110219594|NCT00287170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110219595|NCT00287170|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110219596|NCT00287170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110219597|NCT00287170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219600|NCT00287170|Micronutrients|micronutrients|mesh-ancestor
110219601|NCT00287170|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110219602|NCT00287170|Antimetabolites|antimetabolites|mesh-ancestor
110219603|NCT00287170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110219604|NCT00287170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110219605|NCT00287170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110219606|NCT00287170|Immunologic Factors|immunologic factors|mesh-ancestor
110219607|NCT00287170|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110219608|NCT00287170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110219609|NCT00287209|Amiodarone|amiodarone|mesh-list
110219610|NCT00287209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110219611|NCT00287209|Vasodilator Agents|vasodilator agents|mesh-ancestor
110219612|NCT00287209|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110219613|NCT00287209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110219614|NCT00287209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219615|NCT00287209|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110219616|NCT00287209|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110219617|NCT00287209|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110219619|NCT00287209|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110219620|NCT00287209|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110219621|NCT00287209|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110219622|NCT00077948|Metoprolol|metoprolol|mesh-list
110219623|NCT00077948|Enoximone|enoximone|mesh-list
110219624|NCT00077948|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110219625|NCT00077948|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110219627|NCT00077948|Autonomic Agents|autonomic agents|mesh-ancestor
110219628|NCT00077948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110219629|NCT00077948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110219630|NCT00077948|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110219631|NCT00077948|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110219632|NCT00077948|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110219633|NCT00077948|Adrenergic Agents|adrenergic agents|mesh-ancestor
110219634|NCT00077948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110219635|NCT00077948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219636|NCT00077948|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110219637|NCT00077948|Vasodilator Agents|vasodilator agents|mesh-ancestor
110219638|NCT00077948|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110219639|NCT00077948|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110219640|NCT00077948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110219641|NCT00077948|Protective Agents|protective agents|mesh-ancestor
110219642|NCT00111345|Daunorubicin|daunorubicin|mesh-list
110219643|NCT00111345|Idarubicin|idarubicin|mesh-list
110219645|NCT00111345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110219646|NCT00111345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110219647|NCT00111345|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110219648|NCT00111345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110219649|NCT00111345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110219650|NCT00111345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219651|NCT00111345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110219652|NCT00111345|Immunologic Factors|immunologic factors|mesh-ancestor
110219653|NCT00111345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110219654|NCT00287326|Clonidine|clonidine|mesh-list
110219655|NCT00287326|Morphine|morphine|mesh-list
110219656|NCT00287326|Bupivacaine|bupivacaine|mesh-list
110219657|NCT00287326|Anesthetics, Local|anesthetics, local|mesh-ancestor
110219658|NCT00287326|Anesthetics|anesthetics|mesh-ancestor
110219659|NCT00287326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110219660|NCT00287326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110219661|NCT00287326|Sensory System Agents|sensory system agents|mesh-ancestor
110219662|NCT00287326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110219663|NCT00287326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110219664|NCT00287326|Narcotics|narcotics|mesh-ancestor
110219665|NCT00287326|Analgesics|analgesics|mesh-ancestor
110219666|NCT00287326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110219668|NCT00287326|Autonomic Agents|autonomic agents|mesh-ancestor
110219669|NCT00287326|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110219671|NCT00287326|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110219672|NCT00287326|Adrenergic Agents|adrenergic agents|mesh-ancestor
110219673|NCT00287326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110219674|NCT00287326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219675|NCT00287443|Hormones|hormones|mesh-list
110219676|NCT00287443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110219677|NCT00287443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110219678|NCT00077987|Sunitinib|sunitinib|mesh-list
110219679|NCT00077987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110219680|NCT00077987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110219681|NCT00077987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110219682|NCT00077987|Growth Substances|growth substances|mesh-ancestor
110219683|NCT00077987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110219684|NCT00077987|Growth Inhibitors|growth inhibitors|mesh-ancestor
110219685|NCT00077987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110219686|NCT00077987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110219687|NCT00077987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219688|NCT00287521|Timolol|timolol|mesh-list
110219689|NCT00287521|Latanoprost|latanoprost|mesh-list
110219690|NCT00287521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219691|NCT00287521|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110219692|NCT00287521|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110219693|NCT00287521|Adrenergic Agents|adrenergic agents|mesh-ancestor
110219694|NCT00287521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110219695|NCT00287521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110219696|NCT00287521|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110219697|NCT00287521|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110219698|NCT00287521|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110219699|NCT00287521|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110219700|NCT00287560|Propofol|propofol|mesh-list
110219701|NCT00287560|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110219702|NCT00287560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110219703|NCT00287560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110219704|NCT00287560|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110219706|NCT00287560|Anesthetics|anesthetics|mesh-ancestor
110219707|NCT00111462|Darbepoetin alfa|darbepoetin alfa|mesh-list
110219708|NCT00111462|Hematinics|hematinics|mesh-ancestor
110219709|NCT00287677|Hormones|hormones|mesh-list
110219710|NCT00287677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110219711|NCT00287677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110219712|NCT00287794|Diazepam|diazepam|mesh-list
110219713|NCT00287794|Melatonin|melatonin|mesh-list
110219714|NCT00287794|Antioxidants|antioxidants|mesh-ancestor
110219715|NCT00287794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219716|NCT00287794|Protective Agents|protective agents|mesh-ancestor
110219717|NCT00287794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110219718|NCT00287794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110219719|NCT00287794|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110219720|NCT00287794|Anticonvulsants|anticonvulsants|mesh-ancestor
110219721|NCT00287794|Antiemetics|antiemetics|mesh-ancestor
110219722|NCT00287794|Autonomic Agents|autonomic agents|mesh-ancestor
110219723|NCT00287794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110219724|NCT00287794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110219725|NCT00287794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110219726|NCT00287794|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110219727|NCT00287794|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110219728|NCT00287794|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110219729|NCT00287794|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110219730|NCT00287794|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110219731|NCT00287794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110219734|NCT00287794|GABA Modulators|gaba modulators|mesh-ancestor
110219735|NCT00287794|GABA Agents|gaba agents|mesh-ancestor
110219736|NCT00287794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110219738|NCT00287911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110219739|NCT00287911|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110219740|NCT00287911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110219741|NCT00287911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110219742|NCT00287911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219743|NCT00287950|Cyclophosphamide|cyclophosphamide|mesh-list
110219744|NCT00287950|Carboplatin|carboplatin|mesh-list
110219745|NCT00287950|Etoposide|etoposide|mesh-list
110219746|NCT00287950|Vincristine|vincristine|mesh-list
110219747|NCT00287950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110219748|NCT00287950|Immunologic Factors|immunologic factors|mesh-ancestor
110219749|NCT00287950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110219750|NCT00287950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110219751|NCT00287950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110219752|NCT00287950|Alkylating Agents|alkylating agents|mesh-ancestor
110219753|NCT00287950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219754|NCT00287950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110219755|NCT00287950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110219756|NCT00287950|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110219757|NCT00287950|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110219758|NCT00287950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110219759|NCT00287950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110219760|NCT00287950|Tubulin Modulators|tubulin modulators|mesh-ancestor
110219761|NCT00287950|Antimitotic Agents|antimitotic agents|mesh-ancestor
110219762|NCT00287950|Mitosis Modulators|mitosis modulators|mesh-ancestor
110219763|NCT00288028|Bortezomib|bortezomib|mesh-list
110219764|NCT00288028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110219765|NCT00111540|Exenatide|exenatide|mesh-list
110219766|NCT00111540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110219767|NCT00111540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110219768|NCT00111540|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110219769|NCT00111540|Incretins|incretins|mesh-ancestor
110219771|NCT00111540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110219772|NCT00288184|Allopurinol|allopurinol|mesh-list
110219773|NCT00288184|Antimetabolites|antimetabolites|mesh-ancestor
110219774|NCT00288184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219775|NCT00288184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110219776|NCT00288184|Gout Suppressants|gout suppressants|mesh-ancestor
110219777|NCT00288184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110219778|NCT00288184|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110219779|NCT00288184|Antioxidants|antioxidants|mesh-ancestor
110219780|NCT00288184|Protective Agents|protective agents|mesh-ancestor
110219781|NCT00288184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110219782|NCT00288223|Telithromycin|telithromycin|mesh-list
110219783|NCT00288223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110219784|NCT00288223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110219785|NCT00288262|Melatonin|melatonin|mesh-list
110219786|NCT00288262|Antioxidants|antioxidants|mesh-ancestor
110219787|NCT00288262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219788|NCT00288262|Protective Agents|protective agents|mesh-ancestor
110219789|NCT00288262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110219790|NCT00288262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110219792|NCT00288379|Formoterol Fumarate|formoterol fumarate|mesh-list
110219793|NCT00288379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110219794|NCT00288379|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110219795|NCT00288379|Autonomic Agents|autonomic agents|mesh-ancestor
110219796|NCT00288379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110219797|NCT00288379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110219798|NCT00288379|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110219799|NCT00288379|Respiratory System Agents|respiratory system agents|mesh-ancestor
110219800|NCT00288379|Glucocorticoids|glucocorticoids|mesh-ancestor
110219801|NCT00288379|Hormones|hormones|mesh-ancestor
110219802|NCT00288379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110219803|NCT00288379|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110219804|NCT00288379|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110219805|NCT00288379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110219806|NCT00288379|Adrenergic Agents|adrenergic agents|mesh-ancestor
110219807|NCT00288379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110219808|NCT00288379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219809|NCT00078182|Tenofovir|tenofovir|mesh-list
110219810|NCT00078182|Antiviral Agents|antiviral agents|mesh-ancestor
110219811|NCT00078182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110219812|NCT00078182|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110219813|NCT00078182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110219814|NCT00078182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110219815|NCT00078182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219816|NCT00078182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110219817|NCT00078182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110219819|NCT00111618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110219820|NCT00399425|Heparin|heparin|mesh-list
110219821|NCT00399425|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110219822|NCT00399425|Tinzaparin|tinzaparin|mesh-list
110219823|NCT00399425|Dalteparin|dalteparin|mesh-list
110219824|NCT00399425|Bemiparin|bemiparin|mesh-list
110219825|NCT00399425|Anticoagulants|anticoagulants|mesh-ancestor
110219826|NCT00399425|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110219827|NCT00399425|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110219828|NCT00399425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219829|NCT00288535|Sirolimus|sirolimus|mesh-list
110219830|NCT00288535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110219831|NCT00288535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110219833|NCT00288535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110219834|NCT00288535|Antifungal Agents|antifungal agents|mesh-ancestor
110219835|NCT00288535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110219836|NCT00288535|Immunologic Factors|immunologic factors|mesh-ancestor
110219837|NCT00288535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110219839|NCT00399464|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110219840|NCT00399464|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110219841|NCT00399464|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110219842|NCT00399464|Adrenergic Agents|adrenergic agents|mesh-ancestor
110219843|NCT00399464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110219844|NCT00399464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219845|NCT00399464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110219846|NCT00399464|Urological Agents|urological agents|mesh-ancestor
110219847|NCT00288652|Reboxetine|reboxetine|mesh-list
110219848|NCT00288652|Antidepressive Agents|antidepressive agents|mesh-ancestor
110219849|NCT00288652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110219850|NCT00288652|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110219851|NCT00288652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110219852|NCT00288652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110219853|NCT00288652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219854|NCT00288652|Adrenergic Agents|adrenergic agents|mesh-ancestor
110219855|NCT00288652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110219856|NCT00288652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110219857|NCT00288730|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
110219858|NCT00288730|Natriuretic Agents|natriuretic agents|mesh-ancestor
110219859|NCT00288730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110219860|NCT00288769|Vitamin B 12|vitamin b 12|mesh-list
110219861|NCT00288769|Hydroxocobalamin|hydroxocobalamin|mesh-list
110219863|NCT00288769|Micronutrients|micronutrients|mesh-ancestor
110219864|NCT00288769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110219865|NCT00288769|Vitamin B Complex|vitamin b complex|mesh-ancestor
110219866|NCT00288769|Hematinics|hematinics|mesh-ancestor
110219867|NCT00111852|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
110219868|NCT00111852|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110219869|NCT00111852|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110219870|NCT00111852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219873|NCT00289042|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110219874|NCT00289042|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110219875|NCT00289042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219876|NCT00111891|Niacin|niacin|mesh-list
110219877|NCT00111891|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110219878|NCT00111891|Antimetabolites|antimetabolites|mesh-ancestor
110219879|NCT00111891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219880|NCT00111891|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110219881|NCT00111891|Vasodilator Agents|vasodilator agents|mesh-ancestor
110219882|NCT00111891|Vitamin B Complex|vitamin b complex|mesh-ancestor
110219883|NCT00111891|Vitamins|vitamins|mesh-ancestor
110219884|NCT00111891|Micronutrients|micronutrients|mesh-ancestor
110219885|NCT00111891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110219886|NCT00289354|Chromium|chromium|mesh-list
110219887|NCT00289354|Biotin|biotin|mesh-list
110219888|NCT00289354|Picolinic acid|picolinic acid|mesh-list
110219889|NCT00289354|Trace Elements|trace elements|mesh-ancestor
110219890|NCT00289354|Micronutrients|micronutrients|mesh-ancestor
110219891|NCT00289354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110219892|NCT00289354|Vitamin B Complex|vitamin b complex|mesh-ancestor
110219893|NCT00289354|Vitamins|vitamins|mesh-ancestor
110219894|NCT00289354|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110219895|NCT00289354|Chelating Agents|chelating agents|mesh-ancestor
110219896|NCT00289354|Sequestering Agents|sequestering agents|mesh-ancestor
110219897|NCT00289354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219898|NCT00289510|Vaccines|vaccines|mesh-list
110219899|NCT00289510|Immunologic Factors|immunologic factors|mesh-ancestor
110219900|NCT00289510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110219901|NCT00289588|Mupirocin|mupirocin|mesh-list
110219902|NCT00289588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110219903|NCT00289588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110219904|NCT00289588|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110219906|NCT00289588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219907|NCT00289627|Ipilimumab|ipilimumab|mesh-list
110219908|NCT00289627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110219909|NCT00289627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110219910|NCT00289627|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110219911|NCT00289627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219912|NCT00401661|Alfuzosin|alfuzosin|mesh-list
110219913|NCT00401661|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110219914|NCT00401661|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110219915|NCT00401661|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110219916|NCT00401661|Adrenergic Agents|adrenergic agents|mesh-ancestor
110219917|NCT00401661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110219918|NCT00401661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219919|NCT00401661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110219920|NCT00401661|Urological Agents|urological agents|mesh-ancestor
110219921|NCT00289861|Risperidone|risperidone|mesh-list
110219923|NCT00289861|Serotonin Agents|serotonin agents|mesh-ancestor
110219924|NCT00289861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110219925|NCT00289861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219926|NCT00289861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110219927|NCT00289861|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110219928|NCT00289861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110219929|NCT00289861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110219930|NCT00289861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110219931|NCT00289861|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110219933|NCT00290017|Pemetrexed|pemetrexed|mesh-list
110219934|NCT00290017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110219935|NCT00290017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110219936|NCT00290017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219937|NCT00290017|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110219938|NCT00290017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110219939|NCT00112008|Darbepoetin alfa|darbepoetin alfa|mesh-list
110219940|NCT00112008|Hematinics|hematinics|mesh-ancestor
110219941|NCT00112086|Paclitaxel|paclitaxel|mesh-list
110219942|NCT00112086|Carboplatin|carboplatin|mesh-list
110219943|NCT00112086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110219944|NCT00112086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110219945|NCT00112086|Tubulin Modulators|tubulin modulators|mesh-ancestor
110219946|NCT00112086|Antimitotic Agents|antimitotic agents|mesh-ancestor
110219947|NCT00112086|Mitosis Modulators|mitosis modulators|mesh-ancestor
110219948|NCT00112086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219949|NCT00290173|Ritodrine|ritodrine|mesh-list
110219950|NCT00290173|Sympathomimetics|sympathomimetics|mesh-ancestor
110219951|NCT00290173|Autonomic Agents|autonomic agents|mesh-ancestor
110219952|NCT00290173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110219953|NCT00290173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110219954|NCT00290173|Tocolytic Agents|tocolytic agents|mesh-ancestor
110219955|NCT00290173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110219956|NCT00290173|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110219957|NCT00290173|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110219958|NCT00290173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110219959|NCT00290173|Adrenergic Agents|adrenergic agents|mesh-ancestor
110219960|NCT00290173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110219961|NCT00290173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219962|NCT00290485|Imatinib Mesylate|imatinib mesylate|mesh-list
110219963|NCT00290485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110219964|NCT00290485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110219965|NCT00290485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110219966|NCT00290485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219967|NCT00112164|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
110219968|NCT00112164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110219970|NCT00078260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110219971|NCT00078260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110219972|NCT00078260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219973|NCT00078260|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110219974|NCT00078260|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110219976|NCT00290602|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110219977|NCT00290602|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110219978|NCT00290602|Prednisolone|prednisolone|mesh-list
110219979|NCT00290602|Prednisolone acetate|prednisolone acetate|mesh-list
110219980|NCT00290602|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110219981|NCT00290602|Prednisolone phosphate|prednisolone phosphate|mesh-list
110219982|NCT00290602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110219983|NCT00290602|Antiemetics|antiemetics|mesh-ancestor
110219984|NCT00290602|Autonomic Agents|autonomic agents|mesh-ancestor
110219985|NCT00290602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110219986|NCT00290602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110219987|NCT00290602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110219988|NCT00290602|Glucocorticoids|glucocorticoids|mesh-ancestor
110219990|NCT00290602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110219991|NCT00290602|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110219992|NCT00290602|Protective Agents|protective agents|mesh-ancestor
110219993|NCT00290602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110219994|NCT00290602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110219995|NCT00290641|Cyclosporine|cyclosporine|mesh-list
110219996|NCT00290641|Mycophenolic Acid|mycophenolic acid|mesh-list
110219997|NCT00290641|Cyclophosphamide|cyclophosphamide|mesh-list
110219998|NCT00290641|Fludarabine|fludarabine|mesh-list
110219999|NCT00290641|Fludarabine phosphate|fludarabine phosphate|mesh-list
110220000|NCT00290641|Cyclosporins|cyclosporins|mesh-list
110220001|NCT00290641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110220002|NCT00290641|Immunologic Factors|immunologic factors|mesh-ancestor
110220003|NCT00290641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110220004|NCT00290641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110220005|NCT00290641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110220006|NCT00290641|Alkylating Agents|alkylating agents|mesh-ancestor
110220007|NCT00290641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220008|NCT00290641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110220009|NCT00290641|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110220010|NCT00290641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110220011|NCT00290641|Antimetabolites|antimetabolites|mesh-ancestor
110220012|NCT00290641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110220013|NCT00290641|Antifungal Agents|antifungal agents|mesh-ancestor
110220017|NCT00290641|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110220018|NCT00290641|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110220019|NCT00290641|Antitubercular Agents|antitubercular agents|mesh-ancestor
110220020|NCT00290641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110220021|NCT00290680|Celecoxib|celecoxib|mesh-list
110220022|NCT00290680|Bortezomib|bortezomib|mesh-list
110220023|NCT00290680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110220024|NCT00290680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110220025|NCT00290680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110220026|NCT00290680|Analgesics|analgesics|mesh-ancestor
110220027|NCT00290680|Sensory System Agents|sensory system agents|mesh-ancestor
110220028|NCT00290680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110220029|NCT00290680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110220030|NCT00290680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110220031|NCT00290680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110220032|NCT00290680|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110220033|NCT00290680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110220034|NCT00290680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110220035|NCT00290680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220036|NCT02960815|Imiquimod|imiquimod|mesh-list
110220038|NCT02960815|Immunologic Factors|immunologic factors|mesh-ancestor
110220039|NCT02960815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110220040|NCT02960815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110220041|NCT02960815|Interferon Inducers|interferon inducers|mesh-ancestor
110220042|NCT00112281|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
110220043|NCT00112281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110220044|NCT00112281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220045|NCT00290719|Irinotecan|irinotecan|mesh-list
110220046|NCT00290719|Gefitinib|gefitinib|mesh-list
110220047|NCT00290719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110220048|NCT00290719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110220049|NCT00290719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110220050|NCT00290719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110220051|NCT00290719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220052|NCT00290719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110220054|NCT00290836|Aprotinin|aprotinin|mesh-list
110220055|NCT00290836|Hemostatics|hemostatics|mesh-ancestor
110220056|NCT00290836|Coagulants|coagulants|mesh-ancestor
110220057|NCT00290836|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110220058|NCT00290836|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110220059|NCT00290836|Protease Inhibitors|protease inhibitors|mesh-ancestor
110220060|NCT00290836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110220061|NCT00290836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220062|NCT04729556|Chitosan|chitosan|mesh-list
110220063|NCT04729556|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110220064|NCT04729556|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110220065|NCT04729556|Antimetabolites|antimetabolites|mesh-ancestor
110220066|NCT04729556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220067|NCT04729556|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110220068|NCT04729556|Chelating Agents|chelating agents|mesh-ancestor
110220069|NCT04729556|Sequestering Agents|sequestering agents|mesh-ancestor
110220070|NCT04729556|Hemostatics|hemostatics|mesh-ancestor
110220071|NCT04729556|Coagulants|coagulants|mesh-ancestor
110220072|NCT00290914|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
110220073|NCT00290914|Antidepressive Agents|antidepressive agents|mesh-ancestor
110220074|NCT00290914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110220075|NCT00290914|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110220076|NCT00290914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110220077|NCT00290914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110220078|NCT00290914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220079|NCT00290914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110220080|NCT00290914|Serotonin Agents|serotonin agents|mesh-ancestor
110220081|NCT00290914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110220083|NCT00290914|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110220084|NCT00290992|Rasburicase|rasburicase|mesh-list
110220085|NCT00290992|Gout Suppressants|gout suppressants|mesh-ancestor
110220086|NCT00290992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110220087|NCT00291109|Letrozole|letrozole|mesh-list
110220088|NCT00291109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110220089|NCT00291109|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110220090|NCT00291109|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110220092|NCT00291109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220093|NCT00291109|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110220094|NCT00291109|Hormone Antagonists|hormone antagonists|mesh-ancestor
110220095|NCT00291109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110220097|NCT00291148|Pregabalin|pregabalin|mesh-list
110220098|NCT00291148|Paroxetine|paroxetine|mesh-list
110220099|NCT00291148|Analgesics|analgesics|mesh-ancestor
110220100|NCT00291148|Sensory System Agents|sensory system agents|mesh-ancestor
110220101|NCT00291148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110220102|NCT00291148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110220103|NCT00291148|Anticonvulsants|anticonvulsants|mesh-ancestor
110220104|NCT00291148|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110220105|NCT00291148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110220106|NCT00291148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220107|NCT00291148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110220108|NCT00291148|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110220109|NCT00291148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110220110|NCT00291148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110220111|NCT00291148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110220112|NCT00291148|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110220113|NCT00291148|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110220116|NCT00291148|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110220117|NCT00291148|Antidepressive Agents|antidepressive agents|mesh-ancestor
110220118|NCT00291148|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110220119|NCT00291148|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110220121|NCT00291382|Fluticasone|fluticasone|mesh-list
110220123|NCT00291382|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110220124|NCT00291382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110220125|NCT00291382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110220126|NCT00291382|Autonomic Agents|autonomic agents|mesh-ancestor
110220127|NCT00291382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110220128|NCT00291382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110220129|NCT00291382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110220130|NCT00291382|Respiratory System Agents|respiratory system agents|mesh-ancestor
110220132|NCT00291382|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110220133|NCT00291382|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110220134|NCT00291382|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110220135|NCT00291382|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110220136|NCT00291382|Adrenergic Agents|adrenergic agents|mesh-ancestor
110220137|NCT00291382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110220138|NCT00291382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220140|NCT00112476|Temsirolimus|temsirolimus|mesh-list
110220141|NCT00112476|MTOR Inhibitors|mtor inhibitors|mesh-list
110220142|NCT00112476|Bryostatin 1|bryostatin 1|mesh-list
110220143|NCT00112476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110220144|NCT00112476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110220147|NCT00112476|Immunologic Factors|immunologic factors|mesh-ancestor
110220148|NCT00112476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110220149|NCT00112476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110220150|NCT00112476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110220151|NCT00112476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110220152|NCT00112476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110220153|NCT00112476|Antifungal Agents|antifungal agents|mesh-ancestor
110220154|NCT00112476|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110220156|NCT00291538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110220157|NCT00291616|Interferons|interferons|mesh-list
110220158|NCT00291616|Interferon-alpha|interferon-alpha|mesh-list
110220159|NCT00291616|Interferon alpha-2|interferon alpha-2|mesh-list
110220160|NCT00291616|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110220161|NCT00291616|Thymalfasin|thymalfasin|mesh-list
110220162|NCT00291616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110220163|NCT00291616|Antiviral Agents|antiviral agents|mesh-ancestor
110220164|NCT00291616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110220165|NCT00291616|Immunologic Factors|immunologic factors|mesh-ancestor
110220166|NCT00291616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110220167|NCT00291616|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110220168|NCT00078572|Capecitabine|capecitabine|mesh-list
110220169|NCT00078572|Lapatinib|lapatinib|mesh-list
110220170|NCT00078572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110220172|NCT00078572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220173|NCT00078572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110220174|NCT00078572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110220175|NCT00078572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110220176|NCT00291733|Levetiracetam|levetiracetam|mesh-list
110220177|NCT00291733|Anticonvulsants|anticonvulsants|mesh-ancestor
110220178|NCT00291733|Nootropic Agents|nootropic agents|mesh-ancestor
110220179|NCT00112515|Modafinil|modafinil|mesh-list
110220180|NCT00112515|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110220181|NCT00112515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110220182|NCT00112515|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110220183|NCT00112515|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110220184|NCT00112515|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110220185|NCT00112515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110052858|NCT01482377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110220187|NCT00291772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110237654|NCT00094523|Fosamprenavir|fosamprenavir|mesh-list
110220189|NCT00078611|Natalizumab|natalizumab|mesh-list
110220190|NCT00078611|Immunologic Factors|immunologic factors|mesh-ancestor
110220191|NCT00078611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110220192|NCT00291811|Plerixafor|plerixafor|mesh-list
110220193|NCT00291811|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110220194|NCT00291811|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110220195|NCT00291811|Antiviral Agents|antiviral agents|mesh-ancestor
110220197|NCT00291850|Paclitaxel|paclitaxel|mesh-list
110220198|NCT00291850|Cisplatin|cisplatin|mesh-list
110220199|NCT00291850|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110220200|NCT00291850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110220201|NCT00291850|Tubulin Modulators|tubulin modulators|mesh-ancestor
110220202|NCT00291850|Antimitotic Agents|antimitotic agents|mesh-ancestor
110220203|NCT00291850|Mitosis Modulators|mitosis modulators|mesh-ancestor
110220204|NCT00291850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220205|NCT00112554|Cytarabine|cytarabine|mesh-list
110220206|NCT00112554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110220207|NCT00112554|Antimetabolites|antimetabolites|mesh-ancestor
110220208|NCT00112554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220210|NCT00112554|Antiviral Agents|antiviral agents|mesh-ancestor
110220211|NCT00112554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110220212|NCT00112554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110220213|NCT00112554|Immunologic Factors|immunologic factors|mesh-ancestor
110220214|NCT00112554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110220215|NCT04718311|Tacrolimus|tacrolimus|mesh-list
110220216|NCT04718311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110220217|NCT04718311|Immunologic Factors|immunologic factors|mesh-ancestor
110220218|NCT04718311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110220220|NCT04718311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110220221|NCT04718311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220222|NCT00078689|Daclizumab|daclizumab|mesh-list
110220223|NCT00078689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110220225|NCT00078689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110220226|NCT00112632|Imatinib Mesylate|imatinib mesylate|mesh-list
110220227|NCT00112632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110220228|NCT00112632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110220229|NCT00112632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110220230|NCT00112632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220231|NCT00078845|Amifostine|amifostine|mesh-list
110220232|NCT00078845|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110220233|NCT00078845|Protective Agents|protective agents|mesh-ancestor
110220234|NCT00078845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110220235|NCT00275314|Valganciclovir|valganciclovir|mesh-list
110220236|NCT00275314|Antiviral Agents|antiviral agents|mesh-ancestor
110220237|NCT00275314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110220239|NCT00275275|Ropinirole|ropinirole|mesh-list
110220240|NCT00275275|Antioxidants|antioxidants|mesh-ancestor
110220241|NCT00275275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220242|NCT00275275|Protective Agents|protective agents|mesh-ancestor
110220243|NCT00275275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110220244|NCT00275275|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110220245|NCT00275275|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110220246|NCT00275275|Dopamine Agonists|dopamine agonists|mesh-ancestor
110220247|NCT00275275|Dopamine Agents|dopamine agents|mesh-ancestor
110220248|NCT00275275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110220249|NCT00112710|Carboplatin|carboplatin|mesh-list
110220250|NCT00112710|Gemcitabine|gemcitabine|mesh-list
110220251|NCT00112710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110220252|NCT00112710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110220253|NCT00112710|Antimetabolites|antimetabolites|mesh-ancestor
110220254|NCT00112710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220255|NCT00275236|Rotigotine|rotigotine|mesh-list
110220256|NCT00275236|Dopamine Agonists|dopamine agonists|mesh-ancestor
110220257|NCT00275236|Dopamine Agents|dopamine agents|mesh-ancestor
110220258|NCT00275236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110220259|NCT00275236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220260|NCT00275236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110220261|NCT00275197|Sertraline|sertraline|mesh-list
110220262|NCT00275197|Antidepressive Agents|antidepressive agents|mesh-ancestor
110220263|NCT00275197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110220264|NCT00275197|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110220265|NCT00275197|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110220266|NCT00275197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110220267|NCT00275197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220268|NCT00275197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110220269|NCT00275197|Serotonin Agents|serotonin agents|mesh-ancestor
110220270|NCT00275197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110220272|NCT00275119|Fluorouracil|fluorouracil|mesh-list
110220273|NCT00275119|Oxaliplatin|oxaliplatin|mesh-list
110220274|NCT00275119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110220276|NCT00275119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220277|NCT00275119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110220278|NCT00275119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110220279|NCT00275119|Immunologic Factors|immunologic factors|mesh-ancestor
110220280|NCT00275119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110220281|NCT00275080|Decitabine|decitabine|mesh-list
110220282|NCT00275080|Azacitidine|azacitidine|mesh-list
110220283|NCT00275080|Vorinostat|vorinostat|mesh-list
110220284|NCT00275080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110220285|NCT00275080|Antimetabolites|antimetabolites|mesh-ancestor
110220286|NCT00275080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220287|NCT00275080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110220288|NCT00275080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110220289|NCT00275080|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110220290|NCT00078962|Gemcitabine|gemcitabine|mesh-list
110220291|NCT00078962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110220292|NCT00078962|Antimetabolites|antimetabolites|mesh-ancestor
110220293|NCT00078962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220294|NCT00078962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110220295|NCT00275041|Irinotecan|irinotecan|mesh-list
110220296|NCT00275041|Cetuximab|cetuximab|mesh-list
110220297|NCT00275041|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110220299|NCT00275041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110220300|NCT00275041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220301|NCT00275041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110220302|NCT00275041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110220303|NCT00274963|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110220305|NCT00274963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110220306|NCT00274963|Alkylating Agents|alkylating agents|mesh-ancestor
110220307|NCT00274963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220308|NCT00274963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110220309|NCT00274963|Analgesics|analgesics|mesh-ancestor
110220310|NCT00274963|Sensory System Agents|sensory system agents|mesh-ancestor
110220311|NCT00274963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110220312|NCT00274963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110220313|NCT00274963|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110220314|NCT00274963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110220315|NCT00274963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110220316|NCT00102765|Fluticasone|fluticasone|mesh-list
110220317|NCT00102765|Xhance|xhance|mesh-list
110220318|NCT00102765|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110220319|NCT00102765|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110220320|NCT00102765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110220321|NCT00102765|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110220322|NCT00102765|Autonomic Agents|autonomic agents|mesh-ancestor
110220323|NCT00102765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110220324|NCT00102765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110220325|NCT00102765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110220326|NCT00102765|Respiratory System Agents|respiratory system agents|mesh-ancestor
110220327|NCT00102765|Dermatologic Agents|dermatologic agents|mesh-ancestor
110220328|NCT00102765|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110220329|NCT00102765|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110220330|NCT00102765|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110220331|NCT00102765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110220332|NCT00102765|Adrenergic Agents|adrenergic agents|mesh-ancestor
110220333|NCT00102765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110220334|NCT00102765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220335|NCT00102765|Glucocorticoids|glucocorticoids|mesh-ancestor
110220336|NCT00102765|Hormones|hormones|mesh-ancestor
110220337|NCT00102765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110220338|NCT00102765|Sympathomimetics|sympathomimetics|mesh-ancestor
110220339|NCT00130390|Nitazoxanide|nitazoxanide|mesh-list
110220340|NCT00130390|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110220341|NCT00130390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110220342|NCT00130312|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
110220343|NCT00130312|Anticoagulants|anticoagulants|mesh-ancestor
110220344|NCT00130312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110220346|NCT00130312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220347|NCT00130312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110220348|NCT00130312|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110220350|NCT00130312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110220351|NCT00130312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110220352|NCT00130234|Omalizumab|omalizumab|mesh-list
110220353|NCT00130234|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110220354|NCT00130234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110220355|NCT00130234|Respiratory System Agents|respiratory system agents|mesh-ancestor
110220356|NCT00119301|Leucovorin|leucovorin|mesh-list
110220357|NCT00119301|Trimetrexate|trimetrexate|mesh-list
110220358|NCT00119301|Methotrexate|methotrexate|mesh-list
110220359|NCT00119301|Calcium|calcium|mesh-list
110220360|NCT00119301|Levoleucovorin|levoleucovorin|mesh-list
110220361|NCT00119301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110220362|NCT00119301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110220363|NCT00119301|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110220364|NCT00119301|Abortifacient Agents|abortifacient agents|mesh-ancestor
110220365|NCT00119301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110220366|NCT00119301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110220367|NCT00119301|Antimetabolites|antimetabolites|mesh-ancestor
110220368|NCT00119301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220369|NCT00119301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110220370|NCT00119301|Dermatologic Agents|dermatologic agents|mesh-ancestor
110220371|NCT00119301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110220372|NCT00119301|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110220373|NCT00119301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110220374|NCT00119301|Immunologic Factors|immunologic factors|mesh-ancestor
110220375|NCT00119301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110220376|NCT00119301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110220378|NCT00119301|Protective Agents|protective agents|mesh-ancestor
110220379|NCT00119301|Vitamin B Complex|vitamin b complex|mesh-ancestor
110220380|NCT00119301|Vitamins|vitamins|mesh-ancestor
110220381|NCT00119301|Micronutrients|micronutrients|mesh-ancestor
110220382|NCT00119301|Antifungal Agents|antifungal agents|mesh-ancestor
110220383|NCT00119301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110220384|NCT00079118|Docetaxel|docetaxel|mesh-list
110220385|NCT00079118|Irinotecan|irinotecan|mesh-list
110220386|NCT00079118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110220387|NCT00079118|Tubulin Modulators|tubulin modulators|mesh-ancestor
110220389|NCT00079118|Mitosis Modulators|mitosis modulators|mesh-ancestor
110220390|NCT00079118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220391|NCT00079118|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110220392|NCT00079118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110220393|NCT00079118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110220409|NCT00130195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110220410|NCT00130195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110220411|NCT00130195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110220412|NCT00130195|Antiemetics|antiemetics|mesh-ancestor
110220413|NCT00130195|Autonomic Agents|autonomic agents|mesh-ancestor
110220414|NCT00130195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110220415|NCT00130195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110220416|NCT00130195|Glucocorticoids|glucocorticoids|mesh-ancestor
110220418|NCT00130195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110220419|NCT00130195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110220420|NCT00130195|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110220421|NCT00130195|Abortifacient Agents|abortifacient agents|mesh-ancestor
110220422|NCT00130195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110220423|NCT00130195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110220424|NCT00130195|Antimetabolites|antimetabolites|mesh-ancestor
110220425|NCT00130195|Dermatologic Agents|dermatologic agents|mesh-ancestor
110220426|NCT00130195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110220427|NCT00130195|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110220428|NCT00130195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110220429|NCT00130195|Antiviral Agents|antiviral agents|mesh-ancestor
110220430|NCT00130195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110220431|NCT00130195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110220432|NCT00130195|Tubulin Modulators|tubulin modulators|mesh-ancestor
110220433|NCT00130195|Antimitotic Agents|antimitotic agents|mesh-ancestor
110220434|NCT00130195|Mitosis Modulators|mitosis modulators|mesh-ancestor
110220435|NCT00130195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110220436|NCT00130195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110220437|NCT00130195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110220438|NCT00130195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110220440|NCT00394303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110220441|NCT00394303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110220442|NCT00119340|Cyclosporine|cyclosporine|mesh-list
110220446|NCT00119340|Cyclosporins|cyclosporins|mesh-list
110220447|NCT00119340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110220453|NCT00119340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110220454|NCT00119340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110220455|NCT00119340|Antifungal Agents|antifungal agents|mesh-ancestor
110220456|NCT00119340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110220457|NCT00119340|Dermatologic Agents|dermatologic agents|mesh-ancestor
110220458|NCT00119340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110220459|NCT00119340|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110220460|NCT00119340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110220461|NCT00119340|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110220462|NCT00119340|Antitubercular Agents|antitubercular agents|mesh-ancestor
110220463|NCT00119340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110220465|NCT00130156|Bunazosin|bunazosin|mesh-list
110220466|NCT00130156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110220467|NCT00130156|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110220468|NCT00130156|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110220469|NCT00130156|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110220470|NCT00130156|Adrenergic Agents|adrenergic agents|mesh-ancestor
110220471|NCT00130156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110220472|NCT00130156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220473|NCT00130156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110220474|NCT00130117|Contraceptive Agents|contraceptive agents|mesh-list
110220475|NCT00130117|Contraceptives, Oral|contraceptives, oral|mesh-list
110220476|NCT00130117|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
110220477|NCT00130117|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110220478|NCT00130117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110220479|NCT00130117|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110220481|NCT00079157|Freund's Adjuvant|freund's adjuvant|mesh-list
110220482|NCT00079157|Immunologic Factors|immunologic factors|mesh-ancestor
110220483|NCT00079157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110220484|NCT00079157|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110220486|NCT00130000|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110220487|NCT00130000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110220488|NCT00130000|Immunologic Factors|immunologic factors|mesh-ancestor
110220489|NCT00130000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110220490|NCT00079235|Sirolimus|sirolimus|mesh-list
110220491|NCT00079235|Temsirolimus|temsirolimus|mesh-list
110220492|NCT00079235|MTOR Inhibitors|mtor inhibitors|mesh-list
110220493|NCT00079235|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110237759|NCT00095264|Hematinics|hematinics|mesh-ancestor
110220495|NCT00079235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220496|NCT00079235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110220497|NCT00079235|Immunologic Factors|immunologic factors|mesh-ancestor
110220498|NCT00079235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110220499|NCT00079235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110220500|NCT00079235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110220501|NCT00079235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110220502|NCT00079235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110220503|NCT00079235|Antifungal Agents|antifungal agents|mesh-ancestor
110220504|NCT00129844|Motexafin gadolinium|motexafin gadolinium|mesh-list
110220505|NCT00129844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110220506|NCT00129844|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110220507|NCT00129844|Dermatologic Agents|dermatologic agents|mesh-ancestor
110220510|NCT00129805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110220511|NCT00129805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110220512|NCT00129805|Analgesics|analgesics|mesh-ancestor
110220513|NCT00129805|Sensory System Agents|sensory system agents|mesh-ancestor
110220514|NCT00129805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110220515|NCT00129805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110220516|NCT00129805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110220518|NCT00129805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110220519|NCT00129805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110220520|NCT00129805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220521|NCT00129805|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110220522|NCT00129805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110220523|NCT00129805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110220524|NCT00129805|Antipyretics|antipyretics|mesh-ancestor
110220525|NCT00129805|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110220526|NCT00129805|Serotonin Agents|serotonin agents|mesh-ancestor
110220527|NCT00129805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110220528|NCT00129727|Paclitaxel|paclitaxel|mesh-list
110220529|NCT00129727|Bevacizumab|bevacizumab|mesh-list
110220530|NCT00129727|Carboplatin|carboplatin|mesh-list
110220531|NCT00129727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110220532|NCT00129727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110220533|NCT00129727|Tubulin Modulators|tubulin modulators|mesh-ancestor
110220534|NCT00129727|Antimitotic Agents|antimitotic agents|mesh-ancestor
110220535|NCT00129727|Mitosis Modulators|mitosis modulators|mesh-ancestor
110220536|NCT00129727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220537|NCT00129727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110220538|NCT00129727|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110220539|NCT00129727|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110220540|NCT00129727|Growth Substances|growth substances|mesh-ancestor
110220541|NCT00129727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110220542|NCT00129727|Growth Inhibitors|growth inhibitors|mesh-ancestor
110220544|NCT00129688|Cloxacillin|cloxacillin|mesh-list
110220545|NCT00129688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110220546|NCT00129688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110220547|NCT00079352|Gemcitabine|gemcitabine|mesh-list
110220548|NCT00079352|Irinotecan|irinotecan|mesh-list
110220549|NCT00079352|Alvocidib|alvocidib|mesh-list
110220550|NCT00079352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110220551|NCT00079352|Antimetabolites|antimetabolites|mesh-ancestor
110220552|NCT00079352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220553|NCT00079352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110220554|NCT00079352|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110220555|NCT00079352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110220556|NCT00079352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110220557|NCT00079352|Growth Inhibitors|growth inhibitors|mesh-ancestor
110220559|NCT00079352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110220560|NCT00079352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110220561|NCT00119496|Rosiglitazone|rosiglitazone|mesh-list
110220562|NCT00119496|Beclomethasone|beclomethasone|mesh-list
110220563|NCT00119496|Theophylline|theophylline|mesh-list
110220564|NCT00119496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110220565|NCT00119496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220566|NCT00119496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110220567|NCT00119496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110220568|NCT00119496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110220569|NCT00119496|Glucocorticoids|glucocorticoids|mesh-ancestor
110220570|NCT00119496|Hormones|hormones|mesh-ancestor
110220572|NCT00119496|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110220573|NCT00119496|Respiratory System Agents|respiratory system agents|mesh-ancestor
110220574|NCT00119496|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110220575|NCT00119496|Autonomic Agents|autonomic agents|mesh-ancestor
110220576|NCT00119496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110220577|NCT00119496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110220578|NCT00119496|Vasodilator Agents|vasodilator agents|mesh-ancestor
110220579|NCT00119496|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110220580|NCT00119496|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110220581|NCT00119496|Purinergic Agents|purinergic agents|mesh-ancestor
110220582|NCT00119496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110220583|NCT00298285|Enoxaparin|enoxaparin|mesh-list
110220584|NCT00298285|Anticoagulants|anticoagulants|mesh-ancestor
110220585|NCT00298285|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110220586|NCT00298285|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110220587|NCT00298285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220589|NCT00298324|Mycophenolic Acid|mycophenolic acid|mesh-list
110220590|NCT00298324|Prednisone|prednisone|mesh-list
110220591|NCT00298324|Cyclosporins|cyclosporins|mesh-list
110220593|NCT00298324|Glucocorticoids|glucocorticoids|mesh-ancestor
110220594|NCT00298324|Hormones|hormones|mesh-ancestor
110220595|NCT00298324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110220596|NCT00298324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110220597|NCT00298324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110220598|NCT00298324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110220599|NCT00298324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110220600|NCT00298324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220601|NCT00298324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110220602|NCT00298324|Immunologic Factors|immunologic factors|mesh-ancestor
110220603|NCT00298324|Antifungal Agents|antifungal agents|mesh-ancestor
110220604|NCT00298324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110220605|NCT00298324|Dermatologic Agents|dermatologic agents|mesh-ancestor
110220606|NCT00298324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110220607|NCT00298324|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110220608|NCT00298324|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110220609|NCT00298324|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110220610|NCT00298324|Antitubercular Agents|antitubercular agents|mesh-ancestor
110220611|NCT00298324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110220612|NCT00079430|Paclitaxel|paclitaxel|mesh-list
110220613|NCT00079430|Bevacizumab|bevacizumab|mesh-list
110220614|NCT00079430|Carboplatin|carboplatin|mesh-list
110220615|NCT00079430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110220616|NCT00079430|Antibodies|antibodies|mesh-list
110220617|NCT00079430|Immunoglobulins|immunoglobulins|mesh-list
110220618|NCT00079430|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110220619|NCT00079430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110220620|NCT00079430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110220621|NCT00079430|Tubulin Modulators|tubulin modulators|mesh-ancestor
110220622|NCT00079430|Antimitotic Agents|antimitotic agents|mesh-ancestor
110220623|NCT00079430|Mitosis Modulators|mitosis modulators|mesh-ancestor
110220624|NCT00079430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220625|NCT00079430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110220626|NCT00079430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110220627|NCT00079430|Growth Substances|growth substances|mesh-ancestor
110220628|NCT00079430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110220629|NCT00079430|Growth Inhibitors|growth inhibitors|mesh-ancestor
110220630|NCT00079430|Immunologic Factors|immunologic factors|mesh-ancestor
110220631|NCT00298597|Epoetin Alfa|epoetin alfa|mesh-list
110220632|NCT00298597|Hematinics|hematinics|mesh-ancestor
110220633|NCT00298636|Adenosine|adenosine|mesh-list
110220634|NCT00298636|Analgesics|analgesics|mesh-ancestor
110220635|NCT00298636|Sensory System Agents|sensory system agents|mesh-ancestor
110220636|NCT00298636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110220637|NCT00298636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110220638|NCT00298636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110220639|NCT00298636|Vasodilator Agents|vasodilator agents|mesh-ancestor
110220640|NCT00298636|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110220641|NCT00298636|Purinergic Agonists|purinergic agonists|mesh-ancestor
110220642|NCT00298636|Purinergic Agents|purinergic agents|mesh-ancestor
110220643|NCT00298636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110220644|NCT00298636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220646|NCT00086112|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110220647|NCT00086112|Serotonin Agents|serotonin agents|mesh-ancestor
110220648|NCT00086112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110220649|NCT00086112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220650|NCT00086112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110220651|NCT00086112|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110220652|NCT00086112|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110220653|NCT00086112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110220654|NCT00086112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110220655|NCT00086112|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110220656|NCT00086112|Dopamine Agents|dopamine agents|mesh-ancestor
110220657|NCT00079469|Bupropion|bupropion|mesh-list
110220658|NCT00079469|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110220659|NCT00079469|Antidepressive Agents|antidepressive agents|mesh-ancestor
110220660|NCT00079469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110220661|NCT00079469|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110220662|NCT00079469|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110220663|NCT00079469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110220664|NCT00079469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220665|NCT00079469|Dopamine Agents|dopamine agents|mesh-ancestor
110220666|NCT00079469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110220667|NCT00079469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110220668|NCT00079469|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110220669|NCT00079469|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110220670|NCT00079469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110220671|NCT00298675|Irinotecan|irinotecan|mesh-list
110220672|NCT00298675|Iniparib|iniparib|mesh-list
110220673|NCT00298675|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110220674|NCT00298675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110220675|NCT00298675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110220676|NCT00298675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220677|NCT00298675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110220678|NCT00298675|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110220680|NCT00298714|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110220681|NCT00298714|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110220682|NCT00298714|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110220683|NCT00298714|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110220684|NCT00298714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220685|NCT00079508|Bivalirudin|bivalirudin|mesh-list
110220686|NCT00079508|Antithrombins|antithrombins|mesh-ancestor
110220687|NCT00079508|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110220688|NCT00079508|Protease Inhibitors|protease inhibitors|mesh-ancestor
110220689|NCT00079508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110220690|NCT00079508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220691|NCT00079508|Anticoagulants|anticoagulants|mesh-ancestor
110220692|NCT00298870|Isoniazid|isoniazid|mesh-list
110220693|NCT00298870|Antitubercular Agents|antitubercular agents|mesh-ancestor
110220694|NCT00298870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110220695|NCT00298870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110220696|NCT00298870|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110220697|NCT00298870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110220698|NCT00298870|Antimetabolites|antimetabolites|mesh-ancestor
110220699|NCT00298870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220700|NCT00298870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110220701|NCT00298909|Niacin|niacin|mesh-list
110220704|NCT00298909|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110220705|NCT00298909|Antimetabolites|antimetabolites|mesh-ancestor
110220706|NCT00298909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220707|NCT00298909|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110220708|NCT00298909|Vasodilator Agents|vasodilator agents|mesh-ancestor
110220709|NCT00298909|Vitamin B Complex|vitamin b complex|mesh-ancestor
110220710|NCT00298909|Vitamins|vitamins|mesh-ancestor
110220711|NCT00298909|Micronutrients|micronutrients|mesh-ancestor
110220712|NCT00298909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110220713|NCT00299026|Paclitaxel|paclitaxel|mesh-list
110220714|NCT00299026|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110220715|NCT00299026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110220716|NCT00299026|Tubulin Modulators|tubulin modulators|mesh-ancestor
110220717|NCT00299026|Antimitotic Agents|antimitotic agents|mesh-ancestor
110220718|NCT00299026|Mitosis Modulators|mitosis modulators|mesh-ancestor
110220719|NCT00299026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220720|NCT00299065|Zileuton|zileuton|mesh-list
110220721|NCT00299065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110220722|NCT00299065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110220723|NCT00299065|Analgesics|analgesics|mesh-ancestor
110220724|NCT00299065|Sensory System Agents|sensory system agents|mesh-ancestor
110220725|NCT00299065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110220728|NCT00299065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110220729|NCT00299065|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110220730|NCT00299065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110220731|NCT00299065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220733|NCT00299065|Hormone Antagonists|hormone antagonists|mesh-ancestor
110220734|NCT00299065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110220735|NCT00079586|Heparin|heparin|mesh-list
110220736|NCT00079586|Bivalirudin|bivalirudin|mesh-list
110220737|NCT00079586|Anticoagulants|anticoagulants|mesh-ancestor
110220738|NCT00079586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110220739|NCT00079586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110220740|NCT00079586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220741|NCT00079586|Antithrombins|antithrombins|mesh-ancestor
110220742|NCT00079586|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110220743|NCT00079586|Protease Inhibitors|protease inhibitors|mesh-ancestor
110237805|NCT00429247|Trastuzumab|trastuzumab|mesh-list
110220744|NCT00079586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110220745|NCT00418132|Thalidomide|thalidomide|mesh-list
110220746|NCT00418132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110220747|NCT00418132|Immunologic Factors|immunologic factors|mesh-ancestor
110220748|NCT00418132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110220749|NCT00418132|Leprostatic Agents|leprostatic agents|mesh-ancestor
110220750|NCT00418132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110220751|NCT00418132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110220752|NCT00418132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110220753|NCT00418132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110220754|NCT00418132|Growth Substances|growth substances|mesh-ancestor
110220755|NCT00418132|Growth Inhibitors|growth inhibitors|mesh-ancestor
110220756|NCT00418132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110220757|NCT00119613|Darbepoetin alfa|darbepoetin alfa|mesh-list
110220758|NCT00119613|Hematinics|hematinics|mesh-ancestor
110220759|NCT00299377|Abciximab|abciximab|mesh-list
110220760|NCT00299377|Anticoagulants|anticoagulants|mesh-ancestor
110220761|NCT00299377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110220762|NCT00299455|Amoxicillin|amoxicillin|mesh-list
110220763|NCT00299455|Clavulanic Acid|clavulanic acid|mesh-list
110220764|NCT00299455|Clavulanic Acids|clavulanic acids|mesh-list
110220765|NCT00299455|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110220766|NCT00299455|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110220767|NCT00299455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110220768|NCT00299455|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110220769|NCT00299455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110220770|NCT00299455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220771|NCT00299572|Alendronate|alendronate|mesh-list
110220772|NCT00299572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110220773|NCT00299572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110220774|NCT00299611|Levetiracetam|levetiracetam|mesh-list
110220775|NCT00299611|Sertraline|sertraline|mesh-list
110220776|NCT00299611|Antidepressive Agents|antidepressive agents|mesh-ancestor
110220777|NCT00299611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110220778|NCT00299611|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110220779|NCT00299611|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110220780|NCT00299611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110220781|NCT00299611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220782|NCT00299611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110220784|NCT00299611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110220785|NCT00299611|Anticonvulsants|anticonvulsants|mesh-ancestor
110220786|NCT00299611|Nootropic Agents|nootropic agents|mesh-ancestor
110220787|NCT00299650|Cisatracurium|cisatracurium|mesh-list
110220788|NCT00299650|Atracurium|atracurium|mesh-list
110220789|NCT00299650|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110220790|NCT00299650|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110220791|NCT00299650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110220792|NCT00299650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110220793|NCT00299650|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110220794|NCT00299650|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
110220795|NCT00299650|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110220796|NCT00299650|Cholinergic Agents|cholinergic agents|mesh-ancestor
110220797|NCT00299650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110220798|NCT00299650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220800|NCT04727853|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110220801|NCT04727853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110220802|NCT04727853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110220803|NCT04727853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220804|NCT04727853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110220805|NCT00299845|Lansoprazole|lansoprazole|mesh-list
110220806|NCT00299845|Dexlansoprazole|dexlansoprazole|mesh-list
110220807|NCT00299845|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110220808|NCT00299845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110220809|NCT00299845|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110220810|NCT00299845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110220811|NCT00299845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220812|NCT00299884|Atorvastatin|atorvastatin|mesh-list
110220814|NCT00299884|Fenofibrate|fenofibrate|mesh-list
110220815|NCT00299884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110220816|NCT00299884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110220817|NCT00299884|Antimetabolites|antimetabolites|mesh-ancestor
110220818|NCT00299884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220822|NCT00119652|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110220823|NCT00119652|Paroxetine|paroxetine|mesh-list
110220824|NCT00119652|Antidepressive Agents|antidepressive agents|mesh-ancestor
110220825|NCT00119652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110220826|NCT00119652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110220827|NCT00119652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110220828|NCT00119652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110220829|NCT00119652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110220830|NCT00119652|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110220831|NCT00119652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110220832|NCT00119652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110220833|NCT00119652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220834|NCT00119652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110220836|NCT00119652|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110220837|NCT00119652|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110220838|NCT00119652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110220839|NCT00119652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110220840|NCT00299923|Ribavirin|ribavirin|mesh-list
110220841|NCT00299923|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110220842|NCT00299923|Amantadine|amantadine|mesh-list
110220843|NCT00299923|Antimetabolites|antimetabolites|mesh-ancestor
110220844|NCT00299923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220845|NCT00299923|Antiviral Agents|antiviral agents|mesh-ancestor
110220846|NCT00299923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110220847|NCT00299923|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110220848|NCT00299923|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110220849|NCT00299923|Dopamine Agents|dopamine agents|mesh-ancestor
110220850|NCT00299923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110220851|NCT00299923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110220852|NCT00299923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110220853|NCT00299923|Analgesics|analgesics|mesh-ancestor
110220854|NCT00299923|Sensory System Agents|sensory system agents|mesh-ancestor
110220855|NCT00299923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110220856|NCT00299962|Interferons|interferons|mesh-list
110220857|NCT00299962|Interferon-beta|interferon-beta|mesh-list
110220858|NCT00299962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110220859|NCT00299962|Antiviral Agents|antiviral agents|mesh-ancestor
110220860|NCT00299962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110220863|NCT00418171|Olanzapine|olanzapine|mesh-list
110220864|NCT00418171|Ziprasidone|ziprasidone|mesh-list
110220865|NCT00418171|Antiemetics|antiemetics|mesh-ancestor
110220866|NCT00418171|Autonomic Agents|autonomic agents|mesh-ancestor
110220867|NCT00418171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110237824|NCT01054573|Interferons|interferons|mesh-list
110220876|NCT00418171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110220877|NCT00418171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220878|NCT00418171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110220879|NCT00418171|Serotonin Agents|serotonin agents|mesh-ancestor
110220880|NCT00418171|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110220881|NCT00418171|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110220882|NCT00418171|Dopamine Agents|dopamine agents|mesh-ancestor
110220883|NCT00119691|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
110220884|NCT00119691|Natriuretic Agents|natriuretic agents|mesh-ancestor
110220885|NCT00119691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110220886|NCT00300040|Chrysarobin|chrysarobin|mesh-list
110220887|NCT00300040|HBOC 201|hboc 201|mesh-list
110220888|NCT00300040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110220889|NCT00300040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110220890|NCT00300040|Analgesics|analgesics|mesh-ancestor
110220891|NCT00300040|Sensory System Agents|sensory system agents|mesh-ancestor
110220892|NCT00300040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110220893|NCT00300040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110220894|NCT00300040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110220895|NCT00300040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110220896|NCT00300040|Blood Substitutes|blood substitutes|mesh-ancestor
110220898|NCT00079820|Immunologic Factors|immunologic factors|mesh-ancestor
110220899|NCT00079820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110220900|NCT00300079|Brinzolamide|brinzolamide|mesh-list
110220901|NCT00300079|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110220902|NCT00300079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110220903|NCT00300079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220905|NCT00300118|Mesalamine|mesalamine|mesh-list
110220906|NCT00300118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110220907|NCT00300118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110220908|NCT00300118|Autonomic Agents|autonomic agents|mesh-ancestor
110220909|NCT00300118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110220910|NCT00300118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110220911|NCT00300118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110220912|NCT00300118|Respiratory System Agents|respiratory system agents|mesh-ancestor
110220913|NCT00300118|Glucocorticoids|glucocorticoids|mesh-ancestor
110220914|NCT00300118|Hormones|hormones|mesh-ancestor
110220915|NCT00300118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110220916|NCT00300118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110220917|NCT00300118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110220918|NCT00300118|Analgesics|analgesics|mesh-ancestor
110220929|NCT00119730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220931|NCT00119730|Sensory System Agents|sensory system agents|mesh-ancestor
110220932|NCT00119730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110220933|NCT00119730|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110220934|NCT00119730|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110220935|NCT00119730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110220936|NCT00300196|Ancrod|ancrod|mesh-list
110220937|NCT00300196|Anticoagulants|anticoagulants|mesh-ancestor
110220938|NCT00300196|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110220939|NCT00300196|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110220940|NCT00300196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220951|NCT00300313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110220952|NCT00399659|Tegaserod|tegaserod|mesh-list
110220953|NCT00399659|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110220954|NCT00399659|Serotonin Agents|serotonin agents|mesh-ancestor
110220955|NCT00399659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110220956|NCT00399659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220957|NCT00399659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110220958|NCT00300352|Folic Acid|folic acid|mesh-list
110220959|NCT00300352|Hematinics|hematinics|mesh-ancestor
110220960|NCT00300352|Vitamin B Complex|vitamin b complex|mesh-ancestor
110220961|NCT00300352|Vitamins|vitamins|mesh-ancestor
110220962|NCT00300352|Micronutrients|micronutrients|mesh-ancestor
110220963|NCT00300352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110220964|NCT00300508|Anastrozole|anastrozole|mesh-list
110220965|NCT00300508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110220966|NCT00300508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110220967|NCT00300508|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110220968|NCT00300508|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110220969|NCT00300508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110220970|NCT00300508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220971|NCT00300508|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110220972|NCT00300508|Hormone Antagonists|hormone antagonists|mesh-ancestor
110220973|NCT00300508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110220974|NCT00300508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110220976|NCT00086463|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110220977|NCT00086463|Vasodilator Agents|vasodilator agents|mesh-ancestor
110220978|NCT00079976|Tigecycline|tigecycline|mesh-list
110220979|NCT00079976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110220980|NCT00079976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110220981|NCT00079976|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110220982|NCT00079976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110220983|NCT00079976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220984|NCT00079313|Imatinib Mesylate|imatinib mesylate|mesh-list
110220985|NCT00079313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110220986|NCT00079313|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110220987|NCT00079313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110220988|NCT00079313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220989|NCT00086268|Zoledronic Acid|zoledronic acid|mesh-list
110220990|NCT00086268|Carboplatin|carboplatin|mesh-list
110220992|NCT00086268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110220993|NCT00086268|Tubulin Modulators|tubulin modulators|mesh-ancestor
110220994|NCT00086268|Antimitotic Agents|antimitotic agents|mesh-ancestor
110220995|NCT00086268|Mitosis Modulators|mitosis modulators|mesh-ancestor
110220996|NCT00086268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220997|NCT00086268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110220998|NCT00086268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110220999|NCT00300586|Gemcitabine|gemcitabine|mesh-list
110221000|NCT00300586|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110221001|NCT00300586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110221002|NCT00300586|Antimetabolites|antimetabolites|mesh-ancestor
110221003|NCT00300586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221005|NCT00300586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110221007|NCT00086541|Interferons|interferons|mesh-list
110221008|NCT00086541|Ribavirin|ribavirin|mesh-list
110221009|NCT00086541|Interferon alfacon-1|interferon alfacon-1|mesh-list
110221010|NCT00086541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110221011|NCT00086541|Antiviral Agents|antiviral agents|mesh-ancestor
110221012|NCT00086541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110221013|NCT00086541|Antimetabolites|antimetabolites|mesh-ancestor
110221014|NCT00086541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221016|NCT00300664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110221017|NCT00300664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110221018|NCT04718038|Cetuximab|cetuximab|mesh-list
110221019|NCT04718038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110221020|NCT04718038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110221021|NCT00080054|Motexafin gadolinium|motexafin gadolinium|mesh-list
110221022|NCT00080054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110221023|NCT00080054|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110221024|NCT00080054|Dermatologic Agents|dermatologic agents|mesh-ancestor
110221025|NCT04718233|Sildenafil Citrate|sildenafil citrate|mesh-list
110221026|NCT04718233|Vasodilator Agents|vasodilator agents|mesh-ancestor
110221027|NCT04718233|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110221028|NCT04718233|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110221029|NCT04718233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110221030|NCT04718233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221031|NCT04718233|Urological Agents|urological agents|mesh-ancestor
110221032|NCT00119886|Botulinum Toxins|botulinum toxins|mesh-list
110221033|NCT00119886|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110221034|NCT00119886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110221035|NCT00119886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221036|NCT00119886|Cholinergic Agents|cholinergic agents|mesh-ancestor
110221037|NCT00119886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110221038|NCT00119886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110221039|NCT00300937|Ubiquinone|ubiquinone|mesh-list
110221040|NCT00300937|Coenzyme Q10|coenzyme q10|mesh-list
110221041|NCT00300937|Micronutrients|micronutrients|mesh-ancestor
110221042|NCT00300937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110221043|NCT00300937|Vitamins|vitamins|mesh-ancestor
110221044|NCT00418249|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
110221045|NCT00418249|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110221046|NCT00418249|Immunologic Factors|immunologic factors|mesh-ancestor
110221047|NCT00418249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110221048|NCT00418249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110221049|NCT00418249|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110221051|NCT00418249|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110221052|NCT00418249|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110221053|NCT00418249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110221054|NCT00418249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221055|NCT00418249|Antiviral Agents|antiviral agents|mesh-ancestor
110221056|NCT00418249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110221057|NCT00301054|Pyrimethamine|pyrimethamine|mesh-list
110221058|NCT00301054|Sulfadoxine|sulfadoxine|mesh-list
110221059|NCT00301054|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110221060|NCT00301054|Antimalarials|antimalarials|mesh-ancestor
110221061|NCT00301054|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110221062|NCT00301054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110221063|NCT00301054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110221064|NCT00301054|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110221065|NCT00301054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110221066|NCT00301054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221067|NCT00301054|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110221068|NCT00301093|Imatinib Mesylate|imatinib mesylate|mesh-list
110221069|NCT00301093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110221070|NCT00301093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110221071|NCT00301093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110221072|NCT00301093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221073|NCT00301171|Fluticasone|fluticasone|mesh-list
110221074|NCT00301171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110221076|NCT00301171|Autonomic Agents|autonomic agents|mesh-ancestor
110221077|NCT00301171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110221078|NCT00301171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110221079|NCT00301171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110221080|NCT00301171|Respiratory System Agents|respiratory system agents|mesh-ancestor
110221081|NCT00301171|Dermatologic Agents|dermatologic agents|mesh-ancestor
110221082|NCT00301171|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110221084|NCT00301210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110221085|NCT00301210|Narcotics|narcotics|mesh-ancestor
110221086|NCT00301210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110221087|NCT00301210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110221088|NCT00301210|Analgesics|analgesics|mesh-ancestor
110221089|NCT00301210|Sensory System Agents|sensory system agents|mesh-ancestor
110221090|NCT00301210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110221091|NCT00080327|Aripiprazole|aripiprazole|mesh-list
110221092|NCT00080327|Antidepressive Agents|antidepressive agents|mesh-ancestor
110221093|NCT00080327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110221094|NCT00080327|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110221095|NCT00080327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110221096|NCT00080327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110221097|NCT00080327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110221098|NCT00080327|Dopamine Agonists|dopamine agonists|mesh-ancestor
110221099|NCT00080327|Dopamine Agents|dopamine agents|mesh-ancestor
110221100|NCT00080327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110221101|NCT00080327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221102|NCT00080327|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110221103|NCT00080327|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110221104|NCT00080327|Serotonin Agents|serotonin agents|mesh-ancestor
110221105|NCT00080327|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110221106|NCT00080327|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110221107|NCT00080327|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110221108|NCT00080327|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110221109|NCT00301405|Thalidomide|thalidomide|mesh-list
110221110|NCT00301405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110221111|NCT00301405|Immunologic Factors|immunologic factors|mesh-ancestor
110221112|NCT00301405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110221113|NCT00301405|Leprostatic Agents|leprostatic agents|mesh-ancestor
110221114|NCT00301405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110221115|NCT00301405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110221116|NCT00301405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110221117|NCT00301405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110221118|NCT00301405|Growth Substances|growth substances|mesh-ancestor
110221121|NCT00301483|Chrysarobin|chrysarobin|mesh-list
110221122|NCT00301483|HBOC 201|hboc 201|mesh-list
110221123|NCT00301483|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110221124|NCT00301483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110221125|NCT00301483|Analgesics|analgesics|mesh-ancestor
110221126|NCT00301483|Sensory System Agents|sensory system agents|mesh-ancestor
110221127|NCT00301483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110221128|NCT00301483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110221130|NCT00301483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110221131|NCT00301483|Blood Substitutes|blood substitutes|mesh-ancestor
110221132|NCT00301522|Paclitaxel|paclitaxel|mesh-list
110221133|NCT00301522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110221134|NCT00301522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110221135|NCT00301522|Tubulin Modulators|tubulin modulators|mesh-ancestor
110221136|NCT00301522|Antimitotic Agents|antimitotic agents|mesh-ancestor
110221137|NCT00301522|Mitosis Modulators|mitosis modulators|mesh-ancestor
110221138|NCT00301522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221139|NCT00080405|Bortezomib|bortezomib|mesh-list
110221140|NCT00080405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110221141|NCT00292123|Methadone|methadone|mesh-list
110221142|NCT00292123|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110221143|NCT00292123|Narcotics|narcotics|mesh-ancestor
110221144|NCT00292123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110221145|NCT00292123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110221146|NCT00292123|Analgesics|analgesics|mesh-ancestor
110221147|NCT00292123|Sensory System Agents|sensory system agents|mesh-ancestor
110221148|NCT00292123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110221149|NCT00292123|Antitussive Agents|antitussive agents|mesh-ancestor
110221150|NCT00292123|Respiratory System Agents|respiratory system agents|mesh-ancestor
110221151|NCT00080444|Dexamethasone|dexamethasone|mesh-list
110221152|NCT00080444|Dexamethasone acetate|dexamethasone acetate|mesh-list
110221153|NCT00080444|Ondansetron|ondansetron|mesh-list
110221154|NCT00080444|Aprepitant|aprepitant|mesh-list
110221155|NCT00080444|Fosaprepitant|fosaprepitant|mesh-list
110221156|NCT00080444|BB 1101|bb 1101|mesh-list
110221157|NCT00080444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110221159|NCT00080444|Autonomic Agents|autonomic agents|mesh-ancestor
110221160|NCT00080444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110221161|NCT00080444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110221162|NCT00080444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110221163|NCT00080444|Glucocorticoids|glucocorticoids|mesh-ancestor
110221165|NCT00080444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110221166|NCT00080444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110221167|NCT00080444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110221168|NCT00080444|Protease Inhibitors|protease inhibitors|mesh-ancestor
110221169|NCT00080444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110221170|NCT00080444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221171|NCT00080444|Antipruritics|antipruritics|mesh-ancestor
110221172|NCT00080444|Dermatologic Agents|dermatologic agents|mesh-ancestor
110221173|NCT00080444|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110221174|NCT00080444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110221175|NCT00080444|Serotonin Agents|serotonin agents|mesh-ancestor
110221176|NCT00080444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110221177|NCT00080444|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110221178|NCT00086736|Eflornithine|eflornithine|mesh-list
110221179|NCT00086736|Bicalutamide|bicalutamide|mesh-list
110221180|NCT00086736|Androgen Antagonists|androgen antagonists|mesh-ancestor
110221181|NCT00086736|Hormone Antagonists|hormone antagonists|mesh-ancestor
110221182|NCT00086736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110221183|NCT00086736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110221184|NCT00086736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110221185|NCT00086736|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110221186|NCT00086736|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110221187|NCT00086736|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110221188|NCT00086736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110221189|NCT00086736|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
110221190|NCT00086736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110221191|NCT00086736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221192|NCT00292201|Atorvastatin|atorvastatin|mesh-list
110221193|NCT00292201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110221194|NCT00292201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110221195|NCT00292201|Antimetabolites|antimetabolites|mesh-ancestor
110221196|NCT00292201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221197|NCT00292201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110221198|NCT00292201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110221199|NCT00292201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110221200|NCT00292279|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
110221201|NCT00292279|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
110221203|NCT00292279|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110221204|NCT00080522|Ritonavir|ritonavir|mesh-list
110221205|NCT00080522|Lopinavir|lopinavir|mesh-list
110221206|NCT00080522|Lamivudine|lamivudine|mesh-list
110221207|NCT00080522|Zidovudine|zidovudine|mesh-list
110221208|NCT00080522|Stavudine|stavudine|mesh-list
110221209|NCT00080522|Didanosine|didanosine|mesh-list
110221211|NCT00080522|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110221212|NCT00080522|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110221213|NCT00080522|Protease Inhibitors|protease inhibitors|mesh-ancestor
110221214|NCT00080522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110221215|NCT00080522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221216|NCT00080522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110221217|NCT00080522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110221218|NCT00080522|Antiviral Agents|antiviral agents|mesh-ancestor
110221219|NCT00080522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110221220|NCT00080522|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110221221|NCT00080522|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110221222|NCT00080522|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110221223|NCT00080522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110221225|NCT00080522|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110221226|NCT00080522|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110221227|NCT00080522|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110221228|NCT00080522|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110221229|NCT00080522|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110221233|NCT00086775|Fludarabine phosphate|fludarabine phosphate|mesh-list
110221234|NCT00086775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110221235|NCT00086775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110221236|NCT00086775|Immunologic Factors|immunologic factors|mesh-ancestor
110221237|NCT00086775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110221238|NCT00086775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110221239|NCT00086775|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110221241|NCT00086775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221242|NCT00086775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110221243|NCT00086892|Carboplatin|carboplatin|mesh-list
110221244|NCT00086892|Cetuximab|cetuximab|mesh-list
110221245|NCT00086892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110221246|NCT00086892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110221248|NCT00292708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110221249|NCT00292708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110221250|NCT00086931|Capecitabine|capecitabine|mesh-list
110221251|NCT00086931|Oxaliplatin|oxaliplatin|mesh-list
110221252|NCT00086931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110221253|NCT00086931|Antimetabolites|antimetabolites|mesh-ancestor
110221254|NCT00086931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221255|NCT00086931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110221256|NCT00292747|Ibuprofen|ibuprofen|mesh-list
110221257|NCT00292747|Drotaverin|drotaverin|mesh-list
110221258|NCT00292747|Papaverine|papaverine|mesh-list
110221259|NCT00292747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110221260|NCT00292747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110221261|NCT00292747|Analgesics|analgesics|mesh-ancestor
110221262|NCT00292747|Sensory System Agents|sensory system agents|mesh-ancestor
110221263|NCT00292747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110221264|NCT00292747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110221265|NCT00292747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110221266|NCT00292747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110221267|NCT00292747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110221268|NCT00292747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110221269|NCT00292747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221270|NCT00292747|Parasympatholytics|parasympatholytics|mesh-ancestor
110221271|NCT00292747|Autonomic Agents|autonomic agents|mesh-ancestor
110221272|NCT00292747|Vasodilator Agents|vasodilator agents|mesh-ancestor
110221273|NCT00292747|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110221274|NCT00292747|Urological Agents|urological agents|mesh-ancestor
110221275|NCT00120003|Candesartan|candesartan|mesh-list
110221276|NCT00120003|Candesartan cilexetil|candesartan cilexetil|mesh-list
110221277|NCT00120003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110221278|NCT00120003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110221279|NCT00120003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110221280|NCT00120003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221281|NCT00201721|Cyclophosphamide|cyclophosphamide|mesh-list
110221282|NCT00201721|Rituximab|rituximab|mesh-list
110221283|NCT00201721|Pentostatin|pentostatin|mesh-list
110221284|NCT00201721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110221285|NCT00201721|Immunologic Factors|immunologic factors|mesh-ancestor
110221286|NCT00201721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110221287|NCT00201721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110221288|NCT00201721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110221289|NCT00201721|Alkylating Agents|alkylating agents|mesh-ancestor
110221290|NCT00201721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221291|NCT00201721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110221292|NCT00201721|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110221293|NCT00201721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110221294|NCT00201721|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
110221295|NCT00201721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110221296|NCT00201799|Infliximab|infliximab|mesh-list
110221297|NCT00201799|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110221298|NCT00201799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110221299|NCT00201799|Dermatologic Agents|dermatologic agents|mesh-ancestor
110221300|NCT00201799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110221301|NCT00201799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110221302|NCT00080678|Docetaxel|docetaxel|mesh-list
110221303|NCT00080678|Imatinib Mesylate|imatinib mesylate|mesh-list
110221304|NCT00080678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110221305|NCT00080678|Tubulin Modulators|tubulin modulators|mesh-ancestor
110221306|NCT00080678|Antimitotic Agents|antimitotic agents|mesh-ancestor
110221307|NCT00080678|Mitosis Modulators|mitosis modulators|mesh-ancestor
110221308|NCT00080678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221309|NCT00080678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110221310|NCT00080678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110221312|NCT00086970|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
110221313|NCT00086970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110221314|NCT00086970|Alkylating Agents|alkylating agents|mesh-ancestor
110221315|NCT00086970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221316|NCT00086970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110221317|NCT00086970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110221318|NCT00201955|Rebamipide|rebamipide|mesh-list
110221319|NCT00201955|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110221320|NCT00201955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110221321|NCT00201955|Antioxidants|antioxidants|mesh-ancestor
110221322|NCT00201955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221323|NCT00201955|Protective Agents|protective agents|mesh-ancestor
110221324|NCT00201955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110221325|NCT00201955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110221326|NCT00080795|Gemcitabine|gemcitabine|mesh-list
110221327|NCT00080795|Doxorubicin|doxorubicin|mesh-list
110221328|NCT00080795|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110221329|NCT00080795|Ifosfamide|ifosfamide|mesh-list
110221330|NCT00080795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110221331|NCT00080795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110221332|NCT00080795|Antimetabolites|antimetabolites|mesh-ancestor
110221333|NCT00080795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221334|NCT00080795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110221335|NCT00080795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110221336|NCT00080795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110221337|NCT00080795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110221338|NCT00080795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110221339|NCT00080795|Alkylating Agents|alkylating agents|mesh-ancestor
110221340|NCT00120081|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110221341|NCT00120081|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110221342|NCT00120081|Immunologic Factors|immunologic factors|mesh-ancestor
110221343|NCT00120081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110221344|NCT00120081|Antacids|antacids|mesh-ancestor
110221345|NCT00120081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221346|NCT00120081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110221347|NCT00201994|Tolvaptan|tolvaptan|mesh-list
110221348|NCT00201994|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110221349|NCT00201994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221350|NCT00201994|Natriuretic Agents|natriuretic agents|mesh-ancestor
110221351|NCT00201994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110221352|NCT00120120|Lenalidomide|lenalidomide|mesh-list
110221353|NCT00120120|Immunologic Factors|immunologic factors|mesh-ancestor
110221354|NCT00120120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110221355|NCT00120120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110221356|NCT00120120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110221358|NCT00120120|Growth Inhibitors|growth inhibitors|mesh-ancestor
110221359|NCT00120120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110221360|NCT00202189|Budesonide|budesonide|mesh-list
110221361|NCT00202189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110221362|NCT00202189|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110221363|NCT00202189|Autonomic Agents|autonomic agents|mesh-ancestor
110221364|NCT00202189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110221365|NCT00202189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110221366|NCT00202189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110221367|NCT00202189|Respiratory System Agents|respiratory system agents|mesh-ancestor
110221368|NCT00202189|Glucocorticoids|glucocorticoids|mesh-ancestor
110221369|NCT00202189|Hormones|hormones|mesh-ancestor
110221370|NCT00202189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110221371|NCT00202228|Riboflavin|riboflavin|mesh-list
110221372|NCT00202228|Thiamine|thiamine|mesh-list
110221373|NCT00202228|Vitamin B Complex|vitamin b complex|mesh-ancestor
110221374|NCT00202228|Vitamins|vitamins|mesh-ancestor
110221375|NCT00202228|Micronutrients|micronutrients|mesh-ancestor
110221376|NCT00202228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110221377|NCT00202228|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110221378|NCT00202228|Dermatologic Agents|dermatologic agents|mesh-ancestor
110221379|NCT00087009|Rituximab|rituximab|mesh-list
110221380|NCT00087009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110221381|NCT00087009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110221382|NCT00087009|Immunologic Factors|immunologic factors|mesh-ancestor
110221383|NCT00087009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110221384|NCT00087009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110221385|NCT00306319|Moxifloxacin|moxifloxacin|mesh-list
110221386|NCT00306319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110221387|NCT00306319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110221388|NCT00306319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110221389|NCT00306319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110221390|NCT00306319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110221391|NCT00306319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221392|NCT00306319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110221394|NCT00306358|Hydroxocobalamin|hydroxocobalamin|mesh-list
110221396|NCT00306358|Micronutrients|micronutrients|mesh-ancestor
110221397|NCT00306358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110221398|NCT00306358|Vitamin B Complex|vitamin b complex|mesh-ancestor
110221399|NCT00306358|Hematinics|hematinics|mesh-ancestor
110221400|NCT00306397|Sirolimus|sirolimus|mesh-list
110221401|NCT00306397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110221402|NCT00306397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110221403|NCT00306397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110221404|NCT00306397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110221405|NCT00306397|Antifungal Agents|antifungal agents|mesh-ancestor
110221406|NCT00306397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110221407|NCT00306397|Immunologic Factors|immunologic factors|mesh-ancestor
110221408|NCT00306397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110221409|NCT00418600|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
110221410|NCT00418600|Ergocalciferols|ergocalciferols|mesh-list
110221412|NCT00418600|Micronutrients|micronutrients|mesh-ancestor
110221413|NCT00418600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110221414|NCT00418600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110221415|NCT00418600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110221416|NCT00087048|Topotecan|topotecan|mesh-list
110221417|NCT00087048|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110221418|NCT00087048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110221419|NCT00087048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110221420|NCT00087048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221421|NCT00087048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110221422|NCT00080951|Leucovorin|leucovorin|mesh-list
110221423|NCT00080951|Fluorouracil|fluorouracil|mesh-list
110221424|NCT00080951|Oxaliplatin|oxaliplatin|mesh-list
110221425|NCT00080951|Irinotecan|irinotecan|mesh-list
110221426|NCT00080951|Calcium|calcium|mesh-list
110221427|NCT00080951|Levoleucovorin|levoleucovorin|mesh-list
110221428|NCT00080951|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110221429|NCT00080951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110221430|NCT00080951|Antimetabolites|antimetabolites|mesh-ancestor
110221431|NCT00080951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221432|NCT00080951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110221433|NCT00080951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110221434|NCT00080951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110221435|NCT00080951|Immunologic Factors|immunologic factors|mesh-ancestor
110221436|NCT00080951|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110221437|NCT00080951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110221438|NCT00080951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110221440|NCT00080951|Protective Agents|protective agents|mesh-ancestor
110221441|NCT00080951|Vitamin B Complex|vitamin b complex|mesh-ancestor
110221442|NCT00080951|Vitamins|vitamins|mesh-ancestor
110221443|NCT00080951|Micronutrients|micronutrients|mesh-ancestor
110221444|NCT00301600|Mycophenolic Acid|mycophenolic acid|mesh-list
110221445|NCT00301600|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110221446|NCT00301600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110221447|NCT00301600|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110221448|NCT00301600|Antitubercular Agents|antitubercular agents|mesh-ancestor
110221449|NCT00301600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110221450|NCT00301600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110221451|NCT00301600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110221452|NCT00301600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221453|NCT00301639|Methylphenidate|methylphenidate|mesh-list
110221454|NCT00301639|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110221455|NCT00301639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110221456|NCT00301639|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110221457|NCT00301639|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110221458|NCT00301639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110221459|NCT00301639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221460|NCT00301639|Dopamine Agents|dopamine agents|mesh-ancestor
110221461|NCT00301639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110221463|NCT00087087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110221464|NCT00087087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110221465|NCT00087087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221466|NCT00087087|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110221467|NCT00087087|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110221468|NCT00301795|Rituximab|rituximab|mesh-list
110221469|NCT00301795|Oblimersen|oblimersen|mesh-list
110221470|NCT00301795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110221471|NCT00301795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110221472|NCT00301795|Immunologic Factors|immunologic factors|mesh-ancestor
110221473|NCT00301795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110221474|NCT00301795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110221475|NCT00080990|Leucovorin|leucovorin|mesh-list
110221476|NCT00080990|Fluorouracil|fluorouracil|mesh-list
110221477|NCT00080990|Oxaliplatin|oxaliplatin|mesh-list
110221478|NCT00080990|Alvocidib|alvocidib|mesh-list
110221479|NCT00080990|Calcium|calcium|mesh-list
110221480|NCT00080990|Levoleucovorin|levoleucovorin|mesh-list
110221481|NCT00080990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110221482|NCT00080990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110221483|NCT00080990|Antimetabolites|antimetabolites|mesh-ancestor
110221484|NCT00080990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221485|NCT00080990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110221486|NCT00080990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110221487|NCT00080990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110237930|NCT00429832|Ondansetron|ondansetron|mesh-list
110221488|NCT00080990|Immunologic Factors|immunologic factors|mesh-ancestor
110221489|NCT00080990|Antidotes|antidotes|mesh-ancestor
110221490|NCT00080990|Protective Agents|protective agents|mesh-ancestor
110221491|NCT00080990|Vitamin B Complex|vitamin b complex|mesh-ancestor
110221492|NCT00080990|Vitamins|vitamins|mesh-ancestor
110221493|NCT00080990|Micronutrients|micronutrients|mesh-ancestor
110221494|NCT00080990|Growth Inhibitors|growth inhibitors|mesh-ancestor
110221495|NCT00080990|Growth Substances|growth substances|mesh-ancestor
110221496|NCT00080990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110221497|NCT00080990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110221498|NCT00301912|Methotrexate|methotrexate|mesh-list
110221499|NCT00301912|Fludarabine phosphate|fludarabine phosphate|mesh-list
110221500|NCT00301912|Fludarabine|fludarabine|mesh-list
110221501|NCT00301912|Busulfan|busulfan|mesh-list
110221502|NCT00301912|Tacrolimus|tacrolimus|mesh-list
110221503|NCT00301912|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110221504|NCT00301912|Abortifacient Agents|abortifacient agents|mesh-ancestor
110221505|NCT00301912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110221506|NCT00301912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110221507|NCT00301912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110221508|NCT00301912|Antimetabolites|antimetabolites|mesh-ancestor
110221509|NCT00301912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221510|NCT00301912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110221511|NCT00301912|Dermatologic Agents|dermatologic agents|mesh-ancestor
110221513|NCT00301912|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110221514|NCT00301912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110221515|NCT00301912|Immunologic Factors|immunologic factors|mesh-ancestor
110221516|NCT00301912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110221517|NCT00301912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110221518|NCT00301912|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110221519|NCT00301912|Alkylating Agents|alkylating agents|mesh-ancestor
110221520|NCT00301912|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110221521|NCT00301912|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110221522|NCT00301951|Mycophenolic Acid|mycophenolic acid|mesh-list
110221523|NCT00301951|Fludarabine|fludarabine|mesh-list
110221524|NCT00301951|Fludarabine phosphate|fludarabine phosphate|mesh-list
110221526|NCT00301951|Tacrolimus|tacrolimus|mesh-list
110221527|NCT00301951|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110221528|NCT00301951|Sargramostim|sargramostim|mesh-list
110221529|NCT00301951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110221530|NCT00301951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110221531|NCT00301951|Antimetabolites|antimetabolites|mesh-ancestor
110221532|NCT00301951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221533|NCT00301951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110221534|NCT00301951|Immunologic Factors|immunologic factors|mesh-ancestor
110221535|NCT00301951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110221536|NCT00301951|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110221537|NCT00301951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110221538|NCT00301951|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110221539|NCT00301951|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110221540|NCT00301951|Antitubercular Agents|antitubercular agents|mesh-ancestor
110221541|NCT00301951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110221542|NCT00301951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110221543|NCT00301951|Alkylating Agents|alkylating agents|mesh-ancestor
110221544|NCT00301951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110221545|NCT00301951|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110221547|NCT00301990|Bevacizumab|bevacizumab|mesh-list
110221548|NCT00301990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110221549|NCT00301990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110221550|NCT00301990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110221551|NCT00301990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110221552|NCT00301990|Growth Substances|growth substances|mesh-ancestor
110221553|NCT00301990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110221554|NCT00301990|Growth Inhibitors|growth inhibitors|mesh-ancestor
110221555|NCT00301990|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110221556|NCT00301990|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110221557|NCT00301990|Antiviral Agents|antiviral agents|mesh-ancestor
110221558|NCT00301990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110221560|NCT00120198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110221561|NCT00120198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110221562|NCT00120198|Immunologic Factors|immunologic factors|mesh-ancestor
110221563|NCT00120198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110221564|NCT00120198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110221565|NCT00302224|Ketoconazole|ketoconazole|mesh-list
110221566|NCT00302224|Antifungal Agents|antifungal agents|mesh-ancestor
110221567|NCT00302224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110221568|NCT00302224|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110221569|NCT00302224|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110221570|NCT00302224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110221571|NCT00302224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221572|NCT00302224|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110221573|NCT00302224|Hormone Antagonists|hormone antagonists|mesh-ancestor
110221574|NCT00302224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110221575|NCT00302224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110221576|NCT00302224|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110221577|NCT00081068|Alemtuzumab|alemtuzumab|mesh-list
110221578|NCT00081068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110221579|NCT00081068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110221580|NCT00087165|Prednisone|prednisone|mesh-list
110221581|NCT00087165|Docetaxel|docetaxel|mesh-list
110221582|NCT00087165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110221583|NCT00087165|Tubulin Modulators|tubulin modulators|mesh-ancestor
110221584|NCT00087165|Antimitotic Agents|antimitotic agents|mesh-ancestor
110221585|NCT00087165|Mitosis Modulators|mitosis modulators|mesh-ancestor
110221586|NCT00087165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221587|NCT00087165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110221588|NCT00087165|Glucocorticoids|glucocorticoids|mesh-ancestor
110221589|NCT00087165|Hormones|hormones|mesh-ancestor
110221590|NCT00087165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110221591|NCT00087165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110221592|NCT00087165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110221593|NCT00302341|Trimethoprim|trimethoprim|mesh-list
110221594|NCT00302341|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110221596|NCT00302341|Pafuramidine|pafuramidine|mesh-list
110221597|NCT00302341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110221598|NCT00302341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221599|NCT00302341|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110221600|NCT00302341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110221601|NCT00302341|Antimalarials|antimalarials|mesh-ancestor
110221602|NCT00302341|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110221603|NCT00302341|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110221604|NCT00302341|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110221605|NCT00302341|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110221606|NCT00302341|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110221607|NCT00302341|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110221608|NCT00302341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110221609|NCT00302341|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110221610|NCT00302419|Streptokinase|streptokinase|mesh-list
110221611|NCT00302419|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110221612|NCT00302419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110221613|NCT00302419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221614|NCT00302497|Basiliximab|basiliximab|mesh-list
110221615|NCT00302497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110221616|NCT00302497|Immunologic Factors|immunologic factors|mesh-ancestor
110221617|NCT00302497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110221619|NCT00081107|Desoxyepothilone B|desoxyepothilone b|mesh-list
110221620|NCT00081107|Tubulin Modulators|tubulin modulators|mesh-ancestor
110221621|NCT00081107|Antimitotic Agents|antimitotic agents|mesh-ancestor
110221622|NCT00081107|Mitosis Modulators|mitosis modulators|mesh-ancestor
110221623|NCT00081107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221624|NCT00081107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110221626|NCT00302536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110221627|NCT00302536|Immunologic Factors|immunologic factors|mesh-ancestor
110221628|NCT00302536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110221629|NCT00302536|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110221630|NCT00302536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110221631|NCT00302536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221632|NCT00081224|Celecoxib|celecoxib|mesh-list
110221633|NCT00081224|Capecitabine|capecitabine|mesh-list
110221634|NCT00081224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110221635|NCT00081224|Antimetabolites|antimetabolites|mesh-ancestor
110221636|NCT00081224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221637|NCT00081224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110221638|NCT00081224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110221639|NCT00081224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110221640|NCT00081224|Analgesics|analgesics|mesh-ancestor
110221641|NCT00081224|Sensory System Agents|sensory system agents|mesh-ancestor
110221642|NCT00081224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110221643|NCT00081224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110221644|NCT00081224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110221645|NCT00081224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110221646|NCT00081224|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110221647|NCT00081224|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110221648|NCT00081224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110221649|NCT00120237|Misoprostol|misoprostol|mesh-list
110221650|NCT00120237|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110221651|NCT00120237|Abortifacient Agents|abortifacient agents|mesh-ancestor
110221652|NCT00120237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110221653|NCT00120237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110221654|NCT00120237|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110221655|NCT00120237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110221657|NCT00081302|Paclitaxel|paclitaxel|mesh-list
110237968|NCT00095966|Sorafenib|sorafenib|mesh-list
110221658|NCT00081302|Carboplatin|carboplatin|mesh-list
110221659|NCT00081302|Cetuximab|cetuximab|mesh-list
110221660|NCT00081302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110221661|NCT00081302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110221662|NCT00081302|Tubulin Modulators|tubulin modulators|mesh-ancestor
110221663|NCT00081302|Antimitotic Agents|antimitotic agents|mesh-ancestor
110221664|NCT00081302|Mitosis Modulators|mitosis modulators|mesh-ancestor
110221665|NCT00081302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221666|NCT00081302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110221667|NCT00302653|Rasburicase|rasburicase|mesh-list
110221668|NCT00302653|Gout Suppressants|gout suppressants|mesh-ancestor
110221669|NCT00302653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110221670|NCT00418288|Glucagon|glucagon|mesh-list
110221671|NCT00418288|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110221672|NCT00418288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110221673|NCT00418288|Hormones|hormones|mesh-ancestor
110221674|NCT00418288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110221676|NCT00418288|Incretins|incretins|mesh-ancestor
110221677|NCT00418327|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110221678|NCT00418327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110221679|NCT00418327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110221680|NCT00418327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110221681|NCT00418327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221682|NCT00087282|Irinotecan|irinotecan|mesh-list
110221683|NCT00087282|Alvocidib|alvocidib|mesh-list
110221684|NCT00087282|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110221685|NCT00087282|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110221686|NCT00087282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110221687|NCT00087282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221688|NCT00087282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110221689|NCT00087282|Growth Inhibitors|growth inhibitors|mesh-ancestor
110221690|NCT00087282|Growth Substances|growth substances|mesh-ancestor
110221691|NCT00087282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110221692|NCT00087282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110221693|NCT00418366|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110221694|NCT00418366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110221695|NCT00418366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110221696|NCT00418366|Incretins|incretins|mesh-ancestor
110221697|NCT00418366|Hormones|hormones|mesh-ancestor
110221698|NCT00418366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110221699|NCT00418366|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110221702|NCT00418366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221703|NCT00120315|Esomeprazole|esomeprazole|mesh-list
110221704|NCT00120315|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110221705|NCT00120315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110221706|NCT00120315|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110221707|NCT00120315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110221708|NCT00120315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221709|NCT00081380|Valproic Acid|valproic acid|mesh-list
110221710|NCT00081380|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110221711|NCT00081380|Antipsychotic Agents|antipsychotic agents|mesh-list
110221712|NCT00081380|Antidepressive Agents|antidepressive agents|mesh-ancestor
110221713|NCT00081380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110221714|NCT00081380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110221715|NCT00081380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110221716|NCT00081380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110221717|NCT00081380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110221718|NCT00081380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221719|NCT00081380|Antimanic Agents|antimanic agents|mesh-ancestor
110221720|NCT00081380|Anticonvulsants|anticonvulsants|mesh-ancestor
110221721|NCT00081380|GABA Agents|gaba agents|mesh-ancestor
110221722|NCT00081380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110221723|NCT00418483|Fibrinolysin|fibrinolysin|mesh-list
110221724|NCT00418483|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110221725|NCT00418483|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110221726|NCT00418483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221727|NCT00302692|Metoprolol|metoprolol|mesh-list
110221728|NCT00302692|Esmolol|esmolol|mesh-list
110221729|NCT00302692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110221730|NCT00302692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110221731|NCT00302692|Sympatholytics|sympatholytics|mesh-ancestor
110221732|NCT00302692|Autonomic Agents|autonomic agents|mesh-ancestor
110221733|NCT00302692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110221734|NCT00302692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110221735|NCT00302692|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110221736|NCT00302692|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110221737|NCT00302692|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110221738|NCT00302692|Adrenergic Agents|adrenergic agents|mesh-ancestor
110221739|NCT00302692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110221740|NCT00302692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221741|NCT00302770|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110221742|NCT00302770|Antidepressive Agents|antidepressive agents|mesh-ancestor
110221743|NCT00302770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110221744|NCT00302770|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110221745|NCT00302770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110221746|NCT00302770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110221747|NCT00302770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110221748|NCT00081536|Capecitabine|capecitabine|mesh-list
110221749|NCT00081536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110221750|NCT00081536|Antimetabolites|antimetabolites|mesh-ancestor
110221751|NCT00081536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221752|NCT00081536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110221753|NCT00303004|Bosentan|bosentan|mesh-list
110221754|NCT00303004|Sildenafil Citrate|sildenafil citrate|mesh-list
110221757|NCT00303004|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110221758|NCT00303004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110221759|NCT00303004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221760|NCT00303004|Urological Agents|urological agents|mesh-ancestor
110221761|NCT00303004|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110221762|NCT00303004|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110221763|NCT00081575|Levofloxacin|levofloxacin|mesh-list
110221764|NCT00081575|Tigecycline|tigecycline|mesh-list
110221765|NCT00081575|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110221766|NCT00081575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110221767|NCT00081575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110221768|NCT00081575|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110221769|NCT00081575|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110221770|NCT00081575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110221771|NCT00081575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221773|NCT00081575|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110221774|NCT00081575|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110221775|NCT00081575|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110221776|NCT00087399|Gabapentin|gabapentin|mesh-list
110221777|NCT00087399|Antidepressive Agents|antidepressive agents|mesh-list
110221778|NCT00087399|Analgesics|analgesics|mesh-ancestor
110221779|NCT00087399|Sensory System Agents|sensory system agents|mesh-ancestor
110221780|NCT00087399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110221781|NCT00087399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110221782|NCT00087399|Anticonvulsants|anticonvulsants|mesh-ancestor
110221783|NCT00087399|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110221784|NCT00087399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110221785|NCT00087399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110221786|NCT00087399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110221787|NCT00087399|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110221788|NCT00087399|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110221789|NCT00087399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110221790|NCT00087399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221791|NCT00087399|Antimanic Agents|antimanic agents|mesh-ancestor
110221792|NCT00081614|Bevacizumab|bevacizumab|mesh-list
110221793|NCT00081614|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110221794|NCT00081614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110221795|NCT00081614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110221796|NCT00081614|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110221797|NCT00081614|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110221798|NCT00081614|Growth Substances|growth substances|mesh-ancestor
110221799|NCT00081614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110221800|NCT00081614|Growth Inhibitors|growth inhibitors|mesh-ancestor
110221801|NCT00081614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110221802|NCT00081614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110221803|NCT00081614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221804|NCT00303277|Simvastatin|simvastatin|mesh-list
110221805|NCT00303277|Pravastatin|pravastatin|mesh-list
110221806|NCT00303277|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110221807|NCT00303277|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110221808|NCT00303277|Antimetabolites|antimetabolites|mesh-ancestor
110221809|NCT00303277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221810|NCT00303277|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110221811|NCT00303277|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110221812|NCT00303277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110221813|NCT00303394|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110221814|NCT00303394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110221815|NCT00303433|Memantine|memantine|mesh-list
110221816|NCT00303433|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110221817|NCT00303433|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110221818|NCT00303433|Dopamine Agents|dopamine agents|mesh-ancestor
110221819|NCT00303433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110221820|NCT00303433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221821|NCT00303433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110221822|NCT00303433|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110221824|NCT00303550|Linezolid|linezolid|mesh-list
110221825|NCT00303550|Iclaprim|iclaprim|mesh-list
110221826|NCT00303550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110221827|NCT00303550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110221828|NCT00303550|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110221829|NCT00303550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110221830|NCT00303550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221831|NCT00303550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110221832|NCT00120354|Lamivudine|lamivudine|mesh-list
110221833|NCT00120354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110221834|NCT00120354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110221835|NCT00120354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110221836|NCT00120354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221837|NCT00120354|Antiviral Agents|antiviral agents|mesh-ancestor
110221838|NCT00120354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110221839|NCT00120354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110221840|NCT00120354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110221842|NCT00399698|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110221843|NCT00399698|Serotonin Agents|serotonin agents|mesh-ancestor
110221844|NCT00399698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110221845|NCT00399698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221846|NCT00399698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110221847|NCT00399698|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110221848|NCT00399698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110221849|NCT00399698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110221850|NCT00399698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110221851|NCT00399698|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110221852|NCT00399698|Dopamine Agents|dopamine agents|mesh-ancestor
110221853|NCT00303589|Lactams|lactams|mesh-list
110221854|NCT00303589|beta-Lactams|beta-lactams|mesh-list
110221855|NCT00303589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110221856|NCT00303589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110221858|NCT00081848|Celecoxib|celecoxib|mesh-list
110221859|NCT00081848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110221860|NCT00081848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110221861|NCT00081848|Analgesics|analgesics|mesh-ancestor
110221862|NCT00081848|Sensory System Agents|sensory system agents|mesh-ancestor
110221863|NCT00081848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110221864|NCT00081848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110221865|NCT00081848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110221866|NCT00081848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110221867|NCT00081848|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110221868|NCT00081848|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110221869|NCT00081848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110221870|NCT00081848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221871|NCT00081848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110221872|NCT00081848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110221873|NCT00081848|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110221874|NCT00081848|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110221875|NCT00120432|Phenylephrine|phenylephrine|mesh-list
110221876|NCT00120432|Oxymetazoline|oxymetazoline|mesh-list
110221877|NCT00120432|Tropicamide|tropicamide|mesh-list
110221878|NCT00120432|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110221879|NCT00120432|Mydriatics|mydriatics|mesh-ancestor
110221880|NCT00120432|Autonomic Agents|autonomic agents|mesh-ancestor
110221881|NCT00120432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110221882|NCT00120432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110221883|NCT00120432|Sympathomimetics|sympathomimetics|mesh-ancestor
110221884|NCT00120432|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110221885|NCT00120432|Nasal Decongestants|nasal decongestants|mesh-ancestor
110221886|NCT00120432|Respiratory System Agents|respiratory system agents|mesh-ancestor
110221887|NCT00120432|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110221888|NCT00120432|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110221889|NCT00120432|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110221890|NCT00120432|Adrenergic Agents|adrenergic agents|mesh-ancestor
110221891|NCT00120432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110221892|NCT00120432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221893|NCT00120432|Protective Agents|protective agents|mesh-ancestor
110221894|NCT00120432|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110221895|NCT00120432|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110221896|NCT00120432|Cholinergic Agents|cholinergic agents|mesh-ancestor
110221897|NCT00303745|Capecitabine|capecitabine|mesh-list
110221898|NCT00303745|Irinotecan|irinotecan|mesh-list
110221899|NCT00303745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110221900|NCT00303745|Antimetabolites|antimetabolites|mesh-ancestor
110221901|NCT00303745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221902|NCT00303745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110221903|NCT00303745|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110221904|NCT00303745|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110221905|NCT00303745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110221906|NCT00303784|Goserelin|goserelin|mesh-list
110221907|NCT00303784|Estradiol|estradiol|mesh-list
110221908|NCT00303784|Estrogens|estrogens|mesh-ancestor
110221909|NCT00303784|Hormones|hormones|mesh-ancestor
110221910|NCT00303784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110221911|NCT00303784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110221912|NCT00303784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110221913|NCT00303784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110221914|NCT00081887|Clofarabine|clofarabine|mesh-list
110221915|NCT00081887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110221916|NCT00081887|Antimetabolites|antimetabolites|mesh-ancestor
110221917|NCT00081887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221918|NCT00081887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110221919|NCT00303940|Carboplatin|carboplatin|mesh-list
110221920|NCT00303940|Temozolomide|temozolomide|mesh-list
110221921|NCT00303940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110221922|NCT00303940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110221923|NCT00303940|Alkylating Agents|alkylating agents|mesh-ancestor
110221924|NCT00303940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221926|NCT00304018|Fludarabine|fludarabine|mesh-list
110221927|NCT00304018|Fludarabine phosphate|fludarabine phosphate|mesh-list
110221928|NCT00304018|Etoposide|etoposide|mesh-list
110221929|NCT00304018|Busulfan|busulfan|mesh-list
110221930|NCT00304018|Tacrolimus|tacrolimus|mesh-list
110221931|NCT00304018|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110221932|NCT00304018|Sargramostim|sargramostim|mesh-list
110221933|NCT00304018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110221934|NCT00304018|Glucocorticoids|glucocorticoids|mesh-ancestor
110221935|NCT00304018|Hormones|hormones|mesh-ancestor
110221936|NCT00304018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110221937|NCT00304018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110221938|NCT00304018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110221939|NCT00304018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110221940|NCT00304018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110221942|NCT00304018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221943|NCT00304018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110221944|NCT00304018|Immunologic Factors|immunologic factors|mesh-ancestor
110221945|NCT00304018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110221946|NCT00304018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110221947|NCT00304018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110221948|NCT00304018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110221949|NCT00304018|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110221950|NCT00304018|Alkylating Agents|alkylating agents|mesh-ancestor
110221951|NCT00304018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110221952|NCT00304018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110221953|NCT00081926|Imatinib Mesylate|imatinib mesylate|mesh-list
110221954|NCT00081926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110221955|NCT00081926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110221957|NCT00081926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221959|NCT00304135|Oxaliplatin|oxaliplatin|mesh-list
110221960|NCT00304135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110221961|NCT00304135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110221962|NCT00304135|Antimetabolites|antimetabolites|mesh-ancestor
110221963|NCT00304135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221964|NCT00304213|Testosterone|testosterone|mesh-list
110221965|NCT00304213|Androgens|androgens|mesh-ancestor
110221966|NCT00304213|Hormones|hormones|mesh-ancestor
110221967|NCT00304213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110221968|NCT00304213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110221969|NCT00304252|Interferons|interferons|mesh-list
110221970|NCT00304252|Interferon-beta|interferon-beta|mesh-list
110221971|NCT00304252|Interferon beta-1a|interferon beta-1a|mesh-list
110221972|NCT00304252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110221973|NCT00304252|Antiviral Agents|antiviral agents|mesh-ancestor
110221974|NCT00304252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110221975|NCT00304252|Immunologic Factors|immunologic factors|mesh-ancestor
110221976|NCT00304252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110221977|NCT00304252|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110221978|NCT00120471|Tenofovir|tenofovir|mesh-list
110221979|NCT00120471|Antiviral Agents|antiviral agents|mesh-ancestor
110221980|NCT00120471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110221981|NCT00120471|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110221982|NCT00120471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110221983|NCT00120471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110221984|NCT00120471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221985|NCT00120471|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110221986|NCT00120471|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110221988|NCT00082043|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110221989|NCT00082043|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110221990|NCT00082043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110221991|NCT00082043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221993|NCT00082043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110221994|NCT00082043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110221995|NCT00304291|Mitoxantrone|mitoxantrone|mesh-list
110221996|NCT00304291|Analgesics|analgesics|mesh-ancestor
110221997|NCT00304291|Sensory System Agents|sensory system agents|mesh-ancestor
110221998|NCT00304291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110221999|NCT00304291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222000|NCT00304291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110222001|NCT00304291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110222002|NCT00304291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110222003|NCT00304291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110222004|NCT00304291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110222005|NCT00304369|Metronidazole|metronidazole|mesh-list
110222006|NCT00304369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110222007|NCT00304369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110222008|NCT00304369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110222009|NCT00304369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110222010|NCT00082082|Thymalfasin|thymalfasin|mesh-list
110222011|NCT00082082|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110222012|NCT00082082|Immunologic Factors|immunologic factors|mesh-ancestor
110222013|NCT00082082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222014|NCT00304447|Gemtuzumab|gemtuzumab|mesh-list
110222015|NCT00304447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110222016|NCT00304447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110222017|NCT00304447|Immunotoxins|immunotoxins|mesh-ancestor
110222018|NCT00304447|Immunoconjugates|immunoconjugates|mesh-ancestor
110222019|NCT00304447|Immunologic Factors|immunologic factors|mesh-ancestor
110222020|NCT00304447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222021|NCT00087711|Gemcitabine|gemcitabine|mesh-list
110222022|NCT00087711|Pemetrexed|pemetrexed|mesh-list
110222023|NCT00087711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110222024|NCT00087711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110222025|NCT00087711|Antimetabolites|antimetabolites|mesh-ancestor
110222026|NCT00087711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110222027|NCT00087711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110222028|NCT00087711|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110222029|NCT00087711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110222030|NCT00304642|Dapivirine|dapivirine|mesh-list
110222031|NCT00304642|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110222032|NCT00304642|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110222033|NCT00304642|Antiviral Agents|antiviral agents|mesh-ancestor
110222034|NCT00304642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110222035|NCT00304681|Methylphenidate|methylphenidate|mesh-list
110222036|NCT00304681|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110222037|NCT00304681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222039|NCT00304681|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110238048|NCT01726452|Antidotes|antidotes|mesh-ancestor
110222040|NCT00304681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110222041|NCT00304681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110222044|NCT00304720|Tacrolimus|tacrolimus|mesh-list
110222045|NCT00304720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110222046|NCT00304720|Immunologic Factors|immunologic factors|mesh-ancestor
110222047|NCT00304720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222048|NCT00304720|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110222049|NCT00304720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110222050|NCT00304720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110222051|NCT00082199|Aripiprazole|aripiprazole|mesh-list
110222052|NCT00082199|Antidepressive Agents|antidepressive agents|mesh-ancestor
110222053|NCT00082199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110222054|NCT00082199|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110222055|NCT00082199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110222056|NCT00082199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110222057|NCT00082199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222058|NCT00082199|Dopamine Agonists|dopamine agonists|mesh-ancestor
110222059|NCT00082199|Dopamine Agents|dopamine agents|mesh-ancestor
110222060|NCT00082199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110222061|NCT00082199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110222062|NCT00082199|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110222063|NCT00082199|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110222064|NCT00082199|Serotonin Agents|serotonin agents|mesh-ancestor
110222065|NCT00082199|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110222067|NCT00082199|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110222068|NCT00082199|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110222069|NCT00120510|Lamivudine|lamivudine|mesh-list
110222070|NCT00120510|Zidovudine|zidovudine|mesh-list
110222071|NCT00120510|Efavirenz|efavirenz|mesh-list
110222072|NCT00120510|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
110222073|NCT00120510|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110222074|NCT00120510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110222075|NCT00120510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110222076|NCT00120510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110222077|NCT00120510|Antiviral Agents|antiviral agents|mesh-ancestor
110222078|NCT00120510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110222079|NCT00120510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110222080|NCT00120510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110222081|NCT00120510|Antimetabolites|antimetabolites|mesh-ancestor
110222082|NCT00120510|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110222083|NCT00120510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110222084|NCT00120510|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110222085|NCT00120510|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110222086|NCT00120510|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110222087|NCT00120510|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110222088|NCT00087750|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110222089|NCT00087750|Antidepressive Agents|antidepressive agents|mesh-ancestor
110222090|NCT00087750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110222091|NCT00087750|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110222092|NCT00087750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110222093|NCT00087750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110222094|NCT00087750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222096|NCT00304993|Rosiglitazone|rosiglitazone|mesh-list
110222097|NCT00304993|Fenofibrate|fenofibrate|mesh-list
110222098|NCT00304993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110222099|NCT00304993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222100|NCT00304993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110222101|NCT00304993|Antimetabolites|antimetabolites|mesh-ancestor
110222102|NCT00304993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110222103|NCT00304993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110222105|NCT00304993|Vitamin B Complex|vitamin b complex|mesh-ancestor
110222106|NCT00304993|Vitamins|vitamins|mesh-ancestor
110222107|NCT00304993|Micronutrients|micronutrients|mesh-ancestor
110222108|NCT00082277|Risedronic Acid|risedronic acid|mesh-list
110222109|NCT00082277|Anastrozole|anastrozole|mesh-list
110222110|NCT00082277|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110222111|NCT00082277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110222112|NCT00082277|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110222113|NCT00082277|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110222114|NCT00082277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110222115|NCT00082277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110222116|NCT00082277|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110222117|NCT00082277|Hormone Antagonists|hormone antagonists|mesh-ancestor
110222118|NCT00082277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110222119|NCT00082277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222120|NCT00082277|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110222121|NCT00082277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110222122|NCT00082277|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110222123|NCT00082277|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110222124|NCT00305266|gamma-Globulins|gamma-globulins|mesh-list
110222125|NCT00305266|Immunologic Factors|immunologic factors|mesh-ancestor
110222126|NCT00305266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222127|NCT00082316|Capsaicin|capsaicin|mesh-list
110222128|NCT00082316|Antipruritics|antipruritics|mesh-ancestor
110222129|NCT00082316|Dermatologic Agents|dermatologic agents|mesh-ancestor
110222130|NCT00082316|Sensory System Agents|sensory system agents|mesh-ancestor
110222131|NCT00082316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110222132|NCT00082316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222133|NCT00305383|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110222134|NCT00305383|Taribavirin|taribavirin|mesh-list
110222135|NCT00305383|Antiviral Agents|antiviral agents|mesh-ancestor
110222136|NCT00305383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110222137|NCT00305422|Risperidone|risperidone|mesh-list
110222138|NCT00305422|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110222139|NCT00305422|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110222141|NCT00305422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110222142|NCT00305422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110222143|NCT00305422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222144|NCT00305422|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110222145|NCT00305422|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110222146|NCT00305422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110222147|NCT00305422|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110222148|NCT00305422|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110222150|NCT00305422|Antidepressive Agents|antidepressive agents|mesh-ancestor
110222151|NCT00305461|Ciclesonide|ciclesonide|mesh-list
110222152|NCT00305461|Glucocorticoids|glucocorticoids|mesh-ancestor
110222153|NCT00305461|Hormones|hormones|mesh-ancestor
110222154|NCT00305461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110222155|NCT00305461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222156|NCT00305461|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110222157|NCT00082394|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110222158|NCT00082394|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
110222159|NCT00082394|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110222160|NCT00082394|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110222161|NCT00082394|Protease Inhibitors|protease inhibitors|mesh-ancestor
110222162|NCT00082394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110222163|NCT00082394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110222164|NCT00082394|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110222165|NCT00082394|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110222166|NCT00082394|Antiviral Agents|antiviral agents|mesh-ancestor
110222167|NCT00082394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110222168|NCT00082394|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110222169|NCT00082394|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110222170|NCT00305500|Escitalopram|escitalopram|mesh-list
110222171|NCT00305500|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110222172|NCT00305500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110222173|NCT00305500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110222174|NCT00305500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110222175|NCT00305500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110222176|NCT00305500|Serotonin Agents|serotonin agents|mesh-ancestor
110222177|NCT00305500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222178|NCT00305539|Adalimumab|adalimumab|mesh-list
110222179|NCT00305539|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110222180|NCT00305539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110222181|NCT00305539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110222182|NCT00305617|Antineoplastic Agents|antineoplastic agents|mesh-list
110222183|NCT00305734|Gemcitabine|gemcitabine|mesh-list
110222184|NCT00305734|Bortezomib|bortezomib|mesh-list
110222185|NCT00305734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110222186|NCT00305734|Antimetabolites|antimetabolites|mesh-ancestor
110222187|NCT00305734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110222188|NCT00305734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110222190|NCT00082472|Doxorubicin|doxorubicin|mesh-list
110222191|NCT00082472|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110222192|NCT00082472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110222193|NCT00082472|Tubulin Modulators|tubulin modulators|mesh-ancestor
110222194|NCT00082472|Antimitotic Agents|antimitotic agents|mesh-ancestor
110222195|NCT00082472|Mitosis Modulators|mitosis modulators|mesh-ancestor
110222196|NCT00082472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110222197|NCT00082472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110222198|NCT00082472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110222199|NCT00082472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110222200|NCT00082472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110222201|NCT00087867|Bortezomib|bortezomib|mesh-list
110222202|NCT00087867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110222203|NCT00082511|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
110222204|NCT00082511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110222205|NCT00082511|Immunologic Factors|immunologic factors|mesh-ancestor
110222206|NCT00082511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222207|NCT00306046|Diphosphonates|diphosphonates|mesh-list
110222208|NCT00306046|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110222209|NCT00306046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222210|NCT00306124|Levodopa|levodopa|mesh-list
110222211|NCT00306124|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110222212|NCT00306124|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110222213|NCT00306124|Dopamine Agents|dopamine agents|mesh-ancestor
110222214|NCT00306124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110222215|NCT00306124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110222216|NCT00306124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222217|NCT00082589|Eplerenone|eplerenone|mesh-list
110222218|NCT00082589|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110222219|NCT00082589|Hormone Antagonists|hormone antagonists|mesh-ancestor
110222220|NCT00082589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110222221|NCT00082589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222222|NCT00082589|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110222223|NCT00082589|Diuretics|diuretics|mesh-ancestor
110222224|NCT00082589|Natriuretic Agents|natriuretic agents|mesh-ancestor
110222225|NCT00082589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110222226|NCT00313924|Tolterodine Tartrate|tolterodine tartrate|mesh-list
110222227|NCT00313924|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110222228|NCT00313924|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110222229|NCT00313924|Cholinergic Agents|cholinergic agents|mesh-ancestor
110222231|NCT00313924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110222232|NCT00313924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222233|NCT00313924|Urological Agents|urological agents|mesh-ancestor
110222234|NCT00306475|Valproic Acid|valproic acid|mesh-list
110222235|NCT00306475|Anticonvulsants|anticonvulsants|mesh-ancestor
110222236|NCT00306475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110222237|NCT00306475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110222238|NCT00306475|GABA Agents|gaba agents|mesh-ancestor
110222239|NCT00306475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110222240|NCT00306475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222241|NCT00306475|Antimanic Agents|antimanic agents|mesh-ancestor
110222242|NCT00306475|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110222243|NCT00306475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110222244|NCT00306475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110028787|NCT03839160|Analgesics|analgesics|mesh-ancestor
110222246|NCT00082667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110222247|NCT00082667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110222248|NCT00082667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110222249|NCT00082667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110222250|NCT00306748|Linaclotide|linaclotide|mesh-list
110222251|NCT00306748|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
110222252|NCT00306748|Enzyme Activators|enzyme activators|mesh-ancestor
110222253|NCT00306748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110222254|NCT00306748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110222255|NCT00082784|Bortezomib|bortezomib|mesh-list
110222256|NCT00082784|Alvocidib|alvocidib|mesh-list
110222257|NCT00082784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110222258|NCT00082784|Growth Inhibitors|growth inhibitors|mesh-ancestor
110222259|NCT00082784|Growth Substances|growth substances|mesh-ancestor
110222260|NCT00082784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222261|NCT00082784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110222262|NCT00082784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110222263|NCT00082784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110222265|NCT00306826|Simvastatin|simvastatin|mesh-list
110222266|NCT00306826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110222267|NCT00306826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110222268|NCT00306826|Antimetabolites|antimetabolites|mesh-ancestor
110222269|NCT00306826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110222270|NCT00306826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110222271|NCT00306826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110222272|NCT00306826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110222273|NCT00306826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110222274|NCT00306826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222275|NCT00082823|Aflibercept|aflibercept|mesh-list
110222276|NCT00082823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110222277|NCT00082823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110222278|NCT00082823|Growth Substances|growth substances|mesh-ancestor
110222279|NCT00082823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222280|NCT00082823|Growth Inhibitors|growth inhibitors|mesh-ancestor
110222281|NCT00082823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110222283|NCT00087945|Zidovudine|zidovudine|mesh-list
110222284|NCT00087945|Abacavir|abacavir|mesh-list
110222285|NCT00087945|Dideoxynucleosides|dideoxynucleosides|mesh-list
110222286|NCT00087945|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110222287|NCT00087945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110222288|NCT00087945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110222289|NCT00087945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110222290|NCT00087945|Antiviral Agents|antiviral agents|mesh-ancestor
110222291|NCT00087945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110222292|NCT00087945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110222293|NCT00087945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110222294|NCT00087945|Antimetabolites|antimetabolites|mesh-ancestor
110222295|NCT00082862|Interferons|interferons|mesh-list
110222296|NCT00082862|Interferon-alpha|interferon-alpha|mesh-list
110222297|NCT00082862|Gemcitabine|gemcitabine|mesh-list
110222298|NCT00082862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110222299|NCT00082862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110222300|NCT00082862|Antimetabolites|antimetabolites|mesh-ancestor
110222301|NCT00082862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110222302|NCT00082862|Antiviral Agents|antiviral agents|mesh-ancestor
110222303|NCT00082862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110222304|NCT00082862|Immunologic Factors|immunologic factors|mesh-ancestor
110222305|NCT00082862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222306|NCT00307099|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110222307|NCT00307099|Meropenem|meropenem|mesh-list
110222308|NCT00307099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110222309|NCT00082940|Denileukin diftitox|denileukin diftitox|mesh-list
110222310|NCT00082940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110222311|NCT00307138|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
110222312|NCT00307138|Plasma Substitutes|plasma substitutes|mesh-ancestor
110222313|NCT00307138|Blood Substitutes|blood substitutes|mesh-ancestor
110222314|NCT00307177|Vaccines|vaccines|mesh-list
110222315|NCT00307177|Immunologic Factors|immunologic factors|mesh-ancestor
110222316|NCT00307177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222317|NCT00120705|Darbepoetin alfa|darbepoetin alfa|mesh-list
110222318|NCT00120705|Hematinics|hematinics|mesh-ancestor
110222319|NCT00307255|Paclitaxel|paclitaxel|mesh-list
110222320|NCT00307255|Gemcitabine|gemcitabine|mesh-list
110222321|NCT00307255|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110222322|NCT00307255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110222323|NCT00307255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110222324|NCT00307255|Tubulin Modulators|tubulin modulators|mesh-ancestor
110222325|NCT00307255|Antimitotic Agents|antimitotic agents|mesh-ancestor
110222326|NCT00307255|Mitosis Modulators|mitosis modulators|mesh-ancestor
110222327|NCT00307255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110222328|NCT00307255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110222329|NCT00307255|Antimetabolites|antimetabolites|mesh-ancestor
110222330|NCT00307411|Hormones|hormones|mesh-list
110222331|NCT00307411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110222332|NCT00307411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222333|NCT00307450|Levetiracetam|levetiracetam|mesh-list
110222334|NCT00307450|Anticonvulsants|anticonvulsants|mesh-ancestor
110222335|NCT00307450|Nootropic Agents|nootropic agents|mesh-ancestor
110222336|NCT00307528|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110222337|NCT00307528|Immunologic Factors|immunologic factors|mesh-ancestor
110222338|NCT00307528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222339|NCT00120744|Ondansetron|ondansetron|mesh-list
110222340|NCT00120744|Antiemetics|antiemetics|mesh-ancestor
110222341|NCT00120744|Autonomic Agents|autonomic agents|mesh-ancestor
110222342|NCT00120744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110222343|NCT00120744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222344|NCT00120744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110222346|NCT00120744|Dermatologic Agents|dermatologic agents|mesh-ancestor
110222347|NCT00120744|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110222348|NCT00120744|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110222349|NCT00120744|Serotonin Agents|serotonin agents|mesh-ancestor
110222350|NCT00120744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110222351|NCT00120744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110222353|NCT00083057|Gefitinib|gefitinib|mesh-list
110222354|NCT00083057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110222355|NCT00083057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110222356|NCT00083057|Tubulin Modulators|tubulin modulators|mesh-ancestor
110222357|NCT00083057|Antimitotic Agents|antimitotic agents|mesh-ancestor
110222358|NCT00083057|Mitosis Modulators|mitosis modulators|mesh-ancestor
110222359|NCT00083057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110222360|NCT00083057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110222361|NCT00083057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110222362|NCT00307606|Methylprednisolone|methylprednisolone|mesh-list
110222363|NCT00307606|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110222364|NCT00307606|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110222365|NCT00307606|Prednisolone|prednisolone|mesh-list
110222366|NCT00307606|Prednisolone acetate|prednisolone acetate|mesh-list
110222367|NCT00307606|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110222368|NCT00307606|Prednisolone phosphate|prednisolone phosphate|mesh-list
110222369|NCT00307606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110222370|NCT00307606|Antiemetics|antiemetics|mesh-ancestor
110222371|NCT00307606|Autonomic Agents|autonomic agents|mesh-ancestor
110222372|NCT00307606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110222373|NCT00307606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222374|NCT00307606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110222375|NCT00307606|Glucocorticoids|glucocorticoids|mesh-ancestor
110222376|NCT00307606|Hormones|hormones|mesh-ancestor
110222377|NCT00307606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110222378|NCT00307606|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110222379|NCT00307606|Protective Agents|protective agents|mesh-ancestor
110222380|NCT00307606|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110222381|NCT00307606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110222382|NCT00083096|Temozolomide|temozolomide|mesh-list
110222383|NCT00083096|Lonafarnib|lonafarnib|mesh-list
110222384|NCT00083096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110222385|NCT00083096|Alkylating Agents|alkylating agents|mesh-ancestor
110222386|NCT00083096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110222387|NCT00083096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110222388|NCT00083096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110222389|NCT00307645|Mycophenolic Acid|mycophenolic acid|mesh-list
110222390|NCT00307645|Prednisone|prednisone|mesh-list
110222391|NCT00307645|Methylprednisolone|methylprednisolone|mesh-list
110222392|NCT00307645|Cyclophosphamide|cyclophosphamide|mesh-list
110222393|NCT00307645|Azathioprine|azathioprine|mesh-list
110222394|NCT00307645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110222395|NCT00307645|Immunologic Factors|immunologic factors|mesh-ancestor
110222396|NCT00307645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222397|NCT00307645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110222398|NCT00307645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110222399|NCT00307645|Alkylating Agents|alkylating agents|mesh-ancestor
110028811|NCT03830034|Ferrous fumarate|ferrous fumarate|mesh-list
110222400|NCT00307645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110222401|NCT00307645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110222402|NCT00307645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110222403|NCT00307645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110222404|NCT00307645|Glucocorticoids|glucocorticoids|mesh-ancestor
110222405|NCT00307645|Hormones|hormones|mesh-ancestor
110222406|NCT00307645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110222407|NCT00307645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110238138|NCT00096668|Paclitaxel|paclitaxel|mesh-list
110222408|NCT00307645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110222409|NCT00307645|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110222410|NCT00307645|Antitubercular Agents|antitubercular agents|mesh-ancestor
110222411|NCT00307645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110222412|NCT00307645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110222413|NCT00307645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110222414|NCT00307645|Antiemetics|antiemetics|mesh-ancestor
110222415|NCT00307645|Autonomic Agents|autonomic agents|mesh-ancestor
110222416|NCT00307645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110222417|NCT00307645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110222418|NCT00307645|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110222419|NCT00307645|Protective Agents|protective agents|mesh-ancestor
110222420|NCT00307645|Antimetabolites|antimetabolites|mesh-ancestor
110222421|NCT00307645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110222422|NCT00120783|Ritonavir|ritonavir|mesh-list
110222423|NCT00120783|Indinavir|indinavir|mesh-list
110222424|NCT00120783|Lamivudine|lamivudine|mesh-list
110222425|NCT00120783|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110222426|NCT00120783|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110222427|NCT00120783|Protease Inhibitors|protease inhibitors|mesh-ancestor
110222428|NCT00120783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110222429|NCT00120783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110222430|NCT00120783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110222431|NCT00120783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110222432|NCT00120783|Antiviral Agents|antiviral agents|mesh-ancestor
110222433|NCT00120783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110222434|NCT00120783|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110222435|NCT00120783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110222436|NCT00120783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110222437|NCT00120783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110222439|NCT00307723|Gemcitabine|gemcitabine|mesh-list
110222440|NCT00307723|Fluorouracil|fluorouracil|mesh-list
110222441|NCT00307723|Oxaliplatin|oxaliplatin|mesh-list
110222442|NCT00307723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110222443|NCT00307723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110222444|NCT00307723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110222445|NCT00307723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110222446|NCT00307723|Growth Substances|growth substances|mesh-ancestor
110222447|NCT00307723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222448|NCT00307723|Growth Inhibitors|growth inhibitors|mesh-ancestor
110222449|NCT00307723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110222450|NCT00307723|Antimetabolites|antimetabolites|mesh-ancestor
110222451|NCT00307723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110222452|NCT00307723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110222453|NCT00307723|Immunologic Factors|immunologic factors|mesh-ancestor
110222454|NCT00083135|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
110222455|NCT00083135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110222456|NCT00083135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110222457|NCT00083135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110222458|NCT00083135|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110222459|NCT00120822|Folic Acid|folic acid|mesh-list
110222460|NCT00120822|Hematinics|hematinics|mesh-ancestor
110222461|NCT00120822|Vitamin B Complex|vitamin b complex|mesh-ancestor
110222462|NCT00120822|Vitamins|vitamins|mesh-ancestor
110222463|NCT00120822|Micronutrients|micronutrients|mesh-ancestor
110222464|NCT00120822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222465|NCT00083213|Aflibercept|aflibercept|mesh-list
110222466|NCT00083213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110222467|NCT00083213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110222468|NCT00083213|Growth Substances|growth substances|mesh-ancestor
110222469|NCT00083213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222470|NCT00083213|Growth Inhibitors|growth inhibitors|mesh-ancestor
110222471|NCT00083213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110222472|NCT00307996|Ubiquinone|ubiquinone|mesh-list
110222473|NCT00307996|Coenzyme Q10|coenzyme q10|mesh-list
110222474|NCT00307996|Micronutrients|micronutrients|mesh-ancestor
110222475|NCT00307996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222476|NCT00307996|Vitamins|vitamins|mesh-ancestor
110222477|NCT00083252|Cisplatin|cisplatin|mesh-list
110222478|NCT00083252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110222479|NCT00418639|Nitazoxanide|nitazoxanide|mesh-list
110222480|NCT00418639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110222481|NCT00418639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110222482|NCT00418678|Nabilone|nabilone|mesh-list
110222483|NCT00418678|Antiemetics|antiemetics|mesh-ancestor
110222484|NCT00418678|Autonomic Agents|autonomic agents|mesh-ancestor
110222485|NCT00418678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110222486|NCT00418678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222487|NCT00418678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110222488|NCT00418678|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110222489|NCT00418678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110222490|NCT00418678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110222491|NCT00418678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110222493|NCT00120861|Ribavirin|ribavirin|mesh-list
110222494|NCT00120861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110222495|NCT00120861|Antiviral Agents|antiviral agents|mesh-ancestor
110222496|NCT00120861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110222497|NCT00120861|Antimetabolites|antimetabolites|mesh-ancestor
110222498|NCT00120861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110222499|NCT05446142|Rabeprazole|rabeprazole|mesh-list
110222500|NCT05446142|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110222501|NCT05446142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110222502|NCT05446142|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110222503|NCT05446142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110222504|NCT05446142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110222505|NCT00308191|Bromides|bromides|mesh-list
110222506|NCT00308191|Formoterol Fumarate|formoterol fumarate|mesh-list
110222507|NCT00308191|Tiotropium Bromide|tiotropium bromide|mesh-list
110222508|NCT00308191|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110222509|NCT00308191|Autonomic Agents|autonomic agents|mesh-ancestor
110222510|NCT00308191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110222511|NCT00308191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222512|NCT00308191|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110222513|NCT00308191|Respiratory System Agents|respiratory system agents|mesh-ancestor
110222514|NCT00308191|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110222515|NCT00308191|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110222516|NCT00308191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110222517|NCT00308191|Adrenergic Agents|adrenergic agents|mesh-ancestor
110222518|NCT00308191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110222519|NCT00308191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110222520|NCT00308191|Parasympatholytics|parasympatholytics|mesh-ancestor
110222521|NCT00308191|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110222522|NCT00308191|Cholinergic Agents|cholinergic agents|mesh-ancestor
110222523|NCT00308191|Anticonvulsants|anticonvulsants|mesh-ancestor
110222524|NCT00308269|Folic Acid|folic acid|mesh-list
110222525|NCT00308269|Vinca Alkaloids|vinca alkaloids|mesh-list
110222526|NCT00308269|Hematinics|hematinics|mesh-ancestor
110222527|NCT00308269|Vitamin B Complex|vitamin b complex|mesh-ancestor
110222528|NCT00308269|Vitamins|vitamins|mesh-ancestor
110222529|NCT00308269|Micronutrients|micronutrients|mesh-ancestor
110222530|NCT00308269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222531|NCT00308269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110222532|NCT00308269|Tubulin Modulators|tubulin modulators|mesh-ancestor
110222533|NCT00308269|Antimitotic Agents|antimitotic agents|mesh-ancestor
110238152|NCT00430885|Immunoglobulins|immunoglobulins|mesh-list
110222534|NCT00308269|Mitosis Modulators|mitosis modulators|mesh-ancestor
110222535|NCT00308269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110222537|NCT00308425|Valsartan|valsartan|mesh-list
110222538|NCT00308425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110222539|NCT00308425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110222540|NCT00308425|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110222541|NCT00308425|Antitubercular Agents|antitubercular agents|mesh-ancestor
110222542|NCT00308425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110222543|NCT00308425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110222544|NCT00308425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110222545|NCT00308425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110222546|NCT00308425|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110222547|NCT00308425|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110222548|NCT00308425|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110222549|NCT00308503|SR 46349B|sr 46349b|mesh-list
110222550|NCT00308503|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110222551|NCT00308503|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110222552|NCT00308503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110222553|NCT00308503|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110222554|NCT00308503|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110222555|NCT00308503|Serotonin Agents|serotonin agents|mesh-ancestor
110222556|NCT00308503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110222557|NCT00308503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222558|NCT00308542|Dexamethasone|dexamethasone|mesh-list
110222559|NCT00308542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110222560|NCT00308542|Antiemetics|antiemetics|mesh-ancestor
110222561|NCT00308542|Autonomic Agents|autonomic agents|mesh-ancestor
110222562|NCT00308542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110222563|NCT00308542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222564|NCT00308542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110222565|NCT00308542|Glucocorticoids|glucocorticoids|mesh-ancestor
110222566|NCT00308542|Hormones|hormones|mesh-ancestor
110222567|NCT00308542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110222568|NCT00308542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110222569|NCT00308542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110222570|NCT00308776|Cholecystokinin|cholecystokinin|mesh-list
110222571|NCT00308776|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110222572|NCT00308776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110222573|NCT00083408|Pamidronate|pamidronate|mesh-list
110222574|NCT00083408|Thalidomide|thalidomide|mesh-list
110222575|NCT00083408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110222576|NCT00083408|Immunologic Factors|immunologic factors|mesh-ancestor
110222577|NCT00083408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222578|NCT00083408|Leprostatic Agents|leprostatic agents|mesh-ancestor
110222579|NCT00083408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110222580|NCT00083408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110222581|NCT00083408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110222582|NCT00083408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110222584|NCT00083408|Growth Inhibitors|growth inhibitors|mesh-ancestor
110222585|NCT00083408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110222586|NCT00083408|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110222588|NCT00308971|Tocopherols|tocopherols|mesh-list
110222589|NCT00308971|Tocotrienols|tocotrienols|mesh-list
110222590|NCT00308971|alpha-Tocopherol|alpha-tocopherol|mesh-list
110222591|NCT00308971|Thioctic Acid|thioctic acid|mesh-list
110222592|NCT00308971|Vitamins|vitamins|mesh-ancestor
110222593|NCT00308971|Micronutrients|micronutrients|mesh-ancestor
110222594|NCT00308971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222595|NCT00308971|Antioxidants|antioxidants|mesh-ancestor
110222596|NCT00308971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110222597|NCT00308971|Protective Agents|protective agents|mesh-ancestor
110238167|NCT00096707|Deoxyglucose|deoxyglucose|mesh-list
110222598|NCT00308971|Vitamin B Complex|vitamin b complex|mesh-ancestor
110222599|NCT00120939|Motexafin gadolinium|motexafin gadolinium|mesh-list
110222600|NCT00120939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110222601|NCT00120939|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110222602|NCT00120939|Dermatologic Agents|dermatologic agents|mesh-ancestor
110222603|NCT00309049|Epothilones|epothilones|mesh-list
110222604|NCT00309049|Tubulin Modulators|tubulin modulators|mesh-ancestor
110222605|NCT00309049|Antimitotic Agents|antimitotic agents|mesh-ancestor
110222606|NCT00309049|Mitosis Modulators|mitosis modulators|mesh-ancestor
110222607|NCT00309049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110222608|NCT00309049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110222609|NCT00309088|Tacrolimus|tacrolimus|mesh-list
110222610|NCT00309088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110222611|NCT00309088|Immunologic Factors|immunologic factors|mesh-ancestor
110222612|NCT00309088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222613|NCT00309088|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110222614|NCT00309088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110222615|NCT00309088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110222616|NCT00083486|Epoetin Alfa|epoetin alfa|mesh-list
110222617|NCT00083486|Hematinics|hematinics|mesh-ancestor
110222618|NCT00120978|Fluticasone|fluticasone|mesh-list
110222619|NCT00120978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110222620|NCT00120978|Autonomic Agents|autonomic agents|mesh-ancestor
110222621|NCT00120978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110222622|NCT00120978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222623|NCT00120978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110222624|NCT00120978|Respiratory System Agents|respiratory system agents|mesh-ancestor
110222625|NCT00120978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110222626|NCT00120978|Dermatologic Agents|dermatologic agents|mesh-ancestor
110222627|NCT00120978|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110222629|NCT00309205|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110222630|NCT00309205|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110222631|NCT00309205|Antiviral Agents|antiviral agents|mesh-ancestor
110222632|NCT00309205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110222634|NCT00309283|Hormones|hormones|mesh-ancestor
110222635|NCT00309283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110222636|NCT00309283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222637|NCT00083525|Capecitabine|capecitabine|mesh-list
110222638|NCT00083525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110222639|NCT00083525|Antimetabolites|antimetabolites|mesh-ancestor
110222640|NCT00083525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110222641|NCT00083525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110222642|NCT00309322|Phentolamine|phentolamine|mesh-list
110222643|NCT00309322|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110222644|NCT00309322|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110222645|NCT00309322|Adrenergic Agents|adrenergic agents|mesh-ancestor
110222646|NCT00309322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110222647|NCT00309322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110222648|NCT00309322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222649|NCT00309322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110222650|NCT04727502|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110222651|NCT04727502|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110222652|NCT04727502|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110222653|NCT04727502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110222654|NCT04727502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110222655|NCT04727502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110222656|NCT04727502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222658|NCT04727502|Sensory System Agents|sensory system agents|mesh-ancestor
110222659|NCT04727502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110222660|NCT04727502|Antidepressive Agents|antidepressive agents|mesh-ancestor
110222661|NCT04727502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110222662|NCT04727502|Dopamine Agents|dopamine agents|mesh-ancestor
110222663|NCT00309361|Phentolamine|phentolamine|mesh-list
110222664|NCT00309361|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110222665|NCT00309361|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110222666|NCT00309361|Adrenergic Agents|adrenergic agents|mesh-ancestor
110222667|NCT00309361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110222668|NCT00309361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110222669|NCT00309361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222670|NCT00309361|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110222672|NCT00088491|Antiemetics|antiemetics|mesh-ancestor
110222673|NCT00088491|Autonomic Agents|autonomic agents|mesh-ancestor
110222674|NCT00088491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110222675|NCT00088491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222676|NCT00088491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110222677|NCT00088491|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110222678|NCT00088491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110222679|NCT00088491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110222680|NCT00088491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110222681|NCT00088491|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110222682|NCT00088491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110222683|NCT00088491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110222684|NCT00088491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110222685|NCT00088491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110222686|NCT00088491|Serotonin Agents|serotonin agents|mesh-ancestor
110222688|NCT00309517|Edrecolomab|edrecolomab|mesh-list
110222690|NCT00309517|Protective Agents|protective agents|mesh-ancestor
110222691|NCT00309517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222692|NCT00309517|Vitamin B Complex|vitamin b complex|mesh-ancestor
110222693|NCT00309517|Vitamins|vitamins|mesh-ancestor
110222694|NCT00309517|Micronutrients|micronutrients|mesh-ancestor
110222695|NCT00309517|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110222696|NCT00309517|Immunologic Factors|immunologic factors|mesh-ancestor
110222697|NCT00121017|Ritonavir|ritonavir|mesh-list
110222698|NCT00121017|Lopinavir|lopinavir|mesh-list
110222699|NCT00121017|Tenofovir|tenofovir|mesh-list
110222700|NCT00121017|Emtricitabine|emtricitabine|mesh-list
110222701|NCT00121017|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110222702|NCT00121017|Efavirenz|efavirenz|mesh-list
110222703|NCT00121017|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110222704|NCT00121017|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110222705|NCT00121017|Protease Inhibitors|protease inhibitors|mesh-ancestor
110222706|NCT00121017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110222707|NCT00121017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110222708|NCT00121017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110222709|NCT00121017|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110222711|NCT00121017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110222712|NCT00121017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110222713|NCT00121017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110222714|NCT00121017|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110222715|NCT00121017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110238202|NCT00096863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110222716|NCT00121017|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110222717|NCT00121017|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110222718|NCT00121017|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110222719|NCT00121017|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110222720|NCT00121017|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110222722|NCT00309556|Capecitabine|capecitabine|mesh-list
110222723|NCT00309556|Trastuzumab|trastuzumab|mesh-list
110222724|NCT00309556|Epirubicin|epirubicin|mesh-list
110222725|NCT00309556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110222726|NCT00309556|Tubulin Modulators|tubulin modulators|mesh-ancestor
110222727|NCT00309556|Antimitotic Agents|antimitotic agents|mesh-ancestor
110222728|NCT00309556|Mitosis Modulators|mitosis modulators|mesh-ancestor
110222729|NCT00309556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110222730|NCT00309556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110222731|NCT00309556|Antimetabolites|antimetabolites|mesh-ancestor
110222732|NCT00309556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110222733|NCT00309556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110222734|NCT00309556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110222735|NCT00309556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110222736|NCT00309556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110222737|NCT00402207|Fluticasone|fluticasone|mesh-list
110222738|NCT00402207|Beclomethasone|beclomethasone|mesh-list
110222739|NCT00402207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110222740|NCT00402207|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110222741|NCT00402207|Autonomic Agents|autonomic agents|mesh-ancestor
110222742|NCT00402207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110222743|NCT00402207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222744|NCT00402207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110222745|NCT00402207|Respiratory System Agents|respiratory system agents|mesh-ancestor
110222746|NCT00402207|Dermatologic Agents|dermatologic agents|mesh-ancestor
110222747|NCT00402207|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110222748|NCT00402207|Glucocorticoids|glucocorticoids|mesh-ancestor
110222750|NCT00402207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110222751|NCT00399737|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110222752|NCT00399737|Protease Inhibitors|protease inhibitors|mesh-ancestor
110222753|NCT00399737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110222754|NCT00399737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110222756|NCT00309634|Immunologic Factors|immunologic factors|mesh-ancestor
110222757|NCT00309634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222758|NCT00309712|Simvastatin|simvastatin|mesh-list
110222759|NCT00309712|Fenofibrate|fenofibrate|mesh-list
110222760|NCT00309712|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110222761|NCT00309712|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110222762|NCT00309712|Antimetabolites|antimetabolites|mesh-ancestor
110222763|NCT00309712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110222764|NCT00309712|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110222765|NCT00309712|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110222766|NCT00309712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110222767|NCT00121056|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110222768|NCT00121056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110222769|NCT00309790|Sildenafil Citrate|sildenafil citrate|mesh-list
110222770|NCT00309790|Vasodilator Agents|vasodilator agents|mesh-ancestor
110222771|NCT00309790|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110222772|NCT00309790|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110222774|NCT00309790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110222775|NCT00309790|Urological Agents|urological agents|mesh-ancestor
110222776|NCT00418873|Risperidone|risperidone|mesh-list
110222777|NCT00418873|Zotepine|zotepine|mesh-list
110222778|NCT00418873|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110222779|NCT00418873|Serotonin Agents|serotonin agents|mesh-ancestor
110222780|NCT00418873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110222781|NCT00418873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110222782|NCT00418873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222783|NCT00418873|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110222784|NCT00418873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110222785|NCT00418873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110222786|NCT00418873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110222787|NCT00418873|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110222788|NCT00418873|Dopamine Agents|dopamine agents|mesh-ancestor
110222789|NCT00088608|Pasireotide|pasireotide|mesh-list
110222790|NCT00088608|Hormones|hormones|mesh-ancestor
110222791|NCT00088608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110222792|NCT00088608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222793|NCT00310024|Bortezomib|bortezomib|mesh-list
110222794|NCT00310024|Vorinostat|vorinostat|mesh-list
110222795|NCT00310024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110222796|NCT00310024|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110222797|NCT00310024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110222798|NCT00310024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110222800|NCT00310141|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110222801|NCT00310141|Autonomic Agents|autonomic agents|mesh-ancestor
110222802|NCT00310141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110222803|NCT00310141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222804|NCT00310141|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110222805|NCT00310141|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110222806|NCT00310141|Cholinergic Agents|cholinergic agents|mesh-ancestor
110222807|NCT00310141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110222808|NCT00310141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110222810|NCT00088686|Antipruritics|antipruritics|mesh-ancestor
110222811|NCT00088686|Dermatologic Agents|dermatologic agents|mesh-ancestor
110222812|NCT00088686|Sensory System Agents|sensory system agents|mesh-ancestor
110222813|NCT00088686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110222814|NCT00088686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222816|NCT00083681|Dexamethasone|dexamethasone|mesh-list
110222817|NCT00083681|Etoposide|etoposide|mesh-list
110222818|NCT00083681|Cyclophosphamide|cyclophosphamide|mesh-list
110222819|NCT00083681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110222820|NCT00083681|Antiemetics|antiemetics|mesh-ancestor
110222821|NCT00083681|Autonomic Agents|autonomic agents|mesh-ancestor
110222822|NCT00083681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110222823|NCT00083681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222824|NCT00083681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110222825|NCT00083681|Glucocorticoids|glucocorticoids|mesh-ancestor
110222826|NCT00083681|Hormones|hormones|mesh-ancestor
110222827|NCT00083681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110222828|NCT00083681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110222829|NCT00083681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110222830|NCT00083681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110222831|NCT00083681|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110222832|NCT00083681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110222833|NCT00083681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110222834|NCT00083681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110222835|NCT00083681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110222836|NCT00083681|Immunologic Factors|immunologic factors|mesh-ancestor
110222837|NCT00083681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110222838|NCT00083681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110222839|NCT00083681|Alkylating Agents|alkylating agents|mesh-ancestor
110222840|NCT00083681|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110222841|NCT00083681|Leprostatic Agents|leprostatic agents|mesh-ancestor
110222842|NCT00083681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110222843|NCT00083681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110222844|NCT00083681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110222845|NCT00083681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110222846|NCT00083681|Growth Substances|growth substances|mesh-ancestor
110222847|NCT00083681|Growth Inhibitors|growth inhibitors|mesh-ancestor
110222848|NCT00121095|Docetaxel|docetaxel|mesh-list
110222849|NCT00121095|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
110222850|NCT00121095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110222851|NCT00121095|Tubulin Modulators|tubulin modulators|mesh-ancestor
110222852|NCT00121095|Antimitotic Agents|antimitotic agents|mesh-ancestor
110222853|NCT00121095|Mitosis Modulators|mitosis modulators|mesh-ancestor
110222854|NCT00121095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110222855|NCT00121095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110222856|NCT00121095|Analgesics|analgesics|mesh-ancestor
110222857|NCT00121095|Sensory System Agents|sensory system agents|mesh-ancestor
110222858|NCT00121095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110222859|NCT00121095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222860|NCT00310297|Insulin glulisine|insulin glulisine|mesh-list
110222861|NCT00310297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110222862|NCT00310297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222863|NCT00310336|Interferons|interferons|mesh-list
110222864|NCT00310336|Ribavirin|ribavirin|mesh-list
110222866|NCT00310336|Interferon alpha-2|interferon alpha-2|mesh-list
110222867|NCT00310336|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110222868|NCT00310336|Betaine|betaine|mesh-list
110222869|NCT00310336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110222870|NCT00310336|Antiviral Agents|antiviral agents|mesh-ancestor
110222871|NCT00310336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110222872|NCT00310336|Antimetabolites|antimetabolites|mesh-ancestor
110222873|NCT00310336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110222874|NCT00310336|Immunologic Factors|immunologic factors|mesh-ancestor
110222875|NCT00310336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222876|NCT00310336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110222877|NCT00310336|Lipotropic Agents|lipotropic agents|mesh-ancestor
110222878|NCT00310336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110222879|NCT00310336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110222880|NCT05568602|Dexamethasone|dexamethasone|mesh-list
110222881|NCT05568602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110222882|NCT05568602|Antiemetics|antiemetics|mesh-ancestor
110222883|NCT05568602|Autonomic Agents|autonomic agents|mesh-ancestor
110222884|NCT05568602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110222885|NCT05568602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222886|NCT05568602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110222887|NCT05568602|Glucocorticoids|glucocorticoids|mesh-ancestor
110222890|NCT05568602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110222892|NCT00310492|Immunomodulating Agents|immunomodulating agents|mesh-list
110222893|NCT00310492|Immunologic Factors|immunologic factors|mesh-ancestor
110222894|NCT00310492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222895|NCT00310531|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
110222896|NCT00310531|Estradiol|estradiol|mesh-list
110222897|NCT00310531|Estrogens|estrogens|mesh-ancestor
110222898|NCT00310531|Hormones|hormones|mesh-ancestor
110222899|NCT00310531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110222900|NCT00310531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222901|NCT00310531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110222902|NCT00310531|Hormone Antagonists|hormone antagonists|mesh-ancestor
110222903|NCT00310531|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110222904|NCT00310531|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110222905|NCT00310531|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110222906|NCT00309673|Lidocaine|lidocaine|mesh-list
110222907|NCT00309673|Prilocaine|prilocaine|mesh-list
110222908|NCT00309673|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
110222909|NCT00309673|Anesthetics, Local|anesthetics, local|mesh-ancestor
110222910|NCT00309673|Anesthetics|anesthetics|mesh-ancestor
110222911|NCT00309673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110222912|NCT00309673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222913|NCT00309673|Sensory System Agents|sensory system agents|mesh-ancestor
110222914|NCT00309673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110222915|NCT00309673|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110222916|NCT00309673|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110222917|NCT00309673|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110222918|NCT00309673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110222919|NCT00309673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110222920|NCT00309673|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
110222921|NCT00310765|Pregabalin|pregabalin|mesh-list
110222922|NCT00310765|Gabapentin|gabapentin|mesh-list
110222923|NCT00310765|Analgesics|analgesics|mesh-ancestor
110222924|NCT00310765|Sensory System Agents|sensory system agents|mesh-ancestor
110222925|NCT00310765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110222926|NCT00310765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222927|NCT00310765|Anticonvulsants|anticonvulsants|mesh-ancestor
110222928|NCT00310765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110222929|NCT00310765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110222930|NCT00310765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110222931|NCT00310765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110222932|NCT00310765|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110222933|NCT00310765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110222934|NCT00310765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110222935|NCT00310765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110222936|NCT00310765|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110222937|NCT00310765|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110222938|NCT00310765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110222939|NCT00310765|Antimanic Agents|antimanic agents|mesh-ancestor
110222940|NCT00310843|Nevirapine|nevirapine|mesh-list
110222941|NCT00310843|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110222942|NCT00310843|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110222943|NCT00310843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110222944|NCT00310843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110222945|NCT00310843|Antiviral Agents|antiviral agents|mesh-ancestor
110222946|NCT00310843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110222947|NCT00310843|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110222948|NCT00310843|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110222949|NCT00310843|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110222950|NCT00310843|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110222951|NCT00310921|Misoprostol|misoprostol|mesh-list
110222952|NCT00310921|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110222953|NCT00310921|Abortifacient Agents|abortifacient agents|mesh-ancestor
110222954|NCT00310921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110222955|NCT00310921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222956|NCT00310921|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110222957|NCT00310921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110222958|NCT00310921|Oxytocics|oxytocics|mesh-ancestor
110222959|NCT05568212|Durvalumab|durvalumab|mesh-list
110222960|NCT05568212|Olaparib|olaparib|mesh-list
110222961|NCT05568212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110222962|NCT05568212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110222963|NCT05568212|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110222964|NCT05568212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110222965|NCT05568212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110222966|NCT00121329|Lidocaine|lidocaine|mesh-list
110222967|NCT00121329|Anesthetics, Local|anesthetics, local|mesh-ancestor
110222968|NCT00121329|Anesthetics|anesthetics|mesh-ancestor
110222969|NCT00121329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110222970|NCT00121329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222971|NCT00121329|Sensory System Agents|sensory system agents|mesh-ancestor
110222972|NCT00121329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110222973|NCT00121329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110222974|NCT00121329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110222975|NCT00121329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110222977|NCT00121329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110222978|NCT00311038|Landiolol|landiolol|mesh-list
110222979|NCT00311038|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110222980|NCT00311038|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110222981|NCT00311038|Adrenergic Agents|adrenergic agents|mesh-ancestor
110222982|NCT00311038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110222983|NCT00311038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110222984|NCT00311038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222985|NCT00311038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110222986|NCT00311077|Insulin glulisine|insulin glulisine|mesh-list
110222987|NCT00311077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110222988|NCT00311077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222990|NCT00311116|Vitamins|vitamins|mesh-ancestor
110222991|NCT00311116|Micronutrients|micronutrients|mesh-ancestor
110222992|NCT00311116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222993|NCT00311116|Antioxidants|antioxidants|mesh-ancestor
110222994|NCT00311116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110222996|NCT00088959|Celecoxib|celecoxib|mesh-list
110222997|NCT00088959|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110222998|NCT00088959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110222999|NCT00088959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110223000|NCT00088959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110223001|NCT00088959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110223002|NCT00088959|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110223003|NCT00088959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110223004|NCT00088959|Analgesics|analgesics|mesh-ancestor
110223005|NCT00088959|Sensory System Agents|sensory system agents|mesh-ancestor
110223006|NCT00088959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110223007|NCT00088959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110223008|NCT00088959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110223009|NCT00088959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110223010|NCT00088959|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110223011|NCT00088959|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110223012|NCT05568017|Edotreotide|edotreotide|mesh-list
110223013|NCT05568017|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110223014|NCT05568017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110223015|NCT00311389|Timolol|timolol|mesh-list
110223016|NCT00311389|Travoprost|travoprost|mesh-list
110223017|NCT00311389|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110028985|NCT05767827|Analgesics|analgesics|mesh-ancestor
110223018|NCT00311389|Latanoprost|latanoprost|mesh-list
110223019|NCT00311389|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110223020|NCT00311389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110223021|NCT00311389|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110223022|NCT00311389|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110223023|NCT00311389|Adrenergic Agents|adrenergic agents|mesh-ancestor
110223024|NCT00311389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110223025|NCT00311389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110223026|NCT00311389|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110223027|NCT00311389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110223028|NCT00088998|Bevacizumab|bevacizumab|mesh-list
110223029|NCT00088998|Docetaxel|docetaxel|mesh-list
110223030|NCT00088998|Capecitabine|capecitabine|mesh-list
110223031|NCT00088998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110223032|NCT00088998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110223033|NCT00088998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110223034|NCT00088998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110223036|NCT00088998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110223038|NCT00088998|Tubulin Modulators|tubulin modulators|mesh-ancestor
110223039|NCT00088998|Antimitotic Agents|antimitotic agents|mesh-ancestor
110223040|NCT00088998|Mitosis Modulators|mitosis modulators|mesh-ancestor
110223041|NCT00088998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110223042|NCT00088998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110223043|NCT00088998|Antimetabolites|antimetabolites|mesh-ancestor
110223044|NCT00311467|Interferons|interferons|mesh-list
110223045|NCT00311467|Capecitabine|capecitabine|mesh-list
110223046|NCT00311467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110223047|NCT00311467|Antimetabolites|antimetabolites|mesh-ancestor
110223048|NCT00311467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110223049|NCT00311467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110223050|NCT00311467|Antiviral Agents|antiviral agents|mesh-ancestor
110223051|NCT00311467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110223052|NCT00311545|Siltuximab|siltuximab|mesh-list
110223053|NCT00311545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110223054|NCT00089037|Sirolimus|sirolimus|mesh-list
110223055|NCT00089037|Methotrexate|methotrexate|mesh-list
110223056|NCT00089037|Tacrolimus|tacrolimus|mesh-list
110223057|NCT00089037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110223058|NCT00089037|Abortifacient Agents|abortifacient agents|mesh-ancestor
110223059|NCT00089037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110223060|NCT00089037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110223061|NCT00089037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110223062|NCT00089037|Antimetabolites|antimetabolites|mesh-ancestor
110223063|NCT00089037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110223064|NCT00089037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110223066|NCT00089037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110223067|NCT00089037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110223068|NCT00089037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110223069|NCT00089037|Immunologic Factors|immunologic factors|mesh-ancestor
110223070|NCT00089037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110223071|NCT00089037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110223072|NCT00089037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110223073|NCT00089037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110223074|NCT00089037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110223075|NCT00089037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110223076|NCT00089037|Antifungal Agents|antifungal agents|mesh-ancestor
110223077|NCT00311740|Valsartan|valsartan|mesh-list
110223078|NCT00311740|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110223079|NCT00311740|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110223080|NCT00311740|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110223081|NCT00311740|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110223082|NCT00311740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110223083|NCT00311740|Diuretics|diuretics|mesh-ancestor
110223084|NCT00311740|Natriuretic Agents|natriuretic agents|mesh-ancestor
110223085|NCT00311740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110223086|NCT00311740|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110223087|NCT00311740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110223089|NCT00311818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110223090|NCT00311818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110223092|NCT00121407|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110223093|NCT00121407|Dermatologic Agents|dermatologic agents|mesh-ancestor
110223094|NCT00311857|Cetuximab|cetuximab|mesh-list
110223095|NCT00311857|Temozolomide|temozolomide|mesh-list
110223096|NCT00311857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110223097|NCT00311857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110223098|NCT00311857|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110223099|NCT00311857|Alkylating Agents|alkylating agents|mesh-ancestor
110223101|NCT00311896|Bemiparin|bemiparin|mesh-list
110223102|NCT00311896|Anticoagulants|anticoagulants|mesh-ancestor
110223104|NCT00121446|Tenecteplase|tenecteplase|mesh-list
110223105|NCT00121446|Clopidogrel|clopidogrel|mesh-list
110223106|NCT00121446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110223107|NCT00121446|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110223108|NCT00121446|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110223109|NCT00121446|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110223110|NCT00121446|Purinergic Agents|purinergic agents|mesh-ancestor
110223111|NCT00121446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110223112|NCT00121446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110223113|NCT00121446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110223115|NCT00121446|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110223116|NCT00121446|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110223117|NCT00311974|Dihydralazine|dihydralazine|mesh-list
110223119|NCT00312013|Nadroparin|nadroparin|mesh-list
110223120|NCT00312013|Anticoagulants|anticoagulants|mesh-ancestor
110223121|NCT00312013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110223122|NCT00312013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110223123|NCT00312013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110223124|NCT00121524|Atropine|atropine|mesh-list
110223125|NCT00121524|Amiodarone|amiodarone|mesh-list
110223126|NCT00121524|Epinephrine|epinephrine|mesh-list
110223127|NCT00121524|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110223128|NCT00121524|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110223129|NCT00121524|Adrenergic Agents|adrenergic agents|mesh-ancestor
110223130|NCT00121524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110223131|NCT00121524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110223132|NCT00121524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110223133|NCT00121524|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110223134|NCT00121524|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110223136|NCT00121524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110223137|NCT00121524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110223138|NCT00121524|Respiratory System Agents|respiratory system agents|mesh-ancestor
110223139|NCT00121524|Mydriatics|mydriatics|mesh-ancestor
110223140|NCT00121524|Sympathomimetics|sympathomimetics|mesh-ancestor
110223141|NCT00121524|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110223142|NCT00121524|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110223143|NCT00121524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110223144|NCT00121524|Parasympatholytics|parasympatholytics|mesh-ancestor
110223145|NCT00121524|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110223146|NCT00121524|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110223147|NCT00121524|Cholinergic Agents|cholinergic agents|mesh-ancestor
110223148|NCT00121524|Vasodilator Agents|vasodilator agents|mesh-ancestor
110223149|NCT00121524|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110223150|NCT00121524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110223151|NCT00121524|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110223152|NCT00121524|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110223153|NCT00121524|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110223154|NCT00121524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110223155|NCT00121524|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110223156|NCT00121524|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110223157|NCT00121524|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110223158|NCT00312130|Vildagliptin|vildagliptin|mesh-list
110223159|NCT00312130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110223161|NCT00312130|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110223162|NCT00312130|Protease Inhibitors|protease inhibitors|mesh-ancestor
110223163|NCT00312130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110223164|NCT00312130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110223165|NCT00089115|Rituximab|rituximab|mesh-list
110223166|NCT00089115|Immunoglobulins|immunoglobulins|mesh-list
110223167|NCT00089115|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110223168|NCT00089115|Antibodies|antibodies|mesh-list
110223169|NCT00089115|Sargramostim|sargramostim|mesh-list
110223170|NCT00089115|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
110223171|NCT00089115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110223172|NCT00089115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110223173|NCT00089115|Immunologic Factors|immunologic factors|mesh-ancestor
110223174|NCT00089115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110223175|NCT00089115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110223176|NCT00312325|Prednisolone|prednisolone|mesh-list
110223177|NCT00312325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110223178|NCT00312325|Glucocorticoids|glucocorticoids|mesh-ancestor
110223179|NCT00312325|Hormones|hormones|mesh-ancestor
110223180|NCT00312325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110223181|NCT00312325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110223182|NCT00312325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110223183|NCT00312325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110223184|NCT05567471|Vaccines|vaccines|mesh-list
110223185|NCT05567471|Immunologic Factors|immunologic factors|mesh-ancestor
110223186|NCT05567471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110223187|NCT00089154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110223188|NCT00089154|Antibodies|antibodies|mesh-list
110223189|NCT00089154|Immunoglobulins|immunoglobulins|mesh-list
110223190|NCT00089154|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110223191|NCT00089154|Immunologic Factors|immunologic factors|mesh-ancestor
110223192|NCT00089154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110223193|NCT00089154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110223194|NCT00312481|Ascorbic Acid|ascorbic acid|mesh-list
110223195|NCT00312481|Magnesium citrate|magnesium citrate|mesh-list
110223196|NCT00312481|Picosulfate sodium|picosulfate sodium|mesh-list
110223197|NCT00312481|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
110223198|NCT00312481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110223199|NCT00312481|Antioxidants|antioxidants|mesh-ancestor
110223200|NCT00312481|Protective Agents|protective agents|mesh-ancestor
110223201|NCT00312481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110223202|NCT00312481|Vitamins|vitamins|mesh-ancestor
110223203|NCT00312481|Micronutrients|micronutrients|mesh-ancestor
110223204|NCT00312481|Cathartics|cathartics|mesh-ancestor
110223205|NCT00312481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110223206|NCT00312481|Laxatives|laxatives|mesh-ancestor
110223207|NCT00312520|Methylprednisolone|methylprednisolone|mesh-list
110223208|NCT00312520|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110223209|NCT00312520|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110223210|NCT00312520|Prednisolone|prednisolone|mesh-list
110223211|NCT00312520|Prednisolone acetate|prednisolone acetate|mesh-list
110223212|NCT00312520|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110223213|NCT00312520|Prednisolone phosphate|prednisolone phosphate|mesh-list
110223214|NCT00312520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110223215|NCT00312520|Antiemetics|antiemetics|mesh-ancestor
110223216|NCT00312520|Autonomic Agents|autonomic agents|mesh-ancestor
110223217|NCT00312520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110223218|NCT00312520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110223219|NCT00312520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110223220|NCT00312520|Glucocorticoids|glucocorticoids|mesh-ancestor
110223221|NCT00312520|Hormones|hormones|mesh-ancestor
110223222|NCT00312520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110223223|NCT00312520|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110223224|NCT00312520|Protective Agents|protective agents|mesh-ancestor
110223225|NCT00312520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110223226|NCT00312520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110223227|NCT00089193|Sargramostim|sargramostim|mesh-list
110223228|NCT00089193|Freund's Adjuvant|freund's adjuvant|mesh-list
110223229|NCT00089193|Immunologic Factors|immunologic factors|mesh-ancestor
110223230|NCT00089193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110223231|NCT00089193|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110223232|NCT00293098|Deferiprone|deferiprone|mesh-list
110223233|NCT00293098|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110223234|NCT00293098|Chelating Agents|chelating agents|mesh-ancestor
110223235|NCT00293098|Sequestering Agents|sequestering agents|mesh-ancestor
110223236|NCT00293098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110223237|NCT00293176|Donepezil|donepezil|mesh-list
110223238|NCT00293176|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110223239|NCT00293176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110223240|NCT00293176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110223242|NCT00293176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110223243|NCT00293176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110223244|NCT00293176|Nootropic Agents|nootropic agents|mesh-ancestor
110223245|NCT00121563|Thalidomide|thalidomide|mesh-list
110223246|NCT00121563|Ibuprofen|ibuprofen|mesh-list
110223247|NCT00121563|Diazepam|diazepam|mesh-list
110223248|NCT00121563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110223249|NCT00121563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110223250|NCT00121563|Analgesics|analgesics|mesh-ancestor
110223251|NCT00121563|Sensory System Agents|sensory system agents|mesh-ancestor
110223252|NCT00121563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110223253|NCT00121563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110223254|NCT00121563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110223255|NCT00121563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110223256|NCT00121563|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110223257|NCT00121563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110223258|NCT00121563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110223260|NCT00121563|Immunologic Factors|immunologic factors|mesh-ancestor
110223261|NCT00121563|Leprostatic Agents|leprostatic agents|mesh-ancestor
110223263|NCT00121563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110223264|NCT00121563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110223265|NCT00121563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110223266|NCT00121563|Growth Substances|growth substances|mesh-ancestor
110223267|NCT00121563|Growth Inhibitors|growth inhibitors|mesh-ancestor
110223268|NCT00121563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110223269|NCT00121563|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110223270|NCT00121563|Anticonvulsants|anticonvulsants|mesh-ancestor
110223271|NCT00121563|Antiemetics|antiemetics|mesh-ancestor
110223272|NCT00121563|Autonomic Agents|autonomic agents|mesh-ancestor
110223273|NCT00121563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110223274|NCT00121563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110223275|NCT00121563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110223276|NCT00121563|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110223278|NCT00121563|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110223279|NCT00121563|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110223280|NCT00121563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110223281|NCT00121563|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110223282|NCT00121563|Anesthetics, General|anesthetics, general|mesh-ancestor
110223284|NCT00121563|GABA Modulators|gaba modulators|mesh-ancestor
110223285|NCT00121563|GABA Agents|gaba agents|mesh-ancestor
110223286|NCT00121563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110223288|NCT00293332|Carboplatin|carboplatin|mesh-list
110223289|NCT00293332|Docetaxel|docetaxel|mesh-list
110223290|NCT00293332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110223291|NCT00293332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110223292|NCT00293332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110223293|NCT00293332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110223294|NCT00293332|Growth Substances|growth substances|mesh-ancestor
110223295|NCT00293332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110223296|NCT00293332|Growth Inhibitors|growth inhibitors|mesh-ancestor
110223297|NCT00293332|Tubulin Modulators|tubulin modulators|mesh-ancestor
110223298|NCT00293332|Antimitotic Agents|antimitotic agents|mesh-ancestor
110223299|NCT00293332|Mitosis Modulators|mitosis modulators|mesh-ancestor
110223300|NCT00293332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110223301|NCT00293371|Prednisone|prednisone|mesh-list
110223302|NCT00293371|Docetaxel|docetaxel|mesh-list
110223303|NCT00293371|Vatalanib|vatalanib|mesh-list
110223304|NCT00293371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110223305|NCT00293371|Tubulin Modulators|tubulin modulators|mesh-ancestor
110223306|NCT00293371|Antimitotic Agents|antimitotic agents|mesh-ancestor
110223307|NCT00293371|Mitosis Modulators|mitosis modulators|mesh-ancestor
110223308|NCT00293371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110223309|NCT00293371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110223310|NCT00293371|Glucocorticoids|glucocorticoids|mesh-ancestor
110223311|NCT00293371|Hormones|hormones|mesh-ancestor
110223312|NCT00293371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110223313|NCT00293371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110223314|NCT00293371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110223315|NCT00293371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110223317|NCT00293410|Cyclophosphamide|cyclophosphamide|mesh-list
110223318|NCT00293410|Clofarabine|clofarabine|mesh-list
110223319|NCT00293410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110223320|NCT00293410|Immunologic Factors|immunologic factors|mesh-ancestor
110223321|NCT00293410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110223322|NCT00293410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110223323|NCT00293410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110223324|NCT00293410|Alkylating Agents|alkylating agents|mesh-ancestor
110223325|NCT00293410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110223326|NCT00293410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110223327|NCT00293410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110223328|NCT00293410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110223329|NCT00293410|Antimetabolites|antimetabolites|mesh-ancestor
110223330|NCT00121602|Darbepoetin alfa|darbepoetin alfa|mesh-list
110223331|NCT00121602|Hematinics|hematinics|mesh-ancestor
110223332|NCT00293527|Interferons|interferons|mesh-list
110223333|NCT00293527|Interferon-alpha|interferon-alpha|mesh-list
110223335|NCT00293527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110223336|NCT00293527|Antiviral Agents|antiviral agents|mesh-ancestor
110223337|NCT00293527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110223338|NCT00293527|Immunologic Factors|immunologic factors|mesh-ancestor
110223339|NCT00293527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110223341|NCT04711161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110223342|NCT04711161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110223343|NCT04711161|Tubulin Modulators|tubulin modulators|mesh-ancestor
110223344|NCT04711161|Antimitotic Agents|antimitotic agents|mesh-ancestor
110223345|NCT04711161|Mitosis Modulators|mitosis modulators|mesh-ancestor
110223346|NCT04711161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110223347|NCT00293644|Dicyclomine, doxylamine, pyridoxine drug combination|dicyclomine, doxylamine, pyridoxine drug combination|mesh-list
110223348|NCT00293644|Antiemetics|antiemetics|mesh-ancestor
110223349|NCT00293644|Autonomic Agents|autonomic agents|mesh-ancestor
110223350|NCT00293644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110223351|NCT00293644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110223352|NCT00293644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110223353|NCT00293644|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110223354|NCT00293644|Histamine Antagonists|histamine antagonists|mesh-ancestor
110223355|NCT00293644|Histamine Agents|histamine agents|mesh-ancestor
110223356|NCT00293644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110223357|NCT00293644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110223358|NCT00293761|Travoprost|travoprost|mesh-list
110223359|NCT00293761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110223360|NCT00293800|Timolol|timolol|mesh-list
110223361|NCT00293800|Travoprost|travoprost|mesh-list
110223362|NCT00293800|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110223363|NCT00293800|Latanoprost|latanoprost|mesh-list
110223364|NCT00293800|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110223365|NCT00293800|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110223366|NCT00293800|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110223367|NCT00293800|Adrenergic Agents|adrenergic agents|mesh-ancestor
110223368|NCT00293800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110223369|NCT00293800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110223370|NCT00293800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110223371|NCT00293800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110223372|NCT00293800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110223373|NCT00423969|Galantamine|galantamine|mesh-list
110223375|NCT00423969|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110223376|NCT00423969|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110223377|NCT00423969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110223378|NCT00423969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110223380|NCT00423969|Serotonin Agents|serotonin agents|mesh-ancestor
110223381|NCT00423969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110223382|NCT00423969|Autonomic Agents|autonomic agents|mesh-ancestor
110223383|NCT00423969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110223384|NCT00423969|Cholinergic Agents|cholinergic agents|mesh-ancestor
110223385|NCT00423969|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110223386|NCT00423969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110238400|NCT00431665|Hormones|hormones|mesh-ancestor
110223387|NCT00423969|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110223388|NCT00423969|Nootropic Agents|nootropic agents|mesh-ancestor
110223390|NCT00293839|Parasympatholytics|parasympatholytics|mesh-ancestor
110223391|NCT00293839|Autonomic Agents|autonomic agents|mesh-ancestor
110223392|NCT00293839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110223393|NCT00293839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110223394|NCT00293839|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110223395|NCT00293839|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110223396|NCT00293839|Cholinergic Agents|cholinergic agents|mesh-ancestor
110223397|NCT00293839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110223398|NCT00293839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110223399|NCT00293839|Urological Agents|urological agents|mesh-ancestor
110223400|NCT00293917|Tacrolimus|tacrolimus|mesh-list
110223402|NCT00293917|Immunologic Factors|immunologic factors|mesh-ancestor
110223403|NCT00293917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110223404|NCT00293917|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110223405|NCT00293917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110223406|NCT00293917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110223407|NCT05567081|Triamcinolone|triamcinolone|mesh-list
110223408|NCT05567081|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110223409|NCT05567081|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110223410|NCT05567081|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110223411|NCT05567081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110223413|NCT05567081|Hormones|hormones|mesh-ancestor
110223414|NCT05567081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110223415|NCT05567081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110223416|NCT05567081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110223417|NCT05567081|Immunologic Factors|immunologic factors|mesh-ancestor
110223418|NCT05567081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110223419|NCT05567081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110223420|NCT00294112|Remestemcel-l|remestemcel-l|mesh-list
110223421|NCT00294112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110223422|NCT00294112|Antiviral Agents|antiviral agents|mesh-ancestor
110223423|NCT00294112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110223424|NCT00417898|Aspirin|aspirin|mesh-list
110223425|NCT00417898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110223426|NCT00417898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110223427|NCT00417898|Analgesics|analgesics|mesh-ancestor
110223428|NCT00417898|Sensory System Agents|sensory system agents|mesh-ancestor
110223429|NCT00417898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110223430|NCT00417898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110223431|NCT00417898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110223432|NCT00417898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110223433|NCT00417898|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110223434|NCT00417898|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110223435|NCT00417898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110223436|NCT00417898|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110223437|NCT00417898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110223438|NCT00417898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110223439|NCT00417898|Antipyretics|antipyretics|mesh-ancestor
110223440|NCT00294190|Topotecan|topotecan|mesh-list
110223441|NCT00294190|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110223442|NCT00294190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110223443|NCT00294190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110223444|NCT00294190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110223445|NCT00294190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110223446|NCT02960503|Azithromycin|azithromycin|mesh-list
110223447|NCT02960503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110223448|NCT02960503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110223449|NCT04706091|Suvorexant|suvorexant|mesh-list
110223450|NCT04706091|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110223451|NCT04706091|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110223452|NCT04706091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110223453|NCT04706091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110223454|NCT04706091|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
110223455|NCT04706091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110223456|NCT04706091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110223457|NCT00294385|Gemcitabine|gemcitabine|mesh-list
110223458|NCT00294385|Docetaxel|docetaxel|mesh-list
110223459|NCT00294385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110223460|NCT00294385|Antimetabolites|antimetabolites|mesh-ancestor
110238871|NCT00434044|Etanercept|etanercept|mesh-list
110223461|NCT00294385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110223462|NCT00294385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110223463|NCT00294385|Tubulin Modulators|tubulin modulators|mesh-ancestor
110223464|NCT00294385|Antimitotic Agents|antimitotic agents|mesh-ancestor
110223465|NCT00294385|Mitosis Modulators|mitosis modulators|mesh-ancestor
110223466|NCT00294463|Tibolone|tibolone|mesh-list
110223467|NCT00294463|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110223468|NCT00294463|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110223469|NCT00294463|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110223470|NCT00294463|Medroxyprogesterone|medroxyprogesterone|mesh-list
110223471|NCT00294463|Estradiol|estradiol|mesh-list
110223472|NCT00294463|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110223473|NCT00294463|Progesterone|progesterone|mesh-list
110223474|NCT00294463|Estrogens|estrogens|mesh-ancestor
110223475|NCT00294463|Hormones|hormones|mesh-ancestor
110223476|NCT00294463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110223477|NCT00294463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110223484|NCT00294463|Hormone Antagonists|hormone antagonists|mesh-ancestor
110223485|NCT00294463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110223486|NCT00294463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110223487|NCT00294463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110223488|NCT00294463|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110223489|NCT00294463|Anabolic Agents|anabolic agents|mesh-ancestor
110239012|NCT01051414|Asunaprevir|asunaprevir|mesh-list
110223490|NCT00294463|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110223491|NCT00294463|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110223492|NCT00294463|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110223493|NCT00294463|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110223494|NCT00294502|Minocycline|minocycline|mesh-list
110223495|NCT00294502|Gentamicins|gentamicins|mesh-list
110223496|NCT00294502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110223497|NCT00294502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110223498|NCT00294502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110223499|NCT00294502|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110223500|NCT00294502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110223501|NCT00089349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110223502|NCT00089349|Alemtuzumab|alemtuzumab|mesh-list
110223503|NCT00089349|Methotrexate|methotrexate|mesh-list
110223504|NCT00089349|Mercaptopurine|mercaptopurine|mesh-list
110223505|NCT00089349|Antibodies|antibodies|mesh-list
110223506|NCT00089349|Immunoglobulins|immunoglobulins|mesh-list
110223507|NCT00089349|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110223508|NCT00089349|Immunologic Factors|immunologic factors|mesh-ancestor
110223509|NCT00089349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110223510|NCT00089349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110223511|NCT00089349|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110223512|NCT00089349|Abortifacient Agents|abortifacient agents|mesh-ancestor
110223513|NCT00089349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110223514|NCT00089349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110223515|NCT00089349|Antimetabolites|antimetabolites|mesh-ancestor
110223516|NCT00089349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110223517|NCT00089349|Dermatologic Agents|dermatologic agents|mesh-ancestor
110223518|NCT00089349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110223519|NCT00089349|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110223520|NCT00089349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110223521|NCT00089349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110223522|NCT00089349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110223523|NCT00294580|Maloprim|maloprim|mesh-list
110223524|NCT00294580|Antimalarials|antimalarials|mesh-ancestor
110223525|NCT00294580|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110223526|NCT00294580|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110223527|NCT00294580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110223528|NCT00294619|Hormones|hormones|mesh-list
110223529|NCT00294619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110223530|NCT00294619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110223531|NCT00294736|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110223532|NCT00294736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110223533|NCT00294736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110223534|NCT00294736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110223535|NCT00294736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110223536|NCT00294775|Candesartan|candesartan|mesh-list
110223537|NCT00294775|Candesartan cilexetil|candesartan cilexetil|mesh-list
110223538|NCT00294775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110223539|NCT00294775|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110223540|NCT00294775|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110223541|NCT00294775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110223542|NCT00121680|Lenvatinib|lenvatinib|mesh-list
110223543|NCT00121680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110223544|NCT00121680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110223545|NCT00121680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110223546|NCT00121680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110223547|NCT00294853|Calcium|calcium|mesh-list
110239422|NCT00400790|Propofol|propofol|mesh-list
110223548|NCT00294853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110223549|NCT00294853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110223550|NCT00294892|Nevirapine|nevirapine|mesh-list
110223551|NCT00294892|Carbamazepine|carbamazepine|mesh-list
110223552|NCT00294892|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110239475|NCT00101348|Immunoglobulins|immunoglobulins|mesh-list
110223553|NCT00294892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110223554|NCT00294892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110223555|NCT00294892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110223556|NCT00294892|Antiviral Agents|antiviral agents|mesh-ancestor
110223557|NCT00294892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110223558|NCT00294892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110223559|NCT00294892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110223560|NCT00294892|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110223561|NCT00294892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110223562|NCT00294892|Anticonvulsants|anticonvulsants|mesh-ancestor
110223563|NCT00294892|Antimanic Agents|antimanic agents|mesh-ancestor
110223564|NCT00294892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110223565|NCT00294892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110239756|NCT00135993|Dopamine Agonists|dopamine agonists|mesh-ancestor
110029087|NCT05753267|Fenofibrate|fenofibrate|mesh-list
110223566|NCT00294892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110223567|NCT00294892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110223568|NCT00294892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110223569|NCT00294892|Analgesics|analgesics|mesh-ancestor
110223570|NCT00294892|Sensory System Agents|sensory system agents|mesh-ancestor
110223571|NCT00294892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110223572|NCT00294892|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110223574|NCT00089427|Temozolomide|temozolomide|mesh-list
110223575|NCT00089427|Pseudomonas aeruginosa exotoxin A|pseudomonas aeruginosa exotoxin a|mesh-list
110239895|NCT00103103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110223576|NCT00089427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110223577|NCT00089427|Alkylating Agents|alkylating agents|mesh-ancestor
110223578|NCT00089427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110223579|NCT00089427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110223580|NCT00294931|Bevacizumab|bevacizumab|mesh-list
110223581|NCT00294931|Carboplatin|carboplatin|mesh-list
110223583|NCT00294931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110223584|NCT00294931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110223585|NCT00294931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110223586|NCT00294931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110223587|NCT00294931|Growth Substances|growth substances|mesh-ancestor
110223588|NCT00294931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110223589|NCT00294931|Growth Inhibitors|growth inhibitors|mesh-ancestor
110223590|NCT00294931|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110223592|NCT00294931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110223593|NCT00294931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110223594|NCT02958423|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
110223595|NCT02958423|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110223597|NCT02958423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110223598|NCT02958423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110223599|NCT02958423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110223601|NCT00295165|Immunologic Factors|immunologic factors|mesh-ancestor
110223602|NCT00295165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110223603|NCT00295243|Topotecan|topotecan|mesh-list
110223604|NCT00295243|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110223605|NCT00295243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110223606|NCT00295243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110223607|NCT00295243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110223608|NCT00295243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110223609|NCT00295282|Antibodies|antibodies|mesh-list
110223610|NCT00295282|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110223611|NCT00295282|Immunologic Factors|immunologic factors|mesh-ancestor
110223612|NCT00295282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110223613|NCT00121797|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110223614|NCT00121797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110223616|NCT00089622|Lisuride|lisuride|mesh-list
110223617|NCT00089622|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110223618|NCT00089622|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110223619|NCT00089622|Dopamine Agents|dopamine agents|mesh-ancestor
110223620|NCT00089622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110223621|NCT00089622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110223622|NCT00089622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110223623|NCT00089622|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110223624|NCT00089622|Serotonin Agents|serotonin agents|mesh-ancestor
110223626|NCT00295555|Doxazosin|doxazosin|mesh-list
110223628|NCT00295555|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110223629|NCT00295555|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110223630|NCT00295555|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110223631|NCT00295555|Adrenergic Agents|adrenergic agents|mesh-ancestor
110223632|NCT00295555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110223633|NCT00295555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110223634|NCT00295555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110223635|NCT00295594|Tacrolimus|tacrolimus|mesh-list
110223636|NCT00295594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110223637|NCT00295594|Immunologic Factors|immunologic factors|mesh-ancestor
110223638|NCT00295594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110223639|NCT00295594|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110223640|NCT00295594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110223641|NCT00295594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110223643|NCT00121875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110223644|NCT00121875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110223646|NCT00295672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110223647|NCT00295672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110223648|NCT00295672|Tubulin Modulators|tubulin modulators|mesh-ancestor
110223649|NCT00295672|Antimitotic Agents|antimitotic agents|mesh-ancestor
110223650|NCT00295672|Mitosis Modulators|mitosis modulators|mesh-ancestor
110223651|NCT00295672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110223652|NCT00295789|Paclitaxel|paclitaxel|mesh-list
110223653|NCT00295789|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110223654|NCT00295789|Carboplatin|carboplatin|mesh-list
110223655|NCT00295789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110223656|NCT00295789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110223657|NCT00295789|Tubulin Modulators|tubulin modulators|mesh-ancestor
110223658|NCT00295789|Antimitotic Agents|antimitotic agents|mesh-ancestor
110223659|NCT00295789|Mitosis Modulators|mitosis modulators|mesh-ancestor
110223660|NCT00295789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110223661|NCT00089700|Ibalizumab|ibalizumab|mesh-list
110223662|NCT00089700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110223663|NCT00089700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110223664|NCT00089700|Antiviral Agents|antiviral agents|mesh-ancestor
110223665|NCT00089700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110223666|NCT04718584|Antibodies|antibodies|mesh-list
110223667|NCT04718584|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110223668|NCT04718584|Immunologic Factors|immunologic factors|mesh-ancestor
110223669|NCT04718584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110223670|NCT00417937|Azelaic acid|azelaic acid|mesh-list
110223671|NCT00417937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110223672|NCT00417937|Dermatologic Agents|dermatologic agents|mesh-ancestor
110223673|NCT00418054|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110223674|NCT00418054|Interferon-alpha|interferon-alpha|mesh-list
110223676|NCT00418054|Antiviral Agents|antiviral agents|mesh-ancestor
110223677|NCT00418054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110223678|NCT00418054|Immunologic Factors|immunologic factors|mesh-ancestor
110223679|NCT00418054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110223680|NCT00418054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110223681|NCT00295945|Fentanyl|fentanyl|mesh-list
110223682|NCT00295945|Hydromorphone|hydromorphone|mesh-list
110223683|NCT00295945|Ropivacaine|ropivacaine|mesh-list
110223684|NCT00295945|Anesthetics, Local|anesthetics, local|mesh-ancestor
110223685|NCT00295945|Anesthetics|anesthetics|mesh-ancestor
110223686|NCT00295945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110223687|NCT00295945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110223688|NCT00295945|Sensory System Agents|sensory system agents|mesh-ancestor
110223689|NCT00295945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110223690|NCT00295945|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110223691|NCT00295945|Narcotics|narcotics|mesh-ancestor
110223692|NCT00295945|Analgesics|analgesics|mesh-ancestor
110223693|NCT00295945|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110223694|NCT00295945|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110223695|NCT00295945|Anesthetics, General|anesthetics, general|mesh-ancestor
110223696|NCT00121914|Ethanol|ethanol|mesh-list
110223697|NCT00121914|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110223698|NCT00121914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110223699|NCT00121914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110223700|NCT00121914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110223701|NCT00295984|Nicotine|nicotine|mesh-list
110223702|NCT00295984|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110223703|NCT00295984|Autonomic Agents|autonomic agents|mesh-ancestor
110223704|NCT00295984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110223705|NCT00295984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110223706|NCT00295984|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110223707|NCT00295984|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110223708|NCT00295984|Cholinergic Agents|cholinergic agents|mesh-ancestor
110223709|NCT00295984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110223710|NCT00295984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110223711|NCT00296023|Methotrexate|methotrexate|mesh-list
110223712|NCT00296023|Fludarabine phosphate|fludarabine phosphate|mesh-list
110223713|NCT00296023|Fludarabine|fludarabine|mesh-list
110223714|NCT00296023|Busulfan|busulfan|mesh-list
110223716|NCT00296023|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110223717|NCT00296023|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110223718|NCT00296023|Abortifacient Agents|abortifacient agents|mesh-ancestor
110223719|NCT00296023|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110223720|NCT00296023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110223721|NCT00296023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110223722|NCT00296023|Antimetabolites|antimetabolites|mesh-ancestor
110223723|NCT00296023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110223724|NCT00296023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110223725|NCT00296023|Dermatologic Agents|dermatologic agents|mesh-ancestor
110223726|NCT00296023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110223727|NCT00296023|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110223728|NCT00296023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110223729|NCT00296023|Immunologic Factors|immunologic factors|mesh-ancestor
110223730|NCT00296023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110223731|NCT00296023|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110223732|NCT00296023|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110223733|NCT00296023|Alkylating Agents|alkylating agents|mesh-ancestor
110223734|NCT00296023|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110223736|NCT00121953|Rosiglitazone|rosiglitazone|mesh-list
110223737|NCT00121953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110223738|NCT00121953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110223739|NCT00296062|Bevacizumab|bevacizumab|mesh-list
110223740|NCT00296062|Capecitabine|capecitabine|mesh-list
110223741|NCT00296062|Oxaliplatin|oxaliplatin|mesh-list
110223742|NCT00296062|Irinotecan|irinotecan|mesh-list
110223743|NCT00296062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110223744|NCT00296062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110223745|NCT00296062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110223746|NCT00296062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110223747|NCT00296062|Growth Substances|growth substances|mesh-ancestor
110223748|NCT00296062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110223749|NCT00296062|Growth Inhibitors|growth inhibitors|mesh-ancestor
110223750|NCT00296062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110223752|NCT00296062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110223753|NCT00296062|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110223754|NCT00296062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110223755|NCT00296062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110223756|NCT00296179|Zolpidem|zolpidem|mesh-list
110223757|NCT00296179|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110223758|NCT00296179|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110223759|NCT00296179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110223760|NCT00296179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110223761|NCT00296179|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110223762|NCT00296179|GABA Agonists|gaba agonists|mesh-ancestor
110223763|NCT00296179|GABA Agents|gaba agents|mesh-ancestor
110223764|NCT00296179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110223765|NCT00296179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110223766|NCT00296218|Irbesartan|irbesartan|mesh-list
110223767|NCT00296218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110223768|NCT00296218|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110223769|NCT00296218|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110223770|NCT00296218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110223771|NCT00089856|Prednisone|prednisone|mesh-list
110223773|NCT00089856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110223774|NCT00089856|Glucocorticoids|glucocorticoids|mesh-ancestor
110223775|NCT00089856|Hormones|hormones|mesh-ancestor
110241422|NCT00440869|Protective Agents|protective agents|mesh-ancestor
110223776|NCT00089856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110223778|NCT00089856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110223779|NCT00089856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110223780|NCT00089856|Tubulin Modulators|tubulin modulators|mesh-ancestor
110223781|NCT00089856|Antimitotic Agents|antimitotic agents|mesh-ancestor
110223782|NCT00089856|Mitosis Modulators|mitosis modulators|mesh-ancestor
110223783|NCT00089856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110223784|NCT00296257|Rimacalib|rimacalib|mesh-list
110223785|NCT00296257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110223786|NCT00296257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110223787|NCT00296257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110223788|NCT00296530|Fluticasone|fluticasone|mesh-list
110223790|NCT00296530|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110223791|NCT00296530|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110223792|NCT00296530|Montelukast|montelukast|mesh-list
110223793|NCT00296530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110223794|NCT00296530|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110223795|NCT00296530|Autonomic Agents|autonomic agents|mesh-ancestor
110223796|NCT00296530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110241491|NCT00107822|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110223798|NCT00296530|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110223799|NCT00296530|Respiratory System Agents|respiratory system agents|mesh-ancestor
110223800|NCT00296530|Dermatologic Agents|dermatologic agents|mesh-ancestor
110223801|NCT00296530|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110241541|NCT00441961|Antimetabolites|antimetabolites|mesh-ancestor
110223802|NCT00296530|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110223803|NCT00296530|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110223804|NCT00296530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110223805|NCT00296530|Adrenergic Agents|adrenergic agents|mesh-ancestor
110223806|NCT00296530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110223807|NCT00296530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110223808|NCT00296530|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110223809|NCT00296530|Hormone Antagonists|hormone antagonists|mesh-ancestor
110223810|NCT00296530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110223811|NCT00296530|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110223812|NCT00296530|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110223814|NCT00296530|Hormones|hormones|mesh-ancestor
110223815|NCT00296530|Sympathomimetics|sympathomimetics|mesh-ancestor
110223816|NCT00090012|Olanzapine|olanzapine|mesh-list
110223817|NCT00090012|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110223818|NCT00090012|Antiemetics|antiemetics|mesh-ancestor
110223819|NCT00090012|Autonomic Agents|autonomic agents|mesh-ancestor
110223820|NCT00090012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110223821|NCT00090012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110223822|NCT00090012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110223823|NCT00090012|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110223824|NCT00090012|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110223825|NCT00090012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110223826|NCT00090012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110223827|NCT00090012|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110223828|NCT00090012|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110223829|NCT00090012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110223830|NCT00090012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110223831|NCT00090012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110223832|NCT00090012|Serotonin Agents|serotonin agents|mesh-ancestor
110223833|NCT00090012|Antidepressive Agents|antidepressive agents|mesh-ancestor
110241920|NCT00451360|Diacerein|diacerein|mesh-list
110223835|NCT00296608|Fluorouracil|fluorouracil|mesh-list
110223836|NCT00296608|Calcium|calcium|mesh-list
110223837|NCT00296608|Levoleucovorin|levoleucovorin|mesh-list
110223838|NCT00296608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110223839|NCT00296608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110223843|NCT00296608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110223844|NCT00296608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110223845|NCT00296608|Immunologic Factors|immunologic factors|mesh-ancestor
110223846|NCT00296608|Antidotes|antidotes|mesh-ancestor
110223849|NCT00296608|Vitamins|vitamins|mesh-ancestor
110223850|NCT00296608|Micronutrients|micronutrients|mesh-ancestor
110223851|NCT00296686|Tranylcypromine|tranylcypromine|mesh-list
110223852|NCT00296686|Dextroamphetamine|dextroamphetamine|mesh-list
110223853|NCT00296686|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110223854|NCT00296686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110223855|NCT00296686|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110223856|NCT00296686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110223857|NCT00296686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110223858|NCT00296686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110223860|NCT00296686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110223861|NCT00296686|Antidepressive Agents|antidepressive agents|mesh-ancestor
110223862|NCT00296686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110223863|NCT00296686|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110223864|NCT00296686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110223865|NCT00296686|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110223866|NCT00296686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110223867|NCT00296686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110223869|NCT00122070|Antidepressive Agents|antidepressive agents|mesh-ancestor
110223870|NCT00122070|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110223871|NCT00122070|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110223872|NCT00122070|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110223873|NCT00122070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110223874|NCT00122070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110223875|NCT00296803|Clopidogrel|clopidogrel|mesh-list
110223876|NCT00296803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110223877|NCT00296803|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110223878|NCT00296803|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110223879|NCT00296803|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110223880|NCT00296803|Purinergic Agents|purinergic agents|mesh-ancestor
110223881|NCT00296803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110223882|NCT00296803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110223883|NCT00296803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110223884|NCT00090090|Elsamicin A|elsamicin a|mesh-list
110223885|NCT00090090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110223886|NCT00090090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110223887|NCT00296959|Topiramate|topiramate|mesh-list
110223888|NCT00296959|Anticonvulsants|anticonvulsants|mesh-ancestor
110223889|NCT00296959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110223890|NCT00296959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110223891|NCT00297076|Aplaviroc|aplaviroc|mesh-list
110223892|NCT00297076|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110242048|NCT00452062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110223893|NCT00297076|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110223894|NCT00297076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110223895|NCT00297076|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110223896|NCT00297076|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110223897|NCT00297076|Antiviral Agents|antiviral agents|mesh-ancestor
110223898|NCT00297076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110223900|NCT00297349|Anticonvulsants|anticonvulsants|mesh-ancestor
110223901|NCT00297349|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110223902|NCT00297349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110223904|NCT00297388|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110223905|NCT00297388|Serotonin Agents|serotonin agents|mesh-ancestor
110223906|NCT00297388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110223907|NCT00297388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110223908|NCT00297388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110223909|NCT00297388|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110223910|NCT00297388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110223911|NCT00297388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110223912|NCT00297388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110242287|NCT00453427|Alemtuzumab|alemtuzumab|mesh-list
110223913|NCT00297388|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110223914|NCT00297388|Dopamine Agents|dopamine agents|mesh-ancestor
110223915|NCT00297466|Nicotine|nicotine|mesh-list
110223916|NCT00297466|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110223917|NCT00297466|Autonomic Agents|autonomic agents|mesh-ancestor
110223918|NCT00297466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110223919|NCT00297466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110223920|NCT00297466|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110223921|NCT00297466|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110223922|NCT00297466|Cholinergic Agents|cholinergic agents|mesh-ancestor
110223923|NCT00297466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110223924|NCT00297466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110223926|NCT00297505|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110223927|NCT00297505|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110223928|NCT00297505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110223929|NCT00297505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110223930|NCT00297505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110223931|NCT00297505|Serotonin Agents|serotonin agents|mesh-ancestor
110223932|NCT00297505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110223933|NCT00297505|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110223934|NCT00297505|Antidepressive Agents|antidepressive agents|mesh-ancestor
110223935|NCT00297505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110223936|NCT00297544|Sildenafil Citrate|sildenafil citrate|mesh-list
110223937|NCT00297544|Vasodilator Agents|vasodilator agents|mesh-ancestor
110223938|NCT00297544|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110223939|NCT00297544|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110223940|NCT00297544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110223941|NCT00297544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110223942|NCT00297544|Urological Agents|urological agents|mesh-ancestor
110223943|NCT00297583|Insulin glulisine|insulin glulisine|mesh-list
110223944|NCT00297583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110223945|NCT00297583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110223946|NCT00297661|Sirolimus|sirolimus|mesh-list
110223947|NCT00297661|Paclitaxel|paclitaxel|mesh-list
110223948|NCT00297661|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110223949|NCT00297661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110223950|NCT00297661|Tubulin Modulators|tubulin modulators|mesh-ancestor
110223951|NCT00297661|Antimitotic Agents|antimitotic agents|mesh-ancestor
110223952|NCT00297661|Mitosis Modulators|mitosis modulators|mesh-ancestor
110223953|NCT00297661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110223954|NCT00297661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110223955|NCT00297661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110223956|NCT00297661|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110223957|NCT00297661|Antifungal Agents|antifungal agents|mesh-ancestor
110223958|NCT00297661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110223959|NCT00297661|Immunologic Factors|immunologic factors|mesh-ancestor
110242620|NCT00143949|Protease Inhibitors|protease inhibitors|mesh-ancestor
110223960|NCT00297661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110223964|NCT00090207|Autonomic Agents|autonomic agents|mesh-ancestor
110223965|NCT00090207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110223966|NCT00090207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110223967|NCT00090207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110223969|NCT00090207|Dermatologic Agents|dermatologic agents|mesh-ancestor
110223970|NCT00090207|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110223971|NCT00090207|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110223972|NCT00090207|Serotonin Agents|serotonin agents|mesh-ancestor
110223973|NCT00090207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110223974|NCT00090207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242684|NCT00110669|Glucocorticoids|glucocorticoids|mesh-ancestor
110223975|NCT00090207|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110223976|NCT00297739|Risperidone|risperidone|mesh-list
110223977|NCT00297739|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110223978|NCT00297739|Serotonin Agents|serotonin agents|mesh-ancestor
110223979|NCT00297739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110223980|NCT00297739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110223981|NCT00297739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110223982|NCT00297739|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110223983|NCT00297739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110223984|NCT00297739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110223985|NCT00297739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110223986|NCT00297739|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110223988|NCT00090246|Ondansetron|ondansetron|mesh-list
110223989|NCT00090246|Aprepitant|aprepitant|mesh-list
110223990|NCT00090246|Antiemetics|antiemetics|mesh-ancestor
110223991|NCT00090246|Autonomic Agents|autonomic agents|mesh-ancestor
110223992|NCT00090246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110223993|NCT00090246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110223994|NCT00090246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110223995|NCT00090246|Antipruritics|antipruritics|mesh-ancestor
110223997|NCT00090246|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110223998|NCT00090246|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110223999|NCT00090246|Serotonin Agents|serotonin agents|mesh-ancestor
110224000|NCT00090246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110224001|NCT00090246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110224002|NCT00090246|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110224004|NCT00297817|Immunologic Factors|immunologic factors|mesh-ancestor
110224005|NCT00297817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110224006|NCT00090324|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110224007|NCT00090324|Antidepressive Agents|antidepressive agents|mesh-ancestor
110224008|NCT00090324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110224009|NCT00090324|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110224010|NCT00090324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110224011|NCT00090324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110242936|NCT00466063|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110224012|NCT00090324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110224014|NCT00122226|Lopinavir|lopinavir|mesh-list
110224015|NCT00122226|Lamivudine|lamivudine|mesh-list
110224016|NCT00122226|Zidovudine|zidovudine|mesh-list
110224017|NCT00122226|Nevirapine|nevirapine|mesh-list
110224018|NCT00122226|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110224019|NCT00122226|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110224020|NCT00122226|Protease Inhibitors|protease inhibitors|mesh-ancestor
110224021|NCT00122226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110224022|NCT00122226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110224023|NCT00122226|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110224024|NCT00122226|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110224025|NCT00122226|Antiviral Agents|antiviral agents|mesh-ancestor
110224026|NCT00122226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110224028|NCT00122226|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110224029|NCT00122226|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110224030|NCT00122226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110224031|NCT00122226|Antimetabolites|antimetabolites|mesh-ancestor
110224032|NCT00122226|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110224033|NCT00122226|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110224034|NCT05200559|Pembrolizumab|pembrolizumab|mesh-list
110243134|NCT00348361|Xhance|xhance|mesh-list
110224035|NCT05200559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110224036|NCT05200559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110224037|NCT05200559|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110224038|NCT05200559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110224039|NCT00298012|Methotrexate|methotrexate|mesh-list
110224040|NCT00298012|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110224041|NCT00298012|Abortifacient Agents|abortifacient agents|mesh-ancestor
110224042|NCT00298012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110224043|NCT00298012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110224044|NCT00298012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110224046|NCT00298012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110224047|NCT00298012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110224048|NCT00298012|Dermatologic Agents|dermatologic agents|mesh-ancestor
110224049|NCT00298012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110224050|NCT00298012|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110224051|NCT00298012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110224052|NCT00298012|Immunologic Factors|immunologic factors|mesh-ancestor
110224053|NCT00298012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110224054|NCT00298012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110224055|NCT00298168|polysaccharide-K|polysaccharide-k|mesh-list
110224056|NCT00298168|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110224057|NCT00298168|Immunologic Factors|immunologic factors|mesh-ancestor
110224058|NCT00298168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110224059|NCT00298168|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110224061|NCT00298168|Antiviral Agents|antiviral agents|mesh-ancestor
110224062|NCT00298168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110224063|NCT00298168|Interferon Inducers|interferon inducers|mesh-ancestor
110224064|NCT00298168|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110224065|NCT00298168|Protective Agents|protective agents|mesh-ancestor
110224066|NCT00122304|Eculizumab|eculizumab|mesh-list
110224067|NCT00122304|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110224068|NCT00122304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110224069|NCT00122304|Immunologic Factors|immunologic factors|mesh-ancestor
110224070|NCT00122304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110224071|NCT00322543|Pimecrolimus|pimecrolimus|mesh-list
110224072|NCT00322543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110224073|NCT00322543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110224074|NCT00322543|Analgesics|analgesics|mesh-ancestor
110224075|NCT00322543|Sensory System Agents|sensory system agents|mesh-ancestor
110224076|NCT00322543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110224077|NCT00322543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110224078|NCT00322543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110224079|NCT00322543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110224080|NCT00322543|Dermatologic Agents|dermatologic agents|mesh-ancestor
110224081|NCT00322543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110224082|NCT00322543|Immunologic Factors|immunologic factors|mesh-ancestor
110224083|NCT00322543|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110224084|NCT00322543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110224085|NCT00322543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110224086|NCT00313963|Magnesium Sulfate|magnesium sulfate|mesh-list
110224087|NCT00313963|Analgesics|analgesics|mesh-ancestor
110224088|NCT00313963|Sensory System Agents|sensory system agents|mesh-ancestor
110224089|NCT00313963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110224090|NCT00313963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110224091|NCT00313963|Anesthetics|anesthetics|mesh-ancestor
110224092|NCT00313963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110224093|NCT00313963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110224094|NCT00313963|Anticonvulsants|anticonvulsants|mesh-ancestor
110224095|NCT00313963|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110224096|NCT00313963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110224097|NCT00313963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110224098|NCT00313963|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110224099|NCT00313963|Tocolytic Agents|tocolytic agents|mesh-ancestor
110224100|NCT00313963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110224101|NCT00122343|Sirolimus|sirolimus|mesh-list
110224102|NCT00122343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110224103|NCT00122343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110224104|NCT00122343|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110224105|NCT00122343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110224106|NCT00122343|Antifungal Agents|antifungal agents|mesh-ancestor
110224107|NCT00122343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110224108|NCT00122343|Immunologic Factors|immunologic factors|mesh-ancestor
110224109|NCT00122343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110224111|NCT00314080|Botulinum Antitoxin|botulinum antitoxin|mesh-list
110224112|NCT00314080|Immunologic Factors|immunologic factors|mesh-ancestor
110224113|NCT00314080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110224114|NCT00314158|Timolol|timolol|mesh-list
110224115|NCT00314158|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110224116|NCT00314158|Brinzolamide|brinzolamide|mesh-list
110224117|NCT00314158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110224118|NCT00314158|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110224119|NCT00314158|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110224120|NCT00314158|Adrenergic Agents|adrenergic agents|mesh-ancestor
110224121|NCT00314158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110224122|NCT00314158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110224123|NCT00314158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110224124|NCT00314158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110224125|NCT00314158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110224126|NCT00314158|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110224127|NCT00314158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110224128|NCT00090480|Vaccines|vaccines|mesh-list
110224129|NCT00090480|Immunologic Factors|immunologic factors|mesh-ancestor
110224130|NCT00090480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110224131|NCT00322660|Epinephrine|epinephrine|mesh-list
110224132|NCT00322660|Racepinephrine|racepinephrine|mesh-list
110224133|NCT00322660|Epinephryl borate|epinephryl borate|mesh-list
110224134|NCT00322660|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110224135|NCT00322660|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110224136|NCT00322660|Adrenergic Agents|adrenergic agents|mesh-ancestor
110224137|NCT00322660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110224138|NCT00322660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110224139|NCT00322660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110224140|NCT00322660|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110224141|NCT00322660|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110224142|NCT00322660|Autonomic Agents|autonomic agents|mesh-ancestor
110224143|NCT00322660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110224144|NCT00322660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110224145|NCT00322660|Respiratory System Agents|respiratory system agents|mesh-ancestor
110224147|NCT00322660|Sympathomimetics|sympathomimetics|mesh-ancestor
110224148|NCT00322660|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110224149|NCT00322699|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
110224150|NCT00322699|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
110224152|NCT00322699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110224153|NCT00322699|Dermatologic Agents|dermatologic agents|mesh-ancestor
110224154|NCT00322699|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110224155|NCT00322972|Azithromycin|azithromycin|mesh-list
110224156|NCT00322972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110224157|NCT00322972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110224158|NCT00090558|Nitroglycerin|nitroglycerin|mesh-list
110224159|NCT00090558|Vasodilator Agents|vasodilator agents|mesh-ancestor
110224160|NCT00323011|Leucovorin|leucovorin|mesh-list
110224161|NCT00323011|Folic Acid|folic acid|mesh-list
110224162|NCT00323011|Bevacizumab|bevacizumab|mesh-list
110224163|NCT00323011|Fluorouracil|fluorouracil|mesh-list
110224164|NCT00323011|Irinotecan|irinotecan|mesh-list
110224165|NCT00323011|Dalteparin|dalteparin|mesh-list
110224166|NCT00323011|Levoleucovorin|levoleucovorin|mesh-list
110224167|NCT00323011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110224168|NCT00323011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110224169|NCT00323011|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110224170|NCT00323011|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110224171|NCT00323011|Growth Substances|growth substances|mesh-ancestor
110224172|NCT00323011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110224173|NCT00323011|Growth Inhibitors|growth inhibitors|mesh-ancestor
110224174|NCT00323011|Antimetabolites|antimetabolites|mesh-ancestor
110224175|NCT00323011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110224176|NCT00323011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110224177|NCT00323011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110224178|NCT00323011|Immunologic Factors|immunologic factors|mesh-ancestor
110224179|NCT00323011|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110224180|NCT00323011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110224182|NCT00323011|Antidotes|antidotes|mesh-ancestor
110224183|NCT00323011|Protective Agents|protective agents|mesh-ancestor
110224184|NCT00323011|Vitamin B Complex|vitamin b complex|mesh-ancestor
110224185|NCT00323011|Vitamins|vitamins|mesh-ancestor
110224186|NCT00323011|Micronutrients|micronutrients|mesh-ancestor
110224187|NCT00323011|Hematinics|hematinics|mesh-ancestor
110224188|NCT00323011|Anticoagulants|anticoagulants|mesh-ancestor
110224189|NCT00323011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110224190|NCT00323011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110224191|NCT00323206|Interleukin-12|interleukin-12|mesh-list
110224192|NCT00323206|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110224193|NCT00323206|Immunologic Factors|immunologic factors|mesh-ancestor
110224194|NCT00323206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110224195|NCT00323206|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110224196|NCT00323206|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110224197|NCT00323206|Growth Substances|growth substances|mesh-ancestor
110224198|NCT00323206|Growth Inhibitors|growth inhibitors|mesh-ancestor
110224199|NCT00323206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110224200|NCT04717531|Cyclophosphamide|cyclophosphamide|mesh-list
110224202|NCT04717531|Trastuzumab|trastuzumab|mesh-list
110224203|NCT04717531|Epirubicin|epirubicin|mesh-list
110224204|NCT04717531|Pertuzumab|pertuzumab|mesh-list
110224205|NCT04717531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110224206|NCT04717531|Immunologic Factors|immunologic factors|mesh-ancestor
110224207|NCT04717531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110224208|NCT04717531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110224209|NCT04717531|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110224210|NCT04717531|Alkylating Agents|alkylating agents|mesh-ancestor
110224211|NCT04717531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110224212|NCT04717531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110224213|NCT04717531|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110224214|NCT04717531|Tubulin Modulators|tubulin modulators|mesh-ancestor
110224215|NCT04717531|Antimitotic Agents|antimitotic agents|mesh-ancestor
110224216|NCT04717531|Mitosis Modulators|mitosis modulators|mesh-ancestor
110224217|NCT04717531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110224218|NCT04717531|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110224219|NCT04717531|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110224220|NCT04717531|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110224221|NCT04717531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110224222|NCT00323323|Prednisone|prednisone|mesh-list
110224223|NCT00323323|Cyclophosphamide|cyclophosphamide|mesh-list
110224224|NCT00323323|Doxorubicin|doxorubicin|mesh-list
110224225|NCT00323323|Vincristine|vincristine|mesh-list
110224226|NCT00323323|Alemtuzumab|alemtuzumab|mesh-list
110224227|NCT00323323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110224228|NCT00323323|Immunologic Factors|immunologic factors|mesh-ancestor
110224229|NCT00323323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110224230|NCT00323323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110224231|NCT00323323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110224232|NCT00323323|Alkylating Agents|alkylating agents|mesh-ancestor
110224233|NCT00323323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110224234|NCT00323323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110224235|NCT00323323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110224236|NCT00323323|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110224237|NCT00323323|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110224238|NCT00323323|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110224239|NCT00323323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110224240|NCT00323323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110224243|NCT00323323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110224244|NCT00323323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110224245|NCT00323323|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110224246|NCT00323323|Tubulin Modulators|tubulin modulators|mesh-ancestor
110224247|NCT00323323|Antimitotic Agents|antimitotic agents|mesh-ancestor
110224248|NCT00323323|Mitosis Modulators|mitosis modulators|mesh-ancestor
110224249|NCT00323323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110224250|NCT00122499|Tadalafil|tadalafil|mesh-list
110224251|NCT00122499|Vasodilator Agents|vasodilator agents|mesh-ancestor
110224252|NCT00122499|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110224253|NCT00122499|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110224254|NCT00122499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110224255|NCT00122499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110224256|NCT00122499|Urological Agents|urological agents|mesh-ancestor
110224258|NCT00312598|Antidepressive Agents|antidepressive agents|mesh-ancestor
110224259|NCT00312598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110244710|NCT00114803|Calcitonin|calcitonin|mesh-list
110224260|NCT00312598|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110224261|NCT00312598|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110224262|NCT00312598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110224263|NCT00312598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110224264|NCT00312598|Dopamine Agonists|dopamine agonists|mesh-ancestor
110224265|NCT00312598|Dopamine Agents|dopamine agents|mesh-ancestor
110224266|NCT00312598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110224267|NCT00312598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110224268|NCT00312598|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110224269|NCT00312598|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110224270|NCT00312598|Serotonin Agents|serotonin agents|mesh-ancestor
110224271|NCT00312598|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110224272|NCT00312598|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110224273|NCT00312598|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110224274|NCT00312598|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110224276|NCT00312754|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110224277|NCT00312754|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110224278|NCT00312754|Protease Inhibitors|protease inhibitors|mesh-ancestor
110224279|NCT00312754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110224280|NCT00312754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110224281|NCT00312754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110224282|NCT00312754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110224283|NCT00312754|Antiviral Agents|antiviral agents|mesh-ancestor
110224284|NCT00312754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110224285|NCT00312871|Epoetin Alfa|epoetin alfa|mesh-list
110224286|NCT00312871|Hematinics|hematinics|mesh-ancestor
110224287|NCT00090675|Gefitinib|gefitinib|mesh-list
110224288|NCT00090675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110224289|NCT00090675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110224290|NCT00090675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110224291|NCT00090675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110224292|NCT00312988|Gemcitabine|gemcitabine|mesh-list
110224293|NCT00312988|Topotecan|topotecan|mesh-list
110224294|NCT00312988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110224295|NCT00312988|Antimetabolites|antimetabolites|mesh-ancestor
110224296|NCT00312988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110224297|NCT00312988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110224298|NCT00312988|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110224299|NCT00312988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110224300|NCT00312988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110224301|NCT00122538|Lamivudine|lamivudine|mesh-list
110224302|NCT00122538|Efavirenz|efavirenz|mesh-list
110224303|NCT00122538|Didanosine|didanosine|mesh-list
110224304|NCT00122538|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110224305|NCT00122538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110224306|NCT00122538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110224307|NCT00122538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110224308|NCT00122538|Antiviral Agents|antiviral agents|mesh-ancestor
110224309|NCT00122538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110224310|NCT00122538|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110224311|NCT00122538|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110224312|NCT00122538|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110224313|NCT00122538|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110224314|NCT00122538|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110224315|NCT00122538|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110224316|NCT00122538|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110224317|NCT00122538|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110224318|NCT00122538|Antimetabolites|antimetabolites|mesh-ancestor
110224319|NCT00313105|Lobeline|lobeline|mesh-list
110224320|NCT00313105|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110224321|NCT00313105|Autonomic Agents|autonomic agents|mesh-ancestor
110224322|NCT00313105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110224323|NCT00313105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110224324|NCT00313105|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110224325|NCT00313105|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110224326|NCT00313105|Cholinergic Agents|cholinergic agents|mesh-ancestor
110224327|NCT00313105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110224328|NCT00313105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110224329|NCT00313105|Respiratory System Agents|respiratory system agents|mesh-ancestor
110224330|NCT00313183|Pramlintide|pramlintide|mesh-list
110224331|NCT00313183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110224332|NCT00313183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110224334|NCT06003283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110224335|NCT06003283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110224336|NCT06003283|Immunologic Factors|immunologic factors|mesh-ancestor
110224337|NCT06003283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110224338|NCT06003283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110224339|NCT06003270|Quercetin|quercetin|mesh-list
110224340|NCT06003270|Antioxidants|antioxidants|mesh-ancestor
110224341|NCT06003270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110224342|NCT06003270|Protective Agents|protective agents|mesh-ancestor
110224343|NCT06003270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110224344|NCT06003179|Cyclophosphamide|cyclophosphamide|mesh-list
110224345|NCT06003179|Fludarabine|fludarabine|mesh-list
110224346|NCT06003179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110224347|NCT06003179|Immunologic Factors|immunologic factors|mesh-ancestor
110224348|NCT06003179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110224349|NCT06003179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110224350|NCT06003179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110224351|NCT06003179|Alkylating Agents|alkylating agents|mesh-ancestor
110224352|NCT06003179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110224353|NCT06003179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110224354|NCT06003179|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110224355|NCT06003166|4-Aminopyridine|4-aminopyridine|mesh-list
110244921|NCT00450736|Celecoxib|celecoxib|mesh-list
110224356|NCT06003166|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110224357|NCT06003166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110224358|NCT06003166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110224359|NCT06003075|Nivolumab|nivolumab|mesh-list
110224360|NCT06003075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110224361|NCT06003075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110224362|NCT06003075|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110224363|NCT06003075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110224364|NCT06003049|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110224365|NCT06003049|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110224366|NCT06003049|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110224367|NCT06003049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110245150|NCT00460213|Valsartan|valsartan|mesh-list
110224368|NCT06003049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110224369|NCT06003049|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110224370|NCT06003049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110224371|NCT06003049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110224373|NCT06003049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110224374|NCT06002854|Insulin|insulin|mesh-list
110224376|NCT06002854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110224377|NCT06002854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110224378|NCT06002659|Cyclophosphamide|cyclophosphamide|mesh-list
110224379|NCT06002659|Fludarabine|fludarabine|mesh-list
110224380|NCT06002659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110224382|NCT06002659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110224383|NCT06002659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110224384|NCT06002659|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110224385|NCT06002659|Alkylating Agents|alkylating agents|mesh-ancestor
110224386|NCT06002659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110224387|NCT06002659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110224388|NCT06002659|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110224389|NCT06002646|Chromium|chromium|mesh-list
110224390|NCT06002646|Sodium Hypochlorite|sodium hypochlorite|mesh-list
110224391|NCT06002646|Eusol|eusol|mesh-list
110224392|NCT06002646|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110224393|NCT06002646|Trace Elements|trace elements|mesh-ancestor
110224394|NCT06002646|Micronutrients|micronutrients|mesh-ancestor
110224395|NCT06002646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110224396|NCT06002646|Disinfectants|disinfectants|mesh-ancestor
110224397|NCT06002646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110224398|NCT06002477|Mecamylamine|mecamylamine|mesh-list
110224399|NCT06002477|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110224400|NCT06002477|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
110224401|NCT06002477|Autonomic Agents|autonomic agents|mesh-ancestor
110224402|NCT06002477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110224403|NCT06002477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110224404|NCT06002477|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
110224405|NCT06002477|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110224407|NCT06002477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110224408|NCT06002477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110224409|NCT06002438|Micronutrients|micronutrients|mesh-list
110224410|NCT06002438|Trace Elements|trace elements|mesh-list
110224411|NCT06002438|Pyrimethamine|pyrimethamine|mesh-list
110224412|NCT06002438|Sulfadoxine|sulfadoxine|mesh-list
110224413|NCT06002438|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110224414|NCT06002438|Amodiaquine|amodiaquine|mesh-list
110224415|NCT06002438|Antimalarials|antimalarials|mesh-ancestor
110224416|NCT06002438|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110224417|NCT06002438|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110224418|NCT06002438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110224419|NCT06002438|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110224420|NCT06002438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110224421|NCT06002438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110224422|NCT06002438|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110224423|NCT06002438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110224424|NCT06002217|Levobupivacaine|levobupivacaine|mesh-list
110224425|NCT06002217|Anesthetics, Local|anesthetics, local|mesh-ancestor
110224426|NCT06002217|Anesthetics|anesthetics|mesh-ancestor
110224427|NCT06002217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110224428|NCT06002217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110224429|NCT06002217|Sensory System Agents|sensory system agents|mesh-ancestor
110224430|NCT06002217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110224431|NCT06002035|Vitamin D|vitamin d|mesh-list
110224432|NCT06002035|Vitamins|vitamins|mesh-ancestor
110224433|NCT06002035|Micronutrients|micronutrients|mesh-ancestor
110224434|NCT06002035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110224435|NCT06002035|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110224436|NCT06001788|Cytarabine|cytarabine|mesh-list
110224437|NCT06001788|Fludarabine|fludarabine|mesh-list
110224438|NCT06001788|Idarubicin|idarubicin|mesh-list
110224439|NCT06001788|Lenograstim|lenograstim|mesh-list
110224440|NCT06001788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110224441|NCT06001788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110224442|NCT06001788|Antimetabolites|antimetabolites|mesh-ancestor
110224443|NCT06001788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110224444|NCT06001788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110224445|NCT06001788|Immunologic Factors|immunologic factors|mesh-ancestor
110224446|NCT06001788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110224447|NCT06001788|Antiviral Agents|antiviral agents|mesh-ancestor
110224448|NCT06001788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110224449|NCT06001788|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110224450|NCT06001788|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110224451|NCT06001788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110224452|NCT06001788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110224453|NCT06001788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110224455|NCT06001762|Letrozole|letrozole|mesh-list
110224456|NCT06001762|Anastrozole|anastrozole|mesh-list
110224457|NCT06001762|Exemestane|exemestane|mesh-list
110224458|NCT06001762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110224459|NCT06001762|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110224460|NCT06001762|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110224461|NCT06001762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110224462|NCT06001762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110224463|NCT06001762|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110224464|NCT06001762|Hormone Antagonists|hormone antagonists|mesh-ancestor
110224465|NCT06001762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110224466|NCT06001762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110224467|NCT06001762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110224468|NCT06001762|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110224469|NCT06001762|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110224470|NCT06001762|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110224471|NCT06001749|Psilocybin|psilocybin|mesh-list
110224472|NCT06001749|Hallucinogens|hallucinogens|mesh-ancestor
110224473|NCT06001749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110224475|NCT06001658|Gemcitabine|gemcitabine|mesh-list
110224476|NCT06001658|Pembrolizumab|pembrolizumab|mesh-list
110224477|NCT06001658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110224478|NCT06001658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110224479|NCT06001658|Antimetabolites|antimetabolites|mesh-ancestor
110224480|NCT06001658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110224481|NCT06001658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110224482|NCT06001658|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110224484|NCT06001619|Finasteride|finasteride|mesh-list
110224485|NCT06001619|Dutasteride|dutasteride|mesh-list
110224486|NCT06001619|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110224487|NCT06001619|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110224488|NCT06001619|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110224489|NCT06001619|Adrenergic Agents|adrenergic agents|mesh-ancestor
110224490|NCT06001619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110224491|NCT06001619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110224492|NCT06001619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110224493|NCT06001619|Urological Agents|urological agents|mesh-ancestor
110224494|NCT06001619|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110224495|NCT06001619|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110224496|NCT06001619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110224497|NCT06001619|Hormone Antagonists|hormone antagonists|mesh-ancestor
110245603|NCT00463918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110224498|NCT06001619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110224499|NCT06001593|Betahistine|betahistine|mesh-list
110224500|NCT06001593|Vasodilator Agents|vasodilator agents|mesh-ancestor
110224501|NCT06001593|Histamine Agonists|histamine agonists|mesh-ancestor
110029233|NCT05284019|Analgesics|analgesics|mesh-ancestor
110224502|NCT06001593|Histamine Agents|histamine agents|mesh-ancestor
110224503|NCT06001593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110245671|NCT00464503|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110224504|NCT06001593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110224505|NCT06001593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110224507|NCT06001385|Cyclophosphamide|cyclophosphamide|mesh-list
110224508|NCT06001385|Melphalan|melphalan|mesh-list
110224509|NCT06001385|Busulfan|busulfan|mesh-list
110224510|NCT06001385|Fludarabine|fludarabine|mesh-list
110224511|NCT06001385|Tacrolimus|tacrolimus|mesh-list
110224512|NCT06001385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110245739|NCT00465283|Nootropic Agents|nootropic agents|mesh-ancestor
110224514|NCT06001385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110224515|NCT06001385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110224516|NCT06001385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110245814|NCT00473551|Sirolimus|sirolimus|mesh-list
110224517|NCT06001385|Alkylating Agents|alkylating agents|mesh-ancestor
110224518|NCT06001385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110224519|NCT06001385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110224520|NCT06001385|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110224521|NCT06001385|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110224523|NCT06001385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110224525|NCT06001385|Antitubercular Agents|antitubercular agents|mesh-ancestor
110224526|NCT06001385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110224527|NCT06001385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110224528|NCT06001372|Ketamine|ketamine|mesh-list
110224529|NCT06001372|Analgesics|analgesics|mesh-ancestor
110224530|NCT06001372|Sensory System Agents|sensory system agents|mesh-ancestor
110224531|NCT06001372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110224532|NCT06001372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110224533|NCT06001372|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110224534|NCT06001372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110224535|NCT06001372|Anesthetics, General|anesthetics, general|mesh-ancestor
110224536|NCT06001372|Anesthetics|anesthetics|mesh-ancestor
110224537|NCT06001372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110224538|NCT06001372|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110224539|NCT06001372|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110224540|NCT06001372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110224541|NCT06001372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110224542|NCT06001320|Letermovir|letermovir|mesh-list
110224543|NCT06001320|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110224544|NCT06001320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110224545|NCT06001320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110224546|NCT06001320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110224547|NCT06001320|Antiviral Agents|antiviral agents|mesh-ancestor
110224548|NCT06001320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110224549|NCT06001151|Carboplatin|carboplatin|mesh-list
110224550|NCT06001151|Pemetrexed|pemetrexed|mesh-list
110224551|NCT06001151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110224552|NCT06001151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110224553|NCT06001151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110246243|NCT05367336|Narcotics|narcotics|mesh-ancestor
110224554|NCT06001151|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110224555|NCT06001151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110224556|NCT06001125|Methotrexate|methotrexate|mesh-list
110224557|NCT06001125|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110224558|NCT06001125|Abortifacient Agents|abortifacient agents|mesh-ancestor
110224559|NCT06001125|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110224560|NCT06001125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110224561|NCT06001125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110224562|NCT06001125|Antimetabolites|antimetabolites|mesh-ancestor
110224563|NCT06001125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110224564|NCT06001125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110224565|NCT06001125|Dermatologic Agents|dermatologic agents|mesh-ancestor
110224566|NCT06001125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110224567|NCT06001125|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110246585|NCT00479362|Aspirin|aspirin|mesh-list
110224568|NCT06001125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110224569|NCT06001125|Immunologic Factors|immunologic factors|mesh-ancestor
110224570|NCT06001125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110224571|NCT06001125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110224572|NCT06001112|Etoricoxib|etoricoxib|mesh-list
110029244|NCT05249634|Hormones|hormones|mesh-ancestor
110224573|NCT06001112|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110224574|NCT06001112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110224575|NCT06001112|Analgesics|analgesics|mesh-ancestor
110224576|NCT06001112|Sensory System Agents|sensory system agents|mesh-ancestor
110224577|NCT06001112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110224578|NCT06001112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110224579|NCT06001112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110224580|NCT06001112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110224581|NCT06001112|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110224582|NCT06001112|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110224583|NCT06001112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110246792|NCT00480844|Serotonin Agents|serotonin agents|mesh-ancestor
110224584|NCT06001112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110224585|NCT06001047|Betahistine|betahistine|mesh-list
110224586|NCT06001047|Vasodilator Agents|vasodilator agents|mesh-ancestor
110224587|NCT06001047|Histamine Agonists|histamine agonists|mesh-ancestor
110224588|NCT06001047|Histamine Agents|histamine agents|mesh-ancestor
110224590|NCT06001047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110224591|NCT06001047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110224594|NCT06000917|Trastuzumab|trastuzumab|mesh-list
110224595|NCT06000917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110224596|NCT06000917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110224597|NCT06000917|Tubulin Modulators|tubulin modulators|mesh-ancestor
110224598|NCT06000917|Antimitotic Agents|antimitotic agents|mesh-ancestor
110224599|NCT06000917|Mitosis Modulators|mitosis modulators|mesh-ancestor
110224600|NCT06000917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110224601|NCT06000917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110224611|NCT06000709|Prednisolone|prednisolone|mesh-list
110224612|NCT06000709|Prednisolone acetate|prednisolone acetate|mesh-list
110224613|NCT06000709|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110224614|NCT06000709|Prednisolone phosphate|prednisolone phosphate|mesh-list
110224615|NCT06000709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110224616|NCT06000709|Antiemetics|antiemetics|mesh-ancestor
110224617|NCT06000709|Autonomic Agents|autonomic agents|mesh-ancestor
110224618|NCT06000709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110224619|NCT06000709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110224620|NCT06000709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110224621|NCT06000709|Glucocorticoids|glucocorticoids|mesh-ancestor
110224622|NCT06000709|Hormones|hormones|mesh-ancestor
110224623|NCT06000709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110224624|NCT06000709|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110224625|NCT06000709|Protective Agents|protective agents|mesh-ancestor
110224626|NCT06000709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110224627|NCT06000709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110224628|NCT06000709|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110224629|NCT06000709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110224630|NCT06000709|Disinfectants|disinfectants|mesh-ancestor
110224631|NCT06000709|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
110224632|NCT06000709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110224635|NCT06000657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110224636|NCT06000423|Tranexamic Acid|tranexamic acid|mesh-list
110224637|NCT06000423|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110224638|NCT06000423|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110224639|NCT06000423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110224641|NCT06000423|Coagulants|coagulants|mesh-ancestor
110224642|NCT06000358|Pembrolizumab|pembrolizumab|mesh-list
110224643|NCT06000358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110224644|NCT06000358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110224645|NCT06000358|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110224646|NCT06000358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110224648|NCT06000137|Sufentanil|sufentanil|mesh-list
110224649|NCT06000137|Dsuvia|dsuvia|mesh-list
110224650|NCT06000137|Dezocine|dezocine|mesh-list
110224651|NCT06000137|Granisetron|granisetron|mesh-list
110224652|NCT06000137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110224653|NCT06000137|Narcotics|narcotics|mesh-ancestor
110224654|NCT06000137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110247470|NCT05058417|Empagliflozin|empagliflozin|mesh-list
110224655|NCT06000137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110224657|NCT06000137|Sensory System Agents|sensory system agents|mesh-ancestor
110224658|NCT06000137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110224659|NCT06000137|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110224660|NCT06000137|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110224661|NCT06000137|Anesthetics, General|anesthetics, general|mesh-ancestor
110224663|NCT06000137|Antiemetics|antiemetics|mesh-ancestor
110224664|NCT06000137|Autonomic Agents|autonomic agents|mesh-ancestor
110224665|NCT06000137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110224666|NCT06000137|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110224667|NCT06000137|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110224668|NCT06000137|Serotonin Agents|serotonin agents|mesh-ancestor
110224669|NCT06000137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110247742|NCT00488137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110224670|NCT06000137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110224671|NCT06000137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110224672|NCT06000137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110224673|NCT06000137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110224674|NCT06000137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110224675|NCT06000137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110224676|NCT06000137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110224677|NCT06000033|Disitamab vedotin|disitamab vedotin|mesh-list
110224678|NCT06000033|Immunoconjugates|immunoconjugates|mesh-ancestor
110224679|NCT06000033|Immunologic Factors|immunologic factors|mesh-ancestor
110224680|NCT06000033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110224681|NCT05999994|Cyclophosphamide|cyclophosphamide|mesh-list
110224683|NCT05999994|Gemcitabine|gemcitabine|mesh-list
110224684|NCT05999994|Docetaxel|docetaxel|mesh-list
110224685|NCT05999994|Irinotecan|irinotecan|mesh-list
110224686|NCT05999994|Vinorelbine|vinorelbine|mesh-list
110224688|NCT05999994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110224689|NCT05999994|Immunologic Factors|immunologic factors|mesh-ancestor
110224690|NCT05999994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110224691|NCT05999994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110224692|NCT05999994|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110248018|NCT00122096|Analgesics|analgesics|mesh-ancestor
110224694|NCT05999994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110224695|NCT05999994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110224696|NCT05999994|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110224697|NCT05999994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110224698|NCT05999994|Antimetabolites|antimetabolites|mesh-ancestor
110224700|NCT05999994|Antimitotic Agents|antimitotic agents|mesh-ancestor
110224701|NCT05999994|Mitosis Modulators|mitosis modulators|mesh-ancestor
110224702|NCT05999994|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110224703|NCT05999994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110224704|NCT05999994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110224730|NCT05999890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110224731|NCT05999890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110224732|NCT05999890|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110224733|NCT05999890|Narcotics|narcotics|mesh-ancestor
110224734|NCT05999890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110224735|NCT05999890|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110224736|NCT05999890|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110224737|NCT05999890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110224738|NCT05999890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110224740|NCT05999890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110224741|NCT05999812|Bevacizumab|bevacizumab|mesh-list
110224742|NCT05999812|Atezolizumab|atezolizumab|mesh-list
110224743|NCT05999812|Tretinoin|tretinoin|mesh-list
110224744|NCT05999812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110224745|NCT05999812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110248420|NCT01243996|Ibuprofen|ibuprofen|mesh-list
110224746|NCT05999812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110224747|NCT05999812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110224748|NCT05999812|Growth Substances|growth substances|mesh-ancestor
110224749|NCT05999812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110224750|NCT05999812|Growth Inhibitors|growth inhibitors|mesh-ancestor
110224751|NCT05999812|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110224752|NCT05999812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110224754|NCT05999812|Dermatologic Agents|dermatologic agents|mesh-ancestor
110224755|NCT05999734|Bupivacaine|bupivacaine|mesh-list
110224756|NCT05999734|Anesthetics, Local|anesthetics, local|mesh-ancestor
110224757|NCT05999734|Anesthetics|anesthetics|mesh-ancestor
110224758|NCT05999734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110224759|NCT05999734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110224760|NCT05999734|Sensory System Agents|sensory system agents|mesh-ancestor
110224761|NCT05999734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110224762|NCT05999708|Indomethacin|indomethacin|mesh-list
110224763|NCT05999708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110224764|NCT05999708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110224765|NCT05999708|Analgesics|analgesics|mesh-ancestor
110224766|NCT05999708|Sensory System Agents|sensory system agents|mesh-ancestor
110224767|NCT05999708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110224768|NCT05999708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110224769|NCT05999708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110224770|NCT05999708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110224771|NCT05999708|Gout Suppressants|gout suppressants|mesh-ancestor
110224773|NCT05999708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110224774|NCT05999708|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110248683|NCT00127478|Atrasentan|atrasentan|mesh-list
110224775|NCT05999708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110224776|NCT05999708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110224779|NCT05999487|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110224780|NCT05999487|Sympathomimetics|sympathomimetics|mesh-ancestor
110248776|NCT00497107|Leucovorin|leucovorin|mesh-list
110224782|NCT05999487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110224783|NCT05999487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110224784|NCT05999487|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110224785|NCT05999487|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110224786|NCT05999487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110224787|NCT05999487|Adrenergic Agents|adrenergic agents|mesh-ancestor
110224788|NCT05999487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110224789|NCT05999487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110224790|NCT05999487|Protective Agents|protective agents|mesh-ancestor
110224791|NCT05999487|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110224792|NCT05999487|Vasodilator Agents|vasodilator agents|mesh-ancestor
110224793|NCT05999487|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110224794|NCT05999487|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110224795|NCT05999487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110224796|NCT05999474|Tioconazole|tioconazole|mesh-list
110224797|NCT05999474|Antifungal Agents|antifungal agents|mesh-ancestor
110224798|NCT05999474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110224799|NCT05999474|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110224800|NCT05999474|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110224801|NCT05999474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110224802|NCT05999474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110224803|NCT05999474|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110249032|NCT00498784|Levonorgestrel|levonorgestrel|mesh-list
110224805|NCT05999474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110224806|NCT05999474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110224807|NCT05999435|Fenretinide|fenretinide|mesh-list
110224808|NCT05999435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110224809|NCT05999435|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110224810|NCT05999435|Protective Agents|protective agents|mesh-ancestor
110224811|NCT05999435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110224812|NCT05999383|Nicotine|nicotine|mesh-list
110224813|NCT05999383|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110224815|NCT05999383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110224816|NCT05999383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110224817|NCT05999383|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110224818|NCT05999383|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110224819|NCT05999383|Cholinergic Agents|cholinergic agents|mesh-ancestor
110224820|NCT05999383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110224821|NCT05999383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110224822|NCT05999331|N-Methylaspartate|n-methylaspartate|mesh-list
110224823|NCT05999331|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
110224824|NCT05999331|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110224825|NCT05999331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110224826|NCT05999331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110224827|NCT05999331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110224828|NCT05999240|Pimavanserin|pimavanserin|mesh-list
110224829|NCT05999240|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110224830|NCT05999240|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110224831|NCT05999240|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110224832|NCT05999240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110224833|NCT05999240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110224834|NCT05999240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110224835|NCT05999240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110224836|NCT05999240|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110224837|NCT05999240|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110224838|NCT05999240|Serotonin Agents|serotonin agents|mesh-ancestor
110224839|NCT05999240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110224840|NCT05999240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110224841|NCT05999227|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110224842|NCT05999227|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110224843|NCT05999227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110224844|NCT05998941|Paclitaxel|paclitaxel|mesh-list
110224845|NCT05998941|Bevacizumab|bevacizumab|mesh-list
110224846|NCT05998941|Carboplatin|carboplatin|mesh-list
110224847|NCT05998941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110224848|NCT05998941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110224849|NCT05998941|Tubulin Modulators|tubulin modulators|mesh-ancestor
110224850|NCT05998941|Antimitotic Agents|antimitotic agents|mesh-ancestor
110224851|NCT05998941|Mitosis Modulators|mitosis modulators|mesh-ancestor
110224852|NCT05998941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110224853|NCT05998941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110224854|NCT05998941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110224855|NCT05998941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110224856|NCT05998941|Growth Substances|growth substances|mesh-ancestor
110224857|NCT05998941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110224858|NCT05998941|Growth Inhibitors|growth inhibitors|mesh-ancestor
110224859|NCT05998928|Cyclophosphamide|cyclophosphamide|mesh-list
110224860|NCT05998928|Fludarabine|fludarabine|mesh-list
110224861|NCT05998928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110224862|NCT05998928|Immunologic Factors|immunologic factors|mesh-ancestor
110224863|NCT05998928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110224864|NCT05998928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110224865|NCT05998928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110224866|NCT05998928|Alkylating Agents|alkylating agents|mesh-ancestor
110224867|NCT05998928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110224868|NCT05998928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110224869|NCT05998928|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110224870|NCT05998876|Methadone|methadone|mesh-list
110224871|NCT05998876|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110224872|NCT05998876|Narcotics|narcotics|mesh-ancestor
110224873|NCT05998876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110224874|NCT05998876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110224875|NCT05998876|Analgesics|analgesics|mesh-ancestor
110224876|NCT05998876|Sensory System Agents|sensory system agents|mesh-ancestor
110249779|NCT01248091|Nitroprusside|nitroprusside|mesh-list
110224877|NCT05998876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110224879|NCT05998876|Respiratory System Agents|respiratory system agents|mesh-ancestor
110224880|NCT05998863|Magnesium citrate|magnesium citrate|mesh-list
110224881|NCT05998863|Cathartics|cathartics|mesh-ancestor
110224882|NCT05998863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110249854|NCT00504127|Naproxen|naproxen|mesh-list
110224883|NCT05998837|Dapagliflozin|dapagliflozin|mesh-list
110224884|NCT05998837|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110224885|NCT05998837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110224886|NCT05998837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110224887|NCT05998837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110224888|NCT05998642|Rituximab|rituximab|mesh-list
110224889|NCT05998642|Methotrexate|methotrexate|mesh-list
110224890|NCT05998642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110224891|NCT05998642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110224892|NCT05998642|Immunologic Factors|immunologic factors|mesh-ancestor
110224894|NCT05998642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110224895|NCT05998642|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110224896|NCT05998642|Abortifacient Agents|abortifacient agents|mesh-ancestor
110224897|NCT05998642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110224898|NCT05998642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110224899|NCT05998642|Antimetabolites|antimetabolites|mesh-ancestor
110224900|NCT05998642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110224901|NCT05998642|Dermatologic Agents|dermatologic agents|mesh-ancestor
110224902|NCT05998642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110224903|NCT05998642|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110224904|NCT05998642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110224905|NCT05998642|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110224907|NCT05998551|Dexmedetomidine|dexmedetomidine|mesh-list
110224908|NCT05998551|Bupivacaine|bupivacaine|mesh-list
110224909|NCT05998551|Anesthetics, Local|anesthetics, local|mesh-ancestor
110224910|NCT05998551|Anesthetics|anesthetics|mesh-ancestor
110224911|NCT05998551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110224912|NCT05998551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110250126|NCT02736422|Xenon|xenon|mesh-list
110224913|NCT05998551|Sensory System Agents|sensory system agents|mesh-ancestor
110224914|NCT05998551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110224915|NCT05998551|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110224916|NCT05998551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110224917|NCT05998551|Analgesics|analgesics|mesh-ancestor
110224918|NCT05998551|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110224919|NCT05998551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110250285|NCT03510078|Insulin|insulin|mesh-list
110224920|NCT05998551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110224921|NCT05998551|Adrenergic Agents|adrenergic agents|mesh-ancestor
110224922|NCT05998551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110224923|NCT05998551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110224924|NCT05998551|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110224926|NCT05998551|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110224927|NCT05998551|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110224928|NCT05998551|Anesthetics, General|anesthetics, general|mesh-ancestor
110224929|NCT05998525|Dapagliflozin|dapagliflozin|mesh-list
110224930|NCT05998525|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110224931|NCT05998525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110224932|NCT05998525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110224933|NCT05998525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110224934|NCT05998447|Pembrolizumab|pembrolizumab|mesh-list
110224935|NCT05998447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110224936|NCT05998447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110224937|NCT05998447|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110224938|NCT05998447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110224939|NCT05998421|Aspirin|aspirin|mesh-list
110224940|NCT05998421|Heparin|heparin|mesh-list
110250552|NCT00140166|Niacin|niacin|mesh-list
110224941|NCT05998421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110224942|NCT05998421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110224943|NCT05998421|Analgesics|analgesics|mesh-ancestor
110224944|NCT05998421|Sensory System Agents|sensory system agents|mesh-ancestor
110224945|NCT05998421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110224946|NCT05998421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110224947|NCT05998421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110224948|NCT05998421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110224949|NCT05998421|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110224951|NCT05998421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110224952|NCT05998421|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110224953|NCT05998421|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110224954|NCT05998421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110224955|NCT05998421|Antipyretics|antipyretics|mesh-ancestor
110224956|NCT05998421|Anticoagulants|anticoagulants|mesh-ancestor
110224957|NCT05998356|Anesthetics|anesthetics|mesh-list
110224958|NCT05998356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110224959|NCT05998356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110224960|NCT05998239|8-chloro-cyclic adenosine monophosphate|8-chloro-cyclic adenosine monophosphate|mesh-list
110224961|NCT05998239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110224962|NCT05998239|Immunologic Factors|immunologic factors|mesh-ancestor
110224963|NCT05998239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110224964|NCT05998226|Anti-Infective Agents|anti-infective agents|mesh-list
110224965|NCT05998226|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110224966|NCT05998200|Glycolic acid|glycolic acid|mesh-list
110224967|NCT05998200|Keratolytic Agents|keratolytic agents|mesh-ancestor
110224968|NCT05998200|Dermatologic Agents|dermatologic agents|mesh-ancestor
110224970|NCT05998187|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110224971|NCT05998187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110224972|NCT05998187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110224973|NCT05998187|Cholinergic Agents|cholinergic agents|mesh-ancestor
110224974|NCT05998187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110224975|NCT05998187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110224977|NCT05998135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110224978|NCT05998135|Antimalarials|antimalarials|mesh-ancestor
110224979|NCT05998135|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110224980|NCT05998135|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110224981|NCT05998135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110224982|NCT05998135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110224984|NCT05998096|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110224985|NCT05998096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110224987|NCT05998096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110224988|NCT05998096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110224989|NCT05998096|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110224990|NCT05998096|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110224991|NCT05998096|Purinergic Agents|purinergic agents|mesh-ancestor
110224992|NCT05998096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110224993|NCT05997979|Capsaicin|capsaicin|mesh-list
110224994|NCT05997979|Antipruritics|antipruritics|mesh-ancestor
110224995|NCT05997979|Dermatologic Agents|dermatologic agents|mesh-ancestor
110224996|NCT05997979|Sensory System Agents|sensory system agents|mesh-ancestor
110224997|NCT05997979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110224998|NCT05997979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110224999|NCT05997901|Varenicline|varenicline|mesh-list
110225000|NCT05997901|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110225001|NCT05997901|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110225002|NCT05997901|Cholinergic Agents|cholinergic agents|mesh-ancestor
110225003|NCT05997901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110225004|NCT05997901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110225005|NCT05997901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110225006|NCT05997784|Nitric Oxide|nitric oxide|mesh-list
110225007|NCT05997784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110225008|NCT05997784|Autonomic Agents|autonomic agents|mesh-ancestor
110225009|NCT05997784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110225010|NCT05997784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110225011|NCT05997784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110225012|NCT05997784|Respiratory System Agents|respiratory system agents|mesh-ancestor
110225013|NCT05997784|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110225015|NCT05997784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110225016|NCT05997784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110225017|NCT05997784|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110225018|NCT05997784|Vasodilator Agents|vasodilator agents|mesh-ancestor
110225019|NCT05997784|Gasotransmitters|gasotransmitters|mesh-ancestor
110225020|NCT05997784|Protective Agents|protective agents|mesh-ancestor
110225021|NCT05997693|Ticagrelor|ticagrelor|mesh-list
110225022|NCT05997693|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110225023|NCT05997693|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110225024|NCT05997693|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110225025|NCT05997693|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110225026|NCT05997693|Purinergic Agents|purinergic agents|mesh-ancestor
110225027|NCT05997693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110225028|NCT05997693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110225029|NCT05997693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110225030|NCT05997524|Capecitabine|capecitabine|mesh-list
110225031|NCT05997524|Oxaliplatin|oxaliplatin|mesh-list
110225032|NCT05997524|Trastuzumab|trastuzumab|mesh-list
110225033|NCT05997524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110225036|NCT05997524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110225037|NCT05997524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110225038|NCT05997485|Ritonavir|ritonavir|mesh-list
110225039|NCT05997485|Nirmatrelvir|nirmatrelvir|mesh-list
110225040|NCT05997485|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
110225041|NCT05997485|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110251408|NCT00134888|Narcotics|narcotics|mesh-ancestor
110225042|NCT05997485|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110225043|NCT05997485|Protease Inhibitors|protease inhibitors|mesh-ancestor
110251477|NCT00142350|Antimetabolites|antimetabolites|mesh-ancestor
110225044|NCT05997485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110225045|NCT05997485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110225047|NCT05997485|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110225048|NCT05997485|Antiviral Agents|antiviral agents|mesh-ancestor
110225049|NCT05997485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110225050|NCT05997485|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110251550|NCT00152724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110225051|NCT05997485|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110225052|NCT05997433|Amoxicillin|amoxicillin|mesh-list
110225053|NCT05997433|Tetracycline|tetracycline|mesh-list
110225054|NCT05997433|Bismuth|bismuth|mesh-list
110225055|NCT05997433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110225056|NCT05997433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110225057|NCT05997433|Antacids|antacids|mesh-ancestor
110225058|NCT05997433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110225059|NCT05997433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110225060|NCT05997433|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110225062|NCT05997355|Gabapentin|gabapentin|mesh-list
110225063|NCT05997355|Analgesics|analgesics|mesh-ancestor
110225064|NCT05997355|Sensory System Agents|sensory system agents|mesh-ancestor
110225065|NCT05997355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110225066|NCT05997355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110225067|NCT05997355|Anticonvulsants|anticonvulsants|mesh-ancestor
110225068|NCT05997355|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110225069|NCT05997355|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110225070|NCT05997355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110225071|NCT05997355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110225072|NCT05997355|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110225073|NCT05997355|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110225074|NCT05997355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110225075|NCT05997355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110225076|NCT05997355|Antimanic Agents|antimanic agents|mesh-ancestor
110225077|NCT05997303|Norepinephrine|norepinephrine|mesh-list
110225078|NCT05997303|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110225079|NCT05997303|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110225080|NCT05997303|Adrenergic Agents|adrenergic agents|mesh-ancestor
110225081|NCT05997303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110225082|NCT05997303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110251900|NCT00159666|Pregabalin|pregabalin|mesh-list
110225084|NCT05997303|Sympathomimetics|sympathomimetics|mesh-ancestor
110225085|NCT05997303|Autonomic Agents|autonomic agents|mesh-ancestor
110225086|NCT05997303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110225087|NCT05997303|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110225088|NCT05997277|Deucravacitinib|deucravacitinib|mesh-list
110225089|NCT05997277|Dermatologic Agents|dermatologic agents|mesh-ancestor
110225090|NCT05997277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110225091|NCT05997277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110225092|NCT05997277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110225094|NCT05997238|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110225095|NCT05997238|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110225096|NCT05997238|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110225097|NCT05997238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110225098|NCT05997238|Glucocorticoids|glucocorticoids|mesh-ancestor
110225099|NCT05997238|Hormones|hormones|mesh-ancestor
110225100|NCT05997238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110225101|NCT05997238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110225102|NCT05997238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110225103|NCT05997238|Immunologic Factors|immunologic factors|mesh-ancestor
110225104|NCT05997238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110225105|NCT05997238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110225106|NCT05997225|Varenicline|varenicline|mesh-list
110225107|NCT05997225|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110225108|NCT05997225|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110225109|NCT05997225|Cholinergic Agents|cholinergic agents|mesh-ancestor
110225110|NCT05997225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110225111|NCT05997225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110225112|NCT05997225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110225113|NCT05997056|Sirolimus|sirolimus|mesh-list
110225114|NCT05997056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110225115|NCT05997056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110225116|NCT05997056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110225117|NCT05997056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110225118|NCT05997056|Antifungal Agents|antifungal agents|mesh-ancestor
110225119|NCT05997056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110225120|NCT05997056|Immunologic Factors|immunologic factors|mesh-ancestor
110252236|NCT00154128|Antifungal Agents|antifungal agents|mesh-ancestor
110225121|NCT05997056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110225122|NCT05997043|Antiparkinson Agents|antiparkinson agents|mesh-list
110225124|NCT05997043|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110225125|NCT05997043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110225126|NCT05997043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110225127|NCT05997043|Cholinergic Agents|cholinergic agents|mesh-ancestor
110225128|NCT05997043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110225129|NCT05997043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110225130|NCT05997043|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110225132|NCT05997017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110225133|NCT05997017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110225134|NCT05997017|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110252295|NCT00160875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110225135|NCT05997017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110225136|NCT05997017|Antifungal Agents|antifungal agents|mesh-ancestor
110225137|NCT05997017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110225138|NCT05997017|Immunologic Factors|immunologic factors|mesh-ancestor
110225139|NCT05997017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110225140|NCT05996588|Propofol|propofol|mesh-list
110225141|NCT05996588|Anesthetics|anesthetics|mesh-list
110225143|NCT05996588|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
110225144|NCT05996588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110225145|NCT05996588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110225146|NCT05996588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110225147|NCT05996588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110225148|NCT05996588|Anesthetics, General|anesthetics, general|mesh-ancestor
110225149|NCT05996588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110225150|NCT05996549|Vaccines|vaccines|mesh-list
110225151|NCT05996549|Immunologic Factors|immunologic factors|mesh-ancestor
110225152|NCT05996549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110225153|NCT05996484|Paclitaxel|paclitaxel|mesh-list
110225154|NCT05996484|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110225155|NCT05996484|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110252559|NCT00406341|Difluprednate|difluprednate|mesh-list
110225156|NCT05996484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110225157|NCT05996484|Tubulin Modulators|tubulin modulators|mesh-ancestor
110225159|NCT05996484|Mitosis Modulators|mitosis modulators|mesh-ancestor
110225160|NCT05996484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110225161|NCT05996445|Pembrolizumab|pembrolizumab|mesh-list
110225162|NCT05996445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110225163|NCT05996445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110225164|NCT05996445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110225165|NCT05996445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110225167|NCT05996406|Venetoclax|venetoclax|mesh-list
110225168|NCT05996406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110225169|NCT05996406|Antiemetics|antiemetics|mesh-ancestor
110225170|NCT05996406|Autonomic Agents|autonomic agents|mesh-ancestor
110225171|NCT05996406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110225172|NCT05996406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110225173|NCT05996406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110225174|NCT05996406|Glucocorticoids|glucocorticoids|mesh-ancestor
110225175|NCT05996406|Hormones|hormones|mesh-ancestor
110225176|NCT05996406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110225178|NCT05996406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110225179|NCT05996393|Cyclosporine|cyclosporine|mesh-list
110225180|NCT05996393|Cyclosporins|cyclosporins|mesh-list
110225181|NCT05996393|Thymoglobulin|thymoglobulin|mesh-list
110225182|NCT05996393|Immunoglobulins|immunoglobulins|mesh-list
110225183|NCT05996393|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110225184|NCT05996393|Antibodies|antibodies|mesh-list
110225185|NCT05996393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110225186|NCT05996393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110225187|NCT05996393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110225188|NCT05996393|Immunologic Factors|immunologic factors|mesh-ancestor
110225189|NCT05996393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110225190|NCT05996393|Antifungal Agents|antifungal agents|mesh-ancestor
110225191|NCT05996393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110225192|NCT05996393|Dermatologic Agents|dermatologic agents|mesh-ancestor
110225193|NCT05996393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110225194|NCT05996393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110225196|NCT05996224|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110225197|NCT05996224|Immunologic Factors|immunologic factors|mesh-ancestor
110225198|NCT05996224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110225199|NCT05996224|Viscosupplements|viscosupplements|mesh-ancestor
110225200|NCT05996224|Protective Agents|protective agents|mesh-ancestor
110225201|NCT05996185|Prednisone|prednisone|mesh-list
110225202|NCT05996185|Cyclophosphamide|cyclophosphamide|mesh-list
110225203|NCT05996185|Doxorubicin|doxorubicin|mesh-list
110225204|NCT05996185|Etoposide|etoposide|mesh-list
110225205|NCT05996185|Vincristine|vincristine|mesh-list
110225206|NCT05996185|Mogamulizumab|mogamulizumab|mesh-list
110225207|NCT05996185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110225208|NCT05996185|Immunologic Factors|immunologic factors|mesh-ancestor
110225210|NCT05996185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110225211|NCT05996185|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110225212|NCT05996185|Alkylating Agents|alkylating agents|mesh-ancestor
110225213|NCT05996185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110225214|NCT05996185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110252876|NCT00140894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110225215|NCT05996185|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110225216|NCT05996185|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110225217|NCT05996185|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110225218|NCT05996185|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110225219|NCT05996185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110225220|NCT05996185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110225221|NCT05996185|Glucocorticoids|glucocorticoids|mesh-ancestor
110225222|NCT05996185|Hormones|hormones|mesh-ancestor
110225223|NCT05996185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110225225|NCT05996185|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110225226|NCT05996185|Tubulin Modulators|tubulin modulators|mesh-ancestor
110225227|NCT05996185|Antimitotic Agents|antimitotic agents|mesh-ancestor
110225228|NCT05996185|Mitosis Modulators|mitosis modulators|mesh-ancestor
110225229|NCT05995600|Warfarin|warfarin|mesh-list
110225230|NCT05995600|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
110225231|NCT05995600|Anticoagulants|anticoagulants|mesh-ancestor
110225232|NCT05995535|Lofexidine|lofexidine|mesh-list
110225233|NCT05995535|Clonidine|clonidine|mesh-list
110225234|NCT05995535|Pregabalin|pregabalin|mesh-list
110225236|NCT05995535|Sensory System Agents|sensory system agents|mesh-ancestor
110225237|NCT05995535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110225238|NCT05995535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110225239|NCT05995535|Anticonvulsants|anticonvulsants|mesh-ancestor
110225240|NCT05995535|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110225241|NCT05995535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110253137|NCT00404534|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110225242|NCT05995535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110225243|NCT05995535|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110225244|NCT05995535|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110225245|NCT05995535|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110225246|NCT05995535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110225247|NCT05995535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110225248|NCT05995535|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110225249|NCT05995535|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110225250|NCT05995535|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110225251|NCT05995535|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110225252|NCT05995535|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110225253|NCT05995535|Adrenergic Agents|adrenergic agents|mesh-ancestor
110225254|NCT05995535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110225255|NCT05995535|Sympatholytics|sympatholytics|mesh-ancestor
110225256|NCT05995535|Autonomic Agents|autonomic agents|mesh-ancestor
110225257|NCT05995392|Spironolactone|spironolactone|mesh-list
110225258|NCT05995392|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110225259|NCT05995392|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110225260|NCT05995392|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110225261|NCT05995392|Hormone Antagonists|hormone antagonists|mesh-ancestor
110225262|NCT05995392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110225263|NCT05995392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110225264|NCT05995392|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110225265|NCT05995392|Diuretics|diuretics|mesh-ancestor
110225266|NCT05995392|Natriuretic Agents|natriuretic agents|mesh-ancestor
110225268|NCT05995314|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110225269|NCT05995314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110225270|NCT05995314|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110225271|NCT05995314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110225272|NCT05995314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110225273|NCT05995314|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110225274|NCT05995314|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110225275|NCT05995314|Purinergic Agents|purinergic agents|mesh-ancestor
110225276|NCT05995314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110253346|NCT04516603|4-Aminopyridine|4-aminopyridine|mesh-list
110225278|NCT05995119|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110225279|NCT05995119|Antithrombins|antithrombins|mesh-ancestor
110225280|NCT05995119|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110225281|NCT05995119|Protease Inhibitors|protease inhibitors|mesh-ancestor
110225282|NCT05995119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110225283|NCT05995119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110225284|NCT05995119|Anticoagulants|anticoagulants|mesh-ancestor
110225286|NCT05994534|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110225287|NCT05994534|Cysteamine|cysteamine|mesh-list
110225288|NCT05994534|Antiviral Agents|antiviral agents|mesh-ancestor
110253394|NCT04516174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110225289|NCT05994534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110225290|NCT05994534|Expectorants|expectorants|mesh-ancestor
110225291|NCT05994534|Respiratory System Agents|respiratory system agents|mesh-ancestor
110225292|NCT05994534|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110225294|NCT05994534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110225295|NCT05994534|Protective Agents|protective agents|mesh-ancestor
110225296|NCT05994534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110225297|NCT05994534|Antidotes|antidotes|mesh-ancestor
110225298|NCT05994534|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
110225299|NCT05993039|Remifentanil|remifentanil|mesh-list
110225300|NCT05993039|Propofol|propofol|mesh-list
110225301|NCT05993039|Sevoflurane|sevoflurane|mesh-list
110225302|NCT05993039|Isoflurane|isoflurane|mesh-list
110225303|NCT05993039|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110225304|NCT05993039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110225305|NCT05993039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110225306|NCT05993039|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110225307|NCT05993039|Anesthetics, General|anesthetics, general|mesh-ancestor
110225308|NCT05993039|Anesthetics|anesthetics|mesh-ancestor
110225309|NCT05993039|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110225310|NCT05993039|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110225311|NCT05993039|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110225313|NCT05993039|Analgesics|analgesics|mesh-ancestor
110225314|NCT05993039|Sensory System Agents|sensory system agents|mesh-ancestor
110225315|NCT05993039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110225316|NCT05990985|Prednisolone|prednisolone|mesh-list
110225317|NCT05990985|Cyclophosphamide|cyclophosphamide|mesh-list
110225319|NCT05990985|Vincristine|vincristine|mesh-list
110225320|NCT05990985|Mitoxantrone|mitoxantrone|mesh-list
110225321|NCT05990985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110225322|NCT05990985|Immunologic Factors|immunologic factors|mesh-ancestor
110225323|NCT05990985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110225324|NCT05990985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110225325|NCT05990985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110225326|NCT05990985|Alkylating Agents|alkylating agents|mesh-ancestor
110225327|NCT05990985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110225328|NCT05990985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110225329|NCT05990985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110225330|NCT05990985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110225331|NCT05990985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110225332|NCT05990985|Tubulin Modulators|tubulin modulators|mesh-ancestor
110225333|NCT05990985|Antimitotic Agents|antimitotic agents|mesh-ancestor
110225334|NCT05990985|Mitosis Modulators|mitosis modulators|mesh-ancestor
110225335|NCT05990985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110225336|NCT05990985|Glucocorticoids|glucocorticoids|mesh-ancestor
110225337|NCT05990985|Hormones|hormones|mesh-ancestor
110225338|NCT05990985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110225339|NCT05990985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110225340|NCT05990985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110225342|NCT05990985|Sensory System Agents|sensory system agents|mesh-ancestor
110225343|NCT05990985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110225344|NCT05990985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110225346|NCT05989503|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
110225348|NCT05989503|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110225349|NCT05989503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110225350|NCT05989503|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110253772|NCT04514029|Glucocorticoids|glucocorticoids|mesh-ancestor
110225351|NCT05989503|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110225352|NCT05989503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110253850|NCT00163449|Hormones|hormones|mesh-ancestor
110225354|NCT05989503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110225355|NCT05989074|Fexofenadine|fexofenadine|mesh-list
110225356|NCT05989074|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110225357|NCT05989074|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110225358|NCT05989074|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110225359|NCT05989074|Histamine Antagonists|histamine antagonists|mesh-ancestor
110225360|NCT05989074|Histamine Agents|histamine agents|mesh-ancestor
110225361|NCT05989074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110225362|NCT05989074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110225363|NCT05989074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110225364|NCT05984550|Niacinamide|niacinamide|mesh-list
110225365|NCT05984550|Vitamin B Complex|vitamin b complex|mesh-ancestor
110225366|NCT05984550|Vitamins|vitamins|mesh-ancestor
110225367|NCT05984550|Micronutrients|micronutrients|mesh-ancestor
110225368|NCT05984550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110225369|NCT05980546|Dexamethasone|dexamethasone|mesh-list
110225370|NCT05980546|Dexamethasone acetate|dexamethasone acetate|mesh-list
110225371|NCT05980546|Fentanyl|fentanyl|mesh-list
110225372|NCT05980546|Bupivacaine|bupivacaine|mesh-list
110225373|NCT05980546|Mepivacaine|mepivacaine|mesh-list
110225374|NCT05980546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110254194|NCT05148910|Copper|copper|mesh-list
110225375|NCT05980546|Antiemetics|antiemetics|mesh-ancestor
110225376|NCT05980546|Autonomic Agents|autonomic agents|mesh-ancestor
110225377|NCT05980546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110225378|NCT05980546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110225379|NCT05980546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110225380|NCT05980546|Glucocorticoids|glucocorticoids|mesh-ancestor
110225381|NCT05980546|Hormones|hormones|mesh-ancestor
110225382|NCT05980546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110225383|NCT05980546|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110225384|NCT05980546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110225385|NCT05980546|Anesthetics, Local|anesthetics, local|mesh-ancestor
110225386|NCT05980546|Anesthetics|anesthetics|mesh-ancestor
110225387|NCT05980546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110225388|NCT05980546|Sensory System Agents|sensory system agents|mesh-ancestor
110254198|NCT00148083|Risperidone|risperidone|mesh-list
110225389|NCT05980546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110225390|NCT05980546|Narcotics|narcotics|mesh-ancestor
110225391|NCT05980546|Analgesics|analgesics|mesh-ancestor
110225392|NCT05980546|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110225393|NCT05980546|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110225394|NCT05980546|Anesthetics, General|anesthetics, general|mesh-ancestor
110225395|NCT05975463|Bevacizumab|bevacizumab|mesh-list
110225396|NCT05975463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110225397|NCT05975463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110225398|NCT05975463|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110225432|NCT05971251|Acalabrutinib|acalabrutinib|mesh-list
110225433|NCT05971251|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
110225434|NCT05971251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110225435|NCT05971251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110225436|NCT05966246|Prucalopride|prucalopride|mesh-list
110225438|NCT05966246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110343833|NCT06020755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110343834|NCT06020755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110343835|NCT06019741|Aspirin|aspirin|mesh-list
110343836|NCT06019741|Rivaroxaban|rivaroxaban|mesh-list
110343837|NCT06019741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110343838|NCT06019741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110343839|NCT06019741|Analgesics|analgesics|mesh-ancestor
110343840|NCT06019741|Sensory System Agents|sensory system agents|mesh-ancestor
110343841|NCT06019741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110343842|NCT06019741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110343843|NCT06019741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110343844|NCT06019741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110343845|NCT06019741|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110343846|NCT06019741|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110343847|NCT06019741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110343848|NCT06019741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110343849|NCT06019741|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110343850|NCT06019741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110343851|NCT06019741|Antipyretics|antipyretics|mesh-ancestor
110343852|NCT06019741|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110343853|NCT06019741|Antithrombins|antithrombins|mesh-ancestor
110343854|NCT06019741|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110343855|NCT06019741|Protease Inhibitors|protease inhibitors|mesh-ancestor
110343856|NCT06019741|Anticoagulants|anticoagulants|mesh-ancestor
110343857|NCT06017362|Lubricant Eye Drops|lubricant eye drops|mesh-list
110343858|NCT06017362|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110343859|NCT06017362|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110343861|NCT06016738|Fulvestrant|fulvestrant|mesh-list
110343862|NCT06016738|Anastrozole|anastrozole|mesh-list
110343863|NCT06016738|Exemestane|exemestane|mesh-list
110343864|NCT06016738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110343865|NCT06016738|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110343866|NCT06016738|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110343867|NCT06016738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110343868|NCT06016738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110343869|NCT06016738|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110343870|NCT06016738|Hormone Antagonists|hormone antagonists|mesh-ancestor
110343871|NCT06016738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110343872|NCT06016738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110343873|NCT06016738|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110343874|NCT06016738|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110343876|NCT06016452|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110343877|NCT06016452|Protective Agents|protective agents|mesh-ancestor
110343878|NCT06016452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110343879|NCT06016218|Simvastatin|simvastatin|mesh-list
110343880|NCT06016218|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110343881|NCT06016218|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110343882|NCT06016218|Antimetabolites|antimetabolites|mesh-ancestor
110343883|NCT06016218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110343884|NCT06016218|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110343885|NCT06016218|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110343888|NCT06015880|Antibodies|antibodies|mesh-list
110343889|NCT06015880|Immunoglobulins|immunoglobulins|mesh-list
110343890|NCT06015880|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110343891|NCT06015880|Antibodies, Bispecific|antibodies, bispecific|mesh-list
110343892|NCT06015880|Immunoconjugates|immunoconjugates|mesh-list
110343893|NCT06015880|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
110343894|NCT06015880|Immunologic Factors|immunologic factors|mesh-ancestor
110343895|NCT06015880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110343896|NCT06015880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110343897|NCT06015880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110343898|NCT06015880|Growth Substances|growth substances|mesh-ancestor
110343899|NCT06015880|Growth Inhibitors|growth inhibitors|mesh-ancestor
110343900|NCT06015880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110343901|NCT06015724|Nivolumab|nivolumab|mesh-list
110343902|NCT06015724|Daratumumab|daratumumab|mesh-list
110225439|NCT05966246|Laxatives|laxatives|mesh-ancestor
110343903|NCT06015724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110343904|NCT06015724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110343905|NCT06015724|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110343906|NCT06015724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110343907|NCT06014385|Scopolamine|scopolamine|mesh-list
110343908|NCT06014385|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
110343909|NCT06014385|LSN3172176|lsn3172176|mesh-list
110343910|NCT06014385|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110343911|NCT06014385|Antiemetics|antiemetics|mesh-ancestor
110343912|NCT06014385|Autonomic Agents|autonomic agents|mesh-ancestor
110343913|NCT06014385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110343914|NCT06014385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110343915|NCT06014385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110343916|NCT06014385|Mydriatics|mydriatics|mesh-ancestor
110343917|NCT06014385|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110343918|NCT06014385|Cholinergic Agents|cholinergic agents|mesh-ancestor
110343919|NCT06014385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110343920|NCT06014385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110343921|NCT06014385|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110343922|NCT06014385|Parasympatholytics|parasympatholytics|mesh-ancestor
110343923|NCT06014385|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110343924|NCT06013618|Irinotecan|irinotecan|mesh-list
110343925|NCT06013618|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-list
110343926|NCT06013618|Temozolomide|temozolomide|mesh-list
110343927|NCT06013618|Molgramostim|molgramostim|mesh-list
110343928|NCT06013618|Sargramostim|sargramostim|mesh-list
110343929|NCT06013618|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110343930|NCT06013618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110343931|NCT06013618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110343932|NCT06013618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110343933|NCT06013618|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110343934|NCT06013618|Alkylating Agents|alkylating agents|mesh-ancestor
110343935|NCT06013618|Immunologic Factors|immunologic factors|mesh-ancestor
110343936|NCT06013618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110343937|NCT06012734|Atezolizumab|atezolizumab|mesh-list
110343939|NCT06012734|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110343940|NCT06012734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110343941|NCT06012734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110343942|NCT06012734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110343943|NCT06012734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110343944|NCT06009991|Propofol|propofol|mesh-list
110343945|NCT06009991|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110343946|NCT06009991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110343947|NCT06009991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110343948|NCT06009991|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110343949|NCT06009991|Anesthetics, General|anesthetics, general|mesh-ancestor
110343950|NCT06009991|Anesthetics|anesthetics|mesh-ancestor
110343951|NCT06008405|Azacitidine|azacitidine|mesh-list
110343952|NCT06008405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110343953|NCT06008405|Antimetabolites|antimetabolites|mesh-ancestor
110343954|NCT06008405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110343955|NCT06008405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110173873|NCT00061711|Estrogens|estrogens|mesh-ancestor
110343957|NCT06005610|Estradiol|estradiol|mesh-list
110343958|NCT06005610|Estrogens|estrogens|mesh-ancestor
110343959|NCT06005610|Hormones|hormones|mesh-ancestor
110343960|NCT06005610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110343961|NCT06005610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110343962|NCT05993390|Neostigmine|neostigmine|mesh-list
110343963|NCT05993390|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110343964|NCT05993390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110343965|NCT05993390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110343966|NCT05993390|Cholinergic Agents|cholinergic agents|mesh-ancestor
110343967|NCT05993390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110343968|NCT05993390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110343969|NCT05993390|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110343970|NCT05993390|Autonomic Agents|autonomic agents|mesh-ancestor
110343971|NCT05993390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110343972|NCT05990790|Propofol|propofol|mesh-list
110343973|NCT05990790|Sevoflurane|sevoflurane|mesh-list
110343974|NCT05990790|Desflurane|desflurane|mesh-list
110343975|NCT05990790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110343976|NCT05990790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110343977|NCT05990790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110343978|NCT05990790|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110343979|NCT05990790|Anesthetics, General|anesthetics, general|mesh-ancestor
110343980|NCT05990790|Anesthetics|anesthetics|mesh-ancestor
110343981|NCT05990790|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110343982|NCT05990790|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110343983|NCT05986136|Dapagliflozin|dapagliflozin|mesh-list
110343984|NCT05986136|Mesalamine|mesalamine|mesh-list
110343985|NCT05986136|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110343986|NCT05986136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110343987|NCT05986136|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110343988|NCT05986136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110343989|NCT05986136|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110343990|NCT05986136|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110343991|NCT05986136|Analgesics|analgesics|mesh-ancestor
110343992|NCT05986136|Sensory System Agents|sensory system agents|mesh-ancestor
110343993|NCT05986136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110343994|NCT05986136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110343995|NCT05986136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110343996|NCT05983198|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110343997|NCT05983198|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110343998|NCT05983198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110343999|NCT05982392|Naproxen|naproxen|mesh-list
110344000|NCT05982392|Tramadol|tramadol|mesh-list
110344001|NCT05982392|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110344002|NCT05982392|Narcotics|narcotics|mesh-ancestor
110344003|NCT05982392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110344004|NCT05982392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110344005|NCT05982392|Analgesics|analgesics|mesh-ancestor
110344006|NCT05982392|Sensory System Agents|sensory system agents|mesh-ancestor
110344007|NCT05982392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110344008|NCT05982392|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110344009|NCT05982392|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110344010|NCT05982392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110344011|NCT05982392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110344012|NCT05982392|Gout Suppressants|gout suppressants|mesh-ancestor
110344013|NCT05982392|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110344014|NCT05982392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110344015|NCT05982392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110344016|NCT05971810|Chlorhexidine|chlorhexidine|mesh-list
110344017|NCT05971810|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110344018|NCT05971810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110344019|NCT05971810|Disinfectants|disinfectants|mesh-ancestor
110344020|NCT05958303|Antioxidants|antioxidants|mesh-list
110344021|NCT05958303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110344022|NCT05958303|Protective Agents|protective agents|mesh-ancestor
110344023|NCT05958303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110344025|NCT05943496|Acalabrutinib|acalabrutinib|mesh-list
110344026|NCT05943496|Immunoglobulins|immunoglobulins|mesh-list
110344027|NCT05943496|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
110344028|NCT05943496|Immunologic Factors|immunologic factors|mesh-ancestor
110344029|NCT05943496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110344030|NCT05943496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110344031|NCT05943496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110344032|NCT05943496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110344033|NCT05943496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110344034|NCT05943496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110344035|NCT05942313|Buprenorphine|buprenorphine|mesh-list
110344036|NCT05942313|Methadone|methadone|mesh-list
110344037|NCT05942313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110344038|NCT05942313|Narcotics|narcotics|mesh-ancestor
110344039|NCT05942313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110344040|NCT05942313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110344041|NCT05942313|Analgesics|analgesics|mesh-ancestor
110344042|NCT05942313|Sensory System Agents|sensory system agents|mesh-ancestor
110344043|NCT05942313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110344044|NCT05942313|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110344045|NCT05942313|Antitussive Agents|antitussive agents|mesh-ancestor
110344046|NCT05942313|Respiratory System Agents|respiratory system agents|mesh-ancestor
110344047|NCT05933044|Durvalumab|durvalumab|mesh-list
110344048|NCT05933044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110344049|NCT05933044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110344051|NCT05930197|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
110344052|NCT05930197|Antacids|antacids|mesh-ancestor
110344053|NCT05930197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110344054|NCT05930197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110344055|NCT05930197|Antidiarrheals|antidiarrheals|mesh-ancestor
110344056|NCT05930119|Rabeprazole|rabeprazole|mesh-list
110344057|NCT05930119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110344058|NCT05930119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110344059|NCT05930119|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110344060|NCT05930119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110344061|NCT05930119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110344062|NCT05926427|Rituximab|rituximab|mesh-list
110344063|NCT05926427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110344064|NCT05926427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110344065|NCT05926427|Immunologic Factors|immunologic factors|mesh-ancestor
110344066|NCT05926427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110344067|NCT05926427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110344068|NCT05924880|Durvalumab|durvalumab|mesh-list
110344069|NCT05924880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110344070|NCT05924880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110344071|NCT05924321|Moxifloxacin|moxifloxacin|mesh-list
110344072|NCT05924321|Carbetocin|carbetocin|mesh-list
110344073|NCT05924321|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110344074|NCT05924321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110344075|NCT05924321|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110344076|NCT05924321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110344077|NCT05924321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110225440|NCT05966246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110344078|NCT05924321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110344079|NCT05924321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110344080|NCT05924321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110344081|NCT05924321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110344082|NCT05924321|Oxytocics|oxytocics|mesh-ancestor
110344083|NCT05919537|Paclitaxel|paclitaxel|mesh-list
110344084|NCT05919537|Docetaxel|docetaxel|mesh-list
110344085|NCT05919537|Gemcitabine|gemcitabine|mesh-list
110344086|NCT05919537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110344088|NCT05919537|Tubulin Modulators|tubulin modulators|mesh-ancestor
110344089|NCT05919537|Antimitotic Agents|antimitotic agents|mesh-ancestor
110344090|NCT05919537|Mitosis Modulators|mitosis modulators|mesh-ancestor
110344091|NCT05919537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110344092|NCT05919537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110344093|NCT05919537|Antimetabolites|antimetabolites|mesh-ancestor
110344095|NCT05917275|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110344096|NCT05917275|Olmesartan|olmesartan|mesh-list
110344097|NCT05917275|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110344098|NCT05917275|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110344099|NCT05917275|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110344100|NCT05917275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110344101|NCT05917275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110344102|NCT05917275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110344103|NCT05917275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110344104|NCT05917275|Vasodilator Agents|vasodilator agents|mesh-ancestor
110344105|NCT05917275|Diuretics|diuretics|mesh-ancestor
110344106|NCT05917275|Natriuretic Agents|natriuretic agents|mesh-ancestor
110344107|NCT05917275|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110344108|NCT05917275|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110344109|NCT05917275|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110344111|NCT05911906|Antimetabolites|antimetabolites|mesh-ancestor
110344112|NCT05911906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110344113|NCT05911906|Antiviral Agents|antiviral agents|mesh-ancestor
110344114|NCT05911906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110344115|NCT05911321|Dexamethasone|dexamethasone|mesh-list
110344116|NCT05911321|Pomalidomide|pomalidomide|mesh-list
110344117|NCT05911321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110344118|NCT05911321|Antiemetics|antiemetics|mesh-ancestor
110344119|NCT05911321|Autonomic Agents|autonomic agents|mesh-ancestor
110344120|NCT05911321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110344121|NCT05911321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110344122|NCT05911321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110344123|NCT05911321|Glucocorticoids|glucocorticoids|mesh-ancestor
110344124|NCT05911321|Hormones|hormones|mesh-ancestor
110344125|NCT05911321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110344126|NCT05911321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110344127|NCT05911321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110344128|NCT05911321|Immunologic Factors|immunologic factors|mesh-ancestor
110344129|NCT05911321|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110344130|NCT05911321|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110344131|NCT05911321|Growth Substances|growth substances|mesh-ancestor
110344132|NCT05911321|Growth Inhibitors|growth inhibitors|mesh-ancestor
110344133|NCT05911295|Carboplatin|carboplatin|mesh-list
110344134|NCT05911295|Gemcitabine|gemcitabine|mesh-list
110344135|NCT05911295|Pembrolizumab|pembrolizumab|mesh-list
110344136|NCT05911295|Disitamab vedotin|disitamab vedotin|mesh-list
110344137|NCT05911295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110344138|NCT05911295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110344139|NCT05911295|Antimetabolites|antimetabolites|mesh-ancestor
110344140|NCT05911295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110344141|NCT05911295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110344142|NCT05911295|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110344143|NCT05911295|Immunoconjugates|immunoconjugates|mesh-ancestor
110344144|NCT05911295|Immunologic Factors|immunologic factors|mesh-ancestor
110344145|NCT05911295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110344146|NCT05906836|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110344147|NCT05906836|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110344148|NCT05906836|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110344149|NCT05906836|Antimetabolites|antimetabolites|mesh-ancestor
110344150|NCT05906836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110344151|NCT05906836|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110344152|NCT05906836|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110344154|NCT05903417|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110344155|NCT05903417|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110344156|NCT05903417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110344157|NCT05903417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110344158|NCT05900388|Rivaroxaban|rivaroxaban|mesh-list
110344159|NCT05900388|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110344160|NCT05900388|Antithrombins|antithrombins|mesh-ancestor
110344161|NCT05900388|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110344162|NCT05900388|Protease Inhibitors|protease inhibitors|mesh-ancestor
110344163|NCT05900388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110344164|NCT05900388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110344165|NCT05900388|Anticoagulants|anticoagulants|mesh-ancestor
110344166|NCT05896007|Rituximab|rituximab|mesh-list
110344167|NCT05896007|Methotrexate|methotrexate|mesh-list
110344168|NCT05896007|Temozolomide|temozolomide|mesh-list
110344169|NCT05896007|Zanubrutinib|zanubrutinib|mesh-list
110344170|NCT05896007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110344171|NCT05896007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110344172|NCT05896007|Immunologic Factors|immunologic factors|mesh-ancestor
110344173|NCT05896007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110344174|NCT05896007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110344175|NCT05896007|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110344176|NCT05896007|Abortifacient Agents|abortifacient agents|mesh-ancestor
110344177|NCT05896007|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110344178|NCT05896007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110344179|NCT05896007|Antimetabolites|antimetabolites|mesh-ancestor
110225441|NCT05966246|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
110344180|NCT05896007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110344181|NCT05896007|Dermatologic Agents|dermatologic agents|mesh-ancestor
110344182|NCT05896007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110344183|NCT05896007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110344184|NCT05896007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110344185|NCT05896007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110344186|NCT05896007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110344187|NCT05896007|Alkylating Agents|alkylating agents|mesh-ancestor
110344188|NCT05896007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110344190|NCT05891171|Carboplatin|carboplatin|mesh-list
110344191|NCT05891171|Fluorouracil|fluorouracil|mesh-list
110344192|NCT05891171|Oxaliplatin|oxaliplatin|mesh-list
110344193|NCT05891171|Pemetrexed|pemetrexed|mesh-list
110344194|NCT05891171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110344195|NCT05891171|Antimetabolites|antimetabolites|mesh-ancestor
110344196|NCT05891171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110344197|NCT05891171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110344198|NCT05891171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110344199|NCT05891171|Immunologic Factors|immunologic factors|mesh-ancestor
110344200|NCT05891171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110344201|NCT05891171|Antidotes|antidotes|mesh-ancestor
110344202|NCT05891171|Protective Agents|protective agents|mesh-ancestor
110344203|NCT05891171|Vitamin B Complex|vitamin b complex|mesh-ancestor
110344204|NCT05891171|Vitamins|vitamins|mesh-ancestor
110344205|NCT05891171|Micronutrients|micronutrients|mesh-ancestor
110344206|NCT05891171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110344207|NCT05891171|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110344208|NCT05891171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110344209|NCT05891132|Lidocaine|lidocaine|mesh-list
110344210|NCT05891132|Prilocaine|prilocaine|mesh-list
110344211|NCT05891132|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
110344212|NCT05891132|Anesthetics|anesthetics|mesh-list
110344213|NCT05891132|Anesthetics, Local|anesthetics, local|mesh-ancestor
110344214|NCT05891132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110344215|NCT05891132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110344216|NCT05891132|Sensory System Agents|sensory system agents|mesh-ancestor
110344217|NCT05891132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110344218|NCT05891132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110344219|NCT05891132|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110344220|NCT05891132|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110344221|NCT05891132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110344222|NCT05891132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110344223|NCT05891132|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
110344224|NCT05890638|Albuterol|albuterol|mesh-list
110344225|NCT05890638|Ipratropium|ipratropium|mesh-list
110344226|NCT05890638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110344227|NCT05890638|Autonomic Agents|autonomic agents|mesh-ancestor
110344228|NCT05890638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110344229|NCT05890638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110344230|NCT05890638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110344231|NCT05890638|Respiratory System Agents|respiratory system agents|mesh-ancestor
110344232|NCT05890638|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110344233|NCT05890638|Cholinergic Agents|cholinergic agents|mesh-ancestor
110344234|NCT05890638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110344235|NCT05890638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110344236|NCT05890638|Tocolytic Agents|tocolytic agents|mesh-ancestor
110344237|NCT05890638|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110344238|NCT05890638|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110344240|NCT05890638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110344241|NCT05890638|Adrenergic Agents|adrenergic agents|mesh-ancestor
110344242|NCT05885503|Aflibercept|aflibercept|mesh-list
110344243|NCT05885503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110344244|NCT05885503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110344245|NCT05885503|Growth Substances|growth substances|mesh-ancestor
110344246|NCT05885503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110344247|NCT05885503|Growth Inhibitors|growth inhibitors|mesh-ancestor
110344248|NCT05885503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110344249|NCT05881915|Phenylephrine|phenylephrine|mesh-list
110344250|NCT05881915|Epinephrine|epinephrine|mesh-list
110344251|NCT05881915|Oxymetazoline|oxymetazoline|mesh-list
110344252|NCT05881915|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110344253|NCT05881915|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110344254|NCT05881915|Adrenergic Agents|adrenergic agents|mesh-ancestor
110344255|NCT05881915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110344256|NCT05881915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110344257|NCT05881915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110344258|NCT05881915|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110344259|NCT05881915|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110344260|NCT05881915|Autonomic Agents|autonomic agents|mesh-ancestor
110344261|NCT05881915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110344262|NCT05881915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110344263|NCT05881915|Respiratory System Agents|respiratory system agents|mesh-ancestor
110344264|NCT05881915|Mydriatics|mydriatics|mesh-ancestor
110344265|NCT05881915|Sympathomimetics|sympathomimetics|mesh-ancestor
110344266|NCT05881915|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110344267|NCT05881915|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110344268|NCT05881915|Nasal Decongestants|nasal decongestants|mesh-ancestor
110344269|NCT05881915|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110344270|NCT05881915|Protective Agents|protective agents|mesh-ancestor
110344271|NCT05878769|Astegolimab|astegolimab|mesh-list
110344272|NCT05878769|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110344273|NCT05878769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110344274|NCT05878769|Antiviral Agents|antiviral agents|mesh-ancestor
110344275|NCT05878769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110344276|NCT05876949|Denosumab|denosumab|mesh-list
110344277|NCT05876949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110344278|NCT05876949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110344279|NCT05876754|Ivosidenib|ivosidenib|mesh-list
110344280|NCT05876754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110344281|NCT05876754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110344282|NCT05876754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110344283|NCT05876351|Eculizumab|eculizumab|mesh-list
110344284|NCT05876351|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110344285|NCT05876351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110344286|NCT05876351|Immunologic Factors|immunologic factors|mesh-ancestor
110344287|NCT05876351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110344288|NCT05869812|Calcium, Dietary|calcium, dietary|mesh-list
110344289|NCT05869812|Calcium|calcium|mesh-list
110344290|NCT05869812|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110344291|NCT05869812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110344292|NCT05869812|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110344293|NCT05869591|Apixaban|apixaban|mesh-list
110344294|NCT05869591|Edoxaban|edoxaban|mesh-list
110344295|NCT05869591|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110344296|NCT05869591|Antithrombins|antithrombins|mesh-ancestor
110344297|NCT05869591|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110344298|NCT05869591|Protease Inhibitors|protease inhibitors|mesh-ancestor
110344299|NCT05869591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110344300|NCT05869591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110344301|NCT05869591|Anticoagulants|anticoagulants|mesh-ancestor
110344302|NCT05867121|Paclitaxel|paclitaxel|mesh-list
110344303|NCT05867121|Gemcitabine|gemcitabine|mesh-list
110344304|NCT05867121|Capecitabine|capecitabine|mesh-list
110344305|NCT05867121|Oxaliplatin|oxaliplatin|mesh-list
110344306|NCT05867121|Nivolumab|nivolumab|mesh-list
110344307|NCT05867121|Atezolizumab|atezolizumab|mesh-list
110344308|NCT05867121|Tegafur|tegafur|mesh-list
110344309|NCT05867121|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110344310|NCT05867121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110344311|NCT05867121|Tubulin Modulators|tubulin modulators|mesh-ancestor
110344312|NCT05867121|Antimitotic Agents|antimitotic agents|mesh-ancestor
110344313|NCT05867121|Mitosis Modulators|mitosis modulators|mesh-ancestor
110344314|NCT05867121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110344315|NCT05867121|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110344316|NCT05867121|Antimetabolites|antimetabolites|mesh-ancestor
110344317|NCT05867121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110344318|NCT05867121|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110344319|NCT05856526|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110344320|NCT05855798|Magnesium Sulfate|magnesium sulfate|mesh-list
110344321|NCT05855798|Ketamine|ketamine|mesh-list
110344322|NCT05855798|Bupivacaine|bupivacaine|mesh-list
110344323|NCT05855798|Anesthetics, Local|anesthetics, local|mesh-ancestor
110344324|NCT05855798|Anesthetics|anesthetics|mesh-ancestor
110344325|NCT05855798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110344326|NCT05855798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110344327|NCT05855798|Sensory System Agents|sensory system agents|mesh-ancestor
110344328|NCT05855798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110344329|NCT05855798|Analgesics|analgesics|mesh-ancestor
110344330|NCT05855798|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110173939|NCT04917900|Paclitaxel|paclitaxel|mesh-list
110344331|NCT05855798|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110344332|NCT05855798|Anesthetics, General|anesthetics, general|mesh-ancestor
110344333|NCT05855798|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110344334|NCT05855798|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110344335|NCT05855798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110344336|NCT05855798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110344337|NCT05855798|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110344339|NCT05855798|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110344340|NCT05855798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110344341|NCT05855798|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110344342|NCT05855798|Tocolytic Agents|tocolytic agents|mesh-ancestor
110344343|NCT05855798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110344344|NCT05853367|Pembrolizumab|pembrolizumab|mesh-list
110344345|NCT05853367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110344346|NCT05853367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110344347|NCT05853367|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110344348|NCT05853367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110344349|NCT05847244|Metformin|metformin|mesh-list
110344350|NCT05847244|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110344351|NCT05847244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110344352|NCT05842044|Acetaminophen|acetaminophen|mesh-list
110344353|NCT05842044|Ibuprofen|ibuprofen|mesh-list
110344354|NCT05842044|Ketorolac|ketorolac|mesh-list
110344355|NCT05842044|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110344356|NCT05842044|Oxycodone|oxycodone|mesh-list
110344357|NCT05842044|Hydromorphone|hydromorphone|mesh-list
110344358|NCT05842044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110344359|NCT05842044|Analgesics|analgesics|mesh-ancestor
110344360|NCT05842044|Sensory System Agents|sensory system agents|mesh-ancestor
110344361|NCT05842044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110344362|NCT05842044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110344363|NCT05842044|Antipyretics|antipyretics|mesh-ancestor
110344364|NCT05842044|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110344365|NCT05842044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110344366|NCT05842044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110344367|NCT05842044|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110344368|NCT05842044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110344369|NCT05842044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110344370|NCT05842044|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110344371|NCT05842044|Narcotics|narcotics|mesh-ancestor
110344372|NCT05842044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110344373|NCT05839899|Misoprostol|misoprostol|mesh-list
110344374|NCT05839899|Mifepristone|mifepristone|mesh-list
110344375|NCT05839899|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110344376|NCT05839899|Abortifacient Agents|abortifacient agents|mesh-ancestor
110344377|NCT05839899|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110344378|NCT05839899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110344379|NCT05839899|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110344380|NCT05839899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110344381|NCT05839899|Oxytocics|oxytocics|mesh-ancestor
110344382|NCT05839899|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110344383|NCT05839899|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110344384|NCT05839899|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110344385|NCT05839899|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110344386|NCT05839899|Contraceptive Agents|contraceptive agents|mesh-ancestor
110344387|NCT05839899|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110344388|NCT05839899|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110344389|NCT05839899|Hormone Antagonists|hormone antagonists|mesh-ancestor
110344390|NCT05839899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110344391|NCT05839899|Luteolytic Agents|luteolytic agents|mesh-ancestor
110344392|NCT05839899|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110344393|NCT05839899|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110344395|NCT05838560|Quercetin|quercetin|mesh-list
110344396|NCT05838560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110344397|NCT05838560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110344398|NCT05838560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110344399|NCT05838560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110344401|NCT05838560|Protective Agents|protective agents|mesh-ancestor
110344402|NCT05838560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110344403|NCT05835011|Decitabine|decitabine|mesh-list
110344404|NCT05835011|Magrolimab|magrolimab|mesh-list
110344405|NCT05835011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110344406|NCT05835011|Antimetabolites|antimetabolites|mesh-ancestor
110344407|NCT05835011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110344408|NCT05835011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110344409|NCT05835011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110344410|NCT05835011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110344411|NCT05834569|Acetaminophen|acetaminophen|mesh-list
110344412|NCT05834569|Ibuprofen|ibuprofen|mesh-list
110344413|NCT05834569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110344414|NCT05834569|Analgesics|analgesics|mesh-ancestor
110344415|NCT05834569|Sensory System Agents|sensory system agents|mesh-ancestor
110344416|NCT05834569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110344417|NCT05834569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029532|NCT04477317|Nordefrin|nordefrin|mesh-list
110344419|NCT05834569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110344420|NCT05834569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110344421|NCT05834569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110344422|NCT05834569|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110344423|NCT05834569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110344424|NCT05834569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110344425|NCT05831683|Anesthetics|anesthetics|mesh-list
110344426|NCT05831683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110344427|NCT05831683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110344428|NCT05827016|Lenalidomide|lenalidomide|mesh-list
110344429|NCT05827016|Immunologic Factors|immunologic factors|mesh-ancestor
110344430|NCT05827016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110344431|NCT05827016|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110344432|NCT05827016|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110344433|NCT05827016|Growth Substances|growth substances|mesh-ancestor
110344434|NCT05827016|Growth Inhibitors|growth inhibitors|mesh-ancestor
110344435|NCT05827016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110344436|NCT05822830|Tirzepatide|tirzepatide|mesh-list
110344437|NCT05822830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110344438|NCT05822830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110344439|NCT05822830|Incretins|incretins|mesh-ancestor
110344440|NCT05822830|Hormones|hormones|mesh-ancestor
110344441|NCT05822830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110344442|NCT05820347|Rocuronium|rocuronium|mesh-list
110344443|NCT05820347|Succinylcholine|succinylcholine|mesh-list
110344444|NCT05820347|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110344445|NCT05820347|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110344446|NCT05820347|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110344447|NCT05820347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110344448|NCT05820347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110344449|NCT05820347|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
110344451|NCT05819710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110344452|NCT05819710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110344453|NCT05819710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110344454|NCT05813327|Ifosfamide|ifosfamide|mesh-list
110344456|NCT05813327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110344457|NCT05813327|Alkylating Agents|alkylating agents|mesh-ancestor
110344458|NCT05813327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110344459|NCT05813327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110344460|NCT05813327|Protective Agents|protective agents|mesh-ancestor
110344461|NCT05813327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110344462|NCT05811403|Sodium Hypochlorite|sodium hypochlorite|mesh-list
110344464|NCT05811403|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
110344465|NCT05811403|Disinfectants|disinfectants|mesh-ancestor
110344466|NCT05811403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110344468|NCT05811403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110344469|NCT05811403|Protective Agents|protective agents|mesh-ancestor
110344470|NCT05811403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110344471|NCT05811403|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110344472|NCT05811403|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110344473|NCT05811403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110344474|NCT05811403|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110344476|NCT05807139|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110344477|NCT05807139|Hormone Antagonists|hormone antagonists|mesh-ancestor
110344478|NCT05807139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110344480|NCT05807139|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110344481|NCT05807139|Diuretics|diuretics|mesh-ancestor
110344482|NCT05807139|Natriuretic Agents|natriuretic agents|mesh-ancestor
110344483|NCT05805501|Pembrolizumab|pembrolizumab|mesh-list
110344484|NCT05805501|Axitinib|axitinib|mesh-list
110344485|NCT05805501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110344486|NCT05805501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110344487|NCT05805501|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110344488|NCT05805501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110344489|NCT05805501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110344490|NCT05805501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110344491|NCT05795153|Remibrutinib|remibrutinib|mesh-list
110344492|NCT05795153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110344493|NCT05795153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110344494|NCT05795153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110344495|NCT05789082|Pembrolizumab|pembrolizumab|mesh-list
110344496|NCT05789082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110344497|NCT05789082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110344498|NCT05789082|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110344499|NCT05789082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110344500|NCT05789043|Apatinib|apatinib|mesh-list
110344501|NCT05789043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110344502|NCT05789043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110344503|NCT05789043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110344504|NCT05789043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110344506|NCT05781035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110344507|NCT05781035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110344508|NCT05781035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110344509|NCT05781035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110344510|NCT05781035|Analgesics|analgesics|mesh-ancestor
110344511|NCT05781035|Sensory System Agents|sensory system agents|mesh-ancestor
110344512|NCT05781035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110344513|NCT05781035|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110344514|NCT05781035|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110344515|NCT05781035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110344516|NCT05781035|Adrenergic Agents|adrenergic agents|mesh-ancestor
110344517|NCT05781035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110344518|NCT05781035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110344520|NCT05780801|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110344521|NCT05780801|Protective Agents|protective agents|mesh-ancestor
110344522|NCT05780801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110344523|NCT05775289|Paclitaxel|paclitaxel|mesh-list
110344524|NCT05775289|Carboplatin|carboplatin|mesh-list
110344525|NCT05775289|Pembrolizumab|pembrolizumab|mesh-list
110344526|NCT05775289|Pemetrexed|pemetrexed|mesh-list
110173975|NCT00062023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110344527|NCT05775289|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110344529|NCT05775289|Tubulin Modulators|tubulin modulators|mesh-ancestor
110344530|NCT05775289|Antimitotic Agents|antimitotic agents|mesh-ancestor
110344531|NCT05775289|Mitosis Modulators|mitosis modulators|mesh-ancestor
110344532|NCT05775289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110344533|NCT05775289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110344534|NCT05775289|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110344535|NCT05775289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110344536|NCT05775289|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110344537|NCT05775289|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110344538|NCT05774951|Tamoxifen|tamoxifen|mesh-list
110344539|NCT05774951|Letrozole|letrozole|mesh-list
110344540|NCT05774951|Anastrozole|anastrozole|mesh-list
110344541|NCT05774951|Exemestane|exemestane|mesh-list
110344542|NCT05774951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110344543|NCT05774951|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110344544|NCT05774951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110344545|NCT05774951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110344546|NCT05774951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110344547|NCT05774951|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110344548|NCT05774951|Hormone Antagonists|hormone antagonists|mesh-ancestor
110344549|NCT05774951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110344550|NCT05774951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110344551|NCT05774951|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110344552|NCT05774951|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110344553|NCT05774951|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110344554|NCT05774951|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110344555|NCT05770544|Entrectinib|entrectinib|mesh-list
110344556|NCT05770544|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110344557|NCT05770544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110344558|NCT05770544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110344559|NCT05767346|Metoprolol|metoprolol|mesh-list
110344560|NCT05767346|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110344561|NCT05767346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110344562|NCT05767346|Sympatholytics|sympatholytics|mesh-ancestor
110344563|NCT05767346|Autonomic Agents|autonomic agents|mesh-ancestor
110344564|NCT05767346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110344565|NCT05767346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110344566|NCT05767346|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110344567|NCT05767346|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110344568|NCT05767346|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110344569|NCT05767346|Adrenergic Agents|adrenergic agents|mesh-ancestor
110344570|NCT05767346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110344571|NCT05767346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110344572|NCT05763771|Nicotine|nicotine|mesh-list
110344573|NCT05763771|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110344574|NCT05763771|Autonomic Agents|autonomic agents|mesh-ancestor
110344575|NCT05763771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110344576|NCT05763771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110344577|NCT05763771|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110344578|NCT05763771|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110344579|NCT05763771|Cholinergic Agents|cholinergic agents|mesh-ancestor
110344580|NCT05763771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110344581|NCT05763771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110344582|NCT05760313|Linaclotide|linaclotide|mesh-list
110344583|NCT05760313|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
110344584|NCT05760313|Enzyme Activators|enzyme activators|mesh-ancestor
110344585|NCT05760313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110344586|NCT05760313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110344588|NCT05756166|Interferon-alpha|interferon-alpha|mesh-list
110344589|NCT05756166|Interferon alpha-2|interferon alpha-2|mesh-list
110344590|NCT05756166|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
110344591|NCT05756166|Celecoxib|celecoxib|mesh-list
110344592|NCT05756166|Pembrolizumab|pembrolizumab|mesh-list
110344593|NCT05756166|Benzenesulfonamide|benzenesulfonamide|mesh-list
110344594|NCT05756166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110344595|NCT05756166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110344596|NCT05756166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110344597|NCT05756166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110344598|NCT05756166|Antiviral Agents|antiviral agents|mesh-ancestor
110344599|NCT05756166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110344600|NCT05756166|Immunologic Factors|immunologic factors|mesh-ancestor
110344601|NCT05756166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110344602|NCT05756166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110344603|NCT05756166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110344604|NCT05756166|Analgesics|analgesics|mesh-ancestor
110344605|NCT05756166|Sensory System Agents|sensory system agents|mesh-ancestor
110344606|NCT05756166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110344607|NCT05756166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110344608|NCT05756166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110344609|NCT05756166|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110344610|NCT05756166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110344611|NCT05756166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110344612|NCT05756166|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110344613|NCT05754710|Tofacitinib|tofacitinib|mesh-list
110344614|NCT05754710|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110344615|NCT05754710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110344616|NCT05754710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110344617|NCT05754710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110344619|NCT05737628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110344620|NCT05737628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110344621|NCT05737628|Immunologic Factors|immunologic factors|mesh-ancestor
110344622|NCT05737628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110344623|NCT05737628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110344625|NCT05731895|Nootropic Agents|nootropic agents|mesh-ancestor
110344626|NCT05730036|Dexamethasone|dexamethasone|mesh-list
110344627|NCT05730036|Pomalidomide|pomalidomide|mesh-list
110344628|NCT05730036|Elotuzumab|elotuzumab|mesh-list
110344629|NCT05730036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110344630|NCT05730036|Antiemetics|antiemetics|mesh-ancestor
110344631|NCT05730036|Autonomic Agents|autonomic agents|mesh-ancestor
110344632|NCT05730036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110344643|NCT05730036|Growth Substances|growth substances|mesh-ancestor
110344644|NCT05730036|Growth Inhibitors|growth inhibitors|mesh-ancestor
110173998|NCT00392340|Doxorubicin|doxorubicin|mesh-list
110344655|NCT05722704|Salicylic Acid|salicylic acid|mesh-list
110344656|NCT05722704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110344657|NCT05722704|Antifungal Agents|antifungal agents|mesh-ancestor
110344658|NCT05722704|Keratolytic Agents|keratolytic agents|mesh-ancestor
110344659|NCT05722704|Dermatologic Agents|dermatologic agents|mesh-ancestor
110344660|NCT05722327|Irinotecan|irinotecan|mesh-list
110344661|NCT05722327|Cetuximab|cetuximab|mesh-list
110344662|NCT05722327|Adagrasib|adagrasib|mesh-list
110344663|NCT05722327|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110344664|NCT05722327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110344665|NCT05722327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110344666|NCT05722327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110344667|NCT05722327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110029569|NCT04434196|Obinutuzumab|obinutuzumab|mesh-list
110344668|NCT05722327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110344669|NCT05722015|Paclitaxel|paclitaxel|mesh-list
110344670|NCT05722015|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110344671|NCT05722015|Carboplatin|carboplatin|mesh-list
110344672|NCT05722015|Pembrolizumab|pembrolizumab|mesh-list
110344673|NCT05722015|Pemetrexed|pemetrexed|mesh-list
110344674|NCT05722015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110344675|NCT05722015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110344676|NCT05722015|Tubulin Modulators|tubulin modulators|mesh-ancestor
110344677|NCT05722015|Antimitotic Agents|antimitotic agents|mesh-ancestor
110344678|NCT05722015|Mitosis Modulators|mitosis modulators|mesh-ancestor
110344679|NCT05722015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110344680|NCT05722015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110344681|NCT05722015|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110344682|NCT05722015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110344683|NCT05722015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110344684|NCT05722015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110344685|NCT05701215|Venetoclax|venetoclax|mesh-list
110344686|NCT05701215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110344687|NCT05700422|Varenicline|varenicline|mesh-list
110344688|NCT05700422|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110344689|NCT05700422|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110344690|NCT05700422|Cholinergic Agents|cholinergic agents|mesh-ancestor
110344691|NCT05700422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110344692|NCT05700422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110344693|NCT05700422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110344694|NCT05683691|Acetaminophen, aspirin, caffeine drug combination|acetaminophen, aspirin, caffeine drug combination|mesh-list
110344695|NCT05683691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110344696|NCT05683691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110344698|NCT05683691|Sensory System Agents|sensory system agents|mesh-ancestor
110344699|NCT05683691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110344700|NCT05683691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110344701|NCT05683691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110344702|NCT05683691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110344703|NCT05681377|Flumazenil|flumazenil|mesh-list
110344704|NCT05681377|Antidotes|antidotes|mesh-ancestor
110344705|NCT05681377|Protective Agents|protective agents|mesh-ancestor
110344706|NCT05681377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110344707|NCT05681377|GABA Modulators|gaba modulators|mesh-ancestor
110344708|NCT05681377|GABA Agents|gaba agents|mesh-ancestor
110344709|NCT05681377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110344710|NCT05681377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110344711|NCT05677451|Remibrutinib|remibrutinib|mesh-list
110344712|NCT05677451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110344713|NCT05677451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110344714|NCT05677451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110344715|NCT05671510|Docetaxel|docetaxel|mesh-list
110344716|NCT05671510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110344717|NCT05671510|Tubulin Modulators|tubulin modulators|mesh-ancestor
110344718|NCT05671510|Antimitotic Agents|antimitotic agents|mesh-ancestor
110344719|NCT05671510|Mitosis Modulators|mitosis modulators|mesh-ancestor
110344720|NCT05671510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110344721|NCT05661279|Anesthetics|anesthetics|mesh-list
110344722|NCT05661279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110344723|NCT05661279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110344725|NCT05660967|Immunologic Factors|immunologic factors|mesh-ancestor
110344726|NCT05660967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110344727|NCT05660967|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110344728|NCT05660967|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110344729|NCT05660967|Growth Substances|growth substances|mesh-ancestor
110344730|NCT05660967|Growth Inhibitors|growth inhibitors|mesh-ancestor
110344731|NCT05660967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110344733|NCT05660681|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110344734|NCT05660681|Protective Agents|protective agents|mesh-ancestor
110344735|NCT05660681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110344736|NCT05648110|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
110344737|NCT05648110|Antiviral Agents|antiviral agents|mesh-ancestor
110344738|NCT05648110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110344740|NCT05644665|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110344741|NCT05644665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110344742|NCT05644665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110344743|NCT05644665|Immunologic Factors|immunologic factors|mesh-ancestor
110344744|NCT05644665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110344745|NCT05642923|Thiamine|thiamine|mesh-list
110344746|NCT05642923|Vitamins|vitamins|mesh-ancestor
110344747|NCT05642923|Micronutrients|micronutrients|mesh-ancestor
110344748|NCT05642923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110344749|NCT05642923|Vitamin B Complex|vitamin b complex|mesh-ancestor
110344750|NCT05641363|Ketorolac|ketorolac|mesh-list
110344751|NCT05641363|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110344752|NCT05641363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110344753|NCT05641363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110344754|NCT05641363|Analgesics|analgesics|mesh-ancestor
110344755|NCT05641363|Sensory System Agents|sensory system agents|mesh-ancestor
110344756|NCT05641363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110344757|NCT05641363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110344758|NCT05641363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110344759|NCT05641363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110344760|NCT05641363|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110344761|NCT05641363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110344762|NCT05641363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110344763|NCT05629702|Temozolomide|temozolomide|mesh-list
110344764|NCT05629702|Nabiximols|nabiximols|mesh-list
110344765|NCT05629702|Dronabinol|dronabinol|mesh-list
110344766|NCT05629702|Cannabidiol|cannabidiol|mesh-list
110344767|NCT05629702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110344768|NCT05629702|Alkylating Agents|alkylating agents|mesh-ancestor
110344769|NCT05629702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110344770|NCT05629702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110344771|NCT05629702|Analgesics|analgesics|mesh-ancestor
110344772|NCT05629702|Sensory System Agents|sensory system agents|mesh-ancestor
110344773|NCT05629702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110344774|NCT05629702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110344775|NCT05629702|Anticonvulsants|anticonvulsants|mesh-ancestor
110344776|NCT05629702|Hallucinogens|hallucinogens|mesh-ancestor
110344777|NCT05629702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110344778|NCT05629702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110344779|NCT05629702|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110344780|NCT05629702|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110344781|NCT05629702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110344783|NCT05629702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110344784|NCT05625087|Fulvestrant|fulvestrant|mesh-list
110344785|NCT05625087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110344786|NCT05625087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110344787|NCT05625087|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110344788|NCT05625087|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110344789|NCT05625087|Hormone Antagonists|hormone antagonists|mesh-ancestor
110174013|NCT00062101|Celecoxib|celecoxib|mesh-list
110344798|NCT05595083|Sensory System Agents|sensory system agents|mesh-ancestor
110344799|NCT05595083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110344800|NCT05595083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110344801|NCT05595083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110344802|NCT05595083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110344803|NCT05595083|Adrenergic Agents|adrenergic agents|mesh-ancestor
110344804|NCT05595083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110344805|NCT05595083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110344806|NCT05594043|Pembrolizumab|pembrolizumab|mesh-list
110344807|NCT05594043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110344808|NCT05594043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110344809|NCT05594043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110344810|NCT05594043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110344814|NCT05566795|Antineoplastic Agents|antineoplastic agents|mesh-list
110344815|NCT05563155|Dexamethasone|dexamethasone|mesh-list
110344816|NCT05563155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110344817|NCT05563155|Antiemetics|antiemetics|mesh-ancestor
110344818|NCT05563155|Autonomic Agents|autonomic agents|mesh-ancestor
110344819|NCT05563155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110344820|NCT05563155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110344821|NCT05563155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110344822|NCT05563155|Glucocorticoids|glucocorticoids|mesh-ancestor
110344823|NCT05563155|Hormones|hormones|mesh-ancestor
110344824|NCT05563155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110344825|NCT05563155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110344826|NCT05563155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110344827|NCT05558098|Dapagliflozin|dapagliflozin|mesh-list
110344828|NCT05558098|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110344829|NCT05558098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110344830|NCT05558098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110344831|NCT05558098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110344832|NCT05556616|Lenalidomide|lenalidomide|mesh-list
110344833|NCT05556616|Pomalidomide|pomalidomide|mesh-list
110344834|NCT05556616|Bortezomib|bortezomib|mesh-list
110344835|NCT05556616|Daratumumab|daratumumab|mesh-list
110344836|NCT05556616|Immunologic Factors|immunologic factors|mesh-ancestor
110344837|NCT05556616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110344838|NCT05556616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110344839|NCT05556616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110344840|NCT05556616|Growth Substances|growth substances|mesh-ancestor
110344841|NCT05556616|Growth Inhibitors|growth inhibitors|mesh-ancestor
110344842|NCT05556616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110344843|NCT05556512|Tirzepatide|tirzepatide|mesh-list
110344844|NCT05556512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110344845|NCT05556512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110344846|NCT05556512|Incretins|incretins|mesh-ancestor
110344847|NCT05556512|Hormones|hormones|mesh-ancestor
110344848|NCT05556512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110344859|NCT05552859|Insulin|insulin|mesh-list
110344860|NCT05552859|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110344861|NCT05552859|Insulin Glargine|insulin glargine|mesh-list
110344862|NCT05552859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110344863|NCT05552859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110344864|NCT05552508|Benralizumab|benralizumab|mesh-list
110344865|NCT05552508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110344866|NCT05552508|Respiratory System Agents|respiratory system agents|mesh-ancestor
110344867|NCT05552001|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
110344868|NCT05552001|Immunoconjugates|immunoconjugates|mesh-ancestor
110344869|NCT05552001|Immunologic Factors|immunologic factors|mesh-ancestor
110344870|NCT05552001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110344871|NCT05541341|Tisagenlecleucel|tisagenlecleucel|mesh-list
110344872|NCT05541341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110344873|NCT05541341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110344874|NCT05526586|Ethanol|ethanol|mesh-list
110344875|NCT05526586|Listerine|listerine|mesh-list
110344876|NCT05526586|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
110344877|NCT05526586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110344878|NCT05526586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110344879|NCT05526586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110344880|NCT05519254|Lactoferrin|lactoferrin|mesh-list
110344881|NCT05519254|Muramidase|muramidase|mesh-list
110344882|NCT05519254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110344883|NCT05514444|Pembrolizumab|pembrolizumab|mesh-list
110344884|NCT05514444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110344885|NCT05514444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110344886|NCT05514444|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110344887|NCT05514444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110344888|NCT05514132|Durvalumab|durvalumab|mesh-list
110344889|NCT05514132|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110344890|NCT05514132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110344891|NCT05514132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110344892|NCT05514132|Immunologic Factors|immunologic factors|mesh-ancestor
110344893|NCT05514132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110344894|NCT05504291|Carboplatin|carboplatin|mesh-list
110344895|NCT05504291|Etoposide|etoposide|mesh-list
110344896|NCT05504291|Vincristine|vincristine|mesh-list
110344897|NCT05504291|Etoposide phosphate|etoposide phosphate|mesh-list
110344898|NCT05504291|Melphalan|melphalan|mesh-list
110344899|NCT05504291|Mechlorethamine|mechlorethamine|mesh-list
110344900|NCT05504291|Podophyllotoxin|podophyllotoxin|mesh-list
110344901|NCT05504291|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
110344902|NCT05504291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110344903|NCT05504291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110344904|NCT05504291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110344905|NCT05504291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110344906|NCT05504291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110344907|NCT05504291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110344908|NCT05504291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110344909|NCT05504291|Tubulin Modulators|tubulin modulators|mesh-ancestor
110344910|NCT05504291|Antimitotic Agents|antimitotic agents|mesh-ancestor
110344911|NCT05504291|Mitosis Modulators|mitosis modulators|mesh-ancestor
110344912|NCT05504291|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110344913|NCT05504291|Alkylating Agents|alkylating agents|mesh-ancestor
110344914|NCT05504291|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110344915|NCT05504291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110344916|NCT05504291|Immunologic Factors|immunologic factors|mesh-ancestor
110344917|NCT05504291|Keratolytic Agents|keratolytic agents|mesh-ancestor
110344918|NCT05504291|Dermatologic Agents|dermatologic agents|mesh-ancestor
110344919|NCT05497843|Chiauranib|chiauranib|mesh-list
110344920|NCT05497843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110344921|NCT05497843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110344922|NCT05497843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110344923|NCT05497843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110344924|NCT05488626|Immunomodulating Agents|immunomodulating agents|mesh-list
110344925|NCT05488626|Immunologic Factors|immunologic factors|mesh-ancestor
110344926|NCT05488626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110344928|NCT05485805|Caffeine|caffeine|mesh-list
110344929|NCT05485805|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110344930|NCT05485805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110344931|NCT05485805|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110344932|NCT05485805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110344933|NCT05485805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110344934|NCT05485805|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110344935|NCT05485805|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110344936|NCT05485805|Purinergic Agents|purinergic agents|mesh-ancestor
110344937|NCT05485805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110344938|NCT05485805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110344939|NCT05485805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110344940|NCT05485805|Analgesics|analgesics|mesh-ancestor
110344941|NCT05485805|Sensory System Agents|sensory system agents|mesh-ancestor
110344942|NCT05485805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110344943|NCT05485805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110344944|NCT05485805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110344945|NCT05485805|Gout Suppressants|gout suppressants|mesh-ancestor
110344946|NCT05485805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110344947|NCT05485155|Protease Inhibitors|protease inhibitors|mesh-list
110344948|NCT05485155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110344949|NCT05485155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110344950|NCT05481437|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110344951|NCT05481437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110344952|NCT05481437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110344953|NCT05481437|Immunotoxins|immunotoxins|mesh-ancestor
110344954|NCT05481437|Immunoconjugates|immunoconjugates|mesh-ancestor
110344955|NCT05481437|Immunologic Factors|immunologic factors|mesh-ancestor
110344956|NCT05481437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110344957|NCT05474846|Melatonin|melatonin|mesh-list
110344958|NCT05474846|Methylphenidate|methylphenidate|mesh-list
110344959|NCT05474846|Antioxidants|antioxidants|mesh-ancestor
110344960|NCT05474846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110344961|NCT05474846|Protective Agents|protective agents|mesh-ancestor
110344962|NCT05474846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110344963|NCT05474846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110344964|NCT05474846|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110344965|NCT05474846|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110344966|NCT05474846|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110344967|NCT05474846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110344968|NCT05474846|Dopamine Agents|dopamine agents|mesh-ancestor
110344969|NCT05474846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110344970|NCT05450692|Docetaxel|docetaxel|mesh-list
110344971|NCT05450692|Durvalumab|durvalumab|mesh-list
110344972|NCT05450692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110344974|NCT05450692|Antimitotic Agents|antimitotic agents|mesh-ancestor
110344975|NCT05450692|Mitosis Modulators|mitosis modulators|mesh-ancestor
110344976|NCT05450692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110344977|NCT05450692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110344978|NCT05429502|Temozolomide|temozolomide|mesh-list
110344979|NCT05429502|Topotecan|topotecan|mesh-list
110344980|NCT05429502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110344981|NCT05429502|Alkylating Agents|alkylating agents|mesh-ancestor
110344982|NCT05429502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110344983|NCT05429502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110344984|NCT05429502|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110344985|NCT05429502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110344986|NCT05429502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110344987|NCT05415215|Trastuzumab|trastuzumab|mesh-list
110344989|NCT05415215|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
110344990|NCT05415215|Maytansine|maytansine|mesh-list
110344991|NCT05415215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110344992|NCT05415215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110344993|NCT05415215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110345003|NCT05411718|Naproxen|naproxen|mesh-list
110345004|NCT05411718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110345005|NCT05411718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110345006|NCT05411718|Analgesics|analgesics|mesh-ancestor
110345007|NCT05411718|Sensory System Agents|sensory system agents|mesh-ancestor
110345008|NCT05411718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110345009|NCT05411718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110345010|NCT05411718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110345011|NCT05411718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110345012|NCT05411718|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110345013|NCT05411718|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110345014|NCT05411718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110345015|NCT05411718|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110345045|NCT05401565|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110345046|NCT05401565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110174039|NCT00062179|Celecoxib|celecoxib|mesh-list
110345047|NCT05401565|Natriuretic Agents|natriuretic agents|mesh-ancestor
110345048|NCT05401565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110345049|NCT05385432|Mycophenolic Acid|mycophenolic acid|mesh-list
110345050|NCT05385432|Tacrolimus|tacrolimus|mesh-list
110345051|NCT05385432|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110345052|NCT05385432|Basiliximab|basiliximab|mesh-list
110345053|NCT05385432|Immunosuppressive Agents|immunosuppressive agents|mesh-list
110345054|NCT05385432|Thymoglobulin|thymoglobulin|mesh-list
110345055|NCT05385432|Immunologic Factors|immunologic factors|mesh-ancestor
110345056|NCT05385432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110345057|NCT05385432|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110345058|NCT05385432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110345059|NCT05385432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110345060|NCT05385432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110345061|NCT05385432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110345062|NCT05385432|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110345063|NCT05385432|Antitubercular Agents|antitubercular agents|mesh-ancestor
110345064|NCT05385432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110345065|NCT05385432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110345066|NCT05383456|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110345067|NCT05383456|Antiviral Agents|antiviral agents|mesh-ancestor
110345068|NCT05383456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110345069|NCT05382325|Pembrolizumab|pembrolizumab|mesh-list
110345070|NCT05382325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110345071|NCT05382325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110345072|NCT05382325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110345073|NCT05382325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110345074|NCT05376579|Siponimod|siponimod|mesh-list
110345075|NCT05376579|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110345076|NCT05376579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110345077|NCT05376579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110345078|NCT05376579|Immunologic Factors|immunologic factors|mesh-ancestor
110345079|NCT05376579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110345081|NCT05374603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110345082|NCT05374603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110345084|NCT05374512|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110345085|NCT05374512|Carboplatin|carboplatin|mesh-list
110345086|NCT05374512|Capecitabine|capecitabine|mesh-list
110345087|NCT05374512|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110345088|NCT05374512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110345089|NCT05374512|Tubulin Modulators|tubulin modulators|mesh-ancestor
110345090|NCT05374512|Antimitotic Agents|antimitotic agents|mesh-ancestor
110345091|NCT05374512|Mitosis Modulators|mitosis modulators|mesh-ancestor
110345092|NCT05374512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110345093|NCT05374512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110345094|NCT05374512|Antimetabolites|antimetabolites|mesh-ancestor
110345095|NCT05366816|Sunitinib|sunitinib|mesh-list
110345096|NCT05366816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110345097|NCT05366816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110345098|NCT05366816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110345099|NCT05366816|Growth Substances|growth substances|mesh-ancestor
110345100|NCT05366816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110345101|NCT05366816|Growth Inhibitors|growth inhibitors|mesh-ancestor
110345102|NCT05366816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110345103|NCT05366816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110345104|NCT05366816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110345105|NCT05364424|Rituximab|rituximab|mesh-list
110345107|NCT05364424|Carboplatin|carboplatin|mesh-list
110345108|NCT05364424|Etoposide|etoposide|mesh-list
110345109|NCT05364424|Ifosfamide|ifosfamide|mesh-list
110345110|NCT05364424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110345111|NCT05364424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110345112|NCT05364424|Immunologic Factors|immunologic factors|mesh-ancestor
110345113|NCT05364424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110345114|NCT05364424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110345115|NCT05364424|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110345116|NCT05364424|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110345117|NCT05364424|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110345118|NCT05364424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110345119|NCT05364424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110345120|NCT05364424|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110345121|NCT05364424|Alkylating Agents|alkylating agents|mesh-ancestor
110345122|NCT05359237|Vincristine|vincristine|mesh-list
110345123|NCT05359237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110345124|NCT05359237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110345125|NCT05359237|Tubulin Modulators|tubulin modulators|mesh-ancestor
110345126|NCT05359237|Antimitotic Agents|antimitotic agents|mesh-ancestor
110345127|NCT05359237|Mitosis Modulators|mitosis modulators|mesh-ancestor
110345128|NCT05359237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110345129|NCT05345171|Prednisolone|prednisolone|mesh-list
110345130|NCT05345171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110345131|NCT05345171|Glucocorticoids|glucocorticoids|mesh-ancestor
110345132|NCT05345171|Hormones|hormones|mesh-ancestor
110345133|NCT05345171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110345134|NCT05345171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110345135|NCT05345171|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110345136|NCT05345171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110345137|NCT05320731|Lidocaine|lidocaine|mesh-list
110345138|NCT05320731|Anesthetics, Local|anesthetics, local|mesh-ancestor
110345140|NCT05320731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110345141|NCT05320731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110345142|NCT05320731|Sensory System Agents|sensory system agents|mesh-ancestor
110345143|NCT05320731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110345144|NCT05320731|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110345145|NCT05320731|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110345146|NCT05320731|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110345147|NCT05320731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110345148|NCT05320731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110345149|NCT05319730|Paclitaxel|paclitaxel|mesh-list
110345150|NCT05319730|Pembrolizumab|pembrolizumab|mesh-list
110345151|NCT05319730|Irinotecan|irinotecan|mesh-list
110345152|NCT05319730|Lenvatinib|lenvatinib|mesh-list
110345153|NCT05319730|Immunoglobulins|immunoglobulins|mesh-list
110345154|NCT05319730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110345155|NCT05319730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110345156|NCT05319730|Tubulin Modulators|tubulin modulators|mesh-ancestor
110345157|NCT05319730|Antimitotic Agents|antimitotic agents|mesh-ancestor
110345158|NCT05319730|Mitosis Modulators|mitosis modulators|mesh-ancestor
110345159|NCT05319730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110345160|NCT05319730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110345161|NCT05319730|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110345162|NCT05319730|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110345163|NCT05319730|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110345164|NCT05319730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110345165|NCT05319730|Immunologic Factors|immunologic factors|mesh-ancestor
110345166|NCT05319730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110345167|NCT05319730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110345168|NCT05304351|Vaccines|vaccines|mesh-list
110345169|NCT05304351|Adjuvants, Vaccine|adjuvants, vaccine|mesh-list
110345170|NCT05304351|Immunologic Factors|immunologic factors|mesh-ancestor
110345171|NCT05304351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110345172|NCT05304351|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110345173|NCT05304273|Letrozole|letrozole|mesh-list
110345174|NCT05304273|Misoprostol|misoprostol|mesh-list
110345175|NCT05304273|Mifepristone|mifepristone|mesh-list
110345176|NCT05304273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110345177|NCT05304273|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110345178|NCT05304273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110345179|NCT05304273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110345180|NCT05304273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110345181|NCT05304273|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110345182|NCT05304273|Hormone Antagonists|hormone antagonists|mesh-ancestor
110345183|NCT05304273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110345184|NCT05304273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110345185|NCT05304273|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110345186|NCT05304273|Abortifacient Agents|abortifacient agents|mesh-ancestor
110345187|NCT05304273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110345188|NCT05304273|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110345189|NCT05304273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110345191|NCT05304273|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110345192|NCT05304273|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110345193|NCT05304273|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110345194|NCT05304273|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110345195|NCT05304273|Contraceptive Agents|contraceptive agents|mesh-ancestor
110345196|NCT05304273|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110345197|NCT05304273|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110345198|NCT05304273|Luteolytic Agents|luteolytic agents|mesh-ancestor
110345199|NCT05304273|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110345200|NCT05304273|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110345201|NCT05303805|Sevoflurane|sevoflurane|mesh-list
110345202|NCT05303805|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110345203|NCT05303805|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110345204|NCT05303805|Anesthetics, General|anesthetics, general|mesh-ancestor
110345205|NCT05303805|Anesthetics|anesthetics|mesh-ancestor
110345206|NCT05303805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110345207|NCT05303805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110345209|NCT05302921|Ipilimumab|ipilimumab|mesh-list
110345210|NCT05302921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110345211|NCT05302921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110345212|NCT05302921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110345213|NCT05302921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110345214|NCT05296798|Paclitaxel|paclitaxel|mesh-list
110345215|NCT05296798|Docetaxel|docetaxel|mesh-list
110345216|NCT05296798|Trastuzumab|trastuzumab|mesh-list
110345217|NCT05296798|Pertuzumab|pertuzumab|mesh-list
110345218|NCT05296798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110345219|NCT05296798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110345220|NCT05296798|Tubulin Modulators|tubulin modulators|mesh-ancestor
110345221|NCT05296798|Antimitotic Agents|antimitotic agents|mesh-ancestor
110345222|NCT05296798|Mitosis Modulators|mitosis modulators|mesh-ancestor
110345223|NCT05296798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110345224|NCT05296798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110345225|NCT05296772|Pembrolizumab|pembrolizumab|mesh-list
110345226|NCT05296772|Antibodies|antibodies|mesh-list
110345227|NCT05296772|Immunoglobulins|immunoglobulins|mesh-list
110345228|NCT05296772|Immunologic Factors|immunologic factors|mesh-ancestor
110345229|NCT05296772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110345230|NCT05296772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110345231|NCT05296772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110345232|NCT05296772|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110345233|NCT05296772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110345234|NCT05288374|Celecoxib|celecoxib|mesh-list
110345235|NCT05288374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110345236|NCT05288374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110345237|NCT05288374|Analgesics|analgesics|mesh-ancestor
110345238|NCT05288374|Sensory System Agents|sensory system agents|mesh-ancestor
110345239|NCT05288374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110345240|NCT05288374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110345241|NCT05288374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110345242|NCT05288374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110345243|NCT05288374|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110345244|NCT05288374|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110345245|NCT05288374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110345246|NCT05288374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110345247|NCT05254002|Empagliflozin|empagliflozin|mesh-list
110345248|NCT05254002|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110345249|NCT05254002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110345250|NCT05254002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110345251|NCT05254002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110345252|NCT05245916|Rituximab|rituximab|mesh-list
110345253|NCT05245916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110345254|NCT05245916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110345255|NCT05245916|Immunologic Factors|immunologic factors|mesh-ancestor
110345256|NCT05245916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110345257|NCT05245916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110345258|NCT05243342|Daratumumab|daratumumab|mesh-list
110345259|NCT05243342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110345260|NCT05237947|Vaccines|vaccines|mesh-list
110345261|NCT05237947|Immunologic Factors|immunologic factors|mesh-ancestor
110345262|NCT05237947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110345263|NCT05232071|Empagliflozin|empagliflozin|mesh-list
110345264|NCT05232071|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110345265|NCT05232071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110345266|NCT05232071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110345267|NCT05232071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110345270|NCT05230368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110345271|NCT05230368|Antimetabolites|antimetabolites|mesh-ancestor
110345272|NCT05230368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110345273|NCT05230368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110345274|NCT05230368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110345275|NCT05230368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110345276|NCT05230368|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110345277|NCT05224102|Faricimab|faricimab|mesh-list
110345278|NCT05224102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110345279|NCT05224102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110345280|NCT05224102|Growth Substances|growth substances|mesh-ancestor
110345281|NCT05224102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110345282|NCT05224102|Growth Inhibitors|growth inhibitors|mesh-ancestor
110345283|NCT05224102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110345284|NCT05223478|Phentolamine|phentolamine|mesh-list
110345285|NCT05223478|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110345306|NCT05206084|Everolimus|everolimus|mesh-list
110345307|NCT05206084|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110345308|NCT05206084|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110345309|NCT05206084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110345310|NCT05206084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110345311|NCT05206084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110345312|NCT05206084|Immunologic Factors|immunologic factors|mesh-ancestor
110345313|NCT05206084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110345314|NCT05206084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110345315|NCT05206084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110345316|NCT05206084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110345317|NCT05206084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110345318|NCT05206084|Antifungal Agents|antifungal agents|mesh-ancestor
110345320|NCT05205499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110345321|NCT05205499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110345322|NCT05205499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110345323|NCT05205499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110345324|NCT05205499|Antifungal Agents|antifungal agents|mesh-ancestor
110345325|NCT05205499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110345326|NCT05205499|Immunologic Factors|immunologic factors|mesh-ancestor
110345327|NCT05205499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110345328|NCT05202262|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110345329|NCT05202262|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110345330|NCT05202262|Respiratory System Agents|respiratory system agents|mesh-ancestor
110345331|NCT05188222|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110345332|NCT05177510|Mifepristone|mifepristone|mesh-list
110345333|NCT05177510|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110345334|NCT05177510|Abortifacient Agents|abortifacient agents|mesh-ancestor
110345335|NCT05177510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110345336|NCT05177510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110345337|NCT05177510|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110345338|NCT05177510|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110345339|NCT05177510|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110345340|NCT05177510|Contraceptive Agents|contraceptive agents|mesh-ancestor
110345341|NCT05177510|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110345342|NCT05177510|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110345343|NCT05177510|Hormone Antagonists|hormone antagonists|mesh-ancestor
110345344|NCT05177510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110345345|NCT05177510|Luteolytic Agents|luteolytic agents|mesh-ancestor
110345346|NCT05177510|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110029649|NCT04090567|Olaparib|olaparib|mesh-list
110345347|NCT05177510|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110345348|NCT05173987|Paclitaxel|paclitaxel|mesh-list
110345349|NCT05173987|Docetaxel|docetaxel|mesh-list
110345350|NCT05173987|Carboplatin|carboplatin|mesh-list
110345351|NCT05173987|Pembrolizumab|pembrolizumab|mesh-list
110345352|NCT05173987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110345353|NCT05173987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110345354|NCT05173987|Tubulin Modulators|tubulin modulators|mesh-ancestor
110345355|NCT05173987|Antimitotic Agents|antimitotic agents|mesh-ancestor
110345356|NCT05173987|Mitosis Modulators|mitosis modulators|mesh-ancestor
110345357|NCT05173987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110345358|NCT05173987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110345359|NCT05173987|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110345360|NCT05171387|Androgens|androgens|mesh-list
110345361|NCT05171387|Hormones|hormones|mesh-ancestor
110345362|NCT05171387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110345363|NCT05171387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110345364|NCT05169515|Obinutuzumab|obinutuzumab|mesh-list
110174391|NCT00065923|Topiramate|topiramate|mesh-list
110345365|NCT05169515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110345366|NCT05169515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110345367|NCT05168475|Infliximab|infliximab|mesh-list
110345368|NCT05168475|Rituximab|rituximab|mesh-list
110345369|NCT05168475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110345370|NCT05168475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110345371|NCT05168475|Immunologic Factors|immunologic factors|mesh-ancestor
110345372|NCT05168475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110345373|NCT05168475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110345374|NCT05168475|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110345375|NCT05168475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110345376|NCT05168475|Dermatologic Agents|dermatologic agents|mesh-ancestor
110345377|NCT05168475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110345378|NCT05164861|Vitamins|vitamins|mesh-list
110345379|NCT05164861|Micronutrients|micronutrients|mesh-ancestor
110345380|NCT05164861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110345381|NCT05159453|Insulin|insulin|mesh-list
110345382|NCT05159453|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110345383|NCT05159453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110345384|NCT05159453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110345385|NCT05149287|Ceftriaxone|ceftriaxone|mesh-list
110345386|NCT05149287|Lidocaine|lidocaine|mesh-list
110345387|NCT05149287|Anesthetics, Local|anesthetics, local|mesh-ancestor
110345388|NCT05149287|Anesthetics|anesthetics|mesh-ancestor
110345389|NCT05149287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110345390|NCT05149287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110345391|NCT05149287|Sensory System Agents|sensory system agents|mesh-ancestor
110345392|NCT05149287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110345393|NCT05149287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110345394|NCT05149287|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110345395|NCT05149287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110345396|NCT05149287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110345397|NCT05149287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110345398|NCT05149287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110345399|NCT05149287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110345400|NCT05144854|Capecitabine|capecitabine|mesh-list
110345401|NCT05144854|Tegafur|tegafur|mesh-list
110345403|NCT05144854|Nivolumab|nivolumab|mesh-list
110345404|NCT05144854|Ipilimumab|ipilimumab|mesh-list
110345405|NCT05144854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110345406|NCT05144854|Antimetabolites|antimetabolites|mesh-ancestor
110345407|NCT05144854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110345408|NCT05144854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110345409|NCT05144854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110345410|NCT05144854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110345411|NCT05139017|Rituximab|rituximab|mesh-list
110345412|NCT05139017|Gemcitabine|gemcitabine|mesh-list
110345414|NCT05139017|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110345415|NCT05139017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110345416|NCT05139017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110345417|NCT05139017|Immunologic Factors|immunologic factors|mesh-ancestor
110345418|NCT05139017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110345419|NCT05139017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110345420|NCT05139017|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110345421|NCT05139017|Antimetabolites|antimetabolites|mesh-ancestor
110345422|NCT05139017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110345423|NCT05139017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110345424|NCT05139017|Alkylating Agents|alkylating agents|mesh-ancestor
110345425|NCT05137054|Lenalidomide|lenalidomide|mesh-list
110345426|NCT05137054|Pomalidomide|pomalidomide|mesh-list
110345427|NCT05137054|Bortezomib|bortezomib|mesh-list
110345428|NCT05137054|Daratumumab|daratumumab|mesh-list
110345429|NCT05137054|Cemiplimab|cemiplimab|mesh-list
110345430|NCT05137054|Nirogacestat|nirogacestat|mesh-list
110345431|NCT05137054|Immunologic Factors|immunologic factors|mesh-ancestor
110345432|NCT05137054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110345433|NCT05137054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110345434|NCT05137054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110345435|NCT05137054|Growth Substances|growth substances|mesh-ancestor
110345436|NCT05137054|Growth Inhibitors|growth inhibitors|mesh-ancestor
110345437|NCT05137054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110345438|NCT05137054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110345439|NCT05137054|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
110345440|NCT05137054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110345441|NCT05137054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110345442|NCT05136443|Loteprednol Etabonate|loteprednol etabonate|mesh-list
110345443|NCT05136443|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110345444|NCT05133297|Tofacitinib|tofacitinib|mesh-list
110345445|NCT05133297|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110345446|NCT05133297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110345447|NCT05133297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110345448|NCT05133297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110345449|NCT05121974|Azithromycin|azithromycin|mesh-list
110345450|NCT05121974|Ceftriaxone|ceftriaxone|mesh-list
110345451|NCT05121974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110345452|NCT05121974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110345453|NCT05117398|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110345455|NCT05117398|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110345456|NCT05117398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110345457|NCT05117398|Antitubercular Agents|antitubercular agents|mesh-ancestor
110345458|NCT05117242|Pembrolizumab|pembrolizumab|mesh-list
110345459|NCT05117242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110345460|NCT05117242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110345461|NCT05117242|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110345462|NCT05117242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110345463|NCT05110781|Atezolizumab|atezolizumab|mesh-list
110345464|NCT05110781|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110345465|NCT05110781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110345466|NCT05110781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110345467|NCT05110781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110345468|NCT05110781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110345469|NCT05110781|Immunologic Factors|immunologic factors|mesh-ancestor
110345470|NCT05110781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110345471|NCT05108428|Capecitabine|capecitabine|mesh-list
110345472|NCT05108428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110345473|NCT05108428|Antimetabolites|antimetabolites|mesh-ancestor
110345474|NCT05108428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110345475|NCT05108428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110345476|NCT05100134|Ceritinib|ceritinib|mesh-list
110345477|NCT05100134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110345478|NCT05100134|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110345479|NCT05100134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110345480|NCT05100134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110345481|NCT05084222|Budesonide|budesonide|mesh-list
110345482|NCT05084222|Albuterol|albuterol|mesh-list
110345483|NCT05084222|Formoterol Fumarate|formoterol fumarate|mesh-list
110345484|NCT05084222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110345485|NCT05084222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110345486|NCT05084222|Autonomic Agents|autonomic agents|mesh-ancestor
110345487|NCT05084222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110345488|NCT05084222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110345489|NCT05084222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110345490|NCT05084222|Respiratory System Agents|respiratory system agents|mesh-ancestor
110345491|NCT05084222|Glucocorticoids|glucocorticoids|mesh-ancestor
110345493|NCT05084222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110345494|NCT05084222|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110345495|NCT05084222|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110345496|NCT05084222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110345497|NCT05084222|Adrenergic Agents|adrenergic agents|mesh-ancestor
110345498|NCT05084222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110029680|NCT03965689|Pevonedistat|pevonedistat|mesh-list
110345499|NCT05084222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110345500|NCT05084222|Tocolytic Agents|tocolytic agents|mesh-ancestor
110345501|NCT05084222|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110345502|NCT05081180|Lenvatinib|lenvatinib|mesh-list
110345503|NCT05081180|Avelumab|avelumab|mesh-list
110174489|NCT00066508|Bortezomib|bortezomib|mesh-list
110345504|NCT05081180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110345505|NCT05081180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110345506|NCT05081180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110345507|NCT05081180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110345508|NCT05081180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110345509|NCT05080322|Fluticasone|fluticasone|mesh-list
110345510|NCT05080322|Xhance|xhance|mesh-list
110345511|NCT05080322|Azelastine|azelastine|mesh-list
110345512|NCT05080322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110345513|NCT05080322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110345514|NCT05080322|Autonomic Agents|autonomic agents|mesh-ancestor
110345515|NCT05080322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110345516|NCT05080322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110345517|NCT05080322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110345518|NCT05080322|Respiratory System Agents|respiratory system agents|mesh-ancestor
110345519|NCT05080322|Dermatologic Agents|dermatologic agents|mesh-ancestor
110345520|NCT05080322|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110345521|NCT05080322|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110345522|NCT05080322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110345523|NCT05080322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110345524|NCT05080322|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110345525|NCT05080322|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110345526|NCT05080322|Histamine Antagonists|histamine antagonists|mesh-ancestor
110345527|NCT05080322|Histamine Agents|histamine agents|mesh-ancestor
110345528|NCT05080322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110345529|NCT05076175|Ozanimod|ozanimod|mesh-list
110345530|NCT05076175|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110345531|NCT05076175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110345532|NCT05076175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110345533|NCT05076175|Immunologic Factors|immunologic factors|mesh-ancestor
110345534|NCT05076175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110345536|NCT05066308|Anticonvulsants|anticonvulsants|mesh-ancestor
110345537|NCT05065190|Nintedanib|nintedanib|mesh-list
110345538|NCT05065190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110345539|NCT05065190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110345540|NCT05065190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110345541|NCT05065190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110345542|NCT05056727|Valsartan|valsartan|mesh-list
110345543|NCT05056727|Lisinopril|lisinopril|mesh-list
110345544|NCT05056727|Irbesartan|irbesartan|mesh-list
110345545|NCT05056727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110345546|NCT05056727|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110345547|NCT05056727|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110345548|NCT05056727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110345549|NCT05056727|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110345550|NCT05056727|Protease Inhibitors|protease inhibitors|mesh-ancestor
110345551|NCT05056727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110345552|NCT05056727|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110345553|NCT05056727|Protective Agents|protective agents|mesh-ancestor
110345554|NCT05056727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110345555|NCT05044611|Amiloride|amiloride|mesh-list
110345556|NCT05044611|Diuretics|diuretics|mesh-ancestor
110345557|NCT05044611|Natriuretic Agents|natriuretic agents|mesh-ancestor
110345558|NCT05044611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110345559|NCT05044611|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
110345560|NCT05044611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110345561|NCT05044611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110174509|NCT00066859|Antidepressive Agents|antidepressive agents|mesh-ancestor
110345562|NCT05044611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110345563|NCT05044611|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
110345564|NCT05044611|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110345565|NCT05041907|Ritonavir|ritonavir|mesh-list
110345566|NCT05041907|Ivermectin|ivermectin|mesh-list
110345567|NCT05041907|Nitazoxanide|nitazoxanide|mesh-list
110345568|NCT05041907|Remdesivir|remdesivir|mesh-list
110345569|NCT05041907|Favipiravir|favipiravir|mesh-list
110345570|NCT05041907|Nirmatrelvir|nirmatrelvir|mesh-list
110345571|NCT05041907|Sotrovimab|sotrovimab|mesh-list
110345572|NCT05041907|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
110345573|NCT05041907|Molnupiravir|molnupiravir|mesh-list
110345574|NCT05041907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110345575|NCT05041907|Fluoxetine|fluoxetine|mesh-list
110345576|NCT05041907|Antibodies|antibodies|mesh-list
110345577|NCT05041907|Immunoglobulins|immunoglobulins|mesh-list
110345578|NCT05041907|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110345579|NCT05041907|Immunologic Factors|immunologic factors|mesh-ancestor
110345580|NCT05041907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110345581|NCT05041907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110345582|NCT05041907|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110345583|NCT05041907|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110345584|NCT05041907|Protease Inhibitors|protease inhibitors|mesh-ancestor
110345585|NCT05041907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110345586|NCT05041907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110345587|NCT05041907|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110345588|NCT05041907|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110345589|NCT05041907|Antiviral Agents|antiviral agents|mesh-ancestor
110345590|NCT05041907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110345591|NCT05041907|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110345592|NCT05041907|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110345593|NCT05041907|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110345594|NCT05041907|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110345595|NCT05041907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110345596|NCT05041907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110345598|NCT05041907|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110345599|NCT05041907|Antidepressive Agents|antidepressive agents|mesh-ancestor
110345600|NCT05041907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110345601|NCT05041907|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110345602|NCT05041907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110345603|NCT05041907|Antimetabolites|antimetabolites|mesh-ancestor
110345604|NCT05037929|Astegolimab|astegolimab|mesh-list
110345605|NCT05037929|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110345606|NCT05037929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110345607|NCT05037929|Antiviral Agents|antiviral agents|mesh-ancestor
110345608|NCT05037929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110345609|NCT05036278|Factor VIII|factor viii|mesh-list
110345610|NCT05036278|Coagulants|coagulants|mesh-ancestor
110345611|NCT05028569|Botulinum Toxins|botulinum toxins|mesh-list
110345612|NCT05028569|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110345613|NCT05028569|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110345614|NCT05028569|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110345615|NCT05028569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110345616|NCT05028569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110345617|NCT05028569|Cholinergic Agents|cholinergic agents|mesh-ancestor
110345618|NCT05028569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110345619|NCT05028569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110345620|NCT05028569|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110345621|NCT05028569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110345622|NCT05027048|Calcium|calcium|mesh-list
110345623|NCT05027048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110345624|NCT05027048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110345625|NCT05018585|Cholecalciferol|cholecalciferol|mesh-list
110345626|NCT05018585|Vitamin D|vitamin d|mesh-list
110345627|NCT05018585|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110345628|NCT05018585|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110345629|NCT05018585|Immunologic Factors|immunologic factors|mesh-ancestor
110345630|NCT05018585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110345631|NCT05018585|Antacids|antacids|mesh-ancestor
110345632|NCT05018585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110345633|NCT05018585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110345634|NCT05018585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110345636|NCT05018585|Micronutrients|micronutrients|mesh-ancestor
110345637|NCT05018585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110345638|NCT05017012|Paclitaxel|paclitaxel|mesh-list
110345639|NCT05017012|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110345640|NCT05017012|Carboplatin|carboplatin|mesh-list
110345641|NCT05017012|Pembrolizumab|pembrolizumab|mesh-list
110345642|NCT05017012|Pemetrexed|pemetrexed|mesh-list
110345643|NCT05017012|Axitinib|axitinib|mesh-list
110345644|NCT05017012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110345645|NCT05017012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110345646|NCT05017012|Tubulin Modulators|tubulin modulators|mesh-ancestor
110345647|NCT05017012|Antimitotic Agents|antimitotic agents|mesh-ancestor
110345648|NCT05017012|Mitosis Modulators|mitosis modulators|mesh-ancestor
110345649|NCT05017012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110345650|NCT05017012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110345651|NCT05017012|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110345652|NCT05017012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110345653|NCT05017012|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110345654|NCT05017012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110345656|NCT05014776|Pembrolizumab|pembrolizumab|mesh-list
110345657|NCT05014776|Ipilimumab|ipilimumab|mesh-list
110345658|NCT05014776|Tadalafil|tadalafil|mesh-list
110345659|NCT05014776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110345660|NCT05014776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110345661|NCT05014776|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110345662|NCT05014776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110345663|NCT05014776|Vasodilator Agents|vasodilator agents|mesh-ancestor
110345664|NCT05014776|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110345665|NCT05014776|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110345666|NCT05014776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110345667|NCT05014776|Urological Agents|urological agents|mesh-ancestor
110345668|NCT05013216|Poly ICLC|poly iclc|mesh-list
110345669|NCT05013216|Interferon Inducers|interferon inducers|mesh-ancestor
110345670|NCT05013216|Immunologic Factors|immunologic factors|mesh-ancestor
110345671|NCT05013216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110345672|NCT05007873|Decitabine|decitabine|mesh-list
110345674|NCT05007873|Dasatinib|dasatinib|mesh-list
110345675|NCT05007873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110345676|NCT05007873|Antimetabolites|antimetabolites|mesh-ancestor
110345677|NCT05007873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110345678|NCT05007873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110345679|NCT05007873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110345680|NCT05007873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110345681|NCT05005312|Ritonavir|ritonavir|mesh-list
110345682|NCT05005312|Nirmatrelvir|nirmatrelvir|mesh-list
110345683|NCT05005312|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110345684|NCT05005312|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110345685|NCT05005312|Protease Inhibitors|protease inhibitors|mesh-ancestor
110345686|NCT05005312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110345687|NCT05005312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110345688|NCT05005312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110345689|NCT05005312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110345690|NCT05005312|Antiviral Agents|antiviral agents|mesh-ancestor
110345691|NCT05005312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110345692|NCT05005312|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110345693|NCT05005312|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110345694|NCT05004519|Dexmedetomidine|dexmedetomidine|mesh-list
110345695|NCT05004519|Remifentanil|remifentanil|mesh-list
110345696|NCT05004519|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110345697|NCT05004519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110345698|NCT05004519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110345699|NCT05004519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110345701|NCT05004519|Sensory System Agents|sensory system agents|mesh-ancestor
110345702|NCT05004519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110345703|NCT05004519|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110345704|NCT05004519|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110345705|NCT05004519|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110345706|NCT05004519|Adrenergic Agents|adrenergic agents|mesh-ancestor
110345707|NCT05004519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110345708|NCT05004519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110345709|NCT05004519|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110345710|NCT05004519|Narcotics|narcotics|mesh-ancestor
110345711|NCT05001984|Alirocumab|alirocumab|mesh-list
110345712|NCT05001984|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110345713|NCT05001984|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110345714|NCT05001984|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110345715|NCT05001984|Antimetabolites|antimetabolites|mesh-ancestor
110345716|NCT05001984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110345717|NCT05001984|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110345718|NCT05001984|Protease Inhibitors|protease inhibitors|mesh-ancestor
110345719|NCT05001984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110345720|NCT05001984|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110345727|NCT04992312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110345728|NCT04992312|Hormones|hormones|mesh-ancestor
110345729|NCT04992312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110345730|NCT04992312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110345731|NCT04991493|Tramadol|tramadol|mesh-list
110345732|NCT04991493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110345733|NCT04991493|Narcotics|narcotics|mesh-ancestor
110345734|NCT04991493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110345735|NCT04991493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110345736|NCT04991493|Analgesics|analgesics|mesh-ancestor
110345737|NCT04991493|Sensory System Agents|sensory system agents|mesh-ancestor
110345738|NCT04991493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110345740|NCT04988945|Tremelimumab|tremelimumab|mesh-list
110345741|NCT04988945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110345742|NCT04988945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110345743|NCT04982614|Vaccines|vaccines|mesh-list
110345744|NCT04982614|Immunologic Factors|immunologic factors|mesh-ancestor
110345745|NCT04982614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110345746|NCT04962126|Atezolizumab|atezolizumab|mesh-list
110345747|NCT04962126|Obinutuzumab|obinutuzumab|mesh-list
110345748|NCT04962126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110345749|NCT04962126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110345750|NCT04962126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110345751|NCT04962126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110345752|NCT04962126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110345753|NCT04959175|Mycophenolic Acid|mycophenolic acid|mesh-list
110345754|NCT04959175|Sirolimus|sirolimus|mesh-list
110345755|NCT04959175|Cyclophosphamide|cyclophosphamide|mesh-list
110345756|NCT04959175|Fludarabine|fludarabine|mesh-list
110345757|NCT04959175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110345758|NCT04959175|Immunologic Factors|immunologic factors|mesh-ancestor
110345759|NCT04959175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110345760|NCT04959175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110345761|NCT04959175|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110345762|NCT04959175|Alkylating Agents|alkylating agents|mesh-ancestor
110345763|NCT04959175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110345764|NCT04959175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110345765|NCT04959175|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110345766|NCT04959175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110345767|NCT04959175|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110345768|NCT04959175|Antitubercular Agents|antitubercular agents|mesh-ancestor
110345769|NCT04959175|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110345770|NCT04959175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110345771|NCT04959175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110345772|NCT04959175|Antifungal Agents|antifungal agents|mesh-ancestor
110345773|NCT04956692|Paclitaxel|paclitaxel|mesh-list
110345774|NCT04956692|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110345775|NCT04956692|Carboplatin|carboplatin|mesh-list
110345776|NCT04956692|Pembrolizumab|pembrolizumab|mesh-list
110345778|NCT04956692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110345779|NCT04956692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110345780|NCT04956692|Tubulin Modulators|tubulin modulators|mesh-ancestor
110345781|NCT04956692|Antimitotic Agents|antimitotic agents|mesh-ancestor
110345782|NCT04956692|Mitosis Modulators|mitosis modulators|mesh-ancestor
110345783|NCT04956692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110345784|NCT04956692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110345785|NCT04956692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110345786|NCT04956692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110345787|NCT04956692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110345788|NCT04956692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110345789|NCT04950660|Caffeine|caffeine|mesh-list
110345798|NCT04950660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110345799|NCT04946305|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
110345800|NCT04946305|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110345801|NCT04946305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110345803|NCT04943588|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
110345804|NCT04943588|Immunologic Factors|immunologic factors|mesh-ancestor
110345805|NCT04943588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110345807|NCT04941898|BAX 855|bax 855|mesh-list
110345808|NCT04941898|Coagulants|coagulants|mesh-ancestor
110345819|NCT04915729|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110345820|NCT04915729|Tenecteplase|tenecteplase|mesh-list
110345821|NCT04915729|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110345822|NCT04915729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110345823|NCT04915729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110345824|NCT04910022|Temozolomide|temozolomide|mesh-list
110345825|NCT04910022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110345826|NCT04910022|Alkylating Agents|alkylating agents|mesh-ancestor
110345827|NCT04910022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110345828|NCT04910022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110345829|NCT04909801|Adalimumab|adalimumab|mesh-list
110345830|NCT04909801|Methotrexate|methotrexate|mesh-list
110345831|NCT04909801|Abatacept|abatacept|mesh-list
110345832|NCT04909801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110345833|NCT04909801|Abortifacient Agents|abortifacient agents|mesh-ancestor
110345834|NCT04909801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110345835|NCT04909801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110345836|NCT04909801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110345837|NCT04909801|Antimetabolites|antimetabolites|mesh-ancestor
110345838|NCT04909801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110345839|NCT04909801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110345840|NCT04909801|Dermatologic Agents|dermatologic agents|mesh-ancestor
110345841|NCT04909801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110345842|NCT04909801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110345843|NCT04909801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110345844|NCT04909801|Immunologic Factors|immunologic factors|mesh-ancestor
110345845|NCT04909801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110345846|NCT04909801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110345847|NCT04909801|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110345848|NCT04909801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110345849|NCT04909801|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110345850|NCT04909801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110345852|NCT04895358|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110345853|NCT04895358|Doxorubicin|doxorubicin|mesh-list
110345854|NCT04895358|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110345855|NCT04895358|Pembrolizumab|pembrolizumab|mesh-list
110345856|NCT04895358|Capecitabine|capecitabine|mesh-list
110345857|NCT04895358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110345858|NCT04895358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110345859|NCT04895358|Tubulin Modulators|tubulin modulators|mesh-ancestor
110345860|NCT04895358|Antimitotic Agents|antimitotic agents|mesh-ancestor
110345861|NCT04895358|Mitosis Modulators|mitosis modulators|mesh-ancestor
110345862|NCT04895358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110345863|NCT04895358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110345864|NCT04895358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110345865|NCT04895358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110345866|NCT04895358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110345867|NCT04895358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110345869|NCT04895358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110345870|NCT04895358|Antimetabolites|antimetabolites|mesh-ancestor
110345871|NCT04891809|Dexamethasone|dexamethasone|mesh-list
110345872|NCT04891809|Lenalidomide|lenalidomide|mesh-list
110345873|NCT04891809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110345874|NCT04891809|Antiemetics|antiemetics|mesh-ancestor
110345875|NCT04891809|Autonomic Agents|autonomic agents|mesh-ancestor
110345876|NCT04891809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110345877|NCT04891809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110345878|NCT04891809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110345879|NCT04891809|Glucocorticoids|glucocorticoids|mesh-ancestor
110345880|NCT04891809|Hormones|hormones|mesh-ancestor
110345881|NCT04891809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110345882|NCT04891809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110345883|NCT04891809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110345884|NCT04891809|Immunologic Factors|immunologic factors|mesh-ancestor
110345885|NCT04891809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110345886|NCT04891809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110345887|NCT04891809|Growth Substances|growth substances|mesh-ancestor
110174610|NCT05010707|Spironolactone|spironolactone|mesh-list
110345933|NCT04883528|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110345934|NCT04883528|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110345935|NCT04883528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110345937|NCT04879329|Disitamab vedotin|disitamab vedotin|mesh-list
110345938|NCT04879329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110345939|NCT04879329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110345940|NCT04879329|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110345941|NCT04879329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110345943|NCT04879329|Immunologic Factors|immunologic factors|mesh-ancestor
110174648|NCT00067951|Metformin|metformin|mesh-list
110345944|NCT04879329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110345945|NCT04870645|Chelating Agents|chelating agents|mesh-list
110345946|NCT04870645|Sequestering Agents|sequestering agents|mesh-ancestor
110345947|NCT04870645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110345948|NCT04862780|Osimertinib|osimertinib|mesh-list
110345949|NCT04862780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110345950|NCT04862780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110345951|NCT04862780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110345952|NCT04862780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110345953|NCT04853251|Ranibizumab|ranibizumab|mesh-list
110345954|NCT04853251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110345955|NCT04853251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110345956|NCT04853251|Growth Substances|growth substances|mesh-ancestor
110345957|NCT04853251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110345958|NCT04853251|Growth Inhibitors|growth inhibitors|mesh-ancestor
110345959|NCT04853251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110345960|NCT04852887|Tamoxifen|tamoxifen|mesh-list
110345961|NCT04852887|Letrozole|letrozole|mesh-list
110345962|NCT04852887|Exemestane|exemestane|mesh-list
110345963|NCT04852887|Anastrozole|anastrozole|mesh-list
110345964|NCT04852887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110345965|NCT04852887|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110345966|NCT04852887|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110345967|NCT04852887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110345968|NCT04852887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110345969|NCT04852887|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110345970|NCT04852887|Hormone Antagonists|hormone antagonists|mesh-ancestor
110345971|NCT04852887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110345972|NCT04852887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110345973|NCT04852887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110345974|NCT04852887|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110345975|NCT04852887|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110345976|NCT04852887|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110345977|NCT04851964|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110345978|NCT04851964|Immunologic Factors|immunologic factors|mesh-ancestor
110345979|NCT04851964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110345980|NCT04840615|Ipilimumab|ipilimumab|mesh-list
110345981|NCT04840615|LMB-100|lmb-100|mesh-list
110345982|NCT04840615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110345983|NCT04840615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110345984|NCT04840615|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110345985|NCT04840615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110345986|NCT04840615|Immunoconjugates|immunoconjugates|mesh-ancestor
110345987|NCT04840615|Immunologic Factors|immunologic factors|mesh-ancestor
110345988|NCT04840615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110345989|NCT04835805|Nivolumab|nivolumab|mesh-list
110345990|NCT04835805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110345991|NCT04835805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110345992|NCT04835805|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110345993|NCT04835805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110345994|NCT04828486|Pembrolizumab|pembrolizumab|mesh-list
110345995|NCT04828486|Futibatinib|futibatinib|mesh-list
110345996|NCT04828486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110345997|NCT04828486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110345998|NCT04828486|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110345999|NCT04828486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110346000|NCT04824911|Aspirin|aspirin|mesh-list
110346001|NCT04824911|Clopidogrel|clopidogrel|mesh-list
110346002|NCT04824911|Atorvastatin|atorvastatin|mesh-list
110346003|NCT04824911|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110346004|NCT04824911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110346005|NCT04824911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110346006|NCT04824911|Analgesics|analgesics|mesh-ancestor
110346007|NCT04824911|Sensory System Agents|sensory system agents|mesh-ancestor
110346008|NCT04824911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110346009|NCT04824911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110346010|NCT04824911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110346011|NCT04824911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110346012|NCT04824911|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110346013|NCT04824911|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110346014|NCT04824911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110346016|NCT04824911|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110346017|NCT04824911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110346018|NCT04824911|Antipyretics|antipyretics|mesh-ancestor
110346019|NCT04824911|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110346020|NCT04824911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110346021|NCT04824911|Antimetabolites|antimetabolites|mesh-ancestor
110346022|NCT04824911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110346023|NCT04824911|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110346024|NCT04824911|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110346025|NCT04824911|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110346026|NCT04824911|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110346027|NCT04824911|Purinergic Agents|purinergic agents|mesh-ancestor
110346028|NCT04824911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110346029|NCT04824794|Daratumumab|daratumumab|mesh-list
110346030|NCT04824794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110346032|NCT04824638|Immunologic Factors|immunologic factors|mesh-ancestor
110346033|NCT04824638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110346034|NCT04818489|Colchicine|colchicine|mesh-list
110346035|NCT04818489|Gout Suppressants|gout suppressants|mesh-ancestor
110346036|NCT04818489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110346037|NCT04818489|Tubulin Modulators|tubulin modulators|mesh-ancestor
110346038|NCT04818489|Antimitotic Agents|antimitotic agents|mesh-ancestor
110346039|NCT04818489|Mitosis Modulators|mitosis modulators|mesh-ancestor
110346040|NCT04818489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110346041|NCT04818489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110346042|NCT04803474|Hormones|hormones|mesh-list
110346043|NCT04803474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110346044|NCT04803474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110346045|NCT04790903|Prednisone|prednisone|mesh-list
110346046|NCT04790903|Cyclophosphamide|cyclophosphamide|mesh-list
110346047|NCT04790903|Rituximab|rituximab|mesh-list
110346048|NCT04790903|Doxorubicin|doxorubicin|mesh-list
110346049|NCT04790903|Venetoclax|venetoclax|mesh-list
110346050|NCT04790903|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
110346051|NCT04790903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110346052|NCT04790903|Immunologic Factors|immunologic factors|mesh-ancestor
110346053|NCT04790903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110346054|NCT04790903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110346055|NCT04790903|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110346056|NCT04790903|Alkylating Agents|alkylating agents|mesh-ancestor
110346057|NCT04790903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110346058|NCT04790903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110346059|NCT04790903|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110346060|NCT04790903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110346061|NCT04790903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110346062|NCT04790903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110346063|NCT04790903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110346064|NCT04790903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110346065|NCT04790903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110346066|NCT04790903|Glucocorticoids|glucocorticoids|mesh-ancestor
110346067|NCT04790903|Hormones|hormones|mesh-ancestor
110346068|NCT04790903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110346069|NCT04790903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110346071|NCT04789668|Atezolizumab|atezolizumab|mesh-list
110346072|NCT04789668|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110346073|NCT04789668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110346074|NCT04789668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110346075|NCT04789668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110346076|NCT04787744|Prednisone|prednisone|mesh-list
110346077|NCT04787744|Methylprednisolone|methylprednisolone|mesh-list
110346078|NCT04787744|Docetaxel|docetaxel|mesh-list
110346079|NCT04787744|Leuprolide|leuprolide|mesh-list
110346080|NCT04787744|Goserelin|goserelin|mesh-list
110346081|NCT04787744|Bicalutamide|bicalutamide|mesh-list
110346082|NCT04787744|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110346083|NCT04787744|Flutamide|flutamide|mesh-list
110346084|NCT04787744|Nilutamide|nilutamide|mesh-list
110346085|NCT04787744|Relugolix|relugolix|mesh-list
110346086|NCT04787744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110346087|NCT04787744|Tubulin Modulators|tubulin modulators|mesh-ancestor
110346088|NCT04787744|Antimitotic Agents|antimitotic agents|mesh-ancestor
110346089|NCT04787744|Mitosis Modulators|mitosis modulators|mesh-ancestor
110346090|NCT04787744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110346091|NCT04787744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110346092|NCT04787744|Glucocorticoids|glucocorticoids|mesh-ancestor
110346093|NCT04787744|Hormones|hormones|mesh-ancestor
110346094|NCT04787744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110346095|NCT04787744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110346096|NCT04787744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110346097|NCT04787744|Antiemetics|antiemetics|mesh-ancestor
110346098|NCT04787744|Autonomic Agents|autonomic agents|mesh-ancestor
110346099|NCT04787744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110346100|NCT04787744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110346101|NCT04787744|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110346102|NCT04787744|Protective Agents|protective agents|mesh-ancestor
110346103|NCT04787744|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110346104|NCT04787744|Fertility Agents|fertility agents|mesh-ancestor
110346105|NCT04787744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110346106|NCT04787744|Androgen Antagonists|androgen antagonists|mesh-ancestor
110346107|NCT04787744|Hormone Antagonists|hormone antagonists|mesh-ancestor
110346108|NCT04787744|Luteolytic Agents|luteolytic agents|mesh-ancestor
110346109|NCT04787744|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110346110|NCT04787744|Contraceptive Agents|contraceptive agents|mesh-ancestor
110346111|NCT04787744|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110346112|NCT04781387|REP 3123|rep 3123|mesh-list
110346113|NCT04781387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110346114|NCT04781387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110346136|NCT04763343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110346197|NCT04753879|Irinotecan|irinotecan|mesh-list
110346198|NCT04753879|Olaparib|olaparib|mesh-list
110346199|NCT04753879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110346200|NCT04753879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110346201|NCT04753879|Tubulin Modulators|tubulin modulators|mesh-ancestor
110346202|NCT04753879|Antimitotic Agents|antimitotic agents|mesh-ancestor
110346203|NCT04753879|Mitosis Modulators|mitosis modulators|mesh-ancestor
110346204|NCT04753879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110346205|NCT04753879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110346206|NCT04753879|Antimetabolites|antimetabolites|mesh-ancestor
110346207|NCT04753879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110346208|NCT04753879|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110346209|NCT04753879|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110346210|NCT04753879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110346211|NCT04753879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110346212|NCT04753879|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110346213|NCT04751812|Analgesics, Opioid|analgesics, opioid|mesh-list
110346214|NCT04751812|Narcotics|narcotics|mesh-ancestor
110346215|NCT04751812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110346216|NCT04751812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110346217|NCT04751812|Analgesics|analgesics|mesh-ancestor
110346218|NCT04751812|Sensory System Agents|sensory system agents|mesh-ancestor
110346219|NCT04751812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110346220|NCT04742634|Decitabine|decitabine|mesh-list
110346221|NCT04742634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110346222|NCT04742634|Antimetabolites|antimetabolites|mesh-ancestor
110346223|NCT04742634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110346224|NCT04742634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110346225|NCT04742634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110346226|NCT04738942|Vedolizumab|vedolizumab|mesh-list
110346227|NCT04738942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110346228|NCT04736966|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110346229|NCT04736966|Immunologic Factors|immunologic factors|mesh-ancestor
110346230|NCT04736966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110346231|NCT04731363|Erythritol|erythritol|mesh-list
110346232|NCT04731363|Vasodilator Agents|vasodilator agents|mesh-ancestor
110346233|NCT04713514|Pembrolizumab|pembrolizumab|mesh-list
110346234|NCT04713514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110346235|NCT04713514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110346236|NCT04713514|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110346237|NCT04713514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110346238|NCT04712097|Rituximab|rituximab|mesh-list
110346239|NCT04712097|Lenalidomide|lenalidomide|mesh-list
110346240|NCT04712097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110346241|NCT04712097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110346242|NCT04712097|Immunologic Factors|immunologic factors|mesh-ancestor
110346243|NCT04712097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110346245|NCT04712097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110346246|NCT04712097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110346247|NCT04712097|Growth Substances|growth substances|mesh-ancestor
110346248|NCT04712097|Growth Inhibitors|growth inhibitors|mesh-ancestor
110346249|NCT04700124|Cisplatin|cisplatin|mesh-list
110346250|NCT04700124|Gemcitabine|gemcitabine|mesh-list
110346251|NCT04700124|Pembrolizumab|pembrolizumab|mesh-list
110346252|NCT04700124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110346253|NCT04700124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110346254|NCT04700124|Antimetabolites|antimetabolites|mesh-ancestor
110346255|NCT04700124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110346256|NCT04700124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110346257|NCT04700124|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110346258|NCT04700072|Pembrolizumab|pembrolizumab|mesh-list
110346259|NCT04700072|Lenvatinib|lenvatinib|mesh-list
110346260|NCT04700072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110346261|NCT04700072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110346262|NCT04700072|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110346263|NCT04700072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110346264|NCT04700072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110346265|NCT04700072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110346266|NCT04675827|Trastuzumab|trastuzumab|mesh-list
110346267|NCT04675827|Pertuzumab|pertuzumab|mesh-list
110346268|NCT04675827|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
110346269|NCT04675827|Maytansine|maytansine|mesh-list
110346270|NCT04675827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110174853|NCT00070213|Leucovorin|leucovorin|mesh-list
110346271|NCT04675827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110346272|NCT04675827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110346273|NCT04675827|Tubulin Modulators|tubulin modulators|mesh-ancestor
110346274|NCT04675827|Antimitotic Agents|antimitotic agents|mesh-ancestor
110346275|NCT04675827|Mitosis Modulators|mitosis modulators|mesh-ancestor
110346276|NCT04675827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110346278|NCT04675827|Immunoconjugates|immunoconjugates|mesh-ancestor
110346279|NCT04675827|Immunologic Factors|immunologic factors|mesh-ancestor
110346280|NCT04675827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110346281|NCT04658147|Nivolumab|nivolumab|mesh-list
110346282|NCT04658147|Relatlimab|relatlimab|mesh-list
110346283|NCT04658147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110346284|NCT04658147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110346285|NCT04658147|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110346286|NCT04658147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110346287|NCT04657081|Decitabine|decitabine|mesh-list
110346288|NCT04657081|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
110346289|NCT04657081|Venetoclax|venetoclax|mesh-list
110346290|NCT04657081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110346291|NCT04657081|Antimetabolites|antimetabolites|mesh-ancestor
110346292|NCT04657081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110346293|NCT04657081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110346294|NCT04657081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110346295|NCT04639986|Gemcitabine|gemcitabine|mesh-list
110346296|NCT04639986|Capecitabine|capecitabine|mesh-list
110346297|NCT04639986|Vinorelbine|vinorelbine|mesh-list
110346298|NCT04639986|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
110346299|NCT04639986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110346300|NCT04639986|Antimetabolites|antimetabolites|mesh-ancestor
110346301|NCT04639986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110346302|NCT04639986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110346303|NCT04639986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110346304|NCT04639986|Tubulin Modulators|tubulin modulators|mesh-ancestor
110346305|NCT04639986|Antimitotic Agents|antimitotic agents|mesh-ancestor
110346306|NCT04639986|Mitosis Modulators|mitosis modulators|mesh-ancestor
110346307|NCT04639986|Immunoconjugates|immunoconjugates|mesh-ancestor
110346308|NCT04639986|Immunologic Factors|immunologic factors|mesh-ancestor
110346309|NCT04639986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110346310|NCT04623944|Cytarabine|cytarabine|mesh-list
110346311|NCT04623944|Cyclophosphamide|cyclophosphamide|mesh-list
110346312|NCT04623944|Fludarabine|fludarabine|mesh-list
110346313|NCT04623944|Decitabine|decitabine|mesh-list
110346314|NCT04623944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110346315|NCT04623944|Immunologic Factors|immunologic factors|mesh-ancestor
110346316|NCT04623944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110346317|NCT04623944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110346318|NCT04623944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110346319|NCT04623944|Alkylating Agents|alkylating agents|mesh-ancestor
110346320|NCT04623944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110346321|NCT04623944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110346322|NCT04623944|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110346323|NCT04623944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110346324|NCT04623944|Antimetabolites|antimetabolites|mesh-ancestor
110346325|NCT04623944|Antiviral Agents|antiviral agents|mesh-ancestor
110346326|NCT04623944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110346327|NCT04623944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110346328|NCT04622319|Trastuzumab|trastuzumab|mesh-list
110346329|NCT04622319|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
110346330|NCT04622319|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
110346331|NCT04622319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110346332|NCT04622319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110346333|NCT04622319|Tubulin Modulators|tubulin modulators|mesh-ancestor
110346334|NCT04622319|Antimitotic Agents|antimitotic agents|mesh-ancestor
110346335|NCT04622319|Mitosis Modulators|mitosis modulators|mesh-ancestor
110346336|NCT04622319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110346337|NCT04622319|Immunotoxins|immunotoxins|mesh-ancestor
110346338|NCT04622319|Immunoconjugates|immunoconjugates|mesh-ancestor
110174874|NCT00070252|Tipifarnib|tipifarnib|mesh-list
110346381|NCT04590937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110346382|NCT04590937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110346383|NCT04590937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110346384|NCT04590937|Antimetabolites|antimetabolites|mesh-ancestor
110346385|NCT04590937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110346386|NCT04590937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110346387|NCT04590937|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110346388|NCT04590937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110346389|NCT04590937|Diuretics|diuretics|mesh-ancestor
110346390|NCT04590937|Natriuretic Agents|natriuretic agents|mesh-ancestor
110346391|NCT04590937|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110346392|NCT04590937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110346393|NCT04590937|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110346394|NCT04590937|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110346395|NCT04590937|Protective Agents|protective agents|mesh-ancestor
110346396|NCT04576156|Imetelstat|imetelstat|mesh-list
110346397|NCT04576156|Motesanib diphosphate|motesanib diphosphate|mesh-list
110346398|NCT04576156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110346399|NCT04576156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110346400|NCT04576156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110346401|NCT04563923|Avdoralimab|avdoralimab|mesh-list
110346402|NCT04563923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110346403|NCT04563923|Antiviral Agents|antiviral agents|mesh-ancestor
110346404|NCT04563923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110346405|NCT04562558|Leucovorin|leucovorin|mesh-list
110346406|NCT04562558|Dactinomycin|dactinomycin|mesh-list
110346407|NCT04562558|Methotrexate|methotrexate|mesh-list
110346408|NCT04562558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110346409|NCT04562558|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110346410|NCT04562558|Abortifacient Agents|abortifacient agents|mesh-ancestor
110346411|NCT04562558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110346412|NCT04562558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110346413|NCT04562558|Antimetabolites|antimetabolites|mesh-ancestor
110346414|NCT04562558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110346415|NCT04562558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110346416|NCT04562558|Dermatologic Agents|dermatologic agents|mesh-ancestor
110346417|NCT04562558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110346418|NCT04562558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110346419|NCT04562558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110346420|NCT04562558|Immunologic Factors|immunologic factors|mesh-ancestor
110346421|NCT04562558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110174918|NCT00070486|Celecoxib|celecoxib|mesh-list
110346422|NCT04562558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110346423|NCT04562558|Antidotes|antidotes|mesh-ancestor
110346424|NCT04562558|Protective Agents|protective agents|mesh-ancestor
110346425|NCT04562558|Vitamin B Complex|vitamin b complex|mesh-ancestor
110346426|NCT04562558|Vitamins|vitamins|mesh-ancestor
110346427|NCT04562558|Micronutrients|micronutrients|mesh-ancestor
110346428|NCT04562558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110346429|NCT04562558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110346430|NCT04562558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110346431|NCT04562558|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110346432|NCT04560673|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110346433|NCT04560673|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110346434|NCT04560673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110346435|NCT04560673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110346436|NCT04560673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110346437|NCT04560673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110346438|NCT04560673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110346439|NCT04560673|Analgesics|analgesics|mesh-ancestor
110346440|NCT04560673|Sensory System Agents|sensory system agents|mesh-ancestor
110346441|NCT04560673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110346442|NCT04560673|Antidepressive Agents|antidepressive agents|mesh-ancestor
110346443|NCT04560673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110346444|NCT04560673|Dopamine Agents|dopamine agents|mesh-ancestor
110346445|NCT04555837|Pembrolizumab|pembrolizumab|mesh-list
110346446|NCT04555837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110346447|NCT04555837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110346448|NCT04555837|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110029940|NCT02678377|Cholinergic Agents|cholinergic agents|mesh-ancestor
110346449|NCT04555837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110346451|NCT04538742|Trastuzumab|trastuzumab|mesh-list
110346452|NCT04538742|Durvalumab|durvalumab|mesh-list
110346453|NCT04538742|Pertuzumab|pertuzumab|mesh-list
110346454|NCT04538742|Tucatinib|tucatinib|mesh-list
110346455|NCT04538742|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
110346456|NCT04538742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110346457|NCT04538742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110346458|NCT04538742|Tubulin Modulators|tubulin modulators|mesh-ancestor
110346459|NCT04538742|Antimitotic Agents|antimitotic agents|mesh-ancestor
110346460|NCT04538742|Mitosis Modulators|mitosis modulators|mesh-ancestor
110346461|NCT04538742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110346462|NCT04538742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110346463|NCT04538742|Immunoconjugates|immunoconjugates|mesh-ancestor
110346464|NCT04538742|Immunologic Factors|immunologic factors|mesh-ancestor
110346465|NCT04538742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110346466|NCT04538742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110346467|NCT04538742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110346468|NCT04530409|Dexamethasone|dexamethasone|mesh-list
110346469|NCT04530409|Methylprednisolone|methylprednisolone|mesh-list
110346470|NCT04530409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110346471|NCT04530409|Antiemetics|antiemetics|mesh-ancestor
110346472|NCT04530409|Autonomic Agents|autonomic agents|mesh-ancestor
110346473|NCT04530409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110346474|NCT04530409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110346475|NCT04530409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110346476|NCT04530409|Glucocorticoids|glucocorticoids|mesh-ancestor
110346477|NCT04530409|Hormones|hormones|mesh-ancestor
110346478|NCT04530409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110346479|NCT04530409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110346480|NCT04530409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110346481|NCT04530409|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110346482|NCT04530409|Protective Agents|protective agents|mesh-ancestor
110346483|NCT04528329|Dexamethasone|dexamethasone|mesh-list
110346484|NCT04528329|Dexamethasone acetate|dexamethasone acetate|mesh-list
110346485|NCT04528329|BB 1101|bb 1101|mesh-list
110346486|NCT04528329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110346487|NCT04528329|Antiemetics|antiemetics|mesh-ancestor
110346488|NCT04528329|Autonomic Agents|autonomic agents|mesh-ancestor
110346489|NCT04528329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110346490|NCT04528329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110346491|NCT04528329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110346492|NCT04528329|Glucocorticoids|glucocorticoids|mesh-ancestor
110346493|NCT04528329|Hormones|hormones|mesh-ancestor
110346494|NCT04528329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110346495|NCT04528329|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110346496|NCT04528329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110346497|NCT04528329|Protease Inhibitors|protease inhibitors|mesh-ancestor
110346498|NCT04528329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110346499|NCT04528329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110346500|NCT04527380|Adalimumab|adalimumab|mesh-list
110346501|NCT04527380|Ixekizumab|ixekizumab|mesh-list
110346502|NCT04527380|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110346503|NCT04527380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110346504|NCT04527380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110346505|NCT04527380|Dermatologic Agents|dermatologic agents|mesh-ancestor
110346507|NCT04526288|Daunorubicin|daunorubicin|mesh-list
110346508|NCT04526288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110346509|NCT04526288|Antimetabolites|antimetabolites|mesh-ancestor
110346510|NCT04526288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110346511|NCT04526288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110346512|NCT04526288|Antiviral Agents|antiviral agents|mesh-ancestor
110346513|NCT04526288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110346514|NCT04526288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110346515|NCT04526288|Immunologic Factors|immunologic factors|mesh-ancestor
110346516|NCT04526288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110346517|NCT04526288|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110346518|NCT04526288|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110346519|NCT04526288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110346520|NCT04526288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110346521|NCT04524689|Carboplatin|carboplatin|mesh-list
110346522|NCT04524689|Pembrolizumab|pembrolizumab|mesh-list
110346524|NCT04524689|Maytansine|maytansine|mesh-list
110346525|NCT04524689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110346526|NCT04524689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110346527|NCT04524689|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110346528|NCT04524689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110346529|NCT04524689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110346530|NCT04524689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110346531|NCT04524689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110346532|NCT04524689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110346533|NCT04524689|Tubulin Modulators|tubulin modulators|mesh-ancestor
110346534|NCT04524689|Antimitotic Agents|antimitotic agents|mesh-ancestor
110346535|NCT04524689|Mitosis Modulators|mitosis modulators|mesh-ancestor
110346536|NCT04524000|Fulvestrant|fulvestrant|mesh-list
110346537|NCT04524000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110346538|NCT04524000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110346539|NCT04524000|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110174977|NCT00071266|Niacin|niacin|mesh-list
110346540|NCT04524000|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110346541|NCT04524000|Hormone Antagonists|hormone antagonists|mesh-ancestor
110346542|NCT04524000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110346543|NCT04524000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110346544|NCT04523818|Fluorouracil|fluorouracil|mesh-list
110346545|NCT04523818|Capecitabine|capecitabine|mesh-list
110346546|NCT04523818|Antimetabolites|antimetabolites|mesh-ancestor
110346547|NCT04523818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110346548|NCT04523818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110346549|NCT04523818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110346550|NCT04523818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110346551|NCT04523818|Immunologic Factors|immunologic factors|mesh-ancestor
110346552|NCT04523818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110346553|NCT04495608|Fluconazole|fluconazole|mesh-list
110346554|NCT04495608|Antifungal Agents|antifungal agents|mesh-ancestor
110346555|NCT04495608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110346556|NCT04495608|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110346557|NCT04495608|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110346558|NCT04495608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110346559|NCT04495608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110346560|NCT04495608|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110346561|NCT04495608|Hormone Antagonists|hormone antagonists|mesh-ancestor
110346562|NCT04495608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110346564|NCT04495608|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110346565|NCT04495608|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110346566|NCT04478838|Olanzapine|olanzapine|mesh-list
110346567|NCT04478838|Risperidone|risperidone|mesh-list
110346568|NCT04478838|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110346569|NCT04478838|Serotonin Agents|serotonin agents|mesh-ancestor
110346570|NCT04478838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110346571|NCT04478838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110346572|NCT04478838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110346573|NCT04478838|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110346574|NCT04478838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110346575|NCT04478838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110346576|NCT04478838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110346577|NCT04478838|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110346578|NCT04478838|Dopamine Agents|dopamine agents|mesh-ancestor
110346579|NCT04478838|Antiemetics|antiemetics|mesh-ancestor
110174987|NCT00071266|Vitamins|vitamins|mesh-ancestor
110346581|NCT04478838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110346582|NCT04478838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110346583|NCT04478838|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110346584|NCT04478838|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110346585|NCT04478838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110346586|NCT04478292|Sodium thiosulfate|sodium thiosulfate|mesh-list
110346587|NCT04478292|Cisplatin|cisplatin|mesh-list
110346588|NCT04478292|Carboplatin|carboplatin|mesh-list
110346589|NCT04478292|Doxorubicin|doxorubicin|mesh-list
110346590|NCT04478292|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110346591|NCT04478292|Fluorouracil|fluorouracil|mesh-list
110346592|NCT04478292|Irinotecan|irinotecan|mesh-list
110346593|NCT04478292|Vincristine|vincristine|mesh-list
110346594|NCT04478292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110346595|NCT04478292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110346596|NCT04478292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110346597|NCT04478292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110346598|NCT04478292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110346599|NCT04478292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110346600|NCT04478292|Antimetabolites|antimetabolites|mesh-ancestor
110346601|NCT04478292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110346602|NCT04478292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110346603|NCT04478292|Immunologic Factors|immunologic factors|mesh-ancestor
110346604|NCT04478292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110346605|NCT04478292|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110346606|NCT04478292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110346607|NCT04478292|Tubulin Modulators|tubulin modulators|mesh-ancestor
110346608|NCT04478292|Antimitotic Agents|antimitotic agents|mesh-ancestor
110346609|NCT04478292|Mitosis Modulators|mitosis modulators|mesh-ancestor
110346610|NCT04478292|Antidotes|antidotes|mesh-ancestor
110346611|NCT04478292|Protective Agents|protective agents|mesh-ancestor
110346612|NCT04478292|Antioxidants|antioxidants|mesh-ancestor
110346613|NCT04478292|Antitubercular Agents|antitubercular agents|mesh-ancestor
110346614|NCT04478292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110346616|NCT04478292|Chelating Agents|chelating agents|mesh-ancestor
110346617|NCT04478292|Sequestering Agents|sequestering agents|mesh-ancestor
110346618|NCT04446416|Bevacizumab|bevacizumab|mesh-list
110346619|NCT04446416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110346620|NCT04446416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110346621|NCT04446416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110346622|NCT04446416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110346623|NCT04446416|Growth Substances|growth substances|mesh-ancestor
110346624|NCT04446416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110346625|NCT04446416|Growth Inhibitors|growth inhibitors|mesh-ancestor
110346626|NCT04432584|Eculizumab|eculizumab|mesh-list
110346627|NCT04432584|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110346628|NCT04432584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110346629|NCT04432584|Immunologic Factors|immunologic factors|mesh-ancestor
110346630|NCT04432584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110346631|NCT04428866|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110346632|NCT04428866|Glucagon|glucagon|mesh-list
110346633|NCT04428866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110346634|NCT04428866|Hormones|hormones|mesh-ancestor
110346635|NCT04428866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110346636|NCT04428866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110346637|NCT04421378|Bevacizumab|bevacizumab|mesh-list
110346638|NCT04421378|Temozolomide|temozolomide|mesh-list
110346639|NCT04421378|Carmustine|carmustine|mesh-list
110346640|NCT04421378|Lomustine|lomustine|mesh-list
110346641|NCT04421378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110346642|NCT04421378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110346643|NCT04421378|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110346644|NCT04421378|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110346645|NCT04421378|Growth Substances|growth substances|mesh-ancestor
110346646|NCT04421378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110346647|NCT04421378|Growth Inhibitors|growth inhibitors|mesh-ancestor
110346648|NCT04421378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110346649|NCT04421378|Alkylating Agents|alkylating agents|mesh-ancestor
110346650|NCT04421378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110346651|NCT04409600|Botulinum Toxins|botulinum toxins|mesh-list
110346652|NCT04409600|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110346653|NCT04409600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110346654|NCT04409600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110346655|NCT04409600|Cholinergic Agents|cholinergic agents|mesh-ancestor
110346656|NCT04409600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110346657|NCT04409600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110346658|NCT04408638|Gemcitabine|gemcitabine|mesh-list
110346659|NCT04408638|Oxaliplatin|oxaliplatin|mesh-list
110346660|NCT04408638|Obinutuzumab|obinutuzumab|mesh-list
110175057|NCT00390065|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110346661|NCT04408638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110346662|NCT04408638|Antimetabolites|antimetabolites|mesh-ancestor
110346663|NCT04408638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110346664|NCT04408638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110346665|NCT04408638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110346666|NCT04401761|Aspirin|aspirin|mesh-list
110346667|NCT04401761|Rivaroxaban|rivaroxaban|mesh-list
110346668|NCT04401761|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110346669|NCT04401761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110346670|NCT04401761|Analgesics|analgesics|mesh-ancestor
110346671|NCT04401761|Sensory System Agents|sensory system agents|mesh-ancestor
110346672|NCT04401761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110346673|NCT04401761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110346674|NCT04401761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110346675|NCT04401761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110346676|NCT04401761|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110346677|NCT04401761|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110346678|NCT04401761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110346679|NCT04401761|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110346680|NCT04401761|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110346681|NCT04401761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110346682|NCT04401761|Antipyretics|antipyretics|mesh-ancestor
110346683|NCT04401761|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110346684|NCT04401761|Antithrombins|antithrombins|mesh-ancestor
110346685|NCT04401761|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110346686|NCT04401761|Protease Inhibitors|protease inhibitors|mesh-ancestor
110346687|NCT04401761|Anticoagulants|anticoagulants|mesh-ancestor
110346688|NCT04385277|Vitamin A|vitamin a|mesh-list
110346689|NCT04385277|Irinotecan|irinotecan|mesh-list
110346690|NCT04385277|Temozolomide|temozolomide|mesh-list
110346691|NCT04385277|Tretinoin|tretinoin|mesh-list
110346692|NCT04385277|Dinutuximab|dinutuximab|mesh-list
110346693|NCT04385277|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
110346694|NCT04385277|Isotretinoin|isotretinoin|mesh-list
110346695|NCT04385277|Sargramostim|sargramostim|mesh-list
110346696|NCT04385277|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110346698|NCT04385277|Micronutrients|micronutrients|mesh-ancestor
110346699|NCT04385277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110346700|NCT04385277|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110346701|NCT04385277|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110346702|NCT04385277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110346703|NCT04385277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110346704|NCT04385277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110346705|NCT04385277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110346706|NCT04385277|Alkylating Agents|alkylating agents|mesh-ancestor
110346707|NCT04385277|Immunologic Factors|immunologic factors|mesh-ancestor
110346708|NCT04385277|Keratolytic Agents|keratolytic agents|mesh-ancestor
110346709|NCT04385277|Dermatologic Agents|dermatologic agents|mesh-ancestor
110346710|NCT04385277|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110346711|NCT04381832|Docetaxel|docetaxel|mesh-list
110346712|NCT04381832|Quemliclustat|quemliclustat|mesh-list
110346713|NCT04381832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110346714|NCT04381832|Tubulin Modulators|tubulin modulators|mesh-ancestor
110346715|NCT04381832|Antimitotic Agents|antimitotic agents|mesh-ancestor
110346716|NCT04381832|Mitosis Modulators|mitosis modulators|mesh-ancestor
110346717|NCT04381832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110346718|NCT04381832|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110346719|NCT04381832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110346720|NCT04368559|Fluconazole|fluconazole|mesh-list
110346721|NCT04368559|Posaconazole|posaconazole|mesh-list
110346722|NCT04368559|Rezafungin|rezafungin|mesh-list
110346723|NCT04368559|Trimethoprim|trimethoprim|mesh-list
110346724|NCT04368559|Sulfamethoxazole|sulfamethoxazole|mesh-list
110346725|NCT04368559|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110346726|NCT04368559|Antifungal Agents|antifungal agents|mesh-ancestor
110346727|NCT04368559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110346728|NCT04368559|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110346729|NCT04368559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110346730|NCT04368559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110346731|NCT04368559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110346732|NCT04368559|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110346733|NCT04368559|Hormone Antagonists|hormone antagonists|mesh-ancestor
110346734|NCT04368559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110346735|NCT04368559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110346736|NCT04368559|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110346737|NCT04368559|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110346738|NCT04368559|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110346739|NCT04368559|Antimalarials|antimalarials|mesh-ancestor
110346740|NCT04368559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110346741|NCT04368559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110346742|NCT04368559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110346743|NCT04368559|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110346744|NCT04368559|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110346745|NCT04368559|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110346746|NCT04368559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110346747|NCT04340193|Nivolumab|nivolumab|mesh-list
110346748|NCT04340193|Ipilimumab|ipilimumab|mesh-list
110346749|NCT04340193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110346750|NCT04340193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110346751|NCT04340193|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110346752|NCT04340193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110346753|NCT04337580|Omeprazole|omeprazole|mesh-list
110346754|NCT04337580|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110346755|NCT04337580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110346756|NCT04337580|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110346757|NCT04337580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110346758|NCT04337580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110346759|NCT04322305|Pregabalin|pregabalin|mesh-list
110346760|NCT04322305|Analgesics|analgesics|mesh-ancestor
110346761|NCT04322305|Sensory System Agents|sensory system agents|mesh-ancestor
110346762|NCT04322305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110346763|NCT04322305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110346764|NCT04322305|Anticonvulsants|anticonvulsants|mesh-ancestor
110346765|NCT04322305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110346766|NCT04322305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110346767|NCT04322305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110346768|NCT04322305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110346769|NCT04322305|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110346770|NCT04322305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110346771|NCT04322305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110346772|NCT04322305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110346773|NCT04310007|Paclitaxel|paclitaxel|mesh-list
110346774|NCT04310007|Docetaxel|docetaxel|mesh-list
110346775|NCT04310007|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110346776|NCT04310007|Gemcitabine|gemcitabine|mesh-list
110346777|NCT04310007|Nivolumab|nivolumab|mesh-list
110346779|NCT04310007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110346780|NCT04310007|Antibodies|antibodies|mesh-list
110346781|NCT04310007|Immunoglobulins|immunoglobulins|mesh-list
110346782|NCT04310007|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110346783|NCT04310007|Lexatumumab|lexatumumab|mesh-list
110346784|NCT04310007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110346785|NCT04310007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110346786|NCT04310007|Tubulin Modulators|tubulin modulators|mesh-ancestor
110346787|NCT04310007|Antimitotic Agents|antimitotic agents|mesh-ancestor
110346788|NCT04310007|Mitosis Modulators|mitosis modulators|mesh-ancestor
110346789|NCT04310007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110346790|NCT04310007|Immunologic Factors|immunologic factors|mesh-ancestor
110175097|NCT00072046|Interferons|interferons|mesh-list
110346791|NCT04310007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110346792|NCT04310007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110346793|NCT04310007|Antimetabolites|antimetabolites|mesh-ancestor
110346794|NCT04310007|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110346796|NCT04307576|Doxorubicin|doxorubicin|mesh-list
110346797|NCT04307576|Vincristine|vincristine|mesh-list
110346798|NCT04307576|Imatinib Mesylate|imatinib mesylate|mesh-list
110346799|NCT04307576|Blinatumomab|blinatumomab|mesh-list
110346800|NCT04307576|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
110346801|NCT04307576|Thioguanine|thioguanine|mesh-list
110346802|NCT04307576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110346803|NCT04307576|Antiemetics|antiemetics|mesh-ancestor
110346804|NCT04307576|Autonomic Agents|autonomic agents|mesh-ancestor
110346805|NCT04307576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110346806|NCT04307576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110346807|NCT04307576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110346808|NCT04307576|Glucocorticoids|glucocorticoids|mesh-ancestor
110346809|NCT04307576|Hormones|hormones|mesh-ancestor
110346810|NCT04307576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110346811|NCT04307576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110346812|NCT04307576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110346813|NCT04307576|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110346814|NCT04307576|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110346815|NCT04307576|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110346816|NCT04307576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110346817|NCT04307576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110346818|NCT04307576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110346819|NCT04307576|Tubulin Modulators|tubulin modulators|mesh-ancestor
110346820|NCT04307576|Antimitotic Agents|antimitotic agents|mesh-ancestor
110346821|NCT04307576|Mitosis Modulators|mitosis modulators|mesh-ancestor
110346822|NCT04307576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110346823|NCT04307576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110346824|NCT04307576|Immunotoxins|immunotoxins|mesh-ancestor
110346825|NCT04307576|Immunoconjugates|immunoconjugates|mesh-ancestor
110346826|NCT04307576|Immunologic Factors|immunologic factors|mesh-ancestor
110346827|NCT04307576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110346828|NCT04307576|Antimetabolites|antimetabolites|mesh-ancestor
110346829|NCT04305158|Nitrous Oxide|nitrous oxide|mesh-list
110346830|NCT04305158|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110346831|NCT04305158|Anesthetics, General|anesthetics, general|mesh-ancestor
110346832|NCT04305158|Anesthetics|anesthetics|mesh-ancestor
110346833|NCT04305158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110346834|NCT04305158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110346835|NCT04305158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110346836|NCT04305158|Analgesics|analgesics|mesh-ancestor
110346837|NCT04305158|Sensory System Agents|sensory system agents|mesh-ancestor
110346838|NCT04305158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110346839|NCT04305041|Pembrolizumab|pembrolizumab|mesh-list
110346840|NCT04305041|Lenvatinib|lenvatinib|mesh-list
110346841|NCT04305041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110346842|NCT04305041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110346844|NCT04305041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110346845|NCT04305041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110346846|NCT04305041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110346848|NCT04301778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110346849|NCT04301778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110346850|NCT04293562|Cytarabine|cytarabine|mesh-list
110346851|NCT04293562|Deoxyglucose|deoxyglucose|mesh-list
110346852|NCT04293562|Hydrocortisone|hydrocortisone|mesh-list
110346853|NCT04293562|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110346854|NCT04293562|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110346855|NCT04293562|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110346856|NCT04293562|Methotrexate|methotrexate|mesh-list
110346857|NCT04293562|Etoposide|etoposide|mesh-list
110346858|NCT04293562|Etoposide phosphate|etoposide phosphate|mesh-list
110346859|NCT04293562|Daunorubicin|daunorubicin|mesh-list
110346860|NCT04293562|Asparaginase|asparaginase|mesh-list
110346861|NCT04293562|Mitoxantrone|mitoxantrone|mesh-list
110346862|NCT04293562|Podophyllotoxin|podophyllotoxin|mesh-list
110346863|NCT04293562|Gemtuzumab|gemtuzumab|mesh-list
110346864|NCT04293562|Dexrazoxane|dexrazoxane|mesh-list
110346865|NCT04293562|Razoxane|razoxane|mesh-list
110346866|NCT04293562|Calicheamicins|calicheamicins|mesh-list
110346867|NCT04293562|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110346868|NCT04293562|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110346869|NCT04293562|Abortifacient Agents|abortifacient agents|mesh-ancestor
110346870|NCT04293562|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110346871|NCT04293562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110346872|NCT04293562|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110346873|NCT04293562|Antimetabolites|antimetabolites|mesh-ancestor
110346874|NCT04293562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110346875|NCT04293562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110346876|NCT04293562|Dermatologic Agents|dermatologic agents|mesh-ancestor
110346877|NCT04293562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110346878|NCT04293562|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110346879|NCT04293562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110346880|NCT04293562|Immunologic Factors|immunologic factors|mesh-ancestor
110346881|NCT04293562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110346882|NCT04293562|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110346883|NCT04293562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110346884|NCT04293562|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110346885|NCT04293562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110346886|NCT04293562|Antiviral Agents|antiviral agents|mesh-ancestor
110346887|NCT04293562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110346888|NCT04293562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110346889|NCT04293562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110346891|NCT04293562|Sensory System Agents|sensory system agents|mesh-ancestor
110346892|NCT04293562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110346893|NCT04293562|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110346894|NCT04293562|Keratolytic Agents|keratolytic agents|mesh-ancestor
110346895|NCT04293562|Tubulin Modulators|tubulin modulators|mesh-ancestor
110346896|NCT04293562|Antimitotic Agents|antimitotic agents|mesh-ancestor
110346897|NCT04293562|Mitosis Modulators|mitosis modulators|mesh-ancestor
110346898|NCT04293562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110346899|NCT04293562|Immunotoxins|immunotoxins|mesh-ancestor
110346900|NCT04293562|Immunoconjugates|immunoconjugates|mesh-ancestor
110346901|NCT04293562|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110346902|NCT04293562|Protective Agents|protective agents|mesh-ancestor
110346903|NCT04291209|Acetylcysteine|acetylcysteine|mesh-list
110346904|NCT04291209|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110346905|NCT04291209|Antiviral Agents|antiviral agents|mesh-ancestor
110346906|NCT04291209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110346907|NCT04291209|Expectorants|expectorants|mesh-ancestor
110346908|NCT04291209|Respiratory System Agents|respiratory system agents|mesh-ancestor
110346909|NCT04291209|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110346910|NCT04291209|Antioxidants|antioxidants|mesh-ancestor
110346911|NCT04291209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110346912|NCT04291209|Protective Agents|protective agents|mesh-ancestor
110346913|NCT04291209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110346914|NCT04291209|Antidotes|antidotes|mesh-ancestor
110346915|NCT04291079|Antibodies|antibodies|mesh-list
110346916|NCT04291079|Immunologic Factors|immunologic factors|mesh-ancestor
110346917|NCT04291079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110346918|NCT04266912|Avelumab|avelumab|mesh-list
110346919|NCT04266912|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110346920|NCT04266912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110346921|NCT04266912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110346922|NCT04266912|Immunologic Factors|immunologic factors|mesh-ancestor
110346923|NCT04266912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110346924|NCT04256824|Triclosan|triclosan|mesh-list
110346925|NCT04256824|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110346926|NCT04256824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110346927|NCT04256824|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110346928|NCT04256824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110346929|NCT04256824|Antimetabolites|antimetabolites|mesh-ancestor
110346930|NCT04256824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110346931|NCT04256824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110346932|NCT04256213|Nivolumab|nivolumab|mesh-list
110346933|NCT04256213|Ipilimumab|ipilimumab|mesh-list
110346934|NCT04256213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110346935|NCT04256213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110346936|NCT04256213|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110346937|NCT04256213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110346938|NCT04250155|Atezolizumab|atezolizumab|mesh-list
110346939|NCT04250155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110346940|NCT04250155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110346941|NCT04250155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110346942|NCT04250155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110346943|NCT04248829|Gefitinib|gefitinib|mesh-list
110346944|NCT04248829|Lazertinib|lazertinib|mesh-list
110346945|NCT04248829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110346946|NCT04248829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110346947|NCT04248829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110346948|NCT04248829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110346949|NCT04248569|Nivolumab|nivolumab|mesh-list
110346950|NCT04248569|Ipilimumab|ipilimumab|mesh-list
110346951|NCT04248569|Poly ICLC|poly iclc|mesh-list
110346952|NCT04248569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110346953|NCT04248569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110346954|NCT04248569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110346955|NCT04248569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110346956|NCT04248569|Interferon Inducers|interferon inducers|mesh-ancestor
110346957|NCT04248569|Immunologic Factors|immunologic factors|mesh-ancestor
110346958|NCT04248569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110346959|NCT04247074|Botulinum Toxins|botulinum toxins|mesh-list
110346960|NCT04247074|Neurotransmitter Agents|neurotransmitter agents|mesh-list
110346961|NCT04247074|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110346962|NCT04247074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110175145|NCT04730674|Lidocaine|lidocaine|mesh-list
110346967|NCT04231448|Cyclophosphamide|cyclophosphamide|mesh-list
110346968|NCT04231448|Rituximab|rituximab|mesh-list
110346969|NCT04231448|Doxorubicin|doxorubicin|mesh-list
110346970|NCT04231448|Vincristine|vincristine|mesh-list
110346971|NCT04231448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110346972|NCT04231448|Immunologic Factors|immunologic factors|mesh-ancestor
110346973|NCT04231448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110346974|NCT04231448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110346975|NCT04231448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110346976|NCT04231448|Alkylating Agents|alkylating agents|mesh-ancestor
110346977|NCT04231448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110346978|NCT04231448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110346979|NCT04231448|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110346980|NCT04231448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110346981|NCT04231448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110346982|NCT04231448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110346983|NCT04231448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110346984|NCT04231448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110346985|NCT04231448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110346986|NCT04231448|Glucocorticoids|glucocorticoids|mesh-ancestor
110346988|NCT04231448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110346989|NCT04231448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110346990|NCT04231448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110346991|NCT04231448|Tubulin Modulators|tubulin modulators|mesh-ancestor
110346992|NCT04231448|Antimitotic Agents|antimitotic agents|mesh-ancestor
110346993|NCT04231448|Mitosis Modulators|mitosis modulators|mesh-ancestor
110346994|NCT04228965|Varenicline|varenicline|mesh-list
110346995|NCT04228965|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110346996|NCT04228965|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110346997|NCT04228965|Cholinergic Agents|cholinergic agents|mesh-ancestor
110346998|NCT04228965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110346999|NCT04228965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347000|NCT04228965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110347001|NCT04226456|Acetylcysteine|acetylcysteine|mesh-list
110347002|NCT04226456|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110347003|NCT04226456|Antiviral Agents|antiviral agents|mesh-ancestor
110347004|NCT04226456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110347005|NCT04226456|Expectorants|expectorants|mesh-ancestor
110347006|NCT04226456|Respiratory System Agents|respiratory system agents|mesh-ancestor
110347007|NCT04226456|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110347008|NCT04226456|Antioxidants|antioxidants|mesh-ancestor
110347009|NCT04226456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347010|NCT04226456|Protective Agents|protective agents|mesh-ancestor
110347011|NCT04226456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110347012|NCT04226456|Antidotes|antidotes|mesh-ancestor
110347013|NCT04224051|Metformin|metformin|mesh-list
110347014|NCT04224051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110175161|NCT03959436|Carbetocin|carbetocin|mesh-list
110347015|NCT04224051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110347024|NCT04210115|Oxaliplatin|oxaliplatin|mesh-list
110347025|NCT04210115|Calcium|calcium|mesh-list
110347026|NCT04210115|Levoleucovorin|levoleucovorin|mesh-list
110347027|NCT04210115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110347028|NCT04210115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110347029|NCT04210115|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110347030|NCT04210115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347031|NCT04210115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110347032|NCT04210115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110347033|NCT04210115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110347034|NCT04210115|Antidotes|antidotes|mesh-ancestor
110347035|NCT04210115|Protective Agents|protective agents|mesh-ancestor
110347036|NCT04210115|Vitamin B Complex|vitamin b complex|mesh-ancestor
110347037|NCT04210115|Vitamins|vitamins|mesh-ancestor
110347038|NCT04210115|Micronutrients|micronutrients|mesh-ancestor
110347039|NCT04209686|Paclitaxel|paclitaxel|mesh-list
110347040|NCT04209686|Pembrolizumab|pembrolizumab|mesh-list
110347041|NCT04209686|Olaparib|olaparib|mesh-list
110347042|NCT04209686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110347043|NCT04209686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110347044|NCT04209686|Tubulin Modulators|tubulin modulators|mesh-ancestor
110347045|NCT04209686|Antimitotic Agents|antimitotic agents|mesh-ancestor
110347046|NCT04209686|Mitosis Modulators|mitosis modulators|mesh-ancestor
110347047|NCT04209686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347048|NCT04209686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110347049|NCT04209686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110347050|NCT04209686|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110347051|NCT04209686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110347052|NCT04209114|Nivolumab|nivolumab|mesh-list
110347053|NCT04209114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110347054|NCT04209114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110347055|NCT04209114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110347056|NCT04209114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347057|NCT04208178|Trastuzumab|trastuzumab|mesh-list
110347058|NCT04208178|Pertuzumab|pertuzumab|mesh-list
110347059|NCT04208178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110347060|NCT04208178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110347061|NCT04206319|Listerine|listerine|mesh-list
110347062|NCT04206319|Fluorides|fluorides|mesh-list
110347063|NCT04206319|Sodium Fluoride|sodium fluoride|mesh-list
110347064|NCT04206319|Cariostatic Agents|cariostatic agents|mesh-ancestor
110347065|NCT04206319|Protective Agents|protective agents|mesh-ancestor
110347066|NCT04206319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110347067|NCT04206319|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110347068|NCT04206319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110347069|NCT04198662|Epinephrine|epinephrine|mesh-list
110347070|NCT04198662|Ropivacaine|ropivacaine|mesh-list
110347071|NCT04198662|Anesthetics, Local|anesthetics, local|mesh-ancestor
110347072|NCT04198662|Anesthetics|anesthetics|mesh-ancestor
110347073|NCT04198662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110347074|NCT04198662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110175185|NCT00072163|Growth Inhibitors|growth inhibitors|mesh-ancestor
110347075|NCT04198662|Sensory System Agents|sensory system agents|mesh-ancestor
110347076|NCT04198662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110347077|NCT04198662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110347078|NCT04198662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110347079|NCT04198662|Adrenergic Agents|adrenergic agents|mesh-ancestor
110347080|NCT04198662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110347081|NCT04198662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347082|NCT04198662|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110347083|NCT04198662|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110347084|NCT04198662|Autonomic Agents|autonomic agents|mesh-ancestor
110347085|NCT04198662|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110347086|NCT04198662|Respiratory System Agents|respiratory system agents|mesh-ancestor
110347088|NCT04198662|Sympathomimetics|sympathomimetics|mesh-ancestor
110347089|NCT04198662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110347090|NCT04195399|Imidazole|imidazole|mesh-list
110347091|NCT04195399|Nirogacestat|nirogacestat|mesh-list
110347092|NCT04195399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110347093|NCT04195399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347094|NCT04195399|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
110347095|NCT04176978|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110347096|NCT04176978|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110347097|NCT04176978|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110347098|NCT04176978|Antimetabolites|antimetabolites|mesh-ancestor
110347099|NCT04176978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347100|NCT04176978|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110347101|NCT04176978|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110347102|NCT04176978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110347103|NCT04168710|Bupivacaine|bupivacaine|mesh-list
110347104|NCT04168710|Anesthetics, Local|anesthetics, local|mesh-ancestor
110347105|NCT04168710|Anesthetics|anesthetics|mesh-ancestor
110347106|NCT04168710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110347107|NCT04168710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110347108|NCT04168710|Sensory System Agents|sensory system agents|mesh-ancestor
110347109|NCT04168710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110347112|NCT04166435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110347113|NCT04166435|Alkylating Agents|alkylating agents|mesh-ancestor
110347114|NCT04166435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175206|NCT03959397|Paclitaxel|paclitaxel|mesh-list
110347115|NCT04166435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110347116|NCT04166435|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110347117|NCT04166435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110347118|NCT04165083|Pembrolizumab|pembrolizumab|mesh-list
110347119|NCT04165083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110347120|NCT04165083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110347121|NCT04165083|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110347122|NCT04165083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347123|NCT04165070|Paclitaxel|paclitaxel|mesh-list
110347124|NCT04165070|Carboplatin|carboplatin|mesh-list
110347125|NCT04165070|Pembrolizumab|pembrolizumab|mesh-list
110347126|NCT04165070|Pemetrexed|pemetrexed|mesh-list
110347127|NCT04165070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110347128|NCT04165070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110347129|NCT04165070|Tubulin Modulators|tubulin modulators|mesh-ancestor
110347130|NCT04165070|Antimitotic Agents|antimitotic agents|mesh-ancestor
110347131|NCT04165070|Mitosis Modulators|mitosis modulators|mesh-ancestor
110347132|NCT04165070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347133|NCT04165070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110347134|NCT04165070|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110347135|NCT04165070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110347136|NCT04165070|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110347137|NCT04165070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110347138|NCT04152941|Olaparib|olaparib|mesh-list
110347139|NCT04152941|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110347140|NCT04152941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110347141|NCT04152941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347142|NCT04152941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110347143|NCT04150900|Pembrolizumab|pembrolizumab|mesh-list
110347144|NCT04150900|Bavituximab|bavituximab|mesh-list
110347145|NCT04150900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110347146|NCT04150900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110347147|NCT04150900|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110347148|NCT04150900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347150|NCT04149574|BCG Vaccine|bcg vaccine|mesh-list
110347151|NCT04149574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110347152|NCT04149574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110347153|NCT04149574|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110347154|NCT04149574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347155|NCT04149574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110347156|NCT04149574|Immunologic Factors|immunologic factors|mesh-ancestor
110347157|NCT04149574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110347158|NCT04141696|Midazolam|midazolam|mesh-list
110347159|NCT04141696|Ketamine|ketamine|mesh-list
110347160|NCT04141696|Analgesics|analgesics|mesh-ancestor
110347161|NCT04141696|Sensory System Agents|sensory system agents|mesh-ancestor
110347162|NCT04141696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110347163|NCT04141696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110347164|NCT04141696|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110347165|NCT04141696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110347166|NCT04141696|Anesthetics, General|anesthetics, general|mesh-ancestor
110347167|NCT04141696|Anesthetics|anesthetics|mesh-ancestor
110347168|NCT04141696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110347169|NCT04141696|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110347170|NCT04141696|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110347171|NCT04141696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110347172|NCT04141696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347173|NCT04141696|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110347174|NCT04141696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110347175|NCT04141696|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110347176|NCT04141696|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110347177|NCT04141696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110347178|NCT04141696|GABA Modulators|gaba modulators|mesh-ancestor
110347179|NCT04141696|GABA Agents|gaba agents|mesh-ancestor
110347180|NCT04124965|Rozanolixizumab|rozanolixizumab|mesh-list
110347181|NCT04124965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110347182|NCT04124965|Immunologic Factors|immunologic factors|mesh-ancestor
110347183|NCT04124965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110347184|NCT04117087|Nivolumab|nivolumab|mesh-list
110347185|NCT04117087|Ipilimumab|ipilimumab|mesh-list
110347186|NCT04117087|Poly ICLC|poly iclc|mesh-list
110347187|NCT04117087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110347188|NCT04117087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110347189|NCT04117087|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110347190|NCT04117087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347191|NCT04117087|Interferon Inducers|interferon inducers|mesh-ancestor
110347192|NCT04117087|Immunologic Factors|immunologic factors|mesh-ancestor
110347193|NCT04117087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110347194|NCT04116073|Antibodies|antibodies|mesh-list
110347195|NCT04116073|Immunologic Factors|immunologic factors|mesh-ancestor
110347196|NCT04116073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110347197|NCT04109066|Paclitaxel|paclitaxel|mesh-list
110347198|NCT04109066|Cyclophosphamide|cyclophosphamide|mesh-list
110347199|NCT04109066|Nivolumab|nivolumab|mesh-list
110347200|NCT04109066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110347201|NCT04109066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110347202|NCT04109066|Tubulin Modulators|tubulin modulators|mesh-ancestor
110347203|NCT04109066|Antimitotic Agents|antimitotic agents|mesh-ancestor
110347204|NCT04109066|Mitosis Modulators|mitosis modulators|mesh-ancestor
110347205|NCT04109066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347206|NCT04109066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110347207|NCT04109066|Immunologic Factors|immunologic factors|mesh-ancestor
110347208|NCT04109066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110347209|NCT04109066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110347210|NCT04109066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110175254|NCT00072592|Rituximab|rituximab|mesh-list
110347211|NCT04109066|Alkylating Agents|alkylating agents|mesh-ancestor
110347212|NCT04109066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110347213|NCT04109066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110347214|NCT04109066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110347215|NCT04102020|Azacitidine|azacitidine|mesh-list
110347217|NCT04102020|Cc-486|cc-486|mesh-list
110347218|NCT04102020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110347219|NCT04102020|Antimetabolites|antimetabolites|mesh-ancestor
110347220|NCT04102020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347221|NCT04102020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110347222|NCT04102020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110347223|NCT04098068|Pembrolizumab|pembrolizumab|mesh-list
110347224|NCT04098068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110347225|NCT04098068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110347226|NCT04098068|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110347227|NCT04098068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347228|NCT04083599|Paclitaxel|paclitaxel|mesh-list
110347229|NCT04083599|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110347230|NCT04083599|Carboplatin|carboplatin|mesh-list
110347231|NCT04083599|Gemcitabine|gemcitabine|mesh-list
110347232|NCT04083599|Pembrolizumab|pembrolizumab|mesh-list
110347233|NCT04083599|Pemetrexed|pemetrexed|mesh-list
110347234|NCT04083599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110347235|NCT04083599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110347236|NCT04083599|Tubulin Modulators|tubulin modulators|mesh-ancestor
110347237|NCT04083599|Antimitotic Agents|antimitotic agents|mesh-ancestor
110347238|NCT04083599|Mitosis Modulators|mitosis modulators|mesh-ancestor
110347239|NCT04083599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347240|NCT04083599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110347241|NCT04083599|Antimetabolites|antimetabolites|mesh-ancestor
110175289|NCT00072826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110347242|NCT04083599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110347243|NCT04083599|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110347244|NCT04083599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110347245|NCT04083599|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110347246|NCT04083599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110347248|NCT04078152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110347249|NCT04078152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110347250|NCT04068103|Calcium, Dietary|calcium, dietary|mesh-list
110347251|NCT04068103|Leucovorin|leucovorin|mesh-list
110347252|NCT04068103|Folic Acid|folic acid|mesh-list
110347253|NCT04068103|Fluorouracil|fluorouracil|mesh-list
110347254|NCT04068103|Capecitabine|capecitabine|mesh-list
110347256|NCT04068103|Calcium|calcium|mesh-list
110347257|NCT04068103|Levoleucovorin|levoleucovorin|mesh-list
110347258|NCT04068103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110347259|NCT04068103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110347260|NCT04068103|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110347261|NCT04068103|Antimetabolites|antimetabolites|mesh-ancestor
110347262|NCT04068103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347263|NCT04068103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110347264|NCT04068103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110347265|NCT04068103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110347266|NCT04068103|Immunologic Factors|immunologic factors|mesh-ancestor
110347267|NCT04068103|Antidotes|antidotes|mesh-ancestor
110347268|NCT04068103|Protective Agents|protective agents|mesh-ancestor
110347269|NCT04068103|Vitamin B Complex|vitamin b complex|mesh-ancestor
110347271|NCT04068103|Micronutrients|micronutrients|mesh-ancestor
110347272|NCT04068103|Hematinics|hematinics|mesh-ancestor
110347273|NCT04034251|Paclitaxel|paclitaxel|mesh-list
110347274|NCT04034251|Capecitabine|capecitabine|mesh-list
110347275|NCT04034251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110347276|NCT04034251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110347277|NCT04034251|Tubulin Modulators|tubulin modulators|mesh-ancestor
110347278|NCT04034251|Antimitotic Agents|antimitotic agents|mesh-ancestor
110347279|NCT04034251|Mitosis Modulators|mitosis modulators|mesh-ancestor
110347280|NCT04034251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347281|NCT04034251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110347282|NCT04034251|Antimetabolites|antimetabolites|mesh-ancestor
110347283|NCT04034056|Obinutuzumab|obinutuzumab|mesh-list
110347284|NCT04034056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110347285|NCT04034056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110347286|NCT04030169|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
110347287|NCT04030169|Hallucinogens|hallucinogens|mesh-ancestor
110347288|NCT04030169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110347289|NCT04030169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110347290|NCT04030169|Serotonin Agents|serotonin agents|mesh-ancestor
110347291|NCT04030169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110347292|NCT04030169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347293|NCT04030169|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110347294|NCT04030169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110347295|NCT04030169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110347296|NCT04030169|Adrenergic Agents|adrenergic agents|mesh-ancestor
110347297|NCT04025879|Paclitaxel|paclitaxel|mesh-list
110347298|NCT04025879|Docetaxel|docetaxel|mesh-list
110347299|NCT04025879|Carboplatin|carboplatin|mesh-list
110347300|NCT04025879|Nivolumab|nivolumab|mesh-list
110347301|NCT04025879|Pemetrexed|pemetrexed|mesh-list
110347302|NCT04025879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110347303|NCT04025879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110347304|NCT04025879|Tubulin Modulators|tubulin modulators|mesh-ancestor
110347305|NCT04025879|Antimitotic Agents|antimitotic agents|mesh-ancestor
110347306|NCT04025879|Mitosis Modulators|mitosis modulators|mesh-ancestor
110347307|NCT04025879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347308|NCT04025879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110347309|NCT04025879|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110347310|NCT04025879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110347311|NCT04025879|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110347312|NCT04025879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110347313|NCT04023227|Valsartan|valsartan|mesh-list
110347314|NCT04023227|Enalapril|enalapril|mesh-list
110347315|NCT04023227|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110347316|NCT04023227|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110347317|NCT04023227|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110347318|NCT04023227|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110347319|NCT04023227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347320|NCT04023227|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110347321|NCT04023227|Protease Inhibitors|protease inhibitors|mesh-ancestor
110347322|NCT04023227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110347323|NCT04022967|Ritonavir|ritonavir|mesh-list
110347325|NCT04022967|Tenofovir|tenofovir|mesh-list
110347326|NCT04022967|Lamivudine|lamivudine|mesh-list
110347327|NCT04022967|Dolutegravir|dolutegravir|mesh-list
110347328|NCT04022967|Efavirenz|efavirenz|mesh-list
110347329|NCT04022967|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110347330|NCT04022967|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110347331|NCT04022967|Protease Inhibitors|protease inhibitors|mesh-ancestor
110347332|NCT04022967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110347333|NCT04022967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347334|NCT04022967|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110347335|NCT04022967|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110347336|NCT04022967|Antiviral Agents|antiviral agents|mesh-ancestor
110347337|NCT04022967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110347338|NCT04022967|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110347339|NCT04022967|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110347340|NCT04022967|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110347341|NCT04022967|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110347342|NCT04022967|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110347343|NCT04022967|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110347344|NCT04022967|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110347345|NCT04022967|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110347346|NCT04022967|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110347347|NCT04022967|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110347348|NCT04022967|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110347349|NCT04021862|Antibodies|antibodies|mesh-list
110347350|NCT04021862|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110347351|NCT04021862|Immunologic Factors|immunologic factors|mesh-ancestor
110347352|NCT04021862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110347353|NCT03998813|Ropivacaine|ropivacaine|mesh-list
110347354|NCT03998813|Anesthetics, Local|anesthetics, local|mesh-ancestor
110347355|NCT03998813|Anesthetics|anesthetics|mesh-ancestor
110347356|NCT03998813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110347357|NCT03998813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110347358|NCT03998813|Sensory System Agents|sensory system agents|mesh-ancestor
110347359|NCT03998813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110347360|NCT03997786|Etanercept|etanercept|mesh-list
110347361|NCT03997786|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110347362|NCT03997786|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110347363|NCT03997786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110347364|NCT03997786|Analgesics|analgesics|mesh-ancestor
110347365|NCT03997786|Sensory System Agents|sensory system agents|mesh-ancestor
110347366|NCT03997786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110347367|NCT03997786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110347368|NCT03997786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110347369|NCT03997786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110347370|NCT03997786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110347371|NCT03997786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110347372|NCT03997786|Immunologic Factors|immunologic factors|mesh-ancestor
110347373|NCT03994601|Nivolumab|nivolumab|mesh-list
110347374|NCT03994601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110347375|NCT03994601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110347376|NCT03994601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110347377|NCT03994601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347378|NCT03991091|Oxytocin|oxytocin|mesh-list
110347379|NCT03991091|Oxytocics|oxytocics|mesh-ancestor
110347380|NCT03991091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110347381|NCT03991091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110347382|NCT03984214|Dronabinol|dronabinol|mesh-list
110347383|NCT03984214|Hallucinogens|hallucinogens|mesh-ancestor
110347384|NCT03984214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110347385|NCT03984214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110347386|NCT03984214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110347387|NCT03984214|Analgesics|analgesics|mesh-ancestor
110347388|NCT03984214|Sensory System Agents|sensory system agents|mesh-ancestor
110347389|NCT03984214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110347390|NCT03984214|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110347391|NCT03984214|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110347392|NCT03984214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110347393|NCT03984214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347394|NCT03984214|Hormones|hormones|mesh-ancestor
110347395|NCT03984214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110347396|NCT03971422|Rozanolixizumab|rozanolixizumab|mesh-list
110347397|NCT03971422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110347398|NCT03971422|Immunologic Factors|immunologic factors|mesh-ancestor
110347399|NCT03971422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110347400|NCT03945656|Insulin|insulin|mesh-list
110347401|NCT03945656|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110347402|NCT03945656|Insulin Glargine|insulin glargine|mesh-list
110347403|NCT03945656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110347404|NCT03945656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110347405|NCT03927157|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110347406|NCT03927157|Immunologic Factors|immunologic factors|mesh-ancestor
110347407|NCT03927157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110347408|NCT03927079|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110347409|NCT03927079|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110347410|NCT03927079|Dimercaprol|dimercaprol|mesh-list
110347411|NCT03927079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110347412|NCT03927079|Antitubercular Agents|antitubercular agents|mesh-ancestor
110347413|NCT03927079|Chelating Agents|chelating agents|mesh-ancestor
110347414|NCT03927079|Sequestering Agents|sequestering agents|mesh-ancestor
110347415|NCT03927079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347416|NCT03924869|Pembrolizumab|pembrolizumab|mesh-list
110347417|NCT03924869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110347418|NCT03924869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110347419|NCT03924869|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110347420|NCT03924869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347421|NCT03917381|Docetaxel|docetaxel|mesh-list
110347422|NCT03917381|Pembrolizumab|pembrolizumab|mesh-list
110347423|NCT03917381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110347424|NCT03917381|Tubulin Modulators|tubulin modulators|mesh-ancestor
110347425|NCT03917381|Antimitotic Agents|antimitotic agents|mesh-ancestor
110347433|NCT03909334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110347434|NCT03909334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110347435|NCT03909334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347437|NCT03895099|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110347438|NCT03895099|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110347439|NCT03895099|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110347440|NCT03895099|Contraceptive Agents|contraceptive agents|mesh-ancestor
110347441|NCT03895099|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110347442|NCT03895099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110347443|NCT03895099|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110347444|NCT03895099|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110347446|NCT03895099|Hormones|hormones|mesh-ancestor
110347447|NCT03895099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110347449|NCT03866499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110347450|NCT03866499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110347451|NCT03866499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110347452|NCT03866499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347459|NCT03841617|Hormones|hormones|mesh-list
110347460|NCT03841617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110347461|NCT03841617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110347462|NCT03833167|Pembrolizumab|pembrolizumab|mesh-list
110347463|NCT03833167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110347464|NCT03833167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110347465|NCT03833167|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110347466|NCT03833167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347467|NCT03822962|Acetaminophen|acetaminophen|mesh-list
110347468|NCT03822962|Ibuprofen|ibuprofen|mesh-list
110347469|NCT03822962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110347470|NCT03822962|Analgesics|analgesics|mesh-ancestor
110347471|NCT03822962|Sensory System Agents|sensory system agents|mesh-ancestor
110347472|NCT03822962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110347473|NCT03822962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110347474|NCT03822962|Antipyretics|antipyretics|mesh-ancestor
110347475|NCT03822962|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110347477|NCT03822962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110347478|NCT03822962|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110347479|NCT03822962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110347480|NCT03822962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347481|NCT03816345|Nivolumab|nivolumab|mesh-list
110347482|NCT03816345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110347483|NCT03816345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110347484|NCT03816345|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110347485|NCT03816345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347486|NCT03806387|Alemtuzumab|alemtuzumab|mesh-list
110347487|NCT03806387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110347488|NCT03806387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110347489|NCT03792763|Denosumab|denosumab|mesh-list
110347490|NCT03792763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110347491|NCT03792763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110347492|NCT03792763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110347493|NCT03784326|Fluorouracil|fluorouracil|mesh-list
110347494|NCT03784326|Oxaliplatin|oxaliplatin|mesh-list
110347495|NCT03784326|Atezolizumab|atezolizumab|mesh-list
110347496|NCT03784326|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110347497|NCT03784326|Antimetabolites|antimetabolites|mesh-ancestor
110347498|NCT03784326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347499|NCT03784326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110347500|NCT03784326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110347501|NCT03784326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110347502|NCT03784326|Immunologic Factors|immunologic factors|mesh-ancestor
110347503|NCT03784326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110347504|NCT03784326|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110347505|NCT03784326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110347506|NCT03770260|Ixazomib|ixazomib|mesh-list
110347507|NCT03770260|Enzyme Inhibitors|enzyme inhibitors|mesh-list
110347508|NCT03770260|Pevonedistat|pevonedistat|mesh-list
110347509|NCT03770260|Glycine|glycine|mesh-list
110347510|NCT03770260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347511|NCT03770260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110347512|NCT03770260|Protease Inhibitors|protease inhibitors|mesh-ancestor
110347513|NCT03770260|Glycine Agents|glycine agents|mesh-ancestor
110347514|NCT03770260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110347515|NCT03770260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110347516|NCT03767582|Nivolumab|nivolumab|mesh-list
110347517|NCT03767582|Vaccines|vaccines|mesh-list
110347518|NCT03767582|Immunologic Factors|immunologic factors|mesh-ancestor
110347519|NCT03767582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110347520|NCT03767582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110347521|NCT03767582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110347522|NCT03767582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110347523|NCT03767582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347524|NCT03762850|Dapagliflozin|dapagliflozin|mesh-list
110347525|NCT03762850|Irbesartan|irbesartan|mesh-list
110347526|NCT03762850|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110347527|NCT03762850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347528|NCT03762850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110347529|NCT03762850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110347530|NCT03762850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110347531|NCT03762850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110347532|NCT03762850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110347533|NCT03759093|Thalidomide|thalidomide|mesh-list
110347534|NCT03759093|Dexamethasone|dexamethasone|mesh-list
110347535|NCT03759093|Dexamethasone acetate|dexamethasone acetate|mesh-list
110347536|NCT03759093|Cyclophosphamide|cyclophosphamide|mesh-list
110347537|NCT03759093|Lenalidomide|lenalidomide|mesh-list
110347538|NCT03759093|Bortezomib|bortezomib|mesh-list
110347539|NCT03759093|BB 1101|bb 1101|mesh-list
110347540|NCT03759093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110347541|NCT03759093|Immunologic Factors|immunologic factors|mesh-ancestor
110347542|NCT03759093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110347543|NCT03759093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110347544|NCT03759093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110347545|NCT03759093|Alkylating Agents|alkylating agents|mesh-ancestor
110347546|NCT03759093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347547|NCT03759093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110347548|NCT03759093|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110347549|NCT03759093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110347550|NCT03759093|Antiemetics|antiemetics|mesh-ancestor
110347551|NCT03759093|Autonomic Agents|autonomic agents|mesh-ancestor
110347552|NCT03759093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110347553|NCT03759093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110347554|NCT03759093|Glucocorticoids|glucocorticoids|mesh-ancestor
110347555|NCT03759093|Hormones|hormones|mesh-ancestor
110347556|NCT03759093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110347557|NCT03759093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110347558|NCT03759093|Protease Inhibitors|protease inhibitors|mesh-ancestor
110347559|NCT03759093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110347560|NCT03759093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110347561|NCT03759093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110347562|NCT03759093|Growth Substances|growth substances|mesh-ancestor
110347563|NCT03759093|Growth Inhibitors|growth inhibitors|mesh-ancestor
110347564|NCT03759093|Leprostatic Agents|leprostatic agents|mesh-ancestor
110347565|NCT03759093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110347566|NCT03759093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110347567|NCT03756961|Lidocaine|lidocaine|mesh-list
110347568|NCT03756961|Dexmedetomidine|dexmedetomidine|mesh-list
110347569|NCT03756961|Remifentanil|remifentanil|mesh-list
110347570|NCT03756961|Oxycodone|oxycodone|mesh-list
110347571|NCT03756961|Propofol|propofol|mesh-list
110347572|NCT03756961|Desflurane|desflurane|mesh-list
110347573|NCT03756961|Esketamine|esketamine|mesh-list
110347574|NCT03756961|Anesthetics, Local|anesthetics, local|mesh-ancestor
110347575|NCT03756961|Anesthetics|anesthetics|mesh-ancestor
110347576|NCT03756961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110347577|NCT03756961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110347578|NCT03756961|Sensory System Agents|sensory system agents|mesh-ancestor
110347579|NCT03756961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110347580|NCT03756961|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110347581|NCT03756961|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110347582|NCT03756961|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110347583|NCT03756961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110347584|NCT03756961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347585|NCT03756961|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110347586|NCT03756961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110347587|NCT03756961|Analgesics|analgesics|mesh-ancestor
110347588|NCT03756961|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110347589|NCT03756961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110347590|NCT03756961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110347591|NCT03756961|Adrenergic Agents|adrenergic agents|mesh-ancestor
110347592|NCT03756961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110347593|NCT03756961|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110347594|NCT03756961|Anesthetics, General|anesthetics, general|mesh-ancestor
110347595|NCT03756961|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110347596|NCT03756961|Narcotics|narcotics|mesh-ancestor
110347597|NCT03756961|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110347598|NCT03756961|Antidepressive Agents|antidepressive agents|mesh-ancestor
110347599|NCT03756961|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110347601|NCT03752216|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110347602|NCT03752216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110347603|NCT03752216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347604|NCT03752216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110347606|NCT03745950|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110347607|NCT03745950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110347608|NCT03745950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347609|NCT03745950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110347610|NCT03737110|Rilonacept|rilonacept|mesh-list
110347611|NCT03737110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110347612|NCT03735901|Levodopa|levodopa|mesh-list
110347613|NCT03735901|Carbidopa|carbidopa|mesh-list
110347614|NCT03735901|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110347615|NCT03735901|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110347616|NCT03735901|Dopamine Agents|dopamine agents|mesh-ancestor
110347617|NCT03735901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110347618|NCT03735901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347619|NCT03735901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110347620|NCT03735901|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110347621|NCT03735901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110347622|NCT03733314|Quetmolimab|quetmolimab|mesh-list
110347623|NCT03733314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110347624|NCT03727880|Pembrolizumab|pembrolizumab|mesh-list
110347625|NCT03727880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110347626|NCT03727880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110347627|NCT03727880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110347628|NCT03727880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347635|NCT03723590|Hyaluronic Acid|hyaluronic acid|mesh-list
110347636|NCT03723590|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110347637|NCT03723590|Immunologic Factors|immunologic factors|mesh-ancestor
110347638|NCT03723590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110347639|NCT03723590|Viscosupplements|viscosupplements|mesh-ancestor
110347640|NCT03723590|Protective Agents|protective agents|mesh-ancestor
110347641|NCT03711058|Nivolumab|nivolumab|mesh-list
110347642|NCT03711058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110347643|NCT03711058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110347644|NCT03711058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110347645|NCT03711058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347646|NCT03711032|Pembrolizumab|pembrolizumab|mesh-list
110347647|NCT03711032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110347648|NCT03711032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110347649|NCT03711032|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110347650|NCT03711032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347651|NCT03710122|Vancomycin|vancomycin|mesh-list
110347652|NCT03710122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110347653|NCT03710122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110347654|NCT03698669|Analgesics, Opioid|analgesics, opioid|mesh-list
110347655|NCT03698669|Narcotics|narcotics|mesh-ancestor
110347656|NCT03698669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110347657|NCT03698669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110347658|NCT03698669|Analgesics|analgesics|mesh-ancestor
110347659|NCT03698669|Sensory System Agents|sensory system agents|mesh-ancestor
110347660|NCT03698669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110347661|NCT03691077|Ocrelizumab|ocrelizumab|mesh-list
110347662|NCT03691077|Immunologic Factors|immunologic factors|mesh-ancestor
110347663|NCT03691077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110347671|NCT03678545|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110347672|NCT03678545|Immunologic Factors|immunologic factors|mesh-ancestor
110347673|NCT03678545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110347674|NCT03642067|Nivolumab|nivolumab|mesh-list
110347675|NCT03642067|Relatlimab|relatlimab|mesh-list
110347676|NCT03642067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110347677|NCT03642067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110347678|NCT03642067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110347679|NCT03642067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347680|NCT03638141|Durvalumab|durvalumab|mesh-list
110347681|NCT03638141|Ipilimumab|ipilimumab|mesh-list
110347682|NCT03638141|Tremelimumab|tremelimumab|mesh-list
110347683|NCT03638141|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110347684|NCT03638141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110347685|NCT03638141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110347689|NCT03638141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347690|NCT03625648|Pentoxifylline|pentoxifylline|mesh-list
110347691|NCT03625648|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110347692|NCT03625648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110347693|NCT03625648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347694|NCT03625648|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110347695|NCT03625648|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110347696|NCT03625648|Protective Agents|protective agents|mesh-ancestor
110347697|NCT03625648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110347698|NCT03625648|Vasodilator Agents|vasodilator agents|mesh-ancestor
110347699|NCT03625648|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110347701|NCT03618550|Gemcitabine|gemcitabine|mesh-list
110347702|NCT03618550|Doxorubicin|doxorubicin|mesh-list
110347703|NCT03618550|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110347704|NCT03618550|Pembrolizumab|pembrolizumab|mesh-list
110347705|NCT03618550|Vinorelbine|vinorelbine|mesh-list
110347706|NCT03618550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110347707|NCT03618550|Antimetabolites|antimetabolites|mesh-ancestor
110347708|NCT03618550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347709|NCT03618550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110347710|NCT03618550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110347711|NCT03618550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110347712|NCT03618550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110347713|NCT03618550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110347714|NCT03618550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110347715|NCT03618550|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110347716|NCT03618550|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110347717|NCT03618550|Tubulin Modulators|tubulin modulators|mesh-ancestor
110347718|NCT03618550|Antimitotic Agents|antimitotic agents|mesh-ancestor
110347719|NCT03618550|Mitosis Modulators|mitosis modulators|mesh-ancestor
110347720|NCT03607890|Nivolumab|nivolumab|mesh-list
110347721|NCT03607890|Relatlimab|relatlimab|mesh-list
110347722|NCT03607890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110347723|NCT03607890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110347724|NCT03607890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110347725|NCT03607890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347726|NCT03602157|Fludarabine|fludarabine|mesh-list
110347727|NCT03602157|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110347728|NCT03602157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110347729|NCT03602157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347730|NCT03602157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110347731|NCT03602157|Alkylating Agents|alkylating agents|mesh-ancestor
110347732|NCT03601442|Tisagenlecleucel|tisagenlecleucel|mesh-list
110347733|NCT03601442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110347734|NCT03601442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110347738|NCT03587740|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
110347739|NCT03587740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110347740|NCT03587740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110347741|NCT03587740|Immunotoxins|immunotoxins|mesh-ancestor
110347742|NCT03587740|Immunoconjugates|immunoconjugates|mesh-ancestor
110347743|NCT03587740|Immunologic Factors|immunologic factors|mesh-ancestor
110347744|NCT03587740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110347745|NCT03587740|Tubulin Modulators|tubulin modulators|mesh-ancestor
110347746|NCT03587740|Antimitotic Agents|antimitotic agents|mesh-ancestor
110347748|NCT03587740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347750|NCT03586999|Cyclophosphamide|cyclophosphamide|mesh-list
110347751|NCT03586999|Nivolumab|nivolumab|mesh-list
110347752|NCT03586999|Etoposide|etoposide|mesh-list
110347753|NCT03586999|Vincristine|vincristine|mesh-list
110347754|NCT03586999|Doxorubicin|doxorubicin|mesh-list
110347755|NCT03586999|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110347756|NCT03586999|Prednisolone phosphate|prednisolone phosphate|mesh-list
110347757|NCT03586999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110347758|NCT03586999|Immunologic Factors|immunologic factors|mesh-ancestor
110347759|NCT03586999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110347760|NCT03586999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110347761|NCT03586999|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110347762|NCT03586999|Alkylating Agents|alkylating agents|mesh-ancestor
110347763|NCT03586999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347764|NCT03586999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110347765|NCT03586999|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110347766|NCT03586999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110347767|NCT03586999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110347768|NCT03586999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110347769|NCT03586999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110347770|NCT03586999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110347771|NCT03586999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110347772|NCT03586999|Tubulin Modulators|tubulin modulators|mesh-ancestor
110347773|NCT03586999|Antimitotic Agents|antimitotic agents|mesh-ancestor
110347774|NCT03586999|Mitosis Modulators|mitosis modulators|mesh-ancestor
110347775|NCT03586999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110347776|NCT03586999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110347778|NCT03586999|Hormones|hormones|mesh-ancestor
110347779|NCT03586999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110347780|NCT03586999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110347781|NCT03537495|Linezolid|linezolid|mesh-list
110347782|NCT03537495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110347783|NCT03537495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110347784|NCT03537495|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110347785|NCT03537495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110347786|NCT03537495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347787|NCT03533582|Cisplatin|cisplatin|mesh-list
110347788|NCT03533582|Carboplatin|carboplatin|mesh-list
110347789|NCT03533582|Gemcitabine|gemcitabine|mesh-list
110347790|NCT03533582|Doxorubicin|doxorubicin|mesh-list
110347791|NCT03533582|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110347792|NCT03533582|Fluorouracil|fluorouracil|mesh-list
110347793|NCT03533582|Oxaliplatin|oxaliplatin|mesh-list
110347794|NCT03533582|Irinotecan|irinotecan|mesh-list
110347795|NCT03533582|Etoposide|etoposide|mesh-list
110347796|NCT03533582|Vincristine|vincristine|mesh-list
110347797|NCT03533582|Etoposide phosphate|etoposide phosphate|mesh-list
110347798|NCT03533582|Sorafenib|sorafenib|mesh-list
110347799|NCT03533582|Daunorubicin|daunorubicin|mesh-list
110347800|NCT03533582|Podophyllotoxin|podophyllotoxin|mesh-list
110347801|NCT03533582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110347802|NCT03533582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110347803|NCT03533582|Antimetabolites|antimetabolites|mesh-ancestor
110347804|NCT03533582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347805|NCT03533582|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110347806|NCT03533582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110175441|NCT00074191|Hormones|hormones|mesh-ancestor
110347807|NCT03533582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110347808|NCT03533582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110347809|NCT03533582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110347810|NCT03533582|Immunologic Factors|immunologic factors|mesh-ancestor
110347811|NCT03533582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110347812|NCT03533582|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110347813|NCT03533582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110347814|NCT03533582|Tubulin Modulators|tubulin modulators|mesh-ancestor
110347815|NCT03533582|Antimitotic Agents|antimitotic agents|mesh-ancestor
110347816|NCT03533582|Mitosis Modulators|mitosis modulators|mesh-ancestor
110347817|NCT03533582|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110347818|NCT03533582|Keratolytic Agents|keratolytic agents|mesh-ancestor
110347819|NCT03533582|Dermatologic Agents|dermatologic agents|mesh-ancestor
110347820|NCT03533283|Atezolizumab|atezolizumab|mesh-list
110347821|NCT03533283|Obinutuzumab|obinutuzumab|mesh-list
110347822|NCT03533283|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
110347823|NCT03533283|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110347824|NCT03533283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347825|NCT03533283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110347827|NCT03533283|Immunoconjugates|immunoconjugates|mesh-ancestor
110347828|NCT03533283|Immunologic Factors|immunologic factors|mesh-ancestor
110347829|NCT03533283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110347830|NCT03522168|Risperidone|risperidone|mesh-list
110347831|NCT03522168|Aripiprazole|aripiprazole|mesh-list
110347832|NCT03522168|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110347833|NCT03522168|Serotonin Agents|serotonin agents|mesh-ancestor
110347834|NCT03522168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110347835|NCT03522168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347836|NCT03522168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110347837|NCT03522168|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110347838|NCT03522168|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110347839|NCT03522168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110347840|NCT03522168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110347841|NCT03522168|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110347842|NCT03522168|Dopamine Agents|dopamine agents|mesh-ancestor
110347843|NCT03522168|Antidepressive Agents|antidepressive agents|mesh-ancestor
110347844|NCT03522168|Dopamine Agonists|dopamine agonists|mesh-ancestor
110347845|NCT03522168|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110347846|NCT03522168|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110347847|NCT03522168|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110347848|NCT03522168|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110347850|NCT03518606|Vinorelbine|vinorelbine|mesh-list
110347851|NCT03518606|Tremelimumab|tremelimumab|mesh-list
110347852|NCT03518606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110347853|NCT03518606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110347854|NCT03518606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110347855|NCT03518606|Tubulin Modulators|tubulin modulators|mesh-ancestor
110347856|NCT03518606|Antimitotic Agents|antimitotic agents|mesh-ancestor
110347857|NCT03518606|Mitosis Modulators|mitosis modulators|mesh-ancestor
110347858|NCT03518606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347860|NCT03508570|Ipilimumab|ipilimumab|mesh-list
110347861|NCT03508570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110347862|NCT03508570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110347863|NCT03508570|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110347864|NCT03508570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347865|NCT03486873|Pembrolizumab|pembrolizumab|mesh-list
110347866|NCT03486873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110347867|NCT03486873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110347868|NCT03486873|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110347869|NCT03486873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347870|NCT03480672|Pembrolizumab|pembrolizumab|mesh-list
110347871|NCT03480672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110347872|NCT03480672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110175449|NCT00074191|Antimetabolites|antimetabolites|mesh-ancestor
110347873|NCT03480672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110347874|NCT03480672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347875|NCT03475186|Ramipril|ramipril|mesh-list
110347876|NCT03475186|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110347877|NCT03475186|Protease Inhibitors|protease inhibitors|mesh-ancestor
110347878|NCT03475186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110347879|NCT03475186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347880|NCT03475186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110347881|NCT03450122|Aldesleukin|aldesleukin|mesh-list
110347882|NCT03450122|Cyclophosphamide|cyclophosphamide|mesh-list
110347883|NCT03450122|Interleukin-2|interleukin-2|mesh-list
110347884|NCT03450122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110347885|NCT03450122|Immunologic Factors|immunologic factors|mesh-ancestor
110347886|NCT03450122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110347887|NCT03450122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110347888|NCT03450122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110347889|NCT03450122|Alkylating Agents|alkylating agents|mesh-ancestor
110347890|NCT03450122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347891|NCT03450122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110347892|NCT03450122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110347893|NCT03450122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110347894|NCT03450122|Analgesics|analgesics|mesh-ancestor
110347895|NCT03450122|Sensory System Agents|sensory system agents|mesh-ancestor
110347896|NCT03450122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110347897|NCT03450122|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110347898|NCT03450122|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110347899|NCT03450122|Antiviral Agents|antiviral agents|mesh-ancestor
110347900|NCT03450122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110347901|NCT03448042|Trastuzumab|trastuzumab|mesh-list
110347902|NCT03448042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110347903|NCT03448042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110347904|NCT03436745|Zolpidem|zolpidem|mesh-list
110347905|NCT03436745|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110347906|NCT03436745|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110347907|NCT03436745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110347908|NCT03436745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110347909|NCT03436745|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110347910|NCT03436745|GABA Agonists|gaba agonists|mesh-ancestor
110347911|NCT03436745|GABA Agents|gaba agents|mesh-ancestor
110347912|NCT03436745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110347913|NCT03436745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347914|NCT03407144|Prednisone|prednisone|mesh-list
110347915|NCT03407144|Prednisolone|prednisolone|mesh-list
110347916|NCT03407144|Cyclophosphamide|cyclophosphamide|mesh-list
110347917|NCT03407144|Dacarbazine|dacarbazine|mesh-list
110347918|NCT03407144|Doxorubicin|doxorubicin|mesh-list
110347919|NCT03407144|Pembrolizumab|pembrolizumab|mesh-list
110347920|NCT03407144|Etoposide|etoposide|mesh-list
110347921|NCT03407144|Etoposide phosphate|etoposide phosphate|mesh-list
110347922|NCT03407144|Vincristine|vincristine|mesh-list
110347924|NCT03407144|Vinblastine|vinblastine|mesh-list
110347925|NCT03407144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110347926|NCT03407144|Immunologic Factors|immunologic factors|mesh-ancestor
110347927|NCT03407144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110347928|NCT03407144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110347929|NCT03407144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110347930|NCT03407144|Alkylating Agents|alkylating agents|mesh-ancestor
110347931|NCT03407144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347932|NCT03407144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110347933|NCT03407144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110347934|NCT03407144|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110347935|NCT03407144|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110347936|NCT03407144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110347937|NCT03407144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110347938|NCT03407144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110347939|NCT03407144|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110347940|NCT03407144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110347941|NCT03407144|Glucocorticoids|glucocorticoids|mesh-ancestor
110347942|NCT03407144|Hormones|hormones|mesh-ancestor
110347943|NCT03407144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110347944|NCT03407144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110347945|NCT03407144|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110347946|NCT03407144|Tubulin Modulators|tubulin modulators|mesh-ancestor
110347947|NCT03407144|Antimitotic Agents|antimitotic agents|mesh-ancestor
110347948|NCT03407144|Mitosis Modulators|mitosis modulators|mesh-ancestor
110347949|NCT03390296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110347950|NCT03390296|Avelumab|avelumab|mesh-list
110347951|NCT03390296|Gemtuzumab|gemtuzumab|mesh-list
110347952|NCT03390296|Azacitidine|azacitidine|mesh-list
110347953|NCT03390296|Venetoclax|venetoclax|mesh-list
110347954|NCT03390296|Calicheamicins|calicheamicins|mesh-list
110347955|NCT03390296|Antibodies|antibodies|mesh-list
110347956|NCT03390296|Immunoglobulins|immunoglobulins|mesh-list
110347957|NCT03390296|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110347958|NCT03390296|Maleic acid|maleic acid|mesh-list
110347959|NCT03390296|Immunologic Factors|immunologic factors|mesh-ancestor
110347960|NCT03390296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110347961|NCT03390296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110347962|NCT03390296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110347963|NCT03390296|Antimetabolites|antimetabolites|mesh-ancestor
110347964|NCT03390296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347965|NCT03390296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110347966|NCT03390296|Immunotoxins|immunotoxins|mesh-ancestor
110347967|NCT03390296|Immunoconjugates|immunoconjugates|mesh-ancestor
110347968|NCT03390296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110347969|NCT03386240|Triclosan|triclosan|mesh-list
110347970|NCT03386240|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110347971|NCT03386240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110347972|NCT03386240|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110347973|NCT03386240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110347974|NCT03386240|Antimetabolites|antimetabolites|mesh-ancestor
110347975|NCT03386240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347976|NCT03386240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110347977|NCT03384537|Chlorhexidine|chlorhexidine|mesh-list
110347978|NCT03384537|Listerine|listerine|mesh-list
110347979|NCT03384537|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110347980|NCT03384537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110347981|NCT03384537|Disinfectants|disinfectants|mesh-ancestor
110347983|NCT03383458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110347984|NCT03383458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110347985|NCT03383458|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110347986|NCT03383458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347987|NCT03370406|Fluorouracil|fluorouracil|mesh-list
110347988|NCT03370406|Imiquimod|imiquimod|mesh-list
110347989|NCT03370406|Antimetabolites|antimetabolites|mesh-ancestor
110347990|NCT03370406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347991|NCT03370406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110347992|NCT03370406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110347993|NCT03370406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110347994|NCT03370406|Immunologic Factors|immunologic factors|mesh-ancestor
110347995|NCT03370406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110347996|NCT03370406|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110347997|NCT03370406|Interferon Inducers|interferon inducers|mesh-ancestor
110347999|NCT03360721|Cortisone|cortisone|mesh-list
110348000|NCT03360721|Abiraterone Acetate|abiraterone acetate|mesh-list
110348001|NCT03360721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110348002|NCT03360721|Glucocorticoids|glucocorticoids|mesh-ancestor
110348003|NCT03360721|Hormones|hormones|mesh-ancestor
110348004|NCT03360721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110348005|NCT03360721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110348006|NCT03360721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110348007|NCT03360721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110348008|NCT03360721|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110348009|NCT03360721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110348010|NCT03360721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110348011|NCT03360721|Hormone Antagonists|hormone antagonists|mesh-ancestor
110348012|NCT03360721|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110348013|NCT03339128|Eluxadoline|eluxadoline|mesh-list
110348014|NCT03339128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110348015|NCT03338387|Acipimox|acipimox|mesh-list
110348016|NCT03338387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110348017|NCT03338387|Antimetabolites|antimetabolites|mesh-ancestor
110348018|NCT03338387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110348019|NCT03338387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110348020|NCT03334253|Atropine|atropine|mesh-list
110348021|NCT03334253|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110348022|NCT03334253|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110348023|NCT03334253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110348024|NCT03334253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110348025|NCT03334253|Autonomic Agents|autonomic agents|mesh-ancestor
110348026|NCT03334253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110348027|NCT03334253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110348028|NCT03334253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110348029|NCT03334253|Respiratory System Agents|respiratory system agents|mesh-ancestor
110348030|NCT03334253|Mydriatics|mydriatics|mesh-ancestor
110348031|NCT03334253|Parasympatholytics|parasympatholytics|mesh-ancestor
110348032|NCT03334253|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110348033|NCT03334253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110348034|NCT03334253|Cholinergic Agents|cholinergic agents|mesh-ancestor
110348035|NCT03334253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110348036|NCT03334253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110348037|NCT03334253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110348038|NCT03306264|Decitabine|decitabine|mesh-list
110348039|NCT03306264|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
110348040|NCT03306264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110348042|NCT03306264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110348043|NCT03306264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110348044|NCT03306264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110348045|NCT03304080|Trastuzumab|trastuzumab|mesh-list
110348046|NCT03304080|Pertuzumab|pertuzumab|mesh-list
110348047|NCT03304080|Palbociclib|palbociclib|mesh-list
110348048|NCT03304080|Anastrozole|anastrozole|mesh-list
110348049|NCT03304080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110348050|NCT03304080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110348051|NCT03304080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110348052|NCT03304080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110348053|NCT03304080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110348054|NCT03304080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110348055|NCT03304080|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110348056|NCT03304080|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110348057|NCT03304080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110348058|NCT03304080|Hormone Antagonists|hormone antagonists|mesh-ancestor
110348059|NCT03304080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110348060|NCT03304080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110348062|NCT03294460|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110348063|NCT03294460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110348064|NCT03294460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110348065|NCT03294460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110348066|NCT03277196|Ivacaftor|ivacaftor|mesh-list
110348067|NCT03277196|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110348068|NCT03277196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110348069|NCT03277196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110348070|NCT03276832|Pembrolizumab|pembrolizumab|mesh-list
110348071|NCT03276832|Imiquimod|imiquimod|mesh-list
110348072|NCT03276832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110348073|NCT03276832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110348074|NCT03276832|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110348075|NCT03276832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110348076|NCT03276832|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110348077|NCT03276832|Immunologic Factors|immunologic factors|mesh-ancestor
110348078|NCT03276832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110348079|NCT03276832|Interferon Inducers|interferon inducers|mesh-ancestor
110348080|NCT03275506|Bevacizumab|bevacizumab|mesh-list
110348081|NCT03275506|Pembrolizumab|pembrolizumab|mesh-list
110348082|NCT03275506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110348083|NCT03275506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110348084|NCT03275506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110348085|NCT03275506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110348086|NCT03275506|Growth Substances|growth substances|mesh-ancestor
110348087|NCT03275506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110348088|NCT03275506|Growth Inhibitors|growth inhibitors|mesh-ancestor
110348089|NCT03275506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110348090|NCT03275506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110348091|NCT03268954|Azacitidine|azacitidine|mesh-list
110348092|NCT03268954|Pevonedistat|pevonedistat|mesh-list
110348093|NCT03268954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110348094|NCT03268954|Antimetabolites|antimetabolites|mesh-ancestor
110348095|NCT03268954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110348097|NCT03268954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110348098|NCT03267680|Indomethacin|indomethacin|mesh-list
110348099|NCT03267680|Cyclophosphamide|cyclophosphamide|mesh-list
110348100|NCT03267680|Omeprazole|omeprazole|mesh-list
110348101|NCT03267680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110348102|NCT03267680|Immunologic Factors|immunologic factors|mesh-ancestor
110348103|NCT03267680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110348104|NCT03267680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110348105|NCT03267680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110348106|NCT03267680|Alkylating Agents|alkylating agents|mesh-ancestor
110348107|NCT03267680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110348108|NCT03267680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110348109|NCT03267680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110348110|NCT03267680|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110348111|NCT03267680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110348112|NCT03267680|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110348113|NCT03267680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110348114|NCT03267680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110348115|NCT03267680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110348117|NCT03267680|Sensory System Agents|sensory system agents|mesh-ancestor
110348119|NCT03267680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110348120|NCT03267680|Gout Suppressants|gout suppressants|mesh-ancestor
110348121|NCT03267680|Tocolytic Agents|tocolytic agents|mesh-ancestor
110348122|NCT03267680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110348123|NCT03267680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110348124|NCT03249870|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
110348125|NCT03249870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110348126|NCT03249870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110348127|NCT03249870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110348128|NCT03249870|Immunotoxins|immunotoxins|mesh-ancestor
110348129|NCT03249870|Immunoconjugates|immunoconjugates|mesh-ancestor
110348130|NCT03249870|Immunologic Factors|immunologic factors|mesh-ancestor
110348131|NCT03249870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110348132|NCT03240068|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
110348133|NCT03240068|Angiotensin II|angiotensin ii|mesh-list
110348134|NCT03240068|Angiotensinogen|angiotensinogen|mesh-list
110348135|NCT03240068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110348136|NCT03240068|Vasodilator Agents|vasodilator agents|mesh-ancestor
110348137|NCT03240068|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110348138|NCT03240068|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110348139|NCT03240068|Protease Inhibitors|protease inhibitors|mesh-ancestor
110348140|NCT03240068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110348141|NCT03240068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110348142|NCT03235739|Naloxegol|naloxegol|mesh-list
110348143|NCT03235739|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110348144|NCT03235739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110348145|NCT03235739|Sensory System Agents|sensory system agents|mesh-ancestor
110348146|NCT03235739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110348147|NCT03223610|Prednisone|prednisone|mesh-list
110348148|NCT03223610|Lenalidomide|lenalidomide|mesh-list
110348149|NCT03223610|Venetoclax|venetoclax|mesh-list
110348150|NCT03223610|Obinutuzumab|obinutuzumab|mesh-list
110348151|NCT03223610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110348152|NCT03223610|Glucocorticoids|glucocorticoids|mesh-ancestor
110348153|NCT03223610|Hormones|hormones|mesh-ancestor
110348154|NCT03223610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110348155|NCT03223610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110348156|NCT03223610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110348157|NCT03223610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110348158|NCT03223610|Immunologic Factors|immunologic factors|mesh-ancestor
110348159|NCT03223610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110348160|NCT03223610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110348161|NCT03223610|Growth Substances|growth substances|mesh-ancestor
110348162|NCT03223610|Growth Inhibitors|growth inhibitors|mesh-ancestor
110348163|NCT03223610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110348164|NCT03210688|Alfacalcidol|alfacalcidol|mesh-list
110348165|NCT03210688|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
110348167|NCT03210688|Prednisolone|prednisolone|mesh-list
110348168|NCT03210688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110348170|NCT03210688|Hormones|hormones|mesh-ancestor
110348171|NCT03210688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110348172|NCT03210688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110348173|NCT03210688|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110348174|NCT03210688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110348175|NCT03210688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110348176|NCT03210688|Vitamins|vitamins|mesh-ancestor
110348177|NCT03210688|Micronutrients|micronutrients|mesh-ancestor
110348178|NCT03194893|Crizotinib|crizotinib|mesh-list
110348179|NCT03194893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110348180|NCT03194893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110348181|NCT03194893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110348182|NCT03194893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110348183|NCT03178552|Bevacizumab|bevacizumab|mesh-list
110348184|NCT03178552|Atezolizumab|atezolizumab|mesh-list
110348185|NCT03178552|Carboplatin|carboplatin|mesh-list
110348186|NCT03178552|Gemcitabine|gemcitabine|mesh-list
110348187|NCT03178552|Docetaxel|docetaxel|mesh-list
110348188|NCT03178552|Pemetrexed|pemetrexed|mesh-list
110348189|NCT03178552|Vemurafenib|vemurafenib|mesh-list
110348190|NCT03178552|Entrectinib|entrectinib|mesh-list
110348191|NCT03178552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110348192|NCT03178552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110348193|NCT03178552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110348194|NCT03178552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110348195|NCT03178552|Growth Substances|growth substances|mesh-ancestor
110348196|NCT03178552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110348197|NCT03178552|Growth Inhibitors|growth inhibitors|mesh-ancestor
110348198|NCT03178552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110348199|NCT03178552|Antimetabolites|antimetabolites|mesh-ancestor
110348200|NCT03178552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110348201|NCT03178552|Tubulin Modulators|tubulin modulators|mesh-ancestor
110348202|NCT03178552|Antimitotic Agents|antimitotic agents|mesh-ancestor
110348203|NCT03178552|Mitosis Modulators|mitosis modulators|mesh-ancestor
110348204|NCT03178552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110348205|NCT03178552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110348206|NCT03178552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110348207|NCT03178552|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110348208|NCT03178552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110348209|NCT03153410|Cyclophosphamide|cyclophosphamide|mesh-list
110348210|NCT03153410|Pembrolizumab|pembrolizumab|mesh-list
110348211|NCT03153410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110348212|NCT03153410|Immunologic Factors|immunologic factors|mesh-ancestor
110348213|NCT03153410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110348214|NCT03153410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110348215|NCT03153410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110348216|NCT03153410|Alkylating Agents|alkylating agents|mesh-ancestor
110348217|NCT03153410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110348218|NCT03153410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110348219|NCT03153410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110348220|NCT03153410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110348221|NCT03153410|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110348222|NCT03153202|Pembrolizumab|pembrolizumab|mesh-list
110348223|NCT03153202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110348224|NCT03153202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110348225|NCT03153202|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110348226|NCT03153202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110348227|NCT03109795|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110348228|NCT03109795|Clonidine|clonidine|mesh-list
110348230|NCT03109795|Diuretics|diuretics|mesh-ancestor
110348231|NCT03109795|Natriuretic Agents|natriuretic agents|mesh-ancestor
110348232|NCT03109795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110348233|NCT03109795|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110348234|NCT03109795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110348235|NCT03109795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110348236|NCT03109795|Analgesics|analgesics|mesh-ancestor
110348237|NCT03109795|Sensory System Agents|sensory system agents|mesh-ancestor
110348238|NCT03109795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110348239|NCT03109795|Sympatholytics|sympatholytics|mesh-ancestor
110348240|NCT03109795|Autonomic Agents|autonomic agents|mesh-ancestor
110348241|NCT03109795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110348242|NCT03109795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110348243|NCT03109795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110348244|NCT03109795|Adrenergic Agents|adrenergic agents|mesh-ancestor
110348245|NCT03109795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110348246|NCT03087760|Pembrolizumab|pembrolizumab|mesh-list
110348247|NCT03087760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110348248|NCT03087760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110348249|NCT03087760|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110348250|NCT03087760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110348251|NCT03065335|Ketamine|ketamine|mesh-list
110348252|NCT03065335|Analgesics|analgesics|mesh-ancestor
110348253|NCT03065335|Sensory System Agents|sensory system agents|mesh-ancestor
110348254|NCT03065335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110348255|NCT03065335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110348256|NCT03065335|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110348257|NCT03065335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110348258|NCT03065335|Anesthetics, General|anesthetics, general|mesh-ancestor
110348259|NCT03065335|Anesthetics|anesthetics|mesh-ancestor
110348260|NCT03065335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110348261|NCT03065335|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110348262|NCT03065335|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110348263|NCT03065335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110348264|NCT03065335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110348265|NCT03006172|Metformin|metformin|mesh-list
110348266|NCT03006172|Trastuzumab|trastuzumab|mesh-list
110348267|NCT03006172|Pertuzumab|pertuzumab|mesh-list
110348268|NCT03006172|Letrozole|letrozole|mesh-list
110348269|NCT03006172|Fulvestrant|fulvestrant|mesh-list
110348270|NCT03006172|Palbociclib|palbociclib|mesh-list
110348271|NCT03006172|Inavolisib|inavolisib|mesh-list
110348272|NCT03006172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110348273|NCT03006172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110348274|NCT03006172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110348275|NCT03006172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110348276|NCT03006172|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110348277|NCT03006172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110348278|NCT03006172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110348279|NCT03006172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110348280|NCT03006172|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110348281|NCT03006172|Hormone Antagonists|hormone antagonists|mesh-ancestor
110348282|NCT03006172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110348283|NCT03006172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110348284|NCT03006172|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110348285|NCT03006172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110348286|NCT03006172|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
110348287|NCT03000439|Tofacitinib|tofacitinib|mesh-list
110348288|NCT03000439|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110348289|NCT03000439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110348290|NCT03000439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110348291|NCT03000439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110348292|NCT02980510|Leucovorin|leucovorin|mesh-list
110348293|NCT02980510|Folic Acid|folic acid|mesh-list
110348294|NCT02980510|Oxaliplatin|oxaliplatin|mesh-list
110348295|NCT02980510|Irinotecan|irinotecan|mesh-list
110348296|NCT02980510|Panitumumab|panitumumab|mesh-list
110348297|NCT02980510|Fluorouracil|fluorouracil|mesh-list
110348298|NCT02980510|Levoleucovorin|levoleucovorin|mesh-list
110348299|NCT02980510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110348300|NCT02980510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110348302|NCT02980510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110348303|NCT02980510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110348304|NCT02980510|Antidotes|antidotes|mesh-ancestor
110348305|NCT02980510|Protective Agents|protective agents|mesh-ancestor
110348306|NCT02980510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110348307|NCT02980510|Vitamin B Complex|vitamin b complex|mesh-ancestor
110348308|NCT02980510|Vitamins|vitamins|mesh-ancestor
110348309|NCT02980510|Micronutrients|micronutrients|mesh-ancestor
110348310|NCT02980510|Hematinics|hematinics|mesh-ancestor
110348311|NCT02980510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110348312|NCT02980510|Antimetabolites|antimetabolites|mesh-ancestor
110348313|NCT02980510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110348314|NCT02980510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110348315|NCT02980510|Immunologic Factors|immunologic factors|mesh-ancestor
110348316|NCT02971956|Pembrolizumab|pembrolizumab|mesh-list
110348317|NCT02971956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110348318|NCT02971956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110348319|NCT02971956|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110348320|NCT02971956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110348322|NCT02967289|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110348323|NCT02967289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110348324|NCT02967289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110348325|NCT02967289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110348326|NCT02967289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110348327|NCT02939742|Betamethasone|betamethasone|mesh-list
110348328|NCT02939742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110348329|NCT02939742|Glucocorticoids|glucocorticoids|mesh-ancestor
110348330|NCT02939742|Hormones|hormones|mesh-ancestor
110348331|NCT02939742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110348332|NCT02939742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110348333|NCT02939742|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110348334|NCT02939742|Respiratory System Agents|respiratory system agents|mesh-ancestor
110348335|NCT02927769|Nivolumab|nivolumab|mesh-list
110348336|NCT02927769|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110348337|NCT02927769|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110348338|NCT02927769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110348339|NCT02927769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110348340|NCT02927769|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110348341|NCT02927769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110348342|NCT02927769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110348343|NCT02927769|Alkylating Agents|alkylating agents|mesh-ancestor
110348344|NCT02927769|Immunotoxins|immunotoxins|mesh-ancestor
110348345|NCT02927769|Immunoconjugates|immunoconjugates|mesh-ancestor
110348346|NCT02927769|Immunologic Factors|immunologic factors|mesh-ancestor
110348347|NCT02927769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110348348|NCT02902484|Nintedanib|nintedanib|mesh-list
110348349|NCT02902484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110348350|NCT02902484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110348351|NCT02902484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110348352|NCT02902484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110348353|NCT02891811|Thalidomide|thalidomide|mesh-list
110348354|NCT02891811|Dexamethasone|dexamethasone|mesh-list
110348355|NCT02891811|Lenalidomide|lenalidomide|mesh-list
110348356|NCT02891811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110348357|NCT02891811|Antiemetics|antiemetics|mesh-ancestor
110348358|NCT02891811|Autonomic Agents|autonomic agents|mesh-ancestor
110348359|NCT02891811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110348360|NCT02891811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110348361|NCT02891811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110348362|NCT02891811|Glucocorticoids|glucocorticoids|mesh-ancestor
110348363|NCT02891811|Hormones|hormones|mesh-ancestor
110348364|NCT02891811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110348365|NCT02891811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110348366|NCT02891811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110348367|NCT02891811|Immunologic Factors|immunologic factors|mesh-ancestor
110348368|NCT02891811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110348369|NCT02891811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110348370|NCT02891811|Growth Substances|growth substances|mesh-ancestor
110348371|NCT02891811|Growth Inhibitors|growth inhibitors|mesh-ancestor
110348372|NCT02891811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110348373|NCT02891811|Leprostatic Agents|leprostatic agents|mesh-ancestor
110348374|NCT02891811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110348375|NCT02891811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110348376|NCT02880293|Mycophenolic Acid|mycophenolic acid|mesh-list
110348377|NCT02880293|Cyclophosphamide|cyclophosphamide|mesh-list
110348379|NCT02880293|Thiotepa|thiotepa|mesh-list
110348380|NCT02880293|Fludarabine|fludarabine|mesh-list
110348381|NCT02880293|Tacrolimus|tacrolimus|mesh-list
110348382|NCT02880293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110348383|NCT02880293|Immunologic Factors|immunologic factors|mesh-ancestor
110348384|NCT02880293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110348385|NCT02880293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110348386|NCT02880293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110348387|NCT02880293|Alkylating Agents|alkylating agents|mesh-ancestor
110175494|NCT04767776|Protease Inhibitors|protease inhibitors|mesh-ancestor
110348388|NCT02880293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110348389|NCT02880293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110348390|NCT02880293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110348391|NCT02880293|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110348392|NCT02880293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110348393|NCT02880293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110348394|NCT02880293|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110348395|NCT02880293|Antitubercular Agents|antitubercular agents|mesh-ancestor
110348396|NCT02880293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110348397|NCT02880293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110348399|NCT02864394|Pembrolizumab|pembrolizumab|mesh-list
110348400|NCT02864394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110348401|NCT02864394|Tubulin Modulators|tubulin modulators|mesh-ancestor
110348402|NCT02864394|Antimitotic Agents|antimitotic agents|mesh-ancestor
110348403|NCT02864394|Mitosis Modulators|mitosis modulators|mesh-ancestor
110348404|NCT02864394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110348405|NCT02864394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110348406|NCT02864394|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110348407|NCT02858310|Aldesleukin|aldesleukin|mesh-list
110348408|NCT02858310|Cyclophosphamide|cyclophosphamide|mesh-list
110348409|NCT02858310|Fludarabine|fludarabine|mesh-list
110348410|NCT02858310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110348411|NCT02858310|Immunologic Factors|immunologic factors|mesh-ancestor
110348412|NCT02858310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110348413|NCT02858310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110348414|NCT02858310|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110348415|NCT02858310|Alkylating Agents|alkylating agents|mesh-ancestor
110348416|NCT02858310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110348417|NCT02858310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110348418|NCT02858310|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110348419|NCT02858310|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110348420|NCT02858310|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110348421|NCT02858310|Antiviral Agents|antiviral agents|mesh-ancestor
110348422|NCT02858310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110348423|NCT02845882|Cytarabine|cytarabine|mesh-list
110348424|NCT02845882|Dexamethasone|dexamethasone|mesh-list
110348425|NCT02845882|Dexamethasone acetate|dexamethasone acetate|mesh-list
110348426|NCT02845882|Prednisone|prednisone|mesh-list
110348427|NCT02845882|Cyclophosphamide|cyclophosphamide|mesh-list
110348428|NCT02845882|Ifosfamide|ifosfamide|mesh-list
110348429|NCT02845882|Doxorubicin|doxorubicin|mesh-list
110348430|NCT02845882|Methotrexate|methotrexate|mesh-list
110348431|NCT02845882|Etoposide|etoposide|mesh-list
110348432|NCT02845882|Vincristine|vincristine|mesh-list
110348433|NCT02845882|Daunorubicin|daunorubicin|mesh-list
110348434|NCT02845882|Asparaginase|asparaginase|mesh-list
110348435|NCT02845882|Mercaptopurine|mercaptopurine|mesh-list
110348436|NCT02845882|Vindesine|vindesine|mesh-list
110348437|NCT02845882|Pegaspargase|pegaspargase|mesh-list
110348438|NCT02845882|BB 1101|bb 1101|mesh-list
110348439|NCT02845882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110348440|NCT02845882|Immunologic Factors|immunologic factors|mesh-ancestor
110348441|NCT02845882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110348442|NCT02845882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110348443|NCT02845882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110348445|NCT02845882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110348446|NCT02845882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110348447|NCT02845882|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110348448|NCT02845882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110348449|NCT02845882|Antiemetics|antiemetics|mesh-ancestor
110348450|NCT02845882|Autonomic Agents|autonomic agents|mesh-ancestor
110348451|NCT02845882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110348452|NCT02845882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110348453|NCT02845882|Glucocorticoids|glucocorticoids|mesh-ancestor
110348454|NCT02845882|Hormones|hormones|mesh-ancestor
110348455|NCT02845882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110348456|NCT02845882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110348457|NCT02845882|Protease Inhibitors|protease inhibitors|mesh-ancestor
110348458|NCT02845882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110348459|NCT02845882|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110348460|NCT02845882|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110348461|NCT02845882|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110348462|NCT02845882|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110348463|NCT02845882|Abortifacient Agents|abortifacient agents|mesh-ancestor
110348464|NCT02845882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110348465|NCT02845882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110348466|NCT02845882|Antimetabolites|antimetabolites|mesh-ancestor
110348467|NCT02845882|Dermatologic Agents|dermatologic agents|mesh-ancestor
110348468|NCT02845882|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110348469|NCT02845882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110348470|NCT02845882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110348471|NCT02845882|Antiviral Agents|antiviral agents|mesh-ancestor
110348472|NCT02845882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110348473|NCT02845882|Tubulin Modulators|tubulin modulators|mesh-ancestor
110348474|NCT02845882|Antimitotic Agents|antimitotic agents|mesh-ancestor
110348475|NCT02845882|Mitosis Modulators|mitosis modulators|mesh-ancestor
110348476|NCT02829918|Nivolumab|nivolumab|mesh-list
110348477|NCT02829918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110348478|NCT02829918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110348479|NCT02829918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110348480|NCT02829918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110348481|NCT02808650|Prexasertib|prexasertib|mesh-list
110030636|NCT01387204|Trametinib|trametinib|mesh-list
110348482|NCT02808650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110348483|NCT02808650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110348484|NCT02808650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110348485|NCT02789020|Rasagiline|rasagiline|mesh-list
110348486|NCT02789020|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110348487|NCT02789020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110348488|NCT02789020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110348489|NCT02789020|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110348490|NCT02789020|Protective Agents|protective agents|mesh-ancestor
110348491|NCT02789020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110348492|NCT02784210|Prednisone|prednisone|mesh-list
110348493|NCT02784210|Methylprednisolone|methylprednisolone|mesh-list
110348494|NCT02784210|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110348495|NCT02784210|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110348496|NCT02784210|Prednisolone|prednisolone|mesh-list
110348497|NCT02784210|Prednisolone acetate|prednisolone acetate|mesh-list
110348498|NCT02784210|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110348499|NCT02784210|Prednisolone phosphate|prednisolone phosphate|mesh-list
110348500|NCT02784210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110348501|NCT02784210|Glucocorticoids|glucocorticoids|mesh-ancestor
110348502|NCT02784210|Hormones|hormones|mesh-ancestor
110348503|NCT02784210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110348504|NCT02784210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110348505|NCT02784210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110348506|NCT02784210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110348507|NCT02784210|Antiemetics|antiemetics|mesh-ancestor
110348508|NCT02784210|Autonomic Agents|autonomic agents|mesh-ancestor
110348509|NCT02784210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110348510|NCT02784210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110348511|NCT02784210|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110348512|NCT02784210|Protective Agents|protective agents|mesh-ancestor
110348513|NCT02768792|Pembrolizumab|pembrolizumab|mesh-list
110348514|NCT02768792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110348515|NCT02768792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110348516|NCT02768792|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110348517|NCT02768792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110348518|NCT02719314|Methylprednisolone|methylprednisolone|mesh-list
110348519|NCT02719314|Glucocorticoids|glucocorticoids|mesh-list
110348520|NCT02719314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110348521|NCT02719314|Antiemetics|antiemetics|mesh-ancestor
110348522|NCT02719314|Autonomic Agents|autonomic agents|mesh-ancestor
110348523|NCT02719314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110348524|NCT02719314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110348525|NCT02719314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110348527|NCT02719314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110175506|NCT04730245|Rifaximin|rifaximin|mesh-list
110348528|NCT02719314|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110348529|NCT02719314|Protective Agents|protective agents|mesh-ancestor
110348530|NCT02672917|Paclitaxel|paclitaxel|mesh-list
110348531|NCT02672917|Gemcitabine|gemcitabine|mesh-list
110348532|NCT02672917|Folfirinox|folfirinox|mesh-list
110348533|NCT02672917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110348534|NCT02672917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110348535|NCT02672917|Tubulin Modulators|tubulin modulators|mesh-ancestor
110348536|NCT02672917|Antimitotic Agents|antimitotic agents|mesh-ancestor
110348537|NCT02672917|Mitosis Modulators|mitosis modulators|mesh-ancestor
110348538|NCT02672917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110348539|NCT02672917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110348540|NCT02672917|Antimetabolites|antimetabolites|mesh-ancestor
110348541|NCT02639273|Nalmefene|nalmefene|mesh-list
110348542|NCT02639273|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110348543|NCT02639273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110348544|NCT02639273|Sensory System Agents|sensory system agents|mesh-ancestor
110348545|NCT02639273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110348546|NCT02598362|Ciprofloxacin|ciprofloxacin|mesh-list
110348547|NCT02598362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110348548|NCT02598362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110348549|NCT02598362|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110348550|NCT02598362|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110348551|NCT02598362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110348552|NCT02598362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110348553|NCT02598362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110348554|NCT02598362|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110348555|NCT02598362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110348557|NCT02585388|Vinorelbine|vinorelbine|mesh-list
110348558|NCT02585388|Anastrozole|anastrozole|mesh-list
110348559|NCT02585388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110348560|NCT02585388|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110348561|NCT02585388|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110348562|NCT02585388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110348563|NCT02585388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110348564|NCT02585388|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110348565|NCT02585388|Hormone Antagonists|hormone antagonists|mesh-ancestor
110348566|NCT02585388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110348567|NCT02585388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110348568|NCT02585388|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110348569|NCT02585388|Tubulin Modulators|tubulin modulators|mesh-ancestor
110348570|NCT02585388|Antimitotic Agents|antimitotic agents|mesh-ancestor
110348571|NCT02585388|Mitosis Modulators|mitosis modulators|mesh-ancestor
110348572|NCT02585388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110348574|NCT02584465|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110348575|NCT02584465|Hormone Antagonists|hormone antagonists|mesh-ancestor
110348576|NCT02584465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110348577|NCT02584465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110348578|NCT02584465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110348579|NCT02584465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110348580|NCT02584465|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110348581|NCT02584465|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110348582|NCT02584465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110348583|NCT02579161|Ciprofloxacin|ciprofloxacin|mesh-list
110348584|NCT02579161|Clindamycin|clindamycin|mesh-list
110348585|NCT02579161|Gentamicins|gentamicins|mesh-list
110348586|NCT02579161|Penicillins|penicillins|mesh-list
110348587|NCT02579161|Ampicillin|ampicillin|mesh-list
110348588|NCT02579161|Cephalosporins|cephalosporins|mesh-list
110348589|NCT02579161|Fluoroquinolones|fluoroquinolones|mesh-list
110348590|NCT02579161|Lincosamides|lincosamides|mesh-list
110348591|NCT02579161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110348592|NCT02579161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110348593|NCT02579161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110348594|NCT02579161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110348595|NCT02579161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110348596|NCT02579161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110348597|NCT02579161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110348598|NCT02579161|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110348599|NCT02579161|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110348600|NCT02579161|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110348601|NCT02579161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110348602|NCT02568124|Tranexamic Acid|tranexamic acid|mesh-list
110348603|NCT02568124|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110348604|NCT02568124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110348605|NCT02568124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110348606|NCT02568124|Hemostatics|hemostatics|mesh-ancestor
110348607|NCT02568124|Coagulants|coagulants|mesh-ancestor
110348608|NCT02535533|Selenium|selenium|mesh-list
110348609|NCT02535533|Axitinib|axitinib|mesh-list
110348610|NCT02535533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110348611|NCT02535533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110348612|NCT02535533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110348613|NCT02535533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110348614|NCT02535533|Antioxidants|antioxidants|mesh-ancestor
110348615|NCT02535533|Protective Agents|protective agents|mesh-ancestor
110348616|NCT02535533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110348617|NCT02535533|Trace Elements|trace elements|mesh-ancestor
110348618|NCT02535533|Micronutrients|micronutrients|mesh-ancestor
110348619|NCT02532231|Nivolumab|nivolumab|mesh-list
110348620|NCT02532231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110348621|NCT02532231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110348622|NCT02532231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110348623|NCT02532231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110348624|NCT02498912|Cyclophosphamide|cyclophosphamide|mesh-list
110348625|NCT02498912|Fludarabine|fludarabine|mesh-list
110348626|NCT02498912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110348627|NCT02498912|Immunologic Factors|immunologic factors|mesh-ancestor
110348628|NCT02498912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110348629|NCT02498912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110348630|NCT02498912|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110348631|NCT02498912|Alkylating Agents|alkylating agents|mesh-ancestor
110348632|NCT02498912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110348633|NCT02498912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110348634|NCT02498912|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110348635|NCT02431897|Estrogens|estrogens|mesh-list
110348636|NCT02431897|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110348637|NCT02431897|Hormones|hormones|mesh-ancestor
110348638|NCT02431897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110348639|NCT02431897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110348640|NCT02427841|Paclitaxel|paclitaxel|mesh-list
110348641|NCT02427841|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110348642|NCT02427841|Gemcitabine|gemcitabine|mesh-list
110348643|NCT02427841|Fluorouracil|fluorouracil|mesh-list
110348644|NCT02427841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110348645|NCT02427841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110348646|NCT02427841|Tubulin Modulators|tubulin modulators|mesh-ancestor
110348647|NCT02427841|Antimitotic Agents|antimitotic agents|mesh-ancestor
110348648|NCT02427841|Mitosis Modulators|mitosis modulators|mesh-ancestor
110348649|NCT02427841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110348650|NCT02427841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110348651|NCT02427841|Antimetabolites|antimetabolites|mesh-ancestor
110348652|NCT02427841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110348653|NCT02427841|Immunologic Factors|immunologic factors|mesh-ancestor
110348654|NCT02427841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110348655|NCT02425566|Trimethaphan|trimethaphan|mesh-list
110348656|NCT02425566|Nitroglycerin|nitroglycerin|mesh-list
110348657|NCT02425566|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
110348658|NCT02425566|Vasodilator Agents|vasodilator agents|mesh-ancestor
110348659|NCT02425566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110348660|NCT02425566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110348661|NCT02425566|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
110348662|NCT02425566|Autonomic Agents|autonomic agents|mesh-ancestor
110348663|NCT02425566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110348664|NCT02425566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110348665|NCT02425566|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
110348666|NCT02425566|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110348667|NCT02425566|Cholinergic Agents|cholinergic agents|mesh-ancestor
110348668|NCT02425566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110348669|NCT02425566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110348671|NCT02386735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110348673|NCT02386735|Hormones|hormones|mesh-ancestor
110348674|NCT02386735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110348675|NCT02386735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110348676|NCT02386735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110348677|NCT02386735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110348678|NCT02383251|Paclitaxel|paclitaxel|mesh-list
110348679|NCT02383251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110348680|NCT02383251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110348681|NCT02383251|Tubulin Modulators|tubulin modulators|mesh-ancestor
110348682|NCT02383251|Antimitotic Agents|antimitotic agents|mesh-ancestor
110348683|NCT02383251|Mitosis Modulators|mitosis modulators|mesh-ancestor
110348684|NCT02383251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110348685|NCT02348216|Cyclophosphamide|cyclophosphamide|mesh-list
110348686|NCT02348216|Fludarabine|fludarabine|mesh-list
110348687|NCT02348216|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
110348688|NCT02348216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110348689|NCT02348216|Immunologic Factors|immunologic factors|mesh-ancestor
110348690|NCT02348216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110348691|NCT02348216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110348692|NCT02348216|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110348693|NCT02348216|Alkylating Agents|alkylating agents|mesh-ancestor
110348694|NCT02348216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110348695|NCT02348216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110348696|NCT02348216|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110348697|NCT02348216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110348698|NCT02310321|Cytarabine|cytarabine|mesh-list
110348699|NCT02310321|Idarubicin|idarubicin|mesh-list
110348700|NCT02310321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110348701|NCT02310321|Antimetabolites|antimetabolites|mesh-ancestor
110348702|NCT02310321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110348703|NCT02310321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110348704|NCT02310321|Antiviral Agents|antiviral agents|mesh-ancestor
110348705|NCT02310321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110348706|NCT02310321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110348707|NCT02310321|Immunologic Factors|immunologic factors|mesh-ancestor
110348708|NCT02310321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110348709|NCT02310321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110348710|NCT02310321|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110348711|NCT02310321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110348712|NCT02310321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110348713|NCT02288247|Prednisolone|prednisolone|mesh-list
110348714|NCT02288247|Docetaxel|docetaxel|mesh-list
110348715|NCT02288247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110348716|NCT02288247|Tubulin Modulators|tubulin modulators|mesh-ancestor
110348717|NCT02288247|Antimitotic Agents|antimitotic agents|mesh-ancestor
110348718|NCT02288247|Mitosis Modulators|mitosis modulators|mesh-ancestor
110348719|NCT02288247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110348720|NCT02288247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110348721|NCT02288247|Glucocorticoids|glucocorticoids|mesh-ancestor
110348722|NCT02288247|Hormones|hormones|mesh-ancestor
110348723|NCT02288247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110348724|NCT02288247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110348725|NCT02288247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110348726|NCT02218606|Prednisone|prednisone|mesh-list
110348727|NCT02218606|Abiraterone Acetate|abiraterone acetate|mesh-list
110348728|NCT02218606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110348729|NCT02218606|Glucocorticoids|glucocorticoids|mesh-ancestor
110348730|NCT02218606|Hormones|hormones|mesh-ancestor
110348731|NCT02218606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110348732|NCT02218606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110348733|NCT02218606|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110348734|NCT02218606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110348735|NCT02218606|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110348736|NCT02218606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110348737|NCT02218606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110348738|NCT02218606|Hormone Antagonists|hormone antagonists|mesh-ancestor
110348739|NCT02218606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110348740|NCT02204683|Aflibercept|aflibercept|mesh-list
110348741|NCT02204683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110348753|NCT02152995|Micronutrients|micronutrients|mesh-ancestor
110348754|NCT02152995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110348755|NCT02152995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110348756|NCT02152995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110348757|NCT02152995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110348758|NCT02152995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110348769|NCT02135042|Paclitaxel|paclitaxel|mesh-list
110348770|NCT02135042|Cisplatin|cisplatin|mesh-list
110348771|NCT02135042|Gemcitabine|gemcitabine|mesh-list
110348772|NCT02135042|Fluorouracil|fluorouracil|mesh-list
110348773|NCT02135042|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110348774|NCT02135042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110348775|NCT02135042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110348776|NCT02135042|Tubulin Modulators|tubulin modulators|mesh-ancestor
110348777|NCT02135042|Antimitotic Agents|antimitotic agents|mesh-ancestor
110348778|NCT02135042|Mitosis Modulators|mitosis modulators|mesh-ancestor
110348779|NCT02135042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110348780|NCT02135042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110348781|NCT02135042|Antimetabolites|antimetabolites|mesh-ancestor
110348782|NCT02135042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110348783|NCT02135042|Immunologic Factors|immunologic factors|mesh-ancestor
110348784|NCT02135042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110348785|NCT02134301|Oritavancin|oritavancin|mesh-list
110348786|NCT02134301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110348787|NCT02134301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110348788|NCT02101853|Calcium, Dietary|calcium, dietary|mesh-list
110348789|NCT02101853|Leucovorin|leucovorin|mesh-list
110348790|NCT02101853|Folic Acid|folic acid|mesh-list
110348791|NCT02101853|Cytarabine|cytarabine|mesh-list
110348792|NCT02101853|Dexamethasone|dexamethasone|mesh-list
110348793|NCT02101853|Dexamethasone acetate|dexamethasone acetate|mesh-list
110348794|NCT02101853|Hydrocortisone|hydrocortisone|mesh-list
110348795|NCT02101853|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110348796|NCT02101853|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110348797|NCT02101853|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110348798|NCT02101853|Cyclophosphamide|cyclophosphamide|mesh-list
110348799|NCT02101853|Methotrexate|methotrexate|mesh-list
110348800|NCT02101853|Etoposide|etoposide|mesh-list
110348801|NCT02101853|Vincristine|vincristine|mesh-list
110348802|NCT02101853|Etoposide phosphate|etoposide phosphate|mesh-list
110348803|NCT02101853|Asparaginase|asparaginase|mesh-list
110348804|NCT02101853|Mitoxantrone|mitoxantrone|mesh-list
110348805|NCT02101853|Mercaptopurine|mercaptopurine|mesh-list
110348806|NCT02101853|Podophyllotoxin|podophyllotoxin|mesh-list
110348807|NCT02101853|Pegaspargase|pegaspargase|mesh-list
110348808|NCT02101853|Thioguanine|thioguanine|mesh-list
110348809|NCT02101853|Blinatumomab|blinatumomab|mesh-list
110348810|NCT02101853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110348811|NCT02101853|Muromonab-CD3|muromonab-cd3|mesh-list
110348813|NCT02101853|Immunoglobulins|immunoglobulins|mesh-list
110348814|NCT02101853|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110348815|NCT02101853|Antibodies, Bispecific|antibodies, bispecific|mesh-list
110348816|NCT02101853|BB 1101|bb 1101|mesh-list
110348817|NCT02101853|Calcium|calcium|mesh-list
110348818|NCT02101853|2-Aminopurine|2-aminopurine|mesh-list
110348819|NCT02101853|Levoleucovorin|levoleucovorin|mesh-list
110348820|NCT02101853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110348821|NCT02101853|Immunologic Factors|immunologic factors|mesh-ancestor
110348822|NCT02101853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110348823|NCT02101853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110348824|NCT02101853|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110348825|NCT02101853|Alkylating Agents|alkylating agents|mesh-ancestor
110348826|NCT02101853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110348827|NCT02101853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110348828|NCT02101853|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110348829|NCT02101853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110348830|NCT02101853|Antiemetics|antiemetics|mesh-ancestor
110348831|NCT02101853|Autonomic Agents|autonomic agents|mesh-ancestor
110348832|NCT02101853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110348833|NCT02101853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110348834|NCT02101853|Glucocorticoids|glucocorticoids|mesh-ancestor
110348836|NCT02101853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110348837|NCT02101853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110348838|NCT02101853|Protease Inhibitors|protease inhibitors|mesh-ancestor
110348839|NCT02101853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110348840|NCT02101853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110348841|NCT02101853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110348842|NCT02101853|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110348843|NCT02101853|Abortifacient Agents|abortifacient agents|mesh-ancestor
110348844|NCT02101853|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110348845|NCT02101853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110348846|NCT02101853|Antimetabolites|antimetabolites|mesh-ancestor
110348847|NCT02101853|Dermatologic Agents|dermatologic agents|mesh-ancestor
110348848|NCT02101853|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110348849|NCT02101853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110348850|NCT02101853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110348851|NCT02101853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110348852|NCT02101853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110348853|NCT02101853|Antiviral Agents|antiviral agents|mesh-ancestor
110348854|NCT02101853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110348855|NCT02101853|Antidotes|antidotes|mesh-ancestor
110348856|NCT02101853|Protective Agents|protective agents|mesh-ancestor
110348857|NCT02101853|Vitamin B Complex|vitamin b complex|mesh-ancestor
110348858|NCT02101853|Vitamins|vitamins|mesh-ancestor
110348859|NCT02101853|Micronutrients|micronutrients|mesh-ancestor
110348860|NCT02101853|Tubulin Modulators|tubulin modulators|mesh-ancestor
110348861|NCT02101853|Antimitotic Agents|antimitotic agents|mesh-ancestor
110348862|NCT02101853|Mitosis Modulators|mitosis modulators|mesh-ancestor
110348863|NCT02101853|Hematinics|hematinics|mesh-ancestor
110348864|NCT02101853|Analgesics|analgesics|mesh-ancestor
110348865|NCT02101853|Sensory System Agents|sensory system agents|mesh-ancestor
110348866|NCT02101853|Keratolytic Agents|keratolytic agents|mesh-ancestor
110348867|NCT02094261|Osimertinib|osimertinib|mesh-list
110348868|NCT02094261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110348869|NCT02094261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110348870|NCT02094261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110348871|NCT02094261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110348873|NCT02048813|Rituximab|rituximab|mesh-list
110348874|NCT02048813|Fludarabine|fludarabine|mesh-list
110348875|NCT02048813|Fludarabine phosphate|fludarabine phosphate|mesh-list
110348876|NCT02048813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110348877|NCT02048813|Antibodies|antibodies|mesh-list
110348878|NCT02048813|Immunoglobulins|immunoglobulins|mesh-list
110348879|NCT02048813|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110348880|NCT02048813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110348881|NCT02048813|Immunologic Factors|immunologic factors|mesh-ancestor
110348882|NCT02048813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110348883|NCT02048813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110348884|NCT02048813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110348885|NCT02048813|Alkylating Agents|alkylating agents|mesh-ancestor
110348886|NCT02048813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110348887|NCT02048813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110348888|NCT02048813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110348889|NCT02048813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110348890|NCT02048813|Antimetabolites|antimetabolites|mesh-ancestor
110348891|NCT02037529|Paclitaxel|paclitaxel|mesh-list
110348892|NCT02037529|Halichondrin B|halichondrin b|mesh-list
110348893|NCT02037529|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110348894|NCT02037529|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110348895|NCT02037529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110348896|NCT02037529|Tubulin Modulators|tubulin modulators|mesh-ancestor
110348897|NCT02037529|Antimitotic Agents|antimitotic agents|mesh-ancestor
110348898|NCT02037529|Mitosis Modulators|mitosis modulators|mesh-ancestor
110348899|NCT02037529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110348900|NCT02030028|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
110348901|NCT02030028|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
110348903|NCT02030028|Hormones|hormones|mesh-ancestor
110348904|NCT02030028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110348905|NCT02030028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110348906|NCT02030028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110348907|NCT02030028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110348908|NCT02015013|Plerixafor|plerixafor|mesh-list
110348909|NCT02015013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110348910|NCT02015013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110348911|NCT02015013|Antiviral Agents|antiviral agents|mesh-ancestor
110348912|NCT02015013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110348913|NCT01956123|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110348914|NCT01956123|Hormones|hormones|mesh-ancestor
110348915|NCT01956123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110348916|NCT01956123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110348917|NCT01906814|Carboplatin|carboplatin|mesh-list
110348918|NCT01906814|Etoposide|etoposide|mesh-list
110348919|NCT01906814|Etoposide phosphate|etoposide phosphate|mesh-list
110348920|NCT01906814|Vincristine|vincristine|mesh-list
110348921|NCT01906814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110348922|NCT01906814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110348923|NCT01906814|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110348924|NCT01906814|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110348925|NCT01906814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110348926|NCT01906814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110348927|NCT01906814|Tubulin Modulators|tubulin modulators|mesh-ancestor
110348928|NCT01906814|Antimitotic Agents|antimitotic agents|mesh-ancestor
110052795|NCT01482104|Dermatologic Agents|dermatologic agents|mesh-ancestor
110348929|NCT01906814|Mitosis Modulators|mitosis modulators|mesh-ancestor
110348930|NCT01894308|Testosterone|testosterone|mesh-list
110348931|NCT01894308|Androgens|androgens|mesh-ancestor
110348932|NCT01894308|Hormones|hormones|mesh-ancestor
110348933|NCT01894308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110348934|NCT01894308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110348935|NCT01799538|Albuterol|albuterol|mesh-list
110348936|NCT01799538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110348937|NCT01799538|Autonomic Agents|autonomic agents|mesh-ancestor
110348939|NCT01799538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110348940|NCT01799538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110348941|NCT01799538|Respiratory System Agents|respiratory system agents|mesh-ancestor
110348942|NCT01799538|Tocolytic Agents|tocolytic agents|mesh-ancestor
110348943|NCT01799538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110348944|NCT01799538|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110348945|NCT01799538|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110348946|NCT01799538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110348947|NCT01799538|Adrenergic Agents|adrenergic agents|mesh-ancestor
110348948|NCT01799538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110348949|NCT01799538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110348951|NCT01705158|Doxorubicin|doxorubicin|mesh-list
110348952|NCT01705158|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110348953|NCT01705158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110348954|NCT01705158|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110348955|NCT01705158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110348956|NCT01705158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110348957|NCT01705158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110348958|NCT01705158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110348959|NCT01631617|Doxycycline|doxycycline|mesh-list
110348960|NCT01631617|Cephalexin|cephalexin|mesh-list
110348961|NCT01631617|Trimethoprim|trimethoprim|mesh-list
110348962|NCT01631617|Sulfamethoxazole|sulfamethoxazole|mesh-list
110348963|NCT01631617|Sodium Hypochlorite|sodium hypochlorite|mesh-list
110348965|NCT01631617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110348966|NCT01631617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110348967|NCT01631617|Antimalarials|antimalarials|mesh-ancestor
110348968|NCT01631617|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110348969|NCT01631617|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110348970|NCT01631617|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110348971|NCT01631617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110348972|NCT01631617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110348973|NCT01631617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110348974|NCT01631617|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110348975|NCT01631617|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110348976|NCT01631617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110348977|NCT01631617|Disinfectants|disinfectants|mesh-ancestor
110348979|NCT01583322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110348980|NCT01583322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110348981|NCT01583322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110348982|NCT01583322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110348983|NCT01572506|Biotin|biotin|mesh-list
110348984|NCT01572506|Vitamin B Complex|vitamin b complex|mesh-ancestor
110348985|NCT01572506|Vitamins|vitamins|mesh-ancestor
110348986|NCT01572506|Micronutrients|micronutrients|mesh-ancestor
110348987|NCT01572506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110348988|NCT01571037|Milrinone|milrinone|mesh-list
110348989|NCT01571037|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110348990|NCT01571037|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110348991|NCT01571037|Vasodilator Agents|vasodilator agents|mesh-ancestor
110348992|NCT01571037|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110348993|NCT01571037|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110348994|NCT01571037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110348995|NCT01571037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110348996|NCT01571037|Protective Agents|protective agents|mesh-ancestor
110348997|NCT01571037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110348998|NCT01553214|Dexamethasone|dexamethasone|mesh-list
110348999|NCT01553214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110349000|NCT01553214|Antiemetics|antiemetics|mesh-ancestor
110349001|NCT01553214|Autonomic Agents|autonomic agents|mesh-ancestor
110349002|NCT01553214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110349003|NCT01553214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110349004|NCT01553214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110349005|NCT01553214|Glucocorticoids|glucocorticoids|mesh-ancestor
110349006|NCT01553214|Hormones|hormones|mesh-ancestor
110349007|NCT01553214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110349008|NCT01553214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110349009|NCT01553214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110349010|NCT01469650|Vitamin D|vitamin d|mesh-list
110349011|NCT01469650|Ergocalciferols|ergocalciferols|mesh-list
110349012|NCT01469650|Cholecalciferol|cholecalciferol|mesh-list
110349013|NCT01469650|Vitamins|vitamins|mesh-list
110349014|NCT01469650|Micronutrients|micronutrients|mesh-ancestor
110349015|NCT01469650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110349016|NCT01469650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110349017|NCT01469650|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110349018|NCT01431326|Vancomycin|vancomycin|mesh-list
110349019|NCT01431326|Ciprofloxacin|ciprofloxacin|mesh-list
110349020|NCT01431326|Tazobactam|tazobactam|mesh-list
110349021|NCT01431326|Piperacillin|piperacillin|mesh-list
110349022|NCT01431326|Tobramycin|tobramycin|mesh-list
110349023|NCT01431326|Amikacin|amikacin|mesh-list
110349024|NCT01431326|Cefepime|cefepime|mesh-list
110349025|NCT01431326|Fosfomycin|fosfomycin|mesh-list
110349026|NCT01431326|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
110349027|NCT01431326|Nafcillin|nafcillin|mesh-list
110349028|NCT01431326|Cidofovir|cidofovir|mesh-list
110349029|NCT01431326|Methylprednisolone|methylprednisolone|mesh-list
110349030|NCT01431326|Bosentan|bosentan|mesh-list
110349031|NCT01431326|Labetalol|labetalol|mesh-list
110349032|NCT01431326|Nifedipine|nifedipine|mesh-list
110349033|NCT01431326|Spironolactone|spironolactone|mesh-list
110349034|NCT01431326|Pentobarbital|pentobarbital|mesh-list
110349035|NCT01431326|Oxycodone|oxycodone|mesh-list
110349036|NCT01431326|Alfentanil|alfentanil|mesh-list
110349037|NCT01431326|Haloperidol|haloperidol|mesh-list
110349038|NCT01431326|Zolpidem|zolpidem|mesh-list
110349039|NCT01431326|Ziprasidone|ziprasidone|mesh-list
110349040|NCT01431326|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
110349041|NCT01431326|Clozapine|clozapine|mesh-list
110349042|NCT01431326|Molindone|molindone|mesh-list
110349043|NCT01431326|Warfarin|warfarin|mesh-list
110349044|NCT01431326|Tranexamic Acid|tranexamic acid|mesh-list
110349045|NCT01431326|Aminocaproic Acid|aminocaproic acid|mesh-list
110349046|NCT01431326|Rocuronium|rocuronium|mesh-list
110349047|NCT01431326|Vecuronium Bromide|vecuronium bromide|mesh-list
110349048|NCT01431326|Sevelamer|sevelamer|mesh-list
110349049|NCT01431326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110349050|NCT01431326|Antiemetics|antiemetics|mesh-ancestor
110349051|NCT01431326|Autonomic Agents|autonomic agents|mesh-ancestor
110349052|NCT01431326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110349053|NCT01431326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110349054|NCT01431326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110349055|NCT01431326|Glucocorticoids|glucocorticoids|mesh-ancestor
110349057|NCT01431326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110349058|NCT01431326|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110349059|NCT01431326|Protective Agents|protective agents|mesh-ancestor
110349060|NCT01431326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110349061|NCT01431326|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110349062|NCT01431326|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110349063|NCT01431326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110349064|NCT01431326|Hemostatics|hemostatics|mesh-ancestor
110349065|NCT01431326|Coagulants|coagulants|mesh-ancestor
110349066|NCT01431326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110349067|NCT01431326|Narcotics|narcotics|mesh-ancestor
110349068|NCT01431326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110349069|NCT01431326|Analgesics|analgesics|mesh-ancestor
110349070|NCT01431326|Sensory System Agents|sensory system agents|mesh-ancestor
110349071|NCT01431326|Anticoagulants|anticoagulants|mesh-ancestor
110349072|NCT01431326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110349073|NCT01431326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110349074|NCT01431326|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110349075|NCT01431326|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110349076|NCT01431326|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110349077|NCT01431326|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110349078|NCT01431326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110349079|NCT01431326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110349080|NCT01431326|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110349081|NCT01431326|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110349082|NCT01431326|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110349083|NCT01431326|Hormone Antagonists|hormone antagonists|mesh-ancestor
110349084|NCT01431326|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110349085|NCT01431326|Diuretics|diuretics|mesh-ancestor
110349086|NCT01431326|Natriuretic Agents|natriuretic agents|mesh-ancestor
110349087|NCT01431326|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110349088|NCT01431326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110349089|NCT01431326|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110349090|NCT01431326|Vasodilator Agents|vasodilator agents|mesh-ancestor
110349091|NCT01431326|Tocolytic Agents|tocolytic agents|mesh-ancestor
110349092|NCT01431326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110349093|NCT01431326|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110175551|NCT00075010|Decitabine|decitabine|mesh-list
110349094|NCT01431326|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110349095|NCT01431326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110349096|NCT01431326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110349097|NCT01431326|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110349098|NCT01431326|Dopamine Agents|dopamine agents|mesh-ancestor
110349099|NCT01431326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110349100|NCT01431326|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110349101|NCT01431326|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110349102|NCT01431326|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110349103|NCT01431326|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110349104|NCT01431326|GABA Agonists|gaba agonists|mesh-ancestor
110349105|NCT01431326|GABA Agents|gaba agents|mesh-ancestor
110349106|NCT01431326|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110349107|NCT01431326|Serotonin Agents|serotonin agents|mesh-ancestor
110349108|NCT01431326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110349109|NCT01431326|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110349110|NCT01431326|Chelating Agents|chelating agents|mesh-ancestor
110349111|NCT01431326|Sequestering Agents|sequestering agents|mesh-ancestor
110349112|NCT01431326|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110349113|NCT01431326|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110349114|NCT01431326|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110349115|NCT01431326|Adrenergic Agents|adrenergic agents|mesh-ancestor
110349116|NCT01431326|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110349117|NCT01431326|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110349118|NCT01431326|GABA Antagonists|gaba antagonists|mesh-ancestor
110349119|NCT01431326|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110349120|NCT01431326|Sympathomimetics|sympathomimetics|mesh-ancestor
110349121|NCT01431326|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110349122|NCT01431326|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110349123|NCT01431326|Anesthetics, General|anesthetics, general|mesh-ancestor
110349124|NCT01431326|Anesthetics|anesthetics|mesh-ancestor
110349125|NCT01431326|Antiviral Agents|antiviral agents|mesh-ancestor
110349126|NCT01431326|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
110349127|NCT01431326|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110349128|NCT01431326|Cholinergic Agents|cholinergic agents|mesh-ancestor
110349129|NCT01431326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110349130|NCT01431326|GABA Modulators|gaba modulators|mesh-ancestor
110349131|NCT01424982|Cytarabine|cytarabine|mesh-list
110349132|NCT01424982|Dexamethasone|dexamethasone|mesh-list
110349133|NCT01424982|Prednisone|prednisone|mesh-list
110349134|NCT01424982|Dexamethasone acetate|dexamethasone acetate|mesh-list
110349135|NCT01424982|Cortisone|cortisone|mesh-list
110349136|NCT01424982|Cyclophosphamide|cyclophosphamide|mesh-list
110349137|NCT01424982|Rituximab|rituximab|mesh-list
110349139|NCT01424982|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110349140|NCT01424982|Methotrexate|methotrexate|mesh-list
110349141|NCT01424982|Vincristine|vincristine|mesh-list
110349142|NCT01424982|Daunorubicin|daunorubicin|mesh-list
110349143|NCT01424982|Ponatinib|ponatinib|mesh-list
110349144|NCT01424982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110349145|NCT01424982|Antibodies|antibodies|mesh-list
110349146|NCT01424982|Immunoglobulins|immunoglobulins|mesh-list
110349147|NCT01424982|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110349148|NCT01424982|BB 1101|bb 1101|mesh-list
110349149|NCT01424982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110349150|NCT01424982|Immunologic Factors|immunologic factors|mesh-ancestor
110349151|NCT01424982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110349152|NCT01424982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110349153|NCT01424982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110349154|NCT01424982|Alkylating Agents|alkylating agents|mesh-ancestor
110349155|NCT01424982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110349156|NCT01424982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110349157|NCT01424982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110349158|NCT01424982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110349159|NCT01424982|Antiemetics|antiemetics|mesh-ancestor
110349160|NCT01424982|Autonomic Agents|autonomic agents|mesh-ancestor
110349161|NCT01424982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110349162|NCT01424982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110349163|NCT01424982|Glucocorticoids|glucocorticoids|mesh-ancestor
110349164|NCT01424982|Hormones|hormones|mesh-ancestor
110349165|NCT01424982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110349166|NCT01424982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110349167|NCT01424982|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110349168|NCT01424982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110349169|NCT01424982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110349170|NCT01424982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110349171|NCT01424982|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110349172|NCT01424982|Abortifacient Agents|abortifacient agents|mesh-ancestor
110349173|NCT01424982|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110349174|NCT01424982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110349175|NCT01424982|Antimetabolites|antimetabolites|mesh-ancestor
110349176|NCT01424982|Dermatologic Agents|dermatologic agents|mesh-ancestor
110349177|NCT01424982|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110349178|NCT01424982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110349179|NCT01424982|Antiviral Agents|antiviral agents|mesh-ancestor
110349180|NCT01424982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110349181|NCT01424982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110349182|NCT01424982|Tubulin Modulators|tubulin modulators|mesh-ancestor
110349183|NCT01424982|Antimitotic Agents|antimitotic agents|mesh-ancestor
110349184|NCT01424982|Mitosis Modulators|mitosis modulators|mesh-ancestor
110349185|NCT01424982|Protease Inhibitors|protease inhibitors|mesh-ancestor
110349186|NCT01424982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110349187|NCT01303679|Paclitaxel|paclitaxel|mesh-list
110349188|NCT01303679|Bevacizumab|bevacizumab|mesh-list
110349189|NCT01303679|Exemestane|exemestane|mesh-list
110349190|NCT01303679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110349191|NCT01303679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110349192|NCT01303679|Tubulin Modulators|tubulin modulators|mesh-ancestor
110349193|NCT01303679|Antimitotic Agents|antimitotic agents|mesh-ancestor
110349194|NCT01303679|Mitosis Modulators|mitosis modulators|mesh-ancestor
110349195|NCT01303679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110349196|NCT01303679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110349197|NCT01303679|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110349198|NCT01303679|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110349199|NCT01303679|Growth Substances|growth substances|mesh-ancestor
110349200|NCT01303679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110349201|NCT01303679|Growth Inhibitors|growth inhibitors|mesh-ancestor
110349202|NCT01303679|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110349203|NCT01303679|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110349204|NCT01303679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110349205|NCT01303679|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110349206|NCT01303679|Hormone Antagonists|hormone antagonists|mesh-ancestor
110349207|NCT01303679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110349208|NCT01298713|Tamoxifen|tamoxifen|mesh-list
110349209|NCT01298713|Everolimus|everolimus|mesh-list
110349210|NCT01298713|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110349211|NCT01298713|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110349212|NCT01298713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110349213|NCT01298713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110349214|NCT01298713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110349215|NCT01298713|Immunologic Factors|immunologic factors|mesh-ancestor
110349216|NCT01298713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110349217|NCT01298713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110349218|NCT01298713|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110349219|NCT01298713|Hormone Antagonists|hormone antagonists|mesh-ancestor
110349220|NCT01298713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110349221|NCT01298713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110349222|NCT01298713|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110349223|NCT01298713|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110349224|NCT01298713|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110349225|NCT01263769|Axitinib|axitinib|mesh-list
110349226|NCT01263769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110349227|NCT01263769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110349228|NCT01263769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110349229|NCT01263769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110349230|NCT01191697|Bevacizumab|bevacizumab|mesh-list
110349231|NCT01191697|Trastuzumab|trastuzumab|mesh-list
110349232|NCT01191697|Capecitabine|capecitabine|mesh-list
110349233|NCT01191697|Oxaliplatin|oxaliplatin|mesh-list
110349234|NCT01191697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110349235|NCT01191697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110349236|NCT01191697|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110349237|NCT01191697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110349238|NCT01191697|Growth Substances|growth substances|mesh-ancestor
110349239|NCT01191697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110349240|NCT01191697|Growth Inhibitors|growth inhibitors|mesh-ancestor
110349241|NCT01191697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110349242|NCT01191697|Antimetabolites|antimetabolites|mesh-ancestor
110349243|NCT01191697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110349244|NCT01189643|Bevacizumab|bevacizumab|mesh-list
110349245|NCT01189643|Irinotecan|irinotecan|mesh-list
110349246|NCT01189643|Temozolomide|temozolomide|mesh-list
110349247|NCT01189643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110349248|NCT01189643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110349249|NCT01189643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110349250|NCT01189643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110349251|NCT01189643|Growth Substances|growth substances|mesh-ancestor
110349252|NCT01189643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110349253|NCT01189643|Growth Inhibitors|growth inhibitors|mesh-ancestor
110349254|NCT01189643|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110349255|NCT01189643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110349256|NCT01189643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110349257|NCT01189643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110349258|NCT01189643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110349259|NCT01189643|Alkylating Agents|alkylating agents|mesh-ancestor
110349260|NCT01044745|Mycophenolic Acid|mycophenolic acid|mesh-list
110349261|NCT01044745|Cyclophosphamide|cyclophosphamide|mesh-list
110349262|NCT01044745|Busulfan|busulfan|mesh-list
110349263|NCT01044745|Rituximab|rituximab|mesh-list
110349264|NCT01044745|Fludarabine|fludarabine|mesh-list
110349265|NCT01044745|Fludarabine phosphate|fludarabine phosphate|mesh-list
110349266|NCT01044745|Tacrolimus|tacrolimus|mesh-list
110349267|NCT01044745|Thymoglobulin|thymoglobulin|mesh-list
110349268|NCT01044745|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110349269|NCT01044745|Immunosuppressive Agents|immunosuppressive agents|mesh-list
110349270|NCT01044745|Immunologic Factors|immunologic factors|mesh-ancestor
110349271|NCT01044745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110349272|NCT01044745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110349273|NCT01044745|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110349274|NCT01044745|Alkylating Agents|alkylating agents|mesh-ancestor
110349275|NCT01044745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110349276|NCT01044745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110349277|NCT01044745|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110349278|NCT01044745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110349279|NCT01044745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110349280|NCT01044745|Antimetabolites|antimetabolites|mesh-ancestor
110349281|NCT01044745|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110349291|NCT00990275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110349292|NCT00990275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110349293|NCT00977977|Cyclosporine|cyclosporine|mesh-list
110349294|NCT00977977|Rituximab|rituximab|mesh-list
110349295|NCT00977977|Cyclosporins|cyclosporins|mesh-list
110349296|NCT00977977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110349297|NCT00977977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110349298|NCT00977977|Immunologic Factors|immunologic factors|mesh-ancestor
110349299|NCT00977977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110349300|NCT00977977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110349301|NCT00977977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110349302|NCT00977977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110349303|NCT00977977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110349304|NCT00977977|Antifungal Agents|antifungal agents|mesh-ancestor
110175566|NCT04729595|Tempol|tempol|mesh-list
110349305|NCT00977977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110349306|NCT00977977|Dermatologic Agents|dermatologic agents|mesh-ancestor
110349307|NCT00977977|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110349308|NCT00923013|Rituximab|rituximab|mesh-list
110349309|NCT00923013|Cladribine|cladribine|mesh-list
110349310|NCT00923013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110349311|NCT00923013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110349312|NCT00923013|Immunologic Factors|immunologic factors|mesh-ancestor
110349313|NCT00923013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110349314|NCT00923013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110349315|NCT00923013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110349326|NCT00720785|Bortezomib|bortezomib|mesh-list
110349327|NCT00720785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110349328|NCT00601900|Tamoxifen|tamoxifen|mesh-list
110349329|NCT00601900|Bevacizumab|bevacizumab|mesh-list
110349330|NCT00601900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110349331|NCT00601900|Letrozole|letrozole|mesh-list
110349332|NCT00601900|Endothelial Growth Factors|endothelial growth factors|mesh-list
110349333|NCT00601900|Antibodies|antibodies|mesh-list
110349334|NCT00601900|Immunoglobulins|immunoglobulins|mesh-list
110349335|NCT00601900|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110349336|NCT00601900|Immunoglobulin G|immunoglobulin g|mesh-list
110349337|NCT00601900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110349338|NCT00601900|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110349339|NCT00601900|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110349340|NCT00601900|Growth Substances|growth substances|mesh-ancestor
110349341|NCT00601900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110349342|NCT00601900|Growth Inhibitors|growth inhibitors|mesh-ancestor
110349343|NCT00601900|Immunologic Factors|immunologic factors|mesh-ancestor
110349344|NCT00601900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110349345|NCT00601900|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110349346|NCT00601900|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110349347|NCT00601900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110349348|NCT00601900|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110349349|NCT00601900|Hormone Antagonists|hormone antagonists|mesh-ancestor
110349350|NCT00601900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110349351|NCT00601900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110349352|NCT00601900|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110349353|NCT00601900|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110349354|NCT00601900|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110349355|NCT00588770|Bevacizumab|bevacizumab|mesh-list
110349356|NCT00588770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110349357|NCT00588770|Cisplatin|cisplatin|mesh-list
110349358|NCT00588770|Carboplatin|carboplatin|mesh-list
110349359|NCT00588770|Docetaxel|docetaxel|mesh-list
110349360|NCT00588770|Fluorouracil|fluorouracil|mesh-list
110349361|NCT00588770|Endothelial Growth Factors|endothelial growth factors|mesh-list
110349362|NCT00588770|Antibodies|antibodies|mesh-list
110349363|NCT00588770|Immunoglobulins|immunoglobulins|mesh-list
110349364|NCT00588770|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110349365|NCT00588770|Immunoglobulin G|immunoglobulin g|mesh-list
110349366|NCT00588770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110349367|NCT00588770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110349368|NCT00588770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110349369|NCT00588770|Growth Substances|growth substances|mesh-ancestor
110349370|NCT00588770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110349371|NCT00588770|Growth Inhibitors|growth inhibitors|mesh-ancestor
110349372|NCT00588770|Immunologic Factors|immunologic factors|mesh-ancestor
110349373|NCT00588770|Tubulin Modulators|tubulin modulators|mesh-ancestor
110349374|NCT00588770|Antimitotic Agents|antimitotic agents|mesh-ancestor
110349375|NCT00588770|Mitosis Modulators|mitosis modulators|mesh-ancestor
110349376|NCT00588770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110349378|NCT00588770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110349379|NCT00588770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110349380|NCT00567606|Risedronic Acid|risedronic acid|mesh-list
110349381|NCT00567606|Etidronic Acid|etidronic acid|mesh-list
110349382|NCT00567606|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110349383|NCT00567606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110349384|NCT00567606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110349385|NCT00567606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110349386|NCT00567606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110349387|NCT00567606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110349389|NCT00557193|Leucovorin|leucovorin|mesh-list
110349390|NCT00557193|Folic Acid|folic acid|mesh-list
110349391|NCT00557193|Cytarabine|cytarabine|mesh-list
110349392|NCT00557193|Dexamethasone|dexamethasone|mesh-list
110349393|NCT00557193|Dexamethasone acetate|dexamethasone acetate|mesh-list
110349394|NCT00557193|Prednisone|prednisone|mesh-list
110349395|NCT00557193|Methylprednisolone|methylprednisolone|mesh-list
110349396|NCT00557193|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110349397|NCT00557193|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110349398|NCT00557193|Prednisolone|prednisolone|mesh-list
110349399|NCT00557193|Prednisolone acetate|prednisolone acetate|mesh-list
110349400|NCT00557193|Hydrocortisone|hydrocortisone|mesh-list
110349401|NCT00557193|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110349402|NCT00557193|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110349403|NCT00557193|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110349404|NCT00557193|Cortisone|cortisone|mesh-list
110349405|NCT00557193|Cyclophosphamide|cyclophosphamide|mesh-list
110349406|NCT00557193|Methotrexate|methotrexate|mesh-list
110349408|NCT00557193|Vincristine|vincristine|mesh-list
110349409|NCT00557193|Etoposide phosphate|etoposide phosphate|mesh-list
110349410|NCT00557193|Daunorubicin|daunorubicin|mesh-list
110349411|NCT00557193|Asparaginase|asparaginase|mesh-list
110349412|NCT00557193|Mercaptopurine|mercaptopurine|mesh-list
110349413|NCT00557193|Podophyllotoxin|podophyllotoxin|mesh-list
110349414|NCT00557193|Pegaspargase|pegaspargase|mesh-list
110349415|NCT00557193|Lenograstim|lenograstim|mesh-list
110349416|NCT00557193|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110349417|NCT00557193|Prednisolone phosphate|prednisolone phosphate|mesh-list
110349418|NCT00557193|BB 1101|bb 1101|mesh-list
110349419|NCT00557193|Calcium|calcium|mesh-list
110349420|NCT00557193|Levoleucovorin|levoleucovorin|mesh-list
110349421|NCT00557193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110349422|NCT00557193|Immunologic Factors|immunologic factors|mesh-ancestor
110349423|NCT00557193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110349424|NCT00557193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110349425|NCT00557193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110349426|NCT00557193|Alkylating Agents|alkylating agents|mesh-ancestor
110349427|NCT00557193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110349428|NCT00557193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110349429|NCT00557193|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110349430|NCT00557193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110349431|NCT00557193|Antiemetics|antiemetics|mesh-ancestor
110349432|NCT00557193|Autonomic Agents|autonomic agents|mesh-ancestor
110349433|NCT00557193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110349434|NCT00557193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110349435|NCT00557193|Glucocorticoids|glucocorticoids|mesh-ancestor
110349436|NCT00557193|Hormones|hormones|mesh-ancestor
110349437|NCT00557193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110349438|NCT00557193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110349439|NCT00557193|Protease Inhibitors|protease inhibitors|mesh-ancestor
110349440|NCT00557193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110349441|NCT00557193|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110349442|NCT00557193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110349443|NCT00557193|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110349444|NCT00557193|Abortifacient Agents|abortifacient agents|mesh-ancestor
110349445|NCT00557193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110349446|NCT00557193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110349447|NCT00557193|Antimetabolites|antimetabolites|mesh-ancestor
110349448|NCT00557193|Dermatologic Agents|dermatologic agents|mesh-ancestor
110349449|NCT00557193|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110349450|NCT00557193|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110349451|NCT00557193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110349452|NCT00557193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110349453|NCT00557193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110349454|NCT00557193|Antiviral Agents|antiviral agents|mesh-ancestor
110349455|NCT00557193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110349456|NCT00557193|Antidotes|antidotes|mesh-ancestor
110349457|NCT00557193|Protective Agents|protective agents|mesh-ancestor
110349458|NCT00557193|Vitamin B Complex|vitamin b complex|mesh-ancestor
110349459|NCT00557193|Vitamins|vitamins|mesh-ancestor
110349460|NCT00557193|Micronutrients|micronutrients|mesh-ancestor
110349462|NCT00557193|Tubulin Modulators|tubulin modulators|mesh-ancestor
110349463|NCT00557193|Antimitotic Agents|antimitotic agents|mesh-ancestor
110349464|NCT00557193|Mitosis Modulators|mitosis modulators|mesh-ancestor
110349465|NCT00557193|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110349466|NCT00557193|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110349468|NCT00557193|Keratolytic Agents|keratolytic agents|mesh-ancestor
110349469|NCT00445627|Metformin|metformin|mesh-list
110349470|NCT00445627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110349471|NCT00445627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110349472|NCT00359684|Cysteamine|cysteamine|mesh-list
110349473|NCT00359684|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
110349474|NCT00359684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110349475|NCT00353158|Doxycycline|doxycycline|mesh-list
110349476|NCT00353158|Voriconazole|voriconazole|mesh-list
110349477|NCT00353158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110349478|NCT00353158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110349479|NCT00353158|Antimalarials|antimalarials|mesh-ancestor
110349480|NCT00353158|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110349481|NCT00353158|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110349482|NCT00353158|Antifungal Agents|antifungal agents|mesh-ancestor
110349483|NCT00353158|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110349484|NCT00353158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110349485|NCT00353158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110349486|NCT00353158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110349487|NCT00353158|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110349488|NCT00353158|Hormone Antagonists|hormone antagonists|mesh-ancestor
110349489|NCT00353158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110349490|NCT00353158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110349491|NCT00353158|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110349492|NCT00044304|Imatinib Mesylate|imatinib mesylate|mesh-list
110349493|NCT00044304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110349494|NCT00044304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110349495|NCT00044304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110349496|NCT00044304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110349497|NCT00001481|Estradiol|estradiol|mesh-list
110349498|NCT00001481|Progesterone|progesterone|mesh-list
110349499|NCT00001481|Estrogens|estrogens|mesh-ancestor
110349500|NCT00001481|Hormones|hormones|mesh-ancestor
110349501|NCT00001481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110349502|NCT00001481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110349503|NCT00001481|Progestins|progestins|mesh-ancestor
110349504|NCT00001247|Sirolimus|sirolimus|mesh-list
110349505|NCT00001247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110349506|NCT00001247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110349507|NCT00001247|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110349508|NCT00001247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110349509|NCT00001247|Antifungal Agents|antifungal agents|mesh-ancestor
110349510|NCT00001247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110349511|NCT00001247|Immunologic Factors|immunologic factors|mesh-ancestor
110349512|NCT00001247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110349513|NCT02919072|Ropivacaine|ropivacaine|mesh-list
110349514|NCT02919072|Chloroprocaine|chloroprocaine|mesh-list
110349515|NCT02919072|Anesthetics, Local|anesthetics, local|mesh-ancestor
110349516|NCT02919072|Anesthetics|anesthetics|mesh-ancestor
110175585|NCT00075439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110349517|NCT02919072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110349518|NCT02919072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110349519|NCT02919072|Sensory System Agents|sensory system agents|mesh-ancestor
110349520|NCT02919072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110349521|NCT02941328|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
110349522|NCT02941328|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110349523|NCT02941328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110349524|NCT02941328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110349525|NCT02941328|Cholinergic Agents|cholinergic agents|mesh-ancestor
110349526|NCT02941328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110349527|NCT02941328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110349529|NCT02915796|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110349530|NCT02915796|Immunologic Factors|immunologic factors|mesh-ancestor
110349531|NCT02915796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110349533|NCT02915250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110349534|NCT02915250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110349535|NCT02277041|Misoprostol|misoprostol|mesh-list
110349536|NCT02277041|Carbetocin|carbetocin|mesh-list
110349537|NCT02277041|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110349538|NCT02277041|Abortifacient Agents|abortifacient agents|mesh-ancestor
110349539|NCT02277041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110349540|NCT02277041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110349541|NCT02277041|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110349542|NCT02277041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110349543|NCT02277041|Oxytocics|oxytocics|mesh-ancestor
110349544|NCT02915289|Chlorhexidine|chlorhexidine|mesh-list
110349545|NCT02915289|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110349546|NCT02915289|Povidone-Iodine|povidone-iodine|mesh-list
110349547|NCT02915289|Povidone|povidone|mesh-list
110349548|NCT02915289|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110349549|NCT02915289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110349550|NCT02915289|Disinfectants|disinfectants|mesh-ancestor
110349551|NCT02915289|Dermatologic Agents|dermatologic agents|mesh-ancestor
110349552|NCT02915289|Plasma Substitutes|plasma substitutes|mesh-ancestor
110349553|NCT02915289|Blood Substitutes|blood substitutes|mesh-ancestor
110349554|NCT02939417|Grape Seed Extract|grape seed extract|mesh-list
110349555|NCT02939417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110349556|NCT02939417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110349557|NCT02939417|Antioxidants|antioxidants|mesh-ancestor
110349558|NCT02939417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110349559|NCT02939417|Protective Agents|protective agents|mesh-ancestor
110349560|NCT02939417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110349561|NCT05034536|Infliximab|infliximab|mesh-list
110349562|NCT05034536|Pembrolizumab|pembrolizumab|mesh-list
110349563|NCT05034536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110349564|NCT05034536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110349565|NCT05034536|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110349566|NCT05034536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110349567|NCT05034536|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110349569|NCT05034536|Dermatologic Agents|dermatologic agents|mesh-ancestor
110349570|NCT05034536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110349571|NCT05034536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110349572|NCT02915094|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110349573|NCT02915094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110349574|NCT02915172|Capecitabine|capecitabine|mesh-list
110349575|NCT02915172|Lenvatinib|lenvatinib|mesh-list
110349576|NCT02915172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110349577|NCT02915172|Antimetabolites|antimetabolites|mesh-ancestor
110349578|NCT02915172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110349579|NCT02915172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110349580|NCT02915172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110349581|NCT02915172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110349582|NCT02938988|Anti-Infective Agents|anti-infective agents|mesh-list
110349583|NCT02938988|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110349584|NCT02938988|Methylene Blue|methylene blue|mesh-list
110349585|NCT02938988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110349586|NCT02938988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110349587|NCT02915055|Acetaminophen|acetaminophen|mesh-list
110349589|NCT02915055|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
110349590|NCT02915055|Oxycodone|oxycodone|mesh-list
110349591|NCT02915055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110349592|NCT02915055|Analgesics|analgesics|mesh-ancestor
110349593|NCT02915055|Sensory System Agents|sensory system agents|mesh-ancestor
110349594|NCT02915055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110349595|NCT02915055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110349596|NCT02915055|Antipyretics|antipyretics|mesh-ancestor
110349597|NCT02915055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110349598|NCT02915055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110349599|NCT02915055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110349600|NCT02915055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110349601|NCT02915055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110349602|NCT02915055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110349603|NCT02915055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110349605|NCT02915055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110349606|NCT01295827|Pembrolizumab|pembrolizumab|mesh-list
110349607|NCT01295827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110349608|NCT01295827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110349609|NCT01295827|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110349610|NCT01295827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110349611|NCT02918760|Gabapentin|gabapentin|mesh-list
110349612|NCT02918760|Analgesics|analgesics|mesh-ancestor
110349613|NCT02918760|Sensory System Agents|sensory system agents|mesh-ancestor
110349614|NCT02918760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110349615|NCT02918760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110349616|NCT02918760|Anticonvulsants|anticonvulsants|mesh-ancestor
110349617|NCT02918760|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110349618|NCT02918760|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110349619|NCT02918760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110349620|NCT02918760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110349621|NCT02918760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110349622|NCT02918760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110349623|NCT02918760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110349624|NCT02918760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110349625|NCT02918760|Antimanic Agents|antimanic agents|mesh-ancestor
110349626|NCT04690751|Cenobamate|cenobamate|mesh-list
110349627|NCT04690751|Anticonvulsants|anticonvulsants|mesh-ancestor
110349628|NCT03458078|Magnesium Sulfate|magnesium sulfate|mesh-list
110349629|NCT03458078|Midazolam|midazolam|mesh-list
110349630|NCT03458078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110349631|NCT03458078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110349632|NCT03458078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110349633|NCT03458078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110349634|NCT03458078|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110349635|NCT03458078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110349636|NCT03458078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110349637|NCT03458078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110349638|NCT03458078|Anesthetics, General|anesthetics, general|mesh-ancestor
110349639|NCT03458078|Anesthetics|anesthetics|mesh-ancestor
110349640|NCT03458078|GABA Modulators|gaba modulators|mesh-ancestor
110349641|NCT03458078|GABA Agents|gaba agents|mesh-ancestor
110349642|NCT03458078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110349643|NCT03458078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110349644|NCT03458078|Analgesics|analgesics|mesh-ancestor
110349645|NCT03458078|Sensory System Agents|sensory system agents|mesh-ancestor
110349646|NCT03458078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110349647|NCT03458078|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110349648|NCT03458078|Anticonvulsants|anticonvulsants|mesh-ancestor
110349649|NCT03458078|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110349650|NCT03458078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110349651|NCT03458078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110349652|NCT03458078|Tocolytic Agents|tocolytic agents|mesh-ancestor
110349653|NCT03458078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110349654|NCT04690556|Ranibizumab|ranibizumab|mesh-list
110349655|NCT04690556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110349656|NCT04690556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110349657|NCT04690556|Growth Substances|growth substances|mesh-ancestor
110349658|NCT04690556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110349659|NCT04690556|Growth Inhibitors|growth inhibitors|mesh-ancestor
110349660|NCT04690556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110349661|NCT01294579|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110349662|NCT01294579|Ofatumumab|ofatumumab|mesh-list
110349663|NCT01294579|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110349664|NCT01294579|Alkylating Agents|alkylating agents|mesh-ancestor
110349665|NCT01294579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110349666|NCT01294579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110349667|NCT02914626|Ranibizumab|ranibizumab|mesh-list
110349668|NCT02914626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110349669|NCT02914626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110349670|NCT02914626|Growth Substances|growth substances|mesh-ancestor
110349672|NCT02914626|Growth Inhibitors|growth inhibitors|mesh-ancestor
110349673|NCT02914626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110349674|NCT02918331|Dexamethasone|dexamethasone|mesh-list
110349675|NCT02918331|Lenalidomide|lenalidomide|mesh-list
110349676|NCT02918331|Daratumumab|daratumumab|mesh-list
110349677|NCT02918331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110349678|NCT02918331|Antiemetics|antiemetics|mesh-ancestor
110349679|NCT02918331|Autonomic Agents|autonomic agents|mesh-ancestor
110349680|NCT02918331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110349681|NCT02918331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110349682|NCT02918331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110349683|NCT02918331|Glucocorticoids|glucocorticoids|mesh-ancestor
110349684|NCT02918331|Hormones|hormones|mesh-ancestor
110349685|NCT02918331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110349686|NCT02918331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110349687|NCT02918331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110349688|NCT02918331|Immunologic Factors|immunologic factors|mesh-ancestor
110349689|NCT02918331|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110349690|NCT02918331|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110349691|NCT02918331|Growth Substances|growth substances|mesh-ancestor
110349692|NCT02918331|Growth Inhibitors|growth inhibitors|mesh-ancestor
110349693|NCT02918136|Cortisone|cortisone|mesh-list
110349694|NCT02918136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110349695|NCT01294462|Aspirin|aspirin|mesh-list
110349696|NCT01294462|Clopidogrel|clopidogrel|mesh-list
110349697|NCT01294462|Ticagrelor|ticagrelor|mesh-list
110349698|NCT01294462|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110349699|NCT01294462|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110349700|NCT01294462|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110349701|NCT01294462|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110349702|NCT01294462|Purinergic Agents|purinergic agents|mesh-ancestor
110349703|NCT01294462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110349704|NCT01294462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110349705|NCT01294462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110349706|NCT01294462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110349707|NCT01294462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110349708|NCT01294462|Analgesics|analgesics|mesh-ancestor
110349709|NCT01294462|Sensory System Agents|sensory system agents|mesh-ancestor
110349710|NCT01294462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110349711|NCT01294462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110349712|NCT01294462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110349713|NCT01294462|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110349714|NCT01294462|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110349715|NCT01294462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110349716|NCT01294462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110349717|NCT01294462|Antipyretics|antipyretics|mesh-ancestor
110349718|NCT01294423|Dapagliflozin|dapagliflozin|mesh-list
110349719|NCT01294423|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110349720|NCT01294423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110349721|NCT01294423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110349722|NCT01294423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110349723|NCT02910570|Liraglutide|liraglutide|mesh-list
110349724|NCT02910570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110349725|NCT02910570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110349726|NCT02910570|Incretins|incretins|mesh-ancestor
110349727|NCT02910570|Hormones|hormones|mesh-ancestor
110349728|NCT02910570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110349729|NCT03077685|Paclitaxel|paclitaxel|mesh-list
110349730|NCT03077685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110349731|NCT03077685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110349732|NCT03077685|Tubulin Modulators|tubulin modulators|mesh-ancestor
110349733|NCT03077685|Antimitotic Agents|antimitotic agents|mesh-ancestor
110349734|NCT03077685|Mitosis Modulators|mitosis modulators|mesh-ancestor
110349735|NCT03077685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110349736|NCT02910141|Insulin|insulin|mesh-list
110349737|NCT02910141|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110349738|NCT02910141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110349739|NCT02910141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110349741|NCT04817033|Dexmedetomidine|dexmedetomidine|mesh-list
110349742|NCT04817033|Anesthetics|anesthetics|mesh-list
110349743|NCT04817033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110349744|NCT04817033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110349745|NCT04817033|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110349746|NCT04817033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110349747|NCT04817033|Analgesics|analgesics|mesh-ancestor
110349748|NCT04817033|Sensory System Agents|sensory system agents|mesh-ancestor
110349749|NCT04817033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110349750|NCT04817033|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110349751|NCT04817033|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110349752|NCT04817033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110349753|NCT04817033|Adrenergic Agents|adrenergic agents|mesh-ancestor
110349754|NCT04817033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110349755|NCT04817033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110349756|NCT04817033|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110349757|NCT04817033|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110349758|NCT04817033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110349759|NCT04817033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110349760|NCT04817033|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110349761|NCT04817033|Anesthetics, General|anesthetics, general|mesh-ancestor
110349762|NCT04817033|GABA Modulators|gaba modulators|mesh-ancestor
110349763|NCT04817033|GABA Agents|gaba agents|mesh-ancestor
110349764|NCT01292473|Omalizumab|omalizumab|mesh-list
110349765|NCT01292473|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110349766|NCT01292473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110349767|NCT01292473|Respiratory System Agents|respiratory system agents|mesh-ancestor
110349768|NCT02938286|Epinephrine|epinephrine|mesh-list
110349769|NCT02938286|Carticaine|carticaine|mesh-list
110349770|NCT02938286|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110349771|NCT02938286|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110349772|NCT02938286|Adrenergic Agents|adrenergic agents|mesh-ancestor
110349773|NCT02938286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110349774|NCT02938286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110349775|NCT02938286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110349776|NCT02938286|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110349777|NCT02938286|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110349778|NCT02938286|Autonomic Agents|autonomic agents|mesh-ancestor
110349779|NCT02938286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110349780|NCT02938286|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110349781|NCT02938286|Respiratory System Agents|respiratory system agents|mesh-ancestor
110349782|NCT02938286|Mydriatics|mydriatics|mesh-ancestor
110349783|NCT02938286|Sympathomimetics|sympathomimetics|mesh-ancestor
110349784|NCT02938286|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110349785|NCT02938286|Anesthetics, Local|anesthetics, local|mesh-ancestor
110349786|NCT02938286|Anesthetics|anesthetics|mesh-ancestor
110349787|NCT02938286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110349788|NCT02938286|Sensory System Agents|sensory system agents|mesh-ancestor
110349789|NCT01292239|Ribavirin|ribavirin|mesh-list
110349790|NCT01292239|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110349791|NCT01292239|Simeprevir|simeprevir|mesh-list
110349792|NCT01292239|Antimetabolites|antimetabolites|mesh-ancestor
110349793|NCT01292239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110349794|NCT01292239|Antiviral Agents|antiviral agents|mesh-ancestor
110349795|NCT01292239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110349796|NCT01292239|Protease Inhibitors|protease inhibitors|mesh-ancestor
110349797|NCT01292239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110349798|NCT05600179|Dexamethasone|dexamethasone|mesh-list
110349799|NCT05600179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110349800|NCT05600179|Antiemetics|antiemetics|mesh-ancestor
110349801|NCT05600179|Autonomic Agents|autonomic agents|mesh-ancestor
110349802|NCT05600179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110349803|NCT05600179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110349804|NCT05600179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110349805|NCT05600179|Glucocorticoids|glucocorticoids|mesh-ancestor
110349806|NCT05600179|Hormones|hormones|mesh-ancestor
110349807|NCT05600179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110349808|NCT05600179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110349810|NCT02937662|Cytarabine|cytarabine|mesh-list
110349811|NCT02937662|Cyclophosphamide|cyclophosphamide|mesh-list
110349812|NCT02937662|Idarubicin|idarubicin|mesh-list
110349813|NCT02937662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110349814|NCT02937662|Immunologic Factors|immunologic factors|mesh-ancestor
110349815|NCT02937662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110349816|NCT02937662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110349817|NCT02937662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110349818|NCT02937662|Alkylating Agents|alkylating agents|mesh-ancestor
110349819|NCT02937662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110349820|NCT02937662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110349821|NCT02937662|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110349822|NCT02937662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110349823|NCT02937662|Antimetabolites|antimetabolites|mesh-ancestor
110349824|NCT02937662|Antiviral Agents|antiviral agents|mesh-ancestor
110349825|NCT02937662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110349826|NCT02937662|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110349827|NCT02937662|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110349828|NCT02937662|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110349829|NCT02937662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110349831|NCT01290757|Antithrombins|antithrombins|mesh-ancestor
110349832|NCT01290757|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110349833|NCT01290757|Protease Inhibitors|protease inhibitors|mesh-ancestor
110349834|NCT01290757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110349835|NCT01290757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110349836|NCT01290757|Anticoagulants|anticoagulants|mesh-ancestor
110349837|NCT02937857|Antipyretics|antipyretics|mesh-list
110349838|NCT02937857|Expectorants|expectorants|mesh-list
110349839|NCT02937857|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-list
110349840|NCT02937857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110349841|NCT02937857|Respiratory System Agents|respiratory system agents|mesh-ancestor
110349843|NCT04324060|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110349844|NCT04324060|Hormone Antagonists|hormone antagonists|mesh-ancestor
110349845|NCT04324060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110349846|NCT04324060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110349847|NCT01290718|Capecitabine|capecitabine|mesh-list
110349848|NCT01290718|Trastuzumab|trastuzumab|mesh-list
110349849|NCT01290718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110349850|NCT01290718|Antimetabolites|antimetabolites|mesh-ancestor
110349851|NCT01290718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110349852|NCT01290718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110349853|NCT01290718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110349854|NCT04324294|Pancrelipase|pancrelipase|mesh-list
110349856|NCT02937896|Ketorolac|ketorolac|mesh-list
110349857|NCT02937896|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
110349858|NCT02937896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110349859|NCT02937896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110349860|NCT02937896|Analgesics|analgesics|mesh-ancestor
110349861|NCT02937896|Sensory System Agents|sensory system agents|mesh-ancestor
110349862|NCT02937896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110349863|NCT02937896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110349864|NCT02937896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110349865|NCT02937896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110349866|NCT02937896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110349867|NCT02937896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110349868|NCT02937896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110349869|NCT02937896|Hemostatics|hemostatics|mesh-ancestor
110349870|NCT02937896|Coagulants|coagulants|mesh-ancestor
110349871|NCT02937896|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110349872|NCT02937896|Natriuretic Agents|natriuretic agents|mesh-ancestor
110349873|NCT04688151|Rituximab|rituximab|mesh-list
110349874|NCT04688151|Durvalumab|durvalumab|mesh-list
110349875|NCT04688151|Acalabrutinib|acalabrutinib|mesh-list
110349876|NCT04688151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110349877|NCT04688151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110349878|NCT04688151|Immunologic Factors|immunologic factors|mesh-ancestor
110349879|NCT04688151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110349880|NCT04688151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110349881|NCT02937779|Tenofovir|tenofovir|mesh-list
110349882|NCT02937779|Antiviral Agents|antiviral agents|mesh-ancestor
110349883|NCT02937779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110349884|NCT02937779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110349885|NCT02937779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110349886|NCT02937779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110349887|NCT02937779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110349888|NCT02937779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110349889|NCT02937779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110349890|NCT01290679|Ribavirin|ribavirin|mesh-list
110349891|NCT01290679|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110349892|NCT01290679|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110349893|NCT01290679|Simeprevir|simeprevir|mesh-list
110349894|NCT01290679|Antimetabolites|antimetabolites|mesh-ancestor
110349895|NCT01290679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110349896|NCT01290679|Antiviral Agents|antiviral agents|mesh-ancestor
110349897|NCT01290679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110349898|NCT01290679|Protease Inhibitors|protease inhibitors|mesh-ancestor
110349899|NCT01290679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110349900|NCT03457389|Cabergoline|cabergoline|mesh-list
110349901|NCT03457389|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110349902|NCT03457389|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110349903|NCT03457389|Dopamine Agonists|dopamine agonists|mesh-ancestor
110349904|NCT03457389|Dopamine Agents|dopamine agents|mesh-ancestor
110349905|NCT03457389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110349906|NCT03457389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110349907|NCT03457389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110349909|NCT02890186|Propofol|propofol|mesh-list
110349910|NCT02890186|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110349911|NCT02890186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110349912|NCT02890186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110349913|NCT02890186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110349914|NCT02890186|Anesthetics, General|anesthetics, general|mesh-ancestor
110349915|NCT02890186|Anesthetics|anesthetics|mesh-ancestor
110349916|NCT02890186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110349917|NCT02890186|Narcotics|narcotics|mesh-ancestor
110349918|NCT02890186|Analgesics|analgesics|mesh-ancestor
110349919|NCT02890186|Sensory System Agents|sensory system agents|mesh-ancestor
110349920|NCT02890186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110349921|NCT02909751|Tocotrienols|tocotrienols|mesh-list
110349922|NCT02909751|Vitamin E|vitamin e|mesh-list
110349923|NCT02909751|Tocopherols|tocopherols|mesh-list
110349924|NCT02909751|Docetaxel|docetaxel|mesh-list
110349925|NCT02909751|Cyclophosphamide|cyclophosphamide|mesh-list
110349926|NCT02909751|Trastuzumab|trastuzumab|mesh-list
110349927|NCT02909751|Epirubicin|epirubicin|mesh-list
110349928|NCT02909751|Pertuzumab|pertuzumab|mesh-list
110349929|NCT02909751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110349930|NCT02909751|Tubulin Modulators|tubulin modulators|mesh-ancestor
110349931|NCT02909751|Antimitotic Agents|antimitotic agents|mesh-ancestor
110349932|NCT02909751|Mitosis Modulators|mitosis modulators|mesh-ancestor
110349933|NCT02909751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110349934|NCT02909751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110349935|NCT02909751|Immunologic Factors|immunologic factors|mesh-ancestor
110349936|NCT02909751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110349937|NCT02909751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110349938|NCT02909751|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110349939|NCT02909751|Alkylating Agents|alkylating agents|mesh-ancestor
110349940|NCT02909751|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110349941|NCT02909751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110349942|NCT02909751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110349943|NCT02909751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110349944|NCT02909751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110349945|NCT02909751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110349946|NCT02909751|Antioxidants|antioxidants|mesh-ancestor
110349947|NCT02909751|Protective Agents|protective agents|mesh-ancestor
110349948|NCT02909751|Vitamins|vitamins|mesh-ancestor
110349949|NCT02909751|Micronutrients|micronutrients|mesh-ancestor
110349950|NCT02909712|Pyrimethamine|pyrimethamine|mesh-list
110349951|NCT02909712|Piperaquine|piperaquine|mesh-list
110349952|NCT02909712|Sulfadoxine|sulfadoxine|mesh-list
110349953|NCT02909712|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110349954|NCT02909712|Artenimol|artenimol|mesh-list
110349955|NCT02909712|Antimalarials|antimalarials|mesh-ancestor
110349956|NCT02909712|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110349957|NCT02909712|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110349958|NCT02909712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110349959|NCT02909712|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110349960|NCT02909712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110349961|NCT02909712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110349962|NCT02909712|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110349963|NCT02913885|Fluorides|fluorides|mesh-list
110349964|NCT02913885|Fluorides, Topical|fluorides, topical|mesh-list
110349965|NCT02913885|Cariostatic Agents|cariostatic agents|mesh-ancestor
110349966|NCT02913885|Protective Agents|protective agents|mesh-ancestor
110349967|NCT02913885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110349968|NCT01290601|Chloroquine|chloroquine|mesh-list
110349969|NCT01290601|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
110349970|NCT01290601|Primaquine|primaquine|mesh-list
110349971|NCT01290601|Tafenoquine|tafenoquine|mesh-list
110349972|NCT01290601|Amebicides|amebicides|mesh-ancestor
110349973|NCT01290601|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110349974|NCT01290601|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110349975|NCT01290601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110349976|NCT01290601|Antimalarials|antimalarials|mesh-ancestor
110349977|NCT01290601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110349978|NCT01290601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110349979|NCT01290601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110349980|NCT01290601|Analgesics|analgesics|mesh-ancestor
110349981|NCT01290601|Sensory System Agents|sensory system agents|mesh-ancestor
110349982|NCT01290601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110349983|NCT01290601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110349984|NCT01290601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110349985|NCT01290601|Filaricides|filaricides|mesh-ancestor
110349986|NCT01290601|Antinematodal Agents|antinematodal agents|mesh-ancestor
110349987|NCT01290601|Anthelmintics|anthelmintics|mesh-ancestor
110349988|NCT02978391|Epinephrine|epinephrine|mesh-list
110349989|NCT02978391|Hemostatics|hemostatics|mesh-list
110349990|NCT02978391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110349991|NCT02978391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110349992|NCT02978391|Adrenergic Agents|adrenergic agents|mesh-ancestor
110349993|NCT02978391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110349994|NCT02978391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110036257|NCT01409616|Protease Inhibitors|protease inhibitors|mesh-ancestor
110349995|NCT02978391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110349996|NCT02978391|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110349997|NCT02978391|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110349998|NCT02978391|Autonomic Agents|autonomic agents|mesh-ancestor
110349999|NCT02978391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110350000|NCT02978391|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110350001|NCT02978391|Respiratory System Agents|respiratory system agents|mesh-ancestor
110350002|NCT02978391|Mydriatics|mydriatics|mesh-ancestor
110350003|NCT02978391|Sympathomimetics|sympathomimetics|mesh-ancestor
110350004|NCT02978391|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110350005|NCT02978391|Coagulants|coagulants|mesh-ancestor
110350006|NCT01290094|Ibandronic Acid|ibandronic acid|mesh-list
110350007|NCT01290094|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110350008|NCT01290094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110350009|NCT04688346|Epinephrine|epinephrine|mesh-list
110350010|NCT04688346|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110350011|NCT04688346|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110350012|NCT04688346|Adrenergic Agents|adrenergic agents|mesh-ancestor
110350013|NCT04688346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110350014|NCT04688346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110350015|NCT04688346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110350016|NCT04688346|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110350017|NCT04688346|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110350018|NCT04688346|Autonomic Agents|autonomic agents|mesh-ancestor
110350019|NCT04688346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110350020|NCT04688346|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110350021|NCT04688346|Respiratory System Agents|respiratory system agents|mesh-ancestor
110350022|NCT04688346|Mydriatics|mydriatics|mesh-ancestor
110350023|NCT04688346|Sympathomimetics|sympathomimetics|mesh-ancestor
110350024|NCT04688346|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110350026|NCT01289821|Folic Acid|folic acid|mesh-list
110350027|NCT01289821|Oxaliplatin|oxaliplatin|mesh-list
110350028|NCT01289821|Levoleucovorin|levoleucovorin|mesh-list
110350029|NCT01289821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110350030|NCT01289821|Antidotes|antidotes|mesh-ancestor
110350031|NCT01289821|Protective Agents|protective agents|mesh-ancestor
110350033|NCT01289821|Vitamin B Complex|vitamin b complex|mesh-ancestor
110350034|NCT01289821|Vitamins|vitamins|mesh-ancestor
110350035|NCT01289821|Micronutrients|micronutrients|mesh-ancestor
110350036|NCT01289821|Hematinics|hematinics|mesh-ancestor
110350037|NCT02913768|Ondansetron|ondansetron|mesh-list
110350038|NCT02913768|Antiemetics|antiemetics|mesh-ancestor
110350039|NCT02913768|Autonomic Agents|autonomic agents|mesh-ancestor
110350040|NCT02913768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110350041|NCT02913768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110350042|NCT02913768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110350043|NCT02913768|Antipruritics|antipruritics|mesh-ancestor
110350044|NCT02913768|Dermatologic Agents|dermatologic agents|mesh-ancestor
110350045|NCT02913768|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110350046|NCT02913768|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110350047|NCT02913768|Serotonin Agents|serotonin agents|mesh-ancestor
110350048|NCT02913768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110350049|NCT02913768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110350050|NCT01289782|Ribavirin|ribavirin|mesh-list
110350051|NCT01289782|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110350052|NCT01289782|Simeprevir|simeprevir|mesh-list
110350053|NCT01289782|Antimetabolites|antimetabolites|mesh-ancestor
110350054|NCT01289782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110350055|NCT01289782|Antiviral Agents|antiviral agents|mesh-ancestor
110350056|NCT01289782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110350057|NCT01289782|Protease Inhibitors|protease inhibitors|mesh-ancestor
110350058|NCT01289782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110350059|NCT02913417|Nivolumab|nivolumab|mesh-list
110350060|NCT02913417|Ipilimumab|ipilimumab|mesh-list
110350061|NCT02913417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110350062|NCT02913417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110350063|NCT02913417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110350064|NCT02913417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110350066|NCT02936492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110350067|NCT02936492|Glucocorticoids|glucocorticoids|mesh-ancestor
110350068|NCT02936492|Hormones|hormones|mesh-ancestor
110350069|NCT02936492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110350070|NCT02936492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110350071|NCT02913573|Bupivacaine|bupivacaine|mesh-list
110350072|NCT02913573|Anesthetics, Local|anesthetics, local|mesh-ancestor
110350073|NCT02913573|Anesthetics|anesthetics|mesh-ancestor
110350074|NCT02913573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110350075|NCT02913573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110350076|NCT02913573|Sensory System Agents|sensory system agents|mesh-ancestor
110350077|NCT02913573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110350078|NCT01289353|Carboplatin|carboplatin|mesh-list
110350079|NCT01289353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110350080|NCT02913300|Lidocaine|lidocaine|mesh-list
110350081|NCT02913300|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110350082|NCT02913300|Anesthetics, Local|anesthetics, local|mesh-ancestor
110350083|NCT02913300|Anesthetics|anesthetics|mesh-ancestor
110350084|NCT02913300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110350085|NCT02913300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110350086|NCT02913300|Sensory System Agents|sensory system agents|mesh-ancestor
110350087|NCT02913300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110350088|NCT02913300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110350089|NCT02913300|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110350090|NCT02913300|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110350091|NCT02913300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110350092|NCT02913300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110350093|NCT02936375|Cyclophosphamide|cyclophosphamide|mesh-list
110350094|NCT02936375|Azathioprine|azathioprine|mesh-list
110350095|NCT02936375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110350096|NCT02936375|Immunologic Factors|immunologic factors|mesh-ancestor
110350097|NCT02936375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110350098|NCT02936375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110350099|NCT02936375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110350100|NCT02936375|Alkylating Agents|alkylating agents|mesh-ancestor
110350101|NCT02936375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110350102|NCT02936375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110350103|NCT02936375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110350104|NCT02936375|Antimetabolites|antimetabolites|mesh-ancestor
110350105|NCT02936375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110350106|NCT02913690|Vitamin E|vitamin e|mesh-list
110350107|NCT02913690|Vitamins|vitamins|mesh-ancestor
110350108|NCT02913690|Micronutrients|micronutrients|mesh-ancestor
110350109|NCT02913690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110350111|NCT02913690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110350112|NCT02913690|Protective Agents|protective agents|mesh-ancestor
110350113|NCT01289119|Metformin|metformin|mesh-list
110350114|NCT01289119|Pioglitazone|pioglitazone|mesh-list
110350115|NCT01289119|Alogliptin|alogliptin|mesh-list
110350116|NCT01289119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110350117|NCT01289119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110350118|NCT01289119|Incretins|incretins|mesh-ancestor
110350119|NCT01289119|Hormones|hormones|mesh-ancestor
110350120|NCT01289119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110350121|NCT01289119|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110350122|NCT01289119|Protease Inhibitors|protease inhibitors|mesh-ancestor
110350123|NCT01289119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110350124|NCT01289119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110350125|NCT01287832|Vancomycin|vancomycin|mesh-list
110350126|NCT01287832|Daptomycin|daptomycin|mesh-list
110350127|NCT01287832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110350128|NCT01287832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110350129|NCT02913066|Cisplatin|cisplatin|mesh-list
110350130|NCT02913066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110350131|NCT01287754|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110350132|NCT01287754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110350133|NCT01287754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110350134|NCT01287754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110350135|NCT01287754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110350136|NCT02912793|Betadex|betadex|mesh-list
110350137|NCT02912793|Sequestering Agents|sequestering agents|mesh-ancestor
110350138|NCT02912793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110350139|NCT02935751|Apixaban|apixaban|mesh-list
110350140|NCT02935751|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110350141|NCT02935751|Antithrombins|antithrombins|mesh-ancestor
110350142|NCT02935751|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110350143|NCT02935751|Protease Inhibitors|protease inhibitors|mesh-ancestor
110350144|NCT02935751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110350145|NCT02935751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110350146|NCT02935751|Anticoagulants|anticoagulants|mesh-ancestor
110350147|NCT02935790|Nivolumab|nivolumab|mesh-list
110350148|NCT02935790|Ipilimumab|ipilimumab|mesh-list
110350149|NCT02935790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110350150|NCT02935790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110350151|NCT02935790|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110350152|NCT02935790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110350153|NCT02912637|Xenon|xenon|mesh-list
110350154|NCT02912637|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110350155|NCT02912637|Anesthetics, General|anesthetics, general|mesh-ancestor
110350156|NCT02912637|Anesthetics|anesthetics|mesh-ancestor
110350157|NCT02912637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110350158|NCT02912637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110350159|NCT02912910|Labetalol|labetalol|mesh-list
110350160|NCT02912910|Nifedipine|nifedipine|mesh-list
110350161|NCT02912910|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110350162|NCT02912910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110350163|NCT02912910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110350164|NCT02912910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110350165|NCT02912910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110350166|NCT02912910|Vasodilator Agents|vasodilator agents|mesh-ancestor
110350167|NCT02912910|Tocolytic Agents|tocolytic agents|mesh-ancestor
110350168|NCT02912910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110350169|NCT02912910|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110350170|NCT02912910|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110350171|NCT02912910|Adrenergic Agents|adrenergic agents|mesh-ancestor
110350172|NCT02912910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110350173|NCT02912910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110350174|NCT02912910|Sympathomimetics|sympathomimetics|mesh-ancestor
110350175|NCT02912910|Autonomic Agents|autonomic agents|mesh-ancestor
110350176|NCT02912910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110350177|NCT02912910|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110350178|NCT02912910|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110350179|NCT02935829|Locust bean gum|locust bean gum|mesh-list
110350180|NCT02935829|Antidiarrheals|antidiarrheals|mesh-ancestor
110350181|NCT02935829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110350184|NCT02912676|Thioguanine|thioguanine|mesh-list
110350185|NCT02912676|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110350186|NCT02912676|Abortifacient Agents|abortifacient agents|mesh-ancestor
110350187|NCT02912676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110350188|NCT02912676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110350189|NCT02912676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110350190|NCT02912676|Antimetabolites|antimetabolites|mesh-ancestor
110350191|NCT02912676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110350192|NCT02912676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110350193|NCT02912676|Dermatologic Agents|dermatologic agents|mesh-ancestor
110350194|NCT02912676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110350195|NCT02912676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110350196|NCT02912676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110350197|NCT02912676|Immunologic Factors|immunologic factors|mesh-ancestor
110350198|NCT02912676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110350199|NCT02912676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110350200|NCT02935985|Fibrin fragment D|fibrin fragment d|mesh-list
110350201|NCT02935985|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110350202|NCT02935985|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110350203|NCT02935985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110350204|NCT02935985|Hemostatics|hemostatics|mesh-ancestor
110350205|NCT02935985|Coagulants|coagulants|mesh-ancestor
110350206|NCT02912169|Anesthetics|anesthetics|mesh-list
110350207|NCT02912169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110350208|NCT02912169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110350209|NCT02912520|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110350210|NCT02912520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110350211|NCT02935959|Midazolam|midazolam|mesh-list
110350212|NCT02935959|Dexmedetomidine|dexmedetomidine|mesh-list
110350213|NCT02935959|Ketamine|ketamine|mesh-list
110350214|NCT02935959|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110350215|NCT02935959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110350216|NCT02935959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110350217|NCT02935959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110350218|NCT02935959|Analgesics|analgesics|mesh-ancestor
110350219|NCT02935959|Sensory System Agents|sensory system agents|mesh-ancestor
110350220|NCT02935959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110350221|NCT02935959|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110350222|NCT02935959|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110350223|NCT02935959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110350224|NCT02935959|Adrenergic Agents|adrenergic agents|mesh-ancestor
110350225|NCT02935959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110350226|NCT02935959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110350227|NCT02935959|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110350228|NCT02935959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110350229|NCT02935959|Anesthetics, General|anesthetics, general|mesh-ancestor
110350230|NCT02935959|Anesthetics|anesthetics|mesh-ancestor
110350231|NCT02935959|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110350232|NCT02935959|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110350233|NCT02935959|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110350234|NCT02935959|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110350236|NCT02935959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110350237|NCT02935959|GABA Modulators|gaba modulators|mesh-ancestor
110350238|NCT02935959|GABA Agents|gaba agents|mesh-ancestor
110350239|NCT02935322|Chlorhexidine|chlorhexidine|mesh-list
110350240|NCT02935322|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110350241|NCT02935322|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110350243|NCT02935322|Disinfectants|disinfectants|mesh-ancestor
110350244|NCT02935322|Dermatologic Agents|dermatologic agents|mesh-ancestor
110350245|NCT02935647|Propofol|propofol|mesh-list
110350246|NCT02935647|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110350247|NCT02935647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110350248|NCT02935647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110350249|NCT02935647|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110350250|NCT02935647|Anesthetics, General|anesthetics, general|mesh-ancestor
110350251|NCT02935647|Anesthetics|anesthetics|mesh-ancestor
110350252|NCT02912247|Adalimumab|adalimumab|mesh-list
110350253|NCT02912247|Antibodies|antibodies|mesh-list
110350254|NCT02912247|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110350255|NCT02912247|Immunologic Factors|immunologic factors|mesh-ancestor
110350256|NCT02912247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110350257|NCT02912247|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110350258|NCT02912247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110350259|NCT02912247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110350260|NCT02935010|Amoxicillin|amoxicillin|mesh-list
110350261|NCT02935010|Metronidazole|metronidazole|mesh-list
110350262|NCT02935010|Clarithromycin|clarithromycin|mesh-list
110350263|NCT02935010|Levofloxacin|levofloxacin|mesh-list
110350264|NCT02935010|Potassium Citrate|potassium citrate|mesh-list
110350265|NCT02935010|Esomeprazole|esomeprazole|mesh-list
110350266|NCT02935010|Bismuth|bismuth|mesh-list
110350267|NCT02935010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110350268|NCT02935010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110350269|NCT02935010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110350270|NCT02935010|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110350271|NCT02935010|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110350272|NCT02935010|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110350273|NCT02935010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110350274|NCT02935010|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110350275|NCT02935010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110350276|NCT02935010|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110350277|NCT02935010|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110350278|NCT02935010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110350279|NCT02935010|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110350280|NCT02935010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110350281|NCT02935010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110350282|NCT02935010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110350283|NCT02935010|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110350284|NCT02935010|Antacids|antacids|mesh-ancestor
110350285|NCT02935010|Diuretics|diuretics|mesh-ancestor
110350286|NCT02935010|Natriuretic Agents|natriuretic agents|mesh-ancestor
110350287|NCT02935010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110350288|NCT02935010|Expectorants|expectorants|mesh-ancestor
110350289|NCT02935010|Respiratory System Agents|respiratory system agents|mesh-ancestor
110350290|NCT02935530|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110350291|NCT02935530|Tinzaparin|tinzaparin|mesh-list
110350292|NCT02935530|Dalteparin|dalteparin|mesh-list
110350293|NCT02935530|Argatroban|argatroban|mesh-list
110350294|NCT02935530|Anticoagulants|anticoagulants|mesh-ancestor
110350295|NCT02935530|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110350296|NCT02935530|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110350297|NCT02935530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110350298|NCT02935530|Antithrombins|antithrombins|mesh-ancestor
110350299|NCT02935530|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110350300|NCT02935530|Protease Inhibitors|protease inhibitors|mesh-ancestor
110350301|NCT02935530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110350302|NCT02935530|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110350303|NCT02934464|Leucovorin|leucovorin|mesh-list
110350304|NCT02934464|Paclitaxel|paclitaxel|mesh-list
110350305|NCT02934464|Ramucirumab|ramucirumab|mesh-list
110350306|NCT02934464|Oxaliplatin|oxaliplatin|mesh-list
110350307|NCT02934464|Levoleucovorin|levoleucovorin|mesh-list
110350308|NCT02934464|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110350309|NCT02934464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110350310|NCT02934464|Tubulin Modulators|tubulin modulators|mesh-ancestor
110350311|NCT02934464|Antimitotic Agents|antimitotic agents|mesh-ancestor
110350312|NCT02934464|Mitosis Modulators|mitosis modulators|mesh-ancestor
110350313|NCT02934464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110350314|NCT02934464|Antidotes|antidotes|mesh-ancestor
110350315|NCT02934464|Protective Agents|protective agents|mesh-ancestor
110175708|NCT03958383|Nivolumab|nivolumab|mesh-list
110350316|NCT02934464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110350317|NCT02934464|Vitamin B Complex|vitamin b complex|mesh-ancestor
110350318|NCT02934464|Vitamins|vitamins|mesh-ancestor
110350319|NCT02934464|Micronutrients|micronutrients|mesh-ancestor
110350320|NCT02934035|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110350321|NCT02934035|Fluoxetine|fluoxetine|mesh-list
110350322|NCT02934035|Paroxetine|paroxetine|mesh-list
110350323|NCT02934035|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110350324|NCT02934035|Antidepressive Agents|antidepressive agents|mesh-list
110350325|NCT02934035|Escitalopram|escitalopram|mesh-list
110350326|NCT02934035|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110350327|NCT02934035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110350328|NCT02934035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110350329|NCT02934035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110350330|NCT02934035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110350331|NCT02934035|Serotonin Agents|serotonin agents|mesh-ancestor
110350332|NCT02934035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110350333|NCT02934035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110350334|NCT02934035|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110350335|NCT02934035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110350336|NCT02934035|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110350337|NCT02934035|Analgesics|analgesics|mesh-ancestor
110350338|NCT02934035|Sensory System Agents|sensory system agents|mesh-ancestor
110350339|NCT02934035|Dopamine Agents|dopamine agents|mesh-ancestor
110350340|NCT02934035|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110350341|NCT02934035|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110350342|NCT02934035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110350343|NCT02934152|Amoxicillin|amoxicillin|mesh-list
110350344|NCT02934152|Clarithromycin|clarithromycin|mesh-list
110350345|NCT02934152|Rabeprazole|rabeprazole|mesh-list
110350346|NCT02934152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110350347|NCT02934152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110350348|NCT02934152|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110350349|NCT02934152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110350350|NCT02934152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110350351|NCT02934152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110350352|NCT02934152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110350353|NCT02934152|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110350354|NCT02934152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110350355|NCT02934152|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110350356|NCT02935335|Menotropins|menotropins|mesh-list
110350357|NCT02935335|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110350358|NCT02935335|Fertility Agents|fertility agents|mesh-ancestor
110350359|NCT02935335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110350360|NCT02935335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110350361|NCT02911662|Cephalexin|cephalexin|mesh-list
110350362|NCT02911662|Nitrofurantoin|nitrofurantoin|mesh-list
110350363|NCT02911662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110350364|NCT02911662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110350365|NCT02911662|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110350366|NCT02935101|Prednisolone|prednisolone|mesh-list
110350368|NCT02935101|Methylprednisolone|methylprednisolone|mesh-list
110350369|NCT02935101|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110350370|NCT02935101|Prednisolone acetate|prednisolone acetate|mesh-list
110350371|NCT02935101|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110350372|NCT02935101|Prednisolone phosphate|prednisolone phosphate|mesh-list
110350373|NCT02935101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110350374|NCT02935101|Glucocorticoids|glucocorticoids|mesh-ancestor
110350375|NCT02935101|Hormones|hormones|mesh-ancestor
110350376|NCT02935101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110350377|NCT02935101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110350378|NCT02935101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110350379|NCT02935101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110350381|NCT02935101|Autonomic Agents|autonomic agents|mesh-ancestor
110350382|NCT02935101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110350383|NCT02935101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110350384|NCT02935101|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110350385|NCT02935101|Protective Agents|protective agents|mesh-ancestor
110350387|NCT04689971|Vitamin B Complex|vitamin b complex|mesh-list
110350388|NCT04689971|Micronutrients|micronutrients|mesh-ancestor
110350389|NCT04689971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110350390|NCT02934945|Budesonide|budesonide|mesh-list
110350391|NCT02934945|Formoterol Fumarate|formoterol fumarate|mesh-list
110350392|NCT02934945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110350393|NCT02934945|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110350394|NCT02934945|Autonomic Agents|autonomic agents|mesh-ancestor
110350395|NCT02934945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110350396|NCT02934945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110350397|NCT02934945|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110350398|NCT02934945|Respiratory System Agents|respiratory system agents|mesh-ancestor
110350399|NCT02934945|Glucocorticoids|glucocorticoids|mesh-ancestor
110350400|NCT02934945|Hormones|hormones|mesh-ancestor
110350401|NCT02934945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110350402|NCT02934945|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110350403|NCT02934945|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110350404|NCT02934945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110350405|NCT02934945|Adrenergic Agents|adrenergic agents|mesh-ancestor
110350406|NCT02934945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110350407|NCT02934945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110350409|NCT02933645|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110350410|NCT02933645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110350411|NCT02933645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110350412|NCT02933684|Cycloserine|cycloserine|mesh-list
110350413|NCT02933684|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110350414|NCT02933684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110350415|NCT02933684|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110350416|NCT02933684|Antitubercular Agents|antitubercular agents|mesh-ancestor
110350417|NCT02933684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110350418|NCT02933684|Antimetabolites|antimetabolites|mesh-ancestor
110350419|NCT02933684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110350421|NCT02933333|Lenograstim|lenograstim|mesh-list
110350422|NCT02933333|Sargramostim|sargramostim|mesh-list
110350423|NCT02933333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110350424|NCT02933333|Immunologic Factors|immunologic factors|mesh-ancestor
110350425|NCT02933333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110350426|NCT02933333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110350427|NCT02670252|Cyclophosphamide|cyclophosphamide|mesh-list
110350428|NCT02670252|Busulfan|busulfan|mesh-list
110350429|NCT02670252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110350430|NCT02670252|Immunologic Factors|immunologic factors|mesh-ancestor
110350431|NCT02670252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110350432|NCT02670252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110350433|NCT02670252|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110350434|NCT02670252|Alkylating Agents|alkylating agents|mesh-ancestor
110350435|NCT02670252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110350436|NCT02670252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110350437|NCT02670252|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110350438|NCT02934789|Contraceptive Agents|contraceptive agents|mesh-list
110350439|NCT02934789|Contraceptives, Oral|contraceptives, oral|mesh-list
110350440|NCT02934789|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
110350441|NCT02934789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110350442|NCT02934789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110350443|NCT02934789|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110350444|NCT02933099|Dexamethasone|dexamethasone|mesh-list
110350445|NCT02933099|Dexamethasone acetate|dexamethasone acetate|mesh-list
110350446|NCT02933099|Aprepitant|aprepitant|mesh-list
110350447|NCT02933099|Palonosetron|palonosetron|mesh-list
110350448|NCT02933099|BB 1101|bb 1101|mesh-list
110350449|NCT02933099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110350450|NCT02933099|Antiemetics|antiemetics|mesh-ancestor
110350451|NCT02933099|Autonomic Agents|autonomic agents|mesh-ancestor
110350452|NCT02933099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110350453|NCT02933099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110350454|NCT02933099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110350455|NCT02933099|Glucocorticoids|glucocorticoids|mesh-ancestor
110350457|NCT02933099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110350458|NCT02933099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110031217|NCT01390805|Valacyclovir|valacyclovir|mesh-list
110350459|NCT02933099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110350460|NCT02933099|Protease Inhibitors|protease inhibitors|mesh-ancestor
110350461|NCT02933099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110350462|NCT02933099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110350463|NCT02933099|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110350464|NCT02933099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110350465|NCT02933099|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110350466|NCT02933099|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110350467|NCT02933099|Serotonin Agents|serotonin agents|mesh-ancestor
110350468|NCT02934906|Immunoglobulins|immunoglobulins|mesh-list
110350469|NCT02934906|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110350470|NCT02934906|Antibodies|antibodies|mesh-list
110350471|NCT02934906|gamma-Globulins|gamma-globulins|mesh-list
110350472|NCT02934906|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110350473|NCT02934906|Immunologic Factors|immunologic factors|mesh-ancestor
110350474|NCT02934906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110350475|NCT02911350|Paclitaxel|paclitaxel|mesh-list
110350476|NCT02911350|Hormones|hormones|mesh-list
110350477|NCT02911350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110350478|NCT02911350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110350479|NCT02911350|Tubulin Modulators|tubulin modulators|mesh-ancestor
110350480|NCT02911350|Antimitotic Agents|antimitotic agents|mesh-ancestor
110350481|NCT02911350|Mitosis Modulators|mitosis modulators|mesh-ancestor
110350482|NCT02911350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110350483|NCT02911350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110350484|NCT02911350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110350486|NCT02932397|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110350487|NCT02932397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110350488|NCT02932397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110350489|NCT02932397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110350490|NCT02932397|Anesthetics, General|anesthetics, general|mesh-ancestor
110350491|NCT02932397|Anesthetics|anesthetics|mesh-ancestor
110350493|NCT02911272|Oxytocics|oxytocics|mesh-ancestor
110350494|NCT02911272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110350495|NCT02911272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110350496|NCT02932436|Empagliflozin|empagliflozin|mesh-list
110350497|NCT02932436|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110350498|NCT02932436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110350499|NCT02932436|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110350500|NCT02932436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110350501|NCT02932007|Chloroquine|chloroquine|mesh-list
110350502|NCT02932007|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
110350503|NCT02932007|Amebicides|amebicides|mesh-ancestor
110350504|NCT02932007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110350505|NCT02932007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110350506|NCT02932007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110350507|NCT02932007|Antimalarials|antimalarials|mesh-ancestor
110350508|NCT02932007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110350509|NCT02932007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110350510|NCT02932007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110350511|NCT02932007|Analgesics|analgesics|mesh-ancestor
110350512|NCT02932007|Sensory System Agents|sensory system agents|mesh-ancestor
110350513|NCT02932007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110350514|NCT02932007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110350515|NCT02932007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110350516|NCT02932007|Filaricides|filaricides|mesh-ancestor
110350517|NCT02932007|Antinematodal Agents|antinematodal agents|mesh-ancestor
110350518|NCT02932007|Anthelmintics|anthelmintics|mesh-ancestor
110350519|NCT02910882|Gemcitabine|gemcitabine|mesh-list
110350520|NCT02910882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110350521|NCT02910882|Antimetabolites|antimetabolites|mesh-ancestor
110350522|NCT02910882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110350523|NCT02910882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110350524|NCT02910765|Methylene Blue|methylene blue|mesh-list
110350525|NCT02910765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110350526|NCT02910765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110350527|NCT02925026|Lactoferrin|lactoferrin|mesh-list
110350528|NCT02925026|Muramidase|muramidase|mesh-list
110350529|NCT02925026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110350530|NCT02924987|Aflibercept|aflibercept|mesh-list
110350531|NCT02924987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110350532|NCT02924987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110350533|NCT02924987|Growth Substances|growth substances|mesh-ancestor
110350534|NCT02924987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110350535|NCT02924987|Growth Inhibitors|growth inhibitors|mesh-ancestor
110350536|NCT02924987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110350538|NCT02924909|Carboplatin|carboplatin|mesh-list
110350539|NCT02924909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110350540|NCT02924909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110350541|NCT02924909|Tubulin Modulators|tubulin modulators|mesh-ancestor
110350542|NCT02924909|Antimitotic Agents|antimitotic agents|mesh-ancestor
110350543|NCT02924909|Mitosis Modulators|mitosis modulators|mesh-ancestor
110350544|NCT02924909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110350545|NCT02934321|Erythritol|erythritol|mesh-list
110350546|NCT02934321|Vasodilator Agents|vasodilator agents|mesh-ancestor
110350547|NCT02924753|Cyclophosphamide|cyclophosphamide|mesh-list
110350548|NCT02924753|Fludarabine|fludarabine|mesh-list
110350549|NCT02924753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110350550|NCT02924753|Immunologic Factors|immunologic factors|mesh-ancestor
110350551|NCT02924753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110350553|NCT02924753|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110350554|NCT02924753|Alkylating Agents|alkylating agents|mesh-ancestor
110350555|NCT02924753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110350556|NCT02924753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110350557|NCT02924753|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110350558|NCT02924675|Pregabalin|pregabalin|mesh-list
110350559|NCT02924675|Analgesics|analgesics|mesh-ancestor
110350560|NCT02924675|Sensory System Agents|sensory system agents|mesh-ancestor
110350561|NCT02924675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110350562|NCT02924675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110350563|NCT02924675|Anticonvulsants|anticonvulsants|mesh-ancestor
110350564|NCT02924675|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110350565|NCT02924675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110350566|NCT02924675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110350567|NCT02924675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110350568|NCT02924675|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110350569|NCT02924675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110350570|NCT02924675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110350571|NCT02924675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110350572|NCT03847545|4-Aminopyridine|4-aminopyridine|mesh-list
110350573|NCT03847545|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110350574|NCT03847545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110350575|NCT03847545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110350576|NCT02924285|Amiodarone|amiodarone|mesh-list
110350577|NCT02924285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110350578|NCT02924285|Vasodilator Agents|vasodilator agents|mesh-ancestor
110350579|NCT02924285|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110350580|NCT02924285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110350581|NCT02924285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110350583|NCT02924285|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110350584|NCT02924285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110350585|NCT02924285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110350586|NCT02924285|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110350587|NCT02924285|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110350588|NCT02924285|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110350589|NCT01287520|Carboplatin|carboplatin|mesh-list
110350590|NCT01287520|Pemetrexed|pemetrexed|mesh-list
110350591|NCT01287520|Ranitidine|ranitidine|mesh-list
110350592|NCT01287520|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
110350593|NCT01287520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110350594|NCT01287520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110350595|NCT01287520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110350596|NCT01287520|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110350597|NCT01287520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110350598|NCT01287520|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110350599|NCT01287520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110350600|NCT01287520|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110350601|NCT01287520|Histamine Antagonists|histamine antagonists|mesh-ancestor
110350602|NCT01287520|Histamine Agents|histamine agents|mesh-ancestor
110350603|NCT01287520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110350604|NCT01287520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110350605|NCT00623740|Hydrocortisone|hydrocortisone|mesh-list
110350606|NCT00623740|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110350607|NCT00623740|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110350608|NCT00623740|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110350609|NCT00623740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110350610|NCT01287364|Mometasone Furoate|mometasone furoate|mesh-list
110350611|NCT01287364|Ciclesonide|ciclesonide|mesh-list
110350612|NCT01287364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110350613|NCT01287364|Dermatologic Agents|dermatologic agents|mesh-ancestor
110350614|NCT01287364|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110350615|NCT01287364|Glucocorticoids|glucocorticoids|mesh-ancestor
110350616|NCT01287364|Hormones|hormones|mesh-ancestor
110350617|NCT01287364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110350618|NCT01287364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110350619|NCT02889835|Chlorhexidine|chlorhexidine|mesh-list
110350620|NCT02889835|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110350621|NCT02889835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110350622|NCT02889835|Disinfectants|disinfectants|mesh-ancestor
110350623|NCT02924090|Ketamine|ketamine|mesh-list
110350624|NCT02924090|Etomidate|etomidate|mesh-list
110350625|NCT02924090|Analgesics|analgesics|mesh-ancestor
110350626|NCT02924090|Sensory System Agents|sensory system agents|mesh-ancestor
110350627|NCT02924090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110350628|NCT02924090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110350629|NCT02924090|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110350630|NCT02924090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110350631|NCT02924090|Anesthetics, General|anesthetics, general|mesh-ancestor
110350632|NCT02924090|Anesthetics|anesthetics|mesh-ancestor
110350633|NCT02924090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110350634|NCT02924090|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110350635|NCT02924090|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110350636|NCT02924090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110350637|NCT02924090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110350638|NCT02924090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110350639|NCT04137770|Ketorolac|ketorolac|mesh-list
110350640|NCT04137770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110350641|NCT04137770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110350643|NCT04137770|Sensory System Agents|sensory system agents|mesh-ancestor
110350644|NCT04137770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110350645|NCT04137770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110350646|NCT04137770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110350647|NCT04137770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110350648|NCT04137770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110350649|NCT04137770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110350650|NCT04137770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110350651|NCT01286740|Emtricitabine, Rilpivirine, Tenofovir Drug Combination|emtricitabine, rilpivirine, tenofovir drug combination|mesh-list
110350652|NCT01286740|Antiviral Agents|antiviral agents|mesh-ancestor
110350653|NCT01286740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110350654|NCT01286740|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110350655|NCT01286740|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110350656|NCT01286740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110350657|NCT01286740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110350658|NCT01286740|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110350659|NCT01286740|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110350660|NCT02923856|Clarithromycin|clarithromycin|mesh-list
110350661|NCT02923856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110350662|NCT02923856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110350663|NCT02923856|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110350664|NCT02923856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110350665|NCT02923856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110350666|NCT02923856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110350667|NCT02923856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110350668|NCT02934204|Methotrexate|methotrexate|mesh-list
110350669|NCT02934204|Temozolomide|temozolomide|mesh-list
110350670|NCT02934204|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110350671|NCT02934204|Abortifacient Agents|abortifacient agents|mesh-ancestor
110350672|NCT02934204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110350673|NCT02934204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110350674|NCT02934204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110350675|NCT02934204|Antimetabolites|antimetabolites|mesh-ancestor
110350676|NCT02934204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110350677|NCT02934204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110350678|NCT02934204|Dermatologic Agents|dermatologic agents|mesh-ancestor
110350679|NCT02934204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110350680|NCT02934204|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110350681|NCT02934204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110350682|NCT02934204|Immunologic Factors|immunologic factors|mesh-ancestor
110350683|NCT02934204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110350684|NCT02934204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110350685|NCT02934204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110350686|NCT02934204|Alkylating Agents|alkylating agents|mesh-ancestor
110350687|NCT01286077|Bortezomib|bortezomib|mesh-list
110350688|NCT01286077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110350689|NCT05590936|Ondansetron|ondansetron|mesh-list
110350690|NCT05590936|Dimenhydrinate|dimenhydrinate|mesh-list
110350691|NCT05590936|Antiemetics|antiemetics|mesh-ancestor
110350692|NCT05590936|Autonomic Agents|autonomic agents|mesh-ancestor
110350693|NCT05590936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110350695|NCT05590936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110350696|NCT05590936|Antipruritics|antipruritics|mesh-ancestor
110350697|NCT05590936|Dermatologic Agents|dermatologic agents|mesh-ancestor
110350698|NCT05590936|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110350699|NCT05590936|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110350700|NCT05590936|Serotonin Agents|serotonin agents|mesh-ancestor
110350701|NCT05590936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110350702|NCT05590936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110350703|NCT05590936|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110350704|NCT05590936|Histamine Antagonists|histamine antagonists|mesh-ancestor
110350705|NCT05590936|Histamine Agents|histamine agents|mesh-ancestor
110350706|NCT02933814|Bupivacaine|bupivacaine|mesh-list
110350707|NCT02933814|Anesthetics, Local|anesthetics, local|mesh-ancestor
110350708|NCT02933814|Anesthetics|anesthetics|mesh-ancestor
110350709|NCT02933814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110350710|NCT02933814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110350711|NCT02933814|Sensory System Agents|sensory system agents|mesh-ancestor
110350712|NCT02933814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110350713|NCT02933775|Cyclophosphamide|cyclophosphamide|mesh-list
110350714|NCT02933775|Fludarabine|fludarabine|mesh-list
110350715|NCT02933775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110350716|NCT02933775|Immunologic Factors|immunologic factors|mesh-ancestor
110350717|NCT02933775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110350718|NCT02933775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110350719|NCT02933775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110350720|NCT02933775|Alkylating Agents|alkylating agents|mesh-ancestor
110350721|NCT02933775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110350723|NCT02933775|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110350724|NCT02923583|Abatacept|abatacept|mesh-list
110350725|NCT02923583|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110225442|NCT05966246|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110350726|NCT02923583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110350727|NCT02923583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110350728|NCT02923583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110350729|NCT02923583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110350730|NCT02923583|Immunologic Factors|immunologic factors|mesh-ancestor
110350731|NCT02923583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110350732|NCT02923583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110350733|NCT02933580|JNJ-56136379|jnj-56136379|mesh-list
110350734|NCT02933580|Antiviral Agents|antiviral agents|mesh-ancestor
110350735|NCT02933580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110350736|NCT02923388|Vitamins|vitamins|mesh-list
110350737|NCT02923388|Vitamin B 12|vitamin b 12|mesh-list
110350738|NCT02923388|Pyridoxine|pyridoxine|mesh-list
110350739|NCT02923388|Vitamin B 6|vitamin b 6|mesh-list
110350740|NCT02923388|Vitamin B Complex|vitamin b complex|mesh-list
110350741|NCT02923388|Micronutrients|micronutrients|mesh-ancestor
110350742|NCT02923388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110350743|NCT02933658|Amlodipine|amlodipine|mesh-list
110350744|NCT02933658|Telmisartan|telmisartan|mesh-list
110350745|NCT02933658|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110350746|NCT02933658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110350747|NCT02933658|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110350748|NCT02933658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110350749|NCT02933658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110350750|NCT02933658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110350751|NCT02933658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110350752|NCT02933658|Vasodilator Agents|vasodilator agents|mesh-ancestor
110350753|NCT02933658|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110350754|NCT02933658|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110350755|NCT02933658|Antimetabolites|antimetabolites|mesh-ancestor
110350756|NCT02933658|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110350757|NCT02933658|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110350758|NCT02933658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110350759|NCT02933658|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110350760|NCT02933658|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110350762|NCT02933853|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110350764|NCT02933853|Insulin, Long-Acting|insulin, long-acting|mesh-list
110350765|NCT02933853|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110350766|NCT02933853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110350767|NCT02933853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110350768|NCT00532194|Cediranib|cediranib|mesh-list
110350769|NCT00532194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110350770|NCT00532194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110175753|NCT00076531|Leuprolide|leuprolide|mesh-list
110350771|NCT00532194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110350772|NCT00532194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110350773|NCT02665143|Nintedanib|nintedanib|mesh-list
110350774|NCT02665143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110350775|NCT02665143|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110350776|NCT02665143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110350777|NCT02665143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110350778|NCT00532272|Letrozole|letrozole|mesh-list
110350779|NCT00532272|Goserelin|goserelin|mesh-list
110350780|NCT00532272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110350781|NCT00532272|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110350782|NCT00532272|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110350783|NCT00532272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110350784|NCT00532272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110350785|NCT00532272|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110350786|NCT00532272|Hormone Antagonists|hormone antagonists|mesh-ancestor
110350787|NCT00532272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110350788|NCT00532272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110350789|NCT00532272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110350790|NCT02922803|Calcium, Dietary|calcium, dietary|mesh-list
110350791|NCT02922803|Vitamin D|vitamin d|mesh-list
110350792|NCT02922803|Ergocalciferols|ergocalciferols|mesh-list
110350793|NCT02922803|Cholecalciferol|cholecalciferol|mesh-list
110350794|NCT02922803|Vitamins|vitamins|mesh-list
110350795|NCT02922803|Calcium|calcium|mesh-list
110350796|NCT02922803|Micronutrients|micronutrients|mesh-ancestor
110350797|NCT02922803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110350798|NCT02922803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110350799|NCT02922803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110350800|NCT02834559|Fluorouracil|fluorouracil|mesh-list
110350801|NCT02834559|Heparin|heparin|mesh-list
110350802|NCT02834559|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110350803|NCT02834559|Tinzaparin|tinzaparin|mesh-list
110350805|NCT02834559|Antimetabolites|antimetabolites|mesh-ancestor
110350806|NCT02834559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110350807|NCT02834559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110350808|NCT02834559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110350809|NCT02834559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110350810|NCT02834559|Immunologic Factors|immunologic factors|mesh-ancestor
110350811|NCT02834559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110350812|NCT02834559|Anticoagulants|anticoagulants|mesh-ancestor
110350813|NCT02834559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110350814|NCT02834559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110350815|NCT02922686|Floxacillin|floxacillin|mesh-list
110350816|NCT02922686|Penicillin V|penicillin v|mesh-list
110350817|NCT02922686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110350818|NCT02922686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110350819|NCT02922491|Vitamin E|vitamin e|mesh-list
110350820|NCT02922491|Vitamins|vitamins|mesh-ancestor
110350821|NCT02922491|Micronutrients|micronutrients|mesh-ancestor
110350822|NCT02922491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110350823|NCT02922491|Antioxidants|antioxidants|mesh-ancestor
110350824|NCT02922491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110350825|NCT02922491|Protective Agents|protective agents|mesh-ancestor
110350826|NCT02922179|Insulin|insulin|mesh-list
110350827|NCT02922179|Insulin Detemir|insulin detemir|mesh-list
110350828|NCT02922179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110350829|NCT02922179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110350830|NCT02921984|Docetaxel|docetaxel|mesh-list
110350831|NCT02921984|Pemetrexed|pemetrexed|mesh-list
110350832|NCT02921984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110350833|NCT02921984|Tubulin Modulators|tubulin modulators|mesh-ancestor
110350834|NCT02921984|Antimitotic Agents|antimitotic agents|mesh-ancestor
110350835|NCT02921984|Mitosis Modulators|mitosis modulators|mesh-ancestor
110350836|NCT02921984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110350837|NCT02921984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110350838|NCT02921984|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110350839|NCT02921984|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110350840|NCT01285609|Paclitaxel|paclitaxel|mesh-list
110350841|NCT01285609|Carboplatin|carboplatin|mesh-list
110350842|NCT01285609|Ipilimumab|ipilimumab|mesh-list
110350843|NCT01285609|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110350844|NCT01285609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110350845|NCT01285609|Tubulin Modulators|tubulin modulators|mesh-ancestor
110350846|NCT01285609|Antimitotic Agents|antimitotic agents|mesh-ancestor
110350847|NCT01285609|Mitosis Modulators|mitosis modulators|mesh-ancestor
110350848|NCT01285609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110350849|NCT01285609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110350850|NCT01285609|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110350851|NCT03981341|Bazedoxifene|bazedoxifene|mesh-list
110350853|NCT03981341|Hormones|hormones|mesh-ancestor
110350854|NCT03981341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110350855|NCT03981341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110350856|NCT03981341|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110350857|NCT03981341|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110350858|NCT03981341|Hormone Antagonists|hormone antagonists|mesh-ancestor
110350859|NCT03981341|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110350860|NCT03924440|Nonoxynol|nonoxynol|mesh-list
110350861|NCT03924440|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
110350862|NCT03924440|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
110350863|NCT03924440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110350864|NCT03924440|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110350865|NCT03924440|Contraceptive Agents|contraceptive agents|mesh-ancestor
110350866|NCT03924440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110350867|NCT03924440|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110350868|NCT01285492|Tiotropium Bromide|tiotropium bromide|mesh-list
110350869|NCT01285492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110350870|NCT01285492|Autonomic Agents|autonomic agents|mesh-ancestor
110350871|NCT01285492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110350872|NCT01285492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110350873|NCT01285492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110350874|NCT01285492|Respiratory System Agents|respiratory system agents|mesh-ancestor
110350875|NCT01285492|Parasympatholytics|parasympatholytics|mesh-ancestor
110350876|NCT01285492|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110350877|NCT01285492|Cholinergic Agents|cholinergic agents|mesh-ancestor
110350878|NCT01285492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110350879|NCT01285492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110350880|NCT04615143|Tislelizumab|tislelizumab|mesh-list
110350881|NCT04615143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110350882|NCT04615143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110350883|NCT01284634|Cannabidiol|cannabidiol|mesh-list
110350884|NCT01284634|Anticonvulsants|anticonvulsants|mesh-ancestor
110350885|NCT02932722|Anesthetics|anesthetics|mesh-list
110350886|NCT02932722|Propofol|propofol|mesh-list
110350887|NCT02932722|Sevoflurane|sevoflurane|mesh-list
110350888|NCT02932722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110350889|NCT02932722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110350890|NCT02932722|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110350891|NCT02932722|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110350892|NCT02932722|Anesthetics, General|anesthetics, general|mesh-ancestor
110350893|NCT02932722|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110350894|NCT02932722|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110350895|NCT02932761|Goserelin|goserelin|mesh-list
110350896|NCT02932761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110350897|NCT02932761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110350898|NCT01283971|Adalimumab|adalimumab|mesh-list
110350899|NCT01283971|Methotrexate|methotrexate|mesh-list
110350900|NCT01283971|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110350901|NCT01283971|Abortifacient Agents|abortifacient agents|mesh-ancestor
110350902|NCT01283971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110350903|NCT01283971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110350904|NCT01283971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110350905|NCT01283971|Antimetabolites|antimetabolites|mesh-ancestor
110350906|NCT01283971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110350907|NCT01283971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110350908|NCT01283971|Dermatologic Agents|dermatologic agents|mesh-ancestor
110350909|NCT01283971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110350910|NCT01283971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110350911|NCT01283971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110350912|NCT01283971|Immunologic Factors|immunologic factors|mesh-ancestor
110350913|NCT01283971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110350914|NCT01283971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110350915|NCT01283971|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110350916|NCT01283971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110350917|NCT02921282|Dopamine|dopamine|mesh-list
110350918|NCT02921282|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110350919|NCT02921282|Sympathomimetics|sympathomimetics|mesh-ancestor
110350920|NCT02921282|Autonomic Agents|autonomic agents|mesh-ancestor
110350921|NCT02921282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110350922|NCT02921282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110350923|NCT02921282|Dopamine Agents|dopamine agents|mesh-ancestor
110350924|NCT02921282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110350925|NCT02921282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110350926|NCT02921282|Protective Agents|protective agents|mesh-ancestor
110350927|NCT02921360|Aspirin|aspirin|mesh-list
110350928|NCT02921360|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110350929|NCT02921360|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110350930|NCT02921360|Analgesics|analgesics|mesh-ancestor
110350931|NCT02921360|Sensory System Agents|sensory system agents|mesh-ancestor
110350932|NCT02921360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110350933|NCT02921360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110350934|NCT02921360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110350935|NCT02921360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110350936|NCT02921360|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110350937|NCT02921360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110350938|NCT02921360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110350939|NCT02921360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110350940|NCT02921360|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110350941|NCT02921360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110350942|NCT02921360|Antipyretics|antipyretics|mesh-ancestor
110350943|NCT02932605|Cannabidiol|cannabidiol|mesh-list
110350944|NCT02932605|Anticonvulsants|anticonvulsants|mesh-ancestor
110350945|NCT02921204|Vitamin D|vitamin d|mesh-list
110350946|NCT02921204|Vitamins|vitamins|mesh-ancestor
110350947|NCT02921204|Micronutrients|micronutrients|mesh-ancestor
110350948|NCT02921204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110350949|NCT02921204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110350950|NCT01283581|Vancomycin|vancomycin|mesh-list
110350951|NCT01283581|Linezolid|linezolid|mesh-list
110350952|NCT01283581|Delafloxacin|delafloxacin|mesh-list
110350953|NCT01283581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110350954|NCT01283581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110350955|NCT01283581|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110350956|NCT01283581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110350957|NCT01283581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110350958|NCT01283542|Pasireotide|pasireotide|mesh-list
110350959|NCT01283542|Hormones|hormones|mesh-ancestor
110350960|NCT01283542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110350961|NCT01283542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110350962|NCT02932488|Sumatriptan|sumatriptan|mesh-list
110350963|NCT02932488|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110350964|NCT02932488|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110350965|NCT02932488|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110350966|NCT02932488|Serotonin Agents|serotonin agents|mesh-ancestor
110350967|NCT02932488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110350968|NCT02932488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110350969|NCT02932488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110350971|NCT02921165|Analgesics|analgesics|mesh-list
110350972|NCT02921165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110350973|NCT02921165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110350975|NCT02921165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110350976|NCT02921165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110350977|NCT02921165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110350978|NCT02921165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110350979|NCT02921165|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110350980|NCT02921165|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110350981|NCT02921165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110350982|NCT02921165|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110350983|NCT02921165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110350984|NCT02921165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110350985|NCT02921165|Antipyretics|antipyretics|mesh-ancestor
110350986|NCT01283386|Cyclophosphamide|cyclophosphamide|mesh-list
110350987|NCT01283386|Chlorambucil|chlorambucil|mesh-list
110350988|NCT01283386|Rituximab|rituximab|mesh-list
110350989|NCT01283386|Fludarabine|fludarabine|mesh-list
110350990|NCT01283386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110350991|NCT01283386|Immunologic Factors|immunologic factors|mesh-ancestor
110350992|NCT01283386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110350993|NCT01283386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110350994|NCT01283386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110350995|NCT01283386|Alkylating Agents|alkylating agents|mesh-ancestor
110350996|NCT01283386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110350997|NCT01283386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110350998|NCT01283386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110350999|NCT01283386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110351000|NCT02920931|Tenofovir|tenofovir|mesh-list
110351001|NCT02920931|Antiviral Agents|antiviral agents|mesh-ancestor
110351002|NCT02920931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110351003|NCT02920931|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110351004|NCT02920931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110351005|NCT02920931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110351006|NCT02920931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110351007|NCT02920931|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110351008|NCT02920931|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110351009|NCT01283152|Lactulose|lactulose|mesh-list
110351010|NCT01283152|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
110351011|NCT01283152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110351012|NCT01283152|Laxatives|laxatives|mesh-ancestor
110351013|NCT01283464|Vitamin A|vitamin a|mesh-list
110351014|NCT01283464|Tretinoin|tretinoin|mesh-list
110351015|NCT01283464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110351016|NCT01283464|Keratolytic Agents|keratolytic agents|mesh-ancestor
110351017|NCT01283464|Dermatologic Agents|dermatologic agents|mesh-ancestor
110351018|NCT01283464|Vitamins|vitamins|mesh-ancestor
110351019|NCT01283464|Micronutrients|micronutrients|mesh-ancestor
110351020|NCT01283464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351021|NCT01282801|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110351022|NCT01282801|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110351023|NCT01282801|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110351024|NCT01282801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110351025|NCT01282801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110351026|NCT01282801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110351027|NCT01282801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351028|NCT01282801|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110351029|NCT01282801|Antidepressive Agents|antidepressive agents|mesh-ancestor
110351030|NCT01282801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110351031|NCT00532350|Tiotropium Bromide|tiotropium bromide|mesh-list
110351032|NCT00532350|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110351033|NCT00532350|Autonomic Agents|autonomic agents|mesh-ancestor
110351034|NCT00532350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110351035|NCT00532350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351036|NCT00532350|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110351037|NCT00532350|Respiratory System Agents|respiratory system agents|mesh-ancestor
110351038|NCT00532350|Parasympatholytics|parasympatholytics|mesh-ancestor
110351039|NCT00532350|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110351040|NCT00532350|Cholinergic Agents|cholinergic agents|mesh-ancestor
110351041|NCT00532350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110175803|NCT00077116|Immunoconjugates|immunoconjugates|mesh-ancestor
110351042|NCT00532350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110351045|NCT02932566|Sensory System Agents|sensory system agents|mesh-ancestor
110351046|NCT02932566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110351047|NCT02932566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351048|NCT02932566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110351049|NCT02932566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110351050|NCT02932566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110351051|NCT02932566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110351052|NCT02932566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110351053|NCT00532389|Panobinostat|panobinostat|mesh-list
110351054|NCT00532389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110351055|NCT00532389|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110351056|NCT00532389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110351057|NCT00532389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110351058|NCT02932644|Vitamin D|vitamin d|mesh-list
110351059|NCT02932644|Ergocalciferols|ergocalciferols|mesh-list
110351060|NCT02932644|Cholecalciferol|cholecalciferol|mesh-list
110351061|NCT02932644|Vitamins|vitamins|mesh-list
110351062|NCT02932644|Micronutrients|micronutrients|mesh-ancestor
110351063|NCT02932644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351064|NCT02932644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110351065|NCT02932644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110351066|NCT05466708|Dexmedetomidine|dexmedetomidine|mesh-list
110351067|NCT05466708|Ketamine|ketamine|mesh-list
110351068|NCT05466708|Esketamine|esketamine|mesh-list
110351069|NCT05466708|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110351070|NCT05466708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110351071|NCT05466708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351072|NCT05466708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110351073|NCT05466708|Analgesics|analgesics|mesh-ancestor
110351074|NCT05466708|Sensory System Agents|sensory system agents|mesh-ancestor
110351075|NCT05466708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110351076|NCT05466708|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110351077|NCT05466708|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110351078|NCT05466708|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110351079|NCT05466708|Adrenergic Agents|adrenergic agents|mesh-ancestor
110351080|NCT05466708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110351081|NCT05466708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110351082|NCT05466708|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110351083|NCT05466708|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110351084|NCT05466708|Anesthetics, General|anesthetics, general|mesh-ancestor
110351085|NCT05466708|Anesthetics|anesthetics|mesh-ancestor
110351086|NCT05466708|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110351087|NCT05466708|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110351088|NCT05466708|Antidepressive Agents|antidepressive agents|mesh-ancestor
110351089|NCT05466708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110351090|NCT02920502|Cholecalciferol|cholecalciferol|mesh-list
110351091|NCT02920502|Vitamin D|vitamin d|mesh-list
110351092|NCT02920502|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110351093|NCT02920502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351094|NCT02920502|Vitamins|vitamins|mesh-ancestor
110351095|NCT02920502|Micronutrients|micronutrients|mesh-ancestor
110351096|NCT02920502|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110351097|NCT01282216|Vaccines|vaccines|mesh-list
110351098|NCT01282216|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110351099|NCT01282216|Immunologic Factors|immunologic factors|mesh-ancestor
110351100|NCT01282216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351101|NCT01281865|Everolimus|everolimus|mesh-list
110351102|NCT01281865|Imatinib Mesylate|imatinib mesylate|mesh-list
110351103|NCT01281865|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110351104|NCT01281865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110351105|NCT01281865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110351106|NCT01281865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110351107|NCT01281865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110351108|NCT01281865|Immunologic Factors|immunologic factors|mesh-ancestor
110351109|NCT01281865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351110|NCT01281865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110351111|NCT02920658|Betamethasone|betamethasone|mesh-list
110351112|NCT02920658|Betamethasone Valerate|betamethasone valerate|mesh-list
110351113|NCT02920658|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
110351114|NCT02920658|Betamethasone benzoate|betamethasone benzoate|mesh-list
110351115|NCT02920658|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
110351116|NCT02920658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110351117|NCT02920658|Glucocorticoids|glucocorticoids|mesh-ancestor
110351118|NCT02920658|Hormones|hormones|mesh-ancestor
110351119|NCT02920658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110351120|NCT02920658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351121|NCT02920658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110351122|NCT02920658|Respiratory System Agents|respiratory system agents|mesh-ancestor
110351123|NCT01281202|Vigabatrin|vigabatrin|mesh-list
110351124|NCT01281202|Anticonvulsants|anticonvulsants|mesh-ancestor
110351125|NCT01281202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110351126|NCT01281202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110351127|NCT01281202|GABA Agents|gaba agents|mesh-ancestor
110351128|NCT01281202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110351129|NCT01281202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351130|NCT01281124|Azacitidine|azacitidine|mesh-list
110351131|NCT01281124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110351132|NCT01281124|Antimetabolites|antimetabolites|mesh-ancestor
110351133|NCT01281124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110351134|NCT01281124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110351135|NCT01281124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110351136|NCT00623857|Vitamins|vitamins|mesh-list
110351138|NCT00623857|Micronutrients|micronutrients|mesh-ancestor
110351139|NCT00623857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351140|NCT00623857|Trace Elements|trace elements|mesh-ancestor
110351141|NCT01280968|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110351142|NCT01280968|Vaccines|vaccines|mesh-list
110351143|NCT01280968|Nicotine|nicotine|mesh-list
110351144|NCT01280968|Immunologic Factors|immunologic factors|mesh-ancestor
110351145|NCT01280968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351146|NCT01280968|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110351147|NCT01280968|Autonomic Agents|autonomic agents|mesh-ancestor
110351148|NCT01280968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110351149|NCT01280968|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110351150|NCT01280968|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110351151|NCT01280968|Cholinergic Agents|cholinergic agents|mesh-ancestor
110351152|NCT01280968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110351153|NCT01280968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110351154|NCT01280968|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110351155|NCT01280968|Antacids|antacids|mesh-ancestor
110351156|NCT01280968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110351157|NCT02932020|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110351158|NCT02932020|Methylprednisolone|methylprednisolone|mesh-list
110351159|NCT02932020|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110351160|NCT02932020|Prednisolone|prednisolone|mesh-list
110351161|NCT02932020|Prednisolone acetate|prednisolone acetate|mesh-list
110351162|NCT02932020|Bupivacaine|bupivacaine|mesh-list
110351163|NCT02932020|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110351164|NCT02932020|Prednisolone phosphate|prednisolone phosphate|mesh-list
110351165|NCT02932020|Anesthetics, Local|anesthetics, local|mesh-ancestor
110351166|NCT02932020|Anesthetics|anesthetics|mesh-ancestor
110351167|NCT02932020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110351168|NCT02932020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351169|NCT02932020|Sensory System Agents|sensory system agents|mesh-ancestor
110351171|NCT02932020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110351172|NCT02932020|Antiemetics|antiemetics|mesh-ancestor
110351173|NCT02932020|Autonomic Agents|autonomic agents|mesh-ancestor
110351174|NCT02932020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110351175|NCT02932020|Glucocorticoids|glucocorticoids|mesh-ancestor
110351176|NCT02932020|Hormones|hormones|mesh-ancestor
110351177|NCT02932020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110351178|NCT02932020|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110351179|NCT02932020|Protective Agents|protective agents|mesh-ancestor
110351180|NCT02932020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110351181|NCT02932020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110351182|NCT01280656|Interferons|interferons|mesh-list
110351183|NCT01280656|Ribavirin|ribavirin|mesh-list
110351184|NCT01280656|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110351185|NCT01280656|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110351186|NCT01280656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110351187|NCT01280656|Antiviral Agents|antiviral agents|mesh-ancestor
110351188|NCT01280656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110351189|NCT01280656|Antimetabolites|antimetabolites|mesh-ancestor
110351190|NCT01280656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110351191|NCT03741530|Glyburide|glyburide|mesh-list
110351192|NCT03741530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110351193|NCT03741530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351195|NCT01280617|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110351196|NCT01280617|Immunologic Factors|immunologic factors|mesh-ancestor
110351197|NCT01280617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351198|NCT01280617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110351199|NCT02932137|Interleukin-2|interleukin-2|mesh-list
110351200|NCT02932137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110351201|NCT02932137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110351202|NCT02932137|Analgesics|analgesics|mesh-ancestor
110351203|NCT02932137|Sensory System Agents|sensory system agents|mesh-ancestor
110351204|NCT02932137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110351205|NCT02932137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351207|NCT01280266|Udenafil|udenafil|mesh-list
110351208|NCT01280266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110351209|NCT01280266|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110351210|NCT01280266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110351211|NCT01280266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110351212|NCT01280266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110351213|NCT01280266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351214|NCT01280266|Vasodilator Agents|vasodilator agents|mesh-ancestor
110351215|NCT01280266|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110351216|NCT01280266|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110351217|NCT01280266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110351218|NCT01279447|Bupivacaine|bupivacaine|mesh-list
110351219|NCT01279447|Anesthetics, Local|anesthetics, local|mesh-ancestor
110351220|NCT01279447|Anesthetics|anesthetics|mesh-ancestor
110351221|NCT01279447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110351222|NCT01279447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351223|NCT01279447|Sensory System Agents|sensory system agents|mesh-ancestor
110351224|NCT01279447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110351225|NCT02932254|Magnesium Sulfate|magnesium sulfate|mesh-list
110351226|NCT02932254|Analgesics|analgesics|mesh-ancestor
110351227|NCT02932254|Sensory System Agents|sensory system agents|mesh-ancestor
110351228|NCT02932254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110351229|NCT02932254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351230|NCT02932254|Anesthetics|anesthetics|mesh-ancestor
110351231|NCT02932254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110351232|NCT02932254|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110351233|NCT02932254|Anticonvulsants|anticonvulsants|mesh-ancestor
110351234|NCT02932254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110351235|NCT02932254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110351236|NCT02932254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110351237|NCT02932254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110351239|NCT02932254|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110351240|NCT02920190|Liraglutide|liraglutide|mesh-list
110351241|NCT02920190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110351242|NCT02920190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351243|NCT02920190|Incretins|incretins|mesh-ancestor
110351244|NCT02920190|Hormones|hormones|mesh-ancestor
110351245|NCT02920190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110351246|NCT02919878|Gemcitabine|gemcitabine|mesh-list
110351247|NCT02919878|Capecitabine|capecitabine|mesh-list
110351248|NCT02919878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110351249|NCT02919878|Antimetabolites|antimetabolites|mesh-ancestor
110351250|NCT02919878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110351251|NCT02919878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110351252|NCT02931786|Ketamine|ketamine|mesh-list
110351253|NCT02931786|Propofol|propofol|mesh-list
110351254|NCT02931786|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110351255|NCT02931786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110351256|NCT02931786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351257|NCT02931786|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110351258|NCT02931786|Anesthetics, General|anesthetics, general|mesh-ancestor
110351259|NCT02931786|Anesthetics|anesthetics|mesh-ancestor
110351260|NCT02931786|Analgesics|analgesics|mesh-ancestor
110351261|NCT02931786|Sensory System Agents|sensory system agents|mesh-ancestor
110351262|NCT02931786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110351263|NCT02931786|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110351264|NCT02931786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110351266|NCT02931786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110351267|NCT02931786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110351268|NCT02919605|Pentamidine|pentamidine|mesh-list
110351269|NCT02919605|Antifungal Agents|antifungal agents|mesh-ancestor
110351270|NCT02919605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110351271|NCT02919605|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110351272|NCT02919605|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110351273|NCT02919605|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110351274|NCT00532428|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
110351275|NCT00532428|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110351276|NCT00532428|Hormone Antagonists|hormone antagonists|mesh-ancestor
110351277|NCT00532428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110351278|NCT00532428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351279|NCT00532428|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110351280|NCT00532428|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110351281|NCT00532428|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110351283|NCT05465733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110351284|NCT05465733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110351285|NCT05465733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110351286|NCT05465733|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110351287|NCT05465733|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110351288|NCT03673787|Atezolizumab|atezolizumab|mesh-list
110351289|NCT03673787|Ipatasertib|ipatasertib|mesh-list
110351290|NCT03673787|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110351291|NCT03673787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110351292|NCT03673787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110351293|NCT03673787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110351294|NCT03673787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110351295|NCT03673787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110351296|NCT03571802|Simvastatin|simvastatin|mesh-list
110351297|NCT03571802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110351298|NCT03571802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110351299|NCT03571802|Antimetabolites|antimetabolites|mesh-ancestor
110351300|NCT03571802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110351301|NCT03571802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110351302|NCT03571802|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110351303|NCT03571802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110351304|NCT02919332|Deoxyglucose|deoxyglucose|mesh-list
110351305|NCT02919332|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110351306|NCT02919332|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110351307|NCT02919332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110351308|NCT02919332|Antimetabolites|antimetabolites|mesh-ancestor
110351309|NCT02919332|Antiviral Agents|antiviral agents|mesh-ancestor
110351310|NCT02919332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110351311|NCT02919293|Vaccines|vaccines|mesh-list
110351312|NCT02919293|Immunologic Factors|immunologic factors|mesh-ancestor
110351313|NCT02919293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351314|NCT02919371|Bevacizumab|bevacizumab|mesh-list
110351315|NCT02919371|Sunitinib|sunitinib|mesh-list
110175828|NCT00077233|Oxaliplatin|oxaliplatin|mesh-list
110351316|NCT02919371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110351317|NCT02919371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110351318|NCT02919371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110351319|NCT02919371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110351320|NCT02919371|Growth Substances|growth substances|mesh-ancestor
110351321|NCT02919371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351322|NCT02919371|Growth Inhibitors|growth inhibitors|mesh-ancestor
110351323|NCT02919371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110351324|NCT02919371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110351325|NCT02919371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110351327|NCT04736901|Rivaroxaban|rivaroxaban|mesh-list
110351328|NCT04736901|Apixaban|apixaban|mesh-list
110351329|NCT04736901|Enoxaparin sodium|enoxaparin sodium|mesh-list
110351330|NCT04736901|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110351331|NCT04736901|Antithrombins|antithrombins|mesh-ancestor
110351332|NCT04736901|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110351333|NCT04736901|Protease Inhibitors|protease inhibitors|mesh-ancestor
110351334|NCT04736901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110351335|NCT04736901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110351336|NCT04736901|Anticoagulants|anticoagulants|mesh-ancestor
110351337|NCT04736901|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110351338|NCT04736901|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110351339|NCT02919176|Pioglitazone|pioglitazone|mesh-list
110351340|NCT02919176|Mirabegron|mirabegron|mesh-list
110351341|NCT02919176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110351342|NCT02919176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351343|NCT02919176|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110351344|NCT02919176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110351345|NCT02919176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110351346|NCT02919176|Adrenergic Agents|adrenergic agents|mesh-ancestor
110351347|NCT02919176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110351348|NCT02919176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110351349|NCT02919176|Urological Agents|urological agents|mesh-ancestor
110351350|NCT04734678|Infliximab|infliximab|mesh-list
110351351|NCT04734678|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110351352|NCT04734678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110351353|NCT04734678|Dermatologic Agents|dermatologic agents|mesh-ancestor
110031455|NCT01392430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110351354|NCT04734678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110351355|NCT04734678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110351356|NCT02919059|Dapagliflozin|dapagliflozin|mesh-list
110351357|NCT02919059|Glimepiride|glimepiride|mesh-list
110351358|NCT02919059|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110351359|NCT02919059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110351360|NCT02919059|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110351361|NCT02919059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351362|NCT02919059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110351363|NCT02919059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110351364|NCT02919059|Immunologic Factors|immunologic factors|mesh-ancestor
110351365|NCT04727775|Remdesivir|remdesivir|mesh-list
110351366|NCT04727775|Favipiravir|favipiravir|mesh-list
110351367|NCT04727775|Antimetabolites|antimetabolites|mesh-ancestor
110351368|NCT04727775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110351369|NCT04727775|Antiviral Agents|antiviral agents|mesh-ancestor
110351370|NCT04727775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110351371|NCT02918825|Olanzapine|olanzapine|mesh-list
110351372|NCT02918825|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110351373|NCT02918825|Antiemetics|antiemetics|mesh-ancestor
110351374|NCT02918825|Autonomic Agents|autonomic agents|mesh-ancestor
110351375|NCT02918825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110351376|NCT02918825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351377|NCT02918825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110351378|NCT02918825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110351379|NCT02918825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110351380|NCT02918825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110351381|NCT02918825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110351382|NCT02918825|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110351383|NCT02918825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110351384|NCT02918825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110225443|NCT05966246|Serotonin Agents|serotonin agents|mesh-ancestor
110351385|NCT02918825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110351387|NCT02918825|Serotonin Agents|serotonin agents|mesh-ancestor
110351388|NCT02918825|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110351389|NCT02918825|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110351390|NCT02918825|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110351391|NCT02918825|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110351392|NCT02918825|Dopamine Agents|dopamine agents|mesh-ancestor
110351394|NCT02918747|Prednisone|prednisone|mesh-list
110351395|NCT02918747|Cyclophosphamide|cyclophosphamide|mesh-list
110351396|NCT02918747|Gemcitabine|gemcitabine|mesh-list
110351397|NCT02918747|Doxorubicin|doxorubicin|mesh-list
110351398|NCT02918747|Oxaliplatin|oxaliplatin|mesh-list
110351399|NCT02918747|Vincristine|vincristine|mesh-list
110351400|NCT02918747|Pegaspargase|pegaspargase|mesh-list
110351401|NCT02918747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110351402|NCT02918747|Immunologic Factors|immunologic factors|mesh-ancestor
110351403|NCT02918747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351404|NCT02918747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110351405|NCT02918747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110351406|NCT02918747|Alkylating Agents|alkylating agents|mesh-ancestor
110351407|NCT02918747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110351408|NCT02918747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110351409|NCT02918747|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110351410|NCT02918747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110351411|NCT02918747|Antiemetics|antiemetics|mesh-ancestor
110351412|NCT02918747|Autonomic Agents|autonomic agents|mesh-ancestor
110351413|NCT02918747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110351414|NCT02918747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110351415|NCT02918747|Glucocorticoids|glucocorticoids|mesh-ancestor
110351416|NCT02918747|Hormones|hormones|mesh-ancestor
110351417|NCT02918747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110351418|NCT02918747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110351419|NCT02918747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110351420|NCT02918747|Antimetabolites|antimetabolites|mesh-ancestor
110351421|NCT02918747|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110351422|NCT02918747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110351423|NCT02918747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110351424|NCT02918747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110351425|NCT02918747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110351426|NCT02918747|Tubulin Modulators|tubulin modulators|mesh-ancestor
110351427|NCT02918747|Antimitotic Agents|antimitotic agents|mesh-ancestor
110351428|NCT02918747|Mitosis Modulators|mitosis modulators|mesh-ancestor
110351429|NCT02918708|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110351430|NCT02918708|Immunologic Factors|immunologic factors|mesh-ancestor
110351431|NCT02918708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351432|NCT02918591|Empagliflozin|empagliflozin|mesh-list
110351433|NCT02918591|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110351434|NCT02918591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110351435|NCT02918591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110351436|NCT02918591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351437|NCT02918045|Cellulose, Oxidized|cellulose, oxidized|mesh-list
110351438|NCT02918045|Hemostatics|hemostatics|mesh-ancestor
110351439|NCT02918045|Coagulants|coagulants|mesh-ancestor
110351440|NCT00532545|Teriparatide|teriparatide|mesh-list
110351441|NCT00532545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110175841|NCT00077233|Antidotes|antidotes|mesh-ancestor
110351442|NCT00532545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351443|NCT00532545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110351444|NCT00533520|Ranibizumab|ranibizumab|mesh-list
110351445|NCT00533520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110351446|NCT00533520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110351447|NCT00533520|Growth Substances|growth substances|mesh-ancestor
110351448|NCT00533520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351449|NCT00533520|Growth Inhibitors|growth inhibitors|mesh-ancestor
110351450|NCT00533520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110351452|NCT05356104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110351453|NCT05356104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351454|NCT05356104|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110351455|NCT05356104|Incretins|incretins|mesh-ancestor
110351457|NCT05356104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110351458|NCT00533559|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
110351459|NCT00533559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110351460|NCT03685253|Niacinamide|niacinamide|mesh-list
110351461|NCT03685253|Vitamin B Complex|vitamin b complex|mesh-ancestor
110351462|NCT03685253|Vitamins|vitamins|mesh-ancestor
110351463|NCT03685253|Micronutrients|micronutrients|mesh-ancestor
110351464|NCT03685253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351465|NCT00532220|Ibandronic Acid|ibandronic acid|mesh-list
110351466|NCT00532220|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110351467|NCT00532220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351468|NCT00532584|Beclomethasone|beclomethasone|mesh-list
110351469|NCT00532584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110351470|NCT00532584|Glucocorticoids|glucocorticoids|mesh-ancestor
110351471|NCT00532584|Hormones|hormones|mesh-ancestor
110351472|NCT00532584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110351473|NCT00532584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351474|NCT00532584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110351475|NCT00532584|Respiratory System Agents|respiratory system agents|mesh-ancestor
110351476|NCT04687332|Tryptophan|tryptophan|mesh-list
110351477|NCT04687332|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110351478|NCT04687332|Antidepressive Agents|antidepressive agents|mesh-ancestor
110351479|NCT04687332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110351480|NCT05467709|Midazolam|midazolam|mesh-list
110351481|NCT05467709|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110351482|NCT05467709|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110351483|NCT05467709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110351484|NCT05467709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351485|NCT05467709|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110351486|NCT05467709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110351487|NCT05467709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110351488|NCT05467709|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110351489|NCT05467709|Anesthetics, General|anesthetics, general|mesh-ancestor
110351490|NCT05467709|Anesthetics|anesthetics|mesh-ancestor
110351491|NCT05467709|GABA Modulators|gaba modulators|mesh-ancestor
110351492|NCT05467709|GABA Agents|gaba agents|mesh-ancestor
110351493|NCT05467709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110351494|NCT05467709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110351495|NCT00532623|Gemcitabine|gemcitabine|mesh-list
110351496|NCT00532623|Vinorelbine|vinorelbine|mesh-list
110351497|NCT00532623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110351498|NCT00532623|Antimetabolites|antimetabolites|mesh-ancestor
110351499|NCT00532623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110351500|NCT00532623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110351501|NCT00532623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110351502|NCT00532623|Tubulin Modulators|tubulin modulators|mesh-ancestor
110351503|NCT00532623|Antimitotic Agents|antimitotic agents|mesh-ancestor
110351504|NCT00532623|Mitosis Modulators|mitosis modulators|mesh-ancestor
110351505|NCT00532662|Ketamine|ketamine|mesh-list
110351506|NCT00532662|Analgesics|analgesics|mesh-ancestor
110351507|NCT00532662|Sensory System Agents|sensory system agents|mesh-ancestor
110351508|NCT00532662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110351509|NCT00532662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351511|NCT00532662|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110351512|NCT00532662|Anesthetics, General|anesthetics, general|mesh-ancestor
110351513|NCT00532662|Anesthetics|anesthetics|mesh-ancestor
110351514|NCT00532662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110351515|NCT00532662|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110351516|NCT00532662|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110351517|NCT00532662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110351518|NCT00532662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110351521|NCT05467436|Anesthetics, Local|anesthetics, local|mesh-list
110351522|NCT05467436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110351523|NCT05467436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351524|NCT05467436|Sensory System Agents|sensory system agents|mesh-ancestor
110351525|NCT05467436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110351526|NCT00533637|Cetirizine|cetirizine|mesh-list
110351527|NCT00533637|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110351528|NCT00533637|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110351529|NCT00533637|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110351530|NCT00533637|Histamine Antagonists|histamine antagonists|mesh-ancestor
110351531|NCT00533637|Histamine Agents|histamine agents|mesh-ancestor
110351532|NCT00533637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110351533|NCT00533637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110351534|NCT00533637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351535|NCT00533676|Oxymetazoline|oxymetazoline|mesh-list
110351536|NCT00533676|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110351537|NCT00533676|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110351538|NCT00533676|Adrenergic Agents|adrenergic agents|mesh-ancestor
110351539|NCT00533676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110351540|NCT00533676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110351541|NCT00533676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351542|NCT00533676|Sympathomimetics|sympathomimetics|mesh-ancestor
110351543|NCT00533676|Autonomic Agents|autonomic agents|mesh-ancestor
110351544|NCT00533676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110351545|NCT00533676|Nasal Decongestants|nasal decongestants|mesh-ancestor
110351546|NCT00533676|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110351547|NCT00533676|Respiratory System Agents|respiratory system agents|mesh-ancestor
110351548|NCT05467319|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
110351549|NCT05467319|Hematinics|hematinics|mesh-ancestor
110351550|NCT05466695|Sildenafil Citrate|sildenafil citrate|mesh-list
110351551|NCT05466695|Tadalafil|tadalafil|mesh-list
110351552|NCT05466695|Vasodilator Agents|vasodilator agents|mesh-ancestor
110351553|NCT05466695|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110351554|NCT05466695|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110351555|NCT05466695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110351556|NCT05466695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110351557|NCT05466695|Urological Agents|urological agents|mesh-ancestor
110351558|NCT04484610|Analgesics, Opioid|analgesics, opioid|mesh-list
110351559|NCT04484610|Narcotics|narcotics|mesh-ancestor
110351560|NCT04484610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110351561|NCT04484610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351562|NCT04484610|Analgesics|analgesics|mesh-ancestor
110351563|NCT04484610|Sensory System Agents|sensory system agents|mesh-ancestor
110351564|NCT04484610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110351565|NCT05321316|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110351566|NCT05321316|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110351567|NCT05321316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110351568|NCT05466149|Aflutinib|aflutinib|mesh-list
110351569|NCT05466149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110351570|NCT05466149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110351571|NCT05466149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110351572|NCT00532701|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110351573|NCT00532701|Interferon-alpha|interferon-alpha|mesh-list
110351574|NCT00532701|Ribavirin|ribavirin|mesh-list
110351575|NCT00532701|Antiviral Agents|antiviral agents|mesh-ancestor
110351576|NCT00532701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110351577|NCT00532701|Immunologic Factors|immunologic factors|mesh-ancestor
110351578|NCT00532701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351579|NCT00532701|Antimetabolites|antimetabolites|mesh-ancestor
110351580|NCT00532701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110351581|NCT01276639|Tofacitinib|tofacitinib|mesh-list
110351582|NCT01276639|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110351583|NCT01276639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110351584|NCT01276639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110351585|NCT01276639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110351586|NCT00532415|Triamcinolone|triamcinolone|mesh-list
110351587|NCT00532415|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110351588|NCT00532415|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110351589|NCT00532415|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110351590|NCT00532415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110351591|NCT00532415|Glucocorticoids|glucocorticoids|mesh-ancestor
110351592|NCT00532415|Hormones|hormones|mesh-ancestor
110351593|NCT00532415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110351594|NCT00532415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351595|NCT00532415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110351596|NCT00532415|Immunologic Factors|immunologic factors|mesh-ancestor
110351597|NCT00532415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110351598|NCT00532415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110351599|NCT00532454|Tamoxifen|tamoxifen|mesh-list
110351600|NCT00532454|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110351601|NCT00532454|Hormone Antagonists|hormone antagonists|mesh-ancestor
110351602|NCT00532454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110351603|NCT00532454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351604|NCT00532454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110351605|NCT00532454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110351606|NCT00532454|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110351607|NCT00532454|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110351608|NCT00532454|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110351609|NCT01275625|Maraviroc|maraviroc|mesh-list
110351610|NCT01275625|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110351611|NCT01275625|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110351612|NCT01275625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110351613|NCT01275625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110351614|NCT01275625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110351615|NCT01275625|Antiviral Agents|antiviral agents|mesh-ancestor
110351616|NCT01275625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110351617|NCT01275625|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110351618|NCT05459792|Lidocaine|lidocaine|mesh-list
110351619|NCT05459792|Bupivacaine|bupivacaine|mesh-list
110351620|NCT05459792|Anesthetics, Local|anesthetics, local|mesh-ancestor
110351621|NCT05459792|Anesthetics|anesthetics|mesh-ancestor
110351622|NCT05459792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110351623|NCT05459792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351624|NCT05459792|Sensory System Agents|sensory system agents|mesh-ancestor
110351625|NCT05459792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110351626|NCT05459792|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110351627|NCT05459792|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110351628|NCT05459792|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110351629|NCT05459792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110351630|NCT05459792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110351632|NCT04686825|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110351633|NCT04686825|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110351634|NCT04686825|Cholinergic Agents|cholinergic agents|mesh-ancestor
110351635|NCT04686825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110351636|NCT04686825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110351637|NCT04686825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351638|NCT00533988|Anti-Infective Agents|anti-infective agents|mesh-list
110351639|NCT00533988|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110351640|NCT05281185|Factor VIII|factor viii|mesh-list
110351641|NCT05281185|Coagulants|coagulants|mesh-ancestor
110351642|NCT00532532|Tolperisone|tolperisone|mesh-list
110351643|NCT00532532|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110351644|NCT00532532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351645|NCT00532532|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110351646|NCT00532532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110351647|NCT00532571|Coenzyme Q10|coenzyme q10|mesh-list
110351648|NCT00532571|Vitamins|vitamins|mesh-ancestor
110351649|NCT00532571|Micronutrients|micronutrients|mesh-ancestor
110351650|NCT00532571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351651|NCT04322565|Colchicine|colchicine|mesh-list
110351652|NCT04322565|Gout Suppressants|gout suppressants|mesh-ancestor
110351653|NCT04322565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110351654|NCT04322565|Tubulin Modulators|tubulin modulators|mesh-ancestor
110351655|NCT04322565|Antimitotic Agents|antimitotic agents|mesh-ancestor
110351656|NCT04322565|Mitosis Modulators|mitosis modulators|mesh-ancestor
110351657|NCT04322565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110351658|NCT04322565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110351659|NCT00532688|Acetylcysteine|acetylcysteine|mesh-list
110351660|NCT00532688|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110351661|NCT00532688|Antiviral Agents|antiviral agents|mesh-ancestor
110351662|NCT00532688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110351663|NCT00532688|Expectorants|expectorants|mesh-ancestor
110351664|NCT00532688|Respiratory System Agents|respiratory system agents|mesh-ancestor
110351665|NCT00532688|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110351666|NCT00532688|Antioxidants|antioxidants|mesh-ancestor
110351667|NCT00532688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110351668|NCT00532688|Protective Agents|protective agents|mesh-ancestor
110351669|NCT00532688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351670|NCT00532688|Antidotes|antidotes|mesh-ancestor
110351671|NCT00534144|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
110351672|NCT00534144|Ferric gluconate|ferric gluconate|mesh-list
110351673|NCT00534144|Hematinics|hematinics|mesh-ancestor
110351674|NCT00534183|Haloperidol|haloperidol|mesh-list
110351675|NCT00534183|Olanzapine|olanzapine|mesh-list
110351676|NCT00534183|Risperidone|risperidone|mesh-list
110351677|NCT00534183|Haloperidol decanoate|haloperidol decanoate|mesh-list
110351678|NCT00534183|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110351679|NCT00534183|Serotonin Agents|serotonin agents|mesh-ancestor
110351680|NCT00534183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110351681|NCT00534183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110351682|NCT00534183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351683|NCT00534183|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110351684|NCT00534183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110351685|NCT00534183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110351686|NCT00534183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110351687|NCT00534183|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110351688|NCT00534183|Dopamine Agents|dopamine agents|mesh-ancestor
110351689|NCT00534183|Antiemetics|antiemetics|mesh-ancestor
110351690|NCT00534183|Autonomic Agents|autonomic agents|mesh-ancestor
110351691|NCT00534183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110351692|NCT00534183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110351693|NCT00534183|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110351694|NCT00534183|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110351695|NCT00534183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110351696|NCT00534183|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110351697|NCT00532727|Carboplatin|carboplatin|mesh-list
110351698|NCT00532727|Docetaxel|docetaxel|mesh-list
110351699|NCT00532727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110351700|NCT00532727|Tubulin Modulators|tubulin modulators|mesh-ancestor
110351701|NCT00532727|Antimitotic Agents|antimitotic agents|mesh-ancestor
110351702|NCT00532727|Mitosis Modulators|mitosis modulators|mesh-ancestor
110351703|NCT00532727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110351704|NCT04261218|Paclitaxel|paclitaxel|mesh-list
110351705|NCT04261218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110351706|NCT04261218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110351707|NCT04261218|Tubulin Modulators|tubulin modulators|mesh-ancestor
110351708|NCT04261218|Antimitotic Agents|antimitotic agents|mesh-ancestor
110351709|NCT04261218|Mitosis Modulators|mitosis modulators|mesh-ancestor
110351710|NCT04261218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110351711|NCT04687449|Curcumin|curcumin|mesh-list
110351712|NCT04687449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110351713|NCT04687449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110351714|NCT04687449|Analgesics|analgesics|mesh-ancestor
110351715|NCT04687449|Sensory System Agents|sensory system agents|mesh-ancestor
110351716|NCT04687449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110351717|NCT04687449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351718|NCT04687449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110351719|NCT04687449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110351720|NCT04687449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110351721|NCT04687449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110351722|NCT04687449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110351723|NCT05258279|Carboplatin|carboplatin|mesh-list
110351724|NCT05258279|Pembrolizumab|pembrolizumab|mesh-list
110351725|NCT05258279|Pemetrexed|pemetrexed|mesh-list
110351726|NCT05258279|Lenvatinib|lenvatinib|mesh-list
110351727|NCT05258279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110351728|NCT05258279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110351729|NCT05258279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110351730|NCT05258279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110351731|NCT05258279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110351732|NCT05258279|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110351733|NCT05258279|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110351734|NCT05258279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110351735|NCT00532818|Hydralazine|hydralazine|mesh-list
110351736|NCT00532818|Valproic Acid|valproic acid|mesh-list
110351737|NCT00532818|Anticonvulsants|anticonvulsants|mesh-ancestor
110351738|NCT00532818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110351739|NCT00532818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110351740|NCT00532818|GABA Agents|gaba agents|mesh-ancestor
110351741|NCT00532818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110351742|NCT00532818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351743|NCT00532818|Antimanic Agents|antimanic agents|mesh-ancestor
110351744|NCT00532818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110351745|NCT00532818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110351746|NCT00532818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110351747|NCT00532818|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110351748|NCT00532818|Vasodilator Agents|vasodilator agents|mesh-ancestor
110351749|NCT05209035|Trazodone|trazodone|mesh-list
110351750|NCT05209035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110351751|NCT05209035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110351752|NCT05209035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110351753|NCT05209035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351754|NCT05209035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110351755|NCT05209035|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110351756|NCT05209035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110351757|NCT05209035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110351758|NCT05209035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110351759|NCT05209035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110351760|NCT05209035|Serotonin Agents|serotonin agents|mesh-ancestor
110351761|NCT05209035|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110351762|NCT05209035|Antidepressive Agents|antidepressive agents|mesh-ancestor
110351763|NCT00534261|Interferons|interferons|mesh-list
110351764|NCT00534261|Interferon-beta|interferon-beta|mesh-list
110351765|NCT00534261|Interferon beta-1a|interferon beta-1a|mesh-list
110351766|NCT00534261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110351767|NCT00534261|Antiviral Agents|antiviral agents|mesh-ancestor
110351768|NCT00534261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110351769|NCT00534261|Immunologic Factors|immunologic factors|mesh-ancestor
110351770|NCT00534261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351771|NCT00534261|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110351772|NCT00532857|Paclitaxel|paclitaxel|mesh-list
110351773|NCT00532857|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110351774|NCT00532857|Gemcitabine|gemcitabine|mesh-list
110351775|NCT00532857|Trastuzumab|trastuzumab|mesh-list
110351776|NCT00532857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110351777|NCT00532857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110351778|NCT00532857|Tubulin Modulators|tubulin modulators|mesh-ancestor
110351779|NCT00532857|Antimitotic Agents|antimitotic agents|mesh-ancestor
110351780|NCT00532857|Mitosis Modulators|mitosis modulators|mesh-ancestor
110351781|NCT00532857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110351782|NCT00532857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110351783|NCT00532857|Antimetabolites|antimetabolites|mesh-ancestor
110351784|NCT00532857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110351785|NCT05152004|Amoxicillin|amoxicillin|mesh-list
110351786|NCT05152004|Metronidazole|metronidazole|mesh-list
110351787|NCT05152004|Clarithromycin|clarithromycin|mesh-list
110351788|NCT05152004|Rabeprazole|rabeprazole|mesh-list
110351789|NCT05152004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110351790|NCT05152004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110351791|NCT05152004|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110351792|NCT05152004|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110351793|NCT05152004|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110351794|NCT05152004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110351795|NCT05152004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110351796|NCT05152004|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110351797|NCT05152004|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110351798|NCT05152004|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110351799|NCT05152004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110351800|NCT05152004|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110351801|NCT05132153|Milrinone|milrinone|mesh-list
110351802|NCT05132153|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110351803|NCT05132153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110351804|NCT05132153|Vasodilator Agents|vasodilator agents|mesh-ancestor
110351805|NCT05132153|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110351806|NCT05132153|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110351807|NCT05132153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110351808|NCT05132153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110351809|NCT05132153|Protective Agents|protective agents|mesh-ancestor
110351810|NCT05132153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351812|NCT00534378|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110351813|NCT00534378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110351814|NCT00534378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110175932|NCT04711213|Glucocorticoids|glucocorticoids|mesh-ancestor
110351815|NCT00534378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351816|NCT00534378|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110351817|NCT00534378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110351818|NCT00534378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110351819|NCT00534378|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110351820|NCT00534378|Anesthetics, General|anesthetics, general|mesh-ancestor
110351821|NCT00534378|Anesthetics|anesthetics|mesh-ancestor
110351822|NCT00534378|GABA Modulators|gaba modulators|mesh-ancestor
110351823|NCT00534378|GABA Agents|gaba agents|mesh-ancestor
110351824|NCT00534378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110351825|NCT00534378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110351826|NCT05131997|Atorvastatin|atorvastatin|mesh-list
110351827|NCT05131997|Ezetimibe|ezetimibe|mesh-list
110351828|NCT05131997|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110351829|NCT05131997|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110351830|NCT05131997|Antimetabolites|antimetabolites|mesh-ancestor
110351831|NCT05131997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110351832|NCT05131997|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110351833|NCT05131997|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110351834|NCT05131997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110351835|NCT00534456|Darbepoetin alfa|darbepoetin alfa|mesh-list
110351836|NCT00534456|Hematinics|hematinics|mesh-ancestor
110351837|NCT05104229|Aspirin|aspirin|mesh-list
110351838|NCT05104229|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110351839|NCT05104229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110351840|NCT05104229|Analgesics|analgesics|mesh-ancestor
110351841|NCT05104229|Sensory System Agents|sensory system agents|mesh-ancestor
110351842|NCT05104229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110351843|NCT05104229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351844|NCT05104229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110351845|NCT05104229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110351846|NCT05104229|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110351847|NCT05104229|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110351848|NCT05104229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110351849|NCT05104229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110351850|NCT05104229|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110351851|NCT05104229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110351852|NCT05104229|Antipyretics|antipyretics|mesh-ancestor
110351853|NCT00532961|Loteprednol Etabonate|loteprednol etabonate|mesh-list
110351854|NCT00532961|Tobramycin|tobramycin|mesh-list
110351855|NCT00532961|Dexamethasone|dexamethasone|mesh-list
110351856|NCT00532961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110351857|NCT00532961|Antiemetics|antiemetics|mesh-ancestor
110351858|NCT00532961|Autonomic Agents|autonomic agents|mesh-ancestor
110351859|NCT00532961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110351860|NCT00532961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351861|NCT00532961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110351862|NCT00532961|Glucocorticoids|glucocorticoids|mesh-ancestor
110351863|NCT00532961|Hormones|hormones|mesh-ancestor
110351864|NCT00532961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110351865|NCT00532961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110351866|NCT00532961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110351867|NCT00532961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110351868|NCT00532961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110351869|NCT00532961|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110351870|NCT00534573|Amisulpride|amisulpride|mesh-list
110351871|NCT00534573|Moclobemide|moclobemide|mesh-list
110351872|NCT00534573|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110351873|NCT00534573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110351874|NCT00534573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110351875|NCT00534573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351876|NCT00534573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110351877|NCT00534573|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110351878|NCT00534573|Dopamine Agents|dopamine agents|mesh-ancestor
110351879|NCT00534573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110351880|NCT00534573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110351881|NCT00534573|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110351882|NCT00534573|Antidepressive Agents|antidepressive agents|mesh-ancestor
110351883|NCT00534573|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110351884|NCT00534573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110351886|NCT04686890|Tramadol|tramadol|mesh-list
110351887|NCT04686890|Analgesics|analgesics|mesh-list
110351888|NCT04686890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110351889|NCT04686890|Sensory System Agents|sensory system agents|mesh-ancestor
110351890|NCT04686890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110351891|NCT04686890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351892|NCT04686890|Antipyretics|antipyretics|mesh-ancestor
110351893|NCT04686890|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110351894|NCT04686890|Narcotics|narcotics|mesh-ancestor
110351895|NCT04686890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110351896|NCT00533039|Varespladib methyl|varespladib methyl|mesh-list
110351897|NCT00533039|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
110351898|NCT00533039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110351899|NCT00533039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110351900|NCT05103306|Empagliflozin|empagliflozin|mesh-list
110351901|NCT05103306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110351902|NCT05103306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351903|NCT05103306|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110351904|NCT05103306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110351905|NCT00534651|Acetaminophen|acetaminophen|mesh-list
110351906|NCT00534651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110351907|NCT00534651|Analgesics|analgesics|mesh-ancestor
110351908|NCT00534651|Sensory System Agents|sensory system agents|mesh-ancestor
110351909|NCT00534651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110351910|NCT00534651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351911|NCT00534651|Antipyretics|antipyretics|mesh-ancestor
110351912|NCT05080959|Ropivacaine|ropivacaine|mesh-list
110351913|NCT05080959|Anesthetics, Local|anesthetics, local|mesh-ancestor
110351915|NCT05080959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110351916|NCT05080959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351917|NCT05080959|Sensory System Agents|sensory system agents|mesh-ancestor
110351918|NCT05080959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110351919|NCT04942730|Mycophenolic Acid|mycophenolic acid|mesh-list
110351920|NCT04942730|Cyclophosphamide|cyclophosphamide|mesh-list
110351921|NCT04942730|Busulfan|busulfan|mesh-list
110351922|NCT04942730|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110351923|NCT04942730|Fludarabine|fludarabine|mesh-list
110351924|NCT04942730|Tacrolimus|tacrolimus|mesh-list
110351925|NCT04942730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110351926|NCT04942730|Immunologic Factors|immunologic factors|mesh-ancestor
110351927|NCT04942730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351928|NCT04942730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110351929|NCT04942730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110351930|NCT04942730|Alkylating Agents|alkylating agents|mesh-ancestor
110351931|NCT04942730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110351932|NCT04942730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110351933|NCT04942730|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110351934|NCT04942730|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110351935|NCT04942730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110351936|NCT04942730|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110351937|NCT04942730|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110351938|NCT04942730|Antitubercular Agents|antitubercular agents|mesh-ancestor
110351939|NCT04942730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110351940|NCT04942730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110351942|NCT01272193|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110351943|NCT01272193|Insulin Glargine|insulin glargine|mesh-list
110351944|NCT01272193|Insulin Aspart|insulin aspart|mesh-list
110351945|NCT01272193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110351946|NCT01272193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351947|NCT04899206|Antidepressive Agents|antidepressive agents|mesh-list
110351948|NCT04899206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110351949|NCT04687163|Oxaliplatin|oxaliplatin|mesh-list
110351950|NCT04687163|Fluorouracil|fluorouracil|mesh-list
110351951|NCT04687163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110351952|NCT04687163|Antimetabolites|antimetabolites|mesh-ancestor
110351953|NCT04687163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110351954|NCT04687163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110351956|NCT04687163|Immunologic Factors|immunologic factors|mesh-ancestor
110351957|NCT04687163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351958|NCT01270828|Pregabalin|pregabalin|mesh-list
110351959|NCT01270828|Analgesics|analgesics|mesh-ancestor
110351960|NCT01270828|Sensory System Agents|sensory system agents|mesh-ancestor
110351961|NCT01270828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110351962|NCT01270828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351963|NCT01270828|Anticonvulsants|anticonvulsants|mesh-ancestor
110351964|NCT01270828|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110351965|NCT01270828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110351966|NCT01270828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110351967|NCT01270828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110351968|NCT01270828|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110351969|NCT01270828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110351970|NCT01270828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110351971|NCT01270828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110351972|NCT00533195|5-Methoxypsoralen|5-methoxypsoralen|mesh-list
110351973|NCT00533195|Methoxsalen|methoxsalen|mesh-list
110351974|NCT00533195|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110351975|NCT00533195|Dermatologic Agents|dermatologic agents|mesh-ancestor
110351976|NCT00533195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110351977|NCT03982407|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110351978|NCT03982407|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110351979|NCT03982407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110351980|NCT01269385|Rituximab|rituximab|mesh-list
110351981|NCT01269385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110351983|NCT01269385|Antibodies|antibodies|mesh-list
110351984|NCT01269385|Immunoglobulins|immunoglobulins|mesh-list
110351985|NCT01269385|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110351986|NCT01269385|Immunologic Factors|immunologic factors|mesh-ancestor
110351987|NCT01269385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110351988|NCT01269385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110351989|NCT01269385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110351990|NCT02071862|Paclitaxel|paclitaxel|mesh-list
110351991|NCT02071862|Docetaxel|docetaxel|mesh-list
110351993|NCT02071862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110351994|NCT02071862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110351995|NCT02071862|Tubulin Modulators|tubulin modulators|mesh-ancestor
110351996|NCT02071862|Antimitotic Agents|antimitotic agents|mesh-ancestor
110351997|NCT02071862|Mitosis Modulators|mitosis modulators|mesh-ancestor
110351998|NCT02071862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110351999|NCT02071862|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110352000|NCT02071862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110352001|NCT02071862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110352002|NCT02071862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110352003|NCT02071862|Immunologic Factors|immunologic factors|mesh-ancestor
110352004|NCT02071862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352005|NCT00535691|Tacrolimus|tacrolimus|mesh-list
110352006|NCT00535691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110352007|NCT00535691|Immunologic Factors|immunologic factors|mesh-ancestor
110352008|NCT00535691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352009|NCT00535691|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110352010|NCT00535691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110352011|NCT00535691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110352012|NCT01268683|Glyburide|glyburide|mesh-list
110352013|NCT01268683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110352014|NCT01268683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352016|NCT02021474|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110352017|NCT02021474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110352018|NCT02021474|Disinfectants|disinfectants|mesh-ancestor
110352019|NCT02021474|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
110352020|NCT02021474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110352022|NCT04959825|Antioxidants|antioxidants|mesh-ancestor
110352023|NCT04959825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110352024|NCT04959825|Protective Agents|protective agents|mesh-ancestor
110352025|NCT04959825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352026|NCT04959825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110352027|NCT05471453|Tocotrienols|tocotrienols|mesh-list
110352028|NCT05471453|Vitamin E|vitamin e|mesh-list
110352029|NCT05471453|Tocopherols|tocopherols|mesh-list
110352030|NCT05471453|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
110352031|NCT05471453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110352032|NCT05471453|Immunologic Factors|immunologic factors|mesh-ancestor
110352033|NCT05471453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352034|NCT05471453|Antioxidants|antioxidants|mesh-ancestor
110352035|NCT05471453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110352036|NCT05471453|Protective Agents|protective agents|mesh-ancestor
110352037|NCT05471453|Vitamins|vitamins|mesh-ancestor
110352038|NCT05471453|Micronutrients|micronutrients|mesh-ancestor
110352039|NCT03457233|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110352040|NCT03457233|Cetrorelix|cetrorelix|mesh-list
110352041|NCT03457233|Menotropins|menotropins|mesh-list
110352042|NCT03457233|Progesterone|progesterone|mesh-list
110352043|NCT03457233|Progestins|progestins|mesh-ancestor
110352044|NCT03457233|Hormones|hormones|mesh-ancestor
110352045|NCT03457233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110352046|NCT03457233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352047|NCT03457233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110352048|NCT03457233|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110352049|NCT03457233|Fertility Agents|fertility agents|mesh-ancestor
110352050|NCT03457233|Hormone Antagonists|hormone antagonists|mesh-ancestor
110352051|NCT00535808|Nitroprusside|nitroprusside|mesh-list
110352052|NCT00535808|Nitroglycerin|nitroglycerin|mesh-list
110352053|NCT00535808|Sevoflurane|sevoflurane|mesh-list
110352054|NCT00535808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110352055|NCT00535808|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110352056|NCT00535808|Anesthetics, General|anesthetics, general|mesh-ancestor
110352057|NCT00535808|Anesthetics|anesthetics|mesh-ancestor
110352058|NCT00535808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110352059|NCT00535808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352060|NCT00535808|Vasodilator Agents|vasodilator agents|mesh-ancestor
110352061|NCT00535808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110352063|NCT00535808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110352064|NCT05471063|Fluconazole|fluconazole|mesh-list
110352065|NCT05471063|Amphotericin B|amphotericin b|mesh-list
110352066|NCT05471063|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110352067|NCT05471063|Flucytosine|flucytosine|mesh-list
110352068|NCT05471063|Cholesteryl sulfate|cholesteryl sulfate|mesh-list
110352069|NCT05471063|Antifungal Agents|antifungal agents|mesh-ancestor
110352070|NCT05471063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110352071|NCT05471063|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110352072|NCT05471063|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110352073|NCT05471063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110352074|NCT05471063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110352075|NCT05471063|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110352076|NCT05471063|Hormone Antagonists|hormone antagonists|mesh-ancestor
110352077|NCT05471063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110352078|NCT05471063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352079|NCT05471063|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110352080|NCT05471063|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110352081|NCT05471063|Amebicides|amebicides|mesh-ancestor
110352082|NCT05471063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110352083|NCT05471063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110352084|NCT05471063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110352085|NCT05471063|Antimetabolites|antimetabolites|mesh-ancestor
110352086|NCT05471063|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110352087|NCT05471063|Protease Inhibitors|protease inhibitors|mesh-ancestor
110352088|NCT05471063|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110352089|NCT05471063|Protective Agents|protective agents|mesh-ancestor
110352090|NCT05471063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110352091|NCT04910100|Timolol|timolol|mesh-list
110352092|NCT04910100|Nebivolol|nebivolol|mesh-list
110352093|NCT04910100|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110352094|NCT04910100|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110352095|NCT04910100|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110352096|NCT04910100|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110352097|NCT04910100|Adrenergic Agents|adrenergic agents|mesh-ancestor
110352098|NCT04910100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110352099|NCT04910100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110352100|NCT04910100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352101|NCT04910100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110352102|NCT04910100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110352103|NCT04910100|Vasodilator Agents|vasodilator agents|mesh-ancestor
110352104|NCT04910100|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110352105|NCT04910100|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110352106|NCT04910100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110352108|NCT01268059|Carboplatin|carboplatin|mesh-list
110352109|NCT01268059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110352110|NCT01268059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110352111|NCT01268059|Tubulin Modulators|tubulin modulators|mesh-ancestor
110352112|NCT01268059|Antimitotic Agents|antimitotic agents|mesh-ancestor
110352113|NCT01268059|Mitosis Modulators|mitosis modulators|mesh-ancestor
110352114|NCT01268059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110352115|NCT01267825|Bupivacaine|bupivacaine|mesh-list
110352116|NCT01267825|Anesthetics, Local|anesthetics, local|mesh-ancestor
110352117|NCT01267825|Anesthetics|anesthetics|mesh-ancestor
110352118|NCT01267825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110352119|NCT01267825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352120|NCT01267825|Sensory System Agents|sensory system agents|mesh-ancestor
110352121|NCT01267825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110352122|NCT00536003|Progesterone|progesterone|mesh-list
110352123|NCT00536003|Progestins|progestins|mesh-ancestor
110352125|NCT00536003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110352126|NCT00536003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352127|NCT00533091|Sifalimumab|sifalimumab|mesh-list
110352128|NCT00533091|Immunologic Factors|immunologic factors|mesh-ancestor
110352129|NCT00533091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352130|NCT00536042|Minocycline|minocycline|mesh-list
110352131|NCT00536042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110352132|NCT00536042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110352133|NCT01606384|Vasopressins|vasopressins|mesh-list
110352134|NCT01606384|Arginine Vasopressin|arginine vasopressin|mesh-list
110352135|NCT01606384|Hemostatics|hemostatics|mesh-ancestor
110352136|NCT01606384|Coagulants|coagulants|mesh-ancestor
110352137|NCT01606384|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110352138|NCT01606384|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110352139|NCT01606384|Natriuretic Agents|natriuretic agents|mesh-ancestor
110352140|NCT01606384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352141|NCT01606462|Oxytocin|oxytocin|mesh-list
110352142|NCT01606462|Oxytocics|oxytocics|mesh-ancestor
110352143|NCT01606462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110352144|NCT01606462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352145|NCT05470595|Atezolizumab|atezolizumab|mesh-list
110352146|NCT05470595|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110352147|NCT05470595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110352148|NCT05470595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110352149|NCT05470595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110352150|NCT01606540|Ibuprofen|ibuprofen|mesh-list
110352151|NCT01606540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110352152|NCT01606540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110352153|NCT01606540|Analgesics|analgesics|mesh-ancestor
110175973|NCT00078793|Etanercept|etanercept|mesh-list
110352154|NCT01606540|Sensory System Agents|sensory system agents|mesh-ancestor
110352155|NCT01606540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110352156|NCT01606540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352157|NCT01606540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110352158|NCT01606540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110352159|NCT01606540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110352160|NCT01606540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110352161|NCT01606540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110352162|NCT00533169|Tretinoin|tretinoin|mesh-list
110352163|NCT00533169|Isotretinoin|isotretinoin|mesh-list
110352164|NCT00533169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110352165|NCT00533169|Keratolytic Agents|keratolytic agents|mesh-ancestor
110352166|NCT00533169|Dermatologic Agents|dermatologic agents|mesh-ancestor
110352167|NCT00593710|Losartan|losartan|mesh-list
110352168|NCT00593710|Atenolol|atenolol|mesh-list
110352169|NCT00593710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110352170|NCT00593710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110352171|NCT00593710|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110352172|NCT00593710|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110352173|NCT00593710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110352174|NCT00593710|Sympatholytics|sympatholytics|mesh-ancestor
110352175|NCT00593710|Autonomic Agents|autonomic agents|mesh-ancestor
110352176|NCT00593710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110352177|NCT00593710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352178|NCT00593710|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110352179|NCT00593710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110352180|NCT00593710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110352181|NCT00593710|Adrenergic Agents|adrenergic agents|mesh-ancestor
110352182|NCT00593710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110352183|NCT04885686|Formaldehyde|formaldehyde|mesh-list
110352184|NCT04885686|Thymol|thymol|mesh-list
110352185|NCT04885686|Dexamethasone|dexamethasone|mesh-list
110352186|NCT04885686|Hydrocortisone|hydrocortisone|mesh-list
110352187|NCT04885686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110352188|NCT04885686|Antiemetics|antiemetics|mesh-ancestor
110352189|NCT04885686|Autonomic Agents|autonomic agents|mesh-ancestor
110352190|NCT04885686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110352191|NCT04885686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352192|NCT04885686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110352193|NCT04885686|Glucocorticoids|glucocorticoids|mesh-ancestor
110352194|NCT04885686|Hormones|hormones|mesh-ancestor
110352195|NCT04885686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110352196|NCT04885686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110352197|NCT04885686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110352198|NCT04885686|Disinfectants|disinfectants|mesh-ancestor
110352199|NCT04885686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110352200|NCT04885686|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110352201|NCT04885686|Antifungal Agents|antifungal agents|mesh-ancestor
110352202|NCT00594217|Progesterone|progesterone|mesh-list
110352203|NCT00594217|Progestins|progestins|mesh-ancestor
110352204|NCT00594217|Hormones|hormones|mesh-ancestor
110352205|NCT00594217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110352206|NCT00594217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352207|NCT00536237|Niacin|niacin|mesh-list
110352208|NCT00536237|Niacinamide|niacinamide|mesh-list
110352209|NCT00536237|Nicotinic Acids|nicotinic acids|mesh-list
110352210|NCT00536237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110352211|NCT00536237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352212|NCT00536237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110352213|NCT00536237|Antimetabolites|antimetabolites|mesh-ancestor
110352214|NCT00536237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110352215|NCT00536237|Vasodilator Agents|vasodilator agents|mesh-ancestor
110352216|NCT00536237|Vitamin B Complex|vitamin b complex|mesh-ancestor
110352217|NCT00536237|Vitamins|vitamins|mesh-ancestor
110352218|NCT00536237|Micronutrients|micronutrients|mesh-ancestor
110352219|NCT00533247|Celecoxib|celecoxib|mesh-list
110175977|NCT00078793|Sensory System Agents|sensory system agents|mesh-ancestor
110352220|NCT00533247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110352221|NCT00533247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110352223|NCT00533247|Sensory System Agents|sensory system agents|mesh-ancestor
110352224|NCT00533247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110352225|NCT00533247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352226|NCT00533247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110352227|NCT00533247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110352228|NCT00533247|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110352229|NCT00533247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110352230|NCT00533247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110352231|NCT00533247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110352232|NCT01260181|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110352233|NCT01260181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110352234|NCT01260181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110352235|NCT01260181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110352236|NCT01260181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110352237|NCT00536276|Vitamin D|vitamin d|mesh-list
110352238|NCT00536276|Ergocalciferols|ergocalciferols|mesh-list
110352239|NCT00536276|Cholecalciferol|cholecalciferol|mesh-list
110352240|NCT00536276|Vitamins|vitamins|mesh-list
110352241|NCT00536276|Micronutrients|micronutrients|mesh-ancestor
110352242|NCT00536276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352243|NCT00536276|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110352244|NCT00536276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110352245|NCT02690064|Vitamins|vitamins|mesh-list
110352246|NCT02690064|Ascorbic Acid|ascorbic acid|mesh-list
110352247|NCT02690064|Vitamin E|vitamin e|mesh-list
110352248|NCT02690064|Tocopherols|tocopherols|mesh-list
110352250|NCT02690064|alpha-Tocopherol|alpha-tocopherol|mesh-list
110352251|NCT02690064|Thioctic Acid|thioctic acid|mesh-list
110352252|NCT02690064|Ubiquinone|ubiquinone|mesh-list
110352253|NCT02690064|Resveratrol|resveratrol|mesh-list
110352254|NCT02690064|Antioxidants|antioxidants|mesh-list
110352255|NCT02690064|Micronutrients|micronutrients|mesh-ancestor
110352256|NCT02690064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352257|NCT02690064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110352258|NCT02690064|Protective Agents|protective agents|mesh-ancestor
110352259|NCT02690064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110352260|NCT02690064|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110352261|NCT02690064|Vitamin B Complex|vitamin b complex|mesh-ancestor
110352262|NCT00594373|Tenofovir|tenofovir|mesh-list
110352263|NCT00594373|Antiviral Agents|antiviral agents|mesh-ancestor
110352264|NCT00594373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110352265|NCT00594373|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110352266|NCT00594373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110352267|NCT00594373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110352268|NCT00594373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110352269|NCT00594373|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110352270|NCT00594373|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110352271|NCT05470166|Lidocaine|lidocaine|mesh-list
110352272|NCT05470166|Anesthetics, Local|anesthetics, local|mesh-ancestor
110352273|NCT05470166|Anesthetics|anesthetics|mesh-ancestor
110352274|NCT05470166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110352275|NCT05470166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352276|NCT05470166|Sensory System Agents|sensory system agents|mesh-ancestor
110352277|NCT05470166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110352278|NCT05470166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110352279|NCT05470166|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110352280|NCT05470166|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110352281|NCT05470166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110352282|NCT05470166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110352283|NCT01260142|Propofol|propofol|mesh-list
110352284|NCT01260142|Fospropofol|fospropofol|mesh-list
110352285|NCT01260142|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110352286|NCT01260142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110352287|NCT01260142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352288|NCT01260142|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110352289|NCT01260142|Anesthetics, General|anesthetics, general|mesh-ancestor
110352290|NCT01260142|Anesthetics|anesthetics|mesh-ancestor
110352291|NCT02116335|Bosentan|bosentan|mesh-list
110352292|NCT02116335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110352293|NCT02116335|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110352294|NCT02116335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110352295|NCT05469659|Metformin|metformin|mesh-list
110352296|NCT05469659|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
110352297|NCT05469659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110352298|NCT05469659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352299|NCT05469659|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110352300|NCT05469659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110352301|NCT01808820|Imiquimod|imiquimod|mesh-list
110352302|NCT01808820|Vaccines|vaccines|mesh-list
110352303|NCT01808820|Immunologic Factors|immunologic factors|mesh-ancestor
110352304|NCT01808820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352305|NCT01808820|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110352306|NCT01808820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110352307|NCT01808820|Interferon Inducers|interferon inducers|mesh-ancestor
110352308|NCT05469386|Methylphenidate|methylphenidate|mesh-list
110352309|NCT05469386|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110352310|NCT05469386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352311|NCT05469386|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110352312|NCT05469386|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110352313|NCT05469386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110352314|NCT05469386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110352315|NCT05469386|Dopamine Agents|dopamine agents|mesh-ancestor
110352316|NCT05469386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110352318|NCT05469347|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110352319|NCT05469347|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110352320|NCT05469347|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110352321|NCT05469347|Antimetabolites|antimetabolites|mesh-ancestor
110352322|NCT05469347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110352323|NCT05469347|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110352324|NCT05469347|Protease Inhibitors|protease inhibitors|mesh-ancestor
110352325|NCT05469347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110352326|NCT05469347|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110352328|NCT01462890|Bevacizumab|bevacizumab|mesh-list
110352329|NCT01462890|Carboplatin|carboplatin|mesh-list
110352330|NCT01462890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110352331|NCT01462890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110352332|NCT01462890|Tubulin Modulators|tubulin modulators|mesh-ancestor
110352333|NCT01462890|Antimitotic Agents|antimitotic agents|mesh-ancestor
110352334|NCT01462890|Mitosis Modulators|mitosis modulators|mesh-ancestor
110352335|NCT01462890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110352336|NCT01462890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110352337|NCT01462890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110352338|NCT01462890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110352339|NCT01462890|Growth Substances|growth substances|mesh-ancestor
110352340|NCT01462890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352341|NCT01462890|Growth Inhibitors|growth inhibitors|mesh-ancestor
110352342|NCT05469113|Repaglinide|repaglinide|mesh-list
110352343|NCT05469113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110352344|NCT05469113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352345|NCT01259713|Amphotericin B|amphotericin b|mesh-list
110352346|NCT01259713|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110352347|NCT01259713|Amebicides|amebicides|mesh-ancestor
110352348|NCT01259713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110352349|NCT01259713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110352350|NCT01259713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110352351|NCT01259713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110352352|NCT01259713|Antifungal Agents|antifungal agents|mesh-ancestor
110352354|NCT05469035|Calcium heparin|calcium heparin|mesh-list
110352355|NCT05469035|Anticoagulants|anticoagulants|mesh-ancestor
110352356|NCT05469035|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110352357|NCT05469035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110352358|NCT05469035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110352359|NCT05582590|Cyclophosphamide|cyclophosphamide|mesh-list
110352360|NCT05582590|Fludarabine|fludarabine|mesh-list
110352361|NCT05582590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110352362|NCT05582590|Immunologic Factors|immunologic factors|mesh-ancestor
110352363|NCT05582590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352364|NCT05582590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110352365|NCT05582590|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110352366|NCT05582590|Alkylating Agents|alkylating agents|mesh-ancestor
110352367|NCT05582590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110352368|NCT05582590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110352369|NCT05582590|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110352370|NCT05468879|Glimepiride|glimepiride|mesh-list
110352371|NCT05468879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110352372|NCT05468879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110352373|NCT05468879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352374|NCT05468879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110352375|NCT05468879|Immunologic Factors|immunologic factors|mesh-ancestor
110352376|NCT05471427|Docetaxel|docetaxel|mesh-list
110352377|NCT05471427|Taxane|taxane|mesh-list
110352378|NCT05471427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110352379|NCT05471427|Tubulin Modulators|tubulin modulators|mesh-ancestor
110352380|NCT05471427|Antimitotic Agents|antimitotic agents|mesh-ancestor
110352381|NCT05471427|Mitosis Modulators|mitosis modulators|mesh-ancestor
110352382|NCT05471427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110352383|NCT05558449|Midazolam|midazolam|mesh-list
110352384|NCT05558449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110352385|NCT05558449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110352386|NCT05558449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110352387|NCT05558449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352388|NCT05558449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110352389|NCT05558449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110352390|NCT05558449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110352391|NCT05558449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110352392|NCT05558449|Anesthetics, General|anesthetics, general|mesh-ancestor
110352393|NCT05558449|Anesthetics|anesthetics|mesh-ancestor
110352394|NCT05558449|GABA Modulators|gaba modulators|mesh-ancestor
110352395|NCT05558449|GABA Agents|gaba agents|mesh-ancestor
110352396|NCT05558449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110352397|NCT05558449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110352398|NCT04326985|Hyaluronic Acid|hyaluronic acid|mesh-list
110352399|NCT04326985|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110352400|NCT04326985|Immunologic Factors|immunologic factors|mesh-ancestor
110352401|NCT04326985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352402|NCT04326985|Viscosupplements|viscosupplements|mesh-ancestor
110352403|NCT04326985|Protective Agents|protective agents|mesh-ancestor
110352404|NCT00536393|Doxorubicin|doxorubicin|mesh-list
110352405|NCT00536393|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110352406|NCT00536393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110352407|NCT00536393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110352408|NCT00536393|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110352409|NCT00536393|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110352410|NCT00536393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110352411|NCT00536393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110352412|NCT00595543|Diclofenac|diclofenac|mesh-list
110352413|NCT00595543|Ketorolac|ketorolac|mesh-list
110352414|NCT00595543|Bromfenac|bromfenac|mesh-list
110352415|NCT00595543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110352416|NCT00595543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110352417|NCT00595543|Analgesics|analgesics|mesh-ancestor
110352418|NCT00595543|Sensory System Agents|sensory system agents|mesh-ancestor
110352419|NCT00595543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110352420|NCT00595543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352421|NCT00595543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110352422|NCT00595543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110352423|NCT00595543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110352424|NCT00595543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110352425|NCT00595543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110352426|NCT04326868|Albendazole|albendazole|mesh-list
110352427|NCT04326868|Mebendazole|mebendazole|mesh-list
110352428|NCT04326868|Benzimidazole|benzimidazole|mesh-list
110352429|NCT04326868|Pyrantel|pyrantel|mesh-list
110352430|NCT04326868|Anthelmintics|anthelmintics|mesh-list
110352431|NCT04326868|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110352432|NCT04326868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110352433|NCT04326868|Anticestodal Agents|anticestodal agents|mesh-ancestor
110352434|NCT04326868|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110352435|NCT04326868|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110352436|NCT04326868|Tubulin Modulators|tubulin modulators|mesh-ancestor
110352437|NCT04326868|Antimitotic Agents|antimitotic agents|mesh-ancestor
110352438|NCT04326868|Mitosis Modulators|mitosis modulators|mesh-ancestor
110352439|NCT04326868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110352440|NCT04326868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110352441|NCT04326868|Antinematodal Agents|antinematodal agents|mesh-ancestor
110352442|NCT04326868|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
110352443|NCT04326868|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110352445|NCT04326868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110352446|NCT04326868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352447|NCT00595972|Endostar protein|endostar protein|mesh-list
110352448|NCT00595972|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110352449|NCT00595972|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110352450|NCT00595972|Growth Substances|growth substances|mesh-ancestor
110352451|NCT00595972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352452|NCT00595972|Growth Inhibitors|growth inhibitors|mesh-ancestor
110352453|NCT00595972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110352454|NCT00596050|Lidocaine|lidocaine|mesh-list
110352455|NCT00596050|Fentanyl|fentanyl|mesh-list
110352456|NCT00596050|Midazolam|midazolam|mesh-list
110352458|NCT00596050|Etomidate|etomidate|mesh-list
110352459|NCT00596050|Anesthetics, Local|anesthetics, local|mesh-ancestor
110352460|NCT00596050|Anesthetics|anesthetics|mesh-ancestor
110352461|NCT00596050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110352462|NCT00596050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352463|NCT00596050|Sensory System Agents|sensory system agents|mesh-ancestor
110352464|NCT00596050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110352465|NCT00596050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110352466|NCT00596050|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110352467|NCT00596050|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110352468|NCT00596050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110352469|NCT00596050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110352470|NCT00596050|Analgesics|analgesics|mesh-ancestor
110352471|NCT00596050|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110352472|NCT00596050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110352473|NCT00596050|Anesthetics, General|anesthetics, general|mesh-ancestor
110352474|NCT00596050|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110352475|NCT00596050|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110352476|NCT00596050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110352477|NCT00596050|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110352479|NCT00596050|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110352480|NCT00596050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110352481|NCT00596050|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110352482|NCT00596050|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110352483|NCT00596050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110352484|NCT00596050|GABA Modulators|gaba modulators|mesh-ancestor
110352485|NCT00596050|GABA Agents|gaba agents|mesh-ancestor
110352486|NCT02888899|Loperamide|loperamide|mesh-list
110352487|NCT02888899|Antidiarrheals|antidiarrheals|mesh-list
110352488|NCT02888899|Calcium polycarbophil|calcium polycarbophil|mesh-list
110352489|NCT02888899|Psyllium|psyllium|mesh-list
110352490|NCT02888899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110352491|NCT02888899|Cathartics|cathartics|mesh-ancestor
110352492|NCT05468645|Hemay005|hemay005|mesh-list
110352493|NCT05468645|Dermatologic Agents|dermatologic agents|mesh-ancestor
110352494|NCT05468645|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110352495|NCT05468645|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110176009|NCT00078910|Sulindac sulfone|sulindac sulfone|mesh-list
110031853|NCT01394497|Acetylcysteine|acetylcysteine|mesh-list
110352497|NCT05468645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110352498|NCT00596128|Insulin|insulin|mesh-list
110352499|NCT00596128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110352500|NCT00596128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352501|NCT00596206|Leflunomide|leflunomide|mesh-list
110352502|NCT00596206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110352503|NCT00596206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110352504|NCT00596206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110352505|NCT00596206|Immunologic Factors|immunologic factors|mesh-ancestor
110352506|NCT00596206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352507|NCT00624130|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
110352508|NCT00624130|Dacuronium|dacuronium|mesh-list
110352509|NCT00624130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110352510|NCT00624130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352511|NCT00624130|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110352512|NCT00624130|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110352513|NCT00624130|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110352514|NCT00624130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110352515|NCT05468450|Polidocanol|polidocanol|mesh-list
110352516|NCT05468450|Sclerosing Solutions|sclerosing solutions|mesh-list
110352517|NCT05468450|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110352518|NCT00535860|Teriparatide|teriparatide|mesh-list
110352519|NCT00535860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110352520|NCT00535860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352521|NCT00535860|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110352522|NCT00596479|Lenograstim|lenograstim|mesh-list
110352523|NCT00596479|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110352524|NCT00596479|Immunologic Factors|immunologic factors|mesh-ancestor
110352525|NCT00596479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352526|NCT05468372|Amphotericin B|amphotericin b|mesh-list
110352527|NCT05468372|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110352528|NCT05468372|Posaconazole|posaconazole|mesh-list
110352529|NCT05468372|Amebicides|amebicides|mesh-ancestor
110352530|NCT05468372|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110352531|NCT05468372|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110352532|NCT05468372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110352533|NCT05468372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110352534|NCT05468372|Antifungal Agents|antifungal agents|mesh-ancestor
110352535|NCT05468372|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110352536|NCT05468372|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110352537|NCT05468372|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110352538|NCT05468372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110352539|NCT05468372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110352540|NCT05468372|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110352541|NCT05468372|Hormone Antagonists|hormone antagonists|mesh-ancestor
110352542|NCT05468372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110352543|NCT05468372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352544|NCT04207957|Olorofim|olorofim|mesh-list
110352545|NCT04207957|Antifungal Agents|antifungal agents|mesh-ancestor
110352546|NCT04207957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110352547|NCT00596557|Everolimus|everolimus|mesh-list
110352548|NCT00596557|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110352549|NCT00596557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110352550|NCT00596557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110352551|NCT00596557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110352552|NCT00596557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110352553|NCT00596557|Immunologic Factors|immunologic factors|mesh-ancestor
110352554|NCT00596557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352555|NCT00596557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110352556|NCT00596596|Prucalopride|prucalopride|mesh-list
110352557|NCT00596596|Laxatives|laxatives|mesh-ancestor
110352558|NCT00596596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110352559|NCT00596596|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
110352560|NCT00596596|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110352561|NCT00596596|Serotonin Agents|serotonin agents|mesh-ancestor
110352562|NCT00596596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110176015|NCT00078910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110352563|NCT00596596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110352564|NCT00596596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352565|NCT05468294|Nivolumab|nivolumab|mesh-list
110352566|NCT05468294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110352567|NCT05468294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110352568|NCT05468294|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110352569|NCT05468294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110352570|NCT05312866|Acetaminophen|acetaminophen|mesh-list
110352571|NCT05312866|Dexamethasone|dexamethasone|mesh-list
110352572|NCT05312866|Magnesium Sulfate|magnesium sulfate|mesh-list
110352573|NCT05312866|Fentanyl|fentanyl|mesh-list
110352574|NCT05312866|Bupivacaine|bupivacaine|mesh-list
110352575|NCT05312866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110352576|NCT05312866|Antiemetics|antiemetics|mesh-ancestor
110352577|NCT05312866|Autonomic Agents|autonomic agents|mesh-ancestor
110352578|NCT05312866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110352579|NCT05312866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352580|NCT05312866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110352581|NCT05312866|Glucocorticoids|glucocorticoids|mesh-ancestor
110352583|NCT05312866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110352584|NCT05312866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110352585|NCT05312866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110352586|NCT05312866|Anesthetics, Local|anesthetics, local|mesh-ancestor
110352587|NCT05312866|Anesthetics|anesthetics|mesh-ancestor
110352588|NCT05312866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110352589|NCT05312866|Sensory System Agents|sensory system agents|mesh-ancestor
110352590|NCT05312866|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110352591|NCT05312866|Narcotics|narcotics|mesh-ancestor
110352592|NCT05312866|Analgesics|analgesics|mesh-ancestor
110352593|NCT05312866|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110352594|NCT05312866|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110352595|NCT05312866|Anesthetics, General|anesthetics, general|mesh-ancestor
110352596|NCT05312866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110352597|NCT05312866|Antipyretics|antipyretics|mesh-ancestor
110352598|NCT05312866|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110352599|NCT05312866|Anticonvulsants|anticonvulsants|mesh-ancestor
110352600|NCT05312866|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110352601|NCT05312866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110352602|NCT05312866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110352603|NCT05312866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110352604|NCT05312866|Tocolytic Agents|tocolytic agents|mesh-ancestor
110352605|NCT05312866|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110352606|NCT04326790|Colchicine|colchicine|mesh-list
110352607|NCT04326790|Gout Suppressants|gout suppressants|mesh-ancestor
110352608|NCT04326790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110352609|NCT04326790|Tubulin Modulators|tubulin modulators|mesh-ancestor
110352610|NCT04326790|Antimitotic Agents|antimitotic agents|mesh-ancestor
110352611|NCT04326790|Mitosis Modulators|mitosis modulators|mesh-ancestor
110352612|NCT04326790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110352613|NCT04326790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110352614|NCT00596986|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110352615|NCT00596986|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110352616|NCT00596986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110352617|NCT00596986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110352618|NCT00596986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110352619|NCT00596986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110352620|NCT00596986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352621|NCT00596986|Analgesics|analgesics|mesh-ancestor
110352622|NCT00596986|Sensory System Agents|sensory system agents|mesh-ancestor
110352623|NCT00596986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110352624|NCT00596986|Antidepressive Agents|antidepressive agents|mesh-ancestor
110352625|NCT00596986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110352626|NCT00596986|Dopamine Agents|dopamine agents|mesh-ancestor
110352627|NCT00597064|Prednisone|prednisone|mesh-list
110352628|NCT00597064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110352629|NCT00597064|Glucocorticoids|glucocorticoids|mesh-ancestor
110352630|NCT00597064|Hormones|hormones|mesh-ancestor
110176020|NCT00078910|Sensory System Agents|sensory system agents|mesh-ancestor
110352631|NCT00597064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110352632|NCT00597064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352633|NCT00597064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110352634|NCT00597064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110352636|NCT00597181|Mitomycin|mitomycin|mesh-list
110352637|NCT00597181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110352638|NCT00597181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110352639|NCT00597181|Alkylating Agents|alkylating agents|mesh-ancestor
110352640|NCT00597181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110352641|NCT00597181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110352642|NCT00597181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110352643|NCT00597259|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110352644|NCT00597259|Entecavir|entecavir|mesh-list
110352645|NCT00597259|Antiviral Agents|antiviral agents|mesh-ancestor
110352646|NCT00597259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110352647|NCT05470764|Amlodipine|amlodipine|mesh-list
110352648|NCT05470764|Perindopril|perindopril|mesh-list
110352649|NCT05470764|Indapamide|indapamide|mesh-list
110352650|NCT05470764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110352651|NCT05470764|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110352652|NCT05470764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110352653|NCT05470764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110352654|NCT05470764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110352655|NCT05470764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352656|NCT05470764|Vasodilator Agents|vasodilator agents|mesh-ancestor
110352657|NCT05470764|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110352658|NCT05470764|Protease Inhibitors|protease inhibitors|mesh-ancestor
110352659|NCT05470764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110352660|NCT05470764|Diuretics|diuretics|mesh-ancestor
110352661|NCT05470764|Natriuretic Agents|natriuretic agents|mesh-ancestor
110352662|NCT05470764|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110352663|NCT00597415|Celecoxib|celecoxib|mesh-list
110352664|NCT00597415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110352665|NCT00597415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110352666|NCT00597415|Analgesics|analgesics|mesh-ancestor
110352667|NCT00597415|Sensory System Agents|sensory system agents|mesh-ancestor
110352668|NCT00597415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110352669|NCT00597415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352670|NCT00597415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110352671|NCT00597415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110352672|NCT00597415|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110352673|NCT00597415|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110352674|NCT00597415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110352675|NCT00597415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110352676|NCT00597688|Chlorhexidine|chlorhexidine|mesh-list
110352677|NCT00597688|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110352678|NCT00597688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110352679|NCT00597688|Disinfectants|disinfectants|mesh-ancestor
110352680|NCT05470530|Dexamethasone|dexamethasone|mesh-list
110352681|NCT05470530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110352682|NCT05470530|Antiemetics|antiemetics|mesh-ancestor
110352683|NCT05470530|Autonomic Agents|autonomic agents|mesh-ancestor
110352684|NCT05470530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110352685|NCT05470530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352686|NCT05470530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110352688|NCT05470530|Hormones|hormones|mesh-ancestor
110352689|NCT05470530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110352690|NCT05470530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110352691|NCT05470530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110352692|NCT02891980|Vaccines|vaccines|mesh-list
110352693|NCT02891980|Immunologic Factors|immunologic factors|mesh-ancestor
110352694|NCT02891980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352696|NCT05467826|Sofosbuvir|sofosbuvir|mesh-list
110352697|NCT05467826|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
110352698|NCT05467826|Velpatasvir|velpatasvir|mesh-list
110352699|NCT05467826|Antimetabolites|antimetabolites|mesh-ancestor
110352700|NCT05467826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110352701|NCT05467826|Antiviral Agents|antiviral agents|mesh-ancestor
110352702|NCT05467826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110352703|NCT00598156|Bevacizumab|bevacizumab|mesh-list
110352704|NCT00598156|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110352705|NCT00598156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110352706|NCT00598156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110352707|NCT00598156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110352708|NCT00598156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110352709|NCT00598156|Growth Substances|growth substances|mesh-ancestor
110352710|NCT00598156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352711|NCT00598156|Growth Inhibitors|growth inhibitors|mesh-ancestor
110352712|NCT00598156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110352713|NCT00598156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110352714|NCT00598156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110352716|NCT00598195|Analgesics|analgesics|mesh-ancestor
110352717|NCT00598195|Sensory System Agents|sensory system agents|mesh-ancestor
110031921|NCT01394796|Protective Agents|protective agents|mesh-ancestor
110352718|NCT00598195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110352719|NCT00598195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352720|NCT00598195|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110352721|NCT00598195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110352722|NCT00598195|Anesthetics, General|anesthetics, general|mesh-ancestor
110352723|NCT00598195|Anesthetics|anesthetics|mesh-ancestor
110352724|NCT00598195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110352725|NCT00598195|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110352726|NCT00598195|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110352727|NCT00598195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110352728|NCT00598195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110352729|NCT00598234|Celecoxib|celecoxib|mesh-list
110352730|NCT00598234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110352731|NCT00598234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110352732|NCT00598234|Analgesics|analgesics|mesh-ancestor
110352733|NCT00598234|Sensory System Agents|sensory system agents|mesh-ancestor
110352734|NCT00598234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110352735|NCT00598234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352736|NCT00598234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110352737|NCT00598234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110352738|NCT00598234|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110352739|NCT00598234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110352740|NCT00598234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110352741|NCT00598234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110352742|NCT00598429|Alprostadil|alprostadil|mesh-list
110352743|NCT00598429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110352744|NCT00598429|Vasodilator Agents|vasodilator agents|mesh-ancestor
110352745|NCT00598429|Urological Agents|urological agents|mesh-ancestor
110352746|NCT00598624|Treosulfan|treosulfan|mesh-list
110352747|NCT00598624|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110352748|NCT00598624|Alkylating Agents|alkylating agents|mesh-ancestor
110352749|NCT00598624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110352750|NCT00598624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110352751|NCT02891785|Antipain|antipain|mesh-list
110352752|NCT02891785|Protease Inhibitors|protease inhibitors|mesh-ancestor
110352753|NCT02891785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110352754|NCT02891785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110352755|NCT00598858|Prednisone|prednisone|mesh-list
110352756|NCT00598858|Cortisone|cortisone|mesh-list
110352757|NCT00598858|Docetaxel|docetaxel|mesh-list
110352758|NCT00598858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110352759|NCT00598858|Tubulin Modulators|tubulin modulators|mesh-ancestor
110352761|NCT00598858|Mitosis Modulators|mitosis modulators|mesh-ancestor
110352762|NCT00598858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110352763|NCT00598858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110352764|NCT00598858|Glucocorticoids|glucocorticoids|mesh-ancestor
110352765|NCT00598858|Hormones|hormones|mesh-ancestor
110352766|NCT00598858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110352767|NCT00598858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352768|NCT00598858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110352769|NCT05466305|Cobalt|cobalt|mesh-list
110352770|NCT05466305|Trace Elements|trace elements|mesh-ancestor
110352771|NCT05466305|Micronutrients|micronutrients|mesh-ancestor
110352772|NCT05466305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352773|NCT04207684|Testosterone|testosterone|mesh-list
110352774|NCT04207684|Androgens|androgens|mesh-ancestor
110352775|NCT04207684|Hormones|hormones|mesh-ancestor
110352776|NCT04207684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110352777|NCT04207684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352778|NCT02909400|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|mesh-list
110352779|NCT02909400|Antioxidants|antioxidants|mesh-ancestor
110352780|NCT02909400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110352781|NCT02909400|Protective Agents|protective agents|mesh-ancestor
110352782|NCT02909400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352783|NCT02909478|Dexamethasone|dexamethasone|mesh-list
110352784|NCT02909478|Aprepitant|aprepitant|mesh-list
110352785|NCT02909478|Tropisetron|tropisetron|mesh-list
110352786|NCT02909478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110352787|NCT02909478|Antiemetics|antiemetics|mesh-ancestor
110352788|NCT02909478|Autonomic Agents|autonomic agents|mesh-ancestor
110352789|NCT02909478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110352790|NCT02909478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352791|NCT02909478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110352792|NCT02909478|Glucocorticoids|glucocorticoids|mesh-ancestor
110352793|NCT02909478|Hormones|hormones|mesh-ancestor
110352794|NCT02909478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110352795|NCT02909478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110352796|NCT02909478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110352797|NCT02909478|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110352799|NCT02909478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110352800|NCT02909478|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110352801|NCT02909478|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110352802|NCT02909478|Serotonin Agents|serotonin agents|mesh-ancestor
110352803|NCT00536211|Metformin|metformin|mesh-list
110352804|NCT00536211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110352805|NCT00536211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352806|NCT00536705|Montelukast|montelukast|mesh-list
110352807|NCT00536705|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110352808|NCT00536705|Respiratory System Agents|respiratory system agents|mesh-ancestor
110352809|NCT00536705|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110352810|NCT00536705|Hormone Antagonists|hormone antagonists|mesh-ancestor
110352811|NCT00536705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110352812|NCT00536705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352813|NCT00536705|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110352814|NCT00536705|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110352815|NCT00536705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110352816|NCT00624208|Droperidol|droperidol|mesh-list
110352817|NCT00624208|Ondansetron|ondansetron|mesh-list
110352818|NCT00624208|Antiemetics|antiemetics|mesh-ancestor
110352819|NCT00624208|Autonomic Agents|autonomic agents|mesh-ancestor
110352820|NCT00624208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110352821|NCT00624208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352822|NCT00624208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110352823|NCT00624208|Antipruritics|antipruritics|mesh-ancestor
110352824|NCT00624208|Dermatologic Agents|dermatologic agents|mesh-ancestor
110352825|NCT00624208|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110352826|NCT00624208|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110352827|NCT00624208|Serotonin Agents|serotonin agents|mesh-ancestor
110352828|NCT00624208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110352829|NCT00624208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110352830|NCT00624208|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110352831|NCT00624208|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110352832|NCT00624208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110352833|NCT00624208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110352834|NCT00624208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110352835|NCT00624208|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110352836|NCT00624208|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110352837|NCT00624208|Dopamine Agents|dopamine agents|mesh-ancestor
110352838|NCT00536783|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110352839|NCT00536783|Antidepressive Agents|antidepressive agents|mesh-ancestor
110352840|NCT00536783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110352841|NCT00536783|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110352842|NCT00536783|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110352843|NCT00536783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110352844|NCT00536783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352846|NCT04685642|Atorvastatin|atorvastatin|mesh-list
110352847|NCT04685642|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110352848|NCT04685642|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110352849|NCT04685642|Analgesics|analgesics|mesh-ancestor
110352850|NCT04685642|Sensory System Agents|sensory system agents|mesh-ancestor
110352851|NCT04685642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110352852|NCT04685642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352853|NCT04685642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110352854|NCT04685642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110352855|NCT04685642|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110352856|NCT04685642|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110352857|NCT04685642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110352858|NCT04685642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110352859|NCT04685642|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110352860|NCT04685642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110352861|NCT04685642|Antipyretics|antipyretics|mesh-ancestor
110352862|NCT04685642|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110352863|NCT04685642|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110352864|NCT04685642|Antimetabolites|antimetabolites|mesh-ancestor
110352865|NCT04685642|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110031984|NCT01395108|Nemonoxacin|nemonoxacin|mesh-list
110352866|NCT04685642|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110352867|NCT05312346|Hydroxocobalamin|hydroxocobalamin|mesh-list
110352869|NCT05312346|Hematinics|hematinics|mesh-ancestor
110352871|NCT05312346|Vitamins|vitamins|mesh-ancestor
110352872|NCT05312346|Micronutrients|micronutrients|mesh-ancestor
110352873|NCT05312346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352874|NCT05568563|Ethyl Chloride|ethyl chloride|mesh-list
110352875|NCT05568563|Anesthetics, Local|anesthetics, local|mesh-ancestor
110352876|NCT05568563|Anesthetics|anesthetics|mesh-ancestor
110352877|NCT05568563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110352878|NCT05568563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352879|NCT05568563|Sensory System Agents|sensory system agents|mesh-ancestor
110352880|NCT05568563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110352881|NCT00536861|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110352882|NCT00536861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110352883|NCT00536861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110352884|NCT00536861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110352885|NCT00536861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110352886|NCT05469984|Gentamicins|gentamicins|mesh-list
110352887|NCT05469984|Ampicillin|ampicillin|mesh-list
110352888|NCT05469984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110352889|NCT05469984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110352890|NCT05469984|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110352891|NCT05469984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110352892|NCT05469984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110352894|NCT05312190|Progestins|progestins|mesh-ancestor
110352895|NCT05312190|Hormones|hormones|mesh-ancestor
110352896|NCT05312190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110352897|NCT05312190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352898|NCT00537173|Paclitaxel|paclitaxel|mesh-list
110352899|NCT00537173|Bevacizumab|bevacizumab|mesh-list
110352900|NCT00537173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110352901|NCT00537173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110352902|NCT00537173|Tubulin Modulators|tubulin modulators|mesh-ancestor
110352903|NCT00537173|Antimitotic Agents|antimitotic agents|mesh-ancestor
110352904|NCT00537173|Mitosis Modulators|mitosis modulators|mesh-ancestor
110352905|NCT00537173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110352906|NCT00537173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110352907|NCT00537173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110352908|NCT00537173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110352909|NCT00537173|Growth Substances|growth substances|mesh-ancestor
110352910|NCT00537173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352911|NCT00537173|Growth Inhibitors|growth inhibitors|mesh-ancestor
110352912|NCT02503839|Etoricoxib|etoricoxib|mesh-list
110352913|NCT02503839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110352914|NCT02503839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110352915|NCT02503839|Analgesics|analgesics|mesh-ancestor
110352916|NCT02503839|Sensory System Agents|sensory system agents|mesh-ancestor
110352917|NCT02503839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110352918|NCT02503839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352919|NCT02503839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110352920|NCT02503839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110352921|NCT02503839|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110352922|NCT02503839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110352923|NCT02503839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110352924|NCT02503839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110352925|NCT05469750|Capecitabine|capecitabine|mesh-list
110352927|NCT05469750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110352928|NCT05469750|Antimetabolites|antimetabolites|mesh-ancestor
110352929|NCT05469750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110352930|NCT05469750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110352931|NCT05469750|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110352932|NCT05469750|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110352933|NCT05469750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110352934|NCT05469750|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110352935|NCT05469750|Hormone Antagonists|hormone antagonists|mesh-ancestor
110352936|NCT05469750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110352937|NCT05469750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352938|NCT02143830|Cyclophosphamide|cyclophosphamide|mesh-list
110352939|NCT02143830|Busulfan|busulfan|mesh-list
110352940|NCT02143830|Fludarabine|fludarabine|mesh-list
110352941|NCT02143830|Thymoglobulin|thymoglobulin|mesh-list
110352942|NCT02143830|Lenograstim|lenograstim|mesh-list
110352943|NCT02143830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110352944|NCT02143830|Immunologic Factors|immunologic factors|mesh-ancestor
110352945|NCT02143830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352946|NCT02143830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110352947|NCT02143830|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110352948|NCT02143830|Alkylating Agents|alkylating agents|mesh-ancestor
110352949|NCT02143830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110352950|NCT02143830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110352951|NCT02143830|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110352952|NCT02143830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110352954|NCT00537251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110352955|NCT00537251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352956|NCT03457194|Vaccines|vaccines|mesh-list
110352957|NCT03457194|Immunologic Factors|immunologic factors|mesh-ancestor
110352958|NCT03457194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352959|NCT05478707|Dulaglutide|dulaglutide|mesh-list
110352960|NCT05478707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110352961|NCT05478707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352962|NCT05469165|Cyproheptadine|cyproheptadine|mesh-list
110352963|NCT05469165|Antipruritics|antipruritics|mesh-ancestor
110352964|NCT05469165|Dermatologic Agents|dermatologic agents|mesh-ancestor
110352965|NCT05469165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110352966|NCT05469165|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110352967|NCT05469165|Histamine Antagonists|histamine antagonists|mesh-ancestor
110352968|NCT05469165|Histamine Agents|histamine agents|mesh-ancestor
110352969|NCT05469165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110352970|NCT05469165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110352971|NCT05469165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352972|NCT05469165|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110352973|NCT05469165|Serotonin Agents|serotonin agents|mesh-ancestor
110352974|NCT05469165|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110352975|NCT04319926|Lidocaine|lidocaine|mesh-list
110352976|NCT04319926|Anesthetics, Local|anesthetics, local|mesh-ancestor
110352977|NCT04319926|Anesthetics|anesthetics|mesh-ancestor
110352978|NCT04319926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110352979|NCT04319926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352980|NCT04319926|Sensory System Agents|sensory system agents|mesh-ancestor
110352981|NCT04319926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110352982|NCT04319926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110352983|NCT04319926|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110352984|NCT04319926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110352985|NCT04319926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110352986|NCT04319926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110352987|NCT01313923|Sirolimus|sirolimus|mesh-list
110352988|NCT01313923|Temsirolimus|temsirolimus|mesh-list
110352989|NCT01313923|MTOR Inhibitors|mtor inhibitors|mesh-list
110352990|NCT01313923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110352991|NCT01313923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110352992|NCT01313923|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110352993|NCT01313923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110352994|NCT01313923|Antifungal Agents|antifungal agents|mesh-ancestor
110352995|NCT01313923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110352996|NCT01313923|Immunologic Factors|immunologic factors|mesh-ancestor
110352997|NCT01313923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110352998|NCT01313923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110352999|NCT01313923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110353000|NCT01313923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110353001|NCT01313884|Cyclophosphamide|cyclophosphamide|mesh-list
110353003|NCT01313884|Doxorubicin|doxorubicin|mesh-list
110353004|NCT01313884|Irinotecan|irinotecan|mesh-list
110353005|NCT01313884|Vincristine|vincristine|mesh-list
110353006|NCT01313884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110353007|NCT01313884|Immunologic Factors|immunologic factors|mesh-ancestor
110353008|NCT01313884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353009|NCT01313884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110353010|NCT01313884|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110353011|NCT01313884|Alkylating Agents|alkylating agents|mesh-ancestor
110353012|NCT01313884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110353013|NCT01313884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110353014|NCT01313884|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110353015|NCT01313884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110353016|NCT01313884|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110353017|NCT01313884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110353018|NCT01313884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110353019|NCT01313884|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110353020|NCT01313884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110353021|NCT01313884|Tubulin Modulators|tubulin modulators|mesh-ancestor
110353022|NCT01313884|Antimitotic Agents|antimitotic agents|mesh-ancestor
110353023|NCT01313884|Mitosis Modulators|mitosis modulators|mesh-ancestor
110353024|NCT00537524|Vaccines|vaccines|mesh-list
110353025|NCT00537524|Immunologic Factors|immunologic factors|mesh-ancestor
110353026|NCT00537524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353027|NCT00537563|Telithromycin|telithromycin|mesh-list
110353028|NCT00537563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110353029|NCT00537563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110353030|NCT00537602|Miglustat|miglustat|mesh-list
110353031|NCT00537602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110353032|NCT00537602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110353033|NCT00537602|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110353034|NCT00537602|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110353035|NCT00537602|Antiviral Agents|antiviral agents|mesh-ancestor
110353036|NCT00537602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110353037|NCT00537602|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110353038|NCT00537602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110353039|NCT00537602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353040|NCT01259284|Atorvastatin|atorvastatin|mesh-list
110353041|NCT01259284|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110353042|NCT01259284|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110353043|NCT01259284|Antimetabolites|antimetabolites|mesh-ancestor
110353044|NCT01259284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110353045|NCT01259284|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110353046|NCT01259284|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110353047|NCT01259284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110353048|NCT03457025|Antiviral Agents|antiviral agents|mesh-list
110353049|NCT03457025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110353050|NCT00537836|Estradiol|estradiol|mesh-list
110353051|NCT00537836|Estrogens|estrogens|mesh-ancestor
110353052|NCT00537836|Hormones|hormones|mesh-ancestor
110353053|NCT00537836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110353054|NCT00537836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353055|NCT02277171|Nitric Oxide|nitric oxide|mesh-list
110353056|NCT02277171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110353057|NCT02277171|Autonomic Agents|autonomic agents|mesh-ancestor
110353058|NCT02277171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110353059|NCT02277171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353060|NCT02277171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110353061|NCT02277171|Respiratory System Agents|respiratory system agents|mesh-ancestor
110353062|NCT02277171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110353063|NCT02277171|Antioxidants|antioxidants|mesh-ancestor
110353064|NCT02277171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110353065|NCT02277171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110353066|NCT02277171|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110353067|NCT02277171|Vasodilator Agents|vasodilator agents|mesh-ancestor
110353068|NCT02277171|Gasotransmitters|gasotransmitters|mesh-ancestor
110353069|NCT02277171|Protective Agents|protective agents|mesh-ancestor
110353071|NCT00551564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110353072|NCT00551564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353073|NCT05105061|Ketamine|ketamine|mesh-list
110353074|NCT05105061|Analgesics|analgesics|mesh-ancestor
110353075|NCT05105061|Sensory System Agents|sensory system agents|mesh-ancestor
110353076|NCT05105061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110353077|NCT05105061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353078|NCT05105061|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110353079|NCT05105061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110353080|NCT05105061|Anesthetics, General|anesthetics, general|mesh-ancestor
110353081|NCT05105061|Anesthetics|anesthetics|mesh-ancestor
110353082|NCT05105061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110353083|NCT05105061|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110353084|NCT05105061|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110353085|NCT05105061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110353086|NCT05105061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110353087|NCT05056584|Glucagon|glucagon|mesh-list
110353088|NCT05056584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110353089|NCT05056584|Hormones|hormones|mesh-ancestor
110353090|NCT05056584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110353091|NCT05056584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353092|NCT00551954|Acarbose|acarbose|mesh-list
110353093|NCT00551954|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110353094|NCT00551954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110353095|NCT00551954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110353096|NCT00551954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110353097|NCT00551954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353098|NCT00552149|Cetuximab|cetuximab|mesh-list
110353099|NCT00552149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110353100|NCT00552149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110353101|NCT05467878|Anesthetics|anesthetics|mesh-list
110353102|NCT05467878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110353103|NCT05467878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353104|NCT00536640|Bevacizumab|bevacizumab|mesh-list
110353105|NCT00536640|Gemcitabine|gemcitabine|mesh-list
110353106|NCT00536640|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110353107|NCT00536640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110353108|NCT00536640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110353109|NCT00536640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110353110|NCT00536640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110353111|NCT00536640|Growth Substances|growth substances|mesh-ancestor
110353112|NCT00536640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353113|NCT00536640|Growth Inhibitors|growth inhibitors|mesh-ancestor
110353114|NCT00536640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110353115|NCT00536640|Antimetabolites|antimetabolites|mesh-ancestor
110353116|NCT00536640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110353117|NCT00536640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110353118|NCT00536640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110353119|NCT00552227|Ruboxistaurin|ruboxistaurin|mesh-list
110353120|NCT00552227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110353121|NCT00552227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110353122|NCT01259089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110353123|NCT01259089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110353124|NCT01259089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110353125|NCT01259089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110353126|NCT01259089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110353128|NCT00552266|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110353129|NCT00552266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353130|NCT00552266|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110353131|NCT00552266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110353132|NCT00552266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110353133|NCT00552266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110353134|NCT00552266|Dopamine Agents|dopamine agents|mesh-ancestor
110353135|NCT00552266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110353136|NCT04943757|Cyclophosphamide|cyclophosphamide|mesh-list
110353137|NCT04943757|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110353138|NCT04943757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110353139|NCT04943757|Immunologic Factors|immunologic factors|mesh-ancestor
110353140|NCT04943757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353141|NCT04943757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110353146|NCT04943757|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110353153|NCT00552500|Valproic Acid|valproic acid|mesh-list
110353154|NCT00552500|Anticonvulsants|anticonvulsants|mesh-ancestor
110353155|NCT00552500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110353156|NCT00552500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110353157|NCT00552500|GABA Agents|gaba agents|mesh-ancestor
110353158|NCT00552500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110353159|NCT00552500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353160|NCT00552500|Antimanic Agents|antimanic agents|mesh-ancestor
110353161|NCT00552500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110353162|NCT00552500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110353163|NCT00552500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110353164|NCT01258738|Etanercept|etanercept|mesh-list
110353165|NCT01258738|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
110353167|NCT01258738|Analgesics|analgesics|mesh-ancestor
110353168|NCT01258738|Sensory System Agents|sensory system agents|mesh-ancestor
110353169|NCT01258738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110353170|NCT01258738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353171|NCT01258738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110353172|NCT01258738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110353173|NCT01258738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110353174|NCT01258738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110353175|NCT01258738|Immunologic Factors|immunologic factors|mesh-ancestor
110353176|NCT00552656|Sirolimus|sirolimus|mesh-list
110353177|NCT00552656|Temsirolimus|temsirolimus|mesh-list
110353178|NCT00552656|MTOR Inhibitors|mtor inhibitors|mesh-list
110353179|NCT00552656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110353180|NCT00552656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110353181|NCT00552656|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110353182|NCT00552656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110353183|NCT00552656|Antifungal Agents|antifungal agents|mesh-ancestor
110353184|NCT00552656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110353185|NCT00552656|Immunologic Factors|immunologic factors|mesh-ancestor
110353186|NCT00552656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353187|NCT00552656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110353188|NCT00552656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110353189|NCT00552656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110353190|NCT01824537|Vaccines|vaccines|mesh-list
110353191|NCT01824537|Immunologic Factors|immunologic factors|mesh-ancestor
110353192|NCT01824537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353193|NCT04863339|Tranexamic Acid|tranexamic acid|mesh-list
110353194|NCT04863339|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110353195|NCT04863339|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110225444|NCT05966246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110353196|NCT04863339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110353197|NCT04863339|Hemostatics|hemostatics|mesh-ancestor
110353198|NCT04863339|Coagulants|coagulants|mesh-ancestor
110353199|NCT04684277|Antidepressive Agents|antidepressive agents|mesh-list
110353200|NCT04684277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110353201|NCT00552734|Insulin|insulin|mesh-list
110353202|NCT00552734|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110353203|NCT00552734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110353204|NCT00552734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353205|NCT04543682|Iloprost|iloprost|mesh-list
110353206|NCT04543682|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110353207|NCT04543682|Vasodilator Agents|vasodilator agents|mesh-ancestor
110353208|NCT04802616|Broncho-Vaxom|broncho-vaxom|mesh-list
110353209|NCT04802616|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110353210|NCT04802616|Immunologic Factors|immunologic factors|mesh-ancestor
110176115|NCT00079222|Voriconazole|voriconazole|mesh-list
110353211|NCT04802616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353212|NCT01258660|Folic Acid|folic acid|mesh-list
110353213|NCT01258660|Vitamin B Complex|vitamin b complex|mesh-list
110353214|NCT01258660|Drospirenone|drospirenone|mesh-list
110353215|NCT01258660|Hematinics|hematinics|mesh-ancestor
110353216|NCT01258660|Vitamins|vitamins|mesh-ancestor
110353217|NCT01258660|Micronutrients|micronutrients|mesh-ancestor
110353218|NCT01258660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353219|NCT01258660|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110353220|NCT01258660|Hormone Antagonists|hormone antagonists|mesh-ancestor
110353221|NCT01258660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110353222|NCT01258660|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110353223|NCT01258660|Diuretics|diuretics|mesh-ancestor
110353224|NCT01258660|Natriuretic Agents|natriuretic agents|mesh-ancestor
110353225|NCT04772274|Ustekinumab|ustekinumab|mesh-list
110353226|NCT04772274|Dermatologic Agents|dermatologic agents|mesh-ancestor
110353227|NCT04362527|Milrinone|milrinone|mesh-list
110353228|NCT04362527|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110353229|NCT04362527|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110353230|NCT04362527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110353231|NCT04362527|Vasodilator Agents|vasodilator agents|mesh-ancestor
110353232|NCT04362527|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110353233|NCT04362527|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110353234|NCT04362527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110353235|NCT04362527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110353236|NCT04362527|Protective Agents|protective agents|mesh-ancestor
110353237|NCT04362527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353238|NCT04758975|Rituximab|rituximab|mesh-list
110353239|NCT04758975|Venetoclax|venetoclax|mesh-list
110353240|NCT04758975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110353241|NCT04758975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110353242|NCT04758975|Immunologic Factors|immunologic factors|mesh-ancestor
110353243|NCT04758975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353244|NCT04758975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110353245|NCT01614171|Hormones|hormones|mesh-list
110353246|NCT01614171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110353247|NCT01614171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353248|NCT05567367|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110353249|NCT05567367|Vasodilator Agents|vasodilator agents|mesh-ancestor
110353250|NCT05567367|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110353251|NCT05567367|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110353252|NCT05567367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110032078|NCT01395602|Dopamine Agents|dopamine agents|mesh-ancestor
110353253|NCT05567367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110353254|NCT05567367|Urological Agents|urological agents|mesh-ancestor
110353255|NCT04656951|Daratumumab|daratumumab|mesh-list
110353256|NCT04656951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110353257|NCT04173533|Azacitidine|azacitidine|mesh-list
110353258|NCT04173533|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110353259|NCT04173533|Antimetabolites|antimetabolites|mesh-ancestor
110353260|NCT04173533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110353261|NCT04173533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110353262|NCT04173533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110353263|NCT01258348|Sunitinib|sunitinib|mesh-list
110353264|NCT01258348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110353265|NCT01258348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110353266|NCT01258348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110353267|NCT01258348|Growth Substances|growth substances|mesh-ancestor
110353268|NCT01258348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353269|NCT01258348|Growth Inhibitors|growth inhibitors|mesh-ancestor
110353270|NCT01258348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110353271|NCT01258348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110353272|NCT01258348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110353273|NCT05136898|Mitomycins|mitomycins|mesh-list
110353274|NCT05136898|Mitomycin|mitomycin|mesh-list
110353275|NCT05136898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110353276|NCT05136898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110353277|NCT05136898|Alkylating Agents|alkylating agents|mesh-ancestor
110353278|NCT05136898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110353279|NCT05136898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110353280|NCT05136898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110353281|NCT01258075|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
110353282|NCT01258075|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110353283|NCT01258075|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110353284|NCT01258075|Antimetabolites|antimetabolites|mesh-ancestor
110353285|NCT01258075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110353286|NCT01258075|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110353287|NCT04687878|Insulin|insulin|mesh-list
110353288|NCT04687878|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110353289|NCT04687878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110353290|NCT04687878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353291|NCT05116774|Eculizumab|eculizumab|mesh-list
110353292|NCT05116774|Ravulizumab|ravulizumab|mesh-list
110353293|NCT05116774|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110353295|NCT05116774|Immunologic Factors|immunologic factors|mesh-ancestor
110353296|NCT05116774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353297|NCT01256671|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
110353298|NCT01256671|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110353299|NCT01256671|Immunologic Factors|immunologic factors|mesh-ancestor
110353300|NCT01256671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353301|NCT04687566|Memantine|memantine|mesh-list
110353302|NCT04687566|Dextromethorphan|dextromethorphan|mesh-list
110353303|NCT04687566|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110353305|NCT04687566|Dopamine Agents|dopamine agents|mesh-ancestor
110353306|NCT04687566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110353307|NCT04687566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110353308|NCT04687566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353309|NCT04687566|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110353310|NCT04687566|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110353311|NCT04687566|Antitussive Agents|antitussive agents|mesh-ancestor
110353312|NCT04687566|Respiratory System Agents|respiratory system agents|mesh-ancestor
110353313|NCT01256476|Pravastatin|pravastatin|mesh-list
110353314|NCT01256476|Pitavastatin|pitavastatin|mesh-list
110353315|NCT01256476|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110353316|NCT01256476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110353317|NCT01256476|Antimetabolites|antimetabolites|mesh-ancestor
110353318|NCT01256476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110353319|NCT01256476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110353320|NCT01256476|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110353321|NCT01256476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110353322|NCT05507892|Canagliflozin|canagliflozin|mesh-list
110353323|NCT05507892|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110353324|NCT05507892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110353325|NCT05507892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110353326|NCT05507892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353327|NCT04106999|Dexmedetomidine|dexmedetomidine|mesh-list
110353328|NCT04106999|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110353329|NCT04106999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110353330|NCT04106999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353331|NCT04106999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110353332|NCT04106999|Analgesics|analgesics|mesh-ancestor
110353333|NCT04106999|Sensory System Agents|sensory system agents|mesh-ancestor
110353334|NCT04106999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110353335|NCT04106999|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110353336|NCT04106999|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110353337|NCT04106999|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110353338|NCT04106999|Adrenergic Agents|adrenergic agents|mesh-ancestor
110353339|NCT04106999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110353340|NCT04106999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110353341|NCT05478720|Diazooxonorleucine|diazooxonorleucine|mesh-list
110353342|NCT05478720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110353343|NCT05478720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110353344|NCT05478720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110353346|NCT05478720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110353347|NCT05003089|Prednisolone|prednisolone|mesh-list
110353348|NCT05003089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110353349|NCT05003089|Glucocorticoids|glucocorticoids|mesh-ancestor
110353350|NCT05003089|Hormones|hormones|mesh-ancestor
110353351|NCT05003089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110353352|NCT05003089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353353|NCT05003089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110353354|NCT05003089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110353355|NCT04207021|Curcumin|curcumin|mesh-list
110353356|NCT04207021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110353357|NCT04207021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110353358|NCT04207021|Analgesics|analgesics|mesh-ancestor
110353359|NCT04207021|Sensory System Agents|sensory system agents|mesh-ancestor
110353360|NCT04207021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110353361|NCT04207021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353362|NCT04207021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110353363|NCT04207021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110353364|NCT04207021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110353365|NCT04207021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110353366|NCT04207021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110353367|NCT01255423|Diclofenac|diclofenac|mesh-list
110353368|NCT01255423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110353369|NCT01255423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110353370|NCT01255423|Analgesics|analgesics|mesh-ancestor
110353371|NCT01255423|Sensory System Agents|sensory system agents|mesh-ancestor
110353372|NCT01255423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110353373|NCT01255423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353374|NCT01255423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110353375|NCT01255423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110353376|NCT01255423|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110353377|NCT01255423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110353378|NCT01255423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110353379|NCT01255306|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110353380|NCT01255306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110353381|NCT01255306|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110353382|NCT01255306|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110353383|NCT01255306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110353384|NCT01255306|Adrenergic Agents|adrenergic agents|mesh-ancestor
110353385|NCT01255306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110353386|NCT01255306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110353387|NCT01255306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353388|NCT01254721|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110353389|NCT01254721|Antidepressive Agents|antidepressive agents|mesh-ancestor
110353390|NCT01254721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110353391|NCT01254721|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110353392|NCT01254721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110353393|NCT01254721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110353394|NCT01254721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353396|NCT04003805|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110353397|NCT04003805|Autonomic Agents|autonomic agents|mesh-ancestor
110353398|NCT04003805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110353399|NCT04003805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353400|NCT04003805|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110353401|NCT04003805|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110353402|NCT04003805|Cholinergic Agents|cholinergic agents|mesh-ancestor
110353403|NCT04003805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110353404|NCT04003805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110353405|NCT04842604|Azacitidine|azacitidine|mesh-list
110353406|NCT04842604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110353407|NCT04842604|Antimetabolites|antimetabolites|mesh-ancestor
110353408|NCT04842604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110353409|NCT04842604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110353410|NCT04842604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110353411|NCT01254604|Timolol|timolol|mesh-list
110353412|NCT01254604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110353413|NCT01254604|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110353414|NCT01254604|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110353415|NCT01254604|Adrenergic Agents|adrenergic agents|mesh-ancestor
110353416|NCT01254604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110353417|NCT01254604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353418|NCT01254604|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110353419|NCT01254604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110353420|NCT04390698|Analgesics, Opioid|analgesics, opioid|mesh-list
110353421|NCT04390698|Anesthetics|anesthetics|mesh-list
110353422|NCT04390698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110353423|NCT04390698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353424|NCT04390698|Narcotics|narcotics|mesh-ancestor
110353425|NCT04390698|Analgesics|analgesics|mesh-ancestor
110353426|NCT04390698|Sensory System Agents|sensory system agents|mesh-ancestor
110353427|NCT04390698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110353428|NCT03795701|Liraglutide|liraglutide|mesh-list
110353429|NCT03795701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110353430|NCT03795701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353431|NCT03795701|Incretins|incretins|mesh-ancestor
110353433|NCT03795701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110353434|NCT04673578|Celecoxib|celecoxib|mesh-list
110353435|NCT04673578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110353436|NCT04673578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110353437|NCT04673578|Analgesics|analgesics|mesh-ancestor
110353438|NCT04673578|Sensory System Agents|sensory system agents|mesh-ancestor
110353439|NCT04673578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110353440|NCT04673578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353441|NCT04673578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110353442|NCT04673578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110353443|NCT04673578|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110353444|NCT04673578|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110353445|NCT04673578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110353446|NCT04673578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110353448|NCT05414058|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110353449|NCT05414058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353450|NCT05414058|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110353451|NCT05414058|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110353452|NCT05414058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110353453|NCT05414058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110353454|NCT05414058|Dopamine Agents|dopamine agents|mesh-ancestor
110353455|NCT05414058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110353456|NCT03757403|Mebendazole|mebendazole|mesh-list
110353457|NCT03757403|Piperazine|piperazine|mesh-list
110353458|NCT03757403|Piperazine citrate|piperazine citrate|mesh-list
110353459|NCT03757403|DMP 777|dmp 777|mesh-list
110353460|NCT03757403|Antinematodal Agents|antinematodal agents|mesh-ancestor
110353461|NCT03757403|Anthelmintics|anthelmintics|mesh-ancestor
110353462|NCT03757403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110353463|NCT03757403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110353464|NCT03757403|Tubulin Modulators|tubulin modulators|mesh-ancestor
110353465|NCT03757403|Antimitotic Agents|antimitotic agents|mesh-ancestor
110353466|NCT03757403|Mitosis Modulators|mitosis modulators|mesh-ancestor
110353467|NCT03757403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110353468|NCT03757403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110353469|NCT03757403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110353470|NCT00537342|Immunomodulating Agents|immunomodulating agents|mesh-list
110353471|NCT00537342|Immunologic Factors|immunologic factors|mesh-ancestor
110353472|NCT00537342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353473|NCT00537420|Sibutramine|sibutramine|mesh-list
110353474|NCT00537420|Antidepressive Agents|antidepressive agents|mesh-ancestor
110353475|NCT00537420|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110353476|NCT00537420|Appetite Depressants|appetite depressants|mesh-ancestor
110032108|NCT01395667|Antimetabolites|antimetabolites|mesh-ancestor
110353477|NCT00537420|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110353478|NCT03534284|Trazodone|trazodone|mesh-list
110353479|NCT03534284|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110353480|NCT03534284|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110353481|NCT03534284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110353482|NCT03534284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353483|NCT03534284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110353484|NCT03534284|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110176143|NCT00079261|Antimetabolites|antimetabolites|mesh-ancestor
110353485|NCT03534284|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110353486|NCT03534284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110353487|NCT03534284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110353488|NCT03534284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110353489|NCT03534284|Serotonin Agents|serotonin agents|mesh-ancestor
110353490|NCT03534284|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110353491|NCT03534284|Antidepressive Agents|antidepressive agents|mesh-ancestor
110353492|NCT01254292|Levonorgestrel|levonorgestrel|mesh-list
110353493|NCT01254292|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110353494|NCT01254292|Contraceptive Agents|contraceptive agents|mesh-ancestor
110353495|NCT01254292|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110353496|NCT01254292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353497|NCT01254292|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110353498|NCT01254292|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110353499|NCT01254292|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110353501|NCT04683458|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110353502|NCT04683458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110353503|NCT04683458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110353504|NCT04683458|Tubulin Modulators|tubulin modulators|mesh-ancestor
110353505|NCT04683458|Antimitotic Agents|antimitotic agents|mesh-ancestor
110353506|NCT04683458|Mitosis Modulators|mitosis modulators|mesh-ancestor
110353507|NCT04683458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110353508|NCT01253317|Mecasermin|mecasermin|mesh-list
110353509|NCT01253317|Growth Substances|growth substances|mesh-ancestor
110353510|NCT01253317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353511|NCT00537537|Telbivudine|telbivudine|mesh-list
110353512|NCT00537537|Antiviral Agents|antiviral agents|mesh-ancestor
110353513|NCT00537537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110353514|NCT00537537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110353515|NCT00537537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110353516|NCT00537537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110353517|NCT04319770|Hyaluronic Acid|hyaluronic acid|mesh-list
110353518|NCT04319770|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110353520|NCT04319770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353521|NCT04319770|Viscosupplements|viscosupplements|mesh-ancestor
110353522|NCT04319770|Protective Agents|protective agents|mesh-ancestor
110353523|NCT02722616|Pancrelipase|pancrelipase|mesh-list
110353524|NCT02722616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110353525|NCT01253200|Acifluorfen|acifluorfen|mesh-list
110353526|NCT01253200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110353527|NCT01253200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110353528|NCT04515901|Lidocaine|lidocaine|mesh-list
110353529|NCT04515901|Anesthetics, Local|anesthetics, local|mesh-ancestor
110353530|NCT04515901|Anesthetics|anesthetics|mesh-ancestor
110353531|NCT04515901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110353532|NCT04515901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353533|NCT04515901|Sensory System Agents|sensory system agents|mesh-ancestor
110353534|NCT04515901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110353535|NCT04515901|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110353536|NCT04515901|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110353537|NCT04515901|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110353538|NCT04515901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110353539|NCT04515901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110353540|NCT02605421|Cyclophosphamide|cyclophosphamide|mesh-list
110353541|NCT02605421|Melphalan|melphalan|mesh-list
110353542|NCT02605421|Thiotepa|thiotepa|mesh-list
110353543|NCT02605421|Carboplatin|carboplatin|mesh-list
110353544|NCT02605421|Etoposide|etoposide|mesh-list
110353545|NCT02605421|Lenograstim|lenograstim|mesh-list
110353546|NCT02605421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110353547|NCT02605421|Immunologic Factors|immunologic factors|mesh-ancestor
110353548|NCT02605421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353549|NCT02605421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110353550|NCT02605421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110353551|NCT02605421|Alkylating Agents|alkylating agents|mesh-ancestor
110353552|NCT02605421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110353553|NCT02605421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110353554|NCT02605421|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110353555|NCT02605421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110353556|NCT02605421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110353557|NCT02605421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110353558|NCT02605421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110353559|NCT02605421|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110353560|NCT04320589|Dexmedetomidine|dexmedetomidine|mesh-list
110353561|NCT04320589|Anesthetics|anesthetics|mesh-list
110353562|NCT04320589|Anesthetics, General|anesthetics, general|mesh-list
110353563|NCT04320589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110353564|NCT04320589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110353565|NCT04320589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353566|NCT04320589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110353567|NCT04320589|Analgesics|analgesics|mesh-ancestor
110353568|NCT04320589|Sensory System Agents|sensory system agents|mesh-ancestor
110353569|NCT04320589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110353570|NCT04320589|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110353571|NCT04320589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110353572|NCT04320589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110353573|NCT04320589|Adrenergic Agents|adrenergic agents|mesh-ancestor
110353574|NCT04320589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110353575|NCT04320589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110353576|NCT04397692|Nitric Oxide|nitric oxide|mesh-list
110353577|NCT04397692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110353578|NCT04397692|Autonomic Agents|autonomic agents|mesh-ancestor
110353579|NCT04397692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110353580|NCT04397692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353581|NCT04397692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110353582|NCT04397692|Respiratory System Agents|respiratory system agents|mesh-ancestor
110353583|NCT04397692|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110353584|NCT04397692|Antioxidants|antioxidants|mesh-ancestor
110225445|NCT05966246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353585|NCT04397692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110353586|NCT04397692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110353587|NCT04397692|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110353588|NCT04397692|Vasodilator Agents|vasodilator agents|mesh-ancestor
110353589|NCT04397692|Gasotransmitters|gasotransmitters|mesh-ancestor
110353590|NCT04397692|Protective Agents|protective agents|mesh-ancestor
110353591|NCT02203643|Dexamethasone|dexamethasone|mesh-list
110353592|NCT02203643|Cyclophosphamide|cyclophosphamide|mesh-list
110353593|NCT02203643|Lenalidomide|lenalidomide|mesh-list
110353594|NCT02203643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110353595|NCT02203643|Immunologic Factors|immunologic factors|mesh-ancestor
110353596|NCT02203643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353597|NCT02203643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110353598|NCT02203643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110353599|NCT02203643|Alkylating Agents|alkylating agents|mesh-ancestor
110353600|NCT02203643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110353601|NCT02203643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110353602|NCT02203643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110353603|NCT02203643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110353604|NCT02203643|Antiemetics|antiemetics|mesh-ancestor
110353605|NCT02203643|Autonomic Agents|autonomic agents|mesh-ancestor
110353606|NCT02203643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110353607|NCT02203643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110353608|NCT02203643|Glucocorticoids|glucocorticoids|mesh-ancestor
110353609|NCT02203643|Hormones|hormones|mesh-ancestor
110353610|NCT02203643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110353611|NCT02203643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110353612|NCT02203643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110353613|NCT02203643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110353614|NCT02203643|Growth Substances|growth substances|mesh-ancestor
110176150|NCT00079261|Hormones|hormones|mesh-ancestor
110353615|NCT02203643|Growth Inhibitors|growth inhibitors|mesh-ancestor
110353616|NCT01252186|Contraceptive Agents|contraceptive agents|mesh-list
110353617|NCT01252186|Levonorgestrel|levonorgestrel|mesh-list
110353618|NCT01252186|Desogestrel|desogestrel|mesh-list
110353619|NCT01252186|Contraceptives, Oral|contraceptives, oral|mesh-list
110353620|NCT01252186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110353621|NCT01252186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032149|NCT01395862|Autonomic Agents|autonomic agents|mesh-ancestor
110353622|NCT01252186|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110353623|NCT01252186|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110353624|NCT01252186|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110353625|NCT01252186|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110353626|NCT01252186|Progestins|progestins|mesh-ancestor
110353628|NCT01252186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110353629|NCT01731782|Bupivacaine|bupivacaine|mesh-list
110353630|NCT01731782|Anesthetics, Local|anesthetics, local|mesh-ancestor
110353631|NCT01731782|Anesthetics|anesthetics|mesh-ancestor
110353632|NCT01731782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110353633|NCT01731782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353634|NCT01731782|Sensory System Agents|sensory system agents|mesh-ancestor
110353635|NCT01731782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110353636|NCT01251952|Denileukin diftitox|denileukin diftitox|mesh-list
110353637|NCT01251952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110353639|NCT04356430|Goserelin|goserelin|mesh-list
110353640|NCT04356430|Abiraterone Acetate|abiraterone acetate|mesh-list
110353641|NCT04356430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110353642|NCT04356430|Glucocorticoids|glucocorticoids|mesh-ancestor
110353643|NCT04356430|Hormones|hormones|mesh-ancestor
110353644|NCT04356430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110353645|NCT04356430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353646|NCT04356430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110353647|NCT04356430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110353648|NCT04356430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110353649|NCT04356430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110353650|NCT04356430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110353651|NCT04356430|Hormone Antagonists|hormone antagonists|mesh-ancestor
110353652|NCT04356430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110353654|NCT03974139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110353655|NCT03974139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353656|NCT04320238|Interferons|interferons|mesh-list
110353657|NCT04320238|Interferon-alpha|interferon-alpha|mesh-list
110353658|NCT04320238|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
110353659|NCT04320238|Thymalfasin|thymalfasin|mesh-list
110353660|NCT04320238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110353661|NCT04320238|Antiviral Agents|antiviral agents|mesh-ancestor
110353662|NCT04320238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110353663|NCT04320238|Immunologic Factors|immunologic factors|mesh-ancestor
110353664|NCT04320238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353665|NCT04320238|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110353667|NCT01229072|Calcium heparin|calcium heparin|mesh-list
110353668|NCT01229072|Anticoagulants|anticoagulants|mesh-ancestor
110353669|NCT01229072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110353670|NCT01229072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110353671|NCT01229072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110353673|NCT01199978|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110353674|NCT01199978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110353675|NCT01199978|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110353676|NCT01199978|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110353677|NCT01199978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110353679|NCT00532116|Antidepressive Agents|antidepressive agents|mesh-ancestor
110353680|NCT00532116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110353681|NCT00532116|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110353682|NCT00532116|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110353683|NCT00532116|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110353684|NCT00532116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110353685|NCT00532116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110353686|NCT00532116|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110353687|NCT00532116|Protective Agents|protective agents|mesh-ancestor
110353688|NCT00532116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353689|NCT04283513|Ribavirin|ribavirin|mesh-list
110353690|NCT04283513|Antimetabolites|antimetabolites|mesh-ancestor
110353691|NCT04283513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110353692|NCT04283513|Antiviral Agents|antiviral agents|mesh-ancestor
110353693|NCT04283513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110353694|NCT01251367|Botulinum Toxins|botulinum toxins|mesh-list
110353695|NCT01251367|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110353696|NCT01251367|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110353697|NCT01251367|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110353698|NCT01251367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110353699|NCT01251367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110353700|NCT01251367|Cholinergic Agents|cholinergic agents|mesh-ancestor
110353701|NCT01251367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110353702|NCT01251367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353703|NCT01251367|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110353704|NCT01251367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110353705|NCT03910998|Rocuronium|rocuronium|mesh-list
110353706|NCT03910998|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110353707|NCT03910998|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110353708|NCT03910998|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110353709|NCT03910998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110353710|NCT03910998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353711|NCT04685148|Estradiol|estradiol|mesh-list
110353712|NCT04685148|Estrogens|estrogens|mesh-ancestor
110353713|NCT04685148|Hormones|hormones|mesh-ancestor
110353714|NCT04685148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110353715|NCT04685148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353716|NCT02888548|Botulinum Toxins|botulinum toxins|mesh-list
110353717|NCT02888548|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110353718|NCT02888548|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110353719|NCT02888548|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110353720|NCT02888548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110353721|NCT02888548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110353722|NCT02888548|Cholinergic Agents|cholinergic agents|mesh-ancestor
110353723|NCT02888548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110353724|NCT02888548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353725|NCT02888548|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110353726|NCT02888548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110353727|NCT04246684|Leucovorin|leucovorin|mesh-list
110353728|NCT04246684|Folic Acid|folic acid|mesh-list
110353729|NCT04246684|Capecitabine|capecitabine|mesh-list
110353730|NCT04246684|Fluorouracil|fluorouracil|mesh-list
110353731|NCT04246684|Oxaliplatin|oxaliplatin|mesh-list
110353732|NCT04246684|Levoleucovorin|levoleucovorin|mesh-list
110353733|NCT04246684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110353734|NCT04246684|Antimetabolites|antimetabolites|mesh-ancestor
110353735|NCT04246684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110353736|NCT04246684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110353737|NCT04246684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110353738|NCT04246684|Immunologic Factors|immunologic factors|mesh-ancestor
110353739|NCT04246684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353740|NCT04246684|Antidotes|antidotes|mesh-ancestor
110353741|NCT04246684|Protective Agents|protective agents|mesh-ancestor
110353742|NCT04246684|Vitamin B Complex|vitamin b complex|mesh-ancestor
110353744|NCT04246684|Micronutrients|micronutrients|mesh-ancestor
110353745|NCT04246684|Hematinics|hematinics|mesh-ancestor
110353746|NCT03883893|Acetaminophen|acetaminophen|mesh-list
110353747|NCT03883893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110353748|NCT03883893|Analgesics|analgesics|mesh-ancestor
110353749|NCT03883893|Sensory System Agents|sensory system agents|mesh-ancestor
110353750|NCT03883893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110353751|NCT03883893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353752|NCT03883893|Antipyretics|antipyretics|mesh-ancestor
110353753|NCT00537732|Omeprazole|omeprazole|mesh-list
110353754|NCT00537732|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110353755|NCT00537732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110353756|NCT00537732|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110353757|NCT00537732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110353758|NCT00537732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110353759|NCT04180436|Rivaroxaban|rivaroxaban|mesh-list
110353760|NCT04180436|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110353761|NCT04180436|Antithrombins|antithrombins|mesh-ancestor
110353762|NCT04180436|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110353763|NCT04180436|Protease Inhibitors|protease inhibitors|mesh-ancestor
110353764|NCT04180436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110353765|NCT04180436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110353766|NCT04180436|Anticoagulants|anticoagulants|mesh-ancestor
110353767|NCT01250119|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110353768|NCT01250119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110353769|NCT01250119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110353770|NCT01250119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110353771|NCT01250119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110353773|NCT04320277|Lopinavir|lopinavir|mesh-list
110353774|NCT04320277|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110353775|NCT04320277|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110353776|NCT04320277|Protease Inhibitors|protease inhibitors|mesh-ancestor
110353777|NCT04320277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110353778|NCT04320277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110353779|NCT04320277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110353780|NCT04320277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110353781|NCT04320277|Antiviral Agents|antiviral agents|mesh-ancestor
110353782|NCT04320277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110353783|NCT04320277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110353784|NCT04320277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110353785|NCT01250002|Lidocaine|lidocaine|mesh-list
110353786|NCT01250002|Anesthetics, Local|anesthetics, local|mesh-ancestor
110353787|NCT01250002|Anesthetics|anesthetics|mesh-ancestor
110353788|NCT01250002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110353789|NCT01250002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353790|NCT01250002|Sensory System Agents|sensory system agents|mesh-ancestor
110353791|NCT01250002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110353792|NCT01250002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110353793|NCT01250002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110353794|NCT01250002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110353795|NCT01250002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110225447|NCT05966194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110353796|NCT01250002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110353798|NCT04157153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110353799|NCT04157153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110353800|NCT04157153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110353801|NCT04157153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110353802|NCT04157153|Antifungal Agents|antifungal agents|mesh-ancestor
110353803|NCT04157153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110353804|NCT04157153|Immunologic Factors|immunologic factors|mesh-ancestor
110353805|NCT04157153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353806|NCT05329116|Lidocaine|lidocaine|mesh-list
110353807|NCT05329116|Pentoxifylline|pentoxifylline|mesh-list
110353808|NCT05329116|Anesthetics, Local|anesthetics, local|mesh-ancestor
110353809|NCT05329116|Anesthetics|anesthetics|mesh-ancestor
110353810|NCT05329116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110353811|NCT05329116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353812|NCT05329116|Sensory System Agents|sensory system agents|mesh-ancestor
110353813|NCT05329116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110353814|NCT05329116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110353815|NCT05329116|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110353816|NCT05329116|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110353817|NCT05329116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110353818|NCT05329116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110353819|NCT05329116|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110353820|NCT05329116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110176171|NCT00079378|Anticonvulsants|anticonvulsants|mesh-ancestor
110353821|NCT05329116|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110353822|NCT05329116|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110353823|NCT05329116|Protective Agents|protective agents|mesh-ancestor
110353824|NCT05329116|Vasodilator Agents|vasodilator agents|mesh-ancestor
110353825|NCT05329116|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110353827|NCT00537888|Fluconazole|fluconazole|mesh-list
110353828|NCT00537888|Antifungal Agents|antifungal agents|mesh-ancestor
110353829|NCT00537888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110353830|NCT00537888|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110353831|NCT00537888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110353832|NCT00537888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110353833|NCT00537888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110353834|NCT00537888|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110353835|NCT00537888|Hormone Antagonists|hormone antagonists|mesh-ancestor
110353836|NCT00537888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110353837|NCT00537888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353838|NCT00537888|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110353839|NCT00537888|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110353840|NCT05264142|Voriconazole|voriconazole|mesh-list
110353841|NCT05264142|Fluvoxamine|fluvoxamine|mesh-list
110353843|NCT05264142|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110353844|NCT05264142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110353845|NCT05264142|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110353846|NCT05264142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110353847|NCT05264142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110353848|NCT05264142|Antifungal Agents|antifungal agents|mesh-ancestor
110353849|NCT05264142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110353850|NCT05264142|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110353851|NCT05264142|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110353852|NCT05264142|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110353853|NCT05264142|Hormone Antagonists|hormone antagonists|mesh-ancestor
110353854|NCT05264142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110353855|NCT05264142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353856|NCT05264142|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110353857|NCT05264142|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110353858|NCT05264142|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110353859|NCT05264142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110353860|NCT05264142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110353861|NCT05264142|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110353862|NCT05264142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110353863|NCT05264142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110353864|NCT05264142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110353865|NCT05264142|Serotonin Agents|serotonin agents|mesh-ancestor
110353866|NCT05264142|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110353867|NCT05264142|Antidepressive Agents|antidepressive agents|mesh-ancestor
110353868|NCT05264142|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110353869|NCT05264142|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110353870|NCT01246960|Leucovorin|leucovorin|mesh-list
110353871|NCT01246960|Fluorouracil|fluorouracil|mesh-list
110353872|NCT01246960|Oxaliplatin|oxaliplatin|mesh-list
110353873|NCT01246960|Ramucirumab|ramucirumab|mesh-list
110353874|NCT01246960|Antimetabolites|antimetabolites|mesh-ancestor
110353875|NCT01246960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110353876|NCT01246960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110353877|NCT01246960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110353878|NCT01246960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110353879|NCT01246960|Immunologic Factors|immunologic factors|mesh-ancestor
110353880|NCT01246960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353881|NCT01246960|Antidotes|antidotes|mesh-ancestor
110353882|NCT01246960|Protective Agents|protective agents|mesh-ancestor
110353883|NCT01246960|Vitamin B Complex|vitamin b complex|mesh-ancestor
110353884|NCT01246960|Vitamins|vitamins|mesh-ancestor
110353885|NCT01246960|Micronutrients|micronutrients|mesh-ancestor
110353887|NCT00544986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110353888|NCT00544986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110353889|NCT00544986|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110353890|NCT00544986|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110353891|NCT00544986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110353892|NCT00544986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110353893|NCT00544986|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110353894|NCT00544986|Hormone Antagonists|hormone antagonists|mesh-ancestor
110353895|NCT00544986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110353896|NCT00544986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353897|NCT01244620|Sildenafil Citrate|sildenafil citrate|mesh-list
110353898|NCT01244620|Tadalafil|tadalafil|mesh-list
110353899|NCT01244620|Sitaxsentan|sitaxsentan|mesh-list
110353900|NCT01244620|Vasodilator Agents|vasodilator agents|mesh-ancestor
110353901|NCT01244620|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110353902|NCT01244620|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110353903|NCT01244620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110353904|NCT01244620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110353905|NCT01244620|Urological Agents|urological agents|mesh-ancestor
110353906|NCT01244620|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110353907|NCT04319692|Acetic Acid|acetic acid|mesh-list
110353908|NCT04319692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110353909|NCT04319692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110353910|NCT00545142|Valproic Acid|valproic acid|mesh-list
110353911|NCT00545142|Aripiprazole|aripiprazole|mesh-list
110353912|NCT00545142|Antidepressive Agents|antidepressive agents|mesh-ancestor
110353913|NCT00545142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110353914|NCT00545142|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110353915|NCT00545142|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110353916|NCT00545142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110353917|NCT00545142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353919|NCT00545142|Dopamine Agents|dopamine agents|mesh-ancestor
110353920|NCT00545142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110353921|NCT00545142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110353922|NCT00545142|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110353923|NCT00545142|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110353924|NCT00545142|Serotonin Agents|serotonin agents|mesh-ancestor
110353925|NCT00545142|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110353926|NCT00545142|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110353927|NCT00545142|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110353928|NCT00545142|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110353929|NCT00545142|Anticonvulsants|anticonvulsants|mesh-ancestor
110353930|NCT00545142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110353931|NCT00545142|GABA Agents|gaba agents|mesh-ancestor
110353932|NCT00545142|Antimanic Agents|antimanic agents|mesh-ancestor
110353933|NCT01267201|Methylprednisolone|methylprednisolone|mesh-list
110353934|NCT01267201|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110353935|NCT01267201|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110353936|NCT01267201|Prednisolone|prednisolone|mesh-list
110353937|NCT01267201|Prednisolone acetate|prednisolone acetate|mesh-list
110353938|NCT01267201|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110353939|NCT01267201|Prednisolone phosphate|prednisolone phosphate|mesh-list
110353940|NCT01267201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110353941|NCT01267201|Antiemetics|antiemetics|mesh-ancestor
110353942|NCT01267201|Autonomic Agents|autonomic agents|mesh-ancestor
110353943|NCT01267201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110353944|NCT01267201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353946|NCT01267201|Glucocorticoids|glucocorticoids|mesh-ancestor
110353947|NCT01267201|Hormones|hormones|mesh-ancestor
110353948|NCT01267201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110353949|NCT01267201|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110353950|NCT01267201|Protective Agents|protective agents|mesh-ancestor
110353951|NCT01267201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110353952|NCT01267201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110353953|NCT03778931|Fulvestrant|fulvestrant|mesh-list
110353954|NCT03778931|Anastrozole|anastrozole|mesh-list
110353955|NCT03778931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110353956|NCT03778931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110353957|NCT03778931|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110353958|NCT03778931|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110353959|NCT03778931|Hormone Antagonists|hormone antagonists|mesh-ancestor
110353960|NCT03778931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110353961|NCT03778931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353962|NCT03778931|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110353963|NCT03778931|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110353964|NCT03778931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110353965|NCT03778931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110353967|NCT03736616|Rituximab|rituximab|mesh-list
110353968|NCT03736616|Carboplatin|carboplatin|mesh-list
110353969|NCT03736616|Etoposide|etoposide|mesh-list
110353970|NCT03736616|Melphalan|melphalan|mesh-list
110353971|NCT03736616|Ifosfamide|ifosfamide|mesh-list
110353972|NCT03736616|Carmustine|carmustine|mesh-list
110353973|NCT03736616|Acalabrutinib|acalabrutinib|mesh-list
110353974|NCT03736616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110353975|NCT03736616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110353976|NCT03736616|Immunologic Factors|immunologic factors|mesh-ancestor
110353977|NCT03736616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353978|NCT03736616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110353979|NCT03736616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110353980|NCT03736616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110353981|NCT03736616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110353982|NCT03736616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110353983|NCT03736616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110353984|NCT03736616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110353985|NCT03736616|Antimetabolites|antimetabolites|mesh-ancestor
110353986|NCT03736616|Antiviral Agents|antiviral agents|mesh-ancestor
110353987|NCT03736616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110353988|NCT03736616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110353989|NCT03736616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110353990|NCT03736616|Alkylating Agents|alkylating agents|mesh-ancestor
110353991|NCT03736616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110353992|NCT03718403|Theophylline|theophylline|mesh-list
110353993|NCT03718403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110353994|NCT03718403|Autonomic Agents|autonomic agents|mesh-ancestor
110353995|NCT03718403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110353996|NCT03718403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353997|NCT03718403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110353998|NCT03718403|Respiratory System Agents|respiratory system agents|mesh-ancestor
110353999|NCT03718403|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110354000|NCT03718403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110354001|NCT03718403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110354002|NCT03718403|Vasodilator Agents|vasodilator agents|mesh-ancestor
110354003|NCT03718403|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110354004|NCT03718403|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110354005|NCT03718403|Purinergic Agents|purinergic agents|mesh-ancestor
110354006|NCT03718403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110354008|NCT00537966|Darunavir|darunavir|mesh-list
110354010|NCT00537966|Lamivudine|lamivudine|mesh-list
110354011|NCT00537966|Emtricitabine|emtricitabine|mesh-list
110354012|NCT00537966|Raltegravir Potassium|raltegravir potassium|mesh-list
110354013|NCT00537966|Dolutegravir|dolutegravir|mesh-list
110354014|NCT00537966|Abacavir|abacavir|mesh-list
110354015|NCT00537966|Cobicistat|cobicistat|mesh-list
110354016|NCT00537966|Rilpivirine|rilpivirine|mesh-list
110354017|NCT00537966|Elvitegravir|elvitegravir|mesh-list
110354018|NCT00537966|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110354019|NCT00537966|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110354020|NCT00537966|Protease Inhibitors|protease inhibitors|mesh-ancestor
110354021|NCT00537966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110354022|NCT00537966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110354023|NCT00537966|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110354024|NCT00537966|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110354025|NCT00537966|Antiviral Agents|antiviral agents|mesh-ancestor
110354026|NCT00537966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110354027|NCT00537966|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110354028|NCT00537966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110354029|NCT00537966|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110354030|NCT00537966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110354031|NCT00537966|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110354032|NCT00537966|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110354033|NCT01266967|Dabrafenib|dabrafenib|mesh-list
110354034|NCT01266967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110354035|NCT01266967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110354036|NCT01266967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110354037|NCT01266967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110354038|NCT03615326|Pembrolizumab|pembrolizumab|mesh-list
110354039|NCT03615326|Capecitabine|capecitabine|mesh-list
110354040|NCT03615326|Oxaliplatin|oxaliplatin|mesh-list
110354041|NCT03615326|Trastuzumab|trastuzumab|mesh-list
110354042|NCT03615326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110354043|NCT03615326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110354044|NCT03615326|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110354045|NCT03615326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110354046|NCT03615326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110354047|NCT03615326|Antimetabolites|antimetabolites|mesh-ancestor
110354048|NCT00538005|Bevacizumab|bevacizumab|mesh-list
110354049|NCT00538005|Oxaliplatin|oxaliplatin|mesh-list
110354050|NCT00538005|Sorafenib|sorafenib|mesh-list
110354051|NCT00538005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110354052|NCT00538005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110354053|NCT00538005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110354054|NCT00538005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110354055|NCT00538005|Growth Substances|growth substances|mesh-ancestor
110354056|NCT00538005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110354057|NCT00538005|Growth Inhibitors|growth inhibitors|mesh-ancestor
110354058|NCT00538005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110354059|NCT00538005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110354060|NCT00538005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110354061|NCT03610412|Magnesium Oxide|magnesium oxide|mesh-list
110354062|NCT03610412|Antacids|antacids|mesh-ancestor
110354063|NCT03610412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110354064|NCT03610412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110354065|NCT00538044|Simvastatin|simvastatin|mesh-list
110354066|NCT00538044|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110354067|NCT00538044|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110354068|NCT00538044|Antimetabolites|antimetabolites|mesh-ancestor
110354069|NCT00538044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110354070|NCT00538044|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110354071|NCT00538044|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110354072|NCT00538044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110354073|NCT00545493|Tacrolimus|tacrolimus|mesh-list
110354074|NCT00545493|Immunoglobulins|immunoglobulins|mesh-list
110354075|NCT00545493|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110354076|NCT00545493|Antibodies|antibodies|mesh-list
110354077|NCT00545493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110354079|NCT00545493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110354080|NCT00545493|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110354081|NCT00545493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110354082|NCT00545493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110354083|NCT01266460|Vaccines|vaccines|mesh-list
110354084|NCT01266460|Immunologic Factors|immunologic factors|mesh-ancestor
110354085|NCT01266460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110354086|NCT05119257|Antibodies|antibodies|mesh-list
110354087|NCT05119257|Antibodies, Bispecific|antibodies, bispecific|mesh-list
110354088|NCT05119257|Immunologic Factors|immunologic factors|mesh-ancestor
110354089|NCT05119257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110354090|NCT01266265|Treprostinil|treprostinil|mesh-list
110354091|NCT01266265|Bosentan|bosentan|mesh-list
110354092|NCT01266265|Ambrisentan|ambrisentan|mesh-list
110354093|NCT01266265|Epoprostenol|epoprostenol|mesh-list
110354094|NCT01266265|Sildenafil Citrate|sildenafil citrate|mesh-list
110354095|NCT01266265|Tadalafil|tadalafil|mesh-list
110354096|NCT01266265|Iloprost|iloprost|mesh-list
110354097|NCT01266265|Tezosentan|tezosentan|mesh-list
110354098|NCT01266265|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
110354099|NCT01266265|Vasodilator Agents|vasodilator agents|mesh-ancestor
110354100|NCT01266265|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110354101|NCT01266265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110354102|NCT01266265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110354103|NCT01266265|Urological Agents|urological agents|mesh-ancestor
110354104|NCT01266265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110354105|NCT01266265|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110354106|NCT01266265|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110354107|NCT05112549|Nivolumab|nivolumab|mesh-list
110225448|NCT05962151|Nalbuphine|nalbuphine|mesh-list
110354108|NCT05112549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110354109|NCT05112549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110354110|NCT05112549|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110354111|NCT05112549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110354112|NCT03268382|Doxorubicin|doxorubicin|mesh-list
110354113|NCT03268382|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110354114|NCT03268382|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110354115|NCT03268382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110354116|NCT03268382|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110354117|NCT03268382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110354118|NCT03268382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110354119|NCT03268382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110354120|NCT01266148|Cyclosporine|cyclosporine|mesh-list
110354121|NCT01266148|Mycophenolic Acid|mycophenolic acid|mesh-list
110354123|NCT01266148|Cyclosporins|cyclosporins|mesh-list
110354124|NCT01266148|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110354125|NCT01266148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110354126|NCT01266148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110354127|NCT01266148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110354128|NCT01266148|Immunologic Factors|immunologic factors|mesh-ancestor
110354129|NCT01266148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110354130|NCT01266148|Antifungal Agents|antifungal agents|mesh-ancestor
110354131|NCT01266148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110354132|NCT01266148|Dermatologic Agents|dermatologic agents|mesh-ancestor
110354133|NCT01266148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110354135|NCT01266148|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110354136|NCT01266148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110354137|NCT01266148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110354138|NCT01266148|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110354139|NCT01266148|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110354140|NCT01266148|Antitubercular Agents|antitubercular agents|mesh-ancestor
110354141|NCT01266148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110354142|NCT00538239|Sirolimus|sirolimus|mesh-list
110354143|NCT00538239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110354144|NCT00538239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110354145|NCT00538239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110354146|NCT00538239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110354147|NCT00538239|Antifungal Agents|antifungal agents|mesh-ancestor
110354148|NCT00538239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110354149|NCT00538239|Immunologic Factors|immunologic factors|mesh-ancestor
110354150|NCT00538239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110354151|NCT00538317|Tirofiban|tirofiban|mesh-list
110354152|NCT00538317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110354153|NCT00538317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110354154|NCT00538317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110354155|NCT00538317|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110354156|NCT01265953|Sulforaphane|sulforaphane|mesh-list
110354157|NCT01265953|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110176203|NCT00079612|Sorafenib|sorafenib|mesh-list
110354158|NCT01265953|Protective Agents|protective agents|mesh-ancestor
110354159|NCT01265953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110354160|NCT01265953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110354161|NCT01265875|Secretin|secretin|mesh-list
110354162|NCT01265875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110354163|NCT01265875|Hormones|hormones|mesh-ancestor
110354164|NCT01265875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110354165|NCT01265875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110354166|NCT00538395|Cyclophosphamide|cyclophosphamide|mesh-list
110354167|NCT00538395|Doxorubicin|doxorubicin|mesh-list
110354168|NCT00538395|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110354169|NCT00538395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110354170|NCT00538395|Immunologic Factors|immunologic factors|mesh-ancestor
110354171|NCT00538395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110354172|NCT00538395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110354173|NCT00538395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110354174|NCT00538395|Alkylating Agents|alkylating agents|mesh-ancestor
110354175|NCT00538395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110354176|NCT00538395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110354177|NCT00538395|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110354178|NCT00538395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110354179|NCT00538395|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110354180|NCT00538395|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110354181|NCT00538395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110354182|NCT01265563|Acetylcysteine|acetylcysteine|mesh-list
110354183|NCT01265563|Silybin|silybin|mesh-list
110354184|NCT01265563|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110354185|NCT01265563|Antiviral Agents|antiviral agents|mesh-ancestor
110354186|NCT01265563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110354187|NCT01265563|Expectorants|expectorants|mesh-ancestor
110354188|NCT01265563|Respiratory System Agents|respiratory system agents|mesh-ancestor
110354190|NCT01265563|Antioxidants|antioxidants|mesh-ancestor
110354191|NCT01265563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110354192|NCT01265563|Protective Agents|protective agents|mesh-ancestor
110354193|NCT01265563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110354194|NCT01265563|Antidotes|antidotes|mesh-ancestor
110354195|NCT01265563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110354196|NCT01265563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110354197|NCT01265056|Gabapentin|gabapentin|mesh-list
110354198|NCT01265056|Analgesics|analgesics|mesh-ancestor
110354199|NCT01265056|Sensory System Agents|sensory system agents|mesh-ancestor
110354200|NCT01265056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110354201|NCT01265056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110354202|NCT01265056|Anticonvulsants|anticonvulsants|mesh-ancestor
110354203|NCT01265056|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110354204|NCT01265056|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110354205|NCT01265056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110354206|NCT01265056|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110354207|NCT01265056|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110354208|NCT01265056|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110354209|NCT01265056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110354210|NCT01265056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110354211|NCT01265056|Antimanic Agents|antimanic agents|mesh-ancestor
110354212|NCT02942498|Vitamins|vitamins|mesh-list
110354213|NCT02942498|Vitamin E|vitamin e|mesh-list
110354214|NCT02942498|Micronutrients|micronutrients|mesh-ancestor
110354215|NCT02942498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110354216|NCT02942498|Antioxidants|antioxidants|mesh-ancestor
110354217|NCT02942498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110354218|NCT02942498|Protective Agents|protective agents|mesh-ancestor
110354219|NCT00545961|Amoxicillin|amoxicillin|mesh-list
110354220|NCT00545961|Clavulanic Acid|clavulanic acid|mesh-list
110354221|NCT00545961|Clavulanic Acids|clavulanic acids|mesh-list
110354222|NCT00545961|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110354223|NCT00545961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110354224|NCT00545961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110354225|NCT00545961|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110354227|NCT00545961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110354228|NCT01264939|Omalizumab|omalizumab|mesh-list
110354229|NCT01264939|Diphenhydramine|diphenhydramine|mesh-list
110354230|NCT01264939|Promethazine|promethazine|mesh-list
110354231|NCT01264939|Leukotriene Antagonists|leukotriene antagonists|mesh-list
110354232|NCT01264939|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
110354233|NCT01264939|Histamine Antagonists|histamine antagonists|mesh-list
110354234|NCT01264939|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110354235|NCT01264939|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110354236|NCT01264939|Respiratory System Agents|respiratory system agents|mesh-ancestor
110354237|NCT01264939|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110354238|NCT01264939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110354239|NCT01264939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110354240|NCT01264939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110354241|NCT01264939|Anesthetics, Local|anesthetics, local|mesh-ancestor
110354243|NCT01264939|Sensory System Agents|sensory system agents|mesh-ancestor
110354244|NCT01264939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110354245|NCT01264939|Antiemetics|antiemetics|mesh-ancestor
110354246|NCT01264939|Autonomic Agents|autonomic agents|mesh-ancestor
110354247|NCT01264939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110354248|NCT01264939|Histamine Agents|histamine agents|mesh-ancestor
110354249|NCT01264939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110354250|NCT01264939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110354251|NCT01264939|Antipruritics|antipruritics|mesh-ancestor
110354252|NCT01264939|Dermatologic Agents|dermatologic agents|mesh-ancestor
110354253|NCT01264939|Hormone Antagonists|hormone antagonists|mesh-ancestor
110354254|NCT01264939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110354255|NCT02889367|Odalasvir|odalasvir|mesh-list
110354256|NCT02889367|Antiviral Agents|antiviral agents|mesh-ancestor
110354257|NCT02889367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110354258|NCT00546039|Genistein|genistein|mesh-list
110354259|NCT00546039|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110354260|NCT00546039|Protective Agents|protective agents|mesh-ancestor
110354261|NCT00546039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110354262|NCT00546039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110354263|NCT00546039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110354264|NCT00546039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110354265|NCT00546039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110354266|NCT00546039|Phytoestrogens|phytoestrogens|mesh-ancestor
110354267|NCT00546039|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110354268|NCT00546039|Estrogens|estrogens|mesh-ancestor
110354269|NCT00546039|Hormones|hormones|mesh-ancestor
110354270|NCT00546039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110354271|NCT01264081|Lapatinib|lapatinib|mesh-list
110354272|NCT01264081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110354273|NCT01264081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110354274|NCT01264081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110354275|NCT01264081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110354276|NCT02711969|Apatinib|apatinib|mesh-list
110354277|NCT02711969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110354278|NCT02711969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110354279|NCT02711969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110354280|NCT02711969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110354281|NCT01263925|Pentoxifylline|pentoxifylline|mesh-list
110354282|NCT01263925|Alprostadil|alprostadil|mesh-list
110354283|NCT01263925|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110354284|NCT01263925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110354285|NCT01263925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110354286|NCT01263925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110354287|NCT01263925|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110354288|NCT01263925|Protective Agents|protective agents|mesh-ancestor
110354289|NCT01263925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110354291|NCT01263925|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110354292|NCT01263925|Antioxidants|antioxidants|mesh-ancestor
110354293|NCT01263925|Urological Agents|urological agents|mesh-ancestor
110354294|NCT04323631|Hydroxychloroquine|hydroxychloroquine|mesh-list
110354295|NCT04323631|Antimalarials|antimalarials|mesh-ancestor
110354296|NCT04323631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110354297|NCT04323631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110354298|NCT04323631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110354299|NCT04323631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110354300|NCT04323631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110354301|NCT04323631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110354302|NCT00546234|Tiotropium Bromide|tiotropium bromide|mesh-list
110354303|NCT00546234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110354304|NCT00546234|Autonomic Agents|autonomic agents|mesh-ancestor
110354305|NCT00546234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110354306|NCT00546234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110354307|NCT00546234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110354308|NCT00546234|Respiratory System Agents|respiratory system agents|mesh-ancestor
110354309|NCT00546234|Parasympatholytics|parasympatholytics|mesh-ancestor
110354310|NCT00546234|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110354311|NCT00546234|Cholinergic Agents|cholinergic agents|mesh-ancestor
110354312|NCT00546234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110354313|NCT00546234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110354314|NCT02623439|Cyclophosphamide|cyclophosphamide|mesh-list
110354315|NCT02623439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110354316|NCT02623439|Immunologic Factors|immunologic factors|mesh-ancestor
110354317|NCT02623439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110354318|NCT02623439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110354319|NCT02623439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110354320|NCT02623439|Alkylating Agents|alkylating agents|mesh-ancestor
110354321|NCT02623439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110354322|NCT02623439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110354323|NCT02623439|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110354324|NCT00539331|Paclitaxel|paclitaxel|mesh-list
110354325|NCT00539331|Carboplatin|carboplatin|mesh-list
110354326|NCT00539331|Cediranib|cediranib|mesh-list
110354327|NCT00539331|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110354328|NCT00539331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110354329|NCT00539331|Tubulin Modulators|tubulin modulators|mesh-ancestor
110354330|NCT00539331|Antimitotic Agents|antimitotic agents|mesh-ancestor
110354331|NCT00539331|Mitosis Modulators|mitosis modulators|mesh-ancestor
110354332|NCT00539331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110354333|NCT00539331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110354334|NCT00539331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110354335|NCT02236013|Cytarabine|cytarabine|mesh-list
110354336|NCT02236013|Daunorubicin|daunorubicin|mesh-list
110354337|NCT02236013|Idarubicin|idarubicin|mesh-list
110354338|NCT02236013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110354339|NCT02236013|Antimetabolites|antimetabolites|mesh-ancestor
110354340|NCT02236013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110354341|NCT02236013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110354342|NCT02236013|Antiviral Agents|antiviral agents|mesh-ancestor
110354344|NCT02236013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110354345|NCT02236013|Immunologic Factors|immunologic factors|mesh-ancestor
110354346|NCT02236013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110354347|NCT02236013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110354348|NCT02236013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110354349|NCT02236013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110354350|NCT02236013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110354351|NCT00539409|Insulin|insulin|mesh-list
110354352|NCT00539409|Insulin Aspart|insulin aspart|mesh-list
110354353|NCT00539409|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110354354|NCT00539409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110354355|NCT00539409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110354356|NCT01263691|Vaccines|vaccines|mesh-list
110354357|NCT01263691|Immunologic Factors|immunologic factors|mesh-ancestor
110354358|NCT01263691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110354359|NCT02178410|Vitamin D|vitamin d|mesh-list
110354360|NCT02178410|Ergocalciferols|ergocalciferols|mesh-list
110354361|NCT02178410|Cholecalciferol|cholecalciferol|mesh-list
110354362|NCT02178410|Vitamins|vitamins|mesh-list
110354363|NCT02178410|Micronutrients|micronutrients|mesh-ancestor
110354364|NCT02178410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110354365|NCT02178410|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110354366|NCT02178410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110354367|NCT00539448|Insulin|insulin|mesh-list
110354368|NCT00539448|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110354369|NCT00539448|Insulin Glargine|insulin glargine|mesh-list
110354370|NCT00539448|Insulin glulisine|insulin glulisine|mesh-list
110354371|NCT00539448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110354372|NCT00539448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110354373|NCT05541484|Dapagliflozin|dapagliflozin|mesh-list
110354374|NCT05541484|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
110354375|NCT05541484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110354376|NCT05541484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110354377|NCT05541484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110354378|NCT01808456|Vaccines|vaccines|mesh-list
110354379|NCT01808456|Immunologic Factors|immunologic factors|mesh-ancestor
110354380|NCT01808456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110354381|NCT01715714|Atorvastatin|atorvastatin|mesh-list
110354382|NCT01715714|Simvastatin|simvastatin|mesh-list
110354383|NCT01715714|Pravastatin|pravastatin|mesh-list
110354384|NCT01715714|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110354385|NCT01715714|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110354386|NCT01715714|Antimetabolites|antimetabolites|mesh-ancestor
110354387|NCT01715714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110354388|NCT01715714|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110354389|NCT01715714|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110354390|NCT01715714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110354391|NCT01540253|Docetaxel|docetaxel|mesh-list
110354392|NCT01540253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110354393|NCT01540253|Tubulin Modulators|tubulin modulators|mesh-ancestor
110354394|NCT01540253|Antimitotic Agents|antimitotic agents|mesh-ancestor
110354395|NCT01540253|Mitosis Modulators|mitosis modulators|mesh-ancestor
110354396|NCT01540253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110354397|NCT01497392|Gemcitabine|gemcitabine|mesh-list
110354398|NCT01497392|Capecitabine|capecitabine|mesh-list
110354399|NCT01497392|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
110354400|NCT01497392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110354401|NCT01497392|Antimetabolites|antimetabolites|mesh-ancestor
110354402|NCT01497392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110354403|NCT01497392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110354404|NCT01497392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110354405|NCT01497392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110354406|NCT01310192|Choline|choline|mesh-list
110354408|NCT01310192|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110354409|NCT01310192|Antimetabolites|antimetabolites|mesh-ancestor
110354410|NCT01310192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110354411|NCT01310192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110354412|NCT01310192|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110354413|NCT01310192|Nootropic Agents|nootropic agents|mesh-ancestor
110354414|NCT00539565|Prednisolone|prednisolone|mesh-list
110354415|NCT00539565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110354416|NCT00539565|Glucocorticoids|glucocorticoids|mesh-ancestor
110354417|NCT00539565|Hormones|hormones|mesh-ancestor
110354418|NCT00539565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110354419|NCT00539565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110354420|NCT00539565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110354421|NCT00539565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110354422|NCT00539799|Prednisolone|prednisolone|mesh-list
110354423|NCT00539799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110354424|NCT00539799|Glucocorticoids|glucocorticoids|mesh-ancestor
110354425|NCT00539799|Hormones|hormones|mesh-ancestor
110354426|NCT00539799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110354427|NCT00539799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110354428|NCT00539799|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110354429|NCT00539799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110354430|NCT00945152|Vancomycin|vancomycin|mesh-list
110354431|NCT00945152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110176242|NCT00079924|Teriparatide|teriparatide|mesh-list
110354432|NCT00945152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110354433|NCT00546507|Celecoxib|celecoxib|mesh-list
110354434|NCT00546507|Diclofenac|diclofenac|mesh-list
110354435|NCT00546507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110354436|NCT00546507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110354437|NCT00546507|Analgesics|analgesics|mesh-ancestor
110354438|NCT00546507|Sensory System Agents|sensory system agents|mesh-ancestor
110354439|NCT00546507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110354440|NCT00546507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110354441|NCT00546507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110354442|NCT00546507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110354443|NCT00546507|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110354444|NCT00546507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110354445|NCT00546507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110354446|NCT00546507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110354447|NCT00546546|Methotrexate|methotrexate|mesh-list
110354448|NCT00546546|Azathioprine|azathioprine|mesh-list
110354449|NCT00546546|Immunosuppressive Agents|immunosuppressive agents|mesh-list
110354450|NCT00546546|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110354451|NCT00546546|Abortifacient Agents|abortifacient agents|mesh-ancestor
110354452|NCT00546546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110354453|NCT00546546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110354454|NCT00546546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110354455|NCT00546546|Antimetabolites|antimetabolites|mesh-ancestor
110354456|NCT00546546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110354457|NCT00546546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110354458|NCT00546546|Dermatologic Agents|dermatologic agents|mesh-ancestor
110354459|NCT00546546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110354460|NCT00546546|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110354461|NCT00546546|Immunologic Factors|immunologic factors|mesh-ancestor
110354462|NCT00546546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110354463|NCT00546546|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110354464|NCT00659711|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110354466|NCT00659711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110354467|NCT00659711|Incretins|incretins|mesh-ancestor
110354468|NCT00659711|Hormones|hormones|mesh-ancestor
110354469|NCT00659711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110354470|NCT00659711|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110354471|NCT00659711|Protease Inhibitors|protease inhibitors|mesh-ancestor
110354472|NCT00659711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110354473|NCT00659711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110354474|NCT02581007|Cyclophosphamide|cyclophosphamide|mesh-list
110354475|NCT02581007|Melphalan|melphalan|mesh-list
110354476|NCT02581007|Fludarabine|fludarabine|mesh-list
110354477|NCT02581007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110354478|NCT02581007|Immunologic Factors|immunologic factors|mesh-ancestor
110354479|NCT02581007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110354480|NCT02581007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110354481|NCT02581007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110354482|NCT02581007|Alkylating Agents|alkylating agents|mesh-ancestor
110354483|NCT02581007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110354484|NCT02581007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110354485|NCT02581007|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110354486|NCT00546741|Metformin|metformin|mesh-list
110354487|NCT00546741|Dapagliflozin|dapagliflozin|mesh-list
110354488|NCT00546741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110176252|NCT00079963|Vitamins|vitamins|mesh-list
110354489|NCT00546741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110354490|NCT00546741|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110354491|NCT00546741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110354492|NCT02540330|Fulvestrant|fulvestrant|mesh-list
110354493|NCT02540330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110354494|NCT02540330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110354495|NCT02540330|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110354496|NCT02540330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110354497|NCT02540330|Hormone Antagonists|hormone antagonists|mesh-ancestor
110354498|NCT02540330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110354499|NCT02540330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110354500|NCT02467361|Pembrolizumab|pembrolizumab|mesh-list
110354501|NCT02467361|Nivolumab|nivolumab|mesh-list
110354502|NCT02467361|Ipilimumab|ipilimumab|mesh-list
110354503|NCT02467361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110354504|NCT02467361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110354505|NCT02467361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110354506|NCT02467361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110354507|NCT00546936|Ranibizumab|ranibizumab|mesh-list
110354508|NCT00546936|Verteporfin|verteporfin|mesh-list
110354509|NCT00546936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110354510|NCT00546936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110354511|NCT00546936|Growth Substances|growth substances|mesh-ancestor
110354512|NCT00546936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110354513|NCT00546936|Growth Inhibitors|growth inhibitors|mesh-ancestor
110354514|NCT00546936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110354515|NCT00546936|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110354516|NCT00546936|Dermatologic Agents|dermatologic agents|mesh-ancestor
110354517|NCT02231723|Leucovorin|leucovorin|mesh-list
110354518|NCT02231723|Paclitaxel|paclitaxel|mesh-list
110354519|NCT02231723|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110354520|NCT02231723|Gemcitabine|gemcitabine|mesh-list
110354521|NCT02231723|Fluorouracil|fluorouracil|mesh-list
110354522|NCT02231723|Oxaliplatin|oxaliplatin|mesh-list
110354523|NCT02231723|Irinotecan|irinotecan|mesh-list
110354524|NCT02231723|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110354525|NCT02231723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110354527|NCT02231723|Antimitotic Agents|antimitotic agents|mesh-ancestor
110354528|NCT02231723|Mitosis Modulators|mitosis modulators|mesh-ancestor
110354529|NCT02231723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110354530|NCT02231723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110354531|NCT02231723|Antimetabolites|antimetabolites|mesh-ancestor
110354532|NCT02231723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110354533|NCT02231723|Immunologic Factors|immunologic factors|mesh-ancestor
110354534|NCT02231723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110354535|NCT02231723|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110354536|NCT02231723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110354537|NCT02231723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110354538|NCT02231723|Antidotes|antidotes|mesh-ancestor
110354539|NCT02231723|Protective Agents|protective agents|mesh-ancestor
110354540|NCT02231723|Vitamin B Complex|vitamin b complex|mesh-ancestor
110354541|NCT02231723|Vitamins|vitamins|mesh-ancestor
110354542|NCT02231723|Micronutrients|micronutrients|mesh-ancestor
110354543|NCT01263496|Alogliptin|alogliptin|mesh-list
110354544|NCT01263496|Voglibose|voglibose|mesh-list
110354545|NCT01263496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110354546|NCT01263496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110354547|NCT01263496|Incretins|incretins|mesh-ancestor
110354548|NCT01263496|Hormones|hormones|mesh-ancestor
110354549|NCT01263496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110354550|NCT01263496|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110354551|NCT01263496|Protease Inhibitors|protease inhibitors|mesh-ancestor
110354552|NCT01263496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110354553|NCT01263496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110354554|NCT01263496|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110354555|NCT04681937|Methylprednisolone|methylprednisolone|mesh-list
110354556|NCT04681937|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110354557|NCT04681937|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110354558|NCT04681937|Prednisolone|prednisolone|mesh-list
110354559|NCT04681937|Prednisolone acetate|prednisolone acetate|mesh-list
110354560|NCT04681937|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110354561|NCT04681937|Prednisolone phosphate|prednisolone phosphate|mesh-list
110354562|NCT04681937|Hyaluronic Acid|hyaluronic acid|mesh-list
110354563|NCT04681937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110354564|NCT04681937|Antiemetics|antiemetics|mesh-ancestor
110354565|NCT04681937|Autonomic Agents|autonomic agents|mesh-ancestor
110354566|NCT04681937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110354567|NCT04681937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110354568|NCT04681937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110354570|NCT04681937|Hormones|hormones|mesh-ancestor
110354571|NCT04681937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110354572|NCT04681937|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110354573|NCT04681937|Protective Agents|protective agents|mesh-ancestor
110354574|NCT04681937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110354575|NCT04681937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110354576|NCT04681937|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110354577|NCT04681937|Immunologic Factors|immunologic factors|mesh-ancestor
110354578|NCT04681937|Viscosupplements|viscosupplements|mesh-ancestor
110354579|NCT00547053|Amiloride|amiloride|mesh-list
110354580|NCT00547053|Diuretics|diuretics|mesh-ancestor
110354581|NCT00547053|Natriuretic Agents|natriuretic agents|mesh-ancestor
110354582|NCT00547053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110354583|NCT00547053|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
110354584|NCT00547053|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110354585|NCT00547053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110354586|NCT00547053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110354587|NCT00547053|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
110354588|NCT00547053|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110354589|NCT00547092|Sildenafil Citrate|sildenafil citrate|mesh-list
110354590|NCT00547092|Tadalafil|tadalafil|mesh-list
110354591|NCT00547092|Vasodilator Agents|vasodilator agents|mesh-ancestor
110354592|NCT00547092|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110354593|NCT00547092|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110354594|NCT00547092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110354595|NCT00547092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110354596|NCT00547092|Urological Agents|urological agents|mesh-ancestor
110354597|NCT00547131|Temozolomide|temozolomide|mesh-list
110354598|NCT00547131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110354599|NCT00547131|Alkylating Agents|alkylating agents|mesh-ancestor
110354600|NCT00547131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110354601|NCT00547131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110354602|NCT01964495|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110354603|NCT01964495|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110354604|NCT01964495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110354605|NCT01964495|Antitubercular Agents|antitubercular agents|mesh-ancestor
110354606|NCT00547170|Doxycycline|doxycycline|mesh-list
110354607|NCT00547170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110354608|NCT00547170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110354609|NCT00547170|Antimalarials|antimalarials|mesh-ancestor
110354610|NCT00547170|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110354611|NCT00547170|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110354612|NCT00547209|Nitrous Oxide|nitrous oxide|mesh-list
110354613|NCT00547209|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110354614|NCT00547209|Anesthetics, General|anesthetics, general|mesh-ancestor
110354615|NCT00547209|Anesthetics|anesthetics|mesh-ancestor
110354616|NCT00547209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110032447|NCT04975269|Anticonvulsants|anticonvulsants|mesh-ancestor
110354617|NCT00547209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110354618|NCT00547209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110354619|NCT00547209|Analgesics|analgesics|mesh-ancestor
110354620|NCT00547209|Sensory System Agents|sensory system agents|mesh-ancestor
110354621|NCT00547209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110354622|NCT00547287|Sildenafil Citrate|sildenafil citrate|mesh-list
110354624|NCT00547287|Vasodilator Agents|vasodilator agents|mesh-ancestor
110354625|NCT00547287|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110354626|NCT00547287|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110354627|NCT00547287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110354628|NCT00547287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110354629|NCT00547287|Urological Agents|urological agents|mesh-ancestor
110354630|NCT01263106|Theophylline|theophylline|mesh-list
110354631|NCT01263106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110354632|NCT01263106|Autonomic Agents|autonomic agents|mesh-ancestor
110354633|NCT01263106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110354634|NCT01263106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110354635|NCT01263106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110354636|NCT01263106|Respiratory System Agents|respiratory system agents|mesh-ancestor
110354637|NCT01263106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110354638|NCT01263106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110354639|NCT01263106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110354640|NCT01263106|Vasodilator Agents|vasodilator agents|mesh-ancestor
110354641|NCT01263106|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110354642|NCT01263106|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110354643|NCT01263106|Purinergic Agents|purinergic agents|mesh-ancestor
110354644|NCT01263106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110354645|NCT01263028|Ergocalciferols|ergocalciferols|mesh-list
110354646|NCT01263028|Vitamin D|vitamin d|mesh-list
110354647|NCT01263028|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110354648|NCT01263028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110354649|NCT01263028|Vitamins|vitamins|mesh-ancestor
110354650|NCT01263028|Micronutrients|micronutrients|mesh-ancestor
110354651|NCT01263028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110354652|NCT00547443|Paclitaxel|paclitaxel|mesh-list
110354653|NCT00547443|Carboplatin|carboplatin|mesh-list
110354654|NCT00547443|Sorafenib|sorafenib|mesh-list
110354655|NCT00547443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110354656|NCT00547443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110354657|NCT00547443|Tubulin Modulators|tubulin modulators|mesh-ancestor
110354658|NCT00547443|Antimitotic Agents|antimitotic agents|mesh-ancestor
110354659|NCT00547443|Mitosis Modulators|mitosis modulators|mesh-ancestor
110176295|NCT00080080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110354660|NCT00547443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110354661|NCT00547443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110354662|NCT00547443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110354663|NCT00547560|Begacestat|begacestat|mesh-list
110354665|NCT00547560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110354666|NCT00547560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110354667|NCT00547599|Tadalafil|tadalafil|mesh-list
110354668|NCT00547599|Vasodilator Agents|vasodilator agents|mesh-ancestor
110354669|NCT00547599|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110354670|NCT00547599|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110354671|NCT00547599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110225449|NCT05962151|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110354672|NCT00547599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110354673|NCT00547599|Urological Agents|urological agents|mesh-ancestor
110354674|NCT02908763|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110354675|NCT02908763|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110354676|NCT02908763|Antiviral Agents|antiviral agents|mesh-ancestor
110354677|NCT02908763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110354678|NCT02908412|Bupivacaine|bupivacaine|mesh-list
110354679|NCT02908412|Anesthetics, Local|anesthetics, local|mesh-ancestor
110354680|NCT02908412|Anesthetics|anesthetics|mesh-ancestor
110354681|NCT02908412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110354682|NCT02908412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110354683|NCT02908412|Sensory System Agents|sensory system agents|mesh-ancestor
110354684|NCT02908412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110354685|NCT02908295|Misoprostol|misoprostol|mesh-list
110354686|NCT02908295|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110354687|NCT02908295|Abortifacient Agents|abortifacient agents|mesh-ancestor
110354688|NCT02908295|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110354689|NCT02908295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110354690|NCT02908295|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110354691|NCT02908295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110354692|NCT02908295|Oxytocics|oxytocics|mesh-ancestor
110354693|NCT03809442|Dexamethasone|dexamethasone|mesh-list
110354694|NCT03809442|Midazolam|midazolam|mesh-list
110354695|NCT03809442|Dexmedetomidine|dexmedetomidine|mesh-list
110354696|NCT03809442|Ketamine|ketamine|mesh-list
110354697|NCT03809442|Tramadol|tramadol|mesh-list
110354698|NCT03809442|Ropivacaine|ropivacaine|mesh-list
110354699|NCT03809442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110354700|NCT03809442|Antiemetics|antiemetics|mesh-ancestor
110354701|NCT03809442|Autonomic Agents|autonomic agents|mesh-ancestor
110354702|NCT03809442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110354703|NCT03809442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110354704|NCT03809442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110354705|NCT03809442|Glucocorticoids|glucocorticoids|mesh-ancestor
110354706|NCT03809442|Hormones|hormones|mesh-ancestor
110354707|NCT03809442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110354708|NCT03809442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110354709|NCT03809442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110354710|NCT03809442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110354711|NCT03809442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110354712|NCT03809442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110354713|NCT03809442|Analgesics|analgesics|mesh-ancestor
110354714|NCT03809442|Sensory System Agents|sensory system agents|mesh-ancestor
110354715|NCT03809442|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110354716|NCT03809442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110354717|NCT03809442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110354718|NCT03809442|Adrenergic Agents|adrenergic agents|mesh-ancestor
110354719|NCT03809442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110354720|NCT03809442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110354721|NCT03809442|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110354722|NCT03809442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110354723|NCT03809442|Anesthetics, General|anesthetics, general|mesh-ancestor
110354724|NCT03809442|Anesthetics|anesthetics|mesh-ancestor
110354725|NCT03809442|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110354726|NCT03809442|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110354727|NCT03809442|Anesthetics, Local|anesthetics, local|mesh-ancestor
110354728|NCT03809442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110176301|NCT00080158|Citalopram|citalopram|mesh-list
110354729|NCT03809442|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110354730|NCT03809442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110354731|NCT03809442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110354732|NCT03809442|GABA Modulators|gaba modulators|mesh-ancestor
110354734|NCT03809442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110354735|NCT03809442|Narcotics|narcotics|mesh-ancestor
110354736|NCT00534729|Carboplatin|carboplatin|mesh-list
110354737|NCT00534729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110354738|NCT00547989|Bupivacaine|bupivacaine|mesh-list
110354739|NCT00547989|Ropivacaine|ropivacaine|mesh-list
110354740|NCT00547989|Anesthetics, Local|anesthetics, local|mesh-ancestor
110354741|NCT00547989|Anesthetics|anesthetics|mesh-ancestor
110354742|NCT00547989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110354743|NCT00547989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110354744|NCT00547989|Sensory System Agents|sensory system agents|mesh-ancestor
110354745|NCT00547989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110354746|NCT00534807|Rifampin|rifampin|mesh-list
110354747|NCT00534807|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110354748|NCT00534807|Antitubercular Agents|antitubercular agents|mesh-ancestor
110354749|NCT00534807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110354750|NCT00534807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110354751|NCT00534807|Leprostatic Agents|leprostatic agents|mesh-ancestor
110354752|NCT00534807|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110354753|NCT00534807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110354754|NCT00534807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110354755|NCT00534807|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110354756|NCT00534807|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110354757|NCT00534807|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110354758|NCT00534807|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110354759|NCT00534807|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110354760|NCT00534807|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110354761|NCT00534846|Toremifene|toremifene|mesh-list
110354762|NCT00534846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110354763|NCT00534846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110354764|NCT00534846|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110354765|NCT00534846|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110354766|NCT00534846|Hormone Antagonists|hormone antagonists|mesh-ancestor
110354767|NCT00534846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110354768|NCT00534846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110354769|NCT00534846|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110354770|NCT00548067|Amlodipine|amlodipine|mesh-list
110354771|NCT00548067|Valsartan|valsartan|mesh-list
110354772|NCT00548067|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110354773|NCT00548067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110354774|NCT00548067|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110354775|NCT00548067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110354776|NCT00548067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110354777|NCT00548067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110354778|NCT00548067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110354779|NCT00548067|Vasodilator Agents|vasodilator agents|mesh-ancestor
110354780|NCT00548067|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110354781|NCT00548067|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110354783|NCT00548067|Natriuretic Agents|natriuretic agents|mesh-ancestor
110354784|NCT00548067|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110354785|NCT02907749|Carvedilol|carvedilol|mesh-list
110354786|NCT02907749|Spironolactone|spironolactone|mesh-list
110354787|NCT02907749|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110354788|NCT02907749|Hormone Antagonists|hormone antagonists|mesh-ancestor
110354789|NCT02907749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110354790|NCT02907749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110354791|NCT02907749|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110354793|NCT02907749|Natriuretic Agents|natriuretic agents|mesh-ancestor
110354794|NCT02907749|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110354795|NCT02907749|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110354796|NCT02907749|Adrenergic Agents|adrenergic agents|mesh-ancestor
110354797|NCT02907749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110354798|NCT02907749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110354799|NCT02907749|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110354800|NCT02907749|Antioxidants|antioxidants|mesh-ancestor
110354801|NCT02907749|Protective Agents|protective agents|mesh-ancestor
110354802|NCT02907749|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110354803|NCT02907749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110354804|NCT02907749|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110354805|NCT02907749|Vasodilator Agents|vasodilator agents|mesh-ancestor
110354806|NCT02907749|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110354807|NCT02907749|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110354808|NCT02907593|Budesonide|budesonide|mesh-list
110354809|NCT02907593|Calfactant|calfactant|mesh-list
110354810|NCT02907593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110354811|NCT02907593|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110354812|NCT02907593|Autonomic Agents|autonomic agents|mesh-ancestor
110354813|NCT02907593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110354814|NCT02907593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110354815|NCT02907593|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110354816|NCT02907593|Respiratory System Agents|respiratory system agents|mesh-ancestor
110354817|NCT02907593|Glucocorticoids|glucocorticoids|mesh-ancestor
110354818|NCT02907593|Hormones|hormones|mesh-ancestor
110354819|NCT02907593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110354820|NCT02907593|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
110354821|NCT00548301|Cyclosporine|cyclosporine|mesh-list
110354822|NCT00548301|Cyclosporins|cyclosporins|mesh-list
110354823|NCT00548301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110354824|NCT00548301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110354825|NCT00548301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110354826|NCT00548301|Immunologic Factors|immunologic factors|mesh-ancestor
110354827|NCT00548301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110354828|NCT00548301|Antifungal Agents|antifungal agents|mesh-ancestor
110354829|NCT00548301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110354830|NCT00548301|Dermatologic Agents|dermatologic agents|mesh-ancestor
110354831|NCT00548301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110354832|NCT00548301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110354833|NCT02907710|Endostar protein|endostar protein|mesh-list
110354834|NCT02907710|Endostatins|endostatins|mesh-list
110354835|NCT02907710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110354836|NCT02907710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110354837|NCT02907710|Growth Substances|growth substances|mesh-ancestor
110354838|NCT02907710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110354839|NCT02907710|Growth Inhibitors|growth inhibitors|mesh-ancestor
110354840|NCT02907710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110354842|NCT03781362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110354843|NCT03781362|Antimetabolites|antimetabolites|mesh-ancestor
110354844|NCT03781362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110354845|NCT03781362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110354846|NCT04682249|Apatinib|apatinib|mesh-list
110354847|NCT04682249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110354848|NCT04682249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110354849|NCT04682249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110354850|NCT04682249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110354851|NCT00548379|Vitamin D|vitamin d|mesh-list
110354852|NCT00548379|Vitamins|vitamins|mesh-ancestor
110354853|NCT00548379|Micronutrients|micronutrients|mesh-ancestor
110354854|NCT00548379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110354855|NCT00548379|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110354856|NCT04972617|Furosemide|furosemide|mesh-list
110354857|NCT04972617|Diuretics|diuretics|mesh-ancestor
110354858|NCT04972617|Natriuretic Agents|natriuretic agents|mesh-ancestor
110354859|NCT04972617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110354860|NCT04972617|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110354861|NCT04972617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110354862|NCT04972617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110354863|NCT04682210|Bevacizumab|bevacizumab|mesh-list
110354864|NCT04682210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110354865|NCT04682210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110354866|NCT04682210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110354867|NCT04682210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110354868|NCT04682210|Growth Substances|growth substances|mesh-ancestor
110354869|NCT04682210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110354870|NCT04682210|Growth Inhibitors|growth inhibitors|mesh-ancestor
110354872|NCT04682132|Immunologic Factors|immunologic factors|mesh-ancestor
110354873|NCT04682132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110354874|NCT02907554|Cyclosporine|cyclosporine|mesh-list
110354875|NCT02907554|Cyclosporins|cyclosporins|mesh-list
110354876|NCT02907554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110354877|NCT02907554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110354878|NCT02907554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110354879|NCT02907554|Immunologic Factors|immunologic factors|mesh-ancestor
110354880|NCT02907554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110354881|NCT02907554|Antifungal Agents|antifungal agents|mesh-ancestor
110354882|NCT02907554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110354883|NCT02907554|Dermatologic Agents|dermatologic agents|mesh-ancestor
110354884|NCT02907554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110354885|NCT02907554|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110354886|NCT02907632|Metoclopramide|metoclopramide|mesh-list
110354887|NCT02907632|Antiemetics|antiemetics|mesh-ancestor
110354888|NCT02907632|Autonomic Agents|autonomic agents|mesh-ancestor
110225450|NCT05962151|Narcotics|narcotics|mesh-ancestor
110354889|NCT02907632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110354890|NCT02907632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110354891|NCT02907632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110354892|NCT02907632|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110354893|NCT02907632|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110354894|NCT02907632|Dopamine Agents|dopamine agents|mesh-ancestor
110354895|NCT02907632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110354896|NCT02907632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110354897|NCT02907437|Minocycline|minocycline|mesh-list
110354898|NCT02907437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110354899|NCT02907437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110354900|NCT01262872|Vaccines|vaccines|mesh-list
110354901|NCT01262872|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110354902|NCT01262872|Immunologic Factors|immunologic factors|mesh-ancestor
110354903|NCT01262872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110354904|NCT00548574|Mesalamine|mesalamine|mesh-list
110354905|NCT00548574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110354906|NCT00548574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110354907|NCT00548574|Analgesics|analgesics|mesh-ancestor
110354908|NCT00548574|Sensory System Agents|sensory system agents|mesh-ancestor
110354909|NCT00548574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110354910|NCT00548574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110354911|NCT00548574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110354912|NCT00548574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110354913|NCT01262677|Pregabalin|pregabalin|mesh-list
110354914|NCT01262677|Analgesics|analgesics|mesh-ancestor
110354915|NCT01262677|Sensory System Agents|sensory system agents|mesh-ancestor
110354916|NCT01262677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110354917|NCT01262677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110354918|NCT01262677|Anticonvulsants|anticonvulsants|mesh-ancestor
110354919|NCT01262677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110354920|NCT01262677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110354921|NCT01262677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110176318|NCT00080158|Dopamine Agents|dopamine agents|mesh-ancestor
110354922|NCT01262677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110354923|NCT01262677|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110354924|NCT01262677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110354925|NCT01262677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110354926|NCT01262677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110354927|NCT02899364|Sodium thiosulfate|sodium thiosulfate|mesh-list
110354929|NCT02899364|Protective Agents|protective agents|mesh-ancestor
110354930|NCT02899364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110354931|NCT02899364|Antioxidants|antioxidants|mesh-ancestor
110354932|NCT02899364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110354933|NCT02899364|Antitubercular Agents|antitubercular agents|mesh-ancestor
110354934|NCT02899364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110354935|NCT02899364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110354936|NCT02899364|Chelating Agents|chelating agents|mesh-ancestor
110354937|NCT02899364|Sequestering Agents|sequestering agents|mesh-ancestor
110354938|NCT04206865|Valsartan|valsartan|mesh-list
110354939|NCT04206865|Vasodilator Agents|vasodilator agents|mesh-list
110354940|NCT04206865|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110354941|NCT04206865|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110354942|NCT04206865|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110354943|NCT04206865|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110354944|NCT04206865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110354945|NCT00535080|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
110354946|NCT00535080|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110354947|NCT00535080|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110354948|NCT00535080|Dermatologic Agents|dermatologic agents|mesh-ancestor
110354949|NCT01262638|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
110354950|NCT01262638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110354951|NCT01262638|Antimetabolites|antimetabolites|mesh-ancestor
110354952|NCT01262638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110354953|NCT01262638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110354954|NCT01262638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110354955|NCT01262638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110354956|NCT01262638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110354957|NCT00535119|Paclitaxel|paclitaxel|mesh-list
110354958|NCT00535119|Carboplatin|carboplatin|mesh-list
110354959|NCT00535119|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110354960|NCT00535119|Veliparib|veliparib|mesh-list
110354961|NCT00535119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110354962|NCT00535119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110354963|NCT00535119|Tubulin Modulators|tubulin modulators|mesh-ancestor
110354964|NCT00535119|Antimitotic Agents|antimitotic agents|mesh-ancestor
110354965|NCT00535119|Mitosis Modulators|mitosis modulators|mesh-ancestor
110354966|NCT00535119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110354967|NCT00535119|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110354968|NCT00535119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110354969|NCT00535158|Vitamin D|vitamin d|mesh-list
110354970|NCT00535158|Ergocalciferols|ergocalciferols|mesh-list
110354971|NCT00535158|Vitamins|vitamins|mesh-ancestor
110354972|NCT00535158|Micronutrients|micronutrients|mesh-ancestor
110354973|NCT00535158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110354974|NCT00535158|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110354975|NCT00535158|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110354976|NCT03436992|Resveratrol|resveratrol|mesh-list
110354977|NCT03436992|Antioxidants|antioxidants|mesh-list
110354978|NCT03436992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110354979|NCT03436992|Protective Agents|protective agents|mesh-ancestor
110354980|NCT03436992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110354981|NCT03436992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110354982|NCT03436992|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110354983|NCT04083118|Listerine|listerine|mesh-list
110354984|NCT04083118|Fluorides|fluorides|mesh-list
110354985|NCT04083118|Sodium Fluoride|sodium fluoride|mesh-list
110354986|NCT04083118|Cariostatic Agents|cariostatic agents|mesh-ancestor
110354987|NCT04083118|Protective Agents|protective agents|mesh-ancestor
110354988|NCT04083118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110354989|NCT04083118|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110354990|NCT04083118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110354991|NCT04207450|Glutaral|glutaral|mesh-list
110354992|NCT04207450|Disinfectants|disinfectants|mesh-ancestor
110354993|NCT04207450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110354994|NCT04070443|Imatinib Mesylate|imatinib mesylate|mesh-list
110354995|NCT04070443|Ponatinib|ponatinib|mesh-list
110354996|NCT04070443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110354997|NCT04070443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110354998|NCT04070443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110354999|NCT04070443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110355000|NCT04043494|Cytarabine|cytarabine|mesh-list
110355001|NCT04043494|Dexamethasone|dexamethasone|mesh-list
110355002|NCT04043494|Prednisone|prednisone|mesh-list
110355003|NCT04043494|Prednisolone|prednisolone|mesh-list
110355004|NCT04043494|Cyclophosphamide|cyclophosphamide|mesh-list
110355005|NCT04043494|Ifosfamide|ifosfamide|mesh-list
110355006|NCT04043494|Doxorubicin|doxorubicin|mesh-list
110355007|NCT04043494|Methotrexate|methotrexate|mesh-list
110355008|NCT04043494|Vincristine|vincristine|mesh-list
110355009|NCT04043494|Daunorubicin|daunorubicin|mesh-list
110355010|NCT04043494|Asparaginase|asparaginase|mesh-list
110355011|NCT04043494|Mercaptopurine|mercaptopurine|mesh-list
110355012|NCT04043494|Thioguanine|thioguanine|mesh-list
110355013|NCT04043494|Pegaspargase|pegaspargase|mesh-list
110355014|NCT04043494|Vindesine|vindesine|mesh-list
110355015|NCT04043494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110355016|NCT04043494|Immunologic Factors|immunologic factors|mesh-ancestor
110355017|NCT04043494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110355018|NCT04043494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110355019|NCT04043494|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110355020|NCT04043494|Alkylating Agents|alkylating agents|mesh-ancestor
110355021|NCT04043494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110355022|NCT04043494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110355023|NCT04043494|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110355024|NCT04043494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110355025|NCT04043494|Antiemetics|antiemetics|mesh-ancestor
110355026|NCT04043494|Autonomic Agents|autonomic agents|mesh-ancestor
110355027|NCT04043494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110355028|NCT04043494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110355029|NCT04043494|Glucocorticoids|glucocorticoids|mesh-ancestor
110355030|NCT04043494|Hormones|hormones|mesh-ancestor
110355031|NCT04043494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110355032|NCT04043494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110355033|NCT04043494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110355034|NCT04043494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110355035|NCT04043494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110355036|NCT04043494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110355037|NCT04043494|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110355038|NCT04043494|Abortifacient Agents|abortifacient agents|mesh-ancestor
110355039|NCT04043494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110355040|NCT04043494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110355041|NCT04043494|Antimetabolites|antimetabolites|mesh-ancestor
110355042|NCT04043494|Dermatologic Agents|dermatologic agents|mesh-ancestor
110355043|NCT04043494|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110355044|NCT04043494|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110355045|NCT04043494|Antiviral Agents|antiviral agents|mesh-ancestor
110355046|NCT04043494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110355047|NCT04043494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110355048|NCT04043494|Tubulin Modulators|tubulin modulators|mesh-ancestor
110355049|NCT04043494|Antimitotic Agents|antimitotic agents|mesh-ancestor
110355050|NCT04043494|Mitosis Modulators|mitosis modulators|mesh-ancestor
110355051|NCT02899286|BCT-100|bct-100|mesh-list
110355052|NCT02899286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110355053|NCT04322422|Montelukast|montelukast|mesh-list
110355054|NCT04322422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110355055|NCT04322422|Respiratory System Agents|respiratory system agents|mesh-ancestor
110355056|NCT04322422|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110355057|NCT04322422|Hormone Antagonists|hormone antagonists|mesh-ancestor
110355058|NCT04322422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110355059|NCT04322422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110355060|NCT04322422|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110355061|NCT04322422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110355062|NCT04322422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110355063|NCT02899169|Tretinoin|tretinoin|mesh-list
110355064|NCT02899169|Hydroxyurea|hydroxyurea|mesh-list
110355065|NCT02899169|Arsenic Trioxide|arsenic trioxide|mesh-list
110355066|NCT02899169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110355067|NCT02899169|Keratolytic Agents|keratolytic agents|mesh-ancestor
110355068|NCT02899169|Dermatologic Agents|dermatologic agents|mesh-ancestor
110355069|NCT02899169|Antisickling Agents|antisickling agents|mesh-ancestor
110355070|NCT02899169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110355071|NCT02899169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110355072|NCT02899169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110355073|NCT00548964|Ketamine|ketamine|mesh-list
110355074|NCT00548964|Lithium Carbonate|lithium carbonate|mesh-list
110355075|NCT00548964|Analgesics|analgesics|mesh-ancestor
110355076|NCT00548964|Sensory System Agents|sensory system agents|mesh-ancestor
110355077|NCT00548964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110355078|NCT00548964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110355079|NCT00548964|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110355080|NCT00548964|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110355081|NCT00548964|Anesthetics, General|anesthetics, general|mesh-ancestor
110355082|NCT00548964|Anesthetics|anesthetics|mesh-ancestor
110355083|NCT00548964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110355084|NCT00548964|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110355085|NCT00548964|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110355086|NCT00548964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110355087|NCT00548964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110355088|NCT00548964|Antidepressive Agents|antidepressive agents|mesh-ancestor
110355089|NCT00548964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110355090|NCT00548964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110355092|NCT00548964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110355093|NCT02898779|Primaquine|primaquine|mesh-list
110355094|NCT02898779|Antimalarials|antimalarials|mesh-ancestor
110355095|NCT02898779|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110355096|NCT02898779|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110355097|NCT02898779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110355098|NCT00549120|Propranolol|propranolol|mesh-list
110355099|NCT00549120|Albuterol|albuterol|mesh-list
110355100|NCT00549120|Ipratropium|ipratropium|mesh-list
110355101|NCT00549120|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110355102|NCT00549120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110355103|NCT00549120|Adrenergic Agents|adrenergic agents|mesh-ancestor
110355104|NCT00549120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110355105|NCT00549120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110355106|NCT00549120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110355107|NCT00549120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110355108|NCT00549120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110355109|NCT00549120|Vasodilator Agents|vasodilator agents|mesh-ancestor
110355110|NCT00549120|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110355111|NCT00549120|Autonomic Agents|autonomic agents|mesh-ancestor
110355112|NCT00549120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110355113|NCT00549120|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110355114|NCT00549120|Respiratory System Agents|respiratory system agents|mesh-ancestor
110355115|NCT00549120|Tocolytic Agents|tocolytic agents|mesh-ancestor
110355116|NCT00549120|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110355117|NCT00549120|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110355118|NCT00549120|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110355119|NCT00549120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110355120|NCT00549120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110355121|NCT00549120|Cholinergic Agents|cholinergic agents|mesh-ancestor
110355122|NCT04680884|Antifungal Agents|antifungal agents|mesh-list
110355123|NCT04680884|Clotrimazole|clotrimazole|mesh-list
110355124|NCT04680884|Miconazole|miconazole|mesh-list
110355125|NCT04680884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110355126|NCT04680884|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110355127|NCT04680884|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110355128|NCT04680884|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110355129|NCT04680884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110355130|NCT04680884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110355131|NCT04680884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110355132|NCT04680884|Hormone Antagonists|hormone antagonists|mesh-ancestor
110355133|NCT04680884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110355134|NCT04680884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110355135|NCT04680884|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110355136|NCT04680884|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110355137|NCT00535470|Mechlorethamine|mechlorethamine|mesh-list
110355138|NCT00535470|Alkylating Agents|alkylating agents|mesh-ancestor
110355139|NCT00535470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110355140|NCT00535470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110355141|NCT00535470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110355142|NCT00535509|Cisplatin|cisplatin|mesh-list
110355143|NCT00535509|Docetaxel|docetaxel|mesh-list
110355144|NCT00535509|Trastuzumab|trastuzumab|mesh-list
110355145|NCT00535509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110355146|NCT00535509|Tubulin Modulators|tubulin modulators|mesh-ancestor
110355147|NCT00535509|Antimitotic Agents|antimitotic agents|mesh-ancestor
110355148|NCT00535509|Mitosis Modulators|mitosis modulators|mesh-ancestor
110355149|NCT00535509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110355150|NCT00535509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110355151|NCT01262365|Epratuzumab|epratuzumab|mesh-list
110355152|NCT01262365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110355153|NCT01262365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110355154|NCT03244176|Avelumab|avelumab|mesh-list
110355155|NCT03244176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110355156|NCT03244176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110355157|NCT00535665|Vaccines|vaccines|mesh-list
110355158|NCT00535665|Immunologic Factors|immunologic factors|mesh-ancestor
110355159|NCT00535665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110355160|NCT03971110|Goserelin|goserelin|mesh-list
110355161|NCT03971110|Bicalutamide|bicalutamide|mesh-list
110355162|NCT03971110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110355163|NCT03971110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110355164|NCT03971110|Androgen Antagonists|androgen antagonists|mesh-ancestor
110355165|NCT03971110|Hormone Antagonists|hormone antagonists|mesh-ancestor
110355166|NCT03971110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110355167|NCT03971110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110355168|NCT01262287|Dutasteride|dutasteride|mesh-list
110355169|NCT01262287|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110355170|NCT01262287|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110355171|NCT01262287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110355172|NCT01262287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110355173|NCT01262287|Hormone Antagonists|hormone antagonists|mesh-ancestor
110355174|NCT01262287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110355175|NCT01262287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110355176|NCT01262092|Buprenorphine|buprenorphine|mesh-list
110355177|NCT01262092|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110355178|NCT01262092|Narcotics|narcotics|mesh-ancestor
110355179|NCT01262092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110355180|NCT01262092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110355181|NCT01262092|Analgesics|analgesics|mesh-ancestor
110355182|NCT01262092|Sensory System Agents|sensory system agents|mesh-ancestor
110355183|NCT01262092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110355184|NCT01262092|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110355185|NCT03898180|Pembrolizumab|pembrolizumab|mesh-list
110355186|NCT03898180|Lenvatinib|lenvatinib|mesh-list
110355187|NCT03898180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110355188|NCT03898180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110355189|NCT03898180|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110355190|NCT03898180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110355191|NCT03898180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110355192|NCT03898180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110355193|NCT04680962|Rituximab|rituximab|mesh-list
110355194|NCT04680962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110355195|NCT04680962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110355196|NCT04680962|Immunologic Factors|immunologic factors|mesh-ancestor
110355197|NCT04680962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110355198|NCT04680962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110355199|NCT00549471|Botulinum Toxins|botulinum toxins|mesh-list
110355200|NCT00549471|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110355201|NCT00549471|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110355202|NCT00549471|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110355203|NCT00549471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110355204|NCT00549471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110355205|NCT00549471|Cholinergic Agents|cholinergic agents|mesh-ancestor
110355206|NCT00549471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110355207|NCT00549471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110355208|NCT00549471|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110355209|NCT00549471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110355210|NCT03088410|Zidovudine|zidovudine|mesh-list
110355211|NCT03088410|Nevirapine|nevirapine|mesh-list
110355212|NCT03088410|Antimetabolites|antimetabolites|mesh-ancestor
110355213|NCT03088410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110032682|NCT05273398|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110355214|NCT03088410|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110355215|NCT03088410|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110355216|NCT03088410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110355217|NCT03088410|Antiviral Agents|antiviral agents|mesh-ancestor
110355218|NCT03088410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110355219|NCT03088410|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110355220|NCT03088410|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110355221|NCT03088410|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110355222|NCT03088410|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110355224|NCT02897765|Poly ICLC|poly iclc|mesh-list
110355225|NCT02897765|Immunologic Factors|immunologic factors|mesh-ancestor
110355226|NCT02897765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110355227|NCT02897765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110355228|NCT02897765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110355229|NCT02897765|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110355230|NCT02897765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110355231|NCT02897765|Interferon Inducers|interferon inducers|mesh-ancestor
110355232|NCT00549588|Sunscreening Agents|sunscreening agents|mesh-list
110355233|NCT00549588|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110355234|NCT00549588|Protective Agents|protective agents|mesh-ancestor
110355235|NCT00549588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110355236|NCT00549588|Dermatologic Agents|dermatologic agents|mesh-ancestor
110355237|NCT04321642|Nitrous Oxide|nitrous oxide|mesh-list
110355238|NCT04321642|Entonox|entonox|mesh-list
110355239|NCT04321642|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
110355240|NCT04321642|Anesthetics|anesthetics|mesh-ancestor
110355241|NCT04321642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110355242|NCT04321642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110355243|NCT04321642|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110355244|NCT04321642|Anesthetics, General|anesthetics, general|mesh-ancestor
110355245|NCT04321642|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110355246|NCT04321642|Analgesics|analgesics|mesh-ancestor
110355247|NCT04321642|Sensory System Agents|sensory system agents|mesh-ancestor
110355248|NCT04321642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110355249|NCT02897219|Ipragliflozin|ipragliflozin|mesh-list
110355250|NCT02897219|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110355251|NCT02897219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110355252|NCT02897219|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110355253|NCT02897219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110355254|NCT04321720|Mechlorethamine|mechlorethamine|mesh-list
110355255|NCT04321720|Alkylating Agents|alkylating agents|mesh-ancestor
110355256|NCT04321720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110355257|NCT04321720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110355258|NCT04321720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110355259|NCT04321837|Vitamin D|vitamin d|mesh-list
110355260|NCT04321837|Cholecalciferol|cholecalciferol|mesh-list
110355261|NCT04321837|Ibandronic Acid|ibandronic acid|mesh-list
110355262|NCT04321837|Vitamins|vitamins|mesh-ancestor
110355263|NCT04321837|Micronutrients|micronutrients|mesh-ancestor
110355264|NCT04321837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110355265|NCT04321837|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110355266|NCT04321837|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110355267|NCT02896829|Imatinib Mesylate|imatinib mesylate|mesh-list
110355268|NCT02896829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110355269|NCT02896829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110355270|NCT02896829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110355271|NCT02896829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110355272|NCT00549666|Moxifloxacin|moxifloxacin|mesh-list
110355273|NCT00549666|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
110355274|NCT00549666|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110355275|NCT00549666|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110355276|NCT00549666|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110355277|NCT00549666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110355278|NCT00549666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110355279|NCT00549666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110355280|NCT00549666|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110355281|NCT00549666|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110355282|NCT00549666|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110355283|NCT00549666|Adrenergic Agents|adrenergic agents|mesh-ancestor
110355284|NCT00549666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110355285|NCT00549666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110355286|NCT00549666|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110355287|NCT00549666|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110355288|NCT00549666|Serotonin Agents|serotonin agents|mesh-ancestor
110355289|NCT00549666|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110355290|NCT00549666|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110355291|NCT00549666|Dopamine Agents|dopamine agents|mesh-ancestor
110355292|NCT00549666|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110355293|NCT00549666|Contraceptive Agents|contraceptive agents|mesh-ancestor
110355294|NCT00549666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110355295|NCT00549666|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110355296|NCT00549666|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110355297|NCT00549666|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110355298|NCT00549666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110355299|NCT00549666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110355300|NCT00549666|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110355301|NCT00549666|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110355302|NCT00549666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110355303|NCT00549666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110355304|NCT04680923|Bupivacaine|bupivacaine|mesh-list
110355305|NCT04680923|Anesthetics, Local|anesthetics, local|mesh-ancestor
110355306|NCT04680923|Anesthetics|anesthetics|mesh-ancestor
110355307|NCT04680923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110355308|NCT04680923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110355309|NCT04680923|Sensory System Agents|sensory system agents|mesh-ancestor
110355310|NCT04680923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110355311|NCT00551538|Insulin Glargine|insulin glargine|mesh-list
110355312|NCT00551538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110355313|NCT00551538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110355314|NCT03694522|Bemarituzumab|bemarituzumab|mesh-list
110355315|NCT03694522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110355316|NCT03694522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110355317|NCT04891419|Lidocaine|lidocaine|mesh-list
110355318|NCT04891419|Anesthetics, Local|anesthetics, local|mesh-ancestor
110355319|NCT04891419|Anesthetics|anesthetics|mesh-ancestor
110355320|NCT04891419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110355321|NCT04891419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110355322|NCT04891419|Sensory System Agents|sensory system agents|mesh-ancestor
110355323|NCT04891419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110355324|NCT04891419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110355325|NCT04891419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110355326|NCT04891419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110355327|NCT04891419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110355328|NCT04891419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110355329|NCT00551577|Carboplatin|carboplatin|mesh-list
110355330|NCT00551577|Docetaxel|docetaxel|mesh-list
110355331|NCT00551577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110355332|NCT00551577|Tubulin Modulators|tubulin modulators|mesh-ancestor
110355333|NCT00551577|Antimitotic Agents|antimitotic agents|mesh-ancestor
110355334|NCT00551577|Mitosis Modulators|mitosis modulators|mesh-ancestor
110355335|NCT00551577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110355336|NCT04207723|Paroxetine|paroxetine|mesh-list
110355337|NCT04207723|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110355338|NCT04207723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110355339|NCT04207723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110355340|NCT04207723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110355341|NCT04207723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110355342|NCT04207723|Serotonin Agents|serotonin agents|mesh-ancestor
110355343|NCT04207723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110355344|NCT04207723|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110355345|NCT04207723|Antidepressive Agents|antidepressive agents|mesh-ancestor
110355346|NCT04207723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110355347|NCT04207723|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110355348|NCT04207723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110355349|NCT04207723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110355350|NCT04321096|Camostat|camostat|mesh-list
110355351|NCT04321096|Protease Inhibitors|protease inhibitors|mesh-ancestor
110355352|NCT04321096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110355353|NCT04321096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110355354|NCT04321096|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110355355|NCT04321096|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110355356|NCT03556696|Remifentanil|remifentanil|mesh-list
110355357|NCT03556696|Propofol|propofol|mesh-list
110355358|NCT03556696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110355359|NCT03556696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110355360|NCT03556696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110355361|NCT03556696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110355362|NCT03556696|Anesthetics, General|anesthetics, general|mesh-ancestor
110355363|NCT03556696|Anesthetics|anesthetics|mesh-ancestor
110355364|NCT03556696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110355365|NCT03556696|Narcotics|narcotics|mesh-ancestor
110355366|NCT03556696|Analgesics|analgesics|mesh-ancestor
110355367|NCT03556696|Sensory System Agents|sensory system agents|mesh-ancestor
110355368|NCT03556696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110355369|NCT04320706|Oxytocin|oxytocin|mesh-list
110355370|NCT04320706|Oxytocics|oxytocics|mesh-ancestor
110355371|NCT04320706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110355372|NCT04320706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110355373|NCT03482479|Naltrexone|naltrexone|mesh-list
110355374|NCT03482479|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110355375|NCT03482479|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110355376|NCT03482479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110355377|NCT03482479|Sensory System Agents|sensory system agents|mesh-ancestor
110355378|NCT03482479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110355379|NCT00553709|Nicotine|nicotine|mesh-list
110355380|NCT00553709|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110355381|NCT00553709|Autonomic Agents|autonomic agents|mesh-ancestor
110355382|NCT00553709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110355383|NCT00553709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110355384|NCT00553709|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110355385|NCT00553709|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110355386|NCT00553709|Cholinergic Agents|cholinergic agents|mesh-ancestor
110355387|NCT00553709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110355388|NCT00553709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110355389|NCT00551733|Paclitaxel|paclitaxel|mesh-list
110355390|NCT00551733|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110355391|NCT00551733|Carboplatin|carboplatin|mesh-list
110355392|NCT00551733|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
110355393|NCT00551733|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110355394|NCT00551733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110355395|NCT00551733|Tubulin Modulators|tubulin modulators|mesh-ancestor
110355396|NCT00551733|Antimitotic Agents|antimitotic agents|mesh-ancestor
110355397|NCT00551733|Mitosis Modulators|mitosis modulators|mesh-ancestor
110355398|NCT00551733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110355399|NCT02896205|Mycophenolic Acid|mycophenolic acid|mesh-list
110355400|NCT02896205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110355401|NCT02896205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110355402|NCT02896205|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110355403|NCT02896205|Antitubercular Agents|antitubercular agents|mesh-ancestor
110355404|NCT02896205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110355405|NCT02896205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110355406|NCT02896205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110355407|NCT02896205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110355408|NCT04922424|Atorvastatin|atorvastatin|mesh-list
110355409|NCT04922424|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110355410|NCT04922424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110355411|NCT04922424|Antimetabolites|antimetabolites|mesh-ancestor
110355412|NCT04922424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110355413|NCT04922424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110355414|NCT04922424|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110355415|NCT04922424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110355417|NCT00553748|Antiviral Agents|antiviral agents|mesh-ancestor
110355418|NCT00553748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110355420|NCT00551850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110355421|NCT00551850|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110355422|NCT00551850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110355423|NCT00551850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110355424|NCT00550095|Valsartan|valsartan|mesh-list
110355425|NCT00550095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110355426|NCT00550095|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110355427|NCT00550095|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110355428|NCT00550095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110355429|NCT00551889|Celecoxib|celecoxib|mesh-list
110355430|NCT00551889|Cyclophosphamide|cyclophosphamide|mesh-list
110355431|NCT00551889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110355432|NCT00551889|Immunologic Factors|immunologic factors|mesh-ancestor
110355433|NCT00551889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110355434|NCT00551889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110355435|NCT00551889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110355436|NCT00551889|Alkylating Agents|alkylating agents|mesh-ancestor
110355437|NCT00551889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110355438|NCT00551889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110355439|NCT00551889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110355440|NCT00551889|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110355441|NCT00551889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110355443|NCT00551889|Sensory System Agents|sensory system agents|mesh-ancestor
110355444|NCT00551889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110355445|NCT00551889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110355446|NCT00551889|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110355447|NCT00551889|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110355448|NCT00551889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110355449|NCT03455764|Trametinib|trametinib|mesh-list
110355450|NCT03455764|Dabrafenib|dabrafenib|mesh-list
110355451|NCT03455764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110355452|NCT03455764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110355454|NCT03455764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110355455|NCT04902495|Pemetrexed|pemetrexed|mesh-list
110355456|NCT04902495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110355457|NCT04902495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110355458|NCT04902495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110355459|NCT04902495|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110355460|NCT04902495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110355461|NCT03433183|Sirolimus|sirolimus|mesh-list
110355462|NCT03433183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110355463|NCT03433183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110355464|NCT03433183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110355465|NCT03433183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110355466|NCT03433183|Antifungal Agents|antifungal agents|mesh-ancestor
110355467|NCT03433183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110355468|NCT03433183|Immunologic Factors|immunologic factors|mesh-ancestor
110355469|NCT03433183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110355470|NCT02895659|Norepinephrine|norepinephrine|mesh-list
110355471|NCT02895659|Epinephrine|epinephrine|mesh-list
110355473|NCT02895659|Epinephryl borate|epinephryl borate|mesh-list
110355474|NCT02895659|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110355475|NCT02895659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110355476|NCT02895659|Adrenergic Agents|adrenergic agents|mesh-ancestor
110355477|NCT02895659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110355478|NCT02895659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110355479|NCT02895659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110355480|NCT02895659|Sympathomimetics|sympathomimetics|mesh-ancestor
110355481|NCT02895659|Autonomic Agents|autonomic agents|mesh-ancestor
110355482|NCT02895659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110355483|NCT02895659|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110355484|NCT02895659|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110355485|NCT02895659|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110355486|NCT02895659|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110355487|NCT02895659|Respiratory System Agents|respiratory system agents|mesh-ancestor
110355488|NCT02895659|Mydriatics|mydriatics|mesh-ancestor
110355489|NCT00552201|Tacrolimus|tacrolimus|mesh-list
110355490|NCT00552201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110355491|NCT00552201|Immunologic Factors|immunologic factors|mesh-ancestor
110355492|NCT00552201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110355493|NCT00552201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110355494|NCT00552201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110355495|NCT00552201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110355496|NCT03391882|Apomorphine|apomorphine|mesh-list
110355497|NCT03391882|Emetics|emetics|mesh-ancestor
110355498|NCT03391882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110355499|NCT03391882|Autonomic Agents|autonomic agents|mesh-ancestor
110355500|NCT03391882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110355501|NCT03391882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110355502|NCT03391882|Dopamine Agonists|dopamine agonists|mesh-ancestor
110355503|NCT03391882|Dopamine Agents|dopamine agents|mesh-ancestor
110355504|NCT03391882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110355505|NCT03391882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110355506|NCT00550329|Glipizide|glipizide|mesh-list
110355507|NCT00550329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110355508|NCT00550329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110355509|NCT00550485|Escitalopram|escitalopram|mesh-list
110355510|NCT00550485|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110355511|NCT00550485|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110355512|NCT00550485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110355513|NCT00550485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110355514|NCT00550485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110355515|NCT00550485|Serotonin Agents|serotonin agents|mesh-ancestor
110355516|NCT00550485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110355517|NCT00550563|Cholecalciferol|cholecalciferol|mesh-list
110355518|NCT00550563|Vitamin D|vitamin d|mesh-list
110355519|NCT00550563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110355520|NCT00550563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110355521|NCT00550563|Vitamins|vitamins|mesh-ancestor
110355522|NCT00550563|Micronutrients|micronutrients|mesh-ancestor
110355523|NCT00550563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110355524|NCT02895191|Urinastatin|urinastatin|mesh-list
110355525|NCT02895191|Trypsin Inhibitors|trypsin inhibitors|mesh-list
110355526|NCT02895191|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110355527|NCT02895191|Protease Inhibitors|protease inhibitors|mesh-ancestor
110355528|NCT02895191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110355529|NCT02895191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110355530|NCT04680650|Anesthetics|anesthetics|mesh-list
110355531|NCT04680650|Propofol|propofol|mesh-list
110355532|NCT04680650|Sevoflurane|sevoflurane|mesh-list
110355533|NCT04680650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110355534|NCT04680650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110355535|NCT04680650|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110355536|NCT04680650|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110355537|NCT04680650|Anesthetics, General|anesthetics, general|mesh-ancestor
110355538|NCT04680650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110355539|NCT04680650|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110355541|NCT02895113|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110355542|NCT02895113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110355543|NCT02895113|Analgesics|analgesics|mesh-ancestor
110355544|NCT02895113|Sensory System Agents|sensory system agents|mesh-ancestor
110355545|NCT02895113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110355546|NCT02895113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110355547|NCT02895113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110355548|NCT02895113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110355549|NCT02895113|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110355550|NCT02895113|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110355551|NCT02895113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110355552|NCT02895113|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110355553|NCT02895113|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110355554|NCT02895113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110355555|NCT02895113|Antipyretics|antipyretics|mesh-ancestor
110355556|NCT00552630|Penicillamine|penicillamine|mesh-list
110355557|NCT00552630|Antidotes|antidotes|mesh-ancestor
110355558|NCT00552630|Protective Agents|protective agents|mesh-ancestor
110355559|NCT00552630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110355560|NCT00552630|Chelating Agents|chelating agents|mesh-ancestor
110355561|NCT00552630|Sequestering Agents|sequestering agents|mesh-ancestor
110355562|NCT00552630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110355563|NCT00552630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110355564|NCT02894957|Varenicline|varenicline|mesh-list
110355565|NCT02894957|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110355567|NCT02894957|Cholinergic Agents|cholinergic agents|mesh-ancestor
110355568|NCT02894957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110355569|NCT02894957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110355570|NCT02894957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110355571|NCT00550992|Leucovorin|leucovorin|mesh-list
110355572|NCT00550992|Cytarabine|cytarabine|mesh-list
110355573|NCT00550992|Cyclosporine|cyclosporine|mesh-list
110355575|NCT00550992|Prednisolone|prednisolone|mesh-list
110355576|NCT00550992|Hydrocortisone|hydrocortisone|mesh-list
110355577|NCT00550992|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110355578|NCT00550992|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110355579|NCT00550992|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110355580|NCT00550992|Cyclophosphamide|cyclophosphamide|mesh-list
110355581|NCT00550992|Melphalan|melphalan|mesh-list
110355582|NCT00550992|Busulfan|busulfan|mesh-list
110355583|NCT00550992|Methotrexate|methotrexate|mesh-list
110355584|NCT00550992|Etoposide|etoposide|mesh-list
110355585|NCT00550992|Vincristine|vincristine|mesh-list
110355586|NCT00550992|Daunorubicin|daunorubicin|mesh-list
110355587|NCT00550992|Asparaginase|asparaginase|mesh-list
110355588|NCT00550992|Mitoxantrone|mitoxantrone|mesh-list
110355589|NCT00550992|Mercaptopurine|mercaptopurine|mesh-list
110355590|NCT00550992|Pegaspargase|pegaspargase|mesh-list
110355591|NCT00550992|Thioguanine|thioguanine|mesh-list
110355592|NCT00550992|Cyclosporins|cyclosporins|mesh-list
110355593|NCT00550992|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110355594|NCT00550992|Levoleucovorin|levoleucovorin|mesh-list
110355595|NCT00550992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110355596|NCT00550992|Immunologic Factors|immunologic factors|mesh-ancestor
110355597|NCT00550992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110355598|NCT00550992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110176404|NCT02972411|Diuretics|diuretics|mesh-ancestor
110355599|NCT00550992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110355600|NCT00550992|Alkylating Agents|alkylating agents|mesh-ancestor
110355601|NCT00550992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110355602|NCT00550992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110355603|NCT00550992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110355604|NCT00550992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110355606|NCT00550992|Hormones|hormones|mesh-ancestor
110355607|NCT00550992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110355608|NCT00550992|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110355609|NCT00550992|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110355610|NCT00550992|Abortifacient Agents|abortifacient agents|mesh-ancestor
110355611|NCT00550992|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110355612|NCT00550992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110355613|NCT00550992|Antimetabolites|antimetabolites|mesh-ancestor
110355614|NCT00550992|Dermatologic Agents|dermatologic agents|mesh-ancestor
110355615|NCT00550992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110355616|NCT00550992|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110355617|NCT00550992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110355618|NCT00550992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110355619|NCT00550992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110355620|NCT00550992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110355621|NCT00550992|Antiviral Agents|antiviral agents|mesh-ancestor
110355622|NCT00550992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110355623|NCT00550992|Antidotes|antidotes|mesh-ancestor
110355624|NCT00550992|Protective Agents|protective agents|mesh-ancestor
110355625|NCT00550992|Vitamin B Complex|vitamin b complex|mesh-ancestor
110355627|NCT00550992|Micronutrients|micronutrients|mesh-ancestor
110355628|NCT00550992|Tubulin Modulators|tubulin modulators|mesh-ancestor
110355629|NCT00550992|Antimitotic Agents|antimitotic agents|mesh-ancestor
110355630|NCT00550992|Mitosis Modulators|mitosis modulators|mesh-ancestor
110355631|NCT00550992|Antifungal Agents|antifungal agents|mesh-ancestor
110355632|NCT00550992|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110355633|NCT00550992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110355634|NCT00550992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110355635|NCT00550992|Analgesics|analgesics|mesh-ancestor
110355636|NCT00550992|Sensory System Agents|sensory system agents|mesh-ancestor
110355637|NCT02895074|Proxymetacaine|proxymetacaine|mesh-list
110355638|NCT02895074|Tropicamide|tropicamide|mesh-list
110355639|NCT02895074|Mydriatics|mydriatics|mesh-ancestor
110355640|NCT02895074|Autonomic Agents|autonomic agents|mesh-ancestor
110355641|NCT02895074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110355642|NCT02895074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110355643|NCT02895074|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110355644|NCT02895074|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110355645|NCT02895074|Cholinergic Agents|cholinergic agents|mesh-ancestor
110355646|NCT02895074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110355647|NCT02895074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110355648|NCT02895074|Anesthetics, Local|anesthetics, local|mesh-ancestor
110355649|NCT02895074|Anesthetics|anesthetics|mesh-ancestor
110355650|NCT02895074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110355651|NCT02895074|Sensory System Agents|sensory system agents|mesh-ancestor
110355652|NCT02894918|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110355653|NCT02894918|Antiviral Agents|antiviral agents|mesh-ancestor
110355654|NCT02894918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110355655|NCT00551109|SA 4503|sa 4503|mesh-list
110355656|NCT00551109|Nootropic Agents|nootropic agents|mesh-ancestor
110355657|NCT00551265|Cyclophosphamide|cyclophosphamide|mesh-list
110355658|NCT00551265|Oregovomab|oregovomab|mesh-list
110355659|NCT00551265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110355660|NCT00551265|Antibodies|antibodies|mesh-list
110355661|NCT00551265|Immunoglobulins|immunoglobulins|mesh-list
110355662|NCT00551265|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110355663|NCT00551265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110355664|NCT00551265|Immunologic Factors|immunologic factors|mesh-ancestor
110355665|NCT00551265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110355666|NCT00551265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110355667|NCT00551265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110355668|NCT00551265|Alkylating Agents|alkylating agents|mesh-ancestor
110355669|NCT00551265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110355670|NCT00551265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110355671|NCT00551265|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110355672|NCT02894606|Thymoglobulin|thymoglobulin|mesh-list
110355673|NCT02894606|Basiliximab|basiliximab|mesh-list
110355674|NCT02894606|Immunologic Factors|immunologic factors|mesh-ancestor
110355675|NCT02894606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110355676|NCT02894606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110355678|NCT00551343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110355679|NCT00551343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110355680|NCT00551343|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110355681|NCT00551343|Incretins|incretins|mesh-ancestor
110355682|NCT00551343|Hormones|hormones|mesh-ancestor
110355683|NCT00551343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110355684|NCT00551382|Montelukast|montelukast|mesh-list
110355685|NCT00551382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110355686|NCT00551382|Respiratory System Agents|respiratory system agents|mesh-ancestor
110355687|NCT00551382|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110355688|NCT00551382|Hormone Antagonists|hormone antagonists|mesh-ancestor
110355689|NCT00551382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110355690|NCT00551382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110355691|NCT00551382|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110355692|NCT00551382|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110355693|NCT00551382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110355694|NCT02894684|Aztreonam|aztreonam|mesh-list
110355695|NCT02894684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110355696|NCT02894684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110355697|NCT02894645|Cytarabine|cytarabine|mesh-list
110355698|NCT02894645|Dexamethasone|dexamethasone|mesh-list
110355699|NCT02894645|Prednisolone|prednisolone|mesh-list
110355700|NCT02894645|Cyclophosphamide|cyclophosphamide|mesh-list
110355701|NCT02894645|Doxorubicin|doxorubicin|mesh-list
110355702|NCT02894645|Methotrexate|methotrexate|mesh-list
110355703|NCT02894645|Fludarabine|fludarabine|mesh-list
110355704|NCT02894645|Vincristine|vincristine|mesh-list
110355705|NCT02894645|Daunorubicin|daunorubicin|mesh-list
110355706|NCT02894645|Asparaginase|asparaginase|mesh-list
110355707|NCT02894645|Mercaptopurine|mercaptopurine|mesh-list
110355708|NCT02894645|Thioguanine|thioguanine|mesh-list
110355709|NCT02894645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110355710|NCT02894645|Immunologic Factors|immunologic factors|mesh-ancestor
110355711|NCT02894645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110355712|NCT02894645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110355713|NCT02894645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110355714|NCT02894645|Alkylating Agents|alkylating agents|mesh-ancestor
110355715|NCT02894645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110355716|NCT02894645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110355717|NCT02894645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110355718|NCT02894645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110355719|NCT02894645|Antiemetics|antiemetics|mesh-ancestor
110355720|NCT02894645|Autonomic Agents|autonomic agents|mesh-ancestor
110355721|NCT02894645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110355722|NCT02894645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110355723|NCT02894645|Glucocorticoids|glucocorticoids|mesh-ancestor
110355724|NCT02894645|Hormones|hormones|mesh-ancestor
110355725|NCT02894645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110355726|NCT02894645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110355727|NCT02894645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110355728|NCT02894645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110355729|NCT02894645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110355730|NCT02894645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110355731|NCT02894645|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110355732|NCT02894645|Abortifacient Agents|abortifacient agents|mesh-ancestor
110355733|NCT02894645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110355734|NCT02894645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110355735|NCT02894645|Antimetabolites|antimetabolites|mesh-ancestor
110355736|NCT02894645|Dermatologic Agents|dermatologic agents|mesh-ancestor
110176422|NCT00080743|Tamoxifen|tamoxifen|mesh-list
110355737|NCT02894645|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110355738|NCT02894645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110355739|NCT02894645|Antiviral Agents|antiviral agents|mesh-ancestor
110355740|NCT02894645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110355741|NCT02894645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110355742|NCT02894645|Tubulin Modulators|tubulin modulators|mesh-ancestor
110355743|NCT02894645|Antimitotic Agents|antimitotic agents|mesh-ancestor
110355744|NCT02894645|Mitosis Modulators|mitosis modulators|mesh-ancestor
110355746|NCT00552747|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110355747|NCT00552747|Antimetabolites|antimetabolites|mesh-ancestor
110355748|NCT00552747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110355749|NCT00552747|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110355750|NCT05427617|Fulvestrant|fulvestrant|mesh-list
110355751|NCT05427617|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
110355752|NCT05427617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110355753|NCT05427617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110355754|NCT05427617|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110355755|NCT05427617|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110355756|NCT05427617|Hormone Antagonists|hormone antagonists|mesh-ancestor
110355757|NCT05427617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110355758|NCT05427617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110355759|NCT05427617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110355760|NCT05427617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110355761|NCT05427500|Bupivacaine|bupivacaine|mesh-list
110355762|NCT05427500|Anesthetics, Local|anesthetics, local|mesh-ancestor
110355763|NCT05427500|Anesthetics|anesthetics|mesh-ancestor
110355764|NCT05427500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110355765|NCT05427500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110355766|NCT05427500|Sensory System Agents|sensory system agents|mesh-ancestor
110355767|NCT05427500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110355768|NCT05427383|Paclitaxel|paclitaxel|mesh-list
110355769|NCT05427383|Docetaxel|docetaxel|mesh-list
110355770|NCT05427383|Irinotecan|irinotecan|mesh-list
110355771|NCT05427383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110355772|NCT05427383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110355773|NCT05427383|Tubulin Modulators|tubulin modulators|mesh-ancestor
110355774|NCT05427383|Antimitotic Agents|antimitotic agents|mesh-ancestor
110355775|NCT05427383|Mitosis Modulators|mitosis modulators|mesh-ancestor
110355776|NCT05427383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110355777|NCT05427383|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110355778|NCT05427383|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110355779|NCT05427383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110355780|NCT05427305|Bevacizumab|bevacizumab|mesh-list
110355781|NCT05427305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110355782|NCT05427305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110355783|NCT05427305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110355784|NCT05427305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110355785|NCT05427305|Growth Substances|growth substances|mesh-ancestor
110355786|NCT05427305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110355787|NCT05427305|Growth Inhibitors|growth inhibitors|mesh-ancestor
110355788|NCT01099449|Oxaliplatin|oxaliplatin|mesh-list
110355789|NCT01099449|Magnesium Sulfate|magnesium sulfate|mesh-list
110355790|NCT01099449|Calcium|calcium|mesh-list
110355791|NCT01099449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110355792|NCT01099449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110355793|NCT01099449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110355794|NCT01099449|Analgesics|analgesics|mesh-ancestor
110355795|NCT01099449|Sensory System Agents|sensory system agents|mesh-ancestor
110355796|NCT01099449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110355797|NCT01099449|Anesthetics|anesthetics|mesh-ancestor
110355798|NCT01099449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110355799|NCT01099449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110355800|NCT01099449|Anticonvulsants|anticonvulsants|mesh-ancestor
110355801|NCT01099449|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110355802|NCT01099449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110176423|NCT00080743|Gefitinib|gefitinib|mesh-list
110355803|NCT01099449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110355805|NCT01099449|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110355806|NCT04680143|Epoetin Alfa|epoetin alfa|mesh-list
110355807|NCT04680143|Hematinics|hematinics|mesh-ancestor
110355808|NCT05426798|Azacitidine|azacitidine|mesh-list
110355809|NCT05426798|Decitabine|decitabine|mesh-list
110355810|NCT05426798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110355811|NCT05426798|Antimetabolites|antimetabolites|mesh-ancestor
110355812|NCT05426798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110355814|NCT05426798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110355815|NCT01234402|Capecitabine|capecitabine|mesh-list
110355816|NCT01234402|Ramucirumab|ramucirumab|mesh-list
110355817|NCT01234402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110355818|NCT01234402|Antimetabolites|antimetabolites|mesh-ancestor
110355819|NCT01234402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110355821|NCT01260922|Donepezil|donepezil|mesh-list
110355822|NCT01260922|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110355823|NCT01260922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110355824|NCT01260922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110355825|NCT01260922|Cholinergic Agents|cholinergic agents|mesh-ancestor
110355826|NCT01260922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110355827|NCT01260922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110355828|NCT01260922|Nootropic Agents|nootropic agents|mesh-ancestor
110355829|NCT01212094|Rituximab|rituximab|mesh-list
110355830|NCT01212094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110355831|NCT01212094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110355832|NCT01212094|Immunologic Factors|immunologic factors|mesh-ancestor
110355833|NCT01212094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110355834|NCT01212094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110355835|NCT04369794|BCG Vaccine|bcg vaccine|mesh-list
110355836|NCT04369794|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110355837|NCT04369794|Immunologic Factors|immunologic factors|mesh-ancestor
110355838|NCT04369794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110355839|NCT05409885|Anesthetics|anesthetics|mesh-list
110355840|NCT05409885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110355841|NCT05409885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110355842|NCT00552864|Ropivacaine|ropivacaine|mesh-list
110355843|NCT00552864|Levobupivacaine|levobupivacaine|mesh-list
110355844|NCT00552864|Anesthetics, Local|anesthetics, local|mesh-ancestor
110355845|NCT00552864|Anesthetics|anesthetics|mesh-ancestor
110355846|NCT00552864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110355847|NCT00552864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110355848|NCT00552864|Sensory System Agents|sensory system agents|mesh-ancestor
110355849|NCT00552864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110355850|NCT01211665|Methylprednisolone|methylprednisolone|mesh-list
110355851|NCT01211665|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110355852|NCT01211665|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110355853|NCT01211665|Prednisolone|prednisolone|mesh-list
110355854|NCT01211665|Prednisolone acetate|prednisolone acetate|mesh-list
110355855|NCT01211665|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110355856|NCT01211665|Prednisolone phosphate|prednisolone phosphate|mesh-list
110355857|NCT01211665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110355858|NCT01211665|Antiemetics|antiemetics|mesh-ancestor
110355859|NCT01211665|Autonomic Agents|autonomic agents|mesh-ancestor
110355860|NCT01211665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110355861|NCT01211665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110355862|NCT01211665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110355863|NCT01211665|Glucocorticoids|glucocorticoids|mesh-ancestor
110355864|NCT01211665|Hormones|hormones|mesh-ancestor
110355865|NCT01211665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110355866|NCT01211665|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110355867|NCT01211665|Protective Agents|protective agents|mesh-ancestor
110355868|NCT01211665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110355869|NCT01211665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110355870|NCT04401176|Lidocaine|lidocaine|mesh-list
110355871|NCT04401176|Heparin|heparin|mesh-list
110355872|NCT04401176|Anesthetics, Local|anesthetics, local|mesh-ancestor
110355873|NCT04401176|Anesthetics|anesthetics|mesh-ancestor
110355874|NCT04401176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110355875|NCT04401176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110355876|NCT04401176|Sensory System Agents|sensory system agents|mesh-ancestor
110355877|NCT04401176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110355878|NCT04401176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110355879|NCT04401176|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110355880|NCT04401176|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110355881|NCT04401176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110355882|NCT04401176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110355884|NCT04401176|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110355885|NCT04401176|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110355886|NCT01232491|Insulin Detemir|insulin detemir|mesh-list
110355887|NCT01232491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110355888|NCT01232491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110355889|NCT04335305|Pembrolizumab|pembrolizumab|mesh-list
110355890|NCT04335305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110355891|NCT04335305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110355892|NCT04335305|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110033421|NCT03661996|Anesthetics|anesthetics|mesh-ancestor
110355893|NCT04335305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110355894|NCT04152980|Pentoxifylline|pentoxifylline|mesh-list
110355895|NCT04152980|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110355896|NCT04152980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110355897|NCT04152980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110355898|NCT04152980|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110355899|NCT04152980|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110355900|NCT04152980|Protective Agents|protective agents|mesh-ancestor
110355901|NCT04152980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110355902|NCT04152980|Vasodilator Agents|vasodilator agents|mesh-ancestor
110355903|NCT04152980|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110355904|NCT04152980|Antioxidants|antioxidants|mesh-ancestor
110355906|NCT01232452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110355907|NCT01232452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110355908|NCT01232452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110355909|NCT01232452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110355910|NCT01232452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110355911|NCT01211197|Metformin|metformin|mesh-list
110355912|NCT01211197|Empagliflozin|empagliflozin|mesh-list
110355913|NCT01211197|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110355914|NCT01211197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110355915|NCT01211197|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110355916|NCT01211197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110355917|NCT00553137|Fluconazole|fluconazole|mesh-list
110355918|NCT00553137|Antifungal Agents|antifungal agents|mesh-ancestor
110355919|NCT00553137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110355920|NCT00553137|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110355921|NCT00553137|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110355922|NCT00553137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110355923|NCT00553137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110355924|NCT00553137|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110355925|NCT00553137|Hormone Antagonists|hormone antagonists|mesh-ancestor
110355926|NCT00553137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110355927|NCT00553137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110355928|NCT00553137|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110355929|NCT00553137|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110355931|NCT04090775|Nivolumab|nivolumab|mesh-list
110355932|NCT04090775|Ipilimumab|ipilimumab|mesh-list
110355933|NCT04090775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110355934|NCT04090775|Immunologic Factors|immunologic factors|mesh-ancestor
110355935|NCT04090775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110355936|NCT04090775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110355937|NCT04090775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110355938|NCT04090775|Alkylating Agents|alkylating agents|mesh-ancestor
110355939|NCT04090775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110355940|NCT04090775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110355941|NCT04090775|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110355942|NCT04090775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110355943|NCT04090775|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110355945|NCT01232296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110355946|NCT01232296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110355947|NCT01232296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110355948|NCT01232296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110355950|NCT04041011|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110355951|NCT04041011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110355952|NCT04041011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110355953|NCT04041011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110355954|NCT00554138|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110355955|NCT00554138|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110355956|NCT00554138|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110355957|NCT00554138|Antimetabolites|antimetabolites|mesh-ancestor
110355958|NCT00554138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110355959|NCT00554138|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110355960|NCT00554138|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110355961|NCT00554138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110355962|NCT01231555|Efavirenz|efavirenz|mesh-list
110355963|NCT01231555|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110355964|NCT01231555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110355965|NCT01231555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110355966|NCT01231555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110355968|NCT01231555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110355969|NCT01231555|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110355970|NCT01231555|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110355971|NCT01231555|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110355972|NCT01231555|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110355973|NCT01231555|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110355974|NCT01231555|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110355975|NCT04116528|Ketamine|ketamine|mesh-list
110355976|NCT04116528|Buprenorphine|buprenorphine|mesh-list
110355977|NCT04116528|Analgesics|analgesics|mesh-ancestor
110355978|NCT04116528|Sensory System Agents|sensory system agents|mesh-ancestor
110355979|NCT04116528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110355980|NCT04116528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110355981|NCT04116528|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110355982|NCT04116528|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110355983|NCT04116528|Anesthetics, General|anesthetics, general|mesh-ancestor
110355984|NCT04116528|Anesthetics|anesthetics|mesh-ancestor
110355985|NCT04116528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110355986|NCT04116528|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110355987|NCT04116528|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110355988|NCT04116528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110355989|NCT04116528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110355990|NCT04116528|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110355991|NCT04116528|Narcotics|narcotics|mesh-ancestor
110355992|NCT04116528|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110355993|NCT05288907|Lidocaine|lidocaine|mesh-list
110355994|NCT05288907|Anesthetics, Local|anesthetics, local|mesh-ancestor
110355996|NCT05288907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110355997|NCT05288907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110355998|NCT05288907|Sensory System Agents|sensory system agents|mesh-ancestor
110355999|NCT05288907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110356000|NCT05288907|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110356001|NCT05288907|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110356002|NCT05288907|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110356003|NCT05288907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110356004|NCT05288907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110356006|NCT03911336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
110356007|NCT03911336|Ketoprofen|ketoprofen|mesh-list
110356008|NCT03911336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110356009|NCT03911336|Analgesics|analgesics|mesh-ancestor
110356010|NCT03911336|Sensory System Agents|sensory system agents|mesh-ancestor
110356011|NCT03911336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110356012|NCT03911336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110356013|NCT03911336|Antipyretics|antipyretics|mesh-ancestor
110356014|NCT03911336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110356015|NCT03911336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110356016|NCT03911336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110356017|NCT03911336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110356018|NCT03911336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110356019|NCT03850535|Cytarabine|cytarabine|mesh-list
110356020|NCT03850535|Daunorubicin|daunorubicin|mesh-list
110356021|NCT03850535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110356023|NCT03850535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110356024|NCT03850535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110356025|NCT03850535|Antiviral Agents|antiviral agents|mesh-ancestor
110356026|NCT03850535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110356027|NCT03850535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110356028|NCT03850535|Immunologic Factors|immunologic factors|mesh-ancestor
110356029|NCT03850535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110356030|NCT03850535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110356031|NCT03850535|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110356032|NCT03850535|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110356033|NCT03850535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110356034|NCT03850301|Etifoxine|etifoxine|mesh-list
110356035|NCT03850301|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110356036|NCT03850301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110356037|NCT03850301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110356038|NCT03850301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110356039|NCT03850301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110356041|NCT05255367|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110356042|NCT05255367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110356043|NCT05255367|Disinfectants|disinfectants|mesh-ancestor
110356044|NCT05255367|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
110356045|NCT05255367|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110356046|NCT04017936|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110356047|NCT04017936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110356048|NCT03653000|Anesthetics|anesthetics|mesh-list
110356049|NCT03653000|Anesthetics, Local|anesthetics, local|mesh-list
110356050|NCT03653000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110356051|NCT03653000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110356052|NCT03653000|Sensory System Agents|sensory system agents|mesh-ancestor
110356053|NCT03653000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110356054|NCT03639389|Morphine|morphine|mesh-list
110356055|NCT03639389|Analgesics|analgesics|mesh-list
110356056|NCT03639389|Bupivacaine|bupivacaine|mesh-list
110356057|NCT03639389|Anesthetics, Local|anesthetics, local|mesh-ancestor
110356058|NCT03639389|Anesthetics|anesthetics|mesh-ancestor
110356059|NCT03639389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110356060|NCT03639389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110356061|NCT03639389|Sensory System Agents|sensory system agents|mesh-ancestor
110356062|NCT03639389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110356063|NCT03639389|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110356064|NCT03639389|Narcotics|narcotics|mesh-ancestor
110356065|NCT05172531|Cisatracurium|cisatracurium|mesh-list
110356066|NCT05172531|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110356067|NCT05172531|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110356068|NCT05172531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110356069|NCT05172531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110356070|NCT03570983|Cytarabine|cytarabine|mesh-list
110356071|NCT03570983|Etoposide|etoposide|mesh-list
110356072|NCT03570983|Melphalan|melphalan|mesh-list
110356073|NCT03570983|Carmustine|carmustine|mesh-list
110356074|NCT03570983|Allopurinol|allopurinol|mesh-list
110356075|NCT03570983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110356076|NCT03570983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110356077|NCT03570983|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110356078|NCT03570983|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110356079|NCT03570983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110356080|NCT03570983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110356081|NCT03570983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110356082|NCT03570983|Antimetabolites|antimetabolites|mesh-ancestor
110356083|NCT03570983|Antiviral Agents|antiviral agents|mesh-ancestor
110356084|NCT03570983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110356085|NCT03570983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110356086|NCT03570983|Immunologic Factors|immunologic factors|mesh-ancestor
110356087|NCT03570983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110356088|NCT03570983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110356089|NCT03570983|Alkylating Agents|alkylating agents|mesh-ancestor
110356090|NCT03570983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110356091|NCT03570983|Gout Suppressants|gout suppressants|mesh-ancestor
110356092|NCT03570983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110356093|NCT03570983|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110356094|NCT03570983|Antioxidants|antioxidants|mesh-ancestor
110356095|NCT03570983|Protective Agents|protective agents|mesh-ancestor
110356097|NCT03540758|Nicotinic Acids|nicotinic acids|mesh-list
110356098|NCT03540758|Niacinamide|niacinamide|mesh-list
110356099|NCT03540758|Diazoxide|diazoxide|mesh-list
110356100|NCT03540758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110356101|NCT03540758|Antimetabolites|antimetabolites|mesh-ancestor
110356102|NCT03540758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110356103|NCT03540758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110356104|NCT03540758|Vasodilator Agents|vasodilator agents|mesh-ancestor
110356105|NCT03540758|Vitamin B Complex|vitamin b complex|mesh-ancestor
110356106|NCT03540758|Vitamins|vitamins|mesh-ancestor
110356107|NCT03540758|Micronutrients|micronutrients|mesh-ancestor
110356108|NCT03540758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110356109|NCT03540758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110356110|NCT03187379|Bupivacaine|bupivacaine|mesh-list
110356111|NCT03187379|Anesthetics, Local|anesthetics, local|mesh-ancestor
110356112|NCT03187379|Anesthetics|anesthetics|mesh-ancestor
110356113|NCT03187379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110356114|NCT03187379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110356115|NCT03187379|Sensory System Agents|sensory system agents|mesh-ancestor
110356116|NCT03187379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110356117|NCT03182231|Exenatide|exenatide|mesh-list
110356118|NCT03182231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110356119|NCT03182231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110356120|NCT03182231|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110356121|NCT03182231|Incretins|incretins|mesh-ancestor
110356122|NCT03182231|Hormones|hormones|mesh-ancestor
110356123|NCT03182231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110356124|NCT03182192|Exenatide|exenatide|mesh-list
110356125|NCT03182192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110356126|NCT03182192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110356127|NCT03182192|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110356128|NCT03182192|Incretins|incretins|mesh-ancestor
110356129|NCT03182192|Hormones|hormones|mesh-ancestor
110356130|NCT03182192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110356131|NCT02964884|Lovastatin|lovastatin|mesh-list
110356132|NCT02964884|L 647318|l 647318|mesh-list
110356133|NCT02964884|Dihydromevinolin|dihydromevinolin|mesh-list
110356135|NCT02964884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110356136|NCT02964884|Antimetabolites|antimetabolites|mesh-ancestor
110356137|NCT02964884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110356138|NCT02964884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110356139|NCT02964884|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110356140|NCT02964884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110356141|NCT02837042|Pembrolizumab|pembrolizumab|mesh-list
110356142|NCT02837042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110356143|NCT02837042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110356144|NCT02837042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110356145|NCT02837042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110356147|NCT05098470|Insulin Glargine|insulin glargine|mesh-list
110356148|NCT05098470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110356149|NCT05098470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110356150|NCT02710643|Ofatumumab|ofatumumab|mesh-list
110356151|NCT02710643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110356152|NCT05093205|Midazolam|midazolam|mesh-list
110356153|NCT05093205|Atorvastatin|atorvastatin|mesh-list
110356154|NCT05093205|Levonorgestrel|levonorgestrel|mesh-list
110356155|NCT05093205|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110356156|NCT05093205|Estradiol|estradiol|mesh-list
110356157|NCT05093205|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110356158|NCT05093205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110356159|NCT05093205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110356160|NCT05093205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110356161|NCT05093205|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110356162|NCT05093205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110356163|NCT05093205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110356164|NCT05093205|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110356165|NCT05093205|Anesthetics, General|anesthetics, general|mesh-ancestor
110356166|NCT05093205|Anesthetics|anesthetics|mesh-ancestor
110356167|NCT05093205|GABA Modulators|gaba modulators|mesh-ancestor
110356168|NCT05093205|GABA Agents|gaba agents|mesh-ancestor
110356169|NCT05093205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110356170|NCT05093205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110356171|NCT05093205|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110356172|NCT05093205|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110356173|NCT05093205|Antimetabolites|antimetabolites|mesh-ancestor
110356174|NCT05093205|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110356175|NCT05093205|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110356176|NCT05093205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110356177|NCT05093205|Estrogens|estrogens|mesh-ancestor
110356178|NCT05093205|Hormones|hormones|mesh-ancestor
110356179|NCT05093205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110356180|NCT05093205|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110356181|NCT05093205|Contraceptive Agents|contraceptive agents|mesh-ancestor
110356182|NCT05093205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110356183|NCT05093205|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110356184|NCT05093205|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110356185|NCT05093205|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110356186|NCT05093205|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110356187|NCT02623751|Exemestane|exemestane|mesh-list
110356188|NCT02623751|Entinostat|entinostat|mesh-list
110356189|NCT02623751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110356190|NCT02623751|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110356191|NCT02623751|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110356192|NCT02623751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110356193|NCT02623751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110356194|NCT02623751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110356195|NCT02623751|Hormone Antagonists|hormone antagonists|mesh-ancestor
110356196|NCT02623751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110356197|NCT02623751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110356198|NCT02623751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110356200|NCT02469155|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110356201|NCT02469155|Serotonin Agents|serotonin agents|mesh-ancestor
110176479|NCT00081055|Busulfan|busulfan|mesh-list
110356202|NCT02469155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110356203|NCT02469155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110356204|NCT02469155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110356205|NCT02469155|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110356207|NCT02469155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110356208|NCT02469155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110356209|NCT02469155|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110356210|NCT02469155|Dopamine Agents|dopamine agents|mesh-ancestor
110356211|NCT02465606|Triamcinolone|triamcinolone|mesh-list
110356212|NCT02465606|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110356213|NCT02465606|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110356214|NCT02465606|Hydrocortisone|hydrocortisone|mesh-list
110356215|NCT02465606|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110356216|NCT02465606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110356217|NCT02465606|Glucocorticoids|glucocorticoids|mesh-ancestor
110356219|NCT02465606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110356220|NCT02465606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110356221|NCT02465606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110356222|NCT02465606|Immunologic Factors|immunologic factors|mesh-ancestor
110356223|NCT02465606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110356224|NCT02465606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110356225|NCT05080530|Vitamin D|vitamin d|mesh-list
110356226|NCT05080530|Cholecalciferol|cholecalciferol|mesh-list
110356227|NCT05080530|Vitamins|vitamins|mesh-ancestor
110356228|NCT05080530|Micronutrients|micronutrients|mesh-ancestor
110356229|NCT05080530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110356230|NCT05080530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110356231|NCT05080530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110356232|NCT00554177|Mifepristone|mifepristone|mesh-list
110356233|NCT00554177|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110356234|NCT00554177|Abortifacient Agents|abortifacient agents|mesh-ancestor
110356235|NCT00554177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110356236|NCT00554177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110356237|NCT00554177|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110356238|NCT00554177|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110356239|NCT00554177|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110356240|NCT00554177|Contraceptive Agents|contraceptive agents|mesh-ancestor
110356241|NCT00554177|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110356242|NCT00554177|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110356243|NCT00554177|Hormone Antagonists|hormone antagonists|mesh-ancestor
110356244|NCT00554177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110356245|NCT00554177|Luteolytic Agents|luteolytic agents|mesh-ancestor
110356246|NCT00554177|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110356247|NCT00554177|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110356248|NCT03425565|Pembrolizumab|pembrolizumab|mesh-list
110356249|NCT03425565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110356250|NCT03425565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110356251|NCT03425565|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110356252|NCT03425565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110356253|NCT05073627|Dicloxacillin|dicloxacillin|mesh-list
110356255|NCT05073627|Antithrombins|antithrombins|mesh-ancestor
110356256|NCT05073627|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110356257|NCT05073627|Protease Inhibitors|protease inhibitors|mesh-ancestor
110356258|NCT05073627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110356259|NCT05073627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110356260|NCT05073627|Anticoagulants|anticoagulants|mesh-ancestor
110356261|NCT05073627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110356262|NCT05073627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110356263|NCT04678739|Remdesivir|remdesivir|mesh-list
110356264|NCT04678739|Antimetabolites|antimetabolites|mesh-ancestor
110356265|NCT04678739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110356266|NCT04678739|Antiviral Agents|antiviral agents|mesh-ancestor
110356267|NCT04678739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110356268|NCT03368196|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
110356269|NCT03368196|Immunoconjugates|immunoconjugates|mesh-ancestor
110356270|NCT03368196|Immunologic Factors|immunologic factors|mesh-ancestor
110356271|NCT03368196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110356272|NCT03230565|Ropivacaine|ropivacaine|mesh-list
110356273|NCT03230565|Anesthetics, Local|anesthetics, local|mesh-ancestor
110356274|NCT03230565|Anesthetics|anesthetics|mesh-ancestor
110356275|NCT03230565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110356276|NCT03230565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110356277|NCT03230565|Sensory System Agents|sensory system agents|mesh-ancestor
110356278|NCT03230565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110356279|NCT02389985|Paclitaxel|paclitaxel|mesh-list
110356280|NCT02389985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110356281|NCT02389985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110356282|NCT02389985|Tubulin Modulators|tubulin modulators|mesh-ancestor
110356283|NCT02389985|Antimitotic Agents|antimitotic agents|mesh-ancestor
110356284|NCT02389985|Mitosis Modulators|mitosis modulators|mesh-ancestor
110356285|NCT02389985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110356286|NCT03147612|Cytarabine|cytarabine|mesh-list
110356287|NCT03147612|Cyclophosphamide|cyclophosphamide|mesh-list
110356288|NCT03147612|Rituximab|rituximab|mesh-list
110356289|NCT03147612|Methotrexate|methotrexate|mesh-list
110356290|NCT03147612|Vincristine|vincristine|mesh-list
110356291|NCT03147612|Blinatumomab|blinatumomab|mesh-list
110356292|NCT03147612|Ponatinib|ponatinib|mesh-list
110356293|NCT03147612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110356294|NCT03147612|Muromonab-CD3|muromonab-cd3|mesh-list
110356295|NCT03147612|Antibodies|antibodies|mesh-list
110356296|NCT03147612|Immunoglobulins|immunoglobulins|mesh-list
110356297|NCT03147612|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110356298|NCT03147612|Lenograstim|lenograstim|mesh-list
110356299|NCT03147612|Antibodies, Bispecific|antibodies, bispecific|mesh-list
110356300|NCT03147612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110356301|NCT03147612|Immunologic Factors|immunologic factors|mesh-ancestor
110356302|NCT03147612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110356303|NCT03147612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110356304|NCT03147612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110356305|NCT03147612|Alkylating Agents|alkylating agents|mesh-ancestor
110356306|NCT03147612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110356307|NCT03147612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110356308|NCT03147612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110356309|NCT03147612|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110356310|NCT03147612|Abortifacient Agents|abortifacient agents|mesh-ancestor
110356311|NCT03147612|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110356312|NCT03147612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110356313|NCT03147612|Antimetabolites|antimetabolites|mesh-ancestor
110356314|NCT03147612|Dermatologic Agents|dermatologic agents|mesh-ancestor
110356315|NCT03147612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110356316|NCT03147612|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110356317|NCT03147612|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110356318|NCT03147612|Antiviral Agents|antiviral agents|mesh-ancestor
110356319|NCT03147612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110356320|NCT03147612|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110356321|NCT03147612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110356322|NCT03147612|Tubulin Modulators|tubulin modulators|mesh-ancestor
110356323|NCT03147612|Antimitotic Agents|antimitotic agents|mesh-ancestor
110356324|NCT03147612|Mitosis Modulators|mitosis modulators|mesh-ancestor
110356325|NCT03147612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110356326|NCT02377895|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110356327|NCT03455075|Levonorgestrel|levonorgestrel|mesh-list
110356328|NCT03455075|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110356329|NCT03455075|Contraceptive Agents|contraceptive agents|mesh-ancestor
110356330|NCT03455075|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110356331|NCT03455075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110356332|NCT03455075|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110356333|NCT03455075|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110356334|NCT03455075|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110356335|NCT05007132|Trifluridine|trifluridine|mesh-list
110356336|NCT05007132|Bevacizumab|bevacizumab|mesh-list
110356337|NCT05007132|Panitumumab|panitumumab|mesh-list
110356338|NCT05007132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110356339|NCT05007132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110356340|NCT05007132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110356341|NCT05007132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110356342|NCT05007132|Growth Substances|growth substances|mesh-ancestor
110356343|NCT05007132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110356344|NCT05007132|Growth Inhibitors|growth inhibitors|mesh-ancestor
110356345|NCT05007132|Antimetabolites|antimetabolites|mesh-ancestor
110356346|NCT05007132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110356347|NCT05007132|Antiviral Agents|antiviral agents|mesh-ancestor
110356348|NCT05007132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110356349|NCT04684017|Carboplatin|carboplatin|mesh-list
110356351|NCT04684017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110356352|NCT04684017|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110356353|NCT04684017|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110356354|NCT04684017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110356355|NCT04684017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110356356|NCT04684017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110356357|NCT00554450|Dapagliflozin|dapagliflozin|mesh-list
110356358|NCT00554450|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110356359|NCT00554450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110356360|NCT00554450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110356361|NCT00554450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110356362|NCT00553020|Insulin Glargine|insulin glargine|mesh-list
110356363|NCT00553020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110356364|NCT00553020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110356365|NCT00554528|Meloxicam|meloxicam|mesh-list
110356366|NCT00554528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110356368|NCT00554528|Analgesics|analgesics|mesh-ancestor
110356369|NCT00554528|Sensory System Agents|sensory system agents|mesh-ancestor
110356370|NCT00554528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110356371|NCT00554528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110356372|NCT00554528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110356373|NCT00554528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110356374|NCT00554528|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110356375|NCT00554528|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110356376|NCT00554528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110356377|NCT00554528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110356378|NCT04683198|Carboplatin|carboplatin|mesh-list
110356379|NCT04683198|Etoposide|etoposide|mesh-list
110356380|NCT04683198|Apatinib|apatinib|mesh-list
110356381|NCT04683198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110356382|NCT04683198|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110356383|NCT04683198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110356384|NCT04683198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110356385|NCT04683198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110356386|NCT04683198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110356387|NCT04683198|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110356388|NCT03075423|Nivolumab|nivolumab|mesh-list
110356389|NCT03075423|Ipilimumab|ipilimumab|mesh-list
110356390|NCT03075423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110356391|NCT03075423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110356392|NCT03075423|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110356393|NCT03075423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110356394|NCT02342249|Oseltamivir|oseltamivir|mesh-list
110356395|NCT02342249|Antiviral Agents|antiviral agents|mesh-ancestor
110356396|NCT02342249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110356397|NCT02342249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110356398|NCT02342249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110356399|NCT02339129|Ibuprofen|ibuprofen|mesh-list
110356400|NCT02339129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110356401|NCT02339129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110356402|NCT02339129|Analgesics|analgesics|mesh-ancestor
110356403|NCT02339129|Sensory System Agents|sensory system agents|mesh-ancestor
110356404|NCT02339129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110356405|NCT02339129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110356406|NCT02339129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110356407|NCT02339129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110356408|NCT02339129|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110356409|NCT02339129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110356410|NCT02339129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110356411|NCT02884206|Valsartan|valsartan|mesh-list
110356412|NCT02884206|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110356413|NCT02884206|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110356414|NCT02884206|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110356415|NCT02884206|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110356416|NCT02884206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110356417|NCT04961541|Vaccines|vaccines|mesh-list
110356418|NCT04961541|Immunologic Factors|immunologic factors|mesh-ancestor
110356419|NCT04961541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110356420|NCT02326454|Talaporfin|talaporfin|mesh-list
110356421|NCT02326454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110356422|NCT02326454|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110356423|NCT02326454|Dermatologic Agents|dermatologic agents|mesh-ancestor
110356424|NCT02324309|Insulin Lispro|insulin lispro|mesh-list
110356425|NCT02324309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110356426|NCT02324309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110356427|NCT02306291|Cytarabine|cytarabine|mesh-list
110356428|NCT02306291|Etoposide|etoposide|mesh-list
110356429|NCT02306291|Mitoxantrone|mitoxantrone|mesh-list
110356430|NCT02306291|Idarubicin|idarubicin|mesh-list
110356431|NCT02306291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110356432|NCT02306291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110356433|NCT02306291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110356434|NCT02306291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110356435|NCT02306291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110356436|NCT02306291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110356437|NCT02306291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110356438|NCT02306291|Antimetabolites|antimetabolites|mesh-ancestor
110356439|NCT02306291|Antiviral Agents|antiviral agents|mesh-ancestor
110356440|NCT02306291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110356441|NCT02306291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110356442|NCT02306291|Immunologic Factors|immunologic factors|mesh-ancestor
110356443|NCT02306291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110356444|NCT02306291|Analgesics|analgesics|mesh-ancestor
110356445|NCT02306291|Sensory System Agents|sensory system agents|mesh-ancestor
110356446|NCT02306291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110356447|NCT02306291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110356448|NCT02302079|Ranibizumab|ranibizumab|mesh-list
110356449|NCT02302079|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110356450|NCT02302079|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110356451|NCT02302079|Growth Substances|growth substances|mesh-ancestor
110356452|NCT02302079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110356453|NCT02302079|Growth Inhibitors|growth inhibitors|mesh-ancestor
110356454|NCT02302079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110356455|NCT01210495|Axitinib|axitinib|mesh-list
110356456|NCT01210495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110356457|NCT01210495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110356458|NCT01210495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110356459|NCT01210495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110356460|NCT02289716|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110356461|NCT02289716|Immunologic Factors|immunologic factors|mesh-ancestor
110356462|NCT02289716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110356463|NCT04678076|Ketoprofen|ketoprofen|mesh-list
110356464|NCT04678076|Ketoprofen lysine|ketoprofen lysine|mesh-list
110356465|NCT04678076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110356466|NCT04678076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110356467|NCT04678076|Analgesics|analgesics|mesh-ancestor
110356468|NCT04678076|Sensory System Agents|sensory system agents|mesh-ancestor
110356469|NCT04678076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110356470|NCT04678076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110356471|NCT04678076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110356472|NCT04678076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110356473|NCT04678076|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110356474|NCT04678076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110356475|NCT04678076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110356476|NCT02257619|Docetaxel|docetaxel|mesh-list
110356477|NCT02257619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110356478|NCT02257619|Tubulin Modulators|tubulin modulators|mesh-ancestor
110356479|NCT02257619|Antimitotic Agents|antimitotic agents|mesh-ancestor
110356480|NCT02257619|Mitosis Modulators|mitosis modulators|mesh-ancestor
110356481|NCT02257619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110356482|NCT04891302|Clevudine|clevudine|mesh-list
110356483|NCT04891302|Antiviral Agents|antiviral agents|mesh-ancestor
110356484|NCT04891302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110356485|NCT02224235|Aspirin|aspirin|mesh-list
110356486|NCT02224235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110356487|NCT02224235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110356488|NCT02224235|Analgesics|analgesics|mesh-ancestor
110356489|NCT02224235|Sensory System Agents|sensory system agents|mesh-ancestor
110356490|NCT02224235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110356491|NCT02224235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110356492|NCT02224235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110356493|NCT02224235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110356494|NCT02224235|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110356495|NCT02224235|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110176558|NCT00081796|Capecitabine|capecitabine|mesh-list
110356496|NCT02224235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110356497|NCT02224235|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110356498|NCT02224235|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110356499|NCT02224235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110356501|NCT02529852|Prednisone|prednisone|mesh-list
110356502|NCT02529852|Cyclophosphamide|cyclophosphamide|mesh-list
110356503|NCT02529852|Doxorubicin|doxorubicin|mesh-list
110356504|NCT02529852|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110356505|NCT02529852|Vincristine|vincristine|mesh-list
110356506|NCT02529852|Lenalidomide|lenalidomide|mesh-list
110356507|NCT02529852|Obinutuzumab|obinutuzumab|mesh-list
110356508|NCT02529852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110356509|NCT02529852|Immunologic Factors|immunologic factors|mesh-ancestor
110356510|NCT02529852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110356511|NCT02529852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110356512|NCT02529852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110356513|NCT02529852|Alkylating Agents|alkylating agents|mesh-ancestor
110356514|NCT02529852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110356515|NCT02529852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110356516|NCT02529852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110356517|NCT02529852|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110356518|NCT02529852|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110356519|NCT02529852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110356520|NCT02529852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110356521|NCT02529852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110356522|NCT02529852|Glucocorticoids|glucocorticoids|mesh-ancestor
110356524|NCT02529852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110356525|NCT02529852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110356526|NCT02529852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110356527|NCT02529852|Tubulin Modulators|tubulin modulators|mesh-ancestor
110356528|NCT02529852|Antimitotic Agents|antimitotic agents|mesh-ancestor
110356529|NCT02529852|Mitosis Modulators|mitosis modulators|mesh-ancestor
110356530|NCT02529852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110356531|NCT02529852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110356532|NCT02529852|Growth Substances|growth substances|mesh-ancestor
110356533|NCT02529852|Growth Inhibitors|growth inhibitors|mesh-ancestor
110356534|NCT02529852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110356535|NCT02221232|Ethanol|ethanol|mesh-list
110356536|NCT02221232|Chlorhexidine|chlorhexidine|mesh-list
110356537|NCT02221232|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110356538|NCT02221232|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110356539|NCT02221232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110356540|NCT02221232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110356541|NCT02221232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110356542|NCT02221232|Disinfectants|disinfectants|mesh-ancestor
110356543|NCT02221232|Dermatologic Agents|dermatologic agents|mesh-ancestor
110356544|NCT02206100|Enoxaparin|enoxaparin|mesh-list
110356545|NCT02206100|Anticoagulants|anticoagulants|mesh-ancestor
110356546|NCT02206100|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110356547|NCT02206100|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110356548|NCT02206100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110356549|NCT01231516|Raltegravir Potassium|raltegravir potassium|mesh-list
110356550|NCT01231516|Dolutegravir|dolutegravir|mesh-list
110356551|NCT01231516|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110356552|NCT01231516|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110356553|NCT01231516|Antiviral Agents|antiviral agents|mesh-ancestor
110356554|NCT01231516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110356555|NCT01231516|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110356556|NCT01231516|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110356557|NCT01231516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110356558|NCT01231516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110356559|NCT01962636|Cyclosporine|cyclosporine|mesh-list
110356560|NCT01962636|Cyclophosphamide|cyclophosphamide|mesh-list
110356561|NCT01962636|Fludarabine|fludarabine|mesh-list
110356562|NCT01962636|Cyclosporins|cyclosporins|mesh-list
110356563|NCT01962636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110356564|NCT01962636|Immunologic Factors|immunologic factors|mesh-ancestor
110356565|NCT01962636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110356566|NCT01962636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110356567|NCT01962636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110356568|NCT01962636|Alkylating Agents|alkylating agents|mesh-ancestor
110356569|NCT01962636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110356570|NCT01962636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110356571|NCT01962636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110356572|NCT01962636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110356573|NCT01962636|Antifungal Agents|antifungal agents|mesh-ancestor
110356574|NCT01962636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110017378|NCT02970162|Amifampridine|amifampridine|mesh-list
110356575|NCT01962636|Dermatologic Agents|dermatologic agents|mesh-ancestor
110356576|NCT01962636|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110356578|NCT01231321|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110356579|NCT01231321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110356580|NCT01231321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110356581|NCT01722240|Liraglutide|liraglutide|mesh-list
110356582|NCT01722240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110356583|NCT01722240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110356584|NCT01722240|Incretins|incretins|mesh-ancestor
110356585|NCT01722240|Hormones|hormones|mesh-ancestor
110356586|NCT01722240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110356587|NCT01210222|Trebananib|trebananib|mesh-list
110356588|NCT01210222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110356589|NCT01210222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110356590|NCT01210222|Growth Substances|growth substances|mesh-ancestor
110356591|NCT01210222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110356592|NCT01210222|Growth Inhibitors|growth inhibitors|mesh-ancestor
110356593|NCT01210222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110356594|NCT01210144|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110356595|NCT01210144|Hormones|hormones|mesh-list
110356596|NCT01210144|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
110356597|NCT01210144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110356598|NCT01210144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110356599|NCT01210144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110356601|NCT01209949|Benzoyl Peroxide|benzoyl peroxide|mesh-list
110356602|NCT01209949|Dermatologic Agents|dermatologic agents|mesh-ancestor
110356603|NCT01209949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110356604|NCT01209949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110356605|NCT01209949|Analgesics|analgesics|mesh-ancestor
110356606|NCT01209949|Sensory System Agents|sensory system agents|mesh-ancestor
110356607|NCT01209949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110356608|NCT01209949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110356609|NCT01209949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110356610|NCT01209949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110356611|NCT04831593|Anesthetics|anesthetics|mesh-list
110356612|NCT04831593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110356613|NCT04831593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110356614|NCT04667897|Ranibizumab|ranibizumab|mesh-list
110356615|NCT04667897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110356616|NCT04667897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110356617|NCT04667897|Growth Substances|growth substances|mesh-ancestor
110356618|NCT04667897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110356619|NCT04667897|Growth Inhibitors|growth inhibitors|mesh-ancestor
110356620|NCT04667897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110356621|NCT01209832|Midazolam|midazolam|mesh-list
110356622|NCT01209832|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110356623|NCT01209832|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110356624|NCT01209832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110356625|NCT01209832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110356626|NCT01209832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110356627|NCT01209832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110356628|NCT01209832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110356629|NCT01209832|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110356630|NCT01209832|Anesthetics, General|anesthetics, general|mesh-ancestor
110356631|NCT01209832|Anesthetics|anesthetics|mesh-ancestor
110356632|NCT01209832|GABA Modulators|gaba modulators|mesh-ancestor
110356633|NCT01209832|GABA Agents|gaba agents|mesh-ancestor
110356634|NCT01209832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110356635|NCT01209832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110356636|NCT04667819|Hyaluronic Acid|hyaluronic acid|mesh-list
110356637|NCT04667819|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110356638|NCT04667819|Immunologic Factors|immunologic factors|mesh-ancestor
110356639|NCT04667819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110356640|NCT04667819|Viscosupplements|viscosupplements|mesh-ancestor
110356641|NCT04667819|Protective Agents|protective agents|mesh-ancestor
110356642|NCT04683159|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110356643|NCT04683159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110356644|NCT04683159|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110356645|NCT04683159|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110356646|NCT04683159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110356647|NCT04683159|Adrenergic Agents|adrenergic agents|mesh-ancestor
110356648|NCT04683159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110356649|NCT04683159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110356650|NCT04683159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110356652|NCT01230892|Nebivolol|nebivolol|mesh-list
110356653|NCT01230892|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110356654|NCT01230892|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110356655|NCT01230892|Sympatholytics|sympatholytics|mesh-ancestor
110356656|NCT01230892|Autonomic Agents|autonomic agents|mesh-ancestor
110356657|NCT01230892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110356658|NCT01230892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110356659|NCT01230892|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110356660|NCT01230892|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110356661|NCT01230892|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110356662|NCT01230892|Adrenergic Agents|adrenergic agents|mesh-ancestor
110356663|NCT01230892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110356664|NCT01230892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110356665|NCT01230892|Vasodilator Agents|vasodilator agents|mesh-ancestor
110356666|NCT01230892|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110356667|NCT01230892|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110356668|NCT01230892|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110356669|NCT04667624|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
110356670|NCT04667624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110356671|NCT04667624|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110356672|NCT04667624|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110356673|NCT04667624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110356674|NCT04667351|Fluorouracil|fluorouracil|mesh-list
110356675|NCT04667351|Antimetabolites|antimetabolites|mesh-ancestor
110356676|NCT04667351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110356677|NCT04667351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110356678|NCT04667351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110356679|NCT04667351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110356680|NCT04667351|Immunologic Factors|immunologic factors|mesh-ancestor
110356681|NCT04667351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110356682|NCT01230814|Metronidazole|metronidazole|mesh-list
110356683|NCT01230814|Miconazole|miconazole|mesh-list
110356684|NCT01230814|Clotrimazole|clotrimazole|mesh-list
110356685|NCT01230814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110356686|NCT01230814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110356687|NCT01230814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110356688|NCT01230814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110356689|NCT01230814|Antifungal Agents|antifungal agents|mesh-ancestor
110356690|NCT01230814|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110356691|NCT01230814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110356692|NCT01230814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110176577|NCT00399685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110356693|NCT01230814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110356695|NCT01230814|Hormone Antagonists|hormone antagonists|mesh-ancestor
110356696|NCT01230814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110356697|NCT01230814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110356698|NCT01230814|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110356699|NCT01230814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110356700|NCT01230814|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110356701|NCT01230307|Vitamin D|vitamin d|mesh-list
110356702|NCT01230307|Cholecalciferol|cholecalciferol|mesh-list
110356703|NCT01230307|Vitamins|vitamins|mesh-ancestor
110356704|NCT01230307|Micronutrients|micronutrients|mesh-ancestor
110356705|NCT01230307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110356706|NCT01230307|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110356707|NCT01230307|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110356708|NCT01209598|Palbociclib|palbociclib|mesh-list
110356709|NCT01209598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110356710|NCT01209598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110356711|NCT01209598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110356712|NCT01209598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110356713|NCT00556634|Efavirenz|efavirenz|mesh-list
110356714|NCT00556634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110356715|NCT00556634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110356716|NCT00556634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110356717|NCT00556634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110356718|NCT00556634|Antiviral Agents|antiviral agents|mesh-ancestor
110356719|NCT00556634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110356720|NCT00556634|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110356721|NCT00556634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110356722|NCT00556634|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110356723|NCT00556634|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110356724|NCT00556634|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110356725|NCT00556634|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110356726|NCT01209520|Paclitaxel|paclitaxel|mesh-list
110356727|NCT01209520|Vinorelbine|vinorelbine|mesh-list
110356728|NCT01209520|Docetaxel|docetaxel|mesh-list
110356729|NCT01209520|Cisplatin|cisplatin|mesh-list
110356730|NCT01209520|Carboplatin|carboplatin|mesh-list
110356731|NCT01209520|Pemetrexed|pemetrexed|mesh-list
110356732|NCT01209520|Azacitidine|azacitidine|mesh-list
110356733|NCT01209520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110356734|NCT01209520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110356735|NCT01209520|Tubulin Modulators|tubulin modulators|mesh-ancestor
110356736|NCT01209520|Antimitotic Agents|antimitotic agents|mesh-ancestor
110356737|NCT01209520|Mitosis Modulators|mitosis modulators|mesh-ancestor
110356738|NCT01209520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110356739|NCT01209520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110356740|NCT01209520|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110356741|NCT01209520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110356742|NCT01209520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110356743|NCT01209520|Antimetabolites|antimetabolites|mesh-ancestor
110356744|NCT04805541|Tropicamide|tropicamide|mesh-list
110356745|NCT04805541|Mydriatics|mydriatics|mesh-list
110356746|NCT04805541|Autonomic Agents|autonomic agents|mesh-ancestor
110356747|NCT04805541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110356748|NCT04805541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110356749|NCT04805541|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110356750|NCT04805541|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110356751|NCT04805541|Cholinergic Agents|cholinergic agents|mesh-ancestor
110356752|NCT04805541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110356753|NCT04805541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110356754|NCT04784754|Melatonin|melatonin|mesh-list
110356755|NCT04784754|Antioxidants|antioxidants|mesh-ancestor
110356756|NCT04784754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110356757|NCT04784754|Protective Agents|protective agents|mesh-ancestor
110356758|NCT04784754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110356759|NCT04784754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110356760|NCT04666805|Tamoxifen|tamoxifen|mesh-list
110356761|NCT04666805|Toremifene|toremifene|mesh-list
110356762|NCT04666805|Letrozole|letrozole|mesh-list
110356763|NCT04666805|Anastrozole|anastrozole|mesh-list
110356764|NCT04666805|Exemestane|exemestane|mesh-list
110356765|NCT04666805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110356766|NCT04666805|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110356767|NCT04666805|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110356768|NCT04666805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110356769|NCT04666805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110356770|NCT04666805|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110356771|NCT04666805|Hormone Antagonists|hormone antagonists|mesh-ancestor
110356772|NCT04666805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110356773|NCT04666805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110356774|NCT04666805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110356775|NCT04666805|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110356776|NCT04666805|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110356777|NCT04666805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110356778|NCT04721457|Povidone-Iodine|povidone-iodine|mesh-list
110356779|NCT04721457|Listerine|listerine|mesh-list
110356780|NCT04721457|Hydrogen Peroxide|hydrogen peroxide|mesh-list
110356781|NCT04721457|Cetylpyridinium|cetylpyridinium|mesh-list
110356782|NCT04721457|Sodium Hypochlorite|sodium hypochlorite|mesh-list
110356784|NCT04721457|Povidone|povidone|mesh-list
110356785|NCT04721457|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110356786|NCT04721457|Sodium Fluoride|sodium fluoride|mesh-list
110356787|NCT04721457|Plasma Substitutes|plasma substitutes|mesh-ancestor
110356788|NCT04721457|Blood Substitutes|blood substitutes|mesh-ancestor
110356789|NCT04721457|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110356790|NCT04721457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110356791|NCT04721457|Cariostatic Agents|cariostatic agents|mesh-ancestor
110356792|NCT04721457|Protective Agents|protective agents|mesh-ancestor
110356793|NCT04721457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110356794|NCT04721457|Disinfectants|disinfectants|mesh-ancestor
110356795|NCT04665986|Docetaxel|docetaxel|mesh-list
110356796|NCT04665986|Vinorelbine|vinorelbine|mesh-list
110356797|NCT04665986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110033648|NCT03011775|Pioglitazone|pioglitazone|mesh-list
110356798|NCT04665986|Tubulin Modulators|tubulin modulators|mesh-ancestor
110356800|NCT04665986|Mitosis Modulators|mitosis modulators|mesh-ancestor
110356801|NCT04665986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110356802|NCT04665986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110356803|NCT04638309|Azacitidine|azacitidine|mesh-list
110356804|NCT04638309|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110356805|NCT04638309|Antimetabolites|antimetabolites|mesh-ancestor
110356806|NCT04638309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110356807|NCT04638309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110356808|NCT04638309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110356809|NCT04665830|Evolocumab|evolocumab|mesh-list
110356810|NCT04665830|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110356811|NCT04665830|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110356812|NCT04665830|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110356813|NCT04665830|Antimetabolites|antimetabolites|mesh-ancestor
110356814|NCT04665830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110356815|NCT04665830|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110356816|NCT04665830|Protease Inhibitors|protease inhibitors|mesh-ancestor
110356817|NCT04665830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110356818|NCT04665830|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110356819|NCT04683237|Liraglutide|liraglutide|mesh-list
110356820|NCT04683237|Megestrol|megestrol|mesh-list
110356821|NCT04683237|Megestrol Acetate|megestrol acetate|mesh-list
110356822|NCT04683237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110356823|NCT04683237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110356824|NCT04683237|Incretins|incretins|mesh-ancestor
110356825|NCT04683237|Hormones|hormones|mesh-ancestor
110356826|NCT04683237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110356827|NCT04683237|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110356828|NCT04683237|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110356829|NCT04683237|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110356830|NCT04683237|Contraceptive Agents|contraceptive agents|mesh-ancestor
110356831|NCT04683237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110356832|NCT04683237|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110356833|NCT04683237|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110356834|NCT04683237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110356835|NCT04683237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110356836|NCT04683237|Appetite Stimulants|appetite stimulants|mesh-ancestor
110356837|NCT04683237|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110356839|NCT04665362|Antibodies|antibodies|mesh-list
110356840|NCT04665362|Immunologic Factors|immunologic factors|mesh-ancestor
110356841|NCT04665362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110356842|NCT04665362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110356843|NCT04665362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110356844|NCT04665362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110356845|NCT04665362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110356847|NCT04665284|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110356848|NCT04665284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110356849|NCT04665284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110356850|NCT04665284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110356851|NCT04432974|Anesthetics|anesthetics|mesh-list
110356852|NCT04432974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110356853|NCT04432974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110356854|NCT04664894|Ribavirin|ribavirin|mesh-list
110356855|NCT04664894|Sofosbuvir|sofosbuvir|mesh-list
110356856|NCT04664894|Velpatasvir|velpatasvir|mesh-list
110356857|NCT04664894|Antimetabolites|antimetabolites|mesh-ancestor
110356858|NCT04664894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110356859|NCT04664894|Antiviral Agents|antiviral agents|mesh-ancestor
110356860|NCT04664894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110356862|NCT00557102|Fluorouracil|fluorouracil|mesh-list
110356863|NCT00557102|Irinotecan|irinotecan|mesh-list
110356864|NCT00557102|Cetuximab|cetuximab|mesh-list
110356865|NCT00557102|Calcium|calcium|mesh-list
110356866|NCT00557102|Levoleucovorin|levoleucovorin|mesh-list
110356867|NCT00557102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110356868|NCT00557102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110356869|NCT00557102|Antimetabolites|antimetabolites|mesh-ancestor
110356870|NCT00557102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110356871|NCT00557102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110356872|NCT00557102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110356873|NCT00557102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110356874|NCT00557102|Immunologic Factors|immunologic factors|mesh-ancestor
110356875|NCT00557102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110356876|NCT00557102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110356877|NCT00557102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110356878|NCT00557102|Antidotes|antidotes|mesh-ancestor
110356879|NCT00557102|Protective Agents|protective agents|mesh-ancestor
110356880|NCT00557102|Vitamin B Complex|vitamin b complex|mesh-ancestor
110356882|NCT00557102|Micronutrients|micronutrients|mesh-ancestor
110356883|NCT00557102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110356884|NCT04682691|Erythromycin|erythromycin|mesh-list
110356885|NCT04682691|Erythromycin Estolate|erythromycin estolate|mesh-list
110356886|NCT04682691|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
110356887|NCT04682691|Erythromycin stearate|erythromycin stearate|mesh-list
110356888|NCT04682691|Metoclopramide|metoclopramide|mesh-list
110356889|NCT04682691|Antiemetics|antiemetics|mesh-ancestor
110356890|NCT04682691|Autonomic Agents|autonomic agents|mesh-ancestor
110356891|NCT04682691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110356892|NCT04682691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110356894|NCT04682691|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110356895|NCT04682691|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110356896|NCT04682691|Dopamine Agents|dopamine agents|mesh-ancestor
110356897|NCT04682691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110356898|NCT04682691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110356899|NCT04682691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110356900|NCT04682691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110356901|NCT04682691|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110356902|NCT04682691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110356903|NCT01209286|Blinatumomab|blinatumomab|mesh-list
110356904|NCT01209286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110356905|NCT04663763|Capecitabine|capecitabine|mesh-list
110356906|NCT04663763|Oxaliplatin|oxaliplatin|mesh-list
110356907|NCT04663763|Antibodies|antibodies|mesh-list
110356908|NCT04663763|Immunologic Factors|immunologic factors|mesh-ancestor
110356909|NCT04663763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110356910|NCT04663763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110356911|NCT04663763|Antimetabolites|antimetabolites|mesh-ancestor
110356912|NCT04663763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110356913|NCT04663763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110356914|NCT04351737|Dexamethasone|dexamethasone|mesh-list
110356915|NCT04351737|Prednisolone|prednisolone|mesh-list
110356916|NCT04351737|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110356917|NCT04351737|Methylprednisolone|methylprednisolone|mesh-list
110356918|NCT04351737|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110356919|NCT04351737|Prednisolone acetate|prednisolone acetate|mesh-list
110356920|NCT04351737|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110356921|NCT04351737|Prednisolone phosphate|prednisolone phosphate|mesh-list
110356922|NCT04351737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110356923|NCT04351737|Antiemetics|antiemetics|mesh-ancestor
110356924|NCT04351737|Autonomic Agents|autonomic agents|mesh-ancestor
110356925|NCT04351737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110356926|NCT04351737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110356927|NCT04351737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110356928|NCT04351737|Glucocorticoids|glucocorticoids|mesh-ancestor
110356929|NCT04351737|Hormones|hormones|mesh-ancestor
110356930|NCT04351737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110356931|NCT04351737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110356932|NCT04351737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110356933|NCT04351737|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110356934|NCT04351737|Protective Agents|protective agents|mesh-ancestor
110356936|NCT04347915|Antiviral Agents|antiviral agents|mesh-ancestor
110356937|NCT04347915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110356938|NCT04185051|Aticaprant|aticaprant|mesh-list
110356939|NCT04185051|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110356940|NCT04185051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110356941|NCT04185051|Sensory System Agents|sensory system agents|mesh-ancestor
110356942|NCT04185051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110356944|NCT04662788|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110356945|NCT04662788|Immunologic Factors|immunologic factors|mesh-ancestor
110356946|NCT04662788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110356947|NCT04662866|Metformin|metformin|mesh-list
110356948|NCT04662866|Pioglitazone|pioglitazone|mesh-list
110356949|NCT04662866|Empagliflozin|empagliflozin|mesh-list
110356950|NCT04662866|Linagliptin|linagliptin|mesh-list
110356951|NCT04662866|Biguanides|biguanides|mesh-list
110356952|NCT04662866|Protease Inhibitors|protease inhibitors|mesh-list
110356953|NCT04662866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110356954|NCT04662866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110356955|NCT04662866|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110356956|NCT04662866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110356957|NCT04662866|Incretins|incretins|mesh-ancestor
110356958|NCT04662866|Hormones|hormones|mesh-ancestor
110356959|NCT04662866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110356960|NCT04662866|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110356961|NCT04662866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110356962|NCT04662476|Vitamin D|vitamin d|mesh-list
110356963|NCT04662476|Cholecalciferol|cholecalciferol|mesh-list
110356964|NCT04662476|Vitamins|vitamins|mesh-ancestor
110356965|NCT04662476|Micronutrients|micronutrients|mesh-ancestor
110356966|NCT04662476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110356967|NCT04662476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110356968|NCT04662476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110356970|NCT03986424|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110356971|NCT03986424|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110356972|NCT03986424|Dopamine Agents|dopamine agents|mesh-ancestor
110356973|NCT03986424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110356974|NCT03986424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110356975|NCT03986424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110356976|NCT03986424|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110356977|NCT03986424|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110356979|NCT03918252|Ipilimumab|ipilimumab|mesh-list
110356980|NCT03918252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110356981|NCT03918252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110356982|NCT03918252|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110176649|NCT00082966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110356983|NCT03918252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110356984|NCT04662125|Acetaminophen|acetaminophen|mesh-list
110356985|NCT04662125|Prednisolone|prednisolone|mesh-list
110356986|NCT04662125|Pregabalin|pregabalin|mesh-list
110356987|NCT04662125|Caffeine|caffeine|mesh-list
110356988|NCT04662125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110356989|NCT04662125|Glucocorticoids|glucocorticoids|mesh-ancestor
110356990|NCT04662125|Hormones|hormones|mesh-ancestor
110356991|NCT04662125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110356992|NCT04662125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110356993|NCT04662125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110356994|NCT04662125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110356995|NCT04662125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110356996|NCT04662125|Analgesics|analgesics|mesh-ancestor
110356997|NCT04662125|Sensory System Agents|sensory system agents|mesh-ancestor
110356998|NCT04662125|Anticonvulsants|anticonvulsants|mesh-ancestor
110356999|NCT04662125|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110357000|NCT04662125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110357001|NCT04662125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110357002|NCT04662125|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110357003|NCT04662125|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110357004|NCT04662125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110357005|NCT04662125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110357006|NCT04662125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110357007|NCT04662125|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110357008|NCT04662125|Antipyretics|antipyretics|mesh-ancestor
110357009|NCT04662125|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110357010|NCT04662125|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110357011|NCT04662125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110357012|NCT04662125|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110357013|NCT04662125|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110357014|NCT04662125|Purinergic Agents|purinergic agents|mesh-ancestor
110357015|NCT04662125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110357016|NCT00557180|Beclomethasone|beclomethasone|mesh-list
110357018|NCT00557180|Tiotropium Bromide|tiotropium bromide|mesh-list
110357019|NCT00557180|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110357020|NCT00557180|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110357021|NCT00557180|Autonomic Agents|autonomic agents|mesh-ancestor
110357022|NCT00557180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110357023|NCT00557180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110357024|NCT00557180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110357025|NCT00557180|Respiratory System Agents|respiratory system agents|mesh-ancestor
110357026|NCT00557180|Parasympatholytics|parasympatholytics|mesh-ancestor
110357027|NCT00557180|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110357028|NCT00557180|Cholinergic Agents|cholinergic agents|mesh-ancestor
110357029|NCT00557180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110357030|NCT00557180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110357031|NCT00557180|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110357032|NCT00557180|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110357033|NCT00557180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110357034|NCT00557180|Adrenergic Agents|adrenergic agents|mesh-ancestor
110357035|NCT00557180|Anticonvulsants|anticonvulsants|mesh-ancestor
110357036|NCT00557180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110357037|NCT00557180|Glucocorticoids|glucocorticoids|mesh-ancestor
110357038|NCT00557180|Hormones|hormones|mesh-ancestor
110357039|NCT00557180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110357040|NCT00557219|Fenoldopam|fenoldopam|mesh-list
110357041|NCT00557219|Ketanserin|ketanserin|mesh-list
110357043|NCT00557219|Vasodilator Agents|vasodilator agents|mesh-ancestor
110357044|NCT00557219|Dopamine Agonists|dopamine agonists|mesh-ancestor
110357045|NCT00557219|Dopamine Agents|dopamine agents|mesh-ancestor
110357046|NCT00557219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110357047|NCT00557219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110357048|NCT00557219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110357049|NCT00557219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110357050|NCT00557219|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110357051|NCT00557219|Serotonin Agents|serotonin agents|mesh-ancestor
110357052|NCT00539877|Irinotecan|irinotecan|mesh-list
110357053|NCT00539877|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110357054|NCT00539877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110357055|NCT00539877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110357056|NCT00539877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110357057|NCT00539877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110357058|NCT03798405|Analgesics|analgesics|mesh-list
110357059|NCT03798405|Narcotics|narcotics|mesh-list
110357060|NCT03798405|Sensory System Agents|sensory system agents|mesh-ancestor
110357061|NCT03798405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110357062|NCT03798405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110357063|NCT03798405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110357064|NCT04661696|Paclitaxel|paclitaxel|mesh-list
110357065|NCT04661696|Carboplatin|carboplatin|mesh-list
110357066|NCT04661696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110357067|NCT04661696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110357068|NCT04661696|Tubulin Modulators|tubulin modulators|mesh-ancestor
110357069|NCT04661696|Antimitotic Agents|antimitotic agents|mesh-ancestor
110357070|NCT04661696|Mitosis Modulators|mitosis modulators|mesh-ancestor
110357071|NCT04661696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110357072|NCT04661345|Coagulase|coagulase|mesh-list
110357073|NCT04661345|Coagulants|coagulants|mesh-ancestor
110357074|NCT00540072|Daptomycin|daptomycin|mesh-list
110357075|NCT00540072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110357076|NCT00540072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110357077|NCT04660916|Isotretinoin|isotretinoin|mesh-list
110357078|NCT04660916|Dermatologic Agents|dermatologic agents|mesh-ancestor
110357079|NCT00540150|Immunomodulating Agents|immunomodulating agents|mesh-list
110357080|NCT00540150|Immunologic Factors|immunologic factors|mesh-ancestor
110357081|NCT00540150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110357082|NCT01208233|3-(4-(2-hydroxyethyl)piperazin-1-yl)-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido(3,4-b)pyrazin-2(1H)-one|3-(4-(2-hydroxyethyl)piperazin-1-yl)-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido(3,4-b)pyrazin-2(1h)-one|mesh-list
110357083|NCT01208233|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110357084|NCT01208233|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110357085|NCT01208233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110357086|NCT01208233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110357087|NCT04660565|Prednisone|prednisone|mesh-list
110357088|NCT04660565|Belimumab|belimumab|mesh-list
110357089|NCT04660565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110357090|NCT04660565|Glucocorticoids|glucocorticoids|mesh-ancestor
110357091|NCT04660565|Hormones|hormones|mesh-ancestor
110357092|NCT04660565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110357093|NCT04660565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110357094|NCT04660565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110357095|NCT04660565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110357096|NCT04660565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110357097|NCT04660565|Immunologic Factors|immunologic factors|mesh-ancestor
110357098|NCT04319341|Autoantibodies|autoantibodies|mesh-list
110357099|NCT04319341|Immunologic Factors|immunologic factors|mesh-ancestor
110357100|NCT04319341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110357101|NCT05420935|Immunoglobulin G|immunoglobulin g|mesh-list
110357102|NCT05420935|Immunoglobulin E|immunoglobulin e|mesh-list
110357103|NCT05420935|Immunologic Factors|immunologic factors|mesh-ancestor
110357104|NCT05420935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110357105|NCT01208038|Methyltestosterone|methyltestosterone|mesh-list
110357106|NCT01208038|Testosterone|testosterone|mesh-list
110357107|NCT01208038|Testosterone undecanoate|testosterone undecanoate|mesh-list
110357108|NCT01208038|Testosterone enanthate|testosterone enanthate|mesh-list
110357109|NCT01208038|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110357111|NCT01208038|Hormones|hormones|mesh-ancestor
110357112|NCT01208038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110357113|NCT01208038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110357114|NCT01208038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110357115|NCT01208038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110357117|NCT04659785|Apatinib|apatinib|mesh-list
110357118|NCT04659785|Fluzoparib|fluzoparib|mesh-list
110357119|NCT04659785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110357120|NCT04659785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110357121|NCT04659785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110357122|NCT04659785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110357123|NCT04659785|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110357124|NCT01207687|Bevacizumab|bevacizumab|mesh-list
110357125|NCT01207687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110357126|NCT01207687|Antibodies|antibodies|mesh-list
110357127|NCT01207687|Immunoglobulins|immunoglobulins|mesh-list
110357128|NCT01207687|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110357129|NCT01207687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110357130|NCT01207687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110357131|NCT01207687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110357132|NCT01207687|Growth Substances|growth substances|mesh-ancestor
110357133|NCT01207687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110357134|NCT01207687|Growth Inhibitors|growth inhibitors|mesh-ancestor
110357135|NCT01207687|Immunologic Factors|immunologic factors|mesh-ancestor
110357136|NCT01207453|Milnacipran|milnacipran|mesh-list
110357137|NCT01207453|Levomilnacipran|levomilnacipran|mesh-list
110357138|NCT01207453|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110357139|NCT01207453|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110357140|NCT01207453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110357141|NCT01207453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110357142|NCT01207453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110357143|NCT01207453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110357144|NCT01207453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110357145|NCT01207453|Analgesics|analgesics|mesh-ancestor
110357146|NCT01207453|Sensory System Agents|sensory system agents|mesh-ancestor
110357147|NCT01207453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110357148|NCT01207453|Antidepressive Agents|antidepressive agents|mesh-ancestor
110357149|NCT01207453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110357150|NCT00540345|Interferons|interferons|mesh-list
110357151|NCT00540345|Ribavirin|ribavirin|mesh-list
110357152|NCT00540345|Interferon-alpha|interferon-alpha|mesh-list
110357153|NCT00540345|Interferon alpha-2|interferon alpha-2|mesh-list
110357154|NCT00540345|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110357155|NCT00540345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110357156|NCT00540345|Antiviral Agents|antiviral agents|mesh-ancestor
110357157|NCT00540345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110357158|NCT00540345|Antimetabolites|antimetabolites|mesh-ancestor
110357159|NCT00540345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110357160|NCT00540345|Immunologic Factors|immunologic factors|mesh-ancestor
110357161|NCT00540345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110357162|NCT01207414|Iloperidone|iloperidone|mesh-list
110357165|NCT01207414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110357166|NCT01207414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110357167|NCT01207414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110357168|NCT00540384|Darbepoetin alfa|darbepoetin alfa|mesh-list
110357169|NCT00540384|Hematinics|hematinics|mesh-ancestor
110357171|NCT04659551|Nivolumab|nivolumab|mesh-list
110357172|NCT04659551|Epirubicin|epirubicin|mesh-list
110357173|NCT04659551|Exemestane|exemestane|mesh-list
110357174|NCT04659551|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110357175|NCT04659551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110357176|NCT04659551|Immunologic Factors|immunologic factors|mesh-ancestor
110357177|NCT04659551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110357178|NCT04659551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110357179|NCT04659551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110357180|NCT04659551|Alkylating Agents|alkylating agents|mesh-ancestor
110357181|NCT04659551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110357182|NCT04659551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110357183|NCT04659551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110357184|NCT04659551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110357185|NCT04659551|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110033778|NCT02666794|Sufentanil|sufentanil|mesh-list
110357186|NCT04659551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110357187|NCT04659551|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110357188|NCT04659551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110357189|NCT04659551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110357190|NCT04659551|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110357191|NCT04659551|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110357192|NCT04659551|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110357193|NCT04659551|Hormone Antagonists|hormone antagonists|mesh-ancestor
110357194|NCT04659551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110357195|NCT04659551|Luteolytic Agents|luteolytic agents|mesh-ancestor
110357196|NCT04659551|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110357197|NCT04659551|Contraceptive Agents|contraceptive agents|mesh-ancestor
110357198|NCT04659551|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110357199|NCT04659551|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110357200|NCT04659551|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110357201|NCT01206517|Asenapine|asenapine|mesh-list
110357202|NCT01206517|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110357203|NCT01206517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110357204|NCT01206517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110357205|NCT01206517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110357206|NCT01206517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110357207|NCT01206439|Nebivolol|nebivolol|mesh-list
110357208|NCT01206439|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110357209|NCT01206439|Vasodilator Agents|vasodilator agents|mesh-ancestor
110357210|NCT01206439|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110357211|NCT01206439|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110357212|NCT01206439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110357213|NCT01206439|Adrenergic Agents|adrenergic agents|mesh-ancestor
110357214|NCT01206439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110357215|NCT01206439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110357216|NCT01206439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110357217|NCT01206322|Insulin|insulin|mesh-list
110357218|NCT01206322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110357219|NCT01206322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110357220|NCT00540501|Oseltamivir|oseltamivir|mesh-list
110357221|NCT00540501|Zanamivir|zanamivir|mesh-list
110357222|NCT00540501|Antiviral Agents|antiviral agents|mesh-ancestor
110357223|NCT00540501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110357224|NCT00540501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110225451|NCT05962151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110357225|NCT00540501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110357227|NCT00557453|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110357228|NCT00557453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110357229|NCT00557453|Antitubercular Agents|antitubercular agents|mesh-ancestor
110357230|NCT01207102|Paclitaxel|paclitaxel|mesh-list
110357231|NCT01207102|Carboplatin|carboplatin|mesh-list
110357232|NCT01207102|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110357233|NCT01207102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110357234|NCT01207102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110357235|NCT01207102|Tubulin Modulators|tubulin modulators|mesh-ancestor
110357236|NCT01207102|Antimitotic Agents|antimitotic agents|mesh-ancestor
110357237|NCT01207102|Mitosis Modulators|mitosis modulators|mesh-ancestor
110357238|NCT01207102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110357239|NCT04658732|Dexmedetomidine|dexmedetomidine|mesh-list
110357241|NCT04658732|Alprazolam|alprazolam|mesh-list
110357242|NCT04658732|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110176699|NCT03151863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110357243|NCT04658732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110357244|NCT04658732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110357245|NCT04658732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110357246|NCT04658732|Analgesics|analgesics|mesh-ancestor
110357247|NCT04658732|Sensory System Agents|sensory system agents|mesh-ancestor
110357248|NCT04658732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110357249|NCT04658732|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110357250|NCT04658732|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110357251|NCT04658732|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110357252|NCT04658732|Adrenergic Agents|adrenergic agents|mesh-ancestor
110357253|NCT04658732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110357254|NCT04658732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110357255|NCT04658732|Anticonvulsants|anticonvulsants|mesh-ancestor
110357256|NCT04658732|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110357257|NCT04658732|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110357258|NCT04658732|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110357259|NCT04658732|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110357260|NCT04658732|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110357261|NCT04658732|Antimanic Agents|antimanic agents|mesh-ancestor
110357262|NCT04658732|GABA Modulators|gaba modulators|mesh-ancestor
110357263|NCT04658732|GABA Agents|gaba agents|mesh-ancestor
110357264|NCT00540696|Darbepoetin alfa|darbepoetin alfa|mesh-list
110357265|NCT00540696|Hematinics|hematinics|mesh-ancestor
110357267|NCT04658420|Analgesics|analgesics|mesh-ancestor
110357268|NCT04658420|Sensory System Agents|sensory system agents|mesh-ancestor
110357269|NCT04658420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110357270|NCT04658420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110357271|NCT04658420|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110357272|NCT04658420|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110357273|NCT04658420|Anesthetics, General|anesthetics, general|mesh-ancestor
110357274|NCT04658420|Anesthetics|anesthetics|mesh-ancestor
110357275|NCT04658420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110357276|NCT04658420|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110357277|NCT04658420|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110357278|NCT04658420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110357279|NCT04658420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110357280|NCT00540891|Alfuzosin|alfuzosin|mesh-list
110357281|NCT00540891|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110357282|NCT00540891|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110357283|NCT00540891|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110357284|NCT00540891|Adrenergic Agents|adrenergic agents|mesh-ancestor
110357285|NCT00540891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110357286|NCT00540891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110357287|NCT00540891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110357288|NCT00540891|Urological Agents|urological agents|mesh-ancestor
110357289|NCT04658225|Chlorhexidine|chlorhexidine|mesh-list
110357290|NCT04658225|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110357291|NCT04658225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110357293|NCT00540930|Ranibizumab|ranibizumab|mesh-list
110357294|NCT00540930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110357295|NCT00540930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110357296|NCT00540930|Growth Substances|growth substances|mesh-ancestor
110357297|NCT00540930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110357298|NCT00540930|Growth Inhibitors|growth inhibitors|mesh-ancestor
110357299|NCT00540930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110357300|NCT00541008|Sunitinib|sunitinib|mesh-list
110357301|NCT00541008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110357302|NCT00541008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110357303|NCT00541008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110357304|NCT00541008|Growth Substances|growth substances|mesh-ancestor
110357305|NCT00541008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110357306|NCT00541008|Growth Inhibitors|growth inhibitors|mesh-ancestor
110357307|NCT00541008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110357308|NCT00541008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110357309|NCT00541008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110357310|NCT00541047|Leuprolide|leuprolide|mesh-list
110357311|NCT00541047|Goserelin|goserelin|mesh-list
110357312|NCT00541047|Bicalutamide|bicalutamide|mesh-list
110357313|NCT00541047|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110357314|NCT00541047|Fertility Agents|fertility agents|mesh-ancestor
110357315|NCT00541047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110357316|NCT00541047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110357317|NCT00541047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110357318|NCT00541047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110357319|NCT00541047|Androgen Antagonists|androgen antagonists|mesh-ancestor
110357320|NCT00541047|Hormone Antagonists|hormone antagonists|mesh-ancestor
110357321|NCT00541047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110357323|NCT00541086|Letrozole|letrozole|mesh-list
110357324|NCT00541086|Anastrozole|anastrozole|mesh-list
110357325|NCT00541086|Exemestane|exemestane|mesh-list
110357326|NCT00541086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110357327|NCT00541086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110357328|NCT00541086|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110357329|NCT00541086|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110357330|NCT00541086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110357331|NCT00541086|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110357332|NCT00541086|Hormone Antagonists|hormone antagonists|mesh-ancestor
110357333|NCT00541086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110357334|NCT00541086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110357335|NCT00541086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110357336|NCT00541086|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110357337|NCT00541086|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110357338|NCT00541086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110357339|NCT04657484|Prednisolone|prednisolone|mesh-list
110357340|NCT04657484|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110357341|NCT04657484|Methylprednisolone|methylprednisolone|mesh-list
110357342|NCT04657484|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110357343|NCT04657484|Prednisolone acetate|prednisolone acetate|mesh-list
110357344|NCT04657484|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110357345|NCT04657484|Prednisolone phosphate|prednisolone phosphate|mesh-list
110357346|NCT04657484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110357347|NCT04657484|Glucocorticoids|glucocorticoids|mesh-ancestor
110357348|NCT04657484|Hormones|hormones|mesh-ancestor
110357349|NCT04657484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110357350|NCT04657484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110357351|NCT04657484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110357352|NCT04657484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110357353|NCT04657484|Antiemetics|antiemetics|mesh-ancestor
110357354|NCT04657484|Autonomic Agents|autonomic agents|mesh-ancestor
110357355|NCT04657484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110357356|NCT04657484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110357357|NCT04657484|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110357358|NCT04657484|Protective Agents|protective agents|mesh-ancestor
110357359|NCT00541125|Leucovorin|leucovorin|mesh-list
110357360|NCT00541125|Bevacizumab|bevacizumab|mesh-list
110357361|NCT00541125|Fluorouracil|fluorouracil|mesh-list
110357362|NCT00541125|Irinotecan|irinotecan|mesh-list
110357363|NCT00541125|Calcium|calcium|mesh-list
110357364|NCT00541125|Levoleucovorin|levoleucovorin|mesh-list
110357365|NCT00541125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110357366|NCT00541125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110357367|NCT00541125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110357368|NCT00541125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110357369|NCT00541125|Growth Substances|growth substances|mesh-ancestor
110357370|NCT00541125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110357371|NCT00541125|Growth Inhibitors|growth inhibitors|mesh-ancestor
110357372|NCT00541125|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110357373|NCT00541125|Antimetabolites|antimetabolites|mesh-ancestor
110357374|NCT00541125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110357375|NCT00541125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110357376|NCT00541125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110357377|NCT00541125|Immunologic Factors|immunologic factors|mesh-ancestor
110357378|NCT00541125|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110357379|NCT00541125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110357380|NCT00541125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110357381|NCT00541125|Antidotes|antidotes|mesh-ancestor
110357382|NCT00541125|Protective Agents|protective agents|mesh-ancestor
110357383|NCT00541125|Vitamin B Complex|vitamin b complex|mesh-ancestor
110357385|NCT00541125|Micronutrients|micronutrients|mesh-ancestor
110357386|NCT00541164|Ubiquinone|ubiquinone|mesh-list
110357387|NCT00541164|Coenzyme Q10|coenzyme q10|mesh-list
110357388|NCT00541164|Micronutrients|micronutrients|mesh-ancestor
110357389|NCT00541164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110357391|NCT00541281|Prednisone|prednisone|mesh-list
110357392|NCT00541281|Docetaxel|docetaxel|mesh-list
110357393|NCT00541281|Estramustine|estramustine|mesh-list
110357394|NCT00541281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110357395|NCT00541281|Tubulin Modulators|tubulin modulators|mesh-ancestor
110357396|NCT00541281|Antimitotic Agents|antimitotic agents|mesh-ancestor
110357397|NCT00541281|Mitosis Modulators|mitosis modulators|mesh-ancestor
110357398|NCT00541281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110357399|NCT00541281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110357400|NCT00541281|Glucocorticoids|glucocorticoids|mesh-ancestor
110357401|NCT00541281|Hormones|hormones|mesh-ancestor
110357402|NCT00541281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110357403|NCT00541281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110357404|NCT00541281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110357405|NCT00541281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110357406|NCT00541281|Alkylating Agents|alkylating agents|mesh-ancestor
110357407|NCT00541320|2-(5-chlorothien-2-yl)-N-(1-(1-methyl-2-(morpholin-4-yl)-2-oxoethyl)-2-oxopyrrolidin-3-yl)ethenesulfonamide|2-(5-chlorothien-2-yl)-n-(1-(1-methyl-2-(morpholin-4-yl)-2-oxoethyl)-2-oxopyrrolidin-3-yl)ethenesulfonamide|mesh-list
110357408|NCT00541320|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110357409|NCT00541320|Antithrombins|antithrombins|mesh-ancestor
110357410|NCT00541320|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110357411|NCT00541320|Protease Inhibitors|protease inhibitors|mesh-ancestor
110033850|NCT02578368|Vitamins|vitamins|mesh-ancestor
110357412|NCT00541320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110357413|NCT00541320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110357414|NCT00541320|Anticoagulants|anticoagulants|mesh-ancestor
110357416|NCT04657172|Miotics|miotics|mesh-ancestor
110357417|NCT04657172|Autonomic Agents|autonomic agents|mesh-ancestor
110357418|NCT04657172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110357419|NCT04657172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110357420|NCT04657172|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110357421|NCT04657172|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110357422|NCT04657172|Cholinergic Agents|cholinergic agents|mesh-ancestor
110357423|NCT04657172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110357424|NCT04657172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110357425|NCT03199794|Factor VIII|factor viii|mesh-list
110357426|NCT03199794|Coagulants|coagulants|mesh-ancestor
110357427|NCT00541359|Bortezomib|bortezomib|mesh-list
110357428|NCT00541359|Topotecan|topotecan|mesh-list
110357429|NCT00541359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110357430|NCT00541359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110357431|NCT00541359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110357432|NCT00541359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110357433|NCT00541359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110357434|NCT03096249|Oxytocin|oxytocin|mesh-list
110357435|NCT03096249|Oxytocics|oxytocics|mesh-ancestor
110357436|NCT03096249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110357437|NCT03096249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110357438|NCT04656665|Aspirin|aspirin|mesh-list
110357439|NCT04656665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110357440|NCT04656665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110357441|NCT04656665|Analgesics|analgesics|mesh-ancestor
110357442|NCT04656665|Sensory System Agents|sensory system agents|mesh-ancestor
110357443|NCT04656665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110357444|NCT04656665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110357446|NCT04656665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110357447|NCT04656665|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110357448|NCT04656665|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110357449|NCT04656665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110357450|NCT04656665|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110357451|NCT04656665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110357452|NCT04656665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110357453|NCT04656665|Antipyretics|antipyretics|mesh-ancestor
110357454|NCT03014622|Botulinum Toxins|botulinum toxins|mesh-list
110357455|NCT03014622|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110357456|NCT03014622|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110357457|NCT03014622|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110357458|NCT03014622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110357459|NCT03014622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110357460|NCT03014622|Cholinergic Agents|cholinergic agents|mesh-ancestor
110357461|NCT03014622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110357462|NCT03014622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110357463|NCT03014622|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110357464|NCT03014622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110357465|NCT04655807|Adalimumab|adalimumab|mesh-list
110357466|NCT04655807|Ustekinumab|ustekinumab|mesh-list
110357467|NCT04655807|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110357468|NCT04655807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110357469|NCT04655807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110357470|NCT04655807|Dermatologic Agents|dermatologic agents|mesh-ancestor
110357471|NCT04655417|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
110357472|NCT04655417|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
110357474|NCT00541515|Insulin|insulin|mesh-list
110357475|NCT00541515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110357476|NCT00541515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110357477|NCT04655729|Infliximab|infliximab|mesh-list
110357478|NCT04655729|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110357479|NCT04655729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110357480|NCT04655729|Dermatologic Agents|dermatologic agents|mesh-ancestor
110357481|NCT04655729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110357482|NCT04655729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110357483|NCT00541554|Aripiprazole|aripiprazole|mesh-list
110357484|NCT00541554|Antidepressive Agents|antidepressive agents|mesh-ancestor
110357485|NCT00541554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110357486|NCT00541554|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110357487|NCT00541554|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110357488|NCT00541554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110357489|NCT00541554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110357490|NCT00541554|Dopamine Agonists|dopamine agonists|mesh-ancestor
110357492|NCT00541554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110357493|NCT00541554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110357494|NCT00541554|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110357495|NCT00541554|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110357496|NCT00541554|Serotonin Agents|serotonin agents|mesh-ancestor
110357497|NCT00541554|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110357498|NCT00541554|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110357499|NCT00541554|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110357500|NCT00541554|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110357501|NCT04655183|Niraparib|niraparib|mesh-list
110357502|NCT04655183|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110357503|NCT04655183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110357504|NCT04655183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110357505|NCT04655183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110357506|NCT00541710|Genistein|genistein|mesh-list
110357507|NCT00541710|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110357509|NCT00541710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110357510|NCT00541710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110357511|NCT00541710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110357512|NCT00541710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110357513|NCT00541710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110357514|NCT00541710|Phytoestrogens|phytoestrogens|mesh-ancestor
110357515|NCT00541710|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110357516|NCT00541710|Estrogens|estrogens|mesh-ancestor
110357517|NCT00541710|Hormones|hormones|mesh-ancestor
110357518|NCT00541710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110357519|NCT04654676|Vildagliptin|vildagliptin|mesh-list
110357520|NCT04654676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110357521|NCT04654676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110357522|NCT04654676|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110357523|NCT04654676|Protease Inhibitors|protease inhibitors|mesh-ancestor
110357524|NCT04654676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110357525|NCT04654676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110357526|NCT00541905|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
110357527|NCT00541905|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110357528|NCT00541905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110357529|NCT00541905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110357530|NCT00541905|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110357531|NCT00541905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110357532|NCT00541905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110357533|NCT00541905|Cholinergic Agents|cholinergic agents|mesh-ancestor
110357534|NCT00541905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110357536|NCT00542022|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110357537|NCT00542022|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110357538|NCT00542022|Adrenergic Agents|adrenergic agents|mesh-ancestor
110357539|NCT00542022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110357540|NCT00542022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110357541|NCT00542022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110357542|NCT00542022|Sympathomimetics|sympathomimetics|mesh-ancestor
110357543|NCT00542022|Autonomic Agents|autonomic agents|mesh-ancestor
110357544|NCT00542022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110357545|NCT00542022|Nasal Decongestants|nasal decongestants|mesh-ancestor
110357546|NCT00542022|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110357547|NCT00542022|Respiratory System Agents|respiratory system agents|mesh-ancestor
110176779|NCT00083785|Talaporfin|talaporfin|mesh-list
110357549|NCT02546583|Furosemide|furosemide|mesh-list
110357550|NCT02546583|Bumetanide|bumetanide|mesh-list
110357551|NCT02546583|Diuretics|diuretics|mesh-list
110357552|NCT02546583|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
110357553|NCT02546583|Natriuretic Agents|natriuretic agents|mesh-ancestor
110357554|NCT02546583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110357555|NCT02546583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110357556|NCT02546583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110357557|NCT02546583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110357558|NCT02546583|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110357559|NCT01205581|Vaccines|vaccines|mesh-list
110357560|NCT01205581|Immunologic Factors|immunologic factors|mesh-ancestor
110357561|NCT01205581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110357562|NCT00542139|Betamethasone|betamethasone|mesh-list
110357563|NCT00542139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110357564|NCT00542139|Glucocorticoids|glucocorticoids|mesh-ancestor
110357565|NCT00542139|Hormones|hormones|mesh-ancestor
110357566|NCT00542139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110357567|NCT00542139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110357568|NCT00542139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110357569|NCT00542139|Respiratory System Agents|respiratory system agents|mesh-ancestor
110357570|NCT00542295|Mebeverine|mebeverine|mesh-list
110357571|NCT00542295|Alverine|alverine|mesh-list
110357572|NCT00542295|Parasympatholytics|parasympatholytics|mesh-ancestor
110357573|NCT00542295|Autonomic Agents|autonomic agents|mesh-ancestor
110357574|NCT00542295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110357575|NCT00542295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110357576|NCT00542295|Anticonvulsants|anticonvulsants|mesh-ancestor
110357577|NCT03454841|Ticagrelor|ticagrelor|mesh-list
110357578|NCT03454841|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110357579|NCT03454841|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110357580|NCT03454841|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110357581|NCT03454841|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110357582|NCT03454841|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110357583|NCT03454841|Purinergic Agents|purinergic agents|mesh-ancestor
110357584|NCT03454841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110357585|NCT03454841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110357586|NCT03454841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110357587|NCT02293980|Nivolumab|nivolumab|mesh-list
110357588|NCT02293980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110357589|NCT02293980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110357590|NCT02293980|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110357591|NCT02293980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110357592|NCT04653506|Acetaminophen|acetaminophen|mesh-list
110357593|NCT04653506|Ibuprofen|ibuprofen|mesh-list
110357594|NCT04653506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110357595|NCT04653506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110357596|NCT04653506|Analgesics|analgesics|mesh-ancestor
110357597|NCT04653506|Sensory System Agents|sensory system agents|mesh-ancestor
110357598|NCT04653506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110357599|NCT04653506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110357600|NCT04653506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110357601|NCT04653506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110357602|NCT04653506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110357603|NCT04653506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110357604|NCT04653506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110357605|NCT04653506|Antipyretics|antipyretics|mesh-ancestor
110357606|NCT00542412|Riluzole|riluzole|mesh-list
110357607|NCT00542412|Anticonvulsants|anticonvulsants|mesh-ancestor
110357608|NCT00542412|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110357609|NCT00542412|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110357610|NCT00542412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110357611|NCT00542412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110357612|NCT00542412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110357613|NCT00542412|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110357614|NCT00542412|Protective Agents|protective agents|mesh-ancestor
110357615|NCT04653623|Tranexamic Acid|tranexamic acid|mesh-list
110357616|NCT04653623|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110357617|NCT04653623|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110357618|NCT04653623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110357620|NCT04653623|Coagulants|coagulants|mesh-ancestor
110357621|NCT00542568|Epoetin Alfa|epoetin alfa|mesh-list
110357622|NCT00542568|Hematinics|hematinics|mesh-ancestor
110357623|NCT04653779|Metformin|metformin|mesh-list
110357624|NCT04653779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110357625|NCT04653779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110357626|NCT00542607|Levocetirizine|levocetirizine|mesh-list
110357627|NCT00542607|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110357628|NCT00542607|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110357629|NCT00542607|Histamine Antagonists|histamine antagonists|mesh-ancestor
110357630|NCT00542607|Histamine Agents|histamine agents|mesh-ancestor
110357631|NCT00542607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110357632|NCT00542607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110357633|NCT00542607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110357634|NCT04685031|Clobetasol|clobetasol|mesh-list
110357635|NCT04685031|Nitroglycerin|nitroglycerin|mesh-list
110357636|NCT04685031|Vasodilator Agents|vasodilator agents|mesh-ancestor
110357637|NCT04685031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110357638|NCT04685031|Glucocorticoids|glucocorticoids|mesh-ancestor
110357639|NCT04685031|Hormones|hormones|mesh-ancestor
110033930|NCT02293109|Hormones|hormones|mesh-ancestor
110357640|NCT04685031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110357641|NCT04685031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110357642|NCT00542763|Mycophenolic Acid|mycophenolic acid|mesh-list
110357643|NCT00542763|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110357644|NCT00542763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110357645|NCT00542763|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110357646|NCT00542763|Antitubercular Agents|antitubercular agents|mesh-ancestor
110357647|NCT00542763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110357648|NCT00542763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110357649|NCT00542763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110357650|NCT00542763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110357651|NCT01854684|Temoporfin|temoporfin|mesh-list
110357652|NCT01854684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110357653|NCT01854684|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110357654|NCT01854684|Dermatologic Agents|dermatologic agents|mesh-ancestor
110357655|NCT00542802|Carbamazepine|carbamazepine|mesh-list
110357656|NCT00542802|Levetiracetam|levetiracetam|mesh-list
110357657|NCT00542802|Anticonvulsants|anticonvulsants|mesh-ancestor
110357658|NCT00542802|Nootropic Agents|nootropic agents|mesh-ancestor
110357659|NCT00542802|Antimanic Agents|antimanic agents|mesh-ancestor
110357660|NCT00542802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110357661|NCT00542802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110357662|NCT00542802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110357663|NCT00542802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110357664|NCT00542802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110357665|NCT00542802|Analgesics|analgesics|mesh-ancestor
110357666|NCT00542802|Sensory System Agents|sensory system agents|mesh-ancestor
110357667|NCT00542802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110357668|NCT00542802|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110357669|NCT00542802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110357670|NCT00542802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110357671|NCT00542802|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110357672|NCT00542802|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110357673|NCT04652648|Hydroxychloroquine|hydroxychloroquine|mesh-list
110357674|NCT04652648|Antimalarials|antimalarials|mesh-ancestor
110357675|NCT04652648|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110357676|NCT04652648|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110357677|NCT04652648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110357678|NCT04652648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110357679|NCT04652648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110357680|NCT04652648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110357681|NCT00542841|Hydrocortisone|hydrocortisone|mesh-list
110357682|NCT00542841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110357683|NCT04652765|Bicalutamide|bicalutamide|mesh-list
110357684|NCT04652765|Camostat|camostat|mesh-list
110357685|NCT04652765|Androgen Antagonists|androgen antagonists|mesh-ancestor
110357686|NCT04652765|Hormone Antagonists|hormone antagonists|mesh-ancestor
110357687|NCT04652765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110357688|NCT04652765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110357689|NCT04652765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110357690|NCT04652765|Protease Inhibitors|protease inhibitors|mesh-ancestor
110357691|NCT04652765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110357692|NCT04652765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110357693|NCT04652765|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110357694|NCT04652765|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110357695|NCT04652492|Tislelizumab|tislelizumab|mesh-list
110357696|NCT04652492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110357697|NCT04652492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110357699|NCT00543075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110357700|NCT00543114|Rituximab|rituximab|mesh-list
110357701|NCT00543114|Fludarabine|fludarabine|mesh-list
110357702|NCT00543114|Lenalidomide|lenalidomide|mesh-list
110357703|NCT00543114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110357704|NCT00543114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110357705|NCT00543114|Immunologic Factors|immunologic factors|mesh-ancestor
110357706|NCT00543114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110357707|NCT00543114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110357708|NCT00543114|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110357709|NCT00543114|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110357710|NCT00543114|Growth Substances|growth substances|mesh-ancestor
110357711|NCT00543114|Growth Inhibitors|growth inhibitors|mesh-ancestor
110357712|NCT03454724|Sirolimus|sirolimus|mesh-list
110357713|NCT03454724|Everolimus|everolimus|mesh-list
110357714|NCT03454724|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110357715|NCT03454724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110357716|NCT03454724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110357717|NCT03454724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110357718|NCT03454724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110357719|NCT03454724|Immunologic Factors|immunologic factors|mesh-ancestor
110357720|NCT03454724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110357721|NCT03454724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110357722|NCT03454724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110357723|NCT03454724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110357724|NCT03454724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110357725|NCT03454724|Antifungal Agents|antifungal agents|mesh-ancestor
110357726|NCT01014546|Vitamins|vitamins|mesh-list
110357727|NCT01014546|Ascorbic Acid|ascorbic acid|mesh-list
110357728|NCT01014546|Arsenic Trioxide|arsenic trioxide|mesh-list
110357729|NCT01014546|Micronutrients|micronutrients|mesh-ancestor
110357730|NCT01014546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110357731|NCT01014546|Antioxidants|antioxidants|mesh-ancestor
110357732|NCT01014546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110357733|NCT01014546|Protective Agents|protective agents|mesh-ancestor
110357734|NCT01014546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110357735|NCT00543231|Oblimersen|oblimersen|mesh-list
110357736|NCT00543231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110176810|NCT05568082|Sotorasib|sotorasib|mesh-list
110357737|NCT00557843|Bupivacaine|bupivacaine|mesh-list
110357738|NCT00557843|Anesthetics, Local|anesthetics, local|mesh-ancestor
110357739|NCT00557843|Anesthetics|anesthetics|mesh-ancestor
110357740|NCT00557843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110357741|NCT00557843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110357742|NCT00557843|Sensory System Agents|sensory system agents|mesh-ancestor
110357743|NCT00557843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110357744|NCT04651556|Acetaminophen|acetaminophen|mesh-list
110357745|NCT04651556|Ketorolac|ketorolac|mesh-list
110357746|NCT04651556|Magnesium Sulfate|magnesium sulfate|mesh-list
110357747|NCT04651556|Bupivacaine|bupivacaine|mesh-list
110357748|NCT04651556|Anesthetics, Local|anesthetics, local|mesh-ancestor
110357749|NCT04651556|Anesthetics|anesthetics|mesh-ancestor
110357750|NCT04651556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110357751|NCT04651556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110357752|NCT04651556|Sensory System Agents|sensory system agents|mesh-ancestor
110357753|NCT04651556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110357754|NCT04651556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110357755|NCT04651556|Analgesics|analgesics|mesh-ancestor
110357756|NCT04651556|Antipyretics|antipyretics|mesh-ancestor
110357757|NCT04651556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110357758|NCT04651556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110357759|NCT04651556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110357760|NCT04651556|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110357761|NCT04651556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110357762|NCT04651556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110357763|NCT04651556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110357764|NCT04651556|Anticonvulsants|anticonvulsants|mesh-ancestor
110357765|NCT04651556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110357766|NCT04651556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110357767|NCT04651556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110357768|NCT04651556|Tocolytic Agents|tocolytic agents|mesh-ancestor
110357769|NCT04651556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110357770|NCT04651049|Propranolol|propranolol|mesh-list
110357771|NCT04651049|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110357772|NCT04651049|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110357773|NCT04651049|Adrenergic Agents|adrenergic agents|mesh-ancestor
110357774|NCT04651049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110357775|NCT04651049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110357776|NCT04651049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110357777|NCT04651049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110357778|NCT04651049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110357779|NCT04651049|Vasodilator Agents|vasodilator agents|mesh-ancestor
110357781|NCT04651205|Vitamins|vitamins|mesh-ancestor
110357782|NCT04651205|Micronutrients|micronutrients|mesh-ancestor
110357783|NCT04651205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110357784|NCT04651205|Vitamin B Complex|vitamin b complex|mesh-ancestor
110357785|NCT03456648|Apixaban|apixaban|mesh-list
110357786|NCT03456648|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110357787|NCT03456648|Antithrombins|antithrombins|mesh-ancestor
110357788|NCT03456648|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110357789|NCT03456648|Protease Inhibitors|protease inhibitors|mesh-ancestor
110357790|NCT03456648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110357791|NCT03456648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110357792|NCT03456648|Anticoagulants|anticoagulants|mesh-ancestor
110357793|NCT00557921|Aspirin|aspirin|mesh-list
110357794|NCT00557921|Omeprazole|omeprazole|mesh-list
110357795|NCT00557921|Clopidogrel|clopidogrel|mesh-list
110357796|NCT00557921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110357797|NCT00557921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110357798|NCT00557921|Analgesics|analgesics|mesh-ancestor
110357799|NCT00557921|Sensory System Agents|sensory system agents|mesh-ancestor
110357800|NCT00557921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110357801|NCT00557921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110357802|NCT00557921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110357803|NCT00557921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110357804|NCT00557921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110357805|NCT00557921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110357806|NCT00557921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110357807|NCT00557921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110357808|NCT00557921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110357809|NCT00557921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110357810|NCT00557921|Antipyretics|antipyretics|mesh-ancestor
110357811|NCT00557921|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110357812|NCT00557921|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110357813|NCT00557921|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110357814|NCT00557921|Purinergic Agents|purinergic agents|mesh-ancestor
110357815|NCT00557921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110357817|NCT00557921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110357818|NCT00557921|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110357819|NCT02352558|Dexamethasone|dexamethasone|mesh-list
110357820|NCT02352558|Bortezomib|bortezomib|mesh-list
110357821|NCT02352558|Imatinib Mesylate|imatinib mesylate|mesh-list
110357822|NCT02352558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110357823|NCT02352558|Antiemetics|antiemetics|mesh-ancestor
110357824|NCT02352558|Autonomic Agents|autonomic agents|mesh-ancestor
110357825|NCT02352558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110357826|NCT02352558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110357827|NCT02352558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110357828|NCT02352558|Glucocorticoids|glucocorticoids|mesh-ancestor
110357829|NCT02352558|Hormones|hormones|mesh-ancestor
110357830|NCT02352558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110357831|NCT02352558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110357832|NCT02352558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110357833|NCT02352558|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110357834|NCT02352558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110357835|NCT02352558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110357836|NCT02324283|Propofol|propofol|mesh-list
110357838|NCT02324283|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110357839|NCT02324283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110357840|NCT02324283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110357841|NCT02324283|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110357842|NCT02324283|Anesthetics, General|anesthetics, general|mesh-ancestor
110357843|NCT02324283|Anesthetics|anesthetics|mesh-ancestor
110357844|NCT02324283|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110357845|NCT00557960|Amphetamine|amphetamine|mesh-list
110357846|NCT00557960|Adderall|adderall|mesh-list
110357847|NCT00557960|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110357848|NCT00557960|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110357849|NCT00557960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110357850|NCT00557960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110357851|NCT00557960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110357852|NCT00557960|Adrenergic Agents|adrenergic agents|mesh-ancestor
110357853|NCT00557960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110357854|NCT00557960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110357855|NCT00557960|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110357856|NCT00557960|Sympathomimetics|sympathomimetics|mesh-ancestor
110357857|NCT00557960|Autonomic Agents|autonomic agents|mesh-ancestor
110357858|NCT00557960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110357859|NCT00557960|Dopamine Agents|dopamine agents|mesh-ancestor
110357860|NCT00557960|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110357861|NCT00558077|Metformin|metformin|mesh-list
110357862|NCT00558077|Clomiphene|clomiphene|mesh-list
110357863|NCT00558077|Enclomiphene|enclomiphene|mesh-list
110357864|NCT00558077|Zuclomiphene|zuclomiphene|mesh-list
110357865|NCT00558077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110357866|NCT00558077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110357867|NCT00558077|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110357868|NCT00558077|Hormone Antagonists|hormone antagonists|mesh-ancestor
110260183|NCT02944201|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110357869|NCT00558077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110357870|NCT00558077|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110357871|NCT00558077|Fertility Agents|fertility agents|mesh-ancestor
110357872|NCT00558077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110357873|NCT00558077|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110176825|NCT05567653|Sulfalene|sulfalene|mesh-list
110357874|NCT00558077|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110357875|NCT05077254|Mycophenolic Acid|mycophenolic acid|mesh-list
110357876|NCT05077254|Vaccines|vaccines|mesh-list
110357877|NCT05077254|Tacrolimus|tacrolimus|mesh-list
110357878|NCT05077254|Immunologic Factors|immunologic factors|mesh-ancestor
110357879|NCT05077254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110357880|NCT05077254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110357881|NCT05077254|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110357882|NCT05077254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110357883|NCT05077254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110357884|NCT05077254|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110357885|NCT05077254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110357886|NCT05077254|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110357887|NCT05077254|Antitubercular Agents|antitubercular agents|mesh-ancestor
110357888|NCT05077254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110357889|NCT05077254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110357890|NCT00543504|Bevacizumab|bevacizumab|mesh-list
110357891|NCT00543504|Trastuzumab|trastuzumab|mesh-list
110357892|NCT00543504|Cetuximab|cetuximab|mesh-list
110357893|NCT00543504|Sunitinib|sunitinib|mesh-list
110357894|NCT00543504|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110357895|NCT00543504|Sorafenib|sorafenib|mesh-list
110357896|NCT00543504|Lapatinib|lapatinib|mesh-list
110357897|NCT00543504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110357898|NCT00543504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110357899|NCT00543504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110357900|NCT00543504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110357901|NCT00543504|Growth Substances|growth substances|mesh-ancestor
110357902|NCT00543504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110357903|NCT00543504|Growth Inhibitors|growth inhibitors|mesh-ancestor
110357904|NCT00543504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110357905|NCT00543504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110357906|NCT00543504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110357908|NCT00543933|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110357909|NCT00543933|Autonomic Agents|autonomic agents|mesh-ancestor
110357910|NCT00543933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110357911|NCT00543933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110357912|NCT00543933|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110357913|NCT00543933|Respiratory System Agents|respiratory system agents|mesh-ancestor
110357914|NCT00543933|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110357915|NCT00543933|Antioxidants|antioxidants|mesh-ancestor
110357916|NCT00543933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110357917|NCT00543933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110357918|NCT00543933|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110357919|NCT00543933|Vasodilator Agents|vasodilator agents|mesh-ancestor
110357920|NCT00543933|Gasotransmitters|gasotransmitters|mesh-ancestor
110357921|NCT00543933|Protective Agents|protective agents|mesh-ancestor
110357922|NCT00544011|Bevacizumab|bevacizumab|mesh-list
110357923|NCT00544011|Fluorouracil|fluorouracil|mesh-list
110357924|NCT00544011|Capecitabine|capecitabine|mesh-list
110357925|NCT00544011|Irinotecan|irinotecan|mesh-list
110357926|NCT00544011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110357927|NCT00544011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110357928|NCT00544011|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110357929|NCT00544011|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110357930|NCT00544011|Growth Substances|growth substances|mesh-ancestor
110357931|NCT00544011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110357932|NCT00544011|Growth Inhibitors|growth inhibitors|mesh-ancestor
110357933|NCT00544011|Antimetabolites|antimetabolites|mesh-ancestor
110357934|NCT00544011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110357935|NCT00544011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110357936|NCT00544011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110357937|NCT00544011|Immunologic Factors|immunologic factors|mesh-ancestor
110357938|NCT00544011|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110357939|NCT00544011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110357940|NCT00544011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110357941|NCT00544050|Levetiracetam|levetiracetam|mesh-list
110357942|NCT00544050|Anticonvulsants|anticonvulsants|mesh-ancestor
110357943|NCT00544050|Nootropic Agents|nootropic agents|mesh-ancestor
110357944|NCT04649723|Rifampin|rifampin|mesh-list
110357945|NCT04649723|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110357946|NCT04649723|Antitubercular Agents|antitubercular agents|mesh-ancestor
110357947|NCT04649723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110357948|NCT04649723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110357949|NCT04649723|Leprostatic Agents|leprostatic agents|mesh-ancestor
110357950|NCT04649723|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110357951|NCT04649723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110357952|NCT04649723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110357953|NCT04649723|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110357954|NCT04649723|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110357955|NCT04649723|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110357956|NCT04649723|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110357957|NCT04649723|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110357958|NCT04649723|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110357960|NCT02909088|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110357961|NCT02909088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110357962|NCT02909088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110357963|NCT02909088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110357964|NCT02909088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110357965|NCT02909088|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110357966|NCT02909088|Dopamine Agents|dopamine agents|mesh-ancestor
110357967|NCT02909088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110357968|NCT02909088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110357969|NCT04649645|Nicotine|nicotine|mesh-list
110357970|NCT04649645|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110357971|NCT04649645|Autonomic Agents|autonomic agents|mesh-ancestor
110357972|NCT04649645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110357973|NCT04649645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110357974|NCT04649645|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110357975|NCT04649645|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110357976|NCT04649645|Cholinergic Agents|cholinergic agents|mesh-ancestor
110357977|NCT04649645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110357978|NCT04649645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110357979|NCT00544128|Ritonavir|ritonavir|mesh-list
110357980|NCT00544128|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110357981|NCT00544128|Tenofovir|tenofovir|mesh-list
110357982|NCT00544128|Lamivudine|lamivudine|mesh-list
110357983|NCT00544128|Emtricitabine|emtricitabine|mesh-list
110357984|NCT00544128|Abacavir|abacavir|mesh-list
110357985|NCT00544128|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110357986|NCT00544128|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110357987|NCT00544128|Protease Inhibitors|protease inhibitors|mesh-ancestor
110357988|NCT00544128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110357989|NCT00544128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110357990|NCT00544128|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110357991|NCT00544128|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110357992|NCT00544128|Antiviral Agents|antiviral agents|mesh-ancestor
110357993|NCT00544128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110357994|NCT00544128|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110357995|NCT00544128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110357996|NCT00544128|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110357997|NCT00544128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110357998|NCT05476432|Leucovorin|leucovorin|mesh-list
110357999|NCT05476432|Fluorouracil|fluorouracil|mesh-list
110358000|NCT05476432|Oxaliplatin|oxaliplatin|mesh-list
110358001|NCT05476432|Antimetabolites|antimetabolites|mesh-ancestor
110358002|NCT05476432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110358003|NCT05476432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110358004|NCT05476432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110358005|NCT05476432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110358006|NCT05476432|Immunologic Factors|immunologic factors|mesh-ancestor
110358007|NCT05476432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110358008|NCT05476432|Antidotes|antidotes|mesh-ancestor
110358009|NCT05476432|Protective Agents|protective agents|mesh-ancestor
110358010|NCT05476432|Vitamin B Complex|vitamin b complex|mesh-ancestor
110358011|NCT05476432|Vitamins|vitamins|mesh-ancestor
110358012|NCT05476432|Micronutrients|micronutrients|mesh-ancestor
110358014|NCT01239745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110358015|NCT01239745|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110358016|NCT01239745|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110358017|NCT01239745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110358018|NCT01239745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034009|NCT01729754|Etanercept|etanercept|mesh-list
110358019|NCT01239745|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110358020|NCT01239745|Hormone Antagonists|hormone antagonists|mesh-ancestor
110358021|NCT01239745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110358022|NCT01239745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110358024|NCT01239472|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110358025|NCT01239472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110358026|NCT01239472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110358027|NCT01239472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110358028|NCT01239472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110358029|NCT01239472|Immunologic Factors|immunologic factors|mesh-ancestor
110358030|NCT01239472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110358031|NCT01239472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110358032|NCT00544284|Temozolomide|temozolomide|mesh-list
110358033|NCT00544284|Bortezomib|bortezomib|mesh-list
110358034|NCT00544284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110358035|NCT00544284|Alkylating Agents|alkylating agents|mesh-ancestor
110358036|NCT00544284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110358037|NCT00544284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110358038|NCT02888275|Dexmedetomidine|dexmedetomidine|mesh-list
110358039|NCT02888275|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110358040|NCT02888275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110358041|NCT02888275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110358042|NCT02888275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110358043|NCT02888275|Analgesics|analgesics|mesh-ancestor
110358044|NCT02888275|Sensory System Agents|sensory system agents|mesh-ancestor
110358045|NCT02888275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110358046|NCT02888275|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110358047|NCT02888275|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110358048|NCT02888275|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110358049|NCT02888275|Adrenergic Agents|adrenergic agents|mesh-ancestor
110358050|NCT02888275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110358051|NCT02888275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110358052|NCT03456531|Aspirin|aspirin|mesh-list
110358053|NCT03456531|Analgesics|analgesics|mesh-list
110358054|NCT03456531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110358055|NCT03456531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110358056|NCT03456531|Sensory System Agents|sensory system agents|mesh-ancestor
110358057|NCT03456531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110358058|NCT03456531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110358059|NCT03456531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110358060|NCT03456531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110358062|NCT03456531|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110358063|NCT03456531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110358064|NCT03456531|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110358065|NCT03456531|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110358067|NCT03456531|Antipyretics|antipyretics|mesh-ancestor
110358069|NCT02909049|Ketamine|ketamine|mesh-list
110358070|NCT02909049|Mepivacaine|mepivacaine|mesh-list
110358071|NCT02909049|Analgesics|analgesics|mesh-ancestor
110358072|NCT02909049|Sensory System Agents|sensory system agents|mesh-ancestor
110358073|NCT02909049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110358074|NCT02909049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110358075|NCT02909049|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110358076|NCT02909049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110358077|NCT02909049|Anesthetics, General|anesthetics, general|mesh-ancestor
110358078|NCT02909049|Anesthetics|anesthetics|mesh-ancestor
110358079|NCT02909049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110358080|NCT02909049|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110176847|NCT00135304|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
110358081|NCT02909049|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110358082|NCT02909049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110358083|NCT02909049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110358084|NCT02909049|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110358085|NCT02909049|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110358086|NCT02909049|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110358087|NCT02909049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110358088|NCT02909049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110358089|NCT02909049|GABA Modulators|gaba modulators|mesh-ancestor
110358090|NCT02909049|GABA Agents|gaba agents|mesh-ancestor
110358091|NCT02909049|Anesthetics, Local|anesthetics, local|mesh-ancestor
110358092|NCT01229449|Acetaminophen|acetaminophen|mesh-list
110358094|NCT01229449|Codeine|codeine|mesh-list
110358095|NCT01229449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110358096|NCT01229449|Analgesics|analgesics|mesh-ancestor
110358097|NCT01229449|Sensory System Agents|sensory system agents|mesh-ancestor
110358098|NCT01229449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110358099|NCT01229449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110358100|NCT01229449|Antipyretics|antipyretics|mesh-ancestor
110358101|NCT01229449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110358102|NCT01229449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110358103|NCT01229449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110358104|NCT01229449|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110358105|NCT01229449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110358106|NCT01229449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110358107|NCT01229449|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110358108|NCT01229449|Narcotics|narcotics|mesh-ancestor
110358109|NCT01229449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110358110|NCT01229449|Antitussive Agents|antitussive agents|mesh-ancestor
110358111|NCT01229449|Respiratory System Agents|respiratory system agents|mesh-ancestor
110358112|NCT01238575|Guanfacine|guanfacine|mesh-list
110358113|NCT01238575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110358114|NCT01238575|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110358115|NCT01238575|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110358116|NCT01238575|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110358117|NCT01238575|Adrenergic Agents|adrenergic agents|mesh-ancestor
110358118|NCT01238575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110358119|NCT01238575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110358120|NCT01238575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110358121|NCT06022419|Calpastatin|calpastatin|mesh-list
110358122|NCT06022419|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
110358123|NCT06022419|Protease Inhibitors|protease inhibitors|mesh-ancestor
110358124|NCT06022419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110358125|NCT06022419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110358127|NCT06022276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110358128|NCT06022276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110358130|NCT06022237|Cholecalciferol|cholecalciferol|mesh-list
110358131|NCT06022237|Ibandronic Acid|ibandronic acid|mesh-list
110358132|NCT06022237|Calcium|calcium|mesh-list
110358133|NCT06022237|Vitamins|vitamins|mesh-ancestor
110358134|NCT06022237|Micronutrients|micronutrients|mesh-ancestor
110358135|NCT06022237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110358136|NCT06022237|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110358137|NCT06022237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110358138|NCT06022198|Dimercaprol|dimercaprol|mesh-list
110358139|NCT06022198|Chelating Agents|chelating agents|mesh-ancestor
110358140|NCT06022198|Sequestering Agents|sequestering agents|mesh-ancestor
110358141|NCT06022198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110358142|NCT06022029|Cemiplimab|cemiplimab|mesh-list
110358143|NCT06022029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110358144|NCT06022029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110358145|NCT06021977|Zanubrutinib|zanubrutinib|mesh-list
110358146|NCT06021977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110358147|NCT06021977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110358148|NCT06021977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110358156|NCT06021951|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110358157|NCT06021951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110358158|NCT06021951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110358159|NCT06021951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110358160|NCT06021912|Immunomodulating Agents|immunomodulating agents|mesh-list
110358161|NCT06021912|Immunologic Factors|immunologic factors|mesh-ancestor
110358162|NCT06021912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110358171|NCT06021847|Chlorhexidine|chlorhexidine|mesh-list
110358172|NCT06021847|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110358173|NCT06021847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110358174|NCT06021847|Disinfectants|disinfectants|mesh-ancestor
110358175|NCT06021756|Ketamine|ketamine|mesh-list
110358176|NCT06021756|Analgesics|analgesics|mesh-ancestor
110358177|NCT06021756|Sensory System Agents|sensory system agents|mesh-ancestor
110358178|NCT06021756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110358179|NCT06021756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110358180|NCT06021756|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110358181|NCT06021756|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110358182|NCT06021756|Anesthetics, General|anesthetics, general|mesh-ancestor
110358183|NCT06021756|Anesthetics|anesthetics|mesh-ancestor
110358184|NCT06021756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110358185|NCT06021756|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110358186|NCT06021756|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110358187|NCT06021756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110358188|NCT06021756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110358189|NCT06021717|Ketamine|ketamine|mesh-list
110358190|NCT06021717|Morphine|morphine|mesh-list
110358191|NCT06021717|Analgesics|analgesics|mesh-ancestor
110358192|NCT06021717|Sensory System Agents|sensory system agents|mesh-ancestor
110358193|NCT06021717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110358194|NCT06021717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110358195|NCT06021717|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110358196|NCT06021717|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110358197|NCT06021717|Anesthetics, General|anesthetics, general|mesh-ancestor
110358199|NCT06021717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110358200|NCT06021717|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110358201|NCT06021717|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110358202|NCT06021717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110358203|NCT06021717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110358204|NCT06021717|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110358205|NCT06021717|Narcotics|narcotics|mesh-ancestor
110358206|NCT06021678|Antibodies, Bispecific|antibodies, bispecific|mesh-list
110358207|NCT06021678|Immunologic Factors|immunologic factors|mesh-ancestor
110358208|NCT06021678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110358209|NCT06021587|Simendan|simendan|mesh-list
110358210|NCT06021587|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110358211|NCT06021587|Vasodilator Agents|vasodilator agents|mesh-ancestor
110358212|NCT06021587|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110358213|NCT06021587|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110358214|NCT06021587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110358215|NCT06021587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110358216|NCT06021587|Protective Agents|protective agents|mesh-ancestor
110358217|NCT06021587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110358218|NCT06021522|Ecopipam|ecopipam|mesh-list
110358219|NCT06021522|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110358220|NCT06021522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110358221|NCT06021522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110358222|NCT06021522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110358223|NCT06021522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110358224|NCT06021522|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110358225|NCT06021522|Dopamine Agents|dopamine agents|mesh-ancestor
110358226|NCT06021522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110358227|NCT06021522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110358229|NCT06021210|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110358230|NCT06021210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110358231|NCT06021210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110358232|NCT06021210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110358233|NCT06021210|Antiviral Agents|antiviral agents|mesh-ancestor
110358234|NCT06021210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110358235|NCT06021145|Empagliflozin|empagliflozin|mesh-list
110358236|NCT06021145|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110358237|NCT06021145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110358238|NCT06021145|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110358239|NCT06021145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110358240|NCT06021119|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
110358241|NCT06021119|Protease Inhibitors|protease inhibitors|mesh-ancestor
110358242|NCT06021119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110358243|NCT06021119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110358244|NCT06021119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110358245|NCT06021119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110358246|NCT06021015|Irinotecan|irinotecan|mesh-list
110358247|NCT06021015|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110358248|NCT06021015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110358249|NCT06021015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110358250|NCT06021015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110358251|NCT06021015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110358252|NCT06020989|Carboplatin|carboplatin|mesh-list
110358253|NCT06020989|Pemetrexed|pemetrexed|mesh-list
110358254|NCT06020989|Lazertinib|lazertinib|mesh-list
110358255|NCT06020989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110358256|NCT06020989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110358257|NCT06020989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110358258|NCT06020989|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110358259|NCT06020989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110358260|NCT06020989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110358261|NCT06020963|Tamsulosin|tamsulosin|mesh-list
110358262|NCT06020963|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110358263|NCT06020963|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110358264|NCT06020963|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110358265|NCT06020963|Adrenergic Agents|adrenergic agents|mesh-ancestor
110358266|NCT06020963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110358267|NCT06020963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110358268|NCT06020963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110358269|NCT06020963|Urological Agents|urological agents|mesh-ancestor
110358270|NCT06020898|Valproic Acid|valproic acid|mesh-list
110358271|NCT06020898|Anticonvulsants|anticonvulsants|mesh-ancestor
110358272|NCT06020898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110358273|NCT06020898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110358274|NCT06020898|GABA Agents|gaba agents|mesh-ancestor
110358275|NCT06020898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110358276|NCT06020898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110358277|NCT06020898|Antimanic Agents|antimanic agents|mesh-ancestor
110358278|NCT06020898|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110358279|NCT06020898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110358280|NCT06020898|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110358281|NCT06020885|Immunomodulating Agents|immunomodulating agents|mesh-list
110358282|NCT06020885|Immunologic Factors|immunologic factors|mesh-ancestor
110358283|NCT06020885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110358285|NCT06020833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110358286|NCT06020833|Keratolytic Agents|keratolytic agents|mesh-ancestor
110358287|NCT06020833|Dermatologic Agents|dermatologic agents|mesh-ancestor
110358288|NCT06020781|Dexmedetomidine|dexmedetomidine|mesh-list
110358289|NCT06020781|Bupivacaine|bupivacaine|mesh-list
110358290|NCT06020781|Anesthetics, Local|anesthetics, local|mesh-ancestor
110358291|NCT06020781|Anesthetics|anesthetics|mesh-ancestor
110358292|NCT06020781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110358293|NCT06020781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110358294|NCT06020781|Sensory System Agents|sensory system agents|mesh-ancestor
110358295|NCT06020781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110358296|NCT06020781|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110358297|NCT06020781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110358299|NCT06020781|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110358300|NCT06020781|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110358301|NCT06020781|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110358302|NCT06020781|Adrenergic Agents|adrenergic agents|mesh-ancestor
110358303|NCT06020781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110358304|NCT06020781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110358305|NCT06020716|Amoxicillin|amoxicillin|mesh-list
110358306|NCT06020716|Clavulanic Acid|clavulanic acid|mesh-list
110358307|NCT06020716|Clavulanic Acids|clavulanic acids|mesh-list
110358308|NCT06020716|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110358309|NCT06020716|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110358310|NCT06020716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110358311|NCT06020716|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110358312|NCT06020716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110358313|NCT06020716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110358314|NCT06016972|Timolol|timolol|mesh-list
110358315|NCT06016972|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110358316|NCT06016972|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110358317|NCT06016972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110358319|NCT06016972|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110358320|NCT06016972|Adrenergic Agents|adrenergic agents|mesh-ancestor
110358321|NCT06016972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110358322|NCT06016972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110358323|NCT06016972|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110358324|NCT06016972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110358325|NCT06014957|Anesthetics|anesthetics|mesh-list
110358326|NCT06014957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110358327|NCT06014957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110358328|NCT06011889|Etanercept|etanercept|mesh-list
110358329|NCT06011889|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110358330|NCT06011889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110358331|NCT06011889|Analgesics|analgesics|mesh-ancestor
110358332|NCT06011889|Sensory System Agents|sensory system agents|mesh-ancestor
110358333|NCT06011889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110358334|NCT06011889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110358335|NCT06011889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110358336|NCT06011889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110358337|NCT06011889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110358338|NCT06011889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110358339|NCT06011889|Immunologic Factors|immunologic factors|mesh-ancestor
110358340|NCT06010732|Listerine|listerine|mesh-list
110358341|NCT06010732|Fluorides|fluorides|mesh-list
110358342|NCT06010732|Sodium Fluoride|sodium fluoride|mesh-list
110358343|NCT06010732|Cariostatic Agents|cariostatic agents|mesh-ancestor
110358344|NCT06010732|Protective Agents|protective agents|mesh-ancestor
110358345|NCT06010732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110358346|NCT06010732|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110358347|NCT06010732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110358348|NCT06009185|Zamicastat|zamicastat|mesh-list
110358349|NCT06009185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110358350|NCT06009185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110358351|NCT06004739|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110358352|NCT06004739|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110358353|NCT06004739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110358354|NCT06004739|Antitubercular Agents|antitubercular agents|mesh-ancestor
110358355|NCT05993182|Ephedrine|ephedrine|mesh-list
110358356|NCT05993182|Pseudoephedrine|pseudoephedrine|mesh-list
110358357|NCT05993182|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110358358|NCT05993182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110358359|NCT05993182|Sympathomimetics|sympathomimetics|mesh-ancestor
110358360|NCT05993182|Autonomic Agents|autonomic agents|mesh-ancestor
110358361|NCT05993182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110358362|NCT05993182|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110358363|NCT05993182|Adrenergic Agents|adrenergic agents|mesh-ancestor
110358364|NCT05993182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110358365|NCT05993182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110358366|NCT05993182|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110358367|NCT05993182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110358368|NCT05993182|Respiratory System Agents|respiratory system agents|mesh-ancestor
110358369|NCT05993182|Nasal Decongestants|nasal decongestants|mesh-ancestor
110358370|NCT05989217|Salicylic Acid|salicylic acid|mesh-list
110358371|NCT05989217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110358372|NCT05989217|Antifungal Agents|antifungal agents|mesh-ancestor
110358373|NCT05989217|Keratolytic Agents|keratolytic agents|mesh-ancestor
110358374|NCT05989217|Dermatologic Agents|dermatologic agents|mesh-ancestor
110358375|NCT05975580|Topiramate|topiramate|mesh-list
110358376|NCT05975580|Phentermine|phentermine|mesh-list
110358377|NCT05975580|Anticonvulsants|anticonvulsants|mesh-ancestor
110358378|NCT05975580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110358379|NCT05975580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110358380|NCT05975580|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110358381|NCT05975580|Appetite Depressants|appetite depressants|mesh-ancestor
110358382|NCT05975580|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110358383|NCT05975580|Sympathomimetics|sympathomimetics|mesh-ancestor
110358384|NCT05975580|Autonomic Agents|autonomic agents|mesh-ancestor
110358385|NCT05975580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110358386|NCT05975580|Adrenergic Agents|adrenergic agents|mesh-ancestor
110358387|NCT05975580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110358388|NCT05975580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110358389|NCT05963347|Prednisone|prednisone|mesh-list
110358390|NCT05963347|Cyclophosphamide|cyclophosphamide|mesh-list
110358391|NCT05963347|Doxorubicin|doxorubicin|mesh-list
110358392|NCT05963347|Vincristine|vincristine|mesh-list
110358393|NCT05963347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110358394|NCT05963347|Immunologic Factors|immunologic factors|mesh-ancestor
110358395|NCT05963347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110358396|NCT05963347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110358397|NCT05963347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110358398|NCT05963347|Alkylating Agents|alkylating agents|mesh-ancestor
110358399|NCT05963347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110358400|NCT05963347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110358401|NCT05963347|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110358402|NCT05963347|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110358403|NCT05963347|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110358404|NCT05963347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110358405|NCT05963347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110358406|NCT05963347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110358407|NCT05963347|Glucocorticoids|glucocorticoids|mesh-ancestor
110358408|NCT05963347|Hormones|hormones|mesh-ancestor
110358409|NCT05963347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110358410|NCT05963347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110358411|NCT05963347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110358412|NCT05963347|Tubulin Modulators|tubulin modulators|mesh-ancestor
110358413|NCT05963347|Antimitotic Agents|antimitotic agents|mesh-ancestor
110358414|NCT05963347|Mitosis Modulators|mitosis modulators|mesh-ancestor
110358415|NCT05945485|Vaccines|vaccines|mesh-list
110358416|NCT05945485|Immunologic Factors|immunologic factors|mesh-ancestor
110358417|NCT05945485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110358419|NCT05941897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110358420|NCT05941897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110358421|NCT05932966|Insulin|insulin|mesh-list
110358422|NCT05932966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110358423|NCT05932966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110358424|NCT05918029|Potassium Citrate|potassium citrate|mesh-list
110358425|NCT05918029|Diuretics|diuretics|mesh-ancestor
110358426|NCT05918029|Natriuretic Agents|natriuretic agents|mesh-ancestor
110358427|NCT05918029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110358428|NCT05918029|Expectorants|expectorants|mesh-ancestor
110358429|NCT05918029|Respiratory System Agents|respiratory system agents|mesh-ancestor
110358430|NCT05867329|Cyclosporine|cyclosporine|mesh-list
110358431|NCT05867329|Prednisone|prednisone|mesh-list
110358432|NCT05867329|Methylprednisolone|methylprednisolone|mesh-list
110358433|NCT05867329|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110358435|NCT05867329|Cyclosporins|cyclosporins|mesh-list
110358436|NCT05867329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110358437|NCT05867329|Glucocorticoids|glucocorticoids|mesh-ancestor
110358438|NCT05867329|Hormones|hormones|mesh-ancestor
110358439|NCT05867329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110358440|NCT05867329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110358441|NCT05867329|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110358442|NCT05867329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110358443|NCT05867329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110358444|NCT05867329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110358445|NCT05867329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110358446|NCT05867329|Immunologic Factors|immunologic factors|mesh-ancestor
110358447|NCT05867329|Antifungal Agents|antifungal agents|mesh-ancestor
110358448|NCT05867329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110358449|NCT05867329|Dermatologic Agents|dermatologic agents|mesh-ancestor
110358450|NCT05867329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110358451|NCT05867329|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110358452|NCT05867329|Antiemetics|antiemetics|mesh-ancestor
110358453|NCT05867329|Autonomic Agents|autonomic agents|mesh-ancestor
110358454|NCT05867329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110358455|NCT05867329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110358456|NCT05867329|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110358457|NCT05867329|Protective Agents|protective agents|mesh-ancestor
110358458|NCT05867329|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110358459|NCT05867329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110358460|NCT05857748|Lifitegrast|lifitegrast|mesh-list
110358461|NCT05857748|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110358462|NCT05857748|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110358463|NCT05847517|Metoprolol|metoprolol|mesh-list
110358464|NCT05847517|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110358465|NCT05847517|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110358466|NCT05847517|Sympatholytics|sympatholytics|mesh-ancestor
110358467|NCT05847517|Autonomic Agents|autonomic agents|mesh-ancestor
110358468|NCT05847517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110358469|NCT05847517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110358470|NCT05847517|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110358471|NCT05847517|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110358472|NCT05847517|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110358473|NCT05847517|Adrenergic Agents|adrenergic agents|mesh-ancestor
110358474|NCT05847517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110358475|NCT05847517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110358476|NCT05797623|Cyclosporine|cyclosporine|mesh-list
110358477|NCT05797623|Cyclosporins|cyclosporins|mesh-list
110358478|NCT05797623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110358479|NCT05797623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110358480|NCT05797623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110358481|NCT05797623|Immunologic Factors|immunologic factors|mesh-ancestor
110358482|NCT05797623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110358483|NCT05797623|Antifungal Agents|antifungal agents|mesh-ancestor
110358484|NCT05797623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110358485|NCT05797623|Dermatologic Agents|dermatologic agents|mesh-ancestor
110358486|NCT05797623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110358487|NCT05797623|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110358488|NCT05788081|Rituximab|rituximab|mesh-list
110358489|NCT05788081|Nivolumab|nivolumab|mesh-list
110358490|NCT05788081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110358491|NCT05788081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110358492|NCT05788081|Immunologic Factors|immunologic factors|mesh-ancestor
110358493|NCT05788081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110358494|NCT05788081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110358495|NCT05788081|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110358496|NCT05788081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110358497|NCT05775159|Bevacizumab|bevacizumab|mesh-list
110358498|NCT05775159|Gemcitabine|gemcitabine|mesh-list
110358499|NCT05775159|Lenvatinib|lenvatinib|mesh-list
110358500|NCT05775159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110358501|NCT05775159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110358502|NCT05775159|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110358503|NCT05775159|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110358504|NCT05775159|Growth Substances|growth substances|mesh-ancestor
110358505|NCT05775159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110358506|NCT05775159|Growth Inhibitors|growth inhibitors|mesh-ancestor
110358507|NCT05775159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110358508|NCT05775159|Antimetabolites|antimetabolites|mesh-ancestor
110358509|NCT05775159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110358510|NCT05775159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110358511|NCT05775159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110358512|NCT05761860|Oxycodone|oxycodone|mesh-list
110358513|NCT05761860|Oxytocin|oxytocin|mesh-list
110358514|NCT05761860|Oxytocics|oxytocics|mesh-ancestor
110358515|NCT05761860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110358516|NCT05761860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110358517|NCT05761860|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110358518|NCT05761860|Narcotics|narcotics|mesh-ancestor
110358519|NCT05761860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110358520|NCT05761860|Analgesics|analgesics|mesh-ancestor
110358521|NCT05761860|Sensory System Agents|sensory system agents|mesh-ancestor
110358522|NCT05761860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110358523|NCT05753007|Cannabidiol|cannabidiol|mesh-list
110358524|NCT05753007|Anticonvulsants|anticonvulsants|mesh-ancestor
110358525|NCT05746065|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110358526|NCT05746065|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110358527|NCT05746065|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110358528|NCT05746065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110358529|NCT05746065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110358530|NCT05746065|Antiviral Agents|antiviral agents|mesh-ancestor
110358531|NCT05746065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110358532|NCT05746065|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110358533|NCT05746065|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110358535|NCT05708989|Ropivacaine|ropivacaine|mesh-list
110358536|NCT05708989|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110358537|NCT05708989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110358538|NCT05708989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110358539|NCT05708989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110358540|NCT05708989|Analgesics|analgesics|mesh-ancestor
110358541|NCT05708989|Sensory System Agents|sensory system agents|mesh-ancestor
110358542|NCT05708989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110358543|NCT05708989|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110358544|NCT05708989|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110358545|NCT05708989|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110358546|NCT05708989|Adrenergic Agents|adrenergic agents|mesh-ancestor
110358547|NCT05708989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110358548|NCT05708989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110358549|NCT05708989|Anesthetics, Local|anesthetics, local|mesh-ancestor
110358550|NCT05708989|Anesthetics|anesthetics|mesh-ancestor
110358551|NCT05694871|Palbociclib|palbociclib|mesh-list
110358552|NCT05694871|Cemiplimab|cemiplimab|mesh-list
110358553|NCT05694871|Immunoglobulins|immunoglobulins|mesh-list
110358554|NCT05694871|Immunoglobulin G|immunoglobulin g|mesh-list
110358555|NCT05694871|Immunologic Factors|immunologic factors|mesh-ancestor
110358556|NCT05694871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110358557|NCT05694871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110358558|NCT05694871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110358559|NCT05694871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110358560|NCT05694871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110358561|NCT05694871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110358562|NCT05670795|Clomiphene|clomiphene|mesh-list
110358563|NCT05670795|Enclomiphene|enclomiphene|mesh-list
110358564|NCT05670795|Zuclomiphene|zuclomiphene|mesh-list
110358565|NCT05670795|Hormones|hormones|mesh-list
110358566|NCT05670795|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110358567|NCT05670795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110358568|NCT05670795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110358569|NCT05670795|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110358570|NCT05670795|Hormone Antagonists|hormone antagonists|mesh-ancestor
110358571|NCT05670795|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110358572|NCT05670795|Fertility Agents|fertility agents|mesh-ancestor
110358573|NCT05670795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110358574|NCT05670795|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110358575|NCT05670795|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110358576|NCT05669833|Golimumab|golimumab|mesh-list
110358577|NCT05669833|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110358578|NCT05669833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110358579|NCT05669833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110358580|NCT05669833|Immunologic Factors|immunologic factors|mesh-ancestor
110358581|NCT05669833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110358582|NCT05664217|Antithrombin III|antithrombin iii|mesh-list
110358583|NCT05664217|Antithrombins|antithrombins|mesh-list
110358584|NCT05664217|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110358585|NCT05664217|Protease Inhibitors|protease inhibitors|mesh-ancestor
110358586|NCT05664217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110358587|NCT05664217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110358588|NCT05664217|Anticoagulants|anticoagulants|mesh-ancestor
110358590|NCT05661149|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110358591|NCT05661149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110358592|NCT05657496|Triamcinolone|triamcinolone|mesh-list
110358593|NCT05657496|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110358594|NCT05657496|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110358595|NCT05657496|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110358596|NCT05657496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110358597|NCT05657496|Glucocorticoids|glucocorticoids|mesh-ancestor
110358598|NCT05657496|Hormones|hormones|mesh-ancestor
110358599|NCT05657496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110358600|NCT05657496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110358601|NCT05657496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110358602|NCT05657496|Immunologic Factors|immunologic factors|mesh-ancestor
110358603|NCT05657496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110358604|NCT05657496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110358610|NCT05609929|Omeprazole|omeprazole|mesh-list
110358611|NCT05609929|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110358612|NCT05609929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110358613|NCT05609929|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110358614|NCT05609929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110358615|NCT05609929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110358616|NCT05607407|Methimazole|methimazole|mesh-list
110358617|NCT05607407|Antithyroid Agents|antithyroid agents|mesh-ancestor
110358618|NCT05607407|Hormone Antagonists|hormone antagonists|mesh-ancestor
110358619|NCT05607407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110358620|NCT05607407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110358621|NCT05594563|Eflornithine|eflornithine|mesh-list
110358622|NCT05594563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110358623|NCT05594563|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110358624|NCT05594563|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110358625|NCT05594563|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110358626|NCT05594563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110358627|NCT05594563|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
110358628|NCT05594563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110358629|NCT05594563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110358630|NCT05593497|Abiraterone Acetate|abiraterone acetate|mesh-list
110358631|NCT05593497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110358632|NCT05593497|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110358633|NCT05593497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110358634|NCT05593497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110358635|NCT05593497|Hormone Antagonists|hormone antagonists|mesh-ancestor
110358636|NCT05593497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110358637|NCT05593497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110358638|NCT05593497|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110358640|NCT05591755|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110358641|NCT05591755|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110358642|NCT05591755|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110358643|NCT05591755|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110358644|NCT05591755|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110358645|NCT05591755|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110358646|NCT05591755|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110358647|NCT05591755|Adrenergic Agents|adrenergic agents|mesh-ancestor
110358648|NCT05591755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110358649|NCT05591755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110358650|NCT05591755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110358651|NCT05591755|Antipruritics|antipruritics|mesh-ancestor
110358652|NCT05591755|Dermatologic Agents|dermatologic agents|mesh-ancestor
110358653|NCT05591755|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110358655|NCT05591755|Histamine Agents|histamine agents|mesh-ancestor
110358656|NCT05591755|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110358657|NCT05591144|Prednisone|prednisone|mesh-list
110358658|NCT05591144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110358659|NCT05591144|Glucocorticoids|glucocorticoids|mesh-ancestor
110358660|NCT05591144|Hormones|hormones|mesh-ancestor
110358668|NCT05585229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110358669|NCT05579730|Ketotifen|ketotifen|mesh-list
110358670|NCT05579730|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110358671|NCT05579730|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110358672|NCT05579730|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110358673|NCT05579730|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110358674|NCT05579730|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110358675|NCT05579730|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110358676|NCT05579730|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110358677|NCT05579730|Adrenergic Agents|adrenergic agents|mesh-ancestor
110358678|NCT05579730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110358679|NCT05579730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110358680|NCT05579730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110358681|NCT05579730|Antipruritics|antipruritics|mesh-ancestor
110358682|NCT05579730|Dermatologic Agents|dermatologic agents|mesh-ancestor
110358683|NCT05579730|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110358684|NCT05579730|Histamine Antagonists|histamine antagonists|mesh-ancestor
110358685|NCT05579730|Histamine Agents|histamine agents|mesh-ancestor
110358686|NCT05579730|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110176904|NCT00135811|Dexamethasone|dexamethasone|mesh-list
110358694|NCT05557721|Lidocaine|lidocaine|mesh-list
110358695|NCT05557721|Anesthetics, Local|anesthetics, local|mesh-ancestor
110358696|NCT05557721|Anesthetics|anesthetics|mesh-ancestor
110358697|NCT05557721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110358698|NCT05557721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110358699|NCT05557721|Sensory System Agents|sensory system agents|mesh-ancestor
110358700|NCT05557721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110358701|NCT05557721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110358702|NCT05557721|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110358703|NCT05557721|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110358704|NCT05557721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110358705|NCT05557721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110358706|NCT05548361|Chlorhexidine|chlorhexidine|mesh-list
110358707|NCT05548361|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110358708|NCT05548361|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110358709|NCT05548361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110358710|NCT05548361|Disinfectants|disinfectants|mesh-ancestor
110358711|NCT05548361|Dermatologic Agents|dermatologic agents|mesh-ancestor
110358713|NCT05542667|Fluorides, Topical|fluorides, topical|mesh-list
110358714|NCT05542667|Cariostatic Agents|cariostatic agents|mesh-ancestor
110358715|NCT05542667|Protective Agents|protective agents|mesh-ancestor
110358716|NCT05542667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110358718|NCT05528588|Diuretics|diuretics|mesh-list
110358719|NCT05528588|Natriuretic Agents|natriuretic agents|mesh-ancestor
110358720|NCT05528588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110358721|NCT05528588|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110358722|NCT05528588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110358723|NCT05528588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110358724|NCT05511428|Daratumumab|daratumumab|mesh-list
110358725|NCT05511428|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110358726|NCT05511428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110358727|NCT05511428|Immunologic Factors|immunologic factors|mesh-ancestor
110358728|NCT05511428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110358729|NCT05481684|Progesterone|progesterone|mesh-list
110358730|NCT05481684|Progestins|progestins|mesh-ancestor
110358731|NCT05481684|Hormones|hormones|mesh-ancestor
110358792|NCT05338619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110358732|NCT05481684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110358733|NCT05481684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110358735|NCT05473715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110358736|NCT05473715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110358737|NCT05473715|Growth Substances|growth substances|mesh-ancestor
110358738|NCT05473715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110358739|NCT05473715|Growth Inhibitors|growth inhibitors|mesh-ancestor
110358740|NCT05473715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110358741|NCT05470491|Maraviroc|maraviroc|mesh-list
110358742|NCT05470491|Plerixafor|plerixafor|mesh-list
110358743|NCT05470491|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110358744|NCT05470491|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110358745|NCT05470491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110358746|NCT05470491|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110358747|NCT05470491|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110358748|NCT05470491|Antiviral Agents|antiviral agents|mesh-ancestor
110358749|NCT05470491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110358750|NCT05470491|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110358751|NCT05440708|Bevacizumab|bevacizumab|mesh-list
110358752|NCT05440708|Pembrolizumab|pembrolizumab|mesh-list
110358753|NCT05440708|Atezolizumab|atezolizumab|mesh-list
110358754|NCT05440708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110358755|NCT05440708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110358756|NCT05440708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110358757|NCT05440708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110358758|NCT05440708|Growth Substances|growth substances|mesh-ancestor
110358759|NCT05440708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110358760|NCT05440708|Growth Inhibitors|growth inhibitors|mesh-ancestor
110358761|NCT05440708|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110358762|NCT05440708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110358763|NCT05403450|Decitabine|decitabine|mesh-list
110358764|NCT05403450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110358766|NCT05403450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110358767|NCT05403450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110358768|NCT05403450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110358769|NCT05400603|Zoledronic Acid|zoledronic acid|mesh-list
110358770|NCT05400603|Irinotecan|irinotecan|mesh-list
110358771|NCT05400603|Temozolomide|temozolomide|mesh-list
110358772|NCT05400603|Dinutuximab|dinutuximab|mesh-list
110358773|NCT05400603|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110358774|NCT05400603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110358775|NCT05400603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110358776|NCT05400603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110358777|NCT05400603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110358778|NCT05400603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110358779|NCT05400603|Alkylating Agents|alkylating agents|mesh-ancestor
110358780|NCT05400603|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110358781|NCT05400603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110358782|NCT05384951|Vitamin D|vitamin d|mesh-list
110358783|NCT05384951|Cholecalciferol|cholecalciferol|mesh-list
110358784|NCT05384951|Vitamins|vitamins|mesh-ancestor
110358785|NCT05384951|Micronutrients|micronutrients|mesh-ancestor
110358786|NCT05384951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110358787|NCT05384951|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110358788|NCT05384951|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110358793|NCT05320380|Cytarabine|cytarabine|mesh-list
110358794|NCT05320380|Prednisolone|prednisolone|mesh-list
110358795|NCT05320380|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110358796|NCT05320380|Methylprednisolone|methylprednisolone|mesh-list
110358797|NCT05320380|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110358798|NCT05320380|Prednisolone acetate|prednisolone acetate|mesh-list
110358799|NCT05320380|Hydrocortisone|hydrocortisone|mesh-list
110358800|NCT05320380|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110358801|NCT05320380|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110358802|NCT05320380|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110358803|NCT05320380|Cortisone|cortisone|mesh-list
110358804|NCT05320380|Methotrexate|methotrexate|mesh-list
110358805|NCT05320380|Fludarabine phosphate|fludarabine phosphate|mesh-list
110358806|NCT05320380|Fludarabine|fludarabine|mesh-list
110358807|NCT05320380|Daunorubicin|daunorubicin|mesh-list
110358808|NCT05320380|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110358809|NCT05320380|Prednisolone phosphate|prednisolone phosphate|mesh-list
110358810|NCT05320380|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110358811|NCT05320380|Abortifacient Agents|abortifacient agents|mesh-ancestor
110358812|NCT05320380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110358813|NCT05320380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110358814|NCT05320380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110358815|NCT05320380|Antimetabolites|antimetabolites|mesh-ancestor
110358816|NCT05320380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110358817|NCT05320380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110358818|NCT05320380|Dermatologic Agents|dermatologic agents|mesh-ancestor
110358819|NCT05320380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110358820|NCT05320380|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110358821|NCT05320380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110358822|NCT05320380|Immunologic Factors|immunologic factors|mesh-ancestor
110358823|NCT05320380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110358824|NCT05320380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110358825|NCT05320380|Antiviral Agents|antiviral agents|mesh-ancestor
110358826|NCT05320380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110358827|NCT05320380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110358829|NCT05320380|Hormones|hormones|mesh-ancestor
110358830|NCT05320380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110358831|NCT05320380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110358832|NCT05320380|Antiemetics|antiemetics|mesh-ancestor
110358833|NCT05320380|Autonomic Agents|autonomic agents|mesh-ancestor
110358834|NCT05320380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110358835|NCT05320380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110358836|NCT05320380|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110358837|NCT05320380|Protective Agents|protective agents|mesh-ancestor
110358838|NCT05320380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110358839|NCT05320380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110358840|NCT05320380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110358841|NCT05288283|Cannabidiol|cannabidiol|mesh-list
110358842|NCT05288283|Anticonvulsants|anticonvulsants|mesh-ancestor
110358857|NCT05124275|Pilocarpine|pilocarpine|mesh-list
110358858|NCT05124275|Miotics|miotics|mesh-ancestor
110358859|NCT05124275|Autonomic Agents|autonomic agents|mesh-ancestor
110358860|NCT05124275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110358861|NCT05124275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110358862|NCT05124275|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110358863|NCT05124275|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110358864|NCT05124275|Cholinergic Agents|cholinergic agents|mesh-ancestor
110358865|NCT05124275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110358866|NCT05124275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110358867|NCT05120895|Pravastatin|pravastatin|mesh-list
110358868|NCT05120895|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110358869|NCT05120895|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110358882|NCT05092360|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110358883|NCT05092360|Gemcitabine|gemcitabine|mesh-list
110358884|NCT05092360|Doxorubicin|doxorubicin|mesh-list
110358885|NCT05092360|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110358886|NCT05092360|Pembrolizumab|pembrolizumab|mesh-list
110358887|NCT05092360|Topotecan|topotecan|mesh-list
110358888|NCT05092360|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110358889|NCT05092360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110358890|NCT05092360|Tubulin Modulators|tubulin modulators|mesh-ancestor
110358891|NCT05092360|Antimitotic Agents|antimitotic agents|mesh-ancestor
110358892|NCT05092360|Mitosis Modulators|mitosis modulators|mesh-ancestor
110358893|NCT05092360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110358894|NCT05092360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110358895|NCT05092360|Antimetabolites|antimetabolites|mesh-ancestor
110358896|NCT05092360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110358897|NCT05092360|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110358898|NCT05092360|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110358899|NCT05092360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110358900|NCT05092360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110358901|NCT05092360|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110358902|NCT05092360|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110358903|NCT05033054|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
110358904|NCT05033054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110358905|NCT05033054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110358906|NCT05033054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110358907|NCT05009927|Imatinib Mesylate|imatinib mesylate|mesh-list
110358908|NCT05009927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110358909|NCT05009927|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110358910|NCT05009927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110358911|NCT05009927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110358912|NCT05005442|Pembrolizumab|pembrolizumab|mesh-list
110358913|NCT05005442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110358914|NCT05005442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110358915|NCT05005442|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110358916|NCT05005442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110358918|NCT04995484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110358919|NCT04994522|Belzutifan|belzutifan|mesh-list
110358920|NCT04994522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110358921|NCT04953910|Decitabine|decitabine|mesh-list
110358922|NCT04953910|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
110358923|NCT04953910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110358924|NCT04953910|Antimetabolites|antimetabolites|mesh-ancestor
110358925|NCT04953910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110358926|NCT04953910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110358927|NCT04953910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110176965|NCT00136201|Tigecycline|tigecycline|mesh-list
110358939|NCT04903314|Cenobamate|cenobamate|mesh-list
110358940|NCT04903314|Anticonvulsants|anticonvulsants|mesh-ancestor
110358941|NCT04902261|Paclitaxel|paclitaxel|mesh-list
110358942|NCT04902261|Gemcitabine|gemcitabine|mesh-list
110358943|NCT04902261|Tislelizumab|tislelizumab|mesh-list
110358944|NCT04902261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110358945|NCT04902261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110358946|NCT04902261|Tubulin Modulators|tubulin modulators|mesh-ancestor
110358947|NCT04902261|Antimitotic Agents|antimitotic agents|mesh-ancestor
110358948|NCT04902261|Mitosis Modulators|mitosis modulators|mesh-ancestor
110358949|NCT04902261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110358950|NCT04902261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110358951|NCT04902261|Antimetabolites|antimetabolites|mesh-ancestor
110358952|NCT04902261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110358953|NCT04879849|Pembrolizumab|pembrolizumab|mesh-list
110358954|NCT04879849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110358955|NCT04879849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110358956|NCT04879849|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110358957|NCT04879849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110358958|NCT04873596|Midazolam|midazolam|mesh-list
110358959|NCT04873596|Dexmedetomidine|dexmedetomidine|mesh-list
110358960|NCT04873596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110358961|NCT04873596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110358962|NCT04873596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110358963|NCT04873596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110358964|NCT04873596|Analgesics|analgesics|mesh-ancestor
110358965|NCT04873596|Sensory System Agents|sensory system agents|mesh-ancestor
110358966|NCT04873596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110358967|NCT04873596|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110358968|NCT04873596|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110358969|NCT04873596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110358970|NCT04873596|Adrenergic Agents|adrenergic agents|mesh-ancestor
110358971|NCT04873596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110358972|NCT04873596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110358973|NCT04873596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110358974|NCT04873596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110358975|NCT04873596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110358976|NCT04873596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110358977|NCT04873596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110358978|NCT04873596|Anesthetics, General|anesthetics, general|mesh-ancestor
110358979|NCT04873596|Anesthetics|anesthetics|mesh-ancestor
110358980|NCT04873596|GABA Modulators|gaba modulators|mesh-ancestor
110358981|NCT04873596|GABA Agents|gaba agents|mesh-ancestor
110358982|NCT04872595|Cyclophosphamide|cyclophosphamide|mesh-list
110358983|NCT04872595|Melphalan|melphalan|mesh-list
110358984|NCT04872595|Busulfan|busulfan|mesh-list
110358985|NCT04872595|Thiotepa|thiotepa|mesh-list
110358986|NCT04872595|Fludarabine|fludarabine|mesh-list
110358987|NCT04872595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110358988|NCT04872595|Immunologic Factors|immunologic factors|mesh-ancestor
110358989|NCT04872595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110358990|NCT04872595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110358991|NCT04872595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110358992|NCT04872595|Alkylating Agents|alkylating agents|mesh-ancestor
110358993|NCT04872595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110358994|NCT04872595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110358995|NCT04872595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110358996|NCT04841434|Methotrexate|methotrexate|mesh-list
110358997|NCT04841434|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110358998|NCT04841434|Abortifacient Agents|abortifacient agents|mesh-ancestor
110358999|NCT04841434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110359000|NCT04841434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110359001|NCT04841434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110359002|NCT04841434|Antimetabolites|antimetabolites|mesh-ancestor
110359003|NCT04841434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110359004|NCT04841434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110359005|NCT04841434|Dermatologic Agents|dermatologic agents|mesh-ancestor
110359006|NCT04841434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110359007|NCT04841434|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110359008|NCT04841434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110359009|NCT04841434|Immunologic Factors|immunologic factors|mesh-ancestor
110359010|NCT04841434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110359011|NCT04841434|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110359012|NCT04838301|Pregnanolone|pregnanolone|mesh-list
110359013|NCT04838301|Anesthetics|anesthetics|mesh-ancestor
110359014|NCT04838301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110359015|NCT04838301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110359016|NCT04817189|Dexamethasone|dexamethasone|mesh-list
110359017|NCT04817189|Ondansetron|ondansetron|mesh-list
110359018|NCT04817189|Palonosetron|palonosetron|mesh-list
110359019|NCT04817189|Granisetron|granisetron|mesh-list
110359020|NCT04817189|Tropisetron|tropisetron|mesh-list
110359021|NCT04817189|Dolasetron|dolasetron|mesh-list
110359022|NCT04817189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110359023|NCT04817189|Antiemetics|antiemetics|mesh-ancestor
110359024|NCT04817189|Autonomic Agents|autonomic agents|mesh-ancestor
110359025|NCT04817189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110359026|NCT04817189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110359027|NCT04817189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110359028|NCT04817189|Glucocorticoids|glucocorticoids|mesh-ancestor
110359029|NCT04817189|Hormones|hormones|mesh-ancestor
110359030|NCT04817189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110359031|NCT04817189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110359032|NCT04817189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110359033|NCT04817189|Antipruritics|antipruritics|mesh-ancestor
110359034|NCT04817189|Dermatologic Agents|dermatologic agents|mesh-ancestor
110359035|NCT04817189|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110359036|NCT04817189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110359037|NCT04817189|Serotonin Agents|serotonin agents|mesh-ancestor
110359038|NCT04817189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110359039|NCT04817189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110359040|NCT04724837|Dapagliflozin|dapagliflozin|mesh-list
110359041|NCT04724837|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110359042|NCT04724837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110359043|NCT04724837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110359045|NCT04712643|Atezolizumab|atezolizumab|mesh-list
110359046|NCT04712643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110359047|NCT04712643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110359048|NCT04712643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110359049|NCT04712643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110359050|NCT04708470|Entinostat|entinostat|mesh-list
110359051|NCT04708470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110359052|NCT04708470|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110359053|NCT04708470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110359054|NCT04708470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110359055|NCT04642469|Durvalumab|durvalumab|mesh-list
110359056|NCT04642469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110359057|NCT04642469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110359058|NCT04603001|Azacitidine|azacitidine|mesh-list
110359059|NCT04603001|Venetoclax|venetoclax|mesh-list
110359060|NCT04603001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110359061|NCT04603001|Antimetabolites|antimetabolites|mesh-ancestor
110359062|NCT04603001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110359063|NCT04603001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110359064|NCT04603001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110359065|NCT04588922|Azacitidine|azacitidine|mesh-list
110359066|NCT04588922|Venetoclax|venetoclax|mesh-list
110359067|NCT04588922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110359068|NCT04588922|Antimetabolites|antimetabolites|mesh-ancestor
110359069|NCT04588922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110359070|NCT04588922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110359071|NCT04588922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110359072|NCT04576364|Magnesium Sulfate|magnesium sulfate|mesh-list
110359073|NCT04576364|Analgesics|analgesics|mesh-ancestor
110359074|NCT04576364|Sensory System Agents|sensory system agents|mesh-ancestor
110359075|NCT04576364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110359076|NCT04576364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110359077|NCT04576364|Anesthetics|anesthetics|mesh-ancestor
110359078|NCT04576364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110359079|NCT04576364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110359080|NCT04576364|Anticonvulsants|anticonvulsants|mesh-ancestor
110359081|NCT04576364|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110359082|NCT04576364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110359083|NCT04576364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110359084|NCT04576364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110359085|NCT04576364|Tocolytic Agents|tocolytic agents|mesh-ancestor
110359086|NCT04576364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110359087|NCT04547790|Psyllium|psyllium|mesh-list
110359088|NCT04547790|Cathartics|cathartics|mesh-ancestor
110359089|NCT04547790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110359090|NCT04538976|Sildenafil Citrate|sildenafil citrate|mesh-list
110359091|NCT04538976|Vasodilator Agents|vasodilator agents|mesh-ancestor
110359092|NCT04538976|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110359093|NCT04538976|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110359094|NCT04538976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110359095|NCT04538976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110359096|NCT04538976|Urological Agents|urological agents|mesh-ancestor
110359097|NCT04532346|Hydroxychloroquine|hydroxychloroquine|mesh-list
110359098|NCT04532346|Antimalarials|antimalarials|mesh-ancestor
110359099|NCT04532346|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110359100|NCT04532346|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110359101|NCT04532346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110359102|NCT04532346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110359103|NCT04532346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110359105|NCT04522544|Durvalumab|durvalumab|mesh-list
110359106|NCT04522544|Tremelimumab|tremelimumab|mesh-list
110359107|NCT04522544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110359108|NCT04522544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110359109|NCT04521686|Gemcitabine|gemcitabine|mesh-list
110359110|NCT04521686|Durvalumab|durvalumab|mesh-list
110359111|NCT04521686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110359112|NCT04521686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110359113|NCT04521686|Antimetabolites|antimetabolites|mesh-ancestor
110359114|NCT04521686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110359115|NCT04521686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110359116|NCT04435600|Ustekinumab|ustekinumab|mesh-list
110359117|NCT04435600|Dermatologic Agents|dermatologic agents|mesh-ancestor
110359118|NCT04431635|Rituximab|rituximab|mesh-list
110359119|NCT04431635|Nivolumab|nivolumab|mesh-list
110359120|NCT04431635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110359121|NCT04431635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110359122|NCT04431635|Immunologic Factors|immunologic factors|mesh-ancestor
110359123|NCT04431635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110359124|NCT04431635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110359125|NCT04431635|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110359126|NCT04431635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110359127|NCT04324307|Paclitaxel|paclitaxel|mesh-list
110359128|NCT04324307|Gemcitabine|gemcitabine|mesh-list
110359129|NCT04324307|Fluorouracil|fluorouracil|mesh-list
110359130|NCT04324307|Oxaliplatin|oxaliplatin|mesh-list
110359131|NCT04324307|Irinotecan|irinotecan|mesh-list
110359132|NCT04324307|Folfirinox|folfirinox|mesh-list
110359133|NCT04324307|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110359134|NCT04324307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110359135|NCT04324307|Tubulin Modulators|tubulin modulators|mesh-ancestor
110359136|NCT04324307|Antimitotic Agents|antimitotic agents|mesh-ancestor
110359138|NCT04324307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110359139|NCT04324307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110359140|NCT04324307|Antimetabolites|antimetabolites|mesh-ancestor
110359141|NCT04324307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110359142|NCT04324307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110359143|NCT04324307|Immunologic Factors|immunologic factors|mesh-ancestor
110359144|NCT04324307|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110359145|NCT04324307|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110359164|NCT04245085|Mitosis Modulators|mitosis modulators|mesh-ancestor
110359165|NCT04245085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110359166|NCT04245085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110359167|NCT04245085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110359168|NCT04245085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110359169|NCT04245085|Growth Substances|growth substances|mesh-ancestor
110359170|NCT04245085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110359171|NCT04245085|Growth Inhibitors|growth inhibitors|mesh-ancestor
110034264|NCT01397994|Vitamins|vitamins|mesh-ancestor
110359172|NCT04245085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110359173|NCT04245085|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110359174|NCT04245085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110359175|NCT04245085|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110359176|NCT04225117|Pembrolizumab|pembrolizumab|mesh-list
110359177|NCT04225117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110359178|NCT04225117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110359179|NCT04225117|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110359180|NCT04225117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110359181|NCT04216628|Oxytocin|oxytocin|mesh-list
110359182|NCT04216628|Oxytocics|oxytocics|mesh-ancestor
110359183|NCT04216628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110359184|NCT04216628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110359185|NCT04199117|Nicotine|nicotine|mesh-list
110359186|NCT04199117|Varenicline|varenicline|mesh-list
110359187|NCT04199117|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110359188|NCT04199117|Autonomic Agents|autonomic agents|mesh-ancestor
110359189|NCT04199117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110359190|NCT04199117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110359191|NCT04199117|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110359192|NCT04199117|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110359193|NCT04199117|Cholinergic Agents|cholinergic agents|mesh-ancestor
110359194|NCT04199117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110359195|NCT04199117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110359196|NCT04196868|Metformin|metformin|mesh-list
110359197|NCT04196868|Methotrexate|methotrexate|mesh-list
110359198|NCT04196868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110359199|NCT04196868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110359200|NCT04196868|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110359201|NCT04196868|Abortifacient Agents|abortifacient agents|mesh-ancestor
110359202|NCT04196868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110359203|NCT04196868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110359204|NCT04196868|Antimetabolites|antimetabolites|mesh-ancestor
110359205|NCT04196868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110359206|NCT04196868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110359207|NCT04196868|Dermatologic Agents|dermatologic agents|mesh-ancestor
110359208|NCT04196868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110359209|NCT04196868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110359210|NCT04196868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110359211|NCT04196868|Immunologic Factors|immunologic factors|mesh-ancestor
110359212|NCT04196868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110359213|NCT04196868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110359215|NCT04192019|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110359216|NCT04192019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110359217|NCT04192019|Hormones|hormones|mesh-ancestor
110359218|NCT04192019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110359219|NCT04192019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110359220|NCT04192019|Incretins|incretins|mesh-ancestor
110359221|NCT04188873|Varenicline|varenicline|mesh-list
110359222|NCT04188873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110359223|NCT04188873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110359224|NCT04188873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110359225|NCT04188873|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110359226|NCT04188873|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110359227|NCT04188873|Cholinergic Agents|cholinergic agents|mesh-ancestor
110359228|NCT04174170|Sertraline|sertraline|mesh-list
110359229|NCT04174170|Brexpiprazole|brexpiprazole|mesh-list
110359230|NCT04174170|Antidepressive Agents|antidepressive agents|mesh-ancestor
110359231|NCT04174170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110359232|NCT04174170|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110359233|NCT04174170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110359234|NCT04174170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110359235|NCT04174170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110359236|NCT04174170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110359237|NCT04174170|Serotonin Agents|serotonin agents|mesh-ancestor
110359238|NCT04174170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110359239|NCT04174170|Dopamine Agonists|dopamine agonists|mesh-ancestor
110359240|NCT04174170|Dopamine Agents|dopamine agents|mesh-ancestor
110359241|NCT04172779|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110359242|NCT04172779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110359243|NCT04172779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110359244|NCT04172779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110359245|NCT04172779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110359246|NCT04165317|BCG Vaccine|bcg vaccine|mesh-list
110359247|NCT04165317|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110359248|NCT04165317|Immunologic Factors|immunologic factors|mesh-ancestor
110359249|NCT04165317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110359250|NCT04157335|Benralizumab|benralizumab|mesh-list
110359251|NCT04157335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110359252|NCT04157335|Respiratory System Agents|respiratory system agents|mesh-ancestor
110359253|NCT04146298|Cyclophosphamide|cyclophosphamide|mesh-list
110359254|NCT04146298|Fludarabine|fludarabine|mesh-list
110359255|NCT04146298|Antibodies|antibodies|mesh-list
110359256|NCT04146298|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110359257|NCT04146298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110359258|NCT04146298|Immunologic Factors|immunologic factors|mesh-ancestor
110359259|NCT04146298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110359260|NCT04146298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110359261|NCT04146298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110359262|NCT04146298|Alkylating Agents|alkylating agents|mesh-ancestor
110359263|NCT04146298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110359264|NCT04146298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110359265|NCT04146298|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110359266|NCT04124614|Sertraline|sertraline|mesh-list
110359267|NCT04124614|Brexpiprazole|brexpiprazole|mesh-list
110359268|NCT04124614|Antidepressive Agents|antidepressive agents|mesh-ancestor
110359269|NCT04124614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110359270|NCT04124614|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110359271|NCT04124614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110359272|NCT04124614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110359273|NCT04124614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110359274|NCT04124614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110359275|NCT04124614|Serotonin Agents|serotonin agents|mesh-ancestor
110359276|NCT04124614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110359278|NCT04124614|Dopamine Agents|dopamine agents|mesh-ancestor
110359279|NCT04101357|Carboplatin|carboplatin|mesh-list
110359280|NCT04101357|Etoposide|etoposide|mesh-list
110359281|NCT04101357|Atezolizumab|atezolizumab|mesh-list
110359282|NCT04101357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110359283|NCT04101357|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110359284|NCT04101357|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110359285|NCT04101357|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110359286|NCT04101357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110359287|NCT04101357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110359288|NCT04101357|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110359289|NCT04101357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110359290|NCT04042935|Thioctic Acid|thioctic acid|mesh-list
110359291|NCT04042935|Antioxidants|antioxidants|mesh-ancestor
110359292|NCT04042935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110359293|NCT04042935|Protective Agents|protective agents|mesh-ancestor
110359294|NCT04042935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110359295|NCT04042935|Vitamin B Complex|vitamin b complex|mesh-ancestor
110359296|NCT04042935|Vitamins|vitamins|mesh-ancestor
110359298|NCT03983850|Mycophenolic Acid|mycophenolic acid|mesh-list
110359299|NCT03983850|Sirolimus|sirolimus|mesh-list
110359300|NCT03983850|Cyclophosphamide|cyclophosphamide|mesh-list
110359301|NCT03983850|Busulfan|busulfan|mesh-list
110359302|NCT03983850|Fludarabine|fludarabine|mesh-list
110359303|NCT03983850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110359304|NCT03983850|Immunologic Factors|immunologic factors|mesh-ancestor
110359305|NCT03983850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110359306|NCT03983850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110359307|NCT03983850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110359308|NCT03983850|Alkylating Agents|alkylating agents|mesh-ancestor
110359309|NCT03983850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110359310|NCT03983850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110359311|NCT03983850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110359312|NCT03983850|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110359313|NCT03983850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110359314|NCT03983850|Antitubercular Agents|antitubercular agents|mesh-ancestor
110359315|NCT03983850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110359316|NCT03983850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110359317|NCT03983850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110359318|NCT03983850|Antifungal Agents|antifungal agents|mesh-ancestor
110359319|NCT03953131|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
110359320|NCT03953131|Chelating Agents|chelating agents|mesh-ancestor
110359321|NCT03953131|Sequestering Agents|sequestering agents|mesh-ancestor
110359322|NCT03953131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110359323|NCT03936517|Prednisolone|prednisolone|mesh-list
110359324|NCT03936517|Hydrocortisone|hydrocortisone|mesh-list
110359325|NCT03936517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110359326|NCT03936517|Glucocorticoids|glucocorticoids|mesh-ancestor
110359327|NCT03936517|Hormones|hormones|mesh-ancestor
110359328|NCT03936517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110359329|NCT03936517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110359330|NCT03936517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110359331|NCT03936517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110359332|NCT03889795|Metformin|metformin|mesh-list
110359333|NCT03889795|Digoxin|digoxin|mesh-list
110359334|NCT03889795|Simvastatin|simvastatin|mesh-list
110359335|NCT03889795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110359336|NCT03889795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110359337|NCT03889795|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110359338|NCT03889795|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110359339|NCT03889795|Antimetabolites|antimetabolites|mesh-ancestor
110359340|NCT03889795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110359341|NCT03889795|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110359342|NCT03889795|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110359343|NCT03889795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110359344|NCT03889795|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110359345|NCT03889795|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110359346|NCT03889795|Protective Agents|protective agents|mesh-ancestor
110359348|NCT03808025|Narcotics|narcotics|mesh-ancestor
110359349|NCT03808025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110359350|NCT03808025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110359351|NCT03808025|Analgesics|analgesics|mesh-ancestor
110359352|NCT03808025|Sensory System Agents|sensory system agents|mesh-ancestor
110359353|NCT03808025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110359354|NCT03802084|Imatinib Mesylate|imatinib mesylate|mesh-list
110359355|NCT03802084|Vactosertib|vactosertib|mesh-list
110359356|NCT03802084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110359357|NCT03802084|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110359358|NCT03802084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110359359|NCT03802084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110359360|NCT03777462|Paclitaxel|paclitaxel|mesh-list
110359361|NCT03777462|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110359372|NCT03745326|Cyclophosphamide|cyclophosphamide|mesh-list
110359373|NCT03745326|Fludarabine|fludarabine|mesh-list
110359374|NCT03745326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110359375|NCT03745326|Immunologic Factors|immunologic factors|mesh-ancestor
110359376|NCT03745326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110359377|NCT03745326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110359378|NCT03745326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110359379|NCT03745326|Alkylating Agents|alkylating agents|mesh-ancestor
110359380|NCT03745326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110359381|NCT03745326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110359382|NCT03745326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110359383|NCT03745326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110359384|NCT03745326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110359385|NCT03745326|Antiviral Agents|antiviral agents|mesh-ancestor
110359386|NCT03745326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110359387|NCT03730181|Isoniazid|isoniazid|mesh-list
110359388|NCT03730181|Rifapentine|rifapentine|mesh-list
110359389|NCT03730181|Antitubercular Agents|antitubercular agents|mesh-ancestor
110359390|NCT03730181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110359391|NCT03730181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110359392|NCT03730181|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110359393|NCT03730181|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110359394|NCT03730181|Antimetabolites|antimetabolites|mesh-ancestor
110359395|NCT03730181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110359396|NCT03730181|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110359397|NCT03730181|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110359398|NCT03730181|Leprostatic Agents|leprostatic agents|mesh-ancestor
110359409|NCT03677154|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
110359410|NCT03677154|Immunoconjugates|immunoconjugates|mesh-ancestor
110359412|NCT03677154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110359414|NCT03674671|Analgesics|analgesics|mesh-ancestor
110359415|NCT03674671|Sensory System Agents|sensory system agents|mesh-ancestor
110359417|NCT03674671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110359418|NCT03674671|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110359419|NCT03674671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110359420|NCT03674671|Anesthetics, General|anesthetics, general|mesh-ancestor
110359421|NCT03674671|Anesthetics|anesthetics|mesh-ancestor
110359422|NCT03674671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110359423|NCT03674671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110359424|NCT03674671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110359425|NCT03674671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110359426|NCT03674671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110359427|NCT03668119|Nivolumab|nivolumab|mesh-list
110359428|NCT03668119|Ipilimumab|ipilimumab|mesh-list
110359429|NCT03668119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110359430|NCT03668119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110359431|NCT03668119|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110359432|NCT03668119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110359433|NCT03659799|Insulin|insulin|mesh-list
110359434|NCT03659799|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110359435|NCT03659799|Insulin Aspart|insulin aspart|mesh-list
110359436|NCT03659799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110359437|NCT03659799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110359438|NCT03656562|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110359439|NCT03656562|Immunologic Factors|immunologic factors|mesh-ancestor
110359440|NCT03656562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110359441|NCT03653364|Baloxavir|baloxavir|mesh-list
110359442|NCT03653364|Antiviral Agents|antiviral agents|mesh-ancestor
110359443|NCT03653364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110359444|NCT03653364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110359445|NCT03653364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110359446|NCT03624244|Letrozole|letrozole|mesh-list
110359447|NCT03624244|Exemestane|exemestane|mesh-list
110359448|NCT03624244|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110359449|NCT03624244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110359450|NCT03624244|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110359451|NCT03624244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110359452|NCT03624244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110359453|NCT03624244|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110359454|NCT03624244|Hormone Antagonists|hormone antagonists|mesh-ancestor
110359455|NCT03624244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110359456|NCT03624244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110359457|NCT03620019|Denosumab|denosumab|mesh-list
110359458|NCT03620019|Pembrolizumab|pembrolizumab|mesh-list
110359459|NCT03620019|Nivolumab|nivolumab|mesh-list
110359460|NCT03620019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110359461|NCT03620019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110359462|NCT03620019|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110359463|NCT03620019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110359464|NCT03620019|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110359465|NCT03620019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110359466|NCT03591770|Vaccines|vaccines|mesh-list
110359467|NCT03591770|Immunologic Factors|immunologic factors|mesh-ancestor
110359468|NCT03591770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110359469|NCT03580499|Vitamins|vitamins|mesh-list
110359470|NCT03580499|Vitamin B 6|vitamin b 6|mesh-list
110359471|NCT03580499|Pyridoxal|pyridoxal|mesh-list
110359472|NCT03580499|Pyridoxine|pyridoxine|mesh-list
110359473|NCT03580499|Vitamin B Complex|vitamin b complex|mesh-list
110359474|NCT03580499|Micronutrients|micronutrients|mesh-ancestor
110359475|NCT03580499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110359476|NCT03559647|Atezolizumab|atezolizumab|mesh-list
110359477|NCT03559647|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110359478|NCT03559647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110359479|NCT03559647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110359480|NCT03559647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110359481|NCT03530683|Dexamethasone|dexamethasone|mesh-list
110359482|NCT03530683|Azacitidine|azacitidine|mesh-list
110359483|NCT03530683|Venetoclax|venetoclax|mesh-list
110359488|NCT03530683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110359489|NCT03530683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110359490|NCT03530683|Glucocorticoids|glucocorticoids|mesh-ancestor
110359492|NCT03530683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110359493|NCT03530683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110359494|NCT03530683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110359495|NCT03530683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110359496|NCT03530683|Antimetabolites|antimetabolites|mesh-ancestor
110359497|NCT03530683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110359498|NCT03530683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110359500|NCT03505320|Folic Acid|folic acid|mesh-list
110359501|NCT03505320|Pembrolizumab|pembrolizumab|mesh-list
110359502|NCT03505320|Nivolumab|nivolumab|mesh-list
110359503|NCT03505320|Fluorouracil|fluorouracil|mesh-list
110359504|NCT03505320|Oxaliplatin|oxaliplatin|mesh-list
110359505|NCT03505320|Levoleucovorin|levoleucovorin|mesh-list
110359506|NCT03505320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110359507|NCT03505320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110359508|NCT03505320|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110359509|NCT03505320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110359510|NCT03505320|Antimetabolites|antimetabolites|mesh-ancestor
110359511|NCT03505320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110359512|NCT03505320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110359513|NCT03505320|Immunologic Factors|immunologic factors|mesh-ancestor
110359514|NCT03505320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110359515|NCT03505320|Antidotes|antidotes|mesh-ancestor
110359516|NCT03505320|Protective Agents|protective agents|mesh-ancestor
110359517|NCT03505320|Vitamin B Complex|vitamin b complex|mesh-ancestor
110359518|NCT03505320|Vitamins|vitamins|mesh-ancestor
110359519|NCT03505320|Micronutrients|micronutrients|mesh-ancestor
110359520|NCT03505320|Hematinics|hematinics|mesh-ancestor
110359521|NCT03502668|Decitabine|decitabine|mesh-list
110359522|NCT03502668|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
110359523|NCT03502668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110359524|NCT03502668|Antimetabolites|antimetabolites|mesh-ancestor
110359525|NCT03502668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110359526|NCT03502668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110359527|NCT03502668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110359531|NCT03493685|Irbesartan|irbesartan|mesh-list
110359532|NCT03493685|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110359533|NCT03493685|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110359534|NCT03493685|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110359535|NCT03493685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110359536|NCT03374332|Gemtuzumab|gemtuzumab|mesh-list
110359537|NCT03374332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110359538|NCT03374332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110359539|NCT03374332|Immunotoxins|immunotoxins|mesh-ancestor
110359540|NCT03374332|Immunoconjugates|immunoconjugates|mesh-ancestor
110359541|NCT03374332|Immunologic Factors|immunologic factors|mesh-ancestor
110359542|NCT03374332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110359543|NCT03321734|Caffeine|caffeine|mesh-list
110359544|NCT03321734|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110359545|NCT03321734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110359546|NCT03321734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110359547|NCT03321734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110177029|NCT00136747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110359548|NCT03321734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110359549|NCT03321734|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110359550|NCT03321734|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110359551|NCT03321734|Purinergic Agents|purinergic agents|mesh-ancestor
110359552|NCT03321734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110359553|NCT03284385|Adavosertib|adavosertib|mesh-list
110359554|NCT03284385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110359555|NCT03284385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110359556|NCT03281369|Leucovorin|leucovorin|mesh-list
110359557|NCT03281369|Linagliptin|linagliptin|mesh-list
110359558|NCT03281369|Paclitaxel|paclitaxel|mesh-list
110359559|NCT03281369|Fluorouracil|fluorouracil|mesh-list
110359560|NCT03281369|Oxaliplatin|oxaliplatin|mesh-list
110359562|NCT03281369|Ramucirumab|ramucirumab|mesh-list
110359563|NCT03281369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110359564|NCT03281369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110359565|NCT03281369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110359566|NCT03281369|Tubulin Modulators|tubulin modulators|mesh-ancestor
110359567|NCT03281369|Antimitotic Agents|antimitotic agents|mesh-ancestor
110359568|NCT03281369|Mitosis Modulators|mitosis modulators|mesh-ancestor
110359569|NCT03281369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110359570|NCT03281369|Antimetabolites|antimetabolites|mesh-ancestor
110359571|NCT03281369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110359572|NCT03281369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110359573|NCT03281369|Immunologic Factors|immunologic factors|mesh-ancestor
110359574|NCT03281369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110359575|NCT03281369|Antidotes|antidotes|mesh-ancestor
110359576|NCT03281369|Protective Agents|protective agents|mesh-ancestor
110359577|NCT03281369|Vitamin B Complex|vitamin b complex|mesh-ancestor
110359578|NCT03281369|Vitamins|vitamins|mesh-ancestor
110359579|NCT03281369|Micronutrients|micronutrients|mesh-ancestor
110359580|NCT03281369|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110359581|NCT03281369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110359582|NCT03281369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110359583|NCT03281369|Incretins|incretins|mesh-ancestor
110359584|NCT03281369|Hormones|hormones|mesh-ancestor
110359585|NCT03281369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110359586|NCT03281369|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110359587|NCT03281369|Protease Inhibitors|protease inhibitors|mesh-ancestor
110359588|NCT03281369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110359589|NCT03261830|Clindamycin|clindamycin|mesh-list
110359590|NCT03261830|Clindamycin palmitate|clindamycin palmitate|mesh-list
110359591|NCT03261830|Clindamycin phosphate|clindamycin phosphate|mesh-list
110359592|NCT03261830|Cefazolin|cefazolin|mesh-list
110359593|NCT03261830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110359594|NCT03261830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110359595|NCT03261830|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110359596|NCT03261830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110359597|NCT03261830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110359598|NCT03220893|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
110359599|NCT03220893|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110359600|NCT03220893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110359601|NCT03217071|Pembrolizumab|pembrolizumab|mesh-list
110359602|NCT03217071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110359603|NCT03217071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110359604|NCT03217071|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110359605|NCT03217071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110359607|NCT03190941|Cyclophosphamide|cyclophosphamide|mesh-list
110359608|NCT03190941|Fludarabine|fludarabine|mesh-list
110359617|NCT03190941|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110359618|NCT03190941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110359619|NCT03190941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110359620|NCT03190941|Antiviral Agents|antiviral agents|mesh-ancestor
110359621|NCT03190941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110359622|NCT03064568|Misoprostol|misoprostol|mesh-list
110359623|NCT03064568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110359624|NCT03064568|Abortifacient Agents|abortifacient agents|mesh-ancestor
110359625|NCT03064568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110359626|NCT03064568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110359627|NCT03064568|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110359628|NCT03064568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110359629|NCT03064568|Oxytocics|oxytocics|mesh-ancestor
110359630|NCT02830724|Aldesleukin|aldesleukin|mesh-list
110359631|NCT02830724|Cyclophosphamide|cyclophosphamide|mesh-list
110359632|NCT02830724|Fludarabine|fludarabine|mesh-list
110359633|NCT02830724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110359634|NCT02830724|Immunologic Factors|immunologic factors|mesh-ancestor
110359635|NCT02830724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110359636|NCT02830724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110359637|NCT02830724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110359638|NCT02830724|Alkylating Agents|alkylating agents|mesh-ancestor
110359639|NCT02830724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110359640|NCT02830724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110359641|NCT02830724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110359642|NCT02830724|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110359643|NCT02830724|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110359644|NCT02830724|Antiviral Agents|antiviral agents|mesh-ancestor
110359645|NCT02830724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110359646|NCT02691078|Octreotide|octreotide|mesh-list
110359647|NCT02691078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110359648|NCT02691078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110359649|NCT02691078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110359658|NCT02549573|Apomorphine|apomorphine|mesh-list
110359659|NCT02549573|Emetics|emetics|mesh-ancestor
110359660|NCT02549573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110359661|NCT02549573|Autonomic Agents|autonomic agents|mesh-ancestor
110359662|NCT02549573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110359663|NCT02549573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110359664|NCT02549573|Dopamine Agonists|dopamine agonists|mesh-ancestor
110359665|NCT02549573|Dopamine Agents|dopamine agents|mesh-ancestor
110359666|NCT02549573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110359667|NCT02549573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110359668|NCT02542657|Clarithromycin|clarithromycin|mesh-list
110359669|NCT02542657|Dexamethasone|dexamethasone|mesh-list
110359670|NCT02542657|Pomalidomide|pomalidomide|mesh-list
110359671|NCT02542657|Ixazomib|ixazomib|mesh-list
110359672|NCT02542657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110359673|NCT02542657|Antiemetics|antiemetics|mesh-ancestor
110359674|NCT02542657|Autonomic Agents|autonomic agents|mesh-ancestor
110359675|NCT02542657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110359676|NCT02542657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110359677|NCT02542657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110359678|NCT02542657|Glucocorticoids|glucocorticoids|mesh-ancestor
110359680|NCT02542657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110359681|NCT02542657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110359682|NCT02542657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110359683|NCT02542657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110359684|NCT02542657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110359685|NCT02542657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110359686|NCT02542657|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110359687|NCT02542657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110359688|NCT02542657|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110359689|NCT02542657|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110359690|NCT02542657|Immunologic Factors|immunologic factors|mesh-ancestor
110359691|NCT02542657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110359692|NCT02542657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110359693|NCT02542657|Growth Substances|growth substances|mesh-ancestor
110359694|NCT02542657|Growth Inhibitors|growth inhibitors|mesh-ancestor
110359695|NCT02542657|Protease Inhibitors|protease inhibitors|mesh-ancestor
110359697|NCT02485418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110359698|NCT02485418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110359699|NCT02485418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110359700|NCT02485418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110359701|NCT02485418|Anesthetics, General|anesthetics, general|mesh-ancestor
110359702|NCT02485418|Anesthetics|anesthetics|mesh-ancestor
110359703|NCT02385110|Dexamethasone|dexamethasone|mesh-list
110359704|NCT02385110|Methotrexate|methotrexate|mesh-list
110359705|NCT02385110|Etoposide|etoposide|mesh-list
110359706|NCT02385110|Alemtuzumab|alemtuzumab|mesh-list
110359708|NCT02385110|Antiemetics|antiemetics|mesh-ancestor
110359709|NCT02385110|Autonomic Agents|autonomic agents|mesh-ancestor
110359710|NCT02385110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110359711|NCT02385110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110359712|NCT02385110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110359713|NCT02385110|Glucocorticoids|glucocorticoids|mesh-ancestor
110359714|NCT02385110|Hormones|hormones|mesh-ancestor
110359715|NCT02385110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110359716|NCT02385110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110359717|NCT02385110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110359718|NCT02385110|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110359719|NCT02385110|Abortifacient Agents|abortifacient agents|mesh-ancestor
110359720|NCT02385110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110359721|NCT02385110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110359722|NCT02385110|Antimetabolites|antimetabolites|mesh-ancestor
110359723|NCT02385110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110359724|NCT02385110|Dermatologic Agents|dermatologic agents|mesh-ancestor
110359725|NCT02385110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110359726|NCT02385110|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110359727|NCT02385110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110359728|NCT02385110|Immunologic Factors|immunologic factors|mesh-ancestor
110359729|NCT02385110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110359730|NCT02385110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110359731|NCT02385110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110359732|NCT02385110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110359733|NCT02385110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110359734|NCT02385110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110359735|NCT02229968|Aminocaproic Acid|aminocaproic acid|mesh-list
110359736|NCT02229968|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110359737|NCT02229968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110359738|NCT02229968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110359739|NCT02229968|Hemostatics|hemostatics|mesh-ancestor
110359740|NCT02229968|Coagulants|coagulants|mesh-ancestor
110359741|NCT02201108|Teriflunomide|teriflunomide|mesh-list
110359742|NCT02201108|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110359743|NCT02201108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110359744|NCT02201108|Analgesics|analgesics|mesh-ancestor
110359745|NCT02201108|Sensory System Agents|sensory system agents|mesh-ancestor
110359746|NCT02201108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110359747|NCT02201108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110359748|NCT02201108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110359749|NCT02201108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110034381|NCT01398384|Nitric Oxide|nitric oxide|mesh-list
110359750|NCT02201108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110359751|NCT02201108|Immunologic Factors|immunologic factors|mesh-ancestor
110359752|NCT02153229|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
110359753|NCT02153229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110359754|NCT02153229|Dermatologic Agents|dermatologic agents|mesh-ancestor
110359755|NCT02153229|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110359756|NCT02133196|Aldesleukin|aldesleukin|mesh-list
110359757|NCT02133196|Cyclophosphamide|cyclophosphamide|mesh-list
110359758|NCT02133196|Fludarabine|fludarabine|mesh-list
110359759|NCT02133196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110359760|NCT02133196|Immunologic Factors|immunologic factors|mesh-ancestor
110359761|NCT02133196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110359762|NCT02133196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110359763|NCT02133196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110359765|NCT02133196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110359766|NCT02133196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110359767|NCT02133196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110359768|NCT02133196|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110359769|NCT02133196|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110359770|NCT02133196|Antiviral Agents|antiviral agents|mesh-ancestor
110359771|NCT02133196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110359772|NCT01789879|Efavirenz|efavirenz|mesh-list
110359773|NCT01789879|Nevirapine|nevirapine|mesh-list
110359774|NCT01789879|Levonorgestrel|levonorgestrel|mesh-list
110359775|NCT01789879|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110359776|NCT01789879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110359777|NCT01789879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110359778|NCT01789879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110359779|NCT01789879|Antiviral Agents|antiviral agents|mesh-ancestor
110359780|NCT01789879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110359781|NCT01789879|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110359782|NCT01789879|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110359783|NCT01789879|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110359784|NCT01789879|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110359785|NCT01789879|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110359786|NCT01789879|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110359787|NCT01789879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110359789|NCT01789879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110359790|NCT01789879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110359791|NCT01789879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110359792|NCT01789879|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110359793|NCT01789879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110359794|NCT01789879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110359795|NCT01789879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110359796|NCT01772563|Itraconazole|itraconazole|mesh-list
110359797|NCT01772563|Antifungal Agents|antifungal agents|mesh-ancestor
110359798|NCT01772563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110359799|NCT01772563|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110359800|NCT01772563|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110359802|NCT01772563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110359803|NCT01772563|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110359804|NCT01772563|Hormone Antagonists|hormone antagonists|mesh-ancestor
110359805|NCT01772563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110359806|NCT01772563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110359807|NCT01772563|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110359808|NCT01496976|Methylprednisolone|methylprednisolone|mesh-list
110359809|NCT01496976|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110359810|NCT01496976|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110359811|NCT01496976|Prednisolone|prednisolone|mesh-list
110359812|NCT01496976|Prednisolone acetate|prednisolone acetate|mesh-list
110359813|NCT01496976|Lenalidomide|lenalidomide|mesh-list
110359815|NCT01496976|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110359816|NCT01496976|Prednisolone phosphate|prednisolone phosphate|mesh-list
110359817|NCT01496976|Immunologic Factors|immunologic factors|mesh-ancestor
110359818|NCT01496976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110359819|NCT01496976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110359820|NCT01496976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110359821|NCT01496976|Growth Substances|growth substances|mesh-ancestor
110359822|NCT01496976|Growth Inhibitors|growth inhibitors|mesh-ancestor
110359823|NCT01496976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110359824|NCT01496976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110359825|NCT01496976|Antiemetics|antiemetics|mesh-ancestor
110359826|NCT01496976|Autonomic Agents|autonomic agents|mesh-ancestor
110359827|NCT01496976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110359828|NCT01496976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110359829|NCT01496976|Glucocorticoids|glucocorticoids|mesh-ancestor
110359830|NCT01496976|Hormones|hormones|mesh-ancestor
110359831|NCT01496976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110359832|NCT01496976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110359833|NCT01496976|Protective Agents|protective agents|mesh-ancestor
110359834|NCT01496976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110359835|NCT01316523|Rituximab|rituximab|mesh-list
110359836|NCT01316523|Lenalidomide|lenalidomide|mesh-list
110359837|NCT01316523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110359839|NCT01316523|Immunologic Factors|immunologic factors|mesh-ancestor
110359840|NCT01316523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110359841|NCT01316523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110359842|NCT01316523|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110359843|NCT01316523|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110359844|NCT01316523|Growth Substances|growth substances|mesh-ancestor
110359845|NCT01316523|Growth Inhibitors|growth inhibitors|mesh-ancestor
110359846|NCT01258933|Ofatumumab|ofatumumab|mesh-list
110359847|NCT01258933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110359848|NCT01042561|Vitamin D|vitamin d|mesh-list
110359849|NCT01042561|Ergocalciferols|ergocalciferols|mesh-list
110359850|NCT01042561|Cholecalciferol|cholecalciferol|mesh-list
110359851|NCT01042561|Vitamins|vitamins|mesh-list
110359852|NCT01042561|Micronutrients|micronutrients|mesh-ancestor
110359853|NCT01042561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110359854|NCT01042561|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110359855|NCT01042561|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110359857|NCT00848328|Lenalidomide|lenalidomide|mesh-list
110359858|NCT00848328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110359859|NCT00848328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110359860|NCT00848328|Immunologic Factors|immunologic factors|mesh-ancestor
110359861|NCT00848328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110359862|NCT00848328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110359863|NCT00848328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110359864|NCT00848328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110359865|NCT00848328|Growth Substances|growth substances|mesh-ancestor
110359866|NCT00848328|Growth Inhibitors|growth inhibitors|mesh-ancestor
110359867|NCT00492050|Valacyclovir|valacyclovir|mesh-list
110359868|NCT00492050|Rituximab|rituximab|mesh-list
110359869|NCT00492050|Bortezomib|bortezomib|mesh-list
110359870|NCT00492050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110359871|NCT00492050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110359872|NCT00492050|Immunologic Factors|immunologic factors|mesh-ancestor
110359873|NCT00492050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110359874|NCT00492050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110359875|NCT00492050|Antiviral Agents|antiviral agents|mesh-ancestor
110359876|NCT00492050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110359877|NCT01237951|Dexamethasone|dexamethasone|mesh-list
110359878|NCT01237951|Gemcitabine|gemcitabine|mesh-list
110359879|NCT01237951|Melphalan|melphalan|mesh-list
110359880|NCT01237951|Busulfan|busulfan|mesh-list
110359881|NCT01237951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110359882|NCT01237951|Antiemetics|antiemetics|mesh-ancestor
110359883|NCT01237951|Autonomic Agents|autonomic agents|mesh-ancestor
110359884|NCT01237951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110359885|NCT01237951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110359886|NCT01237951|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110359887|NCT01237951|Glucocorticoids|glucocorticoids|mesh-ancestor
110359888|NCT01237951|Hormones|hormones|mesh-ancestor
110359889|NCT01237951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110359890|NCT01237951|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110359891|NCT01237951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110359892|NCT01237951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110359893|NCT01237951|Antimetabolites|antimetabolites|mesh-ancestor
110359894|NCT01237951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110359895|NCT01237951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110359896|NCT01237951|Alkylating Agents|alkylating agents|mesh-ancestor
110359897|NCT01237951|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110359898|NCT01237951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110359899|NCT01237951|Immunologic Factors|immunologic factors|mesh-ancestor
110359900|NCT02908581|Folic Acid|folic acid|mesh-list
110359901|NCT02908581|Vitamin B Complex|vitamin b complex|mesh-list
110359902|NCT02908581|Hematinics|hematinics|mesh-ancestor
110359903|NCT02908581|Vitamins|vitamins|mesh-ancestor
110359904|NCT02908581|Micronutrients|micronutrients|mesh-ancestor
110359905|NCT02908581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110359906|NCT00544362|Fluorouracil|fluorouracil|mesh-list
110359907|NCT00544362|Cetuximab|cetuximab|mesh-list
110359908|NCT00544362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110359909|NCT00544362|Antimetabolites|antimetabolites|mesh-ancestor
110359910|NCT00544362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110359911|NCT00544362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110359912|NCT00544362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110359913|NCT00544362|Immunologic Factors|immunologic factors|mesh-ancestor
110359914|NCT00544362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110359915|NCT00544362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110359917|NCT01239394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110359918|NCT00553293|Hormones|hormones|mesh-list
110359919|NCT00553293|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110359920|NCT00553293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110359921|NCT00553293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110359922|NCT04648358|Dexamethasone|dexamethasone|mesh-list
110359923|NCT04648358|Bupivacaine|bupivacaine|mesh-list
110359924|NCT04648358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110359925|NCT04648358|Antiemetics|antiemetics|mesh-ancestor
110359926|NCT04648358|Autonomic Agents|autonomic agents|mesh-ancestor
110359927|NCT04648358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110359928|NCT04648358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110359929|NCT04648358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110359930|NCT04648358|Glucocorticoids|glucocorticoids|mesh-ancestor
110359931|NCT04648358|Hormones|hormones|mesh-ancestor
110359932|NCT04648358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110359933|NCT04648358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110359934|NCT04648358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110359935|NCT04648358|Anesthetics, Local|anesthetics, local|mesh-ancestor
110359937|NCT04648358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110359938|NCT04648358|Sensory System Agents|sensory system agents|mesh-ancestor
110359939|NCT00544518|Metformin|metformin|mesh-list
110359940|NCT00544518|Benfluorex|benfluorex|mesh-list
110359941|NCT00544518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110359942|NCT00544518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110359943|NCT00544518|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110359944|NCT00544518|Antimetabolites|antimetabolites|mesh-ancestor
110359945|NCT00544518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110359946|NCT00544518|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110359947|NCT00544518|Appetite Depressants|appetite depressants|mesh-ancestor
110359948|NCT00544518|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110359949|NCT02908698|Prednisone|prednisone|mesh-list
110359950|NCT02908698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110359951|NCT02908698|Glucocorticoids|glucocorticoids|mesh-ancestor
110359952|NCT02908698|Hormones|hormones|mesh-ancestor
110359953|NCT02908698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110359954|NCT02908698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110359955|NCT02908698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110359956|NCT02908698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110359957|NCT00544596|Acetic Acid|acetic acid|mesh-list
110359958|NCT00544596|Etoposide|etoposide|mesh-list
110359959|NCT00544596|Etoposide phosphate|etoposide phosphate|mesh-list
110359960|NCT00544596|Retinol acetate|retinol acetate|mesh-list
110359961|NCT00544596|Gossypol acetic acid|gossypol acetic acid|mesh-list
110359962|NCT00544596|Gossypol|gossypol|mesh-list
110359963|NCT00544596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110359964|NCT00544596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110359965|NCT00544596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110359966|NCT00544596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110359967|NCT00544596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110359968|NCT00544596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110359969|NCT00544596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110359970|NCT00544596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110359971|NCT00544596|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110359972|NCT00544596|Immunologic Factors|immunologic factors|mesh-ancestor
110359973|NCT00544596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110359974|NCT00544596|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110359976|NCT00544596|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110359977|NCT00544596|Contraceptive Agents|contraceptive agents|mesh-ancestor
110359978|NCT00544596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110359979|NCT00544596|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110359980|NCT00544596|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
110359982|NCT02908191|Tenofovir|tenofovir|mesh-list
110359983|NCT02908191|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110359984|NCT02908191|Entecavir|entecavir|mesh-list
110359985|NCT02908191|Antiviral Agents|antiviral agents|mesh-ancestor
110359986|NCT02908191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110359987|NCT02908191|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110359988|NCT02908191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110359989|NCT02908191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110359990|NCT02908191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110359991|NCT02908191|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110359992|NCT02908191|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110359993|NCT00544791|Melatonin|melatonin|mesh-list
110359994|NCT00544791|Antioxidants|antioxidants|mesh-ancestor
110359995|NCT00544791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110359996|NCT00544791|Protective Agents|protective agents|mesh-ancestor
110359997|NCT00544791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110359998|NCT00544791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110359999|NCT04647773|Pregabalin|pregabalin|mesh-list
110360000|NCT04647773|Analgesics|analgesics|mesh-ancestor
110360001|NCT04647773|Sensory System Agents|sensory system agents|mesh-ancestor
110360002|NCT04647773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110360003|NCT04647773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360004|NCT04647773|Anticonvulsants|anticonvulsants|mesh-ancestor
110360005|NCT04647773|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110360006|NCT04647773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110360007|NCT04647773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110360008|NCT04647773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110360010|NCT04647773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110360011|NCT04647773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110360012|NCT04647773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110360013|NCT01237678|Carboplatin|carboplatin|mesh-list
110360014|NCT01237678|Etoposide|etoposide|mesh-list
110360015|NCT01237678|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
110360016|NCT01237678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110360017|NCT01237678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110360018|NCT01237678|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110360019|NCT01237678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110360020|NCT01237678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110360021|NCT01237678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110360022|NCT01237678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110360023|NCT01237678|Immunotoxins|immunotoxins|mesh-ancestor
110360024|NCT01237678|Immunoconjugates|immunoconjugates|mesh-ancestor
110360025|NCT01237678|Immunologic Factors|immunologic factors|mesh-ancestor
110360026|NCT01237678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360027|NCT04647461|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110360028|NCT04647461|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110360029|NCT04647461|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110360030|NCT04647461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110360031|NCT04647461|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110360032|NCT04647461|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110360033|NCT04647461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110360034|NCT04647461|Adrenergic Agents|adrenergic agents|mesh-ancestor
110360035|NCT04647461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110360036|NCT04647461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110360037|NCT04647461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360038|NCT01229371|Vaccines|vaccines|mesh-list
110360039|NCT01229371|Immunologic Factors|immunologic factors|mesh-ancestor
110360040|NCT01229371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360041|NCT02908152|Curcumin|curcumin|mesh-list
110360042|NCT02908152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110360043|NCT02908152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110360044|NCT02908152|Analgesics|analgesics|mesh-ancestor
110360045|NCT02908152|Sensory System Agents|sensory system agents|mesh-ancestor
110360046|NCT02908152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110360047|NCT02908152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360048|NCT02908152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110360049|NCT02908152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110360050|NCT02908152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110360051|NCT02908152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110360052|NCT02908152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110360055|NCT01237327|Megestrol Acetate|megestrol acetate|mesh-list
110360056|NCT01237327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110360057|NCT01237327|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110360058|NCT01237327|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110360059|NCT01237327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110360060|NCT01237327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110360061|NCT01237327|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110360062|NCT01237327|Hormone Antagonists|hormone antagonists|mesh-ancestor
110360063|NCT01237327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110360064|NCT01237327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360065|NCT01237327|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110360066|NCT01237327|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110360067|NCT01237327|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110360068|NCT01237327|Contraceptive Agents|contraceptive agents|mesh-ancestor
110360069|NCT01237327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110360070|NCT01237327|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110360071|NCT01237327|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110360072|NCT01237327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110360073|NCT01237327|Appetite Stimulants|appetite stimulants|mesh-ancestor
110360074|NCT01237327|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110360075|NCT02907021|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110360076|NCT02907021|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110360077|NCT02907021|Adrenergic Agents|adrenergic agents|mesh-ancestor
110360078|NCT02907021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110360079|NCT02907021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110360080|NCT02907021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360081|NCT01237054|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110360082|NCT01237054|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110360083|NCT01237054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110360085|NCT04647695|Interferon-beta|interferon-beta|mesh-list
110360086|NCT04647695|Remdesivir|remdesivir|mesh-list
110360087|NCT04647695|Interferon beta-1b|interferon beta-1b|mesh-list
110360088|NCT04647695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110360089|NCT04647695|Antiviral Agents|antiviral agents|mesh-ancestor
110360090|NCT04647695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110360091|NCT04647695|Immunologic Factors|immunologic factors|mesh-ancestor
110360092|NCT04647695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360093|NCT04647695|Antimetabolites|antimetabolites|mesh-ancestor
110360094|NCT04647695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110360095|NCT04647695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110360096|NCT04647344|Paclitaxel|paclitaxel|mesh-list
110360097|NCT04647344|Carboplatin|carboplatin|mesh-list
110360098|NCT04647344|Pemetrexed|pemetrexed|mesh-list
110360099|NCT04647344|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110360100|NCT04647344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110360101|NCT04647344|Tubulin Modulators|tubulin modulators|mesh-ancestor
110360102|NCT04647344|Antimitotic Agents|antimitotic agents|mesh-ancestor
110360103|NCT04647344|Mitosis Modulators|mitosis modulators|mesh-ancestor
110360104|NCT04647344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110360105|NCT04647344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110360106|NCT04647344|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110360107|NCT04647344|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110360108|NCT02906748|Parathyroid Hormone|parathyroid hormone|mesh-list
110360109|NCT02906748|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110360110|NCT02906748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360111|NCT02907957|Anesthetics|anesthetics|mesh-list
110360112|NCT02907957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110360113|NCT02907957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360114|NCT04646876|Magnesium Sulfate|magnesium sulfate|mesh-list
110360115|NCT04646876|Analgesics|analgesics|mesh-ancestor
110360116|NCT04646876|Sensory System Agents|sensory system agents|mesh-ancestor
110360117|NCT04646876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110360118|NCT04646876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360119|NCT04646876|Anesthetics|anesthetics|mesh-ancestor
110360120|NCT04646876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110360121|NCT04646876|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110360122|NCT04646876|Anticonvulsants|anticonvulsants|mesh-ancestor
110360123|NCT04646876|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110360124|NCT04646876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110360125|NCT04646876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110360126|NCT04646876|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110360127|NCT04646876|Tocolytic Agents|tocolytic agents|mesh-ancestor
110360128|NCT04646876|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110360129|NCT02908035|Sirolimus|sirolimus|mesh-list
110360130|NCT02908035|Temsirolimus|temsirolimus|mesh-list
110360131|NCT02908035|MTOR Inhibitors|mtor inhibitors|mesh-list
110360132|NCT02908035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110360133|NCT02908035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110360134|NCT02908035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110360135|NCT02908035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110360136|NCT02908035|Immunologic Factors|immunologic factors|mesh-ancestor
110360137|NCT02908035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360138|NCT02908035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110360139|NCT02908035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110360140|NCT02908035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110360141|NCT02908035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110360142|NCT02908035|Antifungal Agents|antifungal agents|mesh-ancestor
110360144|NCT04646759|Fulvestrant|fulvestrant|mesh-list
110360145|NCT04646759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110360146|NCT04646759|Antimetabolites|antimetabolites|mesh-ancestor
110360147|NCT04646759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110360148|NCT04646759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110360149|NCT04646759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110360150|NCT04646759|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110360151|NCT04646759|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110360152|NCT04646759|Hormone Antagonists|hormone antagonists|mesh-ancestor
110360153|NCT04646759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110360154|NCT04646759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360155|NCT02906514|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
110360157|NCT02906514|Blood Substitutes|blood substitutes|mesh-ancestor
110360158|NCT04646135|Lorazepam|lorazepam|mesh-list
110360159|NCT04646135|Anticonvulsants|anticonvulsants|mesh-ancestor
110360160|NCT04646135|Antiemetics|antiemetics|mesh-ancestor
110360161|NCT04646135|Autonomic Agents|autonomic agents|mesh-ancestor
110360162|NCT04646135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110360163|NCT04646135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360164|NCT04646135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110360165|NCT04646135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110360166|NCT04646135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110360167|NCT04646135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110360168|NCT04646135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110360169|NCT04646135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110360170|NCT04646135|GABA Modulators|gaba modulators|mesh-ancestor
110360171|NCT04646135|GABA Agents|gaba agents|mesh-ancestor
110360172|NCT04646135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110360173|NCT04646135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110360174|NCT02906553|Nitroglycerin|nitroglycerin|mesh-list
110360175|NCT02906553|Vasodilator Agents|vasodilator agents|mesh-ancestor
110360176|NCT04682184|Propranolol|propranolol|mesh-list
110360177|NCT04682184|Pseudoephedrine|pseudoephedrine|mesh-list
110360178|NCT04682184|Ephedrine|ephedrine|mesh-list
110360179|NCT04682184|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110360180|NCT04682184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110360181|NCT04682184|Adrenergic Agents|adrenergic agents|mesh-ancestor
110360182|NCT04682184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110360183|NCT04682184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110360184|NCT04682184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360185|NCT04682184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110360186|NCT04682184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110360187|NCT04682184|Vasodilator Agents|vasodilator agents|mesh-ancestor
110360188|NCT04682184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110360189|NCT04682184|Autonomic Agents|autonomic agents|mesh-ancestor
110360190|NCT04682184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110360191|NCT04682184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110360192|NCT04682184|Respiratory System Agents|respiratory system agents|mesh-ancestor
110360193|NCT04682184|Nasal Decongestants|nasal decongestants|mesh-ancestor
110360194|NCT04682184|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110360195|NCT04682184|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110360196|NCT04682184|Sympathomimetics|sympathomimetics|mesh-ancestor
110360197|NCT04645940|Rabeprazole|rabeprazole|mesh-list
110360198|NCT04645940|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110360199|NCT04645940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110360200|NCT04645940|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110360201|NCT04645940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110360202|NCT04645940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110360203|NCT00558506|Abatacept|abatacept|mesh-list
110360204|NCT00558506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110360205|NCT00558506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110360206|NCT00558506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110360207|NCT00558506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110360208|NCT00558506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110360209|NCT00558506|Immunologic Factors|immunologic factors|mesh-ancestor
110360210|NCT00558506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360211|NCT00558506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110360212|NCT00558623|Calcium Carbonate|calcium carbonate|mesh-list
110360213|NCT00558623|Calcium|calcium|mesh-list
110360214|NCT00558623|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110360215|NCT00558623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360217|NCT00558623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110360218|NCT00558623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110360219|NCT00558662|Monensin|monensin|mesh-list
110360220|NCT00558662|Antifungal Agents|antifungal agents|mesh-ancestor
110360221|NCT00558662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110360222|NCT00558662|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110360223|NCT00558662|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110360224|NCT00558662|Coccidiostats|coccidiostats|mesh-ancestor
110360225|NCT00558662|Proton Ionophores|proton ionophores|mesh-ancestor
110360226|NCT00558662|Uncoupling Agents|uncoupling agents|mesh-ancestor
110360227|NCT00558662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110360228|NCT00558662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110360229|NCT00558662|Ionophores|ionophores|mesh-ancestor
110360230|NCT00558662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110360231|NCT00558662|Sodium Ionophores|sodium ionophores|mesh-ancestor
110360232|NCT02905890|Norethindrone|norethindrone|mesh-list
110360233|NCT02905890|Norethindrone enanthate|norethindrone enanthate|mesh-list
110360234|NCT02905890|Norethindrone Acetate|norethindrone acetate|mesh-list
110360235|NCT02905890|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110360236|NCT02905890|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110360237|NCT02905890|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110360238|NCT02905890|Contraceptive Agents|contraceptive agents|mesh-ancestor
110360239|NCT02905890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110360240|NCT02905890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360241|NCT02905890|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110360242|NCT02905890|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110360243|NCT02906163|Gefitinib|gefitinib|mesh-list
110360244|NCT02906163|Afatinib|afatinib|mesh-list
110360245|NCT02906163|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
110360246|NCT02906163|Thymalfasin|thymalfasin|mesh-list
110360247|NCT02906163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110360248|NCT02906163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110360249|NCT02906163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110360250|NCT02906163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110360251|NCT02906163|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110360252|NCT02906163|Immunologic Factors|immunologic factors|mesh-ancestor
110360253|NCT02906163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360254|NCT04645745|Folic Acid|folic acid|mesh-list
110360255|NCT04645745|Inositol|inositol|mesh-list
110360256|NCT04645745|Hematinics|hematinics|mesh-ancestor
110360257|NCT04645745|Vitamin B Complex|vitamin b complex|mesh-ancestor
110360258|NCT04645745|Vitamins|vitamins|mesh-ancestor
110360259|NCT04645745|Micronutrients|micronutrients|mesh-ancestor
110360260|NCT04645745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360261|NCT02905695|Levobupivacaine|levobupivacaine|mesh-list
110360262|NCT02905695|Anesthetics, Local|anesthetics, local|mesh-ancestor
110360263|NCT02905695|Anesthetics|anesthetics|mesh-ancestor
110360264|NCT02905695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110360265|NCT02905695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360266|NCT02905695|Sensory System Agents|sensory system agents|mesh-ancestor
110360267|NCT02905695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110360268|NCT00558818|Clevudine|clevudine|mesh-list
110360269|NCT00558818|Antiviral Agents|antiviral agents|mesh-ancestor
110360270|NCT00558818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110360271|NCT04644341|Respiratory System Agents|respiratory system agents|mesh-list
110360272|NCT04681911|Paclitaxel|paclitaxel|mesh-list
110360273|NCT04681911|Vinorelbine|vinorelbine|mesh-list
110360274|NCT04681911|Carboplatin|carboplatin|mesh-list
110360275|NCT04681911|Gemcitabine|gemcitabine|mesh-list
110360276|NCT04681911|Capecitabine|capecitabine|mesh-list
110360277|NCT04681911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110360278|NCT04681911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110360279|NCT04681911|Tubulin Modulators|tubulin modulators|mesh-ancestor
110360280|NCT04681911|Antimitotic Agents|antimitotic agents|mesh-ancestor
110360281|NCT04681911|Mitosis Modulators|mitosis modulators|mesh-ancestor
110360282|NCT04681911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110360283|NCT04681911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110360284|NCT04681911|Antimetabolites|antimetabolites|mesh-ancestor
110360285|NCT02905539|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
110360286|NCT02905539|Hematinics|hematinics|mesh-ancestor
110360288|NCT02905734|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110360289|NCT02905734|Autonomic Agents|autonomic agents|mesh-ancestor
110360290|NCT02905734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110360291|NCT02905734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360292|NCT02905734|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110360293|NCT02905734|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110360294|NCT02905734|Cholinergic Agents|cholinergic agents|mesh-ancestor
110360295|NCT02905734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110360296|NCT02905734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110360297|NCT04644185|Myeloma Proteins|myeloma proteins|mesh-list
110360298|NCT04644185|Paraproteins|paraproteins|mesh-list
110360299|NCT04644185|Immunologic Factors|immunologic factors|mesh-ancestor
110360300|NCT04644185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360301|NCT02905461|Contraceptive Agents|contraceptive agents|mesh-list
110360302|NCT02905461|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110360303|NCT02905461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360304|NCT02905305|Dexamethasone|dexamethasone|mesh-list
110360305|NCT02905305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110360306|NCT02905305|Antiemetics|antiemetics|mesh-ancestor
110360307|NCT02905305|Autonomic Agents|autonomic agents|mesh-ancestor
110360308|NCT02905305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110360309|NCT02905305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360310|NCT02905305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110360311|NCT02905305|Glucocorticoids|glucocorticoids|mesh-ancestor
110360313|NCT02905305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110360314|NCT02905305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110360315|NCT02905305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110360316|NCT02899182|Nitrous Oxide|nitrous oxide|mesh-list
110360317|NCT02899182|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110360318|NCT02899182|Anesthetics, General|anesthetics, general|mesh-ancestor
110360319|NCT02899182|Anesthetics|anesthetics|mesh-ancestor
110360320|NCT02899182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110360321|NCT02899182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360322|NCT02899182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110360323|NCT02899182|Analgesics|analgesics|mesh-ancestor
110360324|NCT02899182|Sensory System Agents|sensory system agents|mesh-ancestor
110360325|NCT02899182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110360326|NCT02905227|Zolmitriptan|zolmitriptan|mesh-list
110360327|NCT02905227|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110360328|NCT02905227|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110360329|NCT02905227|Serotonin Agents|serotonin agents|mesh-ancestor
110360330|NCT02905227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110360331|NCT02905227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110360332|NCT02905227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360333|NCT04643483|Adalimumab|adalimumab|mesh-list
110360334|NCT04643483|Certolizumab Pegol|certolizumab pegol|mesh-list
110360335|NCT04643483|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110360336|NCT04643483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110360337|NCT04643483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110360338|NCT04643483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110360339|NCT04643483|Immunologic Factors|immunologic factors|mesh-ancestor
110360340|NCT04643483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360341|NCT00559052|Pancrelipase|pancrelipase|mesh-list
110360342|NCT00559052|Pancreatin|pancreatin|mesh-list
110360343|NCT00559052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110360344|NCT02899104|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
110360345|NCT02899104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110360347|NCT04643132|Esketamine|esketamine|mesh-list
110360348|NCT04643132|Analgesics|analgesics|mesh-ancestor
110360349|NCT04643132|Sensory System Agents|sensory system agents|mesh-ancestor
110360350|NCT04643132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110360351|NCT04643132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360352|NCT04643132|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110360353|NCT04643132|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110360354|NCT04643132|Anesthetics, General|anesthetics, general|mesh-ancestor
110360355|NCT04643132|Anesthetics|anesthetics|mesh-ancestor
110360356|NCT04643132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110360357|NCT04643132|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110360358|NCT04643132|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110360359|NCT04643132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110360360|NCT04643132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110360361|NCT04643132|Antidepressive Agents|antidepressive agents|mesh-ancestor
110360362|NCT04643132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110360363|NCT02899143|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110360364|NCT02899143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110360365|NCT02899026|Prednisone|prednisone|mesh-list
110360366|NCT02899026|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110360367|NCT02899026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110360368|NCT02899026|Glucocorticoids|glucocorticoids|mesh-ancestor
110360369|NCT02899026|Hormones|hormones|mesh-ancestor
110360370|NCT02899026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110360371|NCT02899026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360372|NCT02899026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110360373|NCT02899026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110360374|NCT02899026|Immunologic Factors|immunologic factors|mesh-ancestor
110360375|NCT00559169|Verapamil|verapamil|mesh-list
110360376|NCT00559169|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110360377|NCT00559169|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110360379|NCT00559169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110360380|NCT00559169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110360381|NCT00559169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360382|NCT00559169|Vasodilator Agents|vasodilator agents|mesh-ancestor
110360384|NCT04642664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110360385|NCT04642664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110360386|NCT04642664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110360387|NCT04642664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110360388|NCT02904759|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
110360389|NCT02904759|Hemostatics|hemostatics|mesh-ancestor
110360390|NCT02904759|Coagulants|coagulants|mesh-ancestor
110360391|NCT02904759|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110360392|NCT02904759|Natriuretic Agents|natriuretic agents|mesh-ancestor
110360393|NCT02904759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360394|NCT02898792|Remifentanil|remifentanil|mesh-list
110360395|NCT02898792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110360396|NCT02898792|Narcotics|narcotics|mesh-ancestor
110360397|NCT02898792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110360398|NCT02898792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360399|NCT02898792|Analgesics|analgesics|mesh-ancestor
110360400|NCT02898792|Sensory System Agents|sensory system agents|mesh-ancestor
110360401|NCT02898792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110360402|NCT04642391|Cosyntropin|cosyntropin|mesh-list
110360403|NCT04642391|Hormones|hormones|mesh-ancestor
110360404|NCT04642391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110360405|NCT04642391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360406|NCT02904564|Fluorouracil|fluorouracil|mesh-list
110360407|NCT02904564|Antimetabolites|antimetabolites|mesh-ancestor
110360408|NCT02904564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110360409|NCT02904564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110360410|NCT02904564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110360411|NCT02904564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110360412|NCT02904564|Immunologic Factors|immunologic factors|mesh-ancestor
110360413|NCT02904564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360414|NCT04642001|Listerine|listerine|mesh-list
110360415|NCT04642001|Sodium Fluoride|sodium fluoride|mesh-list
110360417|NCT04642001|Protective Agents|protective agents|mesh-ancestor
110360418|NCT04642001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360419|NCT04642001|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110360420|NCT04642001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110360422|NCT00559286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110360423|NCT00559286|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110360424|NCT00559286|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110360425|NCT00559286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110360426|NCT04640870|Afatinib|afatinib|mesh-list
110360427|NCT04640870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110360428|NCT04640870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110360429|NCT04640870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110360430|NCT04640870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110360431|NCT02897934|Bupivacaine|bupivacaine|mesh-list
110360432|NCT02897934|Anesthetics, Local|anesthetics, local|mesh-ancestor
110360433|NCT02897934|Anesthetics|anesthetics|mesh-ancestor
110360434|NCT02897934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110360435|NCT02897934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360436|NCT02897934|Sensory System Agents|sensory system agents|mesh-ancestor
110360437|NCT02897934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110368785|NCT05125796|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110368786|NCT05125796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110368787|NCT05125796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110034527|NCT01399645|Incretins|incretins|mesh-ancestor
110368788|NCT05125796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110368789|NCT05125796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110368790|NCT05125796|Analgesics|analgesics|mesh-ancestor
110368791|NCT05125796|Antipyretics|antipyretics|mesh-ancestor
110368792|NCT05125796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110368793|NCT05125796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110368794|NCT05125796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110368795|NCT05125796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110368796|NCT05125796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110368797|NCT04616859|Ethanol|ethanol|mesh-list
110368798|NCT04616859|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110368799|NCT04616859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110360439|NCT04640129|Tenofovir|tenofovir|mesh-list
110360440|NCT04640129|Interferon-alpha|interferon-alpha|mesh-list
110360441|NCT04640129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110360442|NCT04640129|Antiviral Agents|antiviral agents|mesh-ancestor
110360443|NCT04640129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110360444|NCT04640129|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110360445|NCT04640129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110360446|NCT04640129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110360447|NCT04640129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110360448|NCT04640129|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110360449|NCT04640129|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110360450|NCT04640129|Immunologic Factors|immunologic factors|mesh-ancestor
110360451|NCT04640129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360452|NCT02898012|Bevacizumab|bevacizumab|mesh-list
110360453|NCT02898012|Temozolomide|temozolomide|mesh-list
110360454|NCT02898012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110360455|NCT02898012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110360456|NCT02898012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110360457|NCT02898012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110360458|NCT02898012|Growth Substances|growth substances|mesh-ancestor
110177157|NCT03151005|Metformin|metformin|mesh-list
110360459|NCT02898012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360460|NCT02898012|Growth Inhibitors|growth inhibitors|mesh-ancestor
110360461|NCT02898012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110360462|NCT02898012|Alkylating Agents|alkylating agents|mesh-ancestor
110360463|NCT02898012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110360465|NCT04640324|Vitamins|vitamins|mesh-list
110360466|NCT04640324|Vitamin E|vitamin e|mesh-list
110360468|NCT04640324|Micronutrients|micronutrients|mesh-ancestor
110360469|NCT04640324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360470|NCT04640324|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110360471|NCT04640324|Antioxidants|antioxidants|mesh-ancestor
110360472|NCT04640324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110360473|NCT04640324|Protective Agents|protective agents|mesh-ancestor
110360474|NCT04640324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110360475|NCT04640324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110360476|NCT04640285|Menthol|menthol|mesh-list
110360477|NCT04640285|Nicotine|nicotine|mesh-list
110360478|NCT04640285|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110360479|NCT04640285|Autonomic Agents|autonomic agents|mesh-ancestor
110360480|NCT04640285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110360481|NCT04640285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360482|NCT04640285|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110360483|NCT04640285|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110360484|NCT04640285|Cholinergic Agents|cholinergic agents|mesh-ancestor
110360485|NCT04640285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110360486|NCT04640285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110360487|NCT04640285|Antipruritics|antipruritics|mesh-ancestor
110360488|NCT04640285|Dermatologic Agents|dermatologic agents|mesh-ancestor
110360489|NCT00559481|Ketoconazole|ketoconazole|mesh-list
110360490|NCT00559481|Dexamethasone|dexamethasone|mesh-list
110360491|NCT00559481|Hydrocortisone|hydrocortisone|mesh-list
110360492|NCT00559481|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110360493|NCT00559481|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110360494|NCT00559481|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110360495|NCT00559481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110360496|NCT00559481|Antiemetics|antiemetics|mesh-ancestor
110360497|NCT00559481|Autonomic Agents|autonomic agents|mesh-ancestor
110360498|NCT00559481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110360499|NCT00559481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360500|NCT00559481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110360501|NCT00559481|Glucocorticoids|glucocorticoids|mesh-ancestor
110360502|NCT00559481|Hormones|hormones|mesh-ancestor
110360503|NCT00559481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110360504|NCT00559481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110360505|NCT00559481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110360506|NCT00559481|Antifungal Agents|antifungal agents|mesh-ancestor
110360507|NCT00559481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110360508|NCT00559481|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110360509|NCT00559481|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110360510|NCT00559481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110360511|NCT00559481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110360512|NCT00559481|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110360513|NCT00559481|Hormone Antagonists|hormone antagonists|mesh-ancestor
110360514|NCT00559481|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110360515|NCT02897856|Midazolam|midazolam|mesh-list
110360516|NCT02897856|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110360517|NCT02897856|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110360518|NCT02897856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110360519|NCT02897856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360520|NCT02897856|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110360521|NCT02897856|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110360522|NCT02897856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110360523|NCT02897856|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110360524|NCT02897856|Anesthetics, General|anesthetics, general|mesh-ancestor
110360525|NCT02897856|Anesthetics|anesthetics|mesh-ancestor
110360526|NCT02897856|GABA Modulators|gaba modulators|mesh-ancestor
110360528|NCT02897856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110360529|NCT02897856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110360530|NCT01236118|Ixekizumab|ixekizumab|mesh-list
110360531|NCT01236118|Dermatologic Agents|dermatologic agents|mesh-ancestor
110360532|NCT04206631|Doxycycline|doxycycline|mesh-list
110360533|NCT04206631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110360534|NCT04206631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110360535|NCT04206631|Antimalarials|antimalarials|mesh-ancestor
110360536|NCT04206631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110360537|NCT04206631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110360538|NCT04639817|Levofloxacin|levofloxacin|mesh-list
110360539|NCT04639817|Trimethoprim|trimethoprim|mesh-list
110360540|NCT04639817|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110360541|NCT04639817|Sulfamethoxazole|sulfamethoxazole|mesh-list
110360542|NCT04639817|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110360543|NCT04639817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110360544|NCT04639817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110360545|NCT04639817|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110360546|NCT04639817|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110360547|NCT04639817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110360548|NCT04639817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110360549|NCT04639817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110360550|NCT04639817|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110360551|NCT04639817|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110360552|NCT04639817|Antimalarials|antimalarials|mesh-ancestor
110360553|NCT04639817|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110360554|NCT04639817|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110360555|NCT04639817|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110360556|NCT04639817|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110360557|NCT04639817|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110360558|NCT01236001|Lacosamide|lacosamide|mesh-list
110360559|NCT01236001|Anticonvulsants|anticonvulsants|mesh-ancestor
110360560|NCT01236001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110360561|NCT01236001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110360562|NCT01236001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110360563|NCT01236001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110360564|NCT02897466|Anti-Infective Agents|anti-infective agents|mesh-list
110360565|NCT02897466|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110360566|NCT01229254|Amiodarone|amiodarone|mesh-list
110360567|NCT01229254|Betrixaban|betrixaban|mesh-list
110360568|NCT01229254|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110360569|NCT01229254|Vasodilator Agents|vasodilator agents|mesh-ancestor
110360570|NCT01229254|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110360571|NCT01229254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110360572|NCT01229254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110360573|NCT01229254|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110360574|NCT01229254|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110360575|NCT01229254|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110360576|NCT01229254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110360577|NCT01229254|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110360578|NCT01229254|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110360579|NCT01229254|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110360580|NCT01229254|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110360581|NCT01229254|Antithrombins|antithrombins|mesh-ancestor
110360582|NCT01229254|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110360583|NCT01229254|Protease Inhibitors|protease inhibitors|mesh-ancestor
110360584|NCT01229254|Anticoagulants|anticoagulants|mesh-ancestor
110360585|NCT04639232|Probenecid|probenecid|mesh-list
110360586|NCT04639232|Uricosuric Agents|uricosuric agents|mesh-ancestor
110360587|NCT04639232|Gout Suppressants|gout suppressants|mesh-ancestor
110360588|NCT04639232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110360590|NCT01235728|MK 0873|mk 0873|mesh-list
110360591|NCT01235728|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110360592|NCT01235728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360593|NCT01235728|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110360594|NCT01235728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110177170|NCT00137527|Anesthetics|anesthetics|mesh-list
110360595|NCT01235728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110360596|NCT01235728|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110360598|NCT01235728|Micronutrients|micronutrients|mesh-ancestor
110360599|NCT01235728|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110360600|NCT01235728|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110360601|NCT01235728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110360602|NCT01235728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110360603|NCT00559676|Leucovorin|leucovorin|mesh-list
110360604|NCT00559676|Fluorouracil|fluorouracil|mesh-list
110360605|NCT00559676|Capecitabine|capecitabine|mesh-list
110360606|NCT00559676|Oxaliplatin|oxaliplatin|mesh-list
110360607|NCT00559676|Irinotecan|irinotecan|mesh-list
110360608|NCT00559676|Calcium|calcium|mesh-list
110360609|NCT00559676|Levoleucovorin|levoleucovorin|mesh-list
110360610|NCT00559676|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110360611|NCT00559676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360612|NCT00559676|Antimetabolites|antimetabolites|mesh-ancestor
110360613|NCT00559676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110360614|NCT00559676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110360615|NCT00559676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110360616|NCT00559676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110360617|NCT00559676|Immunologic Factors|immunologic factors|mesh-ancestor
110360618|NCT00559676|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110360619|NCT00559676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110360620|NCT00559676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110360621|NCT00559676|Antidotes|antidotes|mesh-ancestor
110360622|NCT00559676|Protective Agents|protective agents|mesh-ancestor
110360623|NCT00559676|Vitamin B Complex|vitamin b complex|mesh-ancestor
110360625|NCT00559676|Micronutrients|micronutrients|mesh-ancestor
110360626|NCT04639271|Trastuzumab|trastuzumab|mesh-list
110360627|NCT04639271|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110360628|NCT04639271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110360629|NCT04639271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110360630|NCT04681053|Ivermectin|ivermectin|mesh-list
110360631|NCT04681053|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110360632|NCT04681053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110360633|NCT04639193|Acetazolamide|acetazolamide|mesh-list
110360634|NCT04639193|Eszopiclone|eszopiclone|mesh-list
110360635|NCT04639193|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110360636|NCT04639193|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110360637|NCT04639193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110360638|NCT04639193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110360639|NCT04639193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110360640|NCT04639193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110360641|NCT04639193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360642|NCT04639193|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110360643|NCT04639193|Antidepressive Agents|antidepressive agents|mesh-ancestor
110360644|NCT04639193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110360645|NCT04639193|Anticonvulsants|anticonvulsants|mesh-ancestor
110360646|NCT04639193|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110360647|NCT04639193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110360648|NCT04639193|Diuretics|diuretics|mesh-ancestor
110360649|NCT04639193|Natriuretic Agents|natriuretic agents|mesh-ancestor
110360650|NCT04639193|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110360651|NCT04639193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110360652|NCT01235689|Prednisone|prednisone|mesh-list
110360653|NCT01235689|Adalimumab|adalimumab|mesh-list
110360654|NCT01235689|Azathioprine|azathioprine|mesh-list
110360655|NCT01235689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110360656|NCT01235689|Glucocorticoids|glucocorticoids|mesh-ancestor
110360657|NCT01235689|Hormones|hormones|mesh-ancestor
110360658|NCT01235689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110360659|NCT01235689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360660|NCT01235689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110360661|NCT01235689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110360662|NCT01235689|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110360663|NCT01235689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110360664|NCT01235689|Antimetabolites|antimetabolites|mesh-ancestor
110360665|NCT01235689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110360666|NCT01235689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110360667|NCT01235689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110360668|NCT01235689|Immunologic Factors|immunologic factors|mesh-ancestor
110360670|NCT04638686|Dolutegravir|dolutegravir|mesh-list
110360671|NCT04638686|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110360672|NCT04638686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110360673|NCT04638686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110360674|NCT04638686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110360675|NCT04638686|Antiviral Agents|antiviral agents|mesh-ancestor
110360676|NCT04638686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110360677|NCT04638686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110360678|NCT04638686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110360679|NCT04638686|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110360680|NCT04638686|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110360681|NCT04680819|Propolis|propolis|mesh-list
110360682|NCT04680819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110360683|NCT02896842|Imatinib Mesylate|imatinib mesylate|mesh-list
110360684|NCT02896842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110360685|NCT02896842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110360686|NCT02896842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110360687|NCT02896842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110360688|NCT00559715|Bevacizumab|bevacizumab|mesh-list
110360689|NCT00559715|Ranibizumab|ranibizumab|mesh-list
110360690|NCT00559715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110360691|NCT00559715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110360692|NCT00559715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110360693|NCT00559715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110360694|NCT00559715|Growth Substances|growth substances|mesh-ancestor
110360695|NCT00559715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360696|NCT00559715|Growth Inhibitors|growth inhibitors|mesh-ancestor
110360697|NCT02896803|Fluorouracil|fluorouracil|mesh-list
110360698|NCT02896803|Oxaliplatin|oxaliplatin|mesh-list
110360699|NCT02896803|Antimetabolites|antimetabolites|mesh-ancestor
110360700|NCT02896803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110360701|NCT02896803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110360702|NCT02896803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110360703|NCT02896803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110360704|NCT02896803|Immunologic Factors|immunologic factors|mesh-ancestor
110360705|NCT02896803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360706|NCT02897037|Heparin|heparin|mesh-list
110360707|NCT02897037|Bivalirudin|bivalirudin|mesh-list
110360708|NCT02897037|Anticoagulants|anticoagulants|mesh-ancestor
110360709|NCT02897037|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110360710|NCT02897037|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110360711|NCT02897037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110360712|NCT02897037|Antithrombins|antithrombins|mesh-ancestor
110360713|NCT02897037|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110360714|NCT02897037|Protease Inhibitors|protease inhibitors|mesh-ancestor
110360715|NCT02897037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110360716|NCT00553683|Cyclophosphamide|cyclophosphamide|mesh-list
110360717|NCT00553683|Poly ICLC|poly iclc|mesh-list
110360718|NCT00553683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110360719|NCT00553683|Immunologic Factors|immunologic factors|mesh-ancestor
110360720|NCT00553683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360721|NCT00553683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110360722|NCT00553683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110360724|NCT00553683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110360725|NCT00553683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110360726|NCT00553683|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110360727|NCT00553683|Interferon Inducers|interferon inducers|mesh-ancestor
110360728|NCT01229176|Vaccines|vaccines|mesh-list
110360729|NCT01229176|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110360730|NCT01229176|Immunologic Factors|immunologic factors|mesh-ancestor
110360731|NCT01229176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360732|NCT01228747|Levetiracetam|levetiracetam|mesh-list
110360733|NCT01228747|Anticonvulsants|anticonvulsants|mesh-ancestor
110360734|NCT01228747|Nootropic Agents|nootropic agents|mesh-ancestor
110360735|NCT02896413|Dexmedetomidine|dexmedetomidine|mesh-list
110360736|NCT02896413|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110360737|NCT02896413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110360738|NCT02896413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360739|NCT02896413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110360740|NCT02896413|Analgesics|analgesics|mesh-ancestor
110360741|NCT02896413|Sensory System Agents|sensory system agents|mesh-ancestor
110360742|NCT02896413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110360743|NCT02896413|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110360744|NCT02896413|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110360745|NCT02896413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110360746|NCT02896413|Adrenergic Agents|adrenergic agents|mesh-ancestor
110360747|NCT02896413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110360748|NCT02896413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110360749|NCT00553722|Eplerenone|eplerenone|mesh-list
110360750|NCT00553722|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110360751|NCT00553722|Hormone Antagonists|hormone antagonists|mesh-ancestor
110360752|NCT00553722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110360753|NCT00553722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360754|NCT00553722|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110360755|NCT00553722|Diuretics|diuretics|mesh-ancestor
110360756|NCT00553722|Natriuretic Agents|natriuretic agents|mesh-ancestor
110360757|NCT00553722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110360758|NCT01235338|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
110360759|NCT01235338|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110360760|NCT01235338|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110360761|NCT01235338|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110360762|NCT01235338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110360763|NCT01235338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110360764|NCT01235338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110360765|NCT01235338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360766|NCT01235338|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110360767|NCT01235338|Antidepressive Agents|antidepressive agents|mesh-ancestor
110360768|NCT01235338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110360769|NCT01235338|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110360770|NCT01235338|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110360771|NCT01235338|Dopamine Agents|dopamine agents|mesh-ancestor
110360772|NCT01234675|Milnacipran|milnacipran|mesh-list
110360773|NCT01234675|Levomilnacipran|levomilnacipran|mesh-list
110360774|NCT01234675|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110360775|NCT01234675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110360776|NCT01234675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110360777|NCT01234675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110360778|NCT01234675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110360779|NCT01234675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360780|NCT01234675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110360781|NCT01234675|Analgesics|analgesics|mesh-ancestor
110360782|NCT01234675|Sensory System Agents|sensory system agents|mesh-ancestor
110360783|NCT01234675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110360784|NCT01234675|Antidepressive Agents|antidepressive agents|mesh-ancestor
110360785|NCT01234675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110360786|NCT02896101|Pimecrolimus|pimecrolimus|mesh-list
110360787|NCT02896101|Tacrolimus|tacrolimus|mesh-list
110360788|NCT02896101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110360789|NCT02896101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110360790|NCT02896101|Analgesics|analgesics|mesh-ancestor
110360791|NCT02896101|Sensory System Agents|sensory system agents|mesh-ancestor
110360792|NCT02896101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110360793|NCT02896101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360794|NCT02896101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110360795|NCT02896101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110360796|NCT02896101|Dermatologic Agents|dermatologic agents|mesh-ancestor
110360797|NCT02896101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110360798|NCT02896101|Immunologic Factors|immunologic factors|mesh-ancestor
110360799|NCT02896101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110360800|NCT02896101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110360801|NCT02896101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110360802|NCT02896023|Menotropins|menotropins|mesh-list
110360803|NCT02896023|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110360804|NCT02896023|Fertility Agents|fertility agents|mesh-ancestor
110360805|NCT02896023|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110360806|NCT02896023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360807|NCT04637633|Lubricant Eye Drops|lubricant eye drops|mesh-list
110360808|NCT04637633|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110360809|NCT04637633|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110360810|NCT01228318|Zoledronic Acid|zoledronic acid|mesh-list
110360811|NCT01228318|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110360812|NCT01228318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360814|NCT02895672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110360815|NCT02895672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360816|NCT02895672|Incretins|incretins|mesh-ancestor
110360817|NCT02895672|Hormones|hormones|mesh-ancestor
110360818|NCT02895672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110360819|NCT02895672|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110360820|NCT01227967|Ribavirin|ribavirin|mesh-list
110360821|NCT01227967|Oseltamivir|oseltamivir|mesh-list
110360822|NCT01227967|Amantadine|amantadine|mesh-list
110360823|NCT01227967|Antimetabolites|antimetabolites|mesh-ancestor
110360824|NCT01227967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110360825|NCT01227967|Antiviral Agents|antiviral agents|mesh-ancestor
110360826|NCT01227967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110360827|NCT01227967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110360828|NCT01227967|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110360829|NCT01227967|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110360830|NCT01227967|Dopamine Agents|dopamine agents|mesh-ancestor
110360831|NCT01227967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110360832|NCT01227967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360833|NCT01227967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110360834|NCT01227967|Analgesics|analgesics|mesh-ancestor
110360835|NCT01227967|Sensory System Agents|sensory system agents|mesh-ancestor
110360836|NCT01227967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110360837|NCT00560144|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110360838|NCT00560144|Immunologic Factors|immunologic factors|mesh-ancestor
110360839|NCT00560144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360840|NCT04637204|Axitinib|axitinib|mesh-list
110360841|NCT04637204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110360842|NCT04637204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110360843|NCT04637204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110360844|NCT04637204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110360846|NCT04637360|Cinacalcet|cinacalcet|mesh-list
110360847|NCT04637360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110360848|NCT04637360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360849|NCT04637360|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110360850|NCT04637360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110360851|NCT04637360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110360852|NCT04637360|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110360853|NCT04637360|Vitamins|vitamins|mesh-ancestor
110360855|NCT04637360|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110360856|NCT04637360|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
110360857|NCT04637360|Hormone Antagonists|hormone antagonists|mesh-ancestor
110360858|NCT04637360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110360860|NCT04317703|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110360861|NCT04317703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360862|NCT00560222|Lactoferrin|lactoferrin|mesh-list
110360863|NCT00560222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110360864|NCT04317508|Benzocaine|benzocaine|mesh-list
110360865|NCT04317508|Anesthetics, Local|anesthetics, local|mesh-ancestor
110360866|NCT04317508|Anesthetics|anesthetics|mesh-ancestor
110360867|NCT04317508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110360868|NCT04317508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360869|NCT04317508|Sensory System Agents|sensory system agents|mesh-ancestor
110360870|NCT04317508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110360871|NCT00560300|Vitamin D|vitamin d|mesh-list
110360872|NCT00560300|Cholecalciferol|cholecalciferol|mesh-list
110360873|NCT00560300|Calcitriol|calcitriol|mesh-list
110360874|NCT00560300|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
110360875|NCT00560300|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
110360876|NCT00560300|Calcium Carbonate|calcium carbonate|mesh-list
110360877|NCT00560300|Calcium|calcium|mesh-list
110360878|NCT00560300|Sevelamer|sevelamer|mesh-list
110360879|NCT00560300|Vitamins|vitamins|mesh-ancestor
110360880|NCT00560300|Micronutrients|micronutrients|mesh-ancestor
110360881|NCT00560300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360882|NCT00560300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110360883|NCT00560300|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110360884|NCT00560300|Antacids|antacids|mesh-ancestor
110360885|NCT00560300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110360886|NCT00560300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110360887|NCT00560300|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110360888|NCT00560300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110360889|NCT00560300|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110360890|NCT00560300|Chelating Agents|chelating agents|mesh-ancestor
110360891|NCT00560300|Sequestering Agents|sequestering agents|mesh-ancestor
110360892|NCT02904369|Tenofovir|tenofovir|mesh-list
110360893|NCT02904369|Emtricitabine|emtricitabine|mesh-list
110360894|NCT02904369|Antiviral Agents|antiviral agents|mesh-ancestor
110360895|NCT02904369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110360896|NCT02904369|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110360897|NCT02904369|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110360898|NCT02904369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110360899|NCT02904369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110360900|NCT02904369|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110360901|NCT02904369|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110360902|NCT00560378|Tacrolimus|tacrolimus|mesh-list
110360903|NCT00560378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110360904|NCT00560378|Immunologic Factors|immunologic factors|mesh-ancestor
110360905|NCT00560378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360906|NCT00560378|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110360907|NCT00560378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110360908|NCT00560378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110360910|NCT02895321|Sodium Fluoride|sodium fluoride|mesh-list
110360911|NCT02895321|Cariostatic Agents|cariostatic agents|mesh-ancestor
110360912|NCT02895321|Protective Agents|protective agents|mesh-ancestor
110360913|NCT02895321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360914|NCT02895321|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110360915|NCT02895321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110360916|NCT02894892|Esomeprazole|esomeprazole|mesh-list
110360917|NCT02894892|Bismuth|bismuth|mesh-list
110360918|NCT02894892|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110360919|NCT02894892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110360920|NCT02894892|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110360921|NCT02894892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110360922|NCT02894892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110360924|NCT04635566|Mebeverine|mebeverine|mesh-list
110360925|NCT04635566|Alverine|alverine|mesh-list
110360926|NCT04635566|Anticonvulsants|anticonvulsants|mesh-ancestor
110360927|NCT04635566|Parasympatholytics|parasympatholytics|mesh-ancestor
110360928|NCT04635566|Autonomic Agents|autonomic agents|mesh-ancestor
110360929|NCT04635566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110360930|NCT04635566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360931|NCT04635293|Simendan|simendan|mesh-list
110360932|NCT04635293|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110360933|NCT04635293|Vasodilator Agents|vasodilator agents|mesh-ancestor
110360934|NCT04635293|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110360935|NCT04635293|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110360936|NCT04635293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110360937|NCT04635293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110360938|NCT04635293|Protective Agents|protective agents|mesh-ancestor
110360939|NCT04635293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360940|NCT01227889|Dacarbazine|dacarbazine|mesh-list
110360941|NCT01227889|Dabrafenib|dabrafenib|mesh-list
110360942|NCT01227889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110360943|NCT01227889|Alkylating Agents|alkylating agents|mesh-ancestor
110360944|NCT01227889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110360945|NCT01227889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110360946|NCT01227889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110360947|NCT01227889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110360948|NCT02888392|Psyllium|psyllium|mesh-list
110360949|NCT02888392|Cathartics|cathartics|mesh-ancestor
110360950|NCT02888392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110360951|NCT00624676|Salicylic Acid|salicylic acid|mesh-list
110360952|NCT00624676|Benzoic Acid|benzoic acid|mesh-list
110360953|NCT00624676|Salicylates|salicylates|mesh-list
110360954|NCT00624676|Benzoyl Peroxide|benzoyl peroxide|mesh-list
110360955|NCT00624676|Dermatologic Agents|dermatologic agents|mesh-ancestor
110360956|NCT00624676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110360957|NCT00624676|Antifungal Agents|antifungal agents|mesh-ancestor
110360958|NCT00624676|Keratolytic Agents|keratolytic agents|mesh-ancestor
110360959|NCT00624676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110360960|NCT00624676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110360961|NCT00624676|Analgesics|analgesics|mesh-ancestor
110360962|NCT00624676|Sensory System Agents|sensory system agents|mesh-ancestor
110360963|NCT00624676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110360964|NCT00624676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360965|NCT00624676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110360967|NCT00624676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110360968|NCT00624676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110360969|NCT00624676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110360970|NCT05655754|Methohexital|methohexital|mesh-list
110360971|NCT05655754|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110360972|NCT05655754|Anesthetics, General|anesthetics, general|mesh-ancestor
110360973|NCT05655754|Anesthetics|anesthetics|mesh-ancestor
110360974|NCT05655754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110360975|NCT05655754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360976|NCT05655715|Nivolumab|nivolumab|mesh-list
110360977|NCT05655715|Ipilimumab|ipilimumab|mesh-list
110360978|NCT05655715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110360979|NCT05655715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110360980|NCT05655715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110360981|NCT05655715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110360982|NCT04317235|Ropivacaine|ropivacaine|mesh-list
110360983|NCT04317235|Anesthetics, Local|anesthetics, local|mesh-ancestor
110360984|NCT04317235|Anesthetics|anesthetics|mesh-ancestor
110360985|NCT04317235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110360986|NCT04317235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360987|NCT04317235|Sensory System Agents|sensory system agents|mesh-ancestor
110360988|NCT04317235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110360989|NCT00560690|Metformin|metformin|mesh-list
110360990|NCT00560690|Interferons|interferons|mesh-list
110360991|NCT00560690|Ribavirin|ribavirin|mesh-list
110360992|NCT00560690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110360993|NCT00560690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360994|NCT00560690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110360995|NCT00560690|Antiviral Agents|antiviral agents|mesh-ancestor
110360996|NCT00560690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110360997|NCT00560690|Antimetabolites|antimetabolites|mesh-ancestor
110360998|NCT00560690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110360999|NCT01227421|Nitazoxanide|nitazoxanide|mesh-list
110361000|NCT01227421|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110361001|NCT01227421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110361003|NCT02903901|Antioxidants|antioxidants|mesh-ancestor
110361004|NCT02903901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110361005|NCT02903901|Protective Agents|protective agents|mesh-ancestor
110361006|NCT02903901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110361007|NCT02903901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110361008|NCT04634981|Anesthetics|anesthetics|mesh-list
110361009|NCT04634981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110361010|NCT04634981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110361011|NCT00553449|Rabeprazole|rabeprazole|mesh-list
110361012|NCT00553449|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110361013|NCT00553449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110361014|NCT00553449|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110361015|NCT00553449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110361016|NCT00553449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110361017|NCT05655130|Dexamethasone|dexamethasone|mesh-list
110361018|NCT05655130|Methylprednisolone|methylprednisolone|mesh-list
110361019|NCT05655130|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110361020|NCT05655130|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110361021|NCT05655130|Prednisolone|prednisolone|mesh-list
110361022|NCT05655130|Prednisolone acetate|prednisolone acetate|mesh-list
110361023|NCT05655130|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110361024|NCT05655130|Prednisolone phosphate|prednisolone phosphate|mesh-list
110361025|NCT05655130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110361026|NCT05655130|Antiemetics|antiemetics|mesh-ancestor
110361027|NCT05655130|Autonomic Agents|autonomic agents|mesh-ancestor
110361028|NCT05655130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110361029|NCT05655130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110361030|NCT05655130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110361031|NCT05655130|Glucocorticoids|glucocorticoids|mesh-ancestor
110361033|NCT05655130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110361034|NCT05655130|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110361035|NCT05655130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110361036|NCT05655130|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110361037|NCT05655130|Protective Agents|protective agents|mesh-ancestor
110361038|NCT04633967|Alemtuzumab|alemtuzumab|mesh-list
110361039|NCT04633967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110361040|NCT04633967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110361042|NCT04633850|Bupivacaine|bupivacaine|mesh-list
110361043|NCT04633850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110361044|NCT04633850|Antiemetics|antiemetics|mesh-ancestor
110361045|NCT04633850|Autonomic Agents|autonomic agents|mesh-ancestor
110361046|NCT04633850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110361047|NCT04633850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110361048|NCT04633850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110361049|NCT04633850|Glucocorticoids|glucocorticoids|mesh-ancestor
110361050|NCT04633850|Hormones|hormones|mesh-ancestor
110361051|NCT04633850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110361052|NCT04633850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110361053|NCT04633850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110361054|NCT04633850|Anesthetics, Local|anesthetics, local|mesh-ancestor
110361055|NCT04633850|Anesthetics|anesthetics|mesh-ancestor
110361056|NCT04633850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110361057|NCT04633850|Sensory System Agents|sensory system agents|mesh-ancestor
110361058|NCT04633733|Tacrolimus|tacrolimus|mesh-list
110361059|NCT04633733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110361060|NCT04633733|Immunologic Factors|immunologic factors|mesh-ancestor
110361061|NCT04633733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110361062|NCT04633733|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110361063|NCT04633733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110361064|NCT04633733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110361066|NCT05427942|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110361067|NCT05427942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110361068|NCT05427942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110361069|NCT05427903|Epinephrine|epinephrine|mesh-list
110361070|NCT05427903|Anesthetics|anesthetics|mesh-list
110361071|NCT05427903|Carticaine|carticaine|mesh-list
110361072|NCT05427903|Anesthetics, Local|anesthetics, local|mesh-list
110361073|NCT05427903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110361074|NCT05427903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110361075|NCT05427903|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110361076|NCT05427903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110361077|NCT05427903|Adrenergic Agents|adrenergic agents|mesh-ancestor
110361078|NCT05427903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110361079|NCT05427903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110361080|NCT05427903|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110361081|NCT05427903|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110361082|NCT05427903|Autonomic Agents|autonomic agents|mesh-ancestor
110361083|NCT05427903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110361084|NCT05427903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110361085|NCT05427903|Respiratory System Agents|respiratory system agents|mesh-ancestor
110361086|NCT05427903|Mydriatics|mydriatics|mesh-ancestor
110361087|NCT05427903|Sympathomimetics|sympathomimetics|mesh-ancestor
110361088|NCT05427903|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110361089|NCT05427903|Sensory System Agents|sensory system agents|mesh-ancestor
110361090|NCT05427747|Meropenem|meropenem|mesh-list
110361091|NCT05427747|Cefotaxime|cefotaxime|mesh-list
110361092|NCT05427747|Cefoxitin|cefoxitin|mesh-list
110361093|NCT05427747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110361094|NCT05427747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110361095|NCT00445406|Bevacizumab|bevacizumab|mesh-list
110361096|NCT00445406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110361097|NCT00445406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110361098|NCT00445406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110361099|NCT00445406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110361100|NCT00445406|Growth Substances|growth substances|mesh-ancestor
110361101|NCT00445406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110361102|NCT00445406|Growth Inhibitors|growth inhibitors|mesh-ancestor
110361103|NCT00445523|Interferons|interferons|mesh-list
110361104|NCT00445523|Interferon-alpha|interferon-alpha|mesh-list
110361105|NCT00445523|Vaccines|vaccines|mesh-list
110361106|NCT00445523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110361107|NCT00445523|Antiviral Agents|antiviral agents|mesh-ancestor
110361108|NCT00445523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110361109|NCT00445523|Immunologic Factors|immunologic factors|mesh-ancestor
110361110|NCT00445523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110361111|NCT02903004|Paclitaxel|paclitaxel|mesh-list
110361112|NCT02903004|Carboplatin|carboplatin|mesh-list
110361113|NCT02903004|Gemcitabine|gemcitabine|mesh-list
110361114|NCT02903004|Doxorubicin|doxorubicin|mesh-list
110361115|NCT02903004|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110361116|NCT02903004|Topotecan|topotecan|mesh-list
110361117|NCT02903004|Trabectedin|trabectedin|mesh-list
110361118|NCT02903004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110361119|NCT02903004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110361120|NCT02903004|Tubulin Modulators|tubulin modulators|mesh-ancestor
110361121|NCT02903004|Antimitotic Agents|antimitotic agents|mesh-ancestor
110361122|NCT02903004|Mitosis Modulators|mitosis modulators|mesh-ancestor
110361123|NCT02903004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110361124|NCT02903004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110361125|NCT02903004|Antimetabolites|antimetabolites|mesh-ancestor
110361126|NCT02903004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110361127|NCT02903004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110361128|NCT02903004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110361129|NCT02903004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110361130|NCT02903004|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110361131|NCT02903004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110361132|NCT02903004|Alkylating Agents|alkylating agents|mesh-ancestor
110361133|NCT00445796|Artesunate|artesunate|mesh-list
110361134|NCT00445796|Amodiaquine|amodiaquine|mesh-list
110361135|NCT00445796|Antimalarials|antimalarials|mesh-ancestor
110361136|NCT00445796|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110361137|NCT00445796|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110361138|NCT00445796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110361139|NCT00445796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110177233|NCT00138112|Vancomycin|vancomycin|mesh-list
110361140|NCT00445796|Antiviral Agents|antiviral agents|mesh-ancestor
110361141|NCT00445796|Schistosomicides|schistosomicides|mesh-ancestor
110361142|NCT00445796|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110361143|NCT00445796|Anthelmintics|anthelmintics|mesh-ancestor
110361144|NCT01225822|Enoxaparin|enoxaparin|mesh-list
110361145|NCT01225822|Dabigatran|dabigatran|mesh-list
110361146|NCT01225822|Anticoagulants|anticoagulants|mesh-ancestor
110361147|NCT01225822|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110361148|NCT01225822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110361149|NCT01225822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110361150|NCT01225822|Antithrombins|antithrombins|mesh-ancestor
110361151|NCT01225822|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110361152|NCT01225822|Protease Inhibitors|protease inhibitors|mesh-ancestor
110361153|NCT01225822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110361154|NCT00445874|Ketotifen|ketotifen|mesh-list
110361155|NCT00445874|Antipruritics|antipruritics|mesh-ancestor
110361156|NCT00445874|Dermatologic Agents|dermatologic agents|mesh-ancestor
110361157|NCT00445874|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110361158|NCT00445874|Histamine Antagonists|histamine antagonists|mesh-ancestor
110361159|NCT00445874|Histamine Agents|histamine agents|mesh-ancestor
110361160|NCT00445874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110361161|NCT00445874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110361162|NCT00445874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110361163|NCT00445874|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110361164|NCT02902731|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110361165|NCT02902731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110361166|NCT01225549|Budesonide|budesonide|mesh-list
110361167|NCT01225549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110361168|NCT01225549|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110361169|NCT01225549|Autonomic Agents|autonomic agents|mesh-ancestor
110361170|NCT01225549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110361171|NCT01225549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110361172|NCT01225549|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110361173|NCT01225549|Respiratory System Agents|respiratory system agents|mesh-ancestor
110361174|NCT01225549|Glucocorticoids|glucocorticoids|mesh-ancestor
110361175|NCT01225549|Hormones|hormones|mesh-ancestor
110361176|NCT01225549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110361177|NCT05469685|Amoxicillin|amoxicillin|mesh-list
110361178|NCT05469685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110361179|NCT05469685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110361180|NCT02956772|Arsenic Trioxide|arsenic trioxide|mesh-list
110361181|NCT02956772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110361182|NCT00446069|Morphine|morphine|mesh-list
110361183|NCT00446069|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110361184|NCT00446069|Narcotics|narcotics|mesh-ancestor
110361185|NCT00446069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110361186|NCT00446069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110361187|NCT00446069|Analgesics|analgesics|mesh-ancestor
110361188|NCT00446069|Sensory System Agents|sensory system agents|mesh-ancestor
110361189|NCT00446069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110361190|NCT02902653|Misoprostol|misoprostol|mesh-list
110361191|NCT02902653|Dinoprostone|dinoprostone|mesh-list
110361192|NCT02902653|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110361193|NCT02902653|Abortifacient Agents|abortifacient agents|mesh-ancestor
110361194|NCT02902653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110361195|NCT02902653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110361196|NCT02902653|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110361197|NCT02902653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110361198|NCT02902653|Oxytocics|oxytocics|mesh-ancestor
110361199|NCT00446303|Azacitidine|azacitidine|mesh-list
110361200|NCT00446303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110361201|NCT00446303|Antimetabolites|antimetabolites|mesh-ancestor
110361202|NCT00446303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110361203|NCT00446303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110361204|NCT00446303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110361205|NCT01223404|Mecamylamine|mecamylamine|mesh-list
110361206|NCT01223404|Nicotine|nicotine|mesh-list
110361207|NCT01223404|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110361208|NCT01223404|Autonomic Agents|autonomic agents|mesh-ancestor
110361209|NCT01223404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110361210|NCT01223404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110361211|NCT01223404|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110361212|NCT01223404|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110361213|NCT01223404|Cholinergic Agents|cholinergic agents|mesh-ancestor
110361214|NCT01223404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110361215|NCT01223404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110361216|NCT01223404|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110361217|NCT01223404|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
110361218|NCT01223404|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
110361219|NCT01223404|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110361221|NCT00446420|Midazolam|midazolam|mesh-list
110361222|NCT00446420|Propofol|propofol|mesh-list
110361223|NCT00446420|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110361224|NCT00446420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110361225|NCT00446420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110361226|NCT00446420|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110361227|NCT00446420|Anesthetics, General|anesthetics, general|mesh-ancestor
110361228|NCT00446420|Anesthetics|anesthetics|mesh-ancestor
110361229|NCT00446420|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110361230|NCT00446420|Narcotics|narcotics|mesh-ancestor
110361232|NCT00446420|Sensory System Agents|sensory system agents|mesh-ancestor
110361233|NCT00446420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110361234|NCT00446420|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110361235|NCT00446420|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110361236|NCT00446420|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110361237|NCT00446420|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110361238|NCT00446420|GABA Modulators|gaba modulators|mesh-ancestor
110361239|NCT00446420|GABA Agents|gaba agents|mesh-ancestor
110361240|NCT00446420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110361241|NCT00446420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110361242|NCT00446537|Methylphenidate|methylphenidate|mesh-list
110361243|NCT00446537|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110361244|NCT00446537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110361245|NCT00446537|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110361246|NCT00446537|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110361247|NCT00446537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110361248|NCT00446537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110361249|NCT00446537|Dopamine Agents|dopamine agents|mesh-ancestor
110361250|NCT00446537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110361251|NCT00446576|Epoetin Alfa|epoetin alfa|mesh-list
110361252|NCT00446576|Hematinics|hematinics|mesh-ancestor
110361253|NCT02902302|Ibuprofen|ibuprofen|mesh-list
110361254|NCT02902302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110361255|NCT02902302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110361256|NCT02902302|Analgesics|analgesics|mesh-ancestor
110361257|NCT02902302|Sensory System Agents|sensory system agents|mesh-ancestor
110361258|NCT02902302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110361259|NCT02902302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110361260|NCT02902302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110361261|NCT02902302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110361262|NCT02902302|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110361263|NCT02902302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110361264|NCT02902302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110361265|NCT01223365|Hydrocodone|hydrocodone|mesh-list
110361266|NCT01223365|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110361267|NCT01223365|Narcotics|narcotics|mesh-ancestor
110361268|NCT01223365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110361269|NCT01223365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110361270|NCT01223365|Analgesics|analgesics|mesh-ancestor
110361271|NCT01223365|Sensory System Agents|sensory system agents|mesh-ancestor
110361272|NCT01223365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110361273|NCT01223365|Antitussive Agents|antitussive agents|mesh-ancestor
110361274|NCT01223365|Respiratory System Agents|respiratory system agents|mesh-ancestor
110361275|NCT02956811|Dapagliflozin|dapagliflozin|mesh-list
110361276|NCT02956811|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110361277|NCT02956811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110361278|NCT02956811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110361279|NCT02956811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110361280|NCT04319419|Micronutrients|micronutrients|mesh-list
110361281|NCT04319419|Trace Elements|trace elements|mesh-list
110361282|NCT04319419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110361283|NCT05657704|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
110361284|NCT05657704|Tramadol|tramadol|mesh-list
110361285|NCT05657704|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110361286|NCT05657704|Narcotics|narcotics|mesh-ancestor
110361287|NCT05657704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110361288|NCT05657704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110361289|NCT05657704|Analgesics|analgesics|mesh-ancestor
110361290|NCT05657704|Sensory System Agents|sensory system agents|mesh-ancestor
110361291|NCT05657704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110361292|NCT05657704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110361293|NCT05657704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110361294|NCT05657704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110361295|NCT05657704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110361296|NCT00446771|Mannitol|mannitol|mesh-list
110361297|NCT00446771|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110361298|NCT00446771|Diuretics|diuretics|mesh-ancestor
110361299|NCT00446771|Natriuretic Agents|natriuretic agents|mesh-ancestor
110361300|NCT00446771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110361301|NCT04317157|Caffeine|caffeine|mesh-list
110361302|NCT04317157|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110361303|NCT04317157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110361304|NCT04317157|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110361305|NCT04317157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110361306|NCT04317157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110361307|NCT04317157|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110361308|NCT04317157|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110361309|NCT04317157|Purinergic Agents|purinergic agents|mesh-ancestor
110361310|NCT04317157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110361311|NCT04317079|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
110361312|NCT04317079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110361313|NCT04317079|Antioxidants|antioxidants|mesh-ancestor
110361314|NCT04317079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110361315|NCT04317079|Protective Agents|protective agents|mesh-ancestor
110361316|NCT04317079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110361317|NCT04317079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110361318|NCT03277430|Tacrolimus|tacrolimus|mesh-list
110361319|NCT03277430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110361320|NCT03277430|Immunologic Factors|immunologic factors|mesh-ancestor
110361321|NCT03277430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110361322|NCT03277430|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110361323|NCT03277430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110361324|NCT03277430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110361325|NCT04699214|Endostar protein|endostar protein|mesh-list
110361326|NCT04699214|Endostatins|endostatins|mesh-list
110361327|NCT04699214|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110361328|NCT04699214|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110361329|NCT04699214|Growth Substances|growth substances|mesh-ancestor
110361330|NCT04699214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110361331|NCT04699214|Growth Inhibitors|growth inhibitors|mesh-ancestor
110361332|NCT04699214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110361333|NCT02902380|Dexmedetomidine|dexmedetomidine|mesh-list
110361334|NCT02902380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110361335|NCT02902380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110361336|NCT02902380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110361337|NCT02902380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110361338|NCT02902380|Analgesics|analgesics|mesh-ancestor
110361339|NCT02902380|Sensory System Agents|sensory system agents|mesh-ancestor
110361340|NCT02902380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110361341|NCT02902380|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110361342|NCT02902380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110361343|NCT02902380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110361344|NCT02902380|Adrenergic Agents|adrenergic agents|mesh-ancestor
110361345|NCT02902380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110361346|NCT02902380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110361348|NCT01221727|Midazolam|midazolam|mesh-list
110361349|NCT01221727|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110361350|NCT01221727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110361351|NCT01221727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110361352|NCT01221727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110361353|NCT01221727|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110361354|NCT01221727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110361355|NCT01221727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110361356|NCT01221727|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110361357|NCT01221727|Anesthetics, General|anesthetics, general|mesh-ancestor
110361358|NCT01221727|Anesthetics|anesthetics|mesh-ancestor
110361359|NCT01221727|GABA Modulators|gaba modulators|mesh-ancestor
110361360|NCT01221727|GABA Agents|gaba agents|mesh-ancestor
110361361|NCT01221727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110361362|NCT01221727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110361363|NCT01221727|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110361364|NCT01221181|Eculizumab|eculizumab|mesh-list
110361365|NCT01221181|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110361366|NCT01221181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110361367|NCT01221181|Immunologic Factors|immunologic factors|mesh-ancestor
110361368|NCT01221181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110361369|NCT03277079|Ezetimibe|ezetimibe|mesh-list
110361370|NCT03277079|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
110361371|NCT03277079|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110361372|NCT03277079|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110361373|NCT03277079|Antimetabolites|antimetabolites|mesh-ancestor
110361374|NCT03277079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110361375|NCT03277079|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110361376|NCT03277079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110361377|NCT01220557|Insulin|insulin|mesh-list
110361378|NCT01220557|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110361379|NCT01220557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110361380|NCT04317001|Modafinil|modafinil|mesh-list
110361381|NCT04317001|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110361382|NCT04317001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110361383|NCT04317001|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110361384|NCT04317001|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110361385|NCT04317001|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110361386|NCT04317001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110361387|NCT05426499|Fluconazole|fluconazole|mesh-list
110361388|NCT05426499|Isavuconazole|isavuconazole|mesh-list
110361389|NCT05426499|Anidulafungin|anidulafungin|mesh-list
110361390|NCT05426499|Meropenem|meropenem|mesh-list
110361391|NCT05426499|Cefotaxime|cefotaxime|mesh-list
110361392|NCT05426499|Cefoxitin|cefoxitin|mesh-list
110361393|NCT05426499|Antifungal Agents|antifungal agents|mesh-ancestor
110361394|NCT05426499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110361395|NCT05426499|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110361396|NCT05426499|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110361397|NCT05426499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110361398|NCT05426499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110361399|NCT05426499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110361400|NCT05426499|Hormone Antagonists|hormone antagonists|mesh-ancestor
110361401|NCT05426499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110361402|NCT05426499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110361403|NCT05426499|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110361404|NCT05426499|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110361405|NCT05426499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110361406|NCT00446810|Benphothiamine|benphothiamine|mesh-list
110361407|NCT00446810|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110361408|NCT00446810|Immunologic Factors|immunologic factors|mesh-ancestor
110361409|NCT00446810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110361410|NCT00446810|Chelating Agents|chelating agents|mesh-ancestor
110361411|NCT00446810|Sequestering Agents|sequestering agents|mesh-ancestor
110361412|NCT00446810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110361413|NCT01220167|Ondansetron|ondansetron|mesh-list
110361414|NCT01220167|Antiemetics|antiemetics|mesh-ancestor
110361415|NCT01220167|Autonomic Agents|autonomic agents|mesh-ancestor
110361416|NCT01220167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110361417|NCT01220167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110361418|NCT01220167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110361419|NCT01220167|Antipruritics|antipruritics|mesh-ancestor
110361420|NCT01220167|Dermatologic Agents|dermatologic agents|mesh-ancestor
110361421|NCT01220167|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110361422|NCT01220167|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110361423|NCT01220167|Serotonin Agents|serotonin agents|mesh-ancestor
110361424|NCT01220167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110361425|NCT01220167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110361427|NCT00447239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110361428|NCT00447239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110361429|NCT05425914|Vitamin D|vitamin d|mesh-list
110361430|NCT05425914|Lubricant Eye Drops|lubricant eye drops|mesh-list
110361431|NCT05425914|Vitamins|vitamins|mesh-ancestor
110361432|NCT05425914|Micronutrients|micronutrients|mesh-ancestor
110361433|NCT05425914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110361434|NCT05425914|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110361435|NCT05425914|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110361436|NCT05425914|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110361437|NCT00447356|Interferons|interferons|mesh-list
110361438|NCT00447356|Interferon-alpha|interferon-alpha|mesh-list
110361439|NCT00447356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110361440|NCT00447356|Antiviral Agents|antiviral agents|mesh-ancestor
110361441|NCT00447356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110361442|NCT00447356|Immunologic Factors|immunologic factors|mesh-ancestor
110361443|NCT00447356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110361444|NCT00447473|Ketoconazole|ketoconazole|mesh-list
110361445|NCT00447473|Mitoxantrone|mitoxantrone|mesh-list
110361446|NCT00447473|Analgesics|analgesics|mesh-ancestor
110361447|NCT00447473|Sensory System Agents|sensory system agents|mesh-ancestor
110361448|NCT00447473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110361449|NCT00447473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110361450|NCT00447473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110361451|NCT00447473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110361452|NCT00447473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110361453|NCT00447473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110361454|NCT00447473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110361455|NCT00447473|Antifungal Agents|antifungal agents|mesh-ancestor
110361456|NCT00447473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110361457|NCT00447473|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110361458|NCT00447473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110361459|NCT00447473|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110361460|NCT00447473|Hormone Antagonists|hormone antagonists|mesh-ancestor
110361461|NCT00447473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110361462|NCT00447473|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110361463|NCT00553488|Insulin|insulin|mesh-list
110361464|NCT00553488|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110361465|NCT00553488|Insulin Lispro|insulin lispro|mesh-list
110361466|NCT00553488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110361467|NCT00553488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110361468|NCT03455322|Octreotide|octreotide|mesh-list
110361469|NCT03455322|Norepinephrine|norepinephrine|mesh-list
110361470|NCT03455322|Midodrine|midodrine|mesh-list
110361471|NCT03455322|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110361472|NCT03455322|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110361473|NCT03455322|Adrenergic Agents|adrenergic agents|mesh-ancestor
110361474|NCT03455322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110361475|NCT03455322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110361476|NCT03455322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110361477|NCT03455322|Sympathomimetics|sympathomimetics|mesh-ancestor
110361478|NCT03455322|Autonomic Agents|autonomic agents|mesh-ancestor
110361479|NCT03455322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110361480|NCT03455322|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110361481|NCT03455322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110361482|NCT03455322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110361483|NCT03455322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110361484|NCT03455322|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110361486|NCT05425368|Cariostatic Agents|cariostatic agents|mesh-ancestor
110361487|NCT05425368|Protective Agents|protective agents|mesh-ancestor
110361488|NCT05425368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110361490|NCT00447863|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110361492|NCT00447863|Estrogens|estrogens|mesh-ancestor
110361493|NCT00447863|Hormones|hormones|mesh-ancestor
110368800|NCT04616859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110361494|NCT00447863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110361495|NCT00447863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110361496|NCT00447863|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110361498|NCT00447863|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110361499|NCT00447863|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110361500|NCT00447863|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110361501|NCT00447863|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110361502|NCT00447863|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110361503|NCT00448097|Docetaxel|docetaxel|mesh-list
110361504|NCT00448097|Cetuximab|cetuximab|mesh-list
110361505|NCT00448097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110361506|NCT00448097|Tubulin Modulators|tubulin modulators|mesh-ancestor
110361507|NCT00448097|Antimitotic Agents|antimitotic agents|mesh-ancestor
110361508|NCT00448097|Mitosis Modulators|mitosis modulators|mesh-ancestor
110361509|NCT00448097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110361510|NCT00448097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110361511|NCT00448214|Warfarin|warfarin|mesh-list
110361512|NCT00448214|Anticoagulants|anticoagulants|mesh-ancestor
110361513|NCT00448253|Immunoglobulins|immunoglobulins|mesh-list
110361514|NCT00448253|Immunologic Factors|immunologic factors|mesh-ancestor
110361515|NCT00448253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110361516|NCT00448292|Naluzotan|naluzotan|mesh-list
110361517|NCT00448292|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110361518|NCT00448292|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110361519|NCT00448292|Serotonin Agents|serotonin agents|mesh-ancestor
110361520|NCT00448292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110361521|NCT00448292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110361522|NCT00448292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110361523|NCT02901561|Misoprostol|misoprostol|mesh-list
110361524|NCT02901561|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110361525|NCT02901561|Abortifacient Agents|abortifacient agents|mesh-ancestor
110361526|NCT02901561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110361527|NCT02901561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110361528|NCT02901561|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110361529|NCT02901561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110361530|NCT02901561|Oxytocics|oxytocics|mesh-ancestor
110361531|NCT00448409|Sargramostim|sargramostim|mesh-list
110361532|NCT00448409|Immunologic Factors|immunologic factors|mesh-ancestor
110361533|NCT00448409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110361534|NCT02901366|Dotinurad|dotinurad|mesh-list
110361535|NCT02901366|Uricosuric Agents|uricosuric agents|mesh-ancestor
110361536|NCT02901366|Gout Suppressants|gout suppressants|mesh-ancestor
110361537|NCT02901366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110361538|NCT03276689|Pregabalin|pregabalin|mesh-list
110361539|NCT03276689|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110361540|NCT03276689|Analgesics|analgesics|mesh-ancestor
110361541|NCT03276689|Sensory System Agents|sensory system agents|mesh-ancestor
110361542|NCT03276689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110361543|NCT03276689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110361544|NCT03276689|Anticonvulsants|anticonvulsants|mesh-ancestor
110361545|NCT03276689|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110361546|NCT03276689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110361547|NCT03276689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110361548|NCT03276689|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110361549|NCT03276689|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110361550|NCT03276689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110361551|NCT03276689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110361552|NCT03276689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110361553|NCT03276689|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110361554|NCT03276689|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110361555|NCT03276689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110361556|NCT03276689|Antidepressive Agents|antidepressive agents|mesh-ancestor
110361557|NCT03276689|Dopamine Agents|dopamine agents|mesh-ancestor
110361558|NCT01220128|Paclitaxel|paclitaxel|mesh-list
110361559|NCT01220128|Docetaxel|docetaxel|mesh-list
110361560|NCT01220128|Cyclophosphamide|cyclophosphamide|mesh-list
110361561|NCT01220128|Carboplatin|carboplatin|mesh-list
110361562|NCT01220128|Doxorubicin|doxorubicin|mesh-list
110361563|NCT01220128|Fluorouracil|fluorouracil|mesh-list
110361564|NCT01220128|Trastuzumab|trastuzumab|mesh-list
110361565|NCT01220128|Epirubicin|epirubicin|mesh-list
110361566|NCT01220128|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110361567|NCT01220128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110361568|NCT01220128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110361569|NCT01220128|Tubulin Modulators|tubulin modulators|mesh-ancestor
110361570|NCT01220128|Antimitotic Agents|antimitotic agents|mesh-ancestor
110361571|NCT01220128|Mitosis Modulators|mitosis modulators|mesh-ancestor
110361572|NCT01220128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110361573|NCT01220128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110361574|NCT01220128|Immunologic Factors|immunologic factors|mesh-ancestor
110361575|NCT01220128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110361576|NCT01220128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110361577|NCT01220128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110361578|NCT01220128|Alkylating Agents|alkylating agents|mesh-ancestor
110361579|NCT01220128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110361580|NCT01220128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110361581|NCT01220128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110361582|NCT01220128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110361583|NCT01220128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110361584|NCT01220128|Antimetabolites|antimetabolites|mesh-ancestor
110361585|NCT01220128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110361586|NCT01220128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110361587|NCT01220128|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110361588|NCT01220128|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110361589|NCT01220128|Hormone Antagonists|hormone antagonists|mesh-ancestor
110361590|NCT01220128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110361592|NCT04698941|Simvastatin|simvastatin|mesh-list
110361593|NCT04698941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110361594|NCT04698941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110361595|NCT04698941|Tubulin Modulators|tubulin modulators|mesh-ancestor
110361596|NCT04698941|Antimitotic Agents|antimitotic agents|mesh-ancestor
110361597|NCT04698941|Mitosis Modulators|mitosis modulators|mesh-ancestor
110361598|NCT04698941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110361599|NCT04698941|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110361600|NCT04698941|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110361601|NCT04698941|Antimetabolites|antimetabolites|mesh-ancestor
110361602|NCT04698941|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110361603|NCT04698941|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110361604|NCT04698941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110361606|NCT02901288|Rifampin|rifampin|mesh-list
110361607|NCT02901288|Isoniazid|isoniazid|mesh-list
110361608|NCT02901288|Pyrazinamide|pyrazinamide|mesh-list
110361609|NCT02901288|Ethambutol|ethambutol|mesh-list
110361610|NCT02901288|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110361611|NCT02901288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110361612|NCT02901288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110361613|NCT02901288|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110361614|NCT02901288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110361615|NCT02901288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110361616|NCT02901288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110361617|NCT02901288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110361618|NCT02901288|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110361619|NCT02901288|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110361620|NCT02901288|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110361621|NCT02901288|Antitubercular Agents|antitubercular agents|mesh-ancestor
110361622|NCT02901288|Leprostatic Agents|leprostatic agents|mesh-ancestor
110361623|NCT02901288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110361624|NCT02901288|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110361625|NCT02901288|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110361626|NCT02901288|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110361627|NCT02901288|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110361628|NCT02901288|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110361629|NCT02901288|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110361630|NCT02901288|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110361631|NCT02901288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110361632|NCT02901288|Antimetabolites|antimetabolites|mesh-ancestor
110361633|NCT02901288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110361634|NCT00448643|Cisplatin|cisplatin|mesh-list
110361635|NCT00448643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110361636|NCT05424393|Etanercept|etanercept|mesh-list
110361637|NCT05424393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110361638|NCT05424393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110361639|NCT05424393|Analgesics|analgesics|mesh-ancestor
110361640|NCT05424393|Sensory System Agents|sensory system agents|mesh-ancestor
110361641|NCT05424393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110361642|NCT05424393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110361643|NCT05424393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110361644|NCT05424393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110361645|NCT05424393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110361646|NCT05424393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110361647|NCT05424393|Immunologic Factors|immunologic factors|mesh-ancestor
110361648|NCT00448838|Gemcitabine|gemcitabine|mesh-list
110361649|NCT00448838|Oxaliplatin|oxaliplatin|mesh-list
110361650|NCT00448838|Cetuximab|cetuximab|mesh-list
110361651|NCT00448838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110361652|NCT00448838|Antimetabolites|antimetabolites|mesh-ancestor
110361653|NCT00448838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110361654|NCT00448838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110361655|NCT00448838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110361656|NCT01219933|Methylprednisolone|methylprednisolone|mesh-list
110361657|NCT01219933|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110361658|NCT01219933|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110361659|NCT01219933|Prednisolone|prednisolone|mesh-list
110361660|NCT01219933|Prednisolone acetate|prednisolone acetate|mesh-list
110361661|NCT01219933|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110361662|NCT01219933|Prednisolone phosphate|prednisolone phosphate|mesh-list
110361663|NCT01219933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110361664|NCT01219933|Antiemetics|antiemetics|mesh-ancestor
110361665|NCT01219933|Autonomic Agents|autonomic agents|mesh-ancestor
110361666|NCT01219933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110361667|NCT01219933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110361668|NCT01219933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110361669|NCT01219933|Glucocorticoids|glucocorticoids|mesh-ancestor
110361670|NCT01219933|Hormones|hormones|mesh-ancestor
110177300|NCT00138619|Protease Inhibitors|protease inhibitors|mesh-ancestor
110361671|NCT01219933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110361672|NCT01219933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110361673|NCT01219933|Protective Agents|protective agents|mesh-ancestor
110361674|NCT01219933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110361675|NCT01219933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110361676|NCT05373901|Tretinoin|tretinoin|mesh-list
110361677|NCT05373901|Dinutuximab|dinutuximab|mesh-list
110361678|NCT05373901|Isotretinoin|isotretinoin|mesh-list
110361679|NCT05373901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110361680|NCT05373901|Keratolytic Agents|keratolytic agents|mesh-ancestor
110361681|NCT05373901|Dermatologic Agents|dermatologic agents|mesh-ancestor
110361682|NCT05368441|Midazolam|midazolam|mesh-list
110361683|NCT05368441|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110361684|NCT05368441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110361685|NCT05368441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110361687|NCT05368441|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110361688|NCT05368441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110361689|NCT05368441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110361690|NCT05368441|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110361691|NCT05368441|Anesthetics, General|anesthetics, general|mesh-ancestor
110361692|NCT05368441|Anesthetics|anesthetics|mesh-ancestor
110361693|NCT05368441|GABA Modulators|gaba modulators|mesh-ancestor
110361694|NCT05368441|GABA Agents|gaba agents|mesh-ancestor
110361695|NCT05368441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110361696|NCT05368441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110361697|NCT05468359|Cyclophosphamide|cyclophosphamide|mesh-list
110361698|NCT05468359|Bevacizumab|bevacizumab|mesh-list
110361699|NCT05468359|Sorafenib|sorafenib|mesh-list
110361700|NCT05468359|Atezolizumab|atezolizumab|mesh-list
110361701|NCT05468359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110361702|NCT05468359|Immunologic Factors|immunologic factors|mesh-ancestor
110361703|NCT05468359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110361704|NCT05468359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110361705|NCT05468359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110361706|NCT05468359|Alkylating Agents|alkylating agents|mesh-ancestor
110361707|NCT05468359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110361708|NCT05468359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110361709|NCT05468359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110361710|NCT05468359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110361711|NCT05468359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110361712|NCT05468359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110361713|NCT05468359|Growth Substances|growth substances|mesh-ancestor
110361714|NCT05468359|Growth Inhibitors|growth inhibitors|mesh-ancestor
110361715|NCT05468359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110361716|NCT05468359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110361717|NCT05468359|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110361718|NCT04316845|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
110361719|NCT04316845|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110361720|NCT04316845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110361721|NCT01218802|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110361722|NCT01218802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110361723|NCT01218802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110361724|NCT01218802|Antimetabolites|antimetabolites|mesh-ancestor
110361725|NCT01218802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110361726|NCT01218802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110361727|NCT01218802|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110361728|NCT01218802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110361729|NCT02887222|Bupivacaine|bupivacaine|mesh-list
110361730|NCT02887222|Anesthetics, Local|anesthetics, local|mesh-ancestor
110361731|NCT02887222|Anesthetics|anesthetics|mesh-ancestor
110361732|NCT02887222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110361733|NCT02887222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110361734|NCT02887222|Sensory System Agents|sensory system agents|mesh-ancestor
110361735|NCT02887222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110361736|NCT01218646|Vaccines|vaccines|mesh-list
110361737|NCT01218646|Immunologic Factors|immunologic factors|mesh-ancestor
110361738|NCT01218646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110361739|NCT00449423|Acipimox|acipimox|mesh-list
110361740|NCT00449423|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110361741|NCT00449423|Antimetabolites|antimetabolites|mesh-ancestor
110361742|NCT00449423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110361743|NCT00449423|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110361745|NCT00449501|Formoterol Fumarate|formoterol fumarate|mesh-list
110361746|NCT00449501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110361747|NCT00449501|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110361748|NCT00449501|Autonomic Agents|autonomic agents|mesh-ancestor
110361749|NCT00449501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110361750|NCT00449501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110361751|NCT00449501|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110361752|NCT00449501|Respiratory System Agents|respiratory system agents|mesh-ancestor
110361753|NCT00449501|Glucocorticoids|glucocorticoids|mesh-ancestor
110361754|NCT00449501|Hormones|hormones|mesh-ancestor
110361755|NCT00449501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110361756|NCT00449501|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110361757|NCT00449501|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110361758|NCT00449501|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110361759|NCT00449501|Adrenergic Agents|adrenergic agents|mesh-ancestor
110361760|NCT00449501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110361761|NCT00449501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110361762|NCT02900820|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110361763|NCT02900820|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110361764|NCT02900820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110361765|NCT02900820|Antitubercular Agents|antitubercular agents|mesh-ancestor
110361766|NCT01188772|Sofosbuvir|sofosbuvir|mesh-list
110361767|NCT01188772|Antiviral Agents|antiviral agents|mesh-ancestor
110361768|NCT01188772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110361769|NCT01188655|Etanercept|etanercept|mesh-list
110361770|NCT01188655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110361772|NCT01188655|Analgesics|analgesics|mesh-ancestor
110361773|NCT01188655|Sensory System Agents|sensory system agents|mesh-ancestor
110361774|NCT01188655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110361775|NCT01188655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110361776|NCT01188655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110361777|NCT01188655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110361778|NCT01188655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110361779|NCT01188655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110361780|NCT01188655|Immunologic Factors|immunologic factors|mesh-ancestor
110361782|NCT00449618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110361783|NCT00449618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110361784|NCT00449618|Analgesics|analgesics|mesh-ancestor
110361785|NCT00449618|Sensory System Agents|sensory system agents|mesh-ancestor
110361786|NCT00449618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110361787|NCT00449618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110361788|NCT00449618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110361789|NCT00449618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110361790|NCT00449618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110361791|NCT00449618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110361792|NCT00449618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110361793|NCT00449618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110361794|NCT00449618|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110361795|NCT00449618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110361796|NCT00449618|Antipyretics|antipyretics|mesh-ancestor
110361797|NCT01188538|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
110361798|NCT01188538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110361799|NCT01188538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110361800|NCT01188538|Analgesics|analgesics|mesh-ancestor
110361801|NCT01188538|Sensory System Agents|sensory system agents|mesh-ancestor
110361802|NCT01188538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110361803|NCT01188538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110361804|NCT01188538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110361805|NCT01188538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110361806|NCT01188538|Dermatologic Agents|dermatologic agents|mesh-ancestor
110361807|NCT00449657|Paclitaxel|paclitaxel|mesh-list
110361808|NCT00449657|Carboplatin|carboplatin|mesh-list
110361809|NCT00449657|Gemcitabine|gemcitabine|mesh-list
110361810|NCT00449657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110361811|NCT00449657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110361812|NCT00449657|Tubulin Modulators|tubulin modulators|mesh-ancestor
110361813|NCT00449657|Antimitotic Agents|antimitotic agents|mesh-ancestor
110361814|NCT00449657|Mitosis Modulators|mitosis modulators|mesh-ancestor
110361815|NCT00449657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110361816|NCT00449657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110361817|NCT00449657|Antimetabolites|antimetabolites|mesh-ancestor
110361818|NCT04318444|Hydroxychloroquine|hydroxychloroquine|mesh-list
110361820|NCT04318444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110361821|NCT04318444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110361822|NCT04318444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110361823|NCT04318444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110361824|NCT04318444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110361825|NCT04318444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110361827|NCT03276143|Apixaban|apixaban|mesh-list
110361828|NCT03276143|Anticoagulants|anticoagulants|mesh-ancestor
110361829|NCT03276143|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110361830|NCT03276143|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110361831|NCT03276143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110361832|NCT03276143|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110361833|NCT03276143|Antithrombins|antithrombins|mesh-ancestor
110361834|NCT03276143|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110361835|NCT03276143|Protease Inhibitors|protease inhibitors|mesh-ancestor
110361836|NCT03276143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110361837|NCT00449774|Lamotrigine|lamotrigine|mesh-list
110361838|NCT00449774|Anticonvulsants|anticonvulsants|mesh-list
110361839|NCT00449774|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110361840|NCT00449774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110361841|NCT00449774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110361842|NCT00449774|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110361843|NCT00449774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110361844|NCT00449774|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110361845|NCT00449774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110361846|NCT00449774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110361847|NCT00449774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110361848|NCT00449774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110361849|NCT02900742|Gemcitabine|gemcitabine|mesh-list
110361851|NCT02900742|Pemetrexed|pemetrexed|mesh-list
110361852|NCT02900742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110361853|NCT02900742|Antimetabolites|antimetabolites|mesh-ancestor
110361854|NCT02900742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110361855|NCT02900742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110361856|NCT02900742|Tubulin Modulators|tubulin modulators|mesh-ancestor
110361857|NCT02900742|Antimitotic Agents|antimitotic agents|mesh-ancestor
110361858|NCT02900742|Mitosis Modulators|mitosis modulators|mesh-ancestor
110361859|NCT02900742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110361860|NCT02900742|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110361861|NCT02900742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110361862|NCT00449813|Pantoprazole|pantoprazole|mesh-list
110361863|NCT00449813|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110361864|NCT00449813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110361865|NCT00449813|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110361866|NCT00449813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110361867|NCT00449813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110361868|NCT01218100|Lisinopril|lisinopril|mesh-list
110361869|NCT01218100|Nebivolol|nebivolol|mesh-list
110361870|NCT01218100|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110361871|NCT01218100|Protease Inhibitors|protease inhibitors|mesh-ancestor
110361872|NCT01218100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110361873|NCT01218100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110361874|NCT01218100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110361875|NCT01218100|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110361876|NCT01218100|Protective Agents|protective agents|mesh-ancestor
110177320|NCT03893825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110361877|NCT01218100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110361878|NCT01218100|Vasodilator Agents|vasodilator agents|mesh-ancestor
110361879|NCT01218100|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110361880|NCT01218100|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110361881|NCT01218100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110361882|NCT01218100|Adrenergic Agents|adrenergic agents|mesh-ancestor
110361883|NCT01218100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110361884|NCT00450008|Thalidomide|thalidomide|mesh-list
110361885|NCT00450008|Docetaxel|docetaxel|mesh-list
110361886|NCT00450008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110361887|NCT00450008|Tubulin Modulators|tubulin modulators|mesh-ancestor
110361888|NCT00450008|Antimitotic Agents|antimitotic agents|mesh-ancestor
110361889|NCT00450008|Mitosis Modulators|mitosis modulators|mesh-ancestor
110361890|NCT00450008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110361891|NCT00450008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110361892|NCT00450008|Immunologic Factors|immunologic factors|mesh-ancestor
110361893|NCT00450008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110361894|NCT00450008|Leprostatic Agents|leprostatic agents|mesh-ancestor
110361895|NCT00450008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110361896|NCT00450008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110361897|NCT00450008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110361898|NCT00450008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110361899|NCT00450008|Growth Substances|growth substances|mesh-ancestor
110361900|NCT00450008|Growth Inhibitors|growth inhibitors|mesh-ancestor
110361901|NCT02900469|Denosumab|denosumab|mesh-list
110361902|NCT02900469|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110361903|NCT02900469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110361904|NCT00450086|Budesonide|budesonide|mesh-list
110361905|NCT00450086|Mesalamine|mesalamine|mesh-list
110361906|NCT00450086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110361907|NCT00450086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110361908|NCT00450086|Autonomic Agents|autonomic agents|mesh-ancestor
110361909|NCT00450086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110361910|NCT00450086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110361911|NCT00450086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110361912|NCT00450086|Respiratory System Agents|respiratory system agents|mesh-ancestor
110361913|NCT00450086|Glucocorticoids|glucocorticoids|mesh-ancestor
110361914|NCT00450086|Hormones|hormones|mesh-ancestor
110361915|NCT00450086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110361916|NCT00450086|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110361917|NCT00450086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110361918|NCT00450086|Analgesics|analgesics|mesh-ancestor
110361919|NCT00450086|Sensory System Agents|sensory system agents|mesh-ancestor
110361920|NCT00450086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110361921|NCT05422911|Abiraterone Acetate|abiraterone acetate|mesh-list
110361922|NCT05422911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110361923|NCT05422911|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110361924|NCT05422911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110361925|NCT05422911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110361926|NCT05422911|Hormone Antagonists|hormone antagonists|mesh-ancestor
110361927|NCT05422911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110361928|NCT05422911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110361929|NCT05422911|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110361930|NCT00450164|Nadolol|nadolol|mesh-list
110361931|NCT00450164|Prazosin|prazosin|mesh-list
110361932|NCT00450164|Isosorbide|isosorbide|mesh-list
110361933|NCT00450164|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
110361934|NCT00450164|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
110361935|NCT00450164|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110361936|NCT00450164|Diuretics|diuretics|mesh-ancestor
110361937|NCT00450164|Natriuretic Agents|natriuretic agents|mesh-ancestor
110361938|NCT00450164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110361939|NCT00450164|Vasodilator Agents|vasodilator agents|mesh-ancestor
110361940|NCT00450164|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110361941|NCT00450164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110361942|NCT00450164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110361943|NCT00450164|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110361944|NCT00450164|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110361945|NCT00450164|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110361946|NCT00450164|Adrenergic Agents|adrenergic agents|mesh-ancestor
110361947|NCT00450164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110361948|NCT00450164|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110361949|NCT00450164|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110361951|NCT00450164|Autonomic Agents|autonomic agents|mesh-ancestor
110361952|NCT00450164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110361953|NCT02900430|Antifungal Agents|antifungal agents|mesh-list
110361955|NCT02900430|Miconazole|miconazole|mesh-list
110361956|NCT02900430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110361957|NCT02900430|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110361958|NCT02900430|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110361959|NCT02900430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110361960|NCT02900430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110361961|NCT02900430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110361962|NCT02900430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110361963|NCT02900430|Hormone Antagonists|hormone antagonists|mesh-ancestor
110361964|NCT02900430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110361965|NCT02900430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110361966|NCT02900430|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110361967|NCT02900430|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110361968|NCT00450203|Bevacizumab|bevacizumab|mesh-list
110361969|NCT00450203|Capecitabine|capecitabine|mesh-list
110361970|NCT00450203|Epirubicin|epirubicin|mesh-list
110361971|NCT00450203|Lapatinib|lapatinib|mesh-list
110361972|NCT00450203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110361973|NCT00450203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110361974|NCT00450203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110361975|NCT00450203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110361976|NCT00450203|Growth Substances|growth substances|mesh-ancestor
110361977|NCT00450203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110361978|NCT00450203|Growth Inhibitors|growth inhibitors|mesh-ancestor
110361979|NCT00450203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110361980|NCT00450203|Antimetabolites|antimetabolites|mesh-ancestor
110361981|NCT00450203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110361982|NCT00450203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110361983|NCT00450203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110361984|NCT00450203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110361985|NCT00450203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110361986|NCT00450203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110361987|NCT00450281|Antibodies|antibodies|mesh-list
110361988|NCT00450281|Immunologic Factors|immunologic factors|mesh-ancestor
110361989|NCT00450281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110361990|NCT04699097|Azithromycin|azithromycin|mesh-list
110361991|NCT04699097|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110361992|NCT04699097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110361993|NCT04698746|Anesthetics|anesthetics|mesh-list
110361994|NCT04698746|Anesthetics, Local|anesthetics, local|mesh-list
110361995|NCT04698746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110361996|NCT04698746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110361997|NCT04698746|Sensory System Agents|sensory system agents|mesh-ancestor
110361998|NCT04698746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110361999|NCT00450320|Sirolimus|sirolimus|mesh-list
110362000|NCT00450320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110362001|NCT00450320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110362002|NCT00450320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110362003|NCT00450320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110362004|NCT00450320|Antifungal Agents|antifungal agents|mesh-ancestor
110362005|NCT00450320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110362006|NCT00450320|Immunologic Factors|immunologic factors|mesh-ancestor
110362007|NCT00450320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362008|NCT00450398|polysaccharide-K|polysaccharide-k|mesh-list
110362009|NCT00450398|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110362010|NCT00450398|Immunologic Factors|immunologic factors|mesh-ancestor
110362011|NCT00450398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362012|NCT00450398|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110362013|NCT00450398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110362014|NCT00450398|Antiviral Agents|antiviral agents|mesh-ancestor
110362015|NCT00450398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110362016|NCT00450398|Interferon Inducers|interferon inducers|mesh-ancestor
110362017|NCT00450398|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110362018|NCT00450398|Protective Agents|protective agents|mesh-ancestor
110362019|NCT00450515|Capecitabine|capecitabine|mesh-list
110362020|NCT00450515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110362021|NCT00450515|Antimetabolites|antimetabolites|mesh-ancestor
110362022|NCT00450515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110362023|NCT00450515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110362024|NCT00450827|Bevacizumab|bevacizumab|mesh-list
110362025|NCT00450827|Antibodies|antibodies|mesh-list
110362026|NCT00450827|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110362027|NCT00450827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110362028|NCT00450827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110362029|NCT00450827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110362030|NCT00450827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110362031|NCT00450827|Growth Substances|growth substances|mesh-ancestor
110362033|NCT00450827|Growth Inhibitors|growth inhibitors|mesh-ancestor
110362034|NCT00450827|Immunologic Factors|immunologic factors|mesh-ancestor
110362035|NCT00450944|Immunotoxins|immunotoxins|mesh-list
110362036|NCT00450944|Immunoconjugates|immunoconjugates|mesh-ancestor
110362037|NCT00450944|Immunologic Factors|immunologic factors|mesh-ancestor
110362038|NCT00450944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362039|NCT00451061|Tamsulosin|tamsulosin|mesh-list
110362040|NCT00451061|Alfuzosin|alfuzosin|mesh-list
110362041|NCT00451061|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110362042|NCT00451061|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110362043|NCT00451061|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110362044|NCT00451061|Adrenergic Agents|adrenergic agents|mesh-ancestor
110362045|NCT00451061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110362046|NCT00451061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110362047|NCT00451061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362048|NCT00451061|Urological Agents|urological agents|mesh-ancestor
110362049|NCT02931383|Liraglutide|liraglutide|mesh-list
110362050|NCT02931383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110362051|NCT02931383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362052|NCT02931383|Incretins|incretins|mesh-ancestor
110362053|NCT02931383|Hormones|hormones|mesh-ancestor
110362054|NCT02931383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110362055|NCT04341441|Hydroxychloroquine|hydroxychloroquine|mesh-list
110362056|NCT04341441|Antimalarials|antimalarials|mesh-ancestor
110362057|NCT04341441|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110362058|NCT04341441|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110362059|NCT04341441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110362060|NCT04341441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110362061|NCT04341441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110362062|NCT04341441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110362064|NCT01187953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110362065|NCT01187953|Immunologic Factors|immunologic factors|mesh-ancestor
110362066|NCT01187953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362067|NCT01187953|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110362068|NCT01187953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110362069|NCT01187953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110362070|NCT02900157|Durvalumab|durvalumab|mesh-list
110362071|NCT02900157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110362072|NCT02900157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110362073|NCT04262817|Nicotine|nicotine|mesh-list
110362074|NCT04262817|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110362075|NCT04262817|Autonomic Agents|autonomic agents|mesh-ancestor
110362076|NCT04262817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110362077|NCT04262817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362078|NCT04262817|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110362079|NCT04262817|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110362080|NCT04262817|Cholinergic Agents|cholinergic agents|mesh-ancestor
110362081|NCT04262817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110362082|NCT04262817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110362083|NCT02931188|Anacetrapib|anacetrapib|mesh-list
110362084|NCT02931188|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110362085|NCT02931188|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110362086|NCT02931188|Antimetabolites|antimetabolites|mesh-ancestor
110362087|NCT02931188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110362088|NCT02931188|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110362089|NCT01217944|Ranibizumab|ranibizumab|mesh-list
110362090|NCT01217944|Verteporfin|verteporfin|mesh-list
110362091|NCT01217944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110362092|NCT01217944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110362093|NCT01217944|Growth Substances|growth substances|mesh-ancestor
110362094|NCT01217944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362095|NCT01217944|Growth Inhibitors|growth inhibitors|mesh-ancestor
110362096|NCT01217944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110362097|NCT01217944|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110362098|NCT01217944|Dermatologic Agents|dermatologic agents|mesh-ancestor
110362099|NCT04689815|Arsenic Trioxide|arsenic trioxide|mesh-list
110362100|NCT04689815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110362101|NCT01187446|Vorinostat|vorinostat|mesh-list
110362102|NCT01187446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110362103|NCT01187446|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110362104|NCT01187446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110362105|NCT01187446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110362106|NCT02931071|Plerixafor|plerixafor|mesh-list
110362107|NCT02931071|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110362108|NCT02931071|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110362109|NCT02931071|Antiviral Agents|antiviral agents|mesh-ancestor
110362110|NCT02931071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110362111|NCT01187407|Serotonin|serotonin|mesh-list
110362112|NCT01187407|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
110362113|NCT01187407|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110362114|NCT01187407|Serotonin Agents|serotonin agents|mesh-ancestor
110362115|NCT01187407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110362116|NCT01187407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110362117|NCT01187407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362118|NCT01187407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110362119|NCT01187407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110362120|NCT01186939|Azacitidine|azacitidine|mesh-list
110362121|NCT01186939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110362122|NCT01186939|Antimetabolites|antimetabolites|mesh-ancestor
110362123|NCT01186939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110362124|NCT01186939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110362125|NCT01186939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110362126|NCT04447040|Acetaminophen|acetaminophen|mesh-list
110362127|NCT04447040|Naproxen|naproxen|mesh-list
110362128|NCT04447040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110362129|NCT04447040|Analgesics|analgesics|mesh-ancestor
110362130|NCT04447040|Sensory System Agents|sensory system agents|mesh-ancestor
110362131|NCT04447040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110362132|NCT04447040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362133|NCT04447040|Antipyretics|antipyretics|mesh-ancestor
110362134|NCT04447040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110362135|NCT04447040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110362136|NCT04447040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110362137|NCT04447040|Gout Suppressants|gout suppressants|mesh-ancestor
110362138|NCT04447040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110362139|NCT04447040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110362140|NCT04447040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110362141|NCT02930954|Bevacizumab|bevacizumab|mesh-list
110362142|NCT02930954|Carboplatin|carboplatin|mesh-list
110362143|NCT02930954|Gemcitabine|gemcitabine|mesh-list
110362144|NCT02930954|Pemetrexed|pemetrexed|mesh-list
110362145|NCT02930954|Gefitinib|gefitinib|mesh-list
110362146|NCT02930954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110362147|NCT02930954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110362148|NCT02930954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110362149|NCT02930954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110362150|NCT02930954|Growth Substances|growth substances|mesh-ancestor
110362151|NCT02930954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362152|NCT02930954|Growth Inhibitors|growth inhibitors|mesh-ancestor
110362153|NCT02930954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110362154|NCT02930954|Antimetabolites|antimetabolites|mesh-ancestor
110362155|NCT02930954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110362156|NCT02930954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110362157|NCT02930954|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110362158|NCT02930954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110362159|NCT02930954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110362160|NCT04117659|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
110362161|NCT04117659|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110362162|NCT04117659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110362163|NCT04117659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110362164|NCT02930057|Betamethasone|betamethasone|mesh-list
110362165|NCT02930057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110362166|NCT02930057|Glucocorticoids|glucocorticoids|mesh-ancestor
110362167|NCT02930057|Hormones|hormones|mesh-ancestor
110362168|NCT02930057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110362169|NCT02930057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362170|NCT02930057|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110362171|NCT02930057|Respiratory System Agents|respiratory system agents|mesh-ancestor
110362173|NCT02929901|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110362174|NCT02929901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362175|NCT02929901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110362176|NCT02929901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110362177|NCT02929901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110362178|NCT02929901|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110362179|NCT02929901|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110362180|NCT02929901|Purinergic Agents|purinergic agents|mesh-ancestor
110362181|NCT02929901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110362182|NCT02929706|Azathioprine|azathioprine|mesh-list
110362183|NCT02929706|Antimetabolites|antimetabolites|mesh-ancestor
110362184|NCT02929706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110362185|NCT02929706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110362186|NCT02929706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110362187|NCT02929706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110362188|NCT02929706|Immunologic Factors|immunologic factors|mesh-ancestor
110362189|NCT02929706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362190|NCT02929706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110177371|NCT03890666|Albuterol|albuterol|mesh-list
110362192|NCT03993132|Glucagon|glucagon|mesh-list
110362193|NCT03993132|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110362194|NCT03993132|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110362195|NCT03993132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110362196|NCT03993132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110362197|NCT03993132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362198|NCT03993132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110362199|NCT03993132|Hormones|hormones|mesh-ancestor
110362200|NCT03993132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110362201|NCT03993132|Incretins|incretins|mesh-ancestor
110362202|NCT00553878|Dutasteride|dutasteride|mesh-list
110362203|NCT00553878|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110362204|NCT00553878|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110362205|NCT00553878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110362206|NCT00553878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110362207|NCT00553878|Hormone Antagonists|hormone antagonists|mesh-ancestor
110362208|NCT00553878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110362209|NCT00553878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362210|NCT00624325|Interferons|interferons|mesh-list
110362211|NCT00624325|Interferon-alpha|interferon-alpha|mesh-list
110362212|NCT00624325|Interferon alpha-2|interferon alpha-2|mesh-list
110362213|NCT00624325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110362214|NCT00624325|Antiviral Agents|antiviral agents|mesh-ancestor
110362216|NCT00624325|Immunologic Factors|immunologic factors|mesh-ancestor
110362217|NCT00624325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362218|NCT04689893|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
110362219|NCT04689893|Chelating Agents|chelating agents|mesh-ancestor
110362220|NCT04689893|Sequestering Agents|sequestering agents|mesh-ancestor
110362221|NCT04689893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110362222|NCT05184192|Gabapentin|gabapentin|mesh-list
110362223|NCT05184192|Analgesics|analgesics|mesh-ancestor
110362224|NCT05184192|Sensory System Agents|sensory system agents|mesh-ancestor
110362225|NCT05184192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110362226|NCT05184192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362227|NCT05184192|Anticonvulsants|anticonvulsants|mesh-ancestor
110362228|NCT05184192|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110362229|NCT05184192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110362230|NCT05184192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110362231|NCT05184192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110362232|NCT05184192|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110362233|NCT05184192|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110362234|NCT05184192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110362235|NCT05184192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110362236|NCT05184192|Antimanic Agents|antimanic agents|mesh-ancestor
110362237|NCT02929121|Doxycycline|doxycycline|mesh-list
110362238|NCT02929121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110362239|NCT02929121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110362240|NCT02929121|Antimalarials|antimalarials|mesh-ancestor
110362241|NCT02929121|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110362242|NCT02929121|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110362243|NCT02929394|Trabectedin|trabectedin|mesh-list
110362244|NCT02929394|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110362245|NCT02929394|Alkylating Agents|alkylating agents|mesh-ancestor
110362246|NCT02929394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110362247|NCT02929394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110362248|NCT02929316|Vedolizumab|vedolizumab|mesh-list
110362249|NCT02929316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110362250|NCT02928965|Minocycline|minocycline|mesh-list
110362251|NCT02928965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110362252|NCT02928965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110362253|NCT02928692|Minocycline|minocycline|mesh-list
110362254|NCT02928692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110362255|NCT02928692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110362256|NCT04679142|Baclofen|baclofen|mesh-list
110362257|NCT04679142|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110362258|NCT04679142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362259|NCT04679142|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110362260|NCT04679142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110362261|NCT04679142|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110362262|NCT04679142|GABA Agonists|gaba agonists|mesh-ancestor
110362263|NCT04679142|GABA Agents|gaba agents|mesh-ancestor
110362264|NCT04679142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110362265|NCT04679142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110362266|NCT02928419|Lenalidomide|lenalidomide|mesh-list
110362267|NCT02928419|Immunologic Factors|immunologic factors|mesh-ancestor
110362268|NCT02928419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362269|NCT02928419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110362270|NCT02928419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110362271|NCT02928419|Growth Substances|growth substances|mesh-ancestor
110362272|NCT02928419|Growth Inhibitors|growth inhibitors|mesh-ancestor
110362273|NCT02928419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110362274|NCT02928614|Liraglutide|liraglutide|mesh-list
110362275|NCT02928614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110362276|NCT02928614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362277|NCT02928614|Incretins|incretins|mesh-ancestor
110362278|NCT02928614|Hormones|hormones|mesh-ancestor
110362279|NCT02928614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110362280|NCT03685500|Emtricitabine|emtricitabine|mesh-list
110362281|NCT03685500|Darunavir|darunavir|mesh-list
110362282|NCT03685500|Cobicistat|cobicistat|mesh-list
110362283|NCT03685500|Antiviral Agents|antiviral agents|mesh-ancestor
110362284|NCT03685500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110362285|NCT03685500|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110362286|NCT03685500|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110362287|NCT03685500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110362288|NCT03685500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110362289|NCT03685500|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110362290|NCT03685500|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110362291|NCT03685500|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110362292|NCT03685500|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110362293|NCT03685500|Protease Inhibitors|protease inhibitors|mesh-ancestor
110362294|NCT03685500|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110362295|NCT03685500|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110362296|NCT02928575|Temozolomide|temozolomide|mesh-list
110362297|NCT02928575|Sunitinib|sunitinib|mesh-list
110362298|NCT02928575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110362299|NCT02928575|Alkylating Agents|alkylating agents|mesh-ancestor
110362300|NCT02928575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110362301|NCT02928575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110362302|NCT02928575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110362303|NCT02928575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110362304|NCT02928575|Growth Substances|growth substances|mesh-ancestor
110362305|NCT02928575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362306|NCT02928575|Growth Inhibitors|growth inhibitors|mesh-ancestor
110362307|NCT02928575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110362308|NCT02928575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110362309|NCT02927951|Pregabalin|pregabalin|mesh-list
110362310|NCT02927951|Analgesics|analgesics|mesh-ancestor
110362311|NCT02927951|Sensory System Agents|sensory system agents|mesh-ancestor
110362312|NCT02927951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110362313|NCT02927951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362314|NCT02927951|Anticonvulsants|anticonvulsants|mesh-ancestor
110362315|NCT02927951|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110362316|NCT02927951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110362317|NCT02927951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110362318|NCT02927951|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110362319|NCT02927951|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110362320|NCT02927951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110362321|NCT02927951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110362322|NCT02927951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110362323|NCT02927405|Gabapentin|gabapentin|mesh-list
110362324|NCT02927405|Analgesics|analgesics|mesh-ancestor
110362325|NCT02927405|Sensory System Agents|sensory system agents|mesh-ancestor
110362326|NCT02927405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110362327|NCT02927405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362328|NCT02927405|Anticonvulsants|anticonvulsants|mesh-ancestor
110362329|NCT02927405|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110362330|NCT02927405|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110362331|NCT02927405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110362332|NCT02927405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110362333|NCT02927405|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110362334|NCT02927405|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110362335|NCT02927405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110362336|NCT02927405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110362338|NCT02927444|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110362339|NCT02927444|Immunologic Factors|immunologic factors|mesh-ancestor
110362340|NCT02927444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362341|NCT02927522|Donepezil|donepezil|mesh-list
110362342|NCT02927522|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110362343|NCT02927522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110362344|NCT02927522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110362345|NCT02927522|Cholinergic Agents|cholinergic agents|mesh-ancestor
110362346|NCT02927522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110362347|NCT02927522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362348|NCT02927522|Nootropic Agents|nootropic agents|mesh-ancestor
110362349|NCT02926976|Valproic Acid|valproic acid|mesh-list
110362350|NCT02926976|Risperidone|risperidone|mesh-list
110362351|NCT02926976|Aripiprazole|aripiprazole|mesh-list
110362352|NCT02926976|Clozapine|clozapine|mesh-list
110362353|NCT02926976|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110362354|NCT02926976|Serotonin Agents|serotonin agents|mesh-ancestor
110362355|NCT02926976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110362356|NCT02926976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110362357|NCT02926976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362358|NCT02926976|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110362359|NCT02926976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110362360|NCT02926976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110362361|NCT02926976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110362362|NCT02926976|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110362363|NCT02926976|Dopamine Agents|dopamine agents|mesh-ancestor
110362364|NCT02926976|Antidepressive Agents|antidepressive agents|mesh-ancestor
110362365|NCT02926976|Dopamine Agonists|dopamine agonists|mesh-ancestor
110362366|NCT02926976|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110362367|NCT02926976|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110362368|NCT02926976|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110362369|NCT02926976|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110362370|NCT02926976|Anticonvulsants|anticonvulsants|mesh-ancestor
110362371|NCT02926976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110362372|NCT02926976|GABA Agents|gaba agents|mesh-ancestor
110362373|NCT02926976|Antimanic Agents|antimanic agents|mesh-ancestor
110362374|NCT02926976|GABA Antagonists|gaba antagonists|mesh-ancestor
110362375|NCT02927015|Iproplatin|iproplatin|mesh-list
110362376|NCT02927015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110362377|NCT04680195|Thalidomide|thalidomide|mesh-list
110362378|NCT04680195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110362379|NCT04680195|Immunologic Factors|immunologic factors|mesh-ancestor
110362380|NCT04680195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362381|NCT04680195|Leprostatic Agents|leprostatic agents|mesh-ancestor
110362382|NCT04680195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110362383|NCT04680195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110362384|NCT04680195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110362385|NCT04680195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110362386|NCT04680195|Growth Substances|growth substances|mesh-ancestor
110362387|NCT04680195|Growth Inhibitors|growth inhibitors|mesh-ancestor
110362388|NCT04680195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110362389|NCT04864431|Vitamin D|vitamin d|mesh-list
110362390|NCT04864431|Cholecalciferol|cholecalciferol|mesh-list
110362391|NCT04864431|Vitamins|vitamins|mesh-ancestor
110362392|NCT04864431|Micronutrients|micronutrients|mesh-ancestor
110362393|NCT04864431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362394|NCT04864431|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110362395|NCT04864431|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110362396|NCT00553995|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
110362397|NCT00553995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110362398|NCT00553995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110362399|NCT00553995|Analgesics|analgesics|mesh-ancestor
110362400|NCT00553995|Sensory System Agents|sensory system agents|mesh-ancestor
110362401|NCT00553995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110362402|NCT00553995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362403|NCT00553995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110362404|NCT00553995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110362407|NCT04798287|Golimumab|golimumab|mesh-list
110362408|NCT04798287|Certolizumab Pegol|certolizumab pegol|mesh-list
110362409|NCT04798287|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
110362410|NCT04798287|Etanercept|etanercept|mesh-list
110362411|NCT04798287|Tofacitinib|tofacitinib|mesh-list
110362412|NCT04798287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110362413|NCT04798287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110362414|NCT04798287|Dermatologic Agents|dermatologic agents|mesh-ancestor
110362415|NCT04798287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110362416|NCT04798287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110362417|NCT04798287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110362418|NCT04798287|Analgesics|analgesics|mesh-ancestor
110362419|NCT04798287|Sensory System Agents|sensory system agents|mesh-ancestor
110362420|NCT04798287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110362421|NCT04798287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362422|NCT04798287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110362423|NCT04798287|Immunologic Factors|immunologic factors|mesh-ancestor
110362424|NCT04798287|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110362425|NCT04798287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110362426|NCT04798287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110362427|NCT04798287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110362428|NCT04689191|Vaccines|vaccines|mesh-list
110362429|NCT04689191|Immunologic Factors|immunologic factors|mesh-ancestor
110362430|NCT04689191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362431|NCT02925299|Insulin|insulin|mesh-list
110362432|NCT02925299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110362433|NCT02925299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362434|NCT02925416|Oritavancin|oritavancin|mesh-list
110362435|NCT02925416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110362436|NCT02925416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110362437|NCT02925533|Pembrolizumab|pembrolizumab|mesh-list
110362438|NCT02925533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110362439|NCT02925533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110362440|NCT02925533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110362441|NCT02925533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110362442|NCT02917889|Caffeine|caffeine|mesh-list
110362443|NCT02917889|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110362444|NCT02917889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362445|NCT02917889|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110362446|NCT02917889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110362447|NCT02917889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110362448|NCT02917889|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110362449|NCT02917889|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110362450|NCT02917889|Purinergic Agents|purinergic agents|mesh-ancestor
110362451|NCT02917889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110362452|NCT02917967|Botulinum Toxins|botulinum toxins|mesh-list
110362453|NCT02917967|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110362454|NCT02917967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110362455|NCT02917967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110362456|NCT02917967|Cholinergic Agents|cholinergic agents|mesh-ancestor
110362457|NCT02917967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110362458|NCT02917967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362459|NCT04485273|Anesthetics|anesthetics|mesh-list
110362460|NCT04485273|Sevoflurane|sevoflurane|mesh-list
110362461|NCT04485273|Bupivacaine|bupivacaine|mesh-list
110362462|NCT04485273|Anesthetics, Local|anesthetics, local|mesh-list
110362463|NCT04485273|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110362464|NCT04485273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110362465|NCT04485273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362466|NCT04485273|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110362467|NCT04485273|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110362468|NCT04485273|Anesthetics, General|anesthetics, general|mesh-ancestor
110362469|NCT04485273|Sensory System Agents|sensory system agents|mesh-ancestor
110362470|NCT04485273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110362472|NCT02205528|Liraglutide|liraglutide|mesh-list
110362473|NCT02205528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110362474|NCT02205528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362475|NCT02205528|Incretins|incretins|mesh-ancestor
110362476|NCT02205528|Hormones|hormones|mesh-ancestor
110260184|NCT02944201|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110362477|NCT02205528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110362478|NCT03532022|Dexamethasone|dexamethasone|mesh-list
110362479|NCT03532022|Prednisone|prednisone|mesh-list
110362480|NCT03532022|Prednisolone|prednisolone|mesh-list
110362481|NCT03532022|Hydrocortisone|hydrocortisone|mesh-list
110362482|NCT03532022|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110362483|NCT03532022|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110362484|NCT03532022|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110362485|NCT03532022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110362486|NCT03532022|Antiemetics|antiemetics|mesh-ancestor
110362487|NCT03532022|Autonomic Agents|autonomic agents|mesh-ancestor
110362488|NCT03532022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110362489|NCT03532022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362490|NCT03532022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110362491|NCT03532022|Glucocorticoids|glucocorticoids|mesh-ancestor
110362492|NCT03532022|Hormones|hormones|mesh-ancestor
110362493|NCT03532022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110362494|NCT03532022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110362495|NCT03532022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110362496|NCT02200380|Plerixafor|plerixafor|mesh-list
110362497|NCT02200380|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110362498|NCT02200380|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110362499|NCT02200380|Antiviral Agents|antiviral agents|mesh-ancestor
110362500|NCT02200380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110362501|NCT02191878|TKM-080301|tkm-080301|mesh-list
110362502|NCT02191878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110362503|NCT02191878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110362504|NCT02191878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110362505|NCT02160678|Tazarotene|tazarotene|mesh-list
110362506|NCT02160678|Dermatologic Agents|dermatologic agents|mesh-ancestor
110362507|NCT02160678|Keratolytic Agents|keratolytic agents|mesh-ancestor
110362508|NCT02153502|Quinidine|quinidine|mesh-list
110362509|NCT02153502|Quinidine gluconate|quinidine gluconate|mesh-list
110362510|NCT02153502|Dextromethorphan|dextromethorphan|mesh-list
110362511|NCT02153502|Antitussive Agents|antitussive agents|mesh-ancestor
110362512|NCT02153502|Respiratory System Agents|respiratory system agents|mesh-ancestor
110362513|NCT02153502|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110362514|NCT02153502|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110362515|NCT02153502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110362516|NCT02153502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110362517|NCT02153502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362518|NCT02153502|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110362519|NCT02153502|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110362520|NCT02153502|Adrenergic Agents|adrenergic agents|mesh-ancestor
110362521|NCT02153502|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110362522|NCT02153502|Antimalarials|antimalarials|mesh-ancestor
110362523|NCT02153502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110362524|NCT02153502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110362525|NCT02153502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110362527|NCT02153502|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110362528|NCT02153502|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110362529|NCT02153502|Cholinergic Agents|cholinergic agents|mesh-ancestor
110362530|NCT02153502|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110362531|NCT02153502|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110362532|NCT02153502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110362533|NCT02153502|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110362534|NCT02153502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110362535|NCT02130687|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110362536|NCT02130687|Aprepitant|aprepitant|mesh-list
110362537|NCT02130687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110362538|NCT02130687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362539|NCT02130687|Incretins|incretins|mesh-ancestor
110362540|NCT02130687|Hormones|hormones|mesh-ancestor
110362541|NCT02130687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110362542|NCT02130687|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110362543|NCT02130687|Protease Inhibitors|protease inhibitors|mesh-ancestor
110362544|NCT02130687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110362545|NCT02130687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110362546|NCT02130687|Antiemetics|antiemetics|mesh-ancestor
110362547|NCT02130687|Autonomic Agents|autonomic agents|mesh-ancestor
110362548|NCT02130687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110362549|NCT02130687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110362550|NCT02130687|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110362551|NCT02130687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110362552|NCT01228656|Mometasone Furoate|mometasone furoate|mesh-list
110362553|NCT01228656|Salicylic Acid|salicylic acid|mesh-list
110362554|NCT01228656|Salicylates|salicylates|mesh-list
110362555|NCT01228656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110362556|NCT01228656|Dermatologic Agents|dermatologic agents|mesh-ancestor
110362557|NCT01228656|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110362558|NCT01228656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110362559|NCT01228656|Antifungal Agents|antifungal agents|mesh-ancestor
110362560|NCT01228656|Keratolytic Agents|keratolytic agents|mesh-ancestor
110362561|NCT01228656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110362562|NCT01228656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110362563|NCT01228656|Analgesics|analgesics|mesh-ancestor
110362564|NCT01228656|Sensory System Agents|sensory system agents|mesh-ancestor
110362565|NCT01228656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110362566|NCT01228656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362567|NCT01228656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110362568|NCT01228656|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110362569|NCT01228656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110362570|NCT01228656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110362571|NCT02128113|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110362572|NCT02128113|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110362573|NCT02125266|Methotrexate|methotrexate|mesh-list
110362574|NCT02125266|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110362575|NCT02125266|Abortifacient Agents|abortifacient agents|mesh-ancestor
110362576|NCT02125266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110362577|NCT02125266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362578|NCT02125266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110362579|NCT02125266|Antimetabolites|antimetabolites|mesh-ancestor
110362580|NCT02125266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110362581|NCT02125266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110362582|NCT02125266|Dermatologic Agents|dermatologic agents|mesh-ancestor
110362583|NCT02125266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110362584|NCT02125266|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110362585|NCT02125266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110362586|NCT02125266|Immunologic Factors|immunologic factors|mesh-ancestor
110362587|NCT02125266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110362588|NCT02125266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110362589|NCT02116998|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110362590|NCT02116998|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110362591|NCT02116998|Immunologic Factors|immunologic factors|mesh-ancestor
110362592|NCT02116998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362593|NCT02116998|Antacids|antacids|mesh-ancestor
110362594|NCT02116998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110362595|NCT02116998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110362596|NCT02110368|Methyltestosterone|methyltestosterone|mesh-list
110362597|NCT02110368|Testosterone|testosterone|mesh-list
110362598|NCT02110368|Testosterone undecanoate|testosterone undecanoate|mesh-list
110362599|NCT02110368|Testosterone enanthate|testosterone enanthate|mesh-list
110362600|NCT02110368|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110362601|NCT02110368|Androgens|androgens|mesh-ancestor
110362602|NCT02110368|Hormones|hormones|mesh-ancestor
110362603|NCT02110368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110362604|NCT02110368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362605|NCT02110368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110362606|NCT02110368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110362607|NCT02110368|Anabolic Agents|anabolic agents|mesh-ancestor
110362608|NCT02916485|Sirolimus|sirolimus|mesh-list
110362609|NCT02916485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110362610|NCT02916485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110362611|NCT02916485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110362612|NCT02916485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110362613|NCT02916485|Antifungal Agents|antifungal agents|mesh-ancestor
110362614|NCT02916485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110362615|NCT02916485|Immunologic Factors|immunologic factors|mesh-ancestor
110362616|NCT02916485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362617|NCT01709214|Oxycodone|oxycodone|mesh-list
110362618|NCT01709214|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110362620|NCT01709214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110362621|NCT01709214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362622|NCT01709214|Analgesics|analgesics|mesh-ancestor
110362623|NCT01709214|Sensory System Agents|sensory system agents|mesh-ancestor
110362624|NCT01709214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110362625|NCT02916602|Losartan|losartan|mesh-list
110362626|NCT02916602|Amlodipine|amlodipine|mesh-list
110362627|NCT02916602|Chlorthalidone|chlorthalidone|mesh-list
110362628|NCT02916602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110362629|NCT02916602|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110362630|NCT02916602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110362631|NCT02916602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110362632|NCT02916602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110362633|NCT02916602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362635|NCT02916602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110362636|NCT02916602|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110362637|NCT02916602|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110362638|NCT02916602|Diuretics|diuretics|mesh-ancestor
110362639|NCT02916602|Natriuretic Agents|natriuretic agents|mesh-ancestor
110362640|NCT02916602|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110362641|NCT02916251|Glucagon|glucagon|mesh-list
110362642|NCT02916251|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110362643|NCT02916251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110362644|NCT02916251|Hormones|hormones|mesh-ancestor
110362645|NCT02916251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110362646|NCT02916251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362647|NCT02916251|Incretins|incretins|mesh-ancestor
110362648|NCT02106546|Paclitaxel|paclitaxel|mesh-list
110362649|NCT02106546|Carboplatin|carboplatin|mesh-list
110362650|NCT02106546|Veliparib|veliparib|mesh-list
110362651|NCT02106546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110362652|NCT02106546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110362653|NCT02106546|Tubulin Modulators|tubulin modulators|mesh-ancestor
110362654|NCT02106546|Antimitotic Agents|antimitotic agents|mesh-ancestor
110362655|NCT02106546|Mitosis Modulators|mitosis modulators|mesh-ancestor
110362656|NCT02106546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110362657|NCT02106546|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110362658|NCT02106546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110362659|NCT02916173|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110362660|NCT02916173|Hormones|hormones|mesh-list
110362661|NCT02916173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110362662|NCT02916173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362663|NCT02916173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110362664|NCT02916134|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110362665|NCT02916134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110362666|NCT02104245|Ciprofloxacin|ciprofloxacin|mesh-list
110362667|NCT02104245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110362668|NCT02104245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110362669|NCT02104245|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110362670|NCT02104245|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110362671|NCT02104245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110362672|NCT02104245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110362673|NCT02104245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110362674|NCT02104245|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110362675|NCT02104245|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110362676|NCT01699737|Glimepiride|glimepiride|mesh-list
110362677|NCT01699737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110362678|NCT01699737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110362679|NCT01699737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362680|NCT01699737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110362681|NCT01699737|Immunologic Factors|immunologic factors|mesh-ancestor
110362682|NCT04688723|Dabigatran|dabigatran|mesh-list
110362683|NCT04688723|Clopidogrel|clopidogrel|mesh-list
110362684|NCT04688723|Ticagrelor|ticagrelor|mesh-list
110362685|NCT04688723|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110362686|NCT04688723|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110362687|NCT04688723|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110362688|NCT04688723|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110362689|NCT04688723|Purinergic Agents|purinergic agents|mesh-ancestor
110362690|NCT04688723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110362691|NCT04688723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110362692|NCT04688723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362694|NCT04688723|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110362695|NCT04688723|Protease Inhibitors|protease inhibitors|mesh-ancestor
110362696|NCT04688723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110362697|NCT04688723|Anticoagulants|anticoagulants|mesh-ancestor
110362698|NCT01699464|Timolol|timolol|mesh-list
110362699|NCT01699464|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110362700|NCT01699464|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110362701|NCT01699464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110362702|NCT01699464|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110362703|NCT01699464|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110362704|NCT01699464|Adrenergic Agents|adrenergic agents|mesh-ancestor
110362705|NCT01699464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110362706|NCT01699464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362707|NCT01699464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110362708|NCT01699464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110362709|NCT04688645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110362710|NCT02104050|Dapansutrile|dapansutrile|mesh-list
110362711|NCT02104050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110362712|NCT01694277|Sunitinib|sunitinib|mesh-list
110362713|NCT01694277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110362714|NCT01694277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110362715|NCT01694277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110362716|NCT01694277|Growth Substances|growth substances|mesh-ancestor
110362717|NCT01694277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362718|NCT01694277|Growth Inhibitors|growth inhibitors|mesh-ancestor
110362719|NCT01694277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110362720|NCT01694277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110362721|NCT01694277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110362722|NCT01669980|Vancomycin|vancomycin|mesh-list
110362723|NCT01669980|Ceftriaxone|ceftriaxone|mesh-list
110362724|NCT01669980|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
110362725|NCT01669980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110362726|NCT01669980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110362727|NCT02915666|Trametinib|trametinib|mesh-list
110362728|NCT02915666|Dabrafenib|dabrafenib|mesh-list
110362729|NCT02915666|Digoxin|digoxin|mesh-list
110362730|NCT02915666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110362731|NCT02915666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110362732|NCT02915666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110362733|NCT02915666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110362734|NCT02915666|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110362735|NCT02915666|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110362736|NCT02915666|Protective Agents|protective agents|mesh-ancestor
110362737|NCT02915666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362738|NCT02092935|Vancomycin|vancomycin|mesh-list
110362739|NCT02092935|Ridinilazole|ridinilazole|mesh-list
110362740|NCT02092935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110362741|NCT02092935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110362742|NCT01666977|Carboplatin|carboplatin|mesh-list
110362743|NCT01666977|Pemetrexed|pemetrexed|mesh-list
110362744|NCT01666977|Trebananib|trebananib|mesh-list
110362745|NCT01666977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110362746|NCT01666977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110362747|NCT01666977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110362748|NCT01666977|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110362749|NCT01666977|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110362750|NCT01666977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110362751|NCT01666977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110362753|NCT01666977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362754|NCT01666977|Growth Inhibitors|growth inhibitors|mesh-ancestor
110362755|NCT02915354|Etanercept|etanercept|mesh-list
110362756|NCT02915354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110362757|NCT02915354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110362758|NCT02915354|Analgesics|analgesics|mesh-ancestor
110362759|NCT02915354|Sensory System Agents|sensory system agents|mesh-ancestor
110362760|NCT02915354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110362761|NCT02915354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362762|NCT02915354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110362763|NCT02915354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110362764|NCT02915354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110362765|NCT02915354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110362766|NCT02915354|Immunologic Factors|immunologic factors|mesh-ancestor
110362767|NCT01661634|Ularitide|ularitide|mesh-list
110362768|NCT01661634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110362769|NCT01661634|Autonomic Agents|autonomic agents|mesh-ancestor
110362770|NCT01661634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110362771|NCT01661634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362772|NCT01661634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110362773|NCT01661634|Respiratory System Agents|respiratory system agents|mesh-ancestor
110362774|NCT01661634|Diuretics|diuretics|mesh-ancestor
110362775|NCT01661634|Natriuretic Agents|natriuretic agents|mesh-ancestor
110362776|NCT01661166|Fesoterodine|fesoterodine|mesh-list
110362778|NCT01661166|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110362779|NCT01661166|Cholinergic Agents|cholinergic agents|mesh-ancestor
110362780|NCT01661166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110362781|NCT01661166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110362782|NCT01661166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362783|NCT01661166|Urological Agents|urological agents|mesh-ancestor
110362784|NCT02915042|Dexmedetomidine|dexmedetomidine|mesh-list
110362785|NCT02915042|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110362786|NCT02915042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110362787|NCT02915042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362788|NCT02915042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110362789|NCT02915042|Analgesics|analgesics|mesh-ancestor
110362790|NCT02915042|Sensory System Agents|sensory system agents|mesh-ancestor
110362791|NCT02915042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110362792|NCT02915042|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110362793|NCT02915042|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110362794|NCT02915042|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110362795|NCT02915042|Adrenergic Agents|adrenergic agents|mesh-ancestor
110362796|NCT02915042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110362797|NCT02915042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110362798|NCT01658826|Valacyclovir|valacyclovir|mesh-list
110362799|NCT01658826|Pritelivir|pritelivir|mesh-list
110362800|NCT01658826|Antiviral Agents|antiviral agents|mesh-ancestor
110362801|NCT01658826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110362802|NCT01658826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110362803|NCT01658826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110362804|NCT02092077|Hormones|hormones|mesh-list
110362805|NCT02092077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110362806|NCT02092077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362807|NCT02914886|Insulin|insulin|mesh-list
110362808|NCT02914886|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110362809|NCT02914886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110362810|NCT02914886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362811|NCT01643226|Riboflavin|riboflavin|mesh-list
110362812|NCT01643226|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110362813|NCT01643226|Vitamin B Complex|vitamin b complex|mesh-ancestor
110362814|NCT01643226|Vitamins|vitamins|mesh-ancestor
110362815|NCT01643226|Micronutrients|micronutrients|mesh-ancestor
110362816|NCT01643226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362817|NCT01643226|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110362818|NCT01643226|Dermatologic Agents|dermatologic agents|mesh-ancestor
110362819|NCT02914652|Albuterol|albuterol|mesh-list
110362820|NCT02914652|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110362821|NCT02914652|Autonomic Agents|autonomic agents|mesh-ancestor
110362822|NCT02914652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110362823|NCT02914652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362824|NCT02914652|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110362825|NCT02914652|Respiratory System Agents|respiratory system agents|mesh-ancestor
110362826|NCT02914652|Tocolytic Agents|tocolytic agents|mesh-ancestor
110362827|NCT02914652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110362828|NCT02914652|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110362829|NCT02914652|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110362830|NCT02914652|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110362831|NCT02914652|Adrenergic Agents|adrenergic agents|mesh-ancestor
110362832|NCT02914652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110362833|NCT02914652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110362834|NCT02081118|Exenatide|exenatide|mesh-list
110362835|NCT02081118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110362836|NCT02081118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362837|NCT02081118|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110362838|NCT02081118|Incretins|incretins|mesh-ancestor
110362839|NCT02081118|Hormones|hormones|mesh-ancestor
110362840|NCT02081118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110362841|NCT02077881|Paclitaxel|paclitaxel|mesh-list
110362842|NCT02077881|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110362843|NCT02077881|Gemcitabine|gemcitabine|mesh-list
110362844|NCT02077881|Tryptophan|tryptophan|mesh-list
110362845|NCT02077881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110362846|NCT02077881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110362847|NCT02077881|Tubulin Modulators|tubulin modulators|mesh-ancestor
110362848|NCT02077881|Antimitotic Agents|antimitotic agents|mesh-ancestor
110362849|NCT02077881|Mitosis Modulators|mitosis modulators|mesh-ancestor
110362850|NCT02077881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110362851|NCT02077881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110362853|NCT02077881|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110362854|NCT02077881|Antidepressive Agents|antidepressive agents|mesh-ancestor
110362855|NCT02077881|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110362856|NCT01632228|Bevacizumab|bevacizumab|mesh-list
110362857|NCT01632228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110362858|NCT01632228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110177462|NCT03844412|Lidocaine|lidocaine|mesh-list
110362859|NCT01632228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110362860|NCT01632228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110362861|NCT01632228|Growth Substances|growth substances|mesh-ancestor
110362862|NCT01632228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362863|NCT01632228|Growth Inhibitors|growth inhibitors|mesh-ancestor
110362864|NCT01628094|Ritonavir|ritonavir|mesh-list
110362865|NCT01628094|Ribavirin|ribavirin|mesh-list
110362866|NCT01628094|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110362867|NCT01628094|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110362868|NCT01628094|Protease Inhibitors|protease inhibitors|mesh-ancestor
110362869|NCT01628094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110362870|NCT01628094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110362871|NCT01628094|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110362872|NCT01628094|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110362873|NCT01628094|Antiviral Agents|antiviral agents|mesh-ancestor
110362874|NCT01628094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110362875|NCT01628094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110362876|NCT01628094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110362877|NCT01628094|Antimetabolites|antimetabolites|mesh-ancestor
110362878|NCT02073123|Pembrolizumab|pembrolizumab|mesh-list
110362879|NCT02073123|Nivolumab|nivolumab|mesh-list
110362880|NCT02073123|Ipilimumab|ipilimumab|mesh-list
110362881|NCT02073123|Tryptophan|tryptophan|mesh-list
110362882|NCT02073123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110362883|NCT02073123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110362884|NCT02073123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110362885|NCT02073123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110362886|NCT02073123|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110362887|NCT02073123|Antidepressive Agents|antidepressive agents|mesh-ancestor
110362888|NCT02073123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110362889|NCT02914145|Piperaquine|piperaquine|mesh-list
110362890|NCT02914145|Artenimol|artenimol|mesh-list
110362891|NCT02914145|Antimalarials|antimalarials|mesh-ancestor
110362892|NCT02914145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110362893|NCT02914145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110362894|NCT02914145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110362895|NCT02914028|Acetaminophen|acetaminophen|mesh-list
110362896|NCT02914028|Tramadol|tramadol|mesh-list
110362897|NCT02914028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110362898|NCT02914028|Analgesics|analgesics|mesh-ancestor
110362899|NCT02914028|Sensory System Agents|sensory system agents|mesh-ancestor
110362900|NCT02914028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110362901|NCT02914028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362902|NCT02914028|Antipyretics|antipyretics|mesh-ancestor
110362903|NCT02914028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110362904|NCT02914028|Narcotics|narcotics|mesh-ancestor
110362905|NCT02914028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110362906|NCT02064426|Epoetin Alfa|epoetin alfa|mesh-list
110362907|NCT02064426|Hematinics|hematinics|mesh-ancestor
110362908|NCT02063997|Colchicine|colchicine|mesh-list
110362909|NCT02063997|Allopurinol|allopurinol|mesh-list
110362910|NCT02063997|Gout Suppressants|gout suppressants|mesh-ancestor
110362911|NCT02063997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110362912|NCT02063997|Tubulin Modulators|tubulin modulators|mesh-ancestor
110362913|NCT02063997|Antimitotic Agents|antimitotic agents|mesh-ancestor
110362914|NCT02063997|Mitosis Modulators|mitosis modulators|mesh-ancestor
110362915|NCT02063997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110362916|NCT02063997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110362917|NCT02063997|Antimetabolites|antimetabolites|mesh-ancestor
110362918|NCT02063997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110362919|NCT02063997|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110362920|NCT02063997|Antioxidants|antioxidants|mesh-ancestor
110362921|NCT02063997|Protective Agents|protective agents|mesh-ancestor
110362922|NCT02063997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362923|NCT00585507|Fulvestrant|fulvestrant|mesh-list
110362924|NCT00585507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110362925|NCT00585507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110362926|NCT00585507|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110362927|NCT00585507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110362928|NCT00585507|Hormone Antagonists|hormone antagonists|mesh-ancestor
110177464|NCT03844412|Estradiol|estradiol|mesh-list
110362929|NCT00585507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110362930|NCT00585507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362931|NCT02063685|Prednisone|prednisone|mesh-list
110362932|NCT02063685|Cyclophosphamide|cyclophosphamide|mesh-list
110362933|NCT02063685|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110362934|NCT02063685|Rituximab|rituximab|mesh-list
110362935|NCT02063685|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110362936|NCT02063685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110362937|NCT02063685|Immunologic Factors|immunologic factors|mesh-ancestor
110362938|NCT02063685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362939|NCT02063685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110362940|NCT02063685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110362941|NCT02063685|Alkylating Agents|alkylating agents|mesh-ancestor
110362942|NCT02063685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110362943|NCT02063685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110362944|NCT02063685|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110362945|NCT02063685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110362946|NCT02063685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110362948|NCT02063685|Hormones|hormones|mesh-ancestor
110362949|NCT02063685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110362950|NCT02063685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110362951|NCT02063295|CKD732|ckd732|mesh-list
110362952|NCT02063295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110362953|NCT02063295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110362954|NCT02063295|Growth Substances|growth substances|mesh-ancestor
110362955|NCT02063295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362956|NCT02063295|Growth Inhibitors|growth inhibitors|mesh-ancestor
110362957|NCT02063295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110362958|NCT02057172|Liraglutide|liraglutide|mesh-list
110362959|NCT02057172|Exenatide|exenatide|mesh-list
110362960|NCT02057172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110362961|NCT02057172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362962|NCT02057172|Incretins|incretins|mesh-ancestor
110362963|NCT02057172|Hormones|hormones|mesh-ancestor
110362964|NCT02057172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110362965|NCT02057172|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110362966|NCT02894307|Rivaroxaban|rivaroxaban|mesh-list
110362967|NCT02894307|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110362968|NCT02894307|Antithrombins|antithrombins|mesh-ancestor
110362969|NCT02894307|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110362970|NCT02894307|Protease Inhibitors|protease inhibitors|mesh-ancestor
110362971|NCT02894307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110362972|NCT02894307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110362973|NCT02894307|Anticoagulants|anticoagulants|mesh-ancestor
110362974|NCT02052648|Bevacizumab|bevacizumab|mesh-list
110362975|NCT02052648|Temozolomide|temozolomide|mesh-list
110362976|NCT02052648|Tryptophan|tryptophan|mesh-list
110362977|NCT02052648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110362978|NCT02052648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110362979|NCT02052648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110362980|NCT02052648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110362981|NCT02052648|Growth Substances|growth substances|mesh-ancestor
110362982|NCT02052648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362983|NCT02052648|Growth Inhibitors|growth inhibitors|mesh-ancestor
110362984|NCT02052648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110362985|NCT02052648|Alkylating Agents|alkylating agents|mesh-ancestor
110362986|NCT02052648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110362987|NCT02052648|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110362988|NCT02052648|Antidepressive Agents|antidepressive agents|mesh-ancestor
110362989|NCT02052648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110362990|NCT01186744|Tofacitinib|tofacitinib|mesh-list
110362991|NCT01186744|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110362992|NCT01186744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110362993|NCT01186744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110362994|NCT01186744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110362995|NCT02044341|Benzocaine|benzocaine|mesh-list
110362996|NCT02044341|Glycerol|glycerol|mesh-list
110362997|NCT02044341|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110362998|NCT02044341|Protective Agents|protective agents|mesh-ancestor
110362999|NCT02044341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110363000|NCT02044341|Anesthetics, Local|anesthetics, local|mesh-ancestor
110363002|NCT02044341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110363003|NCT02044341|Sensory System Agents|sensory system agents|mesh-ancestor
110363004|NCT02044341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110363005|NCT00555399|Temozolomide|temozolomide|mesh-list
110363006|NCT00555399|Vorinostat|vorinostat|mesh-list
110363007|NCT00555399|Isotretinoin|isotretinoin|mesh-list
110363008|NCT00555399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110363009|NCT00555399|Alkylating Agents|alkylating agents|mesh-ancestor
110363010|NCT00555399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110363011|NCT00555399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110363012|NCT00555399|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110363013|NCT00555399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110363014|NCT00555399|Dermatologic Agents|dermatologic agents|mesh-ancestor
110363015|NCT02912663|Magnesium Sulfate|magnesium sulfate|mesh-list
110363016|NCT02912663|Verapamil|verapamil|mesh-list
110363017|NCT02912663|Analgesics|analgesics|mesh-ancestor
110363018|NCT02912663|Sensory System Agents|sensory system agents|mesh-ancestor
110363019|NCT02912663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110363020|NCT02912663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110363021|NCT02912663|Anesthetics|anesthetics|mesh-ancestor
110363022|NCT02912663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110363023|NCT02912663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110363024|NCT02912663|Anticonvulsants|anticonvulsants|mesh-ancestor
110363025|NCT02912663|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110363026|NCT02912663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110363027|NCT02912663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110363028|NCT02912663|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110363029|NCT02912663|Tocolytic Agents|tocolytic agents|mesh-ancestor
110363030|NCT02912663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110363031|NCT02912663|Vasodilator Agents|vasodilator agents|mesh-ancestor
110363032|NCT02894151|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110363033|NCT02894151|Medroxyprogesterone|medroxyprogesterone|mesh-list
110363034|NCT02894151|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110363035|NCT02894151|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110363036|NCT02894151|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110363037|NCT02894151|Contraceptive Agents|contraceptive agents|mesh-ancestor
110363038|NCT02894151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110363039|NCT02894151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110363040|NCT02894151|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110363041|NCT02894151|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110363042|NCT02894151|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110363043|NCT02894151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110363044|NCT02894151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110363045|NCT02912702|Dexamethasone|dexamethasone|mesh-list
110363046|NCT02912702|Methylprednisolone|methylprednisolone|mesh-list
110363047|NCT02912702|Doxorubicin|doxorubicin|mesh-list
110363048|NCT02912702|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110363049|NCT02912702|Etoposide|etoposide|mesh-list
110363050|NCT02912702|Etoposide phosphate|etoposide phosphate|mesh-list
110363051|NCT02912702|Pegaspargase|pegaspargase|mesh-list
110363052|NCT02912702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110363053|NCT02912702|Antiemetics|antiemetics|mesh-ancestor
110363055|NCT02912702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110363056|NCT02912702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110363057|NCT02912702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110363058|NCT02912702|Glucocorticoids|glucocorticoids|mesh-ancestor
110363060|NCT02912702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110363061|NCT02912702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110363062|NCT02912702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110363063|NCT02912702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110363064|NCT02912702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110177476|NCT03844412|Estrogens|estrogens|mesh-ancestor
110363065|NCT02912702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110363066|NCT02912702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110363067|NCT02912702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110363068|NCT02912702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110363069|NCT02912702|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110363070|NCT02912702|Protective Agents|protective agents|mesh-ancestor
110363071|NCT02010333|Benzyl Alcohol|benzyl alcohol|mesh-list
110363072|NCT02010333|Anesthetics, Local|anesthetics, local|mesh-ancestor
110363073|NCT02010333|Anesthetics|anesthetics|mesh-ancestor
110363074|NCT02010333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110363075|NCT02010333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110363076|NCT02010333|Sensory System Agents|sensory system agents|mesh-ancestor
110363077|NCT02010333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110363078|NCT02008344|Favipiravir|favipiravir|mesh-list
110363079|NCT02008344|Antiviral Agents|antiviral agents|mesh-ancestor
110363080|NCT02008344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110363081|NCT02912156|Voriconazole|voriconazole|mesh-list
110363082|NCT02912156|Antifungal Agents|antifungal agents|mesh-ancestor
110363083|NCT02912156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110363084|NCT02912156|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110363085|NCT02912156|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110363086|NCT02912156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110260185|NCT00145340|Pioglitazone|pioglitazone|mesh-list
110363087|NCT02912156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110363088|NCT02912156|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110363089|NCT02912156|Hormone Antagonists|hormone antagonists|mesh-ancestor
110363090|NCT02912156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110363091|NCT02912156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110363092|NCT02912156|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110363093|NCT03455049|Andrographolide|andrographolide|mesh-list
110363094|NCT03455049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110363095|NCT03455049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110363096|NCT03455049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110363097|NCT03455049|Analgesics|analgesics|mesh-ancestor
110363098|NCT03455049|Sensory System Agents|sensory system agents|mesh-ancestor
110363099|NCT03455049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110363100|NCT03455049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110363101|NCT03455049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110363102|NCT03455049|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110363103|NCT03455049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110363104|NCT03455049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110363105|NCT03455049|Antiviral Agents|antiviral agents|mesh-ancestor
110363106|NCT03455049|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110363107|NCT02912234|Clarithromycin|clarithromycin|mesh-list
110363109|NCT02912234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110363110|NCT02912234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110363111|NCT02912234|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110363112|NCT02912234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110363113|NCT02912234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110363114|NCT02912234|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110363115|NCT02912234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110363117|NCT02912234|Antithrombins|antithrombins|mesh-ancestor
110363118|NCT02912234|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110363119|NCT02912234|Protease Inhibitors|protease inhibitors|mesh-ancestor
110363120|NCT02912234|Anticoagulants|anticoagulants|mesh-ancestor
110363122|NCT04676139|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110363123|NCT04676139|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110363124|NCT04676139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110363125|NCT04676139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110363126|NCT04676139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110363127|NCT04676139|Serotonin Agents|serotonin agents|mesh-ancestor
110363128|NCT04676139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110363129|NCT04676139|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110363130|NCT04676139|Antidepressive Agents|antidepressive agents|mesh-ancestor
110363131|NCT04676139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110363132|NCT04676139|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110363133|NCT04676139|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110363134|NCT04676139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110363135|NCT01999764|Retinol acetate|retinol acetate|mesh-list
110363136|NCT01999764|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110363137|NCT01999764|Immunologic Factors|immunologic factors|mesh-ancestor
110363138|NCT01999764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110363139|NCT01999764|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110363140|NCT01999764|Protective Agents|protective agents|mesh-ancestor
110363141|NCT01999764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110363142|NCT02911961|Acetaminophen|acetaminophen|mesh-list
110363143|NCT02911961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110363144|NCT02911961|Analgesics|analgesics|mesh-ancestor
110363145|NCT02911961|Sensory System Agents|sensory system agents|mesh-ancestor
110363146|NCT02911961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110363147|NCT02911961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110363148|NCT02911961|Antipyretics|antipyretics|mesh-ancestor
110363149|NCT01998828|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
110363150|NCT01998828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110363151|NCT01998828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110363152|NCT01998828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110363153|NCT04676061|Norethindrone|norethindrone|mesh-list
110363154|NCT04676061|Norethindrone Acetate|norethindrone acetate|mesh-list
110363155|NCT04676061|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110363156|NCT04676061|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110363157|NCT04676061|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110363158|NCT04676061|Contraceptive Agents|contraceptive agents|mesh-ancestor
110363159|NCT04676061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110363160|NCT04676061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110363161|NCT04676061|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110363162|NCT04676061|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110363163|NCT04675944|Treprostinil|treprostinil|mesh-list
110363165|NCT04675944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110363166|NCT04675944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110363167|NCT04675944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110363168|NCT02911766|Chlorhexidine|chlorhexidine|mesh-list
110363169|NCT02911766|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110363170|NCT02911766|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110363171|NCT02911766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110363172|NCT02911766|Disinfectants|disinfectants|mesh-ancestor
110363173|NCT02911766|Dermatologic Agents|dermatologic agents|mesh-ancestor
110363174|NCT01993641|Azacitidine|azacitidine|mesh-list
110363175|NCT01993641|Decitabine|decitabine|mesh-list
110363176|NCT01993641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110363177|NCT01993641|Antimetabolites|antimetabolites|mesh-ancestor
110363178|NCT01993641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110363179|NCT01993641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110363180|NCT01993641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110363181|NCT01989429|Vitamin D|vitamin d|mesh-list
110363182|NCT01989429|Vitamins|vitamins|mesh-ancestor
110363183|NCT01989429|Micronutrients|micronutrients|mesh-ancestor
110363184|NCT01989429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110363185|NCT01989429|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110363186|NCT02911298|Metronidazole|metronidazole|mesh-list
110363187|NCT02911298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110363188|NCT02911298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110363189|NCT02911298|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110363190|NCT02911298|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110363191|NCT01983306|Dolcanatide|dolcanatide|mesh-list
110363192|NCT01983306|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
110363193|NCT01983306|Enzyme Activators|enzyme activators|mesh-ancestor
110363194|NCT01983306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110363195|NCT01983306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110363196|NCT01982175|Alemtuzumab|alemtuzumab|mesh-list
110363197|NCT01982175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110363198|NCT01982175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110363199|NCT01975818|Epoetin Alfa|epoetin alfa|mesh-list
110363200|NCT01975818|Hematinics|hematinics|mesh-ancestor
110363201|NCT01973049|Ribavirin|ribavirin|mesh-list
110363202|NCT01973049|Asunaprevir|asunaprevir|mesh-list
110363203|NCT01973049|Antimetabolites|antimetabolites|mesh-ancestor
110363204|NCT01973049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110363205|NCT01973049|Antiviral Agents|antiviral agents|mesh-ancestor
110363206|NCT01973049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110363207|NCT01973049|Protease Inhibitors|protease inhibitors|mesh-ancestor
110363208|NCT01973049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110363209|NCT01185964|Doxorubicin|doxorubicin|mesh-list
110363210|NCT01185964|Olaratumab|olaratumab|mesh-list
110363211|NCT01185964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110363212|NCT01185964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110363213|NCT01185964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110363214|NCT01185964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110363215|NCT01185964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110363216|NCT01185964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110363217|NCT01972854|Riboflavin|riboflavin|mesh-list
110363218|NCT01972854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110363219|NCT01972854|Vitamin B Complex|vitamin b complex|mesh-ancestor
110363221|NCT01972854|Micronutrients|micronutrients|mesh-ancestor
110363222|NCT01972854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110363223|NCT01972854|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110363224|NCT01972854|Dermatologic Agents|dermatologic agents|mesh-ancestor
110363225|NCT02550470|Sevoflurane|sevoflurane|mesh-list
110363226|NCT02550470|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110363227|NCT02550470|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110363228|NCT02550470|Anesthetics, General|anesthetics, general|mesh-ancestor
110363229|NCT02550470|Anesthetics|anesthetics|mesh-ancestor
110363230|NCT02550470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110363231|NCT02550470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110363232|NCT02910518|Insulin|insulin|mesh-list
110363233|NCT02910518|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110363234|NCT02910518|Insulin Aspart|insulin aspart|mesh-list
110363235|NCT02910518|Insulin glulisine|insulin glulisine|mesh-list
110363236|NCT02910518|Insulin, Isophane|insulin, isophane|mesh-list
110363237|NCT02910518|Isophane Insulin, Human|isophane insulin, human|mesh-list
110363238|NCT02910518|Isophane insulin, beef|isophane insulin, beef|mesh-list
110363239|NCT02910518|Heparin|heparin|mesh-list
110363240|NCT02910518|Calcium heparin|calcium heparin|mesh-list
110363241|NCT02910518|Glucagon|glucagon|mesh-list
110363242|NCT02910518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110363243|NCT02910518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110363244|NCT02910518|Anticoagulants|anticoagulants|mesh-ancestor
110363245|NCT02910518|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110363246|NCT02910518|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110363247|NCT02910518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110363248|NCT02910518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110363249|NCT02910518|Hormones|hormones|mesh-ancestor
110363250|NCT02910518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110363251|NCT01217437|Bevacizumab|bevacizumab|mesh-list
110363252|NCT01217437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110363254|NCT01217437|Temozolomide|temozolomide|mesh-list
110363255|NCT01217437|Camptothecin|camptothecin|mesh-list
110363256|NCT01217437|Endothelial Growth Factors|endothelial growth factors|mesh-list
110363257|NCT01217437|Antibodies|antibodies|mesh-list
110363258|NCT01217437|Immunoglobulins|immunoglobulins|mesh-list
110363259|NCT01217437|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110363260|NCT01217437|Immunoglobulin G|immunoglobulin g|mesh-list
110363261|NCT01217437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110363262|NCT01217437|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110363263|NCT01217437|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110363264|NCT01217437|Growth Substances|growth substances|mesh-ancestor
110363265|NCT01217437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110363266|NCT01217437|Growth Inhibitors|growth inhibitors|mesh-ancestor
110363267|NCT01217437|Immunologic Factors|immunologic factors|mesh-ancestor
110363268|NCT01217437|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110177499|NCT03837977|Folic Acid|folic acid|mesh-list
110363270|NCT01217437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110363271|NCT01217437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110363272|NCT01217437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110363273|NCT01217437|Alkylating Agents|alkylating agents|mesh-ancestor
110363274|NCT01217437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110363275|NCT00624364|Metformin|metformin|mesh-list
110363276|NCT00624364|Insulin Aspart|insulin aspart|mesh-list
110363277|NCT00624364|Biphasic Insulins|biphasic insulins|mesh-list
110363278|NCT00624364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110363279|NCT00624364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110363280|NCT02910596|Bethanechol|bethanechol|mesh-list
110363281|NCT02910596|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110363282|NCT02910596|Autonomic Agents|autonomic agents|mesh-ancestor
110363283|NCT02910596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110363284|NCT02910596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110363285|NCT02910596|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110363286|NCT02910596|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110363287|NCT02910596|Cholinergic Agents|cholinergic agents|mesh-ancestor
110363288|NCT02910596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110363289|NCT02910596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110363290|NCT04316377|Hydroxychloroquine|hydroxychloroquine|mesh-list
110363291|NCT04316377|Antimalarials|antimalarials|mesh-ancestor
110363292|NCT04316377|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110363293|NCT04316377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110363294|NCT04316377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110363295|NCT04316377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110363296|NCT04316377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110363297|NCT04316377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110363298|NCT02886988|Botulinum Toxins|botulinum toxins|mesh-list
110363299|NCT02886988|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110363300|NCT02886988|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110363301|NCT02886988|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110363302|NCT02886988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110363303|NCT02886988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110363304|NCT02886988|Cholinergic Agents|cholinergic agents|mesh-ancestor
110363305|NCT02886988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110363306|NCT02886988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110363307|NCT02886988|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110363308|NCT02886988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110363310|NCT04676997|Cyclophosphamide|cyclophosphamide|mesh-list
110363311|NCT04676997|Epirubicin|epirubicin|mesh-list
110363312|NCT04676997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110363313|NCT04676997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110363314|NCT04676997|Tubulin Modulators|tubulin modulators|mesh-ancestor
110363315|NCT04676997|Antimitotic Agents|antimitotic agents|mesh-ancestor
110363316|NCT04676997|Mitosis Modulators|mitosis modulators|mesh-ancestor
110363317|NCT04676997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110363318|NCT04676997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110363319|NCT04676997|Immunologic Factors|immunologic factors|mesh-ancestor
110363320|NCT04676997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110363321|NCT04676997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110363322|NCT04676997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110363323|NCT04676997|Alkylating Agents|alkylating agents|mesh-ancestor
110363324|NCT04676997|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110363325|NCT04676997|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110363326|NCT04676997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110363327|NCT04676997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110363328|NCT04676997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110363329|NCT02910206|Sufentanil|sufentanil|mesh-list
110363330|NCT02910206|Propofol|propofol|mesh-list
110363331|NCT02910206|Etomidate|etomidate|mesh-list
110363332|NCT02910206|Cisatracurium|cisatracurium|mesh-list
110363333|NCT02910206|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110363334|NCT02910206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110363335|NCT02910206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110363336|NCT02910206|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110363337|NCT02910206|Anesthetics, General|anesthetics, general|mesh-ancestor
110363338|NCT02910206|Anesthetics|anesthetics|mesh-ancestor
110363339|NCT02910206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110363340|NCT02910206|Narcotics|narcotics|mesh-ancestor
110363341|NCT02910206|Analgesics|analgesics|mesh-ancestor
110363342|NCT02910206|Sensory System Agents|sensory system agents|mesh-ancestor
110363343|NCT02910206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110363344|NCT02910206|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110363345|NCT02910206|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110363346|NCT02910206|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110363347|NCT04675086|Antiviral Agents|antiviral agents|mesh-list
110363348|NCT04675086|Remdesivir|remdesivir|mesh-list
110363349|NCT04675086|Protease Inhibitors|protease inhibitors|mesh-list
110363350|NCT04675086|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
110363351|NCT04675086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110363352|NCT04675086|Antimetabolites|antimetabolites|mesh-ancestor
110363353|NCT04675086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110363354|NCT04675086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110363355|NCT04675086|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110363356|NCT04675086|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110363358|NCT02909972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110363359|NCT02909972|Antimetabolites|antimetabolites|mesh-ancestor
110363360|NCT02909972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110363361|NCT02909972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110363362|NCT02909972|Antiviral Agents|antiviral agents|mesh-ancestor
110363363|NCT02909972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110363364|NCT02909972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110363365|NCT02909972|Immunologic Factors|immunologic factors|mesh-ancestor
110363366|NCT02909972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110363367|NCT00555594|Bevacizumab|bevacizumab|mesh-list
110363368|NCT00555594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110363369|NCT00555594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110363370|NCT00555594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110363371|NCT00555594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110363372|NCT00555594|Growth Substances|growth substances|mesh-ancestor
110363373|NCT00555594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110363374|NCT00555594|Growth Inhibitors|growth inhibitors|mesh-ancestor
110363375|NCT02910050|Letrozole|letrozole|mesh-list
110363376|NCT02910050|Anastrozole|anastrozole|mesh-list
110363377|NCT02910050|Exemestane|exemestane|mesh-list
110363378|NCT02910050|Bicalutamide|bicalutamide|mesh-list
110363379|NCT02910050|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110363380|NCT02910050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110363381|NCT02910050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110363382|NCT02910050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110363383|NCT02910050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110363384|NCT02910050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110363385|NCT02910050|Hormone Antagonists|hormone antagonists|mesh-ancestor
110363386|NCT02910050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110363387|NCT02910050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110363388|NCT02910050|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110363389|NCT02910050|Androgen Antagonists|androgen antagonists|mesh-ancestor
110363390|NCT02909933|Metformin|metformin|mesh-list
110363391|NCT02909933|Liraglutide|liraglutide|mesh-list
110363392|NCT02909933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110363393|NCT02909933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110363394|NCT02909933|Incretins|incretins|mesh-ancestor
110363395|NCT02909933|Hormones|hormones|mesh-ancestor
110260186|NCT00145340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110363396|NCT02909933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110363397|NCT02910245|Prednisone|prednisone|mesh-list
110363398|NCT02910245|Mesalamine|mesalamine|mesh-list
110363399|NCT02910245|Mercaptopurine|mercaptopurine|mesh-list
110363400|NCT02910245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110363401|NCT02910245|Glucocorticoids|glucocorticoids|mesh-ancestor
110363402|NCT02910245|Hormones|hormones|mesh-ancestor
110363403|NCT02910245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110363404|NCT02910245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110363405|NCT02910245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110363406|NCT02910245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110363407|NCT02910245|Antimetabolites|antimetabolites|mesh-ancestor
110363408|NCT02910245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110363409|NCT02910245|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110363410|NCT02910245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110363411|NCT02910245|Immunologic Factors|immunologic factors|mesh-ancestor
110363412|NCT02910245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110363413|NCT02910245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110363414|NCT02910245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110363415|NCT02910245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110363417|NCT02910245|Sensory System Agents|sensory system agents|mesh-ancestor
110363418|NCT02910245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110363419|NCT02910245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110363420|NCT01185340|Serotonin|serotonin|mesh-list
110363421|NCT01185340|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
110363422|NCT01185340|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110363423|NCT01185340|Serotonin Agents|serotonin agents|mesh-ancestor
110363424|NCT01185340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110363425|NCT01185340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110363426|NCT01185340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110363427|NCT01185340|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110363428|NCT01185340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110363429|NCT01959282|Niacinamide|niacinamide|mesh-list
110363430|NCT01959282|Peficitinib|peficitinib|mesh-list
110363431|NCT01959282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110363432|NCT01959282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110363433|NCT01959282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110363434|NCT01959282|Immunologic Factors|immunologic factors|mesh-ancestor
110363435|NCT01959282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110363436|NCT01959282|Vitamin B Complex|vitamin b complex|mesh-ancestor
110363437|NCT01959282|Vitamins|vitamins|mesh-ancestor
110363438|NCT01959282|Micronutrients|micronutrients|mesh-ancestor
110363439|NCT01185301|Adalimumab|adalimumab|mesh-list
110363441|NCT01185301|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110363442|NCT01185301|Abortifacient Agents|abortifacient agents|mesh-ancestor
110363443|NCT01185301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110363444|NCT01185301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110363445|NCT01185301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110363446|NCT01185301|Antimetabolites|antimetabolites|mesh-ancestor
110368801|NCT04616859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110363447|NCT01185301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110363448|NCT01185301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110363449|NCT01185301|Dermatologic Agents|dermatologic agents|mesh-ancestor
110363450|NCT01185301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110363451|NCT01185301|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110363452|NCT01185301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110363453|NCT01185301|Immunologic Factors|immunologic factors|mesh-ancestor
110363454|NCT01185301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110363455|NCT01185301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110363456|NCT01185301|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110363457|NCT01185301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110363458|NCT01216072|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
110363459|NCT01216072|Interferon beta-1b|interferon beta-1b|mesh-list
110363460|NCT01216072|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110363461|NCT01216072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110363462|NCT01216072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110363463|NCT01216072|Immunologic Factors|immunologic factors|mesh-ancestor
110363464|NCT01216072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110363465|NCT01216072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110363466|NCT01940991|Botulinum Toxins|botulinum toxins|mesh-list
110363467|NCT01940991|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110363468|NCT01940991|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110363469|NCT01940991|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110363470|NCT01940991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110363471|NCT01940991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110363472|NCT01940991|Cholinergic Agents|cholinergic agents|mesh-ancestor
110363473|NCT01940991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110363474|NCT01940991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110363475|NCT01940991|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110177517|NCT03837977|Antidotes|antidotes|mesh-ancestor
110363476|NCT01940991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110363477|NCT02909465|Midazolam|midazolam|mesh-list
110363478|NCT02909465|Ketamine|ketamine|mesh-list
110363479|NCT02909465|Haloperidol|haloperidol|mesh-list
110363480|NCT02909465|Haloperidol decanoate|haloperidol decanoate|mesh-list
110363481|NCT02909465|Analgesics|analgesics|mesh-ancestor
110363482|NCT02909465|Sensory System Agents|sensory system agents|mesh-ancestor
110363483|NCT02909465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110363484|NCT02909465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110363485|NCT02909465|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110363486|NCT02909465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110363487|NCT02909465|Anesthetics, General|anesthetics, general|mesh-ancestor
110363488|NCT02909465|Anesthetics|anesthetics|mesh-ancestor
110363489|NCT02909465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110363490|NCT02909465|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110363491|NCT02909465|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110363492|NCT02909465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110363493|NCT02909465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110363494|NCT02909465|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110363495|NCT02909465|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110363496|NCT02909465|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110363497|NCT02909465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110363498|NCT02909465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110363499|NCT02909465|GABA Modulators|gaba modulators|mesh-ancestor
110363500|NCT02909465|GABA Agents|gaba agents|mesh-ancestor
110363501|NCT02909465|Antiemetics|antiemetics|mesh-ancestor
110363502|NCT02909465|Autonomic Agents|autonomic agents|mesh-ancestor
110363503|NCT02909465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110363504|NCT02909465|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110363505|NCT02909465|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110363506|NCT02909465|Dopamine Agents|dopamine agents|mesh-ancestor
110363507|NCT02909465|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110363508|NCT04312555|Alprostadil|alprostadil|mesh-list
110363509|NCT04312555|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110363510|NCT04312555|Vasodilator Agents|vasodilator agents|mesh-ancestor
110363511|NCT04312555|Urological Agents|urological agents|mesh-ancestor
110363512|NCT01184989|Dabigatran|dabigatran|mesh-list
110363513|NCT01184989|Antithrombins|antithrombins|mesh-ancestor
110363514|NCT01184989|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110363515|NCT01184989|Protease Inhibitors|protease inhibitors|mesh-ancestor
110363516|NCT01184989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110363517|NCT01184989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110363518|NCT01184989|Anticoagulants|anticoagulants|mesh-ancestor
110363519|NCT04674423|Tenofovir|tenofovir|mesh-list
110363520|NCT04674423|Antiviral Agents|antiviral agents|mesh-ancestor
110368802|NCT04616586|Siltuximab|siltuximab|mesh-list
110363522|NCT04674423|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110363523|NCT04674423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110363524|NCT04674423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110363525|NCT04674423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110363526|NCT04674423|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110363527|NCT04674423|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110363528|NCT00555867|Anastrozole|anastrozole|mesh-list
110363529|NCT00555867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110363530|NCT00555867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110363531|NCT00555867|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110363532|NCT00555867|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110363533|NCT00555867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110363534|NCT00555867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110363535|NCT00555867|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110363536|NCT00555867|Hormone Antagonists|hormone antagonists|mesh-ancestor
110363537|NCT00555867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110363538|NCT00555867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110363539|NCT00555984|Remifentanil|remifentanil|mesh-list
110363540|NCT00555984|Propofol|propofol|mesh-list
110363541|NCT00555984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
110363542|NCT00555984|Anesthetics|anesthetics|mesh-list
110363543|NCT00555984|Sevoflurane|sevoflurane|mesh-list
110363544|NCT00555984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110363545|NCT00555984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110363547|NCT00555984|Anesthetics, General|anesthetics, general|mesh-ancestor
110363548|NCT00555984|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110363549|NCT00555984|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110363550|NCT00555984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110363551|NCT00555984|Narcotics|narcotics|mesh-ancestor
110363552|NCT00555984|Analgesics|analgesics|mesh-ancestor
110363553|NCT00555984|Sensory System Agents|sensory system agents|mesh-ancestor
110363554|NCT00555984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110363555|NCT03457337|Gefitinib|gefitinib|mesh-list
110363556|NCT03457337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110363557|NCT03457337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110363558|NCT03457337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110363559|NCT03457337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110363560|NCT01908738|Lidocaine|lidocaine|mesh-list
110363561|NCT01908738|Anesthetics, Local|anesthetics, local|mesh-ancestor
110363562|NCT01908738|Anesthetics|anesthetics|mesh-ancestor
110363563|NCT01908738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110363564|NCT01908738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110363565|NCT01908738|Sensory System Agents|sensory system agents|mesh-ancestor
110363566|NCT01908738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110363567|NCT01908738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110363568|NCT01908738|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110363569|NCT01908738|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110363570|NCT01908738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110363571|NCT01908738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110363572|NCT04673955|Cetuximab|cetuximab|mesh-list
110363573|NCT04673955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110363574|NCT04673955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110363575|NCT01904409|Rifaximin|rifaximin|mesh-list
110363576|NCT01904409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110363577|NCT01904409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110363578|NCT01904409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110363579|NCT01902381|Thioctic Acid|thioctic acid|mesh-list
110363580|NCT01902381|Antioxidants|antioxidants|mesh-ancestor
110363581|NCT01902381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110363582|NCT01902381|Protective Agents|protective agents|mesh-ancestor
110363583|NCT01902381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110363584|NCT01902381|Vitamin B Complex|vitamin b complex|mesh-ancestor
110363585|NCT01902381|Vitamins|vitamins|mesh-ancestor
110363586|NCT01902381|Micronutrients|micronutrients|mesh-ancestor
110363587|NCT04673799|Denosumab|denosumab|mesh-list
110363588|NCT04673799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110363589|NCT04673799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110363590|NCT04673487|Immunoglobulin G|immunoglobulin g|mesh-list
110363591|NCT04673487|Immunoglobulin M|immunoglobulin m|mesh-list
110363592|NCT04673487|Immunologic Factors|immunologic factors|mesh-ancestor
110363593|NCT04673487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110363594|NCT01215955|Insulin Lispro|insulin lispro|mesh-list
110363595|NCT01215955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110363596|NCT01215955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110363597|NCT01871415|Metformin|metformin|mesh-list
110363598|NCT01871415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110363599|NCT01871415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110363601|NCT05189717|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110363602|NCT05189717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110363603|NCT05189717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110363604|NCT05189717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110363605|NCT05189717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110363606|NCT05189717|Immunologic Factors|immunologic factors|mesh-ancestor
110363607|NCT05189717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110363608|NCT05189717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110363609|NCT05182463|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110363610|NCT05182463|Antiviral Agents|antiviral agents|mesh-ancestor
110363611|NCT05182463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110363612|NCT02277197|Cetuximab|cetuximab|mesh-list
110363613|NCT02277197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110363614|NCT02277197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110363615|NCT00555087|Methyltestosterone|methyltestosterone|mesh-list
110363617|NCT00555087|Testosterone undecanoate|testosterone undecanoate|mesh-list
110363618|NCT00555087|Testosterone enanthate|testosterone enanthate|mesh-list
110363619|NCT00555087|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110363620|NCT00555087|Androgens|androgens|mesh-ancestor
110363621|NCT00555087|Hormones|hormones|mesh-ancestor
110363622|NCT00555087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110363623|NCT00555087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110363624|NCT00555087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110363625|NCT00555087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110363626|NCT00555087|Anabolic Agents|anabolic agents|mesh-ancestor
110363627|NCT04673214|Acetaminophen|acetaminophen|mesh-list
110363628|NCT04673214|Azithromycin|azithromycin|mesh-list
110363629|NCT04673214|Ivermectin|ivermectin|mesh-list
110363630|NCT04673214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110363631|NCT04673214|Analgesics|analgesics|mesh-ancestor
110363632|NCT04673214|Sensory System Agents|sensory system agents|mesh-ancestor
110363633|NCT04673214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110363634|NCT04673214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110363635|NCT04673214|Antipyretics|antipyretics|mesh-ancestor
110363636|NCT04673214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110363637|NCT04673214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110363638|NCT04673214|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110363639|NCT00556023|Gemcitabine|gemcitabine|mesh-list
110363640|NCT00556023|Tremelimumab|tremelimumab|mesh-list
110363641|NCT00556023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110363642|NCT00556023|Antimetabolites|antimetabolites|mesh-ancestor
110363643|NCT00556023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110363644|NCT00556023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110363645|NCT05011214|Ketamine|ketamine|mesh-list
110363646|NCT05011214|Sevoflurane|sevoflurane|mesh-list
110363647|NCT05011214|Esketamine|esketamine|mesh-list
110363648|NCT05011214|Analgesics|analgesics|mesh-ancestor
110363649|NCT05011214|Sensory System Agents|sensory system agents|mesh-ancestor
110363650|NCT05011214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110363651|NCT05011214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110363652|NCT05011214|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110363653|NCT05011214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110363654|NCT05011214|Anesthetics, General|anesthetics, general|mesh-ancestor
110363655|NCT05011214|Anesthetics|anesthetics|mesh-ancestor
110363656|NCT05011214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110363657|NCT05011214|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110363658|NCT05011214|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110363659|NCT05011214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110363660|NCT05011214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110363661|NCT05011214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110363662|NCT05011214|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110363663|NCT05011214|Antidepressive Agents|antidepressive agents|mesh-ancestor
110363664|NCT05011214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110363665|NCT00556062|Vaccines|vaccines|mesh-list
110363666|NCT00556062|Immunologic Factors|immunologic factors|mesh-ancestor
110363667|NCT00556062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110363668|NCT04676763|Histamine|histamine|mesh-list
110363669|NCT04676763|Substance P|substance p|mesh-list
110363670|NCT04676763|Neurokinin A|neurokinin a|mesh-list
110363671|NCT04676763|Histamine Agonists|histamine agonists|mesh-ancestor
110363672|NCT04676763|Histamine Agents|histamine agents|mesh-ancestor
110363673|NCT04676763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110368803|NCT04616586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110363674|NCT04676763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110363675|NCT04676763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110363677|NCT04672707|Expectorants|expectorants|mesh-ancestor
110363678|NCT04672707|Respiratory System Agents|respiratory system agents|mesh-ancestor
110363679|NCT04932083|Fentanyl|fentanyl|mesh-list
110363680|NCT04932083|Midazolam|midazolam|mesh-list
110363681|NCT04932083|Nalbuphine|nalbuphine|mesh-list
110363682|NCT04932083|Bupivacaine|bupivacaine|mesh-list
110363683|NCT04932083|Anesthetics, Local|anesthetics, local|mesh-ancestor
110363684|NCT04932083|Anesthetics|anesthetics|mesh-ancestor
110363685|NCT04932083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110363686|NCT04932083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110363687|NCT04932083|Sensory System Agents|sensory system agents|mesh-ancestor
110363688|NCT04932083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110363690|NCT04932083|Narcotics|narcotics|mesh-ancestor
110363691|NCT04932083|Analgesics|analgesics|mesh-ancestor
110363692|NCT04932083|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110363693|NCT04932083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110363694|NCT04932083|Anesthetics, General|anesthetics, general|mesh-ancestor
110363695|NCT04932083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110363696|NCT04932083|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110363697|NCT04932083|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110363698|NCT04932083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110363699|NCT04932083|GABA Modulators|gaba modulators|mesh-ancestor
110363700|NCT04932083|GABA Agents|gaba agents|mesh-ancestor
110363701|NCT04932083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110363702|NCT04932083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110363703|NCT01825980|Ritonavir|ritonavir|mesh-list
110363704|NCT01825980|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110363705|NCT01825980|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110363706|NCT01825980|Protease Inhibitors|protease inhibitors|mesh-ancestor
110363707|NCT01825980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110363708|NCT01825980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110363709|NCT01825980|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110363710|NCT01825980|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110363711|NCT01825980|Antiviral Agents|antiviral agents|mesh-ancestor
110363712|NCT01825980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110363713|NCT01825980|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110363714|NCT01825980|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110363715|NCT04672317|Immunomodulating Agents|immunomodulating agents|mesh-list
110363716|NCT04672317|Immunologic Factors|immunologic factors|mesh-ancestor
110363717|NCT04672317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110363719|NCT04790045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110363720|NCT01655225|Pemetrexed|pemetrexed|mesh-list
110363721|NCT01655225|Letrozole|letrozole|mesh-list
110363722|NCT01655225|Fulvestrant|fulvestrant|mesh-list
110363723|NCT01655225|Midazolam|midazolam|mesh-list
110363724|NCT01655225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110363725|NCT01655225|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110363726|NCT01655225|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110363727|NCT01655225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110363728|NCT01655225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110363729|NCT01655225|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110363730|NCT01655225|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110363731|NCT01655225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110363732|NCT01655225|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110363733|NCT01655225|Anesthetics, General|anesthetics, general|mesh-ancestor
110363734|NCT01655225|Anesthetics|anesthetics|mesh-ancestor
110363735|NCT01655225|GABA Modulators|gaba modulators|mesh-ancestor
110363736|NCT01655225|GABA Agents|gaba agents|mesh-ancestor
110363737|NCT01655225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110363738|NCT01655225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110363739|NCT01655225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110363740|NCT01655225|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110363741|NCT01655225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110363742|NCT01655225|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110363743|NCT01655225|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110363744|NCT01655225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110363745|NCT01655225|Hormone Antagonists|hormone antagonists|mesh-ancestor
110363746|NCT01655225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110363747|NCT01655225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110363748|NCT01655225|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110363749|NCT01818921|CKD732|ckd732|mesh-list
110363750|NCT01818921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110363751|NCT01818921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110363752|NCT01818921|Growth Substances|growth substances|mesh-ancestor
110363753|NCT01818921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110363754|NCT01818921|Growth Inhibitors|growth inhibitors|mesh-ancestor
110363755|NCT01818921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110363756|NCT01810575|Alprostadil|alprostadil|mesh-list
110363757|NCT01810575|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110363758|NCT01810575|Vasodilator Agents|vasodilator agents|mesh-ancestor
110363759|NCT01810575|Urological Agents|urological agents|mesh-ancestor
110363760|NCT01785771|Exenatide|exenatide|mesh-list
110363761|NCT01785771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110363762|NCT01785771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110363763|NCT01785771|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110363764|NCT01785771|Incretins|incretins|mesh-ancestor
110363765|NCT01785771|Hormones|hormones|mesh-ancestor
110363766|NCT01785771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110363767|NCT01784874|Vaccines|vaccines|mesh-list
110363768|NCT01784874|Immunologic Factors|immunologic factors|mesh-ancestor
110363769|NCT01784874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110363770|NCT04607252|Metformin|metformin|mesh-list
110363771|NCT04607252|Megestrol|megestrol|mesh-list
110363772|NCT04607252|Megestrol Acetate|megestrol acetate|mesh-list
110363773|NCT04607252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110363774|NCT04607252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110363775|NCT04607252|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110363776|NCT04607252|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110363777|NCT04607252|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110363778|NCT04607252|Contraceptive Agents|contraceptive agents|mesh-ancestor
110363779|NCT04607252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110363780|NCT04607252|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110363781|NCT04607252|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110363782|NCT04607252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110363783|NCT04607252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110363784|NCT04607252|Appetite Stimulants|appetite stimulants|mesh-ancestor
110363785|NCT04607252|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110363787|NCT01782729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110363788|NCT01782729|Immunologic Factors|immunologic factors|mesh-ancestor
110363789|NCT01782729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110363791|NCT01782729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110363792|NCT01782729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110363793|NCT01780428|Acetaminophen|acetaminophen|mesh-list
110363794|NCT01780428|Promethazine|promethazine|mesh-list
110363795|NCT01780428|Diphenhydramine|diphenhydramine|mesh-list
110363796|NCT01780428|Hydrocodone|hydrocodone|mesh-list
110363797|NCT01780428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110363798|NCT01780428|Analgesics|analgesics|mesh-ancestor
110363799|NCT01780428|Sensory System Agents|sensory system agents|mesh-ancestor
110363800|NCT01780428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110363801|NCT01780428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110363802|NCT01780428|Antipyretics|antipyretics|mesh-ancestor
110363803|NCT01780428|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110363804|NCT01780428|Narcotics|narcotics|mesh-ancestor
110363805|NCT01780428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110363806|NCT01780428|Antitussive Agents|antitussive agents|mesh-ancestor
110363807|NCT01780428|Respiratory System Agents|respiratory system agents|mesh-ancestor
110363808|NCT01780428|Antipruritics|antipruritics|mesh-ancestor
110363809|NCT01780428|Dermatologic Agents|dermatologic agents|mesh-ancestor
110363810|NCT01780428|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110363811|NCT01780428|Histamine Antagonists|histamine antagonists|mesh-ancestor
110363812|NCT01780428|Histamine Agents|histamine agents|mesh-ancestor
110363813|NCT01780428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110363814|NCT01780428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110363815|NCT01780428|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110363816|NCT01780428|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110363817|NCT01780428|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110363818|NCT01780428|Anesthetics, Local|anesthetics, local|mesh-ancestor
110363819|NCT01780428|Anesthetics|anesthetics|mesh-ancestor
110363820|NCT01780428|Antiemetics|antiemetics|mesh-ancestor
110363821|NCT01780428|Autonomic Agents|autonomic agents|mesh-ancestor
110363822|NCT01780428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110363823|NCT04671420|Rituximab|rituximab|mesh-list
110363824|NCT04671420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110363825|NCT04671420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110363826|NCT04671420|Immunologic Factors|immunologic factors|mesh-ancestor
110368804|NCT04616352|Cefuroxime|cefuroxime|mesh-list
110363827|NCT04671420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110363828|NCT04671420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110363829|NCT04573556|Lemborexant|lemborexant|mesh-list
110363830|NCT04573556|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
110363831|NCT04573556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110363832|NCT04573556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110363833|NCT04573556|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110363834|NCT04573556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110363835|NCT04573556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110363836|NCT04573556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110363837|NCT04671108|Hyaluronic Acid|hyaluronic acid|mesh-list
110363838|NCT04671108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110363839|NCT04671108|Immunologic Factors|immunologic factors|mesh-ancestor
110363840|NCT04671108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110363841|NCT04671108|Viscosupplements|viscosupplements|mesh-ancestor
110363842|NCT04671108|Protective Agents|protective agents|mesh-ancestor
110363843|NCT01779453|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
110363844|NCT01779453|Atorvastatin|atorvastatin|mesh-list
110363845|NCT01779453|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110363846|NCT01779453|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110363847|NCT01779453|Antimetabolites|antimetabolites|mesh-ancestor
110363848|NCT01779453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110363849|NCT01779453|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110363850|NCT01779453|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110363851|NCT01779453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110363852|NCT01779453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110363853|NCT01779453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110363854|NCT01776606|Botulinum Toxins|botulinum toxins|mesh-list
110363855|NCT01776606|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110363856|NCT01776606|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110363857|NCT01776606|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110363858|NCT01776606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110363859|NCT01776606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110363861|NCT01776606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110363862|NCT01776606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110363863|NCT01776606|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110363864|NCT01776606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110363865|NCT04567160|Propofol|propofol|mesh-list
110363866|NCT04567160|Sevoflurane|sevoflurane|mesh-list
110363867|NCT04567160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110363868|NCT04567160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110363869|NCT04567160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110363870|NCT04567160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110363871|NCT04567160|Anesthetics, General|anesthetics, general|mesh-ancestor
110363872|NCT04567160|Anesthetics|anesthetics|mesh-ancestor
110363873|NCT04567160|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110363874|NCT04567160|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110363875|NCT01774578|Gemcitabine|gemcitabine|mesh-list
110363876|NCT01774578|Docetaxel|docetaxel|mesh-list
110363877|NCT01774578|Pemetrexed|pemetrexed|mesh-list
110363878|NCT01774578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110363879|NCT01774578|Antimetabolites|antimetabolites|mesh-ancestor
110363880|NCT01774578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110363881|NCT01774578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110363882|NCT01774578|Tubulin Modulators|tubulin modulators|mesh-ancestor
110363883|NCT01774578|Antimitotic Agents|antimitotic agents|mesh-ancestor
110363884|NCT01774578|Mitosis Modulators|mitosis modulators|mesh-ancestor
110363885|NCT01774578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110363886|NCT01774578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110363887|NCT01774578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110363888|NCT04543994|Remestemcel-l|remestemcel-l|mesh-list
110363889|NCT04543994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110363890|NCT04543994|Antiviral Agents|antiviral agents|mesh-ancestor
110363891|NCT04543994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110363892|NCT04670601|Flurbiprofen|flurbiprofen|mesh-list
110363893|NCT04670601|Analgesics|analgesics|mesh-ancestor
110363894|NCT04670601|Sensory System Agents|sensory system agents|mesh-ancestor
110363895|NCT04670601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110363896|NCT04670601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110363897|NCT04670601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110363898|NCT04670601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110363899|NCT04670601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110363900|NCT04670601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110363901|NCT04670601|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110363902|NCT04670601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110363903|NCT04670601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110363905|NCT04670913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110363906|NCT04670913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110363907|NCT04670913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110363908|NCT04670913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110363909|NCT04671069|Clopidogrel|clopidogrel|mesh-list
110363910|NCT04671069|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110363911|NCT04671069|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110363912|NCT04671069|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110363913|NCT04671069|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110363914|NCT04671069|Purinergic Agents|purinergic agents|mesh-ancestor
110363915|NCT04671069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110363916|NCT04671069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110363917|NCT04671069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110363918|NCT04322123|Azithromycin|azithromycin|mesh-list
110363919|NCT04322123|Hydroxychloroquine|hydroxychloroquine|mesh-list
110363920|NCT04322123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110363921|NCT04322123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110363923|NCT04322123|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110363924|NCT04322123|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110363925|NCT04322123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110363926|NCT04322123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110363927|NCT04322123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110363929|NCT04259138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110363930|NCT01741155|Docetaxel|docetaxel|mesh-list
110363931|NCT01741155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110363932|NCT01741155|Tubulin Modulators|tubulin modulators|mesh-ancestor
110363933|NCT01741155|Antimitotic Agents|antimitotic agents|mesh-ancestor
110363934|NCT01741155|Mitosis Modulators|mitosis modulators|mesh-ancestor
110363935|NCT01741155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110363936|NCT04244630|Antioxidants|antioxidants|mesh-list
110363937|NCT04244630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110363938|NCT04244630|Protective Agents|protective agents|mesh-ancestor
110363939|NCT04244630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110363940|NCT04239053|Bupivacaine|bupivacaine|mesh-list
110363941|NCT04239053|Anesthetics, Local|anesthetics, local|mesh-ancestor
110363942|NCT04239053|Anesthetics|anesthetics|mesh-ancestor
110363943|NCT04239053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110363944|NCT04239053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110363945|NCT04239053|Sensory System Agents|sensory system agents|mesh-ancestor
110363946|NCT04239053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110363947|NCT01718145|Ribavirin|ribavirin|mesh-list
110363948|NCT01718145|Asunaprevir|asunaprevir|mesh-list
110363949|NCT01718145|Antimetabolites|antimetabolites|mesh-ancestor
110363950|NCT01718145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110363951|NCT01718145|Antiviral Agents|antiviral agents|mesh-ancestor
110363952|NCT01718145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110363953|NCT01718145|Protease Inhibitors|protease inhibitors|mesh-ancestor
110363954|NCT01718145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110363955|NCT00556257|Cyclosporine|cyclosporine|mesh-list
110363956|NCT00556257|Cyclosporins|cyclosporins|mesh-list
110363957|NCT00556257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110363958|NCT00556257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110363959|NCT00556257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110363960|NCT00556257|Immunologic Factors|immunologic factors|mesh-ancestor
110363961|NCT00556257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110363962|NCT00556257|Antifungal Agents|antifungal agents|mesh-ancestor
110363963|NCT00556257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110363964|NCT00556257|Dermatologic Agents|dermatologic agents|mesh-ancestor
110363965|NCT00556257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110363966|NCT00556257|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110363968|NCT01712451|Xhance|xhance|mesh-list
110363969|NCT01712451|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110363970|NCT01712451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110363971|NCT01712451|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110363972|NCT01712451|Autonomic Agents|autonomic agents|mesh-ancestor
110363973|NCT01712451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110363974|NCT01712451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110363975|NCT01712451|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110363976|NCT01712451|Respiratory System Agents|respiratory system agents|mesh-ancestor
110363977|NCT01712451|Dermatologic Agents|dermatologic agents|mesh-ancestor
110363978|NCT01712451|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110363979|NCT01712451|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110363980|NCT01712451|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110363981|NCT01712451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110363982|NCT01712451|Adrenergic Agents|adrenergic agents|mesh-ancestor
110363983|NCT01712451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110363984|NCT01712451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110363985|NCT01712217|Crizotinib|crizotinib|mesh-list
110363986|NCT01712217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110363987|NCT01712217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110363988|NCT01712217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110363989|NCT01712217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110363990|NCT04669158|Idebenone|idebenone|mesh-list
110363991|NCT04669158|Antioxidants|antioxidants|mesh-ancestor
110363992|NCT04669158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110363993|NCT04669158|Protective Agents|protective agents|mesh-ancestor
110363994|NCT04669158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110363995|NCT04669821|Propofol|propofol|mesh-list
110363996|NCT04669821|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110363997|NCT04669821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110363998|NCT04669821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110363999|NCT04669821|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110364000|NCT04669821|Anesthetics, General|anesthetics, general|mesh-ancestor
110364002|NCT00532025|Sorafenib|sorafenib|mesh-list
110364003|NCT00532025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110364004|NCT00532025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110364005|NCT00532025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110364006|NCT00532025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110364008|NCT04669392|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110364009|NCT04669392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110364010|NCT04669392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110364011|NCT04669392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110364012|NCT00532142|Triamcinolone|triamcinolone|mesh-list
110364013|NCT00532142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110364014|NCT00532142|Glucocorticoids|glucocorticoids|mesh-ancestor
110364015|NCT00532142|Hormones|hormones|mesh-ancestor
110364016|NCT00532142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110364017|NCT00532142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110364018|NCT00533312|Niacin|niacin|mesh-list
110364019|NCT00533312|Niacinamide|niacinamide|mesh-list
110364020|NCT00533312|Nicotinic Acids|nicotinic acids|mesh-list
110364021|NCT00533312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110364023|NCT00533312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110364024|NCT00533312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110364025|NCT00533312|Vasodilator Agents|vasodilator agents|mesh-ancestor
110364026|NCT00533312|Vitamin B Complex|vitamin b complex|mesh-ancestor
110364027|NCT00533312|Vitamins|vitamins|mesh-ancestor
110364028|NCT00533312|Micronutrients|micronutrients|mesh-ancestor
110364029|NCT00533312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110364030|NCT00533390|Efavirenz|efavirenz|mesh-list
110364031|NCT00533390|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110364032|NCT00533390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110364033|NCT00533390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110364034|NCT00533390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110364035|NCT00533390|Antiviral Agents|antiviral agents|mesh-ancestor
110364036|NCT00533390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110364037|NCT00533390|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110364038|NCT00533390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110364039|NCT00533390|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110364040|NCT00533390|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110364041|NCT00533390|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110364042|NCT00533390|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110364043|NCT00556296|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
110364044|NCT00556296|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110364045|NCT00556296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177614|NCT00140452|Thalidomide|thalidomide|mesh-list
110364046|NCT00556296|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110364047|NCT00556296|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110364048|NCT00556296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110364049|NCT00556296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110364050|NCT00556296|Dopamine Agents|dopamine agents|mesh-ancestor
110364051|NCT00556296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110364052|NCT04668456|Lidocaine|lidocaine|mesh-list
110364053|NCT04668456|Dexmedetomidine|dexmedetomidine|mesh-list
110364054|NCT04668456|Anesthetics, Local|anesthetics, local|mesh-ancestor
110364055|NCT04668456|Anesthetics|anesthetics|mesh-ancestor
110364056|NCT04668456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110364057|NCT04668456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110364058|NCT04668456|Sensory System Agents|sensory system agents|mesh-ancestor
110364059|NCT04668456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110364060|NCT04668456|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110364061|NCT04668456|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110364062|NCT04668456|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110364063|NCT04668456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110364064|NCT04668456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110364065|NCT04668456|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110364066|NCT04668456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110364067|NCT04668456|Analgesics|analgesics|mesh-ancestor
110364068|NCT04668456|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110364069|NCT04668456|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110364070|NCT04668456|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110364071|NCT04668456|Adrenergic Agents|adrenergic agents|mesh-ancestor
110364072|NCT04668456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110364073|NCT04693169|Choline|choline|mesh-list
110364074|NCT04693169|Lipotropic Agents|lipotropic agents|mesh-ancestor
110364075|NCT04693169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110364076|NCT04693169|Antimetabolites|antimetabolites|mesh-ancestor
110364077|NCT04693169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110364078|NCT04693169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110364079|NCT04693169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110364080|NCT04693169|Nootropic Agents|nootropic agents|mesh-ancestor
110364081|NCT04668417|Vaccines|vaccines|mesh-list
110364082|NCT04668417|Immunologic Factors|immunologic factors|mesh-ancestor
110018710|NCT02345772|Pertuzumab|pertuzumab|mesh-list
110364083|NCT04668417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110364084|NCT00556413|Leucovorin|leucovorin|mesh-list
110364085|NCT00556413|Fluorouracil|fluorouracil|mesh-list
110364086|NCT00556413|Oxaliplatin|oxaliplatin|mesh-list
110364087|NCT00556413|Irinotecan|irinotecan|mesh-list
110364088|NCT00556413|Cetuximab|cetuximab|mesh-list
110364089|NCT00556413|Calcium|calcium|mesh-list
110364090|NCT00556413|Levoleucovorin|levoleucovorin|mesh-list
110364091|NCT00556413|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110364092|NCT00556413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110364093|NCT00556413|Antimetabolites|antimetabolites|mesh-ancestor
110364094|NCT00556413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110364095|NCT00556413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110364096|NCT00556413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110364097|NCT00556413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110364098|NCT00556413|Immunologic Factors|immunologic factors|mesh-ancestor
110364099|NCT00556413|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110364100|NCT00556413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110364101|NCT00556413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110364102|NCT00556413|Antidotes|antidotes|mesh-ancestor
110364103|NCT00556413|Protective Agents|protective agents|mesh-ancestor
110364104|NCT00556413|Vitamin B Complex|vitamin b complex|mesh-ancestor
110364105|NCT00556413|Vitamins|vitamins|mesh-ancestor
110364106|NCT00556413|Micronutrients|micronutrients|mesh-ancestor
110364107|NCT00556413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110364108|NCT04668690|Mitoxantrone|mitoxantrone|mesh-list
110364109|NCT04668690|Analgesics|analgesics|mesh-ancestor
110364110|NCT04668690|Sensory System Agents|sensory system agents|mesh-ancestor
110364111|NCT04668690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110364112|NCT04668690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110364113|NCT04668690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110364114|NCT04668690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110364115|NCT04668690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110364116|NCT04668690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110364117|NCT04668690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110364119|NCT00533585|Bevacizumab|bevacizumab|mesh-list
110364120|NCT00533585|Carboplatin|carboplatin|mesh-list
110364122|NCT00533585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110364123|NCT00533585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110364124|NCT00533585|Tubulin Modulators|tubulin modulators|mesh-ancestor
110364125|NCT00533585|Antimitotic Agents|antimitotic agents|mesh-ancestor
110364126|NCT00533585|Mitosis Modulators|mitosis modulators|mesh-ancestor
110364127|NCT00533585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110364128|NCT00533585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110364129|NCT00533585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110364130|NCT00533585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110364131|NCT00533585|Growth Substances|growth substances|mesh-ancestor
110364132|NCT00533585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110364133|NCT00533585|Growth Inhibitors|growth inhibitors|mesh-ancestor
110364134|NCT00533585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110364135|NCT00533585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110364146|NCT04659057|Dexmedetomidine|dexmedetomidine|mesh-list
110364147|NCT04659057|Anesthetics, Local|anesthetics, local|mesh-ancestor
110364148|NCT04659057|Anesthetics|anesthetics|mesh-ancestor
110364149|NCT04659057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110364150|NCT04659057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110364151|NCT04659057|Sensory System Agents|sensory system agents|mesh-ancestor
110364152|NCT04659057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110364153|NCT04659057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110364154|NCT04659057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110364155|NCT04659057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110364156|NCT04659057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110364157|NCT04659057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110364158|NCT04659057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110364159|NCT04659057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110364160|NCT04659057|Analgesics|analgesics|mesh-ancestor
110364161|NCT04659057|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110364162|NCT04659057|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110364163|NCT04659057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110364164|NCT04659057|Adrenergic Agents|adrenergic agents|mesh-ancestor
110364165|NCT04659057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110364166|NCT00533741|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110364167|NCT00533741|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110364168|NCT00533741|Immunologic Factors|immunologic factors|mesh-ancestor
110018865|NCT01602198|Rivastigmine|rivastigmine|mesh-list
110364169|NCT00533741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110364171|NCT00533741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110364173|NCT00533858|Losartan|losartan|mesh-list
110364174|NCT00533858|Lacidipine|lacidipine|mesh-list
110364175|NCT00533858|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110364176|NCT00533858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110364177|NCT00533858|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110364178|NCT00533858|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110364179|NCT00533858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110364180|NCT00533858|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110364181|NCT00533858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110364182|NCT00533858|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110364183|NCT00533858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110364184|NCT04658355|Chlorhexidine|chlorhexidine|mesh-list
110364185|NCT04658355|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110364186|NCT04658355|Povidone-Iodine|povidone-iodine|mesh-list
110364188|NCT04658355|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110364189|NCT04658355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110364190|NCT04658355|Disinfectants|disinfectants|mesh-ancestor
110364191|NCT04658355|Dermatologic Agents|dermatologic agents|mesh-ancestor
110364192|NCT04658355|Plasma Substitutes|plasma substitutes|mesh-ancestor
110364193|NCT04658355|Blood Substitutes|blood substitutes|mesh-ancestor
110364195|NCT00533936|Cyclophosphamide|cyclophosphamide|mesh-list
110364196|NCT00533936|Doxorubicin|doxorubicin|mesh-list
110364197|NCT00533936|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110364198|NCT00533936|Fluorouracil|fluorouracil|mesh-list
110364199|NCT00533936|Trastuzumab|trastuzumab|mesh-list
110364200|NCT00533936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110364201|NCT00533936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110364203|NCT00533936|Antimitotic Agents|antimitotic agents|mesh-ancestor
110364204|NCT00533936|Mitosis Modulators|mitosis modulators|mesh-ancestor
110364205|NCT00533936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110364206|NCT00533936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110364207|NCT00533936|Immunologic Factors|immunologic factors|mesh-ancestor
110364208|NCT00533936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110364209|NCT00533936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110364210|NCT00533936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110364211|NCT00533936|Alkylating Agents|alkylating agents|mesh-ancestor
110364212|NCT00533936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110364213|NCT00533936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110364214|NCT00533936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110364215|NCT00533936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110364216|NCT00533936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110364217|NCT00533936|Antimetabolites|antimetabolites|mesh-ancestor
110364218|NCT00533936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110364219|NCT00533936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110364220|NCT00557544|Ketoprofen|ketoprofen|mesh-list
110364221|NCT00557544|Metoclopramide|metoclopramide|mesh-list
110364223|NCT00557544|Autonomic Agents|autonomic agents|mesh-ancestor
110364224|NCT00557544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110364225|NCT00557544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110364226|NCT00557544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110364227|NCT00557544|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110364228|NCT00557544|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110364230|NCT00557544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110364231|NCT00557544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110364232|NCT00557544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110364233|NCT00557544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110364234|NCT00557544|Analgesics|analgesics|mesh-ancestor
110364235|NCT00557544|Sensory System Agents|sensory system agents|mesh-ancestor
110364236|NCT00557544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110364237|NCT00557544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110364238|NCT00557544|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110364239|NCT00557544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110364240|NCT04667910|Ranibizumab|ranibizumab|mesh-list
110364241|NCT04667910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110364242|NCT04667910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110364243|NCT04667910|Growth Substances|growth substances|mesh-ancestor
110364244|NCT04667910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110364245|NCT04667910|Growth Inhibitors|growth inhibitors|mesh-ancestor
110364246|NCT04667910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110364247|NCT00556608|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110364248|NCT00556608|Hyaluronic Acid|hyaluronic acid|mesh-list
110364249|NCT00556608|Hylan|hylan|mesh-list
110364250|NCT00556608|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110364251|NCT00556608|Immunologic Factors|immunologic factors|mesh-ancestor
110364252|NCT00556608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110364253|NCT00556608|Viscosupplements|viscosupplements|mesh-ancestor
110364254|NCT00556608|Protective Agents|protective agents|mesh-ancestor
110364255|NCT00534287|Moxifloxacin|moxifloxacin|mesh-list
110364256|NCT00534287|Meropenem|meropenem|mesh-list
110364257|NCT00534287|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110364258|NCT00534287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110364259|NCT00534287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110364260|NCT00534287|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110364261|NCT00534287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110364262|NCT00534287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110364263|NCT00534287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110364264|NCT00534287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110364265|NCT00534287|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110364266|NCT00534287|Contraceptive Agents|contraceptive agents|mesh-ancestor
110364267|NCT00534287|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110364268|NCT00534287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110364269|NCT00534287|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110364270|NCT00534287|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110364271|NCT00534287|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110364272|NCT04168502|Gemtuzumab|gemtuzumab|mesh-list
110364273|NCT04168502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110364274|NCT04168502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110364276|NCT04168502|Immunoconjugates|immunoconjugates|mesh-ancestor
110364277|NCT04168502|Immunologic Factors|immunologic factors|mesh-ancestor
110364278|NCT04168502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110364279|NCT01215916|Pemetrexed|pemetrexed|mesh-list
110364280|NCT01215916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110364281|NCT01215916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110364282|NCT01215916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110364283|NCT01215916|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110364284|NCT01215916|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110364285|NCT01184872|Vancomycin|vancomycin|mesh-list
110364286|NCT01184872|Daptomycin|daptomycin|mesh-list
110364287|NCT01184872|Penicillins|penicillins|mesh-list
110364288|NCT01184872|Floxacillin|floxacillin|mesh-list
110364289|NCT01184872|Cloxacillin|cloxacillin|mesh-list
110364290|NCT01184872|Oxacillin|oxacillin|mesh-list
110364291|NCT01184872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110364292|NCT01184872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110364293|NCT01215721|Solifenacin Succinate|solifenacin succinate|mesh-list
110364294|NCT01215721|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110364295|NCT01215721|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110364296|NCT01215721|Cholinergic Agents|cholinergic agents|mesh-ancestor
110364297|NCT01215721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110364298|NCT01215721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110364299|NCT01215721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110364300|NCT01215721|Urological Agents|urological agents|mesh-ancestor
110364301|NCT04666623|Esketamine|esketamine|mesh-list
110364302|NCT04666623|Antidepressive Agents|antidepressive agents|mesh-ancestor
110364303|NCT04666623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110364304|NCT00534677|Octreotide|octreotide|mesh-list
110364305|NCT00534677|Terlipressin|terlipressin|mesh-list
110364306|NCT00534677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110364307|NCT00534677|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110364308|NCT00534677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110364309|NCT00534677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110364310|NCT00534677|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110364311|NCT00556959|Clonidine|clonidine|mesh-list
110364312|NCT00556959|Analgesics|analgesics|mesh-ancestor
110364313|NCT00556959|Sensory System Agents|sensory system agents|mesh-ancestor
110364314|NCT00556959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110364315|NCT00556959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110364316|NCT00556959|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110364317|NCT00556959|Sympatholytics|sympatholytics|mesh-ancestor
110364318|NCT00556959|Autonomic Agents|autonomic agents|mesh-ancestor
110364319|NCT00556959|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110364320|NCT00556959|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110364321|NCT00556959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110364322|NCT00556959|Adrenergic Agents|adrenergic agents|mesh-ancestor
110364323|NCT00556959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110364324|NCT00556959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110364326|NCT01184326|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110364327|NCT01184326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110364328|NCT01184326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110177648|NCT00140647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110364329|NCT01184326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110364330|NCT01184326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110364331|NCT01184326|Immunologic Factors|immunologic factors|mesh-ancestor
110364332|NCT01184326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110364333|NCT01184326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110364334|NCT01215253|Ranolazine|ranolazine|mesh-list
110364335|NCT01215253|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110364336|NCT01215253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110364337|NCT01215253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110364338|NCT01184053|Arsenic Trioxide|arsenic trioxide|mesh-list
110364339|NCT01184053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110364340|NCT03813875|Fentanyl|fentanyl|mesh-list
110364341|NCT03813875|Midazolam|midazolam|mesh-list
110364342|NCT03813875|Alfentanil|alfentanil|mesh-list
110364343|NCT03813875|Propofol|propofol|mesh-list
110364344|NCT03813875|Sevoflurane|sevoflurane|mesh-list
110364345|NCT03813875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110364346|NCT03813875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110364347|NCT03813875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110364348|NCT03813875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110364349|NCT03813875|Anesthetics, General|anesthetics, general|mesh-ancestor
110364350|NCT03813875|Anesthetics|anesthetics|mesh-ancestor
110364351|NCT03813875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110364352|NCT03813875|Narcotics|narcotics|mesh-ancestor
110364353|NCT03813875|Analgesics|analgesics|mesh-ancestor
110364354|NCT03813875|Sensory System Agents|sensory system agents|mesh-ancestor
110364355|NCT03813875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110364356|NCT03813875|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110364357|NCT03813875|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110364358|NCT03813875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110364359|NCT03813875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110364360|NCT03813875|GABA Modulators|gaba modulators|mesh-ancestor
110364361|NCT03813875|GABA Agents|gaba agents|mesh-ancestor
110364362|NCT03813875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110364363|NCT03813875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110364364|NCT03813875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110364365|NCT03813875|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110364366|NCT01183858|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110364367|NCT01183858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110364368|NCT01183858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110364369|NCT01183858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110364370|NCT01183858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110364372|NCT05449522|Vitamins|vitamins|mesh-ancestor
110364373|NCT05449522|Micronutrients|micronutrients|mesh-ancestor
110364374|NCT05449522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110364375|NCT05449522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110364376|NCT04665609|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110364377|NCT03737981|Venetoclax|venetoclax|mesh-list
110364378|NCT03737981|Obinutuzumab|obinutuzumab|mesh-list
110364379|NCT03737981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110364380|NCT03737981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110364381|NCT04665141|Omalizumab|omalizumab|mesh-list
110364382|NCT04665141|Benralizumab|benralizumab|mesh-list
110364383|NCT04665141|Reslizumab|reslizumab|mesh-list
110364384|NCT04665141|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110364385|NCT04665141|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110364386|NCT04665141|Respiratory System Agents|respiratory system agents|mesh-ancestor
110364387|NCT04665063|Cyclophosphamide|cyclophosphamide|mesh-list
110364388|NCT04665063|Fludarabine|fludarabine|mesh-list
110364389|NCT04665063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110364390|NCT04665063|Immunologic Factors|immunologic factors|mesh-ancestor
110364391|NCT04665063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110364392|NCT04665063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110364393|NCT04665063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110364394|NCT04665063|Alkylating Agents|alkylating agents|mesh-ancestor
110364395|NCT04665063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110364396|NCT04665063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110364397|NCT04665063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110364398|NCT04664595|Propofol|propofol|mesh-list
110364399|NCT04664595|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110364400|NCT04664595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110364401|NCT04664595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110364402|NCT04664595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110364403|NCT04664595|Anesthetics, General|anesthetics, general|mesh-ancestor
110364404|NCT04664595|Anesthetics|anesthetics|mesh-ancestor
110364405|NCT01215175|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110364406|NCT01215175|Immunologic Factors|immunologic factors|mesh-ancestor
110364407|NCT01215175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110364408|NCT03580148|Cortisone|cortisone|mesh-list
110364409|NCT03580148|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110364410|NCT03580148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110364411|NCT04664517|Anesthetics|anesthetics|mesh-list
110364412|NCT04664517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110364413|NCT04664517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110364415|NCT05335915|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110364416|NCT05335915|Autonomic Agents|autonomic agents|mesh-ancestor
110364417|NCT05335915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110364418|NCT05335915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110364419|NCT05335915|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110364420|NCT05335915|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110364421|NCT05335915|Cholinergic Agents|cholinergic agents|mesh-ancestor
110364422|NCT05335915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110364423|NCT05335915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110364424|NCT01215097|Linagliptin|linagliptin|mesh-list
110364425|NCT01215097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110364426|NCT01215097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110364427|NCT01215097|Incretins|incretins|mesh-ancestor
110364429|NCT01215097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110364430|NCT01215097|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110364431|NCT01215097|Protease Inhibitors|protease inhibitors|mesh-ancestor
110364432|NCT01215097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110364433|NCT01215097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110364434|NCT03527576|Dexamethasone|dexamethasone|mesh-list
110364435|NCT03527576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110364436|NCT03527576|Antiemetics|antiemetics|mesh-ancestor
110364437|NCT03527576|Autonomic Agents|autonomic agents|mesh-ancestor
110364438|NCT03527576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110364439|NCT03527576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110364440|NCT03527576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110364441|NCT03527576|Glucocorticoids|glucocorticoids|mesh-ancestor
110364442|NCT03527576|Hormones|hormones|mesh-ancestor
110364443|NCT03527576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110364444|NCT03527576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110364446|NCT04664010|Vitamins|vitamins|mesh-list
110364447|NCT04664010|Ascorbic Acid|ascorbic acid|mesh-list
110364448|NCT04664010|Interferons|interferons|mesh-list
110364449|NCT04664010|Ribavirin|ribavirin|mesh-list
110364450|NCT04664010|Interferon-alpha|interferon-alpha|mesh-list
110364451|NCT04664010|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
110364452|NCT04664010|Micronutrients|micronutrients|mesh-ancestor
110364453|NCT04664010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110364454|NCT04664010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110364455|NCT04664010|Antiviral Agents|antiviral agents|mesh-ancestor
110364456|NCT04664010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110364457|NCT04664010|Antimetabolites|antimetabolites|mesh-ancestor
110364458|NCT04664010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110364459|NCT04664010|Immunologic Factors|immunologic factors|mesh-ancestor
110364460|NCT04664010|Antioxidants|antioxidants|mesh-ancestor
110364461|NCT04664010|Protective Agents|protective agents|mesh-ancestor
110364462|NCT04664127|Valacyclovir|valacyclovir|mesh-list
110364463|NCT04664127|Antiviral Agents|antiviral agents|mesh-ancestor
110364464|NCT04664127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110364465|NCT04664088|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110364466|NCT04664088|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110364467|NCT04664088|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110364468|NCT04664088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110364469|NCT04664088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110364470|NCT04664088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110364471|NCT04664088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110364472|NCT04664088|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110364473|NCT04664088|Antidepressive Agents|antidepressive agents|mesh-ancestor
110364474|NCT04664088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110364475|NCT04664244|Nimotuzumab|nimotuzumab|mesh-list
110364476|NCT04664244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110364477|NCT04664244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110364478|NCT04663386|Budesonide|budesonide|mesh-list
110364479|NCT04663386|Formoterol Fumarate|formoterol fumarate|mesh-list
110364480|NCT04663386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110364481|NCT04663386|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110364482|NCT04663386|Autonomic Agents|autonomic agents|mesh-ancestor
110364483|NCT04663386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110364484|NCT04663386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110364485|NCT04663386|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110364486|NCT04663386|Respiratory System Agents|respiratory system agents|mesh-ancestor
110364487|NCT04663386|Glucocorticoids|glucocorticoids|mesh-ancestor
110364488|NCT04663386|Hormones|hormones|mesh-ancestor
110364489|NCT04663386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110364490|NCT04663386|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110364491|NCT04663386|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110364492|NCT04663386|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110364493|NCT04663386|Adrenergic Agents|adrenergic agents|mesh-ancestor
110364494|NCT04663386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110364495|NCT04663386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110364496|NCT04663269|Dexamethasone|dexamethasone|mesh-list
110364497|NCT04663269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110364498|NCT04663269|Antiemetics|antiemetics|mesh-ancestor
110364499|NCT04663269|Autonomic Agents|autonomic agents|mesh-ancestor
110364500|NCT04663269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110364501|NCT04663269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110364502|NCT04663269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110364503|NCT04663269|Glucocorticoids|glucocorticoids|mesh-ancestor
110364504|NCT04663269|Hormones|hormones|mesh-ancestor
110364505|NCT04663269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110364506|NCT04663269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110364507|NCT04663269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110364508|NCT03312738|Everolimus|everolimus|mesh-list
110364509|NCT03312738|Exemestane|exemestane|mesh-list
110364510|NCT03312738|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110364511|NCT03312738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110364512|NCT03312738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110364513|NCT03312738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110364514|NCT03312738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110364515|NCT03312738|Immunologic Factors|immunologic factors|mesh-ancestor
110364516|NCT03312738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110364517|NCT03312738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110364518|NCT03312738|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110364519|NCT03312738|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110364520|NCT03312738|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110364521|NCT03312738|Hormone Antagonists|hormone antagonists|mesh-ancestor
110364522|NCT03312738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110364523|NCT03303339|Cytarabine|cytarabine|mesh-list
110364524|NCT03303339|Decitabine|decitabine|mesh-list
110364525|NCT03303339|Onvansertib|onvansertib|mesh-list
110364526|NCT03303339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110364527|NCT03303339|Antimetabolites|antimetabolites|mesh-ancestor
110364528|NCT03303339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110364529|NCT03303339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110364530|NCT03303339|Antiviral Agents|antiviral agents|mesh-ancestor
110364531|NCT03303339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110364532|NCT03303339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110364533|NCT03303339|Immunologic Factors|immunologic factors|mesh-ancestor
110364534|NCT03303339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110364535|NCT03303339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110364536|NCT03303339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110364537|NCT03422471|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110364538|NCT03422471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110364539|NCT03299946|Nivolumab|nivolumab|mesh-list
110364540|NCT03299946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110364541|NCT03299946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110364542|NCT03299946|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110364543|NCT03299946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110364544|NCT00535340|Amibegron|amibegron|mesh-list
110364545|NCT00535340|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
110364546|NCT00535340|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110364547|NCT00535340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110364548|NCT00535340|Adrenergic Agents|adrenergic agents|mesh-ancestor
110364549|NCT00535340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110364550|NCT00535340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110364551|NCT00535340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110364552|NCT00535340|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110364553|NCT00535379|Sunitinib|sunitinib|mesh-list
110364554|NCT00535379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110364555|NCT00535379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110364556|NCT00535379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110364557|NCT00535379|Growth Substances|growth substances|mesh-ancestor
110364558|NCT00535379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110364559|NCT00535379|Growth Inhibitors|growth inhibitors|mesh-ancestor
110364560|NCT00535379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110364561|NCT00535379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110364562|NCT00535379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110364564|NCT00535418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110364565|NCT00535418|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110364566|NCT00535418|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110364567|NCT00535418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110364568|NCT00535418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110364570|NCT00535418|Hormone Antagonists|hormone antagonists|mesh-ancestor
110364571|NCT00535418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110364572|NCT00535418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110364574|NCT04679064|Bevacizumab|bevacizumab|mesh-list
110364575|NCT04679064|Gemcitabine|gemcitabine|mesh-list
110364577|NCT04679064|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110364578|NCT04679064|Topotecan|topotecan|mesh-list
110364579|NCT04679064|Niraparib|niraparib|mesh-list
110364580|NCT04679064|Dostarlimab|dostarlimab|mesh-list
110364581|NCT04679064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110364582|NCT04679064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110364583|NCT04679064|Tubulin Modulators|tubulin modulators|mesh-ancestor
110364584|NCT04679064|Antimitotic Agents|antimitotic agents|mesh-ancestor
110364585|NCT04679064|Mitosis Modulators|mitosis modulators|mesh-ancestor
110364586|NCT04679064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110364587|NCT04679064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110364588|NCT04679064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110364589|NCT04679064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110364590|NCT04679064|Growth Substances|growth substances|mesh-ancestor
110364591|NCT04679064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110364592|NCT04679064|Growth Inhibitors|growth inhibitors|mesh-ancestor
110364593|NCT04679064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110364594|NCT04679064|Antimetabolites|antimetabolites|mesh-ancestor
110364595|NCT04679064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110364596|NCT04679064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110364597|NCT04679064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110364598|NCT04679064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110364599|NCT04679064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110364600|NCT04679064|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110364602|NCT01183780|Folic Acid|folic acid|mesh-list
110364603|NCT01183780|Fluorouracil|fluorouracil|mesh-list
110364604|NCT01183780|Irinotecan|irinotecan|mesh-list
110364605|NCT01183780|Ramucirumab|ramucirumab|mesh-list
110364606|NCT01183780|Levoleucovorin|levoleucovorin|mesh-list
110364607|NCT01183780|Antimetabolites|antimetabolites|mesh-ancestor
110364608|NCT01183780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110364609|NCT01183780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110364610|NCT01183780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110364611|NCT01183780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110364612|NCT01183780|Immunologic Factors|immunologic factors|mesh-ancestor
110364613|NCT01183780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110364614|NCT01183780|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110364615|NCT01183780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110364616|NCT01183780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110364617|NCT01183780|Antidotes|antidotes|mesh-ancestor
110364618|NCT01183780|Protective Agents|protective agents|mesh-ancestor
110364619|NCT01183780|Vitamin B Complex|vitamin b complex|mesh-ancestor
110364620|NCT01183780|Vitamins|vitamins|mesh-ancestor
110364621|NCT01183780|Micronutrients|micronutrients|mesh-ancestor
110364622|NCT01183780|Hematinics|hematinics|mesh-ancestor
110364623|NCT04679103|Eculizumab|eculizumab|mesh-list
110364624|NCT04679103|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110364625|NCT04679103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110364626|NCT04679103|Immunologic Factors|immunologic factors|mesh-ancestor
110364627|NCT04679103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110364628|NCT00535574|Bexarotene|bexarotene|mesh-list
110364629|NCT00535574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110364630|NCT04678830|Leronlimab|leronlimab|mesh-list
110364631|NCT04678830|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110364632|NCT04678830|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110364633|NCT04678830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110364634|NCT04678830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110364635|NCT04678830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110364637|NCT04678830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110364638|NCT01183468|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
110364639|NCT01183468|Protein C Inhibitor|protein c inhibitor|mesh-list
110364640|NCT01183468|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110364641|NCT01183468|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110364642|NCT01183468|Protease Inhibitors|protease inhibitors|mesh-ancestor
110364643|NCT01183468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110364644|NCT01183468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110364646|NCT03245021|Nivolumab|nivolumab|mesh-list
110364647|NCT03245021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110364648|NCT03245021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110364649|NCT03245021|Immunologic Factors|immunologic factors|mesh-ancestor
110364650|NCT03245021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110364651|NCT03245021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110364652|NCT03245021|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110364653|NCT03245021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110364655|NCT04678791|Nimotuzumab|nimotuzumab|mesh-list
110364656|NCT04678791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110364657|NCT04678791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110364658|NCT01183390|Anastrozole|anastrozole|mesh-list
110364659|NCT01183390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110364660|NCT01183390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110364661|NCT01183390|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110364662|NCT01183390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110364663|NCT01183390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110364664|NCT01183390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110364665|NCT01183390|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110364666|NCT01183390|Hormone Antagonists|hormone antagonists|mesh-ancestor
110364667|NCT01183390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110364668|NCT01183390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110364670|NCT02887807|Cyclosporins|cyclosporins|mesh-list
110364671|NCT02887807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110364672|NCT02887807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110364673|NCT02887807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110364674|NCT02887807|Immunologic Factors|immunologic factors|mesh-ancestor
110364675|NCT02887807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110364676|NCT02887807|Antifungal Agents|antifungal agents|mesh-ancestor
110364677|NCT02887807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110364678|NCT02887807|Dermatologic Agents|dermatologic agents|mesh-ancestor
110364679|NCT02887807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110364680|NCT02887807|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110364681|NCT04663035|Tislelizumab|tislelizumab|mesh-list
110364682|NCT04663035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110364683|NCT04663035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110364685|NCT03098589|Immunologic Factors|immunologic factors|mesh-ancestor
110364686|NCT03098589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110364687|NCT03098589|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110364688|NCT03098589|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110364689|NCT03098589|Growth Substances|growth substances|mesh-ancestor
110364690|NCT03098589|Growth Inhibitors|growth inhibitors|mesh-ancestor
110364691|NCT03098589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110364692|NCT04662177|Dexmedetomidine|dexmedetomidine|mesh-list
110364693|NCT04662177|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110364694|NCT04662177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110364695|NCT04662177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110364696|NCT04662177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110364697|NCT04662177|Analgesics|analgesics|mesh-ancestor
110364698|NCT04662177|Sensory System Agents|sensory system agents|mesh-ancestor
110364699|NCT04662177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110364700|NCT04662177|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110364701|NCT04662177|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110364702|NCT04662177|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110364703|NCT04662177|Adrenergic Agents|adrenergic agents|mesh-ancestor
110364704|NCT04662177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110364705|NCT04662177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110364706|NCT03026517|Phenformin|phenformin|mesh-list
110364707|NCT03026517|Trametinib|trametinib|mesh-list
110364708|NCT03026517|Dabrafenib|dabrafenib|mesh-list
110364709|NCT03026517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110364710|NCT03026517|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110364711|NCT03026517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110364712|NCT03026517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110364713|NCT03026517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110364714|NCT03026517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110364715|NCT00537953|Miltefosine|miltefosine|mesh-list
110364716|NCT00537953|Meglumine Antimoniate|meglumine antimoniate|mesh-list
110364717|NCT00537953|Antifungal Agents|antifungal agents|mesh-ancestor
110364718|NCT00537953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110364719|NCT00537953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110364720|NCT00537953|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110364721|NCT00537953|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110364722|NCT04662138|Antiviral Agents|antiviral agents|mesh-list
110364723|NCT04662138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110364724|NCT05226299|Capsaicin|capsaicin|mesh-list
110364725|NCT05226299|Antipruritics|antipruritics|mesh-ancestor
110364726|NCT05226299|Dermatologic Agents|dermatologic agents|mesh-ancestor
110364727|NCT05226299|Sensory System Agents|sensory system agents|mesh-ancestor
110364728|NCT05226299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110364729|NCT05226299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110364731|NCT00557232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110364732|NCT00557232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110364733|NCT00557232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110364734|NCT00557232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110364735|NCT00557232|Growth Substances|growth substances|mesh-ancestor
110364736|NCT00557232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110364737|NCT00557232|Growth Inhibitors|growth inhibitors|mesh-ancestor
110364738|NCT02797119|Tranexamic Acid|tranexamic acid|mesh-list
110364739|NCT02797119|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110364740|NCT02797119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110364741|NCT02797119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110364742|NCT02797119|Hemostatics|hemostatics|mesh-ancestor
110364743|NCT02797119|Coagulants|coagulants|mesh-ancestor
110364744|NCT05161208|Varenicline|varenicline|mesh-list
110364745|NCT05161208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110364746|NCT05161208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110364747|NCT05161208|Cholinergic Agents|cholinergic agents|mesh-ancestor
110364748|NCT05161208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110364749|NCT05161208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110364750|NCT05161208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110364751|NCT00538070|Glycine|glycine|mesh-list
110364752|NCT00538070|Glycine Agents|glycine agents|mesh-ancestor
110364753|NCT00538070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110364754|NCT00538070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110364755|NCT00538070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110364757|NCT00538109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110364758|NCT00538109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110364759|NCT00538109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110364760|NCT00538109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110364761|NCT00538148|Telithromycin|telithromycin|mesh-list
110364762|NCT00538148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110364763|NCT00538148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110364764|NCT04661670|Salicylic Acid|salicylic acid|mesh-list
110364765|NCT04661670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110364766|NCT04661670|Antifungal Agents|antifungal agents|mesh-ancestor
110364767|NCT04661670|Keratolytic Agents|keratolytic agents|mesh-ancestor
110364768|NCT04661670|Dermatologic Agents|dermatologic agents|mesh-ancestor
110364769|NCT05110391|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110364770|NCT05110391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110364771|NCT05110391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110364772|NCT00538187|Bortezomib|bortezomib|mesh-list
110364773|NCT00538187|Obatoclax|obatoclax|mesh-list
110364774|NCT00538187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110364775|NCT00538187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110364776|NCT00538187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110364777|NCT04661709|Aspirin|aspirin|mesh-list
110364778|NCT04661709|Metoprolol|metoprolol|mesh-list
110364779|NCT04661709|Isosorbide|isosorbide|mesh-list
110364780|NCT04661709|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
110364781|NCT04661709|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
110364782|NCT04661709|Nitroglycerin|nitroglycerin|mesh-list
110364783|NCT04661709|Trimetazidine|trimetazidine|mesh-list
110364784|NCT04661709|Clopidogrel|clopidogrel|mesh-list
110364785|NCT04661709|Atorvastatin|atorvastatin|mesh-list
110364786|NCT04661709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110364787|NCT04661709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110364788|NCT04661709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110364789|NCT04661709|Analgesics|analgesics|mesh-ancestor
110364790|NCT04661709|Sensory System Agents|sensory system agents|mesh-ancestor
110364791|NCT04661709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110364792|NCT04661709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110364793|NCT04661709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110364794|NCT04661709|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110364795|NCT04661709|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110364796|NCT04661709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110364797|NCT04661709|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110364798|NCT04661709|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110364799|NCT04661709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110364800|NCT04661709|Antipyretics|antipyretics|mesh-ancestor
110364801|NCT04661709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110364802|NCT04661709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110364803|NCT04661709|Antimetabolites|antimetabolites|mesh-ancestor
110364804|NCT04661709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110364805|NCT04661709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110364806|NCT04661709|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110364807|NCT04661709|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110364808|NCT04661709|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110364809|NCT04661709|Purinergic Agents|purinergic agents|mesh-ancestor
110364810|NCT04661709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110364811|NCT04661709|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110364812|NCT04661709|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110364813|NCT04661709|Sympatholytics|sympatholytics|mesh-ancestor
110364814|NCT04661709|Autonomic Agents|autonomic agents|mesh-ancestor
110364815|NCT04661709|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110364816|NCT04661709|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110364817|NCT04661709|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110364818|NCT04661709|Adrenergic Agents|adrenergic agents|mesh-ancestor
110364819|NCT04661709|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110364820|NCT04661709|Diuretics|diuretics|mesh-ancestor
110364821|NCT04661709|Natriuretic Agents|natriuretic agents|mesh-ancestor
110364822|NCT04661709|Vasodilator Agents|vasodilator agents|mesh-ancestor
110364823|NCT04661709|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110364824|NCT02466867|Naftifine|naftifine|mesh-list
110364825|NCT02466867|Antifungal Agents|antifungal agents|mesh-ancestor
110364826|NCT02466867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110364827|NCT00538265|Mycophenolic Acid|mycophenolic acid|mesh-list
110364828|NCT00538265|Tacrolimus|tacrolimus|mesh-list
110364829|NCT00538265|Thymoglobulin|thymoglobulin|mesh-list
110364830|NCT00538265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110364831|NCT00538265|Immunologic Factors|immunologic factors|mesh-ancestor
110364832|NCT00538265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110364833|NCT00538265|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110364834|NCT00538265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110364835|NCT00538265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110364836|NCT00538265|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110364837|NCT00538265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110364838|NCT00538265|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110364839|NCT00538265|Antitubercular Agents|antitubercular agents|mesh-ancestor
110364840|NCT00538265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110364841|NCT00538265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110364842|NCT02462811|Acetaminophen|acetaminophen|mesh-list
110364843|NCT02462811|Promethazine|promethazine|mesh-list
110364844|NCT02462811|Diphenhydramine|diphenhydramine|mesh-list
110364845|NCT02462811|Hydrocodone|hydrocodone|mesh-list
110364846|NCT02462811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110364847|NCT02462811|Analgesics|analgesics|mesh-ancestor
110364848|NCT02462811|Sensory System Agents|sensory system agents|mesh-ancestor
110364849|NCT02462811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110364850|NCT02462811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110364851|NCT02462811|Antipyretics|antipyretics|mesh-ancestor
110364852|NCT02462811|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110364853|NCT02462811|Narcotics|narcotics|mesh-ancestor
110364854|NCT02462811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110364855|NCT02462811|Antitussive Agents|antitussive agents|mesh-ancestor
110364856|NCT02462811|Respiratory System Agents|respiratory system agents|mesh-ancestor
110364857|NCT02462811|Antipruritics|antipruritics|mesh-ancestor
110364858|NCT02462811|Dermatologic Agents|dermatologic agents|mesh-ancestor
110364859|NCT02462811|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110364860|NCT02462811|Histamine Antagonists|histamine antagonists|mesh-ancestor
110364861|NCT02462811|Histamine Agents|histamine agents|mesh-ancestor
110364862|NCT02462811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110364863|NCT02462811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110364864|NCT02462811|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110364865|NCT02462811|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110364866|NCT02462811|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110364867|NCT02462811|Anesthetics, Local|anesthetics, local|mesh-ancestor
110364868|NCT02462811|Anesthetics|anesthetics|mesh-ancestor
110364869|NCT02462811|Antiemetics|antiemetics|mesh-ancestor
110364870|NCT02462811|Autonomic Agents|autonomic agents|mesh-ancestor
110364871|NCT02462811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110364872|NCT00538382|Artesunate|artesunate|mesh-list
110364873|NCT00538382|Antimalarials|antimalarials|mesh-ancestor
110364874|NCT00538382|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110364875|NCT00538382|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110364876|NCT00538382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110364877|NCT00538382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110364878|NCT00538382|Antiviral Agents|antiviral agents|mesh-ancestor
110364879|NCT00538382|Schistosomicides|schistosomicides|mesh-ancestor
110364880|NCT00538382|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110364881|NCT00538382|Anthelmintics|anthelmintics|mesh-ancestor
110364882|NCT00538421|Propofol|propofol|mesh-list
110364883|NCT00538421|Sevoflurane|sevoflurane|mesh-list
110364884|NCT00538421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110364885|NCT00538421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110364886|NCT00538421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110364887|NCT00538421|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110364888|NCT00538421|Anesthetics, General|anesthetics, general|mesh-ancestor
110364889|NCT00538421|Anesthetics|anesthetics|mesh-ancestor
110364890|NCT00538421|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110364891|NCT00538421|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110364892|NCT04661475|Dexmedetomidine|dexmedetomidine|mesh-list
110364893|NCT04661475|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110364894|NCT04661475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110364895|NCT04661475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110364896|NCT04661475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110364897|NCT04661475|Analgesics|analgesics|mesh-ancestor
110364898|NCT04661475|Sensory System Agents|sensory system agents|mesh-ancestor
110364899|NCT04661475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110364900|NCT04661475|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110364901|NCT04661475|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110364902|NCT04661475|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110364903|NCT04661475|Adrenergic Agents|adrenergic agents|mesh-ancestor
110364904|NCT04661475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110364905|NCT04661475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110364906|NCT00538499|Fentanyl|fentanyl|mesh-list
110364907|NCT00538499|Bupivacaine|bupivacaine|mesh-list
110364908|NCT00538499|Anesthetics, Local|anesthetics, local|mesh-ancestor
110364909|NCT00538499|Anesthetics|anesthetics|mesh-ancestor
110364910|NCT00538499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110364911|NCT00538499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110364912|NCT00538499|Sensory System Agents|sensory system agents|mesh-ancestor
110364913|NCT00538499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110364914|NCT00538499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110364916|NCT00538499|Analgesics|analgesics|mesh-ancestor
110364917|NCT00538499|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110364918|NCT00538499|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110364919|NCT00538499|Anesthetics, General|anesthetics, general|mesh-ancestor
110364920|NCT00538538|Ranibizumab|ranibizumab|mesh-list
110364921|NCT00538538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110177727|NCT00141193|Celecoxib|celecoxib|mesh-list
110364922|NCT00538538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110364923|NCT00538538|Growth Substances|growth substances|mesh-ancestor
110364924|NCT00538538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110364925|NCT00538538|Growth Inhibitors|growth inhibitors|mesh-ancestor
110364926|NCT00538538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110364927|NCT00554346|Etoricoxib|etoricoxib|mesh-list
110364928|NCT00554346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110364929|NCT00554346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110364930|NCT00554346|Analgesics|analgesics|mesh-ancestor
110364931|NCT00554346|Sensory System Agents|sensory system agents|mesh-ancestor
110364932|NCT00554346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110364933|NCT00554346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110364934|NCT00554346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110364935|NCT00554346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110364936|NCT00554346|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110364937|NCT00554346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110364938|NCT00554346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110364939|NCT00554346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110364940|NCT00538655|Modafinil|modafinil|mesh-list
110364941|NCT00538655|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110364942|NCT00538655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110364943|NCT00538655|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110364944|NCT00538655|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110364945|NCT00538655|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110364946|NCT00538655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110364947|NCT00538694|Daptomycin|daptomycin|mesh-list
110364948|NCT00538694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110364949|NCT00538694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110364950|NCT02436096|Cyclobenzaprine|cyclobenzaprine|mesh-list
110364951|NCT02436096|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110364952|NCT02436096|Antidepressive Agents|antidepressive agents|mesh-ancestor
110364953|NCT02436096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110364954|NCT02436096|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110364955|NCT02436096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110364956|NCT02436096|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110364957|NCT02436096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110364958|NCT02436096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110364959|NCT02436096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110364961|NCT00538811|Ribavirin|ribavirin|mesh-list
110364962|NCT00538811|Interferon-alpha|interferon-alpha|mesh-list
110364963|NCT00538811|Interferon alpha-2|interferon alpha-2|mesh-list
110364964|NCT00538811|Interferon-gamma|interferon-gamma|mesh-list
110364966|NCT00538811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110364967|NCT00538811|Antiviral Agents|antiviral agents|mesh-ancestor
110364968|NCT00538811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110364969|NCT00538811|Antimetabolites|antimetabolites|mesh-ancestor
110364970|NCT00538811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110364971|NCT00538811|Immunologic Factors|immunologic factors|mesh-ancestor
110364972|NCT00538811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110364973|NCT00538811|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110364974|NCT00538811|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110364975|NCT00538811|Dopamine Agents|dopamine agents|mesh-ancestor
110364976|NCT00538811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110369429|NCT01165021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110369431|NCT01165021|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110364977|NCT00538811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110364978|NCT00538811|Analgesics|analgesics|mesh-ancestor
110364979|NCT00538811|Sensory System Agents|sensory system agents|mesh-ancestor
110364980|NCT00538811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110364981|NCT04660773|Pregabalin|pregabalin|mesh-list
110364982|NCT04660773|Analgesics|analgesics|mesh-ancestor
110364984|NCT04660773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110364985|NCT04660773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110364986|NCT04660773|Anticonvulsants|anticonvulsants|mesh-ancestor
110364987|NCT04660773|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110364988|NCT04660773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110364989|NCT04660773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110364990|NCT04660773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110364991|NCT04660773|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110364992|NCT04660773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110369559|NCT04629846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110369561|NCT01909427|Methotrexate|methotrexate|mesh-list
110364993|NCT04660773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110364994|NCT04660773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110364995|NCT00538889|Citalopram|citalopram|mesh-list
110364996|NCT00538889|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110364997|NCT00538889|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110364998|NCT00538889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110364999|NCT00538889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110365000|NCT00538889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110365001|NCT00538889|Serotonin Agents|serotonin agents|mesh-ancestor
110365002|NCT00538889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365003|NCT00538889|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110365004|NCT00538889|Antidepressive Agents|antidepressive agents|mesh-ancestor
110365005|NCT00538889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110365006|NCT02413827|Ipilimumab|ipilimumab|mesh-list
110369618|NCT01873703|Azacitidine|azacitidine|mesh-list
110365007|NCT02413827|Poly ICLC|poly iclc|mesh-list
110365008|NCT02413827|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110369619|NCT01873703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110369620|NCT01873703|Antimetabolites|antimetabolites|mesh-ancestor
110365009|NCT02413827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110365010|NCT02413827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110365011|NCT02413827|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110365012|NCT02413827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110365013|NCT02413827|Interferon Inducers|interferon inducers|mesh-ancestor
110365014|NCT02413827|Immunologic Factors|immunologic factors|mesh-ancestor
110365015|NCT02413827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365016|NCT00538967|Doxycycline|doxycycline|mesh-list
110365017|NCT00538967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110365018|NCT00538967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110369672|NCT01847573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110365019|NCT00538967|Antimalarials|antimalarials|mesh-ancestor
110365020|NCT00538967|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110369673|NCT01847573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110365022|NCT00539123|Buprenorphine|buprenorphine|mesh-list
110365023|NCT00539123|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110365024|NCT00539123|Narcotics|narcotics|mesh-ancestor
110365025|NCT00539123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110365026|NCT00539123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365027|NCT00539123|Analgesics|analgesics|mesh-ancestor
110365028|NCT00539123|Sensory System Agents|sensory system agents|mesh-ancestor
110365029|NCT00539123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110365030|NCT00539123|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110369733|NCT01804829|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110365031|NCT02382510|Tiotropium Bromide|tiotropium bromide|mesh-list
110365032|NCT02382510|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110365034|NCT02382510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110369735|NCT01804829|Immunoglobulin G|immunoglobulin g|mesh-list
110365035|NCT02382510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365036|NCT02382510|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110365037|NCT02382510|Respiratory System Agents|respiratory system agents|mesh-ancestor
110365038|NCT02382510|Parasympatholytics|parasympatholytics|mesh-ancestor
110365039|NCT02382510|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110365041|NCT02382510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110369874|NCT04608669|Acetaminophen|acetaminophen|mesh-list
110365042|NCT02382510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110365043|NCT00539396|Insulin|insulin|mesh-list
110365044|NCT00539396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110365045|NCT00539396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365046|NCT00539435|Insulin|insulin|mesh-list
110365047|NCT00539435|Insulin Aspart|insulin aspart|mesh-list
110365048|NCT00539435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110365049|NCT00539435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365050|NCT00539630|Docetaxel|docetaxel|mesh-list
110365051|NCT00539630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110365052|NCT00539630|Tubulin Modulators|tubulin modulators|mesh-ancestor
110365053|NCT00539630|Antimitotic Agents|antimitotic agents|mesh-ancestor
110369936|NCT01858883|Antimetabolites|antimetabolites|mesh-ancestor
110365054|NCT00539630|Mitosis Modulators|mitosis modulators|mesh-ancestor
110365055|NCT00539630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110365056|NCT04660461|Lansoprazole|lansoprazole|mesh-list
110365057|NCT04660461|Dexlansoprazole|dexlansoprazole|mesh-list
110365058|NCT04660461|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110365059|NCT04660461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110365060|NCT04660461|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110365061|NCT04660461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110365062|NCT04660461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110365063|NCT00539669|Docetaxel|docetaxel|mesh-list
110365064|NCT00539669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110370142|NCT00555347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365065|NCT00539669|Tubulin Modulators|tubulin modulators|mesh-ancestor
110365066|NCT00539669|Antimitotic Agents|antimitotic agents|mesh-ancestor
110365067|NCT00539669|Mitosis Modulators|mitosis modulators|mesh-ancestor
110365068|NCT00539669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110365069|NCT00554424|Lidocaine|lidocaine|mesh-list
110365070|NCT00554424|Anesthetics, Local|anesthetics, local|mesh-ancestor
110365071|NCT00554424|Anesthetics|anesthetics|mesh-ancestor
110365072|NCT00554424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110365073|NCT00554424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365074|NCT00554424|Sensory System Agents|sensory system agents|mesh-ancestor
110365075|NCT00554424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110365076|NCT00554424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110365077|NCT00554424|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110365078|NCT00554424|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110370205|NCT05305300|Somatomedin B|somatomedin b|mesh-list
110370206|NCT05305300|Immunologic Factors|immunologic factors|mesh-ancestor
110365079|NCT00554424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110365080|NCT00554424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110365081|NCT04660305|Insulin Aspart|insulin aspart|mesh-list
110365082|NCT04660305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110365083|NCT04660305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365084|NCT00554502|Immunosuppressive Agents|immunosuppressive agents|mesh-list
110260187|NCT00145340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365085|NCT00554502|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110365086|NCT00554502|Immunologic Factors|immunologic factors|mesh-ancestor
110365087|NCT00554502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365088|NCT00554502|Protease Inhibitors|protease inhibitors|mesh-ancestor
110365089|NCT00554502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110365090|NCT00554502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110365091|NCT00539786|Rabeprazole|rabeprazole|mesh-list
110365092|NCT00539786|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
110365093|NCT00539786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110365094|NCT00539786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110365095|NCT00539786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110365096|NCT00539786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110365097|NCT00540098|Paroxetine|paroxetine|mesh-list
110365098|NCT00540098|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110365099|NCT00540098|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110365100|NCT00540098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110365101|NCT00540098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110365102|NCT00540098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110365104|NCT00540098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365105|NCT00540098|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110365106|NCT00540098|Antidepressive Agents|antidepressive agents|mesh-ancestor
110365107|NCT00540098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110365108|NCT00540098|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110365109|NCT00540098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110365110|NCT00540098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110365112|NCT00540137|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110365113|NCT00540137|Nevirapine|nevirapine|mesh-list
110365114|NCT00540137|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110365115|NCT00540137|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110365116|NCT00540137|Protease Inhibitors|protease inhibitors|mesh-ancestor
110365117|NCT00540137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110365118|NCT00540137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110365120|NCT00540137|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110365121|NCT00540137|Antiviral Agents|antiviral agents|mesh-ancestor
110365122|NCT00540137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110370321|NCT01161472|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110365123|NCT00540137|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110365124|NCT00540137|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110365125|NCT00540137|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110365126|NCT00540137|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110365127|NCT00540137|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110370379|NCT01160770|GABA Agonists|gaba agonists|mesh-ancestor
110365128|NCT00540137|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110365129|NCT04660110|Piperaquine|piperaquine|mesh-list
110365130|NCT04660110|Artenimol|artenimol|mesh-list
110365131|NCT04660110|Antimalarials|antimalarials|mesh-ancestor
110365132|NCT04660110|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110365133|NCT04660110|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110365134|NCT04660110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110365135|NCT02336685|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110365136|NCT02336685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365137|NCT02336685|Immunologic Factors|immunologic factors|mesh-ancestor
110365138|NCT00540410|Artesunate|artesunate|mesh-list
110365139|NCT00540410|Lumefantrine|lumefantrine|mesh-list
110365140|NCT00540410|Amodiaquine|amodiaquine|mesh-list
110365141|NCT00540410|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110370534|NCT04631315|Hormones|hormones|mesh-ancestor
110365142|NCT00540410|Antimalarials|antimalarials|mesh-ancestor
110365143|NCT00540410|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110365144|NCT00540410|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110365145|NCT00540410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110365146|NCT00540410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110365147|NCT00540410|Antiviral Agents|antiviral agents|mesh-ancestor
110365148|NCT00540410|Schistosomicides|schistosomicides|mesh-ancestor
110365149|NCT00540410|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110365150|NCT00540410|Anthelmintics|anthelmintics|mesh-ancestor
110365151|NCT00540527|Plasminogen|plasminogen|mesh-list
110365152|NCT00540527|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110365153|NCT00540527|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110365154|NCT00540527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110365155|NCT00540527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110365157|NCT00540605|Antiviral Agents|antiviral agents|mesh-ancestor
110365158|NCT00540605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110365159|NCT00540605|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110365160|NCT00540605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110365161|NCT00540605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110365162|NCT00540605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110365163|NCT00540605|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110365164|NCT00540605|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110365165|NCT04659915|Metformin|metformin|mesh-list
110365166|NCT04659915|Prednisone|prednisone|mesh-list
110365167|NCT04659915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110365168|NCT04659915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370856|NCT04626752|Immunologic Factors|immunologic factors|mesh-ancestor
110365169|NCT04659915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110365170|NCT04659915|Glucocorticoids|glucocorticoids|mesh-ancestor
110365171|NCT04659915|Hormones|hormones|mesh-ancestor
110365172|NCT04659915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110365173|NCT04659915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110365174|NCT04659915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110365175|NCT00557427|Fluoxetine|fluoxetine|mesh-list
110365176|NCT00557427|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110370930|NCT01154452|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
110370931|NCT01154452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110365177|NCT00557427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110365178|NCT00557427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110365179|NCT00557427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110365180|NCT00557427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110365181|NCT00557427|Serotonin Agents|serotonin agents|mesh-ancestor
110365182|NCT00557427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370996|NCT00565383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110365183|NCT00557427|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110365184|NCT00557427|Antidepressive Agents|antidepressive agents|mesh-ancestor
110365185|NCT00557427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110365186|NCT00557427|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110365187|NCT00557427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110365188|NCT00557427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110365189|NCT00540800|Docetaxel|docetaxel|mesh-list
110365190|NCT00540800|Capecitabine|capecitabine|mesh-list
110365191|NCT00540800|Epirubicin|epirubicin|mesh-list
110365192|NCT00540800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110365193|NCT00540800|Tubulin Modulators|tubulin modulators|mesh-ancestor
110365194|NCT00540800|Antimitotic Agents|antimitotic agents|mesh-ancestor
110365195|NCT00540800|Mitosis Modulators|mitosis modulators|mesh-ancestor
110365196|NCT00540800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110365197|NCT00540800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110365198|NCT00540800|Antimetabolites|antimetabolites|mesh-ancestor
110371199|NCT04313218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365199|NCT00540800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110365200|NCT00540800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110365201|NCT00540800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110365202|NCT00540800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110365203|NCT00540956|Cytarabine|cytarabine|mesh-list
110365204|NCT00540956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110365205|NCT00540956|Antimetabolites|antimetabolites|mesh-ancestor
110371266|NCT04622891|Azithromycin|azithromycin|mesh-list
110365206|NCT00540956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110371267|NCT04622891|Clarithromycin|clarithromycin|mesh-list
110371275|NCT04622579|Rituximab|rituximab|mesh-list
110365208|NCT00540956|Antiviral Agents|antiviral agents|mesh-ancestor
110365209|NCT00540956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110365210|NCT00540956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110365211|NCT00540956|Immunologic Factors|immunologic factors|mesh-ancestor
110365212|NCT00540956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365213|NCT00541073|Vitamin B 12|vitamin b 12|mesh-list
110365214|NCT00541073|Hydroxocobalamin|hydroxocobalamin|mesh-list
110371329|NCT04621370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110365215|NCT00541073|Pemetrexed|pemetrexed|mesh-list
110365216|NCT00541073|Vitamins|vitamins|mesh-ancestor
110365217|NCT00541073|Micronutrients|micronutrients|mesh-ancestor
110365218|NCT00541073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365219|NCT00541073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110365220|NCT00541073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110365221|NCT00541073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110365222|NCT00541073|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110365223|NCT00541073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110365224|NCT00541073|Vitamin B Complex|vitamin b complex|mesh-ancestor
110365225|NCT00541073|Hematinics|hematinics|mesh-ancestor
110365226|NCT00541112|Leucovorin|leucovorin|mesh-list
110371394|NCT04649697|Clobetasol|clobetasol|mesh-list
110365227|NCT00541112|Fluorouracil|fluorouracil|mesh-list
110365228|NCT00541112|Capecitabine|capecitabine|mesh-list
110365229|NCT00541112|Oxaliplatin|oxaliplatin|mesh-list
110365231|NCT00541112|Calcium|calcium|mesh-list
110365232|NCT00541112|Levoleucovorin|levoleucovorin|mesh-list
110365233|NCT00541112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110365234|NCT00541112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365236|NCT00541112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110365237|NCT00541112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110365238|NCT00541112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110365239|NCT00541112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110365240|NCT00541112|Immunologic Factors|immunologic factors|mesh-ancestor
110365241|NCT00541112|Antidotes|antidotes|mesh-ancestor
110365242|NCT00541112|Protective Agents|protective agents|mesh-ancestor
110365243|NCT00541112|Vitamin B Complex|vitamin b complex|mesh-ancestor
110365244|NCT00541112|Vitamins|vitamins|mesh-ancestor
110365245|NCT00541112|Micronutrients|micronutrients|mesh-ancestor
110365246|NCT00541112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110365247|NCT04659525|Ezetimibe|ezetimibe|mesh-list
110365248|NCT04659525|Evolocumab|evolocumab|mesh-list
110365249|NCT04659525|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110365250|NCT04659525|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110365251|NCT04659525|Antimetabolites|antimetabolites|mesh-ancestor
110365252|NCT04659525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110371517|NCT04619303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110371518|NCT04619303|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110371519|NCT04619303|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110371520|NCT04619303|Growth Substances|growth substances|mesh-ancestor
110371521|NCT04619303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110371522|NCT04619303|Growth Inhibitors|growth inhibitors|mesh-ancestor
110371523|NCT04619303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110365253|NCT04659525|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110365254|NCT04659525|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110365255|NCT04659525|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110365256|NCT04659525|Protease Inhibitors|protease inhibitors|mesh-ancestor
110365257|NCT04659525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110365258|NCT02333643|Digoxin|digoxin|mesh-list
110365259|NCT02333643|Furosemide|furosemide|mesh-list
110365260|NCT02333643|Diuretics|diuretics|mesh-ancestor
110365261|NCT02333643|Natriuretic Agents|natriuretic agents|mesh-ancestor
110365262|NCT02333643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365263|NCT02333643|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110365264|NCT02333643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110365265|NCT02333643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110365266|NCT02333643|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110365267|NCT02333643|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110365268|NCT02333643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110365269|NCT02333643|Protective Agents|protective agents|mesh-ancestor
110365270|NCT00541463|Nelfinavir|nelfinavir|mesh-list
110365271|NCT00541463|Indinavir|indinavir|mesh-list
110365272|NCT00541463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110365273|NCT00541463|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110365274|NCT00541463|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110365275|NCT00541463|Protease Inhibitors|protease inhibitors|mesh-ancestor
110365276|NCT00541463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110365277|NCT00541463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110365278|NCT00541463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110365279|NCT00541463|Antiviral Agents|antiviral agents|mesh-ancestor
110365280|NCT00541463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110365281|NCT02324985|Ibuprofen|ibuprofen|mesh-list
110365282|NCT02324985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110371647|NCT04619069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365284|NCT02324985|Analgesics|analgesics|mesh-ancestor
110365285|NCT02324985|Sensory System Agents|sensory system agents|mesh-ancestor
110365286|NCT02324985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110365287|NCT02324985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365288|NCT02324985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110365289|NCT02324985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110365290|NCT02324985|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110365291|NCT02324985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110365292|NCT02324985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110365293|NCT04659642|Fentanyl|fentanyl|mesh-list
110365294|NCT04659642|Dexmedetomidine|dexmedetomidine|mesh-list
110365295|NCT04659642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110371696|NCT05035316|Antipyretics|antipyretics|mesh-ancestor
110371697|NCT04618601|Spironolactone|spironolactone|mesh-list
110260188|NCT00168909|Alfacalcidol|alfacalcidol|mesh-list
110371698|NCT04618601|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110365296|NCT04659642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110365297|NCT04659642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365298|NCT04659642|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110365299|NCT04659642|Analgesics|analgesics|mesh-ancestor
110365300|NCT04659642|Sensory System Agents|sensory system agents|mesh-ancestor
110365301|NCT04659642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110365302|NCT04659642|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110365303|NCT04659642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110365304|NCT04659642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110371754|NCT00567957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110371755|NCT00567957|Narcotics|narcotics|mesh-ancestor
110365305|NCT04659642|Adrenergic Agents|adrenergic agents|mesh-ancestor
110365306|NCT04659642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110365307|NCT04659642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110365308|NCT04659642|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110365310|NCT04659642|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110365311|NCT04659642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110365312|NCT04659642|Anesthetics, General|anesthetics, general|mesh-ancestor
110365313|NCT04659642|Anesthetics|anesthetics|mesh-ancestor
110365314|NCT00541736|Nitroglycerin|nitroglycerin|mesh-list
110371819|NCT02939495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110365315|NCT00541736|Vasodilator Agents|vasodilator agents|mesh-ancestor
110365317|NCT00541814|Cyclosporins|cyclosporins|mesh-list
110365318|NCT00541814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110365319|NCT00541814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110365320|NCT00541814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110365321|NCT00541814|Immunologic Factors|immunologic factors|mesh-ancestor
110365322|NCT00541814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365323|NCT00541814|Antifungal Agents|antifungal agents|mesh-ancestor
110371884|NCT04610879|Sensory System Agents|sensory system agents|mesh-ancestor
110365324|NCT00541814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110365325|NCT00541814|Dermatologic Agents|dermatologic agents|mesh-ancestor
110365326|NCT00541814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110365327|NCT00541814|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110365328|NCT00541853|Candesartan|candesartan|mesh-list
110365329|NCT00541853|Candesartan cilexetil|candesartan cilexetil|mesh-list
110365331|NCT00541853|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110365332|NCT00541853|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110365333|NCT00541853|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110365334|NCT00541853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110365335|NCT00541853|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110365336|NCT00541853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110365337|NCT00541853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110365338|NCT00541853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365339|NCT02301234|Celecoxib|celecoxib|mesh-list
110365340|NCT02301234|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110365341|NCT02301234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110371949|NCT00563147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110365342|NCT02301234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110365343|NCT02301234|Analgesics|analgesics|mesh-ancestor
110365344|NCT02301234|Sensory System Agents|sensory system agents|mesh-ancestor
110365345|NCT02301234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110365346|NCT02301234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365347|NCT02301234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110365348|NCT02301234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110365349|NCT02301234|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110365350|NCT02301234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110365351|NCT02301234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110365352|NCT02301234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110365353|NCT02301234|Immunologic Factors|immunologic factors|mesh-ancestor
110365354|NCT02300142|Vaccines|vaccines|mesh-list
110365355|NCT02300142|Immunologic Factors|immunologic factors|mesh-ancestor
110365356|NCT02300142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365357|NCT01214668|Doxorubicin|doxorubicin|mesh-list
110372005|NCT04614584|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110365358|NCT01214668|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110365359|NCT01214668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110365360|NCT01214668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110365361|NCT01214668|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110365362|NCT01214668|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110365363|NCT01214668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110365364|NCT01214668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110365365|NCT00542126|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110365366|NCT00542126|Luteolytic Agents|luteolytic agents|mesh-ancestor
110365367|NCT00542126|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110365368|NCT00542126|Contraceptive Agents|contraceptive agents|mesh-ancestor
110365369|NCT00542126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110372065|NCT00563342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110365370|NCT00542126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365371|NCT00542126|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110365372|NCT00542126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110365373|NCT00542126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110365374|NCT00542165|Alfuzosin|alfuzosin|mesh-list
110365375|NCT00542165|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110365376|NCT00542165|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110365377|NCT00542165|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110365378|NCT00542165|Adrenergic Agents|adrenergic agents|mesh-ancestor
110365379|NCT00542165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110365380|NCT00542165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110365381|NCT00542165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372123|NCT04613180|Hormone Antagonists|hormone antagonists|mesh-ancestor
110365382|NCT00542165|Urological Agents|urological agents|mesh-ancestor
110372125|NCT04613180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365383|NCT00542243|Finasteride|finasteride|mesh-list
110365384|NCT00542243|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110365385|NCT00542243|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110365386|NCT00542243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110365387|NCT00542243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110365388|NCT00542243|Hormone Antagonists|hormone antagonists|mesh-ancestor
110365389|NCT00542243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110365390|NCT00542243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365391|NCT00542243|Urological Agents|urological agents|mesh-ancestor
110365392|NCT00542399|Insulin Detemir|insulin detemir|mesh-list
110372186|NCT00572208|Antimanic Agents|antimanic agents|mesh-ancestor
110365393|NCT00542399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110365394|NCT00542399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365395|NCT00542555|Naproxen|naproxen|mesh-list
110365396|NCT00542555|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
110372245|NCT04611464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372246|NCT04611464|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110365397|NCT00542555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110365398|NCT00542555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110365399|NCT00542555|Analgesics|analgesics|mesh-ancestor
110365400|NCT00542555|Sensory System Agents|sensory system agents|mesh-ancestor
110365401|NCT00542555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110365402|NCT00542555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365403|NCT00542555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110365404|NCT00542555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110365405|NCT00542555|Gout Suppressants|gout suppressants|mesh-ancestor
110365406|NCT00542555|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110365407|NCT00542555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110365408|NCT00542555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110365409|NCT00542555|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110365411|NCT00542711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110365412|NCT00542711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110365413|NCT00542711|Analgesics|analgesics|mesh-ancestor
110372311|NCT00575406|Glucocorticoids|glucocorticoids|mesh-ancestor
110372312|NCT00575406|Hormones|hormones|mesh-ancestor
110372313|NCT00575406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110365414|NCT00542711|Sensory System Agents|sensory system agents|mesh-ancestor
110365415|NCT00542711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110365416|NCT00542711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365417|NCT00542711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110365418|NCT00542711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110365419|NCT00542711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110365420|NCT00542711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110365421|NCT00542711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110365422|NCT00542984|Teriparatide|teriparatide|mesh-list
110365423|NCT00542984|Calcitonin|calcitonin|mesh-list
110365424|NCT00542984|Salmon calcitonin|salmon calcitonin|mesh-list
110365425|NCT00542984|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
110365426|NCT00542984|Katacalcin|katacalcin|mesh-list
110365427|NCT00542984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110365428|NCT00542984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365429|NCT00542984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110365430|NCT00542984|Vasodilator Agents|vasodilator agents|mesh-ancestor
110365431|NCT02257983|Ubiquinone|ubiquinone|mesh-list
110365432|NCT02257983|Micronutrients|micronutrients|mesh-ancestor
110365433|NCT02257983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372371|NCT04600271|Sympathomimetics|sympathomimetics|mesh-ancestor
110365434|NCT00543023|Teriparatide|teriparatide|mesh-list
110365435|NCT00543023|Calcitonin|calcitonin|mesh-list
110365436|NCT00543023|Salmon calcitonin|salmon calcitonin|mesh-list
110365437|NCT00543023|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
110365438|NCT00543023|Katacalcin|katacalcin|mesh-list
110365439|NCT00543023|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110365440|NCT00543023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365441|NCT00543023|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110365442|NCT00543023|Vasodilator Agents|vasodilator agents|mesh-ancestor
110365443|NCT04648917|Caffeic acid|caffeic acid|mesh-list
110365444|NCT04648917|Antioxidants|antioxidants|mesh-ancestor
110365445|NCT04648917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110365446|NCT04648917|Protective Agents|protective agents|mesh-ancestor
110365447|NCT04648917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365448|NCT00543179|Lanreotide|lanreotide|mesh-list
110365449|NCT00543179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110365450|NCT00543218|Teriparatide|teriparatide|mesh-list
110365452|NCT00543218|Salmon calcitonin|salmon calcitonin|mesh-list
110365453|NCT00543218|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
110365454|NCT00543218|Katacalcin|katacalcin|mesh-list
110365455|NCT00543218|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110365456|NCT00543218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365457|NCT00543218|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110365458|NCT00543218|Vasodilator Agents|vasodilator agents|mesh-ancestor
110365459|NCT02252835|Colchicine|colchicine|mesh-list
110365460|NCT02252835|Febuxostat|febuxostat|mesh-list
110365461|NCT02252835|Gout Suppressants|gout suppressants|mesh-ancestor
110365462|NCT02252835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110365463|NCT02252835|Tubulin Modulators|tubulin modulators|mesh-ancestor
110365464|NCT02252835|Antimitotic Agents|antimitotic agents|mesh-ancestor
110365465|NCT02252835|Mitosis Modulators|mitosis modulators|mesh-ancestor
110365466|NCT02252835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110365467|NCT02252835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110365468|NCT03456752|Dexamethasone|dexamethasone|mesh-list
110365469|NCT03456752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110365471|NCT03456752|Autonomic Agents|autonomic agents|mesh-ancestor
110365472|NCT03456752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110365473|NCT03456752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365474|NCT03456752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110365475|NCT03456752|Glucocorticoids|glucocorticoids|mesh-ancestor
110365476|NCT03456752|Hormones|hormones|mesh-ancestor
110365477|NCT03456752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110365478|NCT03456752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110365479|NCT03456752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110365480|NCT03456713|Mirikizumab|mirikizumab|mesh-list
110372539|NCT00576069|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110365481|NCT03456713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110365482|NCT03456713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110365483|NCT03456713|Analgesics|analgesics|mesh-ancestor
110365484|NCT03456713|Sensory System Agents|sensory system agents|mesh-ancestor
110365485|NCT03456713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110365486|NCT03456713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365487|NCT03456713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110365488|NCT03456713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110365489|NCT03456713|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110365490|NCT03456713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110365491|NCT04648137|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
110372601|NCT00573924|Lansoprazole|lansoprazole|mesh-list
110365493|NCT04648137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365494|NCT04648137|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110365495|NCT04648137|Serotonin Agents|serotonin agents|mesh-ancestor
110365496|NCT04648137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110365497|NCT04648137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110365498|NCT04648137|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110365499|NCT04648137|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110365500|NCT04648137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110365501|NCT04648137|Adrenergic Agents|adrenergic agents|mesh-ancestor
110365502|NCT04648332|Bupivacaine|bupivacaine|mesh-list
110365503|NCT04648332|Anesthetics, Local|anesthetics, local|mesh-ancestor
110365504|NCT04648332|Anesthetics|anesthetics|mesh-ancestor
110365505|NCT04648332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110365506|NCT04648332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365507|NCT04648332|Sensory System Agents|sensory system agents|mesh-ancestor
110365508|NCT04648332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110365509|NCT00543335|Sorafenib|sorafenib|mesh-list
110365510|NCT00543335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110365511|NCT00543335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110365512|NCT00543335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110365513|NCT00543335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110365514|NCT00543413|Enalapril|enalapril|mesh-list
110365515|NCT00543413|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110365516|NCT00543413|Protease Inhibitors|protease inhibitors|mesh-ancestor
110365517|NCT00543413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110365518|NCT00543413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110365519|NCT00543413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110365520|NCT00554658|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110365521|NCT00554658|Antidepressive Agents|antidepressive agents|mesh-ancestor
110365522|NCT00554658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110365523|NCT00554658|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110365524|NCT00554658|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110365525|NCT00554658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110365526|NCT00554658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365528|NCT00543608|Iclaprim|iclaprim|mesh-list
110365529|NCT00543608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110365530|NCT00543608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110365531|NCT00543608|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110365532|NCT00543608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110365533|NCT00543608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110365534|NCT00554775|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110365535|NCT00554775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110365536|NCT00554775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110365537|NCT00554775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110365538|NCT00554775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110365539|NCT00543647|Fenofibrate|fenofibrate|mesh-list
110365540|NCT00543647|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110365541|NCT00543647|Antimetabolites|antimetabolites|mesh-ancestor
110365542|NCT00543647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110365543|NCT00543647|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110365544|NCT04647669|Interferons|interferons|mesh-list
110365545|NCT04647669|Interferon-beta|interferon-beta|mesh-list
110365546|NCT04647669|Interferon beta-1a|interferon beta-1a|mesh-list
110365547|NCT04647669|Remdesivir|remdesivir|mesh-list
110365548|NCT04647669|Acalabrutinib|acalabrutinib|mesh-list
110365549|NCT04647669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110365550|NCT04647669|Antiviral Agents|antiviral agents|mesh-ancestor
110372770|NCT01147744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110365551|NCT04647669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110365553|NCT04647669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365554|NCT04647669|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110365555|NCT04647669|Antimetabolites|antimetabolites|mesh-ancestor
110368806|NCT04616352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110365556|NCT04647669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110365557|NCT00543686|Fluticasone|fluticasone|mesh-list
110365558|NCT00543686|Montelukast|montelukast|mesh-list
110365559|NCT00543686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110365560|NCT00543686|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110365561|NCT00543686|Autonomic Agents|autonomic agents|mesh-ancestor
110365562|NCT00543686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110365563|NCT00543686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365564|NCT00543686|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110365565|NCT00543686|Respiratory System Agents|respiratory system agents|mesh-ancestor
110365566|NCT00543686|Dermatologic Agents|dermatologic agents|mesh-ancestor
110365567|NCT00543686|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110365568|NCT00543686|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110365569|NCT00543686|Hormone Antagonists|hormone antagonists|mesh-ancestor
110365570|NCT00543686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110365571|NCT00543686|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110365572|NCT00543686|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110372887|NCT00566891|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110365573|NCT00543686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110365574|NCT00543842|Bevacizumab|bevacizumab|mesh-list
110365575|NCT00543842|Capecitabine|capecitabine|mesh-list
110365576|NCT00543842|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110365577|NCT00543842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110365578|NCT00543842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110365579|NCT00543842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110365580|NCT00543842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110365581|NCT00543842|Growth Substances|growth substances|mesh-ancestor
110365582|NCT00543842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372946|NCT04592081|Glucocorticoids|glucocorticoids|mesh-ancestor
110372947|NCT04592081|Hormones|hormones|mesh-ancestor
110365583|NCT00543842|Growth Inhibitors|growth inhibitors|mesh-ancestor
110365584|NCT00543842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110365585|NCT00543842|Antimetabolites|antimetabolites|mesh-ancestor
110365586|NCT00543842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110365587|NCT00543842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110365588|NCT00543842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110365589|NCT04638816|Lidocaine|lidocaine|mesh-list
110365591|NCT04638816|Anesthetics, Local|anesthetics, local|mesh-ancestor
110365592|NCT04638816|Anesthetics|anesthetics|mesh-ancestor
110365593|NCT04638816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110365594|NCT04638816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365595|NCT04638816|Sensory System Agents|sensory system agents|mesh-ancestor
110365596|NCT04638816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110365597|NCT04638816|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110365598|NCT04638816|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110365599|NCT04638816|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110365600|NCT04638816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110365601|NCT04638816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110365602|NCT04638816|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110365603|NCT04638816|Immunologic Factors|immunologic factors|mesh-ancestor
110373079|NCT00567554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110365605|NCT04638816|Protective Agents|protective agents|mesh-ancestor
110365606|NCT00543959|Pioglitazone|pioglitazone|mesh-list
110365607|NCT00543959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110365608|NCT00543959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365610|NCT00544037|Interferon-beta|interferon-beta|mesh-list
110365611|NCT00544037|Interferon beta-1b|interferon beta-1b|mesh-list
110365612|NCT00544037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110365613|NCT00544037|Antiviral Agents|antiviral agents|mesh-ancestor
110365614|NCT00544037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110365615|NCT00544037|Immunologic Factors|immunologic factors|mesh-ancestor
110365616|NCT00544037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365617|NCT00544037|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110365618|NCT00544154|Certolizumab Pegol|certolizumab pegol|mesh-list
110365619|NCT00544154|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110365620|NCT00544154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110365621|NCT00544154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110365622|NCT00544154|Immunologic Factors|immunologic factors|mesh-ancestor
110365623|NCT00544154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365624|NCT00544154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110365625|NCT04638582|Paclitaxel|paclitaxel|mesh-list
110365626|NCT04638582|Carboplatin|carboplatin|mesh-list
110365627|NCT04638582|Pembrolizumab|pembrolizumab|mesh-list
110365628|NCT04638582|Pemetrexed|pemetrexed|mesh-list
110365629|NCT04638582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110365630|NCT04638582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110365631|NCT04638582|Tubulin Modulators|tubulin modulators|mesh-ancestor
110365632|NCT04638582|Antimitotic Agents|antimitotic agents|mesh-ancestor
110365633|NCT04638582|Mitosis Modulators|mitosis modulators|mesh-ancestor
110365634|NCT04638582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110373271|NCT04585334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365635|NCT04638582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110365636|NCT04638582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110365637|NCT04638582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110365638|NCT04638582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110365639|NCT04638582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110365640|NCT00544193|Gemcitabine|gemcitabine|mesh-list
110365641|NCT00544193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110365642|NCT00544193|Antimetabolites|antimetabolites|mesh-ancestor
110365643|NCT00544193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110365644|NCT00544193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110365646|NCT00544232|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110365647|NCT00544232|Cyclophosphamide|cyclophosphamide|mesh-list
110365648|NCT00544232|Methotrexate|methotrexate|mesh-list
110365649|NCT00544232|Epirubicin|epirubicin|mesh-list
110365650|NCT00544232|Darbepoetin alfa|darbepoetin alfa|mesh-list
110365651|NCT00544232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110365653|NCT00544232|Tubulin Modulators|tubulin modulators|mesh-ancestor
110365654|NCT00544232|Antimitotic Agents|antimitotic agents|mesh-ancestor
110365655|NCT00544232|Mitosis Modulators|mitosis modulators|mesh-ancestor
110365656|NCT00544232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110365657|NCT00544232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110365658|NCT00544232|Immunologic Factors|immunologic factors|mesh-ancestor
110365659|NCT00544232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365660|NCT00544232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110365661|NCT00544232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110365662|NCT00544232|Alkylating Agents|alkylating agents|mesh-ancestor
110365663|NCT00544232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110365664|NCT00544232|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110365665|NCT00544232|Abortifacient Agents|abortifacient agents|mesh-ancestor
110365666|NCT00544232|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110365667|NCT00544232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110365668|NCT00544232|Antimetabolites|antimetabolites|mesh-ancestor
110365669|NCT00544232|Dermatologic Agents|dermatologic agents|mesh-ancestor
110365670|NCT00544232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110365671|NCT00544232|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110365672|NCT00544232|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110365673|NCT00544232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110365674|NCT00544232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110365675|NCT00544232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110365676|NCT00544232|Hematinics|hematinics|mesh-ancestor
110365677|NCT01191268|Insulin|insulin|mesh-list
110365678|NCT01191268|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110365679|NCT01191268|Insulin Glargine|insulin glargine|mesh-list
110365680|NCT01191268|Insulin Lispro|insulin lispro|mesh-list
110365681|NCT01191268|Dulaglutide|dulaglutide|mesh-list
110365682|NCT01191268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110365683|NCT01191268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365684|NCT04647552|Hydrocortisone|hydrocortisone|mesh-list
110365685|NCT04647552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110373524|NCT01145482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110365687|NCT00544349|Fluorouracil|fluorouracil|mesh-list
110365688|NCT00544349|Oxaliplatin|oxaliplatin|mesh-list
110365689|NCT00544349|Cetuximab|cetuximab|mesh-list
110365690|NCT00544349|Calcium|calcium|mesh-list
110365691|NCT00544349|Levoleucovorin|levoleucovorin|mesh-list
110365692|NCT00544349|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110365693|NCT00544349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365694|NCT00544349|Antimetabolites|antimetabolites|mesh-ancestor
110365695|NCT00544349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110365696|NCT00544349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110365697|NCT00544349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110365698|NCT00544349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110365699|NCT00544349|Immunologic Factors|immunologic factors|mesh-ancestor
110365701|NCT00544349|Protective Agents|protective agents|mesh-ancestor
110365702|NCT00544349|Vitamin B Complex|vitamin b complex|mesh-ancestor
110365703|NCT00544349|Vitamins|vitamins|mesh-ancestor
110365704|NCT00544349|Micronutrients|micronutrients|mesh-ancestor
110365705|NCT00544349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110365706|NCT01191190|Ofatumumab|ofatumumab|mesh-list
110365707|NCT01191190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110365708|NCT00544388|Levocetirizine|levocetirizine|mesh-list
110365709|NCT00544388|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110365710|NCT00544388|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110365711|NCT00544388|Histamine Antagonists|histamine antagonists|mesh-ancestor
110365712|NCT00544388|Histamine Agents|histamine agents|mesh-ancestor
110365713|NCT00544388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110365714|NCT00544388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110365715|NCT00544388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365716|NCT00544505|Cyclophosphamide|cyclophosphamide|mesh-list
110365717|NCT00544505|Fluorouracil|fluorouracil|mesh-list
110365718|NCT00544505|Epirubicin|epirubicin|mesh-list
110365719|NCT00544505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110365720|NCT00544505|Immunologic Factors|immunologic factors|mesh-ancestor
110365721|NCT00544505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365722|NCT00544505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110365723|NCT00544505|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110373713|NCT00569699|Bevacizumab|bevacizumab|mesh-list
110365724|NCT00544505|Alkylating Agents|alkylating agents|mesh-ancestor
110365725|NCT00544505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110365726|NCT00544505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110365727|NCT00544505|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110365728|NCT00544505|Antimetabolites|antimetabolites|mesh-ancestor
110365729|NCT00544505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110365730|NCT00544505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110365731|NCT00544505|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110365732|NCT00544505|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110365733|NCT00544505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110365734|NCT00544700|Bevacizumab|bevacizumab|mesh-list
110365735|NCT00544700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110365736|NCT00544700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110365737|NCT00544700|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110365738|NCT00544700|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110365739|NCT00544700|Growth Substances|growth substances|mesh-ancestor
110365740|NCT00544700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365741|NCT00544700|Growth Inhibitors|growth inhibitors|mesh-ancestor
110365742|NCT05824481|Lenvatinib|lenvatinib|mesh-list
110365743|NCT05824481|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
110365744|NCT05824481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110365745|NCT05824481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110365746|NCT05824481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110365747|NCT05824481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110365748|NCT05824468|Lenvatinib|lenvatinib|mesh-list
110365749|NCT05824468|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
110365750|NCT05824468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110365752|NCT05824468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110365753|NCT05824468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110365754|NCT05824455|Irinotecan|irinotecan|mesh-list
110365755|NCT05824455|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110365756|NCT05824455|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110365757|NCT05824455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110365758|NCT05824455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110365759|NCT05824455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110365760|NCT05824390|Rituximab|rituximab|mesh-list
110373893|NCT00571298|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110373897|NCT00571298|Antioxidants|antioxidants|mesh-ancestor
110365761|NCT05824390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110365762|NCT05824390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110365763|NCT05824390|Immunologic Factors|immunologic factors|mesh-ancestor
110365764|NCT05824390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365765|NCT05824390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110365766|NCT05824312|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
110365767|NCT05824312|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110365769|NCT05824312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110373954|NCT01143337|Dermatologic Agents|dermatologic agents|mesh-ancestor
110365770|NCT05824156|Streptococcal polysaccharide type III group B|streptococcal polysaccharide type iii group b|mesh-list
110365771|NCT05824156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110365772|NCT05823883|Metformin|metformin|mesh-list
110365773|NCT05823883|Empagliflozin|empagliflozin|mesh-list
110365774|NCT05823883|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110365775|NCT05823883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365776|NCT05823883|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110365777|NCT05823883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110365778|NCT05823870|Metformin|metformin|mesh-list
110365779|NCT05823870|Empagliflozin|empagliflozin|mesh-list
110365780|NCT05823870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110365781|NCT05823870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110374021|NCT01142128|Pancreatin|pancreatin|mesh-list
110365782|NCT05823870|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110365783|NCT05823870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110365784|NCT05823701|Azacitidine|azacitidine|mesh-list
110365785|NCT05823701|Mitoxantrone|mitoxantrone|mesh-list
110365786|NCT05823701|Obinutuzumab|obinutuzumab|mesh-list
110365787|NCT05823701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110365788|NCT05823701|Antimetabolites|antimetabolites|mesh-ancestor
110365789|NCT05823701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110365790|NCT05823701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110365791|NCT05823701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110365792|NCT05823701|Analgesics|analgesics|mesh-ancestor
110365793|NCT05823701|Sensory System Agents|sensory system agents|mesh-ancestor
110365794|NCT05823701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110365795|NCT05823701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365796|NCT05823701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110365797|NCT05823701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110365798|NCT05823701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110365799|NCT05823480|Azacitidine|azacitidine|mesh-list
110365800|NCT05823480|Magrolimab|magrolimab|mesh-list
110365801|NCT05823480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110365802|NCT05823480|Antimetabolites|antimetabolites|mesh-ancestor
110365803|NCT05823480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374137|NCT00573404|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110365804|NCT05823480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110365805|NCT05823480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110365806|NCT05823480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110365807|NCT05823168|Anticonvulsants|anticonvulsants|mesh-list
110365808|NCT05823155|Penicillins|penicillins|mesh-list
110365809|NCT05823155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110365810|NCT05823155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110365811|NCT05822882|Anesthetics|anesthetics|mesh-list
110365812|NCT05822882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110365813|NCT05822882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110374202|NCT01138657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110365815|NCT05822713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110365816|NCT05822713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110365817|NCT05822713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110365818|NCT05822713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365819|NCT05822713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110365820|NCT05822713|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110365821|NCT05822713|Dopamine Agents|dopamine agents|mesh-ancestor
110365822|NCT05822713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110365823|NCT05822713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110365824|NCT05822713|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110365825|NCT05822713|Antidepressive Agents|antidepressive agents|mesh-ancestor
110365827|NCT05822674|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110365828|NCT05822674|Empagliflozin|empagliflozin|mesh-list
110365829|NCT05822674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110365831|NCT05822674|Incretins|incretins|mesh-ancestor
110365832|NCT05822674|Hormones|hormones|mesh-ancestor
110365833|NCT05822674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110365834|NCT05822674|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110365835|NCT05822674|Protease Inhibitors|protease inhibitors|mesh-ancestor
110365836|NCT05822674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110365837|NCT05822674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374324|NCT00574925|Esomeprazole|esomeprazole|mesh-list
110365838|NCT05822674|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110365839|NCT05820451|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110365841|NCT05817474|Tranexamic Acid|tranexamic acid|mesh-list
110365842|NCT05817474|Anesthetics, Local|anesthetics, local|mesh-ancestor
110365843|NCT05817474|Anesthetics|anesthetics|mesh-ancestor
110365844|NCT05817474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110365845|NCT05817474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365846|NCT05817474|Sensory System Agents|sensory system agents|mesh-ancestor
110365847|NCT05817474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110365848|NCT05817474|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110365849|NCT05817474|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110374389|NCT00575549|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110365850|NCT05817474|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110365851|NCT05817474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110365852|NCT05817474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110365853|NCT05817474|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110365854|NCT05817474|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110365856|NCT05817474|Coagulants|coagulants|mesh-ancestor
110365857|NCT05824338|Bupivacaine|bupivacaine|mesh-list
110365858|NCT05824338|Ropivacaine|ropivacaine|mesh-list
110365859|NCT05824338|Anesthetics|anesthetics|mesh-list
110365860|NCT05824338|Anesthetics, Local|anesthetics, local|mesh-ancestor
110365861|NCT05824338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110365862|NCT05824338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365863|NCT05824338|Sensory System Agents|sensory system agents|mesh-ancestor
110365864|NCT05824338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110365865|NCT05780567|Tamoxifen|tamoxifen|mesh-list
110365866|NCT05780567|Letrozole|letrozole|mesh-list
110365867|NCT05780567|Anastrozole|anastrozole|mesh-list
110365868|NCT05780567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110365869|NCT05780567|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110365870|NCT05780567|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110365871|NCT05780567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110365872|NCT05780567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110365873|NCT05780567|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110374521|NCT00197145|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110365874|NCT05780567|Hormone Antagonists|hormone antagonists|mesh-ancestor
110365875|NCT05780567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110365876|NCT05780567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365877|NCT05780567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110365878|NCT05780567|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110365879|NCT05780567|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110365880|NCT05780567|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110365881|NCT05751629|Bevacizumab|bevacizumab|mesh-list
110365882|NCT05751629|Niraparib|niraparib|mesh-list
110365884|NCT05751629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110365885|NCT05751629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110365886|NCT05751629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110365887|NCT05751629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110365888|NCT05751629|Growth Substances|growth substances|mesh-ancestor
110365889|NCT05751629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365891|NCT05751629|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110365892|NCT05751629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110365893|NCT05751629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110365894|NCT05746273|Nicotine|nicotine|mesh-list
110365895|NCT05746273|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110365896|NCT05746273|Autonomic Agents|autonomic agents|mesh-ancestor
110365897|NCT05746273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110365898|NCT05746273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365899|NCT05746273|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110365900|NCT05746273|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110365901|NCT05746273|Cholinergic Agents|cholinergic agents|mesh-ancestor
110365902|NCT05746273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110365903|NCT05746273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110365904|NCT05736640|Denosumab|denosumab|mesh-list
110365905|NCT05736640|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110365906|NCT05736640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365908|NCT05728294|Anesthetics, Local|anesthetics, local|mesh-ancestor
110365909|NCT05728294|Anesthetics|anesthetics|mesh-ancestor
110365910|NCT05728294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110365911|NCT05728294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365912|NCT05728294|Sensory System Agents|sensory system agents|mesh-ancestor
110365913|NCT05728294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110365914|NCT05726916|Eculizumab|eculizumab|mesh-list
110365915|NCT05726916|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110365916|NCT05726916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110365917|NCT05726916|Immunologic Factors|immunologic factors|mesh-ancestor
110365918|NCT05726916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365919|NCT05704829|Trastuzumab|trastuzumab|mesh-list
110365920|NCT05704829|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
110365921|NCT05704829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110365922|NCT05704829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110365923|NCT05704829|Immunoconjugates|immunoconjugates|mesh-ancestor
110365924|NCT05704829|Immunologic Factors|immunologic factors|mesh-ancestor
110365925|NCT05704829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110374772|NCT00564200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110365926|NCT05681572|Midazolam|midazolam|mesh-list
110365928|NCT05681572|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110365929|NCT05681572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110365930|NCT05681572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365931|NCT05681572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110365932|NCT05681572|Analgesics|analgesics|mesh-ancestor
110365933|NCT05681572|Sensory System Agents|sensory system agents|mesh-ancestor
110365934|NCT05681572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110365935|NCT05681572|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110365936|NCT05681572|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110365937|NCT05681572|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110365938|NCT05681572|Adrenergic Agents|adrenergic agents|mesh-ancestor
110365939|NCT05681572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110365940|NCT05681572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110365941|NCT05681572|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110365942|NCT05681572|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110365943|NCT05681572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110365944|NCT05681572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110365945|NCT05681572|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110365946|NCT05681572|Anesthetics, General|anesthetics, general|mesh-ancestor
110365947|NCT05681572|Anesthetics|anesthetics|mesh-ancestor
110365948|NCT05681572|GABA Modulators|gaba modulators|mesh-ancestor
110365949|NCT05681572|GABA Agents|gaba agents|mesh-ancestor
110365950|NCT05608252|Fulvestrant|fulvestrant|mesh-list
110365951|NCT05608252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110365952|NCT05608252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110365953|NCT05608252|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110365954|NCT05608252|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110365955|NCT05608252|Hormone Antagonists|hormone antagonists|mesh-ancestor
110177828|NCT00141544|Estrogens|estrogens|mesh-list
110365956|NCT05608252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110365957|NCT05608252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365958|NCT05564221|Omalizumab|omalizumab|mesh-list
110365959|NCT05564221|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110365960|NCT05564221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110365961|NCT05564221|Respiratory System Agents|respiratory system agents|mesh-ancestor
110365962|NCT05491200|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110365963|NCT05491200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110375038|NCT00564590|Omeprazole|omeprazole|mesh-list
110375039|NCT00564590|Antioxidants|antioxidants|mesh-ancestor
110375041|NCT00564590|Protective Agents|protective agents|mesh-ancestor
110365964|NCT05490888|Terlipressin|terlipressin|mesh-list
110365965|NCT05490888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110365966|NCT05490888|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110365967|NCT05410301|Bevacizumab|bevacizumab|mesh-list
110365968|NCT05410301|Lomustine|lomustine|mesh-list
110365969|NCT05410301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110365970|NCT05410301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110365971|NCT05410301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110365972|NCT05410301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110365973|NCT05410301|Growth Substances|growth substances|mesh-ancestor
110365974|NCT05410301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365975|NCT05410301|Growth Inhibitors|growth inhibitors|mesh-ancestor
110365976|NCT05410301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110365977|NCT05410301|Alkylating Agents|alkylating agents|mesh-ancestor
110365978|NCT05410301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110365979|NCT05297578|Vaccines|vaccines|mesh-list
110365980|NCT05297578|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110365981|NCT05297578|Immunologic Factors|immunologic factors|mesh-ancestor
110365982|NCT05297578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365983|NCT05172934|Tenecteplase|tenecteplase|mesh-list
110365984|NCT05172934|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110365985|NCT05172934|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110375094|NCT00564824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365986|NCT05172934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110365987|NCT05126966|Ranibizumab|ranibizumab|mesh-list
110365988|NCT05126966|Aflibercept|aflibercept|mesh-list
110365989|NCT05126966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110365990|NCT05126966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110365991|NCT05126966|Growth Substances|growth substances|mesh-ancestor
110365992|NCT05126966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365993|NCT05126966|Growth Inhibitors|growth inhibitors|mesh-ancestor
110365994|NCT05126966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110365995|NCT05065294|Psilocybin|psilocybin|mesh-list
110365996|NCT05065294|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
110365997|NCT05065294|Hallucinogens|hallucinogens|mesh-ancestor
110365998|NCT05065294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365999|NCT05065294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110366000|NCT05065294|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110366001|NCT05065294|Serotonin Agents|serotonin agents|mesh-ancestor
110366002|NCT05065294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110366003|NCT05065294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110366004|NCT05065294|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110366005|NCT05058287|Methylprednisolone|methylprednisolone|mesh-list
110375147|NCT00565097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110375148|NCT04604756|Losartan|losartan|mesh-list
110375149|NCT04604756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110375150|NCT04604756|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110375151|NCT04604756|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110375152|NCT04604756|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110375153|NCT04604756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110375154|NCT00590343|Vatalanib|vatalanib|mesh-list
110375155|NCT00590343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110375156|NCT00590343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110366006|NCT05058287|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110366007|NCT05058287|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110366008|NCT05058287|Prednisolone|prednisolone|mesh-list
110366009|NCT05058287|Prednisolone acetate|prednisolone acetate|mesh-list
110366010|NCT05058287|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110366011|NCT05058287|Prednisolone phosphate|prednisolone phosphate|mesh-list
110366012|NCT05058287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110366013|NCT05058287|Antiemetics|antiemetics|mesh-ancestor
110366014|NCT05058287|Autonomic Agents|autonomic agents|mesh-ancestor
110366015|NCT05058287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110375191|NCT00477165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375192|NCT00477165|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110375193|NCT00477165|Antidepressive Agents|antidepressive agents|mesh-ancestor
110366016|NCT05058287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366017|NCT05058287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110366018|NCT05058287|Glucocorticoids|glucocorticoids|mesh-ancestor
110366019|NCT05058287|Hormones|hormones|mesh-ancestor
110366020|NCT05058287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110366021|NCT05058287|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110366022|NCT05058287|Protective Agents|protective agents|mesh-ancestor
110366023|NCT05058287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110366024|NCT05058287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110366025|NCT04968899|Dexamethasone|dexamethasone|mesh-list
110366026|NCT04968899|Immunoglobulins|immunoglobulins|mesh-list
110177835|NCT00141544|Hormones|hormones|mesh-ancestor
110366027|NCT04968899|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110366028|NCT04968899|Antibodies|antibodies|mesh-list
110366029|NCT04968899|gamma-Globulins|gamma-globulins|mesh-list
110366030|NCT04968899|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110366031|NCT04968899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110366033|NCT04968899|Autonomic Agents|autonomic agents|mesh-ancestor
110366034|NCT04968899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110366035|NCT04968899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366036|NCT04968899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110366037|NCT04968899|Glucocorticoids|glucocorticoids|mesh-ancestor
110366038|NCT04968899|Hormones|hormones|mesh-ancestor
110375314|NCT00565253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110366039|NCT04968899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110366040|NCT04968899|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110366041|NCT04968899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110366042|NCT04968899|Immunologic Factors|immunologic factors|mesh-ancestor
110366043|NCT04965818|Futibatinib|futibatinib|mesh-list
110366044|NCT04965818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110366045|NCT04943224|Trametinib|trametinib|mesh-list
110366046|NCT04943224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110366047|NCT04943224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110366048|NCT04943224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110366049|NCT04943224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110366050|NCT04943211|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110366051|NCT04943211|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110366052|NCT04943211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110366053|NCT04943198|Vemurafenib|vemurafenib|mesh-list
110366054|NCT04943198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110366055|NCT04943198|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110366056|NCT04943198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110366057|NCT04943198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110366058|NCT04941105|Evolocumab|evolocumab|mesh-list
110366059|NCT04941105|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110366060|NCT04941105|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110366061|NCT04941105|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110366062|NCT04941105|Antimetabolites|antimetabolites|mesh-ancestor
110366063|NCT04941105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110366064|NCT04941105|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110375448|NCT00473382|Ranibizumab|ranibizumab|mesh-list
110375449|NCT00473382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110375450|NCT00473382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110375451|NCT00473382|Growth Substances|growth substances|mesh-ancestor
110375452|NCT00473382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110567467|NCT05176223|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110567468|NCT05176223|Chelating Agents|chelating agents|mesh-ancestor
110567469|NCT05176223|Sequestering Agents|sequestering agents|mesh-ancestor
110567470|NCT05176223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110567471|NCT05176223|Anticoagulants|anticoagulants|mesh-ancestor
110567472|NCT05176223|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110567473|NCT05176223|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110567474|NCT05157464|Losartan|losartan|mesh-list
110567475|NCT05157464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110567476|NCT05157464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110567477|NCT05157464|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110567478|NCT05157464|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110567479|NCT05157464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110567480|NCT05156385|Antihypertensive Agents|antihypertensive agents|mesh-list
110567481|NCT05152901|Epinephrine|epinephrine|mesh-list
110567482|NCT05152901|Racepinephrine|racepinephrine|mesh-list
110567483|NCT05152901|Epinephryl borate|epinephryl borate|mesh-list
110567484|NCT05152901|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110567485|NCT05152901|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110567486|NCT05152901|Adrenergic Agents|adrenergic agents|mesh-ancestor
110567487|NCT05152901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110567488|NCT05152901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110567489|NCT05152901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110567490|NCT05152901|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110567491|NCT05152901|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110567492|NCT05152901|Autonomic Agents|autonomic agents|mesh-ancestor
110567493|NCT05152901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110567494|NCT05152901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110567495|NCT05152901|Respiratory System Agents|respiratory system agents|mesh-ancestor
110567496|NCT05152901|Mydriatics|mydriatics|mesh-ancestor
110567497|NCT05152901|Sympathomimetics|sympathomimetics|mesh-ancestor
110567498|NCT05152901|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110567499|NCT05124210|Sotrovimab|sotrovimab|mesh-list
110567500|NCT05124210|Antiviral Agents|antiviral agents|mesh-ancestor
110567501|NCT05124210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110567502|NCT05124080|Deucravacitinib|deucravacitinib|mesh-list
110567503|NCT05124080|Dermatologic Agents|dermatologic agents|mesh-ancestor
110567504|NCT05124080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110567505|NCT05124080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110567506|NCT05124080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110567507|NCT05118399|Bupivacaine|bupivacaine|mesh-list
110567508|NCT05118399|Anesthetics, Local|anesthetics, local|mesh-ancestor
110567509|NCT05118399|Anesthetics|anesthetics|mesh-ancestor
110567510|NCT05118399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110567511|NCT05118399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110567512|NCT05118399|Sensory System Agents|sensory system agents|mesh-ancestor
110567513|NCT05118399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110567517|NCT05074433|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
110567518|NCT05074433|Antiviral Agents|antiviral agents|mesh-ancestor
110567519|NCT05074433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110567520|NCT05064319|Gabapentin|gabapentin|mesh-list
110567521|NCT05064319|Analgesics|analgesics|mesh-ancestor
110567522|NCT05064319|Sensory System Agents|sensory system agents|mesh-ancestor
110567523|NCT05064319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110567524|NCT05064319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110567525|NCT05064319|Anticonvulsants|anticonvulsants|mesh-ancestor
110567526|NCT05064319|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110567527|NCT05064319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110567528|NCT05064319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110567529|NCT05064319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110567530|NCT05064319|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110567531|NCT05064319|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110567532|NCT05064319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110567533|NCT05064319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110567534|NCT05064319|Antimanic Agents|antimanic agents|mesh-ancestor
110567535|NCT05063994|Hydrocortisone|hydrocortisone|mesh-list
110567536|NCT05063994|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110567537|NCT05063994|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110567538|NCT05063994|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110567539|NCT05063994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110567540|NCT04970355|Erenumab|erenumab|mesh-list
110567541|NCT04970355|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
110215060|NCT00253318|Docetaxel|docetaxel|mesh-list
110567542|NCT04970355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110567543|NCT04970355|Analgesics|analgesics|mesh-ancestor
110567544|NCT04970355|Sensory System Agents|sensory system agents|mesh-ancestor
110567545|NCT04970355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110567546|NCT04970355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110567547|NCT04952571|Bevacizumab|bevacizumab|mesh-list
110567548|NCT04952571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110567549|NCT04952571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110567550|NCT04952571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110567551|NCT04952571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110567552|NCT04952571|Growth Substances|growth substances|mesh-ancestor
110567553|NCT04952571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110567554|NCT04952571|Growth Inhibitors|growth inhibitors|mesh-ancestor
110567555|NCT04945733|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
110567556|NCT04945733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110567557|NCT04945733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110567558|NCT04940390|Dihydroergotamine|dihydroergotamine|mesh-list
110567559|NCT04940390|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110567560|NCT04940390|Dopamine Agonists|dopamine agonists|mesh-ancestor
110567561|NCT04940390|Dopamine Agents|dopamine agents|mesh-ancestor
110567562|NCT04940390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110567563|NCT04940390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110567564|NCT04940390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110567565|NCT04940390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110567566|NCT04940390|Analgesics|analgesics|mesh-ancestor
110567567|NCT04940390|Sensory System Agents|sensory system agents|mesh-ancestor
110567568|NCT04940390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110567569|NCT04939142|Dexamethasone|dexamethasone|mesh-list
110567570|NCT04939142|Dexamethasone acetate|dexamethasone acetate|mesh-list
110567571|NCT04939142|Bortezomib|bortezomib|mesh-list
110567572|NCT04939142|BB 1101|bb 1101|mesh-list
110567573|NCT04939142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110567574|NCT04939142|Antiemetics|antiemetics|mesh-ancestor
110567575|NCT04939142|Autonomic Agents|autonomic agents|mesh-ancestor
110567576|NCT04939142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110567577|NCT04939142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110567578|NCT04939142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110567579|NCT04939142|Glucocorticoids|glucocorticoids|mesh-ancestor
110567580|NCT04939142|Hormones|hormones|mesh-ancestor
110567581|NCT04939142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110567582|NCT04939142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110567583|NCT04939142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110567584|NCT04939142|Protease Inhibitors|protease inhibitors|mesh-ancestor
110567586|NCT04939142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110567588|NCT04909450|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110567589|NCT04767984|Calcium, Dietary|calcium, dietary|mesh-list
110567590|NCT04767984|Atorvastatin|atorvastatin|mesh-list
110567591|NCT04767984|Calcium|calcium|mesh-list
110567592|NCT04767984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110567593|NCT04767984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110567594|NCT04767984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110567595|NCT04767984|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110567596|NCT04767984|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110567597|NCT04767984|Antimetabolites|antimetabolites|mesh-ancestor
110567598|NCT04767984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110567599|NCT04767984|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110567600|NCT04767984|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110567601|NCT04767984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110567602|NCT04722354|Abscisic Acid|abscisic acid|mesh-list
110567603|NCT04722354|Plant Growth Regulators|plant growth regulators|mesh-ancestor
110567604|NCT04722354|Growth Substances|growth substances|mesh-ancestor
110567605|NCT04722354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110567606|NCT04721977|Capecitabine|capecitabine|mesh-list
110567607|NCT04721977|Trastuzumab|trastuzumab|mesh-list
110567608|NCT04721977|Tucatinib|tucatinib|mesh-list
110567609|NCT04721977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110567610|NCT04721977|Antimetabolites|antimetabolites|mesh-ancestor
110567611|NCT04721977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110567612|NCT04721977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110567613|NCT04721977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110567614|NCT04721977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110567615|NCT04721977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110567616|NCT04657302|Obinutuzumab|obinutuzumab|mesh-list
110567617|NCT04657302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110567618|NCT04657302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110567619|NCT04608019|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110567620|NCT04608019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110567621|NCT04607954|Durvalumab|durvalumab|mesh-list
110567622|NCT04607954|Immunoglobulins|immunoglobulins|mesh-list
110567623|NCT04607954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110567624|NCT04607954|Immunoglobulin G|immunoglobulin g|mesh-list
110567625|NCT04607954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110567626|NCT04607954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110567627|NCT04607954|Immunologic Factors|immunologic factors|mesh-ancestor
110567628|NCT04607954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110567629|NCT04585841|Cannabidiol|cannabidiol|mesh-list
110567630|NCT04585841|Anticonvulsants|anticonvulsants|mesh-ancestor
110567631|NCT04583007|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110567632|NCT04583007|Immunologic Factors|immunologic factors|mesh-ancestor
110567633|NCT04583007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110567634|NCT04557020|Gemcitabine|gemcitabine|mesh-list
110567635|NCT04557020|Antibodies|antibodies|mesh-list
110567636|NCT04557020|Immunologic Factors|immunologic factors|mesh-ancestor
110567637|NCT04557020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110567638|NCT04557020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110567639|NCT04557020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110567640|NCT04557020|Antimetabolites|antimetabolites|mesh-ancestor
110567641|NCT04557020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110567653|NCT04521140|Dexamethasone|dexamethasone|mesh-list
110567654|NCT04521140|Prednisolone|prednisolone|mesh-list
110567656|NCT04521140|Methylprednisolone|methylprednisolone|mesh-list
110567657|NCT04521140|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110567658|NCT04521140|Prednisolone acetate|prednisolone acetate|mesh-list
110567659|NCT04521140|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110567660|NCT04521140|Prednisolone phosphate|prednisolone phosphate|mesh-list
110567661|NCT04521140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110567662|NCT04521140|Antiemetics|antiemetics|mesh-ancestor
110567663|NCT04521140|Autonomic Agents|autonomic agents|mesh-ancestor
110567664|NCT04521140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110567665|NCT04521140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110567666|NCT04521140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110567667|NCT04521140|Glucocorticoids|glucocorticoids|mesh-ancestor
110567668|NCT04521140|Hormones|hormones|mesh-ancestor
110567669|NCT04521140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110567670|NCT04521140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110567671|NCT04521140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110567672|NCT04521140|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110567673|NCT04521140|Protective Agents|protective agents|mesh-ancestor
110567674|NCT04507178|Nadroparin|nadroparin|mesh-list
110567675|NCT04507178|Anticoagulants|anticoagulants|mesh-ancestor
110567676|NCT04507178|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110567677|NCT04507178|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110567678|NCT04507178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110567679|NCT04493060|Niraparib|niraparib|mesh-list
110567680|NCT04493060|Dostarlimab|dostarlimab|mesh-list
110567681|NCT04493060|Immunoglobulins|immunoglobulins|mesh-list
110567682|NCT04493060|Immunoglobulin G|immunoglobulin g|mesh-list
110567683|NCT04493060|Immunologic Factors|immunologic factors|mesh-ancestor
110567684|NCT04493060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110567685|NCT04493060|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110567686|NCT04493060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110567687|NCT04493060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110567688|NCT04493060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110567689|NCT04485949|Temozolomide|temozolomide|mesh-list
110567690|NCT04485949|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110567691|NCT04485949|Alkylating Agents|alkylating agents|mesh-ancestor
110567692|NCT04485949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110567693|NCT04485949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110567694|NCT04457258|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110567695|NCT04457258|FAPI-46|fapi-46|mesh-list
110567696|NCT04457258|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110567697|NCT04457258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110567698|NCT04449861|Durvalumab|durvalumab|mesh-list
110567699|NCT04449861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110567700|NCT04449861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110567701|NCT04423211|Leuprolide|leuprolide|mesh-list
110567702|NCT04423211|Goserelin|goserelin|mesh-list
110567703|NCT04423211|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110567704|NCT04423211|Tryptophan|tryptophan|mesh-list
110567705|NCT04423211|Relugolix|relugolix|mesh-list
110567706|NCT04423211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110567707|NCT04423211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110567708|NCT04423211|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110567709|NCT04423211|Fertility Agents|fertility agents|mesh-ancestor
110567710|NCT04423211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110567711|NCT04423211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110567712|NCT04423211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110567713|NCT04423211|Luteolytic Agents|luteolytic agents|mesh-ancestor
110567714|NCT04423211|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110567715|NCT04423211|Contraceptive Agents|contraceptive agents|mesh-ancestor
110567716|NCT04423211|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110567717|NCT04423211|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110567718|NCT04423211|Antidepressive Agents|antidepressive agents|mesh-ancestor
110567719|NCT04423211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110567720|NCT04423211|Androgen Antagonists|androgen antagonists|mesh-ancestor
110567721|NCT04423211|Hormone Antagonists|hormone antagonists|mesh-ancestor
110567722|NCT04392375|Nifedipine|nifedipine|mesh-list
110567723|NCT04392375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110567724|NCT04392375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110190680|NCT00025142|Vitamins|vitamins|mesh-ancestor
110567725|NCT04392375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110567726|NCT04392375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110567727|NCT04392375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110567728|NCT04392375|Vasodilator Agents|vasodilator agents|mesh-ancestor
110567730|NCT04392375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110567731|NCT04314570|Ropivacaine|ropivacaine|mesh-list
110567732|NCT04314570|Anesthetics, Local|anesthetics, local|mesh-ancestor
110567733|NCT04314570|Anesthetics|anesthetics|mesh-ancestor
110567734|NCT04314570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110567735|NCT04314570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110567736|NCT04314570|Sensory System Agents|sensory system agents|mesh-ancestor
110567737|NCT04314570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110567738|NCT04278573|Vitamin D|vitamin d|mesh-list
110567739|NCT04278573|Cholecalciferol|cholecalciferol|mesh-list
110567740|NCT04278573|Vitamins|vitamins|mesh-ancestor
110567741|NCT04278573|Micronutrients|micronutrients|mesh-ancestor
110567742|NCT04278573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110567743|NCT04278573|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110567744|NCT04278573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110567745|NCT04252742|Erenumab|erenumab|mesh-list
110567746|NCT04252742|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
110567747|NCT04252742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110567748|NCT04252742|Analgesics|analgesics|mesh-ancestor
110567749|NCT04252742|Sensory System Agents|sensory system agents|mesh-ancestor
110567750|NCT04252742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110567751|NCT04252742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110567752|NCT04247542|Vancomycin|vancomycin|mesh-list
110567753|NCT04247542|Ibezapolstat|ibezapolstat|mesh-list
110567754|NCT04247542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110567755|NCT04247542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110567756|NCT04247542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110567757|NCT04247542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110567758|NCT04247542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110567759|NCT04233580|Chlorhexidine|chlorhexidine|mesh-list
110567760|NCT04233580|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110567761|NCT04233580|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110567762|NCT04233580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110567763|NCT04233580|Disinfectants|disinfectants|mesh-ancestor
110567764|NCT04233580|Dermatologic Agents|dermatologic agents|mesh-ancestor
110567765|NCT04201197|Dronabinol|dronabinol|mesh-list
110567766|NCT04201197|Hallucinogens|hallucinogens|mesh-ancestor
110567767|NCT04201197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110567768|NCT04201197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110567769|NCT04201197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110567771|NCT04201197|Sensory System Agents|sensory system agents|mesh-ancestor
110567772|NCT04201197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110567773|NCT04201197|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110567774|NCT04201197|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110567775|NCT04201197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110567776|NCT04201197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110567777|NCT04201197|Hormones|hormones|mesh-ancestor
110567778|NCT04201197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110567779|NCT04107740|TA 0910|ta 0910|mesh-list
110567780|NCT04107740|Nootropic Agents|nootropic agents|mesh-ancestor
110567781|NCT04104139|Trifluridine|trifluridine|mesh-list
110567782|NCT04104139|Antimetabolites|antimetabolites|mesh-ancestor
110567783|NCT04104139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110567784|NCT04104139|Antiviral Agents|antiviral agents|mesh-ancestor
110567785|NCT04104139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110567786|NCT04085315|Osimertinib|osimertinib|mesh-list
110567787|NCT04085315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110567788|NCT04085315|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110567790|NCT04085315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110567791|NCT04082520|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
110567792|NCT04082520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110567793|NCT04082520|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110567794|NCT04064060|Luspatercept|luspatercept|mesh-list
110567795|NCT04064060|Hematinics|hematinics|mesh-ancestor
110567796|NCT04028050|Carboplatin|carboplatin|mesh-list
110567797|NCT04028050|Etoposide|etoposide|mesh-list
110567798|NCT04028050|Atezolizumab|atezolizumab|mesh-list
110567799|NCT04028050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110567800|NCT04028050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110567801|NCT04028050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110567802|NCT04028050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110567803|NCT04028050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110567804|NCT04028050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110567805|NCT04028050|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110567806|NCT04028050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110567807|NCT04016805|Venetoclax|venetoclax|mesh-list
110567808|NCT04016805|Acalabrutinib|acalabrutinib|mesh-list
110567809|NCT04016805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110567810|NCT03979885|Nicotine|nicotine|mesh-list
110567811|NCT03979885|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110567812|NCT03979885|Autonomic Agents|autonomic agents|mesh-ancestor
110567813|NCT03979885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110567814|NCT03979885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110567815|NCT03979885|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110567816|NCT03979885|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110567817|NCT03979885|Cholinergic Agents|cholinergic agents|mesh-ancestor
110567818|NCT03979885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110567819|NCT03979885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110567820|NCT03972527|Analgesics|analgesics|mesh-list
110567821|NCT03972527|Sensory System Agents|sensory system agents|mesh-ancestor
110567822|NCT03972527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110567823|NCT03972527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110567824|NCT03968393|Rivaroxaban|rivaroxaban|mesh-list
110567825|NCT03968393|Apixaban|apixaban|mesh-list
110567826|NCT03968393|Edoxaban|edoxaban|mesh-list
110567827|NCT03968393|Dabigatran|dabigatran|mesh-list
110567828|NCT03968393|Anticoagulants|anticoagulants|mesh-list
110567829|NCT03968393|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110567830|NCT03968393|Antithrombins|antithrombins|mesh-ancestor
110567831|NCT03968393|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110567832|NCT03968393|Protease Inhibitors|protease inhibitors|mesh-ancestor
110567833|NCT03968393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110567834|NCT03968393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110567835|NCT03959358|Lenalidomide|lenalidomide|mesh-list
110567836|NCT03959358|Pomalidomide|pomalidomide|mesh-list
110567837|NCT03959358|Immunologic Factors|immunologic factors|mesh-ancestor
110567838|NCT03959358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110567839|NCT03959358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110567840|NCT03959358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110567841|NCT03959358|Growth Substances|growth substances|mesh-ancestor
110567842|NCT03959358|Growth Inhibitors|growth inhibitors|mesh-ancestor
110567843|NCT03959358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110567844|NCT03941730|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110567846|NCT03941730|Estradiol|estradiol|mesh-list
110567847|NCT03941730|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110567848|NCT03941730|Estrogens|estrogens|mesh-ancestor
110567849|NCT03941730|Hormones|hormones|mesh-ancestor
110567850|NCT03941730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110567851|NCT03941730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110567852|NCT03941730|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110567853|NCT03941730|Contraceptive Agents|contraceptive agents|mesh-ancestor
110567854|NCT03941730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110567855|NCT03941730|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110567856|NCT03866239|Atezolizumab|atezolizumab|mesh-list
110567857|NCT03866239|Obinutuzumab|obinutuzumab|mesh-list
110567858|NCT03866239|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110567859|NCT03866239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110567860|NCT03866239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110567861|NCT03866239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110567862|NCT03714308|Aflibercept|aflibercept|mesh-list
110567863|NCT03714308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110567864|NCT03714308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110567868|NCT03714308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110567869|NCT03713593|Pembrolizumab|pembrolizumab|mesh-list
110567870|NCT03713593|Lenvatinib|lenvatinib|mesh-list
110567871|NCT03713593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110567872|NCT03713593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110567873|NCT03713593|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110567874|NCT03713593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110567875|NCT03713593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110567876|NCT03713593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110567877|NCT03702270|Penicillins|penicillins|mesh-list
110567878|NCT03702270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110567879|NCT03702270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110567880|NCT03687957|Temozolomide|temozolomide|mesh-list
110567881|NCT03687957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110567882|NCT03687957|Alkylating Agents|alkylating agents|mesh-ancestor
110567883|NCT03687957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110567884|NCT03687957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110567885|NCT03617679|Rucaparib|rucaparib|mesh-list
110567886|NCT03617679|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110567887|NCT03617679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110567888|NCT03617679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110567889|NCT03617679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110567890|NCT03580369|Omalizumab|omalizumab|mesh-list
110567891|NCT03580369|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110567892|NCT03580369|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110567893|NCT03580369|Respiratory System Agents|respiratory system agents|mesh-ancestor
110567894|NCT03554083|Atezolizumab|atezolizumab|mesh-list
110567895|NCT03554083|Vemurafenib|vemurafenib|mesh-list
110567896|NCT03554083|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110567897|NCT03554083|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110567898|NCT03554083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110567899|NCT03554083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110567900|NCT03554083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110567901|NCT03554083|Immunologic Factors|immunologic factors|mesh-ancestor
110567902|NCT03554083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110567903|NCT03554083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110567904|NCT03554083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110567905|NCT03539900|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
110567906|NCT03539900|Naltrexone|naltrexone|mesh-list
110567907|NCT03539900|Bupropion|bupropion|mesh-list
110567908|NCT03539900|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110567909|NCT03539900|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110567910|NCT03539900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110567911|NCT03539900|Sensory System Agents|sensory system agents|mesh-ancestor
110567912|NCT03539900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110567913|NCT03539900|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110567914|NCT03539900|Antidepressive Agents|antidepressive agents|mesh-ancestor
110567915|NCT03539900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110567916|NCT03539900|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110567917|NCT03539900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110567918|NCT03539900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110567919|NCT03539900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110567920|NCT03539900|Dopamine Agents|dopamine agents|mesh-ancestor
110567949|NCT03399539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110567950|NCT03399539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110567951|NCT03399539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110567952|NCT03399539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110567953|NCT03399539|Protease Inhibitors|protease inhibitors|mesh-ancestor
110567954|NCT03399539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110567955|NCT03399539|Dermatologic Agents|dermatologic agents|mesh-ancestor
110567956|NCT03399539|Glycine Agents|glycine agents|mesh-ancestor
110567957|NCT03399539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110567980|NCT03358706|Vitamin K|vitamin k|mesh-list
110567982|NCT03358706|Dextromethorphan|dextromethorphan|mesh-list
110567983|NCT03358706|Caffeine|caffeine|mesh-list
110567984|NCT03358706|Ustekinumab|ustekinumab|mesh-list
110567985|NCT03358706|Omeprazole|omeprazole|mesh-list
110567986|NCT03358706|Warfarin|warfarin|mesh-list
110567987|NCT03358706|Vitamins|vitamins|mesh-ancestor
110567988|NCT03358706|Micronutrients|micronutrients|mesh-ancestor
110567989|NCT03358706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110215489|NCT00415285|Capecitabine|capecitabine|mesh-list
110567990|NCT03358706|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110567991|NCT03358706|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110567992|NCT03358706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110567993|NCT03358706|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110567994|NCT03358706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110567995|NCT03358706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110567996|NCT03358706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110567997|NCT03358706|Anesthetics, General|anesthetics, general|mesh-ancestor
110567998|NCT03358706|Anesthetics|anesthetics|mesh-ancestor
110567999|NCT03358706|GABA Modulators|gaba modulators|mesh-ancestor
110568000|NCT03358706|GABA Agents|gaba agents|mesh-ancestor
110568001|NCT03358706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110568002|NCT03358706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568003|NCT03358706|Anticoagulants|anticoagulants|mesh-ancestor
110568004|NCT03358706|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110568005|NCT03358706|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110568006|NCT03358706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110568007|NCT03358706|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110568008|NCT03358706|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110568009|NCT03358706|Purinergic Agents|purinergic agents|mesh-ancestor
110568010|NCT03358706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110568011|NCT03358706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110568012|NCT03358706|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110568013|NCT03358706|Dermatologic Agents|dermatologic agents|mesh-ancestor
110568014|NCT03358706|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110568015|NCT03358706|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110568016|NCT03358706|Hemostatics|hemostatics|mesh-ancestor
110568017|NCT03358706|Coagulants|coagulants|mesh-ancestor
110568018|NCT03358706|Antitussive Agents|antitussive agents|mesh-ancestor
110568019|NCT03358706|Respiratory System Agents|respiratory system agents|mesh-ancestor
110568020|NCT03358706|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110568021|NCT03358706|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110568022|NCT03338920|Sumatriptan|sumatriptan|mesh-list
110568023|NCT03338920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110568024|NCT03338920|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110568025|NCT03338920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110568026|NCT03338920|Serotonin Agents|serotonin agents|mesh-ancestor
110568027|NCT03338920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110568028|NCT03338920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568029|NCT03338920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568030|NCT03331289|Dapagliflozin|dapagliflozin|mesh-list
110568031|NCT03331289|Exenatide|exenatide|mesh-list
110568032|NCT03331289|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110568033|NCT03331289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568034|NCT03331289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110568035|NCT03331289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568036|NCT03331289|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110568037|NCT03331289|Incretins|incretins|mesh-ancestor
110568038|NCT03331289|Hormones|hormones|mesh-ancestor
110568039|NCT03331289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110568040|NCT03220776|Acetylcysteine|acetylcysteine|mesh-list
110568041|NCT03220776|Gabapentin|gabapentin|mesh-list
110568042|NCT03220776|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110568044|NCT03220776|Sensory System Agents|sensory system agents|mesh-ancestor
110568045|NCT03220776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110568046|NCT03220776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568047|NCT03220776|Anticonvulsants|anticonvulsants|mesh-ancestor
110568048|NCT03220776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110568049|NCT03220776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110568050|NCT03220776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110568051|NCT03220776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110568052|NCT03220776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110568053|NCT03220776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110568054|NCT03220776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110568055|NCT03220776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568056|NCT03220776|Antimanic Agents|antimanic agents|mesh-ancestor
110568057|NCT03220776|Antiviral Agents|antiviral agents|mesh-ancestor
110568058|NCT03220776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110568059|NCT03220776|Expectorants|expectorants|mesh-ancestor
110568060|NCT03220776|Respiratory System Agents|respiratory system agents|mesh-ancestor
110568061|NCT03220776|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110568062|NCT03220776|Antioxidants|antioxidants|mesh-ancestor
110568063|NCT03220776|Protective Agents|protective agents|mesh-ancestor
110568064|NCT03220776|Antidotes|antidotes|mesh-ancestor
110568065|NCT03215810|Cyclophosphamide|cyclophosphamide|mesh-list
110568066|NCT03215810|Nivolumab|nivolumab|mesh-list
110568067|NCT03215810|Fludarabine|fludarabine|mesh-list
110215563|NCT00100737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110568068|NCT03215810|Interleukin-2|interleukin-2|mesh-list
110568069|NCT03215810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110568070|NCT03215810|Immunologic Factors|immunologic factors|mesh-ancestor
110568071|NCT03215810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568072|NCT03215810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110568073|NCT03215810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110568074|NCT03215810|Alkylating Agents|alkylating agents|mesh-ancestor
110568075|NCT03215810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568076|NCT03215810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110568077|NCT03215810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110568078|NCT03215810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110568079|NCT03215810|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110568080|NCT03215810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110568081|NCT03215810|Analgesics|analgesics|mesh-ancestor
110568082|NCT03215810|Sensory System Agents|sensory system agents|mesh-ancestor
110568083|NCT03215810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110568084|NCT03036930|Vaccines|vaccines|mesh-list
110568085|NCT03036930|Immunologic Factors|immunologic factors|mesh-ancestor
110568086|NCT03036930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568087|NCT03032406|Hydroxychloroquine|hydroxychloroquine|mesh-list
110568088|NCT03032406|Everolimus|everolimus|mesh-list
110568089|NCT03032406|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110568090|NCT03032406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110568091|NCT03032406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110568092|NCT03032406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568093|NCT03032406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110568094|NCT03032406|Immunologic Factors|immunologic factors|mesh-ancestor
110568095|NCT03032406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568096|NCT03032406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110568097|NCT03032406|Antimalarials|antimalarials|mesh-ancestor
110568098|NCT03032406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110568099|NCT03032406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110568100|NCT03032406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110568101|NCT03032406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110568103|NCT02977468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110568104|NCT02977468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110568105|NCT02977468|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110568106|NCT02977468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568107|NCT02955355|Immunoglobulins|immunoglobulins|mesh-list
110568108|NCT02955355|Immunologic Factors|immunologic factors|mesh-ancestor
110568109|NCT02955355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568110|NCT02953457|Durvalumab|durvalumab|mesh-list
110568111|NCT02953457|Ipilimumab|ipilimumab|mesh-list
110568112|NCT02953457|Olaparib|olaparib|mesh-list
110568113|NCT02953457|Tremelimumab|tremelimumab|mesh-list
110568114|NCT02953457|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
110568115|NCT02953457|Immunoglobulins|immunoglobulins|mesh-list
110568116|NCT02953457|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110568117|NCT02953457|Immunoglobulin G|immunoglobulin g|mesh-list
110568118|NCT02953457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110568119|NCT02953457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110568120|NCT02953457|Immunologic Factors|immunologic factors|mesh-ancestor
110568121|NCT02953457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568122|NCT02953457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110568123|NCT02953457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568124|NCT02953457|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110568125|NCT02891538|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
110568126|NCT02891538|Antioxidants|antioxidants|mesh-ancestor
110568127|NCT02891538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568128|NCT02891538|Protective Agents|protective agents|mesh-ancestor
110568129|NCT02891538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568130|NCT02891538|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110568131|NCT02891538|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110568132|NCT02891538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110568133|NCT02891538|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110568134|NCT02817659|Glucagon|glucagon|mesh-list
110568135|NCT02817659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110568136|NCT02817659|Hormones|hormones|mesh-ancestor
110568137|NCT02817659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110568138|NCT02817659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568139|NCT02677922|Azacitidine|azacitidine|mesh-list
110568140|NCT02677922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110568141|NCT02677922|Antimetabolites|antimetabolites|mesh-ancestor
110568142|NCT02677922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568143|NCT02677922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110568144|NCT02677922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110568145|NCT02565628|PF-06669571|pf-06669571|mesh-list
110568146|NCT02565628|Dopamine Agonists|dopamine agonists|mesh-ancestor
110568147|NCT02565628|Dopamine Agents|dopamine agents|mesh-ancestor
110568148|NCT02565628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110568149|NCT02565628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568150|NCT02565628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568151|NCT02496585|Prednisone|prednisone|mesh-list
110568152|NCT02496585|Nintedanib|nintedanib|mesh-list
110568153|NCT02496585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110568154|NCT02496585|Glucocorticoids|glucocorticoids|mesh-ancestor
110568155|NCT02496585|Hormones|hormones|mesh-ancestor
110568156|NCT02496585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110568157|NCT02496585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568158|NCT02496585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110568159|NCT02496585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110568160|NCT02496585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110568161|NCT02496585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110568162|NCT02496585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568163|NCT02486640|Interferons|interferons|mesh-list
110568164|NCT02486640|Interferon-beta|interferon-beta|mesh-list
110568165|NCT02486640|Interferon beta-1b|interferon beta-1b|mesh-list
110568166|NCT02486640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110568167|NCT02486640|Antiviral Agents|antiviral agents|mesh-ancestor
110568168|NCT02486640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110568169|NCT02486640|Immunologic Factors|immunologic factors|mesh-ancestor
110568170|NCT02486640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568171|NCT02486640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110568172|NCT02330991|Temozolomide|temozolomide|mesh-list
110568173|NCT02330991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110568174|NCT02330991|Alkylating Agents|alkylating agents|mesh-ancestor
110568175|NCT02330991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568176|NCT02330991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110568180|NCT01582737|Rivaroxaban|rivaroxaban|mesh-list
110568181|NCT01582737|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110568182|NCT01582737|Antithrombins|antithrombins|mesh-ancestor
110568183|NCT01582737|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110568184|NCT01582737|Protease Inhibitors|protease inhibitors|mesh-ancestor
110568185|NCT01582737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110568186|NCT01582737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568187|NCT01582737|Anticoagulants|anticoagulants|mesh-ancestor
110568188|NCT01321567|Rabeprazole|rabeprazole|mesh-list
110568189|NCT01321567|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110568190|NCT01321567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110568191|NCT01321567|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110568192|NCT01321567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110568193|NCT01321567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568194|NCT01290445|Varenicline|varenicline|mesh-list
110568195|NCT01290445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110568196|NCT01290445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110568197|NCT01290445|Cholinergic Agents|cholinergic agents|mesh-ancestor
110568198|NCT01290445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110568199|NCT01290445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568200|NCT01290445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568201|NCT01251718|Donepezil|donepezil|mesh-list
110190734|NCT00053196|Tacrolimus|tacrolimus|mesh-list
110568202|NCT01251718|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110568203|NCT01251718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110568204|NCT01251718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568205|NCT01251718|Cholinergic Agents|cholinergic agents|mesh-ancestor
110568206|NCT01251718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110568207|NCT01251718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568208|NCT01251718|Nootropic Agents|nootropic agents|mesh-ancestor
110568209|NCT01211405|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
110568210|NCT01211405|Hallucinogens|hallucinogens|mesh-ancestor
110568211|NCT01211405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568212|NCT01211405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110568213|NCT01211405|Serotonin Agents|serotonin agents|mesh-ancestor
110568214|NCT01211405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110568215|NCT01211405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568216|NCT01211405|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110568217|NCT01211405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110568218|NCT01211405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110568219|NCT01211405|Adrenergic Agents|adrenergic agents|mesh-ancestor
110568221|NCT01012817|Veliparib|veliparib|mesh-list
110568222|NCT01012817|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110568223|NCT01012817|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110568224|NCT01012817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110568225|NCT01012817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568226|NCT01012817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110568227|NCT01012817|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110568228|NCT00581828|Vitamin D|vitamin d|mesh-list
110568229|NCT00581828|Ergocalciferols|ergocalciferols|mesh-list
110568230|NCT00581828|Cholecalciferol|cholecalciferol|mesh-list
110568231|NCT00581828|Vitamins|vitamins|mesh-list
110568232|NCT00581828|Micronutrients|micronutrients|mesh-ancestor
110568233|NCT00581828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568234|NCT00581828|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110568235|NCT00581828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110568236|NCT00220337|Lacosamide|lacosamide|mesh-list
110568237|NCT00220337|Anticonvulsants|anticonvulsants|mesh-ancestor
110568238|NCT00220337|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110568239|NCT00220337|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110568240|NCT00220337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110568241|NCT00220337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568242|NCT00090064|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
110568243|NCT00090064|Hallucinogens|hallucinogens|mesh-ancestor
110568244|NCT00090064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568245|NCT00090064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110568246|NCT00090064|Serotonin Agents|serotonin agents|mesh-ancestor
110568247|NCT00090064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110568248|NCT00090064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568249|NCT00090064|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110568250|NCT00090064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110568251|NCT00090064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110568252|NCT00090064|Adrenergic Agents|adrenergic agents|mesh-ancestor
110568253|NCT00576316|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110568254|NCT00576316|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110568255|NCT00576316|Respiratory System Agents|respiratory system agents|mesh-ancestor
110568256|NCT00745810|Complement System Proteins|complement system proteins|mesh-list
110568257|NCT00745810|Immunologic Factors|immunologic factors|mesh-ancestor
110568258|NCT00745810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568259|NCT00755872|Risedronic Acid|risedronic acid|mesh-list
110568260|NCT00755872|Etidronic Acid|etidronic acid|mesh-list
110568261|NCT00755872|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110568262|NCT00755872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110568263|NCT00755872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568264|NCT00755872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110568265|NCT00755872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568266|NCT00755872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110568267|NCT00755950|Silymarin|silymarin|mesh-list
110568268|NCT00755950|Antioxidants|antioxidants|mesh-ancestor
110190737|NCT00053196|Abortifacient Agents|abortifacient agents|mesh-ancestor
110568269|NCT00755950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568270|NCT00755950|Protective Agents|protective agents|mesh-ancestor
110568271|NCT00755950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568272|NCT00705354|Bacitracin|bacitracin|mesh-list
110568273|NCT00705354|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110568274|NCT00705354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110568275|NCT00705354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110568276|NCT00575380|Moxifloxacin|moxifloxacin|mesh-list
110568277|NCT00575380|Azithromycin|azithromycin|mesh-list
110568278|NCT00575380|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110568279|NCT00575380|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110568280|NCT00575380|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110568281|NCT00575380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110568282|NCT00575380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110568283|NCT00575380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110568284|NCT00575380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110568285|NCT00575380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110568286|NCT00575380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568287|NCT00575380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110568288|NCT00575380|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110568289|NCT00575380|Contraceptive Agents|contraceptive agents|mesh-ancestor
110568290|NCT00575380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110568291|NCT00575380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568292|NCT00575380|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110568294|NCT00575380|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110568295|NCT00840996|Lidocaine|lidocaine|mesh-list
110568296|NCT00840996|Anesthetics, Local|anesthetics, local|mesh-ancestor
110568297|NCT00840996|Anesthetics|anesthetics|mesh-ancestor
110568298|NCT00840996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110568299|NCT00840996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568300|NCT00840996|Sensory System Agents|sensory system agents|mesh-ancestor
110568301|NCT00840996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110568302|NCT00840996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110568303|NCT00840996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110568304|NCT00840996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110568305|NCT00840996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110568306|NCT00840996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568307|NCT00756184|Travoprost|travoprost|mesh-list
110568308|NCT00756184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110568309|NCT00756340|Bevacizumab|bevacizumab|mesh-list
110568310|NCT00756340|Everolimus|everolimus|mesh-list
110568311|NCT00756340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110568312|NCT00756340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110568313|NCT00756340|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110568314|NCT00756340|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110568315|NCT00756340|Growth Substances|growth substances|mesh-ancestor
110568316|NCT00756340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568317|NCT00756340|Growth Inhibitors|growth inhibitors|mesh-ancestor
110568318|NCT00756340|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110568319|NCT00756340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110568320|NCT00756340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110568321|NCT00756340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568322|NCT00756340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110568323|NCT00756340|Immunologic Factors|immunologic factors|mesh-ancestor
110568324|NCT00705510|Cyclosporine|cyclosporine|mesh-list
110568325|NCT00705510|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110568326|NCT00705510|Cyclosporins|cyclosporins|mesh-list
110568327|NCT00705510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110568328|NCT00705510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568329|NCT00705510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110568330|NCT00705510|Immunologic Factors|immunologic factors|mesh-ancestor
110568331|NCT00705510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568332|NCT00705510|Antifungal Agents|antifungal agents|mesh-ancestor
110568333|NCT00705510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110568334|NCT00705510|Dermatologic Agents|dermatologic agents|mesh-ancestor
110568335|NCT00705510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110190744|NCT00053196|Dermatologic Agents|dermatologic agents|mesh-ancestor
110568336|NCT00705510|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110568337|NCT00705510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110568338|NCT00680914|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110568339|NCT00680914|Immunologic Factors|immunologic factors|mesh-ancestor
110568340|NCT00680914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568341|NCT00680836|Rifaximin|rifaximin|mesh-list
110568342|NCT00680836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110568343|NCT00680836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110568344|NCT00680836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110568345|NCT05428306|Acetaminophen|acetaminophen|mesh-list
110568346|NCT05428306|Ibuprofen|ibuprofen|mesh-list
110568347|NCT05428306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110568348|NCT05428306|Analgesics|analgesics|mesh-ancestor
110568349|NCT05428306|Sensory System Agents|sensory system agents|mesh-ancestor
110568350|NCT05428306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110568351|NCT05428306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568352|NCT05428306|Antipyretics|antipyretics|mesh-ancestor
110568353|NCT05428306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110568354|NCT05428306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110568355|NCT05428306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110568356|NCT05428306|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110568357|NCT05428306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110568358|NCT05428306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568359|NCT05424796|Hemostatics|hemostatics|mesh-list
110568360|NCT05424796|Coagulants|coagulants|mesh-ancestor
110568361|NCT00757198|Remifentanil|remifentanil|mesh-list
110568363|NCT00757198|Narcotics|narcotics|mesh-ancestor
110568364|NCT00757198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110568365|NCT00757198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568366|NCT00757198|Analgesics|analgesics|mesh-ancestor
110568368|NCT00757198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110568369|NCT00679432|Budesonide|budesonide|mesh-list
110568370|NCT00679432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110568371|NCT00679432|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110568372|NCT00679432|Autonomic Agents|autonomic agents|mesh-ancestor
110568373|NCT00679432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110568374|NCT00679432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568375|NCT00679432|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110568376|NCT00679432|Respiratory System Agents|respiratory system agents|mesh-ancestor
110568377|NCT00679432|Glucocorticoids|glucocorticoids|mesh-ancestor
110568378|NCT00679432|Hormones|hormones|mesh-ancestor
110568379|NCT00679432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110568380|NCT02560870|Chlorhexidine|chlorhexidine|mesh-list
110568381|NCT02560870|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110568382|NCT02560870|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110568383|NCT02560870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110568384|NCT02560870|Disinfectants|disinfectants|mesh-ancestor
110568385|NCT02560870|Dermatologic Agents|dermatologic agents|mesh-ancestor
110568386|NCT04050826|Lidocaine|lidocaine|mesh-list
110568387|NCT04050826|Prilocaine|prilocaine|mesh-list
110568388|NCT04050826|Anesthetics, Local|anesthetics, local|mesh-ancestor
110568389|NCT04050826|Anesthetics|anesthetics|mesh-ancestor
110568390|NCT04050826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110568391|NCT04050826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568392|NCT04050826|Sensory System Agents|sensory system agents|mesh-ancestor
110568393|NCT04050826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110568394|NCT04050826|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110568395|NCT04050826|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110568396|NCT04050826|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110568397|NCT04050826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110568398|NCT04050826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568400|NCT00757978|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110568401|NCT00757978|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110568402|NCT00757978|Dopamine Agents|dopamine agents|mesh-ancestor
110568403|NCT00757978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110568404|NCT00757978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568405|NCT00757978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568406|NCT00757978|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110568407|NCT00757978|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110568408|NCT00754702|Vinorelbine|vinorelbine|mesh-list
110568409|NCT00754702|Lapatinib|lapatinib|mesh-list
110568410|NCT00754702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110568411|NCT00754702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110568412|NCT00754702|Tubulin Modulators|tubulin modulators|mesh-ancestor
110568413|NCT00754702|Antimitotic Agents|antimitotic agents|mesh-ancestor
110568414|NCT00754702|Mitosis Modulators|mitosis modulators|mesh-ancestor
110568415|NCT00754702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568416|NCT00754702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110568417|NCT00754702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110568418|NCT00754780|Pirfenidone|pirfenidone|mesh-list
110568419|NCT00754780|Analgesics|analgesics|mesh-ancestor
110568420|NCT00754780|Sensory System Agents|sensory system agents|mesh-ancestor
110568421|NCT00754780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110568422|NCT00754780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568423|NCT00754780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110568424|NCT00754780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110568425|NCT00754780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110568426|NCT00754780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110568427|NCT00754780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110568428|NCT00822900|Progesterone|progesterone|mesh-list
110568429|NCT00822900|Progestins|progestins|mesh-ancestor
110568430|NCT00822900|Hormones|hormones|mesh-ancestor
110568431|NCT00822900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110568432|NCT00822900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568434|NCT00682786|Irinotecan|irinotecan|mesh-list
110568435|NCT00682786|Antimetabolites|antimetabolites|mesh-ancestor
110568436|NCT00682786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568437|NCT00682786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110568438|NCT00682786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110568439|NCT00682786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110568440|NCT00682786|Immunologic Factors|immunologic factors|mesh-ancestor
110568441|NCT00682786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568442|NCT00682786|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110568443|NCT00682786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110568444|NCT00682786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110568445|NCT00840450|Paclitaxel|paclitaxel|mesh-list
110568446|NCT00840450|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110568447|NCT00840450|Imatinib Mesylate|imatinib mesylate|mesh-list
110568448|NCT00840450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110568449|NCT00840450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110568450|NCT00840450|Tubulin Modulators|tubulin modulators|mesh-ancestor
110568451|NCT00840450|Antimitotic Agents|antimitotic agents|mesh-ancestor
110568452|NCT00840450|Mitosis Modulators|mitosis modulators|mesh-ancestor
110568453|NCT00840450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568454|NCT00840450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110568455|NCT00840450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110568456|NCT00754858|Belotecan|belotecan|mesh-list
110568457|NCT00754858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110568458|NCT00754858|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110568459|NCT00754858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110568460|NCT00754858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110568461|NCT00754858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568462|NCT00755014|Ethanol|ethanol|mesh-list
110568463|NCT00755014|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110568464|NCT00755014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110568465|NCT00755014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110568466|NCT00755014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568467|NCT00705588|Tadalafil|tadalafil|mesh-list
110568468|NCT00705588|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110568469|NCT00705588|Vasodilator Agents|vasodilator agents|mesh-ancestor
110568470|NCT00705588|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110568471|NCT00705588|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110568472|NCT00705588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110568473|NCT00705588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568474|NCT00705588|Urological Agents|urological agents|mesh-ancestor
110568475|NCT00755170|Bevacizumab|bevacizumab|mesh-list
110568476|NCT00755170|Vinorelbine|vinorelbine|mesh-list
110568477|NCT00755170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110568478|NCT00755170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110568479|NCT00755170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110568480|NCT00755170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110568481|NCT00755170|Growth Substances|growth substances|mesh-ancestor
110568482|NCT00755170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568483|NCT00755170|Growth Inhibitors|growth inhibitors|mesh-ancestor
110568484|NCT00755170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110568485|NCT00755170|Tubulin Modulators|tubulin modulators|mesh-ancestor
110568486|NCT00755170|Antimitotic Agents|antimitotic agents|mesh-ancestor
110568487|NCT00755170|Mitosis Modulators|mitosis modulators|mesh-ancestor
110568488|NCT00755170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568490|NCT00705822|Hydrocortisone|hydrocortisone|mesh-list
110568491|NCT00705822|Docetaxel|docetaxel|mesh-list
110568492|NCT00705822|Estramustine|estramustine|mesh-list
110568493|NCT00705822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110568494|NCT00705822|Tubulin Modulators|tubulin modulators|mesh-ancestor
110568495|NCT00705822|Antimitotic Agents|antimitotic agents|mesh-ancestor
110568496|NCT00705822|Mitosis Modulators|mitosis modulators|mesh-ancestor
110568497|NCT00705822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568498|NCT00705822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110568499|NCT00705822|Glucocorticoids|glucocorticoids|mesh-ancestor
110568500|NCT00705822|Hormones|hormones|mesh-ancestor
110568501|NCT00705822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110568502|NCT00705822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568503|NCT00705822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110568504|NCT00705822|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110568505|NCT00705822|Alkylating Agents|alkylating agents|mesh-ancestor
110568506|NCT00840294|Ciprofloxacin|ciprofloxacin|mesh-list
110568507|NCT00840294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110568508|NCT00840294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110568509|NCT00840294|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110568510|NCT00840294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110568511|NCT00840294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110568512|NCT00840294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568513|NCT00840294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110568514|NCT00840294|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110568515|NCT00840294|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110568517|NCT00703170|Sirolimus|sirolimus|mesh-list
110568518|NCT00703170|Doxorubicin|doxorubicin|mesh-list
110568519|NCT00703170|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110568520|NCT00703170|Temsirolimus|temsirolimus|mesh-list
110568521|NCT00703170|MTOR Inhibitors|mtor inhibitors|mesh-list
110568522|NCT00703170|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110568523|NCT00703170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110568524|NCT00703170|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110568525|NCT00703170|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110568526|NCT00703170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110568527|NCT00703170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568528|NCT00703170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110568529|NCT00703170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110568530|NCT00703170|Immunologic Factors|immunologic factors|mesh-ancestor
110568531|NCT00703170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568532|NCT00703170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110568533|NCT00703170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110568534|NCT00703170|Antifungal Agents|antifungal agents|mesh-ancestor
110568538|NCT00758134|Trastuzumab|trastuzumab|mesh-list
110568539|NCT00758134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110568540|NCT00758134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110568541|NCT02560636|Pembrolizumab|pembrolizumab|mesh-list
110568542|NCT02560636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110568543|NCT02560636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110568544|NCT02560636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110568545|NCT02560636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568546|NCT00758212|Vaccines|vaccines|mesh-list
110568547|NCT00758212|Immunologic Factors|immunologic factors|mesh-ancestor
110568548|NCT00758212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568549|NCT00680056|Formoterol Fumarate|formoterol fumarate|mesh-list
110568550|NCT00680056|Tiotropium Bromide|tiotropium bromide|mesh-list
110568551|NCT00680056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110568552|NCT00680056|Autonomic Agents|autonomic agents|mesh-ancestor
110568553|NCT00680056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110568554|NCT00680056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568555|NCT00680056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110568556|NCT00680056|Respiratory System Agents|respiratory system agents|mesh-ancestor
110568557|NCT00680056|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110568558|NCT00680056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110568559|NCT00680056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110568560|NCT00680056|Adrenergic Agents|adrenergic agents|mesh-ancestor
110568561|NCT00680056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110568562|NCT00680056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568563|NCT00680056|Parasympatholytics|parasympatholytics|mesh-ancestor
110568564|NCT00680056|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110568565|NCT00680056|Cholinergic Agents|cholinergic agents|mesh-ancestor
110568567|NCT00758368|Emetics|emetics|mesh-ancestor
110568568|NCT00758368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568569|NCT00758368|Autonomic Agents|autonomic agents|mesh-ancestor
110568570|NCT00758368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110568571|NCT00758368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110568572|NCT00758368|Dopamine Agonists|dopamine agonists|mesh-ancestor
110568573|NCT00758368|Dopamine Agents|dopamine agents|mesh-ancestor
110568574|NCT00758368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110568575|NCT00758368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568577|NCT05435560|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110568578|NCT05435560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110568579|NCT05435560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568580|NCT05435560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110568581|NCT05435560|Analgesics|analgesics|mesh-ancestor
110568582|NCT05435560|Sensory System Agents|sensory system agents|mesh-ancestor
110568583|NCT05435560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110568584|NCT05435560|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110568585|NCT05435560|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110568586|NCT05435560|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110568587|NCT05435560|Adrenergic Agents|adrenergic agents|mesh-ancestor
110568588|NCT05435560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110568589|NCT05435560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568590|NCT00680992|Denosumab|denosumab|mesh-list
110568591|NCT00680992|Immunoglobulins|immunoglobulins|mesh-list
110568592|NCT00680992|Immunoglobulin G|immunoglobulin g|mesh-list
110568593|NCT00680992|Immunologic Factors|immunologic factors|mesh-ancestor
110568594|NCT00680992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568595|NCT00680992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110568596|NCT02559154|Thalidomide|thalidomide|mesh-list
110568597|NCT02559154|Dexamethasone|dexamethasone|mesh-list
110568598|NCT02559154|Cyclophosphamide|cyclophosphamide|mesh-list
110568599|NCT02559154|Doxorubicin|doxorubicin|mesh-list
110568600|NCT02559154|Bortezomib|bortezomib|mesh-list
110568601|NCT02559154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110568602|NCT02559154|Immunologic Factors|immunologic factors|mesh-ancestor
110568603|NCT02559154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568604|NCT02559154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110568605|NCT02559154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110568606|NCT02559154|Alkylating Agents|alkylating agents|mesh-ancestor
110260189|NCT00168909|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
110568607|NCT02559154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568608|NCT02559154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110568609|NCT02559154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110568610|NCT02559154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110568611|NCT02559154|Antiemetics|antiemetics|mesh-ancestor
110568612|NCT02559154|Autonomic Agents|autonomic agents|mesh-ancestor
110568613|NCT02559154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110568614|NCT02559154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110568615|NCT02559154|Glucocorticoids|glucocorticoids|mesh-ancestor
110568616|NCT02559154|Hormones|hormones|mesh-ancestor
110568617|NCT02559154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110568618|NCT02559154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110568619|NCT02559154|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110568620|NCT02559154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110568621|NCT02559154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110568622|NCT02559154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110568623|NCT02559154|Leprostatic Agents|leprostatic agents|mesh-ancestor
110568624|NCT02559154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110568625|NCT02559154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110568626|NCT02559154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110568627|NCT02559154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110568628|NCT02559154|Growth Substances|growth substances|mesh-ancestor
110568629|NCT02559154|Growth Inhibitors|growth inhibitors|mesh-ancestor
110568630|NCT00678886|Muromonab-CD3|muromonab-cd3|mesh-list
110568631|NCT00678886|Immunologic Factors|immunologic factors|mesh-ancestor
110568632|NCT00678886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568633|NCT00678886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110568634|NCT05747469|Lidocaine|lidocaine|mesh-list
110568635|NCT05747469|Anesthetics, Local|anesthetics, local|mesh-list
110568636|NCT05747469|Anesthetics|anesthetics|mesh-list
110568637|NCT05747469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110568638|NCT05747469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568639|NCT05747469|Sensory System Agents|sensory system agents|mesh-ancestor
110568640|NCT05747469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110568641|NCT05747469|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110568642|NCT05747469|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110568643|NCT05747469|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110568644|NCT05747469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110568645|NCT05747469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568646|NCT00804843|Niacin|niacin|mesh-list
110568647|NCT00804843|Atorvastatin|atorvastatin|mesh-list
110568648|NCT00804843|Simvastatin|simvastatin|mesh-list
110568649|NCT00804843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110568650|NCT00804843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110568651|NCT00804843|Antimetabolites|antimetabolites|mesh-ancestor
110568652|NCT00804843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568653|NCT00804843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110568654|NCT00804843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110568655|NCT00804843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110568656|NCT00804843|Vasodilator Agents|vasodilator agents|mesh-ancestor
110568657|NCT00804843|Vitamin B Complex|vitamin b complex|mesh-ancestor
110568658|NCT00804843|Vitamins|vitamins|mesh-ancestor
110568659|NCT00804843|Micronutrients|micronutrients|mesh-ancestor
110568660|NCT00804843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568662|NCT00822120|Cyclophosphamide|cyclophosphamide|mesh-list
110568663|NCT00822120|Dacarbazine|dacarbazine|mesh-list
110568664|NCT00822120|Doxorubicin|doxorubicin|mesh-list
110568665|NCT00822120|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110568667|NCT00822120|Vincristine|vincristine|mesh-list
110568668|NCT00822120|Bleomycin|bleomycin|mesh-list
110568669|NCT00822120|Vinblastine|vinblastine|mesh-list
110568670|NCT00822120|Procarbazine|procarbazine|mesh-list
110568671|NCT00822120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110568672|NCT00822120|Immunologic Factors|immunologic factors|mesh-ancestor
110568673|NCT00822120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568674|NCT00822120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110568675|NCT00822120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110568676|NCT00822120|Alkylating Agents|alkylating agents|mesh-ancestor
110568677|NCT00822120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568678|NCT00822120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110568679|NCT00822120|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110568680|NCT00822120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110568681|NCT00822120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110568682|NCT00822120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110568683|NCT00822120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110568684|NCT00822120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110568685|NCT00822120|Glucocorticoids|glucocorticoids|mesh-ancestor
110568686|NCT00822120|Hormones|hormones|mesh-ancestor
110568687|NCT00822120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110568688|NCT00822120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110568689|NCT00822120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110568690|NCT00822120|Tubulin Modulators|tubulin modulators|mesh-ancestor
110568691|NCT00822120|Antimitotic Agents|antimitotic agents|mesh-ancestor
110568692|NCT00822120|Mitosis Modulators|mitosis modulators|mesh-ancestor
110568693|NCT00804687|Pseudoephedrine|pseudoephedrine|mesh-list
110568694|NCT00804687|Ephedrine|ephedrine|mesh-list
110568695|NCT00804687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110568696|NCT00804687|Autonomic Agents|autonomic agents|mesh-ancestor
110568697|NCT00804687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110568698|NCT00804687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568699|NCT00804687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110568700|NCT00804687|Respiratory System Agents|respiratory system agents|mesh-ancestor
110568701|NCT00804687|Nasal Decongestants|nasal decongestants|mesh-ancestor
110568702|NCT00804687|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110568703|NCT00804687|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110568704|NCT00804687|Sympathomimetics|sympathomimetics|mesh-ancestor
110568705|NCT00804687|Adrenergic Agents|adrenergic agents|mesh-ancestor
110568706|NCT00804687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110568707|NCT00804687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568708|NCT00678652|Vaccines|vaccines|mesh-list
110568709|NCT00678652|Immunologic Factors|immunologic factors|mesh-ancestor
110568710|NCT00678652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568711|NCT02607657|Eplerenone|eplerenone|mesh-list
110568712|NCT02607657|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110568714|NCT02607657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110568715|NCT02607657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568716|NCT02607657|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110568717|NCT02607657|Diuretics|diuretics|mesh-ancestor
110568718|NCT02607657|Natriuretic Agents|natriuretic agents|mesh-ancestor
110568719|NCT02607657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110568720|NCT00574912|Insulin|insulin|mesh-list
110568721|NCT00574912|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110568722|NCT00574912|Insulin Glargine|insulin glargine|mesh-list
110568723|NCT00574912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110568724|NCT00574912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568725|NCT00922896|Gemcitabine|gemcitabine|mesh-list
110568726|NCT00922896|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110568727|NCT00922896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110568728|NCT00922896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110568729|NCT00922896|Antimetabolites|antimetabolites|mesh-ancestor
110190802|NCT00025493|Mitosis Modulators|mitosis modulators|mesh-ancestor
110568730|NCT00922896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568731|NCT00922896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110568732|NCT00922896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110568734|NCT00761020|Antimalarials|antimalarials|mesh-ancestor
110568735|NCT00761020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110568736|NCT00761020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110568737|NCT00761020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110568738|NCT00804141|Bromides|bromides|mesh-list
110568739|NCT00804141|Methylnaltrexone|methylnaltrexone|mesh-list
110568740|NCT00804141|Anticonvulsants|anticonvulsants|mesh-ancestor
110568741|NCT00804141|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110568742|NCT00804141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568743|NCT00804141|Sensory System Agents|sensory system agents|mesh-ancestor
110568744|NCT00804141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110568745|NCT00677092|Imatinib Mesylate|imatinib mesylate|mesh-list
110568746|NCT00677092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110568747|NCT00677092|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110568748|NCT00677092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110568749|NCT00677092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568750|NCT02607579|Ropivacaine|ropivacaine|mesh-list
110568751|NCT02607579|Anesthetics, Local|anesthetics, local|mesh-ancestor
110568752|NCT02607579|Anesthetics|anesthetics|mesh-ancestor
110568753|NCT02607579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110568754|NCT02607579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568755|NCT02607579|Sensory System Agents|sensory system agents|mesh-ancestor
110568756|NCT02607579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110568757|NCT03539367|Acetazolamide|acetazolamide|mesh-list
110568758|NCT03539367|Anticonvulsants|anticonvulsants|mesh-ancestor
110568759|NCT03539367|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110568760|NCT03539367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110568761|NCT03539367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568762|NCT03539367|Diuretics|diuretics|mesh-ancestor
110568763|NCT03539367|Natriuretic Agents|natriuretic agents|mesh-ancestor
110568764|NCT03539367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568765|NCT03416361|Vitamin D|vitamin d|mesh-list
110568766|NCT03416361|Cholecalciferol|cholecalciferol|mesh-list
110568767|NCT03416361|Vitamins|vitamins|mesh-ancestor
110568768|NCT03416361|Micronutrients|micronutrients|mesh-ancestor
110568769|NCT03416361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568770|NCT03416361|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110568771|NCT03416361|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110568772|NCT00761254|Domperidone|domperidone|mesh-list
110568773|NCT00761254|Antiemetics|antiemetics|mesh-ancestor
110568774|NCT00761254|Autonomic Agents|autonomic agents|mesh-ancestor
110568775|NCT00761254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110568776|NCT00761254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568777|NCT00761254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110568778|NCT00761254|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110568779|NCT00761254|Dopamine Agents|dopamine agents|mesh-ancestor
110568780|NCT00761254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110568781|NCT00761254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568782|NCT00761332|Teriparatide|teriparatide|mesh-list
110568783|NCT00761332|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
110568785|NCT00761332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110568786|NCT00761332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568787|NCT00761332|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110568788|NCT00761332|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110568789|NCT00761332|Hormone Antagonists|hormone antagonists|mesh-ancestor
110568790|NCT00761332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110568791|NCT00761332|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110568792|NCT00761332|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110568793|NCT03321201|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110568794|NCT03321201|Hemostatics|hemostatics|mesh-ancestor
110568795|NCT03321201|Coagulants|coagulants|mesh-ancestor
110568796|NCT02612220|Hemostatics|hemostatics|mesh-list
110568797|NCT02612220|Coagulants|coagulants|mesh-ancestor
110568798|NCT04627246|Vaccines|vaccines|mesh-list
110568799|NCT04627246|Immunologic Factors|immunologic factors|mesh-ancestor
110568801|NCT00761644|Sirolimus|sirolimus|mesh-list
110568802|NCT00761644|Bevacizumab|bevacizumab|mesh-list
110568803|NCT00761644|Doxorubicin|doxorubicin|mesh-list
110568804|NCT00761644|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110568805|NCT00761644|Temsirolimus|temsirolimus|mesh-list
110568806|NCT00761644|MTOR Inhibitors|mtor inhibitors|mesh-list
110568807|NCT00761644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110568808|NCT00761644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110568809|NCT00761644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110568810|NCT00761644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110568811|NCT00761644|Growth Substances|growth substances|mesh-ancestor
110568812|NCT00761644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568813|NCT00761644|Growth Inhibitors|growth inhibitors|mesh-ancestor
110568814|NCT00761644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110568815|NCT00761644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110568816|NCT00761644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110568817|NCT00761644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110568818|NCT00761644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568819|NCT00761644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110568820|NCT00761644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110568821|NCT00761644|Immunologic Factors|immunologic factors|mesh-ancestor
110568822|NCT00761644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110568823|NCT00761644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110568824|NCT00761644|Antifungal Agents|antifungal agents|mesh-ancestor
110568825|NCT02559388|Montelukast|montelukast|mesh-list
110568826|NCT02559388|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110568827|NCT02559388|Respiratory System Agents|respiratory system agents|mesh-ancestor
110568828|NCT02559388|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110568829|NCT02559388|Hormone Antagonists|hormone antagonists|mesh-ancestor
110568830|NCT02559388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110568831|NCT02559388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568832|NCT02559388|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110568833|NCT02559388|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110568834|NCT02559388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568835|NCT03168256|Apremilast|apremilast|mesh-list
110568836|NCT03168256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110568837|NCT03168256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110568838|NCT03168256|Analgesics|analgesics|mesh-ancestor
110568839|NCT03168256|Sensory System Agents|sensory system agents|mesh-ancestor
110568840|NCT03168256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110568841|NCT03168256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568842|NCT03168256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110568843|NCT03168256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110568844|NCT03168256|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110568845|NCT03168256|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110568846|NCT03168256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110568847|NCT03168256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568848|NCT00761722|Azacitidine|azacitidine|mesh-list
110568849|NCT00761722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110568850|NCT00761722|Antimetabolites|antimetabolites|mesh-ancestor
110568851|NCT00761722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568852|NCT00761722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110568853|NCT00761722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110568854|NCT04507906|Nivolumab|nivolumab|mesh-list
110568855|NCT04507906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110568856|NCT04507906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110568857|NCT04507906|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110568858|NCT04507906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568860|NCT00762190|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110568861|NCT00762190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110568862|NCT00762190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568863|NCT00762346|Zoledronic Acid|zoledronic acid|mesh-list
110568864|NCT00762346|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110568865|NCT00762346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568866|NCT00762658|Betamethasone|betamethasone|mesh-list
110568867|NCT00762658|Tacrolimus|tacrolimus|mesh-list
110568868|NCT00762658|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
110568869|NCT00762658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110568870|NCT00762658|Immunologic Factors|immunologic factors|mesh-ancestor
110568871|NCT00762658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568872|NCT00762658|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110568873|NCT00762658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110568874|NCT00762658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568875|NCT00762658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110568876|NCT00762658|Glucocorticoids|glucocorticoids|mesh-ancestor
110568877|NCT00762658|Hormones|hormones|mesh-ancestor
110568878|NCT00762658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110568879|NCT00762658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110568880|NCT00762658|Respiratory System Agents|respiratory system agents|mesh-ancestor
110568881|NCT02558452|Tacrolimus|tacrolimus|mesh-list
110568882|NCT02558452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110568883|NCT02558452|Immunologic Factors|immunologic factors|mesh-ancestor
110568884|NCT02558452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568885|NCT02558452|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110568886|NCT02558452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110568887|NCT02558452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568888|NCT00762736|Pioglitazone|pioglitazone|mesh-list
110568889|NCT00762736|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
110216400|NCT02966288|Ibuprofen|ibuprofen|mesh-list
110568890|NCT00762736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110568891|NCT00762736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568892|NCT00762736|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110568893|NCT00762736|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110568894|NCT00762736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568895|NCT02915224|Obinutuzumab|obinutuzumab|mesh-list
110568896|NCT02915224|Chlorambucil|chlorambucil|mesh-list
110568897|NCT02915224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110568898|NCT02915224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110568899|NCT02915224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110568900|NCT02915224|Alkylating Agents|alkylating agents|mesh-ancestor
110568901|NCT02915224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568902|NCT02813824|Aspirin|aspirin|mesh-list
110568903|NCT02813824|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
110568904|NCT02813824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110568905|NCT02813824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110568906|NCT02813824|Analgesics|analgesics|mesh-ancestor
110190844|NCT00025649|Melphalan|melphalan|mesh-list
110568907|NCT02813824|Sensory System Agents|sensory system agents|mesh-ancestor
110568908|NCT02813824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110568909|NCT02813824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568910|NCT02813824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110568911|NCT02813824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110568912|NCT02813824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110568913|NCT02813824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110568914|NCT02813824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568915|NCT02813824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110568916|NCT02813824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110568917|NCT02813824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110568918|NCT02813824|Antipyretics|antipyretics|mesh-ancestor
110568919|NCT00673894|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110568920|NCT00673894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110568921|NCT00673894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568924|NCT00673894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110568925|NCT00673894|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110568926|NCT00673894|Protease Inhibitors|protease inhibitors|mesh-ancestor
110568927|NCT00673894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110568928|NCT00673894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568929|NCT00763204|Betamethasone|betamethasone|mesh-list
110568930|NCT00763204|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
110568931|NCT00763204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110568932|NCT00763204|Glucocorticoids|glucocorticoids|mesh-ancestor
110568933|NCT00763204|Hormones|hormones|mesh-ancestor
110568934|NCT00763204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110568935|NCT00763204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568936|NCT00763204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110568937|NCT00763204|Respiratory System Agents|respiratory system agents|mesh-ancestor
110568938|NCT02558218|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
110568939|NCT02558218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110568940|NCT02558218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110568941|NCT02558218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110568942|NCT02558218|Glucocorticoids|glucocorticoids|mesh-ancestor
110568943|NCT02558218|Hormones|hormones|mesh-ancestor
110568944|NCT02558218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110568945|NCT02558218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568946|NCT02558218|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110568947|NCT02558218|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110568948|NCT00763438|Sertindole|sertindole|mesh-list
110568949|NCT00763438|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110568950|NCT00763438|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110568951|NCT00763438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110568952|NCT00763438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568953|NCT00763438|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110568954|NCT02559232|Anticoagulants|anticoagulants|mesh-list
110568955|NCT00673816|Sunitinib|sunitinib|mesh-list
110568956|NCT00673816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110568957|NCT00673816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110568958|NCT00673816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110568959|NCT00673816|Growth Substances|growth substances|mesh-ancestor
110568960|NCT00673816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568961|NCT00673816|Growth Inhibitors|growth inhibitors|mesh-ancestor
110568962|NCT00673816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110568963|NCT00673816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110568964|NCT00673816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568966|NCT00763906|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110568967|NCT00763906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110568968|NCT00763906|Adrenergic Agents|adrenergic agents|mesh-ancestor
110568969|NCT00763906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110568970|NCT00763906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568971|NCT00763906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568972|NCT00763906|Sympathomimetics|sympathomimetics|mesh-ancestor
110568973|NCT00763906|Autonomic Agents|autonomic agents|mesh-ancestor
110568974|NCT00763906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110568975|NCT00763906|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110568976|NCT00764062|Amoxicillin|amoxicillin|mesh-list
110568977|NCT00764062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110568978|NCT00764062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110568980|NCT00758914|Vitamins|vitamins|mesh-ancestor
110568981|NCT00758914|Micronutrients|micronutrients|mesh-ancestor
110568982|NCT00758914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568983|NCT00758914|Antioxidants|antioxidants|mesh-ancestor
110568984|NCT00758914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568985|NCT00758914|Protective Agents|protective agents|mesh-ancestor
110568986|NCT00759070|Ritonavir|ritonavir|mesh-list
110568987|NCT00759070|Lopinavir|lopinavir|mesh-list
110568988|NCT00759070|Tenofovir|tenofovir|mesh-list
110568989|NCT00759070|Emtricitabine|emtricitabine|mesh-list
110568990|NCT00759070|Efavirenz|efavirenz|mesh-list
110568991|NCT00759070|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110568992|NCT00759070|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110568993|NCT00759070|Protease Inhibitors|protease inhibitors|mesh-ancestor
110568994|NCT00759070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110568995|NCT00759070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568996|NCT00759070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110568997|NCT00759070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110568999|NCT00759070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110569000|NCT00759070|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110569001|NCT00759070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110569002|NCT00759070|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110569003|NCT00759070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110569004|NCT00759070|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110569005|NCT00759070|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110569006|NCT00759070|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110569007|NCT00759070|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110569008|NCT00759070|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110569009|NCT00764140|Mitogens|mitogens|mesh-list
110569010|NCT00764140|Mitosis Modulators|mitosis modulators|mesh-ancestor
110569011|NCT00764140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110569012|NCT00672958|Vortioxetine|vortioxetine|mesh-list
110569013|NCT00672958|Antidepressive Agents|antidepressive agents|mesh-ancestor
110569014|NCT00672958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110569015|NCT00672958|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110569016|NCT00672958|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110569017|NCT00672958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110569018|NCT00672958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110569019|NCT00672958|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110569020|NCT00672958|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110569021|NCT00672958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110569022|NCT00672958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110569023|NCT00672958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110569024|NCT00672958|Serotonin Agents|serotonin agents|mesh-ancestor
110569025|NCT00672958|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110569026|NCT00672958|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110569027|NCT00672958|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110569028|NCT00672958|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110569029|NCT00764374|Z 338|z 338|mesh-list
110569030|NCT00764374|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110569031|NCT00764374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110569032|NCT00764374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110569033|NCT00764374|Cholinergic Agents|cholinergic agents|mesh-ancestor
110569034|NCT00764374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110569035|NCT00764374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110569036|NCT00764374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110569037|NCT00759226|Leucovorin|leucovorin|mesh-list
110569038|NCT00759226|Folic Acid|folic acid|mesh-list
110569039|NCT00759226|Cisplatin|cisplatin|mesh-list
110569040|NCT00759226|Gemcitabine|gemcitabine|mesh-list
110569041|NCT00759226|Levoleucovorin|levoleucovorin|mesh-list
110569042|NCT00759226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110569043|NCT00759226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110569044|NCT00759226|Antimetabolites|antimetabolites|mesh-ancestor
110569045|NCT00759226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110569046|NCT00759226|Antidotes|antidotes|mesh-ancestor
110569047|NCT00759226|Protective Agents|protective agents|mesh-ancestor
110569048|NCT00759226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110569049|NCT00759226|Vitamin B Complex|vitamin b complex|mesh-ancestor
110569050|NCT00759226|Vitamins|vitamins|mesh-ancestor
110569051|NCT00759226|Micronutrients|micronutrients|mesh-ancestor
110569052|NCT00759226|Hematinics|hematinics|mesh-ancestor
110569053|NCT00672646|Naproxen|naproxen|mesh-list
110569054|NCT00672646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110569055|NCT00672646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110569056|NCT00672646|Analgesics|analgesics|mesh-ancestor
110569057|NCT00672646|Sensory System Agents|sensory system agents|mesh-ancestor
110569058|NCT00672646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110569059|NCT00672646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110569060|NCT00672646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110569061|NCT00672646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110569062|NCT00672646|Gout Suppressants|gout suppressants|mesh-ancestor
110569063|NCT00672646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110569064|NCT00672646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110569065|NCT00672646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110569067|NCT00759460|Sertindole|sertindole|mesh-list
110569068|NCT00759460|Antiemetics|antiemetics|mesh-ancestor
110569069|NCT00759460|Autonomic Agents|autonomic agents|mesh-ancestor
110569070|NCT00759460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110569071|NCT00759460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110569072|NCT00759460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110569073|NCT00759460|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110569074|NCT00759460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110569075|NCT00759460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110569076|NCT00759460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110569077|NCT00759460|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110569078|NCT00759460|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110569079|NCT00759460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110569080|NCT00759460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110569081|NCT00759460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110569082|NCT00759460|Serotonin Agents|serotonin agents|mesh-ancestor
110569083|NCT00765154|Ritonavir|ritonavir|mesh-list
110569084|NCT00765154|Darunavir|darunavir|mesh-list
110569085|NCT00765154|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110569086|NCT00765154|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110569087|NCT00765154|Protease Inhibitors|protease inhibitors|mesh-ancestor
110569088|NCT00765154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110569089|NCT00765154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110569090|NCT00765154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110569091|NCT00765154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110569092|NCT00765154|Antiviral Agents|antiviral agents|mesh-ancestor
110569093|NCT00765154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110569094|NCT00765154|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110569095|NCT00765154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110569096|NCT00672490|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110569097|NCT00672490|Antidepressive Agents|antidepressive agents|mesh-ancestor
110569098|NCT00672490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110569099|NCT00672490|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110569100|NCT00672490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110569101|NCT00672490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110569102|NCT00672490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110569103|NCT00770302|Saxagliptin|saxagliptin|mesh-list
110569104|NCT00770302|Incretins|incretins|mesh-ancestor
110569105|NCT00770302|Hormones|hormones|mesh-ancestor
110569106|NCT00770302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110569107|NCT00770302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110569108|NCT00770302|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110569109|NCT00770302|Protease Inhibitors|protease inhibitors|mesh-ancestor
110569110|NCT00770302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110569111|NCT00770302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110569112|NCT00770302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110569113|NCT02557984|Naltrexone|naltrexone|mesh-list
110569114|NCT02557984|Amisulpride|amisulpride|mesh-list
110569115|NCT02557984|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110569116|NCT02557984|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110569117|NCT02557984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110569118|NCT02557984|Sensory System Agents|sensory system agents|mesh-ancestor
110569119|NCT02557984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110569120|NCT02557984|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110569121|NCT02557984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110569122|NCT02557984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110569123|NCT02557984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110569124|NCT02557984|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110569125|NCT02557984|Dopamine Agents|dopamine agents|mesh-ancestor
110569126|NCT02557984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110569127|NCT02557984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110569128|NCT02557984|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110569129|NCT02557984|Antidepressive Agents|antidepressive agents|mesh-ancestor
110569130|NCT00759928|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110569132|NCT00759928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110569133|NCT00759928|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110569134|NCT00759928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110569135|NCT00759928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110569136|NCT00670930|Omalizumab|omalizumab|mesh-list
110569137|NCT00670930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110569138|NCT00670930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110569139|NCT00670930|Respiratory System Agents|respiratory system agents|mesh-ancestor
110569140|NCT00770536|Doxorubicin|doxorubicin|mesh-list
110569141|NCT00770536|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110569142|NCT00770536|Topotecan|topotecan|mesh-list
110569143|NCT00770536|Trebananib|trebananib|mesh-list
110569144|NCT00770536|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110569145|NCT00770536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110569146|NCT00770536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110569147|NCT00770536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110569148|NCT00770536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110569149|NCT00770536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110569150|NCT00770536|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110569151|NCT00770536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110569152|NCT00770536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110569153|NCT00770536|Growth Substances|growth substances|mesh-ancestor
110569154|NCT00770536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110569155|NCT00770536|Growth Inhibitors|growth inhibitors|mesh-ancestor
110569156|NCT00771004|Pioglitazone|pioglitazone|mesh-list
110569157|NCT00771004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110569158|NCT00771004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110569159|NCT00674362|Certolizumab Pegol|certolizumab pegol|mesh-list
110569160|NCT00674362|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110569161|NCT00674362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110569162|NCT00674362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110569163|NCT00674362|Immunologic Factors|immunologic factors|mesh-ancestor
110569164|NCT00674362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110569165|NCT00674362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110569166|NCT00820950|Betamethasone|betamethasone|mesh-list
110569167|NCT00820950|Betamethasone Valerate|betamethasone valerate|mesh-list
110569168|NCT00820950|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
110569169|NCT00820950|Betamethasone benzoate|betamethasone benzoate|mesh-list
110569170|NCT00820950|Calcipotriene|calcipotriene|mesh-list
110569171|NCT00820950|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
110569172|NCT00820950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110569173|NCT00820950|Glucocorticoids|glucocorticoids|mesh-ancestor
110569174|NCT00820950|Hormones|hormones|mesh-ancestor
110569175|NCT00820950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110569176|NCT00820950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110569177|NCT00820950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110569178|NCT00820950|Respiratory System Agents|respiratory system agents|mesh-ancestor
110569179|NCT00820950|Dermatologic Agents|dermatologic agents|mesh-ancestor
110569180|NCT00765934|Lidocaine|lidocaine|mesh-list
110569181|NCT00765934|Tetracaine|tetracaine|mesh-list
110569182|NCT00765934|Anesthetics, Local|anesthetics, local|mesh-ancestor
110569183|NCT00765934|Anesthetics|anesthetics|mesh-ancestor
110569184|NCT00765934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110569185|NCT00765934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110569186|NCT00765934|Sensory System Agents|sensory system agents|mesh-ancestor
110569187|NCT00765934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110569188|NCT00765934|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110569189|NCT00765934|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110569190|NCT00765934|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110569191|NCT00765934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110569192|NCT00765934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110569193|NCT04049344|Oxaliplatin|oxaliplatin|mesh-list
110569194|NCT04049344|Decitabine|decitabine|mesh-list
110569195|NCT04049344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110569196|NCT04049344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110569197|NCT04049344|Antimetabolites|antimetabolites|mesh-ancestor
110569198|NCT04049344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110569199|NCT04049344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110569200|NCT00670306|Cetrorelix|cetrorelix|mesh-list
110569201|NCT00670306|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110569202|NCT00670306|Fertility Agents|fertility agents|mesh-ancestor
110569203|NCT00670306|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110569204|NCT00670306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110569205|NCT00670306|Hormone Antagonists|hormone antagonists|mesh-ancestor
110569206|NCT00670306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110569207|NCT00709254|Fentanyl|fentanyl|mesh-list
110569208|NCT00709254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110569209|NCT00709254|Narcotics|narcotics|mesh-ancestor
110569210|NCT00709254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110569211|NCT00709254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110569213|NCT00709254|Sensory System Agents|sensory system agents|mesh-ancestor
110569214|NCT00709254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110569215|NCT00709254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110569216|NCT00709254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110569217|NCT00709254|Anesthetics, General|anesthetics, general|mesh-ancestor
110569218|NCT00709254|Anesthetics|anesthetics|mesh-ancestor
110569219|NCT00760318|Levetiracetam|levetiracetam|mesh-list
110569220|NCT00760318|Anticonvulsants|anticonvulsants|mesh-ancestor
110569221|NCT00760318|Nootropic Agents|nootropic agents|mesh-ancestor
110569222|NCT00591630|Cytarabine|cytarabine|mesh-list
110569223|NCT00591630|Rituximab|rituximab|mesh-list
110569224|NCT00591630|Etoposide|etoposide|mesh-list
110569225|NCT00591630|Melphalan|melphalan|mesh-list
110569226|NCT00591630|Carmustine|carmustine|mesh-list
110569227|NCT00591630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110569228|NCT00591630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110569229|NCT00591630|Immunologic Factors|immunologic factors|mesh-ancestor
110569230|NCT00591630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110569231|NCT00591630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110569232|NCT00591630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110569233|NCT00591630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110569234|NCT00591630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110569235|NCT00591630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110569236|NCT00591630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110569237|NCT00591630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110569238|NCT00591630|Antimetabolites|antimetabolites|mesh-ancestor
110569239|NCT00591630|Antiviral Agents|antiviral agents|mesh-ancestor
110569240|NCT00591630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110569241|NCT00591630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110569242|NCT00591630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110569243|NCT00591630|Alkylating Agents|alkylating agents|mesh-ancestor
110569244|NCT00591630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110569245|NCT00771394|Tamsulosin|tamsulosin|mesh-list
110569246|NCT00771394|Solifenacin Succinate|solifenacin succinate|mesh-list
110569247|NCT00771394|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110569248|NCT00771394|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110569249|NCT00771394|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110569250|NCT00771394|Adrenergic Agents|adrenergic agents|mesh-ancestor
110569251|NCT00771394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110569252|NCT00771394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110569253|NCT00771394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110569254|NCT00771394|Urological Agents|urological agents|mesh-ancestor
110569255|NCT00771394|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110569256|NCT00771394|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110569257|NCT00771394|Cholinergic Agents|cholinergic agents|mesh-ancestor
110569258|NCT00670228|Insulin|insulin|mesh-list
110569259|NCT00670228|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110569260|NCT00670228|Insulin Glargine|insulin glargine|mesh-list
110569261|NCT00670228|Insulin glulisine|insulin glulisine|mesh-list
110569262|NCT00670228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110569263|NCT00670228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110569264|NCT00766246|Bevacizumab|bevacizumab|mesh-list
110569265|NCT00766246|Carboplatin|carboplatin|mesh-list
110569266|NCT00766246|Docetaxel|docetaxel|mesh-list
110569267|NCT00766246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110569268|NCT00766246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110569269|NCT00766246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110569270|NCT00766246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110569271|NCT00766246|Growth Substances|growth substances|mesh-ancestor
110569272|NCT00766246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110569273|NCT00766246|Growth Inhibitors|growth inhibitors|mesh-ancestor
110569274|NCT00766246|Tubulin Modulators|tubulin modulators|mesh-ancestor
110569275|NCT00766246|Antimitotic Agents|antimitotic agents|mesh-ancestor
110569276|NCT00766246|Mitosis Modulators|mitosis modulators|mesh-ancestor
110569277|NCT00766246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110569278|NCT00766402|Acetaminophen|acetaminophen|mesh-list
110569279|NCT00766402|Diclofenac|diclofenac|mesh-list
110569280|NCT00766402|Tramadol|tramadol|mesh-list
110569281|NCT00766402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110569282|NCT00766402|Analgesics|analgesics|mesh-ancestor
110569283|NCT00766402|Sensory System Agents|sensory system agents|mesh-ancestor
110569284|NCT00766402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110569285|NCT00766402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110569286|NCT00766402|Antipyretics|antipyretics|mesh-ancestor
110569287|NCT00766402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110569288|NCT00766402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110569289|NCT00766402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110569290|NCT00766402|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110569291|NCT00766402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110569292|NCT00766402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110569293|NCT00766402|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110569294|NCT00766402|Narcotics|narcotics|mesh-ancestor
110569295|NCT00766402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110569296|NCT00771706|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
110569297|NCT00771706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110569298|NCT00771706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110569299|NCT00760864|Methotrexate|methotrexate|mesh-list
110569300|NCT00760864|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110569301|NCT00760864|Abortifacient Agents|abortifacient agents|mesh-ancestor
110569302|NCT00760864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110569303|NCT00760864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110569304|NCT00760864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110569305|NCT00760864|Antimetabolites|antimetabolites|mesh-ancestor
110569306|NCT00760864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110569307|NCT00760864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110569308|NCT00760864|Dermatologic Agents|dermatologic agents|mesh-ancestor
110569309|NCT00760864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110569310|NCT00760864|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110569311|NCT00760864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110569312|NCT00760864|Immunologic Factors|immunologic factors|mesh-ancestor
110569313|NCT00760864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110569314|NCT00760864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110569315|NCT00766480|Fluorouracil|fluorouracil|mesh-list
110569316|NCT00766480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110569317|NCT00766480|Antimetabolites|antimetabolites|mesh-ancestor
110569318|NCT00766480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110569319|NCT00766480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110569320|NCT00766480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110569321|NCT00766480|Immunologic Factors|immunologic factors|mesh-ancestor
110569322|NCT00766480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110569323|NCT00772174|Metformin|metformin|mesh-list
110569324|NCT00772174|Pioglitazone|pioglitazone|mesh-list
110569325|NCT00772174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110569326|NCT00772174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110569327|NCT00772564|Atorvastatin|atorvastatin|mesh-list
110569328|NCT00772564|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110569329|NCT00772564|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110569330|NCT00772564|Antimetabolites|antimetabolites|mesh-ancestor
110569331|NCT00772564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110569332|NCT00772564|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110569333|NCT00772564|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110569334|NCT00772564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110569335|NCT00766870|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110569336|NCT00766870|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110569337|NCT00766870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110569338|NCT00766870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110569339|NCT00766870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110569340|NCT00766870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110569341|NCT00766870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110569342|NCT00766870|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110569343|NCT00766870|Antidepressive Agents|antidepressive agents|mesh-ancestor
110569344|NCT00766870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110569345|NCT00772720|Raltegravir Potassium|raltegravir potassium|mesh-list
110569346|NCT00772720|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110569347|NCT00772720|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110569348|NCT00772720|Antiviral Agents|antiviral agents|mesh-ancestor
110569349|NCT00772720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110569350|NCT00772720|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110569351|NCT00772720|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110569352|NCT00772720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110569353|NCT00772720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110569354|NCT00775294|Maraviroc|maraviroc|mesh-list
110569355|NCT00775294|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110569356|NCT00775294|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110569357|NCT00775294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110569358|NCT00775294|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110569359|NCT00775294|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110569360|NCT00775294|Antiviral Agents|antiviral agents|mesh-ancestor
110569361|NCT00775294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110569362|NCT00775294|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110569363|NCT00772798|Paclitaxel|paclitaxel|mesh-list
110569364|NCT00772798|Carboplatin|carboplatin|mesh-list
110569365|NCT00772798|Vorinostat|vorinostat|mesh-list
110569366|NCT00772798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110569367|NCT00772798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110569368|NCT00772798|Tubulin Modulators|tubulin modulators|mesh-ancestor
110569369|NCT00772798|Antimitotic Agents|antimitotic agents|mesh-ancestor
110569370|NCT00772798|Mitosis Modulators|mitosis modulators|mesh-ancestor
110569371|NCT00772798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110569372|NCT00772798|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110569373|NCT00772798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110569374|NCT00570778|Glycopyrrolate|glycopyrrolate|mesh-list
110569375|NCT00570778|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110569376|NCT00570778|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110569377|NCT00570778|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110569378|NCT00570778|Cholinergic Agents|cholinergic agents|mesh-ancestor
110569379|NCT00570778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110569380|NCT00570778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110569381|NCT00570778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110569382|NCT00775372|Clarithromycin|clarithromycin|mesh-list
110569383|NCT00775372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110569384|NCT00775372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110569385|NCT00775372|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110569386|NCT00775372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110569387|NCT00775372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110569388|NCT00775372|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110569389|NCT00775372|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110569390|NCT00668746|Minocycline|minocycline|mesh-list
110569391|NCT00668746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110569392|NCT00668746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110569394|NCT04047940|Valsartan|valsartan|mesh-list
110569395|NCT04047940|Atorvastatin|atorvastatin|mesh-list
110569396|NCT04047940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110569397|NCT04047940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110569398|NCT04047940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110569399|NCT04047940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110569400|NCT04047940|Antimetabolites|antimetabolites|mesh-ancestor
110569401|NCT04047940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110569402|NCT04047940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110569403|NCT04047940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110569404|NCT04047940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110569405|NCT04047940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110569406|NCT04047940|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110569407|NCT04047940|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110569408|NCT00773188|Bevacizumab|bevacizumab|mesh-list
110569409|NCT00773188|Vinorelbine|vinorelbine|mesh-list
110569410|NCT00773188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110569411|NCT00773188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110569412|NCT00773188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110569413|NCT00773188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110569414|NCT00773188|Growth Substances|growth substances|mesh-ancestor
110569415|NCT00773188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110569416|NCT00773188|Growth Inhibitors|growth inhibitors|mesh-ancestor
110569417|NCT00773188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110569418|NCT00773188|Tubulin Modulators|tubulin modulators|mesh-ancestor
110569419|NCT00773188|Antimitotic Agents|antimitotic agents|mesh-ancestor
110569420|NCT00773188|Mitosis Modulators|mitosis modulators|mesh-ancestor
110569421|NCT00773188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110569422|NCT00767260|Insulin|insulin|mesh-list
110569423|NCT00767260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110569424|NCT00767260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110569425|NCT00767494|Travoprost|travoprost|mesh-list
110569427|NCT00767494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110569428|NCT00767494|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110569429|NCT00767494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110569430|NCT00767494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110569431|NCT00773578|Nitric Oxide|nitric oxide|mesh-list
110569432|NCT00773578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110569433|NCT00773578|Autonomic Agents|autonomic agents|mesh-ancestor
110569434|NCT00773578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110569435|NCT00773578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110569436|NCT00773578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110569437|NCT00773578|Respiratory System Agents|respiratory system agents|mesh-ancestor
110569438|NCT00773578|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110569439|NCT00773578|Antioxidants|antioxidants|mesh-ancestor
110569440|NCT00773578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110569441|NCT00773578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110569442|NCT00773578|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110569443|NCT00773578|Vasodilator Agents|vasodilator agents|mesh-ancestor
110569444|NCT00773578|Gasotransmitters|gasotransmitters|mesh-ancestor
110569445|NCT00773578|Protective Agents|protective agents|mesh-ancestor
110569446|NCT00775762|Aspirin|aspirin|mesh-list
110569447|NCT00775762|Clopidogrel|clopidogrel|mesh-list
110569448|NCT00775762|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110569449|NCT00775762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110569450|NCT00775762|Analgesics|analgesics|mesh-ancestor
110569451|NCT00775762|Sensory System Agents|sensory system agents|mesh-ancestor
110569452|NCT00775762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110569453|NCT00775762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110569454|NCT00775762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110569455|NCT00775762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110569456|NCT00775762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110569457|NCT00775762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110569458|NCT00775762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110569459|NCT00775762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110569460|NCT00775762|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110569461|NCT00775762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110569462|NCT00775762|Antipyretics|antipyretics|mesh-ancestor
110569463|NCT00775762|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110569464|NCT00775762|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110569465|NCT00775762|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110569466|NCT00775762|Purinergic Agents|purinergic agents|mesh-ancestor
110569467|NCT00775762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110569468|NCT00775840|Candesartan|candesartan|mesh-list
110569469|NCT00775840|Candesartan cilexetil|candesartan cilexetil|mesh-list
110569470|NCT00775840|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110569471|NCT00775840|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110569472|NCT00775840|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110569473|NCT00775840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110569474|NCT00775918|Doxycycline|doxycycline|mesh-list
110569475|NCT00775918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110569476|NCT00775918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110569477|NCT00775918|Antimalarials|antimalarials|mesh-ancestor
110569478|NCT00775918|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110569479|NCT00775918|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110569480|NCT00878189|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
110569481|NCT00878189|Nirogacestat|nirogacestat|mesh-list
110569482|NCT00878189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110569483|NCT00878189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110569484|NCT00775996|Clorazepate Dipotassium|clorazepate dipotassium|mesh-list
110569485|NCT00775996|Anticonvulsants|anticonvulsants|mesh-ancestor
110569487|NCT00775996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110569488|NCT00775996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110569489|NCT00775996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110569490|NCT00775996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110190938|NCT00053976|Hormones|hormones|mesh-ancestor
110569491|NCT00775996|GABA Modulators|gaba modulators|mesh-ancestor
110569492|NCT00775996|GABA Agents|gaba agents|mesh-ancestor
110569493|NCT00775996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110569494|NCT00775996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110569495|NCT00773812|Mecamylamine|mecamylamine|mesh-list
110569496|NCT00773812|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110569497|NCT00773812|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
110569498|NCT00773812|Autonomic Agents|autonomic agents|mesh-ancestor
110569499|NCT00773812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110569500|NCT00773812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110569501|NCT00773812|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
110569502|NCT00773812|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110569503|NCT00773812|Cholinergic Agents|cholinergic agents|mesh-ancestor
110569505|NCT00773812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110569506|NCT00767728|Mesalamine|mesalamine|mesh-list
110569507|NCT00767728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110569508|NCT00767728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110569509|NCT00767728|Analgesics|analgesics|mesh-ancestor
110569510|NCT00767728|Sensory System Agents|sensory system agents|mesh-ancestor
110569511|NCT00767728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110569512|NCT00767728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110569513|NCT00767728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110569514|NCT00767728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110569515|NCT00776074|Leuprolide|leuprolide|mesh-list
110569516|NCT00776074|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110569517|NCT00776074|Fertility Agents|fertility agents|mesh-ancestor
110569518|NCT00776074|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110569519|NCT00776074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110569520|NCT00776074|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110569521|NCT00776074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110569522|NCT02628587|Clopidogrel|clopidogrel|mesh-list
110569523|NCT02628587|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110569524|NCT02628587|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110569525|NCT02628587|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110569526|NCT02628587|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110569527|NCT02628587|Purinergic Agents|purinergic agents|mesh-ancestor
110569528|NCT02628587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110569529|NCT02628587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110569530|NCT02628587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110569531|NCT02634437|Ulipristal acetate|ulipristal acetate|mesh-list
110569532|NCT02634437|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110569533|NCT02634437|Contraceptive Agents|contraceptive agents|mesh-ancestor
110569534|NCT02634437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110569535|NCT02634437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110569536|NCT02634437|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110569537|NCT00668200|Vitamin D|vitamin d|mesh-list
110569538|NCT00668200|Zoledronic Acid|zoledronic acid|mesh-list
110569539|NCT00668200|Calcium|calcium|mesh-list
110569540|NCT00668200|Vitamins|vitamins|mesh-ancestor
110569541|NCT00668200|Micronutrients|micronutrients|mesh-ancestor
110569542|NCT00668200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110569543|NCT00668200|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110569544|NCT00668200|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110569545|NCT00679601|Tavaborole|tavaborole|mesh-list
110569546|NCT00679601|Antifungal Agents|antifungal agents|mesh-ancestor
110569547|NCT00679601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110569548|NCT00675779|Atorvastatin|atorvastatin|mesh-list
110569549|NCT00675779|Contraceptive Agents|contraceptive agents|mesh-list
110569550|NCT00675779|Contraceptives, Oral|contraceptives, oral|mesh-list
110569551|NCT00675779|Dacuronium|dacuronium|mesh-list
110569552|NCT00675779|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110569553|NCT00675779|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110569554|NCT00675779|Antimetabolites|antimetabolites|mesh-ancestor
110569555|NCT00675779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110569556|NCT00675779|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110190951|NCT00054054|Docetaxel|docetaxel|mesh-list
110569557|NCT00675779|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110569558|NCT00675779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110569559|NCT00675779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110569560|NCT00675779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110569561|NCT00675779|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110569562|NCT00675779|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110569563|NCT00675779|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110569564|NCT00675779|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110569565|NCT00675779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110569566|NCT00774280|Cyclophosphamide|cyclophosphamide|mesh-list
110569567|NCT00774280|Busulfan|busulfan|mesh-list
110569568|NCT00774280|Fludarabine|fludarabine|mesh-list
110569569|NCT00774280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110569570|NCT00774280|Immunologic Factors|immunologic factors|mesh-ancestor
110569571|NCT00774280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110569572|NCT00774280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110569573|NCT00774280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110569574|NCT00774280|Alkylating Agents|alkylating agents|mesh-ancestor
110569575|NCT00774280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110569576|NCT00774280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110569577|NCT00774280|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110569578|NCT04151147|Mitogens|mitogens|mesh-list
110569579|NCT04151147|Mitosis Modulators|mitosis modulators|mesh-ancestor
110569580|NCT04151147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110569581|NCT00774358|Aldesleukin|aldesleukin|mesh-list
110569582|NCT00774358|Interleukin-2|interleukin-2|mesh-list
110569583|NCT00774358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110569584|NCT00774358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110569585|NCT00774358|Analgesics|analgesics|mesh-ancestor
110569586|NCT00774358|Sensory System Agents|sensory system agents|mesh-ancestor
110569587|NCT00774358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110569588|NCT00774358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110569589|NCT00774358|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110569590|NCT00774358|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110569591|NCT00774358|Antiviral Agents|antiviral agents|mesh-ancestor
110569592|NCT00774358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110569593|NCT02627417|Dapsone|dapsone|mesh-list
110569594|NCT02627417|Prednisone|prednisone|mesh-list
110569595|NCT02627417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110569596|NCT02627417|Glucocorticoids|glucocorticoids|mesh-ancestor
110569597|NCT02627417|Hormones|hormones|mesh-ancestor
110569598|NCT02627417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110569599|NCT02627417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110569600|NCT02627417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110569601|NCT02627417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110569602|NCT02627417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110569603|NCT02627417|Antimalarials|antimalarials|mesh-ancestor
110569604|NCT02627417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110569605|NCT02627417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110569606|NCT02627417|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110569607|NCT02627417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110569608|NCT02627417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110569609|NCT02627417|Leprostatic Agents|leprostatic agents|mesh-ancestor
110569610|NCT02627417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110569611|NCT00679679|Metformin|metformin|mesh-list
110569612|NCT00679679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110569613|NCT00679679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110569614|NCT00838578|Irinotecan|irinotecan|mesh-list
110569615|NCT00838578|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110569616|NCT00838578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110569617|NCT00838578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110569618|NCT00838578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110569619|NCT00838578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110569621|NCT02634515|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110569622|NCT02634515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110569623|NCT02634515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110569624|NCT00705900|Calcipotriene|calcipotriene|mesh-list
110569625|NCT00705900|Dermatologic Agents|dermatologic agents|mesh-ancestor
110569626|NCT00679835|Daptomycin|daptomycin|mesh-list
110569627|NCT00679835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110569628|NCT00679835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110569629|NCT00774904|Losartan|losartan|mesh-list
110569630|NCT00774904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110569631|NCT00774904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110569632|NCT00774904|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110569633|NCT00774904|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110569634|NCT00774904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110569635|NCT00829296|Metoprolol|metoprolol|mesh-list
110569636|NCT00829296|Nebivolol|nebivolol|mesh-list
110569637|NCT00829296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110569638|NCT00829296|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110569639|NCT00829296|Sympatholytics|sympatholytics|mesh-ancestor
110569640|NCT00829296|Autonomic Agents|autonomic agents|mesh-ancestor
110569641|NCT00829296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110569642|NCT00829296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110569643|NCT00829296|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110569644|NCT00829296|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110569645|NCT00829296|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110569646|NCT00829296|Adrenergic Agents|adrenergic agents|mesh-ancestor
110569647|NCT00829296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110569648|NCT00829296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110569649|NCT00829296|Vasodilator Agents|vasodilator agents|mesh-ancestor
110569650|NCT00829296|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110569651|NCT00829296|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110569652|NCT00829296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110569653|NCT00774982|Mercaptopurine|mercaptopurine|mesh-list
110569654|NCT00774982|Antimetabolites|antimetabolites|mesh-ancestor
110569655|NCT00774982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110569656|NCT00774982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110569657|NCT00774982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110569658|NCT00774982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110569659|NCT00774982|Immunologic Factors|immunologic factors|mesh-ancestor
110569660|NCT00774982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110569661|NCT00774982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110569662|NCT00774982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110569663|NCT00881621|Capecitabine|capecitabine|mesh-list
110569664|NCT00881621|Lapatinib|lapatinib|mesh-list
110569665|NCT00881621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110569666|NCT00881621|Antimetabolites|antimetabolites|mesh-ancestor
110569667|NCT00881621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110569668|NCT00881621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110569669|NCT00881621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110569670|NCT00881621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110569671|NCT02634281|Varenicline|varenicline|mesh-list
110569672|NCT02634281|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110569673|NCT02634281|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110569674|NCT02634281|Cholinergic Agents|cholinergic agents|mesh-ancestor
110569675|NCT02634281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110569676|NCT02634281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110569677|NCT02634281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110569678|NCT00818766|Vancomycin|vancomycin|mesh-list
110569679|NCT00818766|Cefazolin|cefazolin|mesh-list
110569680|NCT00818766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110569681|NCT00818766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110569682|NCT00779350|Sertraline|sertraline|mesh-list
110569683|NCT00779350|Antidepressive Agents|antidepressive agents|mesh-ancestor
110569684|NCT00779350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110569685|NCT00779350|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110569686|NCT00779350|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110569688|NCT00779350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110569689|NCT00779350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110569690|NCT00779350|Serotonin Agents|serotonin agents|mesh-ancestor
110569691|NCT00779350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110569692|NCT00705978|Pancreatin|pancreatin|mesh-list
110569693|NCT00705978|Pancrelipase|pancrelipase|mesh-list
110569694|NCT00705978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110569695|NCT02556970|Acetaminophen|acetaminophen|mesh-list
110569696|NCT02556970|Diclofenac|diclofenac|mesh-list
110569697|NCT02556970|Levobupivacaine|levobupivacaine|mesh-list
110569698|NCT02556970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110569699|NCT02556970|Analgesics|analgesics|mesh-ancestor
110569700|NCT02556970|Sensory System Agents|sensory system agents|mesh-ancestor
110569701|NCT02556970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110569702|NCT02556970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110569703|NCT02556970|Antipyretics|antipyretics|mesh-ancestor
110569704|NCT02556970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110569705|NCT02556970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110569706|NCT02556970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110569707|NCT02556970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110569709|NCT02556970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110569710|NCT02556970|Anesthetics, Local|anesthetics, local|mesh-ancestor
110569712|NCT02556970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110569713|NCT00594815|Leucovorin|leucovorin|mesh-list
110569714|NCT00594815|Cytarabine|cytarabine|mesh-list
110569715|NCT00594815|Rituximab|rituximab|mesh-list
110569716|NCT00594815|Methotrexate|methotrexate|mesh-list
110569717|NCT00594815|Vincristine|vincristine|mesh-list
110569718|NCT00594815|Procarbazine|procarbazine|mesh-list
110569719|NCT00594815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110569720|NCT00594815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110569721|NCT00594815|Immunologic Factors|immunologic factors|mesh-ancestor
110569722|NCT00594815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110569723|NCT00594815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110569724|NCT00594815|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110569725|NCT00594815|Abortifacient Agents|abortifacient agents|mesh-ancestor
110569726|NCT00594815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110569727|NCT00594815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110569728|NCT00594815|Antimetabolites|antimetabolites|mesh-ancestor
110569729|NCT00594815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110569730|NCT00594815|Dermatologic Agents|dermatologic agents|mesh-ancestor
110569731|NCT00594815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110569732|NCT00594815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110569733|NCT00594815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110569734|NCT00594815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110569735|NCT00594815|Antiviral Agents|antiviral agents|mesh-ancestor
110569736|NCT00594815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110569737|NCT00594815|Antidotes|antidotes|mesh-ancestor
110569738|NCT00594815|Protective Agents|protective agents|mesh-ancestor
110569739|NCT00594815|Vitamin B Complex|vitamin b complex|mesh-ancestor
110569740|NCT00594815|Vitamins|vitamins|mesh-ancestor
110569741|NCT00594815|Micronutrients|micronutrients|mesh-ancestor
110569742|NCT00594815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110569743|NCT00594815|Tubulin Modulators|tubulin modulators|mesh-ancestor
110569744|NCT00594815|Antimitotic Agents|antimitotic agents|mesh-ancestor
110569745|NCT00594815|Mitosis Modulators|mitosis modulators|mesh-ancestor
110569746|NCT00776542|Minocycline|minocycline|mesh-list
110569747|NCT00776542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110569749|NCT00776620|Glimepiride|glimepiride|mesh-list
110569750|NCT00776620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110569751|NCT00776620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110569752|NCT00776620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110569753|NCT00776620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110569754|NCT00776620|Immunologic Factors|immunologic factors|mesh-ancestor
110569755|NCT00776698|Bevacizumab|bevacizumab|mesh-list
110569756|NCT00776698|Etoposide|etoposide|mesh-list
110569757|NCT00776698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110569758|NCT00776698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110569759|NCT00776698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110569760|NCT00776698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110569761|NCT00776698|Growth Substances|growth substances|mesh-ancestor
110569762|NCT00776698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110569763|NCT00776698|Growth Inhibitors|growth inhibitors|mesh-ancestor
110569764|NCT00776698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110569765|NCT00776698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110569766|NCT00776698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110569767|NCT00776698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110569768|NCT00776698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110569770|NCT04150757|Analgesics|analgesics|mesh-ancestor
110569771|NCT04150757|Sensory System Agents|sensory system agents|mesh-ancestor
110569772|NCT04150757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110569773|NCT04150757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110569774|NCT04150757|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110569775|NCT04150757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110569776|NCT04150757|Anesthetics, General|anesthetics, general|mesh-ancestor
110569777|NCT04150757|Anesthetics|anesthetics|mesh-ancestor
110569778|NCT04150757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110569779|NCT04150757|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110569780|NCT04150757|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110569781|NCT04150757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110569782|NCT04150757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110569783|NCT04150367|Rifampin|rifampin|mesh-list
110569784|NCT04150367|Isoniazid|isoniazid|mesh-list
110569785|NCT04150367|Ethambutol|ethambutol|mesh-list
110569786|NCT04150367|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110217302|NCT00269542|Iron|iron|mesh-list
110569787|NCT04150367|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110569788|NCT04150367|Antitubercular Agents|antitubercular agents|mesh-ancestor
110569789|NCT04150367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110569790|NCT04150367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110569791|NCT04150367|Leprostatic Agents|leprostatic agents|mesh-ancestor
110569792|NCT04150367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110569793|NCT04150367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110569794|NCT04150367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110569795|NCT04150367|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110569796|NCT04150367|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110569797|NCT04150367|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110569798|NCT04150367|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110569799|NCT04150367|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110569800|NCT04150367|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110569801|NCT04150367|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110569802|NCT04150367|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110569803|NCT04150367|Antimetabolites|antimetabolites|mesh-ancestor
110569804|NCT04150367|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110569805|NCT02634203|Riociguat|riociguat|mesh-list
110569806|NCT02634203|Enzyme Activators|enzyme activators|mesh-ancestor
110569807|NCT02634203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110569808|NCT00681005|Rabeprazole|rabeprazole|mesh-list
110569809|NCT00681005|Pantoprazole|pantoprazole|mesh-list
110569810|NCT00681005|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110569811|NCT00681005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110569812|NCT00681005|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110569813|NCT00681005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110569814|NCT00681005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110569815|NCT02633969|Indomethacin|indomethacin|mesh-list
110569816|NCT02633969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110569817|NCT02633969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110569818|NCT02633969|Analgesics|analgesics|mesh-ancestor
110569819|NCT02633969|Sensory System Agents|sensory system agents|mesh-ancestor
110569820|NCT02633969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110569821|NCT02633969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110569822|NCT02633969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110569823|NCT02633969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110569824|NCT02633969|Gout Suppressants|gout suppressants|mesh-ancestor
110569825|NCT02633969|Tocolytic Agents|tocolytic agents|mesh-ancestor
110569826|NCT02633969|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110569827|NCT02633969|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110569828|NCT02633969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110569829|NCT02633969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110569830|NCT00684827|Albuterol|albuterol|mesh-list
110569831|NCT00684827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110569832|NCT00684827|Autonomic Agents|autonomic agents|mesh-ancestor
110569833|NCT00684827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110569834|NCT00684827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110569835|NCT00684827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110569836|NCT00684827|Respiratory System Agents|respiratory system agents|mesh-ancestor
110569837|NCT00684827|Tocolytic Agents|tocolytic agents|mesh-ancestor
110569838|NCT00684827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110569839|NCT00684827|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110569840|NCT00684827|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110569841|NCT00684827|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110569842|NCT00684827|Adrenergic Agents|adrenergic agents|mesh-ancestor
110569843|NCT00684827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110569844|NCT00684827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110569845|NCT00820170|Paclitaxel|paclitaxel|mesh-list
110569846|NCT00820170|Dasatinib|dasatinib|mesh-list
110569847|NCT00820170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110569848|NCT00820170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110569849|NCT00820170|Tubulin Modulators|tubulin modulators|mesh-ancestor
110569850|NCT00820170|Antimitotic Agents|antimitotic agents|mesh-ancestor
110569851|NCT00820170|Mitosis Modulators|mitosis modulators|mesh-ancestor
110569852|NCT00820170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110569854|NCT00820170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110569855|NCT02627027|Metformin|metformin|mesh-list
110569856|NCT02627027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110569857|NCT02627027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110569858|NCT00709332|Folic Acid|folic acid|mesh-list
110569859|NCT00709332|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110217359|NCT00269737|Narcotics|narcotics|mesh-ancestor
110569860|NCT00709332|Norgestimate|norgestimate|mesh-list
110569861|NCT00709332|Estradiol|estradiol|mesh-list
110569862|NCT00709332|Estrogens|estrogens|mesh-ancestor
110569863|NCT00709332|Hormones|hormones|mesh-ancestor
110569864|NCT00709332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110569865|NCT00709332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110569866|NCT00709332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110569868|NCT00709332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110569869|NCT00709332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110569870|NCT00709332|Hematinics|hematinics|mesh-ancestor
110569871|NCT00709332|Vitamin B Complex|vitamin b complex|mesh-ancestor
110569872|NCT00709332|Vitamins|vitamins|mesh-ancestor
110569873|NCT00709332|Micronutrients|micronutrients|mesh-ancestor
110569874|NCT00709332|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110569875|NCT00709332|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110569876|NCT00709332|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110569877|NCT00684905|Leuprolide|leuprolide|mesh-list
110569878|NCT00684905|Bicalutamide|bicalutamide|mesh-list
110569879|NCT00684905|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110569880|NCT00684905|Fertility Agents|fertility agents|mesh-ancestor
110569881|NCT00684905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110569882|NCT00684905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110569883|NCT00684905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110569884|NCT00684905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110569885|NCT00684905|Androgen Antagonists|androgen antagonists|mesh-ancestor
110569886|NCT00684905|Hormone Antagonists|hormone antagonists|mesh-ancestor
110569887|NCT00684905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110569888|NCT00685061|Alemtuzumab|alemtuzumab|mesh-list
110569889|NCT00685061|Thymoglobulin|thymoglobulin|mesh-list
110569890|NCT00685061|Daclizumab|daclizumab|mesh-list
110569891|NCT00685061|Immunologic Factors|immunologic factors|mesh-ancestor
110569892|NCT00685061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110569893|NCT00685061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110569894|NCT00685061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110019102|NCT00738972|Pravastatin|pravastatin|mesh-list
110569895|NCT00685061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110569896|NCT02633813|Naftifine|naftifine|mesh-list
110569897|NCT02633813|Antifungal Agents|antifungal agents|mesh-ancestor
110569898|NCT02633813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110569899|NCT00818454|Albuterol|albuterol|mesh-list
110569900|NCT00818454|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110569901|NCT00818454|Autonomic Agents|autonomic agents|mesh-ancestor
110569902|NCT00818454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110569903|NCT00818454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110569904|NCT00818454|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110569905|NCT00818454|Respiratory System Agents|respiratory system agents|mesh-ancestor
110569906|NCT00818454|Tocolytic Agents|tocolytic agents|mesh-ancestor
110569907|NCT00818454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110569908|NCT00818454|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110569909|NCT00818454|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110569910|NCT00818454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110569911|NCT00818454|Adrenergic Agents|adrenergic agents|mesh-ancestor
110569912|NCT00818454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110569913|NCT00818454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110569914|NCT02626247|Vitamin A|vitamin a|mesh-list
110569915|NCT02626247|Vitamins|vitamins|mesh-ancestor
110569916|NCT02626247|Micronutrients|micronutrients|mesh-ancestor
110569917|NCT02626247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110569919|NCT00828984|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
110569920|NCT00828984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110569921|NCT00819390|Chloroquine|chloroquine|mesh-list
110569922|NCT00819390|Amebicides|amebicides|mesh-ancestor
110569923|NCT00819390|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110569924|NCT00819390|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110569925|NCT00819390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110569926|NCT00819390|Antimalarials|antimalarials|mesh-ancestor
110569927|NCT00819390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110569928|NCT00876395|Paclitaxel|paclitaxel|mesh-list
110569929|NCT00876395|Trastuzumab|trastuzumab|mesh-list
110569930|NCT00876395|Everolimus|everolimus|mesh-list
110569931|NCT00876395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110569932|NCT00876395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110569933|NCT00876395|Tubulin Modulators|tubulin modulators|mesh-ancestor
110569934|NCT00876395|Antimitotic Agents|antimitotic agents|mesh-ancestor
110569935|NCT00876395|Mitosis Modulators|mitosis modulators|mesh-ancestor
110569936|NCT00876395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110569937|NCT00876395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110569938|NCT00876395|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110569939|NCT00876395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110569940|NCT00876395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110569941|NCT00876395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110569942|NCT00876395|Immunologic Factors|immunologic factors|mesh-ancestor
110569943|NCT00876395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110569945|NCT05758662|Fluorides|fluorides|mesh-list
110569946|NCT05758662|Sodium Fluoride|sodium fluoride|mesh-list
110569947|NCT05758662|Cariostatic Agents|cariostatic agents|mesh-ancestor
110569948|NCT05758662|Protective Agents|protective agents|mesh-ancestor
110569949|NCT05758662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110569950|NCT05758662|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110569951|NCT05758662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110569952|NCT02633657|Gabapentin|gabapentin|mesh-list
110569953|NCT02633657|Analgesics|analgesics|mesh-ancestor
110569954|NCT02633657|Sensory System Agents|sensory system agents|mesh-ancestor
110569955|NCT02633657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110569956|NCT02633657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110569957|NCT02633657|Anticonvulsants|anticonvulsants|mesh-ancestor
110569958|NCT02633657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110569959|NCT02633657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110569960|NCT02633657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110569961|NCT02633657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110569962|NCT02633657|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110569963|NCT02633657|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110569964|NCT02633657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110225489|NCT05952713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110569965|NCT02633657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110569966|NCT02633657|Antimanic Agents|antimanic agents|mesh-ancestor
110569967|NCT02626169|Clopidogrel|clopidogrel|mesh-list
110569968|NCT02626169|Ticagrelor|ticagrelor|mesh-list
110569969|NCT02626169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110569970|NCT02626169|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110569971|NCT02626169|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110569972|NCT02626169|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110569973|NCT02626169|Purinergic Agents|purinergic agents|mesh-ancestor
110569974|NCT02626169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110569975|NCT02626169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110569976|NCT02626169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110569977|NCT04139915|Dactolisib|dactolisib|mesh-list
110569978|NCT04139915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110569979|NCT04148183|Metformin|metformin|mesh-list
110569980|NCT04148183|Rosiglitazone|rosiglitazone|mesh-list
110569981|NCT04148183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110569982|NCT04148183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110569983|NCT00681395|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110569984|NCT00681395|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110569985|NCT00681395|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110569986|NCT00681395|Antimetabolites|antimetabolites|mesh-ancestor
110569987|NCT00681395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110569988|NCT00681395|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110569989|NCT00681395|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110569990|NCT00681395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110569991|NCT02633579|Erythromycin|erythromycin|mesh-list
110569992|NCT02633579|Erythromycin Estolate|erythromycin estolate|mesh-list
110569993|NCT02633579|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
110569994|NCT02633579|Erythromycin stearate|erythromycin stearate|mesh-list
110569995|NCT02633579|Erythromycin lactobionate|erythromycin lactobionate|mesh-list
110569996|NCT02633579|Atropine|atropine|mesh-list
110569997|NCT02633579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110569998|NCT02633579|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110569999|NCT02633579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110570000|NCT02633579|Autonomic Agents|autonomic agents|mesh-ancestor
110570001|NCT02633579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110570002|NCT02633579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110570003|NCT02633579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110570004|NCT02633579|Respiratory System Agents|respiratory system agents|mesh-ancestor
110570006|NCT02633579|Parasympatholytics|parasympatholytics|mesh-ancestor
110570007|NCT02633579|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110570008|NCT02633579|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110570009|NCT02633579|Cholinergic Agents|cholinergic agents|mesh-ancestor
110570010|NCT02633579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110570011|NCT02633579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110570012|NCT02633579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110570013|NCT02633579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110570014|NCT02633579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110570015|NCT02633579|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110570016|NCT02633579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110570017|NCT00685529|Formoterol Fumarate|formoterol fumarate|mesh-list
110570018|NCT00685529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110570019|NCT00685529|Autonomic Agents|autonomic agents|mesh-ancestor
110570020|NCT00685529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110570021|NCT00685529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110570022|NCT00685529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110570023|NCT00685529|Respiratory System Agents|respiratory system agents|mesh-ancestor
110570024|NCT00685529|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110570025|NCT00685529|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110570026|NCT00685529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110570027|NCT00685529|Adrenergic Agents|adrenergic agents|mesh-ancestor
110570028|NCT00685529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110570029|NCT00685529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110570032|NCT00685607|Antidiarrheals|antidiarrheals|mesh-list
110570033|NCT00685607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110570034|NCT00685607|Antifoaming Agents|antifoaming agents|mesh-ancestor
110570035|NCT00685607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110570036|NCT00685607|Emollients|emollients|mesh-ancestor
110570037|NCT00685607|Dermatologic Agents|dermatologic agents|mesh-ancestor
110570038|NCT00657059|Mycophenolic Acid|mycophenolic acid|mesh-list
110570039|NCT00657059|Prednisone|prednisone|mesh-list
110570040|NCT00657059|Methylprednisolone|methylprednisolone|mesh-list
110570041|NCT00657059|Irbesartan|irbesartan|mesh-list
110570042|NCT00657059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110570043|NCT00657059|Glucocorticoids|glucocorticoids|mesh-ancestor
110570044|NCT00657059|Hormones|hormones|mesh-ancestor
110570045|NCT00657059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110570046|NCT00657059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110570047|NCT00657059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110570048|NCT00657059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110570049|NCT00657059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110570050|NCT00657059|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110570051|NCT00657059|Antitubercular Agents|antitubercular agents|mesh-ancestor
110570052|NCT00657059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110570053|NCT00657059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110570054|NCT00657059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110570055|NCT00657059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110570056|NCT00657059|Antiemetics|antiemetics|mesh-ancestor
110570057|NCT00657059|Autonomic Agents|autonomic agents|mesh-ancestor
110570058|NCT00657059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110570059|NCT00657059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110191122|NCT00054522|Vitamins|vitamins|mesh-ancestor
110570060|NCT00657059|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110570061|NCT00657059|Protective Agents|protective agents|mesh-ancestor
110570062|NCT00657059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110570063|NCT00657059|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110570064|NCT00657059|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110570066|NCT00667732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110570067|NCT00667732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110570068|NCT00667732|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110570069|NCT00667732|Incretins|incretins|mesh-ancestor
110570070|NCT00667732|Hormones|hormones|mesh-ancestor
110570071|NCT00667732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110570072|NCT04161209|Citalopram|citalopram|mesh-list
110570073|NCT04161209|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110570074|NCT04161209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110570075|NCT04161209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110570076|NCT04161209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110570077|NCT04161209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110570078|NCT04161209|Serotonin Agents|serotonin agents|mesh-ancestor
110570079|NCT04161209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110570080|NCT04161209|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110570081|NCT04161209|Antidepressive Agents|antidepressive agents|mesh-ancestor
110570082|NCT04161209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110570083|NCT04161053|Rifaximin|rifaximin|mesh-list
110570084|NCT04161053|Nitazoxanide|nitazoxanide|mesh-list
110570085|NCT04161053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110570086|NCT04161053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110570087|NCT04161053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110570088|NCT04161053|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110570089|NCT00685841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110570090|NCT00685841|Formoterol Fumarate|formoterol fumarate|mesh-list
110570091|NCT00685841|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110570092|NCT00685841|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110570093|NCT00685841|Autonomic Agents|autonomic agents|mesh-ancestor
110570094|NCT00685841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110570095|NCT00685841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110570096|NCT00685841|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110570097|NCT00685841|Respiratory System Agents|respiratory system agents|mesh-ancestor
110570098|NCT00685841|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110570099|NCT00685841|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110570100|NCT00685841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110570101|NCT00685841|Adrenergic Agents|adrenergic agents|mesh-ancestor
110570102|NCT00685841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110570103|NCT00685841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110570105|NCT00681785|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110570106|NCT00681785|Anticoagulants|anticoagulants|mesh-ancestor
110570107|NCT00681785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110570108|NCT00681785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110570109|NCT00681785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110570110|NCT00671788|Dasatinib|dasatinib|mesh-list
110570111|NCT00671788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110570112|NCT00671788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110570113|NCT00671788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110570114|NCT00671788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110570116|NCT02626481|Daratumumab|daratumumab|mesh-list
110570117|NCT02626481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110570118|NCT02626481|Antiemetics|antiemetics|mesh-ancestor
110570119|NCT02626481|Autonomic Agents|autonomic agents|mesh-ancestor
110570120|NCT02626481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110570121|NCT02626481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110570122|NCT02626481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110570123|NCT02626481|Glucocorticoids|glucocorticoids|mesh-ancestor
110570124|NCT02626481|Hormones|hormones|mesh-ancestor
110260190|NCT00168909|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110570125|NCT02626481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110570126|NCT02626481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110570127|NCT02626481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110570128|NCT00777166|Oxytocin|oxytocin|mesh-list
110570129|NCT00777166|Oxytocics|oxytocics|mesh-ancestor
110570130|NCT00777166|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110570131|NCT00777166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110570132|NCT00681941|Sevelamer|sevelamer|mesh-list
110570133|NCT00681941|Chelating Agents|chelating agents|mesh-ancestor
110570134|NCT00681941|Sequestering Agents|sequestering agents|mesh-ancestor
110570135|NCT00681941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110570136|NCT00657137|Capecitabine|capecitabine|mesh-list
110570137|NCT00657137|Lapatinib|lapatinib|mesh-list
110570138|NCT00657137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110570139|NCT00657137|Antimetabolites|antimetabolites|mesh-ancestor
110570140|NCT00657137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110570141|NCT00657137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110570142|NCT00657137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110570144|NCT00777244|Mitotane|mitotane|mesh-list
110570145|NCT00777244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110570146|NCT00777244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110570147|NCT04160897|Tenofovir|tenofovir|mesh-list
110570148|NCT04160897|Entecavir|entecavir|mesh-list
110570149|NCT04160897|Antiviral Agents|antiviral agents|mesh-ancestor
110570150|NCT04160897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110570151|NCT04160897|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110570152|NCT04160897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110570153|NCT04160897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110570154|NCT04160897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110570155|NCT04160897|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110570156|NCT04160897|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110570157|NCT00777322|Riboflavin|riboflavin|mesh-list
110570158|NCT00777322|Dextrans|dextrans|mesh-list
110570159|NCT00777322|Vitamin B Complex|vitamin b complex|mesh-ancestor
110570160|NCT00777322|Vitamins|vitamins|mesh-ancestor
110570161|NCT00777322|Micronutrients|micronutrients|mesh-ancestor
110570162|NCT00777322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110570163|NCT00777322|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110570164|NCT00777322|Dermatologic Agents|dermatologic agents|mesh-ancestor
110570165|NCT00777322|Anticoagulants|anticoagulants|mesh-ancestor
110570166|NCT00777322|Plasma Substitutes|plasma substitutes|mesh-ancestor
110570167|NCT00777322|Blood Substitutes|blood substitutes|mesh-ancestor
110570168|NCT00682019|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110570169|NCT00682019|Vasodilator Agents|vasodilator agents|mesh-ancestor
110570170|NCT00682019|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110570171|NCT00682019|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110570172|NCT00682019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110570173|NCT00682019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110570174|NCT00682019|Urological Agents|urological agents|mesh-ancestor
110570175|NCT00779896|Tazarotene|tazarotene|mesh-list
110570176|NCT00779896|Dermatologic Agents|dermatologic agents|mesh-ancestor
110570177|NCT00779896|Keratolytic Agents|keratolytic agents|mesh-ancestor
110570178|NCT02556268|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110570179|NCT02556268|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110570180|NCT02556268|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110570181|NCT02556268|Abacavir, dolutegravir, and lamivudine drug combination|abacavir, dolutegravir, and lamivudine drug combination|mesh-list
110570182|NCT02556268|Emtricitabine, Rilpivirine, Tenofovir Drug Combination|emtricitabine, rilpivirine, tenofovir drug combination|mesh-list
110570183|NCT02556268|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
110570184|NCT02556268|Riociguat|riociguat|mesh-list
110570185|NCT02556268|Protease Inhibitors|protease inhibitors|mesh-list
110570186|NCT02556268|Antiviral Agents|antiviral agents|mesh-ancestor
110570187|NCT02556268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110570188|NCT02556268|Enzyme Activators|enzyme activators|mesh-ancestor
110570189|NCT02556268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110570190|NCT02556268|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110570191|NCT02556268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110570192|NCT02556268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110570193|NCT02556268|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110570194|NCT02556268|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110570195|NCT00875615|Carboplatin|carboplatin|mesh-list
110570196|NCT00875615|Sorafenib|sorafenib|mesh-list
110570197|NCT00875615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110570198|NCT00875615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110570199|NCT00875615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110570200|NCT00875615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110570201|NCT02626559|Bupivacaine|bupivacaine|mesh-list
110570202|NCT02626559|Anesthetics, Local|anesthetics, local|mesh-ancestor
110570203|NCT02626559|Anesthetics|anesthetics|mesh-ancestor
110570204|NCT02626559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110570205|NCT02626559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110570206|NCT02626559|Sensory System Agents|sensory system agents|mesh-ancestor
110570207|NCT02626559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110570209|NCT00768508|Ondansetron|ondansetron|mesh-list
110570210|NCT00768508|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110570211|NCT00768508|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110570212|NCT00768508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110570213|NCT00768508|Sensory System Agents|sensory system agents|mesh-ancestor
110570214|NCT00768508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110570215|NCT00768508|Antiemetics|antiemetics|mesh-ancestor
110570216|NCT00768508|Autonomic Agents|autonomic agents|mesh-ancestor
110570217|NCT00768508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110570218|NCT00768508|Antipruritics|antipruritics|mesh-ancestor
110570219|NCT00768508|Dermatologic Agents|dermatologic agents|mesh-ancestor
110570220|NCT00768508|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110570221|NCT00768508|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110570222|NCT00768508|Serotonin Agents|serotonin agents|mesh-ancestor
110570223|NCT00768508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110570224|NCT00768508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110570225|NCT00682487|Hydrocortisone|hydrocortisone|mesh-list
110570226|NCT00682487|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110570227|NCT00682487|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110570228|NCT00682487|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110570229|NCT00682487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110570231|NCT00777478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110570232|NCT00777478|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110570233|NCT00777478|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110570234|NCT00777478|Growth Substances|growth substances|mesh-ancestor
110570235|NCT00777478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110570236|NCT00777478|Growth Inhibitors|growth inhibitors|mesh-ancestor
110570237|NCT00777478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110570238|NCT00777478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110570239|NCT00777478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110570240|NCT00780598|Tosedostat|tosedostat|mesh-list
110570241|NCT00780598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110570242|NCT00780598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110570243|NCT00780754|Dutasteride|dutasteride|mesh-list
110570244|NCT00780754|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110570245|NCT00780754|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110570246|NCT00780754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110570247|NCT00780754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110570248|NCT00780754|Hormone Antagonists|hormone antagonists|mesh-ancestor
110570249|NCT00780754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110570250|NCT00780754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110570251|NCT00780832|Caffeine|caffeine|mesh-list
110570252|NCT00780832|Cholinergic Antagonists|cholinergic antagonists|mesh-list
110570253|NCT00780832|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110570254|NCT00780832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110570255|NCT00780832|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110570256|NCT00780832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110570257|NCT00780832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110570258|NCT00780832|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110570259|NCT00780832|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110570260|NCT00780832|Purinergic Agents|purinergic agents|mesh-ancestor
110570261|NCT00780832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110570262|NCT00780832|Cholinergic Agents|cholinergic agents|mesh-ancestor
110570263|NCT00597701|Lorazepam|lorazepam|mesh-list
110570264|NCT00597701|Baclofen|baclofen|mesh-list
110570265|NCT00597701|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110570266|NCT00597701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110570267|NCT00597701|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110570268|NCT00597701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110570269|NCT00597701|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110570270|NCT00597701|GABA Agonists|gaba agonists|mesh-ancestor
110570271|NCT00597701|GABA Agents|gaba agents|mesh-ancestor
110570272|NCT00597701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110570273|NCT00597701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110570274|NCT00597701|Anticonvulsants|anticonvulsants|mesh-ancestor
110570275|NCT00597701|Antiemetics|antiemetics|mesh-ancestor
110570276|NCT00597701|Autonomic Agents|autonomic agents|mesh-ancestor
110570277|NCT00597701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110570278|NCT00597701|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110570279|NCT00597701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110570280|NCT00597701|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110570281|NCT00597701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110570282|NCT00597701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110570283|NCT00597701|GABA Modulators|gaba modulators|mesh-ancestor
110570285|NCT02556658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110570286|NCT02556658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110570287|NCT00682721|Valacyclovir|valacyclovir|mesh-list
110570288|NCT00682721|Antiviral Agents|antiviral agents|mesh-ancestor
110570289|NCT00682721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110570290|NCT02556814|Dexamethasone|dexamethasone|mesh-list
110570291|NCT02556814|Caffeic acid|caffeic acid|mesh-list
110570292|NCT02556814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110570293|NCT02556814|Antiemetics|antiemetics|mesh-ancestor
110570294|NCT02556814|Autonomic Agents|autonomic agents|mesh-ancestor
110570295|NCT02556814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110570296|NCT02556814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110570297|NCT02556814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110570298|NCT02556814|Glucocorticoids|glucocorticoids|mesh-ancestor
110570299|NCT02556814|Hormones|hormones|mesh-ancestor
110570300|NCT02556814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110570301|NCT02556814|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110570302|NCT02556814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110570303|NCT02556814|Antioxidants|antioxidants|mesh-ancestor
110570304|NCT02556814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110570305|NCT02556814|Protective Agents|protective agents|mesh-ancestor
110570306|NCT00682955|Zinc|zinc|mesh-list
110570307|NCT00682955|Zinc Sulfate|zinc sulfate|mesh-list
110570308|NCT00682955|Trace Elements|trace elements|mesh-ancestor
110570309|NCT00682955|Micronutrients|micronutrients|mesh-ancestor
110570310|NCT00682955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110570311|NCT00682955|Astringents|astringents|mesh-ancestor
110570312|NCT00682955|Dermatologic Agents|dermatologic agents|mesh-ancestor
110570313|NCT00686621|Posaconazole|posaconazole|mesh-list
110570314|NCT00686621|Antifungal Agents|antifungal agents|mesh-ancestor
110570315|NCT00686621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110570316|NCT00686621|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110570317|NCT00686621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110570318|NCT00686621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110570319|NCT00686621|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110570320|NCT00686621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110570321|NCT00686621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110570322|NCT00686621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110570323|NCT00686621|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110570324|NCT00686621|Hormone Antagonists|hormone antagonists|mesh-ancestor
110570325|NCT00686621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110570326|NCT00686621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110570327|NCT00683111|Esomeprazole|esomeprazole|mesh-list
110570329|NCT00683111|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110570330|NCT00683111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110570331|NCT00683111|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110570332|NCT00683111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110570333|NCT00683111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110570334|NCT00683111|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110570335|NCT00683111|Histamine Antagonists|histamine antagonists|mesh-ancestor
110570336|NCT00683111|Histamine Agents|histamine agents|mesh-ancestor
110570337|NCT00683111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110570338|NCT00683111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110570339|NCT04138901|Ropivacaine|ropivacaine|mesh-list
110570340|NCT04138901|Anesthetics, Local|anesthetics, local|mesh-ancestor
110570341|NCT04138901|Anesthetics|anesthetics|mesh-ancestor
110570342|NCT04138901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110570343|NCT04138901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110570344|NCT04138901|Sensory System Agents|sensory system agents|mesh-ancestor
110570345|NCT04138901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110570346|NCT00922649|Insulin|insulin|mesh-list
110570347|NCT00922649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110570348|NCT00922649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110570349|NCT04142411|Insulin|insulin|mesh-list
110570350|NCT04142411|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110570351|NCT04142411|Hyaluronic Acid|hyaluronic acid|mesh-list
110570352|NCT04142411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110570353|NCT04142411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110570354|NCT04142411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110570355|NCT04142411|Immunologic Factors|immunologic factors|mesh-ancestor
110570356|NCT04142411|Viscosupplements|viscosupplements|mesh-ancestor
110570357|NCT04142411|Protective Agents|protective agents|mesh-ancestor
110570359|NCT00683189|Anticoagulants|anticoagulants|mesh-ancestor
110570360|NCT00667576|Maxacalcitol|maxacalcitol|mesh-list
110570361|NCT00667576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110570362|NCT00667576|Dermatologic Agents|dermatologic agents|mesh-ancestor
110570363|NCT00667576|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110570364|NCT00667576|Protective Agents|protective agents|mesh-ancestor
110570365|NCT00667576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110570367|NCT04141787|Cefazolin|cefazolin|mesh-list
110570368|NCT04141787|Ceftriaxone|ceftriaxone|mesh-list
110570369|NCT04141787|Daptomycin|daptomycin|mesh-list
110570370|NCT04141787|Cloxacillin|cloxacillin|mesh-list
110570371|NCT04141787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110570372|NCT02557594|Tenofovir|tenofovir|mesh-list
110570373|NCT02557594|Antiviral Agents|antiviral agents|mesh-ancestor
110570374|NCT02557594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110570375|NCT02557594|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110570376|NCT02557594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110570377|NCT02557594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110570378|NCT02557594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110570379|NCT02557594|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110570380|NCT02557594|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110570381|NCT00687011|Dexamethasone|dexamethasone|mesh-list
110570382|NCT00687011|Palonosetron|palonosetron|mesh-list
110570383|NCT00687011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110570384|NCT00687011|Antiemetics|antiemetics|mesh-ancestor
110570385|NCT00687011|Autonomic Agents|autonomic agents|mesh-ancestor
110570386|NCT00687011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110570387|NCT00687011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110570388|NCT00687011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110570389|NCT00687011|Glucocorticoids|glucocorticoids|mesh-ancestor
110570390|NCT00687011|Hormones|hormones|mesh-ancestor
110570391|NCT00687011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110570392|NCT00687011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110570393|NCT00687011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110570394|NCT00687011|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110570395|NCT00687011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110570396|NCT00687011|Serotonin Agents|serotonin agents|mesh-ancestor
110570397|NCT00687011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110570398|NCT00687011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110570399|NCT00683267|Capsaicin|capsaicin|mesh-list
110570400|NCT00683267|Antipruritics|antipruritics|mesh-ancestor
110570401|NCT00683267|Dermatologic Agents|dermatologic agents|mesh-ancestor
110570402|NCT00683267|Sensory System Agents|sensory system agents|mesh-ancestor
110570403|NCT00683267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110570404|NCT00683267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110570405|NCT00683345|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110570406|NCT00683345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110570407|NCT00687245|Esomeprazole|esomeprazole|mesh-list
110570408|NCT00687245|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110570409|NCT00687245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110570410|NCT00687245|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110570411|NCT00687245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110570412|NCT00687245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110570413|NCT00690521|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110570414|NCT00690521|Metolazone|metolazone|mesh-list
110570415|NCT00690521|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110570416|NCT00690521|Diuretics|diuretics|mesh-ancestor
110570417|NCT00690521|Natriuretic Agents|natriuretic agents|mesh-ancestor
110570418|NCT00690521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110570419|NCT00690521|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110570420|NCT00690521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110570421|NCT00690521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110570422|NCT00666718|Insulin|insulin|mesh-list
110570423|NCT00666718|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110570424|NCT00666718|Insulin Glargine|insulin glargine|mesh-list
110570425|NCT00666718|Insulin Lispro|insulin lispro|mesh-list
110570426|NCT00666718|Protamines|protamines|mesh-list
110570427|NCT00666718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110570428|NCT00666718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110570429|NCT00666718|Heparin Antagonists|heparin antagonists|mesh-ancestor
110570430|NCT00666718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110570432|NCT00683735|Metformin|metformin|mesh-list
110570433|NCT00683735|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110570434|NCT00683735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110570435|NCT00683735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110570436|NCT00683735|Incretins|incretins|mesh-ancestor
110570437|NCT00683735|Hormones|hormones|mesh-ancestor
110570438|NCT00683735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110570439|NCT00683735|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110570440|NCT00683735|Protease Inhibitors|protease inhibitors|mesh-ancestor
110570441|NCT00683735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110570442|NCT00683735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110570443|NCT04139681|Menthol|menthol|mesh-list
110570444|NCT04139681|Antipruritics|antipruritics|mesh-ancestor
110570445|NCT04139681|Dermatologic Agents|dermatologic agents|mesh-ancestor
110570446|NCT04047394|Rasburicase|rasburicase|mesh-list
110570447|NCT04047394|Gout Suppressants|gout suppressants|mesh-ancestor
110570448|NCT04047394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110570449|NCT02625779|Valproic Acid|valproic acid|mesh-list
110570450|NCT02625779|Anticonvulsants|anticonvulsants|mesh-ancestor
110570451|NCT02625779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110570452|NCT02625779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110570453|NCT02625779|GABA Agents|gaba agents|mesh-ancestor
110570454|NCT02625779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110570455|NCT02625779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110570456|NCT02625779|Antimanic Agents|antimanic agents|mesh-ancestor
110570457|NCT02625779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110570458|NCT02625779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110570459|NCT02625779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110570460|NCT00667420|Oxaliplatin|oxaliplatin|mesh-list
110570461|NCT00667420|Epirubicin|epirubicin|mesh-list
110570462|NCT00667420|Panitumumab|panitumumab|mesh-list
110217963|NCT00108186|Celecoxib|celecoxib|mesh-list
110570463|NCT00667420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110570464|NCT00667420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110570465|NCT00667420|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110570466|NCT00667420|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110570467|NCT00667420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110570468|NCT00667420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110570469|NCT00667420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110570470|NCT04141319|Ketorolac|ketorolac|mesh-list
110570471|NCT04141319|Epinephrine|epinephrine|mesh-list
110570472|NCT04141319|Ropivacaine|ropivacaine|mesh-list
110570473|NCT04141319|Anesthetics, Local|anesthetics, local|mesh-ancestor
110570474|NCT04141319|Anesthetics|anesthetics|mesh-ancestor
110570475|NCT04141319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110570476|NCT04141319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110570477|NCT04141319|Sensory System Agents|sensory system agents|mesh-ancestor
110570478|NCT04141319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110570479|NCT04141319|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110570480|NCT04141319|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110570481|NCT04141319|Adrenergic Agents|adrenergic agents|mesh-ancestor
110570482|NCT04141319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110570483|NCT04141319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110570484|NCT04141319|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110570485|NCT04141319|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110570486|NCT04141319|Autonomic Agents|autonomic agents|mesh-ancestor
110570487|NCT04141319|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110570488|NCT04141319|Respiratory System Agents|respiratory system agents|mesh-ancestor
110570489|NCT04141319|Mydriatics|mydriatics|mesh-ancestor
110570490|NCT04141319|Sympathomimetics|sympathomimetics|mesh-ancestor
110570491|NCT04141319|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110570492|NCT04141319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110570493|NCT04141319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110570494|NCT04141319|Analgesics|analgesics|mesh-ancestor
110570495|NCT04141319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110570496|NCT04141319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110191215|NCT00055302|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110570497|NCT04141319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110570498|NCT04141319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110570499|NCT00683891|Clozapine|clozapine|mesh-list
110570500|NCT00683891|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110570501|NCT00683891|Serotonin Agents|serotonin agents|mesh-ancestor
110570502|NCT00683891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110570503|NCT00683891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110570504|NCT00683891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110570505|NCT00683891|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110570506|NCT00683891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110570507|NCT00683891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110570508|NCT00683891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110570509|NCT00683891|GABA Antagonists|gaba antagonists|mesh-ancestor
110570510|NCT00683891|GABA Agents|gaba agents|mesh-ancestor
110570511|NCT00683969|Mycophenolic Acid|mycophenolic acid|mesh-list
110570512|NCT00683969|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110570513|NCT00683969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110570514|NCT00683969|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110570515|NCT00683969|Antitubercular Agents|antitubercular agents|mesh-ancestor
110570516|NCT00683969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110570517|NCT00683969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110570518|NCT00683969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110570519|NCT00683969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110570520|NCT00778024|Fluoxetine|fluoxetine|mesh-list
110570521|NCT00778024|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110570522|NCT00778024|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110570523|NCT00778024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110570524|NCT00778024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110570525|NCT00778024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110570526|NCT00778024|Serotonin Agents|serotonin agents|mesh-ancestor
110570527|NCT00778024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110570528|NCT00778024|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110570529|NCT00778024|Antidepressive Agents|antidepressive agents|mesh-ancestor
110570530|NCT00778024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110570531|NCT00778024|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110570532|NCT00778024|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110570533|NCT00778024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110570535|NCT00853658|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110570536|NCT00853658|Protease Inhibitors|protease inhibitors|mesh-ancestor
110570537|NCT00853658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110218032|NCT00274573|Parasympatholytics|parasympatholytics|mesh-ancestor
110570538|NCT00853658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110570539|NCT00853658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110570540|NCT00690677|Panobinostat|panobinostat|mesh-list
110570541|NCT00690677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110570542|NCT00690677|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110570543|NCT00690677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110570544|NCT00690677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110570545|NCT00781300|Loteprednol Etabonate|loteprednol etabonate|mesh-list
110570546|NCT00781300|Dexamethasone|dexamethasone|mesh-list
110570547|NCT00781300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110570548|NCT00781300|Antiemetics|antiemetics|mesh-ancestor
110570549|NCT00781300|Autonomic Agents|autonomic agents|mesh-ancestor
110570550|NCT00781300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110570551|NCT00781300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110570552|NCT00781300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110570553|NCT00781300|Glucocorticoids|glucocorticoids|mesh-ancestor
110570554|NCT00781300|Hormones|hormones|mesh-ancestor
110164772|NCT00021307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110570555|NCT00781300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110570556|NCT00781300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110570557|NCT00781300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110570559|NCT00781378|Plasminogen|plasminogen|mesh-list
110570560|NCT00781378|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110570561|NCT00781378|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110570562|NCT00781378|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110570563|NCT00781378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110570564|NCT02625389|Ethiodized Oil|ethiodized oil|mesh-list
110570565|NCT02625389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110570566|NCT00666562|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
110570567|NCT00666562|Antioxidants|antioxidants|mesh-ancestor
110570568|NCT00666562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110570569|NCT00666562|Protective Agents|protective agents|mesh-ancestor
110570570|NCT00666562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110570571|NCT00666562|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110570572|NCT00666562|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110570573|NCT00666562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110570574|NCT00666562|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110570575|NCT00769054|Ropivacaine|ropivacaine|mesh-list
110570576|NCT00769054|Anesthetics, Local|anesthetics, local|mesh-ancestor
110570577|NCT00769054|Anesthetics|anesthetics|mesh-ancestor
110570578|NCT00769054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110570579|NCT00769054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110570580|NCT00769054|Sensory System Agents|sensory system agents|mesh-ancestor
110570581|NCT00769054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110570582|NCT04138979|Cyclophosphamide|cyclophosphamide|mesh-list
110570583|NCT04138979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110570584|NCT04138979|Immunologic Factors|immunologic factors|mesh-ancestor
110570585|NCT04138979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110570586|NCT04138979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110570587|NCT04138979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110570588|NCT04138979|Alkylating Agents|alkylating agents|mesh-ancestor
110570589|NCT04138979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110570590|NCT04138979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110570591|NCT04138979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110570592|NCT00666328|Clevidipine|clevidipine|mesh-list
110570593|NCT00666328|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110570594|NCT00666328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110570595|NCT00666328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110570596|NCT00666328|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110570597|NCT00666328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110570598|NCT00694343|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110570600|NCT00778180|Diuretics|diuretics|mesh-ancestor
110570601|NCT00778180|Natriuretic Agents|natriuretic agents|mesh-ancestor
110570602|NCT00778180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110570603|NCT00778180|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110570604|NCT00778180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110570605|NCT00778180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110570606|NCT00769210|Simvastatin|simvastatin|mesh-list
110570607|NCT00769210|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110570608|NCT00769210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110570609|NCT00769210|Antimetabolites|antimetabolites|mesh-ancestor
110570610|NCT00769210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110570611|NCT00769210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110570612|NCT00769210|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110570613|NCT00769210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110570614|NCT00690911|Adalimumab|adalimumab|mesh-list
110570615|NCT00690911|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110570616|NCT00690911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110570617|NCT00690911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110570618|NCT00781846|Sirolimus|sirolimus|mesh-list
110570619|NCT00781846|Bevacizumab|bevacizumab|mesh-list
110570620|NCT00781846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110570621|NCT00781846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110570622|NCT00781846|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110570623|NCT00781846|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110570624|NCT00781846|Growth Substances|growth substances|mesh-ancestor
110570625|NCT00781846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110570626|NCT00781846|Growth Inhibitors|growth inhibitors|mesh-ancestor
110570627|NCT00781846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110570628|NCT00781846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110570629|NCT00781846|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110570630|NCT00781846|Antifungal Agents|antifungal agents|mesh-ancestor
110570631|NCT00781846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110570632|NCT00781846|Immunologic Factors|immunologic factors|mesh-ancestor
110570633|NCT00853580|Lovastatin|lovastatin|mesh-list
110570634|NCT00853580|L 647318|l 647318|mesh-list
110570635|NCT00853580|Dihydromevinolin|dihydromevinolin|mesh-list
110570636|NCT00853580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110570637|NCT00853580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110570639|NCT00853580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110570640|NCT00853580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110570641|NCT00853580|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110570642|NCT00853580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110570643|NCT00688493|Dapagliflozin|dapagliflozin|mesh-list
110570644|NCT00688493|Moxifloxacin|moxifloxacin|mesh-list
110570645|NCT00688493|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110570646|NCT00688493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110570647|NCT00688493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110570648|NCT00688493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110570649|NCT00688493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110570650|NCT00688493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110570651|NCT00688493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110570652|NCT00688493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110570653|NCT00688493|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110570654|NCT00688493|Contraceptive Agents|contraceptive agents|mesh-ancestor
110570655|NCT00688493|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110570656|NCT00688493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110570657|NCT00688493|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110570658|NCT00688493|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110570659|NCT00688493|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110570660|NCT00688493|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110570661|NCT00688493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110570662|NCT00778414|Amoxicillin|amoxicillin|mesh-list
110570663|NCT00778414|Clavulanic Acids|clavulanic acids|mesh-list
110570664|NCT00778414|Clavulanic Acid|clavulanic acid|mesh-list
110570665|NCT00778414|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110570666|NCT00778414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110570667|NCT00778414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110570668|NCT00778414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110570669|NCT00778414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110570670|NCT00778414|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110570671|NCT00769288|2'-fluoro-5-ethylarabinosyluracil|2'-fluoro-5-ethylarabinosyluracil|mesh-list
110570672|NCT00769288|Deoxyuridine|deoxyuridine|mesh-list
110570673|NCT00769288|Antimetabolites|antimetabolites|mesh-ancestor
110570674|NCT00769288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110570675|NCT00769288|Antiviral Agents|antiviral agents|mesh-ancestor
110570676|NCT00769288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110570677|NCT00769288|Growth Inhibitors|growth inhibitors|mesh-ancestor
110570678|NCT00769288|Growth Substances|growth substances|mesh-ancestor
110570679|NCT00769288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110570680|NCT00912938|Zoledronic Acid|zoledronic acid|mesh-list
110570681|NCT00912938|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110570682|NCT00912938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110570683|NCT00688805|Propranolol|propranolol|mesh-list
110570684|NCT00688805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110218218|NCT00108615|Metformin|metformin|mesh-list
110570685|NCT00688805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110570686|NCT00688805|Adrenergic Agents|adrenergic agents|mesh-ancestor
110570687|NCT00688805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110570688|NCT00688805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110570689|NCT00688805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110570690|NCT00688805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110570691|NCT00688805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110570692|NCT00688805|Vasodilator Agents|vasodilator agents|mesh-ancestor
110570693|NCT04136639|Proanthocyanidin|proanthocyanidin|mesh-list
110570694|NCT04136639|Grape Seed Extract|grape seed extract|mesh-list
110570695|NCT04136639|Fluorides|fluorides|mesh-list
110570696|NCT04136639|Sodium Fluoride|sodium fluoride|mesh-list
110570697|NCT04136639|Cariostatic Agents|cariostatic agents|mesh-ancestor
110570698|NCT04136639|Protective Agents|protective agents|mesh-ancestor
110570699|NCT04136639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110570700|NCT04136639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110570701|NCT04136639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110570702|NCT04136639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110570703|NCT04136639|Antioxidants|antioxidants|mesh-ancestor
110570704|NCT04136639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110570705|NCT04136639|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110570706|NCT04136639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110570708|NCT02613026|Docetaxel|docetaxel|mesh-list
110570709|NCT02613026|Pirarubicin|pirarubicin|mesh-list
110570710|NCT02613026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110570711|NCT02613026|Immunologic Factors|immunologic factors|mesh-ancestor
110570712|NCT02613026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110570713|NCT02613026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110570714|NCT02613026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110570715|NCT02613026|Alkylating Agents|alkylating agents|mesh-ancestor
110570716|NCT02613026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110570717|NCT02613026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110570718|NCT02613026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110570719|NCT02613026|Tubulin Modulators|tubulin modulators|mesh-ancestor
110570720|NCT02613026|Antimitotic Agents|antimitotic agents|mesh-ancestor
110570721|NCT02613026|Mitosis Modulators|mitosis modulators|mesh-ancestor
110570722|NCT00778726|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110570723|NCT00778726|Benazepril|benazepril|mesh-list
110570724|NCT00778726|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110570725|NCT00778726|Diuretics|diuretics|mesh-ancestor
110570726|NCT00778726|Natriuretic Agents|natriuretic agents|mesh-ancestor
110570727|NCT00778726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110570728|NCT00778726|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110570729|NCT00778726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110570730|NCT00778726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110570731|NCT00778726|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110570732|NCT00778726|Protease Inhibitors|protease inhibitors|mesh-ancestor
110570733|NCT00778726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110570734|NCT00688883|Fludarabine|fludarabine|mesh-list
110570735|NCT00688883|Fludarabine phosphate|fludarabine phosphate|mesh-list
110570736|NCT00688883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110570737|NCT00688883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110570738|NCT00688883|Antimetabolites|antimetabolites|mesh-ancestor
110570739|NCT00688883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110570740|NCT00688883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110570741|NCT00688883|Immunologic Factors|immunologic factors|mesh-ancestor
110570742|NCT00688883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110570743|NCT00769522|Cyclophosphamide|cyclophosphamide|mesh-list
110570744|NCT00769522|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110570745|NCT00769522|Rituximab|rituximab|mesh-list
110570746|NCT00769522|Fludarabine|fludarabine|mesh-list
110570747|NCT00769522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110570748|NCT00769522|Immunologic Factors|immunologic factors|mesh-ancestor
110570749|NCT00769522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110570750|NCT00769522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110570751|NCT00769522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110570752|NCT00769522|Alkylating Agents|alkylating agents|mesh-ancestor
110570753|NCT00769522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110570754|NCT00769522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110570755|NCT00769522|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110570756|NCT00769522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110570757|NCT00688961|Aspirin|aspirin|mesh-list
110570758|NCT00688961|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110218280|NCT00108771|Fentanyl|fentanyl|mesh-list
110570760|NCT00688961|Analgesics|analgesics|mesh-ancestor
110570761|NCT00688961|Sensory System Agents|sensory system agents|mesh-ancestor
110570762|NCT00688961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110570763|NCT00688961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110570764|NCT00688961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110570766|NCT00688961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110570767|NCT00688961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110570768|NCT00688961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110570769|NCT00688961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110570770|NCT00688961|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110570771|NCT00688961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110570772|NCT00688961|Antipyretics|antipyretics|mesh-ancestor
110570773|NCT00782470|Factor VIII|factor viii|mesh-list
110570774|NCT00782470|Coagulants|coagulants|mesh-ancestor
110570775|NCT00865280|Moxifloxacin|moxifloxacin|mesh-list
110570777|NCT00865280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110570778|NCT00865280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110570779|NCT00865280|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110570780|NCT00865280|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110570781|NCT00865280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110570782|NCT00865280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110570783|NCT00865280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110570784|NCT00865280|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110570785|NCT04136327|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110570786|NCT00782548|Morphine|morphine|mesh-list
110570787|NCT00782548|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110570788|NCT00782548|Narcotics|narcotics|mesh-ancestor
110570789|NCT00782548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110570790|NCT00782548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110570791|NCT00782548|Analgesics|analgesics|mesh-ancestor
110570792|NCT00782548|Sensory System Agents|sensory system agents|mesh-ancestor
110570793|NCT00782548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110570794|NCT00689195|Curcumin|curcumin|mesh-list
110570795|NCT00689195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110570796|NCT00689195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110570797|NCT00689195|Analgesics|analgesics|mesh-ancestor
110570798|NCT00689195|Sensory System Agents|sensory system agents|mesh-ancestor
110570799|NCT00689195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110570800|NCT00689195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110570801|NCT00689195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110570802|NCT00689195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110570803|NCT00689195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110570804|NCT00689195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110570805|NCT00689195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110570806|NCT00865124|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110570807|NCT00865124|Spironolactone|spironolactone|mesh-list
110570808|NCT00865124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110570809|NCT00865124|Diuretics|diuretics|mesh-ancestor
110570810|NCT00865124|Natriuretic Agents|natriuretic agents|mesh-ancestor
110570811|NCT00865124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110570812|NCT00865124|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110570813|NCT00865124|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110570814|NCT00865124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110570815|NCT00865124|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110570816|NCT00865124|Hormone Antagonists|hormone antagonists|mesh-ancestor
110570817|NCT00865124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110570818|NCT00865124|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110570819|NCT00691067|Mifepristone|mifepristone|mesh-list
110570820|NCT00691067|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110570821|NCT00691067|Abortifacient Agents|abortifacient agents|mesh-ancestor
110570822|NCT00691067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110570823|NCT00691067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110570824|NCT00691067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110570825|NCT00691067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110570826|NCT00691067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110570827|NCT00691067|Contraceptive Agents|contraceptive agents|mesh-ancestor
110570828|NCT00691067|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110570829|NCT00691067|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110570830|NCT00691067|Hormone Antagonists|hormone antagonists|mesh-ancestor
110218333|NCT00108849|Estradiol|estradiol|mesh-list
110570831|NCT00691067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110570832|NCT00691067|Luteolytic Agents|luteolytic agents|mesh-ancestor
110570833|NCT00691067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110570834|NCT00691067|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110570835|NCT00691145|Tacrolimus|tacrolimus|mesh-list
110570836|NCT00691145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110570837|NCT00691145|Immunologic Factors|immunologic factors|mesh-ancestor
110570838|NCT00691145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110570839|NCT00691145|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110570840|NCT00691145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110570841|NCT00691145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110570842|NCT00694967|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
110570843|NCT00694967|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
110570844|NCT00694967|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110570845|NCT00694967|Hormone Antagonists|hormone antagonists|mesh-ancestor
110570846|NCT00694967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110570847|NCT00694967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110570848|NCT00694967|Progestins|progestins|mesh-ancestor
110570849|NCT00694967|Hormones|hormones|mesh-ancestor
110570850|NCT00695045|Morphine|morphine|mesh-list
110570851|NCT00695045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110570852|NCT00695045|Narcotics|narcotics|mesh-ancestor
110570853|NCT00695045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110570854|NCT00695045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110570855|NCT00695045|Analgesics|analgesics|mesh-ancestor
110570856|NCT00695045|Sensory System Agents|sensory system agents|mesh-ancestor
110570857|NCT00695045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110570858|NCT02624453|Fluconazole|fluconazole|mesh-list
110570859|NCT02624453|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110570860|NCT02624453|Antifungal Agents|antifungal agents|mesh-ancestor
110570861|NCT02624453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110570862|NCT02624453|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110570863|NCT02624453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110570865|NCT02624453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110570866|NCT02624453|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110570867|NCT02624453|Hormone Antagonists|hormone antagonists|mesh-ancestor
110570868|NCT02624453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110570869|NCT02624453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110570870|NCT02624453|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110570871|NCT02624453|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110570872|NCT02624453|Antiviral Agents|antiviral agents|mesh-ancestor
110570873|NCT00819234|Pramlintide|pramlintide|mesh-list
110570874|NCT00819234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110570875|NCT00819234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110570876|NCT00695201|Oxaliplatin|oxaliplatin|mesh-list
110570877|NCT00695201|Irinotecan|irinotecan|mesh-list
110570878|NCT00695201|Floxuridine|floxuridine|mesh-list
110570879|NCT00695201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110570880|NCT00695201|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110191266|NCT00027599|Bevacizumab|bevacizumab|mesh-list
110570881|NCT00695201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110570882|NCT00695201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110570883|NCT00695201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110570884|NCT00695201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110570885|NCT00695201|Antimetabolites|antimetabolites|mesh-ancestor
110570886|NCT00689585|Ethosuximide|ethosuximide|mesh-list
110570887|NCT00689585|Anticonvulsants|anticonvulsants|mesh-ancestor
110570888|NCT00783016|Morphine|morphine|mesh-list
110570889|NCT00783016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110570890|NCT00783016|Narcotics|narcotics|mesh-ancestor
110570891|NCT00783016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110570892|NCT00783016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110570893|NCT00783016|Analgesics|analgesics|mesh-ancestor
110570894|NCT00783016|Sensory System Agents|sensory system agents|mesh-ancestor
110570895|NCT00783016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110570896|NCT00769990|Genistein|genistein|mesh-list
110570897|NCT00769990|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110570898|NCT00769990|Protective Agents|protective agents|mesh-ancestor
110570899|NCT00769990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110570900|NCT00769990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110570901|NCT00769990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110570902|NCT00769990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110570903|NCT00769990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110218403|NCT00279565|Buprenorphine|buprenorphine|mesh-list
110570904|NCT00769990|Phytoestrogens|phytoestrogens|mesh-ancestor
110570905|NCT00769990|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110570906|NCT00769990|Estrogens|estrogens|mesh-ancestor
110570907|NCT00769990|Hormones|hormones|mesh-ancestor
110570908|NCT00769990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110570909|NCT00784420|Raltegravir Potassium|raltegravir potassium|mesh-list
110570910|NCT00784420|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110191279|NCT00055653|Melphalan|melphalan|mesh-list
110570911|NCT00784420|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110570913|NCT00784420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110570914|NCT00784420|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110570915|NCT00784420|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110570916|NCT00784420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110570917|NCT00784420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110570918|NCT02555800|Cidofovir|cidofovir|mesh-list
110570919|NCT02555800|Bevacizumab|bevacizumab|mesh-list
110570920|NCT02555800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110570921|NCT02555800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110570922|NCT02555800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110570923|NCT02555800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110570924|NCT02555800|Growth Substances|growth substances|mesh-ancestor
110570925|NCT02555800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110570926|NCT02555800|Growth Inhibitors|growth inhibitors|mesh-ancestor
110570927|NCT02555800|Antiviral Agents|antiviral agents|mesh-ancestor
110570928|NCT02555800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110570929|NCT02555800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110570930|NCT02555800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110570931|NCT00783172|Gemcitabine|gemcitabine|mesh-list
110570932|NCT00783172|Mitogens|mitogens|mesh-list
110570933|NCT00783172|Enkephalins|enkephalins|mesh-list
110570934|NCT00783172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110570935|NCT00783172|Antimetabolites|antimetabolites|mesh-ancestor
110570936|NCT00783172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110570937|NCT00783172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110570938|NCT00783172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110570939|NCT00783172|Mitosis Modulators|mitosis modulators|mesh-ancestor
110570940|NCT00783172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110570941|NCT00783250|Albuterol|albuterol|mesh-list
110570942|NCT00783250|Tiotropium Bromide|tiotropium bromide|mesh-list
110570943|NCT00783250|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110570944|NCT00783250|Autonomic Agents|autonomic agents|mesh-ancestor
110570945|NCT00783250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110570946|NCT00783250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110570947|NCT00783250|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110570948|NCT00783250|Respiratory System Agents|respiratory system agents|mesh-ancestor
110570949|NCT00783250|Parasympatholytics|parasympatholytics|mesh-ancestor
110570950|NCT00783250|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110570951|NCT00783250|Cholinergic Agents|cholinergic agents|mesh-ancestor
110570952|NCT00783250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110570953|NCT00783250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110570954|NCT00783250|Tocolytic Agents|tocolytic agents|mesh-ancestor
110570955|NCT00783250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110570956|NCT00783250|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110570957|NCT00783250|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110570958|NCT00783250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110570959|NCT00783250|Adrenergic Agents|adrenergic agents|mesh-ancestor
110570960|NCT02555644|Cetuximab|cetuximab|mesh-list
110570961|NCT02555644|Prexasertib|prexasertib|mesh-list
110570962|NCT02555644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110570963|NCT02555644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110570964|NCT02555644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110570965|NCT02555644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110570966|NCT02555644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110570967|NCT00871403|Pemetrexed|pemetrexed|mesh-list
110570968|NCT00871403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110570969|NCT00871403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110570970|NCT00871403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110570971|NCT00871403|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110570972|NCT00871403|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110570973|NCT00691379|Paclitaxel|paclitaxel|mesh-list
110570974|NCT00691379|Bevacizumab|bevacizumab|mesh-list
110570975|NCT00691379|Carboplatin|carboplatin|mesh-list
110570976|NCT00691379|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110570977|NCT00691379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110570978|NCT00691379|Tubulin Modulators|tubulin modulators|mesh-ancestor
110570979|NCT00691379|Antimitotic Agents|antimitotic agents|mesh-ancestor
110570980|NCT00691379|Mitosis Modulators|mitosis modulators|mesh-ancestor
110570981|NCT00691379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110570982|NCT00691379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110570983|NCT00691379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110570984|NCT00691379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110570985|NCT00691379|Growth Substances|growth substances|mesh-ancestor
110570986|NCT00691379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110570987|NCT00691379|Growth Inhibitors|growth inhibitors|mesh-ancestor
110570989|NCT02624531|Taxane|taxane|mesh-list
110570990|NCT02624531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110570991|NCT00691457|Contact Lens Solutions|contact lens solutions|mesh-list
110570992|NCT00691457|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110570993|NCT00691457|Disinfectants|disinfectants|mesh-ancestor
110570994|NCT00691457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110570995|NCT04136015|Dasatinib|dasatinib|mesh-list
110570996|NCT04136015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110570997|NCT04136015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110570998|NCT04136015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110570999|NCT04136015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110571000|NCT02624063|Sofosbuvir|sofosbuvir|mesh-list
110571001|NCT02624063|Simeprevir|simeprevir|mesh-list
110571002|NCT02624063|Antiviral Agents|antiviral agents|mesh-ancestor
110571003|NCT02624063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110571004|NCT02624063|Protease Inhibitors|protease inhibitors|mesh-ancestor
110571005|NCT02624063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110571006|NCT02624063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110571007|NCT05298683|Acetaminophen|acetaminophen|mesh-list
110571008|NCT05298683|Diphenhydramine|diphenhydramine|mesh-list
110571009|NCT05298683|Promethazine|promethazine|mesh-list
110571010|NCT05298683|Dexamethasone|dexamethasone|mesh-list
110571011|NCT05298683|Pomalidomide|pomalidomide|mesh-list
110571012|NCT05298683|Ranitidine|ranitidine|mesh-list
110571013|NCT05298683|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
110571014|NCT05298683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110571015|NCT05298683|Antiemetics|antiemetics|mesh-ancestor
110571016|NCT05298683|Autonomic Agents|autonomic agents|mesh-ancestor
110571017|NCT05298683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110571018|NCT05298683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110571019|NCT05298683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110571020|NCT05298683|Glucocorticoids|glucocorticoids|mesh-ancestor
110571021|NCT05298683|Hormones|hormones|mesh-ancestor
110571022|NCT05298683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110571023|NCT05298683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110571024|NCT05298683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110571025|NCT05298683|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110571026|NCT05298683|Analgesics|analgesics|mesh-ancestor
110571027|NCT05298683|Sensory System Agents|sensory system agents|mesh-ancestor
110571028|NCT05298683|Antipyretics|antipyretics|mesh-ancestor
110571029|NCT05298683|Immunologic Factors|immunologic factors|mesh-ancestor
110571030|NCT05298683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110571031|NCT05298683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110571032|NCT05298683|Growth Substances|growth substances|mesh-ancestor
110571033|NCT05298683|Growth Inhibitors|growth inhibitors|mesh-ancestor
110571034|NCT05298683|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110571035|NCT05298683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110571036|NCT05298683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110571037|NCT05298683|Anesthetics, Local|anesthetics, local|mesh-ancestor
110571038|NCT05298683|Anesthetics|anesthetics|mesh-ancestor
110571039|NCT05298683|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110571040|NCT05298683|Histamine Antagonists|histamine antagonists|mesh-ancestor
110571041|NCT05298683|Histamine Agents|histamine agents|mesh-ancestor
110571042|NCT05298683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110571043|NCT05298683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110571044|NCT05298683|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110571046|NCT05298683|Dermatologic Agents|dermatologic agents|mesh-ancestor
110571047|NCT05298683|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110571048|NCT05298683|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110571049|NCT00853112|Sildenafil Citrate|sildenafil citrate|mesh-list
110571050|NCT00853112|Vasodilator Agents|vasodilator agents|mesh-ancestor
110571051|NCT00853112|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110571052|NCT00853112|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110571053|NCT00853112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110571054|NCT00853112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110571055|NCT00853112|Urological Agents|urological agents|mesh-ancestor
110571056|NCT02624141|Epoetin Alfa|epoetin alfa|mesh-list
110571057|NCT02624141|Hematinics|hematinics|mesh-ancestor
110571058|NCT00691613|Epoetin Alfa|epoetin alfa|mesh-list
110571059|NCT00691613|Hematinics|hematinics|mesh-ancestor
110571060|NCT00460603|Bevacizumab|bevacizumab|mesh-list
110571062|NCT00460603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110571063|NCT00460603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110571064|NCT00460603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110571065|NCT00460603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110571066|NCT00460603|Growth Substances|growth substances|mesh-ancestor
110571067|NCT00460603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110571068|NCT00460603|Growth Inhibitors|growth inhibitors|mesh-ancestor
110571069|NCT00460603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110571070|NCT00460603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110571071|NCT00460603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110571072|NCT00696059|Adalimumab|adalimumab|mesh-list
110571073|NCT00696059|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110571074|NCT00696059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110571075|NCT00696059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110571076|NCT00700466|Metoprolol|metoprolol|mesh-list
110571077|NCT00700466|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110571078|NCT00700466|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110571079|NCT00700466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110571080|NCT00700466|Sympatholytics|sympatholytics|mesh-ancestor
110571081|NCT00700466|Autonomic Agents|autonomic agents|mesh-ancestor
110571082|NCT00700466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110571083|NCT00700466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110571084|NCT00700466|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110571085|NCT00700466|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110571086|NCT00700466|Adrenergic Agents|adrenergic agents|mesh-ancestor
110571087|NCT00700466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110571088|NCT00700466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110571089|NCT00700544|Norethandrolone|norethandrolone|mesh-list
110571090|NCT00700544|Anabolic Agents|anabolic agents|mesh-ancestor
110571091|NCT00700544|Hormones|hormones|mesh-ancestor
110571092|NCT00700544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110571093|NCT00700544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110571094|NCT02612792|Atorvastatin|atorvastatin|mesh-list
110571095|NCT02612792|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110571096|NCT02612792|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110571097|NCT02612792|Antimetabolites|antimetabolites|mesh-ancestor
110571098|NCT02612792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110571099|NCT02612792|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110571100|NCT02612792|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110571101|NCT02612792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110571102|NCT00662038|Pirfenidone|pirfenidone|mesh-list
110571103|NCT00662038|Analgesics|analgesics|mesh-ancestor
110571104|NCT00662038|Sensory System Agents|sensory system agents|mesh-ancestor
110571105|NCT00662038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110571106|NCT00662038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110571107|NCT00662038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110571108|NCT00662038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110571109|NCT00662038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110571110|NCT00662038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110571111|NCT00662038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110571112|NCT00701792|Liver Extracts|liver extracts|mesh-list
110571113|NCT00701792|Hematinics|hematinics|mesh-ancestor
110571114|NCT00784498|Midazolam|midazolam|mesh-list
110571115|NCT00784498|Ketamine|ketamine|mesh-list
110571116|NCT00784498|Propofol|propofol|mesh-list
110571117|NCT00784498|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110571118|NCT00784498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110571119|NCT00784498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110571120|NCT00784498|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110571121|NCT00784498|Anesthetics, General|anesthetics, general|mesh-ancestor
110571122|NCT00784498|Anesthetics|anesthetics|mesh-ancestor
110571123|NCT00784498|Analgesics|analgesics|mesh-ancestor
110571124|NCT00784498|Sensory System Agents|sensory system agents|mesh-ancestor
110571125|NCT00784498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110571126|NCT00784498|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110571127|NCT00784498|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110571128|NCT00784498|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110571129|NCT00784498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110571130|NCT00784498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110571131|NCT00784498|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110571132|NCT00784498|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110571133|NCT00784498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110571134|NCT00784498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110571135|NCT00784498|GABA Modulators|gaba modulators|mesh-ancestor
110571136|NCT00784498|GABA Agents|gaba agents|mesh-ancestor
110571138|NCT01022983|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110571139|NCT01022983|Vasodilator Agents|vasodilator agents|mesh-ancestor
110571140|NCT01022983|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110571141|NCT01022983|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110571142|NCT01022983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110571143|NCT01022983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110571144|NCT01022983|Protective Agents|protective agents|mesh-ancestor
110571145|NCT01022983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110571146|NCT00912860|Interferons|interferons|mesh-list
110571147|NCT00912860|Interferon-beta|interferon-beta|mesh-list
110571148|NCT00912860|Interferon beta-1a|interferon beta-1a|mesh-list
110571149|NCT00912860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110571150|NCT00912860|Antiviral Agents|antiviral agents|mesh-ancestor
110571151|NCT00912860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110571152|NCT00912860|Immunologic Factors|immunologic factors|mesh-ancestor
110571153|NCT00912860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110571154|NCT00912860|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110571155|NCT02623673|Dexamethasone|dexamethasone|mesh-list
110571156|NCT02623673|Bevacizumab|bevacizumab|mesh-list
110164773|NCT00021307|Alkylating Agents|alkylating agents|mesh-ancestor
110571157|NCT02623673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110571158|NCT02623673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110571159|NCT02623673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110571160|NCT02623673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110571161|NCT02623673|Growth Substances|growth substances|mesh-ancestor
110571162|NCT02623673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110571163|NCT02623673|Growth Inhibitors|growth inhibitors|mesh-ancestor
110571164|NCT02623673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110571165|NCT02623673|Antiemetics|antiemetics|mesh-ancestor
110571166|NCT02623673|Autonomic Agents|autonomic agents|mesh-ancestor
110571167|NCT02623673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110571168|NCT02623673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110571169|NCT02623673|Glucocorticoids|glucocorticoids|mesh-ancestor
110571170|NCT02623673|Hormones|hormones|mesh-ancestor
110571171|NCT02623673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110571172|NCT02623673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110571173|NCT00784732|Mometasone Furoate|mometasone furoate|mesh-list
110571174|NCT00784732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110571175|NCT00784732|Dermatologic Agents|dermatologic agents|mesh-ancestor
110571176|NCT00784732|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110571177|NCT00459979|Sunitinib|sunitinib|mesh-list
110571178|NCT00459979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110571179|NCT00459979|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110571180|NCT00459979|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110571181|NCT00459979|Growth Substances|growth substances|mesh-ancestor
110571182|NCT00459979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110571183|NCT00459979|Growth Inhibitors|growth inhibitors|mesh-ancestor
110571184|NCT00459979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110571185|NCT00459979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110571186|NCT00459979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110571187|NCT00783484|Maraviroc|maraviroc|mesh-list
110571188|NCT00783484|Darunavir|darunavir|mesh-list
110571189|NCT00783484|Midazolam|midazolam|mesh-list
110571190|NCT00783484|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110571191|NCT00783484|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110571192|NCT00783484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110571193|NCT00783484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110571194|NCT00783484|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110571195|NCT00783484|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110571196|NCT00783484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110571197|NCT00783484|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110571198|NCT00783484|Anesthetics, General|anesthetics, general|mesh-ancestor
110571199|NCT00783484|Anesthetics|anesthetics|mesh-ancestor
110571200|NCT00783484|GABA Modulators|gaba modulators|mesh-ancestor
110571201|NCT00783484|GABA Agents|gaba agents|mesh-ancestor
110571202|NCT00783484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110571203|NCT00783484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110571204|NCT00783484|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110571205|NCT00783484|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110571206|NCT00783484|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110571207|NCT00783484|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110571208|NCT00783484|Antiviral Agents|antiviral agents|mesh-ancestor
110571209|NCT00783484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110571210|NCT00783484|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110571211|NCT00783484|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110571212|NCT00783484|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110571213|NCT00783484|Protease Inhibitors|protease inhibitors|mesh-ancestor
110571214|NCT00783484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110571215|NCT00828672|Bevacizumab|bevacizumab|mesh-list
110571216|NCT00828672|Capecitabine|capecitabine|mesh-list
110571217|NCT00828672|Oxaliplatin|oxaliplatin|mesh-list
110571218|NCT00828672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110571219|NCT00828672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110571220|NCT00828672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110571221|NCT00828672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110571222|NCT00828672|Growth Substances|growth substances|mesh-ancestor
110571223|NCT00828672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110571224|NCT00828672|Growth Inhibitors|growth inhibitors|mesh-ancestor
110571225|NCT00828672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110571226|NCT00828672|Antimetabolites|antimetabolites|mesh-ancestor
110571227|NCT00828672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110571228|NCT00784888|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110571229|NCT00784888|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110571230|NCT00784888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110571231|NCT00784888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110571232|NCT00784888|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110571233|NCT00784888|Hormone Antagonists|hormone antagonists|mesh-ancestor
110571234|NCT00784888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110571235|NCT00784888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110571236|NCT00873119|Paclitaxel|paclitaxel|mesh-list
110571237|NCT00873119|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110571238|NCT00873119|Carboplatin|carboplatin|mesh-list
110571239|NCT00873119|Belinostat|belinostat|mesh-list
110571240|NCT00873119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110571241|NCT00873119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110571242|NCT00873119|Tubulin Modulators|tubulin modulators|mesh-ancestor
110571243|NCT00873119|Antimitotic Agents|antimitotic agents|mesh-ancestor
110571244|NCT00873119|Mitosis Modulators|mitosis modulators|mesh-ancestor
110571245|NCT00873119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110571246|NCT00873119|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110571247|NCT00873119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110571248|NCT00661726|Decitabine|decitabine|mesh-list
110571249|NCT00661726|Azacitidine|azacitidine|mesh-list
110571250|NCT00661726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110571251|NCT00661726|Antimetabolites|antimetabolites|mesh-ancestor
110571252|NCT00661726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110571253|NCT00661726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110571254|NCT00661726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110571255|NCT00706680|Cyclosporine|cyclosporine|mesh-list
110571256|NCT00706680|Mycophenolic Acid|mycophenolic acid|mesh-list
110571257|NCT00706680|Prednisone|prednisone|mesh-list
110571258|NCT00706680|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110571259|NCT00706680|Cyclosporins|cyclosporins|mesh-list
110571260|NCT00706680|Thymoglobulin|thymoglobulin|mesh-list
110571261|NCT00706680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110571262|NCT00706680|Glucocorticoids|glucocorticoids|mesh-ancestor
110571263|NCT00706680|Hormones|hormones|mesh-ancestor
110571264|NCT00706680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110571265|NCT00706680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110571266|NCT00706680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110571267|NCT00706680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110571268|NCT00706680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110571269|NCT00706680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110571270|NCT00706680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110571271|NCT00706680|Immunologic Factors|immunologic factors|mesh-ancestor
110571272|NCT00706680|Antifungal Agents|antifungal agents|mesh-ancestor
110571273|NCT00706680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110571274|NCT00706680|Dermatologic Agents|dermatologic agents|mesh-ancestor
110571275|NCT00706680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110191390|NCT00027404|Serotonin Agents|serotonin agents|mesh-ancestor
110571276|NCT00706680|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110571277|NCT00706680|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110571278|NCT00706680|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110571279|NCT00706680|Antitubercular Agents|antitubercular agents|mesh-ancestor
110571280|NCT00706680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110571281|NCT00706680|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110571282|NCT00706680|Protective Agents|protective agents|mesh-ancestor
110571283|NCT02624999|Cisplatin|cisplatin|mesh-list
110571284|NCT02624999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110571286|NCT02612480|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
110571287|NCT02612480|Clopidogrel|clopidogrel|mesh-list
110571288|NCT02612480|Ticagrelor|ticagrelor|mesh-list
110571289|NCT02612480|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110571290|NCT02612480|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110571291|NCT02612480|Analgesics|analgesics|mesh-ancestor
110571292|NCT02612480|Sensory System Agents|sensory system agents|mesh-ancestor
110571293|NCT02612480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110571294|NCT02612480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110571295|NCT02612480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110571296|NCT02612480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110571297|NCT02612480|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110571298|NCT02612480|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110571299|NCT02612480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110571300|NCT02612480|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110571301|NCT02612480|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110571302|NCT02612480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110571303|NCT02612480|Antipyretics|antipyretics|mesh-ancestor
110571304|NCT02612480|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110571305|NCT02612480|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110571306|NCT02612480|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110571307|NCT02612480|Purinergic Agents|purinergic agents|mesh-ancestor
110571308|NCT02612480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110571309|NCT00784966|Etanercept|etanercept|mesh-list
110571310|NCT00784966|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110571312|NCT00784966|Analgesics|analgesics|mesh-ancestor
110571313|NCT00784966|Sensory System Agents|sensory system agents|mesh-ancestor
110571314|NCT00784966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110571315|NCT00784966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110571316|NCT00784966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110571317|NCT00784966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110571318|NCT00784966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110571319|NCT00784966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110571320|NCT00784966|Immunologic Factors|immunologic factors|mesh-ancestor
110571321|NCT02623595|Molgramostim|molgramostim|mesh-list
110571322|NCT02623595|Sargramostim|sargramostim|mesh-list
110571323|NCT02623595|Immunologic Factors|immunologic factors|mesh-ancestor
110571324|NCT02623595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110571325|NCT02623595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110571326|NCT00665392|Docetaxel|docetaxel|mesh-list
110571327|NCT00665392|Fluorouracil|fluorouracil|mesh-list
110571328|NCT00665392|Cetuximab|cetuximab|mesh-list
110571329|NCT00665392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110571330|NCT00665392|Tubulin Modulators|tubulin modulators|mesh-ancestor
110571331|NCT00665392|Antimitotic Agents|antimitotic agents|mesh-ancestor
110571332|NCT00665392|Mitosis Modulators|mitosis modulators|mesh-ancestor
110571333|NCT00665392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110571334|NCT00665392|Antimetabolites|antimetabolites|mesh-ancestor
110571335|NCT00665392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110571336|NCT00665392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110571337|NCT00665392|Immunologic Factors|immunologic factors|mesh-ancestor
110571338|NCT00665392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110571339|NCT00665392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110571340|NCT00851630|Lamivudine|lamivudine|mesh-list
110571341|NCT00851630|Zidovudine|zidovudine|mesh-list
110571342|NCT00851630|Abacavir|abacavir|mesh-list
110571343|NCT00851630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110571344|NCT00851630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110571345|NCT00851630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110571346|NCT00851630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110571347|NCT00851630|Antiviral Agents|antiviral agents|mesh-ancestor
110169089|NCT00037180|Vitamin B Complex|vitamin b complex|mesh-ancestor
110169090|NCT00037180|Vitamins|vitamins|mesh-ancestor
110169091|NCT00037180|Micronutrients|micronutrients|mesh-ancestor
110169092|NCT00037180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110169093|NCT00037180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110169094|NCT00037180|Analgesics|analgesics|mesh-ancestor
110169095|NCT00037180|Sensory System Agents|sensory system agents|mesh-ancestor
110169096|NCT00037180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110169097|NCT00037180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110169098|NCT00037180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110169099|NCT00037180|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110169100|NCT00037180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110169101|NCT00037219|Anidulafungin|anidulafungin|mesh-list
110169102|NCT00037219|Antifungal Agents|antifungal agents|mesh-ancestor
110169103|NCT00037219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110169104|NCT00000893|Efavirenz|efavirenz|mesh-list
110169105|NCT00000893|Nelfinavir|nelfinavir|mesh-list
110169106|NCT00000893|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110169107|NCT00000893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110169108|NCT00000893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110169109|NCT00000893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110169110|NCT00000893|Antiviral Agents|antiviral agents|mesh-ancestor
110169111|NCT00000893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110169112|NCT00000893|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110169113|NCT00000893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110169114|NCT00000893|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110169115|NCT00000893|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110169116|NCT00000893|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110169117|NCT00000893|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110169118|NCT00000893|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110169119|NCT00000893|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110169120|NCT00000893|Protease Inhibitors|protease inhibitors|mesh-ancestor
110169122|NCT00000893|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110169123|NCT00396526|Amoxicillin|amoxicillin|mesh-list
110169124|NCT00396526|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110169125|NCT00396526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110169126|NCT00396526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110169127|NCT00396526|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110169128|NCT00396526|Antimalarials|antimalarials|mesh-ancestor
110169129|NCT00396526|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110169130|NCT00396526|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110169131|NCT00037531|Sirolimus|sirolimus|mesh-list
110169132|NCT00037531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110169133|NCT00037531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110169134|NCT00037531|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110169135|NCT00037531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110169136|NCT00037531|Antifungal Agents|antifungal agents|mesh-ancestor
110169137|NCT00037531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110169138|NCT00037531|Immunologic Factors|immunologic factors|mesh-ancestor
110169139|NCT00037531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110169140|NCT00037570|Pantoprazole|pantoprazole|mesh-list
110169141|NCT00037570|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110169142|NCT00037570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110169143|NCT00037570|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110169144|NCT00037570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110169145|NCT00037570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110169147|NCT00000899|Stavudine|stavudine|mesh-list
110169148|NCT00000899|Nelfinavir|nelfinavir|mesh-list
110169149|NCT00000899|Cyclophosphamide|cyclophosphamide|mesh-list
110169150|NCT00000899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110169151|NCT00000899|Immunologic Factors|immunologic factors|mesh-ancestor
110169152|NCT00000899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110169153|NCT00000899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110169154|NCT00000899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110169155|NCT00000899|Alkylating Agents|alkylating agents|mesh-ancestor
110169156|NCT00000899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110169157|NCT00000899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110169158|NCT00000899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110169159|NCT00000899|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110169160|NCT00000899|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110169161|NCT00000899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110169162|NCT00000899|Antiviral Agents|antiviral agents|mesh-ancestor
110169163|NCT00000899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110169164|NCT00000899|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110169165|NCT00000899|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110169166|NCT00000899|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110169167|NCT00000899|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110169168|NCT00000899|Protease Inhibitors|protease inhibitors|mesh-ancestor
110169169|NCT00000899|Antimetabolites|antimetabolites|mesh-ancestor
110169170|NCT00037609|Sulindac sulfone|sulindac sulfone|mesh-list
110169171|NCT00037609|Capecitabine|capecitabine|mesh-list
110169172|NCT00037609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110169173|NCT00037609|Antimetabolites|antimetabolites|mesh-ancestor
110169174|NCT00037609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110169175|NCT00037609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110169176|NCT00037609|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110169177|NCT00037609|Protective Agents|protective agents|mesh-ancestor
110169178|NCT00037609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110169179|NCT00037609|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110169180|NCT00037609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110169181|NCT00037609|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110169182|NCT00037609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110169183|NCT00037609|Analgesics|analgesics|mesh-ancestor
110169184|NCT00037609|Sensory System Agents|sensory system agents|mesh-ancestor
110169185|NCT00037609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110169186|NCT00037609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110169187|NCT00037609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110169188|NCT00037648|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110169189|NCT00037648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110169191|NCT00037804|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110169192|NCT00037804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110169193|NCT00037804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110169194|NCT00037804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110169195|NCT00037804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110169196|NCT00037882|Interferons|interferons|mesh-list
110169197|NCT00037882|Interferon-alpha|interferon-alpha|mesh-list
110169198|NCT00037882|Interferon alpha-2|interferon alpha-2|mesh-list
110169199|NCT00037882|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110169200|NCT00037882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110169201|NCT00037882|Antiviral Agents|antiviral agents|mesh-ancestor
110169202|NCT00037882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110169203|NCT00037882|Immunologic Factors|immunologic factors|mesh-ancestor
110169204|NCT00037882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110169205|NCT00037999|Testosterone|testosterone|mesh-list
110169206|NCT00037999|Androgens|androgens|mesh-ancestor
110169207|NCT00037999|Hormones|hormones|mesh-ancestor
110169208|NCT00037999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110169209|NCT00037999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110169210|NCT00038077|Metoprolol|metoprolol|mesh-list
110169211|NCT00038077|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110169212|NCT00038077|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110169213|NCT00038077|Sympatholytics|sympatholytics|mesh-ancestor
110169214|NCT00038077|Autonomic Agents|autonomic agents|mesh-ancestor
110169215|NCT00038077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110169216|NCT00038077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110169217|NCT00038077|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110169218|NCT00038077|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110169219|NCT00038077|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110169220|NCT00038077|Adrenergic Agents|adrenergic agents|mesh-ancestor
110169221|NCT00038077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110169222|NCT00038077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110169223|NCT00038116|Dopamine|dopamine|mesh-list
110169224|NCT00038116|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110169225|NCT00038116|Sympathomimetics|sympathomimetics|mesh-ancestor
110169226|NCT00038116|Autonomic Agents|autonomic agents|mesh-ancestor
110169227|NCT00038116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110169228|NCT00038116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110169229|NCT00038116|Dopamine Agents|dopamine agents|mesh-ancestor
110169230|NCT00038116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110169231|NCT00038116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110169232|NCT00038116|Protective Agents|protective agents|mesh-ancestor
110169233|NCT00038194|Docetaxel|docetaxel|mesh-list
110169234|NCT00038194|Imatinib Mesylate|imatinib mesylate|mesh-list
110169235|NCT00038194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110169236|NCT00038194|Tubulin Modulators|tubulin modulators|mesh-ancestor
110169237|NCT00038194|Antimitotic Agents|antimitotic agents|mesh-ancestor
110169238|NCT00038194|Mitosis Modulators|mitosis modulators|mesh-ancestor
110169239|NCT00038194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110169240|NCT00038194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110169241|NCT00038194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110169242|NCT00038233|Thalidomide|thalidomide|mesh-list
110169243|NCT00038233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110169244|NCT00038233|Immunologic Factors|immunologic factors|mesh-ancestor
110169245|NCT00038233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110169246|NCT00038233|Leprostatic Agents|leprostatic agents|mesh-ancestor
110169247|NCT00038233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110169248|NCT00038233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110169249|NCT00038233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110169250|NCT00038233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110169251|NCT00038233|Growth Substances|growth substances|mesh-ancestor
110169252|NCT00038233|Growth Inhibitors|growth inhibitors|mesh-ancestor
110169253|NCT00038233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110169255|NCT00000926|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
110169256|NCT00000926|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
110169257|NCT00000926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110169258|NCT00000926|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110169259|NCT00000926|Contraceptive Agents|contraceptive agents|mesh-ancestor
110169260|NCT00000926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110169261|NCT00000926|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110169262|NCT00038272|Mycophenolic Acid|mycophenolic acid|mesh-list
110169263|NCT00038272|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110169264|NCT00038272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110169265|NCT00038272|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110169266|NCT00038272|Antitubercular Agents|antitubercular agents|mesh-ancestor
110169267|NCT00038272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110169268|NCT00038272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110169269|NCT00038272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110169270|NCT00038272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110169272|NCT00000941|Nelfinavir|nelfinavir|mesh-list
110169273|NCT00000941|Saquinavir|saquinavir|mesh-list
110169274|NCT00000941|Atorvastatin|atorvastatin|mesh-list
110169275|NCT00000941|Simvastatin|simvastatin|mesh-list
110169276|NCT00000941|Pravastatin|pravastatin|mesh-list
110169278|NCT00000941|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110169279|NCT00000941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110169280|NCT00000941|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110169281|NCT00000941|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110169282|NCT00000941|Antimetabolites|antimetabolites|mesh-ancestor
110169283|NCT00000941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110169284|NCT00000941|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110169285|NCT00000941|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110169286|NCT00000941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110169287|NCT00000941|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110169288|NCT00000941|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110169290|NCT00000941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110169291|NCT00000941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110169292|NCT00000941|Antiviral Agents|antiviral agents|mesh-ancestor
110169293|NCT00000941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110169294|NCT00000941|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110169295|NCT00000941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110169296|NCT00014937|Ritonavir|ritonavir|mesh-list
110169298|NCT00014937|Lamivudine|lamivudine|mesh-list
110169299|NCT00014937|Zidovudine|zidovudine|mesh-list
110169300|NCT00014937|Stavudine|stavudine|mesh-list
110169301|NCT00014937|Didanosine|didanosine|mesh-list
110169302|NCT00014937|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
110169303|NCT00014937|Efavirenz|efavirenz|mesh-list
110169304|NCT00014937|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110169305|NCT00014937|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110169306|NCT00014937|Protease Inhibitors|protease inhibitors|mesh-ancestor
110169307|NCT00014937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110169308|NCT00014937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110169309|NCT00014937|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110169310|NCT00014937|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110169311|NCT00014937|Antiviral Agents|antiviral agents|mesh-ancestor
110169312|NCT00014937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110169313|NCT00014937|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110169314|NCT00014937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110169315|NCT00014937|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110169316|NCT00014937|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110169318|NCT00014937|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110169319|NCT00014937|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110169320|NCT00014937|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110169321|NCT00014937|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110169322|NCT00014937|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110169323|NCT00000959|Pyridoxine|pyridoxine|mesh-list
110169324|NCT00000959|Vitamin B 6|vitamin b 6|mesh-list
110169325|NCT00000959|Isoniazid|isoniazid|mesh-list
110169326|NCT00000959|Antitubercular Agents|antitubercular agents|mesh-ancestor
110169327|NCT00000959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110169328|NCT00000959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110169329|NCT00000959|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110169330|NCT00000959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110169331|NCT00000959|Antimetabolites|antimetabolites|mesh-ancestor
110169332|NCT00000959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110169333|NCT00000959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110169334|NCT00000959|Vitamin B Complex|vitamin b complex|mesh-ancestor
110169335|NCT00000959|Vitamins|vitamins|mesh-ancestor
110169336|NCT00000959|Micronutrients|micronutrients|mesh-ancestor
110169337|NCT00000959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110169338|NCT00000962|Nevirapine|nevirapine|mesh-list
110169339|NCT00000962|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110169340|NCT00000962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110169341|NCT00000962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110169342|NCT00000962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110169343|NCT00000962|Antiviral Agents|antiviral agents|mesh-ancestor
110169344|NCT00000962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110169345|NCT00000962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110169346|NCT00000962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110169347|NCT00000962|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110169348|NCT00000962|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110169349|NCT00396682|Cyclophosphamide|cyclophosphamide|mesh-list
110169350|NCT00396682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110169351|NCT00396682|Immunologic Factors|immunologic factors|mesh-ancestor
110169352|NCT00396682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110169354|NCT00396682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110169355|NCT00396682|Alkylating Agents|alkylating agents|mesh-ancestor
110169356|NCT00396682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110169357|NCT00396682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110169358|NCT00396682|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110169359|NCT00396721|Sirolimus|sirolimus|mesh-list
110169360|NCT00396721|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
110169361|NCT00396721|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110169362|NCT00396721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110169363|NCT00396721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110169364|NCT00396721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110169365|NCT00396721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110169366|NCT00396721|Antifungal Agents|antifungal agents|mesh-ancestor
110169367|NCT00396721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110191533|NCT00056277|Lamotrigine|lamotrigine|mesh-list
110169369|NCT00396721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110169370|NCT00396721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110169371|NCT00396721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110169372|NCT00396721|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110169373|NCT00396721|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110169375|NCT00396721|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110169376|NCT00396721|Protease Inhibitors|protease inhibitors|mesh-ancestor
110169377|NCT00000965|Zidovudine|zidovudine|mesh-list
110169378|NCT00000965|Antimetabolites|antimetabolites|mesh-ancestor
110169379|NCT00000965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110169380|NCT00000965|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110169381|NCT00000965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110169382|NCT00000965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110169383|NCT00000965|Antiviral Agents|antiviral agents|mesh-ancestor
110169384|NCT00000965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110169385|NCT00000965|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110169386|NCT00000965|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110169387|NCT00015054|Methylphenidate|methylphenidate|mesh-list
110169388|NCT00015054|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110169389|NCT00015054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110169390|NCT00015054|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110169391|NCT00015054|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110169392|NCT00015054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110169393|NCT00015054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110169394|NCT00015054|Dopamine Agents|dopamine agents|mesh-ancestor
110169395|NCT00015054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110169396|NCT00015132|Sertraline|sertraline|mesh-list
110169397|NCT00015132|Antidepressive Agents|antidepressive agents|mesh-ancestor
110169398|NCT00015132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110169399|NCT00015132|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110169400|NCT00015132|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110169401|NCT00015132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110169402|NCT00015132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110169403|NCT00015132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110169404|NCT00015132|Serotonin Agents|serotonin agents|mesh-ancestor
110169405|NCT00015132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110169406|NCT00000971|Zidovudine|zidovudine|mesh-list
110169407|NCT00000971|Didanosine|didanosine|mesh-list
110169408|NCT00000971|Clarithromycin|clarithromycin|mesh-list
110169409|NCT00000971|Antimetabolites|antimetabolites|mesh-ancestor
110169410|NCT00000971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110169411|NCT00000971|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110169412|NCT00000971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110169413|NCT00000971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110169414|NCT00000971|Antiviral Agents|antiviral agents|mesh-ancestor
110169415|NCT00000971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110169416|NCT00000971|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110169417|NCT00000971|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110169418|NCT00000971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110169419|NCT00000971|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110169420|NCT00000971|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110169421|NCT00000971|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110169422|NCT00015171|Buprenorphine|buprenorphine|mesh-list
110169423|NCT00015171|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
110169425|NCT00015171|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110169426|NCT00015171|Narcotics|narcotics|mesh-ancestor
110169427|NCT00015171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110169428|NCT00015171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110169429|NCT00015171|Analgesics|analgesics|mesh-ancestor
110169430|NCT00015171|Sensory System Agents|sensory system agents|mesh-ancestor
110169431|NCT00015171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110169432|NCT00015171|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110169433|NCT00015210|Nefazodone|nefazodone|mesh-list
110191539|NCT00056277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110169434|NCT00015210|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110169435|NCT00015210|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110169436|NCT00015210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110169437|NCT00015210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110169438|NCT00015210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110169439|NCT00015210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110169440|NCT00015210|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110169441|NCT00015210|Antidepressive Agents|antidepressive agents|mesh-ancestor
110169442|NCT00015210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110169443|NCT00015210|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110169444|NCT00015210|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110169445|NCT00015210|Serotonin Agents|serotonin agents|mesh-ancestor
110169447|NCT00000986|Aldesleukin|aldesleukin|mesh-list
110169448|NCT00000986|Antimetabolites|antimetabolites|mesh-ancestor
110169449|NCT00000986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110169450|NCT00000986|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110169451|NCT00000986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110169452|NCT00000986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110169453|NCT00000986|Antiviral Agents|antiviral agents|mesh-ancestor
110169454|NCT00000986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110169455|NCT00000986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110169456|NCT00000986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110169457|NCT00000986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110169458|NCT00015249|Amantadine|amantadine|mesh-list
110169459|NCT00015249|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110169460|NCT00015249|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110169461|NCT00015249|Antiviral Agents|antiviral agents|mesh-ancestor
110169462|NCT00015249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110169463|NCT00015249|Dopamine Agents|dopamine agents|mesh-ancestor
110169464|NCT00015249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110169465|NCT00015249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110169466|NCT00015249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110169467|NCT00015249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110169468|NCT00015249|Analgesics|analgesics|mesh-ancestor
110169469|NCT00015249|Sensory System Agents|sensory system agents|mesh-ancestor
110169470|NCT00015249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110169471|NCT05195242|Dexamethasone|dexamethasone|mesh-list
110169472|NCT05195242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110169473|NCT05195242|Antiemetics|antiemetics|mesh-ancestor
110169474|NCT05195242|Autonomic Agents|autonomic agents|mesh-ancestor
110169475|NCT05195242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110169476|NCT05195242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110169477|NCT05195242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110169478|NCT05195242|Glucocorticoids|glucocorticoids|mesh-ancestor
110169479|NCT05195242|Hormones|hormones|mesh-ancestor
110169480|NCT05195242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110169481|NCT05195242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110169482|NCT05195242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110169483|NCT00015288|Buprenorphine|buprenorphine|mesh-list
110169484|NCT00015288|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
110169485|NCT00015288|Naloxone|naloxone|mesh-list
110169486|NCT00015288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110169487|NCT00015288|Narcotics|narcotics|mesh-ancestor
110169488|NCT00015288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110169489|NCT00015288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110169490|NCT00015288|Analgesics|analgesics|mesh-ancestor
110169491|NCT00015288|Sensory System Agents|sensory system agents|mesh-ancestor
110169492|NCT00015288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110169493|NCT00015288|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110169494|NCT05083975|Anesthetics|anesthetics|mesh-list
110169495|NCT05083975|Anesthetics, Local|anesthetics, local|mesh-list
110169496|NCT05083975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110169497|NCT05083975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110169499|NCT05083975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110169501|NCT00000998|Trimetrexate|trimetrexate|mesh-list
110169502|NCT00000998|Calcium|calcium|mesh-list
110169503|NCT00000998|Levoleucovorin|levoleucovorin|mesh-list
110169504|NCT00000998|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110169505|NCT00000998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110169506|NCT00000998|Antidotes|antidotes|mesh-ancestor
110169507|NCT00000998|Protective Agents|protective agents|mesh-ancestor
110169508|NCT00000998|Vitamin B Complex|vitamin b complex|mesh-ancestor
110169509|NCT00000998|Vitamins|vitamins|mesh-ancestor
110169510|NCT00000998|Micronutrients|micronutrients|mesh-ancestor
110169511|NCT00000998|Antifungal Agents|antifungal agents|mesh-ancestor
110169512|NCT00000998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110169513|NCT00000998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110169514|NCT00000998|Antimetabolites|antimetabolites|mesh-ancestor
110169515|NCT00000998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110169516|NCT00000998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110169517|NCT00000998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110169518|NCT00000998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110169519|NCT00001001|Zidovudine|zidovudine|mesh-list
110169520|NCT00001001|Antimetabolites|antimetabolites|mesh-ancestor
110169521|NCT00001001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110169522|NCT00001001|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110169523|NCT00001001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110169524|NCT00001001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110169525|NCT00001001|Antiviral Agents|antiviral agents|mesh-ancestor
110169526|NCT00001001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110169527|NCT00001001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110169528|NCT00001001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110169529|NCT05076877|Metformin|metformin|mesh-list
110169530|NCT05076877|Midazolam|midazolam|mesh-list
110169531|NCT05076877|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110169532|NCT05076877|Lazertinib|lazertinib|mesh-list
110169533|NCT05076877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110169534|NCT05076877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110169535|NCT05076877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110169536|NCT05076877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110169537|NCT05076877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110169538|NCT05076877|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110169539|NCT05076877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110169540|NCT05076877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110169541|NCT05076877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110169542|NCT05076877|Anesthetics, General|anesthetics, general|mesh-ancestor
110169543|NCT05076877|Anesthetics|anesthetics|mesh-ancestor
110169544|NCT05076877|GABA Modulators|gaba modulators|mesh-ancestor
110169545|NCT05076877|GABA Agents|gaba agents|mesh-ancestor
110169546|NCT05076877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110169547|NCT05076877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110169548|NCT05076877|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110169549|NCT05076877|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110169551|NCT05076877|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110169552|NCT05076877|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110169553|NCT05076877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110169554|NCT05076877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110169555|NCT00001004|Interferons|interferons|mesh-list
110169556|NCT00001004|Interferon-gamma|interferon-gamma|mesh-list
110169557|NCT00001004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110169558|NCT00001004|Antiviral Agents|antiviral agents|mesh-ancestor
110169559|NCT00001004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110169561|NCT00396604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110169562|NCT00396604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110191550|NCT00028574|Anticonvulsants|anticonvulsants|mesh-ancestor
110169563|NCT04896541|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
110169565|NCT04896541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110169566|NCT00396760|Tranexamic Acid|tranexamic acid|mesh-list
110169567|NCT00396760|Aprotinin|aprotinin|mesh-list
110169568|NCT00396760|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110169569|NCT00396760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110169570|NCT00396760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110169571|NCT00396760|Hemostatics|hemostatics|mesh-ancestor
110169572|NCT00396760|Coagulants|coagulants|mesh-ancestor
110169573|NCT00396760|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110169574|NCT00396760|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110169575|NCT00396760|Protease Inhibitors|protease inhibitors|mesh-ancestor
110169576|NCT00396760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110169577|NCT00001007|Zidovudine|zidovudine|mesh-list
110169578|NCT00001007|Antimetabolites|antimetabolites|mesh-ancestor
110169579|NCT00001007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110169580|NCT00001007|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110169581|NCT00001007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110169582|NCT00001007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110169583|NCT00001007|Antiviral Agents|antiviral agents|mesh-ancestor
110169584|NCT00001007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110169585|NCT00001007|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110169586|NCT00001007|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110169587|NCT00396799|Bazedoxifene|bazedoxifene|mesh-list
110169588|NCT00396799|Estrogens|estrogens|mesh-list
110169589|NCT00396799|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110169590|NCT00396799|Hormones|hormones|mesh-ancestor
110169591|NCT00396799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110169592|NCT00396799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110169593|NCT00396799|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110169594|NCT00396799|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110169595|NCT00396799|Hormone Antagonists|hormone antagonists|mesh-ancestor
110169596|NCT00396799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110169597|NCT01786434|Fentanyl|fentanyl|mesh-list
110169598|NCT01786434|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110169599|NCT01786434|Narcotics|narcotics|mesh-ancestor
110169600|NCT01786434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110169601|NCT01786434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110169602|NCT01786434|Analgesics|analgesics|mesh-ancestor
110169603|NCT01786434|Sensory System Agents|sensory system agents|mesh-ancestor
110169604|NCT01786434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110169605|NCT01786434|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110169606|NCT01786434|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110169607|NCT01786434|Anesthetics, General|anesthetics, general|mesh-ancestor
110169608|NCT01786434|Anesthetics|anesthetics|mesh-ancestor
110169609|NCT00001010|Zidovudine|zidovudine|mesh-list
110169610|NCT00001010|Acyclovir|acyclovir|mesh-list
110169611|NCT00001010|Antimetabolites|antimetabolites|mesh-ancestor
110169612|NCT00001010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110169613|NCT00001010|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110169614|NCT00001010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110169615|NCT00001010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110169616|NCT00001010|Antiviral Agents|antiviral agents|mesh-ancestor
110169617|NCT00001010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110169618|NCT00001010|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110169619|NCT00001010|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110169620|NCT00001013|Leucovorin|leucovorin|mesh-list
110169621|NCT00001013|Trimethoprim|trimethoprim|mesh-list
110169622|NCT00001013|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110169623|NCT00001013|Sulfamethoxazole|sulfamethoxazole|mesh-list
110169624|NCT00001013|Pentamidine|pentamidine|mesh-list
110169625|NCT00001013|Trimetrexate|trimetrexate|mesh-list
110169626|NCT00001013|Calcium|calcium|mesh-list
110169627|NCT00001013|Levoleucovorin|levoleucovorin|mesh-list
110169628|NCT00001013|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110169629|NCT00001013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110169630|NCT00001013|Antidotes|antidotes|mesh-ancestor
110169631|NCT00001013|Protective Agents|protective agents|mesh-ancestor
110169632|NCT00001013|Vitamin B Complex|vitamin b complex|mesh-ancestor
110169633|NCT00001013|Vitamins|vitamins|mesh-ancestor
110169634|NCT00001013|Micronutrients|micronutrients|mesh-ancestor
110169635|NCT00001013|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110169636|NCT00001013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110169637|NCT00001013|Antimalarials|antimalarials|mesh-ancestor
110169638|NCT00001013|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110169639|NCT00001013|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110169640|NCT00001013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110169641|NCT00001013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110169642|NCT00001013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110169643|NCT00001013|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110169644|NCT00001013|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110169645|NCT00001013|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110169646|NCT00001013|Antifungal Agents|antifungal agents|mesh-ancestor
110169647|NCT00001013|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110169648|NCT00001013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110169649|NCT00001013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110169650|NCT00001013|Antimetabolites|antimetabolites|mesh-ancestor
110169651|NCT00001013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110169653|NCT04680442|Pertuzumab|pertuzumab|mesh-list
110169654|NCT04680442|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
110169655|NCT04680442|Maytansine|maytansine|mesh-list
110169656|NCT04680442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110169657|NCT04680442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110169658|NCT04680442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110169659|NCT04680442|Tubulin Modulators|tubulin modulators|mesh-ancestor
110169660|NCT04680442|Antimitotic Agents|antimitotic agents|mesh-ancestor
110169661|NCT04680442|Mitosis Modulators|mitosis modulators|mesh-ancestor
110169662|NCT04680442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110169663|NCT04680442|Immunotoxins|immunotoxins|mesh-ancestor
110169664|NCT04680442|Immunoconjugates|immunoconjugates|mesh-ancestor
110169665|NCT04680442|Immunologic Factors|immunologic factors|mesh-ancestor
110169666|NCT04680442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110169667|NCT00015834|Cytarabine|cytarabine|mesh-list
110169668|NCT00015834|Imatinib Mesylate|imatinib mesylate|mesh-list
110169669|NCT00015834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110169670|NCT00015834|Antimetabolites|antimetabolites|mesh-ancestor
110169671|NCT00015834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110169672|NCT00015834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110169673|NCT00015834|Antiviral Agents|antiviral agents|mesh-ancestor
110169674|NCT00015834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110169675|NCT00015834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110169676|NCT00015834|Immunologic Factors|immunologic factors|mesh-ancestor
110169677|NCT00015834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110169678|NCT00015834|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110169680|NCT00001040|Zidovudine|zidovudine|mesh-list
110169681|NCT00001040|Zalcitabine|zalcitabine|mesh-list
110169682|NCT00001040|Saquinavir|saquinavir|mesh-list
110169683|NCT00001040|Antimetabolites|antimetabolites|mesh-ancestor
110169684|NCT00001040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110169685|NCT00001040|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110169686|NCT00001040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110169687|NCT00001040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110169688|NCT00001040|Antiviral Agents|antiviral agents|mesh-ancestor
110169689|NCT00001040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110169691|NCT00001040|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110169692|NCT00001040|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110169693|NCT00001040|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110169694|NCT00001040|Protease Inhibitors|protease inhibitors|mesh-ancestor
110169695|NCT00001040|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110169696|NCT00001040|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110169697|NCT00015873|Cytarabine|cytarabine|mesh-list
110169698|NCT00015873|Prednisolone|prednisolone|mesh-list
110169699|NCT00015873|Methotrexate|methotrexate|mesh-list
110169700|NCT00015873|Mercaptopurine|mercaptopurine|mesh-list
110169701|NCT00015873|Vincristine|vincristine|mesh-list
110169702|NCT00015873|Asparaginase|asparaginase|mesh-list
110169703|NCT00015873|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110169704|NCT00015873|Abortifacient Agents|abortifacient agents|mesh-ancestor
110169705|NCT00015873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110169706|NCT00015873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110169707|NCT00015873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110169708|NCT00015873|Antimetabolites|antimetabolites|mesh-ancestor
110169709|NCT00015873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110169710|NCT00015873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110169711|NCT00015873|Dermatologic Agents|dermatologic agents|mesh-ancestor
110169712|NCT00015873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110169713|NCT00015873|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110169714|NCT00015873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110169715|NCT00015873|Immunologic Factors|immunologic factors|mesh-ancestor
110169716|NCT00015873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110169717|NCT00015873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110169718|NCT00015873|Antiviral Agents|antiviral agents|mesh-ancestor
110169719|NCT00015873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110169720|NCT00015873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110169721|NCT00015873|Tubulin Modulators|tubulin modulators|mesh-ancestor
110169722|NCT00015873|Antimitotic Agents|antimitotic agents|mesh-ancestor
110169723|NCT00015873|Mitosis Modulators|mitosis modulators|mesh-ancestor
110169724|NCT00015873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110169725|NCT00015873|Glucocorticoids|glucocorticoids|mesh-ancestor
110169726|NCT00015873|Hormones|hormones|mesh-ancestor
110169727|NCT00015873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110169728|NCT00015873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110169730|NCT00015912|Interferon-alpha|interferon-alpha|mesh-list
110169731|NCT00015912|Interferon alpha-2|interferon alpha-2|mesh-list
110169732|NCT00015912|Thalidomide|thalidomide|mesh-list
110169733|NCT00015912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110169734|NCT00015912|Antiviral Agents|antiviral agents|mesh-ancestor
110169735|NCT00015912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110169736|NCT00015912|Immunologic Factors|immunologic factors|mesh-ancestor
110169737|NCT00015912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110169738|NCT00015912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110169739|NCT00015912|Leprostatic Agents|leprostatic agents|mesh-ancestor
110169740|NCT00015912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110169741|NCT00015912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110169742|NCT00015912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110169743|NCT00015912|Growth Substances|growth substances|mesh-ancestor
110169744|NCT00015912|Growth Inhibitors|growth inhibitors|mesh-ancestor
110169745|NCT03668431|Trametinib|trametinib|mesh-list
110169746|NCT03668431|Dabrafenib|dabrafenib|mesh-list
110169747|NCT03668431|Spartalizumab|spartalizumab|mesh-list
110169748|NCT03668431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110169749|NCT03668431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110169750|NCT03668431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110169751|NCT03668431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110169752|NCT03668431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110169753|NCT03668431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110169754|NCT00001073|Isotretinoin|isotretinoin|mesh-list
110169755|NCT00001073|Dermatologic Agents|dermatologic agents|mesh-ancestor
110169756|NCT02970721|Antipsychotic Agents|antipsychotic agents|mesh-list
110169757|NCT02970721|Antidepressive Agents|antidepressive agents|mesh-list
110169758|NCT02970721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110169759|NCT02970721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110169760|NCT02970721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110169761|NCT02970721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110169762|NCT03636958|Anticonvulsants|anticonvulsants|mesh-list
110169763|NCT00015951|Cytarabine|cytarabine|mesh-list
110169764|NCT00015951|Bevacizumab|bevacizumab|mesh-list
110169765|NCT00015951|Mitoxantrone|mitoxantrone|mesh-list
110169766|NCT00015951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110169767|NCT00015951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110169768|NCT00015951|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110169769|NCT00015951|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110169770|NCT00015951|Growth Substances|growth substances|mesh-ancestor
110169771|NCT00015951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110169772|NCT00015951|Growth Inhibitors|growth inhibitors|mesh-ancestor
110169773|NCT00015951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110169774|NCT00015951|Antimetabolites|antimetabolites|mesh-ancestor
110169775|NCT00015951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110169776|NCT00015951|Antiviral Agents|antiviral agents|mesh-ancestor
110169777|NCT00015951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110169778|NCT00015951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110169779|NCT00015951|Immunologic Factors|immunologic factors|mesh-ancestor
110169780|NCT00015951|Analgesics|analgesics|mesh-ancestor
110169782|NCT00015951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110169783|NCT00015951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110169784|NCT00015951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110169785|NCT00015951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110169787|NCT00001076|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110169788|NCT00001076|Immunologic Factors|immunologic factors|mesh-ancestor
110169789|NCT00001076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110169790|NCT00001076|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110169791|NCT00001076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110169792|NCT00001076|Antiviral Agents|antiviral agents|mesh-ancestor
110169793|NCT00001076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110169794|NCT00001076|Interferon Inducers|interferon inducers|mesh-ancestor
110169795|NCT00001076|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110169796|NCT00001076|Protective Agents|protective agents|mesh-ancestor
110169798|NCT00015990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110169799|NCT00015990|Immunologic Factors|immunologic factors|mesh-ancestor
110169800|NCT00015990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110169801|NCT00015990|Leprostatic Agents|leprostatic agents|mesh-ancestor
110169802|NCT00015990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110169803|NCT00015990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110169804|NCT00015990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110169805|NCT00015990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110169806|NCT00015990|Growth Substances|growth substances|mesh-ancestor
110169808|NCT00015990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110169809|NCT00001085|Lamivudine|lamivudine|mesh-list
110169810|NCT00001085|Zidovudine|zidovudine|mesh-list
110169811|NCT00001085|Amprenavir|amprenavir|mesh-list
110169812|NCT00001085|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110169813|NCT00001085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110169814|NCT00001085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110169815|NCT00001085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110169816|NCT00001085|Antiviral Agents|antiviral agents|mesh-ancestor
110169817|NCT00001085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110169818|NCT00001085|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110169819|NCT00001085|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110169820|NCT00001085|Antimetabolites|antimetabolites|mesh-ancestor
110169821|NCT00001085|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110169822|NCT00001085|Antitubercular Agents|antitubercular agents|mesh-ancestor
110169823|NCT00001085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110169824|NCT00001085|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110169825|NCT00001085|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110169826|NCT00001085|Protease Inhibitors|protease inhibitors|mesh-ancestor
110169827|NCT02970916|Aflibercept|aflibercept|mesh-list
110169829|NCT02970916|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110169830|NCT02970916|Growth Substances|growth substances|mesh-ancestor
110169831|NCT02970916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110169832|NCT02970916|Growth Inhibitors|growth inhibitors|mesh-ancestor
110169833|NCT02970916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110169834|NCT00016068|Valganciclovir|valganciclovir|mesh-list
110169835|NCT00016068|Ganciclovir|ganciclovir|mesh-list
110169836|NCT00016068|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
110169837|NCT00016068|Antiviral Agents|antiviral agents|mesh-ancestor
110169838|NCT00016068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110169839|NCT00016068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110169840|NCT00016068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110169841|NCT00016068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110169842|NCT00016107|Bevacizumab|bevacizumab|mesh-list
110169843|NCT00016107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110169845|NCT00016107|Estramustine|estramustine|mesh-list
110169846|NCT00016107|Antibodies|antibodies|mesh-list
110169847|NCT00016107|Immunoglobulins|immunoglobulins|mesh-list
110169849|NCT00016107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110169850|NCT00016107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110169851|NCT00016107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110169852|NCT00016107|Growth Substances|growth substances|mesh-ancestor
110169853|NCT00016107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110169855|NCT00016107|Immunologic Factors|immunologic factors|mesh-ancestor
110169856|NCT00016107|Tubulin Modulators|tubulin modulators|mesh-ancestor
110169858|NCT00016107|Mitosis Modulators|mitosis modulators|mesh-ancestor
110169859|NCT00016107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110169860|NCT00016107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110169861|NCT00016107|Alkylating Agents|alkylating agents|mesh-ancestor
110169862|NCT00016107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110169863|NCT00001118|Enfuvirtide|enfuvirtide|mesh-list
110169865|NCT00001118|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110169866|NCT00001118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110169867|NCT00001118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110191605|NCT00028847|Cytarabine|cytarabine|mesh-list
110169868|NCT00001118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110169869|NCT00001118|Antiviral Agents|antiviral agents|mesh-ancestor
110169870|NCT00001118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110169871|NCT00016185|Docetaxel|docetaxel|mesh-list
110169872|NCT00016185|Alvocidib|alvocidib|mesh-list
110169873|NCT00016185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110169874|NCT00016185|Tubulin Modulators|tubulin modulators|mesh-ancestor
110169875|NCT00016185|Antimitotic Agents|antimitotic agents|mesh-ancestor
110169876|NCT00016185|Mitosis Modulators|mitosis modulators|mesh-ancestor
110169877|NCT00016185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110169878|NCT00016185|Growth Inhibitors|growth inhibitors|mesh-ancestor
110169879|NCT00016185|Growth Substances|growth substances|mesh-ancestor
110169880|NCT00016185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110169881|NCT00016185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110169882|NCT00016185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110169883|NCT00001151|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
110169884|NCT00001151|Calcitriol|calcitriol|mesh-list
110169885|NCT00001151|Vitamins|vitamins|mesh-ancestor
110169886|NCT00001151|Micronutrients|micronutrients|mesh-ancestor
110169887|NCT00001151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110169888|NCT00001151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110169889|NCT00001151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110169890|NCT00001151|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110169891|NCT00001151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110169892|NCT00001151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110169893|NCT00001151|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110169895|NCT00016224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110169896|NCT00016224|Immunologic Factors|immunologic factors|mesh-ancestor
110169897|NCT00016224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110169898|NCT00016224|Leprostatic Agents|leprostatic agents|mesh-ancestor
110169899|NCT00016224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110169901|NCT00016224|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110169902|NCT00016224|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110169903|NCT00016224|Growth Substances|growth substances|mesh-ancestor
110169904|NCT00016224|Growth Inhibitors|growth inhibitors|mesh-ancestor
110169905|NCT00016224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110169906|NCT00016263|Dacarbazine|dacarbazine|mesh-list
110169907|NCT00016263|Oblimersen|oblimersen|mesh-list
110169908|NCT00016263|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110169909|NCT00016263|Alkylating Agents|alkylating agents|mesh-ancestor
110169910|NCT00016263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110169911|NCT00016263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110169912|NCT00016302|Leucovorin|leucovorin|mesh-list
110169913|NCT00016302|Cytarabine|cytarabine|mesh-list
110169914|NCT00016302|Dexamethasone|dexamethasone|mesh-list
110169915|NCT00016302|Prednisone|prednisone|mesh-list
110169916|NCT00016302|Cyclophosphamide|cyclophosphamide|mesh-list
110169917|NCT00016302|Doxorubicin|doxorubicin|mesh-list
110169918|NCT00016302|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110169919|NCT00016302|Methotrexate|methotrexate|mesh-list
110169920|NCT00016302|Vincristine|vincristine|mesh-list
110169921|NCT00016302|Daunorubicin|daunorubicin|mesh-list
110169922|NCT00016302|Asparaginase|asparaginase|mesh-list
110169923|NCT00016302|Mercaptopurine|mercaptopurine|mesh-list
110169924|NCT00016302|Pegaspargase|pegaspargase|mesh-list
110169925|NCT00016302|Thioguanine|thioguanine|mesh-list
110169926|NCT00016302|Levoleucovorin|levoleucovorin|mesh-list
110169927|NCT00016302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110169928|NCT00016302|Immunologic Factors|immunologic factors|mesh-ancestor
110169929|NCT00016302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110169930|NCT00016302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110169931|NCT00016302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110169932|NCT00016302|Alkylating Agents|alkylating agents|mesh-ancestor
110169933|NCT00016302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110169934|NCT00016302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110169935|NCT00016302|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110191642|NCT00028886|Hormones|hormones|mesh-ancestor
110169936|NCT00016302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110169938|NCT00016302|Autonomic Agents|autonomic agents|mesh-ancestor
110169939|NCT00016302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110169941|NCT00016302|Glucocorticoids|glucocorticoids|mesh-ancestor
110169942|NCT00016302|Hormones|hormones|mesh-ancestor
110169943|NCT00016302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110169944|NCT00016302|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110169945|NCT00016302|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110169946|NCT00016302|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110169947|NCT00016302|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110169948|NCT00016302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110169949|NCT00016302|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110169950|NCT00016302|Abortifacient Agents|abortifacient agents|mesh-ancestor
110169951|NCT00016302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110169952|NCT00016302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110169953|NCT00016302|Antimetabolites|antimetabolites|mesh-ancestor
110169954|NCT00016302|Dermatologic Agents|dermatologic agents|mesh-ancestor
110169955|NCT00016302|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110169956|NCT00016302|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110169957|NCT00016302|Antiviral Agents|antiviral agents|mesh-ancestor
110169958|NCT00016302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110169959|NCT00016302|Antidotes|antidotes|mesh-ancestor
110169960|NCT00016302|Protective Agents|protective agents|mesh-ancestor
110169961|NCT00016302|Vitamin B Complex|vitamin b complex|mesh-ancestor
110169962|NCT00016302|Vitamins|vitamins|mesh-ancestor
110169964|NCT00016302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110169965|NCT00016302|Tubulin Modulators|tubulin modulators|mesh-ancestor
110169966|NCT00016302|Antimitotic Agents|antimitotic agents|mesh-ancestor
110169967|NCT00016302|Mitosis Modulators|mitosis modulators|mesh-ancestor
110169968|NCT00389285|Sorafenib|sorafenib|mesh-list
110169969|NCT00389285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110169970|NCT00389285|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110169971|NCT00389285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110169972|NCT00389285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110169973|NCT00016341|Tamoxifen|tamoxifen|mesh-list
110169975|NCT00016341|Doxorubicin|doxorubicin|mesh-list
110169976|NCT00016341|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110169977|NCT00016341|Megestrol|megestrol|mesh-list
110169978|NCT00016341|Megestrol Acetate|megestrol acetate|mesh-list
110169979|NCT00016341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110169980|NCT00016341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110169981|NCT00016341|Tubulin Modulators|tubulin modulators|mesh-ancestor
110169982|NCT00016341|Antimitotic Agents|antimitotic agents|mesh-ancestor
110169983|NCT00016341|Mitosis Modulators|mitosis modulators|mesh-ancestor
110169984|NCT00016341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110169985|NCT00016341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110169986|NCT00016341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110169987|NCT00016341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110169988|NCT00016341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110169989|NCT00016341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110169990|NCT00016341|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110169992|NCT00016341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110169993|NCT00016341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110169994|NCT00016341|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110169995|NCT00016341|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110169996|NCT00016341|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110169997|NCT00016341|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110169998|NCT00016341|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110169999|NCT00016341|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110170000|NCT00016341|Contraceptive Agents|contraceptive agents|mesh-ancestor
110170001|NCT00016341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110170002|NCT00016341|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110170003|NCT00016341|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110170004|NCT00016341|Appetite Stimulants|appetite stimulants|mesh-ancestor
110170005|NCT00016341|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110170006|NCT00001181|Testolactone|testolactone|mesh-list
110170007|NCT00001181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110170008|NCT00001181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110170011|NCT00016380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110170013|NCT00016380|Autonomic Agents|autonomic agents|mesh-ancestor
110170014|NCT00016380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110170015|NCT00016380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110170016|NCT00016380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110170018|NCT00016380|Hormones|hormones|mesh-ancestor
110170019|NCT00016380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110170020|NCT00016380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110170021|NCT00016380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110170022|NCT00016380|Antipruritics|antipruritics|mesh-ancestor
110170023|NCT00016380|Dermatologic Agents|dermatologic agents|mesh-ancestor
110170024|NCT00016380|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110170025|NCT00016380|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110170026|NCT00016380|Serotonin Agents|serotonin agents|mesh-ancestor
110170027|NCT00016380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110170028|NCT00016380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110170029|NCT00001190|Deslorelin|deslorelin|mesh-list
110170030|NCT00001190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110170031|NCT00001190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110170033|NCT00001202|Spironolactone|spironolactone|mesh-list
110170035|NCT00001202|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110170036|NCT00001202|Hormone Antagonists|hormone antagonists|mesh-ancestor
110170037|NCT00001202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110170038|NCT00001202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110170039|NCT00001202|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110170040|NCT00001202|Diuretics|diuretics|mesh-ancestor
110170041|NCT00001202|Natriuretic Agents|natriuretic agents|mesh-ancestor
110170042|NCT00001202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110170043|NCT00001202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110170044|NCT00001202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110170045|NCT00001202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110170046|NCT00016419|Cyclosporine|cyclosporine|mesh-list
110170047|NCT00016419|Cyclosporins|cyclosporins|mesh-list
110170048|NCT00016419|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110170049|NCT00016419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110170050|NCT00016419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110170051|NCT00016419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110170052|NCT00016419|Immunologic Factors|immunologic factors|mesh-ancestor
110170053|NCT00016419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110170054|NCT00016419|Antifungal Agents|antifungal agents|mesh-ancestor
110170055|NCT00016419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110170056|NCT00016419|Dermatologic Agents|dermatologic agents|mesh-ancestor
110170057|NCT00016419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110170058|NCT00016419|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110170059|NCT00016458|Cyclophosphamide|cyclophosphamide|mesh-list
110170060|NCT00016458|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110170061|NCT00016458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110170062|NCT00016458|Immunologic Factors|immunologic factors|mesh-ancestor
110170063|NCT00016458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110170064|NCT00016458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110170065|NCT00016458|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110170066|NCT00016458|Alkylating Agents|alkylating agents|mesh-ancestor
110170067|NCT00016458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110170068|NCT00016458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110170069|NCT00016458|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110170070|NCT01156545|Afatinib|afatinib|mesh-list
110170071|NCT01156545|Simvastatin|simvastatin|mesh-list
110170072|NCT01156545|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110170073|NCT01156545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110170074|NCT01156545|Antimetabolites|antimetabolites|mesh-ancestor
110170075|NCT01156545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110170076|NCT01156545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110170077|NCT01156545|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110170078|NCT01156545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110170079|NCT01156545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110170080|NCT01156545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110170081|NCT01140516|Trimethoprim|trimethoprim|mesh-list
110170082|NCT01140516|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110170083|NCT01140516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110170085|NCT01140516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110170086|NCT01140516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110170087|NCT01140516|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110170088|NCT01140516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110170089|NCT01140516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110170090|NCT01140516|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110170091|NCT01140516|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110170092|NCT01140516|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110170093|NCT02347111|Sotalol|sotalol|mesh-list
110170094|NCT02347111|Flecainide|flecainide|mesh-list
110170095|NCT02347111|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110170096|NCT02347111|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110170097|NCT02347111|Adrenergic Agents|adrenergic agents|mesh-ancestor
110170098|NCT02347111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110170099|NCT02347111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110170100|NCT02347111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110170101|NCT02347111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110170102|NCT02347111|Sympatholytics|sympatholytics|mesh-ancestor
110170103|NCT02347111|Autonomic Agents|autonomic agents|mesh-ancestor
110170104|NCT02347111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110170105|NCT02347111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110170106|NCT02347111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110170107|NCT02347111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110170108|NCT00001262|Copper|copper|mesh-list
110170109|NCT00001262|Trace Elements|trace elements|mesh-ancestor
110170110|NCT00001262|Micronutrients|micronutrients|mesh-ancestor
110170111|NCT00001262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110170112|NCT00001280|Itraconazole|itraconazole|mesh-list
110170113|NCT00001280|Antifungal Agents|antifungal agents|mesh-ancestor
110170114|NCT00001280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110170115|NCT00001280|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110170116|NCT00001280|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110170117|NCT00001280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110170118|NCT00001280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110170119|NCT00001280|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110170120|NCT00001280|Hormone Antagonists|hormone antagonists|mesh-ancestor
110170121|NCT00001280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110170122|NCT00001280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110170123|NCT00001280|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110170124|NCT00016887|Interferons|interferons|mesh-list
110170125|NCT00016887|Cytarabine|cytarabine|mesh-list
110170126|NCT00016887|Interferon-alpha|interferon-alpha|mesh-list
110170127|NCT00016887|Dexamethasone|dexamethasone|mesh-list
110170128|NCT00016887|Cyclophosphamide|cyclophosphamide|mesh-list
110170129|NCT00016887|Melphalan|melphalan|mesh-list
110170130|NCT00016887|Carmustine|carmustine|mesh-list
110170131|NCT00016887|Etoposide|etoposide|mesh-list
110170132|NCT00016887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110170133|NCT00016887|Immunologic Factors|immunologic factors|mesh-ancestor
110170134|NCT00016887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110170135|NCT00016887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110170136|NCT00016887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110170137|NCT00016887|Alkylating Agents|alkylating agents|mesh-ancestor
110170138|NCT00016887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110170139|NCT00016887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110170140|NCT00016887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110170141|NCT00016887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110170142|NCT00016887|Antiemetics|antiemetics|mesh-ancestor
110170143|NCT00016887|Autonomic Agents|autonomic agents|mesh-ancestor
110170144|NCT00016887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110170145|NCT00016887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110170146|NCT00016887|Glucocorticoids|glucocorticoids|mesh-ancestor
110170147|NCT00016887|Hormones|hormones|mesh-ancestor
110170148|NCT00016887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110170149|NCT00016887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110170150|NCT00016887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110170151|NCT00016887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110170152|NCT00016887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110170153|NCT00016887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110170154|NCT00016887|Antiviral Agents|antiviral agents|mesh-ancestor
110170155|NCT00016887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110170156|NCT00016887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110170157|NCT00016887|Antimetabolites|antimetabolites|mesh-ancestor
110170159|NCT00038389|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110170160|NCT00038389|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110170161|NCT00038389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110170162|NCT00038389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110170163|NCT00038389|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110170164|NCT00038389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110170165|NCT00038389|Analgesics|analgesics|mesh-ancestor
110170166|NCT00038389|Sensory System Agents|sensory system agents|mesh-ancestor
110170167|NCT00038389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110170168|NCT00038389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110170169|NCT00038389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110170170|NCT00038389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110170171|NCT00038506|Tenofovir|tenofovir|mesh-list
110170172|NCT00038506|Lamivudine|lamivudine|mesh-list
110170174|NCT00038506|Abacavir|abacavir|mesh-list
110170175|NCT00038506|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
110170176|NCT00038506|Antiviral Agents|antiviral agents|mesh-ancestor
110170177|NCT00038506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110170178|NCT00038506|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110170179|NCT00038506|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110170180|NCT00038506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110170181|NCT00038506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110170182|NCT00038506|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110170183|NCT00038506|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110170184|NCT00038506|Antimetabolites|antimetabolites|mesh-ancestor
110170185|NCT00016926|Capecitabine|capecitabine|mesh-list
110170186|NCT00016926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110170187|NCT00016926|Antimetabolites|antimetabolites|mesh-ancestor
110170188|NCT00016926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110170189|NCT00016926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110170190|NCT00038545|Paclitaxel|paclitaxel|mesh-list
110170191|NCT00038545|Topotecan|topotecan|mesh-list
110170192|NCT00038545|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110170193|NCT00038545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110170194|NCT00038545|Tubulin Modulators|tubulin modulators|mesh-ancestor
110170195|NCT00038545|Antimitotic Agents|antimitotic agents|mesh-ancestor
110170196|NCT00038545|Mitosis Modulators|mitosis modulators|mesh-ancestor
110170197|NCT00038545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110170198|NCT00038545|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110170200|NCT00038545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110170202|NCT00038584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110170203|NCT00038584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110170205|NCT00038623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110170206|NCT00038623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110170207|NCT00038623|Immunologic Factors|immunologic factors|mesh-ancestor
110170208|NCT00038623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110170209|NCT00038623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110170211|NCT00038662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110170212|NCT00038662|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
110170213|NCT00038662|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110170214|NCT00038662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110170215|NCT00038701|O-(Chloroacetylcarbamoyl)fumagillol|o-(chloroacetylcarbamoyl)fumagillol|mesh-list
110170216|NCT00038701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110170217|NCT00038701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110170218|NCT00038701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110170219|NCT00038701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110170220|NCT00038701|Growth Substances|growth substances|mesh-ancestor
110170221|NCT00038701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110170222|NCT00038701|Growth Inhibitors|growth inhibitors|mesh-ancestor
110170223|NCT00038896|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110170224|NCT00038896|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110170225|NCT00038896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110170226|NCT00038896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110170227|NCT00038896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110170228|NCT00038896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110170229|NCT00038896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110170230|NCT00038896|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110170231|NCT00038896|Antidepressive Agents|antidepressive agents|mesh-ancestor
110170232|NCT00038896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110170233|NCT00038935|Factor VIII|factor viii|mesh-list
110170234|NCT00038935|Coagulants|coagulants|mesh-ancestor
110170235|NCT00017004|Epoetin Alfa|epoetin alfa|mesh-list
110170237|NCT00038974|Ribavirin|ribavirin|mesh-list
110170238|NCT00038974|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110170239|NCT00038974|Antimetabolites|antimetabolites|mesh-ancestor
110170240|NCT00038974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110170241|NCT00038974|Antiviral Agents|antiviral agents|mesh-ancestor
110170242|NCT00038974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110170243|NCT00039013|Exenatide|exenatide|mesh-list
110170244|NCT00039013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110170245|NCT00039013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110170246|NCT00039013|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110170247|NCT00039013|Incretins|incretins|mesh-ancestor
110170248|NCT00039013|Hormones|hormones|mesh-ancestor
110170249|NCT00039013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110170250|NCT00039052|Interleukin-4|interleukin-4|mesh-list
110170252|NCT00039052|Immunologic Factors|immunologic factors|mesh-ancestor
110170253|NCT00039052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110170254|NCT00039052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110170255|NCT00039052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110170256|NCT00017082|Oxaliplatin|oxaliplatin|mesh-list
110170257|NCT00017082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110170258|NCT00039091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110170260|NCT00039091|Antibodies|antibodies|mesh-list
110170261|NCT00039091|Immunoglobulins|immunoglobulins|mesh-list
110170262|NCT00039091|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110170263|NCT00039091|Immunologic Factors|immunologic factors|mesh-ancestor
110170264|NCT00039091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110170265|NCT00039091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110170266|NCT00039091|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110170267|NCT00039091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110170269|NCT00039169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110170270|NCT00001304|Vitamin D|vitamin d|mesh-list
110170271|NCT00001304|Calcitriol|calcitriol|mesh-list
110170272|NCT00001304|Calcium|calcium|mesh-list
110170273|NCT00001304|Parathyroid Hormone|parathyroid hormone|mesh-list
110170274|NCT00001304|Hormones|hormones|mesh-list
110170275|NCT00001304|Vitamins|vitamins|mesh-ancestor
110170276|NCT00001304|Micronutrients|micronutrients|mesh-ancestor
110170277|NCT00001304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110170278|NCT00001304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110170279|NCT00001304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110170280|NCT00001304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110170281|NCT00001304|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110170282|NCT00001304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110170283|NCT00001304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110170284|NCT00001304|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110170286|NCT00039208|Fluorouracil|fluorouracil|mesh-list
110170287|NCT00039208|Oxaliplatin|oxaliplatin|mesh-list
110170288|NCT00039208|Irinotecan|irinotecan|mesh-list
110170289|NCT00039208|Calcium|calcium|mesh-list
110170290|NCT00039208|Levoleucovorin|levoleucovorin|mesh-list
110170291|NCT00039208|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110170292|NCT00039208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110170293|NCT00039208|Antimetabolites|antimetabolites|mesh-ancestor
110170294|NCT00039208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110170295|NCT00039208|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110170296|NCT00039208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110170297|NCT00039208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110170298|NCT00039208|Immunologic Factors|immunologic factors|mesh-ancestor
110170299|NCT00039208|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110170300|NCT00039208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110170301|NCT00039208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110170302|NCT00039208|Antidotes|antidotes|mesh-ancestor
110170303|NCT00039208|Protective Agents|protective agents|mesh-ancestor
110170304|NCT00039208|Vitamin B Complex|vitamin b complex|mesh-ancestor
110170305|NCT00039208|Vitamins|vitamins|mesh-ancestor
110170306|NCT00039208|Micronutrients|micronutrients|mesh-ancestor
110170308|NCT00017121|Immunologic Factors|immunologic factors|mesh-ancestor
110170309|NCT00017121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110170310|NCT00039286|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110170311|NCT00039286|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110170312|NCT00039286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110170313|NCT00039364|Imatinib Mesylate|imatinib mesylate|mesh-list
110170314|NCT00039364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110170315|NCT00039364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110170317|NCT00039364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110170318|NCT00039403|Gemcitabine|gemcitabine|mesh-list
110170319|NCT00039403|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
110170320|NCT00039403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110170321|NCT00039403|Antimetabolites|antimetabolites|mesh-ancestor
110170322|NCT00039403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110170323|NCT00039403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110170324|NCT00039403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110170325|NCT00039403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110170326|NCT00039442|Capecitabine|capecitabine|mesh-list
110170327|NCT00039442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110170328|NCT00039442|Antimetabolites|antimetabolites|mesh-ancestor
110170329|NCT00039442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110170330|NCT00039442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110170331|NCT00039481|Cyclophosphamide|cyclophosphamide|mesh-list
110170332|NCT00039481|Doxorubicin|doxorubicin|mesh-list
110170333|NCT00039481|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110170334|NCT00039481|Dexrazoxane|dexrazoxane|mesh-list
110170335|NCT00039481|Razoxane|razoxane|mesh-list
110170336|NCT00039481|Oblimersen|oblimersen|mesh-list
110170337|NCT00039481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110170338|NCT00039481|Immunologic Factors|immunologic factors|mesh-ancestor
110170339|NCT00039481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110170340|NCT00039481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110170341|NCT00039481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110170342|NCT00039481|Alkylating Agents|alkylating agents|mesh-ancestor
110170343|NCT00039481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110170344|NCT00039481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110170345|NCT00039481|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110170346|NCT00039481|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110170347|NCT00039481|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110170348|NCT00039481|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110170349|NCT00039481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110170350|NCT00039481|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110170351|NCT00039481|Protective Agents|protective agents|mesh-ancestor
110170352|NCT00039481|Antimitotic Agents|antimitotic agents|mesh-ancestor
110170353|NCT00039481|Mitosis Modulators|mitosis modulators|mesh-ancestor
110170354|NCT00001322|Leuprolide|leuprolide|mesh-list
110170355|NCT00001322|Estradiol|estradiol|mesh-list
110170356|NCT00001322|Progesterone|progesterone|mesh-list
110170357|NCT00001322|Estrogens|estrogens|mesh-ancestor
110170358|NCT00001322|Hormones|hormones|mesh-ancestor
110170359|NCT00001322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110170360|NCT00001322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110170361|NCT00001322|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110170362|NCT00001322|Progestins|progestins|mesh-ancestor
110170363|NCT00001322|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110170364|NCT00001322|Fertility Agents|fertility agents|mesh-ancestor
110170365|NCT00001322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110170366|NCT00001322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110170367|NCT00039520|Sulindac|sulindac|mesh-list
110170368|NCT00039520|Docetaxel|docetaxel|mesh-list
110170369|NCT00039520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110170370|NCT00039520|Tubulin Modulators|tubulin modulators|mesh-ancestor
110170371|NCT00039520|Antimitotic Agents|antimitotic agents|mesh-ancestor
110170372|NCT00039520|Mitosis Modulators|mitosis modulators|mesh-ancestor
110170373|NCT00039520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110170374|NCT00039520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110170376|NCT00039520|Analgesics|analgesics|mesh-ancestor
110170377|NCT00039520|Sensory System Agents|sensory system agents|mesh-ancestor
110170378|NCT00039520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110170379|NCT00039520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110170380|NCT00039520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110170381|NCT00039520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110170382|NCT00039520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110170384|NCT00001328|Ganciclovir|ganciclovir|mesh-list
110170385|NCT00001328|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
110170386|NCT00001328|Antiviral Agents|antiviral agents|mesh-ancestor
110170387|NCT00001328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110170388|NCT00001328|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110170390|NCT00001328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110170391|NCT00017160|Doxorubicin|doxorubicin|mesh-list
110170392|NCT00017160|Ifosfamide|ifosfamide|mesh-list
110170393|NCT00017160|Immunologic Factors|immunologic factors|mesh-list
110170394|NCT00017160|Immunomodulating Agents|immunomodulating agents|mesh-list
110170395|NCT00017160|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110170396|NCT00017160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110170397|NCT00017160|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110170398|NCT00017160|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110170399|NCT00017160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110191698|NCT00028964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110170400|NCT00017160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110170401|NCT00017160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110170402|NCT00017160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110170404|NCT00039832|Reteplase|reteplase|mesh-list
110170405|NCT00039832|Abciximab|abciximab|mesh-list
110170406|NCT00039832|Anticoagulants|anticoagulants|mesh-ancestor
110170407|NCT00039832|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110170408|NCT00039832|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110170409|NCT00039832|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110170410|NCT00039832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110170411|NCT00039988|Glatiramer Acetate|glatiramer acetate|mesh-list
110170412|NCT00039988|Albuterol|albuterol|mesh-list
110170413|NCT00039988|(T,G)-A-L|(t,g)-a-l|mesh-list
110170414|NCT00039988|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110170415|NCT00039988|Autonomic Agents|autonomic agents|mesh-ancestor
110170416|NCT00039988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110170417|NCT00039988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110170418|NCT00039988|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110170419|NCT00039988|Respiratory System Agents|respiratory system agents|mesh-ancestor
110170420|NCT00039988|Tocolytic Agents|tocolytic agents|mesh-ancestor
110170421|NCT00039988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110170422|NCT00039988|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110170423|NCT00039988|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110170424|NCT00039988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110170425|NCT00039988|Adrenergic Agents|adrenergic agents|mesh-ancestor
110170426|NCT00039988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110170427|NCT00039988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110170428|NCT00039988|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110170429|NCT00039988|Immunologic Factors|immunologic factors|mesh-ancestor
110170430|NCT00039988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110170431|NCT00039988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110170432|NCT00040027|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110170433|NCT00040027|Interferon-alpha|interferon-alpha|mesh-list
110170435|NCT00040027|Antiviral Agents|antiviral agents|mesh-ancestor
110170436|NCT00040027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110170437|NCT00040027|Immunologic Factors|immunologic factors|mesh-ancestor
110170438|NCT00040027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110170439|NCT00040027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110170440|NCT00001343|Oxandrolone|oxandrolone|mesh-list
110170441|NCT00001343|Androgens|androgens|mesh-ancestor
110170443|NCT00001343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110170444|NCT00001343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110170445|NCT00001343|Anabolic Agents|anabolic agents|mesh-ancestor
110170446|NCT00040066|Cocaine|cocaine|mesh-list
110170447|NCT00040066|Anesthetics, Local|anesthetics, local|mesh-ancestor
110170448|NCT00040066|Anesthetics|anesthetics|mesh-ancestor
110170449|NCT00040066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110170450|NCT00040066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110170451|NCT00040066|Sensory System Agents|sensory system agents|mesh-ancestor
110170452|NCT00040066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110170453|NCT00040066|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110170454|NCT00040066|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110170455|NCT00040066|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110170456|NCT00040066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110170457|NCT00040066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110170458|NCT00040066|Dopamine Agents|dopamine agents|mesh-ancestor
110170459|NCT00040066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110170460|NCT00040105|Imatinib Mesylate|imatinib mesylate|mesh-list
110170461|NCT00040105|Tipifarnib|tipifarnib|mesh-list
110170462|NCT00040105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110170463|NCT00040105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110170464|NCT00040105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110170465|NCT00040105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110170467|NCT00040144|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110170468|NCT00040144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110170469|NCT00040144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110170470|NCT00040144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110170471|NCT00040144|Antiviral Agents|antiviral agents|mesh-ancestor
110170472|NCT00040144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110170473|NCT00040144|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110170474|NCT00040144|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110170475|NCT00040183|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110170476|NCT00040183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110170477|NCT00040183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110170478|NCT00040183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110170479|NCT00040183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110170480|NCT00040261|Memantine|memantine|mesh-list
110170481|NCT00040261|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110170482|NCT00040261|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110170483|NCT00040261|Dopamine Agents|dopamine agents|mesh-ancestor
110170484|NCT00040261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110170485|NCT00040261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110170486|NCT00040261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110170487|NCT00040261|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110170488|NCT00040261|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110170489|NCT00040300|Racivir|racivir|mesh-list
110170490|NCT00040300|Antiviral Agents|antiviral agents|mesh-ancestor
110170491|NCT00040300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110170492|NCT00040378|Vitamins|vitamins|mesh-list
110170493|NCT00040378|Vitamin E|vitamin e|mesh-list
110170494|NCT00040378|Tocopherols|tocopherols|mesh-list
110170495|NCT00040378|Tocotrienols|tocotrienols|mesh-list
110170496|NCT00040378|alpha-Tocopherol|alpha-tocopherol|mesh-list
110170497|NCT00040378|Selenium|selenium|mesh-list
110170498|NCT00040378|Micronutrients|micronutrients|mesh-ancestor
110170499|NCT00040378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110170500|NCT00040378|Antioxidants|antioxidants|mesh-ancestor
110170501|NCT00040378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110170502|NCT00040378|Protective Agents|protective agents|mesh-ancestor
110170503|NCT00040378|Trace Elements|trace elements|mesh-ancestor
110170504|NCT00017199|Bortezomib|bortezomib|mesh-list
110170505|NCT00017199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110170506|NCT00040417|Fludarabine|fludarabine|mesh-list
110170507|NCT00040417|Alemtuzumab|alemtuzumab|mesh-list
110170508|NCT00040417|Lenograstim|lenograstim|mesh-list
110170509|NCT00040417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110170510|NCT00040417|Immunologic Factors|immunologic factors|mesh-ancestor
110170511|NCT00040417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110170512|NCT00040417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110170513|NCT00040417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110170514|NCT00040495|Pantoprazole|pantoprazole|mesh-list
110170515|NCT00040495|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110170516|NCT00040495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110170517|NCT00040495|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110170518|NCT00040495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110170519|NCT00040495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110170520|NCT00040651|Cyclophosphamide|cyclophosphamide|mesh-list
110170521|NCT00040651|Fludarabine|fludarabine|mesh-list
110170522|NCT00040651|Thymoglobulin|thymoglobulin|mesh-list
110170523|NCT00040651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110170524|NCT00040651|Immunologic Factors|immunologic factors|mesh-ancestor
110170525|NCT00040651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110170526|NCT00040651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110170527|NCT00040651|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110170528|NCT00040651|Alkylating Agents|alkylating agents|mesh-ancestor
110170529|NCT00040651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110170530|NCT00040651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110170531|NCT00040651|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110170534|NCT00040690|Cyclophosphamide|cyclophosphamide|mesh-list
110170535|NCT00040690|Ifosfamide|ifosfamide|mesh-list
110170536|NCT00040690|Doxorubicin|doxorubicin|mesh-list
110170537|NCT00040690|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110170538|NCT00040690|Methotrexate|methotrexate|mesh-list
110170539|NCT00040690|Etoposide|etoposide|mesh-list
110170540|NCT00040690|Vincristine|vincristine|mesh-list
110170541|NCT00040690|Levoleucovorin|levoleucovorin|mesh-list
110170542|NCT00040690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110170543|NCT00040690|Immunologic Factors|immunologic factors|mesh-ancestor
110170544|NCT00040690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110170545|NCT00040690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110170546|NCT00040690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110170547|NCT00040690|Alkylating Agents|alkylating agents|mesh-ancestor
110170548|NCT00040690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110170549|NCT00040690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110170550|NCT00040690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110170551|NCT00040690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110170552|NCT00040690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110170553|NCT00040690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110170554|NCT00040690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110170555|NCT00040690|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110170556|NCT00040690|Abortifacient Agents|abortifacient agents|mesh-ancestor
110170557|NCT00040690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110170558|NCT00040690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110170559|NCT00040690|Antimetabolites|antimetabolites|mesh-ancestor
110170560|NCT00040690|Dermatologic Agents|dermatologic agents|mesh-ancestor
110170561|NCT00040690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110170562|NCT00040690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110170563|NCT00040690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110170564|NCT00040690|Antiviral Agents|antiviral agents|mesh-ancestor
110170565|NCT00040690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110170566|NCT00040690|Antidotes|antidotes|mesh-ancestor
110170567|NCT00040690|Protective Agents|protective agents|mesh-ancestor
110170568|NCT00040690|Vitamin B Complex|vitamin b complex|mesh-ancestor
110170569|NCT00040690|Vitamins|vitamins|mesh-ancestor
110170570|NCT00040690|Micronutrients|micronutrients|mesh-ancestor
110170571|NCT00040690|Tubulin Modulators|tubulin modulators|mesh-ancestor
110170572|NCT00040690|Antimitotic Agents|antimitotic agents|mesh-ancestor
110170573|NCT00040690|Mitosis Modulators|mitosis modulators|mesh-ancestor
110170574|NCT00040768|Bortezomib|bortezomib|mesh-list
110170575|NCT00040768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110170576|NCT00017238|KRN 5500|krn 5500|mesh-list
110170577|NCT00017238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110170578|NCT00017238|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110170579|NCT00017238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110170580|NCT00017238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110170581|NCT00040885|Infliximab|infliximab|mesh-list
110170582|NCT00040885|Docetaxel|docetaxel|mesh-list
110170583|NCT00040885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110170584|NCT00040885|Tubulin Modulators|tubulin modulators|mesh-ancestor
110170585|NCT00040885|Antimitotic Agents|antimitotic agents|mesh-ancestor
110170586|NCT00040885|Mitosis Modulators|mitosis modulators|mesh-ancestor
110170587|NCT00040885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110170588|NCT00040885|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110170589|NCT00040885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110170590|NCT00040885|Dermatologic Agents|dermatologic agents|mesh-ancestor
110170591|NCT00040885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110170592|NCT00040885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110170594|NCT00001421|Antithyroid Agents|antithyroid agents|mesh-ancestor
110170595|NCT00001421|Hormone Antagonists|hormone antagonists|mesh-ancestor
110191729|NCT00423540|Tocolytic Agents|tocolytic agents|mesh-ancestor
110170596|NCT00001421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110170597|NCT00001421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110170598|NCT00017277|Epoetin Alfa|epoetin alfa|mesh-list
110170599|NCT00017277|Hematinics|hematinics|mesh-ancestor
110170600|NCT00041041|Imatinib Mesylate|imatinib mesylate|mesh-list
110170601|NCT00041041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110170602|NCT00041041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110170603|NCT00041041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110170604|NCT00041041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110170605|NCT00041197|Imatinib Mesylate|imatinib mesylate|mesh-list
110170606|NCT00041197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110170607|NCT00041197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110170608|NCT00041197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110170609|NCT00041197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110170610|NCT00001427|9-aminocamptothecin|9-aminocamptothecin|mesh-list
110170611|NCT00001427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110170613|NCT00041236|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110170614|NCT00041236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110170615|NCT00041236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110170616|NCT00041236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110170617|NCT00041236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110170619|NCT00017316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110170620|NCT00017316|Immunologic Factors|immunologic factors|mesh-ancestor
110170621|NCT00017316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110170622|NCT00017316|Leprostatic Agents|leprostatic agents|mesh-ancestor
110170623|NCT00017316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110170624|NCT00017316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110170625|NCT00017316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110170626|NCT00017316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110170627|NCT00017316|Growth Substances|growth substances|mesh-ancestor
110170628|NCT00017316|Growth Inhibitors|growth inhibitors|mesh-ancestor
110170629|NCT00017316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110170631|NCT00041275|Megestrol Acetate|megestrol acetate|mesh-list
110170632|NCT00041275|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110170633|NCT00041275|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110170634|NCT00041275|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110170635|NCT00041275|Contraceptive Agents|contraceptive agents|mesh-ancestor
110170636|NCT00041275|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110170637|NCT00041275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110170638|NCT00041275|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110170639|NCT00041275|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110170640|NCT00041275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110170641|NCT00041275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110170642|NCT00041275|Appetite Stimulants|appetite stimulants|mesh-ancestor
110170643|NCT00041275|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110170644|NCT00017355|Lenograstim|lenograstim|mesh-list
110191738|NCT00423696|Fluorouracil|fluorouracil|mesh-list
110170645|NCT00017355|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110170647|NCT00017355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110170649|NCT00397072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110170650|NCT00017394|Bevacizumab|bevacizumab|mesh-list
110170651|NCT00017394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110170653|NCT00017394|Antibodies|antibodies|mesh-list
110170654|NCT00017394|Immunoglobulins|immunoglobulins|mesh-list
110170655|NCT00017394|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110170656|NCT00017394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110170657|NCT00017394|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110170658|NCT00017394|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110170659|NCT00017394|Growth Substances|growth substances|mesh-ancestor
110170660|NCT00017394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110170661|NCT00017394|Growth Inhibitors|growth inhibitors|mesh-ancestor
110170662|NCT00017394|Immunologic Factors|immunologic factors|mesh-ancestor
110170663|NCT00017394|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110170664|NCT00017394|Tubulin Modulators|tubulin modulators|mesh-ancestor
110170665|NCT00017394|Antimitotic Agents|antimitotic agents|mesh-ancestor
110170666|NCT00017394|Mitosis Modulators|mitosis modulators|mesh-ancestor
110170667|NCT00017394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110170668|NCT00041431|Hormones|hormones|mesh-list
110170669|NCT00041431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110170670|NCT00041431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110170671|NCT00001436|Tamoxifen|tamoxifen|mesh-list
110170672|NCT00001436|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110170673|NCT00001436|Hormone Antagonists|hormone antagonists|mesh-ancestor
110170674|NCT00001436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110170675|NCT00001436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110170676|NCT00001436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110170677|NCT00001436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110170678|NCT00001436|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110170679|NCT00001436|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110170680|NCT00001436|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110170682|NCT00041548|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110170684|NCT00041548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110170685|NCT00041548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110170686|NCT00041548|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110170687|NCT00041548|Respiratory System Agents|respiratory system agents|mesh-ancestor
110170688|NCT00041548|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110170690|NCT00041548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110170691|NCT00041548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110170692|NCT00041548|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110170693|NCT00041548|Vasodilator Agents|vasodilator agents|mesh-ancestor
110170694|NCT00041548|Gasotransmitters|gasotransmitters|mesh-ancestor
110170695|NCT00041548|Protective Agents|protective agents|mesh-ancestor
110170696|NCT00041587|Pseudomonas aeruginosa exotoxin A|pseudomonas aeruginosa exotoxin a|mesh-list
110170697|NCT00041587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110170698|NCT00017433|Arsenic Trioxide|arsenic trioxide|mesh-list
110170699|NCT00017433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110170700|NCT00041665|Mitogens|mitogens|mesh-list
110170701|NCT00041665|Mitosis Modulators|mitosis modulators|mesh-ancestor
110170702|NCT00041665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110170703|NCT00041704|Anidulafungin|anidulafungin|mesh-list
110170704|NCT00041704|Antifungal Agents|antifungal agents|mesh-ancestor
110170705|NCT00041704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110170706|NCT00017472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110170707|NCT00017472|Antibodies|antibodies|mesh-list
110170708|NCT00017472|Immunoglobulins|immunoglobulins|mesh-list
110170709|NCT00017472|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110170710|NCT00017472|Immunologic Factors|immunologic factors|mesh-ancestor
110170711|NCT00017472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110170715|NCT00041782|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110170716|NCT00041782|Anticoagulants|anticoagulants|mesh-ancestor
110170717|NCT00041782|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110170718|NCT00041782|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110170719|NCT00041782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110170720|NCT00017511|Cevimeline|cevimeline|mesh-list
110170721|NCT00017511|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110170722|NCT00017511|Autonomic Agents|autonomic agents|mesh-ancestor
110170723|NCT00017511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110170724|NCT00017511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110170725|NCT00017511|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110170726|NCT00017511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110170727|NCT00017511|Cholinergic Agents|cholinergic agents|mesh-ancestor
110170728|NCT00017511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110170729|NCT00017511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110170730|NCT00041899|Ulipristal acetate|ulipristal acetate|mesh-list
110170731|NCT00041899|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110170732|NCT00041899|Contraceptive Agents|contraceptive agents|mesh-ancestor
110170733|NCT00041899|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110170734|NCT00041899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110170735|NCT00041899|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110170736|NCT00041977|Doxycycline|doxycycline|mesh-list
110170737|NCT00041977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110170738|NCT00041977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110170739|NCT00041977|Antimalarials|antimalarials|mesh-ancestor
110170740|NCT00041977|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110170741|NCT00041977|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110170742|NCT00042016|Decitabine|decitabine|mesh-list
110170743|NCT00042016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110170744|NCT00042016|Antimetabolites|antimetabolites|mesh-ancestor
110170745|NCT00042016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110170746|NCT00042016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110170747|NCT00042016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110170748|NCT00017550|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110170749|NCT00017550|Immunologic Factors|immunologic factors|mesh-ancestor
110170750|NCT00017550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110170751|NCT00017550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110170752|NCT00001457|Lamivudine|lamivudine|mesh-list
110170753|NCT00001457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110170754|NCT00001457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110170755|NCT00001457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110170756|NCT00001457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110170757|NCT00001457|Antiviral Agents|antiviral agents|mesh-ancestor
110170758|NCT00001457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110170759|NCT00001457|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110170760|NCT00001457|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110170761|NCT00042172|Donepezil|donepezil|mesh-list
110170762|NCT00042172|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110170763|NCT00042172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110170764|NCT00042172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110170765|NCT00042172|Cholinergic Agents|cholinergic agents|mesh-ancestor
110170766|NCT00042172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110170767|NCT00042172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110170768|NCT00042172|Nootropic Agents|nootropic agents|mesh-ancestor
110170770|NCT00017589|Oblimersen|oblimersen|mesh-list
110170771|NCT00017589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110170772|NCT00017589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110170773|NCT00017589|Immunotoxins|immunotoxins|mesh-ancestor
110170774|NCT00017589|Immunoconjugates|immunoconjugates|mesh-ancestor
110170775|NCT00017589|Immunologic Factors|immunologic factors|mesh-ancestor
110170776|NCT00017589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110170777|NCT00001475|Thalidomide|thalidomide|mesh-list
110170778|NCT00001475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110170779|NCT00001475|Immunologic Factors|immunologic factors|mesh-ancestor
110170780|NCT00001475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110170781|NCT00001475|Leprostatic Agents|leprostatic agents|mesh-ancestor
110170782|NCT00001475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110170783|NCT00001475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110170784|NCT00001475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110170785|NCT00001475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110170786|NCT00001475|Growth Substances|growth substances|mesh-ancestor
110170787|NCT00001475|Growth Inhibitors|growth inhibitors|mesh-ancestor
110170788|NCT00001475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110170791|NCT00042328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110170792|NCT00042367|Mafosfamide|mafosfamide|mesh-list
110170793|NCT00042367|Cyclophosphamide|cyclophosphamide|mesh-list
110170794|NCT00042367|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110170795|NCT00042367|Immunologic Factors|immunologic factors|mesh-ancestor
110170796|NCT00042367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110170797|NCT00042367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110170798|NCT00042367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110170800|NCT00042367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110170801|NCT00042367|Alkylating Agents|alkylating agents|mesh-ancestor
110170802|NCT00042367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110170803|NCT00042367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110170805|NCT02970643|Palonosetron|palonosetron|mesh-list
110170806|NCT02970643|Antiemetics|antiemetics|mesh-ancestor
110170807|NCT02970643|Autonomic Agents|autonomic agents|mesh-ancestor
110170808|NCT02970643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110170809|NCT02970643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110170810|NCT02970643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110170811|NCT02970643|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110170812|NCT02970643|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110170813|NCT02970643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110170814|NCT02970643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110170815|NCT02970643|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110170816|NCT02970643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110170817|NCT02970643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110170818|NCT02970643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110170819|NCT02970643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110170820|NCT02970643|Serotonin Agents|serotonin agents|mesh-ancestor
110170821|NCT02970643|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110170822|NCT02970643|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110170823|NCT00017628|Methylprednisolone|methylprednisolone|mesh-list
110170824|NCT00017628|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110170825|NCT00017628|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110170827|NCT00017628|Prednisolone acetate|prednisolone acetate|mesh-list
110170828|NCT00017628|Cyclophosphamide|cyclophosphamide|mesh-list
110170829|NCT00017628|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110170830|NCT00017628|Prednisolone phosphate|prednisolone phosphate|mesh-list
110170831|NCT00017628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110170832|NCT00017628|Immunologic Factors|immunologic factors|mesh-ancestor
110170833|NCT00017628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110170835|NCT00017628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110170836|NCT00017628|Alkylating Agents|alkylating agents|mesh-ancestor
110170837|NCT00017628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110170838|NCT00017628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110170839|NCT00017628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110170840|NCT00017628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110170841|NCT00017628|Antiemetics|antiemetics|mesh-ancestor
110170842|NCT00017628|Autonomic Agents|autonomic agents|mesh-ancestor
110170843|NCT00017628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110170844|NCT00017628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110170845|NCT00017628|Glucocorticoids|glucocorticoids|mesh-ancestor
110170846|NCT00017628|Hormones|hormones|mesh-ancestor
110170847|NCT00017628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110170848|NCT00017628|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110170849|NCT00017628|Protective Agents|protective agents|mesh-ancestor
110170850|NCT00017628|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110170852|NCT00042562|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110170853|NCT00042562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110170854|NCT00042562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110170855|NCT00042562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110170856|NCT00042562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110170857|NCT00042562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110170858|NCT00042562|Analgesics|analgesics|mesh-ancestor
110170859|NCT00042562|Sensory System Agents|sensory system agents|mesh-ancestor
110170860|NCT00042562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110170861|NCT00042562|Antidepressive Agents|antidepressive agents|mesh-ancestor
110170862|NCT00042562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110170863|NCT00042562|Dopamine Agents|dopamine agents|mesh-ancestor
110170864|NCT00001487|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
110170866|NCT00001487|Immunologic Factors|immunologic factors|mesh-ancestor
110170867|NCT00001487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110170869|NCT00042601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110170870|NCT00042601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110170871|NCT00042679|Carboplatin|carboplatin|mesh-list
110170872|NCT00042679|Gemcitabine|gemcitabine|mesh-list
110170873|NCT00042679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110170874|NCT00042679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110170875|NCT00042679|Antimetabolites|antimetabolites|mesh-ancestor
110170876|NCT00042679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110170877|NCT00042718|Amoxicillin|amoxicillin|mesh-list
110170878|NCT00042718|Azithromycin|azithromycin|mesh-list
110170879|NCT00042718|Levofloxacin|levofloxacin|mesh-list
110170880|NCT00042718|Clavulanic Acid|clavulanic acid|mesh-list
110170881|NCT00042718|Clavulanic Acids|clavulanic acids|mesh-list
110170882|NCT00042718|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110170883|NCT00042718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110170884|NCT00042718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110170885|NCT00042718|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110170886|NCT00042718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110170887|NCT00042718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110170888|NCT00042718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110170889|NCT00042718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110170890|NCT00042718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110170891|NCT00042718|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110170892|NCT00042718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110170893|NCT00042718|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110170895|NCT00042796|Azacitidine|azacitidine|mesh-list
110170896|NCT00042796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110170897|NCT00042796|Antimetabolites|antimetabolites|mesh-ancestor
110170898|NCT00042796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110170899|NCT00042796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110170900|NCT00042796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110170901|NCT00042835|Paclitaxel|paclitaxel|mesh-list
110170902|NCT00042835|Etoposide|etoposide|mesh-list
110170903|NCT00042835|Docetaxel|docetaxel|mesh-list
110170904|NCT00042835|Carboplatin|carboplatin|mesh-list
110170905|NCT00042835|Etoposide phosphate|etoposide phosphate|mesh-list
110170906|NCT00042835|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110170908|NCT00042835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110170909|NCT00042835|Tubulin Modulators|tubulin modulators|mesh-ancestor
110170910|NCT00042835|Antimitotic Agents|antimitotic agents|mesh-ancestor
110170911|NCT00042835|Mitosis Modulators|mitosis modulators|mesh-ancestor
110170912|NCT00042835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110170913|NCT00042835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110170914|NCT00042835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110170915|NCT00042835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110170916|NCT00042835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110170917|NCT00017784|Valganciclovir|valganciclovir|mesh-list
110170918|NCT00017784|Antiviral Agents|antiviral agents|mesh-ancestor
110170919|NCT00017784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110170920|NCT00042874|Leucovorin|leucovorin|mesh-list
110170921|NCT00042874|Fluorouracil|fluorouracil|mesh-list
110170922|NCT00042874|Irinotecan|irinotecan|mesh-list
110170923|NCT00042874|Alvocidib|alvocidib|mesh-list
110170924|NCT00042874|Calcium|calcium|mesh-list
110170925|NCT00042874|Levoleucovorin|levoleucovorin|mesh-list
110170926|NCT00042874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110170927|NCT00042874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110170928|NCT00042874|Antimetabolites|antimetabolites|mesh-ancestor
110170929|NCT00042874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110170930|NCT00042874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110170931|NCT00042874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110170932|NCT00042874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110170933|NCT00042874|Immunologic Factors|immunologic factors|mesh-ancestor
110170934|NCT00042874|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110170935|NCT00042874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110170936|NCT00042874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110170937|NCT00042874|Antidotes|antidotes|mesh-ancestor
110170938|NCT00042874|Protective Agents|protective agents|mesh-ancestor
110170939|NCT00042874|Vitamin B Complex|vitamin b complex|mesh-ancestor
110170940|NCT00042874|Vitamins|vitamins|mesh-ancestor
110170941|NCT00042874|Micronutrients|micronutrients|mesh-ancestor
110170942|NCT00042874|Growth Inhibitors|growth inhibitors|mesh-ancestor
110170943|NCT00042874|Growth Substances|growth substances|mesh-ancestor
110170944|NCT00042874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110170945|NCT00042913|Epratuzumab|epratuzumab|mesh-list
110170946|NCT00042913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110170947|NCT00042913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110170948|NCT00042952|Imatinib Mesylate|imatinib mesylate|mesh-list
110170949|NCT00042952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110170950|NCT00042952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110170951|NCT00042952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110170952|NCT00042952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110170953|NCT00043069|Cholecalciferol|cholecalciferol|mesh-list
110170954|NCT00043069|Risedronic Acid|risedronic acid|mesh-list
110170955|NCT00043069|Calcium Carbonate|calcium carbonate|mesh-list
110170956|NCT00043069|Estrogens|estrogens|mesh-list
110170957|NCT00043069|Estrogen Antagonists|estrogen antagonists|mesh-list
110170958|NCT00043069|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-list
110170959|NCT00043069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110170960|NCT00043069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110170961|NCT00043069|Vitamins|vitamins|mesh-ancestor
110170963|NCT00043069|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110170964|NCT00043069|Hormones|hormones|mesh-ancestor
110170965|NCT00043069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110170967|NCT00043069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110170968|NCT00043069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110170969|NCT00043069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110170970|NCT00043069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110170971|NCT00043069|Hormone Antagonists|hormone antagonists|mesh-ancestor
110170972|NCT00043147|Prednisone|prednisone|mesh-list
110170973|NCT00043147|Methylprednisolone|methylprednisolone|mesh-list
110170974|NCT00043147|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110170975|NCT00043147|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110170976|NCT00043147|Prednisolone|prednisolone|mesh-list
110170977|NCT00043147|Prednisolone acetate|prednisolone acetate|mesh-list
110170978|NCT00043147|Beclomethasone|beclomethasone|mesh-list
110170979|NCT00043147|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110170980|NCT00043147|Prednisolone phosphate|prednisolone phosphate|mesh-list
110170981|NCT00043147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110170982|NCT00043147|Glucocorticoids|glucocorticoids|mesh-ancestor
110170983|NCT00043147|Hormones|hormones|mesh-ancestor
110170984|NCT00043147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110170986|NCT00043147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110170987|NCT00043147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110170988|NCT00043147|Antiemetics|antiemetics|mesh-ancestor
110170989|NCT00043147|Autonomic Agents|autonomic agents|mesh-ancestor
110170990|NCT00043147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110170991|NCT00043147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110170992|NCT00043147|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110170993|NCT00043147|Protective Agents|protective agents|mesh-ancestor
110170994|NCT00043147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110170995|NCT00043147|Respiratory System Agents|respiratory system agents|mesh-ancestor
110170996|NCT00017862|Reslizumab|reslizumab|mesh-list
110170997|NCT00017862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110170998|NCT00017862|Respiratory System Agents|respiratory system agents|mesh-ancestor
110170999|NCT00043264|Azithromycin|azithromycin|mesh-list
110171000|NCT00043264|Rifampin|rifampin|mesh-list
110171001|NCT00043264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110171002|NCT00043264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110171003|NCT00043264|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110171004|NCT00043264|Antitubercular Agents|antitubercular agents|mesh-ancestor
110171005|NCT00043264|Leprostatic Agents|leprostatic agents|mesh-ancestor
110171006|NCT00043264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110171007|NCT00043264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110171008|NCT00043264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110171009|NCT00043264|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110171010|NCT00043264|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110171011|NCT00043264|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110171012|NCT00043264|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110171013|NCT00043264|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110171014|NCT00043264|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110171015|NCT00043303|Interferons|interferons|mesh-list
110171016|NCT00043303|Interferon-gamma|interferon-gamma|mesh-list
110171017|NCT00043303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110171018|NCT00043303|Antiviral Agents|antiviral agents|mesh-ancestor
110171019|NCT00043303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110171021|NCT00017940|Mitosis Modulators|mitosis modulators|mesh-ancestor
110171022|NCT00017940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110171023|NCT02970604|Aspirin|aspirin|mesh-list
110171024|NCT02970604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110171025|NCT02970604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110171027|NCT02970604|Sensory System Agents|sensory system agents|mesh-ancestor
110171028|NCT02970604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110171029|NCT02970604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110171030|NCT02970604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110171031|NCT02970604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110171032|NCT02970604|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110171033|NCT02970604|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110171034|NCT02970604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110171035|NCT02970604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110171036|NCT02970604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110171037|NCT02970604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110171038|NCT02970604|Antipyretics|antipyretics|mesh-ancestor
110171039|NCT00043342|Interferons|interferons|mesh-list
110171040|NCT00043342|Interferon-gamma|interferon-gamma|mesh-list
110171041|NCT00043342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110171042|NCT00043342|Antiviral Agents|antiviral agents|mesh-ancestor
110171043|NCT00043342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110171045|NCT00043381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110171046|NCT00043381|Antimetabolites|antimetabolites|mesh-ancestor
110171047|NCT00043381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110171048|NCT00043381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110171049|NCT00043381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110171050|NCT00001568|Deoxyglucose|deoxyglucose|mesh-list
110171051|NCT00001568|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110171052|NCT00001568|Antimetabolites|antimetabolites|mesh-ancestor
110171053|NCT00001568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110171054|NCT00001568|Antiviral Agents|antiviral agents|mesh-ancestor
110171055|NCT00001568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110171056|NCT00001568|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110171058|NCT00043537|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110171059|NCT00043537|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110171060|NCT00043537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110171061|NCT00043537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110171063|NCT00043537|Serotonin Agents|serotonin agents|mesh-ancestor
110171064|NCT00043537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110171065|NCT00043537|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110171066|NCT00043537|Antidepressive Agents|antidepressive agents|mesh-ancestor
110171067|NCT00043537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110171068|NCT00043537|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110171069|NCT00043537|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110171070|NCT00043537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110171071|NCT00043576|Calcitriol|calcitriol|mesh-list
110171072|NCT00043576|Docetaxel|docetaxel|mesh-list
110171073|NCT00043576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110171074|NCT00043576|Tubulin Modulators|tubulin modulators|mesh-ancestor
110171075|NCT00043576|Antimitotic Agents|antimitotic agents|mesh-ancestor
110171076|NCT00043576|Mitosis Modulators|mitosis modulators|mesh-ancestor
110171077|NCT00043576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110171078|NCT00043576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110171079|NCT00043576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110171080|NCT00043576|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110171081|NCT00043576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110171083|NCT00043576|Vitamins|vitamins|mesh-ancestor
110171084|NCT00043576|Micronutrients|micronutrients|mesh-ancestor
110171085|NCT00043576|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110171086|NCT00043654|Mifepristone|mifepristone|mesh-list
110171087|NCT00043654|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110171088|NCT00043654|Abortifacient Agents|abortifacient agents|mesh-ancestor
110171089|NCT00043654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110171090|NCT00043654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110171091|NCT00043654|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110171092|NCT00043654|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110171093|NCT00043654|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110171094|NCT00043654|Contraceptive Agents|contraceptive agents|mesh-ancestor
110171095|NCT00043654|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110171096|NCT00043654|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110171097|NCT00043654|Hormone Antagonists|hormone antagonists|mesh-ancestor
110171098|NCT00043654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110171099|NCT00043654|Luteolytic Agents|luteolytic agents|mesh-ancestor
110171100|NCT00043654|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110171101|NCT00043654|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110171102|NCT00043771|Tolvaptan|tolvaptan|mesh-list
110171103|NCT00043771|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110171104|NCT00043771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110171105|NCT00043771|Natriuretic Agents|natriuretic agents|mesh-ancestor
110171106|NCT00043771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110171107|NCT00043810|Fludarabine|fludarabine|mesh-list
110171108|NCT00043810|Fludarabine phosphate|fludarabine phosphate|mesh-list
110171109|NCT00043810|Busulfan|busulfan|mesh-list
110171110|NCT00043810|GEL protein, Gelonium multiflorum|gel protein, gelonium multiflorum|mesh-list
110171111|NCT00043810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110171112|NCT00043810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110171113|NCT00043810|Antimetabolites|antimetabolites|mesh-ancestor
110171114|NCT00043810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110171115|NCT00043810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110171116|NCT00043810|Immunologic Factors|immunologic factors|mesh-ancestor
110171117|NCT00043810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110171118|NCT00043810|Alkylating Agents|alkylating agents|mesh-ancestor
110171119|NCT00043810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110171120|NCT00043810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110171121|NCT00043810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110171122|NCT00043810|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110171123|NCT00043810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110171124|NCT00043849|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110171125|NCT00043849|Antidepressive Agents|antidepressive agents|mesh-ancestor
110171126|NCT00043849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110171127|NCT00043849|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110171128|NCT00043849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110171129|NCT00043849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110171130|NCT00043849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110171132|NCT00001586|Fludarabine|fludarabine|mesh-list
110171133|NCT00001586|Fludarabine phosphate|fludarabine phosphate|mesh-list
110171134|NCT00001586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110171135|NCT00001586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110171136|NCT00001586|Immunologic Factors|immunologic factors|mesh-ancestor
110171137|NCT00001586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110171138|NCT00001586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110171139|NCT00001586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110171140|NCT00001586|Antimetabolites|antimetabolites|mesh-ancestor
110056793|NCT01504347|Vaccines|vaccines|mesh-list
110171141|NCT00001586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110171142|NCT00001586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110171145|NCT00043888|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
110171146|NCT00043888|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110171147|NCT00043888|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110171148|NCT00043888|Protease Inhibitors|protease inhibitors|mesh-ancestor
110171149|NCT00043888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110171150|NCT00043888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110171151|NCT00043888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110171152|NCT00043888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110171153|NCT00043888|Antiviral Agents|antiviral agents|mesh-ancestor
110171154|NCT00043888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110171155|NCT00043888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110171156|NCT00043888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110171157|NCT00043888|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110171158|NCT00043888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110171159|NCT00018018|Zidovudine|zidovudine|mesh-list
110171160|NCT00018018|Antimetabolites|antimetabolites|mesh-ancestor
110171161|NCT00018018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110171162|NCT00018018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110171163|NCT00018018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110171164|NCT00018018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110171165|NCT00018018|Antiviral Agents|antiviral agents|mesh-ancestor
110171166|NCT00018018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110171167|NCT00018018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110171168|NCT00018018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110171169|NCT00043927|Cisplatin|cisplatin|mesh-list
110171170|NCT00043927|Etoposide|etoposide|mesh-list
110171171|NCT00043927|Topotecan|topotecan|mesh-list
110171172|NCT00043927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110171173|NCT00043927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110171174|NCT00043927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110171176|NCT00043927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110171177|NCT00043927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110171178|NCT00043927|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110171180|NCT00043966|Lopinavir|lopinavir|mesh-list
110171181|NCT00043966|Tenofovir|tenofovir|mesh-list
110171182|NCT00043966|Emtricitabine|emtricitabine|mesh-list
110171183|NCT00043966|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110171184|NCT00043966|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110171185|NCT00043966|Protease Inhibitors|protease inhibitors|mesh-ancestor
110171186|NCT00043966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110171187|NCT00043966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110171188|NCT00043966|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110171189|NCT00043966|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110171190|NCT00043966|Antiviral Agents|antiviral agents|mesh-ancestor
110171191|NCT00043966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110171192|NCT00043966|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110171193|NCT00043966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110171195|NCT00043966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110171196|NCT00001598|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
110171197|NCT00001598|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110171198|NCT00001598|Immunologic Factors|immunologic factors|mesh-ancestor
110171199|NCT00001598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110171200|NCT04731727|Riboflavin|riboflavin|mesh-list
110171201|NCT04731727|Vitamin B Complex|vitamin b complex|mesh-ancestor
110171202|NCT04731727|Vitamins|vitamins|mesh-ancestor
110171203|NCT04731727|Micronutrients|micronutrients|mesh-ancestor
110171204|NCT04731727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110171205|NCT04731727|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110171206|NCT04731727|Dermatologic Agents|dermatologic agents|mesh-ancestor
110171207|NCT00044278|Lamotrigine|lamotrigine|mesh-list
110171208|NCT00044278|Anticonvulsants|anticonvulsants|mesh-ancestor
110171209|NCT00044278|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110171210|NCT00044278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110171211|NCT00044278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110171212|NCT00044278|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110171213|NCT00044278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110171214|NCT00044278|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110171215|NCT00044278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110171216|NCT00044278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110171217|NCT00044278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110171218|NCT00044278|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110171219|NCT00044395|Ruboxistaurin|ruboxistaurin|mesh-list
110171220|NCT00044395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110171221|NCT00044395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110171222|NCT00044434|Bupropion|bupropion|mesh-list
110171223|NCT00044434|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110171224|NCT00044434|Antidepressive Agents|antidepressive agents|mesh-ancestor
110171225|NCT00044434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110171226|NCT00044434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110171227|NCT00044434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110171228|NCT00044434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110171229|NCT00044434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110171230|NCT00044434|Dopamine Agents|dopamine agents|mesh-ancestor
110171231|NCT00044434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110171232|NCT00044434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110171233|NCT00044434|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110171234|NCT00044434|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110171235|NCT00044434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110171237|NCT00044473|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110171238|NCT00044473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110171239|NCT00044473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110171240|NCT00044473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110171241|NCT00044473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110171242|NCT00044473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110171243|NCT00044473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110171244|NCT00044473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110171245|NCT00044473|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110171246|NCT00044473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110171247|NCT00044551|Taxane|taxane|mesh-list
110171248|NCT00044551|IDN 5109|idn 5109|mesh-list
110171249|NCT00044551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110171250|NCT00018135|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110171251|NCT00018135|Calcium|calcium|mesh-list
110171252|NCT00018135|Sevelamer|sevelamer|mesh-list
110171253|NCT00018135|Calcium acetate|calcium acetate|mesh-list
110171254|NCT00018135|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110171255|NCT00018135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110171256|NCT00018135|Chelating Agents|chelating agents|mesh-ancestor
110171257|NCT00018135|Sequestering Agents|sequestering agents|mesh-ancestor
110171258|NCT00018135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110171260|NCT00018135|Immunologic Factors|immunologic factors|mesh-ancestor
110171261|NCT00018135|Antacids|antacids|mesh-ancestor
110171262|NCT00018135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110171263|NCT00397384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110171264|NCT00397384|Cetuximab|cetuximab|mesh-list
110171265|NCT00397384|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110171266|NCT00397384|Antibodies|antibodies|mesh-list
110171267|NCT00397384|Immunoglobulins|immunoglobulins|mesh-list
110171268|NCT00397384|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110171269|NCT00397384|Immunologic Factors|immunologic factors|mesh-ancestor
110171270|NCT00397384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110171271|NCT00397384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110171272|NCT00397384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110171273|NCT00397384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110171274|NCT00397384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110171275|NCT00397423|Lenograstim|lenograstim|mesh-list
110171276|NCT00397423|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110171277|NCT00397423|Immunologic Factors|immunologic factors|mesh-ancestor
110171278|NCT00397423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110171279|NCT00397501|Sodium thiosulfate|sodium thiosulfate|mesh-list
110171280|NCT00397501|Carboplatin|carboplatin|mesh-list
110171282|NCT00397501|Trastuzumab|trastuzumab|mesh-list
110171283|NCT00397501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110171284|NCT00397501|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110171285|NCT00397501|Abortifacient Agents|abortifacient agents|mesh-ancestor
110171286|NCT00397501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110171287|NCT00397501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110171288|NCT00397501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110171289|NCT00397501|Antimetabolites|antimetabolites|mesh-ancestor
110171290|NCT00397501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110171291|NCT00397501|Dermatologic Agents|dermatologic agents|mesh-ancestor
110171292|NCT00397501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110171293|NCT00397501|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110171294|NCT00397501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110171295|NCT00397501|Immunologic Factors|immunologic factors|mesh-ancestor
110171296|NCT00397501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110171297|NCT00397501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110171298|NCT00397501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110171300|NCT00397501|Protective Agents|protective agents|mesh-ancestor
110171301|NCT00397501|Antioxidants|antioxidants|mesh-ancestor
110171302|NCT00397501|Antitubercular Agents|antitubercular agents|mesh-ancestor
110171303|NCT00397501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110171304|NCT00397501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110171305|NCT00397501|Chelating Agents|chelating agents|mesh-ancestor
110171306|NCT00397501|Sequestering Agents|sequestering agents|mesh-ancestor
110171307|NCT00018174|Fluoxetine|fluoxetine|mesh-list
110171308|NCT00018174|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110171309|NCT00018174|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110171310|NCT00018174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110171311|NCT00018174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110171312|NCT00018174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110171313|NCT00018174|Serotonin Agents|serotonin agents|mesh-ancestor
110171314|NCT00018174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110171315|NCT00018174|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110171316|NCT00018174|Antidepressive Agents|antidepressive agents|mesh-ancestor
110171317|NCT00018174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110171318|NCT00018174|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110171319|NCT00018174|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110171320|NCT00018174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110171321|NCT00044629|Zolpidem|zolpidem|mesh-list
110171322|NCT00044629|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110171323|NCT00044629|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110171324|NCT00044629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110171325|NCT00044629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110171326|NCT00044629|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110171327|NCT00044629|GABA Agonists|gaba agonists|mesh-ancestor
110171328|NCT00044629|GABA Agents|gaba agents|mesh-ancestor
110171329|NCT00044629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110171330|NCT00044629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110171331|NCT00044668|Exenatide|exenatide|mesh-list
110171332|NCT00044668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110171333|NCT00044668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110171334|NCT00044668|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110171335|NCT00044668|Incretins|incretins|mesh-ancestor
110171337|NCT00044668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110171338|NCT00044707|Pramlintide|pramlintide|mesh-list
110171339|NCT00044707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110171340|NCT00044707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110171343|NCT00044746|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
110171344|NCT00044746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110171345|NCT00044746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110171346|NCT00044746|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110171347|NCT00044746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110171348|NCT00044746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110171349|NCT00044785|Leucovorin|leucovorin|mesh-list
110171350|NCT00044785|Fluorouracil|fluorouracil|mesh-list
110171351|NCT00044785|Irinotecan|irinotecan|mesh-list
110171352|NCT00044785|Antimetabolites|antimetabolites|mesh-ancestor
110171353|NCT00044785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110171354|NCT00044785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110171355|NCT00044785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110171356|NCT00044785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110171357|NCT00044785|Immunologic Factors|immunologic factors|mesh-ancestor
110171358|NCT00044785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110171359|NCT00044785|Antidotes|antidotes|mesh-ancestor
110171360|NCT00044785|Protective Agents|protective agents|mesh-ancestor
110171361|NCT00044785|Vitamin B Complex|vitamin b complex|mesh-ancestor
110171363|NCT00044785|Micronutrients|micronutrients|mesh-ancestor
110171364|NCT00044785|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110171365|NCT00044785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110171366|NCT00044785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110171367|NCT00044824|Fexofenadine|fexofenadine|mesh-list
110171368|NCT00044824|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110171369|NCT00044824|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110171370|NCT00044824|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110191925|NCT00030368|Paclitaxel|paclitaxel|mesh-list
110171371|NCT00044824|Histamine Antagonists|histamine antagonists|mesh-ancestor
110171372|NCT00044824|Histamine Agents|histamine agents|mesh-ancestor
110171373|NCT00044824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110171374|NCT00044824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110171375|NCT00044824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110171376|NCT00018213|Naltrexone|naltrexone|mesh-list
110171377|NCT00018213|Nicotine|nicotine|mesh-list
110171378|NCT00018213|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110171379|NCT00018213|Autonomic Agents|autonomic agents|mesh-ancestor
110171380|NCT00018213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110171381|NCT00018213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110171382|NCT00018213|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110171383|NCT00018213|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110171384|NCT00018213|Cholinergic Agents|cholinergic agents|mesh-ancestor
110171385|NCT00018213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110171386|NCT00018213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110171387|NCT00018213|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110171388|NCT00018213|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110171390|NCT00044863|Cetuximab|cetuximab|mesh-list
110171391|NCT00044863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110171392|NCT00044863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110171393|NCT00044902|Epratuzumab|epratuzumab|mesh-list
110171394|NCT00044902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110171395|NCT00044902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110171396|NCT00045136|Melphalan|melphalan|mesh-list
110171397|NCT00045136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110171398|NCT00045136|Alkylating Agents|alkylating agents|mesh-ancestor
110171399|NCT00045136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110171400|NCT00045136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110171401|NCT00045136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110171402|NCT00045136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110171403|NCT00045136|Immunologic Factors|immunologic factors|mesh-ancestor
110171404|NCT00045136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110171405|NCT00001649|Valacyclovir|valacyclovir|mesh-list
110171406|NCT00001649|Antiviral Agents|antiviral agents|mesh-ancestor
110171407|NCT00001649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110171409|NCT00018291|Risperidone|risperidone|mesh-list
110171410|NCT00018291|Analgesics|analgesics|mesh-ancestor
110171411|NCT00018291|Sensory System Agents|sensory system agents|mesh-ancestor
110171412|NCT00018291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110171413|NCT00018291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110171414|NCT00018291|Anticonvulsants|anticonvulsants|mesh-ancestor
110171415|NCT00018291|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110171416|NCT00018291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110171417|NCT00018291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110171418|NCT00018291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110171419|NCT00018291|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110171420|NCT00018291|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110171421|NCT00018291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110171422|NCT00018291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110171423|NCT00018291|Antimanic Agents|antimanic agents|mesh-ancestor
110171424|NCT00018291|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110171425|NCT00018291|Serotonin Agents|serotonin agents|mesh-ancestor
110171426|NCT00018291|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110171427|NCT00018291|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110171428|NCT00018291|Dopamine Agents|dopamine agents|mesh-ancestor
110171429|NCT00045175|Topotecan|topotecan|mesh-list
110171430|NCT00045175|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
110171431|NCT00045175|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110171432|NCT00045175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110171433|NCT00045175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110171434|NCT00045175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110171435|NCT00045175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110171436|NCT00045175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110171437|NCT00045292|Valacyclovir|valacyclovir|mesh-list
110171439|NCT00045292|Antiviral Agents|antiviral agents|mesh-ancestor
110171440|NCT00045292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110171443|NCT00045370|Sirolimus|sirolimus|mesh-list
110171444|NCT00045370|Temsirolimus|temsirolimus|mesh-list
110171445|NCT00045370|MTOR Inhibitors|mtor inhibitors|mesh-list
110171446|NCT00045370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110171447|NCT00045370|Antiviral Agents|antiviral agents|mesh-ancestor
110171448|NCT00045370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110171449|NCT00045370|Immunologic Factors|immunologic factors|mesh-ancestor
110171450|NCT00045370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110171451|NCT00045370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110171452|NCT00045370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110171453|NCT00045370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110171454|NCT00045370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110171455|NCT00045370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110171456|NCT00045370|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110171457|NCT00045370|Antifungal Agents|antifungal agents|mesh-ancestor
110171458|NCT02970682|Tamoxifen|tamoxifen|mesh-list
110171459|NCT02970682|Fulvestrant|fulvestrant|mesh-list
110171460|NCT02970682|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110171461|NCT02970682|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110171462|NCT02970682|Hormone Antagonists|hormone antagonists|mesh-ancestor
110171463|NCT02970682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110171464|NCT02970682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110171465|NCT02970682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110171466|NCT02970682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110171467|NCT02970682|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110171468|NCT02970682|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110171469|NCT02970682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110171470|NCT02970682|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110171471|NCT02970682|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110171472|NCT02970682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110171473|NCT02970682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110171474|NCT00045448|Docetaxel|docetaxel|mesh-list
110171475|NCT00045448|Alvocidib|alvocidib|mesh-list
110171476|NCT00045448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110171477|NCT00045448|Tubulin Modulators|tubulin modulators|mesh-ancestor
110171478|NCT00045448|Antimitotic Agents|antimitotic agents|mesh-ancestor
110171479|NCT00045448|Mitosis Modulators|mitosis modulators|mesh-ancestor
110171480|NCT00045448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110171481|NCT00045448|Growth Inhibitors|growth inhibitors|mesh-ancestor
110171482|NCT00045448|Growth Substances|growth substances|mesh-ancestor
110171483|NCT00045448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110171484|NCT00045448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110171486|NCT00045526|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110171487|NCT00045526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110171488|NCT00045526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110171489|NCT00045526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110171490|NCT00045526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110171491|NCT00045565|Arsenic Trioxide|arsenic trioxide|mesh-list
110171492|NCT00045565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110171493|NCT00045604|Irinotecan|irinotecan|mesh-list
110171494|NCT00045604|Imatinib Mesylate|imatinib mesylate|mesh-list
110171495|NCT00045604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110171496|NCT00045604|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110171497|NCT00045604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110171498|NCT00045604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110191943|NCT00030407|Sensory System Agents|sensory system agents|mesh-ancestor
110171499|NCT00045604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110171500|NCT00045604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110171502|NCT00045682|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110171503|NCT00045682|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
110171504|NCT00045682|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110171505|NCT00045682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110171506|NCT00045682|Tubulin Modulators|tubulin modulators|mesh-ancestor
110171507|NCT00045682|Antimitotic Agents|antimitotic agents|mesh-ancestor
110171508|NCT00045682|Mitosis Modulators|mitosis modulators|mesh-ancestor
110171509|NCT00045682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110171510|NCT00045721|Carmustine|carmustine|mesh-list
110171511|NCT00045721|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
110171512|NCT00045721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110171513|NCT00045721|Alkylating Agents|alkylating agents|mesh-ancestor
110171514|NCT00045721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110171515|NCT00045721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110171516|NCT00045721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110171517|NCT04731766|Listerine|listerine|mesh-list
110171518|NCT04731766|Fluorides|fluorides|mesh-list
110171519|NCT04731766|Sodium Fluoride|sodium fluoride|mesh-list
110171520|NCT04731766|Cariostatic Agents|cariostatic agents|mesh-ancestor
110171521|NCT04731766|Protective Agents|protective agents|mesh-ancestor
110171522|NCT04731766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110171523|NCT04731766|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110171524|NCT04731766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110171525|NCT00045760|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
110171526|NCT00045760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110171527|NCT00018447|Fluorides|fluorides|mesh-list
110171528|NCT00018447|Cariostatic Agents|cariostatic agents|mesh-ancestor
110171529|NCT00018447|Protective Agents|protective agents|mesh-ancestor
110171530|NCT00018447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110171531|NCT00001688|Ritonavir|ritonavir|mesh-list
110171532|NCT00001688|Nevirapine|nevirapine|mesh-list
110171533|NCT00001688|Stavudine|stavudine|mesh-list
110171534|NCT00001688|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110171535|NCT00001688|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110171536|NCT00001688|Protease Inhibitors|protease inhibitors|mesh-ancestor
110171537|NCT00001688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110171538|NCT00001688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110171539|NCT00001688|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110171540|NCT00001688|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110171541|NCT00001688|Antiviral Agents|antiviral agents|mesh-ancestor
110171542|NCT00001688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110171543|NCT00001688|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110171544|NCT00001688|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110171545|NCT00001688|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110171546|NCT00001688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110171547|NCT00001688|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110171548|NCT00001688|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110171549|NCT00001688|Antimetabolites|antimetabolites|mesh-ancestor
110171550|NCT00389402|Ritonavir|ritonavir|mesh-list
110171551|NCT00389402|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110171552|NCT00389402|Saquinavir|saquinavir|mesh-list
110171553|NCT00389402|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110171554|NCT00389402|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110171555|NCT00389402|Protease Inhibitors|protease inhibitors|mesh-ancestor
110171556|NCT00389402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110171557|NCT00389402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110171558|NCT00389402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110171559|NCT00389402|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110171560|NCT00389402|Antiviral Agents|antiviral agents|mesh-ancestor
110171561|NCT00389402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110171562|NCT00389402|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110171563|NCT00389402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110171564|NCT00001703|Freund's Adjuvant|freund's adjuvant|mesh-list
110171565|NCT00001703|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110171566|NCT00001703|Immunologic Factors|immunologic factors|mesh-ancestor
110171567|NCT00001703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110171569|NCT00045799|Cimetidine|cimetidine|mesh-list
110171570|NCT00045799|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
110171571|NCT00045799|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110171572|NCT00045799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110171573|NCT00045799|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110171574|NCT00045799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110171575|NCT00045799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110171577|NCT00045799|Histamine Antagonists|histamine antagonists|mesh-ancestor
110171578|NCT00045799|Histamine Agents|histamine agents|mesh-ancestor
110171579|NCT00045799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110171580|NCT00045799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110171581|NCT00045799|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110171582|NCT00045799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110171583|NCT04394130|Ropivacaine|ropivacaine|mesh-list
110171584|NCT04394130|Anesthetics, Local|anesthetics, local|mesh-ancestor
110171585|NCT04394130|Anesthetics|anesthetics|mesh-ancestor
110171586|NCT04394130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110171587|NCT04394130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110171588|NCT04394130|Sensory System Agents|sensory system agents|mesh-ancestor
110171589|NCT04394130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110171590|NCT00045877|Aldesleukin|aldesleukin|mesh-list
110171592|NCT00045877|Interleukin-2|interleukin-2|mesh-list
110171593|NCT00045877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110171594|NCT00045877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110171595|NCT00045877|Immunologic Factors|immunologic factors|mesh-ancestor
110171596|NCT00045877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110171597|NCT00045877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110171598|NCT00045877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110171599|NCT00045877|Analgesics|analgesics|mesh-ancestor
110171600|NCT00045877|Sensory System Agents|sensory system agents|mesh-ancestor
110171601|NCT00045877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110171602|NCT00045877|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110171603|NCT00045877|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110171604|NCT00045877|Antiviral Agents|antiviral agents|mesh-ancestor
110171605|NCT00045877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110171606|NCT00045916|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110171608|NCT00045916|Antidepressive Agents|antidepressive agents|mesh-ancestor
110171609|NCT00045916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110171610|NCT00045916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110171611|NCT00045916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110171612|NCT00045916|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110171613|NCT00045916|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110171614|NCT00045916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110171615|NCT00045916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110171616|NCT00045916|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110171617|NCT00045916|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110171618|NCT00045916|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110171619|NCT00045916|Adrenergic Agents|adrenergic agents|mesh-ancestor
110171621|NCT04380207|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110171622|NCT04380207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110171623|NCT04380207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110171624|NCT04380207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110171625|NCT04380207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110171626|NCT00045955|Fexofenadine|fexofenadine|mesh-list
110171627|NCT00045955|Montelukast|montelukast|mesh-list
110191975|NCT00057720|Doxorubicin|doxorubicin|mesh-list
110171628|NCT00045955|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110171629|NCT00045955|Respiratory System Agents|respiratory system agents|mesh-ancestor
110171630|NCT00045955|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110171632|NCT00045955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110171633|NCT00045955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110171634|NCT00045955|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110171635|NCT00045955|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110171636|NCT00045955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110171637|NCT00045955|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110171638|NCT00045955|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110171639|NCT00045955|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110171640|NCT00045955|Histamine Antagonists|histamine antagonists|mesh-ancestor
110171641|NCT00045955|Histamine Agents|histamine agents|mesh-ancestor
110171642|NCT00045955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110171644|NCT00046033|Lopinavir|lopinavir|mesh-list
110171645|NCT00046033|Saquinavir|saquinavir|mesh-list
110171646|NCT00046033|Amprenavir|amprenavir|mesh-list
110171647|NCT00046033|Tenofovir|tenofovir|mesh-list
110171648|NCT00046033|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110171649|NCT00046033|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110171650|NCT00046033|Protease Inhibitors|protease inhibitors|mesh-ancestor
110171651|NCT00046033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110171652|NCT00046033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110171653|NCT00046033|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110171654|NCT00046033|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110171655|NCT00046033|Antiviral Agents|antiviral agents|mesh-ancestor
110171656|NCT00046033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110171657|NCT00046033|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110171658|NCT00046033|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110171659|NCT00046033|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110171660|NCT00046033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110171661|NCT00046033|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110171662|NCT00046033|Antitubercular Agents|antitubercular agents|mesh-ancestor
110171663|NCT00046033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110171664|NCT04369560|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
110171665|NCT04369560|Hematinics|hematinics|mesh-ancestor
110171666|NCT04369560|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110171667|NCT04369560|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110171668|NCT00046111|Topotecan|topotecan|mesh-list
110171669|NCT00046111|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110171670|NCT00046111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110171671|NCT00046111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110171672|NCT00046111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110171673|NCT00046111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110171675|NCT00001724|Analgesics|analgesics|mesh-ancestor
110171676|NCT00001724|Sensory System Agents|sensory system agents|mesh-ancestor
110171677|NCT00001724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110171678|NCT00001724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110171679|NCT00001724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110171680|NCT00001724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110171681|NCT00001724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110171682|NCT00001724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110171683|NCT00001724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110171684|NCT00001724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110171685|NCT00001724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110171686|NCT00046150|Insulin glulisine|insulin glulisine|mesh-list
110171687|NCT00046150|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110171688|NCT00046150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110171690|NCT00046267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110171691|NCT00046267|Antimetabolites|antimetabolites|mesh-ancestor
110171692|NCT00046267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110171693|NCT00046267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110171694|NCT00046267|Vasodilator Agents|vasodilator agents|mesh-ancestor
110171695|NCT00046267|Vitamin B Complex|vitamin b complex|mesh-ancestor
110171696|NCT00046267|Vitamins|vitamins|mesh-ancestor
110171697|NCT00046267|Micronutrients|micronutrients|mesh-ancestor
110171698|NCT00046267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110171699|NCT00046306|Antioxidants|antioxidants|mesh-list
110171700|NCT00046306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110171701|NCT00046306|Protective Agents|protective agents|mesh-ancestor
110171702|NCT00046306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110171703|NCT00046345|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110171704|NCT00046345|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110171705|NCT00046345|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110171706|NCT00046345|Protease Inhibitors|protease inhibitors|mesh-ancestor
110171707|NCT00046345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110171708|NCT00046345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110171709|NCT00046345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110171710|NCT00046345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110171711|NCT00046345|Antiviral Agents|antiviral agents|mesh-ancestor
110171712|NCT00046345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110171714|NCT00397657|Ezetimibe|ezetimibe|mesh-list
110171715|NCT00397657|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110171716|NCT00397657|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110171717|NCT00397657|Antimetabolites|antimetabolites|mesh-ancestor
110171718|NCT00397657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110171719|NCT00397657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110171720|NCT00397657|Vasodilator Agents|vasodilator agents|mesh-ancestor
110171721|NCT00397657|Vitamin B Complex|vitamin b complex|mesh-ancestor
110171722|NCT00397657|Vitamins|vitamins|mesh-ancestor
110171723|NCT00397657|Micronutrients|micronutrients|mesh-ancestor
110171724|NCT00397657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110171725|NCT00001763|Interleukin-12|interleukin-12|mesh-list
110171726|NCT00001763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110171727|NCT00001763|Immunologic Factors|immunologic factors|mesh-ancestor
110171728|NCT00001763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110171729|NCT00001763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110171730|NCT00001763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110171732|NCT00001763|Growth Inhibitors|growth inhibitors|mesh-ancestor
110171733|NCT00001763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110171734|NCT00397735|Acetylcysteine|acetylcysteine|mesh-list
110171735|NCT00397735|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110171736|NCT00397735|Antiviral Agents|antiviral agents|mesh-ancestor
110171737|NCT00397735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110171738|NCT00397735|Expectorants|expectorants|mesh-ancestor
110060609|NCT01524315|Micronutrients|micronutrients|mesh-ancestor
110171739|NCT00397735|Respiratory System Agents|respiratory system agents|mesh-ancestor
110171740|NCT00397735|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110171741|NCT00397735|Antioxidants|antioxidants|mesh-ancestor
110171742|NCT00397735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110171743|NCT00397735|Protective Agents|protective agents|mesh-ancestor
110171744|NCT00397735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110171745|NCT00397735|Antidotes|antidotes|mesh-ancestor
110192007|NCT00030641|Docetaxel|docetaxel|mesh-list
110171746|NCT00046384|Aripiprazole|aripiprazole|mesh-list
110171747|NCT00046384|Antidepressive Agents|antidepressive agents|mesh-ancestor
110017637|NCT03096444|Analgesics|analgesics|mesh-ancestor
110171749|NCT00046384|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110171750|NCT00046384|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110171751|NCT00046384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110171752|NCT00046384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110017713|NCT05093790|Antipyretics|antipyretics|mesh-ancestor
110171753|NCT00046384|Dopamine Agonists|dopamine agonists|mesh-ancestor
110171754|NCT00046384|Dopamine Agents|dopamine agents|mesh-ancestor
110171755|NCT00046384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110017772|NCT04426500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110171756|NCT00046384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110171757|NCT00046384|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110171758|NCT00046384|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110171759|NCT00046384|Serotonin Agents|serotonin agents|mesh-ancestor
110171760|NCT00046384|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110171761|NCT00046384|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110171762|NCT00046384|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110171763|NCT00046384|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110171764|NCT00046423|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110171765|NCT00046423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110171766|NCT04258410|Quercetin|quercetin|mesh-list
110171767|NCT04258410|Antioxidants|antioxidants|mesh-ancestor
110171768|NCT04258410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110171769|NCT04258410|Protective Agents|protective agents|mesh-ancestor
110171770|NCT04258410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110171771|NCT00046462|Metformin|metformin|mesh-list
110171772|NCT00046462|Insulin Glargine|insulin glargine|mesh-list
110171773|NCT00046462|Glyburide|glyburide|mesh-list
110171774|NCT00046462|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
110171775|NCT00046462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110171776|NCT00046462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110171777|NCT00001766|Ritonavir|ritonavir|mesh-list
110171778|NCT00001766|Nelfinavir|nelfinavir|mesh-list
110171779|NCT00001766|Amprenavir|amprenavir|mesh-list
110171781|NCT00001766|Efavirenz|efavirenz|mesh-list
110171782|NCT00001766|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110171783|NCT00001766|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110171784|NCT00001766|Protease Inhibitors|protease inhibitors|mesh-ancestor
110171785|NCT00001766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110018043|NCT03395808|Narcotics|narcotics|mesh-ancestor
110171786|NCT00001766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110171788|NCT00001766|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110171789|NCT00001766|Antiviral Agents|antiviral agents|mesh-ancestor
110171790|NCT00001766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110171791|NCT00001766|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110171792|NCT00001766|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110171793|NCT00001766|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110171794|NCT00001766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110171795|NCT00001766|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110171796|NCT00001766|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110171797|NCT00001766|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110171798|NCT00001766|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110171799|NCT00001766|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110171800|NCT00001766|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110171801|NCT00001766|Antitubercular Agents|antitubercular agents|mesh-ancestor
110171802|NCT00001766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110171804|NCT00046501|Insulin Glargine|insulin glargine|mesh-list
110171805|NCT00046501|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110171806|NCT00046501|Insulin, Isophane|insulin, isophane|mesh-list
110171807|NCT00046501|Isophane Insulin, Human|isophane insulin, human|mesh-list
110171808|NCT00046501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110171809|NCT00046501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110171810|NCT00046735|Lenalidomide|lenalidomide|mesh-list
110171811|NCT00046735|Immunologic Factors|immunologic factors|mesh-ancestor
110171812|NCT00046735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110171813|NCT00046735|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110171814|NCT00046735|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110171815|NCT00046735|Growth Substances|growth substances|mesh-ancestor
110171816|NCT00046735|Growth Inhibitors|growth inhibitors|mesh-ancestor
110171817|NCT00046735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110171818|NCT00001784|Mexiletine|mexiletine|mesh-list
110171819|NCT00001784|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110171820|NCT00001784|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110171821|NCT00001784|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110171822|NCT00001784|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110171823|NCT00001784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110171824|NCT00046813|Nicotine|nicotine|mesh-list
110171825|NCT00046813|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110171826|NCT00046813|Autonomic Agents|autonomic agents|mesh-ancestor
110171827|NCT00046813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110171828|NCT00046813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110171829|NCT00046813|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110171830|NCT00046813|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110171831|NCT00046813|Cholinergic Agents|cholinergic agents|mesh-ancestor
110171832|NCT00046813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110171833|NCT00046813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110171834|NCT00046852|Cyclophosphamide|cyclophosphamide|mesh-list
110171835|NCT00046852|Melphalan|melphalan|mesh-list
110171836|NCT00046852|Carmustine|carmustine|mesh-list
110171837|NCT00046852|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110171838|NCT00046852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110171839|NCT00046852|Immunologic Factors|immunologic factors|mesh-ancestor
110171840|NCT00046852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110171842|NCT00046852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110171843|NCT00046852|Alkylating Agents|alkylating agents|mesh-ancestor
110171844|NCT00046852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110171845|NCT00046852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110171846|NCT00046852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110171847|NCT00046969|Cisplatin|cisplatin|mesh-list
110171848|NCT00046969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110171849|NCT00001805|Rituximab|rituximab|mesh-list
110171850|NCT00001805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110171851|NCT00001805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110171852|NCT00001805|Immunologic Factors|immunologic factors|mesh-ancestor
110171853|NCT00001805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110171854|NCT00001805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110171855|NCT00047047|Gemcitabine|gemcitabine|mesh-list
110171856|NCT00047047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110171857|NCT00047047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110171858|NCT00047047|Antimetabolites|antimetabolites|mesh-ancestor
110171859|NCT00047047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110171861|NCT04733781|Epinephrine|epinephrine|mesh-list
110171862|NCT04733781|Anesthetics, Local|anesthetics, local|mesh-ancestor
110171864|NCT04733781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110171865|NCT04733781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110171866|NCT04733781|Sensory System Agents|sensory system agents|mesh-ancestor
110171867|NCT04733781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110171868|NCT04733781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110171869|NCT04733781|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110171870|NCT04733781|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110171871|NCT04733781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110171872|NCT04733781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110171873|NCT04733781|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110171874|NCT04733781|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110171875|NCT04733781|Adrenergic Agents|adrenergic agents|mesh-ancestor
110171876|NCT04733781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110171877|NCT04733781|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110171878|NCT04733781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110171879|NCT04733781|Autonomic Agents|autonomic agents|mesh-ancestor
110171880|NCT04733781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110171881|NCT04733781|Respiratory System Agents|respiratory system agents|mesh-ancestor
110171882|NCT04733781|Mydriatics|mydriatics|mesh-ancestor
110171883|NCT04733781|Sympathomimetics|sympathomimetics|mesh-ancestor
110171884|NCT04733781|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110171885|NCT00047164|Ipilimumab|ipilimumab|mesh-list
110171886|NCT00047164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110171887|NCT00047164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110171888|NCT00047164|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110171889|NCT00047164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110171890|NCT00047203|Alvocidib|alvocidib|mesh-list
110171891|NCT00047203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110171892|NCT00047203|Growth Inhibitors|growth inhibitors|mesh-ancestor
110171893|NCT00047203|Growth Substances|growth substances|mesh-ancestor
110171894|NCT00047203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110171895|NCT00047203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110171896|NCT00047203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110171897|NCT00047203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110171898|NCT04163874|Pramlintide|pramlintide|mesh-list
110171899|NCT04163874|Pancrelipase|pancrelipase|mesh-list
110171900|NCT04163874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110171901|NCT04163874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110171904|NCT00047242|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
110171905|NCT00047242|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110171906|NCT00047242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110171907|NCT00047242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110171908|NCT00047242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110171909|NCT00047242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110171910|NCT00047242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110171911|NCT00047281|Thalidomide|thalidomide|mesh-list
110171912|NCT00047281|Celecoxib|celecoxib|mesh-list
110171913|NCT00047281|Cyclophosphamide|cyclophosphamide|mesh-list
110171914|NCT00047281|Etoposide|etoposide|mesh-list
110171915|NCT00047281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110171916|NCT00047281|Immunologic Factors|immunologic factors|mesh-ancestor
110171917|NCT00047281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110171918|NCT00047281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110171919|NCT00047281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110171921|NCT00047281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110171922|NCT00047281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110171924|NCT00047281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110171925|NCT00047281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110171926|NCT00047281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110171927|NCT00047281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110171928|NCT00047281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110171929|NCT00047281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110171930|NCT00047281|Analgesics|analgesics|mesh-ancestor
110171931|NCT00047281|Sensory System Agents|sensory system agents|mesh-ancestor
110171932|NCT00047281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110171933|NCT00047281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110171934|NCT00047281|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110171935|NCT00047281|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110171936|NCT00047281|Leprostatic Agents|leprostatic agents|mesh-ancestor
110019184|NCT00586716|Antibodies|antibodies|mesh-list
110171937|NCT00047281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110171938|NCT00047281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110171939|NCT00047281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110171940|NCT00047281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110171942|NCT00047281|Growth Inhibitors|growth inhibitors|mesh-ancestor
110171943|NCT00047476|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
110019237|NCT05001048|Synephrine|synephrine|mesh-list
110171944|NCT00047476|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110171945|NCT00047476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110171947|NCT00047476|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110171948|NCT00047476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110171949|NCT00047476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110171950|NCT00047476|Dopamine Agents|dopamine agents|mesh-ancestor
110171951|NCT00047476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110171952|NCT00047554|Travoprost|travoprost|mesh-list
110171953|NCT00047554|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110171954|NCT00047554|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110171955|NCT00047554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110171956|NCT00047632|Interferons|interferons|mesh-list
110171957|NCT00047632|Interferon-gamma|interferon-gamma|mesh-list
110171958|NCT00047632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110171959|NCT00047632|Antiviral Agents|antiviral agents|mesh-ancestor
110171960|NCT00047632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110171961|NCT00047671|Citalopram|citalopram|mesh-list
110171962|NCT00047671|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110171963|NCT00047671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110171964|NCT00047671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110171965|NCT00047671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110171966|NCT00047671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110171967|NCT00047671|Serotonin Agents|serotonin agents|mesh-ancestor
110171968|NCT00047671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110171969|NCT00047671|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110171970|NCT00047671|Antidepressive Agents|antidepressive agents|mesh-ancestor
110171971|NCT00047671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110171972|NCT00047710|Bevacizumab|bevacizumab|mesh-list
110171973|NCT00047710|Capecitabine|capecitabine|mesh-list
110171974|NCT00047710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110171975|NCT00047710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110171976|NCT00047710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110171977|NCT00047710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110171978|NCT00047710|Growth Substances|growth substances|mesh-ancestor
110171979|NCT00047710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110171980|NCT00047710|Growth Inhibitors|growth inhibitors|mesh-ancestor
110171981|NCT00047710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110171982|NCT00047710|Antimetabolites|antimetabolites|mesh-ancestor
110019716|NCT00000354|Sensory System Agents|sensory system agents|mesh-ancestor
110171983|NCT00047710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110171984|NCT00047749|Ziconotide|ziconotide|mesh-list
110171985|NCT00047749|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110171986|NCT00047749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110171987|NCT00047749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110171988|NCT00047749|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110171989|NCT00047749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110171990|NCT00047749|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110171991|NCT00047749|Protective Agents|protective agents|mesh-ancestor
110171992|NCT00047749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110171993|NCT00047749|Analgesics|analgesics|mesh-ancestor
110171994|NCT00047749|Sensory System Agents|sensory system agents|mesh-ancestor
110192173|NCT00058305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110171995|NCT00047749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110171996|NCT00047827|Amphotericin B|amphotericin b|mesh-list
110171997|NCT00047827|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110171998|NCT00047827|Micafungin|micafungin|mesh-list
110171999|NCT00047827|Amebicides|amebicides|mesh-ancestor
110172000|NCT00047827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110172001|NCT00047827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110172002|NCT00047827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110172003|NCT00047827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110172004|NCT00047827|Antifungal Agents|antifungal agents|mesh-ancestor
110172005|NCT00048139|Capecitabine|capecitabine|mesh-list
110172006|NCT00048139|Irinotecan|irinotecan|mesh-list
110172007|NCT00048139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110172008|NCT00048139|Antimetabolites|antimetabolites|mesh-ancestor
110172009|NCT00048139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110172010|NCT00048139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110172011|NCT00048139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110172013|NCT00048139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110172014|NCT00048334|Romidepsin|romidepsin|mesh-list
110172015|NCT00048334|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110172016|NCT00048334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110172017|NCT00048334|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110172019|NCT00048334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110172020|NCT00048373|Etanercept|etanercept|mesh-list
110172021|NCT00048373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110172022|NCT00048373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110172023|NCT00048373|Analgesics|analgesics|mesh-ancestor
110172024|NCT00048373|Sensory System Agents|sensory system agents|mesh-ancestor
110172025|NCT00048373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110020053|NCT00000918|Efavirenz|efavirenz|mesh-list
110172026|NCT00048373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110172027|NCT00048373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110172028|NCT00048373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110172029|NCT00048373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110172030|NCT00048373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110172031|NCT00048373|Immunologic Factors|immunologic factors|mesh-ancestor
110172032|NCT05641337|Insulin|insulin|mesh-list
110172033|NCT05641337|Metformin|metformin|mesh-list
110172034|NCT05641337|Insulin Aspart|insulin aspart|mesh-list
110172035|NCT05641337|Linagliptin|linagliptin|mesh-list
110172036|NCT05641337|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110172037|NCT05641337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110172038|NCT05641337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110172039|NCT05641337|Incretins|incretins|mesh-ancestor
110172040|NCT05641337|Hormones|hormones|mesh-ancestor
110172041|NCT05641337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110172042|NCT05641337|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110172043|NCT05641337|Protease Inhibitors|protease inhibitors|mesh-ancestor
110172044|NCT05641337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110172045|NCT05641337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110172046|NCT00048412|Fludarabine|fludarabine|mesh-list
110172047|NCT00048412|Alemtuzumab|alemtuzumab|mesh-list
110172048|NCT00048412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110172049|NCT00048412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110172050|NCT02970526|Oxaliplatin|oxaliplatin|mesh-list
110172051|NCT02970526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110172052|NCT00048607|Aprepitant|aprepitant|mesh-list
110172053|NCT00048607|Paroxetine|paroxetine|mesh-list
110172054|NCT00048607|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110172055|NCT00048607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110172056|NCT00048607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110172057|NCT00048607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110172058|NCT00048607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110172059|NCT00048607|Serotonin Agents|serotonin agents|mesh-ancestor
110172060|NCT00048607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110172061|NCT00048607|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110172062|NCT00048607|Antidepressive Agents|antidepressive agents|mesh-ancestor
110172063|NCT00048607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110172064|NCT00048607|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110020313|NCT00001626|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110192209|NCT00058461|Alkylating Agents|alkylating agents|mesh-ancestor
110172065|NCT00048607|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110172066|NCT00048607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110172067|NCT00048607|Antiemetics|antiemetics|mesh-ancestor
110172068|NCT00048607|Autonomic Agents|autonomic agents|mesh-ancestor
110172069|NCT00048607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110172070|NCT00048607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110172071|NCT00048607|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110172072|NCT00048646|Progesterone|progesterone|mesh-list
110172073|NCT00048646|Progestins|progestins|mesh-ancestor
110172074|NCT00048646|Hormones|hormones|mesh-ancestor
110172075|NCT00048646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110172076|NCT00048646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110172077|NCT00048763|Cilostazol|cilostazol|mesh-list
110172078|NCT00048763|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110172079|NCT00048763|Autonomic Agents|autonomic agents|mesh-ancestor
110172080|NCT00048763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110020458|NCT00002022|Epoetin Alfa|epoetin alfa|mesh-list
110172081|NCT00048763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110172082|NCT00048763|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110172083|NCT00048763|Respiratory System Agents|respiratory system agents|mesh-ancestor
110172084|NCT00048763|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110172085|NCT00048763|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110172086|NCT00048763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110172087|NCT00048763|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110020515|NCT00002064|Clindamycin|clindamycin|mesh-list
110172088|NCT00048763|Vasodilator Agents|vasodilator agents|mesh-ancestor
110172089|NCT00048763|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110172090|NCT00048763|Protective Agents|protective agents|mesh-ancestor
110172091|NCT00048763|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110172092|NCT00048763|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110172093|NCT00048763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110172094|NCT05576298|Insulin|insulin|mesh-list
110172095|NCT05576298|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110020592|NCT00002112|Ionophores|ionophores|mesh-ancestor
110172096|NCT05576298|Insulin, Long-Acting|insulin, long-acting|mesh-list
110172097|NCT05576298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110172098|NCT05576298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110172100|NCT00048802|Olanzapine|olanzapine|mesh-list
110172101|NCT00048802|Risperidone|risperidone|mesh-list
110172102|NCT00048802|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110172103|NCT00048802|Ziprasidone|ziprasidone|mesh-list
110172104|NCT00048802|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110172105|NCT00048802|Serotonin Agents|serotonin agents|mesh-ancestor
110172106|NCT00048802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110172107|NCT00048802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110172108|NCT00048802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110172109|NCT00048802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110172110|NCT00048802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110172111|NCT00048802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110172112|NCT00048802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110172113|NCT00048802|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110172114|NCT00048802|Dopamine Agents|dopamine agents|mesh-ancestor
110172115|NCT00048802|Antiemetics|antiemetics|mesh-ancestor
110172116|NCT00048802|Autonomic Agents|autonomic agents|mesh-ancestor
110172117|NCT00048802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110172118|NCT00048802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110172119|NCT00048802|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110172120|NCT00048802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110172121|NCT00048802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110172122|NCT00048802|Antidepressive Agents|antidepressive agents|mesh-ancestor
110172123|NCT00048802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110172124|NCT00048802|Antimanic Agents|antimanic agents|mesh-ancestor
110172125|NCT00048802|Anticonvulsants|anticonvulsants|mesh-ancestor
110172126|NCT00048802|GABA Agents|gaba agents|mesh-ancestor
110172127|NCT00048841|Alendronate|alendronate|mesh-list
110172128|NCT00048841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110172129|NCT00048841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110172130|NCT00048880|Antibodies|antibodies|mesh-list
110172132|NCT00048880|Immunologic Factors|immunologic factors|mesh-ancestor
110172133|NCT00048880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110020843|NCT00002274|Antiviral Agents|antiviral agents|mesh-ancestor
110172135|NCT00049075|Fludarabine phosphate|fludarabine phosphate|mesh-list
110172136|NCT00049075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110172137|NCT00049075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110172138|NCT00049075|Antimetabolites|antimetabolites|mesh-ancestor
110172139|NCT00049075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110172140|NCT00049075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110172141|NCT00049075|Immunologic Factors|immunologic factors|mesh-ancestor
110172142|NCT00049075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110172143|NCT00049114|Cyclophosphamide|cyclophosphamide|mesh-list
110172144|NCT00049114|Doxorubicin|doxorubicin|mesh-list
110172145|NCT00049114|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110172146|NCT00049114|Tipifarnib|tipifarnib|mesh-list
110172147|NCT00049114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110172149|NCT00049114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110172150|NCT00049114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110172151|NCT00049114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110172152|NCT00049114|Alkylating Agents|alkylating agents|mesh-ancestor
110172153|NCT00049114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110172154|NCT00049114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110172155|NCT00049114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110172156|NCT00049114|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110172157|NCT00049114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110172158|NCT00049114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110172159|NCT00049114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110172161|NCT00049192|Oblimersen|oblimersen|mesh-list
110172162|NCT00049192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110172163|NCT00049192|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110172164|NCT00049192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110172165|NCT00049192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110172166|NCT05576181|Cyclophosphamide|cyclophosphamide|mesh-list
110172167|NCT05576181|Fludarabine|fludarabine|mesh-list
110172169|NCT05576181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110172170|NCT05576181|Immunologic Factors|immunologic factors|mesh-ancestor
110172171|NCT05576181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110172172|NCT05576181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110172173|NCT05576181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110172174|NCT05576181|Alkylating Agents|alkylating agents|mesh-ancestor
110021331|NCT00002544|Analgesics|analgesics|mesh-ancestor
110172175|NCT05576181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110172176|NCT05576181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110172177|NCT05576181|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110172178|NCT05576181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110172179|NCT05576181|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110172180|NCT05576181|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110172181|NCT05576181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110172182|NCT00049387|Temozolomide|temozolomide|mesh-list
110172184|NCT00049387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110172185|NCT00049387|Alkylating Agents|alkylating agents|mesh-ancestor
110260191|NCT00168909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110172186|NCT00049387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110172187|NCT00049387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110172188|NCT05640791|Paclitaxel|paclitaxel|mesh-list
110172189|NCT05640791|Gemcitabine|gemcitabine|mesh-list
110172190|NCT05640791|Durvalumab|durvalumab|mesh-list
110172191|NCT05640791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110172192|NCT05640791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110172193|NCT05640791|Tubulin Modulators|tubulin modulators|mesh-ancestor
110172194|NCT05640791|Antimitotic Agents|antimitotic agents|mesh-ancestor
110172195|NCT05640791|Mitosis Modulators|mitosis modulators|mesh-ancestor
110172196|NCT05640791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110172197|NCT05640791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110172198|NCT05640791|Antimetabolites|antimetabolites|mesh-ancestor
110172199|NCT05640791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110172200|NCT00391911|Acetylcysteine|acetylcysteine|mesh-list
110172201|NCT00391911|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110172202|NCT00391911|Antiviral Agents|antiviral agents|mesh-ancestor
110172203|NCT00391911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110172204|NCT00391911|Expectorants|expectorants|mesh-ancestor
110172205|NCT00391911|Respiratory System Agents|respiratory system agents|mesh-ancestor
110172206|NCT00391911|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110172208|NCT00391911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110021841|NCT00002742|Ionophores|ionophores|mesh-ancestor
110172209|NCT00391911|Protective Agents|protective agents|mesh-ancestor
110172210|NCT00391911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110172211|NCT00391911|Antidotes|antidotes|mesh-ancestor
110172212|NCT02970409|Heparin|heparin|mesh-list
110172213|NCT02970409|Anticoagulants|anticoagulants|mesh-ancestor
110172215|NCT02970409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110172216|NCT02970409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110172217|NCT00049582|Decitabine|decitabine|mesh-list
110172218|NCT00049582|Azacitidine|azacitidine|mesh-list
110172219|NCT00049582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110172220|NCT00049582|Antimetabolites|antimetabolites|mesh-ancestor
110172221|NCT00049582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110172222|NCT00049582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110172223|NCT00049582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110172224|NCT00049660|Capecitabine|capecitabine|mesh-list
110172225|NCT00049660|Vinorelbine|vinorelbine|mesh-list
110022048|NCT05588388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110172226|NCT00049660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110172227|NCT00049660|Antimetabolites|antimetabolites|mesh-ancestor
110172228|NCT00049660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110172229|NCT00049660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110172230|NCT00049660|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110172231|NCT00049660|Tubulin Modulators|tubulin modulators|mesh-ancestor
110172232|NCT00049660|Antimitotic Agents|antimitotic agents|mesh-ancestor
110172233|NCT00049660|Mitosis Modulators|mitosis modulators|mesh-ancestor
110172234|NCT05640713|Cyclophosphamide|cyclophosphamide|mesh-list
110172236|NCT05640713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110172237|NCT05640713|Immunologic Factors|immunologic factors|mesh-ancestor
110172238|NCT05640713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110172239|NCT05640713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110172240|NCT05640713|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110172241|NCT05640713|Alkylating Agents|alkylating agents|mesh-ancestor
110172242|NCT05640713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110172243|NCT05640713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110172244|NCT05640713|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110172245|NCT00391950|Zoledronic Acid|zoledronic acid|mesh-list
110172246|NCT00391950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110172247|NCT00391950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110172248|NCT00049777|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
110172249|NCT00049777|Heparin|heparin|mesh-list
110172250|NCT00049777|Calcium heparin|calcium heparin|mesh-list
110172251|NCT00049777|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110172253|NCT00049777|Dalteparin|dalteparin|mesh-list
110172254|NCT00049777|Anticoagulants|anticoagulants|mesh-ancestor
110172255|NCT00049777|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110172256|NCT00049777|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110172257|NCT00049777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110022309|NCT01821690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110172258|NCT00049777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110172260|NCT00392028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110172261|NCT00392028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110172262|NCT00392067|Calcipotriene|calcipotriene|mesh-list
110172263|NCT00392067|Dermatologic Agents|dermatologic agents|mesh-ancestor
110172264|NCT00389558|Amikacin|amikacin|mesh-list
110172265|NCT00389558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110172266|NCT00389558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110172267|NCT00049972|Paroxetine|paroxetine|mesh-list
110172268|NCT00049972|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110172269|NCT00049972|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110172270|NCT00049972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110172271|NCT00049972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110172272|NCT00049972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110172274|NCT00049972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110172275|NCT00049972|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110172276|NCT00049972|Antidepressive Agents|antidepressive agents|mesh-ancestor
110022538|NCT00002928|Paclitaxel|paclitaxel|mesh-list
110172277|NCT00049972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110172278|NCT00049972|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110172279|NCT00049972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110172280|NCT00049972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110172281|NCT00389636|Becaplermin|becaplermin|mesh-list
110172282|NCT00389636|Anticoagulants|anticoagulants|mesh-ancestor
110022591|NCT00002976|Estrogens|estrogens|mesh-list
110172283|NCT00389636|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
110172284|NCT00389636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110172285|NCT00389636|Growth Substances|growth substances|mesh-ancestor
110172286|NCT00389636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110172287|NCT00050206|Olanzapine|olanzapine|mesh-list
110172288|NCT00050206|Antiemetics|antiemetics|mesh-ancestor
110172289|NCT00050206|Autonomic Agents|autonomic agents|mesh-ancestor
110172290|NCT00050206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110172291|NCT00050206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110172292|NCT00050206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110172293|NCT00050206|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110172294|NCT00050206|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110172295|NCT00050206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110172296|NCT00050206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110172297|NCT00050206|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110172298|NCT00050206|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110172299|NCT00050206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110172300|NCT00050206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110172301|NCT00050206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110172302|NCT00050206|Serotonin Agents|serotonin agents|mesh-ancestor
110172303|NCT00050245|Rituximab|rituximab|mesh-list
110172304|NCT00050245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110172305|NCT00050245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110172306|NCT00050245|Immunologic Factors|immunologic factors|mesh-ancestor
110172307|NCT00050245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110172308|NCT00050245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110172309|NCT00050362|Rofecoxib|rofecoxib|mesh-list
110172310|NCT00050362|Bupivacaine|bupivacaine|mesh-list
110172311|NCT00050362|Anesthetics, Local|anesthetics, local|mesh-ancestor
110172312|NCT00050362|Anesthetics|anesthetics|mesh-ancestor
110172313|NCT00050362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110172314|NCT00050362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110172315|NCT00050362|Sensory System Agents|sensory system agents|mesh-ancestor
110172316|NCT00050362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110172317|NCT00050362|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110172318|NCT00050362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110172319|NCT00050362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110172320|NCT00050362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110172321|NCT00050362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110172322|NCT00050362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110172323|NCT00050362|Analgesics|analgesics|mesh-ancestor
110172324|NCT00050362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110172325|NCT00050362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110172327|NCT00050401|Tobramycin|tobramycin|mesh-list
110172328|NCT00050401|Meropenem|meropenem|mesh-list
110172329|NCT00050401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110172330|NCT00050401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110172331|NCT05640362|Benzydamine|benzydamine|mesh-list
110172332|NCT05640362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110172333|NCT00050440|Dexamethasone|dexamethasone|mesh-list
110172334|NCT00050440|Trabectedin|trabectedin|mesh-list
110172335|NCT00050440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110172336|NCT00050440|Antiemetics|antiemetics|mesh-ancestor
110172337|NCT00050440|Autonomic Agents|autonomic agents|mesh-ancestor
110260193|NCT00168909|Micronutrients|micronutrients|mesh-ancestor
110172338|NCT00050440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110172339|NCT00050440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110172340|NCT00050440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110172341|NCT00050440|Glucocorticoids|glucocorticoids|mesh-ancestor
110172342|NCT00050440|Hormones|hormones|mesh-ancestor
110023058|NCT00003342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110172343|NCT00050440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110023132|NCT00003402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110172344|NCT00050440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110172345|NCT00050440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110172346|NCT00050440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110172347|NCT00050440|Alkylating Agents|alkylating agents|mesh-ancestor
110023208|NCT00003552|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110172348|NCT00050440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110172349|NCT00050479|Celecoxib|celecoxib|mesh-list
110172350|NCT00050479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110172351|NCT00050479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110172352|NCT00050479|Analgesics|analgesics|mesh-ancestor
110172353|NCT00050479|Sensory System Agents|sensory system agents|mesh-ancestor
110172354|NCT00050479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110172355|NCT00050479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110172356|NCT00050479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110172357|NCT00050479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110172358|NCT00050479|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110172359|NCT00050479|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110172360|NCT00050479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110172361|NCT00050479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110172362|NCT00050596|Docetaxel|docetaxel|mesh-list
110172363|NCT00050596|Ipilimumab|ipilimumab|mesh-list
110172364|NCT00050596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110172365|NCT00050596|Tubulin Modulators|tubulin modulators|mesh-ancestor
110172366|NCT00050596|Antimitotic Agents|antimitotic agents|mesh-ancestor
110172367|NCT00050596|Mitosis Modulators|mitosis modulators|mesh-ancestor
110172368|NCT00050596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110172369|NCT00050596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110172370|NCT00050596|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110172371|NCT00050635|Octreotide|octreotide|mesh-list
110172372|NCT00050635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110172373|NCT00050635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110172374|NCT00050635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110172375|NCT00050674|Lenograstim|lenograstim|mesh-list
110172376|NCT00050674|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110172377|NCT00050674|Immunologic Factors|immunologic factors|mesh-ancestor
110172378|NCT00050674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110172379|NCT00050713|Sirolimus|sirolimus|mesh-list
110172380|NCT00050713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110172381|NCT00050713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110172382|NCT00050713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110172383|NCT00050713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110172384|NCT00050713|Antifungal Agents|antifungal agents|mesh-ancestor
110172385|NCT00050713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110172386|NCT00050713|Immunologic Factors|immunologic factors|mesh-ancestor
110172387|NCT00050713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110172388|NCT00050830|Canertinib dihydrochloride|canertinib dihydrochloride|mesh-list
110172389|NCT00050830|Anesthetics, Local|anesthetics, local|mesh-ancestor
110172390|NCT00050830|Anesthetics|anesthetics|mesh-ancestor
110172391|NCT00050830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110023558|NCT00003858|Sensory System Agents|sensory system agents|mesh-ancestor
110172392|NCT00050830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110192253|NCT00058890|Gabapentin|gabapentin|mesh-list
110172394|NCT00050830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110172395|NCT00050830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110172396|NCT00050830|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110172397|NCT00050830|Protective Agents|protective agents|mesh-ancestor
110172399|NCT00050947|Anticonvulsants|anticonvulsants|mesh-ancestor
110172400|NCT00050947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110172401|NCT00050947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110172402|NCT00050947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110172403|NCT00050947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110172404|NCT00050947|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110172405|NCT00050947|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110172408|NCT00051142|Latanoprost|latanoprost|mesh-list
110172409|NCT00051142|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110172410|NCT00051142|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110023753|NCT00003984|Lintuzumab|lintuzumab|mesh-list
110172411|NCT00051142|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110172413|NCT00051181|Latanoprost|latanoprost|mesh-list
110172414|NCT00051181|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110172415|NCT00051181|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110172416|NCT00051181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110172417|NCT00051259|Bupropion|bupropion|mesh-list
110023818|NCT00004062|Antimetabolites|antimetabolites|mesh-ancestor
110172418|NCT00051259|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110172419|NCT00051259|Antidepressive Agents|antidepressive agents|mesh-ancestor
110172420|NCT00051259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110172421|NCT00051259|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110172422|NCT00051259|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110172423|NCT00051259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110172424|NCT00051259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110172425|NCT00051259|Dopamine Agents|dopamine agents|mesh-ancestor
110172426|NCT00051259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110172427|NCT00051259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110172428|NCT00051259|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110172429|NCT00051259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110172430|NCT00051259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110172431|NCT05639777|Dexmedetomidine|dexmedetomidine|mesh-list
110172432|NCT05639777|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110172433|NCT05639777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110172434|NCT05639777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110023886|NCT00004110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110172436|NCT05639777|Analgesics|analgesics|mesh-ancestor
110172437|NCT05639777|Sensory System Agents|sensory system agents|mesh-ancestor
110172438|NCT05639777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110172439|NCT05639777|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110172440|NCT05639777|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110172441|NCT05639777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110172442|NCT05639777|Adrenergic Agents|adrenergic agents|mesh-ancestor
110172444|NCT05639777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110172445|NCT00051298|Olanzapine|olanzapine|mesh-list
110172446|NCT00051298|Antiemetics|antiemetics|mesh-ancestor
110172447|NCT00051298|Autonomic Agents|autonomic agents|mesh-ancestor
110172448|NCT00051298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110172449|NCT00051298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110172450|NCT00051298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110172451|NCT00051298|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110172452|NCT00051298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110024018|NCT00004206|Leucovorin|leucovorin|mesh-list
110192268|NCT00058929|Treprostinil|treprostinil|mesh-list
110172453|NCT00051298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110172454|NCT00051298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110172455|NCT00051298|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110172456|NCT00051298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110172457|NCT00051298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110172458|NCT00051298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110172459|NCT00051298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110172460|NCT00051298|Serotonin Agents|serotonin agents|mesh-ancestor
110172461|NCT00398008|Naltrexone|naltrexone|mesh-list
110172462|NCT00398008|Buprenorphine|buprenorphine|mesh-list
110172463|NCT00398008|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110172464|NCT00398008|Narcotics|narcotics|mesh-ancestor
110172465|NCT00398008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110024144|NCT00004266|Nifedipine|nifedipine|mesh-list
110172466|NCT00398008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110172467|NCT00398008|Analgesics|analgesics|mesh-ancestor
110172469|NCT00398008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110172470|NCT00398008|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110172471|NCT00398008|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110172472|NCT00051493|Carboplatin|carboplatin|mesh-list
110172473|NCT00051493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110172474|NCT00051532|Seocalcitol|seocalcitol|mesh-list
110172475|NCT00051532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110172476|NCT00051532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110172477|NCT00051532|Immunologic Factors|immunologic factors|mesh-ancestor
110172478|NCT00051532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110172479|NCT00051571|Docetaxel|docetaxel|mesh-list
110172480|NCT00051571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110172481|NCT00051571|Tubulin Modulators|tubulin modulators|mesh-ancestor
110172482|NCT00051571|Antimitotic Agents|antimitotic agents|mesh-ancestor
110172483|NCT00051571|Mitosis Modulators|mitosis modulators|mesh-ancestor
110172484|NCT00051571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110172485|NCT05573958|Aspirin|aspirin|mesh-list
110172486|NCT05573958|Rivaroxaban|rivaroxaban|mesh-list
110172487|NCT05573958|Clopidogrel|clopidogrel|mesh-list
110172488|NCT05573958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110172489|NCT05573958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110172490|NCT05573958|Analgesics|analgesics|mesh-ancestor
110172491|NCT05573958|Sensory System Agents|sensory system agents|mesh-ancestor
110172492|NCT05573958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110172493|NCT05573958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110172494|NCT05573958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110172495|NCT05573958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110172496|NCT05573958|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110172497|NCT05573958|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110172498|NCT05573958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110172499|NCT05573958|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110172500|NCT05573958|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110172501|NCT05573958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110172502|NCT05573958|Antipyretics|antipyretics|mesh-ancestor
110172503|NCT05573958|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110172504|NCT05573958|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110172505|NCT05573958|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110172506|NCT05573958|Purinergic Agents|purinergic agents|mesh-ancestor
110172507|NCT05573958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110172508|NCT05573958|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110172509|NCT05573958|Antithrombins|antithrombins|mesh-ancestor
110172510|NCT05573958|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110172511|NCT05573958|Protease Inhibitors|protease inhibitors|mesh-ancestor
110172512|NCT05573958|Anticoagulants|anticoagulants|mesh-ancestor
110172513|NCT00051688|Oxaliplatin|oxaliplatin|mesh-list
110172514|NCT00051688|Tezacitabine|tezacitabine|mesh-list
110172515|NCT00051688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110172516|NCT00051688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110172517|NCT00051688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110172518|NCT00051844|Capravirine|capravirine|mesh-list
110172519|NCT00051844|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110172520|NCT00051844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110172521|NCT00051844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110172522|NCT00051844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110172523|NCT00051844|Antiviral Agents|antiviral agents|mesh-ancestor
110172524|NCT00051844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110172525|NCT00051844|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110172526|NCT00051844|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110172527|NCT00052000|Antibodies|antibodies|mesh-list
110172528|NCT00052000|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110172529|NCT00052000|Immunologic Factors|immunologic factors|mesh-ancestor
110172530|NCT00052000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110172531|NCT00052039|Interferons|interferons|mesh-list
110172532|NCT00052039|Interferon-gamma|interferon-gamma|mesh-list
110172533|NCT00052039|Azathioprine|azathioprine|mesh-list
110172534|NCT00052039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110172535|NCT00052039|Antiviral Agents|antiviral agents|mesh-ancestor
110172536|NCT00052039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110172537|NCT00052039|Antimetabolites|antimetabolites|mesh-ancestor
110172538|NCT00052039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110172539|NCT00052039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110172540|NCT00052039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110172541|NCT00052039|Immunologic Factors|immunologic factors|mesh-ancestor
110172542|NCT00052039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110172543|NCT00052039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110172545|NCT00052117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110172546|NCT00052117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110172547|NCT00052117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110172548|NCT00052117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110172549|NCT00052117|Antiviral Agents|antiviral agents|mesh-ancestor
110172550|NCT00052117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110172551|NCT00052117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110172552|NCT00052117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110172554|NCT00052273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110172555|NCT00052273|Antimetabolites|antimetabolites|mesh-ancestor
110024678|NCT00005076|Cetuximab|cetuximab|mesh-list
110172556|NCT00052273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110172557|NCT00052273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110172559|NCT00052312|Doxorubicin|doxorubicin|mesh-list
110172560|NCT00052312|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110172561|NCT00052312|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110172562|NCT00052312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110172563|NCT00052312|Tubulin Modulators|tubulin modulators|mesh-ancestor
110172564|NCT00052312|Antimitotic Agents|antimitotic agents|mesh-ancestor
110172565|NCT00052312|Mitosis Modulators|mitosis modulators|mesh-ancestor
110172566|NCT00052312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110172567|NCT00052312|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110172568|NCT00052312|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110172569|NCT00052312|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110172570|NCT00052312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110172572|NCT00052351|Paclitaxel|paclitaxel|mesh-list
110172573|NCT00052351|Cyclophosphamide|cyclophosphamide|mesh-list
110172574|NCT00052351|Doxorubicin|doxorubicin|mesh-list
110172575|NCT00052351|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110172576|NCT00052351|Vaccines|vaccines|mesh-list
110172577|NCT00052351|Sargramostim|sargramostim|mesh-list
110172578|NCT00052351|Immunologic Factors|immunologic factors|mesh-ancestor
110172579|NCT00052351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110024725|NCT00005118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110172580|NCT00052351|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110172581|NCT00052351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110172582|NCT00052351|Tubulin Modulators|tubulin modulators|mesh-ancestor
110172583|NCT00052351|Antimitotic Agents|antimitotic agents|mesh-ancestor
110172584|NCT00052351|Mitosis Modulators|mitosis modulators|mesh-ancestor
110172585|NCT00052351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110172586|NCT00052351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110172587|NCT00052351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110172588|NCT00052351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110172589|NCT00052351|Alkylating Agents|alkylating agents|mesh-ancestor
110172590|NCT00052351|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110172591|NCT00052351|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110172592|NCT00052351|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110172593|NCT00052351|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110172594|NCT00052351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110172595|NCT00052351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110172596|NCT00052351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110172597|NCT00052351|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110172598|NCT00052351|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110172599|NCT00052390|Bevacizumab|bevacizumab|mesh-list
110172600|NCT00052390|Doxorubicin|doxorubicin|mesh-list
110172601|NCT00052390|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110172602|NCT00052390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110172603|NCT00052390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110172604|NCT00052390|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110172605|NCT00052390|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110172606|NCT00052390|Growth Substances|growth substances|mesh-ancestor
110172607|NCT00052390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110172608|NCT00052390|Growth Inhibitors|growth inhibitors|mesh-ancestor
110172609|NCT00052390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110172610|NCT00052390|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110172611|NCT00052390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110172612|NCT00052390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110172613|NCT00052390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110172614|NCT00052468|Paclitaxel|paclitaxel|mesh-list
110172615|NCT00052468|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110172616|NCT00052468|Carboplatin|carboplatin|mesh-list
110172617|NCT00052468|Gemcitabine|gemcitabine|mesh-list
110172618|NCT00052468|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110172619|NCT00052468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110172620|NCT00052468|Tubulin Modulators|tubulin modulators|mesh-ancestor
110172621|NCT00052468|Antimitotic Agents|antimitotic agents|mesh-ancestor
110172622|NCT00052468|Mitosis Modulators|mitosis modulators|mesh-ancestor
110172623|NCT00052468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110172624|NCT00052468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110172625|NCT00052468|Antimetabolites|antimetabolites|mesh-ancestor
110172626|NCT00052507|Bortezomib|bortezomib|mesh-list
110172627|NCT00052507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110172628|NCT00052585|Leucovorin|leucovorin|mesh-list
110172629|NCT00052585|Fluorouracil|fluorouracil|mesh-list
110172630|NCT00052585|Irinotecan|irinotecan|mesh-list
110172631|NCT00052585|Gefitinib|gefitinib|mesh-list
110172632|NCT00052585|Calcium|calcium|mesh-list
110172633|NCT00052585|Levoleucovorin|levoleucovorin|mesh-list
110172634|NCT00052585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110172635|NCT00052585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110172636|NCT00052585|Antimetabolites|antimetabolites|mesh-ancestor
110172637|NCT00052585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110172638|NCT00052585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110172639|NCT00052585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110172640|NCT00052585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110172641|NCT00052585|Immunologic Factors|immunologic factors|mesh-ancestor
110172642|NCT00052585|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110172643|NCT00052585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110172644|NCT00052585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110172645|NCT00052585|Antidotes|antidotes|mesh-ancestor
110172646|NCT00052585|Protective Agents|protective agents|mesh-ancestor
110172647|NCT00052585|Vitamin B Complex|vitamin b complex|mesh-ancestor
110172648|NCT00052585|Vitamins|vitamins|mesh-ancestor
110172649|NCT00052585|Micronutrients|micronutrients|mesh-ancestor
110172650|NCT00052585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110172651|NCT00052780|Temozolomide|temozolomide|mesh-list
110172652|NCT00052780|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
110172653|NCT00052780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110172654|NCT00052780|Alkylating Agents|alkylating agents|mesh-ancestor
110172655|NCT00052780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110172656|NCT00052780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110172657|NCT00052780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110172658|NCT00052936|Prednisone|prednisone|mesh-list
110172659|NCT00052936|Cyclophosphamide|cyclophosphamide|mesh-list
110172660|NCT00052936|Rituximab|rituximab|mesh-list
110172661|NCT00052936|Doxorubicin|doxorubicin|mesh-list
110172662|NCT00052936|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110172663|NCT00052936|Vincristine|vincristine|mesh-list
110172664|NCT00052936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110172665|NCT00052936|Immunologic Factors|immunologic factors|mesh-ancestor
110172666|NCT00052936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110172667|NCT00052936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110172668|NCT00052936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110172669|NCT00052936|Alkylating Agents|alkylating agents|mesh-ancestor
110172670|NCT00052936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110172671|NCT00052936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110172672|NCT00052936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110172673|NCT00052936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110172674|NCT00052936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110172675|NCT00052936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110172676|NCT00052936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110172677|NCT00052936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110172678|NCT00052936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110172679|NCT00052936|Glucocorticoids|glucocorticoids|mesh-ancestor
110172681|NCT00052936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110172682|NCT00052936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110172683|NCT00052936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110172684|NCT00052936|Tubulin Modulators|tubulin modulators|mesh-ancestor
110172685|NCT00052936|Antimitotic Agents|antimitotic agents|mesh-ancestor
110172686|NCT00052936|Mitosis Modulators|mitosis modulators|mesh-ancestor
110172687|NCT00053092|Cyclophosphamide|cyclophosphamide|mesh-list
110172690|NCT00053092|Fludarabine phosphate|fludarabine phosphate|mesh-list
110172691|NCT00053092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110172692|NCT00053092|Immunologic Factors|immunologic factors|mesh-ancestor
110172693|NCT00053092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110172694|NCT00053092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110172695|NCT00053092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110172696|NCT00053092|Alkylating Agents|alkylating agents|mesh-ancestor
110172697|NCT00053092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110172698|NCT00053092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110172699|NCT00053092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110172700|NCT00053092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110172701|NCT00053092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110172704|NCT00053131|Mitoxantrone|mitoxantrone|mesh-list
110172705|NCT00053131|Sargramostim|sargramostim|mesh-list
110172706|NCT00053131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110172707|NCT00053131|Antimetabolites|antimetabolites|mesh-ancestor
110172708|NCT00053131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110172709|NCT00053131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110172710|NCT00053131|Antiviral Agents|antiviral agents|mesh-ancestor
110172711|NCT00053131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110172712|NCT00053131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110172713|NCT00053131|Immunologic Factors|immunologic factors|mesh-ancestor
110172714|NCT00053131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110172715|NCT00053131|Analgesics|analgesics|mesh-ancestor
110172716|NCT00053131|Sensory System Agents|sensory system agents|mesh-ancestor
110172717|NCT00053131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110172718|NCT00053131|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110172719|NCT00053131|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110172720|NCT00053131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110172721|NCT00053248|Imatinib Mesylate|imatinib mesylate|mesh-list
110172722|NCT00053248|Arsenic Trioxide|arsenic trioxide|mesh-list
110172723|NCT00053248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110172724|NCT00053248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110172725|NCT00053248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110172726|NCT00053248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110172727|NCT00053287|Thalidomide|thalidomide|mesh-list
110172728|NCT00053287|Carboplatin|carboplatin|mesh-list
110172729|NCT00053287|Fludarabine|fludarabine|mesh-list
110172730|NCT00053287|Fludarabine phosphate|fludarabine phosphate|mesh-list
110172731|NCT00053287|Topotecan|topotecan|mesh-list
110172732|NCT00053287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110172733|NCT00053287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110172734|NCT00053287|Antimetabolites|antimetabolites|mesh-ancestor
110172735|NCT00053287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110172736|NCT00053287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110172737|NCT00053287|Immunologic Factors|immunologic factors|mesh-ancestor
110172738|NCT00053287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110172739|NCT00053287|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110172740|NCT00053287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110172741|NCT00053287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110172742|NCT00053287|Leprostatic Agents|leprostatic agents|mesh-ancestor
110172743|NCT00053287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110172744|NCT00053287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110172745|NCT00053287|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110172746|NCT00053287|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110172747|NCT00053287|Growth Substances|growth substances|mesh-ancestor
110172748|NCT00053287|Growth Inhibitors|growth inhibitors|mesh-ancestor
110172749|NCT00053326|Fenretinide|fenretinide|mesh-list
110172750|NCT00053326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110172751|NCT00053326|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110172752|NCT00053326|Protective Agents|protective agents|mesh-ancestor
110172753|NCT00053326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110172754|NCT00053560|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
110172755|NCT00053560|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110172756|NCT00053560|Immunologic Factors|immunologic factors|mesh-ancestor
110172757|NCT00053560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110172758|NCT00053599|Simvastatin|simvastatin|mesh-list
110172759|NCT00053599|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110172760|NCT00053599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110172761|NCT00053599|Antimetabolites|antimetabolites|mesh-ancestor
110172762|NCT00053599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110172764|NCT00053599|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110172765|NCT00053599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110172766|NCT00053638|Tenofovir|tenofovir|mesh-list
110172767|NCT00053638|Lamivudine|lamivudine|mesh-list
110172768|NCT00053638|Efavirenz|efavirenz|mesh-list
110172769|NCT00053638|Abacavir|abacavir|mesh-list
110172770|NCT00053638|Antiviral Agents|antiviral agents|mesh-ancestor
110172771|NCT00053638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110172772|NCT00053638|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110172773|NCT00053638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110172774|NCT00053638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110172775|NCT00053638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110172776|NCT00053638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110172777|NCT00053638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110172779|NCT00053638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110172780|NCT00053638|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110172781|NCT00053638|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110172782|NCT00053638|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110172783|NCT00053638|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110172785|NCT00053716|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110172786|NCT00053716|Vasodilator Agents|vasodilator agents|mesh-ancestor
110172787|NCT00053716|Urological Agents|urological agents|mesh-ancestor
110172788|NCT02970175|Terlipressin|terlipressin|mesh-list
110172789|NCT02970175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110172790|NCT02970175|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110172791|NCT00053833|Irinotecan|irinotecan|mesh-list
110172792|NCT00053833|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110172793|NCT00053833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110172794|NCT00053833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110172795|NCT00053833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110172796|NCT00053833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110172797|NCT00053872|Vincristine|vincristine|mesh-list
110172799|NCT00053872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110172800|NCT00053872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110172801|NCT00053872|Tubulin Modulators|tubulin modulators|mesh-ancestor
110172802|NCT00053872|Antimitotic Agents|antimitotic agents|mesh-ancestor
110172803|NCT00053872|Mitosis Modulators|mitosis modulators|mesh-ancestor
110172804|NCT00053872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110172805|NCT00053872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110172806|NCT00053872|Alkylating Agents|alkylating agents|mesh-ancestor
110172807|NCT00053911|Tamoxifen|tamoxifen|mesh-list
110172808|NCT00053911|Cyclophosphamide|cyclophosphamide|mesh-list
110172809|NCT00053911|Docetaxel|docetaxel|mesh-list
110172810|NCT00053911|Fluorouracil|fluorouracil|mesh-list
110172811|NCT00053911|Epirubicin|epirubicin|mesh-list
110172812|NCT00053911|Anastrozole|anastrozole|mesh-list
110172813|NCT00053911|Goserelin|goserelin|mesh-list
110172814|NCT00053911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110172815|NCT00053911|Immunologic Factors|immunologic factors|mesh-ancestor
110172816|NCT00053911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110172817|NCT00053911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110172818|NCT00053911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110172819|NCT00053911|Alkylating Agents|alkylating agents|mesh-ancestor
110172820|NCT00053911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110172821|NCT00053911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110172822|NCT00053911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110172823|NCT00053911|Tubulin Modulators|tubulin modulators|mesh-ancestor
110172824|NCT00053911|Antimitotic Agents|antimitotic agents|mesh-ancestor
110172825|NCT00053911|Mitosis Modulators|mitosis modulators|mesh-ancestor
110172826|NCT00053911|Antimetabolites|antimetabolites|mesh-ancestor
110172827|NCT00053911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110172828|NCT00053911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110172829|NCT00053911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110172830|NCT00053911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110172831|NCT00053911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110172832|NCT00053911|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110172833|NCT00053911|Hormone Antagonists|hormone antagonists|mesh-ancestor
110172834|NCT00053911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110172835|NCT00053911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110172836|NCT00053911|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110172837|NCT00053911|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110172838|NCT00053911|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110172839|NCT00053911|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110172840|NCT00053911|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110172841|NCT00053950|NSC 366140|nsc 366140|mesh-list
110172842|NCT00053950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110172843|NCT00054067|Cisplatin|cisplatin|mesh-list
110172844|NCT00054067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110172845|NCT00054184|Paclitaxel|paclitaxel|mesh-list
110172846|NCT00054184|Docetaxel|docetaxel|mesh-list
110172847|NCT00054184|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
110172848|NCT00054184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110172849|NCT00054184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110172850|NCT00054184|Tubulin Modulators|tubulin modulators|mesh-ancestor
110172851|NCT00054184|Antimitotic Agents|antimitotic agents|mesh-ancestor
110172852|NCT00054184|Mitosis Modulators|mitosis modulators|mesh-ancestor
110260194|NCT00145379|Metformin|metformin|mesh-list
110172853|NCT00054184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110172854|NCT00054340|Cyclosporine|cyclosporine|mesh-list
110172855|NCT00054340|Cyclophosphamide|cyclophosphamide|mesh-list
110172856|NCT00054340|Busulfan|busulfan|mesh-list
110172857|NCT00054340|Methotrexate|methotrexate|mesh-list
110172858|NCT00054340|Cyclosporins|cyclosporins|mesh-list
110172859|NCT00054340|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110172860|NCT00054340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110172861|NCT00054340|Immunologic Factors|immunologic factors|mesh-ancestor
110172862|NCT00054340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110172863|NCT00054340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110172864|NCT00054340|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110172865|NCT00054340|Alkylating Agents|alkylating agents|mesh-ancestor
110172866|NCT00054340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110172867|NCT00054340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110172868|NCT00054340|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110172869|NCT00054340|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110172870|NCT00054340|Abortifacient Agents|abortifacient agents|mesh-ancestor
110172871|NCT00054340|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110172872|NCT00054340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110172873|NCT00054340|Antimetabolites|antimetabolites|mesh-ancestor
110172874|NCT00054340|Dermatologic Agents|dermatologic agents|mesh-ancestor
110172875|NCT00054340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110172876|NCT00054340|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110172877|NCT00054340|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110172878|NCT00054340|Antifungal Agents|antifungal agents|mesh-ancestor
110172879|NCT00054340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110172880|NCT00054340|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110172882|NCT00054418|Risedronic Acid|risedronic acid|mesh-list
110172883|NCT00054418|Calcium Carbonate|calcium carbonate|mesh-list
110172884|NCT00054418|Calcium|calcium|mesh-list
110172885|NCT00054418|Vitamins|vitamins|mesh-ancestor
110172886|NCT00054418|Micronutrients|micronutrients|mesh-ancestor
110172887|NCT00054418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110172888|NCT00054418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110172889|NCT00054418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110172890|NCT00054418|Antacids|antacids|mesh-ancestor
110172891|NCT00054418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110172892|NCT00054418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110172893|NCT00054418|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110172894|NCT00054418|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110172895|NCT05560230|Clonidine|clonidine|mesh-list
110172896|NCT05560230|Analgesics|analgesics|mesh-ancestor
110172897|NCT05560230|Sensory System Agents|sensory system agents|mesh-ancestor
110172898|NCT05560230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110172899|NCT05560230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110172900|NCT05560230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110172901|NCT05560230|Sympatholytics|sympatholytics|mesh-ancestor
110172902|NCT05560230|Autonomic Agents|autonomic agents|mesh-ancestor
110172903|NCT05560230|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110172904|NCT05560230|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110172905|NCT05560230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110172906|NCT05560230|Adrenergic Agents|adrenergic agents|mesh-ancestor
110172907|NCT05560230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110172908|NCT05560230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110172909|NCT00054457|Docetaxel|docetaxel|mesh-list
110172910|NCT00054457|Capecitabine|capecitabine|mesh-list
110172911|NCT00054457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110024892|NCT00005802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110172912|NCT00054457|Tubulin Modulators|tubulin modulators|mesh-ancestor
110172913|NCT00054457|Antimitotic Agents|antimitotic agents|mesh-ancestor
110172914|NCT00054457|Mitosis Modulators|mitosis modulators|mesh-ancestor
110172915|NCT00054457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110172916|NCT00054457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110172917|NCT00054457|Antimetabolites|antimetabolites|mesh-ancestor
110172918|NCT00054496|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110172919|NCT00054496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110172920|NCT00054496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110172921|NCT00054496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110172922|NCT00054496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110172923|NCT00054535|Aldesleukin|aldesleukin|mesh-list
110172924|NCT00054535|Vaccines|vaccines|mesh-list
110192546|NCT00032396|Glucocorticoids|glucocorticoids|mesh-ancestor
110172925|NCT00054535|Immunologic Factors|immunologic factors|mesh-ancestor
110260195|NCT00145379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110172926|NCT00054535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110172927|NCT00054535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110172928|NCT00054535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110172929|NCT00054535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110172931|NCT00054535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110172932|NCT00054574|Panitumumab|panitumumab|mesh-list
110172933|NCT00054574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110172934|NCT00054574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110172935|NCT00054613|Methoxsalen|methoxsalen|mesh-list
110172936|NCT00054613|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110172937|NCT00054613|Dermatologic Agents|dermatologic agents|mesh-ancestor
110172938|NCT00054808|Gallium nitrate|gallium nitrate|mesh-list
110172939|NCT00054808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110172940|NCT00054808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110172941|NCT00054808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110172942|NCT00054886|Sunitinib|sunitinib|mesh-list
110172943|NCT00054886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110172944|NCT00054886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110172945|NCT00054886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110172946|NCT00054886|Growth Substances|growth substances|mesh-ancestor
110172947|NCT00054886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110172948|NCT00054886|Growth Inhibitors|growth inhibitors|mesh-ancestor
110172949|NCT00054886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110172950|NCT00054886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110172951|NCT00054886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110172952|NCT02970097|Fentanyl|fentanyl|mesh-list
110172953|NCT02970097|Midazolam|midazolam|mesh-list
110172954|NCT02970097|Ropivacaine|ropivacaine|mesh-list
110172955|NCT02970097|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110172956|NCT02970097|Narcotics|narcotics|mesh-ancestor
110172957|NCT02970097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110172958|NCT02970097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110172959|NCT02970097|Analgesics|analgesics|mesh-ancestor
110172960|NCT02970097|Sensory System Agents|sensory system agents|mesh-ancestor
110172961|NCT02970097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110172962|NCT02970097|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110172963|NCT02970097|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110172965|NCT02970097|Anesthetics|anesthetics|mesh-ancestor
110172966|NCT02970097|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110172967|NCT02970097|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110172968|NCT02970097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110172969|NCT02970097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110172970|NCT02970097|GABA Modulators|gaba modulators|mesh-ancestor
110172971|NCT02970097|GABA Agents|gaba agents|mesh-ancestor
110172972|NCT02970097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110172973|NCT02970097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110172974|NCT02970097|Anesthetics, Local|anesthetics, local|mesh-ancestor
110172975|NCT00398281|Dutasteride|dutasteride|mesh-list
110172976|NCT00398281|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110172977|NCT00398281|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110172978|NCT00398281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110172979|NCT00398281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110172980|NCT00398281|Hormone Antagonists|hormone antagonists|mesh-ancestor
110172981|NCT00398281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110172982|NCT00398281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110172984|NCT00055042|Vitamins|vitamins|mesh-ancestor
110172985|NCT00055042|Micronutrients|micronutrients|mesh-ancestor
110172986|NCT00055042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110172987|NCT00055042|Antioxidants|antioxidants|mesh-ancestor
110172988|NCT00055042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110172989|NCT00055042|Protective Agents|protective agents|mesh-ancestor
110172990|NCT00055120|Ritonavir|ritonavir|mesh-list
110172991|NCT00055120|Lopinavir|lopinavir|mesh-list
110172992|NCT00055120|Tenofovir|tenofovir|mesh-list
110172993|NCT00055120|Emtricitabine|emtricitabine|mesh-list
110172994|NCT00055120|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110172996|NCT00055120|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110172997|NCT00055120|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110172998|NCT00055120|Protease Inhibitors|protease inhibitors|mesh-ancestor
110172999|NCT00055120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110173000|NCT00055120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173001|NCT00055120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110173002|NCT00055120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110173003|NCT00055120|Antiviral Agents|antiviral agents|mesh-ancestor
110173004|NCT00055120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110173005|NCT00055120|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110173006|NCT00055120|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110025349|NCT00363090|Alkylating Agents|alkylating agents|mesh-ancestor
110173007|NCT00055120|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110173008|NCT00055120|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110173009|NCT00055120|Antimetabolites|antimetabolites|mesh-ancestor
110173010|NCT00055159|Plasminogen|plasminogen|mesh-list
110173011|NCT00055159|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110173012|NCT00055159|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110173013|NCT00055159|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110025419|NCT00365040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110173014|NCT00055159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173015|NCT00055198|Daptomycin|daptomycin|mesh-list
110173016|NCT00055198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110173017|NCT00055198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110173018|NCT05525325|Anesthetics|anesthetics|mesh-list
110173019|NCT05525325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110173020|NCT05525325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110173021|NCT00055393|Bupropion|bupropion|mesh-list
110025485|NCT00367068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110173022|NCT00055393|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110173023|NCT00055393|Antidepressive Agents|antidepressive agents|mesh-ancestor
110173024|NCT00055393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110173025|NCT00055393|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110192603|NCT00060411|Antimetabolites|antimetabolites|mesh-ancestor
110173026|NCT00055393|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110173027|NCT00055393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110173028|NCT00055393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173029|NCT00055393|Dopamine Agents|dopamine agents|mesh-ancestor
110173031|NCT00055393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110173032|NCT00055393|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110173033|NCT00055393|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110173034|NCT00055393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110173035|NCT00055432|Gemcitabine|gemcitabine|mesh-list
110173036|NCT00055432|Pemetrexed|pemetrexed|mesh-list
110173037|NCT00055432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110173038|NCT00055432|Antimetabolites|antimetabolites|mesh-ancestor
110173039|NCT00055432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110025686|NCT00371124|Mydriatics|mydriatics|mesh-ancestor
110173040|NCT00055432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110173041|NCT00055432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110173042|NCT00055432|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110173043|NCT00055432|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110173045|NCT00055549|Dextromethorphan|dextromethorphan|mesh-list
110173046|NCT00055549|Antitussive Agents|antitussive agents|mesh-ancestor
110173047|NCT00055549|Respiratory System Agents|respiratory system agents|mesh-ancestor
110173048|NCT00055549|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110173049|NCT00055549|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110173050|NCT00055549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110173051|NCT00055549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110025829|NCT00376584|Niacin|niacin|mesh-list
110173052|NCT00055549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110173053|NCT00055549|Anticonvulsants|anticonvulsants|mesh-ancestor
110173054|NCT00055549|Antiemetics|antiemetics|mesh-ancestor
110173055|NCT00055549|Autonomic Agents|autonomic agents|mesh-ancestor
110173056|NCT00055549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110173057|NCT00055549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110173058|NCT00055549|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110173059|NCT00055549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110173060|NCT00055549|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110173061|NCT00055549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110173062|NCT00055549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110173063|NCT00055549|GABA Modulators|gaba modulators|mesh-ancestor
110173064|NCT00055549|GABA Agents|gaba agents|mesh-ancestor
110173066|NCT00055666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110173068|NCT00055666|Hormones|hormones|mesh-ancestor
110173069|NCT00055666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110173070|NCT00055666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026028|NCT00381654|MP 412|mp 412|mesh-list
110173071|NCT00055666|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110173072|NCT00055666|Respiratory System Agents|respiratory system agents|mesh-ancestor
110173073|NCT00055822|Leucovorin|leucovorin|mesh-list
110173074|NCT00055822|Fluorouracil|fluorouracil|mesh-list
110173075|NCT00055822|Oxaliplatin|oxaliplatin|mesh-list
110173076|NCT00055822|Oblimersen|oblimersen|mesh-list
110173077|NCT00055822|Calcium|calcium|mesh-list
110173078|NCT00055822|Levoleucovorin|levoleucovorin|mesh-list
110173079|NCT00055822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110173080|NCT00055822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110173081|NCT00055822|Antimetabolites|antimetabolites|mesh-ancestor
110173082|NCT00055822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173083|NCT00055822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110173084|NCT00055822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110173085|NCT00055822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110173086|NCT00055822|Immunologic Factors|immunologic factors|mesh-ancestor
110173087|NCT00055822|Antidotes|antidotes|mesh-ancestor
110173088|NCT00055822|Protective Agents|protective agents|mesh-ancestor
110173089|NCT00055822|Vitamin B Complex|vitamin b complex|mesh-ancestor
110173090|NCT00055822|Vitamins|vitamins|mesh-ancestor
110173091|NCT00055822|Micronutrients|micronutrients|mesh-ancestor
110173092|NCT00055861|Bevacizumab|bevacizumab|mesh-list
110173093|NCT00055861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110173095|NCT00055861|Antibodies|antibodies|mesh-list
110173096|NCT00055861|Immunoglobulins|immunoglobulins|mesh-list
110173097|NCT00055861|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110173098|NCT00055861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110173099|NCT00055861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110173100|NCT00055861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110173101|NCT00055861|Growth Substances|growth substances|mesh-ancestor
110173102|NCT00055861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110173103|NCT00055861|Growth Inhibitors|growth inhibitors|mesh-ancestor
110173104|NCT00055861|Immunologic Factors|immunologic factors|mesh-ancestor
110173105|NCT00055861|Tubulin Modulators|tubulin modulators|mesh-ancestor
110173106|NCT00055861|Antimitotic Agents|antimitotic agents|mesh-ancestor
110173107|NCT00055861|Mitosis Modulators|mitosis modulators|mesh-ancestor
110173108|NCT00055861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173109|NCT00392106|Amiodarone|amiodarone|mesh-list
110173110|NCT00392106|Flecainide|flecainide|mesh-list
110173111|NCT00392106|Propafenone|propafenone|mesh-list
110173112|NCT00392106|Dofetilide|dofetilide|mesh-list
110173113|NCT00392106|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110173114|NCT00392106|Vasodilator Agents|vasodilator agents|mesh-ancestor
110173115|NCT00392106|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110173116|NCT00392106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110173117|NCT00392106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173118|NCT00392106|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110173119|NCT00392106|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110026505|NCT02999958|Antiviral Agents|antiviral agents|mesh-ancestor
110173120|NCT00392106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110173121|NCT00392106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110173122|NCT00392106|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110173123|NCT00392106|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110173124|NCT00392106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110173125|NCT00392106|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110173127|NCT00055939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110173128|NCT00055939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110026646|NCT01273506|Tapentadol|tapentadol|mesh-list
110173130|NCT00055939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173131|NCT00055939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110173132|NCT00055978|Celecoxib|celecoxib|mesh-list
110173133|NCT00055978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110173136|NCT00055978|Sensory System Agents|sensory system agents|mesh-ancestor
110173137|NCT00055978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110173138|NCT00055978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110173139|NCT00055978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110173140|NCT00055978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110026794|NCT01275144|GABA Agents|gaba agents|mesh-ancestor
110173141|NCT00055978|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110173142|NCT00055978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110173143|NCT00055978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110192621|NCT00060450|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110173144|NCT00055978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173145|NCT00056056|Bexarotene|bexarotene|mesh-list
110173146|NCT00056056|Methoxsalen|methoxsalen|mesh-list
110173147|NCT00056056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110173148|NCT00056056|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110173149|NCT00056056|Dermatologic Agents|dermatologic agents|mesh-ancestor
110173150|NCT00056095|Cyclosporine|cyclosporine|mesh-list
110173151|NCT00056095|Cyclophosphamide|cyclophosphamide|mesh-list
110173152|NCT00056095|Fludarabine|fludarabine|mesh-list
110173153|NCT00056095|Fludarabine phosphate|fludarabine phosphate|mesh-list
110173154|NCT00056095|Cyclosporins|cyclosporins|mesh-list
110173155|NCT00056095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110173156|NCT00056095|Immunologic Factors|immunologic factors|mesh-ancestor
110173157|NCT00056095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110173158|NCT00056095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110173159|NCT00056095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110173160|NCT00056095|Alkylating Agents|alkylating agents|mesh-ancestor
110173161|NCT00056095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173162|NCT00056095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110173163|NCT00056095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110173164|NCT00056095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110173165|NCT00056095|Antimetabolites|antimetabolites|mesh-ancestor
110173166|NCT00056095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110173167|NCT00056095|Antifungal Agents|antifungal agents|mesh-ancestor
110173168|NCT00056095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110173169|NCT00056095|Dermatologic Agents|dermatologic agents|mesh-ancestor
110173170|NCT00056095|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110173171|NCT00056329|Vitamin E|vitamin e|mesh-list
110173172|NCT00056329|Tocopherols|tocopherols|mesh-list
110173173|NCT00056329|Vitamins|vitamins|mesh-ancestor
110173174|NCT00056329|Micronutrients|micronutrients|mesh-ancestor
110173175|NCT00056329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110173176|NCT00056329|Antioxidants|antioxidants|mesh-ancestor
110173177|NCT00056329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173178|NCT00056329|Protective Agents|protective agents|mesh-ancestor
110173179|NCT00056368|Fluconazole|fluconazole|mesh-list
110173180|NCT00056368|Anidulafungin|anidulafungin|mesh-list
110173181|NCT00056368|Antifungal Agents|antifungal agents|mesh-ancestor
110173182|NCT00056368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110173183|NCT00056368|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110173184|NCT00056368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110173185|NCT00056368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110173186|NCT00056368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173187|NCT00056368|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110173188|NCT00056368|Hormone Antagonists|hormone antagonists|mesh-ancestor
110173189|NCT00056368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110173190|NCT00056368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110173191|NCT00056368|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110173192|NCT00056368|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110173193|NCT00056446|Vatalanib|vatalanib|mesh-list
110173194|NCT00056446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110173195|NCT00056446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110173196|NCT00056446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173197|NCT00056641|Ritonavir|ritonavir|mesh-list
110173198|NCT00056641|Lopinavir|lopinavir|mesh-list
110173199|NCT00056641|Saquinavir|saquinavir|mesh-list
110173200|NCT00056641|Amprenavir|amprenavir|mesh-list
110173201|NCT00056641|Tipranavir|tipranavir|mesh-list
110173202|NCT00056641|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110173203|NCT00056641|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110173204|NCT00056641|Protease Inhibitors|protease inhibitors|mesh-ancestor
110173205|NCT00056641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110173206|NCT00056641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173207|NCT00056641|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110173208|NCT00056641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110173209|NCT00056641|Antiviral Agents|antiviral agents|mesh-ancestor
110173210|NCT00056641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110173211|NCT00056641|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110173212|NCT00056641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110173214|NCT00056641|Antitubercular Agents|antitubercular agents|mesh-ancestor
110173215|NCT00056641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110173216|NCT00398437|Trastuzumab|trastuzumab|mesh-list
110173217|NCT00398437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110173218|NCT00398437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110173219|NCT05433675|Macitentan|macitentan|mesh-list
110173220|NCT05433675|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
110173221|NCT05433675|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110173222|NCT05433675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173223|NCT05433675|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
110173224|NCT00423709|Fludarabine|fludarabine|mesh-list
110173225|NCT00423709|Melphalan|melphalan|mesh-list
110026859|NCT01278498|Escitalopram|escitalopram|mesh-list
110173226|NCT00423709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110173227|NCT00423709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173228|NCT00423709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110173229|NCT00423709|Immunologic Factors|immunologic factors|mesh-ancestor
110173230|NCT00423709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110173231|NCT00423709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110026919|NCT00247416|Dexamethasone|dexamethasone|mesh-list
110173232|NCT00423709|Alkylating Agents|alkylating agents|mesh-ancestor
110173233|NCT00423709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110173235|NCT00056797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110173236|NCT00056797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110173237|NCT00056797|Analgesics|analgesics|mesh-ancestor
110173238|NCT00056797|Sensory System Agents|sensory system agents|mesh-ancestor
110173239|NCT00056797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110026992|NCT03804840|Hormones|hormones|mesh-ancestor
110173240|NCT00056797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110173241|NCT00056836|Ranibizumab|ranibizumab|mesh-list
110173242|NCT00056836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110173243|NCT00056836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110173244|NCT00056836|Growth Substances|growth substances|mesh-ancestor
110173245|NCT00056836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027053|NCT04581408|Ivacaftor|ivacaftor|mesh-list
110173247|NCT00056836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110173248|NCT05495321|Aldesleukin|aldesleukin|mesh-list
110173249|NCT05495321|Interleukin-2|interleukin-2|mesh-list
110173250|NCT05495321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110173251|NCT05495321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110173252|NCT05495321|Analgesics|analgesics|mesh-ancestor
110027121|NCT01622322|Anesthetics, General|anesthetics, general|mesh-ancestor
110173254|NCT05495321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110173255|NCT05495321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110173256|NCT05495321|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110173257|NCT05495321|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110173258|NCT05495321|Antiviral Agents|antiviral agents|mesh-ancestor
110173259|NCT05495321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110173260|NCT00056875|Mitogens|mitogens|mesh-list
110173261|NCT00056875|Mitosis Modulators|mitosis modulators|mesh-ancestor
110173262|NCT00056875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173263|NCT05410197|Gemcitabine|gemcitabine|mesh-list
110173264|NCT05410197|Lenvatinib|lenvatinib|mesh-list
110173265|NCT05410197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110173266|NCT05410197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110173267|NCT05410197|Antimetabolites|antimetabolites|mesh-ancestor
110173268|NCT05410197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173269|NCT05410197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110173270|NCT05410197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110173271|NCT03262454|Atezolizumab|atezolizumab|mesh-list
110173272|NCT03262454|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110173273|NCT03262454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173274|NCT03262454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110173275|NCT03262454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110173276|NCT00057031|Calcitriol|calcitriol|mesh-list
110173277|NCT00057031|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110173278|NCT00057031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110173279|NCT00057031|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110173280|NCT00057031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110173281|NCT00057031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173282|NCT00057031|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110173283|NCT00057031|Vitamins|vitamins|mesh-ancestor
110173284|NCT00057031|Micronutrients|micronutrients|mesh-ancestor
110173285|NCT00057031|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110173286|NCT02969980|Cyclophosphamide|cyclophosphamide|mesh-list
110173287|NCT02969980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110173288|NCT02969980|Immunologic Factors|immunologic factors|mesh-ancestor
110173289|NCT02969980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110173290|NCT02969980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110173291|NCT02969980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110173292|NCT02969980|Alkylating Agents|alkylating agents|mesh-ancestor
110173293|NCT02969980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173294|NCT02969980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110173295|NCT02969980|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110173296|NCT00057265|Lamivudine|lamivudine|mesh-list
110173297|NCT00057265|Telbivudine|telbivudine|mesh-list
110173298|NCT00057265|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110173299|NCT00057265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110173300|NCT00057265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110173301|NCT00057265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173302|NCT00057265|Antiviral Agents|antiviral agents|mesh-ancestor
110173303|NCT00057265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110173304|NCT00057265|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110173305|NCT00057265|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110173306|NCT00057343|Rituximab|rituximab|mesh-list
110173307|NCT00057343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110173308|NCT00057343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110173309|NCT00057343|Immunologic Factors|immunologic factors|mesh-ancestor
110173310|NCT00057343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110173312|NCT00057382|Doxorubicin|doxorubicin|mesh-list
110173313|NCT00057382|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110173314|NCT00057382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110173315|NCT00057382|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110173316|NCT00057382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110173318|NCT00057382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173319|NCT00057421|Prednisolone|prednisolone|mesh-list
110173320|NCT00057421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110173322|NCT00057421|Hormones|hormones|mesh-ancestor
110173323|NCT00057421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110173324|NCT00057421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110173325|NCT00057421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110173326|NCT00057421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110173327|NCT00057616|Lenalidomide|lenalidomide|mesh-list
110173328|NCT00057616|Immunologic Factors|immunologic factors|mesh-ancestor
110173329|NCT00057616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110173330|NCT00057616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110173331|NCT00057616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110173332|NCT00057616|Growth Substances|growth substances|mesh-ancestor
110173333|NCT00057616|Growth Inhibitors|growth inhibitors|mesh-ancestor
110173334|NCT00057616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110173335|NCT02969746|Charcoal|charcoal|mesh-list
110027717|NCT01724268|Hormones|hormones|mesh-ancestor
110173336|NCT02969746|Antidotes|antidotes|mesh-ancestor
110173337|NCT02969746|Protective Agents|protective agents|mesh-ancestor
110173338|NCT02969746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110173340|NCT00057850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110173341|NCT00057889|Ipilimumab|ipilimumab|mesh-list
110173342|NCT00057889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110173343|NCT00057889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110173344|NCT00057889|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110173345|NCT00057889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173346|NCT00057928|Paclitaxel|paclitaxel|mesh-list
110173347|NCT00057928|Gemcitabine|gemcitabine|mesh-list
110173348|NCT00057928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110173349|NCT00057928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110173350|NCT00057928|Tubulin Modulators|tubulin modulators|mesh-ancestor
110173351|NCT00057928|Antimitotic Agents|antimitotic agents|mesh-ancestor
110173352|NCT00057928|Mitosis Modulators|mitosis modulators|mesh-ancestor
110173353|NCT00057928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173354|NCT00057928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110173355|NCT00057928|Antimetabolites|antimetabolites|mesh-ancestor
110173356|NCT05309304|Cefazolin|cefazolin|mesh-list
110173357|NCT05309304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110173358|NCT05309304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110173359|NCT00057967|Alemtuzumab|alemtuzumab|mesh-list
110173360|NCT00057967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110173361|NCT00057967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110173362|NCT00058006|Celecoxib|celecoxib|mesh-list
110173363|NCT00058006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110173364|NCT00058006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110173365|NCT00058006|Analgesics|analgesics|mesh-ancestor
110173366|NCT00058006|Sensory System Agents|sensory system agents|mesh-ancestor
110173367|NCT00058006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110173368|NCT00058006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110173369|NCT00058006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110173370|NCT00058006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110173371|NCT00058006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110173372|NCT00058006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110173373|NCT00058006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110173374|NCT00058006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173375|NCT00058045|Aldesleukin|aldesleukin|mesh-list
110173376|NCT00058045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110173377|NCT00058045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110173378|NCT00058045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110173379|NCT00058045|Antiviral Agents|antiviral agents|mesh-ancestor
110173380|NCT00058045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110173381|NCT00058084|Prednisone|prednisone|mesh-list
110173382|NCT00058084|Mitoxantrone|mitoxantrone|mesh-list
110173383|NCT00058084|Epothilone B|epothilone b|mesh-list
110173384|NCT00058084|Epothilones|epothilones|mesh-list
110173385|NCT00058084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110028180|NCT02241564|Sirolimus|sirolimus|mesh-list
110173386|NCT00058084|Glucocorticoids|glucocorticoids|mesh-ancestor
110173387|NCT00058084|Hormones|hormones|mesh-ancestor
110173388|NCT00058084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110173389|NCT00058084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110173390|NCT00058084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110173391|NCT00058084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110173392|NCT00058084|Analgesics|analgesics|mesh-ancestor
110173393|NCT00058084|Sensory System Agents|sensory system agents|mesh-ancestor
110173394|NCT00058084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110173395|NCT00058084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110173396|NCT00058084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110173397|NCT00058084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110173398|NCT00058084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173399|NCT00058084|Tubulin Modulators|tubulin modulators|mesh-ancestor
110173400|NCT00058084|Antimitotic Agents|antimitotic agents|mesh-ancestor
110173401|NCT00058084|Mitosis Modulators|mitosis modulators|mesh-ancestor
110173402|NCT02969629|Apomorphine|apomorphine|mesh-list
110173403|NCT02969629|Emetics|emetics|mesh-ancestor
110173404|NCT02969629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110173405|NCT02969629|Autonomic Agents|autonomic agents|mesh-ancestor
110028391|NCT02247414|Antipyretics|antipyretics|mesh-ancestor
110173406|NCT02969629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110173407|NCT02969629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110173408|NCT02969629|Dopamine Agonists|dopamine agonists|mesh-ancestor
110173409|NCT02969629|Dopamine Agents|dopamine agents|mesh-ancestor
110173410|NCT02969629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110028452|NCT02248896|Antihypertensive Agents|antihypertensive agents|mesh-list
110173411|NCT02969629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173412|NCT00058201|Leucovorin|leucovorin|mesh-list
110173413|NCT00058201|Gemcitabine|gemcitabine|mesh-list
110173414|NCT00058201|Fluorouracil|fluorouracil|mesh-list
110173415|NCT00058201|Calcium|calcium|mesh-list
110173416|NCT00058201|Levoleucovorin|levoleucovorin|mesh-list
110173417|NCT00058201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110173418|NCT00058201|Antimetabolites|antimetabolites|mesh-ancestor
110173419|NCT00058201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173420|NCT00058201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110173421|NCT00058201|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110173422|NCT00058201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110173423|NCT00058201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110173424|NCT00058201|Immunologic Factors|immunologic factors|mesh-ancestor
110173425|NCT00058201|Antidotes|antidotes|mesh-ancestor
110173426|NCT00058201|Protective Agents|protective agents|mesh-ancestor
110173427|NCT00058201|Vitamin B Complex|vitamin b complex|mesh-ancestor
110173428|NCT00058201|Vitamins|vitamins|mesh-ancestor
110173429|NCT00058201|Micronutrients|micronutrients|mesh-ancestor
110173431|NCT00058279|Ipilimumab|ipilimumab|mesh-list
110173432|NCT00058279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110173433|NCT00058279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110173434|NCT00058279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110173435|NCT00058279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173436|NCT00058279|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110173437|NCT00058279|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110173438|NCT00058279|Antiviral Agents|antiviral agents|mesh-ancestor
110173439|NCT00058279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110173440|NCT00058318|Gemcitabine|gemcitabine|mesh-list
110173441|NCT00058318|Capecitabine|capecitabine|mesh-list
110173442|NCT00058318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110173443|NCT00058318|Antimetabolites|antimetabolites|mesh-ancestor
110173444|NCT00058318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173445|NCT00058318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110173446|NCT00058357|Lidocaine|lidocaine|mesh-list
110173447|NCT00058357|Anesthetics, Local|anesthetics, local|mesh-ancestor
110173449|NCT00058357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110173451|NCT00058357|Sensory System Agents|sensory system agents|mesh-ancestor
110173452|NCT00058357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110173453|NCT00058357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110173454|NCT00058357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110173455|NCT00058357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110173456|NCT00058357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110173457|NCT00058357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173458|NCT00058435|Abagovomab|abagovomab|mesh-list
110173459|NCT00058435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110173460|NCT00058435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110173462|NCT00058474|Capecitabine|capecitabine|mesh-list
110173463|NCT00058474|Oxaliplatin|oxaliplatin|mesh-list
110173464|NCT00058474|Antimetabolites|antimetabolites|mesh-ancestor
110173465|NCT00058474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173466|NCT00058474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110173467|NCT00058474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110173468|NCT00058474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110173469|NCT00058474|Immunologic Factors|immunologic factors|mesh-ancestor
110173470|NCT00058474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110173471|NCT00392262|Amlodipine|amlodipine|mesh-list
110173472|NCT00392262|Valsartan|valsartan|mesh-list
110173473|NCT00392262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110173474|NCT00392262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110173475|NCT00392262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110173476|NCT00392262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173477|NCT00392262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110173478|NCT00392262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110173479|NCT00392262|Vasodilator Agents|vasodilator agents|mesh-ancestor
110173480|NCT00392262|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110029056|NCT05767255|Incretins|incretins|mesh-ancestor
110173481|NCT00392262|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110173482|NCT00058747|Imatinib Mesylate|imatinib mesylate|mesh-list
110173483|NCT00058747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110173484|NCT00058747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110173485|NCT00058747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110173486|NCT00058747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173488|NCT00058903|Antidepressive Agents|antidepressive agents|mesh-ancestor
110173489|NCT00058903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110173490|NCT00058903|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110173491|NCT00058903|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110173492|NCT00058903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110173493|NCT00058903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173494|NCT00058903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110173495|NCT00058903|Serotonin Agents|serotonin agents|mesh-ancestor
110173496|NCT00058903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110173500|NCT02969473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110173501|NCT02969473|Tubulin Modulators|tubulin modulators|mesh-ancestor
110173503|NCT02969473|Mitosis Modulators|mitosis modulators|mesh-ancestor
110173504|NCT02969473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173505|NCT02969473|Antimetabolites|antimetabolites|mesh-ancestor
110173506|NCT02969473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110173507|NCT02969473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110173508|NCT02969473|Immunologic Factors|immunologic factors|mesh-ancestor
110173509|NCT02969473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110173510|NCT00059254|Palmitic Acid|palmitic acid|mesh-list
110173511|NCT00059254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110029475|NCT04612920|Antipyretics|antipyretics|mesh-ancestor
110173512|NCT00059254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173513|NCT01349907|Asenapine|asenapine|mesh-list
110173514|NCT01349907|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110173515|NCT01349907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110173516|NCT01349907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110173517|NCT01349907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110173518|NCT01349907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110173520|NCT02969278|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110173521|NCT02969278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173522|NCT05223582|Prednisone|prednisone|mesh-list
110173523|NCT05223582|Abiraterone Acetate|abiraterone acetate|mesh-list
110173524|NCT05223582|Fluzoparib|fluzoparib|mesh-list
110173525|NCT05223582|Androgens|androgens|mesh-list
110173526|NCT05223582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110173527|NCT05223582|Glucocorticoids|glucocorticoids|mesh-ancestor
110173528|NCT05223582|Hormones|hormones|mesh-ancestor
110173529|NCT05223582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110173530|NCT05223582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110173531|NCT05223582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110173532|NCT05223582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110173533|NCT05223582|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110173534|NCT05223582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110173535|NCT05223582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173536|NCT05223582|Hormone Antagonists|hormone antagonists|mesh-ancestor
110173537|NCT05223582|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110173538|NCT05223582|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110173539|NCT00059722|Gefitinib|gefitinib|mesh-list
110173540|NCT00059722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110173541|NCT00059722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110173542|NCT00059722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110173543|NCT00059722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173544|NCT02969239|Phenylephrine|phenylephrine|mesh-list
110173545|NCT02969239|Oxymetazoline|oxymetazoline|mesh-list
110173546|NCT02969239|Norepinephrine|norepinephrine|mesh-list
110173547|NCT02969239|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
110173548|NCT02969239|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110173549|NCT02969239|Mydriatics|mydriatics|mesh-ancestor
110173550|NCT02969239|Autonomic Agents|autonomic agents|mesh-ancestor
110173551|NCT02969239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110029828|NCT03227458|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
110029829|NCT03227458|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110029830|NCT03227458|Immunologic Factors|immunologic factors|mesh-ancestor
110029831|NCT03227458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029832|NCT03141983|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110029833|NCT03141983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110029837|NCT03030131|Durvalumab|durvalumab|mesh-list
110173552|NCT02969239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110173553|NCT02969239|Sympathomimetics|sympathomimetics|mesh-ancestor
110173554|NCT02969239|Nasal Decongestants|nasal decongestants|mesh-ancestor
110173555|NCT02969239|Respiratory System Agents|respiratory system agents|mesh-ancestor
110173556|NCT02969239|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110173557|NCT02969239|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110173558|NCT02969239|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110173559|NCT02969239|Adrenergic Agents|adrenergic agents|mesh-ancestor
110173560|NCT02969239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110173561|NCT02969239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173562|NCT02969239|Protective Agents|protective agents|mesh-ancestor
110173563|NCT00059761|Irinotecan|irinotecan|mesh-list
110173564|NCT00059761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110173565|NCT00059761|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110173566|NCT00059761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110173567|NCT00059761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110173568|NCT00059761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173569|NCT00059800|Boron|boron|mesh-list
110173570|NCT00059800|Trace Elements|trace elements|mesh-ancestor
110173571|NCT00059800|Micronutrients|micronutrients|mesh-ancestor
110173572|NCT00059800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110173573|NCT03216083|Tranexamic Acid|tranexamic acid|mesh-list
110173574|NCT03216083|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110173575|NCT03216083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110173576|NCT03216083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173577|NCT03216083|Hemostatics|hemostatics|mesh-ancestor
110173578|NCT03216083|Coagulants|coagulants|mesh-ancestor
110173579|NCT00059878|Interferons|interferons|mesh-list
110173580|NCT00059878|Interferon-gamma|interferon-gamma|mesh-list
110173581|NCT00059878|Voriconazole|voriconazole|mesh-list
110173582|NCT00059878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110173583|NCT00059878|Antiviral Agents|antiviral agents|mesh-ancestor
110173584|NCT00059878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110173585|NCT00059878|Antifungal Agents|antifungal agents|mesh-ancestor
110173586|NCT00059878|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110173587|NCT00059878|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110173588|NCT00059878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110173589|NCT00059878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173590|NCT00059878|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110173591|NCT00059878|Hormone Antagonists|hormone antagonists|mesh-ancestor
110030170|NCT01683084|Telmisartan|telmisartan|mesh-list
110173592|NCT00059878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110173593|NCT00059878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110173594|NCT00059878|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110173595|NCT00059917|Camptothecin|camptothecin|mesh-list
110173596|NCT00059917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110173597|NCT00059917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110173598|NCT00059917|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110173599|NCT00059917|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110173600|NCT00059917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110173601|NCT00059917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173602|NCT00060112|Gemcitabine|gemcitabine|mesh-list
110173603|NCT00060112|Oblimersen|oblimersen|mesh-list
110173604|NCT00060112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110173605|NCT00060112|Antimetabolites|antimetabolites|mesh-ancestor
110030228|NCT01384643|Anesthetics|anesthetics|mesh-ancestor
110173606|NCT00060112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173607|NCT00060112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110173608|NCT00060307|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110173609|NCT00060307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110173610|NCT00060307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110173611|NCT00060307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110173612|NCT00060307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173614|NCT02968927|Cholecalciferol|cholecalciferol|mesh-list
110173615|NCT02968927|Rifabutin|rifabutin|mesh-list
110173616|NCT02968927|Everolimus|everolimus|mesh-list
110173617|NCT02968927|Auranofin|auranofin|mesh-list
110173618|NCT02968927|CC-11050|cc-11050|mesh-list
110173619|NCT02968927|Vitamins|vitamins|mesh-ancestor
110173620|NCT02968927|Micronutrients|micronutrients|mesh-ancestor
110173621|NCT02968927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110173622|NCT02968927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110173623|NCT02968927|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110173624|NCT02968927|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110173625|NCT02968927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110192800|NCT00033254|Growth Inhibitors|growth inhibitors|mesh-ancestor
110173626|NCT02968927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173628|NCT02968927|Immunologic Factors|immunologic factors|mesh-ancestor
110173629|NCT02968927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110173630|NCT02968927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110173631|NCT02968927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110173632|NCT02968927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110173633|NCT02968927|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110173634|NCT02968927|Antitubercular Agents|antitubercular agents|mesh-ancestor
110173635|NCT02968927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110173636|NCT02968927|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110173637|NCT02968927|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110173638|NCT00398515|Sirolimus|sirolimus|mesh-list
110173639|NCT00398515|Lenalidomide|lenalidomide|mesh-list
110173640|NCT00398515|Temsirolimus|temsirolimus|mesh-list
110173641|NCT00398515|MTOR Inhibitors|mtor inhibitors|mesh-list
110173642|NCT00398515|Immunologic Factors|immunologic factors|mesh-ancestor
110173643|NCT00398515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110173644|NCT00398515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110173645|NCT00398515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110173646|NCT00398515|Growth Substances|growth substances|mesh-ancestor
110173647|NCT00398515|Growth Inhibitors|growth inhibitors|mesh-ancestor
110173648|NCT00398515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110173649|NCT00398515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110173650|NCT00398515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110173651|NCT00398515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173652|NCT00398515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110173653|NCT00398515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110173654|NCT00398515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110173655|NCT00398515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110173656|NCT00398515|Antifungal Agents|antifungal agents|mesh-ancestor
110030467|NCT01386398|Bortezomib|bortezomib|mesh-list
110173658|NCT05105685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110173659|NCT05105685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110173660|NCT05325164|Morphine|morphine|mesh-list
110173661|NCT05325164|Methadone|methadone|mesh-list
110173662|NCT05325164|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110173663|NCT05325164|Narcotics|narcotics|mesh-ancestor
110173664|NCT05325164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110173665|NCT05325164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110173666|NCT05325164|Analgesics|analgesics|mesh-ancestor
110173667|NCT05325164|Sensory System Agents|sensory system agents|mesh-ancestor
110173668|NCT05325164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110173669|NCT05325164|Antitussive Agents|antitussive agents|mesh-ancestor
110173670|NCT05325164|Respiratory System Agents|respiratory system agents|mesh-ancestor
110173671|NCT00060385|Prednisone|prednisone|mesh-list
110173672|NCT00060385|Cyclophosphamide|cyclophosphamide|mesh-list
110173673|NCT00060385|Doxorubicin|doxorubicin|mesh-list
110173674|NCT00060385|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110173675|NCT00060385|Etoposide|etoposide|mesh-list
110173676|NCT00060385|Vincristine|vincristine|mesh-list
110173677|NCT00060385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110173678|NCT00060385|Immunologic Factors|immunologic factors|mesh-ancestor
110173679|NCT00060385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110173680|NCT00060385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110173681|NCT00060385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110173682|NCT00060385|Alkylating Agents|alkylating agents|mesh-ancestor
110192822|NCT00033332|Glucocorticoids|glucocorticoids|mesh-ancestor
110173683|NCT00060385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173684|NCT00060385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110173685|NCT00060385|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110173686|NCT00060385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110173687|NCT00060385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110173688|NCT00060385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110173689|NCT00060385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110173690|NCT00060385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110173691|NCT00060385|Glucocorticoids|glucocorticoids|mesh-ancestor
110173693|NCT00060385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110173694|NCT00060385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110173695|NCT00060385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110173696|NCT00060385|Tubulin Modulators|tubulin modulators|mesh-ancestor
110173697|NCT00060385|Antimitotic Agents|antimitotic agents|mesh-ancestor
110173698|NCT00060385|Mitosis Modulators|mitosis modulators|mesh-ancestor
110030722|NCT01388075|Rifampin|rifampin|mesh-list
110173699|NCT00060463|Contraceptive Agents|contraceptive agents|mesh-list
110173700|NCT00060463|Contraceptives, Postcoital|contraceptives, postcoital|mesh-list
110173701|NCT00060463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110173702|NCT00060463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110030786|NCT01388517|Micronutrients|micronutrients|mesh-ancestor
110173703|NCT00060463|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110173704|NCT02968693|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110173705|NCT02968693|Vancomycin|vancomycin|mesh-list
110173706|NCT02968693|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110173707|NCT02968693|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
110173708|NCT02968693|Calcium|calcium|mesh-list
110173709|NCT02968693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110173710|NCT02968693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110173711|NCT02968693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110173712|NCT02968693|Antitubercular Agents|antitubercular agents|mesh-ancestor
110173713|NCT02968693|Vasodilator Agents|vasodilator agents|mesh-ancestor
110173714|NCT02968693|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110173715|NCT02968693|Protective Agents|protective agents|mesh-ancestor
110173717|NCT00060502|Gemcitabine|gemcitabine|mesh-list
110173718|NCT00060502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110173719|NCT00060502|Antimetabolites|antimetabolites|mesh-ancestor
110173720|NCT00060502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173721|NCT00060502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110173722|NCT00060502|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110173723|NCT00060502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110173724|NCT00060502|Dermatologic Agents|dermatologic agents|mesh-ancestor
110173725|NCT00060502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110173726|NCT00060502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110173729|NCT05312372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110173730|NCT05312372|Tubulin Modulators|tubulin modulators|mesh-ancestor
110173731|NCT05312372|Antimitotic Agents|antimitotic agents|mesh-ancestor
110173732|NCT05312372|Mitosis Modulators|mitosis modulators|mesh-ancestor
110173733|NCT05312372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173735|NCT05038410|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110173736|NCT05038410|Immunologic Factors|immunologic factors|mesh-ancestor
110173737|NCT05038410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110173738|NCT05030493|Bevacizumab|bevacizumab|mesh-list
110173739|NCT05030493|Panitumumab|panitumumab|mesh-list
110173740|NCT05030493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110173741|NCT05030493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110173742|NCT05030493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110173743|NCT05030493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110173744|NCT05030493|Growth Substances|growth substances|mesh-ancestor
110173745|NCT05030493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110173746|NCT05030493|Growth Inhibitors|growth inhibitors|mesh-ancestor
110173747|NCT02968498|Methamphetamine|methamphetamine|mesh-list
110173748|NCT02968498|Lactulose|lactulose|mesh-list
110173749|NCT02968498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110173750|NCT02968498|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110173751|NCT02968498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110173752|NCT02968498|Sympathomimetics|sympathomimetics|mesh-ancestor
110173753|NCT02968498|Autonomic Agents|autonomic agents|mesh-ancestor
110173754|NCT02968498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110173755|NCT02968498|Dopamine Agents|dopamine agents|mesh-ancestor
110173756|NCT02968498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110173757|NCT02968498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173758|NCT02968498|Adrenergic Agents|adrenergic agents|mesh-ancestor
110173759|NCT02968498|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110173760|NCT02968498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110173761|NCT02968498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110173762|NCT02968498|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110173764|NCT00060931|Carvedilol|carvedilol|mesh-list
110173765|NCT00060931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110173766|NCT00060931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110173767|NCT00060931|Sympatholytics|sympatholytics|mesh-ancestor
110173768|NCT00060931|Autonomic Agents|autonomic agents|mesh-ancestor
110173769|NCT00060931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110173770|NCT00060931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110173771|NCT00060931|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110173772|NCT00060931|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110173773|NCT00060931|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110173774|NCT00060931|Adrenergic Agents|adrenergic agents|mesh-ancestor
110173775|NCT00060931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110173776|NCT00060931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173777|NCT00060931|Antioxidants|antioxidants|mesh-ancestor
110173778|NCT00060931|Protective Agents|protective agents|mesh-ancestor
110173779|NCT00060931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110173780|NCT00060931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110173781|NCT00060931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110031691|NCT01393574|Dopamine Agents|dopamine agents|mesh-ancestor
110173782|NCT00060931|Vasodilator Agents|vasodilator agents|mesh-ancestor
110173783|NCT00060931|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110173784|NCT00060931|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110173785|NCT00061087|Methylphenidate|methylphenidate|mesh-list
110173786|NCT00061087|Bupropion|bupropion|mesh-list
110173787|NCT00061087|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110192856|NCT00061113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110173788|NCT00061087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110173789|NCT00061087|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110173790|NCT00061087|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110173791|NCT00061087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110173792|NCT00061087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173793|NCT00061087|Dopamine Agents|dopamine agents|mesh-ancestor
110173794|NCT00061087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110173795|NCT00061087|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110173796|NCT00061087|Antidepressive Agents|antidepressive agents|mesh-ancestor
110173797|NCT00061087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110173798|NCT00061087|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110173799|NCT00061087|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110173800|NCT00061087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110173802|NCT00061243|Immunologic Factors|immunologic factors|mesh-ancestor
110173803|NCT00061243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110173804|NCT04711564|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
110173805|NCT04711564|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
110173806|NCT04711564|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110173807|NCT04711564|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110173809|NCT00061321|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110173810|NCT00061321|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110173811|NCT00061321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110173812|NCT00061321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173813|NCT00061321|Antiviral Agents|antiviral agents|mesh-ancestor
110173814|NCT00061321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110173815|NCT00061321|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110173816|NCT00061321|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110173817|NCT00061321|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110173818|NCT00061321|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110173821|NCT00061360|Cyclosporins|cyclosporins|mesh-list
110173822|NCT00061360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110173823|NCT00061360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173824|NCT00061360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110173825|NCT00061360|Immunologic Factors|immunologic factors|mesh-ancestor
110173826|NCT00061360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110173828|NCT00061360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110173829|NCT00061360|Dermatologic Agents|dermatologic agents|mesh-ancestor
110173830|NCT00061360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110173831|NCT00061360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110173832|NCT00061360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110032083|NCT01395654|Isoniazid|isoniazid|mesh-list
110173833|NCT00061360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110173834|NCT00061360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110173836|NCT00061438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110173837|NCT00061438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110173838|NCT00061477|Gemcitabine|gemcitabine|mesh-list
110173839|NCT00061477|Pemetrexed|pemetrexed|mesh-list
110032152|NCT01395862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110173840|NCT00061477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110173841|NCT00061477|Antimetabolites|antimetabolites|mesh-ancestor
110173842|NCT00061477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173843|NCT00061477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110173844|NCT00061477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110173845|NCT00061477|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110173846|NCT00061477|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110173847|NCT02968342|Progesterone|progesterone|mesh-list
110173848|NCT02968342|Progestins|progestins|mesh-ancestor
110173849|NCT02968342|Hormones|hormones|mesh-ancestor
110173850|NCT02968342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110173851|NCT02968342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110173852|NCT02968303|Vemurafenib|vemurafenib|mesh-list
110173853|NCT02968303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110173854|NCT02968303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110173855|NCT02968303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110173856|NCT02968303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173858|NCT00061516|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110173859|NCT00061516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110173860|NCT00061516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173861|NCT00061594|Ranibizumab|ranibizumab|mesh-list
110173862|NCT00061594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110173863|NCT00061594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110173864|NCT00061594|Growth Substances|growth substances|mesh-ancestor
110173865|NCT00061594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110173866|NCT00061594|Growth Inhibitors|growth inhibitors|mesh-ancestor
110173867|NCT00061594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110173868|NCT00061711|Hormones|hormones|mesh-list
110173869|NCT00061711|Phytoestrogens|phytoestrogens|mesh-list
110173870|NCT00061711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110173871|NCT00061711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110173872|NCT00061711|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110032584|NCT02094716|Permethrin|permethrin|mesh-list
110173874|NCT00061750|Deferasirox|deferasirox|mesh-list
110173875|NCT00061750|Deferoxamine|deferoxamine|mesh-list
110173876|NCT00061750|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110173877|NCT00061750|Chelating Agents|chelating agents|mesh-ancestor
110173878|NCT00061750|Sequestering Agents|sequestering agents|mesh-ancestor
110173879|NCT00061750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173880|NCT00061750|Siderophores|siderophores|mesh-ancestor
110173881|NCT00061789|Acetylcholine|acetylcholine|mesh-list
110173882|NCT00061789|Vasodilator Agents|vasodilator agents|mesh-ancestor
110173883|NCT00061789|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110173884|NCT00061789|Cholinergic Agents|cholinergic agents|mesh-ancestor
110173885|NCT00061789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110173886|NCT00061789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173887|NCT00061789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110173888|NCT00061867|Doxorubicin|doxorubicin|mesh-list
110173889|NCT00061867|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110173890|NCT00061867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110173891|NCT00061867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110032770|NCT05271058|Hormones|hormones|mesh-ancestor
110173892|NCT00061867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110173893|NCT00061867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110173894|NCT00061867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110037655|NCT01419847|Antifungal Agents|antifungal agents|mesh-ancestor
110173895|NCT00061867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173896|NCT00061906|Celecoxib|celecoxib|mesh-list
110173897|NCT00061906|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110173898|NCT00061906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110173899|NCT00061906|Analgesics|analgesics|mesh-ancestor
110173900|NCT00061906|Sensory System Agents|sensory system agents|mesh-ancestor
110173901|NCT00061906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110192968|NCT00061503|Travoprost|travoprost|mesh-list
110173902|NCT00061906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110173903|NCT00061906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110173904|NCT00061906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110173905|NCT00061906|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110173906|NCT00061906|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110173907|NCT00061906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110173908|NCT00061906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173910|NCT00398554|Prednisone|prednisone|mesh-list
110173911|NCT00398554|Cyclophosphamide|cyclophosphamide|mesh-list
110173912|NCT00398554|Doxorubicin|doxorubicin|mesh-list
110173913|NCT00398554|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110173914|NCT00398554|Etoposide|etoposide|mesh-list
110173915|NCT00398554|Vincristine|vincristine|mesh-list
110173916|NCT00398554|Vinblastine|vinblastine|mesh-list
110173917|NCT00398554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110173918|NCT00398554|Immunologic Factors|immunologic factors|mesh-ancestor
110173919|NCT00398554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110173920|NCT00398554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110173921|NCT00398554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110173922|NCT00398554|Alkylating Agents|alkylating agents|mesh-ancestor
110173923|NCT00398554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173924|NCT00398554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110173925|NCT00398554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110173926|NCT00398554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110173927|NCT00398554|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110173928|NCT00398554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110173929|NCT00398554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110173930|NCT00398554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110173931|NCT00398554|Glucocorticoids|glucocorticoids|mesh-ancestor
110173933|NCT00398554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110173934|NCT00398554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110173935|NCT00398554|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110173936|NCT00398554|Tubulin Modulators|tubulin modulators|mesh-ancestor
110032983|NCT05088928|Apixaban|apixaban|mesh-list
110173937|NCT00398554|Antimitotic Agents|antimitotic agents|mesh-ancestor
110173938|NCT00398554|Mitosis Modulators|mitosis modulators|mesh-ancestor
110173940|NCT04917900|Trastuzumab|trastuzumab|mesh-list
110173941|NCT04917900|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110173942|NCT04917900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110173943|NCT04917900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110173944|NCT04917900|Tubulin Modulators|tubulin modulators|mesh-ancestor
110173945|NCT04917900|Antimitotic Agents|antimitotic agents|mesh-ancestor
110173946|NCT04917900|Mitosis Modulators|mitosis modulators|mesh-ancestor
110173947|NCT04917900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173948|NCT04917900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110173949|NCT05219435|Nivolumab|nivolumab|mesh-list
110173950|NCT05219435|Ipilimumab|ipilimumab|mesh-list
110173951|NCT05219435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110173952|NCT05219435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110173953|NCT05219435|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110173954|NCT05219435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173955|NCT00061984|Doxorubicin|doxorubicin|mesh-list
110173956|NCT00061984|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110173957|NCT00061984|Ifosfamide|ifosfamide|mesh-list
110173958|NCT00061984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110173959|NCT00061984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110173960|NCT00061984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110173961|NCT00061984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110173962|NCT00061984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110173963|NCT00061984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173964|NCT00061984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110173965|NCT00061984|Alkylating Agents|alkylating agents|mesh-ancestor
110173966|NCT00062023|Aspirin|aspirin|mesh-list
110173967|NCT00062023|Sulindac|sulindac|mesh-list
110173968|NCT00062023|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
110173969|NCT00062023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110173970|NCT00062023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110173971|NCT00062023|Analgesics|analgesics|mesh-ancestor
110173972|NCT00062023|Sensory System Agents|sensory system agents|mesh-ancestor
110173973|NCT00062023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110033150|NCT04783376|Insulin|insulin|mesh-list
110173974|NCT00062023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110173976|NCT00062023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110173977|NCT00062023|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110173978|NCT00062023|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110173979|NCT00062023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173980|NCT00062023|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110173981|NCT00062023|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110173982|NCT00062023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110173983|NCT00062023|Antipyretics|antipyretics|mesh-ancestor
110173984|NCT00062023|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110173985|NCT00062023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110173986|NCT00062023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110173987|NCT00062062|Paclitaxel|paclitaxel|mesh-list
110173988|NCT00062062|Carboplatin|carboplatin|mesh-list
110173989|NCT00062062|Gefitinib|gefitinib|mesh-list
110173990|NCT00062062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110173991|NCT00062062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110173992|NCT00062062|Tubulin Modulators|tubulin modulators|mesh-ancestor
110173993|NCT00062062|Antimitotic Agents|antimitotic agents|mesh-ancestor
110173994|NCT00062062|Mitosis Modulators|mitosis modulators|mesh-ancestor
110173995|NCT00062062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173996|NCT00062062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110173997|NCT00062062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110173999|NCT00392340|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110174000|NCT00392340|Vincristine|vincristine|mesh-list
110174001|NCT00392340|Topotecan|topotecan|mesh-list
110174002|NCT00392340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110174003|NCT00392340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110174004|NCT00392340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110174005|NCT00392340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110174006|NCT00392340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110174007|NCT00392340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110174008|NCT00392340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110174009|NCT00392340|Tubulin Modulators|tubulin modulators|mesh-ancestor
110174010|NCT00392340|Antimitotic Agents|antimitotic agents|mesh-ancestor
110174011|NCT00392340|Mitosis Modulators|mitosis modulators|mesh-ancestor
110174012|NCT00392340|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110174014|NCT00062101|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110174015|NCT00062101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110174016|NCT00062101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110174017|NCT00062101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110174018|NCT00062101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110174019|NCT00062101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110174020|NCT00062101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110174021|NCT00062101|Analgesics|analgesics|mesh-ancestor
110174022|NCT00062101|Sensory System Agents|sensory system agents|mesh-ancestor
110174023|NCT00062101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110174024|NCT00062101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174025|NCT00062101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110174026|NCT00062101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110174027|NCT00062101|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110174028|NCT00062101|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110174029|NCT00062140|Cyclophosphamide|cyclophosphamide|mesh-list
110174030|NCT00062140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110174031|NCT00062140|Immunologic Factors|immunologic factors|mesh-ancestor
110174032|NCT00062140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174033|NCT00062140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110033611|NCT03055390|Scopolamine|scopolamine|mesh-list
110174034|NCT00062140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110174035|NCT00062140|Alkylating Agents|alkylating agents|mesh-ancestor
110174036|NCT00062140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193066|NCT00034502|Irinotecan|irinotecan|mesh-list
110174037|NCT00062140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110174038|NCT00062140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110174041|NCT00062179|Carboplatin|carboplatin|mesh-list
110174042|NCT00062179|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110174043|NCT00062179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110174044|NCT00062179|Tubulin Modulators|tubulin modulators|mesh-ancestor
110174045|NCT00062179|Antimitotic Agents|antimitotic agents|mesh-ancestor
110174046|NCT00062179|Mitosis Modulators|mitosis modulators|mesh-ancestor
110174047|NCT00062179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110174048|NCT00062179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110174049|NCT00062179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110174050|NCT00062179|Analgesics|analgesics|mesh-ancestor
110174051|NCT00062179|Sensory System Agents|sensory system agents|mesh-ancestor
110174052|NCT00062179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110174053|NCT00062179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174054|NCT00062179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110174055|NCT00062179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110174056|NCT00062179|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110174057|NCT00062179|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110174058|NCT00062179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110174059|NCT00062257|Irofulven|irofulven|mesh-list
110174060|NCT00062257|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110174061|NCT00062257|Alkylating Agents|alkylating agents|mesh-ancestor
110174062|NCT00062257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110174063|NCT00062257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110174065|NCT00062296|Epirubicin|epirubicin|mesh-list
110174066|NCT00062296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110174067|NCT00062296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110174068|NCT00062296|Immunologic Factors|immunologic factors|mesh-ancestor
110174069|NCT00062296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174070|NCT00062296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110174071|NCT00062296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110174072|NCT00062296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110174073|NCT00062296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110174074|NCT00062296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110174075|NCT00062296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110174076|NCT05183984|Bevacizumab|bevacizumab|mesh-list
110174077|NCT05183984|Niraparib|niraparib|mesh-list
110174078|NCT05183984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110174079|NCT05183984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110174080|NCT05183984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110174081|NCT05183984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110174082|NCT05183984|Growth Substances|growth substances|mesh-ancestor
110174083|NCT05183984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174084|NCT05183984|Growth Inhibitors|growth inhibitors|mesh-ancestor
110174085|NCT05183984|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110174086|NCT05183984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110174087|NCT05183984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110174088|NCT02967874|Hyaluronic Acid|hyaluronic acid|mesh-list
110174089|NCT02967874|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110174090|NCT02967874|Immunologic Factors|immunologic factors|mesh-ancestor
110174091|NCT02967874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174092|NCT02967874|Viscosupplements|viscosupplements|mesh-ancestor
110174093|NCT02967874|Protective Agents|protective agents|mesh-ancestor
110174095|NCT04733625|Cholecalciferol|cholecalciferol|mesh-list
110174096|NCT04733625|Vitamins|vitamins|mesh-ancestor
110174097|NCT04733625|Micronutrients|micronutrients|mesh-ancestor
110174098|NCT04733625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174099|NCT04733625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110174100|NCT04733625|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110174101|NCT00062686|Lapatinib|lapatinib|mesh-list
110174102|NCT00062686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110174103|NCT00062686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110174104|NCT00062686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110174105|NCT00062686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110174106|NCT00062803|Heparin|heparin|mesh-list
110174107|NCT00062803|Warfarin|warfarin|mesh-list
110174108|NCT00062803|Acenocoumarol|acenocoumarol|mesh-list
110174109|NCT00062803|Anticoagulants|anticoagulants|mesh-ancestor
110174110|NCT00062803|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110174111|NCT00062803|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110174112|NCT00062803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110174113|NCT00062842|Irinotecan|irinotecan|mesh-list
110174114|NCT00062842|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110174115|NCT00062842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110174116|NCT00062842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110174117|NCT00062842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110174118|NCT00062842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110174119|NCT00062881|Mafosfamide|mafosfamide|mesh-list
110174120|NCT00062881|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110174121|NCT00062881|Immunologic Factors|immunologic factors|mesh-ancestor
110174122|NCT00062881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174123|NCT00062881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110174124|NCT00389909|Doxapram|doxapram|mesh-list
110174125|NCT00389909|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110174126|NCT00389909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174127|NCT00389909|Respiratory System Agents|respiratory system agents|mesh-ancestor
110174129|NCT00063076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110174130|NCT00063193|Minocycline|minocycline|mesh-list
110174131|NCT00063193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110174132|NCT00063193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110174133|NCT00063310|Leuprolide|leuprolide|mesh-list
110174134|NCT00063310|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110174135|NCT00063310|Fertility Agents|fertility agents|mesh-ancestor
110174136|NCT00063310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110174137|NCT00063310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174138|NCT00063310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110174139|NCT00063310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110174140|NCT00063388|Cetuximab|cetuximab|mesh-list
110174141|NCT00063388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110174142|NCT00063388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110174143|NCT00063583|Pirfenidone|pirfenidone|mesh-list
110174144|NCT00063583|Analgesics|analgesics|mesh-ancestor
110174145|NCT00063583|Sensory System Agents|sensory system agents|mesh-ancestor
110174146|NCT00063583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110174147|NCT00063583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174148|NCT00063583|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110174149|NCT00063583|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110174150|NCT00063583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110033847|NCT02578368|Antidotes|antidotes|mesh-ancestor
110174151|NCT00063583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110174152|NCT00063583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110174153|NCT00063895|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110174154|NCT00063895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110174155|NCT00063895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110174156|NCT00063895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110174157|NCT00063895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110174158|NCT00064012|Docetaxel|docetaxel|mesh-list
110174159|NCT00064012|Bortezomib|bortezomib|mesh-list
110174160|NCT00064012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110174161|NCT00064012|Tubulin Modulators|tubulin modulators|mesh-ancestor
110174162|NCT00064012|Antimitotic Agents|antimitotic agents|mesh-ancestor
110174163|NCT00064012|Mitosis Modulators|mitosis modulators|mesh-ancestor
110174164|NCT00064012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110174165|NCT00064051|Gemcitabine|gemcitabine|mesh-list
110174166|NCT00064051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110174167|NCT00064051|Antimetabolites|antimetabolites|mesh-ancestor
110174168|NCT00064051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110174169|NCT00064051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110174170|NCT02967172|Epinephrine|epinephrine|mesh-list
110174171|NCT02967172|Morphine|morphine|mesh-list
110174172|NCT02967172|Ropivacaine|ropivacaine|mesh-list
110174173|NCT02967172|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110174174|NCT02967172|Narcotics|narcotics|mesh-ancestor
110174175|NCT02967172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110174176|NCT02967172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174177|NCT02967172|Analgesics|analgesics|mesh-ancestor
110174178|NCT02967172|Sensory System Agents|sensory system agents|mesh-ancestor
110174179|NCT02967172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110174180|NCT02967172|Anesthetics, Local|anesthetics, local|mesh-ancestor
110174181|NCT02967172|Anesthetics|anesthetics|mesh-ancestor
110174182|NCT02967172|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110174183|NCT02967172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110174184|NCT02967172|Adrenergic Agents|adrenergic agents|mesh-ancestor
110174185|NCT02967172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110174186|NCT02967172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110174187|NCT02967172|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110174188|NCT02967172|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110174189|NCT02967172|Autonomic Agents|autonomic agents|mesh-ancestor
110174190|NCT02967172|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110174191|NCT02967172|Respiratory System Agents|respiratory system agents|mesh-ancestor
110174192|NCT02967172|Mydriatics|mydriatics|mesh-ancestor
110174193|NCT02967172|Sympathomimetics|sympathomimetics|mesh-ancestor
110174194|NCT02967172|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110174195|NCT00064090|Cytarabine|cytarabine|mesh-list
110174196|NCT00064090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110174197|NCT00064090|Antimetabolites|antimetabolites|mesh-ancestor
110174198|NCT00064090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110174199|NCT00064090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110174200|NCT00064090|Antiviral Agents|antiviral agents|mesh-ancestor
110174201|NCT00064090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110174202|NCT00064090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110174203|NCT00064090|Immunologic Factors|immunologic factors|mesh-ancestor
110174204|NCT00064090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174206|NCT05141357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110174207|NCT05141357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110174208|NCT05141357|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110174209|NCT05141357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110174211|NCT00064129|Sargramostim|sargramostim|mesh-list
110174212|NCT00064129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110174213|NCT00064129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110174214|NCT00064129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110174215|NCT00064129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110174216|NCT00064129|Immunologic Factors|immunologic factors|mesh-ancestor
110174217|NCT00064129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174218|NCT00064207|Gemcitabine|gemcitabine|mesh-list
110174219|NCT00064207|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110174220|NCT00064207|Antimetabolites|antimetabolites|mesh-ancestor
110174221|NCT00064207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110174222|NCT00064207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110174223|NCT00064246|Rituximab|rituximab|mesh-list
110174224|NCT00064246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110174225|NCT00064246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110174226|NCT00064246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110174227|NCT00064246|Immunologic Factors|immunologic factors|mesh-ancestor
110174228|NCT00064246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174229|NCT00064246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110174230|NCT00064285|Imatinib Mesylate|imatinib mesylate|mesh-list
110174231|NCT00064285|Alvocidib|alvocidib|mesh-list
110174232|NCT00064285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110174233|NCT00064285|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110174234|NCT00064285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110174235|NCT00064285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110174236|NCT00064285|Growth Inhibitors|growth inhibitors|mesh-ancestor
110174237|NCT00064285|Growth Substances|growth substances|mesh-ancestor
110174238|NCT00064285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174239|NCT00392418|Micronutrients|micronutrients|mesh-list
110174240|NCT00392418|Trace Elements|trace elements|mesh-list
110174241|NCT00392418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174242|NCT05126147|Hydroxychloroquine|hydroxychloroquine|mesh-list
110174243|NCT05126147|Antimalarials|antimalarials|mesh-ancestor
110174244|NCT05126147|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110174245|NCT05126147|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110174246|NCT05126147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110174247|NCT05126147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110174248|NCT05126147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110174249|NCT05126147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110174250|NCT00064402|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110174251|NCT00064402|Formoterol Fumarate|formoterol fumarate|mesh-list
110174252|NCT00064402|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110174253|NCT00064402|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110174254|NCT00064402|Autonomic Agents|autonomic agents|mesh-ancestor
110174255|NCT00064402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110174256|NCT00064402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174257|NCT00064402|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110174258|NCT00064402|Respiratory System Agents|respiratory system agents|mesh-ancestor
110033957|NCT02195986|Estradiol|estradiol|mesh-list
110174259|NCT00064402|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110174260|NCT00064402|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110174261|NCT00064402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110174262|NCT00064402|Adrenergic Agents|adrenergic agents|mesh-ancestor
110174263|NCT00064402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110174264|NCT00064402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110174265|NCT00423748|Ambrisentan|ambrisentan|mesh-list
110174266|NCT00423748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110174267|NCT02967211|Insulin|insulin|mesh-list
110174268|NCT02967211|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110375502|NCT00583193|Dopamine Agents|dopamine agents|mesh-ancestor
110375503|NCT01133821|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110375504|NCT01133821|Antidepressive Agents|antidepressive agents|mesh-ancestor
110375505|NCT01133821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110375506|NCT01133821|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110375507|NCT01133821|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110375508|NCT01133821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110375509|NCT01133821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375510|NCT00583271|Ethanol|ethanol|mesh-list
110375511|NCT00583271|Triamcinolone|triamcinolone|mesh-list
110375512|NCT00583271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110375513|NCT00583271|Glucocorticoids|glucocorticoids|mesh-ancestor
110375514|NCT00583271|Hormones|hormones|mesh-ancestor
110375515|NCT00583271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110375516|NCT00583271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375517|NCT00583271|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110375518|NCT00583271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110375519|NCT00583271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110375520|NCT00583349|Paclitaxel|paclitaxel|mesh-list
110375521|NCT00583349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110375522|NCT00583349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110375523|NCT00583349|Tubulin Modulators|tubulin modulators|mesh-ancestor
110375524|NCT00583349|Antimitotic Agents|antimitotic agents|mesh-ancestor
110375525|NCT00583349|Mitosis Modulators|mitosis modulators|mesh-ancestor
110375526|NCT00583349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110375527|NCT01133665|Lenalidomide|lenalidomide|mesh-list
110375528|NCT01133665|Cetuximab|cetuximab|mesh-list
110375529|NCT01133665|Immunologic Factors|immunologic factors|mesh-ancestor
110375530|NCT01133665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375531|NCT01133665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110375532|NCT01133665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110375533|NCT01133665|Growth Substances|growth substances|mesh-ancestor
110375534|NCT01133665|Growth Inhibitors|growth inhibitors|mesh-ancestor
110375535|NCT01133665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110375536|NCT01133665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110375537|NCT00583427|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
110375539|NCT00583427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110375540|NCT00583427|Antimetabolites|antimetabolites|mesh-ancestor
110375541|NCT00583427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110375542|NCT00583427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110375543|NCT00583427|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110375544|NCT00583427|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110375545|NCT00583427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110375546|NCT00583427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375547|NCT01133626|Prednisone|prednisone|mesh-list
110375548|NCT01133626|Beclomethasone|beclomethasone|mesh-list
110375549|NCT01133626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110375550|NCT01133626|Glucocorticoids|glucocorticoids|mesh-ancestor
110375551|NCT01133626|Hormones|hormones|mesh-ancestor
110375552|NCT01133626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110375553|NCT01133626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375554|NCT01133626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110375555|NCT01133626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110375556|NCT01133626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110375557|NCT01133626|Respiratory System Agents|respiratory system agents|mesh-ancestor
110375558|NCT01133392|Insulin|insulin|mesh-list
110375559|NCT01133392|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110375561|NCT01133392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110375562|NCT01133392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375563|NCT00471354|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110375564|NCT00471354|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110375565|NCT00471354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110375566|NCT00471354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110375567|NCT00471354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110375568|NCT00471354|Adrenergic Agents|adrenergic agents|mesh-ancestor
110375569|NCT00471354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110375570|NCT00471354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375571|NCT02882893|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110375572|NCT02882893|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110375573|NCT02882893|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110375574|NCT02882893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110375575|NCT02882893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375576|NCT02882893|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110375577|NCT02882893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110375578|NCT02882893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110375579|NCT02882893|Cholinergic Agents|cholinergic agents|mesh-ancestor
110375580|NCT02882893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110375581|NCT02210364|Capecitabine|capecitabine|mesh-list
110375582|NCT02210364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110375583|NCT02210364|Antimetabolites|antimetabolites|mesh-ancestor
110375584|NCT02210364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110375585|NCT02210364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110375586|NCT00471315|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110375587|NCT00471315|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110375588|NCT00471315|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110375589|NCT00471315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110375590|NCT00471315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110375591|NCT00471315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110375592|NCT00471315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375593|NCT00471315|Analgesics|analgesics|mesh-ancestor
110375594|NCT00471315|Sensory System Agents|sensory system agents|mesh-ancestor
110375595|NCT00471315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110375596|NCT00471315|Antidepressive Agents|antidepressive agents|mesh-ancestor
110375597|NCT00471315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110375598|NCT00471315|Dopamine Agents|dopamine agents|mesh-ancestor
110375599|NCT00471237|Alendronate|alendronate|mesh-list
110375600|NCT00471237|Teriparatide|teriparatide|mesh-list
110375601|NCT00471237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110375602|NCT00471237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375603|NCT00471237|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110375604|NCT04570683|Nivolumab|nivolumab|mesh-list
110375605|NCT04570683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110375606|NCT04570683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110375607|NCT04570683|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110375608|NCT04570683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110375609|NCT04570449|Fluoxetine|fluoxetine|mesh-list
110375610|NCT04570449|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110375611|NCT04570449|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110375613|NCT04570449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110375614|NCT04570449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110375615|NCT04570449|Serotonin Agents|serotonin agents|mesh-ancestor
110375616|NCT04570449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375617|NCT04570449|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110375618|NCT04570449|Antidepressive Agents|antidepressive agents|mesh-ancestor
110375619|NCT04570449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110375620|NCT04570449|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110375621|NCT04570449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110375623|NCT00470847|Trastuzumab|trastuzumab|mesh-list
110375624|NCT00470847|Lapatinib|lapatinib|mesh-list
110375625|NCT00470847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110375626|NCT00470847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110375627|NCT00470847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110375628|NCT00470847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110375629|NCT00470847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110375630|NCT00584090|Solifenacin Succinate|solifenacin succinate|mesh-list
110375631|NCT00584090|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110375632|NCT00584090|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110375633|NCT00584090|Cholinergic Agents|cholinergic agents|mesh-ancestor
110375634|NCT00584090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110375635|NCT00584090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110375636|NCT00584090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375637|NCT00584090|Urological Agents|urological agents|mesh-ancestor
110375638|NCT00584168|Dexamethasone|dexamethasone|mesh-list
110375639|NCT00584168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110375640|NCT00584168|Antiemetics|antiemetics|mesh-ancestor
110375641|NCT00584168|Autonomic Agents|autonomic agents|mesh-ancestor
110375642|NCT00584168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110375643|NCT00584168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375644|NCT00584168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110375645|NCT00584168|Glucocorticoids|glucocorticoids|mesh-ancestor
110375646|NCT00584168|Hormones|hormones|mesh-ancestor
110375647|NCT00584168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110375648|NCT00584168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110375649|NCT00584168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110375650|NCT00470535|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110375651|NCT00470535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110375652|NCT00470535|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110375653|NCT00470535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110375654|NCT00470535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110375655|NCT01133275|Prednisone|prednisone|mesh-list
110375656|NCT01133275|Lenalidomide|lenalidomide|mesh-list
110375657|NCT01133275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110375658|NCT01133275|Glucocorticoids|glucocorticoids|mesh-ancestor
110375660|NCT01133275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110375661|NCT01133275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375662|NCT01133275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110375663|NCT01133275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110375664|NCT01133275|Immunologic Factors|immunologic factors|mesh-ancestor
110375665|NCT01133275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110375666|NCT01133275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110375667|NCT01133275|Growth Substances|growth substances|mesh-ancestor
110375668|NCT01133275|Growth Inhibitors|growth inhibitors|mesh-ancestor
110375669|NCT00470184|Capecitabine|capecitabine|mesh-list
110375670|NCT00470184|Oxaliplatin|oxaliplatin|mesh-list
110375671|NCT00470184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110375672|NCT00470184|Antimetabolites|antimetabolites|mesh-ancestor
110375673|NCT00470184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110375674|NCT00470184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110375679|NCT04570254|Melatonin|melatonin|mesh-list
110375680|NCT04570254|Antioxidants|antioxidants|mesh-list
110375681|NCT04570254|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110375682|NCT04570254|Micronutrients|micronutrients|mesh-ancestor
110375683|NCT04570254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375684|NCT04570254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110375685|NCT04570254|Protective Agents|protective agents|mesh-ancestor
110375686|NCT04570254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110375687|NCT04570254|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110375688|NCT04570254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110375689|NCT04570254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110375690|NCT04570254|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110375691|NCT04570254|Vasodilator Agents|vasodilator agents|mesh-ancestor
110375692|NCT04570254|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110375693|NCT04570254|Antiviral Agents|antiviral agents|mesh-ancestor
110375694|NCT04570254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110375695|NCT04570254|Expectorants|expectorants|mesh-ancestor
110375696|NCT04570254|Respiratory System Agents|respiratory system agents|mesh-ancestor
110375698|NCT00470067|Carboplatin|carboplatin|mesh-list
110375699|NCT00470067|Doxorubicin|doxorubicin|mesh-list
110375700|NCT00470067|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110375701|NCT00470067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110375702|NCT00470067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110375703|NCT00470067|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110375704|NCT00470067|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110375705|NCT00470067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110375706|NCT00470067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110375708|NCT00584636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110375709|NCT00584636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110375710|NCT00584636|Autonomic Agents|autonomic agents|mesh-ancestor
110375711|NCT00584636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110375712|NCT00584636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375713|NCT00584636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110375714|NCT00584636|Respiratory System Agents|respiratory system agents|mesh-ancestor
110375715|NCT00584636|Glucocorticoids|glucocorticoids|mesh-ancestor
110375716|NCT00584636|Hormones|hormones|mesh-ancestor
110375717|NCT00584636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110375718|NCT00479817|Paclitaxel|paclitaxel|mesh-list
110375719|NCT00479817|Trebananib|trebananib|mesh-list
110375720|NCT00479817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110375721|NCT00479817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110375722|NCT00479817|Tubulin Modulators|tubulin modulators|mesh-ancestor
110375723|NCT00479817|Antimitotic Agents|antimitotic agents|mesh-ancestor
110375724|NCT00479817|Mitosis Modulators|mitosis modulators|mesh-ancestor
110375725|NCT00479817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110375726|NCT00479817|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110375727|NCT00479817|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110375728|NCT00479817|Growth Substances|growth substances|mesh-ancestor
110375729|NCT00479817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375730|NCT00479817|Growth Inhibitors|growth inhibitors|mesh-ancestor
110375731|NCT04575194|Liraglutide|liraglutide|mesh-list
110375732|NCT04575194|Naltrexone|naltrexone|mesh-list
110375734|NCT04575194|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110375735|NCT04575194|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110375736|NCT04575194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375737|NCT04575194|Sensory System Agents|sensory system agents|mesh-ancestor
110375742|NCT04575194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110375743|NCT04575194|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110375744|NCT04575194|Antidepressive Agents|antidepressive agents|mesh-ancestor
110375745|NCT04575194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110375746|NCT04575194|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110375747|NCT04575194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110375748|NCT04575194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110375749|NCT04575194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110375750|NCT04575194|Dopamine Agents|dopamine agents|mesh-ancestor
110375751|NCT04575194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110375752|NCT04575194|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110375753|NCT04575194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110375754|NCT04575194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110375755|NCT00478179|Bupivacaine|bupivacaine|mesh-list
110375756|NCT00478179|Anesthetics, Local|anesthetics, local|mesh-ancestor
110375757|NCT00478179|Anesthetics|anesthetics|mesh-ancestor
110375758|NCT00478179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110375759|NCT00478179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375760|NCT00478179|Sensory System Agents|sensory system agents|mesh-ancestor
110375761|NCT00478179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110375762|NCT00585143|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110375763|NCT00585143|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110375764|NCT00585143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110375765|NCT00585143|Antimetabolites|antimetabolites|mesh-ancestor
110375766|NCT00585143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110375767|NCT00585143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110375768|NCT00585143|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110375769|NCT00585143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110375770|NCT00585260|Mannitol|mannitol|mesh-list
110375771|NCT00585260|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110375772|NCT00585260|Diuretics|diuretics|mesh-ancestor
110375773|NCT00585260|Natriuretic Agents|natriuretic agents|mesh-ancestor
110375774|NCT00585260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375775|NCT00475020|Fludarabine|fludarabine|mesh-list
110375776|NCT00475020|Fludarabine phosphate|fludarabine phosphate|mesh-list
110375777|NCT00475020|Busulfan|busulfan|mesh-list
110375778|NCT00475020|Thymoglobulin|thymoglobulin|mesh-list
110375779|NCT00475020|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110375780|NCT00475020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110375781|NCT00475020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110375782|NCT00475020|Antimetabolites|antimetabolites|mesh-ancestor
110375783|NCT00475020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110375784|NCT00475020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110375785|NCT00475020|Immunologic Factors|immunologic factors|mesh-ancestor
110375786|NCT00475020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375787|NCT00475020|Alkylating Agents|alkylating agents|mesh-ancestor
110375788|NCT00475020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110375789|NCT00475020|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110375790|NCT00585455|Sertraline|sertraline|mesh-list
110375791|NCT00585455|Antidepressive Agents|antidepressive agents|mesh-ancestor
110375792|NCT00585455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110375793|NCT00585455|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110375794|NCT00585455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110375795|NCT00585455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110375796|NCT00585455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110375797|NCT00585455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110375799|NCT00585455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375800|NCT01083966|Bevacizumab|bevacizumab|mesh-list
110375801|NCT01083966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110375802|NCT01083966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110375803|NCT01083966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110375804|NCT01083966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110375805|NCT01083966|Growth Substances|growth substances|mesh-ancestor
110375806|NCT01083966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375807|NCT01083966|Growth Inhibitors|growth inhibitors|mesh-ancestor
110375808|NCT01132807|Prednisone|prednisone|mesh-list
110375809|NCT01132807|Cyclophosphamide|cyclophosphamide|mesh-list
110375810|NCT01132807|Dacarbazine|dacarbazine|mesh-list
110375811|NCT01132807|Doxorubicin|doxorubicin|mesh-list
110375812|NCT01132807|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110375813|NCT01132807|Etoposide|etoposide|mesh-list
110375814|NCT01132807|Bleomycin|bleomycin|mesh-list
110375815|NCT01132807|Vinblastine|vinblastine|mesh-list
110375816|NCT01132807|Etoposide phosphate|etoposide phosphate|mesh-list
110375817|NCT01132807|Procarbazine|procarbazine|mesh-list
110375818|NCT01132807|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110375819|NCT01132807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110375820|NCT01132807|Immunologic Factors|immunologic factors|mesh-ancestor
110375821|NCT01132807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375822|NCT01132807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110375823|NCT01132807|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110375824|NCT01132807|Alkylating Agents|alkylating agents|mesh-ancestor
110375825|NCT01132807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110375826|NCT01132807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110375827|NCT01132807|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110375828|NCT01132807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110375829|NCT01132807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110375830|NCT01132807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110375831|NCT01132807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110375832|NCT01132807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110375833|NCT01132807|Glucocorticoids|glucocorticoids|mesh-ancestor
110375835|NCT01132807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110375836|NCT01132807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110375837|NCT01132807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110375838|NCT01132807|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110375839|NCT01132807|Tubulin Modulators|tubulin modulators|mesh-ancestor
110375840|NCT01132807|Antimitotic Agents|antimitotic agents|mesh-ancestor
110375841|NCT01132807|Mitosis Modulators|mitosis modulators|mesh-ancestor
110375842|NCT04569513|Parathyroid Hormone|parathyroid hormone|mesh-list
110375843|NCT04569513|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110375844|NCT04569513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375845|NCT01089543|Rabeprazole|rabeprazole|mesh-list
110375846|NCT01089543|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110375847|NCT01089543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110375848|NCT01089543|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110375849|NCT01089543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110375850|NCT01089543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110375851|NCT04569630|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110375852|NCT04569630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375855|NCT01089504|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110375856|NCT01089504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110375857|NCT01089504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375858|NCT01089504|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110375859|NCT01089504|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110375860|NCT01089504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110375861|NCT01089504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110375862|NCT01089504|GABA Modulators|gaba modulators|mesh-ancestor
110375863|NCT01089504|GABA Agents|gaba agents|mesh-ancestor
110375864|NCT01089504|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110375865|NCT01089504|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110375866|NCT01089504|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110375867|NCT03452696|Calcium|calcium|mesh-list
110375868|NCT03452696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110375869|NCT03452696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375870|NCT01088997|Milrinone|milrinone|mesh-list
110375871|NCT01088997|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110375872|NCT01088997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110375873|NCT01088997|Vasodilator Agents|vasodilator agents|mesh-ancestor
110375874|NCT01088997|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110375875|NCT01088997|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110375876|NCT01088997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110375877|NCT01088997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110375878|NCT01088997|Protective Agents|protective agents|mesh-ancestor
110375879|NCT01088997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375880|NCT00586118|Propofol|propofol|mesh-list
110375881|NCT00586118|Sevoflurane|sevoflurane|mesh-list
110375882|NCT00586118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110375883|NCT00586118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110375884|NCT00586118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375885|NCT00586118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110375886|NCT00586118|Anesthetics, General|anesthetics, general|mesh-ancestor
110375888|NCT00586118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110375889|NCT00586118|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110375890|NCT01088529|Prednisone|prednisone|mesh-list
110375892|NCT01088529|Goserelin|goserelin|mesh-list
110375893|NCT01088529|Abiraterone Acetate|abiraterone acetate|mesh-list
110375894|NCT01088529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110375895|NCT01088529|Glucocorticoids|glucocorticoids|mesh-ancestor
110375896|NCT01088529|Hormones|hormones|mesh-ancestor
110375897|NCT01088529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110375898|NCT01088529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375899|NCT01088529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110375901|NCT01088529|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110375902|NCT01088529|Fertility Agents|fertility agents|mesh-ancestor
110375906|NCT01088529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110375907|NCT01088529|Hormone Antagonists|hormone antagonists|mesh-ancestor
110375908|NCT01088529|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110375909|NCT00586274|Fludarabine|fludarabine|mesh-list
110375910|NCT00586274|Alemtuzumab|alemtuzumab|mesh-list
110375911|NCT00586274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110375912|NCT00586274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110375913|NCT00586430|Lorazepam|lorazepam|mesh-list
110375914|NCT00586430|Anticonvulsants|anticonvulsants|mesh-ancestor
110375916|NCT00586430|Autonomic Agents|autonomic agents|mesh-ancestor
110375917|NCT00586430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110375918|NCT00586430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375919|NCT00586430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110375920|NCT00586430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110375921|NCT00586430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110375922|NCT00586430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110375923|NCT00586430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110375924|NCT00586430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110375925|NCT00586430|GABA Modulators|gaba modulators|mesh-ancestor
110375927|NCT00586430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110375928|NCT00586430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110375929|NCT04569279|Warfarin|warfarin|mesh-list
110375930|NCT04569279|Rivaroxaban|rivaroxaban|mesh-list
110375931|NCT04569279|Anticoagulants|anticoagulants|mesh-ancestor
110375932|NCT04569279|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110375933|NCT04569279|Antithrombins|antithrombins|mesh-ancestor
110375934|NCT04569279|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110375935|NCT04569279|Protease Inhibitors|protease inhibitors|mesh-ancestor
110375937|NCT04569279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110375938|NCT04312204|Carboplatin|carboplatin|mesh-list
110375939|NCT04312204|Gemcitabine|gemcitabine|mesh-list
110375940|NCT04312204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110375941|NCT04312204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110375942|NCT04312204|Antimetabolites|antimetabolites|mesh-ancestor
110375943|NCT04312204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110375945|NCT04312282|Rifampin|rifampin|mesh-list
110375946|NCT04312282|Antifungal Agents|antifungal agents|mesh-ancestor
110375947|NCT04312282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110375948|NCT04312282|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110375949|NCT04312282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110375950|NCT04312282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110375951|NCT04312282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110375952|NCT04312282|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110375953|NCT04312282|Hormone Antagonists|hormone antagonists|mesh-ancestor
110375954|NCT04312282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110375955|NCT04312282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375956|NCT04312282|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110375957|NCT04312282|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110375958|NCT04312282|Antitubercular Agents|antitubercular agents|mesh-ancestor
110375959|NCT04312282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110375960|NCT04312282|Leprostatic Agents|leprostatic agents|mesh-ancestor
110375961|NCT04312282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110375962|NCT04312282|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110375965|NCT04312282|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110375966|NCT04312282|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110375967|NCT04312282|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110375969|NCT01087905|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110375970|NCT01087905|Autonomic Agents|autonomic agents|mesh-ancestor
110038302|NCT01423747|Fludarabine|fludarabine|mesh-list
110375971|NCT01087905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110375972|NCT01087905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375974|NCT01087905|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110375975|NCT01087905|Cholinergic Agents|cholinergic agents|mesh-ancestor
110375976|NCT01087905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110375977|NCT01087905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110375979|NCT01087788|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110375980|NCT01087788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110375981|NCT01087788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110375982|NCT01087788|Immunologic Factors|immunologic factors|mesh-ancestor
110375983|NCT01087788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375984|NCT01087788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110375986|NCT00586976|Anesthetics, Local|anesthetics, local|mesh-ancestor
110375987|NCT00586976|Anesthetics|anesthetics|mesh-ancestor
110375988|NCT00586976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110375989|NCT00586976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375990|NCT00586976|Sensory System Agents|sensory system agents|mesh-ancestor
110375991|NCT00586976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110375992|NCT00587015|Immunotoxin HA22|immunotoxin ha22|mesh-list
110375993|NCT00587015|Immunotoxins|immunotoxins|mesh-ancestor
110375994|NCT00587015|Immunoconjugates|immunoconjugates|mesh-ancestor
110375995|NCT00587015|Immunologic Factors|immunologic factors|mesh-ancestor
110375996|NCT00587015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375997|NCT00587015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110376000|NCT04568772|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
110376001|NCT04568772|Esomeprazole|esomeprazole|mesh-list
110376002|NCT04568772|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110376003|NCT04568772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110376004|NCT04568772|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110376005|NCT04568772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110376006|NCT04568772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376007|NCT04568772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110376008|NCT04568772|Antimalarials|antimalarials|mesh-ancestor
110376009|NCT04568772|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110376010|NCT04568772|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110376011|NCT04568772|Antimetabolites|antimetabolites|mesh-ancestor
110376012|NCT04575389|Uric Acid|uric acid|mesh-list
110376013|NCT04575389|Antioxidants|antioxidants|mesh-ancestor
110376014|NCT04575389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376015|NCT04575389|Protective Agents|protective agents|mesh-ancestor
110376016|NCT04575389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376017|NCT01086150|Lidocaine|lidocaine|mesh-list
110376018|NCT01086150|Anesthetics, Local|anesthetics, local|mesh-ancestor
110376019|NCT01086150|Anesthetics|anesthetics|mesh-ancestor
110376020|NCT01086150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110376021|NCT01086150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376022|NCT01086150|Sensory System Agents|sensory system agents|mesh-ancestor
110376023|NCT01086150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110376024|NCT01086150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110376025|NCT01086150|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110376026|NCT01086150|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110376027|NCT01086150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110376028|NCT01086150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376029|NCT00587249|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110376030|NCT00587249|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110376031|NCT00587249|Immunologic Factors|immunologic factors|mesh-ancestor
110376032|NCT00587249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376033|NCT00587249|Antacids|antacids|mesh-ancestor
110376034|NCT00587249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376035|NCT00587249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110376036|NCT00587327|Atosiban|atosiban|mesh-list
110376037|NCT00587327|Hormone Antagonists|hormone antagonists|mesh-ancestor
110376038|NCT00587327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110376039|NCT00587327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376040|NCT00587327|Tocolytic Agents|tocolytic agents|mesh-ancestor
110376041|NCT00587327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110376043|NCT00587444|Calcium heparin|calcium heparin|mesh-list
110376044|NCT00587444|Anticoagulants|anticoagulants|mesh-ancestor
110376045|NCT00587444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110376046|NCT00587444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110376047|NCT00587444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376048|NCT02278302|Ethanol|ethanol|mesh-list
110376049|NCT02278302|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
110376050|NCT02278302|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110376051|NCT02278302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110376052|NCT02278302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110376053|NCT02278302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376054|NCT02278302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110376055|NCT00587717|Simvastatin|simvastatin|mesh-list
110376056|NCT00587717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110376057|NCT00587717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110376058|NCT00587717|Antimetabolites|antimetabolites|mesh-ancestor
110376059|NCT00587717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376060|NCT00587717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110376061|NCT00587717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110376062|NCT00587717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110376063|NCT01085136|Afatinib|afatinib|mesh-list
110376064|NCT01085136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110376065|NCT01085136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110376067|NCT01085136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376068|NCT00587873|Leucovorin|leucovorin|mesh-list
110376069|NCT00587873|Methotrexate|methotrexate|mesh-list
110376070|NCT00587873|Thioguanine|thioguanine|mesh-list
110376071|NCT00587873|Calcium|calcium|mesh-list
110376072|NCT00587873|Levoleucovorin|levoleucovorin|mesh-list
110376073|NCT00587873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110376074|NCT00587873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376075|NCT00587873|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110376076|NCT00587873|Abortifacient Agents|abortifacient agents|mesh-ancestor
110376077|NCT00587873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110376078|NCT00587873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110376079|NCT00587873|Antimetabolites|antimetabolites|mesh-ancestor
110376080|NCT00587873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376081|NCT00587873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110376082|NCT00587873|Dermatologic Agents|dermatologic agents|mesh-ancestor
110376083|NCT00587873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110376084|NCT00587873|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110376085|NCT00587873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110376086|NCT00587873|Immunologic Factors|immunologic factors|mesh-ancestor
110376087|NCT00587873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110376088|NCT00587873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110376089|NCT00587873|Antidotes|antidotes|mesh-ancestor
110376090|NCT00587873|Protective Agents|protective agents|mesh-ancestor
110376091|NCT00587873|Vitamin B Complex|vitamin b complex|mesh-ancestor
110376092|NCT00587873|Vitamins|vitamins|mesh-ancestor
110376093|NCT00587873|Micronutrients|micronutrients|mesh-ancestor
110376094|NCT01084707|Nicotine|nicotine|mesh-list
110376095|NCT01084707|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110376096|NCT01084707|Autonomic Agents|autonomic agents|mesh-ancestor
110376097|NCT01084707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110376098|NCT01084707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376099|NCT01084707|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110376100|NCT01084707|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110376101|NCT01084707|Cholinergic Agents|cholinergic agents|mesh-ancestor
110376102|NCT01084707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110376103|NCT01084707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376105|NCT02210598|Oxytocics|oxytocics|mesh-ancestor
110376106|NCT02210598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110376107|NCT02210598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376108|NCT03452657|Ranibizumab|ranibizumab|mesh-list
110376109|NCT03452657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110376110|NCT03452657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110376111|NCT03452657|Growth Substances|growth substances|mesh-ancestor
110376112|NCT03452657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376113|NCT03452657|Growth Inhibitors|growth inhibitors|mesh-ancestor
110376114|NCT03452657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110376115|NCT03452501|Infliximab|infliximab|mesh-list
110376116|NCT03452501|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110376117|NCT03452501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110376118|NCT03452501|Dermatologic Agents|dermatologic agents|mesh-ancestor
110376119|NCT03452501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110376120|NCT03452501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110376121|NCT00588302|Moexipril|moexipril|mesh-list
110376122|NCT00588302|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110376123|NCT00588302|Protease Inhibitors|protease inhibitors|mesh-ancestor
110376124|NCT00588302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110376125|NCT00588302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376126|NCT00588302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110376127|NCT01084005|Linagliptin|linagliptin|mesh-list
110376128|NCT01084005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110376129|NCT01084005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376130|NCT01084005|Incretins|incretins|mesh-ancestor
110376131|NCT01084005|Hormones|hormones|mesh-ancestor
110376132|NCT01084005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110376133|NCT01084005|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110376134|NCT01084005|Protease Inhibitors|protease inhibitors|mesh-ancestor
110376135|NCT01084005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110376136|NCT01084005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376138|NCT01083810|Lopinavir|lopinavir|mesh-list
110376139|NCT01083810|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110376140|NCT01083810|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110376141|NCT01083810|Protease Inhibitors|protease inhibitors|mesh-ancestor
110376142|NCT01083810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110376143|NCT01083810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376144|NCT01083810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110376145|NCT01083810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110376146|NCT01083810|Antiviral Agents|antiviral agents|mesh-ancestor
110376147|NCT01083810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110376148|NCT01083810|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110376149|NCT01083810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110376150|NCT00588926|Remifentanil|remifentanil|mesh-list
110376151|NCT00588926|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110376152|NCT00588926|Narcotics|narcotics|mesh-ancestor
110376154|NCT00588926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376156|NCT00588926|Sensory System Agents|sensory system agents|mesh-ancestor
110376157|NCT00588926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110376159|NCT00589082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110376160|NCT00589082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110376161|NCT00589082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110376162|NCT00589082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110376163|NCT00589082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110376164|NCT00589082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376165|NCT00589238|Paclitaxel|paclitaxel|mesh-list
110376166|NCT00589238|Cyclophosphamide|cyclophosphamide|mesh-list
110376167|NCT00589238|Carboplatin|carboplatin|mesh-list
110376168|NCT00589238|Doxorubicin|doxorubicin|mesh-list
110376169|NCT00589238|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110376170|NCT00589238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110376171|NCT00589238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110376172|NCT00589238|Tubulin Modulators|tubulin modulators|mesh-ancestor
110376173|NCT00589238|Antimitotic Agents|antimitotic agents|mesh-ancestor
110376174|NCT00589238|Mitosis Modulators|mitosis modulators|mesh-ancestor
110376175|NCT00589238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376176|NCT00589238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110376177|NCT00589238|Immunologic Factors|immunologic factors|mesh-ancestor
110376178|NCT00589238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376179|NCT00589238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110376180|NCT00589238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110376181|NCT00589238|Alkylating Agents|alkylating agents|mesh-ancestor
110376182|NCT00589238|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110376183|NCT00589238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110376184|NCT00589238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110376185|NCT00589238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110376186|NCT00589238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110376187|NCT00589394|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110376188|NCT00589394|Immunologic Factors|immunologic factors|mesh-ancestor
110376189|NCT00589394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376190|NCT01083576|Gentamicins|gentamicins|mesh-list
110376191|NCT01083576|Paromomycin|paromomycin|mesh-list
110376192|NCT01083576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110376193|NCT01083576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110376194|NCT01083576|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110376195|NCT01083576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110376196|NCT01083576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376197|NCT01083576|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110376198|NCT01083576|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110376199|NCT04568265|Entecavir|entecavir|mesh-list
110376200|NCT04568265|Antiviral Agents|antiviral agents|mesh-ancestor
110376201|NCT04568265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110376202|NCT04568304|Carboplatin|carboplatin|mesh-list
110376203|NCT04568304|Gemcitabine|gemcitabine|mesh-list
110376204|NCT04568304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110376206|NCT04568304|Antimetabolites|antimetabolites|mesh-ancestor
110376207|NCT04568304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376209|NCT01082640|Gout Suppressants|gout suppressants|mesh-ancestor
110376210|NCT01082640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110376211|NCT00589862|Clopidogrel|clopidogrel|mesh-list
110376212|NCT00589862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110376213|NCT00589862|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110376214|NCT00589862|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110376215|NCT00589862|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110376216|NCT00589862|Purinergic Agents|purinergic agents|mesh-ancestor
110376217|NCT00589862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110376218|NCT00589862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376219|NCT00589862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376221|NCT00589901|Capecitabine|capecitabine|mesh-list
110376222|NCT00589901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110376223|NCT00589901|Immunologic Factors|immunologic factors|mesh-ancestor
110376224|NCT00589901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376225|NCT00589901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110376226|NCT00589901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110376227|NCT00589901|Alkylating Agents|alkylating agents|mesh-ancestor
110376228|NCT00589901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376229|NCT00589901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110376230|NCT00589901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110376231|NCT00589901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110376232|NCT00589901|Antimetabolites|antimetabolites|mesh-ancestor
110376233|NCT00590174|Aspirin|aspirin|mesh-list
110376234|NCT00590174|Clopidogrel|clopidogrel|mesh-list
110376235|NCT00590174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110376236|NCT00590174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110376237|NCT00590174|Analgesics|analgesics|mesh-ancestor
110376238|NCT00590174|Sensory System Agents|sensory system agents|mesh-ancestor
110376239|NCT00590174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110376240|NCT00590174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376241|NCT00590174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110376242|NCT00590174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110376243|NCT00590174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110376244|NCT00590174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110376245|NCT00590174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376246|NCT00590174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110376247|NCT00590174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110376248|NCT00590174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110376249|NCT00590174|Antipyretics|antipyretics|mesh-ancestor
110376250|NCT00590174|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110376251|NCT00590174|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110376252|NCT00590174|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110376253|NCT00590174|Purinergic Agents|purinergic agents|mesh-ancestor
110376254|NCT00590174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110376255|NCT00590213|Bicalutamide|bicalutamide|mesh-list
110376256|NCT00590213|Androgen Antagonists|androgen antagonists|mesh-ancestor
110376257|NCT00590213|Hormone Antagonists|hormone antagonists|mesh-ancestor
110376258|NCT00590213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110376259|NCT00590213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376260|NCT00590213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110376261|NCT00590408|Ubiquinone|ubiquinone|mesh-list
110376262|NCT00590408|Coenzyme Q10|coenzyme q10|mesh-list
110376263|NCT00590408|Micronutrients|micronutrients|mesh-ancestor
110376264|NCT00590408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376265|NCT00590408|Vitamins|vitamins|mesh-ancestor
110376267|NCT00590447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110376268|NCT00590447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110376269|NCT00590447|Immunologic Factors|immunologic factors|mesh-ancestor
110376270|NCT00590447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376272|NCT01081626|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110376274|NCT01081626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110376275|NCT01081626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376276|NCT01080768|Amlodipine|amlodipine|mesh-list
110376277|NCT01080768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110376278|NCT01080768|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110376279|NCT01080768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110376280|NCT01080768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376281|NCT01080768|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110376282|NCT01080768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376283|NCT01080768|Vasodilator Agents|vasodilator agents|mesh-ancestor
110376284|NCT03452345|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110376285|NCT03452345|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110376286|NCT03452345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110376287|NCT03452345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376288|NCT03452345|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110376289|NCT03452345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110376290|NCT03452345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376291|NCT03452345|Cholinergic Agents|cholinergic agents|mesh-ancestor
110376292|NCT03452345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110376293|NCT03452306|Metformin|metformin|mesh-list
110376294|NCT03452306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110376295|NCT03452306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376296|NCT01080300|Gabapentin|gabapentin|mesh-list
110376297|NCT01080300|Analgesics|analgesics|mesh-ancestor
110376298|NCT01080300|Sensory System Agents|sensory system agents|mesh-ancestor
110376299|NCT01080300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110376300|NCT01080300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376301|NCT01080300|Anticonvulsants|anticonvulsants|mesh-ancestor
110376302|NCT01080300|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110376303|NCT01080300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110376304|NCT01080300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110376305|NCT01080300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110376306|NCT01080300|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110376307|NCT01080300|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110376308|NCT01080300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110376309|NCT01080300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376310|NCT01080300|Antimanic Agents|antimanic agents|mesh-ancestor
110376311|NCT02210715|Raltegravir Potassium|raltegravir potassium|mesh-list
110376312|NCT02210715|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110376313|NCT02210715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110376314|NCT02210715|Antiviral Agents|antiviral agents|mesh-ancestor
110376315|NCT02210715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110376316|NCT02210715|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110376317|NCT02210715|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110376318|NCT02210715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110376319|NCT02210715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376320|NCT00590603|Ascorbic Acid|ascorbic acid|mesh-list
110376321|NCT00590603|Bortezomib|bortezomib|mesh-list
110376322|NCT00590603|Arsenic Trioxide|arsenic trioxide|mesh-list
110376323|NCT00590603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110376325|NCT00590603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376327|NCT00590603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376328|NCT00590603|Vitamins|vitamins|mesh-ancestor
110376329|NCT00590603|Micronutrients|micronutrients|mesh-ancestor
110376330|NCT01085097|Mycophenolic Acid|mycophenolic acid|mesh-list
110376331|NCT01085097|Prednisone|prednisone|mesh-list
110376332|NCT01085097|Methylprednisolone|methylprednisolone|mesh-list
110376333|NCT01085097|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110376334|NCT01085097|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110376335|NCT01085097|Prednisolone|prednisolone|mesh-list
110376336|NCT01085097|Prednisolone acetate|prednisolone acetate|mesh-list
110376337|NCT01085097|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110376338|NCT01085097|Prednisolone phosphate|prednisolone phosphate|mesh-list
110376339|NCT01085097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110376340|NCT01085097|Glucocorticoids|glucocorticoids|mesh-ancestor
110376341|NCT01085097|Hormones|hormones|mesh-ancestor
110376342|NCT01085097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110376343|NCT01085097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376344|NCT01085097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110376346|NCT01085097|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110376347|NCT01085097|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110376348|NCT01085097|Antitubercular Agents|antitubercular agents|mesh-ancestor
110376349|NCT01085097|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110376350|NCT01085097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110376351|NCT01085097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110376352|NCT01085097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376353|NCT01085097|Antiemetics|antiemetics|mesh-ancestor
110376354|NCT01085097|Autonomic Agents|autonomic agents|mesh-ancestor
110376355|NCT01085097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110376356|NCT01085097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110376357|NCT01085097|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110376358|NCT01085097|Protective Agents|protective agents|mesh-ancestor
110376359|NCT00590837|Lomustine|lomustine|mesh-list
110376360|NCT00590837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110376361|NCT00590837|Alkylating Agents|alkylating agents|mesh-ancestor
110376362|NCT00590837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376363|NCT00590837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110376364|NCT01086267|Cetuximab|cetuximab|mesh-list
110376365|NCT01086267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110376366|NCT01086267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110376367|NCT00590915|Asparaginase|asparaginase|mesh-list
110376368|NCT00590915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110376369|NCT04567290|Ticagrelor|ticagrelor|mesh-list
110376370|NCT04567290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110376371|NCT04567290|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110376372|NCT04567290|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110376373|NCT04567290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110376374|NCT04567290|Purinergic Agents|purinergic agents|mesh-ancestor
110376375|NCT04567290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110376376|NCT04567290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376377|NCT04567290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376378|NCT01084161|Morphine|morphine|mesh-list
110376379|NCT01084161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110376380|NCT01084161|Narcotics|narcotics|mesh-ancestor
110376382|NCT01084161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376384|NCT01084161|Sensory System Agents|sensory system agents|mesh-ancestor
110376385|NCT01084161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110376386|NCT01083615|Prednisone|prednisone|mesh-list
110376387|NCT01083615|Docetaxel|docetaxel|mesh-list
110376388|NCT01083615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110376389|NCT01083615|Tubulin Modulators|tubulin modulators|mesh-ancestor
110376390|NCT01083615|Antimitotic Agents|antimitotic agents|mesh-ancestor
110376391|NCT01083615|Mitosis Modulators|mitosis modulators|mesh-ancestor
110376392|NCT01083615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376393|NCT01083615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110376394|NCT01083615|Glucocorticoids|glucocorticoids|mesh-ancestor
110376396|NCT01083615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110376397|NCT01083615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376398|NCT01083615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110376399|NCT00591188|Interferons|interferons|mesh-list
110376400|NCT00591188|Interferon-alpha|interferon-alpha|mesh-list
110376401|NCT00591188|Capecitabine|capecitabine|mesh-list
110376402|NCT00591188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110376403|NCT00591188|Antimetabolites|antimetabolites|mesh-ancestor
110376404|NCT00591188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376405|NCT00591188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110376406|NCT00591188|Antiviral Agents|antiviral agents|mesh-ancestor
110376407|NCT00591188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110376408|NCT00591188|Immunologic Factors|immunologic factors|mesh-ancestor
110376409|NCT00591188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376410|NCT00591383|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110376411|NCT00591383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110376412|NCT00591383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110376413|NCT00591383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110376414|NCT00591383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376415|NCT01081782|Ceralifimod|ceralifimod|mesh-list
110376416|NCT01081782|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110376417|NCT01081782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376418|NCT01081782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110376419|NCT01081782|Immunologic Factors|immunologic factors|mesh-ancestor
110376420|NCT01081782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376422|NCT01080222|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110376423|NCT01080222|Antimetabolites|antimetabolites|mesh-ancestor
110376424|NCT01080222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376425|NCT01080222|Antiviral Agents|antiviral agents|mesh-ancestor
110376426|NCT01080222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110376427|NCT03452267|Metformin|metformin|mesh-list
110376428|NCT03452267|Pioglitazone|pioglitazone|mesh-list
110376429|NCT03452267|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110376430|NCT03452267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376431|NCT01088802|Carboplatin|carboplatin|mesh-list
110376432|NCT01088802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110376433|NCT03451682|Procyanidin|procyanidin|mesh-list
110376435|NCT03451682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376436|NCT03451682|Protective Agents|protective agents|mesh-ancestor
110376437|NCT03451682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376440|NCT02210754|Glycerol|glycerol|mesh-list
110376441|NCT02210754|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110376442|NCT02210754|Autonomic Agents|autonomic agents|mesh-ancestor
110376443|NCT02210754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110376444|NCT02210754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376445|NCT02210754|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110376446|NCT02210754|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110376447|NCT02210754|Cholinergic Agents|cholinergic agents|mesh-ancestor
110376448|NCT02210754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110376449|NCT02210754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376450|NCT02210754|Antipruritics|antipruritics|mesh-ancestor
110376451|NCT02210754|Dermatologic Agents|dermatologic agents|mesh-ancestor
110376452|NCT02210754|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110376453|NCT02210754|Protective Agents|protective agents|mesh-ancestor
110376454|NCT04574141|Melatonin|melatonin|mesh-list
110376455|NCT04574141|Antioxidants|antioxidants|mesh-ancestor
110376456|NCT04574141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376457|NCT04574141|Protective Agents|protective agents|mesh-ancestor
110376458|NCT04574141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376459|NCT04574141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110376460|NCT04998981|Fenofibrate|fenofibrate|mesh-list
110376461|NCT04998981|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110376462|NCT04998981|Antimetabolites|antimetabolites|mesh-ancestor
110376463|NCT04998981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376464|NCT04998981|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110376465|NCT04573049|Simendan|simendan|mesh-list
110376466|NCT04573049|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110376467|NCT04573049|Vasodilator Agents|vasodilator agents|mesh-ancestor
110376468|NCT04573049|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110376469|NCT04573049|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110376470|NCT04573049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110376471|NCT04573049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376472|NCT04573049|Protective Agents|protective agents|mesh-ancestor
110376473|NCT04573049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376474|NCT04572698|Endothelial Growth Factors|endothelial growth factors|mesh-list
110376475|NCT04572698|Growth Substances|growth substances|mesh-ancestor
110376476|NCT04572698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376477|NCT04572542|Paclitaxel|paclitaxel|mesh-list
110376478|NCT04572542|Apatinib|apatinib|mesh-list
110376479|NCT04572542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110376480|NCT04572542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110376481|NCT04572542|Tubulin Modulators|tubulin modulators|mesh-ancestor
110376482|NCT04572542|Antimitotic Agents|antimitotic agents|mesh-ancestor
110376483|NCT04572542|Mitosis Modulators|mitosis modulators|mesh-ancestor
110376484|NCT04572542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376485|NCT04572542|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110376486|NCT04572542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110376487|NCT04991103|Dexamethasone|dexamethasone|mesh-list
110376488|NCT04991103|Lenalidomide|lenalidomide|mesh-list
110376489|NCT04991103|Bortezomib|bortezomib|mesh-list
110376490|NCT04991103|Daratumumab|daratumumab|mesh-list
110376491|NCT04991103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110376492|NCT04991103|Antiemetics|antiemetics|mesh-ancestor
110376493|NCT04991103|Autonomic Agents|autonomic agents|mesh-ancestor
110376494|NCT04991103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110376495|NCT04991103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376498|NCT04991103|Hormones|hormones|mesh-ancestor
110376499|NCT04991103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110376500|NCT04991103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110376501|NCT04991103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110376502|NCT04991103|Immunologic Factors|immunologic factors|mesh-ancestor
110376503|NCT04991103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110376504|NCT04991103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110376506|NCT04991103|Growth Inhibitors|growth inhibitors|mesh-ancestor
110376507|NCT04572620|Rituximab|rituximab|mesh-list
110376508|NCT04572620|Abatacept|abatacept|mesh-list
110376509|NCT04572620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110376510|NCT04572620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110376511|NCT04572620|Immunologic Factors|immunologic factors|mesh-ancestor
110376512|NCT04572620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376513|NCT04572620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110376514|NCT04572620|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110376515|NCT04572620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376516|NCT04572620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110376518|NCT03451019|Chelating Agents|chelating agents|mesh-ancestor
110376519|NCT03451019|Sequestering Agents|sequestering agents|mesh-ancestor
110376520|NCT03451019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376521|NCT03450863|Insulin Aspart|insulin aspart|mesh-list
110376522|NCT03450863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110376523|NCT03450863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376524|NCT02211066|Clopidogrel|clopidogrel|mesh-list
110376525|NCT02211066|Ticagrelor|ticagrelor|mesh-list
110376526|NCT02211066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110376527|NCT02211066|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110376528|NCT02211066|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110376529|NCT02211066|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110376530|NCT02211066|Purinergic Agents|purinergic agents|mesh-ancestor
110376531|NCT02211066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110376532|NCT02211066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376533|NCT02211066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376534|NCT03450317|Aspirin|aspirin|mesh-list
110376535|NCT03450317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110376536|NCT03450317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110376537|NCT03450317|Analgesics|analgesics|mesh-ancestor
110376538|NCT03450317|Sensory System Agents|sensory system agents|mesh-ancestor
110376539|NCT03450317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110376540|NCT03450317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376541|NCT03450317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110376543|NCT03450317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110376544|NCT03450317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110376545|NCT03450317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376546|NCT03450317|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110376547|NCT03450317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110376548|NCT03450317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110376549|NCT03450317|Antipyretics|antipyretics|mesh-ancestor
110376550|NCT04565496|Pembrolizumab|pembrolizumab|mesh-list
110376551|NCT04565496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110376552|NCT04565496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110376553|NCT04565496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110376554|NCT04565496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376556|NCT03450161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110376557|NCT03450161|Narcotics|narcotics|mesh-ancestor
110376558|NCT03450161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110376559|NCT03450161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376560|NCT03450161|Analgesics|analgesics|mesh-ancestor
110376561|NCT03450161|Sensory System Agents|sensory system agents|mesh-ancestor
110376562|NCT03450161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110376563|NCT03450161|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110376564|NCT03450161|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110376565|NCT03450161|Anesthetics, General|anesthetics, general|mesh-ancestor
110036349|NCT01410747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110376566|NCT03450161|Anesthetics|anesthetics|mesh-ancestor
110376567|NCT04565184|Artesunate|artesunate|mesh-list
110376568|NCT04565184|Lumefantrine|lumefantrine|mesh-list
110376569|NCT04565184|Artemether|artemether|mesh-list
110376570|NCT04565184|Amodiaquine|amodiaquine|mesh-list
110376571|NCT04565184|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110376572|NCT04565184|Amodiaquine, artesunate drug combination|amodiaquine, artesunate drug combination|mesh-list
110376573|NCT04565184|Antimalarials|antimalarials|mesh-ancestor
110376574|NCT04565184|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110376575|NCT04565184|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110376576|NCT04565184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110376577|NCT04565184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110376579|NCT04565184|Schistosomicides|schistosomicides|mesh-ancestor
110376580|NCT04565184|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110376581|NCT04565184|Anthelmintics|anthelmintics|mesh-ancestor
110376582|NCT03452579|Bevacizumab|bevacizumab|mesh-list
110376583|NCT03452579|Nivolumab|nivolumab|mesh-list
110376584|NCT03452579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110376585|NCT03452579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110376586|NCT03452579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110376587|NCT03452579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110376588|NCT03452579|Growth Substances|growth substances|mesh-ancestor
110376589|NCT03452579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376590|NCT03452579|Growth Inhibitors|growth inhibitors|mesh-ancestor
110376591|NCT03452579|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110019645|NCT00000294|Adrenergic Agents|adrenergic agents|mesh-ancestor
110376592|NCT03452579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376593|NCT04997850|Lenvatinib|lenvatinib|mesh-list
110376595|NCT04997850|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110376597|NCT04997850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376598|NCT03450629|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110376599|NCT03450629|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110376600|NCT03450629|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110376601|NCT03450629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110376602|NCT03450629|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110376603|NCT03450629|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110376604|NCT03450629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110376605|NCT03450629|Adrenergic Agents|adrenergic agents|mesh-ancestor
110376606|NCT03450629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110376607|NCT03450629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376608|NCT03450629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376609|NCT03456947|Pregabalin|pregabalin|mesh-list
110376610|NCT03456947|Analgesics|analgesics|mesh-ancestor
110376611|NCT03456947|Sensory System Agents|sensory system agents|mesh-ancestor
110376612|NCT03456947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110376613|NCT03456947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376614|NCT03456947|Anticonvulsants|anticonvulsants|mesh-ancestor
110376617|NCT03456947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376618|NCT03456947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110376619|NCT03456947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110376620|NCT03456947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110376621|NCT03456947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110376622|NCT03456947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110376623|NCT03456791|Protease Inhibitors|protease inhibitors|mesh-list
110376624|NCT03456791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110376625|NCT03456791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376627|NCT04564638|Cyclosporins|cyclosporins|mesh-list
110376628|NCT04564638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110376629|NCT04564638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376630|NCT04564638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110376631|NCT04564638|Immunologic Factors|immunologic factors|mesh-ancestor
110376632|NCT04564638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376633|NCT04564638|Antifungal Agents|antifungal agents|mesh-ancestor
110376634|NCT04564638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110376636|NCT04564638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110376637|NCT04564638|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110376638|NCT04564326|Fentanyl|fentanyl|mesh-list
110376639|NCT04564326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110376640|NCT04564326|Narcotics|narcotics|mesh-ancestor
110376641|NCT04564326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110376642|NCT04564326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376643|NCT04564326|Analgesics|analgesics|mesh-ancestor
110376644|NCT04564326|Sensory System Agents|sensory system agents|mesh-ancestor
110376645|NCT04564326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110376646|NCT04564326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110376647|NCT04564326|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110376648|NCT04564326|Anesthetics, General|anesthetics, general|mesh-ancestor
110376650|NCT03453164|Nivolumab|nivolumab|mesh-list
110376651|NCT03453164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110376652|NCT03453164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110376653|NCT03453164|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110376654|NCT03453164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376655|NCT03450434|Histamine|histamine|mesh-list
110376656|NCT03450434|Glutarimide|glutarimide|mesh-list
110376657|NCT03450434|Histamine Agonists|histamine agonists|mesh-ancestor
110376658|NCT03450434|Histamine Agents|histamine agents|mesh-ancestor
110376659|NCT03450434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110376660|NCT03450434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376661|NCT03450434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376662|NCT03450434|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110376663|NCT03450434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110376664|NCT00198029|Hylan|hylan|mesh-list
110376665|NCT00198029|Viscosupplements|viscosupplements|mesh-ancestor
110376666|NCT00198029|Protective Agents|protective agents|mesh-ancestor
110376667|NCT00198029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376668|NCT02215122|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110376669|NCT02215122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110376670|NCT02215122|Autonomic Agents|autonomic agents|mesh-ancestor
110376671|NCT02215122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110376672|NCT02215122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376674|NCT02215122|Respiratory System Agents|respiratory system agents|mesh-ancestor
110376675|NCT02215122|Glucocorticoids|glucocorticoids|mesh-ancestor
110376676|NCT02215122|Hormones|hormones|mesh-ancestor
110376677|NCT02215122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110376678|NCT02215122|Sympathomimetics|sympathomimetics|mesh-ancestor
110376679|NCT00196976|Edetic Acid|edetic acid|mesh-list
110376680|NCT00196976|Vaccines|vaccines|mesh-list
110376681|NCT00196976|Pentetic Acid|pentetic acid|mesh-list
110376682|NCT00196976|Immunologic Factors|immunologic factors|mesh-ancestor
110376684|NCT00196976|Antidotes|antidotes|mesh-ancestor
110376685|NCT00196976|Protective Agents|protective agents|mesh-ancestor
110376686|NCT00196976|Chelating Agents|chelating agents|mesh-ancestor
110376687|NCT00196976|Sequestering Agents|sequestering agents|mesh-ancestor
110376688|NCT00196976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376689|NCT00196976|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110376690|NCT00196976|Anticoagulants|anticoagulants|mesh-ancestor
110376691|NCT00196976|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110376692|NCT04563936|Goserelin|goserelin|mesh-list
110376693|NCT04563936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110376694|NCT04563936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110376695|NCT04563975|Paclitaxel|paclitaxel|mesh-list
110376696|NCT04563975|Docetaxel|docetaxel|mesh-list
110376697|NCT04563975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110376698|NCT04563975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110376699|NCT04563975|Tubulin Modulators|tubulin modulators|mesh-ancestor
110376700|NCT04563975|Antimitotic Agents|antimitotic agents|mesh-ancestor
110376701|NCT04563975|Mitosis Modulators|mitosis modulators|mesh-ancestor
110376702|NCT04563975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376703|NCT00196313|Levonorgestrel|levonorgestrel|mesh-list
110376704|NCT00196313|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110376705|NCT00196313|Contraceptive Agents|contraceptive agents|mesh-ancestor
110376706|NCT00196313|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110376707|NCT00196313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376708|NCT00196313|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110376709|NCT00196313|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110376710|NCT00196313|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110376711|NCT00195650|Adalimumab|adalimumab|mesh-list
110376712|NCT00195650|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110376713|NCT00195650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110376714|NCT00195650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110376715|NCT04563780|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
110376716|NCT04563780|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110376717|NCT04563780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376718|NCT04560894|Sorafenib|sorafenib|mesh-list
110376719|NCT04560894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110376720|NCT04560894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110376721|NCT04560894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110376722|NCT04560894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376723|NCT04560465|Tranexamic Acid|tranexamic acid|mesh-list
110376724|NCT04560465|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110376725|NCT04560465|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110376726|NCT04560465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376727|NCT04560465|Hemostatics|hemostatics|mesh-ancestor
110376728|NCT04560465|Coagulants|coagulants|mesh-ancestor
110376730|NCT00195494|Methotrexate|methotrexate|mesh-list
110376731|NCT00195494|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110376732|NCT00195494|Abortifacient Agents|abortifacient agents|mesh-ancestor
110376733|NCT00195494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110376734|NCT00195494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376735|NCT00195494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110376736|NCT00195494|Antimetabolites|antimetabolites|mesh-ancestor
110376737|NCT00195494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376738|NCT00195494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110376739|NCT00195494|Dermatologic Agents|dermatologic agents|mesh-ancestor
110376740|NCT00195494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110376741|NCT00195494|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110376742|NCT00195494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110376743|NCT00195494|Immunologic Factors|immunologic factors|mesh-ancestor
110376744|NCT00195494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110376745|NCT00195494|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110376748|NCT00195494|Analgesics|analgesics|mesh-ancestor
110376749|NCT00195494|Sensory System Agents|sensory system agents|mesh-ancestor
110376750|NCT00195494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110376751|NCT00195494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110376752|NCT00195494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110376753|NCT00194987|Prednisone|prednisone|mesh-list
110376754|NCT00194987|Immunoglobulins|immunoglobulins|mesh-list
110376755|NCT00194987|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110376756|NCT00194987|Antibodies|antibodies|mesh-list
110376757|NCT00194987|gamma-Globulins|gamma-globulins|mesh-list
110376758|NCT00194987|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110376759|NCT00194987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110376760|NCT00194987|Glucocorticoids|glucocorticoids|mesh-ancestor
110376761|NCT00194987|Hormones|hormones|mesh-ancestor
110376762|NCT00194987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110376763|NCT00194987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376764|NCT00194987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110376765|NCT00194987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110376766|NCT00194987|Immunologic Factors|immunologic factors|mesh-ancestor
110376768|NCT00194792|Vinorelbine|vinorelbine|mesh-list
110376769|NCT00194792|Capecitabine|capecitabine|mesh-list
110376770|NCT00194792|Methotrexate|methotrexate|mesh-list
110376771|NCT00194792|Exemestane|exemestane|mesh-list
110376772|NCT00194792|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110376773|NCT00194792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110376774|NCT00194792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110376775|NCT00194792|Tubulin Modulators|tubulin modulators|mesh-ancestor
110376776|NCT00194792|Antimitotic Agents|antimitotic agents|mesh-ancestor
110376777|NCT00194792|Mitosis Modulators|mitosis modulators|mesh-ancestor
110376778|NCT00194792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376779|NCT00194792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110376780|NCT00194792|Antimetabolites|antimetabolites|mesh-ancestor
110376781|NCT00194792|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110376782|NCT00194792|Abortifacient Agents|abortifacient agents|mesh-ancestor
110376783|NCT00194792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110376784|NCT00194792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376785|NCT00194792|Dermatologic Agents|dermatologic agents|mesh-ancestor
110376786|NCT00194792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110376787|NCT00194792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110376788|NCT00194792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110376789|NCT00194792|Immunologic Factors|immunologic factors|mesh-ancestor
110376790|NCT00194792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110376791|NCT00194792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110376792|NCT00194792|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110376793|NCT00194792|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110376794|NCT00194792|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110376795|NCT00194792|Hormone Antagonists|hormone antagonists|mesh-ancestor
110376796|NCT00194792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110376797|NCT00194792|Luteolytic Agents|luteolytic agents|mesh-ancestor
110376798|NCT00194792|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110376799|NCT00194792|Contraceptive Agents|contraceptive agents|mesh-ancestor
110376800|NCT00194792|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110376801|NCT00194792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110376802|NCT02486367|Clopidogrel|clopidogrel|mesh-list
110376803|NCT02486367|Ticagrelor|ticagrelor|mesh-list
110376804|NCT02486367|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110376805|NCT02486367|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110376806|NCT02486367|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110376807|NCT02486367|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110376808|NCT02486367|Purinergic Agents|purinergic agents|mesh-ancestor
110376809|NCT02486367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110376814|NCT00194675|Androgens|androgens|mesh-ancestor
110376815|NCT00194675|Hormones|hormones|mesh-ancestor
110376816|NCT00194675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110376817|NCT00194675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376818|NCT00194675|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110376819|NCT00194675|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110376820|NCT00194675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110376821|NCT00194675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376823|NCT00194012|Aripiprazole|aripiprazole|mesh-list
110376824|NCT00194012|Antidepressive Agents|antidepressive agents|mesh-ancestor
110376825|NCT00194012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110376826|NCT00194012|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110376827|NCT00194012|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110376828|NCT00194012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110376829|NCT00194012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376830|NCT00194012|Dopamine Agonists|dopamine agonists|mesh-ancestor
110376831|NCT00194012|Dopamine Agents|dopamine agents|mesh-ancestor
110376832|NCT00194012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110376833|NCT00194012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376834|NCT00194012|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110376835|NCT00194012|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110376836|NCT00194012|Serotonin Agents|serotonin agents|mesh-ancestor
110376837|NCT00194012|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110376838|NCT00194012|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110376839|NCT00194012|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110376840|NCT00194012|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110376841|NCT04563351|Anesthetics|anesthetics|mesh-list
110376842|NCT04563351|Anesthetics, Local|anesthetics, local|mesh-list
110376843|NCT04563351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110376844|NCT04563351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376845|NCT04563351|Sensory System Agents|sensory system agents|mesh-ancestor
110376846|NCT04563351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110376847|NCT00192647|Ribavirin|ribavirin|mesh-list
110376848|NCT00192647|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110376849|NCT00192647|Interferon alpha-2|interferon alpha-2|mesh-list
110376850|NCT00192647|Antimetabolites|antimetabolites|mesh-ancestor
110376851|NCT00192647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376852|NCT00192647|Antiviral Agents|antiviral agents|mesh-ancestor
110376853|NCT00192647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110376854|NCT00192647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110376855|NCT04563429|Vitamin A|vitamin a|mesh-list
110376856|NCT04563429|Vitamins|vitamins|mesh-ancestor
110376857|NCT04563429|Micronutrients|micronutrients|mesh-ancestor
110376858|NCT04563429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376859|NCT00192023|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110376860|NCT00192023|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110376861|NCT00192023|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110376862|NCT00192023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110376863|NCT00192023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376865|NCT00192023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110376868|NCT00191984|Pemetrexed|pemetrexed|mesh-list
110376869|NCT00191984|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110376870|NCT00191984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110376872|NCT00191984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376874|NCT00191984|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110376875|NCT00191984|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110376876|NCT04560426|Parathyroid Hormone|parathyroid hormone|mesh-list
110376877|NCT04560426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110376878|NCT04560426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376879|NCT00191906|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110376880|NCT00191906|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110376881|NCT00191906|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110376882|NCT00191906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110376883|NCT00191906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376884|NCT00191906|Adrenergic Agents|adrenergic agents|mesh-ancestor
110376885|NCT00191906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110376886|NCT00191906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376887|NCT00191789|Gemcitabine|gemcitabine|mesh-list
110376888|NCT00191789|Doxorubicin|doxorubicin|mesh-list
110376889|NCT00191789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110376890|NCT00191789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110376891|NCT00191789|Antimetabolites|antimetabolites|mesh-ancestor
110376892|NCT00191789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376893|NCT00191789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110376894|NCT00191789|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110376895|NCT00191789|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110376896|NCT00191789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110376897|NCT00191282|Insulin|insulin|mesh-list
110376898|NCT00191282|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110376899|NCT00191282|Insulin Glargine|insulin glargine|mesh-list
110376900|NCT00191282|Insulin Lispro|insulin lispro|mesh-list
110376901|NCT00191282|Isophane Insulin, Human|isophane insulin, human|mesh-list
110376902|NCT00191282|Insulin, Isophane|insulin, isophane|mesh-list
110376903|NCT00191282|Isophane insulin, beef|isophane insulin, beef|mesh-list
110376904|NCT00191282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110376905|NCT00191282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376906|NCT04560231|Remdesivir|remdesivir|mesh-list
110376907|NCT04560231|Antimetabolites|antimetabolites|mesh-ancestor
110039037|NCT04425902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110376908|NCT04560231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376909|NCT04560231|Antiviral Agents|antiviral agents|mesh-ancestor
110376910|NCT04560231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110376911|NCT00190775|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110376912|NCT00190775|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110376913|NCT00190775|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110376914|NCT00190775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110376915|NCT00190775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376916|NCT00190775|Adrenergic Agents|adrenergic agents|mesh-ancestor
110376917|NCT00190775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110376918|NCT00190775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376919|NCT00198263|Bleomycin|bleomycin|mesh-list
110376920|NCT00198263|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110376921|NCT00198263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110376922|NCT00198107|Cycloserine|cycloserine|mesh-list
110376923|NCT00198107|Aripiprazole|aripiprazole|mesh-list
110376924|NCT00198107|Antidepressive Agents|antidepressive agents|mesh-ancestor
110376925|NCT00198107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110376926|NCT00198107|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110376927|NCT00198107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110376929|NCT00198107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376930|NCT00198107|Dopamine Agonists|dopamine agonists|mesh-ancestor
110376931|NCT00198107|Dopamine Agents|dopamine agents|mesh-ancestor
110376932|NCT00198107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110376933|NCT00198107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376934|NCT00198107|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110376935|NCT00198107|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110376936|NCT00198107|Serotonin Agents|serotonin agents|mesh-ancestor
110376937|NCT00198107|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110376938|NCT00198107|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110376939|NCT00198107|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110376940|NCT00198107|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110376941|NCT00198107|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110376942|NCT00198107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110376943|NCT00198107|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110376944|NCT00198107|Antitubercular Agents|antitubercular agents|mesh-ancestor
110376945|NCT00198107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110376946|NCT00198107|Antimetabolites|antimetabolites|mesh-ancestor
110376948|NCT00179660|Immunologic Factors|immunologic factors|mesh-ancestor
110376949|NCT00179660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376950|NCT00179660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110376951|NCT00179660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110376952|NCT00179660|Growth Substances|growth substances|mesh-ancestor
110376953|NCT00179660|Growth Inhibitors|growth inhibitors|mesh-ancestor
110376955|NCT00178256|Paclitaxel|paclitaxel|mesh-list
110376956|NCT00178256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110376957|NCT00178256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110376958|NCT00178256|Tubulin Modulators|tubulin modulators|mesh-ancestor
110376959|NCT00178256|Antimitotic Agents|antimitotic agents|mesh-ancestor
110376960|NCT00178256|Mitosis Modulators|mitosis modulators|mesh-ancestor
110376961|NCT00178256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376962|NCT02211222|Lenvatinib|lenvatinib|mesh-list
110376963|NCT02211222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110376964|NCT02211222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110376965|NCT02211222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110376966|NCT02211222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376967|NCT00177164|Olanzapine|olanzapine|mesh-list
110376968|NCT00177164|Risperidone|risperidone|mesh-list
110376969|NCT00177164|Aripiprazole|aripiprazole|mesh-list
110376970|NCT00177164|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110376971|NCT00177164|Ziprasidone|ziprasidone|mesh-list
110376972|NCT00177164|Antipsychotic Agents|antipsychotic agents|mesh-list
110376973|NCT00177164|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110376974|NCT00177164|Serotonin Agents|serotonin agents|mesh-ancestor
110376975|NCT00177164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110376976|NCT00177164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376977|NCT00177164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376978|NCT00177164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110376979|NCT00177164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110376980|NCT00177164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110376981|NCT00177164|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110376982|NCT00177164|Dopamine Agents|dopamine agents|mesh-ancestor
110376983|NCT00177164|Antiemetics|antiemetics|mesh-ancestor
110376984|NCT00177164|Autonomic Agents|autonomic agents|mesh-ancestor
110376985|NCT00177164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110376986|NCT00177164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110376987|NCT00177164|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110376988|NCT00177164|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110376989|NCT00177164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110376990|NCT00177164|Antidepressive Agents|antidepressive agents|mesh-ancestor
110376991|NCT00177164|Dopamine Agonists|dopamine agonists|mesh-ancestor
110376992|NCT00177164|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110376993|NCT00177164|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110376994|NCT00177164|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110376995|NCT00177164|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110376996|NCT04559841|Simvastatin|simvastatin|mesh-list
110376997|NCT04559841|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110376999|NCT04559841|Antimetabolites|antimetabolites|mesh-ancestor
110377000|NCT04559841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110377001|NCT04559841|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110377002|NCT04559841|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110377003|NCT04559841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110377004|NCT02489942|Empagliflozin|empagliflozin|mesh-list
110377005|NCT02489942|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110377006|NCT02489942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110377007|NCT02489942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110377008|NCT02489942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110377009|NCT04559568|Midazolam|midazolam|mesh-list
110377010|NCT04559568|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110377011|NCT04559568|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110377012|NCT04559568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110377013|NCT04559568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110377014|NCT04559568|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110377015|NCT04559568|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110377016|NCT04559568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110377017|NCT04559568|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110377018|NCT04559568|Anesthetics, General|anesthetics, general|mesh-ancestor
110377020|NCT04559568|GABA Modulators|gaba modulators|mesh-ancestor
110377021|NCT04559568|GABA Agents|gaba agents|mesh-ancestor
110377022|NCT04559568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110377023|NCT04559568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110377024|NCT00176462|Leucovorin|leucovorin|mesh-list
110377025|NCT00176462|Cytarabine|cytarabine|mesh-list
110377026|NCT00176462|Dexamethasone|dexamethasone|mesh-list
110377027|NCT00176462|Hydrocortisone|hydrocortisone|mesh-list
110377028|NCT00176462|Cyclophosphamide|cyclophosphamide|mesh-list
110377029|NCT00176462|Methotrexate|methotrexate|mesh-list
110377030|NCT00176462|Vincristine|vincristine|mesh-list
110377031|NCT00176462|Asparaginase|asparaginase|mesh-list
110377032|NCT00176462|Mercaptopurine|mercaptopurine|mesh-list
110377033|NCT00176462|Daunorubicin|daunorubicin|mesh-list
110377034|NCT00176462|Thioguanine|thioguanine|mesh-list
110377035|NCT00176462|Aminopterin|aminopterin|mesh-list
110377036|NCT00176462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110377037|NCT00176462|Immunologic Factors|immunologic factors|mesh-ancestor
110377038|NCT00176462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110377039|NCT00176462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110377040|NCT00176462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110377041|NCT00176462|Alkylating Agents|alkylating agents|mesh-ancestor
110377042|NCT00176462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110377043|NCT00176462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110377044|NCT00176462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110377045|NCT00176462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110377046|NCT00176462|Antiemetics|antiemetics|mesh-ancestor
110377047|NCT00176462|Autonomic Agents|autonomic agents|mesh-ancestor
110377048|NCT00176462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110377049|NCT00176462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110377050|NCT00176462|Glucocorticoids|glucocorticoids|mesh-ancestor
110377052|NCT00176462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110377053|NCT00176462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110377054|NCT00176462|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110377056|NCT00176462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110377057|NCT00176462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110377059|NCT00176462|Dermatologic Agents|dermatologic agents|mesh-ancestor
110377060|NCT00176462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110377061|NCT00176462|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110377062|NCT00176462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110377063|NCT00176462|Antiviral Agents|antiviral agents|mesh-ancestor
110377064|NCT00176462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110377065|NCT00176462|Antidotes|antidotes|mesh-ancestor
110377066|NCT00176462|Protective Agents|protective agents|mesh-ancestor
110377067|NCT00176462|Vitamin B Complex|vitamin b complex|mesh-ancestor
110377068|NCT00176462|Vitamins|vitamins|mesh-ancestor
110377069|NCT00176462|Micronutrients|micronutrients|mesh-ancestor
110377070|NCT00176462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110377071|NCT00176462|Tubulin Modulators|tubulin modulators|mesh-ancestor
110377072|NCT00176462|Antimitotic Agents|antimitotic agents|mesh-ancestor
110377073|NCT00176462|Mitosis Modulators|mitosis modulators|mesh-ancestor
110377074|NCT00176462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110377075|NCT00176462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110377076|NCT00176462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110377077|NCT00175019|Allopurinol|allopurinol|mesh-list
110377078|NCT00175019|Febuxostat|febuxostat|mesh-list
110377079|NCT00175019|Antimetabolites|antimetabolites|mesh-ancestor
110377080|NCT00175019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110377081|NCT00175019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110377082|NCT00175019|Gout Suppressants|gout suppressants|mesh-ancestor
110377083|NCT00175019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110377084|NCT00175019|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110377085|NCT00175019|Antioxidants|antioxidants|mesh-ancestor
110377086|NCT00175019|Protective Agents|protective agents|mesh-ancestor
110377087|NCT00175019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110377088|NCT00174941|Febuxostat|febuxostat|mesh-list
110377089|NCT00174941|Gout Suppressants|gout suppressants|mesh-ancestor
110377090|NCT00174941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110377091|NCT00171704|Tamoxifen|tamoxifen|mesh-list
110377092|NCT00171704|Letrozole|letrozole|mesh-list
110377093|NCT00171704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110377094|NCT00171704|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110377095|NCT00171704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110377096|NCT00171704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110377097|NCT00171704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110377098|NCT00171704|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110377099|NCT00171704|Hormone Antagonists|hormone antagonists|mesh-ancestor
110377100|NCT00171704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110377101|NCT00171704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110377102|NCT00171704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110377103|NCT00171704|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110377104|NCT00171704|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110377105|NCT00171704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110377107|NCT00171314|Letrozole|letrozole|mesh-list
110377108|NCT00171314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110377109|NCT00171314|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110377110|NCT00171314|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110377111|NCT00171314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110377112|NCT00171314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110377113|NCT00171314|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110377114|NCT00171314|Hormone Antagonists|hormone antagonists|mesh-ancestor
110377115|NCT00171314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110377116|NCT00171314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110377117|NCT00171314|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110377119|NCT00171158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110377120|NCT00171158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110377121|NCT00171158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110377122|NCT00171158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110377123|NCT00170846|Everolimus|everolimus|mesh-list
110377124|NCT00170846|Azathioprine|azathioprine|mesh-list
110377125|NCT00170846|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
110377126|NCT00170846|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110377127|NCT00170846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110377128|NCT00170846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110377129|NCT00170846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110377130|NCT00170846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110377131|NCT00170846|Immunologic Factors|immunologic factors|mesh-ancestor
110377132|NCT00170846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110377133|NCT00170846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110377134|NCT00170846|Antimetabolites|antimetabolites|mesh-ancestor
110377135|NCT00170846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110377136|NCT00170846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110377137|NCT00476606|Ritonavir|ritonavir|mesh-list
110377138|NCT00476606|Nelfinavir|nelfinavir|mesh-list
110377139|NCT00476606|Indinavir|indinavir|mesh-list
110377140|NCT00476606|Saquinavir|saquinavir|mesh-list
110377141|NCT00476606|Lamivudine|lamivudine|mesh-list
110377142|NCT00476606|Zidovudine|zidovudine|mesh-list
110377143|NCT00476606|Nevirapine|nevirapine|mesh-list
110377144|NCT00476606|Stavudine|stavudine|mesh-list
110377145|NCT00476606|Didanosine|didanosine|mesh-list
110377146|NCT00476606|Efavirenz|efavirenz|mesh-list
110377147|NCT00476606|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110377148|NCT00476606|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110377149|NCT00476606|Protease Inhibitors|protease inhibitors|mesh-ancestor
110377150|NCT00476606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110377151|NCT00476606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110377153|NCT00476606|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110377154|NCT00476606|Antiviral Agents|antiviral agents|mesh-ancestor
110377155|NCT00476606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110377156|NCT00476606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110377157|NCT00476606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110377158|NCT00476606|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110377159|NCT00476606|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110377160|NCT00476606|Antimetabolites|antimetabolites|mesh-ancestor
110377161|NCT00476606|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110377162|NCT00476606|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110377163|NCT00476606|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110377164|NCT00476606|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110377165|NCT00476606|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110377167|NCT04562103|Ropivacaine|ropivacaine|mesh-list
110377168|NCT04562103|Anesthetics, Local|anesthetics, local|mesh-ancestor
110377170|NCT04562103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110377171|NCT04562103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110377172|NCT04562103|Sensory System Agents|sensory system agents|mesh-ancestor
110377175|NCT04562103|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110377176|NCT04562103|Adrenergic Agents|adrenergic agents|mesh-ancestor
110377177|NCT04562103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110377178|NCT04562103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110377179|NCT04562103|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110377180|NCT04562103|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110377181|NCT04562103|Autonomic Agents|autonomic agents|mesh-ancestor
110377182|NCT04562103|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110377183|NCT04562103|Respiratory System Agents|respiratory system agents|mesh-ancestor
110377184|NCT04562103|Mydriatics|mydriatics|mesh-ancestor
110377185|NCT04562103|Sympathomimetics|sympathomimetics|mesh-ancestor
110377186|NCT04562103|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110377187|NCT04561635|Micronutrients|micronutrients|mesh-list
110377188|NCT04561635|Trace Elements|trace elements|mesh-list
110377189|NCT04561635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110377190|NCT00479882|Simvastatin|simvastatin|mesh-list
110377191|NCT00479882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110377192|NCT00479882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110377193|NCT00479882|Antimetabolites|antimetabolites|mesh-ancestor
110377194|NCT00479882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110377195|NCT00479882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110377196|NCT00479882|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110377197|NCT00479882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110377198|NCT00479765|Paclitaxel|paclitaxel|mesh-list
110377199|NCT00479765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110377200|NCT00479765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110377201|NCT00479765|Tubulin Modulators|tubulin modulators|mesh-ancestor
110377202|NCT00479765|Antimitotic Agents|antimitotic agents|mesh-ancestor
110377203|NCT00479765|Mitosis Modulators|mitosis modulators|mesh-ancestor
110377204|NCT00479765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110377205|NCT00479687|Hyaluronic Acid|hyaluronic acid|mesh-list
110377206|NCT00479687|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110377207|NCT00479687|Immunologic Factors|immunologic factors|mesh-ancestor
110377208|NCT00479687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110377209|NCT00479687|Viscosupplements|viscosupplements|mesh-ancestor
110377210|NCT00479687|Protective Agents|protective agents|mesh-ancestor
110377211|NCT00479336|Tolvaptan|tolvaptan|mesh-list
110377212|NCT00479336|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110377213|NCT00479336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110377214|NCT00479336|Natriuretic Agents|natriuretic agents|mesh-ancestor
110377215|NCT00479336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110377216|NCT00478244|Cyclophosphamide|cyclophosphamide|mesh-list
110377217|NCT00478244|Busulfan|busulfan|mesh-list
110377218|NCT00478244|Fludarabine|fludarabine|mesh-list
110377219|NCT00478244|Fludarabine phosphate|fludarabine phosphate|mesh-list
110039343|NCT01426737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110377220|NCT00478244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110377221|NCT00478244|Immunologic Factors|immunologic factors|mesh-ancestor
110377222|NCT00478244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110377223|NCT00478244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110377224|NCT00478244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110377225|NCT00478244|Alkylating Agents|alkylating agents|mesh-ancestor
110377226|NCT00478244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110377227|NCT00478244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110377228|NCT00478244|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110377229|NCT00478244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110377230|NCT00478244|Antimetabolites|antimetabolites|mesh-ancestor
110377231|NCT00478205|Donepezil|donepezil|mesh-list
110377232|NCT00478205|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110377233|NCT00478205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110377234|NCT00478205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110377235|NCT00478205|Cholinergic Agents|cholinergic agents|mesh-ancestor
110377237|NCT00478205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110377238|NCT00478205|Nootropic Agents|nootropic agents|mesh-ancestor
110377239|NCT00477971|Dexamethasone|dexamethasone|mesh-list
110377240|NCT00477971|Melphalan|melphalan|mesh-list
110377241|NCT00477971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110377242|NCT00477971|Antiemetics|antiemetics|mesh-ancestor
110377244|NCT00477971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110377245|NCT00477971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110377246|NCT00477971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110377247|NCT00477971|Glucocorticoids|glucocorticoids|mesh-ancestor
110377248|NCT00477971|Hormones|hormones|mesh-ancestor
110377249|NCT00477971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110377250|NCT00477971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110377251|NCT00477971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110377252|NCT00477971|Immunologic Factors|immunologic factors|mesh-ancestor
110377253|NCT00477971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110377254|NCT00477971|Alkylating Agents|alkylating agents|mesh-ancestor
110377255|NCT00477971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110377256|NCT00477971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110377257|NCT00477971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110377258|NCT00477464|Capecitabine|capecitabine|mesh-list
110377259|NCT00477464|Lapatinib|lapatinib|mesh-list
110377260|NCT00477464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110377261|NCT00477464|Antimetabolites|antimetabolites|mesh-ancestor
110377262|NCT00477464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110377263|NCT00477464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110377264|NCT00477464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110377266|NCT00477386|Decitabine|decitabine|mesh-list
110377267|NCT00477386|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110377268|NCT00477386|Antimetabolites|antimetabolites|mesh-ancestor
110377269|NCT00477386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110377270|NCT00477386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110377271|NCT00477386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110377272|NCT00477269|Imatinib Mesylate|imatinib mesylate|mesh-list
110377273|NCT00477269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110377274|NCT00477269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110377275|NCT00477269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110377276|NCT00477269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110377277|NCT00476996|Methotrexate|methotrexate|mesh-list
110377278|NCT00476996|Leflunomide|leflunomide|mesh-list
110377279|NCT00476996|Ocrelizumab|ocrelizumab|mesh-list
110377280|NCT00476996|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110377281|NCT00476996|Abortifacient Agents|abortifacient agents|mesh-ancestor
110377282|NCT00476996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110377283|NCT00476996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110377284|NCT00476996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110377285|NCT00476996|Antimetabolites|antimetabolites|mesh-ancestor
110377286|NCT00476996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110377287|NCT00476996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110377288|NCT00476996|Dermatologic Agents|dermatologic agents|mesh-ancestor
110377289|NCT00476996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110377290|NCT00476996|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110377291|NCT00476996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110377292|NCT00476996|Immunologic Factors|immunologic factors|mesh-ancestor
110377293|NCT00476996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110377294|NCT00476996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110377295|NCT00476957|Sirolimus|sirolimus|mesh-list
110377296|NCT00476957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110377297|NCT00476957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110377298|NCT00476957|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110377299|NCT00476957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110377302|NCT00476957|Immunologic Factors|immunologic factors|mesh-ancestor
110377303|NCT00476957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110377304|NCT00475865|Teriflunomide|teriflunomide|mesh-list
110377305|NCT00475865|Glatiramer Acetate|glatiramer acetate|mesh-list
110377306|NCT00475865|(T,G)-A-L|(t,g)-a-l|mesh-list
110377307|NCT00475865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110377309|NCT00475865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110377310|NCT00475865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110377311|NCT00475865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110377312|NCT00475865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110377313|NCT00475865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110377315|NCT00475865|Sensory System Agents|sensory system agents|mesh-ancestor
110377316|NCT00475865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110377317|NCT00475865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110377319|NCT00475670|Docetaxel|docetaxel|mesh-list
110377320|NCT00475670|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110377321|NCT00475670|Trastuzumab|trastuzumab|mesh-list
110377322|NCT00475670|Taxane|taxane|mesh-list
110377323|NCT00475670|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110377324|NCT00475670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110377325|NCT00475670|Tubulin Modulators|tubulin modulators|mesh-ancestor
110377326|NCT00475670|Antimitotic Agents|antimitotic agents|mesh-ancestor
110377327|NCT00475670|Mitosis Modulators|mitosis modulators|mesh-ancestor
110377328|NCT00475670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110377330|NCT04556760|Prednisolone|prednisolone|mesh-list
110377331|NCT04556760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110377332|NCT04556760|Glucocorticoids|glucocorticoids|mesh-ancestor
110377333|NCT04556760|Hormones|hormones|mesh-ancestor
110377334|NCT04556760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110377335|NCT04556760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110377336|NCT04556760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110377337|NCT04556760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110377338|NCT00474929|Everolimus|everolimus|mesh-list
110377339|NCT00474929|Sorafenib|sorafenib|mesh-list
110377341|NCT00474929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110377342|NCT00474929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110377343|NCT00474929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110377344|NCT00474929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110377345|NCT00474929|Immunologic Factors|immunologic factors|mesh-ancestor
110377346|NCT00474929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110377347|NCT00474929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110377348|NCT00474812|Dasatinib|dasatinib|mesh-list
110377349|NCT00474812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110377350|NCT00474812|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110377351|NCT00474812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110377352|NCT00474812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110377353|NCT00474383|Abiraterone Acetate|abiraterone acetate|mesh-list
110377354|NCT00474383|Glucocorticoids|glucocorticoids|mesh-list
110377355|NCT00474383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110377356|NCT00474383|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110377357|NCT00474383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110377358|NCT00474383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110377359|NCT00474383|Hormone Antagonists|hormone antagonists|mesh-ancestor
110377360|NCT00474383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110377361|NCT00474383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110377362|NCT00474383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110377363|NCT00474383|Hormones|hormones|mesh-ancestor
110377364|NCT00472199|Pramipexole|pramipexole|mesh-list
110377365|NCT00472199|Antioxidants|antioxidants|mesh-ancestor
110377367|NCT00472199|Protective Agents|protective agents|mesh-ancestor
110377368|NCT00472199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110377369|NCT00472199|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110377370|NCT00472199|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110377371|NCT00472199|Dopamine Agonists|dopamine agonists|mesh-ancestor
110377373|NCT00472199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110377374|NCT04556136|Vitamin D|vitamin d|mesh-list
110377375|NCT04556136|Vitamins|vitamins|mesh-ancestor
110377376|NCT04556136|Micronutrients|micronutrients|mesh-ancestor
110377377|NCT04556136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110377378|NCT04556136|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110377379|NCT00471887|Tremelimumab|tremelimumab|mesh-list
110377380|NCT00471887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110377381|NCT04556058|Perindopril|perindopril|mesh-list
110377382|NCT04556058|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110377383|NCT04556058|Protease Inhibitors|protease inhibitors|mesh-ancestor
110377384|NCT04556058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110377385|NCT04556058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110377386|NCT04556058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110377387|NCT00470834|Bicalutamide|bicalutamide|mesh-list
110377388|NCT00470834|Dutasteride|dutasteride|mesh-list
110377389|NCT00470834|Androgen Antagonists|androgen antagonists|mesh-ancestor
110377390|NCT00470834|Hormone Antagonists|hormone antagonists|mesh-ancestor
110377391|NCT00470834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110377392|NCT00470834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110377394|NCT00470834|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110377395|NCT00470834|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110377396|NCT00470834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110377397|NCT00470834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110377399|NCT00470366|Ifosfamide|ifosfamide|mesh-list
110377400|NCT00470366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110377401|NCT00470366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110377402|NCT00470366|Tubulin Modulators|tubulin modulators|mesh-ancestor
110377403|NCT00470366|Antimitotic Agents|antimitotic agents|mesh-ancestor
110377404|NCT00470366|Mitosis Modulators|mitosis modulators|mesh-ancestor
110377405|NCT00470366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110377406|NCT00470366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110377407|NCT00470366|Alkylating Agents|alkylating agents|mesh-ancestor
110377408|NCT02212431|Cysteamine|cysteamine|mesh-list
110377409|NCT02212431|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
110377410|NCT02212431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110377411|NCT00470093|Interferons|interferons|mesh-list
110377412|NCT00470093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110377413|NCT00470093|Antiviral Agents|antiviral agents|mesh-ancestor
110377414|NCT00470093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110377415|NCT00470054|Dasatinib|dasatinib|mesh-list
110377416|NCT00470054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110377417|NCT00470054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110377418|NCT00470054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110377419|NCT00470054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110377420|NCT00478595|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110377421|NCT00478595|Rimonabant|rimonabant|mesh-list
110377422|NCT00478595|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110377423|NCT00478595|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
110377424|NCT00478595|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110377425|NCT00478595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110377426|NCT00478595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110377427|NCT00478595|Hormones|hormones|mesh-ancestor
110377428|NCT00478595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110377429|NCT00478595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110377430|NCT04555707|Betamethasone|betamethasone|mesh-list
110377431|NCT04555707|Betamethasone Valerate|betamethasone valerate|mesh-list
110377432|NCT04555707|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
110377433|NCT04555707|Betamethasone benzoate|betamethasone benzoate|mesh-list
110377434|NCT04555707|Apremilast|apremilast|mesh-list
110377435|NCT04555707|Calcipotriene|calcipotriene|mesh-list
110377436|NCT04555707|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
110377437|NCT04555707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110377438|NCT04555707|Glucocorticoids|glucocorticoids|mesh-ancestor
110377439|NCT04555707|Hormones|hormones|mesh-ancestor
110377440|NCT04555707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110377441|NCT04555707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110377442|NCT04555707|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110377443|NCT04555707|Respiratory System Agents|respiratory system agents|mesh-ancestor
110377444|NCT04555707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110377445|NCT04555707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110377446|NCT04555707|Analgesics|analgesics|mesh-ancestor
110377447|NCT04555707|Sensory System Agents|sensory system agents|mesh-ancestor
110377448|NCT04555707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110377449|NCT04555707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110377450|NCT04555707|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110377451|NCT04555707|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110377452|NCT04555707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110377453|NCT04555707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110377454|NCT04555707|Dermatologic Agents|dermatologic agents|mesh-ancestor
110377455|NCT00474188|Dexamethasone|dexamethasone|mesh-list
110377456|NCT00474188|Lenalidomide|lenalidomide|mesh-list
110377457|NCT00474188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110377458|NCT00474188|Antiemetics|antiemetics|mesh-ancestor
110377459|NCT00474188|Autonomic Agents|autonomic agents|mesh-ancestor
110377460|NCT00474188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110377461|NCT00474188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110377462|NCT00474188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110377463|NCT00474188|Glucocorticoids|glucocorticoids|mesh-ancestor
110377464|NCT00474188|Hormones|hormones|mesh-ancestor
110377465|NCT00474188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110377466|NCT00474188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110377467|NCT00474188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110377468|NCT00474188|Immunologic Factors|immunologic factors|mesh-ancestor
110377469|NCT00474188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110377470|NCT00474188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110377471|NCT00474188|Growth Substances|growth substances|mesh-ancestor
110377472|NCT00474188|Growth Inhibitors|growth inhibitors|mesh-ancestor
110377473|NCT01089647|Budesonide|budesonide|mesh-list
110377474|NCT01089647|Montelukast|montelukast|mesh-list
110377475|NCT01089647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110377476|NCT01089647|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110377477|NCT01089647|Autonomic Agents|autonomic agents|mesh-ancestor
110377478|NCT01089647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110377479|NCT01089647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110377480|NCT01089647|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110377481|NCT01089647|Respiratory System Agents|respiratory system agents|mesh-ancestor
110377482|NCT01089647|Glucocorticoids|glucocorticoids|mesh-ancestor
110377483|NCT01089647|Hormones|hormones|mesh-ancestor
110377484|NCT01089647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110377485|NCT01089647|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110377486|NCT01089647|Hormone Antagonists|hormone antagonists|mesh-ancestor
110377487|NCT01089647|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110377488|NCT01089647|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110377490|NCT04673240|Botulinum Toxins|botulinum toxins|mesh-list
110377491|NCT04673240|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110377492|NCT04673240|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110377493|NCT04673240|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110377494|NCT04673240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110377495|NCT04673240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110377496|NCT04673240|Cholinergic Agents|cholinergic agents|mesh-ancestor
110377497|NCT04673240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110377498|NCT04673240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110377499|NCT04673240|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110377500|NCT04673240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110377501|NCT01089608|Azithromycin|azithromycin|mesh-list
110377502|NCT01089608|Povidone|povidone|mesh-list
110377503|NCT01089608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110377504|NCT01089608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110377505|NCT01089608|Plasma Substitutes|plasma substitutes|mesh-ancestor
110377506|NCT01089608|Blood Substitutes|blood substitutes|mesh-ancestor
110377507|NCT04554654|Progesterone|progesterone|mesh-list
110377508|NCT04554654|Progestins|progestins|mesh-ancestor
110377509|NCT04554654|Hormones|hormones|mesh-ancestor
110377510|NCT04554654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110377511|NCT04554654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110377512|NCT04554615|Insulin|insulin|mesh-list
110377513|NCT04554615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110377514|NCT04554615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110377515|NCT01089413|Bevacizumab|bevacizumab|mesh-list
110377516|NCT01089413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110377517|NCT01089413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110377518|NCT01089413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110377519|NCT01089413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110377520|NCT01089413|Growth Substances|growth substances|mesh-ancestor
110377521|NCT01089413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110377522|NCT01089413|Growth Inhibitors|growth inhibitors|mesh-ancestor
110377523|NCT02212782|Linagliptin|linagliptin|mesh-list
110377524|NCT02212782|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110377525|NCT02212782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110377526|NCT02212782|Incretins|incretins|mesh-ancestor
110377527|NCT02212782|Hormones|hormones|mesh-ancestor
110377528|NCT02212782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110377529|NCT02212782|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110377530|NCT02212782|Protease Inhibitors|protease inhibitors|mesh-ancestor
110377531|NCT02212782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110377532|NCT02212782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110377533|NCT01088984|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110377534|NCT01088984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110377535|NCT01088984|Alkylating Agents|alkylating agents|mesh-ancestor
110377536|NCT01088984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110377537|NCT01088984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110377539|NCT02212821|Erythromycin Estolate|erythromycin estolate|mesh-list
110377540|NCT02212821|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
110377541|NCT02212821|Erythromycin stearate|erythromycin stearate|mesh-list
110377542|NCT02212821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110377543|NCT02212821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110377544|NCT02212821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110377545|NCT02212821|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110377546|NCT02212821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110377547|NCT02212821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110377548|NCT01088243|Mesalamine|mesalamine|mesh-list
110377549|NCT01088243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110377550|NCT01088243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110377553|NCT01088243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110377554|NCT01088243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110377555|NCT01088243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110377556|NCT01088243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110377558|NCT04672499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110377559|NCT04554303|Amlodipine|amlodipine|mesh-list
110377560|NCT04554303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110377561|NCT04554303|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110377562|NCT04554303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110377563|NCT04554303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110377564|NCT04554303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110377565|NCT04554303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110377566|NCT04554303|Vasodilator Agents|vasodilator agents|mesh-ancestor
110377568|NCT01088048|Fludarabine|fludarabine|mesh-list
110377569|NCT01088048|Lenalidomide|lenalidomide|mesh-list
110377571|NCT01088048|Bortezomib|bortezomib|mesh-list
110377572|NCT01088048|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110377573|NCT01088048|Ofatumumab|ofatumumab|mesh-list
110377574|NCT01088048|Idelalisib|idelalisib|mesh-list
110377575|NCT01088048|Chlorambucil|chlorambucil|mesh-list
110377576|NCT01088048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110377577|NCT01088048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110377578|NCT01088048|Immunologic Factors|immunologic factors|mesh-ancestor
110377579|NCT01088048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110377580|NCT01088048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110377581|NCT01088048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110377582|NCT01088048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110377583|NCT01088048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110377584|NCT01088048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110377585|NCT01088048|Growth Substances|growth substances|mesh-ancestor
110377586|NCT01088048|Growth Inhibitors|growth inhibitors|mesh-ancestor
110377587|NCT01088048|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110377588|NCT01088048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110377589|NCT01088048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110377590|NCT01088048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110377591|NCT01088048|Alkylating Agents|alkylating agents|mesh-ancestor
110377592|NCT01087970|Carboplatin|carboplatin|mesh-list
110377593|NCT01087970|Pemetrexed|pemetrexed|mesh-list
110377594|NCT01087970|Cetuximab|cetuximab|mesh-list
110377595|NCT01087970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110377596|NCT01087970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110377597|NCT01087970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110377598|NCT01087970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110377599|NCT01087970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110377600|NCT01087970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110377602|NCT01087814|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110377603|NCT01087814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110377604|NCT01087814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110377605|NCT01087814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110377608|NCT01087814|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110377609|NCT01087814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110377610|NCT01087814|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110377611|NCT01087814|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110377612|NCT01087814|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110377613|NCT01087814|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110377615|NCT04554030|Immunologic Factors|immunologic factors|mesh-ancestor
110377616|NCT04554030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110377617|NCT01087502|Glimepiride|glimepiride|mesh-list
110377618|NCT01087502|Linagliptin|linagliptin|mesh-list
110377619|NCT01087502|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110377620|NCT01087502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110377621|NCT01087502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110377622|NCT01087502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110377623|NCT01087502|Immunologic Factors|immunologic factors|mesh-ancestor
110377624|NCT01087502|Incretins|incretins|mesh-ancestor
110377626|NCT01087502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110377627|NCT01087502|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110377628|NCT01087502|Protease Inhibitors|protease inhibitors|mesh-ancestor
110377629|NCT01087502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110377630|NCT01087502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110377631|NCT02213211|Lumefantrine|lumefantrine|mesh-list
110377632|NCT02213211|Artemether|artemether|mesh-list
110377633|NCT02213211|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110377634|NCT02213211|Artemisinins|artemisinins|mesh-list
110377635|NCT02213211|Artemisinin|artemisinin|mesh-list
110377636|NCT02213211|Antimalarials|antimalarials|mesh-ancestor
110377637|NCT02213211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110377638|NCT02213211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110377639|NCT02213211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110377640|NCT01086410|Fluticasone|fluticasone|mesh-list
110377641|NCT01086410|Xhance|xhance|mesh-list
110377642|NCT01086410|Prednisolone|prednisolone|mesh-list
110377643|NCT01086410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110377644|NCT01086410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110377645|NCT01086410|Autonomic Agents|autonomic agents|mesh-ancestor
110377646|NCT01086410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110377647|NCT01086410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110377648|NCT01086410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110377649|NCT01086410|Respiratory System Agents|respiratory system agents|mesh-ancestor
110377650|NCT01086410|Dermatologic Agents|dermatologic agents|mesh-ancestor
110377651|NCT01086410|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110377652|NCT01086410|Glucocorticoids|glucocorticoids|mesh-ancestor
110377653|NCT01086410|Hormones|hormones|mesh-ancestor
110377654|NCT01086410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110377655|NCT01086410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110377656|NCT01086410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110377658|NCT04553601|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110377659|NCT04553601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110377660|NCT04553328|Bupivacaine|bupivacaine|mesh-list
110377661|NCT04553328|Anesthetics, Local|anesthetics, local|mesh-ancestor
110377662|NCT04553328|Anesthetics|anesthetics|mesh-ancestor
110377663|NCT04553328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110377664|NCT04553328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110377665|NCT04553328|Sensory System Agents|sensory system agents|mesh-ancestor
110377666|NCT04553328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110377667|NCT01085591|Vancomycin|vancomycin|mesh-list
110377668|NCT01085591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110377669|NCT01085591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110377670|NCT04552977|Temozolomide|temozolomide|mesh-list
110377671|NCT04552977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110377672|NCT04552977|Alkylating Agents|alkylating agents|mesh-ancestor
110377673|NCT04552977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110377674|NCT04552977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110377675|NCT01085201|Regadenoson|regadenoson|mesh-list
110377676|NCT01085201|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
110377677|NCT01085201|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110377678|NCT01085201|Purinergic Agonists|purinergic agonists|mesh-ancestor
110377679|NCT01085201|Purinergic Agents|purinergic agents|mesh-ancestor
110377680|NCT01085201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110377681|NCT01085201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110377683|NCT02213718|Sufentanil|sufentanil|mesh-list
110377684|NCT02213718|Propofol|propofol|mesh-list
110377685|NCT02213718|Desflurane|desflurane|mesh-list
110377686|NCT02213718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110377687|NCT02213718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110377688|NCT02213718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110377689|NCT02213718|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110377690|NCT02213718|Anesthetics, General|anesthetics, general|mesh-ancestor
110377692|NCT02213718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110377693|NCT02213718|Narcotics|narcotics|mesh-ancestor
110377694|NCT02213718|Analgesics|analgesics|mesh-ancestor
110377695|NCT02213718|Sensory System Agents|sensory system agents|mesh-ancestor
110377696|NCT02213718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110377697|NCT02213718|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110377698|NCT02213718|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110377699|NCT01085045|Bromides|bromides|mesh-list
110377700|NCT01085045|Formoterol Fumarate|formoterol fumarate|mesh-list
110377701|NCT01085045|Tiotropium Bromide|tiotropium bromide|mesh-list
110377702|NCT01085045|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110377703|NCT01085045|Autonomic Agents|autonomic agents|mesh-ancestor
110377704|NCT01085045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110377705|NCT01085045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110377706|NCT01085045|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110377707|NCT01085045|Respiratory System Agents|respiratory system agents|mesh-ancestor
110377708|NCT01085045|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110377709|NCT01085045|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110377710|NCT01085045|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110377711|NCT01085045|Adrenergic Agents|adrenergic agents|mesh-ancestor
110377712|NCT01085045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110377713|NCT01085045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110377714|NCT01085045|Parasympatholytics|parasympatholytics|mesh-ancestor
110377715|NCT01085045|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110377716|NCT01085045|Cholinergic Agents|cholinergic agents|mesh-ancestor
110377717|NCT01085045|Anticonvulsants|anticonvulsants|mesh-ancestor
110377718|NCT02213796|Meropenem|meropenem|mesh-list
110377719|NCT02213796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110377720|NCT02213796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110377721|NCT00179673|Lenalidomide|lenalidomide|mesh-list
110377722|NCT00179673|Immunologic Factors|immunologic factors|mesh-ancestor
110377723|NCT00179673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110377724|NCT00179673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110377725|NCT00179673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110377726|NCT00179673|Growth Substances|growth substances|mesh-ancestor
110377727|NCT00179673|Growth Inhibitors|growth inhibitors|mesh-ancestor
110377728|NCT00179673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110377729|NCT01084655|Prednisone|prednisone|mesh-list
110377730|NCT01084655|Docetaxel|docetaxel|mesh-list
110377731|NCT01084655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110377733|NCT01084655|Antimitotic Agents|antimitotic agents|mesh-ancestor
110377734|NCT01084655|Mitosis Modulators|mitosis modulators|mesh-ancestor
110377735|NCT01084655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110377736|NCT01084655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110377737|NCT01084655|Glucocorticoids|glucocorticoids|mesh-ancestor
110377738|NCT01084655|Hormones|hormones|mesh-ancestor
110377739|NCT01084655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110377740|NCT01084655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110377741|NCT01084655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110377742|NCT04552431|Ciprofloxacin|ciprofloxacin|mesh-list
110377743|NCT04552431|Tamsulosin|tamsulosin|mesh-list
110377744|NCT04552431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110377745|NCT04552431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110377746|NCT04552431|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110377747|NCT04552431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110377748|NCT04552431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110377749|NCT04552431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110377750|NCT04552431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110377751|NCT04552431|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110377752|NCT04552431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110377753|NCT04552431|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110377754|NCT04552431|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110377756|NCT04552431|Adrenergic Agents|adrenergic agents|mesh-ancestor
110377757|NCT04552431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110377758|NCT04552431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110377759|NCT04552431|Urological Agents|urological agents|mesh-ancestor
110377760|NCT01084538|Ergocalciferols|ergocalciferols|mesh-list
110377761|NCT01084538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110377762|NCT01084538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110377763|NCT01084538|Vitamins|vitamins|mesh-ancestor
110377764|NCT01084538|Micronutrients|micronutrients|mesh-ancestor
110377765|NCT01084538|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110377766|NCT00179517|Anastrozole|anastrozole|mesh-list
110377767|NCT00179517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110377768|NCT00179517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110377769|NCT00179517|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110377770|NCT00179517|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110377771|NCT00179517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110377772|NCT00179517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110377773|NCT00179517|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110377774|NCT00179517|Hormone Antagonists|hormone antagonists|mesh-ancestor
110377775|NCT00179517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110377776|NCT00179517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110377777|NCT01083641|Estradiol|estradiol|mesh-list
110377778|NCT01083641|Estrogens|estrogens|mesh-ancestor
110377780|NCT01083641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110377781|NCT01083641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110377782|NCT00179010|Adenosine|adenosine|mesh-list
110377783|NCT00179010|Analgesics|analgesics|mesh-ancestor
110377784|NCT00179010|Sensory System Agents|sensory system agents|mesh-ancestor
110377785|NCT00179010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110377786|NCT00179010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110377788|NCT00179010|Vasodilator Agents|vasodilator agents|mesh-ancestor
110377789|NCT00179010|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110377790|NCT00179010|Purinergic Agonists|purinergic agonists|mesh-ancestor
110377793|NCT00179010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110377794|NCT01083602|Dexamethasone|dexamethasone|mesh-list
110377795|NCT01083602|Bortezomib|bortezomib|mesh-list
110377796|NCT01083602|Panobinostat|panobinostat|mesh-list
110377797|NCT01083602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110377798|NCT01083602|Antiemetics|antiemetics|mesh-ancestor
110377799|NCT01083602|Autonomic Agents|autonomic agents|mesh-ancestor
110377800|NCT01083602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110377801|NCT01083602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110377802|NCT01083602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110377803|NCT01083602|Glucocorticoids|glucocorticoids|mesh-ancestor
110377804|NCT01083602|Hormones|hormones|mesh-ancestor
110377805|NCT01083602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110377806|NCT01083602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110377807|NCT01083602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110377808|NCT01083602|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110377809|NCT01083602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110377810|NCT01083602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110377811|NCT00178464|Aspirin|aspirin|mesh-list
110377812|NCT00178464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110377813|NCT00178464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110377814|NCT00178464|Analgesics|analgesics|mesh-ancestor
110377815|NCT00178464|Sensory System Agents|sensory system agents|mesh-ancestor
110377816|NCT00178464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110377817|NCT00178464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110377818|NCT00178464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110377819|NCT00178464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110377820|NCT00178464|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110377821|NCT00178464|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110377822|NCT00178464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110377823|NCT00178464|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110377824|NCT00178464|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110377825|NCT00178464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110377826|NCT00178464|Antipyretics|antipyretics|mesh-ancestor
110377827|NCT04671914|Hyaluronic Acid|hyaluronic acid|mesh-list
110377828|NCT04671914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110377829|NCT04671914|Immunologic Factors|immunologic factors|mesh-ancestor
110377830|NCT04671914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110377831|NCT04671914|Viscosupplements|viscosupplements|mesh-ancestor
110377832|NCT04671914|Protective Agents|protective agents|mesh-ancestor
110377833|NCT01083485|Oxycodone|oxycodone|mesh-list
110377834|NCT01083485|Naloxone|naloxone|mesh-list
110377835|NCT01083485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110377836|NCT01083485|Narcotics|narcotics|mesh-ancestor
110377837|NCT01083485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110377838|NCT01083485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110377839|NCT01083485|Analgesics|analgesics|mesh-ancestor
110377840|NCT01083485|Sensory System Agents|sensory system agents|mesh-ancestor
110377841|NCT01083485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110377842|NCT01083485|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110377843|NCT04551924|Ropivacaine|ropivacaine|mesh-list
110377844|NCT04551924|Anesthetics, Local|anesthetics, local|mesh-ancestor
110377845|NCT04551924|Anesthetics|anesthetics|mesh-ancestor
110377846|NCT04551924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110377847|NCT04551924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110377848|NCT04551924|Sensory System Agents|sensory system agents|mesh-ancestor
110377849|NCT04551924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110377850|NCT04671836|Lorazepam|lorazepam|mesh-list
110377851|NCT04671836|Anticonvulsants|anticonvulsants|mesh-ancestor
110377852|NCT04671836|Antiemetics|antiemetics|mesh-ancestor
110377853|NCT04671836|Autonomic Agents|autonomic agents|mesh-ancestor
110377854|NCT04671836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110377855|NCT04671836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110377856|NCT04671836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110377857|NCT04671836|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110377858|NCT04671836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110377859|NCT04671836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110377860|NCT04671836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110377861|NCT04671836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110377862|NCT04671836|GABA Modulators|gaba modulators|mesh-ancestor
110377863|NCT04671836|GABA Agents|gaba agents|mesh-ancestor
110377864|NCT04671836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110377865|NCT04671836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110377867|NCT00556088|Bevacizumab|bevacizumab|mesh-list
110377868|NCT00556088|Carboplatin|carboplatin|mesh-list
110377869|NCT00556088|Panobinostat|panobinostat|mesh-list
110377870|NCT00556088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110377871|NCT00556088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110377872|NCT00556088|Tubulin Modulators|tubulin modulators|mesh-ancestor
110377873|NCT00556088|Antimitotic Agents|antimitotic agents|mesh-ancestor
110377874|NCT00556088|Mitosis Modulators|mitosis modulators|mesh-ancestor
110377875|NCT00556088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110377876|NCT00556088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110377877|NCT00556088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110377878|NCT00556088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110377879|NCT00556088|Growth Substances|growth substances|mesh-ancestor
110377880|NCT00556088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110377881|NCT00556088|Growth Inhibitors|growth inhibitors|mesh-ancestor
110377882|NCT00556088|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110377883|NCT00556088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110377884|NCT00177294|Escitalopram|escitalopram|mesh-list
110377885|NCT00177294|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110377886|NCT00177294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110377887|NCT00177294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110377888|NCT00177294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110377889|NCT00177294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110377890|NCT00177294|Serotonin Agents|serotonin agents|mesh-ancestor
110377891|NCT00177294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110377892|NCT01082081|Acetaminophen|acetaminophen|mesh-list
110377893|NCT01082081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110377894|NCT01082081|Analgesics|analgesics|mesh-ancestor
110377895|NCT01082081|Sensory System Agents|sensory system agents|mesh-ancestor
110377896|NCT01082081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110377897|NCT01082081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110377898|NCT01082081|Antipyretics|antipyretics|mesh-ancestor
110377899|NCT00177216|Zolpidem|zolpidem|mesh-list
110377900|NCT00177216|Escitalopram|escitalopram|mesh-list
110377901|NCT00177216|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110377902|NCT00177216|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110377903|NCT00177216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110377904|NCT00177216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110377905|NCT00177216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110377907|NCT00177216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110377908|NCT00177216|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110377909|NCT00177216|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110377910|NCT00177216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110377911|NCT00177216|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110377912|NCT00177216|GABA Agonists|gaba agonists|mesh-ancestor
110377913|NCT00177216|GABA Agents|gaba agents|mesh-ancestor
110377914|NCT01081769|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110377915|NCT01081769|Antipsychotic Agents|antipsychotic agents|mesh-list
110377916|NCT01081769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110377917|NCT01081769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110377918|NCT01081769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110377919|NCT01081769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110377920|NCT01081769|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110377921|NCT01081769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110377922|NCT01081769|Serotonin Agents|serotonin agents|mesh-ancestor
110377923|NCT01081769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110377924|NCT01081769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110377925|NCT01081769|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110377926|NCT01081769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110377927|NCT01081769|Dopamine Agents|dopamine agents|mesh-ancestor
110377929|NCT04551768|Antimetabolites|antimetabolites|mesh-ancestor
110377930|NCT04551768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110377931|NCT04551768|Antiviral Agents|antiviral agents|mesh-ancestor
110377932|NCT04551768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110377934|NCT04671563|Antiviral Agents|antiviral agents|mesh-ancestor
110377935|NCT04671563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110377936|NCT04671563|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110377937|NCT04671563|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110377938|NCT04671563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110377939|NCT04671563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110377940|NCT04671563|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110377941|NCT04671563|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110377942|NCT04551573|Rifapentine|rifapentine|mesh-list
110377944|NCT04551573|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110377946|NCT04551573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110377947|NCT04551573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110377948|NCT04551573|Leprostatic Agents|leprostatic agents|mesh-ancestor
110377949|NCT04551573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110377950|NCT04551573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110377951|NCT04551573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110377952|NCT04551573|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110377953|NCT04551573|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110377954|NCT04551573|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110377955|NCT04551573|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110377956|NCT04551573|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110377957|NCT04551573|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110377958|NCT01081145|Guanfacine|guanfacine|mesh-list
110377959|NCT01081145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110377960|NCT01081145|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110377962|NCT01081145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110377963|NCT01081145|Adrenergic Agents|adrenergic agents|mesh-ancestor
110377965|NCT01081145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110377966|NCT01081145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110377969|NCT00174915|Antimetabolites|antimetabolites|mesh-ancestor
110377970|NCT00174915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110377971|NCT00174915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110377972|NCT00174915|Gout Suppressants|gout suppressants|mesh-ancestor
110377973|NCT00174915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110377974|NCT00174915|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110377975|NCT00174915|Antioxidants|antioxidants|mesh-ancestor
110377976|NCT00174915|Protective Agents|protective agents|mesh-ancestor
110377977|NCT00174915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110377978|NCT01080716|Vaccines|vaccines|mesh-list
110377979|NCT01080716|Complement Factor H|complement factor h|mesh-list
110377980|NCT01080716|Immunologic Factors|immunologic factors|mesh-ancestor
110377981|NCT01080716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110377982|NCT01080716|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110377983|NCT01080716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110377984|NCT04671446|Autoantibodies|autoantibodies|mesh-list
110377985|NCT04671446|Immunologic Factors|immunologic factors|mesh-ancestor
110377986|NCT04671446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110377987|NCT04571489|Gemcitabine|gemcitabine|mesh-list
110377989|NCT04571489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110377990|NCT04571489|Antimetabolites|antimetabolites|mesh-ancestor
110377991|NCT04571489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110377992|NCT04571489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110377993|NCT00172185|Teduglutide|teduglutide|mesh-list
110377994|NCT00172185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110377995|NCT00172185|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110377996|NCT00172185|Protective Agents|protective agents|mesh-ancestor
110377997|NCT00172185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110377998|NCT00171951|Pasireotide|pasireotide|mesh-list
110377999|NCT00171951|Hormones|hormones|mesh-ancestor
110378000|NCT00171951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110378001|NCT00171951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378003|NCT01080131|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110378004|NCT01080131|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110378005|NCT01080131|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110378006|NCT01080131|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110378007|NCT01080131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110378008|NCT01080131|Glucocorticoids|glucocorticoids|mesh-ancestor
110378009|NCT01080131|Hormones|hormones|mesh-ancestor
110378010|NCT01080131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110378011|NCT01080131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378012|NCT01080131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110378013|NCT01080131|Immunologic Factors|immunologic factors|mesh-ancestor
110378014|NCT01080131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110378015|NCT01080131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110378016|NCT00171873|Octreotide|octreotide|mesh-list
110378017|NCT00171873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110378018|NCT00171873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110378019|NCT00171873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110378020|NCT01087151|Rituximab|rituximab|mesh-list
110378021|NCT01087151|Navitoclax|navitoclax|mesh-list
110378022|NCT01087151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110378024|NCT01087151|Immunologic Factors|immunologic factors|mesh-ancestor
110378025|NCT01087151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378026|NCT01087151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110378027|NCT00171834|Epothilones|epothilones|mesh-list
110378028|NCT00171834|Epothilone B|epothilone b|mesh-list
110378029|NCT00171834|Tubulin Modulators|tubulin modulators|mesh-ancestor
110378030|NCT00171834|Antimitotic Agents|antimitotic agents|mesh-ancestor
110378031|NCT00171834|Mitosis Modulators|mitosis modulators|mesh-ancestor
110378032|NCT00171834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110378033|NCT00171834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110378038|NCT04571996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110378039|NCT04571996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378040|NCT04571996|Antipyretics|antipyretics|mesh-ancestor
110378041|NCT00171249|Imatinib Mesylate|imatinib mesylate|mesh-list
110378042|NCT00171249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110378043|NCT00171249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110378044|NCT00171249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110378045|NCT00171249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110378046|NCT04671056|Pioglitazone|pioglitazone|mesh-list
110378047|NCT04671056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110378048|NCT04671056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378049|NCT01082549|Carboplatin|carboplatin|mesh-list
110378050|NCT01082549|Gemcitabine|gemcitabine|mesh-list
110378051|NCT01082549|Iniparib|iniparib|mesh-list
110378052|NCT01082549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110378053|NCT01082549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110378054|NCT01082549|Antimetabolites|antimetabolites|mesh-ancestor
110378055|NCT01082549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110378056|NCT01082549|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110378057|NCT01082549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110378058|NCT04550949|Denosumab|denosumab|mesh-list
110378059|NCT04550949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110378060|NCT04550949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378061|NCT01085630|Pemetrexed|pemetrexed|mesh-list
110378062|NCT01085630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110378063|NCT01085630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110378064|NCT01085630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110378065|NCT01085630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110378066|NCT01085630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110378067|NCT00171210|Deferasirox|deferasirox|mesh-list
110378068|NCT00171210|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110378069|NCT00171210|Chelating Agents|chelating agents|mesh-ancestor
110378070|NCT00171210|Sequestering Agents|sequestering agents|mesh-ancestor
110378071|NCT00171210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110378072|NCT00171054|Amlodipine|amlodipine|mesh-list
110378073|NCT00171054|Valsartan|valsartan|mesh-list
110378074|NCT00171054|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110378075|NCT00171054|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110378076|NCT00171054|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110378077|NCT00171054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110378078|NCT00171054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110378079|NCT00171054|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110378080|NCT00171054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378081|NCT00171054|Vasodilator Agents|vasodilator agents|mesh-ancestor
110378082|NCT00171054|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110378083|NCT00171054|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110378085|NCT00171054|Natriuretic Agents|natriuretic agents|mesh-ancestor
110378086|NCT00171054|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110378087|NCT00174837|Tirapazamine|tirapazamine|mesh-list
110378088|NCT00174837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110378089|NCT00179400|Pioglitazone|pioglitazone|mesh-list
110378090|NCT00179400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110378091|NCT00179400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378095|NCT04550793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110378097|NCT04550793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110378098|NCT04550793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378099|NCT00479856|Paclitaxel|paclitaxel|mesh-list
110378100|NCT00479856|Docetaxel|docetaxel|mesh-list
110378101|NCT00479856|Capecitabine|capecitabine|mesh-list
110378102|NCT00479856|Lapatinib|lapatinib|mesh-list
110378103|NCT00479856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110378104|NCT00479856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110378105|NCT00479856|Tubulin Modulators|tubulin modulators|mesh-ancestor
110378106|NCT00479856|Antimitotic Agents|antimitotic agents|mesh-ancestor
110378107|NCT00479856|Mitosis Modulators|mitosis modulators|mesh-ancestor
110378108|NCT00479856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110378109|NCT00479856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110378110|NCT00479856|Antimetabolites|antimetabolites|mesh-ancestor
110378111|NCT00479856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110378112|NCT00479856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110378113|NCT04997759|Neostigmine|neostigmine|mesh-list
110378114|NCT04997759|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110378115|NCT04997759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110378116|NCT04997759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110378117|NCT04997759|Cholinergic Agents|cholinergic agents|mesh-ancestor
110378118|NCT04997759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110378119|NCT04997759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378120|NCT04997759|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110378121|NCT04997759|Autonomic Agents|autonomic agents|mesh-ancestor
110378122|NCT04997759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110378123|NCT00479466|Metformin|metformin|mesh-list
110378124|NCT00479466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110378125|NCT00479466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378126|NCT04991948|Pembrolizumab|pembrolizumab|mesh-list
110378127|NCT04991948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110378128|NCT04991948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110378129|NCT04991948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110378130|NCT04991948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110378131|NCT04990778|Venetoclax|venetoclax|mesh-list
110378132|NCT04990778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110378135|NCT00479388|Simvastatin|simvastatin|mesh-list
110378136|NCT00479388|Calcium|calcium|mesh-list
110378137|NCT00479388|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110378138|NCT00479388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378139|NCT00479388|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110378140|NCT00479388|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110378141|NCT00479388|Antimetabolites|antimetabolites|mesh-ancestor
110378142|NCT00479388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110378143|NCT00479388|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110378144|NCT00479388|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110378145|NCT00479388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110378146|NCT00479388|Vasodilator Agents|vasodilator agents|mesh-ancestor
110378147|NCT00479388|Vitamin B Complex|vitamin b complex|mesh-ancestor
110378148|NCT00479388|Vitamins|vitamins|mesh-ancestor
110378149|NCT00479388|Micronutrients|micronutrients|mesh-ancestor
110378150|NCT00479232|Decitabine|decitabine|mesh-list
110378151|NCT00479232|Vorinostat|vorinostat|mesh-list
110378152|NCT00479232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110378155|NCT00479232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110378156|NCT00479232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110378157|NCT00479232|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110378158|NCT00478881|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110378159|NCT00478881|Vasodilator Agents|vasodilator agents|mesh-ancestor
110378160|NCT00478881|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110378162|NCT00478881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110378163|NCT00478881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110378164|NCT00478881|Urological Agents|urological agents|mesh-ancestor
110378165|NCT00556127|Cytarabine|cytarabine|mesh-list
110378166|NCT00556127|Dexamethasone|dexamethasone|mesh-list
110378167|NCT00556127|Prednisone|prednisone|mesh-list
110378168|NCT00556127|Cyclophosphamide|cyclophosphamide|mesh-list
110378169|NCT00556127|Melphalan|melphalan|mesh-list
110378170|NCT00556127|Carmustine|carmustine|mesh-list
110378171|NCT00556127|Rituximab|rituximab|mesh-list
110378172|NCT00556127|Etoposide|etoposide|mesh-list
110378173|NCT00556127|Vincristine|vincristine|mesh-list
110378174|NCT00556127|Epirubicin|epirubicin|mesh-list
110378175|NCT00556127|Mitoxantrone|mitoxantrone|mesh-list
110378176|NCT00556127|Lenograstim|lenograstim|mesh-list
110378177|NCT00556127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110378178|NCT00556127|Immunologic Factors|immunologic factors|mesh-ancestor
110378179|NCT00556127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378180|NCT00556127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110378181|NCT00556127|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110378182|NCT00556127|Alkylating Agents|alkylating agents|mesh-ancestor
110378183|NCT00556127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110378184|NCT00556127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110378185|NCT00556127|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110378186|NCT00556127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110378187|NCT00556127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110378188|NCT00556127|Antiemetics|antiemetics|mesh-ancestor
110378189|NCT00556127|Autonomic Agents|autonomic agents|mesh-ancestor
110378190|NCT00556127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110378191|NCT00556127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110378192|NCT00556127|Glucocorticoids|glucocorticoids|mesh-ancestor
110378193|NCT00556127|Hormones|hormones|mesh-ancestor
110378194|NCT00556127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110378195|NCT00556127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110378196|NCT00556127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110378197|NCT00556127|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110378198|NCT00556127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110378199|NCT00556127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110378200|NCT00556127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110378201|NCT00556127|Antimetabolites|antimetabolites|mesh-ancestor
110378202|NCT00556127|Antiviral Agents|antiviral agents|mesh-ancestor
110378203|NCT00556127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110378204|NCT00556127|Tubulin Modulators|tubulin modulators|mesh-ancestor
110378206|NCT00556127|Mitosis Modulators|mitosis modulators|mesh-ancestor
110378207|NCT00556127|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110378208|NCT00556127|Analgesics|analgesics|mesh-ancestor
110378209|NCT00556127|Sensory System Agents|sensory system agents|mesh-ancestor
110378210|NCT00556127|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110378211|NCT00556205|Bevacizumab|bevacizumab|mesh-list
110378212|NCT00556205|Sunitinib|sunitinib|mesh-list
110378213|NCT00556205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110378214|NCT00556205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110378217|NCT00556205|Growth Substances|growth substances|mesh-ancestor
110378218|NCT00556205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378219|NCT00556205|Growth Inhibitors|growth inhibitors|mesh-ancestor
110378220|NCT00556205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110378221|NCT00556205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110378222|NCT00556205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110378224|NCT00478608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110378225|NCT00478608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110378226|NCT00478608|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110378227|NCT00478608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110378228|NCT00478608|Antifungal Agents|antifungal agents|mesh-ancestor
110378229|NCT00478608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110378230|NCT00478608|Immunologic Factors|immunologic factors|mesh-ancestor
110378231|NCT00478608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378232|NCT00478140|Trastuzumab|trastuzumab|mesh-list
110378233|NCT00478140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110378234|NCT00478140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110378236|NCT00478023|Tapentadol|tapentadol|mesh-list
110378237|NCT00478023|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110378238|NCT00478023|Narcotics|narcotics|mesh-ancestor
110378239|NCT00478023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110378240|NCT00478023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378241|NCT00478023|Analgesics|analgesics|mesh-ancestor
110378242|NCT00478023|Sensory System Agents|sensory system agents|mesh-ancestor
110378243|NCT00478023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110378244|NCT00478023|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110378245|NCT00478023|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110378246|NCT00478023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110378247|NCT00478023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110378248|NCT00478023|Adrenergic Agents|adrenergic agents|mesh-ancestor
110378249|NCT00478023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110378250|NCT00477750|Prednisone|prednisone|mesh-list
110378251|NCT00477750|Lenalidomide|lenalidomide|mesh-list
110378252|NCT00477750|Melphalan|melphalan|mesh-list
110378253|NCT00477750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110378254|NCT00477750|Glucocorticoids|glucocorticoids|mesh-ancestor
110378255|NCT00477750|Hormones|hormones|mesh-ancestor
110378256|NCT00477750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110378257|NCT00477750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378258|NCT00477750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110378259|NCT00477750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110378260|NCT00477750|Immunologic Factors|immunologic factors|mesh-ancestor
110378261|NCT00477750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110378262|NCT00477750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110378263|NCT00477750|Growth Substances|growth substances|mesh-ancestor
110378264|NCT00477750|Growth Inhibitors|growth inhibitors|mesh-ancestor
110378265|NCT00477750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110378266|NCT00477750|Alkylating Agents|alkylating agents|mesh-ancestor
110378267|NCT00477750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110378268|NCT00477750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110378269|NCT00477750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110378270|NCT00477672|Pimavanserin|pimavanserin|mesh-list
110378271|NCT00477672|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110378272|NCT00477672|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110378273|NCT00477672|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110378274|NCT00477672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110378275|NCT00477672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110378276|NCT00477672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378277|NCT00477672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110378279|NCT00477672|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110378280|NCT00477672|Serotonin Agents|serotonin agents|mesh-ancestor
110378281|NCT00477672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110378282|NCT00477672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110378283|NCT04549935|Prednisolone|prednisolone|mesh-list
110378284|NCT04549935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110378285|NCT04549935|Glucocorticoids|glucocorticoids|mesh-ancestor
110378286|NCT04549935|Hormones|hormones|mesh-ancestor
110378287|NCT04549935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110378288|NCT04549935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378289|NCT04549935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110378290|NCT04549935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110378291|NCT00477633|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110378292|NCT00477633|Norethindrone|norethindrone|mesh-list
110378293|NCT00477633|Norethindrone Acetate|norethindrone acetate|mesh-list
110378294|NCT00477633|Estradiol|estradiol|mesh-list
110378295|NCT00477633|Estrogens|estrogens|mesh-ancestor
110378297|NCT00477633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110378298|NCT00477633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378299|NCT00477633|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110378300|NCT00477633|Contraceptive Agents|contraceptive agents|mesh-ancestor
110378301|NCT00477633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110378302|NCT00477633|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110378303|NCT00477633|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110378304|NCT00477633|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110378305|NCT00477633|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110378306|NCT04541823|Propofol|propofol|mesh-list
110378307|NCT04541823|Desflurane|desflurane|mesh-list
110378308|NCT04541823|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110378309|NCT04541823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110378310|NCT04541823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378311|NCT04541823|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110378312|NCT04541823|Anesthetics, General|anesthetics, general|mesh-ancestor
110378313|NCT04541823|Anesthetics|anesthetics|mesh-ancestor
110378314|NCT04541823|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110378315|NCT00556361|Ketamine|ketamine|mesh-list
110378316|NCT00556361|Analgesics|analgesics|mesh-ancestor
110378317|NCT00556361|Sensory System Agents|sensory system agents|mesh-ancestor
110378318|NCT00556361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110378319|NCT00556361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378320|NCT00556361|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110378321|NCT00556361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110378322|NCT00556361|Anesthetics, General|anesthetics, general|mesh-ancestor
110378323|NCT00556361|Anesthetics|anesthetics|mesh-ancestor
110378324|NCT00556361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110378325|NCT00556361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110378326|NCT00556361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110378328|NCT00556361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110378329|NCT04571606|Bupivacaine|bupivacaine|mesh-list
110378330|NCT04571606|Anesthetics, Local|anesthetics, local|mesh-ancestor
110378331|NCT04571606|Anesthetics|anesthetics|mesh-ancestor
110378332|NCT04571606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110378333|NCT04571606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378334|NCT04571606|Sensory System Agents|sensory system agents|mesh-ancestor
110378335|NCT04571606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110378336|NCT02210117|Bevacizumab|bevacizumab|mesh-list
110378337|NCT02210117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110378338|NCT02210117|Nivolumab|nivolumab|mesh-list
110378339|NCT02210117|Ipilimumab|ipilimumab|mesh-list
110378340|NCT02210117|Endothelial Growth Factors|endothelial growth factors|mesh-list
110378341|NCT02210117|Antibodies|antibodies|mesh-list
110378342|NCT02210117|Immunoglobulins|immunoglobulins|mesh-list
110378343|NCT02210117|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110378344|NCT02210117|Immunoglobulin G|immunoglobulin g|mesh-list
110378345|NCT02210117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110378346|NCT02210117|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110378347|NCT02210117|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110378348|NCT02210117|Growth Substances|growth substances|mesh-ancestor
110378349|NCT02210117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378350|NCT02210117|Growth Inhibitors|growth inhibitors|mesh-ancestor
110378351|NCT02210117|Immunologic Factors|immunologic factors|mesh-ancestor
110378352|NCT02210117|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110378353|NCT02210117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110378354|NCT04541277|Cytarabine|cytarabine|mesh-list
110378355|NCT04541277|Azacitidine|azacitidine|mesh-list
110378356|NCT04541277|Decitabine|decitabine|mesh-list
110378357|NCT04541277|Tislelizumab|tislelizumab|mesh-list
110378358|NCT04541277|Idarubicin|idarubicin|mesh-list
110378359|NCT04541277|Lenograstim|lenograstim|mesh-list
110378360|NCT04541277|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110378361|NCT04541277|Antimetabolites|antimetabolites|mesh-ancestor
110378362|NCT04541277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110378363|NCT04541277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110378364|NCT04541277|Antiviral Agents|antiviral agents|mesh-ancestor
110378365|NCT04541277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110378366|NCT04541277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110378367|NCT04541277|Immunologic Factors|immunologic factors|mesh-ancestor
110378368|NCT04541277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378369|NCT04541277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110378370|NCT04541277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110378371|NCT04541277|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110378372|NCT04541277|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110378373|NCT04541277|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110378374|NCT04541277|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110378376|NCT04540926|Cyclosporins|cyclosporins|mesh-list
110378377|NCT04540926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110378378|NCT04540926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110378379|NCT04540926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110378380|NCT04540926|Immunologic Factors|immunologic factors|mesh-ancestor
110378381|NCT04540926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378382|NCT04540926|Antifungal Agents|antifungal agents|mesh-ancestor
110378383|NCT04540926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110378384|NCT04540926|Dermatologic Agents|dermatologic agents|mesh-ancestor
110378385|NCT04540926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110378386|NCT04540926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110378387|NCT04540965|Famotidine|famotidine|mesh-list
110378388|NCT04540965|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110378389|NCT04540965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110378390|NCT04540965|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110378391|NCT04540965|Histamine Antagonists|histamine antagonists|mesh-ancestor
110378392|NCT04540965|Histamine Agents|histamine agents|mesh-ancestor
110378393|NCT04540965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110378394|NCT04540965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110378395|NCT04540965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378397|NCT04570865|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110378398|NCT04570865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110378400|NCT04570865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378401|NCT04570592|Dexamethasone|dexamethasone|mesh-list
110378402|NCT04570592|Granisetron|granisetron|mesh-list
110378403|NCT04570592|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110378404|NCT04570592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110378406|NCT04570592|Autonomic Agents|autonomic agents|mesh-ancestor
110378407|NCT04570592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110378408|NCT04570592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378409|NCT04570592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110378410|NCT04570592|Glucocorticoids|glucocorticoids|mesh-ancestor
110378411|NCT04570592|Hormones|hormones|mesh-ancestor
110378412|NCT04570592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110378413|NCT04570592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110378414|NCT04570592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110378415|NCT04570592|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110378416|NCT04570592|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110378417|NCT04570592|Serotonin Agents|serotonin agents|mesh-ancestor
110378418|NCT04570592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110378419|NCT04570592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110378420|NCT02215395|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110378421|NCT02215395|Contraceptive Agents|contraceptive agents|mesh-list
110378422|NCT02215395|Estradiol|estradiol|mesh-list
110378423|NCT02215395|Estrogens|estrogens|mesh-ancestor
110378424|NCT02215395|Hormones|hormones|mesh-ancestor
110378425|NCT02215395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110378426|NCT02215395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378427|NCT02215395|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110378428|NCT02215395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110378429|NCT02215395|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110378430|NCT02215395|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110378431|NCT02215395|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110378432|NCT02215434|Methyltestosterone|methyltestosterone|mesh-list
110378433|NCT02215434|Testosterone|testosterone|mesh-list
110378434|NCT02215434|Testosterone undecanoate|testosterone undecanoate|mesh-list
110378435|NCT02215434|Testosterone enanthate|testosterone enanthate|mesh-list
110378436|NCT02215434|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110378437|NCT02215434|Androgens|androgens|mesh-ancestor
110378438|NCT02215434|Hormones|hormones|mesh-ancestor
110378439|NCT02215434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110378440|NCT02215434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378441|NCT02215434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110378442|NCT02215434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110378443|NCT02215434|Anabolic Agents|anabolic agents|mesh-ancestor
110378444|NCT04561076|Myeloma Proteins|myeloma proteins|mesh-list
110378445|NCT04561076|Paraproteins|paraproteins|mesh-list
110378446|NCT04561076|Immunologic Factors|immunologic factors|mesh-ancestor
110378447|NCT04561076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378448|NCT02215473|Chlorhexidine|chlorhexidine|mesh-list
110378449|NCT02215473|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110378450|NCT02215473|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110378451|NCT02215473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110378452|NCT02215473|Disinfectants|disinfectants|mesh-ancestor
110378453|NCT02215473|Dermatologic Agents|dermatologic agents|mesh-ancestor
110378454|NCT04548219|Mirikizumab|mirikizumab|mesh-list
110378455|NCT04548219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110378456|NCT04548219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110378457|NCT04548219|Analgesics|analgesics|mesh-ancestor
110378458|NCT04548219|Sensory System Agents|sensory system agents|mesh-ancestor
110378459|NCT04548219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110378460|NCT04548219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378461|NCT04548219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110378462|NCT04548219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110378463|NCT04548219|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110378464|NCT04548219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110378465|NCT04547829|Lenograstim|lenograstim|mesh-list
110378466|NCT04547829|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110378467|NCT04547829|Immunologic Factors|immunologic factors|mesh-ancestor
110378468|NCT04547829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378469|NCT02211911|Bisacodyl|bisacodyl|mesh-list
110378470|NCT02211911|Picosulfate sodium|picosulfate sodium|mesh-list
110378471|NCT02211911|Cathartics|cathartics|mesh-ancestor
110378472|NCT02211911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110378473|NCT02211911|Laxatives|laxatives|mesh-ancestor
110378474|NCT01131676|Empagliflozin|empagliflozin|mesh-list
110378475|NCT01131676|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110378476|NCT01131676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110378477|NCT01131676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110378478|NCT01131676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378479|NCT04560569|Antibodies|antibodies|mesh-list
110378480|NCT04560569|Immunologic Factors|immunologic factors|mesh-ancestor
110378481|NCT04560569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378482|NCT04560101|Botulinum Toxins|botulinum toxins|mesh-list
110378483|NCT04560101|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110378484|NCT04560101|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110378485|NCT04560101|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110378486|NCT04560101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110378487|NCT04560101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110378488|NCT04560101|Cholinergic Agents|cholinergic agents|mesh-ancestor
110378489|NCT04560101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110378490|NCT04560101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378491|NCT04560101|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110378492|NCT04560101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110378493|NCT02214498|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110378494|NCT02214498|Enalapril|enalapril|mesh-list
110378495|NCT02214498|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110378496|NCT02214498|Diuretics|diuretics|mesh-ancestor
110378497|NCT02214498|Natriuretic Agents|natriuretic agents|mesh-ancestor
110378498|NCT02214498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378499|NCT02214498|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110378500|NCT02214498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110378501|NCT02214498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110378502|NCT02214498|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110378503|NCT02214498|Protease Inhibitors|protease inhibitors|mesh-ancestor
110378504|NCT02214498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110378506|NCT04560218|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110378507|NCT04560218|Abortifacient Agents|abortifacient agents|mesh-ancestor
110378508|NCT04560218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110378509|NCT04560218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378510|NCT04560218|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110378511|NCT04560218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110378512|NCT04560218|Oxytocics|oxytocics|mesh-ancestor
110378513|NCT05135104|Palbociclib|palbociclib|mesh-list
110378515|NCT05135104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110378516|NCT05135104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110378517|NCT05135104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110378518|NCT04540185|Neuroprotective Agents|neuroprotective agents|mesh-list
110378519|NCT04540185|Vaccines|vaccines|mesh-list
110378520|NCT04540185|Immunologic Factors|immunologic factors|mesh-ancestor
110378521|NCT04540185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378522|NCT04540185|Protective Agents|protective agents|mesh-ancestor
110378523|NCT01130272|Eluxadoline|eluxadoline|mesh-list
110378524|NCT01130272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110378525|NCT04546815|Daptomycin|daptomycin|mesh-list
110378526|NCT04546815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110378527|NCT04546815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110378529|NCT01129960|Anticonvulsants|anticonvulsants|mesh-ancestor
110378530|NCT01129960|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110378531|NCT01129960|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110378532|NCT01129960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110378533|NCT01129960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110378534|NCT04559165|Chitosan|chitosan|mesh-list
110378535|NCT04559165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110378536|NCT04559165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110378537|NCT04559165|Antimetabolites|antimetabolites|mesh-ancestor
110378538|NCT04559165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110378539|NCT04559165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110378540|NCT04559165|Chelating Agents|chelating agents|mesh-ancestor
110378541|NCT04559165|Sequestering Agents|sequestering agents|mesh-ancestor
110378542|NCT04559165|Hemostatics|hemostatics|mesh-ancestor
110378543|NCT04559165|Coagulants|coagulants|mesh-ancestor
110378544|NCT04312048|Isosorbide|isosorbide|mesh-list
110378545|NCT04312048|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
110378546|NCT04312048|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
110378547|NCT04312048|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110378548|NCT04312048|Diuretics|diuretics|mesh-ancestor
110378549|NCT04312048|Natriuretic Agents|natriuretic agents|mesh-ancestor
110378550|NCT04312048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378551|NCT04312048|Vasodilator Agents|vasodilator agents|mesh-ancestor
110378552|NCT04312048|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110378553|NCT04312048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110378554|NCT04311697|Phentolamine|phentolamine|mesh-list
110378555|NCT04311697|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
110378556|NCT04311697|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110378558|NCT04311697|Adrenergic Agents|adrenergic agents|mesh-ancestor
110378559|NCT04311697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110378560|NCT04311697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110378561|NCT04311697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378562|NCT04311697|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110378563|NCT04311697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110378564|NCT04311697|Vasodilator Agents|vasodilator agents|mesh-ancestor
110378565|NCT04311697|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110378566|NCT04311697|Protective Agents|protective agents|mesh-ancestor
110378568|NCT00575861|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110378569|NCT00575861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110378570|NCT00575861|Analgesics|analgesics|mesh-ancestor
110378571|NCT00575861|Sensory System Agents|sensory system agents|mesh-ancestor
110378572|NCT00575861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110378573|NCT00575861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378574|NCT00575861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110378575|NCT00575861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110378576|NCT00575861|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110378577|NCT00575861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110378578|NCT00575861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110378579|NCT00575861|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110378580|NCT00575861|Hormone Antagonists|hormone antagonists|mesh-ancestor
110378581|NCT00575861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110378582|NCT04547088|Apatinib|apatinib|mesh-list
110378583|NCT04547088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110378584|NCT04547088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110378585|NCT04547088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110378586|NCT04547088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110378588|NCT01129882|Antidepressive Agents|antidepressive agents|mesh-ancestor
110378589|NCT01129882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110378590|NCT01129882|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110378591|NCT01129882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110378592|NCT01129882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110378593|NCT01129882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378594|NCT01129882|Dopamine Agonists|dopamine agonists|mesh-ancestor
110378595|NCT01129882|Dopamine Agents|dopamine agents|mesh-ancestor
110378596|NCT01129882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110378597|NCT01129882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110378598|NCT01129882|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110378599|NCT01129882|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110378600|NCT01129882|Serotonin Agents|serotonin agents|mesh-ancestor
110378601|NCT01129882|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110378602|NCT01129882|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110378603|NCT01129882|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110378604|NCT01129882|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110378606|NCT02278419|Simeprevir|simeprevir|mesh-list
110378607|NCT02278419|Antiviral Agents|antiviral agents|mesh-ancestor
110378608|NCT02278419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110378609|NCT02278419|Protease Inhibitors|protease inhibitors|mesh-ancestor
110378610|NCT02278419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110378611|NCT02278419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110378612|NCT02882737|Glucagon|glucagon|mesh-list
110378613|NCT02882737|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110378614|NCT02882737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110378615|NCT02882737|Hormones|hormones|mesh-ancestor
110378616|NCT02882737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110378617|NCT02882737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378618|NCT02882737|Incretins|incretins|mesh-ancestor
110378619|NCT02211950|Acarbose|acarbose|mesh-list
110378620|NCT02211950|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110378621|NCT02211950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110378622|NCT02211950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110378623|NCT02211950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110378624|NCT02211950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378625|NCT04559048|Tacrolimus|tacrolimus|mesh-list
110378626|NCT04559048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110378627|NCT04559048|Immunologic Factors|immunologic factors|mesh-ancestor
110378628|NCT04559048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378629|NCT04559048|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110378630|NCT04559048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110378631|NCT04559048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110378632|NCT04538820|Dexamethasone|dexamethasone|mesh-list
110378633|NCT04538820|Dexamethasone acetate|dexamethasone acetate|mesh-list
110378634|NCT04538820|BB 1101|bb 1101|mesh-list
110378635|NCT04538820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110378636|NCT04538820|Antiemetics|antiemetics|mesh-ancestor
110378637|NCT04538820|Autonomic Agents|autonomic agents|mesh-ancestor
110378638|NCT04538820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110378639|NCT04538820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378640|NCT04538820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110378641|NCT04538820|Glucocorticoids|glucocorticoids|mesh-ancestor
110378642|NCT04538820|Hormones|hormones|mesh-ancestor
110378643|NCT04538820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110378644|NCT04538820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110378645|NCT04538820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110378646|NCT04538820|Protease Inhibitors|protease inhibitors|mesh-ancestor
110378647|NCT04538820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110378648|NCT04538820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110378649|NCT00575978|Hydralazine|hydralazine|mesh-list
110378650|NCT00575978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110378651|NCT00575978|Vasodilator Agents|vasodilator agents|mesh-ancestor
110378652|NCT04546347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110378653|NCT02882932|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110378654|NCT04539054|Caffeine|caffeine|mesh-list
110378655|NCT04539054|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110378656|NCT04539054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378658|NCT04539054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110378659|NCT04539054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110378660|NCT04539054|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110378661|NCT04539054|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110378662|NCT04539054|Purinergic Agents|purinergic agents|mesh-ancestor
110378663|NCT04539054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110378665|NCT00576017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110378666|NCT00576017|Narcotics|narcotics|mesh-ancestor
110378667|NCT00576017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110378668|NCT00576017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378669|NCT00576017|Analgesics|analgesics|mesh-ancestor
110378670|NCT00576017|Sensory System Agents|sensory system agents|mesh-ancestor
110378671|NCT00576017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110378672|NCT00576017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110378673|NCT00576017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110378674|NCT00576017|Anesthetics, General|anesthetics, general|mesh-ancestor
110378675|NCT00576017|Anesthetics|anesthetics|mesh-ancestor
110378676|NCT04558697|Tea Tree Oil|tea tree oil|mesh-list
110378677|NCT04558697|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110378678|NCT04558697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110378680|NCT04558580|Anticonvulsants|anticonvulsants|mesh-ancestor
110378681|NCT04558580|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110378682|NCT04558580|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110378683|NCT04558580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110378684|NCT04558580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110378685|NCT02278458|Gemcitabine|gemcitabine|mesh-list
110378686|NCT02278458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110378687|NCT02278458|Antimetabolites|antimetabolites|mesh-ancestor
110378688|NCT02278458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110378689|NCT02278458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110378690|NCT01128595|Fluticasone|fluticasone|mesh-list
110378691|NCT01128595|Xhance|xhance|mesh-list
110378692|NCT01128595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110378693|NCT01128595|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110378694|NCT01128595|Autonomic Agents|autonomic agents|mesh-ancestor
110378695|NCT01128595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110378696|NCT01128595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378697|NCT01128595|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110378698|NCT01128595|Respiratory System Agents|respiratory system agents|mesh-ancestor
110378699|NCT01128595|Dermatologic Agents|dermatologic agents|mesh-ancestor
110378700|NCT01128595|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110378701|NCT01129336|Zoledronic Acid|zoledronic acid|mesh-list
110378702|NCT01129336|Diphosphonates|diphosphonates|mesh-list
110378703|NCT01129336|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110040702|NCT01435161|Vasodilator Agents|vasodilator agents|mesh-ancestor
110378704|NCT01129336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378705|NCT01128244|Pyridoxine|pyridoxine|mesh-list
110378706|NCT01128244|Pyridoxal|pyridoxal|mesh-list
110378707|NCT01128244|Vitamin B 6|vitamin b 6|mesh-list
110378708|NCT01128244|Vitamins|vitamins|mesh-ancestor
110378709|NCT01128244|Micronutrients|micronutrients|mesh-ancestor
110378710|NCT01128244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378711|NCT01128244|Vitamin B Complex|vitamin b complex|mesh-ancestor
110378712|NCT01127893|Tanezumab|tanezumab|mesh-list
110378713|NCT01127893|Analgesics|analgesics|mesh-ancestor
110378714|NCT01127893|Sensory System Agents|sensory system agents|mesh-ancestor
110378715|NCT01127893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110378716|NCT01127893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378717|NCT00576173|Acetaminophen|acetaminophen|mesh-list
110378718|NCT00576173|Tramadol|tramadol|mesh-list
110378719|NCT00576173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110378720|NCT00576173|Analgesics|analgesics|mesh-ancestor
110378722|NCT00576173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110378723|NCT00576173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378724|NCT00576173|Antipyretics|antipyretics|mesh-ancestor
110378725|NCT00576173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110378726|NCT00576173|Narcotics|narcotics|mesh-ancestor
110378727|NCT00576173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110378728|NCT00625339|Lamivudine|lamivudine|mesh-list
110378729|NCT00625339|Entecavir|entecavir|mesh-list
110378730|NCT00625339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110378731|NCT00625339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110378732|NCT00625339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110378733|NCT00625339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110378734|NCT00625339|Antiviral Agents|antiviral agents|mesh-ancestor
110378735|NCT00625339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110378736|NCT00625339|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110378737|NCT00625339|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110378738|NCT02215863|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110378739|NCT02215863|Immunologic Factors|immunologic factors|mesh-ancestor
110378740|NCT02215863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378741|NCT04558463|Oseltamivir|oseltamivir|mesh-list
110378742|NCT04558463|Favipiravir|favipiravir|mesh-list
110378743|NCT04558463|Antiviral Agents|antiviral agents|mesh-ancestor
110378744|NCT04558463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110378745|NCT04558463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110378746|NCT04558463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110378747|NCT01126879|Genistein|genistein|mesh-list
110378748|NCT01126879|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110378749|NCT01126879|Protective Agents|protective agents|mesh-ancestor
110378750|NCT01126879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378751|NCT01126879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110378752|NCT01126879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110378753|NCT01126879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110378754|NCT01126879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110378755|NCT01126879|Phytoestrogens|phytoestrogens|mesh-ancestor
110378756|NCT01126879|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110378757|NCT01126879|Estrogens|estrogens|mesh-ancestor
110378758|NCT01126879|Hormones|hormones|mesh-ancestor
110378759|NCT01126879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110378760|NCT04311658|Isosorbide|isosorbide|mesh-list
110378761|NCT04311658|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
110378762|NCT04311658|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
110378763|NCT04311658|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110378764|NCT04311658|Diuretics|diuretics|mesh-ancestor
110378765|NCT04311658|Natriuretic Agents|natriuretic agents|mesh-ancestor
110378766|NCT04311658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378767|NCT04311658|Vasodilator Agents|vasodilator agents|mesh-ancestor
110378768|NCT04311658|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110378769|NCT04311658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110378770|NCT02882308|Durvalumab|durvalumab|mesh-list
110378771|NCT02882308|Olaparib|olaparib|mesh-list
110378772|NCT02882308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110378773|NCT02882308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110378774|NCT02882308|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110378775|NCT02882308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110378776|NCT02882308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110378777|NCT00625456|Molgramostim|molgramostim|mesh-list
110378778|NCT00625456|Sargramostim|sargramostim|mesh-list
110378779|NCT00625456|Immunologic Factors|immunologic factors|mesh-ancestor
110378780|NCT00625456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378781|NCT00625456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110378784|NCT04539444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110378785|NCT04539444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110378786|NCT04539444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110378787|NCT00576329|Ketorolac|ketorolac|mesh-list
110378788|NCT00576329|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110378789|NCT00576329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110378790|NCT00576329|Analgesics|analgesics|mesh-ancestor
110378791|NCT00576329|Sensory System Agents|sensory system agents|mesh-ancestor
110378792|NCT00576329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110378793|NCT00576329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378794|NCT00576329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110378795|NCT00576329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110378796|NCT00576329|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110378797|NCT00576329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110378798|NCT00576329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110378800|NCT02882581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110378801|NCT02882581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378802|NCT02882347|Somatostatin|somatostatin|mesh-list
110378803|NCT02882347|Hormones|hormones|mesh-ancestor
110378804|NCT02882347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110378805|NCT02882347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378806|NCT00576368|Insulin Glargine|insulin glargine|mesh-list
110378807|NCT00576368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110378808|NCT00576368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378809|NCT00637468|Aspirin|aspirin|mesh-list
110378810|NCT00637468|Heparin|heparin|mesh-list
110378811|NCT00637468|Acetazolamide|acetazolamide|mesh-list
110378812|NCT00637468|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110378813|NCT00637468|Anticoagulants|anticoagulants|mesh-ancestor
110378814|NCT00637468|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110378815|NCT00637468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110378816|NCT00637468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110378817|NCT00637468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110378818|NCT00637468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110378819|NCT00637468|Analgesics|analgesics|mesh-ancestor
110378820|NCT00637468|Sensory System Agents|sensory system agents|mesh-ancestor
110378821|NCT00637468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110378822|NCT00637468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378823|NCT00637468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110378824|NCT00637468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110378825|NCT00637468|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110378826|NCT00637468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110378827|NCT00637468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110378828|NCT00637468|Antipyretics|antipyretics|mesh-ancestor
110378829|NCT00637468|Anticonvulsants|anticonvulsants|mesh-ancestor
110378830|NCT00637468|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110378831|NCT00637468|Diuretics|diuretics|mesh-ancestor
110378832|NCT00637468|Natriuretic Agents|natriuretic agents|mesh-ancestor
110378833|NCT00637468|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110378834|NCT00637468|Adrenergic Agents|adrenergic agents|mesh-ancestor
110378835|NCT00637468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110378836|NCT02278575|Antithrombins|antithrombins|mesh-list
110378837|NCT02278575|Antithrombin III|antithrombin iii|mesh-list
110378838|NCT02278575|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110378839|NCT02278575|Protease Inhibitors|protease inhibitors|mesh-ancestor
110378840|NCT02278575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110378841|NCT02278575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110378842|NCT02278575|Anticoagulants|anticoagulants|mesh-ancestor
110378843|NCT01126060|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110378844|NCT01126060|Hemostatics|hemostatics|mesh-ancestor
110378846|NCT01125748|Omalizumab|omalizumab|mesh-list
110378847|NCT01125748|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110378848|NCT01125748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110378849|NCT01125748|Respiratory System Agents|respiratory system agents|mesh-ancestor
110378850|NCT04558268|Folic Acid|folic acid|mesh-list
110378851|NCT04558268|Prednisone|prednisone|mesh-list
110378852|NCT04558268|Progesterone|progesterone|mesh-list
110378853|NCT04558268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110378854|NCT04558268|Glucocorticoids|glucocorticoids|mesh-ancestor
110378855|NCT04558268|Hormones|hormones|mesh-ancestor
110378856|NCT04558268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110378857|NCT04558268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378858|NCT04558268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110378859|NCT04558268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110378861|NCT04558268|Hematinics|hematinics|mesh-ancestor
110378862|NCT04558268|Vitamin B Complex|vitamin b complex|mesh-ancestor
110378863|NCT04558268|Vitamins|vitamins|mesh-ancestor
110378864|NCT04558268|Micronutrients|micronutrients|mesh-ancestor
110378865|NCT01125514|Furosemide|furosemide|mesh-list
110378866|NCT01125514|Diuretics|diuretics|mesh-ancestor
110378867|NCT01125514|Natriuretic Agents|natriuretic agents|mesh-ancestor
110378868|NCT01125514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378869|NCT01125514|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110378870|NCT01125514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110378871|NCT01125514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110378872|NCT04545879|Allicin|allicin|mesh-list
110378873|NCT04545879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110378874|NCT04545879|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110378875|NCT04545879|Antimetabolites|antimetabolites|mesh-ancestor
110378876|NCT04545879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110378877|NCT04545879|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110378878|NCT04545879|Antioxidants|antioxidants|mesh-ancestor
110378879|NCT04545879|Protective Agents|protective agents|mesh-ancestor
110378880|NCT04545879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378881|NCT04545879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110378882|NCT04545879|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110378883|NCT04578782|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110378884|NCT04578782|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110378885|NCT04578782|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110378886|NCT04578782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110378887|NCT04578782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378888|NCT04578782|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110378889|NCT04578782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110378890|NCT04578782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110378891|NCT04578782|Cholinergic Agents|cholinergic agents|mesh-ancestor
110378892|NCT04578782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110378894|NCT04538391|Anesthetics, Local|anesthetics, local|mesh-ancestor
110378895|NCT04538391|Anesthetics|anesthetics|mesh-ancestor
110378896|NCT04538391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110378897|NCT04538391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378898|NCT04538391|Sensory System Agents|sensory system agents|mesh-ancestor
110378899|NCT04538391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110378901|NCT04545801|Analgesics|analgesics|mesh-ancestor
110378902|NCT04545801|Sensory System Agents|sensory system agents|mesh-ancestor
110378903|NCT04545801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110378904|NCT04545801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378905|NCT04545801|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110378906|NCT04545801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110378907|NCT04545801|Anesthetics, General|anesthetics, general|mesh-ancestor
110378908|NCT04545801|Anesthetics|anesthetics|mesh-ancestor
110378909|NCT04545801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110378910|NCT04545801|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110378911|NCT04545801|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110378912|NCT04545801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110378913|NCT04545801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110378915|NCT04558424|Antioxidants|antioxidants|mesh-ancestor
110378916|NCT04558424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110378917|NCT04558424|Protective Agents|protective agents|mesh-ancestor
110378918|NCT04558424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378920|NCT04558424|Micronutrients|micronutrients|mesh-ancestor
110378921|NCT00576602|Epoetin Alfa|epoetin alfa|mesh-list
110378922|NCT00576602|Hematinics|hematinics|mesh-ancestor
110378923|NCT02212223|Vitamin D|vitamin d|mesh-list
110378924|NCT02212223|Cholecalciferol|cholecalciferol|mesh-list
110378925|NCT02212223|Vitamins|vitamins|mesh-ancestor
110378926|NCT02212223|Micronutrients|micronutrients|mesh-ancestor
110378927|NCT02212223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378928|NCT02212223|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110378929|NCT02212223|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110378930|NCT00637585|Fexofenadine|fexofenadine|mesh-list
110378931|NCT00637585|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110378932|NCT00637585|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110378933|NCT00637585|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110378934|NCT00637585|Histamine Antagonists|histamine antagonists|mesh-ancestor
110378935|NCT00637585|Histamine Agents|histamine agents|mesh-ancestor
110378936|NCT00637585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110378937|NCT00637585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110378938|NCT00637585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378939|NCT02214810|Bupivacaine|bupivacaine|mesh-list
110378940|NCT02214810|Anesthetics, Local|anesthetics, local|mesh-ancestor
110378941|NCT02214810|Anesthetics|anesthetics|mesh-ancestor
110378942|NCT02214810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110378943|NCT02214810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378944|NCT02214810|Sensory System Agents|sensory system agents|mesh-ancestor
110378945|NCT02214810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110378946|NCT01125046|Bevacizumab|bevacizumab|mesh-list
110378947|NCT01125046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110378948|NCT01125046|Antibodies|antibodies|mesh-list
110378949|NCT01125046|Immunoglobulins|immunoglobulins|mesh-list
110378950|NCT01125046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110378951|NCT01125046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110378952|NCT01125046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110378953|NCT01125046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110378954|NCT01125046|Growth Substances|growth substances|mesh-ancestor
110378955|NCT01125046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378956|NCT01125046|Growth Inhibitors|growth inhibitors|mesh-ancestor
110378957|NCT01125046|Immunologic Factors|immunologic factors|mesh-ancestor
110378958|NCT04557878|Mitogens|mitogens|mesh-list
110378959|NCT04557878|Mitosis Modulators|mitosis modulators|mesh-ancestor
110378960|NCT04557878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110378962|NCT01124734|Interleukin-2|interleukin-2|mesh-list
110378963|NCT01124734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110378964|NCT01124734|Alkylating Agents|alkylating agents|mesh-ancestor
110378965|NCT01124734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110378966|NCT01124734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110378967|NCT01124734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110378968|NCT01124734|Analgesics|analgesics|mesh-ancestor
110378969|NCT01124734|Sensory System Agents|sensory system agents|mesh-ancestor
110378970|NCT01124734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110378971|NCT01124734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378972|NCT04545450|Methyltestosterone|methyltestosterone|mesh-list
110378973|NCT04545450|Testosterone|testosterone|mesh-list
110378974|NCT04545450|Testosterone undecanoate|testosterone undecanoate|mesh-list
110378975|NCT04545450|Testosterone enanthate|testosterone enanthate|mesh-list
110378976|NCT04545450|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110378977|NCT04545450|Dutasteride|dutasteride|mesh-list
110378978|NCT04545450|Androgens|androgens|mesh-ancestor
110378979|NCT04545450|Hormones|hormones|mesh-ancestor
110378980|NCT04545450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110378981|NCT04545450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378982|NCT04545450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110378983|NCT04545450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110378984|NCT04545450|Anabolic Agents|anabolic agents|mesh-ancestor
110378985|NCT04545450|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110378986|NCT04545450|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110378987|NCT04545450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110378988|NCT04545450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110378989|NCT04545450|Hormone Antagonists|hormone antagonists|mesh-ancestor
110378991|NCT04579133|Olaparib|olaparib|mesh-list
110378992|NCT04579133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110378993|NCT04579133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110378994|NCT04579133|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110378995|NCT04579133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110378996|NCT04579133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110378997|NCT00576914|Endostatins|endostatins|mesh-list
110378998|NCT00576914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110378999|NCT00576914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110379000|NCT00576914|Growth Substances|growth substances|mesh-ancestor
110379001|NCT00576914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110379002|NCT00576914|Growth Inhibitors|growth inhibitors|mesh-ancestor
110379003|NCT00576914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110379004|NCT02212340|Remifentanil|remifentanil|mesh-list
110379005|NCT02212340|Desflurane|desflurane|mesh-list
110379006|NCT02212340|Propofol|propofol|mesh-list
110379007|NCT02212340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110379008|NCT02212340|Narcotics|narcotics|mesh-ancestor
110379009|NCT02212340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110379010|NCT02212340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110379011|NCT02212340|Analgesics|analgesics|mesh-ancestor
110379012|NCT02212340|Sensory System Agents|sensory system agents|mesh-ancestor
110379013|NCT02212340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110379014|NCT02212340|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110379015|NCT02212340|Anesthetics, General|anesthetics, general|mesh-ancestor
110379016|NCT02212340|Anesthetics|anesthetics|mesh-ancestor
110379019|NCT01124617|Tapentadol|tapentadol|mesh-list
110379020|NCT01124617|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110379021|NCT01124617|Narcotics|narcotics|mesh-ancestor
110379022|NCT01124617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110379023|NCT01124617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110379024|NCT01124617|Analgesics|analgesics|mesh-ancestor
110379025|NCT01124617|Sensory System Agents|sensory system agents|mesh-ancestor
110379026|NCT01124617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110379027|NCT01124617|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110379028|NCT01124617|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110379029|NCT01124617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110379030|NCT01124617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110379031|NCT01124617|Adrenergic Agents|adrenergic agents|mesh-ancestor
110379032|NCT01124617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110379034|NCT04205890|Analgesics|analgesics|mesh-ancestor
110379035|NCT04205890|Sensory System Agents|sensory system agents|mesh-ancestor
110379036|NCT04205890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110379037|NCT04205890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110379038|NCT04205890|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110379039|NCT04205890|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110379040|NCT04205890|Anesthetics, General|anesthetics, general|mesh-ancestor
110379041|NCT04205890|Anesthetics|anesthetics|mesh-ancestor
110379042|NCT04205890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110379043|NCT04205890|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110379044|NCT04205890|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110379045|NCT04205890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110379046|NCT04205890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110379047|NCT00577109|Leucovorin|leucovorin|mesh-list
110379048|NCT00577109|Bevacizumab|bevacizumab|mesh-list
110379049|NCT00577109|Cetuximab|cetuximab|mesh-list
110379050|NCT00577109|Irinotecan|irinotecan|mesh-list
110379051|NCT00577109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110379052|NCT00577109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110379053|NCT00577109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110379054|NCT00577109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110379055|NCT00577109|Growth Substances|growth substances|mesh-ancestor
110379056|NCT00577109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110379057|NCT00577109|Growth Inhibitors|growth inhibitors|mesh-ancestor
110379058|NCT00577109|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110379059|NCT00577109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110379060|NCT00577109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110379061|NCT00577109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110379062|NCT00577109|Antidotes|antidotes|mesh-ancestor
110379063|NCT00577109|Protective Agents|protective agents|mesh-ancestor
110379064|NCT00577109|Vitamin B Complex|vitamin b complex|mesh-ancestor
110379065|NCT00577109|Vitamins|vitamins|mesh-ancestor
110379066|NCT00577109|Micronutrients|micronutrients|mesh-ancestor
110379067|NCT01124422|Fluticasone|fluticasone|mesh-list
110379068|NCT01124422|Xhance|xhance|mesh-list
110379069|NCT01124422|Bromides|bromides|mesh-list
110379070|NCT01124422|Tiotropium Bromide|tiotropium bromide|mesh-list
110379071|NCT01124422|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110379072|NCT01124422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110379073|NCT01124422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110379074|NCT01124422|Autonomic Agents|autonomic agents|mesh-ancestor
110379075|NCT01124422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110379076|NCT01124422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110379077|NCT01124422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110379078|NCT01124422|Respiratory System Agents|respiratory system agents|mesh-ancestor
110379080|NCT01124422|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110379081|NCT01124422|Parasympatholytics|parasympatholytics|mesh-ancestor
110379082|NCT01124422|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110379083|NCT01124422|Cholinergic Agents|cholinergic agents|mesh-ancestor
110379084|NCT01124422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110379085|NCT01124422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110379086|NCT01124422|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110379087|NCT01124422|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110379088|NCT01124422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110379089|NCT01124422|Adrenergic Agents|adrenergic agents|mesh-ancestor
110379090|NCT01124422|Anticonvulsants|anticonvulsants|mesh-ancestor
110379091|NCT00625495|Esomeprazole|esomeprazole|mesh-list
110379092|NCT00625495|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110379093|NCT00625495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110379094|NCT00625495|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110379095|NCT00625495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110379096|NCT00625495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110379097|NCT02882425|Selexipag|selexipag|mesh-list
110379098|NCT02882425|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110379099|NCT00577304|Nitroglycerin|nitroglycerin|mesh-list
110379100|NCT00577304|Vasodilator Agents|vasodilator agents|mesh-ancestor
110379101|NCT01124149|Mesalamine|mesalamine|mesh-list
110379102|NCT01124149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110379103|NCT01124149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110379104|NCT01124149|Analgesics|analgesics|mesh-ancestor
110379105|NCT01124149|Sensory System Agents|sensory system agents|mesh-ancestor
110379106|NCT01124149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110379107|NCT01124149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110379108|NCT01124149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110379109|NCT01124149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110379111|NCT04545099|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110379112|NCT04545099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110379113|NCT04545099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110379114|NCT04545099|Cholinergic Agents|cholinergic agents|mesh-ancestor
110379115|NCT04545099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110379116|NCT04545099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110379117|NCT04545099|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110379118|NCT04545099|Autonomic Agents|autonomic agents|mesh-ancestor
110379119|NCT04545099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110379120|NCT02882269|Capecitabine|capecitabine|mesh-list
110379121|NCT02882269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110379122|NCT02882269|Antimetabolites|antimetabolites|mesh-ancestor
110379123|NCT02882269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110379124|NCT02882269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110379125|NCT01122862|Chlorhexidine|chlorhexidine|mesh-list
110379126|NCT01122862|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110379127|NCT01122862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110379128|NCT01122862|Disinfectants|disinfectants|mesh-ancestor
110379129|NCT04537767|Esmolol|esmolol|mesh-list
110379130|NCT04537767|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110379131|NCT04537767|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110379132|NCT04537767|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110379133|NCT04537767|Adrenergic Agents|adrenergic agents|mesh-ancestor
110379134|NCT04537767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110379135|NCT04537767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110379136|NCT04537767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110379137|NCT01121926|Trazodone|trazodone|mesh-list
110379138|NCT01121926|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110379139|NCT01121926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110379140|NCT01121926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110379141|NCT01121926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110379142|NCT01121926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110379143|NCT01121926|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110379144|NCT01121926|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110379145|NCT01121926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110379146|NCT01121926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110379147|NCT01121926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110379148|NCT01121926|Serotonin Agents|serotonin agents|mesh-ancestor
110379149|NCT01121926|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110379150|NCT01121926|Antidepressive Agents|antidepressive agents|mesh-ancestor
110379151|NCT00577421|Risedronic Acid|risedronic acid|mesh-list
110379152|NCT00577421|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110379153|NCT00577421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110379154|NCT00577421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110379155|NCT00577421|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110379156|NCT00577421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110379157|NCT00577421|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110379159|NCT00577694|Gemtuzumab|gemtuzumab|mesh-list
110379160|NCT00577694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110379161|NCT00577694|Antimetabolites|antimetabolites|mesh-ancestor
110379162|NCT00577694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110379163|NCT00577694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110379164|NCT00577694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110379165|NCT00577694|Immunotoxins|immunotoxins|mesh-ancestor
110379166|NCT00577694|Immunoconjugates|immunoconjugates|mesh-ancestor
110379167|NCT00577694|Immunologic Factors|immunologic factors|mesh-ancestor
110379168|NCT00577694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110379169|NCT04537533|Tranexamic Acid|tranexamic acid|mesh-list
110379170|NCT04537533|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110379171|NCT04537533|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110379172|NCT04537533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110379173|NCT04537533|Hemostatics|hemostatics|mesh-ancestor
110379174|NCT04537533|Coagulants|coagulants|mesh-ancestor
110379176|NCT02216058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110379177|NCT02216058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110379178|NCT02216058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110379179|NCT02216058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110379180|NCT02216058|Antifungal Agents|antifungal agents|mesh-ancestor
110379181|NCT02216058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110379182|NCT02216058|Immunologic Factors|immunologic factors|mesh-ancestor
110379183|NCT02216058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110379184|NCT00577850|Alendronate|alendronate|mesh-list
110379185|NCT00577850|Risedronic Acid|risedronic acid|mesh-list
110379186|NCT00577850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110379187|NCT00577850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110379188|NCT00577850|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110379189|NCT00577850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110379190|NCT00577850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110379191|NCT00577850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110379193|NCT00577967|Analgesics|analgesics|mesh-ancestor
110379194|NCT00577967|Sensory System Agents|sensory system agents|mesh-ancestor
110379195|NCT00577967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110379196|NCT00577967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110379197|NCT00577967|Anticonvulsants|anticonvulsants|mesh-ancestor
110379198|NCT00577967|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110379199|NCT00577967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110379200|NCT00577967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110379201|NCT00577967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110379202|NCT00577967|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110379203|NCT00577967|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110379204|NCT00577967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110379205|NCT00577967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110379206|NCT00577967|Antimanic Agents|antimanic agents|mesh-ancestor
110379207|NCT00578201|Cetuximab|cetuximab|mesh-list
110379208|NCT00578201|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110379209|NCT00578201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110379210|NCT04544319|Dapagliflozin|dapagliflozin|mesh-list
110379211|NCT04544319|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110379212|NCT04544319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110379213|NCT04544319|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110379214|NCT04544319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110379216|NCT04578470|Vitamins|vitamins|mesh-ancestor
110379217|NCT04578470|Micronutrients|micronutrients|mesh-ancestor
110379218|NCT04578470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110379219|NCT04578470|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110379220|NCT00578435|Cyclophosphamide|cyclophosphamide|mesh-list
110379221|NCT00578435|Busulfan|busulfan|mesh-list
110379222|NCT00578435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110379223|NCT00578435|Immunologic Factors|immunologic factors|mesh-ancestor
110379224|NCT00578435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110379225|NCT00578435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110379226|NCT00578435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110379227|NCT00578435|Alkylating Agents|alkylating agents|mesh-ancestor
110379228|NCT00578435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110379229|NCT00578435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110379230|NCT00578435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110379231|NCT04537065|Mydriatics|mydriatics|mesh-list
110379232|NCT04537065|Autonomic Agents|autonomic agents|mesh-ancestor
110379233|NCT04537065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110379234|NCT04537065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110379235|NCT04544163|Lidocaine|lidocaine|mesh-list
110379236|NCT04544163|Magnesium Sulfate|magnesium sulfate|mesh-list
110379237|NCT04544163|Fentanyl|fentanyl|mesh-list
110379238|NCT04544163|Anesthetics, Local|anesthetics, local|mesh-ancestor
110379239|NCT04544163|Anesthetics|anesthetics|mesh-ancestor
110379240|NCT04544163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110379241|NCT04544163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110379242|NCT04544163|Sensory System Agents|sensory system agents|mesh-ancestor
110379243|NCT04544163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110379244|NCT04544163|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110379245|NCT04544163|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110379246|NCT04544163|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110379247|NCT04544163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110379248|NCT04544163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110379249|NCT04544163|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110379250|NCT04544163|Narcotics|narcotics|mesh-ancestor
110379251|NCT04544163|Analgesics|analgesics|mesh-ancestor
110379252|NCT04544163|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110379253|NCT04544163|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110379254|NCT04544163|Anesthetics, General|anesthetics, general|mesh-ancestor
110379255|NCT04544163|Anticonvulsants|anticonvulsants|mesh-ancestor
110379256|NCT04544163|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110379257|NCT04544163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110379258|NCT04544163|Tocolytic Agents|tocolytic agents|mesh-ancestor
110379259|NCT04544163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110379260|NCT04543851|Carbon Fiber|carbon fiber|mesh-list
110379261|NCT04543851|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110379262|NCT04543851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110379263|NCT00578591|Rituximab|rituximab|mesh-list
110379264|NCT00578591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110379265|NCT00578591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110379266|NCT00578591|Immunologic Factors|immunologic factors|mesh-ancestor
110379267|NCT00578591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110379268|NCT00578591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110379269|NCT04536948|Methyl salicylate|methyl salicylate|mesh-list
110379270|NCT04536948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110379271|NCT04543890|Etoposide|etoposide|mesh-list
110379272|NCT04543890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110379273|NCT04543890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110379274|NCT04543890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110379275|NCT04543890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110379276|NCT04543890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110379277|NCT04543890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110379278|NCT04536831|Vitamin D|vitamin d|mesh-list
110379279|NCT04536831|Ergocalciferols|ergocalciferols|mesh-list
110379280|NCT04536831|Cholecalciferol|cholecalciferol|mesh-list
110379281|NCT04536831|Vitamins|vitamins|mesh-list
110379282|NCT04536831|Micronutrients|micronutrients|mesh-ancestor
110379283|NCT04536831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110379284|NCT04536831|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110379285|NCT04536831|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110379286|NCT02214966|Telmisartan|telmisartan|mesh-list
110379288|NCT02214966|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110379289|NCT02214966|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110379290|NCT02214966|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110379291|NCT02214966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110379292|NCT02214966|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110379293|NCT02214966|Protease Inhibitors|protease inhibitors|mesh-ancestor
110379294|NCT02214966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110379295|NCT04536558|Olanzapine|olanzapine|mesh-list
110379296|NCT04536558|Fosaprepitant|fosaprepitant|mesh-list
110379297|NCT04536558|Aprepitant|aprepitant|mesh-list
110379298|NCT04536558|Antiemetics|antiemetics|mesh-ancestor
110379299|NCT04536558|Autonomic Agents|autonomic agents|mesh-ancestor
110379300|NCT04536558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110379301|NCT04536558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110379302|NCT04536558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110379303|NCT04536558|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110379304|NCT04536558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110379305|NCT04536558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110379306|NCT04536558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110379307|NCT04536558|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110379308|NCT04536558|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110379309|NCT04536558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110379310|NCT04536558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110379311|NCT04536558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110379313|NCT04536558|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110379314|NCT04557137|Somatostatin|somatostatin|mesh-list
110379315|NCT04557137|Hormones|hormones|mesh-ancestor
110379316|NCT04557137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110379317|NCT04557137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110379318|NCT04536675|Bromides|bromides|mesh-list
110379319|NCT04536675|Anticonvulsants|anticonvulsants|mesh-ancestor
110379320|NCT00578825|Ritonavir|ritonavir|mesh-list
110379322|NCT00578825|Ribavirin|ribavirin|mesh-list
110379323|NCT00578825|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110379324|NCT00578825|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110379325|NCT00578825|Protease Inhibitors|protease inhibitors|mesh-ancestor
110379326|NCT00578825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110379327|NCT00578825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110379328|NCT00578825|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110379329|NCT00578825|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110379330|NCT00578825|Antiviral Agents|antiviral agents|mesh-ancestor
110379331|NCT00578825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110379332|NCT00578825|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110379333|NCT00578825|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110379334|NCT00578825|Antimetabolites|antimetabolites|mesh-ancestor
110379335|NCT04536129|Hydrocortisone|hydrocortisone|mesh-list
110379336|NCT04536129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110379337|NCT04556708|Chlorhexidine|chlorhexidine|mesh-list
110379338|NCT04556708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110379339|NCT04556708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110379340|NCT04556708|Disinfectants|disinfectants|mesh-ancestor
110379341|NCT04535973|Hormones|hormones|mesh-list
110379342|NCT04535973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110379343|NCT04535973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110379344|NCT04536051|Acetaminophen|acetaminophen|mesh-list
110379345|NCT04536051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110379346|NCT04536051|Analgesics|analgesics|mesh-ancestor
110379347|NCT04536051|Sensory System Agents|sensory system agents|mesh-ancestor
110379348|NCT04536051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110379349|NCT04536051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110379350|NCT04536051|Antipyretics|antipyretics|mesh-ancestor
110379351|NCT02215005|Telmisartan|telmisartan|mesh-list
110379352|NCT02215005|Ramipril|ramipril|mesh-list
110379353|NCT02215005|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110379354|NCT02215005|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110379355|NCT02215005|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110379356|NCT02215005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110379357|NCT02215005|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110379358|NCT02215005|Protease Inhibitors|protease inhibitors|mesh-ancestor
110379359|NCT02215005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110379360|NCT02215044|Gemcitabine|gemcitabine|mesh-list
110379361|NCT02215044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110379362|NCT02215044|Antimetabolites|antimetabolites|mesh-ancestor
110379363|NCT02215044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110379364|NCT02215044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110379365|NCT04556279|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
110379366|NCT04556279|Hormone Antagonists|hormone antagonists|mesh-ancestor
110379367|NCT04556279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110379368|NCT04556279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110379369|NCT04556279|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110379370|NCT04556279|Diuretics|diuretics|mesh-ancestor
110379371|NCT04556279|Natriuretic Agents|natriuretic agents|mesh-ancestor
110379372|NCT02216331|Rifampin|rifampin|mesh-list
110379373|NCT02216331|Rifapentine|rifapentine|mesh-list
110379374|NCT02216331|Bedaquiline|bedaquiline|mesh-list
110379375|NCT02216331|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110379376|NCT02216331|Antitubercular Agents|antitubercular agents|mesh-ancestor
110379377|NCT02216331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110379378|NCT02216331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110379380|NCT02216331|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110379381|NCT02216331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110379382|NCT02216331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110379383|NCT02216331|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110379384|NCT02216331|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110379385|NCT02216331|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110379386|NCT02216331|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110379387|NCT02216331|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110379388|NCT02216331|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110379389|NCT04535817|Omalizumab|omalizumab|mesh-list
110379390|NCT04535817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110379391|NCT04535817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110379392|NCT04535817|Respiratory System Agents|respiratory system agents|mesh-ancestor
110379393|NCT04578236|Tretinoin|tretinoin|mesh-list
110379394|NCT04578236|Captopril|captopril|mesh-list
110379395|NCT04578236|Isotretinoin|isotretinoin|mesh-list
110379396|NCT04578236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110379397|NCT04578236|Keratolytic Agents|keratolytic agents|mesh-ancestor
110379398|NCT04578236|Dermatologic Agents|dermatologic agents|mesh-ancestor
110379399|NCT04578236|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110379400|NCT04578236|Protease Inhibitors|protease inhibitors|mesh-ancestor
110379401|NCT04578236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110379402|NCT04578236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110379403|NCT04578236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110379404|NCT04542759|Besifloxacin|besifloxacin|mesh-list
110379405|NCT04542759|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110379406|NCT04542759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110379407|NCT04542759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110379408|NCT04542759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110379409|NCT04542759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110379410|NCT04542759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110379411|NCT04542759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110379412|NCT04542759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110379413|NCT04542759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110379414|NCT04542213|Insulin|insulin|mesh-list
110379415|NCT04542213|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110379416|NCT04542213|Linagliptin|linagliptin|mesh-list
110379417|NCT04542213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110379418|NCT04542213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110379419|NCT04542213|Incretins|incretins|mesh-ancestor
110379420|NCT04542213|Hormones|hormones|mesh-ancestor
110379421|NCT04542213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110379422|NCT04542213|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110379424|NCT04542213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110379425|NCT04542213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110379428|NCT04542252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110379429|NCT04542252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110379430|NCT04542252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110379431|NCT04542252|Immunologic Factors|immunologic factors|mesh-ancestor
110379432|NCT04542252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110379433|NCT04542252|Antifungal Agents|antifungal agents|mesh-ancestor
110379434|NCT04542252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110379435|NCT04542252|Dermatologic Agents|dermatologic agents|mesh-ancestor
110379436|NCT04542252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110379437|NCT04542252|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110379438|NCT04555694|Loteprednol Etabonate|loteprednol etabonate|mesh-list
110379439|NCT04555694|Cyclosporine|cyclosporine|mesh-list
110379440|NCT04555694|Dexamethasone|dexamethasone|mesh-list
110379441|NCT04555694|Cyclosporins|cyclosporins|mesh-list
110379443|NCT04555694|Antiemetics|antiemetics|mesh-ancestor
110379444|NCT04555694|Autonomic Agents|autonomic agents|mesh-ancestor
110379445|NCT04555694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110379446|NCT04555694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110379447|NCT04555694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110379448|NCT04555694|Glucocorticoids|glucocorticoids|mesh-ancestor
110379449|NCT04555694|Hormones|hormones|mesh-ancestor
110379450|NCT04555694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110379451|NCT04555694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110379452|NCT04555694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110379453|NCT04555694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110379454|NCT04555694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110379455|NCT04555694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110379456|NCT04555694|Immunologic Factors|immunologic factors|mesh-ancestor
110379457|NCT04555694|Antifungal Agents|antifungal agents|mesh-ancestor
110379458|NCT04555694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110379459|NCT04555694|Dermatologic Agents|dermatologic agents|mesh-ancestor
110379460|NCT04555694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110379461|NCT04555694|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110379462|NCT04555694|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110379463|NCT04532775|Methylprednisolone|methylprednisolone|mesh-list
110379464|NCT04532775|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110379465|NCT04532775|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110379466|NCT04532775|Prednisolone|prednisolone|mesh-list
110379467|NCT04532775|Prednisolone acetate|prednisolone acetate|mesh-list
110379468|NCT04532775|Magnesium Sulfate|magnesium sulfate|mesh-list
110379469|NCT04532775|Bupivacaine|bupivacaine|mesh-list
110379470|NCT04532775|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110379471|NCT04532775|Prednisolone phosphate|prednisolone phosphate|mesh-list
110379472|NCT04532775|Anesthetics, Local|anesthetics, local|mesh-ancestor
110379473|NCT04532775|Anesthetics|anesthetics|mesh-ancestor
110041455|NCT04660799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110379474|NCT04532775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110379475|NCT04532775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110379476|NCT04532775|Sensory System Agents|sensory system agents|mesh-ancestor
110379477|NCT04532775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110379478|NCT04532775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110379479|NCT04532775|Antiemetics|antiemetics|mesh-ancestor
110379480|NCT04532775|Autonomic Agents|autonomic agents|mesh-ancestor
110379481|NCT04532775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110379482|NCT04532775|Glucocorticoids|glucocorticoids|mesh-ancestor
110379483|NCT04532775|Hormones|hormones|mesh-ancestor
110379484|NCT04532775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110379485|NCT04532775|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110379486|NCT04532775|Protective Agents|protective agents|mesh-ancestor
110379487|NCT04532775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110379488|NCT04532775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110379489|NCT04532775|Analgesics|analgesics|mesh-ancestor
110379490|NCT04532775|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110379491|NCT04532775|Anticonvulsants|anticonvulsants|mesh-ancestor
110379492|NCT04532775|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110379493|NCT04532775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110379494|NCT04532775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110379495|NCT04532775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110379496|NCT04532775|Tocolytic Agents|tocolytic agents|mesh-ancestor
110379497|NCT04532775|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110379498|NCT00579644|Minocycline|minocycline|mesh-list
110379499|NCT00579644|Methotrexate|methotrexate|mesh-list
110379500|NCT00579644|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110379501|NCT00579644|Abortifacient Agents|abortifacient agents|mesh-ancestor
110379502|NCT00579644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110379503|NCT00579644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110379504|NCT00579644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110379505|NCT00579644|Antimetabolites|antimetabolites|mesh-ancestor
110379506|NCT00579644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110379507|NCT00579644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110379508|NCT00579644|Dermatologic Agents|dermatologic agents|mesh-ancestor
110379509|NCT00579644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110379510|NCT00579644|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110379511|NCT00579644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110379512|NCT00579644|Immunologic Factors|immunologic factors|mesh-ancestor
110379513|NCT00579644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110379514|NCT00579644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110379515|NCT00579644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110379516|NCT00579644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110379517|NCT04578158|Quercetin|quercetin|mesh-list
110379518|NCT04578158|Antioxidants|antioxidants|mesh-ancestor
110379519|NCT04578158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110379520|NCT04578158|Protective Agents|protective agents|mesh-ancestor
110379521|NCT04578158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110379522|NCT04532736|Mometasone Furoate|mometasone furoate|mesh-list
110379523|NCT04532736|Methylprednisolone|methylprednisolone|mesh-list
110379524|NCT04532736|Methotrexate|methotrexate|mesh-list
110379525|NCT04532736|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110379526|NCT04532736|Abortifacient Agents|abortifacient agents|mesh-ancestor
110379527|NCT04532736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110379528|NCT04532736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110379529|NCT04532736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110379530|NCT04532736|Antimetabolites|antimetabolites|mesh-ancestor
110379531|NCT04532736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110379532|NCT04532736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110379533|NCT04532736|Dermatologic Agents|dermatologic agents|mesh-ancestor
110379534|NCT04532736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110379535|NCT04532736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110379536|NCT04532736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110379537|NCT04532736|Immunologic Factors|immunologic factors|mesh-ancestor
110379538|NCT04532736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110379539|NCT04532736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110379540|NCT04532736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110379541|NCT04532736|Antiemetics|antiemetics|mesh-ancestor
110379542|NCT04532736|Autonomic Agents|autonomic agents|mesh-ancestor
110379543|NCT04532736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110379544|NCT04532736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110379545|NCT04532736|Glucocorticoids|glucocorticoids|mesh-ancestor
110379547|NCT04532736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110379548|NCT04532736|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110379549|NCT04532736|Protective Agents|protective agents|mesh-ancestor
110379550|NCT04532736|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110379551|NCT04555733|Lemborexant|lemborexant|mesh-list
110379552|NCT04555733|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
110379553|NCT04555733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110379554|NCT04555733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110379555|NCT04555733|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110379556|NCT04555733|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110379557|NCT04555733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110379558|NCT04555733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110379561|NCT02216994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110379562|NCT02216994|Emollients|emollients|mesh-ancestor
110379563|NCT02216994|Dermatologic Agents|dermatologic agents|mesh-ancestor
110379564|NCT02212613|Brexpiprazole|brexpiprazole|mesh-list
110379565|NCT02212613|Serotonin Agents|serotonin agents|mesh-ancestor
110379566|NCT02212613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110379567|NCT02212613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110379568|NCT02212613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110379569|NCT02212613|Dopamine Agonists|dopamine agonists|mesh-ancestor
110379570|NCT02212613|Dopamine Agents|dopamine agents|mesh-ancestor
110379571|NCT02217189|Zinc Sulfate|zinc sulfate|mesh-list
110379572|NCT02217189|Astringents|astringents|mesh-ancestor
110379573|NCT02217189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110379574|NCT02217189|Dermatologic Agents|dermatologic agents|mesh-ancestor
110379575|NCT00579956|Meropenem|meropenem|mesh-list
110379576|NCT00579956|Ceftazidime|ceftazidime|mesh-list
110379577|NCT00579956|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110379578|NCT00579956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110379579|NCT04555304|Paclitaxel|paclitaxel|mesh-list
110379580|NCT04555304|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110379581|NCT04555304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110379582|NCT04555304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110379583|NCT04555304|Tubulin Modulators|tubulin modulators|mesh-ancestor
110379584|NCT04555304|Antimitotic Agents|antimitotic agents|mesh-ancestor
110379585|NCT04555304|Mitosis Modulators|mitosis modulators|mesh-ancestor
110379586|NCT04555304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110379587|NCT04531800|Mitogens|mitogens|mesh-list
110379588|NCT04531800|Mitosis Modulators|mitosis modulators|mesh-ancestor
110379589|NCT04531800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110379590|NCT00579995|Acetylcysteine|acetylcysteine|mesh-list
110379591|NCT00579995|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110379592|NCT00579995|Antiviral Agents|antiviral agents|mesh-ancestor
110379593|NCT00579995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110379594|NCT00579995|Expectorants|expectorants|mesh-ancestor
110379595|NCT00579995|Respiratory System Agents|respiratory system agents|mesh-ancestor
110379596|NCT00579995|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110379597|NCT00579995|Antioxidants|antioxidants|mesh-ancestor
110379598|NCT00579995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110379599|NCT00579995|Protective Agents|protective agents|mesh-ancestor
110379600|NCT00579995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110379601|NCT00579995|Antidotes|antidotes|mesh-ancestor
110379602|NCT04531371|Dexmedetomidine|dexmedetomidine|mesh-list
110379603|NCT04531371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110379604|NCT04531371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110379605|NCT04531371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110379606|NCT04531371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110379607|NCT04531371|Analgesics|analgesics|mesh-ancestor
110379608|NCT04531371|Sensory System Agents|sensory system agents|mesh-ancestor
110379609|NCT04531371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110379610|NCT04531371|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110379611|NCT04531371|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110379612|NCT04531371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110379613|NCT04531371|Adrenergic Agents|adrenergic agents|mesh-ancestor
110379614|NCT04531371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110379615|NCT04531371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110379616|NCT00580112|Dexamethasone|dexamethasone|mesh-list
110379617|NCT00580112|Trabectedin|trabectedin|mesh-list
110379618|NCT00580112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110379619|NCT00580112|Antiemetics|antiemetics|mesh-ancestor
110379620|NCT00580112|Autonomic Agents|autonomic agents|mesh-ancestor
110379621|NCT00580112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110379622|NCT00580112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110379623|NCT00580112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110379624|NCT00580112|Glucocorticoids|glucocorticoids|mesh-ancestor
110379625|NCT00580112|Hormones|hormones|mesh-ancestor
110379626|NCT00580112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110379627|NCT00580112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110379628|NCT00580112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110379629|NCT00580112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110379630|NCT00580112|Alkylating Agents|alkylating agents|mesh-ancestor
110379631|NCT00580112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110379633|NCT04531332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110379634|NCT04531332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110379635|NCT04531332|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110379636|NCT04531332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110379637|NCT04531332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110379639|NCT04530864|Dexamethasone acetate|dexamethasone acetate|mesh-list
110379640|NCT04530864|BB 1101|bb 1101|mesh-list
110379641|NCT04530864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110379642|NCT04530864|Antiemetics|antiemetics|mesh-ancestor
110379643|NCT04530864|Autonomic Agents|autonomic agents|mesh-ancestor
110379644|NCT04530864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110379645|NCT04530864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110379646|NCT04530864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110379647|NCT04530864|Glucocorticoids|glucocorticoids|mesh-ancestor
110379648|NCT04530864|Hormones|hormones|mesh-ancestor
110379649|NCT04530864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110379650|NCT04530864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110379651|NCT04530864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110379652|NCT04530864|Protease Inhibitors|protease inhibitors|mesh-ancestor
110379653|NCT04530864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110379654|NCT04530864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110379655|NCT00580190|Alprazolam|alprazolam|mesh-list
110379656|NCT00580190|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110379657|NCT00580190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110379658|NCT00580190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110379659|NCT00580190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110379660|NCT00580190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110379661|NCT00580190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110379662|NCT00580190|GABA Modulators|gaba modulators|mesh-ancestor
110379663|NCT00580190|GABA Agents|gaba agents|mesh-ancestor
110379664|NCT00580190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110379665|NCT00580190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110379666|NCT04530903|Clonidine|clonidine|mesh-list
110379667|NCT04530903|Levobupivacaine|levobupivacaine|mesh-list
110379668|NCT04530903|Analgesics|analgesics|mesh-ancestor
110379669|NCT04530903|Sensory System Agents|sensory system agents|mesh-ancestor
110379670|NCT04530903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110379671|NCT04530903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110379672|NCT04530903|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110379673|NCT04530903|Sympatholytics|sympatholytics|mesh-ancestor
110379674|NCT04530903|Autonomic Agents|autonomic agents|mesh-ancestor
110379675|NCT04530903|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110379676|NCT04530903|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110379677|NCT04530903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110379678|NCT04530903|Adrenergic Agents|adrenergic agents|mesh-ancestor
110379679|NCT04530903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110379680|NCT04530903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110379681|NCT04530903|Anesthetics, Local|anesthetics, local|mesh-ancestor
110379682|NCT04530903|Anesthetics|anesthetics|mesh-ancestor
110379683|NCT04530903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110379684|NCT04530474|Ivermectin|ivermectin|mesh-list
110379685|NCT04530474|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110379686|NCT04530474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110379687|NCT04554680|Trametinib|trametinib|mesh-list
110379688|NCT04554680|Dabrafenib|dabrafenib|mesh-list
110379689|NCT04554680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110379690|NCT04554680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110379691|NCT04554680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110379692|NCT04554680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110379693|NCT00580424|Norethindrone|norethindrone|mesh-list
110379694|NCT00580424|Norethindrone Acetate|norethindrone acetate|mesh-list
110379695|NCT00580424|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110379696|NCT00580424|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110379697|NCT00580424|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110379698|NCT00580424|Contraceptive Agents|contraceptive agents|mesh-ancestor
110379699|NCT00580424|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110379700|NCT00580424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110379701|NCT00580424|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110379702|NCT00580424|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110379703|NCT01121575|Crizotinib|crizotinib|mesh-list
110379704|NCT01121575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110379705|NCT01121575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110379706|NCT01121575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110379707|NCT01121575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110379708|NCT00625573|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110379709|NCT00625573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110379710|NCT04205851|Gimsilumab|gimsilumab|mesh-list
110379711|NCT04205851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110379712|NCT04205851|Antiviral Agents|antiviral agents|mesh-ancestor
110379713|NCT04205851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110379714|NCT02882113|Tacrolimus|tacrolimus|mesh-list
110379715|NCT02882113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110379716|NCT02882113|Immunologic Factors|immunologic factors|mesh-ancestor
110379717|NCT02882113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110379718|NCT02882113|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110379719|NCT02882113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110379720|NCT02882113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110379721|NCT04530045|Piperacillin|piperacillin|mesh-list
110379722|NCT04530045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110379723|NCT04530045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110379724|NCT01121536|Modafinil|modafinil|mesh-list
110379725|NCT01121536|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110379726|NCT01121536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110379727|NCT01121536|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110379728|NCT01121536|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110379729|NCT01121536|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110379730|NCT01121536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110379731|NCT00580619|Methyldopa|methyldopa|mesh-list
110379732|NCT00580619|Trimethaphan|trimethaphan|mesh-list
110379733|NCT00580619|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
110379734|NCT00580619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110379735|NCT00580619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110379736|NCT00580619|Sympatholytics|sympatholytics|mesh-ancestor
110379737|NCT00580619|Autonomic Agents|autonomic agents|mesh-ancestor
110379738|NCT00580619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110379739|NCT00580619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110379740|NCT00580619|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110379741|NCT00580619|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110379742|NCT00580619|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110379743|NCT00580619|Adrenergic Agents|adrenergic agents|mesh-ancestor
110379744|NCT00580619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110379745|NCT00580619|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110379746|NCT00580619|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
110379747|NCT00580619|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
110379748|NCT00580619|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110379750|NCT00580619|Vasodilator Agents|vasodilator agents|mesh-ancestor
110379751|NCT04554524|Paclitaxel|paclitaxel|mesh-list
110379752|NCT04554524|Pembrolizumab|pembrolizumab|mesh-list
110379753|NCT04554524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110379754|NCT04554524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110379755|NCT04554524|Tubulin Modulators|tubulin modulators|mesh-ancestor
110379756|NCT04554524|Antimitotic Agents|antimitotic agents|mesh-ancestor
110379757|NCT04554524|Mitosis Modulators|mitosis modulators|mesh-ancestor
110379758|NCT04554524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110379759|NCT04554524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110379760|NCT04554524|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110379762|NCT02212652|Ergocalciferols|ergocalciferols|mesh-list
110379763|NCT02212652|Cholecalciferol|cholecalciferol|mesh-list
110379764|NCT02212652|Vitamins|vitamins|mesh-list
110379765|NCT02212652|Micronutrients|micronutrients|mesh-ancestor
110379766|NCT02212652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110379767|NCT02212652|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110379768|NCT02212652|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110379769|NCT02212769|Losartan|losartan|mesh-list
110379770|NCT02212769|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110379771|NCT02212769|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110379772|NCT02212769|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110379773|NCT02212769|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110379774|NCT02212769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110379775|NCT02212808|Anti-Infective Agents|anti-infective agents|mesh-list
110379776|NCT02212808|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110379777|NCT02217852|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110379778|NCT02217852|Captopril|captopril|mesh-list
110379779|NCT02217852|Antihypertensive Agents|antihypertensive agents|mesh-list
110379780|NCT02217852|Nitrendipine|nitrendipine|mesh-list
110379781|NCT02217852|Diuretics|diuretics|mesh-ancestor
110379782|NCT02217852|Natriuretic Agents|natriuretic agents|mesh-ancestor
110379783|NCT02217852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110379784|NCT02217852|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110379785|NCT02217852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110379786|NCT02217852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110379787|NCT02217852|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110379789|NCT02217852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110379790|NCT02217852|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110379791|NCT02217852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110379792|NCT02217852|Vasodilator Agents|vasodilator agents|mesh-ancestor
110379793|NCT02217930|Moxifloxacin|moxifloxacin|mesh-list
110379794|NCT02217930|Levonadifloxacin|levonadifloxacin|mesh-list
110379795|NCT02217930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110379796|NCT02217930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110379797|NCT02217930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110379798|NCT02217930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110379799|NCT02217930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110379800|NCT02217930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110379801|NCT02217930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110379802|NCT02217930|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110379803|NCT04577846|Cephalexin|cephalexin|mesh-list
110379804|NCT04577846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110379805|NCT04577846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110379806|NCT04529811|Rifaximin|rifaximin|mesh-list
110379807|NCT04529811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110379808|NCT04529811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110379809|NCT04529811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110379810|NCT02218047|Interferons|interferons|mesh-list
110379811|NCT02218047|Interferon-alpha|interferon-alpha|mesh-list
110379812|NCT02218047|Interferon alpha-2|interferon alpha-2|mesh-list
110379813|NCT02218047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110379814|NCT02218047|Antiviral Agents|antiviral agents|mesh-ancestor
110379815|NCT02218047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110379816|NCT02218047|Immunologic Factors|immunologic factors|mesh-ancestor
110379817|NCT02218047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110379818|NCT00580814|Methylphenidate|methylphenidate|mesh-list
110379819|NCT00580814|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110379820|NCT00580814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110379821|NCT00580814|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110379822|NCT00580814|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110379823|NCT00580814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110379824|NCT00580814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110379825|NCT00580814|Dopamine Agents|dopamine agents|mesh-ancestor
110379826|NCT00580814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110379828|NCT01120600|Cholecalciferol|cholecalciferol|mesh-list
110379829|NCT01120600|Calcium Carbonate|calcium carbonate|mesh-list
110379830|NCT01120600|Calcium|calcium|mesh-list
110379831|NCT01120600|Vitamins|vitamins|mesh-ancestor
110379832|NCT01120600|Micronutrients|micronutrients|mesh-ancestor
110379833|NCT01120600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110379834|NCT01120600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110379835|NCT01120600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110379836|NCT01120600|Antacids|antacids|mesh-ancestor
110379837|NCT01120600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110379838|NCT01120600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110379839|NCT04577885|Rifampin|rifampin|mesh-list
110379840|NCT04577885|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110379841|NCT04577885|Antitubercular Agents|antitubercular agents|mesh-ancestor
110379842|NCT04577885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110379843|NCT04577885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110379844|NCT04577885|Leprostatic Agents|leprostatic agents|mesh-ancestor
110379845|NCT04577885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110379846|NCT04577885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110379847|NCT04577885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110379848|NCT04577885|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110379849|NCT04577885|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110379850|NCT04577885|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110019956|NCT00000810|Delavirdine|delavirdine|mesh-list
110379851|NCT04577885|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110379852|NCT04577885|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110379853|NCT04577885|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110379854|NCT00580931|Niacinamide|niacinamide|mesh-list
110379855|NCT00580931|Niacin|niacin|mesh-list
110379856|NCT00580931|Nicotinic Acids|nicotinic acids|mesh-list
110379857|NCT00580931|Vitamin B Complex|vitamin b complex|mesh-ancestor
110379858|NCT00580931|Vitamins|vitamins|mesh-ancestor
110379859|NCT00580931|Micronutrients|micronutrients|mesh-ancestor
110379860|NCT00580931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110379861|NCT00580931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110379862|NCT00580931|Antimetabolites|antimetabolites|mesh-ancestor
110379863|NCT00580931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110379864|NCT00580931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110379865|NCT00580931|Vasodilator Agents|vasodilator agents|mesh-ancestor
110379866|NCT01120093|Bromides|bromides|mesh-list
110379867|NCT01120093|Formoterol Fumarate|formoterol fumarate|mesh-list
110379868|NCT01120093|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110379869|NCT01120093|Autonomic Agents|autonomic agents|mesh-ancestor
110379871|NCT01120093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110379872|NCT01120093|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110379873|NCT01120093|Respiratory System Agents|respiratory system agents|mesh-ancestor
110379874|NCT01120093|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110379875|NCT01120093|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110379876|NCT01120093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110379877|NCT01120093|Adrenergic Agents|adrenergic agents|mesh-ancestor
110379878|NCT01120093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110379879|NCT01120093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110379880|NCT01120093|Anticonvulsants|anticonvulsants|mesh-ancestor
110379881|NCT00581009|Lithium Carbonate|lithium carbonate|mesh-list
110379882|NCT00581009|Sertraline|sertraline|mesh-list
110379883|NCT00581009|Antidepressive Agents|antidepressive agents|mesh-ancestor
110379884|NCT00581009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110379885|NCT00581009|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110379886|NCT00581009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110379887|NCT00581009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110379888|NCT00581009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110379889|NCT00581009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110379890|NCT00581009|Serotonin Agents|serotonin agents|mesh-ancestor
110379891|NCT00581009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110379892|NCT00581009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110379893|NCT00581009|Antimanic Agents|antimanic agents|mesh-ancestor
110379894|NCT00581009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110379895|NCT00581009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110379896|NCT02218359|Amikacin|amikacin|mesh-list
110379897|NCT02218359|Fosfomycin|fosfomycin|mesh-list
110379898|NCT02218359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110379899|NCT02218359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110379900|NCT02218359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110379901|NCT02882191|Levonorgestrel|levonorgestrel|mesh-list
110379903|NCT02882191|Contraceptive Agents|contraceptive agents|mesh-ancestor
110379904|NCT02882191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110379905|NCT02882191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110379906|NCT02882191|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110379907|NCT02882191|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110379908|NCT02882191|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110379909|NCT02218398|Albuterol|albuterol|mesh-list
110379910|NCT02218398|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110379911|NCT02218398|Autonomic Agents|autonomic agents|mesh-ancestor
110379912|NCT02218398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110379913|NCT02218398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110379914|NCT02218398|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110379915|NCT02218398|Respiratory System Agents|respiratory system agents|mesh-ancestor
110379916|NCT02218398|Tocolytic Agents|tocolytic agents|mesh-ancestor
110379917|NCT02218398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110379918|NCT02218398|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110379919|NCT02218398|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110379920|NCT02218398|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110379921|NCT02218398|Adrenergic Agents|adrenergic agents|mesh-ancestor
110379922|NCT02218398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110379923|NCT02218398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110379924|NCT02218671|Brotizolam|brotizolam|mesh-list
110379925|NCT02218671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110379926|NCT02218671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110041900|NCT01438736|Progestins|progestins|mesh-ancestor
110379927|NCT02218671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110379928|NCT01119937|Glycopyrrolate|glycopyrrolate|mesh-list
110379929|NCT01119937|Tiotropium Bromide|tiotropium bromide|mesh-list
110379930|NCT01119937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110379931|NCT01119937|Autonomic Agents|autonomic agents|mesh-ancestor
110379932|NCT01119937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110379933|NCT01119937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110379934|NCT01119937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110379935|NCT01119937|Respiratory System Agents|respiratory system agents|mesh-ancestor
110379936|NCT01119937|Parasympatholytics|parasympatholytics|mesh-ancestor
110379937|NCT01119937|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110379938|NCT01119937|Cholinergic Agents|cholinergic agents|mesh-ancestor
110379939|NCT01119937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110379940|NCT01119937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110379941|NCT01119937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110379942|NCT01119937|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110379944|NCT01119898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110379945|NCT01119898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110379946|NCT01119898|Analgesics|analgesics|mesh-ancestor
110379947|NCT01119898|Sensory System Agents|sensory system agents|mesh-ancestor
110379948|NCT01119898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110379949|NCT01119898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110379950|NCT01119898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110379951|NCT01119898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110379952|NCT01119898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110379953|NCT01119898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110379954|NCT01119898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110379956|NCT01119859|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110379957|NCT01119859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110379958|NCT01119859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110379959|NCT02278926|Insulin|insulin|mesh-list
110379960|NCT02278926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110379961|NCT02278926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110379962|NCT01119703|Vaccines|vaccines|mesh-list
110379964|NCT01119703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110379965|NCT02882230|Dolutegravir|dolutegravir|mesh-list
110379966|NCT02882230|Rilpivirine|rilpivirine|mesh-list
110379967|NCT02882230|Elvitegravir|elvitegravir|mesh-list
110379968|NCT02882230|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110379969|NCT02882230|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110379970|NCT02882230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110379971|NCT02882230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110379972|NCT02882230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110379973|NCT02882230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110379974|NCT02882230|Antiviral Agents|antiviral agents|mesh-ancestor
110379975|NCT02882230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110379976|NCT02882230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110379977|NCT02882230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110379978|NCT01119625|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110379979|NCT01119625|Immunologic Factors|immunologic factors|mesh-ancestor
110379980|NCT01119625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110379981|NCT02218827|Loteprednol Etabonate|loteprednol etabonate|mesh-list
110379983|NCT02881762|Maraviroc|maraviroc|mesh-list
110379984|NCT02881762|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110379985|NCT02881762|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110379986|NCT02881762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110379987|NCT02881762|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110379988|NCT02881762|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110379989|NCT02881762|Antiviral Agents|antiviral agents|mesh-ancestor
110379990|NCT02881762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110379991|NCT02881762|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110379992|NCT04561947|Mitogens|mitogens|mesh-list
110379993|NCT04561947|Mitosis Modulators|mitosis modulators|mesh-ancestor
110379994|NCT04561947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110379995|NCT01118962|Lacosamide|lacosamide|mesh-list
110379996|NCT01118962|Anticonvulsants|anticonvulsants|mesh-ancestor
110379997|NCT01118962|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110379998|NCT01118962|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110379999|NCT01118962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110380000|NCT01118962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110380001|NCT00581165|Etanercept|etanercept|mesh-list
110380002|NCT00581165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110380003|NCT00581165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110380004|NCT00581165|Analgesics|analgesics|mesh-ancestor
110380005|NCT00581165|Sensory System Agents|sensory system agents|mesh-ancestor
110380006|NCT00581165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110380007|NCT00581165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380008|NCT00581165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110380009|NCT00581165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110380010|NCT00581165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110380011|NCT00581165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110380012|NCT00581165|Immunologic Factors|immunologic factors|mesh-ancestor
110380014|NCT05092984|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110380015|NCT05092984|Hormone Antagonists|hormone antagonists|mesh-ancestor
110380016|NCT05092984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110380017|NCT05092984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380018|NCT05092984|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110380019|NCT05092984|Diuretics|diuretics|mesh-ancestor
110380020|NCT05092984|Natriuretic Agents|natriuretic agents|mesh-ancestor
110380021|NCT02213159|Dexmedetomidine|dexmedetomidine|mesh-list
110380022|NCT02213159|Morphine|morphine|mesh-list
110380023|NCT02213159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110380024|NCT02213159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110380025|NCT02213159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380026|NCT02213159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110380027|NCT02213159|Analgesics|analgesics|mesh-ancestor
110380028|NCT02213159|Sensory System Agents|sensory system agents|mesh-ancestor
110380029|NCT02213159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110380030|NCT02213159|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110380031|NCT02213159|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110380032|NCT02213159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110380033|NCT02213159|Adrenergic Agents|adrenergic agents|mesh-ancestor
110380034|NCT02213159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110380035|NCT02213159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110380036|NCT02213159|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110380037|NCT02213159|Narcotics|narcotics|mesh-ancestor
110380038|NCT01118455|Anticonvulsants|anticonvulsants|mesh-list
110380039|NCT02219100|Mifepristone|mifepristone|mesh-list
110380040|NCT02219100|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110380041|NCT02219100|Abortifacient Agents|abortifacient agents|mesh-ancestor
110380042|NCT02219100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110380043|NCT02219100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380044|NCT02219100|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110380045|NCT02219100|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110380046|NCT02219100|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110380047|NCT02219100|Contraceptive Agents|contraceptive agents|mesh-ancestor
110380048|NCT02219100|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110380049|NCT02219100|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110380050|NCT02219100|Hormone Antagonists|hormone antagonists|mesh-ancestor
110380051|NCT02219100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110380052|NCT02219100|Luteolytic Agents|luteolytic agents|mesh-ancestor
110380053|NCT02219100|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110380054|NCT02219100|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110380055|NCT01118377|Capecitabine|capecitabine|mesh-list
110380056|NCT01118377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110380057|NCT01118377|Antimetabolites|antimetabolites|mesh-ancestor
110380058|NCT01118377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110380059|NCT01118377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110380060|NCT02219178|Dexamethasone|dexamethasone|mesh-list
110380061|NCT02219178|Lenalidomide|lenalidomide|mesh-list
110380062|NCT02219178|Bortezomib|bortezomib|mesh-list
110380063|NCT02219178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110380064|NCT02219178|Antiemetics|antiemetics|mesh-ancestor
110380065|NCT02219178|Autonomic Agents|autonomic agents|mesh-ancestor
110380066|NCT02219178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110380067|NCT02219178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380068|NCT02219178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110380069|NCT02219178|Glucocorticoids|glucocorticoids|mesh-ancestor
110380070|NCT02219178|Hormones|hormones|mesh-ancestor
110380071|NCT02219178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110380072|NCT02219178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110380073|NCT02219178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110380074|NCT02219178|Immunologic Factors|immunologic factors|mesh-ancestor
110380075|NCT02219178|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110380076|NCT02219178|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110380077|NCT02219178|Growth Substances|growth substances|mesh-ancestor
110380078|NCT02219178|Growth Inhibitors|growth inhibitors|mesh-ancestor
110380079|NCT02213315|Mavrilimumab|mavrilimumab|mesh-list
110380080|NCT02213315|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110380081|NCT02213315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110380082|NCT02213315|Immunologic Factors|immunologic factors|mesh-ancestor
110380083|NCT02213315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380084|NCT02219217|Dolutegravir|dolutegravir|mesh-list
110380085|NCT02219217|Cobicistat|cobicistat|mesh-list
110380086|NCT02219217|Elvitegravir|elvitegravir|mesh-list
110380087|NCT02219217|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110380088|NCT02219217|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110380089|NCT02219217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110380090|NCT02219217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110380091|NCT02219217|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110380092|NCT02219217|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110380093|NCT02219217|Antiviral Agents|antiviral agents|mesh-ancestor
110380094|NCT02219217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110380095|NCT02219217|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110380096|NCT02219217|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110380097|NCT04577378|Itraconazole|itraconazole|mesh-list
110380098|NCT04577378|Tretinoin|tretinoin|mesh-list
110380099|NCT04577378|Isotretinoin|isotretinoin|mesh-list
110380100|NCT04577378|Antifungal Agents|antifungal agents|mesh-ancestor
110380101|NCT04577378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110380102|NCT04577378|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110380103|NCT04577378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110380104|NCT04577378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110380105|NCT04577378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110380106|NCT04577378|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110380107|NCT04577378|Hormone Antagonists|hormone antagonists|mesh-ancestor
110380108|NCT04577378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110380109|NCT04577378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380110|NCT04577378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110380111|NCT04577378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110380112|NCT04577378|Keratolytic Agents|keratolytic agents|mesh-ancestor
110380113|NCT04577378|Dermatologic Agents|dermatologic agents|mesh-ancestor
110380114|NCT02219412|Aspirin|aspirin|mesh-list
110380115|NCT02219412|Ticagrelor|ticagrelor|mesh-list
110380116|NCT02219412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110380117|NCT02219412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110380118|NCT02219412|Analgesics|analgesics|mesh-ancestor
110380119|NCT02219412|Sensory System Agents|sensory system agents|mesh-ancestor
110380120|NCT02219412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110380121|NCT02219412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380122|NCT02219412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110380123|NCT02219412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110380124|NCT02219412|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110380125|NCT02219412|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110380126|NCT02219412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110380127|NCT02219412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110380128|NCT02219412|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110380129|NCT02219412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110380130|NCT02219412|Antipyretics|antipyretics|mesh-ancestor
110380131|NCT02219412|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110380132|NCT02219412|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110380133|NCT02219412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110380134|NCT02219412|Purinergic Agents|purinergic agents|mesh-ancestor
110380135|NCT02219412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110380137|NCT04577027|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110380138|NCT02211690|Tenofovir|tenofovir|mesh-list
110380139|NCT02211690|Emtricitabine|emtricitabine|mesh-list
110380140|NCT02211690|Dolutegravir|dolutegravir|mesh-list
110380141|NCT02211690|Antiviral Agents|antiviral agents|mesh-ancestor
110380142|NCT02211690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110380143|NCT02211690|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110380144|NCT02211690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110380146|NCT02211690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110380147|NCT02211690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110380148|NCT02211690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110380149|NCT02211690|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110380150|NCT02211690|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110380152|NCT04553393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110380153|NCT04553393|Antimetabolites|antimetabolites|mesh-ancestor
110380154|NCT04553393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110380155|NCT04553393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110380156|NCT04553393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110380157|NCT02211846|Mirabegron|mirabegron|mesh-list
110380158|NCT02211846|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110380159|NCT02211846|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110380160|NCT02211846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110380161|NCT02211846|Adrenergic Agents|adrenergic agents|mesh-ancestor
110380162|NCT02211846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110380163|NCT02211846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110380164|NCT02211846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380165|NCT02211846|Urological Agents|urological agents|mesh-ancestor
110380166|NCT02219646|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110380167|NCT02219646|Vasodilator Agents|vasodilator agents|mesh-ancestor
110380168|NCT02219646|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110380169|NCT02219646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110380170|NCT02219646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110380171|NCT02219646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110380174|NCT04553510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110380175|NCT04553510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110380176|NCT04553510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110380177|NCT04553510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110380178|NCT04553510|Growth Substances|growth substances|mesh-ancestor
110380179|NCT04553510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380180|NCT04553510|Growth Inhibitors|growth inhibitors|mesh-ancestor
110380181|NCT03453281|Aflibercept|aflibercept|mesh-list
110380182|NCT03453281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110380183|NCT03453281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110380184|NCT03453281|Growth Substances|growth substances|mesh-ancestor
110380185|NCT03453281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380186|NCT03453281|Growth Inhibitors|growth inhibitors|mesh-ancestor
110380187|NCT03453281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110380188|NCT01642134|Aspirin|aspirin|mesh-list
110380189|NCT01642134|Clopidogrel|clopidogrel|mesh-list
110380190|NCT01642134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110380191|NCT01642134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110380192|NCT01642134|Analgesics|analgesics|mesh-ancestor
110380193|NCT01642134|Sensory System Agents|sensory system agents|mesh-ancestor
110380194|NCT01642134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110380195|NCT01642134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380196|NCT01642134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110380197|NCT01642134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110380198|NCT01642134|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110380199|NCT01642134|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110380200|NCT01642134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110380201|NCT01642134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110380202|NCT01642134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110380203|NCT01642134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110380204|NCT01642134|Antipyretics|antipyretics|mesh-ancestor
110380205|NCT01642134|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110380206|NCT01642134|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110380207|NCT01642134|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110380208|NCT01642134|Purinergic Agents|purinergic agents|mesh-ancestor
110380209|NCT01642134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110380210|NCT00581789|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110380211|NCT00581789|Sunitinib|sunitinib|mesh-list
110380212|NCT00581789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110380213|NCT00581789|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110380214|NCT00581789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110380215|NCT00581789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110380216|NCT00581789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110380217|NCT00581789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110380218|NCT00581789|Growth Substances|growth substances|mesh-ancestor
110380219|NCT00581789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380220|NCT00581789|Growth Inhibitors|growth inhibitors|mesh-ancestor
110380221|NCT02213588|Antioxidants|antioxidants|mesh-list
110380222|NCT02213588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110380223|NCT02213588|Protective Agents|protective agents|mesh-ancestor
110380224|NCT02213588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380225|NCT01642524|Dextrans|dextrans|mesh-list
110380226|NCT01642524|Anticoagulants|anticoagulants|mesh-ancestor
110380227|NCT01642524|Plasma Substitutes|plasma substitutes|mesh-ancestor
110380228|NCT01642524|Blood Substitutes|blood substitutes|mesh-ancestor
110380229|NCT02213783|Imipenem|imipenem|mesh-list
110380230|NCT02213783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110380231|NCT02213783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110380232|NCT04552613|Carboplatin|carboplatin|mesh-list
110380234|NCT04552613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110380235|NCT04552613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110380236|NCT04552613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110380237|NCT04552613|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110380238|NCT04552613|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110380239|NCT01117987|Imatinib Mesylate|imatinib mesylate|mesh-list
110380240|NCT01117987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110380241|NCT01117987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110380242|NCT01117987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110380243|NCT01117987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110380244|NCT02219490|Ritonavir|ritonavir|mesh-list
110380245|NCT02219490|Ribavirin|ribavirin|mesh-list
110380246|NCT02219490|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110380247|NCT02219490|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110380248|NCT02219490|Protease Inhibitors|protease inhibitors|mesh-ancestor
110380249|NCT02219490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110380250|NCT02219490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110380251|NCT02219490|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110380252|NCT02219490|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110380253|NCT02219490|Antiviral Agents|antiviral agents|mesh-ancestor
110380254|NCT02219490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110380255|NCT02219490|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110380256|NCT02219490|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110380257|NCT02219490|Antimetabolites|antimetabolites|mesh-ancestor
110380258|NCT01117051|Prucalopride|prucalopride|mesh-list
110380259|NCT01117051|Laxatives|laxatives|mesh-ancestor
110380260|NCT01117051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110380261|NCT01117051|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
110380262|NCT01117051|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110380263|NCT01117051|Serotonin Agents|serotonin agents|mesh-ancestor
110380264|NCT01117051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110380265|NCT01117051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110380266|NCT01117051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380267|NCT02211417|Evening primrose oil|evening primrose oil|mesh-list
110380268|NCT02211417|Mineral Oil|mineral oil|mesh-list
110380269|NCT02211417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110380270|NCT02211417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110380271|NCT02211417|Analgesics|analgesics|mesh-ancestor
110380272|NCT02211417|Sensory System Agents|sensory system agents|mesh-ancestor
110380273|NCT02211417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110380274|NCT02211417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380275|NCT02211417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110380276|NCT02211417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110380277|NCT02211417|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110380278|NCT02211417|Antimetabolites|antimetabolites|mesh-ancestor
110380279|NCT02211417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110380280|NCT02211417|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110380281|NCT02211417|Dermatologic Agents|dermatologic agents|mesh-ancestor
110380282|NCT02211417|Emollients|emollients|mesh-ancestor
110380283|NCT02279121|Taurolidine|taurolidine|mesh-list
110380284|NCT02279121|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110380285|NCT02279121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110380286|NCT02279121|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110380287|NCT02279121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110380288|NCT02218164|Interferons|interferons|mesh-list
110380289|NCT02218164|Interferon-alpha|interferon-alpha|mesh-list
110380290|NCT02218164|Interferon alpha-2|interferon alpha-2|mesh-list
110380291|NCT02218164|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110380292|NCT02218164|Fluorouracil|fluorouracil|mesh-list
110380293|NCT02218164|Capecitabine|capecitabine|mesh-list
110380294|NCT02218164|Antimetabolites|antimetabolites|mesh-ancestor
110380295|NCT02218164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110380297|NCT02218164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110380298|NCT02218164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110380299|NCT02218164|Immunologic Factors|immunologic factors|mesh-ancestor
110380300|NCT02218164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380301|NCT02218164|Antiviral Agents|antiviral agents|mesh-ancestor
110380302|NCT02218164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110380303|NCT04552067|Enoxaparin|enoxaparin|mesh-list
110380304|NCT04552067|Anticoagulants|anticoagulants|mesh-ancestor
110380305|NCT04552067|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110380306|NCT04552067|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110380307|NCT04552067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110380308|NCT01643187|Vitamins|vitamins|mesh-list
110380309|NCT01643187|Micronutrients|micronutrients|mesh-ancestor
110380310|NCT01643187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380311|NCT01643265|Caseins|caseins|mesh-list
110380312|NCT01643265|Chelating Agents|chelating agents|mesh-ancestor
110380313|NCT01643265|Sequestering Agents|sequestering agents|mesh-ancestor
110380314|NCT01643265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110380315|NCT04551833|Levobupivacaine|levobupivacaine|mesh-list
110380316|NCT04551833|Anesthetics, Local|anesthetics, local|mesh-ancestor
110380317|NCT04551833|Anesthetics|anesthetics|mesh-ancestor
110380318|NCT04551833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110380319|NCT04551833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380320|NCT04551833|Sensory System Agents|sensory system agents|mesh-ancestor
110380321|NCT04551833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110380322|NCT04551755|Doxycycline|doxycycline|mesh-list
110380323|NCT04551755|Ivermectin|ivermectin|mesh-list
110380324|NCT04551755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110380325|NCT04551755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110380326|NCT04551755|Antimalarials|antimalarials|mesh-ancestor
110380327|NCT04551755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110380328|NCT04551755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110380329|NCT01643499|Leucovorin|leucovorin|mesh-list
110380330|NCT01643499|Fluorouracil|fluorouracil|mesh-list
110380331|NCT01643499|Oxaliplatin|oxaliplatin|mesh-list
110380332|NCT01643499|Irinotecan|irinotecan|mesh-list
110380333|NCT01643499|Calcium|calcium|mesh-list
110380334|NCT01643499|Levoleucovorin|levoleucovorin|mesh-list
110380335|NCT01643499|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110380336|NCT01643499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380337|NCT01643499|Antimetabolites|antimetabolites|mesh-ancestor
110380338|NCT01643499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110380339|NCT01643499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110380340|NCT01643499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110380341|NCT01643499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110380342|NCT01643499|Immunologic Factors|immunologic factors|mesh-ancestor
110380344|NCT01643499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110380345|NCT01643499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110380346|NCT01643499|Antidotes|antidotes|mesh-ancestor
110380347|NCT01643499|Protective Agents|protective agents|mesh-ancestor
110380348|NCT01643499|Vitamin B Complex|vitamin b complex|mesh-ancestor
110380349|NCT01643499|Vitamins|vitamins|mesh-ancestor
110380350|NCT01643499|Micronutrients|micronutrients|mesh-ancestor
110380351|NCT01117012|Ivacaftor|ivacaftor|mesh-list
110380352|NCT01117012|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110380353|NCT01117012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110380354|NCT01117012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110380355|NCT01116739|Fluorides|fluorides|mesh-list
110380356|NCT01116739|Fluorides, Topical|fluorides, topical|mesh-list
110380357|NCT01116739|Cariostatic Agents|cariostatic agents|mesh-ancestor
110380358|NCT01116739|Protective Agents|protective agents|mesh-ancestor
110380359|NCT01116739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380360|NCT01640496|Vitamin D|vitamin d|mesh-list
110380361|NCT01640496|Cholecalciferol|cholecalciferol|mesh-list
110380362|NCT01640496|Vitamins|vitamins|mesh-ancestor
110380363|NCT01640496|Micronutrients|micronutrients|mesh-ancestor
110380364|NCT01640496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380365|NCT01640496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110380366|NCT01640496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110380368|NCT04551248|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110380369|NCT04551248|Immunologic Factors|immunologic factors|mesh-ancestor
110380370|NCT04551248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380371|NCT01640535|Cetirizine|cetirizine|mesh-list
110380372|NCT01640535|Montelukast|montelukast|mesh-list
110380373|NCT01640535|Levocetirizine|levocetirizine|mesh-list
110380374|NCT01640535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110380375|NCT01640535|Respiratory System Agents|respiratory system agents|mesh-ancestor
110380376|NCT01640535|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110380377|NCT01640535|Hormone Antagonists|hormone antagonists|mesh-ancestor
110380378|NCT01640535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110380379|NCT01640535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380380|NCT01640535|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110380381|NCT01640535|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110042349|NCT01441804|Ribavirin|ribavirin|mesh-list
110380382|NCT01640535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110380383|NCT01640535|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110380384|NCT01640535|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110380385|NCT01640535|Histamine Antagonists|histamine antagonists|mesh-ancestor
110380386|NCT01640535|Histamine Agents|histamine agents|mesh-ancestor
110380387|NCT01640535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110380388|NCT01640535|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110380389|NCT04550936|Isavuconazole|isavuconazole|mesh-list
110380390|NCT04550936|Antifungal Agents|antifungal agents|mesh-ancestor
110380391|NCT04550936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110380392|NCT04550858|Rebamipide|rebamipide|mesh-list
110380393|NCT04550858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110380394|NCT04550858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110380395|NCT04550858|Antioxidants|antioxidants|mesh-ancestor
110380396|NCT04550858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110380397|NCT04550858|Protective Agents|protective agents|mesh-ancestor
110380398|NCT04550858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380399|NCT04550858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110380400|NCT01640574|Chloroquine|chloroquine|mesh-list
110380401|NCT01640574|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
110380402|NCT01640574|Piperaquine|piperaquine|mesh-list
110380403|NCT01640574|Artenimol|artenimol|mesh-list
110380404|NCT01640574|Artemisinins|artemisinins|mesh-list
110380405|NCT01640574|Amebicides|amebicides|mesh-ancestor
110380406|NCT01640574|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110380407|NCT01640574|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110380408|NCT01640574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110380409|NCT01640574|Antimalarials|antimalarials|mesh-ancestor
110380410|NCT01640574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110380411|NCT01640574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110380412|NCT01640574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110380413|NCT01640574|Analgesics|analgesics|mesh-ancestor
110380414|NCT01640574|Sensory System Agents|sensory system agents|mesh-ancestor
110380415|NCT01640574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110380416|NCT01640574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380417|NCT01640574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110380418|NCT01640574|Filaricides|filaricides|mesh-ancestor
110380419|NCT01640574|Antinematodal Agents|antinematodal agents|mesh-ancestor
110380420|NCT01640574|Anthelmintics|anthelmintics|mesh-ancestor
110380421|NCT01116427|Abatacept|abatacept|mesh-list
110380422|NCT01116427|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110380423|NCT01116427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110380424|NCT01116427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110380425|NCT01116427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110380426|NCT01116427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110380427|NCT01116427|Immunologic Factors|immunologic factors|mesh-ancestor
110380428|NCT01116427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380429|NCT01116427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110380430|NCT04529226|Haloperidol|haloperidol|mesh-list
110380431|NCT04529226|Pimozide|pimozide|mesh-list
110380432|NCT04529226|Olanzapine|olanzapine|mesh-list
110380433|NCT04529226|Risperidone|risperidone|mesh-list
110380434|NCT04529226|Haloperidol decanoate|haloperidol decanoate|mesh-list
110380435|NCT04529226|Clozapine|clozapine|mesh-list
110380436|NCT04529226|Amisulpride|amisulpride|mesh-list
110380437|NCT04529226|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110380438|NCT04529226|Serotonin Agents|serotonin agents|mesh-ancestor
110380439|NCT04529226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110380440|NCT04529226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110380441|NCT04529226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380442|NCT04529226|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110380443|NCT04529226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110380444|NCT04529226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110380445|NCT04529226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110380446|NCT04529226|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110380447|NCT04529226|Dopamine Agents|dopamine agents|mesh-ancestor
110380448|NCT04529226|Antiemetics|antiemetics|mesh-ancestor
110380449|NCT04529226|Autonomic Agents|autonomic agents|mesh-ancestor
110380450|NCT04529226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110380451|NCT04529226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110380452|NCT04529226|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110380453|NCT04529226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110380454|NCT04529226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110380455|NCT04529226|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110380456|NCT04529226|GABA Antagonists|gaba antagonists|mesh-ancestor
110380457|NCT04529226|GABA Agents|gaba agents|mesh-ancestor
110380458|NCT04529226|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110380459|NCT04529226|Antidepressive Agents|antidepressive agents|mesh-ancestor
110380460|NCT04310683|Hormones|hormones|mesh-list
110380461|NCT04310683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110380462|NCT04310683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380464|NCT04550702|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110380465|NCT04550702|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110380466|NCT04550702|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110380467|NCT04550702|Adrenergic Agents|adrenergic agents|mesh-ancestor
110380468|NCT04550702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110380469|NCT04550702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110380472|NCT01116232|Sirolimus|sirolimus|mesh-list
110380473|NCT01116232|Rituximab|rituximab|mesh-list
110380474|NCT01116232|Tacrolimus|tacrolimus|mesh-list
110380475|NCT01116232|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110380476|NCT01116232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110380477|NCT01116232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110380478|NCT01116232|Immunologic Factors|immunologic factors|mesh-ancestor
110380479|NCT01116232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380480|NCT01116232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110380481|NCT01116232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110380482|NCT01116232|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110380483|NCT01116232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110380484|NCT01116232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110380485|NCT01116232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110380486|NCT01116232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110380487|NCT01116232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110380488|NCT01116232|Antifungal Agents|antifungal agents|mesh-ancestor
110380489|NCT02214095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110380490|NCT04550351|Vaccines|vaccines|mesh-list
110380492|NCT04550351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380493|NCT01640691|Vaccines|vaccines|mesh-list
110380494|NCT01640691|Immunologic Factors|immunologic factors|mesh-ancestor
110380495|NCT01640691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380496|NCT01643889|Moxifloxacin|moxifloxacin|mesh-list
110380497|NCT01643889|Domperidone|domperidone|mesh-list
110380498|NCT01643889|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110380499|NCT01643889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110380500|NCT01643889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110380501|NCT01643889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110380502|NCT01643889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110380503|NCT01643889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110380504|NCT01643889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110380505|NCT01643889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380506|NCT01643889|Antiemetics|antiemetics|mesh-ancestor
110380507|NCT01643889|Autonomic Agents|autonomic agents|mesh-ancestor
110380508|NCT01643889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110380509|NCT01643889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110380510|NCT01643889|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110380511|NCT01643889|Dopamine Agents|dopamine agents|mesh-ancestor
110380512|NCT01643889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110380513|NCT04550078|Calcium, Dietary|calcium, dietary|mesh-list
110380514|NCT04550078|Calcium Carbonate|calcium carbonate|mesh-list
110380515|NCT04550078|Calcium|calcium|mesh-list
110380516|NCT04550078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110380517|NCT04550078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380518|NCT04550078|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110380519|NCT04550078|Antacids|antacids|mesh-ancestor
110380520|NCT04550078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110380521|NCT04550078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110380522|NCT01205035|Ranibizumab|ranibizumab|mesh-list
110380523|NCT01205035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110380524|NCT01205035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110380525|NCT01205035|Growth Substances|growth substances|mesh-ancestor
110380526|NCT01205035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380527|NCT01205035|Growth Inhibitors|growth inhibitors|mesh-ancestor
110380528|NCT01205035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110380529|NCT04549844|Bupivacaine|bupivacaine|mesh-list
110380530|NCT04549844|Anesthetics, Local|anesthetics, local|mesh-ancestor
110380531|NCT04549844|Anesthetics|anesthetics|mesh-ancestor
110380532|NCT04549844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110380533|NCT04549844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380534|NCT04549844|Sensory System Agents|sensory system agents|mesh-ancestor
110042500|NCT01442610|Rasagiline|rasagiline|mesh-list
110380535|NCT04549844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110380536|NCT01644084|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
110380538|NCT01644084|Blood Substitutes|blood substitutes|mesh-ancestor
110380539|NCT01204918|Riluzole|riluzole|mesh-list
110380540|NCT01204918|Anticonvulsants|anticonvulsants|mesh-ancestor
110380541|NCT01204918|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110380542|NCT01204918|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110380543|NCT01204918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110380544|NCT01204918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110380545|NCT01204918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380546|NCT01204918|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110380547|NCT01204918|Protective Agents|protective agents|mesh-ancestor
110380548|NCT04528797|Methylprednisolone|methylprednisolone|mesh-list
110380549|NCT04528797|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110380550|NCT04528797|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110380551|NCT04528797|Prednisolone|prednisolone|mesh-list
110380552|NCT04528797|Prednisolone acetate|prednisolone acetate|mesh-list
110380553|NCT04528797|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110380554|NCT04528797|Prednisolone phosphate|prednisolone phosphate|mesh-list
110380555|NCT04528797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110380556|NCT04528797|Antiemetics|antiemetics|mesh-ancestor
110380557|NCT04528797|Autonomic Agents|autonomic agents|mesh-ancestor
110380558|NCT04528797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110380559|NCT04528797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380560|NCT04528797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110380561|NCT04528797|Glucocorticoids|glucocorticoids|mesh-ancestor
110380562|NCT04528797|Hormones|hormones|mesh-ancestor
110380563|NCT04528797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110380564|NCT04528797|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110380565|NCT04528797|Protective Agents|protective agents|mesh-ancestor
110380566|NCT04528797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110380567|NCT04528797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110380568|NCT00624481|Teriparatide|teriparatide|mesh-list
110380569|NCT00624481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110380570|NCT00624481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380571|NCT00624481|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110380572|NCT04529187|Midazolam|midazolam|mesh-list
110380573|NCT04529187|Dexmedetomidine|dexmedetomidine|mesh-list
110380574|NCT04529187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110380575|NCT04529187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110380576|NCT04529187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380577|NCT04529187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110380578|NCT04529187|Analgesics|analgesics|mesh-ancestor
110380579|NCT04529187|Sensory System Agents|sensory system agents|mesh-ancestor
110380580|NCT04529187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110380581|NCT04529187|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110380582|NCT04529187|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110380583|NCT04529187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110380584|NCT04529187|Adrenergic Agents|adrenergic agents|mesh-ancestor
110380585|NCT04529187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110380586|NCT04529187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110380587|NCT04529187|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110380588|NCT04529187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110380589|NCT04529187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110380590|NCT04529187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110380591|NCT04529187|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110380592|NCT04529187|Anesthetics, General|anesthetics, general|mesh-ancestor
110380593|NCT04529187|Anesthetics|anesthetics|mesh-ancestor
110380594|NCT04529187|GABA Modulators|gaba modulators|mesh-ancestor
110380595|NCT04529187|GABA Agents|gaba agents|mesh-ancestor
110380596|NCT04549415|Metformin|metformin|mesh-list
110380597|NCT04549415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110380598|NCT04549415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380599|NCT02214368|Propofol|propofol|mesh-list
110380600|NCT02214368|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110042577|NCT01442935|Antidotes|antidotes|mesh-ancestor
110380601|NCT02214368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110380602|NCT02214368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380603|NCT02214368|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110380604|NCT02214368|Anesthetics, General|anesthetics, general|mesh-ancestor
110380605|NCT02214368|Anesthetics|anesthetics|mesh-ancestor
110380607|NCT01204294|Linagliptin|linagliptin|mesh-list
110380608|NCT01204294|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110380609|NCT01204294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380610|NCT01204294|Incretins|incretins|mesh-ancestor
110380611|NCT01204294|Hormones|hormones|mesh-ancestor
110380612|NCT01204294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110380613|NCT01204294|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110380614|NCT01204294|Protease Inhibitors|protease inhibitors|mesh-ancestor
110380615|NCT01204294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110380616|NCT01204294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110380618|NCT01182181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110380619|NCT01182181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110380620|NCT01182181|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110380621|NCT01182181|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110380622|NCT01182181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110380623|NCT01182181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110380624|NCT01182181|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110380625|NCT01182181|Hormone Antagonists|hormone antagonists|mesh-ancestor
110380626|NCT01182181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110380627|NCT01182181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380628|NCT01181986|Exenatide|exenatide|mesh-list
110380629|NCT01181986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110380630|NCT01181986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380631|NCT01181986|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110380632|NCT01181986|Incretins|incretins|mesh-ancestor
110380633|NCT01181986|Hormones|hormones|mesh-ancestor
110380634|NCT01181986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110380635|NCT04315909|Vitamin E|vitamin e|mesh-list
110380636|NCT04315909|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110380637|NCT04315909|Vitamins|vitamins|mesh-ancestor
110380638|NCT04315909|Micronutrients|micronutrients|mesh-ancestor
110380639|NCT04315909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380640|NCT04315909|Antioxidants|antioxidants|mesh-ancestor
110380641|NCT04315909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110380642|NCT04315909|Protective Agents|protective agents|mesh-ancestor
110380643|NCT04315909|Hemostatics|hemostatics|mesh-ancestor
110380644|NCT04315909|Coagulants|coagulants|mesh-ancestor
110380646|NCT01181167|Enoxaparin sodium|enoxaparin sodium|mesh-list
110380647|NCT01181167|Edoxaban|edoxaban|mesh-list
110380648|NCT01181167|Anticoagulants|anticoagulants|mesh-ancestor
110380649|NCT01181167|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110380650|NCT01181167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110380651|NCT01181167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110380652|NCT01181167|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110380653|NCT01181167|Antithrombins|antithrombins|mesh-ancestor
110380654|NCT01181167|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110380655|NCT01181167|Protease Inhibitors|protease inhibitors|mesh-ancestor
110380656|NCT01181167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110380657|NCT04548557|Immunoglobulins|immunoglobulins|mesh-list
110380658|NCT04548557|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110380659|NCT04548557|Antibodies|antibodies|mesh-list
110380660|NCT04548557|gamma-Globulins|gamma-globulins|mesh-list
110380661|NCT04548557|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110380662|NCT04548557|Immunologic Factors|immunologic factors|mesh-ancestor
110380663|NCT04548557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380664|NCT01181128|Factor VIII|factor viii|mesh-list
110380665|NCT01181128|Coagulants|coagulants|mesh-ancestor
110380666|NCT04548401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
110380667|NCT04548284|Glucocorticoids|glucocorticoids|mesh-list
110380669|NCT04548284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110380670|NCT04548284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380672|NCT04547894|Protease Inhibitors|protease inhibitors|mesh-ancestor
110380673|NCT04547894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110380674|NCT04547894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110380675|NCT01641315|Immunoglobulins|immunoglobulins|mesh-list
110380676|NCT01641315|Immunologic Factors|immunologic factors|mesh-ancestor
110380677|NCT01641315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380678|NCT01644825|Paclitaxel|paclitaxel|mesh-list
110380679|NCT01644825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110380680|NCT01644825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110380681|NCT01644825|Tubulin Modulators|tubulin modulators|mesh-ancestor
110380682|NCT01644825|Antimitotic Agents|antimitotic agents|mesh-ancestor
110380683|NCT01644825|Mitosis Modulators|mitosis modulators|mesh-ancestor
110380684|NCT01644825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110380686|NCT01644864|Anesthetics, Local|anesthetics, local|mesh-ancestor
110380687|NCT01644864|Anesthetics|anesthetics|mesh-ancestor
110380688|NCT01644864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110380689|NCT01644864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380690|NCT01644864|Sensory System Agents|sensory system agents|mesh-ancestor
110380691|NCT01644864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110380692|NCT04547855|Temozolomide|temozolomide|mesh-list
110380693|NCT04547855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110380694|NCT04547855|Alkylating Agents|alkylating agents|mesh-ancestor
110380695|NCT04547855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110380696|NCT04547855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110380697|NCT01641510|Clopidogrel|clopidogrel|mesh-list
110380698|NCT01641510|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110380699|NCT01641510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110380700|NCT01641510|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110380701|NCT01641510|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110380702|NCT01641510|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110380703|NCT01641510|Purinergic Agents|purinergic agents|mesh-ancestor
110380704|NCT01641510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110380705|NCT01641510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110380706|NCT01641510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380707|NCT04547621|Temozolomide|temozolomide|mesh-list
110380708|NCT04547621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110380709|NCT04547621|Alkylating Agents|alkylating agents|mesh-ancestor
110380710|NCT04547621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110380711|NCT04547621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110380712|NCT01641549|Fibrinolytic Agents|fibrinolytic agents|mesh-list
110380713|NCT01641549|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110380714|NCT01641549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110380715|NCT04547348|Denosumab|denosumab|mesh-list
110380716|NCT04547348|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110380717|NCT04547348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380718|NCT04547426|Nicotine|nicotine|mesh-list
110380719|NCT04547426|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110380720|NCT04547426|Autonomic Agents|autonomic agents|mesh-ancestor
110380721|NCT04547426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110380722|NCT04547426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380723|NCT04547426|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110380724|NCT04547426|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110380725|NCT04547426|Cholinergic Agents|cholinergic agents|mesh-ancestor
110380726|NCT04547426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110380727|NCT04547426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110380729|NCT01641666|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110380730|NCT01641666|Interferon-alpha|interferon-alpha|mesh-list
110380731|NCT01641666|Antimetabolites|antimetabolites|mesh-ancestor
110380732|NCT01641666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110380733|NCT01641666|Antiviral Agents|antiviral agents|mesh-ancestor
110380734|NCT01641666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110380735|NCT01641666|Immunologic Factors|immunologic factors|mesh-ancestor
110380736|NCT01641666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380737|NCT01203787|Sorafenib|sorafenib|mesh-list
110380738|NCT01203787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110380739|NCT01203787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110380740|NCT01203787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110380741|NCT01203787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110380742|NCT04547504|Pembrolizumab|pembrolizumab|mesh-list
110380743|NCT04547504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110380744|NCT04547504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110380745|NCT04547504|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110380746|NCT04547504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110380747|NCT01645254|Antimalarials|antimalarials|mesh-list
110380748|NCT01645254|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110380749|NCT01645254|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110380750|NCT01645254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110380751|NCT01181011|Amlodipine|amlodipine|mesh-list
110380752|NCT01181011|Telmisartan|telmisartan|mesh-list
110380753|NCT01181011|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
110380754|NCT01181011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110380755|NCT01181011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110380756|NCT01181011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110380757|NCT01181011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110380758|NCT01181011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110380759|NCT01181011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380761|NCT01181011|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110380762|NCT01181011|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110380763|NCT01641783|Paclitaxel|paclitaxel|mesh-list
110380764|NCT01641783|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110380765|NCT01641783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110380766|NCT01641783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110380767|NCT01641783|Tubulin Modulators|tubulin modulators|mesh-ancestor
110380768|NCT01641783|Antimitotic Agents|antimitotic agents|mesh-ancestor
110380769|NCT01641783|Mitosis Modulators|mitosis modulators|mesh-ancestor
110380770|NCT01641783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110380771|NCT02214602|Doxorubicin|doxorubicin|mesh-list
110380772|NCT02214602|Epirubicin|epirubicin|mesh-list
110380773|NCT02214602|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110380774|NCT02214602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110380775|NCT02214602|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110380776|NCT02214602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110380777|NCT02214602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110380778|NCT02214602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110380779|NCT01646580|Ciclopirox|ciclopirox|mesh-list
110380780|NCT01646580|Antifungal Agents|antifungal agents|mesh-ancestor
110380782|NCT04546802|Grazoprevir|grazoprevir|mesh-list
110380783|NCT04546802|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
110380784|NCT04546802|Antiviral Agents|antiviral agents|mesh-ancestor
110380785|NCT04546802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110380786|NCT01580033|Vaccines|vaccines|mesh-list
110380787|NCT01580033|Immunologic Factors|immunologic factors|mesh-ancestor
110380788|NCT01580033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380789|NCT04546373|Niraparib|niraparib|mesh-list
110380790|NCT04546373|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110380791|NCT04546373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110380792|NCT04546373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110380793|NCT04546373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110380794|NCT01645410|Atorvastatin|atorvastatin|mesh-list
110380795|NCT01645410|Calcium|calcium|mesh-list
110380796|NCT01645410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110380797|NCT01645410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380798|NCT01645410|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110380799|NCT01645410|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110380800|NCT01645410|Antimetabolites|antimetabolites|mesh-ancestor
110380801|NCT01645410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110380802|NCT01645410|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110380803|NCT01645410|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110380804|NCT01645410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110380805|NCT04546334|Magnesium Sulfate|magnesium sulfate|mesh-list
110380806|NCT04546334|Analgesics|analgesics|mesh-ancestor
110380807|NCT04546334|Sensory System Agents|sensory system agents|mesh-ancestor
110380808|NCT04546334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110380809|NCT04546334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380810|NCT04546334|Anesthetics|anesthetics|mesh-ancestor
110380811|NCT04546334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110380812|NCT04546334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110380813|NCT04546334|Anticonvulsants|anticonvulsants|mesh-ancestor
110380814|NCT04546334|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110380815|NCT04546334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110380816|NCT04546334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110380817|NCT04546334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110380818|NCT04546334|Tocolytic Agents|tocolytic agents|mesh-ancestor
110380819|NCT04546334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110380820|NCT04546256|Fluticasone|fluticasone|mesh-list
110380822|NCT04546256|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110380823|NCT04546256|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110380824|NCT04546256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110380825|NCT04546256|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110380826|NCT04546256|Autonomic Agents|autonomic agents|mesh-ancestor
110380827|NCT04546256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110380828|NCT04546256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380829|NCT04546256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110380830|NCT04546256|Respiratory System Agents|respiratory system agents|mesh-ancestor
110380831|NCT04546256|Dermatologic Agents|dermatologic agents|mesh-ancestor
110380832|NCT04546256|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110380833|NCT04546256|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110380834|NCT04546256|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110380835|NCT04546256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110380836|NCT04546256|Adrenergic Agents|adrenergic agents|mesh-ancestor
110380837|NCT04546256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110380838|NCT04546256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110380839|NCT04546256|Glucocorticoids|glucocorticoids|mesh-ancestor
110380840|NCT04546256|Hormones|hormones|mesh-ancestor
110380841|NCT04546256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110380842|NCT04546256|Sympathomimetics|sympathomimetics|mesh-ancestor
110380843|NCT01645449|Atorvastatin|atorvastatin|mesh-list
110380844|NCT01645449|Calcium|calcium|mesh-list
110380845|NCT01645449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110380846|NCT01645449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380847|NCT01645449|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110380848|NCT01645449|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110380849|NCT01645449|Antimetabolites|antimetabolites|mesh-ancestor
110380850|NCT01645449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110380851|NCT01645449|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110380852|NCT01645449|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110380853|NCT01645449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110380854|NCT04546022|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110380855|NCT01645800|Muramidase|muramidase|mesh-list
110380856|NCT01645800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110380857|NCT02214680|Timolol|timolol|mesh-list
110380858|NCT02214680|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110380859|NCT02214680|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
110380860|NCT02214680|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110380861|NCT02214680|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110380862|NCT02214680|Adrenergic Agents|adrenergic agents|mesh-ancestor
110380863|NCT02214680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110380864|NCT02214680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110380865|NCT02214680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380866|NCT02214680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110380867|NCT02214680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110380868|NCT02214680|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110380869|NCT02214680|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110380870|NCT02214680|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110380871|NCT02756208|Vaccines|vaccines|mesh-list
110380872|NCT02756208|Immunologic Factors|immunologic factors|mesh-ancestor
110380873|NCT02756208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380874|NCT04545788|Linezolid|linezolid|mesh-list
110380875|NCT04545788|Cycloserine|cycloserine|mesh-list
110380876|NCT04545788|Bedaquiline|bedaquiline|mesh-list
110380877|NCT04545788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110380878|NCT04545788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110380879|NCT04545788|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110380880|NCT04545788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110380881|NCT04545788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110380882|NCT04545788|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110380883|NCT04545788|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110380884|NCT04545788|Antitubercular Agents|antitubercular agents|mesh-ancestor
110380885|NCT04545788|Antimetabolites|antimetabolites|mesh-ancestor
110380886|NCT02756013|Paclitaxel|paclitaxel|mesh-list
110380887|NCT02756013|Carboplatin|carboplatin|mesh-list
110380888|NCT02756013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110380889|NCT02756013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110380890|NCT02756013|Tubulin Modulators|tubulin modulators|mesh-ancestor
110380891|NCT02756013|Antimitotic Agents|antimitotic agents|mesh-ancestor
110380892|NCT02756013|Mitosis Modulators|mitosis modulators|mesh-ancestor
110380893|NCT02756013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110380894|NCT01680042|Phenytoin|phenytoin|mesh-list
110380895|NCT01680042|Anticonvulsants|anticonvulsants|mesh-ancestor
110380896|NCT01680042|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110380897|NCT01680042|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110380898|NCT01680042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110380899|NCT01680042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110380900|NCT01680042|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110042852|NCT01444586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110380901|NCT01680042|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110380902|NCT01646229|Polymyxins|polymyxins|mesh-list
110380903|NCT01646229|Polymyxin B|polymyxin b|mesh-list
110380904|NCT01646229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110380905|NCT01646229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110380906|NCT01680081|Adenosine|adenosine|mesh-list
110380907|NCT01680081|Analgesics|analgesics|mesh-ancestor
110380908|NCT01680081|Sensory System Agents|sensory system agents|mesh-ancestor
110380909|NCT01680081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110380910|NCT01680081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380911|NCT01680081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110380912|NCT01680081|Vasodilator Agents|vasodilator agents|mesh-ancestor
110380913|NCT01680081|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110380914|NCT01680081|Purinergic Agonists|purinergic agonists|mesh-ancestor
110380915|NCT01680081|Purinergic Agents|purinergic agents|mesh-ancestor
110380916|NCT01680081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110380917|NCT01680081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110380918|NCT01646307|Atorvastatin|atorvastatin|mesh-list
110380919|NCT01646307|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110380920|NCT01646307|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110380921|NCT01646307|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110380922|NCT01646307|Antimetabolites|antimetabolites|mesh-ancestor
110380923|NCT01646307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110380924|NCT01646307|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110380925|NCT01646307|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110380926|NCT01646307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110380929|NCT04544969|Docetaxel|docetaxel|mesh-list
110380930|NCT04544969|Fluorouracil|fluorouracil|mesh-list
110380931|NCT04544969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110380932|NCT04544969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110380933|NCT04544969|Antimetabolites|antimetabolites|mesh-ancestor
110380934|NCT04544969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110380935|NCT04544969|Tubulin Modulators|tubulin modulators|mesh-ancestor
110380936|NCT04544969|Antimitotic Agents|antimitotic agents|mesh-ancestor
110380937|NCT04544969|Mitosis Modulators|mitosis modulators|mesh-ancestor
110380938|NCT04544969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110380939|NCT04544969|Immunologic Factors|immunologic factors|mesh-ancestor
110380940|NCT04544969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380941|NCT04541732|Anesthetics|anesthetics|mesh-list
110380942|NCT04541732|Propofol|propofol|mesh-list
110380943|NCT04541732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110380944|NCT04541732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380945|NCT04541732|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110380946|NCT04541732|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110380947|NCT04541732|Anesthetics, General|anesthetics, general|mesh-ancestor
110380948|NCT01680471|Midazolam|midazolam|mesh-list
110380949|NCT01680471|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110380950|NCT01680471|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110380951|NCT01680471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110380952|NCT01680471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380953|NCT01680471|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110380954|NCT01680471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110380955|NCT01680471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110380956|NCT01680471|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110380957|NCT01680471|Anesthetics, General|anesthetics, general|mesh-ancestor
110380958|NCT01680471|Anesthetics|anesthetics|mesh-ancestor
110380959|NCT01680471|GABA Modulators|gaba modulators|mesh-ancestor
110380960|NCT01680471|GABA Agents|gaba agents|mesh-ancestor
110380961|NCT01680471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110380962|NCT01680471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110380963|NCT02279316|Vitamin D|vitamin d|mesh-list
110380964|NCT02279316|Cholecalciferol|cholecalciferol|mesh-list
110380965|NCT02279316|Vitamins|vitamins|mesh-ancestor
110380966|NCT02279316|Micronutrients|micronutrients|mesh-ancestor
110380967|NCT02279316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380968|NCT02279316|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110380969|NCT02279316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110380970|NCT04544306|Anti-Infective Agents|anti-infective agents|mesh-list
110380971|NCT04544306|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110380972|NCT04544228|Ketamine|ketamine|mesh-list
110380973|NCT04544228|Bupivacaine|bupivacaine|mesh-list
110380974|NCT04544228|Neostigmine|neostigmine|mesh-list
110380975|NCT04544228|Anesthetics, Local|anesthetics, local|mesh-ancestor
110380976|NCT04544228|Anesthetics|anesthetics|mesh-ancestor
110380977|NCT04544228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110042932|NCT01445106|Nelfinavir|nelfinavir|mesh-list
110380978|NCT04544228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380979|NCT04544228|Sensory System Agents|sensory system agents|mesh-ancestor
110380980|NCT04544228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110380981|NCT04544228|Analgesics|analgesics|mesh-ancestor
110380982|NCT04544228|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110380983|NCT04544228|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110380984|NCT04544228|Anesthetics, General|anesthetics, general|mesh-ancestor
110380985|NCT04544228|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110380986|NCT04544228|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110380987|NCT04544228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110380988|NCT04544228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110380989|NCT04544228|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110380990|NCT04544228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110380991|NCT04544228|Cholinergic Agents|cholinergic agents|mesh-ancestor
110380992|NCT04544228|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110380993|NCT04544228|Autonomic Agents|autonomic agents|mesh-ancestor
110380994|NCT01646736|Cyclophosphamide|cyclophosphamide|mesh-list
110380995|NCT01646736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110380996|NCT01646736|Immunologic Factors|immunologic factors|mesh-ancestor
110380997|NCT01646736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380998|NCT01646736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110380999|NCT01646736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110381000|NCT01646736|Alkylating Agents|alkylating agents|mesh-ancestor
110381001|NCT01646736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381002|NCT01646736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110381003|NCT01646736|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110381004|NCT04542005|Albuterol|albuterol|mesh-list
110381005|NCT04542005|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110381006|NCT04542005|Autonomic Agents|autonomic agents|mesh-ancestor
110381007|NCT04542005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110381008|NCT04542005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110381009|NCT04542005|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110381010|NCT04542005|Respiratory System Agents|respiratory system agents|mesh-ancestor
110381011|NCT04542005|Tocolytic Agents|tocolytic agents|mesh-ancestor
110381012|NCT04542005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110381013|NCT04542005|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110381014|NCT04542005|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110381015|NCT04542005|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110381016|NCT04542005|Adrenergic Agents|adrenergic agents|mesh-ancestor
110381017|NCT04542005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110381018|NCT04542005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381019|NCT01646775|Fentanyl|fentanyl|mesh-list
110381020|NCT01646775|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110381022|NCT01646775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110381023|NCT01646775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110381024|NCT01646775|Analgesics|analgesics|mesh-ancestor
110381025|NCT01646775|Sensory System Agents|sensory system agents|mesh-ancestor
110381026|NCT01646775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110381027|NCT01646775|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110381028|NCT01646775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110381029|NCT01646775|Anesthetics, General|anesthetics, general|mesh-ancestor
110381030|NCT01646775|Anesthetics|anesthetics|mesh-ancestor
110381031|NCT01646853|Fluorouracil|fluorouracil|mesh-list
110381032|NCT01646853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110381033|NCT01646853|Antimetabolites|antimetabolites|mesh-ancestor
110381034|NCT01646853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381035|NCT01646853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110381036|NCT01646853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110381037|NCT01646853|Immunologic Factors|immunologic factors|mesh-ancestor
110381038|NCT01646853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110381039|NCT01647165|Dexamethasone|dexamethasone|mesh-list
110381040|NCT01647165|Lenalidomide|lenalidomide|mesh-list
110381042|NCT01647165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110381043|NCT01647165|Antiemetics|antiemetics|mesh-ancestor
110381044|NCT01647165|Autonomic Agents|autonomic agents|mesh-ancestor
110381045|NCT01647165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110381046|NCT01647165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110381047|NCT01647165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110381048|NCT01647165|Glucocorticoids|glucocorticoids|mesh-ancestor
110381049|NCT01647165|Hormones|hormones|mesh-ancestor
110381050|NCT01647165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110381051|NCT01647165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110381052|NCT01647165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110381053|NCT01647165|Immunologic Factors|immunologic factors|mesh-ancestor
110381054|NCT01647165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110381055|NCT01647165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110381056|NCT01647165|Growth Substances|growth substances|mesh-ancestor
110381057|NCT01647165|Growth Inhibitors|growth inhibitors|mesh-ancestor
110381058|NCT01681134|Tacrolimus|tacrolimus|mesh-list
110381059|NCT01681134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110381060|NCT01681134|Immunologic Factors|immunologic factors|mesh-ancestor
110381061|NCT01681134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110381062|NCT01681134|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110381063|NCT01681134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110381064|NCT01681134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381065|NCT04543916|Irinotecan|irinotecan|mesh-list
110381066|NCT04543916|Venetoclax|venetoclax|mesh-list
110381067|NCT04543916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110381068|NCT04543916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110381069|NCT04543916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110381070|NCT04543916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381071|NCT04543916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110381072|NCT04541147|Dexamethasone|dexamethasone|mesh-list
110381073|NCT04541147|Analgesics|analgesics|mesh-list
110381074|NCT04541147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110381075|NCT04541147|Antiemetics|antiemetics|mesh-ancestor
110381076|NCT04541147|Autonomic Agents|autonomic agents|mesh-ancestor
110381077|NCT04541147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110381078|NCT04541147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110381079|NCT04541147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110381080|NCT04541147|Glucocorticoids|glucocorticoids|mesh-ancestor
110381082|NCT04541147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110381083|NCT04541147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110381084|NCT04541147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110381085|NCT04541147|Sensory System Agents|sensory system agents|mesh-ancestor
110381086|NCT04541303|Tranexamic Acid|tranexamic acid|mesh-list
110381087|NCT04541303|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110381088|NCT04541303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110381089|NCT04541303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381090|NCT04541303|Hemostatics|hemostatics|mesh-ancestor
110381091|NCT04541303|Coagulants|coagulants|mesh-ancestor
110381092|NCT02214992|Telmisartan|telmisartan|mesh-list
110381093|NCT02214992|Ramipril|ramipril|mesh-list
110381094|NCT02214992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110381095|NCT02214992|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110381096|NCT02214992|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110381097|NCT02214992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381098|NCT02214992|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110381099|NCT02214992|Protease Inhibitors|protease inhibitors|mesh-ancestor
110381100|NCT02214992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110381101|NCT04528095|Clozapine|clozapine|mesh-list
110381102|NCT04528095|Amisulpride|amisulpride|mesh-list
110381103|NCT04528095|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110381104|NCT04528095|Serotonin Agents|serotonin agents|mesh-ancestor
110381105|NCT04528095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110381106|NCT04528095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381107|NCT04528095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110381108|NCT04528095|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110381109|NCT04528095|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110381110|NCT04528095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110381111|NCT04528095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110381112|NCT04528095|GABA Antagonists|gaba antagonists|mesh-ancestor
110381113|NCT04528095|GABA Agents|gaba agents|mesh-ancestor
110381114|NCT04528095|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110381115|NCT04528095|Dopamine Agents|dopamine agents|mesh-ancestor
110381116|NCT04528095|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110381117|NCT04528095|Antidepressive Agents|antidepressive agents|mesh-ancestor
110381118|NCT04528056|Sulfasalazine|sulfasalazine|mesh-list
110381119|NCT04528056|Ambrisentan|ambrisentan|mesh-list
110381120|NCT04528056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110381121|NCT04528056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110381122|NCT04528056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110381123|NCT04528056|Analgesics|analgesics|mesh-ancestor
110381124|NCT04528056|Sensory System Agents|sensory system agents|mesh-ancestor
110381125|NCT04528056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110381126|NCT04528056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110381127|NCT04528056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110381128|NCT04528056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110381129|NCT04528056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110381130|NCT04528056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110381131|NCT04543565|Tenofovir|tenofovir|mesh-list
110381132|NCT04543565|Pradefovir|pradefovir|mesh-list
110381133|NCT04543565|Antiviral Agents|antiviral agents|mesh-ancestor
110381134|NCT04543565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110381135|NCT04543565|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110381136|NCT04543565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110381137|NCT04543565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110381138|NCT04543565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381139|NCT04543565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110381140|NCT04543565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110381141|NCT01647555|Cetuximab|cetuximab|mesh-list
110381142|NCT01647555|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110381143|NCT01647555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110381144|NCT04543370|Deflazacort|deflazacort|mesh-list
110381145|NCT04543370|Midazolam|midazolam|mesh-list
110381146|NCT04543370|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110381147|NCT04543370|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110381148|NCT04543370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110381149|NCT04543370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110381150|NCT04543370|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110381151|NCT04543370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110381152|NCT04543370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110381153|NCT04543370|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110381154|NCT04543370|Anesthetics, General|anesthetics, general|mesh-ancestor
110381155|NCT04543370|Anesthetics|anesthetics|mesh-ancestor
110381156|NCT04543370|GABA Modulators|gaba modulators|mesh-ancestor
110381157|NCT04543370|GABA Agents|gaba agents|mesh-ancestor
110381158|NCT04543370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110381159|NCT04543370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381161|NCT04543370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110381162|NCT04543370|Immunologic Factors|immunologic factors|mesh-ancestor
110381163|NCT01681563|Cyclophosphamide|cyclophosphamide|mesh-list
110381164|NCT01681563|Ofatumumab|ofatumumab|mesh-list
110381165|NCT01681563|Pentostatin|pentostatin|mesh-list
110381166|NCT01681563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110381167|NCT01681563|Immunologic Factors|immunologic factors|mesh-ancestor
110381168|NCT01681563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110381169|NCT01681563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110381170|NCT01681563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110381171|NCT01681563|Alkylating Agents|alkylating agents|mesh-ancestor
110381172|NCT01681563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381173|NCT01681563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110381174|NCT01681563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110381175|NCT01681563|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
110381176|NCT01681563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110381177|NCT01681680|Metformin|metformin|mesh-list
110381178|NCT01681680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110381179|NCT01681680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110381180|NCT01647633|Calcium|calcium|mesh-list
110381181|NCT01647633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110381182|NCT01647633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110381183|NCT01647672|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110381184|NCT01647672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110381185|NCT01647984|Vitamins|vitamins|mesh-list
110381186|NCT01647984|Vitamin E|vitamin e|mesh-list
110381187|NCT01647984|Vitamin B Complex|vitamin b complex|mesh-list
110381188|NCT01647984|Micronutrients|micronutrients|mesh-ancestor
110381189|NCT01647984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110381190|NCT01647984|Antioxidants|antioxidants|mesh-ancestor
110381191|NCT01647984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381192|NCT01647984|Protective Agents|protective agents|mesh-ancestor
110381193|NCT02215382|Atropine|atropine|mesh-list
110381194|NCT02215382|Neostigmine|neostigmine|mesh-list
110381195|NCT02215382|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110381196|NCT02215382|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110381197|NCT02215382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110381198|NCT02215382|Autonomic Agents|autonomic agents|mesh-ancestor
110381199|NCT02215382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110381200|NCT02215382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110381201|NCT02215382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110381202|NCT02215382|Respiratory System Agents|respiratory system agents|mesh-ancestor
110381203|NCT02215382|Mydriatics|mydriatics|mesh-ancestor
110381204|NCT02215382|Parasympatholytics|parasympatholytics|mesh-ancestor
110381205|NCT02215382|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110381206|NCT02215382|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110381207|NCT02215382|Cholinergic Agents|cholinergic agents|mesh-ancestor
110381208|NCT02215382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110381209|NCT02215382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381210|NCT02215382|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110381211|NCT02215382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110381212|NCT02215382|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110381213|NCT01682109|Valacyclovir|valacyclovir|mesh-list
110381214|NCT01682109|Antiviral Agents|antiviral agents|mesh-ancestor
110381215|NCT01682109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110381217|NCT02215148|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110381218|NCT02215148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381219|NCT02215148|Natriuretic Agents|natriuretic agents|mesh-ancestor
110381220|NCT02215148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110381221|NCT01682343|Calcium|calcium|mesh-list
110381222|NCT01682343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110381223|NCT01682343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110381224|NCT01648257|Cabotegravir|cabotegravir|mesh-list
110381225|NCT01648257|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110381226|NCT01648257|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110381227|NCT01648257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110381228|NCT01648257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381229|NCT01648257|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110381230|NCT01648257|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110381231|NCT01648257|Antiviral Agents|antiviral agents|mesh-ancestor
110381232|NCT01648257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110381233|NCT02215460|Chlorhexidine|chlorhexidine|mesh-list
110381234|NCT02215460|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110381235|NCT02215460|Azithromycin|azithromycin|mesh-list
110381236|NCT02215460|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110381237|NCT02215460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110381238|NCT02215460|Disinfectants|disinfectants|mesh-ancestor
110381239|NCT02215460|Dermatologic Agents|dermatologic agents|mesh-ancestor
110381240|NCT02215460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110381241|NCT02215499|Sodium Oxybate|sodium oxybate|mesh-list
110381242|NCT02215499|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110381243|NCT02215499|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110381244|NCT02215499|Anesthetics, General|anesthetics, general|mesh-ancestor
110381245|NCT02215499|Anesthetics|anesthetics|mesh-ancestor
110381246|NCT02215499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110381247|NCT02215499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110381248|NCT01648608|Exemestane|exemestane|mesh-list
110381249|NCT01648608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110381250|NCT01648608|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110381251|NCT01648608|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110381252|NCT01648608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110381253|NCT01648608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381254|NCT01648608|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110381255|NCT01648608|Hormone Antagonists|hormone antagonists|mesh-ancestor
110381256|NCT01648608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110381257|NCT01648608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110381258|NCT02215538|Methylphenidate|methylphenidate|mesh-list
110381259|NCT02215538|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110381260|NCT02215538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110381261|NCT02215538|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110381262|NCT02215538|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110381263|NCT02215538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110381264|NCT02215538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381265|NCT02215538|Dopamine Agents|dopamine agents|mesh-ancestor
110381266|NCT02215538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110381267|NCT01682421|Dexamethasone|dexamethasone|mesh-list
110381268|NCT01682421|Dexamethasone acetate|dexamethasone acetate|mesh-list
110381269|NCT01682421|BB 1101|bb 1101|mesh-list
110381270|NCT01682421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381271|NCT01682421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110381272|NCT01682421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110381273|NCT01682421|Antiemetics|antiemetics|mesh-ancestor
110381274|NCT01682421|Autonomic Agents|autonomic agents|mesh-ancestor
110381275|NCT01682421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110381276|NCT01682421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110381277|NCT01682421|Glucocorticoids|glucocorticoids|mesh-ancestor
110381278|NCT01682421|Hormones|hormones|mesh-ancestor
110381279|NCT01682421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110381280|NCT01682421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110381281|NCT01682421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110381282|NCT01682421|Protease Inhibitors|protease inhibitors|mesh-ancestor
110381283|NCT01682421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110381284|NCT01682499|Calcium, Dietary|calcium, dietary|mesh-list
110381285|NCT01682499|Magnesium Sulfate|magnesium sulfate|mesh-list
110381287|NCT01682499|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110381288|NCT01682499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110381289|NCT01682499|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110381291|NCT01682499|Sensory System Agents|sensory system agents|mesh-ancestor
110381292|NCT01682499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110381293|NCT01682499|Anesthetics|anesthetics|mesh-ancestor
110381294|NCT01682499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110381295|NCT01682499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110381296|NCT01682499|Anticonvulsants|anticonvulsants|mesh-ancestor
110381297|NCT01682499|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110381298|NCT01682499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110381299|NCT01682499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381300|NCT01682499|Tocolytic Agents|tocolytic agents|mesh-ancestor
110381301|NCT01682499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110381302|NCT04540055|Anesthetics|anesthetics|mesh-list
110381303|NCT04540055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110381304|NCT04540055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110381305|NCT01180660|Lidocaine|lidocaine|mesh-list
110381306|NCT01180660|Anesthetics, Local|anesthetics, local|mesh-ancestor
110381307|NCT01180660|Anesthetics|anesthetics|mesh-ancestor
110381308|NCT01180660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110381309|NCT01180660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110381310|NCT01180660|Sensory System Agents|sensory system agents|mesh-ancestor
110381311|NCT01180660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110381312|NCT01180660|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110381313|NCT01180660|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110381314|NCT01180660|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110381315|NCT01180660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110381316|NCT01180660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381317|NCT01648881|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110381318|NCT01648881|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110381319|NCT01648881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381320|NCT01202227|Pregabalin|pregabalin|mesh-list
110381321|NCT01202227|Analgesics|analgesics|mesh-ancestor
110381322|NCT01202227|Sensory System Agents|sensory system agents|mesh-ancestor
110381323|NCT01202227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110381324|NCT01202227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110381325|NCT01202227|Anticonvulsants|anticonvulsants|mesh-ancestor
110381327|NCT01202227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110381328|NCT01202227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381329|NCT01202227|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110381332|NCT01202227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110381333|NCT01202227|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110381334|NCT01682733|Botulinum Toxins|botulinum toxins|mesh-list
110381335|NCT01682733|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110381336|NCT01682733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110381337|NCT01682733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381338|NCT01682733|Cholinergic Agents|cholinergic agents|mesh-ancestor
110381339|NCT01682733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110381340|NCT01682733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110381341|NCT01682772|Olaparib|olaparib|mesh-list
110381342|NCT01682772|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110381343|NCT01682772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110381344|NCT01682772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381345|NCT01682772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110381346|NCT01649037|Terlipressin|terlipressin|mesh-list
110381347|NCT01649037|Epinephrine|epinephrine|mesh-list
110381348|NCT01649037|Racepinephrine|racepinephrine|mesh-list
110381349|NCT01649037|Norepinephrine|norepinephrine|mesh-list
110381350|NCT01649037|Epinephryl borate|epinephryl borate|mesh-list
110381351|NCT01649037|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110381352|NCT01649037|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110381353|NCT01649037|Adrenergic Agents|adrenergic agents|mesh-ancestor
110381354|NCT01649037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110381355|NCT01649037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381356|NCT01649037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110381357|NCT01649037|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110381358|NCT01649037|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110381359|NCT01649037|Autonomic Agents|autonomic agents|mesh-ancestor
110381360|NCT01649037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110381361|NCT01649037|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110381362|NCT01649037|Respiratory System Agents|respiratory system agents|mesh-ancestor
110381363|NCT01649037|Mydriatics|mydriatics|mesh-ancestor
110381364|NCT01649037|Sympathomimetics|sympathomimetics|mesh-ancestor
110381365|NCT01649037|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110381366|NCT01649037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110381367|NCT04539119|Tenofovir|tenofovir|mesh-list
110381368|NCT04539119|Entecavir|entecavir|mesh-list
110381369|NCT04539119|Antiviral Agents|antiviral agents|mesh-ancestor
110381370|NCT04539119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110381371|NCT04539119|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110381372|NCT04539119|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110381373|NCT04539119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110381374|NCT04539119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381375|NCT04539119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110381376|NCT04539119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110381377|NCT02279511|Adenosine|adenosine|mesh-list
110381378|NCT02279511|Analgesics|analgesics|mesh-ancestor
110381379|NCT02279511|Sensory System Agents|sensory system agents|mesh-ancestor
110381380|NCT02279511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110381381|NCT02279511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110381382|NCT02279511|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110381383|NCT02279511|Vasodilator Agents|vasodilator agents|mesh-ancestor
110381385|NCT02279511|Purinergic Agonists|purinergic agonists|mesh-ancestor
110381386|NCT02279511|Purinergic Agents|purinergic agents|mesh-ancestor
110381387|NCT02279511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110381388|NCT02279511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381390|NCT02279628|Ropivacaine|ropivacaine|mesh-list
110381391|NCT02279628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110381392|NCT02279628|Narcotics|narcotics|mesh-ancestor
110381393|NCT02279628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110381394|NCT02279628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110381395|NCT02279628|Analgesics|analgesics|mesh-ancestor
110381396|NCT02279628|Sensory System Agents|sensory system agents|mesh-ancestor
110381397|NCT02279628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110381398|NCT02279628|Anesthetics, Local|anesthetics, local|mesh-ancestor
110381399|NCT02279628|Anesthetics|anesthetics|mesh-ancestor
110381400|NCT04542629|Trace Elements|trace elements|mesh-list
110381401|NCT04542629|Rituximab|rituximab|mesh-list
110381402|NCT04542629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110381403|NCT04542629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110381404|NCT04542629|Immunologic Factors|immunologic factors|mesh-ancestor
110381405|NCT04542629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110381406|NCT04542629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110381407|NCT04542629|Micronutrients|micronutrients|mesh-ancestor
110381408|NCT01683006|Rocuronium|rocuronium|mesh-list
110381409|NCT01683006|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110381410|NCT01683006|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110381411|NCT01683006|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110381412|NCT01683006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110381413|NCT01683006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110381414|NCT01683162|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
110381415|NCT01683162|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
110381416|NCT01683162|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110381417|NCT01683162|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110381418|NCT02215733|Telmisartan|telmisartan|mesh-list
110381419|NCT02215733|Diuretics|diuretics|mesh-list
110381420|NCT02215733|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110381421|NCT02215733|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110381422|NCT02215733|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110381423|NCT02215733|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110381424|NCT02215733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381425|NCT02215733|Natriuretic Agents|natriuretic agents|mesh-ancestor
110381426|NCT02215733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110381427|NCT02215733|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110381428|NCT02215733|Adrenergic Agents|adrenergic agents|mesh-ancestor
110381429|NCT02215733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110381430|NCT01202188|Glycopyrrolate|glycopyrrolate|mesh-list
110381431|NCT01202188|Tiotropium Bromide|tiotropium bromide|mesh-list
110381432|NCT01202188|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110381433|NCT01202188|Autonomic Agents|autonomic agents|mesh-ancestor
110381434|NCT01202188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110381435|NCT01202188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110381436|NCT01202188|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110381437|NCT01202188|Respiratory System Agents|respiratory system agents|mesh-ancestor
110381438|NCT01202188|Parasympatholytics|parasympatholytics|mesh-ancestor
110381439|NCT01202188|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110381440|NCT01202188|Cholinergic Agents|cholinergic agents|mesh-ancestor
110381441|NCT01202188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110381442|NCT01202188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381443|NCT01202188|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110381444|NCT01202188|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110381445|NCT01179919|Oseltamivir|oseltamivir|mesh-list
110381446|NCT01179919|Antiviral Agents|antiviral agents|mesh-ancestor
110381447|NCT01179919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110381448|NCT01179919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110381449|NCT01179919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381451|NCT01201798|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110381452|NCT01201798|Methylprednisolone|methylprednisolone|mesh-list
110381453|NCT01201798|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110381454|NCT01201798|Prednisolone acetate|prednisolone acetate|mesh-list
110381455|NCT01201798|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110381456|NCT01201798|Prednisolone phosphate|prednisolone phosphate|mesh-list
110381458|NCT01201798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110381459|NCT01201798|Glucocorticoids|glucocorticoids|mesh-ancestor
110381461|NCT01201798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110381462|NCT01201798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110381463|NCT01201798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110381464|NCT01201798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110381465|NCT01201798|Antiemetics|antiemetics|mesh-ancestor
110381466|NCT01201798|Autonomic Agents|autonomic agents|mesh-ancestor
110381467|NCT01201798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110381468|NCT01201798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110381469|NCT01201798|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110381470|NCT01201798|Protective Agents|protective agents|mesh-ancestor
110381471|NCT01201759|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
110381472|NCT01201759|Sodium Salicylate|sodium salicylate|mesh-list
110381473|NCT01201759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110381474|NCT01201759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110381475|NCT01201759|Analgesics|analgesics|mesh-ancestor
110381476|NCT01201759|Sensory System Agents|sensory system agents|mesh-ancestor
110381477|NCT01201759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110381478|NCT01201759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110381479|NCT01201759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110381480|NCT01201759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110381481|NCT01201759|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110381482|NCT01201759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110381483|NCT01201759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381484|NCT04532684|Pregabalin|pregabalin|mesh-list
110381485|NCT04532684|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110381486|NCT04532684|Analgesics|analgesics|mesh-ancestor
110381487|NCT04532684|Sensory System Agents|sensory system agents|mesh-ancestor
110381488|NCT04532684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110381489|NCT04532684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110381490|NCT04532684|Anticonvulsants|anticonvulsants|mesh-ancestor
110381491|NCT04532684|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110381492|NCT04532684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110381493|NCT04532684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381494|NCT04532684|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110381495|NCT04532684|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110381496|NCT04532684|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110381497|NCT04532684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110381498|NCT04532684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110381499|NCT04532684|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110381500|NCT04532684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110381501|NCT04532684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110381502|NCT04532684|Antidepressive Agents|antidepressive agents|mesh-ancestor
110381504|NCT01649466|Insulin|insulin|mesh-list
110381505|NCT01649466|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110381506|NCT01649466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110381507|NCT01649466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110381508|NCT01200589|Rituximab|rituximab|mesh-list
110381509|NCT01200589|Ofatumumab|ofatumumab|mesh-list
110381510|NCT01200589|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110381511|NCT01200589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110381512|NCT01200589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110381513|NCT01200589|Immunologic Factors|immunologic factors|mesh-ancestor
110381514|NCT01200589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110381515|NCT01200589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110381516|NCT01683552|Fexofenadine|fexofenadine|mesh-list
110381517|NCT01683552|Prednisone|prednisone|mesh-list
110381518|NCT01683552|Aprepitant|aprepitant|mesh-list
110381519|NCT01683552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110381520|NCT01683552|Glucocorticoids|glucocorticoids|mesh-ancestor
110381521|NCT01683552|Hormones|hormones|mesh-ancestor
110381522|NCT01683552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110381523|NCT01683552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110381524|NCT01683552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110381526|NCT01683552|Antiemetics|antiemetics|mesh-ancestor
110381527|NCT01683552|Autonomic Agents|autonomic agents|mesh-ancestor
110381528|NCT01683552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110381529|NCT01683552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110381530|NCT01683552|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110381531|NCT01683552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110381532|NCT01683552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381533|NCT01683552|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110381534|NCT01683552|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110381535|NCT01683552|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110381536|NCT01683552|Histamine Antagonists|histamine antagonists|mesh-ancestor
110381537|NCT01683552|Histamine Agents|histamine agents|mesh-ancestor
110381538|NCT01649544|Amiodarone|amiodarone|mesh-list
110381539|NCT01649544|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110381540|NCT01649544|Vasodilator Agents|vasodilator agents|mesh-ancestor
110381541|NCT01649544|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110381542|NCT01649544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110381543|NCT01649544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381544|NCT01649544|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110381545|NCT01649544|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110381546|NCT01649544|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110381547|NCT01649544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110381548|NCT01649544|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110381549|NCT01649544|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110381550|NCT01649544|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110381551|NCT04528290|Ozanimod|ozanimod|mesh-list
110381552|NCT04528290|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110381553|NCT04528290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381554|NCT04528290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110381555|NCT04528290|Immunologic Factors|immunologic factors|mesh-ancestor
110381556|NCT04528290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110381557|NCT01179334|Sildenafil Citrate|sildenafil citrate|mesh-list
110381558|NCT01179334|Riociguat|riociguat|mesh-list
110381560|NCT01179334|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110381561|NCT01179334|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110381562|NCT01179334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110381563|NCT01179334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381564|NCT01179334|Urological Agents|urological agents|mesh-ancestor
110381565|NCT01179334|Enzyme Activators|enzyme activators|mesh-ancestor
110381566|NCT01649622|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110381567|NCT01649622|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110381568|NCT01649622|Alkylating Agents|alkylating agents|mesh-ancestor
110381569|NCT01649622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381570|NCT01649622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110381571|NCT01683747|Tranexamic Acid|tranexamic acid|mesh-list
110381574|NCT01683747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381575|NCT01683747|Hemostatics|hemostatics|mesh-ancestor
110381576|NCT01683747|Coagulants|coagulants|mesh-ancestor
110381577|NCT01178671|Mirtazapine|mirtazapine|mesh-list
110381578|NCT01178671|Sertraline|sertraline|mesh-list
110381579|NCT01178671|Antidepressive Agents|antidepressive agents|mesh-ancestor
110381580|NCT01178671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110381581|NCT01178671|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110381582|NCT01178671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110381583|NCT01178671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110381584|NCT01178671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381585|NCT01178671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110381586|NCT01178671|Serotonin Agents|serotonin agents|mesh-ancestor
110381587|NCT01178671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110381588|NCT01178671|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110381589|NCT01178671|Histamine Antagonists|histamine antagonists|mesh-ancestor
110381590|NCT01178671|Histamine Agents|histamine agents|mesh-ancestor
110381591|NCT01178671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110381592|NCT01178671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110381593|NCT01178671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110381594|NCT01178671|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110381595|NCT01178671|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110381596|NCT01178671|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110381597|NCT01178671|Adrenergic Agents|adrenergic agents|mesh-ancestor
110381598|NCT01178671|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110381599|NCT01178671|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110381600|NCT01178671|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110381601|NCT04532060|Anti-Infective Agents|anti-infective agents|mesh-list
110381603|NCT04532060|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110381604|NCT04532060|Antifungal Agents|antifungal agents|mesh-ancestor
110381605|NCT04532060|Ionophores|ionophores|mesh-ancestor
110381606|NCT04532060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110381607|NCT04532060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381608|NCT01649739|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110381609|NCT01649739|Vasodilator Agents|vasodilator agents|mesh-ancestor
110381610|NCT01649739|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110381611|NCT01649739|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110381612|NCT01649739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110381613|NCT01649739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381614|NCT01649739|Urological Agents|urological agents|mesh-ancestor
110381616|NCT04532333|Bivalirudin|bivalirudin|mesh-list
110381617|NCT04532333|Anticoagulants|anticoagulants|mesh-ancestor
110381618|NCT04532333|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110381619|NCT04532333|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110381620|NCT04532333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381621|NCT04532333|Antithrombins|antithrombins|mesh-ancestor
110381622|NCT04532333|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110381623|NCT04532333|Protease Inhibitors|protease inhibitors|mesh-ancestor
110381624|NCT04532333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110381625|NCT01649895|Cycloserine|cycloserine|mesh-list
110381626|NCT01649895|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110381627|NCT01649895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110381628|NCT01649895|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110381629|NCT01649895|Antitubercular Agents|antitubercular agents|mesh-ancestor
110381630|NCT01649895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110381631|NCT01649895|Antimetabolites|antimetabolites|mesh-ancestor
110381632|NCT01649895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381633|NCT01649505|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110381634|NCT01649505|Hemostatics|hemostatics|mesh-ancestor
110381635|NCT01649505|Coagulants|coagulants|mesh-ancestor
110381636|NCT01178086|Rituximab|rituximab|mesh-list
110381637|NCT01178086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110381638|NCT01178086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110381639|NCT01178086|Immunologic Factors|immunologic factors|mesh-ancestor
110381640|NCT01178086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110381641|NCT01178086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110381643|NCT04531865|Rituximab|rituximab|mesh-list
110381644|NCT04531865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110381645|NCT04531865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110381646|NCT04531865|Immunologic Factors|immunologic factors|mesh-ancestor
110381647|NCT04531865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110381648|NCT04531865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110381649|NCT04531865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110381650|NCT04531865|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110381651|NCT04531865|Antitubercular Agents|antitubercular agents|mesh-ancestor
110381652|NCT04531865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110381653|NCT04531865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110381654|NCT04531865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110381655|NCT04531865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381656|NCT01643070|Capecitabine|capecitabine|mesh-list
110381657|NCT01643070|Oxaliplatin|oxaliplatin|mesh-list
110381658|NCT01643070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110381659|NCT01643070|Antimetabolites|antimetabolites|mesh-ancestor
110381660|NCT01643070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381661|NCT01643070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110381662|NCT01684059|Zinc Sulfate|zinc sulfate|mesh-list
110381663|NCT01684059|Astringents|astringents|mesh-ancestor
110381664|NCT01684059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110381665|NCT01684059|Dermatologic Agents|dermatologic agents|mesh-ancestor
110381666|NCT04531748|Toremifene|toremifene|mesh-list
110381667|NCT04531748|Melatonin|melatonin|mesh-list
110381668|NCT04531748|Antioxidants|antioxidants|mesh-ancestor
110381669|NCT04531748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381670|NCT04531748|Protective Agents|protective agents|mesh-ancestor
110381671|NCT04531748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110381672|NCT04531748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110381673|NCT04531748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110381674|NCT04531748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110381675|NCT04531748|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110381676|NCT04531748|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110381677|NCT04531748|Hormone Antagonists|hormone antagonists|mesh-ancestor
110381678|NCT04531748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110381679|NCT04531748|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110381680|NCT01177813|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110381681|NCT01177813|Empagliflozin|empagliflozin|mesh-list
110381682|NCT01177813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110381683|NCT01177813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110381684|NCT01177813|Incretins|incretins|mesh-ancestor
110381686|NCT01177813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110381687|NCT01177813|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110381688|NCT01177813|Protease Inhibitors|protease inhibitors|mesh-ancestor
110381689|NCT01177813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110381690|NCT01177813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381691|NCT01177813|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110381692|NCT04315831|Buprenorphine|buprenorphine|mesh-list
110381693|NCT04315831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110381694|NCT04315831|Narcotics|narcotics|mesh-ancestor
110381695|NCT04315831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110381696|NCT04315831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110381697|NCT04315831|Analgesics|analgesics|mesh-ancestor
110381698|NCT04315831|Sensory System Agents|sensory system agents|mesh-ancestor
110381699|NCT04315831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110381700|NCT04315831|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110381701|NCT02216045|Ribavirin|ribavirin|mesh-list
110381702|NCT02216045|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110381703|NCT02216045|Interferon-alpha|interferon-alpha|mesh-list
110381704|NCT02216045|Antimetabolites|antimetabolites|mesh-ancestor
110381705|NCT02216045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381706|NCT02216045|Antiviral Agents|antiviral agents|mesh-ancestor
110381707|NCT02216045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110381708|NCT02216045|Immunologic Factors|immunologic factors|mesh-ancestor
110381709|NCT02216045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110381710|NCT01684371|Tea Tree Oil|tea tree oil|mesh-list
110381711|NCT01684371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110381712|NCT01684371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110381713|NCT01684371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110381715|NCT04531397|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110381716|NCT04531397|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110381717|NCT04531397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381718|NCT04531397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110381719|NCT04531397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110381720|NCT04531397|Protease Inhibitors|protease inhibitors|mesh-ancestor
110381721|NCT04531397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110381722|NCT04531475|Lansoprazole|lansoprazole|mesh-list
110381723|NCT04531475|Dexlansoprazole|dexlansoprazole|mesh-list
110381724|NCT04531475|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110381725|NCT04531475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110381726|NCT04531475|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110381727|NCT04531475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110381728|NCT04531475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381729|NCT01684449|Sirolimus|sirolimus|mesh-list
110381730|NCT01684449|Gemcitabine|gemcitabine|mesh-list
110381731|NCT01684449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110381732|NCT01684449|Antimetabolites|antimetabolites|mesh-ancestor
110381733|NCT01684449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381734|NCT01684449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110381735|NCT01684449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110381736|NCT01684449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110381737|NCT01684449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110381738|NCT01684449|Antifungal Agents|antifungal agents|mesh-ancestor
110381739|NCT01684449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110381740|NCT01684449|Immunologic Factors|immunologic factors|mesh-ancestor
110381741|NCT01684449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110381742|NCT04537403|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
110381744|NCT04537403|Sequestering Agents|sequestering agents|mesh-ancestor
110381745|NCT04537403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381746|NCT01684683|Theophylline|theophylline|mesh-list
110381747|NCT01684683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110381748|NCT01684683|Autonomic Agents|autonomic agents|mesh-ancestor
110381749|NCT01684683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110381750|NCT01684683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110381751|NCT01684683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110381752|NCT01684683|Respiratory System Agents|respiratory system agents|mesh-ancestor
110381753|NCT01684683|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110381754|NCT01684683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110381755|NCT01684683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381756|NCT01684683|Vasodilator Agents|vasodilator agents|mesh-ancestor
110381757|NCT01684683|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110381758|NCT01684683|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110381759|NCT01684683|Purinergic Agents|purinergic agents|mesh-ancestor
110381760|NCT01684683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110381761|NCT01684800|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
110381762|NCT01684800|Hemostatics|hemostatics|mesh-ancestor
110381763|NCT01684800|Coagulants|coagulants|mesh-ancestor
110381764|NCT01684800|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110381765|NCT01684800|Natriuretic Agents|natriuretic agents|mesh-ancestor
110381766|NCT01684800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110381767|NCT04531163|Acetylcysteine|acetylcysteine|mesh-list
110381768|NCT04531163|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110381769|NCT04531163|Antiviral Agents|antiviral agents|mesh-ancestor
110381770|NCT04531163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110381771|NCT04531163|Expectorants|expectorants|mesh-ancestor
110381772|NCT04531163|Respiratory System Agents|respiratory system agents|mesh-ancestor
110381773|NCT04531163|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110381774|NCT04531163|Antioxidants|antioxidants|mesh-ancestor
110381775|NCT04531163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381776|NCT04531163|Protective Agents|protective agents|mesh-ancestor
110381777|NCT04531163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110381778|NCT04531163|Antidotes|antidotes|mesh-ancestor
110381779|NCT01684995|Nicotine|nicotine|mesh-list
110381780|NCT01684995|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110381781|NCT01684995|Autonomic Agents|autonomic agents|mesh-ancestor
110381782|NCT01684995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110381783|NCT01684995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110381784|NCT01684995|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110381785|NCT01684995|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110381786|NCT01684995|Cholinergic Agents|cholinergic agents|mesh-ancestor
110381787|NCT01684995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110381788|NCT01684995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381789|NCT01685502|Acarbose|acarbose|mesh-list
110381790|NCT01685502|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110381791|NCT01685502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110381792|NCT01685502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381793|NCT01685502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110381794|NCT01685502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110381795|NCT04527276|Chlorhexidine|chlorhexidine|mesh-list
110381796|NCT04527276|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110381797|NCT04527276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110381798|NCT04527276|Disinfectants|disinfectants|mesh-ancestor
110381799|NCT01200355|Posaconazole|posaconazole|mesh-list
110381800|NCT01200355|Micafungin|micafungin|mesh-list
110381801|NCT01200355|Antifungal Agents|antifungal agents|mesh-ancestor
110381802|NCT01200355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110381803|NCT01200355|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110381804|NCT01200355|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110381805|NCT01200355|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110381806|NCT01200355|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110381807|NCT01200355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110381809|NCT01200355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381810|NCT01200355|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110381811|NCT01200355|Hormone Antagonists|hormone antagonists|mesh-ancestor
110381812|NCT01200355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110381813|NCT01200355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110381816|NCT04530500|Hormones|hormones|mesh-ancestor
110381817|NCT04530500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110381818|NCT04530500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110381819|NCT01685658|Acetaminophen|acetaminophen|mesh-list
110381820|NCT01685658|Ketoprofen|ketoprofen|mesh-list
110381821|NCT01685658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110381822|NCT01685658|Analgesics|analgesics|mesh-ancestor
110381823|NCT01685658|Sensory System Agents|sensory system agents|mesh-ancestor
110381824|NCT01685658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110381825|NCT01685658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110381826|NCT01685658|Antipyretics|antipyretics|mesh-ancestor
110381827|NCT01685658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110381828|NCT01685658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110381829|NCT01685658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110381830|NCT01685658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110381831|NCT01685658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110381832|NCT01685658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381834|NCT04530578|Calcium heparin|calcium heparin|mesh-list
110381835|NCT04530578|Enoxaparin|enoxaparin|mesh-list
110381836|NCT04530578|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110381837|NCT04530578|Tinzaparin|tinzaparin|mesh-list
110381838|NCT04530578|Dalteparin|dalteparin|mesh-list
110381839|NCT04530578|Anticoagulants|anticoagulants|mesh-ancestor
110381840|NCT04530578|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110381841|NCT04530578|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110381842|NCT04530578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381843|NCT01685853|Bisacodyl|bisacodyl|mesh-list
110381844|NCT01685853|Cathartics|cathartics|mesh-ancestor
110381845|NCT01685853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110381846|NCT01685853|Laxatives|laxatives|mesh-ancestor
110381847|NCT04530422|Azithromycin|azithromycin|mesh-list
110381848|NCT04530422|Hydroxychloroquine|hydroxychloroquine|mesh-list
110381849|NCT04530422|Sofosbuvir|sofosbuvir|mesh-list
110381850|NCT04530422|Oseltamivir|oseltamivir|mesh-list
110381851|NCT04530422|Ledipasvir|ledipasvir|mesh-list
110381852|NCT04530422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110381853|NCT04530422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110381854|NCT04530422|Antimalarials|antimalarials|mesh-ancestor
110381855|NCT04530422|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110381856|NCT04530422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110381857|NCT04530422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110381858|NCT04530422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381859|NCT04530422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110381860|NCT04530422|Antiviral Agents|antiviral agents|mesh-ancestor
110381861|NCT02887573|Mosapride|mosapride|mesh-list
110381862|NCT02887573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381863|NCT02887573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110381864|NCT02887573|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110381865|NCT02887573|Serotonin Agents|serotonin agents|mesh-ancestor
110381866|NCT02887573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110381867|NCT02887573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110381869|NCT01685892|Obinutuzumab|obinutuzumab|mesh-list
110381870|NCT01685892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110381871|NCT01685892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110381872|NCT02887534|Tizanidine|tizanidine|mesh-list
110381873|NCT02887534|Analgesics|analgesics|mesh-ancestor
110381874|NCT02887534|Sensory System Agents|sensory system agents|mesh-ancestor
110381875|NCT02887534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110381876|NCT02887534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110381877|NCT02887534|Anticonvulsants|anticonvulsants|mesh-ancestor
110381878|NCT02887534|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110381879|NCT02887534|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110381880|NCT02887534|Parasympatholytics|parasympatholytics|mesh-ancestor
110381881|NCT02887534|Autonomic Agents|autonomic agents|mesh-ancestor
110043752|NCT01449578|Protective Agents|protective agents|mesh-ancestor
110381882|NCT02887534|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110381883|NCT02887534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110381884|NCT02887534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110381885|NCT02887534|Adrenergic Agents|adrenergic agents|mesh-ancestor
110381886|NCT02887534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110381887|NCT02887534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381888|NCT01685931|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110381889|NCT01685931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110381890|NCT01685931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110381891|NCT01685931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110381892|NCT01685931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110381893|NCT01685931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110381894|NCT01685931|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110381895|NCT01685931|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110381896|NCT01685931|Serotonin Agents|serotonin agents|mesh-ancestor
110381897|NCT01685931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110381898|NCT01685931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381899|NCT01685931|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110381900|NCT01685931|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110381901|NCT01685931|Dopamine Agents|dopamine agents|mesh-ancestor
110381902|NCT01685970|Picosulfate sodium|picosulfate sodium|mesh-list
110381903|NCT01685970|Cathartics|cathartics|mesh-ancestor
110381904|NCT01685970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110381905|NCT04530617|Camostat|camostat|mesh-list
110381906|NCT04530617|Protease Inhibitors|protease inhibitors|mesh-ancestor
110381907|NCT04530617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110381908|NCT04530617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381909|NCT04530617|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110381910|NCT04530617|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110381911|NCT01686009|Ketamine|ketamine|mesh-list
110381912|NCT01686009|Analgesics|analgesics|mesh-ancestor
110381913|NCT01686009|Sensory System Agents|sensory system agents|mesh-ancestor
110381914|NCT01686009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110381915|NCT01686009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110381916|NCT01686009|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110381917|NCT01686009|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110381918|NCT01686009|Anesthetics, General|anesthetics, general|mesh-ancestor
110381919|NCT01686009|Anesthetics|anesthetics|mesh-ancestor
110381920|NCT01686009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110381921|NCT01686009|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110381924|NCT01686009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381925|NCT04536662|Dexamethasone|dexamethasone|mesh-list
110381926|NCT04536662|Prednisone|prednisone|mesh-list
110381927|NCT04536662|Hydrocortisone|hydrocortisone|mesh-list
110381928|NCT04536662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110381929|NCT04536662|Antiemetics|antiemetics|mesh-ancestor
110381930|NCT04536662|Autonomic Agents|autonomic agents|mesh-ancestor
110381931|NCT04536662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110381932|NCT04536662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110381933|NCT04536662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110381934|NCT04536662|Glucocorticoids|glucocorticoids|mesh-ancestor
110381935|NCT04536662|Hormones|hormones|mesh-ancestor
110381936|NCT04536662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110381937|NCT04536662|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110381938|NCT04536662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110381939|NCT01686321|Rituximab|rituximab|mesh-list
110381940|NCT01686321|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110381941|NCT01686321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110381942|NCT01686321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110381943|NCT01686321|Immunologic Factors|immunologic factors|mesh-ancestor
110381944|NCT01686321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110381945|NCT01686321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110381946|NCT01686321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110381947|NCT01686321|Alkylating Agents|alkylating agents|mesh-ancestor
110381948|NCT01686321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381949|NCT01199731|Etravirine|etravirine|mesh-list
110381950|NCT01199731|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110381951|NCT01199731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110381952|NCT01199731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110381953|NCT01199731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381954|NCT01199731|Antiviral Agents|antiviral agents|mesh-ancestor
110381955|NCT01199731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110381956|NCT01686555|Venetoclax|venetoclax|mesh-list
110381957|NCT01686555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110381958|NCT01686789|Interferons|interferons|mesh-list
110381959|NCT01686789|Interferon-alpha|interferon-alpha|mesh-list
110381960|NCT01686789|Interferon alpha-2|interferon alpha-2|mesh-list
110381961|NCT01686789|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110381962|NCT01686789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110381963|NCT01686789|Antiviral Agents|antiviral agents|mesh-ancestor
110381964|NCT01686789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110381965|NCT01686789|Immunologic Factors|immunologic factors|mesh-ancestor
110381966|NCT01686789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110381967|NCT02217683|Nitric Oxide|nitric oxide|mesh-list
110381968|NCT02217683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110381969|NCT02217683|Autonomic Agents|autonomic agents|mesh-ancestor
110381970|NCT02217683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110381971|NCT02217683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110381972|NCT02217683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110381973|NCT02217683|Respiratory System Agents|respiratory system agents|mesh-ancestor
110381974|NCT02217683|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110381975|NCT02217683|Antioxidants|antioxidants|mesh-ancestor
110381976|NCT02217683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381977|NCT02217683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110381978|NCT02217683|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110381979|NCT02217683|Vasodilator Agents|vasodilator agents|mesh-ancestor
110381980|NCT02217683|Gasotransmitters|gasotransmitters|mesh-ancestor
110381981|NCT02217683|Protective Agents|protective agents|mesh-ancestor
110381982|NCT02217722|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110381983|NCT02217722|Amoxicillin|amoxicillin|mesh-list
110381984|NCT02217722|Metronidazole|metronidazole|mesh-list
110381985|NCT02217722|Doxycycline|doxycycline|mesh-list
110381986|NCT02217722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110381987|NCT02217722|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110381988|NCT02217722|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110381989|NCT02217722|Antimalarials|antimalarials|mesh-ancestor
110381990|NCT02217839|Octreotide|octreotide|mesh-list
110381991|NCT02217839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110381992|NCT02217839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110381993|NCT02217839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110381994|NCT01687062|Fe(III)-EDTA|fe(iii)-edta|mesh-list
110381995|NCT01687062|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110381996|NCT01687062|Chelating Agents|chelating agents|mesh-ancestor
110381997|NCT01687062|Sequestering Agents|sequestering agents|mesh-ancestor
110381998|NCT01687062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381999|NCT02217956|Bevacizumab|bevacizumab|mesh-list
110382000|NCT02217956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110382001|NCT02217956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110382002|NCT02217956|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110382003|NCT02217956|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110382004|NCT02217956|Growth Substances|growth substances|mesh-ancestor
110382005|NCT02217956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382006|NCT02217956|Growth Inhibitors|growth inhibitors|mesh-ancestor
110382007|NCT01687140|Cycloserine|cycloserine|mesh-list
110382008|NCT01687140|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110382009|NCT01687140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110382010|NCT01687140|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110382011|NCT01687140|Antitubercular Agents|antitubercular agents|mesh-ancestor
110382012|NCT01687140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110382014|NCT01687140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110382015|NCT04535960|Liraglutide|liraglutide|mesh-list
110382016|NCT04535960|Empagliflozin|empagliflozin|mesh-list
110382017|NCT04535960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110382018|NCT04535960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382019|NCT04535960|Incretins|incretins|mesh-ancestor
110382020|NCT04535960|Hormones|hormones|mesh-ancestor
110382021|NCT04535960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110382022|NCT04535960|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110382023|NCT04535960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110382024|NCT04536428|Hemostatics|hemostatics|mesh-list
110382025|NCT04536428|Coagulants|coagulants|mesh-ancestor
110382026|NCT01687374|Hormones|hormones|mesh-list
110382027|NCT01687374|Parathyroid Hormone|parathyroid hormone|mesh-list
110382028|NCT01687374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110382029|NCT01687374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382030|NCT01687374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110382031|NCT04530188|Propofol|propofol|mesh-list
110382032|NCT04530188|Sevoflurane|sevoflurane|mesh-list
110382033|NCT04530188|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110382034|NCT04530188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110382035|NCT04530188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382036|NCT04530188|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110382037|NCT04530188|Anesthetics, General|anesthetics, general|mesh-ancestor
110382038|NCT04530188|Anesthetics|anesthetics|mesh-ancestor
110382039|NCT04530188|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110382042|NCT01687491|Anticoagulants|anticoagulants|mesh-ancestor
110382043|NCT01687491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110382044|NCT01687491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110382045|NCT01687491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110382047|NCT04530227|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110382048|NCT04530227|Pemetrexed|pemetrexed|mesh-list
110382049|NCT04530227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110382050|NCT04530227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110382051|NCT04530227|Tubulin Modulators|tubulin modulators|mesh-ancestor
110382052|NCT04530227|Antimitotic Agents|antimitotic agents|mesh-ancestor
110382053|NCT04530227|Mitosis Modulators|mitosis modulators|mesh-ancestor
110382054|NCT04530227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110382055|NCT04530227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110382056|NCT04530227|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110382057|NCT04530227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110382058|NCT01199263|Paclitaxel|paclitaxel|mesh-list
110382059|NCT01199263|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110382060|NCT01199263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110382061|NCT01199263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110382062|NCT01199263|Tubulin Modulators|tubulin modulators|mesh-ancestor
110382063|NCT01199263|Antimitotic Agents|antimitotic agents|mesh-ancestor
110382064|NCT01199263|Mitosis Modulators|mitosis modulators|mesh-ancestor
110382065|NCT01199263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110382066|NCT02218034|Nicotinic Acids|nicotinic acids|mesh-list
110382067|NCT02218034|Tazarotene|tazarotene|mesh-list
110382068|NCT02218034|Dermatologic Agents|dermatologic agents|mesh-ancestor
110382069|NCT02218034|Keratolytic Agents|keratolytic agents|mesh-ancestor
110382070|NCT02218034|Vitamin B Complex|vitamin b complex|mesh-ancestor
110382071|NCT02218034|Vitamins|vitamins|mesh-ancestor
110382072|NCT02218034|Micronutrients|micronutrients|mesh-ancestor
110382073|NCT02218034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382074|NCT01688154|Proanthocyanidin|proanthocyanidin|mesh-list
110382076|NCT01688154|Antioxidants|antioxidants|mesh-ancestor
110382077|NCT01688154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110382078|NCT01688154|Protective Agents|protective agents|mesh-ancestor
110382079|NCT01688154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382080|NCT01688154|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110382081|NCT01688154|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110382082|NCT01688154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110382083|NCT01688349|Glucocorticoids|glucocorticoids|mesh-list
110382085|NCT01688349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110382086|NCT01688349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382087|NCT05138484|Chlorhexidine|chlorhexidine|mesh-list
110382088|NCT05138484|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110382089|NCT05138484|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110382090|NCT05138484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110382091|NCT05138484|Disinfectants|disinfectants|mesh-ancestor
110382092|NCT05138484|Dermatologic Agents|dermatologic agents|mesh-ancestor
110382093|NCT04535804|Aspirin|aspirin|mesh-list
110382094|NCT04535804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110382095|NCT04535804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110382097|NCT04535804|Sensory System Agents|sensory system agents|mesh-ancestor
110382098|NCT04535804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110382099|NCT04535804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382100|NCT04535804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110382101|NCT04535804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110382102|NCT04535804|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110036427|NCT01411254|Betamethasone|betamethasone|mesh-list
110382103|NCT04535804|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110382104|NCT04535804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110382105|NCT04535804|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110382106|NCT04535804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110382107|NCT04535804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110382108|NCT04535804|Antipyretics|antipyretics|mesh-ancestor
110382110|NCT04529525|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110382111|NCT04529525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110382112|NCT02216409|Magrolimab|magrolimab|mesh-list
110382113|NCT02216409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110382114|NCT02216409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110382115|NCT05126121|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110382116|NCT05126121|Amoxicillin|amoxicillin|mesh-list
110382118|NCT05126121|Levofloxacin|levofloxacin|mesh-list
110382119|NCT05126121|Ofloxacin|ofloxacin|mesh-list
110382120|NCT05126121|Tetracycline|tetracycline|mesh-list
110382121|NCT05126121|Tinidazole|tinidazole|mesh-list
110382122|NCT05126121|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110382123|NCT05126121|Furazolidone|furazolidone|mesh-list
110382124|NCT05126121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110382125|NCT05126121|Antitubercular Agents|antitubercular agents|mesh-ancestor
110382126|NCT05126121|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110382127|NCT05126121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110382128|NCT05126121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110382129|NCT05126121|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110382130|NCT05126121|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110382131|NCT05126121|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110382132|NCT05126121|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110382133|NCT05126121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110382134|NCT05126121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110382135|NCT05126121|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110382136|NCT05126121|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110382137|NCT05126121|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
110382138|NCT05126121|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110382139|NCT05126121|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110382140|NCT05126121|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110382141|NCT05126121|Alkylating Agents|alkylating agents|mesh-ancestor
110382142|NCT02218658|Brotizolam|brotizolam|mesh-list
110382143|NCT02218658|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110382144|NCT02218658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110382145|NCT02218658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382146|NCT01199068|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110382147|NCT01199068|Efatutazone|efatutazone|mesh-list
110382148|NCT01199068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110382150|NCT01199068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110382151|NCT01199068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110382152|NCT01198873|Dronedarone|dronedarone|mesh-list
110382154|NCT01198795|Escitalopram|escitalopram|mesh-list
110382155|NCT01198795|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110382156|NCT01198795|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110382157|NCT01198795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110382158|NCT01198795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110382159|NCT01198795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110382160|NCT01198795|Serotonin Agents|serotonin agents|mesh-ancestor
110382161|NCT01198795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382163|NCT02278913|Insulin Glargine|insulin glargine|mesh-list
110382164|NCT02278913|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110382165|NCT02278913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110382166|NCT02278913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382167|NCT02216513|Deferoxamine|deferoxamine|mesh-list
110382168|NCT02216513|Siderophores|siderophores|mesh-ancestor
110382169|NCT02216513|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110382170|NCT02216513|Chelating Agents|chelating agents|mesh-ancestor
110382171|NCT02216513|Sequestering Agents|sequestering agents|mesh-ancestor
110382172|NCT02216513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110382173|NCT02218775|Aticaprant|aticaprant|mesh-list
110382174|NCT02218775|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110382175|NCT02218775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382176|NCT02218775|Sensory System Agents|sensory system agents|mesh-ancestor
110382177|NCT02218775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110382178|NCT02216552|Resveratrol|resveratrol|mesh-list
110382179|NCT02216552|Antioxidants|antioxidants|mesh-ancestor
110382180|NCT02216552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110382181|NCT02216552|Protective Agents|protective agents|mesh-ancestor
110036538|NCT01412073|Oxytocin|oxytocin|mesh-list
110382182|NCT02216552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382183|NCT02216552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110382184|NCT02216552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110382186|NCT01198756|Immunologic Factors|immunologic factors|mesh-ancestor
110382187|NCT01198756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382188|NCT02216487|Irinotecan|irinotecan|mesh-list
110382189|NCT02216487|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110382190|NCT02216487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110382191|NCT02216487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110382192|NCT02216487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110382193|NCT02216487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110382194|NCT02218814|Bupivacaine|bupivacaine|mesh-list
110382195|NCT02218814|Anesthetics, Local|anesthetics, local|mesh-ancestor
110382196|NCT02218814|Anesthetics|anesthetics|mesh-ancestor
110382197|NCT02218814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110382198|NCT02218814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382199|NCT02218814|Sensory System Agents|sensory system agents|mesh-ancestor
110382200|NCT02218814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110382201|NCT02216565|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110382202|NCT02216565|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110382203|NCT02216565|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110382204|NCT02216565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110382207|NCT04534803|Immunologic Factors|immunologic factors|mesh-ancestor
110382208|NCT04534803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382209|NCT01198132|Vitamin D|vitamin d|mesh-list
110382210|NCT01198132|Ergocalciferols|ergocalciferols|mesh-list
110382211|NCT01198132|Cholecalciferol|cholecalciferol|mesh-list
110382212|NCT01198132|Vitamins|vitamins|mesh-list
110382213|NCT01198132|Interferons|interferons|mesh-list
110382214|NCT01198132|Interferon-beta|interferon-beta|mesh-list
110382215|NCT01198132|Interferon beta-1a|interferon beta-1a|mesh-list
110382216|NCT01198132|Micronutrients|micronutrients|mesh-ancestor
110382217|NCT01198132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382218|NCT01198132|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110382219|NCT01198132|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110382220|NCT01198132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110382221|NCT01198132|Antiviral Agents|antiviral agents|mesh-ancestor
110382222|NCT01198132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110382223|NCT01198132|Immunologic Factors|immunologic factors|mesh-ancestor
110382224|NCT01198132|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110382225|NCT02219165|Immunoglobulins|immunoglobulins|mesh-list
110382226|NCT02219165|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110382227|NCT02219165|Antibodies|antibodies|mesh-list
110382228|NCT02219165|Immunologic Factors|immunologic factors|mesh-ancestor
110382229|NCT02219165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382230|NCT04534478|Prednisone|prednisone|mesh-list
110382231|NCT04534478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110382232|NCT04534478|Glucocorticoids|glucocorticoids|mesh-ancestor
110382233|NCT04534478|Hormones|hormones|mesh-ancestor
110382234|NCT04534478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110382235|NCT04534478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382236|NCT04534478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110382237|NCT04534478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110382238|NCT02216669|Imidazole|imidazole|mesh-list
110382239|NCT02216669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110382240|NCT02216669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110382241|NCT03772158|Cetirizine|cetirizine|mesh-list
110382242|NCT03772158|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110382243|NCT03772158|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110382244|NCT03772158|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110382245|NCT03772158|Histamine Antagonists|histamine antagonists|mesh-ancestor
110382246|NCT03772158|Histamine Agents|histamine agents|mesh-ancestor
110382247|NCT03772158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110382248|NCT03772158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110382249|NCT03772158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382250|NCT01196416|Cisplatin|cisplatin|mesh-list
110382251|NCT01196416|Temozolomide|temozolomide|mesh-list
110382252|NCT01196416|Vinblastine|vinblastine|mesh-list
110382253|NCT01196416|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
110382254|NCT01196416|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
110382255|NCT01196416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110382258|NCT01196416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110382259|NCT01196416|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110382260|NCT01196416|Tubulin Modulators|tubulin modulators|mesh-ancestor
110382261|NCT01196416|Antimitotic Agents|antimitotic agents|mesh-ancestor
110382262|NCT01196416|Mitosis Modulators|mitosis modulators|mesh-ancestor
110382263|NCT01196416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110382265|NCT01196104|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110382266|NCT01196104|Insulin Glargine|insulin glargine|mesh-list
110382267|NCT01196104|Insulin Aspart|insulin aspart|mesh-list
110382268|NCT01196104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110382269|NCT01196104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382270|NCT04534322|Dexamethasone|dexamethasone|mesh-list
110382271|NCT04534322|Melphalan|melphalan|mesh-list
110382272|NCT04534322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110382273|NCT04534322|Antiemetics|antiemetics|mesh-ancestor
110382274|NCT04534322|Autonomic Agents|autonomic agents|mesh-ancestor
110382275|NCT04534322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110382276|NCT04534322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382277|NCT04534322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110382278|NCT04534322|Glucocorticoids|glucocorticoids|mesh-ancestor
110382279|NCT04534322|Hormones|hormones|mesh-ancestor
110382280|NCT04534322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110382281|NCT04534322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110382282|NCT04534322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110382283|NCT04534322|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110382284|NCT04534322|Alkylating Agents|alkylating agents|mesh-ancestor
110382285|NCT04534322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110382286|NCT04534322|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110382287|NCT04534322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110382288|NCT04534322|Immunologic Factors|immunologic factors|mesh-ancestor
110382289|NCT02219672|Ritonavir|ritonavir|mesh-list
110382290|NCT02219672|Lopinavir|lopinavir|mesh-list
110382291|NCT02219672|Tenofovir|tenofovir|mesh-list
110382292|NCT02219672|Lamivudine|lamivudine|mesh-list
110382293|NCT02219672|Raltegravir Potassium|raltegravir potassium|mesh-list
110382294|NCT02219672|Triptolide|triptolide|mesh-list
110382295|NCT02219672|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110382296|NCT02219672|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110382297|NCT02219672|Protease Inhibitors|protease inhibitors|mesh-ancestor
110382298|NCT02219672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110382299|NCT02219672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110382300|NCT02219672|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110382301|NCT02219672|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110382302|NCT02219672|Antiviral Agents|antiviral agents|mesh-ancestor
110382303|NCT02219672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110382304|NCT02219672|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110382305|NCT02219672|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110382306|NCT02219672|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110382307|NCT02219672|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110382308|NCT02219672|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110382309|NCT02219672|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110382310|NCT02219672|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
110382311|NCT02219672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382313|NCT02219672|Contraceptive Agents|contraceptive agents|mesh-ancestor
110382314|NCT02219672|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110382315|NCT02219672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110382316|NCT02219672|Immunologic Factors|immunologic factors|mesh-ancestor
110382317|NCT02219672|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110382318|NCT02219672|Alkylating Agents|alkylating agents|mesh-ancestor
110382319|NCT02219672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110382320|NCT03113955|Epirubicin|epirubicin|mesh-list
110382321|NCT03113955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110382322|NCT03113955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110382323|NCT03113955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110382324|NCT03113955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110382325|NCT03113955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110382326|NCT03113955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110382327|NCT02219750|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110382328|NCT02219750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110382329|NCT02219750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382330|NCT04534452|Phenylephrine|phenylephrine|mesh-list
110382331|NCT04534452|Oxymetazoline|oxymetazoline|mesh-list
110036650|NCT01413022|Leucovorin|leucovorin|mesh-list
110382332|NCT04534452|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110382333|NCT04534452|Mydriatics|mydriatics|mesh-ancestor
110382334|NCT04534452|Autonomic Agents|autonomic agents|mesh-ancestor
110382335|NCT04534452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110382336|NCT04534452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382337|NCT04534452|Sympathomimetics|sympathomimetics|mesh-ancestor
110382338|NCT04534452|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110382339|NCT04534452|Nasal Decongestants|nasal decongestants|mesh-ancestor
110382340|NCT04534452|Respiratory System Agents|respiratory system agents|mesh-ancestor
110382341|NCT04534452|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110382342|NCT04534452|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110382343|NCT04534452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110382344|NCT04534452|Adrenergic Agents|adrenergic agents|mesh-ancestor
110382345|NCT04534452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110260196|NCT00145379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382346|NCT04534452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110382347|NCT04534452|Protective Agents|protective agents|mesh-ancestor
110382349|NCT02219789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110382350|NCT02219789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110382351|NCT02219789|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110382352|NCT02219789|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110382353|NCT02219789|Hormone Antagonists|hormone antagonists|mesh-ancestor
110382354|NCT02219789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110382355|NCT02219789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382356|NCT02219828|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110382357|NCT02219828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110382358|NCT04533867|Ondansetron|ondansetron|mesh-list
110382359|NCT04533867|Palonosetron|palonosetron|mesh-list
110382360|NCT04533867|Antiemetics|antiemetics|mesh-ancestor
110382361|NCT04533867|Autonomic Agents|autonomic agents|mesh-ancestor
110382362|NCT04533867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110382363|NCT04533867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382364|NCT04533867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110382365|NCT04533867|Antipruritics|antipruritics|mesh-ancestor
110382366|NCT04533867|Dermatologic Agents|dermatologic agents|mesh-ancestor
110382367|NCT04533867|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110382368|NCT04533867|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110382369|NCT04533867|Serotonin Agents|serotonin agents|mesh-ancestor
110382370|NCT04533867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110382371|NCT04533867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110382374|NCT02219867|Sensory System Agents|sensory system agents|mesh-ancestor
110382375|NCT02219867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110382376|NCT02219867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382377|NCT02219867|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110382378|NCT02219867|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110382379|NCT02219867|Anesthetics, General|anesthetics, general|mesh-ancestor
110382380|NCT02219867|Anesthetics|anesthetics|mesh-ancestor
110382381|NCT02219867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110382382|NCT02219867|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110382383|NCT02219867|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110382384|NCT02219867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110382385|NCT02219867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110382386|NCT04533906|Povidone-Iodine|povidone-iodine|mesh-list
110382387|NCT04533906|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110382388|NCT04533906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110382389|NCT02219906|Resveratrol|resveratrol|mesh-list
110382390|NCT02219906|Antioxidants|antioxidants|mesh-ancestor
110382391|NCT02219906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110382392|NCT02219906|Protective Agents|protective agents|mesh-ancestor
110382393|NCT02219906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382394|NCT02219906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110382395|NCT02219906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110382396|NCT04533243|Fentanyl|fentanyl|mesh-list
110382397|NCT04533243|Morphine|morphine|mesh-list
110382398|NCT04533243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110382399|NCT04533243|Narcotics|narcotics|mesh-ancestor
110382400|NCT04533243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110382401|NCT04533243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382402|NCT04533243|Analgesics|analgesics|mesh-ancestor
110382403|NCT04533243|Sensory System Agents|sensory system agents|mesh-ancestor
110382404|NCT04533243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110036719|NCT01413490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110382405|NCT04533243|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110382406|NCT04533243|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110382407|NCT04533243|Anesthetics, General|anesthetics, general|mesh-ancestor
110382408|NCT04533243|Anesthetics|anesthetics|mesh-ancestor
110382409|NCT04533321|Afatinib|afatinib|mesh-list
110382410|NCT04533321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110382411|NCT04533321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110382412|NCT04533321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110382413|NCT04533321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110382414|NCT01195831|Calcipotriene|calcipotriene|mesh-list
110382415|NCT01195831|Dermatologic Agents|dermatologic agents|mesh-ancestor
110382416|NCT01195675|Empagliflozin|empagliflozin|mesh-list
110382417|NCT01195675|Moxifloxacin|moxifloxacin|mesh-list
110382418|NCT01195675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110382419|NCT01195675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110382420|NCT01195675|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110382421|NCT01195675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110382422|NCT01195675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110382423|NCT01195675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110382424|NCT01195675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110382425|NCT01195675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382426|NCT01195675|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110382427|NCT01195675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110382428|NCT04532931|Acetaminophen|acetaminophen|mesh-list
110382429|NCT04532931|Sofosbuvir|sofosbuvir|mesh-list
110382430|NCT04532931|Artesunate|artesunate|mesh-list
110382431|NCT04532931|Favipiravir|favipiravir|mesh-list
110382432|NCT04532931|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
110382434|NCT04532931|Nitazoxanide|nitazoxanide|mesh-list
110382435|NCT04532931|Pyronaridine|pyronaridine|mesh-list
110382436|NCT04532931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110382437|NCT04532931|Analgesics|analgesics|mesh-ancestor
110382438|NCT04532931|Sensory System Agents|sensory system agents|mesh-ancestor
110382439|NCT04532931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110382440|NCT04532931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382441|NCT04532931|Antipyretics|antipyretics|mesh-ancestor
110382442|NCT04532931|Antiviral Agents|antiviral agents|mesh-ancestor
110382443|NCT04532931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110382444|NCT04532931|Antimalarials|antimalarials|mesh-ancestor
110382445|NCT04532931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110382446|NCT04532931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110382447|NCT04532931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110382448|NCT04532931|Schistosomicides|schistosomicides|mesh-ancestor
110382449|NCT04532931|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110382450|NCT04532931|Anthelmintics|anthelmintics|mesh-ancestor
110382451|NCT01195363|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110382452|NCT01195363|Antidepressive Agents|antidepressive agents|mesh-ancestor
110382453|NCT01195363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110382454|NCT01195363|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110382455|NCT01195363|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110382456|NCT01195363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110382457|NCT01195363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382458|NCT01195090|Pioglitazone|pioglitazone|mesh-list
110382459|NCT01195090|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110382460|NCT01195090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110382461|NCT01195090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382462|NCT01195090|Incretins|incretins|mesh-ancestor
110382463|NCT01195090|Hormones|hormones|mesh-ancestor
110382464|NCT01195090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110382465|NCT01195090|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110382466|NCT01195090|Protease Inhibitors|protease inhibitors|mesh-ancestor
110382467|NCT01195090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110382468|NCT01195090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110382469|NCT02213081|Ulipristal acetate|ulipristal acetate|mesh-list
110382470|NCT02213081|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110382471|NCT02213081|Contraceptive Agents|contraceptive agents|mesh-ancestor
110382472|NCT02213081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110382473|NCT02213081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382474|NCT02213081|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110382475|NCT02213627|Menotropins|menotropins|mesh-list
110382476|NCT02213627|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110382477|NCT02213627|Fertility Agents|fertility agents|mesh-ancestor
110382478|NCT02213627|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110382479|NCT02213627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382480|NCT02216799|Insulin|insulin|mesh-list
110382481|NCT02216799|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110382482|NCT02216799|Insulin Glargine|insulin glargine|mesh-list
110382483|NCT02216799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110382484|NCT02216799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382485|NCT02216877|Magnesium Hydroxide|magnesium hydroxide|mesh-list
110382486|NCT02216877|Antacids|antacids|mesh-ancestor
110382487|NCT02216877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110382488|NCT02216877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110382489|NCT02214563|Vitamin D|vitamin d|mesh-list
110382490|NCT02214563|Ergocalciferols|ergocalciferols|mesh-list
110382491|NCT02214563|Cholecalciferol|cholecalciferol|mesh-list
110382492|NCT02214563|Vitamins|vitamins|mesh-list
110382493|NCT02214563|Micronutrients|micronutrients|mesh-ancestor
110382494|NCT02214563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382495|NCT02214563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110382496|NCT02214563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110382497|NCT01194973|Eculizumab|eculizumab|mesh-list
110382498|NCT01194973|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110382499|NCT01194973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110382500|NCT01194973|Immunologic Factors|immunologic factors|mesh-ancestor
110382501|NCT01194973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382503|NCT02218619|Antiviral Agents|antiviral agents|mesh-ancestor
110382504|NCT02218619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110382505|NCT02218619|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110382506|NCT02218619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110382507|NCT02218697|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110382508|NCT02218697|Immunologic Factors|immunologic factors|mesh-ancestor
110382509|NCT02218697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382510|NCT02216747|Prednisone|prednisone|mesh-list
110382511|NCT02216747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110382512|NCT02216747|Glucocorticoids|glucocorticoids|mesh-ancestor
110382513|NCT02216747|Hormones|hormones|mesh-ancestor
110382514|NCT02216747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110382515|NCT02216747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382516|NCT02216747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110382517|NCT02216747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110382518|NCT02216786|Everolimus|everolimus|mesh-list
110382519|NCT02216786|Fulvestrant|fulvestrant|mesh-list
110382520|NCT02216786|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110382521|NCT02216786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110382522|NCT02216786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110382523|NCT02216786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110382524|NCT02216786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110382525|NCT02216786|Immunologic Factors|immunologic factors|mesh-ancestor
110382526|NCT02216786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382527|NCT02216786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110382528|NCT02216786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110382529|NCT02216786|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110382530|NCT02216786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110382531|NCT02216786|Hormone Antagonists|hormone antagonists|mesh-ancestor
110382532|NCT02216786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110382533|NCT02279147|Neostigmine|neostigmine|mesh-list
110382534|NCT02279147|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110382535|NCT02279147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110382536|NCT02279147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110382537|NCT02279147|Cholinergic Agents|cholinergic agents|mesh-ancestor
110382538|NCT02279147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110382539|NCT02279147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382540|NCT02279147|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110382541|NCT02279147|Autonomic Agents|autonomic agents|mesh-ancestor
110382542|NCT02279147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110382543|NCT02279186|Tranexamic Acid|tranexamic acid|mesh-list
110382544|NCT02279186|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110382545|NCT02279186|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110382546|NCT02279186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110382548|NCT02279186|Coagulants|coagulants|mesh-ancestor
110382550|NCT01177540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110382551|NCT01177540|Antimetabolites|antimetabolites|mesh-ancestor
110382552|NCT01177540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110382553|NCT01177540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110382554|NCT01177540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110036868|NCT01415128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110382555|NCT01177384|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110382556|NCT01177384|Glimepiride|glimepiride|mesh-list
110382557|NCT01177384|Acarbose|acarbose|mesh-list
110382558|NCT01177384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110382559|NCT01177384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382560|NCT01177384|Incretins|incretins|mesh-ancestor
110382561|NCT01177384|Hormones|hormones|mesh-ancestor
110382562|NCT01177384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110382563|NCT01177384|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110382564|NCT01177384|Protease Inhibitors|protease inhibitors|mesh-ancestor
110382565|NCT01177384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110382566|NCT01177384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110382567|NCT01177384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110382568|NCT01177384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110382569|NCT01177384|Immunologic Factors|immunologic factors|mesh-ancestor
110382570|NCT01177384|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110382571|NCT01640093|Abiraterone Acetate|abiraterone acetate|mesh-list
110382572|NCT01640093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110382573|NCT01640093|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110382574|NCT01640093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110382575|NCT01640093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110382576|NCT01640093|Hormone Antagonists|hormone antagonists|mesh-ancestor
110382577|NCT01640093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110382578|NCT01640093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382579|NCT01640093|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110382580|NCT01194154|Epoetin Alfa|epoetin alfa|mesh-list
110382581|NCT01194154|Hematinics|hematinics|mesh-ancestor
110382582|NCT01640210|Insulin|insulin|mesh-list
110382583|NCT01640210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110382584|NCT01640210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382585|NCT01640405|Bevacizumab|bevacizumab|mesh-list
110382586|NCT01640405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110382587|NCT01640405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110382588|NCT01640405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110382589|NCT01640405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110382590|NCT01640405|Growth Substances|growth substances|mesh-ancestor
110382591|NCT01640405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382592|NCT01640405|Growth Inhibitors|growth inhibitors|mesh-ancestor
110382593|NCT01640444|Bevacizumab|bevacizumab|mesh-list
110382594|NCT01640444|Cetuximab|cetuximab|mesh-list
110382595|NCT01640444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110382596|NCT01640444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110382597|NCT01640444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110382598|NCT01640444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110382599|NCT01640444|Growth Substances|growth substances|mesh-ancestor
110382600|NCT01640444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382601|NCT01640444|Growth Inhibitors|growth inhibitors|mesh-ancestor
110382603|NCT01642433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110382604|NCT01642433|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110382605|NCT01642433|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110382606|NCT01642433|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110382607|NCT01642433|Adrenergic Agents|adrenergic agents|mesh-ancestor
110382608|NCT01642433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110382609|NCT01642433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110382610|NCT01642433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382612|NCT01642472|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110382613|NCT01642472|Contraceptive Agents|contraceptive agents|mesh-ancestor
110382614|NCT01642472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110382615|NCT01642472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382616|NCT01642472|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110382617|NCT01640639|Thalidomide|thalidomide|mesh-list
110382618|NCT01640639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110382619|NCT01640639|Immunologic Factors|immunologic factors|mesh-ancestor
110382620|NCT01640639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382621|NCT01640639|Leprostatic Agents|leprostatic agents|mesh-ancestor
110382622|NCT01640639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110382623|NCT01640639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110382624|NCT01640639|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110382625|NCT01640639|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110382626|NCT01640639|Growth Substances|growth substances|mesh-ancestor
110382627|NCT01640639|Growth Inhibitors|growth inhibitors|mesh-ancestor
110382628|NCT01640639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110036941|NCT01415596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110382629|NCT01642667|Saruplase|saruplase|mesh-list
110382630|NCT01642667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110382631|NCT01642667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110382632|NCT01642667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110382633|NCT01642745|Mannitol|mannitol|mesh-list
110382634|NCT01642745|Methacholine Chloride|methacholine chloride|mesh-list
110044488|NCT05734625|Prednisolone|prednisolone|mesh-list
110382635|NCT01642745|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110382636|NCT01642745|Diuretics|diuretics|mesh-ancestor
110382637|NCT01642745|Natriuretic Agents|natriuretic agents|mesh-ancestor
110382638|NCT01642745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382639|NCT01642745|Miotics|miotics|mesh-ancestor
110382640|NCT01642745|Autonomic Agents|autonomic agents|mesh-ancestor
110382641|NCT01642745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110382642|NCT01642745|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110382643|NCT01642745|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
110382644|NCT01642745|Respiratory System Agents|respiratory system agents|mesh-ancestor
110382645|NCT01642745|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110382647|NCT01642745|Cholinergic Agents|cholinergic agents|mesh-ancestor
110382648|NCT01642745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110382649|NCT01642745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110382651|NCT01640990|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
110382652|NCT01640990|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110382653|NCT01640990|Purinergic Agonists|purinergic agonists|mesh-ancestor
110382654|NCT01640990|Purinergic Agents|purinergic agents|mesh-ancestor
110382655|NCT01640990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110382656|NCT01640990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110382657|NCT01640990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382658|NCT01642862|Simvastatin|simvastatin|mesh-list
110382659|NCT01642862|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110382660|NCT01642862|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110382661|NCT01642862|Antimetabolites|antimetabolites|mesh-ancestor
110382662|NCT01642862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110382663|NCT01642862|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110382664|NCT01642862|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110382665|NCT01642862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110382666|NCT01642940|Ticagrelor|ticagrelor|mesh-list
110382667|NCT01642940|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110382668|NCT01642940|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110382669|NCT01642940|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110382670|NCT01642940|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110382671|NCT01642940|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110382672|NCT01642940|Purinergic Agents|purinergic agents|mesh-ancestor
110382673|NCT01642940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110382674|NCT01642940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110382675|NCT01642940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382676|NCT04497519|Hydroxychloroquine|hydroxychloroquine|mesh-list
110382677|NCT04497519|Antimalarials|antimalarials|mesh-ancestor
110382678|NCT04497519|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110382679|NCT04497519|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110382680|NCT04497519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110382681|NCT04497519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110382682|NCT04497519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110382683|NCT04497519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110382684|NCT01641224|Pinaverium|pinaverium|mesh-list
110382685|NCT01641224|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110382686|NCT01641224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110382687|NCT01641224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110382688|NCT01641224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110382689|NCT01641224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382690|NCT01641224|Parasympatholytics|parasympatholytics|mesh-ancestor
110382691|NCT01641224|Autonomic Agents|autonomic agents|mesh-ancestor
110382692|NCT01641224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110382693|NCT01643135|Tranylcypromine|tranylcypromine|mesh-list
110382694|NCT01643135|Tranexamic Acid|tranexamic acid|mesh-list
110382695|NCT01643135|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110382696|NCT01643135|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110382697|NCT01643135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110382698|NCT01643135|Hemostatics|hemostatics|mesh-ancestor
110382699|NCT01643135|Coagulants|coagulants|mesh-ancestor
110382700|NCT01643135|Antidepressive Agents|antidepressive agents|mesh-ancestor
110382701|NCT01643135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110382702|NCT01643135|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110382703|NCT01643135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110382704|NCT01643135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110382705|NCT01643135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110382706|NCT01643135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110382707|NCT01643135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382708|NCT01641419|Dexamethasone|dexamethasone|mesh-list
110382709|NCT01641419|Dexamethasone acetate|dexamethasone acetate|mesh-list
110382710|NCT01641419|BB 1101|bb 1101|mesh-list
110382711|NCT01641419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110382712|NCT01641419|Antiemetics|antiemetics|mesh-ancestor
110382713|NCT01641419|Autonomic Agents|autonomic agents|mesh-ancestor
110382714|NCT01641419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110382715|NCT01641419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382716|NCT01641419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110382717|NCT01641419|Glucocorticoids|glucocorticoids|mesh-ancestor
110382718|NCT01641419|Hormones|hormones|mesh-ancestor
110382719|NCT01641419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110382720|NCT01641419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110382721|NCT01641419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110382722|NCT01641419|Protease Inhibitors|protease inhibitors|mesh-ancestor
110382723|NCT01641419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110382724|NCT01641419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110382726|NCT01643252|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110382727|NCT01643252|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110382728|NCT01643252|Vitamin B Complex|vitamin b complex|mesh-ancestor
110382729|NCT01643252|Vitamins|vitamins|mesh-ancestor
110382730|NCT01643252|Micronutrients|micronutrients|mesh-ancestor
110382731|NCT01643252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382732|NCT01643252|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110382733|NCT01643252|Dermatologic Agents|dermatologic agents|mesh-ancestor
110382734|NCT01641458|Capecitabine|capecitabine|mesh-list
110382735|NCT01641458|Fluorouracil|fluorouracil|mesh-list
110382736|NCT01641458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110382737|NCT01641458|Antimetabolites|antimetabolites|mesh-ancestor
110382738|NCT01641458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110382739|NCT01641458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110382740|NCT01641458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110382741|NCT01641458|Immunologic Factors|immunologic factors|mesh-ancestor
110382742|NCT01641458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382743|NCT01641536|Entecavir|entecavir|mesh-list
110382744|NCT01641536|Antiviral Agents|antiviral agents|mesh-ancestor
110382745|NCT01641536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110382746|NCT01641575|Gemcitabine|gemcitabine|mesh-list
110382747|NCT01641575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110382748|NCT01641575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110382749|NCT01641575|Antimetabolites|antimetabolites|mesh-ancestor
110382750|NCT01641575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110382751|NCT01643447|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
110382752|NCT01643447|Urinastatin|urinastatin|mesh-list
110382753|NCT01643447|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110382754|NCT01643447|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110382755|NCT01643447|Protease Inhibitors|protease inhibitors|mesh-ancestor
110382756|NCT01643447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110382757|NCT01643447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110382758|NCT01643447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110382759|NCT01643603|Dasatinib|dasatinib|mesh-list
110382760|NCT01643603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110382761|NCT01643603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110382762|NCT01643603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110382763|NCT01643603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110382764|NCT02754011|Capecitabine|capecitabine|mesh-list
110382765|NCT02754011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110382766|NCT02754011|Antimetabolites|antimetabolites|mesh-ancestor
110382767|NCT02754011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110382768|NCT02754011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110382769|NCT02755844|Metformin|metformin|mesh-list
110382770|NCT02755844|Cyclophosphamide|cyclophosphamide|mesh-list
110382771|NCT02755844|Olaparib|olaparib|mesh-list
110382772|NCT02755844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110382773|NCT02755844|Immunologic Factors|immunologic factors|mesh-ancestor
110382774|NCT02755844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382775|NCT02755844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110382776|NCT02755844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110382777|NCT02755844|Alkylating Agents|alkylating agents|mesh-ancestor
110382778|NCT02755844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110382779|NCT02755844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110382780|NCT02755844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110382781|NCT02755844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110382782|NCT02755844|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110382783|NCT02755844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110382784|NCT06032195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110382785|NCT06032039|Triamcinolone|triamcinolone|mesh-list
110382786|NCT06032039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110382787|NCT06032039|Glucocorticoids|glucocorticoids|mesh-ancestor
110382788|NCT06032039|Hormones|hormones|mesh-ancestor
110382789|NCT06032039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110382790|NCT06032039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382791|NCT06031961|Melatonin|melatonin|mesh-list
110382792|NCT06031961|Antioxidants|antioxidants|mesh-ancestor
110382793|NCT06031961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110382794|NCT06031961|Protective Agents|protective agents|mesh-ancestor
110382795|NCT06031961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382796|NCT06031961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110382797|NCT06031883|Fentanyl|fentanyl|mesh-list
110382798|NCT06031883|Ketamine|ketamine|mesh-list
110382799|NCT06031883|Analgesics|analgesics|mesh-ancestor
110382800|NCT06031883|Sensory System Agents|sensory system agents|mesh-ancestor
110382801|NCT06031883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110382802|NCT06031883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382803|NCT06031883|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110382804|NCT06031883|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110382805|NCT06031883|Anesthetics, General|anesthetics, general|mesh-ancestor
110382806|NCT06031883|Anesthetics|anesthetics|mesh-ancestor
110382807|NCT06031883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110382808|NCT06031883|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110382809|NCT06031883|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110382810|NCT06031883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110382811|NCT06031883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110382812|NCT06031883|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110382813|NCT06031883|Narcotics|narcotics|mesh-ancestor
110382814|NCT06031883|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110382815|NCT06031688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110382816|NCT06031688|Ramucirumab|ramucirumab|mesh-list
110382817|NCT06031688|Tepotinib|tepotinib|mesh-list
110382818|NCT06031688|Antibodies|antibodies|mesh-list
110382819|NCT06031688|Immunoglobulins|immunoglobulins|mesh-list
110382820|NCT06031688|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110382821|NCT06031688|Lexatumumab|lexatumumab|mesh-list
110382822|NCT06031688|Immunologic Factors|immunologic factors|mesh-ancestor
110382823|NCT06031688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382824|NCT06031688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110382825|NCT06049160|Misoprostol|misoprostol|mesh-list
110382826|NCT06049160|Oxytocin|oxytocin|mesh-list
110382827|NCT06049160|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110382828|NCT06049160|Abortifacient Agents|abortifacient agents|mesh-ancestor
110382829|NCT06049160|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110382830|NCT06049160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382831|NCT06049160|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110382832|NCT06049160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110382833|NCT06049160|Oxytocics|oxytocics|mesh-ancestor
110382834|NCT06048926|Paclitaxel|paclitaxel|mesh-list
110382835|NCT06048926|Cisplatin|cisplatin|mesh-list
110382836|NCT06048926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110382837|NCT06048926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110382838|NCT06048926|Tubulin Modulators|tubulin modulators|mesh-ancestor
110382839|NCT06048926|Antimitotic Agents|antimitotic agents|mesh-ancestor
110382840|NCT06048926|Mitosis Modulators|mitosis modulators|mesh-ancestor
110382841|NCT06048926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110382842|NCT06048913|Nimotuzumab|nimotuzumab|mesh-list
110382843|NCT06048913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110382844|NCT06048913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110382845|NCT06048887|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110382846|NCT06048809|Fluorides|fluorides|mesh-list
110382847|NCT06048809|Tin Fluorides|tin fluorides|mesh-list
110382848|NCT06048809|Cariostatic Agents|cariostatic agents|mesh-ancestor
110382849|NCT06048809|Protective Agents|protective agents|mesh-ancestor
110382850|NCT06048809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382851|NCT06048718|Trastuzumab|trastuzumab|mesh-list
110382852|NCT06048718|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
110382853|NCT06048718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110382854|NCT06048718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110037170|NCT01416961|Etoposide|etoposide|mesh-list
110382855|NCT06048718|Immunoconjugates|immunoconjugates|mesh-ancestor
110382856|NCT06048718|Immunologic Factors|immunologic factors|mesh-ancestor
110382857|NCT06048718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382858|NCT06048705|Cyclophosphamide|cyclophosphamide|mesh-list
110382860|NCT06048705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110382861|NCT06048705|Immunologic Factors|immunologic factors|mesh-ancestor
110382862|NCT06048705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382863|NCT06048705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110382864|NCT06048705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110382865|NCT06048705|Alkylating Agents|alkylating agents|mesh-ancestor
110382866|NCT06048705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110382867|NCT06048705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110382868|NCT06048705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110382869|NCT06048692|Ampicillin|ampicillin|mesh-list
110382870|NCT06048692|Cefepime|cefepime|mesh-list
110382871|NCT06048692|Sulbactam|sulbactam|mesh-list
110382872|NCT06048692|Sultamicillin|sultamicillin|mesh-list
110382873|NCT06048692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110382874|NCT06048692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110382875|NCT06048692|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110382876|NCT06048692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110382877|NCT06048692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110382878|NCT06048627|Fluorides|fluorides|mesh-list
110382879|NCT06048627|Cariostatic Agents|cariostatic agents|mesh-ancestor
110382880|NCT06048627|Protective Agents|protective agents|mesh-ancestor
110382881|NCT06048627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382882|NCT06048484|Folfirinox|folfirinox|mesh-list
110382883|NCT06048484|Quemliclustat|quemliclustat|mesh-list
110382884|NCT06048484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110382885|NCT06048484|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110382886|NCT06048484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110382887|NCT06048484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110382889|NCT06048367|Trace Elements|trace elements|mesh-ancestor
110382890|NCT06048367|Micronutrients|micronutrients|mesh-ancestor
110382891|NCT06048367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382892|NCT06048263|Ketamine|ketamine|mesh-list
110382893|NCT06048263|Analgesics|analgesics|mesh-ancestor
110382894|NCT06048263|Sensory System Agents|sensory system agents|mesh-ancestor
110382895|NCT06048263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110382896|NCT06048263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382897|NCT06048263|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110382898|NCT06048263|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110382899|NCT06048263|Anesthetics, General|anesthetics, general|mesh-ancestor
110382900|NCT06048263|Anesthetics|anesthetics|mesh-ancestor
110382901|NCT06048263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110382902|NCT06048263|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110382903|NCT06048263|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110382904|NCT06048263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110382905|NCT06048263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110382906|NCT06048133|Gemcitabine|gemcitabine|mesh-list
110382907|NCT06048133|Quemliclustat|quemliclustat|mesh-list
110382908|NCT06048133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110382909|NCT06048133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110382910|NCT06048133|Antimetabolites|antimetabolites|mesh-ancestor
110382911|NCT06048133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110382944|NCT06047860|Sensory System Agents|sensory system agents|mesh-ancestor
110382945|NCT06047860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110382946|NCT06047860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382947|NCT06047860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110382948|NCT06047860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110382949|NCT06047860|Growth Substances|growth substances|mesh-ancestor
110382950|NCT06047860|Growth Inhibitors|growth inhibitors|mesh-ancestor
110382951|NCT06047860|Immunologic Factors|immunologic factors|mesh-ancestor
110382952|NCT06047860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110382953|NCT06047860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110382954|NCT06047834|Lofexidine|lofexidine|mesh-list
110382955|NCT06047834|Clonidine|clonidine|mesh-list
110382956|NCT06047834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110382957|NCT06047834|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110382958|NCT06047834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382959|NCT06047834|Sensory System Agents|sensory system agents|mesh-ancestor
110382960|NCT06047834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110382961|NCT06047834|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110382962|NCT06047834|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110382963|NCT06047834|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110382964|NCT06047834|Adrenergic Agents|adrenergic agents|mesh-ancestor
110382965|NCT06047834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110383011|NCT06047379|Nivolumab|nivolumab|mesh-list
110383012|NCT06047379|Ipilimumab|ipilimumab|mesh-list
110383013|NCT06047379|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110383014|NCT06047379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110383015|NCT06047379|Tubulin Modulators|tubulin modulators|mesh-ancestor
110383016|NCT06047379|Antimitotic Agents|antimitotic agents|mesh-ancestor
110383017|NCT06047379|Mitosis Modulators|mitosis modulators|mesh-ancestor
110383018|NCT06047379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110383019|NCT06047379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110383020|NCT06047379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110383021|NCT06047379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110383022|NCT06047379|Growth Substances|growth substances|mesh-ancestor
110383023|NCT06047379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110383024|NCT06047379|Growth Inhibitors|growth inhibitors|mesh-ancestor
110383025|NCT06047379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110383057|NCT06047184|Letrozole|letrozole|mesh-list
110383058|NCT06047184|Fulvestrant|fulvestrant|mesh-list
110383059|NCT06047184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110383060|NCT06047184|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110383061|NCT06047184|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110383062|NCT06047184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110383063|NCT06047184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110383064|NCT06047184|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110383065|NCT06047184|Hormone Antagonists|hormone antagonists|mesh-ancestor
110383066|NCT06047184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110383067|NCT06047184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110383068|NCT06047184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110383069|NCT06047184|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110383070|NCT06047171|Cyclophosphamide|cyclophosphamide|mesh-list
110383071|NCT06047171|Rituximab|rituximab|mesh-list
110383072|NCT06047171|Immunosuppressive Agents|immunosuppressive agents|mesh-list
110383073|NCT06047171|Glucocorticoids|glucocorticoids|mesh-list
110383074|NCT06047171|Immunologic Factors|immunologic factors|mesh-ancestor
110383075|NCT06047171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110383076|NCT06047171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110383077|NCT06047171|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110383078|NCT06047171|Alkylating Agents|alkylating agents|mesh-ancestor
110383079|NCT06047171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110383080|NCT06047171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110383081|NCT06047171|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110383082|NCT06047171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110383083|NCT06047171|Hormones|hormones|mesh-ancestor
110383084|NCT06047171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110383085|NCT06047080|Prednisone|prednisone|mesh-list
110383086|NCT06047080|Cyclophosphamide|cyclophosphamide|mesh-list
110383087|NCT06047080|Rituximab|rituximab|mesh-list
110383088|NCT06047080|Doxorubicin|doxorubicin|mesh-list
110383089|NCT06047080|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
110383090|NCT06047080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110383091|NCT06047080|Immunologic Factors|immunologic factors|mesh-ancestor
110383092|NCT06047080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110383093|NCT06047080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110383094|NCT06047080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110383095|NCT06047080|Alkylating Agents|alkylating agents|mesh-ancestor
110383096|NCT06047080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110383097|NCT06047080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110383098|NCT06047080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110383099|NCT06047080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110383100|NCT06047080|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110383101|NCT06047080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110383102|NCT06047080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110383103|NCT06047080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110383104|NCT06047080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110383105|NCT06047080|Glucocorticoids|glucocorticoids|mesh-ancestor
110383106|NCT06047080|Hormones|hormones|mesh-ancestor
110383107|NCT06047080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110383108|NCT06047080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110383109|NCT06047080|Immunoconjugates|immunoconjugates|mesh-ancestor
110383110|NCT06047015|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
110383111|NCT06047015|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110383112|NCT06047015|Immunologic Factors|immunologic factors|mesh-ancestor
110383113|NCT06047015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110383114|NCT06046963|Paclitaxel|paclitaxel|mesh-list
110383115|NCT06046963|Oxaliplatin|oxaliplatin|mesh-list
110383116|NCT06046963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110383117|NCT06046963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110383118|NCT06046963|Tubulin Modulators|tubulin modulators|mesh-ancestor
110383119|NCT06046963|Antimitotic Agents|antimitotic agents|mesh-ancestor
110383120|NCT06046963|Mitosis Modulators|mitosis modulators|mesh-ancestor
110383121|NCT06046963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110383122|NCT06046937|Mupirocin|mupirocin|mesh-list
110383123|NCT06046937|Monolaurin|monolaurin|mesh-list
110383124|NCT06046937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110383125|NCT06046937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110383126|NCT06046937|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110383127|NCT06046937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110383128|NCT06046937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110383129|NCT06046937|Cariostatic Agents|cariostatic agents|mesh-ancestor
110383130|NCT06046937|Protective Agents|protective agents|mesh-ancestor
110383131|NCT06046937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110383132|NCT06046859|Fluoxetine|fluoxetine|mesh-list
110383133|NCT06046859|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110383134|NCT06046859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110383135|NCT06046859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110383136|NCT06046859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110383137|NCT06046859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110383138|NCT06046859|Serotonin Agents|serotonin agents|mesh-ancestor
110383139|NCT06046859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110383140|NCT06046859|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110383141|NCT06046859|Antidepressive Agents|antidepressive agents|mesh-ancestor
110383142|NCT06046859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110383143|NCT06046859|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110383144|NCT06046859|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110383145|NCT06046859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110383146|NCT06046638|Propofol|propofol|mesh-list
110383147|NCT06046638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110383148|NCT06046638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110037470|NCT01418599|Alfuzosin|alfuzosin|mesh-list
110383149|NCT06046638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110383150|NCT06046638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110383151|NCT06046638|Anesthetics, General|anesthetics, general|mesh-ancestor
110383152|NCT06046638|Anesthetics|anesthetics|mesh-ancestor
110383153|NCT06046612|Empagliflozin|empagliflozin|mesh-list
110383154|NCT06046612|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110383155|NCT06046612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110383156|NCT06046612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110383157|NCT06046612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110383158|NCT06046560|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
110383159|NCT06046560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110383161|NCT06046560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110383163|NCT06046482|Pembrolizumab|pembrolizumab|mesh-list
110383164|NCT06046482|Cetuximab|cetuximab|mesh-list
110383165|NCT06046482|Magrolimab|magrolimab|mesh-list
110383166|NCT06046482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110383167|NCT06046482|Tubulin Modulators|tubulin modulators|mesh-ancestor
110383168|NCT06046482|Antimitotic Agents|antimitotic agents|mesh-ancestor
110383169|NCT06046482|Mitosis Modulators|mitosis modulators|mesh-ancestor
110383170|NCT06046482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110383171|NCT06046482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110383172|NCT06046482|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110383173|NCT06046417|Insulin|insulin|mesh-list
110383174|NCT06046417|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110383175|NCT06046417|Insulin Aspart|insulin aspart|mesh-list
110383176|NCT06046417|Insulin Lispro|insulin lispro|mesh-list
110383177|NCT06046417|Pramlintide|pramlintide|mesh-list
110383178|NCT06046417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110383179|NCT06046417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110383180|NCT06046313|Decitabine|decitabine|mesh-list
110383181|NCT06046313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110383182|NCT06046313|Antimetabolites|antimetabolites|mesh-ancestor
110383183|NCT06046313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110383184|NCT06046313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110383185|NCT06046313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110383189|NCT06046274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110383190|NCT06046274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110383191|NCT06046274|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110383192|NCT06046274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110383193|NCT06046196|Sarpogrelate|sarpogrelate|mesh-list
110383194|NCT06046196|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110383195|NCT06046196|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110383196|NCT06046196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110383197|NCT06046196|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110383198|NCT06046196|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110383199|NCT06046196|Serotonin Agents|serotonin agents|mesh-ancestor
110383200|NCT06046196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110383201|NCT06046196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110383202|NCT06046105|Ibuprofen|ibuprofen|mesh-list
110383203|NCT06046105|Dexmedetomidine|dexmedetomidine|mesh-list
110383204|NCT06046105|Bupivacaine|bupivacaine|mesh-list
110383205|NCT06046105|Anesthetics, Local|anesthetics, local|mesh-ancestor
110383206|NCT06046105|Anesthetics|anesthetics|mesh-ancestor
110383207|NCT06046105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110383208|NCT06046105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110383209|NCT06046105|Sensory System Agents|sensory system agents|mesh-ancestor
110383210|NCT06046105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110383211|NCT06046105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110383212|NCT06046105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110383213|NCT06046105|Analgesics|analgesics|mesh-ancestor
110383214|NCT06046105|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110383215|NCT06046105|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110383216|NCT06046105|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110383217|NCT06046105|Adrenergic Agents|adrenergic agents|mesh-ancestor
110383218|NCT06046105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110383219|NCT06046105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110383220|NCT06046105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110383221|NCT06046105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110383222|NCT06046105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110383223|NCT06046105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110383224|NCT06046105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110383225|NCT06045975|Durvalumab|durvalumab|mesh-list
110383226|NCT06045975|Tremelimumab|tremelimumab|mesh-list
110383227|NCT06045975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110383228|NCT06045975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110383230|NCT06045936|Anesthetics, Local|anesthetics, local|mesh-ancestor
110383231|NCT06045936|Anesthetics|anesthetics|mesh-ancestor
110383232|NCT06045936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110383233|NCT06045936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110383234|NCT06045936|Sensory System Agents|sensory system agents|mesh-ancestor
110383235|NCT06045936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110383236|NCT06045936|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110383238|NCT06045936|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110383239|NCT06045936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110383240|NCT06045936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110383241|NCT06045858|Anticoagulants|anticoagulants|mesh-list
110383242|NCT06045832|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110383243|NCT06045832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110383244|NCT06045819|Venetoclax|venetoclax|mesh-list
110383245|NCT06045819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110383246|NCT06045793|Cocaine|cocaine|mesh-list
110383247|NCT06045793|Anesthetics, Local|anesthetics, local|mesh-ancestor
110383248|NCT06045793|Anesthetics|anesthetics|mesh-ancestor
110383249|NCT06045793|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110383250|NCT06045793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110383251|NCT06045793|Sensory System Agents|sensory system agents|mesh-ancestor
110383252|NCT06045793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110383253|NCT06045793|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110383254|NCT06045793|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110383255|NCT06045793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110383256|NCT06045793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110383257|NCT06045793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110383258|NCT06045793|Dopamine Agents|dopamine agents|mesh-ancestor
110383259|NCT06045793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110383262|NCT06045754|Vedolizumab|vedolizumab|mesh-list
110383263|NCT06045754|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110383264|NCT06045754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110383265|NCT06045754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110019957|NCT00000810|Antimetabolites|antimetabolites|mesh-ancestor
110383266|NCT06045754|Dermatologic Agents|dermatologic agents|mesh-ancestor
110383267|NCT06045754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110383268|NCT06045689|Luspatercept|luspatercept|mesh-list
110383269|NCT06045689|Hematinics|hematinics|mesh-ancestor
110383270|NCT06045650|Oxytocin|oxytocin|mesh-list
110383271|NCT06045650|Oxytocics|oxytocics|mesh-ancestor
110383272|NCT06045650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110383273|NCT06045650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110383274|NCT06045429|Chlorhexidine|chlorhexidine|mesh-list
110383275|NCT06045429|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110383276|NCT06045429|Hydrogen Peroxide|hydrogen peroxide|mesh-list
110383277|NCT06045429|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110383278|NCT06045429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110383282|NCT06045364|Glycopyrrolate|glycopyrrolate|mesh-list
110383283|NCT06045364|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110383284|NCT06045364|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110383285|NCT06045364|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110383286|NCT06045364|Cholinergic Agents|cholinergic agents|mesh-ancestor
110383287|NCT06045364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110383288|NCT06045364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110383289|NCT06045364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110383290|NCT06045364|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110383291|NCT06045364|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110383292|NCT06045364|Adrenergic Agents|adrenergic agents|mesh-ancestor
110383293|NCT06045364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110383294|NCT06045364|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110383295|NCT06045364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110383296|NCT06045364|Analgesics|analgesics|mesh-ancestor
110383297|NCT06045364|Sensory System Agents|sensory system agents|mesh-ancestor
110383298|NCT06045364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110383299|NCT06045364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110383300|NCT06045364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110383301|NCT06045364|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110383302|NCT06045364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110383303|NCT06045364|Parasympatholytics|parasympatholytics|mesh-ancestor
110383304|NCT06045364|Autonomic Agents|autonomic agents|mesh-ancestor
110383305|NCT06045364|Vasodilator Agents|vasodilator agents|mesh-ancestor
110383306|NCT06045364|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110383307|NCT06045364|Antioxidants|antioxidants|mesh-ancestor
110383308|NCT06045364|Protective Agents|protective agents|mesh-ancestor
110383316|NCT06045299|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110383318|NCT06045299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110383319|NCT06045299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110383320|NCT06045299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110383321|NCT06045299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110383322|NCT06045299|Adrenergic Agents|adrenergic agents|mesh-ancestor
110383323|NCT06045299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110383324|NCT06045299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110383325|NCT06045299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110383326|NCT06045299|Miotics|miotics|mesh-ancestor
110383327|NCT06045299|Autonomic Agents|autonomic agents|mesh-ancestor
110383328|NCT06045299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110383329|NCT06045299|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110383330|NCT06045286|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110383331|NCT06045286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110383332|NCT06045286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110383333|NCT06045286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110383334|NCT06045260|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
110383335|NCT06045260|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110383336|NCT06045260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110383337|NCT06045247|Prednisone|prednisone|mesh-list
110383338|NCT06045247|Cyclophosphamide|cyclophosphamide|mesh-list
110383339|NCT06045247|Rituximab|rituximab|mesh-list
110383340|NCT06045247|Vincristine|vincristine|mesh-list
110383341|NCT06045247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110383342|NCT06045247|Immunologic Factors|immunologic factors|mesh-ancestor
110383343|NCT06045247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110383344|NCT06045247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110383345|NCT06045247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110383346|NCT06045247|Alkylating Agents|alkylating agents|mesh-ancestor
110383347|NCT06045247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110383348|NCT06045247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110383349|NCT06045247|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110383350|NCT06045247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110383351|NCT06045247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110383352|NCT06045247|Glucocorticoids|glucocorticoids|mesh-ancestor
110383353|NCT06045247|Hormones|hormones|mesh-ancestor
110383354|NCT06045247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110383355|NCT06045247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110383356|NCT06045247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110383357|NCT06045247|Tubulin Modulators|tubulin modulators|mesh-ancestor
110383358|NCT06045247|Antimitotic Agents|antimitotic agents|mesh-ancestor
110383359|NCT06045247|Mitosis Modulators|mitosis modulators|mesh-ancestor
110383360|NCT06045195|Pembrolizumab|pembrolizumab|mesh-list
110383361|NCT06045195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110383362|NCT06045195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110383363|NCT06045195|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110383364|NCT06045195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110383365|NCT06045156|Tirofiban|tirofiban|mesh-list
110383366|NCT06045156|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110383367|NCT06045156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110383368|NCT06045156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110383369|NCT06045156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110383370|NCT06045104|Micronutrients|micronutrients|mesh-list
110383371|NCT06045104|Trace Elements|trace elements|mesh-list
110383372|NCT06045104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110383373|NCT06045026|Fluorides|fluorides|mesh-list
110383374|NCT06045026|Tin Fluorides|tin fluorides|mesh-list
110383375|NCT06045026|Cariostatic Agents|cariostatic agents|mesh-ancestor
110383376|NCT06045026|Protective Agents|protective agents|mesh-ancestor
110383377|NCT06045026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110383379|NCT06045013|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110383380|NCT06045013|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110383381|NCT06045013|Prednisolone|prednisolone|mesh-list
110383382|NCT06045013|Prednisolone acetate|prednisolone acetate|mesh-list
110383383|NCT06045013|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110383384|NCT06045013|Prednisolone phosphate|prednisolone phosphate|mesh-list
110383385|NCT06045013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110383386|NCT06045013|Antiemetics|antiemetics|mesh-ancestor
110383387|NCT06045013|Autonomic Agents|autonomic agents|mesh-ancestor
110383388|NCT06045013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110383389|NCT06045013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110383390|NCT06045013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110383391|NCT06045013|Glucocorticoids|glucocorticoids|mesh-ancestor
110383393|NCT06045013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110383394|NCT06045013|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110383395|NCT06045013|Protective Agents|protective agents|mesh-ancestor
110383396|NCT06045013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110383397|NCT06045013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110383398|NCT06044974|Mitogens|mitogens|mesh-list
110383399|NCT06044974|Mitosis Modulators|mitosis modulators|mesh-ancestor
110383400|NCT06044974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110383401|NCT06044883|Botulinum Toxins|botulinum toxins|mesh-list
110383402|NCT06044883|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110383403|NCT06044883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110383404|NCT06044883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110383405|NCT06044883|Cholinergic Agents|cholinergic agents|mesh-ancestor
110383406|NCT06044883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110383407|NCT06044883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110383408|NCT06044857|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110383409|NCT06044857|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110383410|NCT06044857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110383411|NCT06044844|Tofacitinib|tofacitinib|mesh-list
110383412|NCT06044844|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110383413|NCT06044844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110383414|NCT06044844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110383415|NCT06044844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110383416|NCT06044740|Sevoflurane|sevoflurane|mesh-list
110383417|NCT06044740|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110383418|NCT06044740|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110383419|NCT06044740|Anesthetics, General|anesthetics, general|mesh-ancestor
110383420|NCT06044740|Anesthetics|anesthetics|mesh-ancestor
110383421|NCT06044740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110383422|NCT06044740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110383423|NCT06044675|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
110383424|NCT06044675|Hallucinogens|hallucinogens|mesh-ancestor
110383425|NCT06044675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110383426|NCT06044675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110383427|NCT06044675|Serotonin Agents|serotonin agents|mesh-ancestor
110383428|NCT06044675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110383487|NCT06044480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110383488|NCT06044480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110383489|NCT06044480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110383490|NCT06044480|Glucocorticoids|glucocorticoids|mesh-ancestor
110383492|NCT06044480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110383493|NCT06044480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110383494|NCT06044480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110383495|NCT06044467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110383496|NCT06044467|Streptococcal polysaccharide type III group B|streptococcal polysaccharide type iii group b|mesh-list
110383497|NCT06044467|Antibodies|antibodies|mesh-list
110383498|NCT06044467|Immunoglobulins|immunoglobulins|mesh-list
110383499|NCT06044467|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110383500|NCT06044467|Immunologic Factors|immunologic factors|mesh-ancestor
110383501|NCT06044467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110383514|NCT06044142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110383515|NCT06044142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110383516|NCT06044142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110383517|NCT06044142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110383518|NCT06044142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110383519|NCT06044142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110383520|NCT06044142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110383521|NCT06044090|Minocycline|minocycline|mesh-list
110383522|NCT06044090|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110383523|NCT06044090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110383524|NCT06044077|Vaccines|vaccines|mesh-list
110383525|NCT06044077|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110383526|NCT06044077|Immunologic Factors|immunologic factors|mesh-ancestor
110383527|NCT06044077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110383528|NCT06044025|Metformin|metformin|mesh-list
110383529|NCT06044025|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110383530|NCT06044025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110383531|NCT06043908|Cyclosporine|cyclosporine|mesh-list
110383532|NCT06043908|Lubricant Eye Drops|lubricant eye drops|mesh-list
110383533|NCT06043908|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110383534|NCT06043908|Cyclosporins|cyclosporins|mesh-list
110383535|NCT06043908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110383536|NCT06043908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110383537|NCT06043908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110383538|NCT06043908|Immunologic Factors|immunologic factors|mesh-ancestor
110383539|NCT06043908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110383540|NCT06043908|Antifungal Agents|antifungal agents|mesh-ancestor
110383541|NCT06043908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110383543|NCT06043908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110383544|NCT06043908|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110383545|NCT06043908|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110383546|NCT06043830|Acetazolamide|acetazolamide|mesh-list
110383547|NCT06043830|Anticonvulsants|anticonvulsants|mesh-ancestor
110383548|NCT06043830|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110383549|NCT06043830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110383550|NCT06043830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110383551|NCT06043830|Diuretics|diuretics|mesh-ancestor
110383552|NCT06043830|Natriuretic Agents|natriuretic agents|mesh-ancestor
110383553|NCT06043830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110383567|NCT06043674|Obinutuzumab|obinutuzumab|mesh-list
110383568|NCT06043674|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
110383569|NCT06043674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110383570|NCT06043674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110383571|NCT06043674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110383572|NCT06043674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110383573|NCT06043674|Immunoconjugates|immunoconjugates|mesh-ancestor
110383574|NCT06043674|Immunologic Factors|immunologic factors|mesh-ancestor
110383575|NCT06043674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110383576|NCT06043544|Hyaluronic Acid|hyaluronic acid|mesh-list
110383577|NCT06043544|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110383578|NCT06043544|Immunologic Factors|immunologic factors|mesh-ancestor
110383579|NCT06043544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110383580|NCT06043544|Viscosupplements|viscosupplements|mesh-ancestor
110383581|NCT06043544|Protective Agents|protective agents|mesh-ancestor
110383582|NCT06043427|Paclitaxel|paclitaxel|mesh-list
110383583|NCT06043427|Ramucirumab|ramucirumab|mesh-list
110260197|NCT00168948|Pyrimethamine|pyrimethamine|mesh-list
110383584|NCT06043427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110383585|NCT06043427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110383586|NCT06043427|Tubulin Modulators|tubulin modulators|mesh-ancestor
110383587|NCT06043427|Antimitotic Agents|antimitotic agents|mesh-ancestor
110383588|NCT06043427|Mitosis Modulators|mitosis modulators|mesh-ancestor
110383589|NCT06043427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110383590|NCT06043414|Triclosan|triclosan|mesh-list
110383591|NCT06043414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110383592|NCT06043414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110383593|NCT06043414|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110383594|NCT06043414|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110383595|NCT06043414|Antimetabolites|antimetabolites|mesh-ancestor
110383596|NCT06043414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110383597|NCT06043414|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110383598|NCT06043349|Minoxidil|minoxidil|mesh-list
110383599|NCT06043349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110383600|NCT06043349|Vasodilator Agents|vasodilator agents|mesh-ancestor
110383601|NCT06043336|Dexamethasone|dexamethasone|mesh-list
110383602|NCT06043336|Palonosetron|palonosetron|mesh-list
110383604|NCT06043336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110383606|NCT06043336|Autonomic Agents|autonomic agents|mesh-ancestor
110383607|NCT06043336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110383608|NCT06043336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110383609|NCT06043336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110383610|NCT06043336|Glucocorticoids|glucocorticoids|mesh-ancestor
110383611|NCT06043336|Hormones|hormones|mesh-ancestor
110383612|NCT06043336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110383613|NCT06043336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110383614|NCT06043336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110383615|NCT06043336|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110383616|NCT06043336|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110383617|NCT06043336|Serotonin Agents|serotonin agents|mesh-ancestor
110383619|NCT06043336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110383620|NCT06043310|Nitroprusside|nitroprusside|mesh-list
110383621|NCT06043310|Acetylcholine|acetylcholine|mesh-list
110383622|NCT06043310|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110383623|NCT06043310|Vasodilator Agents|vasodilator agents|mesh-ancestor
110383624|NCT06043310|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110383625|NCT06043310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110383626|NCT06043310|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110383627|NCT06043310|Cholinergic Agents|cholinergic agents|mesh-ancestor
110383659|NCT06042985|Calcium Carbonate|calcium carbonate|mesh-list
110383661|NCT06042985|Sodium Citrate|sodium citrate|mesh-list
110383662|NCT06042985|Calcium|calcium|mesh-list
110383663|NCT06042985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110383664|NCT06042985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110383665|NCT06042985|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110383666|NCT06042985|Anticoagulants|anticoagulants|mesh-ancestor
110383667|NCT06042985|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110383668|NCT06042985|Chelating Agents|chelating agents|mesh-ancestor
110383669|NCT06042985|Sequestering Agents|sequestering agents|mesh-ancestor
110383670|NCT06042985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110383672|NCT06042985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110383673|NCT06042920|Deucravacitinib|deucravacitinib|mesh-list
110383674|NCT06042920|Dermatologic Agents|dermatologic agents|mesh-ancestor
110383675|NCT06042920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110383676|NCT06042920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110383677|NCT06042920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110383679|NCT06042855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110383680|NCT06042855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110383681|NCT06042816|Analgesics, Opioid|analgesics, opioid|mesh-list
110383682|NCT06042816|Anesthetics|anesthetics|mesh-list
110383683|NCT06042816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110383684|NCT06042816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110383685|NCT06042816|Narcotics|narcotics|mesh-ancestor
110383686|NCT06042816|Analgesics|analgesics|mesh-ancestor
110383687|NCT06042816|Sensory System Agents|sensory system agents|mesh-ancestor
110383688|NCT06042816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110383689|NCT06042257|Guanfacine|guanfacine|mesh-list
110383690|NCT06042257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110383691|NCT06042257|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110383692|NCT06042257|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110383693|NCT06042257|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110383694|NCT06042257|Adrenergic Agents|adrenergic agents|mesh-ancestor
110383695|NCT06042257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110383696|NCT06042257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110383697|NCT06042257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110383699|NCT06041932|Pentoxifylline|pentoxifylline|mesh-list
110383700|NCT06041932|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110383701|NCT06041932|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110383702|NCT06041932|Adrenergic Agents|adrenergic agents|mesh-ancestor
110383703|NCT06041932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110383704|NCT06041932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110383705|NCT06041932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110383706|NCT06041932|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110383707|NCT06041932|Antioxidants|antioxidants|mesh-ancestor
110383708|NCT06041932|Protective Agents|protective agents|mesh-ancestor
110383709|NCT06041932|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110383710|NCT06041932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110383711|NCT06041932|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110383712|NCT06041932|Vasodilator Agents|vasodilator agents|mesh-ancestor
110383713|NCT06041932|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110383714|NCT06041932|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110383715|NCT06041932|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110383716|NCT06041932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110383717|NCT06041932|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110383718|NCT06041932|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110383719|NCT06041932|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110383720|NCT06039995|Chlorhexidine|chlorhexidine|mesh-list
110383721|NCT06039995|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110383722|NCT06039995|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110383723|NCT06039995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110383724|NCT06039995|Disinfectants|disinfectants|mesh-ancestor
110383725|NCT06039995|Dermatologic Agents|dermatologic agents|mesh-ancestor
110383726|NCT06039358|Caffeine|caffeine|mesh-list
110383727|NCT06039358|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110383728|NCT06039358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110383729|NCT06039358|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110383730|NCT06039358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110383731|NCT06039358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110383732|NCT06039358|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110383733|NCT06039358|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110383734|NCT06039358|Purinergic Agents|purinergic agents|mesh-ancestor
110383735|NCT06039358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110383736|NCT06038903|Caffeine|caffeine|mesh-list
110383737|NCT06038903|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110383738|NCT06038903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110383739|NCT06038903|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110383740|NCT06038903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110383741|NCT06038903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110383742|NCT06038903|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110383743|NCT06038903|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110383744|NCT06038903|Purinergic Agents|purinergic agents|mesh-ancestor
110383745|NCT06038903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110383746|NCT06038682|Heparin|heparin|mesh-list
110383747|NCT06038682|Argatroban|argatroban|mesh-list
110383748|NCT06038682|Anticoagulants|anticoagulants|mesh-ancestor
110383749|NCT06038682|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110383750|NCT06038682|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110383751|NCT06038682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110383752|NCT06038682|Antithrombins|antithrombins|mesh-ancestor
110038049|NCT01422460|Mitogens|mitogens|mesh-list
110383753|NCT06038682|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110383754|NCT06038682|Protease Inhibitors|protease inhibitors|mesh-ancestor
110383755|NCT06038682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110383756|NCT06038682|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110383757|NCT06037993|Palmidrol|palmidrol|mesh-list
110383758|NCT06037993|Analgesics|analgesics|mesh-ancestor
110383759|NCT06037993|Sensory System Agents|sensory system agents|mesh-ancestor
110383760|NCT06037993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110383761|NCT06037993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110383762|NCT06037993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110383763|NCT06037993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110383764|NCT06037993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110383765|NCT06037993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110383766|NCT06037993|Antiviral Agents|antiviral agents|mesh-ancestor
110383767|NCT06037993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110383768|NCT06037993|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110383769|NCT06037993|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110383770|NCT06037993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110383771|NCT06037993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110383772|NCT06037993|Hormones|hormones|mesh-ancestor
110383773|NCT06037993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110383774|NCT06037980|Paclitaxel|paclitaxel|mesh-list
110383775|NCT06037980|Gemcitabine|gemcitabine|mesh-list
110383776|NCT06037980|Capecitabine|capecitabine|mesh-list
110383777|NCT06037980|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110383778|NCT06037980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110383780|NCT06037980|Antimitotic Agents|antimitotic agents|mesh-ancestor
110383781|NCT06037980|Mitosis Modulators|mitosis modulators|mesh-ancestor
110383782|NCT06037980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110383783|NCT06037980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110383784|NCT06037980|Antimetabolites|antimetabolites|mesh-ancestor
110383785|NCT06037889|Aspirin|aspirin|mesh-list
110383786|NCT06037889|Tirofiban|tirofiban|mesh-list
110383787|NCT06037889|Clopidogrel|clopidogrel|mesh-list
110383788|NCT06037889|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110383789|NCT06037889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110383790|NCT06037889|Analgesics|analgesics|mesh-ancestor
110383791|NCT06037889|Sensory System Agents|sensory system agents|mesh-ancestor
110383792|NCT06037889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110383793|NCT06037889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110383794|NCT06037889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110383795|NCT06037889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110383796|NCT06037889|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110383797|NCT06037889|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110383798|NCT06037889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110383799|NCT06037889|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110383800|NCT06037889|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110383801|NCT06037889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110383802|NCT06037889|Antipyretics|antipyretics|mesh-ancestor
110383803|NCT06037889|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110383804|NCT06037889|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110383805|NCT06037889|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110383806|NCT06037889|Purinergic Agents|purinergic agents|mesh-ancestor
110383807|NCT06037889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110383808|NCT06034873|Fentanyl|fentanyl|mesh-list
110383809|NCT06034873|Bupivacaine|bupivacaine|mesh-list
110383810|NCT06034873|Propofol|propofol|mesh-list
110383811|NCT06034873|Anesthetics, Local|anesthetics, local|mesh-ancestor
110383812|NCT06034873|Anesthetics|anesthetics|mesh-ancestor
110383813|NCT06034873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110383814|NCT06034873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110383815|NCT06034873|Sensory System Agents|sensory system agents|mesh-ancestor
110383816|NCT06034873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110383817|NCT06034873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110383818|NCT06034873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110383819|NCT06034873|Anesthetics, General|anesthetics, general|mesh-ancestor
110383820|NCT06034873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110383821|NCT06034873|Narcotics|narcotics|mesh-ancestor
110383822|NCT06034873|Analgesics|analgesics|mesh-ancestor
110383823|NCT06034873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110383824|NCT06034379|Atropine|atropine|mesh-list
110383825|NCT06034379|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110383826|NCT06034379|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110383827|NCT06034379|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110383828|NCT06034379|Autonomic Agents|autonomic agents|mesh-ancestor
110383829|NCT06034379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110383830|NCT06034379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110383831|NCT06034379|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110383832|NCT06034379|Respiratory System Agents|respiratory system agents|mesh-ancestor
110383833|NCT06034379|Mydriatics|mydriatics|mesh-ancestor
110383834|NCT06034379|Parasympatholytics|parasympatholytics|mesh-ancestor
110383835|NCT06034379|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110383836|NCT06034379|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110383837|NCT06034379|Cholinergic Agents|cholinergic agents|mesh-ancestor
110383838|NCT06034379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110383839|NCT06034379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110383840|NCT06034158|Propranolol|propranolol|mesh-list
110383841|NCT06034158|Benserazide|benserazide|mesh-list
110383842|NCT06034158|Levodopa|levodopa|mesh-list
110383843|NCT06034158|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
110383844|NCT06034158|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110383845|NCT06034158|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110383846|NCT06034158|Adrenergic Agents|adrenergic agents|mesh-ancestor
110383847|NCT06034158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110383848|NCT06034158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110383849|NCT06034158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110383850|NCT06034158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110383851|NCT06034158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110383852|NCT06034158|Vasodilator Agents|vasodilator agents|mesh-ancestor
110383853|NCT06034158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110383854|NCT06034158|Dopamine Agents|dopamine agents|mesh-ancestor
110383855|NCT06034158|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110383856|NCT06034158|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110383857|NCT06018688|Aspirin|aspirin|mesh-list
110383858|NCT06018688|Osimertinib|osimertinib|mesh-list
110383859|NCT06018688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110383860|NCT06018688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110383861|NCT06018688|Analgesics|analgesics|mesh-ancestor
110383862|NCT06018688|Sensory System Agents|sensory system agents|mesh-ancestor
110383863|NCT06018688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110383864|NCT06018688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110383865|NCT06018688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110383866|NCT06018688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110383867|NCT06018688|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110383868|NCT06018688|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110383869|NCT06018688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110383870|NCT06018688|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110383871|NCT06018688|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110383872|NCT06018688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110383874|NCT06018688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110383875|NCT06018688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110383876|NCT06010810|Tranexamic Acid|tranexamic acid|mesh-list
110383877|NCT06010810|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110383878|NCT06010810|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110383879|NCT06010810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110383881|NCT06010810|Coagulants|coagulants|mesh-ancestor
110383882|NCT06009653|Tirzepatide|tirzepatide|mesh-list
110383883|NCT06009653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110383884|NCT06009653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110383885|NCT06009653|Incretins|incretins|mesh-ancestor
110383886|NCT06009653|Hormones|hormones|mesh-ancestor
110383887|NCT06009653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110383888|NCT06009107|Cyclophosphamide|cyclophosphamide|mesh-list
110383889|NCT06009107|Fludarabine|fludarabine|mesh-list
110383890|NCT06009107|Fludarabine phosphate|fludarabine phosphate|mesh-list
110383891|NCT06009107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110383892|NCT06009107|Immunologic Factors|immunologic factors|mesh-ancestor
110383893|NCT06009107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110383894|NCT06009107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110383895|NCT06009107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110383896|NCT06009107|Alkylating Agents|alkylating agents|mesh-ancestor
110383897|NCT06009107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110383898|NCT06009107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110383899|NCT06009107|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110383900|NCT06009107|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110383901|NCT06009107|Antimetabolites|antimetabolites|mesh-ancestor
110383902|NCT06007846|Memantine|memantine|mesh-list
110038211|NCT01423292|Bupivacaine|bupivacaine|mesh-list
110383903|NCT06007846|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110383904|NCT06007846|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110383905|NCT06007846|Dopamine Agents|dopamine agents|mesh-ancestor
110383906|NCT06007846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110383965|NCT05976464|Sensory System Agents|sensory system agents|mesh-ancestor
110383966|NCT05976464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110383967|NCT05976464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110383968|NCT05976464|Anesthetics|anesthetics|mesh-ancestor
110383969|NCT05976464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110383971|NCT05976464|Anticonvulsants|anticonvulsants|mesh-ancestor
110383972|NCT05976464|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110383973|NCT05976464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110383974|NCT05976464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110260198|NCT00168948|Antimalarials|antimalarials|mesh-ancestor
110383975|NCT05976464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110383976|NCT05976464|Tocolytic Agents|tocolytic agents|mesh-ancestor
110383977|NCT05976464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110383978|NCT05976243|Remibrutinib|remibrutinib|mesh-list
110383979|NCT05976243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110383980|NCT05976243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110383981|NCT05976243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110383982|NCT05976230|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110383983|NCT05976230|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110383984|NCT05976230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110383985|NCT05975684|Baclofen|baclofen|mesh-list
110383986|NCT05975684|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110383987|NCT05975684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110383988|NCT05975684|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110383989|NCT05975684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110383990|NCT05975684|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110383991|NCT05975684|GABA Agonists|gaba agonists|mesh-ancestor
110383992|NCT05975684|GABA Agents|gaba agents|mesh-ancestor
110383993|NCT05975684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110383994|NCT05975684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110383995|NCT05970289|Interferons|interferons|mesh-list
110383996|NCT05970289|Interferon-alpha|interferon-alpha|mesh-list
110383997|NCT05970289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110383998|NCT05970289|Antiviral Agents|antiviral agents|mesh-ancestor
110383999|NCT05970289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110384000|NCT05970289|Immunologic Factors|immunologic factors|mesh-ancestor
110384001|NCT05970289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110384002|NCT05969431|Hydrocortisone|hydrocortisone|mesh-list
110384003|NCT05969431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110384004|NCT05968599|Abiraterone Acetate|abiraterone acetate|mesh-list
110384005|NCT05968599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110384006|NCT05968599|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110384007|NCT05968599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110384008|NCT05968599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110384009|NCT05968599|Hormone Antagonists|hormone antagonists|mesh-ancestor
110384010|NCT05968599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110384011|NCT05968599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110384012|NCT05968599|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110384013|NCT05966376|Hemostatics|hemostatics|mesh-list
110384014|NCT05966376|Coagulants|coagulants|mesh-ancestor
110384015|NCT05964452|Methimazole|methimazole|mesh-list
110384016|NCT05964452|Antithyroid Agents|antithyroid agents|mesh-ancestor
110384017|NCT05964452|Hormone Antagonists|hormone antagonists|mesh-ancestor
110384018|NCT05964452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110384019|NCT05964452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110384020|NCT05957081|Pembrolizumab|pembrolizumab|mesh-list
110384021|NCT05957081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110384022|NCT05957081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110384023|NCT05957081|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110384024|NCT05957081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110384025|NCT05956041|Pembrolizumab|pembrolizumab|mesh-list
110384026|NCT05956041|Mogamulizumab|mogamulizumab|mesh-list
110384027|NCT05956041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110384028|NCT05956041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110384029|NCT05956041|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110384030|NCT05956041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110384031|NCT05954143|Pertuzumab|pertuzumab|mesh-list
110384032|NCT05954143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110384033|NCT05954143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110384034|NCT05948462|Cisplatin|cisplatin|mesh-list
110384035|NCT05948462|Carboplatin|carboplatin|mesh-list
110384036|NCT05948462|Pemetrexed|pemetrexed|mesh-list
110384037|NCT05948462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110384038|NCT05948462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110384039|NCT05948462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110384040|NCT05948462|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110384041|NCT05948462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110384042|NCT05945615|Phenylephrine|phenylephrine|mesh-list
110384043|NCT05945615|Oxymetazoline|oxymetazoline|mesh-list
110384044|NCT05945615|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110384045|NCT05945615|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110384046|NCT05945615|Adrenergic Agents|adrenergic agents|mesh-ancestor
110035385|NCT01404715|Metformin|metformin|mesh-list
110384047|NCT05945615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110384048|NCT05945615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110384049|NCT05945615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110384050|NCT05945615|Sympathomimetics|sympathomimetics|mesh-ancestor
110384051|NCT05945615|Autonomic Agents|autonomic agents|mesh-ancestor
110384052|NCT05945615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110384053|NCT05945615|Nasal Decongestants|nasal decongestants|mesh-ancestor
110384054|NCT05945615|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110384055|NCT05945615|Respiratory System Agents|respiratory system agents|mesh-ancestor
110384056|NCT05945615|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110384057|NCT05945615|Mydriatics|mydriatics|mesh-ancestor
110384058|NCT05945615|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110384059|NCT05945615|Protective Agents|protective agents|mesh-ancestor
110384060|NCT05944510|Dextromethorphan|dextromethorphan|mesh-list
110384061|NCT05944510|Antitussive Agents|antitussive agents|mesh-ancestor
110384062|NCT05944510|Respiratory System Agents|respiratory system agents|mesh-ancestor
110384063|NCT05944510|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110384064|NCT05944510|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110384065|NCT05944510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110384066|NCT05944510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110384067|NCT05944510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110384068|NCT05943535|Treprostinil|treprostinil|mesh-list
110384069|NCT05943535|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110384070|NCT05939414|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
110384071|NCT05939414|Chelating Agents|chelating agents|mesh-ancestor
110384072|NCT05939414|Sequestering Agents|sequestering agents|mesh-ancestor
110384073|NCT05939414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110384074|NCT05938907|Mitogens|mitogens|mesh-list
110384075|NCT05938907|Mitosis Modulators|mitosis modulators|mesh-ancestor
110384076|NCT05938907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110384078|NCT05935306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110384079|NCT05935306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110384080|NCT05935306|Analgesics|analgesics|mesh-ancestor
110384081|NCT05935306|Sensory System Agents|sensory system agents|mesh-ancestor
110384082|NCT05935306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110384083|NCT05935306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110384084|NCT05935306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110384085|NCT05935306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110384086|NCT05935306|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110384087|NCT05935306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110384088|NCT05935306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110384089|NCT05935098|Tislelizumab|tislelizumab|mesh-list
110384090|NCT05935098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110384091|NCT05935098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110384092|NCT05934253|Chloroprocaine|chloroprocaine|mesh-list
110384093|NCT05934253|Anesthetics, Local|anesthetics, local|mesh-ancestor
110384094|NCT05934253|Anesthetics|anesthetics|mesh-ancestor
110384095|NCT05934253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110384098|NCT05934253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110384100|NCT05927649|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110384101|NCT05927649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110384102|NCT05927649|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110384104|NCT05927649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110384105|NCT05927649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110384106|NCT05927649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110384107|NCT05925478|Bupivacaine|bupivacaine|mesh-list
110384108|NCT05925478|Anesthetics, Local|anesthetics, local|mesh-ancestor
110384109|NCT05925478|Anesthetics|anesthetics|mesh-ancestor
110384110|NCT05925478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110384111|NCT05925478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110384112|NCT05925478|Sensory System Agents|sensory system agents|mesh-ancestor
110384113|NCT05925478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110384114|NCT05924815|Moxifloxacin|moxifloxacin|mesh-list
110384115|NCT05924815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110384116|NCT05924815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110384117|NCT05924815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110384118|NCT05924815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110384119|NCT05924815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110384120|NCT05924815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110384121|NCT05924815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110384123|NCT05918822|Rabeprazole|rabeprazole|mesh-list
110384124|NCT05918822|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110038423|NCT01424332|Antipyretics|antipyretics|mesh-ancestor
110384125|NCT05918822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110384126|NCT05918822|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110384127|NCT05918822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110384128|NCT05918822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110384129|NCT05918822|Antiviral Agents|antiviral agents|mesh-ancestor
110384130|NCT05918822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110384135|NCT05909644|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110384136|NCT05909644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110384137|NCT05909644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110384138|NCT05909644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110384139|NCT05909644|Antiviral Agents|antiviral agents|mesh-ancestor
110384140|NCT05909644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110384141|NCT05909644|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110384142|NCT05909644|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110384143|NCT05909644|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110384144|NCT05909644|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110384145|NCT05909644|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110384146|NCT05909644|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110384147|NCT05895838|Dexamethasone|dexamethasone|mesh-list
110384148|NCT05895838|Olanzapine|olanzapine|mesh-list
110384149|NCT05895838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110384150|NCT05895838|Antiemetics|antiemetics|mesh-ancestor
110384151|NCT05895838|Autonomic Agents|autonomic agents|mesh-ancestor
110384152|NCT05895838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110384153|NCT05895838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110384154|NCT05895838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110384155|NCT05895838|Glucocorticoids|glucocorticoids|mesh-ancestor
110384156|NCT05895838|Hormones|hormones|mesh-ancestor
110384157|NCT05895838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110384158|NCT05895838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110384159|NCT05895838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110384160|NCT05895838|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110384161|NCT05895838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110384162|NCT05895838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110384163|NCT05895838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110384164|NCT05895838|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110384165|NCT05895838|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110384166|NCT05895838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110384167|NCT05895838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110384168|NCT05895838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110384169|NCT05895838|Serotonin Agents|serotonin agents|mesh-ancestor
110384170|NCT05891613|Bupivacaine|bupivacaine|mesh-list
110384171|NCT05891613|Anesthetics, Local|anesthetics, local|mesh-ancestor
110384172|NCT05891613|Anesthetics|anesthetics|mesh-ancestor
110384173|NCT05891613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110384174|NCT05891613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110384175|NCT05891613|Sensory System Agents|sensory system agents|mesh-ancestor
110384176|NCT05891613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110384177|NCT05891249|Luspatercept|luspatercept|mesh-list
110384178|NCT05891249|Hematinics|hematinics|mesh-ancestor
110384179|NCT05888896|Antihypertensive Agents|antihypertensive agents|mesh-list
110384180|NCT05888896|Methyldopa|methyldopa|mesh-list
110384181|NCT05888896|Sympatholytics|sympatholytics|mesh-ancestor
110384182|NCT05888896|Autonomic Agents|autonomic agents|mesh-ancestor
110384183|NCT05888896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110384184|NCT05888896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110384185|NCT05888896|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110384186|NCT05888896|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110384187|NCT05888896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110384188|NCT05888896|Adrenergic Agents|adrenergic agents|mesh-ancestor
110384189|NCT05888896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110384190|NCT05888896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110384191|NCT05886582|Rotigotine|rotigotine|mesh-list
110384192|NCT05886582|Dopamine Agonists|dopamine agonists|mesh-ancestor
110384193|NCT05886582|Dopamine Agents|dopamine agents|mesh-ancestor
110384194|NCT05886582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110384195|NCT05886582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110384196|NCT05886582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110384197|NCT05885932|Aspirin|aspirin|mesh-list
110384198|NCT05885932|Sirolimus|sirolimus|mesh-list
110384199|NCT05885932|Clopidogrel|clopidogrel|mesh-list
110384200|NCT05885932|Ticagrelor|ticagrelor|mesh-list
110384201|NCT05885932|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110260199|NCT00168948|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110384202|NCT05885932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110384203|NCT05885932|Analgesics|analgesics|mesh-ancestor
110384204|NCT05885932|Sensory System Agents|sensory system agents|mesh-ancestor
110384205|NCT05885932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110384206|NCT05885932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110384207|NCT05885932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110384208|NCT05885932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110384209|NCT05885932|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110384210|NCT05885932|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110384211|NCT05885932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110384212|NCT05885932|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110384213|NCT05885932|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110384214|NCT05885932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110384216|NCT05885932|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110384217|NCT05885932|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110384218|NCT05885932|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110384219|NCT05885932|Purinergic Agents|purinergic agents|mesh-ancestor
110384220|NCT05885932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110384221|NCT05885932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110384222|NCT05885932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110384223|NCT05885932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110384224|NCT05885932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110384225|NCT05885932|Antifungal Agents|antifungal agents|mesh-ancestor
110384226|NCT05885932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110384227|NCT05885932|Immunologic Factors|immunologic factors|mesh-ancestor
110384228|NCT05884671|Sulpiride|sulpiride|mesh-list
110384229|NCT05884671|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110384230|NCT05884671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110384231|NCT05884671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110384232|NCT05884671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110384233|NCT05884671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110384234|NCT05884671|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110384235|NCT05884671|Dopamine Agents|dopamine agents|mesh-ancestor
110384236|NCT05884671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110384237|NCT05884671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110384238|NCT05884671|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110384239|NCT05884671|Antidepressive Agents|antidepressive agents|mesh-ancestor
110384240|NCT05882214|Niacinamide|niacinamide|mesh-list
110384242|NCT05882214|Nicotinic Acids|nicotinic acids|mesh-list
110384243|NCT05882214|Vitamin B Complex|vitamin b complex|mesh-ancestor
110384244|NCT05882214|Vitamins|vitamins|mesh-ancestor
110384245|NCT05882214|Micronutrients|micronutrients|mesh-ancestor
110384246|NCT05882214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110384247|NCT05882214|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110384248|NCT05882214|Antimetabolites|antimetabolites|mesh-ancestor
110384249|NCT05882214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110384250|NCT05882214|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110384251|NCT05882214|Vasodilator Agents|vasodilator agents|mesh-ancestor
110384252|NCT05879926|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110384253|NCT05879926|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110384254|NCT05879926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110384255|NCT05879926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110384256|NCT05879926|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110384257|NCT05879926|Hormone Antagonists|hormone antagonists|mesh-ancestor
110384258|NCT05879926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110384259|NCT05879926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110384260|NCT05875441|Moxidectin|moxidectin|mesh-list
110384261|NCT05875441|Anthelmintics|anthelmintics|mesh-ancestor
110384262|NCT05875441|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110384263|NCT05875441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110384264|NCT05875441|Antinematodal Agents|antinematodal agents|mesh-ancestor
110384265|NCT05852691|Paclitaxel|paclitaxel|mesh-list
110384266|NCT05852691|Pembrolizumab|pembrolizumab|mesh-list
110384267|NCT05852691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110384268|NCT05852691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110384269|NCT05852691|Tubulin Modulators|tubulin modulators|mesh-ancestor
110384270|NCT05852691|Antimitotic Agents|antimitotic agents|mesh-ancestor
110384271|NCT05852691|Mitosis Modulators|mitosis modulators|mesh-ancestor
110384272|NCT05852691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110384273|NCT05852691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110384274|NCT05852691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110384275|NCT05851976|Naproxen|naproxen|mesh-list
110384276|NCT05851976|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110045896|NCT05954871|Osimertinib|osimertinib|mesh-list
110384277|NCT05851976|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110384278|NCT05851976|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110384279|NCT05851976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110384280|NCT05851976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110384281|NCT05851976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110384282|NCT05851976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110384283|NCT05851976|Analgesics|analgesics|mesh-ancestor
110384284|NCT05851976|Sensory System Agents|sensory system agents|mesh-ancestor
110384285|NCT05851976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110384286|NCT05851976|Antidepressive Agents|antidepressive agents|mesh-ancestor
110384287|NCT05851976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110384288|NCT05851976|Dopamine Agents|dopamine agents|mesh-ancestor
110384289|NCT05851976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110384290|NCT05851976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110384291|NCT05851976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110384292|NCT05851976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110384293|NCT05851976|Gout Suppressants|gout suppressants|mesh-ancestor
110384294|NCT05851976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110384295|NCT05851976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110384296|NCT05851781|Acetaminophen|acetaminophen|mesh-list
110384297|NCT05851781|Lacosamide|lacosamide|mesh-list
110384298|NCT05851781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110384299|NCT05851781|Analgesics|analgesics|mesh-ancestor
110384300|NCT05851781|Sensory System Agents|sensory system agents|mesh-ancestor
110384301|NCT05851781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110384302|NCT05851781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110384303|NCT05851781|Antipyretics|antipyretics|mesh-ancestor
110384304|NCT05851781|Anticonvulsants|anticonvulsants|mesh-ancestor
110384305|NCT05851781|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110384306|NCT05851781|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110384307|NCT05851781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110384308|NCT05851781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110384309|NCT05846568|Immunoglobulins|immunoglobulins|mesh-list
110384310|NCT05846568|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110384311|NCT05846568|Antibodies|antibodies|mesh-list
110384313|NCT05846568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110384314|NCT05845450|Trastuzumab|trastuzumab|mesh-list
110384315|NCT05845450|Durvalumab|durvalumab|mesh-list
110384316|NCT05845450|Panitumumab|panitumumab|mesh-list
110384317|NCT05845450|Sotorasib|sotorasib|mesh-list
110384318|NCT05845450|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
110384319|NCT05845450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110384320|NCT05845450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110384321|NCT05845450|Immunoconjugates|immunoconjugates|mesh-ancestor
110384322|NCT05845450|Immunologic Factors|immunologic factors|mesh-ancestor
110384323|NCT05845450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110384324|NCT05845450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110384325|NCT05845450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110384326|NCT05842213|Golimumab|golimumab|mesh-list
110384327|NCT05842213|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110384328|NCT05842213|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110384329|NCT05842213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110384330|NCT05842213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110384331|NCT05842213|Immunologic Factors|immunologic factors|mesh-ancestor
110384332|NCT05842213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110384333|NCT05837013|Anesthetics|anesthetics|mesh-list
110384334|NCT05837013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110384335|NCT05837013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110384336|NCT05811377|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
110384337|NCT05811377|Hematinics|hematinics|mesh-ancestor
110384338|NCT05811377|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110384339|NCT05811377|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110384340|NCT05807126|Olaparib|olaparib|mesh-list
110384341|NCT05807126|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
110384342|NCT05807126|Magrolimab|magrolimab|mesh-list
110384343|NCT05807126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110384344|NCT05807126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110384345|NCT05807126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110384346|NCT05807126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110384348|NCT05802225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110384349|NCT05802225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110384350|NCT05801835|Cytarabine|cytarabine|mesh-list
110384351|NCT05801835|Daunorubicin|daunorubicin|mesh-list
110384352|NCT05801835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110384353|NCT05801835|Antimetabolites|antimetabolites|mesh-ancestor
110384354|NCT05801835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110384355|NCT05801835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110384356|NCT05801835|Antiviral Agents|antiviral agents|mesh-ancestor
110384357|NCT05801835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110384358|NCT05801835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110384359|NCT05801835|Immunologic Factors|immunologic factors|mesh-ancestor
110384360|NCT05801835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110384361|NCT05801835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110384362|NCT05801835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110384363|NCT05801835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110384364|NCT05801835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110384366|NCT05799079|Venetoclax|venetoclax|mesh-list
110384367|NCT05799079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110384368|NCT05799079|Antimetabolites|antimetabolites|mesh-ancestor
110384369|NCT05799079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110384370|NCT05799079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110384371|NCT05799079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110384372|NCT05790681|Insulin|insulin|mesh-list
110384373|NCT05790681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110384374|NCT05790681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110384375|NCT05788458|Bupivacaine|bupivacaine|mesh-list
110384376|NCT05788458|Anesthetics, Local|anesthetics, local|mesh-ancestor
110384377|NCT05788458|Anesthetics|anesthetics|mesh-ancestor
110384378|NCT05788458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110384379|NCT05788458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110384380|NCT05788458|Sensory System Agents|sensory system agents|mesh-ancestor
110384381|NCT05788458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110384382|NCT05784363|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
110384383|NCT05784363|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110384384|NCT05784363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110384385|NCT05784363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110384386|NCT05784363|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110384387|NCT05784363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110384388|NCT05784363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110384389|NCT05784363|Cholinergic Agents|cholinergic agents|mesh-ancestor
110384390|NCT05784363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110384391|NCT05784012|Niraparib|niraparib|mesh-list
110384392|NCT05784012|Dostarlimab|dostarlimab|mesh-list
110384393|NCT05784012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110384394|NCT05784012|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110384395|NCT05784012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110384396|NCT05784012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110384397|NCT05782907|Upadacitinib|upadacitinib|mesh-list
110384398|NCT05782907|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110384399|NCT05782907|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110384400|NCT05782907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110384401|NCT05782907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110384402|NCT05782907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110384403|NCT05780216|Harmine|harmine|mesh-list
110384404|NCT05780216|Hallucinogens|hallucinogens|mesh-ancestor
110384405|NCT05780216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110384406|NCT05780216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110384407|NCT05780216|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110384408|NCT05780216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110384409|NCT05780216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110046058|NCT05774639|Omalizumab|omalizumab|mesh-list
110384410|NCT05776862|Ursolic acid|ursolic acid|mesh-list
110384411|NCT05776862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110384412|NCT05776862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110384413|NCT05776862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110384414|NCT05776862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110384415|NCT05776862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110384416|NCT05776862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110384417|NCT05776862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110384418|NCT05776862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110384419|NCT05776862|Analgesics|analgesics|mesh-ancestor
110384420|NCT05776862|Sensory System Agents|sensory system agents|mesh-ancestor
110384421|NCT05776862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110384422|NCT05776862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110384423|NCT05776862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110384424|NCT05776862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110384425|NCT05773066|Lidocaine|lidocaine|mesh-list
110384426|NCT05773066|Anesthetics, Local|anesthetics, local|mesh-ancestor
110384427|NCT05773066|Anesthetics|anesthetics|mesh-ancestor
110384428|NCT05773066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110384429|NCT05773066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110384430|NCT05773066|Sensory System Agents|sensory system agents|mesh-ancestor
110384431|NCT05773066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110384432|NCT05773066|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110384433|NCT05773066|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110384434|NCT05773066|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110384435|NCT05773066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110384436|NCT05773066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110384437|NCT05773053|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
110384438|NCT05773053|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110384439|NCT05773053|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110384440|NCT05773053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110384441|NCT05773053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110384442|NCT05773053|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110384443|NCT05773053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110384444|NCT05773053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110384445|NCT05773053|Cholinergic Agents|cholinergic agents|mesh-ancestor
110384446|NCT05773053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110384447|NCT05768854|Diphosphonates|diphosphonates|mesh-list
110384448|NCT05768854|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110384449|NCT05768854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110384450|NCT05766631|Methadone|methadone|mesh-list
110384451|NCT05766631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110384452|NCT05766631|Narcotics|narcotics|mesh-ancestor
110384453|NCT05766631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110384454|NCT05766631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110384455|NCT05766631|Analgesics|analgesics|mesh-ancestor
110384456|NCT05766631|Sensory System Agents|sensory system agents|mesh-ancestor
110384457|NCT05766631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110384458|NCT05766631|Antitussive Agents|antitussive agents|mesh-ancestor
110384459|NCT05766631|Respiratory System Agents|respiratory system agents|mesh-ancestor
110384460|NCT05765578|Vaccines|vaccines|mesh-list
110384461|NCT05765578|Immunologic Factors|immunologic factors|mesh-ancestor
110384462|NCT05765578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110384463|NCT05753306|Cisplatin|cisplatin|mesh-list
110384464|NCT05753306|Docetaxel|docetaxel|mesh-list
110384465|NCT05753306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110384466|NCT05753306|Tubulin Modulators|tubulin modulators|mesh-ancestor
110384467|NCT05753306|Antimitotic Agents|antimitotic agents|mesh-ancestor
110384468|NCT05753306|Mitosis Modulators|mitosis modulators|mesh-ancestor
110384469|NCT05753306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110384470|NCT05752734|Dexamethasone|dexamethasone|mesh-list
110384471|NCT05752734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110384472|NCT05752734|Antiemetics|antiemetics|mesh-ancestor
110384473|NCT05752734|Autonomic Agents|autonomic agents|mesh-ancestor
110384474|NCT05752734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110384475|NCT05752734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110384477|NCT05752734|Glucocorticoids|glucocorticoids|mesh-ancestor
110384479|NCT05752734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110384480|NCT05752734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110384481|NCT05752734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110384496|NCT05741905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110384497|NCT05741905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110384498|NCT05741905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110384499|NCT05741905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110384500|NCT05741905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110384501|NCT05741905|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110384502|NCT05741905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110384503|NCT05741164|Pembrolizumab|pembrolizumab|mesh-list
110384504|NCT05741164|Propranolol|propranolol|mesh-list
110384505|NCT05741164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110384506|NCT05741164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110384507|NCT05741164|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110384508|NCT05741164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110384509|NCT05741164|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110384510|NCT05741164|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110384511|NCT05741164|Adrenergic Agents|adrenergic agents|mesh-ancestor
110384512|NCT05741164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110384513|NCT05741164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110384514|NCT05741164|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110384515|NCT05741164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110384516|NCT05741164|Vasodilator Agents|vasodilator agents|mesh-ancestor
110384529|NCT05734105|Growth Substances|growth substances|mesh-ancestor
110384530|NCT05734105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110384531|NCT05734105|Growth Inhibitors|growth inhibitors|mesh-ancestor
110384532|NCT05734105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110384533|NCT05734105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110384534|NCT05734105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110384535|NCT05719883|Sirolimus|sirolimus|mesh-list
110384536|NCT05719883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110384537|NCT05719883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110384538|NCT05719883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110384539|NCT05719883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110384540|NCT05719883|Antifungal Agents|antifungal agents|mesh-ancestor
110384541|NCT05719883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110384542|NCT05719883|Immunologic Factors|immunologic factors|mesh-ancestor
110384543|NCT05719883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110384544|NCT05717049|Theophylline|theophylline|mesh-list
110384545|NCT05717049|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110384546|NCT05717049|Autonomic Agents|autonomic agents|mesh-ancestor
110384547|NCT05717049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110384548|NCT05717049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110384549|NCT05717049|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110384550|NCT05717049|Respiratory System Agents|respiratory system agents|mesh-ancestor
110384551|NCT05717049|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110384552|NCT05717049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110384553|NCT05717049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110384554|NCT05717049|Vasodilator Agents|vasodilator agents|mesh-ancestor
110384555|NCT05717049|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110384556|NCT05717049|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110384557|NCT05717049|Purinergic Agents|purinergic agents|mesh-ancestor
110384558|NCT05717049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110384560|NCT05698147|Methotrexate|methotrexate|mesh-list
110384561|NCT05698147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110384562|NCT05698147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110384563|NCT05698147|Immunologic Factors|immunologic factors|mesh-ancestor
110384564|NCT05698147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110384568|NCT05698147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110384569|NCT05698147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110384570|NCT05698147|Antimetabolites|antimetabolites|mesh-ancestor
110384571|NCT05698147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110384572|NCT05698147|Dermatologic Agents|dermatologic agents|mesh-ancestor
110384573|NCT05698147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110384574|NCT05698147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110384575|NCT05698147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110384576|NCT05698147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110384577|NCT05696236|Tin Fluorides|tin fluorides|mesh-list
110384578|NCT05696236|Cariostatic Agents|cariostatic agents|mesh-ancestor
110384579|NCT05696236|Protective Agents|protective agents|mesh-ancestor
110384580|NCT05696236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110384581|NCT05691491|Temozolomide|temozolomide|mesh-list
110384582|NCT05691491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110384583|NCT05691491|Alkylating Agents|alkylating agents|mesh-ancestor
110384584|NCT05691491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110384585|NCT05691491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110384586|NCT05691478|Cisplatin|cisplatin|mesh-list
110384588|NCT05691478|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110384589|NCT05691478|Methotrexate|methotrexate|mesh-list
110384590|NCT05691478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110384591|NCT05691478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110384592|NCT05691478|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110384593|NCT05691478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110384594|NCT05691478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110384595|NCT05691478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110384596|NCT05691478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110384597|NCT05691478|Abortifacient Agents|abortifacient agents|mesh-ancestor
110384598|NCT05691478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110384599|NCT05691478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110384600|NCT05691478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110384601|NCT05691478|Antimetabolites|antimetabolites|mesh-ancestor
110384602|NCT05691478|Dermatologic Agents|dermatologic agents|mesh-ancestor
110384603|NCT05691478|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110384604|NCT05691478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110384605|NCT05691478|Immunologic Factors|immunologic factors|mesh-ancestor
110384606|NCT05691478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110384607|NCT05691478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110384611|NCT05691400|Palbociclib|palbociclib|mesh-list
110384612|NCT05691400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110384658|NCT05672550|Enoxaparin|enoxaparin|mesh-list
110384659|NCT05672550|Enoxaparin sodium|enoxaparin sodium|mesh-list
110384660|NCT05672550|Anticoagulants|anticoagulants|mesh-ancestor
110384661|NCT05672550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110384662|NCT05672550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110384663|NCT05672550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110384664|NCT05672407|Tranexamic Acid|tranexamic acid|mesh-list
110384665|NCT05672407|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110384666|NCT05672407|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110384667|NCT05672407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110384668|NCT05672407|Hemostatics|hemostatics|mesh-ancestor
110384669|NCT05672407|Coagulants|coagulants|mesh-ancestor
110384670|NCT05663515|Insulin|insulin|mesh-list
110384671|NCT05663515|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110384672|NCT05663515|Exenatide|exenatide|mesh-list
110384673|NCT05663515|Biguanides|biguanides|mesh-list
110384674|NCT05663515|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
110384675|NCT05663515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110384676|NCT05663515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110384677|NCT05663515|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110384678|NCT05663515|Incretins|incretins|mesh-ancestor
110384679|NCT05663515|Hormones|hormones|mesh-ancestor
110384680|NCT05663515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110384681|NCT05654623|Fulvestrant|fulvestrant|mesh-list
110384682|NCT05654623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110384683|NCT05654623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110384684|NCT05654623|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110384685|NCT05654623|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110384686|NCT05654623|Hormone Antagonists|hormone antagonists|mesh-ancestor
110384687|NCT05654623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110384688|NCT05654623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110384689|NCT05654363|Morphine|morphine|mesh-list
110384690|NCT05654363|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110384691|NCT05654363|Narcotics|narcotics|mesh-ancestor
110384692|NCT05654363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110384693|NCT05654363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110384694|NCT05654363|Analgesics|analgesics|mesh-ancestor
110384695|NCT05654363|Sensory System Agents|sensory system agents|mesh-ancestor
110384696|NCT05654363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110384698|NCT05653401|Lidocaine|lidocaine|mesh-list
110384699|NCT05653401|Magnesium Sulfate|magnesium sulfate|mesh-list
110384700|NCT05653401|Anesthetics, Local|anesthetics, local|mesh-ancestor
110384701|NCT05653401|Anesthetics|anesthetics|mesh-ancestor
110384702|NCT05653401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110384703|NCT05653401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110384704|NCT05653401|Sensory System Agents|sensory system agents|mesh-ancestor
110384705|NCT05653401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110384706|NCT05653401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110384707|NCT05653401|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110384708|NCT05653401|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110384709|NCT05653401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110384710|NCT05653401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110384711|NCT05653401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110384712|NCT05653401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110384713|NCT05653401|Analgesics|analgesics|mesh-ancestor
110384714|NCT05653401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110384715|NCT05653401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110384716|NCT05653401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110384718|NCT05653401|Anticonvulsants|anticonvulsants|mesh-ancestor
110384719|NCT05653401|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110039033|NCT04425902|Analgesics|analgesics|mesh-ancestor
110384720|NCT05653401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110384721|NCT05653401|Tocolytic Agents|tocolytic agents|mesh-ancestor
110384722|NCT05653401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110384723|NCT05650476|Talazoparib|talazoparib|mesh-list
110384724|NCT05650476|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110384725|NCT05650476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110384726|NCT05650476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110384727|NCT05650476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110384728|NCT05644873|Magnesium Sulfate|magnesium sulfate|mesh-list
110384729|NCT05644873|Analgesics|analgesics|mesh-ancestor
110384730|NCT05644873|Sensory System Agents|sensory system agents|mesh-ancestor
110384731|NCT05644873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110384732|NCT05644873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110384733|NCT05644873|Anesthetics|anesthetics|mesh-ancestor
110384734|NCT05644873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110384735|NCT05644873|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110384736|NCT05644873|Anticonvulsants|anticonvulsants|mesh-ancestor
110384737|NCT05644873|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110384738|NCT05644873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110384739|NCT05644873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110384740|NCT05644873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110384741|NCT05644873|Tocolytic Agents|tocolytic agents|mesh-ancestor
110384742|NCT05644873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110384743|NCT05635708|Paclitaxel|paclitaxel|mesh-list
110384744|NCT05635708|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110384745|NCT05635708|Carboplatin|carboplatin|mesh-list
110384746|NCT05635708|Pemetrexed|pemetrexed|mesh-list
110384747|NCT05635708|Tislelizumab|tislelizumab|mesh-list
110384748|NCT05635708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110384749|NCT05635708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110384750|NCT05635708|Tubulin Modulators|tubulin modulators|mesh-ancestor
110384751|NCT05635708|Antimitotic Agents|antimitotic agents|mesh-ancestor
110384752|NCT05635708|Mitosis Modulators|mitosis modulators|mesh-ancestor
110384753|NCT05635708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110384755|NCT05635708|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110384756|NCT05635708|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110384757|NCT05635708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110384758|NCT05633979|Trastuzumab|trastuzumab|mesh-list
110384759|NCT05633979|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
110384760|NCT05633979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110384761|NCT05633979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110384762|NCT05633979|Immunoconjugates|immunoconjugates|mesh-ancestor
110384763|NCT05633979|Immunologic Factors|immunologic factors|mesh-ancestor
110384764|NCT05633979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110384765|NCT05633654|Pembrolizumab|pembrolizumab|mesh-list
110384766|NCT05633654|Capecitabine|capecitabine|mesh-list
110384767|NCT05633654|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
110384768|NCT05633654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110384769|NCT05633654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110384770|NCT05633654|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110384771|NCT05633654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110384772|NCT05633654|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110384773|NCT05633654|Antimetabolites|antimetabolites|mesh-ancestor
110384774|NCT05633654|Immunoconjugates|immunoconjugates|mesh-ancestor
110384775|NCT05633654|Immunologic Factors|immunologic factors|mesh-ancestor
110384776|NCT05633654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110384777|NCT05630183|Paclitaxel|paclitaxel|mesh-list
110384778|NCT05630183|Gemcitabine|gemcitabine|mesh-list
110384779|NCT05630183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110384780|NCT05630183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110384781|NCT05630183|Tubulin Modulators|tubulin modulators|mesh-ancestor
110384782|NCT05630183|Antimitotic Agents|antimitotic agents|mesh-ancestor
110384783|NCT05630183|Mitosis Modulators|mitosis modulators|mesh-ancestor
110384784|NCT05630183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110384785|NCT05630183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110384786|NCT05630183|Antimetabolites|antimetabolites|mesh-ancestor
110384787|NCT05624996|Paclitaxel|paclitaxel|mesh-list
110384788|NCT05624996|Etoposide|etoposide|mesh-list
110384789|NCT05624996|Podophyllotoxin|podophyllotoxin|mesh-list
110384790|NCT05624996|Cisplatin|cisplatin|mesh-list
110384791|NCT05624996|Carboplatin|carboplatin|mesh-list
110384792|NCT05624996|Pemetrexed|pemetrexed|mesh-list
110384793|NCT05624996|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110039087|NCT03734211|Evolocumab|evolocumab|mesh-list
110384794|NCT05624996|Etoposide phosphate|etoposide phosphate|mesh-list
110384795|NCT05624996|Durvalumab|durvalumab|mesh-list
110384796|NCT05624996|Immunoglobulins|immunoglobulins|mesh-list
110384797|NCT05624996|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110384798|NCT05624996|Immunoglobulin G|immunoglobulin g|mesh-list
110384799|NCT05624996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110384800|NCT05624996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110384801|NCT05624996|Tubulin Modulators|tubulin modulators|mesh-ancestor
110384802|NCT05624996|Antimitotic Agents|antimitotic agents|mesh-ancestor
110384803|NCT05624996|Mitosis Modulators|mitosis modulators|mesh-ancestor
110384804|NCT05624996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110384805|NCT05624996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110384806|NCT05624996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110384807|NCT05624996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110384808|NCT05624996|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110384809|NCT05624996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110384817|NCT05619653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110384818|NCT05619653|Glucocorticoids|glucocorticoids|mesh-ancestor
110384819|NCT05619653|Hormones|hormones|mesh-ancestor
110384820|NCT05619653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110384821|NCT05619653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110384822|NCT05619653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110384823|NCT05619653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110384824|NCT05619653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110384825|NCT05619653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110384826|NCT05619653|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110384827|NCT05619653|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110384828|NCT05619653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110384829|NCT05615974|Rituximab|rituximab|mesh-list
110384830|NCT05615974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110384831|NCT05615974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110384832|NCT05615974|Immunologic Factors|immunologic factors|mesh-ancestor
110384833|NCT05615974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110384834|NCT05615974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110384835|NCT05610657|Mitapivat|mitapivat|mesh-list
110384836|NCT05610657|Enzyme Activators|enzyme activators|mesh-ancestor
110384837|NCT05610657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110384838|NCT05610319|Faricimab|faricimab|mesh-list
110384839|NCT05610319|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110384840|NCT05610319|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110384841|NCT05610319|Growth Substances|growth substances|mesh-ancestor
110384842|NCT05610319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110384843|NCT05610319|Growth Inhibitors|growth inhibitors|mesh-ancestor
110384844|NCT05610319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110384852|NCT05600114|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110384853|NCT05600114|Anticonvulsants|anticonvulsants|mesh-ancestor
110384854|NCT05599841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110384855|NCT05595642|Astegolimab|astegolimab|mesh-list
110384856|NCT05595642|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110384857|NCT05595642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110384858|NCT05595642|Antiviral Agents|antiviral agents|mesh-ancestor
110384859|NCT05595642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110384860|NCT05593328|Bevacizumab|bevacizumab|mesh-list
110384861|NCT05593328|Onvansertib|onvansertib|mesh-list
110384862|NCT05593328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110384863|NCT05593328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110384864|NCT05593328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110384865|NCT05593328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110384866|NCT05593328|Growth Substances|growth substances|mesh-ancestor
110384867|NCT05593328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110384868|NCT05593328|Growth Inhibitors|growth inhibitors|mesh-ancestor
110384869|NCT05593328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110384870|NCT05593328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110384871|NCT05593328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110384873|NCT05590585|Dermatologic Agents|dermatologic agents|mesh-ancestor
110384875|NCT05589220|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110384876|NCT05589220|Autonomic Agents|autonomic agents|mesh-ancestor
110384877|NCT05589220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110384878|NCT05589220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110384879|NCT05589220|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110384880|NCT05589220|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110384881|NCT05589220|Cholinergic Agents|cholinergic agents|mesh-ancestor
110384882|NCT05589220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110384883|NCT05589220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110384884|NCT05582434|Clindamycin|clindamycin|mesh-list
110384885|NCT05582434|Clindamycin palmitate|clindamycin palmitate|mesh-list
110384886|NCT05582434|Clindamycin phosphate|clindamycin phosphate|mesh-list
110384887|NCT05582434|Adapalene|adapalene|mesh-list
110384888|NCT05582434|Benzoyl Peroxide|benzoyl peroxide|mesh-list
110384889|NCT05582434|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110384890|NCT05582434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110384891|NCT05582434|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110384892|NCT05582434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110384893|NCT05582434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110384894|NCT05582434|Dermatologic Agents|dermatologic agents|mesh-ancestor
110384895|NCT05582434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110384896|NCT05582434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110384897|NCT05582434|Analgesics|analgesics|mesh-ancestor
110384898|NCT05582434|Sensory System Agents|sensory system agents|mesh-ancestor
110384899|NCT05582434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110384900|NCT05582434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110384901|NCT05582434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110384902|NCT05582434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110384903|NCT05581706|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110384905|NCT05581706|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110384906|NCT05581706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110384907|NCT05581706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110384908|NCT05580562|TIC10 compound|tic10 compound|mesh-list
110384909|NCT05580562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110384910|NCT05569811|Letrozole|letrozole|mesh-list
110384911|NCT05569811|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
110384912|NCT05569811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110384913|NCT05569811|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110384914|NCT05569811|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110384915|NCT05569811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110384916|NCT05569811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110384917|NCT05569811|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110384918|NCT05569811|Hormone Antagonists|hormone antagonists|mesh-ancestor
110384919|NCT05569811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110384920|NCT05569811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110384921|NCT05569811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110384922|NCT05568095|Leucovorin|leucovorin|mesh-list
110384923|NCT05568095|Fluorouracil|fluorouracil|mesh-list
110384924|NCT05568095|Capecitabine|capecitabine|mesh-list
110384925|NCT05568095|Oxaliplatin|oxaliplatin|mesh-list
110384926|NCT05568095|Nivolumab|nivolumab|mesh-list
110384927|NCT05568095|Antimetabolites|antimetabolites|mesh-ancestor
110384928|NCT05568095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110384929|NCT05568095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110384930|NCT05568095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110384931|NCT05568095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110384932|NCT05568095|Immunologic Factors|immunologic factors|mesh-ancestor
110384933|NCT05568095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110384934|NCT05568095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110046497|NCT05192889|Leucovorin|leucovorin|mesh-list
110384935|NCT05568095|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110384936|NCT05568095|Antidotes|antidotes|mesh-ancestor
110384937|NCT05568095|Protective Agents|protective agents|mesh-ancestor
110384938|NCT05568095|Vitamin B Complex|vitamin b complex|mesh-ancestor
110384939|NCT05568095|Vitamins|vitamins|mesh-ancestor
110384940|NCT05568095|Micronutrients|micronutrients|mesh-ancestor
110384941|NCT05554380|Paclitaxel|paclitaxel|mesh-list
110384943|NCT05554380|Ipatasertib|ipatasertib|mesh-list
110384944|NCT05554380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110384945|NCT05554380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110384946|NCT05554380|Tubulin Modulators|tubulin modulators|mesh-ancestor
110384947|NCT05554380|Antimitotic Agents|antimitotic agents|mesh-ancestor
110384948|NCT05554380|Mitosis Modulators|mitosis modulators|mesh-ancestor
110384949|NCT05554380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110384950|NCT05554380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110384951|NCT05554380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110384952|NCT05548062|Hydroxyurea|hydroxyurea|mesh-list
110384953|NCT05548062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110384954|NCT05548062|Antisickling Agents|antisickling agents|mesh-ancestor
110384955|NCT05548062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110384956|NCT05548062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110384957|NCT05548062|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110384958|NCT05544929|Tislelizumab|tislelizumab|mesh-list
110384959|NCT05544929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110384960|NCT05544929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110384961|NCT05537766|Cyclophosphamide|cyclophosphamide|mesh-list
110384962|NCT05537766|Fludarabine|fludarabine|mesh-list
110384963|NCT05537766|Brexucabtagene autoleucel|brexucabtagene autoleucel|mesh-list
110384964|NCT05537766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110384965|NCT05537766|Immunologic Factors|immunologic factors|mesh-ancestor
110384966|NCT05537766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110384967|NCT05537766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110384968|NCT05537766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110384969|NCT05537766|Alkylating Agents|alkylating agents|mesh-ancestor
110384970|NCT05537766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110384971|NCT05537766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110384972|NCT05537766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110384973|NCT05537766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110384974|NCT05535166|Cyclophosphamide|cyclophosphamide|mesh-list
110384975|NCT05535166|Carboplatin|carboplatin|mesh-list
110384976|NCT05535166|Methotrexate|methotrexate|mesh-list
110384977|NCT05535166|Etoposide|etoposide|mesh-list
110384978|NCT05535166|Vincristine|vincristine|mesh-list
110384979|NCT05535166|Topotecan|topotecan|mesh-list
110384980|NCT05535166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110384981|NCT05535166|Immunologic Factors|immunologic factors|mesh-ancestor
110384982|NCT05535166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110384983|NCT05535166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110384984|NCT05535166|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110384985|NCT05535166|Alkylating Agents|alkylating agents|mesh-ancestor
110384986|NCT05535166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110384987|NCT05535166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110384988|NCT05535166|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110384989|NCT05535166|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110384990|NCT05535166|Abortifacient Agents|abortifacient agents|mesh-ancestor
110384991|NCT05535166|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110384992|NCT05535166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110384993|NCT05535166|Antimetabolites|antimetabolites|mesh-ancestor
110384994|NCT05535166|Dermatologic Agents|dermatologic agents|mesh-ancestor
110384995|NCT05535166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110384996|NCT05535166|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110384997|NCT05535166|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110384998|NCT05535166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110384999|NCT05535166|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110385000|NCT05535166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110385001|NCT05535166|Tubulin Modulators|tubulin modulators|mesh-ancestor
110385002|NCT05535166|Antimitotic Agents|antimitotic agents|mesh-ancestor
110385003|NCT05535166|Mitosis Modulators|mitosis modulators|mesh-ancestor
110385004|NCT05535166|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110385005|NCT05525546|Vaccines|vaccines|mesh-list
110385006|NCT05525546|Immunologic Factors|immunologic factors|mesh-ancestor
110385007|NCT05525546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110385008|NCT05525247|Gemcitabine|gemcitabine|mesh-list
110385009|NCT05525247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110385010|NCT05525247|Antimetabolites|antimetabolites|mesh-ancestor
110385011|NCT05525247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110385012|NCT05525247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110385013|NCT05521997|Cisplatin|cisplatin|mesh-list
110385014|NCT05521997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110385015|NCT05521880|Oritavancin|oritavancin|mesh-list
110385016|NCT05521880|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110385017|NCT05521880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110385018|NCT05520814|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110385019|NCT05520814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110039309|NCT01426399|Metformin|metformin|mesh-list
110385020|NCT05520814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110385021|NCT05520814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110385022|NCT05519085|Dexamethasone|dexamethasone|mesh-list
110385024|NCT05519085|Pomalidomide|pomalidomide|mesh-list
110385025|NCT05519085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110385026|NCT05519085|Antiemetics|antiemetics|mesh-ancestor
110385027|NCT05519085|Autonomic Agents|autonomic agents|mesh-ancestor
110385028|NCT05519085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110385029|NCT05519085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110385030|NCT05519085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110385031|NCT05519085|Glucocorticoids|glucocorticoids|mesh-ancestor
110385032|NCT05519085|Hormones|hormones|mesh-ancestor
110385033|NCT05519085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110385034|NCT05519085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110385035|NCT05519085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110385036|NCT05519085|Immunologic Factors|immunologic factors|mesh-ancestor
110385037|NCT05519085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110385038|NCT05519085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110385039|NCT05519085|Growth Substances|growth substances|mesh-ancestor
110385040|NCT05519085|Growth Inhibitors|growth inhibitors|mesh-ancestor
110385041|NCT05518032|Pembrolizumab|pembrolizumab|mesh-list
110385042|NCT05518032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110385043|NCT05518032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110385044|NCT05518032|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110385045|NCT05518032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110385046|NCT05517590|Tranexamic Acid|tranexamic acid|mesh-list
110385047|NCT05517590|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110385048|NCT05517590|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110385049|NCT05517590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110385050|NCT05517590|Hemostatics|hemostatics|mesh-ancestor
110385051|NCT05517590|Coagulants|coagulants|mesh-ancestor
110385053|NCT05516914|Gemcitabine|gemcitabine|mesh-list
110385054|NCT05516914|Docetaxel|docetaxel|mesh-list
110385055|NCT05516914|Tislelizumab|tislelizumab|mesh-list
110385056|NCT05516914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110385057|NCT05516914|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110385058|NCT05516914|Antimetabolites|antimetabolites|mesh-ancestor
110385059|NCT05516914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110385060|NCT05516914|Tubulin Modulators|tubulin modulators|mesh-ancestor
110385061|NCT05516914|Antimitotic Agents|antimitotic agents|mesh-ancestor
110385062|NCT05516914|Mitosis Modulators|mitosis modulators|mesh-ancestor
110385063|NCT05516914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110385072|NCT05513209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110385073|NCT05513209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110385074|NCT05511610|Sevoflurane|sevoflurane|mesh-list
110385075|NCT05511610|Desflurane|desflurane|mesh-list
110385076|NCT05511610|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110385077|NCT05511610|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110385078|NCT05511610|Anesthetics, General|anesthetics, general|mesh-ancestor
110385079|NCT05511610|Anesthetics|anesthetics|mesh-ancestor
110385080|NCT05511610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110385081|NCT05511610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110385082|NCT05509569|Icatibant|icatibant|mesh-list
110385083|NCT05509569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110385084|NCT05509569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110385085|NCT05509569|Analgesics|analgesics|mesh-ancestor
110385086|NCT05509569|Sensory System Agents|sensory system agents|mesh-ancestor
110385087|NCT05509569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110385088|NCT05509569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110385089|NCT05509569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110385091|NCT05509569|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
110385092|NCT05509569|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
110385093|NCT05509569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110385094|NCT05509569|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110385095|NCT05509569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110385096|NCT05509569|Immunologic Factors|immunologic factors|mesh-ancestor
110385097|NCT05508867|Gemcitabine|gemcitabine|mesh-list
110385098|NCT05508867|Pembrolizumab|pembrolizumab|mesh-list
110385099|NCT05508867|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110385100|NCT05508867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110385101|NCT05508867|Antimetabolites|antimetabolites|mesh-ancestor
110385102|NCT05508867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110385103|NCT05508867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110385104|NCT05508867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110385105|NCT05508867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110385106|NCT05508867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110385107|NCT05508867|Alkylating Agents|alkylating agents|mesh-ancestor
110385108|NCT05507580|Upadacitinib|upadacitinib|mesh-list
110385109|NCT05507580|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110385110|NCT05507580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110385111|NCT05507580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110385112|NCT05507580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110385113|NCT05507580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110385121|NCT05506566|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110385122|NCT05506566|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110385123|NCT05506566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110385124|NCT05505825|Chiauranib|chiauranib|mesh-list
110385125|NCT05505825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110385126|NCT05505825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110385127|NCT05505825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110385128|NCT05505825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110385131|NCT05500170|Nicotinic Acids|nicotinic acids|mesh-list
110385132|NCT05500170|Vitamins|vitamins|mesh-ancestor
110385133|NCT05500170|Micronutrients|micronutrients|mesh-ancestor
110385134|NCT05500170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110385135|NCT05500170|Vitamin B Complex|vitamin b complex|mesh-ancestor
110385136|NCT05500170|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110385137|NCT05500170|Antimetabolites|antimetabolites|mesh-ancestor
110385138|NCT05500170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110385139|NCT05500170|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110385140|NCT05500170|Vasodilator Agents|vasodilator agents|mesh-ancestor
110385141|NCT05499390|Pembrolizumab|pembrolizumab|mesh-list
110385142|NCT05499390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110385143|NCT05499390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110385144|NCT05499390|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110385145|NCT05499390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110385147|NCT05490381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110385148|NCT05487586|Ceftazidime|ceftazidime|mesh-list
110385149|NCT05487586|Avibactam|avibactam|mesh-list
110385150|NCT05487586|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
110385151|NCT05487586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110385152|NCT05487586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110385153|NCT05487586|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110385154|NCT05487586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110385155|NCT05487586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110385156|NCT05466578|Abrocitinib|abrocitinib|mesh-list
110385157|NCT05466578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110385158|NCT05466578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110385159|NCT05466578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110385160|NCT05454891|Insulin|insulin|mesh-list
110385161|NCT05454891|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110385162|NCT05454891|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110385163|NCT05454891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110385164|NCT05446129|Pembrolizumab|pembrolizumab|mesh-list
110385165|NCT05446129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110385166|NCT05446129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110385167|NCT05446129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110385168|NCT05446129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110385169|NCT05440383|Leuprolide|leuprolide|mesh-list
110385170|NCT05440383|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110385171|NCT05440383|Fertility Agents|fertility agents|mesh-ancestor
110385172|NCT05440383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110385173|NCT05440383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110385174|NCT05440383|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110385175|NCT05440383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110385177|NCT05434689|Daratumumab|daratumumab|mesh-list
110385178|NCT05434689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110385179|NCT05434689|Antiemetics|antiemetics|mesh-ancestor
110385180|NCT05434689|Autonomic Agents|autonomic agents|mesh-ancestor
110385181|NCT05434689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110385182|NCT05434689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110385183|NCT05434689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110385184|NCT05434689|Glucocorticoids|glucocorticoids|mesh-ancestor
110385185|NCT05434689|Hormones|hormones|mesh-ancestor
110385186|NCT05434689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110385187|NCT05434689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110385188|NCT05434689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110385189|NCT05431920|Vitamin D|vitamin d|mesh-list
110385190|NCT05431920|Ergocalciferols|ergocalciferols|mesh-list
110385191|NCT05431920|Cholecalciferol|cholecalciferol|mesh-list
110385192|NCT05431920|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
110385193|NCT05431920|Calcifediol|calcifediol|mesh-list
110385194|NCT05431920|Vitamins|vitamins|mesh-list
110385195|NCT05431920|Micronutrients|micronutrients|mesh-ancestor
110385196|NCT05431920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110385197|NCT05431920|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110385198|NCT05431920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110385199|NCT05425940|Atezolizumab|atezolizumab|mesh-list
110385200|NCT05425940|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110385201|NCT05425940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110385202|NCT05425940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110385203|NCT05425940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110385204|NCT05421858|Fluconazole|fluconazole|mesh-list
110385205|NCT05421858|Caspofungin|caspofungin|mesh-list
110385206|NCT05421858|Antifungal Agents|antifungal agents|mesh-ancestor
110385207|NCT05421858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110385208|NCT05421858|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110385209|NCT05421858|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110385210|NCT05421858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110385211|NCT05421858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110385212|NCT05421858|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110385213|NCT05421858|Hormone Antagonists|hormone antagonists|mesh-ancestor
110385214|NCT05421858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110385215|NCT05421858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110385216|NCT05421858|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110385217|NCT05421858|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110385219|NCT05418244|Antiemetics|antiemetics|mesh-ancestor
110385220|NCT05418244|Autonomic Agents|autonomic agents|mesh-ancestor
110385221|NCT05418244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110385222|NCT05418244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110385223|NCT05418244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110385224|NCT05418244|Antipruritics|antipruritics|mesh-ancestor
110385225|NCT05418244|Dermatologic Agents|dermatologic agents|mesh-ancestor
110385226|NCT05418244|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110385227|NCT05418244|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110385228|NCT05418244|Serotonin Agents|serotonin agents|mesh-ancestor
110385229|NCT05418244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110385230|NCT05418244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110385231|NCT05411991|Chlorthalidone|chlorthalidone|mesh-list
110385232|NCT05411991|Acetazolamide|acetazolamide|mesh-list
110385233|NCT05411991|Bumetanide|bumetanide|mesh-list
110385234|NCT05411991|Diuretics|diuretics|mesh-list
110385235|NCT05411991|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
110385236|NCT05411991|Natriuretic Agents|natriuretic agents|mesh-ancestor
110385237|NCT05411991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110385238|NCT05411991|Anticonvulsants|anticonvulsants|mesh-ancestor
110385239|NCT05411991|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110385240|NCT05411991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110385241|NCT05411991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110385242|NCT05411991|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110385243|NCT05411991|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110385244|NCT05411991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110385245|NCT05410860|Etripamil|etripamil|mesh-list
110385246|NCT05410860|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110385247|NCT05410860|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110385248|NCT05410860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110385249|NCT05410860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110385250|NCT05410860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110385251|NCT05408845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110385252|NCT05408845|Trastuzumab|trastuzumab|mesh-list
110385253|NCT05408845|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
110385254|NCT05408845|Docetaxel|docetaxel|mesh-list
110385255|NCT05408845|Maytansine|maytansine|mesh-list
110385256|NCT05408845|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
110385257|NCT05408845|Antibodies|antibodies|mesh-list
110385258|NCT05408845|Immunoglobulins|immunoglobulins|mesh-list
110385259|NCT05408845|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110385260|NCT05408845|Immunoconjugates|immunoconjugates|mesh-list
110385261|NCT05408845|Immunologic Factors|immunologic factors|mesh-ancestor
110385262|NCT05408845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110385264|NCT05408845|Tubulin Modulators|tubulin modulators|mesh-ancestor
110385265|NCT05408845|Antimitotic Agents|antimitotic agents|mesh-ancestor
110385266|NCT05408845|Mitosis Modulators|mitosis modulators|mesh-ancestor
110385267|NCT05408845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110385268|NCT05408845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110385269|NCT05408845|Immunotoxins|immunotoxins|mesh-ancestor
110385270|NCT05407662|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
110385271|NCT05407662|Mineralocorticoids|mineralocorticoids|mesh-list
110385272|NCT05407662|Hormone Antagonists|hormone antagonists|mesh-ancestor
110385273|NCT05407662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110385274|NCT05407662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110385275|NCT05407662|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110385276|NCT05407662|Diuretics|diuretics|mesh-ancestor
110385277|NCT05407662|Natriuretic Agents|natriuretic agents|mesh-ancestor
110385279|NCT05403385|Carboplatin|carboplatin|mesh-list
110385280|NCT05403385|Pemetrexed|pemetrexed|mesh-list
110385281|NCT05403385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110385283|NCT05403385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110385284|NCT05403385|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110385285|NCT05403385|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110385286|NCT05401110|Osimertinib|osimertinib|mesh-list
110385287|NCT05401110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110385288|NCT05401110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110385289|NCT05401110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110385290|NCT05401110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110385291|NCT05400863|Metformin|metformin|mesh-list
110385292|NCT05400863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110385293|NCT05400863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110385294|NCT05396833|Avelumab|avelumab|mesh-list
110385295|NCT05396833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110385296|NCT05396833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110385297|NCT05395052|Cyclophosphamide|cyclophosphamide|mesh-list
110385298|NCT05395052|Pembrolizumab|pembrolizumab|mesh-list
110385299|NCT05395052|Nivolumab|nivolumab|mesh-list
110385300|NCT05395052|Trastuzumab|trastuzumab|mesh-list
110385301|NCT05395052|Fludarabine|fludarabine|mesh-list
110385302|NCT05395052|Cetuximab|cetuximab|mesh-list
110385303|NCT05395052|Atezolizumab|atezolizumab|mesh-list
110385304|NCT05395052|Interleukin-2|interleukin-2|mesh-list
110385305|NCT05395052|Avelumab|avelumab|mesh-list
110385306|NCT05395052|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
110385307|NCT05395052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110385308|NCT05395052|Immunologic Factors|immunologic factors|mesh-ancestor
110385309|NCT05395052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110385310|NCT05395052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110385311|NCT05395052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110385312|NCT05395052|Alkylating Agents|alkylating agents|mesh-ancestor
110385313|NCT05395052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110385314|NCT05395052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110385316|NCT05395052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110385317|NCT05395052|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110385318|NCT05395052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110385319|NCT05395052|Analgesics|analgesics|mesh-ancestor
110385320|NCT05395052|Sensory System Agents|sensory system agents|mesh-ancestor
110385321|NCT05395052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110385322|NCT05392452|Insulin|insulin|mesh-list
110385323|NCT05392452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110385324|NCT05392452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110385325|NCT05389527|Pembrolizumab|pembrolizumab|mesh-list
110385326|NCT05389527|Lenvatinib|lenvatinib|mesh-list
110385327|NCT05389527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110385328|NCT05389527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110385329|NCT05389527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110385330|NCT05389527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110385331|NCT05389527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110385333|NCT05389423|Prednisone|prednisone|mesh-list
110385334|NCT05389423|Cyclophosphamide|cyclophosphamide|mesh-list
110385335|NCT05389423|Rituximab|rituximab|mesh-list
110385336|NCT05389423|Doxorubicin|doxorubicin|mesh-list
110385337|NCT05389423|Etoposide|etoposide|mesh-list
110385338|NCT05389423|Vincristine|vincristine|mesh-list
110385339|NCT05389423|Pomalidomide|pomalidomide|mesh-list
110385340|NCT05389423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110385341|NCT05389423|Immunologic Factors|immunologic factors|mesh-ancestor
110385342|NCT05389423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110385343|NCT05389423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110385344|NCT05389423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110385345|NCT05389423|Alkylating Agents|alkylating agents|mesh-ancestor
110385346|NCT05389423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110385347|NCT05389423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110385348|NCT05389423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110385349|NCT05389423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110385350|NCT05389423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110385351|NCT05389423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110385352|NCT05389423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110385353|NCT05389423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110385354|NCT05389423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110385355|NCT05389423|Glucocorticoids|glucocorticoids|mesh-ancestor
110385356|NCT05389423|Hormones|hormones|mesh-ancestor
110385357|NCT05389423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110385358|NCT05389423|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110385359|NCT05389423|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110385360|NCT05389423|Tubulin Modulators|tubulin modulators|mesh-ancestor
110385361|NCT05389423|Antimitotic Agents|antimitotic agents|mesh-ancestor
110385362|NCT05389423|Mitosis Modulators|mitosis modulators|mesh-ancestor
110385363|NCT05389423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110385364|NCT05389423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110385365|NCT05389423|Growth Substances|growth substances|mesh-ancestor
110385366|NCT05389423|Growth Inhibitors|growth inhibitors|mesh-ancestor
110385367|NCT05370235|Afamelanotide|afamelanotide|mesh-list
110385368|NCT05370235|Dermatologic Agents|dermatologic agents|mesh-ancestor
110385369|NCT05369832|Ozanimod|ozanimod|mesh-list
110385370|NCT05369832|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110385371|NCT05369832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110385372|NCT05369832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110385373|NCT05369832|Immunologic Factors|immunologic factors|mesh-ancestor
110385374|NCT05369832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110385375|NCT05369533|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110385376|NCT05369533|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110385377|NCT05369533|Immunologic Factors|immunologic factors|mesh-ancestor
110385378|NCT05369533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110385379|NCT05369533|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110385380|NCT05369533|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110385381|NCT05369533|Dopamine Agonists|dopamine agonists|mesh-ancestor
110385382|NCT05369533|Dopamine Agents|dopamine agents|mesh-ancestor
110385383|NCT05369533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110385384|NCT05369533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110385385|NCT05368558|Cariprazine|cariprazine|mesh-list
110385386|NCT05368558|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110385387|NCT05368558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110385388|NCT05368558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110385389|NCT05368558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110385390|NCT05368558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110385392|NCT05366166|Pembrolizumab|pembrolizumab|mesh-list
110385393|NCT05366166|Olaparib|olaparib|mesh-list
110385394|NCT05366166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110385395|NCT05366166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110385396|NCT05366166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110385397|NCT05366166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110385398|NCT05366166|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110385399|NCT05366166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110260200|NCT00168948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110385401|NCT05363319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110385402|NCT05363319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110385403|NCT05361720|Nivolumab|nivolumab|mesh-list
110385404|NCT05361720|Ipilimumab|ipilimumab|mesh-list
110385405|NCT05361720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110385406|NCT05361720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110385408|NCT05361720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110385409|NCT05359653|Clemastine|clemastine|mesh-list
110385410|NCT05359653|Antipruritics|antipruritics|mesh-ancestor
110385411|NCT05359653|Dermatologic Agents|dermatologic agents|mesh-ancestor
110385412|NCT05359653|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110385413|NCT05359653|Histamine Antagonists|histamine antagonists|mesh-ancestor
110385414|NCT05359653|Histamine Agents|histamine agents|mesh-ancestor
110385415|NCT05359653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110385416|NCT05359653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110385417|NCT05359653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110385418|NCT05359653|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110385419|NCT05358704|Leucovorin|leucovorin|mesh-list
110385420|NCT05358704|Fluorouracil|fluorouracil|mesh-list
110385421|NCT05358704|Capecitabine|capecitabine|mesh-list
110385422|NCT05358704|Oxaliplatin|oxaliplatin|mesh-list
110385423|NCT05358704|Irinotecan|irinotecan|mesh-list
110385424|NCT05358704|Antimetabolites|antimetabolites|mesh-ancestor
110385425|NCT05358704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110385426|NCT05358704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110385427|NCT05358704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110385428|NCT05358704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110385429|NCT05358704|Immunologic Factors|immunologic factors|mesh-ancestor
110385430|NCT05358704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110385431|NCT05358704|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110385432|NCT05358704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110385433|NCT05358704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110385435|NCT05358704|Protective Agents|protective agents|mesh-ancestor
110385436|NCT05358704|Vitamin B Complex|vitamin b complex|mesh-ancestor
110385437|NCT05358704|Vitamins|vitamins|mesh-ancestor
110385438|NCT05358704|Micronutrients|micronutrients|mesh-ancestor
110385439|NCT05358691|Durvalumab|durvalumab|mesh-list
110385440|NCT05358691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110385441|NCT05358691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110385442|NCT05358249|Cetuximab|cetuximab|mesh-list
110385443|NCT05358249|Trametinib|trametinib|mesh-list
110385444|NCT05358249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110385445|NCT05358249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110385446|NCT05358249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110385447|NCT05358249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110385448|NCT05358249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110385450|NCT05352815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110385451|NCT05352815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110385452|NCT05347238|Dopamine|dopamine|mesh-list
110385453|NCT05347238|Norepinephrine|norepinephrine|mesh-list
110385454|NCT05347238|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110385455|NCT05347238|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110385456|NCT05347238|Adrenergic Agents|adrenergic agents|mesh-ancestor
110385457|NCT05347238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110385458|NCT05347238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110385459|NCT05347238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110385460|NCT05347238|Sympathomimetics|sympathomimetics|mesh-ancestor
110385461|NCT05347238|Autonomic Agents|autonomic agents|mesh-ancestor
110385462|NCT05347238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110385463|NCT05347238|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110385464|NCT05347238|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110385465|NCT05347238|Dopamine Agents|dopamine agents|mesh-ancestor
110385466|NCT05347238|Protective Agents|protective agents|mesh-ancestor
110385477|NCT05316168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110385479|NCT05316168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110385480|NCT05316168|Anesthetics, Local|anesthetics, local|mesh-ancestor
110385481|NCT05316168|Anesthetics|anesthetics|mesh-ancestor
110385482|NCT05316168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110385483|NCT05316168|Sensory System Agents|sensory system agents|mesh-ancestor
110385484|NCT05312970|Polidocanol|polidocanol|mesh-list
110385485|NCT05312970|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
110385486|NCT05312970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110385498|NCT05300191|Dialysis Solutions|dialysis solutions|mesh-list
110385499|NCT05300191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110385500|NCT05299125|Pemetrexed|pemetrexed|mesh-list
110385501|NCT05299125|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
110385502|NCT05299125|Lazertinib|lazertinib|mesh-list
110385503|NCT05299125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110385504|NCT05299125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110385505|NCT05299125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110385506|NCT05299125|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110385507|NCT05299125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110385508|NCT05299125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110385509|NCT05299125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110385510|NCT05293509|Cyclosporine|cyclosporine|mesh-list
110385511|NCT05293509|Mycophenolic Acid|mycophenolic acid|mesh-list
110385512|NCT05293509|Dexamethasone|dexamethasone|mesh-list
110385513|NCT05293509|Cyclophosphamide|cyclophosphamide|mesh-list
110385514|NCT05293509|Busulfan|busulfan|mesh-list
110385515|NCT05293509|Rituximab|rituximab|mesh-list
110385516|NCT05293509|Fludarabine|fludarabine|mesh-list
110385517|NCT05293509|Bortezomib|bortezomib|mesh-list
110385518|NCT05293509|Tacrolimus|tacrolimus|mesh-list
110385519|NCT05293509|Cyclosporins|cyclosporins|mesh-list
110385520|NCT05293509|Thymoglobulin|thymoglobulin|mesh-list
110385521|NCT05293509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110385522|NCT05293509|Immunologic Factors|immunologic factors|mesh-ancestor
110385523|NCT05293509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110385524|NCT05293509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110385525|NCT05293509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110385526|NCT05293509|Alkylating Agents|alkylating agents|mesh-ancestor
110385527|NCT05293509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110385528|NCT05293509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110385529|NCT05293509|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110385530|NCT05293509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110385531|NCT05293509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110385532|NCT05293509|Antiemetics|antiemetics|mesh-ancestor
110385533|NCT05293509|Autonomic Agents|autonomic agents|mesh-ancestor
110385534|NCT05293509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110385535|NCT05293509|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110385536|NCT05293509|Glucocorticoids|glucocorticoids|mesh-ancestor
110385537|NCT05293509|Hormones|hormones|mesh-ancestor
110385538|NCT05293509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110385539|NCT05293509|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110385540|NCT05293509|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110385541|NCT05293509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110385542|NCT05293509|Antifungal Agents|antifungal agents|mesh-ancestor
110385543|NCT05293509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110385544|NCT05293509|Dermatologic Agents|dermatologic agents|mesh-ancestor
110385545|NCT05293509|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110385546|NCT05293509|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110385547|NCT05293509|Antitubercular Agents|antitubercular agents|mesh-ancestor
110385548|NCT05293509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110385550|NCT05284643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110385551|NCT05284643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110385552|NCT05284643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110385553|NCT05284643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110385554|NCT05284643|Growth Substances|growth substances|mesh-ancestor
110385555|NCT05284643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110385556|NCT05284643|Growth Inhibitors|growth inhibitors|mesh-ancestor
110385557|NCT05281601|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
110385558|NCT05281601|Antiviral Agents|antiviral agents|mesh-ancestor
110385559|NCT05281601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110385582|NCT05276219|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110385583|NCT05276219|Vasodilator Agents|vasodilator agents|mesh-ancestor
110385584|NCT05276219|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110385585|NCT05267613|Esomeprazole|esomeprazole|mesh-list
110385586|NCT05267613|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110385587|NCT05267613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110385588|NCT05267613|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110385589|NCT05267613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110385590|NCT05267613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110385591|NCT05263206|Loratadine|loratadine|mesh-list
110385593|NCT05263206|Antipruritics|antipruritics|mesh-ancestor
110385594|NCT05263206|Dermatologic Agents|dermatologic agents|mesh-ancestor
110385595|NCT05263206|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110385596|NCT05263206|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110385597|NCT05263206|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110385598|NCT05263206|Histamine Antagonists|histamine antagonists|mesh-ancestor
110385599|NCT05263206|Histamine Agents|histamine agents|mesh-ancestor
110385600|NCT05263206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110260201|NCT00168948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110385601|NCT05263206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110385602|NCT05263206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110385603|NCT05262270|Naltrexone|naltrexone|mesh-list
110385604|NCT05262270|Buprenorphine|buprenorphine|mesh-list
110385605|NCT05262270|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110385606|NCT05262270|Narcotics|narcotics|mesh-ancestor
110385607|NCT05262270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110385608|NCT05262270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110385609|NCT05262270|Analgesics|analgesics|mesh-ancestor
110385610|NCT05262270|Sensory System Agents|sensory system agents|mesh-ancestor
110385611|NCT05262270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110385612|NCT05262270|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110385613|NCT05262270|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110385614|NCT05256472|Axitinib|axitinib|mesh-list
110385615|NCT05256472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110385616|NCT05256472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110385617|NCT05256472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110385618|NCT05256472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110385620|NCT05239624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110385621|NCT05239624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110039895|NCT01429831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110385622|NCT05239624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110385623|NCT05239624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110385624|NCT05231629|Dexamethasone|dexamethasone|mesh-list
110385625|NCT05231629|Dexamethasone acetate|dexamethasone acetate|mesh-list
110385626|NCT05231629|Melphalan|melphalan|mesh-list
110385627|NCT05231629|Lenalidomide|lenalidomide|mesh-list
110385628|NCT05231629|Bortezomib|bortezomib|mesh-list
110385629|NCT05231629|Daratumumab|daratumumab|mesh-list
110385630|NCT05231629|BB 1101|bb 1101|mesh-list
110385631|NCT05231629|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110385632|NCT05231629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110385633|NCT05231629|Antiemetics|antiemetics|mesh-ancestor
110385634|NCT05231629|Autonomic Agents|autonomic agents|mesh-ancestor
110385635|NCT05231629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110385636|NCT05231629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110385637|NCT05231629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110385638|NCT05231629|Glucocorticoids|glucocorticoids|mesh-ancestor
110385640|NCT05231629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110385641|NCT05231629|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110385642|NCT05231629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110385643|NCT05231629|Protease Inhibitors|protease inhibitors|mesh-ancestor
110385644|NCT05231629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110385645|NCT05231629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110385646|NCT05231629|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110385647|NCT05231629|Alkylating Agents|alkylating agents|mesh-ancestor
110385648|NCT05231629|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110385649|NCT05231629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110385650|NCT05231629|Immunologic Factors|immunologic factors|mesh-ancestor
110385651|NCT05231629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110385652|NCT05231629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110385674|NCT05201313|Mepivacaine|mepivacaine|mesh-list
110385675|NCT05201313|Anesthetics, Local|anesthetics, local|mesh-ancestor
110385676|NCT05201313|Anesthetics|anesthetics|mesh-ancestor
110385677|NCT05201313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110385678|NCT05201313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110385679|NCT05201313|Sensory System Agents|sensory system agents|mesh-ancestor
110385680|NCT05201313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110385681|NCT05201313|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110385682|NCT05201313|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110385683|NCT05201313|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110385684|NCT05201313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110385685|NCT05201313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110385686|NCT05200988|Nivolumab|nivolumab|mesh-list
110385687|NCT05200988|Ipilimumab|ipilimumab|mesh-list
110385688|NCT05200988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110385689|NCT05200988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110385690|NCT05200988|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110385691|NCT05200988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110385692|NCT05199753|Antibodies|antibodies|mesh-list
110385693|NCT05199753|Immunologic Factors|immunologic factors|mesh-ancestor
110385694|NCT05199753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110385695|NCT05198934|Trifluridine|trifluridine|mesh-list
110385696|NCT05198934|Panitumumab|panitumumab|mesh-list
110385697|NCT05198934|Sotorasib|sotorasib|mesh-list
110385698|NCT05198934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110385699|NCT05198934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110385700|NCT05198934|Antimetabolites|antimetabolites|mesh-ancestor
110385701|NCT05198934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110385703|NCT05198934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110385704|NCT05198934|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110385705|NCT05195918|Pirfenidone|pirfenidone|mesh-list
110385706|NCT05195918|Nintedanib|nintedanib|mesh-list
110385707|NCT05195918|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
110385708|NCT05195918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110385709|NCT05195918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110385710|NCT05195918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110385711|NCT05195918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110385712|NCT05195918|Analgesics|analgesics|mesh-ancestor
110385713|NCT05195918|Sensory System Agents|sensory system agents|mesh-ancestor
110385714|NCT05195918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110385715|NCT05195918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110385716|NCT05195918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110385717|NCT05195918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110385718|NCT05195918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110385719|NCT05195918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110385720|NCT05195918|Antioxidants|antioxidants|mesh-ancestor
110385721|NCT05195918|Protective Agents|protective agents|mesh-ancestor
110385722|NCT05195918|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110385723|NCT05195918|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110385724|NCT05195918|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110385725|NCT05184348|Acitretin|acitretin|mesh-list
110385726|NCT05184348|Keratolytic Agents|keratolytic agents|mesh-ancestor
110385727|NCT05184348|Dermatologic Agents|dermatologic agents|mesh-ancestor
110385728|NCT05183412|Methamphetamine|methamphetamine|mesh-list
110385729|NCT05183412|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110385730|NCT05183412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110385731|NCT05183412|Sympathomimetics|sympathomimetics|mesh-ancestor
110385732|NCT05183412|Autonomic Agents|autonomic agents|mesh-ancestor
110385733|NCT05183412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110385734|NCT05183412|Dopamine Agents|dopamine agents|mesh-ancestor
110385735|NCT05183412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110385736|NCT05183412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110385737|NCT05183412|Adrenergic Agents|adrenergic agents|mesh-ancestor
110385738|NCT05183412|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110385739|NCT05183412|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110385740|NCT05183412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110385741|NCT05183412|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110385742|NCT05183035|Cytarabine|cytarabine|mesh-list
110385743|NCT05183035|Fludarabine|fludarabine|mesh-list
110385744|NCT05183035|Azacitidine|azacitidine|mesh-list
110385745|NCT05183035|Venetoclax|venetoclax|mesh-list
110385746|NCT05183035|Gemtuzumab|gemtuzumab|mesh-list
110385747|NCT05183035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110385748|NCT05183035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110385749|NCT05183035|Antimetabolites|antimetabolites|mesh-ancestor
110385750|NCT05183035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110385751|NCT05183035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110385752|NCT05183035|Immunologic Factors|immunologic factors|mesh-ancestor
110385753|NCT05183035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110385754|NCT05183035|Antiviral Agents|antiviral agents|mesh-ancestor
110385755|NCT05183035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110385756|NCT05183035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110385757|NCT05183035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110385758|NCT05183035|Immunotoxins|immunotoxins|mesh-ancestor
110385759|NCT05183035|Immunoconjugates|immunoconjugates|mesh-ancestor
110385760|NCT05181527|Dextromethorphan|dextromethorphan|mesh-list
110385761|NCT05181527|Serotonin|serotonin|mesh-list
110385762|NCT05181527|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
110385763|NCT05181527|Antitussive Agents|antitussive agents|mesh-ancestor
110385764|NCT05181527|Respiratory System Agents|respiratory system agents|mesh-ancestor
110385765|NCT05181527|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110385766|NCT05181527|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110385767|NCT05181527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110385768|NCT05181527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110047293|NCT04294264|Oxaliplatin|oxaliplatin|mesh-list
110385769|NCT05181527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110385770|NCT05181527|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110385772|NCT05181527|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110385773|NCT05181527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110385774|NCT05180240|Cannabidiol|cannabidiol|mesh-list
110385775|NCT05180240|Anticonvulsants|anticonvulsants|mesh-ancestor
110385777|NCT05171075|Tinzaparin|tinzaparin|mesh-list
110385778|NCT05171075|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110385779|NCT05171075|Anticoagulants|anticoagulants|mesh-ancestor
110385780|NCT05171075|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110385781|NCT05171075|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110385782|NCT05171075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110385783|NCT05171049|Apixaban|apixaban|mesh-list
110385784|NCT05171049|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110385785|NCT05171049|Antithrombins|antithrombins|mesh-ancestor
110385786|NCT05171049|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110385787|NCT05171049|Protease Inhibitors|protease inhibitors|mesh-ancestor
110385788|NCT05171049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110385789|NCT05171049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110385790|NCT05171049|Anticoagulants|anticoagulants|mesh-ancestor
110385791|NCT05170399|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110385792|NCT05170399|Immunologic Factors|immunologic factors|mesh-ancestor
110385793|NCT05170399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110385794|NCT05161533|Cisplatin|cisplatin|mesh-list
110385795|NCT05161533|Carboplatin|carboplatin|mesh-list
110385796|NCT05161533|Etoposide|etoposide|mesh-list
110385797|NCT05161533|Etoposide phosphate|etoposide phosphate|mesh-list
110385798|NCT05161533|Durvalumab|durvalumab|mesh-list
110385799|NCT05161533|Podophyllotoxin|podophyllotoxin|mesh-list
110385800|NCT05161533|Immunoglobulins|immunoglobulins|mesh-list
110385801|NCT05161533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110385802|NCT05161533|Immunoglobulin G|immunoglobulin g|mesh-list
110385803|NCT05161533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110385804|NCT05161533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110385805|NCT05161533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110385806|NCT05161533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110385807|NCT05161533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110385808|NCT05161533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110385809|NCT05161533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110385810|NCT05161533|Immunologic Factors|immunologic factors|mesh-ancestor
110385811|NCT05161533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110385812|NCT05161533|Keratolytic Agents|keratolytic agents|mesh-ancestor
110385813|NCT05161533|Dermatologic Agents|dermatologic agents|mesh-ancestor
110385814|NCT05161533|Tubulin Modulators|tubulin modulators|mesh-ancestor
110385815|NCT05161533|Antimitotic Agents|antimitotic agents|mesh-ancestor
110385816|NCT05161533|Mitosis Modulators|mitosis modulators|mesh-ancestor
110385817|NCT05147376|Curcumin|curcumin|mesh-list
110385818|NCT05147376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110385819|NCT05147376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110385820|NCT05147376|Analgesics|analgesics|mesh-ancestor
110385821|NCT05147376|Sensory System Agents|sensory system agents|mesh-ancestor
110385822|NCT05147376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110385823|NCT05147376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110385824|NCT05147376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110385825|NCT05147376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110385826|NCT05147376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110385827|NCT05147376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110385828|NCT05147376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110385829|NCT05146739|Leucovorin|leucovorin|mesh-list
110385830|NCT05146739|Cytarabine|cytarabine|mesh-list
110385831|NCT05146739|Fludarabine|fludarabine|mesh-list
110385832|NCT05146739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110385833|NCT05146739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110385834|NCT05146739|Antimetabolites|antimetabolites|mesh-ancestor
110385835|NCT05146739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110385836|NCT05146739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110385837|NCT05146739|Immunologic Factors|immunologic factors|mesh-ancestor
110385838|NCT05146739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110385839|NCT05146739|Antiviral Agents|antiviral agents|mesh-ancestor
110385840|NCT05146739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110385841|NCT05146739|Antidotes|antidotes|mesh-ancestor
110385842|NCT05146739|Protective Agents|protective agents|mesh-ancestor
110385843|NCT05146739|Vitamin B Complex|vitamin b complex|mesh-ancestor
110385845|NCT05146739|Micronutrients|micronutrients|mesh-ancestor
110385846|NCT05118854|Cisplatin|cisplatin|mesh-list
110385847|NCT05118854|Carboplatin|carboplatin|mesh-list
110385848|NCT05118854|Pemetrexed|pemetrexed|mesh-list
110385849|NCT05118854|Sotorasib|sotorasib|mesh-list
110385850|NCT05118854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110385851|NCT05118854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110385852|NCT05118854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110385853|NCT05118854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110385854|NCT05118854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110385855|NCT05118854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110385856|NCT05118854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110385857|NCT05116007|Carboplatin|carboplatin|mesh-list
110385858|NCT05116007|Etoposide|etoposide|mesh-list
110385859|NCT05116007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110385860|NCT05116007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110385861|NCT05116007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110385862|NCT05116007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110385875|NCT05095376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110385876|NCT05095376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110385877|NCT05090358|Canagliflozin|canagliflozin|mesh-list
110385878|NCT05090358|Fulvestrant|fulvestrant|mesh-list
110385879|NCT05090358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110385880|NCT05090358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110385881|NCT05090358|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110385882|NCT05090358|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110385883|NCT05090358|Hormone Antagonists|hormone antagonists|mesh-ancestor
110385884|NCT05090358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110385885|NCT05090358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110385886|NCT05090358|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110385887|NCT05090358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110385888|NCT05090358|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110385889|NCT05086692|Pembrolizumab|pembrolizumab|mesh-list
110385890|NCT05086692|Interleukin-2|interleukin-2|mesh-list
110385891|NCT05086692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110385892|NCT05086692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110385893|NCT05086692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110385894|NCT05086692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110385895|NCT05086692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110385896|NCT05086692|Analgesics|analgesics|mesh-ancestor
110385897|NCT05086692|Sensory System Agents|sensory system agents|mesh-ancestor
110385898|NCT05086692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110385899|NCT05086692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110385900|NCT05083312|Fluticasone|fluticasone|mesh-list
110385901|NCT05083312|Xhance|xhance|mesh-list
110385902|NCT05083312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110385903|NCT05083312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110385904|NCT05083312|Autonomic Agents|autonomic agents|mesh-ancestor
110385905|NCT05083312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110385906|NCT05083312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110385907|NCT05083312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110385908|NCT05083312|Respiratory System Agents|respiratory system agents|mesh-ancestor
110385910|NCT05083312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110385911|NCT05080946|Aspirin|aspirin|mesh-list
110385912|NCT05080946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110385913|NCT05080946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110385914|NCT05080946|Analgesics|analgesics|mesh-ancestor
110385915|NCT05080946|Sensory System Agents|sensory system agents|mesh-ancestor
110385916|NCT05080946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110385917|NCT05080946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110385918|NCT05080946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110385919|NCT05080946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110385920|NCT05080946|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110385921|NCT05080946|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110385922|NCT05080946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110385923|NCT05080946|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110040203|NCT01432028|Estradiol|estradiol|mesh-list
110385924|NCT05080946|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110385925|NCT05080946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110385926|NCT05080946|Antipyretics|antipyretics|mesh-ancestor
110385927|NCT05079698|177Lu-PSMA-617|177lu-psma-617|mesh-list
110385928|NCT05079698|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110385929|NCT05079698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110385930|NCT05078138|Epoetin Alfa|epoetin alfa|mesh-list
110385931|NCT05078138|Hematinics|hematinics|mesh-ancestor
110385932|NCT05069935|Cyclophosphamide|cyclophosphamide|mesh-list
110385933|NCT05069935|Fludarabine|fludarabine|mesh-list
110385934|NCT05069935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110385935|NCT05069935|Antibodies|antibodies|mesh-list
110385936|NCT05069935|Immunoglobulins|immunoglobulins|mesh-list
110385937|NCT05069935|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110385938|NCT05069935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110385939|NCT05069935|Immunologic Factors|immunologic factors|mesh-ancestor
110385940|NCT05069935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110385941|NCT05069935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110385942|NCT05069935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110385943|NCT05069935|Alkylating Agents|alkylating agents|mesh-ancestor
110385944|NCT05069935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110385945|NCT05069935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110385946|NCT05069935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110385947|NCT05069545|Insulin|insulin|mesh-list
110385948|NCT05069545|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110385949|NCT05069545|Insulin Aspart|insulin aspart|mesh-list
110385950|NCT05069545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110385951|NCT05069545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110385952|NCT05062902|Botulinum Toxins|botulinum toxins|mesh-list
110385953|NCT05062902|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110385954|NCT05062902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110385955|NCT05062902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110385956|NCT05062902|Cholinergic Agents|cholinergic agents|mesh-ancestor
110385957|NCT05062902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110385958|NCT05062902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110385959|NCT05059522|Pemetrexed|pemetrexed|mesh-list
110385960|NCT05059522|Avelumab|avelumab|mesh-list
110385961|NCT05059522|Axitinib|axitinib|mesh-list
110385962|NCT05059522|Talazoparib|talazoparib|mesh-list
110385963|NCT05059522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110385964|NCT05059522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110386002|NCT05057247|Mitosis Modulators|mitosis modulators|mesh-ancestor
110386003|NCT05057247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110386005|NCT05053152|Androgen Antagonists|androgen antagonists|mesh-ancestor
110386006|NCT05053152|Hormone Antagonists|hormone antagonists|mesh-ancestor
110386007|NCT05053152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110386008|NCT05053152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110386009|NCT05050500|Dapagliflozin|dapagliflozin|mesh-list
110386010|NCT05050500|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110386011|NCT05050500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110386012|NCT05050500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110386013|NCT05050500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110386015|NCT05050162|1,2-diaminocyclohexaneplatinum II citrate|1,2-diaminocyclohexaneplatinum ii citrate|mesh-list
110386016|NCT05050162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110386017|NCT05050084|Leuprolide|leuprolide|mesh-list
110386018|NCT05050084|Goserelin|goserelin|mesh-list
110386019|NCT05050084|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110386020|NCT05050084|Flutamide|flutamide|mesh-list
110386021|NCT05050084|Bicalutamide|bicalutamide|mesh-list
110386022|NCT05050084|Tryptophan|tryptophan|mesh-list
110386023|NCT05050084|Buserelin|buserelin|mesh-list
110386024|NCT05050084|Hormones|hormones|mesh-list
110386025|NCT05050084|Relugolix|relugolix|mesh-list
110386026|NCT05050084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110386027|NCT05050084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110386028|NCT05050084|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110386029|NCT05050084|Fertility Agents|fertility agents|mesh-ancestor
110386030|NCT05050084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110386031|NCT05050084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110386032|NCT05050084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110386033|NCT05050084|Androgen Antagonists|androgen antagonists|mesh-ancestor
110386034|NCT05050084|Hormone Antagonists|hormone antagonists|mesh-ancestor
110386035|NCT05050084|Luteolytic Agents|luteolytic agents|mesh-ancestor
110386036|NCT05050084|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110386037|NCT05050084|Contraceptive Agents|contraceptive agents|mesh-ancestor
110386038|NCT05050084|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110386039|NCT05050084|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110386040|NCT05050084|Antidepressive Agents|antidepressive agents|mesh-ancestor
110386041|NCT05050084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110386042|NCT05045066|Vitamin D|vitamin d|mesh-list
110386043|NCT05045066|Cholecalciferol|cholecalciferol|mesh-list
110386044|NCT05045066|Vitamins|vitamins|mesh-ancestor
110386045|NCT05045066|Micronutrients|micronutrients|mesh-ancestor
110386046|NCT05045066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110047538|NCT03742102|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
110386047|NCT05045066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110386048|NCT05045066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110386049|NCT05043870|Infliximab|infliximab|mesh-list
110386050|NCT05043870|Immunosuppressive Agents|immunosuppressive agents|mesh-list
110386051|NCT05043870|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110386052|NCT05043870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110386053|NCT05043870|Dermatologic Agents|dermatologic agents|mesh-ancestor
110386054|NCT05043870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110386055|NCT05043870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110386056|NCT05043870|Immunologic Factors|immunologic factors|mesh-ancestor
110386057|NCT05043870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110386058|NCT05038839|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
110386059|NCT05038839|Pamiparib|pamiparib|mesh-list
110386060|NCT05038839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110386061|NCT05038839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110386062|NCT05038839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110386063|NCT05032183|Leucovorin|leucovorin|mesh-list
110386064|NCT05032183|Cytarabine|cytarabine|mesh-list
110386065|NCT05032183|Dexamethasone|dexamethasone|mesh-list
110386066|NCT05032183|Dexamethasone acetate|dexamethasone acetate|mesh-list
110386067|NCT05032183|Prednisone|prednisone|mesh-list
110386068|NCT05032183|Cortisone|cortisone|mesh-list
110386069|NCT05032183|Cyclophosphamide|cyclophosphamide|mesh-list
110386070|NCT05032183|Rituximab|rituximab|mesh-list
110386071|NCT05032183|Methotrexate|methotrexate|mesh-list
110386072|NCT05032183|Vincristine|vincristine|mesh-list
110386073|NCT05032183|Mercaptopurine|mercaptopurine|mesh-list
110386074|NCT05032183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110386075|NCT05032183|Antibodies|antibodies|mesh-list
110386076|NCT05032183|Immunoglobulins|immunoglobulins|mesh-list
110386077|NCT05032183|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110386079|NCT05032183|BB 1101|bb 1101|mesh-list
110386081|NCT05032183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110386082|NCT05032183|Immunologic Factors|immunologic factors|mesh-ancestor
110386083|NCT05032183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110386084|NCT05032183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110386085|NCT05032183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110386086|NCT05032183|Alkylating Agents|alkylating agents|mesh-ancestor
110386087|NCT05032183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110386088|NCT05032183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110386089|NCT05032183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110386090|NCT05032183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110386091|NCT05032183|Antiemetics|antiemetics|mesh-ancestor
110386092|NCT05032183|Autonomic Agents|autonomic agents|mesh-ancestor
110386093|NCT05032183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110386094|NCT05032183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110386095|NCT05032183|Glucocorticoids|glucocorticoids|mesh-ancestor
110386096|NCT05032183|Hormones|hormones|mesh-ancestor
110386097|NCT05032183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110386098|NCT05032183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110386099|NCT05032183|Protease Inhibitors|protease inhibitors|mesh-ancestor
110386100|NCT05032183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110386101|NCT05032183|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110386102|NCT05032183|Abortifacient Agents|abortifacient agents|mesh-ancestor
110386103|NCT05032183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110386104|NCT05032183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110386105|NCT05032183|Antimetabolites|antimetabolites|mesh-ancestor
110386106|NCT05032183|Dermatologic Agents|dermatologic agents|mesh-ancestor
110386107|NCT05032183|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110386108|NCT05032183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110386109|NCT05032183|Antiviral Agents|antiviral agents|mesh-ancestor
110386110|NCT05032183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110386111|NCT05032183|Antidotes|antidotes|mesh-ancestor
110386112|NCT05032183|Protective Agents|protective agents|mesh-ancestor
110386113|NCT05032183|Vitamin B Complex|vitamin b complex|mesh-ancestor
110386114|NCT05032183|Vitamins|vitamins|mesh-ancestor
110386115|NCT05032183|Micronutrients|micronutrients|mesh-ancestor
110386116|NCT05032183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110386117|NCT05032183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110386118|NCT05032183|Tubulin Modulators|tubulin modulators|mesh-ancestor
110386119|NCT05032183|Antimitotic Agents|antimitotic agents|mesh-ancestor
110386120|NCT05032183|Mitosis Modulators|mitosis modulators|mesh-ancestor
110386121|NCT05029596|Heparin|heparin|mesh-list
110386122|NCT05029596|Calcium heparin|calcium heparin|mesh-list
110386123|NCT05029596|Anticoagulants|anticoagulants|mesh-ancestor
110386124|NCT05029596|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110386125|NCT05029596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110386126|NCT05029596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110386127|NCT05027386|Irinotecan|irinotecan|mesh-list
110386128|NCT05027386|Temozolomide|temozolomide|mesh-list
110386129|NCT05027386|Apatinib|apatinib|mesh-list
110386130|NCT05027386|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110386131|NCT05027386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110386132|NCT05027386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110386133|NCT05027386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110386134|NCT05027386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110386135|NCT05027386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110386136|NCT05027386|Alkylating Agents|alkylating agents|mesh-ancestor
110386137|NCT05027386|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110386138|NCT05013229|Insulin|insulin|mesh-list
110386150|NCT05010434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110386152|NCT05004116|Irinotecan|irinotecan|mesh-list
110386153|NCT05004116|Temozolomide|temozolomide|mesh-list
110386154|NCT05004116|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110386155|NCT05004116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110386156|NCT05004116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110386157|NCT05004116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110386158|NCT05004116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110386159|NCT05004116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110386160|NCT05004116|Alkylating Agents|alkylating agents|mesh-ancestor
110386175|NCT04984993|Tadalafil|tadalafil|mesh-list
110386176|NCT04984993|Vasodilator Agents|vasodilator agents|mesh-ancestor
110386177|NCT04984993|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110386178|NCT04984993|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110386179|NCT04984993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110386180|NCT04984993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110386181|NCT04984993|Urological Agents|urological agents|mesh-ancestor
110386182|NCT04982848|Talazoparib|talazoparib|mesh-list
110386183|NCT04982848|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110386184|NCT04982848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110386185|NCT04982848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110386186|NCT04982848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110386187|NCT04979611|Exenatide|exenatide|mesh-list
110386188|NCT04979611|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110386189|NCT04979611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110386190|NCT04979611|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110386191|NCT04979611|Incretins|incretins|mesh-ancestor
110386192|NCT04979611|Hormones|hormones|mesh-ancestor
110386193|NCT04979611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110386194|NCT04971577|Simvastatin|simvastatin|mesh-list
110386195|NCT04971577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110386196|NCT04971577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110386197|NCT04971577|Antimetabolites|antimetabolites|mesh-ancestor
110386198|NCT04971577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110386199|NCT04971577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110386200|NCT04971577|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110386201|NCT04971577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110386202|NCT04967248|Fulvestrant|fulvestrant|mesh-list
110386203|NCT04967248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110386204|NCT04967248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110386205|NCT04967248|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110386206|NCT04967248|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110386207|NCT04967248|Hormone Antagonists|hormone antagonists|mesh-ancestor
110386208|NCT04967248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110386209|NCT04967248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110386211|NCT04964947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110386212|NCT04964947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110386213|NCT04952792|Apixaban|apixaban|mesh-list
110386214|NCT04952792|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110386215|NCT04952792|Antithrombins|antithrombins|mesh-ancestor
110386216|NCT04952792|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110386217|NCT04952792|Protease Inhibitors|protease inhibitors|mesh-ancestor
110386218|NCT04952792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110386219|NCT04952792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110386220|NCT04952792|Anticoagulants|anticoagulants|mesh-ancestor
110386221|NCT04952389|Budesonide|budesonide|mesh-list
110386222|NCT04952389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110386223|NCT04952389|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110386224|NCT04952389|Autonomic Agents|autonomic agents|mesh-ancestor
110386225|NCT04952389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110386226|NCT04952389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110386227|NCT04952389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110386228|NCT04952389|Respiratory System Agents|respiratory system agents|mesh-ancestor
110386229|NCT04952389|Glucocorticoids|glucocorticoids|mesh-ancestor
110386230|NCT04952389|Hormones|hormones|mesh-ancestor
110386231|NCT04952389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110386232|NCT04947631|Tadalafil|tadalafil|mesh-list
110386236|NCT04947631|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110386237|NCT04947631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110386238|NCT04947631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110386240|NCT04947631|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110386241|NCT04947631|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110386242|NCT04947631|Hormone Antagonists|hormone antagonists|mesh-ancestor
110386243|NCT04947631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110386244|NCT04947631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110386248|NCT04914910|Insulin|insulin|mesh-list
110386249|NCT04914910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110386250|NCT04914910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110386251|NCT04913610|Ivermectin|ivermectin|mesh-list
110386252|NCT04913610|Albendazole|albendazole|mesh-list
110386253|NCT04913610|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110386254|NCT04913610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110386255|NCT04913610|Anthelmintics|anthelmintics|mesh-ancestor
110386256|NCT04913610|Anticestodal Agents|anticestodal agents|mesh-ancestor
110386257|NCT04913610|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110386258|NCT04913610|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110386259|NCT04913610|Tubulin Modulators|tubulin modulators|mesh-ancestor
110386260|NCT04913610|Antimitotic Agents|antimitotic agents|mesh-ancestor
110386261|NCT04913610|Mitosis Modulators|mitosis modulators|mesh-ancestor
110386262|NCT04913610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110386263|NCT04913610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110386264|NCT04907851|Denosumab|denosumab|mesh-list
110386265|NCT04907851|Pembrolizumab|pembrolizumab|mesh-list
110386266|NCT04907851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110386267|NCT04907851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110386293|NCT04903197|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110386294|NCT04903197|Growth Substances|growth substances|mesh-ancestor
110386295|NCT04903197|Growth Inhibitors|growth inhibitors|mesh-ancestor
110386296|NCT04903197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110386297|NCT04895436|Venetoclax|venetoclax|mesh-list
110386298|NCT04895436|Obinutuzumab|obinutuzumab|mesh-list
110386299|NCT04895436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110386300|NCT04895436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110386301|NCT04893161|Belimumab|belimumab|mesh-list
110386302|NCT04893161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110386303|NCT04893161|Immunologic Factors|immunologic factors|mesh-ancestor
110386304|NCT04893161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110386306|NCT04892446|Bortezomib|bortezomib|mesh-list
110386307|NCT04892446|Daratumumab|daratumumab|mesh-list
110386308|NCT04892446|Pomalidomide|pomalidomide|mesh-list
110386309|NCT04892446|Magrolimab|magrolimab|mesh-list
110386310|NCT04892446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110386311|NCT04892446|Antiemetics|antiemetics|mesh-ancestor
110386312|NCT04892446|Autonomic Agents|autonomic agents|mesh-ancestor
110386313|NCT04892446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110386314|NCT04892446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110386315|NCT04892446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110386316|NCT04892446|Glucocorticoids|glucocorticoids|mesh-ancestor
110386317|NCT04892446|Hormones|hormones|mesh-ancestor
110386318|NCT04892446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110386319|NCT04892446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110386320|NCT04892446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110386321|NCT04892446|Immunologic Factors|immunologic factors|mesh-ancestor
110386322|NCT04892446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110386323|NCT04892446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110386324|NCT04892446|Growth Substances|growth substances|mesh-ancestor
110386325|NCT04892446|Growth Inhibitors|growth inhibitors|mesh-ancestor
110386326|NCT04892446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110386327|NCT04891757|Cytarabine|cytarabine|mesh-list
110386328|NCT04891757|Decitabine|decitabine|mesh-list
110386329|NCT04891757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110386331|NCT04891757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110386332|NCT04891757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110386333|NCT04891757|Antiviral Agents|antiviral agents|mesh-ancestor
110386334|NCT04891757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110386335|NCT04891757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110386336|NCT04891757|Immunologic Factors|immunologic factors|mesh-ancestor
110386337|NCT04891757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110386338|NCT04891757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110386339|NCT04890470|Vasopressins|vasopressins|mesh-list
110386340|NCT04890470|Arginine Vasopressin|arginine vasopressin|mesh-list
110386341|NCT04890470|Oxytocin|oxytocin|mesh-list
110386342|NCT04890470|Oxytocics|oxytocics|mesh-ancestor
110386343|NCT04890470|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110386344|NCT04890470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110386346|NCT04890470|Coagulants|coagulants|mesh-ancestor
110386347|NCT04890470|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110386348|NCT04890470|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110386349|NCT04890470|Natriuretic Agents|natriuretic agents|mesh-ancestor
110386350|NCT04883645|Imiquimod|imiquimod|mesh-list
110386351|NCT04883645|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110386352|NCT04883645|Immunologic Factors|immunologic factors|mesh-ancestor
110386353|NCT04883645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110386354|NCT04883645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110386355|NCT04883645|Interferon Inducers|interferon inducers|mesh-ancestor
110386356|NCT04878211|Interferons|interferons|mesh-list
110386357|NCT04878211|Ofatumumab|ofatumumab|mesh-list
110386358|NCT04878211|Glatiramer Acetate|glatiramer acetate|mesh-list
110386359|NCT04878211|(T,G)-A-L|(t,g)-a-l|mesh-list
110386360|NCT04878211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110386361|NCT04878211|Antiviral Agents|antiviral agents|mesh-ancestor
110386362|NCT04878211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110386363|NCT04878211|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110386364|NCT04878211|Immunologic Factors|immunologic factors|mesh-ancestor
110386365|NCT04878211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110386366|NCT04878211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110386367|NCT04878211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110386368|NCT04876248|Lenalidomide|lenalidomide|mesh-list
110386369|NCT04876248|Immunologic Factors|immunologic factors|mesh-ancestor
110386370|NCT04876248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110386371|NCT04876248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110386372|NCT04876248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110386373|NCT04876248|Growth Substances|growth substances|mesh-ancestor
110386374|NCT04876248|Growth Inhibitors|growth inhibitors|mesh-ancestor
110386375|NCT04876248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110386376|NCT04865159|Tipifarnib|tipifarnib|mesh-list
110386377|NCT04865159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110386378|NCT04864210|Bupivacaine|bupivacaine|mesh-list
110386379|NCT04864210|Anesthetics, Local|anesthetics, local|mesh-ancestor
110386380|NCT04864210|Anesthetics|anesthetics|mesh-ancestor
110386381|NCT04864210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110386382|NCT04864210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110386383|NCT04864210|Sensory System Agents|sensory system agents|mesh-ancestor
110386384|NCT04864210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110386385|NCT04858334|Olaparib|olaparib|mesh-list
110386386|NCT04858334|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
110386387|NCT04858334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110386388|NCT04858334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110386389|NCT04858334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110386390|NCT04849390|Mometasone Furoate|mometasone furoate|mesh-list
110386391|NCT04849390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110386392|NCT04849390|Dermatologic Agents|dermatologic agents|mesh-ancestor
110386393|NCT04849390|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110386394|NCT04831541|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110386395|NCT04831541|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110386396|NCT04831541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110386397|NCT04829760|Psyllium|psyllium|mesh-list
110386398|NCT04829760|Cathartics|cathartics|mesh-ancestor
110386399|NCT04829760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110386400|NCT04828031|Vitamin D|vitamin d|mesh-list
110386401|NCT04828031|Vitamins|vitamins|mesh-ancestor
110386402|NCT04828031|Micronutrients|micronutrients|mesh-ancestor
110386403|NCT04828031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110386404|NCT04828031|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110386405|NCT04825496|Cyclophosphamide|cyclophosphamide|mesh-list
110386407|NCT04825496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110386408|NCT04825496|Immunologic Factors|immunologic factors|mesh-ancestor
110386409|NCT04825496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110386410|NCT04825496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110386411|NCT04825496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110386412|NCT04825496|Alkylating Agents|alkylating agents|mesh-ancestor
110386413|NCT04825496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110386414|NCT04825496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110386415|NCT04825496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110386416|NCT04810078|Nivolumab|nivolumab|mesh-list
110386417|NCT04810078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110386418|NCT04810078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110386419|NCT04810078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110386420|NCT04810078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110386421|NCT04809220|Dulaglutide|dulaglutide|mesh-list
110386422|NCT04809220|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110386423|NCT04809220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110386424|NCT04804644|Memantine|memantine|mesh-list
110386425|NCT04804644|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110386426|NCT04804644|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110386427|NCT04804644|Dopamine Agents|dopamine agents|mesh-ancestor
110386428|NCT04804644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110386429|NCT04804644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110386430|NCT04804644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110386431|NCT04804644|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110386432|NCT04804644|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110386434|NCT04800471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110386435|NCT04800471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110386436|NCT04798755|Adalimumab|adalimumab|mesh-list
110386437|NCT04798755|Methotrexate|methotrexate|mesh-list
110386438|NCT04798755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110386439|NCT04798755|Abortifacient Agents|abortifacient agents|mesh-ancestor
110386440|NCT04798755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110386441|NCT04798755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110386442|NCT04798755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110386443|NCT04798755|Antimetabolites|antimetabolites|mesh-ancestor
110386444|NCT04798755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110386445|NCT04798755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110386446|NCT04798755|Dermatologic Agents|dermatologic agents|mesh-ancestor
110386447|NCT04798755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110386448|NCT04798755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110386449|NCT04798755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110386450|NCT04798755|Immunologic Factors|immunologic factors|mesh-ancestor
110386451|NCT04798755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110386452|NCT04798755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110386453|NCT04798755|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110386454|NCT04798755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110386455|NCT04792073|Avelumab|avelumab|mesh-list
110386456|NCT04792073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110386457|NCT04792073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110386458|NCT04789408|Cyclophosphamide|cyclophosphamide|mesh-list
110386459|NCT04789408|Fludarabine|fludarabine|mesh-list
110386460|NCT04789408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110386461|NCT04789408|Immunologic Factors|immunologic factors|mesh-ancestor
110386462|NCT04789408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110386463|NCT04789408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110386464|NCT04789408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110386465|NCT04789408|Alkylating Agents|alkylating agents|mesh-ancestor
110386466|NCT04789408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110386467|NCT04789408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110386468|NCT04789408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110386469|NCT04786340|Pirenzepine|pirenzepine|mesh-list
110386470|NCT04786340|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110386471|NCT04786340|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110386472|NCT04786340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110386473|NCT04786340|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110386474|NCT04786340|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110386475|NCT04786340|Cholinergic Agents|cholinergic agents|mesh-ancestor
110386476|NCT04786340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110386477|NCT04786340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110386478|NCT04786340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110386479|NCT04777201|Faricimab|faricimab|mesh-list
110386480|NCT04777201|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110386481|NCT04777201|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110386482|NCT04777201|Growth Substances|growth substances|mesh-ancestor
110386483|NCT04777201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110386484|NCT04777201|Growth Inhibitors|growth inhibitors|mesh-ancestor
110386485|NCT04777201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110386486|NCT04775550|Dexamethasone|dexamethasone|mesh-list
110386487|NCT04775550|Lenalidomide|lenalidomide|mesh-list
110386488|NCT04775550|Bortezomib|bortezomib|mesh-list
110386489|NCT04775550|Daratumumab|daratumumab|mesh-list
110386490|NCT04775550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110386491|NCT04775550|Antiemetics|antiemetics|mesh-ancestor
110386492|NCT04775550|Autonomic Agents|autonomic agents|mesh-ancestor
110386493|NCT04775550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110386494|NCT04775550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110386495|NCT04775550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110386496|NCT04775550|Glucocorticoids|glucocorticoids|mesh-ancestor
110386497|NCT04775550|Hormones|hormones|mesh-ancestor
110386498|NCT04775550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110386499|NCT04775550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110386500|NCT04775550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110386501|NCT04775550|Immunologic Factors|immunologic factors|mesh-ancestor
110386502|NCT04775550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110386503|NCT04775550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110386504|NCT04775550|Growth Substances|growth substances|mesh-ancestor
110386505|NCT04775550|Growth Inhibitors|growth inhibitors|mesh-ancestor
110386506|NCT04775082|Liraglutide|liraglutide|mesh-list
110386507|NCT04775082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110386508|NCT04775082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110386509|NCT04775082|Incretins|incretins|mesh-ancestor
110386510|NCT04775082|Hormones|hormones|mesh-ancestor
110386511|NCT04775082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110386512|NCT04774991|Azithromycin|azithromycin|mesh-list
110386513|NCT04774991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110386514|NCT04774991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110386515|NCT04764162|Choline|choline|mesh-list
110386516|NCT04764162|Lipotropic Agents|lipotropic agents|mesh-ancestor
110386517|NCT04764162|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110386518|NCT04764162|Antimetabolites|antimetabolites|mesh-ancestor
110386519|NCT04764162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110386520|NCT04764162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110386521|NCT04764162|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110386522|NCT04764162|Nootropic Agents|nootropic agents|mesh-ancestor
110386523|NCT04760613|Cannabidiol|cannabidiol|mesh-list
110386524|NCT04760613|Anticonvulsants|anticonvulsants|mesh-ancestor
110386525|NCT04750954|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
110386526|NCT04750954|Peposertib|peposertib|mesh-list
110386527|NCT04750954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110386528|NCT04750954|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110386529|NCT04750954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110386530|NCT04750954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110386531|NCT04746924|Pembrolizumab|pembrolizumab|mesh-list
110386532|NCT04746924|Tislelizumab|tislelizumab|mesh-list
110386533|NCT04746924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110386534|NCT04746924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110386535|NCT04746924|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110386536|NCT04746924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110386538|NCT04744883|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110386539|NCT04744883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110386540|NCT04744883|Sensory System Agents|sensory system agents|mesh-ancestor
110386541|NCT04744883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110386543|NCT04740697|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110386544|NCT04740697|Hormone Antagonists|hormone antagonists|mesh-ancestor
110386545|NCT04740697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110386546|NCT04740697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110386547|NCT04740697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110386548|NCT04740697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110386549|NCT04740697|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110386550|NCT04740697|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110386551|NCT04740697|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110386552|NCT04736173|Paclitaxel|paclitaxel|mesh-list
110386553|NCT04736173|Carboplatin|carboplatin|mesh-list
110386554|NCT04736173|Pembrolizumab|pembrolizumab|mesh-list
110386555|NCT04736173|Pemetrexed|pemetrexed|mesh-list
110386556|NCT04736173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110386557|NCT04736173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110386558|NCT04736173|Tubulin Modulators|tubulin modulators|mesh-ancestor
110386559|NCT04736173|Antimitotic Agents|antimitotic agents|mesh-ancestor
110386560|NCT04736173|Mitosis Modulators|mitosis modulators|mesh-ancestor
110386561|NCT04736173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110386562|NCT04736173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110386563|NCT04736173|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110386564|NCT04736173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110386565|NCT04736173|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110386566|NCT04736173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110386567|NCT04732494|Tislelizumab|tislelizumab|mesh-list
110386568|NCT04732494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110386569|NCT04732494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110386571|NCT04721132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110386572|NCT04721132|Atezolizumab|atezolizumab|mesh-list
110386573|NCT04721132|Endothelial Growth Factors|endothelial growth factors|mesh-list
110386575|NCT04721132|Immunoglobulins|immunoglobulins|mesh-list
110386576|NCT04721132|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110386577|NCT04721132|Immunoglobulin G|immunoglobulin g|mesh-list
110386578|NCT04721132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110386579|NCT04721132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110386580|NCT04721132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110386581|NCT04721132|Growth Substances|growth substances|mesh-ancestor
110386582|NCT04721132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110386583|NCT04721132|Growth Inhibitors|growth inhibitors|mesh-ancestor
110386584|NCT04721132|Immunologic Factors|immunologic factors|mesh-ancestor
110386585|NCT04721132|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110386586|NCT04721132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110386587|NCT04720157|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110386588|NCT04720157|177Lu-PSMA-617|177lu-psma-617|mesh-list
110386589|NCT04720157|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110386590|NCT04720157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110386591|NCT04717375|Carboplatin|carboplatin|mesh-list
110386592|NCT04717375|Pembrolizumab|pembrolizumab|mesh-list
110386593|NCT04717375|Pemetrexed|pemetrexed|mesh-list
110386594|NCT04717375|Cetuximab|cetuximab|mesh-list
110386595|NCT04717375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110386596|NCT04717375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110386597|NCT04717375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110386598|NCT04717375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110386599|NCT04717375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110386600|NCT04717375|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110386601|NCT04717375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110386602|NCT04714359|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
110386603|NCT04714359|Hallucinogens|hallucinogens|mesh-ancestor
110386604|NCT04714359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110386605|NCT04714359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110386606|NCT04714359|Serotonin Agents|serotonin agents|mesh-ancestor
110386607|NCT04714359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110386608|NCT04714359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110386609|NCT04714359|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110386610|NCT04714359|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110386611|NCT04714359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110386612|NCT04714359|Adrenergic Agents|adrenergic agents|mesh-ancestor
110386613|NCT04701476|Pembrolizumab|pembrolizumab|mesh-list
110386614|NCT04701476|Tirapazamine|tirapazamine|mesh-list
110386615|NCT04701476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110386616|NCT04701476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110386617|NCT04701476|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110386618|NCT04701476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110386619|NCT04674813|Cyclophosphamide|cyclophosphamide|mesh-list
110386620|NCT04674813|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110386621|NCT04674813|Fludarabine|fludarabine|mesh-list
110386622|NCT04674813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110386623|NCT04674813|Immunologic Factors|immunologic factors|mesh-ancestor
110386624|NCT04674813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110386625|NCT04674813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110386626|NCT04674813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110386653|NCT04620746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110386654|NCT04620746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110386655|NCT04614909|Temozolomide|temozolomide|mesh-list
110386656|NCT04614909|Olaparib|olaparib|mesh-list
110386657|NCT04614909|Pamiparib|pamiparib|mesh-list
110386658|NCT04614909|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110386659|NCT04614909|Alkylating Agents|alkylating agents|mesh-ancestor
110386660|NCT04614909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110386661|NCT04614909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110386662|NCT04614909|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110386664|NCT04614636|Cyclophosphamide|cyclophosphamide|mesh-list
110386665|NCT04614636|Fludarabine|fludarabine|mesh-list
110386666|NCT04614636|Daratumumab|daratumumab|mesh-list
110386667|NCT04614636|Elotuzumab|elotuzumab|mesh-list
110386668|NCT04614636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110386669|NCT04614636|Immunologic Factors|immunologic factors|mesh-ancestor
110386670|NCT04614636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110386671|NCT04614636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110386672|NCT04614636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110386673|NCT04614636|Alkylating Agents|alkylating agents|mesh-ancestor
110386674|NCT04614636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110386675|NCT04614636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110386676|NCT04614636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110386677|NCT04599634|Venetoclax|venetoclax|mesh-list
110386678|NCT04599634|Obinutuzumab|obinutuzumab|mesh-list
110386679|NCT04599634|Magrolimab|magrolimab|mesh-list
110386680|NCT04599634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110386681|NCT04599634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110386682|NCT04596995|Rozanolixizumab|rozanolixizumab|mesh-list
110386683|NCT04596995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110386684|NCT04596995|Immunologic Factors|immunologic factors|mesh-ancestor
110386688|NCT04593927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110386689|NCT04593927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110386690|NCT04593927|Immunologic Factors|immunologic factors|mesh-ancestor
110386691|NCT04593927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110386693|NCT04592809|Ketamine|ketamine|mesh-list
110386694|NCT04592809|Analgesics|analgesics|mesh-ancestor
110386695|NCT04592809|Sensory System Agents|sensory system agents|mesh-ancestor
110386696|NCT04592809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110386697|NCT04592809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110386698|NCT04592809|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110386699|NCT04592809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110386700|NCT04592809|Anesthetics, General|anesthetics, general|mesh-ancestor
110386701|NCT04592809|Anesthetics|anesthetics|mesh-ancestor
110386702|NCT04592809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110386703|NCT04592809|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110386704|NCT04592809|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110386705|NCT04592809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110386706|NCT04592809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110386707|NCT04592809|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110386708|NCT04592809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110386709|NCT04592809|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110386710|NCT04592809|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110386711|NCT04592809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110386712|NCT04592809|GABA Modulators|gaba modulators|mesh-ancestor
110386713|NCT04592809|GABA Agents|gaba agents|mesh-ancestor
110386714|NCT04588246|Memantine|memantine|mesh-list
110386715|NCT04588246|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110386716|NCT04588246|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110386717|NCT04588246|Dopamine Agents|dopamine agents|mesh-ancestor
110386718|NCT04588246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110386719|NCT04588246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110386720|NCT04588246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110386721|NCT04588246|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110386722|NCT04588246|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110386723|NCT04586023|Teriflunomide|teriflunomide|mesh-list
110386724|NCT04586023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110386725|NCT04586023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110386726|NCT04586023|Analgesics|analgesics|mesh-ancestor
110386727|NCT04586023|Sensory System Agents|sensory system agents|mesh-ancestor
110386728|NCT04586023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110386729|NCT04586023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110386730|NCT04586023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110386731|NCT04586023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110386732|NCT04586023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110386733|NCT04586023|Immunologic Factors|immunologic factors|mesh-ancestor
110386734|NCT04564755|Abrocitinib|abrocitinib|mesh-list
110386735|NCT04564755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110386736|NCT04564755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110386737|NCT04564755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110386793|NCT04551885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110386794|NCT04551885|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110386795|NCT04551885|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110386796|NCT04551885|Antiviral Agents|antiviral agents|mesh-ancestor
110386797|NCT04551885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110386798|NCT04551885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110386799|NCT04548752|Pembrolizumab|pembrolizumab|mesh-list
110386800|NCT04548752|Olaparib|olaparib|mesh-list
110386801|NCT04548752|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
110048134|NCT02131597|Azacitidine|azacitidine|mesh-list
110386802|NCT04548752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110386803|NCT04548752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110386804|NCT04548752|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110386805|NCT04548752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110386806|NCT04548752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110386807|NCT04545762|Cyclophosphamide|cyclophosphamide|mesh-list
110386808|NCT04545762|Fludarabine|fludarabine|mesh-list
110386809|NCT04545762|Fludarabine phosphate|fludarabine phosphate|mesh-list
110386810|NCT04545762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110386811|NCT04545762|Immunologic Factors|immunologic factors|mesh-ancestor
110386812|NCT04545762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110386813|NCT04545762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110386814|NCT04545762|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110386815|NCT04545762|Alkylating Agents|alkylating agents|mesh-ancestor
110386816|NCT04545762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110386817|NCT04545762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110386818|NCT04545762|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110386819|NCT04545762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110386820|NCT04545762|Antimetabolites|antimetabolites|mesh-ancestor
110386821|NCT04545242|Dexamethasone|dexamethasone|mesh-list
110386822|NCT04545242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110386922|NCT04516447|Doxorubicin|doxorubicin|mesh-list
110386923|NCT04516447|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110386924|NCT04516447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110386925|NCT04516447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110386926|NCT04516447|Tubulin Modulators|tubulin modulators|mesh-ancestor
110386927|NCT04516447|Antimitotic Agents|antimitotic agents|mesh-ancestor
110386928|NCT04516447|Mitosis Modulators|mitosis modulators|mesh-ancestor
110386929|NCT04516447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110386930|NCT04516447|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110386931|NCT04516447|Antimetabolites|antimetabolites|mesh-ancestor
110386932|NCT04516447|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110386933|NCT04516447|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110386934|NCT04516447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110386935|NCT04516447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110386936|NCT04515186|Miltefosine|miltefosine|mesh-list
110386937|NCT04515186|Meglumine Antimoniate|meglumine antimoniate|mesh-list
110386938|NCT04515186|Antifungal Agents|antifungal agents|mesh-ancestor
110386939|NCT04515186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110386940|NCT04515186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110386941|NCT04515186|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110386942|NCT04515186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110386944|NCT04513717|Goserelin|goserelin|mesh-list
110386945|NCT04513717|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110386946|NCT04513717|Flutamide|flutamide|mesh-list
110386947|NCT04513717|Bicalutamide|bicalutamide|mesh-list
110386948|NCT04513717|Tryptophan|tryptophan|mesh-list
110386949|NCT04513717|Buserelin|buserelin|mesh-list
110386950|NCT04513717|Hormones|hormones|mesh-list
110386951|NCT04513717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110386952|NCT04513717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110386953|NCT04513717|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110386954|NCT04513717|Fertility Agents|fertility agents|mesh-ancestor
110386955|NCT04513717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110386956|NCT04513717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110386957|NCT04513717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110386958|NCT04513717|Androgen Antagonists|androgen antagonists|mesh-ancestor
110386959|NCT04513717|Hormone Antagonists|hormone antagonists|mesh-ancestor
110386960|NCT04513717|Luteolytic Agents|luteolytic agents|mesh-ancestor
110386961|NCT04513717|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110386962|NCT04513717|Contraceptive Agents|contraceptive agents|mesh-ancestor
110386963|NCT04513717|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110386965|NCT04513717|Antidepressive Agents|antidepressive agents|mesh-ancestor
110386966|NCT04513717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110386969|NCT04505254|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
110386970|NCT04505254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110386971|NCT04505254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110386972|NCT04505254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110386973|NCT04505254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110386974|NCT04505254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110386975|NCT04504669|Durvalumab|durvalumab|mesh-list
110386976|NCT04504669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110386977|NCT04504669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110386978|NCT04502693|Vaccines|vaccines|mesh-list
110386979|NCT04502693|Immunologic Factors|immunologic factors|mesh-ancestor
110386980|NCT04502693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110386981|NCT04491136|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110386982|NCT04491136|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110386983|NCT04491136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110386984|NCT04485559|Everolimus|everolimus|mesh-list
110386985|NCT04485559|Trametinib|trametinib|mesh-list
110386986|NCT04485559|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110386987|NCT04485559|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110386988|NCT04485559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110386989|NCT04485559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110386990|NCT04485559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110386991|NCT04485559|Immunologic Factors|immunologic factors|mesh-ancestor
110386992|NCT04485559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110386993|NCT04485559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110386994|NCT04478279|Temozolomide|temozolomide|mesh-list
110386995|NCT04478279|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110386996|NCT04478279|Alkylating Agents|alkylating agents|mesh-ancestor
110386997|NCT04478279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110386998|NCT04478279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110387001|NCT04466150|Ocrelizumab|ocrelizumab|mesh-list
110387002|NCT04466150|Immunologic Factors|immunologic factors|mesh-ancestor
110387003|NCT04466150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110387004|NCT04464265|Propofol|propofol|mesh-list
110387005|NCT04464265|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110387006|NCT04464265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110387007|NCT04464265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110387008|NCT04464265|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110387009|NCT04464265|Anesthetics, General|anesthetics, general|mesh-ancestor
110387010|NCT04464265|Anesthetics|anesthetics|mesh-ancestor
110387011|NCT04462328|Durvalumab|durvalumab|mesh-list
110387012|NCT04462328|Acalabrutinib|acalabrutinib|mesh-list
110387013|NCT04462328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110387014|NCT04462328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110387015|NCT04450173|Venetoclax|venetoclax|mesh-list
110387016|NCT04450173|Obinutuzumab|obinutuzumab|mesh-list
110387017|NCT04450173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110387018|NCT04450173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110387019|NCT04448184|Tranexamic Acid|tranexamic acid|mesh-list
110387020|NCT04448184|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110387021|NCT04448184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110387022|NCT04448184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110387023|NCT04448184|Hemostatics|hemostatics|mesh-ancestor
110387025|NCT04437888|Ketamine|ketamine|mesh-list
110387026|NCT04437888|Analgesics|analgesics|mesh-ancestor
110387027|NCT04437888|Sensory System Agents|sensory system agents|mesh-ancestor
110387028|NCT04437888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110387029|NCT04437888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110387030|NCT04437888|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110387031|NCT04437888|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110387032|NCT04437888|Anesthetics, General|anesthetics, general|mesh-ancestor
110387033|NCT04437888|Anesthetics|anesthetics|mesh-ancestor
110387034|NCT04437888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110387035|NCT04437888|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110387036|NCT04437888|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110387037|NCT04437888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110387038|NCT04437888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110387039|NCT04432506|Cyclophosphamide|cyclophosphamide|mesh-list
110387040|NCT04432506|Fludarabine|fludarabine|mesh-list
110387041|NCT04432506|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
110387042|NCT04432506|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110387043|NCT04432506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110387044|NCT04432506|Immunologic Factors|immunologic factors|mesh-ancestor
110387045|NCT04432506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110387046|NCT04432506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110387047|NCT04432506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110387048|NCT04432506|Alkylating Agents|alkylating agents|mesh-ancestor
110387049|NCT04432506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110387050|NCT04432506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110387051|NCT04432506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110387052|NCT04432506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110387053|NCT04417062|Olaparib|olaparib|mesh-list
110387054|NCT04417062|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110387055|NCT04417062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110387056|NCT04417062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110387057|NCT04417062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110387058|NCT04410796|Carboplatin|carboplatin|mesh-list
110387059|NCT04410796|Pemetrexed|pemetrexed|mesh-list
110387060|NCT04410796|Osimertinib|osimertinib|mesh-list
110387061|NCT04410796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110387062|NCT04410796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110387063|NCT04410796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110041308|NCT05164159|Anesthetics, General|anesthetics, general|mesh-ancestor
110387065|NCT04410796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110387066|NCT04410796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110387067|NCT04408625|Sirolimus|sirolimus|mesh-list
110387068|NCT04408625|Prednisone|prednisone|mesh-list
110387069|NCT04408625|Methylprednisolone|methylprednisolone|mesh-list
110387070|NCT04408625|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110387071|NCT04408625|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110387072|NCT04408625|Prednisolone|prednisolone|mesh-list
110387073|NCT04408625|Prednisolone acetate|prednisolone acetate|mesh-list
110387074|NCT04408625|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110387075|NCT04408625|Prednisolone phosphate|prednisolone phosphate|mesh-list
110387076|NCT04408625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110387077|NCT04408625|Glucocorticoids|glucocorticoids|mesh-ancestor
110387078|NCT04408625|Hormones|hormones|mesh-ancestor
110387079|NCT04408625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110387080|NCT04408625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110387081|NCT04408625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110387082|NCT04408625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110387083|NCT04408625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110387084|NCT04408625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110387085|NCT04408625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110387086|NCT04408625|Antifungal Agents|antifungal agents|mesh-ancestor
110387087|NCT04408625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110387089|NCT04408625|Antiemetics|antiemetics|mesh-ancestor
110387090|NCT04408625|Autonomic Agents|autonomic agents|mesh-ancestor
110387091|NCT04408625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110387092|NCT04408625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110387093|NCT04408625|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110387094|NCT04408625|Protective Agents|protective agents|mesh-ancestor
110387095|NCT04406389|Heparin|heparin|mesh-list
110387096|NCT04406389|Calcium heparin|calcium heparin|mesh-list
110387097|NCT04406389|Enoxaparin|enoxaparin|mesh-list
110387098|NCT04406389|Enoxaparin sodium|enoxaparin sodium|mesh-list
110387099|NCT04406389|Argatroban|argatroban|mesh-list
110387100|NCT04406389|Anticoagulants|anticoagulants|mesh-ancestor
110387101|NCT04406389|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110387102|NCT04406389|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110387103|NCT04406389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110387104|NCT04406389|Antithrombins|antithrombins|mesh-ancestor
110387105|NCT04406389|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110387106|NCT04406389|Protease Inhibitors|protease inhibitors|mesh-ancestor
110387107|NCT04406389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110387108|NCT04406389|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110387109|NCT04394858|Temozolomide|temozolomide|mesh-list
110387110|NCT04394858|Olaparib|olaparib|mesh-list
110387111|NCT04394858|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
110387112|NCT04394858|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110387113|NCT04394858|Alkylating Agents|alkylating agents|mesh-ancestor
110387114|NCT04394858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110387115|NCT04394858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110387116|NCT04394858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110387118|NCT04387201|Hydroxocobalamin|hydroxocobalamin|mesh-list
110387119|NCT04387201|Dulaglutide|dulaglutide|mesh-list
110387120|NCT04387201|Vitamins|vitamins|mesh-ancestor
110387121|NCT04387201|Micronutrients|micronutrients|mesh-ancestor
110387122|NCT04387201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110387123|NCT04387201|Vitamin B Complex|vitamin b complex|mesh-ancestor
110387124|NCT04387201|Hematinics|hematinics|mesh-ancestor
110387125|NCT04387201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110387126|NCT04384484|Rituximab|rituximab|mesh-list
110387127|NCT04384484|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
110387128|NCT04384484|Gemcitabine|gemcitabine|mesh-list
110387129|NCT04384484|Oxaliplatin|oxaliplatin|mesh-list
110387130|NCT04384484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110387131|NCT04384484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110387132|NCT04384484|Immunologic Factors|immunologic factors|mesh-ancestor
110387133|NCT04384484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110387134|NCT04384484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110387135|NCT04384484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110387136|NCT04384484|Antimetabolites|antimetabolites|mesh-ancestor
110387137|NCT04384484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110387138|NCT04380857|Dexamethasone|dexamethasone|mesh-list
110387139|NCT04380857|Prednisolone|prednisolone|mesh-list
110387140|NCT04380857|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110387141|NCT04380857|Methylprednisolone|methylprednisolone|mesh-list
110387142|NCT04380857|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110387143|NCT04380857|Prednisolone acetate|prednisolone acetate|mesh-list
110387144|NCT04380857|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110387145|NCT04380857|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110387146|NCT04380857|Prednisolone phosphate|prednisolone phosphate|mesh-list
110387147|NCT04380857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110387148|NCT04380857|Antiemetics|antiemetics|mesh-ancestor
110387149|NCT04380857|Autonomic Agents|autonomic agents|mesh-ancestor
110387150|NCT04380857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110387151|NCT04380857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110387152|NCT04380857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110387153|NCT04380857|Glucocorticoids|glucocorticoids|mesh-ancestor
110387154|NCT04380857|Hormones|hormones|mesh-ancestor
110387155|NCT04380857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110387156|NCT04380857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110387157|NCT04380857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110387158|NCT04380857|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110387159|NCT04380857|Protective Agents|protective agents|mesh-ancestor
110387160|NCT04380857|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110387161|NCT04356729|Bevacizumab|bevacizumab|mesh-list
110387162|NCT04356729|Atezolizumab|atezolizumab|mesh-list
110387163|NCT04356729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110387170|NCT04356729|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110387171|NCT04356729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110387172|NCT04353492|Ofatumumab|ofatumumab|mesh-list
110387173|NCT04353492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110387180|NCT04333576|Contraceptive Agents|contraceptive agents|mesh-list
110387181|NCT04333576|Contraceptives, Oral|contraceptives, oral|mesh-list
110387182|NCT04333576|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
110387183|NCT04333576|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110387184|NCT04333576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110387185|NCT04333576|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110387187|NCT04329650|Siltuximab|siltuximab|mesh-list
110387195|NCT04329650|Hormones|hormones|mesh-ancestor
110387196|NCT04329650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110387197|NCT04329650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110387198|NCT04329650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110387199|NCT04327310|Meplazumab|meplazumab|mesh-list
110387200|NCT04327310|Antiviral Agents|antiviral agents|mesh-ancestor
110387201|NCT04327310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110387202|NCT04307134|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
110387203|NCT04307134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110387204|NCT04307134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110387205|NCT04307134|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110387206|NCT04307134|Immunotoxins|immunotoxins|mesh-ancestor
110387207|NCT04307134|Immunoconjugates|immunoconjugates|mesh-ancestor
110387208|NCT04307134|Immunologic Factors|immunologic factors|mesh-ancestor
110387209|NCT04307134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110387210|NCT04282187|Azacitidine|azacitidine|mesh-list
110387211|NCT04282187|Decitabine|decitabine|mesh-list
110387212|NCT04282187|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
110387213|NCT04282187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110387214|NCT04282187|Antimetabolites|antimetabolites|mesh-ancestor
110387215|NCT04282187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110387216|NCT04282187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110387217|NCT04282187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110387218|NCT04282187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110387226|NCT04275336|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
110387227|NCT04275336|Anesthetics, Local|anesthetics, local|mesh-ancestor
110387228|NCT04275336|Anesthetics|anesthetics|mesh-ancestor
110387229|NCT04275336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110387230|NCT04275336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110387231|NCT04275336|Sensory System Agents|sensory system agents|mesh-ancestor
110387232|NCT04275336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110387233|NCT04275336|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
110387235|NCT04269213|Daunorubicin|daunorubicin|mesh-list
110387236|NCT04269213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110387237|NCT04269213|Antimetabolites|antimetabolites|mesh-ancestor
110387238|NCT04269213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110387239|NCT04269213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110387240|NCT04269213|Antiviral Agents|antiviral agents|mesh-ancestor
110387241|NCT04269213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110387242|NCT04269213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110387243|NCT04269213|Immunologic Factors|immunologic factors|mesh-ancestor
110387244|NCT04269213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110387245|NCT04269213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110387246|NCT04269213|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110387247|NCT04269213|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110387248|NCT04269213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110387249|NCT04264208|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110387250|NCT04264208|Bombesin|bombesin|mesh-list
110387251|NCT04264208|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110387252|NCT04264208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110387253|NCT04264208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110387254|NCT04264208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110387255|NCT04260529|Pembrolizumab|pembrolizumab|mesh-list
110387256|NCT04260529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110387257|NCT04260529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110387258|NCT04260529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110387259|NCT04260529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110387260|NCT04257500|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110387262|NCT04257500|NuvaRing|nuvaring|mesh-list
110387263|NCT04257500|Estradiol|estradiol|mesh-list
110387264|NCT04257500|Estrogens|estrogens|mesh-ancestor
110387265|NCT04257500|Hormones|hormones|mesh-ancestor
110387266|NCT04257500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110387267|NCT04257500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110387268|NCT04257500|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110387269|NCT04257500|Contraceptive Agents|contraceptive agents|mesh-ancestor
110387270|NCT04257500|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110387271|NCT04257500|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110387272|NCT04257500|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110387274|NCT04251910|Dexmedetomidine|dexmedetomidine|mesh-list
110387275|NCT04251910|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110387276|NCT04251910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110387277|NCT04251910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110387278|NCT04251910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110387279|NCT04251910|Analgesics|analgesics|mesh-ancestor
110387280|NCT04251910|Sensory System Agents|sensory system agents|mesh-ancestor
110387281|NCT04251910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110387282|NCT04251910|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110387283|NCT04251910|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110387284|NCT04251910|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110387285|NCT04251910|Adrenergic Agents|adrenergic agents|mesh-ancestor
110387286|NCT04251910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110387287|NCT04251910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110387289|NCT04246151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110387290|NCT04246151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110387292|NCT04242329|Immunologic Factors|immunologic factors|mesh-ancestor
110387293|NCT04242329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110387295|NCT04235140|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110387296|NCT04235140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110387297|NCT04235140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110387298|NCT04234360|Prednisone|prednisone|mesh-list
110387299|NCT04234360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110387300|NCT04234360|Glucocorticoids|glucocorticoids|mesh-ancestor
110387301|NCT04234360|Hormones|hormones|mesh-ancestor
110387302|NCT04234360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110387303|NCT04234360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110387304|NCT04234360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110387305|NCT04234360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110387306|NCT04220684|Cytarabine|cytarabine|mesh-list
110387307|NCT04220684|Fludarabine|fludarabine|mesh-list
110387308|NCT04220684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110387309|NCT04220684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110387310|NCT04220684|Antimetabolites|antimetabolites|mesh-ancestor
110387311|NCT04220684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110387312|NCT04220684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110387313|NCT04220684|Immunologic Factors|immunologic factors|mesh-ancestor
110387359|NCT04204798|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110387360|NCT04204798|Adrenergic Agents|adrenergic agents|mesh-ancestor
110387361|NCT04204798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110387362|NCT04204798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110387363|NCT04193293|Pembrolizumab|pembrolizumab|mesh-list
110387364|NCT04193293|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110387365|NCT04193293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110387367|NCT04193293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110387375|NCT04171843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110387376|NCT04171843|Immunologic Factors|immunologic factors|mesh-ancestor
110387377|NCT04171843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110387378|NCT04171843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110387379|NCT04171843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110387380|NCT04171843|Alkylating Agents|alkylating agents|mesh-ancestor
110387381|NCT04171843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110387382|NCT04171843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110387383|NCT04171843|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110387384|NCT04171843|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
110387388|NCT04170283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110387389|NCT04170283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110387390|NCT04170283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110387391|NCT04170283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110387392|NCT04170283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110387393|NCT04165993|Docetaxel|docetaxel|mesh-list
110387394|NCT04165993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110387417|NCT04141501|Psilocybin|psilocybin|mesh-list
110387418|NCT04141501|Hallucinogens|hallucinogens|mesh-ancestor
110387419|NCT04141501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110387420|NCT04141501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110387421|NCT04134260|Hormones|hormones|mesh-list
110387422|NCT04134260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110387423|NCT04134260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110387431|NCT04123795|Certolizumab Pegol|certolizumab pegol|mesh-list
110387432|NCT04123795|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110387433|NCT04123795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110387434|NCT04123795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110387435|NCT04123795|Immunologic Factors|immunologic factors|mesh-ancestor
110387436|NCT04123795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110387437|NCT04123795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110387438|NCT04111133|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110387439|NCT04111133|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110387441|NCT04111133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110387442|NCT04111133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110387443|NCT04111133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110387444|NCT04093323|Interferons|interferons|mesh-list
110387445|NCT04093323|Interferon-alpha|interferon-alpha|mesh-list
110387446|NCT04093323|Interferon alpha-2|interferon alpha-2|mesh-list
110387447|NCT04093323|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
110387448|NCT04093323|Celecoxib|celecoxib|mesh-list
110387449|NCT04093323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110387450|NCT04093323|Benzenesulfonamide|benzenesulfonamide|mesh-list
110387451|NCT04093323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110387452|NCT04093323|Antiviral Agents|antiviral agents|mesh-ancestor
110387453|NCT04093323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110387454|NCT04093323|Immunologic Factors|immunologic factors|mesh-ancestor
110387455|NCT04093323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110387456|NCT04093323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110387457|NCT04093323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110387458|NCT04093323|Analgesics|analgesics|mesh-ancestor
110387459|NCT04093323|Sensory System Agents|sensory system agents|mesh-ancestor
110387460|NCT04093323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110387461|NCT04093323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110387462|NCT04093323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110387463|NCT04093323|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110387464|NCT04093323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110387465|NCT04093323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110260202|NCT00168948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110387466|NCT04093323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110387467|NCT04093323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110387468|NCT04093323|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110387469|NCT04091490|Nivolumab|nivolumab|mesh-list
110387470|NCT04091490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110387471|NCT04091490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110387472|NCT04091490|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110387473|NCT04091490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110387483|NCT04082780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110387484|NCT04080284|Niraparib|niraparib|mesh-list
110387485|NCT04080284|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110387486|NCT04080284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110387487|NCT04080284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110387488|NCT04080284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110387489|NCT04075747|Venetoclax|venetoclax|mesh-list
110387490|NCT04075747|Midostaurin|midostaurin|mesh-list
110387491|NCT04075747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110387492|NCT04075747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110387493|NCT04075747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110387494|NCT04075747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110387495|NCT04067115|Alovudine|alovudine|mesh-list
110387496|NCT04067115|Irinotecan|irinotecan|mesh-list
110387497|NCT04067115|Trabectedin|trabectedin|mesh-list
110387498|NCT04067115|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110387499|NCT04067115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110387500|NCT04067115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110387501|NCT04067115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110387502|NCT04067115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110387503|NCT04067115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110387504|NCT04067115|Alkylating Agents|alkylating agents|mesh-ancestor
110387505|NCT04067115|Antiviral Agents|antiviral agents|mesh-ancestor
110387506|NCT04067115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110387507|NCT04054375|Prednisone|prednisone|mesh-list
110387508|NCT04054375|Prednisolone|prednisolone|mesh-list
110387509|NCT04054375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110387510|NCT04054375|Glucocorticoids|glucocorticoids|mesh-ancestor
110387511|NCT04054375|Hormones|hormones|mesh-ancestor
110387512|NCT04054375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110387513|NCT04054375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110387514|NCT04054375|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110387515|NCT04054375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110387516|NCT04053634|Benralizumab|benralizumab|mesh-list
110387517|NCT04053634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110387518|NCT04053634|Respiratory System Agents|respiratory system agents|mesh-ancestor
110387519|NCT04047628|Alemtuzumab|alemtuzumab|mesh-list
110387520|NCT04047628|Ofatumumab|ofatumumab|mesh-list
110387521|NCT04047628|Cladribine|cladribine|mesh-list
110387522|NCT04047628|Ocrelizumab|ocrelizumab|mesh-list
110387523|NCT04047628|Natalizumab|natalizumab|mesh-list
110387524|NCT04047628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110387525|NCT04047628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110387527|NCT04047628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110387528|NCT04047628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110387529|NCT04044690|Immunoglobulins|immunoglobulins|mesh-list
110387530|NCT04044690|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110387532|NCT04044690|Immunoglobulin G|immunoglobulin g|mesh-list
110387533|NCT04044690|Immunologic Factors|immunologic factors|mesh-ancestor
110387534|NCT04044690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110387535|NCT04037254|Niraparib|niraparib|mesh-list
110387536|NCT04037254|Hormones|hormones|mesh-list
110387537|NCT04037254|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
110387538|NCT04037254|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110387539|NCT04037254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110387540|NCT04037254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110387541|NCT04037254|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110387542|NCT04037254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110387543|NCT04037254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110387544|NCT04037254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110387545|NCT04028830|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110387546|NCT04028830|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110387547|NCT04028830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110387548|NCT04028830|Antitubercular Agents|antitubercular agents|mesh-ancestor
110387549|NCT04026412|Nivolumab|nivolumab|mesh-list
110387550|NCT04026412|Ipilimumab|ipilimumab|mesh-list
110387551|NCT04026412|Durvalumab|durvalumab|mesh-list
110387552|NCT04026412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110387553|NCT04026412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110387554|NCT04026412|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110387555|NCT04026412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110387556|NCT04021121|Linezolid|linezolid|mesh-list
110387557|NCT04021121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110387558|NCT04021121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110387559|NCT04021121|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110387560|NCT04021121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110387561|NCT04021121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110387562|NCT04017650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110387564|NCT04017650|Cetuximab|cetuximab|mesh-list
110387565|NCT04017650|Antibodies|antibodies|mesh-list
110387566|NCT04017650|Immunoglobulins|immunoglobulins|mesh-list
110387567|NCT04017650|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110387568|NCT04017650|Immunologic Factors|immunologic factors|mesh-ancestor
110387569|NCT04017650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110387570|NCT04017650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110387571|NCT04017650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110387572|NCT04017650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110387573|NCT04017442|Morphine|morphine|mesh-list
110387574|NCT04017442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110387575|NCT04017442|Narcotics|narcotics|mesh-ancestor
110387576|NCT04017442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110387577|NCT04017442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110387578|NCT04017442|Analgesics|analgesics|mesh-ancestor
110387579|NCT04017442|Sensory System Agents|sensory system agents|mesh-ancestor
110387580|NCT04017442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110387581|NCT04015622|Docetaxel|docetaxel|mesh-list
110387582|NCT04015622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110387583|NCT04015622|Tubulin Modulators|tubulin modulators|mesh-ancestor
110387584|NCT04015622|Antimitotic Agents|antimitotic agents|mesh-ancestor
110387585|NCT04015622|Mitosis Modulators|mitosis modulators|mesh-ancestor
110387586|NCT04015622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110387587|NCT04010578|Vitamin D|vitamin d|mesh-list
110387588|NCT04010578|Cholecalciferol|cholecalciferol|mesh-list
110387589|NCT04010578|Vitamins|vitamins|mesh-ancestor
110387590|NCT04010578|Micronutrients|micronutrients|mesh-ancestor
110387591|NCT04010578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110387592|NCT04010578|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110387593|NCT04010578|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110387594|NCT04000529|Spartalizumab|spartalizumab|mesh-list
110387595|NCT04000529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110387596|NCT04000529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110387597|NCT04000529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110387606|NCT03994874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110387608|NCT03994055|Antioxidants|antioxidants|mesh-list
110387609|NCT03994055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110387610|NCT03994055|Protective Agents|protective agents|mesh-ancestor
110387611|NCT03994055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110387612|NCT03991104|Oxaliplatin|oxaliplatin|mesh-list
110387613|NCT03991104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110387614|NCT03971253|Peficitinib|peficitinib|mesh-list
110387615|NCT03971253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110387616|NCT03971253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110387617|NCT03971253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110387618|NCT03971253|Immunologic Factors|immunologic factors|mesh-ancestor
110387619|NCT03971253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110387629|NCT03968913|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110387630|NCT03968913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110387631|NCT03959488|Palivizumab|palivizumab|mesh-list
110387632|NCT03959488|Antiviral Agents|antiviral agents|mesh-ancestor
110387633|NCT03959488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110387634|NCT03950817|Ketamine|ketamine|mesh-list
110387635|NCT03950817|Analgesics|analgesics|mesh-ancestor
110387636|NCT03950817|Sensory System Agents|sensory system agents|mesh-ancestor
110387637|NCT03950817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110387638|NCT03950817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110387639|NCT03950817|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110387640|NCT03950817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110387641|NCT03950817|Anesthetics, General|anesthetics, general|mesh-ancestor
110387642|NCT03950817|Anesthetics|anesthetics|mesh-ancestor
110387643|NCT03950817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110387659|NCT03943901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110387661|NCT03943901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110387662|NCT03943901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110387663|NCT03943901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110387664|NCT03943901|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110387665|NCT03943901|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110387666|NCT03943901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110387667|NCT03943901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110387668|NCT03943901|Glucocorticoids|glucocorticoids|mesh-ancestor
110387669|NCT03943901|Hormones|hormones|mesh-ancestor
110387670|NCT03943901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110387671|NCT03943901|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110387672|NCT03943901|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110387673|NCT03943901|Tubulin Modulators|tubulin modulators|mesh-ancestor
110387674|NCT03943901|Antimitotic Agents|antimitotic agents|mesh-ancestor
110387675|NCT03943901|Mitosis Modulators|mitosis modulators|mesh-ancestor
110387676|NCT03939767|Aflibercept|aflibercept|mesh-list
110387677|NCT03939767|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110387678|NCT03939767|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110387679|NCT03939767|Growth Substances|growth substances|mesh-ancestor
110387680|NCT03939767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110387681|NCT03939767|Growth Inhibitors|growth inhibitors|mesh-ancestor
110387682|NCT03939767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110387683|NCT03936894|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110387684|NCT03936894|Immunologic Factors|immunologic factors|mesh-ancestor
110387685|NCT03936894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110387706|NCT03913195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110387707|NCT03913195|Antiviral Agents|antiviral agents|mesh-ancestor
110387708|NCT03913195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110387710|NCT03912428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110387711|NCT03912428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110387712|NCT03912428|Analgesics|analgesics|mesh-ancestor
110387713|NCT03912428|Sensory System Agents|sensory system agents|mesh-ancestor
110387714|NCT03912428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110387715|NCT03912428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110387716|NCT03912428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110387717|NCT03912428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110387718|NCT03912428|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110387719|NCT03912428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110387720|NCT03912428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110387721|NCT03912428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110387722|NCT03907124|Psychotropic Drugs|psychotropic drugs|mesh-list
110387723|NCT03889912|Cemiplimab|cemiplimab|mesh-list
110387724|NCT03889912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110387725|NCT03889912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110387726|NCT03880019|Temozolomide|temozolomide|mesh-list
110387727|NCT03880019|Olaparib|olaparib|mesh-list
110387728|NCT03880019|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
110387729|NCT03880019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110387730|NCT03880019|Alkylating Agents|alkylating agents|mesh-ancestor
110387731|NCT03880019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110387732|NCT03880019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110387733|NCT03880019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110387734|NCT03873818|Pembrolizumab|pembrolizumab|mesh-list
110387735|NCT03873818|Ipilimumab|ipilimumab|mesh-list
110387736|NCT03873818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110387737|NCT03873818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110387738|NCT03873818|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110387739|NCT03873818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110387740|NCT03870529|Vitamins|vitamins|mesh-list
110387741|NCT03870529|Vitamin A|vitamin a|mesh-list
110387742|NCT03870529|Anti-Infective Agents|anti-infective agents|mesh-list
110387743|NCT03870529|Retinol palmitate|retinol palmitate|mesh-list
110387744|NCT03870529|Micronutrients|micronutrients|mesh-ancestor
110387745|NCT03870529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110387746|NCT03870529|Antioxidants|antioxidants|mesh-ancestor
110387747|NCT03870529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110387748|NCT03870529|Protective Agents|protective agents|mesh-ancestor
110387749|NCT03870529|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110387750|NCT03870529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110387751|NCT03853798|Mitapivat|mitapivat|mesh-list
110387752|NCT03853798|Enzyme Activators|enzyme activators|mesh-ancestor
110387753|NCT03853798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110387754|NCT03848676|Immunomodulating Agents|immunomodulating agents|mesh-list
110387755|NCT03848676|Immunologic Factors|immunologic factors|mesh-ancestor
110387756|NCT03848676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110387757|NCT03843294|Nivolumab|nivolumab|mesh-list
110387758|NCT03843294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110387759|NCT03843294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110387760|NCT03843294|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110387761|NCT03843294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110387762|NCT03816176|Isavuconazole|isavuconazole|mesh-list
110387763|NCT03816176|Antifungal Agents|antifungal agents|mesh-ancestor
110387764|NCT03816176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110387765|NCT03802591|Capecitabine|capecitabine|mesh-list
110387766|NCT03802591|Oxaliplatin|oxaliplatin|mesh-list
110387767|NCT03802591|Antibodies|antibodies|mesh-list
110387768|NCT03802591|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110387769|NCT03802591|Immunologic Factors|immunologic factors|mesh-ancestor
110387770|NCT03802591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110387771|NCT03802591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110387772|NCT03802591|Antimetabolites|antimetabolites|mesh-ancestor
110387773|NCT03802591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110387774|NCT03802591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110387775|NCT03801876|Paclitaxel|paclitaxel|mesh-list
110387776|NCT03801876|Docetaxel|docetaxel|mesh-list
110387777|NCT03801876|Carboplatin|carboplatin|mesh-list
110387778|NCT03801876|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110387779|NCT03801876|Fluorouracil|fluorouracil|mesh-list
110387780|NCT03801876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110387781|NCT03801876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110387782|NCT03801876|Tubulin Modulators|tubulin modulators|mesh-ancestor
110387783|NCT03801876|Antimitotic Agents|antimitotic agents|mesh-ancestor
110387784|NCT03801876|Mitosis Modulators|mitosis modulators|mesh-ancestor
110387785|NCT03801876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110387786|NCT03801876|Antimetabolites|antimetabolites|mesh-ancestor
110387787|NCT03801876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110387788|NCT03801876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110387789|NCT03801876|Immunologic Factors|immunologic factors|mesh-ancestor
110387790|NCT03801876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110387791|NCT03794999|Benralizumab|benralizumab|mesh-list
110387792|NCT03794999|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110387793|NCT03794999|Respiratory System Agents|respiratory system agents|mesh-ancestor
110387794|NCT03765541|Cytarabine|cytarabine|mesh-list
110387795|NCT03765541|Dexamethasone|dexamethasone|mesh-list
110387796|NCT03765541|Azacitidine|azacitidine|mesh-list
110387797|NCT03765541|Amsacrine|amsacrine|mesh-list
110387798|NCT03765541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110387799|NCT03765541|Antiemetics|antiemetics|mesh-ancestor
110387800|NCT03765541|Autonomic Agents|autonomic agents|mesh-ancestor
110387801|NCT03765541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110387802|NCT03765541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110387803|NCT03765541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110387804|NCT03765541|Glucocorticoids|glucocorticoids|mesh-ancestor
110387805|NCT03765541|Hormones|hormones|mesh-ancestor
110387806|NCT03765541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110387807|NCT03765541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110387808|NCT03765541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110387809|NCT03765541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110387810|NCT03765541|Antimetabolites|antimetabolites|mesh-ancestor
110387811|NCT03765541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110387812|NCT03765541|Antiviral Agents|antiviral agents|mesh-ancestor
110387813|NCT03765541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110387814|NCT03765541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110042060|NCT01440114|Fentanyl|fentanyl|mesh-list
110387815|NCT03765541|Immunologic Factors|immunologic factors|mesh-ancestor
110387816|NCT03765541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110387817|NCT03712956|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110387819|NCT03712956|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110387820|NCT03712956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110387821|NCT03712956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110387822|NCT03712956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110387823|NCT03712956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110387824|NCT03712956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110387825|NCT03712098|Liraglutide|liraglutide|mesh-list
110387826|NCT03712098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110387827|NCT03712098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110387828|NCT03712098|Incretins|incretins|mesh-ancestor
110387829|NCT03712098|Hormones|hormones|mesh-ancestor
110387830|NCT03712098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110387831|NCT03710772|Cytarabine|cytarabine|mesh-list
110387832|NCT03710772|Dexamethasone|dexamethasone|mesh-list
110387833|NCT03710772|Dexamethasone acetate|dexamethasone acetate|mesh-list
110387834|NCT03710772|Cyclophosphamide|cyclophosphamide|mesh-list
110387835|NCT03710772|Rituximab|rituximab|mesh-list
110387836|NCT03710772|Doxorubicin|doxorubicin|mesh-list
110387837|NCT03710772|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110387838|NCT03710772|Methotrexate|methotrexate|mesh-list
110387839|NCT03710772|Vincristine|vincristine|mesh-list
110387840|NCT03710772|Venetoclax|venetoclax|mesh-list
110387841|NCT03710772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110387842|NCT03710772|Antibodies|antibodies|mesh-list
110387843|NCT03710772|Immunoglobulins|immunoglobulins|mesh-list
110387844|NCT03710772|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110387845|NCT03710772|BB 1101|bb 1101|mesh-list
110387846|NCT03710772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110387847|NCT03710772|Immunologic Factors|immunologic factors|mesh-ancestor
110387848|NCT03710772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110387849|NCT03710772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110387850|NCT03710772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110387851|NCT03710772|Alkylating Agents|alkylating agents|mesh-ancestor
110387852|NCT03710772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110387853|NCT03710772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110387854|NCT03710772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110387855|NCT03710772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110387857|NCT03710772|Autonomic Agents|autonomic agents|mesh-ancestor
110387858|NCT03710772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110387859|NCT03710772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110387860|NCT03710772|Glucocorticoids|glucocorticoids|mesh-ancestor
110387861|NCT03710772|Hormones|hormones|mesh-ancestor
110387862|NCT03710772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110387863|NCT03710772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110387864|NCT03710772|Protease Inhibitors|protease inhibitors|mesh-ancestor
110387865|NCT03710772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110387866|NCT03710772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110387867|NCT03710772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110387868|NCT03710772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110387869|NCT03710772|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110387870|NCT03710772|Abortifacient Agents|abortifacient agents|mesh-ancestor
110387871|NCT03710772|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110387872|NCT03710772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110387873|NCT03710772|Antimetabolites|antimetabolites|mesh-ancestor
110387874|NCT03710772|Dermatologic Agents|dermatologic agents|mesh-ancestor
110387875|NCT03710772|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110387876|NCT03710772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110387877|NCT03710772|Antiviral Agents|antiviral agents|mesh-ancestor
110387878|NCT03710772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110387879|NCT03710772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110387880|NCT03710772|Tubulin Modulators|tubulin modulators|mesh-ancestor
110387881|NCT03710772|Antimitotic Agents|antimitotic agents|mesh-ancestor
110387882|NCT03710772|Mitosis Modulators|mitosis modulators|mesh-ancestor
110387884|NCT03704688|Ponatinib|ponatinib|mesh-list
110387885|NCT03704688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110387886|NCT03704688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110387887|NCT03704688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110387888|NCT03704688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110387889|NCT03686332|Atezolizumab|atezolizumab|mesh-list
110387890|NCT03686332|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110387891|NCT03686332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110387892|NCT03686332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110387893|NCT03686332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110387894|NCT03686332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110387895|NCT03686332|Immunologic Factors|immunologic factors|mesh-ancestor
110387896|NCT03686332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110387897|NCT03671746|Ketorolac|ketorolac|mesh-list
110387898|NCT03671746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110387899|NCT03671746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110387900|NCT03671746|Analgesics|analgesics|mesh-ancestor
110387901|NCT03671746|Sensory System Agents|sensory system agents|mesh-ancestor
110387902|NCT03671746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110387903|NCT03671746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110387904|NCT03671746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110387905|NCT03671746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110387906|NCT03671746|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110387907|NCT03671746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110387908|NCT03671746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110387909|NCT03671018|Rituximab|rituximab|mesh-list
110387910|NCT03671018|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
110387911|NCT03671018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110387912|NCT03671018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110387913|NCT03671018|Immunologic Factors|immunologic factors|mesh-ancestor
110387914|NCT03671018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110387915|NCT03671018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110387916|NCT03671018|Immunoconjugates|immunoconjugates|mesh-ancestor
110387917|NCT03646175|Choline|choline|mesh-list
110387918|NCT03646175|Lipotropic Agents|lipotropic agents|mesh-ancestor
110387919|NCT03646175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110387920|NCT03646175|Antimetabolites|antimetabolites|mesh-ancestor
110387921|NCT03646175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110387922|NCT03646175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110387923|NCT03646175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110387924|NCT03646175|Nootropic Agents|nootropic agents|mesh-ancestor
110387925|NCT03641560|Androgens|androgens|mesh-list
110387926|NCT03641560|Hormones|hormones|mesh-ancestor
110387927|NCT03641560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110387928|NCT03641560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110387929|NCT03630991|Calcium, Dietary|calcium, dietary|mesh-list
110387930|NCT03630991|Edetic Acid|edetic acid|mesh-list
110387931|NCT03630991|Calcium|calcium|mesh-list
110387932|NCT03630991|Pentetic Acid|pentetic acid|mesh-list
110387933|NCT03630991|Succimer|succimer|mesh-list
110387934|NCT03630991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110387935|NCT03630991|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110387936|NCT03630991|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110387937|NCT03630991|Anticoagulants|anticoagulants|mesh-ancestor
110387938|NCT03630991|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110387939|NCT03630991|Chelating Agents|chelating agents|mesh-ancestor
110387940|NCT03630991|Sequestering Agents|sequestering agents|mesh-ancestor
110387941|NCT03630991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110387942|NCT03630991|Antidotes|antidotes|mesh-ancestor
110387943|NCT03630991|Protective Agents|protective agents|mesh-ancestor
110387944|NCT03630991|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110387945|NCT03616886|Paclitaxel|paclitaxel|mesh-list
110387946|NCT03616886|Carboplatin|carboplatin|mesh-list
110387947|NCT03616886|Durvalumab|durvalumab|mesh-list
110387948|NCT03616886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110387949|NCT03616886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110387950|NCT03616886|Tubulin Modulators|tubulin modulators|mesh-ancestor
110387951|NCT03616886|Antimitotic Agents|antimitotic agents|mesh-ancestor
110387952|NCT03616886|Mitosis Modulators|mitosis modulators|mesh-ancestor
110387953|NCT03616886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110387954|NCT03616886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110387955|NCT03609840|Thiotepa|thiotepa|mesh-list
110387956|NCT03609840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-list
110387957|NCT03609840|Antineoplastic Agents|antineoplastic agents|mesh-list
110387958|NCT03609840|Alkylating Agents|alkylating agents|mesh-ancestor
110387959|NCT03609840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110387960|NCT03609840|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110387961|NCT03609840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110387962|NCT03609840|Immunologic Factors|immunologic factors|mesh-ancestor
110387963|NCT03609840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110387964|NCT03601897|Paclitaxel|paclitaxel|mesh-list
110387965|NCT03601897|Rebastinib|rebastinib|mesh-list
110387966|NCT03601897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110387967|NCT03601897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110387968|NCT03601897|Tubulin Modulators|tubulin modulators|mesh-ancestor
110387969|NCT03601897|Antimitotic Agents|antimitotic agents|mesh-ancestor
110387970|NCT03601897|Mitosis Modulators|mitosis modulators|mesh-ancestor
110387971|NCT03601897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110387972|NCT03601897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110387973|NCT03601897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110387974|NCT03599622|Deucravacitinib|deucravacitinib|mesh-list
110387975|NCT03599622|Dermatologic Agents|dermatologic agents|mesh-ancestor
110387976|NCT03599622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110387977|NCT03599622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110387978|NCT03599622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110387980|NCT03577431|Everolimus|everolimus|mesh-list
110387981|NCT03577431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110387982|NCT03577431|Immunologic Factors|immunologic factors|mesh-ancestor
110387983|NCT03577431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110387993|NCT03573349|Ketamine|ketamine|mesh-list
110387994|NCT03573349|Analgesics|analgesics|mesh-ancestor
110387995|NCT03573349|Sensory System Agents|sensory system agents|mesh-ancestor
110387996|NCT03573349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110387997|NCT03573349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110387998|NCT03573349|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110387999|NCT03573349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110388000|NCT03573349|Anesthetics, General|anesthetics, general|mesh-ancestor
110388001|NCT03573349|Anesthetics|anesthetics|mesh-ancestor
110388002|NCT03573349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110388003|NCT03573349|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110388004|NCT03573349|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110388005|NCT03573349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110388006|NCT03573349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110388023|NCT03562507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110388024|NCT03562507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110388025|NCT03562507|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110388026|NCT03562507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110388027|NCT03552705|Tranexamic Acid|tranexamic acid|mesh-list
110388028|NCT03552705|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110388029|NCT03552705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110388030|NCT03552705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110388031|NCT03552705|Hemostatics|hemostatics|mesh-ancestor
110388032|NCT03552705|Coagulants|coagulants|mesh-ancestor
110388033|NCT03534713|Paclitaxel|paclitaxel|mesh-list
110388034|NCT03534713|Carboplatin|carboplatin|mesh-list
110388035|NCT03534713|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110388036|NCT03534713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110388037|NCT03534713|Tubulin Modulators|tubulin modulators|mesh-ancestor
110388038|NCT03534713|Antimitotic Agents|antimitotic agents|mesh-ancestor
110388039|NCT03534713|Mitosis Modulators|mitosis modulators|mesh-ancestor
110388040|NCT03534713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110388041|NCT03519971|Paclitaxel|paclitaxel|mesh-list
110388042|NCT03519971|Etoposide|etoposide|mesh-list
110388043|NCT03519971|Cisplatin|cisplatin|mesh-list
110388045|NCT03519971|Pemetrexed|pemetrexed|mesh-list
110388046|NCT03519971|Durvalumab|durvalumab|mesh-list
110388047|NCT03519971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110388048|NCT03519971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110388049|NCT03519971|Tubulin Modulators|tubulin modulators|mesh-ancestor
110388050|NCT03519971|Antimitotic Agents|antimitotic agents|mesh-ancestor
110388051|NCT03519971|Mitosis Modulators|mitosis modulators|mesh-ancestor
110388052|NCT03519971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110388054|NCT03519971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110388055|NCT03519971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110388056|NCT03519971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110388057|NCT03519971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110388058|NCT03519971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110388059|NCT03518203|Eculizumab|eculizumab|mesh-list
110388060|NCT03518203|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110388061|NCT03518203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110388062|NCT03518203|Immunologic Factors|immunologic factors|mesh-ancestor
110388063|NCT03518203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110388064|NCT03511196|Prednisone|prednisone|mesh-list
110388065|NCT03511196|Glucocorticoids|glucocorticoids|mesh-list
110388066|NCT03511196|Androgens|androgens|mesh-list
110388067|NCT03511196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110388068|NCT03511196|Hormones|hormones|mesh-ancestor
110388069|NCT03511196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110388070|NCT03511196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110388071|NCT03511196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110388072|NCT03511196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110388073|NCT03507062|Plasma-lyte 148|plasma-lyte 148|mesh-list
110388074|NCT03507062|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110388075|NCT03507062|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110388076|NCT03493932|Nivolumab|nivolumab|mesh-list
110388077|NCT03493932|Relatlimab|relatlimab|mesh-list
110388078|NCT03493932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110388079|NCT03493932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110388080|NCT03493932|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110388081|NCT03493932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110388082|NCT03487809|Budesonide|budesonide|mesh-list
110388083|NCT03487809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110388084|NCT03487809|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110388085|NCT03487809|Autonomic Agents|autonomic agents|mesh-ancestor
110388086|NCT03487809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110388087|NCT03487809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110388088|NCT03487809|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110388089|NCT03487809|Respiratory System Agents|respiratory system agents|mesh-ancestor
110388090|NCT03487809|Glucocorticoids|glucocorticoids|mesh-ancestor
110388092|NCT03487809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110388093|NCT03470922|Nivolumab|nivolumab|mesh-list
110388094|NCT03470922|Relatlimab|relatlimab|mesh-list
110388095|NCT03470922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110388096|NCT03470922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110388097|NCT03470922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110388098|NCT03470922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110388099|NCT03465774|Doxycycline|doxycycline|mesh-list
110388100|NCT03465774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110388101|NCT03465774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110388102|NCT03465774|Antimalarials|antimalarials|mesh-ancestor
110388103|NCT03465774|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110388104|NCT03465774|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110388105|NCT03457142|Dexamethasone|dexamethasone|mesh-list
110388106|NCT03457142|Dexamethasone acetate|dexamethasone acetate|mesh-list
110388107|NCT03457142|Abatacept|abatacept|mesh-list
110388108|NCT03457142|Ixazomib|ixazomib|mesh-list
110388109|NCT03457142|Ichthammol|ichthammol|mesh-list
110388110|NCT03457142|BB 1101|bb 1101|mesh-list
110388111|NCT03457142|Glycine|glycine|mesh-list
110388112|NCT03457142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110388113|NCT03457142|Antiemetics|antiemetics|mesh-ancestor
110388114|NCT03457142|Autonomic Agents|autonomic agents|mesh-ancestor
110388115|NCT03457142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110388116|NCT03457142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110388117|NCT03457142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110388118|NCT03457142|Glucocorticoids|glucocorticoids|mesh-ancestor
110388120|NCT03457142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110388121|NCT03457142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110388122|NCT03457142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110388123|NCT03457142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110388124|NCT03457142|Protease Inhibitors|protease inhibitors|mesh-ancestor
110388125|NCT03457142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110388126|NCT03457142|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110388127|NCT03457142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110388128|NCT03457142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110388129|NCT03457142|Immunologic Factors|immunologic factors|mesh-ancestor
110388130|NCT03457142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110388131|NCT03457142|Dermatologic Agents|dermatologic agents|mesh-ancestor
110388132|NCT03457142|Glycine Agents|glycine agents|mesh-ancestor
110388133|NCT03457142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110388135|NCT03456076|Gemcitabine|gemcitabine|mesh-list
110388136|NCT03456076|Pemetrexed|pemetrexed|mesh-list
110388137|NCT03456076|Vinorelbine|vinorelbine|mesh-list
110388138|NCT03456076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110388139|NCT03456076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110388141|NCT03456076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110388142|NCT03456076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110388143|NCT03456076|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110388144|NCT03456076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110388145|NCT03456076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110388146|NCT03456076|Tubulin Modulators|tubulin modulators|mesh-ancestor
110388147|NCT03456076|Antimitotic Agents|antimitotic agents|mesh-ancestor
110388148|NCT03456076|Mitosis Modulators|mitosis modulators|mesh-ancestor
110388149|NCT03427814|Pamiparib|pamiparib|mesh-list
110388150|NCT03427814|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110388151|NCT03427814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110388152|NCT03427814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110388153|NCT03427814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110388154|NCT03399773|Cyclophosphamide|cyclophosphamide|mesh-list
110388155|NCT03399773|Thiotepa|thiotepa|mesh-list
110388156|NCT03399773|Fludarabine|fludarabine|mesh-list
110388157|NCT03399773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110388158|NCT03399773|Immunologic Factors|immunologic factors|mesh-ancestor
110388159|NCT03399773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110388160|NCT03399773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110388161|NCT03399773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110388163|NCT03399773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110388164|NCT03399773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110388165|NCT03399773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110388166|NCT03383692|Ritonavir|ritonavir|mesh-list
110388167|NCT03383692|Itraconazole|itraconazole|mesh-list
110388168|NCT03383692|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
110388169|NCT03383692|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110388170|NCT03383692|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110388171|NCT03383692|Protease Inhibitors|protease inhibitors|mesh-ancestor
110388172|NCT03383692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110388173|NCT03383692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110388174|NCT03383692|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110388175|NCT03383692|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110388176|NCT03383692|Antiviral Agents|antiviral agents|mesh-ancestor
110388177|NCT03383692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110388178|NCT03383692|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110388179|NCT03383692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110388180|NCT03383692|Antifungal Agents|antifungal agents|mesh-ancestor
110388181|NCT03383692|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110388182|NCT03383692|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110388183|NCT03383692|Hormone Antagonists|hormone antagonists|mesh-ancestor
110388184|NCT03383692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110388185|NCT03383692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110388186|NCT03383692|Immunoconjugates|immunoconjugates|mesh-ancestor
110388187|NCT03383692|Immunologic Factors|immunologic factors|mesh-ancestor
110388188|NCT03380559|Botulinum Toxins|botulinum toxins|mesh-list
110388189|NCT03380559|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110388190|NCT03380559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110388191|NCT03380559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110388192|NCT03380559|Cholinergic Agents|cholinergic agents|mesh-ancestor
110388193|NCT03380559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110388194|NCT03380559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110388195|NCT03379909|Metformin|metformin|mesh-list
110388196|NCT03379909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110388197|NCT03379909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110388198|NCT03375242|Crizotinib|crizotinib|mesh-list
110388199|NCT03375242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110388200|NCT03375242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110388201|NCT03375242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110388202|NCT03375242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110388203|NCT03368664|Interferons|interferons|mesh-list
110388204|NCT03368664|Acyclovir|acyclovir|mesh-list
110388205|NCT03368664|Interferon-beta|interferon-beta|mesh-list
110388206|NCT03368664|Methylprednisolone|methylprednisolone|mesh-list
110388207|NCT03368664|Prednisolone|prednisolone|mesh-list
110388208|NCT03368664|Alemtuzumab|alemtuzumab|mesh-list
110388209|NCT03368664|Glatiramer Acetate|glatiramer acetate|mesh-list
110388210|NCT03368664|Ranitidine|ranitidine|mesh-list
110388211|NCT03368664|(T,G)-A-L|(t,g)-a-l|mesh-list
110388212|NCT03368664|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
110388213|NCT03368664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110388214|NCT03368664|Antiviral Agents|antiviral agents|mesh-ancestor
110388215|NCT03368664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110388216|NCT03368664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110388217|NCT03368664|Antiemetics|antiemetics|mesh-ancestor
110388218|NCT03368664|Autonomic Agents|autonomic agents|mesh-ancestor
110388219|NCT03368664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110388220|NCT03368664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110388221|NCT03368664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110388222|NCT03368664|Glucocorticoids|glucocorticoids|mesh-ancestor
110388223|NCT03368664|Hormones|hormones|mesh-ancestor
110388224|NCT03368664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110388225|NCT03368664|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110388226|NCT03368664|Protective Agents|protective agents|mesh-ancestor
110388227|NCT03368664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110388228|NCT03368664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110388229|NCT03368664|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110388231|NCT03368664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110388232|NCT03368664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110388233|NCT03368664|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110388234|NCT03368664|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110388235|NCT03368664|Histamine Antagonists|histamine antagonists|mesh-ancestor
110388236|NCT03368664|Histamine Agents|histamine agents|mesh-ancestor
110388237|NCT03368664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110388238|NCT03368664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110388239|NCT03368664|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110388240|NCT03343054|Talazoparib|talazoparib|mesh-list
110388241|NCT03343054|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110388242|NCT03343054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110388243|NCT03343054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110388244|NCT03343054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110388245|NCT03339596|Epoetin Alfa|epoetin alfa|mesh-list
110388246|NCT03339596|Hematinics|hematinics|mesh-ancestor
110388247|NCT03332797|Palbociclib|palbociclib|mesh-list
110388248|NCT03332797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110388249|NCT03332797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110388250|NCT03332797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110388251|NCT03332797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110388252|NCT03330847|Olaparib|olaparib|mesh-list
110388253|NCT03330847|Adavosertib|adavosertib|mesh-list
110388254|NCT03330847|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110388255|NCT03330847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110388256|NCT03330847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110388257|NCT03330847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110388258|NCT03322358|Diphenhydramine|diphenhydramine|mesh-list
110388259|NCT03322358|Promethazine|promethazine|mesh-list
110388260|NCT03322358|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110388261|NCT03322358|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110388262|NCT03322358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110388263|NCT03322358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110388264|NCT03322358|Anesthetics, Local|anesthetics, local|mesh-ancestor
110388265|NCT03322358|Anesthetics|anesthetics|mesh-ancestor
110388266|NCT03322358|Sensory System Agents|sensory system agents|mesh-ancestor
110388267|NCT03322358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110388268|NCT03322358|Antiemetics|antiemetics|mesh-ancestor
110388269|NCT03322358|Autonomic Agents|autonomic agents|mesh-ancestor
110388270|NCT03322358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110388271|NCT03322358|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110388272|NCT03322358|Histamine Antagonists|histamine antagonists|mesh-ancestor
110388273|NCT03322358|Histamine Agents|histamine agents|mesh-ancestor
110388274|NCT03322358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110388275|NCT03322358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110388276|NCT03322358|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110388277|NCT03322358|Antipruritics|antipruritics|mesh-ancestor
110388278|NCT03322358|Dermatologic Agents|dermatologic agents|mesh-ancestor
110388279|NCT03309878|Pembrolizumab|pembrolizumab|mesh-list
110388280|NCT03309878|Mogamulizumab|mogamulizumab|mesh-list
110388281|NCT03309878|Immunoglobulins|immunoglobulins|mesh-list
110388282|NCT03309878|Immunoglobulin G|immunoglobulin g|mesh-list
110388283|NCT03309878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110388284|NCT03309878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110388285|NCT03309878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110388286|NCT03309878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110388287|NCT03309878|Immunologic Factors|immunologic factors|mesh-ancestor
110388288|NCT03309878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110388289|NCT03298295|Insulin|insulin|mesh-list
110388290|NCT03298295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110388291|NCT03298295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110388292|NCT03291158|Minocycline|minocycline|mesh-list
110388293|NCT03291158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110388294|NCT03291158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110388295|NCT03259867|Nivolumab|nivolumab|mesh-list
110388296|NCT03259867|Tirapazamine|tirapazamine|mesh-list
110388297|NCT03259867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110388298|NCT03259867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110388299|NCT03259867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110388300|NCT03259867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110388301|NCT03239340|Osimertinib|osimertinib|mesh-list
110388302|NCT03239340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110388303|NCT03239340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110388304|NCT03239340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110388305|NCT03239340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110388306|NCT03226691|Plerixafor|plerixafor|mesh-list
110388307|NCT03226691|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110388308|NCT03226691|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110388309|NCT03226691|Antiviral Agents|antiviral agents|mesh-ancestor
110388310|NCT03226691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110388311|NCT03224507|Dexamethasone|dexamethasone|mesh-list
110388312|NCT03224507|Dexamethasone acetate|dexamethasone acetate|mesh-list
110388313|NCT03224507|Lenalidomide|lenalidomide|mesh-list
110388314|NCT03224507|Daratumumab|daratumumab|mesh-list
110388315|NCT03224507|BB 1101|bb 1101|mesh-list
110388316|NCT03224507|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110388317|NCT03224507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110388318|NCT03224507|Antiemetics|antiemetics|mesh-ancestor
110388319|NCT03224507|Autonomic Agents|autonomic agents|mesh-ancestor
110388320|NCT03224507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110388321|NCT03224507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110388322|NCT03224507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110388323|NCT03224507|Glucocorticoids|glucocorticoids|mesh-ancestor
110388324|NCT03224507|Hormones|hormones|mesh-ancestor
110388325|NCT03224507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110388326|NCT03224507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110388327|NCT03224507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110388328|NCT03224507|Protease Inhibitors|protease inhibitors|mesh-ancestor
110388329|NCT03224507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110388330|NCT03224507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110388331|NCT03224507|Immunologic Factors|immunologic factors|mesh-ancestor
110388332|NCT03224507|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110388333|NCT03224507|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110388334|NCT03224507|Growth Substances|growth substances|mesh-ancestor
110388335|NCT03224507|Growth Inhibitors|growth inhibitors|mesh-ancestor
110388336|NCT03218826|Docetaxel|docetaxel|mesh-list
110388337|NCT03218826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110388338|NCT03218826|Tubulin Modulators|tubulin modulators|mesh-ancestor
110388339|NCT03218826|Antimitotic Agents|antimitotic agents|mesh-ancestor
110388340|NCT03218826|Mitosis Modulators|mitosis modulators|mesh-ancestor
110388341|NCT03218826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110388342|NCT03215030|Dexamethasone|dexamethasone|mesh-list
110388343|NCT03215030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110388344|NCT03215030|Antiemetics|antiemetics|mesh-ancestor
110388345|NCT03215030|Autonomic Agents|autonomic agents|mesh-ancestor
110388346|NCT03215030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110388347|NCT03215030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110388348|NCT03215030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110388349|NCT03215030|Glucocorticoids|glucocorticoids|mesh-ancestor
110388351|NCT03215030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110388352|NCT03215030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110388353|NCT03215030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110388354|NCT03212274|Olaparib|olaparib|mesh-list
110388355|NCT03212274|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
110388356|NCT03212274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110388357|NCT03212274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110388358|NCT03212274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110388359|NCT03202628|Dexamethasone|dexamethasone|mesh-list
110388360|NCT03202628|Dexamethasone acetate|dexamethasone acetate|mesh-list
110388361|NCT03202628|Pomalidomide|pomalidomide|mesh-list
110388363|NCT03202628|Ichthammol|ichthammol|mesh-list
110388364|NCT03202628|BB 1101|bb 1101|mesh-list
110388365|NCT03202628|Glycine|glycine|mesh-list
110388366|NCT03202628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110388368|NCT03202628|Autonomic Agents|autonomic agents|mesh-ancestor
110388369|NCT03202628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110388370|NCT03202628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110388371|NCT03202628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110388372|NCT03202628|Glucocorticoids|glucocorticoids|mesh-ancestor
110388373|NCT03202628|Hormones|hormones|mesh-ancestor
110388374|NCT03202628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110388375|NCT03202628|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110388376|NCT03202628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110388377|NCT03202628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110388378|NCT03202628|Protease Inhibitors|protease inhibitors|mesh-ancestor
110388379|NCT03202628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110388380|NCT03202628|Immunologic Factors|immunologic factors|mesh-ancestor
110388381|NCT03202628|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110388382|NCT03202628|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110388383|NCT03202628|Growth Substances|growth substances|mesh-ancestor
110388384|NCT03202628|Growth Inhibitors|growth inhibitors|mesh-ancestor
110388385|NCT03202628|Dermatologic Agents|dermatologic agents|mesh-ancestor
110388386|NCT03202628|Glycine Agents|glycine agents|mesh-ancestor
110388387|NCT03202628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110388388|NCT03176472|Ricolinostat|ricolinostat|mesh-list
110388389|NCT03176472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110388390|NCT03176472|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110388391|NCT03176472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110388392|NCT03176472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110388393|NCT03173950|Nivolumab|nivolumab|mesh-list
110388394|NCT03173950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110388395|NCT03173950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110388396|NCT03173950|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110388397|NCT03173950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110388398|NCT03168737|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
110388399|NCT03168737|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110388400|NCT03168737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110388401|NCT03164057|Cytarabine|cytarabine|mesh-list
110388402|NCT03164057|Hydrocortisone|hydrocortisone|mesh-list
110388403|NCT03164057|Methotrexate|methotrexate|mesh-list
110388404|NCT03164057|Azacitidine|azacitidine|mesh-list
110388405|NCT03164057|Decitabine|decitabine|mesh-list
110388406|NCT03164057|Fludarabine|fludarabine|mesh-list
110388407|NCT03164057|Etoposide|etoposide|mesh-list
110388408|NCT03164057|Etoposide phosphate|etoposide phosphate|mesh-list
110388409|NCT03164057|Sorafenib|sorafenib|mesh-list
110388410|NCT03164057|Daunorubicin|daunorubicin|mesh-list
110388411|NCT03164057|Asparaginase|asparaginase|mesh-list
110388412|NCT03164057|Mitoxantrone|mitoxantrone|mesh-list
110388413|NCT03164057|Idarubicin|idarubicin|mesh-list
110388414|NCT03164057|Dexrazoxane|dexrazoxane|mesh-list
110388415|NCT03164057|Razoxane|razoxane|mesh-list
110388416|NCT03164057|Asparaginase erwinia chrysanthemi, recombinant-rywn|asparaginase erwinia chrysanthemi, recombinant-rywn|mesh-list
110388417|NCT03164057|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110388418|NCT03164057|Abortifacient Agents|abortifacient agents|mesh-ancestor
110388419|NCT03164057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110388420|NCT03164057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110388421|NCT03164057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110388422|NCT03164057|Antimetabolites|antimetabolites|mesh-ancestor
110388423|NCT03164057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110388424|NCT03164057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110388425|NCT03164057|Dermatologic Agents|dermatologic agents|mesh-ancestor
110388426|NCT03164057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110388427|NCT03164057|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110388428|NCT03164057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110388429|NCT03164057|Immunologic Factors|immunologic factors|mesh-ancestor
110388430|NCT03164057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110388431|NCT03164057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110388432|NCT03164057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110388433|NCT03164057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110388434|NCT03164057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110388436|NCT03164057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110388437|NCT03164057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110388438|NCT03164057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110388439|NCT03164057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110388440|NCT03164057|Analgesics|analgesics|mesh-ancestor
110388441|NCT03164057|Sensory System Agents|sensory system agents|mesh-ancestor
110388442|NCT03164057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110388444|NCT03164057|Protective Agents|protective agents|mesh-ancestor
110388445|NCT03164057|Antimitotic Agents|antimitotic agents|mesh-ancestor
110388446|NCT03164057|Mitosis Modulators|mitosis modulators|mesh-ancestor
110388447|NCT03136146|Dexamethasone|dexamethasone|mesh-list
110388448|NCT03136146|Dexamethasone acetate|dexamethasone acetate|mesh-list
110388449|NCT03136146|Cyclophosphamide|cyclophosphamide|mesh-list
110388450|NCT03136146|Rituximab|rituximab|mesh-list
110388451|NCT03136146|Etoposide|etoposide|mesh-list
110388452|NCT03136146|Vincristine|vincristine|mesh-list
110388453|NCT03136146|Etoposide phosphate|etoposide phosphate|mesh-list
110388454|NCT03136146|Bortezomib|bortezomib|mesh-list
110388455|NCT03136146|Clofarabine|clofarabine|mesh-list
110388456|NCT03136146|Ofatumumab|ofatumumab|mesh-list
110388457|NCT03136146|Podophyllotoxin|podophyllotoxin|mesh-list
110388458|NCT03136146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110388459|NCT03136146|Antibodies|antibodies|mesh-list
110388460|NCT03136146|Immunoglobulins|immunoglobulins|mesh-list
110388461|NCT03136146|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110388462|NCT03136146|Lenograstim|lenograstim|mesh-list
110388463|NCT03136146|BB 1101|bb 1101|mesh-list
110388464|NCT03136146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110388465|NCT03136146|Immunologic Factors|immunologic factors|mesh-ancestor
110388466|NCT03136146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110388467|NCT03136146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110388468|NCT03136146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110388469|NCT03136146|Alkylating Agents|alkylating agents|mesh-ancestor
110388470|NCT03136146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110388471|NCT03136146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110388472|NCT03136146|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110388473|NCT03136146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110388474|NCT03136146|Antiemetics|antiemetics|mesh-ancestor
110388475|NCT03136146|Autonomic Agents|autonomic agents|mesh-ancestor
110388476|NCT03136146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110388477|NCT03136146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110388478|NCT03136146|Glucocorticoids|glucocorticoids|mesh-ancestor
110388480|NCT03136146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110388481|NCT03136146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110388482|NCT03136146|Protease Inhibitors|protease inhibitors|mesh-ancestor
110388483|NCT03136146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110388484|NCT03136146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110388485|NCT03136146|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110388486|NCT03136146|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110388487|NCT03136146|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110388488|NCT03136146|Tubulin Modulators|tubulin modulators|mesh-ancestor
110388489|NCT03136146|Antimitotic Agents|antimitotic agents|mesh-ancestor
110388490|NCT03136146|Mitosis Modulators|mitosis modulators|mesh-ancestor
110388491|NCT03136146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110388492|NCT03136146|Antimetabolites|antimetabolites|mesh-ancestor
110388493|NCT03136146|Keratolytic Agents|keratolytic agents|mesh-ancestor
110388494|NCT03136146|Dermatologic Agents|dermatologic agents|mesh-ancestor
110388495|NCT03129828|Bortezomib|bortezomib|mesh-list
110388496|NCT03129828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110388497|NCT03128866|Tranexamic Acid|tranexamic acid|mesh-list
110388498|NCT03128866|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110388499|NCT03128866|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110388504|NCT03127631|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110388505|NCT03127631|Simvastatin|simvastatin|mesh-list
110388506|NCT03127631|Pravastatin|pravastatin|mesh-list
110388507|NCT03127631|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110388508|NCT03127631|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110388509|NCT03127631|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110388510|NCT03127631|Antimetabolites|antimetabolites|mesh-ancestor
110388511|NCT03127631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110388512|NCT03127631|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110388513|NCT03127631|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110388514|NCT03127631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110388515|NCT03127631|Protease Inhibitors|protease inhibitors|mesh-ancestor
110388516|NCT03095352|Carboplatin|carboplatin|mesh-list
110388517|NCT03095352|Pembrolizumab|pembrolizumab|mesh-list
110388518|NCT03095352|Trastuzumab|trastuzumab|mesh-list
110388519|NCT03095352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110388520|NCT03095352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110388521|NCT03095352|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110388522|NCT03095352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110388523|NCT03067571|Daratumumab|daratumumab|mesh-list
110388524|NCT03067571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110388546|NCT03020199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110388547|NCT03020199|Glucocorticoids|glucocorticoids|mesh-ancestor
110388549|NCT03020199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110388550|NCT03020199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110388551|NCT03020199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110388552|NCT03020199|Respiratory System Agents|respiratory system agents|mesh-ancestor
110388553|NCT03020199|Immunologic Factors|immunologic factors|mesh-ancestor
110388554|NCT03020199|Dermatologic Agents|dermatologic agents|mesh-ancestor
110388555|NCT03006068|Upadacitinib|upadacitinib|mesh-list
110388556|NCT03006068|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110388557|NCT03006068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110388558|NCT03006068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110388559|NCT03006068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110388560|NCT03006068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110388561|NCT02999022|Lithium Carbonate|lithium carbonate|mesh-list
110388562|NCT02999022|Antidepressive Agents|antidepressive agents|mesh-ancestor
110388563|NCT02999022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110388564|NCT02999022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110388565|NCT02999022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110388566|NCT02999022|Antimanic Agents|antimanic agents|mesh-ancestor
110388567|NCT02999022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110388568|NCT02999022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110388569|NCT02999022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110388571|NCT02964182|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110388572|NCT02964182|Autonomic Agents|autonomic agents|mesh-ancestor
110388573|NCT02964182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110388574|NCT02964182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110388578|NCT02964182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110388579|NCT02964182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110388580|NCT02964078|Aldesleukin|aldesleukin|mesh-list
110388581|NCT02964078|Pembrolizumab|pembrolizumab|mesh-list
110388582|NCT02964078|Interleukin-2|interleukin-2|mesh-list
110388583|NCT02964078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110388584|NCT02964078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110388585|NCT02964078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110388586|NCT02964078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110388587|NCT02964078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110388588|NCT02964078|Analgesics|analgesics|mesh-ancestor
110388589|NCT02964078|Sensory System Agents|sensory system agents|mesh-ancestor
110388590|NCT02964078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110388591|NCT02964078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110388592|NCT02964078|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110388593|NCT02964078|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110388594|NCT02964078|Antiviral Agents|antiviral agents|mesh-ancestor
110388595|NCT02964078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110388596|NCT02954874|Pembrolizumab|pembrolizumab|mesh-list
110388597|NCT02954874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110388598|NCT02954874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110388599|NCT02954874|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110388600|NCT02954874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110388601|NCT02926859|Cannabidiol|cannabidiol|mesh-list
110388602|NCT02926859|Anticonvulsants|anticonvulsants|mesh-ancestor
110388607|NCT02911142|Cyclophosphamide|cyclophosphamide|mesh-list
110388608|NCT02911142|Rituximab|rituximab|mesh-list
110388609|NCT02911142|Doxorubicin|doxorubicin|mesh-list
110388610|NCT02911142|Vincristine|vincristine|mesh-list
110388611|NCT02911142|Lenalidomide|lenalidomide|mesh-list
110388612|NCT02911142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110388613|NCT02911142|Immunologic Factors|immunologic factors|mesh-ancestor
110388614|NCT02911142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110388615|NCT02911142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110388616|NCT02911142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110388617|NCT02911142|Alkylating Agents|alkylating agents|mesh-ancestor
110388618|NCT02911142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110388619|NCT02911142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110388620|NCT02911142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110388638|NCT02911142|Growth Inhibitors|growth inhibitors|mesh-ancestor
110042872|NCT01444677|Beta-lapachone|beta-lapachone|mesh-list
110388721|NCT02876107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110388722|NCT02876107|Antibodies|antibodies|mesh-list
110388723|NCT02876107|Immunoglobulins|immunoglobulins|mesh-list
110388724|NCT02876107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110388725|NCT02876107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110388726|NCT02876107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110042938|NCT01445106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110388727|NCT02876107|Tubulin Modulators|tubulin modulators|mesh-ancestor
110388728|NCT02876107|Antimitotic Agents|antimitotic agents|mesh-ancestor
110388729|NCT02876107|Mitosis Modulators|mitosis modulators|mesh-ancestor
110388730|NCT02876107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110388731|NCT02876107|Immunologic Factors|immunologic factors|mesh-ancestor
110388732|NCT02876107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110388733|NCT02873195|Bevacizumab|bevacizumab|mesh-list
110388734|NCT02873195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110388735|NCT02873195|Atezolizumab|atezolizumab|mesh-list
110388736|NCT02873195|Capecitabine|capecitabine|mesh-list
110388737|NCT02873195|Endothelial Growth Factors|endothelial growth factors|mesh-list
110388738|NCT02873195|Antibodies|antibodies|mesh-list
110388739|NCT02873195|Immunoglobulins|immunoglobulins|mesh-list
110388740|NCT02873195|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110388741|NCT02873195|Immunoglobulin G|immunoglobulin g|mesh-list
110388742|NCT02873195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110388743|NCT02873195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110388744|NCT02873195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110388745|NCT02873195|Growth Substances|growth substances|mesh-ancestor
110388746|NCT02873195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110388747|NCT02873195|Growth Inhibitors|growth inhibitors|mesh-ancestor
110388748|NCT02873195|Immunologic Factors|immunologic factors|mesh-ancestor
110388749|NCT02873195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110388750|NCT02873195|Antimetabolites|antimetabolites|mesh-ancestor
110388751|NCT02873195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110388752|NCT02873195|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110388753|NCT02872259|Pembrolizumab|pembrolizumab|mesh-list
110388755|NCT02872259|Dabrafenib|dabrafenib|mesh-list
110388756|NCT02872259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110388757|NCT02872259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110388758|NCT02872259|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110388759|NCT02872259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110388760|NCT02872259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110388761|NCT02872259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110388763|NCT02831933|Nivolumab|nivolumab|mesh-list
110388764|NCT02831933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110388765|NCT02831933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110388766|NCT02831933|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110388767|NCT02831933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110388768|NCT02831933|Antiviral Agents|antiviral agents|mesh-ancestor
110388769|NCT02831933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110388770|NCT02784496|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
110388771|NCT02784496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110388783|NCT02763566|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110388784|NCT02763566|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110388785|NCT02763566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110388786|NCT02763566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110388787|NCT02763566|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110388788|NCT02763566|Hormone Antagonists|hormone antagonists|mesh-ancestor
110388789|NCT02763566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110388790|NCT02763566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110388791|NCT02763566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110388792|NCT02763566|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110388793|NCT02760407|Adalimumab|adalimumab|mesh-list
110388794|NCT02760407|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110388795|NCT02760407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110388796|NCT02760407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110388797|NCT02756897|Venetoclax|venetoclax|mesh-list
110388798|NCT02756897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110388799|NCT02747004|Tamoxifen|tamoxifen|mesh-list
110388800|NCT02747004|Loperamide|loperamide|mesh-list
110388801|NCT02747004|Antidiarrheals|antidiarrheals|mesh-list
110388802|NCT02747004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110388803|NCT02747004|Hormone Antagonists|hormone antagonists|mesh-ancestor
110388804|NCT02747004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110388805|NCT02747004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110388806|NCT02747004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110388807|NCT02747004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110388808|NCT02747004|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110388809|NCT02747004|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110388810|NCT02747004|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110388811|NCT02747004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110388812|NCT02741570|Cisplatin|cisplatin|mesh-list
110388813|NCT02741570|Carboplatin|carboplatin|mesh-list
110388814|NCT02741570|Fluorouracil|fluorouracil|mesh-list
110388815|NCT02741570|Nivolumab|nivolumab|mesh-list
110388816|NCT02741570|Cetuximab|cetuximab|mesh-list
110388817|NCT02741570|Ipilimumab|ipilimumab|mesh-list
110388818|NCT02741570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110388819|NCT02741570|Antimetabolites|antimetabolites|mesh-ancestor
110388820|NCT02741570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110388821|NCT02741570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110388822|NCT02741570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110388823|NCT02741570|Immunologic Factors|immunologic factors|mesh-ancestor
110388824|NCT02741570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110388825|NCT02741570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110388826|NCT02741570|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110388828|NCT02739035|Celecoxib|celecoxib|mesh-list
110388829|NCT02739035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110388830|NCT02739035|Antiemetics|antiemetics|mesh-ancestor
110388831|NCT02739035|Autonomic Agents|autonomic agents|mesh-ancestor
110388832|NCT02739035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110388833|NCT02739035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110388834|NCT02739035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110388835|NCT02739035|Glucocorticoids|glucocorticoids|mesh-ancestor
110388836|NCT02739035|Hormones|hormones|mesh-ancestor
110388837|NCT02739035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110388838|NCT02739035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110388839|NCT02739035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110388840|NCT02739035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110388841|NCT02739035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110388843|NCT02739035|Sensory System Agents|sensory system agents|mesh-ancestor
110388844|NCT02739035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110388845|NCT02739035|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110388846|NCT02739035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110388847|NCT02739035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110388848|NCT02739035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110388849|NCT02730416|Paclitaxel|paclitaxel|mesh-list
110388850|NCT02730416|Carboplatin|carboplatin|mesh-list
110388851|NCT02730416|Nintedanib|nintedanib|mesh-list
110388852|NCT02730416|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110388853|NCT02730416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110388855|NCT02730416|Antimitotic Agents|antimitotic agents|mesh-ancestor
110388856|NCT02730416|Mitosis Modulators|mitosis modulators|mesh-ancestor
110388857|NCT02730416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110388858|NCT02730416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110388859|NCT02730416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110388860|NCT02723760|HYNIC-3PRGD(2)|hynic-3prgd(2)|mesh-list
110388861|NCT02723760|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110388862|NCT02723760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110388863|NCT02707042|Amoxicillin|amoxicillin|mesh-list
110388864|NCT02707042|Azithromycin|azithromycin|mesh-list
110388865|NCT02707042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110388866|NCT02707042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110388867|NCT02703610|Acetaminophen|acetaminophen|mesh-list
110388868|NCT02703610|Ibuprofen|ibuprofen|mesh-list
110388869|NCT02703610|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
110388870|NCT02703610|Oxycodone|oxycodone|mesh-list
110388871|NCT02703610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110388872|NCT02703610|Analgesics|analgesics|mesh-ancestor
110388873|NCT02703610|Sensory System Agents|sensory system agents|mesh-ancestor
110388874|NCT02703610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110388875|NCT02703610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110388876|NCT02703610|Antipyretics|antipyretics|mesh-ancestor
110388877|NCT02703610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110388878|NCT02703610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110388879|NCT02703610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110388880|NCT02703610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110388881|NCT02703610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110388882|NCT02703610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110388883|NCT02703610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110388884|NCT02703610|Narcotics|narcotics|mesh-ancestor
110388885|NCT02703610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110388886|NCT02675231|Trastuzumab|trastuzumab|mesh-list
110388887|NCT02675231|Fulvestrant|fulvestrant|mesh-list
110388888|NCT02675231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110388889|NCT02675231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110388890|NCT02675231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110388891|NCT02675231|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110388892|NCT02675231|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110388893|NCT02675231|Hormone Antagonists|hormone antagonists|mesh-ancestor
110388894|NCT02675231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110388895|NCT02675231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110388896|NCT02665117|Chlorthalidone|chlorthalidone|mesh-list
110388897|NCT02665117|Magnesium citrate|magnesium citrate|mesh-list
110388898|NCT02665117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110388899|NCT02665117|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110388900|NCT02665117|Diuretics|diuretics|mesh-ancestor
110388901|NCT02665117|Natriuretic Agents|natriuretic agents|mesh-ancestor
110388902|NCT02665117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110388903|NCT02665117|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110388904|NCT02665117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110388905|NCT02665117|Cathartics|cathartics|mesh-ancestor
110388906|NCT02665117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110388907|NCT02661035|Mycophenolic Acid|mycophenolic acid|mesh-list
110388908|NCT02661035|Cyclophosphamide|cyclophosphamide|mesh-list
110388909|NCT02661035|Fludarabine|fludarabine|mesh-list
110388910|NCT02661035|Allopurinol|allopurinol|mesh-list
110388911|NCT02661035|Tacrolimus|tacrolimus|mesh-list
110388912|NCT02661035|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110388913|NCT02661035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110388914|NCT02661035|Immunologic Factors|immunologic factors|mesh-ancestor
110388915|NCT02661035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110388916|NCT02661035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110388917|NCT02661035|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110388918|NCT02661035|Alkylating Agents|alkylating agents|mesh-ancestor
110388919|NCT02661035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110388920|NCT02661035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110388921|NCT02661035|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110388922|NCT02661035|Antimetabolites|antimetabolites|mesh-ancestor
110388923|NCT02661035|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110388924|NCT02661035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110388925|NCT02661035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110388926|NCT02661035|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110388927|NCT02661035|Antitubercular Agents|antitubercular agents|mesh-ancestor
110388928|NCT02661035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110388929|NCT02661035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110388930|NCT02661035|Gout Suppressants|gout suppressants|mesh-ancestor
110388931|NCT02661035|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110388932|NCT02661035|Antioxidants|antioxidants|mesh-ancestor
110388933|NCT02661035|Protective Agents|protective agents|mesh-ancestor
110388934|NCT02659930|Doxorubicin|doxorubicin|mesh-list
110388935|NCT02659930|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110388936|NCT02659930|Pomalidomide|pomalidomide|mesh-list
110388937|NCT02659930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110388938|NCT02659930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110388939|NCT02659930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110388940|NCT02659930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110388941|NCT02659930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110388942|NCT02659930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110388953|NCT02627846|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
110388955|NCT02627846|Anesthetics, Local|anesthetics, local|mesh-ancestor
110388956|NCT02627846|Anesthetics|anesthetics|mesh-ancestor
110388957|NCT02627846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110388958|NCT02627846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110388959|NCT02627846|Sensory System Agents|sensory system agents|mesh-ancestor
110388960|NCT02627846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110388961|NCT02627846|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110388962|NCT02627846|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110388963|NCT02627846|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110388964|NCT02627846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110388965|NCT02627846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110388966|NCT02627846|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110388967|NCT02627846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110388968|NCT02627846|Adrenergic Agents|adrenergic agents|mesh-ancestor
110388969|NCT02627846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110388970|NCT02627846|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110388971|NCT02627846|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110388972|NCT02627846|Autonomic Agents|autonomic agents|mesh-ancestor
110388973|NCT02627846|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110388974|NCT02627846|Respiratory System Agents|respiratory system agents|mesh-ancestor
110388975|NCT02627846|Mydriatics|mydriatics|mesh-ancestor
110388976|NCT02627846|Sympathomimetics|sympathomimetics|mesh-ancestor
110388977|NCT02627846|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110388978|NCT02627846|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
110388988|NCT02603887|Pembrolizumab|pembrolizumab|mesh-list
110388989|NCT02603887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110388990|NCT02603887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110388991|NCT02603887|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110388992|NCT02603887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110388993|NCT02581787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110388994|NCT02581787|Antibodies|antibodies|mesh-list
110388995|NCT02581787|Immunoglobulins|immunoglobulins|mesh-list
110388996|NCT02581787|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110388997|NCT02581787|Immunoglobulin G|immunoglobulin g|mesh-list
110388998|NCT02581787|Immunologic Factors|immunologic factors|mesh-ancestor
110388999|NCT02581787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110389000|NCT02581787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110389001|NCT02580604|Calcium|calcium|mesh-list
110389002|NCT02580604|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110389003|NCT02580604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110389004|NCT02576509|Nivolumab|nivolumab|mesh-list
110389005|NCT02576509|Sorafenib|sorafenib|mesh-list
110389006|NCT02576509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110389007|NCT02576509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110389008|NCT02576509|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110389009|NCT02576509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110389010|NCT02576509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110389011|NCT02576509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110389012|NCT02567435|Sirolimus|sirolimus|mesh-list
110389013|NCT02567435|Dactinomycin|dactinomycin|mesh-list
110389014|NCT02567435|Cyclophosphamide|cyclophosphamide|mesh-list
110389015|NCT02567435|Irinotecan|irinotecan|mesh-list
110389016|NCT02567435|Vincristine|vincristine|mesh-list
110389017|NCT02567435|Temsirolimus|temsirolimus|mesh-list
110389018|NCT02567435|Vinorelbine|vinorelbine|mesh-list
110389019|NCT02567435|Camptothecin|camptothecin|mesh-list
110389020|NCT02567435|MTOR Inhibitors|mtor inhibitors|mesh-list
110389022|NCT02567435|Immunologic Factors|immunologic factors|mesh-ancestor
110389023|NCT02567435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110389024|NCT02567435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110389025|NCT02567435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110389026|NCT02567435|Alkylating Agents|alkylating agents|mesh-ancestor
110389027|NCT02567435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110389028|NCT02567435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110389029|NCT02567435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110389030|NCT02567435|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110389031|NCT02567435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110389032|NCT02567435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110389033|NCT02567435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110389034|NCT02567435|Tubulin Modulators|tubulin modulators|mesh-ancestor
110043238|NCT01446523|Lactulose|lactulose|mesh-list
110389035|NCT02567435|Antimitotic Agents|antimitotic agents|mesh-ancestor
110389036|NCT02567435|Mitosis Modulators|mitosis modulators|mesh-ancestor
110389037|NCT02567435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110389038|NCT02567435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110389039|NCT02567435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110389040|NCT02567435|Antifungal Agents|antifungal agents|mesh-ancestor
110389041|NCT02567435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110389042|NCT02567435|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110389043|NCT02567435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110389044|NCT02564900|Camptothecin|camptothecin|mesh-list
110389045|NCT02564900|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
110389046|NCT02564900|Immunoconjugates|immunoconjugates|mesh-list
110389047|NCT02564900|Immunologic Factors|immunologic factors|mesh-ancestor
110389048|NCT02564900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110389049|NCT02564900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110389050|NCT02564900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110389051|NCT02564900|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110389052|NCT02564900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110389053|NCT02564900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110389054|NCT02564900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110389055|NCT02554279|Menotropins|menotropins|mesh-list
110389056|NCT02554279|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110389057|NCT02554279|Fertility Agents|fertility agents|mesh-ancestor
110389058|NCT02554279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110389059|NCT02554279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110389060|NCT02550028|Levetiracetam|levetiracetam|mesh-list
110389061|NCT02550028|Phenobarbital|phenobarbital|mesh-list
110389062|NCT02550028|Anticonvulsants|anticonvulsants|mesh-ancestor
110389063|NCT02550028|Nootropic Agents|nootropic agents|mesh-ancestor
110389064|NCT02550028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110389065|NCT02550028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110389066|NCT02550028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110389067|NCT02550028|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110389068|NCT02550028|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110389069|NCT02550028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110389070|NCT02550028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110389071|NCT02550028|GABA Modulators|gaba modulators|mesh-ancestor
110389072|NCT02550028|GABA Agents|gaba agents|mesh-ancestor
110389073|NCT02550028|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110389074|NCT02550028|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110389075|NCT02550028|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110389078|NCT02542293|Carboplatin|carboplatin|mesh-list
110389079|NCT02542293|Gemcitabine|gemcitabine|mesh-list
110389080|NCT02542293|Pemetrexed|pemetrexed|mesh-list
110389081|NCT02542293|Durvalumab|durvalumab|mesh-list
110389082|NCT02542293|Tremelimumab|tremelimumab|mesh-list
110389083|NCT02542293|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110389084|NCT02542293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110389085|NCT02542293|Tubulin Modulators|tubulin modulators|mesh-ancestor
110389086|NCT02542293|Antimitotic Agents|antimitotic agents|mesh-ancestor
110389087|NCT02542293|Mitosis Modulators|mitosis modulators|mesh-ancestor
110389088|NCT02542293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110389089|NCT02542293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110389090|NCT02542293|Antimetabolites|antimetabolites|mesh-ancestor
110389091|NCT02542293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110389092|NCT02542293|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110389093|NCT02542293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110389094|NCT02542293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110389095|NCT02535988|Thymalfasin|thymalfasin|mesh-list
110389096|NCT02535988|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110389097|NCT02535988|Immunologic Factors|immunologic factors|mesh-ancestor
110389098|NCT02535988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110389099|NCT02515773|Metformin|metformin|mesh-list
110389100|NCT02515773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110389101|NCT02515773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110389102|NCT02484248|Ketotifen|ketotifen|mesh-list
110389103|NCT02484248|Antipruritics|antipruritics|mesh-ancestor
110389104|NCT02484248|Dermatologic Agents|dermatologic agents|mesh-ancestor
110389105|NCT02484248|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110389106|NCT02484248|Histamine Antagonists|histamine antagonists|mesh-ancestor
110389107|NCT02484248|Histamine Agents|histamine agents|mesh-ancestor
110389108|NCT02484248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110389109|NCT02484248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110043307|NCT01447095|Tezosentan|tezosentan|mesh-list
110389110|NCT02484248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110389111|NCT02484248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110389112|NCT02478788|Amphetamine|amphetamine|mesh-list
110389113|NCT02478788|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110389114|NCT02478788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110389115|NCT02478788|Sympathomimetics|sympathomimetics|mesh-ancestor
110389116|NCT02478788|Autonomic Agents|autonomic agents|mesh-ancestor
110389117|NCT02478788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110389118|NCT02478788|Dopamine Agents|dopamine agents|mesh-ancestor
110389119|NCT02478788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110389120|NCT02478788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110389121|NCT02478788|Adrenergic Agents|adrenergic agents|mesh-ancestor
110389122|NCT02478788|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110389123|NCT02478788|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110389124|NCT02478788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110389125|NCT02478788|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110389126|NCT02456194|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110389128|NCT02456194|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110389129|NCT02456194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110389130|NCT02456194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110389131|NCT02443077|Cytarabine|cytarabine|mesh-list
110389132|NCT02443077|Cyclophosphamide|cyclophosphamide|mesh-list
110389133|NCT02443077|Melphalan|melphalan|mesh-list
110389134|NCT02443077|Mechlorethamine|mechlorethamine|mesh-list
110389136|NCT02443077|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
110389137|NCT02443077|Etoposide|etoposide|mesh-list
110389138|NCT02443077|Etoposide phosphate|etoposide phosphate|mesh-list
110389139|NCT02443077|Podophyllotoxin|podophyllotoxin|mesh-list
110389140|NCT02443077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110389141|NCT02443077|Immunologic Factors|immunologic factors|mesh-ancestor
110389142|NCT02443077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110389143|NCT02443077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110389144|NCT02443077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110389145|NCT02443077|Alkylating Agents|alkylating agents|mesh-ancestor
110389146|NCT02443077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110389147|NCT02443077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110389148|NCT02443077|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110389149|NCT02443077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110389150|NCT02443077|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110389151|NCT02443077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110389152|NCT02443077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110389153|NCT02443077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110389154|NCT02443077|Antimetabolites|antimetabolites|mesh-ancestor
110389155|NCT02443077|Antiviral Agents|antiviral agents|mesh-ancestor
110389156|NCT02443077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110389157|NCT02443077|Keratolytic Agents|keratolytic agents|mesh-ancestor
110389158|NCT02443077|Dermatologic Agents|dermatologic agents|mesh-ancestor
110389159|NCT02443077|Tubulin Modulators|tubulin modulators|mesh-ancestor
110389160|NCT02443077|Antimitotic Agents|antimitotic agents|mesh-ancestor
110389161|NCT02443077|Mitosis Modulators|mitosis modulators|mesh-ancestor
110389162|NCT02439450|Pembrolizumab|pembrolizumab|mesh-list
110389163|NCT02439450|Nivolumab|nivolumab|mesh-list
110389164|NCT02439450|Pemetrexed|pemetrexed|mesh-list
110389165|NCT02439450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110389166|NCT02439450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110389167|NCT02439450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110389168|NCT02439450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110389169|NCT02439450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110389170|NCT02439450|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110389171|NCT02439450|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110389172|NCT02437136|Pembrolizumab|pembrolizumab|mesh-list
110389173|NCT02437136|Entinostat|entinostat|mesh-list
110389177|NCT02437136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110389178|NCT02437136|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110389179|NCT02437136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110389188|NCT02421939|Etoposide|etoposide|mesh-list
110389189|NCT02421939|Azacitidine|azacitidine|mesh-list
110389190|NCT02421939|Mitoxantrone|mitoxantrone|mesh-list
110389191|NCT02421939|Idarubicin|idarubicin|mesh-list
110389192|NCT02421939|Lenograstim|lenograstim|mesh-list
110389193|NCT02421939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110389194|NCT02421939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110389195|NCT02421939|Antimetabolites|antimetabolites|mesh-ancestor
110389196|NCT02421939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110389197|NCT02421939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110389198|NCT02421939|Immunologic Factors|immunologic factors|mesh-ancestor
110389199|NCT02421939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110389200|NCT02421939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110389201|NCT02421939|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110389202|NCT02421939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110389203|NCT02421939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110389204|NCT02421939|Antiviral Agents|antiviral agents|mesh-ancestor
110389205|NCT02421939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110389207|NCT02421939|Sensory System Agents|sensory system agents|mesh-ancestor
110389208|NCT02421939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110389209|NCT02421939|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110389210|NCT02421939|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110389211|NCT02404870|Canagliflozin|canagliflozin|mesh-list
110389212|NCT02404870|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110389213|NCT02404870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110389214|NCT02404870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110389215|NCT02404870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110389217|NCT02403778|Tretinoin|tretinoin|mesh-list
110389218|NCT02403778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110389219|NCT02403778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110389220|NCT02403778|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110389221|NCT02403778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110389222|NCT02403778|Keratolytic Agents|keratolytic agents|mesh-ancestor
110389223|NCT02403778|Dermatologic Agents|dermatologic agents|mesh-ancestor
110389224|NCT02390284|Timolol|timolol|mesh-list
110389225|NCT02390284|Bimatoprost|bimatoprost|mesh-list
110389226|NCT02390284|Travoprost|travoprost|mesh-list
110389227|NCT02390284|Dorzolamide|dorzolamide|mesh-list
110389228|NCT02390284|Acetazolamide|acetazolamide|mesh-list
110389229|NCT02390284|Methazolamide|methazolamide|mesh-list
110389230|NCT02390284|Latanoprost|latanoprost|mesh-list
110389231|NCT02390284|Brinzolamide|brinzolamide|mesh-list
110389232|NCT02390284|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110389233|NCT02390284|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110389234|NCT02390284|Adrenergic Agents|adrenergic agents|mesh-ancestor
110389235|NCT02390284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110389236|NCT02390284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110389237|NCT02390284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110389238|NCT02390284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110389239|NCT02390284|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110389241|NCT02390284|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110389242|NCT02390284|Anticonvulsants|anticonvulsants|mesh-ancestor
110389243|NCT02390284|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110389244|NCT02390284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110389245|NCT02390284|Diuretics|diuretics|mesh-ancestor
110389246|NCT02390284|Natriuretic Agents|natriuretic agents|mesh-ancestor
110389247|NCT02386826|Bevacizumab|bevacizumab|mesh-list
110389248|NCT02386826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110389249|NCT02386826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110389250|NCT02386826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110389251|NCT02386826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110389252|NCT02386826|Growth Substances|growth substances|mesh-ancestor
110389253|NCT02386826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110389254|NCT02386826|Growth Inhibitors|growth inhibitors|mesh-ancestor
110389255|NCT02356159|Rituximab|rituximab|mesh-list
110389256|NCT02356159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110389257|NCT02356159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110389259|NCT02356159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110389260|NCT02356159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110389261|NCT02312258|Ixazomib|ixazomib|mesh-list
110389262|NCT02312258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110389264|NCT02312258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110389265|NCT02312258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110389266|NCT02276274|Alogliptin|alogliptin|mesh-list
110389267|NCT02276274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110389268|NCT02276274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110389269|NCT02276274|Incretins|incretins|mesh-ancestor
110389270|NCT02276274|Hormones|hormones|mesh-ancestor
110389271|NCT02276274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110389272|NCT02276274|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110389273|NCT02276274|Protease Inhibitors|protease inhibitors|mesh-ancestor
110389274|NCT02276274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110389275|NCT02276274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110389276|NCT02242942|Venetoclax|venetoclax|mesh-list
110389277|NCT02242942|Obinutuzumab|obinutuzumab|mesh-list
110389278|NCT02242942|Chlorambucil|chlorambucil|mesh-list
110389279|NCT02242942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110389280|NCT02242942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110389281|NCT02242942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110389282|NCT02242942|Alkylating Agents|alkylating agents|mesh-ancestor
110389283|NCT02242942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110389285|NCT02203526|Isavuconazole|isavuconazole|mesh-list
110389286|NCT02203526|Rituximab|rituximab|mesh-list
110389287|NCT02203526|Methotrexate|methotrexate|mesh-list
110389288|NCT02203526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110389289|NCT02203526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110389290|NCT02203526|Immunologic Factors|immunologic factors|mesh-ancestor
110389291|NCT02203526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110389292|NCT02203526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110389293|NCT02203526|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110389294|NCT02203526|Abortifacient Agents|abortifacient agents|mesh-ancestor
110389295|NCT02203526|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110389296|NCT02203526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110389297|NCT02203526|Antimetabolites|antimetabolites|mesh-ancestor
110389298|NCT02203526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110389299|NCT02203526|Dermatologic Agents|dermatologic agents|mesh-ancestor
110389300|NCT02203526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110389301|NCT02203526|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110389302|NCT02203526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110389303|NCT02203526|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110389304|NCT02203526|Antiviral Agents|antiviral agents|mesh-ancestor
110389305|NCT02203526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110389306|NCT02203526|Antifungal Agents|antifungal agents|mesh-ancestor
110389307|NCT02199184|Prednisone|prednisone|mesh-list
110389308|NCT02199184|Cortisone|cortisone|mesh-list
110389309|NCT02199184|Cyclophosphamide|cyclophosphamide|mesh-list
110389310|NCT02199184|Rituximab|rituximab|mesh-list
110389311|NCT02199184|Doxorubicin|doxorubicin|mesh-list
110389312|NCT02199184|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110389313|NCT02199184|Etoposide|etoposide|mesh-list
110389314|NCT02199184|Vincristine|vincristine|mesh-list
110389315|NCT02199184|Etoposide phosphate|etoposide phosphate|mesh-list
110389317|NCT02199184|Podophyllotoxin|podophyllotoxin|mesh-list
110389318|NCT02199184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110389319|NCT02199184|Antibodies|antibodies|mesh-list
110389320|NCT02199184|Immunoglobulins|immunoglobulins|mesh-list
110389321|NCT02199184|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110389322|NCT02199184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110389323|NCT02199184|Immunologic Factors|immunologic factors|mesh-ancestor
110389324|NCT02199184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110389325|NCT02199184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110389326|NCT02199184|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110389327|NCT02199184|Alkylating Agents|alkylating agents|mesh-ancestor
110389328|NCT02199184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110389329|NCT02199184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110389330|NCT02199184|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110389331|NCT02199184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110389332|NCT02199184|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110389333|NCT02199184|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110389334|NCT02199184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110389335|NCT02199184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110389336|NCT02199184|Glucocorticoids|glucocorticoids|mesh-ancestor
110389338|NCT02199184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110389339|NCT02199184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110389340|NCT02199184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110389341|NCT02199184|Tubulin Modulators|tubulin modulators|mesh-ancestor
110389342|NCT02199184|Antimitotic Agents|antimitotic agents|mesh-ancestor
110389343|NCT02199184|Mitosis Modulators|mitosis modulators|mesh-ancestor
110389344|NCT02199184|Keratolytic Agents|keratolytic agents|mesh-ancestor
110389345|NCT02199184|Dermatologic Agents|dermatologic agents|mesh-ancestor
110389347|NCT02165007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110389348|NCT02165007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110389349|NCT02165007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110389350|NCT02165007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110389351|NCT02165007|Antifungal Agents|antifungal agents|mesh-ancestor
110389352|NCT02165007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110389353|NCT02165007|Immunologic Factors|immunologic factors|mesh-ancestor
110389354|NCT02165007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110389355|NCT02164734|Remifentanil|remifentanil|mesh-list
110389356|NCT02164734|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110389357|NCT02164734|Narcotics|narcotics|mesh-ancestor
110389358|NCT02164734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110389359|NCT02164734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110389360|NCT02164734|Analgesics|analgesics|mesh-ancestor
110389361|NCT02164734|Sensory System Agents|sensory system agents|mesh-ancestor
110389362|NCT02164734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110389363|NCT02135133|Ofatumumab|ofatumumab|mesh-list
110389364|NCT02135133|Idelalisib|idelalisib|mesh-list
110389365|NCT02135133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110389366|NCT02135133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110389367|NCT02135133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110389368|NCT02110069|Sirolimus|sirolimus|mesh-list
110389369|NCT02110069|Vincristine|vincristine|mesh-list
110389370|NCT02110069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110389371|NCT02110069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110389372|NCT02110069|Tubulin Modulators|tubulin modulators|mesh-ancestor
110389373|NCT02110069|Antimitotic Agents|antimitotic agents|mesh-ancestor
110389374|NCT02110069|Mitosis Modulators|mitosis modulators|mesh-ancestor
110389375|NCT02110069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110389376|NCT02110069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110389377|NCT02110069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110389378|NCT02110069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110389379|NCT02110069|Antifungal Agents|antifungal agents|mesh-ancestor
110389380|NCT02110069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110389381|NCT02110069|Immunologic Factors|immunologic factors|mesh-ancestor
110389382|NCT02110069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110389383|NCT02091960|Trastuzumab|trastuzumab|mesh-list
110389384|NCT02091960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110389385|NCT02091960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110389386|NCT02049515|Ofatumumab|ofatumumab|mesh-list
110389387|NCT02049515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110389388|NCT02046460|Aspirin|aspirin|mesh-list
110389389|NCT02046460|Vitamin K|vitamin k|mesh-list
110389390|NCT02046460|Warfarin|warfarin|mesh-list
110389391|NCT02046460|Acenocoumarol|acenocoumarol|mesh-list
110389392|NCT02046460|Phenprocoumon|phenprocoumon|mesh-list
110389393|NCT02046460|Vitamins|vitamins|mesh-ancestor
110389394|NCT02046460|Micronutrients|micronutrients|mesh-ancestor
110389395|NCT02046460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110389396|NCT02046460|Anticoagulants|anticoagulants|mesh-ancestor
110389397|NCT02046460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110389398|NCT02046460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110389399|NCT02046460|Analgesics|analgesics|mesh-ancestor
110389400|NCT02046460|Sensory System Agents|sensory system agents|mesh-ancestor
110389401|NCT02046460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110389402|NCT02046460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110389403|NCT02046460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110389404|NCT02046460|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110389405|NCT02046460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110389406|NCT02046460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110389407|NCT02046460|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110389408|NCT02046460|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110389409|NCT02046460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110389410|NCT02046460|Antipyretics|antipyretics|mesh-ancestor
110389411|NCT02046460|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110389412|NCT02046460|Hemostatics|hemostatics|mesh-ancestor
110389413|NCT02046460|Coagulants|coagulants|mesh-ancestor
110389414|NCT02004522|Ofatumumab|ofatumumab|mesh-list
110389415|NCT02004522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110389416|NCT01959139|Leucovorin|leucovorin|mesh-list
110389417|NCT01959139|Fluorouracil|fluorouracil|mesh-list
110389418|NCT01959139|Oxaliplatin|oxaliplatin|mesh-list
110389419|NCT01959139|Irinotecan|irinotecan|mesh-list
110389420|NCT01959139|Levoleucovorin|levoleucovorin|mesh-list
110389421|NCT01959139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110389422|NCT01959139|Antimetabolites|antimetabolites|mesh-ancestor
110389423|NCT01959139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110389424|NCT01959139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110389425|NCT01959139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110389426|NCT01959139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110389427|NCT01959139|Immunologic Factors|immunologic factors|mesh-ancestor
110389428|NCT01959139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110389429|NCT01959139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110389430|NCT01959139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110389431|NCT01959139|Antidotes|antidotes|mesh-ancestor
110389432|NCT01959139|Protective Agents|protective agents|mesh-ancestor
110389433|NCT01959139|Vitamin B Complex|vitamin b complex|mesh-ancestor
110389435|NCT01959139|Micronutrients|micronutrients|mesh-ancestor
110389436|NCT01932697|Docetaxel|docetaxel|mesh-list
110389437|NCT01932697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110389438|NCT01932697|Tubulin Modulators|tubulin modulators|mesh-ancestor
110389439|NCT01932697|Antimitotic Agents|antimitotic agents|mesh-ancestor
110389440|NCT01932697|Mitosis Modulators|mitosis modulators|mesh-ancestor
110389441|NCT01932697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110389442|NCT01927744|Docetaxel|docetaxel|mesh-list
110389443|NCT01927744|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110389444|NCT01927744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110389445|NCT01927744|Tubulin Modulators|tubulin modulators|mesh-ancestor
110389446|NCT01927744|Antimitotic Agents|antimitotic agents|mesh-ancestor
110389447|NCT01927744|Mitosis Modulators|mitosis modulators|mesh-ancestor
110389448|NCT01927744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110389449|NCT01927744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110389450|NCT01927744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110389451|NCT01844505|Nivolumab|nivolumab|mesh-list
110389452|NCT01844505|Ipilimumab|ipilimumab|mesh-list
110389453|NCT01844505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110389454|NCT01844505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110389455|NCT01844505|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110389456|NCT01844505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110389457|NCT01752049|Timolol|timolol|mesh-list
110389458|NCT01752049|Maleic acid|maleic acid|mesh-list
110389459|NCT01752049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110389460|NCT01752049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110389461|NCT01752049|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110389462|NCT01752049|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110389463|NCT01752049|Adrenergic Agents|adrenergic agents|mesh-ancestor
110389464|NCT01752049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110389465|NCT01752049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110389466|NCT01752049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110389467|NCT01752049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110389468|NCT01747447|Vitamin D|vitamin d|mesh-list
110389469|NCT01747447|Ergocalciferols|ergocalciferols|mesh-list
110389470|NCT01747447|Cholecalciferol|cholecalciferol|mesh-list
110389471|NCT01747447|Vitamins|vitamins|mesh-list
110389472|NCT01747447|Micronutrients|micronutrients|mesh-ancestor
110389473|NCT01747447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110389474|NCT01747447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110389475|NCT01747447|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110389476|NCT01724346|Chlorambucil|chlorambucil|mesh-list
110389477|NCT01724346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110389478|NCT01724346|Alkylating Agents|alkylating agents|mesh-ancestor
110389479|NCT01724346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110389480|NCT01724346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110389481|NCT01659658|Thalidomide|thalidomide|mesh-list
110389482|NCT01659658|Dexamethasone|dexamethasone|mesh-list
110389483|NCT01659658|Cyclophosphamide|cyclophosphamide|mesh-list
110389484|NCT01659658|Melphalan|melphalan|mesh-list
110389485|NCT01659658|Lenalidomide|lenalidomide|mesh-list
110389486|NCT01659658|Ixazomib|ixazomib|mesh-list
110389487|NCT01659658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110389488|NCT01659658|Immunologic Factors|immunologic factors|mesh-ancestor
110389489|NCT01659658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110389490|NCT01659658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110389491|NCT01659658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110389492|NCT01659658|Alkylating Agents|alkylating agents|mesh-ancestor
110389493|NCT01659658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110389494|NCT01659658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110389495|NCT01659658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110389496|NCT01659658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110389498|NCT01659658|Autonomic Agents|autonomic agents|mesh-ancestor
110389499|NCT01659658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110389500|NCT01659658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110389501|NCT01659658|Glucocorticoids|glucocorticoids|mesh-ancestor
110389502|NCT01659658|Hormones|hormones|mesh-ancestor
110389503|NCT01659658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110389504|NCT01659658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110389505|NCT01659658|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110389506|NCT01659658|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110389507|NCT01659658|Growth Substances|growth substances|mesh-ancestor
110389508|NCT01659658|Growth Inhibitors|growth inhibitors|mesh-ancestor
110389509|NCT01659658|Leprostatic Agents|leprostatic agents|mesh-ancestor
110389510|NCT01659658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110389511|NCT01659658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110389512|NCT01659658|Protease Inhibitors|protease inhibitors|mesh-ancestor
110389513|NCT01659658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110389514|NCT01619176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
110389515|NCT01619176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110389516|NCT01619176|Methotrexate|methotrexate|mesh-list
110389518|NCT01619176|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110389519|NCT01619176|Abortifacient Agents|abortifacient agents|mesh-ancestor
110389520|NCT01619176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110389521|NCT01619176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110389522|NCT01619176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110389523|NCT01619176|Antimetabolites|antimetabolites|mesh-ancestor
110389524|NCT01619176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110389525|NCT01619176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110389526|NCT01619176|Dermatologic Agents|dermatologic agents|mesh-ancestor
110389527|NCT01619176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110389529|NCT01619176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110389530|NCT01619176|Immunologic Factors|immunologic factors|mesh-ancestor
110389531|NCT01619176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110389532|NCT01619176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110389533|NCT01619176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110389534|NCT01619176|Analgesics|analgesics|mesh-ancestor
110389535|NCT01619176|Sensory System Agents|sensory system agents|mesh-ancestor
110389536|NCT01619176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110389537|NCT01523977|Prednisone|prednisone|mesh-list
110389538|NCT01523977|Doxorubicin|doxorubicin|mesh-list
110389539|NCT01523977|Dexrazoxane|dexrazoxane|mesh-list
110389540|NCT01523977|Vincristine|vincristine|mesh-list
110389541|NCT01523977|Everolimus|everolimus|mesh-list
110389542|NCT01523977|Asparaginase|asparaginase|mesh-list
110389543|NCT01523977|Pegaspargase|pegaspargase|mesh-list
110389544|NCT01523977|Razoxane|razoxane|mesh-list
110389545|NCT01523977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110389546|NCT01523977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110389547|NCT01523977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110389548|NCT01523977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110389549|NCT01523977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110389550|NCT01523977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110389551|NCT01523977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110389552|NCT01523977|Glucocorticoids|glucocorticoids|mesh-ancestor
110389553|NCT01523977|Hormones|hormones|mesh-ancestor
110389554|NCT01523977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110389555|NCT01523977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110389556|NCT01523977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110389557|NCT01523977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110389558|NCT01523977|Tubulin Modulators|tubulin modulators|mesh-ancestor
110389559|NCT01523977|Antimitotic Agents|antimitotic agents|mesh-ancestor
110389560|NCT01523977|Mitosis Modulators|mitosis modulators|mesh-ancestor
110389561|NCT01523977|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110389562|NCT01523977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110389563|NCT01523977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110389564|NCT01523977|Immunologic Factors|immunologic factors|mesh-ancestor
110389565|NCT01523977|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110389566|NCT01523977|Protective Agents|protective agents|mesh-ancestor
110389567|NCT01517243|Sirolimus|sirolimus|mesh-list
110389568|NCT01517243|Sunitinib|sunitinib|mesh-list
110043782|NCT01449799|Xhance|xhance|mesh-list
110389569|NCT01517243|Temsirolimus|temsirolimus|mesh-list
110389570|NCT01517243|MTOR Inhibitors|mtor inhibitors|mesh-list
110389571|NCT01517243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110389572|NCT01517243|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110389573|NCT01517243|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110389574|NCT01517243|Growth Substances|growth substances|mesh-ancestor
110389575|NCT01517243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110389576|NCT01517243|Growth Inhibitors|growth inhibitors|mesh-ancestor
110389577|NCT01517243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110389578|NCT01517243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110389579|NCT01517243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110389580|NCT01517243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110389581|NCT01517243|Immunologic Factors|immunologic factors|mesh-ancestor
110389582|NCT01517243|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110389583|NCT01517243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110389584|NCT01517243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110389585|NCT01517243|Antifungal Agents|antifungal agents|mesh-ancestor
110389586|NCT01357161|Paclitaxel|paclitaxel|mesh-list
110389587|NCT01357161|Carboplatin|carboplatin|mesh-list
110389588|NCT01357161|Adavosertib|adavosertib|mesh-list
110389589|NCT01357161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110389590|NCT01357161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110389591|NCT01357161|Tubulin Modulators|tubulin modulators|mesh-ancestor
110389592|NCT01357161|Antimitotic Agents|antimitotic agents|mesh-ancestor
110389593|NCT01357161|Mitosis Modulators|mitosis modulators|mesh-ancestor
110389594|NCT01357161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110389595|NCT01357161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110389596|NCT01321073|Treprostinil|treprostinil|mesh-list
110389597|NCT01321073|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110389598|NCT01319565|Aldesleukin|aldesleukin|mesh-list
110389599|NCT01319565|Cyclophosphamide|cyclophosphamide|mesh-list
110389600|NCT01319565|Fludarabine|fludarabine|mesh-list
110389601|NCT01319565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110389602|NCT01319565|Immunologic Factors|immunologic factors|mesh-ancestor
110389603|NCT01319565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110389604|NCT01319565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110389605|NCT01319565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110389606|NCT01319565|Alkylating Agents|alkylating agents|mesh-ancestor
110389607|NCT01319565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110389608|NCT01319565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110389609|NCT01319565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110389610|NCT01319565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110389611|NCT01319565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110389612|NCT01319565|Antiviral Agents|antiviral agents|mesh-ancestor
110389613|NCT01319565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110389615|NCT01308203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110389616|NCT01308203|Antimetabolites|antimetabolites|mesh-ancestor
110389617|NCT01308203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110389618|NCT01308203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110389619|NCT01308203|Vasodilator Agents|vasodilator agents|mesh-ancestor
110389620|NCT01308203|Vitamin B Complex|vitamin b complex|mesh-ancestor
110389622|NCT01308203|Micronutrients|micronutrients|mesh-ancestor
110260203|NCT00168948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110389623|NCT01308203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110389624|NCT01289171|Glycolic acid|glycolic acid|mesh-list
110389625|NCT01289171|Keratolytic Agents|keratolytic agents|mesh-ancestor
110389627|NCT01276704|Secoisolariciresinol|secoisolariciresinol|mesh-list
110389628|NCT01276704|Phytoestrogens|phytoestrogens|mesh-ancestor
110389629|NCT01276704|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110389630|NCT01276704|Estrogens|estrogens|mesh-ancestor
110389632|NCT01276704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110389633|NCT01276704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110389634|NCT01190930|Calcium, Dietary|calcium, dietary|mesh-list
110389635|NCT01190930|Leucovorin|leucovorin|mesh-list
110389636|NCT01190930|Folic Acid|folic acid|mesh-list
110389637|NCT01190930|Cytarabine|cytarabine|mesh-list
110389638|NCT01190930|Dexamethasone|dexamethasone|mesh-list
110389639|NCT01190930|Dexamethasone acetate|dexamethasone acetate|mesh-list
110389640|NCT01190930|Cyclophosphamide|cyclophosphamide|mesh-list
110389641|NCT01190930|Doxorubicin|doxorubicin|mesh-list
110389642|NCT01190930|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110389643|NCT01190930|Methotrexate|methotrexate|mesh-list
110389644|NCT01190930|Vincristine|vincristine|mesh-list
110389645|NCT01190930|Asparaginase|asparaginase|mesh-list
110389646|NCT01190930|Mercaptopurine|mercaptopurine|mesh-list
110389647|NCT01190930|Pegaspargase|pegaspargase|mesh-list
110389648|NCT01190930|Thioguanine|thioguanine|mesh-list
110389649|NCT01190930|BB 1101|bb 1101|mesh-list
110389650|NCT01190930|Calcium|calcium|mesh-list
110389652|NCT01190930|Levoleucovorin|levoleucovorin|mesh-list
110389654|NCT01190930|Immunologic Factors|immunologic factors|mesh-ancestor
110389655|NCT01190930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110389656|NCT01190930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110389657|NCT01190930|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110389658|NCT01190930|Alkylating Agents|alkylating agents|mesh-ancestor
110389659|NCT01190930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110389660|NCT01190930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110389661|NCT01190930|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110389662|NCT01190930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110389663|NCT01190930|Antiemetics|antiemetics|mesh-ancestor
110389664|NCT01190930|Autonomic Agents|autonomic agents|mesh-ancestor
110389665|NCT01190930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110389666|NCT01190930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110389667|NCT01190930|Glucocorticoids|glucocorticoids|mesh-ancestor
110389668|NCT01190930|Hormones|hormones|mesh-ancestor
110389669|NCT01190930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110389670|NCT01190930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110389671|NCT01190930|Protease Inhibitors|protease inhibitors|mesh-ancestor
110389672|NCT01190930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110389673|NCT01190930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110389674|NCT01190930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110389675|NCT01190930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110389676|NCT01190930|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110389677|NCT01190930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110389678|NCT01190930|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110389679|NCT01190930|Abortifacient Agents|abortifacient agents|mesh-ancestor
110389680|NCT01190930|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110389681|NCT01190930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110389682|NCT01190930|Antimetabolites|antimetabolites|mesh-ancestor
110389683|NCT01190930|Dermatologic Agents|dermatologic agents|mesh-ancestor
110389684|NCT01190930|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110389685|NCT01190930|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110389686|NCT01190930|Antiviral Agents|antiviral agents|mesh-ancestor
110389687|NCT01190930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110389688|NCT01190930|Antidotes|antidotes|mesh-ancestor
110389689|NCT01190930|Protective Agents|protective agents|mesh-ancestor
110389690|NCT01190930|Vitamin B Complex|vitamin b complex|mesh-ancestor
110389691|NCT01190930|Vitamins|vitamins|mesh-ancestor
110389692|NCT01190930|Micronutrients|micronutrients|mesh-ancestor
110389693|NCT01190930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110389694|NCT01190930|Tubulin Modulators|tubulin modulators|mesh-ancestor
110389695|NCT01190930|Antimitotic Agents|antimitotic agents|mesh-ancestor
110389696|NCT01190930|Mitosis Modulators|mitosis modulators|mesh-ancestor
110389697|NCT01190930|Hematinics|hematinics|mesh-ancestor
110389698|NCT01169259|Vitamin D|vitamin d|mesh-list
110389699|NCT01169259|Ergocalciferols|ergocalciferols|mesh-list
110389700|NCT01169259|Cholecalciferol|cholecalciferol|mesh-list
110389701|NCT01169259|Vitamins|vitamins|mesh-list
110389702|NCT01169259|Micronutrients|micronutrients|mesh-ancestor
110389703|NCT01169259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110389704|NCT01169259|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110389705|NCT01169259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110389706|NCT01047007|Cisplatin|cisplatin|mesh-list
110389707|NCT01047007|Adavosertib|adavosertib|mesh-list
110389708|NCT01047007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110389709|NCT01047007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110389710|NCT01047007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110389711|NCT01007578|Paclitaxel|paclitaxel|mesh-list
110389712|NCT01007578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110389713|NCT01007578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110389714|NCT01007578|Tubulin Modulators|tubulin modulators|mesh-ancestor
110389715|NCT01007578|Antimitotic Agents|antimitotic agents|mesh-ancestor
110389716|NCT01007578|Mitosis Modulators|mitosis modulators|mesh-ancestor
110389717|NCT01007578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110389718|NCT00954226|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110389719|NCT00954226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110389720|NCT00954226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110389722|NCT00954226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110389723|NCT00707473|Cisplatin|cisplatin|mesh-list
110389724|NCT00707473|Carboplatin|carboplatin|mesh-list
110389725|NCT00707473|Docetaxel|docetaxel|mesh-list
110389726|NCT00707473|Fluorouracil|fluorouracil|mesh-list
110389727|NCT00707473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110389728|NCT00707473|Tubulin Modulators|tubulin modulators|mesh-ancestor
110389729|NCT00707473|Antimitotic Agents|antimitotic agents|mesh-ancestor
110389730|NCT00707473|Mitosis Modulators|mitosis modulators|mesh-ancestor
110389731|NCT00707473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110389732|NCT00707473|Antimetabolites|antimetabolites|mesh-ancestor
110389733|NCT00707473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110389734|NCT00707473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110389735|NCT00707473|Immunologic Factors|immunologic factors|mesh-ancestor
110389736|NCT00707473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110389737|NCT00680901|Capecitabine|capecitabine|mesh-list
110389738|NCT00680901|Oxaliplatin|oxaliplatin|mesh-list
110389739|NCT00680901|Lapatinib|lapatinib|mesh-list
110389740|NCT00680901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110389741|NCT00680901|Antimetabolites|antimetabolites|mesh-ancestor
110389742|NCT00680901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110389743|NCT00680901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110389744|NCT00680901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110389745|NCT00680901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110389746|NCT00648648|Carboplatin|carboplatin|mesh-list
110389747|NCT00648648|Gemcitabine|gemcitabine|mesh-list
110389748|NCT00648648|Adavosertib|adavosertib|mesh-list
110389749|NCT00648648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110389750|NCT00648648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110389751|NCT00648648|Antimetabolites|antimetabolites|mesh-ancestor
110389752|NCT00648648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110389753|NCT00648648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110389754|NCT00608725|Propranolol|propranolol|mesh-list
110389755|NCT00608725|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110389756|NCT00608725|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110389757|NCT00608725|Adrenergic Agents|adrenergic agents|mesh-ancestor
110389758|NCT00608725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110389759|NCT00608725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110389760|NCT00608725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110389761|NCT00608725|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110389762|NCT00608725|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110389763|NCT00608725|Vasodilator Agents|vasodilator agents|mesh-ancestor
110389764|NCT00546351|Lacosamide|lacosamide|mesh-list
110389765|NCT00546351|Anticonvulsants|anticonvulsants|mesh-ancestor
110389766|NCT00546351|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110389767|NCT00546351|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110389768|NCT00546351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110389769|NCT00546351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110389770|NCT00536172|Escitalopram|escitalopram|mesh-list
110389771|NCT00536172|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110389772|NCT00536172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110389773|NCT00536172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110389774|NCT00536172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110389775|NCT00536172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110389776|NCT00536172|Serotonin Agents|serotonin agents|mesh-ancestor
110389777|NCT00536172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110389778|NCT00217737|Calcium, Dietary|calcium, dietary|mesh-list
110389779|NCT00217737|Leucovorin|leucovorin|mesh-list
110389780|NCT00217737|Folic Acid|folic acid|mesh-list
110389781|NCT00217737|Bevacizumab|bevacizumab|mesh-list
110389782|NCT00217737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110389802|NCT00217737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110389803|NCT00217737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110389804|NCT00217737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110389806|NCT00217737|Protective Agents|protective agents|mesh-ancestor
110389807|NCT00217737|Vitamin B Complex|vitamin b complex|mesh-ancestor
110389809|NCT00217737|Micronutrients|micronutrients|mesh-ancestor
110389810|NCT00217737|Hematinics|hematinics|mesh-ancestor
110389837|NCT00024622|Dopamine Agents|dopamine agents|mesh-ancestor
110389838|NCT00024622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110389839|NCT00024622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110389840|NCT00024622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110389841|NCT00018057|Fluoxetine|fluoxetine|mesh-list
110389842|NCT00018057|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110389843|NCT00018057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110389844|NCT00018057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110389845|NCT00018057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110389846|NCT00018057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110389847|NCT00018057|Serotonin Agents|serotonin agents|mesh-ancestor
110389848|NCT00018057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110389849|NCT00018057|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110389850|NCT00018057|Antidepressive Agents|antidepressive agents|mesh-ancestor
110389851|NCT00018057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110389852|NCT00018057|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110389853|NCT00018057|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110389854|NCT00018057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110389855|NCT00018044|Clofazimine|clofazimine|mesh-list
110389856|NCT00018044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110389857|NCT00018044|Leprostatic Agents|leprostatic agents|mesh-ancestor
110389858|NCT00018044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110389859|NCT00018044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110389860|NCT00003838|Cyclosporine|cyclosporine|mesh-list
110389861|NCT00003838|Methotrexate|methotrexate|mesh-list
110389862|NCT00003838|Cyclosporins|cyclosporins|mesh-list
110389863|NCT00003838|Lenograstim|lenograstim|mesh-list
110389864|NCT00003838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110389865|NCT00003838|Abortifacient Agents|abortifacient agents|mesh-ancestor
110389866|NCT00003838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110389867|NCT00003838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110389868|NCT00003838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110389869|NCT00003838|Antimetabolites|antimetabolites|mesh-ancestor
110389870|NCT00003838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110389871|NCT00003838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110389872|NCT00003838|Dermatologic Agents|dermatologic agents|mesh-ancestor
110389873|NCT00003838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110389874|NCT00003838|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110389875|NCT00003838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110389876|NCT00003838|Immunologic Factors|immunologic factors|mesh-ancestor
110389896|NCT06031454|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110389897|NCT06031454|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110389898|NCT06031454|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110389899|NCT06031454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110389900|NCT06031454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110389901|NCT06031454|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110389902|NCT06031454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110389903|NCT06031454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110389904|NCT06031454|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110389905|NCT06031454|Anesthetics, General|anesthetics, general|mesh-ancestor
110389907|NCT06031454|GABA Modulators|gaba modulators|mesh-ancestor
110389908|NCT06031454|GABA Agents|gaba agents|mesh-ancestor
110389909|NCT06031454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110389910|NCT06031454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110389911|NCT06031454|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110389912|NCT06031454|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110389913|NCT06031454|Antimetabolites|antimetabolites|mesh-ancestor
110389914|NCT06031454|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110389915|NCT06031454|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110389916|NCT06031454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110389917|NCT06031454|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110389918|NCT06031454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110389919|NCT06031454|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110389920|NCT06031454|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110389922|NCT06031454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110389923|NCT06031454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110389924|NCT06031454|Leprostatic Agents|leprostatic agents|mesh-ancestor
110389925|NCT06031454|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110389926|NCT06031454|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110389927|NCT06031454|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110389928|NCT06031454|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110389929|NCT06031454|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110389930|NCT06031454|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110389931|NCT06031454|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110389933|NCT06031454|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110389934|NCT06031454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110389935|NCT06031454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110389936|NCT06031454|Vasodilator Agents|vasodilator agents|mesh-ancestor
110389937|NCT06031441|Atezolizumab|atezolizumab|mesh-list
110389938|NCT06031441|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110389939|NCT06031441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110389940|NCT06031441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110389941|NCT06031441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110389942|NCT06031376|Trifluridine|trifluridine|mesh-list
110389943|NCT06031376|Bevacizumab|bevacizumab|mesh-list
110389944|NCT06031376|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110389945|NCT06031376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110389946|NCT06031376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110389947|NCT06031376|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110389948|NCT06031376|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110389950|NCT06031376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110389951|NCT06031376|Growth Inhibitors|growth inhibitors|mesh-ancestor
110389952|NCT06031376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110389953|NCT06031376|Antimetabolites|antimetabolites|mesh-ancestor
110389954|NCT06031376|Antiviral Agents|antiviral agents|mesh-ancestor
110389955|NCT06031376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110389956|NCT06031363|Indomethacin|indomethacin|mesh-list
110389957|NCT06031363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110389958|NCT06031363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110389959|NCT06031363|Analgesics|analgesics|mesh-ancestor
110389960|NCT06031363|Sensory System Agents|sensory system agents|mesh-ancestor
110389961|NCT06031363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110389962|NCT06031363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110389963|NCT06031363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110389964|NCT06031363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110389965|NCT06031363|Gout Suppressants|gout suppressants|mesh-ancestor
110389966|NCT06031363|Tocolytic Agents|tocolytic agents|mesh-ancestor
110389967|NCT06031363|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110389968|NCT06031363|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110389969|NCT06031363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110389970|NCT06031363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110389971|NCT06031285|Bevacizumab|bevacizumab|mesh-list
110389972|NCT06031285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110389973|NCT06031285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110389974|NCT06031285|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110389975|NCT06031285|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110389976|NCT06031285|Growth Substances|growth substances|mesh-ancestor
110389977|NCT06031285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110389978|NCT06031285|Growth Inhibitors|growth inhibitors|mesh-ancestor
110389979|NCT06031233|Bevacizumab|bevacizumab|mesh-list
110389980|NCT06031233|Pembrolizumab|pembrolizumab|mesh-list
110389982|NCT06031233|Trastuzumab|trastuzumab|mesh-list
110389983|NCT06031233|Ipilimumab|ipilimumab|mesh-list
110389984|NCT06031233|Atezolizumab|atezolizumab|mesh-list
110389985|NCT06031233|Durvalumab|durvalumab|mesh-list
110389986|NCT06031233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110389987|NCT06031233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110389989|NCT06031233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110389991|NCT06031233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110389992|NCT06031233|Growth Inhibitors|growth inhibitors|mesh-ancestor
110389993|NCT06031233|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110389994|NCT06031233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110389995|NCT06031168|Metformin|metformin|mesh-list
110389996|NCT06031168|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110389997|NCT06031168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110389998|NCT06031129|Butorphanol|butorphanol|mesh-list
110389999|NCT06031129|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110390000|NCT06031129|Narcotics|narcotics|mesh-ancestor
110390001|NCT06031129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110390002|NCT06031129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110390003|NCT06031129|Analgesics|analgesics|mesh-ancestor
110390004|NCT06031129|Sensory System Agents|sensory system agents|mesh-ancestor
110390005|NCT06031129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110390006|NCT06031129|Antitussive Agents|antitussive agents|mesh-ancestor
110390007|NCT06031129|Respiratory System Agents|respiratory system agents|mesh-ancestor
110390008|NCT06031129|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110390009|NCT06031090|Clonidine|clonidine|mesh-list
110390010|NCT06031090|Granisetron|granisetron|mesh-list
110390011|NCT06031090|Analgesics|analgesics|mesh-ancestor
110390012|NCT06031090|Sensory System Agents|sensory system agents|mesh-ancestor
110390013|NCT06031090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110390014|NCT06031090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110390015|NCT06031090|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110390016|NCT06031090|Sympatholytics|sympatholytics|mesh-ancestor
110390017|NCT06031090|Autonomic Agents|autonomic agents|mesh-ancestor
110390018|NCT06031090|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110390019|NCT06031090|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110390020|NCT06031090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110390021|NCT06031090|Adrenergic Agents|adrenergic agents|mesh-ancestor
110390022|NCT06031090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110390023|NCT06031090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110390024|NCT06031090|Antiemetics|antiemetics|mesh-ancestor
110390025|NCT06031090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110390026|NCT06031090|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110390028|NCT06031090|Serotonin Agents|serotonin agents|mesh-ancestor
110390030|NCT06031012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110390031|NCT06031012|Immunologic Factors|immunologic factors|mesh-ancestor
110390032|NCT06031012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110390033|NCT06031012|Leprostatic Agents|leprostatic agents|mesh-ancestor
110390034|NCT06031012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110390035|NCT06031012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110390036|NCT06031012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110390037|NCT06031012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110390038|NCT06031012|Growth Substances|growth substances|mesh-ancestor
110390039|NCT06031012|Growth Inhibitors|growth inhibitors|mesh-ancestor
110390040|NCT06031012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110390043|NCT06030934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110390044|NCT06030934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110390045|NCT06030934|Tubulin Modulators|tubulin modulators|mesh-ancestor
110390046|NCT06030934|Antimitotic Agents|antimitotic agents|mesh-ancestor
110390047|NCT06030934|Mitosis Modulators|mitosis modulators|mesh-ancestor
110390048|NCT06030934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110390049|NCT06030934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110390050|NCT06030934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110390051|NCT06030895|Sorafenib|sorafenib|mesh-list
110390052|NCT06030895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110390053|NCT06030895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110390054|NCT06030895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110390055|NCT06030895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110390083|NCT06030479|Epinephrine|epinephrine|mesh-list
110390084|NCT06030479|Racepinephrine|racepinephrine|mesh-list
110390085|NCT06030479|Epinephryl borate|epinephryl borate|mesh-list
110390086|NCT06030479|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110390087|NCT06030479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110390088|NCT06030479|Adrenergic Agents|adrenergic agents|mesh-ancestor
110390089|NCT06030479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110390090|NCT06030479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110390091|NCT06030479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110390092|NCT06030479|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110390093|NCT06030479|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110390094|NCT06030479|Autonomic Agents|autonomic agents|mesh-ancestor
110390095|NCT06030479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110390096|NCT06030479|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110390097|NCT06030479|Respiratory System Agents|respiratory system agents|mesh-ancestor
110390098|NCT06030479|Mydriatics|mydriatics|mesh-ancestor
110390099|NCT06030479|Sympathomimetics|sympathomimetics|mesh-ancestor
110390100|NCT06030479|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110390102|NCT06029998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110390103|NCT06029179|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
110044275|NCT05955365|Analgesics|analgesics|mesh-ancestor
110390104|NCT06029179|Chelating Agents|chelating agents|mesh-ancestor
110390105|NCT06029179|Sequestering Agents|sequestering agents|mesh-ancestor
110390106|NCT06029179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110390107|NCT06028672|Dactinomycin|dactinomycin|mesh-list
110390108|NCT06028672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110390109|NCT06028672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110390110|NCT06028672|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110390111|NCT06028672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110390112|NCT06028672|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110390113|NCT06028672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110390114|NCT06028672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110390115|NCT06028672|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110390116|NCT06028347|Vaccines|vaccines|mesh-list
110390117|NCT06028347|Immunologic Factors|immunologic factors|mesh-ancestor
110390118|NCT06028347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110390119|NCT06027528|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110390120|NCT06027528|Hemostatics|hemostatics|mesh-ancestor
110390121|NCT06027528|Coagulants|coagulants|mesh-ancestor
110390123|NCT06027099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110390124|NCT06027099|Analgesics|analgesics|mesh-ancestor
110390125|NCT06027099|Sensory System Agents|sensory system agents|mesh-ancestor
110390126|NCT06027099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110390127|NCT06027099|Anticonvulsants|anticonvulsants|mesh-ancestor
110390128|NCT06027099|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110390129|NCT06027099|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110390130|NCT06027099|Parasympatholytics|parasympatholytics|mesh-ancestor
110390131|NCT06027099|Autonomic Agents|autonomic agents|mesh-ancestor
110390132|NCT06027099|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110390133|NCT06027099|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110390134|NCT06027099|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110390135|NCT06027099|Adrenergic Agents|adrenergic agents|mesh-ancestor
110390136|NCT06027099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110390137|NCT06027099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110390138|NCT06026358|Tirbanibulin|tirbanibulin|mesh-list
110390139|NCT06026358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110390140|NCT06026358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110390141|NCT06023706|Capsaicin|capsaicin|mesh-list
110390142|NCT06023706|Antipruritics|antipruritics|mesh-ancestor
110390143|NCT06023706|Dermatologic Agents|dermatologic agents|mesh-ancestor
110390144|NCT06023706|Sensory System Agents|sensory system agents|mesh-ancestor
110390145|NCT06023706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110390146|NCT06023706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110390147|NCT06021275|Insulin|insulin|mesh-list
110390148|NCT06021275|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110390149|NCT06021275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110390150|NCT06021275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110390151|NCT06014515|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110390152|NCT06014515|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110390153|NCT06014515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110390154|NCT06014073|Cyclophosphamide|cyclophosphamide|mesh-list
110390156|NCT06014073|Fludarabine phosphate|fludarabine phosphate|mesh-list
110390157|NCT06014073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110390158|NCT06014073|Immunologic Factors|immunologic factors|mesh-ancestor
110390159|NCT06014073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110390160|NCT06014073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110390161|NCT06014073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110390162|NCT06014073|Alkylating Agents|alkylating agents|mesh-ancestor
110390163|NCT06014073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110390164|NCT06014073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110390165|NCT06014073|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110390166|NCT06014073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110390168|NCT06013319|Esmolol|esmolol|mesh-list
110390169|NCT06013319|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110390170|NCT06013319|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110390171|NCT06013319|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110390172|NCT06013319|Adrenergic Agents|adrenergic agents|mesh-ancestor
110390173|NCT06013319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110390174|NCT06013319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110390175|NCT06013319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110390176|NCT05989828|Aldesleukin|aldesleukin|mesh-list
110390177|NCT05989828|Cyclophosphamide|cyclophosphamide|mesh-list
110390178|NCT05989828|Fludarabine|fludarabine|mesh-list
110390180|NCT05989828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110390181|NCT05989828|Immunologic Factors|immunologic factors|mesh-ancestor
110390182|NCT05989828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110390183|NCT05989828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110390184|NCT05989828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110390185|NCT05989828|Alkylating Agents|alkylating agents|mesh-ancestor
110390186|NCT05989828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110390187|NCT05989828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110390188|NCT05989828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110390189|NCT05989828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110390191|NCT05989828|Sensory System Agents|sensory system agents|mesh-ancestor
110390192|NCT05989828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110390193|NCT05989828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110390194|NCT05989828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110390195|NCT05989828|Antiviral Agents|antiviral agents|mesh-ancestor
110390196|NCT05989828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110390197|NCT05976217|Venetoclax|venetoclax|mesh-list
110390198|NCT05976217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110390199|NCT05975060|Vaccines|vaccines|mesh-list
110390200|NCT05975060|Immunologic Factors|immunologic factors|mesh-ancestor
110390201|NCT05975060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110390202|NCT05972551|Diphosphonates|diphosphonates|mesh-list
110390203|NCT05972551|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110390204|NCT05972551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110390205|NCT05950724|Etanercept|etanercept|mesh-list
110390206|NCT05950724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110390207|NCT05950724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110390208|NCT05950724|Analgesics|analgesics|mesh-ancestor
110390209|NCT05950724|Sensory System Agents|sensory system agents|mesh-ancestor
110390210|NCT05950724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110390211|NCT05950724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110390212|NCT05950724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110390213|NCT05950724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110390214|NCT05950724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110390215|NCT05950724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110390216|NCT05950724|Immunologic Factors|immunologic factors|mesh-ancestor
110390217|NCT05946551|Cetirizine|cetirizine|mesh-list
110390218|NCT05946551|Naltrexone|naltrexone|mesh-list
110390219|NCT05946551|Famotidine|famotidine|mesh-list
110390220|NCT05946551|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110390221|NCT05946551|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110390222|NCT05946551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110390223|NCT05946551|Sensory System Agents|sensory system agents|mesh-ancestor
110390224|NCT05946551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110390225|NCT05946551|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110390226|NCT05946551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110390227|NCT05946551|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110390228|NCT05946551|Histamine Antagonists|histamine antagonists|mesh-ancestor
110390229|NCT05946551|Histamine Agents|histamine agents|mesh-ancestor
110390230|NCT05946551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110390231|NCT05946551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110390232|NCT05946551|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110390233|NCT05946551|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110390234|NCT05946551|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110390235|NCT05931965|Vitamin B 12|vitamin b 12|mesh-list
110390236|NCT05931965|Hydroxocobalamin|hydroxocobalamin|mesh-list
110390237|NCT05931965|Vitamins|vitamins|mesh-ancestor
110390238|NCT05931965|Micronutrients|micronutrients|mesh-ancestor
110390239|NCT05931965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110390240|NCT05931965|Vitamin B Complex|vitamin b complex|mesh-ancestor
110390241|NCT05931965|Hematinics|hematinics|mesh-ancestor
110390242|NCT05931276|Metoprolol|metoprolol|mesh-list
110390243|NCT05931276|Carvedilol|carvedilol|mesh-list
110390244|NCT05931276|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110390245|NCT05931276|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110390246|NCT05931276|Sympatholytics|sympatholytics|mesh-ancestor
110044417|NCT05841420|Antimetabolites|antimetabolites|mesh-ancestor
110390247|NCT05931276|Autonomic Agents|autonomic agents|mesh-ancestor
110390248|NCT05931276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110390249|NCT05931276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110390250|NCT05931276|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110390251|NCT05931276|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110390252|NCT05931276|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110390253|NCT05931276|Adrenergic Agents|adrenergic agents|mesh-ancestor
110390254|NCT05931276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110390255|NCT05931276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110390257|NCT05931276|Protective Agents|protective agents|mesh-ancestor
110390258|NCT05931276|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110390259|NCT05931276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110390260|NCT05931276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110390261|NCT05931276|Vasodilator Agents|vasodilator agents|mesh-ancestor
110390262|NCT05931276|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110390283|NCT05898672|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110390284|NCT05898672|Protease Inhibitors|protease inhibitors|mesh-ancestor
110390285|NCT05898672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110390286|NCT05898672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110390287|NCT05898672|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110390288|NCT05898672|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110390289|NCT05898672|Antiviral Agents|antiviral agents|mesh-ancestor
110390290|NCT05898672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110390291|NCT05898672|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110390292|NCT05898672|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110390293|NCT05898672|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110390294|NCT05898672|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110390295|NCT05898672|Antimetabolites|antimetabolites|mesh-ancestor
110390296|NCT05898672|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110390297|NCT05898672|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110390298|NCT05897554|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110390299|NCT05897554|Plasminogen|plasminogen|mesh-list
110390300|NCT05897554|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110390301|NCT05897554|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110390302|NCT05897554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110390303|NCT05856994|Tacrolimus|tacrolimus|mesh-list
110390304|NCT05856994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110390305|NCT05856994|Immunologic Factors|immunologic factors|mesh-ancestor
110390306|NCT05856994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110390307|NCT05856994|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110390308|NCT05856994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110390309|NCT05856994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110390310|NCT05846399|Amoxicillin|amoxicillin|mesh-list
110390311|NCT05846399|Ciprofloxacin|ciprofloxacin|mesh-list
110390312|NCT05846399|Clindamycin|clindamycin|mesh-list
110390313|NCT05846399|Clindamycin palmitate|clindamycin palmitate|mesh-list
110390314|NCT05846399|Clindamycin phosphate|clindamycin phosphate|mesh-list
110390315|NCT05846399|Clavulanic Acid|clavulanic acid|mesh-list
110390316|NCT05846399|Clavulanic Acids|clavulanic acids|mesh-list
110390317|NCT05846399|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110390318|NCT05846399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110390319|NCT05846399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110390320|NCT05846399|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110390321|NCT05846399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110390322|NCT05846399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110390323|NCT05846399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110390324|NCT05846399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110390325|NCT05846399|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110390326|NCT05846399|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110390327|NCT05846399|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110390328|NCT05846399|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110390329|NCT05842954|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110390330|NCT05842954|Antimalarials|antimalarials|mesh-ancestor
110390331|NCT05842954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110390332|NCT05842954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110390333|NCT05842954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110390334|NCT05842759|Norepinephrine|norepinephrine|mesh-list
110390335|NCT05842759|Propofol|propofol|mesh-list
110390336|NCT05842759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110390337|NCT05842759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110390338|NCT05842759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110390339|NCT05842759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110390340|NCT05842759|Anesthetics, General|anesthetics, general|mesh-ancestor
110390341|NCT05842759|Anesthetics|anesthetics|mesh-ancestor
110390342|NCT05842759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110390344|NCT05842759|Adrenergic Agents|adrenergic agents|mesh-ancestor
110390345|NCT05842759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110390346|NCT05842759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110390347|NCT05842759|Sympathomimetics|sympathomimetics|mesh-ancestor
110390348|NCT05842759|Autonomic Agents|autonomic agents|mesh-ancestor
110390349|NCT05842759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110390350|NCT05842759|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110390351|NCT05801029|Osimertinib|osimertinib|mesh-list
110390352|NCT05801029|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
110390353|NCT05801029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110390354|NCT05801029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110390355|NCT05801029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110390356|NCT05801029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110390357|NCT05801029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110390358|NCT05794555|Lactulose|lactulose|mesh-list
110390359|NCT05794555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110390360|NCT05789589|Dexamethasone|dexamethasone|mesh-list
110390361|NCT05789589|Methylprednisolone|methylprednisolone|mesh-list
110390362|NCT05789589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110390363|NCT05789589|Antiemetics|antiemetics|mesh-ancestor
110390364|NCT05789589|Autonomic Agents|autonomic agents|mesh-ancestor
110390365|NCT05789589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110390366|NCT05789589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110390367|NCT05789589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110390368|NCT05789589|Glucocorticoids|glucocorticoids|mesh-ancestor
110390369|NCT05789589|Hormones|hormones|mesh-ancestor
110390370|NCT05789589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110390371|NCT05789589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110390372|NCT05789589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110390373|NCT05789589|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110390374|NCT05789589|Protective Agents|protective agents|mesh-ancestor
110390375|NCT05781542|MEDI9197|medi9197|mesh-list
110390376|NCT05781542|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110390377|NCT05781542|Immunologic Factors|immunologic factors|mesh-ancestor
110390378|NCT05781542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110390379|NCT05779007|Pirfenidone|pirfenidone|mesh-list
110390380|NCT05779007|Nintedanib|nintedanib|mesh-list
110390381|NCT05779007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110390382|NCT05779007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110390383|NCT05779007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110390384|NCT05779007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110390385|NCT05779007|Analgesics|analgesics|mesh-ancestor
110390386|NCT05779007|Sensory System Agents|sensory system agents|mesh-ancestor
110390387|NCT05779007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110390388|NCT05779007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110390389|NCT05779007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110390390|NCT05779007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110390391|NCT05779007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110390392|NCT05779007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110390393|NCT05776927|Fluticasone|fluticasone|mesh-list
110390394|NCT05776927|Xhance|xhance|mesh-list
110390395|NCT05776927|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110390396|NCT05776927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110390397|NCT05776927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110390398|NCT05776927|Autonomic Agents|autonomic agents|mesh-ancestor
110390399|NCT05776927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110390400|NCT05776927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110390401|NCT05776927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110390402|NCT05776927|Respiratory System Agents|respiratory system agents|mesh-ancestor
110390403|NCT05776927|Dermatologic Agents|dermatologic agents|mesh-ancestor
110390404|NCT05776927|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110390405|NCT05776927|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110390406|NCT05776927|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110390407|NCT05776927|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110390408|NCT05776927|Adrenergic Agents|adrenergic agents|mesh-ancestor
110390409|NCT05776927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110390410|NCT05776927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110390411|NCT05731323|Cycloserine|cycloserine|mesh-list
110390412|NCT05731323|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110390413|NCT05731323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110390414|NCT05731323|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110390415|NCT05731323|Antitubercular Agents|antitubercular agents|mesh-ancestor
110390416|NCT05731323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110390417|NCT05731323|Antimetabolites|antimetabolites|mesh-ancestor
110390418|NCT05731323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110390419|NCT05672524|Trastuzumab|trastuzumab|mesh-list
110390420|NCT05672524|Tucatinib|tucatinib|mesh-list
110390421|NCT05672524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110390422|NCT05672524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110051103|NCT01471132|Mitosis Modulators|mitosis modulators|mesh-ancestor
110390423|NCT05672524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110390424|NCT05672524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110390425|NCT05672524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110390426|NCT05672095|Selenium|selenium|mesh-list
110390427|NCT05672095|Niraparib|niraparib|mesh-list
110390428|NCT05672095|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110390429|NCT05672095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110390430|NCT05672095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110390431|NCT05672095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110390432|NCT05672095|Antioxidants|antioxidants|mesh-ancestor
110390433|NCT05672095|Protective Agents|protective agents|mesh-ancestor
110390434|NCT05672095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110390435|NCT05672095|Trace Elements|trace elements|mesh-ancestor
110390436|NCT05672095|Micronutrients|micronutrients|mesh-ancestor
110390437|NCT05646563|Eculizumab|eculizumab|mesh-list
110390438|NCT05646563|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110390439|NCT05646563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110390440|NCT05646563|Immunologic Factors|immunologic factors|mesh-ancestor
110390441|NCT05646563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110390442|NCT05630976|Isavuconazole|isavuconazole|mesh-list
110390443|NCT05630976|Antifungal Agents|antifungal agents|mesh-ancestor
110390444|NCT05630976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110390445|NCT05629260|Cyclophosphamide|cyclophosphamide|mesh-list
110390446|NCT05629260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110390447|NCT05629260|Immunologic Factors|immunologic factors|mesh-ancestor
110390448|NCT05629260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110390449|NCT05629260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110390450|NCT05629260|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110390451|NCT05629260|Alkylating Agents|alkylating agents|mesh-ancestor
110390452|NCT05629260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110390453|NCT05629260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110390454|NCT05629260|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110390455|NCT05627466|Magrolimab|magrolimab|mesh-list
110390456|NCT05627466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110390457|NCT05627466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110390458|NCT05615012|Leucovorin|leucovorin|mesh-list
110390459|NCT05615012|Metformin|metformin|mesh-list
110390460|NCT05615012|Methotrexate|methotrexate|mesh-list
110390461|NCT05615012|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110390462|NCT05615012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110390463|NCT05615012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110390464|NCT05615012|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110390465|NCT05615012|Abortifacient Agents|abortifacient agents|mesh-ancestor
110390466|NCT05615012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110390467|NCT05615012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110390468|NCT05615012|Antimetabolites|antimetabolites|mesh-ancestor
110390469|NCT05615012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110390470|NCT05615012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110390471|NCT05615012|Dermatologic Agents|dermatologic agents|mesh-ancestor
110390472|NCT05615012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110390473|NCT05615012|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110390474|NCT05615012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110044635|NCT05603104|Serotonin Agents|serotonin agents|mesh-ancestor
110390475|NCT05615012|Immunologic Factors|immunologic factors|mesh-ancestor
110390476|NCT05615012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110390477|NCT05615012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110390479|NCT05615012|Protective Agents|protective agents|mesh-ancestor
110390480|NCT05615012|Vitamin B Complex|vitamin b complex|mesh-ancestor
110390481|NCT05615012|Vitamins|vitamins|mesh-ancestor
110390482|NCT05615012|Micronutrients|micronutrients|mesh-ancestor
110390483|NCT05615012|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110390484|NCT05615012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110390485|NCT05615012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110390486|NCT05615012|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110390487|NCT05613777|BI 425809|bi 425809|mesh-list
110390488|NCT05613777|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
110390489|NCT05613777|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
110390490|NCT05613777|Nootropic Agents|nootropic agents|mesh-ancestor
110390491|NCT05613777|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110390492|NCT05613777|Contraceptive Agents|contraceptive agents|mesh-ancestor
110390493|NCT05613777|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110390494|NCT05613777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110390495|NCT05613777|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110390496|NCT05613777|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110390497|NCT05613777|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110390498|NCT05613777|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110390499|NCT05613777|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110390500|NCT05613777|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
110390501|NCT05613777|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110390502|NCT05613777|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110390503|NCT05613413|Pembrolizumab|pembrolizumab|mesh-list
110390504|NCT05613413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110390505|NCT05613413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110390506|NCT05613413|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110390507|NCT05613413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110390508|NCT05609240|Cefuroxime|cefuroxime|mesh-list
110390509|NCT05609240|Cefuroxime axetil|cefuroxime axetil|mesh-list
110390510|NCT05609240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110390511|NCT05609240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110390512|NCT05592379|Psilocybin|psilocybin|mesh-list
110390513|NCT05592379|Hallucinogens|hallucinogens|mesh-ancestor
110390514|NCT05592379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110390515|NCT05592379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110390516|NCT05511623|Tislelizumab|tislelizumab|mesh-list
110390517|NCT05511623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110390518|NCT05511623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110390519|NCT05511025|Acetaminophen|acetaminophen|mesh-list
110390520|NCT05511025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110390522|NCT05511025|Sensory System Agents|sensory system agents|mesh-ancestor
110390523|NCT05511025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110390524|NCT05511025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110390525|NCT05511025|Antipyretics|antipyretics|mesh-ancestor
110390526|NCT05493215|Imatinib Mesylate|imatinib mesylate|mesh-list
110390527|NCT05493215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110390528|NCT05493215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110390529|NCT05493215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110390530|NCT05493215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110390531|NCT05465317|Empagliflozin|empagliflozin|mesh-list
110390532|NCT05465317|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
110390533|NCT05465317|Glucagon|glucagon|mesh-list
110390534|NCT05465317|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110390535|NCT05465317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110390536|NCT05465317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110390537|NCT05465317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110390538|NCT05465317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110390540|NCT05465317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110390541|NCT05465317|Incretins|incretins|mesh-ancestor
110390543|NCT05438602|Nirmatrelvir|nirmatrelvir|mesh-list
110390544|NCT05438602|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110390545|NCT05438602|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110390546|NCT05438602|Protease Inhibitors|protease inhibitors|mesh-ancestor
110390547|NCT05438602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110390548|NCT05438602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110390549|NCT05438602|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110390550|NCT05438602|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110390551|NCT05438602|Antiviral Agents|antiviral agents|mesh-ancestor
110390552|NCT05438602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110390553|NCT05438602|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110390554|NCT05438602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110390556|NCT05405270|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110390557|NCT05405270|Immunologic Factors|immunologic factors|mesh-ancestor
110390558|NCT05405270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110390559|NCT05405270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110390560|NCT05405270|Interferon Inducers|interferon inducers|mesh-ancestor
110390561|NCT05371132|Deferoxamine|deferoxamine|mesh-list
110390562|NCT05371132|Siderophores|siderophores|mesh-ancestor
110390563|NCT05371132|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110390564|NCT05371132|Chelating Agents|chelating agents|mesh-ancestor
110390565|NCT05371132|Sequestering Agents|sequestering agents|mesh-ancestor
110390566|NCT05371132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110390567|NCT05338190|Rituximab|rituximab|mesh-list
110390568|NCT05338190|Belimumab|belimumab|mesh-list
110390569|NCT05338190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110390570|NCT05338190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110390572|NCT05338190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110390573|NCT05338190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110390574|NCT05338190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110390575|NCT05287503|Ambroxol|ambroxol|mesh-list
110390576|NCT05287503|Expectorants|expectorants|mesh-ancestor
110390577|NCT05287503|Respiratory System Agents|respiratory system agents|mesh-ancestor
110390578|NCT05281510|Vesatolimod|vesatolimod|mesh-list
110390579|NCT05281510|Antiviral Agents|antiviral agents|mesh-ancestor
110390580|NCT05281510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110390581|NCT05263908|Ritonavir|ritonavir|mesh-list
110390582|NCT05263908|Nirmatrelvir|nirmatrelvir|mesh-list
110390583|NCT05263908|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
110390584|NCT05263908|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110390585|NCT05263908|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110390586|NCT05263908|Protease Inhibitors|protease inhibitors|mesh-ancestor
110390587|NCT05263908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110390588|NCT05263908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110390590|NCT05263908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110390591|NCT05263908|Antiviral Agents|antiviral agents|mesh-ancestor
110390592|NCT05263908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110390593|NCT05263908|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110390594|NCT05263908|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110390595|NCT05261139|Ritonavir|ritonavir|mesh-list
110390596|NCT05261139|Nirmatrelvir|nirmatrelvir|mesh-list
110390597|NCT05261139|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110390598|NCT05261139|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110390599|NCT05261139|Protease Inhibitors|protease inhibitors|mesh-ancestor
110390600|NCT05261139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110390601|NCT05261139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110390602|NCT05261139|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110390603|NCT05261139|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110390604|NCT05261139|Antiviral Agents|antiviral agents|mesh-ancestor
110390605|NCT05261139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110390606|NCT05261139|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110390607|NCT05261139|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110390608|NCT05239741|Leucovorin|leucovorin|mesh-list
110390609|NCT05239741|Bevacizumab|bevacizumab|mesh-list
110390610|NCT05239741|Pembrolizumab|pembrolizumab|mesh-list
110390611|NCT05239741|Cetuximab|cetuximab|mesh-list
110390612|NCT05239741|Fluorouracil|fluorouracil|mesh-list
110390613|NCT05239741|Oxaliplatin|oxaliplatin|mesh-list
110390614|NCT05239741|Irinotecan|irinotecan|mesh-list
110390615|NCT05239741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110390616|NCT05239741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110390617|NCT05239741|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110390618|NCT05239741|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110390619|NCT05239741|Growth Substances|growth substances|mesh-ancestor
110390620|NCT05239741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110390621|NCT05239741|Growth Inhibitors|growth inhibitors|mesh-ancestor
110390622|NCT05239741|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110390623|NCT05239741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110390624|NCT05239741|Antimetabolites|antimetabolites|mesh-ancestor
110390628|NCT05239741|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110390629|NCT05239741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110390631|NCT05239741|Antidotes|antidotes|mesh-ancestor
110390632|NCT05239741|Protective Agents|protective agents|mesh-ancestor
110390633|NCT05239741|Vitamin B Complex|vitamin b complex|mesh-ancestor
110390634|NCT05239741|Vitamins|vitamins|mesh-ancestor
110390635|NCT05239741|Micronutrients|micronutrients|mesh-ancestor
110390636|NCT05227001|Camphor|camphor|mesh-list
110390637|NCT05227001|Menthol|menthol|mesh-list
110390638|NCT05227001|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110390639|NCT05227001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110390640|NCT05227001|Antipruritics|antipruritics|mesh-ancestor
110390641|NCT05227001|Dermatologic Agents|dermatologic agents|mesh-ancestor
110390673|NCT05212571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110390674|NCT05212571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110390675|NCT05212571|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110390676|NCT05212571|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110390677|NCT05212571|Anesthetics, General|anesthetics, general|mesh-ancestor
110390678|NCT05212571|Anesthetics|anesthetics|mesh-ancestor
110390679|NCT05212571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110390680|NCT05212571|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110390681|NCT05212571|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110390682|NCT05212571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110390683|NCT05212571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110390684|NCT05212571|Antidepressive Agents|antidepressive agents|mesh-ancestor
110390686|NCT05201001|Carboplatin|carboplatin|mesh-list
110390687|NCT05201001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110390688|NCT05198050|Letrozole|letrozole|mesh-list
110390689|NCT05198050|Alprostadil|alprostadil|mesh-list
110390690|NCT05198050|Misoprostol|misoprostol|mesh-list
110390691|NCT05198050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110390692|NCT05198050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110390693|NCT05198050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110390694|NCT05198050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110390695|NCT05198050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110390696|NCT05198050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110390697|NCT05198050|Hormone Antagonists|hormone antagonists|mesh-ancestor
110390698|NCT05198050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110390699|NCT05198050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110390700|NCT05198050|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110390701|NCT05198050|Abortifacient Agents|abortifacient agents|mesh-ancestor
110390702|NCT05198050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110390703|NCT05198050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110044848|NCT05289323|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110390704|NCT05198050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110390706|NCT05198050|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110390707|NCT05198050|Vasodilator Agents|vasodilator agents|mesh-ancestor
110390708|NCT05198050|Urological Agents|urological agents|mesh-ancestor
110390710|NCT05189223|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110390711|NCT05189223|Narcotics|narcotics|mesh-ancestor
110390712|NCT05189223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110390713|NCT05189223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110390714|NCT05189223|Analgesics|analgesics|mesh-ancestor
110390715|NCT05189223|Sensory System Agents|sensory system agents|mesh-ancestor
110390716|NCT05189223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110390717|NCT05189223|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110390718|NCT05176418|Nicotine|nicotine|mesh-list
110390719|NCT05176418|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110390720|NCT05176418|Autonomic Agents|autonomic agents|mesh-ancestor
110390721|NCT05176418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110390722|NCT05176418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110390723|NCT05176418|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110390724|NCT05176418|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110390725|NCT05176418|Cholinergic Agents|cholinergic agents|mesh-ancestor
110390726|NCT05176418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110390727|NCT05176418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110390728|NCT05130060|Trifluridine|trifluridine|mesh-list
110390729|NCT05130060|Vaccines|vaccines|mesh-list
110390730|NCT05130060|Immunologic Factors|immunologic factors|mesh-ancestor
110390731|NCT05130060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110390732|NCT05130060|Antimetabolites|antimetabolites|mesh-ancestor
110390733|NCT05130060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110390734|NCT05130060|Antiviral Agents|antiviral agents|mesh-ancestor
110390735|NCT05130060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110390736|NCT05114486|Pilocarpine|pilocarpine|mesh-list
110390737|NCT05114486|Miotics|miotics|mesh-ancestor
110390738|NCT05114486|Autonomic Agents|autonomic agents|mesh-ancestor
110390739|NCT05114486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110390740|NCT05114486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110390741|NCT05114486|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110390742|NCT05114486|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110390743|NCT05114486|Cholinergic Agents|cholinergic agents|mesh-ancestor
110390744|NCT05114486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110390745|NCT05114486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110390746|NCT05097599|Pembrolizumab|pembrolizumab|mesh-list
110390747|NCT05097599|Trastuzumab|trastuzumab|mesh-list
110390748|NCT05097599|Axitinib|axitinib|mesh-list
110390749|NCT05097599|Talazoparib|talazoparib|mesh-list
110390750|NCT05097599|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
110390751|NCT05097599|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
110390752|NCT05097599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110390753|NCT05097599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110390754|NCT05097599|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110390755|NCT05097599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110390756|NCT05097599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110390757|NCT05097599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110390758|NCT05097599|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110390759|NCT05097599|Immunoconjugates|immunoconjugates|mesh-ancestor
110390760|NCT05097599|Immunologic Factors|immunologic factors|mesh-ancestor
110390761|NCT05097599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110390762|NCT05094336|Docetaxel|docetaxel|mesh-list
110390764|NCT05094336|Tubulin Modulators|tubulin modulators|mesh-ancestor
110390765|NCT05094336|Antimitotic Agents|antimitotic agents|mesh-ancestor
110390766|NCT05094336|Mitosis Modulators|mitosis modulators|mesh-ancestor
110390767|NCT05094336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110390768|NCT05061550|Paclitaxel|paclitaxel|mesh-list
110390769|NCT05061550|Cisplatin|cisplatin|mesh-list
110390770|NCT05061550|Carboplatin|carboplatin|mesh-list
110390771|NCT05061550|Pemetrexed|pemetrexed|mesh-list
110390772|NCT05061550|Durvalumab|durvalumab|mesh-list
110390773|NCT05061550|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110390774|NCT05061550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110390775|NCT05061550|Tubulin Modulators|tubulin modulators|mesh-ancestor
110390776|NCT05061550|Antimitotic Agents|antimitotic agents|mesh-ancestor
110390777|NCT05061550|Mitosis Modulators|mitosis modulators|mesh-ancestor
110390778|NCT05061550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110390779|NCT05061550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110390780|NCT05061550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110390781|NCT05061550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110390782|NCT05061550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110390783|NCT05058976|Vitamin D|vitamin d|mesh-list
110390784|NCT05058976|Zoledronic Acid|zoledronic acid|mesh-list
110390785|NCT05058976|Calcium|calcium|mesh-list
110390786|NCT05058976|Vitamins|vitamins|mesh-ancestor
110390787|NCT05058976|Micronutrients|micronutrients|mesh-ancestor
110390788|NCT05058976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110390789|NCT05058976|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110390790|NCT05058976|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110390791|NCT05041647|Dronabinol|dronabinol|mesh-list
110390792|NCT05041647|Hallucinogens|hallucinogens|mesh-ancestor
110390793|NCT05041647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110390794|NCT05041647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110390795|NCT05041647|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110390796|NCT05041647|Analgesics|analgesics|mesh-ancestor
110390797|NCT05041647|Sensory System Agents|sensory system agents|mesh-ancestor
110390798|NCT05041647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110390799|NCT05041647|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110390800|NCT05041647|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110390801|NCT05041647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110390802|NCT05041647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110390803|NCT05041647|Hormones|hormones|mesh-ancestor
110390804|NCT05041647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110390805|NCT05014815|Tislelizumab|tislelizumab|mesh-list
110390806|NCT05014815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110390807|NCT05014815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110390808|NCT05002465|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110390809|NCT05002465|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110390810|NCT05002465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110390812|NCT04966299|Vasodilator Agents|vasodilator agents|mesh-ancestor
110390813|NCT04943848|Iodine|iodine|mesh-list
110390814|NCT04943848|Vaccines|vaccines|mesh-list
110390815|NCT04943848|Immunologic Factors|immunologic factors|mesh-ancestor
110390816|NCT04943848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110390817|NCT04943848|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110390818|NCT04943848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110390819|NCT04943848|Trace Elements|trace elements|mesh-ancestor
110390820|NCT04943848|Micronutrients|micronutrients|mesh-ancestor
110390821|NCT04942860|Methotrexate|methotrexate|mesh-list
110390822|NCT04942860|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110390823|NCT04942860|Abortifacient Agents|abortifacient agents|mesh-ancestor
110390824|NCT04942860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110390825|NCT04942860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110390826|NCT04942860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110390827|NCT04942860|Antimetabolites|antimetabolites|mesh-ancestor
110390828|NCT04942860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110390829|NCT04942860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110390830|NCT04942860|Dermatologic Agents|dermatologic agents|mesh-ancestor
110390831|NCT04942860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110390832|NCT04942860|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110390833|NCT04942860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110390834|NCT04942860|Immunologic Factors|immunologic factors|mesh-ancestor
110390835|NCT04942860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110390836|NCT04942860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110390837|NCT04927975|Upadacitinib|upadacitinib|mesh-list
110390838|NCT04927975|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110390839|NCT04927975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110390840|NCT04927975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110390841|NCT04927975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110390842|NCT04927975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110390843|NCT04877990|Deucravacitinib|deucravacitinib|mesh-list
110390844|NCT04877990|Dermatologic Agents|dermatologic agents|mesh-ancestor
110390845|NCT04877990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110390846|NCT04877990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110390847|NCT04877990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110390849|NCT04866017|Tislelizumab|tislelizumab|mesh-list
110390850|NCT04866017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110390851|NCT04866017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110390852|NCT04821622|Talazoparib|talazoparib|mesh-list
110390853|NCT04821622|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110390854|NCT04821622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110390855|NCT04821622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110390856|NCT04821622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110390857|NCT04813926|Riociguat|riociguat|mesh-list
110390858|NCT04813926|Enzyme Activators|enzyme activators|mesh-ancestor
110390859|NCT04813926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110390860|NCT04804735|Anesthetics|anesthetics|mesh-list
110390861|NCT04804735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110390862|NCT04804735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110390863|NCT04800822|Cetuximab|cetuximab|mesh-list
110390864|NCT04800822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110390865|NCT04800822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110390866|NCT04781673|Lidocaine|lidocaine|mesh-list
110390867|NCT04781673|Ketamine|ketamine|mesh-list
110390868|NCT04781673|Anesthetics, Local|anesthetics, local|mesh-ancestor
110390869|NCT04781673|Anesthetics|anesthetics|mesh-ancestor
110390870|NCT04781673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110390871|NCT04781673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110390872|NCT04781673|Sensory System Agents|sensory system agents|mesh-ancestor
110390873|NCT04781673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110390874|NCT04781673|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110390875|NCT04781673|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110390876|NCT04781673|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110390877|NCT04781673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110390878|NCT04781673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110390879|NCT04781673|Analgesics|analgesics|mesh-ancestor
110390880|NCT04781673|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110390881|NCT04781673|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110390882|NCT04781673|Anesthetics, General|anesthetics, general|mesh-ancestor
110390883|NCT04781673|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110390884|NCT04781673|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110390885|NCT04781673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110390886|NCT04767594|Palbociclib|palbociclib|mesh-list
110390887|NCT04767594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110390888|NCT04767594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110390889|NCT04767594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110390890|NCT04767594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110390892|NCT04753749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110390893|NCT04753749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110390894|NCT04753749|Analgesics|analgesics|mesh-ancestor
110390895|NCT04753749|Sensory System Agents|sensory system agents|mesh-ancestor
110390896|NCT04753749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110390897|NCT04753749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110390898|NCT04753749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110390899|NCT04753749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110390900|NCT04753749|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110390901|NCT04753749|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110390902|NCT04753749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110390903|NCT04753749|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110390904|NCT04753749|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110390905|NCT04753749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110390906|NCT04753749|Antipyretics|antipyretics|mesh-ancestor
110390909|NCT04751370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110390910|NCT04751370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110390911|NCT04751370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110390912|NCT04751370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110390913|NCT04734990|Azacitidine|azacitidine|mesh-list
110390914|NCT04734990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110390915|NCT04734990|Antimetabolites|antimetabolites|mesh-ancestor
110390916|NCT04734990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110390917|NCT04734990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110390918|NCT04734990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110390919|NCT04708782|Treprostinil|treprostinil|mesh-list
110390920|NCT04708782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110390921|NCT04699630|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
110390922|NCT04699630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110390924|NCT04691986|Niacinamide|niacinamide|mesh-list
110390925|NCT04691986|Niacin|niacin|mesh-list
110390926|NCT04691986|Nicotinic Acids|nicotinic acids|mesh-list
110390927|NCT04691986|Vitamin B Complex|vitamin b complex|mesh-ancestor
110390928|NCT04691986|Vitamins|vitamins|mesh-ancestor
110390929|NCT04691986|Micronutrients|micronutrients|mesh-ancestor
110390930|NCT04691986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110390932|NCT04691986|Antimetabolites|antimetabolites|mesh-ancestor
110390933|NCT04691986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110390934|NCT04691986|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110390937|NCT04670471|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110390938|NCT04670471|Narcotics|narcotics|mesh-ancestor
110390939|NCT04670471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110390940|NCT04670471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110390941|NCT04670471|Analgesics|analgesics|mesh-ancestor
110390942|NCT04670471|Sensory System Agents|sensory system agents|mesh-ancestor
110390943|NCT04670471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110390944|NCT04660344|Atezolizumab|atezolizumab|mesh-list
110390945|NCT04660344|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110390946|NCT04660344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110390947|NCT04660344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110390948|NCT04660344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110390949|NCT04620213|Phentolamine|phentolamine|mesh-list
110390950|NCT04620213|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110390951|NCT04620213|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110390952|NCT04620213|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110390953|NCT04620213|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110390954|NCT04620213|Adrenergic Agents|adrenergic agents|mesh-ancestor
110390955|NCT04620213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110390956|NCT04620213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110390957|NCT04620213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110390958|NCT04620213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110390959|NCT04608955|Bedaquiline|bedaquiline|mesh-list
110390960|NCT04608955|Antitubercular Agents|antitubercular agents|mesh-ancestor
110390961|NCT04608955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110390962|NCT04608955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110390963|NCT04607421|Leucovorin|leucovorin|mesh-list
110390964|NCT04607421|Bevacizumab|bevacizumab|mesh-list
110390965|NCT04607421|Cetuximab|cetuximab|mesh-list
110390966|NCT04607421|Fluorouracil|fluorouracil|mesh-list
110390967|NCT04607421|Capecitabine|capecitabine|mesh-list
110390968|NCT04607421|Oxaliplatin|oxaliplatin|mesh-list
110390969|NCT04607421|Irinotecan|irinotecan|mesh-list
110390970|NCT04607421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110390971|NCT04607421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110390972|NCT04607421|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110390973|NCT04607421|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110390974|NCT04607421|Growth Substances|growth substances|mesh-ancestor
110390975|NCT04607421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110390976|NCT04607421|Growth Inhibitors|growth inhibitors|mesh-ancestor
110390977|NCT04607421|Antimetabolites|antimetabolites|mesh-ancestor
110390978|NCT04607421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110390979|NCT04607421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110390980|NCT04607421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110390981|NCT04607421|Immunologic Factors|immunologic factors|mesh-ancestor
110390982|NCT04607421|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110390983|NCT04607421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110390984|NCT04607421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110390985|NCT04607421|Antidotes|antidotes|mesh-ancestor
110390986|NCT04607421|Protective Agents|protective agents|mesh-ancestor
110390987|NCT04607421|Vitamin B Complex|vitamin b complex|mesh-ancestor
110390988|NCT04607421|Vitamins|vitamins|mesh-ancestor
110390989|NCT04607421|Micronutrients|micronutrients|mesh-ancestor
110390990|NCT04569084|Edaravone|edaravone|mesh-list
110390991|NCT04569084|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110390992|NCT04569084|Antioxidants|antioxidants|mesh-ancestor
110390993|NCT04569084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110390994|NCT04569084|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110390995|NCT04569084|Protective Agents|protective agents|mesh-ancestor
110390996|NCT04569084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110390997|NCT04546633|Lumefantrine|lumefantrine|mesh-list
110390998|NCT04546633|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110390999|NCT04546633|Antimalarials|antimalarials|mesh-ancestor
110391000|NCT04546633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110391001|NCT04546633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110391002|NCT04546633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110391003|NCT04538664|Carboplatin|carboplatin|mesh-list
110391004|NCT04538664|Pemetrexed|pemetrexed|mesh-list
110391005|NCT04538664|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
110391006|NCT04538664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110391007|NCT04538664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110391008|NCT04538664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391009|NCT04538664|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110391010|NCT04538664|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110391011|NCT04538664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110391013|NCT04535362|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110391015|NCT04535362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110391016|NCT04535362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110391017|NCT04535362|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110391018|NCT04535362|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110391019|NCT04535362|Cholinergic Agents|cholinergic agents|mesh-ancestor
110391020|NCT04535362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110391021|NCT04535362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391022|NCT04476173|Morphine|morphine|mesh-list
110391023|NCT04476173|Methoxyflurane|methoxyflurane|mesh-list
110391024|NCT04476173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110391025|NCT04476173|Narcotics|narcotics|mesh-ancestor
110391026|NCT04476173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110391027|NCT04476173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110391028|NCT04476173|Analgesics|analgesics|mesh-ancestor
110391029|NCT04476173|Sensory System Agents|sensory system agents|mesh-ancestor
110391030|NCT04476173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110391031|NCT04476173|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110391032|NCT04476173|Anesthetics, General|anesthetics, general|mesh-ancestor
110391033|NCT04476173|Anesthetics|anesthetics|mesh-ancestor
110391034|NCT04467723|Pirfenidone|pirfenidone|mesh-list
110391035|NCT04467723|Atezolizumab|atezolizumab|mesh-list
110391036|NCT04467723|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110391037|NCT04467723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391038|NCT04467723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110391039|NCT04467723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110391041|NCT04467723|Sensory System Agents|sensory system agents|mesh-ancestor
110391042|NCT04467723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110391043|NCT04467723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110391044|NCT04467723|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110391045|NCT04467723|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110391046|NCT04467723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110391047|NCT04467723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110391048|NCT04464070|Aspirin|aspirin|mesh-list
110391049|NCT04464070|Niacin|niacin|mesh-list
110391050|NCT04464070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110391051|NCT04464070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110391052|NCT04464070|Analgesics|analgesics|mesh-ancestor
110391053|NCT04464070|Sensory System Agents|sensory system agents|mesh-ancestor
110391054|NCT04464070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110391055|NCT04464070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110391056|NCT04464070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110391057|NCT04464070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110391058|NCT04464070|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110391059|NCT04464070|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110391067|NCT04464070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110391068|NCT04464070|Vasodilator Agents|vasodilator agents|mesh-ancestor
110391069|NCT04464070|Vitamin B Complex|vitamin b complex|mesh-ancestor
110391070|NCT04464070|Vitamins|vitamins|mesh-ancestor
110391071|NCT04464070|Micronutrients|micronutrients|mesh-ancestor
110391072|NCT04459234|Ketamine|ketamine|mesh-list
110391073|NCT04459234|Analgesics|analgesics|mesh-ancestor
110391074|NCT04459234|Sensory System Agents|sensory system agents|mesh-ancestor
110391075|NCT04459234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110391076|NCT04459234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110391077|NCT04459234|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110391078|NCT04459234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110391079|NCT04459234|Anesthetics, General|anesthetics, general|mesh-ancestor
110391080|NCT04459234|Anesthetics|anesthetics|mesh-ancestor
110391081|NCT04459234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110391082|NCT04459234|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110391083|NCT04459234|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110391084|NCT04459234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110391085|NCT04459234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391087|NCT04458259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110391088|NCT04458259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110391089|NCT04458259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110391090|NCT04458259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391111|NCT04395222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391112|NCT04395222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110391113|NCT04395222|Immunologic Factors|immunologic factors|mesh-ancestor
110391114|NCT04395222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110391115|NCT04395222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110391116|NCT04395222|Alkylating Agents|alkylating agents|mesh-ancestor
110391117|NCT04395222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110391121|NCT04311502|Pyridoxal|pyridoxal|mesh-list
110391122|NCT04311502|Vitamin B 6|vitamin b 6|mesh-list
110391123|NCT04311502|Rifampin|rifampin|mesh-list
110391124|NCT04311502|Rifapentine|rifapentine|mesh-list
110391125|NCT04311502|Clofazimine|clofazimine|mesh-list
110391126|NCT04311502|Isoniazid|isoniazid|mesh-list
110391127|NCT04311502|Pyrazinamide|pyrazinamide|mesh-list
110391128|NCT04311502|Ethambutol|ethambutol|mesh-list
110391129|NCT04311502|Vitamins|vitamins|mesh-ancestor
110391130|NCT04311502|Micronutrients|micronutrients|mesh-ancestor
110391131|NCT04311502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110391132|NCT04311502|Vitamin B Complex|vitamin b complex|mesh-ancestor
110391133|NCT04311502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110391134|NCT04311502|Antitubercular Agents|antitubercular agents|mesh-ancestor
110391135|NCT04311502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110391136|NCT04311502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110391138|NCT04311502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110391139|NCT04311502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110391140|NCT04311502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391141|NCT04311502|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110391142|NCT04311502|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110391143|NCT04311502|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110391144|NCT04311502|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110391145|NCT04311502|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110391146|NCT04311502|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110391147|NCT04311502|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110391148|NCT04311502|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110391149|NCT04311502|Antimetabolites|antimetabolites|mesh-ancestor
110391150|NCT04311502|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110391151|NCT04311502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110391152|NCT04311073|Tranexamic Acid|tranexamic acid|mesh-list
110391153|NCT04311073|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110045291|NCT04892732|Adrenergic Agents|adrenergic agents|mesh-ancestor
110391154|NCT04311073|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110391155|NCT04311073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391157|NCT04311073|Coagulants|coagulants|mesh-ancestor
110391159|NCT04283669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110391160|NCT04283669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110391161|NCT04283669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110391162|NCT04283669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391163|NCT04276883|Dexmedetomidine|dexmedetomidine|mesh-list
110391164|NCT04276883|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110391165|NCT04276883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110391166|NCT04276883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110391167|NCT04276883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110391168|NCT04276883|Analgesics|analgesics|mesh-ancestor
110391169|NCT04276883|Sensory System Agents|sensory system agents|mesh-ancestor
110391170|NCT04276883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110391171|NCT04276883|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110391172|NCT04276883|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110391173|NCT04276883|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110391174|NCT04276883|Adrenergic Agents|adrenergic agents|mesh-ancestor
110391175|NCT04276883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110391176|NCT04276883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391178|NCT04267939|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110391179|NCT04267939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110391180|NCT04267939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391181|NCT04267939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110391199|NCT04241185|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110391200|NCT04241185|Antimetabolites|antimetabolites|mesh-ancestor
110391201|NCT04241185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391202|NCT04241185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110391203|NCT04241185|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110391204|NCT04241185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110391205|NCT04241185|Immunologic Factors|immunologic factors|mesh-ancestor
110391206|NCT04241185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110391207|NCT04241185|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110391208|NCT04241185|Alkylating Agents|alkylating agents|mesh-ancestor
110391209|NCT04241185|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110391210|NCT04241185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110391211|NCT04238546|Sirolimus|sirolimus|mesh-list
110391212|NCT04238546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110391213|NCT04238546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110391214|NCT04238546|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110391215|NCT04238546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110391216|NCT04238546|Antifungal Agents|antifungal agents|mesh-ancestor
110391217|NCT04238546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110391218|NCT04238546|Immunologic Factors|immunologic factors|mesh-ancestor
110391219|NCT04238546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110391220|NCT04212416|Leflunomide|leflunomide|mesh-list
110391221|NCT04212416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110391222|NCT04212416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391224|NCT04212416|Immunologic Factors|immunologic factors|mesh-ancestor
110391225|NCT04212416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110391226|NCT04187105|Cyclophosphamide|cyclophosphamide|mesh-list
110391227|NCT04187105|Fludarabine|fludarabine|mesh-list
110391228|NCT04187105|Tacrolimus|tacrolimus|mesh-list
110391229|NCT04187105|Complement Factor H|complement factor h|mesh-list
110391230|NCT04187105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110391231|NCT04187105|Immunologic Factors|immunologic factors|mesh-ancestor
110391232|NCT04187105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110391233|NCT04187105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110391234|NCT04187105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110391235|NCT04187105|Alkylating Agents|alkylating agents|mesh-ancestor
110391236|NCT04187105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391237|NCT04187105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110391238|NCT04187105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110391239|NCT04187105|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110391241|NCT04187105|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110391243|NCT04172246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110391244|NCT04172246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110391245|NCT04172246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110391246|NCT04172246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391247|NCT04117945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110391248|NCT04117945|Cetuximab|cetuximab|mesh-list
110391249|NCT04117945|Panitumumab|panitumumab|mesh-list
110391250|NCT04117945|Irinotecan|irinotecan|mesh-list
110391251|NCT04117945|Antibodies|antibodies|mesh-list
110391252|NCT04117945|Immunoglobulins|immunoglobulins|mesh-list
110391253|NCT04117945|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110391254|NCT04117945|Immunologic Factors|immunologic factors|mesh-ancestor
110391255|NCT04117945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110391256|NCT04117945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110391257|NCT04117945|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110391258|NCT04117945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110391260|NCT04117945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391261|NCT04099888|Gemcitabine|gemcitabine|mesh-list
110391262|NCT04099888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110391263|NCT04099888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110391264|NCT04099888|Antimetabolites|antimetabolites|mesh-ancestor
110391265|NCT04099888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391266|NCT04082364|Trastuzumab|trastuzumab|mesh-list
110391267|NCT04082364|Margetuximab|margetuximab|mesh-list
110391268|NCT04082364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110391269|NCT04082364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110391270|NCT04081389|Interferons|interferons|mesh-list
110391271|NCT04081389|Interferon-alpha|interferon-alpha|mesh-list
110391272|NCT04081389|Interferon alpha-2|interferon alpha-2|mesh-list
110391273|NCT04081389|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
110391274|NCT04081389|Celecoxib|celecoxib|mesh-list
110391275|NCT04081389|Paclitaxel|paclitaxel|mesh-list
110391276|NCT04081389|Cyclophosphamide|cyclophosphamide|mesh-list
110391277|NCT04081389|Doxorubicin|doxorubicin|mesh-list
110391278|NCT04081389|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110391279|NCT04081389|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110391280|NCT04081389|Daunorubicin|daunorubicin|mesh-list
110391281|NCT04081389|Benzenesulfonamide|benzenesulfonamide|mesh-list
110391282|NCT04081389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110391283|NCT04081389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110391284|NCT04081389|Tubulin Modulators|tubulin modulators|mesh-ancestor
110391285|NCT04081389|Antimitotic Agents|antimitotic agents|mesh-ancestor
110391286|NCT04081389|Mitosis Modulators|mitosis modulators|mesh-ancestor
110391287|NCT04081389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391288|NCT04081389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110391289|NCT04081389|Immunologic Factors|immunologic factors|mesh-ancestor
110391290|NCT04081389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110391291|NCT04081389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110391292|NCT04081389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110391293|NCT04081389|Alkylating Agents|alkylating agents|mesh-ancestor
110391294|NCT04081389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110391295|NCT04081389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110391296|NCT04081389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110391297|NCT04081389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110391298|NCT04081389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110391299|NCT04081389|Antiviral Agents|antiviral agents|mesh-ancestor
110391300|NCT04081389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110391301|NCT04081389|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110391303|NCT04081389|Analgesics|analgesics|mesh-ancestor
110391304|NCT04081389|Sensory System Agents|sensory system agents|mesh-ancestor
110391305|NCT04081389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110391306|NCT04081389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110391307|NCT04081389|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110391308|NCT04081389|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110391309|NCT04081389|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110391310|NCT04079218|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110391311|NCT04079218|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110391313|NCT04079218|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110391314|NCT04079218|Estrogens|estrogens|mesh-ancestor
110391315|NCT04079218|Hormones|hormones|mesh-ancestor
110391316|NCT04079218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110391317|NCT04079218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110391318|NCT04079218|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110391319|NCT04079218|Contraceptive Agents|contraceptive agents|mesh-ancestor
110391320|NCT04079218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110391321|NCT04079218|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110391322|NCT04075396|Lazertinib|lazertinib|mesh-list
110391323|NCT04075396|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110391324|NCT04075396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110391325|NCT04075396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391326|NCT04042831|Olaparib|olaparib|mesh-list
110391327|NCT04042831|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
110391328|NCT04042831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110391329|NCT04042831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391330|NCT04042831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110391331|NCT04032080|Prexasertib|prexasertib|mesh-list
110391332|NCT04032080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110391333|NCT04032080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110391334|NCT04032080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391336|NCT04022005|Gemcitabine|gemcitabine|mesh-list
110391337|NCT04022005|Oxaliplatin|oxaliplatin|mesh-list
110391338|NCT04022005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110391339|NCT04022005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110391340|NCT04022005|Immunologic Factors|immunologic factors|mesh-ancestor
110391341|NCT04022005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110391342|NCT04022005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110391343|NCT04022005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110391344|NCT04022005|Antimetabolites|antimetabolites|mesh-ancestor
110391345|NCT04022005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391346|NCT04016142|Paclitaxel|paclitaxel|mesh-list
110391347|NCT04016142|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110391348|NCT04016142|Carboplatin|carboplatin|mesh-list
110391349|NCT04016142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110391350|NCT04016142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110391351|NCT04016142|Tubulin Modulators|tubulin modulators|mesh-ancestor
110391352|NCT04016142|Antimitotic Agents|antimitotic agents|mesh-ancestor
110391353|NCT04016142|Mitosis Modulators|mitosis modulators|mesh-ancestor
110391354|NCT04016142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391355|NCT03992196|Rotigotine|rotigotine|mesh-list
110391356|NCT03992196|Dopamine Agonists|dopamine agonists|mesh-ancestor
110391357|NCT03992196|Dopamine Agents|dopamine agents|mesh-ancestor
110391358|NCT03992196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110391359|NCT03992196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391360|NCT03992196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110391361|NCT03970720|Metoclopramide|metoclopramide|mesh-list
110391362|NCT03970720|Antiemetics|antiemetics|mesh-ancestor
110391363|NCT03970720|Autonomic Agents|autonomic agents|mesh-ancestor
110391364|NCT03970720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110391365|NCT03970720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110391366|NCT03970720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110391367|NCT03970720|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110391368|NCT03970720|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110391369|NCT03970720|Dopamine Agents|dopamine agents|mesh-ancestor
110391370|NCT03970720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110391371|NCT03970720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391372|NCT03943498|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
110391373|NCT03943498|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110391374|NCT03943498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391375|NCT03943498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110391376|NCT03943498|Immunologic Factors|immunologic factors|mesh-ancestor
110391377|NCT03943498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110391379|NCT03924895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110391380|NCT03924895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110391381|NCT03924895|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110391382|NCT03924895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391384|NCT03912818|Gemcitabine|gemcitabine|mesh-list
110391385|NCT03912818|Doxorubicin|doxorubicin|mesh-list
110391386|NCT03912818|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110391387|NCT03912818|Methotrexate|methotrexate|mesh-list
110391388|NCT03912818|Durvalumab|durvalumab|mesh-list
110391389|NCT03912818|Daunorubicin|daunorubicin|mesh-list
110391390|NCT03912818|Vinblastine|vinblastine|mesh-list
110391391|NCT03912818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110391392|NCT03912818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110391393|NCT03912818|Antimetabolites|antimetabolites|mesh-ancestor
110391394|NCT03912818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391395|NCT03912818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110391396|NCT03912818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110391397|NCT03912818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110391398|NCT03912818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110391399|NCT03912818|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110391400|NCT03912818|Abortifacient Agents|abortifacient agents|mesh-ancestor
110391401|NCT03912818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110391402|NCT03912818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110391403|NCT03912818|Dermatologic Agents|dermatologic agents|mesh-ancestor
110391404|NCT03912818|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110391405|NCT03912818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110391406|NCT03912818|Immunologic Factors|immunologic factors|mesh-ancestor
110391407|NCT03912818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110391408|NCT03912818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110391409|NCT03912818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110391410|NCT03912818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110391411|NCT03912818|Tubulin Modulators|tubulin modulators|mesh-ancestor
110391412|NCT03912818|Antimitotic Agents|antimitotic agents|mesh-ancestor
110391413|NCT03912818|Mitosis Modulators|mitosis modulators|mesh-ancestor
110391414|NCT03865992|Curcumin|curcumin|mesh-list
110391415|NCT03865992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110391416|NCT03865992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110391417|NCT03865992|Analgesics|analgesics|mesh-ancestor
110391418|NCT03865992|Sensory System Agents|sensory system agents|mesh-ancestor
110391419|NCT03865992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110391420|NCT03865992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110391422|NCT03865992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110391423|NCT03865992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110391424|NCT03865992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110391425|NCT03865992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391426|NCT03865212|Interferons|interferons|mesh-list
110391427|NCT03865212|Interferon-beta|interferon-beta|mesh-list
110391428|NCT03865212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110391429|NCT03865212|Antiviral Agents|antiviral agents|mesh-ancestor
110391430|NCT03865212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110391431|NCT03865212|Immunologic Factors|immunologic factors|mesh-ancestor
110391432|NCT03865212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110391433|NCT03829111|Nivolumab|nivolumab|mesh-list
110391434|NCT03829111|Ipilimumab|ipilimumab|mesh-list
110391435|NCT03829111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110391436|NCT03829111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110391437|NCT03829111|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110391438|NCT03829111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391439|NCT03781934|Pembrolizumab|pembrolizumab|mesh-list
110391440|NCT03781934|Lenvatinib|lenvatinib|mesh-list
110391441|NCT03781934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110391442|NCT03781934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110391443|NCT03781934|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110391444|NCT03781934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391445|NCT03781934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110391446|NCT03781934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110391448|NCT03779854|Cyclophosphamide|cyclophosphamide|mesh-list
110391449|NCT03779854|Busulfan|busulfan|mesh-list
110391450|NCT03779854|Thiotepa|thiotepa|mesh-list
110391451|NCT03779854|Methotrexate|methotrexate|mesh-list
110391452|NCT03779854|Fludarabine|fludarabine|mesh-list
110391453|NCT03779854|Fludarabine phosphate|fludarabine phosphate|mesh-list
110391454|NCT03779854|Tacrolimus|tacrolimus|mesh-list
110391455|NCT03779854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110045606|NCT06039540|Diuretics|diuretics|mesh-ancestor
110391456|NCT03779854|Immunologic Factors|immunologic factors|mesh-ancestor
110391457|NCT03779854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110391458|NCT03779854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110391459|NCT03779854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110391460|NCT03779854|Alkylating Agents|alkylating agents|mesh-ancestor
110391461|NCT03779854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391462|NCT03779854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110391463|NCT03779854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110391464|NCT03779854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110391465|NCT03779854|Abortifacient Agents|abortifacient agents|mesh-ancestor
110391466|NCT03779854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110391467|NCT03779854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110391468|NCT03779854|Antimetabolites|antimetabolites|mesh-ancestor
110391469|NCT03779854|Dermatologic Agents|dermatologic agents|mesh-ancestor
110391470|NCT03779854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110391471|NCT03779854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110391472|NCT03779854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110391473|NCT03779854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110391474|NCT03779854|Antiviral Agents|antiviral agents|mesh-ancestor
110391475|NCT03779854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110391477|NCT03776487|Oxaliplatin|oxaliplatin|mesh-list
110391478|NCT03776487|Nivolumab|nivolumab|mesh-list
110391479|NCT03776487|Ipilimumab|ipilimumab|mesh-list
110391480|NCT03776487|Antimetabolites|antimetabolites|mesh-ancestor
110391481|NCT03776487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391482|NCT03776487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110391483|NCT03776487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110391484|NCT03776487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110391485|NCT03776487|Immunologic Factors|immunologic factors|mesh-ancestor
110391486|NCT03776487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110391487|NCT03776487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110391488|NCT03776487|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110391489|NCT03729362|Miglustat|miglustat|mesh-list
110391490|NCT03729362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110391491|NCT03729362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391492|NCT03729362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110391493|NCT03729362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110391494|NCT03729362|Antiviral Agents|antiviral agents|mesh-ancestor
110391495|NCT03729362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110391496|NCT03729362|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110391497|NCT03729362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110391498|NCT03729362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110391499|NCT03725202|Upadacitinib|upadacitinib|mesh-list
110391500|NCT03725202|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110391501|NCT03725202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110391502|NCT03725202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110391503|NCT03725202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391504|NCT03725202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110391505|NCT03630211|Cyclophosphamide|cyclophosphamide|mesh-list
110391506|NCT03630211|Thiotepa|thiotepa|mesh-list
110391507|NCT03630211|Rituximab|rituximab|mesh-list
110391508|NCT03630211|Alemtuzumab|alemtuzumab|mesh-list
110391510|NCT03630211|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110391511|NCT03630211|Immunoglobulins|immunoglobulins|mesh-list
110391512|NCT03630211|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110391513|NCT03630211|gamma-Globulins|gamma-globulins|mesh-list
110391539|NCT03599635|Anesthetics, Local|anesthetics, local|mesh-ancestor
110391540|NCT03599635|Anesthetics|anesthetics|mesh-ancestor
110391541|NCT03599635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110391542|NCT03599635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110391543|NCT03599635|Sensory System Agents|sensory system agents|mesh-ancestor
110391544|NCT03599635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110391545|NCT03587961|Ivacaftor|ivacaftor|mesh-list
110391546|NCT03587961|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110391547|NCT03587961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110391551|NCT03534453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110391552|NCT03534453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391553|NCT03534453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110391557|NCT03502733|Nivolumab|nivolumab|mesh-list
110391558|NCT03502733|Ipilimumab|ipilimumab|mesh-list
110391559|NCT03502733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110391560|NCT03502733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110391561|NCT03502733|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110391562|NCT03502733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391563|NCT03473756|Atezolizumab|atezolizumab|mesh-list
110391564|NCT03473756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110391565|NCT03473756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391566|NCT03473756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110391567|NCT03473756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110391568|NCT03426293|Heparin|heparin|mesh-list
110391569|NCT03426293|Anticoagulants|anticoagulants|mesh-ancestor
110391570|NCT03426293|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110391571|NCT03426293|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110391572|NCT03426293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391573|NCT03387423|Tofacitinib|tofacitinib|mesh-list
110391574|NCT03387423|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110391575|NCT03387423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110391576|NCT03387423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110391577|NCT03387423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391578|NCT03386539|Mycophenolic Acid|mycophenolic acid|mesh-list
110391579|NCT03386539|Everolimus|everolimus|mesh-list
110391580|NCT03386539|Tacrolimus|tacrolimus|mesh-list
110391581|NCT03386539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110391582|NCT03386539|Immunologic Factors|immunologic factors|mesh-ancestor
110391583|NCT03386539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110391584|NCT03386539|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110391585|NCT03386539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110391586|NCT03386539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391587|NCT03386539|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110391588|NCT03386539|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110391589|NCT03386539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110391590|NCT03386539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110391591|NCT03386539|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110391592|NCT03386539|Antitubercular Agents|antitubercular agents|mesh-ancestor
110391593|NCT03386539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110391594|NCT03386539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110391595|NCT03340766|Pembrolizumab|pembrolizumab|mesh-list
110391596|NCT03340766|Blinatumomab|blinatumomab|mesh-list
110391597|NCT03340766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110391598|NCT03340766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110391599|NCT03340766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110391600|NCT03340766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391601|NCT03334617|Trastuzumab|trastuzumab|mesh-list
110391602|NCT03334617|Durvalumab|durvalumab|mesh-list
110391603|NCT03334617|Olaparib|olaparib|mesh-list
110391604|NCT03334617|Cediranib|cediranib|mesh-list
110391605|NCT03334617|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
110391606|NCT03334617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110391607|NCT03334617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110391608|NCT03334617|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110391610|NCT03334617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391611|NCT03334617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110391612|NCT03334617|Immunoconjugates|immunoconjugates|mesh-ancestor
110391613|NCT03334617|Immunologic Factors|immunologic factors|mesh-ancestor
110391614|NCT03334617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110391615|NCT03267589|Durvalumab|durvalumab|mesh-list
110391616|NCT03267589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110391617|NCT03267589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110225495|NCT05952713|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110225497|NCT05952713|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110225499|NCT05952713|Sensory System Agents|sensory system agents|mesh-ancestor
110254986|NCT00470041|Antiviral Agents|antiviral agents|mesh-list
110225501|NCT05952713|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110225502|NCT05952713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110225504|NCT05952713|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110255062|NCT05378906|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110225505|NCT05952713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110225506|NCT05952713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110225507|NCT05952713|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110225508|NCT05952713|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110225509|NCT05952713|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110225510|NCT05952713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110225511|NCT05952713|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110225512|NCT05952713|Histamine Antagonists|histamine antagonists|mesh-ancestor
110225513|NCT05952713|Histamine Agents|histamine agents|mesh-ancestor
110225514|NCT05952713|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110225515|NCT05952713|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110225516|NCT05952713|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110225517|NCT05952713|Adrenergic Agents|adrenergic agents|mesh-ancestor
110225518|NCT05952713|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110225519|NCT05952713|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110225520|NCT05952713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110225521|NCT05952713|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110225522|NCT05952713|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110225523|NCT05944237|Atezolizumab|atezolizumab|mesh-list
110225524|NCT05944237|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110255263|NCT00149604|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110225525|NCT05944237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110225526|NCT05944237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110225527|NCT05944237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110225529|NCT05943795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110225530|NCT05943795|Tubulin Modulators|tubulin modulators|mesh-ancestor
110225531|NCT05943795|Antimitotic Agents|antimitotic agents|mesh-ancestor
110225532|NCT05943795|Mitosis Modulators|mitosis modulators|mesh-ancestor
110225533|NCT05943795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110225535|NCT05925023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110225536|NCT05925023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110225537|NCT05925023|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110225538|NCT05925023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110225539|NCT05925023|Antifungal Agents|antifungal agents|mesh-ancestor
110225540|NCT05925023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110225541|NCT05925023|Immunologic Factors|immunologic factors|mesh-ancestor
110225542|NCT05925023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110225544|NCT05908786|Atezolizumab|atezolizumab|mesh-list
110255621|NCT00509470|Diuretics|diuretics|mesh-ancestor
110225545|NCT05908786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110225547|NCT05908786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110255690|NCT02953210|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110225548|NCT05908786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110225549|NCT05908786|Growth Substances|growth substances|mesh-ancestor
110225550|NCT05908786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110225556|NCT05905419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110225557|NCT05905419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110225558|NCT05905419|Analgesics|analgesics|mesh-ancestor
110225559|NCT05905419|Sensory System Agents|sensory system agents|mesh-ancestor
110225560|NCT05905419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110225561|NCT05896566|Anastrozole|anastrozole|mesh-list
110225562|NCT05896566|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110225563|NCT05896566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110225564|NCT05896566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110225565|NCT05896566|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110225566|NCT05896566|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110225568|NCT05896566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110225569|NCT05896566|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110225570|NCT05896566|Hormone Antagonists|hormone antagonists|mesh-ancestor
110255825|NCT00338338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110225571|NCT05896566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110225572|NCT05896566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110225573|NCT05896566|Luteolytic Agents|luteolytic agents|mesh-ancestor
110225574|NCT05896566|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110225575|NCT05896566|Contraceptive Agents|contraceptive agents|mesh-ancestor
110225576|NCT05896566|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110225577|NCT05896566|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110225579|NCT05896228|Diphenhydramine|diphenhydramine|mesh-list
110225580|NCT05896228|Promethazine|promethazine|mesh-list
110225581|NCT05896228|Dexamethasone|dexamethasone|mesh-list
110225582|NCT05896228|Daratumumab|daratumumab|mesh-list
110225583|NCT05896228|Montelukast|montelukast|mesh-list
110225584|NCT05896228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110225585|NCT05896228|Antiemetics|antiemetics|mesh-ancestor
110225586|NCT05896228|Autonomic Agents|autonomic agents|mesh-ancestor
110225587|NCT05896228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110225588|NCT05896228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110225589|NCT05896228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110255955|NCT00158730|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110225592|NCT05896228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110225593|NCT05896228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110225594|NCT05896228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110225595|NCT05896228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110225596|NCT05896228|Analgesics|analgesics|mesh-ancestor
110225597|NCT05896228|Sensory System Agents|sensory system agents|mesh-ancestor
110225598|NCT05896228|Antipyretics|antipyretics|mesh-ancestor
110225599|NCT05896228|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110225600|NCT05896228|Respiratory System Agents|respiratory system agents|mesh-ancestor
110225601|NCT05896228|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110225602|NCT05896228|Hormone Antagonists|hormone antagonists|mesh-ancestor
110225603|NCT05896228|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110225604|NCT05896228|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110225605|NCT05896228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110225606|NCT05896228|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110225607|NCT05896228|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110225608|NCT05896228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110225609|NCT05896228|Anesthetics, Local|anesthetics, local|mesh-ancestor
110225610|NCT05896228|Anesthetics|anesthetics|mesh-ancestor
110225611|NCT05896228|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110225612|NCT05896228|Histamine Antagonists|histamine antagonists|mesh-ancestor
110225613|NCT05896228|Histamine Agents|histamine agents|mesh-ancestor
110225614|NCT05896228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110225615|NCT05896228|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110225616|NCT05896228|Antipruritics|antipruritics|mesh-ancestor
110225617|NCT05896228|Dermatologic Agents|dermatologic agents|mesh-ancestor
110225618|NCT05894928|Cholestyramine Resin|cholestyramine resin|mesh-list
110225619|NCT05894928|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110225620|NCT05894928|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110225622|NCT05894928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110225623|NCT05894928|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110225625|NCT05888493|Prednisolone|prednisolone|mesh-list
110225626|NCT05888493|Cyclophosphamide|cyclophosphamide|mesh-list
110225627|NCT05888493|Rituximab|rituximab|mesh-list
110225628|NCT05888493|Doxorubicin|doxorubicin|mesh-list
110225629|NCT05888493|Vincristine|vincristine|mesh-list
110225630|NCT05888493|Lenalidomide|lenalidomide|mesh-list
110225631|NCT05888493|Tisagenlecleucel|tisagenlecleucel|mesh-list
110225632|NCT05888493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110225633|NCT05888493|Immunologic Factors|immunologic factors|mesh-ancestor
110225634|NCT05888493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110225635|NCT05888493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110225636|NCT05888493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110225637|NCT05888493|Alkylating Agents|alkylating agents|mesh-ancestor
110256131|NCT00511771|Tegaserod|tegaserod|mesh-list
110225638|NCT05888493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110225639|NCT05888493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110225640|NCT05888493|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110225641|NCT05888493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110225642|NCT05888493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110225643|NCT05888493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110225644|NCT05888493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110225645|NCT05888493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110225646|NCT05888493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110225647|NCT05888493|Glucocorticoids|glucocorticoids|mesh-ancestor
110225648|NCT05888493|Hormones|hormones|mesh-ancestor
110225649|NCT05888493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110225651|NCT05888493|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110256195|NCT00150735|Levetiracetam|levetiracetam|mesh-list
110225652|NCT05888493|Tubulin Modulators|tubulin modulators|mesh-ancestor
110225653|NCT05888493|Antimitotic Agents|antimitotic agents|mesh-ancestor
110225654|NCT05888493|Mitosis Modulators|mitosis modulators|mesh-ancestor
110225655|NCT05888493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110225656|NCT05888493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110225657|NCT05888493|Growth Substances|growth substances|mesh-ancestor
110225658|NCT05888493|Growth Inhibitors|growth inhibitors|mesh-ancestor
110225659|NCT05877313|Nitric Oxide|nitric oxide|mesh-list
110225660|NCT05877313|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110225661|NCT05877313|Autonomic Agents|autonomic agents|mesh-ancestor
110225662|NCT05877313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110225663|NCT05877313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110225664|NCT05877313|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110225665|NCT05877313|Respiratory System Agents|respiratory system agents|mesh-ancestor
110225666|NCT05877313|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110225667|NCT05877313|Antioxidants|antioxidants|mesh-ancestor
110225668|NCT05877313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110225669|NCT05877313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110225670|NCT05877313|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110225671|NCT05877313|Vasodilator Agents|vasodilator agents|mesh-ancestor
110225672|NCT05877313|Gasotransmitters|gasotransmitters|mesh-ancestor
110225673|NCT05877313|Protective Agents|protective agents|mesh-ancestor
110225675|NCT05868122|Naproxen|naproxen|mesh-list
110225676|NCT05868122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110225677|NCT05868122|Analgesics|analgesics|mesh-ancestor
110225678|NCT05868122|Sensory System Agents|sensory system agents|mesh-ancestor
110225679|NCT05868122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110225680|NCT05868122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110225681|NCT05868122|Antipyretics|antipyretics|mesh-ancestor
110225682|NCT05868122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110225683|NCT05868122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110225684|NCT05868122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110225685|NCT05868122|Gout Suppressants|gout suppressants|mesh-ancestor
110225686|NCT05868122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110225687|NCT05868122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110225688|NCT05868122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110225690|NCT05843188|Hydroxychloroquine|hydroxychloroquine|mesh-list
110225691|NCT05843188|Bevacizumab|bevacizumab|mesh-list
110225692|NCT05843188|Fluorouracil|fluorouracil|mesh-list
110225693|NCT05843188|Irinotecan|irinotecan|mesh-list
110225694|NCT05843188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110225695|NCT05843188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110225696|NCT05843188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110256322|NCT00512980|Hormones|hormones|mesh-ancestor
110225697|NCT05843188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110225698|NCT05843188|Growth Substances|growth substances|mesh-ancestor
110225699|NCT05843188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110225700|NCT05843188|Growth Inhibitors|growth inhibitors|mesh-ancestor
110225701|NCT05843188|Antimetabolites|antimetabolites|mesh-ancestor
110225702|NCT05843188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110225703|NCT05843188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110225704|NCT05843188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110225705|NCT05843188|Immunologic Factors|immunologic factors|mesh-ancestor
110225706|NCT05843188|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110225707|NCT05843188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110225708|NCT05843188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110225709|NCT05843188|Antidotes|antidotes|mesh-ancestor
110225710|NCT05843188|Protective Agents|protective agents|mesh-ancestor
110225712|NCT05843188|Vitamins|vitamins|mesh-ancestor
110225713|NCT05843188|Micronutrients|micronutrients|mesh-ancestor
110225714|NCT05843188|Antimalarials|antimalarials|mesh-ancestor
110225715|NCT05843188|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110225716|NCT05843188|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110225717|NCT05843188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110225718|NCT05843188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110225719|NCT05838573|Metformin|metformin|mesh-list
110225720|NCT05838573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110256362|NCT02951962|Amlodipine|amlodipine|mesh-list
110225721|NCT05838573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110225722|NCT05834738|Atrasentan|atrasentan|mesh-list
110225723|NCT05834738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110225724|NCT05834738|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
110225725|NCT05834738|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110225726|NCT05834738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110225727|NCT05831358|Myeloma Proteins|myeloma proteins|mesh-list
110225728|NCT05831358|Paraproteins|paraproteins|mesh-list
110225729|NCT05831358|Immunologic Factors|immunologic factors|mesh-ancestor
110225730|NCT05831358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110225731|NCT05829434|Cytarabine|cytarabine|mesh-list
110225732|NCT05829434|Magrolimab|magrolimab|mesh-list
110225733|NCT05829434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110225734|NCT05829434|Antimetabolites|antimetabolites|mesh-ancestor
110225735|NCT05829434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110225736|NCT05829434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110225737|NCT05829434|Antiviral Agents|antiviral agents|mesh-ancestor
110225738|NCT05829434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110225739|NCT05829434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110225740|NCT05829434|Immunologic Factors|immunologic factors|mesh-ancestor
110225741|NCT05829434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110225742|NCT05829434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110225743|NCT05828966|Magnesium Sulfate|magnesium sulfate|mesh-list
110225744|NCT05828966|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110225745|NCT05828966|Analgesics|analgesics|mesh-ancestor
110225746|NCT05828966|Sensory System Agents|sensory system agents|mesh-ancestor
110225747|NCT05828966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110225748|NCT05828966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110225749|NCT05828966|Anesthetics|anesthetics|mesh-ancestor
110225750|NCT05828966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110225751|NCT05828966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110225752|NCT05828966|Anticonvulsants|anticonvulsants|mesh-ancestor
110225753|NCT05828966|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110225754|NCT05828966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110225755|NCT05828966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110225756|NCT05828966|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110225757|NCT05828966|Tocolytic Agents|tocolytic agents|mesh-ancestor
110225758|NCT05828966|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110225759|NCT05827042|Tenecteplase|tenecteplase|mesh-list
110225760|NCT05827042|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110225761|NCT05827042|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110225762|NCT05827042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110225763|NCT05826964|Tamoxifen|tamoxifen|mesh-list
110225764|NCT05826964|Sirolimus|sirolimus|mesh-list
110225765|NCT05826964|Capecitabine|capecitabine|mesh-list
110225766|NCT05826964|Everolimus|everolimus|mesh-list
110225767|NCT05826964|Letrozole|letrozole|mesh-list
110225768|NCT05826964|Vinorelbine|vinorelbine|mesh-list
110225769|NCT05826964|Fulvestrant|fulvestrant|mesh-list
110225770|NCT05826964|Palbociclib|palbociclib|mesh-list
110225772|NCT05826964|Exemestane|exemestane|mesh-list
110225774|NCT05826964|MTOR Inhibitors|mtor inhibitors|mesh-list
110225776|NCT05826964|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110256660|NCT00515866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110225777|NCT05826964|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-list
110225778|NCT05826964|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-list
110225780|NCT05826964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110225781|NCT05826964|Antimetabolites|antimetabolites|mesh-ancestor
110225782|NCT05826964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110225783|NCT05826964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110225784|NCT05826964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110225785|NCT05826964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110225786|NCT05826964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110225787|NCT05826964|Immunologic Factors|immunologic factors|mesh-ancestor
110225788|NCT05826964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110225789|NCT05826964|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110225790|NCT05826964|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110225791|NCT05826964|Hormone Antagonists|hormone antagonists|mesh-ancestor
110225792|NCT05826964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110225794|NCT05826964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110256753|NCT00508885|Niacin|niacin|mesh-list
110225795|NCT05826964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110225796|NCT05826964|Antifungal Agents|antifungal agents|mesh-ancestor
110225797|NCT05826964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110225798|NCT05826964|Tubulin Modulators|tubulin modulators|mesh-ancestor
110225799|NCT05826964|Antimitotic Agents|antimitotic agents|mesh-ancestor
110225800|NCT05826964|Mitosis Modulators|mitosis modulators|mesh-ancestor
110225801|NCT05826964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110225802|NCT05826964|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110225803|NCT05826964|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110225805|NCT05826964|Protease Inhibitors|protease inhibitors|mesh-ancestor
110225806|NCT05826574|Rifampin|rifampin|mesh-list
110225807|NCT05826574|Esomeprazole|esomeprazole|mesh-list
110225808|NCT05826574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110225809|NCT05826574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110225810|NCT05826574|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110225811|NCT05826574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110225812|NCT05826574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110225813|NCT05826574|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110225814|NCT05826574|Antitubercular Agents|antitubercular agents|mesh-ancestor
110225815|NCT05826574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110225816|NCT05826574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110225818|NCT05826574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110225819|NCT05826574|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110225820|NCT05826574|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110225821|NCT05826574|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110225822|NCT05826574|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110225823|NCT05826574|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110225824|NCT05826574|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110225825|NCT05814666|Pembrolizumab|pembrolizumab|mesh-list
110225826|NCT05814666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110225827|NCT05814666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110225828|NCT05814666|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110225829|NCT05814666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110225830|NCT05806749|Belumosudil|belumosudil|mesh-list
110225831|NCT05806749|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110225832|NCT05806749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110256787|NCT05861466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110225833|NCT05806749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110225836|NCT05798663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110225837|NCT05798663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110225838|NCT05798663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110225839|NCT05787613|Paclitaxel|paclitaxel|mesh-list
110225840|NCT05787613|Carboplatin|carboplatin|mesh-list
110225841|NCT05787613|Pemetrexed|pemetrexed|mesh-list
110225842|NCT05787613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110225843|NCT05787613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110225844|NCT05787613|Tubulin Modulators|tubulin modulators|mesh-ancestor
110225845|NCT05787613|Antimitotic Agents|antimitotic agents|mesh-ancestor
110225846|NCT05787613|Mitosis Modulators|mitosis modulators|mesh-ancestor
110225847|NCT05787613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110225848|NCT05787613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110225849|NCT05787613|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110225850|NCT05787613|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110225851|NCT05776953|Ketorolac|ketorolac|mesh-list
110225852|NCT05776953|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110225853|NCT05776953|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110225854|NCT05776953|Analgesics|analgesics|mesh-ancestor
110225855|NCT05776953|Sensory System Agents|sensory system agents|mesh-ancestor
110225856|NCT05776953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110225857|NCT05776953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110225858|NCT05776953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110225859|NCT05776953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110225860|NCT05776953|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110225861|NCT05776953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110225862|NCT05776953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110225863|NCT05776056|Methylphenidate|methylphenidate|mesh-list
110256826|NCT05861297|Antimetabolites|antimetabolites|mesh-ancestor
110225864|NCT05776056|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110225865|NCT05776056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110225867|NCT05776056|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110225868|NCT05776056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110225869|NCT05776056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110225871|NCT05776056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110225872|NCT05768139|Fulvestrant|fulvestrant|mesh-list
110225873|NCT05768139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110225874|NCT05768139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110225875|NCT05768139|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110225876|NCT05768139|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110225877|NCT05768139|Hormone Antagonists|hormone antagonists|mesh-ancestor
110225878|NCT05768139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110225879|NCT05768139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110225880|NCT05767736|Dimethyl Fumarate|dimethyl fumarate|mesh-list
110225881|NCT05767736|Dermatologic Agents|dermatologic agents|mesh-ancestor
110225882|NCT05767736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110225883|NCT05767736|Immunologic Factors|immunologic factors|mesh-ancestor
110225884|NCT05767736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110225885|NCT05757167|Lumefantrine|lumefantrine|mesh-list
110225887|NCT05757167|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110256928|NCT05860010|Bupivacaine|bupivacaine|mesh-list
110225888|NCT05757167|Antimalarials|antimalarials|mesh-ancestor
110225889|NCT05757167|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110225890|NCT05757167|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110225891|NCT05757167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110225892|NCT05756569|Pembrolizumab|pembrolizumab|mesh-list
110225893|NCT05756569|Immunoconjugates|immunoconjugates|mesh-list
110225894|NCT05756569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110225895|NCT05756569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110225896|NCT05756569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110225897|NCT05756569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110225898|NCT05756569|Immunologic Factors|immunologic factors|mesh-ancestor
110225899|NCT05756569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110225900|NCT05750628|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110225901|NCT05750628|Antimalarials|antimalarials|mesh-ancestor
110225902|NCT05750628|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110225903|NCT05750628|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110225904|NCT05750628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110225905|NCT05750459|Artesunate|artesunate|mesh-list
110225906|NCT05750459|Antimalarials|antimalarials|mesh-ancestor
110225907|NCT05750459|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110225908|NCT05750459|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110256991|NCT05859412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110225909|NCT05750459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110225910|NCT05750459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110225911|NCT05750459|Antiviral Agents|antiviral agents|mesh-ancestor
110225912|NCT05750459|Schistosomicides|schistosomicides|mesh-ancestor
110225913|NCT05750459|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110225914|NCT05750459|Anthelmintics|anthelmintics|mesh-ancestor
110225915|NCT05744375|Trastuzumab|trastuzumab|mesh-list
110225916|NCT05744375|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
110225917|NCT05744375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110225918|NCT05744375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110225919|NCT05744375|Immunoconjugates|immunoconjugates|mesh-ancestor
110225920|NCT05744375|Immunologic Factors|immunologic factors|mesh-ancestor
110225921|NCT05744375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110225922|NCT05742607|Paclitaxel|paclitaxel|mesh-list
110225923|NCT05742607|Cisplatin|cisplatin|mesh-list
110225924|NCT05742607|Carboplatin|carboplatin|mesh-list
110225925|NCT05742607|Pemetrexed|pemetrexed|mesh-list
110225926|NCT05742607|Durvalumab|durvalumab|mesh-list
110225927|NCT05742607|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110225928|NCT05742607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110225929|NCT05742607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110225930|NCT05742607|Tubulin Modulators|tubulin modulators|mesh-ancestor
110257099|NCT05684744|Dermatologic Agents|dermatologic agents|mesh-ancestor
110225933|NCT05742607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110225934|NCT05742607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110225935|NCT05742607|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110225936|NCT05742607|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110225937|NCT05742607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110225938|NCT05742607|Immunologic Factors|immunologic factors|mesh-ancestor
110225939|NCT05742607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110225940|NCT05741866|Chlorhexidine|chlorhexidine|mesh-list
110225941|NCT05741866|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110225942|NCT05741866|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110225943|NCT05741866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110225944|NCT05741866|Disinfectants|disinfectants|mesh-ancestor
110225945|NCT05741866|Dermatologic Agents|dermatologic agents|mesh-ancestor
110225947|NCT05733351|Antibodies|antibodies|mesh-list
110225948|NCT05733351|Immunoglobulins|immunoglobulins|mesh-list
110225949|NCT05733351|Antibodies, Bispecific|antibodies, bispecific|mesh-list
110225950|NCT05733351|Immunologic Factors|immunologic factors|mesh-ancestor
110225951|NCT05733351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110225953|NCT05733351|Tubulin Modulators|tubulin modulators|mesh-ancestor
110225954|NCT05733351|Antimitotic Agents|antimitotic agents|mesh-ancestor
110225955|NCT05733351|Mitosis Modulators|mitosis modulators|mesh-ancestor
110225956|NCT05733351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110225957|NCT05726383|Viscum album peptide|viscum album peptide|mesh-list
110225958|NCT05726383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110225959|NCT05726383|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110225960|NCT05726383|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110225961|NCT05726383|Antiviral Agents|antiviral agents|mesh-ancestor
110225962|NCT05726383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110225963|NCT05722340|Anesthetics|anesthetics|mesh-list
110225964|NCT05722340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110225965|NCT05722340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110225966|NCT05721027|Dexamethasone|dexamethasone|mesh-list
110225967|NCT05721027|Ibuprofen|ibuprofen|mesh-list
110225968|NCT05721027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110225969|NCT05721027|Antiemetics|antiemetics|mesh-ancestor
110225970|NCT05721027|Autonomic Agents|autonomic agents|mesh-ancestor
110225971|NCT05721027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110225973|NCT05721027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110225974|NCT05721027|Glucocorticoids|glucocorticoids|mesh-ancestor
110225975|NCT05721027|Hormones|hormones|mesh-ancestor
110225976|NCT05721027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110257294|NCT05190705|Hormones|hormones|mesh-ancestor
110225977|NCT05721027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110225978|NCT05721027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110225979|NCT05721027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110225980|NCT05721027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110225981|NCT05721027|Analgesics|analgesics|mesh-ancestor
110225982|NCT05721027|Sensory System Agents|sensory system agents|mesh-ancestor
110225983|NCT05721027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110225984|NCT05721027|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110225985|NCT05721027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110225986|NCT05721027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110225987|NCT05718856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110225988|NCT05718856|Antibodies|antibodies|mesh-list
110225989|NCT05718856|Immunoglobulins|immunoglobulins|mesh-list
110225990|NCT05718856|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110225991|NCT05718856|Immunologic Factors|immunologic factors|mesh-ancestor
110225992|NCT05718856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110225993|NCT05718856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110225994|NCT05714865|Pulmonary Surfactants|pulmonary surfactants|mesh-list
110225995|NCT05714865|Respiratory System Agents|respiratory system agents|mesh-ancestor
110225996|NCT05712707|Lofexidine|lofexidine|mesh-list
110225997|NCT05712707|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110225998|NCT05712707|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110225999|NCT05712707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110226000|NCT05712707|Sensory System Agents|sensory system agents|mesh-ancestor
110226001|NCT05712707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110226002|NCT05712707|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110226003|NCT05712707|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110226004|NCT05712707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110226005|NCT05712707|Adrenergic Agents|adrenergic agents|mesh-ancestor
110226006|NCT05712707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110226007|NCT05712707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110226009|NCT05706753|Midazolam|midazolam|mesh-list
110226010|NCT05706753|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110226011|NCT05706753|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110226012|NCT05706753|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110226013|NCT05706753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110226014|NCT05706753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110226015|NCT05706753|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110226016|NCT05706753|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110226017|NCT05706753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110226018|NCT05706753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110226019|NCT05706753|Anesthetics, General|anesthetics, general|mesh-ancestor
110226020|NCT05706753|Anesthetics|anesthetics|mesh-ancestor
110226021|NCT05706753|GABA Modulators|gaba modulators|mesh-ancestor
110226022|NCT05706753|GABA Agents|gaba agents|mesh-ancestor
110226023|NCT05706753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110226024|NCT05706753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110226025|NCT05706753|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110226026|NCT05706753|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110226027|NCT05706753|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110226028|NCT05706753|Contraceptive Agents|contraceptive agents|mesh-ancestor
110257541|NCT04634162|Cangrelor|cangrelor|mesh-list
110226029|NCT05706753|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110226030|NCT05706753|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110226031|NCT05706753|Estrogens|estrogens|mesh-ancestor
110226032|NCT05706753|Hormones|hormones|mesh-ancestor
110226033|NCT05706753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110226034|NCT05706753|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110226035|NCT05706753|Hormone Antagonists|hormone antagonists|mesh-ancestor
110226036|NCT05706753|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110226037|NCT05706753|Diuretics|diuretics|mesh-ancestor
110226038|NCT05706753|Natriuretic Agents|natriuretic agents|mesh-ancestor
110226039|NCT05704985|Paclitaxel|paclitaxel|mesh-list
110226040|NCT05704985|Carboplatin|carboplatin|mesh-list
110226041|NCT05704985|Pembrolizumab|pembrolizumab|mesh-list
110226043|NCT05704985|Capecitabine|capecitabine|mesh-list
110226044|NCT05704985|Oxaliplatin|oxaliplatin|mesh-list
110226045|NCT05704985|Nivolumab|nivolumab|mesh-list
110226046|NCT05704985|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110226047|NCT05704985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110226048|NCT05704985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110226049|NCT05704985|Tubulin Modulators|tubulin modulators|mesh-ancestor
110226050|NCT05704985|Antimitotic Agents|antimitotic agents|mesh-ancestor
110226051|NCT05704985|Mitosis Modulators|mitosis modulators|mesh-ancestor
110226052|NCT05704985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110226053|NCT05704985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110226054|NCT05704985|Antimetabolites|antimetabolites|mesh-ancestor
110257806|NCT03815019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110226055|NCT05704985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110226056|NCT05704985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110226057|NCT05704985|Immunologic Factors|immunologic factors|mesh-ancestor
110226058|NCT05704985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110226059|NCT05700903|Leuprolide|leuprolide|mesh-list
110226060|NCT05700903|Goserelin|goserelin|mesh-list
110226061|NCT05700903|Flutamide|flutamide|mesh-list
110226062|NCT05700903|Bicalutamide|bicalutamide|mesh-list
110226063|NCT05700903|Hormones|hormones|mesh-list
110226064|NCT05700903|Androgens|androgens|mesh-list
110226065|NCT05700903|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
110226066|NCT05700903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110226067|NCT05700903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110226068|NCT05700903|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110226069|NCT05700903|Fertility Agents|fertility agents|mesh-ancestor
110226070|NCT05700903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110226071|NCT05700903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110226072|NCT05700903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110226073|NCT05700903|Androgen Antagonists|androgen antagonists|mesh-ancestor
110226074|NCT05700903|Hormone Antagonists|hormone antagonists|mesh-ancestor
110226075|NCT05688098|Amlodipine|amlodipine|mesh-list
110257937|NCT02750319|Amiodarone|amiodarone|mesh-list
110226077|NCT05688098|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110226078|NCT05688098|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110226080|NCT05688098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110226081|NCT05688098|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110226082|NCT05688098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110226083|NCT05688098|Vasodilator Agents|vasodilator agents|mesh-ancestor
110052706|NCT01481610|Diclofenac|diclofenac|mesh-list
110226084|NCT05688098|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110226085|NCT05688098|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110226086|NCT05688085|Amlodipine|amlodipine|mesh-list
110226087|NCT05688085|Irbesartan|irbesartan|mesh-list
110226088|NCT05688085|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110226089|NCT05688085|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110226090|NCT05688085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110226091|NCT05688085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110226093|NCT05688085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110226095|NCT05688085|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110226096|NCT05688085|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110226097|NCT05686863|Remifentanil|remifentanil|mesh-list
110226098|NCT05686863|Propofol|propofol|mesh-list
110226099|NCT05686863|Esketamine|esketamine|mesh-list
110226100|NCT05686863|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110226101|NCT05686863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110226102|NCT05686863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110226103|NCT05686863|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110226104|NCT05686863|Anesthetics, General|anesthetics, general|mesh-ancestor
110226105|NCT05686863|Anesthetics|anesthetics|mesh-ancestor
110226106|NCT05686863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110226107|NCT05686863|Narcotics|narcotics|mesh-ancestor
110226108|NCT05686863|Analgesics|analgesics|mesh-ancestor
110226109|NCT05686863|Sensory System Agents|sensory system agents|mesh-ancestor
110226110|NCT05686863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110226111|NCT05686863|Antidepressive Agents|antidepressive agents|mesh-ancestor
110226112|NCT05686863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110226113|NCT05681884|Faricimab|faricimab|mesh-list
110226114|NCT05681884|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110226115|NCT05681884|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110226116|NCT05681884|Growth Substances|growth substances|mesh-ancestor
110226117|NCT05681884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110226118|NCT05681884|Growth Inhibitors|growth inhibitors|mesh-ancestor
110226119|NCT05681884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110226120|NCT05677373|Trametinib|trametinib|mesh-list
110226121|NCT05677373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110226122|NCT05677373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110226123|NCT05677373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110226124|NCT05677373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110226126|NCT05665699|Antimetabolites|antimetabolites|mesh-ancestor
110226127|NCT05665699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110226128|NCT05665699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110226129|NCT05665699|Gout Suppressants|gout suppressants|mesh-ancestor
110226130|NCT05665699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110226131|NCT05665699|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110226132|NCT05665699|Antioxidants|antioxidants|mesh-ancestor
110226133|NCT05665699|Protective Agents|protective agents|mesh-ancestor
110226134|NCT05665699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110226135|NCT05663073|Amlodipine|amlodipine|mesh-list
110226136|NCT05663073|Irbesartan|irbesartan|mesh-list
110226137|NCT05663073|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110226138|NCT05663073|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110226139|NCT05663073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110226140|NCT05663073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110258234|NCT00151632|Mycophenolic Acid|mycophenolic acid|mesh-list
110226141|NCT05663073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110226142|NCT05663073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110226143|NCT05663073|Vasodilator Agents|vasodilator agents|mesh-ancestor
110226144|NCT05663073|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110226145|NCT05663073|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110226146|NCT05660538|Pregabalin|pregabalin|mesh-list
110226147|NCT05660538|Analgesics|analgesics|mesh-ancestor
110226148|NCT05660538|Sensory System Agents|sensory system agents|mesh-ancestor
110226150|NCT05660538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110226152|NCT05660538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110226155|NCT05660538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110226157|NCT05660538|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110226158|NCT05660538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110226159|NCT05660538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110226163|NCT05656534|Suvorexant|suvorexant|mesh-list
110226164|NCT05656534|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110226165|NCT05656534|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110052776|NCT01481870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110226166|NCT05656534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110226167|NCT05656534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110226168|NCT05656534|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
110226169|NCT05656534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110226170|NCT05656534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110226171|NCT05654506|Daratumumab|daratumumab|mesh-list
110226172|NCT05654506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110226173|NCT05647564|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110226174|NCT05647564|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110226175|NCT05647564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110258567|NCT00521092|Sunitinib|sunitinib|mesh-list
110226176|NCT05646459|Cannabidiol|cannabidiol|mesh-list
110226177|NCT05646459|Anticonvulsants|anticonvulsants|mesh-ancestor
110226178|NCT05620862|Irinotecan|irinotecan|mesh-list
110226179|NCT05620862|Vincristine|vincristine|mesh-list
110226180|NCT05620862|Mitoxantrone|mitoxantrone|mesh-list
110226181|NCT05620862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110226182|NCT05620862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110226183|NCT05620862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110226184|NCT05620862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110226185|NCT05620862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110226186|NCT05620862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110226187|NCT05620862|Tubulin Modulators|tubulin modulators|mesh-ancestor
110226188|NCT05620862|Antimitotic Agents|antimitotic agents|mesh-ancestor
110226189|NCT05620862|Mitosis Modulators|mitosis modulators|mesh-ancestor
110226190|NCT05620862|Analgesics|analgesics|mesh-ancestor
110226191|NCT05620862|Sensory System Agents|sensory system agents|mesh-ancestor
110226192|NCT05620862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110258854|NCT02951728|Hormones|hormones|mesh-ancestor
110226193|NCT05620862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110226194|NCT05620862|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110226195|NCT05617859|Lenvatinib|lenvatinib|mesh-list
110226196|NCT05617859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110226197|NCT05617859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110226198|NCT05617859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110226199|NCT05617859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110226200|NCT05615844|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110226201|NCT05615844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110226202|NCT05609968|Pembrolizumab|pembrolizumab|mesh-list
110226203|NCT05609968|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
110226204|NCT05609968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110258993|NCT00512668|Sirolimus|sirolimus|mesh-list
110226227|NCT05597878|Ketamine|ketamine|mesh-list
110226228|NCT05597878|Oxycodone|oxycodone|mesh-list
110226229|NCT05597878|Analgesics|analgesics|mesh-ancestor
110226230|NCT05597878|Sensory System Agents|sensory system agents|mesh-ancestor
110226231|NCT05597878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110226232|NCT05597878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110226234|NCT05597878|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110226235|NCT05597878|Anesthetics, General|anesthetics, general|mesh-ancestor
110226236|NCT05597878|Anesthetics|anesthetics|mesh-ancestor
110226237|NCT05597878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110226238|NCT05597878|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110226239|NCT05597878|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110226240|NCT05597878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110226241|NCT05597878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110226242|NCT05597878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110226243|NCT05597878|Antipyretics|antipyretics|mesh-ancestor
110226244|NCT05597878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110226245|NCT05597878|Narcotics|narcotics|mesh-ancestor
110226246|NCT05597878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110226247|NCT05597878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110226248|NCT05597878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110226249|NCT05597878|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110226250|NCT05597878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110226251|NCT05590624|Phentermine|phentermine|mesh-list
110226252|NCT05590624|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110226253|NCT05590624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110226254|NCT05590624|Appetite Depressants|appetite depressants|mesh-ancestor
110226255|NCT05590624|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110226256|NCT05590624|Sympathomimetics|sympathomimetics|mesh-ancestor
110226257|NCT05590624|Autonomic Agents|autonomic agents|mesh-ancestor
110226258|NCT05590624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110226259|NCT05590624|Adrenergic Agents|adrenergic agents|mesh-ancestor
110226260|NCT05590624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110226261|NCT05590624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110226262|NCT05581030|Rituximab|rituximab|mesh-list
110226263|NCT05581030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110226264|NCT05581030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110226265|NCT05581030|Immunologic Factors|immunologic factors|mesh-ancestor
110226266|NCT05581030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110226267|NCT05581030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110226268|NCT05579574|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
110226269|NCT05579574|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110226270|NCT05579574|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110226271|NCT05579574|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110226272|NCT05579574|Contraceptive Agents|contraceptive agents|mesh-ancestor
110226273|NCT05579574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110226274|NCT05579574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110226275|NCT05579574|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110226276|NCT05579574|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110226277|NCT05579574|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
110226278|NCT05579574|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110226280|NCT05576662|Nirmatrelvir|nirmatrelvir|mesh-list
110226281|NCT05576662|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110226282|NCT05576662|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110226283|NCT05576662|Protease Inhibitors|protease inhibitors|mesh-ancestor
110226284|NCT05576662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110226285|NCT05576662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110226286|NCT05576662|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110226287|NCT05576662|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110226288|NCT05576662|Antiviral Agents|antiviral agents|mesh-ancestor
110226289|NCT05576662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110226291|NCT05576662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110226292|NCT05569746|Immunoglobulins|immunoglobulins|mesh-list
110226293|NCT05569746|Immunoglobulin Fragments|immunoglobulin fragments|mesh-list
110226294|NCT05569746|Shiga Toxins|shiga toxins|mesh-list
110226295|NCT05569746|Immunologic Factors|immunologic factors|mesh-ancestor
110226296|NCT05569746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110226297|NCT05569746|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110226298|NCT05569746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110226299|NCT05569746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110226300|NCT05566756|Ofatumumab|ofatumumab|mesh-list
110226301|NCT05566756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110226303|NCT05564650|Decitabine|decitabine|mesh-list
110226304|NCT05564650|Venetoclax|venetoclax|mesh-list
110226305|NCT05564650|Navitoclax|navitoclax|mesh-list
110226306|NCT05564650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110226325|NCT05562063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110226326|NCT05562063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259614|NCT02945527|Antiemetics|antiemetics|mesh-ancestor
110226328|NCT05561751|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110226329|NCT05561751|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110226330|NCT05561751|Adrenergic Agents|adrenergic agents|mesh-ancestor
110226331|NCT05561751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110226332|NCT05561751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110259675|NCT00173862|Alkylating Agents|alkylating agents|mesh-ancestor
110226333|NCT05561751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110226334|NCT05561751|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110226335|NCT05561751|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110226336|NCT05561751|Vasodilator Agents|vasodilator agents|mesh-ancestor
110226337|NCT05558982|Pembrolizumab|pembrolizumab|mesh-list
110226338|NCT05558982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110226339|NCT05558982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110226340|NCT05558982|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110226341|NCT05558982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110226342|NCT05556798|Pomalidomide|pomalidomide|mesh-list
110226343|NCT05556798|Nirogacestat|nirogacestat|mesh-list
110226344|NCT05556798|Immunologic Factors|immunologic factors|mesh-ancestor
110226345|NCT05556798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110226346|NCT05556798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110226347|NCT05556798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110226348|NCT05556798|Growth Substances|growth substances|mesh-ancestor
110226349|NCT05556798|Growth Inhibitors|growth inhibitors|mesh-ancestor
110053215|NCT01485562|Misoprostol|misoprostol|mesh-list
110226350|NCT05556798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110226351|NCT05556798|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
110226352|NCT05556798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110226353|NCT05556798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110226354|NCT05553938|Empagliflozin|empagliflozin|mesh-list
110226355|NCT05553938|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110226356|NCT05553938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110226357|NCT05553938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110226358|NCT05553938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110226359|NCT05546411|Leucovorin|leucovorin|mesh-list
110226360|NCT05546411|Fluorouracil|fluorouracil|mesh-list
110226361|NCT05546411|Oxaliplatin|oxaliplatin|mesh-list
110226362|NCT05546411|Irinotecan|irinotecan|mesh-list
110226363|NCT05546411|Camptothecin|camptothecin|mesh-list
110226364|NCT05546411|Levoleucovorin|levoleucovorin|mesh-list
110226367|NCT05546411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110226368|NCT05546411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110226369|NCT05546411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110226370|NCT05546411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110226371|NCT05546411|Immunologic Factors|immunologic factors|mesh-ancestor
110226372|NCT05546411|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110226373|NCT05546411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110226374|NCT05546411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110226375|NCT05546411|Antidotes|antidotes|mesh-ancestor
110226376|NCT05546411|Protective Agents|protective agents|mesh-ancestor
110226377|NCT05546411|Vitamin B Complex|vitamin b complex|mesh-ancestor
110226378|NCT05546411|Vitamins|vitamins|mesh-ancestor
110226379|NCT05546411|Micronutrients|micronutrients|mesh-ancestor
110226380|NCT05546411|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110226381|NCT05540522|Vaccines|vaccines|mesh-list
110226382|NCT05540522|Immunologic Factors|immunologic factors|mesh-ancestor
110226383|NCT05540522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110226384|NCT05536154|Cytarabine|cytarabine|mesh-list
110260144|NCT02944552|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110226386|NCT05536154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110226387|NCT05536154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110226388|NCT05536154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110226390|NCT05536154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110226391|NCT05536154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110226392|NCT05536154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110226393|NCT05536154|Antimetabolites|antimetabolites|mesh-ancestor
110226394|NCT05536154|Antiviral Agents|antiviral agents|mesh-ancestor
110226395|NCT05536154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110226396|NCT05536154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110226397|NCT05536154|Immunologic Factors|immunologic factors|mesh-ancestor
110226398|NCT05536154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110226399|NCT05535309|Sulbactam|sulbactam|mesh-list
110226400|NCT05535309|Cefoperazone|cefoperazone|mesh-list
110226401|NCT05535309|Sulperazone|sulperazone|mesh-list
110226402|NCT05535309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110226403|NCT05535309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110226404|NCT05535309|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110226405|NCT05535309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110226406|NCT05535309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110226407|NCT05535309|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110226408|NCT05518877|Ketamine|ketamine|mesh-list
110226409|NCT05518877|Analgesics|analgesics|mesh-ancestor
110226410|NCT05518877|Sensory System Agents|sensory system agents|mesh-ancestor
110226411|NCT05518877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110226412|NCT05518877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110226413|NCT05518877|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110226414|NCT05518877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110226415|NCT05518877|Anesthetics, General|anesthetics, general|mesh-ancestor
110226416|NCT05518877|Anesthetics|anesthetics|mesh-ancestor
110226417|NCT05518877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110226418|NCT05518877|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110226419|NCT05518877|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110226420|NCT05518877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110226421|NCT05518877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110226422|NCT05513027|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110226423|NCT05513027|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110226424|NCT05513027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110053291|NCT01485744|Leucovorin|leucovorin|mesh-list
110226425|NCT05512039|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110226426|NCT05512039|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110226427|NCT05512039|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110226428|NCT05512039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110226429|NCT05512039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110226430|NCT05512039|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110226431|NCT05512039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110226432|NCT05512039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110226433|NCT05512039|Cholinergic Agents|cholinergic agents|mesh-ancestor
110226434|NCT05512039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110226436|NCT05510089|Etoposide|etoposide|mesh-list
110226437|NCT05510089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110226438|NCT05510089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110226439|NCT05510089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110226440|NCT05510089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110226441|NCT05510089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110226442|NCT05510089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110226443|NCT05510089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110226444|NCT05510089|Antimetabolites|antimetabolites|mesh-ancestor
110226445|NCT05510089|Antiviral Agents|antiviral agents|mesh-ancestor
110226446|NCT05510089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110260527|NCT02942602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110226447|NCT05510089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110226448|NCT05510089|Immunologic Factors|immunologic factors|mesh-ancestor
110226449|NCT05510089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110226451|NCT05491317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110226452|NCT05491317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110226453|NCT05491317|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110226454|NCT05491317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110226455|NCT05488457|Oxytocin|oxytocin|mesh-list
110226456|NCT05488457|Oxytocics|oxytocics|mesh-ancestor
110226457|NCT05488457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110226459|NCT05483933|Doxorubicin|doxorubicin|mesh-list
110226460|NCT05483933|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110226461|NCT05483933|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110226462|NCT05483933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110226463|NCT05483933|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110226464|NCT05483933|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110226465|NCT05483933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110226466|NCT05483933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110226467|NCT05480865|Sotorasib|sotorasib|mesh-list
110226468|NCT05480865|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110260739|NCT00175032|Aspirin|aspirin|mesh-list
110226469|NCT05480865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110226470|NCT05480865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110226472|NCT05477576|Everolimus|everolimus|mesh-list
110226473|NCT05477576|Sunitinib|sunitinib|mesh-list
110226474|NCT05477576|Octreotide|octreotide|mesh-list
110226475|NCT05477576|Lanreotide|lanreotide|mesh-list
110226476|NCT05477576|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110226477|NCT05477576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110226478|NCT05477576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110226479|NCT05477576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110226480|NCT05477576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110226481|NCT05477576|Immunologic Factors|immunologic factors|mesh-ancestor
110226482|NCT05477576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110226483|NCT05477576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110226484|NCT05477576|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110226485|NCT05477576|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110226486|NCT05477576|Growth Substances|growth substances|mesh-ancestor
110226487|NCT05477576|Growth Inhibitors|growth inhibitors|mesh-ancestor
110226488|NCT05477576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110226489|NCT05477576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110226490|NCT05476354|Amlodipine|amlodipine|mesh-list
110226491|NCT05476354|Irbesartan|irbesartan|mesh-list
110226492|NCT05476354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110226493|NCT05476354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110226494|NCT05476354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110260928|NCT02939482|Hormones|hormones|mesh-ancestor
110226495|NCT05476354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110226496|NCT05476354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110226497|NCT05476354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110226498|NCT05476354|Vasodilator Agents|vasodilator agents|mesh-ancestor
110226499|NCT05476354|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110226500|NCT05476354|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110226501|NCT05475665|Amlodipine|amlodipine|mesh-list
110226502|NCT05475665|Irbesartan|irbesartan|mesh-list
110226503|NCT05475665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110226504|NCT05475665|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110226505|NCT05475665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110226506|NCT05475665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110226507|NCT05475665|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110226508|NCT05475665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110226509|NCT05475665|Vasodilator Agents|vasodilator agents|mesh-ancestor
110226510|NCT05475665|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110226511|NCT05475665|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110226512|NCT05467670|Doxorubicin|doxorubicin|mesh-list
110226514|NCT05467670|Pembrolizumab|pembrolizumab|mesh-list
110226515|NCT05467670|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110226516|NCT05467670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110226517|NCT05467670|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110226518|NCT05467670|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110226519|NCT05467670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110226520|NCT05467670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110226521|NCT05467670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110226522|NCT05467670|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110226529|NCT05460533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110226530|NCT05460533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110226531|NCT05447910|Letrozole|letrozole|mesh-list
110226532|NCT05447910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110226533|NCT05447910|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110226534|NCT05447910|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110226535|NCT05447910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110226536|NCT05447910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110226537|NCT05447910|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110226538|NCT05447910|Hormone Antagonists|hormone antagonists|mesh-ancestor
110226539|NCT05447910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110226540|NCT05447910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110226546|NCT05424445|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110226547|NCT05424445|Abortifacient Agents|abortifacient agents|mesh-ancestor
110226548|NCT05424445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110226549|NCT05424445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110226550|NCT05424445|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110226551|NCT05424445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110226553|NCT05423379|Everolimus|everolimus|mesh-list
110226554|NCT05423379|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110226555|NCT05423379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110226556|NCT05423379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110226557|NCT05423379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110226558|NCT05423379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110226559|NCT05423379|Immunologic Factors|immunologic factors|mesh-ancestor
110226560|NCT05423379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110226561|NCT05423379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110226562|NCT05407636|Aflibercept|aflibercept|mesh-list
110226563|NCT05407636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110226564|NCT05407636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110226565|NCT05407636|Growth Substances|growth substances|mesh-ancestor
110226566|NCT05407636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110226567|NCT05407636|Growth Inhibitors|growth inhibitors|mesh-ancestor
110226568|NCT05407636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110226569|NCT05406700|Niraparib|niraparib|mesh-list
110261690|NCT00170664|Paclitaxel|paclitaxel|mesh-list
110226570|NCT05406700|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110226571|NCT05406700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110226572|NCT05406700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110226573|NCT05406700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110226574|NCT05405452|Ethyl Chloride|ethyl chloride|mesh-list
110226575|NCT05405452|Anesthetics|anesthetics|mesh-ancestor
110226576|NCT05405452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110226577|NCT05405452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110226578|NCT05405452|Anesthetics, Local|anesthetics, local|mesh-ancestor
110226579|NCT05405452|Sensory System Agents|sensory system agents|mesh-ancestor
110226580|NCT05405452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110226581|NCT05401916|Acetaminophen|acetaminophen|mesh-list
110226582|NCT05401916|Ibuprofen|ibuprofen|mesh-list
110226583|NCT05401916|Tramadol|tramadol|mesh-list
110226584|NCT05401916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110261892|NCT00171015|Valsartan|valsartan|mesh-list
110226585|NCT05401916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110226586|NCT05401916|Analgesics|analgesics|mesh-ancestor
110226587|NCT05401916|Sensory System Agents|sensory system agents|mesh-ancestor
110226603|NCT05400265|Immunologic Factors|immunologic factors|mesh-ancestor
110226604|NCT05400265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110226605|NCT05400265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110262094|NCT05774405|Estradiol|estradiol|mesh-list
110226606|NCT05400109|Cyclophosphamide|cyclophosphamide|mesh-list
110226608|NCT05400109|Fludarabine phosphate|fludarabine phosphate|mesh-list
110226609|NCT05400109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110226610|NCT05400109|Immunologic Factors|immunologic factors|mesh-ancestor
110226611|NCT05400109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110226612|NCT05400109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110226613|NCT05400109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110226614|NCT05400109|Alkylating Agents|alkylating agents|mesh-ancestor
110226615|NCT05400109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110226616|NCT05400109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110226617|NCT05400109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110226618|NCT05400109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110226619|NCT05400109|Antimetabolites|antimetabolites|mesh-ancestor
110226620|NCT05384691|Luspatercept|luspatercept|mesh-list
110226621|NCT05384691|Hematinics|hematinics|mesh-ancestor
110226622|NCT05384496|Nivolumab|nivolumab|mesh-list
110226623|NCT05384496|Ipilimumab|ipilimumab|mesh-list
110226624|NCT05384496|Axitinib|axitinib|mesh-list
110226625|NCT05384496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110226626|NCT05384496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110226627|NCT05384496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110226628|NCT05384496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110226629|NCT05384496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110226661|NCT05382650|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110226662|NCT05382650|Immunologic Factors|immunologic factors|mesh-ancestor
110262549|NCT04173585|Bortezomib|bortezomib|mesh-list
110226663|NCT05382650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262762|NCT03283150|Anesthetics|anesthetics|mesh-ancestor
110226686|NCT05375903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110226687|NCT05375903|Antimetabolites|antimetabolites|mesh-ancestor
110226688|NCT05375903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110226689|NCT05375903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110226690|NCT05375903|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110226691|NCT05375903|Immunologic Factors|immunologic factors|mesh-ancestor
110226692|NCT05375903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110226693|NCT05375903|Interferon Inducers|interferon inducers|mesh-ancestor
110226695|NCT05375084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110226696|NCT05375084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110226697|NCT05375084|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110226698|NCT05375084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110226700|NCT05370885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110226701|NCT05370885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110226702|NCT05362760|Fulvestrant|fulvestrant|mesh-list
110226703|NCT05362760|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110226704|NCT05362760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110226705|NCT05362760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110226706|NCT05362760|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110226707|NCT05362760|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110226708|NCT05362760|Hormone Antagonists|hormone antagonists|mesh-ancestor
110226709|NCT05362760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110226710|NCT05362760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110226711|NCT05362760|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110226712|NCT05362760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110226713|NCT05362760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110226714|NCT05357482|Sirolimus|sirolimus|mesh-list
110226715|NCT05357482|Plerixafor|plerixafor|mesh-list
110226716|NCT05357482|Alemtuzumab|alemtuzumab|mesh-list
110226717|NCT05357482|Hydroxyurea|hydroxyurea|mesh-list
110226718|NCT05357482|Immunologic Factors|immunologic factors|mesh-ancestor
110226719|NCT05357482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110226720|NCT05357482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110226721|NCT05357482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110226722|NCT05357482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110226723|NCT05357482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110226724|NCT05357482|Antifungal Agents|antifungal agents|mesh-ancestor
110226725|NCT05357482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110226726|NCT05357482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110226727|NCT05357482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110226728|NCT05357482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110226729|NCT05357482|Antisickling Agents|antisickling agents|mesh-ancestor
110226730|NCT05357482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110226731|NCT05357482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110226732|NCT05357482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110226733|NCT05357482|Antiviral Agents|antiviral agents|mesh-ancestor
110226735|NCT05356741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110226736|NCT05356741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110226737|NCT05356741|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110226738|NCT05356741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110226739|NCT05346354|Ravulizumab|ravulizumab|mesh-list
110226740|NCT05346354|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110226741|NCT05346354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110226742|NCT05346354|Immunologic Factors|immunologic factors|mesh-ancestor
110226743|NCT05346354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110226744|NCT05342636|Paclitaxel|paclitaxel|mesh-list
110226745|NCT05342636|Pembrolizumab|pembrolizumab|mesh-list
110226746|NCT05342636|Irinotecan|irinotecan|mesh-list
110226747|NCT05342636|Lenvatinib|lenvatinib|mesh-list
110226748|NCT05342636|Immunoglobulins|immunoglobulins|mesh-list
110226749|NCT05342636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110226750|NCT05342636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110226751|NCT05342636|Tubulin Modulators|tubulin modulators|mesh-ancestor
110226752|NCT05342636|Antimitotic Agents|antimitotic agents|mesh-ancestor
110226753|NCT05342636|Mitosis Modulators|mitosis modulators|mesh-ancestor
110226754|NCT05342636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110226755|NCT05342636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110226756|NCT05342636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110226757|NCT05342636|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110226758|NCT05342636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110226759|NCT05342636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110226760|NCT05342636|Immunologic Factors|immunologic factors|mesh-ancestor
110226761|NCT05342636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110226762|NCT05342636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110226763|NCT05342519|Sirolimus|sirolimus|mesh-list
110226764|NCT05342519|Temsirolimus|temsirolimus|mesh-list
110226765|NCT05342519|MTOR Inhibitors|mtor inhibitors|mesh-list
110226766|NCT05342519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110226767|NCT05342519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110226768|NCT05342519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110226769|NCT05342519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110226770|NCT05342519|Antifungal Agents|antifungal agents|mesh-ancestor
110226772|NCT05342519|Immunologic Factors|immunologic factors|mesh-ancestor
110226773|NCT05342519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110226774|NCT05342519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110226775|NCT05342519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110226776|NCT05342519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110226777|NCT05338970|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
110226778|NCT05338970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110226779|NCT05338970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110226780|NCT05331664|Moxifloxacin|moxifloxacin|mesh-list
110226781|NCT05331664|Polymyxins|polymyxins|mesh-list
110226782|NCT05331664|Trimethoprim|trimethoprim|mesh-list
110226783|NCT05331664|Prednisolone|prednisolone|mesh-list
110226784|NCT05331664|Prednisolone acetate|prednisolone acetate|mesh-list
110226785|NCT05331664|Triamcinolone|triamcinolone|mesh-list
110226786|NCT05331664|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110226787|NCT05331664|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110226788|NCT05331664|Atropine|atropine|mesh-list
110226789|NCT05331664|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110226790|NCT05331664|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110226793|NCT05331664|Hormones|hormones|mesh-ancestor
110226794|NCT05331664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110226795|NCT05331664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110226796|NCT05331664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110226798|NCT05331664|Autonomic Agents|autonomic agents|mesh-ancestor
110226799|NCT05331664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110226800|NCT05331664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110226801|NCT05331664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110226802|NCT05331664|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110226803|NCT05331664|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110226804|NCT05331664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110226805|NCT05331664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110226806|NCT05331664|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110226807|NCT05331664|Contraceptive Agents|contraceptive agents|mesh-ancestor
110226808|NCT05331664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110226809|NCT05331664|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110226810|NCT05331664|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110226811|NCT05331664|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110226812|NCT05331664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110226813|NCT05331664|Immunologic Factors|immunologic factors|mesh-ancestor
110226814|NCT05331664|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110226815|NCT05331664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110226816|NCT05331664|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110226817|NCT05331664|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110226818|NCT05331664|Respiratory System Agents|respiratory system agents|mesh-ancestor
110226820|NCT05331664|Parasympatholytics|parasympatholytics|mesh-ancestor
110226821|NCT05331664|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110226822|NCT05331664|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110226823|NCT05331664|Cholinergic Agents|cholinergic agents|mesh-ancestor
110226824|NCT05331664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110226825|NCT05331664|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110226826|NCT05331664|Antimalarials|antimalarials|mesh-ancestor
110226827|NCT05331664|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110226828|NCT05331664|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110226829|NCT05331664|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110226830|NCT05331664|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110226831|NCT05331664|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110226832|NCT05331664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110226834|NCT05321940|Vaccines|vaccines|mesh-list
110226835|NCT05321940|Immunologic Factors|immunologic factors|mesh-ancestor
110226836|NCT05321940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110226837|NCT05321940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110226838|NCT05321940|Antiviral Agents|antiviral agents|mesh-ancestor
110226839|NCT05321940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110226840|NCT05307874|Aldesleukin|aldesleukin|mesh-list
110226841|NCT05307874|Pembrolizumab|pembrolizumab|mesh-list
110226842|NCT05307874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110226843|NCT05307874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110226844|NCT05307874|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110226845|NCT05307874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110226846|NCT05307874|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110226847|NCT05307874|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110226848|NCT05307874|Antiviral Agents|antiviral agents|mesh-ancestor
110226849|NCT05307874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110226850|NCT05290129|Oxytocin|oxytocin|mesh-list
110226851|NCT05290129|Oxytocics|oxytocics|mesh-ancestor
110226852|NCT05290129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110226855|NCT05289830|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110226856|NCT05289830|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110226857|NCT05289830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110226858|NCT05289830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110226859|NCT05289830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110226860|NCT05289830|Serotonin Agents|serotonin agents|mesh-ancestor
110226861|NCT05289830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110226862|NCT05288023|Azithromycin|azithromycin|mesh-list
110226863|NCT05288023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110226864|NCT05288023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110226865|NCT05280405|Infliximab|infliximab|mesh-list
110226866|NCT05280405|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110226867|NCT05280405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110226868|NCT05280405|Dermatologic Agents|dermatologic agents|mesh-ancestor
110226869|NCT05280405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110226871|NCT05275439|Azacitidine|azacitidine|mesh-list
110226872|NCT05275439|Venetoclax|venetoclax|mesh-list
110226873|NCT05275439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110226874|NCT05275439|Antimetabolites|antimetabolites|mesh-ancestor
110226875|NCT05275439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110226876|NCT05275439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110226877|NCT05275439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110226878|NCT05263284|Venetoclax|venetoclax|mesh-list
110226879|NCT05263284|Adenosine|adenosine|mesh-list
110053664|NCT01487993|Metformin|metformin|mesh-list
110226880|NCT05263284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110226881|NCT05263284|Analgesics|analgesics|mesh-ancestor
110226882|NCT05263284|Sensory System Agents|sensory system agents|mesh-ancestor
110226883|NCT05263284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110226884|NCT05263284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110226885|NCT05263284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110226886|NCT05263284|Vasodilator Agents|vasodilator agents|mesh-ancestor
110226887|NCT05263284|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110226888|NCT05263284|Purinergic Agonists|purinergic agonists|mesh-ancestor
110226889|NCT05263284|Purinergic Agents|purinergic agents|mesh-ancestor
110226890|NCT05263284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110226891|NCT05263284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110226892|NCT05260008|Epinephrine|epinephrine|mesh-list
110226893|NCT05260008|Bupivacaine|bupivacaine|mesh-list
110226894|NCT05260008|Anesthetics, Local|anesthetics, local|mesh-ancestor
110226895|NCT05260008|Anesthetics|anesthetics|mesh-ancestor
110226896|NCT05260008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110226897|NCT05260008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110226898|NCT05260008|Sensory System Agents|sensory system agents|mesh-ancestor
110226899|NCT05260008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110226900|NCT05260008|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110226901|NCT05260008|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110226902|NCT05260008|Adrenergic Agents|adrenergic agents|mesh-ancestor
110226903|NCT05260008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110226904|NCT05260008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263256|NCT00150449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110226908|NCT05260008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110226909|NCT05260008|Respiratory System Agents|respiratory system agents|mesh-ancestor
110226910|NCT05260008|Mydriatics|mydriatics|mesh-ancestor
110226911|NCT05260008|Sympathomimetics|sympathomimetics|mesh-ancestor
110226912|NCT05260008|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110226913|NCT05253209|Plasma-lyte 148|plasma-lyte 148|mesh-list
110226914|NCT05253209|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110226915|NCT05253209|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110226916|NCT05227742|Psilocybin|psilocybin|mesh-list
110226917|NCT05227742|Hallucinogens|hallucinogens|mesh-ancestor
110226918|NCT05227742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110226919|NCT05227742|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110226920|NCT05221749|Fluorides|fluorides|mesh-list
110226921|NCT05221749|Cariostatic Agents|cariostatic agents|mesh-ancestor
110226922|NCT05221749|Protective Agents|protective agents|mesh-ancestor
110226923|NCT05221749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110226927|NCT05190471|Decitabine|decitabine|mesh-list
110226929|NCT05190471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110226930|NCT05190471|Antimetabolites|antimetabolites|mesh-ancestor
110226931|NCT05190471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110226932|NCT05190471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110226933|NCT05190471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110226934|NCT05186974|Carboplatin|carboplatin|mesh-list
110226935|NCT05186974|Pembrolizumab|pembrolizumab|mesh-list
110226936|NCT05186974|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
110226937|NCT05186974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110226938|NCT05186974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110226939|NCT05186974|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110226940|NCT05186974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110226941|NCT05186974|Immunoconjugates|immunoconjugates|mesh-ancestor
110226942|NCT05186974|Immunologic Factors|immunologic factors|mesh-ancestor
110226943|NCT05186974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110226944|NCT05182151|Istradefylline|istradefylline|mesh-list
110226945|NCT05182151|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
110226946|NCT05182151|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110226947|NCT05182151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110226948|NCT05182151|Purinergic Agents|purinergic agents|mesh-ancestor
110226949|NCT05182151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110226950|NCT05182151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110226951|NCT05182151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110226952|NCT05171777|Atezolizumab|atezolizumab|mesh-list
110226953|NCT05171777|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110226954|NCT05171777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110226955|NCT05171777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110226956|NCT05171777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110226957|NCT05170204|Durvalumab|durvalumab|mesh-list
110226958|NCT05170204|Pralsetinib|pralsetinib|mesh-list
110226959|NCT05170204|Entrectinib|entrectinib|mesh-list
110226960|NCT05170204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110226961|NCT05170204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110226962|NCT05170204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110226963|NCT05170204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110226964|NCT05170204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110226965|NCT05151744|Ranibizumab|ranibizumab|mesh-list
110226966|NCT05151744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110226967|NCT05151744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110226968|NCT05151744|Growth Substances|growth substances|mesh-ancestor
110226969|NCT05151744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110226970|NCT05151744|Growth Inhibitors|growth inhibitors|mesh-ancestor
110226971|NCT05151744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110226972|NCT05139121|Contraceptive Agents|contraceptive agents|mesh-list
110226973|NCT05139121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110226974|NCT05139121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110226975|NCT05137067|Cisplatin|cisplatin|mesh-list
110226976|NCT05137067|Docetaxel|docetaxel|mesh-list
110226977|NCT05137067|Antineoplastic Agents|antineoplastic agents|mesh-list
110226978|NCT05137067|Tubulin Modulators|tubulin modulators|mesh-ancestor
110226979|NCT05137067|Antimitotic Agents|antimitotic agents|mesh-ancestor
110226980|NCT05137067|Mitosis Modulators|mitosis modulators|mesh-ancestor
110227005|NCT05068791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110227006|NCT05068791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110227007|NCT05068791|Antitussive Agents|antitussive agents|mesh-ancestor
110227008|NCT05068791|Respiratory System Agents|respiratory system agents|mesh-ancestor
110227009|NCT05068791|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110227010|NCT05068791|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110227011|NCT05068791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110227012|NCT05068791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110227013|NCT05065918|Ethanol|ethanol|mesh-list
110227014|NCT05065918|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110227015|NCT05065918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110227016|NCT05065918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110227017|NCT05065918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110227018|NCT05065424|Atropine|atropine|mesh-list
110227019|NCT05065424|Fentanyl|fentanyl|mesh-list
110227020|NCT05065424|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110227022|NCT05065424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110227023|NCT05065424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110227025|NCT05065424|Sensory System Agents|sensory system agents|mesh-ancestor
110227026|NCT05065424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110227027|NCT05065424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110227028|NCT05065424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110227029|NCT05065424|Anesthetics, General|anesthetics, general|mesh-ancestor
110227030|NCT05065424|Anesthetics|anesthetics|mesh-ancestor
110227031|NCT05065424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110227032|NCT05065424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110227033|NCT05065424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110227034|NCT05065424|Autonomic Agents|autonomic agents|mesh-ancestor
110227035|NCT05065424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110227044|NCT05063734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110227045|NCT05063734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110227046|NCT05063734|Growth Substances|growth substances|mesh-ancestor
110227047|NCT05063734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110227048|NCT05063734|Growth Inhibitors|growth inhibitors|mesh-ancestor
110227049|NCT05063734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110227054|NCT05062083|11C-PS13|11c-ps13|mesh-list
110227055|NCT05062083|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110227056|NCT05062083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110227058|NCT05061134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110227059|NCT05061134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110227060|NCT05060822|Pirfenidone|pirfenidone|mesh-list
110227061|NCT05060822|Analgesics|analgesics|mesh-ancestor
110227062|NCT05060822|Sensory System Agents|sensory system agents|mesh-ancestor
110227063|NCT05060822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110227064|NCT05060822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110227065|NCT05060822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110227066|NCT05060822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110227067|NCT05060822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110227068|NCT05060822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110227069|NCT05060822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110227070|NCT05057494|Venetoclax|venetoclax|mesh-list
110227071|NCT05057494|Obinutuzumab|obinutuzumab|mesh-list
110227072|NCT05057494|Acalabrutinib|acalabrutinib|mesh-list
110227073|NCT05057494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110227074|NCT05057494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110227076|NCT05050916|Vitamins|vitamins|mesh-ancestor
110227077|NCT05050916|Micronutrients|micronutrients|mesh-ancestor
110227078|NCT05050916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110227079|NCT05050916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110227080|NCT05046795|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110227081|NCT05045612|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110227082|NCT05045612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110227083|NCT05035407|Aldesleukin|aldesleukin|mesh-list
110227084|NCT05035407|Cyclophosphamide|cyclophosphamide|mesh-list
110227085|NCT05035407|Fludarabine|fludarabine|mesh-list
110227086|NCT05035407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110227087|NCT05035407|Immunologic Factors|immunologic factors|mesh-ancestor
110227088|NCT05035407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110227089|NCT05035407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110227090|NCT05035407|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110227091|NCT05035407|Alkylating Agents|alkylating agents|mesh-ancestor
110227092|NCT05035407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110227094|NCT05035407|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110227096|NCT05035407|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110227097|NCT05035407|Antiviral Agents|antiviral agents|mesh-ancestor
110227098|NCT05035407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110227099|NCT05011383|Testosterone|testosterone|mesh-list
110227100|NCT05011383|Androgens|androgens|mesh-list
110227101|NCT05011383|Hormones|hormones|mesh-ancestor
110227102|NCT05011383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110227103|NCT05011383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110227104|NCT05003895|Cyclophosphamide|cyclophosphamide|mesh-list
110227105|NCT05003895|Fludarabine|fludarabine|mesh-list
110227106|NCT05003895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110227107|NCT05003895|Immunologic Factors|immunologic factors|mesh-ancestor
110227108|NCT05003895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110227109|NCT05003895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110227110|NCT05003895|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110227111|NCT05003895|Alkylating Agents|alkylating agents|mesh-ancestor
110227112|NCT05003895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110227113|NCT05003895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110227114|NCT05003895|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110227115|NCT04999761|Bevacizumab|bevacizumab|mesh-list
110227116|NCT04999761|Ramucirumab|ramucirumab|mesh-list
110227117|NCT04999761|Futibatinib|futibatinib|mesh-list
110227118|NCT04999761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110227119|NCT04999761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110227120|NCT04999761|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110227121|NCT04999761|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110227122|NCT04999761|Growth Substances|growth substances|mesh-ancestor
110227123|NCT04999761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110227124|NCT04999761|Growth Inhibitors|growth inhibitors|mesh-ancestor
110227125|NCT04989491|Rituximab|rituximab|mesh-list
110227126|NCT04989491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110227127|NCT04989491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110227128|NCT04989491|Immunologic Factors|immunologic factors|mesh-ancestor
110227129|NCT04989491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110227130|NCT04989491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110227131|NCT04984369|Cetuximab|cetuximab|mesh-list
110227132|NCT04984369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110227133|NCT04984369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110227134|NCT04981158|Anesthetics|anesthetics|mesh-list
110227135|NCT04981158|Anesthetics, General|anesthetics, general|mesh-list
110227136|NCT04981158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110227137|NCT04981158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110227138|NCT04969887|Nivolumab|nivolumab|mesh-list
110227139|NCT04969887|Ipilimumab|ipilimumab|mesh-list
110227140|NCT04969887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110227141|NCT04969887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110227142|NCT04969887|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110227143|NCT04969887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110227144|NCT04965389|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110227145|NCT04938765|Magnesium Sulfate|magnesium sulfate|mesh-list
110227146|NCT04938765|Analgesics|analgesics|mesh-ancestor
110227147|NCT04938765|Sensory System Agents|sensory system agents|mesh-ancestor
110227148|NCT04938765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110227149|NCT04938765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110227150|NCT04938765|Anesthetics|anesthetics|mesh-ancestor
110227151|NCT04938765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110227152|NCT04938765|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110227155|NCT04938765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110227156|NCT04938765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110227157|NCT04938765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110227158|NCT04938765|Tocolytic Agents|tocolytic agents|mesh-ancestor
110227159|NCT04938765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110227160|NCT04935931|Naltrexone|naltrexone|mesh-list
110227161|NCT04935931|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110227162|NCT04935931|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110227163|NCT04935931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110227164|NCT04935931|Sensory System Agents|sensory system agents|mesh-ancestor
110227165|NCT04935931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110227166|NCT04933227|Capecitabine|capecitabine|mesh-list
110227167|NCT04933227|Oxaliplatin|oxaliplatin|mesh-list
110227168|NCT04933227|Atezolizumab|atezolizumab|mesh-list
110227169|NCT04933227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110227170|NCT04933227|Antimetabolites|antimetabolites|mesh-ancestor
110227171|NCT04933227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110227172|NCT04933227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110227173|NCT04933227|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110227174|NCT04933227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110227176|NCT04926181|Hormones|hormones|mesh-ancestor
110227177|NCT04926181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110227178|NCT04926181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110227179|NCT04923542|Hormones|hormones|mesh-list
110227180|NCT04923542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110227181|NCT04923542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110227182|NCT04921189|Ascorbic Acid|ascorbic acid|mesh-list
110227183|NCT04921189|Thiamine|thiamine|mesh-list
110227184|NCT04921189|Hydrocortisone|hydrocortisone|mesh-list
110227185|NCT04921189|Antioxidants|antioxidants|mesh-ancestor
110227186|NCT04921189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110227187|NCT04921189|Protective Agents|protective agents|mesh-ancestor
110227188|NCT04921189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110227189|NCT04921189|Vitamins|vitamins|mesh-ancestor
110227190|NCT04921189|Micronutrients|micronutrients|mesh-ancestor
110227191|NCT04921189|Vitamin B Complex|vitamin b complex|mesh-ancestor
110227192|NCT04921189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110227193|NCT04905277|Atenolol|atenolol|mesh-list
110227194|NCT04905277|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110227195|NCT04905277|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110227196|NCT04905277|Sympatholytics|sympatholytics|mesh-ancestor
110227197|NCT04905277|Autonomic Agents|autonomic agents|mesh-ancestor
110227198|NCT04905277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110227199|NCT04905277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110227200|NCT04905277|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110227201|NCT04905277|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110227202|NCT04905277|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110227203|NCT04905277|Adrenergic Agents|adrenergic agents|mesh-ancestor
110227204|NCT04905277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110227205|NCT04905277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110227207|NCT04887935|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110227208|NCT04887935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110227209|NCT04887935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110227210|NCT04887935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110227211|NCT04885998|AMG 757|amg 757|mesh-list
110227212|NCT04885998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110227213|NCT04885530|Metformin|metformin|mesh-list
110227214|NCT04885530|Fluticasone|fluticasone|mesh-list
110227215|NCT04885530|Xhance|xhance|mesh-list
110227216|NCT04885530|Ivermectin|ivermectin|mesh-list
110227217|NCT04885530|Fluvoxamine|fluvoxamine|mesh-list
110227218|NCT04885530|Montelukast|montelukast|mesh-list
110227219|NCT04885530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110227220|NCT04885530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110227221|NCT04885530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110053962|NCT01489631|Sufentanil|sufentanil|mesh-list
110227222|NCT04885530|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110227223|NCT04885530|Autonomic Agents|autonomic agents|mesh-ancestor
110227224|NCT04885530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110227225|NCT04885530|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110227226|NCT04885530|Respiratory System Agents|respiratory system agents|mesh-ancestor
110227227|NCT04885530|Dermatologic Agents|dermatologic agents|mesh-ancestor
110227228|NCT04885530|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110227229|NCT04885530|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110227230|NCT04885530|Hormone Antagonists|hormone antagonists|mesh-ancestor
110227231|NCT04885530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110227232|NCT04885530|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110227233|NCT04885530|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110227234|NCT04885530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110227235|NCT04885530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110227236|NCT04885530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110227237|NCT04885530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110227238|NCT04885530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110227239|NCT04885530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110227240|NCT04885530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110227241|NCT04885530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110227242|NCT04885530|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110227243|NCT04885530|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110227244|NCT04885530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110227245|NCT04885530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110227247|NCT04885530|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110227248|NCT04885530|Antidepressive Agents|antidepressive agents|mesh-ancestor
110227249|NCT04885530|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110227250|NCT04885530|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110227251|NCT04885530|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110227252|NCT04872790|Prednisone|prednisone|mesh-list
110227253|NCT04872790|Cortisone|cortisone|mesh-list
110227254|NCT04872790|Rituximab|rituximab|mesh-list
110227255|NCT04872790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110227256|NCT04872790|Methotrexate|methotrexate|mesh-list
110227257|NCT04872790|Venetoclax|venetoclax|mesh-list
110227258|NCT04872790|Dasatinib|dasatinib|mesh-list
110227259|NCT04872790|Antibodies|antibodies|mesh-list
110227260|NCT04872790|Immunoglobulins|immunoglobulins|mesh-list
110227261|NCT04872790|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110227262|NCT04872790|Immunologic Factors|immunologic factors|mesh-ancestor
110227263|NCT04872790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110227264|NCT04872790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110227265|NCT04872790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110227266|NCT04872790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110227267|NCT04872790|Glucocorticoids|glucocorticoids|mesh-ancestor
110227268|NCT04872790|Hormones|hormones|mesh-ancestor
110227269|NCT04872790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110227270|NCT04872790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110227271|NCT04872790|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110227272|NCT04872790|Abortifacient Agents|abortifacient agents|mesh-ancestor
110227273|NCT04872790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110227274|NCT04872790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110227275|NCT04872790|Antimetabolites|antimetabolites|mesh-ancestor
110227276|NCT04872790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110227278|NCT04872790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110227279|NCT04872790|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110227280|NCT04872790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110227281|NCT04872790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110227282|NCT04872790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110227283|NCT04856215|Antibodies|antibodies|mesh-list
110227284|NCT04856215|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110227285|NCT04856215|Immunologic Factors|immunologic factors|mesh-ancestor
110227286|NCT04856215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110227287|NCT04843111|Vaccines|vaccines|mesh-list
110227288|NCT04843111|Immunologic Factors|immunologic factors|mesh-ancestor
110227289|NCT04843111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110227290|NCT04838769|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
110227291|NCT04838769|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
110227292|NCT04838769|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110227293|NCT04838769|Adrenergic Agents|adrenergic agents|mesh-ancestor
110227294|NCT04838769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110263395|NCT00164112|Telithromycin|telithromycin|mesh-list
110227295|NCT04838769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110227296|NCT04838769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110227297|NCT04838769|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110227298|NCT04838769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110227299|NCT04838769|Hormone Antagonists|hormone antagonists|mesh-ancestor
110227300|NCT04838769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110227301|NCT04837196|Pembrolizumab|pembrolizumab|mesh-list
110227302|NCT04837196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110227303|NCT04837196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110227304|NCT04837196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110227305|NCT04837196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110227306|NCT04808843|Dienogest|dienogest|mesh-list
110227307|NCT04808843|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110227308|NCT04808843|Contraceptive Agents|contraceptive agents|mesh-ancestor
110227309|NCT04808843|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110227310|NCT04808843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110227311|NCT04808843|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110227312|NCT04808843|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110227313|NCT04808843|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110227314|NCT04808843|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110227315|NCT04808843|Hormone Antagonists|hormone antagonists|mesh-ancestor
110227316|NCT04808843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110227317|NCT04808843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110227318|NCT04808843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110227319|NCT04802837|Vancomycin|vancomycin|mesh-list
110227320|NCT04802837|Ridinilazole|ridinilazole|mesh-list
110227321|NCT04802837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110227322|NCT04802837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110227323|NCT04798612|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110227324|NCT04798612|Antiviral Agents|antiviral agents|mesh-ancestor
110227325|NCT04798612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110227326|NCT04796012|Irinotecan|irinotecan|mesh-list
110227327|NCT04796012|Vincristine|vincristine|mesh-list
110227328|NCT04796012|Temozolomide|temozolomide|mesh-list
110227329|NCT04796012|Atezolizumab|atezolizumab|mesh-list
110227330|NCT04796012|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110227331|NCT04796012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110227332|NCT04796012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110227333|NCT04796012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110227334|NCT04796012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110227335|NCT04796012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110227336|NCT04796012|Tubulin Modulators|tubulin modulators|mesh-ancestor
110227337|NCT04796012|Antimitotic Agents|antimitotic agents|mesh-ancestor
110227338|NCT04796012|Mitosis Modulators|mitosis modulators|mesh-ancestor
110227339|NCT04796012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110227340|NCT04796012|Alkylating Agents|alkylating agents|mesh-ancestor
110227341|NCT04796012|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110227342|NCT04796012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110227343|NCT04768881|Pembrolizumab|pembrolizumab|mesh-list
110227344|NCT04768881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110227345|NCT04768881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110227346|NCT04768881|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110227347|NCT04768881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110227348|NCT04765202|Carisoprodol|carisoprodol|mesh-list
110227349|NCT04765202|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110227350|NCT04765202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110227351|NCT04765202|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110227352|NCT04765202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110227353|NCT04757883|Antibodies|antibodies|mesh-list
110227354|NCT04757883|Immunologic Factors|immunologic factors|mesh-ancestor
110227355|NCT04757883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110227356|NCT04739761|Trastuzumab|trastuzumab|mesh-list
110227357|NCT04739761|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
110227358|NCT04739761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110227359|NCT04739761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110227360|NCT04739761|Immunoconjugates|immunoconjugates|mesh-ancestor
110227361|NCT04739761|Immunologic Factors|immunologic factors|mesh-ancestor
110227362|NCT04739761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110227363|NCT04736199|Androgens|androgens|mesh-list
110227364|NCT04736199|Hormones|hormones|mesh-ancestor
110227365|NCT04736199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110054111|NCT01490047|Etanercept|etanercept|mesh-list
110227366|NCT04736199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110227367|NCT04722172|Obinutuzumab|obinutuzumab|mesh-list
110227368|NCT04722172|Acalabrutinib|acalabrutinib|mesh-list
110227369|NCT04722172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110227370|NCT04722172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110227371|NCT04721353|Prazosin|prazosin|mesh-list
110227372|NCT04721353|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110227373|NCT04721353|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110227374|NCT04721353|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110227375|NCT04721353|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110227376|NCT04721353|Adrenergic Agents|adrenergic agents|mesh-ancestor
110227377|NCT04721353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110227378|NCT04721353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110227379|NCT04721353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110227380|NCT04712942|Azacitidine|azacitidine|mesh-list
110227381|NCT04712942|Pevonedistat|pevonedistat|mesh-list
110227382|NCT04712942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110227383|NCT04712942|Antimetabolites|antimetabolites|mesh-ancestor
110227384|NCT04712942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110227385|NCT04712942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110227386|NCT04712942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110227387|NCT04708145|Aflibercept|aflibercept|mesh-list
110227388|NCT04708145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110227389|NCT04708145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110227390|NCT04708145|Growth Substances|growth substances|mesh-ancestor
110227391|NCT04708145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110227392|NCT04708145|Growth Inhibitors|growth inhibitors|mesh-ancestor
110227393|NCT04708145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110227394|NCT04708067|Atezolizumab|atezolizumab|mesh-list
110227396|NCT04708067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110227397|NCT04708067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110227398|NCT04708067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110227399|NCT04694846|Bupropion|bupropion|mesh-list
110227400|NCT04694846|Nicotine|nicotine|mesh-list
110227401|NCT04694846|Varenicline|varenicline|mesh-list
110227402|NCT04694846|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110227403|NCT04694846|Autonomic Agents|autonomic agents|mesh-ancestor
110227404|NCT04694846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110227405|NCT04694846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110227406|NCT04694846|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110227407|NCT04694846|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110227408|NCT04694846|Cholinergic Agents|cholinergic agents|mesh-ancestor
110227409|NCT04694846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110227410|NCT04694846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110227411|NCT04694846|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110227412|NCT04694846|Antidepressive Agents|antidepressive agents|mesh-ancestor
110227413|NCT04694846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110227414|NCT04694846|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110227415|NCT04694846|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110227416|NCT04694846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110227417|NCT04694846|Dopamine Agents|dopamine agents|mesh-ancestor
110227418|NCT04694846|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110227419|NCT04694846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110227420|NCT04694846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110227421|NCT04692103|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110227422|NCT04692103|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110227423|NCT04692103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110227425|NCT04680052|Lenalidomide|lenalidomide|mesh-list
110227426|NCT04680052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110227428|NCT04680052|Immunologic Factors|immunologic factors|mesh-ancestor
110227429|NCT04680052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110227430|NCT04680052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110227431|NCT04680052|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110227432|NCT04680052|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110227433|NCT04680052|Growth Substances|growth substances|mesh-ancestor
110227434|NCT04680052|Growth Inhibitors|growth inhibitors|mesh-ancestor
110227435|NCT04671615|Palbociclib|palbociclib|mesh-list
110227436|NCT04671615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110227437|NCT04671615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110227438|NCT04671615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110227439|NCT04671615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110227440|NCT04665843|Atezolizumab|atezolizumab|mesh-list
110227441|NCT04665843|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110227442|NCT04665843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110227443|NCT04665843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110227444|NCT04665843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110227445|NCT04661150|Capecitabine|capecitabine|mesh-list
110227446|NCT04661150|Oxaliplatin|oxaliplatin|mesh-list
110227447|NCT04661150|Trastuzumab|trastuzumab|mesh-list
110227448|NCT04661150|Atezolizumab|atezolizumab|mesh-list
110227449|NCT04661150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110227450|NCT04661150|Antimetabolites|antimetabolites|mesh-ancestor
110227451|NCT04661150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110227452|NCT04661150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110227453|NCT04661150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110227454|NCT04661150|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110227455|NCT04659382|Bevacizumab|bevacizumab|mesh-list
110227456|NCT04659382|Atezolizumab|atezolizumab|mesh-list
110227457|NCT04659382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110227458|NCT04659382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110227459|NCT04659382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110227460|NCT04659382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110227461|NCT04659382|Growth Substances|growth substances|mesh-ancestor
110227462|NCT04659382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110227463|NCT04659382|Growth Inhibitors|growth inhibitors|mesh-ancestor
110227464|NCT04659382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110227465|NCT04659382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110227467|NCT04652700|Emtricitabine|emtricitabine|mesh-list
110227468|NCT04652700|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110227469|NCT04652700|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
110227470|NCT04652700|Antiviral Agents|antiviral agents|mesh-ancestor
110227471|NCT04652700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110227472|NCT04652700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110227473|NCT04652700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110227474|NCT04652700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110227475|NCT04652700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110227476|NCT04652700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110227477|NCT04652700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110227478|NCT04651088|Potassium Citrate|potassium citrate|mesh-list
110227479|NCT04651088|Diuretics|diuretics|mesh-ancestor
110227480|NCT04651088|Natriuretic Agents|natriuretic agents|mesh-ancestor
110227481|NCT04651088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110227482|NCT04651088|Expectorants|expectorants|mesh-ancestor
110227483|NCT04651088|Respiratory System Agents|respiratory system agents|mesh-ancestor
110227484|NCT04647084|Lidocaine|lidocaine|mesh-list
110227485|NCT04647084|Anesthetics, Local|anesthetics, local|mesh-ancestor
110227486|NCT04647084|Anesthetics|anesthetics|mesh-ancestor
110227487|NCT04647084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110227488|NCT04647084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110227489|NCT04647084|Sensory System Agents|sensory system agents|mesh-ancestor
110227490|NCT04647084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110227491|NCT04647084|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110227492|NCT04647084|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110227493|NCT04647084|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110227494|NCT04647084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110227495|NCT04647084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110227496|NCT04643379|Carboplatin|carboplatin|mesh-list
110227497|NCT04643379|Pembrolizumab|pembrolizumab|mesh-list
110227498|NCT04643379|Olaparib|olaparib|mesh-list
110227499|NCT04643379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110227500|NCT04643379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110227501|NCT04643379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110263469|NCT00532168|Tenofovir|tenofovir|mesh-list
110227502|NCT04643379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110227503|NCT04643379|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110227504|NCT04643379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110227506|NCT04630756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110227508|NCT04630002|Darunavir|darunavir|mesh-list
110227509|NCT04630002|Etravirine|etravirine|mesh-list
110227510|NCT04630002|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110227511|NCT04630002|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110227512|NCT04630002|Protease Inhibitors|protease inhibitors|mesh-ancestor
110227513|NCT04630002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110227514|NCT04630002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110227515|NCT04630002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110227516|NCT04630002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110227517|NCT04630002|Antiviral Agents|antiviral agents|mesh-ancestor
110227518|NCT04630002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110227519|NCT04630002|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110227520|NCT04630002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110227521|NCT04630002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110227522|NCT04630002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110227523|NCT04612751|Carboplatin|carboplatin|mesh-list
110227524|NCT04612751|Durvalumab|durvalumab|mesh-list
110227525|NCT04612751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110227526|NCT04612751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110227527|NCT04609878|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110227528|NCT04609878|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110227529|NCT04609878|Respiratory System Agents|respiratory system agents|mesh-ancestor
110227530|NCT04605731|Durvalumab|durvalumab|mesh-list
110227531|NCT04605731|Ipilimumab|ipilimumab|mesh-list
110227532|NCT04605731|Tremelimumab|tremelimumab|mesh-list
110227533|NCT04605731|Immunoglobulins|immunoglobulins|mesh-list
110227534|NCT04605731|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110227535|NCT04605731|Immunoglobulin G|immunoglobulin g|mesh-list
110227536|NCT04605731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110227537|NCT04605731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110227538|NCT04605731|Immunologic Factors|immunologic factors|mesh-ancestor
110227539|NCT04605731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110227540|NCT04605731|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110227541|NCT04605731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110227542|NCT04605393|Dronabinol|dronabinol|mesh-list
110227543|NCT04605393|Cannabidiol|cannabidiol|mesh-list
110227544|NCT04605393|Anticonvulsants|anticonvulsants|mesh-ancestor
110227545|NCT04605393|Hallucinogens|hallucinogens|mesh-ancestor
110227546|NCT04605393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110227547|NCT04605393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110227548|NCT04605393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110227549|NCT04605393|Analgesics|analgesics|mesh-ancestor
110227550|NCT04605393|Sensory System Agents|sensory system agents|mesh-ancestor
110227551|NCT04605393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110227552|NCT04605393|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110227553|NCT04605393|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110227554|NCT04605393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110227555|NCT04605393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110227556|NCT04605393|Hormones|hormones|mesh-ancestor
110263497|NCT04723836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110227557|NCT04605393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110227558|NCT04587427|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
110227559|NCT04587427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110227561|NCT04574778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110227562|NCT04574778|Analgesics|analgesics|mesh-ancestor
110227563|NCT04574778|Sensory System Agents|sensory system agents|mesh-ancestor
110227564|NCT04574778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110227565|NCT04574778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110227566|NCT04574778|Antipyretics|antipyretics|mesh-ancestor
110227567|NCT04569747|Tamoxifen|tamoxifen|mesh-list
110227568|NCT04569747|Trastuzumab|trastuzumab|mesh-list
110227569|NCT04569747|Pertuzumab|pertuzumab|mesh-list
110227570|NCT04569747|Letrozole|letrozole|mesh-list
110227571|NCT04569747|Anastrozole|anastrozole|mesh-list
110227572|NCT04569747|Leuprolide|leuprolide|mesh-list
110227573|NCT04569747|Exemestane|exemestane|mesh-list
110227574|NCT04569747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110227575|NCT04569747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110227576|NCT04569747|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110227577|NCT04569747|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110227579|NCT04569747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110227580|NCT04569747|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110227581|NCT04569747|Hormone Antagonists|hormone antagonists|mesh-ancestor
110227582|NCT04569747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110227583|NCT04569747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110227584|NCT04569747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110227585|NCT04569747|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110054339|NCT01491048|Autonomic Agents|autonomic agents|mesh-ancestor
110227586|NCT04569747|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110227587|NCT04569747|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110227588|NCT04569747|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110227590|NCT04569747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110227591|NCT04566133|Hydroxychloroquine|hydroxychloroquine|mesh-list
110227592|NCT04566133|Trametinib|trametinib|mesh-list
110227593|NCT04566133|Antimalarials|antimalarials|mesh-ancestor
110227594|NCT04566133|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110227595|NCT04566133|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110227596|NCT04566133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110227597|NCT04566133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110227598|NCT04566133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110227599|NCT04566133|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110227600|NCT04566133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110227601|NCT04566133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110227602|NCT04558736|Cyclophosphamide|cyclophosphamide|mesh-list
110227603|NCT04558736|Fludarabine|fludarabine|mesh-list
110227604|NCT04558736|Thymoglobulin|thymoglobulin|mesh-list
110227605|NCT04558736|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110227606|NCT04558736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110227607|NCT04558736|Immunologic Factors|immunologic factors|mesh-ancestor
110227608|NCT04558736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110227609|NCT04558736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110227610|NCT04558736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110227611|NCT04558736|Alkylating Agents|alkylating agents|mesh-ancestor
110227612|NCT04558736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110227613|NCT04558736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110227614|NCT04558736|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110227615|NCT04533451|Carboplatin|carboplatin|mesh-list
110227616|NCT04533451|Pembrolizumab|pembrolizumab|mesh-list
110227617|NCT04533451|Pemetrexed|pemetrexed|mesh-list
110227618|NCT04533451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110227619|NCT04533451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110227620|NCT04533451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110227621|NCT04533451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110227622|NCT04533451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110227623|NCT04533451|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110227624|NCT04533451|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110227625|NCT04528082|Apremilast|apremilast|mesh-list
110227626|NCT04528082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110227627|NCT04528082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110227628|NCT04528082|Analgesics|analgesics|mesh-ancestor
110227629|NCT04528082|Sensory System Agents|sensory system agents|mesh-ancestor
110227630|NCT04528082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110227631|NCT04528082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110227632|NCT04528082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110227633|NCT04528082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110227634|NCT04528082|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110227635|NCT04528082|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110227636|NCT04528082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110227637|NCT04528082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110227639|NCT04526197|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
110227640|NCT04526197|Choline|choline|mesh-list
110227641|NCT04526197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110227642|NCT04526197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110227643|NCT04526197|Analgesics|analgesics|mesh-ancestor
110227644|NCT04526197|Sensory System Agents|sensory system agents|mesh-ancestor
110227645|NCT04526197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110227646|NCT04526197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110227647|NCT04526197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110227648|NCT04526197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110227649|NCT04526197|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110227650|NCT04526197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110227651|NCT04526197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110227652|NCT04526197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110227653|NCT04526197|Lipotropic Agents|lipotropic agents|mesh-ancestor
110227654|NCT04526197|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110227655|NCT04526197|Antimetabolites|antimetabolites|mesh-ancestor
110227656|NCT04526197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110227657|NCT04526197|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110227658|NCT04526197|Nootropic Agents|nootropic agents|mesh-ancestor
110227659|NCT04526197|Chelating Agents|chelating agents|mesh-ancestor
110227660|NCT04526197|Sequestering Agents|sequestering agents|mesh-ancestor
110227661|NCT04526197|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110227662|NCT04526197|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110227663|NCT04526197|Growth Substances|growth substances|mesh-ancestor
110227664|NCT04526197|Growth Inhibitors|growth inhibitors|mesh-ancestor
110227665|NCT04526197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110227666|NCT04513925|Atezolizumab|atezolizumab|mesh-list
110227667|NCT04513925|Durvalumab|durvalumab|mesh-list
110227668|NCT04513925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110227669|NCT04513925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110227670|NCT04513925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110227671|NCT04513925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110227672|NCT04454203|Anesthetics|anesthetics|mesh-list
110227673|NCT04454203|Mepivacaine|mepivacaine|mesh-list
110227674|NCT04454203|Anesthetics, Local|anesthetics, local|mesh-list
110227675|NCT04454203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110227676|NCT04454203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110227677|NCT04454203|Sensory System Agents|sensory system agents|mesh-ancestor
110227678|NCT04454203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110227679|NCT04447027|Dexamethasone|dexamethasone|mesh-list
110227680|NCT04447027|Lenalidomide|lenalidomide|mesh-list
110227681|NCT04447027|Azacitidine|azacitidine|mesh-list
110227684|NCT04447027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110227686|NCT04447027|Autonomic Agents|autonomic agents|mesh-ancestor
110227687|NCT04447027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110227688|NCT04447027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110227689|NCT04447027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110227690|NCT04447027|Glucocorticoids|glucocorticoids|mesh-ancestor
110227691|NCT04447027|Hormones|hormones|mesh-ancestor
110227692|NCT04447027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110227693|NCT04447027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110227694|NCT04447027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110227695|NCT04447027|Immunologic Factors|immunologic factors|mesh-ancestor
110227696|NCT04447027|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110263524|NCT00532285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110227697|NCT04447027|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110227698|NCT04447027|Growth Substances|growth substances|mesh-ancestor
110227699|NCT04447027|Growth Inhibitors|growth inhibitors|mesh-ancestor
110227700|NCT04447027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110227702|NCT04447027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110227703|NCT04447027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110227704|NCT04447027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110227705|NCT04447027|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110227706|NCT04434664|Metoprolol|metoprolol|mesh-list
110227707|NCT04434664|Amlodipine|amlodipine|mesh-list
110227708|NCT04434664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110227709|NCT04434664|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110227710|NCT04434664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110227711|NCT04434664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110227712|NCT04434664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110227713|NCT04434664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110227714|NCT04434664|Vasodilator Agents|vasodilator agents|mesh-ancestor
110227716|NCT04434664|Sympatholytics|sympatholytics|mesh-ancestor
110227717|NCT04434664|Autonomic Agents|autonomic agents|mesh-ancestor
110227718|NCT04434664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110227719|NCT04434664|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110227720|NCT04434664|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110227721|NCT04434664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110227722|NCT04434664|Adrenergic Agents|adrenergic agents|mesh-ancestor
110227723|NCT04434664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110227724|NCT04430192|177Lu-PSMA-617|177lu-psma-617|mesh-list
110227725|NCT04430192|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110227726|NCT04430192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110227727|NCT04419272|Methylphenidate|methylphenidate|mesh-list
110227728|NCT04419272|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110227729|NCT04419272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110227730|NCT04419272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110227731|NCT04419272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110227732|NCT04419272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110227733|NCT04419272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110227734|NCT04419272|Dopamine Agents|dopamine agents|mesh-ancestor
110227735|NCT04419272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110227736|NCT04416984|Cyclophosphamide|cyclophosphamide|mesh-list
110227737|NCT04416984|Fludarabine|fludarabine|mesh-list
110054485|NCT01492218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110227738|NCT04416984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110227739|NCT04416984|Immunologic Factors|immunologic factors|mesh-ancestor
110227740|NCT04416984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110263530|NCT00532285|Antimetabolites|antimetabolites|mesh-ancestor
110227742|NCT04416984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110227743|NCT04416984|Alkylating Agents|alkylating agents|mesh-ancestor
110227744|NCT04416984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110227745|NCT04416984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110227746|NCT04416984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110227747|NCT04409314|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
110227748|NCT04409314|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110227749|NCT04409314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110227751|NCT04404088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110227752|NCT04404088|Lenalidomide|lenalidomide|mesh-list
110227753|NCT04404088|Acalabrutinib|acalabrutinib|mesh-list
110227754|NCT04404088|Antibodies|antibodies|mesh-list
110227755|NCT04404088|Immunoglobulins|immunoglobulins|mesh-list
110227756|NCT04404088|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110227757|NCT04404088|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
110227758|NCT04404088|Immunologic Factors|immunologic factors|mesh-ancestor
110227759|NCT04404088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110227760|NCT04404088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110227761|NCT04404088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110227762|NCT04404088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110227763|NCT04404088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110227764|NCT04404088|Growth Substances|growth substances|mesh-ancestor
110227765|NCT04404088|Growth Inhibitors|growth inhibitors|mesh-ancestor
110227766|NCT04404088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110227767|NCT04404088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110227768|NCT04404088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110227769|NCT04400175|Silicon|silicon|mesh-list
110227770|NCT04400175|Trace Elements|trace elements|mesh-ancestor
110227771|NCT04400175|Micronutrients|micronutrients|mesh-ancestor
110227772|NCT04400175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110227773|NCT04396873|11C-PS13|11c-ps13|mesh-list
110227774|NCT04396873|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110227775|NCT04396873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110227783|NCT04341571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110227789|NCT04294628|Trastuzumab|trastuzumab|mesh-list
110227790|NCT04294628|Camptothecin|camptothecin|mesh-list
110227791|NCT04294628|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
110227792|NCT04294628|Immunoconjugates|immunoconjugates|mesh-list
110227793|NCT04294628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110227794|NCT04294628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110227795|NCT04294628|Immunologic Factors|immunologic factors|mesh-ancestor
110227796|NCT04294628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110227797|NCT04294628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110227799|NCT04294628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110227800|NCT04294628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110227801|NCT04294628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110227802|NCT04291703|Thymoglobulin|thymoglobulin|mesh-list
110227803|NCT04291703|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110227804|NCT04291703|Immunologic Factors|immunologic factors|mesh-ancestor
110227805|NCT04291703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110227806|NCT04291703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110227808|NCT04288778|Canagliflozin|canagliflozin|mesh-list
110227809|NCT04288778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110227810|NCT04288778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110227811|NCT04288778|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110227812|NCT04288778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110227815|NCT04278781|Ivosidenib|ivosidenib|mesh-list
110227816|NCT04278781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110227817|NCT04278781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110227818|NCT04278781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110227819|NCT04270409|Dexamethasone|dexamethasone|mesh-list
110227821|NCT04270409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110227822|NCT04270409|Antiemetics|antiemetics|mesh-ancestor
110227823|NCT04270409|Autonomic Agents|autonomic agents|mesh-ancestor
110227824|NCT04270409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110227825|NCT04270409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110227826|NCT04270409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110227827|NCT04270409|Glucocorticoids|glucocorticoids|mesh-ancestor
110227828|NCT04270409|Hormones|hormones|mesh-ancestor
110227829|NCT04270409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110227830|NCT04270409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110227831|NCT04270409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110227832|NCT04270409|Immunologic Factors|immunologic factors|mesh-ancestor
110227833|NCT04270409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110227834|NCT04270409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110227835|NCT04270409|Growth Substances|growth substances|mesh-ancestor
110227836|NCT04270409|Growth Inhibitors|growth inhibitors|mesh-ancestor
110227837|NCT04262687|Bevacizumab|bevacizumab|mesh-list
110227838|NCT04262687|Pembrolizumab|pembrolizumab|mesh-list
110227839|NCT04262687|Capecitabine|capecitabine|mesh-list
110227840|NCT04262687|Oxaliplatin|oxaliplatin|mesh-list
110227841|NCT04262687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110227842|NCT04262687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110227843|NCT04262687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110227844|NCT04262687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110227845|NCT04262687|Growth Substances|growth substances|mesh-ancestor
110227846|NCT04262687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110227847|NCT04262687|Growth Inhibitors|growth inhibitors|mesh-ancestor
110227848|NCT04262687|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110227849|NCT04262687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110227850|NCT04262687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110227851|NCT04262687|Antimetabolites|antimetabolites|mesh-ancestor
110227852|NCT04246697|Acetaminophen|acetaminophen|mesh-list
110227853|NCT04246697|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110227855|NCT04246697|Oxycodone|oxycodone|mesh-list
110227856|NCT04246697|Gabapentin|gabapentin|mesh-list
110227857|NCT04246697|Bupivacaine|bupivacaine|mesh-list
110227858|NCT04246697|Anesthetics, Local|anesthetics, local|mesh-ancestor
110227859|NCT04246697|Anesthetics|anesthetics|mesh-ancestor
110227860|NCT04246697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110227861|NCT04246697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110227862|NCT04246697|Sensory System Agents|sensory system agents|mesh-ancestor
110227863|NCT04246697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110227864|NCT04246697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110227865|NCT04246697|Narcotics|narcotics|mesh-ancestor
110227866|NCT04246697|Analgesics|analgesics|mesh-ancestor
110227867|NCT04246697|Anticonvulsants|anticonvulsants|mesh-ancestor
110227868|NCT04246697|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110227869|NCT04246697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110227870|NCT04246697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110227871|NCT04246697|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110227873|NCT04246697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110227874|NCT04246697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110227875|NCT04246697|Antimanic Agents|antimanic agents|mesh-ancestor
110227876|NCT04246697|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110227877|NCT04246697|Antipyretics|antipyretics|mesh-ancestor
110227878|NCT04246697|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110227879|NCT04246697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110227880|NCT04246697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110227881|NCT04246697|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110227882|NCT04246697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110227884|NCT04240002|Fludarabine|fludarabine|mesh-list
110227885|NCT04240002|Lenograstim|lenograstim|mesh-list
110227886|NCT04240002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110227887|NCT04240002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110227888|NCT04240002|Antimetabolites|antimetabolites|mesh-ancestor
110227889|NCT04240002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110227890|NCT04240002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110227891|NCT04240002|Immunologic Factors|immunologic factors|mesh-ancestor
110227892|NCT04240002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110227893|NCT04240002|Antiviral Agents|antiviral agents|mesh-ancestor
110227894|NCT04240002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110227895|NCT04240002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110227896|NCT04233164|Methylprednisolone|methylprednisolone|mesh-list
110227897|NCT04233164|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110227898|NCT04233164|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110227899|NCT04233164|Prednisolone|prednisolone|mesh-list
110227900|NCT04233164|Prednisolone acetate|prednisolone acetate|mesh-list
110227901|NCT04233164|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110227902|NCT04233164|Prednisolone phosphate|prednisolone phosphate|mesh-list
110227903|NCT04233164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110227904|NCT04233164|Antiemetics|antiemetics|mesh-ancestor
110227905|NCT04233164|Autonomic Agents|autonomic agents|mesh-ancestor
110227906|NCT04233164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110227907|NCT04233164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110227908|NCT04233164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110227909|NCT04233164|Glucocorticoids|glucocorticoids|mesh-ancestor
110227910|NCT04233164|Hormones|hormones|mesh-ancestor
110227911|NCT04233164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110227912|NCT04233164|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110227913|NCT04233164|Protective Agents|protective agents|mesh-ancestor
110227914|NCT04233164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110227915|NCT04233164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110227916|NCT04230265|Cyclophosphamide|cyclophosphamide|mesh-list
110227917|NCT04230265|Fludarabine|fludarabine|mesh-list
110227918|NCT04230265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110227919|NCT04230265|Immunologic Factors|immunologic factors|mesh-ancestor
110227920|NCT04230265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110227921|NCT04230265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110227922|NCT04230265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110227924|NCT04230265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110227926|NCT04230265|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110227927|NCT04227275|Cyclophosphamide|cyclophosphamide|mesh-list
110227928|NCT04227275|Fludarabine|fludarabine|mesh-list
110227929|NCT04227275|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110227930|NCT04227275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110227931|NCT04227275|Immunologic Factors|immunologic factors|mesh-ancestor
110227932|NCT04227275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110227933|NCT04227275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110227934|NCT04227275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110227935|NCT04227275|Alkylating Agents|alkylating agents|mesh-ancestor
110227936|NCT04227275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110227937|NCT04227275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110227938|NCT04227275|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110227939|NCT04222023|Immunoglobulins|immunoglobulins|mesh-list
110227940|NCT04222023|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110227941|NCT04222023|Antibodies|antibodies|mesh-list
110227942|NCT04222023|gamma-Globulins|gamma-globulins|mesh-list
110227943|NCT04222023|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110227944|NCT04222023|Immunologic Factors|immunologic factors|mesh-ancestor
110227945|NCT04222023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110227946|NCT04209660|Pembrolizumab|pembrolizumab|mesh-list
110227947|NCT04209660|Lenvatinib|lenvatinib|mesh-list
110227948|NCT04209660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110227949|NCT04209660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110227950|NCT04209660|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110227951|NCT04209660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110227952|NCT04209660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110227953|NCT04209660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110227954|NCT04209504|Bupivacaine|bupivacaine|mesh-list
110227955|NCT04209504|Ropivacaine|ropivacaine|mesh-list
110227956|NCT04209504|Anesthetics, Local|anesthetics, local|mesh-ancestor
110227957|NCT04209504|Anesthetics|anesthetics|mesh-ancestor
110227958|NCT04209504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110227959|NCT04209504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110227960|NCT04209504|Sensory System Agents|sensory system agents|mesh-ancestor
110227961|NCT04209504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110227962|NCT04198649|Azithromycin|azithromycin|mesh-list
110227963|NCT04198649|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110227964|NCT04198649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110227965|NCT04194944|Carboplatin|carboplatin|mesh-list
110227966|NCT04194944|Pembrolizumab|pembrolizumab|mesh-list
110227967|NCT04194944|Pemetrexed|pemetrexed|mesh-list
110227968|NCT04194944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110227969|NCT04194944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110227970|NCT04194944|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110227971|NCT04194944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110227972|NCT04194944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110227973|NCT04194944|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110227974|NCT04194944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110227976|NCT04177706|Analgesics|analgesics|mesh-ancestor
110227977|NCT04177706|Sensory System Agents|sensory system agents|mesh-ancestor
110227978|NCT04177706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110227979|NCT04177706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110227980|NCT04177706|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110227981|NCT04177706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110227982|NCT04177706|Anesthetics, General|anesthetics, general|mesh-ancestor
110227983|NCT04177706|Anesthetics|anesthetics|mesh-ancestor
110227984|NCT04177706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110227985|NCT04177706|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110227986|NCT04177706|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110227987|NCT04177706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110227988|NCT04177706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110227990|NCT04177004|Cyclophosphamide|cyclophosphamide|mesh-list
110227991|NCT04177004|Etoposide|etoposide|mesh-list
110227992|NCT04177004|Etoposide phosphate|etoposide phosphate|mesh-list
110227993|NCT04177004|Podophyllotoxin|podophyllotoxin|mesh-list
110227994|NCT04177004|Tacrolimus|tacrolimus|mesh-list
110227995|NCT04177004|Mitogens|mitogens|mesh-list
110227996|NCT04177004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110227997|NCT04177004|Immunologic Factors|immunologic factors|mesh-ancestor
110227998|NCT04177004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110227999|NCT04177004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110228000|NCT04177004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110228001|NCT04177004|Alkylating Agents|alkylating agents|mesh-ancestor
110228002|NCT04177004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228003|NCT04177004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110228004|NCT04177004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110228005|NCT04177004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110228006|NCT04177004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110228007|NCT04177004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110228008|NCT04177004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110228009|NCT04177004|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110228010|NCT04177004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110228011|NCT04177004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110228012|NCT04177004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110228013|NCT04177004|Antifungal Agents|antifungal agents|mesh-ancestor
110228014|NCT04177004|Mitosis Modulators|mitosis modulators|mesh-ancestor
110228015|NCT04177004|Keratolytic Agents|keratolytic agents|mesh-ancestor
110228016|NCT04177004|Dermatologic Agents|dermatologic agents|mesh-ancestor
110228017|NCT04177004|Tubulin Modulators|tubulin modulators|mesh-ancestor
110228018|NCT04177004|Antimitotic Agents|antimitotic agents|mesh-ancestor
110228019|NCT04165772|Capecitabine|capecitabine|mesh-list
110228020|NCT04165772|Dostarlimab|dostarlimab|mesh-list
110228021|NCT04165772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110228022|NCT04165772|Antimetabolites|antimetabolites|mesh-ancestor
110228023|NCT04165772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228024|NCT04165772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110228025|NCT04164069|Calcium, Dietary|calcium, dietary|mesh-list
110228026|NCT04164069|Leucovorin|leucovorin|mesh-list
110228027|NCT04164069|Folic Acid|folic acid|mesh-list
110228028|NCT04164069|Bevacizumab|bevacizumab|mesh-list
110228029|NCT04164069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110228030|NCT04164069|Fluorouracil|fluorouracil|mesh-list
110228031|NCT04164069|Oxaliplatin|oxaliplatin|mesh-list
110228032|NCT04164069|Dasatinib|dasatinib|mesh-list
110228033|NCT04164069|Endothelial Growth Factors|endothelial growth factors|mesh-list
110228034|NCT04164069|Antibodies|antibodies|mesh-list
110228035|NCT04164069|Immunoglobulins|immunoglobulins|mesh-list
110228036|NCT04164069|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110228037|NCT04164069|Immunoglobulin G|immunoglobulin g|mesh-list
110228038|NCT04164069|Calcium|calcium|mesh-list
110228039|NCT04164069|Levoleucovorin|levoleucovorin|mesh-list
110228040|NCT04164069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110228041|NCT04164069|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110228042|NCT04164069|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110228043|NCT04164069|Growth Substances|growth substances|mesh-ancestor
110228044|NCT04164069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110228045|NCT04164069|Growth Inhibitors|growth inhibitors|mesh-ancestor
110228046|NCT04164069|Immunologic Factors|immunologic factors|mesh-ancestor
110228047|NCT04164069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110228048|NCT04164069|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110228049|NCT04164069|Antimetabolites|antimetabolites|mesh-ancestor
110228050|NCT04164069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228051|NCT04164069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110228052|NCT04164069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110228053|NCT04164069|Antidotes|antidotes|mesh-ancestor
110228054|NCT04164069|Protective Agents|protective agents|mesh-ancestor
110228055|NCT04164069|Vitamin B Complex|vitamin b complex|mesh-ancestor
110228056|NCT04164069|Vitamins|vitamins|mesh-ancestor
110263617|NCT05467189|Paclitaxel|paclitaxel|mesh-list
110228058|NCT04164069|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110228059|NCT04164069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110228060|NCT04164069|Hematinics|hematinics|mesh-ancestor
110228061|NCT04157517|Pembrolizumab|pembrolizumab|mesh-list
110228062|NCT04157517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110228063|NCT04157517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110228064|NCT04157517|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110228065|NCT04157517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228066|NCT04152200|Lumasiran|lumasiran|mesh-list
110228067|NCT04152200|Renal Agents|renal agents|mesh-ancestor
110228068|NCT04140487|Azacitidine|azacitidine|mesh-list
110228069|NCT04140487|Venetoclax|venetoclax|mesh-list
110228070|NCT04140487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110228071|NCT04140487|Antimetabolites|antimetabolites|mesh-ancestor
110228072|NCT04140487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228073|NCT04140487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110228074|NCT04140487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110228075|NCT04126473|Ivacaftor|ivacaftor|mesh-list
110228076|NCT04126473|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110228077|NCT04126473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110228078|NCT04126473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228079|NCT04119336|Dexamethasone|dexamethasone|mesh-list
110228080|NCT04119336|Cyclophosphamide|cyclophosphamide|mesh-list
110228081|NCT04119336|Nivolumab|nivolumab|mesh-list
110228082|NCT04119336|Ixazomib|ixazomib|mesh-list
110228083|NCT04119336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110228084|NCT04119336|Immunologic Factors|immunologic factors|mesh-ancestor
110228085|NCT04119336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110228086|NCT04119336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110228087|NCT04119336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110228088|NCT04119336|Alkylating Agents|alkylating agents|mesh-ancestor
110228089|NCT04119336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228090|NCT04119336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110228091|NCT04119336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110228092|NCT04119336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110228093|NCT04119336|Antiemetics|antiemetics|mesh-ancestor
110228094|NCT04119336|Autonomic Agents|autonomic agents|mesh-ancestor
110228095|NCT04119336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110228096|NCT04119336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110228097|NCT04119336|Glucocorticoids|glucocorticoids|mesh-ancestor
110228098|NCT04119336|Hormones|hormones|mesh-ancestor
110228099|NCT04119336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110228100|NCT04119336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110228101|NCT04119336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110228102|NCT04119336|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110228103|NCT04119336|Protease Inhibitors|protease inhibitors|mesh-ancestor
110228104|NCT04119336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110228105|NCT04115163|Paclitaxel|paclitaxel|mesh-list
110228106|NCT04115163|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110228107|NCT04115163|Gemcitabine|gemcitabine|mesh-list
110228108|NCT04115163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110228110|NCT04115163|Tubulin Modulators|tubulin modulators|mesh-ancestor
110228111|NCT04115163|Antimitotic Agents|antimitotic agents|mesh-ancestor
110228112|NCT04115163|Mitosis Modulators|mitosis modulators|mesh-ancestor
110228113|NCT04115163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228114|NCT04115163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110228115|NCT04115163|Antimetabolites|antimetabolites|mesh-ancestor
110228116|NCT04113018|Dexamethasone|dexamethasone|mesh-list
110228117|NCT04113018|Lenalidomide|lenalidomide|mesh-list
110228118|NCT04113018|Daratumumab|daratumumab|mesh-list
110228119|NCT04113018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110228120|NCT04113018|Antiemetics|antiemetics|mesh-ancestor
110228121|NCT04113018|Autonomic Agents|autonomic agents|mesh-ancestor
110228122|NCT04113018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110228123|NCT04113018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110228124|NCT04113018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110228125|NCT04113018|Glucocorticoids|glucocorticoids|mesh-ancestor
110228126|NCT04113018|Hormones|hormones|mesh-ancestor
110228127|NCT04113018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110228128|NCT04113018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110228129|NCT04113018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110228130|NCT04113018|Immunologic Factors|immunologic factors|mesh-ancestor
110228131|NCT04113018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110228132|NCT04113018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110228133|NCT04113018|Growth Substances|growth substances|mesh-ancestor
110228134|NCT04113018|Growth Inhibitors|growth inhibitors|mesh-ancestor
110228135|NCT04092101|Nicotine|nicotine|mesh-list
110228136|NCT04092101|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110228137|NCT04092101|Autonomic Agents|autonomic agents|mesh-ancestor
110228138|NCT04092101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110228139|NCT04092101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110228140|NCT04092101|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110228141|NCT04092101|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110228142|NCT04092101|Cholinergic Agents|cholinergic agents|mesh-ancestor
110228143|NCT04092101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110228144|NCT04092101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228145|NCT04090879|Nicotine|nicotine|mesh-list
110228146|NCT04090879|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110228147|NCT04090879|Autonomic Agents|autonomic agents|mesh-ancestor
110228148|NCT04090879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110228149|NCT04090879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110228150|NCT04090879|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110228151|NCT04090879|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110228152|NCT04090879|Cholinergic Agents|cholinergic agents|mesh-ancestor
110228153|NCT04090879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110228154|NCT04090879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228155|NCT04047797|Rituximab|rituximab|mesh-list
110228156|NCT04047797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110228157|NCT04047797|Ixazomib|ixazomib|mesh-list
110228158|NCT04047797|Antibodies|antibodies|mesh-list
110228159|NCT04047797|Immunoglobulins|immunoglobulins|mesh-list
110228160|NCT04047797|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110228161|NCT04047797|Glycine|glycine|mesh-list
110228162|NCT04047797|Immunologic Factors|immunologic factors|mesh-ancestor
110228163|NCT04047797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110228164|NCT04047797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110228165|NCT04047797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110228166|NCT04047797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228167|NCT04047797|Protease Inhibitors|protease inhibitors|mesh-ancestor
110228168|NCT04047797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110228169|NCT04047797|Glycine Agents|glycine agents|mesh-ancestor
110228170|NCT04047797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110228171|NCT04039867|Gemcitabine|gemcitabine|mesh-list
110228172|NCT04039867|Oxaliplatin|oxaliplatin|mesh-list
110228173|NCT04039867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110228174|NCT04039867|Antimetabolites|antimetabolites|mesh-ancestor
110228175|NCT04039867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228176|NCT04039867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110228177|NCT04029038|Cyclophosphamide|cyclophosphamide|mesh-list
110228178|NCT04029038|Fludarabine|fludarabine|mesh-list
110228179|NCT04029038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110228180|NCT04029038|Immunologic Factors|immunologic factors|mesh-ancestor
110228181|NCT04029038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110228182|NCT04029038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110228183|NCT04029038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110228184|NCT04029038|Alkylating Agents|alkylating agents|mesh-ancestor
110228185|NCT04029038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228187|NCT04029038|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110228188|NCT04024436|Fulvestrant|fulvestrant|mesh-list
110228189|NCT04024436|Futibatinib|futibatinib|mesh-list
110228190|NCT04024436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110228192|NCT04024436|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110228193|NCT04024436|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110228194|NCT04024436|Hormone Antagonists|hormone antagonists|mesh-ancestor
110228195|NCT04024436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110228196|NCT04024436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110228197|NCT04019288|Durvalumab|durvalumab|mesh-list
110228198|NCT04019288|Immunoglobulins|immunoglobulins|mesh-list
110228199|NCT04019288|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110228200|NCT04019288|Immunoglobulin G|immunoglobulin g|mesh-list
110228201|NCT04019288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110228202|NCT04019288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110228203|NCT04019288|Immunologic Factors|immunologic factors|mesh-ancestor
110228204|NCT04019288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110228205|NCT03996772|Rivaroxaban|rivaroxaban|mesh-list
110228206|NCT03996772|Apixaban|apixaban|mesh-list
110228207|NCT03996772|Edoxaban|edoxaban|mesh-list
110228208|NCT03996772|Dabigatran|dabigatran|mesh-list
110228209|NCT03996772|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110228210|NCT03996772|Antithrombins|antithrombins|mesh-ancestor
110263670|NCT05466019|Antidotes|antidotes|mesh-ancestor
110228211|NCT03996772|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110228212|NCT03996772|Protease Inhibitors|protease inhibitors|mesh-ancestor
110228213|NCT03996772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110228214|NCT03996772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228215|NCT03996772|Anticoagulants|anticoagulants|mesh-ancestor
110228216|NCT03996044|Anti-Infective Agents|anti-infective agents|mesh-list
110228217|NCT03996044|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110228218|NCT03977467|Atezolizumab|atezolizumab|mesh-list
110228219|NCT03977467|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110228220|NCT03977467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228221|NCT03977467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110228222|NCT03977467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110228223|NCT03946202|Hydrogen Peroxide|hydrogen peroxide|mesh-list
110228224|NCT03946202|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110228225|NCT03946202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110228226|NCT03908593|Pantoprazole|pantoprazole|mesh-list
110228227|NCT03908593|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110228228|NCT03908593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110228229|NCT03908593|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110228231|NCT03908593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228232|NCT03901612|Ropivacaine|ropivacaine|mesh-list
110228233|NCT03901612|Anesthetics, Local|anesthetics, local|mesh-ancestor
110228234|NCT03901612|Anesthetics|anesthetics|mesh-ancestor
110228235|NCT03901612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110228236|NCT03901612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110228237|NCT03901612|Sensory System Agents|sensory system agents|mesh-ancestor
110228238|NCT03901612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110228239|NCT03874884|Olaparib|olaparib|mesh-list
110228240|NCT03874884|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110228241|NCT03874884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110228242|NCT03874884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228243|NCT03874884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110228244|NCT03840915|Paclitaxel|paclitaxel|mesh-list
110228245|NCT03840915|Docetaxel|docetaxel|mesh-list
110228246|NCT03840915|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110228247|NCT03840915|Carboplatin|carboplatin|mesh-list
110228248|NCT03840915|Gemcitabine|gemcitabine|mesh-list
110228249|NCT03840915|Pemetrexed|pemetrexed|mesh-list
110228250|NCT03840915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110228251|NCT03840915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110228252|NCT03840915|Tubulin Modulators|tubulin modulators|mesh-ancestor
110228253|NCT03840915|Antimitotic Agents|antimitotic agents|mesh-ancestor
110228254|NCT03840915|Mitosis Modulators|mitosis modulators|mesh-ancestor
110228255|NCT03840915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228256|NCT03840915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110228257|NCT03840915|Antimetabolites|antimetabolites|mesh-ancestor
110228258|NCT03840915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110228259|NCT03840915|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110228260|NCT03840915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110228261|NCT03829501|Atezolizumab|atezolizumab|mesh-list
110228262|NCT03829501|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110228263|NCT03829501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228264|NCT03829501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110263707|NCT00171678|Diclofenac|diclofenac|mesh-list
110228265|NCT03829501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110228266|NCT03827798|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110228267|NCT03827798|Immunologic Factors|immunologic factors|mesh-ancestor
110228268|NCT03827798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110228269|NCT03821792|Prednisone|prednisone|mesh-list
110228270|NCT03821792|Cortisone|cortisone|mesh-list
110228271|NCT03821792|Abiraterone Acetate|abiraterone acetate|mesh-list
110228273|NCT03821792|Glucocorticoids|glucocorticoids|mesh-ancestor
110228274|NCT03821792|Hormones|hormones|mesh-ancestor
110228275|NCT03821792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110228276|NCT03821792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110228277|NCT03821792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110228278|NCT03821792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110228279|NCT03821792|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110228280|NCT03821792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110228281|NCT03821792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228282|NCT03821792|Hormone Antagonists|hormone antagonists|mesh-ancestor
110228283|NCT03821792|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110228284|NCT03786614|Antidepressive Agents|antidepressive agents|mesh-list
110228285|NCT03786614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110228286|NCT03779334|Risdiplam|risdiplam|mesh-list
110228287|NCT03779334|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110228288|NCT03779334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110228289|NCT03779334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110228290|NCT03776071|Temozolomide|temozolomide|mesh-list
110228291|NCT03776071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110228292|NCT03776071|Alkylating Agents|alkylating agents|mesh-ancestor
110228293|NCT03776071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228294|NCT03776071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110228296|NCT03774394|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110228297|NCT03774394|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110228298|NCT03774394|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110228299|NCT03774394|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110228300|NCT03774394|Purinergic Agents|purinergic agents|mesh-ancestor
110228301|NCT03774394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110228302|NCT03774394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228303|NCT03774394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110228304|NCT03766126|Cyclophosphamide|cyclophosphamide|mesh-list
110228305|NCT03766126|Fludarabine|fludarabine|mesh-list
110228306|NCT03766126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110228307|NCT03766126|Immunologic Factors|immunologic factors|mesh-ancestor
110228308|NCT03766126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110228309|NCT03766126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110228310|NCT03766126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110228311|NCT03766126|Alkylating Agents|alkylating agents|mesh-ancestor
110228312|NCT03766126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228313|NCT03766126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110228314|NCT03766126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110228315|NCT03765788|Prednisolone|prednisolone|mesh-list
110228316|NCT03765788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110228317|NCT03765788|Glucocorticoids|glucocorticoids|mesh-ancestor
110228318|NCT03765788|Hormones|hormones|mesh-ancestor
110228319|NCT03765788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110228320|NCT03765788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110228321|NCT03765788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110228322|NCT03765788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110228323|NCT03760822|Paclitaxel|paclitaxel|mesh-list
110228324|NCT03760822|Ramucirumab|ramucirumab|mesh-list
110228325|NCT03760822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110228326|NCT03760822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110228328|NCT03760822|Antimitotic Agents|antimitotic agents|mesh-ancestor
110228329|NCT03760822|Mitosis Modulators|mitosis modulators|mesh-ancestor
110228330|NCT03760822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228331|NCT03754725|Deferiprone|deferiprone|mesh-list
110228332|NCT03754725|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110228333|NCT03754725|Chelating Agents|chelating agents|mesh-ancestor
110228334|NCT03754725|Sequestering Agents|sequestering agents|mesh-ancestor
110228335|NCT03754725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228336|NCT03748641|Prednisone|prednisone|mesh-list
110228337|NCT03748641|Abiraterone Acetate|abiraterone acetate|mesh-list
110228338|NCT03748641|Niraparib|niraparib|mesh-list
110228339|NCT03748641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110228340|NCT03748641|Glucocorticoids|glucocorticoids|mesh-ancestor
110228341|NCT03748641|Hormones|hormones|mesh-ancestor
110228342|NCT03748641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110228343|NCT03748641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110228344|NCT03748641|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110228345|NCT03748641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110228346|NCT03748641|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110228347|NCT03748641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110228348|NCT03748641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228349|NCT03748641|Hormone Antagonists|hormone antagonists|mesh-ancestor
110228350|NCT03748641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110228351|NCT03748641|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110228353|NCT03744793|Avelumab|avelumab|mesh-list
110228354|NCT03744793|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110228355|NCT03744793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110228356|NCT03744793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110228357|NCT03744793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228358|NCT03744793|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110228359|NCT03744793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110228360|NCT03744793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110228362|NCT03744793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110228363|NCT03731923|Liver Extracts|liver extracts|mesh-list
110228364|NCT03731923|Hematinics|hematinics|mesh-ancestor
110228366|NCT03726268|Sufentanil|sufentanil|mesh-list
110228367|NCT03726268|Morphine|morphine|mesh-list
110228368|NCT03726268|Methadone|methadone|mesh-list
110228369|NCT03726268|Hydromorphone|hydromorphone|mesh-list
110228370|NCT03726268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110228371|NCT03726268|Narcotics|narcotics|mesh-ancestor
110228372|NCT03726268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110228373|NCT03726268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110228374|NCT03726268|Analgesics|analgesics|mesh-ancestor
110228375|NCT03726268|Sensory System Agents|sensory system agents|mesh-ancestor
110228376|NCT03726268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110228377|NCT03726268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110228378|NCT03726268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110228379|NCT03726268|Anesthetics, General|anesthetics, general|mesh-ancestor
110228380|NCT03726268|Anesthetics|anesthetics|mesh-ancestor
110228381|NCT03726268|Antitussive Agents|antitussive agents|mesh-ancestor
110228382|NCT03726268|Respiratory System Agents|respiratory system agents|mesh-ancestor
110228383|NCT03724747|BAY 2315497|bay 2315497|mesh-list
110228384|NCT03724747|Immunoconjugates|immunoconjugates|mesh-ancestor
110228385|NCT03724747|Immunologic Factors|immunologic factors|mesh-ancestor
110228386|NCT03724747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110228387|NCT03719924|Paclitaxel|paclitaxel|mesh-list
110228388|NCT03719924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110228389|NCT03719924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110228390|NCT03719924|Tubulin Modulators|tubulin modulators|mesh-ancestor
110228391|NCT03719924|Antimitotic Agents|antimitotic agents|mesh-ancestor
110228392|NCT03719924|Mitosis Modulators|mitosis modulators|mesh-ancestor
110228393|NCT03719924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228394|NCT03713801|Metformin|metformin|mesh-list
110228395|NCT03713801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110228396|NCT03713801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110228397|NCT03699995|Lidocaine|lidocaine|mesh-list
110228398|NCT03699995|Anesthetics, Local|anesthetics, local|mesh-ancestor
110228399|NCT03699995|Anesthetics|anesthetics|mesh-ancestor
110228400|NCT03699995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110228401|NCT03699995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110228402|NCT03699995|Sensory System Agents|sensory system agents|mesh-ancestor
110228403|NCT03699995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110228404|NCT03699995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110228405|NCT03699995|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110228406|NCT03699995|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110228407|NCT03699995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110228408|NCT03699995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228410|NCT03693677|Gemcitabine|gemcitabine|mesh-list
110228411|NCT03693677|Irinotecan|irinotecan|mesh-list
110228412|NCT03693677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110228413|NCT03693677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110228414|NCT03693677|Tubulin Modulators|tubulin modulators|mesh-ancestor
110228415|NCT03693677|Antimitotic Agents|antimitotic agents|mesh-ancestor
110228416|NCT03693677|Mitosis Modulators|mitosis modulators|mesh-ancestor
110228417|NCT03693677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228418|NCT03693677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110228419|NCT03693677|Antimetabolites|antimetabolites|mesh-ancestor
110228420|NCT03693677|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110228421|NCT03693677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110228422|NCT03693677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110228424|NCT03692403|Dopamine Agonists|dopamine agonists|mesh-ancestor
110228425|NCT03692403|Dopamine Agents|dopamine agents|mesh-ancestor
110228426|NCT03692403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110228427|NCT03692403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228428|NCT03692403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110228429|NCT03689972|Natalizumab|natalizumab|mesh-list
110228430|NCT03689972|Immunologic Factors|immunologic factors|mesh-ancestor
110228431|NCT03689972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110228432|NCT03683433|Azacitidine|azacitidine|mesh-list
110228433|NCT03683433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110228434|NCT03683433|Antimetabolites|antimetabolites|mesh-ancestor
110228435|NCT03683433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228436|NCT03683433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110228437|NCT03683433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110228438|NCT03653507|Capecitabine|capecitabine|mesh-list
110228439|NCT03653507|Oxaliplatin|oxaliplatin|mesh-list
110228440|NCT03653507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110228441|NCT03653507|Antimetabolites|antimetabolites|mesh-ancestor
110228442|NCT03653507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228443|NCT03653507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110228444|NCT03649230|Palonosetron|palonosetron|mesh-list
110228445|NCT03649230|Antiemetics|antiemetics|mesh-ancestor
110228446|NCT03649230|Autonomic Agents|autonomic agents|mesh-ancestor
110228447|NCT03649230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110228448|NCT03649230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110228449|NCT03649230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110228450|NCT03649230|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110228451|NCT03649230|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110228452|NCT03649230|Serotonin Agents|serotonin agents|mesh-ancestor
110228453|NCT03649230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110228454|NCT03649230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228456|NCT03626545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110228457|NCT03626545|Tubulin Modulators|tubulin modulators|mesh-ancestor
110228458|NCT03626545|Antimitotic Agents|antimitotic agents|mesh-ancestor
110228459|NCT03626545|Mitosis Modulators|mitosis modulators|mesh-ancestor
110228460|NCT03626545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228461|NCT03620201|Atezolizumab|atezolizumab|mesh-list
110228462|NCT03620201|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110228463|NCT03620201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228464|NCT03620201|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110228465|NCT03620201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110228466|NCT03587662|Gemcitabine|gemcitabine|mesh-list
110228467|NCT03587662|Doxorubicin|doxorubicin|mesh-list
110228468|NCT03587662|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110228469|NCT03587662|Daunorubicin|daunorubicin|mesh-list
110228470|NCT03587662|Ixazomib|ixazomib|mesh-list
110228471|NCT03587662|Glycine|glycine|mesh-list
110228472|NCT03587662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110228473|NCT03587662|Antimetabolites|antimetabolites|mesh-ancestor
110228474|NCT03587662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228475|NCT03587662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110228476|NCT03587662|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110228477|NCT03587662|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110228478|NCT03587662|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110228479|NCT03587662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110228480|NCT03587662|Protease Inhibitors|protease inhibitors|mesh-ancestor
110228481|NCT03587662|Glycine Agents|glycine agents|mesh-ancestor
110228482|NCT03587662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110228483|NCT03587662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110228484|NCT03584711|Panitumumab|panitumumab|mesh-list
110228485|NCT03584711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110228486|NCT03584711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110228487|NCT03578367|Niacinamide|niacinamide|mesh-list
110228488|NCT03578367|Imatinib Mesylate|imatinib mesylate|mesh-list
110228489|NCT03578367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110041925|NCT01438866|Fluorides|fluorides|mesh-list
110228490|NCT03578367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110228491|NCT03578367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110228492|NCT03578367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228493|NCT03578367|Vitamin B Complex|vitamin b complex|mesh-ancestor
110228494|NCT03578367|Vitamins|vitamins|mesh-ancestor
110228495|NCT03578367|Micronutrients|micronutrients|mesh-ancestor
110228496|NCT03578367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110228497|NCT03558867|Metformin|metformin|mesh-list
110228498|NCT03558867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110228499|NCT03558867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110228500|NCT03557749|Dimercaprol|dimercaprol|mesh-list
110228501|NCT03557749|Chelating Agents|chelating agents|mesh-ancestor
110228502|NCT03557749|Sequestering Agents|sequestering agents|mesh-ancestor
110228503|NCT03557749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228504|NCT03548064|Vaccines|vaccines|mesh-list
110228505|NCT03548064|Immunologic Factors|immunologic factors|mesh-ancestor
110228506|NCT03548064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110228507|NCT03535350|Temozolomide|temozolomide|mesh-list
110228508|NCT03535350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110228509|NCT03535350|Alkylating Agents|alkylating agents|mesh-ancestor
110228510|NCT03535350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228511|NCT03535350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110228513|NCT03527108|Ramucirumab|ramucirumab|mesh-list
110228514|NCT03527108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110228515|NCT03527108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110228516|NCT03527108|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110228517|NCT03527108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228518|NCT03514069|Temozolomide|temozolomide|mesh-list
110228519|NCT03514069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110228520|NCT03514069|Alkylating Agents|alkylating agents|mesh-ancestor
110228521|NCT03514069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228522|NCT03514069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110228523|NCT03512197|Midostaurin|midostaurin|mesh-list
110228524|NCT03512197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110228525|NCT03512197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110228526|NCT03512197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110228527|NCT03512197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228528|NCT03505723|Tranexamic Acid|tranexamic acid|mesh-list
110228529|NCT03505723|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110228530|NCT03505723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110228531|NCT03505723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228532|NCT03505723|Hemostatics|hemostatics|mesh-ancestor
110228533|NCT03505723|Coagulants|coagulants|mesh-ancestor
110228534|NCT03502330|Nivolumab|nivolumab|mesh-list
110228535|NCT03502330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110228536|NCT03502330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110228537|NCT03502330|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110228538|NCT03502330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228539|NCT03463057|Atezolizumab|atezolizumab|mesh-list
110228540|NCT03463057|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110228541|NCT03463057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228542|NCT03463057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110228544|NCT03460756|Ganaxolone|ganaxolone|mesh-list
110228545|NCT03460756|Neurosteroids|neurosteroids|mesh-ancestor
110228546|NCT03460756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110228547|NCT03460756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228548|NCT03460756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110228549|NCT03460756|GABA Modulators|gaba modulators|mesh-ancestor
110228550|NCT03460756|GABA Agents|gaba agents|mesh-ancestor
110228551|NCT03457948|Pembrolizumab|pembrolizumab|mesh-list
110228552|NCT03457948|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
110228553|NCT03457948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110228554|NCT03457948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110228555|NCT03457948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110228556|NCT03457948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228557|NCT03457948|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110228558|NCT03443999|Sirolimus|sirolimus|mesh-list
110228559|NCT03443999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110228560|NCT03443999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110228561|NCT03443999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110228562|NCT03443999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110228563|NCT03443999|Antifungal Agents|antifungal agents|mesh-ancestor
110228564|NCT03443999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110228565|NCT03443999|Immunologic Factors|immunologic factors|mesh-ancestor
110228566|NCT03443999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110228568|NCT03431350|Abiraterone Acetate|abiraterone acetate|mesh-list
110228569|NCT03431350|Niraparib|niraparib|mesh-list
110228570|NCT03431350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110228571|NCT03431350|Glucocorticoids|glucocorticoids|mesh-ancestor
110228572|NCT03431350|Hormones|hormones|mesh-ancestor
110228573|NCT03431350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110228574|NCT03431350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110228575|NCT03431350|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110228576|NCT03431350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110228577|NCT03431350|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110228578|NCT03431350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110228579|NCT03431350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228580|NCT03431350|Hormone Antagonists|hormone antagonists|mesh-ancestor
110228581|NCT03431350|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110228582|NCT03431350|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110228583|NCT03430297|Dacarbazine|dacarbazine|mesh-list
110228584|NCT03430297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110228585|NCT03430297|Alkylating Agents|alkylating agents|mesh-ancestor
110228586|NCT03430297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228587|NCT03430297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110228588|NCT03425838|Letrozole|letrozole|mesh-list
110228589|NCT03425838|Fulvestrant|fulvestrant|mesh-list
110228590|NCT03425838|Palbociclib|palbociclib|mesh-list
110228591|NCT03425838|Anastrozole|anastrozole|mesh-list
110228592|NCT03425838|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110228593|NCT03425838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110228594|NCT03425838|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110228595|NCT03425838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110228596|NCT03425838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228597|NCT03425838|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110228598|NCT03425838|Hormone Antagonists|hormone antagonists|mesh-ancestor
110228599|NCT03425838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110228600|NCT03425838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110228601|NCT03425838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110228602|NCT03425838|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110228603|NCT03425838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110228605|NCT03399981|Immunologic Factors|immunologic factors|mesh-ancestor
110228606|NCT03399981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110228607|NCT03382834|Tamoxifen|tamoxifen|mesh-list
110228608|NCT03382834|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110228609|NCT03382834|Vorinostat|vorinostat|mesh-list
110228610|NCT03382834|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110228611|NCT03382834|Hormone Antagonists|hormone antagonists|mesh-ancestor
110228612|NCT03382834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110228613|NCT03382834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110228614|NCT03382834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110228615|NCT03382834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110228616|NCT03382834|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110228617|NCT03382834|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110228618|NCT03382834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110228619|NCT03382834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110228620|NCT03382834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110228621|NCT03382834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228622|NCT03382834|Antiviral Agents|antiviral agents|mesh-ancestor
110228623|NCT03382834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110228625|NCT03374085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110228627|NCT03374085|Autonomic Agents|autonomic agents|mesh-ancestor
110228628|NCT03374085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110228629|NCT03374085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110228630|NCT03374085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110228631|NCT03374085|Glucocorticoids|glucocorticoids|mesh-ancestor
110228632|NCT03374085|Hormones|hormones|mesh-ancestor
110228633|NCT03374085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110228634|NCT03374085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110228635|NCT03374085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110228636|NCT03367156|Dexamethasone|dexamethasone|mesh-list
110228637|NCT03367156|Dexamethasone acetate|dexamethasone acetate|mesh-list
110228638|NCT03367156|Ichthammol|ichthammol|mesh-list
110228639|NCT03367156|BB 1101|bb 1101|mesh-list
110228640|NCT03367156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110228641|NCT03367156|Antiemetics|antiemetics|mesh-ancestor
110228642|NCT03367156|Autonomic Agents|autonomic agents|mesh-ancestor
110228643|NCT03367156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110228644|NCT03367156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110228645|NCT03367156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110228646|NCT03367156|Glucocorticoids|glucocorticoids|mesh-ancestor
110228647|NCT03367156|Hormones|hormones|mesh-ancestor
110228648|NCT03367156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110228649|NCT03367156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110228650|NCT03367156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110228651|NCT03367156|Protease Inhibitors|protease inhibitors|mesh-ancestor
110228652|NCT03367156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110228653|NCT03367156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228654|NCT03367156|Dermatologic Agents|dermatologic agents|mesh-ancestor
110228655|NCT03367013|Lactoferrin|lactoferrin|mesh-list
110228656|NCT03367013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110228658|NCT03336398|Analgesics|analgesics|mesh-ancestor
110228659|NCT03336398|Sensory System Agents|sensory system agents|mesh-ancestor
110228660|NCT03336398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110228661|NCT03336398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110228662|NCT03336398|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110228663|NCT03336398|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110228664|NCT03336398|Anesthetics, General|anesthetics, general|mesh-ancestor
110228665|NCT03336398|Anesthetics|anesthetics|mesh-ancestor
110228666|NCT03336398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110228667|NCT03336398|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110228668|NCT03336398|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110228669|NCT03336398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110228670|NCT03336398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228671|NCT03332667|Vorinostat|vorinostat|mesh-list
110228672|NCT03332667|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
110228673|NCT03332667|Dinutuximab|dinutuximab|mesh-list
110228674|NCT03332667|Sargramostim|sargramostim|mesh-list
110228675|NCT03332667|Immunologic Factors|immunologic factors|mesh-ancestor
110228676|NCT03332667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110228677|NCT03332667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110228678|NCT03332667|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110228679|NCT03332667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110228680|NCT03332667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228681|NCT03332667|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110228682|NCT03331731|Pembrolizumab|pembrolizumab|mesh-list
110228683|NCT03331731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110228684|NCT03331731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110228685|NCT03331731|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110228686|NCT03331731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228687|NCT03322995|Fluorouracil|fluorouracil|mesh-list
110228688|NCT03322995|Antimetabolites|antimetabolites|mesh-ancestor
110228689|NCT03322995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228690|NCT03322995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110228691|NCT03322995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110228692|NCT03322995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110228693|NCT03322995|Immunologic Factors|immunologic factors|mesh-ancestor
110228694|NCT03322995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110228695|NCT03319498|Peppermint oil|peppermint oil|mesh-list
110228696|NCT03319498|Mineral Oil|mineral oil|mesh-list
110228697|NCT03319498|Antiemetics|antiemetics|mesh-ancestor
110228698|NCT03319498|Autonomic Agents|autonomic agents|mesh-ancestor
110228699|NCT03319498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110228700|NCT03319498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110228701|NCT03319498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110228702|NCT03319498|Parasympatholytics|parasympatholytics|mesh-ancestor
110228703|NCT03319498|Emollients|emollients|mesh-ancestor
110228704|NCT03319498|Dermatologic Agents|dermatologic agents|mesh-ancestor
110228705|NCT03291847|Buprenorphine|buprenorphine|mesh-list
110228706|NCT03291847|Methadone|methadone|mesh-list
110228707|NCT03291847|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
110228708|NCT03291847|Naloxone|naloxone|mesh-list
110228709|NCT03291847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110228710|NCT03291847|Narcotics|narcotics|mesh-ancestor
110228711|NCT03291847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110228712|NCT03291847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110228713|NCT03291847|Analgesics|analgesics|mesh-ancestor
110228714|NCT03291847|Sensory System Agents|sensory system agents|mesh-ancestor
110228715|NCT03291847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110228716|NCT03291847|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110228717|NCT03291847|Antitussive Agents|antitussive agents|mesh-ancestor
110228718|NCT03291847|Respiratory System Agents|respiratory system agents|mesh-ancestor
110228719|NCT03289962|Atezolizumab|atezolizumab|mesh-list
110228720|NCT03289962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110228721|NCT03289962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228722|NCT03289962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110228723|NCT03289962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110228724|NCT03283384|Letrozole|letrozole|mesh-list
110228725|NCT03283384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110228726|NCT03283384|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110228727|NCT03283384|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110228728|NCT03283384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110228729|NCT03283384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228730|NCT03283384|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110228731|NCT03283384|Hormone Antagonists|hormone antagonists|mesh-ancestor
110228732|NCT03283384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110228734|NCT03260504|Aldesleukin|aldesleukin|mesh-list
110228735|NCT03260504|Pembrolizumab|pembrolizumab|mesh-list
110228736|NCT03260504|Interleukin-2|interleukin-2|mesh-list
110228737|NCT03260504|Immunoglobulins|immunoglobulins|mesh-list
110228738|NCT03260504|Immunoglobulin G|immunoglobulin g|mesh-list
110228739|NCT03260504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110228740|NCT03260504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110228741|NCT03260504|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110228742|NCT03260504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228743|NCT03260504|Immunologic Factors|immunologic factors|mesh-ancestor
110228744|NCT03260504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110228745|NCT03260504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110228747|NCT03260504|Sensory System Agents|sensory system agents|mesh-ancestor
110228748|NCT03260504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110228749|NCT03260504|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110228750|NCT03260504|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110228751|NCT03260504|Antiviral Agents|antiviral agents|mesh-ancestor
110228752|NCT03260504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110228753|NCT03259074|Adalimumab|adalimumab|mesh-list
110228754|NCT03259074|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110228755|NCT03259074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110228756|NCT03259074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110228757|NCT03247088|Mycophenolic Acid|mycophenolic acid|mesh-list
110228758|NCT03247088|Cyclophosphamide|cyclophosphamide|mesh-list
110228759|NCT03247088|Busulfan|busulfan|mesh-list
110228760|NCT03247088|Fludarabine|fludarabine|mesh-list
110228761|NCT03247088|Sorafenib|sorafenib|mesh-list
110228762|NCT03247088|Tacrolimus|tacrolimus|mesh-list
110228763|NCT03247088|Lenograstim|lenograstim|mesh-list
110228764|NCT03247088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110228765|NCT03247088|Immunologic Factors|immunologic factors|mesh-ancestor
110228766|NCT03247088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110228767|NCT03247088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110228768|NCT03247088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110228769|NCT03247088|Alkylating Agents|alkylating agents|mesh-ancestor
110228770|NCT03247088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228771|NCT03247088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110228772|NCT03247088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110228773|NCT03247088|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110228774|NCT03247088|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110228775|NCT03247088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110228776|NCT03247088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110228777|NCT03247088|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110228778|NCT03247088|Antitubercular Agents|antitubercular agents|mesh-ancestor
110228779|NCT03247088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110228780|NCT03247088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110228781|NCT03247088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110228782|NCT03246074|Paclitaxel|paclitaxel|mesh-list
110228783|NCT03246074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110228784|NCT03246074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110228785|NCT03246074|Tubulin Modulators|tubulin modulators|mesh-ancestor
110228786|NCT03246074|Antimitotic Agents|antimitotic agents|mesh-ancestor
110228787|NCT03246074|Mitosis Modulators|mitosis modulators|mesh-ancestor
110263889|NCT00532714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110228788|NCT03246074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228790|NCT03216967|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110228791|NCT03216967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110228792|NCT03216967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110228793|NCT03216967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228794|NCT03216967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110228795|NCT03216967|Immunologic Factors|immunologic factors|mesh-ancestor
110228796|NCT03216967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110228797|NCT03216967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110228798|NCT03210662|Pembrolizumab|pembrolizumab|mesh-list
110228799|NCT03210662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110228800|NCT03210662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110228801|NCT03210662|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110228802|NCT03210662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228803|NCT03182244|Cytarabine|cytarabine|mesh-list
110228804|NCT03182244|Fludarabine|fludarabine|mesh-list
110228805|NCT03182244|Etoposide|etoposide|mesh-list
110228806|NCT03182244|Mitoxantrone|mitoxantrone|mesh-list
110228807|NCT03182244|Lenograstim|lenograstim|mesh-list
110228808|NCT03182244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110228809|NCT03182244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110228810|NCT03182244|Antimetabolites|antimetabolites|mesh-ancestor
110228811|NCT03182244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228812|NCT03182244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110228813|NCT03182244|Immunologic Factors|immunologic factors|mesh-ancestor
110228814|NCT03182244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110228815|NCT03182244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110228816|NCT03182244|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110228817|NCT03182244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110228818|NCT03182244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110228819|NCT03182244|Antiviral Agents|antiviral agents|mesh-ancestor
110228820|NCT03182244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110228822|NCT03182244|Sensory System Agents|sensory system agents|mesh-ancestor
110228823|NCT03182244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110228825|NCT03164928|Denosumab|denosumab|mesh-list
110228826|NCT03164928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110228827|NCT03164928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110228828|NCT03132467|Durvalumab|durvalumab|mesh-list
110228829|NCT03132467|Ipilimumab|ipilimumab|mesh-list
110228830|NCT03132467|Tremelimumab|tremelimumab|mesh-list
110228831|NCT03132467|Immunoglobulins|immunoglobulins|mesh-list
110228832|NCT03132467|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110228833|NCT03132467|Immunoglobulin G|immunoglobulin g|mesh-list
110228834|NCT03132467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110228835|NCT03132467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110228836|NCT03132467|Immunologic Factors|immunologic factors|mesh-ancestor
110228837|NCT03132467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110228838|NCT03132467|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110228839|NCT03132467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228840|NCT03126214|Warfarin|warfarin|mesh-list
110228841|NCT03126214|Anticoagulants|anticoagulants|mesh-list
110228842|NCT03121586|Pimavanserin|pimavanserin|mesh-list
110228843|NCT03121586|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110228844|NCT03121586|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110228845|NCT03121586|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110228846|NCT03121586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110228847|NCT03121586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110228848|NCT03121586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110228849|NCT03121586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110228850|NCT03121586|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110263929|NCT00164736|Ritonavir|ritonavir|mesh-list
110228851|NCT03121586|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110228852|NCT03121586|Serotonin Agents|serotonin agents|mesh-ancestor
110228853|NCT03121586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110228854|NCT03121586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228855|NCT03118492|Mycophenolic Acid|mycophenolic acid|mesh-list
110228856|NCT03118492|Cyclophosphamide|cyclophosphamide|mesh-list
110228858|NCT03118492|Mechlorethamine|mechlorethamine|mesh-list
110228859|NCT03118492|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
110228860|NCT03118492|Fludarabine|fludarabine|mesh-list
110228861|NCT03118492|Tacrolimus|tacrolimus|mesh-list
110228862|NCT03118492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110228863|NCT03118492|Immunologic Factors|immunologic factors|mesh-ancestor
110228864|NCT03118492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110228865|NCT03118492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110228866|NCT03118492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110228867|NCT03118492|Alkylating Agents|alkylating agents|mesh-ancestor
110228868|NCT03118492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228869|NCT03118492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110228870|NCT03118492|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110228871|NCT03118492|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110228872|NCT03118492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110228873|NCT03118492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110228874|NCT03118492|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110228875|NCT03118492|Antitubercular Agents|antitubercular agents|mesh-ancestor
110228876|NCT03118492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110228877|NCT03118492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110228878|NCT03107793|Ustekinumab|ustekinumab|mesh-list
110228879|NCT03107793|Dermatologic Agents|dermatologic agents|mesh-ancestor
110228880|NCT02971748|Pembrolizumab|pembrolizumab|mesh-list
110228881|NCT02971748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110228882|NCT02971748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110228883|NCT02971748|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110228884|NCT02971748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228885|NCT02959619|Ensartinib|ensartinib|mesh-list
110228886|NCT02959619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110228887|NCT02959619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110228888|NCT02959619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110228889|NCT02959619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228890|NCT02912715|Paclitaxel|paclitaxel|mesh-list
110228891|NCT02912715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110228892|NCT02912715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110228893|NCT02912715|Tubulin Modulators|tubulin modulators|mesh-ancestor
110228894|NCT02912715|Antimitotic Agents|antimitotic agents|mesh-ancestor
110228895|NCT02912715|Mitosis Modulators|mitosis modulators|mesh-ancestor
110228896|NCT02912715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228897|NCT02908685|Risdiplam|risdiplam|mesh-list
110228898|NCT02908685|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110228899|NCT02908685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110228900|NCT02908685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110228901|NCT02886962|Vitamin K|vitamin k|mesh-list
110228902|NCT02886962|Vitamins|vitamins|mesh-ancestor
110228903|NCT02886962|Micronutrients|micronutrients|mesh-ancestor
110263939|NCT00164736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110228905|NCT02886962|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110228906|NCT02886962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110228907|NCT02886962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228908|NCT02886962|Hemostatics|hemostatics|mesh-ancestor
110228909|NCT02886962|Coagulants|coagulants|mesh-ancestor
110228910|NCT02885753|Leucovorin|leucovorin|mesh-list
110228911|NCT02885753|Folic Acid|folic acid|mesh-list
110228912|NCT02885753|Bevacizumab|bevacizumab|mesh-list
110228913|NCT02885753|Panitumumab|panitumumab|mesh-list
110228914|NCT02885753|Oxaliplatin|oxaliplatin|mesh-list
110228915|NCT02885753|Irinotecan|irinotecan|mesh-list
110228916|NCT02885753|Fluorouracil|fluorouracil|mesh-list
110228917|NCT02885753|Levoleucovorin|levoleucovorin|mesh-list
110228918|NCT02885753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110228919|NCT02885753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110228920|NCT02885753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110228921|NCT02885753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110228922|NCT02885753|Growth Substances|growth substances|mesh-ancestor
110228923|NCT02885753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110228924|NCT02885753|Growth Inhibitors|growth inhibitors|mesh-ancestor
110228925|NCT02885753|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110228926|NCT02885753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110228927|NCT02885753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110228928|NCT02885753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228929|NCT02885753|Antimetabolites|antimetabolites|mesh-ancestor
110228930|NCT02885753|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110228931|NCT02885753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110228932|NCT02885753|Immunologic Factors|immunologic factors|mesh-ancestor
110228933|NCT02885753|Antidotes|antidotes|mesh-ancestor
110228934|NCT02885753|Protective Agents|protective agents|mesh-ancestor
110228935|NCT02885753|Vitamin B Complex|vitamin b complex|mesh-ancestor
110228936|NCT02885753|Vitamins|vitamins|mesh-ancestor
110228937|NCT02885753|Micronutrients|micronutrients|mesh-ancestor
110228938|NCT02885753|Hematinics|hematinics|mesh-ancestor
110228939|NCT02815592|Carboplatin|carboplatin|mesh-list
110228940|NCT02815592|Etoposide|etoposide|mesh-list
110228941|NCT02815592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110228942|NCT02815592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110228943|NCT02815592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110228944|NCT02815592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110228945|NCT02815592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110228946|NCT02815592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228947|NCT02790853|Proflavine|proflavine|mesh-list
110228948|NCT02790853|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110228949|NCT02790853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110228950|NCT02780583|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110228951|NCT02780583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110228952|NCT02754583|Azithromycin|azithromycin|mesh-list
110228953|NCT02754583|Tetracycline|tetracycline|mesh-list
110228954|NCT02754583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110228955|NCT02754583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110228956|NCT02754583|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110228957|NCT02754583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110228958|NCT02754583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228960|NCT02741323|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110228961|NCT02741323|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110228962|NCT02741323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228964|NCT02741323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110228965|NCT02741323|Antiviral Agents|antiviral agents|mesh-ancestor
110228966|NCT02741323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110228967|NCT02741323|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110228968|NCT02726997|Paclitaxel|paclitaxel|mesh-list
110228969|NCT02726997|Carboplatin|carboplatin|mesh-list
110228970|NCT02726997|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110228971|NCT02726997|Durvalumab|durvalumab|mesh-list
110228972|NCT02726997|Immunoglobulins|immunoglobulins|mesh-list
110228973|NCT02726997|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110228974|NCT02726997|Immunoglobulin G|immunoglobulin g|mesh-list
110228975|NCT02726997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110228976|NCT02726997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110228977|NCT02726997|Tubulin Modulators|tubulin modulators|mesh-ancestor
110228978|NCT02726997|Antimitotic Agents|antimitotic agents|mesh-ancestor
110228979|NCT02726997|Mitosis Modulators|mitosis modulators|mesh-ancestor
110228980|NCT02726997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228981|NCT02726997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110228982|NCT02726997|Immunologic Factors|immunologic factors|mesh-ancestor
110228983|NCT02726997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110228984|NCT02703220|Acetazolamide|acetazolamide|mesh-list
110228985|NCT02703220|Finasteride|finasteride|mesh-list
110228986|NCT02703220|Anticonvulsants|anticonvulsants|mesh-ancestor
110228987|NCT02703220|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110228988|NCT02703220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110228989|NCT02703220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228990|NCT02703220|Diuretics|diuretics|mesh-ancestor
110228991|NCT02703220|Natriuretic Agents|natriuretic agents|mesh-ancestor
110228992|NCT02703220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110228993|NCT02703220|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110228994|NCT02703220|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110228995|NCT02703220|Hormone Antagonists|hormone antagonists|mesh-ancestor
110228996|NCT02703220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110228997|NCT02703220|Urological Agents|urological agents|mesh-ancestor
110228998|NCT02677051|Sulforaphane|sulforaphane|mesh-list
110228999|NCT02677051|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110229000|NCT02677051|Protective Agents|protective agents|mesh-ancestor
110229001|NCT02677051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110229002|NCT02677051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110229003|NCT02638701|Infliximab|infliximab|mesh-list
110229004|NCT02638701|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110229005|NCT02638701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110229006|NCT02638701|Dermatologic Agents|dermatologic agents|mesh-ancestor
110229007|NCT02638701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110229008|NCT02638701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110229009|NCT02615184|Dexlansoprazole|dexlansoprazole|mesh-list
110229010|NCT02615184|Lansoprazole|lansoprazole|mesh-list
110229011|NCT02615184|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110229012|NCT02615184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110229013|NCT02615184|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110229014|NCT02615184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110229015|NCT02615184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110229016|NCT02595866|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110229017|NCT02595866|Pembrolizumab|pembrolizumab|mesh-list
110229018|NCT02595866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110229019|NCT02595866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110229020|NCT02595866|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110229021|NCT02595866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110229022|NCT02595866|Antiviral Agents|antiviral agents|mesh-ancestor
110229023|NCT02595866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110229024|NCT02520063|Everolimus|everolimus|mesh-list
110229025|NCT02520063|Letrozole|letrozole|mesh-list
110229026|NCT02520063|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110229027|NCT02520063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110229028|NCT02520063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110229029|NCT02520063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110229030|NCT02520063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110229031|NCT02520063|Immunologic Factors|immunologic factors|mesh-ancestor
110229032|NCT02520063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110229033|NCT02520063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110229034|NCT02520063|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110229035|NCT02520063|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110229036|NCT02520063|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110229037|NCT02520063|Hormone Antagonists|hormone antagonists|mesh-ancestor
110229038|NCT02520063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110229039|NCT02494258|Azacitidine|azacitidine|mesh-list
110229041|NCT02494258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110229042|NCT02494258|Antimetabolites|antimetabolites|mesh-ancestor
110229043|NCT02494258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110229044|NCT02494258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110229045|NCT02494258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110229046|NCT02484404|Durvalumab|durvalumab|mesh-list
110229047|NCT02484404|Olaparib|olaparib|mesh-list
110229048|NCT02484404|Cediranib|cediranib|mesh-list
110229049|NCT02484404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110229050|NCT02484404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110229051|NCT02484404|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110229052|NCT02484404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110229053|NCT02484404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110229054|NCT02484404|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110229055|NCT02480803|Levodopa|levodopa|mesh-list
110229056|NCT02480803|Carbidopa|carbidopa|mesh-list
110229057|NCT02480803|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110229058|NCT02480803|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110229059|NCT02480803|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110229060|NCT02480803|Dopamine Agents|dopamine agents|mesh-ancestor
110229061|NCT02480803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110229062|NCT02480803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110229063|NCT02480803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110229064|NCT02480803|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110229065|NCT02480803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110229066|NCT02480803|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110229067|NCT02480803|Immunologic Factors|immunologic factors|mesh-ancestor
110229068|NCT02480803|Dopamine Agonists|dopamine agonists|mesh-ancestor
110229069|NCT02475681|Obinutuzumab|obinutuzumab|mesh-list
110229070|NCT02475681|Acalabrutinib|acalabrutinib|mesh-list
110229071|NCT02475681|Chlorambucil|chlorambucil|mesh-list
110229072|NCT02475681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110229073|NCT02475681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110229074|NCT02475681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110229075|NCT02475681|Alkylating Agents|alkylating agents|mesh-ancestor
110229076|NCT02475681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110229077|NCT02471391|Venetoclax|venetoclax|mesh-list
110229078|NCT02471391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110229079|NCT02426125|Docetaxel|docetaxel|mesh-list
110229080|NCT02426125|Ramucirumab|ramucirumab|mesh-list
110229081|NCT02426125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110229082|NCT02426125|Tubulin Modulators|tubulin modulators|mesh-ancestor
110229083|NCT02426125|Antimitotic Agents|antimitotic agents|mesh-ancestor
110229084|NCT02426125|Mitosis Modulators|mitosis modulators|mesh-ancestor
110229085|NCT02426125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110229086|NCT02395497|Antibodies|antibodies|mesh-list
110229087|NCT02395497|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110229088|NCT02395497|Tacrolimus|tacrolimus|mesh-list
110229089|NCT02395497|Immunologic Factors|immunologic factors|mesh-ancestor
110229090|NCT02395497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110229091|NCT02395497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110229093|NCT02395497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110229094|NCT02395497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110229095|NCT02362594|Pembrolizumab|pembrolizumab|mesh-list
110229096|NCT02362594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110263989|NCT04687111|Valsartan|valsartan|mesh-list
110229097|NCT02362594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110229098|NCT02362594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110229099|NCT02362594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110229101|NCT02355379|Fluorouracil|fluorouracil|mesh-list
110229102|NCT02355379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110229103|NCT02355379|Antimetabolites|antimetabolites|mesh-ancestor
110229104|NCT02355379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110229105|NCT02355379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110229106|NCT02355379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110229107|NCT02355379|Immunologic Factors|immunologic factors|mesh-ancestor
110229108|NCT02355379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110229109|NCT02346747|Immunomodulating Agents|immunomodulating agents|mesh-list
110229110|NCT02346747|Immunologic Factors|immunologic factors|mesh-ancestor
110229111|NCT02346747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110229112|NCT02157974|Exenatide|exenatide|mesh-list
110229113|NCT02157974|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110229114|NCT02157974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110229115|NCT02157974|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110229116|NCT02157974|Incretins|incretins|mesh-ancestor
110229117|NCT02157974|Hormones|hormones|mesh-ancestor
110229118|NCT02157974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110229119|NCT02140255|Ritonavir|ritonavir|mesh-list
110229120|NCT02140255|Lopinavir|lopinavir|mesh-list
110229121|NCT02140255|Raltegravir Potassium|raltegravir potassium|mesh-list
110229122|NCT02140255|Nevirapine|nevirapine|mesh-list
110229123|NCT02140255|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
110229124|NCT02140255|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110229125|NCT02140255|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110229126|NCT02140255|Protease Inhibitors|protease inhibitors|mesh-ancestor
110229127|NCT02140255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110229128|NCT02140255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110229129|NCT02140255|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110229130|NCT02140255|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110229131|NCT02140255|Antiviral Agents|antiviral agents|mesh-ancestor
110229132|NCT02140255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110229133|NCT02140255|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110229134|NCT02140255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110229135|NCT02140255|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110229136|NCT02140255|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110229137|NCT02140255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110229138|NCT02140255|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110229139|NCT02140255|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110229140|NCT02120365|Anticonvulsants|anticonvulsants|mesh-list
110229141|NCT02085148|Irinotecan|irinotecan|mesh-list
110229142|NCT02085148|Vincristine|vincristine|mesh-list
110229143|NCT02085148|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110229144|NCT02085148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110229145|NCT02085148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110229146|NCT02085148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110229147|NCT02085148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110229148|NCT02085148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110229149|NCT02085148|Tubulin Modulators|tubulin modulators|mesh-ancestor
110229150|NCT02085148|Antimitotic Agents|antimitotic agents|mesh-ancestor
110229151|NCT02085148|Mitosis Modulators|mitosis modulators|mesh-ancestor
110229152|NCT02081378|Imatinib Mesylate|imatinib mesylate|mesh-list
110229154|NCT02081378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110229155|NCT02081378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110229156|NCT02081378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110263991|NCT04687111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110229157|NCT02081378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110229159|NCT02046395|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110229160|NCT02046395|Hydralazine|hydralazine|mesh-list
110229161|NCT02046395|Terazosin|terazosin|mesh-list
110229162|NCT02046395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110229163|NCT02046395|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110229164|NCT02046395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110229165|NCT02046395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110229166|NCT02046395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110229167|NCT02046395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110229168|NCT02046395|Vasodilator Agents|vasodilator agents|mesh-ancestor
110229169|NCT02046395|Diuretics|diuretics|mesh-ancestor
110229170|NCT02046395|Natriuretic Agents|natriuretic agents|mesh-ancestor
110229171|NCT02046395|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110229172|NCT02046395|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110229173|NCT02046395|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110229174|NCT02046395|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110229175|NCT02046395|Adrenergic Agents|adrenergic agents|mesh-ancestor
110229176|NCT02046395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110229177|NCT02046395|Urological Agents|urological agents|mesh-ancestor
110229178|NCT02037126|Diphenhydramine|diphenhydramine|mesh-list
110229179|NCT02037126|Promethazine|promethazine|mesh-list
110229180|NCT02037126|Psilocybin|psilocybin|mesh-list
110229181|NCT02037126|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110229182|NCT02037126|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110229183|NCT02037126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110229184|NCT02037126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110229185|NCT02037126|Anesthetics, Local|anesthetics, local|mesh-ancestor
110229186|NCT02037126|Anesthetics|anesthetics|mesh-ancestor
110229187|NCT02037126|Sensory System Agents|sensory system agents|mesh-ancestor
110229188|NCT02037126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110229189|NCT02037126|Antiemetics|antiemetics|mesh-ancestor
110229190|NCT02037126|Autonomic Agents|autonomic agents|mesh-ancestor
110229191|NCT02037126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110229192|NCT02037126|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110229193|NCT02037126|Histamine Antagonists|histamine antagonists|mesh-ancestor
110229194|NCT02037126|Histamine Agents|histamine agents|mesh-ancestor
110229195|NCT02037126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110021282|NCT00002532|Vindesine|vindesine|mesh-list
110229196|NCT02037126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110229197|NCT02037126|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110229198|NCT02037126|Antipruritics|antipruritics|mesh-ancestor
110229199|NCT02037126|Dermatologic Agents|dermatologic agents|mesh-ancestor
110229200|NCT02037126|Hallucinogens|hallucinogens|mesh-ancestor
110229201|NCT02037126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110229202|NCT01954979|Abatacept|abatacept|mesh-list
110229203|NCT01954979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110229204|NCT01954979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110229205|NCT01954979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110229206|NCT01954979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110229207|NCT01954979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110229208|NCT01954979|Immunologic Factors|immunologic factors|mesh-ancestor
110229209|NCT01954979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110229210|NCT01954979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110229211|NCT01861106|Mycophenolic Acid|mycophenolic acid|mesh-list
110229212|NCT01861106|Cyclophosphamide|cyclophosphamide|mesh-list
110229213|NCT01861106|Busulfan|busulfan|mesh-list
110229215|NCT01861106|Fludarabine phosphate|fludarabine phosphate|mesh-list
110229216|NCT01861106|Tacrolimus|tacrolimus|mesh-list
110229218|NCT01861106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110229219|NCT01861106|Immunologic Factors|immunologic factors|mesh-ancestor
110229220|NCT01861106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110229221|NCT01861106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110229222|NCT01861106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110229223|NCT01861106|Alkylating Agents|alkylating agents|mesh-ancestor
110229224|NCT01861106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110229225|NCT01861106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110229226|NCT01861106|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110264007|NCT00533026|Warfarin|warfarin|mesh-list
110229227|NCT01861106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110229228|NCT01861106|Antimetabolites|antimetabolites|mesh-ancestor
110229229|NCT01861106|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110229230|NCT01861106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110229231|NCT01861106|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110229232|NCT01861106|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110229233|NCT01861106|Antitubercular Agents|antitubercular agents|mesh-ancestor
110229234|NCT01861106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110229235|NCT01861106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110229236|NCT01854775|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110229237|NCT01854775|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110229238|NCT01854775|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110229239|NCT01854775|Antiviral Agents|antiviral agents|mesh-ancestor
110229240|NCT01854775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110229241|NCT01851642|Albuterol|albuterol|mesh-list
110229242|NCT01851642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110229243|NCT01851642|Autonomic Agents|autonomic agents|mesh-ancestor
110229244|NCT01851642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110229245|NCT01851642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110229246|NCT01851642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110229247|NCT01851642|Respiratory System Agents|respiratory system agents|mesh-ancestor
110229248|NCT01851642|Tocolytic Agents|tocolytic agents|mesh-ancestor
110229249|NCT01851642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110229250|NCT01851642|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110229251|NCT01851642|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110229252|NCT01851642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110229253|NCT01851642|Adrenergic Agents|adrenergic agents|mesh-ancestor
110229254|NCT01851642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110229255|NCT01851642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110229256|NCT01838187|Vorinostat|vorinostat|mesh-list
110229257|NCT01838187|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
110229258|NCT01838187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110229259|NCT01838187|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110229260|NCT01838187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110229261|NCT01838187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110229262|NCT01838187|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110229263|NCT01828099|Carboplatin|carboplatin|mesh-list
110229264|NCT01828099|Pemetrexed|pemetrexed|mesh-list
110229265|NCT01828099|Ceritinib|ceritinib|mesh-list
110229266|NCT01828099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110229267|NCT01828099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110229268|NCT01828099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110229269|NCT01828099|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110229270|NCT01828099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110229271|NCT01828099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110229272|NCT01515527|Cytarabine|cytarabine|mesh-list
110229273|NCT01515527|Decitabine|decitabine|mesh-list
110229274|NCT01515527|Cladribine|cladribine|mesh-list
110229275|NCT01515527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110229276|NCT01515527|Antimetabolites|antimetabolites|mesh-ancestor
110229277|NCT01515527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110229278|NCT01515527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110229279|NCT01515527|Antiviral Agents|antiviral agents|mesh-ancestor
110229280|NCT01515527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110229281|NCT01515527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110229282|NCT01515527|Immunologic Factors|immunologic factors|mesh-ancestor
110264021|NCT00152126|Melphalan|melphalan|mesh-list
110229283|NCT01515527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110229284|NCT01515527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110229285|NCT01454154|Glyburide|glyburide|mesh-list
110229286|NCT01454154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110229287|NCT01454154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110229288|NCT01445509|Bevacizumab|bevacizumab|mesh-list
110229289|NCT01445509|Dasatinib|dasatinib|mesh-list
110229290|NCT01445509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110229291|NCT01445509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110229292|NCT01445509|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110229293|NCT01445509|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110229294|NCT01445509|Growth Substances|growth substances|mesh-ancestor
110229295|NCT01445509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110229297|NCT01445509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110229298|NCT01445509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110229299|NCT01445509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110229300|NCT01367301|Paclitaxel|paclitaxel|mesh-list
110229301|NCT01367301|Carboplatin|carboplatin|mesh-list
110229302|NCT01367301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110229303|NCT01367301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110229304|NCT01367301|Tubulin Modulators|tubulin modulators|mesh-ancestor
110229305|NCT01367301|Antimitotic Agents|antimitotic agents|mesh-ancestor
110229306|NCT01367301|Mitosis Modulators|mitosis modulators|mesh-ancestor
110229307|NCT01367301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110229308|NCT01352962|Carboplatin|carboplatin|mesh-list
110229309|NCT01352962|Gemcitabine|gemcitabine|mesh-list
110229310|NCT01352962|Lenalidomide|lenalidomide|mesh-list
110229311|NCT01352962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110229312|NCT01352962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110229313|NCT01352962|Antimetabolites|antimetabolites|mesh-ancestor
110229314|NCT01352962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110229315|NCT01352962|Immunologic Factors|immunologic factors|mesh-ancestor
110229316|NCT01352962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110229317|NCT01352962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110229318|NCT01352962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110229319|NCT01352962|Growth Substances|growth substances|mesh-ancestor
110229320|NCT01352962|Growth Inhibitors|growth inhibitors|mesh-ancestor
110229321|NCT01294020|Tacrolimus|tacrolimus|mesh-list
110229322|NCT01294020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110229323|NCT01294020|Immunologic Factors|immunologic factors|mesh-ancestor
110229324|NCT01294020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110229325|NCT01294020|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110229326|NCT01294020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110229327|NCT01294020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110229328|NCT01220583|Cisplatin|cisplatin|mesh-list
110229329|NCT01220583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110229330|NCT01199575|Rituximab|rituximab|mesh-list
110229332|NCT01199575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110229333|NCT01199575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110229334|NCT01199575|Immunologic Factors|immunologic factors|mesh-ancestor
110229335|NCT01199575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110229336|NCT01199575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110229337|NCT01199575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110264031|NCT05039593|Chlorhexidine|chlorhexidine|mesh-list
110229338|NCT01199575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110229339|NCT01199575|Growth Substances|growth substances|mesh-ancestor
110229340|NCT01199575|Growth Inhibitors|growth inhibitors|mesh-ancestor
110229341|NCT01166594|Bevacizumab|bevacizumab|mesh-list
110229342|NCT01166594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110229343|NCT01166594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110229344|NCT01166594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110229345|NCT01166594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110229346|NCT01166594|Growth Substances|growth substances|mesh-ancestor
110229347|NCT01166594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110229348|NCT01166594|Growth Inhibitors|growth inhibitors|mesh-ancestor
110229349|NCT00980954|Paclitaxel|paclitaxel|mesh-list
110229350|NCT00980954|Carboplatin|carboplatin|mesh-list
110229351|NCT00980954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110229352|NCT00980954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110229353|NCT00980954|Tubulin Modulators|tubulin modulators|mesh-ancestor
110229354|NCT00980954|Antimitotic Agents|antimitotic agents|mesh-ancestor
110229355|NCT00980954|Mitosis Modulators|mitosis modulators|mesh-ancestor
110229356|NCT00980954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110229357|NCT00871013|Thalidomide|thalidomide|mesh-list
110229358|NCT00871013|Dexamethasone|dexamethasone|mesh-list
110229359|NCT00871013|Cyclophosphamide|cyclophosphamide|mesh-list
110229360|NCT00871013|Melphalan|melphalan|mesh-list
110229361|NCT00871013|Doxorubicin|doxorubicin|mesh-list
110229362|NCT00871013|Etoposide|etoposide|mesh-list
110229363|NCT00871013|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110229364|NCT00871013|Bortezomib|bortezomib|mesh-list
110229365|NCT00871013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110229366|NCT00871013|Immunologic Factors|immunologic factors|mesh-ancestor
110229367|NCT00871013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110229368|NCT00871013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110229369|NCT00871013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110229370|NCT00871013|Alkylating Agents|alkylating agents|mesh-ancestor
110229371|NCT00871013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110229372|NCT00871013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110229373|NCT00871013|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110229374|NCT00871013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110229375|NCT00871013|Antiemetics|antiemetics|mesh-ancestor
110229376|NCT00871013|Autonomic Agents|autonomic agents|mesh-ancestor
110229377|NCT00871013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110229378|NCT00871013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110229379|NCT00871013|Glucocorticoids|glucocorticoids|mesh-ancestor
110229380|NCT00871013|Hormones|hormones|mesh-ancestor
110229381|NCT00871013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110229382|NCT00871013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110229383|NCT00871013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110229384|NCT00871013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110229385|NCT00871013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110229386|NCT00871013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110229387|NCT00871013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110229388|NCT00871013|Leprostatic Agents|leprostatic agents|mesh-ancestor
110229389|NCT00871013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110229390|NCT00871013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110264053|NCT00152204|Pyrimethamine|pyrimethamine|mesh-list
110229391|NCT00871013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110229392|NCT00871013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110229393|NCT00871013|Growth Substances|growth substances|mesh-ancestor
110229394|NCT00871013|Growth Inhibitors|growth inhibitors|mesh-ancestor
110229396|NCT00694850|Enzyme Activators|enzyme activators|mesh-ancestor
110229397|NCT00694850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110229398|NCT00585650|Etanercept|etanercept|mesh-list
110229399|NCT00585650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110229400|NCT00585650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110229401|NCT00585650|Analgesics|analgesics|mesh-ancestor
110229402|NCT00585650|Sensory System Agents|sensory system agents|mesh-ancestor
110229403|NCT00585650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110229404|NCT00585650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110229405|NCT00585650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110229406|NCT00585650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110229407|NCT00585650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110229408|NCT00585650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110229409|NCT00585650|Immunologic Factors|immunologic factors|mesh-ancestor
110229410|NCT00172029|Zoledronic Acid|zoledronic acid|mesh-list
110229411|NCT00172029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110229412|NCT00172029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110229413|NCT00085202|Cyclophosphamide|cyclophosphamide|mesh-list
110229414|NCT00085202|Vincristine|vincristine|mesh-list
110229415|NCT00085202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110229416|NCT00085202|Immunologic Factors|immunologic factors|mesh-ancestor
110229417|NCT00085202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110229418|NCT00085202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110229419|NCT00085202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110229421|NCT00085202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110229422|NCT00085202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110229423|NCT00085202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110229424|NCT00085202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110229425|NCT00085202|Tubulin Modulators|tubulin modulators|mesh-ancestor
110229426|NCT00085202|Antimitotic Agents|antimitotic agents|mesh-ancestor
110229427|NCT00085202|Mitosis Modulators|mitosis modulators|mesh-ancestor
110229428|NCT00076310|Cisplatin|cisplatin|mesh-list
110229429|NCT00076310|Docetaxel|docetaxel|mesh-list
110229430|NCT00076310|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110229431|NCT00076310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110229432|NCT00076310|Tubulin Modulators|tubulin modulators|mesh-ancestor
110229433|NCT00076310|Antimitotic Agents|antimitotic agents|mesh-ancestor
110229434|NCT00076310|Mitosis Modulators|mitosis modulators|mesh-ancestor
110229435|NCT00076310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110229436|NCT00076310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110229437|NCT00076310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110229438|NCT00039130|Leucovorin|leucovorin|mesh-list
110229439|NCT00039130|Cytarabine|cytarabine|mesh-list
110229440|NCT00039130|Dexamethasone|dexamethasone|mesh-list
110229441|NCT00039130|Prednisone|prednisone|mesh-list
110229442|NCT00039130|Cyclophosphamide|cyclophosphamide|mesh-list
110229443|NCT00039130|Ifosfamide|ifosfamide|mesh-list
110229444|NCT00039130|Rituximab|rituximab|mesh-list
110229445|NCT00039130|Doxorubicin|doxorubicin|mesh-list
110229446|NCT00039130|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110229447|NCT00039130|Methotrexate|methotrexate|mesh-list
110229448|NCT00039130|Etoposide|etoposide|mesh-list
110229449|NCT00039130|Vincristine|vincristine|mesh-list
110229450|NCT00039130|Allopurinol|allopurinol|mesh-list
110229451|NCT00039130|Levoleucovorin|levoleucovorin|mesh-list
110229452|NCT00039130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110229453|NCT00039130|Immunologic Factors|immunologic factors|mesh-ancestor
110229454|NCT00039130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110229455|NCT00039130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110229456|NCT00039130|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110229457|NCT00039130|Alkylating Agents|alkylating agents|mesh-ancestor
110229458|NCT00039130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110229459|NCT00039130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110229460|NCT00039130|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110229461|NCT00039130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110229462|NCT00039130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110229463|NCT00039130|Antiemetics|antiemetics|mesh-ancestor
110229464|NCT00039130|Autonomic Agents|autonomic agents|mesh-ancestor
110229465|NCT00039130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110229466|NCT00039130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110229467|NCT00039130|Glucocorticoids|glucocorticoids|mesh-ancestor
110229468|NCT00039130|Hormones|hormones|mesh-ancestor
110229469|NCT00039130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110229470|NCT00039130|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110229471|NCT00039130|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110229472|NCT00039130|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110229473|NCT00039130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110229474|NCT00039130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110229475|NCT00039130|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110229476|NCT00039130|Abortifacient Agents|abortifacient agents|mesh-ancestor
110229477|NCT00039130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110229478|NCT00039130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110229479|NCT00039130|Antimetabolites|antimetabolites|mesh-ancestor
110229480|NCT00039130|Dermatologic Agents|dermatologic agents|mesh-ancestor
110229481|NCT00039130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110229482|NCT00039130|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110229483|NCT00039130|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110229484|NCT00039130|Antiviral Agents|antiviral agents|mesh-ancestor
110229485|NCT00039130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110229486|NCT00039130|Antidotes|antidotes|mesh-ancestor
110229487|NCT00039130|Protective Agents|protective agents|mesh-ancestor
110229488|NCT00039130|Vitamin B Complex|vitamin b complex|mesh-ancestor
110229489|NCT00039130|Vitamins|vitamins|mesh-ancestor
110229491|NCT00039130|Tubulin Modulators|tubulin modulators|mesh-ancestor
110229492|NCT00039130|Antimitotic Agents|antimitotic agents|mesh-ancestor
110229493|NCT00039130|Mitosis Modulators|mitosis modulators|mesh-ancestor
110229494|NCT00039130|Gout Suppressants|gout suppressants|mesh-ancestor
110229495|NCT00039130|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110229496|NCT00039130|Antioxidants|antioxidants|mesh-ancestor
110229497|NCT00002889|Leuprolide|leuprolide|mesh-list
110229498|NCT00002889|Goserelin|goserelin|mesh-list
110229499|NCT00002889|Flutamide|flutamide|mesh-list
110229500|NCT00002889|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110229501|NCT00002889|Fertility Agents|fertility agents|mesh-ancestor
110229502|NCT00002889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110229503|NCT00002889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110229504|NCT00002889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110229505|NCT00002889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110229506|NCT00002889|Androgen Antagonists|androgen antagonists|mesh-ancestor
110229507|NCT00002889|Hormone Antagonists|hormone antagonists|mesh-ancestor
110229508|NCT00002889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110229509|NCT00122577|Ritonavir|ritonavir|mesh-list
110229510|NCT00122577|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110229511|NCT00122577|Tenofovir|tenofovir|mesh-list
110229512|NCT00122577|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110229513|NCT00122577|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110229514|NCT00122577|Protease Inhibitors|protease inhibitors|mesh-ancestor
110229516|NCT00122577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110229517|NCT00122577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110229518|NCT00122577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110229519|NCT00122577|Antiviral Agents|antiviral agents|mesh-ancestor
110229520|NCT00122577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110229521|NCT00122577|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110229522|NCT00122577|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110229523|NCT00122577|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110229524|NCT00122577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110229525|NCT00313261|Clevudine|clevudine|mesh-list
110229526|NCT00313261|Antiviral Agents|antiviral agents|mesh-ancestor
110229527|NCT00313261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110229528|NCT00425074|Aspirin|aspirin|mesh-list
110229529|NCT00425074|Salicylic Acid|salicylic acid|mesh-list
110229530|NCT00425074|Salicylates|salicylates|mesh-list
110229531|NCT00425074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110229532|NCT00425074|Antifungal Agents|antifungal agents|mesh-ancestor
110229533|NCT00425074|Keratolytic Agents|keratolytic agents|mesh-ancestor
110229534|NCT00425074|Dermatologic Agents|dermatologic agents|mesh-ancestor
110229535|NCT00425074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110229536|NCT00425074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110229537|NCT00425074|Analgesics|analgesics|mesh-ancestor
110229538|NCT00425074|Sensory System Agents|sensory system agents|mesh-ancestor
110229539|NCT00425074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110229540|NCT00425074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110229541|NCT00425074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110229542|NCT00425074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110229543|NCT00425074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110229544|NCT00425074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110229545|NCT00425074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110229546|NCT00425074|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110229547|NCT00425074|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110229548|NCT00425074|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110229549|NCT00425074|Antipyretics|antipyretics|mesh-ancestor
110229550|NCT00425152|Leucovorin|leucovorin|mesh-list
110229551|NCT00425152|Levamisole|levamisole|mesh-list
110229552|NCT00425152|Fluorouracil|fluorouracil|mesh-list
110229553|NCT00425152|Calcium|calcium|mesh-list
110229554|NCT00425152|Levoleucovorin|levoleucovorin|mesh-list
110229555|NCT00425152|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110229556|NCT00425152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110229557|NCT00425152|Antimetabolites|antimetabolites|mesh-ancestor
110229558|NCT00425152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110229559|NCT00425152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110229560|NCT00425152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110229561|NCT00425152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110229562|NCT00425152|Immunologic Factors|immunologic factors|mesh-ancestor
110229563|NCT00425152|Antidotes|antidotes|mesh-ancestor
110229564|NCT00425152|Protective Agents|protective agents|mesh-ancestor
110229565|NCT00425152|Vitamin B Complex|vitamin b complex|mesh-ancestor
110229566|NCT00425152|Vitamins|vitamins|mesh-ancestor
110229567|NCT00425152|Micronutrients|micronutrients|mesh-ancestor
110229568|NCT00425152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110229569|NCT00425152|Antinematodal Agents|antinematodal agents|mesh-ancestor
110229570|NCT00425152|Anthelmintics|anthelmintics|mesh-ancestor
110229571|NCT00425152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110229572|NCT00425152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110229573|NCT00425152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110229574|NCT00314314|Insulin|insulin|mesh-list
110229575|NCT00314314|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110229576|NCT00314314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110229577|NCT00122616|Ribavirin|ribavirin|mesh-list
110229578|NCT00122616|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110229579|NCT00122616|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110229580|NCT00122616|Antimetabolites|antimetabolites|mesh-ancestor
110229581|NCT00122616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110229582|NCT00122616|Antiviral Agents|antiviral agents|mesh-ancestor
110229583|NCT00122616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110229584|NCT04984070|Metformin|metformin|mesh-list
110229585|NCT04984070|Drospirenone|drospirenone|mesh-list
110229586|NCT04984070|Contraceptive Agents|contraceptive agents|mesh-list
110229587|NCT04984070|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110229588|NCT04984070|Contraceptives, Oral|contraceptives, oral|mesh-list
110229589|NCT04984070|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
110229590|NCT04984070|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
110229591|NCT04984070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110229592|NCT04984070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110229593|NCT04984070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110229595|NCT04984070|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110229596|NCT04984070|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110229597|NCT04984070|Estrogens|estrogens|mesh-ancestor
110229598|NCT04984070|Hormones|hormones|mesh-ancestor
110229599|NCT04984070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110229600|NCT04984070|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110229601|NCT04984070|Hormone Antagonists|hormone antagonists|mesh-ancestor
110229602|NCT04984070|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110229603|NCT04984070|Diuretics|diuretics|mesh-ancestor
110229604|NCT04984070|Natriuretic Agents|natriuretic agents|mesh-ancestor
110229605|NCT00314509|Ciclesonide|ciclesonide|mesh-list
110229606|NCT00314509|Formoterol Fumarate|formoterol fumarate|mesh-list
110229607|NCT00314509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110229608|NCT00314509|Autonomic Agents|autonomic agents|mesh-ancestor
110229609|NCT00314509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110229610|NCT00314509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110229611|NCT00314509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110229612|NCT00314509|Respiratory System Agents|respiratory system agents|mesh-ancestor
110229613|NCT00314509|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110229614|NCT00314509|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110229616|NCT00314509|Adrenergic Agents|adrenergic agents|mesh-ancestor
110229617|NCT00314509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110229618|NCT00314509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110229619|NCT00314509|Glucocorticoids|glucocorticoids|mesh-ancestor
110229620|NCT00314509|Hormones|hormones|mesh-ancestor
110229621|NCT00314509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110229622|NCT00314509|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110229623|NCT00314548|Epoprostenol|epoprostenol|mesh-list
110229624|NCT00314548|Alprostadil|alprostadil|mesh-list
110229625|NCT00314548|Tezosentan|tezosentan|mesh-list
110229626|NCT00314548|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110229627|NCT00314548|Vasodilator Agents|vasodilator agents|mesh-ancestor
110229628|NCT00314548|Urological Agents|urological agents|mesh-ancestor
110229629|NCT00314548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110229630|NCT00314626|Lamivudine|lamivudine|mesh-list
110229631|NCT00314626|Efavirenz|efavirenz|mesh-list
110229632|NCT00314626|Abacavir|abacavir|mesh-list
110229633|NCT00314626|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110229634|NCT00314626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110229635|NCT00314626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110229636|NCT00314626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110229637|NCT00314626|Antiviral Agents|antiviral agents|mesh-ancestor
110229638|NCT00314626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110229639|NCT00314626|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110229640|NCT00314626|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110229641|NCT00314626|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110229642|NCT00314626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110229643|NCT00314626|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110229644|NCT00314626|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110229645|NCT00314626|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110229646|NCT00314626|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110229647|NCT00314665|Thalidomide|thalidomide|mesh-list
110229648|NCT00314665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110229649|NCT00314665|Immunologic Factors|immunologic factors|mesh-ancestor
110229650|NCT00314665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110229651|NCT00314665|Leprostatic Agents|leprostatic agents|mesh-ancestor
110229652|NCT00314665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110229653|NCT00314665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110229654|NCT00314665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110229655|NCT00314665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110229656|NCT00314665|Growth Substances|growth substances|mesh-ancestor
110229657|NCT00314665|Growth Inhibitors|growth inhibitors|mesh-ancestor
110229658|NCT00314665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110229659|NCT00314704|Dopamine|dopamine|mesh-list
110229660|NCT00314704|Norepinephrine|norepinephrine|mesh-list
110229661|NCT00314704|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110229662|NCT00314704|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110229663|NCT00314704|Adrenergic Agents|adrenergic agents|mesh-ancestor
110229664|NCT00314704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110229665|NCT00314704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110229666|NCT00314704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110229667|NCT00314704|Sympathomimetics|sympathomimetics|mesh-ancestor
110229668|NCT00314704|Autonomic Agents|autonomic agents|mesh-ancestor
110229669|NCT00314704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110229670|NCT00314704|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110229671|NCT00314704|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110229672|NCT00314704|Dopamine Agents|dopamine agents|mesh-ancestor
110229673|NCT00314704|Protective Agents|protective agents|mesh-ancestor
110229674|NCT00090909|Dexamethasone|dexamethasone|mesh-list
110229675|NCT00090909|Gemcitabine|gemcitabine|mesh-list
110229676|NCT00090909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110229677|NCT00090909|Antiemetics|antiemetics|mesh-ancestor
110229678|NCT00090909|Autonomic Agents|autonomic agents|mesh-ancestor
110229679|NCT00090909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110229680|NCT00090909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110229681|NCT00090909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110229682|NCT00090909|Glucocorticoids|glucocorticoids|mesh-ancestor
110229684|NCT00090909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110229685|NCT00090909|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110229686|NCT00090909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110229687|NCT00090909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110229688|NCT00090909|Antimetabolites|antimetabolites|mesh-ancestor
110229689|NCT00090909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110229690|NCT04943627|Gemcitabine|gemcitabine|mesh-list
110229691|NCT04943627|Irinotecan|irinotecan|mesh-list
110229692|NCT04943627|Pemetrexed|pemetrexed|mesh-list
110229693|NCT04943627|Topotecan|topotecan|mesh-list
110229694|NCT04943627|Vinorelbine|vinorelbine|mesh-list
110229695|NCT04943627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110229696|NCT04943627|Antimetabolites|antimetabolites|mesh-ancestor
110229697|NCT04943627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110229698|NCT04943627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110229699|NCT04943627|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110229700|NCT04943627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110229701|NCT04943627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110229702|NCT04943627|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110229703|NCT04943627|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110229704|NCT04943627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110229705|NCT04943627|Tubulin Modulators|tubulin modulators|mesh-ancestor
110229706|NCT04943627|Antimitotic Agents|antimitotic agents|mesh-ancestor
110229707|NCT04943627|Mitosis Modulators|mitosis modulators|mesh-ancestor
110229708|NCT00314743|Dexamethasone|dexamethasone|mesh-list
110229709|NCT00314743|Ondansetron|ondansetron|mesh-list
110229710|NCT00314743|Aprepitant|aprepitant|mesh-list
110229711|NCT00314743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110229712|NCT00314743|Antiemetics|antiemetics|mesh-ancestor
110229714|NCT00314743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110229715|NCT00314743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110229716|NCT00314743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110229717|NCT00314743|Glucocorticoids|glucocorticoids|mesh-ancestor
110229718|NCT00314743|Hormones|hormones|mesh-ancestor
110229719|NCT00314743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110229720|NCT00314743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110229721|NCT00314743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110229722|NCT00314743|Antipruritics|antipruritics|mesh-ancestor
110229723|NCT00314743|Dermatologic Agents|dermatologic agents|mesh-ancestor
110229724|NCT00314743|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110229725|NCT00314743|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110229727|NCT00314743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110229728|NCT00314743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110229729|NCT00314743|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110229730|NCT00314782|Docetaxel|docetaxel|mesh-list
110229731|NCT00314782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110229732|NCT00314782|Tubulin Modulators|tubulin modulators|mesh-ancestor
110229733|NCT00314782|Antimitotic Agents|antimitotic agents|mesh-ancestor
110229734|NCT00314782|Mitosis Modulators|mitosis modulators|mesh-ancestor
110229735|NCT00314782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110229736|NCT00122655|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
110229737|NCT00122655|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
110229738|NCT00122655|Protease Inhibitors|protease inhibitors|mesh-list
110229739|NCT00122655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110229740|NCT00122655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110229741|NCT00122655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110229742|NCT00122655|Antiviral Agents|antiviral agents|mesh-ancestor
110229743|NCT00122655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110229744|NCT00122655|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110229745|NCT00122655|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110229746|NCT00122655|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110229747|NCT00314821|Ropinirole|ropinirole|mesh-list
110229748|NCT00314821|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110229749|NCT00314821|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110229750|NCT00314821|Dopamine Agonists|dopamine agonists|mesh-ancestor
110229751|NCT00314821|Dopamine Agents|dopamine agents|mesh-ancestor
110229752|NCT00314821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110229753|NCT00314821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110229754|NCT00314821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110229755|NCT00314860|Ropinirole|ropinirole|mesh-list
110229756|NCT00314860|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110229757|NCT00314860|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110229758|NCT00314860|Dopamine Agonists|dopamine agonists|mesh-ancestor
110229759|NCT00314860|Dopamine Agents|dopamine agents|mesh-ancestor
110229760|NCT00314860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110229761|NCT00314860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110229762|NCT00314860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110229763|NCT04928339|Bupivacaine|bupivacaine|mesh-list
110229765|NCT04928339|Anesthetics|anesthetics|mesh-ancestor
110229766|NCT04928339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110229767|NCT04928339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110229768|NCT04928339|Sensory System Agents|sensory system agents|mesh-ancestor
110229769|NCT04928339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110229770|NCT00091104|Aldesleukin|aldesleukin|mesh-list
110229771|NCT00091104|Cyclophosphamide|cyclophosphamide|mesh-list
110229772|NCT00091104|Fludarabine|fludarabine|mesh-list
110229773|NCT00091104|Fludarabine phosphate|fludarabine phosphate|mesh-list
110229774|NCT00091104|Freund's Adjuvant|freund's adjuvant|mesh-list
110229775|NCT00091104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110229776|NCT00091104|Immunologic Factors|immunologic factors|mesh-ancestor
110229777|NCT00091104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110229778|NCT00091104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110229779|NCT00091104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110229780|NCT00091104|Alkylating Agents|alkylating agents|mesh-ancestor
110229781|NCT00091104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110229782|NCT00091104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110229783|NCT00091104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110229784|NCT00091104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110229785|NCT00091104|Antimetabolites|antimetabolites|mesh-ancestor
110229786|NCT00091104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110229787|NCT00091104|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110229788|NCT00091104|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110229789|NCT00091104|Antiviral Agents|antiviral agents|mesh-ancestor
110229790|NCT00091104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110229791|NCT00122694|Carbon Monoxide|carbon monoxide|mesh-list
110229792|NCT00122694|Antimetabolites|antimetabolites|mesh-ancestor
110229793|NCT00122694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110229794|NCT00122694|Gasotransmitters|gasotransmitters|mesh-ancestor
110229795|NCT00122694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110229796|NCT00122694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110229797|NCT00313456|Satraplatin|satraplatin|mesh-list
110229798|NCT00313456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110229799|NCT00313534|Masoprocol|masoprocol|mesh-list
110229800|NCT00313534|Antioxidants|antioxidants|mesh-ancestor
110229801|NCT00313534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110229802|NCT00313534|Protective Agents|protective agents|mesh-ancestor
110229803|NCT00313534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110229804|NCT00313534|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110229805|NCT00313534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110229806|NCT00313534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110229807|NCT00313534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110229808|NCT00313534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110229809|NCT00313534|Analgesics|analgesics|mesh-ancestor
110229810|NCT00313534|Sensory System Agents|sensory system agents|mesh-ancestor
110229811|NCT00313534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110229812|NCT00313534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110229813|NCT00313534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110229814|NCT00313690|Docetaxel|docetaxel|mesh-list
110229815|NCT00313690|Bortezomib|bortezomib|mesh-list
110229816|NCT00313690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110229817|NCT00313690|Tubulin Modulators|tubulin modulators|mesh-ancestor
110229818|NCT00313690|Antimitotic Agents|antimitotic agents|mesh-ancestor
110229819|NCT00313690|Mitosis Modulators|mitosis modulators|mesh-ancestor
110229820|NCT00313690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110229822|NCT00313885|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110229823|NCT00313885|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110229824|NCT00313885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110229825|NCT00313885|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110229826|NCT00313885|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110229828|NCT00313885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110229829|NCT00313885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110229830|NCT00091143|Fludarabine|fludarabine|mesh-list
110229831|NCT00091143|Fludarabine phosphate|fludarabine phosphate|mesh-list
110229832|NCT00091143|Freund's Adjuvant|freund's adjuvant|mesh-list
110229833|NCT00091143|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
110229834|NCT00091143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110229835|NCT00091143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110229836|NCT00091143|Antimetabolites|antimetabolites|mesh-ancestor
110229837|NCT00091143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110229838|NCT00091143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110229839|NCT00091143|Immunologic Factors|immunologic factors|mesh-ancestor
110229840|NCT00091143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110229841|NCT00091143|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110229842|NCT00091182|Oxaliplatin|oxaliplatin|mesh-list
110229843|NCT00091182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110229844|NCT04635280|Pancrelipase|pancrelipase|mesh-list
110229845|NCT04635280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110229846|NCT00122733|Loxapine|loxapine|mesh-list
110229847|NCT00122733|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110229848|NCT00122733|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110229849|NCT00122733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110229850|NCT00122733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110229851|NCT00122733|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110229852|NCT00122733|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110229853|NCT00122733|Dopamine Agents|dopamine agents|mesh-ancestor
110229854|NCT00122733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110229855|NCT00122733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110229856|NCT00091299|Warfarin|warfarin|mesh-list
110229857|NCT00091299|Anticoagulants|anticoagulants|mesh-ancestor
110229858|NCT04607603|Cannabidiol|cannabidiol|mesh-list
110229859|NCT04607603|Anticonvulsants|anticonvulsants|mesh-ancestor
110229860|NCT00122772|Cisplatin|cisplatin|mesh-list
110229861|NCT00122772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110229862|NCT00091338|Freund's Adjuvant|freund's adjuvant|mesh-list
110229863|NCT00091338|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110229864|NCT00091338|Immunologic Factors|immunologic factors|mesh-ancestor
110229865|NCT00091338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110229866|NCT00122811|Perindopril|perindopril|mesh-list
110229867|NCT00122811|Indapamide|indapamide|mesh-list
110229868|NCT00122811|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110229869|NCT00122811|Protease Inhibitors|protease inhibitors|mesh-ancestor
110229877|NCT00122811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110229878|NCT04551170|Theophylline|theophylline|mesh-list
110229879|NCT04551170|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110229880|NCT04551170|Autonomic Agents|autonomic agents|mesh-ancestor
110229881|NCT04551170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110229882|NCT04551170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110229883|NCT04551170|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110229884|NCT04551170|Respiratory System Agents|respiratory system agents|mesh-ancestor
110229885|NCT04551170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110229886|NCT04551170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110229887|NCT04551170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110229888|NCT04551170|Vasodilator Agents|vasodilator agents|mesh-ancestor
110229889|NCT04551170|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110229890|NCT04551170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110229891|NCT04551170|Purinergic Agents|purinergic agents|mesh-ancestor
110229892|NCT04551170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110229893|NCT00122850|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110229894|NCT00122850|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110229895|NCT00122850|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110229896|NCT00122850|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110229897|NCT00122850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110229898|NCT00122850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110229899|NCT00122850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110229900|NCT00122850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110229901|NCT00122850|Analgesics|analgesics|mesh-ancestor
110229902|NCT00122850|Sensory System Agents|sensory system agents|mesh-ancestor
110229903|NCT00122850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110229904|NCT00122850|Antidepressive Agents|antidepressive agents|mesh-ancestor
110229905|NCT00122850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110229906|NCT00122850|Dopamine Agents|dopamine agents|mesh-ancestor
110229907|NCT00122850|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110229908|NCT04542278|Prednisone|prednisone|mesh-list
110229909|NCT04542278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110229910|NCT04542278|Glucocorticoids|glucocorticoids|mesh-ancestor
110229911|NCT04542278|Hormones|hormones|mesh-ancestor
110264210|NCT00152633|Metoprolol|metoprolol|mesh-list
110229912|NCT04542278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110229913|NCT04542278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110229914|NCT04542278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110229915|NCT04542278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110229916|NCT03975439|Chrysarobin|chrysarobin|mesh-list
110229917|NCT03975439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110229918|NCT03975439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110229919|NCT03975439|Analgesics|analgesics|mesh-ancestor
110229920|NCT03975439|Sensory System Agents|sensory system agents|mesh-ancestor
110229921|NCT03975439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110229922|NCT03975439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110229923|NCT03975439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110229924|NCT03975439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110229926|NCT00091377|Cisplatin|cisplatin|mesh-list
110229927|NCT00091377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110229928|NCT00091377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110229929|NCT00091377|Tubulin Modulators|tubulin modulators|mesh-ancestor
110229930|NCT00091377|Antimitotic Agents|antimitotic agents|mesh-ancestor
110229931|NCT00091377|Mitosis Modulators|mitosis modulators|mesh-ancestor
110229932|NCT00091377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110229933|NCT03897868|Losartan|losartan|mesh-list
110229934|NCT03897868|Amlodipine|amlodipine|mesh-list
110229935|NCT03897868|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110264217|NCT00152633|Autonomic Agents|autonomic agents|mesh-ancestor
110229936|NCT03897868|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110229937|NCT03897868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110229938|NCT03897868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110229939|NCT03897868|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110229940|NCT03897868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110229941|NCT03897868|Vasodilator Agents|vasodilator agents|mesh-ancestor
110229942|NCT03897868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110229943|NCT03897868|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110229944|NCT03897868|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110229945|NCT00122889|Allicin|allicin|mesh-list
110229946|NCT00122889|Allyl sulfide|allyl sulfide|mesh-list
110229947|NCT00122889|Antioxidants|antioxidants|mesh-ancestor
110229948|NCT00122889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110229949|NCT00122889|Protective Agents|protective agents|mesh-ancestor
110229950|NCT00122889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110229951|NCT00122889|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110229952|NCT00122889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110229953|NCT00122889|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110229954|NCT00122889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110229955|NCT00122889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110229956|NCT00122889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110229957|NCT00122889|Antimetabolites|antimetabolites|mesh-ancestor
110229958|NCT00122889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110229959|NCT00122889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110229960|NCT00122889|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110229961|NCT04729868|Dexmedetomidine|dexmedetomidine|mesh-list
110229962|NCT04729868|Bupivacaine|bupivacaine|mesh-list
110229963|NCT04729868|Levobupivacaine|levobupivacaine|mesh-list
110229964|NCT04729868|Anesthetics, Local|anesthetics, local|mesh-ancestor
110229965|NCT04729868|Anesthetics|anesthetics|mesh-ancestor
110229967|NCT04729868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110229968|NCT04729868|Sensory System Agents|sensory system agents|mesh-ancestor
110229969|NCT04729868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110229970|NCT04729868|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110229971|NCT04729868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110229972|NCT04729868|Analgesics|analgesics|mesh-ancestor
110229973|NCT04729868|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110229974|NCT04729868|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110229975|NCT04729868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110229976|NCT04729868|Adrenergic Agents|adrenergic agents|mesh-ancestor
110229977|NCT04729868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110229978|NCT04729868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110229980|NCT00419887|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110229981|NCT00419887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110229982|NCT00419887|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110229983|NCT00419887|Protease Inhibitors|protease inhibitors|mesh-ancestor
110229984|NCT00419887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110229985|NCT00419887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110229987|NCT03690544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110229988|NCT03690544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110229989|NCT03690544|Analgesics|analgesics|mesh-ancestor
110229990|NCT03690544|Sensory System Agents|sensory system agents|mesh-ancestor
110229991|NCT03690544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110229992|NCT03690544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110229993|NCT03690544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110229994|NCT03690544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110229995|NCT03690544|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110229996|NCT03690544|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110229997|NCT03690544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110229998|NCT03690544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110229999|NCT00314977|Cyclophosphamide|cyclophosphamide|mesh-list
110230001|NCT00314977|Doxorubicin|doxorubicin|mesh-list
110230002|NCT00314977|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110230003|NCT00314977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110230004|NCT00314977|Immunologic Factors|immunologic factors|mesh-ancestor
110230005|NCT00314977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110230006|NCT00314977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110230007|NCT00314977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110230008|NCT00314977|Alkylating Agents|alkylating agents|mesh-ancestor
110230009|NCT00314977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110230010|NCT00314977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110230011|NCT00314977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110230012|NCT00314977|Tubulin Modulators|tubulin modulators|mesh-ancestor
110230013|NCT00314977|Antimitotic Agents|antimitotic agents|mesh-ancestor
110230014|NCT00314977|Mitosis Modulators|mitosis modulators|mesh-ancestor
110230015|NCT00314977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110230016|NCT00314977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110230017|NCT00314977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110230018|NCT00314977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110230019|NCT00315016|Eplerenone|eplerenone|mesh-list
110230020|NCT00315016|Fosinopril|fosinopril|mesh-list
110230021|NCT00315016|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110230022|NCT00315016|Hormone Antagonists|hormone antagonists|mesh-ancestor
110230023|NCT00315016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110230024|NCT00315016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110230025|NCT00315016|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110230026|NCT00315016|Diuretics|diuretics|mesh-ancestor
110230027|NCT00315016|Natriuretic Agents|natriuretic agents|mesh-ancestor
110230028|NCT00315016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110230029|NCT00315016|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110230030|NCT00315016|Protease Inhibitors|protease inhibitors|mesh-ancestor
110230031|NCT00315016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110230032|NCT00315016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110230033|NCT00419068|Cholecalciferol|cholecalciferol|mesh-list
110230034|NCT00419068|Vitamin D|vitamin d|mesh-list
110230035|NCT00419068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110230036|NCT00419068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110230037|NCT00419068|Vitamins|vitamins|mesh-ancestor
110230038|NCT00419068|Micronutrients|micronutrients|mesh-ancestor
110230039|NCT00419068|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110230040|NCT00419146|Vitamins|vitamins|mesh-list
110230041|NCT00419146|Vitamin E|vitamin e|mesh-list
110230042|NCT00419146|Tocopherols|tocopherols|mesh-list
110230043|NCT00419146|Tocotrienols|tocotrienols|mesh-list
110230044|NCT00419146|alpha-Tocopherol|alpha-tocopherol|mesh-list
110230045|NCT00419146|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
110230046|NCT00419146|Micronutrients|micronutrients|mesh-ancestor
110230047|NCT00419146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110230048|NCT00419146|Antioxidants|antioxidants|mesh-ancestor
110230049|NCT00419146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110230050|NCT00419146|Protective Agents|protective agents|mesh-ancestor
110230051|NCT00419146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110230052|NCT00419146|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110230054|NCT02965196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110230055|NCT02965196|Antiemetics|antiemetics|mesh-ancestor
110230056|NCT02965196|Autonomic Agents|autonomic agents|mesh-ancestor
110230057|NCT02965196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110230058|NCT02965196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110230059|NCT02965196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110230060|NCT02965196|Glucocorticoids|glucocorticoids|mesh-ancestor
110230061|NCT02965196|Hormones|hormones|mesh-ancestor
110230062|NCT02965196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110230063|NCT02965196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110230064|NCT02965196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110230065|NCT00091611|Cyclophosphamide|cyclophosphamide|mesh-list
110230066|NCT00091611|Fludarabine|fludarabine|mesh-list
110230067|NCT00091611|Interleukin-2|interleukin-2|mesh-list
110230068|NCT00091611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110230069|NCT00091611|Immunologic Factors|immunologic factors|mesh-ancestor
110230070|NCT00091611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110230071|NCT00091611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110230072|NCT00091611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110230073|NCT00091611|Alkylating Agents|alkylating agents|mesh-ancestor
110230074|NCT00091611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110230075|NCT00091611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110230076|NCT00091611|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110230077|NCT00091611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110230078|NCT00091611|Analgesics|analgesics|mesh-ancestor
110230079|NCT00091611|Sensory System Agents|sensory system agents|mesh-ancestor
110230080|NCT00091611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110230081|NCT00123201|Dronabinol|dronabinol|mesh-list
110230082|NCT00123201|Hallucinogens|hallucinogens|mesh-ancestor
110230083|NCT00123201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110230084|NCT00123201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110230085|NCT00123201|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110230086|NCT00123201|Analgesics|analgesics|mesh-ancestor
110230087|NCT00123201|Sensory System Agents|sensory system agents|mesh-ancestor
110230088|NCT00123201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110230089|NCT00123201|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110230090|NCT00123201|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110230091|NCT00123201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110230092|NCT00123201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110230093|NCT00123201|Hormones|hormones|mesh-ancestor
110230094|NCT00123201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110230095|NCT03031483|Clarithromycin|clarithromycin|mesh-list
110230096|NCT03031483|Lenalidomide|lenalidomide|mesh-list
110230097|NCT03031483|Immunologic Factors|immunologic factors|mesh-ancestor
110230098|NCT03031483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110230099|NCT03031483|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110230100|NCT03031483|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110230101|NCT03031483|Growth Substances|growth substances|mesh-ancestor
110230102|NCT03031483|Growth Inhibitors|growth inhibitors|mesh-ancestor
110230103|NCT03031483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110230104|NCT03031483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110230105|NCT03031483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110230106|NCT03031483|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110230107|NCT03031483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110230108|NCT03031483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110230109|NCT03031483|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110230110|NCT03031483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110230112|NCT00091650|Antiemetics|antiemetics|mesh-ancestor
110230113|NCT00091650|Autonomic Agents|autonomic agents|mesh-ancestor
110230114|NCT00091650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110230115|NCT00091650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110230116|NCT00091650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110230117|NCT00091650|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110230118|NCT00091650|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110230119|NCT00091650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110230120|NCT00091650|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110230121|NCT00091650|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110230122|NCT00091650|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110230123|NCT00091650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110230124|NCT00091650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110230125|NCT00091650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110230127|NCT01691833|Vitamin D|vitamin d|mesh-list
110230128|NCT01691833|Vitamins|vitamins|mesh-ancestor
110230129|NCT01691833|Micronutrients|micronutrients|mesh-ancestor
110230130|NCT01691833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110230131|NCT01691833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110230132|NCT00091728|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110230133|NCT00091728|Contraceptive Agents|contraceptive agents|mesh-list
110230134|NCT00091728|Medroxyprogesterone|medroxyprogesterone|mesh-list
110230135|NCT00091728|Contraceptives, Oral|contraceptives, oral|mesh-list
110230136|NCT00091728|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
110230137|NCT00091728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110230138|NCT00091728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110230139|NCT00091728|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110230140|NCT00091728|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110230141|NCT00091728|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110230142|NCT00091728|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110230143|NCT00091728|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110230144|NCT00091728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110230145|NCT00091728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110230146|NCT00123279|Plasminogen|plasminogen|mesh-list
110230147|NCT00123279|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110230148|NCT00123279|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110230149|NCT00123279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110230150|NCT00091806|Panitumumab|panitumumab|mesh-list
110230151|NCT00091806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110230152|NCT00091806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110230153|NCT01589302|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
110230154|NCT01589302|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110230155|NCT01589302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110230156|NCT01589302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110230157|NCT00123318|Cisplatin|cisplatin|mesh-list
110230158|NCT00123318|Fluorouracil|fluorouracil|mesh-list
110230159|NCT00123318|Epirubicin|epirubicin|mesh-list
110230160|NCT00123318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110230161|NCT00123318|Antimetabolites|antimetabolites|mesh-ancestor
110230162|NCT00123318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110230163|NCT00123318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110230164|NCT00123318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110230165|NCT00123318|Immunologic Factors|immunologic factors|mesh-ancestor
110230166|NCT00123318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110230167|NCT00123318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110230168|NCT00123318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110230169|NCT00123318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110230170|NCT00123318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110230171|NCT00327535|Epoetin Alfa|epoetin alfa|mesh-list
110230172|NCT00327535|Darbepoetin alfa|darbepoetin alfa|mesh-list
110230173|NCT00327535|Hematinics|hematinics|mesh-ancestor
110230174|NCT00327691|Atorvastatin|atorvastatin|mesh-list
110230175|NCT00327691|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110230176|NCT00327691|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110230177|NCT00327691|Antimetabolites|antimetabolites|mesh-ancestor
110230178|NCT00327691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110230179|NCT00327691|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110230180|NCT00327691|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110230181|NCT00327691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110230182|NCT03913832|Sirolimus|sirolimus|mesh-list
110230183|NCT03913832|Paclitaxel|paclitaxel|mesh-list
110230184|NCT03913832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110230185|NCT03913832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110230186|NCT03913832|Tubulin Modulators|tubulin modulators|mesh-ancestor
110230187|NCT03913832|Antimitotic Agents|antimitotic agents|mesh-ancestor
110230188|NCT03913832|Mitosis Modulators|mitosis modulators|mesh-ancestor
110230189|NCT03913832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110230190|NCT03913832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110230191|NCT03913832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110230192|NCT03913832|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110230193|NCT03913832|Antifungal Agents|antifungal agents|mesh-ancestor
110230194|NCT03913832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110230195|NCT03913832|Immunologic Factors|immunologic factors|mesh-ancestor
110230196|NCT03913832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110230197|NCT00327730|Eperisone|eperisone|mesh-list
110230198|NCT00327730|Anticonvulsants|anticonvulsants|mesh-ancestor
110230199|NCT00327730|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110230200|NCT00327730|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110230201|NCT00327730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110230202|NCT00327730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110230203|NCT00327730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110230204|NCT00327730|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110230205|NCT00327730|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110230206|NCT00327730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110230207|NCT00327730|Parasympatholytics|parasympatholytics|mesh-ancestor
110230208|NCT00327730|Autonomic Agents|autonomic agents|mesh-ancestor
110230209|NCT00327730|Vasodilator Agents|vasodilator agents|mesh-ancestor
110230210|NCT04716868|Levan|levan|mesh-list
110230211|NCT04716868|Psyllium|psyllium|mesh-list
110230212|NCT04716868|Cathartics|cathartics|mesh-ancestor
110230213|NCT04716868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110230214|NCT04716868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110230215|NCT00327769|Fulvestrant|fulvestrant|mesh-list
110230216|NCT00327769|Anastrozole|anastrozole|mesh-list
110230217|NCT00327769|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110230218|NCT00327769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110230219|NCT00327769|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110230220|NCT00327769|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110230221|NCT00327769|Hormone Antagonists|hormone antagonists|mesh-ancestor
110230222|NCT00327769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110230223|NCT00327769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110230224|NCT00327769|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110230226|NCT00327769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110230227|NCT00327769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110230228|NCT00092001|Sunitinib|sunitinib|mesh-list
110230229|NCT00092001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110230230|NCT00092001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110230231|NCT00092001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110230232|NCT00092001|Growth Substances|growth substances|mesh-ancestor
110230233|NCT00092001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110230234|NCT00092001|Growth Inhibitors|growth inhibitors|mesh-ancestor
110230235|NCT00092001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110230236|NCT00092001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110230237|NCT00092001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110230238|NCT03883919|Vitamin D|vitamin d|mesh-list
110230239|NCT03883919|Leucovorin|leucovorin|mesh-list
110230240|NCT03883919|Fluorouracil|fluorouracil|mesh-list
110230241|NCT03883919|Irinotecan|irinotecan|mesh-list
110230242|NCT03883919|Vitamins|vitamins|mesh-ancestor
110230243|NCT03883919|Micronutrients|micronutrients|mesh-ancestor
110230244|NCT03883919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110230245|NCT03883919|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110230246|NCT03883919|Antimetabolites|antimetabolites|mesh-ancestor
110230247|NCT03883919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110230248|NCT03883919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110230249|NCT03883919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110230250|NCT03883919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110230251|NCT03883919|Immunologic Factors|immunologic factors|mesh-ancestor
110230252|NCT03883919|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110230253|NCT03883919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110230254|NCT03883919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110230255|NCT03883919|Antidotes|antidotes|mesh-ancestor
110230256|NCT03883919|Protective Agents|protective agents|mesh-ancestor
110230257|NCT03883919|Vitamin B Complex|vitamin b complex|mesh-ancestor
110230258|NCT00327808|Budesonide|budesonide|mesh-list
110230259|NCT00327808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110230260|NCT00327808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110230261|NCT00327808|Autonomic Agents|autonomic agents|mesh-ancestor
110230262|NCT00327808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110230263|NCT00327808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110230264|NCT00327808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110230265|NCT00327808|Respiratory System Agents|respiratory system agents|mesh-ancestor
110230266|NCT00327808|Glucocorticoids|glucocorticoids|mesh-ancestor
110230267|NCT00327808|Hormones|hormones|mesh-ancestor
110230268|NCT00327808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110230269|NCT00092079|Cholecalciferol|cholecalciferol|mesh-list
110230270|NCT00092079|Vitamin D|vitamin d|mesh-list
110230271|NCT00092079|Alendronate|alendronate|mesh-list
110230272|NCT00092079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110230273|NCT00092079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110230274|NCT00092079|Vitamins|vitamins|mesh-ancestor
110230275|NCT00092079|Micronutrients|micronutrients|mesh-ancestor
110230276|NCT00092079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110230277|NCT00327847|Vitamin D|vitamin d|mesh-list
110230278|NCT00327847|Vitamins|vitamins|mesh-ancestor
110230279|NCT00327847|Micronutrients|micronutrients|mesh-ancestor
110230280|NCT00327847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110230281|NCT00327847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110230282|NCT00327925|Antibodies|antibodies|mesh-list
110230283|NCT00327925|Immunologic Factors|immunologic factors|mesh-ancestor
110230284|NCT00327925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110230285|NCT03709550|Decitabine|decitabine|mesh-list
110230286|NCT03709550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110230287|NCT03709550|Antimetabolites|antimetabolites|mesh-ancestor
110230288|NCT03709550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110230289|NCT03709550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110230290|NCT03709550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110230291|NCT00315211|Docetaxel|docetaxel|mesh-list
110230292|NCT00315211|Topotecan|topotecan|mesh-list
110230293|NCT00315211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110230294|NCT00315211|Tubulin Modulators|tubulin modulators|mesh-ancestor
110230295|NCT00315211|Antimitotic Agents|antimitotic agents|mesh-ancestor
110230296|NCT00315211|Mitosis Modulators|mitosis modulators|mesh-ancestor
110230297|NCT00315211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110230298|NCT00315211|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110230299|NCT00315211|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110230300|NCT00315211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110230301|NCT00315367|Donepezil|donepezil|mesh-list
110230302|NCT00315367|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110230303|NCT00315367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110230304|NCT00315367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110230306|NCT00315367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110230307|NCT00315367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110230308|NCT00315367|Nootropic Agents|nootropic agents|mesh-ancestor
110230309|NCT00315484|Epoetin Alfa|epoetin alfa|mesh-list
110230310|NCT00315484|Darbepoetin alfa|darbepoetin alfa|mesh-list
110230311|NCT00315484|Hematinics|hematinics|mesh-ancestor
110230312|NCT00315523|Levocetirizine|levocetirizine|mesh-list
110230313|NCT00315523|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110230314|NCT00315523|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110230315|NCT00315523|Histamine Antagonists|histamine antagonists|mesh-ancestor
110230316|NCT00315523|Histamine Agents|histamine agents|mesh-ancestor
110230317|NCT00315523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110230318|NCT00315523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110230319|NCT00315523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110230320|NCT00092196|Aprepitant|aprepitant|mesh-list
110230321|NCT00092196|Antiemetics|antiemetics|mesh-ancestor
110230322|NCT00092196|Autonomic Agents|autonomic agents|mesh-ancestor
110230323|NCT00092196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110230324|NCT00092196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110230325|NCT00092196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110230326|NCT00092196|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110230327|NCT00092196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110230328|NCT00092196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110230329|NCT00315601|Azithromycin|azithromycin|mesh-list
110230330|NCT00315601|Telithromycin|telithromycin|mesh-list
110230331|NCT00315601|Dimercaprol|dimercaprol|mesh-list
110230332|NCT00315601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110230333|NCT00315601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110230334|NCT00315601|Chelating Agents|chelating agents|mesh-ancestor
110230335|NCT00315601|Sequestering Agents|sequestering agents|mesh-ancestor
110230336|NCT00315601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110230337|NCT00315679|Pentoxifylline|pentoxifylline|mesh-list
110230338|NCT00315679|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110230339|NCT00315679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110230340|NCT00315679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110230341|NCT00315679|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110230342|NCT00315679|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110230343|NCT00315679|Protective Agents|protective agents|mesh-ancestor
110230344|NCT00315679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110230345|NCT00315679|Vasodilator Agents|vasodilator agents|mesh-ancestor
110230346|NCT00315679|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110230347|NCT00315679|Antioxidants|antioxidants|mesh-ancestor
110230348|NCT00092274|Ofatumumab|ofatumumab|mesh-list
110230349|NCT00092274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110230350|NCT00315835|Buprenorphine|buprenorphine|mesh-list
110230351|NCT00315835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110230352|NCT00315835|Narcotics|narcotics|mesh-ancestor
110230353|NCT00315835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110230354|NCT00315835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110230356|NCT00315835|Sensory System Agents|sensory system agents|mesh-ancestor
110230357|NCT00315835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110230358|NCT00315835|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110230359|NCT00315874|Buprenorphine|buprenorphine|mesh-list
110230360|NCT00315874|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110230361|NCT00315874|Narcotics|narcotics|mesh-ancestor
110230362|NCT00315874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110230363|NCT00315874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110230364|NCT00315874|Analgesics|analgesics|mesh-ancestor
110230365|NCT00315874|Sensory System Agents|sensory system agents|mesh-ancestor
110230366|NCT00315874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110230367|NCT00315874|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110230368|NCT00315913|Propranolol|propranolol|mesh-list
110230369|NCT00315913|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110230370|NCT00315913|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110230371|NCT00315913|Adrenergic Agents|adrenergic agents|mesh-ancestor
110230372|NCT00315913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110230373|NCT00315913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110230374|NCT00315913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110230375|NCT00315913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110230376|NCT00315913|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110230377|NCT00315913|Vasodilator Agents|vasodilator agents|mesh-ancestor
110230378|NCT00092313|Acetaminophen|acetaminophen|mesh-list
110230379|NCT00092313|Rofecoxib|rofecoxib|mesh-list
110230380|NCT00092313|Oxycodone|oxycodone|mesh-list
110230381|NCT00092313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110230382|NCT00092313|Analgesics|analgesics|mesh-ancestor
110230383|NCT00092313|Sensory System Agents|sensory system agents|mesh-ancestor
110230384|NCT00092313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110230385|NCT00092313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110230386|NCT00092313|Antipyretics|antipyretics|mesh-ancestor
110230387|NCT00092313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110230388|NCT00092313|Narcotics|narcotics|mesh-ancestor
110230389|NCT00092313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110230390|NCT00092313|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110230391|NCT00092313|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110230392|NCT00092313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110230393|NCT00092313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110230394|NCT00092313|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110230395|NCT00092313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110230396|NCT00092313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110230397|NCT00399971|Immunomodulating Agents|immunomodulating agents|mesh-list
110230398|NCT00399971|Immunologic Factors|immunologic factors|mesh-list
110230399|NCT00399971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110230400|NCT00316030|Bexarotene|bexarotene|mesh-list
110230401|NCT00316030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110230402|NCT00123552|Artesunate|artesunate|mesh-list
110230403|NCT00123552|Lumefantrine|lumefantrine|mesh-list
110230405|NCT00123552|Pyrimethamine|pyrimethamine|mesh-list
110230406|NCT00123552|Sulfadoxine|sulfadoxine|mesh-list
110230407|NCT00123552|Amodiaquine|amodiaquine|mesh-list
110230408|NCT00123552|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110230409|NCT00123552|Antimalarials|antimalarials|mesh-ancestor
110230410|NCT00123552|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110230411|NCT00123552|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110230413|NCT00123552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110230414|NCT00123552|Antiviral Agents|antiviral agents|mesh-ancestor
110230415|NCT00123552|Schistosomicides|schistosomicides|mesh-ancestor
110230416|NCT00123552|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110230417|NCT00123552|Anthelmintics|anthelmintics|mesh-ancestor
110230418|NCT00123552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110230419|NCT00123552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110230420|NCT00123552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110230421|NCT00123552|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110230422|NCT03352427|Everolimus|everolimus|mesh-list
110230423|NCT03352427|Dasatinib|dasatinib|mesh-list
110230424|NCT03352427|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110230425|NCT03352427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110230426|NCT03352427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110230427|NCT03352427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110230428|NCT03352427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110230430|NCT03352427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110230431|NCT03352427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110230432|NCT00316420|Gemcitabine|gemcitabine|mesh-list
110230433|NCT00316420|Capecitabine|capecitabine|mesh-list
110230434|NCT00316420|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110230435|NCT00316420|Antimetabolites|antimetabolites|mesh-ancestor
110230436|NCT00316420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110230437|NCT00316420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110230438|NCT00092352|Celecoxib|celecoxib|mesh-list
110230439|NCT00092352|Rofecoxib|rofecoxib|mesh-list
110230440|NCT00092352|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110230441|NCT00092352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110230442|NCT00092352|Analgesics|analgesics|mesh-ancestor
110230443|NCT00092352|Sensory System Agents|sensory system agents|mesh-ancestor
110230444|NCT00092352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110230445|NCT00092352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110230446|NCT00092352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110230447|NCT00092352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110230448|NCT00092352|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110230449|NCT00092352|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110230450|NCT00092352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110230451|NCT00092352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110230452|NCT00316498|Miglustat|miglustat|mesh-list
110230453|NCT00316498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110230454|NCT00316498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110230455|NCT00316498|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110230456|NCT00316498|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110230457|NCT00316498|Antiviral Agents|antiviral agents|mesh-ancestor
110230458|NCT00316498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110230459|NCT00316498|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110230460|NCT00316498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110230461|NCT00316498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110230462|NCT00316810|Alemtuzumab|alemtuzumab|mesh-list
110230463|NCT00316810|Thymoglobulin|thymoglobulin|mesh-list
110230464|NCT00316810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110230465|NCT00316810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110230466|NCT00316810|Immunologic Factors|immunologic factors|mesh-ancestor
110230467|NCT00316810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110230468|NCT00316810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110230469|NCT00092391|Vaccines|vaccines|mesh-list
110230470|NCT00092391|Immunologic Factors|immunologic factors|mesh-ancestor
110230473|NCT00316849|Temozolomide|temozolomide|mesh-list
110230474|NCT00316849|Temsirolimus|temsirolimus|mesh-list
110230475|NCT00316849|MTOR Inhibitors|mtor inhibitors|mesh-list
110230476|NCT00316849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110230477|NCT00316849|Alkylating Agents|alkylating agents|mesh-ancestor
110230478|NCT00316849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110230479|NCT00316849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110230480|NCT00316849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110230481|NCT00316849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110230482|NCT00316849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110230483|NCT00316849|Immunologic Factors|immunologic factors|mesh-ancestor
110230484|NCT00316849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110230485|NCT00316849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110230486|NCT00316849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110230487|NCT00316849|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110230488|NCT00316849|Antifungal Agents|antifungal agents|mesh-ancestor
110230490|NCT03272477|Paclitaxel|paclitaxel|mesh-list
110230491|NCT03272477|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110230492|NCT03272477|Cyclophosphamide|cyclophosphamide|mesh-list
110230493|NCT03272477|Trastuzumab|trastuzumab|mesh-list
110230494|NCT03272477|Letrozole|letrozole|mesh-list
110230495|NCT03272477|Epirubicin|epirubicin|mesh-list
110230496|NCT03272477|Pertuzumab|pertuzumab|mesh-list
110230497|NCT03272477|Anastrozole|anastrozole|mesh-list
110230498|NCT03272477|Exemestane|exemestane|mesh-list
110230499|NCT03272477|Goserelin|goserelin|mesh-list
110230500|NCT03272477|Leuprolide|leuprolide|mesh-list
110230501|NCT03272477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110230502|NCT03272477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110230503|NCT03272477|Tubulin Modulators|tubulin modulators|mesh-ancestor
110230504|NCT03272477|Antimitotic Agents|antimitotic agents|mesh-ancestor
110230505|NCT03272477|Mitosis Modulators|mitosis modulators|mesh-ancestor
110230506|NCT03272477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110230507|NCT03272477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110230508|NCT03272477|Immunologic Factors|immunologic factors|mesh-ancestor
110230509|NCT03272477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110230510|NCT03272477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110230511|NCT03272477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110230512|NCT03272477|Alkylating Agents|alkylating agents|mesh-ancestor
110230513|NCT03272477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110230514|NCT03272477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110230515|NCT03272477|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110230516|NCT03272477|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110230517|NCT03272477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110230518|NCT03272477|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110230519|NCT03272477|Hormone Antagonists|hormone antagonists|mesh-ancestor
110230520|NCT03272477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110230521|NCT03272477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110230522|NCT03272477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110230523|NCT03272477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110230524|NCT03272477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110230525|NCT03272477|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110230526|NCT03272477|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110230527|NCT03272477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110230528|NCT03272477|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110230529|NCT03272477|Fertility Agents|fertility agents|mesh-ancestor
110230530|NCT03272477|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110230533|NCT02959957|Temocillin|temocillin|mesh-list
110230534|NCT02959957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110230535|NCT02959957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110230536|NCT00316927|Aspirin|aspirin|mesh-list
110230537|NCT00316927|Dexamethasone|dexamethasone|mesh-list
110230539|NCT00316927|Diethylstilbestrol|diethylstilbestrol|mesh-list
110230540|NCT00316927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110230541|NCT00316927|Antiemetics|antiemetics|mesh-ancestor
110230542|NCT00316927|Autonomic Agents|autonomic agents|mesh-ancestor
110230543|NCT00316927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110230544|NCT00316927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110230545|NCT00316927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110230546|NCT00316927|Glucocorticoids|glucocorticoids|mesh-ancestor
110230547|NCT00316927|Hormones|hormones|mesh-ancestor
110230548|NCT00316927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110230549|NCT00316927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110230550|NCT00316927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110230551|NCT00316927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110230552|NCT00316927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110230554|NCT00316927|Sensory System Agents|sensory system agents|mesh-ancestor
110230555|NCT00316927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110230556|NCT00316927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110230557|NCT00316927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110230558|NCT00316927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110021444|NCT00002586|Protective Agents|protective agents|mesh-ancestor
110230559|NCT00316927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110230560|NCT00316927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110230561|NCT00316927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110230562|NCT00316927|Antipyretics|antipyretics|mesh-ancestor
110230563|NCT00316927|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110230564|NCT00316927|Estrogens|estrogens|mesh-ancestor
110230565|NCT00123669|Progesterone|progesterone|mesh-list
110230566|NCT00123669|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
110230567|NCT00123669|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
110230568|NCT00123669|Progestins|progestins|mesh-ancestor
110230569|NCT00123669|Hormones|hormones|mesh-ancestor
110230570|NCT00123669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110230571|NCT00123669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110230572|NCT00123669|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110230573|NCT00123669|Hormone Antagonists|hormone antagonists|mesh-ancestor
110230574|NCT00317200|Paclitaxel|paclitaxel|mesh-list
110230575|NCT00317200|Bevacizumab|bevacizumab|mesh-list
110230576|NCT00317200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110230577|NCT00317200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110230578|NCT00317200|Tubulin Modulators|tubulin modulators|mesh-ancestor
110230579|NCT00317200|Antimitotic Agents|antimitotic agents|mesh-ancestor
110230580|NCT00317200|Mitosis Modulators|mitosis modulators|mesh-ancestor
110230581|NCT00317200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110230582|NCT00317200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110230583|NCT00317200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110230584|NCT00317200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110230585|NCT00317200|Growth Substances|growth substances|mesh-ancestor
110230586|NCT00317200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110230587|NCT00317200|Growth Inhibitors|growth inhibitors|mesh-ancestor
110230588|NCT02960035|Etanercept|etanercept|mesh-list
110230589|NCT02960035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110230590|NCT02960035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110230591|NCT02960035|Analgesics|analgesics|mesh-ancestor
110230592|NCT02960035|Sensory System Agents|sensory system agents|mesh-ancestor
110230593|NCT02960035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110230594|NCT02960035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110230595|NCT02960035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110230596|NCT02960035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110230597|NCT02960035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110230598|NCT02960035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110230599|NCT02960035|Immunologic Factors|immunologic factors|mesh-ancestor
110230600|NCT00317434|Lapatinib|lapatinib|mesh-list
110230601|NCT00317434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110230602|NCT00317434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110230603|NCT00317434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110230604|NCT00317434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110230605|NCT00328120|Fulvestrant|fulvestrant|mesh-list
110230606|NCT00328120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110230607|NCT00328120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110230608|NCT00328120|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110230609|NCT00328120|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110230610|NCT00328120|Hormone Antagonists|hormone antagonists|mesh-ancestor
110230611|NCT00328120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110230612|NCT00328120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110230613|NCT00328393|Pioglitazone|pioglitazone|mesh-list
110230614|NCT00328393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110230615|NCT00328393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110230616|NCT00328432|Celecoxib|celecoxib|mesh-list
110230617|NCT00328432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110230618|NCT00328432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110230619|NCT00328432|Analgesics|analgesics|mesh-ancestor
110230620|NCT00328432|Sensory System Agents|sensory system agents|mesh-ancestor
110230621|NCT00328432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110230622|NCT00328432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110230623|NCT00328432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110230624|NCT00328432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110230625|NCT00328432|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110230626|NCT00328432|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110230627|NCT00328432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110230628|NCT00328432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110230630|NCT02571725|Tremelimumab|tremelimumab|mesh-list
110230631|NCT02571725|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110230632|NCT02571725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110230633|NCT02571725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110230634|NCT02571725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110230635|NCT00328549|Interferons|interferons|mesh-list
110230636|NCT00328549|Ribavirin|ribavirin|mesh-list
110230637|NCT00328549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110230638|NCT00328549|Antiviral Agents|antiviral agents|mesh-ancestor
110230639|NCT00328549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110230640|NCT00328549|Antimetabolites|antimetabolites|mesh-ancestor
110230641|NCT00328549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110230642|NCT00092508|Mesalamine|mesalamine|mesh-list
110230643|NCT00092508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110230644|NCT00092508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110230646|NCT00092508|Sensory System Agents|sensory system agents|mesh-ancestor
110230647|NCT00092508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110230648|NCT00092508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110230649|NCT00092508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110230650|NCT00092508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110230651|NCT00328822|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110230652|NCT00328822|Antidepressive Agents|antidepressive agents|mesh-ancestor
110230655|NCT00328822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110230656|NCT00328822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110230657|NCT00328822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110230658|NCT00420043|Imatinib Mesylate|imatinib mesylate|mesh-list
110230659|NCT00420043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110230660|NCT00420043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110230661|NCT00420043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110230662|NCT00420043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110230664|NCT00420082|Fexofenadine|fexofenadine|mesh-list
110230665|NCT00420082|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110230666|NCT00420082|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110230667|NCT00420082|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110230668|NCT00420082|Histamine Antagonists|histamine antagonists|mesh-ancestor
110230669|NCT00420082|Histamine Agents|histamine agents|mesh-ancestor
110230670|NCT00420082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110230671|NCT00420082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110230672|NCT00420082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110230673|NCT01821833|Paclitaxel|paclitaxel|mesh-list
110230674|NCT01821833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110230676|NCT01821833|Tubulin Modulators|tubulin modulators|mesh-ancestor
110230677|NCT01821833|Antimitotic Agents|antimitotic agents|mesh-ancestor
110230678|NCT01821833|Mitosis Modulators|mitosis modulators|mesh-ancestor
110230679|NCT01821833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110230680|NCT00328900|Atropine|atropine|mesh-list
110230681|NCT00328900|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110230682|NCT00328900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110230683|NCT00328900|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110230684|NCT00328900|Autonomic Agents|autonomic agents|mesh-ancestor
110230685|NCT00328900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110230686|NCT00328900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110230687|NCT00328900|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110230688|NCT00328900|Respiratory System Agents|respiratory system agents|mesh-ancestor
110230689|NCT00328900|Mydriatics|mydriatics|mesh-ancestor
110230690|NCT00328900|Parasympatholytics|parasympatholytics|mesh-ancestor
110230691|NCT00328900|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110230692|NCT00328900|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110230693|NCT00328900|Cholinergic Agents|cholinergic agents|mesh-ancestor
110230694|NCT00328900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110230695|NCT00328900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110230698|NCT00328939|Fondaparinux|fondaparinux|mesh-list
110230699|NCT00328939|Anticoagulants|anticoagulants|mesh-ancestor
110230700|NCT00328939|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110230701|NCT00328939|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110230702|NCT00328939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110230703|NCT00328939|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110230704|NCT00328939|Antithrombins|antithrombins|mesh-ancestor
110230705|NCT00328939|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110230706|NCT00328939|Protease Inhibitors|protease inhibitors|mesh-ancestor
110230707|NCT00328939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110230708|NCT00328978|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110230709|NCT00328978|Antidepressive Agents|antidepressive agents|mesh-ancestor
110021603|NCT00002658|Amsacrine|amsacrine|mesh-list
110230710|NCT00328978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110230711|NCT00328978|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110230712|NCT00328978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110230713|NCT00328978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110230714|NCT00328978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110230715|NCT00329095|Bimatoprost|bimatoprost|mesh-list
110230716|NCT00329095|Travoprost|travoprost|mesh-list
110230717|NCT00329095|Antihypertensive Agents|antihypertensive agents|mesh-list
110230718|NCT00329095|Latanoprost|latanoprost|mesh-list
110230719|NCT00329095|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110230720|NCT00329095|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110230721|NCT00329134|Quinine|quinine|mesh-list
110230722|NCT00329134|Antimalarials|antimalarials|mesh-ancestor
110230723|NCT00329134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110230724|NCT00329134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110230725|NCT00329134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110230726|NCT00329134|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110230727|NCT00329134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110230728|NCT00329134|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110230729|NCT00329134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110230730|NCT00329134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110230731|NCT00329134|Analgesics|analgesics|mesh-ancestor
110230732|NCT00329134|Sensory System Agents|sensory system agents|mesh-ancestor
110230733|NCT00329173|Atorvastatin|atorvastatin|mesh-list
110230734|NCT00329173|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110230735|NCT00329173|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110230736|NCT00329173|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110230737|NCT00329173|Antimetabolites|antimetabolites|mesh-ancestor
110230738|NCT00329173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110230739|NCT00329173|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110230740|NCT00329173|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110230741|NCT00329173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110230742|NCT00123825|Gemcitabine|gemcitabine|mesh-list
110230743|NCT00123825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110230744|NCT00123825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110230745|NCT00123825|Antimetabolites|antimetabolites|mesh-ancestor
110230746|NCT00123825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110230747|NCT00329329|Capecitabine|capecitabine|mesh-list
110230748|NCT00329329|Satraplatin|satraplatin|mesh-list
110230749|NCT00329329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110230750|NCT00329329|Antimetabolites|antimetabolites|mesh-ancestor
110230751|NCT00329329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110230752|NCT00329329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110230753|NCT00329368|Folic Acid|folic acid|mesh-list
110230754|NCT00329368|Vitamin B Complex|vitamin b complex|mesh-list
110230755|NCT00329368|Interferons|interferons|mesh-list
110230756|NCT00329368|Interferon-alpha|interferon-alpha|mesh-list
110230757|NCT00329368|Interleukin-2|interleukin-2|mesh-list
110230758|NCT00329368|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
110230759|NCT00329368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110230760|NCT00329368|Antiviral Agents|antiviral agents|mesh-ancestor
110230761|NCT00329368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110230762|NCT00329368|Immunologic Factors|immunologic factors|mesh-ancestor
110230763|NCT00329368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110230764|NCT00329368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110230765|NCT00329368|Analgesics|analgesics|mesh-ancestor
110230766|NCT00329368|Sensory System Agents|sensory system agents|mesh-ancestor
110230767|NCT00329368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110230768|NCT00329368|Hematinics|hematinics|mesh-ancestor
110230770|NCT00329368|Micronutrients|micronutrients|mesh-ancestor
110230771|NCT00329368|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110230772|NCT00329446|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110230773|NCT00329446|Escitalopram|escitalopram|mesh-list
110230774|NCT00329446|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110230775|NCT00329446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110230776|NCT00329446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110230777|NCT00329446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110230778|NCT00329446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110230779|NCT00329446|Serotonin Agents|serotonin agents|mesh-ancestor
110230780|NCT00329446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110230781|NCT00329446|Antidepressive Agents|antidepressive agents|mesh-ancestor
110230782|NCT00329446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110230783|NCT00329446|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110230784|NCT00329446|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110230785|NCT00329446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110230786|NCT00092937|Busulfan|busulfan|mesh-list
110230787|NCT00092937|Alkylating Agents|alkylating agents|mesh-ancestor
110230788|NCT00092937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110230789|NCT00092937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110230790|NCT00092937|Immunologic Factors|immunologic factors|mesh-ancestor
110230791|NCT00092937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110230792|NCT00092937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110230793|NCT00092937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110230794|NCT00092937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110230795|NCT00420277|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
110230796|NCT00420277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110230797|NCT00420277|Plasma Substitutes|plasma substitutes|mesh-ancestor
110230798|NCT00420277|Blood Substitutes|blood substitutes|mesh-ancestor
110230799|NCT04716751|Paclitaxel|paclitaxel|mesh-list
110230800|NCT04716751|Carboplatin|carboplatin|mesh-list
110230801|NCT04716751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110230802|NCT04716751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110230803|NCT04716751|Tubulin Modulators|tubulin modulators|mesh-ancestor
110230804|NCT04716751|Antimitotic Agents|antimitotic agents|mesh-ancestor
110230805|NCT04716751|Mitosis Modulators|mitosis modulators|mesh-ancestor
110230806|NCT04716751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110230809|NCT00123903|Lisinopril|lisinopril|mesh-list
110230810|NCT00123903|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110230811|NCT00123903|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110230812|NCT00123903|Sympatholytics|sympatholytics|mesh-ancestor
110230813|NCT00123903|Autonomic Agents|autonomic agents|mesh-ancestor
110230814|NCT00123903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110230815|NCT00123903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110230816|NCT00123903|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110230817|NCT00123903|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110230818|NCT00123903|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110230819|NCT00123903|Adrenergic Agents|adrenergic agents|mesh-ancestor
110230820|NCT00123903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110230821|NCT00123903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110230822|NCT00123903|Antioxidants|antioxidants|mesh-ancestor
110230823|NCT00123903|Protective Agents|protective agents|mesh-ancestor
110230824|NCT00123903|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110230825|NCT00123903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110230826|NCT00123903|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110230827|NCT00123903|Vasodilator Agents|vasodilator agents|mesh-ancestor
110230828|NCT00123903|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110230829|NCT00123903|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110230830|NCT00123903|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110230831|NCT00123903|Protease Inhibitors|protease inhibitors|mesh-ancestor
110230832|NCT00123903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110230833|NCT00123903|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110230834|NCT00329680|Evening primrose oil|evening primrose oil|mesh-list
110230835|NCT00329680|Antioxidants|antioxidants|mesh-list
110230836|NCT00329680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110230837|NCT00329680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110230839|NCT00329680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110230840|NCT00329680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110230841|NCT00329680|Analgesics|analgesics|mesh-ancestor
110230842|NCT00329680|Sensory System Agents|sensory system agents|mesh-ancestor
110230843|NCT00329680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110230844|NCT00329680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110230845|NCT00329680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110230846|NCT00329680|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110230847|NCT00329680|Antimetabolites|antimetabolites|mesh-ancestor
110230848|NCT00329680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110230849|NCT00329680|Dermatologic Agents|dermatologic agents|mesh-ancestor
110230850|NCT00329758|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110230851|NCT00329758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110230852|NCT00329758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110230853|NCT00329758|Antimetabolites|antimetabolites|mesh-ancestor
110230854|NCT00329758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110230855|NCT00329758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110230856|NCT00329758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110230857|NCT00329758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110230858|NCT00329914|Progesterone|progesterone|mesh-list
110230859|NCT00329914|Progestins|progestins|mesh-ancestor
110230860|NCT00329914|Hormones|hormones|mesh-ancestor
110230861|NCT00329914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110057612|NCT01508104|Everolimus|everolimus|mesh-list
110230862|NCT00329914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110230864|NCT00092976|Coagulants|coagulants|mesh-ancestor
110230865|NCT00083876|Thalidomide|thalidomide|mesh-list
110230866|NCT00083876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110230867|NCT00083876|Immunologic Factors|immunologic factors|mesh-ancestor
110230868|NCT00083876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110230869|NCT00083876|Leprostatic Agents|leprostatic agents|mesh-ancestor
110230870|NCT00083876|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110230871|NCT00083876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110230872|NCT00083876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110230873|NCT00083876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110230874|NCT00083876|Growth Substances|growth substances|mesh-ancestor
110230875|NCT00083876|Growth Inhibitors|growth inhibitors|mesh-ancestor
110230876|NCT00083876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110230877|NCT00330148|Eflornithine|eflornithine|mesh-list
110230878|NCT00330148|Nifurtimox|nifurtimox|mesh-list
110230879|NCT00330148|Melarsoprol|melarsoprol|mesh-list
110230880|NCT00330148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110230881|NCT00330148|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110230882|NCT00330148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110230883|NCT00330148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110230884|NCT00330148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110230885|NCT00330148|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
110230886|NCT00330148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110230887|NCT00330148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110230889|NCT00093093|Ribavirin|ribavirin|mesh-list
110230890|NCT00093093|Interferon-alpha|interferon-alpha|mesh-list
110230891|NCT00093093|Interferon alpha-2|interferon alpha-2|mesh-list
110230892|NCT00093093|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110230893|NCT00093093|Taribavirin|taribavirin|mesh-list
110230894|NCT00093093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110230895|NCT00093093|Antiviral Agents|antiviral agents|mesh-ancestor
110230896|NCT00093093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110230897|NCT00093093|Antimetabolites|antimetabolites|mesh-ancestor
110230898|NCT00093093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110230899|NCT00093093|Immunologic Factors|immunologic factors|mesh-ancestor
110230900|NCT00093093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110230901|NCT00330304|Isoniazid|isoniazid|mesh-list
110230902|NCT00330304|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110230903|NCT00330304|Antitubercular Agents|antitubercular agents|mesh-ancestor
110230904|NCT00330304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110230905|NCT00330304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110230906|NCT00330304|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110230907|NCT00330304|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110230908|NCT00330304|Antimetabolites|antimetabolites|mesh-ancestor
110230909|NCT00330304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110230910|NCT00330304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110230911|NCT00330304|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110230912|NCT00330304|Antimalarials|antimalarials|mesh-ancestor
110230913|NCT00330304|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110230914|NCT00330304|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110230915|NCT00330499|Cisplatin|cisplatin|mesh-list
110230916|NCT00330499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110230917|NCT00083954|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110230918|NCT00083954|Antidepressive Agents|antidepressive agents|mesh-ancestor
110230919|NCT00083954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110230920|NCT00083954|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110230921|NCT00083954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110230922|NCT00083954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110230923|NCT00083954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110230924|NCT00330577|Timolol|timolol|mesh-list
110230926|NCT00330577|Lubricant Eye Drops|lubricant eye drops|mesh-list
110230927|NCT00330577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110230928|NCT00330577|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110264624|NCT00165399|Docetaxel|docetaxel|mesh-list
110230929|NCT00330577|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110230930|NCT00330577|Adrenergic Agents|adrenergic agents|mesh-ancestor
110230931|NCT00330577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110230932|NCT00330577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110230933|NCT00330577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110230934|NCT00330577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110230935|NCT00330577|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110230936|NCT00330577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110230938|NCT00083993|Letrozole|letrozole|mesh-list
110230939|NCT00083993|Temsirolimus|temsirolimus|mesh-list
110230940|NCT00083993|MTOR Inhibitors|mtor inhibitors|mesh-list
110230941|NCT00083993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110230942|NCT00083993|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110230943|NCT00083993|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110230944|NCT00083993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110230945|NCT00083993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110230946|NCT00083993|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110230947|NCT00083993|Hormone Antagonists|hormone antagonists|mesh-ancestor
110230948|NCT00083993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110230949|NCT00083993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110230950|NCT00083993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110230951|NCT00083993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110230952|NCT00083993|Immunologic Factors|immunologic factors|mesh-ancestor
110230953|NCT00083993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110230954|NCT00083993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110230955|NCT00083993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110230956|NCT00083993|Antifungal Agents|antifungal agents|mesh-ancestor
110230958|NCT00323791|Imatinib Mesylate|imatinib mesylate|mesh-list
110230959|NCT00323791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110230960|NCT00323791|Antimetabolites|antimetabolites|mesh-ancestor
110230961|NCT00323791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110230962|NCT00323791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110230963|NCT00323791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110230964|NCT00323791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110230965|NCT00323830|Capecitabine|capecitabine|mesh-list
110230966|NCT00323830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110230967|NCT00323830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110230968|NCT00323830|Antimetabolites|antimetabolites|mesh-ancestor
110230969|NCT00323830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110230970|NCT00317512|Chrysarobin|chrysarobin|mesh-list
110230971|NCT00317512|HBOC 201|hboc 201|mesh-list
110230972|NCT00317512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110230973|NCT00317512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110230974|NCT00317512|Analgesics|analgesics|mesh-ancestor
110230975|NCT00317512|Sensory System Agents|sensory system agents|mesh-ancestor
110230976|NCT00317512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110230977|NCT00317512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110230978|NCT00317512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110230979|NCT00317512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110230980|NCT00317512|Blood Substitutes|blood substitutes|mesh-ancestor
110230981|NCT00124059|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110230982|NCT00124059|Antidepressive Agents|antidepressive agents|mesh-ancestor
110230983|NCT00124059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110230984|NCT00124059|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110230985|NCT00124059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110230986|NCT00124059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110230987|NCT00124059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110230988|NCT00084032|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110230989|NCT00084032|Antiviral Agents|antiviral agents|mesh-ancestor
110230990|NCT00084032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110230991|NCT00323947|Methylphenidate|methylphenidate|mesh-list
110230992|NCT00323947|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110230993|NCT00323947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110230994|NCT00323947|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110230995|NCT00323947|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110230996|NCT00323947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110230997|NCT00323947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110230998|NCT00323947|Dopamine Agents|dopamine agents|mesh-ancestor
110230999|NCT00323947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110231000|NCT00323986|Azithromycin|azithromycin|mesh-list
110231001|NCT00323986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110231002|NCT00323986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110231003|NCT00324025|Efungumab|efungumab|mesh-list
110231004|NCT00324025|Antifungal Agents|antifungal agents|mesh-ancestor
110231005|NCT00324025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110231006|NCT00317629|Meglumine Antimoniate|meglumine antimoniate|mesh-list
110231007|NCT00317629|Nitric Oxide|nitric oxide|mesh-list
110231008|NCT00317629|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110231009|NCT00317629|Autonomic Agents|autonomic agents|mesh-ancestor
110231010|NCT00317629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110231011|NCT00317629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110231012|NCT00317629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110231013|NCT00317629|Respiratory System Agents|respiratory system agents|mesh-ancestor
110231014|NCT00317629|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110231015|NCT00317629|Antioxidants|antioxidants|mesh-ancestor
110231016|NCT00317629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231017|NCT00317629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110231018|NCT00317629|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110231019|NCT00317629|Vasodilator Agents|vasodilator agents|mesh-ancestor
110231020|NCT00317629|Gasotransmitters|gasotransmitters|mesh-ancestor
110231021|NCT00317629|Protective Agents|protective agents|mesh-ancestor
110231022|NCT00317629|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110231023|NCT00317629|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110231024|NCT00317629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110231025|NCT00093249|Clevidipine|clevidipine|mesh-list
110231026|NCT00093249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110231027|NCT00093249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110231028|NCT00093249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231029|NCT00093249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110231030|NCT00093249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110231031|NCT00124098|Darbepoetin alfa|darbepoetin alfa|mesh-list
110231032|NCT00124098|Hematinics|hematinics|mesh-ancestor
110231033|NCT00324142|Tinidazole|tinidazole|mesh-list
110231034|NCT00324142|Alkylating Agents|alkylating agents|mesh-ancestor
110231035|NCT00324142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231036|NCT00324142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110231037|NCT00324142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110231038|NCT00324142|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
110231039|NCT00324142|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110231040|NCT00324142|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110231042|NCT00324298|Bleomycin|bleomycin|mesh-list
110231043|NCT00324298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110231044|NCT00324298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110231045|NCT00324298|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110231046|NCT00324298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110231047|NCT00324298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110231048|NCT00324298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231049|NCT00324298|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110231050|NCT00124137|Diuretics|diuretics|mesh-list
110231051|NCT00124137|Natriuretic Agents|natriuretic agents|mesh-ancestor
110231052|NCT00124137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110231053|NCT00324376|Sevelamer|sevelamer|mesh-list
110231054|NCT00324376|Chelating Agents|chelating agents|mesh-ancestor
110231055|NCT00324376|Sequestering Agents|sequestering agents|mesh-ancestor
110231056|NCT00324376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231057|NCT00084227|Azithromycin|azithromycin|mesh-list
110231058|NCT00084227|Chloroquine|chloroquine|mesh-list
110231059|NCT00084227|Atovaquone|atovaquone|mesh-list
110231060|NCT00084227|Proguanil|proguanil|mesh-list
110231061|NCT00084227|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
110231062|NCT00084227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110231063|NCT00084227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110231064|NCT00084227|Amebicides|amebicides|mesh-ancestor
110231065|NCT00084227|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110231066|NCT00084227|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110231067|NCT00084227|Antimalarials|antimalarials|mesh-ancestor
110231069|NCT00084227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110231070|NCT00084227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231071|NCT00084227|Antimetabolites|antimetabolites|mesh-ancestor
110231072|NCT00317746|Citalopram|citalopram|mesh-list
110231073|NCT00317746|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110231074|NCT00317746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110231075|NCT00317746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110231076|NCT00317746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231077|NCT00317746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110231078|NCT00317746|Serotonin Agents|serotonin agents|mesh-ancestor
110231079|NCT00317746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110231080|NCT00317746|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110231081|NCT00317746|Antidepressive Agents|antidepressive agents|mesh-ancestor
110231082|NCT00317746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110231084|NCT00317785|Sirolimus|sirolimus|mesh-list
110231085|NCT00317785|Mycophenolic Acid|mycophenolic acid|mesh-list
110231086|NCT00317785|Cyclophosphamide|cyclophosphamide|mesh-list
110231087|NCT00317785|Methotrexate|methotrexate|mesh-list
110231088|NCT00317785|Tacrolimus|tacrolimus|mesh-list
110231089|NCT00317785|Cyclosporins|cyclosporins|mesh-list
110231090|NCT00317785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110231091|NCT00317785|Immunologic Factors|immunologic factors|mesh-ancestor
110231092|NCT00317785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110231093|NCT00317785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110231094|NCT00317785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110231095|NCT00317785|Alkylating Agents|alkylating agents|mesh-ancestor
110231096|NCT00317785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231097|NCT00317785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110231098|NCT00317785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110231099|NCT00317785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110231100|NCT00317785|Abortifacient Agents|abortifacient agents|mesh-ancestor
110231101|NCT00317785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110231102|NCT00317785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110231103|NCT00317785|Antimetabolites|antimetabolites|mesh-ancestor
110231104|NCT00317785|Dermatologic Agents|dermatologic agents|mesh-ancestor
110231105|NCT00317785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110231107|NCT00317785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110231108|NCT00317785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110231109|NCT00317785|Antifungal Agents|antifungal agents|mesh-ancestor
110231110|NCT00317785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110231111|NCT00317785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110231112|NCT00317785|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110231113|NCT00317785|Antitubercular Agents|antitubercular agents|mesh-ancestor
110231114|NCT00317785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110231116|NCT00093288|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110231117|NCT00093288|Antidepressive Agents|antidepressive agents|mesh-ancestor
110231118|NCT00093288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110231119|NCT00093288|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110231120|NCT00093288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110231121|NCT00093288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110231122|NCT00093288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231123|NCT00093288|Dopamine Agents|dopamine agents|mesh-ancestor
110231124|NCT00093288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110231125|NCT00093288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110231126|NCT00093288|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110231127|NCT00093288|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110231128|NCT00093288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110231129|NCT00324454|Levetiracetam|levetiracetam|mesh-list
110231130|NCT00324454|Anticonvulsants|anticonvulsants|mesh-ancestor
110231131|NCT00324454|Nootropic Agents|nootropic agents|mesh-ancestor
110231132|NCT00317902|Epoetin Alfa|epoetin alfa|mesh-list
110231133|NCT00317902|Hematinics|hematinics|mesh-ancestor
110231134|NCT00317980|Meglumine Antimoniate|meglumine antimoniate|mesh-list
110231135|NCT00317980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110231136|NCT00317980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110231137|NCT00317980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110231139|NCT00324571|Sevelamer|sevelamer|mesh-list
110231140|NCT00324571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110231141|NCT00324571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110231142|NCT00324571|Chelating Agents|chelating agents|mesh-ancestor
110231143|NCT00324571|Sequestering Agents|sequestering agents|mesh-ancestor
110231144|NCT00324571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231145|NCT00084461|Romidepsin|romidepsin|mesh-list
110231146|NCT00084461|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110231147|NCT00084461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110231148|NCT00084461|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110231149|NCT00084461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110231150|NCT00084461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231151|NCT00324610|Capecitabine|capecitabine|mesh-list
110231152|NCT00324610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110231153|NCT00324610|Antimetabolites|antimetabolites|mesh-ancestor
110231154|NCT00324610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231155|NCT00324610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110231156|NCT00093366|Etanercept|etanercept|mesh-list
110231157|NCT00093366|Arsenic Trioxide|arsenic trioxide|mesh-list
110231158|NCT00093366|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110231159|NCT00093366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110231160|NCT00093366|Analgesics|analgesics|mesh-ancestor
110231161|NCT00093366|Sensory System Agents|sensory system agents|mesh-ancestor
110231162|NCT00093366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110231163|NCT00093366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110231164|NCT00093366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110231165|NCT00093366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110231167|NCT00093366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110231168|NCT00093366|Immunologic Factors|immunologic factors|mesh-ancestor
110264810|NCT02931877|Propofol|propofol|mesh-list
110231169|NCT00093366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110231170|NCT00324688|Tenofovir|tenofovir|mesh-list
110231171|NCT00324688|Antiviral Agents|antiviral agents|mesh-ancestor
110231172|NCT00324688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110231173|NCT00324688|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110231174|NCT00324688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110231175|NCT00324688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110231176|NCT00324688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231177|NCT00324688|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110231178|NCT00324688|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110231179|NCT00324727|Melphalan|melphalan|mesh-list
110231180|NCT00324727|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110231181|NCT00324727|Alkylating Agents|alkylating agents|mesh-ancestor
110231182|NCT00324727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231183|NCT00324727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110231184|NCT00324727|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110231185|NCT00324727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110231186|NCT00324727|Immunologic Factors|immunologic factors|mesh-ancestor
110231187|NCT00324727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110231189|NCT00324766|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110231190|NCT00324766|Vasodilator Agents|vasodilator agents|mesh-ancestor
110231191|NCT00324766|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110231192|NCT00324766|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110231193|NCT00324766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110231194|NCT00324766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231195|NCT00324766|Protective Agents|protective agents|mesh-ancestor
110231196|NCT00324766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110231197|NCT00084578|Rosiglitazone|rosiglitazone|mesh-list
110231198|NCT00084578|Celecoxib|celecoxib|mesh-list
110231199|NCT00084578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110231200|NCT00084578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110231201|NCT00084578|Analgesics|analgesics|mesh-ancestor
110264843|NCT00153998|Hematinics|hematinics|mesh-ancestor
110231202|NCT00084578|Sensory System Agents|sensory system agents|mesh-ancestor
110231203|NCT00084578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110231204|NCT00084578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110231205|NCT00084578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110231206|NCT00084578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110231207|NCT00084578|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110231208|NCT00084578|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110231209|NCT00084578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110231210|NCT00084578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231211|NCT00084578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110231212|NCT00318175|Bosentan|bosentan|mesh-list
110231213|NCT00318175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110231214|NCT00318175|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110231215|NCT00318175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231216|NCT00093444|Doxorubicin|doxorubicin|mesh-list
110231217|NCT00093444|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110231218|NCT00093444|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110231219|NCT00093444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110231220|NCT00093444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110231221|NCT00093444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110231222|NCT00093444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110231223|NCT00093444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231224|NCT00325000|Amitriptyline|amitriptyline|mesh-list
110231225|NCT00325000|Sertraline|sertraline|mesh-list
110231226|NCT00325000|Antidepressive Agents|antidepressive agents|mesh-ancestor
110231227|NCT00325000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110231228|NCT00325000|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110231229|NCT00325000|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110231230|NCT00325000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110231231|NCT00325000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231232|NCT00325000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110231233|NCT00325000|Serotonin Agents|serotonin agents|mesh-ancestor
110231236|NCT00325000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110231238|NCT00325000|Sensory System Agents|sensory system agents|mesh-ancestor
110231239|NCT00325000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110231240|NCT00325000|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110231241|NCT00325000|Adrenergic Agents|adrenergic agents|mesh-ancestor
110231243|NCT00318448|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110231244|NCT00318448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110231245|NCT00318448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110231246|NCT00318448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110231247|NCT00318448|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110231248|NCT00318448|GABA Agonists|gaba agonists|mesh-ancestor
110231249|NCT00318448|GABA Agents|gaba agents|mesh-ancestor
110231250|NCT00318448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110231251|NCT00318448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231253|NCT00325117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110231254|NCT00325117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110231255|NCT00325117|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110231256|NCT00325117|Protease Inhibitors|protease inhibitors|mesh-ancestor
110231257|NCT00325117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110231258|NCT00325117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231259|NCT00084695|Methylprednisolone|methylprednisolone|mesh-list
110231260|NCT00084695|Cyclophosphamide|cyclophosphamide|mesh-list
110231261|NCT00084695|Melphalan|melphalan|mesh-list
110231262|NCT00084695|Busulfan|busulfan|mesh-list
110231263|NCT00084695|Fludarabine|fludarabine|mesh-list
110231264|NCT00084695|Fludarabine phosphate|fludarabine phosphate|mesh-list
110231265|NCT00084695|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110231266|NCT00084695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110231267|NCT00084695|Immunologic Factors|immunologic factors|mesh-ancestor
110231268|NCT00084695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110231269|NCT00084695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110231270|NCT00084695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110231271|NCT00084695|Alkylating Agents|alkylating agents|mesh-ancestor
110231272|NCT00084695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231273|NCT00084695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110231274|NCT00084695|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110231275|NCT00084695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110231276|NCT00084695|Antimetabolites|antimetabolites|mesh-ancestor
110231277|NCT00084695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110231278|NCT00084695|Antiemetics|antiemetics|mesh-ancestor
110231279|NCT00084695|Autonomic Agents|autonomic agents|mesh-ancestor
110231280|NCT00084695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110231281|NCT00084695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110231282|NCT00084695|Glucocorticoids|glucocorticoids|mesh-ancestor
110231283|NCT00084695|Hormones|hormones|mesh-ancestor
110231284|NCT00084695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110231285|NCT00084695|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110231286|NCT00084695|Protective Agents|protective agents|mesh-ancestor
110231287|NCT00325351|Carboplatin|carboplatin|mesh-list
110231288|NCT00325351|Sagopilone|sagopilone|mesh-list
110231289|NCT00325351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110231290|NCT00093483|Cytarabine|cytarabine|mesh-list
110231291|NCT00093483|Idarubicin|idarubicin|mesh-list
110231292|NCT00093483|Arsenic Trioxide|arsenic trioxide|mesh-list
110231293|NCT00093483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110231294|NCT00093483|Antimetabolites|antimetabolites|mesh-ancestor
110231295|NCT00093483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231296|NCT00093483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110231297|NCT00093483|Antiviral Agents|antiviral agents|mesh-ancestor
110231298|NCT00093483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110231299|NCT00093483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110231300|NCT00093483|Immunologic Factors|immunologic factors|mesh-ancestor
110231301|NCT00093483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110231302|NCT00093483|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110231303|NCT00093483|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110231304|NCT00093483|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110231305|NCT00093483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110231306|NCT00325390|Clopidogrel|clopidogrel|mesh-list
110231307|NCT00325390|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110231308|NCT00325390|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110231309|NCT00325390|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110231310|NCT00325390|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110231311|NCT00325390|Purinergic Agents|purinergic agents|mesh-ancestor
110231312|NCT00325390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110231313|NCT00325390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231314|NCT00325390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110231315|NCT00325429|Vildagliptin|vildagliptin|mesh-list
110231316|NCT00325429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110231317|NCT00325429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110231318|NCT00325429|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110231319|NCT00325429|Protease Inhibitors|protease inhibitors|mesh-ancestor
110231320|NCT00325429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110231321|NCT00325429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231322|NCT00093522|Fludarabine|fludarabine|mesh-list
110231323|NCT00093522|Fludarabine phosphate|fludarabine phosphate|mesh-list
110231324|NCT00093522|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
110231325|NCT00093522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110231326|NCT00093522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110231328|NCT00093522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231329|NCT00093522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110231330|NCT00093522|Immunologic Factors|immunologic factors|mesh-ancestor
110231331|NCT00093522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110231332|NCT00093522|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110231333|NCT00084773|Fluorouracil|fluorouracil|mesh-list
110231334|NCT00084773|Cetuximab|cetuximab|mesh-list
110231335|NCT00084773|Antimetabolites|antimetabolites|mesh-ancestor
110231336|NCT00084773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231337|NCT00084773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110231338|NCT00084773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110231339|NCT00084773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110231340|NCT00084773|Immunologic Factors|immunologic factors|mesh-ancestor
110231341|NCT00084773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110231342|NCT00084773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110231343|NCT00325546|Rimonabant|rimonabant|mesh-list
110231344|NCT00325546|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110231345|NCT00325546|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
110231346|NCT00325546|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110231347|NCT00325546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110231348|NCT00325546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231350|NCT00325546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110231351|NCT00325546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110231352|NCT00084812|Safingol|safingol|mesh-list
110231353|NCT00084812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110231354|NCT00084812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231355|NCT02959879|Folfirinox|folfirinox|mesh-list
110231356|NCT02959879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110231357|NCT04717609|Ropivacaine|ropivacaine|mesh-list
110231358|NCT04717609|Anesthetics, Local|anesthetics, local|mesh-ancestor
110231359|NCT04717609|Anesthetics|anesthetics|mesh-ancestor
110231360|NCT04717609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110231361|NCT04717609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110231362|NCT04717609|Sensory System Agents|sensory system agents|mesh-ancestor
110231363|NCT04717609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110231364|NCT00318760|Clonidine|clonidine|mesh-list
110231365|NCT00318760|Analgesics|analgesics|mesh-ancestor
110231366|NCT00318760|Sensory System Agents|sensory system agents|mesh-ancestor
110231367|NCT00318760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110231368|NCT00318760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110231369|NCT00318760|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110231370|NCT00318760|Sympatholytics|sympatholytics|mesh-ancestor
110264999|NCT02923258|Docetaxel|docetaxel|mesh-list
110231371|NCT00318760|Autonomic Agents|autonomic agents|mesh-ancestor
110231372|NCT00318760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110231373|NCT00318760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110231374|NCT00318760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110231375|NCT00318760|Adrenergic Agents|adrenergic agents|mesh-ancestor
110231376|NCT00318760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110231377|NCT00318760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231378|NCT00093561|Lycopene|lycopene|mesh-list
110231379|NCT00093561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110231380|NCT00093561|Antioxidants|antioxidants|mesh-ancestor
110231381|NCT00093561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231382|NCT00093561|Protective Agents|protective agents|mesh-ancestor
110231383|NCT00093561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110231384|NCT00093561|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110231385|NCT00093561|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110231386|NCT00093561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110231387|NCT00084890|Carboplatin|carboplatin|mesh-list
110231388|NCT00084890|Docetaxel|docetaxel|mesh-list
110231389|NCT00084890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110231390|NCT00084890|Tubulin Modulators|tubulin modulators|mesh-ancestor
110231391|NCT00084890|Antimitotic Agents|antimitotic agents|mesh-ancestor
110231392|NCT00084890|Mitosis Modulators|mitosis modulators|mesh-ancestor
110231393|NCT00084890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231394|NCT00318838|Azimilide|azimilide|mesh-list
110231395|NCT00318838|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110231396|NCT00318838|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110231397|NCT00318838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110231398|NCT00318838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231399|NCT00318838|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110231400|NCT00318838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110231401|NCT00085124|Cytarabine|cytarabine|mesh-list
110231402|NCT00085124|Daunorubicin|daunorubicin|mesh-list
110231403|NCT00085124|Oblimersen|oblimersen|mesh-list
110231404|NCT00085124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110231405|NCT00085124|Antimetabolites|antimetabolites|mesh-ancestor
110231406|NCT00085124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231407|NCT00085124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110231408|NCT00085124|Antiviral Agents|antiviral agents|mesh-ancestor
110231409|NCT00085124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110231410|NCT00085124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110231411|NCT00085124|Immunologic Factors|immunologic factors|mesh-ancestor
110231412|NCT00085124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110231413|NCT00085124|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110231414|NCT00085124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110231415|NCT00085124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110231416|NCT00085124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110231417|NCT00402441|Risedronic Acid|risedronic acid|mesh-list
110231418|NCT00402441|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110231419|NCT00402441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110231420|NCT00402441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231421|NCT00402441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110231422|NCT00402441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110231423|NCT00402441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110231424|NCT00325858|Tramadol|tramadol|mesh-list
110231425|NCT00325858|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110231426|NCT00325858|Narcotics|narcotics|mesh-ancestor
110231427|NCT00325858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110231428|NCT00325858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110231429|NCT00325858|Analgesics|analgesics|mesh-ancestor
110231430|NCT00325858|Sensory System Agents|sensory system agents|mesh-ancestor
110231431|NCT00325858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110231432|NCT00318955|Dexmedetomidine|dexmedetomidine|mesh-list
110231433|NCT00318955|Propofol|propofol|mesh-list
110231434|NCT00318955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110231435|NCT00318955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110231436|NCT00318955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110231437|NCT00318955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110231438|NCT00318955|Analgesics|analgesics|mesh-ancestor
110231439|NCT00318955|Sensory System Agents|sensory system agents|mesh-ancestor
110231440|NCT00318955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110231441|NCT00318955|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110231442|NCT00318955|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110231444|NCT00318955|Adrenergic Agents|adrenergic agents|mesh-ancestor
110231445|NCT00318955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110231446|NCT00318955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231447|NCT00318955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110231448|NCT00318955|Anesthetics, General|anesthetics, general|mesh-ancestor
110231449|NCT00318955|Anesthetics|anesthetics|mesh-ancestor
110231450|NCT00325936|Cilnidipine|cilnidipine|mesh-list
110231451|NCT00325936|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110231452|NCT00325936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110231453|NCT00325936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231454|NCT00325936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110231455|NCT00325936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110231456|NCT00318994|Meropenem|meropenem|mesh-list
110231457|NCT00318994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110231458|NCT00318994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110231459|NCT00093600|Cytarabine|cytarabine|mesh-list
110231460|NCT00093600|Daunorubicin|daunorubicin|mesh-list
110231461|NCT00093600|Midostaurin|midostaurin|mesh-list
110231462|NCT00093600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110231463|NCT00093600|Antimetabolites|antimetabolites|mesh-ancestor
110231464|NCT00093600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231465|NCT00093600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110231466|NCT00093600|Antiviral Agents|antiviral agents|mesh-ancestor
110231467|NCT00093600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110231468|NCT00093600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110231469|NCT00093600|Immunologic Factors|immunologic factors|mesh-ancestor
110231471|NCT00093600|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110231472|NCT00093600|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110231473|NCT00093600|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110231474|NCT00093600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110231475|NCT00093600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110231476|NCT00319033|Bosentan|bosentan|mesh-list
110231477|NCT00319033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110231478|NCT00319033|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110231479|NCT00319033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231480|NCT00085163|Leucovorin|leucovorin|mesh-list
110231481|NCT00085163|Celecoxib|celecoxib|mesh-list
110231482|NCT00085163|Fluorouracil|fluorouracil|mesh-list
110231483|NCT00085163|Calcium|calcium|mesh-list
110231484|NCT00085163|Levoleucovorin|levoleucovorin|mesh-list
110231485|NCT00085163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110231486|NCT00085163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110231487|NCT00085163|Antimetabolites|antimetabolites|mesh-ancestor
110231488|NCT00085163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231489|NCT00085163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110231490|NCT00085163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110231491|NCT00085163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110231492|NCT00085163|Immunologic Factors|immunologic factors|mesh-ancestor
110231493|NCT00085163|Antidotes|antidotes|mesh-ancestor
110231494|NCT00085163|Protective Agents|protective agents|mesh-ancestor
110231495|NCT00085163|Vitamin B Complex|vitamin b complex|mesh-ancestor
110231496|NCT00085163|Vitamins|vitamins|mesh-ancestor
110231497|NCT00085163|Micronutrients|micronutrients|mesh-ancestor
110231498|NCT00085163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110231499|NCT00085163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110231500|NCT00085163|Analgesics|analgesics|mesh-ancestor
110231501|NCT00085163|Sensory System Agents|sensory system agents|mesh-ancestor
110231502|NCT00085163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110231503|NCT00085163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110231504|NCT00085163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110231505|NCT00085163|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110231506|NCT00085163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110231507|NCT00085163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110231508|NCT00319072|Hormones|hormones|mesh-list
110231509|NCT00319072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110231510|NCT00319072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110231511|NCT00093639|Everolimus|everolimus|mesh-list
110231512|NCT00093639|Imatinib Mesylate|imatinib mesylate|mesh-list
110231513|NCT00093639|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110231514|NCT00093639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110231515|NCT00093639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110231516|NCT00093639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231517|NCT00093639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110231518|NCT00093639|Immunologic Factors|immunologic factors|mesh-ancestor
110231519|NCT00093639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110231520|NCT00093639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110231521|NCT00319150|Epoetin Alfa|epoetin alfa|mesh-list
110231522|NCT00319150|Hematinics|hematinics|mesh-ancestor
110231523|NCT00326053|Budesonide|budesonide|mesh-list
110231524|NCT00326053|Formoterol Fumarate|formoterol fumarate|mesh-list
110231525|NCT00326053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110231526|NCT00326053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110231527|NCT00326053|Autonomic Agents|autonomic agents|mesh-ancestor
110231528|NCT00326053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110231529|NCT00326053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110231530|NCT00326053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110231531|NCT00326053|Respiratory System Agents|respiratory system agents|mesh-ancestor
110231532|NCT00326053|Glucocorticoids|glucocorticoids|mesh-ancestor
110231533|NCT00326053|Hormones|hormones|mesh-ancestor
110231534|NCT00326053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110231535|NCT00326053|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110231536|NCT00326053|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110231537|NCT00326053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110231538|NCT00326053|Adrenergic Agents|adrenergic agents|mesh-ancestor
110231539|NCT00326053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110231540|NCT00326053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231541|NCT00400088|Lithium Carbonate|lithium carbonate|mesh-list
110231542|NCT00400088|Paroxetine|paroxetine|mesh-list
110231543|NCT00400088|Antidepressive Agents|antidepressive agents|mesh-ancestor
110231544|NCT00400088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110231545|NCT00400088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110231546|NCT00400088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231547|NCT00400088|Antimanic Agents|antimanic agents|mesh-ancestor
110231548|NCT00400088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110265028|NCT02922712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110231549|NCT00400088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110231550|NCT00400088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110231551|NCT00400088|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110231552|NCT00400088|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110231553|NCT00400088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110231554|NCT00400088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110231555|NCT00400088|Serotonin Agents|serotonin agents|mesh-ancestor
110231556|NCT00400088|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110231557|NCT00400088|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110231558|NCT00400088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110231559|NCT00326092|Timolol|timolol|mesh-list
110231560|NCT00326092|Brinzolamide|brinzolamide|mesh-list
110231561|NCT00326092|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110231562|NCT00326092|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110231563|NCT00326092|Adrenergic Agents|adrenergic agents|mesh-ancestor
110231564|NCT00326092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110231565|NCT00326092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231566|NCT00326092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110231567|NCT00326092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110231568|NCT00326092|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110231569|NCT00326092|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110231570|NCT00326092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110231572|NCT00326131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110231574|NCT00319189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110231575|NCT00319189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110231576|NCT00319267|Bosentan|bosentan|mesh-list
110231577|NCT00319267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110231578|NCT00319267|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110231579|NCT00319267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231580|NCT00085280|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110231581|NCT00085280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110231582|NCT00085280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110231583|NCT00085280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110231584|NCT00085280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231585|NCT00326248|Casopitant|casopitant|mesh-list
110231586|NCT00326248|Antiemetics|antiemetics|mesh-ancestor
110231587|NCT00326248|Autonomic Agents|autonomic agents|mesh-ancestor
110231588|NCT00326248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110231590|NCT00326248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110265051|NCT02922283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110231591|NCT00326248|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110231592|NCT00326248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110231593|NCT00326248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231594|NCT00319306|Budesonide|budesonide|mesh-list
110231595|NCT00319306|Formoterol Fumarate|formoterol fumarate|mesh-list
110231596|NCT00319306|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110231597|NCT00319306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110231598|NCT00319306|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110231599|NCT00319306|Autonomic Agents|autonomic agents|mesh-ancestor
110231600|NCT00319306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110231601|NCT00319306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110231602|NCT00319306|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110231603|NCT00319306|Respiratory System Agents|respiratory system agents|mesh-ancestor
110231604|NCT00319306|Glucocorticoids|glucocorticoids|mesh-ancestor
110231605|NCT00319306|Hormones|hormones|mesh-ancestor
110231606|NCT00319306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110231607|NCT00319306|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110231608|NCT00319306|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110231609|NCT00319306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110231610|NCT00319306|Adrenergic Agents|adrenergic agents|mesh-ancestor
110231611|NCT00319306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110231612|NCT00319306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231613|NCT00085358|Paclitaxel|paclitaxel|mesh-list
110231614|NCT00085358|Docetaxel|docetaxel|mesh-list
110231615|NCT00085358|Bevacizumab|bevacizumab|mesh-list
110231616|NCT00085358|Carboplatin|carboplatin|mesh-list
110231617|NCT00085358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110231618|NCT00085358|Antibodies|antibodies|mesh-list
110231619|NCT00085358|Immunoglobulins|immunoglobulins|mesh-list
110231620|NCT00085358|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110231621|NCT00085358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110231623|NCT00085358|Tubulin Modulators|tubulin modulators|mesh-ancestor
110231624|NCT00085358|Antimitotic Agents|antimitotic agents|mesh-ancestor
110231625|NCT00085358|Mitosis Modulators|mitosis modulators|mesh-ancestor
110231626|NCT00085358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231627|NCT00085358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110231628|NCT00085358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110231629|NCT00085358|Growth Substances|growth substances|mesh-ancestor
110231630|NCT00085358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110231631|NCT00085358|Growth Inhibitors|growth inhibitors|mesh-ancestor
110231632|NCT00085358|Immunologic Factors|immunologic factors|mesh-ancestor
110231633|NCT00093678|Celecoxib|celecoxib|mesh-list
110231634|NCT00093678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110231635|NCT00093678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110231636|NCT00093678|Analgesics|analgesics|mesh-ancestor
110231637|NCT00093678|Sensory System Agents|sensory system agents|mesh-ancestor
110231638|NCT00093678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110231639|NCT00093678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110231640|NCT00093678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110231642|NCT00093678|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110231643|NCT00093678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110231644|NCT00093678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110231645|NCT00093678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231646|NCT00319345|Mannitol|mannitol|mesh-list
110231647|NCT00319345|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110231648|NCT00319345|Diuretics|diuretics|mesh-ancestor
110231649|NCT00319345|Natriuretic Agents|natriuretic agents|mesh-ancestor
110231650|NCT00319345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110231651|NCT00419536|Panobinostat|panobinostat|mesh-list
110231652|NCT00419536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110231653|NCT00419536|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110231654|NCT00419536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110231655|NCT00419536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231656|NCT00326404|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110231657|NCT00326404|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110231658|NCT00326404|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110231659|NCT00326404|Desogestrel|desogestrel|mesh-list
110231660|NCT00326404|Estradiol|estradiol|mesh-list
110231661|NCT00326404|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110231662|NCT00326404|Estrogens|estrogens|mesh-ancestor
110231663|NCT00326404|Hormones|hormones|mesh-ancestor
110231664|NCT00326404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110231665|NCT00326404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110231666|NCT00326404|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110231667|NCT00326404|Contraceptive Agents|contraceptive agents|mesh-ancestor
110231668|NCT00326404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110231669|NCT00326404|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110231670|NCT00326404|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110231671|NCT00326404|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110231672|NCT00326404|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110231673|NCT00326404|Progestins|progestins|mesh-ancestor
110231674|NCT00085475|Imatinib Mesylate|imatinib mesylate|mesh-list
110231675|NCT00085475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110231676|NCT00085475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110231677|NCT00085475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110231678|NCT00085475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231679|NCT00319618|Docetaxel|docetaxel|mesh-list
110231680|NCT00319618|Gefitinib|gefitinib|mesh-list
110231681|NCT00319618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110231682|NCT00319618|Tubulin Modulators|tubulin modulators|mesh-ancestor
110231683|NCT00319618|Antimitotic Agents|antimitotic agents|mesh-ancestor
110231684|NCT00319618|Mitosis Modulators|mitosis modulators|mesh-ancestor
110231685|NCT00319618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231686|NCT00319618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110231687|NCT00319618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110231688|NCT00124332|Rimonabant|rimonabant|mesh-list
110231689|NCT00124332|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110231690|NCT00124332|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
110231691|NCT00124332|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110231692|NCT00124332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110231693|NCT00124332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231694|NCT00124332|Hormones|hormones|mesh-ancestor
110231695|NCT00124332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110231696|NCT00124332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110231698|NCT00085553|Tipifarnib|tipifarnib|mesh-list
110231699|NCT00085553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110231700|NCT00085553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110231702|NCT00085553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231703|NCT00400335|Methyltestosterone|methyltestosterone|mesh-list
110231704|NCT00400335|Testosterone|testosterone|mesh-list
110231705|NCT00400335|Testosterone undecanoate|testosterone undecanoate|mesh-list
110231706|NCT00400335|Testosterone enanthate|testosterone enanthate|mesh-list
110231707|NCT00400335|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110231708|NCT00400335|Dutasteride|dutasteride|mesh-list
110231709|NCT00400335|Androgens|androgens|mesh-ancestor
110231710|NCT00400335|Hormones|hormones|mesh-ancestor
110231711|NCT00400335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110231712|NCT00400335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110231713|NCT00400335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110231714|NCT00400335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110231715|NCT00400335|Anabolic Agents|anabolic agents|mesh-ancestor
110231716|NCT00400335|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110231717|NCT00400335|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110231718|NCT00400335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110231719|NCT00400335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231720|NCT00400335|Hormone Antagonists|hormone antagonists|mesh-ancestor
110231721|NCT00319852|Vaccines|vaccines|mesh-list
110231722|NCT00319852|Immunologic Factors|immunologic factors|mesh-ancestor
110231723|NCT00319852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110231724|NCT00326833|Vitamin B 12|vitamin b 12|mesh-list
110231725|NCT00326833|Hydroxocobalamin|hydroxocobalamin|mesh-list
110231726|NCT00326833|Vitamins|vitamins|mesh-ancestor
110231727|NCT00326833|Micronutrients|micronutrients|mesh-ancestor
110231728|NCT00326833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110231729|NCT00326833|Vitamin B Complex|vitamin b complex|mesh-ancestor
110231730|NCT00326833|Hematinics|hematinics|mesh-ancestor
110231731|NCT00085748|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110231732|NCT00085748|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110231733|NCT00085748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110231734|NCT00085748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110231735|NCT00085748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110231736|NCT00085748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110231737|NCT00085748|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110231738|NCT00085748|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110231739|NCT00085748|Serotonin Agents|serotonin agents|mesh-ancestor
110231740|NCT00085748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110231741|NCT00085748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231742|NCT00085748|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110231743|NCT00085748|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110231744|NCT00085748|Dopamine Agents|dopamine agents|mesh-ancestor
110231745|NCT04717102|Desflurane|desflurane|mesh-list
110231746|NCT04717102|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110231747|NCT04717102|Anesthetics, General|anesthetics, general|mesh-ancestor
110231748|NCT04717102|Anesthetics|anesthetics|mesh-ancestor
110231749|NCT04717102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110231750|NCT04717102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110231751|NCT00320047|Baclofen|baclofen|mesh-list
110231752|NCT00320047|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110231753|NCT00320047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110231754|NCT00320047|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110231755|NCT00320047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110231756|NCT00320047|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110231757|NCT00320047|GABA Agonists|gaba agonists|mesh-ancestor
110231758|NCT00320047|GABA Agents|gaba agents|mesh-ancestor
110231759|NCT00320047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110231760|NCT00320047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231761|NCT00085826|Sulindac sulfone|sulindac sulfone|mesh-list
110231762|NCT00085826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110231763|NCT00085826|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110231764|NCT00085826|Protective Agents|protective agents|mesh-ancestor
110231765|NCT00085826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110231766|NCT00085826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110231767|NCT00085826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110231768|NCT00085826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231769|NCT00085826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110231770|NCT00085826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110231771|NCT00085826|Analgesics|analgesics|mesh-ancestor
110231772|NCT00085826|Sensory System Agents|sensory system agents|mesh-ancestor
110231773|NCT00085826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110231774|NCT00085826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110231775|NCT00085826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110231776|NCT00320125|Calcium|calcium|mesh-list
110231777|NCT00320125|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110231778|NCT00320125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110231779|NCT00093873|Motesanib diphosphate|motesanib diphosphate|mesh-list
110231780|NCT00093873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110231781|NCT00093873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110231782|NCT00093873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231783|NCT00320320|Irinotecan|irinotecan|mesh-list
110231784|NCT00320320|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110231785|NCT00320320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110231786|NCT00320320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110231787|NCT00320320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231788|NCT00320320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110231789|NCT00327106|Tranexamic Acid|tranexamic acid|mesh-list
110231790|NCT00327106|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110231791|NCT00327106|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110231792|NCT00327106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231793|NCT00327106|Hemostatics|hemostatics|mesh-ancestor
110231794|NCT00327106|Coagulants|coagulants|mesh-ancestor
110231796|NCT00320359|Etoposide|etoposide|mesh-list
110231797|NCT00320359|Topotecan|topotecan|mesh-list
110231798|NCT00320359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110231799|NCT00320359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110231800|NCT00320359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110231801|NCT00320359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110231802|NCT00320359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110231803|NCT00320359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231804|NCT00320359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110231805|NCT00093912|Nitroprusside|nitroprusside|mesh-list
110231806|NCT00093912|Clevidipine|clevidipine|mesh-list
110231807|NCT00093912|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110231808|NCT00093912|Vasodilator Agents|vasodilator agents|mesh-ancestor
110231809|NCT00093912|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110231810|NCT00093912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231812|NCT00093912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110231813|NCT00093912|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110231814|NCT00093912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110231816|NCT00327145|Valsartan|valsartan|mesh-list
110231817|NCT00327145|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110231818|NCT00327145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110231819|NCT00327145|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110231820|NCT00327145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110231821|NCT00327145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231822|NCT00327145|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110231823|NCT00327145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110231824|NCT00327145|Vasodilator Agents|vasodilator agents|mesh-ancestor
110231825|NCT00327145|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110231826|NCT00327145|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110231827|NCT00327145|Diuretics|diuretics|mesh-ancestor
110231828|NCT00327145|Natriuretic Agents|natriuretic agents|mesh-ancestor
110231829|NCT00327145|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110231830|NCT00085943|Ritonavir|ritonavir|mesh-list
110231831|NCT00085943|Fosamprenavir|fosamprenavir|mesh-list
110231832|NCT00085943|Lamivudine|lamivudine|mesh-list
110231833|NCT00085943|Abacavir|abacavir|mesh-list
110231834|NCT00085943|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110231836|NCT00085943|Protease Inhibitors|protease inhibitors|mesh-ancestor
110231837|NCT00085943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110231838|NCT00085943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231839|NCT00085943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110231840|NCT00085943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110231841|NCT00085943|Antiviral Agents|antiviral agents|mesh-ancestor
110231842|NCT00085943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110231843|NCT00085943|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110231844|NCT00085943|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110231845|NCT00085943|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110231846|NCT00085943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110231847|NCT00327184|PENTA|penta|mesh-list
110231848|NCT00327184|Anticoagulants|anticoagulants|mesh-ancestor
110231849|NCT00327184|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110231850|NCT00327184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110231851|NCT00327184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231852|NCT00419302|Insulin|insulin|mesh-list
110231853|NCT00419302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110231854|NCT00419302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110231855|NCT00093951|(3-aminopropyl)(n-butyl)phosphinic acid|(3-aminopropyl)(n-butyl)phosphinic acid|mesh-list
110231856|NCT00093951|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110231857|NCT00093951|Protective Agents|protective agents|mesh-ancestor
110231858|NCT00093951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110231859|NCT00093951|GABA Antagonists|gaba antagonists|mesh-ancestor
110231860|NCT00093951|GABA Agents|gaba agents|mesh-ancestor
110231861|NCT00093951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110231862|NCT00093951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231863|NCT00419419|Nitroglycerin|nitroglycerin|mesh-list
110231864|NCT00419419|Vasodilator Agents|vasodilator agents|mesh-ancestor
110231865|NCT00320476|Bortezomib|bortezomib|mesh-list
110231866|NCT00320476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110231867|NCT00327262|Imatinib Mesylate|imatinib mesylate|mesh-list
110231868|NCT00327262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110231869|NCT00327262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110231870|NCT00327262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110231872|NCT00093990|Tipifarnib|tipifarnib|mesh-list
110231873|NCT00093990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110231874|NCT00327379|Aprotinin|aprotinin|mesh-list
110231875|NCT00327379|Hemostatics|hemostatics|mesh-ancestor
110231876|NCT00327379|Coagulants|coagulants|mesh-ancestor
110231877|NCT00327379|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110231878|NCT00327379|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110231879|NCT00327379|Protease Inhibitors|protease inhibitors|mesh-ancestor
110231880|NCT00327379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110231881|NCT00327379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231882|NCT00327418|Atorvastatin|atorvastatin|mesh-list
110231883|NCT00327418|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110231884|NCT00327418|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110231885|NCT00327418|Antimetabolites|antimetabolites|mesh-ancestor
110231886|NCT00327418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231887|NCT00327418|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110265209|NCT00154661|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110231888|NCT00327418|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110231890|NCT00094029|Sunitinib|sunitinib|mesh-list
110231891|NCT00094029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110231892|NCT00094029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110231893|NCT00094029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110231894|NCT00094029|Growth Substances|growth substances|mesh-ancestor
110231895|NCT00094029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110231896|NCT00094029|Growth Inhibitors|growth inhibitors|mesh-ancestor
110231897|NCT00094029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110231898|NCT00094029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110231899|NCT00094029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231900|NCT00086099|Amifostine|amifostine|mesh-list
110231901|NCT00086099|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110231902|NCT00086099|Protective Agents|protective agents|mesh-ancestor
110231903|NCT00086099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110231904|NCT00320632|Desipramine|desipramine|mesh-list
110231905|NCT00320632|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110231907|NCT00320632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110231908|NCT00320632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110231909|NCT00320632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231910|NCT00320632|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110231911|NCT00320632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110231912|NCT00320632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110231913|NCT00320632|Adrenergic Agents|adrenergic agents|mesh-ancestor
110231914|NCT00320632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110231915|NCT00320632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110231917|NCT00320827|Immunologic Factors|immunologic factors|mesh-ancestor
110231918|NCT00320827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110231919|NCT00320983|Topotecan|topotecan|mesh-list
110231920|NCT00320983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110231921|NCT00320983|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110231922|NCT00320983|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110231923|NCT00320983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110231924|NCT00320983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231925|NCT00086177|Progesterone|progesterone|mesh-list
110231926|NCT00086177|Progestins|progestins|mesh-ancestor
110231927|NCT00086177|Hormones|hormones|mesh-ancestor
110231928|NCT00086177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110231929|NCT00086177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110231930|NCT00094146|Octreotide|octreotide|mesh-list
110231931|NCT00094146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110231932|NCT00094146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110231933|NCT00094146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110231934|NCT00086255|Tiagabine|tiagabine|mesh-list
110231935|NCT00086255|Anticonvulsants|anticonvulsants|mesh-ancestor
110231936|NCT00086255|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
110231937|NCT00086255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110231938|NCT00086255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110231939|NCT00086255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231940|NCT00086255|GABA Agents|gaba agents|mesh-ancestor
110231941|NCT00086255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110231942|NCT00086255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110231943|NCT00321178|Clarithromycin|clarithromycin|mesh-list
110231944|NCT00321178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110231945|NCT00321178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110231946|NCT00321178|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110231947|NCT00321178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110231948|NCT00321178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231949|NCT00321178|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110231950|NCT00321178|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110231951|NCT00124527|Capecitabine|capecitabine|mesh-list
110231952|NCT00124527|Irofulven|irofulven|mesh-list
110231953|NCT00124527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110231954|NCT00124527|Antimetabolites|antimetabolites|mesh-ancestor
110231955|NCT00124527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231956|NCT00124527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110231957|NCT00124527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110231958|NCT00124527|Alkylating Agents|alkylating agents|mesh-ancestor
110231959|NCT00086294|Levodopa|levodopa|mesh-list
110231960|NCT00086294|Pimavanserin|pimavanserin|mesh-list
110231961|NCT00086294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110231962|NCT00086294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110231963|NCT00086294|Dopamine Agents|dopamine agents|mesh-ancestor
110231964|NCT00086294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110231965|NCT00086294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231966|NCT00086294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110231967|NCT00086294|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110231968|NCT00086294|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110231969|NCT00086294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110231970|NCT00086294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110231971|NCT00086294|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110231972|NCT00086294|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110231973|NCT00086294|Serotonin Agents|serotonin agents|mesh-ancestor
110231975|NCT05458492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110231976|NCT05458492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110231977|NCT05458492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110231978|NCT05458492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110231979|NCT05458492|Antifungal Agents|antifungal agents|mesh-ancestor
110231980|NCT05458492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110231981|NCT05458492|Immunologic Factors|immunologic factors|mesh-ancestor
110231982|NCT05458492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110231983|NCT00086333|Docetaxel|docetaxel|mesh-list
110231984|NCT00086333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110231985|NCT00086333|Tubulin Modulators|tubulin modulators|mesh-ancestor
110231988|NCT00086333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231989|NCT05458180|Prednisone|prednisone|mesh-list
110231990|NCT05458180|Cyclophosphamide|cyclophosphamide|mesh-list
110231991|NCT05458180|Etoposide|etoposide|mesh-list
110231992|NCT05458180|Vincristine|vincristine|mesh-list
110231993|NCT05458180|Mitoxantrone|mitoxantrone|mesh-list
110231994|NCT05458180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110231995|NCT05458180|Immunologic Factors|immunologic factors|mesh-ancestor
110231996|NCT05458180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110231997|NCT05458180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110231998|NCT05458180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110231999|NCT05458180|Alkylating Agents|alkylating agents|mesh-ancestor
110232000|NCT05458180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110232001|NCT05458180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110232002|NCT05458180|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110232003|NCT05458180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110232004|NCT05458180|Glucocorticoids|glucocorticoids|mesh-ancestor
110232005|NCT05458180|Hormones|hormones|mesh-ancestor
110232006|NCT05458180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110232007|NCT05458180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110232008|NCT05458180|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110232009|NCT05458180|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110232010|NCT05458180|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110232011|NCT05458180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110232012|NCT05458180|Tubulin Modulators|tubulin modulators|mesh-ancestor
110232013|NCT05458180|Antimitotic Agents|antimitotic agents|mesh-ancestor
110232014|NCT05458180|Mitosis Modulators|mitosis modulators|mesh-ancestor
110232015|NCT05458180|Analgesics|analgesics|mesh-ancestor
110232016|NCT05458180|Sensory System Agents|sensory system agents|mesh-ancestor
110232017|NCT05458180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110232018|NCT00419653|Haloperidol|haloperidol|mesh-list
110232019|NCT00419653|Olanzapine|olanzapine|mesh-list
110232020|NCT00419653|Haloperidol decanoate|haloperidol decanoate|mesh-list
110232021|NCT00419653|Amisulpride|amisulpride|mesh-list
110232022|NCT00419653|Antiemetics|antiemetics|mesh-ancestor
110232023|NCT00419653|Autonomic Agents|autonomic agents|mesh-ancestor
110232024|NCT00419653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110265310|NCT02918110|Oxytocics|oxytocics|mesh-ancestor
110232025|NCT00419653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110232026|NCT00419653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110232027|NCT00419653|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110232028|NCT00419653|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110232029|NCT00419653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110232030|NCT00419653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110232031|NCT00419653|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110232032|NCT00419653|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110232033|NCT00419653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110232034|NCT00419653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110232035|NCT00419653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110232036|NCT00419653|Serotonin Agents|serotonin agents|mesh-ancestor
110232037|NCT00419653|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110232038|NCT00419653|Dopamine Agents|dopamine agents|mesh-ancestor
110232039|NCT00419653|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110232040|NCT00419653|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110232041|NCT00419653|Antidepressive Agents|antidepressive agents|mesh-ancestor
110232042|NCT00094341|Etanercept|etanercept|mesh-list
110232043|NCT00094341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110232044|NCT00094341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110232046|NCT00094341|Sensory System Agents|sensory system agents|mesh-ancestor
110232047|NCT00094341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110232048|NCT00094341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110232049|NCT00094341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110232050|NCT00094341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110232051|NCT00094341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110232052|NCT00094341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110232053|NCT00094341|Immunologic Factors|immunologic factors|mesh-ancestor
110232054|NCT00086489|Tremelimumab|tremelimumab|mesh-list
110232055|NCT00086489|Ipilimumab|ipilimumab|mesh-list
110232056|NCT00086489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110232057|NCT00086489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110232058|NCT00086489|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110232059|NCT00086489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110232060|NCT00094380|Cyclophosphamide|cyclophosphamide|mesh-list
110232061|NCT00094380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110232062|NCT00094380|Immunologic Factors|immunologic factors|mesh-ancestor
110232063|NCT00094380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110232064|NCT00094380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110232065|NCT00094380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110232066|NCT00094380|Alkylating Agents|alkylating agents|mesh-ancestor
110232067|NCT00094380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110232068|NCT00094380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110232069|NCT00094380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110232070|NCT00321490|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110232071|NCT00321490|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110232072|NCT00321490|Antidepressive Agents|antidepressive agents|mesh-ancestor
110232073|NCT00321490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110232074|NCT00321490|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110232075|NCT00321490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110232076|NCT00321490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110232077|NCT00321490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110232078|NCT00321490|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110232079|NCT00321490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110232080|NCT00321490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110232081|NCT00321490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110232082|NCT00321490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110232083|NCT00321490|Analgesics|analgesics|mesh-ancestor
110232084|NCT00321490|Sensory System Agents|sensory system agents|mesh-ancestor
110265326|NCT00188565|Celecoxib|celecoxib|mesh-list
110232085|NCT00321490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110232086|NCT00321490|Dopamine Agents|dopamine agents|mesh-ancestor
110232087|NCT00086528|XL647|xl647|mesh-list
110232088|NCT00086528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110232089|NCT00086528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110232090|NCT00086528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110232091|NCT00086528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110232092|NCT05457829|Doxorubicin|doxorubicin|mesh-list
110232093|NCT05457829|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110232094|NCT05457829|Irinotecan|irinotecan|mesh-list
110232095|NCT05457829|Vincristine|vincristine|mesh-list
110232096|NCT05457829|Temozolomide|temozolomide|mesh-list
110232097|NCT05457829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110232098|NCT05457829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110232099|NCT05457829|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110232100|NCT05457829|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110232101|NCT05457829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110232102|NCT05457829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110232103|NCT05457829|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110232104|NCT05457829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110232105|NCT05457829|Tubulin Modulators|tubulin modulators|mesh-ancestor
110232106|NCT05457829|Antimitotic Agents|antimitotic agents|mesh-ancestor
110232107|NCT05457829|Mitosis Modulators|mitosis modulators|mesh-ancestor
110232108|NCT05457829|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110232109|NCT05457829|Alkylating Agents|alkylating agents|mesh-ancestor
110232110|NCT05457751|Rocuronium|rocuronium|mesh-list
110232111|NCT05457751|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110232112|NCT05457751|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110232113|NCT05457751|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110232114|NCT05457751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110232115|NCT05457751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110232116|NCT00086606|Omalizumab|omalizumab|mesh-list
110232117|NCT00086606|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110232118|NCT00086606|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110232119|NCT00086606|Respiratory System Agents|respiratory system agents|mesh-ancestor
110232120|NCT00124566|Prednisone|prednisone|mesh-list
110232121|NCT00124566|Capecitabine|capecitabine|mesh-list
110232122|NCT00124566|Mitoxantrone|mitoxantrone|mesh-list
110232123|NCT00124566|Irofulven|irofulven|mesh-list
110232124|NCT00124566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110232125|NCT00124566|Glucocorticoids|glucocorticoids|mesh-ancestor
110232126|NCT00124566|Hormones|hormones|mesh-ancestor
110265336|NCT00188565|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110232127|NCT00124566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110232128|NCT00124566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110232129|NCT00124566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110232130|NCT00124566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110232131|NCT00124566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110232132|NCT00124566|Antimetabolites|antimetabolites|mesh-ancestor
110232133|NCT00124566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110232134|NCT00124566|Analgesics|analgesics|mesh-ancestor
110232135|NCT00124566|Sensory System Agents|sensory system agents|mesh-ancestor
110232136|NCT00124566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110232137|NCT00124566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110232138|NCT00124566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110232139|NCT00124566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110232140|NCT00124566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110232141|NCT00124566|Alkylating Agents|alkylating agents|mesh-ancestor
110232142|NCT00321724|Cediranib|cediranib|mesh-list
110232143|NCT00321724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110232144|NCT00321724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110232145|NCT00321724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110232146|NCT00321724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110232148|NCT00086645|Citalopram|citalopram|mesh-list
110232149|NCT00086645|Escitalopram|escitalopram|mesh-list
110232150|NCT00086645|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110232151|NCT00086645|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110232152|NCT00086645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110232153|NCT00086645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110232154|NCT00086645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110232155|NCT00086645|Serotonin Agents|serotonin agents|mesh-ancestor
110232156|NCT00086645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110232157|NCT00086645|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110232158|NCT00086645|Antidepressive Agents|antidepressive agents|mesh-ancestor
110232159|NCT00086645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110232160|NCT00086645|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110232161|NCT00086645|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110232162|NCT00086645|Parasympatholytics|parasympatholytics|mesh-ancestor
110232163|NCT00086645|Autonomic Agents|autonomic agents|mesh-ancestor
110232164|NCT00086645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110232166|NCT00086645|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110232167|NCT00086645|Cholinergic Agents|cholinergic agents|mesh-ancestor
110232168|NCT00321802|Simvastatin|simvastatin|mesh-list
110232169|NCT00321802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110232170|NCT00321802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110232171|NCT00321802|Antimetabolites|antimetabolites|mesh-ancestor
110232172|NCT00321802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110232173|NCT00321802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110232174|NCT00321802|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110265373|NCT02908945|Anesthetics|anesthetics|mesh-ancestor
110232175|NCT00321802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110232177|NCT00124605|Arsenic Trioxide|arsenic trioxide|mesh-list
110232178|NCT00124605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110232179|NCT00124605|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110232180|NCT00124605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110232181|NCT05457361|Azacitidine|azacitidine|mesh-list
110232182|NCT05457361|Homoharringtonine|homoharringtonine|mesh-list
110232183|NCT05457361|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110232184|NCT05457361|Antimetabolites|antimetabolites|mesh-ancestor
110232185|NCT05457361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110232186|NCT05457361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110232187|NCT05457361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110232188|NCT05457361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110232189|NCT05457361|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110232190|NCT00086801|Gemcitabine|gemcitabine|mesh-list
110232191|NCT00086801|Doxorubicin|doxorubicin|mesh-list
110232192|NCT00086801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110232193|NCT00086801|Vinblastine|vinblastine|mesh-list
110232194|NCT00086801|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110232195|NCT00086801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110232196|NCT00086801|Antimetabolites|antimetabolites|mesh-ancestor
110232197|NCT00086801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110232198|NCT00086801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110232199|NCT00086801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110232200|NCT00086801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110232201|NCT00086801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110232202|NCT00086801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110232203|NCT00086801|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110232204|NCT00086801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110232205|NCT00086801|Tubulin Modulators|tubulin modulators|mesh-ancestor
110232206|NCT00086801|Antimitotic Agents|antimitotic agents|mesh-ancestor
110232207|NCT00086801|Mitosis Modulators|mitosis modulators|mesh-ancestor
110232208|NCT05456113|Cannabidiol|cannabidiol|mesh-list
110232209|NCT05456113|Anticonvulsants|anticonvulsants|mesh-ancestor
110232211|NCT00124644|Etoposide|etoposide|mesh-list
110232212|NCT00124644|Daunorubicin|daunorubicin|mesh-list
110232215|NCT00124644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110232216|NCT00124644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110232217|NCT00124644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110232218|NCT00124644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110232219|NCT00124644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110232220|NCT00124644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110232221|NCT00124644|Antimetabolites|antimetabolites|mesh-ancestor
110232222|NCT00124644|Antiviral Agents|antiviral agents|mesh-ancestor
110232223|NCT00124644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110232224|NCT00124644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110232225|NCT00124644|Immunologic Factors|immunologic factors|mesh-ancestor
110232226|NCT00124644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110232227|NCT00124644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110232228|NCT00086840|Sirolimus|sirolimus|mesh-list
110232229|NCT00086840|Temsirolimus|temsirolimus|mesh-list
110232230|NCT00086840|MTOR Inhibitors|mtor inhibitors|mesh-list
110232231|NCT00086840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110232232|NCT00086840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110232233|NCT00086840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110232234|NCT00086840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110232235|NCT00086840|Immunologic Factors|immunologic factors|mesh-ancestor
110232236|NCT00086840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110232237|NCT00086840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110232238|NCT00086840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110265394|NCT00188643|Lamotrigine|lamotrigine|mesh-list
110232239|NCT00086840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110232240|NCT00086840|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110232241|NCT00086840|Antifungal Agents|antifungal agents|mesh-ancestor
110232242|NCT00124683|Bupropion|bupropion|mesh-list
110232243|NCT00124683|Nicotine|nicotine|mesh-list
110232244|NCT00124683|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110232245|NCT00124683|Autonomic Agents|autonomic agents|mesh-ancestor
110232246|NCT00124683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110232247|NCT00124683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110232248|NCT00124683|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110232249|NCT00124683|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110232250|NCT00124683|Cholinergic Agents|cholinergic agents|mesh-ancestor
110232251|NCT00124683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110232252|NCT00124683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110232253|NCT00124683|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110232254|NCT00124683|Antidepressive Agents|antidepressive agents|mesh-ancestor
110232255|NCT00124683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110232256|NCT00124683|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110232257|NCT00124683|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110232258|NCT00124683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110232259|NCT00124683|Dopamine Agents|dopamine agents|mesh-ancestor
110232260|NCT00124683|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110232261|NCT00124683|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110232262|NCT00124683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110232263|NCT04717063|Hydrogen Peroxide|hydrogen peroxide|mesh-list
110232264|NCT04717063|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110232265|NCT04717063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110232266|NCT00086879|Temozolomide|temozolomide|mesh-list
110232267|NCT00086879|Carmustine|carmustine|mesh-list
110265412|NCT00533299|Hydralazine|hydralazine|mesh-list
110232268|NCT00086879|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110232269|NCT00086879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110232270|NCT00086879|Alkylating Agents|alkylating agents|mesh-ancestor
110232271|NCT00086879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110232272|NCT00086879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110232273|NCT00086879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110232274|NCT00086879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110232276|NCT00124722|Rocuronium|rocuronium|mesh-list
110232277|NCT00124722|Anticonvulsants|anticonvulsants|mesh-ancestor
110232278|NCT00124722|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110232279|NCT00124722|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110232280|NCT00124722|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110232281|NCT00124722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110232282|NCT00124722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110232283|NCT00322036|Flurbiprofen|flurbiprofen|mesh-list
110232284|NCT00322036|Tarenflurbil|tarenflurbil|mesh-list
110059011|NCT01515774|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110232285|NCT00322036|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
110232286|NCT00322036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110232287|NCT00322036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110232288|NCT00322036|Analgesics|analgesics|mesh-ancestor
110232289|NCT00322036|Sensory System Agents|sensory system agents|mesh-ancestor
110232290|NCT00322036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110232291|NCT00322036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110232292|NCT00322036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110232293|NCT00322036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110232294|NCT00322036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110232295|NCT00322036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110232296|NCT00322036|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110232297|NCT00094614|Atropine|atropine|mesh-list
110232298|NCT00094614|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110232299|NCT00094614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110232300|NCT00094614|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110232301|NCT00094614|Autonomic Agents|autonomic agents|mesh-ancestor
110232302|NCT00094614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110232303|NCT00094614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110232304|NCT00094614|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110232305|NCT00094614|Respiratory System Agents|respiratory system agents|mesh-ancestor
110232306|NCT00094614|Mydriatics|mydriatics|mesh-ancestor
110232307|NCT00094614|Parasympatholytics|parasympatholytics|mesh-ancestor
110232308|NCT00094614|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110232309|NCT00094614|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110232310|NCT00094614|Cholinergic Agents|cholinergic agents|mesh-ancestor
110232311|NCT00094614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110232312|NCT00094614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110232313|NCT00087035|Docetaxel|docetaxel|mesh-list
110232314|NCT00087035|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110232315|NCT00087035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110232316|NCT00087035|Tubulin Modulators|tubulin modulators|mesh-ancestor
110232317|NCT00087035|Antimitotic Agents|antimitotic agents|mesh-ancestor
110232318|NCT00087035|Mitosis Modulators|mitosis modulators|mesh-ancestor
110232319|NCT00087035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110232320|NCT00087035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110232321|NCT00087035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110265455|NCT00155558|Antidotes|antidotes|mesh-ancestor
110232323|NCT00322075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110232324|NCT00322075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110232325|NCT00322114|Lycopene|lycopene|mesh-list
110232326|NCT00322114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110232327|NCT00322114|Antioxidants|antioxidants|mesh-ancestor
110232328|NCT00322114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110232329|NCT00322114|Protective Agents|protective agents|mesh-ancestor
110232330|NCT00322114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110232333|NCT00322114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110232334|NCT00087074|Sirolimus|sirolimus|mesh-list
110232335|NCT00087074|Temsirolimus|temsirolimus|mesh-list
110232336|NCT00087074|MTOR Inhibitors|mtor inhibitors|mesh-list
110232337|NCT00087074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110232338|NCT00087074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110232339|NCT00087074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110232340|NCT00087074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110232341|NCT00087074|Immunologic Factors|immunologic factors|mesh-ancestor
110232342|NCT00087074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110232343|NCT00087074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110232344|NCT00087074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110232345|NCT00087074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110232346|NCT00087074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110232347|NCT00087074|Antifungal Agents|antifungal agents|mesh-ancestor
110232348|NCT00332176|Ribavirin|ribavirin|mesh-list
110232349|NCT00332176|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110232350|NCT00332176|Antimetabolites|antimetabolites|mesh-ancestor
110232351|NCT00332176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110232352|NCT00332176|Antiviral Agents|antiviral agents|mesh-ancestor
110232353|NCT00332176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110232354|NCT00087113|Pemetrexed|pemetrexed|mesh-list
110232355|NCT00087113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110232356|NCT00087113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110232357|NCT00087113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110021684|NCT00002682|Metronidazole|metronidazole|mesh-list
110232358|NCT00087113|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110232359|NCT00087113|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110232360|NCT00332254|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110232361|NCT00332254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110232362|NCT00332293|Moxifloxacin|moxifloxacin|mesh-list
110232363|NCT00332293|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110232364|NCT00332293|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110232365|NCT00332293|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110232366|NCT00332293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110232367|NCT00332293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110232368|NCT00332293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110232369|NCT00332293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110232370|NCT00332293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110232371|NCT00332293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110232372|NCT00332293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110232373|NCT00332293|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110232374|NCT00332293|Contraceptive Agents|contraceptive agents|mesh-ancestor
110232375|NCT00332293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110232376|NCT00332293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110232377|NCT00332293|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110232378|NCT00332293|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110232379|NCT00332293|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110232380|NCT00087191|Motexafin lutetium|motexafin lutetium|mesh-list
110232381|NCT00087191|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110232382|NCT00087191|Dermatologic Agents|dermatologic agents|mesh-ancestor
110232383|NCT05222152|Hydrocortisone|hydrocortisone|mesh-list
110232384|NCT05222152|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110232385|NCT05222152|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110232386|NCT05222152|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110232387|NCT05222152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110232388|NCT00094692|Atropine|atropine|mesh-list
110232389|NCT00094692|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110232390|NCT00094692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110232391|NCT00094692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110232392|NCT00094692|Autonomic Agents|autonomic agents|mesh-ancestor
110232393|NCT00094692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110232394|NCT00094692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110232395|NCT00094692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110232396|NCT00094692|Respiratory System Agents|respiratory system agents|mesh-ancestor
110232397|NCT00094692|Mydriatics|mydriatics|mesh-ancestor
110232398|NCT00094692|Parasympatholytics|parasympatholytics|mesh-ancestor
110232399|NCT00094692|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110232400|NCT00094692|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110232401|NCT00094692|Cholinergic Agents|cholinergic agents|mesh-ancestor
110232402|NCT00094692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110232403|NCT00094692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110232404|NCT05181007|Valproic Acid|valproic acid|mesh-list
110232405|NCT05181007|Anticonvulsants|anticonvulsants|mesh-ancestor
110232406|NCT05181007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110232407|NCT05181007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110232408|NCT05181007|GABA Agents|gaba agents|mesh-ancestor
110232409|NCT05181007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110232410|NCT05181007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110232411|NCT05181007|Antimanic Agents|antimanic agents|mesh-ancestor
110232412|NCT05181007|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110232413|NCT05181007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110232414|NCT05181007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110232416|NCT00124839|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110232417|NCT00124839|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110232418|NCT00124839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110232419|NCT00124839|Sensory System Agents|sensory system agents|mesh-ancestor
110232420|NCT00124839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110232421|NCT00087269|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110232422|NCT00087269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110232423|NCT00087269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110232426|NCT00087347|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
110232427|NCT00087347|Hematinics|hematinics|mesh-ancestor
110232428|NCT00087347|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110232429|NCT00087347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110232433|NCT00419692|Ropinirole|ropinirole|mesh-list
110232434|NCT00419692|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110232435|NCT00419692|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110232436|NCT00419692|Dopamine Agonists|dopamine agonists|mesh-ancestor
110232437|NCT00419692|Dopamine Agents|dopamine agents|mesh-ancestor
110232438|NCT00419692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110232439|NCT00419692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110232440|NCT00419692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110232442|NCT00419731|Bupropion|bupropion|mesh-list
110232443|NCT00419731|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110232444|NCT00419731|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110232445|NCT00419731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110232446|NCT00419731|Sensory System Agents|sensory system agents|mesh-ancestor
110232447|NCT00419731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110232448|NCT00419731|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110232449|NCT00419731|Antidepressive Agents|antidepressive agents|mesh-ancestor
110232450|NCT00419731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110232451|NCT00419731|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110232452|NCT00419731|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110232453|NCT00419731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110232454|NCT00419731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110232456|NCT00419731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110232457|NCT00419731|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110232458|NCT00419731|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110232459|NCT00419731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110232460|NCT00419848|Azithromycin|azithromycin|mesh-list
110232461|NCT00419848|Doxycycline|doxycycline|mesh-list
110232462|NCT00419848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110232463|NCT00419848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110232464|NCT00419848|Antimalarials|antimalarials|mesh-ancestor
110232465|NCT00419848|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110232466|NCT00419848|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110232467|NCT00094848|Mapatumumab|mapatumumab|mesh-list
110232468|NCT00094848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110232469|NCT00087425|Rituximab|rituximab|mesh-list
110232470|NCT00087425|Bryostatin 1|bryostatin 1|mesh-list
110232471|NCT00087425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110232472|NCT00087425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110232473|NCT00087425|Immunologic Factors|immunologic factors|mesh-ancestor
110232474|NCT00087425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110232475|NCT00087425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110232476|NCT00087425|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110232477|NCT00330655|Memantine|memantine|mesh-list
110232478|NCT00330655|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110232479|NCT00330655|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110232480|NCT00330655|Dopamine Agents|dopamine agents|mesh-ancestor
110232481|NCT00330655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110232482|NCT00330655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110232483|NCT00330655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110232484|NCT00330655|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110232485|NCT00330655|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110232487|NCT00330772|Clopidogrel|clopidogrel|mesh-list
110232488|NCT00330772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110232489|NCT00330772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110232490|NCT00330772|Analgesics|analgesics|mesh-ancestor
110232491|NCT00330772|Sensory System Agents|sensory system agents|mesh-ancestor
110232492|NCT00330772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110232493|NCT00330772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110232494|NCT00330772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110232495|NCT00330772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110232496|NCT00330772|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110232497|NCT00330772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110232498|NCT00330772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110232499|NCT00330772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110232500|NCT00330772|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110232501|NCT00330772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110232502|NCT00330772|Antipyretics|antipyretics|mesh-ancestor
110232503|NCT00330772|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110232504|NCT00330772|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110232505|NCT00330772|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110232506|NCT00330772|Purinergic Agents|purinergic agents|mesh-ancestor
110232507|NCT00330772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110232508|NCT00094926|Risperidone|risperidone|mesh-list
110232509|NCT00094926|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110232510|NCT00094926|Serotonin Agents|serotonin agents|mesh-ancestor
110232511|NCT00094926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110232512|NCT00094926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110232513|NCT00094926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110232514|NCT00094926|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110232515|NCT00094926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110232516|NCT00094926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110232517|NCT00094926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110232518|NCT00094926|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110232519|NCT00094926|Dopamine Agents|dopamine agents|mesh-ancestor
110232521|NCT00087464|Emtricitabine|emtricitabine|mesh-list
110232522|NCT00087464|Nevirapine|nevirapine|mesh-list
110232523|NCT00087464|Antiviral Agents|antiviral agents|mesh-ancestor
110232524|NCT00087464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110232525|NCT00087464|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110232526|NCT00087464|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110232527|NCT00087464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110232528|NCT00087464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110232529|NCT00087464|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110232530|NCT00087464|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110232531|NCT00087464|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110232532|NCT00087464|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110232534|NCT00331045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110232535|NCT00331084|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110232536|NCT00331084|Moxifloxacin|moxifloxacin|mesh-list
110232537|NCT00331084|Dexamethasone|dexamethasone|mesh-list
110232538|NCT00331084|Dexamethasone acetate|dexamethasone acetate|mesh-list
110232539|NCT00331084|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110232540|NCT00331084|BB 1101|bb 1101|mesh-list
110232541|NCT00331084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110232542|NCT00331084|Antiemetics|antiemetics|mesh-ancestor
110232544|NCT00331084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110232545|NCT00331084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110232546|NCT00331084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110232547|NCT00331084|Glucocorticoids|glucocorticoids|mesh-ancestor
110232548|NCT00331084|Hormones|hormones|mesh-ancestor
110232549|NCT00331084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110232550|NCT00331084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110232551|NCT00331084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110232552|NCT00331084|Protease Inhibitors|protease inhibitors|mesh-ancestor
110232553|NCT00331084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110232554|NCT00331084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110232555|NCT00331084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110232556|NCT00331084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110232557|NCT00331084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110232558|NCT00331084|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110232559|NCT00331084|Contraceptive Agents|contraceptive agents|mesh-ancestor
110232560|NCT00331084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110232561|NCT00331084|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110232562|NCT00331084|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110232563|NCT00331084|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110232564|NCT00420355|Ritonavir|ritonavir|mesh-list
110232565|NCT00420355|Lopinavir|lopinavir|mesh-list
110232566|NCT00420355|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110232567|NCT00420355|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110232568|NCT00420355|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110232569|NCT00420355|Protease Inhibitors|protease inhibitors|mesh-ancestor
110232570|NCT00420355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110232571|NCT00420355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110232572|NCT00420355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110232573|NCT00420355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110232574|NCT00420355|Antiviral Agents|antiviral agents|mesh-ancestor
110232575|NCT00420355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110232576|NCT00420355|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110232577|NCT00420355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110232578|NCT00331123|Testosterone|testosterone|mesh-list
110232579|NCT00331123|Androgens|androgens|mesh-ancestor
110232580|NCT00331123|Hormones|hormones|mesh-ancestor
110232581|NCT00331123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110232582|NCT00331123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110232583|NCT00087542|Pimavanserin|pimavanserin|mesh-list
110232584|NCT00087542|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110232585|NCT00087542|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110232586|NCT00087542|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110232587|NCT00087542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110232588|NCT00087542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110265560|NCT00533962|Anecortave|anecortave|mesh-list
110232589|NCT00087542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110232590|NCT00087542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110232591|NCT00087542|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110232592|NCT00087542|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110232593|NCT00087542|Serotonin Agents|serotonin agents|mesh-ancestor
110232594|NCT00087542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110232595|NCT00087542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110232597|NCT00331240|Travoprost|travoprost|mesh-list
110232598|NCT00331240|Lubricant Eye Drops|lubricant eye drops|mesh-list
110232599|NCT00331240|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110232600|NCT00331240|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110232601|NCT00331240|Adrenergic Agents|adrenergic agents|mesh-ancestor
110232602|NCT00331240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110232603|NCT00331240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110232604|NCT00331240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110232605|NCT00331240|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110232606|NCT00331240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110232607|NCT00331240|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110232608|NCT00331240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110232609|NCT00124956|Doxorubicin|doxorubicin|mesh-list
110232610|NCT00124956|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110232611|NCT00124956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110232612|NCT00124956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110232613|NCT00124956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110232614|NCT00124956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110232615|NCT00124956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110232617|NCT00087581|Mycophenolic Acid|mycophenolic acid|mesh-list
110232618|NCT00087581|Tacrolimus|tacrolimus|mesh-list
110232619|NCT00087581|Cyclosporins|cyclosporins|mesh-list
110232620|NCT00087581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110232621|NCT00087581|Immunologic Factors|immunologic factors|mesh-ancestor
110232622|NCT00087581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110232623|NCT00087581|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110232624|NCT00087581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110232626|NCT00087581|Antifungal Agents|antifungal agents|mesh-ancestor
110232627|NCT00087581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110232628|NCT00087581|Dermatologic Agents|dermatologic agents|mesh-ancestor
110232629|NCT00087581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110232630|NCT00087581|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110232631|NCT00087581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110232632|NCT00087581|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110232633|NCT00087581|Antitubercular Agents|antitubercular agents|mesh-ancestor
110232634|NCT00087581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110232635|NCT00094965|Oxaliplatin|oxaliplatin|mesh-list
110232636|NCT00094965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110232637|NCT00331435|Verteporfin|verteporfin|mesh-list
110265581|NCT04462627|Antibodies|antibodies|mesh-list
110232638|NCT00331435|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110232639|NCT00331435|Dermatologic Agents|dermatologic agents|mesh-ancestor
110232641|NCT00331513|Idarubicin|idarubicin|mesh-list
110232642|NCT00331513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110232643|NCT00331513|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110232644|NCT00331513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110232645|NCT00331513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110232646|NCT00331513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110232647|NCT00331513|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110232648|NCT00331513|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110232649|NCT00087620|Capecitabine|capecitabine|mesh-list
110232650|NCT00087620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110232651|NCT00087620|Antimetabolites|antimetabolites|mesh-ancestor
110232652|NCT00087620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110232653|NCT00087620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110232654|NCT00124995|Terbutaline|terbutaline|mesh-list
110232655|NCT00124995|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110232656|NCT00124995|Autonomic Agents|autonomic agents|mesh-ancestor
110232657|NCT00124995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110232658|NCT00124995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110232659|NCT00124995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110232660|NCT00124995|Respiratory System Agents|respiratory system agents|mesh-ancestor
110232661|NCT00124995|Sympathomimetics|sympathomimetics|mesh-ancestor
110232662|NCT00124995|Tocolytic Agents|tocolytic agents|mesh-ancestor
110232663|NCT00124995|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110232664|NCT00124995|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110232665|NCT00124995|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110232666|NCT00124995|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110232667|NCT00124995|Adrenergic Agents|adrenergic agents|mesh-ancestor
110232668|NCT00124995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110232669|NCT00124995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110232671|NCT00331708|Pyrimethamine|pyrimethamine|mesh-list
110232672|NCT00331708|Sulfadoxine|sulfadoxine|mesh-list
110232673|NCT00331708|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110232674|NCT00331708|Antimalarials|antimalarials|mesh-ancestor
110232675|NCT00331708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110232676|NCT00331708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110232677|NCT00331708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110232678|NCT00331708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110232679|NCT00331708|Antiviral Agents|antiviral agents|mesh-ancestor
110232680|NCT00331708|Schistosomicides|schistosomicides|mesh-ancestor
110232681|NCT00331708|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110232682|NCT00331708|Anthelmintics|anthelmintics|mesh-ancestor
110232684|NCT00331708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110232685|NCT00331708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110232686|NCT00331708|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110232687|NCT00331747|Glatiramer Acetate|glatiramer acetate|mesh-list
110232688|NCT00331747|(T,G)-A-L|(t,g)-a-l|mesh-list
110232689|NCT00331747|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110232690|NCT00331747|Immunologic Factors|immunologic factors|mesh-ancestor
110232691|NCT00331747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110232692|NCT00331747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110232693|NCT00331747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110232694|NCT00087659|Zoledronic Acid|zoledronic acid|mesh-list
110232695|NCT00087659|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110232696|NCT00087659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110232697|NCT00331786|Aspirin|aspirin|mesh-list
110232698|NCT00331786|Nitroaspirin|nitroaspirin|mesh-list
110232699|NCT00331786|Nitric Oxide|nitric oxide|mesh-list
110232700|NCT00331786|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110232701|NCT00331786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110232702|NCT00331786|Analgesics|analgesics|mesh-ancestor
110232703|NCT00331786|Sensory System Agents|sensory system agents|mesh-ancestor
110232704|NCT00331786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110232705|NCT00331786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110232706|NCT00331786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110232707|NCT00331786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110232708|NCT00331786|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110232709|NCT00331786|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110232710|NCT00331786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110232711|NCT00331786|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110232712|NCT00331786|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110232713|NCT00331786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110232714|NCT00331786|Antipyretics|antipyretics|mesh-ancestor
110232715|NCT00331786|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110232716|NCT00331786|Autonomic Agents|autonomic agents|mesh-ancestor
110232717|NCT00331786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110232718|NCT00331786|Respiratory System Agents|respiratory system agents|mesh-ancestor
110232719|NCT00331786|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110232720|NCT00331786|Antioxidants|antioxidants|mesh-ancestor
110232721|NCT00331786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110232722|NCT00331786|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110232723|NCT00331786|Vasodilator Agents|vasodilator agents|mesh-ancestor
110232724|NCT00331786|Gasotransmitters|gasotransmitters|mesh-ancestor
110232725|NCT00331786|Protective Agents|protective agents|mesh-ancestor
110232726|NCT00331786|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
110232727|NCT00331786|Protease Inhibitors|protease inhibitors|mesh-ancestor
110232728|NCT00331825|Olanzapine|olanzapine|mesh-list
110232729|NCT00331825|Risperidone|risperidone|mesh-list
110232730|NCT00331825|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110232731|NCT00331825|Serotonin Agents|serotonin agents|mesh-ancestor
110232732|NCT00331825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110232733|NCT00331825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110232734|NCT00331825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110232735|NCT00331825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110232736|NCT00331825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110232737|NCT00331825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110232738|NCT00331825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110232739|NCT00331825|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110232740|NCT00331825|Dopamine Agents|dopamine agents|mesh-ancestor
110232741|NCT00331825|Antiemetics|antiemetics|mesh-ancestor
110232742|NCT00331825|Autonomic Agents|autonomic agents|mesh-ancestor
110232743|NCT00331825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110232744|NCT00331825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110232745|NCT00331825|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110232746|NCT00331825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110232747|NCT00331825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110232748|NCT00420472|Mycophenolic Acid|mycophenolic acid|mesh-list
110232749|NCT00420472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110232750|NCT00420472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110232751|NCT00420472|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110232752|NCT00420472|Antitubercular Agents|antitubercular agents|mesh-ancestor
110232753|NCT00420472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110232754|NCT00420472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110232755|NCT00420472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110232756|NCT00420472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110232757|NCT00087737|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110232758|NCT00087737|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110232759|NCT00087737|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110232760|NCT00087737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110232761|NCT00087737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110232762|NCT00087737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110232763|NCT00087737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110232764|NCT00087737|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110232765|NCT00087737|Antidepressive Agents|antidepressive agents|mesh-ancestor
110232766|NCT00087737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110232768|NCT00331981|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110232769|NCT00331981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110232770|NCT00331981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110232771|NCT00331981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110232772|NCT00331981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110232773|NCT00331981|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110232774|NCT00331981|Dopamine Agents|dopamine agents|mesh-ancestor
110232775|NCT00331981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110232776|NCT00331981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110232777|NCT00331981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110232778|NCT00331981|Antidepressive Agents|antidepressive agents|mesh-ancestor
110232779|NCT00126633|Bevacizumab|bevacizumab|mesh-list
110232780|NCT00126633|Gemcitabine|gemcitabine|mesh-list
110232781|NCT00126633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110232782|NCT00126633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110232783|NCT00126633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110232784|NCT00126633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110232785|NCT00126633|Growth Substances|growth substances|mesh-ancestor
110232786|NCT00126633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110232787|NCT00126633|Growth Inhibitors|growth inhibitors|mesh-ancestor
110232788|NCT00126633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110232789|NCT00126633|Antimetabolites|antimetabolites|mesh-ancestor
110232790|NCT00126633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110232791|NCT00332020|Enoxaparin|enoxaparin|mesh-list
110232792|NCT00332020|Rivaroxaban|rivaroxaban|mesh-list
110232793|NCT00332020|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110232794|NCT00332020|Antithrombins|antithrombins|mesh-ancestor
110232795|NCT00332020|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110232796|NCT00332020|Protease Inhibitors|protease inhibitors|mesh-ancestor
110232797|NCT00332020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110232798|NCT00332020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110232799|NCT00332020|Anticoagulants|anticoagulants|mesh-ancestor
110232800|NCT00332020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110232801|NCT00332020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110232802|NCT02965274|Fluoxetine|fluoxetine|mesh-list
110232803|NCT02965274|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110232804|NCT02965274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110232805|NCT02965274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110232806|NCT02965274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110232807|NCT02965274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110232809|NCT02965274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110059540|NCT01518231|Atorvastatin|atorvastatin|mesh-list
110232810|NCT02965274|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110232811|NCT02965274|Antidepressive Agents|antidepressive agents|mesh-ancestor
110232812|NCT02965274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110232813|NCT02965274|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110232814|NCT02965274|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110232815|NCT02965274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110232816|NCT00332059|Timolol|timolol|mesh-list
110232817|NCT00332059|Bimatoprost|bimatoprost|mesh-list
110232818|NCT00332059|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110232819|NCT00332059|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110232820|NCT00332059|Adrenergic Agents|adrenergic agents|mesh-ancestor
110232821|NCT00332059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110232822|NCT00332059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110232823|NCT00332059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110232824|NCT00332059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110232825|NCT00332059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110232826|NCT00332137|Tolterodine Tartrate|tolterodine tartrate|mesh-list
110232827|NCT00332137|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110232828|NCT00332137|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110232829|NCT00332137|Cholinergic Agents|cholinergic agents|mesh-ancestor
110232830|NCT00332137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110232831|NCT00332137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110232832|NCT00332137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110232833|NCT00332137|Urological Agents|urological agents|mesh-ancestor
110232834|NCT00126789|Fentanyl|fentanyl|mesh-list
110232835|NCT00126789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110232836|NCT00126789|Narcotics|narcotics|mesh-ancestor
110232837|NCT00126789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110232838|NCT00126789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110232839|NCT00126789|Analgesics|analgesics|mesh-ancestor
110232840|NCT00126789|Sensory System Agents|sensory system agents|mesh-ancestor
110232841|NCT00126789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110232842|NCT00126789|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110232843|NCT00126789|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110265671|NCT04893148|Dulaglutide|dulaglutide|mesh-list
110232844|NCT00126789|Anesthetics, General|anesthetics, general|mesh-ancestor
110232845|NCT00126789|Anesthetics|anesthetics|mesh-ancestor
110232846|NCT05831969|Lenalidomide|lenalidomide|mesh-list
110232847|NCT05831969|Immunologic Factors|immunologic factors|mesh-ancestor
110232848|NCT05831969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110232849|NCT05831969|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110232850|NCT05831969|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110232851|NCT05831969|Growth Substances|growth substances|mesh-ancestor
110232852|NCT05831969|Growth Inhibitors|growth inhibitors|mesh-ancestor
110232853|NCT05831969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110232854|NCT05831761|Lidocaine|lidocaine|mesh-list
110232855|NCT05831761|Analgesics|analgesics|mesh-list
110232856|NCT05831761|Anesthetics, Local|anesthetics, local|mesh-ancestor
110232857|NCT05831761|Anesthetics|anesthetics|mesh-ancestor
110232858|NCT05831761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110232859|NCT05831761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110232861|NCT05831761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110232862|NCT05831761|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110232863|NCT05831761|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110232864|NCT05831761|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110232865|NCT05831761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110232866|NCT05831761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110232868|NCT05831566|Formoterol Fumarate|formoterol fumarate|mesh-list
110232869|NCT05831566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110232870|NCT05831566|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110232871|NCT05831566|Autonomic Agents|autonomic agents|mesh-ancestor
110232872|NCT05831566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110232873|NCT05831566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110232874|NCT05831566|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110232875|NCT05831566|Respiratory System Agents|respiratory system agents|mesh-ancestor
110232876|NCT05831566|Glucocorticoids|glucocorticoids|mesh-ancestor
110232877|NCT05831566|Hormones|hormones|mesh-ancestor
110232878|NCT05831566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110232879|NCT05831566|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110232880|NCT05831566|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110232881|NCT05831566|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110232883|NCT05831566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110232884|NCT05831566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110232885|NCT05831462|Ticagrelor|ticagrelor|mesh-list
110232886|NCT05831462|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110232887|NCT05831462|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110232888|NCT05831462|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110232889|NCT05831462|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110232890|NCT05831462|Purinergic Agents|purinergic agents|mesh-ancestor
110232891|NCT05831462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110232892|NCT05831462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110232893|NCT05831462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110232894|NCT05831345|Sufentanil|sufentanil|mesh-list
110232895|NCT05831345|Dsuvia|dsuvia|mesh-list
110232896|NCT05831345|Methadone|methadone|mesh-list
110232897|NCT05831345|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110232898|NCT05831345|Narcotics|narcotics|mesh-ancestor
110232899|NCT05831345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110232900|NCT05831345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110232901|NCT05831345|Analgesics|analgesics|mesh-ancestor
110232902|NCT05831345|Sensory System Agents|sensory system agents|mesh-ancestor
110232903|NCT05831345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110232904|NCT05831345|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110232905|NCT05831345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110232906|NCT05831345|Anesthetics, General|anesthetics, general|mesh-ancestor
110232907|NCT05831345|Anesthetics|anesthetics|mesh-ancestor
110232908|NCT05831345|Antitussive Agents|antitussive agents|mesh-ancestor
110232909|NCT05831345|Respiratory System Agents|respiratory system agents|mesh-ancestor
110232910|NCT05831267|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110232911|NCT05831267|Hemostatics|hemostatics|mesh-ancestor
110232912|NCT05831267|Coagulants|coagulants|mesh-ancestor
110232913|NCT05831098|Antibodies|antibodies|mesh-list
110232915|NCT05831098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110232917|NCT05830916|Antibodies, Antiphospholipid|antibodies, antiphospholipid|mesh-list
110232918|NCT05830916|Immunologic Factors|immunologic factors|mesh-ancestor
110232919|NCT05830916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110232920|NCT05830864|Isoflurane|isoflurane|mesh-list
110232921|NCT05830864|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110232922|NCT05830864|Anesthetics, General|anesthetics, general|mesh-ancestor
110232923|NCT05830864|Anesthetics|anesthetics|mesh-ancestor
110232924|NCT05830864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110232925|NCT05830864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110232926|NCT05830747|Prednisone|prednisone|mesh-list
110232927|NCT05830747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110232928|NCT05830747|Glucocorticoids|glucocorticoids|mesh-ancestor
110232929|NCT05830747|Hormones|hormones|mesh-ancestor
110232930|NCT05830747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110232931|NCT05830747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110232932|NCT05830747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110232933|NCT05830747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110232934|NCT05830604|Salicylic Acid|salicylic acid|mesh-list
110232935|NCT05830604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110232936|NCT05830604|Antifungal Agents|antifungal agents|mesh-ancestor
110232937|NCT05830604|Keratolytic Agents|keratolytic agents|mesh-ancestor
110232938|NCT05830604|Dermatologic Agents|dermatologic agents|mesh-ancestor
110232939|NCT05830136|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110232940|NCT05830071|Moxifloxacin|moxifloxacin|mesh-list
110232941|NCT05830071|Beclomethasone|beclomethasone|mesh-list
110232942|NCT05830071|Glycopyrrolate|glycopyrrolate|mesh-list
110232943|NCT05830071|Bromides|bromides|mesh-list
110232944|NCT05830071|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110232945|NCT05830071|Formoterol Fumarate|formoterol fumarate|mesh-list
110232946|NCT05830071|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110232947|NCT05830071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110232948|NCT05830071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110232949|NCT05830071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110232950|NCT05830071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110232951|NCT05830071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110232952|NCT05830071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110232953|NCT05830071|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110232954|NCT05830071|Contraceptive Agents|contraceptive agents|mesh-ancestor
110232955|NCT05830071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110232956|NCT05830071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110232957|NCT05830071|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110232958|NCT05830071|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110232959|NCT05830071|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110232960|NCT05830071|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110232961|NCT05830071|Autonomic Agents|autonomic agents|mesh-ancestor
110232962|NCT05830071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110232963|NCT05830071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110232964|NCT05830071|Respiratory System Agents|respiratory system agents|mesh-ancestor
110232965|NCT05830071|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110232966|NCT05830071|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110232967|NCT05830071|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110232968|NCT05830071|Adrenergic Agents|adrenergic agents|mesh-ancestor
110232969|NCT05830071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110232970|NCT05830071|Anticonvulsants|anticonvulsants|mesh-ancestor
110232971|NCT05830071|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110232972|NCT05830071|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110232982|NCT05820997|Ropivacaine|ropivacaine|mesh-list
110233001|NCT05776017|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110233002|NCT05776017|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110233003|NCT05776017|Immunologic Factors|immunologic factors|mesh-ancestor
110233004|NCT05776017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110233006|NCT05776017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110233007|NCT05776017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110233022|NCT05670379|Exenatide|exenatide|mesh-list
110233023|NCT05670379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110233024|NCT05670379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110233025|NCT05670379|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110233026|NCT05670379|Incretins|incretins|mesh-ancestor
110233027|NCT05670379|Hormones|hormones|mesh-ancestor
110233028|NCT05670379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110233029|NCT05665270|Prednisolone|prednisolone|mesh-list
110233030|NCT05665270|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110233031|NCT05665270|Methylprednisolone|methylprednisolone|mesh-list
110265778|NCT04686058|Propofol|propofol|mesh-list
110233032|NCT05665270|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110233033|NCT05665270|Prednisolone acetate|prednisolone acetate|mesh-list
110233034|NCT05665270|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110233035|NCT05665270|Prednisolone phosphate|prednisolone phosphate|mesh-list
110233036|NCT05665270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110233037|NCT05665270|Glucocorticoids|glucocorticoids|mesh-ancestor
110233039|NCT05665270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110233040|NCT05665270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110233041|NCT05665270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110233042|NCT05665270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110233043|NCT05665270|Antiemetics|antiemetics|mesh-ancestor
110233044|NCT05665270|Autonomic Agents|autonomic agents|mesh-ancestor
110233045|NCT05665270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110233046|NCT05665270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110233047|NCT05665270|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110233048|NCT05665270|Protective Agents|protective agents|mesh-ancestor
110233049|NCT05660447|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110233050|NCT05660447|Lubricant Eye Drops|lubricant eye drops|mesh-list
110233051|NCT05660447|Glycerol|glycerol|mesh-list
110233052|NCT05660447|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110233053|NCT05660447|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110233054|NCT05660447|Protective Agents|protective agents|mesh-ancestor
110233055|NCT05660447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110233056|NCT05653973|Acetylcholine|acetylcholine|mesh-list
110233057|NCT05653973|Vasodilator Agents|vasodilator agents|mesh-ancestor
110233058|NCT05653973|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110233059|NCT05653973|Cholinergic Agents|cholinergic agents|mesh-ancestor
110233060|NCT05653973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110233061|NCT05653973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110233062|NCT05653973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110233063|NCT05628363|Androgens|androgens|mesh-list
110233064|NCT05628363|Hormones|hormones|mesh-ancestor
110233065|NCT05628363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110233066|NCT05628363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110233068|NCT05574400|Caffeine citrate|caffeine citrate|mesh-list
110233069|NCT05574400|Citric Acid|citric acid|mesh-list
110233070|NCT05574400|Sodium Citrate|sodium citrate|mesh-list
110233071|NCT05574400|Anticoagulants|anticoagulants|mesh-ancestor
110233072|NCT05574400|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110233073|NCT05574400|Chelating Agents|chelating agents|mesh-ancestor
110233074|NCT05574400|Sequestering Agents|sequestering agents|mesh-ancestor
110233075|NCT05574400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110233076|NCT05574400|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110233077|NCT05574400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110233078|NCT05574400|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110233079|NCT05574400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110233080|NCT05574400|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110233081|NCT05574400|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110233082|NCT05574400|Purinergic Agents|purinergic agents|mesh-ancestor
110233083|NCT05574400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110233084|NCT05546359|Dexamethasone|dexamethasone|mesh-list
110233085|NCT05546359|Amisulpride|amisulpride|mesh-list
110233086|NCT05546359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110233087|NCT05546359|Antiemetics|antiemetics|mesh-ancestor
110233088|NCT05546359|Autonomic Agents|autonomic agents|mesh-ancestor
110233089|NCT05546359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110233090|NCT05546359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110233091|NCT05546359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110233092|NCT05546359|Glucocorticoids|glucocorticoids|mesh-ancestor
110233093|NCT05546359|Hormones|hormones|mesh-ancestor
110233094|NCT05546359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110233095|NCT05546359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110233096|NCT05546359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110233097|NCT05546359|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110233098|NCT05546359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110233099|NCT05546359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110233100|NCT05546359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110233101|NCT05546359|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110233102|NCT05546359|Dopamine Agents|dopamine agents|mesh-ancestor
110233103|NCT05546359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110233104|NCT05546359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110233105|NCT05546359|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110233106|NCT05546359|Antidepressive Agents|antidepressive agents|mesh-ancestor
110233107|NCT05510115|Empagliflozin|empagliflozin|mesh-list
110233108|NCT05510115|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110233109|NCT05510115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110233110|NCT05510115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110233111|NCT05510115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110233112|NCT05413330|Triamcinolone|triamcinolone|mesh-list
110233113|NCT05413330|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110233114|NCT05413330|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110233115|NCT05413330|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110233117|NCT05413330|Glucocorticoids|glucocorticoids|mesh-ancestor
110233119|NCT05413330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110233120|NCT05413330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110233121|NCT05413330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110233122|NCT05413330|Immunologic Factors|immunologic factors|mesh-ancestor
110233123|NCT05413330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110233124|NCT05413330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110233125|NCT05254639|Donepezil|donepezil|mesh-list
110233126|NCT05254639|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110233127|NCT05254639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110233128|NCT05254639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110233129|NCT05254639|Cholinergic Agents|cholinergic agents|mesh-ancestor
110265828|NCT00188955|Sirolimus|sirolimus|mesh-list
110233130|NCT05254639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110233131|NCT05254639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110233132|NCT05254639|Nootropic Agents|nootropic agents|mesh-ancestor
110233133|NCT05243940|Lidocaine|lidocaine|mesh-list
110233134|NCT05243940|Dexmedetomidine|dexmedetomidine|mesh-list
110233135|NCT05243940|Ketamine|ketamine|mesh-list
110233136|NCT05243940|Remifentanil|remifentanil|mesh-list
110233137|NCT05243940|Anesthetics, Local|anesthetics, local|mesh-ancestor
110233138|NCT05243940|Anesthetics|anesthetics|mesh-ancestor
110233139|NCT05243940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110233140|NCT05243940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110233141|NCT05243940|Sensory System Agents|sensory system agents|mesh-ancestor
110233142|NCT05243940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110233143|NCT05243940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110233144|NCT05243940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110233145|NCT05243940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110233146|NCT05243940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110233147|NCT05243940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110233148|NCT05243940|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110233149|NCT05243940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110233150|NCT05243940|Analgesics|analgesics|mesh-ancestor
110233151|NCT05243940|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110233152|NCT05243940|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110233153|NCT05243940|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110233154|NCT05243940|Adrenergic Agents|adrenergic agents|mesh-ancestor
110233155|NCT05243940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110233156|NCT05243940|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110233157|NCT05243940|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110233158|NCT05243940|Anesthetics, General|anesthetics, general|mesh-ancestor
110233159|NCT05243940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110233160|NCT05243940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110233161|NCT05243940|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110233163|NCT05209347|Carbon Fiber|carbon fiber|mesh-list
110233164|NCT05209347|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110233165|NCT05209347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110233166|NCT05198544|Hyaluronic Acid|hyaluronic acid|mesh-list
110233167|NCT05198544|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110233168|NCT05198544|Immunologic Factors|immunologic factors|mesh-ancestor
110233169|NCT05198544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110233170|NCT05198544|Viscosupplements|viscosupplements|mesh-ancestor
110233171|NCT05198544|Protective Agents|protective agents|mesh-ancestor
110233173|NCT05167734|Epoetin Alfa|epoetin alfa|mesh-list
110233174|NCT05167734|Iron-Dextran Complex|iron-dextran complex|mesh-list
110233175|NCT05167734|Hematinics|hematinics|mesh-ancestor
110233176|NCT05167734|Anticoagulants|anticoagulants|mesh-ancestor
110233177|NCT05167734|Plasma Substitutes|plasma substitutes|mesh-ancestor
110233178|NCT05167734|Blood Substitutes|blood substitutes|mesh-ancestor
110233179|NCT05145309|Magnesium citrate|magnesium citrate|mesh-list
110233180|NCT05145309|Cathartics|cathartics|mesh-ancestor
110233181|NCT05145309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110233182|NCT05141474|Aldesleukin|aldesleukin|mesh-list
110233183|NCT05141474|Cyclophosphamide|cyclophosphamide|mesh-list
110233184|NCT05141474|Fludarabine|fludarabine|mesh-list
110233185|NCT05141474|Interleukin-2|interleukin-2|mesh-list
110233186|NCT05141474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110233187|NCT05141474|Immunologic Factors|immunologic factors|mesh-ancestor
110233188|NCT05141474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110233189|NCT05141474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110233190|NCT05141474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110233191|NCT05141474|Alkylating Agents|alkylating agents|mesh-ancestor
110233192|NCT05141474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110233193|NCT05141474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110233194|NCT05141474|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110233195|NCT05141474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110233196|NCT05141474|Analgesics|analgesics|mesh-ancestor
110233197|NCT05141474|Sensory System Agents|sensory system agents|mesh-ancestor
110233198|NCT05141474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110233199|NCT05141474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110233200|NCT05141474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110233201|NCT05141474|Antiviral Agents|antiviral agents|mesh-ancestor
110233202|NCT05141474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110233203|NCT05126719|Docetaxel|docetaxel|mesh-list
110233204|NCT05126719|Capecitabine|capecitabine|mesh-list
110233205|NCT05126719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110233206|NCT05126719|Tubulin Modulators|tubulin modulators|mesh-ancestor
110233207|NCT05126719|Antimitotic Agents|antimitotic agents|mesh-ancestor
110233208|NCT05126719|Mitosis Modulators|mitosis modulators|mesh-ancestor
110233209|NCT05126719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110233210|NCT05126719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110233212|NCT05119140|Hydroxychloroquine|hydroxychloroquine|mesh-list
110233213|NCT05119140|Mesalamine|mesalamine|mesh-list
110233214|NCT05119140|Antimalarials|antimalarials|mesh-ancestor
110233215|NCT05119140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110233216|NCT05119140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110233217|NCT05119140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110233218|NCT05119140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110233219|NCT05119140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110233220|NCT05119140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110233221|NCT05119140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110233222|NCT05119140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110233223|NCT05119140|Analgesics|analgesics|mesh-ancestor
110233224|NCT05119140|Sensory System Agents|sensory system agents|mesh-ancestor
110233225|NCT05119140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110233226|NCT05119140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110233227|NCT05119140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110233228|NCT05107050|Anti-Infective Agents|anti-infective agents|mesh-list
110233229|NCT05107050|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110233231|NCT05097261|Analgesics|analgesics|mesh-ancestor
110233232|NCT05097261|Sensory System Agents|sensory system agents|mesh-ancestor
110233233|NCT05097261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110233234|NCT05097261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110059919|NCT01520389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110233235|NCT05097261|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110233236|NCT05097261|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110233237|NCT05097261|Anesthetics, General|anesthetics, general|mesh-ancestor
110233238|NCT05097261|Anesthetics|anesthetics|mesh-ancestor
110233239|NCT05097261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110233240|NCT05097261|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110233241|NCT05097261|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110233242|NCT05097261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110233243|NCT05097261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110233245|NCT05037032|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110233246|NCT05037032|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110233247|NCT05037032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110233248|NCT05037032|Sensory System Agents|sensory system agents|mesh-ancestor
110233249|NCT05037032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110233250|NCT04857931|Colchicine|colchicine|mesh-list
110233251|NCT04857931|Gout Suppressants|gout suppressants|mesh-ancestor
110233252|NCT04857931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110233253|NCT04857931|Tubulin Modulators|tubulin modulators|mesh-ancestor
110233254|NCT04857931|Antimitotic Agents|antimitotic agents|mesh-ancestor
110233255|NCT04857931|Mitosis Modulators|mitosis modulators|mesh-ancestor
110233256|NCT04857931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110233257|NCT04857931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110233258|NCT04840199|Letermovir|letermovir|mesh-list
110233259|NCT04840199|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110233260|NCT04840199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110233261|NCT04840199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110233262|NCT04840199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110233263|NCT04840199|Antiviral Agents|antiviral agents|mesh-ancestor
110233264|NCT04840199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110233265|NCT04800393|Propofol|propofol|mesh-list
110233266|NCT04800393|Sevoflurane|sevoflurane|mesh-list
110233267|NCT04800393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110233268|NCT04800393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110233269|NCT04800393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110233270|NCT04800393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110233272|NCT04800393|Anesthetics|anesthetics|mesh-ancestor
110233273|NCT04800393|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110233274|NCT04800393|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110233275|NCT04718220|Antibodies|antibodies|mesh-list
110233276|NCT04718220|Immunologic Factors|immunologic factors|mesh-ancestor
110233277|NCT04718220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110233278|NCT04668300|Durvalumab|durvalumab|mesh-list
110233279|NCT04668300|Immunoglobulins|immunoglobulins|mesh-list
110233280|NCT04668300|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110233281|NCT04668300|Immunoglobulin G|immunoglobulin g|mesh-list
110233282|NCT04668300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110233283|NCT04668300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110233284|NCT04668300|Immunologic Factors|immunologic factors|mesh-ancestor
110233285|NCT04668300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110233286|NCT04521868|Sulforaphane|sulforaphane|mesh-list
110233287|NCT04521868|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110233288|NCT04521868|Protective Agents|protective agents|mesh-ancestor
110233289|NCT04521868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110233290|NCT04521868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110233291|NCT04481204|Leucovorin|leucovorin|mesh-list
110233292|NCT04481204|Paclitaxel|paclitaxel|mesh-list
110233293|NCT04481204|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110233294|NCT04481204|Cisplatin|cisplatin|mesh-list
110233295|NCT04481204|Gemcitabine|gemcitabine|mesh-list
110233296|NCT04481204|Fluorouracil|fluorouracil|mesh-list
110233297|NCT04481204|Oxaliplatin|oxaliplatin|mesh-list
110233298|NCT04481204|Irinotecan|irinotecan|mesh-list
110233299|NCT04481204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110233300|NCT04481204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110233301|NCT04481204|Tubulin Modulators|tubulin modulators|mesh-ancestor
110233303|NCT04481204|Mitosis Modulators|mitosis modulators|mesh-ancestor
110233304|NCT04481204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110233305|NCT04481204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110233306|NCT04481204|Antimetabolites|antimetabolites|mesh-ancestor
110233307|NCT04481204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110233308|NCT04481204|Immunologic Factors|immunologic factors|mesh-ancestor
110233309|NCT04481204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110233310|NCT04481204|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110233311|NCT04481204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110233312|NCT04481204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110233313|NCT04481204|Antidotes|antidotes|mesh-ancestor
110233314|NCT04481204|Protective Agents|protective agents|mesh-ancestor
110233315|NCT04481204|Vitamin B Complex|vitamin b complex|mesh-ancestor
110233316|NCT04481204|Vitamins|vitamins|mesh-ancestor
110233317|NCT04481204|Micronutrients|micronutrients|mesh-ancestor
110233318|NCT04419493|Heparin|heparin|mesh-list
110233319|NCT04419493|Calcium heparin|calcium heparin|mesh-list
110233320|NCT04419493|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110233321|NCT04419493|Anticoagulants|anticoagulants|mesh-ancestor
110233322|NCT04419493|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110233323|NCT04419493|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110233324|NCT04419493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110233325|NCT04401748|Azacitidine|azacitidine|mesh-list
110233326|NCT04401748|Venetoclax|venetoclax|mesh-list
110233327|NCT04401748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110233328|NCT04401748|Antimetabolites|antimetabolites|mesh-ancestor
110233329|NCT04401748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110233330|NCT04401748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110233331|NCT04401748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110233332|NCT04395183|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
110233333|NCT04395183|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110233334|NCT04395183|Antidepressive Agents|antidepressive agents|mesh-ancestor
110233335|NCT04395183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110233336|NCT04394975|Sunitinib|sunitinib|mesh-list
110233337|NCT04394975|Axitinib|axitinib|mesh-list
110233338|NCT04394975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110233339|NCT04394975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110233340|NCT04394975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110233341|NCT04394975|Growth Substances|growth substances|mesh-ancestor
110233342|NCT04394975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110233343|NCT04394975|Growth Inhibitors|growth inhibitors|mesh-ancestor
110233344|NCT04394975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110233345|NCT04394975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110233346|NCT04394975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110233347|NCT04381910|Irinotecan|irinotecan|mesh-list
110233348|NCT04381910|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110233349|NCT04381910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110233350|NCT04381910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110233351|NCT04381910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110233352|NCT04381910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110233353|NCT04334876|Antibodies|antibodies|mesh-list
110233354|NCT04334876|Immunoglobulin G|immunoglobulin g|mesh-list
110233355|NCT04334876|Immunologic Factors|immunologic factors|mesh-ancestor
110233356|NCT04334876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110233357|NCT04302870|Amantadine|amantadine|mesh-list
110233358|NCT04302870|Memantine|memantine|mesh-list
110233359|NCT04302870|Trazodone|trazodone|mesh-list
110233360|NCT04302870|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110233361|NCT04302870|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110233362|NCT04302870|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110233363|NCT04302870|Dopamine Agents|dopamine agents|mesh-ancestor
110233364|NCT04302870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110265962|NCT00156689|Anticonvulsants|anticonvulsants|mesh-ancestor
110233365|NCT04302870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110233366|NCT04302870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110233367|NCT04302870|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110233368|NCT04302870|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110233370|NCT04302870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110233371|NCT04302870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110233372|NCT04302870|Analgesics|analgesics|mesh-ancestor
110233373|NCT04302870|Sensory System Agents|sensory system agents|mesh-ancestor
110233374|NCT04302870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110233375|NCT04302870|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110233376|NCT04302870|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110233377|NCT04302870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110233378|NCT04302870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110233379|NCT04302870|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110233380|NCT04302870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110233381|NCT04302870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110233382|NCT04302870|Serotonin Agents|serotonin agents|mesh-ancestor
110233383|NCT04302870|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110233384|NCT04302870|Antidepressive Agents|antidepressive agents|mesh-ancestor
110233385|NCT04231214|Tiotropium Bromide|tiotropium bromide|mesh-list
110233386|NCT04231214|Olodaterol|olodaterol|mesh-list
110233387|NCT04231214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110233388|NCT04231214|Autonomic Agents|autonomic agents|mesh-ancestor
110060068|NCT01521455|Hormones|hormones|mesh-ancestor
110233389|NCT04231214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110233390|NCT04231214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110233391|NCT04231214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110233392|NCT04231214|Respiratory System Agents|respiratory system agents|mesh-ancestor
110233393|NCT04231214|Parasympatholytics|parasympatholytics|mesh-ancestor
110233394|NCT04231214|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110233395|NCT04231214|Cholinergic Agents|cholinergic agents|mesh-ancestor
110233396|NCT04231214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110233397|NCT04231214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110233398|NCT04229095|Suvorexant|suvorexant|mesh-list
110233399|NCT04229095|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110233400|NCT04229095|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110266000|NCT00536653|Vitamins|vitamins|mesh-list
110233405|NCT04229095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110233407|NCT04088604|Irinotecan|irinotecan|mesh-list
110233408|NCT04088604|Antimetabolites|antimetabolites|mesh-ancestor
110233409|NCT04088604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110233410|NCT04088604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110233412|NCT04088604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110233413|NCT04088604|Immunologic Factors|immunologic factors|mesh-ancestor
110233414|NCT04088604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110233415|NCT04088604|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110233416|NCT04088604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110233417|NCT04088604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110233423|NCT04006288|Aspirin|aspirin|mesh-list
110233424|NCT04006288|Rivaroxaban|rivaroxaban|mesh-list
110233425|NCT04006288|Clopidogrel|clopidogrel|mesh-list
110233426|NCT04006288|Ticagrelor|ticagrelor|mesh-list
110233427|NCT04006288|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110233428|NCT04006288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110233429|NCT04006288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110233430|NCT04006288|Analgesics|analgesics|mesh-ancestor
110233431|NCT04006288|Sensory System Agents|sensory system agents|mesh-ancestor
110233432|NCT04006288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110233433|NCT04006288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110233434|NCT04006288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110233435|NCT04006288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110233436|NCT04006288|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110233437|NCT04006288|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110233438|NCT04006288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110233439|NCT04006288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110233440|NCT04006288|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110233441|NCT04006288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110233443|NCT04006288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110233444|NCT04006288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110233445|NCT04006288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110233446|NCT04006288|Purinergic Agents|purinergic agents|mesh-ancestor
110233447|NCT04006288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110233448|NCT04006288|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110233449|NCT04006288|Antithrombins|antithrombins|mesh-ancestor
110233450|NCT04006288|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110233451|NCT04006288|Protease Inhibitors|protease inhibitors|mesh-ancestor
110233452|NCT04006288|Anticoagulants|anticoagulants|mesh-ancestor
110233453|NCT03979131|Avelumab|avelumab|mesh-list
110233454|NCT03979131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110233455|NCT03979131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110233456|NCT03958045|Nivolumab|nivolumab|mesh-list
110233457|NCT03958045|Rucaparib|rucaparib|mesh-list
110233458|NCT03958045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110233459|NCT03958045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110233460|NCT03958045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110233461|NCT03958045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110233462|NCT03958045|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110233463|NCT03958045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110233465|NCT03956680|Ipilimumab|ipilimumab|mesh-list
110233466|NCT03956680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110233467|NCT03956680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110233468|NCT03956680|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110233469|NCT03956680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110233470|NCT03952273|Sirolimus|sirolimus|mesh-list
110233471|NCT03952273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110233472|NCT03952273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110233473|NCT03952273|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110233474|NCT03952273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110233475|NCT03952273|Antifungal Agents|antifungal agents|mesh-ancestor
110233476|NCT03952273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110233477|NCT03952273|Immunologic Factors|immunologic factors|mesh-ancestor
110233478|NCT03952273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110233479|NCT03947827|Minocycline|minocycline|mesh-list
110233480|NCT03947827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110233481|NCT03947827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110233482|NCT03927989|Nicotine|nicotine|mesh-list
110233483|NCT03927989|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110233484|NCT03927989|Autonomic Agents|autonomic agents|mesh-ancestor
110233485|NCT03927989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110233486|NCT03927989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110233487|NCT03927989|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110233488|NCT03927989|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110233489|NCT03927989|Cholinergic Agents|cholinergic agents|mesh-ancestor
110233490|NCT03927989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110233491|NCT03927989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110233492|NCT03843645|Anesthetics|anesthetics|mesh-list
110233493|NCT03843645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110233494|NCT03843645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110233495|NCT03803787|Budesonide|budesonide|mesh-list
110233496|NCT03803787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110233497|NCT03803787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110233498|NCT03803787|Autonomic Agents|autonomic agents|mesh-ancestor
110233499|NCT03803787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110233500|NCT03803787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110233501|NCT03803787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110233502|NCT03803787|Respiratory System Agents|respiratory system agents|mesh-ancestor
110233503|NCT03803787|Glucocorticoids|glucocorticoids|mesh-ancestor
110233504|NCT03803787|Hormones|hormones|mesh-ancestor
110233505|NCT03803787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110233506|NCT03728881|Vaccines|vaccines|mesh-list
110233507|NCT03728881|Immunologic Factors|immunologic factors|mesh-ancestor
110233508|NCT03728881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110233509|NCT03711253|Tenofovir|tenofovir|mesh-list
110233510|NCT03711253|Emtricitabine|emtricitabine|mesh-list
110233511|NCT03711253|Antiviral Agents|antiviral agents|mesh-ancestor
110233512|NCT03711253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110233513|NCT03711253|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110233514|NCT03711253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110233515|NCT03711253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110233516|NCT03711253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110233517|NCT03711253|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110233518|NCT03711253|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110233519|NCT03643822|Dexamethasone|dexamethasone|mesh-list
110233520|NCT03643822|Dexamethasone acetate|dexamethasone acetate|mesh-list
110233521|NCT03643822|Dexmedetomidine|dexmedetomidine|mesh-list
110233522|NCT03643822|BB 1101|bb 1101|mesh-list
110233523|NCT03643822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110233524|NCT03643822|Antiemetics|antiemetics|mesh-ancestor
110233525|NCT03643822|Autonomic Agents|autonomic agents|mesh-ancestor
110233526|NCT03643822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110233527|NCT03643822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110233528|NCT03643822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110233529|NCT03643822|Glucocorticoids|glucocorticoids|mesh-ancestor
110233530|NCT03643822|Hormones|hormones|mesh-ancestor
110233531|NCT03643822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110233532|NCT03643822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110233533|NCT03643822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110233534|NCT03643822|Protease Inhibitors|protease inhibitors|mesh-ancestor
110233535|NCT03643822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110233536|NCT03643822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110233537|NCT03643822|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110233538|NCT03643822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110233539|NCT03643822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110233540|NCT03643822|Analgesics|analgesics|mesh-ancestor
110233541|NCT03643822|Sensory System Agents|sensory system agents|mesh-ancestor
110233542|NCT03643822|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110233543|NCT03643822|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110233544|NCT03643822|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110233545|NCT03643822|Adrenergic Agents|adrenergic agents|mesh-ancestor
110233546|NCT03643822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110233547|NCT03603964|Guadecitabine|guadecitabine|mesh-list
110233548|NCT03603964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110233549|NCT03575000|Bromocriptine|bromocriptine|mesh-list
110233550|NCT03575000|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110233551|NCT03575000|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110233552|NCT03575000|Hormone Antagonists|hormone antagonists|mesh-ancestor
110233553|NCT03575000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110233554|NCT03575000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110233555|NCT03575000|Dopamine Agonists|dopamine agonists|mesh-ancestor
110233556|NCT03575000|Dopamine Agents|dopamine agents|mesh-ancestor
110233557|NCT03575000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110233558|NCT03575000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110233560|NCT03513952|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110233561|NCT03513952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110233562|NCT03513952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110233563|NCT03513952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110233564|NCT03513952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110233565|NCT03513952|Immunologic Factors|immunologic factors|mesh-ancestor
110233566|NCT03513952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110233567|NCT03498261|Gabapentin|gabapentin|mesh-list
110233568|NCT03498261|Analgesics|analgesics|mesh-ancestor
110233569|NCT03498261|Sensory System Agents|sensory system agents|mesh-ancestor
110233570|NCT03498261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110233571|NCT03498261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110233572|NCT03498261|Anticonvulsants|anticonvulsants|mesh-ancestor
110233573|NCT03498261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110233574|NCT03498261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110233575|NCT03498261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110233576|NCT03498261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110233577|NCT03498261|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110233578|NCT03498261|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110233579|NCT03498261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110233580|NCT03498261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110233581|NCT03498261|Antimanic Agents|antimanic agents|mesh-ancestor
110233582|NCT03495921|Irinotecan|irinotecan|mesh-list
110233583|NCT03495921|Camptothecin|camptothecin|mesh-list
110233584|NCT03495921|Temozolomide|temozolomide|mesh-list
110233585|NCT03495921|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110233586|NCT03495921|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110233587|NCT03495921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110233588|NCT03495921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110233589|NCT03495921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110233590|NCT03495921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110233591|NCT03495921|Alkylating Agents|alkylating agents|mesh-ancestor
110233592|NCT03495921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110233593|NCT03191864|Fluticasone|fluticasone|mesh-list
110233595|NCT03191864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110233596|NCT03191864|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110233597|NCT03191864|Autonomic Agents|autonomic agents|mesh-ancestor
110233598|NCT03191864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110233599|NCT03191864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110233600|NCT03191864|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110233601|NCT03191864|Respiratory System Agents|respiratory system agents|mesh-ancestor
110233602|NCT03191864|Dermatologic Agents|dermatologic agents|mesh-ancestor
110233603|NCT03191864|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110233605|NCT03123978|Anticestodal Agents|anticestodal agents|mesh-ancestor
110233606|NCT03123978|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110233607|NCT03123978|Anthelmintics|anthelmintics|mesh-ancestor
110233608|NCT03123978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110233609|NCT03123978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110233610|NCT03123978|Antinematodal Agents|antinematodal agents|mesh-ancestor
110233611|NCT03114072|Methamphetamine|methamphetamine|mesh-list
110233612|NCT03114072|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110233613|NCT03114072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110233614|NCT03114072|Sympathomimetics|sympathomimetics|mesh-ancestor
110233615|NCT03114072|Autonomic Agents|autonomic agents|mesh-ancestor
110233616|NCT03114072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110233617|NCT03114072|Dopamine Agents|dopamine agents|mesh-ancestor
110233618|NCT03114072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110233619|NCT03114072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110233620|NCT03114072|Adrenergic Agents|adrenergic agents|mesh-ancestor
110233621|NCT03114072|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110233622|NCT03114072|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110233623|NCT03114072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110233624|NCT03114072|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110233626|NCT03063619|Afimoxifene|afimoxifene|mesh-list
110233627|NCT03063619|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110233628|NCT03063619|Hormone Antagonists|hormone antagonists|mesh-ancestor
110233629|NCT03063619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110233630|NCT03063619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110233631|NCT03063619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110233632|NCT03063619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110233633|NCT03063619|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110233634|NCT03063619|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110233635|NCT03063619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110233637|NCT03002103|Gemcitabine|gemcitabine|mesh-list
110233638|NCT03002103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110233639|NCT03002103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110233640|NCT03002103|Tubulin Modulators|tubulin modulators|mesh-ancestor
110233641|NCT03002103|Antimitotic Agents|antimitotic agents|mesh-ancestor
110233642|NCT03002103|Mitosis Modulators|mitosis modulators|mesh-ancestor
110233643|NCT03002103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110233644|NCT03002103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110233645|NCT03002103|Antimetabolites|antimetabolites|mesh-ancestor
110233646|NCT02975882|Sirolimus|sirolimus|mesh-list
110233647|NCT02975882|Irinotecan|irinotecan|mesh-list
110233648|NCT02975882|Camptothecin|camptothecin|mesh-list
110233649|NCT02975882|Temozolomide|temozolomide|mesh-list
110233650|NCT02975882|Temsirolimus|temsirolimus|mesh-list
110233651|NCT02975882|MTOR Inhibitors|mtor inhibitors|mesh-list
110233652|NCT02975882|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110233653|NCT02975882|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110233654|NCT02975882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110233655|NCT02975882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110233656|NCT02975882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110233657|NCT02975882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110233658|NCT02975882|Alkylating Agents|alkylating agents|mesh-ancestor
110233659|NCT02975882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110233660|NCT02975882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110233661|NCT02975882|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110233662|NCT02975882|Antifungal Agents|antifungal agents|mesh-ancestor
110233663|NCT02975882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110233664|NCT02975882|Immunologic Factors|immunologic factors|mesh-ancestor
110233665|NCT02975882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110233666|NCT02975882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110233667|NCT02975882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110233668|NCT02968810|Simvastatin|simvastatin|mesh-list
110233669|NCT02968810|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110233670|NCT02968810|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110233671|NCT02968810|Antimetabolites|antimetabolites|mesh-ancestor
110233672|NCT02968810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110233673|NCT02968810|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110233674|NCT02968810|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110233675|NCT02968810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110233676|NCT02935205|Indomethacin|indomethacin|mesh-list
110233677|NCT02935205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110233678|NCT02935205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110233679|NCT02935205|Analgesics|analgesics|mesh-ancestor
110233680|NCT02935205|Sensory System Agents|sensory system agents|mesh-ancestor
110233681|NCT02935205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110233682|NCT02935205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110233683|NCT02935205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110233684|NCT02935205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110233685|NCT02935205|Gout Suppressants|gout suppressants|mesh-ancestor
110233686|NCT02935205|Tocolytic Agents|tocolytic agents|mesh-ancestor
110233687|NCT02935205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110233688|NCT02935205|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110233689|NCT02935205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110233690|NCT02935205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110233691|NCT02898207|Olaparib|olaparib|mesh-list
110233692|NCT02898207|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
110233693|NCT02898207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110233694|NCT02898207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110233695|NCT02898207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110233696|NCT02862275|Atezolizumab|atezolizumab|mesh-list
110060374|NCT01523080|Acetaminophen|acetaminophen|mesh-list
110233697|NCT02862275|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110233698|NCT02862275|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110233699|NCT02862275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110233700|NCT02862275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110233701|NCT02862275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110233702|NCT02862275|Immunologic Factors|immunologic factors|mesh-ancestor
110233703|NCT02862275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110233704|NCT02807805|Niclosamide|niclosamide|mesh-list
110233705|NCT02807805|Prednisone|prednisone|mesh-list
110233706|NCT02807805|Cortisone|cortisone|mesh-list
110233707|NCT02807805|Abiraterone Acetate|abiraterone acetate|mesh-list
110233708|NCT02807805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110233709|NCT02807805|Glucocorticoids|glucocorticoids|mesh-ancestor
110233710|NCT02807805|Hormones|hormones|mesh-ancestor
110233711|NCT02807805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110233712|NCT02807805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110233713|NCT02807805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110233714|NCT02807805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110233715|NCT02807805|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110233716|NCT02807805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110233717|NCT02807805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110233718|NCT02807805|Hormone Antagonists|hormone antagonists|mesh-ancestor
110233719|NCT02807805|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110233720|NCT02807805|Anticestodal Agents|anticestodal agents|mesh-ancestor
110266153|NCT00182520|Topiramate|topiramate|mesh-list
110233722|NCT02807805|Anthelmintics|anthelmintics|mesh-ancestor
110233723|NCT02807805|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110233724|NCT02807805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110233725|NCT02807805|Antinematodal Agents|antinematodal agents|mesh-ancestor
110233726|NCT02737046|Interferons|interferons|mesh-list
110233727|NCT02737046|Interferon-alpha|interferon-alpha|mesh-list
110233728|NCT02737046|Interferon alpha-2|interferon alpha-2|mesh-list
110233729|NCT02737046|Zidovudine|zidovudine|mesh-list
110233730|NCT02737046|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110233731|NCT02737046|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
110233732|NCT02737046|Belinostat|belinostat|mesh-list
110233733|NCT02737046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110233734|NCT02737046|Antiviral Agents|antiviral agents|mesh-ancestor
110233735|NCT02737046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110233736|NCT02737046|Immunologic Factors|immunologic factors|mesh-ancestor
110233737|NCT02737046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110233738|NCT02737046|Antimetabolites|antimetabolites|mesh-ancestor
110233739|NCT02737046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110233740|NCT02737046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110233741|NCT02737046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110233742|NCT02737046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110233743|NCT02737046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110233744|NCT02737046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110233745|NCT02737046|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110233746|NCT02682485|Metronidazole|metronidazole|mesh-list
110233747|NCT02682485|Ciprofloxacin|ciprofloxacin|mesh-list
110233748|NCT02682485|Neomycin|neomycin|mesh-list
110233749|NCT02682485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110233750|NCT02682485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110233751|NCT02682485|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110233752|NCT02682485|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110233753|NCT02682485|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110233754|NCT02682485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110233755|NCT02682485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110233756|NCT02682485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110233757|NCT02682485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110233758|NCT02682485|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110233759|NCT02682485|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110233760|NCT02682485|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110233761|NCT02636725|Pembrolizumab|pembrolizumab|mesh-list
110233762|NCT02636725|Axitinib|axitinib|mesh-list
110233763|NCT02636725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110233764|NCT02636725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110233765|NCT02636725|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110233766|NCT02636725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110233767|NCT02636725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110233768|NCT02636725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110233769|NCT02573493|Paclitaxel|paclitaxel|mesh-list
110233770|NCT02573493|Cisplatin|cisplatin|mesh-list
110233771|NCT02573493|Cetuximab|cetuximab|mesh-list
110060449|NCT01523418|Rivaroxaban|rivaroxaban|mesh-list
110233772|NCT02573493|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110233773|NCT02573493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110233774|NCT02573493|Tubulin Modulators|tubulin modulators|mesh-ancestor
110233775|NCT02573493|Antimitotic Agents|antimitotic agents|mesh-ancestor
110233776|NCT02573493|Mitosis Modulators|mitosis modulators|mesh-ancestor
110233777|NCT02573493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110233778|NCT02573493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110233779|NCT02521493|Cytarabine|cytarabine|mesh-list
110233780|NCT02521493|Etoposide|etoposide|mesh-list
110233781|NCT02521493|Podophyllotoxin|podophyllotoxin|mesh-list
110233782|NCT02521493|Daunorubicin|daunorubicin|mesh-list
110233783|NCT02521493|Mitoxantrone|mitoxantrone|mesh-list
110233784|NCT02521493|Etoposide phosphate|etoposide phosphate|mesh-list
110233785|NCT02521493|Asparaginase|asparaginase|mesh-list
110233786|NCT02521493|Mercaptopurine|mercaptopurine|mesh-list
110233787|NCT02521493|Thioguanine|thioguanine|mesh-list
110233788|NCT02521493|2-Aminopurine|2-aminopurine|mesh-list
110233789|NCT02521493|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110233790|NCT02521493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110233791|NCT02521493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110233792|NCT02521493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110233793|NCT02521493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110233794|NCT02521493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110233795|NCT02521493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110233796|NCT02521493|Antimetabolites|antimetabolites|mesh-ancestor
110233797|NCT02521493|Antiviral Agents|antiviral agents|mesh-ancestor
110233798|NCT02521493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110233799|NCT02521493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110233800|NCT02521493|Immunologic Factors|immunologic factors|mesh-ancestor
110233801|NCT02521493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110233802|NCT02521493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110233803|NCT02521493|Analgesics|analgesics|mesh-ancestor
110233804|NCT02521493|Sensory System Agents|sensory system agents|mesh-ancestor
110233805|NCT02521493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110233806|NCT02521493|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110233807|NCT02521493|Keratolytic Agents|keratolytic agents|mesh-ancestor
110233808|NCT02521493|Dermatologic Agents|dermatologic agents|mesh-ancestor
110233809|NCT02521493|Tubulin Modulators|tubulin modulators|mesh-ancestor
110233810|NCT02521493|Antimitotic Agents|antimitotic agents|mesh-ancestor
110233811|NCT02521493|Mitosis Modulators|mitosis modulators|mesh-ancestor
110233812|NCT02394834|Calcium, Dietary|calcium, dietary|mesh-list
110233814|NCT02394834|Bevacizumab|bevacizumab|mesh-list
110233815|NCT02394834|Panitumumab|panitumumab|mesh-list
110233816|NCT02394834|Oxaliplatin|oxaliplatin|mesh-list
110233817|NCT02394834|Fluorouracil|fluorouracil|mesh-list
110233818|NCT02394834|Calcium|calcium|mesh-list
110233819|NCT02394834|Levoleucovorin|levoleucovorin|mesh-list
110233820|NCT02394834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110233821|NCT02394834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110233822|NCT02394834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110233823|NCT02394834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110233824|NCT02394834|Growth Substances|growth substances|mesh-ancestor
110233825|NCT02394834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110266183|NCT00425568|Testosterone|testosterone|mesh-list
110233826|NCT02394834|Growth Inhibitors|growth inhibitors|mesh-ancestor
110233827|NCT02394834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110233828|NCT02394834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110233829|NCT02394834|Antimetabolites|antimetabolites|mesh-ancestor
110233830|NCT02394834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110233831|NCT02394834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110233832|NCT02394834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110233833|NCT02394834|Immunologic Factors|immunologic factors|mesh-ancestor
110233834|NCT02394834|Antidotes|antidotes|mesh-ancestor
110233835|NCT02394834|Protective Agents|protective agents|mesh-ancestor
110233836|NCT02394834|Vitamin B Complex|vitamin b complex|mesh-ancestor
110233837|NCT02394834|Vitamins|vitamins|mesh-ancestor
110233838|NCT02394834|Micronutrients|micronutrients|mesh-ancestor
110233839|NCT02381561|Ropidoxuridine|ropidoxuridine|mesh-list
110233840|NCT02381561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110233841|NCT02381535|Cisplatin|cisplatin|mesh-list
110233842|NCT02381535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110233843|NCT02327078|Nivolumab|nivolumab|mesh-list
110233844|NCT02327078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110233845|NCT02327078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110233846|NCT02327078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110233847|NCT02327078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110233848|NCT02304458|Nivolumab|nivolumab|mesh-list
110233849|NCT02304458|Ipilimumab|ipilimumab|mesh-list
110233850|NCT02304458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110233851|NCT02304458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110233852|NCT02304458|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110233853|NCT02304458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110233854|NCT02219373|Oxcarbazepine|oxcarbazepine|mesh-list
110233855|NCT02219373|Gabapentin|gabapentin|mesh-list
110233856|NCT02219373|Analgesics|analgesics|mesh-ancestor
110233857|NCT02219373|Sensory System Agents|sensory system agents|mesh-ancestor
110233858|NCT02219373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110233859|NCT02219373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110233860|NCT02219373|Anticonvulsants|anticonvulsants|mesh-ancestor
110233861|NCT02219373|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110233862|NCT02219373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110233863|NCT02219373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110233864|NCT02219373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110233865|NCT02219373|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110233866|NCT02219373|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110233867|NCT02219373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110233868|NCT02219373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110233869|NCT02219373|Antimanic Agents|antimanic agents|mesh-ancestor
110233870|NCT02219373|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110233871|NCT02219373|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110233872|NCT02219373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110233873|NCT02219373|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110233874|NCT02219373|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110233875|NCT02187224|Progesterone|progesterone|mesh-list
110233876|NCT02187224|Progestins|progestins|mesh-ancestor
110233877|NCT02187224|Hormones|hormones|mesh-ancestor
110233878|NCT02187224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110233879|NCT02187224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110233880|NCT02159066|Infigratinib|infigratinib|mesh-list
110233881|NCT02159066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110233882|NCT02099825|Cycloserine|cycloserine|mesh-list
110233883|NCT02099825|Mifepristone|mifepristone|mesh-list
110233884|NCT02099825|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110233885|NCT02099825|Abortifacient Agents|abortifacient agents|mesh-ancestor
110233886|NCT02099825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110233887|NCT02099825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110233888|NCT02099825|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110233889|NCT02099825|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110233890|NCT02099825|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110233891|NCT02099825|Contraceptive Agents|contraceptive agents|mesh-ancestor
110233892|NCT02099825|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110233893|NCT02099825|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110233894|NCT02099825|Hormone Antagonists|hormone antagonists|mesh-ancestor
110233895|NCT02099825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110233896|NCT02099825|Luteolytic Agents|luteolytic agents|mesh-ancestor
110233897|NCT02099825|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110233898|NCT02099825|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110233899|NCT02099825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110233900|NCT02099825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110233901|NCT02099825|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110233902|NCT02099825|Antitubercular Agents|antitubercular agents|mesh-ancestor
110233903|NCT02099825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110233904|NCT02099825|Antimetabolites|antimetabolites|mesh-ancestor
110233905|NCT02099825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110233906|NCT02057978|Chlorhexidine|chlorhexidine|mesh-list
110233907|NCT02057978|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110233908|NCT02057978|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110233909|NCT02057978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110233910|NCT02057978|Disinfectants|disinfectants|mesh-ancestor
110233911|NCT02057978|Dermatologic Agents|dermatologic agents|mesh-ancestor
110233912|NCT02032823|Olaparib|olaparib|mesh-list
110233913|NCT02032823|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110233914|NCT02032823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110233915|NCT02032823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110233916|NCT02032823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110233917|NCT01958021|Letrozole|letrozole|mesh-list
110233918|NCT01958021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110060600|NCT01524237|Anesthetics|anesthetics|mesh-ancestor
110233919|NCT01958021|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110233920|NCT01958021|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110233921|NCT01958021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110233922|NCT01958021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110233923|NCT01958021|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110233924|NCT01958021|Hormone Antagonists|hormone antagonists|mesh-ancestor
110233925|NCT01958021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110233926|NCT01958021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110233927|NCT01946477|Dexamethasone|dexamethasone|mesh-list
110233928|NCT01946477|Daratumumab|daratumumab|mesh-list
110233929|NCT01946477|Pomalidomide|pomalidomide|mesh-list
110233930|NCT01946477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110233931|NCT01946477|Antiemetics|antiemetics|mesh-ancestor
110233932|NCT01946477|Autonomic Agents|autonomic agents|mesh-ancestor
110233933|NCT01946477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110233934|NCT01946477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110233935|NCT01946477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110233936|NCT01946477|Glucocorticoids|glucocorticoids|mesh-ancestor
110233937|NCT01946477|Hormones|hormones|mesh-ancestor
110233938|NCT01946477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110233939|NCT01946477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110233940|NCT01946477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110233941|NCT01946477|Immunologic Factors|immunologic factors|mesh-ancestor
110233942|NCT01946477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110233943|NCT01946477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110233944|NCT01946477|Growth Substances|growth substances|mesh-ancestor
110233945|NCT01946477|Growth Inhibitors|growth inhibitors|mesh-ancestor
110233948|NCT01742299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110233949|NCT01742299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110233950|NCT01742299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110233951|NCT05953168|Trastuzumab|trastuzumab|mesh-list
110233952|NCT05953168|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
110233953|NCT05953168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110233954|NCT05953168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110233955|NCT05953168|Immunoconjugates|immunoconjugates|mesh-ancestor
110233956|NCT05953168|Immunologic Factors|immunologic factors|mesh-ancestor
110233957|NCT05953168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110233959|NCT05953142|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110233960|NCT05953142|Sympathomimetics|sympathomimetics|mesh-ancestor
110233961|NCT05953142|Autonomic Agents|autonomic agents|mesh-ancestor
110233962|NCT05953142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110233963|NCT05953142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110233964|NCT05953142|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110233965|NCT05953142|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110233966|NCT05953142|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110233967|NCT05953142|Adrenergic Agents|adrenergic agents|mesh-ancestor
110233968|NCT05953142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110233969|NCT05953142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110233970|NCT05953142|Protective Agents|protective agents|mesh-ancestor
110233971|NCT05953038|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
110233972|NCT05953038|Hallucinogens|hallucinogens|mesh-ancestor
110233973|NCT05953038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110233974|NCT05953038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110233975|NCT05953038|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110233976|NCT05953038|Serotonin Agents|serotonin agents|mesh-ancestor
110233977|NCT05953038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110233978|NCT05953038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110233979|NCT05953038|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110233980|NCT05952947|Cyclophosphamide|cyclophosphamide|mesh-list
110233981|NCT05952947|Fludarabine|fludarabine|mesh-list
110233982|NCT05952947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110233983|NCT05952947|Immunologic Factors|immunologic factors|mesh-ancestor
110233984|NCT05952947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110233985|NCT05952947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110233986|NCT05952947|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110233987|NCT05952947|Alkylating Agents|alkylating agents|mesh-ancestor
110233988|NCT05952947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110233989|NCT05952947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110233990|NCT05952947|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110233991|NCT05952921|Chlorhexidine|chlorhexidine|mesh-list
110233992|NCT05952921|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110233993|NCT05952921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110233994|NCT05952921|Disinfectants|disinfectants|mesh-ancestor
110233995|NCT05952882|Metformin|metformin|mesh-list
110233996|NCT05952882|Liraglutide|liraglutide|mesh-list
110233997|NCT05952882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110233998|NCT05952882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110233999|NCT05952882|Incretins|incretins|mesh-ancestor
110234000|NCT05952882|Hormones|hormones|mesh-ancestor
110234001|NCT05952882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110234002|NCT05952596|Vaccines|vaccines|mesh-list
110234003|NCT05952596|Immunologic Factors|immunologic factors|mesh-ancestor
110234004|NCT05952596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110234005|NCT05952557|Tamoxifen|tamoxifen|mesh-list
110234006|NCT05952557|Letrozole|letrozole|mesh-list
110234007|NCT05952557|Anastrozole|anastrozole|mesh-list
110234008|NCT05952557|Exemestane|exemestane|mesh-list
110234009|NCT05952557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110234010|NCT05952557|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110234011|NCT05952557|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110234012|NCT05952557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110234013|NCT05952557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110234014|NCT05952557|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110234015|NCT05952557|Hormone Antagonists|hormone antagonists|mesh-ancestor
110234016|NCT05952557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110234017|NCT05952557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110234018|NCT05952557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110234019|NCT05952557|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110234020|NCT05952557|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110234021|NCT05952557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110234022|NCT05952505|Vaccines|vaccines|mesh-list
110234023|NCT05952505|Immunologic Factors|immunologic factors|mesh-ancestor
110234024|NCT05952505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110234025|NCT05952206|Sirolimus|sirolimus|mesh-list
110234026|NCT05952206|Temsirolimus|temsirolimus|mesh-list
110234027|NCT05952206|MTOR Inhibitors|mtor inhibitors|mesh-list
110234028|NCT05952206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110234029|NCT05952206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110234030|NCT05952206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110234031|NCT05952206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110234032|NCT05952206|Antifungal Agents|antifungal agents|mesh-ancestor
110234033|NCT05952206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110234034|NCT05952206|Immunologic Factors|immunologic factors|mesh-ancestor
110234035|NCT05952206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110234036|NCT05952206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110234037|NCT05952206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110234038|NCT05952206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110234039|NCT05952128|Fluzoparib|fluzoparib|mesh-list
110234040|NCT05952128|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110234041|NCT05952128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110234042|NCT05952128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110234043|NCT05952128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110234044|NCT05952050|Dexmedetomidine|dexmedetomidine|mesh-list
110234045|NCT05952050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110266277|NCT00534586|Sevoflurane|sevoflurane|mesh-list
110234046|NCT05952050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110234047|NCT05952050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110234048|NCT05952050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110234049|NCT05952050|Analgesics|analgesics|mesh-ancestor
110234050|NCT05952050|Sensory System Agents|sensory system agents|mesh-ancestor
110234051|NCT05952050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110234052|NCT05952050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110234053|NCT05952050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110234054|NCT05952050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110234055|NCT05952050|Adrenergic Agents|adrenergic agents|mesh-ancestor
110234056|NCT05952050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110234057|NCT05952050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110234058|NCT05952024|Rituximab|rituximab|mesh-list
110234059|NCT05952024|Acalabrutinib|acalabrutinib|mesh-list
110234060|NCT05952024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110234061|NCT05952024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110234062|NCT05952024|Immunologic Factors|immunologic factors|mesh-ancestor
110234063|NCT05952024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110234064|NCT05952024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110234066|NCT05951959|Venetoclax|venetoclax|mesh-list
110234067|NCT05951959|Acalabrutinib|acalabrutinib|mesh-list
110234068|NCT05951959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110234069|NCT05951959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110234070|NCT05951959|Immunologic Factors|immunologic factors|mesh-ancestor
110234071|NCT05951959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110234072|NCT05951959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110234073|NCT05951842|Anesthetics|anesthetics|mesh-list
110234074|NCT05951842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110234075|NCT05951842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110234076|NCT05951816|Technetium Tc 99m Pyrophosphate|technetium tc 99m pyrophosphate|mesh-list
110234077|NCT05951816|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110234078|NCT05951816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110234080|NCT05951725|Immunologic Factors|immunologic factors|mesh-ancestor
110234081|NCT05951725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110234082|NCT05951686|Remifentanil|remifentanil|mesh-list
110234083|NCT05951686|Propofol|propofol|mesh-list
110234084|NCT05951686|Desflurane|desflurane|mesh-list
110234085|NCT05951686|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110234086|NCT05951686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110234087|NCT05951686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110234088|NCT05951686|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110234089|NCT05951686|Anesthetics, General|anesthetics, general|mesh-ancestor
110234090|NCT05951686|Anesthetics|anesthetics|mesh-ancestor
110234091|NCT05951686|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110234092|NCT05951686|Narcotics|narcotics|mesh-ancestor
110234093|NCT05951686|Analgesics|analgesics|mesh-ancestor
110234094|NCT05951686|Sensory System Agents|sensory system agents|mesh-ancestor
110234095|NCT05951686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110234096|NCT05951686|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110234097|NCT05951569|Insulin|insulin|mesh-list
110234098|NCT05951569|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110234099|NCT05951569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110234100|NCT05951465|Propofol|propofol|mesh-list
110234101|NCT05951465|Esketamine|esketamine|mesh-list
110234102|NCT05951465|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110234103|NCT05951465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110234104|NCT05951465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110234105|NCT05951465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110234106|NCT05951465|Anesthetics, General|anesthetics, general|mesh-ancestor
110266299|NCT00534625|Zileuton|zileuton|mesh-list
110234108|NCT05951465|Antidepressive Agents|antidepressive agents|mesh-ancestor
110234109|NCT05951465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110234110|NCT05951452|Oxytocin|oxytocin|mesh-list
110234111|NCT05951452|Testosterone|testosterone|mesh-list
110234112|NCT05951452|Oxytocics|oxytocics|mesh-ancestor
110234113|NCT05951452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110234114|NCT05951452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110234115|NCT05951452|Androgens|androgens|mesh-ancestor
110234116|NCT05951452|Hormones|hormones|mesh-ancestor
110234117|NCT05951452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110234118|NCT05951413|Sildenafil Citrate|sildenafil citrate|mesh-list
110234119|NCT05951413|Estradiol|estradiol|mesh-list
110234120|NCT05951413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110234121|NCT05951413|Estrogens|estrogens|mesh-ancestor
110234122|NCT05951413|Hormones|hormones|mesh-ancestor
110234123|NCT05951413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110234124|NCT05951413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110234125|NCT05951413|Vasodilator Agents|vasodilator agents|mesh-ancestor
110234126|NCT05951413|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110234127|NCT05951413|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110234128|NCT05951413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110234129|NCT05951413|Urological Agents|urological agents|mesh-ancestor
110234130|NCT05951361|Triamcinolone|triamcinolone|mesh-list
110234131|NCT05951361|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110234132|NCT05951361|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110234133|NCT05951361|Benzocaine|benzocaine|mesh-list
110234134|NCT05951361|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110234135|NCT05951361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110234136|NCT05951361|Glucocorticoids|glucocorticoids|mesh-ancestor
110234137|NCT05951361|Hormones|hormones|mesh-ancestor
110234138|NCT05951361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110234140|NCT05951361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110234141|NCT05951361|Immunologic Factors|immunologic factors|mesh-ancestor
110234142|NCT05951361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110234143|NCT05951361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110234144|NCT05951361|Anesthetics, Local|anesthetics, local|mesh-ancestor
110234145|NCT05951361|Anesthetics|anesthetics|mesh-ancestor
110234146|NCT05951361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110234147|NCT05951361|Sensory System Agents|sensory system agents|mesh-ancestor
110266309|NCT00534625|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110234148|NCT05951361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110234149|NCT05951309|Metformin|metformin|mesh-list
110234150|NCT05951309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110234151|NCT05951309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110234152|NCT05951283|Insulin|insulin|mesh-list
110234153|NCT05951283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110234154|NCT05951283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110234155|NCT05950646|Dexmedetomidine|dexmedetomidine|mesh-list
110234156|NCT05950646|Esketamine|esketamine|mesh-list
110234157|NCT05950646|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110234158|NCT05950646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110234159|NCT05950646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110234160|NCT05950646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110234161|NCT05950646|Analgesics|analgesics|mesh-ancestor
110234162|NCT05950646|Sensory System Agents|sensory system agents|mesh-ancestor
110234163|NCT05950646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110234164|NCT05950646|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110234165|NCT05950646|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110234166|NCT05950646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110234167|NCT05950646|Adrenergic Agents|adrenergic agents|mesh-ancestor
110234168|NCT05950646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110234169|NCT05950646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110234170|NCT05950646|Antidepressive Agents|antidepressive agents|mesh-ancestor
110234171|NCT05950646|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110234172|NCT05949632|Axitinib|axitinib|mesh-list
110234173|NCT05949632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110234174|NCT05949632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110234175|NCT05949632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110234176|NCT05949632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110234177|NCT05949008|Metformin|metformin|mesh-list
110234178|NCT05949008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110234179|NCT05949008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110234180|NCT05947435|Tranexamic Acid|tranexamic acid|mesh-list
110234181|NCT05947435|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110234182|NCT05947435|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110234183|NCT05947435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110234184|NCT05947435|Hemostatics|hemostatics|mesh-ancestor
110234185|NCT05947435|Coagulants|coagulants|mesh-ancestor
110234186|NCT05936671|Remifentanil|remifentanil|mesh-list
110234187|NCT05936671|Anesthetics|anesthetics|mesh-list
110234188|NCT05936671|Sevoflurane|sevoflurane|mesh-list
110234189|NCT05936671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110234190|NCT05936671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110234203|NCT05933499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110234204|NCT05933499|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110234205|NCT05933499|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110234206|NCT05925179|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110234207|NCT05925179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110234213|NCT05921968|Lactoferrin|lactoferrin|mesh-list
110234214|NCT05921968|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
110234215|NCT05921968|Trace Elements|trace elements|mesh-ancestor
110234216|NCT05921968|Micronutrients|micronutrients|mesh-ancestor
110234217|NCT05921968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110234218|NCT05921968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110234219|NCT05921968|Hematinics|hematinics|mesh-ancestor
110234230|NCT05904379|Paclitaxel|paclitaxel|mesh-list
110234231|NCT05904379|Docetaxel|docetaxel|mesh-list
110234232|NCT05904379|Pemetrexed|pemetrexed|mesh-list
110234233|NCT05904379|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110234234|NCT05904379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110234235|NCT05904379|Tubulin Modulators|tubulin modulators|mesh-ancestor
110234236|NCT05904379|Antimitotic Agents|antimitotic agents|mesh-ancestor
110234237|NCT05904379|Mitosis Modulators|mitosis modulators|mesh-ancestor
110234238|NCT05904379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110234239|NCT05904379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110234240|NCT05904379|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110234241|NCT05904379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110234242|NCT05901974|Venetoclax|venetoclax|mesh-list
110234243|NCT05901974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110234244|NCT05901467|Hormones|hormones|mesh-list
110234245|NCT05901467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110234246|NCT05901467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110234247|NCT05890898|Nitrous Oxide|nitrous oxide|mesh-list
110234248|NCT05890898|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110234249|NCT05890898|Anesthetics, General|anesthetics, general|mesh-ancestor
110234250|NCT05890898|Anesthetics|anesthetics|mesh-ancestor
110234251|NCT05890898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110234252|NCT05890898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110234253|NCT05890898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110234254|NCT05890898|Analgesics|analgesics|mesh-ancestor
110234255|NCT05890898|Sensory System Agents|sensory system agents|mesh-ancestor
110234256|NCT05890898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110234261|NCT05871333|Losartan|losartan|mesh-list
110234262|NCT05871333|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110234263|NCT05871333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110234264|NCT05871333|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110234265|NCT05871333|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110234266|NCT05871333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110234267|NCT05860933|Itraconazole|itraconazole|mesh-list
110234268|NCT05860933|Carbamazepine|carbamazepine|mesh-list
110234269|NCT05860933|Antifungal Agents|antifungal agents|mesh-ancestor
110234270|NCT05860933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110234271|NCT05860933|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110234272|NCT05860933|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110234273|NCT05860933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110234274|NCT05860933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110234275|NCT05860933|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110234276|NCT05860933|Hormone Antagonists|hormone antagonists|mesh-ancestor
110234277|NCT05860933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110234278|NCT05860933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110234279|NCT05860933|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110234280|NCT05860933|Anticonvulsants|anticonvulsants|mesh-ancestor
110234281|NCT05860933|Antimanic Agents|antimanic agents|mesh-ancestor
110234282|NCT05860933|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110234283|NCT05860933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110234284|NCT05860933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110234285|NCT05860933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110234287|NCT05860933|Sensory System Agents|sensory system agents|mesh-ancestor
110234288|NCT05860933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110234289|NCT05860933|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110234290|NCT05860933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110234291|NCT05860933|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110234292|NCT05860933|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110234293|NCT05846750|Lenalidomide|lenalidomide|mesh-list
110234294|NCT05846750|Obinutuzumab|obinutuzumab|mesh-list
110234295|NCT05846750|Immunologic Factors|immunologic factors|mesh-ancestor
110234296|NCT05846750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110234297|NCT05846750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110234298|NCT05846750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110234299|NCT05846750|Growth Substances|growth substances|mesh-ancestor
110234300|NCT05846750|Growth Inhibitors|growth inhibitors|mesh-ancestor
110234301|NCT05846750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110234302|NCT05846750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110234304|NCT05819892|Cisplatin|cisplatin|mesh-list
110234305|NCT05819892|Carboplatin|carboplatin|mesh-list
110234306|NCT05819892|Dostarlimab|dostarlimab|mesh-list
110234307|NCT05819892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110234308|NCT05819892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110234310|NCT05819892|Antimitotic Agents|antimitotic agents|mesh-ancestor
110234311|NCT05819892|Mitosis Modulators|mitosis modulators|mesh-ancestor
110234312|NCT05819892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110234314|NCT05811390|Vasodilator Agents|vasodilator agents|mesh-ancestor
110234315|NCT05794997|Propranolol|propranolol|mesh-list
110234316|NCT05794997|Atenolol|atenolol|mesh-list
110234317|NCT05794997|Sotalol|sotalol|mesh-list
110234318|NCT05794997|Carvedilol|carvedilol|mesh-list
110234319|NCT05794997|Bisoprolol|bisoprolol|mesh-list
110234320|NCT05794997|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110234321|NCT05794997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110234322|NCT05794997|Adrenergic Agents|adrenergic agents|mesh-ancestor
110234323|NCT05794997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110234324|NCT05794997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110234325|NCT05794997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110234326|NCT05794997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110234327|NCT05794997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110234328|NCT05794997|Vasodilator Agents|vasodilator agents|mesh-ancestor
110234329|NCT05794997|Antioxidants|antioxidants|mesh-ancestor
110234330|NCT05794997|Protective Agents|protective agents|mesh-ancestor
110234331|NCT05794997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110234332|NCT05794997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110234333|NCT05794997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110234334|NCT05794997|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110234338|NCT05794997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110234339|NCT05794997|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110234340|NCT05794828|Bupivacaine|bupivacaine|mesh-list
110234341|NCT05794828|Anesthetics, Local|anesthetics, local|mesh-ancestor
110234342|NCT05794828|Anesthetics|anesthetics|mesh-ancestor
110234343|NCT05794828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110234344|NCT05794828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110234345|NCT05794828|Sensory System Agents|sensory system agents|mesh-ancestor
110234346|NCT05794828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110234347|NCT05789524|Protein C|protein c|mesh-list
110234348|NCT05789524|Anticoagulants|anticoagulants|mesh-ancestor
110234349|NCT05789524|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110234350|NCT05789524|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110234351|NCT05789524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110234352|NCT05752526|Diclofenac|diclofenac|mesh-list
110234353|NCT05752526|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110234354|NCT05752526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110234355|NCT05752526|Analgesics|analgesics|mesh-ancestor
110234356|NCT05752526|Sensory System Agents|sensory system agents|mesh-ancestor
110234357|NCT05752526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110234358|NCT05752526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110234359|NCT05752526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110234360|NCT05752526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110234361|NCT05752526|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110234362|NCT05752526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110234363|NCT05752526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110234364|NCT05742399|Hyaluronic Acid|hyaluronic acid|mesh-list
110234365|NCT05742399|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110234366|NCT05742399|Immunologic Factors|immunologic factors|mesh-ancestor
110234367|NCT05742399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110234368|NCT05742399|Viscosupplements|viscosupplements|mesh-ancestor
110234369|NCT05742399|Protective Agents|protective agents|mesh-ancestor
110234370|NCT05734560|D2C7-(scdsFv)-PE38KDEL|d2c7-(scdsfv)-pe38kdel|mesh-list
110234371|NCT05734560|Immunoconjugates|immunoconjugates|mesh-ancestor
110234372|NCT05734560|Immunologic Factors|immunologic factors|mesh-ancestor
110234373|NCT05734560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110234374|NCT05726110|Cytarabine|cytarabine|mesh-list
110234375|NCT05726110|Daunorubicin|daunorubicin|mesh-list
110234376|NCT05726110|Homoharringtonine|homoharringtonine|mesh-list
110234377|NCT05726110|Aclacinomycins|aclacinomycins|mesh-list
110234378|NCT05726110|Lenograstim|lenograstim|mesh-list
110234379|NCT05726110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110234380|NCT05726110|Antimetabolites|antimetabolites|mesh-ancestor
110234381|NCT05726110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110234382|NCT05726110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110234383|NCT05726110|Antiviral Agents|antiviral agents|mesh-ancestor
110234384|NCT05726110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110234385|NCT05726110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110234386|NCT05726110|Immunologic Factors|immunologic factors|mesh-ancestor
110234387|NCT05726110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110234388|NCT05726110|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110234389|NCT05726110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110234390|NCT05726110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110234391|NCT05726110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110234392|NCT05726110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110234393|NCT05726110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110234394|NCT05726110|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110234395|NCT05716516|Estradiol|estradiol|mesh-list
110234396|NCT05716516|Estrogens|estrogens|mesh-ancestor
110234397|NCT05716516|Hormones|hormones|mesh-ancestor
110234398|NCT05716516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110234399|NCT05716516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110234406|NCT05679024|Apixaban|apixaban|mesh-list
110234407|NCT05679024|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110234408|NCT05679024|Antithrombins|antithrombins|mesh-ancestor
110234409|NCT05679024|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110234410|NCT05679024|Protease Inhibitors|protease inhibitors|mesh-ancestor
110234411|NCT05679024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110234412|NCT05679024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110234413|NCT05679024|Anticoagulants|anticoagulants|mesh-ancestor
110234414|NCT05645718|Cytarabine|cytarabine|mesh-list
110234415|NCT05645718|Dexamethasone|dexamethasone|mesh-list
110234416|NCT05645718|Prednisone|prednisone|mesh-list
110234417|NCT05645718|Cyclophosphamide|cyclophosphamide|mesh-list
110234418|NCT05645718|Rituximab|rituximab|mesh-list
110234419|NCT05645718|Methotrexate|methotrexate|mesh-list
110234420|NCT05645718|Vincristine|vincristine|mesh-list
110234421|NCT05645718|Mercaptopurine|mercaptopurine|mesh-list
110234422|NCT05645718|Blinatumomab|blinatumomab|mesh-list
110234423|NCT05645718|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
110234424|NCT05645718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110234425|NCT05645718|Immunologic Factors|immunologic factors|mesh-ancestor
110234426|NCT05645718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110234427|NCT05645718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110234428|NCT05645718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110234429|NCT05645718|Alkylating Agents|alkylating agents|mesh-ancestor
110234430|NCT05645718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110234431|NCT05645718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110234432|NCT05645718|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110234433|NCT05645718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110234434|NCT05645718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110234436|NCT05645718|Autonomic Agents|autonomic agents|mesh-ancestor
110234437|NCT05645718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110234438|NCT05645718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110234439|NCT05645718|Glucocorticoids|glucocorticoids|mesh-ancestor
110234440|NCT05645718|Hormones|hormones|mesh-ancestor
110234441|NCT05645718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110234442|NCT05645718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110234443|NCT05645718|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110234444|NCT05645718|Abortifacient Agents|abortifacient agents|mesh-ancestor
110234445|NCT05645718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110234446|NCT05645718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110234447|NCT05645718|Antimetabolites|antimetabolites|mesh-ancestor
110234448|NCT05645718|Dermatologic Agents|dermatologic agents|mesh-ancestor
110234449|NCT05645718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110234450|NCT05645718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110234451|NCT05645718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110234452|NCT05645718|Antiviral Agents|antiviral agents|mesh-ancestor
110234459|NCT05645718|Immunotoxins|immunotoxins|mesh-ancestor
110234460|NCT05645718|Immunoconjugates|immunoconjugates|mesh-ancestor
110234461|NCT05641298|Fusidic Acid|fusidic acid|mesh-list
110234462|NCT05641298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110234463|NCT05641298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110234464|NCT05641298|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110234465|NCT05641298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110234466|NCT05641298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110234468|NCT05635370|Pentoxifylline|pentoxifylline|mesh-list
110234469|NCT05635370|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110234470|NCT05635370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110234471|NCT05635370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110234472|NCT05635370|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110266366|NCT00406952|Serotonin Agents|serotonin agents|mesh-ancestor
110234473|NCT05635370|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110234474|NCT05635370|Protective Agents|protective agents|mesh-ancestor
110234475|NCT05635370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110234476|NCT05635370|Vasodilator Agents|vasodilator agents|mesh-ancestor
110234477|NCT05635370|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110234479|NCT05635370|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110234480|NCT05635370|Autonomic Agents|autonomic agents|mesh-ancestor
110234481|NCT05635370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110234482|NCT05635370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110234483|NCT05635370|Respiratory System Agents|respiratory system agents|mesh-ancestor
110234484|NCT05635370|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110234485|NCT05635370|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110234486|NCT05635370|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110234487|NCT05635370|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110234488|NCT05635357|Letrozole|letrozole|mesh-list
110234489|NCT05635357|Anastrozole|anastrozole|mesh-list
110234490|NCT05635357|Exemestane|exemestane|mesh-list
110234491|NCT05635357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110234492|NCT05635357|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110234493|NCT05635357|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110234494|NCT05635357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110234495|NCT05635357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110234496|NCT05635357|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110234497|NCT05635357|Hormone Antagonists|hormone antagonists|mesh-ancestor
110234498|NCT05635357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110234499|NCT05635357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110234500|NCT05635357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110234501|NCT05633966|Hormones|hormones|mesh-list
110234502|NCT05633966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110234503|NCT05633966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110234505|NCT05614089|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110234506|NCT05614089|Insulin Glargine|insulin glargine|mesh-list
110234507|NCT05614089|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110234508|NCT05614089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110234509|NCT05559931|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
110234510|NCT05559931|Hallucinogens|hallucinogens|mesh-ancestor
110234511|NCT05559931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110234512|NCT05559931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110234513|NCT05559931|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110234519|NCT05559879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110234520|NCT05491083|Pembrolizumab|pembrolizumab|mesh-list
110234521|NCT05491083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110234522|NCT05491083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110234523|NCT05491083|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110234524|NCT05491083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110234525|NCT05481112|Buprenorphine|buprenorphine|mesh-list
110234526|NCT05481112|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110234527|NCT05481112|Narcotics|narcotics|mesh-ancestor
110234528|NCT05481112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110234529|NCT05481112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110234530|NCT05481112|Analgesics|analgesics|mesh-ancestor
110234531|NCT05481112|Sensory System Agents|sensory system agents|mesh-ancestor
110234532|NCT05481112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110234533|NCT05481112|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110234535|NCT05473585|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110234536|NCT05473585|Autonomic Agents|autonomic agents|mesh-ancestor
110234537|NCT05473585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110234538|NCT05473585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110234539|NCT05473585|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110234540|NCT05473585|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110234541|NCT05473585|Cholinergic Agents|cholinergic agents|mesh-ancestor
110234542|NCT05473585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110234543|NCT05473585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110234544|NCT05457855|Fluticasone|fluticasone|mesh-list
110234545|NCT05457855|Montelukast|montelukast|mesh-list
110234546|NCT05457855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110234547|NCT05457855|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110234549|NCT05457855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110234550|NCT05457855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110234551|NCT05457855|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110234552|NCT05457855|Respiratory System Agents|respiratory system agents|mesh-ancestor
110234553|NCT05457855|Dermatologic Agents|dermatologic agents|mesh-ancestor
110234554|NCT05457855|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110234555|NCT05457855|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110234556|NCT05457855|Hormone Antagonists|hormone antagonists|mesh-ancestor
110234557|NCT05457855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110234558|NCT05457855|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110234559|NCT05457855|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110234560|NCT05457855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110234561|NCT05381948|Aflibercept|aflibercept|mesh-list
110234562|NCT05381948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110234564|NCT05381948|Growth Substances|growth substances|mesh-ancestor
110234565|NCT05381948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110234566|NCT05381948|Growth Inhibitors|growth inhibitors|mesh-ancestor
110234567|NCT05381948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110234568|NCT05379491|Linaclotide|linaclotide|mesh-list
110234569|NCT05379491|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
110234570|NCT05379491|Enzyme Activators|enzyme activators|mesh-ancestor
110234571|NCT05379491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110234572|NCT05379491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110234573|NCT05376111|Azacitidine|azacitidine|mesh-list
110234574|NCT05376111|Venetoclax|venetoclax|mesh-list
110234575|NCT05376111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110234576|NCT05376111|Antimetabolites|antimetabolites|mesh-ancestor
110234577|NCT05376111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110234578|NCT05376111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110234579|NCT05376111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110234580|NCT05363670|Albuterol|albuterol|mesh-list
110234581|NCT05363670|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110234582|NCT05363670|Autonomic Agents|autonomic agents|mesh-ancestor
110234583|NCT05363670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110234584|NCT05363670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110234585|NCT05363670|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110266396|NCT04061161|Bromides|bromides|mesh-list
110234586|NCT05363670|Respiratory System Agents|respiratory system agents|mesh-ancestor
110234587|NCT05363670|Tocolytic Agents|tocolytic agents|mesh-ancestor
110234588|NCT05363670|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110234589|NCT05363670|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110234590|NCT05363670|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110234591|NCT05363670|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110234592|NCT05363670|Adrenergic Agents|adrenergic agents|mesh-ancestor
110234593|NCT05363670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110234594|NCT05363670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110234595|NCT05343312|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110234596|NCT05343312|Antimalarials|antimalarials|mesh-ancestor
110234597|NCT05343312|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110234598|NCT05343312|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110234599|NCT05343312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110234601|NCT05322902|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110234602|NCT05322902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110234603|NCT05322902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110234604|NCT05322902|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110234605|NCT05322902|Anesthetics, General|anesthetics, general|mesh-ancestor
110234606|NCT05322902|Anesthetics|anesthetics|mesh-ancestor
110234607|NCT05291299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110234608|NCT05287906|Cardiac Glycosides|cardiac glycosides|mesh-list
110234609|NCT05287906|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110234610|NCT05287906|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110234611|NCT05287906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110234612|NCT05287906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110234613|NCT05287906|Protective Agents|protective agents|mesh-ancestor
110234614|NCT05287906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110234615|NCT05286060|Pembrolizumab|pembrolizumab|mesh-list
110234616|NCT05286060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110234617|NCT05286060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110234618|NCT05286060|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110234619|NCT05286060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110234620|NCT05253833|Allopurinol|allopurinol|mesh-list
110234622|NCT05253833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110234623|NCT05253833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110234624|NCT05253833|Gout Suppressants|gout suppressants|mesh-ancestor
110234625|NCT05253833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110234626|NCT05253833|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110234628|NCT05253833|Protective Agents|protective agents|mesh-ancestor
110234629|NCT05253833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110234630|NCT05242458|Ustekinumab|ustekinumab|mesh-list
110234631|NCT05242458|Dermatologic Agents|dermatologic agents|mesh-ancestor
110234633|NCT05222971|Olaparib|olaparib|mesh-list
110234634|NCT05222971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110234635|NCT05222971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110234636|NCT05222971|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110234637|NCT05222971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110234638|NCT05222971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110234639|NCT05170893|Ubiquinone|ubiquinone|mesh-list
110234640|NCT05170893|Coenzyme Q10|coenzyme q10|mesh-list
110234641|NCT05170893|Micronutrients|micronutrients|mesh-ancestor
110061711|NCT05603702|Lacosamide|lacosamide|mesh-list
110234642|NCT05170893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110234644|NCT05167864|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110234645|NCT05167864|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
110234646|NCT05167864|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110234647|NCT05167864|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110234648|NCT05167864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110266410|NCT00157586|Manidipine|manidipine|mesh-list
110234649|NCT05167864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110234650|NCT05167864|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110234651|NCT05167864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110234652|NCT05167864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110234653|NCT05167864|Cholinergic Agents|cholinergic agents|mesh-ancestor
110234654|NCT05167864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110234655|NCT05125276|Aspirin|aspirin|mesh-list
110234656|NCT05125276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110234657|NCT05125276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110234658|NCT05125276|Analgesics|analgesics|mesh-ancestor
110234659|NCT05125276|Sensory System Agents|sensory system agents|mesh-ancestor
110234660|NCT05125276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110234661|NCT05125276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110234662|NCT05125276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110234663|NCT05125276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110234664|NCT05125276|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110234665|NCT05125276|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110234666|NCT05125276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110234667|NCT05125276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110234668|NCT05125276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110234669|NCT05125276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110234670|NCT05125276|Antipyretics|antipyretics|mesh-ancestor
110234671|NCT05083780|Hydroxychloroquine|hydroxychloroquine|mesh-list
110234672|NCT05083780|Chlorphenesin|chlorphenesin|mesh-list
110234673|NCT05083780|Antimalarials|antimalarials|mesh-ancestor
110234674|NCT05083780|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110234675|NCT05083780|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110234676|NCT05083780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110234677|NCT05083780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110234678|NCT05083780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110234679|NCT05083780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110234680|NCT05083780|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110234681|NCT05083780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110234682|NCT05083780|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110234683|NCT05083780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110234684|NCT05074823|Ketamine|ketamine|mesh-list
110234685|NCT05074823|Analgesics|analgesics|mesh-ancestor
110234687|NCT05074823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110234688|NCT05074823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110234689|NCT05074823|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110234690|NCT05074823|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110234692|NCT05074823|Anesthetics|anesthetics|mesh-ancestor
110234693|NCT05074823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110234694|NCT05074823|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110234695|NCT05074823|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110234696|NCT05074823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110234697|NCT05074823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110234698|NCT05059600|Pregnanolone|pregnanolone|mesh-list
110234699|NCT05059600|Brexanolone|brexanolone|mesh-list
110234700|NCT05059600|Anesthetics|anesthetics|mesh-ancestor
110234701|NCT05059600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110234702|NCT05059600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110234703|NCT05059600|Neurosteroids|neurosteroids|mesh-ancestor
110234704|NCT05059600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110234705|NCT05059600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110234706|NCT05059600|GABA Modulators|gaba modulators|mesh-ancestor
110234707|NCT05059600|GABA Agents|gaba agents|mesh-ancestor
110234708|NCT05049902|Amoxicillin|amoxicillin|mesh-list
110234709|NCT05049902|Metronidazole|metronidazole|mesh-list
110234710|NCT05049902|Clarithromycin|clarithromycin|mesh-list
110234711|NCT05049902|Tetracycline|tetracycline|mesh-list
110234712|NCT05049902|Potassium Citrate|potassium citrate|mesh-list
110234713|NCT05049902|Bismuth|bismuth|mesh-list
110266411|NCT00157586|Delapril|delapril|mesh-list
110234714|NCT05049902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110061847|NCT05548296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110234715|NCT05049902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110234716|NCT05049902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110234718|NCT05049902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110234719|NCT05049902|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110234720|NCT05049902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110234721|NCT05049902|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110234722|NCT05049902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110234723|NCT05049902|Antacids|antacids|mesh-ancestor
110234724|NCT05049902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110234725|NCT05049902|Diuretics|diuretics|mesh-ancestor
110234726|NCT05049902|Natriuretic Agents|natriuretic agents|mesh-ancestor
110234727|NCT05049902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110234728|NCT05049902|Expectorants|expectorants|mesh-ancestor
110234729|NCT05049902|Respiratory System Agents|respiratory system agents|mesh-ancestor
110234730|NCT05026593|Carboplatin|carboplatin|mesh-list
110234731|NCT05026593|Etoposide|etoposide|mesh-list
110234732|NCT05026593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110234733|NCT05026593|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110234734|NCT05026593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110234735|NCT05026593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110234736|NCT05026593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110234737|NCT05026593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110234739|NCT04977986|Anticonvulsants|anticonvulsants|mesh-ancestor
110234740|NCT04976855|Buprenorphine|buprenorphine|mesh-list
110234741|NCT04976855|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
110234742|NCT04976855|Naloxone|naloxone|mesh-list
110234743|NCT04976855|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110234744|NCT04976855|Narcotics|narcotics|mesh-ancestor
110234745|NCT04976855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110234746|NCT04976855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110234748|NCT04976855|Sensory System Agents|sensory system agents|mesh-ancestor
110234749|NCT04976855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110234750|NCT04976855|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110234751|NCT04974398|Cisplatin|cisplatin|mesh-list
110234752|NCT04974398|Gemcitabine|gemcitabine|mesh-list
110234753|NCT04974398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110234754|NCT04974398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110234755|NCT04974398|Antimetabolites|antimetabolites|mesh-ancestor
110234756|NCT04974398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110234757|NCT04971785|Firsocostat|firsocostat|mesh-list
110234758|NCT04971785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110234759|NCT04971785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110234760|NCT04971109|Tecovirimat|tecovirimat|mesh-list
110234761|NCT04971109|Antiviral Agents|antiviral agents|mesh-ancestor
110234762|NCT04971109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110234764|NCT04957485|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
110234765|NCT04957485|Antiviral Agents|antiviral agents|mesh-ancestor
110234766|NCT04957485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110234767|NCT04943900|Nivolumab|nivolumab|mesh-list
110234768|NCT04943900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110234769|NCT04943900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110234770|NCT04943900|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110234771|NCT04943900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110234772|NCT04833959|Panitumumab|panitumumab|mesh-list
110234773|NCT04833959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110234774|NCT04833959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110234775|NCT04795661|Pembrolizumab|pembrolizumab|mesh-list
110234776|NCT04795661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110266423|NCT00182871|Hormones|hormones|mesh-ancestor
110234777|NCT04795661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110234778|NCT04795661|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110234779|NCT04795661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110234781|NCT04793906|Trace Elements|trace elements|mesh-ancestor
110234782|NCT04793906|Micronutrients|micronutrients|mesh-ancestor
110234783|NCT04793906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110234784|NCT04784715|Trastuzumab|trastuzumab|mesh-list
110234785|NCT04784715|Pertuzumab|pertuzumab|mesh-list
110234787|NCT04784715|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
110234788|NCT04784715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110234789|NCT04784715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110234790|NCT04784715|Immunoconjugates|immunoconjugates|mesh-ancestor
110234791|NCT04784715|Immunologic Factors|immunologic factors|mesh-ancestor
110234792|NCT04784715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110234794|NCT04716413|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110234795|NCT04716413|Narcotics|narcotics|mesh-ancestor
110234796|NCT04716413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110234797|NCT04716413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110234798|NCT04716413|Analgesics|analgesics|mesh-ancestor
110234799|NCT04716413|Sensory System Agents|sensory system agents|mesh-ancestor
110234800|NCT04716413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110234802|NCT04696042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110234803|NCT04684212|Warfarin|warfarin|mesh-list
110234804|NCT04684212|Rivaroxaban|rivaroxaban|mesh-list
110234805|NCT04684212|Dabigatran|dabigatran|mesh-list
110234806|NCT04684212|Edoxaban|edoxaban|mesh-list
110234807|NCT04684212|Apixaban|apixaban|mesh-list
110234808|NCT04684212|Betrixaban|betrixaban|mesh-list
110234809|NCT04684212|Anticoagulants|anticoagulants|mesh-ancestor
110234810|NCT04684212|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110234811|NCT04684212|Antithrombins|antithrombins|mesh-ancestor
110234812|NCT04684212|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110234813|NCT04684212|Protease Inhibitors|protease inhibitors|mesh-ancestor
110234814|NCT04684212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110234815|NCT04684212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110234816|NCT04635189|Dexamethasone|dexamethasone|mesh-list
110234817|NCT04635189|Lenalidomide|lenalidomide|mesh-list
110234818|NCT04635189|Daratumumab|daratumumab|mesh-list
110234819|NCT04635189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110234820|NCT04635189|Antiemetics|antiemetics|mesh-ancestor
110234821|NCT04635189|Autonomic Agents|autonomic agents|mesh-ancestor
110234822|NCT04635189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110234823|NCT04635189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110234824|NCT04635189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110234825|NCT04635189|Glucocorticoids|glucocorticoids|mesh-ancestor
110234827|NCT04635189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110234828|NCT04635189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110234829|NCT04635189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110234830|NCT04635189|Immunologic Factors|immunologic factors|mesh-ancestor
110234831|NCT04635189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110234832|NCT04635189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110234833|NCT04635189|Growth Substances|growth substances|mesh-ancestor
110234834|NCT04635189|Growth Inhibitors|growth inhibitors|mesh-ancestor
110234835|NCT04608448|Sirolimus|sirolimus|mesh-list
110234836|NCT04608448|Petrolatum|petrolatum|mesh-list
110234837|NCT04608448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110234838|NCT04608448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110234839|NCT04608448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110234840|NCT04608448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110234841|NCT04608448|Antifungal Agents|antifungal agents|mesh-ancestor
110234842|NCT04608448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110234843|NCT04608448|Immunologic Factors|immunologic factors|mesh-ancestor
110234844|NCT04608448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110234845|NCT04608448|Emollients|emollients|mesh-ancestor
110234847|NCT04592653|Pembrolizumab|pembrolizumab|mesh-list
110234848|NCT04592653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110234849|NCT04592653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110234850|NCT04592653|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110234851|NCT04592653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110234852|NCT04562285|Antibodies|antibodies|mesh-list
110234853|NCT04562285|Immunologic Factors|immunologic factors|mesh-ancestor
110234854|NCT04562285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110234855|NCT04528004|Niacinamide|niacinamide|mesh-list
110234857|NCT04528004|Nicotinic Acids|nicotinic acids|mesh-list
110234858|NCT04528004|Vitamin B Complex|vitamin b complex|mesh-ancestor
110234859|NCT04528004|Vitamins|vitamins|mesh-ancestor
110234860|NCT04528004|Micronutrients|micronutrients|mesh-ancestor
110234861|NCT04528004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110234862|NCT04528004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110234863|NCT04528004|Antimetabolites|antimetabolites|mesh-ancestor
110234864|NCT04528004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110234865|NCT04528004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110234866|NCT04528004|Vasodilator Agents|vasodilator agents|mesh-ancestor
110234867|NCT04500899|Phenylephrine|phenylephrine|mesh-list
110234868|NCT04500899|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110234869|NCT04500899|Mydriatics|mydriatics|mesh-ancestor
110234870|NCT04500899|Autonomic Agents|autonomic agents|mesh-ancestor
110234871|NCT04500899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110234872|NCT04500899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110234873|NCT04500899|Sympathomimetics|sympathomimetics|mesh-ancestor
110234874|NCT04500899|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110234875|NCT04500899|Nasal Decongestants|nasal decongestants|mesh-ancestor
110234876|NCT04500899|Respiratory System Agents|respiratory system agents|mesh-ancestor
110234877|NCT04500899|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110234878|NCT04500899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110234879|NCT04500899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110234880|NCT04500899|Adrenergic Agents|adrenergic agents|mesh-ancestor
110234881|NCT04500899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110234882|NCT04500899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110234883|NCT04500899|Protective Agents|protective agents|mesh-ancestor
110234884|NCT04485039|Tecovirimat|tecovirimat|mesh-list
110234885|NCT04485039|Sevelamer|sevelamer|mesh-list
110234886|NCT04485039|Calcium acetate|calcium acetate|mesh-list
110234887|NCT04485039|Chelating Agents|chelating agents|mesh-ancestor
110234888|NCT04485039|Sequestering Agents|sequestering agents|mesh-ancestor
110234889|NCT04485039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110234890|NCT04485039|Antiviral Agents|antiviral agents|mesh-ancestor
110234891|NCT04485039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110234892|NCT04428671|Cemiplimab|cemiplimab|mesh-list
110234893|NCT04428671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110234894|NCT04428671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110234895|NCT04413890|Dinoprostone|dinoprostone|mesh-list
110234896|NCT04413890|Oxytocics|oxytocics|mesh-ancestor
110234897|NCT04413890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110234898|NCT04413890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110234900|NCT04318405|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
110234901|NCT04318405|Trace Elements|trace elements|mesh-ancestor
110234909|NCT04313790|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110234910|NCT04313790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110234912|NCT04293393|Docetaxel|docetaxel|mesh-list
110234913|NCT04293393|Cyclophosphamide|cyclophosphamide|mesh-list
110234914|NCT04293393|Doxorubicin|doxorubicin|mesh-list
110234915|NCT04293393|Letrozole|letrozole|mesh-list
110234916|NCT04293393|Leuprolide|leuprolide|mesh-list
110234917|NCT04293393|Goserelin|goserelin|mesh-list
110234918|NCT04293393|Taxane|taxane|mesh-list
110234919|NCT04293393|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110234920|NCT04293393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110234921|NCT04293393|Tubulin Modulators|tubulin modulators|mesh-ancestor
110234922|NCT04293393|Antimitotic Agents|antimitotic agents|mesh-ancestor
110234923|NCT04293393|Mitosis Modulators|mitosis modulators|mesh-ancestor
110234924|NCT04293393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110234925|NCT04293393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110234926|NCT04293393|Immunologic Factors|immunologic factors|mesh-ancestor
110234927|NCT04293393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110234928|NCT04293393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110234929|NCT04293393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110234930|NCT04293393|Alkylating Agents|alkylating agents|mesh-ancestor
110234931|NCT04293393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110234932|NCT04293393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110234933|NCT04293393|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110234934|NCT04293393|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110234935|NCT04293393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110234936|NCT04293393|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110234937|NCT04293393|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110234938|NCT04293393|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110234939|NCT04293393|Hormone Antagonists|hormone antagonists|mesh-ancestor
110234940|NCT04293393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110234941|NCT04293393|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110234942|NCT04293393|Fertility Agents|fertility agents|mesh-ancestor
110234943|NCT04293393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110234944|NCT04293393|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110234945|NCT04285567|Cyclophosphamide|cyclophosphamide|mesh-list
110234946|NCT04285567|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110234947|NCT04285567|Rituximab|rituximab|mesh-list
110234948|NCT04285567|Fludarabine|fludarabine|mesh-list
110234949|NCT04285567|Venetoclax|venetoclax|mesh-list
110234950|NCT04285567|Obinutuzumab|obinutuzumab|mesh-list
110234951|NCT04285567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110234952|NCT04285567|Immunologic Factors|immunologic factors|mesh-ancestor
110234953|NCT04285567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110234954|NCT04285567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110234955|NCT04285567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110234956|NCT04285567|Alkylating Agents|alkylating agents|mesh-ancestor
110234957|NCT04285567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110234958|NCT04285567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110234959|NCT04285567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110234960|NCT04285567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110234961|NCT04276480|Tazobactam|tazobactam|mesh-list
110234962|NCT04276480|Piperacillin|piperacillin|mesh-list
110234963|NCT04276480|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
110234964|NCT04276480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110234965|NCT04276480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110234966|NCT04276480|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110234967|NCT04276480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110234968|NCT04276480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110234969|NCT04263896|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
110234970|NCT04263896|Laxatives|laxatives|mesh-ancestor
110234971|NCT04263896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110234972|NCT04182373|Antithrombins|antithrombins|mesh-list
110234973|NCT04182373|Antithrombin III|antithrombin iii|mesh-list
110234974|NCT04182373|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110234975|NCT04182373|Protease Inhibitors|protease inhibitors|mesh-ancestor
110234976|NCT04182373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110234977|NCT04182373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110234978|NCT04182373|Anticoagulants|anticoagulants|mesh-ancestor
110234979|NCT04161898|Prednisolone|prednisolone|mesh-list
110234980|NCT04161898|Upadacitinib|upadacitinib|mesh-list
110234981|NCT04161898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110234982|NCT04161898|Glucocorticoids|glucocorticoids|mesh-ancestor
110234983|NCT04161898|Hormones|hormones|mesh-ancestor
110234984|NCT04161898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110234985|NCT04161898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110234986|NCT04161898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110234987|NCT04161898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110234988|NCT04161898|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110234989|NCT04161898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110234990|NCT04161898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110234991|NCT04161898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110234992|NCT04161898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110234993|NCT04153487|Ascorbic Acid|ascorbic acid|mesh-list
110234994|NCT04153487|Vitamins|vitamins|mesh-ancestor
110234995|NCT04153487|Micronutrients|micronutrients|mesh-ancestor
110234996|NCT04153487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110234997|NCT04153487|Antioxidants|antioxidants|mesh-ancestor
110234998|NCT04153487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110234999|NCT04153487|Protective Agents|protective agents|mesh-ancestor
110235001|NCT04153032|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110235002|NCT04153032|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110235003|NCT04153032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110235004|NCT04153032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110235005|NCT04153032|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110235006|NCT04153032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110235007|NCT04153032|Vasodilator Agents|vasodilator agents|mesh-ancestor
110235008|NCT04116437|Zanubrutinib|zanubrutinib|mesh-list
110235009|NCT04116437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110235010|NCT04116437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110235011|NCT04116437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110235012|NCT04116437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110235013|NCT04092179|Venetoclax|venetoclax|mesh-list
110235014|NCT04092179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110235015|NCT04065841|Licogliflozin|licogliflozin|mesh-list
110235016|NCT04065841|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110235017|NCT04065841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110235018|NCT04065841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110235019|NCT04065841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110235020|NCT03895567|Ceftriaxone|ceftriaxone|mesh-list
110235021|NCT03895567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110235022|NCT03895567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110235024|NCT03800134|Cisplatin|cisplatin|mesh-list
110235025|NCT03800134|Carboplatin|carboplatin|mesh-list
110235026|NCT03800134|Gemcitabine|gemcitabine|mesh-list
110235027|NCT03800134|Pemetrexed|pemetrexed|mesh-list
110235028|NCT03800134|Durvalumab|durvalumab|mesh-list
110235029|NCT03800134|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110235030|NCT03800134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110235031|NCT03800134|Tubulin Modulators|tubulin modulators|mesh-ancestor
110235032|NCT03800134|Antimitotic Agents|antimitotic agents|mesh-ancestor
110235033|NCT03800134|Mitosis Modulators|mitosis modulators|mesh-ancestor
110235034|NCT03800134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110235035|NCT03800134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110235036|NCT03800134|Antimetabolites|antimetabolites|mesh-ancestor
110235037|NCT03800134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110235038|NCT03800134|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110235039|NCT03800134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110235040|NCT03800134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110235042|NCT03774810|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110235043|NCT03774810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110235044|NCT03774810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110235045|NCT03774810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110235046|NCT03774810|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110235048|NCT03774810|GABA Agents|gaba agents|mesh-ancestor
110235049|NCT03774810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110235050|NCT03774810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110235051|NCT03688178|Temozolomide|temozolomide|mesh-list
110235052|NCT03688178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110235053|NCT03688178|Alkylating Agents|alkylating agents|mesh-ancestor
110235054|NCT03688178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110235055|NCT03688178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110235057|NCT03678883|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110235058|NCT03678883|Carboplatin|carboplatin|mesh-list
110235059|NCT03678883|Gemcitabine|gemcitabine|mesh-list
110235060|NCT03678883|Doxorubicin|doxorubicin|mesh-list
110235061|NCT03678883|Irinotecan|irinotecan|mesh-list
110235062|NCT03678883|Lomustine|lomustine|mesh-list
110235063|NCT03678883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110235064|NCT03678883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110235065|NCT03678883|Tubulin Modulators|tubulin modulators|mesh-ancestor
110235066|NCT03678883|Antimitotic Agents|antimitotic agents|mesh-ancestor
110235067|NCT03678883|Mitosis Modulators|mitosis modulators|mesh-ancestor
110235068|NCT03678883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110235069|NCT03678883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110235070|NCT03678883|Antimetabolites|antimetabolites|mesh-ancestor
110235071|NCT03678883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110235072|NCT03678883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110235073|NCT03678883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110235074|NCT03678883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110235075|NCT03678883|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110235076|NCT03678883|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110235077|NCT03678883|Alkylating Agents|alkylating agents|mesh-ancestor
110235078|NCT03671109|Piperaquine|piperaquine|mesh-list
110235080|NCT03671109|Antimalarials|antimalarials|mesh-ancestor
110235081|NCT03671109|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110235082|NCT03671109|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110235083|NCT03671109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110235084|NCT03582774|Edetic Acid|edetic acid|mesh-list
110235085|NCT03582774|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110235086|NCT03582774|Chelating Agents|chelating agents|mesh-ancestor
110235089|NCT03582774|Anticoagulants|anticoagulants|mesh-ancestor
110235090|NCT03582774|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110235091|NCT03582774|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110235092|NCT03532399|Bivalirudin|bivalirudin|mesh-list
110235093|NCT03532399|Antithrombins|antithrombins|mesh-ancestor
110235094|NCT03532399|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110235095|NCT03532399|Protease Inhibitors|protease inhibitors|mesh-ancestor
110235096|NCT03532399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110235097|NCT03532399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110235098|NCT03532399|Anticoagulants|anticoagulants|mesh-ancestor
110235099|NCT03504956|Metoprolol|metoprolol|mesh-list
110235100|NCT03504956|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110235101|NCT03504956|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110235102|NCT03504956|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110235103|NCT03504956|Sympatholytics|sympatholytics|mesh-ancestor
110235104|NCT03504956|Autonomic Agents|autonomic agents|mesh-ancestor
110235105|NCT03504956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110235106|NCT03504956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110235107|NCT03504956|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110235108|NCT03504956|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110235109|NCT03504956|Adrenergic Agents|adrenergic agents|mesh-ancestor
110235110|NCT03504956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110235111|NCT03504956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110235113|NCT03464942|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110235114|NCT03464942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110235115|NCT03464942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110235117|NCT03431831|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
110235118|NCT03431831|Naltrexone|naltrexone|mesh-list
110235119|NCT03431831|Bupropion|bupropion|mesh-list
110235120|NCT03431831|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110235121|NCT03431831|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110235122|NCT03431831|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110235123|NCT03431831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110235124|NCT03431831|Sensory System Agents|sensory system agents|mesh-ancestor
110235125|NCT03431831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110235126|NCT03431831|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110235127|NCT03431831|Antidepressive Agents|antidepressive agents|mesh-ancestor
110235128|NCT03431831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110235129|NCT03431831|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110235130|NCT03431831|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110235131|NCT03431831|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110235132|NCT03431831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110235133|NCT03431831|Dopamine Agents|dopamine agents|mesh-ancestor
110235134|NCT03431831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110235135|NCT03431831|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110235136|NCT03431831|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110235137|NCT03431831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110235138|NCT03426891|Pembrolizumab|pembrolizumab|mesh-list
110235139|NCT03426891|Temozolomide|temozolomide|mesh-list
110235140|NCT03426891|Vorinostat|vorinostat|mesh-list
110235141|NCT03426891|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
110235142|NCT03426891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110235143|NCT03426891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110235144|NCT03426891|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110235145|NCT03426891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110235148|NCT03426891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110235149|NCT03422536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110235151|NCT03422536|Antibodies|antibodies|mesh-list
110235152|NCT03422536|Immunoglobulins|immunoglobulins|mesh-list
110235153|NCT03422536|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110235154|NCT03422536|Immunologic Factors|immunologic factors|mesh-ancestor
110235155|NCT03422536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110235156|NCT03422536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110235157|NCT03397966|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
110235158|NCT03397966|Natriuretic Agents|natriuretic agents|mesh-ancestor
110235159|NCT03397966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110235160|NCT03382977|Carmustine|carmustine|mesh-list
110235161|NCT03382977|Lomustine|lomustine|mesh-list
110235162|NCT03382977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110235163|NCT03382977|Alkylating Agents|alkylating agents|mesh-ancestor
110235164|NCT03382977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110235165|NCT03382977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110235166|NCT03358693|Infliximab|infliximab|mesh-list
110235167|NCT03358693|Upadacitinib|upadacitinib|mesh-list
110235168|NCT03358693|Ustekinumab|ustekinumab|mesh-list
110235169|NCT03358693|Ixekizumab|ixekizumab|mesh-list
110235170|NCT03358693|Brodalumab|brodalumab|mesh-list
110235171|NCT03358693|Abrocitinib|abrocitinib|mesh-list
110235172|NCT03358693|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110235173|NCT03358693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110235174|NCT03358693|Dermatologic Agents|dermatologic agents|mesh-ancestor
110235175|NCT03358693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110235176|NCT03358693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110235177|NCT03358693|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110235178|NCT03358693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110235179|NCT03358693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110235180|NCT03358693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110235181|NCT03228394|Ganaxolone|ganaxolone|mesh-list
110235182|NCT03228394|Neurosteroids|neurosteroids|mesh-ancestor
110235183|NCT03228394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110235184|NCT03228394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110235185|NCT03228394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110235186|NCT03228394|GABA Modulators|gaba modulators|mesh-ancestor
110235187|NCT03228394|GABA Agents|gaba agents|mesh-ancestor
110235188|NCT03213977|Prednisone|prednisone|mesh-list
110235189|NCT03213977|Cyclophosphamide|cyclophosphamide|mesh-list
110235190|NCT03213977|Doxorubicin|doxorubicin|mesh-list
110235191|NCT03213977|Etoposide|etoposide|mesh-list
110235192|NCT03213977|Vincristine|vincristine|mesh-list
110235193|NCT03213977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110235194|NCT03213977|Immunologic Factors|immunologic factors|mesh-ancestor
110235195|NCT03213977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110235196|NCT03213977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110235197|NCT03213977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110235198|NCT03213977|Alkylating Agents|alkylating agents|mesh-ancestor
110235199|NCT03213977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110235200|NCT03213977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110235201|NCT03213977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110235202|NCT03213977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110235203|NCT03213977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110235208|NCT03213977|Glucocorticoids|glucocorticoids|mesh-ancestor
110235209|NCT03213977|Hormones|hormones|mesh-ancestor
110235210|NCT03213977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110235211|NCT03213977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110235212|NCT03213977|Tubulin Modulators|tubulin modulators|mesh-ancestor
110235213|NCT03213977|Antimitotic Agents|antimitotic agents|mesh-ancestor
110235214|NCT03213977|Mitosis Modulators|mitosis modulators|mesh-ancestor
110235215|NCT03043872|Carboplatin|carboplatin|mesh-list
110235216|NCT03043872|Etoposide|etoposide|mesh-list
110235217|NCT03043872|Durvalumab|durvalumab|mesh-list
110235218|NCT03043872|Tremelimumab|tremelimumab|mesh-list
110235219|NCT03043872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110235220|NCT03043872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110235221|NCT03043872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110235222|NCT03043872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110235224|NCT03043872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110235225|NCT03043872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110235226|NCT02956447|Hormones|hormones|mesh-list
110235227|NCT02956447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110235228|NCT02956447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110235229|NCT02953834|Insulin|insulin|mesh-list
110235230|NCT02953834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110235231|NCT02953834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110235232|NCT02849639|Scopolamine|scopolamine|mesh-list
110235233|NCT02849639|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
110235234|NCT02849639|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110235235|NCT02849639|Antiemetics|antiemetics|mesh-ancestor
110235236|NCT02849639|Autonomic Agents|autonomic agents|mesh-ancestor
110235237|NCT02849639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110235238|NCT02849639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110235240|NCT02849639|Mydriatics|mydriatics|mesh-ancestor
110235241|NCT02849639|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110266492|NCT03669523|Denosumab|denosumab|mesh-list
110235242|NCT02849639|Cholinergic Agents|cholinergic agents|mesh-ancestor
110235243|NCT02849639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110235244|NCT02849639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110235245|NCT02849639|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110235246|NCT02849639|Parasympatholytics|parasympatholytics|mesh-ancestor
110235247|NCT02728388|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110235248|NCT02728388|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110235249|NCT02728388|Dermatologic Agents|dermatologic agents|mesh-ancestor
110235250|NCT02633397|Riociguat|riociguat|mesh-list
110235251|NCT02633397|Enzyme Activators|enzyme activators|mesh-ancestor
110235252|NCT02633397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110235253|NCT02594384|Rituximab|rituximab|mesh-list
110235254|NCT02594384|Atezolizumab|atezolizumab|mesh-list
110235255|NCT02594384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110235256|NCT02594384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110235257|NCT02594384|Immunologic Factors|immunologic factors|mesh-ancestor
110235258|NCT02594384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110235259|NCT02594384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110235260|NCT02594384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110235261|NCT02594384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110235262|NCT02592707|Dexamethasone|dexamethasone|mesh-list
110235263|NCT02592707|Ondansetron|ondansetron|mesh-list
110235264|NCT02592707|Antiemetics|antiemetics|mesh-list
110235265|NCT02592707|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
110235266|NCT02592707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110235267|NCT02592707|Autonomic Agents|autonomic agents|mesh-ancestor
110235268|NCT02592707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110235269|NCT02592707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110235270|NCT02592707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110235271|NCT02592707|Glucocorticoids|glucocorticoids|mesh-ancestor
110235272|NCT02592707|Hormones|hormones|mesh-ancestor
110235273|NCT02592707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110235274|NCT02592707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110235275|NCT02592707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110235276|NCT02592707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110235277|NCT02592707|Antipruritics|antipruritics|mesh-ancestor
110235278|NCT02592707|Dermatologic Agents|dermatologic agents|mesh-ancestor
110235279|NCT02592707|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110235280|NCT02592707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110235281|NCT02592707|Serotonin Agents|serotonin agents|mesh-ancestor
110235282|NCT02592707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110235283|NCT02592707|Chelating Agents|chelating agents|mesh-ancestor
110235284|NCT02592707|Sequestering Agents|sequestering agents|mesh-ancestor
110235285|NCT02326805|Metronidazole|metronidazole|mesh-list
110235286|NCT02326805|Vaccines|vaccines|mesh-list
110235287|NCT02326805|Immunologic Factors|immunologic factors|mesh-ancestor
110235288|NCT02326805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110235289|NCT02326805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110235290|NCT02326805|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110235291|NCT02326805|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110235292|NCT02326805|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110235294|NCT01952782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110235296|NCT01952782|Sensory System Agents|sensory system agents|mesh-ancestor
110235297|NCT01952782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110235298|NCT01423812|Ritonavir|ritonavir|mesh-list
110235299|NCT01423812|Darunavir|darunavir|mesh-list
110235300|NCT01423812|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110235301|NCT01423812|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110235302|NCT01423812|Protease Inhibitors|protease inhibitors|mesh-ancestor
110266503|NCT00158093|Moxifloxacin|moxifloxacin|mesh-list
110235304|NCT01423812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110235305|NCT01423812|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110235306|NCT01423812|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110235307|NCT01423812|Antiviral Agents|antiviral agents|mesh-ancestor
110235308|NCT01423812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110235309|NCT01423812|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110235310|NCT01423812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110235311|NCT01291719|Insulin|insulin|mesh-list
110235312|NCT01291719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110235313|NCT01291719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110235314|NCT01176474|Nivolumab|nivolumab|mesh-list
110235315|NCT01176474|Ipilimumab|ipilimumab|mesh-list
110235316|NCT01176474|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
110235317|NCT01176474|Immunologic Factors|immunologic factors|mesh-ancestor
110235319|NCT01176474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110235320|NCT01176474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110235321|NCT01176474|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110235322|NCT01176474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110235323|NCT01176474|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110235324|NCT01141309|Everolimus|everolimus|mesh-list
110235325|NCT01141309|Sorafenib|sorafenib|mesh-list
110235326|NCT01141309|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110235327|NCT01141309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110235328|NCT01141309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110235329|NCT01141309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110235330|NCT01141309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110235331|NCT01141309|Immunologic Factors|immunologic factors|mesh-ancestor
110235332|NCT01141309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110235333|NCT01141309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110235334|NCT00914823|Hormones|hormones|mesh-list
110235335|NCT00914823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110235336|NCT00914823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110235337|NCT00859781|Ketoconazole|ketoconazole|mesh-list
110235338|NCT00859781|Hydrocortisone|hydrocortisone|mesh-list
110235339|NCT00859781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110235340|NCT00859781|Antifungal Agents|antifungal agents|mesh-ancestor
110235341|NCT00859781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110235342|NCT00859781|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110235343|NCT00859781|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110235344|NCT00859781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110235345|NCT00859781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110235346|NCT00859781|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110235347|NCT00859781|Hormone Antagonists|hormone antagonists|mesh-ancestor
110235348|NCT00859781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110235349|NCT00859781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110235350|NCT00859781|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110235351|NCT00792740|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
110235352|NCT00792740|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110235353|NCT00792740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110235354|NCT00792740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110235355|NCT00729300|Disulfiram|disulfiram|mesh-list
110235356|NCT00729300|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110266516|NCT00158093|Sympatholytics|sympatholytics|mesh-ancestor
110235357|NCT00729300|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
110235358|NCT00729300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110235359|NCT00729300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110235361|NCT00099086|Leuprolide|leuprolide|mesh-list
110235363|NCT00099086|Bicalutamide|bicalutamide|mesh-list
110235364|NCT00099086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110235365|NCT00099086|Tubulin Modulators|tubulin modulators|mesh-ancestor
110235366|NCT00099086|Antimitotic Agents|antimitotic agents|mesh-ancestor
110235367|NCT00099086|Mitosis Modulators|mitosis modulators|mesh-ancestor
110235368|NCT00099086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110235369|NCT00099086|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110235370|NCT00099086|Fertility Agents|fertility agents|mesh-ancestor
110235371|NCT00099086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110235372|NCT00099086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110235373|NCT00099086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110235374|NCT00099086|Androgen Antagonists|androgen antagonists|mesh-ancestor
110235375|NCT00099086|Hormone Antagonists|hormone antagonists|mesh-ancestor
110235376|NCT00099086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110235377|NCT00856947|Vitamin D|vitamin d|mesh-list
110235379|NCT00856947|Vitamins|vitamins|mesh-ancestor
110235380|NCT00856947|Micronutrients|micronutrients|mesh-ancestor
110235381|NCT00856947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110235382|NCT00856947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110235383|NCT00856947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110235384|NCT00655993|Simvastatin|simvastatin|mesh-list
110235385|NCT00655993|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110235386|NCT00655993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110235387|NCT00655993|Antimetabolites|antimetabolites|mesh-ancestor
110235388|NCT00655993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110235389|NCT00655993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110235390|NCT00655993|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110235391|NCT00655993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110235392|NCT00567580|Leuprolide|leuprolide|mesh-list
110235393|NCT00567580|Goserelin|goserelin|mesh-list
110235394|NCT00567580|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110235395|NCT00567580|Flutamide|flutamide|mesh-list
110235396|NCT00567580|Bicalutamide|bicalutamide|mesh-list
110235397|NCT00567580|Buserelin|buserelin|mesh-list
110235398|NCT00567580|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110235399|NCT00567580|Fertility Agents|fertility agents|mesh-ancestor
110235400|NCT00567580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110235401|NCT00567580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110235402|NCT00567580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110235403|NCT00567580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110235404|NCT00567580|Androgen Antagonists|androgen antagonists|mesh-ancestor
110235405|NCT00567580|Hormone Antagonists|hormone antagonists|mesh-ancestor
110235406|NCT00567580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110235407|NCT00567580|Luteolytic Agents|luteolytic agents|mesh-ancestor
110235408|NCT00567580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110235409|NCT00567580|Contraceptive Agents|contraceptive agents|mesh-ancestor
110235410|NCT00567580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110235411|NCT00125151|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
110235412|NCT00125151|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110235413|NCT00125151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110235414|NCT00125151|Immunologic Factors|immunologic factors|mesh-ancestor
110235415|NCT00125151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110235416|NCT00087815|Dexamethasone|dexamethasone|mesh-list
110235417|NCT00087815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110235418|NCT00087815|Antiemetics|antiemetics|mesh-ancestor
110235419|NCT00087815|Autonomic Agents|autonomic agents|mesh-ancestor
110235420|NCT00087815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110235421|NCT00087815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110235422|NCT00087815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110235423|NCT00087815|Glucocorticoids|glucocorticoids|mesh-ancestor
110235424|NCT00087815|Hormones|hormones|mesh-ancestor
110235425|NCT00087815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110235426|NCT00087815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110235427|NCT00087815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110235429|NCT00087854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110235430|NCT00087854|Antiviral Agents|antiviral agents|mesh-ancestor
110235431|NCT00087854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110235432|NCT00087854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110235433|NCT00087854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110235435|NCT04715620|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110235436|NCT04715620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110235437|NCT04715620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110235438|NCT04715620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110235439|NCT00125229|Mannitol|mannitol|mesh-list
110235443|NCT00125229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110235445|NCT00126906|Sulfadoxine|sulfadoxine|mesh-list
110235446|NCT00126906|Antimalarials|antimalarials|mesh-ancestor
110235447|NCT00126906|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110235448|NCT00126906|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110235449|NCT00126906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110235450|NCT00126906|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110235451|NCT00126906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110235452|NCT00126906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110235453|NCT00126906|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110235454|NCT00088049|Olanzapine|olanzapine|mesh-list
110235455|NCT00088049|Aripiprazole|aripiprazole|mesh-list
110235456|NCT00088049|Antiemetics|antiemetics|mesh-ancestor
110235457|NCT00088049|Autonomic Agents|autonomic agents|mesh-ancestor
110235458|NCT00088049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110235459|NCT00088049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110235460|NCT00088049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110235461|NCT00088049|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110235462|NCT00088049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110235463|NCT00088049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110235464|NCT00088049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110235465|NCT00088049|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110235466|NCT00088049|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110235467|NCT00088049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110235468|NCT00088049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110235469|NCT00088049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110235470|NCT00088049|Serotonin Agents|serotonin agents|mesh-ancestor
110235471|NCT00088049|Antidepressive Agents|antidepressive agents|mesh-ancestor
110235472|NCT00088049|Dopamine Agonists|dopamine agonists|mesh-ancestor
110235473|NCT00088049|Dopamine Agents|dopamine agents|mesh-ancestor
110235474|NCT00088049|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110235475|NCT00088049|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110235476|NCT00088049|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110235477|NCT00088049|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110235478|NCT00088049|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110235479|NCT00088049|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110235480|NCT00088088|Paclitaxel|paclitaxel|mesh-list
110235481|NCT00088088|Carboplatin|carboplatin|mesh-list
110235482|NCT00088088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110235483|NCT00088088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110235484|NCT00088088|Tubulin Modulators|tubulin modulators|mesh-ancestor
110235485|NCT00088088|Antimitotic Agents|antimitotic agents|mesh-ancestor
110235486|NCT00088088|Mitosis Modulators|mitosis modulators|mesh-ancestor
110266562|NCT00158171|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110235487|NCT00088088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110235488|NCT00125307|Tacrolimus|tacrolimus|mesh-list
110235489|NCT00125307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110235490|NCT00125307|Immunologic Factors|immunologic factors|mesh-ancestor
110235491|NCT00125307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110235492|NCT00125307|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110235493|NCT00125307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110235494|NCT00125307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110235496|NCT00127023|Immunologic Factors|immunologic factors|mesh-ancestor
110235497|NCT00127023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110235499|NCT00332761|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110235500|NCT00332761|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110235501|NCT00332761|Antimetabolites|antimetabolites|mesh-ancestor
110235502|NCT00332761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110235503|NCT00332761|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110235504|NCT00332761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110235505|NCT00332761|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110235506|NCT00332761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110235507|NCT00332761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110235508|NCT00332761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110235509|NCT00332761|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110235510|NCT00332761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110235511|NCT00332995|Dapivirine|dapivirine|mesh-list
110235512|NCT00332995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110235513|NCT00332995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110235514|NCT00332995|Antiviral Agents|antiviral agents|mesh-ancestor
110235515|NCT00332995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110235516|NCT00333034|Etanercept|etanercept|mesh-list
110235517|NCT00333034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110235518|NCT00333034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110235519|NCT00333034|Analgesics|analgesics|mesh-ancestor
110235520|NCT00333034|Sensory System Agents|sensory system agents|mesh-ancestor
110235521|NCT00333034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110235522|NCT00333034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110235523|NCT00333034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110235524|NCT00333034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110235525|NCT00333034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110235526|NCT00333034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110235527|NCT00333034|Immunologic Factors|immunologic factors|mesh-ancestor
110235528|NCT00088478|Olanzapine|olanzapine|mesh-list
110235529|NCT00088478|Antiemetics|antiemetics|mesh-ancestor
110235530|NCT00088478|Autonomic Agents|autonomic agents|mesh-ancestor
110235531|NCT00088478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110235532|NCT00088478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110235533|NCT00088478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110235534|NCT00088478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110235535|NCT00088478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110235536|NCT00088478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110235537|NCT00088478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110235538|NCT00088478|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110235539|NCT00088478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110235540|NCT00088478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110235541|NCT00088478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110235542|NCT00088478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110235543|NCT00088478|Serotonin Agents|serotonin agents|mesh-ancestor
110235544|NCT00125346|Tobramycin|tobramycin|mesh-list
110235545|NCT00125346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110235546|NCT00125346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110235547|NCT00333112|Tamsulosin|tamsulosin|mesh-list
110235548|NCT00333112|Solifenacin Succinate|solifenacin succinate|mesh-list
110235549|NCT00333112|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110235550|NCT00333112|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110235551|NCT00333112|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110235552|NCT00333112|Adrenergic Agents|adrenergic agents|mesh-ancestor
110235553|NCT00333112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110235554|NCT00333112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110235558|NCT00333112|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110235559|NCT00333112|Cholinergic Agents|cholinergic agents|mesh-ancestor
110235560|NCT00333151|Metformin|metformin|mesh-list
110235561|NCT00333151|Liraglutide|liraglutide|mesh-list
110235562|NCT00333151|Rosiglitazone|rosiglitazone|mesh-list
110235563|NCT00333151|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110235564|NCT00333151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110235565|NCT00333151|Incretins|incretins|mesh-ancestor
110235566|NCT00333151|Hormones|hormones|mesh-ancestor
110235567|NCT00333151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110235568|NCT00125385|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110235569|NCT00125385|Immunologic Factors|immunologic factors|mesh-ancestor
110235570|NCT00125385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110235572|NCT00088556|Carboplatin|carboplatin|mesh-list
110235573|NCT00088556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110235574|NCT00088556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110235575|NCT00088556|Tubulin Modulators|tubulin modulators|mesh-ancestor
110235576|NCT00088556|Antimitotic Agents|antimitotic agents|mesh-ancestor
110235577|NCT00088556|Mitosis Modulators|mitosis modulators|mesh-ancestor
110235578|NCT00088556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110235579|NCT00127140|Vorinostat|vorinostat|mesh-list
110235580|NCT00127140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110235581|NCT00127140|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110235582|NCT00127140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110235583|NCT00127140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110235584|NCT00333307|Methocarbamol|methocarbamol|mesh-list
110235585|NCT00333307|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110235586|NCT00333307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110235587|NCT00333307|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110235588|NCT00333307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110235589|NCT00125424|Midazolam|midazolam|mesh-list
110235590|NCT00125424|Fospropofol|fospropofol|mesh-list
110235591|NCT00125424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110235592|NCT00125424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110235593|NCT00125424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110235594|NCT00125424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110235595|NCT00125424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110235596|NCT00125424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110235597|NCT00125424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110235598|NCT00125424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110235599|NCT00125424|Anesthetics, General|anesthetics, general|mesh-ancestor
110235601|NCT00125424|GABA Modulators|gaba modulators|mesh-ancestor
110235602|NCT00125424|GABA Agents|gaba agents|mesh-ancestor
110235603|NCT00125424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110235604|NCT00125424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110235605|NCT00333346|Tramadol|tramadol|mesh-list
110235606|NCT00333346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110235607|NCT00333346|Narcotics|narcotics|mesh-ancestor
110235608|NCT00333346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110235609|NCT00333346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110235610|NCT00333346|Analgesics|analgesics|mesh-ancestor
110235611|NCT00333346|Sensory System Agents|sensory system agents|mesh-ancestor
110235612|NCT00333346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110235614|NCT00333385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110235615|NCT00333385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110235616|NCT00127257|Diazepam|diazepam|mesh-list
110235617|NCT00127257|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110235619|NCT00127257|Antiemetics|antiemetics|mesh-ancestor
110235620|NCT00127257|Autonomic Agents|autonomic agents|mesh-ancestor
110235621|NCT00127257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110235622|NCT00127257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110235623|NCT00127257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110235624|NCT00127257|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110235625|NCT00127257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110235626|NCT00127257|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110235627|NCT00127257|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110235628|NCT00127257|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110235629|NCT00127257|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110235630|NCT00127257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110235631|NCT00127257|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110235632|NCT00127257|Anesthetics, General|anesthetics, general|mesh-ancestor
110235633|NCT00127257|Anesthetics|anesthetics|mesh-ancestor
110235634|NCT00127257|GABA Modulators|gaba modulators|mesh-ancestor
110235636|NCT00127257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110235637|NCT00127257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110235638|NCT00333424|Vaccines|vaccines|mesh-list
110235639|NCT00333424|Immunologic Factors|immunologic factors|mesh-ancestor
110235640|NCT00333424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110235641|NCT00125463|Candesartan|candesartan|mesh-list
110235642|NCT00125463|Candesartan cilexetil|candesartan cilexetil|mesh-list
110235643|NCT00125463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110235644|NCT00125463|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110235645|NCT00125463|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110235646|NCT00125463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110235647|NCT00088946|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110235648|NCT00088946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110235649|NCT00088946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110235650|NCT00088946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110235651|NCT00088946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110235652|NCT00421018|Montelukast|montelukast|mesh-list
110235653|NCT00421018|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110235654|NCT00421018|Respiratory System Agents|respiratory system agents|mesh-ancestor
110235655|NCT00421018|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110235656|NCT00421018|Hormone Antagonists|hormone antagonists|mesh-ancestor
110235657|NCT00421018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110235658|NCT00421018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110235659|NCT00421018|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110235660|NCT00421018|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110235661|NCT00421018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110235662|NCT00421096|Gemcitabine|gemcitabine|mesh-list
110235663|NCT00421096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110235664|NCT00421096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110235665|NCT00421096|Antimetabolites|antimetabolites|mesh-ancestor
110235666|NCT00421096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110235667|NCT00089063|Sargramostim|sargramostim|mesh-list
110235668|NCT00089063|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
110235669|NCT00089063|Freund's Adjuvant|freund's adjuvant|mesh-list
110235670|NCT00089063|Immunologic Factors|immunologic factors|mesh-ancestor
110235671|NCT00089063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110235672|NCT00089063|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110235673|NCT00333931|Phenytoin|phenytoin|mesh-list
110235674|NCT00333931|Anticonvulsants|anticonvulsants|mesh-ancestor
110235675|NCT00333931|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110235676|NCT00333931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110235677|NCT00333931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110235679|NCT00333931|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110235680|NCT00333931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110235682|NCT00334048|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110235683|NCT00334048|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110235684|NCT00334048|Dopamine Agonists|dopamine agonists|mesh-ancestor
110235685|NCT00334048|Dopamine Agents|dopamine agents|mesh-ancestor
110235686|NCT00334048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110235687|NCT00334048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110235688|NCT00334048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110235689|NCT00334126|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110235690|NCT00334126|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110235691|NCT00334126|Antidepressive Agents|antidepressive agents|mesh-ancestor
110235692|NCT00334126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110235693|NCT00334126|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110235694|NCT00334126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110235695|NCT00334126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110235696|NCT00334126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110235697|NCT00334126|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110235698|NCT00334126|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110235699|NCT00334126|Serotonin Agents|serotonin agents|mesh-ancestor
110235700|NCT00334126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110235701|NCT00334126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110235702|NCT00334126|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110235703|NCT00334126|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110235704|NCT00334126|Dopamine Agents|dopamine agents|mesh-ancestor
110235706|NCT00089219|Freund's Adjuvant|freund's adjuvant|mesh-list
110235707|NCT00089219|Immunologic Factors|immunologic factors|mesh-ancestor
110235708|NCT00089219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110235709|NCT00089219|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110235710|NCT00334321|Paclitaxel|paclitaxel|mesh-list
110235711|NCT00334321|Carboplatin|carboplatin|mesh-list
110235712|NCT00334321|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110235714|NCT00334321|Tubulin Modulators|tubulin modulators|mesh-ancestor
110235715|NCT00334321|Antimitotic Agents|antimitotic agents|mesh-ancestor
110235716|NCT00334321|Mitosis Modulators|mitosis modulators|mesh-ancestor
110235717|NCT00334321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110235718|NCT00334360|Dexmedetomidine|dexmedetomidine|mesh-list
110235719|NCT00334360|Buspirone|buspirone|mesh-list
110235720|NCT00334360|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110235721|NCT00334360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110235722|NCT00334360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110235723|NCT00334360|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110235724|NCT00334360|Analgesics|analgesics|mesh-ancestor
110235725|NCT00334360|Sensory System Agents|sensory system agents|mesh-ancestor
110235726|NCT00334360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110235727|NCT00334360|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110235728|NCT00334360|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110235729|NCT00334360|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110235730|NCT00334360|Adrenergic Agents|adrenergic agents|mesh-ancestor
110235731|NCT00334360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110235732|NCT00334360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110235733|NCT00334360|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110235734|NCT00334360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110235735|NCT00334360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110235736|NCT00334360|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110235738|NCT00334399|Miglitol|miglitol|mesh-list
110235739|NCT00334399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110235740|NCT00334399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110235742|NCT00334399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110235743|NCT00334399|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110235745|NCT00334438|Bortezomib|bortezomib|mesh-list
110235746|NCT00334438|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110235747|NCT00334438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110235748|NCT00334438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110235749|NCT00334438|Immunologic Factors|immunologic factors|mesh-ancestor
110235750|NCT00334438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110235751|NCT00334438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110235752|NCT00334477|Tadalafil|tadalafil|mesh-list
110235753|NCT00334477|Vasodilator Agents|vasodilator agents|mesh-ancestor
110235754|NCT00334477|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110235755|NCT00334477|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110235756|NCT00334477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110235757|NCT00334477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110235758|NCT00334477|Urological Agents|urological agents|mesh-ancestor
110235759|NCT04715269|Alprazolam|alprazolam|mesh-list
110235760|NCT04715269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110235761|NCT04715269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110235762|NCT04715269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110235763|NCT04715269|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110235764|NCT04715269|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110235765|NCT04715269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110235766|NCT04715269|GABA Modulators|gaba modulators|mesh-ancestor
110235767|NCT04715269|GABA Agents|gaba agents|mesh-ancestor
110235768|NCT04715269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110235769|NCT04715269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110235770|NCT00125541|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
110235771|NCT00125541|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110235772|NCT00125541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110235773|NCT00125541|Immunologic Factors|immunologic factors|mesh-ancestor
110235774|NCT00125541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110235777|NCT00089258|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110235778|NCT00089258|Sargramostim|sargramostim|mesh-list
110235779|NCT00089258|Immunologic Factors|immunologic factors|mesh-ancestor
110235780|NCT00089258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110235781|NCT00089258|Dermatologic Agents|dermatologic agents|mesh-ancestor
110235782|NCT00127569|Rituximab|rituximab|mesh-list
110235783|NCT00127569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110235784|NCT00127569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110235785|NCT00127569|Immunologic Factors|immunologic factors|mesh-ancestor
110235786|NCT00127569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110235787|NCT00127569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110235788|NCT00334594|Pemetrexed|pemetrexed|mesh-list
110235789|NCT00334594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110235790|NCT00334594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110235791|NCT00334594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110235792|NCT00334594|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110235793|NCT00334594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110235794|NCT00334672|Cyclosporine|cyclosporine|mesh-list
110235795|NCT00334672|Mycophenolic Acid|mycophenolic acid|mesh-list
110235796|NCT00334672|Dexamethasone|dexamethasone|mesh-list
110235797|NCT00334672|Hydrocortisone|hydrocortisone|mesh-list
110235798|NCT00334672|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110235799|NCT00334672|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110235800|NCT00334672|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110235801|NCT00334672|Cyclophosphamide|cyclophosphamide|mesh-list
110235805|NCT00334672|Cyclosporins|cyclosporins|mesh-list
110266662|NCT05169229|Vancomycin|vancomycin|mesh-list
110235806|NCT00334672|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110235807|NCT00334672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110235808|NCT00334672|Immunologic Factors|immunologic factors|mesh-ancestor
110235809|NCT00334672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110235810|NCT00334672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110235811|NCT00334672|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110235812|NCT00334672|Alkylating Agents|alkylating agents|mesh-ancestor
110235813|NCT00334672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110235814|NCT00334672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110235815|NCT00334672|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110235816|NCT00334672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110235817|NCT00334672|Antiemetics|antiemetics|mesh-ancestor
110235818|NCT00334672|Autonomic Agents|autonomic agents|mesh-ancestor
110235819|NCT00334672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110235820|NCT00334672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110235821|NCT00334672|Glucocorticoids|glucocorticoids|mesh-ancestor
110235822|NCT00334672|Hormones|hormones|mesh-ancestor
110235823|NCT00334672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110235824|NCT00334672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110235825|NCT00334672|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110235826|NCT00334672|Abortifacient Agents|abortifacient agents|mesh-ancestor
110235827|NCT00334672|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110235828|NCT00334672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110235829|NCT00334672|Antimetabolites|antimetabolites|mesh-ancestor
110235830|NCT00334672|Dermatologic Agents|dermatologic agents|mesh-ancestor
110235831|NCT00334672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110235832|NCT00334672|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110235833|NCT00334672|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110235834|NCT00334672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110235835|NCT00334672|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110235836|NCT00334672|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110235837|NCT00334672|Antifungal Agents|antifungal agents|mesh-ancestor
110235838|NCT00334672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110235839|NCT00334672|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110235840|NCT00334672|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110235841|NCT00334672|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110235842|NCT00334672|Antitubercular Agents|antitubercular agents|mesh-ancestor
110235843|NCT00334672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110235844|NCT00089453|Dexamethasone|dexamethasone|mesh-list
110235845|NCT00089453|Cyclophosphamide|cyclophosphamide|mesh-list
110235846|NCT00089453|Melphalan|melphalan|mesh-list
110235847|NCT00089453|Fludarabine|fludarabine|mesh-list
110235848|NCT00089453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110235849|NCT00089453|Immunologic Factors|immunologic factors|mesh-ancestor
110235850|NCT00089453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110235851|NCT00089453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110235852|NCT00089453|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110235853|NCT00089453|Alkylating Agents|alkylating agents|mesh-ancestor
110235854|NCT00089453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110235855|NCT00089453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110235856|NCT00089453|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110235857|NCT00089453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110235858|NCT00089453|Antiemetics|antiemetics|mesh-ancestor
110235859|NCT00089453|Autonomic Agents|autonomic agents|mesh-ancestor
110235860|NCT00089453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110235861|NCT00089453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110235863|NCT00089453|Hormones|hormones|mesh-ancestor
110266670|NCT00538096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110235864|NCT00089453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110235865|NCT00089453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110235866|NCT00089492|Enfuvirtide|enfuvirtide|mesh-list
110235867|NCT00089492|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110235868|NCT00089492|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110235869|NCT00089492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110235870|NCT00089492|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110235871|NCT00089492|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110235872|NCT00089492|Antiviral Agents|antiviral agents|mesh-ancestor
110235873|NCT00089492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110235874|NCT00127686|Dextromethorphan|dextromethorphan|mesh-list
110235875|NCT00127686|Antitussive Agents|antitussive agents|mesh-ancestor
110235876|NCT00127686|Respiratory System Agents|respiratory system agents|mesh-ancestor
110235877|NCT00127686|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110235878|NCT00127686|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110235879|NCT00127686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110235880|NCT00127686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110235881|NCT00127686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110235883|NCT00334789|Tretinoin|tretinoin|mesh-list
110235884|NCT00334789|Belinostat|belinostat|mesh-list
110235885|NCT00334789|Isotretinoin|isotretinoin|mesh-list
110235886|NCT00334789|Vitamins|vitamins|mesh-ancestor
110235887|NCT00334789|Micronutrients|micronutrients|mesh-ancestor
110235888|NCT00334789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110235889|NCT00334789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110235890|NCT00334789|Keratolytic Agents|keratolytic agents|mesh-ancestor
110235891|NCT00334789|Dermatologic Agents|dermatologic agents|mesh-ancestor
110235892|NCT00334789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110235893|NCT00334789|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110235894|NCT00334789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110235895|NCT00334867|Cyclophosphamide|cyclophosphamide|mesh-list
110235896|NCT00334867|Ifosfamide|ifosfamide|mesh-list
110235897|NCT00334867|Doxorubicin|doxorubicin|mesh-list
110235898|NCT00334867|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110235899|NCT00334867|Etoposide|etoposide|mesh-list
110235900|NCT00334867|Vincristine|vincristine|mesh-list
110235901|NCT00334867|Topotecan|topotecan|mesh-list
110235902|NCT00334867|Dexrazoxane|dexrazoxane|mesh-list
110235903|NCT00334867|Razoxane|razoxane|mesh-list
110235904|NCT00334867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110235905|NCT00334867|Immunologic Factors|immunologic factors|mesh-ancestor
110235906|NCT00334867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110235907|NCT00334867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110235910|NCT00334867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110235911|NCT00334867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110235912|NCT00334867|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110235913|NCT00334867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110235914|NCT00334867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110235915|NCT00334867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110235916|NCT00334867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110235917|NCT00334867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110235918|NCT00334867|Tubulin Modulators|tubulin modulators|mesh-ancestor
110235919|NCT00334867|Antimitotic Agents|antimitotic agents|mesh-ancestor
110235920|NCT00334867|Mitosis Modulators|mitosis modulators|mesh-ancestor
110235921|NCT00334867|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110235922|NCT00334867|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110235923|NCT00334867|Protective Agents|protective agents|mesh-ancestor
110235924|NCT04715152|Dexamethasone|dexamethasone|mesh-list
110235925|NCT04715152|Dexamethasone acetate|dexamethasone acetate|mesh-list
110235926|NCT04715152|Levobupivacaine|levobupivacaine|mesh-list
110235927|NCT04715152|BB 1101|bb 1101|mesh-list
110235928|NCT04715152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110235929|NCT04715152|Antiemetics|antiemetics|mesh-ancestor
110235930|NCT04715152|Autonomic Agents|autonomic agents|mesh-ancestor
110235931|NCT04715152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110235932|NCT04715152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110235933|NCT04715152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110235934|NCT04715152|Glucocorticoids|glucocorticoids|mesh-ancestor
110235935|NCT04715152|Hormones|hormones|mesh-ancestor
110235936|NCT04715152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110235937|NCT04715152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110235938|NCT04715152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110235939|NCT04715152|Protease Inhibitors|protease inhibitors|mesh-ancestor
110235940|NCT04715152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110235941|NCT04715152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110235942|NCT04715152|Anesthetics, Local|anesthetics, local|mesh-ancestor
110235943|NCT04715152|Anesthetics|anesthetics|mesh-ancestor
110235944|NCT04715152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110235945|NCT04715152|Sensory System Agents|sensory system agents|mesh-ancestor
110235946|NCT00334906|Memantine|memantine|mesh-list
110235947|NCT00334906|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110235948|NCT00334906|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110235949|NCT00334906|Dopamine Agents|dopamine agents|mesh-ancestor
110235950|NCT00334906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110235951|NCT00334906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110235952|NCT00334906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110235953|NCT00334906|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110235954|NCT00334906|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110235955|NCT00089570|Terlipressin|terlipressin|mesh-list
110235956|NCT00089570|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110235957|NCT00089570|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110235958|NCT00342862|Alefacept|alefacept|mesh-list
110235959|NCT00342862|Dermatologic Agents|dermatologic agents|mesh-ancestor
110235960|NCT00342862|Immunologic Factors|immunologic factors|mesh-ancestor
110235961|NCT00342862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110235962|NCT00089687|Vanoxerine|vanoxerine|mesh-list
110235963|NCT00089687|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110235964|NCT00089687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110235965|NCT00089687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110235966|NCT00089687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110235968|NCT00089687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110235969|NCT00089687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110235970|NCT00127764|Dexamethasone|dexamethasone|mesh-list
110235971|NCT00127764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110235972|NCT00127764|Antiemetics|antiemetics|mesh-ancestor
110235973|NCT00127764|Autonomic Agents|autonomic agents|mesh-ancestor
110235974|NCT00127764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110235975|NCT00127764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110235976|NCT00127764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110235977|NCT00127764|Glucocorticoids|glucocorticoids|mesh-ancestor
110235978|NCT00127764|Hormones|hormones|mesh-ancestor
110235979|NCT00127764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110235980|NCT00127764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110235981|NCT00127764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110235982|NCT00089726|Cyclophosphamide|cyclophosphamide|mesh-list
110235983|NCT00089726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110235985|NCT00089726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110235986|NCT00089726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110235987|NCT00089726|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110235988|NCT00089726|Alkylating Agents|alkylating agents|mesh-ancestor
110235989|NCT00089726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110235990|NCT00089726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110235991|NCT00089726|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110235992|NCT00343096|Lorazepam|lorazepam|mesh-list
110235993|NCT00343096|Anticonvulsants|anticonvulsants|mesh-ancestor
110235994|NCT00343096|Antiemetics|antiemetics|mesh-ancestor
110235995|NCT00343096|Autonomic Agents|autonomic agents|mesh-ancestor
110235996|NCT00343096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110235997|NCT00343096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110235998|NCT00343096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110235999|NCT00343096|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110236000|NCT00343096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110236001|NCT00343096|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110236002|NCT00343096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110236003|NCT00343096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110236004|NCT00343096|GABA Modulators|gaba modulators|mesh-ancestor
110236005|NCT00343096|GABA Agents|gaba agents|mesh-ancestor
110236006|NCT00343096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110236007|NCT00343096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110236008|NCT00335179|Imiquimod|imiquimod|mesh-list
110236009|NCT00335179|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110236010|NCT00335179|Immunologic Factors|immunologic factors|mesh-ancestor
110236011|NCT00335179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236012|NCT00335179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110236013|NCT00335179|Interferon Inducers|interferon inducers|mesh-ancestor
110236014|NCT00089765|Ranibizumab|ranibizumab|mesh-list
110236015|NCT00089765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110236016|NCT00089765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110236017|NCT00089765|Growth Substances|growth substances|mesh-ancestor
110236018|NCT00089765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236019|NCT00089765|Growth Inhibitors|growth inhibitors|mesh-ancestor
110236020|NCT00089765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110236021|NCT00343135|Amoxicillin|amoxicillin|mesh-list
110236022|NCT00343135|Clavulanic Acid|clavulanic acid|mesh-list
110236023|NCT00343135|Clavulanic Acids|clavulanic acids|mesh-list
110236026|NCT00343135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110236027|NCT00343135|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110236028|NCT00343135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110236029|NCT00343135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110236031|NCT00343174|Anticoagulants|anticoagulants|mesh-ancestor
110236032|NCT00343174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110236033|NCT00343174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110236034|NCT00343174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110236035|NCT00343369|Cytarabine|cytarabine|mesh-list
110236036|NCT00343369|Dexamethasone|dexamethasone|mesh-list
110236037|NCT00343369|Prednisolone|prednisolone|mesh-list
110236038|NCT00343369|Cyclophosphamide|cyclophosphamide|mesh-list
110236039|NCT00343369|Doxorubicin|doxorubicin|mesh-list
110236040|NCT00343369|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110236041|NCT00343369|Methotrexate|methotrexate|mesh-list
110236042|NCT00343369|Vincristine|vincristine|mesh-list
110236043|NCT00343369|Daunorubicin|daunorubicin|mesh-list
110236044|NCT00343369|Asparaginase|asparaginase|mesh-list
110236045|NCT00343369|Mercaptopurine|mercaptopurine|mesh-list
110236046|NCT00343369|Pegaspargase|pegaspargase|mesh-list
110236047|NCT00343369|Thioguanine|thioguanine|mesh-list
110236048|NCT00343369|Teniposide|teniposide|mesh-list
110236049|NCT00343369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110236050|NCT00343369|Immunologic Factors|immunologic factors|mesh-ancestor
110236051|NCT00343369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236052|NCT00343369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110266705|NCT00158717|Antiviral Agents|antiviral agents|mesh-ancestor
110236053|NCT00343369|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110236054|NCT00343369|Alkylating Agents|alkylating agents|mesh-ancestor
110236055|NCT00343369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110236056|NCT00343369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110236057|NCT00343369|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110236058|NCT00343369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110236059|NCT00343369|Antiemetics|antiemetics|mesh-ancestor
110236060|NCT00343369|Autonomic Agents|autonomic agents|mesh-ancestor
110236061|NCT00343369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110236062|NCT00343369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110236063|NCT00343369|Glucocorticoids|glucocorticoids|mesh-ancestor
110236065|NCT00343369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110236066|NCT00343369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110236067|NCT00343369|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110236068|NCT00343369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110236069|NCT00343369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110236070|NCT00343369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110236071|NCT00343369|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110236072|NCT00343369|Abortifacient Agents|abortifacient agents|mesh-ancestor
110236075|NCT00343369|Antimetabolites|antimetabolites|mesh-ancestor
110236076|NCT00343369|Dermatologic Agents|dermatologic agents|mesh-ancestor
110236077|NCT00343369|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110236078|NCT00343369|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110236079|NCT00343369|Antiviral Agents|antiviral agents|mesh-ancestor
110236080|NCT00343369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110236081|NCT00343369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110236082|NCT00343369|Tubulin Modulators|tubulin modulators|mesh-ancestor
110236083|NCT00343369|Antimitotic Agents|antimitotic agents|mesh-ancestor
110236084|NCT00343369|Mitosis Modulators|mitosis modulators|mesh-ancestor
110236085|NCT02958111|Capecitabine|capecitabine|mesh-list
110236086|NCT02958111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110236087|NCT02958111|Antimetabolites|antimetabolites|mesh-ancestor
110236088|NCT02958111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110236089|NCT02958111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110236090|NCT00343447|Cyclophosphamide|cyclophosphamide|mesh-list
110236091|NCT00343447|Rituximab|rituximab|mesh-list
110236092|NCT00343447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110236093|NCT00343447|Immunologic Factors|immunologic factors|mesh-ancestor
110236094|NCT00343447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236095|NCT00343447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110236096|NCT00343447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110236097|NCT00343447|Alkylating Agents|alkylating agents|mesh-ancestor
110236098|NCT00343447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110236099|NCT00343447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110236100|NCT00343447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110266711|NCT00538486|Metformin|metformin|mesh-list
110236101|NCT00343447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110236103|NCT00343486|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110236104|NCT00343486|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110236105|NCT00343486|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110236106|NCT00343486|Adrenergic Agents|adrenergic agents|mesh-ancestor
110236107|NCT00343486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110236108|NCT00343486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110236109|NCT00343486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236110|NCT00089804|Abetimus|abetimus|mesh-list
110236111|NCT00089804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110236112|NCT00089804|Immunologic Factors|immunologic factors|mesh-ancestor
110236113|NCT00089804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236114|NCT00343525|Bavituximab|bavituximab|mesh-list
110236115|NCT00343525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110236116|NCT00343525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110236117|NCT00127881|Zanolimumab|zanolimumab|mesh-list
110236118|NCT00127881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110236119|NCT00127881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110236120|NCT00343720|Bortezomib|bortezomib|mesh-list
110236121|NCT00343720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110236122|NCT00343759|Lapatinib|lapatinib|mesh-list
110236123|NCT00343759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110236124|NCT00343759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110236125|NCT00343759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110236126|NCT00343759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110236128|NCT00127920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110236129|NCT00127920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110236130|NCT00127920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110236131|NCT00127920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110236132|NCT00127920|Growth Substances|growth substances|mesh-ancestor
110236133|NCT00127920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236134|NCT00127920|Growth Inhibitors|growth inhibitors|mesh-ancestor
110236135|NCT00343798|Cyclosporine|cyclosporine|mesh-list
110236136|NCT00343798|Mycophenolic Acid|mycophenolic acid|mesh-list
110236137|NCT00343798|Cyclophosphamide|cyclophosphamide|mesh-list
110236138|NCT00343798|Fludarabine|fludarabine|mesh-list
110236139|NCT00343798|Fludarabine phosphate|fludarabine phosphate|mesh-list
110236140|NCT00343798|Cyclosporins|cyclosporins|mesh-list
110236141|NCT00343798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110236142|NCT00343798|Immunologic Factors|immunologic factors|mesh-ancestor
110236143|NCT00343798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236144|NCT00343798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110236145|NCT00343798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110236146|NCT00343798|Alkylating Agents|alkylating agents|mesh-ancestor
110236147|NCT00343798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110236148|NCT00343798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110236149|NCT00343798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110236150|NCT00343798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110236151|NCT00343798|Antimetabolites|antimetabolites|mesh-ancestor
110236152|NCT00343798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110236153|NCT00343798|Antifungal Agents|antifungal agents|mesh-ancestor
110236154|NCT00343798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110236155|NCT00343798|Dermatologic Agents|dermatologic agents|mesh-ancestor
110236156|NCT00343798|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110236157|NCT00343798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110236158|NCT00343798|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110236159|NCT00343798|Antitubercular Agents|antitubercular agents|mesh-ancestor
110236160|NCT00343798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110236161|NCT00343876|Aspirin|aspirin|mesh-list
110236162|NCT00343876|Clopidogrel|clopidogrel|mesh-list
110236163|NCT00343876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110236164|NCT00343876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110236165|NCT00343876|Analgesics|analgesics|mesh-ancestor
110266737|NCT00538564|Tadalafil|tadalafil|mesh-list
110236166|NCT00343876|Sensory System Agents|sensory system agents|mesh-ancestor
110236167|NCT00343876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110236168|NCT00343876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236170|NCT00343876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110236171|NCT00343876|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110236172|NCT00343876|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110236173|NCT00343876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110236174|NCT00343876|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110236175|NCT00343876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110236176|NCT00343876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110236177|NCT00343876|Antipyretics|antipyretics|mesh-ancestor
110236178|NCT00343876|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110236179|NCT00343876|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110236180|NCT00343876|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110236181|NCT00343876|Purinergic Agents|purinergic agents|mesh-ancestor
110236182|NCT00343876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110236183|NCT00402636|Sirolimus|sirolimus|mesh-list
110236184|NCT00402636|Temsirolimus|temsirolimus|mesh-list
110236185|NCT00402636|MTOR Inhibitors|mtor inhibitors|mesh-list
110236186|NCT00402636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110236187|NCT00402636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110236188|NCT00402636|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110236189|NCT00402636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110236190|NCT00402636|Antifungal Agents|antifungal agents|mesh-ancestor
110236191|NCT00402636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110236192|NCT00402636|Immunologic Factors|immunologic factors|mesh-ancestor
110236193|NCT00402636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236194|NCT00402636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110236196|NCT00402636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110236197|NCT00344149|Rituximab|rituximab|mesh-list
110236198|NCT00344149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110236199|NCT00344149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110236200|NCT00344149|Immunologic Factors|immunologic factors|mesh-ancestor
110236201|NCT00344149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236202|NCT00344149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110236203|NCT00089960|Motesanib diphosphate|motesanib diphosphate|mesh-list
110236204|NCT00089960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110236205|NCT00089960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110236206|NCT00089960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110236207|NCT00344227|Ranibizumab|ranibizumab|mesh-list
110236208|NCT00344227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110236209|NCT00344227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110236210|NCT00344227|Growth Substances|growth substances|mesh-ancestor
110236211|NCT00344227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236212|NCT00344227|Growth Inhibitors|growth inhibitors|mesh-ancestor
110236213|NCT00344227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110236214|NCT00344383|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110236215|NCT00344383|Norgestimate|norgestimate|mesh-list
110236216|NCT00344383|Estradiol|estradiol|mesh-list
110236217|NCT00344383|Estrogens|estrogens|mesh-ancestor
110236218|NCT00344383|Hormones|hormones|mesh-ancestor
110236219|NCT00344383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110236220|NCT00344383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236221|NCT00344383|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110236222|NCT00344383|Contraceptive Agents|contraceptive agents|mesh-ancestor
110236223|NCT00344383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110236224|NCT00344383|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110236225|NCT00344383|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110236226|NCT00344383|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110236227|NCT00344383|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110236229|NCT00344422|Dexamethasone acetate|dexamethasone acetate|mesh-list
110236230|NCT00344422|Doxorubicin|doxorubicin|mesh-list
110236231|NCT00344422|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110236232|NCT00344422|Vincristine|vincristine|mesh-list
110236233|NCT00344422|BB 1101|bb 1101|mesh-list
110236234|NCT00344422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110236235|NCT00344422|Antiemetics|antiemetics|mesh-ancestor
110236236|NCT00344422|Autonomic Agents|autonomic agents|mesh-ancestor
110236237|NCT00344422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110236238|NCT00344422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236239|NCT00344422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110236240|NCT00344422|Glucocorticoids|glucocorticoids|mesh-ancestor
110236241|NCT00344422|Hormones|hormones|mesh-ancestor
110236242|NCT00344422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110236243|NCT00344422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110236244|NCT00344422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110236245|NCT00344422|Protease Inhibitors|protease inhibitors|mesh-ancestor
110236246|NCT00344422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110236247|NCT00344422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110236248|NCT00344422|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110236249|NCT00344422|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110236250|NCT00344422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110236251|NCT00344422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110236252|NCT00344422|Tubulin Modulators|tubulin modulators|mesh-ancestor
110236253|NCT00344422|Antimitotic Agents|antimitotic agents|mesh-ancestor
110236254|NCT00344422|Mitosis Modulators|mitosis modulators|mesh-ancestor
110236255|NCT00090038|Rituximab|rituximab|mesh-list
110236256|NCT00090038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110236257|NCT00090038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110236258|NCT00090038|Immunologic Factors|immunologic factors|mesh-ancestor
110236259|NCT00090038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236260|NCT00090038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110236261|NCT00402792|Acetaminophen|acetaminophen|mesh-list
110236263|NCT00402792|Hydrocodone|hydrocodone|mesh-list
110236264|NCT00402792|Oxycodone|oxycodone|mesh-list
110236265|NCT00402792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110236266|NCT00402792|Analgesics|analgesics|mesh-ancestor
110236267|NCT00402792|Sensory System Agents|sensory system agents|mesh-ancestor
110236268|NCT00402792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110236269|NCT00402792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236270|NCT00402792|Antipyretics|antipyretics|mesh-ancestor
110236271|NCT00402792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110236272|NCT00402792|Narcotics|narcotics|mesh-ancestor
110236273|NCT00402792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110236274|NCT00402792|Antitussive Agents|antitussive agents|mesh-ancestor
110236275|NCT00402792|Respiratory System Agents|respiratory system agents|mesh-ancestor
110236276|NCT00402792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110236277|NCT00402792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110236278|NCT00402792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110236280|NCT00127959|Emtricitabine|emtricitabine|mesh-list
110236281|NCT00127959|Zidovudine|zidovudine|mesh-list
110236282|NCT00127959|Efavirenz|efavirenz|mesh-list
110236283|NCT00127959|Antiviral Agents|antiviral agents|mesh-ancestor
110236284|NCT00127959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110236285|NCT00127959|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110236286|NCT00127959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110236287|NCT00127959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110236288|NCT00127959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110236290|NCT00127959|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110236291|NCT00127959|Antimetabolites|antimetabolites|mesh-ancestor
110236292|NCT00127959|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110236293|NCT00127959|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110236294|NCT00127959|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110236295|NCT00127959|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110236296|NCT00127959|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110236297|NCT00127959|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110236298|NCT00344539|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110236299|NCT00344539|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110236300|NCT00344539|Immunologic Factors|immunologic factors|mesh-ancestor
110236301|NCT00344539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236302|NCT00344539|Antacids|antacids|mesh-ancestor
110236303|NCT00344539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110236304|NCT00344539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110236305|NCT04715503|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110236306|NCT04715503|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110236307|NCT04715503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110236308|NCT00344617|Bevacizumab|bevacizumab|mesh-list
110236309|NCT00344617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110236310|NCT00344617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110236311|NCT00344617|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110236312|NCT00344617|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110236313|NCT00344617|Growth Substances|growth substances|mesh-ancestor
110236314|NCT00344617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236315|NCT00344617|Growth Inhibitors|growth inhibitors|mesh-ancestor
110236317|NCT00127998|Chloroquine|chloroquine|mesh-list
110236319|NCT00127998|Artemether|artemether|mesh-list
110236320|NCT00127998|Pyrimethamine|pyrimethamine|mesh-list
110236321|NCT00127998|Sulfadoxine|sulfadoxine|mesh-list
110236322|NCT00127998|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110236323|NCT00127998|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110236324|NCT00127998|Amodiaquine|amodiaquine|mesh-list
110236326|NCT00127998|Antimalarials|antimalarials|mesh-ancestor
110236327|NCT00127998|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110236328|NCT00127998|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110236329|NCT00127998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110236330|NCT00127998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110236331|NCT00127998|Antiviral Agents|antiviral agents|mesh-ancestor
110236332|NCT00127998|Schistosomicides|schistosomicides|mesh-ancestor
110236333|NCT00127998|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110236334|NCT00127998|Anthelmintics|anthelmintics|mesh-ancestor
110236335|NCT00127998|Amebicides|amebicides|mesh-ancestor
110236336|NCT00127998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110236337|NCT00127998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110236338|NCT00127998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110236339|NCT00127998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110236340|NCT00127998|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110236341|NCT00420589|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
110236342|NCT00420589|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110236343|NCT00420589|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110236344|NCT00420589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110236345|NCT00420589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110236346|NCT00420589|Hormones|hormones|mesh-ancestor
110236347|NCT00420589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110236348|NCT00420589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236349|NCT00344695|Bupropion|bupropion|mesh-list
110236350|NCT00344695|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110236351|NCT00344695|Antidepressive Agents|antidepressive agents|mesh-ancestor
110236352|NCT00344695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110236353|NCT00344695|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110236354|NCT00344695|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110236355|NCT00344695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110236356|NCT00344695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110236357|NCT00344695|Dopamine Agents|dopamine agents|mesh-ancestor
110236358|NCT00344695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110236359|NCT00344695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236360|NCT00344695|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110236361|NCT00344695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110236362|NCT00344695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110236363|NCT00128037|Mitomycins|mitomycins|mesh-list
110236364|NCT00128037|Mitomycin|mitomycin|mesh-list
110236365|NCT00128037|Vindesine|vindesine|mesh-list
110236366|NCT00128037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110236367|NCT00128037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110236368|NCT00128037|Alkylating Agents|alkylating agents|mesh-ancestor
110236369|NCT00128037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110236370|NCT00128037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110236371|NCT00128037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110236372|NCT00128037|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110236373|NCT00128037|Tubulin Modulators|tubulin modulators|mesh-ancestor
110236374|NCT00128037|Antimitotic Agents|antimitotic agents|mesh-ancestor
110236375|NCT00128037|Mitosis Modulators|mitosis modulators|mesh-ancestor
110236376|NCT00344734|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
110236377|NCT00344734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110236379|NCT00344812|Buprenorphine|buprenorphine|mesh-list
110236380|NCT00344812|Methadone|methadone|mesh-list
110236381|NCT00344812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110236383|NCT00344812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110236384|NCT00344812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236385|NCT00344812|Analgesics|analgesics|mesh-ancestor
110236386|NCT00344812|Sensory System Agents|sensory system agents|mesh-ancestor
110236387|NCT00344812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110236388|NCT00344812|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110236389|NCT00344812|Antitussive Agents|antitussive agents|mesh-ancestor
110236390|NCT00344812|Respiratory System Agents|respiratory system agents|mesh-ancestor
110236391|NCT00344851|Metformin|metformin|mesh-list
110236392|NCT00344851|Exenatide|exenatide|mesh-list
110236393|NCT00344851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110236394|NCT00344851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236395|NCT00344851|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110236396|NCT00344851|Incretins|incretins|mesh-ancestor
110236397|NCT00344851|Hormones|hormones|mesh-ancestor
110236398|NCT00344851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110236399|NCT00090155|Ondansetron|ondansetron|mesh-list
110236401|NCT00090155|Antiemetics|antiemetics|mesh-ancestor
110236402|NCT00090155|Autonomic Agents|autonomic agents|mesh-ancestor
110236403|NCT00090155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110236404|NCT00090155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236405|NCT00090155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110236406|NCT00090155|Antipruritics|antipruritics|mesh-ancestor
110236407|NCT00090155|Dermatologic Agents|dermatologic agents|mesh-ancestor
110236408|NCT00090155|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110236409|NCT00090155|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110236410|NCT00090155|Serotonin Agents|serotonin agents|mesh-ancestor
110236411|NCT00090155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110236412|NCT00090155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110236413|NCT00090155|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110236414|NCT00335413|Spironolactone|spironolactone|mesh-list
110236415|NCT00335413|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110236416|NCT00335413|Hormone Antagonists|hormone antagonists|mesh-ancestor
110236417|NCT00335413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110236418|NCT00335413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236419|NCT00335413|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110236420|NCT00335413|Diuretics|diuretics|mesh-ancestor
110236422|NCT00090194|Immunoglobulins|immunoglobulins|mesh-list
110236423|NCT00090194|Antibodies|antibodies|mesh-list
110236424|NCT00090194|gamma-Globulins|gamma-globulins|mesh-list
110236425|NCT00090194|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110236426|NCT00090194|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110236427|NCT00090194|Immunologic Factors|immunologic factors|mesh-ancestor
110236428|NCT00090194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236429|NCT00345163|Bevacizumab|bevacizumab|mesh-list
110236430|NCT00345163|Irinotecan|irinotecan|mesh-list
110236431|NCT00345163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110236432|NCT00345163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110236433|NCT00345163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110236434|NCT00345163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110236436|NCT00345163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236437|NCT00345163|Growth Inhibitors|growth inhibitors|mesh-ancestor
110236438|NCT00345163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110236439|NCT00345163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110236441|NCT00345163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110236442|NCT00345202|Atorvastatin|atorvastatin|mesh-list
110236443|NCT00345202|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110236444|NCT00345202|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110236445|NCT00345202|Antimetabolites|antimetabolites|mesh-ancestor
110236446|NCT00345202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110236447|NCT00345202|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110236448|NCT00345202|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110236449|NCT00345202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110236450|NCT00335647|Fluphenazine|fluphenazine|mesh-list
110236451|NCT00335647|Fluphenazine depot|fluphenazine depot|mesh-list
110236452|NCT00335647|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
110236453|NCT00335647|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110236454|NCT00335647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110236455|NCT00335647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110236456|NCT00335647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236457|NCT00335647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110236459|NCT00335647|Dopamine Agents|dopamine agents|mesh-ancestor
110236460|NCT00335647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110236461|NCT00335647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110236462|NCT00128154|Chromium|chromium|mesh-list
110236463|NCT00128154|Picolinic acid|picolinic acid|mesh-list
110236464|NCT00128154|Trace Elements|trace elements|mesh-ancestor
110236465|NCT00128154|Micronutrients|micronutrients|mesh-ancestor
110236466|NCT00128154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236467|NCT00128154|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110236468|NCT00128154|Chelating Agents|chelating agents|mesh-ancestor
110236469|NCT00128154|Sequestering Agents|sequestering agents|mesh-ancestor
110236470|NCT00128154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110236471|NCT00335686|Lopinavir|lopinavir|mesh-list
110236472|NCT00335686|Nevirapine|nevirapine|mesh-list
110236473|NCT00335686|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110236474|NCT00335686|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110236475|NCT00335686|Protease Inhibitors|protease inhibitors|mesh-ancestor
110236476|NCT00335686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110236477|NCT00335686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110236478|NCT00335686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110236479|NCT00335686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110236480|NCT00335686|Antiviral Agents|antiviral agents|mesh-ancestor
110236481|NCT00335686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110236482|NCT00335686|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110236483|NCT00335686|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110236484|NCT00335686|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110236485|NCT00335686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110236486|NCT00335686|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110236487|NCT00335686|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110236489|NCT00128232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110236490|NCT00128232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110236492|NCT04708249|Inositol|inositol|mesh-list
110236493|NCT04708249|Vitamin B Complex|vitamin b complex|mesh-ancestor
110236494|NCT04708249|Vitamins|vitamins|mesh-ancestor
110236495|NCT04708249|Micronutrients|micronutrients|mesh-ancestor
110236496|NCT04708249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236497|NCT00090272|Ertapenem|ertapenem|mesh-list
110236498|NCT00090272|Cefotetan|cefotetan|mesh-list
110236499|NCT00090272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110236500|NCT00090272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110236501|NCT00345787|Buprenorphine|buprenorphine|mesh-list
110236502|NCT00345787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110236503|NCT00345787|Narcotics|narcotics|mesh-ancestor
110236504|NCT00345787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110236505|NCT00345787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236506|NCT00345787|Analgesics|analgesics|mesh-ancestor
110236507|NCT00345787|Sensory System Agents|sensory system agents|mesh-ancestor
110236508|NCT00345787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110236509|NCT00345787|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110236510|NCT00128271|Bavituximab|bavituximab|mesh-list
110236511|NCT00128271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110236512|NCT00128271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110236513|NCT00090311|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110236514|NCT00090311|Antidepressive Agents|antidepressive agents|mesh-ancestor
110236515|NCT00090311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110236516|NCT00090311|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110236517|NCT00090311|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110236518|NCT00090311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110236519|NCT00090311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236520|NCT02959762|Vitamins|vitamins|mesh-list
110236521|NCT02959762|Vitamin K|vitamin k|mesh-list
110236522|NCT02959762|Vitamin K 2|vitamin k 2|mesh-list
110236523|NCT02959762|Menaquinone 7|menaquinone 7|mesh-list
110236524|NCT02959762|Micronutrients|micronutrients|mesh-ancestor
110236525|NCT02959762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236526|NCT02959762|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110236527|NCT02959762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110236528|NCT02959762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110236529|NCT02959762|Hemostatics|hemostatics|mesh-ancestor
110236530|NCT02959762|Coagulants|coagulants|mesh-ancestor
110236531|NCT00345826|Dasatinib|dasatinib|mesh-list
110236532|NCT00345826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110236533|NCT00345826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110236534|NCT00345826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110236535|NCT00345826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110236536|NCT00345982|Sertindole|sertindole|mesh-list
110236537|NCT00345982|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110266816|NCT00158873|Anticonvulsants|anticonvulsants|mesh-ancestor
110236538|NCT00345982|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110236540|NCT00345982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236542|NCT00346099|Capecitabine|capecitabine|mesh-list
110236543|NCT00346099|Oxaliplatin|oxaliplatin|mesh-list
110236544|NCT00346099|Panitumumab|panitumumab|mesh-list
110236545|NCT00346099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110236546|NCT00346099|Antimetabolites|antimetabolites|mesh-ancestor
110236547|NCT00346099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110236548|NCT00346099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110236549|NCT00346099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110236550|NCT00125736|Rabeprazole|rabeprazole|mesh-list
110236551|NCT00125736|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110236552|NCT00125736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110236553|NCT00125736|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110236554|NCT00125736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110236555|NCT00125736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110236556|NCT00090428|Caseins|caseins|mesh-list
110236557|NCT00090428|Chelating Agents|chelating agents|mesh-ancestor
110236558|NCT00090428|Sequestering Agents|sequestering agents|mesh-ancestor
110236559|NCT00090428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110236560|NCT00346255|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
110236561|NCT00346255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110236562|NCT00346255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110236563|NCT00346255|Immunotoxins|immunotoxins|mesh-ancestor
110236564|NCT00346255|Immunoconjugates|immunoconjugates|mesh-ancestor
110236565|NCT00346255|Immunologic Factors|immunologic factors|mesh-ancestor
110236566|NCT00346255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236567|NCT00346255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110236568|NCT00346294|Etanercept|etanercept|mesh-list
110236569|NCT00346294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110236570|NCT00346294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110236571|NCT00346294|Analgesics|analgesics|mesh-ancestor
110236572|NCT00346294|Sensory System Agents|sensory system agents|mesh-ancestor
110236573|NCT00346294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110236574|NCT00346294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236575|NCT00346294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110236576|NCT00346294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110236577|NCT00346294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110236578|NCT00346294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110236579|NCT00346294|Immunologic Factors|immunologic factors|mesh-ancestor
110236580|NCT00346489|Fluorouracil|fluorouracil|mesh-list
110236581|NCT00346489|Mitomycins|mitomycins|mesh-list
110236582|NCT00346489|Mitomycin|mitomycin|mesh-list
110236583|NCT00346489|Antimetabolites|antimetabolites|mesh-ancestor
110236584|NCT00346489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110236585|NCT00346489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110236586|NCT00346489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110236587|NCT00346489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110236588|NCT00346489|Immunologic Factors|immunologic factors|mesh-ancestor
110236589|NCT00346489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236590|NCT00346489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110236591|NCT00346489|Alkylating Agents|alkylating agents|mesh-ancestor
110236592|NCT00346489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110236593|NCT00346489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110236594|NCT00125814|Interferons|interferons|mesh-list
110236595|NCT00125814|Interferon-alpha|interferon-alpha|mesh-list
110236596|NCT00125814|Interferon alpha-2|interferon alpha-2|mesh-list
110236597|NCT00125814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110236598|NCT00125814|Antiviral Agents|antiviral agents|mesh-ancestor
110236599|NCT00125814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110236610|NCT00346567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110236611|NCT00346567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110236613|NCT00346567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110236614|NCT00346567|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110236615|NCT00346567|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110236616|NCT00346567|Antimetabolites|antimetabolites|mesh-ancestor
110236617|NCT00090623|Ranibizumab|ranibizumab|mesh-list
110236618|NCT00090623|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110236619|NCT00090623|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110236620|NCT00090623|Growth Substances|growth substances|mesh-ancestor
110236621|NCT00090623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236622|NCT00090623|Growth Inhibitors|growth inhibitors|mesh-ancestor
110236623|NCT00090623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110236625|NCT02957994|Antiviral Agents|antiviral agents|mesh-ancestor
110236626|NCT02957994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110236627|NCT02957994|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110236628|NCT02957994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110236629|NCT02957994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110236630|NCT02957994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110236631|NCT02957994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110236632|NCT02957994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110236633|NCT00346645|Bortezomib|bortezomib|mesh-list
110236634|NCT00346645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110236635|NCT00346684|Rituximab|rituximab|mesh-list
110236636|NCT00346684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110236637|NCT00346684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110236638|NCT00346684|Immunologic Factors|immunologic factors|mesh-ancestor
110236639|NCT00346684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236640|NCT00346684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110236641|NCT04728932|Simendan|simendan|mesh-list
110236642|NCT04728932|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110236643|NCT04728932|Vasodilator Agents|vasodilator agents|mesh-ancestor
110236644|NCT04728932|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110236645|NCT04728932|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110236646|NCT04728932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110236649|NCT04728932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236650|NCT00125892|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110236651|NCT00125892|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110236652|NCT00125892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110236653|NCT00125892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110236654|NCT00125892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110236655|NCT00125892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110236656|NCT00125892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236657|NCT00125892|Analgesics|analgesics|mesh-ancestor
110236658|NCT00125892|Sensory System Agents|sensory system agents|mesh-ancestor
110236659|NCT00125892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110236660|NCT00125892|Antidepressive Agents|antidepressive agents|mesh-ancestor
110236661|NCT00125892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110236662|NCT00125892|Dopamine Agents|dopamine agents|mesh-ancestor
110236663|NCT00346801|Celecoxib|celecoxib|mesh-list
110236664|NCT00346801|Cisplatin|cisplatin|mesh-list
110236665|NCT00346801|Irinotecan|irinotecan|mesh-list
110236666|NCT00346801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110236667|NCT00346801|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110236668|NCT00346801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110236669|NCT00346801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110236670|NCT00346801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110236671|NCT00346801|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110236672|NCT00346801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110236674|NCT00346801|Sensory System Agents|sensory system agents|mesh-ancestor
110236675|NCT00346801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110236676|NCT00346801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236677|NCT00346801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110236678|NCT00346801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110236679|NCT00346801|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110236680|NCT00346801|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110236681|NCT00346840|Misoprostol|misoprostol|mesh-list
110236682|NCT00346840|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110236683|NCT00346840|Abortifacient Agents|abortifacient agents|mesh-ancestor
110236684|NCT00346840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110236685|NCT00346840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236686|NCT00346840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110236687|NCT00346840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110236688|NCT00346840|Oxytocics|oxytocics|mesh-ancestor
110236690|NCT00346879|Fondaparinux|fondaparinux|mesh-list
110236691|NCT00346879|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110236692|NCT00346879|Antithrombins|antithrombins|mesh-ancestor
110236693|NCT00346879|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110236694|NCT00346879|Protease Inhibitors|protease inhibitors|mesh-ancestor
110236695|NCT00346879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110236696|NCT00346879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110236697|NCT00346879|Anticoagulants|anticoagulants|mesh-ancestor
110236698|NCT00346879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110236699|NCT00346879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110236700|NCT00126009|Amisulpride|amisulpride|mesh-list
110236701|NCT00126009|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110236702|NCT00126009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110236703|NCT00126009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110236704|NCT00126009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236705|NCT00126009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110236707|NCT00126009|Dopamine Agents|dopamine agents|mesh-ancestor
110236708|NCT00126009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110236709|NCT00126009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110236710|NCT00126009|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110236711|NCT00126009|Antidepressive Agents|antidepressive agents|mesh-ancestor
110236713|NCT00346918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110236714|NCT00346918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110236715|NCT00346918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110236716|NCT00346918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110236717|NCT00346918|Antifungal Agents|antifungal agents|mesh-ancestor
110236719|NCT00346918|Immunologic Factors|immunologic factors|mesh-ancestor
110236720|NCT00346918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236722|NCT00346957|Anecortave|anecortave|mesh-list
110236723|NCT00346957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110236724|NCT00346957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110236725|NCT00346957|Growth Substances|growth substances|mesh-ancestor
110236726|NCT00346957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236727|NCT00346957|Growth Inhibitors|growth inhibitors|mesh-ancestor
110236728|NCT00346957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110236729|NCT00346957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110236730|NCT00346996|Insulin|insulin|mesh-list
110236731|NCT00346996|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110236732|NCT00346996|Insulin Detemir|insulin detemir|mesh-list
110236733|NCT00346996|Isophane Insulin, Human|isophane insulin, human|mesh-list
110236734|NCT00346996|Insulin, Isophane|insulin, isophane|mesh-list
110236735|NCT00346996|Isophane insulin, beef|isophane insulin, beef|mesh-list
110236736|NCT00346996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110236737|NCT00346996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236738|NCT00402480|Hydroxyurea|hydroxyurea|mesh-list
110236739|NCT00402480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110236740|NCT00402480|Antisickling Agents|antisickling agents|mesh-ancestor
110236741|NCT00402480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110236742|NCT00402480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110236743|NCT00402480|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110236744|NCT00347035|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110236745|NCT00347035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110236746|NCT00347035|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110236747|NCT00347035|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110236748|NCT00347035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110236749|NCT00347035|Adrenergic Agents|adrenergic agents|mesh-ancestor
110236750|NCT00347035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110236751|NCT00347035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110236752|NCT00347035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236753|NCT00347113|Albendazole|albendazole|mesh-list
110236754|NCT00347113|Praziquantel|praziquantel|mesh-list
110236755|NCT00347113|Anthelmintics|anthelmintics|mesh-ancestor
110236756|NCT00347113|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110236757|NCT00347113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110236758|NCT00347113|Anticestodal Agents|anticestodal agents|mesh-ancestor
110236759|NCT00347113|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110236760|NCT00347113|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110236761|NCT00347113|Tubulin Modulators|tubulin modulators|mesh-ancestor
110236762|NCT00347113|Antimitotic Agents|antimitotic agents|mesh-ancestor
110236763|NCT00347113|Mitosis Modulators|mitosis modulators|mesh-ancestor
110236764|NCT00347113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110236765|NCT00347113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110236766|NCT00347152|Valproic Acid|valproic acid|mesh-list
110236767|NCT00347152|Anticonvulsants|anticonvulsants|mesh-ancestor
110236768|NCT00347152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110236770|NCT00347152|GABA Agents|gaba agents|mesh-ancestor
110236771|NCT00347152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110236772|NCT00347152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236773|NCT00347152|Antimanic Agents|antimanic agents|mesh-ancestor
110236774|NCT00347152|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110236775|NCT00347152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110236776|NCT00347152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110236777|NCT00090896|Ipilimumab|ipilimumab|mesh-list
110236778|NCT00090896|Antibodies|antibodies|mesh-list
110236779|NCT00090896|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110236780|NCT00090896|Immunologic Factors|immunologic factors|mesh-ancestor
110236781|NCT00090896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236782|NCT00090896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110236783|NCT00090896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110236784|NCT00090896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110236785|NCT00090896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110236786|NCT00402558|Aldesleukin|aldesleukin|mesh-list
110236787|NCT00402558|Methotrexate|methotrexate|mesh-list
110236788|NCT00402558|Fludarabine phosphate|fludarabine phosphate|mesh-list
110236789|NCT00402558|Fludarabine|fludarabine|mesh-list
110236790|NCT00402558|Busulfan|busulfan|mesh-list
110236791|NCT00402558|Interleukin-2|interleukin-2|mesh-list
110236792|NCT00402558|Tacrolimus|tacrolimus|mesh-list
110236793|NCT00402558|Thymoglobulin|thymoglobulin|mesh-list
110236794|NCT00402558|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110236795|NCT00402558|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110236796|NCT00402558|Abortifacient Agents|abortifacient agents|mesh-ancestor
110236797|NCT00402558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110236798|NCT00402558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236799|NCT00402558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110236800|NCT00402558|Antimetabolites|antimetabolites|mesh-ancestor
110236801|NCT00402558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110236802|NCT00402558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110236803|NCT00402558|Dermatologic Agents|dermatologic agents|mesh-ancestor
110236804|NCT00402558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110236805|NCT00402558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110236806|NCT00402558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110236807|NCT00402558|Immunologic Factors|immunologic factors|mesh-ancestor
110236808|NCT00402558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110236809|NCT00402558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110236810|NCT00402558|Antiviral Agents|antiviral agents|mesh-ancestor
110236811|NCT00402558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110236812|NCT00402558|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110236813|NCT00402558|Alkylating Agents|alkylating agents|mesh-ancestor
110236814|NCT00402558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110236815|NCT00402558|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110236816|NCT00402558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110236817|NCT00402558|Analgesics|analgesics|mesh-ancestor
110236818|NCT00402558|Sensory System Agents|sensory system agents|mesh-ancestor
110236819|NCT00402558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110236820|NCT00402558|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110236821|NCT00402558|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110236822|NCT00347386|Zinc Sulfate|zinc sulfate|mesh-list
110236823|NCT00347386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236824|NCT00347386|Astringents|astringents|mesh-ancestor
110236825|NCT00347386|Dermatologic Agents|dermatologic agents|mesh-ancestor
110236826|NCT00347425|Olanzapine|olanzapine|mesh-list
110236827|NCT00347425|Risperidone|risperidone|mesh-list
110236828|NCT00347425|Aripiprazole|aripiprazole|mesh-list
110236829|NCT00347425|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110236830|NCT00347425|Ziprasidone|ziprasidone|mesh-list
110236831|NCT00347425|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110236832|NCT00347425|Serotonin Agents|serotonin agents|mesh-ancestor
110236833|NCT00347425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110266884|NCT00183612|Olanzapine|olanzapine|mesh-list
110236834|NCT00347425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110236835|NCT00347425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236838|NCT00347425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110236839|NCT00347425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110236840|NCT00347425|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110236841|NCT00347425|Dopamine Agents|dopamine agents|mesh-ancestor
110236843|NCT00347425|Autonomic Agents|autonomic agents|mesh-ancestor
110236844|NCT00347425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110236845|NCT00347425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110236846|NCT00347425|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110236847|NCT00347425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110236848|NCT00347425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110236849|NCT00347425|Antidepressive Agents|antidepressive agents|mesh-ancestor
110236850|NCT00347425|Dopamine Agonists|dopamine agonists|mesh-ancestor
110236851|NCT00347425|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110236852|NCT00347425|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110236853|NCT00347425|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110236854|NCT00347425|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110236855|NCT00126048|Atorvastatin|atorvastatin|mesh-list
110236856|NCT00126048|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110236857|NCT00126048|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110236858|NCT00126048|Antimetabolites|antimetabolites|mesh-ancestor
110236859|NCT00126048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110236860|NCT00126048|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110236861|NCT00126048|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110236862|NCT00126048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110236863|NCT00126087|Dopamine|dopamine|mesh-list
110236864|NCT00126087|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110236865|NCT00126087|Sympathomimetics|sympathomimetics|mesh-ancestor
110236866|NCT00126087|Autonomic Agents|autonomic agents|mesh-ancestor
110236867|NCT00126087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110236868|NCT00126087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236870|NCT00126087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110236871|NCT00126087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110236872|NCT00126087|Protective Agents|protective agents|mesh-ancestor
110236873|NCT00347503|Ketorolac|ketorolac|mesh-list
110236874|NCT00347503|Bromfenac|bromfenac|mesh-list
110236875|NCT00347503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110236876|NCT00347503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110236877|NCT00347503|Analgesics|analgesics|mesh-ancestor
110236878|NCT00347503|Sensory System Agents|sensory system agents|mesh-ancestor
110236879|NCT00347503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110236880|NCT00347503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236881|NCT00347503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110236882|NCT00347503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110236883|NCT00347503|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110236884|NCT00347503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110236885|NCT00347503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110236886|NCT00347542|Vitamin D|vitamin d|mesh-list
110236887|NCT00347542|Vitamins|vitamins|mesh-ancestor
110236888|NCT00347542|Micronutrients|micronutrients|mesh-ancestor
110236889|NCT00347542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236890|NCT00347542|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110236891|NCT00091052|Sargramostim|sargramostim|mesh-list
110236892|NCT00091052|Immunologic Factors|immunologic factors|mesh-ancestor
110236893|NCT00091052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236894|NCT00347581|Methamphetamine|methamphetamine|mesh-list
110236895|NCT00347581|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110236896|NCT00347581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236897|NCT00347581|Sympathomimetics|sympathomimetics|mesh-ancestor
110236898|NCT00347581|Autonomic Agents|autonomic agents|mesh-ancestor
110236899|NCT00347581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110236900|NCT00347581|Dopamine Agents|dopamine agents|mesh-ancestor
110236901|NCT00347581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110236902|NCT00347581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110236903|NCT00347581|Adrenergic Agents|adrenergic agents|mesh-ancestor
110236904|NCT00347581|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110236905|NCT00347581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110236906|NCT00347581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110236907|NCT00347581|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110236909|NCT00421252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110236910|NCT00421252|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110236911|NCT00421252|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110236912|NCT00421252|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110236913|NCT00421252|Purinergic Agents|purinergic agents|mesh-ancestor
110236914|NCT00421252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110236915|NCT00421252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110236916|NCT00421252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236918|NCT00126204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110236919|NCT00126204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110236920|NCT00126204|Antimalarials|antimalarials|mesh-ancestor
110236921|NCT00126204|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110236922|NCT00126204|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110236923|NCT04705402|Mannitol|mannitol|mesh-list
110236924|NCT04705402|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110236925|NCT04705402|Diuretics|diuretics|mesh-ancestor
110236926|NCT04705402|Natriuretic Agents|natriuretic agents|mesh-ancestor
110236927|NCT04705402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236928|NCT00091130|Vaccines|vaccines|mesh-list
110236929|NCT00091130|Immunologic Factors|immunologic factors|mesh-ancestor
110236930|NCT00091130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236932|NCT00126243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110236933|NCT00126243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110236934|NCT00126243|Immunologic Factors|immunologic factors|mesh-ancestor
110236935|NCT00126243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236936|NCT00126243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110236937|NCT00426439|Chloroquine|chloroquine|mesh-list
110236938|NCT00426439|Lumefantrine|lumefantrine|mesh-list
110236939|NCT00426439|Artemether|artemether|mesh-list
110236940|NCT00426439|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110236941|NCT00426439|Amebicides|amebicides|mesh-ancestor
110236942|NCT00426439|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110236943|NCT00426439|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110236944|NCT00426439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110236945|NCT00426439|Antimalarials|antimalarials|mesh-ancestor
110236946|NCT00426439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110236948|NCT00426478|Valsartan|valsartan|mesh-list
110236949|NCT00426478|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110236950|NCT00426478|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110236951|NCT00426478|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110236952|NCT00426478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110236953|NCT00426478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110236954|NCT00426478|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110236955|NCT00426478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236956|NCT00426478|Vasodilator Agents|vasodilator agents|mesh-ancestor
110236957|NCT00426478|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110236958|NCT00426478|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110236959|NCT00426478|Diuretics|diuretics|mesh-ancestor
110236960|NCT00426478|Natriuretic Agents|natriuretic agents|mesh-ancestor
110236961|NCT00426478|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110236962|NCT04705519|Paclitaxel|paclitaxel|mesh-list
110236963|NCT04705519|Bevacizumab|bevacizumab|mesh-list
110236964|NCT04705519|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110236966|NCT04705519|Tubulin Modulators|tubulin modulators|mesh-ancestor
110236967|NCT04705519|Antimitotic Agents|antimitotic agents|mesh-ancestor
110236968|NCT04705519|Mitosis Modulators|mitosis modulators|mesh-ancestor
110236969|NCT04705519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110236970|NCT04705519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110236971|NCT04705519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110236972|NCT04705519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110236973|NCT04705519|Growth Substances|growth substances|mesh-ancestor
110236974|NCT04705519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236975|NCT04705519|Growth Inhibitors|growth inhibitors|mesh-ancestor
110236976|NCT00126282|Cycloserine|cycloserine|mesh-list
110236977|NCT00126282|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110236978|NCT00126282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110236979|NCT00126282|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110236980|NCT00126282|Antitubercular Agents|antitubercular agents|mesh-ancestor
110236981|NCT00126282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110236982|NCT00126282|Antimetabolites|antimetabolites|mesh-ancestor
110236983|NCT00126282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110236984|NCT04705129|Tislelizumab|tislelizumab|mesh-list
110236985|NCT04705129|Zanubrutinib|zanubrutinib|mesh-list
110236986|NCT04705129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110236987|NCT04705129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110236988|NCT04705129|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110236989|NCT04705129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110236990|NCT04705129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110236992|NCT00126321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110236993|NCT00126321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110236994|NCT00126321|Immunologic Factors|immunologic factors|mesh-ancestor
110236995|NCT00126321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236996|NCT00426595|Omeprazole|omeprazole|mesh-list
110236997|NCT00426595|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110236998|NCT00426595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110236999|NCT00426595|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110237000|NCT00426595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110237001|NCT00426595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110237002|NCT00426673|Brivaracetam|brivaracetam|mesh-list
110237003|NCT00426673|Anticonvulsants|anticonvulsants|mesh-ancestor
110237004|NCT00426712|1018 oligonucleotide|1018 oligonucleotide|mesh-list
110237005|NCT00426712|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110237006|NCT00426712|Immunologic Factors|immunologic factors|mesh-ancestor
110237007|NCT00426712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110237008|NCT00091247|Tetracycline|tetracycline|mesh-list
110237009|NCT00091247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110237010|NCT00091247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110237011|NCT00091247|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110237012|NCT00091247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110237013|NCT00091247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110237014|NCT00126360|Anastrozole|anastrozole|mesh-list
110237015|NCT00126360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110237016|NCT00126360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110237017|NCT00126360|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110237018|NCT00126360|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110237020|NCT00126360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110237021|NCT00126360|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110237022|NCT00126360|Hormone Antagonists|hormone antagonists|mesh-ancestor
110237023|NCT00126360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110237024|NCT00126360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110237026|NCT01058863|Procaterol|procaterol|mesh-list
110237027|NCT01058863|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110237028|NCT01058863|Autonomic Agents|autonomic agents|mesh-ancestor
110237030|NCT01058863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110237031|NCT01058863|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110237032|NCT01058863|Respiratory System Agents|respiratory system agents|mesh-ancestor
110237033|NCT01058863|Tocolytic Agents|tocolytic agents|mesh-ancestor
110237034|NCT01058863|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110237035|NCT01058863|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110237036|NCT01058863|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110237037|NCT01058863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110237038|NCT01058863|Adrenergic Agents|adrenergic agents|mesh-ancestor
110237039|NCT01058863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110237040|NCT01058863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110237041|NCT01058863|Sympathomimetics|sympathomimetics|mesh-ancestor
110237042|NCT00091286|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
110237043|NCT00091286|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110237044|NCT00091286|Immunologic Factors|immunologic factors|mesh-ancestor
110237045|NCT00091286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110237046|NCT00126399|Doxycycline|doxycycline|mesh-list
110237047|NCT00126399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110237048|NCT00126399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110237049|NCT00126399|Antimalarials|antimalarials|mesh-ancestor
110237050|NCT00126399|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110237051|NCT00126399|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110237052|NCT01058395|Minocycline|minocycline|mesh-list
110237053|NCT01058395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110237054|NCT01058395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110237055|NCT00091325|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
110237056|NCT00091325|Antioxidants|antioxidants|mesh-ancestor
110237057|NCT00091325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110237058|NCT00091325|Protective Agents|protective agents|mesh-ancestor
110237059|NCT00091325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110237060|NCT00091325|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110237061|NCT00091325|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110237062|NCT00091325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110237063|NCT00091325|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110237064|NCT00126516|Angiotensin II|angiotensin ii|mesh-list
110237065|NCT00126516|Giapreza|giapreza|mesh-list
110237066|NCT00126516|Enzyme Inhibitors|enzyme inhibitors|mesh-list
110237067|NCT00126516|Angiotensinogen|angiotensinogen|mesh-list
110237068|NCT00126516|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110237069|NCT00126516|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
110237070|NCT00126516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110237071|NCT00126516|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110237072|NCT00126516|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110237074|NCT00091520|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
110237075|NCT00091520|Natriuretic Agents|natriuretic agents|mesh-ancestor
110237076|NCT00091520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110237077|NCT04710888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110237078|NCT01058005|Interferons|interferons|mesh-list
110237079|NCT01058005|Interferon-beta|interferon-beta|mesh-list
110237080|NCT01058005|Interferon beta-1a|interferon beta-1a|mesh-list
110237081|NCT01058005|Glatiramer Acetate|glatiramer acetate|mesh-list
110237082|NCT01058005|Natalizumab|natalizumab|mesh-list
110237083|NCT01058005|(T,G)-A-L|(t,g)-a-l|mesh-list
110237084|NCT01058005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110237085|NCT01058005|Antiviral Agents|antiviral agents|mesh-ancestor
110237089|NCT01058005|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110237090|NCT01058005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110237091|NCT01058005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110237093|NCT00091559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110237094|NCT00091559|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110237095|NCT00091559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110237096|NCT00091559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110237097|NCT00426829|Bevacizumab|bevacizumab|mesh-list
110237098|NCT00426829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110237099|NCT00426829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110237100|NCT00426829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110237101|NCT00426829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110237102|NCT00426829|Growth Substances|growth substances|mesh-ancestor
110237103|NCT00426829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110237104|NCT00426829|Growth Inhibitors|growth inhibitors|mesh-ancestor
110237106|NCT00426946|Antidepressive Agents|antidepressive agents|mesh-ancestor
110237107|NCT00426946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110237108|NCT00426946|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110237109|NCT00426946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110237110|NCT00426946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110237111|NCT00426946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110237112|NCT00426946|Adrenergic Agents|adrenergic agents|mesh-ancestor
110237113|NCT00426946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110237114|NCT00426946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110237115|NCT00091598|Ambrisentan|ambrisentan|mesh-list
110237116|NCT00091598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110237117|NCT00426985|Ketoprofen|ketoprofen|mesh-list
110237118|NCT00426985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110237119|NCT00426985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110237120|NCT00426985|Analgesics|analgesics|mesh-ancestor
110237121|NCT00426985|Sensory System Agents|sensory system agents|mesh-ancestor
110237122|NCT00426985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110237123|NCT00426985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110237124|NCT00426985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110237125|NCT00426985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110237127|NCT00426985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110237128|NCT00426985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110237129|NCT00427102|Cisplatin|cisplatin|mesh-list
110237130|NCT00427102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110237131|NCT00427414|Daunorubicin|daunorubicin|mesh-list
110237132|NCT00427414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110237133|NCT00427414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110237134|NCT00427414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110237135|NCT00427414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110237137|NCT00427414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110237138|NCT03929718|Spironolactone|spironolactone|mesh-list
110237139|NCT03929718|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110237140|NCT03929718|Hormone Antagonists|hormone antagonists|mesh-ancestor
110237141|NCT03929718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110237142|NCT03929718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110237143|NCT03929718|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110237144|NCT03929718|Diuretics|diuretics|mesh-ancestor
110237152|NCT01056523|Antiviral Agents|antiviral agents|mesh-ancestor
110237153|NCT01056523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110237154|NCT01056523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110237155|NCT01056523|Immunologic Factors|immunologic factors|mesh-ancestor
110237156|NCT01056523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110237158|NCT00091715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110237159|NCT00091715|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110237160|NCT00091715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110237161|NCT00427492|Magnesium Oxide|magnesium oxide|mesh-list
110237162|NCT00427492|Antacids|antacids|mesh-ancestor
110237163|NCT00427492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110237164|NCT00427492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110237165|NCT00427570|Fluorouracil|fluorouracil|mesh-list
110237166|NCT00427570|Vincristine|vincristine|mesh-list
110237167|NCT00427570|Semustine|semustine|mesh-list
110237168|NCT00427570|BCG Vaccine|bcg vaccine|mesh-list
110237169|NCT00427570|Antimetabolites|antimetabolites|mesh-ancestor
110237170|NCT00427570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110237171|NCT00427570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110237172|NCT00427570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110237173|NCT00427570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110237174|NCT00427570|Immunologic Factors|immunologic factors|mesh-ancestor
110237175|NCT00427570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110237176|NCT00427570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110237177|NCT00427570|Tubulin Modulators|tubulin modulators|mesh-ancestor
110237178|NCT00427570|Antimitotic Agents|antimitotic agents|mesh-ancestor
110237179|NCT00427570|Mitosis Modulators|mitosis modulators|mesh-ancestor
110237180|NCT00427570|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110237181|NCT00427570|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110237182|NCT00427570|Alkylating Agents|alkylating agents|mesh-ancestor
110237183|NCT00427609|Penicillin G Benzathine|penicillin g benzathine|mesh-list
110237184|NCT00427609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110237185|NCT00427609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110237186|NCT00091910|Epoetin Alfa|epoetin alfa|mesh-list
110237187|NCT00091910|Hematinics|hematinics|mesh-ancestor
110237188|NCT00427882|Alfuzosin|alfuzosin|mesh-list
110237189|NCT00427882|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110237190|NCT00427882|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110237191|NCT00427882|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110237192|NCT00427882|Adrenergic Agents|adrenergic agents|mesh-ancestor
110237193|NCT00427882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110237194|NCT00427882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110237195|NCT00427882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110237198|NCT04704622|Dexmedetomidine|dexmedetomidine|mesh-list
110237199|NCT04704622|Ketamine|ketamine|mesh-list
110237200|NCT04704622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110237201|NCT04704622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110237202|NCT04704622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110237203|NCT04704622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110237204|NCT04704622|Analgesics|analgesics|mesh-ancestor
110237205|NCT04704622|Sensory System Agents|sensory system agents|mesh-ancestor
110237206|NCT04704622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110237207|NCT04704622|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110237208|NCT04704622|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110237209|NCT04704622|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110237210|NCT04704622|Adrenergic Agents|adrenergic agents|mesh-ancestor
110237211|NCT04704622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110237212|NCT04704622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110237213|NCT04704622|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110237214|NCT04704622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110237215|NCT04704622|Anesthetics, General|anesthetics, general|mesh-ancestor
110237216|NCT04704622|Anesthetics|anesthetics|mesh-ancestor
110237217|NCT04704622|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110237218|NCT04704622|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110237219|NCT04704622|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110237220|NCT04704622|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110237221|NCT04704622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110237222|NCT04704622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110237223|NCT04704622|GABA Modulators|gaba modulators|mesh-ancestor
110237224|NCT04704622|GABA Agents|gaba agents|mesh-ancestor
110237225|NCT00428194|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110237226|NCT00428194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110237227|NCT00428194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110237228|NCT00428194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110237229|NCT00428194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110237230|NCT03769467|Pembrolizumab|pembrolizumab|mesh-list
110237231|NCT03769467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110237232|NCT03769467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110237233|NCT03769467|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110237234|NCT03769467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110237235|NCT00092183|Ondansetron|ondansetron|mesh-list
110237236|NCT00092183|Aprepitant|aprepitant|mesh-list
110237237|NCT00092183|Antiemetics|antiemetics|mesh-ancestor
110237238|NCT00092183|Autonomic Agents|autonomic agents|mesh-ancestor
110237239|NCT00092183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110237240|NCT00092183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110237241|NCT00092183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110237242|NCT00092183|Antipruritics|antipruritics|mesh-ancestor
110237244|NCT00092183|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110237245|NCT00092183|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110237246|NCT00092183|Serotonin Agents|serotonin agents|mesh-ancestor
110237247|NCT00092183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110237248|NCT00092183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110237249|NCT00092183|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110237251|NCT00428272|Interferon-gamma|interferon-gamma|mesh-list
110237252|NCT00428272|Lexatumumab|lexatumumab|mesh-list
110237253|NCT00428272|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110237254|NCT00428272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110237255|NCT00428272|Antiviral Agents|antiviral agents|mesh-ancestor
110237256|NCT00428272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110237257|NCT00428272|Immunologic Factors|immunologic factors|mesh-ancestor
110237258|NCT00428272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110237259|NCT01580254|Latanoprost|latanoprost|mesh-list
110237260|NCT01580254|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110237261|NCT01580254|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110237262|NCT00428311|Metformin|metformin|mesh-list
110237263|NCT00428311|Cyproterone Acetate|cyproterone acetate|mesh-list
110237264|NCT00428311|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110237265|NCT00428311|Estradiol|estradiol|mesh-list
110237266|NCT00428311|Cyproterone|cyproterone|mesh-list
110237267|NCT00428311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110237268|NCT00428311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110237269|NCT00428311|Estrogens|estrogens|mesh-ancestor
110237270|NCT00428311|Hormones|hormones|mesh-ancestor
110237271|NCT00428311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110237272|NCT00428311|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110237273|NCT00428311|Contraceptive Agents|contraceptive agents|mesh-ancestor
110237274|NCT00428311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110237275|NCT00428311|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110237276|NCT00428311|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110237277|NCT00428311|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110237279|NCT00428311|Hormone Antagonists|hormone antagonists|mesh-ancestor
110237280|NCT00428311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110237281|NCT00428311|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110237283|NCT00092300|Rofecoxib|rofecoxib|mesh-list
110237284|NCT00092300|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110237285|NCT00092300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110237286|NCT00092300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110237287|NCT00092300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110237288|NCT00092300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110237289|NCT00092300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110237290|NCT00092300|Analgesics|analgesics|mesh-ancestor
110237291|NCT00092300|Sensory System Agents|sensory system agents|mesh-ancestor
110237292|NCT00092300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110237293|NCT00092300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110237294|NCT00092300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110237295|NCT00092300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110237296|NCT00428350|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110237297|NCT00428350|Antidepressive Agents|antidepressive agents|mesh-ancestor
110237298|NCT00428350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110237299|NCT00428350|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110237300|NCT00428350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110237301|NCT00428350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110237302|NCT00428350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110237303|NCT00428428|Isoproterenol|isoproterenol|mesh-list
110237304|NCT00428428|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110237305|NCT00428428|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110237306|NCT00428428|Adrenergic Agents|adrenergic agents|mesh-ancestor
110237307|NCT00428428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110237308|NCT00428428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110237309|NCT00428428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110237310|NCT00428428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110237311|NCT00428428|Autonomic Agents|autonomic agents|mesh-ancestor
110237312|NCT00428428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110237313|NCT00428428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110237314|NCT00428428|Respiratory System Agents|respiratory system agents|mesh-ancestor
110237315|NCT00428428|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110237316|NCT00428428|Sympathomimetics|sympathomimetics|mesh-ancestor
110237317|NCT00428428|Protective Agents|protective agents|mesh-ancestor
110237319|NCT00092339|Rofecoxib|rofecoxib|mesh-list
110237320|NCT00092339|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110237321|NCT00092339|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110266992|NCT00539773|Interferons|interferons|mesh-list
110237322|NCT00092339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110237323|NCT00092339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110237324|NCT00092339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110237326|NCT00092339|Analgesics|analgesics|mesh-ancestor
110237327|NCT00092339|Sensory System Agents|sensory system agents|mesh-ancestor
110237328|NCT00092339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110237329|NCT00092339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110237330|NCT00092339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110237331|NCT00092339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110237332|NCT00428545|Bevacizumab|bevacizumab|mesh-list
110237333|NCT00428545|Bortezomib|bortezomib|mesh-list
110237334|NCT00428545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110237335|NCT00428545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110237336|NCT00428545|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110237337|NCT00428545|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110237338|NCT00428545|Growth Substances|growth substances|mesh-ancestor
110237339|NCT00428545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110237340|NCT00428545|Growth Inhibitors|growth inhibitors|mesh-ancestor
110237341|NCT00092378|Diclofenac|diclofenac|mesh-list
110237342|NCT00092378|Rofecoxib|rofecoxib|mesh-list
110237343|NCT00092378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110237344|NCT00092378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110237345|NCT00092378|Analgesics|analgesics|mesh-ancestor
110237346|NCT00092378|Sensory System Agents|sensory system agents|mesh-ancestor
110237347|NCT00092378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110237348|NCT00092378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110237349|NCT00092378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110237350|NCT00092378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110237351|NCT00092378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110237352|NCT00092378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110237353|NCT00092378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110237354|NCT00092378|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110237355|NCT00092846|Lovastatin|lovastatin|mesh-list
110237356|NCT00092846|L 647318|l 647318|mesh-list
110237357|NCT00092846|Dihydromevinolin|dihydromevinolin|mesh-list
110237358|NCT00092846|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110237359|NCT00092846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110237360|NCT00092846|Antimetabolites|antimetabolites|mesh-ancestor
110237361|NCT00092846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110237362|NCT00092846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110237363|NCT00092846|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110237364|NCT00092846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110237365|NCT00092924|Mapatumumab|mapatumumab|mesh-list
110237366|NCT00092924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110237367|NCT00093002|Fulvestrant|fulvestrant|mesh-list
110237368|NCT00093002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110237369|NCT00093002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110237370|NCT00093002|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110237371|NCT00093002|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110237372|NCT00093002|Hormone Antagonists|hormone antagonists|mesh-ancestor
110260204|NCT00168948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110237373|NCT00093002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110237374|NCT00093002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110237375|NCT00093119|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110237376|NCT00093119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110237377|NCT00093158|Anticoagulants|anticoagulants|mesh-list
110237378|NCT00093158|Bivalirudin|bivalirudin|mesh-list
110237379|NCT00093158|Antithrombins|antithrombins|mesh-ancestor
110237380|NCT00093158|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110237381|NCT00093158|Protease Inhibitors|protease inhibitors|mesh-ancestor
110237382|NCT00093158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110237383|NCT00093158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110237384|NCT03501498|Loperamide|loperamide|mesh-list
110237385|NCT03501498|Antidiarrheals|antidiarrheals|mesh-list
110237386|NCT03501498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110237387|NCT05561049|Thalidomide|thalidomide|mesh-list
110237388|NCT05561049|Dexamethasone|dexamethasone|mesh-list
110237389|NCT05561049|Bortezomib|bortezomib|mesh-list
110237390|NCT05561049|Daratumumab|daratumumab|mesh-list
110237391|NCT05561049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110237392|NCT05561049|Antiemetics|antiemetics|mesh-ancestor
110237393|NCT05561049|Autonomic Agents|autonomic agents|mesh-ancestor
110237394|NCT05561049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110237395|NCT05561049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110237396|NCT05561049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110237397|NCT05561049|Glucocorticoids|glucocorticoids|mesh-ancestor
110237398|NCT05561049|Hormones|hormones|mesh-ancestor
110237399|NCT05561049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110237400|NCT05561049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110237401|NCT05561049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110237404|NCT05561049|Leprostatic Agents|leprostatic agents|mesh-ancestor
110237405|NCT05561049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110237406|NCT05561049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110237407|NCT05561049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110237408|NCT05561049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110237409|NCT05561049|Growth Substances|growth substances|mesh-ancestor
110237410|NCT05561049|Growth Inhibitors|growth inhibitors|mesh-ancestor
110237411|NCT00424034|Ambrisentan|ambrisentan|mesh-list
110237412|NCT00424034|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110237413|NCT05561010|Bupivacaine|bupivacaine|mesh-list
110237414|NCT05561010|Anesthetics, Local|anesthetics, local|mesh-ancestor
110237415|NCT05561010|Anesthetics|anesthetics|mesh-ancestor
110237416|NCT05561010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110237417|NCT05561010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110237418|NCT05561010|Sensory System Agents|sensory system agents|mesh-ancestor
110237419|NCT05561010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110237420|NCT03448107|Fluorides|fluorides|mesh-list
110237421|NCT03448107|Fluorides, Topical|fluorides, topical|mesh-list
110237422|NCT03448107|Cariostatic Agents|cariostatic agents|mesh-ancestor
110237423|NCT03448107|Protective Agents|protective agents|mesh-ancestor
110237424|NCT03448107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110237425|NCT00093314|Ofatumumab|ofatumumab|mesh-list
110237426|NCT00093314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110237427|NCT00093353|Cefixime|cefixime|mesh-list
110237428|NCT00093353|Irinotecan|irinotecan|mesh-list
110237429|NCT00093353|Temozolomide|temozolomide|mesh-list
110237430|NCT00093353|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110237431|NCT00093353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110237432|NCT00093353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110237433|NCT00093353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110237434|NCT00093353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110237435|NCT00093353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110237436|NCT00093353|Alkylating Agents|alkylating agents|mesh-ancestor
110237437|NCT00093353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110237438|NCT00093353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110237439|NCT00093509|Doxorubicin|doxorubicin|mesh-list
110237440|NCT00093509|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110237442|NCT00093509|Isophosphamide mustard|isophosphamide mustard|mesh-list
110237444|NCT00093509|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110267009|NCT00539890|Insulin|insulin|mesh-list
110237452|NCT00093509|Protective Agents|protective agents|mesh-ancestor
110237453|NCT00093509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110237454|NCT00093548|Vaccines|vaccines|mesh-list
110237455|NCT00093548|Sargramostim|sargramostim|mesh-list
110237456|NCT00093548|Adjuvants, Vaccine|adjuvants, vaccine|mesh-list
110237457|NCT00093548|Immunologic Factors|immunologic factors|mesh-ancestor
110237458|NCT00093548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110237459|NCT00093548|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110237460|NCT05549895|Dexamethasone|dexamethasone|mesh-list
110237461|NCT05549895|Bupivacaine|bupivacaine|mesh-list
110237462|NCT05549895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110237463|NCT05549895|Antiemetics|antiemetics|mesh-ancestor
110237464|NCT05549895|Autonomic Agents|autonomic agents|mesh-ancestor
110237465|NCT05549895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110237466|NCT05549895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110237467|NCT05549895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110237468|NCT05549895|Glucocorticoids|glucocorticoids|mesh-ancestor
110237470|NCT05549895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110237471|NCT05549895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110237472|NCT05549895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110237473|NCT05549895|Anesthetics, Local|anesthetics, local|mesh-ancestor
110237474|NCT05549895|Anesthetics|anesthetics|mesh-ancestor
110237475|NCT05549895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110237476|NCT05549895|Sensory System Agents|sensory system agents|mesh-ancestor
110237477|NCT00093587|Cyclosporine|cyclosporine|mesh-list
110237478|NCT00093587|Cyclophosphamide|cyclophosphamide|mesh-list
110237479|NCT00093587|Busulfan|busulfan|mesh-list
110237480|NCT00093587|Cyclosporins|cyclosporins|mesh-list
110237481|NCT00093587|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110237482|NCT00093587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110237483|NCT00093587|Immunologic Factors|immunologic factors|mesh-ancestor
110237484|NCT00093587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110237485|NCT00093587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110237486|NCT00093587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110237487|NCT00093587|Alkylating Agents|alkylating agents|mesh-ancestor
110237488|NCT00093587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110237489|NCT00093587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110237490|NCT00093587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110237491|NCT00093587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110237492|NCT00093587|Antifungal Agents|antifungal agents|mesh-ancestor
110237493|NCT00093587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110237494|NCT00093587|Dermatologic Agents|dermatologic agents|mesh-ancestor
110237495|NCT00093587|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110237496|NCT00093626|Sorafenib|sorafenib|mesh-list
110237497|NCT00093626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110237498|NCT00093626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110237499|NCT00093626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110237500|NCT00093626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110237501|NCT05543109|Fentanyl|fentanyl|mesh-list
110237502|NCT05543109|Narcotics|narcotics|mesh-list
110237503|NCT05543109|Propofol|propofol|mesh-list
110237504|NCT05543109|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
110237505|NCT05543109|Ropivacaine|ropivacaine|mesh-list
110237506|NCT05543109|Anesthetics|anesthetics|mesh-list
110237507|NCT05543109|Sevoflurane|sevoflurane|mesh-list
110237508|NCT05543109|Anesthetics, Local|anesthetics, local|mesh-list
110237509|NCT05543109|Rocuronium|rocuronium|mesh-list
110237510|NCT05543109|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110237511|NCT05543109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110237512|NCT05543109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110237513|NCT05543109|Anesthetics, General|anesthetics, general|mesh-ancestor
110237514|NCT05543109|Sensory System Agents|sensory system agents|mesh-ancestor
110237515|NCT05543109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110237516|NCT05543109|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110237518|NCT05543109|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110237519|NCT05543109|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110237520|NCT05543109|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110237521|NCT05543109|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110237522|NCT05543109|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110237523|NCT05543109|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110237524|NCT00093665|Fluorouracil|fluorouracil|mesh-list
110237525|NCT00093665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110237526|NCT00093665|Antimetabolites|antimetabolites|mesh-ancestor
110237527|NCT00093665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110237528|NCT00093665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110237529|NCT00093665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110237530|NCT00093665|Immunologic Factors|immunologic factors|mesh-ancestor
110237531|NCT00093665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110237532|NCT00093704|Ganciclovir|ganciclovir|mesh-list
110237533|NCT00093704|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
110237534|NCT00093704|Bortezomib|bortezomib|mesh-list
110237535|NCT00093704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110237536|NCT00093704|Antiviral Agents|antiviral agents|mesh-ancestor
110237537|NCT00093704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110237538|NCT00093704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110237539|NCT00093704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110260205|NCT00530413|Phenobarbital|phenobarbital|mesh-list
110237540|NCT00093704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110237541|NCT01055314|Dactinomycin|dactinomycin|mesh-list
110237542|NCT01055314|Cyclophosphamide|cyclophosphamide|mesh-list
110237543|NCT01055314|Temozolomide|temozolomide|mesh-list
110237544|NCT01055314|Ifosfamide|ifosfamide|mesh-list
110237545|NCT01055314|Isophosphamide mustard|isophosphamide mustard|mesh-list
110237546|NCT01055314|Doxorubicin|doxorubicin|mesh-list
110237547|NCT01055314|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110237548|NCT01055314|Irinotecan|irinotecan|mesh-list
110237549|NCT01055314|Etoposide|etoposide|mesh-list
110237551|NCT01055314|Etoposide phosphate|etoposide phosphate|mesh-list
110237552|NCT01055314|Podophyllotoxin|podophyllotoxin|mesh-list
110237553|NCT01055314|Camptothecin|camptothecin|mesh-list
110237554|NCT01055314|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110237555|NCT01055314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110237556|NCT01055314|Immunologic Factors|immunologic factors|mesh-ancestor
110237557|NCT01055314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110237558|NCT01055314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110237559|NCT01055314|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110237560|NCT01055314|Alkylating Agents|alkylating agents|mesh-ancestor
110237561|NCT01055314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110237562|NCT01055314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110237563|NCT01055314|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110237564|NCT01055314|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110237565|NCT01055314|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110237566|NCT01055314|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110237567|NCT01055314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110237568|NCT01055314|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110237569|NCT01055314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110237570|NCT01055314|Tubulin Modulators|tubulin modulators|mesh-ancestor
110237571|NCT01055314|Antimitotic Agents|antimitotic agents|mesh-ancestor
110237572|NCT01055314|Mitosis Modulators|mitosis modulators|mesh-ancestor
110237573|NCT01055314|Keratolytic Agents|keratolytic agents|mesh-ancestor
110237574|NCT01055314|Dermatologic Agents|dermatologic agents|mesh-ancestor
110237575|NCT01055314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110237576|NCT01055314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110237577|NCT01055314|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110237578|NCT01055314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110237579|NCT00093743|Cyclosporine|cyclosporine|mesh-list
110237580|NCT00093743|Mycophenolic Acid|mycophenolic acid|mesh-list
110237581|NCT00093743|Fludarabine|fludarabine|mesh-list
110237582|NCT00093743|Fludarabine phosphate|fludarabine phosphate|mesh-list
110237584|NCT00093743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110237585|NCT00093743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110237586|NCT00093743|Antimetabolites|antimetabolites|mesh-ancestor
110237587|NCT00093743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110237588|NCT00093743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110237589|NCT00093743|Immunologic Factors|immunologic factors|mesh-ancestor
110237590|NCT00093743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110237591|NCT00093743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110237592|NCT00093743|Antifungal Agents|antifungal agents|mesh-ancestor
110237593|NCT00093743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110237594|NCT00093743|Dermatologic Agents|dermatologic agents|mesh-ancestor
110237595|NCT00093743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110237596|NCT00093743|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110237597|NCT00093743|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110237598|NCT00093743|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110237599|NCT00093743|Antitubercular Agents|antitubercular agents|mesh-ancestor
110237600|NCT00093743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110237601|NCT00400322|Valganciclovir|valganciclovir|mesh-list
110237602|NCT00400322|Antiviral Agents|antiviral agents|mesh-ancestor
110237603|NCT00400322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110237604|NCT00093860|Propranolol|propranolol|mesh-list
110237605|NCT00093860|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110237606|NCT00093860|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110237607|NCT00093860|Adrenergic Agents|adrenergic agents|mesh-ancestor
110237608|NCT00093860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110237609|NCT00093860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110237610|NCT00093860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110237611|NCT00093860|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110237612|NCT00093860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110237613|NCT00093860|Vasodilator Agents|vasodilator agents|mesh-ancestor
110237614|NCT00402909|Nateglinide|nateglinide|mesh-list
110237615|NCT00402909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110237616|NCT00402909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110237617|NCT02823366|Fenofibrate|fenofibrate|mesh-list
110237618|NCT02823366|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110237619|NCT02823366|Antimetabolites|antimetabolites|mesh-ancestor
110237620|NCT02823366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110237621|NCT02823366|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110237622|NCT00093977|Darbepoetin alfa|darbepoetin alfa|mesh-list
110237623|NCT00093977|Hematinics|hematinics|mesh-ancestor
110237624|NCT00094289|Disulfiram|disulfiram|mesh-list
110237625|NCT00094289|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110237626|NCT00094289|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
110237628|NCT00094289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110237630|NCT00094367|Abacavir|abacavir|mesh-list
110237631|NCT00094367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110237632|NCT00094367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110237633|NCT00094367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110237634|NCT00094367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110237635|NCT00094367|Antiviral Agents|antiviral agents|mesh-ancestor
110237636|NCT00094367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110237637|NCT00094367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110237638|NCT00094367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110237639|NCT00094406|Dimercaprol|dimercaprol|mesh-list
110237640|NCT00094406|Carbon Monoxide|carbon monoxide|mesh-list
110237641|NCT00094406|Chelating Agents|chelating agents|mesh-ancestor
110267047|NCT00540241|Pemetrexed|pemetrexed|mesh-list
110237643|NCT00094406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110237644|NCT00094406|Antimetabolites|antimetabolites|mesh-ancestor
110237645|NCT00094406|Gasotransmitters|gasotransmitters|mesh-ancestor
110237646|NCT00094406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110237653|NCT00094484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110237655|NCT00094523|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110237656|NCT00094523|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110237657|NCT00094523|Protease Inhibitors|protease inhibitors|mesh-ancestor
110237658|NCT00094523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110237659|NCT00094523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110237660|NCT00094523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110237661|NCT00094523|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110237662|NCT00094523|Antiviral Agents|antiviral agents|mesh-ancestor
110237663|NCT00094523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110237664|NCT00428701|Esomeprazole|esomeprazole|mesh-list
110237665|NCT00428701|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110237666|NCT00428701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110237667|NCT00428701|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110237668|NCT00428701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110237669|NCT00428701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110237670|NCT00428818|Doxycycline|doxycycline|mesh-list
110237671|NCT00428818|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110237672|NCT00428818|Trimethoprim|trimethoprim|mesh-list
110237673|NCT00428818|Sulfamethoxazole|sulfamethoxazole|mesh-list
110237674|NCT00428818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110237675|NCT00428818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110237676|NCT00428818|Antimalarials|antimalarials|mesh-ancestor
110237677|NCT00428818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110237678|NCT00428818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110237679|NCT00428818|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110237680|NCT00428818|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110237681|NCT00428818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110237682|NCT00428818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110237683|NCT00428818|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110237684|NCT00428818|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110237685|NCT00428818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110237686|NCT00094640|Olanzapine|olanzapine|mesh-list
110237687|NCT00094640|Antiemetics|antiemetics|mesh-ancestor
110237688|NCT00094640|Autonomic Agents|autonomic agents|mesh-ancestor
110237689|NCT00094640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110237690|NCT00094640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110237691|NCT00094640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110237692|NCT00094640|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110237693|NCT00094640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110237694|NCT00094640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110237695|NCT00094640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110237696|NCT00094640|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110237697|NCT00094640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110237698|NCT00094640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110237699|NCT00094640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110237700|NCT00094640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110237703|NCT02415309|Antioxidants|antioxidants|mesh-ancestor
110237704|NCT02415309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110237705|NCT02415309|Protective Agents|protective agents|mesh-ancestor
110237706|NCT02415309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110237707|NCT02415309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110237708|NCT05393817|Caffeine|caffeine|mesh-list
110237709|NCT05393817|Caffeine citrate|caffeine citrate|mesh-list
110237710|NCT05393817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110237711|NCT05393817|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110237712|NCT05393817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110237713|NCT05393817|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110237714|NCT05393817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110237715|NCT05393817|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110237716|NCT05393817|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110237717|NCT05393817|Purinergic Agents|purinergic agents|mesh-ancestor
110237718|NCT05393817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110237719|NCT00403338|Sirolimus|sirolimus|mesh-list
110237720|NCT00403338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110237721|NCT00403338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110237722|NCT00403338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110237723|NCT00403338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110237724|NCT00403338|Antifungal Agents|antifungal agents|mesh-ancestor
110237725|NCT00403338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110237726|NCT00403338|Immunologic Factors|immunologic factors|mesh-ancestor
110237727|NCT00403338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110237728|NCT00095069|Gaboxadol|gaboxadol|mesh-list
110237729|NCT00095069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110237730|NCT00095069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110237731|NCT00095069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110237732|NCT00095069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110237733|NCT00095069|Analgesics|analgesics|mesh-ancestor
110237734|NCT00095069|Sensory System Agents|sensory system agents|mesh-ancestor
110237735|NCT00095069|Anticonvulsants|anticonvulsants|mesh-ancestor
110237736|NCT00095069|GABA Agonists|gaba agonists|mesh-ancestor
110237737|NCT00095069|GABA Agents|gaba agents|mesh-ancestor
110237738|NCT00403533|Atorvastatin|atorvastatin|mesh-list
110237739|NCT00403533|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110237740|NCT00403533|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110237741|NCT00403533|Antimetabolites|antimetabolites|mesh-ancestor
110237742|NCT00403533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110237743|NCT00403533|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110237744|NCT00403533|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110237745|NCT00403533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110237746|NCT00095225|Bevacizumab|bevacizumab|mesh-list
110237747|NCT00095225|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110237748|NCT00095225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110237752|NCT00095225|Growth Substances|growth substances|mesh-ancestor
110237753|NCT00095225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110237754|NCT00095225|Growth Inhibitors|growth inhibitors|mesh-ancestor
110237755|NCT00095225|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110237756|NCT00095225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110237757|NCT00095225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110237758|NCT00095264|Darbepoetin alfa|darbepoetin alfa|mesh-list
110237760|NCT01054729|Sofosbuvir|sofosbuvir|mesh-list
110237761|NCT01054729|Antiviral Agents|antiviral agents|mesh-ancestor
110237762|NCT01054729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110237763|NCT00403611|Praziquantel|praziquantel|mesh-list
110237764|NCT00403611|Anthelmintics|anthelmintics|mesh-ancestor
110237765|NCT00403611|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110237766|NCT00403611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110237767|NCT00428896|Gefitinib|gefitinib|mesh-list
110237768|NCT00428896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110237769|NCT00428896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110237770|NCT00428896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110237771|NCT00428896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110237772|NCT01990911|Diuretics|diuretics|mesh-list
110237773|NCT01990911|Natriuretic Agents|natriuretic agents|mesh-ancestor
110237774|NCT01990911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110237775|NCT00429091|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110237776|NCT00429091|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110237777|NCT00429091|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110237778|NCT00429091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110237779|NCT00429091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110237780|NCT00429091|Adrenergic Agents|adrenergic agents|mesh-ancestor
110237781|NCT00429091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110237782|NCT00429091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110237783|NCT00095459|Bevacizumab|bevacizumab|mesh-list
110237784|NCT00095459|Sorafenib|sorafenib|mesh-list
110237785|NCT00095459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110237786|NCT00095459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110237787|NCT00095459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110237788|NCT00095459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110237789|NCT00095459|Growth Substances|growth substances|mesh-ancestor
110237790|NCT00095459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110237791|NCT00095459|Growth Inhibitors|growth inhibitors|mesh-ancestor
110237792|NCT00095459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110237793|NCT00095459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110237794|NCT00095459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110237795|NCT00429208|Nicotine|nicotine|mesh-list
110237796|NCT00429208|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110237797|NCT00429208|Autonomic Agents|autonomic agents|mesh-ancestor
110237798|NCT00429208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110237799|NCT00429208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110237800|NCT00429208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110237801|NCT00429208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110237802|NCT00429208|Cholinergic Agents|cholinergic agents|mesh-ancestor
110237803|NCT00429208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110237806|NCT00429247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110237807|NCT00429247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110237808|NCT00095654|Rosiglitazone|rosiglitazone|mesh-list
110237809|NCT00095654|Ramipril|ramipril|mesh-list
110237810|NCT00095654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110237811|NCT00095654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110237812|NCT00095654|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110237813|NCT00095654|Protease Inhibitors|protease inhibitors|mesh-ancestor
110237814|NCT00095654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110237815|NCT00095654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110237816|NCT00095654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110237817|NCT00095693|Sorafenib|sorafenib|mesh-list
110237818|NCT00095693|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110237819|NCT00095693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110267075|NCT00183924|Tubulin Modulators|tubulin modulators|mesh-ancestor
110237820|NCT00095693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110237821|NCT00095693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110237822|NCT00095693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110237823|NCT00095693|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110237825|NCT01054573|Ribavirin|ribavirin|mesh-list
110237826|NCT01054573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110237827|NCT01054573|Antiviral Agents|antiviral agents|mesh-ancestor
110237828|NCT01054573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110237829|NCT01054573|Antimetabolites|antimetabolites|mesh-ancestor
110237830|NCT01054573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110237831|NCT00095771|Arsenic Trioxide|arsenic trioxide|mesh-list
110237832|NCT00095771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110237833|NCT00429442|Simvastatin|simvastatin|mesh-list
110237834|NCT00429442|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110237835|NCT00429442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110237836|NCT00429442|Antimetabolites|antimetabolites|mesh-ancestor
110237837|NCT00429442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110237838|NCT00429442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110237839|NCT00429442|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110237840|NCT00429442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110237841|NCT00429520|Hyaluronic Acid|hyaluronic acid|mesh-list
110237842|NCT00429520|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110237843|NCT00429520|Immunologic Factors|immunologic factors|mesh-ancestor
110237844|NCT00429520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110237845|NCT00429520|Viscosupplements|viscosupplements|mesh-ancestor
110237846|NCT00429520|Protective Agents|protective agents|mesh-ancestor
110237847|NCT00429559|Gemcitabine|gemcitabine|mesh-list
110051184|NCT01471704|Verapamil|verapamil|mesh-list
110237849|NCT00429559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110237850|NCT00429559|Antimetabolites|antimetabolites|mesh-ancestor
110237851|NCT00429559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110237852|NCT00429559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110237853|NCT00429559|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110237854|NCT00429559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110237855|NCT00429559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110237857|NCT00095810|Antidepressive Agents|antidepressive agents|mesh-ancestor
110237858|NCT00095810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110237859|NCT00095810|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110237860|NCT00095810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110237862|NCT00095810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110237863|NCT00095810|Dopamine Agonists|dopamine agonists|mesh-ancestor
110237864|NCT00095810|Dopamine Agents|dopamine agents|mesh-ancestor
110237865|NCT00095810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110237866|NCT00095810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110237867|NCT00095810|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110237868|NCT00095810|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110237869|NCT00095810|Serotonin Agents|serotonin agents|mesh-ancestor
110237870|NCT00095810|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110237871|NCT00095810|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110237872|NCT00095810|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110237873|NCT00095810|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110237874|NCT05234112|Acetic Acid|acetic acid|mesh-list
110237875|NCT05234112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110237876|NCT05234112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110237877|NCT01054300|Ertugliflozin|ertugliflozin|mesh-list
110237878|NCT01054300|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110237879|NCT01054300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110237880|NCT01054300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110237881|NCT01054300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110237882|NCT00095888|Gemcitabine|gemcitabine|mesh-list
110237883|NCT00095888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110237884|NCT00095888|Antimetabolites|antimetabolites|mesh-ancestor
110237885|NCT00095888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110237887|NCT00429676|Haloperidol|haloperidol|mesh-list
110237888|NCT00429676|Haloperidol decanoate|haloperidol decanoate|mesh-list
110237889|NCT00429676|Antiemetics|antiemetics|mesh-ancestor
110237890|NCT00429676|Autonomic Agents|autonomic agents|mesh-ancestor
110237891|NCT00429676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110237892|NCT00429676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110237893|NCT00429676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110237894|NCT00429676|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110237895|NCT00429676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110237896|NCT00429676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110237897|NCT00429676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110237898|NCT00429676|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110237899|NCT00429676|Dopamine Agents|dopamine agents|mesh-ancestor
110237900|NCT00429676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110237901|NCT00429676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110237902|NCT00429676|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110237903|NCT00429715|Aluminum sulfate|aluminum sulfate|mesh-list
110237904|NCT00429715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110237905|NCT00429715|Immunologic Factors|immunologic factors|mesh-ancestor
110237906|NCT00429715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110237908|NCT00095927|Carboplatin|carboplatin|mesh-list
110237910|NCT00095927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110237911|NCT00095927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110237912|NCT00095927|Tubulin Modulators|tubulin modulators|mesh-ancestor
110237913|NCT00095927|Antimitotic Agents|antimitotic agents|mesh-ancestor
110237914|NCT00095927|Mitosis Modulators|mitosis modulators|mesh-ancestor
110237915|NCT00095927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110237916|NCT00095927|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110237917|NCT00095927|Protective Agents|protective agents|mesh-ancestor
110237918|NCT00095927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110237919|NCT00429754|Aprepitant|aprepitant|mesh-list
110237920|NCT00429754|Antiemetics|antiemetics|mesh-ancestor
110237921|NCT00429754|Autonomic Agents|autonomic agents|mesh-ancestor
110237924|NCT00429754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110237925|NCT00429754|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110237926|NCT00429754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110237927|NCT00429754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110237929|NCT00429832|Diphenhydramine|diphenhydramine|mesh-list
110237931|NCT00429832|Antiemetics|antiemetics|mesh-ancestor
110237932|NCT00429832|Autonomic Agents|autonomic agents|mesh-ancestor
110237933|NCT00429832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110237934|NCT00429832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110237935|NCT00429832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110237936|NCT00429832|Antipruritics|antipruritics|mesh-ancestor
110237937|NCT00429832|Dermatologic Agents|dermatologic agents|mesh-ancestor
110237938|NCT00429832|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110237939|NCT00429832|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110237940|NCT00429832|Serotonin Agents|serotonin agents|mesh-ancestor
110237941|NCT00429832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110237942|NCT00429832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110237943|NCT00429832|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110237944|NCT00429832|Histamine Antagonists|histamine antagonists|mesh-ancestor
110237945|NCT00429832|Histamine Agents|histamine agents|mesh-ancestor
110237946|NCT00429832|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110237947|NCT00429832|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110237948|NCT00429832|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110237949|NCT00429832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110237950|NCT00429832|Anesthetics, Local|anesthetics, local|mesh-ancestor
110237951|NCT00429832|Anesthetics|anesthetics|mesh-ancestor
110237952|NCT00429832|Sensory System Agents|sensory system agents|mesh-ancestor
110237953|NCT00429871|Docetaxel|docetaxel|mesh-list
110237954|NCT00429871|Capecitabine|capecitabine|mesh-list
110237955|NCT00429871|Epirubicin|epirubicin|mesh-list
110237956|NCT00429871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110237957|NCT00429871|Tubulin Modulators|tubulin modulators|mesh-ancestor
110237958|NCT00429871|Antimitotic Agents|antimitotic agents|mesh-ancestor
110237959|NCT00429871|Mitosis Modulators|mitosis modulators|mesh-ancestor
110237960|NCT00429871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110237961|NCT00429871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110237962|NCT00429871|Antimetabolites|antimetabolites|mesh-ancestor
110237963|NCT00429871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110237964|NCT00429871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110237965|NCT00429871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110237966|NCT00429871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110237967|NCT00095966|Gemcitabine|gemcitabine|mesh-list
110237969|NCT00095966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110237970|NCT00095966|Antimetabolites|antimetabolites|mesh-ancestor
110237971|NCT00095966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110237972|NCT00095966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110237973|NCT00095966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110237974|NCT00095966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110237975|NCT01803594|Nicotinic Acids|nicotinic acids|mesh-list
110237977|NCT01803594|Niacinamide|niacinamide|mesh-list
110237978|NCT01803594|Vitamin B Complex|vitamin b complex|mesh-ancestor
110237979|NCT01803594|Vitamins|vitamins|mesh-ancestor
110237980|NCT01803594|Micronutrients|micronutrients|mesh-ancestor
110237981|NCT01803594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110237982|NCT01803594|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110237984|NCT01803594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110237985|NCT01803594|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110237986|NCT01803594|Vasodilator Agents|vasodilator agents|mesh-ancestor
110237987|NCT00430066|Imatinib Mesylate|imatinib mesylate|mesh-list
110237988|NCT00430066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110237989|NCT00430066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110237990|NCT00430066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110237991|NCT00430066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110237992|NCT00096005|Bortezomib|bortezomib|mesh-list
110237993|NCT00096005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110237994|NCT00430105|Cyclophosphamide|cyclophosphamide|mesh-list
110237995|NCT00430105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110237996|NCT00430105|Immunologic Factors|immunologic factors|mesh-ancestor
110237997|NCT00430105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110237998|NCT00430105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110237999|NCT00430105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110238000|NCT00430105|Alkylating Agents|alkylating agents|mesh-ancestor
110238001|NCT00430105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238002|NCT00430105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110238003|NCT00430105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110238005|NCT00430144|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110238006|NCT00430144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110238007|NCT00430144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110238008|NCT00430144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238009|NCT00430144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110238010|NCT00430261|Sunitinib|sunitinib|mesh-list
110238011|NCT00430261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110238012|NCT00430261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110238013|NCT00430261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110238014|NCT00430261|Growth Substances|growth substances|mesh-ancestor
110238015|NCT00430261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110238016|NCT00430261|Growth Inhibitors|growth inhibitors|mesh-ancestor
110238017|NCT00430261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110238018|NCT00430261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110238019|NCT00430261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238020|NCT00096083|Melphalan|melphalan|mesh-list
110238021|NCT00096083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110238022|NCT00096083|Alkylating Agents|alkylating agents|mesh-ancestor
110238023|NCT00096083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238024|NCT00096083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110238025|NCT00096083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110238026|NCT00096083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110238027|NCT00096083|Immunologic Factors|immunologic factors|mesh-ancestor
110238028|NCT00096083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110238029|NCT01726452|Leucovorin|leucovorin|mesh-list
110238030|NCT01726452|Paclitaxel|paclitaxel|mesh-list
110238031|NCT01726452|Docetaxel|docetaxel|mesh-list
110238032|NCT01726452|Carboplatin|carboplatin|mesh-list
110238033|NCT01726452|Fluorouracil|fluorouracil|mesh-list
110238034|NCT01726452|Capecitabine|capecitabine|mesh-list
110238035|NCT01726452|Oxaliplatin|oxaliplatin|mesh-list
110238036|NCT01726452|Epirubicin|epirubicin|mesh-list
110238037|NCT01726452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110238038|NCT01726452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110238039|NCT01726452|Tubulin Modulators|tubulin modulators|mesh-ancestor
110238040|NCT01726452|Antimitotic Agents|antimitotic agents|mesh-ancestor
110238041|NCT01726452|Mitosis Modulators|mitosis modulators|mesh-ancestor
110238042|NCT01726452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238043|NCT01726452|Antimetabolites|antimetabolites|mesh-ancestor
110238044|NCT01726452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110238045|NCT01726452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110238046|NCT01726452|Immunologic Factors|immunologic factors|mesh-ancestor
110238047|NCT01726452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110238049|NCT01726452|Protective Agents|protective agents|mesh-ancestor
110238050|NCT01726452|Vitamin B Complex|vitamin b complex|mesh-ancestor
110238053|NCT01726452|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110238054|NCT01726452|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110238055|NCT01726452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110238056|NCT01726452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110238057|NCT00096317|Ketoconazole|ketoconazole|mesh-list
110238058|NCT00096317|Antifungal Agents|antifungal agents|mesh-ancestor
110238059|NCT00096317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110238060|NCT00096317|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110238061|NCT00096317|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110238062|NCT00096317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110238063|NCT00096317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238064|NCT00096317|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110238065|NCT00096317|Hormone Antagonists|hormone antagonists|mesh-ancestor
110238066|NCT00096317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110238067|NCT00096317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110238068|NCT00096317|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110238069|NCT00096395|Gemcitabine|gemcitabine|mesh-list
110238070|NCT00096395|Sorafenib|sorafenib|mesh-list
110238071|NCT00096395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110238072|NCT00096395|Antimetabolites|antimetabolites|mesh-ancestor
110238073|NCT00096395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238074|NCT00096395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110238075|NCT00096395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110238076|NCT00096395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110238078|NCT00096434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110238079|NCT00096434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110238080|NCT00096434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110238081|NCT00096434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238082|NCT00096473|Donepezil|donepezil|mesh-list
110238083|NCT00096473|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110238084|NCT00096473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110238085|NCT00096473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238086|NCT00096473|Cholinergic Agents|cholinergic agents|mesh-ancestor
110238087|NCT00096473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110238088|NCT00096473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110238089|NCT00096473|Nootropic Agents|nootropic agents|mesh-ancestor
110238090|NCT00130494|Zoledronic Acid|zoledronic acid|mesh-list
110238091|NCT00130494|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110238092|NCT00130494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110238093|NCT00096512|Sorafenib|sorafenib|mesh-list
110238094|NCT00096512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110238095|NCT00096512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110238096|NCT00096512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110238097|NCT00096512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238098|NCT00096551|Metronidazole|metronidazole|mesh-list
110238099|NCT00096551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110238100|NCT00096551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110238101|NCT00096551|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110238102|NCT00096551|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110238103|NCT00095186|Lactoferrin|lactoferrin|mesh-list
110238104|NCT00095186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110238107|NCT00130572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110238108|NCT00130572|Analgesics|analgesics|mesh-ancestor
110238109|NCT00130572|Sensory System Agents|sensory system agents|mesh-ancestor
110238110|NCT00130572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110238111|NCT00130572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110238112|NCT00130572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110238113|NCT00130572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110238114|NCT00130572|Dermatologic Agents|dermatologic agents|mesh-ancestor
110238115|NCT00130572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110238116|NCT00130572|Immunologic Factors|immunologic factors|mesh-ancestor
110238117|NCT00130572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110238118|NCT00130572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110238119|NCT00130572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238120|NCT00096629|Vaccines|vaccines|mesh-list
110238121|NCT00096629|Immunologic Factors|immunologic factors|mesh-ancestor
110238122|NCT00096629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110238123|NCT00430651|Carboplatin|carboplatin|mesh-list
110238124|NCT00430651|Docetaxel|docetaxel|mesh-list
110238125|NCT00430651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110238126|NCT00430651|Tubulin Modulators|tubulin modulators|mesh-ancestor
110238127|NCT00430651|Antimitotic Agents|antimitotic agents|mesh-ancestor
110238128|NCT00430651|Mitosis Modulators|mitosis modulators|mesh-ancestor
110238129|NCT00430651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238130|NCT00430807|Hydroxychloroquine|hydroxychloroquine|mesh-list
110238131|NCT00430807|Antimalarials|antimalarials|mesh-ancestor
110238132|NCT00430807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110238133|NCT00430807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110238134|NCT00430807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110238135|NCT00430807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110238136|NCT00430807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238137|NCT00430807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110238139|NCT00096668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110238140|NCT00096668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110238141|NCT00096668|Tubulin Modulators|tubulin modulators|mesh-ancestor
110238142|NCT00096668|Antimitotic Agents|antimitotic agents|mesh-ancestor
110238143|NCT00096668|Mitosis Modulators|mitosis modulators|mesh-ancestor
110238144|NCT00096668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238145|NCT00430846|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110238146|NCT00430846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110238147|NCT00430846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110238148|NCT00430846|Immunotoxins|immunotoxins|mesh-ancestor
110238149|NCT00430846|Immunoconjugates|immunoconjugates|mesh-ancestor
110238150|NCT00430846|Immunologic Factors|immunologic factors|mesh-ancestor
110238151|NCT00430846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110238153|NCT00430885|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110238154|NCT00430885|gamma-Globulins|gamma-globulins|mesh-list
110238155|NCT00430885|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110238156|NCT00430885|Immunologic Factors|immunologic factors|mesh-ancestor
110238157|NCT00430885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110238158|NCT00430924|Eplerenone|eplerenone|mesh-list
110238159|NCT00430924|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110238160|NCT00430924|Hormone Antagonists|hormone antagonists|mesh-ancestor
110238161|NCT00430924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110238162|NCT00430924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110238163|NCT00430924|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110238164|NCT00430924|Diuretics|diuretics|mesh-ancestor
110238165|NCT00430924|Natriuretic Agents|natriuretic agents|mesh-ancestor
110238168|NCT00096707|Antimetabolites|antimetabolites|mesh-ancestor
110238169|NCT00096707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238170|NCT00096707|Antiviral Agents|antiviral agents|mesh-ancestor
110238171|NCT00096707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110238172|NCT00430963|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
110238173|NCT00430963|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110238174|NCT00430963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110238175|NCT00430963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110238176|NCT00430963|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110238177|NCT00430963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110260206|NCT00530413|Anticonvulsants|anticonvulsants|mesh-ancestor
110238178|NCT00430963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238179|NCT00430963|Cholinergic Agents|cholinergic agents|mesh-ancestor
110238180|NCT00430963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110238181|NCT05102409|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110238182|NCT05102409|Lifitegrast|lifitegrast|mesh-list
110238183|NCT05102409|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110238184|NCT01053247|Tacrolimus|tacrolimus|mesh-list
110238185|NCT01053247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110238186|NCT01053247|Immunologic Factors|immunologic factors|mesh-ancestor
110238187|NCT01053247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110238188|NCT01053247|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110238189|NCT01053247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110238190|NCT01053247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238191|NCT00096863|Haloperidol|haloperidol|mesh-list
110238192|NCT00096863|Haloperidol decanoate|haloperidol decanoate|mesh-list
110238193|NCT00096863|Ziprasidone|ziprasidone|mesh-list
110238194|NCT00096863|Antiemetics|antiemetics|mesh-ancestor
110238195|NCT00096863|Autonomic Agents|autonomic agents|mesh-ancestor
110238196|NCT00096863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110238197|NCT00096863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110238198|NCT00096863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110238199|NCT00096863|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110238200|NCT00096863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110238201|NCT00096863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110238203|NCT00096863|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110238204|NCT00096863|Dopamine Agents|dopamine agents|mesh-ancestor
110238205|NCT00096863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110238206|NCT00096863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238207|NCT00096863|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110238208|NCT00096863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110238209|NCT00096863|Serotonin Agents|serotonin agents|mesh-ancestor
110238210|NCT00130767|Finasteride|finasteride|mesh-list
110238211|NCT00130767|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110238212|NCT00130767|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110238213|NCT00130767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110238214|NCT00130767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238215|NCT00130767|Hormone Antagonists|hormone antagonists|mesh-ancestor
110238216|NCT00130767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110238217|NCT00130767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110238218|NCT00130767|Urological Agents|urological agents|mesh-ancestor
110238219|NCT00431080|Paclitaxel|paclitaxel|mesh-list
110238220|NCT00431080|Docetaxel|docetaxel|mesh-list
110238221|NCT00431080|Cyclophosphamide|cyclophosphamide|mesh-list
110238224|NCT00431080|Lenograstim|lenograstim|mesh-list
110238225|NCT00431080|Mitogens|mitogens|mesh-list
110238226|NCT00431080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110238227|NCT00431080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110238228|NCT00431080|Tubulin Modulators|tubulin modulators|mesh-ancestor
110238229|NCT00431080|Antimitotic Agents|antimitotic agents|mesh-ancestor
110238231|NCT00431080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238232|NCT00431080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110238233|NCT00431080|Immunologic Factors|immunologic factors|mesh-ancestor
110238234|NCT00431080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110238235|NCT00431080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110238236|NCT00431080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110238237|NCT00431080|Alkylating Agents|alkylating agents|mesh-ancestor
110238238|NCT00431080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110238239|NCT00431080|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110238240|NCT00431080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110238241|NCT00431080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110238242|NCT00431080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110238243|NCT00431080|Antimetabolites|antimetabolites|mesh-ancestor
110238244|NCT00431080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110238245|NCT00431080|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110238246|NCT00431119|Mycophenolic Acid|mycophenolic acid|mesh-list
110238247|NCT00431119|Azathioprine|azathioprine|mesh-list
110238248|NCT00431119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110238249|NCT00431119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110238250|NCT00431119|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110238251|NCT00431119|Antitubercular Agents|antitubercular agents|mesh-ancestor
110238252|NCT00431119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110238253|NCT00431119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110238254|NCT00431119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110238255|NCT00431119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238256|NCT00431119|Antimetabolites|antimetabolites|mesh-ancestor
110238257|NCT00431119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110238258|NCT00431119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110238259|NCT00431119|Immunologic Factors|immunologic factors|mesh-ancestor
110238260|NCT00431119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110238261|NCT00431119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110238262|NCT00097019|Bevacizumab|bevacizumab|mesh-list
110238263|NCT00097019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110238264|NCT00097019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110238265|NCT00097019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110238266|NCT00097019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110238267|NCT00097019|Growth Substances|growth substances|mesh-ancestor
110238268|NCT00097019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267153|NCT00159380|Pimagedine|pimagedine|mesh-list
110238269|NCT00097019|Growth Inhibitors|growth inhibitors|mesh-ancestor
110238270|NCT00431197|Ketoconazole|ketoconazole|mesh-list
110238271|NCT00431197|Testosterone|testosterone|mesh-list
110238272|NCT00431197|Antifungal Agents|antifungal agents|mesh-ancestor
110238273|NCT00431197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110238274|NCT00431197|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110238275|NCT00431197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110238276|NCT00431197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110238277|NCT00431197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238278|NCT00431197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110238279|NCT00431197|Hormone Antagonists|hormone antagonists|mesh-ancestor
110238280|NCT00431197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110238281|NCT00431197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110238282|NCT00431197|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110238283|NCT00431197|Androgens|androgens|mesh-ancestor
110238284|NCT00431197|Hormones|hormones|mesh-ancestor
110238285|NCT00431236|Dexamethasone|dexamethasone|mesh-list
110238286|NCT00431236|Ondansetron|ondansetron|mesh-list
110238287|NCT00431236|Casopitant|casopitant|mesh-list
110238288|NCT00431236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110238289|NCT00431236|Antiemetics|antiemetics|mesh-ancestor
110238290|NCT00431236|Autonomic Agents|autonomic agents|mesh-ancestor
110238291|NCT00431236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110238293|NCT00431236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110238295|NCT00431236|Hormones|hormones|mesh-ancestor
110238296|NCT00431236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110238297|NCT00431236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110238298|NCT00431236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110238299|NCT00431236|Antipruritics|antipruritics|mesh-ancestor
110238300|NCT00431236|Dermatologic Agents|dermatologic agents|mesh-ancestor
110238301|NCT00431236|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110238302|NCT00431236|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110238303|NCT00431236|Serotonin Agents|serotonin agents|mesh-ancestor
110238304|NCT00431236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110238305|NCT00431236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238306|NCT00431236|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110238307|NCT00431275|Tremelimumab|tremelimumab|mesh-list
110238308|NCT00431275|Ipilimumab|ipilimumab|mesh-list
110238309|NCT00431275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110238310|NCT00431275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110238311|NCT00431275|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110238312|NCT00431275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238313|NCT00431353|Valganciclovir|valganciclovir|mesh-list
110238314|NCT00431353|Ganciclovir|ganciclovir|mesh-list
110238315|NCT00431353|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
110238316|NCT00431353|Antiviral Agents|antiviral agents|mesh-ancestor
110238317|NCT00431353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110238318|NCT00431353|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110238319|NCT00431353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110267159|NCT00540826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110238320|NCT00431353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238321|NCT00130845|Octreotide|octreotide|mesh-list
110238322|NCT00130845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110238323|NCT00130845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110238324|NCT00130845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110238325|NCT00431392|Atropine|atropine|mesh-list
110238326|NCT00431392|Propranolol|propranolol|mesh-list
110238327|NCT00431392|Phenylephrine|phenylephrine|mesh-list
110238328|NCT00431392|Oxymetazoline|oxymetazoline|mesh-list
110238329|NCT00431392|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
110238330|NCT00431392|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110238331|NCT00431392|Mydriatics|mydriatics|mesh-ancestor
110238332|NCT00431392|Autonomic Agents|autonomic agents|mesh-ancestor
110238333|NCT00431392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110238334|NCT00431392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110238335|NCT00431392|Sympathomimetics|sympathomimetics|mesh-ancestor
110238336|NCT00431392|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110238337|NCT00431392|Nasal Decongestants|nasal decongestants|mesh-ancestor
110238338|NCT00431392|Respiratory System Agents|respiratory system agents|mesh-ancestor
110238339|NCT00431392|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110238340|NCT00431392|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110238341|NCT00431392|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110238342|NCT00431392|Adrenergic Agents|adrenergic agents|mesh-ancestor
110238343|NCT00431392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110238345|NCT00431392|Protective Agents|protective agents|mesh-ancestor
110238346|NCT00431392|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110238347|NCT00431392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110238348|NCT00431392|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110238349|NCT00431392|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110238350|NCT00431392|Parasympatholytics|parasympatholytics|mesh-ancestor
110238351|NCT00431392|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110238352|NCT00431392|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110238353|NCT00431392|Cholinergic Agents|cholinergic agents|mesh-ancestor
110238354|NCT00431392|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110238355|NCT00431392|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110238356|NCT00431392|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110238357|NCT00431392|Vasodilator Agents|vasodilator agents|mesh-ancestor
110238358|NCT00431392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110238359|NCT00130884|Simendan|simendan|mesh-list
110238360|NCT00130884|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110238361|NCT00130884|Vasodilator Agents|vasodilator agents|mesh-ancestor
110238362|NCT00130884|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110238363|NCT00130884|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110238364|NCT00130884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110238365|NCT00130884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238366|NCT00130884|Protective Agents|protective agents|mesh-ancestor
110238367|NCT00130884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110238369|NCT01052662|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110238370|NCT01052662|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110238371|NCT01052662|Dopamine Agents|dopamine agents|mesh-ancestor
110238372|NCT01052662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110238373|NCT01052662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238374|NCT01052662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110238375|NCT01052662|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110238376|NCT01052662|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110238377|NCT00097214|Carboplatin|carboplatin|mesh-list
110238378|NCT00097214|Cetuximab|cetuximab|mesh-list
110238379|NCT00097214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110238380|NCT00097214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110238381|NCT05049057|Erenumab|erenumab|mesh-list
110238382|NCT05049057|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
110238383|NCT05049057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238385|NCT05049057|Sensory System Agents|sensory system agents|mesh-ancestor
110238386|NCT05049057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110238387|NCT05049057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110238388|NCT00431665|Heparin|heparin|mesh-list
110238389|NCT00431665|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
110238390|NCT00431665|Somatostatin|somatostatin|mesh-list
110238391|NCT00431665|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
110238392|NCT00431665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110238393|NCT00431665|Anticoagulants|anticoagulants|mesh-ancestor
110238394|NCT00431665|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110238395|NCT00431665|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110238396|NCT00431665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238397|NCT00431665|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
110238398|NCT00431665|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110238399|NCT00431665|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110238401|NCT00431665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110238402|NCT00431665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110238403|NCT04703608|Ivermectin|ivermectin|mesh-list
110238404|NCT04703608|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110238405|NCT04703608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110238406|NCT04727073|Spironolactone|spironolactone|mesh-list
110238407|NCT04727073|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110238408|NCT04727073|Hormone Antagonists|hormone antagonists|mesh-ancestor
110238409|NCT04727073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110238410|NCT04727073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110238411|NCT04727073|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110238412|NCT04727073|Diuretics|diuretics|mesh-ancestor
110238413|NCT04727073|Natriuretic Agents|natriuretic agents|mesh-ancestor
110238414|NCT00432016|Zidovudine|zidovudine|mesh-list
110238415|NCT00432016|Antimetabolites|antimetabolites|mesh-ancestor
110238416|NCT00432016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238417|NCT00432016|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110238418|NCT00432016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110238419|NCT00432016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110238420|NCT00432016|Antiviral Agents|antiviral agents|mesh-ancestor
110238421|NCT00432016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110238422|NCT00432016|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110238423|NCT00432016|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110238424|NCT01052077|Antidepressive Agents|antidepressive agents|mesh-list
110238425|NCT01052077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110238426|NCT00131040|Aprotinin|aprotinin|mesh-list
110238427|NCT00131040|Hemostatics|hemostatics|mesh-ancestor
110238428|NCT00131040|Coagulants|coagulants|mesh-ancestor
110238429|NCT00131040|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110238430|NCT00131040|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110238431|NCT00131040|Protease Inhibitors|protease inhibitors|mesh-ancestor
110238432|NCT00131040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110238433|NCT00131040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238434|NCT00400478|Rituximab|rituximab|mesh-list
110238435|NCT00400478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110238436|NCT00400478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110238437|NCT00400478|Immunologic Factors|immunologic factors|mesh-ancestor
110238438|NCT00400478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110238439|NCT00400478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110238440|NCT01052038|Dexamethasone|dexamethasone|mesh-list
110238441|NCT01052038|Dexamethasone acetate|dexamethasone acetate|mesh-list
110238442|NCT01052038|BB 1101|bb 1101|mesh-list
110238443|NCT01052038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110238444|NCT01052038|Antiemetics|antiemetics|mesh-ancestor
110238445|NCT01052038|Autonomic Agents|autonomic agents|mesh-ancestor
110267202|NCT00541177|Atropine|atropine|mesh-list
110238446|NCT01052038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110238447|NCT01052038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110238448|NCT01052038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110238449|NCT01052038|Glucocorticoids|glucocorticoids|mesh-ancestor
110238450|NCT01052038|Hormones|hormones|mesh-ancestor
110238451|NCT01052038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110238452|NCT01052038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110238453|NCT01052038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110238454|NCT01052038|Protease Inhibitors|protease inhibitors|mesh-ancestor
110238455|NCT01052038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110238456|NCT01052038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238457|NCT00432055|Botulinum Toxins|botulinum toxins|mesh-list
110238458|NCT00432055|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110238459|NCT00432055|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110238460|NCT00432055|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110238461|NCT00432055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110238462|NCT00432055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238463|NCT00432055|Cholinergic Agents|cholinergic agents|mesh-ancestor
110238464|NCT00432055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110238465|NCT00432055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110238466|NCT00432055|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110238467|NCT00432055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110238469|NCT04711044|Histamine|histamine|mesh-list
110238470|NCT04711044|Antipruritics|antipruritics|mesh-ancestor
110238471|NCT04711044|Dermatologic Agents|dermatologic agents|mesh-ancestor
110238472|NCT04711044|Histamine Agonists|histamine agonists|mesh-ancestor
110238473|NCT04711044|Histamine Agents|histamine agents|mesh-ancestor
110238474|NCT04711044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110238475|NCT04711044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238476|NCT04711044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110238477|NCT01051960|Ambrisentan|ambrisentan|mesh-list
110238478|NCT01051960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110238479|NCT00432367|Artesunate|artesunate|mesh-list
110238480|NCT00432367|Pyrimethamine|pyrimethamine|mesh-list
110238481|NCT00432367|Sulfadoxine|sulfadoxine|mesh-list
110238482|NCT00432367|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110238483|NCT00432367|Amodiaquine|amodiaquine|mesh-list
110238484|NCT00432367|Antimalarials|antimalarials|mesh-ancestor
110238485|NCT00432367|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110238486|NCT00432367|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110238487|NCT00432367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110238488|NCT00432367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110238489|NCT00432367|Antiviral Agents|antiviral agents|mesh-ancestor
110238490|NCT00432367|Schistosomicides|schistosomicides|mesh-ancestor
110238491|NCT00432367|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110238492|NCT00432367|Anthelmintics|anthelmintics|mesh-ancestor
110238493|NCT00432367|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110238494|NCT00432367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110238495|NCT00432367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238496|NCT00432367|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110238497|NCT00097760|Natalizumab|natalizumab|mesh-list
110238498|NCT00097760|Immunologic Factors|immunologic factors|mesh-ancestor
110238499|NCT00097760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110238500|NCT00432406|Infliximab|infliximab|mesh-list
110238501|NCT00432406|Etanercept|etanercept|mesh-list
110238502|NCT00432406|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110238503|NCT00432406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110238504|NCT00432406|Dermatologic Agents|dermatologic agents|mesh-ancestor
110238505|NCT00432406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110238506|NCT00432406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110238507|NCT00432406|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110238509|NCT00432406|Analgesics|analgesics|mesh-ancestor
110238510|NCT00432406|Sensory System Agents|sensory system agents|mesh-ancestor
110238511|NCT00432406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110238512|NCT00432406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110238513|NCT00432406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110238514|NCT00432406|Immunologic Factors|immunologic factors|mesh-ancestor
110238515|NCT00131118|Zoledronic Acid|zoledronic acid|mesh-list
110238516|NCT00131118|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110238517|NCT00131118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110238518|NCT02957656|Vaccines|vaccines|mesh-list
110238519|NCT02957656|Immunologic Factors|immunologic factors|mesh-ancestor
110238520|NCT02957656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110238521|NCT00097799|Ritonavir|ritonavir|mesh-list
110238522|NCT00097799|Tipranavir|tipranavir|mesh-list
110238523|NCT00097799|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110238524|NCT00097799|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110238525|NCT00097799|Protease Inhibitors|protease inhibitors|mesh-ancestor
110238526|NCT00097799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110238527|NCT00097799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238528|NCT00097799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110238529|NCT00097799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110238530|NCT00097799|Antiviral Agents|antiviral agents|mesh-ancestor
110238531|NCT00097799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110238532|NCT00097799|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110238533|NCT00097799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110238534|NCT01051921|Interferons|interferons|mesh-list
110238535|NCT01051921|Ribavirin|ribavirin|mesh-list
110238536|NCT01051921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110238537|NCT01051921|Antiviral Agents|antiviral agents|mesh-ancestor
110238538|NCT01051921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110238539|NCT01051921|Antimetabolites|antimetabolites|mesh-ancestor
110238540|NCT01051921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238541|NCT02273479|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
110238542|NCT02273479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110238543|NCT02273518|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
110238544|NCT02273518|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110238545|NCT00432757|Ketotifen|ketotifen|mesh-list
110238546|NCT00432757|Antipruritics|antipruritics|mesh-ancestor
110238547|NCT00432757|Dermatologic Agents|dermatologic agents|mesh-ancestor
110238548|NCT00432757|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110238549|NCT00432757|Histamine Antagonists|histamine antagonists|mesh-ancestor
110238550|NCT00432757|Histamine Agents|histamine agents|mesh-ancestor
110238551|NCT00432757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110238552|NCT00432757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238553|NCT00432757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110238554|NCT00432757|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110238555|NCT00432796|Dalteparin|dalteparin|mesh-list
110238556|NCT00432796|Tinzaparin|tinzaparin|mesh-list
110238557|NCT00432796|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110238558|NCT00432796|Anticoagulants|anticoagulants|mesh-ancestor
110238559|NCT00432796|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110238560|NCT00432796|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110238561|NCT00432796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238562|NCT00097877|Insulin|insulin|mesh-list
110238563|NCT00097877|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110238564|NCT00097877|Insulin Glargine|insulin glargine|mesh-list
110238565|NCT00097877|Insulin Aspart|insulin aspart|mesh-list
110238566|NCT00097877|Biphasic Insulins|biphasic insulins|mesh-list
110238567|NCT00097877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110238568|NCT00097877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110238570|NCT00097916|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110238571|NCT00097916|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110238572|NCT00097916|Dopamine Agents|dopamine agents|mesh-ancestor
110238573|NCT00097916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110238574|NCT00097916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238575|NCT00097916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110238576|NCT00097916|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110238577|NCT00097916|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110238578|NCT00433069|Pioglitazone|pioglitazone|mesh-list
110238579|NCT00433069|Interferons|interferons|mesh-list
110238580|NCT00433069|Ribavirin|ribavirin|mesh-list
110238581|NCT00433069|Interferon-alpha|interferon-alpha|mesh-list
110238582|NCT00433069|Interferon alpha-2|interferon alpha-2|mesh-list
110238583|NCT00433069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110238584|NCT00433069|Antiviral Agents|antiviral agents|mesh-ancestor
110238585|NCT00433069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110238586|NCT00433069|Antimetabolites|antimetabolites|mesh-ancestor
110238587|NCT00433069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238588|NCT00433069|Immunologic Factors|immunologic factors|mesh-ancestor
110238589|NCT00433069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110238590|NCT00433069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110238591|NCT01580371|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
110238592|NCT01580371|CKD-581|ckd-581|mesh-list
110238593|NCT01580371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110238594|NCT01580371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238595|NCT00403026|Bevacizumab|bevacizumab|mesh-list
110238596|NCT00403026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110238597|NCT00403026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110238598|NCT00403026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110238599|NCT00403026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110238601|NCT00403026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110238603|NCT00131274|Imatinib Mesylate|imatinib mesylate|mesh-list
110238604|NCT00131274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110238605|NCT00131274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110238606|NCT00131274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110238607|NCT00131274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238608|NCT00098033|Clofarabine|clofarabine|mesh-list
110238609|NCT00098033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110238610|NCT00098033|Antimetabolites|antimetabolites|mesh-ancestor
110238611|NCT00098033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238612|NCT00098033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110238613|NCT00403065|Dexamethasone|dexamethasone|mesh-list
110238614|NCT00403065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110238615|NCT00403065|Antiemetics|antiemetics|mesh-ancestor
110238616|NCT00403065|Autonomic Agents|autonomic agents|mesh-ancestor
110238617|NCT00403065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110238618|NCT00403065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110238619|NCT00403065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110238620|NCT00403065|Glucocorticoids|glucocorticoids|mesh-ancestor
110238621|NCT00403065|Hormones|hormones|mesh-ancestor
110238622|NCT00403065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110238623|NCT00403065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110238624|NCT00403065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110238625|NCT00098111|Azathioprine|azathioprine|mesh-list
110238626|NCT00098111|Antimetabolites|antimetabolites|mesh-ancestor
110238627|NCT00098111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238628|NCT00098111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110238629|NCT00098111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110238630|NCT00098111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110238631|NCT00098111|Immunologic Factors|immunologic factors|mesh-ancestor
110238632|NCT00098111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110238633|NCT00098111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110238634|NCT04702906|Trimetazidine|trimetazidine|mesh-list
110267229|NCT00541333|Glatiramer Acetate|glatiramer acetate|mesh-list
110238636|NCT00131313|Cyclophosphamide|cyclophosphamide|mesh-list
110238638|NCT00131313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110238639|NCT00131313|Immunologic Factors|immunologic factors|mesh-ancestor
110238640|NCT00131313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110238641|NCT00131313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110238642|NCT00131313|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110238643|NCT00131313|Alkylating Agents|alkylating agents|mesh-ancestor
110238644|NCT00131313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238645|NCT00131313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110238646|NCT00131313|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110238647|NCT00131313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110238648|NCT00433186|Mycophenolic Acid|mycophenolic acid|mesh-list
110238649|NCT00433186|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110238650|NCT00433186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110238651|NCT00433186|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110238652|NCT00433186|Antitubercular Agents|antitubercular agents|mesh-ancestor
110238653|NCT00433186|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110238654|NCT00433186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110238655|NCT00433186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110238656|NCT00433186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238658|NCT00433225|Prednisolone|prednisolone|mesh-list
110238659|NCT00433225|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110238660|NCT00433225|Methylprednisolone|methylprednisolone|mesh-list
110238661|NCT00433225|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110238662|NCT00433225|Prednisolone acetate|prednisolone acetate|mesh-list
110238663|NCT00433225|Ketorolac|ketorolac|mesh-list
110238664|NCT00433225|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110238666|NCT00433225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110238667|NCT00433225|Glucocorticoids|glucocorticoids|mesh-ancestor
110238669|NCT00433225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110238670|NCT00433225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110238671|NCT00433225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110238672|NCT00433225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110238674|NCT00433225|Autonomic Agents|autonomic agents|mesh-ancestor
110238675|NCT00433225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110238676|NCT00433225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110238677|NCT00433225|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110238678|NCT00433225|Protective Agents|protective agents|mesh-ancestor
110238679|NCT00433225|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110238680|NCT00433225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110238681|NCT00433225|Analgesics|analgesics|mesh-ancestor
110238682|NCT00433225|Sensory System Agents|sensory system agents|mesh-ancestor
110238683|NCT00433225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110238684|NCT00433225|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110238685|NCT00433225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110238686|NCT00433225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238687|NCT00433225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110238688|NCT00433225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110238689|NCT00433225|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110238690|NCT00433225|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110238691|NCT00433225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110238692|NCT00433225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110238693|NCT00433342|Floxacillin|floxacillin|mesh-list
110238694|NCT00433342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110238695|NCT00433342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110267241|NCT00541411|Dactinomycin|dactinomycin|mesh-list
110238696|NCT00131391|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
110238697|NCT00131391|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110238698|NCT00131391|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110238699|NCT00131391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110238700|NCT00131391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238702|NCT00131391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110238703|NCT00131391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110238704|NCT00433459|Prednisone|prednisone|mesh-list
110238705|NCT00433459|Prednisolone|prednisolone|mesh-list
110238706|NCT00433459|Cyclophosphamide|cyclophosphamide|mesh-list
110238707|NCT00433459|Dacarbazine|dacarbazine|mesh-list
110238708|NCT00433459|Vincristine|vincristine|mesh-list
110238709|NCT00433459|Procarbazine|procarbazine|mesh-list
110238710|NCT00433459|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110238711|NCT00433459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110238712|NCT00433459|Immunologic Factors|immunologic factors|mesh-ancestor
110238713|NCT00433459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110238714|NCT00433459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110238715|NCT00433459|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110238716|NCT00433459|Alkylating Agents|alkylating agents|mesh-ancestor
110238717|NCT00433459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238718|NCT00433459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110238719|NCT00433459|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110238720|NCT00433459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110238721|NCT00433459|Glucocorticoids|glucocorticoids|mesh-ancestor
110238722|NCT00433459|Hormones|hormones|mesh-ancestor
110238723|NCT00433459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110238724|NCT00433459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110238725|NCT00433459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110238727|NCT00433459|Antimitotic Agents|antimitotic agents|mesh-ancestor
110238728|NCT00433459|Mitosis Modulators|mitosis modulators|mesh-ancestor
110238729|NCT00433459|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110238730|NCT00433498|Carboplatin|carboplatin|mesh-list
110238731|NCT00433498|Etoposide|etoposide|mesh-list
110238732|NCT00433498|Etoposide phosphate|etoposide phosphate|mesh-list
110238733|NCT00433498|Pravastatin|pravastatin|mesh-list
110238734|NCT00433498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110238735|NCT00433498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110238736|NCT00433498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110238737|NCT00433498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110238738|NCT00433498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110238739|NCT00433498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238740|NCT00433498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110238741|NCT00433498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110238742|NCT00433498|Antimetabolites|antimetabolites|mesh-ancestor
110238743|NCT00433498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110238744|NCT00433498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110238745|NCT00433576|Resveratrol|resveratrol|mesh-list
110238746|NCT00433576|Antioxidants|antioxidants|mesh-ancestor
110238747|NCT00433576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238748|NCT00433576|Protective Agents|protective agents|mesh-ancestor
110238749|NCT00433576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110238750|NCT00433576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110238751|NCT00433576|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110238752|NCT00433615|Epoetin Alfa|epoetin alfa|mesh-list
110238753|NCT00433615|Hematinics|hematinics|mesh-ancestor
110238755|NCT00098384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110238756|NCT00098384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110238757|NCT00098384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110238758|NCT00433732|Naproxen|naproxen|mesh-list
110238759|NCT00433732|Sumatriptan|sumatriptan|mesh-list
110238760|NCT00433732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110238761|NCT00433732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110238762|NCT00433732|Analgesics|analgesics|mesh-ancestor
110238763|NCT00433732|Sensory System Agents|sensory system agents|mesh-ancestor
110238764|NCT00433732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110238765|NCT00433732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110238766|NCT00433732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110238767|NCT00433732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110238768|NCT00433732|Gout Suppressants|gout suppressants|mesh-ancestor
110238769|NCT00433732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110238770|NCT00433732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110238771|NCT00433732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238772|NCT00433732|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110238773|NCT00433732|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110238774|NCT00433732|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110238775|NCT00433732|Serotonin Agents|serotonin agents|mesh-ancestor
110238776|NCT00433732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110238777|NCT00098423|Cytarabine|cytarabine|mesh-list
110238778|NCT00098423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110238779|NCT00098423|Antimetabolites|antimetabolites|mesh-ancestor
110238780|NCT00098423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238781|NCT00098423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110238782|NCT00098423|Antiviral Agents|antiviral agents|mesh-ancestor
110238783|NCT00098423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110238784|NCT00098423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110238786|NCT00098423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110238787|NCT01050790|Lenalidomide|lenalidomide|mesh-list
110238788|NCT01050790|Azacitidine|azacitidine|mesh-list
110238789|NCT01050790|Immunologic Factors|immunologic factors|mesh-ancestor
110238790|NCT01050790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110238791|NCT01050790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110238792|NCT01050790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110238793|NCT01050790|Growth Substances|growth substances|mesh-ancestor
110238794|NCT01050790|Growth Inhibitors|growth inhibitors|mesh-ancestor
110238795|NCT01050790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110238796|NCT01050790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110238797|NCT01050790|Antimetabolites|antimetabolites|mesh-ancestor
110238798|NCT01050790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238799|NCT01050790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110238800|NCT00433927|Leucovorin|leucovorin|mesh-list
110238801|NCT00433927|Folic Acid|folic acid|mesh-list
110238802|NCT00433927|Bevacizumab|bevacizumab|mesh-list
110238803|NCT00433927|Cetuximab|cetuximab|mesh-list
110238804|NCT00433927|Irinotecan|irinotecan|mesh-list
110238805|NCT00433927|Levoleucovorin|levoleucovorin|mesh-list
110238806|NCT00433927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110238807|NCT00433927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110238808|NCT00433927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110238809|NCT00433927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110238810|NCT00433927|Growth Substances|growth substances|mesh-ancestor
110238811|NCT00433927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110238812|NCT00433927|Growth Inhibitors|growth inhibitors|mesh-ancestor
110238813|NCT00433927|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110238814|NCT00433927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110238815|NCT00433927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110238816|NCT00433927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238817|NCT00433927|Antidotes|antidotes|mesh-ancestor
110238818|NCT00433927|Protective Agents|protective agents|mesh-ancestor
110238819|NCT00433927|Vitamin B Complex|vitamin b complex|mesh-ancestor
110238821|NCT00433927|Micronutrients|micronutrients|mesh-ancestor
110238822|NCT00433927|Hematinics|hematinics|mesh-ancestor
110238823|NCT00131430|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
110238824|NCT00131430|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110238825|NCT00131430|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110238826|NCT00131430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110238827|NCT00131430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238828|NCT00131430|Hormones|hormones|mesh-ancestor
110238829|NCT00131430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110238830|NCT00131430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110238831|NCT00098462|Sirolimus|sirolimus|mesh-list
110238832|NCT00098462|Gefitinib|gefitinib|mesh-list
110238833|NCT00098462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110238834|NCT00098462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110238835|NCT00098462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110238836|NCT00098462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110238837|NCT00098462|Antifungal Agents|antifungal agents|mesh-ancestor
110238838|NCT00098462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110238839|NCT00098462|Immunologic Factors|immunologic factors|mesh-ancestor
110238840|NCT00098462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110238841|NCT00098462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110238842|NCT00098462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110238843|NCT00098462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238844|NCT00098501|Sirolimus|sirolimus|mesh-list
110238845|NCT00098501|Temsirolimus|temsirolimus|mesh-list
110238846|NCT00098501|MTOR Inhibitors|mtor inhibitors|mesh-list
110238847|NCT00098501|EKB 569|ekb 569|mesh-list
110238848|NCT00098501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110238849|NCT00098501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110238850|NCT00098501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238852|NCT00098501|Immunologic Factors|immunologic factors|mesh-ancestor
110238853|NCT00098501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110238854|NCT00098501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110238855|NCT00098501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110238856|NCT00098501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110238857|NCT00098501|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110238858|NCT00098501|Antifungal Agents|antifungal agents|mesh-ancestor
110238859|NCT00434005|Acetylcysteine|acetylcysteine|mesh-list
110238860|NCT00434005|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110238861|NCT00434005|Antiviral Agents|antiviral agents|mesh-ancestor
110238862|NCT00434005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110238863|NCT00434005|Expectorants|expectorants|mesh-ancestor
110238864|NCT00434005|Respiratory System Agents|respiratory system agents|mesh-ancestor
110238865|NCT00434005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110238866|NCT00434005|Antioxidants|antioxidants|mesh-ancestor
110238867|NCT00434005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238868|NCT00434005|Protective Agents|protective agents|mesh-ancestor
110238869|NCT00434005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110238870|NCT00434005|Antidotes|antidotes|mesh-ancestor
110238872|NCT00434044|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110238873|NCT00434044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110238874|NCT00434044|Analgesics|analgesics|mesh-ancestor
110238875|NCT00434044|Sensory System Agents|sensory system agents|mesh-ancestor
110238876|NCT00434044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110238877|NCT00434044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110238878|NCT00434044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110238879|NCT00434044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110238880|NCT00434044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110238881|NCT00434044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110238882|NCT00434044|Immunologic Factors|immunologic factors|mesh-ancestor
110238883|NCT00434083|Naproxen|naproxen|mesh-list
110238884|NCT00434083|Sumatriptan|sumatriptan|mesh-list
110238885|NCT00434083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110238886|NCT00434083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110238887|NCT00434083|Analgesics|analgesics|mesh-ancestor
110238888|NCT00434083|Sensory System Agents|sensory system agents|mesh-ancestor
110238889|NCT00434083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110238890|NCT00434083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110238891|NCT00434083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110238892|NCT00434083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110238894|NCT00434083|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110238895|NCT00434083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110238896|NCT00434083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238897|NCT00434083|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110238898|NCT00434083|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110238899|NCT00434083|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110238900|NCT00434083|Serotonin Agents|serotonin agents|mesh-ancestor
110238901|NCT00434083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110238903|NCT00098540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110238904|NCT00098540|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110238905|NCT00098540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110238906|NCT00098540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238907|NCT00098579|Doxorubicin|doxorubicin|mesh-list
110238908|NCT00098579|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110238909|NCT00098579|Alvocidib|alvocidib|mesh-list
110238910|NCT00098579|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110238911|NCT00098579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110238912|NCT00098579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110238913|NCT00098579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110238914|NCT00098579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110238915|NCT00098579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238916|NCT00098579|Growth Inhibitors|growth inhibitors|mesh-ancestor
110238917|NCT00098579|Growth Substances|growth substances|mesh-ancestor
110238919|NCT00098579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110238920|NCT00098618|Interferons|interferons|mesh-list
110238921|NCT00098618|Interferon-alpha|interferon-alpha|mesh-list
110238922|NCT00098618|Interferon alpha-2|interferon alpha-2|mesh-list
110238924|NCT00098618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110238925|NCT00098618|Antiviral Agents|antiviral agents|mesh-ancestor
110238926|NCT00098618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110238927|NCT00098618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110238928|NCT00098618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110238929|NCT00098618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238930|NCT00098618|Immunologic Factors|immunologic factors|mesh-ancestor
110238931|NCT00098618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110238932|NCT00098735|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
110238933|NCT00098735|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110238934|NCT00098735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238935|NCT00098735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110238936|NCT00098735|Immunologic Factors|immunologic factors|mesh-ancestor
110238937|NCT00098735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110238938|NCT00098852|Rosiglitazone|rosiglitazone|mesh-list
110238939|NCT00098852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110238940|NCT00098852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110238941|NCT01059448|Brodalumab|brodalumab|mesh-list
110238942|NCT01059448|Dermatologic Agents|dermatologic agents|mesh-ancestor
110238943|NCT00098891|Entinostat|entinostat|mesh-list
110238944|NCT00098891|Isotretinoin|isotretinoin|mesh-list
110238945|NCT00098891|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
110238946|NCT00098891|Dermatologic Agents|dermatologic agents|mesh-ancestor
110238947|NCT00098891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110238948|NCT00098891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110238949|NCT00098891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238950|NCT00098969|Resveratrol|resveratrol|mesh-list
110238951|NCT00098969|Antioxidants|antioxidants|mesh-ancestor
110238952|NCT00098969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238953|NCT00098969|Protective Agents|protective agents|mesh-ancestor
110238954|NCT00098969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110238955|NCT00098969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110238956|NCT00098969|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110238957|NCT00099008|Genistein|genistein|mesh-list
110238958|NCT00099008|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110238959|NCT00099008|Protective Agents|protective agents|mesh-ancestor
110238960|NCT00099008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110238961|NCT00099008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110238962|NCT00099008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110238963|NCT00099008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110238964|NCT00099008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238965|NCT00099008|Phytoestrogens|phytoestrogens|mesh-ancestor
110238966|NCT00099008|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110238967|NCT00099008|Estrogens|estrogens|mesh-ancestor
110238969|NCT00099008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110238970|NCT00434239|Lenalidomide|lenalidomide|mesh-list
110238971|NCT00434239|Immunologic Factors|immunologic factors|mesh-ancestor
110238972|NCT00434239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110238973|NCT00434239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110238974|NCT00434239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110238975|NCT00434239|Growth Substances|growth substances|mesh-ancestor
110238976|NCT00434239|Growth Inhibitors|growth inhibitors|mesh-ancestor
110238977|NCT00434239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110238978|NCT01057147|Rebamipide|rebamipide|mesh-list
110238979|NCT01057147|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110238980|NCT01057147|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110238981|NCT01057147|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110238982|NCT01057147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110238983|NCT01057147|Antioxidants|antioxidants|mesh-ancestor
110238984|NCT01057147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238985|NCT01057147|Protective Agents|protective agents|mesh-ancestor
110238986|NCT01057147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110238987|NCT01057147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110238988|NCT00099125|Irinotecan|irinotecan|mesh-list
110238989|NCT00099125|Temozolomide|temozolomide|mesh-list
110238990|NCT00099125|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110238991|NCT00099125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110238992|NCT00099125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110238993|NCT00099125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238994|NCT00099125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110238995|NCT00099125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110238996|NCT00099125|Alkylating Agents|alkylating agents|mesh-ancestor
110238997|NCT00131703|Chloroquine|chloroquine|mesh-list
110238998|NCT00131703|Pyrimethamine|pyrimethamine|mesh-list
110238999|NCT00131703|Sulfadoxine|sulfadoxine|mesh-list
110239000|NCT00131703|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110239001|NCT00131703|Amodiaquine|amodiaquine|mesh-list
110239002|NCT00131703|Amebicides|amebicides|mesh-ancestor
110239003|NCT00131703|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110239004|NCT00131703|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110239005|NCT00131703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110239006|NCT00131703|Antimalarials|antimalarials|mesh-ancestor
110239007|NCT00131703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110239008|NCT00131703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110239009|NCT00131703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110239010|NCT00131703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110239011|NCT00131703|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110239013|NCT01051414|Protease Inhibitors|protease inhibitors|mesh-ancestor
110239014|NCT01051414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110239015|NCT01051414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110239016|NCT00434317|Zoledronic Acid|zoledronic acid|mesh-list
110239017|NCT00434317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110239018|NCT00434317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110239019|NCT00099164|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
110239020|NCT00099164|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
110239021|NCT00099164|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110239022|NCT00099164|Hormone Antagonists|hormone antagonists|mesh-ancestor
110239023|NCT00099164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110239024|NCT00099164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110239025|NCT00099164|Progestins|progestins|mesh-ancestor
110239026|NCT00099164|Hormones|hormones|mesh-ancestor
110239027|NCT00131742|Lamivudine|lamivudine|mesh-list
110239028|NCT00131742|Telbivudine|telbivudine|mesh-list
110239029|NCT00131742|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110239030|NCT00131742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110239031|NCT00131742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110239032|NCT00131742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110239033|NCT00131742|Antiviral Agents|antiviral agents|mesh-ancestor
110239034|NCT00131742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110239035|NCT00131742|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110239036|NCT00131742|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110239037|NCT04621149|Lactoferrin|lactoferrin|mesh-list
110239040|NCT04621149|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110239041|NCT04621149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110239042|NCT04621149|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110239043|NCT04621149|Histamine Antagonists|histamine antagonists|mesh-ancestor
110239044|NCT04621149|Histamine Agents|histamine agents|mesh-ancestor
110239045|NCT04621149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110239046|NCT04621149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110239047|NCT04621149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110239048|NCT04621149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110239049|NCT04621149|Dental Disinfectants|dental disinfectants|mesh-ancestor
110239050|NCT04621149|Disinfectants|disinfectants|mesh-ancestor
110239051|NCT00099203|Zoledronic Acid|zoledronic acid|mesh-list
110239052|NCT00099203|Ibandronic Acid|ibandronic acid|mesh-list
110239053|NCT00099203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110239054|NCT00099203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110239055|NCT00099242|Rivastigmine|rivastigmine|mesh-list
110239056|NCT00099242|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110239057|NCT00099242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110239058|NCT00099242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110239059|NCT00099242|Cholinergic Agents|cholinergic agents|mesh-ancestor
110239060|NCT00099242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110239061|NCT00099242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110239062|NCT00099242|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110239063|NCT00099242|Protective Agents|protective agents|mesh-ancestor
110239064|NCT00099320|Exenatide|exenatide|mesh-list
110239065|NCT00099320|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110239066|NCT00099320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110239067|NCT00099320|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110239068|NCT00099320|Incretins|incretins|mesh-ancestor
110239070|NCT00099320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110239071|NCT00403650|Iloprost|iloprost|mesh-list
110239072|NCT00403650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110239073|NCT00403650|Vasodilator Agents|vasodilator agents|mesh-ancestor
110239075|NCT00403728|Cyclosporins|cyclosporins|mesh-list
110239076|NCT00403728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110239077|NCT00403728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110239078|NCT00403728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110239079|NCT00403728|Immunologic Factors|immunologic factors|mesh-ancestor
110239080|NCT00403728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110239081|NCT00403728|Antifungal Agents|antifungal agents|mesh-ancestor
110239082|NCT00403728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110239083|NCT00403728|Dermatologic Agents|dermatologic agents|mesh-ancestor
110239084|NCT00403728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110239085|NCT00403728|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110239086|NCT00403806|Dexamethasone|dexamethasone|mesh-list
110239087|NCT00403806|Dexamethasone acetate|dexamethasone acetate|mesh-list
110239088|NCT00403806|BB 1101|bb 1101|mesh-list
110239089|NCT00403806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110239090|NCT00403806|Antiemetics|antiemetics|mesh-ancestor
110239091|NCT00403806|Autonomic Agents|autonomic agents|mesh-ancestor
110239092|NCT00403806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110239093|NCT00403806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110239094|NCT00403806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110239095|NCT00403806|Glucocorticoids|glucocorticoids|mesh-ancestor
110239096|NCT00403806|Hormones|hormones|mesh-ancestor
110239097|NCT00403806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110239098|NCT00403806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110239099|NCT00403806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110239100|NCT00403806|Protease Inhibitors|protease inhibitors|mesh-ancestor
110239101|NCT00403806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110239102|NCT00403806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110239103|NCT00400556|Lenograstim|lenograstim|mesh-list
110239104|NCT00400556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110239105|NCT00400556|Immunologic Factors|immunologic factors|mesh-ancestor
110239106|NCT00400556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110239107|NCT00400595|Mupirocin|mupirocin|mesh-list
110239108|NCT00400595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110239109|NCT00400595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110239110|NCT00400595|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110239111|NCT00400595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110239112|NCT00400595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110239113|NCT00099554|Etanercept|etanercept|mesh-list
110239114|NCT00099554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110239115|NCT00099554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110239116|NCT00099554|Analgesics|analgesics|mesh-ancestor
110239118|NCT00099554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110239119|NCT00099554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110239120|NCT00099554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110239121|NCT00099554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110239122|NCT00099554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110239123|NCT00099554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110239124|NCT00099554|Immunologic Factors|immunologic factors|mesh-ancestor
110239125|NCT00132054|Irinotecan|irinotecan|mesh-list
110239126|NCT00132054|Amrubicin|amrubicin|mesh-list
110239127|NCT00132054|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110239128|NCT00132054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110239129|NCT00132054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110239130|NCT00132054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110239131|NCT00132054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110239132|NCT00099710|Curcumin|curcumin|mesh-list
110239133|NCT00099710|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110239134|NCT00099710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110239135|NCT00099710|Analgesics|analgesics|mesh-ancestor
110239136|NCT00099710|Sensory System Agents|sensory system agents|mesh-ancestor
110239137|NCT00099710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110239138|NCT00099710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110239139|NCT00099710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110239140|NCT00099710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110239141|NCT00099710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110239142|NCT00099710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110239143|NCT00099710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110239144|NCT00099749|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
110239145|NCT00099749|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110239146|NCT00099749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110239147|NCT00099749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110239148|NCT00099749|Immunologic Factors|immunologic factors|mesh-ancestor
110239149|NCT00099749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110239150|NCT00132093|Eplerenone|eplerenone|mesh-list
110239151|NCT00132093|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110239152|NCT00132093|Hormone Antagonists|hormone antagonists|mesh-ancestor
110239153|NCT00132093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110239154|NCT00132093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110239155|NCT00132093|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110239156|NCT00132093|Diuretics|diuretics|mesh-ancestor
110239157|NCT00132093|Natriuretic Agents|natriuretic agents|mesh-ancestor
110239158|NCT00132093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110239160|NCT00099788|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110239161|NCT00099788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110239162|NCT00099788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110239163|NCT00099866|Metformin|metformin|mesh-list
110239164|NCT00099866|Vildagliptin|vildagliptin|mesh-list
110239165|NCT00099866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110239166|NCT00099866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110239167|NCT00099866|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110239168|NCT00099866|Protease Inhibitors|protease inhibitors|mesh-ancestor
110239169|NCT00099866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110239170|NCT00099866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110239171|NCT00099905|Vildagliptin|vildagliptin|mesh-list
110239172|NCT00099905|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110239173|NCT00099905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110239174|NCT00099905|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110239175|NCT00099905|Protease Inhibitors|protease inhibitors|mesh-ancestor
110239176|NCT00099905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110239177|NCT00099905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110239178|NCT00132210|Interferons|interferons|mesh-list
110239179|NCT00132210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110239180|NCT00132210|Antiviral Agents|antiviral agents|mesh-ancestor
110239181|NCT00132210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110239182|NCT00099944|Glimepiride|glimepiride|mesh-list
110239183|NCT00099944|Vildagliptin|vildagliptin|mesh-list
110239184|NCT00099944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110239185|NCT00099944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110239186|NCT00099944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110239187|NCT00099944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110239188|NCT00099944|Immunologic Factors|immunologic factors|mesh-ancestor
110239189|NCT00099944|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110239190|NCT00099944|Protease Inhibitors|protease inhibitors|mesh-ancestor
110239191|NCT00099944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110239192|NCT00099944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110239193|NCT04333914|Avdoralimab|avdoralimab|mesh-list
110239194|NCT04333914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110239195|NCT04333914|Antiviral Agents|antiviral agents|mesh-ancestor
110239196|NCT04333914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110239197|NCT00100100|Modafinil|modafinil|mesh-list
110239198|NCT00100100|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110239199|NCT00100100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110239200|NCT00100100|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110239201|NCT00100100|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110239202|NCT00100100|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110239203|NCT00100100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110239205|NCT00100139|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110239206|NCT00100139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110239207|NCT00100139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110239208|NCT00100139|Tubulin Modulators|tubulin modulators|mesh-ancestor
110239209|NCT00100139|Antimitotic Agents|antimitotic agents|mesh-ancestor
110239210|NCT00100139|Mitosis Modulators|mitosis modulators|mesh-ancestor
110239211|NCT00100139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110239212|NCT00100412|Phenylephrine|phenylephrine|mesh-list
110239213|NCT00100412|Dobutamine|dobutamine|mesh-list
110239214|NCT00100412|Oxymetazoline|oxymetazoline|mesh-list
110239215|NCT00100412|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110239216|NCT00100412|Mydriatics|mydriatics|mesh-ancestor
110239217|NCT00100412|Autonomic Agents|autonomic agents|mesh-ancestor
110239218|NCT00100412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110239219|NCT00100412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110239220|NCT00100412|Sympathomimetics|sympathomimetics|mesh-ancestor
110239221|NCT00100412|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110239222|NCT00100412|Nasal Decongestants|nasal decongestants|mesh-ancestor
110239223|NCT00100412|Respiratory System Agents|respiratory system agents|mesh-ancestor
110239224|NCT00100412|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110239225|NCT00100412|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110239226|NCT00100412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110239227|NCT00100412|Adrenergic Agents|adrenergic agents|mesh-ancestor
110239228|NCT00100412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110239229|NCT00100412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110239230|NCT00100412|Protective Agents|protective agents|mesh-ancestor
110239231|NCT00100412|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110239232|NCT00100412|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110239233|NCT04244058|Amantadine|amantadine|mesh-list
110239234|NCT04244058|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110239235|NCT04244058|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110239236|NCT04244058|Antiviral Agents|antiviral agents|mesh-ancestor
110239237|NCT04244058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110239238|NCT04244058|Dopamine Agents|dopamine agents|mesh-ancestor
110239239|NCT04244058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110239240|NCT04244058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110239241|NCT04244058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110239242|NCT04244058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110239243|NCT04244058|Analgesics|analgesics|mesh-ancestor
110239244|NCT04244058|Sensory System Agents|sensory system agents|mesh-ancestor
110239245|NCT04244058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110239246|NCT00132444|UC-781|uc-781|mesh-list
110239247|NCT00132444|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110239248|NCT00132444|Antiviral Agents|antiviral agents|mesh-ancestor
110239249|NCT00132444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110239250|NCT00100568|Lamivudine|lamivudine|mesh-list
110239251|NCT00100568|Zidovudine|zidovudine|mesh-list
110239252|NCT00100568|Efavirenz|efavirenz|mesh-list
110239253|NCT00100568|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
110239254|NCT00100568|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110239255|NCT00100568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110239256|NCT00100568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110239257|NCT00100568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110239258|NCT00100568|Antiviral Agents|antiviral agents|mesh-ancestor
110239259|NCT00100568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110239260|NCT00100568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110239261|NCT00100568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110239262|NCT00100568|Antimetabolites|antimetabolites|mesh-ancestor
110239263|NCT00100568|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110239264|NCT00100568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110239265|NCT00100568|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110239266|NCT00100568|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110239267|NCT00100568|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110239268|NCT00100568|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110239270|NCT00132561|Pyrimethamine|pyrimethamine|mesh-list
110239271|NCT00132561|Sulfadoxine|sulfadoxine|mesh-list
110239272|NCT00132561|Antimalarials|antimalarials|mesh-ancestor
110239273|NCT00132561|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110239274|NCT00132561|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110239275|NCT00132561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110239276|NCT00132561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110239278|NCT00132561|Schistosomicides|schistosomicides|mesh-ancestor
110239279|NCT00132561|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110239280|NCT00132561|Anthelmintics|anthelmintics|mesh-ancestor
110239282|NCT00132561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110239283|NCT00132561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110239284|NCT00132561|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110239285|NCT04728659|Desogestrel|desogestrel|mesh-list
110239286|NCT04728659|Ganirelix|ganirelix|mesh-list
110239287|NCT04728659|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110239288|NCT04728659|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110239289|NCT04728659|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110239290|NCT04728659|Contraceptive Agents|contraceptive agents|mesh-ancestor
110239291|NCT04728659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110239292|NCT04728659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110239293|NCT04728659|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110239294|NCT04728659|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110239295|NCT04728659|Progestins|progestins|mesh-ancestor
110239296|NCT04728659|Hormones|hormones|mesh-ancestor
110239297|NCT04728659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110239298|NCT04728659|Hormone Antagonists|hormone antagonists|mesh-ancestor
110239299|NCT00132600|Bacitracin|bacitracin|mesh-list
110239300|NCT00132600|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110239301|NCT00132600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110239302|NCT00132600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110239303|NCT00132639|Docetaxel|docetaxel|mesh-list
110239304|NCT00132639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110239305|NCT00132639|Tubulin Modulators|tubulin modulators|mesh-ancestor
110239306|NCT00132639|Antimitotic Agents|antimitotic agents|mesh-ancestor
110239307|NCT00132639|Mitosis Modulators|mitosis modulators|mesh-ancestor
110239308|NCT00132639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110239309|NCT04728386|Sodium Hypochlorite|sodium hypochlorite|mesh-list
110239310|NCT04728386|Eusol|eusol|mesh-list
110239311|NCT04728386|Curcumin|curcumin|mesh-list
110239312|NCT04728386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110239313|NCT04728386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110239314|NCT04728386|Analgesics|analgesics|mesh-ancestor
110239315|NCT04728386|Sensory System Agents|sensory system agents|mesh-ancestor
110239316|NCT04728386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110239317|NCT04728386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110239318|NCT04728386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110239319|NCT04728386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110239320|NCT04728386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110239321|NCT04728386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110239322|NCT04728386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110239323|NCT04728386|Disinfectants|disinfectants|mesh-ancestor
110239324|NCT04728386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110239325|NCT00100646|Ritonavir|ritonavir|mesh-list
110239326|NCT00100646|Lopinavir|lopinavir|mesh-list
110239327|NCT00100646|Lamivudine|lamivudine|mesh-list
110239328|NCT00100646|Stavudine|stavudine|mesh-list
110239329|NCT00100646|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110239330|NCT00100646|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110239331|NCT00100646|Protease Inhibitors|protease inhibitors|mesh-ancestor
110239332|NCT00100646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110239333|NCT00100646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267350|NCT00190515|Vitamins|vitamins|mesh-ancestor
110239334|NCT00100646|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110239335|NCT00100646|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110239336|NCT00100646|Antiviral Agents|antiviral agents|mesh-ancestor
110239338|NCT00100646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110239339|NCT00100646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110239340|NCT00100646|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110239341|NCT00100646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110239343|NCT00100685|Volociximab|volociximab|mesh-list
110239344|NCT00100685|Antibodies|antibodies|mesh-list
110239345|NCT00100685|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110239346|NCT00100685|Immunologic Factors|immunologic factors|mesh-ancestor
110239347|NCT00100685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110239348|NCT00100685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110239349|NCT00100685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110239350|NCT00100685|Growth Substances|growth substances|mesh-ancestor
110239351|NCT00100685|Growth Inhibitors|growth inhibitors|mesh-ancestor
110239352|NCT00100685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110239353|NCT00132756|Estramustine|estramustine|mesh-list
110239354|NCT00132756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110239355|NCT00132756|Alkylating Agents|alkylating agents|mesh-ancestor
110239356|NCT00132756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110239357|NCT00132756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110239358|NCT00132756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110239359|NCT00100880|Lenalidomide|lenalidomide|mesh-list
110239360|NCT00100880|Immunologic Factors|immunologic factors|mesh-ancestor
110239361|NCT00100880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110239362|NCT00100880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110239363|NCT00100880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110239364|NCT00100880|Growth Substances|growth substances|mesh-ancestor
110239365|NCT00100880|Growth Inhibitors|growth inhibitors|mesh-ancestor
110239366|NCT00100880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110239367|NCT00100958|Indole-3-carbinol|indole-3-carbinol|mesh-list
110239368|NCT00100958|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110239369|NCT00100958|Protective Agents|protective agents|mesh-ancestor
110239370|NCT00100958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110239371|NCT00100958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110239372|NCT00101075|Capecitabine|capecitabine|mesh-list
110239373|NCT00101075|Oxaliplatin|oxaliplatin|mesh-list
110239374|NCT00101075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110239375|NCT00101075|Antimetabolites|antimetabolites|mesh-ancestor
110239376|NCT00101075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110239377|NCT00101075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110239378|NCT00132912|Vorapaxar|vorapaxar|mesh-list
110239379|NCT00132912|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110239380|NCT00403182|Letrozole|letrozole|mesh-list
110239381|NCT00403182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110239383|NCT00403182|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110239384|NCT00403182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110239385|NCT00403182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110239386|NCT00403182|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110239387|NCT00403182|Hormone Antagonists|hormone antagonists|mesh-ancestor
110239388|NCT00403182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110239389|NCT00403182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110239390|NCT00101114|Interferons|interferons|mesh-list
110239391|NCT00101114|Interferon-alpha|interferon-alpha|mesh-list
110239392|NCT00101114|Interferon alpha-2|interferon alpha-2|mesh-list
110239393|NCT00101114|Sorafenib|sorafenib|mesh-list
110239394|NCT00101114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110239395|NCT00101114|Antiviral Agents|antiviral agents|mesh-ancestor
110239396|NCT00101114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110239397|NCT00101114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110239398|NCT00101114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110267360|NCT00542074|Ethanol|ethanol|mesh-list
110239399|NCT00101114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110239400|NCT00101114|Immunologic Factors|immunologic factors|mesh-ancestor
110239401|NCT00101114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110239402|NCT00101153|Cytarabine|cytarabine|mesh-list
110239403|NCT00101153|Daunorubicin|daunorubicin|mesh-list
110239404|NCT00101153|Tipifarnib|tipifarnib|mesh-list
110239405|NCT00101153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110239406|NCT00101153|Antimetabolites|antimetabolites|mesh-ancestor
110239407|NCT00101153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110239408|NCT00101153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110239409|NCT00101153|Antiviral Agents|antiviral agents|mesh-ancestor
110239410|NCT00101153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110239411|NCT00101153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110239412|NCT00101153|Immunologic Factors|immunologic factors|mesh-ancestor
110239413|NCT00101153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110239414|NCT00101153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110239415|NCT00101153|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110239416|NCT00101153|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110239417|NCT00101153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110239418|NCT00132951|Azithromycin|azithromycin|mesh-list
110239419|NCT00132951|Telithromycin|telithromycin|mesh-list
110239420|NCT00132951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110239421|NCT00132951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110239423|NCT00400790|Desflurane|desflurane|mesh-list
110239424|NCT00400790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110239425|NCT00400790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110239426|NCT00400790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110239427|NCT00400790|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110239428|NCT00400790|Anesthetics, General|anesthetics, general|mesh-ancestor
110239429|NCT00400790|Anesthetics|anesthetics|mesh-ancestor
110239430|NCT00400790|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110239431|NCT00133029|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110239432|NCT00133029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110239433|NCT00135408|Budesonide|budesonide|mesh-list
110239434|NCT00135408|Ipilimumab|ipilimumab|mesh-list
110239435|NCT00135408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110239436|NCT00135408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110239437|NCT00135408|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110239438|NCT00135408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110239439|NCT00135408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110239440|NCT00135408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110239441|NCT00135408|Autonomic Agents|autonomic agents|mesh-ancestor
110239442|NCT00135408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110239443|NCT00135408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110239444|NCT00135408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110239445|NCT00135408|Respiratory System Agents|respiratory system agents|mesh-ancestor
110239446|NCT00135408|Glucocorticoids|glucocorticoids|mesh-ancestor
110239448|NCT00135408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110239449|NCT00101231|Alvocidib|alvocidib|mesh-list
110239450|NCT00101231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110239451|NCT00101231|Growth Inhibitors|growth inhibitors|mesh-ancestor
110239452|NCT00101231|Growth Substances|growth substances|mesh-ancestor
110239453|NCT00101231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110239454|NCT00101231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110239455|NCT00101231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110239456|NCT00101231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110239457|NCT00101270|Oxaliplatin|oxaliplatin|mesh-list
110239458|NCT00101270|Irinotecan|irinotecan|mesh-list
110239459|NCT00101270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110239460|NCT00101270|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110239461|NCT00101270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110239462|NCT00101270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110239463|NCT00101270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110239464|NCT00101309|Aldesleukin|aldesleukin|mesh-list
110239465|NCT00101309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110239466|NCT00101309|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110239467|NCT00101309|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110239468|NCT00101309|Antiviral Agents|antiviral agents|mesh-ancestor
110239469|NCT00101309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110239470|NCT00101348|Bevacizumab|bevacizumab|mesh-list
110239471|NCT00101348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110239472|NCT00101348|Cetuximab|cetuximab|mesh-list
110239473|NCT00101348|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110239474|NCT00101348|Antibodies|antibodies|mesh-list
110239476|NCT00101348|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110052766|NCT01481844|Antacids|antacids|mesh-ancestor
110239477|NCT00101348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110239478|NCT00101348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110239479|NCT00101348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110239480|NCT00101348|Growth Substances|growth substances|mesh-ancestor
110239481|NCT00101348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110239482|NCT00101348|Growth Inhibitors|growth inhibitors|mesh-ancestor
110239483|NCT00101348|Immunologic Factors|immunologic factors|mesh-ancestor
110239484|NCT00101348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110239485|NCT00101348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110239486|NCT00101348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110239487|NCT00101426|Ranirestat|ranirestat|mesh-list
110239488|NCT00101426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110239489|NCT00101426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110239491|NCT00133185|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110239492|NCT00133185|Telmisartan|telmisartan|mesh-list
110239493|NCT00133185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110239494|NCT00133185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110239495|NCT00133185|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110239496|NCT00133185|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110239497|NCT00133185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110239498|NCT00133185|Diuretics|diuretics|mesh-ancestor
110239499|NCT00133185|Natriuretic Agents|natriuretic agents|mesh-ancestor
110239500|NCT00133185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110239502|NCT00133185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110239503|NCT00135603|Amoxicillin|amoxicillin|mesh-list
110239504|NCT00135603|Clavulanic Acid|clavulanic acid|mesh-list
110239505|NCT00135603|Clavulanic Acids|clavulanic acids|mesh-list
110239506|NCT00135603|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110239507|NCT00135603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110239508|NCT00135603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110267408|NCT00542347|Omeprazole|omeprazole|mesh-list
110239509|NCT00135603|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110239510|NCT00135603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110239511|NCT00135603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110239513|NCT00133224|Docetaxel|docetaxel|mesh-list
110239514|NCT00133224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110239515|NCT00133224|Tubulin Modulators|tubulin modulators|mesh-ancestor
110239516|NCT00133224|Antimitotic Agents|antimitotic agents|mesh-ancestor
110239517|NCT00133224|Mitosis Modulators|mitosis modulators|mesh-ancestor
110239518|NCT00133224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110239519|NCT00133224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110239520|NCT00133224|Glucocorticoids|glucocorticoids|mesh-ancestor
110239521|NCT00133224|Hormones|hormones|mesh-ancestor
110239522|NCT00133224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110239523|NCT00133224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110239524|NCT00133224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110239525|NCT00101738|Mycophenolic Acid|mycophenolic acid|mesh-list
110239526|NCT00101738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110239527|NCT00101738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110239528|NCT00101738|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110239529|NCT00101738|Antitubercular Agents|antitubercular agents|mesh-ancestor
110239530|NCT00101738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110239531|NCT00101738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110239532|NCT00101738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110239533|NCT00101738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110239534|NCT00135681|Nedocromil|nedocromil|mesh-list
110239535|NCT00135681|Budesonide|budesonide|mesh-list
110239536|NCT00135681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110239537|NCT00135681|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110239538|NCT00135681|Autonomic Agents|autonomic agents|mesh-ancestor
110239539|NCT00135681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110239540|NCT00135681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110239541|NCT00135681|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110239542|NCT00135681|Respiratory System Agents|respiratory system agents|mesh-ancestor
110239543|NCT00135681|Glucocorticoids|glucocorticoids|mesh-ancestor
110239544|NCT00135681|Hormones|hormones|mesh-ancestor
110239545|NCT00135681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110239546|NCT00135681|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
110239547|NCT00135681|Immunologic Factors|immunologic factors|mesh-ancestor
110239548|NCT00135681|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110239550|NCT00135720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110239551|NCT00135720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110239552|NCT00135720|Analgesics|analgesics|mesh-ancestor
110239553|NCT00135720|Sensory System Agents|sensory system agents|mesh-ancestor
110239554|NCT00135720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110239555|NCT00135720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110239556|NCT00135720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110239557|NCT00135720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110239558|NCT00135720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110239559|NCT00135720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110239560|NCT00135720|Immunologic Factors|immunologic factors|mesh-ancestor
110239561|NCT00101894|Panitumumab|panitumumab|mesh-list
110239562|NCT00101894|Motesanib diphosphate|motesanib diphosphate|mesh-list
110239563|NCT00101894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110239564|NCT00101894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110239565|NCT00101894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110239566|NCT00101894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110239567|NCT00101894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267412|NCT00542347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110239568|NCT00102050|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-list
110239569|NCT00102050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110239570|NCT00102050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110239571|NCT00135759|Naltrexone|naltrexone|mesh-list
110239572|NCT00135759|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110239573|NCT00135759|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110239574|NCT00135759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110239575|NCT00135759|Sensory System Agents|sensory system agents|mesh-ancestor
110239576|NCT00135759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110239577|NCT00133341|Parthenolide|parthenolide|mesh-list
110239578|NCT00133341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110239579|NCT00133341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110239580|NCT00133341|Analgesics|analgesics|mesh-ancestor
110239581|NCT00133341|Sensory System Agents|sensory system agents|mesh-ancestor
110239582|NCT00133341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110239583|NCT00133341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110239584|NCT00133341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110239585|NCT00133341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110239586|NCT00135837|Verteporfin|verteporfin|mesh-list
110239587|NCT00135837|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110239588|NCT00135837|Dermatologic Agents|dermatologic agents|mesh-ancestor
110239589|NCT00133380|Atorvastatin|atorvastatin|mesh-list
110239590|NCT00133380|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110239591|NCT00133380|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110239592|NCT00133380|Antimetabolites|antimetabolites|mesh-ancestor
110239593|NCT00133380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110239594|NCT00133380|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110239595|NCT00133380|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110239596|NCT00133380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110239597|NCT00102167|Gaboxadol|gaboxadol|mesh-list
110239598|NCT00102167|Analgesics|analgesics|mesh-ancestor
110239599|NCT00102167|Sensory System Agents|sensory system agents|mesh-ancestor
110239600|NCT00102167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110239601|NCT00102167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110239602|NCT00102167|Anticonvulsants|anticonvulsants|mesh-ancestor
110239603|NCT00102167|GABA Agonists|gaba agonists|mesh-ancestor
110239604|NCT00102167|GABA Agents|gaba agents|mesh-ancestor
110239605|NCT00102167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110239606|NCT00102167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110239607|NCT00135876|Dalteparin|dalteparin|mesh-list
110239608|NCT00135876|Tinzaparin|tinzaparin|mesh-list
110239609|NCT00135876|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110239611|NCT00135876|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110239612|NCT00135876|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110239613|NCT00135876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110239614|NCT00102206|Ritonavir|ritonavir|mesh-list
110239615|NCT00102206|Lopinavir|lopinavir|mesh-list
110239616|NCT00102206|Saquinavir|saquinavir|mesh-list
110239617|NCT00102206|Tenofovir|tenofovir|mesh-list
110239618|NCT00102206|Lamivudine|lamivudine|mesh-list
110239619|NCT00102206|Emtricitabine|emtricitabine|mesh-list
110239620|NCT00102206|Zidovudine|zidovudine|mesh-list
110239621|NCT00102206|Abacavir|abacavir|mesh-list
110239622|NCT00102206|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110239623|NCT00102206|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110239624|NCT00102206|Protease Inhibitors|protease inhibitors|mesh-ancestor
110239625|NCT00102206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110239626|NCT00102206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110239628|NCT00102206|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110239629|NCT00102206|Antiviral Agents|antiviral agents|mesh-ancestor
110239630|NCT00102206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110239631|NCT00102206|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110239632|NCT00102206|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110239633|NCT00102206|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110239634|NCT00102206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110239635|NCT00102206|Antimetabolites|antimetabolites|mesh-ancestor
110239636|NCT00102284|Levodopa|levodopa|mesh-list
110239637|NCT00102284|Modafinil|modafinil|mesh-list
110239638|NCT00102284|Rivastigmine|rivastigmine|mesh-list
110239639|NCT00102284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110239640|NCT00102284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110239641|NCT00102284|Dopamine Agents|dopamine agents|mesh-ancestor
110239642|NCT00102284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110239643|NCT00102284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110239644|NCT00102284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110239645|NCT00102284|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110239646|NCT00102284|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110239647|NCT00102284|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110239648|NCT00102284|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110239649|NCT00102284|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110239650|NCT00102284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110239651|NCT00102284|Cholinergic Agents|cholinergic agents|mesh-ancestor
110239652|NCT00102284|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110239653|NCT00102284|Protective Agents|protective agents|mesh-ancestor
110239654|NCT00135525|Paroxetine|paroxetine|mesh-list
110239655|NCT00135525|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110239656|NCT00135525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110239657|NCT00135525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110239658|NCT00135525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110239659|NCT00135525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110239660|NCT00135525|Serotonin Agents|serotonin agents|mesh-ancestor
110239661|NCT00135525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110239662|NCT00135525|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110239663|NCT00135525|Antidepressive Agents|antidepressive agents|mesh-ancestor
110239664|NCT00135525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110239665|NCT00135525|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110239666|NCT00135525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110239667|NCT00135525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110239668|NCT00403962|Paroxetine|paroxetine|mesh-list
110239669|NCT00403962|Vestipitant|vestipitant|mesh-list
110239670|NCT00403962|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110239671|NCT00403962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110239672|NCT00403962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110239673|NCT00403962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110239674|NCT00403962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110239675|NCT00403962|Serotonin Agents|serotonin agents|mesh-ancestor
110239676|NCT00403962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110239677|NCT00403962|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110239678|NCT00403962|Antidepressive Agents|antidepressive agents|mesh-ancestor
110239679|NCT00403962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110239680|NCT00403962|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110239681|NCT00403962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110239682|NCT00403962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110239683|NCT00403962|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110239684|NCT00102479|Aripiprazole|aripiprazole|mesh-list
110239685|NCT00102479|Antidepressive Agents|antidepressive agents|mesh-ancestor
110239686|NCT00102479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110239687|NCT00102479|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110239688|NCT00102479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110239689|NCT00102479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110239690|NCT00102479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110239691|NCT00102479|Dopamine Agonists|dopamine agonists|mesh-ancestor
110239692|NCT00102479|Dopamine Agents|dopamine agents|mesh-ancestor
110239693|NCT00102479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110239694|NCT00102479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110239695|NCT00102479|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110239696|NCT00102479|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110239697|NCT00102479|Serotonin Agents|serotonin agents|mesh-ancestor
110239698|NCT00102479|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110239699|NCT00102479|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110239700|NCT00102479|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110239701|NCT00102479|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110239702|NCT00135954|Prednisolone|prednisolone|mesh-list
110239703|NCT00135954|Cyclophosphamide|cyclophosphamide|mesh-list
110239704|NCT00135954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110239705|NCT00135954|Immunologic Factors|immunologic factors|mesh-ancestor
110239706|NCT00135954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110239707|NCT00135954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110239708|NCT00135954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110239709|NCT00135954|Alkylating Agents|alkylating agents|mesh-ancestor
110239710|NCT00135954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110239711|NCT00135954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110239712|NCT00135954|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110239713|NCT00135954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110239714|NCT00135954|Glucocorticoids|glucocorticoids|mesh-ancestor
110239715|NCT00135954|Hormones|hormones|mesh-ancestor
110239716|NCT00135954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110239717|NCT00135954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110239718|NCT00102557|Hydroxychloroquine|hydroxychloroquine|mesh-list
110239719|NCT00102557|Antimalarials|antimalarials|mesh-ancestor
110239720|NCT00102557|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110239721|NCT00102557|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110239722|NCT00102557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110239723|NCT00102557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110239724|NCT00102557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110239725|NCT00102557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110239726|NCT00102635|Fenretinide|fenretinide|mesh-list
110239727|NCT00102635|Lonafarnib|lonafarnib|mesh-list
110239728|NCT00102635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110239729|NCT00102635|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110239730|NCT00102635|Protective Agents|protective agents|mesh-ancestor
110239731|NCT00102635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110239732|NCT00102635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110239733|NCT00102635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110239734|NCT00133419|Vitamins|vitamins|mesh-list
110239735|NCT00133419|Vitamin A|vitamin a|mesh-list
110239737|NCT00133419|Trace Elements|trace elements|mesh-list
110239738|NCT00133419|Micronutrients|micronutrients|mesh-list
110239739|NCT00133419|Retinol palmitate|retinol palmitate|mesh-list
110239740|NCT00133419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110239741|NCT00133419|Antioxidants|antioxidants|mesh-ancestor
110239742|NCT00133419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110239743|NCT00133419|Protective Agents|protective agents|mesh-ancestor
110239744|NCT00133419|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110239746|NCT00102674|Cangrelor|cangrelor|mesh-list
110239747|NCT00102674|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110239748|NCT00102674|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110239749|NCT00102674|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110239750|NCT00102674|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110239751|NCT00102674|Purinergic Agents|purinergic agents|mesh-ancestor
110239752|NCT00102674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110239753|NCT00102674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110239754|NCT00102674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110239755|NCT00135993|Rotigotine|rotigotine|mesh-list
110239757|NCT00135993|Dopamine Agents|dopamine agents|mesh-ancestor
110239758|NCT00135993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110239759|NCT00135993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110239760|NCT00135993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110239761|NCT00102713|Valproic Acid|valproic acid|mesh-list
110239762|NCT00102713|Anticonvulsants|anticonvulsants|mesh-ancestor
110239763|NCT00102713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110239764|NCT00102713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110239765|NCT00102713|GABA Agents|gaba agents|mesh-ancestor
110239766|NCT00102713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110239767|NCT00102713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110239768|NCT00102713|Antimanic Agents|antimanic agents|mesh-ancestor
110239769|NCT00102713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110239770|NCT00102713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110239771|NCT00102713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110239772|NCT00133458|Albendazole|albendazole|mesh-list
110239773|NCT00133458|Anthelmintics|anthelmintics|mesh-ancestor
110239774|NCT00133458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110239775|NCT00133458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110239776|NCT00133458|Anticestodal Agents|anticestodal agents|mesh-ancestor
110239777|NCT00133458|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110239778|NCT00133458|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110239779|NCT00133458|Tubulin Modulators|tubulin modulators|mesh-ancestor
110239780|NCT00133458|Antimitotic Agents|antimitotic agents|mesh-ancestor
110239781|NCT00133458|Mitosis Modulators|mitosis modulators|mesh-ancestor
110239782|NCT00133458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110239783|NCT00133458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110239784|NCT00102752|Gemcitabine|gemcitabine|mesh-list
110239785|NCT00102752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110239786|NCT00102752|Antimetabolites|antimetabolites|mesh-ancestor
110239787|NCT00102752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110239788|NCT00102752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110239789|NCT00102830|Trebananib|trebananib|mesh-list
110239790|NCT00102830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110239791|NCT00102830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110239792|NCT00102830|Growth Substances|growth substances|mesh-ancestor
110239793|NCT00102830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110239794|NCT00102830|Growth Inhibitors|growth inhibitors|mesh-ancestor
110239795|NCT00102830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110239797|NCT00136110|Anticonvulsants|anticonvulsants|mesh-ancestor
110239798|NCT00136110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110239799|NCT00136110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110239800|NCT00136110|GABA Agents|gaba agents|mesh-ancestor
110239801|NCT00136110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110239802|NCT00136110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110239803|NCT00136110|Antimanic Agents|antimanic agents|mesh-ancestor
110239804|NCT00136110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110239805|NCT00136110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110239806|NCT00136110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110239808|NCT00136188|Hematinics|hematinics|mesh-ancestor
110239809|NCT00136188|Vitamin B Complex|vitamin b complex|mesh-ancestor
110239810|NCT00136188|Vitamins|vitamins|mesh-ancestor
110267469|NCT00184041|Pegaspargase|pegaspargase|mesh-list
110239811|NCT00136188|Micronutrients|micronutrients|mesh-ancestor
110239812|NCT00136188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110239814|NCT00102869|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110239815|NCT00102869|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110239816|NCT00102869|Dopamine Agents|dopamine agents|mesh-ancestor
110239817|NCT00102869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110239818|NCT00102869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110239819|NCT00102869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110239820|NCT00102908|Zoledronic Acid|zoledronic acid|mesh-list
110239821|NCT00102908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110239822|NCT00102908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110239823|NCT00401024|Imatinib Mesylate|imatinib mesylate|mesh-list
110239824|NCT00401024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110239825|NCT00401024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110239826|NCT00401024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110239827|NCT00401024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110239828|NCT00136266|Vitamin D|vitamin d|mesh-list
110239829|NCT00136266|Vitamins|vitamins|mesh-list
110239830|NCT00136266|Vitamin A|vitamin a|mesh-list
110239831|NCT00136266|Ferrous fumarate|ferrous fumarate|mesh-list
110239832|NCT00136266|Micronutrients|micronutrients|mesh-ancestor
110239833|NCT00136266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110239834|NCT00136266|Trace Elements|trace elements|mesh-ancestor
110239835|NCT00136266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110239836|NCT00102947|Daptomycin|daptomycin|mesh-list
110239837|NCT00102947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110239838|NCT00102947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110239839|NCT00136344|Levofloxacin|levofloxacin|mesh-list
110239840|NCT00136344|Cefuroxime|cefuroxime|mesh-list
110239841|NCT00136344|Cefuroxime axetil|cefuroxime axetil|mesh-list
110239842|NCT00136344|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110239843|NCT00136344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110239844|NCT00136344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110239845|NCT00136344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110239846|NCT00136344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110239847|NCT00136344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110239848|NCT00136344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110239849|NCT00136344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110239850|NCT00136344|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110239851|NCT00136344|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110239852|NCT00102986|Ritonavir|ritonavir|mesh-list
110239853|NCT00102986|Lopinavir|lopinavir|mesh-list
110239854|NCT00102986|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110239855|NCT00102986|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110239856|NCT00102986|Protease Inhibitors|protease inhibitors|mesh-ancestor
110239857|NCT00102986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110239858|NCT00102986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110239859|NCT00102986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110239860|NCT00102986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110239861|NCT00102986|Antiviral Agents|antiviral agents|mesh-ancestor
110239862|NCT00102986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110239863|NCT00102986|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110239864|NCT00102986|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110239865|NCT00136383|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110239866|NCT00136383|Paroxetine|paroxetine|mesh-list
110239867|NCT00136383|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110239868|NCT00136383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110239869|NCT00136383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110239870|NCT00136383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110239871|NCT00136383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110239872|NCT00136383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110239873|NCT00136383|Analgesics|analgesics|mesh-ancestor
110239874|NCT00136383|Sensory System Agents|sensory system agents|mesh-ancestor
110239875|NCT00136383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110239876|NCT00136383|Antidepressive Agents|antidepressive agents|mesh-ancestor
110239878|NCT00136383|Dopamine Agents|dopamine agents|mesh-ancestor
110239879|NCT00136383|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110239880|NCT00136383|Serotonin Agents|serotonin agents|mesh-ancestor
110239881|NCT00136383|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110239882|NCT00136383|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110239883|NCT00136383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110239884|NCT00136383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110239885|NCT00103103|Leucovorin|leucovorin|mesh-list
110239886|NCT00103103|Fluorouracil|fluorouracil|mesh-list
110239887|NCT00103103|Bortezomib|bortezomib|mesh-list
110239888|NCT00103103|Calcium|calcium|mesh-list
110239889|NCT00103103|Levoleucovorin|levoleucovorin|mesh-list
110239890|NCT00103103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110239891|NCT00103103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110239892|NCT00103103|Antimetabolites|antimetabolites|mesh-ancestor
110239893|NCT00103103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110239894|NCT00103103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110239896|NCT00103103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110239897|NCT00103103|Immunologic Factors|immunologic factors|mesh-ancestor
110239898|NCT00103103|Antidotes|antidotes|mesh-ancestor
110239899|NCT00103103|Protective Agents|protective agents|mesh-ancestor
110239900|NCT00103103|Vitamin B Complex|vitamin b complex|mesh-ancestor
110239901|NCT00103103|Vitamins|vitamins|mesh-ancestor
110239902|NCT00103103|Micronutrients|micronutrients|mesh-ancestor
110239903|NCT00133692|Atenolol|atenolol|mesh-list
110239904|NCT00133692|Verapamil|verapamil|mesh-list
110239905|NCT00133692|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110239906|NCT00133692|Trandolapril|trandolapril|mesh-list
110239907|NCT00133692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110239908|NCT00133692|Diuretics|diuretics|mesh-ancestor
110239909|NCT00133692|Natriuretic Agents|natriuretic agents|mesh-ancestor
110239910|NCT00133692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110239911|NCT00133692|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110239912|NCT00133692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110239913|NCT00133692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110239914|NCT00133692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110239915|NCT00133692|Sympatholytics|sympatholytics|mesh-ancestor
110239916|NCT00133692|Autonomic Agents|autonomic agents|mesh-ancestor
110239917|NCT00133692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110239918|NCT00133692|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110239919|NCT00133692|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110239920|NCT00133692|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110239921|NCT00133692|Adrenergic Agents|adrenergic agents|mesh-ancestor
110239922|NCT00133692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110239923|NCT00133692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110239924|NCT00133692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110239925|NCT00133692|Vasodilator Agents|vasodilator agents|mesh-ancestor
110239926|NCT00133692|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110239927|NCT00133692|Protease Inhibitors|protease inhibitors|mesh-ancestor
110239928|NCT00133692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110239930|NCT00133731|Calcium heparin|calcium heparin|mesh-list
110239931|NCT00133731|Otamixaban|otamixaban|mesh-list
110239932|NCT00133731|Anticoagulants|anticoagulants|mesh-ancestor
110239933|NCT00133731|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110239934|NCT00133731|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110239935|NCT00133731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110239936|NCT00133731|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110239937|NCT00133731|Antithrombins|antithrombins|mesh-ancestor
110239938|NCT00133731|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110239939|NCT00133731|Protease Inhibitors|protease inhibitors|mesh-ancestor
110239940|NCT00133731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110239941|NCT00103298|Leucovorin|leucovorin|mesh-list
110239942|NCT00103298|Fluorouracil|fluorouracil|mesh-list
110239943|NCT00103298|Oxaliplatin|oxaliplatin|mesh-list
110239944|NCT00103298|Melphalan|melphalan|mesh-list
110239945|NCT00103298|Calcium|calcium|mesh-list
110239946|NCT00103298|Levoleucovorin|levoleucovorin|mesh-list
110239947|NCT00103298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110239948|NCT00103298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110239949|NCT00103298|Antimetabolites|antimetabolites|mesh-ancestor
110239950|NCT00103298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110239951|NCT00103298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110239952|NCT00103298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110239953|NCT00103298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110239954|NCT00103298|Immunologic Factors|immunologic factors|mesh-ancestor
110239955|NCT00103298|Antidotes|antidotes|mesh-ancestor
110239956|NCT00103298|Protective Agents|protective agents|mesh-ancestor
110239957|NCT00103298|Vitamin B Complex|vitamin b complex|mesh-ancestor
110239958|NCT00103298|Vitamins|vitamins|mesh-ancestor
110239959|NCT00103298|Micronutrients|micronutrients|mesh-ancestor
110239960|NCT00103298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110239961|NCT00103298|Alkylating Agents|alkylating agents|mesh-ancestor
110239962|NCT00103298|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110239963|NCT00136461|Tretinoin|tretinoin|mesh-list
110239964|NCT00136461|Bryostatin 1|bryostatin 1|mesh-list
110239965|NCT00136461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110239966|NCT00136461|Keratolytic Agents|keratolytic agents|mesh-ancestor
110239967|NCT00136461|Dermatologic Agents|dermatologic agents|mesh-ancestor
110239968|NCT00136461|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110239969|NCT00136461|Immunologic Factors|immunologic factors|mesh-ancestor
110239970|NCT00136461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110239971|NCT00133770|Pantoprazole|pantoprazole|mesh-list
110239972|NCT00133770|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110239973|NCT00133770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110239974|NCT00133770|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110239975|NCT00133770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110239976|NCT00133770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110239977|NCT00133848|Retapamulin|retapamulin|mesh-list
110239978|NCT00133848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110239979|NCT00133848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110239980|NCT00133887|Sirolimus|sirolimus|mesh-list
110239981|NCT00133887|Cyclosporine|cyclosporine|mesh-list
110239982|NCT00133887|Tacrolimus|tacrolimus|mesh-list
110239983|NCT00133887|Cyclosporins|cyclosporins|mesh-list
110239984|NCT00133887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110239985|NCT00133887|Immunologic Factors|immunologic factors|mesh-ancestor
110239986|NCT00133887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110239987|NCT00133887|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110239988|NCT00133887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110239989|NCT00133887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110239990|NCT00133887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110239991|NCT00133887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110239992|NCT00133887|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110239993|NCT00133887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110239994|NCT00133887|Antifungal Agents|antifungal agents|mesh-ancestor
110239996|NCT00133887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110239997|NCT00136539|Cyclophosphamide|cyclophosphamide|mesh-list
110239999|NCT00136539|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110240000|NCT00136539|Trastuzumab|trastuzumab|mesh-list
110240001|NCT00136539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110240002|NCT00136539|Immunologic Factors|immunologic factors|mesh-ancestor
110240003|NCT00136539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110240004|NCT00136539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110240005|NCT00136539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110240006|NCT00136539|Alkylating Agents|alkylating agents|mesh-ancestor
110240007|NCT00136539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240008|NCT00136539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110240009|NCT00136539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110240010|NCT00136539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110240011|NCT00136539|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110240012|NCT00136539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110240013|NCT00136539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110240014|NCT00136539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110240015|NCT00103571|Olanzapine|olanzapine|mesh-list
110240016|NCT00103571|Aripiprazole|aripiprazole|mesh-list
110240017|NCT00103571|Antiemetics|antiemetics|mesh-ancestor
110240018|NCT00103571|Autonomic Agents|autonomic agents|mesh-ancestor
110240019|NCT00103571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110240020|NCT00103571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110240021|NCT00103571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110240022|NCT00103571|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110240023|NCT00103571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110240024|NCT00103571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110240025|NCT00103571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110240026|NCT00103571|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110240027|NCT00103571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110240028|NCT00103571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110240029|NCT00103571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240030|NCT00103571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110240031|NCT00103571|Serotonin Agents|serotonin agents|mesh-ancestor
110240032|NCT00103571|Antidepressive Agents|antidepressive agents|mesh-ancestor
110240033|NCT00103571|Dopamine Agonists|dopamine agonists|mesh-ancestor
110240034|NCT00103571|Dopamine Agents|dopamine agents|mesh-ancestor
110240035|NCT00103571|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110240036|NCT00103571|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110240037|NCT00103571|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110240038|NCT00103571|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110240039|NCT00103571|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110240040|NCT00103571|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110240041|NCT00136578|Carboplatin|carboplatin|mesh-list
110240042|NCT00136578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110240043|NCT00103649|Xaliproden|xaliproden|mesh-list
110240044|NCT00103649|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110240045|NCT00103649|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110240046|NCT00103649|Serotonin Agents|serotonin agents|mesh-ancestor
110240047|NCT00103649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110240048|NCT00103649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240049|NCT00103649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110240050|NCT00136617|Chlordiazepoxide|chlordiazepoxide|mesh-list
110240051|NCT00136617|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110267529|NCT00190632|Analgesics|analgesics|mesh-ancestor
110240052|NCT00136617|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110240053|NCT00136617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110240054|NCT00136617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110240055|NCT00136617|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110240056|NCT00136617|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110240057|NCT00136617|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110240058|NCT00136617|GABA Modulators|gaba modulators|mesh-ancestor
110240059|NCT00136617|GABA Agents|gaba agents|mesh-ancestor
110240060|NCT00136617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110240061|NCT00136617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240062|NCT00103727|Risperidone|risperidone|mesh-list
110240063|NCT00103727|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110240064|NCT00103727|Serotonin Agents|serotonin agents|mesh-ancestor
110240065|NCT00103727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110240066|NCT00103727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240067|NCT00103727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110240068|NCT00103727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110240069|NCT00103727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110240070|NCT00103727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110240071|NCT00103727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110240072|NCT00103727|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110240073|NCT00103727|Dopamine Agents|dopamine agents|mesh-ancestor
110240074|NCT00103766|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110240075|NCT00103766|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110240076|NCT00103766|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110240077|NCT00103766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240078|NCT00103805|Levodopa|levodopa|mesh-list
110240079|NCT00103805|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110240080|NCT00103805|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110240081|NCT00103805|Dopamine Agents|dopamine agents|mesh-ancestor
110240082|NCT00103805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110240083|NCT00103805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240084|NCT00103805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110240085|NCT00404040|Lactulose|lactulose|mesh-list
110240086|NCT00404040|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
110240087|NCT00404040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110240088|NCT00404040|Laxatives|laxatives|mesh-ancestor
110240089|NCT00103922|Cilomilast|cilomilast|mesh-list
110240090|NCT00103922|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110240091|NCT00103922|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110240092|NCT00103922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110240093|NCT00103922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240094|NCT00134160|Amlodipine|amlodipine|mesh-list
110240095|NCT00134160|Olmesartan|olmesartan|mesh-list
110240096|NCT00134160|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110240097|NCT00134160|Calcium Channel Blockers|calcium channel blockers|mesh-list
110240098|NCT00134160|Calcium|calcium|mesh-list
110240099|NCT00134160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110240100|NCT00134160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110240101|NCT00134160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110240102|NCT00134160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110260207|NCT00530413|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110240103|NCT00134160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240104|NCT00134160|Vasodilator Agents|vasodilator agents|mesh-ancestor
110240105|NCT00134160|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110240106|NCT00134160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110240107|NCT00136656|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110240108|NCT00136656|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110240109|NCT00136656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110240110|NCT00136656|Antitubercular Agents|antitubercular agents|mesh-ancestor
110240111|NCT00134199|Sibutramine|sibutramine|mesh-list
110240112|NCT00134199|Antidepressive Agents|antidepressive agents|mesh-ancestor
110240113|NCT00134199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110240114|NCT00134199|Appetite Depressants|appetite depressants|mesh-ancestor
110240115|NCT00134199|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110240116|NCT04729088|Isosorbide|isosorbide|mesh-list
110240117|NCT04729088|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
110240119|NCT04729088|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110240120|NCT04729088|Diuretics|diuretics|mesh-ancestor
110240121|NCT04729088|Natriuretic Agents|natriuretic agents|mesh-ancestor
110240122|NCT04729088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110240123|NCT04729088|Vasodilator Agents|vasodilator agents|mesh-ancestor
110240124|NCT04729088|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110240125|NCT04729088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240126|NCT00136734|Methylphenidate|methylphenidate|mesh-list
110240127|NCT00136734|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110240128|NCT00136734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110240129|NCT00136734|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110240130|NCT00136734|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110240131|NCT00136734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110240132|NCT00136734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240134|NCT00136734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110240136|NCT00136773|Benazepril|benazepril|mesh-list
110240137|NCT00136773|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110240138|NCT00136773|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110240139|NCT00136773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110240140|NCT00136773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240141|NCT00136773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110240142|NCT00136773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110240143|NCT00136773|Vasodilator Agents|vasodilator agents|mesh-ancestor
110240144|NCT00136773|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110240145|NCT00136773|Protease Inhibitors|protease inhibitors|mesh-ancestor
110240146|NCT00136773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110240147|NCT00136851|Amlodipine|amlodipine|mesh-list
110240148|NCT00136851|Benazepril|benazepril|mesh-list
110240149|NCT00136851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110240150|NCT00136851|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110240151|NCT00136851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110240152|NCT00136851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240153|NCT00136851|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110240154|NCT00136851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110240155|NCT00136851|Vasodilator Agents|vasodilator agents|mesh-ancestor
110240156|NCT00136851|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110240157|NCT00136851|Protease Inhibitors|protease inhibitors|mesh-ancestor
110240158|NCT00136851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110240159|NCT00104273|Rasagiline|rasagiline|mesh-list
110240160|NCT00104273|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110240161|NCT00104273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110240162|NCT00104273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240163|NCT00104273|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110240164|NCT00104273|Protective Agents|protective agents|mesh-ancestor
110240165|NCT00104273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110240166|NCT00136929|Fibrinolytic Agents|fibrinolytic agents|mesh-list
110240167|NCT00136929|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110240168|NCT00136929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240169|NCT00134355|Vatalanib|vatalanib|mesh-list
110240170|NCT00134355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110240171|NCT00134355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110240172|NCT00134355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240173|NCT00104429|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
110240174|NCT00104429|Aplaviroc|aplaviroc|mesh-list
110240175|NCT00104429|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110240176|NCT00104429|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110240177|NCT00104429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110240178|NCT00104429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240180|NCT00104429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110240181|NCT00104429|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110240182|NCT00104429|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110240183|NCT00104429|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110240184|NCT00104429|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110240185|NCT00136968|Voriconazole|voriconazole|mesh-list
110240186|NCT00136968|Antifungal Agents|antifungal agents|mesh-ancestor
110240187|NCT00136968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110240188|NCT00136968|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110240189|NCT00136968|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110240190|NCT00136968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110240191|NCT00136968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240192|NCT00136968|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110240193|NCT00136968|Hormone Antagonists|hormone antagonists|mesh-ancestor
110240194|NCT00136968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110240195|NCT00136968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110240196|NCT00136968|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110240197|NCT00104468|Troxacitabine|troxacitabine|mesh-list
110240198|NCT00104468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110240199|NCT00104468|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110240200|NCT00104468|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110240201|NCT00104468|Antiviral Agents|antiviral agents|mesh-ancestor
110240202|NCT00104468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110240203|NCT00137007|Azithromycin|azithromycin|mesh-list
110240204|NCT00137007|Ampicillin|ampicillin|mesh-list
110240205|NCT00137007|Sulbactam|sulbactam|mesh-list
110240206|NCT00137007|Sultamicillin|sultamicillin|mesh-list
110240207|NCT00137007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110240208|NCT00137007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110240209|NCT00137007|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110240210|NCT00137007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110240211|NCT00137007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240212|NCT00137085|Ketamine|ketamine|mesh-list
110240213|NCT00137085|Analgesics|analgesics|mesh-ancestor
110240214|NCT00137085|Sensory System Agents|sensory system agents|mesh-ancestor
110240215|NCT00137085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110240216|NCT00137085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110240217|NCT00137085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110240218|NCT00137085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110240219|NCT00137085|Anesthetics, General|anesthetics, general|mesh-ancestor
110240220|NCT00137085|Anesthetics|anesthetics|mesh-ancestor
110240221|NCT00137085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110240222|NCT00137085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110240223|NCT00137085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110240224|NCT00137085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110240225|NCT00137085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240226|NCT00104546|Vitamin K|vitamin k|mesh-list
110240227|NCT00104546|Vitamins|vitamins|mesh-ancestor
110240228|NCT00104546|Micronutrients|micronutrients|mesh-ancestor
110240229|NCT00104546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110240230|NCT00104546|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110240231|NCT00104546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110240232|NCT00104546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240233|NCT00104546|Hemostatics|hemostatics|mesh-ancestor
110240236|NCT00134394|Tacrolimus|tacrolimus|mesh-list
110240237|NCT00134394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110240238|NCT00134394|Immunologic Factors|immunologic factors|mesh-ancestor
110240239|NCT00134394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110240240|NCT00134394|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110240241|NCT00134394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110240242|NCT00134394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240243|NCT00134394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110240244|NCT00134394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110240245|NCT00134394|Analgesics|analgesics|mesh-ancestor
110240246|NCT00134394|Sensory System Agents|sensory system agents|mesh-ancestor
110240247|NCT00134394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110240248|NCT00134394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110240249|NCT00134394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110240250|NCT00134394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110240251|NCT00104624|Docetaxel|docetaxel|mesh-list
110240252|NCT00104624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110240253|NCT00104624|Tubulin Modulators|tubulin modulators|mesh-ancestor
110240254|NCT00104624|Antimitotic Agents|antimitotic agents|mesh-ancestor
110240255|NCT00104624|Mitosis Modulators|mitosis modulators|mesh-ancestor
110240256|NCT00104624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240257|NCT00104663|Quinacrine|quinacrine|mesh-list
110240258|NCT00104663|Anticestodal Agents|anticestodal agents|mesh-ancestor
110240259|NCT00104663|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110240260|NCT00104663|Anthelmintics|anthelmintics|mesh-ancestor
110240261|NCT00104663|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110240262|NCT00104663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110240263|NCT00104663|Antimalarials|antimalarials|mesh-ancestor
110240264|NCT00104663|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110240265|NCT00104663|Antinematodal Agents|antinematodal agents|mesh-ancestor
110240266|NCT00104663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110240267|NCT00104663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110240268|NCT00104663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240269|NCT00104741|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110240270|NCT00104741|Flutamide|flutamide|mesh-list
110240271|NCT00104741|Luteolytic Agents|luteolytic agents|mesh-ancestor
110240272|NCT00104741|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110240273|NCT00104741|Contraceptive Agents|contraceptive agents|mesh-ancestor
110240274|NCT00104741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110240275|NCT00104741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110240276|NCT00104741|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110240277|NCT00104741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110240278|NCT00104741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110240279|NCT00104741|Androgen Antagonists|androgen antagonists|mesh-ancestor
110240280|NCT00104741|Hormone Antagonists|hormone antagonists|mesh-ancestor
110240281|NCT00104741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110240282|NCT00134511|Atorvastatin|atorvastatin|mesh-list
110240283|NCT00134511|Torcetrapib|torcetrapib|mesh-list
110240284|NCT00134511|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110240285|NCT00134511|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110240286|NCT00134511|Antimetabolites|antimetabolites|mesh-ancestor
110240287|NCT00134511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240288|NCT00134511|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110240289|NCT00134511|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110240290|NCT00134511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110240291|NCT00104780|Freund's Adjuvant|freund's adjuvant|mesh-list
110240292|NCT00104780|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110240293|NCT00104780|Immunologic Factors|immunologic factors|mesh-ancestor
110240294|NCT00104780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110240295|NCT00134550|Atorvastatin|atorvastatin|mesh-list
110240296|NCT00134550|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110240297|NCT00134550|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110240298|NCT00134550|Antimetabolites|antimetabolites|mesh-ancestor
110267575|NCT03456661|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110240299|NCT00134550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240301|NCT00134550|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110240302|NCT00134550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110240303|NCT00104819|Immunoglobulins|immunoglobulins|mesh-list
110240304|NCT00104819|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110240305|NCT00104819|Antibodies|antibodies|mesh-list
110240306|NCT00104819|Sargramostim|sargramostim|mesh-list
110240307|NCT00104819|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
110240308|NCT00104819|Immunologic Factors|immunologic factors|mesh-ancestor
110240309|NCT00104819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110240310|NCT00137202|Diphenhydramine|diphenhydramine|mesh-list
110240311|NCT00137202|Promethazine|promethazine|mesh-list
110240312|NCT00137202|Ondansetron|ondansetron|mesh-list
110240313|NCT00137202|Antiemetics|antiemetics|mesh-ancestor
110240314|NCT00137202|Autonomic Agents|autonomic agents|mesh-ancestor
110240315|NCT00137202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110240316|NCT00137202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110240317|NCT00137202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110240318|NCT00137202|Antipruritics|antipruritics|mesh-ancestor
110240319|NCT00137202|Dermatologic Agents|dermatologic agents|mesh-ancestor
110240320|NCT00137202|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110240321|NCT00137202|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110240322|NCT00137202|Serotonin Agents|serotonin agents|mesh-ancestor
110240323|NCT00137202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110240324|NCT00137202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240325|NCT00137202|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110240326|NCT00137202|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110240327|NCT00137202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110240328|NCT00137202|Anesthetics, Local|anesthetics, local|mesh-ancestor
110240329|NCT00137202|Anesthetics|anesthetics|mesh-ancestor
110240330|NCT00137202|Sensory System Agents|sensory system agents|mesh-ancestor
110240331|NCT00137202|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110240332|NCT00137202|Histamine Antagonists|histamine antagonists|mesh-ancestor
110240333|NCT00137202|Histamine Agents|histamine agents|mesh-ancestor
110240334|NCT00137202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110240335|NCT00104975|Fludarabine|fludarabine|mesh-list
110240336|NCT00104975|Fludarabine phosphate|fludarabine phosphate|mesh-list
110240337|NCT00104975|Melphalan|melphalan|mesh-list
110240338|NCT00104975|Alemtuzumab|alemtuzumab|mesh-list
110240339|NCT00104975|Thiotepa|thiotepa|mesh-list
110240340|NCT00104975|Tacrolimus|tacrolimus|mesh-list
110240341|NCT00104975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110240342|NCT00104975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110240343|NCT00104975|Antimetabolites|antimetabolites|mesh-ancestor
110240344|NCT00104975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240345|NCT00104975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110240346|NCT00104975|Immunologic Factors|immunologic factors|mesh-ancestor
110240347|NCT00104975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110240348|NCT00104975|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110240349|NCT00104975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110240350|NCT00104975|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110240351|NCT00104975|Alkylating Agents|alkylating agents|mesh-ancestor
110240352|NCT00104975|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110240353|NCT00104975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110240354|NCT00137358|Amifostine|amifostine|mesh-list
110240355|NCT00137358|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110240356|NCT00137358|Protective Agents|protective agents|mesh-ancestor
110240357|NCT00137358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110240358|NCT00134667|Verteporfin|verteporfin|mesh-list
110240359|NCT00134667|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110240360|NCT00134667|Dermatologic Agents|dermatologic agents|mesh-ancestor
110240361|NCT00134706|Carboplatin|carboplatin|mesh-list
110240362|NCT00134706|Docetaxel|docetaxel|mesh-list
110240363|NCT00134706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110240364|NCT00134706|Tubulin Modulators|tubulin modulators|mesh-ancestor
110240365|NCT00134706|Antimitotic Agents|antimitotic agents|mesh-ancestor
110240366|NCT00134706|Mitosis Modulators|mitosis modulators|mesh-ancestor
110240367|NCT00134706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240368|NCT00137397|Tolterodine Tartrate|tolterodine tartrate|mesh-list
110240369|NCT00137397|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110240370|NCT00137397|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110240371|NCT00137397|Cholinergic Agents|cholinergic agents|mesh-ancestor
110240372|NCT00137397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110240373|NCT00137397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240374|NCT00137397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110240375|NCT00137397|Urological Agents|urological agents|mesh-ancestor
110240376|NCT00134745|Estradiol|estradiol|mesh-list
110240377|NCT00134745|Estrogens|estrogens|mesh-ancestor
110240378|NCT00134745|Hormones|hormones|mesh-ancestor
110240379|NCT00134745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110240380|NCT00134745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110240381|NCT00105209|Aspirin|aspirin|mesh-list
110240382|NCT00105209|Clopidogrel|clopidogrel|mesh-list
110240383|NCT00105209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110240384|NCT00105209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110240385|NCT00105209|Analgesics|analgesics|mesh-ancestor
110240387|NCT00105209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110240388|NCT00105209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110240389|NCT00105209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110240390|NCT00105209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110240391|NCT00105209|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110240392|NCT00105209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110240393|NCT00105209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240394|NCT00105209|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110240395|NCT00105209|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110240396|NCT00105209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110240397|NCT00105209|Antipyretics|antipyretics|mesh-ancestor
110240398|NCT00105209|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110240399|NCT00105209|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110240400|NCT00105209|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110240401|NCT00105209|Purinergic Agents|purinergic agents|mesh-ancestor
110240402|NCT00105209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110240403|NCT00105287|Fentanyl|fentanyl|mesh-list
110240404|NCT00105287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110240405|NCT00105287|Narcotics|narcotics|mesh-ancestor
110240406|NCT00105287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110240407|NCT00105287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110240408|NCT00105287|Analgesics|analgesics|mesh-ancestor
110240409|NCT00105287|Sensory System Agents|sensory system agents|mesh-ancestor
110240410|NCT00105287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110240411|NCT00105287|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110240412|NCT00105287|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110240413|NCT00105287|Anesthetics, General|anesthetics, general|mesh-ancestor
110240414|NCT00105287|Anesthetics|anesthetics|mesh-ancestor
110240415|NCT00137514|Chloroquine|chloroquine|mesh-list
110240416|NCT00137514|Amodiaquine|amodiaquine|mesh-list
110240417|NCT00137514|Amebicides|amebicides|mesh-ancestor
110240418|NCT00137514|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110240419|NCT00137514|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110240420|NCT00137514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110240421|NCT00137514|Antimalarials|antimalarials|mesh-ancestor
110240422|NCT00137514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110240423|NCT00105326|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110240424|NCT00105326|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110240425|NCT00105326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110240426|NCT00105326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110240427|NCT00105326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110240428|NCT00105326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110240429|NCT00105326|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110240430|NCT00105326|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110240431|NCT00105326|Serotonin Agents|serotonin agents|mesh-ancestor
110240432|NCT00105326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110240433|NCT00105326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240436|NCT00105326|Dopamine Agents|dopamine agents|mesh-ancestor
110240437|NCT00137553|Pyrimethamine|pyrimethamine|mesh-list
110240438|NCT00137553|Sulfadoxine|sulfadoxine|mesh-list
110240439|NCT00137553|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110240440|NCT00137553|Antimalarials|antimalarials|mesh-ancestor
110240441|NCT00137553|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110240442|NCT00137553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110240443|NCT00137553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110240444|NCT00137553|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110240445|NCT00137553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110240446|NCT00137553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240447|NCT00137553|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110240448|NCT00105404|Triamcinolone|triamcinolone|mesh-list
110240449|NCT00105404|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110240450|NCT00105404|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110240451|NCT00105404|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110240452|NCT00105404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110240453|NCT00105404|Glucocorticoids|glucocorticoids|mesh-ancestor
110240454|NCT00105404|Hormones|hormones|mesh-ancestor
110240455|NCT00105404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110240456|NCT00105404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110240457|NCT00105404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110240458|NCT00105404|Immunologic Factors|immunologic factors|mesh-ancestor
110240459|NCT00105404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110240460|NCT00105404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240461|NCT00134979|Formoterol Fumarate|formoterol fumarate|mesh-list
110240462|NCT00134979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110240463|NCT00134979|Autonomic Agents|autonomic agents|mesh-ancestor
110240464|NCT00134979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110240465|NCT00134979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110240466|NCT00134979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110240467|NCT00134979|Respiratory System Agents|respiratory system agents|mesh-ancestor
110240468|NCT00134979|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110240469|NCT00134979|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110240470|NCT00134979|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110240471|NCT00134979|Adrenergic Agents|adrenergic agents|mesh-ancestor
110240472|NCT00134979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110240473|NCT00134979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240475|NCT00135018|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110240476|NCT00135018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110240477|NCT00135018|Analgesics|analgesics|mesh-ancestor
110240478|NCT00135018|Sensory System Agents|sensory system agents|mesh-ancestor
110240479|NCT00135018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110240480|NCT00135018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110240481|NCT00135018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110240482|NCT00135018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110240483|NCT00135018|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110240484|NCT00135018|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110240485|NCT00135018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110240486|NCT00135018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240487|NCT00137709|Lamotrigine|lamotrigine|mesh-list
110240488|NCT00137709|Valproic Acid|valproic acid|mesh-list
110240489|NCT00137709|Anticonvulsants|anticonvulsants|mesh-ancestor
110240490|NCT00137709|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110240491|NCT00137709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110240492|NCT00137709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240493|NCT00137709|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110240494|NCT00137709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110240495|NCT00137709|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110240496|NCT00137709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110240497|NCT00137709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110240498|NCT00137709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110240499|NCT00137709|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110240500|NCT00137709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110240501|NCT00137709|GABA Agents|gaba agents|mesh-ancestor
110240502|NCT00137709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110240503|NCT00137709|Antimanic Agents|antimanic agents|mesh-ancestor
110240504|NCT01054144|Dexamethasone|dexamethasone|mesh-list
110240506|NCT01054144|Lenalidomide|lenalidomide|mesh-list
110240507|NCT01054144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110240508|NCT01054144|Antiemetics|antiemetics|mesh-ancestor
110240509|NCT01054144|Autonomic Agents|autonomic agents|mesh-ancestor
110240510|NCT01054144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110240511|NCT01054144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110240512|NCT01054144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110240513|NCT01054144|Glucocorticoids|glucocorticoids|mesh-ancestor
110240514|NCT01054144|Hormones|hormones|mesh-ancestor
110240515|NCT01054144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110240516|NCT01054144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110240517|NCT01054144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110240518|NCT01054144|Immunologic Factors|immunologic factors|mesh-ancestor
110240519|NCT01054144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110240520|NCT01054144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110240521|NCT01054144|Growth Substances|growth substances|mesh-ancestor
110240522|NCT01054144|Growth Inhibitors|growth inhibitors|mesh-ancestor
110240523|NCT00137787|Ciprofloxacin|ciprofloxacin|mesh-list
110240524|NCT00137787|Cefepime|cefepime|mesh-list
110240525|NCT00137787|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110240526|NCT00137787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110240527|NCT00137787|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110240528|NCT00137787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110240529|NCT00137787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110240530|NCT00137787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240531|NCT00137787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110240532|NCT00137787|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110240533|NCT00137787|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110240534|NCT04702048|Aflibercept|aflibercept|mesh-list
110240535|NCT04702048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110240536|NCT04702048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110240538|NCT04702048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110240539|NCT04702048|Growth Inhibitors|growth inhibitors|mesh-ancestor
110240540|NCT04702048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110240541|NCT00434629|Tositumomab I-131|tositumomab i-131|mesh-list
110240542|NCT00434629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110240543|NCT00135057|Insulin|insulin|mesh-list
110240544|NCT00135057|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110240545|NCT00135057|Insulin Glargine|insulin glargine|mesh-list
110240546|NCT00135057|Insulin glulisine|insulin glulisine|mesh-list
110240547|NCT00135057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110240548|NCT00135057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110240549|NCT00434668|Cisplatin|cisplatin|mesh-list
110240550|NCT00434668|Docetaxel|docetaxel|mesh-list
110240551|NCT00434668|Vinorelbine|vinorelbine|mesh-list
110240552|NCT00434668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110240553|NCT00434668|Tubulin Modulators|tubulin modulators|mesh-ancestor
110240554|NCT00434668|Antimitotic Agents|antimitotic agents|mesh-ancestor
110240555|NCT00434668|Mitosis Modulators|mitosis modulators|mesh-ancestor
110240556|NCT00434668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240557|NCT00434668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110240558|NCT00434746|Fezakinumab|fezakinumab|mesh-list
110240560|NCT00137826|Bevacizumab|bevacizumab|mesh-list
110240561|NCT00137826|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110240562|NCT00137826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110240563|NCT00137826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110240564|NCT00137826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110240565|NCT00137826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110240566|NCT00137826|Growth Substances|growth substances|mesh-ancestor
110240567|NCT00137826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110240568|NCT00137826|Growth Inhibitors|growth inhibitors|mesh-ancestor
110240569|NCT00137826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110240570|NCT00137826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110240571|NCT00137826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240572|NCT00434824|Methyltestosterone|methyltestosterone|mesh-list
110240573|NCT00434824|Testosterone|testosterone|mesh-list
110240574|NCT00434824|Testosterone undecanoate|testosterone undecanoate|mesh-list
110240575|NCT00434824|Testosterone enanthate|testosterone enanthate|mesh-list
110240576|NCT00434824|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110240577|NCT00434824|Androgens|androgens|mesh-ancestor
110240578|NCT00434824|Hormones|hormones|mesh-ancestor
110240579|NCT00434824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110240580|NCT00434824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110240581|NCT00434824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110240582|NCT00434824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110240583|NCT00434824|Anabolic Agents|anabolic agents|mesh-ancestor
110240584|NCT00105950|Lapatinib|lapatinib|mesh-list
110240585|NCT00105950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110240586|NCT00105950|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110240587|NCT00105950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110240588|NCT00105950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240589|NCT00434863|Botulinum Toxins|botulinum toxins|mesh-list
110240590|NCT00434863|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110240591|NCT00434863|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110240592|NCT00434863|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110240593|NCT00434863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110240594|NCT00434863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240595|NCT00434863|Cholinergic Agents|cholinergic agents|mesh-ancestor
110240596|NCT00434863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110240597|NCT00434863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110240598|NCT00434863|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110240599|NCT00434863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110240600|NCT00434941|Capecitabine|capecitabine|mesh-list
110240601|NCT00434941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110240602|NCT00434941|Antimetabolites|antimetabolites|mesh-ancestor
110240603|NCT00434941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240604|NCT00434941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110240606|NCT00135096|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110240607|NCT00135096|Insulin Glargine|insulin glargine|mesh-list
110240608|NCT00135096|Insulin glulisine|insulin glulisine|mesh-list
110240609|NCT00135096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110240610|NCT00135096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110240611|NCT00435058|Timolol|timolol|mesh-list
110240612|NCT00435058|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110240613|NCT00435058|Travoprost|travoprost|mesh-list
110240614|NCT00435058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240615|NCT00435058|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110240616|NCT00435058|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110240617|NCT00435058|Adrenergic Agents|adrenergic agents|mesh-ancestor
110240618|NCT00435058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110240619|NCT00435058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110240620|NCT00435058|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110240622|NCT00435058|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110240623|NCT00435058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110240624|NCT00435058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110240625|NCT00435175|Estradiol|estradiol|mesh-list
110240626|NCT00435175|Estrogens|estrogens|mesh-ancestor
110240627|NCT00435175|Hormones|hormones|mesh-ancestor
110240628|NCT00435175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110240629|NCT00435175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110240630|NCT00135135|Carboplatin|carboplatin|mesh-list
110240631|NCT00135135|Doxorubicin|doxorubicin|mesh-list
110240632|NCT00135135|Irinotecan|irinotecan|mesh-list
110240633|NCT00135135|Etoposide|etoposide|mesh-list
110240634|NCT00135135|Melphalan|melphalan|mesh-list
110240635|NCT00135135|Topotecan|topotecan|mesh-list
110240636|NCT00135135|Gefitinib|gefitinib|mesh-list
110240637|NCT00135135|Tretinoin|tretinoin|mesh-list
110240638|NCT00135135|Isotretinoin|isotretinoin|mesh-list
110240639|NCT00135135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110240640|NCT00135135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110240641|NCT00135135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110240642|NCT00135135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110240643|NCT00135135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110240644|NCT00135135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240645|NCT00135135|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110240646|NCT00135135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110240647|NCT00135135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110240648|NCT00135135|Alkylating Agents|alkylating agents|mesh-ancestor
110240649|NCT00135135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110240650|NCT00135135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110240651|NCT00135135|Immunologic Factors|immunologic factors|mesh-ancestor
110240652|NCT00135135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110240653|NCT00135135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110240654|NCT00135135|Keratolytic Agents|keratolytic agents|mesh-ancestor
110240655|NCT00135135|Dermatologic Agents|dermatologic agents|mesh-ancestor
110240656|NCT00435292|Naproxen|naproxen|mesh-list
110240657|NCT00435292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110240658|NCT00435292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110240659|NCT00435292|Analgesics|analgesics|mesh-ancestor
110240660|NCT00435292|Sensory System Agents|sensory system agents|mesh-ancestor
110240661|NCT00435292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110240662|NCT00435292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110240663|NCT00435292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110240664|NCT00435292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110240665|NCT00435292|Gout Suppressants|gout suppressants|mesh-ancestor
110240666|NCT00435292|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110240667|NCT00435292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110240668|NCT00435292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240669|NCT00435331|Verapamil|verapamil|mesh-list
110240670|NCT00435331|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110240671|NCT00435331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110240672|NCT00435331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110240673|NCT00435331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240674|NCT00435331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110240675|NCT00435331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110240676|NCT00435331|Vasodilator Agents|vasodilator agents|mesh-ancestor
110240677|NCT00435448|Lonidamine|lonidamine|mesh-list
110240678|NCT00435448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110240679|NCT00435448|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
110240680|NCT00435448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110240681|NCT00435448|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110240682|NCT00435448|Contraceptive Agents|contraceptive agents|mesh-ancestor
110240684|NCT00435448|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110240685|NCT00435448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110240686|NCT00435448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110240687|NCT00435448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110240688|NCT00435760|Bromides|bromides|mesh-list
110240689|NCT00435760|Tiotropium Bromide|tiotropium bromide|mesh-list
110240690|NCT00435760|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110240691|NCT00435760|Autonomic Agents|autonomic agents|mesh-ancestor
110240692|NCT00435760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110240693|NCT00435760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110240694|NCT00435760|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110240695|NCT00435760|Respiratory System Agents|respiratory system agents|mesh-ancestor
110240696|NCT00435760|Parasympatholytics|parasympatholytics|mesh-ancestor
110240697|NCT00435760|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110240698|NCT00435760|Cholinergic Agents|cholinergic agents|mesh-ancestor
110240699|NCT00435760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110240700|NCT00435760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240701|NCT00435760|Anticonvulsants|anticonvulsants|mesh-ancestor
110240702|NCT00435799|Riboflavin|riboflavin|mesh-list
110240703|NCT00435799|Dextrans|dextrans|mesh-list
110240704|NCT00435799|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110240705|NCT00435799|Vitamin B Complex|vitamin b complex|mesh-ancestor
110240706|NCT00435799|Vitamins|vitamins|mesh-ancestor
110240707|NCT00435799|Micronutrients|micronutrients|mesh-ancestor
110240708|NCT00435799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110240709|NCT00435799|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110240710|NCT00435799|Dermatologic Agents|dermatologic agents|mesh-ancestor
110240711|NCT00435799|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110240712|NCT00435799|Anticoagulants|anticoagulants|mesh-ancestor
110240713|NCT00435799|Plasma Substitutes|plasma substitutes|mesh-ancestor
110240714|NCT00435799|Blood Substitutes|blood substitutes|mesh-ancestor
110240715|NCT00142467|Bevacizumab|bevacizumab|mesh-list
110240716|NCT00142467|Gemcitabine|gemcitabine|mesh-list
110240717|NCT00142467|Oxaliplatin|oxaliplatin|mesh-list
110240718|NCT00142467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110240719|NCT00142467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110240720|NCT00142467|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110240721|NCT00142467|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110240722|NCT00142467|Growth Substances|growth substances|mesh-ancestor
110240723|NCT00142467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110240724|NCT00142467|Growth Inhibitors|growth inhibitors|mesh-ancestor
110240725|NCT00142467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110240726|NCT00142467|Antimetabolites|antimetabolites|mesh-ancestor
110240727|NCT00142467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240728|NCT00435955|Rituximab|rituximab|mesh-list
110240729|NCT00435955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110240730|NCT00435955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110240731|NCT00435955|Immunologic Factors|immunologic factors|mesh-ancestor
110240732|NCT00435955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110240733|NCT00435955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110240734|NCT00436033|Milnacipran|milnacipran|mesh-list
110240735|NCT00436033|Levomilnacipran|levomilnacipran|mesh-list
110240736|NCT00436033|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110240737|NCT00436033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110240738|NCT00436033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110240739|NCT00436033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240740|NCT00436033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110240741|NCT00436033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110240742|NCT00436033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110240743|NCT00436033|Analgesics|analgesics|mesh-ancestor
110240744|NCT00436033|Sensory System Agents|sensory system agents|mesh-ancestor
110240745|NCT00436033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110240746|NCT00436033|Antidepressive Agents|antidepressive agents|mesh-ancestor
110240747|NCT00436033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110240748|NCT00436072|Irinotecan|irinotecan|mesh-list
110240750|NCT00436072|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110240751|NCT00436072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110240752|NCT00436072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110240753|NCT00436072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240754|NCT00436072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110240755|NCT00436072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110240756|NCT03276052|Bromides|bromides|mesh-list
110240757|NCT03276052|Anticonvulsants|anticonvulsants|mesh-ancestor
110240758|NCT03273322|Rivaroxaban|rivaroxaban|mesh-list
110240759|NCT03273322|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110240760|NCT03273322|Antithrombins|antithrombins|mesh-ancestor
110240761|NCT03273322|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110240762|NCT03273322|Protease Inhibitors|protease inhibitors|mesh-ancestor
110240763|NCT03273322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110240764|NCT03273322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240765|NCT03273322|Anticoagulants|anticoagulants|mesh-ancestor
110240766|NCT04702360|Ivacaftor|ivacaftor|mesh-list
110240767|NCT04702360|Elexacaftor|elexacaftor|mesh-list
110240768|NCT04702360|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110240769|NCT04702360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110240770|NCT04702360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240771|NCT04702204|Denosumab|denosumab|mesh-list
110240772|NCT04702204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110240773|NCT04702204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110240774|NCT00138060|Fluorouracil|fluorouracil|mesh-list
110240775|NCT00138060|Irinotecan|irinotecan|mesh-list
110240776|NCT00138060|Antimetabolites|antimetabolites|mesh-ancestor
110240777|NCT00138060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240778|NCT00138060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110240779|NCT00138060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110240780|NCT00138060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110240781|NCT00138060|Immunologic Factors|immunologic factors|mesh-ancestor
110240782|NCT00138060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110240783|NCT00138060|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110240784|NCT00138060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110240785|NCT00138060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110240786|NCT04702009|Antibodies|antibodies|mesh-list
110240787|NCT04702009|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110240788|NCT04702009|Immunologic Factors|immunologic factors|mesh-ancestor
110240789|NCT04702009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110240790|NCT00106145|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|mesh-list
110240791|NCT00106145|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
110240792|NCT00106145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110240793|NCT00106145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240794|NCT00142545|Apomorphine|apomorphine|mesh-list
110240795|NCT00142545|Emetics|emetics|mesh-ancestor
110240796|NCT00142545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110240797|NCT00142545|Autonomic Agents|autonomic agents|mesh-ancestor
110240798|NCT00142545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110240799|NCT00142545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110240800|NCT00142545|Dopamine Agonists|dopamine agonists|mesh-ancestor
110240801|NCT00142545|Dopamine Agents|dopamine agents|mesh-ancestor
110240802|NCT00142545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110240803|NCT00142545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240804|NCT00106262|Irinotecan|irinotecan|mesh-list
110240805|NCT00106262|Bortezomib|bortezomib|mesh-list
110240806|NCT00106262|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110240807|NCT00106262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110240808|NCT00106262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110240809|NCT00106262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240810|NCT00106262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110240811|NCT00106301|Romidepsin|romidepsin|mesh-list
110240812|NCT00106301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110240813|NCT00106301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110240814|NCT00106301|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110240815|NCT00106301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110240816|NCT00106301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240818|NCT00436267|Antimetabolites|antimetabolites|mesh-ancestor
110240819|NCT00436267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240820|NCT00436267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110240821|NCT00436267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110240822|NCT00436267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110240823|NCT00436267|Immunologic Factors|immunologic factors|mesh-ancestor
110240824|NCT00436267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110240825|NCT00436306|Contraceptive Agents|contraceptive agents|mesh-list
110240826|NCT00436306|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110240827|NCT00436306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110240829|NCT00138099|Tinzaparin|tinzaparin|mesh-list
110240830|NCT00138099|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110240831|NCT00138099|Anticoagulants|anticoagulants|mesh-ancestor
110240832|NCT00138099|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110240833|NCT00138099|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110240834|NCT00138099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240836|NCT00106379|Emtricitabine|emtricitabine|mesh-list
110240837|NCT00106379|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110240838|NCT00106379|Antiviral Agents|antiviral agents|mesh-ancestor
110240839|NCT00106379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110240840|NCT00106379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110240841|NCT00106379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110240842|NCT00106379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110240843|NCT00106379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240844|NCT00106379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110240845|NCT00106379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110240846|NCT00436423|Gemcitabine|gemcitabine|mesh-list
110240847|NCT00436423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110240848|NCT00436423|Antimetabolites|antimetabolites|mesh-ancestor
110240849|NCT00436423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240850|NCT00436423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110240851|NCT00436579|Sorafenib|sorafenib|mesh-list
110240852|NCT00436579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110240853|NCT00436579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110240854|NCT00436579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110240855|NCT00436579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240856|NCT00436657|Cisplatin|cisplatin|mesh-list
110240857|NCT00436657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110240858|NCT00106418|Romidepsin|romidepsin|mesh-list
110240859|NCT00106418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110240860|NCT00106418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110240861|NCT00106418|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110240862|NCT00106418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110240863|NCT00106418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240864|NCT00436930|Sargramostim|sargramostim|mesh-list
110240865|NCT00436930|Immunologic Factors|immunologic factors|mesh-ancestor
110240866|NCT00436930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110240867|NCT00437008|Benphothiamine|benphothiamine|mesh-list
110240868|NCT00437008|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110240869|NCT00437008|Immunologic Factors|immunologic factors|mesh-ancestor
110240870|NCT00437008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110240871|NCT00437008|Chelating Agents|chelating agents|mesh-ancestor
110240872|NCT00437008|Sequestering Agents|sequestering agents|mesh-ancestor
110240873|NCT00437008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240874|NCT00437086|Bortezomib|bortezomib|mesh-list
110240875|NCT00437086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110240876|NCT00437164|Insulin|insulin|mesh-list
110240877|NCT00437164|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110240878|NCT00437164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110240879|NCT00437164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110240880|NCT00437320|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
110240881|NCT00437320|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110240883|NCT00106496|Tacrolimus|tacrolimus|mesh-list
110240884|NCT00106496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110240885|NCT00106496|Immunologic Factors|immunologic factors|mesh-ancestor
110240886|NCT00106496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110240887|NCT00106496|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110240890|NCT00437359|Toremifene|toremifene|mesh-list
110240891|NCT00437359|Anastrozole|anastrozole|mesh-list
110240892|NCT00437359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240893|NCT00437359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110240894|NCT00437359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110240895|NCT00437359|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110240896|NCT00437359|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110240897|NCT00437359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110240898|NCT00437359|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110240899|NCT00437359|Hormone Antagonists|hormone antagonists|mesh-ancestor
110240900|NCT00437359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110240901|NCT00437359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110240902|NCT00437359|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110240903|NCT00437359|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110240904|NCT00437359|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110240905|NCT00437476|Ribavirin|ribavirin|mesh-list
110240906|NCT00437476|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110240908|NCT00437476|Antimetabolites|antimetabolites|mesh-ancestor
110240909|NCT00437476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240910|NCT00437476|Antiviral Agents|antiviral agents|mesh-ancestor
110240911|NCT00437476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110240912|NCT00437476|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110240913|NCT00437476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110240914|NCT00437554|Glimepiride|glimepiride|mesh-list
110240915|NCT00437554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110240916|NCT00437554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110240917|NCT00437554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110240918|NCT00437554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110240919|NCT00437554|Immunologic Factors|immunologic factors|mesh-ancestor
110240920|NCT00437632|Caffeine|caffeine|mesh-list
110240921|NCT00437632|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110240922|NCT00437632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110240923|NCT00437632|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110240924|NCT00437632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110240925|NCT00437632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240926|NCT00437632|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110240927|NCT00437632|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110240928|NCT00437632|Purinergic Agents|purinergic agents|mesh-ancestor
110240929|NCT00437632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110240930|NCT00437671|Immunoglobulins|immunoglobulins|mesh-list
110240931|NCT00437671|Antibodies|antibodies|mesh-list
110240932|NCT00437671|gamma-Globulins|gamma-globulins|mesh-list
110240933|NCT00437671|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110240934|NCT00437671|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110240935|NCT00437671|Immunologic Factors|immunologic factors|mesh-ancestor
110240936|NCT00437671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110240937|NCT00106613|Romidepsin|romidepsin|mesh-list
110240938|NCT00106613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110240939|NCT00106613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110240940|NCT00106613|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110240941|NCT00106613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110240942|NCT00106613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240943|NCT00401180|Docetaxel|docetaxel|mesh-list
110240944|NCT00401180|Temozolomide|temozolomide|mesh-list
110240945|NCT00401180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110240946|NCT00401180|Tubulin Modulators|tubulin modulators|mesh-ancestor
110240947|NCT00401180|Antimitotic Agents|antimitotic agents|mesh-ancestor
110240948|NCT00401180|Mitosis Modulators|mitosis modulators|mesh-ancestor
110240949|NCT00401180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240950|NCT00401180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110240951|NCT00401180|Alkylating Agents|alkylating agents|mesh-ancestor
110240952|NCT03278665|Pembrolizumab|pembrolizumab|mesh-list
110240953|NCT03278665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110240954|NCT03278665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110240955|NCT03278665|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110240956|NCT03278665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240957|NCT00401219|Estrogens|estrogens|mesh-list
110240958|NCT00401219|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110240959|NCT00401219|Progestins|progestins|mesh-list
110240960|NCT00401219|Hormones|hormones|mesh-ancestor
110240961|NCT00401219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110240964|NCT04701463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110240965|NCT04701463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110240966|NCT00438139|Dronabinol|dronabinol|mesh-list
110240967|NCT00438139|Hallucinogens|hallucinogens|mesh-ancestor
110240968|NCT00438139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110240969|NCT00438139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110240970|NCT00438139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110240971|NCT00438139|Analgesics|analgesics|mesh-ancestor
110240972|NCT00438139|Sensory System Agents|sensory system agents|mesh-ancestor
110240973|NCT00438139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110240974|NCT00438139|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110240975|NCT00438139|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110240976|NCT00438139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110240977|NCT00438139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240978|NCT00438139|Hormones|hormones|mesh-ancestor
110240979|NCT00438139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110240981|NCT00438178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110240982|NCT00438178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240983|NCT00438217|Leuprolide|leuprolide|mesh-list
110240984|NCT00438217|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110240985|NCT00438217|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
110240986|NCT00438217|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110240987|NCT00438217|Fertility Agents|fertility agents|mesh-ancestor
110240988|NCT00438217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110240989|NCT00438217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110240990|NCT00438217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110240991|NCT00438217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110240992|NCT00438217|Hormones|hormones|mesh-ancestor
110240993|NCT00438217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110240994|NCT00438217|Luteolytic Agents|luteolytic agents|mesh-ancestor
110240995|NCT00438217|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110240996|NCT00438217|Contraceptive Agents|contraceptive agents|mesh-ancestor
110240997|NCT00438217|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110240998|NCT03279757|Lidocaine|lidocaine|mesh-list
110240999|NCT03279757|Epinephrine|epinephrine|mesh-list
110241000|NCT03279757|Racepinephrine|racepinephrine|mesh-list
110241001|NCT03279757|Tetracaine|tetracaine|mesh-list
110241002|NCT03279757|Carticaine|carticaine|mesh-list
110241003|NCT03279757|Epinephryl borate|epinephryl borate|mesh-list
110241004|NCT03279757|Anesthetics, Local|anesthetics, local|mesh-ancestor
110241005|NCT03279757|Anesthetics|anesthetics|mesh-ancestor
110241006|NCT03279757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110241007|NCT03279757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110241008|NCT03279757|Sensory System Agents|sensory system agents|mesh-ancestor
110241009|NCT03279757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110241010|NCT03279757|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110241011|NCT03279757|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110241012|NCT03279757|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110241013|NCT03279757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110241014|NCT03279757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110241015|NCT03279757|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110241016|NCT03279757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110241017|NCT03279757|Adrenergic Agents|adrenergic agents|mesh-ancestor
110241018|NCT03279757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110241019|NCT03279757|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110241020|NCT03279757|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110241021|NCT03279757|Autonomic Agents|autonomic agents|mesh-ancestor
110241022|NCT03279757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110241023|NCT03279757|Respiratory System Agents|respiratory system agents|mesh-ancestor
110241024|NCT03279757|Mydriatics|mydriatics|mesh-ancestor
110241025|NCT03279757|Sympathomimetics|sympathomimetics|mesh-ancestor
110241026|NCT03279757|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110241027|NCT00438568|Insulin|insulin|mesh-list
110241028|NCT00438568|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110241029|NCT00438568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110241030|NCT00438568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110241031|NCT00438607|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
110241032|NCT00438607|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
110241033|NCT00438607|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110241034|NCT00438607|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110241035|NCT00438607|Purinergic Agents|purinergic agents|mesh-ancestor
110241036|NCT00438607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110241037|NCT00438607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110241038|NCT00438607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110241040|NCT00106847|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110241041|NCT00106847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110241042|NCT00106847|Dermatologic Agents|dermatologic agents|mesh-ancestor
110241043|NCT00106847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110241044|NCT00106847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110241045|NCT00106886|Folic Acid|folic acid|mesh-list
110241046|NCT00106886|Vitamin B 6|vitamin b 6|mesh-list
110241047|NCT00106886|Pyridoxal|pyridoxal|mesh-list
110241048|NCT00106886|Pyridoxine|pyridoxine|mesh-list
110241049|NCT00106886|Vitamins|vitamins|mesh-ancestor
110241050|NCT00106886|Micronutrients|micronutrients|mesh-ancestor
110241051|NCT00106886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110241052|NCT00106886|Hematinics|hematinics|mesh-ancestor
110241053|NCT00106886|Vitamin B Complex|vitamin b complex|mesh-ancestor
110241054|NCT00438841|Thalidomide|thalidomide|mesh-list
110241055|NCT00438841|Dexamethasone|dexamethasone|mesh-list
110241056|NCT00438841|Cyclophosphamide|cyclophosphamide|mesh-list
110241057|NCT00438841|Bortezomib|bortezomib|mesh-list
110241058|NCT00438841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110241059|NCT00438841|Immunologic Factors|immunologic factors|mesh-ancestor
110241060|NCT00438841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110241061|NCT00438841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110241062|NCT00438841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110241063|NCT00438841|Alkylating Agents|alkylating agents|mesh-ancestor
110241064|NCT00438841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110241065|NCT00438841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110241066|NCT00438841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110241067|NCT00438841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110241068|NCT00438841|Antiemetics|antiemetics|mesh-ancestor
110241069|NCT00438841|Autonomic Agents|autonomic agents|mesh-ancestor
110241070|NCT00438841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110241071|NCT00438841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110241072|NCT00438841|Glucocorticoids|glucocorticoids|mesh-ancestor
110241073|NCT00438841|Hormones|hormones|mesh-ancestor
110241074|NCT00438841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110241075|NCT00438841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110241076|NCT00438841|Leprostatic Agents|leprostatic agents|mesh-ancestor
110241077|NCT00438841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110241078|NCT00438841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110241079|NCT00438841|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110241080|NCT00438841|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110241081|NCT00438841|Growth Substances|growth substances|mesh-ancestor
110241082|NCT00438841|Growth Inhibitors|growth inhibitors|mesh-ancestor
110241083|NCT00438958|Lenograstim|lenograstim|mesh-list
110241084|NCT00438958|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110241085|NCT00438958|Immunologic Factors|immunologic factors|mesh-ancestor
110241086|NCT00438958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110241087|NCT00107003|Lapatinib|lapatinib|mesh-list
110241088|NCT00107003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110241089|NCT00107003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110241090|NCT00107003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110241091|NCT00107003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110241092|NCT00107081|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110241093|NCT00107081|Amoxicillin|amoxicillin|mesh-list
110241094|NCT00107081|Ciprofloxacin|ciprofloxacin|mesh-list
110241095|NCT00107081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110241096|NCT00107081|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110241097|NCT00107081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110241098|NCT00107081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110241099|NCT00107081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110241100|NCT00107081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110241101|NCT00107081|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110241102|NCT00107081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110241103|NCT00439192|Tolterodine Tartrate|tolterodine tartrate|mesh-list
110241104|NCT00439192|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110241105|NCT00439192|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110241106|NCT00439192|Cholinergic Agents|cholinergic agents|mesh-ancestor
110241107|NCT00439192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110241108|NCT00439192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110241109|NCT00439192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110241110|NCT00439192|Urological Agents|urological agents|mesh-ancestor
110241111|NCT00439426|Capecitabine|capecitabine|mesh-list
110241112|NCT00439426|Oxaliplatin|oxaliplatin|mesh-list
110241113|NCT00439426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110241114|NCT00439426|Antimetabolites|antimetabolites|mesh-ancestor
110241115|NCT00439426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110241116|NCT00439426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110241117|NCT00138138|Methylphenidate|methylphenidate|mesh-list
110241118|NCT00138138|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110241119|NCT00138138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110241120|NCT00138138|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110241121|NCT00138138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110241122|NCT00138138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110241123|NCT00138138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110241124|NCT00138138|Dopamine Agents|dopamine agents|mesh-ancestor
110241125|NCT00138138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110241126|NCT00439504|Lobeline|lobeline|mesh-list
110241127|NCT00439504|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110241128|NCT00439504|Autonomic Agents|autonomic agents|mesh-ancestor
110241129|NCT00439504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110241130|NCT00439504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110241131|NCT00439504|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110241132|NCT00439504|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110241133|NCT00439504|Cholinergic Agents|cholinergic agents|mesh-ancestor
110241134|NCT00439504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110241135|NCT00439504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110241136|NCT00439504|Respiratory System Agents|respiratory system agents|mesh-ancestor
110241137|NCT00439543|Iloprost|iloprost|mesh-list
110241138|NCT00439543|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110241139|NCT00439543|Vasodilator Agents|vasodilator agents|mesh-ancestor
110241140|NCT00107237|Everolimus|everolimus|mesh-list
110241141|NCT00107237|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110267695|NCT00544219|Tubulin Modulators|tubulin modulators|mesh-ancestor
110241142|NCT00107237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110241143|NCT00107237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110241144|NCT00107237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110241145|NCT00107237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110241146|NCT00107237|Immunologic Factors|immunologic factors|mesh-ancestor
110241147|NCT00107237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110241148|NCT00107237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110241150|NCT00439699|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110241151|NCT00439699|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110241152|NCT00439699|Dopamine Agents|dopamine agents|mesh-ancestor
110241153|NCT00439699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110241154|NCT00439699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110241155|NCT00439699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110241157|NCT00439699|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110241158|NCT00439855|Heparin|heparin|mesh-list
110241159|NCT00439855|Enoxaparin|enoxaparin|mesh-list
110241160|NCT00439855|Calcium heparin|calcium heparin|mesh-list
110241161|NCT00439855|Anticoagulants|anticoagulants|mesh-ancestor
110241162|NCT00439855|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110241163|NCT00439855|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110241164|NCT00439855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110241165|NCT00107354|Cytarabine|cytarabine|mesh-list
110241166|NCT00107354|Aldesleukin|aldesleukin|mesh-list
110241167|NCT00107354|Etoposide|etoposide|mesh-list
110241168|NCT00107354|Mitoxantrone|mitoxantrone|mesh-list
110241169|NCT00107354|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110241170|NCT00107354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110241171|NCT00107354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110241172|NCT00107354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110241173|NCT00107354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110241174|NCT00107354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110241175|NCT00107354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110241176|NCT00107354|Antimetabolites|antimetabolites|mesh-ancestor
110241177|NCT00107354|Antiviral Agents|antiviral agents|mesh-ancestor
110241178|NCT00107354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110241179|NCT00107354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110241180|NCT00107354|Immunologic Factors|immunologic factors|mesh-ancestor
110241181|NCT00107354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110241182|NCT00107354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110241183|NCT00107354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110241184|NCT00107354|Analgesics|analgesics|mesh-ancestor
110241185|NCT00107354|Sensory System Agents|sensory system agents|mesh-ancestor
110241186|NCT00107354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110241187|NCT00138177|Leucovorin|leucovorin|mesh-list
110241188|NCT00138177|Fluorouracil|fluorouracil|mesh-list
110241189|NCT00138177|Oxaliplatin|oxaliplatin|mesh-list
110241190|NCT00138177|Vorinostat|vorinostat|mesh-list
110241191|NCT00138177|Calcium|calcium|mesh-list
110241192|NCT00138177|Levoleucovorin|levoleucovorin|mesh-list
110241193|NCT00138177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110241194|NCT00138177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110241195|NCT00138177|Antimetabolites|antimetabolites|mesh-ancestor
110241196|NCT00138177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110241197|NCT00138177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110241198|NCT00138177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110241199|NCT00138177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110241200|NCT00138177|Immunologic Factors|immunologic factors|mesh-ancestor
110241201|NCT00138177|Antidotes|antidotes|mesh-ancestor
110241202|NCT00138177|Protective Agents|protective agents|mesh-ancestor
110241204|NCT00138177|Vitamins|vitamins|mesh-ancestor
110241205|NCT00138177|Micronutrients|micronutrients|mesh-ancestor
110241206|NCT00138177|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110241207|NCT00138177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110241208|NCT03279601|Capecitabine|capecitabine|mesh-list
110241209|NCT03279601|Temozolomide|temozolomide|mesh-list
110241210|NCT03279601|Dacarbazine|dacarbazine|mesh-list
110241211|NCT03279601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110241212|NCT03279601|Antimetabolites|antimetabolites|mesh-ancestor
110241213|NCT03279601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110241214|NCT03279601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110241215|NCT03279601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110241216|NCT03279601|Alkylating Agents|alkylating agents|mesh-ancestor
110241217|NCT00107393|Capecitabine|capecitabine|mesh-list
110241218|NCT00107393|Trastuzumab|trastuzumab|mesh-list
110241219|NCT00107393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110241220|NCT00107393|Antimetabolites|antimetabolites|mesh-ancestor
110241221|NCT00107393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110241222|NCT00107393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110241223|NCT00107393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110241224|NCT00138216|Irinotecan|irinotecan|mesh-list
110241225|NCT00138216|Vincristine|vincristine|mesh-list
110241226|NCT00138216|Temozolomide|temozolomide|mesh-list
110241227|NCT00138216|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110241228|NCT00138216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110241229|NCT00138216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110241230|NCT00138216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110241231|NCT00138216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110241232|NCT00138216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110241233|NCT00138216|Tubulin Modulators|tubulin modulators|mesh-ancestor
110241234|NCT00138216|Antimitotic Agents|antimitotic agents|mesh-ancestor
110241235|NCT00138216|Mitosis Modulators|mitosis modulators|mesh-ancestor
110241236|NCT00138216|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110241237|NCT00138216|Alkylating Agents|alkylating agents|mesh-ancestor
110241238|NCT00105586|Escitalopram|escitalopram|mesh-list
110241239|NCT00105586|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110241240|NCT00105586|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110241241|NCT00105586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110241242|NCT00105586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110241243|NCT00105586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110241244|NCT00105586|Serotonin Agents|serotonin agents|mesh-ancestor
110241245|NCT00105586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110241247|NCT00107432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110241248|NCT00107432|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110241249|NCT00107432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110241250|NCT00107432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110241251|NCT00439972|Moxifloxacin|moxifloxacin|mesh-list
110241252|NCT00439972|Ortho Evra|ortho evra|mesh-list
110241253|NCT00439972|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110241254|NCT00439972|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110241255|NCT00439972|Contraceptive Agents|contraceptive agents|mesh-ancestor
110241256|NCT00439972|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110241257|NCT00439972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110241258|NCT00439972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110241259|NCT00439972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110241260|NCT00439972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110241261|NCT00439972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110241262|NCT00439972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110241263|NCT00439972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110241264|NCT00439972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110241265|NCT00439972|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110241266|NCT00439972|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110241267|NCT00439972|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110241268|NCT00440128|Docetaxel|docetaxel|mesh-list
110241269|NCT00440128|Casopitant|casopitant|mesh-list
110241270|NCT00440128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110241271|NCT00440128|Tubulin Modulators|tubulin modulators|mesh-ancestor
110241272|NCT00440128|Antimitotic Agents|antimitotic agents|mesh-ancestor
110241273|NCT00440128|Mitosis Modulators|mitosis modulators|mesh-ancestor
110241274|NCT00440128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110241275|NCT00440128|Antiemetics|antiemetics|mesh-ancestor
110241276|NCT00440128|Autonomic Agents|autonomic agents|mesh-ancestor
110241277|NCT00440128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110241278|NCT00440128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110241279|NCT00440128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110241280|NCT00440128|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110241281|NCT00440128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110241283|NCT00440167|Capecitabine|capecitabine|mesh-list
110241284|NCT00440167|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110241285|NCT00440167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110241286|NCT00440167|Antimetabolites|antimetabolites|mesh-ancestor
110241287|NCT00440167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110241288|NCT00440167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110241289|NCT00440167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110241290|NCT00440167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110241291|NCT00107471|Topotecan|topotecan|mesh-list
110241292|NCT00107471|Lenograstim|lenograstim|mesh-list
110241293|NCT00107471|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110241294|NCT00107471|Immunologic Factors|immunologic factors|mesh-ancestor
110241295|NCT00107471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110241296|NCT00107471|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110241297|NCT00107471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110241298|NCT00107471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110241299|NCT00107471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110241300|NCT00107471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110241302|NCT00404157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110241303|NCT00404157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110241304|NCT00404157|Immunologic Factors|immunologic factors|mesh-ancestor
110241305|NCT00404157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110241306|NCT00404157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110241307|NCT02957266|Gemcitabine|gemcitabine|mesh-list
110241308|NCT02957266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110241309|NCT02957266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110241310|NCT02957266|Antimetabolites|antimetabolites|mesh-ancestor
110241311|NCT02957266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110241312|NCT03279562|Nalmefene|nalmefene|mesh-list
110241313|NCT03279562|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110241314|NCT03279562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110241315|NCT03279562|Sensory System Agents|sensory system agents|mesh-ancestor
110241316|NCT03279562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110241317|NCT00404196|Calcipotriene|calcipotriene|mesh-list
110241318|NCT00404196|Dermatologic Agents|dermatologic agents|mesh-ancestor
110241319|NCT00107510|Carboplatin|carboplatin|mesh-list
110241320|NCT00107510|Docetaxel|docetaxel|mesh-list
110241321|NCT00107510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110241322|NCT00107510|Tubulin Modulators|tubulin modulators|mesh-ancestor
110241323|NCT00107510|Antimitotic Agents|antimitotic agents|mesh-ancestor
110241324|NCT00107510|Mitosis Modulators|mitosis modulators|mesh-ancestor
110241325|NCT00107510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110241326|NCT00440245|Albuterol|albuterol|mesh-list
110241327|NCT00440245|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110241328|NCT00440245|Autonomic Agents|autonomic agents|mesh-ancestor
110241329|NCT00440245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110241330|NCT00440245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110241331|NCT00440245|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110241332|NCT00440245|Respiratory System Agents|respiratory system agents|mesh-ancestor
110241333|NCT00440245|Tocolytic Agents|tocolytic agents|mesh-ancestor
110241334|NCT00440245|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110241335|NCT00440245|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110241336|NCT00440245|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110241337|NCT00440245|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110241338|NCT00440245|Adrenergic Agents|adrenergic agents|mesh-ancestor
110241339|NCT00440245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110241340|NCT00440245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110241341|NCT00440284|Insulin|insulin|mesh-list
110241342|NCT00440284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110241343|NCT00440284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110241344|NCT00142779|Fluoxetine|fluoxetine|mesh-list
110241345|NCT00142779|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110241346|NCT00142779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110241347|NCT00142779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110241348|NCT00142779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110241350|NCT00142779|Serotonin Agents|serotonin agents|mesh-ancestor
110241351|NCT00142779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110241352|NCT00142779|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110241353|NCT00142779|Antidepressive Agents|antidepressive agents|mesh-ancestor
110241354|NCT00142779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110241355|NCT00142779|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110241356|NCT00142779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110241357|NCT00142779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110241359|NCT00440323|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110241360|NCT00440323|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110241361|NCT00440323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110241362|NCT00440323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110241363|NCT00440323|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110241364|NCT00440323|GABA Agonists|gaba agonists|mesh-ancestor
110241365|NCT00440323|GABA Agents|gaba agents|mesh-ancestor
110241366|NCT00440323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110241367|NCT00440323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110241368|NCT00440440|Testosterone|testosterone|mesh-list
110241369|NCT00440440|Androgens|androgens|mesh-ancestor
110241370|NCT00440440|Hormones|hormones|mesh-ancestor
110241371|NCT00440440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110241372|NCT00440440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110241373|NCT00142896|Morphine|morphine|mesh-list
110241374|NCT00142896|Tramadol|tramadol|mesh-list
110241375|NCT00142896|Naloxone|naloxone|mesh-list
110241376|NCT00142896|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110241377|NCT00142896|Narcotics|narcotics|mesh-ancestor
110241378|NCT00142896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110241379|NCT00142896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110241380|NCT00142896|Analgesics|analgesics|mesh-ancestor
110241381|NCT00142896|Sensory System Agents|sensory system agents|mesh-ancestor
110241382|NCT00142896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110241383|NCT00142896|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110241384|NCT00440479|Bortezomib|bortezomib|mesh-list
110241385|NCT00440479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110241386|NCT00440635|Bortezomib|bortezomib|mesh-list
110241387|NCT00440635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110241388|NCT00440674|Paclitaxel|paclitaxel|mesh-list
110241389|NCT00440674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110241390|NCT00440674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110241391|NCT00440674|Tubulin Modulators|tubulin modulators|mesh-ancestor
110241392|NCT00440674|Antimitotic Agents|antimitotic agents|mesh-ancestor
110241393|NCT00440674|Mitosis Modulators|mitosis modulators|mesh-ancestor
110241394|NCT00440674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110241395|NCT00440713|Aripiprazole|aripiprazole|mesh-list
110241396|NCT00440713|Antidepressive Agents|antidepressive agents|mesh-ancestor
110241397|NCT00440713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110241398|NCT00440713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110241399|NCT00440713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110241400|NCT00440713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110241401|NCT00440713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110241402|NCT00440713|Dopamine Agonists|dopamine agonists|mesh-ancestor
110241403|NCT00440713|Dopamine Agents|dopamine agents|mesh-ancestor
110241404|NCT00440713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110241405|NCT00440713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110241406|NCT00440713|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110241407|NCT00440713|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110241409|NCT00440713|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110241410|NCT00440713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110241411|NCT00440713|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110241412|NCT00440713|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110241413|NCT00440869|Acetylcysteine|acetylcysteine|mesh-list
110241414|NCT00440869|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110241415|NCT00440869|Antiviral Agents|antiviral agents|mesh-ancestor
110241416|NCT00440869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110241417|NCT00440869|Expectorants|expectorants|mesh-ancestor
110241418|NCT00440869|Respiratory System Agents|respiratory system agents|mesh-ancestor
110241419|NCT00440869|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110241420|NCT00440869|Antioxidants|antioxidants|mesh-ancestor
110241421|NCT00440869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110241423|NCT00440869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110241424|NCT00440869|Antidotes|antidotes|mesh-ancestor
110241425|NCT00441025|Alemtuzumab|alemtuzumab|mesh-list
110241426|NCT00441025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110241427|NCT00441025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110241429|NCT00441181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110241430|NCT00441298|Tenofovir|tenofovir|mesh-list
110241431|NCT00441298|Antiviral Agents|antiviral agents|mesh-ancestor
110241432|NCT00441298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110241433|NCT00441298|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110241434|NCT00441298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110241435|NCT00441298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110241436|NCT00441298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110241437|NCT00441298|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110241438|NCT00441298|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110241439|NCT00441415|Adapalene|adapalene|mesh-list
110241440|NCT00441415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110241441|NCT00441415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110241442|NCT00441415|Analgesics|analgesics|mesh-ancestor
110241443|NCT00441415|Sensory System Agents|sensory system agents|mesh-ancestor
110241444|NCT00441415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110241445|NCT00441415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110241446|NCT00441415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110241447|NCT00441415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110241448|NCT00441415|Dermatologic Agents|dermatologic agents|mesh-ancestor
110241449|NCT02964728|Botulinum Toxins|botulinum toxins|mesh-list
110241450|NCT02964728|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110241451|NCT02964728|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110241452|NCT02964728|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110241453|NCT02964728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110241454|NCT02964728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110241455|NCT02964728|Cholinergic Agents|cholinergic agents|mesh-ancestor
110241456|NCT02964728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110241457|NCT02964728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110241458|NCT02964728|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110241459|NCT02964728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110241460|NCT00441532|Lidocaine|lidocaine|mesh-list
110241461|NCT00441532|Anesthetics, Local|anesthetics, local|mesh-ancestor
110241462|NCT00441532|Anesthetics|anesthetics|mesh-ancestor
110241463|NCT00441532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110241464|NCT00441532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110241465|NCT00441532|Sensory System Agents|sensory system agents|mesh-ancestor
110241466|NCT00441532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110241467|NCT00441532|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110241468|NCT00441532|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110241469|NCT00441532|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110241470|NCT00441532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110241471|NCT00441532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267746|NCT00544609|Sorafenib|sorafenib|mesh-list
110241473|NCT00441649|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110241474|NCT00441649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110241475|NCT00441649|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110241476|NCT00441649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110241477|NCT00441649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110241478|NCT00441649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110241479|NCT00441649|Dopamine Agents|dopamine agents|mesh-ancestor
110241480|NCT00441649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110241481|NCT00107822|Lidocaine|lidocaine|mesh-list
110241482|NCT00107822|Tetracaine|tetracaine|mesh-list
110241483|NCT00107822|Anesthetics, Local|anesthetics, local|mesh-ancestor
110241484|NCT00107822|Anesthetics|anesthetics|mesh-ancestor
110241485|NCT00107822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110241486|NCT00107822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110241487|NCT00107822|Sensory System Agents|sensory system agents|mesh-ancestor
110241488|NCT00107822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110241489|NCT00107822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110241490|NCT00107822|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110241492|NCT00107822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110241493|NCT00107822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110241494|NCT03279328|Petrolatum|petrolatum|mesh-list
110241495|NCT03279328|Emollients|emollients|mesh-ancestor
110241496|NCT03279328|Dermatologic Agents|dermatologic agents|mesh-ancestor
110241497|NCT00142974|Tegaserod|tegaserod|mesh-list
110241500|NCT00142974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110241501|NCT00142974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110241502|NCT00142974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110241503|NCT00441844|Simvastatin|simvastatin|mesh-list
110241504|NCT00441844|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110241505|NCT00441844|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110241506|NCT00441844|Antimetabolites|antimetabolites|mesh-ancestor
110241507|NCT00441844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110241508|NCT00441844|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110241509|NCT00441844|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110241510|NCT00441844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110241511|NCT03279133|Ledipasvir|ledipasvir|mesh-list
110241512|NCT03279133|Antiviral Agents|antiviral agents|mesh-ancestor
110241513|NCT03279133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110241514|NCT00108017|Timolol|timolol|mesh-list
110241515|NCT00108017|Dorzolamide|dorzolamide|mesh-list
110241516|NCT00108017|Maleic acid|maleic acid|mesh-list
110241517|NCT00108017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110241518|NCT00108017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110241519|NCT00108017|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110241520|NCT00108017|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110241521|NCT00108017|Adrenergic Agents|adrenergic agents|mesh-ancestor
110241522|NCT00108017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110241523|NCT00108017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110241524|NCT00108017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110241525|NCT00108017|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110241526|NCT00108017|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110241527|NCT00441922|Docetaxel|docetaxel|mesh-list
110241528|NCT00441922|Vinorelbine|vinorelbine|mesh-list
110241529|NCT00441922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110241530|NCT00441922|Tubulin Modulators|tubulin modulators|mesh-ancestor
110241531|NCT00441922|Antimitotic Agents|antimitotic agents|mesh-ancestor
110241532|NCT00441922|Mitosis Modulators|mitosis modulators|mesh-ancestor
110241533|NCT00441922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110241534|NCT00441922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110241535|NCT00441961|Methotrexate|methotrexate|mesh-list
110241536|NCT00441961|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110241537|NCT00441961|Abortifacient Agents|abortifacient agents|mesh-ancestor
110241538|NCT00441961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110241539|NCT00441961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110241540|NCT00441961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110241542|NCT00441961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110241543|NCT00441961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110241544|NCT00441961|Dermatologic Agents|dermatologic agents|mesh-ancestor
110241545|NCT00441961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110241546|NCT00441961|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110241547|NCT00441961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110241548|NCT00441961|Immunologic Factors|immunologic factors|mesh-ancestor
110241549|NCT00441961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110241550|NCT00441961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110241551|NCT00138411|Ciprofloxacin|ciprofloxacin|mesh-list
110241552|NCT00138411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110241553|NCT00138411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110241554|NCT00138411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110241555|NCT00138411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110241556|NCT00138411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110241557|NCT00138411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110241558|NCT00138411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110241559|NCT00138411|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110241560|NCT00138411|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110241562|NCT00442234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110241563|NCT00442234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110241564|NCT00442234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110241566|NCT00108095|Antiemetics|antiemetics|mesh-ancestor
110241567|NCT00108095|Autonomic Agents|autonomic agents|mesh-ancestor
110241568|NCT00108095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110241569|NCT00108095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110241570|NCT00108095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110241571|NCT00108095|Antipruritics|antipruritics|mesh-ancestor
110241573|NCT00108095|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110241574|NCT00108095|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110241575|NCT00108095|Serotonin Agents|serotonin agents|mesh-ancestor
110241576|NCT00108095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110241577|NCT00108095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110241578|NCT03278938|Bupropion|bupropion|mesh-list
110241579|NCT03278938|Citalopram|citalopram|mesh-list
110241580|NCT03278938|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110241581|NCT03278938|Antidepressive Agents|antidepressive agents|mesh-ancestor
110241582|NCT03278938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110241583|NCT03278938|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110241584|NCT03278938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110241585|NCT03278938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110241586|NCT03278938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110241587|NCT03278938|Dopamine Agents|dopamine agents|mesh-ancestor
110241588|NCT03278938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110241589|NCT03278938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110241590|NCT03278938|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110241591|NCT03278938|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110241592|NCT03278938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110241593|NCT03278938|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110241594|NCT03278938|Serotonin Agents|serotonin agents|mesh-ancestor
110241595|NCT03278860|Oxytocin|oxytocin|mesh-list
110241596|NCT03278860|Oxytocics|oxytocics|mesh-ancestor
110241597|NCT03278860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110241598|NCT03278860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110241599|NCT00442273|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110241600|NCT00442273|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110241601|NCT00442312|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
110241602|NCT00442312|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110241604|NCT00442312|Adrenergic Agents|adrenergic agents|mesh-ancestor
110241605|NCT00442312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110241606|NCT00442312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110241607|NCT00442312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110241608|NCT00442312|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110241609|NCT00442312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110241610|NCT00442312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110241611|NCT00442390|Hydrocortisone|hydrocortisone|mesh-list
110241612|NCT00442390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110241613|NCT00442585|Ibuprofen|ibuprofen|mesh-list
110241614|NCT00442585|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110241615|NCT00442585|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110241616|NCT00442585|Analgesics|analgesics|mesh-ancestor
110241617|NCT00442585|Sensory System Agents|sensory system agents|mesh-ancestor
110241618|NCT00442585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110241619|NCT00442585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110241620|NCT00442585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110241621|NCT00442585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110241622|NCT00442585|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110241623|NCT00442585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110241624|NCT00442585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110241626|NCT00442741|Epothilones|epothilones|mesh-list
110241627|NCT00442741|Omeprazole|omeprazole|mesh-list
110241628|NCT00442741|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110241629|NCT00442741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110241630|NCT00442741|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110241631|NCT00442741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110241632|NCT00442741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110241633|NCT00442741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110241634|NCT00442741|Tubulin Modulators|tubulin modulators|mesh-ancestor
110241635|NCT00442741|Antimitotic Agents|antimitotic agents|mesh-ancestor
110241636|NCT00442741|Mitosis Modulators|mitosis modulators|mesh-ancestor
110241637|NCT00442780|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
110241638|NCT00442780|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
110241639|NCT00442780|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110241640|NCT00442780|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110241641|NCT00442780|Purinergic Agents|purinergic agents|mesh-ancestor
110241642|NCT00442780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110241643|NCT00442780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110241644|NCT00442780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110241645|NCT00404586|Fluticasone|fluticasone|mesh-list
110241647|NCT00404586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110241648|NCT00404586|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110241649|NCT00404586|Autonomic Agents|autonomic agents|mesh-ancestor
110241650|NCT00404586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110241651|NCT00404586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110241652|NCT00404586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110241653|NCT00404586|Respiratory System Agents|respiratory system agents|mesh-ancestor
110241654|NCT00404586|Dermatologic Agents|dermatologic agents|mesh-ancestor
110241655|NCT00404586|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110241656|NCT00442819|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
110241657|NCT00442819|Vasodilator Agents|vasodilator agents|mesh-ancestor
110241658|NCT00442819|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110241659|NCT00442819|Protective Agents|protective agents|mesh-ancestor
110241660|NCT00442819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110241661|NCT00108251|Eplerenone|eplerenone|mesh-list
110241662|NCT00108251|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110241663|NCT00108251|Hormone Antagonists|hormone antagonists|mesh-ancestor
110241664|NCT00108251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110241665|NCT00108251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267767|NCT00160238|Vasodilator Agents|vasodilator agents|mesh-ancestor
110241666|NCT00108251|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110241667|NCT00108251|Diuretics|diuretics|mesh-ancestor
110241668|NCT00108251|Natriuretic Agents|natriuretic agents|mesh-ancestor
110241669|NCT00108251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110241670|NCT00443170|Rosiglitazone|rosiglitazone|mesh-list
110241671|NCT00443170|Flurbiprofen|flurbiprofen|mesh-list
110241672|NCT00443170|Midazolam|midazolam|mesh-list
110241673|NCT00443170|Caffeine|caffeine|mesh-list
110241674|NCT00443170|Omeprazole|omeprazole|mesh-list
110241675|NCT00443170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110241676|NCT00443170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110241677|NCT00443170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110241678|NCT00443170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110241679|NCT00443170|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110241680|NCT00443170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110241681|NCT00443170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110241682|NCT00443170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110241683|NCT00443170|Anesthetics, General|anesthetics, general|mesh-ancestor
110241684|NCT00443170|Anesthetics|anesthetics|mesh-ancestor
110241685|NCT00443170|GABA Modulators|gaba modulators|mesh-ancestor
110241686|NCT00443170|GABA Agents|gaba agents|mesh-ancestor
110241687|NCT00443170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110241688|NCT00443170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110241689|NCT00443170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110241690|NCT00443170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110241691|NCT00443170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110241692|NCT00443170|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110241693|NCT00443170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110241694|NCT00443170|Purinergic Agents|purinergic agents|mesh-ancestor
110241695|NCT00443170|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110241696|NCT00443170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110241697|NCT00443170|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110241698|NCT00443170|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110241699|NCT00443170|Analgesics|analgesics|mesh-ancestor
110241700|NCT00443170|Sensory System Agents|sensory system agents|mesh-ancestor
110241701|NCT00443170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110241702|NCT00443170|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110241703|NCT00443170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110241705|NCT00443170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110241706|NCT00443170|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110241707|NCT00404625|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110241708|NCT00404625|Anti-Infective Agents|anti-infective agents|mesh-list
110241709|NCT00138567|Vildagliptin|vildagliptin|mesh-list
110241710|NCT00138567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110241711|NCT00138567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110241712|NCT00138567|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110241713|NCT00138567|Protease Inhibitors|protease inhibitors|mesh-ancestor
110241714|NCT00138567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110241715|NCT00138567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110241716|NCT00108368|Olanzapine|olanzapine|mesh-list
110241717|NCT00108368|Risperidone|risperidone|mesh-list
110241718|NCT00108368|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110241719|NCT00108368|Serotonin Agents|serotonin agents|mesh-ancestor
110241720|NCT00108368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110241721|NCT00108368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110241722|NCT00108368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110241723|NCT00108368|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110241724|NCT00108368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110241725|NCT00108368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110241726|NCT00108368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110241727|NCT00108368|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110241728|NCT00108368|Dopamine Agents|dopamine agents|mesh-ancestor
110241729|NCT00108368|Antiemetics|antiemetics|mesh-ancestor
110241730|NCT00108368|Autonomic Agents|autonomic agents|mesh-ancestor
110241731|NCT00108368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110241732|NCT00108368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110241733|NCT00108368|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110241734|NCT00108368|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110241735|NCT00108368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110241736|NCT00108446|Lidocaine|lidocaine|mesh-list
110241737|NCT00108446|Fentanyl|fentanyl|mesh-list
110241738|NCT00108446|Dextromethorphan|dextromethorphan|mesh-list
110241739|NCT00108446|Naloxone|naloxone|mesh-list
110241740|NCT00108446|Anesthetics, Local|anesthetics, local|mesh-ancestor
110241742|NCT00108446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110241743|NCT00108446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110241744|NCT00108446|Sensory System Agents|sensory system agents|mesh-ancestor
110241745|NCT00108446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110241746|NCT00108446|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110241747|NCT00108446|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110241748|NCT00108446|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110241749|NCT00108446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110241750|NCT00108446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110241751|NCT00108446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110241752|NCT00108446|Narcotics|narcotics|mesh-ancestor
110241753|NCT00108446|Analgesics|analgesics|mesh-ancestor
110241754|NCT00108446|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110241755|NCT00108446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110241756|NCT00108446|Anesthetics, General|anesthetics, general|mesh-ancestor
110241757|NCT00108446|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110241758|NCT00108446|Antitussive Agents|antitussive agents|mesh-ancestor
110241759|NCT00108446|Respiratory System Agents|respiratory system agents|mesh-ancestor
110241760|NCT00108446|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110241761|NCT00108446|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110241762|NCT00108446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110241763|NCT00138606|Vildagliptin|vildagliptin|mesh-list
110241764|NCT00138606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110241765|NCT00138606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110241766|NCT00138606|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110241767|NCT00138606|Protease Inhibitors|protease inhibitors|mesh-ancestor
110241768|NCT00138606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110241769|NCT00138606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110241770|NCT00443482|Formoterol Fumarate|formoterol fumarate|mesh-list
110241771|NCT00443482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110241772|NCT00443482|Autonomic Agents|autonomic agents|mesh-ancestor
110241773|NCT00443482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110241774|NCT00443482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110241775|NCT00443482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110241776|NCT00443482|Respiratory System Agents|respiratory system agents|mesh-ancestor
110241777|NCT00443482|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110241778|NCT00443482|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110241779|NCT00443482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110241780|NCT00443482|Adrenergic Agents|adrenergic agents|mesh-ancestor
110241781|NCT00443482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110241782|NCT00443482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110241783|NCT00443521|Triamcinolone|triamcinolone|mesh-list
110241784|NCT00443521|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110241785|NCT00443521|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110241786|NCT00443521|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110241787|NCT00443521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110241788|NCT00443521|Glucocorticoids|glucocorticoids|mesh-ancestor
110241789|NCT00443521|Hormones|hormones|mesh-ancestor
110241790|NCT00443521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110241791|NCT00443521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110241792|NCT00443521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110241793|NCT00443521|Immunologic Factors|immunologic factors|mesh-ancestor
110241794|NCT00443521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110267778|NCT00160277|Moxonidine|moxonidine|mesh-list
110267780|NCT02963181|Melatonin|melatonin|mesh-list
110241795|NCT00443521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110241796|NCT03278431|Albendazole|albendazole|mesh-list
110241797|NCT03278431|Mebendazole|mebendazole|mesh-list
110241799|NCT03278431|Piperazine citrate|piperazine citrate|mesh-list
110241800|NCT03278431|Pyrantel|pyrantel|mesh-list
110241801|NCT03278431|Pyrantel Pamoate|pyrantel pamoate|mesh-list
110241802|NCT03278431|Oxantel|oxantel|mesh-list
110241803|NCT03278431|Oxantel pamoate|oxantel pamoate|mesh-list
110241804|NCT03278431|DMP 777|dmp 777|mesh-list
110241805|NCT03278431|Anthelmintics|anthelmintics|mesh-ancestor
110241806|NCT03278431|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110241807|NCT03278431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110241808|NCT03278431|Anticestodal Agents|anticestodal agents|mesh-ancestor
110241809|NCT03278431|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110241810|NCT03278431|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110241812|NCT03278431|Antimitotic Agents|antimitotic agents|mesh-ancestor
110241813|NCT03278431|Mitosis Modulators|mitosis modulators|mesh-ancestor
110241814|NCT03278431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110241815|NCT03278431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110241816|NCT03278431|Antinematodal Agents|antinematodal agents|mesh-ancestor
110241817|NCT03278431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110241818|NCT03278431|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
110241819|NCT03278431|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110241820|NCT03278431|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110241821|NCT03278431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110241822|NCT03278431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110241823|NCT00108563|Citalopram|citalopram|mesh-list
110241824|NCT00108563|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110241825|NCT00108563|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110241826|NCT00108563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110241827|NCT00108563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110241828|NCT00108563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110241829|NCT00108563|Serotonin Agents|serotonin agents|mesh-ancestor
110241830|NCT00108563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110241831|NCT00108563|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110241832|NCT00108563|Antidepressive Agents|antidepressive agents|mesh-ancestor
110241833|NCT00108563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110241834|NCT00443716|Estrogens|estrogens|mesh-list
110241835|NCT00443716|Hormones|hormones|mesh-ancestor
110241836|NCT00443716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110241837|NCT00443716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110241838|NCT00443794|Aspirin|aspirin|mesh-list
110241839|NCT00443794|Atenolol|atenolol|mesh-list
110241840|NCT00443794|Ramipril|ramipril|mesh-list
110241841|NCT00443794|Simvastatin|simvastatin|mesh-list
110241842|NCT00443794|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
110241843|NCT00443794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110241844|NCT00443794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110241845|NCT00443794|Analgesics|analgesics|mesh-ancestor
110241846|NCT00443794|Sensory System Agents|sensory system agents|mesh-ancestor
110241847|NCT00443794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110241848|NCT00443794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110241849|NCT00443794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110241850|NCT00443794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110241851|NCT00443794|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110241852|NCT00443794|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110241854|NCT00443794|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110241855|NCT00443794|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110241856|NCT00443794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110241857|NCT00443794|Antipyretics|antipyretics|mesh-ancestor
110241858|NCT00443794|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110241859|NCT00443794|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110241860|NCT00443794|Antimetabolites|antimetabolites|mesh-ancestor
110241861|NCT00443794|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110241862|NCT00443794|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110241863|NCT00443794|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110241864|NCT00443794|Protease Inhibitors|protease inhibitors|mesh-ancestor
110241865|NCT00443794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110241866|NCT00443794|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110241867|NCT00443794|Sympatholytics|sympatholytics|mesh-ancestor
110241868|NCT00443794|Autonomic Agents|autonomic agents|mesh-ancestor
110241869|NCT00443794|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110241870|NCT00443794|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110241871|NCT00443794|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110241872|NCT00443794|Adrenergic Agents|adrenergic agents|mesh-ancestor
110241873|NCT00443794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110241874|NCT00443794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110241875|NCT00443794|Diuretics|diuretics|mesh-ancestor
110241876|NCT00443794|Natriuretic Agents|natriuretic agents|mesh-ancestor
110241877|NCT00108602|Acetazolamide|acetazolamide|mesh-list
110241878|NCT00108602|Anticonvulsants|anticonvulsants|mesh-ancestor
110241879|NCT00108602|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110241880|NCT00108602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110241881|NCT00108602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110241882|NCT00108602|Diuretics|diuretics|mesh-ancestor
110241883|NCT00108602|Natriuretic Agents|natriuretic agents|mesh-ancestor
110241884|NCT00108602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110241885|NCT03278314|Ivacaftor|ivacaftor|mesh-list
110241886|NCT03278314|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110241887|NCT03278314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110241888|NCT03278314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110241889|NCT00443950|Etanercept|etanercept|mesh-list
110241890|NCT00443950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110241891|NCT00443950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110241892|NCT00443950|Analgesics|analgesics|mesh-ancestor
110241893|NCT00443950|Sensory System Agents|sensory system agents|mesh-ancestor
110241894|NCT00443950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110241895|NCT00443950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110241896|NCT00443950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110241897|NCT00443950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110241898|NCT00443950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110241926|NCT00108797|Coagulants|coagulants|mesh-ancestor
110241927|NCT04698772|Ketamine|ketamine|mesh-list
110241928|NCT04698772|Morphine|morphine|mesh-list
110241929|NCT04698772|Analgesics|analgesics|mesh-ancestor
110241930|NCT04698772|Sensory System Agents|sensory system agents|mesh-ancestor
110241931|NCT04698772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110241932|NCT04698772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110241933|NCT04698772|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110241934|NCT04698772|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110241935|NCT04698772|Anesthetics, General|anesthetics, general|mesh-ancestor
110241936|NCT04698772|Anesthetics|anesthetics|mesh-ancestor
110241937|NCT04698772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110241938|NCT04698772|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110241939|NCT04698772|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110241940|NCT04698772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110241941|NCT04698772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110241942|NCT04698772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110241943|NCT04698772|Narcotics|narcotics|mesh-ancestor
110241944|NCT00451594|Dexamethasone|dexamethasone|mesh-list
110241945|NCT00451594|Prednisolone|prednisolone|mesh-list
110241946|NCT00451594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110241947|NCT00451594|Antiemetics|antiemetics|mesh-ancestor
110241948|NCT00451594|Autonomic Agents|autonomic agents|mesh-ancestor
110241949|NCT00451594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110241950|NCT00451594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110241951|NCT00451594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110241952|NCT00451594|Glucocorticoids|glucocorticoids|mesh-ancestor
110241953|NCT00451594|Hormones|hormones|mesh-ancestor
110241954|NCT00451594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110241955|NCT00451594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110241956|NCT00451594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110241957|NCT00139035|Cyclosporine|cyclosporine|mesh-list
110241958|NCT00139035|Cyclosporins|cyclosporins|mesh-list
110241959|NCT00139035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110241960|NCT00139035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110241961|NCT00139035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110241962|NCT00139035|Immunologic Factors|immunologic factors|mesh-ancestor
110241963|NCT00139035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110241964|NCT00139035|Antifungal Agents|antifungal agents|mesh-ancestor
110241965|NCT00139035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110241967|NCT00139035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110241968|NCT00139035|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110241969|NCT00451672|Bromocriptine|bromocriptine|mesh-list
110241970|NCT00451672|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110241971|NCT00451672|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110241972|NCT00451672|Hormone Antagonists|hormone antagonists|mesh-ancestor
110241973|NCT00451672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110241974|NCT00451672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110241975|NCT00451672|Dopamine Agonists|dopamine agonists|mesh-ancestor
110241976|NCT00451672|Dopamine Agents|dopamine agents|mesh-ancestor
110241977|NCT00451672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110241978|NCT00451672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110241979|NCT00108875|BIRC5 protein, human|birc5 protein, human|mesh-list
110241980|NCT00108875|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
110241981|NCT00108875|Protease Inhibitors|protease inhibitors|mesh-ancestor
110241982|NCT00108875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110241983|NCT00108875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110241984|NCT00451711|Amphotericin B|amphotericin b|mesh-list
110241985|NCT00451711|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110241986|NCT00451711|Amebicides|amebicides|mesh-ancestor
110241987|NCT00451711|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110241988|NCT00451711|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110241989|NCT00451711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110241990|NCT00451711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110241991|NCT00451711|Antifungal Agents|antifungal agents|mesh-ancestor
110241993|NCT00139074|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110241994|NCT00139074|Antidepressive Agents|antidepressive agents|mesh-ancestor
110241995|NCT00139074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110241996|NCT00139074|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110241997|NCT00139074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110241998|NCT00139074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110241999|NCT00139074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110242000|NCT00139074|Anticonvulsants|anticonvulsants|mesh-ancestor
110242001|NCT00139074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110242002|NCT00139074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242003|NCT00139074|GABA Agents|gaba agents|mesh-ancestor
110242004|NCT00139074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110242005|NCT00139074|Antimanic Agents|antimanic agents|mesh-ancestor
110242006|NCT00451750|Hydrocortisone|hydrocortisone|mesh-list
110242007|NCT00451750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110242008|NCT00451828|Simvastatin|simvastatin|mesh-list
110242009|NCT00451828|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110242010|NCT00451828|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110242011|NCT00451828|Antimetabolites|antimetabolites|mesh-ancestor
110242012|NCT00451828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242013|NCT00451828|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110242014|NCT00451828|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110242015|NCT00451828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110242016|NCT00451867|Mycophenolic Acid|mycophenolic acid|mesh-list
110242017|NCT00451867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110242018|NCT00451867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110242019|NCT00451867|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110242020|NCT00451867|Antitubercular Agents|antitubercular agents|mesh-ancestor
110242021|NCT00451867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110242022|NCT00451867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110242023|NCT00451867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110242024|NCT00451867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242025|NCT00143091|Sertraline|sertraline|mesh-list
110242026|NCT00143091|Antidepressive Agents|antidepressive agents|mesh-ancestor
110242027|NCT00143091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110242028|NCT00143091|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110242029|NCT00143091|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110242030|NCT00143091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110242031|NCT00143091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242032|NCT00143091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110242033|NCT00143091|Serotonin Agents|serotonin agents|mesh-ancestor
110242034|NCT00143091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110242036|NCT00451984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110242037|NCT00451984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110242038|NCT00451984|Analgesics|analgesics|mesh-ancestor
110242039|NCT00451984|Sensory System Agents|sensory system agents|mesh-ancestor
110242040|NCT00451984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110242041|NCT00451984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110242042|NCT00452062|Dexamethasone|dexamethasone|mesh-list
110242043|NCT00452062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110242044|NCT00452062|Antiemetics|antiemetics|mesh-ancestor
110242045|NCT00452062|Autonomic Agents|autonomic agents|mesh-ancestor
110242046|NCT00452062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110242047|NCT00452062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110242049|NCT00452062|Glucocorticoids|glucocorticoids|mesh-ancestor
110242050|NCT00452062|Hormones|hormones|mesh-ancestor
110242051|NCT00452062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110242052|NCT00452062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110242053|NCT00452062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110242054|NCT00108992|Diclofenac|diclofenac|mesh-list
110242055|NCT00108992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110242056|NCT00108992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110242057|NCT00108992|Analgesics|analgesics|mesh-ancestor
110242058|NCT00108992|Sensory System Agents|sensory system agents|mesh-ancestor
110242059|NCT00108992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110242060|NCT00108992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110242061|NCT00108992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110242062|NCT00108992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110242063|NCT00108992|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110242064|NCT00108992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110242065|NCT00108992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242066|NCT00143130|Pregabalin|pregabalin|mesh-list
110242067|NCT00143130|Analgesics|analgesics|mesh-ancestor
110242068|NCT00143130|Sensory System Agents|sensory system agents|mesh-ancestor
110242069|NCT00143130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110242070|NCT00143130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110242071|NCT00143130|Anticonvulsants|anticonvulsants|mesh-ancestor
110242072|NCT00143130|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110242073|NCT00143130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110242074|NCT00143130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242075|NCT00143130|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110242076|NCT00143130|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110242077|NCT00143130|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110242078|NCT00143130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110242079|NCT00143130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110242080|NCT00109070|Bevacizumab|bevacizumab|mesh-list
110242081|NCT00109070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110242082|NCT00109070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110242083|NCT00109070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110242084|NCT00109070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110242085|NCT00109070|Growth Substances|growth substances|mesh-ancestor
110242086|NCT00109070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110242087|NCT00109070|Growth Inhibitors|growth inhibitors|mesh-ancestor
110242088|NCT00452218|Sorafenib|sorafenib|mesh-list
110242089|NCT00452218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110242090|NCT00452218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110242091|NCT00452218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110242092|NCT00452218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242093|NCT00143169|Parecoxib|parecoxib|mesh-list
110242094|NCT00143169|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110267832|NCT03456466|Immunologic Factors|immunologic factors|mesh-ancestor
110242095|NCT00143169|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110242096|NCT00143169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110055658|NCT01499485|Acetazolamide|acetazolamide|mesh-list
110242097|NCT00143169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242098|NCT00143169|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110242099|NCT00143169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110242101|NCT00143169|Sensory System Agents|sensory system agents|mesh-ancestor
110242102|NCT00143169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110242103|NCT00143169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110242104|NCT00143169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110242105|NCT00143169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110242107|NCT00109109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110242108|NCT00109109|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110242109|NCT00109109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110242110|NCT00109109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242111|NCT03275116|Bromides|bromides|mesh-list
110242112|NCT03275116|Formoterol Fumarate|formoterol fumarate|mesh-list
110242113|NCT03275116|Tiotropium Bromide|tiotropium bromide|mesh-list
110242114|NCT03275116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110242115|NCT03275116|Autonomic Agents|autonomic agents|mesh-ancestor
110242116|NCT03275116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110242117|NCT03275116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110242118|NCT03275116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110242119|NCT03275116|Respiratory System Agents|respiratory system agents|mesh-ancestor
110242120|NCT03275116|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110242121|NCT03275116|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110242122|NCT03275116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110242123|NCT03275116|Adrenergic Agents|adrenergic agents|mesh-ancestor
110242124|NCT03275116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110242125|NCT03275116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242126|NCT03275116|Parasympatholytics|parasympatholytics|mesh-ancestor
110242127|NCT03275116|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110242128|NCT03275116|Cholinergic Agents|cholinergic agents|mesh-ancestor
110242129|NCT03275116|Anticonvulsants|anticonvulsants|mesh-ancestor
110242130|NCT00109148|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
110242131|NCT00109148|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110242132|NCT00109148|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110242133|NCT00109148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110242134|NCT00109148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242135|NCT00109148|Hormones|hormones|mesh-ancestor
110242136|NCT00109148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110242137|NCT00109148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110242138|NCT00452296|Insulin|insulin|mesh-list
110242139|NCT00452296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110242140|NCT00452296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110242141|NCT00452569|Thalidomide|thalidomide|mesh-list
110242142|NCT00452569|Dexamethasone|dexamethasone|mesh-list
110242143|NCT00452569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110242144|NCT00452569|Antiemetics|antiemetics|mesh-ancestor
110242145|NCT00452569|Autonomic Agents|autonomic agents|mesh-ancestor
110242146|NCT00452569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110242147|NCT00452569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110242148|NCT00452569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110242149|NCT00452569|Glucocorticoids|glucocorticoids|mesh-ancestor
110242150|NCT00452569|Hormones|hormones|mesh-ancestor
110242151|NCT00452569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110267840|NCT00160355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110242152|NCT00452569|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110242153|NCT00452569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110242154|NCT00452569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110242155|NCT00452569|Immunologic Factors|immunologic factors|mesh-ancestor
110242156|NCT00452569|Leprostatic Agents|leprostatic agents|mesh-ancestor
110242158|NCT00452569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110242159|NCT00452569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110242160|NCT00452569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110242161|NCT00452569|Growth Substances|growth substances|mesh-ancestor
110242162|NCT00452569|Growth Inhibitors|growth inhibitors|mesh-ancestor
110242163|NCT00143286|Varenicline|varenicline|mesh-list
110242164|NCT00143286|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110242165|NCT00143286|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110242166|NCT00143286|Cholinergic Agents|cholinergic agents|mesh-ancestor
110242167|NCT00143286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110242168|NCT00143286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242169|NCT00143286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110242170|NCT00109187|Omalizumab|omalizumab|mesh-list
110242171|NCT00109187|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110242172|NCT00109187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110242173|NCT00109187|Respiratory System Agents|respiratory system agents|mesh-ancestor
110242174|NCT00452608|Atorvastatin|atorvastatin|mesh-list
110242175|NCT00452608|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110242176|NCT00452608|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110242177|NCT00452608|Antimetabolites|antimetabolites|mesh-ancestor
110242178|NCT00452608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242179|NCT00452608|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110242180|NCT00452608|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110242181|NCT00452608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110242182|NCT00109226|Bevacizumab|bevacizumab|mesh-list
110242183|NCT00109226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110242184|NCT00109226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110242185|NCT00109226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110242186|NCT00109226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110035732|NCT01406301|PENTA|penta|mesh-list
110242187|NCT00109226|Growth Substances|growth substances|mesh-ancestor
110242188|NCT00109226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110242189|NCT00109226|Growth Inhibitors|growth inhibitors|mesh-ancestor
110242190|NCT00452725|Hormones|hormones|mesh-list
110242191|NCT00452725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110242192|NCT00452725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110242193|NCT00109265|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110242194|NCT00109265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110242195|NCT00109265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110242196|NCT00109265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110242197|NCT00109265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242198|NCT00143364|Varenicline|varenicline|mesh-list
110242199|NCT00143364|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110242200|NCT00143364|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110242201|NCT00143364|Cholinergic Agents|cholinergic agents|mesh-ancestor
110242202|NCT00143364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110242203|NCT00143364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242204|NCT00143364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110242205|NCT00452881|Gemcitabine|gemcitabine|mesh-list
110242206|NCT00452881|Oxaliplatin|oxaliplatin|mesh-list
110242207|NCT00452881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110242208|NCT00452881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110242210|NCT00452881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242211|NCT00452920|Docetaxel|docetaxel|mesh-list
110242212|NCT00452920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110242213|NCT00452920|Tubulin Modulators|tubulin modulators|mesh-ancestor
110242214|NCT00452920|Antimitotic Agents|antimitotic agents|mesh-ancestor
110242215|NCT00452920|Mitosis Modulators|mitosis modulators|mesh-ancestor
110242216|NCT00452920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242217|NCT00143442|Reboxetine|reboxetine|mesh-list
110242218|NCT00143442|Antidepressive Agents|antidepressive agents|mesh-ancestor
110242219|NCT00143442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110242220|NCT00143442|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110242221|NCT00143442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110242222|NCT00143442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110242223|NCT00143442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242224|NCT00143442|Adrenergic Agents|adrenergic agents|mesh-ancestor
110242225|NCT00143442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110242226|NCT00143442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110242227|NCT00109382|Aspirin|aspirin|mesh-list
110242228|NCT00109382|Clopidogrel|clopidogrel|mesh-list
110242229|NCT00109382|Simvastatin|simvastatin|mesh-list
110242230|NCT00109382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110242231|NCT00109382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110242232|NCT00109382|Analgesics|analgesics|mesh-ancestor
110242233|NCT00109382|Sensory System Agents|sensory system agents|mesh-ancestor
110242234|NCT00109382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110242235|NCT00109382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110242236|NCT00109382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110242237|NCT00109382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110242238|NCT00109382|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110242239|NCT00109382|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110242240|NCT00109382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242241|NCT00109382|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110242242|NCT00109382|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110242243|NCT00109382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110242244|NCT00109382|Antipyretics|antipyretics|mesh-ancestor
110242245|NCT00109382|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110242246|NCT00109382|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110242247|NCT00109382|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110242248|NCT00109382|Purinergic Agents|purinergic agents|mesh-ancestor
110242249|NCT00109382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110242250|NCT00109382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110242251|NCT00109382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110242252|NCT00109382|Antimetabolites|antimetabolites|mesh-ancestor
110242253|NCT00109382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110242254|NCT00109382|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110242255|NCT00453076|Paclitaxel|paclitaxel|mesh-list
110242256|NCT00453076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110242257|NCT00453076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110242258|NCT00453076|Tubulin Modulators|tubulin modulators|mesh-ancestor
110242259|NCT00453076|Antimitotic Agents|antimitotic agents|mesh-ancestor
110242260|NCT00453076|Mitosis Modulators|mitosis modulators|mesh-ancestor
110242261|NCT00453076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242262|NCT00453115|Gemcitabine|gemcitabine|mesh-list
110242263|NCT00453115|Oxaliplatin|oxaliplatin|mesh-list
110242264|NCT00453115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110242265|NCT00453115|Antimetabolites|antimetabolites|mesh-ancestor
110242266|NCT00453115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242267|NCT00453115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110242268|NCT00143481|Tolterodine Tartrate|tolterodine tartrate|mesh-list
110242269|NCT00143481|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110242270|NCT00143481|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110242271|NCT00143481|Cholinergic Agents|cholinergic agents|mesh-ancestor
110242272|NCT00143481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110242273|NCT00143481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242274|NCT00143481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110242275|NCT00143481|Urological Agents|urological agents|mesh-ancestor
110242276|NCT02273557|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
110242277|NCT02273557|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110242279|NCT00453232|Bleomycin|bleomycin|mesh-list
110242280|NCT00453232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110242281|NCT00453232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110242282|NCT00453232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110242283|NCT00453232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110242284|NCT00453232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110242285|NCT00453232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242286|NCT00453232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110242288|NCT00453427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110242289|NCT00453427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110242290|NCT00143520|Pioglitazone|pioglitazone|mesh-list
110242291|NCT00143520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110242292|NCT00143520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110242293|NCT00143559|Antibodies|antibodies|mesh-list
110242294|NCT00143559|Immunologic Factors|immunologic factors|mesh-ancestor
110242295|NCT00143559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110242296|NCT00453778|Fluticasone|fluticasone|mesh-list
110242297|NCT00453778|Xhance|xhance|mesh-list
110242298|NCT00453778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110242299|NCT00453778|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110242300|NCT00453778|Autonomic Agents|autonomic agents|mesh-ancestor
110242301|NCT00453778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110242302|NCT00453778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110242303|NCT00453778|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110242304|NCT00453778|Respiratory System Agents|respiratory system agents|mesh-ancestor
110242305|NCT00453778|Dermatologic Agents|dermatologic agents|mesh-ancestor
110242306|NCT00453778|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110242307|NCT00109616|Chlorhexidine|chlorhexidine|mesh-list
110242308|NCT00109616|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110242309|NCT00109616|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110242310|NCT00109616|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110242311|NCT00109616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110242312|NCT00109616|Disinfectants|disinfectants|mesh-ancestor
110242313|NCT00109616|Dermatologic Agents|dermatologic agents|mesh-ancestor
110242314|NCT00453856|Pyrimethamine|pyrimethamine|mesh-list
110242315|NCT00453856|Sulfadoxine|sulfadoxine|mesh-list
110242316|NCT00453856|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110242317|NCT00453856|Antimalarials|antimalarials|mesh-ancestor
110242318|NCT00453856|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110242319|NCT00453856|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110242320|NCT00453856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110242321|NCT00453856|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110242322|NCT00453856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110242323|NCT00453856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242324|NCT00453856|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110242325|NCT00454168|Sargramostim|sargramostim|mesh-list
110242326|NCT00454168|Immunologic Factors|immunologic factors|mesh-ancestor
110242327|NCT00454168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110242328|NCT00109811|Freund's Adjuvant|freund's adjuvant|mesh-list
110242329|NCT00109811|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110242330|NCT00109811|Immunologic Factors|immunologic factors|mesh-ancestor
110242331|NCT00109811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110242332|NCT03274765|Estradiol|estradiol|mesh-list
110242333|NCT03274765|Estrogens|estrogens|mesh-ancestor
110242334|NCT03274765|Hormones|hormones|mesh-ancestor
110242335|NCT03274765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110242336|NCT03274765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110242337|NCT00454402|Alfuzosin|alfuzosin|mesh-list
110242339|NCT00454402|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110242340|NCT00454402|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110242341|NCT00454402|Adrenergic Agents|adrenergic agents|mesh-ancestor
110242342|NCT00454402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110242343|NCT00454402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242344|NCT00454402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110242345|NCT00454402|Urological Agents|urological agents|mesh-ancestor
110242346|NCT00143676|Atorvastatin|atorvastatin|mesh-list
110242347|NCT00143676|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110242348|NCT00143676|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110242349|NCT00143676|Antimetabolites|antimetabolites|mesh-ancestor
110242350|NCT00143676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242351|NCT00143676|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110242352|NCT00143676|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110242353|NCT00143676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110242354|NCT00454480|Cytarabine|cytarabine|mesh-list
110242355|NCT00454480|Fludarabine|fludarabine|mesh-list
110242356|NCT00454480|Fludarabine phosphate|fludarabine phosphate|mesh-list
110242357|NCT00454480|Azacitidine|azacitidine|mesh-list
110242358|NCT00454480|Melphalan|melphalan|mesh-list
110242359|NCT00454480|Busulfan|busulfan|mesh-list
110242360|NCT00454480|Daunorubicin|daunorubicin|mesh-list
110242361|NCT00454480|Alemtuzumab|alemtuzumab|mesh-list
110242362|NCT00454480|Clofarabine|clofarabine|mesh-list
110242363|NCT00454480|Arsenic Trioxide|arsenic trioxide|mesh-list
110242364|NCT00454480|Gemtuzumab|gemtuzumab|mesh-list
110242365|NCT00454480|Tipifarnib|tipifarnib|mesh-list
110242366|NCT00454480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110242367|NCT00454480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110242368|NCT00454480|Antimetabolites|antimetabolites|mesh-ancestor
110242369|NCT00454480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242370|NCT00454480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110242371|NCT00454480|Immunologic Factors|immunologic factors|mesh-ancestor
110242372|NCT00454480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110242373|NCT00454480|Antiviral Agents|antiviral agents|mesh-ancestor
110242374|NCT00454480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110242375|NCT00454480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110242376|NCT00454480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110242377|NCT00454480|Alkylating Agents|alkylating agents|mesh-ancestor
110242378|NCT00454480|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110242379|NCT00454480|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110242380|NCT00454480|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110242381|NCT00454480|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110267913|NCT00545935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110242382|NCT00454480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110242384|NCT00454480|Immunoconjugates|immunoconjugates|mesh-ancestor
110242385|NCT00110006|Prednisone|prednisone|mesh-list
110242386|NCT00110006|Cyclophosphamide|cyclophosphamide|mesh-list
110242387|NCT00110006|Rituximab|rituximab|mesh-list
110242388|NCT00110006|Doxorubicin|doxorubicin|mesh-list
110242389|NCT00110006|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110242390|NCT00110006|Vincristine|vincristine|mesh-list
110242391|NCT00110006|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110242392|NCT00110006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110242393|NCT00110006|Immunologic Factors|immunologic factors|mesh-ancestor
110242394|NCT00110006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110242395|NCT00110006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110242396|NCT00110006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110242397|NCT00110006|Alkylating Agents|alkylating agents|mesh-ancestor
110242398|NCT00110006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242399|NCT00110006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110242400|NCT00110006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110242401|NCT00110006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110242402|NCT00110006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110242403|NCT00110006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110242404|NCT00110006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110242405|NCT00110006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110242406|NCT00110006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110242407|NCT00110006|Glucocorticoids|glucocorticoids|mesh-ancestor
110242408|NCT00110006|Hormones|hormones|mesh-ancestor
110242409|NCT00110006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110242410|NCT00110006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110242411|NCT00110006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110242412|NCT00110006|Tubulin Modulators|tubulin modulators|mesh-ancestor
110242413|NCT00110006|Antimitotic Agents|antimitotic agents|mesh-ancestor
110242414|NCT00110006|Mitosis Modulators|mitosis modulators|mesh-ancestor
110242415|NCT00110006|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110242416|NCT00454519|Mitomycins|mitomycins|mesh-list
110242417|NCT00454519|Mitomycin|mitomycin|mesh-list
110242418|NCT00454519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110242419|NCT00454519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110242420|NCT00454519|Alkylating Agents|alkylating agents|mesh-ancestor
110242421|NCT00454519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242422|NCT00454519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110242423|NCT00454519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110242424|NCT00112749|Infliximab|infliximab|mesh-list
110242425|NCT00112749|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110242426|NCT00112749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110242427|NCT00112749|Dermatologic Agents|dermatologic agents|mesh-ancestor
110242428|NCT00112749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110242429|NCT00112749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110242431|NCT00110045|Antifungal Agents|antifungal agents|mesh-ancestor
110242432|NCT00110045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110242433|NCT00110045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110242434|NCT00110045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242435|NCT00454714|Sildenafil Citrate|sildenafil citrate|mesh-list
110242436|NCT00454714|Vasodilator Agents|vasodilator agents|mesh-ancestor
110242437|NCT00454714|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110242438|NCT00454714|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110242439|NCT00454714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110242440|NCT00454714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242442|NCT00143715|Vitamin K|vitamin k|mesh-list
110242443|NCT00143715|Vitamin K 1|vitamin k 1|mesh-list
110242444|NCT00143715|Vitamins|vitamins|mesh-ancestor
110242445|NCT00143715|Micronutrients|micronutrients|mesh-ancestor
110242446|NCT00143715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110242447|NCT00143715|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110242448|NCT00143715|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110242449|NCT00143715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242450|NCT00143715|Hemostatics|hemostatics|mesh-ancestor
110242451|NCT00143715|Coagulants|coagulants|mesh-ancestor
110242452|NCT00454831|Chitosan|chitosan|mesh-list
110242453|NCT00454831|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110242454|NCT00454831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110242455|NCT00454831|Antimetabolites|antimetabolites|mesh-ancestor
110242456|NCT00454831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242457|NCT00454831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110242458|NCT00454831|Chelating Agents|chelating agents|mesh-ancestor
110242459|NCT00454831|Sequestering Agents|sequestering agents|mesh-ancestor
110242460|NCT00454831|Hemostatics|hemostatics|mesh-ancestor
110242461|NCT00454831|Coagulants|coagulants|mesh-ancestor
110242462|NCT00110123|Fotemustine|fotemustine|mesh-list
110242463|NCT00110123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110242464|NCT00455026|Remifentanil|remifentanil|mesh-list
110242465|NCT00455026|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110242466|NCT00455026|Narcotics|narcotics|mesh-ancestor
110242467|NCT00455026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110242468|NCT00455026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110242469|NCT00455026|Analgesics|analgesics|mesh-ancestor
110242470|NCT00455026|Sensory System Agents|sensory system agents|mesh-ancestor
110242471|NCT00455026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110242472|NCT00143325|Varenicline|varenicline|mesh-list
110242473|NCT00143325|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110242474|NCT00143325|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110242475|NCT00143325|Cholinergic Agents|cholinergic agents|mesh-ancestor
110242476|NCT00143325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110242477|NCT00143325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242478|NCT00143325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110242479|NCT00112983|Eculizumab|eculizumab|mesh-list
110242480|NCT00112983|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110242481|NCT00112983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110242482|NCT00112983|Immunologic Factors|immunologic factors|mesh-ancestor
110242483|NCT00112983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110242484|NCT00110162|Hormones|hormones|mesh-list
110242485|NCT00110162|Androgen Antagonists|androgen antagonists|mesh-list
110242486|NCT00110162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110242487|NCT00110162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110242488|NCT00110162|Hormone Antagonists|hormone antagonists|mesh-ancestor
110242489|NCT02273713|Paclitaxel|paclitaxel|mesh-list
110242490|NCT02273713|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110242491|NCT02273713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110242492|NCT02273713|Tubulin Modulators|tubulin modulators|mesh-ancestor
110242493|NCT02273713|Antimitotic Agents|antimitotic agents|mesh-ancestor
110242494|NCT02273713|Mitosis Modulators|mitosis modulators|mesh-ancestor
110242495|NCT02273713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242496|NCT00110201|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
110242497|NCT00110201|Natriuretic Agents|natriuretic agents|mesh-ancestor
110242498|NCT00110201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110242499|NCT02273791|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110242500|NCT02273791|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110242501|NCT02273791|Clomiphene|clomiphene|mesh-list
110242502|NCT02273791|Enclomiphene|enclomiphene|mesh-list
110242503|NCT02273791|Zuclomiphene|zuclomiphene|mesh-list
110242504|NCT02273791|Estradiol|estradiol|mesh-list
110242505|NCT02273791|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110242506|NCT02273791|Estrogens|estrogens|mesh-ancestor
110242507|NCT02273791|Hormones|hormones|mesh-ancestor
110242508|NCT02273791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110242509|NCT02273791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110242510|NCT02273791|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110242511|NCT02273791|Contraceptive Agents|contraceptive agents|mesh-ancestor
110242512|NCT02273791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110242513|NCT02273791|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110242514|NCT02273791|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110242515|NCT02273791|Hormone Antagonists|hormone antagonists|mesh-ancestor
110242516|NCT02273791|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110242517|NCT02273791|Fertility Agents|fertility agents|mesh-ancestor
110242518|NCT02273791|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110242519|NCT02273791|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110242520|NCT00110240|Vildagliptin|vildagliptin|mesh-list
110242521|NCT00110240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110242522|NCT00110240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110242523|NCT00110240|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110242524|NCT00110240|Protease Inhibitors|protease inhibitors|mesh-ancestor
110242525|NCT00110240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110242526|NCT00110240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242527|NCT00455416|Selenium|selenium|mesh-list
110242528|NCT00455416|Allicin|allicin|mesh-list
110242529|NCT00455416|Resveratrol|resveratrol|mesh-list
110242530|NCT00455416|Quercetin|quercetin|mesh-list
110242531|NCT00455416|Antioxidants|antioxidants|mesh-ancestor
110242532|NCT00455416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242533|NCT00455416|Protective Agents|protective agents|mesh-ancestor
110242534|NCT00455416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110242535|NCT00455416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110242536|NCT00455416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110242537|NCT00455416|Trace Elements|trace elements|mesh-ancestor
110242538|NCT00455416|Micronutrients|micronutrients|mesh-ancestor
110242539|NCT00455416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110242540|NCT00455416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110242541|NCT00455416|Antimetabolites|antimetabolites|mesh-ancestor
110242542|NCT00455416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110242543|NCT00455416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110242544|NCT00455416|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110242545|NCT00143871|Rituximab|rituximab|mesh-list
110242546|NCT00143871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110242547|NCT00143871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110242548|NCT00143871|Immunologic Factors|immunologic factors|mesh-ancestor
110242549|NCT00143871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110242550|NCT00143871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110242551|NCT00455572|Vinorelbine|vinorelbine|mesh-list
110242552|NCT00455572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110242553|NCT00455572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110242554|NCT00455572|Tubulin Modulators|tubulin modulators|mesh-ancestor
110242555|NCT00455572|Antimitotic Agents|antimitotic agents|mesh-ancestor
110242556|NCT00455572|Mitosis Modulators|mitosis modulators|mesh-ancestor
110242557|NCT00455572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242559|NCT00401492|Vinorelbine|vinorelbine|mesh-list
110242560|NCT00401492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110242561|NCT00401492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110242562|NCT00401492|Antimetabolites|antimetabolites|mesh-ancestor
110242563|NCT00401492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242564|NCT00401492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110242565|NCT00401492|Tubulin Modulators|tubulin modulators|mesh-ancestor
110242566|NCT00401492|Antimitotic Agents|antimitotic agents|mesh-ancestor
110242567|NCT00401492|Mitosis Modulators|mitosis modulators|mesh-ancestor
110242568|NCT00455806|Amoxicillin|amoxicillin|mesh-list
110242569|NCT00455806|Moxifloxacin|moxifloxacin|mesh-list
110242570|NCT00455806|Esomeprazole|esomeprazole|mesh-list
110242571|NCT00455806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110242572|NCT00455806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110242573|NCT00455806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110242574|NCT00455806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110242575|NCT00455806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110242576|NCT00455806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242577|NCT00455806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110242578|NCT00455806|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110242579|NCT00455806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110242580|NCT00455806|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110242581|NCT00455845|Levonorgestrel|levonorgestrel|mesh-list
110267942|NCT00160589|Histamine Agents|histamine agents|mesh-ancestor
110242582|NCT00455845|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110242583|NCT00455845|Contraceptive Agents|contraceptive agents|mesh-ancestor
110242584|NCT00455845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110242585|NCT00455845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110242586|NCT00455845|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110242587|NCT00455845|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110242588|NCT00455845|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110242590|NCT00110474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110242591|NCT00110474|Analgesics|analgesics|mesh-ancestor
110242592|NCT00110474|Sensory System Agents|sensory system agents|mesh-ancestor
110242593|NCT00110474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110242594|NCT00110474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110242595|NCT00110474|Antipyretics|antipyretics|mesh-ancestor
110242596|NCT00113100|Ethanol|ethanol|mesh-list
110242597|NCT00113100|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110242598|NCT00113100|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110242599|NCT00113100|Estradiol|estradiol|mesh-list
110242600|NCT00113100|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110242602|NCT00113100|Hormones|hormones|mesh-ancestor
110242603|NCT00113100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110242604|NCT00113100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110242605|NCT00113100|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110242606|NCT00113100|Contraceptive Agents|contraceptive agents|mesh-ancestor
110242607|NCT00113100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110242608|NCT00113100|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110242609|NCT00113100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110242610|NCT00113100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110242611|NCT00113100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110242612|NCT00143949|Losartan|losartan|mesh-list
110242613|NCT00143949|Enalapril|enalapril|mesh-list
110242614|NCT00143949|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110242615|NCT00143949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110242616|NCT00143949|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110242617|NCT00143949|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110242618|NCT00143949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242619|NCT00143949|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110242621|NCT00143949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110242622|NCT00456235|Mycophenolic Acid|mycophenolic acid|mesh-list
110242623|NCT00456235|Cyclosporine|cyclosporine|mesh-list
110242624|NCT00456235|Tacrolimus|tacrolimus|mesh-list
110242625|NCT00456235|Cyclosporins|cyclosporins|mesh-list
110242626|NCT00456235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110242627|NCT00456235|Immunologic Factors|immunologic factors|mesh-ancestor
110242628|NCT00456235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110242629|NCT00456235|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110242630|NCT00456235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110242631|NCT00456235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242632|NCT00456235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110242633|NCT00456235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110242634|NCT00456235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110242635|NCT00456235|Antitubercular Agents|antitubercular agents|mesh-ancestor
110242636|NCT00456235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110242637|NCT00456235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110242638|NCT00456235|Antifungal Agents|antifungal agents|mesh-ancestor
110242639|NCT00456235|Dermatologic Agents|dermatologic agents|mesh-ancestor
110242640|NCT00456235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110242641|NCT00456313|Fluticasone|fluticasone|mesh-list
110242642|NCT00456313|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110242643|NCT00456313|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110242644|NCT00456313|Autonomic Agents|autonomic agents|mesh-ancestor
110242645|NCT00456313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110267951|NCT00546130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110242646|NCT00456313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110242647|NCT00456313|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110242648|NCT00456313|Respiratory System Agents|respiratory system agents|mesh-ancestor
110242649|NCT00456313|Glucocorticoids|glucocorticoids|mesh-ancestor
110242650|NCT00456313|Hormones|hormones|mesh-ancestor
110242651|NCT00456313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110242652|NCT00456313|Sympathomimetics|sympathomimetics|mesh-ancestor
110242653|NCT00456313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110242654|NCT00456313|Dermatologic Agents|dermatologic agents|mesh-ancestor
110242655|NCT00456313|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110242656|NCT00110630|Nicotine|nicotine|mesh-list
110242657|NCT00110630|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110242658|NCT00110630|Autonomic Agents|autonomic agents|mesh-ancestor
110242659|NCT00110630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110242660|NCT00110630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110242661|NCT00110630|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110242662|NCT00110630|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110242663|NCT00110630|Cholinergic Agents|cholinergic agents|mesh-ancestor
110242664|NCT00110630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110242665|NCT00110630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242666|NCT00456430|Escitalopram|escitalopram|mesh-list
110242667|NCT00456430|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110242668|NCT00456430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110242669|NCT00456430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110242670|NCT00456430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242671|NCT00456430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110242672|NCT00456430|Serotonin Agents|serotonin agents|mesh-ancestor
110242673|NCT00456430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110242674|NCT00456586|Istradefylline|istradefylline|mesh-list
110242675|NCT00456586|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
110242676|NCT00456586|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110242677|NCT00456586|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110242678|NCT00456586|Purinergic Agents|purinergic agents|mesh-ancestor
110242679|NCT00456586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110242680|NCT00456586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242681|NCT00456586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110242682|NCT00110669|Prednisone|prednisone|mesh-list
110242683|NCT00110669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110242685|NCT00110669|Hormones|hormones|mesh-ancestor
110242686|NCT00110669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110242687|NCT00110669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110242688|NCT00110669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110242689|NCT00110669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110242690|NCT00454558|Riociguat|riociguat|mesh-list
110242691|NCT00454558|Enzyme Activators|enzyme activators|mesh-ancestor
110242692|NCT00454558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242693|NCT00113256|Rubitecan|rubitecan|mesh-list
110242694|NCT00113256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110242695|NCT00113256|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110242696|NCT00113256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110242697|NCT00113256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110242698|NCT00113256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242699|NCT00110708|Immunoglobulins|immunoglobulins|mesh-list
110242700|NCT00110708|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110242701|NCT00110708|Antibodies|antibodies|mesh-list
110242702|NCT00110708|Immunologic Factors|immunologic factors|mesh-ancestor
110242703|NCT00110708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110242704|NCT00456820|Bupropion|bupropion|mesh-list
110242705|NCT00456820|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110242706|NCT00456820|Antidepressive Agents|antidepressive agents|mesh-ancestor
110242707|NCT00456820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110242708|NCT00456820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110242709|NCT00456820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110242710|NCT00456820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110242711|NCT00456820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242712|NCT00456820|Dopamine Agents|dopamine agents|mesh-ancestor
110242713|NCT00456820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110242714|NCT00456820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110242715|NCT00456820|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110242716|NCT00456820|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110242717|NCT00456820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110242718|NCT00456898|Codeine|codeine|mesh-list
110242719|NCT00456898|Paroxetine|paroxetine|mesh-list
110242720|NCT00456898|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
110242721|NCT00456898|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110242722|NCT00456898|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110242723|NCT00456898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110242724|NCT00456898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242725|NCT00456898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110242726|NCT00456898|Serotonin Agents|serotonin agents|mesh-ancestor
110242727|NCT00456898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110242728|NCT00456898|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110242729|NCT00456898|Antidepressive Agents|antidepressive agents|mesh-ancestor
110242730|NCT00456898|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110242731|NCT00456898|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110242732|NCT00456898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110242733|NCT00456898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110242734|NCT00456898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110242735|NCT00456898|Narcotics|narcotics|mesh-ancestor
110242736|NCT00456898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110242737|NCT00456898|Analgesics|analgesics|mesh-ancestor
110242738|NCT00456898|Sensory System Agents|sensory system agents|mesh-ancestor
110242739|NCT00456898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110242740|NCT00456898|Antitussive Agents|antitussive agents|mesh-ancestor
110242741|NCT00456898|Respiratory System Agents|respiratory system agents|mesh-ancestor
110242742|NCT00456898|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110242743|NCT03274102|Vaccines|vaccines|mesh-list
110242744|NCT03274102|Immunologic Factors|immunologic factors|mesh-ancestor
110242745|NCT03274102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110242746|NCT00110747|Lidocaine|lidocaine|mesh-list
110242747|NCT00110747|Tetracaine|tetracaine|mesh-list
110242748|NCT00110747|Anesthetics, Local|anesthetics, local|mesh-ancestor
110242749|NCT00110747|Anesthetics|anesthetics|mesh-ancestor
110242750|NCT00110747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110242751|NCT00110747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110242752|NCT00110747|Sensory System Agents|sensory system agents|mesh-ancestor
110242753|NCT00110747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110242754|NCT00110747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110242755|NCT00110747|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110242756|NCT00110747|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110242757|NCT00110747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110242758|NCT00110747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242759|NCT00456937|Escitalopram|escitalopram|mesh-list
110242760|NCT00456937|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110267977|NCT00160628|Anticonvulsants|anticonvulsants|mesh-ancestor
110242761|NCT00456937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110242762|NCT00456937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110242763|NCT00456937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242764|NCT00456937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110242765|NCT00456937|Serotonin Agents|serotonin agents|mesh-ancestor
110242766|NCT00456937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110242768|NCT00456976|Antidepressive Agents|antidepressive agents|mesh-ancestor
110242769|NCT00456976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110242770|NCT00456976|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110242771|NCT00456976|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110242772|NCT00456976|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110242773|NCT00456976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110242774|NCT00456976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242775|NCT00456976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110242776|NCT00456976|Protective Agents|protective agents|mesh-ancestor
110242777|NCT00456976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110242778|NCT00144066|Gefitinib|gefitinib|mesh-list
110242779|NCT00144066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110242780|NCT00144066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110242781|NCT00144066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110242782|NCT00144066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242783|NCT00457054|Lithium Carbonate|lithium carbonate|mesh-list
110242784|NCT00457054|Antidepressive Agents|antidepressive agents|mesh-ancestor
110242785|NCT00457054|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110242786|NCT00457054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110242787|NCT00457054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242788|NCT00457054|Antimanic Agents|antimanic agents|mesh-ancestor
110242789|NCT00457054|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110242790|NCT00457054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110242791|NCT00457054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110242792|NCT00457093|Insulin Glargine|insulin glargine|mesh-list
110242793|NCT00457093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110242794|NCT00457093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110242795|NCT00457405|Dipyridamole|dipyridamole|mesh-list
110242796|NCT00457405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110242797|NCT00457405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110242798|NCT00457405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242799|NCT00457405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110242800|NCT00457405|Vasodilator Agents|vasodilator agents|mesh-ancestor
110242801|NCT00457483|Valsartan|valsartan|mesh-list
110242802|NCT00457483|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110242803|NCT00457483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110242804|NCT00457483|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110242805|NCT00457483|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110242806|NCT00457483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242807|NCT00457483|Diuretics|diuretics|mesh-ancestor
110242808|NCT00457483|Natriuretic Agents|natriuretic agents|mesh-ancestor
110242809|NCT00457483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110242810|NCT00457483|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110242811|NCT00457483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110242812|NCT00110864|Insulin|insulin|mesh-list
110242813|NCT00110864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110242814|NCT00110864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110242815|NCT00457678|Dexamethasone|dexamethasone|mesh-list
110242816|NCT00457678|Ranibizumab|ranibizumab|mesh-list
110242817|NCT00457678|Verteporfin|verteporfin|mesh-list
110242818|NCT00457678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110242819|NCT00457678|Antiemetics|antiemetics|mesh-ancestor
110242820|NCT00457678|Autonomic Agents|autonomic agents|mesh-ancestor
110242821|NCT00457678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110242822|NCT00457678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110242823|NCT00457678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110242824|NCT00457678|Glucocorticoids|glucocorticoids|mesh-ancestor
110242825|NCT00457678|Hormones|hormones|mesh-ancestor
110242826|NCT00457678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110242827|NCT00457678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110242828|NCT00457678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110242829|NCT00457678|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110242830|NCT00457678|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110242831|NCT00457678|Growth Substances|growth substances|mesh-ancestor
110242832|NCT00457678|Growth Inhibitors|growth inhibitors|mesh-ancestor
110242833|NCT00457678|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110242834|NCT00457678|Dermatologic Agents|dermatologic agents|mesh-ancestor
110242835|NCT00457717|Atropine|atropine|mesh-list
110242836|NCT00457717|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110242837|NCT00457717|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110242838|NCT00457717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110242839|NCT00457717|Autonomic Agents|autonomic agents|mesh-ancestor
110242840|NCT00457717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110242841|NCT00457717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110242842|NCT00457717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110242843|NCT00457717|Respiratory System Agents|respiratory system agents|mesh-ancestor
110242844|NCT00457717|Mydriatics|mydriatics|mesh-ancestor
110242845|NCT00457717|Parasympatholytics|parasympatholytics|mesh-ancestor
110242846|NCT00457717|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110242847|NCT00457717|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110242848|NCT00457717|Cholinergic Agents|cholinergic agents|mesh-ancestor
110242849|NCT00457717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110242850|NCT00457717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242851|NCT00110903|Etanercept|etanercept|mesh-list
110242852|NCT00110903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110242853|NCT00110903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110242854|NCT00110903|Analgesics|analgesics|mesh-ancestor
110242855|NCT00110903|Sensory System Agents|sensory system agents|mesh-ancestor
110242856|NCT00110903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110242857|NCT00110903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110242858|NCT00110903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110242859|NCT00110903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110242860|NCT00110903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110242861|NCT00110903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110242862|NCT00110903|Immunologic Factors|immunologic factors|mesh-ancestor
110242863|NCT00144144|Calcium Channel Blockers|calcium channel blockers|mesh-list
110242864|NCT00144144|Angiotensin II|angiotensin ii|mesh-list
110242865|NCT00144144|Giapreza|giapreza|mesh-list
110242866|NCT00144144|Calcium|calcium|mesh-list
110242867|NCT00144144|Angiotensinogen|angiotensinogen|mesh-list
110242868|NCT00144144|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
110242869|NCT00144144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110242870|NCT00144144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110242871|NCT00144144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110242872|NCT00144144|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110242873|NCT00144144|Protease Inhibitors|protease inhibitors|mesh-ancestor
110242874|NCT00144144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110242875|NCT00144144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242876|NCT00144144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110242877|NCT00465673|Doxorubicin|doxorubicin|mesh-list
110242879|NCT00465673|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110242880|NCT00465673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110242881|NCT00465673|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110242882|NCT00465673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110242883|NCT00465673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110242884|NCT00465673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242885|NCT00144183|Zidovudine|zidovudine|mesh-list
110242886|NCT00144183|Nevirapine|nevirapine|mesh-list
110242887|NCT00144183|Antimetabolites|antimetabolites|mesh-ancestor
110242888|NCT00144183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242889|NCT00144183|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110242890|NCT00144183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110242891|NCT00144183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110242893|NCT00144183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110242894|NCT00144183|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110242895|NCT00144183|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110242896|NCT00144183|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110242897|NCT00144183|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110242898|NCT00465751|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
110242899|NCT00465751|Cathartics|cathartics|mesh-ancestor
110242900|NCT00465751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110242901|NCT00110981|Etanercept|etanercept|mesh-list
110242902|NCT00110981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110242903|NCT00110981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110242904|NCT00110981|Analgesics|analgesics|mesh-ancestor
110242905|NCT00110981|Sensory System Agents|sensory system agents|mesh-ancestor
110242906|NCT00110981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110242907|NCT00110981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110242908|NCT00110981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110242909|NCT00110981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110242910|NCT00110981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110242911|NCT00110981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110242912|NCT00110981|Immunologic Factors|immunologic factors|mesh-ancestor
110242913|NCT00465907|Paclitaxel|paclitaxel|mesh-list
110242914|NCT00465907|Carboplatin|carboplatin|mesh-list
110242915|NCT00465907|Irinotecan|irinotecan|mesh-list
110242916|NCT00465907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110242917|NCT00465907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110242918|NCT00465907|Tubulin Modulators|tubulin modulators|mesh-ancestor
110242919|NCT00465907|Antimitotic Agents|antimitotic agents|mesh-ancestor
110242920|NCT00465907|Mitosis Modulators|mitosis modulators|mesh-ancestor
110242921|NCT00465907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242922|NCT00465907|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110242923|NCT00465907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110242924|NCT00465907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110242925|NCT00113685|Dextrans|dextrans|mesh-list
110242926|NCT00113685|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110242927|NCT00113685|Anticoagulants|anticoagulants|mesh-ancestor
110242928|NCT00113685|Plasma Substitutes|plasma substitutes|mesh-ancestor
110242929|NCT00113685|Blood Substitutes|blood substitutes|mesh-ancestor
110242930|NCT00111020|Sorafenib|sorafenib|mesh-list
110242931|NCT00111020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110242932|NCT00111020|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110242933|NCT00111020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110242934|NCT00111020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242935|NCT00466063|Deferasirox|deferasirox|mesh-list
110242937|NCT00466063|Chelating Agents|chelating agents|mesh-ancestor
110242938|NCT00466063|Sequestering Agents|sequestering agents|mesh-ancestor
110242939|NCT00466063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242940|NCT00466102|Everolimus|everolimus|mesh-list
110242941|NCT00466102|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110242942|NCT00466102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110242943|NCT00466102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110242944|NCT00466102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242945|NCT00466102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110242946|NCT00466102|Immunologic Factors|immunologic factors|mesh-ancestor
110242947|NCT00466102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110242948|NCT00466102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110242949|NCT00144222|Telmisartan|telmisartan|mesh-list
110242950|NCT00144222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110242951|NCT00144222|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110242952|NCT00144222|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110242953|NCT00144222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242954|NCT00466180|Nevirapine|nevirapine|mesh-list
110242955|NCT00466180|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110242957|NCT00466180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110242958|NCT00466180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242959|NCT00466180|Antiviral Agents|antiviral agents|mesh-ancestor
110242960|NCT00466180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110242961|NCT00466180|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110242962|NCT00466180|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110242963|NCT00466180|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110242964|NCT00466180|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110242965|NCT00466219|Interferons|interferons|mesh-list
110242966|NCT00466219|Ribavirin|ribavirin|mesh-list
110242967|NCT00466219|Interferon-alpha|interferon-alpha|mesh-list
110242968|NCT00466219|Interferon alpha-2|interferon alpha-2|mesh-list
110242969|NCT00466219|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110242970|NCT00466219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110242971|NCT00466219|Antiviral Agents|antiviral agents|mesh-ancestor
110242972|NCT00466219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110242973|NCT00466219|Antimetabolites|antimetabolites|mesh-ancestor
110242974|NCT00466219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242975|NCT00466219|Immunologic Factors|immunologic factors|mesh-ancestor
110242976|NCT00466219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110242977|NCT00144261|Nevirapine|nevirapine|mesh-list
110242978|NCT00144261|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110242979|NCT00144261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110242980|NCT00144261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110242981|NCT00144261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242982|NCT00144261|Antiviral Agents|antiviral agents|mesh-ancestor
110242983|NCT00144261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110242984|NCT00144261|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110242985|NCT00144261|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110242986|NCT00144261|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110242987|NCT00144261|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110242988|NCT00466258|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110242989|NCT00466258|Antiviral Agents|antiviral agents|mesh-ancestor
110242990|NCT00466258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110242991|NCT00144378|Irinotecan|irinotecan|mesh-list
110242992|NCT00144378|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110242993|NCT00144378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110242994|NCT00144378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110242995|NCT00144378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242996|NCT00144378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110242997|NCT00111098|Darbepoetin alfa|darbepoetin alfa|mesh-list
110242998|NCT00111098|Hematinics|hematinics|mesh-ancestor
110242999|NCT00347698|Bevacizumab|bevacizumab|mesh-list
110243000|NCT00347698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110243001|NCT00347698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110243002|NCT00347698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110243003|NCT00347698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110243004|NCT00347698|Growth Substances|growth substances|mesh-ancestor
110243005|NCT00347698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110243006|NCT00347698|Growth Inhibitors|growth inhibitors|mesh-ancestor
110243007|NCT00347737|Teriparatide|teriparatide|mesh-list
110243008|NCT00347737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110243009|NCT00347737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110243010|NCT00347737|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110243011|NCT00347815|Buprenorphine|buprenorphine|mesh-list
110243012|NCT00347815|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110243013|NCT00347815|Narcotics|narcotics|mesh-ancestor
110243014|NCT00347815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110243015|NCT00347815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110243016|NCT00347815|Analgesics|analgesics|mesh-ancestor
110243017|NCT00347815|Sensory System Agents|sensory system agents|mesh-ancestor
110243018|NCT00347815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110243019|NCT00347815|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110243020|NCT00113802|Epratuzumab|epratuzumab|mesh-list
110243021|NCT00113802|Antibodies|antibodies|mesh-list
110243022|NCT00113802|Immunologic Factors|immunologic factors|mesh-ancestor
110243023|NCT00113802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110243024|NCT00113802|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110243025|NCT00113802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110243026|NCT00111137|Darbepoetin alfa|darbepoetin alfa|mesh-list
110243027|NCT00111137|Hematinics|hematinics|mesh-ancestor
110243028|NCT00347854|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110243029|NCT00347854|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110243030|NCT00347854|Lubricant Eye Drops|lubricant eye drops|mesh-list
110243031|NCT00347854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110243033|NCT00347854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110243034|NCT00347971|Rituximab|rituximab|mesh-list
110243035|NCT00347971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110243036|NCT00347971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110243037|NCT00347971|Immunologic Factors|immunologic factors|mesh-ancestor
110243038|NCT00347971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110243039|NCT00347971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110243040|NCT00113958|Cinacalcet|cinacalcet|mesh-list
110243041|NCT00113958|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110243042|NCT00113958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110243043|NCT00113958|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
110243044|NCT00113958|Hormone Antagonists|hormone antagonists|mesh-ancestor
110243045|NCT00113958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110243046|NCT00348010|Tramadol|tramadol|mesh-list
110243047|NCT00348010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110243048|NCT00348010|Narcotics|narcotics|mesh-ancestor
110243049|NCT00348010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110243050|NCT00348010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110243051|NCT00348010|Analgesics|analgesics|mesh-ancestor
110243052|NCT00348010|Sensory System Agents|sensory system agents|mesh-ancestor
110243053|NCT00348010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110243054|NCT00144417|Moxifloxacin|moxifloxacin|mesh-list
110243055|NCT00144417|Rifampin|rifampin|mesh-list
110243056|NCT00144417|Isoniazid|isoniazid|mesh-list
110243057|NCT00144417|Pyrazinamide|pyrazinamide|mesh-list
110243058|NCT00144417|Ethambutol|ethambutol|mesh-list
110243059|NCT00144417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110243060|NCT00144417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110243061|NCT00144417|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110243062|NCT00144417|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110243063|NCT00144417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110243064|NCT00144417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110243065|NCT00144417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110243066|NCT00144417|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110243067|NCT00144417|Antitubercular Agents|antitubercular agents|mesh-ancestor
110243069|NCT00144417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110243070|NCT00144417|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110243071|NCT00144417|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110243072|NCT00144417|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110243073|NCT00144417|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110243074|NCT00144417|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110243075|NCT00144417|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110243076|NCT00144417|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110243077|NCT00144417|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110243079|NCT00144417|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110243080|NCT00111215|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
110243081|NCT00111215|Tranexamic Acid|tranexamic acid|mesh-list
110243082|NCT00111215|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110243083|NCT00111215|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110243084|NCT00111215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110243085|NCT00111215|Hemostatics|hemostatics|mesh-ancestor
110243086|NCT00111215|Coagulants|coagulants|mesh-ancestor
110243087|NCT00111215|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110243088|NCT00111215|Natriuretic Agents|natriuretic agents|mesh-ancestor
110243089|NCT00111215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110243090|NCT00348166|Cyclopentolate|cyclopentolate|mesh-list
110243091|NCT00348166|Mydriatics|mydriatics|mesh-ancestor
110243092|NCT00348166|Autonomic Agents|autonomic agents|mesh-ancestor
110243093|NCT00348166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110243094|NCT00348166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110243095|NCT00348166|Parasympatholytics|parasympatholytics|mesh-ancestor
110243096|NCT00348166|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110243097|NCT00348166|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110243098|NCT00348166|Cholinergic Agents|cholinergic agents|mesh-ancestor
110243099|NCT00348166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110243100|NCT00348166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110243101|NCT00348244|Prednisolone|prednisolone|mesh-list
110243102|NCT00348244|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110243103|NCT00348244|Methylprednisolone|methylprednisolone|mesh-list
110243104|NCT00348244|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110243105|NCT00348244|Prednisolone acetate|prednisolone acetate|mesh-list
110243106|NCT00348244|Ketorolac|ketorolac|mesh-list
110243107|NCT00348244|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110243108|NCT00348244|Prednisolone phosphate|prednisolone phosphate|mesh-list
110243109|NCT00348244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110243110|NCT00348244|Glucocorticoids|glucocorticoids|mesh-ancestor
110243111|NCT00348244|Hormones|hormones|mesh-ancestor
110243112|NCT00348244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110243113|NCT00348244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110243114|NCT00348244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110243115|NCT00348244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110243116|NCT00348244|Antiemetics|antiemetics|mesh-ancestor
110243117|NCT00348244|Autonomic Agents|autonomic agents|mesh-ancestor
110243118|NCT00348244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110243119|NCT00348244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110243120|NCT00348244|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110243121|NCT00348244|Protective Agents|protective agents|mesh-ancestor
110243122|NCT00348244|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110243123|NCT00348244|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110243124|NCT00348244|Analgesics|analgesics|mesh-ancestor
110243125|NCT00348244|Sensory System Agents|sensory system agents|mesh-ancestor
110243127|NCT00348244|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110243128|NCT00348244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110243129|NCT00348244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110243130|NCT00348322|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110243131|NCT00348322|Lubricant Eye Drops|lubricant eye drops|mesh-list
110243132|NCT00348322|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110243133|NCT00348361|Fluticasone|fluticasone|mesh-list
110243135|NCT00348361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110243136|NCT00348361|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110243137|NCT00348361|Autonomic Agents|autonomic agents|mesh-ancestor
110243138|NCT00348361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110243139|NCT00348361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110243140|NCT00348361|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110243141|NCT00348361|Respiratory System Agents|respiratory system agents|mesh-ancestor
110243142|NCT00348361|Dermatologic Agents|dermatologic agents|mesh-ancestor
110243143|NCT00348361|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110243144|NCT00348400|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110243145|NCT00348400|Dorzolamide|dorzolamide|mesh-list
110243146|NCT00348400|Latanoprost|latanoprost|mesh-list
110243147|NCT00348400|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110243148|NCT00348400|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110243149|NCT00348400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110243150|NCT00348400|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110243151|NCT00348400|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110243152|NCT00348400|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110243153|NCT00348400|Adrenergic Agents|adrenergic agents|mesh-ancestor
110243154|NCT00348400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110243155|NCT00348400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110243156|NCT00348400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110243157|NCT00348400|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110243158|NCT00348400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110243159|NCT00144456|Alfacalcidol|alfacalcidol|mesh-list
110243160|NCT00144456|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
110243161|NCT00144456|Eldecalcitol|eldecalcitol|mesh-list
110243162|NCT00144456|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110243163|NCT00144456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110243164|NCT00144456|Vitamins|vitamins|mesh-ancestor
110243165|NCT00144456|Micronutrients|micronutrients|mesh-ancestor
110243166|NCT00348439|Fibrinolysin|fibrinolysin|mesh-list
110243167|NCT00348439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110243168|NCT00348439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110243169|NCT00348439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110243170|NCT00348517|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110243171|NCT00348517|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110243172|NCT00348517|Lubricant Eye Drops|lubricant eye drops|mesh-list
110243173|NCT00348517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110243174|NCT00348517|Laxatives|laxatives|mesh-ancestor
110243175|NCT00348517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110243176|NCT00348634|Tegaserod|tegaserod|mesh-list
110243177|NCT00348634|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110243178|NCT00348634|Serotonin Agents|serotonin agents|mesh-ancestor
110243179|NCT00348634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110243180|NCT00348634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110243181|NCT00348634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110243182|NCT00348712|Insulin|insulin|mesh-list
110243183|NCT00348712|Metformin|metformin|mesh-list
110243184|NCT00348712|Rosiglitazone|rosiglitazone|mesh-list
110243185|NCT00348712|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110243186|NCT00348712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110243187|NCT00348712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110243188|NCT02964689|Pemetrexed|pemetrexed|mesh-list
110243189|NCT02964689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110243190|NCT02964689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110243191|NCT02964689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110243192|NCT02964689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110243193|NCT02964689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110243196|NCT00348985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110243197|NCT00348985|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110243198|NCT00348985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110243199|NCT00348985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110243200|NCT00349024|Povidone|povidone|mesh-list
110243201|NCT00349024|Hyaluronic Acid|hyaluronic acid|mesh-list
110243202|NCT00349024|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110243203|NCT00349024|Immunologic Factors|immunologic factors|mesh-ancestor
110243204|NCT00349024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110243205|NCT00349024|Viscosupplements|viscosupplements|mesh-ancestor
110243206|NCT00349024|Protective Agents|protective agents|mesh-ancestor
110243207|NCT00349024|Plasma Substitutes|plasma substitutes|mesh-ancestor
110243208|NCT00349024|Blood Substitutes|blood substitutes|mesh-ancestor
110243209|NCT00111371|Levodopa|levodopa|mesh-list
110243210|NCT00111371|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110243211|NCT00111371|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110243212|NCT00111371|Dopamine Agents|dopamine agents|mesh-ancestor
110243213|NCT00111371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110243214|NCT00111371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110243215|NCT00111371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110243216|NCT00349180|Enoxaparin|enoxaparin|mesh-list
110243217|NCT00349180|Enoxaparin sodium|enoxaparin sodium|mesh-list
110243218|NCT00349180|Anticoagulants|anticoagulants|mesh-ancestor
110243219|NCT00349180|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110243220|NCT00349180|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110243221|NCT00349180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110243222|NCT00421369|Sertraline|sertraline|mesh-list
110243223|NCT00421369|Reboxetine|reboxetine|mesh-list
110243224|NCT00421369|Antidepressive Agents|antidepressive agents|mesh-ancestor
110243225|NCT00421369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110243226|NCT00421369|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110243227|NCT00421369|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110243228|NCT00421369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110243229|NCT00421369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110243230|NCT00421369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110243231|NCT00421369|Serotonin Agents|serotonin agents|mesh-ancestor
110243232|NCT00421369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110243233|NCT00421369|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110243234|NCT00421369|Adrenergic Agents|adrenergic agents|mesh-ancestor
110243235|NCT00111410|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110243236|NCT00111410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110243237|NCT00421447|Anastrozole|anastrozole|mesh-list
110243238|NCT00421447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110243239|NCT00421447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110243240|NCT00421447|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110243241|NCT00421447|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110243242|NCT00421447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110243243|NCT00421447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110243244|NCT00421447|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110243245|NCT00421447|Hormone Antagonists|hormone antagonists|mesh-ancestor
110243246|NCT00421447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110243247|NCT00421447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110243248|NCT04729140|Doxycycline|doxycycline|mesh-list
110243249|NCT04729140|Ivermectin|ivermectin|mesh-list
110243250|NCT04729140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110243251|NCT04729140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110243252|NCT04729140|Antimalarials|antimalarials|mesh-ancestor
110243253|NCT04729140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110243254|NCT04729140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110243255|NCT00349219|Cisplatin|cisplatin|mesh-list
110243256|NCT00349219|Gemcitabine|gemcitabine|mesh-list
110243257|NCT00349219|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110243258|NCT00349219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110243259|NCT00349219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110243260|NCT00349219|Antimetabolites|antimetabolites|mesh-ancestor
110243261|NCT00349219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110243262|NCT00349219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110243263|NCT00349219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110243265|NCT00111449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110243266|NCT00111449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110243267|NCT00111449|Analgesics|analgesics|mesh-ancestor
110243268|NCT00111449|Sensory System Agents|sensory system agents|mesh-ancestor
110243269|NCT00111449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110243270|NCT00111449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110243271|NCT00111449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110243272|NCT00111449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110243273|NCT00111449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110243274|NCT00111449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110243275|NCT00111449|Immunologic Factors|immunologic factors|mesh-ancestor
110243276|NCT00349258|Leuprolide|leuprolide|mesh-list
110243277|NCT00349258|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110243278|NCT00349258|Fertility Agents|fertility agents|mesh-ancestor
110243279|NCT00349258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110243280|NCT00349258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110243281|NCT00349258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110243282|NCT00349258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110243283|NCT00349375|Simvastatin|simvastatin|mesh-list
110243284|NCT00349375|Fenofibrate|fenofibrate|mesh-list
110243285|NCT00349375|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110243286|NCT00349375|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110243287|NCT00349375|Antimetabolites|antimetabolites|mesh-ancestor
110243288|NCT00349375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110243289|NCT00349375|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110243290|NCT00349375|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110243291|NCT00349375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110243292|NCT00349453|Deferiprone|deferiprone|mesh-list
110243293|NCT00349453|Deferoxamine|deferoxamine|mesh-list
110243294|NCT00349453|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110243295|NCT00349453|Chelating Agents|chelating agents|mesh-ancestor
110243296|NCT00349453|Sequestering Agents|sequestering agents|mesh-ancestor
110243297|NCT00349453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110243298|NCT00349453|Siderophores|siderophores|mesh-ancestor
110243299|NCT00349492|Cisplatin|cisplatin|mesh-list
110243300|NCT00349492|Irinotecan|irinotecan|mesh-list
110243301|NCT00349492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110243302|NCT00349492|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110243303|NCT00349492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110243304|NCT00349492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110243305|NCT00349492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110243306|NCT00349531|Pramipexole|pramipexole|mesh-list
110243307|NCT00349531|Antioxidants|antioxidants|mesh-ancestor
110243308|NCT00349531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110243309|NCT00349531|Protective Agents|protective agents|mesh-ancestor
110243310|NCT00349531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110243311|NCT00349531|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110243312|NCT00349531|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110243313|NCT00349531|Dopamine Agonists|dopamine agonists|mesh-ancestor
110243314|NCT00349531|Dopamine Agents|dopamine agents|mesh-ancestor
110243315|NCT00349531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110243316|NCT00111566|Eptifibatide|eptifibatide|mesh-list
110243317|NCT00111566|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110243318|NCT00404703|Bevacizumab|bevacizumab|mesh-list
110243319|NCT00404703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110243320|NCT00404703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110243321|NCT00404703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110243322|NCT00404703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110243323|NCT00404703|Growth Substances|growth substances|mesh-ancestor
110243324|NCT00404703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110243325|NCT00404703|Growth Inhibitors|growth inhibitors|mesh-ancestor
110243326|NCT00349726|Inositol|inositol|mesh-list
110243327|NCT00349726|Vitamin B Complex|vitamin b complex|mesh-ancestor
110243328|NCT00349726|Vitamins|vitamins|mesh-ancestor
110243329|NCT00349726|Micronutrients|micronutrients|mesh-ancestor
110243330|NCT00349726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110243331|NCT00111644|Ceftriaxone|ceftriaxone|mesh-list
110243332|NCT00111644|Lactams|lactams|mesh-list
110243333|NCT00111644|beta-Lactams|beta-lactams|mesh-list
110243334|NCT00111644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110243335|NCT00111644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110243337|NCT00350038|Ciprofibrate|ciprofibrate|mesh-list
110243338|NCT00350038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110243339|NCT00350038|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110243340|NCT00350038|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110243341|NCT00350038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110243342|NCT00350038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110243343|NCT00350038|Antimetabolites|antimetabolites|mesh-ancestor
110243344|NCT00350038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110243346|NCT00350077|Ascorbic Acid|ascorbic acid|mesh-list
110243347|NCT00350077|Micronutrients|micronutrients|mesh-ancestor
110243348|NCT00350077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110243349|NCT00350077|Antioxidants|antioxidants|mesh-ancestor
110243350|NCT00350077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110243351|NCT00350077|Protective Agents|protective agents|mesh-ancestor
110243352|NCT00114153|Carboplatin|carboplatin|mesh-list
110243353|NCT00114153|Capecitabine|capecitabine|mesh-list
110243354|NCT00114153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110243355|NCT00114153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110243356|NCT00114153|Antimetabolites|antimetabolites|mesh-ancestor
110243357|NCT00114153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110243358|NCT00350116|Vitamin B 12|vitamin b 12|mesh-list
110243359|NCT00350116|Hydroxocobalamin|hydroxocobalamin|mesh-list
110243360|NCT00350116|Vitamins|vitamins|mesh-ancestor
110243361|NCT00350116|Micronutrients|micronutrients|mesh-ancestor
110243362|NCT00350116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110243363|NCT00350116|Vitamin B Complex|vitamin b complex|mesh-ancestor
110243364|NCT00350116|Hematinics|hematinics|mesh-ancestor
110243365|NCT00350155|Lumiracoxib|lumiracoxib|mesh-list
110243366|NCT00350155|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110243367|NCT00350155|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110243368|NCT00350155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110243369|NCT00350155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110243370|NCT00350155|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110243371|NCT00350155|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110243372|NCT00350155|Analgesics|analgesics|mesh-ancestor
110243373|NCT00350155|Sensory System Agents|sensory system agents|mesh-ancestor
110243374|NCT00350155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110243375|NCT00350155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110243376|NCT00350155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110243377|NCT00350155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110243378|NCT00404781|Aspirin|aspirin|mesh-list
110243379|NCT00404781|Cilostazol|cilostazol|mesh-list
110243380|NCT00404781|Clopidogrel|clopidogrel|mesh-list
110243381|NCT00404781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110243382|NCT00404781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110243383|NCT00404781|Analgesics|analgesics|mesh-ancestor
110243384|NCT00404781|Sensory System Agents|sensory system agents|mesh-ancestor
110243385|NCT00404781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110243386|NCT00404781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110243387|NCT00404781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110243388|NCT00404781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110243389|NCT00404781|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110243390|NCT00404781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110243391|NCT00404781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110243392|NCT00404781|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110243393|NCT00404781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110243395|NCT00404781|Antipyretics|antipyretics|mesh-ancestor
110243396|NCT00404781|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110243397|NCT00404781|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110243398|NCT00404781|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110243399|NCT00404781|Purinergic Agents|purinergic agents|mesh-ancestor
110243400|NCT00404781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110243401|NCT00404781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110243402|NCT00404781|Autonomic Agents|autonomic agents|mesh-ancestor
110243403|NCT00404781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110243404|NCT00404781|Respiratory System Agents|respiratory system agents|mesh-ancestor
110243405|NCT00404781|Vasodilator Agents|vasodilator agents|mesh-ancestor
110243406|NCT00404781|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110243407|NCT00404781|Protective Agents|protective agents|mesh-ancestor
110243408|NCT00404781|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110243409|NCT00404781|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110243411|NCT00350311|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110243412|NCT00350311|Autonomic Agents|autonomic agents|mesh-ancestor
110243413|NCT00350311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110243414|NCT00350311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110243415|NCT00350311|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110243416|NCT00350311|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110243417|NCT00350311|Cholinergic Agents|cholinergic agents|mesh-ancestor
110243418|NCT00350311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110243419|NCT00350311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110243420|NCT00114192|Thalidomide|thalidomide|mesh-list
110243421|NCT00114192|Docetaxel|docetaxel|mesh-list
110243422|NCT00114192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110243423|NCT00114192|Tubulin Modulators|tubulin modulators|mesh-ancestor
110243424|NCT00114192|Antimitotic Agents|antimitotic agents|mesh-ancestor
110243425|NCT00114192|Mitosis Modulators|mitosis modulators|mesh-ancestor
110243426|NCT00114192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110243427|NCT00114192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110243428|NCT00114192|Immunologic Factors|immunologic factors|mesh-ancestor
110243429|NCT00114192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110243430|NCT00114192|Leprostatic Agents|leprostatic agents|mesh-ancestor
110243431|NCT00114192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110243432|NCT00114192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110243433|NCT00114192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110243434|NCT00114192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110243435|NCT00114192|Growth Substances|growth substances|mesh-ancestor
110243436|NCT00114192|Growth Inhibitors|growth inhibitors|mesh-ancestor
110243437|NCT00350467|Olanzapine|olanzapine|mesh-list
110243438|NCT00350467|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110243439|NCT00350467|Antiemetics|antiemetics|mesh-ancestor
110243440|NCT00350467|Autonomic Agents|autonomic agents|mesh-ancestor
110243441|NCT00350467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110243442|NCT00350467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110243443|NCT00350467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110243444|NCT00350467|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110243445|NCT00350467|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110243446|NCT00350467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110243447|NCT00350467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110243448|NCT00350467|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110243449|NCT00350467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110243450|NCT00350467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110243451|NCT00350467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110243452|NCT00350467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110243453|NCT00350467|Serotonin Agents|serotonin agents|mesh-ancestor
110243454|NCT00350467|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110243455|NCT00350467|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110243456|NCT00350467|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110243457|NCT00350467|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110243458|NCT00350467|Dopamine Agents|dopamine agents|mesh-ancestor
110243459|NCT00350662|Deferiprone|deferiprone|mesh-list
110243460|NCT00350662|Deferoxamine|deferoxamine|mesh-list
110243461|NCT00350662|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110243462|NCT00350662|Chelating Agents|chelating agents|mesh-ancestor
110243463|NCT00350662|Sequestering Agents|sequestering agents|mesh-ancestor
110243464|NCT00350662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110243465|NCT00350662|Siderophores|siderophores|mesh-ancestor
110243466|NCT00350818|Azacitidine|azacitidine|mesh-list
110243467|NCT00350818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110243468|NCT00350818|Antimetabolites|antimetabolites|mesh-ancestor
110243469|NCT00350818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110243470|NCT00350818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110243471|NCT00350818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110243472|NCT00350857|Carbamazepine|carbamazepine|mesh-list
110243473|NCT00350857|Anticonvulsants|anticonvulsants|mesh-ancestor
110243474|NCT00350857|Antimanic Agents|antimanic agents|mesh-ancestor
110243475|NCT00350857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110243476|NCT00350857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110243477|NCT00350857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110243478|NCT00350857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110243479|NCT00350857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110243480|NCT00350857|Analgesics|analgesics|mesh-ancestor
110243481|NCT00350857|Sensory System Agents|sensory system agents|mesh-ancestor
110243482|NCT00350857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110243483|NCT00350857|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110243484|NCT00350857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110243485|NCT00350857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110243486|NCT00350857|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110243487|NCT00350857|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110243488|NCT00111956|Etanercept|etanercept|mesh-list
110243489|NCT00111956|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110243490|NCT00111956|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110243491|NCT00111956|Analgesics|analgesics|mesh-ancestor
110243492|NCT00111956|Sensory System Agents|sensory system agents|mesh-ancestor
110243493|NCT00111956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110243494|NCT00111956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110243495|NCT00111956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110243496|NCT00111956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110243497|NCT00111956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110243498|NCT00111956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110243499|NCT00111956|Immunologic Factors|immunologic factors|mesh-ancestor
110243500|NCT00114270|Zoledronic Acid|zoledronic acid|mesh-list
110243501|NCT00114270|Letrozole|letrozole|mesh-list
110243502|NCT00114270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110243503|NCT00114270|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110243504|NCT00114270|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110243505|NCT00114270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110243506|NCT00114270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110243507|NCT00114270|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110243508|NCT00114270|Hormone Antagonists|hormone antagonists|mesh-ancestor
110243509|NCT00114270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110243511|NCT00114270|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110243512|NCT00111995|Darbepoetin alfa|darbepoetin alfa|mesh-list
110243513|NCT00111995|Hematinics|hematinics|mesh-ancestor
110243514|NCT00351052|Pimecrolimus|pimecrolimus|mesh-list
110243515|NCT00351052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110243518|NCT00351052|Sensory System Agents|sensory system agents|mesh-ancestor
110243519|NCT00351052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110243520|NCT00351052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110243521|NCT00351052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110243522|NCT00351052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110243523|NCT00351052|Dermatologic Agents|dermatologic agents|mesh-ancestor
110243524|NCT00351052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110243525|NCT00351052|Immunologic Factors|immunologic factors|mesh-ancestor
110243526|NCT00351052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110243527|NCT00351052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110243528|NCT00351052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110243529|NCT00401609|Carboplatin|carboplatin|mesh-list
110243530|NCT00401609|Gemcitabine|gemcitabine|mesh-list
110243531|NCT00401609|Etoposide|etoposide|mesh-list
110243532|NCT00401609|Vinorelbine|vinorelbine|mesh-list
110243533|NCT00401609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110243534|NCT00401609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110243535|NCT00401609|Antimetabolites|antimetabolites|mesh-ancestor
110243536|NCT00401609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110243537|NCT00401609|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110243538|NCT00401609|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110243539|NCT00401609|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110243540|NCT00401609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110243541|NCT00401609|Tubulin Modulators|tubulin modulators|mesh-ancestor
110243542|NCT00401609|Antimitotic Agents|antimitotic agents|mesh-ancestor
110243543|NCT00401609|Mitosis Modulators|mitosis modulators|mesh-ancestor
110243544|NCT00351091|Risedronic Acid|risedronic acid|mesh-list
110243545|NCT00351091|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110243546|NCT00351091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110243547|NCT00351091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110243548|NCT00351091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110243549|NCT00351091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110243550|NCT00351091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110243551|NCT00351130|Amlodipine|amlodipine|mesh-list
110243552|NCT00351130|Valsartan|valsartan|mesh-list
110243553|NCT00351130|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110243554|NCT00351130|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110243555|NCT00351130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110243556|NCT00351130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110243557|NCT00351130|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110243558|NCT00351130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110243559|NCT00351130|Vasodilator Agents|vasodilator agents|mesh-ancestor
110243560|NCT00351130|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110243561|NCT00351130|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110243562|NCT00351169|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110243563|NCT00351169|Escitalopram|escitalopram|mesh-list
110243564|NCT00351169|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110243565|NCT00351169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110243566|NCT00351169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110243567|NCT00351169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110243568|NCT00351169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110243569|NCT00351169|Serotonin Agents|serotonin agents|mesh-ancestor
110243570|NCT00351169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110243571|NCT00351169|Antidepressive Agents|antidepressive agents|mesh-ancestor
110243572|NCT00351169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110243573|NCT00351169|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110243574|NCT00351169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110243575|NCT00351169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110243576|NCT00401648|Brivaracetam|brivaracetam|mesh-list
110243577|NCT00401648|Anticonvulsants|anticonvulsants|mesh-ancestor
110243578|NCT00351286|Simvastatin|simvastatin|mesh-list
110243579|NCT00351286|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110243580|NCT00351286|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110243581|NCT00351286|Antimetabolites|antimetabolites|mesh-ancestor
110243582|NCT00351286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110243583|NCT00351286|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110243584|NCT00351286|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110243585|NCT00351286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110243586|NCT00112034|Methylprednisolone|methylprednisolone|mesh-list
110243587|NCT00112034|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110243588|NCT00112034|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110243589|NCT00112034|Prednisolone|prednisolone|mesh-list
110243590|NCT00112034|Prednisolone acetate|prednisolone acetate|mesh-list
110243591|NCT00112034|Methotrexate|methotrexate|mesh-list
110243592|NCT00112034|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110243593|NCT00112034|Prednisolone phosphate|prednisolone phosphate|mesh-list
110243594|NCT00112034|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110243595|NCT00112034|Abortifacient Agents|abortifacient agents|mesh-ancestor
110243596|NCT00112034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110243597|NCT00112034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110243598|NCT00112034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110243599|NCT00112034|Antimetabolites|antimetabolites|mesh-ancestor
110243600|NCT00112034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110243601|NCT00112034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110243602|NCT00112034|Dermatologic Agents|dermatologic agents|mesh-ancestor
110243603|NCT00112034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110243604|NCT00112034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110243605|NCT00112034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110243606|NCT00112034|Immunologic Factors|immunologic factors|mesh-ancestor
110243607|NCT00112034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110243608|NCT00112034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110243609|NCT00112034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110243610|NCT00112034|Antiemetics|antiemetics|mesh-ancestor
110243611|NCT00112034|Autonomic Agents|autonomic agents|mesh-ancestor
110243612|NCT00112034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110243613|NCT00112034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110243614|NCT00112034|Glucocorticoids|glucocorticoids|mesh-ancestor
110243615|NCT00112034|Hormones|hormones|mesh-ancestor
110243616|NCT00112034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110243617|NCT00112034|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110243618|NCT00112034|Protective Agents|protective agents|mesh-ancestor
110243619|NCT00112034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110243620|NCT00114387|Tocopherols|tocopherols|mesh-list
110243621|NCT00114387|Vitamin E|vitamin e|mesh-list
110243622|NCT00114387|Tocotrienols|tocotrienols|mesh-list
110243623|NCT00114387|alpha-Tocopherol|alpha-tocopherol|mesh-list
110243624|NCT00114387|Antioxidants|antioxidants|mesh-ancestor
110243625|NCT00114387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110243626|NCT00114387|Protective Agents|protective agents|mesh-ancestor
110243627|NCT00114387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110243629|NCT00114387|Micronutrients|micronutrients|mesh-ancestor
110243630|NCT00351364|Montelukast|montelukast|mesh-list
110243631|NCT00351364|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110243632|NCT00351364|Respiratory System Agents|respiratory system agents|mesh-ancestor
110243633|NCT00351364|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110243634|NCT00351364|Hormone Antagonists|hormone antagonists|mesh-ancestor
110243635|NCT00351364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110243636|NCT00351364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110243637|NCT00351364|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110243638|NCT00351364|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110243639|NCT00351364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110243641|NCT00351403|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110243642|NCT00351403|Antimetabolites|antimetabolites|mesh-ancestor
110243643|NCT00351403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110243644|NCT00351403|Antiviral Agents|antiviral agents|mesh-ancestor
110243645|NCT00351403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110243646|NCT05595096|Anesthetics|anesthetics|mesh-list
110243647|NCT05595096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110243648|NCT05595096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110243649|NCT00351637|Methadone|methadone|mesh-list
110243650|NCT00351637|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110243651|NCT00351637|Narcotics|narcotics|mesh-ancestor
110243652|NCT00351637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110243653|NCT00351637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110243654|NCT00351637|Analgesics|analgesics|mesh-ancestor
110243655|NCT00351637|Sensory System Agents|sensory system agents|mesh-ancestor
110243656|NCT00351637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110243657|NCT00351637|Antitussive Agents|antitussive agents|mesh-ancestor
110243658|NCT00351637|Respiratory System Agents|respiratory system agents|mesh-ancestor
110243659|NCT00351715|Methadone|methadone|mesh-list
110243660|NCT00351715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110243661|NCT00351715|Narcotics|narcotics|mesh-ancestor
110243662|NCT00351715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110243663|NCT00351715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110243664|NCT00351715|Analgesics|analgesics|mesh-ancestor
110243665|NCT00351715|Sensory System Agents|sensory system agents|mesh-ancestor
110243666|NCT00351715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110243667|NCT00351715|Antitussive Agents|antitussive agents|mesh-ancestor
110243668|NCT00351715|Respiratory System Agents|respiratory system agents|mesh-ancestor
110243669|NCT00351832|Vildagliptin|vildagliptin|mesh-list
110243670|NCT00351832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110243671|NCT00351832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110243672|NCT00351832|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110243673|NCT00351832|Protease Inhibitors|protease inhibitors|mesh-ancestor
110243674|NCT00351832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110243675|NCT00351832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110243676|NCT00351871|Ribavirin|ribavirin|mesh-list
110243677|NCT00351871|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110243678|NCT00351871|Antimetabolites|antimetabolites|mesh-ancestor
110243679|NCT00351871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110243680|NCT00351871|Antiviral Agents|antiviral agents|mesh-ancestor
110243681|NCT00351871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110243682|NCT00351910|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110243683|NCT00351910|Amitriptyline|amitriptyline|mesh-list
110243684|NCT00351910|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110243685|NCT00351910|Citalopram|citalopram|mesh-list
110243686|NCT00351910|Bupropion|bupropion|mesh-list
110243687|NCT00351910|Fluoxetine|fluoxetine|mesh-list
110243688|NCT00351910|Paroxetine|paroxetine|mesh-list
110243689|NCT00351910|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110243690|NCT00351910|Sertraline|sertraline|mesh-list
110243691|NCT00351910|Escitalopram|escitalopram|mesh-list
110243692|NCT00351910|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110243693|NCT00351910|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110243694|NCT00351910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110243695|NCT00351910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110243696|NCT00351910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110243697|NCT00351910|Serotonin Agents|serotonin agents|mesh-ancestor
110243698|NCT00351910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110243699|NCT00351910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110243700|NCT00351910|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110243701|NCT00351910|Antidepressive Agents|antidepressive agents|mesh-ancestor
110243702|NCT00351910|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110243703|NCT00351910|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110243704|NCT00351910|Dopamine Agents|dopamine agents|mesh-ancestor
110243705|NCT00351910|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110243706|NCT00351910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110243707|NCT00351910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110243708|NCT00351910|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110243709|NCT00351910|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110243710|NCT00351910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110243711|NCT00351910|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110243712|NCT00351910|Analgesics|analgesics|mesh-ancestor
110243713|NCT00351910|Sensory System Agents|sensory system agents|mesh-ancestor
110243714|NCT00351910|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110243715|NCT00351910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110243716|NCT00351910|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110243717|NCT00351910|Adrenergic Agents|adrenergic agents|mesh-ancestor
110243718|NCT00112346|Gemcitabine|gemcitabine|mesh-list
110243719|NCT00112346|Cetuximab|cetuximab|mesh-list
110243720|NCT00112346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110243721|NCT00112346|Antimetabolites|antimetabolites|mesh-ancestor
110243722|NCT00112346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110243723|NCT00112346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110243724|NCT00112346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110243726|NCT00352144|Zopiclone|zopiclone|mesh-list
110243727|NCT00352144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110243728|NCT00352144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110243729|NCT00352144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110243730|NCT00352183|Simvastatin|simvastatin|mesh-list
110243731|NCT00352183|Fenofibrate|fenofibrate|mesh-list
110243732|NCT00352183|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110243733|NCT00352183|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110243734|NCT00352183|Antimetabolites|antimetabolites|mesh-ancestor
110243735|NCT00352183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110243736|NCT00352183|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110243737|NCT00352183|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110243738|NCT00352183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110243739|NCT00112619|Topotecan|topotecan|mesh-list
110243740|NCT00112619|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110243741|NCT00112619|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110243742|NCT00112619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110243743|NCT00112619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110243744|NCT00112619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110243745|NCT00352261|Esomeprazole|esomeprazole|mesh-list
110243746|NCT00352261|Lansoprazole|lansoprazole|mesh-list
110243747|NCT00352261|Dexlansoprazole|dexlansoprazole|mesh-list
110243748|NCT00352261|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110243749|NCT00352261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110243750|NCT00352261|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110243751|NCT00352261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110243752|NCT00352261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110243753|NCT00352300|Paclitaxel|paclitaxel|mesh-list
110243754|NCT00352300|Carboplatin|carboplatin|mesh-list
110243755|NCT00352300|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110268173|NCT04983238|Chelating Agents|chelating agents|mesh-ancestor
110243756|NCT00352300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110243757|NCT00352300|Tubulin Modulators|tubulin modulators|mesh-ancestor
110243758|NCT00352300|Antimitotic Agents|antimitotic agents|mesh-ancestor
110243759|NCT00352300|Mitosis Modulators|mitosis modulators|mesh-ancestor
110243760|NCT00352300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110243761|NCT00112658|Leucovorin|leucovorin|mesh-list
110243762|NCT00112658|Gemcitabine|gemcitabine|mesh-list
110243763|NCT00112658|Fluorouracil|fluorouracil|mesh-list
110243764|NCT00112658|Oxaliplatin|oxaliplatin|mesh-list
110243765|NCT00112658|Irinotecan|irinotecan|mesh-list
110243766|NCT00112658|Calcium|calcium|mesh-list
110243767|NCT00112658|Levoleucovorin|levoleucovorin|mesh-list
110243768|NCT00112658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110243769|NCT00112658|Antimetabolites|antimetabolites|mesh-ancestor
110243770|NCT00112658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110243771|NCT00112658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110243772|NCT00112658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110243773|NCT00112658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110243774|NCT00112658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110243775|NCT00112658|Immunologic Factors|immunologic factors|mesh-ancestor
110243776|NCT00112658|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110243777|NCT00112658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110243778|NCT00112658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110243779|NCT00112658|Antidotes|antidotes|mesh-ancestor
110243780|NCT00112658|Protective Agents|protective agents|mesh-ancestor
110243781|NCT00112658|Vitamin B Complex|vitamin b complex|mesh-ancestor
110243783|NCT00112658|Micronutrients|micronutrients|mesh-ancestor
110243784|NCT00352339|Aripiprazole|aripiprazole|mesh-list
110243785|NCT00352339|Antidepressive Agents|antidepressive agents|mesh-ancestor
110243786|NCT00352339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110243787|NCT00352339|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110243788|NCT00352339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110243789|NCT00352339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110243790|NCT00352339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110243791|NCT00352339|Dopamine Agonists|dopamine agonists|mesh-ancestor
110243792|NCT00352339|Dopamine Agents|dopamine agents|mesh-ancestor
110243793|NCT00352339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110243794|NCT00352339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110243795|NCT00352339|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110243796|NCT00352339|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110243797|NCT00352339|Serotonin Agents|serotonin agents|mesh-ancestor
110243798|NCT00352339|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110243799|NCT00352339|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110243800|NCT00352339|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110243801|NCT00352339|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110243802|NCT00352378|Cyclophosphamide|cyclophosphamide|mesh-list
110243803|NCT00352378|Docetaxel|docetaxel|mesh-list
110243804|NCT00352378|Doxorubicin|doxorubicin|mesh-list
110243805|NCT00352378|Capecitabine|capecitabine|mesh-list
110243806|NCT00352378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110243807|NCT00352378|Immunologic Factors|immunologic factors|mesh-ancestor
110243808|NCT00352378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110243809|NCT00352378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110243810|NCT00352378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110243811|NCT00352378|Alkylating Agents|alkylating agents|mesh-ancestor
110243812|NCT00352378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110243813|NCT00352378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110243815|NCT00352378|Tubulin Modulators|tubulin modulators|mesh-ancestor
110243816|NCT00352378|Antimitotic Agents|antimitotic agents|mesh-ancestor
110243817|NCT00352378|Mitosis Modulators|mitosis modulators|mesh-ancestor
110243818|NCT00352378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110243819|NCT00352378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110243820|NCT00352378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110243821|NCT00352378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110243822|NCT00352378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110243823|NCT00352378|Antimetabolites|antimetabolites|mesh-ancestor
110243824|NCT00352495|Carboplatin|carboplatin|mesh-list
110243826|NCT00352495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110243827|NCT00352495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110243828|NCT00352495|Tubulin Modulators|tubulin modulators|mesh-ancestor
110243829|NCT00352495|Antimitotic Agents|antimitotic agents|mesh-ancestor
110243830|NCT00352495|Mitosis Modulators|mitosis modulators|mesh-ancestor
110243831|NCT00352495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110243832|NCT00112697|Docetaxel|docetaxel|mesh-list
110243833|NCT00112697|Fluorouracil|fluorouracil|mesh-list
110243834|NCT00112697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110243835|NCT00112697|Tubulin Modulators|tubulin modulators|mesh-ancestor
110243836|NCT00112697|Antimitotic Agents|antimitotic agents|mesh-ancestor
110243837|NCT00112697|Mitosis Modulators|mitosis modulators|mesh-ancestor
110243838|NCT00112697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110243839|NCT00112697|Antimetabolites|antimetabolites|mesh-ancestor
110243840|NCT00112697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110243841|NCT00112697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110243842|NCT00112697|Immunologic Factors|immunologic factors|mesh-ancestor
110243843|NCT00112697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110243844|NCT02959606|Sarpogrelate|sarpogrelate|mesh-list
110243845|NCT02959606|Clopidogrel|clopidogrel|mesh-list
110243846|NCT02959606|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110243847|NCT02959606|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110243848|NCT02959606|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110243849|NCT02959606|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110243850|NCT02959606|Purinergic Agents|purinergic agents|mesh-ancestor
110243851|NCT02959606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110243852|NCT02959606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110243853|NCT02959606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110243854|NCT02959606|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110243855|NCT02959606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110243856|NCT02959606|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110243857|NCT02959606|Serotonin Agents|serotonin agents|mesh-ancestor
110243858|NCT00352651|Pregabalin|pregabalin|mesh-list
110243859|NCT00352651|Analgesics|analgesics|mesh-ancestor
110243860|NCT00352651|Sensory System Agents|sensory system agents|mesh-ancestor
110243861|NCT00352651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110243862|NCT00352651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110243863|NCT00352651|Anticonvulsants|anticonvulsants|mesh-ancestor
110243864|NCT00352651|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110243865|NCT00352651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110243866|NCT00352651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110243867|NCT00352651|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110243868|NCT00352651|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110243869|NCT00352651|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110243870|NCT00352651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110243871|NCT00352651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110243872|NCT00112775|Imatinib Mesylate|imatinib mesylate|mesh-list
110243873|NCT00112775|Dasatinib|dasatinib|mesh-list
110243874|NCT00112775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110243875|NCT00112775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110243876|NCT00112775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110243877|NCT00112775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110243878|NCT00352768|Fluvoxamine|fluvoxamine|mesh-list
110243879|NCT00352768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110243880|NCT00352768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110243881|NCT00352768|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110243882|NCT00352768|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110243883|NCT00352768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110243884|NCT00352768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110243885|NCT00352768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110243886|NCT00352768|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110268207|NCT00191412|Pemetrexed|pemetrexed|mesh-list
110243887|NCT00352768|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110243888|NCT00352768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110243890|NCT00352768|Serotonin Agents|serotonin agents|mesh-ancestor
110243891|NCT00352768|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110243892|NCT00352768|Antidepressive Agents|antidepressive agents|mesh-ancestor
110243893|NCT00352768|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110243894|NCT00352768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110243895|NCT00352768|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110243896|NCT00352807|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110243897|NCT00352807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110243898|NCT00352807|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110243899|NCT00352807|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110243900|NCT00352807|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110243901|NCT00352807|Adrenergic Agents|adrenergic agents|mesh-ancestor
110243902|NCT00352807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110243903|NCT00352807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110243904|NCT00352807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110243905|NCT00112853|Etoposide|etoposide|mesh-list
110243906|NCT00112853|Etoposide phosphate|etoposide phosphate|mesh-list
110243907|NCT00112853|Tipifarnib|tipifarnib|mesh-list
110243908|NCT00112853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110243909|NCT00112853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110243910|NCT00112853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110243911|NCT00112853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110243912|NCT00112853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110243913|NCT00112853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110243914|NCT00353002|Lidocaine|lidocaine|mesh-list
110243915|NCT00353002|Tetracaine|tetracaine|mesh-list
110243916|NCT00353002|Anesthetics, Local|anesthetics, local|mesh-ancestor
110243917|NCT00353002|Anesthetics|anesthetics|mesh-ancestor
110243918|NCT00353002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110243919|NCT00353002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110243920|NCT00353002|Sensory System Agents|sensory system agents|mesh-ancestor
110243921|NCT00353002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110243922|NCT00353002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110243923|NCT00353002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110243924|NCT00353002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110243925|NCT00353002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110243926|NCT00353002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110243928|NCT00353041|Anesthetics, Local|anesthetics, local|mesh-ancestor
110243929|NCT00353041|Anesthetics|anesthetics|mesh-ancestor
110243930|NCT00353041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110057500|NCT01507558|BB 1101|bb 1101|mesh-list
110243931|NCT00353041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110243932|NCT00353041|Sensory System Agents|sensory system agents|mesh-ancestor
110243933|NCT00353041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110243934|NCT00353041|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110243935|NCT00353041|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110243936|NCT00353041|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110243937|NCT00353041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110243938|NCT00353041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110243939|NCT00353080|Risedronic Acid|risedronic acid|mesh-list
110243940|NCT00353080|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110243941|NCT00353080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110243942|NCT00353080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110243943|NCT00353080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110243944|NCT00353080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110243945|NCT00353080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110243947|NCT00112892|Irinotecan|irinotecan|mesh-list
110243948|NCT00112892|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110243949|NCT00112892|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110243950|NCT00112892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110243951|NCT00112892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110243952|NCT00112892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110243953|NCT00112892|Antioxidants|antioxidants|mesh-ancestor
110243954|NCT00112892|Protective Agents|protective agents|mesh-ancestor
110243955|NCT00112892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110243956|NCT00112892|Trace Elements|trace elements|mesh-ancestor
110243957|NCT00112892|Micronutrients|micronutrients|mesh-ancestor
110243958|NCT00353665|Riluzole|riluzole|mesh-list
110243959|NCT00353665|Memantine|memantine|mesh-list
110243960|NCT00353665|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110243961|NCT00353665|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110243962|NCT00353665|Dopamine Agents|dopamine agents|mesh-ancestor
110243963|NCT00353665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110243964|NCT00353665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110243965|NCT00353665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110243966|NCT00353665|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110243967|NCT00353665|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110243968|NCT00353665|Anticonvulsants|anticonvulsants|mesh-ancestor
110243969|NCT00353665|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110243970|NCT00353665|Protective Agents|protective agents|mesh-ancestor
110243971|NCT05594784|Prednisone|prednisone|mesh-list
110243972|NCT05594784|Vincristine|vincristine|mesh-list
110243973|NCT05594784|Venetoclax|venetoclax|mesh-list
110243974|NCT05594784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110243975|NCT05594784|Glucocorticoids|glucocorticoids|mesh-ancestor
110243976|NCT05594784|Hormones|hormones|mesh-ancestor
110243977|NCT05594784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110243978|NCT05594784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110243979|NCT05594784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110243980|NCT05594784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110243981|NCT05594784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110243982|NCT05594784|Tubulin Modulators|tubulin modulators|mesh-ancestor
110243983|NCT05594784|Antimitotic Agents|antimitotic agents|mesh-ancestor
110243984|NCT05594784|Mitosis Modulators|mitosis modulators|mesh-ancestor
110243985|NCT05594784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110243986|NCT00113048|Alemtuzumab|alemtuzumab|mesh-list
110243987|NCT00113048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110243988|NCT00113048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110243989|NCT00353743|Metronidazole|metronidazole|mesh-list
110243990|NCT00353743|Doxycycline|doxycycline|mesh-list
110243991|NCT00353743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110243992|NCT00353743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110243993|NCT00353743|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110243994|NCT00353743|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110243995|NCT00353743|Antimalarials|antimalarials|mesh-ancestor
110243996|NCT00113165|Lamotrigine|lamotrigine|mesh-list
110243997|NCT00113165|Anticonvulsants|anticonvulsants|mesh-ancestor
110243998|NCT00113165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110243999|NCT00113165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110244000|NCT00113165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110244001|NCT00113165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110244002|NCT00113165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244003|NCT00113165|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110244004|NCT00113165|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110244005|NCT00113165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110244006|NCT00113165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110244007|NCT00113165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110244008|NCT00354094|Reboxetine|reboxetine|mesh-list
110244009|NCT00354094|Antidepressive Agents|antidepressive agents|mesh-ancestor
110244010|NCT00354094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110244011|NCT00354094|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110244012|NCT00354094|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110244013|NCT00354094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110244014|NCT00354094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110244015|NCT00354094|Adrenergic Agents|adrenergic agents|mesh-ancestor
110244016|NCT00354094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110244017|NCT00354094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244018|NCT00114816|Docetaxel|docetaxel|mesh-list
110244019|NCT00114816|Capecitabine|capecitabine|mesh-list
110244020|NCT00114816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110244021|NCT00114816|Tubulin Modulators|tubulin modulators|mesh-ancestor
110244022|NCT00114816|Antimitotic Agents|antimitotic agents|mesh-ancestor
110244023|NCT00114816|Mitosis Modulators|mitosis modulators|mesh-ancestor
110244024|NCT00114816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110244025|NCT00114816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110244026|NCT00114816|Antimetabolites|antimetabolites|mesh-ancestor
110244027|NCT00354367|Certolizumab Pegol|certolizumab pegol|mesh-list
110244028|NCT00354367|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110244029|NCT00354367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110244030|NCT00354367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110244031|NCT00354367|Immunologic Factors|immunologic factors|mesh-ancestor
110244032|NCT00354367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244033|NCT00354367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110244034|NCT00354406|Abciximab|abciximab|mesh-list
110244035|NCT00354406|Anticoagulants|anticoagulants|mesh-ancestor
110244036|NCT00354406|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110244037|NCT00354523|Capecitabine|capecitabine|mesh-list
110244038|NCT00354523|Imatinib Mesylate|imatinib mesylate|mesh-list
110244039|NCT00354523|Dacarbazine|dacarbazine|mesh-list
110244040|NCT00354523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110244041|NCT00354523|Antimetabolites|antimetabolites|mesh-ancestor
110244042|NCT00354523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110244043|NCT00354523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110244044|NCT00354523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110244045|NCT00354523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110244046|NCT00354523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110244047|NCT00354523|Alkylating Agents|alkylating agents|mesh-ancestor
110244048|NCT00114933|Ritonavir|ritonavir|mesh-list
110244049|NCT00114933|Lopinavir|lopinavir|mesh-list
110244050|NCT00114933|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110244051|NCT00114933|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110244052|NCT00114933|Protease Inhibitors|protease inhibitors|mesh-ancestor
110244053|NCT00114933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110244054|NCT00114933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110244055|NCT00114933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110244056|NCT00114933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110244057|NCT00114933|Antiviral Agents|antiviral agents|mesh-ancestor
110244058|NCT00114933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110244059|NCT00114933|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110244060|NCT00114933|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110244061|NCT00113282|Interleukin-2|interleukin-2|mesh-list
110244062|NCT00113282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110244063|NCT00113282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110244064|NCT00113282|Analgesics|analgesics|mesh-ancestor
110244065|NCT00113282|Sensory System Agents|sensory system agents|mesh-ancestor
110244066|NCT00113282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110244067|NCT00113282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244069|NCT00425932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110244070|NCT00425932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110244071|NCT00425932|Immunologic Factors|immunologic factors|mesh-ancestor
110244072|NCT00425932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244073|NCT00425932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110244074|NCT00426010|Caffeine|caffeine|mesh-list
110268225|NCT00191490|Gemcitabine|gemcitabine|mesh-list
110244075|NCT00426010|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110244076|NCT00426010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244077|NCT00426010|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110244078|NCT00426010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110244079|NCT00426010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110244080|NCT00426010|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110244081|NCT00426010|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110244082|NCT00426010|Purinergic Agents|purinergic agents|mesh-ancestor
110244083|NCT00426010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110244084|NCT00115011|Escitalopram|escitalopram|mesh-list
110244085|NCT00115011|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110244086|NCT00115011|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110244087|NCT00115011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110244088|NCT00115011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110244089|NCT00115011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110244090|NCT00115011|Serotonin Agents|serotonin agents|mesh-ancestor
110244091|NCT00115011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244092|NCT00113594|Olanzapine|olanzapine|mesh-list
110244093|NCT00113594|Antiemetics|antiemetics|mesh-ancestor
110244094|NCT00113594|Autonomic Agents|autonomic agents|mesh-ancestor
110244095|NCT00113594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110244096|NCT00113594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244097|NCT00113594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110244098|NCT00113594|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110244099|NCT00113594|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110244100|NCT00113594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110244101|NCT00113594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110244102|NCT00113594|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110244103|NCT00113594|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110244104|NCT00113594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110244105|NCT00113594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110244106|NCT00113594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110244107|NCT00113594|Serotonin Agents|serotonin agents|mesh-ancestor
110244108|NCT00426049|Everolimus|everolimus|mesh-list
110244109|NCT00426049|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110244110|NCT00426049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110244111|NCT00426049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110244112|NCT00426049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110244113|NCT00426049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110244114|NCT00426049|Immunologic Factors|immunologic factors|mesh-ancestor
110244115|NCT00426049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244116|NCT00426049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110244117|NCT05594433|Lenograstim|lenograstim|mesh-list
110244118|NCT05594433|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110244119|NCT05594433|Immunologic Factors|immunologic factors|mesh-ancestor
110244120|NCT05594433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244121|NCT00115089|Beclomethasone|beclomethasone|mesh-list
110244122|NCT00115089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110244123|NCT00115089|Glucocorticoids|glucocorticoids|mesh-ancestor
110244124|NCT00115089|Hormones|hormones|mesh-ancestor
110244125|NCT00115089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110244126|NCT00115089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244127|NCT00115089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110244128|NCT00115089|Respiratory System Agents|respiratory system agents|mesh-ancestor
110244129|NCT00115128|Lenograstim|lenograstim|mesh-list
110244130|NCT00115128|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110244131|NCT00115128|Immunologic Factors|immunologic factors|mesh-ancestor
110244132|NCT00115128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244133|NCT00115167|Darbepoetin alfa|darbepoetin alfa|mesh-list
110244134|NCT00115167|Hematinics|hematinics|mesh-ancestor
110244135|NCT00115245|Adefovir|adefovir|mesh-list
110244136|NCT00115245|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
110244137|NCT00115245|Telbivudine|telbivudine|mesh-list
110244138|NCT00115245|Antiviral Agents|antiviral agents|mesh-ancestor
110244139|NCT00115245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110244140|NCT00115245|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110244141|NCT00115245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110244142|NCT00115245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110244143|NCT00115245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110244145|NCT01059526|Analgesics|analgesics|mesh-ancestor
110244146|NCT01059526|Sensory System Agents|sensory system agents|mesh-ancestor
110244147|NCT01059526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110244148|NCT01059526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244149|NCT01059526|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110244150|NCT01059526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110244151|NCT01059526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110244152|NCT01059526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110244153|NCT00444340|Etanercept|etanercept|mesh-list
110244154|NCT00444340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110244155|NCT00444340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110244156|NCT00444340|Analgesics|analgesics|mesh-ancestor
110244157|NCT00444340|Sensory System Agents|sensory system agents|mesh-ancestor
110244158|NCT00444340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110244159|NCT00444340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244160|NCT00444340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110244161|NCT00444340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110244162|NCT00444340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110244163|NCT00444340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110244164|NCT00444340|Immunologic Factors|immunologic factors|mesh-ancestor
110244165|NCT00444379|Ritonavir|ritonavir|mesh-list
110244166|NCT00444379|Lopinavir|lopinavir|mesh-list
110244167|NCT00444379|Tenofovir|tenofovir|mesh-list
110244168|NCT00444379|Emtricitabine|emtricitabine|mesh-list
110244169|NCT00444379|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110244170|NCT00444379|Efavirenz|efavirenz|mesh-list
110244171|NCT00444379|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110244172|NCT00444379|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110244173|NCT00444379|Protease Inhibitors|protease inhibitors|mesh-ancestor
110244174|NCT00444379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110244175|NCT00444379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110244176|NCT00444379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110244177|NCT00444379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110244178|NCT00444379|Antiviral Agents|antiviral agents|mesh-ancestor
110244179|NCT00444379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110244180|NCT00444379|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110244181|NCT00444379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110244182|NCT00444379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110244183|NCT00444379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110244184|NCT00444379|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110244185|NCT00444379|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110244186|NCT00444379|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110244187|NCT00444379|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110244188|NCT00444379|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110244190|NCT00444418|Naloxone|naloxone|mesh-list
110244191|NCT00444418|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110244192|NCT00444418|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110244193|NCT00444418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244194|NCT00444418|Sensory System Agents|sensory system agents|mesh-ancestor
110244195|NCT00444418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110244196|NCT00444574|Methylphenidate|methylphenidate|mesh-list
110244197|NCT00444574|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110244198|NCT00444574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244199|NCT00444574|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110244200|NCT00444574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110244201|NCT00444574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110244202|NCT00444574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110244203|NCT00444574|Dopamine Agents|dopamine agents|mesh-ancestor
110244204|NCT00444574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110244205|NCT00444652|Enoxaparin|enoxaparin|mesh-list
110244206|NCT00444652|Anticoagulants|anticoagulants|mesh-ancestor
110244207|NCT00444652|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110244208|NCT00444652|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110244209|NCT00444652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110244210|NCT04699903|Antibodies|antibodies|mesh-list
110244211|NCT04699903|Immunoglobulin G|immunoglobulin g|mesh-list
110244212|NCT04699903|Immunologic Factors|immunologic factors|mesh-ancestor
110244213|NCT04699903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244214|NCT00444808|Calcitonin|calcitonin|mesh-list
110244215|NCT00444808|Salmon calcitonin|salmon calcitonin|mesh-list
110244216|NCT00444808|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
110244217|NCT00444808|Katacalcin|katacalcin|mesh-list
110244218|NCT00444808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110244219|NCT00444808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244220|NCT00444808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110244221|NCT00444808|Vasodilator Agents|vasodilator agents|mesh-ancestor
110244222|NCT00113828|Cyclosporine|cyclosporine|mesh-list
110244223|NCT00113828|Cyclosporins|cyclosporins|mesh-list
110244224|NCT00113828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110244225|NCT00113828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110244226|NCT00113828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110244227|NCT00113828|Immunologic Factors|immunologic factors|mesh-ancestor
110244228|NCT00113828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244229|NCT00113828|Antifungal Agents|antifungal agents|mesh-ancestor
110244230|NCT00113828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110244231|NCT00113828|Dermatologic Agents|dermatologic agents|mesh-ancestor
110244232|NCT00113828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110244233|NCT00113828|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110244234|NCT00444886|Botulinum Toxins|botulinum toxins|mesh-list
110244235|NCT00444886|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110244236|NCT00444886|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110244237|NCT00444886|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110244238|NCT00444886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110244239|NCT00444886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110244240|NCT00444886|Cholinergic Agents|cholinergic agents|mesh-ancestor
110244241|NCT00444886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110244242|NCT00444886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244243|NCT00444886|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110244244|NCT00444886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110244245|NCT05594121|Buprenorphine|buprenorphine|mesh-list
110244246|NCT05594121|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110244247|NCT05594121|Narcotics|narcotics|mesh-ancestor
110244248|NCT05594121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110244249|NCT05594121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244250|NCT05594121|Analgesics|analgesics|mesh-ancestor
110244251|NCT05594121|Sensory System Agents|sensory system agents|mesh-ancestor
110244252|NCT05594121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110244253|NCT05594121|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110244254|NCT00115362|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110244255|NCT00115362|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110244256|NCT00115362|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110244257|NCT00115362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110244258|NCT00115362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110244259|NCT00115362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110244260|NCT00115362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244261|NCT00115362|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110244262|NCT00115362|Antidepressive Agents|antidepressive agents|mesh-ancestor
110244263|NCT00115362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110244264|NCT00445042|Sorafenib|sorafenib|mesh-list
110244265|NCT00445042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110244266|NCT00445042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110244267|NCT00445042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110244268|NCT00445042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110244270|NCT00445081|Prednisolone|prednisolone|mesh-list
110244271|NCT00445081|Cyclosporins|cyclosporins|mesh-list
110244272|NCT00445081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110244273|NCT00445081|Glucocorticoids|glucocorticoids|mesh-ancestor
110244275|NCT00445081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110244276|NCT00445081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244277|NCT00445081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110244278|NCT00445081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110244279|NCT00445081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110244280|NCT00445081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110244281|NCT00445081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110244282|NCT00445081|Immunologic Factors|immunologic factors|mesh-ancestor
110244283|NCT00445081|Antifungal Agents|antifungal agents|mesh-ancestor
110244284|NCT00445081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110244285|NCT00445081|Dermatologic Agents|dermatologic agents|mesh-ancestor
110244286|NCT00445081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110244287|NCT00445081|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110244288|NCT00113906|Melatonin|melatonin|mesh-list
110244289|NCT00113906|Antioxidants|antioxidants|mesh-ancestor
110244290|NCT00113906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110244291|NCT00113906|Protective Agents|protective agents|mesh-ancestor
110244292|NCT00113906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244293|NCT00113906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110244294|NCT00113945|Cinacalcet|cinacalcet|mesh-list
110244295|NCT00113945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110244296|NCT00113945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244297|NCT00113945|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
110244298|NCT00113945|Hormone Antagonists|hormone antagonists|mesh-ancestor
110244299|NCT00113945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110244300|NCT00445159|Treprostinil|treprostinil|mesh-list
110244301|NCT00445159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110244302|NCT00445276|Diacerein|diacerein|mesh-list
110244303|NCT00445276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110244304|NCT00113984|Metronidazole|metronidazole|mesh-list
110244305|NCT00113984|Ipilimumab|ipilimumab|mesh-list
110244306|NCT00113984|Sargramostim|sargramostim|mesh-list
110244307|NCT00113984|Immunologic Factors|immunologic factors|mesh-ancestor
110244308|NCT00113984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244309|NCT00113984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110244310|NCT00113984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110244311|NCT00113984|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110244312|NCT00113984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110244313|NCT00113984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110244314|NCT00113984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110244316|NCT00113984|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110244317|NCT00445510|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
110244318|NCT00445510|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110244319|NCT00445510|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110244320|NCT00445510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110244321|NCT00445510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110244322|NCT00114023|Imiquimod|imiquimod|mesh-list
110244323|NCT00114023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110244324|NCT00114023|Immunologic Factors|immunologic factors|mesh-ancestor
110244325|NCT00114023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244326|NCT00114023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110244327|NCT00114023|Interferon Inducers|interferon inducers|mesh-ancestor
110244328|NCT00445861|Docetaxel|docetaxel|mesh-list
110244329|NCT00445861|Cetuximab|cetuximab|mesh-list
110244330|NCT00445861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110244331|NCT00445861|Tubulin Modulators|tubulin modulators|mesh-ancestor
110244332|NCT00445861|Antimitotic Agents|antimitotic agents|mesh-ancestor
110244333|NCT00445861|Mitosis Modulators|mitosis modulators|mesh-ancestor
110244334|NCT00445861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110244335|NCT00445861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110244336|NCT00445900|Thalidomide|thalidomide|mesh-list
110244338|NCT00445900|Cyclophosphamide|cyclophosphamide|mesh-list
110244339|NCT00445900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110244340|NCT00445900|Immunologic Factors|immunologic factors|mesh-ancestor
110244341|NCT00445900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244342|NCT00445900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110244343|NCT00445900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110244344|NCT00445900|Alkylating Agents|alkylating agents|mesh-ancestor
110244345|NCT00445900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110244346|NCT00445900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110244347|NCT00445900|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110244348|NCT00445900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110244349|NCT00445900|Glucocorticoids|glucocorticoids|mesh-ancestor
110244350|NCT00445900|Hormones|hormones|mesh-ancestor
110244351|NCT00445900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110244352|NCT00445900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110244353|NCT00445900|Leprostatic Agents|leprostatic agents|mesh-ancestor
110244354|NCT00445900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110244355|NCT00445900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110244356|NCT00445900|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110244357|NCT00445900|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110244358|NCT00445900|Growth Substances|growth substances|mesh-ancestor
110244359|NCT00445900|Growth Inhibitors|growth inhibitors|mesh-ancestor
110244360|NCT00115479|Insulin|insulin|mesh-list
110244361|NCT00115479|Benzocaine|benzocaine|mesh-list
110244362|NCT00115479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110244363|NCT00115479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244364|NCT00115479|Anesthetics, Local|anesthetics, local|mesh-ancestor
110244365|NCT00115479|Anesthetics|anesthetics|mesh-ancestor
110244366|NCT00115479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110244367|NCT00115479|Sensory System Agents|sensory system agents|mesh-ancestor
110244368|NCT00115479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110244369|NCT00446017|Milrinone|milrinone|mesh-list
110244370|NCT00446017|Epinephrine|epinephrine|mesh-list
110244371|NCT00446017|Racepinephrine|racepinephrine|mesh-list
110244372|NCT00446017|Epinephryl borate|epinephryl borate|mesh-list
110244373|NCT00446017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110244374|NCT00446017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110244375|NCT00446017|Adrenergic Agents|adrenergic agents|mesh-ancestor
110244376|NCT00446017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110244377|NCT00446017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110244378|NCT00446017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244379|NCT00446017|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110244380|NCT00446017|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110244381|NCT00446017|Autonomic Agents|autonomic agents|mesh-ancestor
110244382|NCT00446017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110244383|NCT00446017|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110244384|NCT00446017|Respiratory System Agents|respiratory system agents|mesh-ancestor
110244385|NCT00446017|Mydriatics|mydriatics|mesh-ancestor
110244386|NCT00446017|Sympathomimetics|sympathomimetics|mesh-ancestor
110244387|NCT00446017|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110244388|NCT00446017|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110244389|NCT00446017|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110244390|NCT00446017|Vasodilator Agents|vasodilator agents|mesh-ancestor
110244391|NCT00446017|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110244392|NCT00446017|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110244393|NCT00446017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110244394|NCT00446017|Protective Agents|protective agents|mesh-ancestor
110244395|NCT00446173|Cyclophosphamide|cyclophosphamide|mesh-list
110244397|NCT00446173|Sargramostim|sargramostim|mesh-list
110244398|NCT00446173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110244399|NCT00446173|Immunologic Factors|immunologic factors|mesh-ancestor
110244400|NCT00446173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244401|NCT00446173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110244402|NCT00446173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110244403|NCT00446173|Alkylating Agents|alkylating agents|mesh-ancestor
110244404|NCT00446173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110244405|NCT00446173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110244406|NCT00446173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110244408|NCT00446212|Desflurane|desflurane|mesh-list
110244409|NCT00446212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110244410|NCT00446212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110244411|NCT00446212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244412|NCT00446212|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110244413|NCT00446212|Anesthetics, General|anesthetics, general|mesh-ancestor
110244414|NCT00446212|Anesthetics|anesthetics|mesh-ancestor
110244415|NCT00446212|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110244416|NCT00446329|Cinacalcet|cinacalcet|mesh-list
110244417|NCT00446329|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110244418|NCT00446329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244419|NCT00446329|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
110244420|NCT00446329|Hormone Antagonists|hormone antagonists|mesh-ancestor
110244421|NCT00446329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110244422|NCT00446368|Everolimus|everolimus|mesh-list
110244423|NCT00446368|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110244424|NCT00446368|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110244425|NCT00446368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110244426|NCT00446368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110244427|NCT00446368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110244428|NCT00446368|Immunologic Factors|immunologic factors|mesh-ancestor
110244429|NCT00446368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244430|NCT00446368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110244431|NCT00401765|Docetaxel|docetaxel|mesh-list
110244432|NCT00401765|Siltuximab|siltuximab|mesh-list
110244433|NCT00401765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110244434|NCT00401765|Tubulin Modulators|tubulin modulators|mesh-ancestor
110244435|NCT00401765|Antimitotic Agents|antimitotic agents|mesh-ancestor
110244436|NCT00401765|Mitosis Modulators|mitosis modulators|mesh-ancestor
110244437|NCT00401765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110244438|NCT00115518|Cetuximab|cetuximab|mesh-list
110244439|NCT00115518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110244440|NCT00115518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110244441|NCT00446524|Amlodipine|amlodipine|mesh-list
110244443|NCT00446524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110244444|NCT00446524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110244445|NCT00446524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110244446|NCT00446524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110244447|NCT00446524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110244448|NCT00446524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244449|NCT00446524|Vasodilator Agents|vasodilator agents|mesh-ancestor
110244450|NCT00446524|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110244451|NCT00446524|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110244452|NCT00446602|Epoetin Alfa|epoetin alfa|mesh-list
110244453|NCT00446602|Hematinics|hematinics|mesh-ancestor
110244454|NCT05589753|Acetazolamide|acetazolamide|mesh-list
110244455|NCT05589753|Anticonvulsants|anticonvulsants|mesh-ancestor
110244456|NCT05589753|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110244457|NCT05589753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110244458|NCT05589753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110244459|NCT05589753|Diuretics|diuretics|mesh-ancestor
110244460|NCT05589753|Natriuretic Agents|natriuretic agents|mesh-ancestor
110244461|NCT05589753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244462|NCT00114179|Bevacizumab|bevacizumab|mesh-list
110244463|NCT00114179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110244464|NCT00114179|Gemcitabine|gemcitabine|mesh-list
110244465|NCT00114179|Capecitabine|capecitabine|mesh-list
110244466|NCT00114179|Antibodies|antibodies|mesh-list
110244467|NCT00114179|Immunoglobulins|immunoglobulins|mesh-list
110244468|NCT00114179|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110244469|NCT00114179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110244471|NCT00114179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110244472|NCT00114179|Growth Substances|growth substances|mesh-ancestor
110244473|NCT00114179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244474|NCT00114179|Growth Inhibitors|growth inhibitors|mesh-ancestor
110244475|NCT00114179|Immunologic Factors|immunologic factors|mesh-ancestor
110244476|NCT00114179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110244477|NCT00114179|Antimetabolites|antimetabolites|mesh-ancestor
110244478|NCT00114179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110244479|NCT00446680|Mannitol|mannitol|mesh-list
110244480|NCT00446680|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110244481|NCT00446680|Diuretics|diuretics|mesh-ancestor
110244482|NCT00446680|Natriuretic Agents|natriuretic agents|mesh-ancestor
110244483|NCT00446680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244484|NCT00114257|Decitabine|decitabine|mesh-list
110244485|NCT00114257|Romidepsin|romidepsin|mesh-list
110244486|NCT00114257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110244487|NCT00114257|Antimetabolites|antimetabolites|mesh-ancestor
110244488|NCT00114257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110244489|NCT00114257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110244490|NCT00114257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110244491|NCT00114257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110244492|NCT00114257|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110244493|NCT00404937|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110244494|NCT00404937|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
110244495|NCT00404937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110244496|NCT00404937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110244497|NCT00404937|Glucocorticoids|glucocorticoids|mesh-ancestor
110244498|NCT00404937|Hormones|hormones|mesh-ancestor
110244499|NCT00404937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110244500|NCT00404937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244501|NCT00404937|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110244502|NCT00404937|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110244503|NCT00446836|Paclitaxel|paclitaxel|mesh-list
110244504|NCT00446836|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
110244505|NCT00446836|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110244506|NCT00446836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110244507|NCT00446836|Tubulin Modulators|tubulin modulators|mesh-ancestor
110244508|NCT00446836|Antimitotic Agents|antimitotic agents|mesh-ancestor
110244510|NCT00446836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110244511|NCT00114374|Escitalopram|escitalopram|mesh-list
110244512|NCT00114374|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110244513|NCT00114374|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110244514|NCT00114374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110244515|NCT00114374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110244516|NCT00114374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110244517|NCT00114374|Serotonin Agents|serotonin agents|mesh-ancestor
110244518|NCT00114374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244519|NCT00446953|Betamethasone|betamethasone|mesh-list
110244520|NCT00446953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110244521|NCT00446953|Glucocorticoids|glucocorticoids|mesh-ancestor
110244523|NCT00446953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110244524|NCT00446953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244525|NCT00446953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110244526|NCT00446953|Respiratory System Agents|respiratory system agents|mesh-ancestor
110244527|NCT00447031|Triamcinolone|triamcinolone|mesh-list
110244528|NCT00447031|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110244529|NCT00447031|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110244530|NCT00447031|Bevacizumab|bevacizumab|mesh-list
110244531|NCT00447031|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110244532|NCT00447031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110244533|NCT00447031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110244534|NCT00447031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110244535|NCT00447031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110244536|NCT00447031|Growth Substances|growth substances|mesh-ancestor
110244537|NCT00447031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244538|NCT00447031|Growth Inhibitors|growth inhibitors|mesh-ancestor
110244539|NCT00447031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110244540|NCT00447031|Glucocorticoids|glucocorticoids|mesh-ancestor
110244541|NCT00447031|Hormones|hormones|mesh-ancestor
110244542|NCT00447031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110244543|NCT00447031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110244544|NCT00447031|Immunologic Factors|immunologic factors|mesh-ancestor
110244545|NCT00447031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110244546|NCT00447031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110244547|NCT00447070|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110244548|NCT00447070|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110244549|NCT00447070|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110244550|NCT00447070|Protease Inhibitors|protease inhibitors|mesh-ancestor
110244551|NCT00447070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110244552|NCT00447070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110244553|NCT00447070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110244554|NCT00447070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110244555|NCT00447070|Antiviral Agents|antiviral agents|mesh-ancestor
110244556|NCT00447070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110244557|NCT00115635|Gemcitabine|gemcitabine|mesh-list
110244558|NCT00115635|Docetaxel|docetaxel|mesh-list
110244559|NCT00115635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110244560|NCT00115635|Antimetabolites|antimetabolites|mesh-ancestor
110244561|NCT00115635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110244562|NCT00115635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110244563|NCT00115635|Tubulin Modulators|tubulin modulators|mesh-ancestor
110244564|NCT00115635|Antimitotic Agents|antimitotic agents|mesh-ancestor
110244565|NCT00115635|Mitosis Modulators|mitosis modulators|mesh-ancestor
110244566|NCT00447304|Moxifloxacin|moxifloxacin|mesh-list
110244567|NCT00447304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110244568|NCT00447304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110244569|NCT00447304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110244571|NCT00447304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110244572|NCT00447304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110244573|NCT00447304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110244574|NCT00447577|Loteprednol Etabonate|loteprednol etabonate|mesh-list
110244575|NCT00447577|Tobramycin|tobramycin|mesh-list
110244576|NCT00447577|Dexamethasone|dexamethasone|mesh-list
110244577|NCT00447577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110244578|NCT00447577|Antiemetics|antiemetics|mesh-ancestor
110244579|NCT00447577|Autonomic Agents|autonomic agents|mesh-ancestor
110244580|NCT00447577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110244581|NCT00447577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244582|NCT00447577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110244583|NCT00447577|Glucocorticoids|glucocorticoids|mesh-ancestor
110244584|NCT00447577|Hormones|hormones|mesh-ancestor
110244585|NCT00447577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110244586|NCT00447577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110244587|NCT00447577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110244588|NCT00447577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110244589|NCT00447577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110244590|NCT00447577|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110244591|NCT00114491|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110244592|NCT00114491|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110244593|NCT00114491|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110244594|NCT00114491|Antimetabolites|antimetabolites|mesh-ancestor
110244595|NCT00114491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110244596|NCT00114491|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110244597|NCT00114491|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110244598|NCT00114491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110244599|NCT00114569|Lorazepam|lorazepam|mesh-list
110244600|NCT00114569|Anticonvulsants|anticonvulsants|mesh-ancestor
110244601|NCT00114569|Antiemetics|antiemetics|mesh-ancestor
110244602|NCT00114569|Autonomic Agents|autonomic agents|mesh-ancestor
110244603|NCT00114569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110244604|NCT00114569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244605|NCT00114569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110244606|NCT00114569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110244607|NCT00114569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110244608|NCT00114569|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110244609|NCT00114569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110244610|NCT00114569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110244611|NCT00114569|GABA Modulators|gaba modulators|mesh-ancestor
110244612|NCT00114569|GABA Agents|gaba agents|mesh-ancestor
110244613|NCT00114569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110244614|NCT00114569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110244615|NCT00447928|Nitroglycerin|nitroglycerin|mesh-list
110244616|NCT00447928|Vasodilator Agents|vasodilator agents|mesh-ancestor
110244617|NCT00447967|Leucovorin|leucovorin|mesh-list
110244618|NCT00447967|Fluorouracil|fluorouracil|mesh-list
110244619|NCT00447967|Oxaliplatin|oxaliplatin|mesh-list
110244620|NCT00447967|Irinotecan|irinotecan|mesh-list
110244621|NCT00447967|Antimetabolites|antimetabolites|mesh-ancestor
110244622|NCT00447967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110244623|NCT00447967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110244624|NCT00447967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110244625|NCT00447967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110244626|NCT00447967|Immunologic Factors|immunologic factors|mesh-ancestor
110244627|NCT00447967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244628|NCT00447967|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110244629|NCT00447967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110244630|NCT00447967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110244631|NCT00447967|Antidotes|antidotes|mesh-ancestor
110244632|NCT00447967|Protective Agents|protective agents|mesh-ancestor
110244633|NCT00447967|Vitamin B Complex|vitamin b complex|mesh-ancestor
110244634|NCT00447967|Vitamins|vitamins|mesh-ancestor
110244635|NCT00447967|Micronutrients|micronutrients|mesh-ancestor
110244636|NCT00401856|Eplerenone|eplerenone|mesh-list
110244637|NCT00401856|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110244639|NCT00401856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110244640|NCT00401856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244641|NCT00401856|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110244642|NCT00401856|Diuretics|diuretics|mesh-ancestor
110244643|NCT00401856|Natriuretic Agents|natriuretic agents|mesh-ancestor
110244644|NCT00401856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110244645|NCT00448240|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110244646|NCT00448240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110244647|NCT00448240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110244648|NCT00448240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110244649|NCT00448240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110244650|NCT00448396|Epothilone B|epothilone b|mesh-list
110244651|NCT00448396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110244652|NCT00448396|Tubulin Modulators|tubulin modulators|mesh-ancestor
110244653|NCT00448396|Antimitotic Agents|antimitotic agents|mesh-ancestor
110244654|NCT00448396|Mitosis Modulators|mitosis modulators|mesh-ancestor
110244655|NCT00448396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110244656|NCT00114686|Valproic Acid|valproic acid|mesh-list
110244657|NCT00114686|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110244658|NCT00114686|Antidepressive Agents|antidepressive agents|mesh-ancestor
110244659|NCT00114686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110244660|NCT00114686|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110244661|NCT00114686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110244662|NCT00114686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110244663|NCT00114686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244664|NCT00114686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110244665|NCT00114686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110244666|NCT00114686|Antimanic Agents|antimanic agents|mesh-ancestor
110244667|NCT00114686|Anticonvulsants|anticonvulsants|mesh-ancestor
110244668|NCT00114686|GABA Agents|gaba agents|mesh-ancestor
110244669|NCT00114686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110244670|NCT05553678|Midazolam|midazolam|mesh-list
110244671|NCT05553678|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110244672|NCT05553678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110244673|NCT05553678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110244674|NCT05553678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244675|NCT05553678|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110244676|NCT05553678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110244677|NCT05553678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110244678|NCT05553678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110244679|NCT05553678|Anesthetics, General|anesthetics, general|mesh-ancestor
110244680|NCT05553678|Anesthetics|anesthetics|mesh-ancestor
110244681|NCT05553678|GABA Modulators|gaba modulators|mesh-ancestor
110244682|NCT05553678|GABA Agents|gaba agents|mesh-ancestor
110244683|NCT05553678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110244684|NCT05553678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110244685|NCT00448552|Capecitabine|capecitabine|mesh-list
110244686|NCT00448552|Oxaliplatin|oxaliplatin|mesh-list
110244687|NCT00448552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110244688|NCT00448552|Antimetabolites|antimetabolites|mesh-ancestor
110244689|NCT00448552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110244690|NCT00448552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110244691|NCT03276520|Ethanol|ethanol|mesh-list
110244692|NCT03276520|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110244693|NCT03276520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110244694|NCT03276520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110244695|NCT03276520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244696|NCT00114764|Lenograstim|lenograstim|mesh-list
110244697|NCT00114764|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110244698|NCT00114764|Immunologic Factors|immunologic factors|mesh-ancestor
110244699|NCT00114764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244700|NCT00448786|Niacinamide|niacinamide|mesh-list
110244701|NCT00448786|Motesanib diphosphate|motesanib diphosphate|mesh-list
110244703|NCT00448786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110244704|NCT00448786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110244705|NCT00448786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110244706|NCT00448786|Vitamin B Complex|vitamin b complex|mesh-ancestor
110244707|NCT00448786|Vitamins|vitamins|mesh-ancestor
110244708|NCT00448786|Micronutrients|micronutrients|mesh-ancestor
110244709|NCT00448786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244711|NCT00114803|Salmon calcitonin|salmon calcitonin|mesh-list
110244712|NCT00114803|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
110244713|NCT00114803|Katacalcin|katacalcin|mesh-list
110244714|NCT00114803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110244715|NCT00114803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244716|NCT00114803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110244717|NCT00114803|Vasodilator Agents|vasodilator agents|mesh-ancestor
110244718|NCT00448825|Topiramate|topiramate|mesh-list
110244719|NCT00448825|Anticonvulsants|anticonvulsants|mesh-ancestor
110244720|NCT00448825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110244721|NCT00448825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244722|NCT00448903|Bemiparin|bemiparin|mesh-list
110244723|NCT00448903|Anticoagulants|anticoagulants|mesh-ancestor
110244724|NCT00448942|Chlorhexidine|chlorhexidine|mesh-list
110244725|NCT00448942|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110244726|NCT00448942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110244727|NCT00448942|Disinfectants|disinfectants|mesh-ancestor
110244728|NCT00402012|Pioglitazone|pioglitazone|mesh-list
110244729|NCT00402012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110244730|NCT00402012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244731|NCT00448981|Hand Sanitizers|hand sanitizers|mesh-list
110244732|NCT00448981|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110244733|NCT00448981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110244734|NCT00448981|Disinfectants|disinfectants|mesh-ancestor
110244735|NCT03276325|Dexamethasone|dexamethasone|mesh-list
110244736|NCT03276325|Nalbuphine|nalbuphine|mesh-list
110244737|NCT03276325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110244738|NCT03276325|Antiemetics|antiemetics|mesh-ancestor
110244739|NCT03276325|Autonomic Agents|autonomic agents|mesh-ancestor
110244740|NCT03276325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110244741|NCT03276325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244742|NCT03276325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110244743|NCT03276325|Glucocorticoids|glucocorticoids|mesh-ancestor
110244744|NCT03276325|Hormones|hormones|mesh-ancestor
110244745|NCT03276325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110244746|NCT03276325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110244747|NCT03276325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110244748|NCT03276325|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110244749|NCT03276325|Narcotics|narcotics|mesh-ancestor
110244750|NCT03276325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110244751|NCT03276325|Analgesics|analgesics|mesh-ancestor
110244752|NCT03276325|Sensory System Agents|sensory system agents|mesh-ancestor
110244753|NCT00449020|Carboplatin|carboplatin|mesh-list
110244754|NCT00449020|Docetaxel|docetaxel|mesh-list
110244755|NCT00449020|Irinotecan|irinotecan|mesh-list
110244756|NCT00449020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110244757|NCT00449020|Tubulin Modulators|tubulin modulators|mesh-ancestor
110244758|NCT00449020|Antimitotic Agents|antimitotic agents|mesh-ancestor
110244759|NCT00449020|Mitosis Modulators|mitosis modulators|mesh-ancestor
110244760|NCT00449020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110244761|NCT00449020|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110244762|NCT00449020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110244763|NCT00449020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110244764|NCT00115752|Valdecoxib|valdecoxib|mesh-list
110244765|NCT00115752|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
110244766|NCT00115752|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110244767|NCT00115752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110244768|NCT00115752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110244769|NCT00115752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110244771|NCT00115752|Analgesics|analgesics|mesh-ancestor
110244772|NCT00115752|Sensory System Agents|sensory system agents|mesh-ancestor
110244773|NCT00115752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110244774|NCT00115752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244775|NCT00115752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110244776|NCT00115752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110244777|NCT00449059|Nitroglycerin|nitroglycerin|mesh-list
110244778|NCT00449059|Vasodilator Agents|vasodilator agents|mesh-ancestor
110244779|NCT00449137|Leucovorin|leucovorin|mesh-list
110244780|NCT00449137|Fluorouracil|fluorouracil|mesh-list
110244781|NCT00449137|Arsenic Trioxide|arsenic trioxide|mesh-list
110244782|NCT00449137|Calcium|calcium|mesh-list
110244783|NCT00449137|Levoleucovorin|levoleucovorin|mesh-list
110244784|NCT00449137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110244785|NCT00449137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244787|NCT00449137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110244788|NCT00449137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110244789|NCT00449137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110244790|NCT00449137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110244791|NCT00449137|Immunologic Factors|immunologic factors|mesh-ancestor
110244792|NCT00449137|Antidotes|antidotes|mesh-ancestor
110244793|NCT00449137|Protective Agents|protective agents|mesh-ancestor
110244794|NCT00449137|Vitamin B Complex|vitamin b complex|mesh-ancestor
110244795|NCT00449137|Vitamins|vitamins|mesh-ancestor
110244796|NCT00449137|Micronutrients|micronutrients|mesh-ancestor
110244797|NCT00449254|Oleoyl-estrone|oleoyl-estrone|mesh-list
110244798|NCT00449254|Estrone|estrone|mesh-list
110244799|NCT00449254|Estrogens|estrogens|mesh-ancestor
110244800|NCT00449254|Hormones|hormones|mesh-ancestor
110244801|NCT00449254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110244802|NCT00449254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244803|NCT00449254|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110244804|NCT00449410|Atorvastatin|atorvastatin|mesh-list
110244805|NCT00449410|Ezetimibe|ezetimibe|mesh-list
110244806|NCT00449410|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110244807|NCT00449410|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110244808|NCT00449410|Antimetabolites|antimetabolites|mesh-ancestor
110244809|NCT00449410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110244810|NCT00449410|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110244811|NCT00449410|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110244812|NCT00449410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110244813|NCT00449449|Lidocaine|lidocaine|mesh-list
110244814|NCT00449449|Anesthetics, Local|anesthetics, local|mesh-ancestor
110244815|NCT00449449|Anesthetics|anesthetics|mesh-ancestor
110244816|NCT00449449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110244817|NCT00449449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244818|NCT00449449|Sensory System Agents|sensory system agents|mesh-ancestor
110244819|NCT00449449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110244820|NCT00449449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110244821|NCT00449449|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110244822|NCT00449449|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110244823|NCT00449449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110244824|NCT00449449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110244825|NCT00115115|Dopamine|dopamine|mesh-list
110244826|NCT00115115|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110244827|NCT00115115|Sympathomimetics|sympathomimetics|mesh-ancestor
110244828|NCT00115115|Autonomic Agents|autonomic agents|mesh-ancestor
110244829|NCT00115115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110244830|NCT00115115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244831|NCT00115115|Dopamine Agents|dopamine agents|mesh-ancestor
110244832|NCT00115115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110244833|NCT00115115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110244834|NCT00115115|Protective Agents|protective agents|mesh-ancestor
110244835|NCT00449488|Epoetin Alfa|epoetin alfa|mesh-list
110244836|NCT00449488|Hematinics|hematinics|mesh-ancestor
110244837|NCT00115830|Atorvastatin|atorvastatin|mesh-list
110244838|NCT00115830|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110244839|NCT00115830|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110244840|NCT00115830|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110244841|NCT00115830|Antimetabolites|antimetabolites|mesh-ancestor
110244842|NCT00115830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110244843|NCT00115830|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110244844|NCT00115830|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110244845|NCT00115830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110244846|NCT00115154|Imiquimod|imiquimod|mesh-list
110244847|NCT00115154|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110244848|NCT00115154|Immunologic Factors|immunologic factors|mesh-ancestor
110244849|NCT00115154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244850|NCT00115154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110244851|NCT00115154|Interferon Inducers|interferon inducers|mesh-ancestor
110244852|NCT00449527|Budesonide|budesonide|mesh-list
110244853|NCT00449527|Formoterol Fumarate|formoterol fumarate|mesh-list
110244854|NCT00449527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110244855|NCT00449527|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110244856|NCT00449527|Autonomic Agents|autonomic agents|mesh-ancestor
110244857|NCT00449527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110244858|NCT00449527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244859|NCT00449527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110244860|NCT00449527|Respiratory System Agents|respiratory system agents|mesh-ancestor
110244861|NCT00449527|Glucocorticoids|glucocorticoids|mesh-ancestor
110244862|NCT00449527|Hormones|hormones|mesh-ancestor
110244863|NCT00449527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110244864|NCT00449527|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110244865|NCT00449527|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110244867|NCT00449527|Adrenergic Agents|adrenergic agents|mesh-ancestor
110244868|NCT00449527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110244869|NCT00449527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110244870|NCT00449683|Terazosin|terazosin|mesh-list
110244871|NCT00449683|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110244872|NCT00449683|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110244873|NCT00449683|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110244874|NCT00449683|Adrenergic Agents|adrenergic agents|mesh-ancestor
110244875|NCT00449683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110244876|NCT00449683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110244877|NCT00449683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244878|NCT00449683|Urological Agents|urological agents|mesh-ancestor
110244879|NCT00449722|Mesalamine|mesalamine|mesh-list
110244880|NCT00449722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110244881|NCT00449722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110244882|NCT00449722|Analgesics|analgesics|mesh-ancestor
110244883|NCT00449722|Sensory System Agents|sensory system agents|mesh-ancestor
110244884|NCT00449722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110244885|NCT00449722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244886|NCT00449722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110244888|NCT00449800|Ceftriaxone|ceftriaxone|mesh-list
110244889|NCT00449800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110244890|NCT00449800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110244891|NCT00449839|Insulin|insulin|mesh-list
110244892|NCT00449839|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110244893|NCT00449839|Insulin Aspart|insulin aspart|mesh-list
110244894|NCT00449839|Insulin, Long-Acting|insulin, long-acting|mesh-list
110244895|NCT00449839|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110244896|NCT00449839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110244897|NCT00449839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244898|NCT00450229|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
110244899|NCT00450229|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110244900|NCT00450229|Protective Agents|protective agents|mesh-ancestor
110244901|NCT00450229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244902|NCT00450229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110244903|NCT04699279|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110244904|NCT04699279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110244905|NCT04699279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110244906|NCT04699279|Antimetabolites|antimetabolites|mesh-ancestor
110244907|NCT04699279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110244908|NCT04699279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110244909|NCT04699279|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110244910|NCT04699279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110244911|NCT00450307|Antibodies|antibodies|mesh-list
110244912|NCT00450307|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110244913|NCT00450307|Sargramostim|sargramostim|mesh-list
110244914|NCT00450307|Immunologic Factors|immunologic factors|mesh-ancestor
110244915|NCT00450307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244916|NCT03276013|Pembrolizumab|pembrolizumab|mesh-list
110244917|NCT03276013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110244918|NCT03276013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110244919|NCT03276013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110244920|NCT03276013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110244922|NCT00450736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110244923|NCT00450736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110244924|NCT00450736|Analgesics|analgesics|mesh-ancestor
110244925|NCT00450736|Sensory System Agents|sensory system agents|mesh-ancestor
110244926|NCT00450736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110244927|NCT00450736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244928|NCT00450736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110244929|NCT00450736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110244930|NCT00450736|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110244931|NCT00450736|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110244932|NCT00450736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110244933|NCT00450736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110244935|NCT05536362|Ketamine|ketamine|mesh-list
110244936|NCT05536362|Propofol|propofol|mesh-list
110244937|NCT05536362|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110244938|NCT05536362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110244939|NCT05536362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244940|NCT05536362|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110244941|NCT05536362|Anesthetics, General|anesthetics, general|mesh-ancestor
110244942|NCT05536362|Anesthetics|anesthetics|mesh-ancestor
110244943|NCT05536362|Analgesics|analgesics|mesh-ancestor
110244944|NCT05536362|Sensory System Agents|sensory system agents|mesh-ancestor
110244945|NCT05536362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110244946|NCT05536362|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110244947|NCT05536362|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110244948|NCT05536362|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110244949|NCT05536362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110244950|NCT05536362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110244951|NCT05536362|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110244952|NCT05536362|Sympatholytics|sympatholytics|mesh-ancestor
110244953|NCT05536362|Autonomic Agents|autonomic agents|mesh-ancestor
110244954|NCT05536362|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110244955|NCT05536362|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110244956|NCT05536362|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110244957|NCT05536362|Adrenergic Agents|adrenergic agents|mesh-ancestor
110244958|NCT00450853|Granisetron|granisetron|mesh-list
110244959|NCT00450853|Antiemetics|antiemetics|mesh-ancestor
110244960|NCT00450853|Autonomic Agents|autonomic agents|mesh-ancestor
110244961|NCT00450853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110244962|NCT00450853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244963|NCT00450853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110244964|NCT00450853|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110244965|NCT00450853|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110244966|NCT00450853|Serotonin Agents|serotonin agents|mesh-ancestor
110244967|NCT00450853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110244968|NCT00450853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110244969|NCT00450892|Docetaxel|docetaxel|mesh-list
110244970|NCT00450892|Trastuzumab|trastuzumab|mesh-list
110244971|NCT00450892|Lapatinib|lapatinib|mesh-list
110244972|NCT00450892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110244973|NCT00450892|Tubulin Modulators|tubulin modulators|mesh-ancestor
110244974|NCT00450892|Antimitotic Agents|antimitotic agents|mesh-ancestor
110244975|NCT00450892|Mitosis Modulators|mitosis modulators|mesh-ancestor
110244976|NCT00450892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110244977|NCT00450892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110244978|NCT00450892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110244979|NCT00450892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110244980|NCT00115310|Capsaicin|capsaicin|mesh-list
110244981|NCT00115310|Antipruritics|antipruritics|mesh-ancestor
110244982|NCT00115310|Dermatologic Agents|dermatologic agents|mesh-ancestor
110244983|NCT00115310|Sensory System Agents|sensory system agents|mesh-ancestor
110244984|NCT00115310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110244985|NCT00115310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244986|NCT00115908|Ribavirin|ribavirin|mesh-list
110244987|NCT00115908|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110244988|NCT00115908|Antimetabolites|antimetabolites|mesh-ancestor
110244989|NCT00115908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110244990|NCT00115908|Antiviral Agents|antiviral agents|mesh-ancestor
110244991|NCT00115908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110244993|NCT00458185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110244994|NCT00458185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110244995|NCT00458185|Analgesics|analgesics|mesh-ancestor
110244996|NCT00458185|Sensory System Agents|sensory system agents|mesh-ancestor
110244997|NCT00458185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110244998|NCT00458185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110244999|NCT00458185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110245000|NCT00458185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110245001|NCT00458185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110245002|NCT00458185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110245003|NCT00458185|Immunologic Factors|immunologic factors|mesh-ancestor
110245004|NCT00458263|Hormones|hormones|mesh-list
110245005|NCT00458263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110245006|NCT00458263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110245007|NCT00458419|Naloxone|naloxone|mesh-list
110245008|NCT00458419|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110245009|NCT00458419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110245010|NCT00458419|Sensory System Agents|sensory system agents|mesh-ancestor
110245011|NCT00458419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110245012|NCT00458458|Leuprolide|leuprolide|mesh-list
110245013|NCT00458458|Norethindrone|norethindrone|mesh-list
110245014|NCT00458458|Norethindrone Acetate|norethindrone acetate|mesh-list
110245015|NCT00458458|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110245016|NCT00458458|Fertility Agents|fertility agents|mesh-ancestor
110245017|NCT00458458|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110245018|NCT00458458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110245019|NCT00458458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110245020|NCT00458458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110245021|NCT00458458|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110245023|NCT00458458|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110245024|NCT00458458|Contraceptive Agents|contraceptive agents|mesh-ancestor
110245025|NCT00458458|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110245026|NCT00458458|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110245027|NCT00458614|Lansoprazole|lansoprazole|mesh-list
110245028|NCT00458614|Dexlansoprazole|dexlansoprazole|mesh-list
110245029|NCT00458614|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110245030|NCT00458614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110245031|NCT00458614|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110245032|NCT00458614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110245033|NCT00458614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110245034|NCT00458731|Bevacizumab|bevacizumab|mesh-list
110245035|NCT00458731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110245036|NCT00458731|Cediranib|cediranib|mesh-list
110245037|NCT00458731|Antibodies|antibodies|mesh-list
110245038|NCT00458731|Immunoglobulins|immunoglobulins|mesh-list
110245039|NCT00458731|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110245040|NCT00458731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110245041|NCT00458731|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110245042|NCT00458731|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110245043|NCT00458731|Growth Substances|growth substances|mesh-ancestor
110245044|NCT00458731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110245045|NCT00458731|Growth Inhibitors|growth inhibitors|mesh-ancestor
110245046|NCT00458731|Immunologic Factors|immunologic factors|mesh-ancestor
110245047|NCT00458731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110245048|NCT00458731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110245049|NCT00458731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110245050|NCT03274024|Mitomycins|mitomycins|mesh-list
110245051|NCT03274024|Mitomycin|mitomycin|mesh-list
110245052|NCT03274024|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110245053|NCT03274024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110245054|NCT03274024|Alkylating Agents|alkylating agents|mesh-ancestor
110268377|NCT00549289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110245055|NCT03274024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110245056|NCT03274024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110245059|NCT00115947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110245060|NCT00115947|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110245061|NCT00458809|Oxaliplatin|oxaliplatin|mesh-list
110245062|NCT00458809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110245063|NCT00115544|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
110245064|NCT00115544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110245065|NCT00115544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110245066|NCT00459004|Rimonabant|rimonabant|mesh-list
110245067|NCT00459004|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110245068|NCT00459004|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
110245069|NCT00459004|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110245070|NCT00459004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110245071|NCT00459004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110245072|NCT00459004|Hormones|hormones|mesh-ancestor
110245073|NCT00459004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110245074|NCT00459004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110245075|NCT00459160|Antihypertensive Agents|antihypertensive agents|mesh-list
110245076|NCT00115583|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
110245077|NCT00115583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110245078|NCT00115583|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110245079|NCT00115583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110245080|NCT00115622|Fluticasone|fluticasone|mesh-list
110245081|NCT00115622|Xhance|xhance|mesh-list
110245082|NCT00115622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110245083|NCT00115622|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110245084|NCT00115622|Autonomic Agents|autonomic agents|mesh-ancestor
110245085|NCT00115622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110245086|NCT00115622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110245087|NCT00115622|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110245088|NCT00115622|Respiratory System Agents|respiratory system agents|mesh-ancestor
110245089|NCT00115622|Dermatologic Agents|dermatologic agents|mesh-ancestor
110245090|NCT00115622|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110245091|NCT00459511|Hydrocortisone|hydrocortisone|mesh-list
110245092|NCT00459511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110245093|NCT00115661|Rosiglitazone|rosiglitazone|mesh-list
110245094|NCT00115661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110245095|NCT00115661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110245096|NCT04728321|Lenvatinib|lenvatinib|mesh-list
110245097|NCT04728321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110245098|NCT04728321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110245099|NCT04728321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110245100|NCT04728321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110245101|NCT00459901|Capecitabine|capecitabine|mesh-list
110245102|NCT00459901|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110245103|NCT00459901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110245104|NCT00459901|Antimetabolites|antimetabolites|mesh-ancestor
110245105|NCT00459901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110245106|NCT00459901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110245107|NCT00459901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110245108|NCT00459901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110245109|NCT00401804|Dexamethasone|dexamethasone|mesh-list
110245110|NCT00401804|Doxorubicin|doxorubicin|mesh-list
110245111|NCT00401804|Bortezomib|bortezomib|mesh-list
110245112|NCT00401804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110245113|NCT00401804|Antiemetics|antiemetics|mesh-ancestor
110245114|NCT00401804|Autonomic Agents|autonomic agents|mesh-ancestor
110245115|NCT00401804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110245116|NCT00401804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110245117|NCT00401804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110245118|NCT00401804|Glucocorticoids|glucocorticoids|mesh-ancestor
110245119|NCT00401804|Hormones|hormones|mesh-ancestor
110245120|NCT00401804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110245121|NCT00401804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110245122|NCT00401804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110245123|NCT00401804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110245124|NCT00401804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110245126|NCT00401804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110245127|NCT00401804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110245128|NCT00459940|Pioglitazone|pioglitazone|mesh-list
110245129|NCT00459940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110245130|NCT00459940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110245131|NCT00460057|Alendronate|alendronate|mesh-list
110245132|NCT00460057|Diphosphonates|diphosphonates|mesh-list
110245133|NCT00460057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110245134|NCT00460057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110245135|NCT00401921|Minocycline|minocycline|mesh-list
110245136|NCT00401921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110245137|NCT00401921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110245138|NCT00460174|Bevacizumab|bevacizumab|mesh-list
110245139|NCT00460174|Gemcitabine|gemcitabine|mesh-list
110245140|NCT00460174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110245141|NCT00460174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110245142|NCT00460174|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110245143|NCT00460174|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110245144|NCT00460174|Growth Substances|growth substances|mesh-ancestor
110245145|NCT00460174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110245146|NCT00460174|Growth Inhibitors|growth inhibitors|mesh-ancestor
110245147|NCT00460174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110245148|NCT00460174|Antimetabolites|antimetabolites|mesh-ancestor
110245149|NCT00460174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110245151|NCT00460213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110245152|NCT00460213|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110245153|NCT00460213|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110245154|NCT00460213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110245156|NCT00460252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110245157|NCT00460252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110245158|NCT00115817|Atorvastatin|atorvastatin|mesh-list
110245159|NCT00115817|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110245160|NCT00115817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110245161|NCT00115817|Antimetabolites|antimetabolites|mesh-ancestor
110245162|NCT00115817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110245163|NCT00115817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110245164|NCT00115817|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110245165|NCT00115817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110245166|NCT00460369|Artesunate|artesunate|mesh-list
110245167|NCT00460369|Lumefantrine|lumefantrine|mesh-list
110245168|NCT00460369|Artemether|artemether|mesh-list
110245169|NCT00460369|Pyrimethamine|pyrimethamine|mesh-list
110245170|NCT00460369|Sulfadoxine|sulfadoxine|mesh-list
110245171|NCT00460369|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110245172|NCT00460369|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110245173|NCT00460369|Amodiaquine|amodiaquine|mesh-list
110245174|NCT00460369|Antimalarials|antimalarials|mesh-ancestor
110245175|NCT00460369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110245176|NCT00460369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110245177|NCT00460369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110245178|NCT00460369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110245179|NCT00460369|Antiviral Agents|antiviral agents|mesh-ancestor
110245180|NCT00460369|Schistosomicides|schistosomicides|mesh-ancestor
110245181|NCT00460369|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110245182|NCT00460369|Anthelmintics|anthelmintics|mesh-ancestor
110245183|NCT00460369|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110245184|NCT00460369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110245185|NCT00460369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110245186|NCT00460369|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110245187|NCT00460447|Gemtuzumab|gemtuzumab|mesh-list
110245188|NCT00460447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110245189|NCT00460447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110245190|NCT00460447|Immunotoxins|immunotoxins|mesh-ancestor
110245191|NCT00460447|Immunoconjugates|immunoconjugates|mesh-ancestor
110245192|NCT00460447|Immunologic Factors|immunologic factors|mesh-ancestor
110245193|NCT00460447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110245194|NCT00460642|Cetrorelix|cetrorelix|mesh-list
110245195|NCT00460642|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110245196|NCT00460642|Fertility Agents|fertility agents|mesh-ancestor
110245197|NCT00460642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110245198|NCT00460642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110245199|NCT00460642|Hormone Antagonists|hormone antagonists|mesh-ancestor
110245200|NCT00460642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110245201|NCT00460681|Thymopentin|thymopentin|mesh-list
110245202|NCT00460681|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110245203|NCT00460681|Immunologic Factors|immunologic factors|mesh-ancestor
110245204|NCT00460681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110245205|NCT00460759|Moxifloxacin|moxifloxacin|mesh-list
110245206|NCT00460759|Rifapentine|rifapentine|mesh-list
110245207|NCT00460759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110245208|NCT00460759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110245209|NCT00460759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110245210|NCT00460759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110245211|NCT00460759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110245212|NCT00460759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110245213|NCT00460759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110245214|NCT00460759|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110245215|NCT00460759|Antitubercular Agents|antitubercular agents|mesh-ancestor
110245216|NCT00460759|Leprostatic Agents|leprostatic agents|mesh-ancestor
110245217|NCT00460837|Picosulfate sodium|picosulfate sodium|mesh-list
110245218|NCT00460837|Cathartics|cathartics|mesh-ancestor
110245219|NCT00460837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110245220|NCT00460876|Topotecan|topotecan|mesh-list
110245221|NCT00460876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110245222|NCT00460876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110245223|NCT00460876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110245224|NCT00460876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110245225|NCT00460876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110245226|NCT00460915|Amlodipine|amlodipine|mesh-list
110245227|NCT00460915|Lacidipine|lacidipine|mesh-list
110245228|NCT00460915|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110245229|NCT00460915|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110245230|NCT00460915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110245231|NCT00460915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110245232|NCT00460915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110245233|NCT00460915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110245234|NCT00460915|Vasodilator Agents|vasodilator agents|mesh-ancestor
110245235|NCT00460954|Levodopa|levodopa|mesh-list
110245236|NCT00460954|Carbidopa|carbidopa|mesh-list
110245237|NCT00460954|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110245238|NCT00460954|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110245239|NCT00460954|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110245240|NCT00460954|Dopamine Agents|dopamine agents|mesh-ancestor
110245241|NCT00460954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110245242|NCT00460954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110245243|NCT00460954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110245244|NCT00460954|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110245245|NCT00460954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110245246|NCT00460954|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110245247|NCT00460954|Immunologic Factors|immunologic factors|mesh-ancestor
110245248|NCT00460954|Dopamine Agonists|dopamine agonists|mesh-ancestor
110245250|NCT00461149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110245251|NCT00461149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110245252|NCT00461149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110245253|NCT00115973|Insulin Aspart|insulin aspart|mesh-list
110245254|NCT00115973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110245255|NCT00115973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110268405|NCT00184977|Antidotes|antidotes|mesh-ancestor
110245256|NCT00461266|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110245258|NCT00461266|Antiviral Agents|antiviral agents|mesh-ancestor
110245259|NCT00461266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110245260|NCT00461266|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110245261|NCT00461266|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110245262|NCT00461266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110245263|NCT00461266|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110245264|NCT00461344|Docetaxel|docetaxel|mesh-list
110245265|NCT00461344|Doxorubicin|doxorubicin|mesh-list
110245266|NCT00461344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110245267|NCT00461344|Tubulin Modulators|tubulin modulators|mesh-ancestor
110245268|NCT00461344|Antimitotic Agents|antimitotic agents|mesh-ancestor
110245269|NCT00461344|Mitosis Modulators|mitosis modulators|mesh-ancestor
110245270|NCT00461344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110245271|NCT00461344|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110245272|NCT00461344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110245273|NCT00461344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110245274|NCT00461344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110245275|NCT03273634|Lansoprazole|lansoprazole|mesh-list
110245276|NCT03273634|Dexlansoprazole|dexlansoprazole|mesh-list
110245277|NCT03273634|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110245278|NCT03273634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110245279|NCT03273634|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110245280|NCT03273634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110245281|NCT03273634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110245283|NCT03273595|Cyclophosphamide|cyclophosphamide|mesh-list
110245284|NCT03273595|Trastuzumab|trastuzumab|mesh-list
110245285|NCT03273595|Epirubicin|epirubicin|mesh-list
110245286|NCT03273595|Lapatinib|lapatinib|mesh-list
110245287|NCT03273595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110245288|NCT03273595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110245289|NCT03273595|Tubulin Modulators|tubulin modulators|mesh-ancestor
110245290|NCT03273595|Antimitotic Agents|antimitotic agents|mesh-ancestor
110245291|NCT03273595|Mitosis Modulators|mitosis modulators|mesh-ancestor
110245292|NCT03273595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110245293|NCT03273595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110245294|NCT03273595|Immunologic Factors|immunologic factors|mesh-ancestor
110245295|NCT03273595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110245296|NCT03273595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110245297|NCT03273595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110245298|NCT03273595|Alkylating Agents|alkylating agents|mesh-ancestor
110245299|NCT03273595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110245300|NCT03273595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110245301|NCT03273595|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110245302|NCT03273595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110245303|NCT03273595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110245304|NCT03273595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110245305|NCT03273595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110245306|NCT03273556|Lidocaine|lidocaine|mesh-list
110245307|NCT03273556|Anesthetics, Local|anesthetics, local|mesh-ancestor
110245308|NCT03273556|Anesthetics|anesthetics|mesh-ancestor
110245309|NCT03273556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110245310|NCT03273556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110245311|NCT03273556|Sensory System Agents|sensory system agents|mesh-ancestor
110245312|NCT03273556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110245313|NCT03273556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110245314|NCT03273556|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110245315|NCT03273556|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110245316|NCT03273556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110245317|NCT03273556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110245318|NCT04728308|Bupivacaine|bupivacaine|mesh-list
110245319|NCT04728308|Anesthetics, Local|anesthetics, local|mesh-ancestor
110245320|NCT04728308|Anesthetics|anesthetics|mesh-ancestor
110245321|NCT04728308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110245322|NCT04728308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110245323|NCT04728308|Sensory System Agents|sensory system agents|mesh-ancestor
110245324|NCT04728308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110245325|NCT00461422|Ganirelix|ganirelix|mesh-list
110245326|NCT00461422|Hormone Antagonists|hormone antagonists|mesh-ancestor
110245327|NCT00461422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110245328|NCT00461422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110245329|NCT04697992|Vitamins|vitamins|mesh-list
110245330|NCT04697992|Ascorbic Acid|ascorbic acid|mesh-list
110245331|NCT04697992|Tranexamic Acid|tranexamic acid|mesh-list
110245332|NCT04697992|Micronutrients|micronutrients|mesh-ancestor
110245333|NCT04697992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110245334|NCT04697992|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110245335|NCT04697992|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110245336|NCT04697992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110245337|NCT04697992|Hemostatics|hemostatics|mesh-ancestor
110245338|NCT04697992|Coagulants|coagulants|mesh-ancestor
110245339|NCT04697992|Antioxidants|antioxidants|mesh-ancestor
110245340|NCT04697992|Protective Agents|protective agents|mesh-ancestor
110245341|NCT05483634|Estrogens|estrogens|mesh-list
110245342|NCT05483634|Hormones|hormones|mesh-ancestor
110245343|NCT05483634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110245344|NCT05483634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110245345|NCT00461578|Artesunate|artesunate|mesh-list
110245346|NCT00461578|Dapsone|dapsone|mesh-list
110245347|NCT00461578|Chlorproguanil|chlorproguanil|mesh-list
110245348|NCT00461578|Antimalarials|antimalarials|mesh-ancestor
110245349|NCT00461578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110245350|NCT00461578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110245351|NCT00461578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110245352|NCT00461578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110245353|NCT00461578|Antiviral Agents|antiviral agents|mesh-ancestor
110245354|NCT00461578|Schistosomicides|schistosomicides|mesh-ancestor
110245355|NCT00461578|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110245356|NCT00461578|Anthelmintics|anthelmintics|mesh-ancestor
110245357|NCT00461578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110245358|NCT00461578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110245359|NCT00461578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110245360|NCT00461578|Leprostatic Agents|leprostatic agents|mesh-ancestor
110245361|NCT00461578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110245362|NCT00461617|Mitiglinide|mitiglinide|mesh-list
110245363|NCT00461617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110245364|NCT00461617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110245366|NCT00116064|Paraldehyde|paraldehyde|mesh-list
110245367|NCT00116064|Anticonvulsants|anticonvulsants|mesh-ancestor
110245368|NCT00116064|Antiemetics|antiemetics|mesh-ancestor
110245369|NCT00116064|Autonomic Agents|autonomic agents|mesh-ancestor
110245370|NCT00116064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110245371|NCT00116064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110245372|NCT00116064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110245373|NCT00116064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110245374|NCT00116064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110245375|NCT00116064|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110245376|NCT00116064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110245377|NCT00116064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110245378|NCT00116064|GABA Modulators|gaba modulators|mesh-ancestor
110245379|NCT00116064|GABA Agents|gaba agents|mesh-ancestor
110245380|NCT00116064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110245381|NCT00116064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110245382|NCT04728035|Irinotecan|irinotecan|mesh-list
110245383|NCT04728035|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110245384|NCT04728035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110245385|NCT04728035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110245386|NCT04728035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110245387|NCT04728035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110245388|NCT00461890|Naltrexone|naltrexone|mesh-list
110245389|NCT00461890|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110245390|NCT00461890|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110245391|NCT00461890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110245392|NCT00461890|Sensory System Agents|sensory system agents|mesh-ancestor
110245393|NCT00461890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110245394|NCT00461968|Simvastatin|simvastatin|mesh-list
110245395|NCT00461968|Ezetimibe|ezetimibe|mesh-list
110245396|NCT00461968|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110245397|NCT00461968|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110245398|NCT00461968|Antimetabolites|antimetabolites|mesh-ancestor
110245399|NCT00461968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110245400|NCT00461968|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110245401|NCT00461968|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110245402|NCT00461968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110245403|NCT00116103|Tacrolimus|tacrolimus|mesh-list
110245404|NCT00116103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110245405|NCT00116103|Immunologic Factors|immunologic factors|mesh-ancestor
110245406|NCT00116103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110245407|NCT00116103|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110245408|NCT00116103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110245409|NCT00116103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110245410|NCT02956252|Anesthetics|anesthetics|mesh-list
110245411|NCT02956252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110245412|NCT02956252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110245413|NCT00462358|Filanesib|filanesib|mesh-list
110245414|NCT00462358|Lenograstim|lenograstim|mesh-list
110245415|NCT00462358|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110245416|NCT00462358|Immunologic Factors|immunologic factors|mesh-ancestor
110245417|NCT00462358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110245418|NCT00462358|Antimitotic Agents|antimitotic agents|mesh-ancestor
110245419|NCT00462358|Mitosis Modulators|mitosis modulators|mesh-ancestor
110245420|NCT00462358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110245421|NCT00462358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110245422|NCT00116181|Etanercept|etanercept|mesh-list
110245423|NCT00116181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110245424|NCT00116181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110245425|NCT00116181|Analgesics|analgesics|mesh-ancestor
110245426|NCT00116181|Sensory System Agents|sensory system agents|mesh-ancestor
110245427|NCT00116181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110245428|NCT00116181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110245429|NCT00116181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110245430|NCT00116181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110245431|NCT00116181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110245432|NCT00116181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110245433|NCT00116181|Immunologic Factors|immunologic factors|mesh-ancestor
110245434|NCT00462397|Paclitaxel|paclitaxel|mesh-list
110245435|NCT00462397|Carboplatin|carboplatin|mesh-list
110245436|NCT00462397|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110245437|NCT00462397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110245438|NCT00462397|Tubulin Modulators|tubulin modulators|mesh-ancestor
110245439|NCT00462397|Antimitotic Agents|antimitotic agents|mesh-ancestor
110245440|NCT00462397|Mitosis Modulators|mitosis modulators|mesh-ancestor
110245441|NCT00462397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110245442|NCT00462475|Hormones|hormones|mesh-list
110245443|NCT00462475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110245444|NCT00462475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110245446|NCT00462553|Sunitinib|sunitinib|mesh-list
110245447|NCT00462553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110245448|NCT00462553|Antimetabolites|antimetabolites|mesh-ancestor
110245449|NCT00462553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110245450|NCT00462553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110245451|NCT00462553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110245452|NCT00462553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110245453|NCT00462553|Growth Substances|growth substances|mesh-ancestor
110245454|NCT00462553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110245455|NCT00462553|Growth Inhibitors|growth inhibitors|mesh-ancestor
110245456|NCT00462553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110245457|NCT00462553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110245458|NCT00462592|Budesonide|budesonide|mesh-list
110245459|NCT00462592|Montelukast|montelukast|mesh-list
110245460|NCT00462592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110245461|NCT00462592|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110245462|NCT00462592|Autonomic Agents|autonomic agents|mesh-ancestor
110245463|NCT00462592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110245464|NCT00462592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110245465|NCT00462592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110245466|NCT00462592|Respiratory System Agents|respiratory system agents|mesh-ancestor
110245467|NCT00462592|Glucocorticoids|glucocorticoids|mesh-ancestor
110245468|NCT00462592|Hormones|hormones|mesh-ancestor
110245469|NCT00462592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110245470|NCT00462592|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110245471|NCT00462592|Hormone Antagonists|hormone antagonists|mesh-ancestor
110245472|NCT00462592|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110245473|NCT00462592|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110245474|NCT00462592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110245475|NCT00405015|Rosiglitazone|rosiglitazone|mesh-list
110245476|NCT00405015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110245477|NCT00405015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110245478|NCT00462631|Paclitaxel|paclitaxel|mesh-list
110245479|NCT00462631|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110245480|NCT00462631|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110245481|NCT00462631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110245482|NCT00462631|Tubulin Modulators|tubulin modulators|mesh-ancestor
110245483|NCT00462631|Antimitotic Agents|antimitotic agents|mesh-ancestor
110245484|NCT00462631|Mitosis Modulators|mitosis modulators|mesh-ancestor
110245485|NCT00462631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110245486|NCT00462787|Dexamethasone|dexamethasone|mesh-list
110245487|NCT00462787|Topotecan|topotecan|mesh-list
110245488|NCT00462787|Vinorelbine|vinorelbine|mesh-list
110245489|NCT00462787|Thiotepa|thiotepa|mesh-list
110245490|NCT00462787|Clofarabine|clofarabine|mesh-list
110245491|NCT00462787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110245492|NCT00462787|Antiemetics|antiemetics|mesh-ancestor
110245493|NCT00462787|Autonomic Agents|autonomic agents|mesh-ancestor
110245494|NCT00462787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110245495|NCT00462787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110245496|NCT00462787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110245497|NCT00462787|Glucocorticoids|glucocorticoids|mesh-ancestor
110245498|NCT00462787|Hormones|hormones|mesh-ancestor
110245499|NCT00462787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110245500|NCT00462787|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110245501|NCT00462787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110245502|NCT00462787|Immunologic Factors|immunologic factors|mesh-ancestor
110245503|NCT00462787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110245504|NCT00462787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110245505|NCT00462787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110268457|NCT00549874|Rosiglitazone|rosiglitazone|mesh-list
110245506|NCT00462787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110245507|NCT00462787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110245508|NCT00462787|Tubulin Modulators|tubulin modulators|mesh-ancestor
110245509|NCT00462787|Antimitotic Agents|antimitotic agents|mesh-ancestor
110245510|NCT00462787|Mitosis Modulators|mitosis modulators|mesh-ancestor
110245511|NCT00462787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110245512|NCT00462787|Alkylating Agents|alkylating agents|mesh-ancestor
110245513|NCT00462787|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110245514|NCT00462787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110245515|NCT00462787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110245517|NCT00463021|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
110245518|NCT00463021|Vitamins|vitamins|mesh-ancestor
110245519|NCT00463021|Micronutrients|micronutrients|mesh-ancestor
110245520|NCT00463021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110245521|NCT00463021|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110245522|NCT00116259|Aripiprazole|aripiprazole|mesh-list
110245523|NCT00116259|Antidepressive Agents|antidepressive agents|mesh-ancestor
110245524|NCT00116259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110245525|NCT00116259|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110245526|NCT00116259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110245527|NCT00116259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110245528|NCT00116259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110245530|NCT00116259|Dopamine Agents|dopamine agents|mesh-ancestor
110245531|NCT00116259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110245532|NCT00116259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110245533|NCT00116259|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110245534|NCT00116259|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110245535|NCT00116259|Serotonin Agents|serotonin agents|mesh-ancestor
110245536|NCT00116259|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110245537|NCT00116259|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110245538|NCT00116259|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110245539|NCT00116259|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110245540|NCT00116324|Montelukast|montelukast|mesh-list
110245541|NCT00116324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110245542|NCT00116324|Respiratory System Agents|respiratory system agents|mesh-ancestor
110245543|NCT00116324|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110245544|NCT00116324|Hormone Antagonists|hormone antagonists|mesh-ancestor
110245545|NCT00116324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110245546|NCT00116324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110245547|NCT00116324|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110245548|NCT00116324|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110245549|NCT00116324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110245550|NCT00116402|Fluticasone|fluticasone|mesh-list
110245551|NCT00116402|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110245552|NCT00116402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110245553|NCT00116402|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110245554|NCT00116402|Autonomic Agents|autonomic agents|mesh-ancestor
110245555|NCT00116402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110245556|NCT00116402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110245557|NCT00116402|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110245558|NCT00116402|Respiratory System Agents|respiratory system agents|mesh-ancestor
110245559|NCT00116402|Dermatologic Agents|dermatologic agents|mesh-ancestor
110245560|NCT00116402|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110245561|NCT00116402|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110245562|NCT00116402|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110245563|NCT00116402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110268466|NCT00161564|Rituximab|rituximab|mesh-list
110245564|NCT00116402|Adrenergic Agents|adrenergic agents|mesh-ancestor
110245565|NCT00116402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110245566|NCT00116402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110245567|NCT00463723|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110245568|NCT00463723|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110245570|NCT00463762|Cefoperazone|cefoperazone|mesh-list
110245571|NCT00463762|Sulperazone|sulperazone|mesh-list
110245572|NCT00463762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110245573|NCT00463762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110245574|NCT00463762|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110245575|NCT00463762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110245576|NCT00463762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110245577|NCT00463762|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110245578|NCT00116480|Misoprostol|misoprostol|mesh-list
110245579|NCT00116480|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110245580|NCT00116480|Abortifacient Agents|abortifacient agents|mesh-ancestor
110245581|NCT00116480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110245582|NCT00116480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110245583|NCT00116480|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110245584|NCT00116480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110245585|NCT00116480|Oxytocics|oxytocics|mesh-ancestor
110245586|NCT00463879|Galantamine|galantamine|mesh-list
110245587|NCT00463879|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110245588|NCT00463879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110245589|NCT00463879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110245590|NCT00463879|Cholinergic Agents|cholinergic agents|mesh-ancestor
110245591|NCT00463879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110245592|NCT00463879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110245593|NCT00463879|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110245594|NCT00463879|Autonomic Agents|autonomic agents|mesh-ancestor
110245595|NCT00463879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110245596|NCT00463879|Nootropic Agents|nootropic agents|mesh-ancestor
110245597|NCT00463918|Varenicline|varenicline|mesh-list
110245598|NCT00463918|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110245599|NCT00463918|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110245600|NCT00463918|Cholinergic Agents|cholinergic agents|mesh-ancestor
110245601|NCT00463918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110245602|NCT00463918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110245604|NCT00463957|Sildenafil Citrate|sildenafil citrate|mesh-list
110245606|NCT00463957|Vasodilator Agents|vasodilator agents|mesh-ancestor
110245607|NCT00463957|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110245608|NCT00463957|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110245609|NCT00463957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110245610|NCT00463957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110245611|NCT00463957|Urological Agents|urological agents|mesh-ancestor
110245612|NCT00464035|Calcium|calcium|mesh-list
110245613|NCT00464035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110245614|NCT00464035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110245615|NCT00116454|Ethiodized Oil|ethiodized oil|mesh-list
110245616|NCT00116454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110245617|NCT00464191|Escitalopram|escitalopram|mesh-list
110245618|NCT00464191|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110245619|NCT00464191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110245620|NCT00464191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110245621|NCT00464191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110245622|NCT00464191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110245623|NCT00464191|Serotonin Agents|serotonin agents|mesh-ancestor
110245624|NCT00464191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110245625|NCT00464347|Triamcinolone|triamcinolone|mesh-list
110245626|NCT00464347|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110245627|NCT00464347|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110245628|NCT00464347|Bevacizumab|bevacizumab|mesh-list
110245629|NCT00464347|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110245630|NCT00464347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110245631|NCT00464347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110245632|NCT00464347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110245633|NCT00464347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110245634|NCT00464347|Growth Substances|growth substances|mesh-ancestor
110245635|NCT00464347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110245636|NCT00464347|Growth Inhibitors|growth inhibitors|mesh-ancestor
110245637|NCT00464347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110245638|NCT00464347|Glucocorticoids|glucocorticoids|mesh-ancestor
110245639|NCT00464347|Hormones|hormones|mesh-ancestor
110245640|NCT00464347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110245641|NCT00464347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110245642|NCT00464347|Immunologic Factors|immunologic factors|mesh-ancestor
110245643|NCT00464347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110245644|NCT00464347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110245645|NCT00116493|Folic Acid|folic acid|mesh-list
110245646|NCT00116493|Mebendazole|mebendazole|mesh-list
110245647|NCT00116493|Piperazine|piperazine|mesh-list
110245648|NCT00116493|Piperazine citrate|piperazine citrate|mesh-list
110245649|NCT00116493|DMP 777|dmp 777|mesh-list
110245650|NCT00116493|Hematinics|hematinics|mesh-ancestor
110245651|NCT00116493|Vitamin B Complex|vitamin b complex|mesh-ancestor
110245652|NCT00116493|Vitamins|vitamins|mesh-ancestor
110245653|NCT00116493|Micronutrients|micronutrients|mesh-ancestor
110245654|NCT00116493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110245655|NCT00116493|Antinematodal Agents|antinematodal agents|mesh-ancestor
110245656|NCT00116493|Anthelmintics|anthelmintics|mesh-ancestor
110245657|NCT00116493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110245658|NCT00116493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110245659|NCT00116493|Tubulin Modulators|tubulin modulators|mesh-ancestor
110245660|NCT00116493|Antimitotic Agents|antimitotic agents|mesh-ancestor
110245661|NCT00116493|Mitosis Modulators|mitosis modulators|mesh-ancestor
110245662|NCT00116493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110245663|NCT00116493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110245664|NCT00116493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110245665|NCT00464503|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110245666|NCT00464503|Pravastatin|pravastatin|mesh-list
110245667|NCT00464503|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110245668|NCT00464503|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110245669|NCT00464503|Antimetabolites|antimetabolites|mesh-ancestor
110245670|NCT00464503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110245672|NCT00464503|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110245673|NCT00464503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110245674|NCT00116532|Escitalopram|escitalopram|mesh-list
110245675|NCT00116532|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110245676|NCT00116532|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110245677|NCT00116532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110245678|NCT00116532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110245679|NCT00116532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110245680|NCT00116532|Serotonin Agents|serotonin agents|mesh-ancestor
110268504|NCT00550303|Estrogens|estrogens|mesh-list
110245681|NCT00116532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110245682|NCT00464854|Insulin Aspart|insulin aspart|mesh-list
110245683|NCT00464854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110245684|NCT00464854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110245685|NCT00464893|Catumaxomab|catumaxomab|mesh-list
110245686|NCT00464893|Antibodies, Bispecific|antibodies, bispecific|mesh-list
110245687|NCT00464893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110245688|NCT00464893|Immunologic Factors|immunologic factors|mesh-ancestor
110245689|NCT00464893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110245690|NCT00464932|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
110245691|NCT00464932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110245692|NCT00464932|Vasodilator Agents|vasodilator agents|mesh-ancestor
110245693|NCT00464932|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110245694|NCT00464932|Protective Agents|protective agents|mesh-ancestor
110245695|NCT00464932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110245696|NCT00464971|Estradiol|estradiol|mesh-list
110245697|NCT00464971|Estrogens|estrogens|mesh-ancestor
110245698|NCT00464971|Hormones|hormones|mesh-ancestor
110245699|NCT00464971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110245700|NCT00464971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110245701|NCT00116870|Lovastatin|lovastatin|mesh-list
110245702|NCT00116870|L 647318|l 647318|mesh-list
110245703|NCT00116870|Dihydromevinolin|dihydromevinolin|mesh-list
110245704|NCT00116870|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110245705|NCT00116870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110245706|NCT00116870|Antimetabolites|antimetabolites|mesh-ancestor
110245707|NCT00116870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110245708|NCT00116870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110245709|NCT00116870|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110245710|NCT00116870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110245712|NCT00465205|Antiviral Agents|antiviral agents|mesh-ancestor
110245713|NCT00465205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110245714|NCT00465244|Levetiracetam|levetiracetam|mesh-list
110245715|NCT00465244|Lorazepam|lorazepam|mesh-list
110245716|NCT00465244|Anticonvulsants|anticonvulsants|mesh-ancestor
110245717|NCT00465244|Nootropic Agents|nootropic agents|mesh-ancestor
110245718|NCT00465244|Antiemetics|antiemetics|mesh-ancestor
110245719|NCT00465244|Autonomic Agents|autonomic agents|mesh-ancestor
110245720|NCT00465244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110245721|NCT00465244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110245722|NCT00465244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110245723|NCT00465244|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110245724|NCT00465244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110245725|NCT00465244|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110245726|NCT00465244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110245727|NCT00465244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110245728|NCT00465244|GABA Modulators|gaba modulators|mesh-ancestor
110245729|NCT00465244|GABA Agents|gaba agents|mesh-ancestor
110245730|NCT00465244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110245731|NCT00465244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110245732|NCT00465283|Donepezil|donepezil|mesh-list
110245733|NCT00465283|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110245734|NCT00465283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110245735|NCT00465283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110245736|NCT00465283|Cholinergic Agents|cholinergic agents|mesh-ancestor
110245737|NCT00465283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110245738|NCT00465283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110245740|NCT03272425|Allopurinol|allopurinol|mesh-list
110245741|NCT03272425|Lesinurad|lesinurad|mesh-list
110245742|NCT03272425|Antimetabolites|antimetabolites|mesh-ancestor
110245743|NCT03272425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110245744|NCT03272425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110245745|NCT03272425|Gout Suppressants|gout suppressants|mesh-ancestor
110245746|NCT03272425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110245747|NCT03272425|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110245748|NCT03272425|Antioxidants|antioxidants|mesh-ancestor
110245749|NCT03272425|Protective Agents|protective agents|mesh-ancestor
110245750|NCT03272425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110245751|NCT03272425|Uricosuric Agents|uricosuric agents|mesh-ancestor
110245752|NCT00116948|Cimetidine|cimetidine|mesh-list
110245753|NCT00116948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110245754|NCT00116948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110245755|NCT00116948|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110245756|NCT00116948|Histamine Antagonists|histamine antagonists|mesh-ancestor
110245757|NCT00116948|Histamine Agents|histamine agents|mesh-ancestor
110245758|NCT00116948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110245759|NCT00116948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110245760|NCT00116948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110245761|NCT00116948|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110245762|NCT00116948|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110245763|NCT00116948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110245764|NCT03272503|Pimozide|pimozide|mesh-list
110245765|NCT03272503|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110245766|NCT03272503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110245767|NCT03272503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110245768|NCT03272503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110245769|NCT03272503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110245770|NCT03272503|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110245771|NCT03272503|Dopamine Agents|dopamine agents|mesh-ancestor
110245772|NCT03272503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110245773|NCT03272503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110245774|NCT03272503|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110245775|NCT00465439|Lidocaine|lidocaine|mesh-list
110245776|NCT00465439|Epinephrine|epinephrine|mesh-list
110245777|NCT00465439|Racepinephrine|racepinephrine|mesh-list
110245778|NCT00465439|Epinephryl borate|epinephryl borate|mesh-list
110245779|NCT00465439|Anesthetics, Local|anesthetics, local|mesh-ancestor
110245780|NCT00465439|Anesthetics|anesthetics|mesh-ancestor
110245781|NCT00465439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110245782|NCT00465439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110245783|NCT00465439|Sensory System Agents|sensory system agents|mesh-ancestor
110245784|NCT00465439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110245785|NCT00465439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110245786|NCT00465439|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110245787|NCT00465439|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110245788|NCT00465439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110245789|NCT00465439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110245790|NCT00465439|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110245791|NCT00465439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110245792|NCT00465439|Adrenergic Agents|adrenergic agents|mesh-ancestor
110245793|NCT00465439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110245794|NCT00465439|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110245795|NCT00465439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110245796|NCT00465439|Autonomic Agents|autonomic agents|mesh-ancestor
110245797|NCT00465439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110245798|NCT00465439|Respiratory System Agents|respiratory system agents|mesh-ancestor
110245800|NCT00465439|Sympathomimetics|sympathomimetics|mesh-ancestor
110245801|NCT00465439|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110245802|NCT00116727|Etanercept|etanercept|mesh-list
110245803|NCT00116727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110245804|NCT00116727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110245805|NCT00116727|Analgesics|analgesics|mesh-ancestor
110245806|NCT00116727|Sensory System Agents|sensory system agents|mesh-ancestor
110245807|NCT00116727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110245808|NCT00116727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110245809|NCT00116727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110245810|NCT00116727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110245811|NCT00116727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110245812|NCT00116727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110245813|NCT00116727|Immunologic Factors|immunologic factors|mesh-ancestor
110245815|NCT00473551|Cyclophosphamide|cyclophosphamide|mesh-list
110245816|NCT00473551|Rituximab|rituximab|mesh-list
110245817|NCT00473551|Fludarabine|fludarabine|mesh-list
110245818|NCT00473551|Fludarabine phosphate|fludarabine phosphate|mesh-list
110245819|NCT00473551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110245820|NCT00473551|Immunologic Factors|immunologic factors|mesh-ancestor
110245821|NCT00473551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110245822|NCT00473551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110245823|NCT00473551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110245824|NCT00473551|Alkylating Agents|alkylating agents|mesh-ancestor
110245825|NCT00473551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110245826|NCT00473551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110245827|NCT00473551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110245828|NCT00473551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110245829|NCT00473551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110245830|NCT00473551|Antimetabolites|antimetabolites|mesh-ancestor
110245831|NCT00473551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110245832|NCT00473551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110245833|NCT00473551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110245834|NCT00473551|Antifungal Agents|antifungal agents|mesh-ancestor
110245835|NCT00117026|Benphothiamine|benphothiamine|mesh-list
110245836|NCT00117026|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110245837|NCT00117026|Immunologic Factors|immunologic factors|mesh-ancestor
110245838|NCT00117026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110245839|NCT00117026|Chelating Agents|chelating agents|mesh-ancestor
110245840|NCT00117026|Sequestering Agents|sequestering agents|mesh-ancestor
110245841|NCT00117026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110245842|NCT00473980|Celecoxib|celecoxib|mesh-list
110245843|NCT00473980|Indomethacin|indomethacin|mesh-list
110245844|NCT00473980|Esomeprazole|esomeprazole|mesh-list
110245845|NCT00473980|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110245846|NCT00473980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110245847|NCT00473980|Analgesics|analgesics|mesh-ancestor
110245848|NCT00473980|Sensory System Agents|sensory system agents|mesh-ancestor
110245849|NCT00473980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110245850|NCT00473980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110245851|NCT00473980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110245852|NCT00473980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110245853|NCT00473980|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110245854|NCT00473980|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110245855|NCT00473980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110245856|NCT00473980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110245857|NCT00473980|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110245858|NCT00473980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110245859|NCT00473980|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110245860|NCT00473980|Gout Suppressants|gout suppressants|mesh-ancestor
110245861|NCT00473980|Tocolytic Agents|tocolytic agents|mesh-ancestor
110245862|NCT00473980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110245864|NCT00474019|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110245865|NCT00474019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110245866|NCT00474019|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110245867|NCT00474019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110245868|NCT00474019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110245869|NCT00117065|Darbepoetin alfa|darbepoetin alfa|mesh-list
110245870|NCT00117065|Hematinics|hematinics|mesh-ancestor
110245871|NCT00474136|Diclofenac|diclofenac|mesh-list
110245872|NCT00474136|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110245873|NCT00474136|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110245874|NCT00474136|Analgesics|analgesics|mesh-ancestor
110245875|NCT00474136|Sensory System Agents|sensory system agents|mesh-ancestor
110245876|NCT00474136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110245877|NCT00474136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110245878|NCT00474136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110245879|NCT00474136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110245880|NCT00474136|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110245881|NCT00474136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110245882|NCT00474136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110245883|NCT00117104|Darbepoetin alfa|darbepoetin alfa|mesh-list
110245884|NCT00117104|Hematinics|hematinics|mesh-ancestor
110245885|NCT03270709|Vitamin D|vitamin d|mesh-list
110245886|NCT03270709|Cholecalciferol|cholecalciferol|mesh-list
110245887|NCT03270709|Vitamins|vitamins|mesh-ancestor
110245888|NCT03270709|Micronutrients|micronutrients|mesh-ancestor
110245889|NCT03270709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110245890|NCT03270709|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110245891|NCT03270709|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110245892|NCT03270553|Metformin|metformin|mesh-list
110245893|NCT03270553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110245894|NCT03270553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110245895|NCT00117182|Budesonide|budesonide|mesh-list
110245896|NCT00117182|Mannitol|mannitol|mesh-list
110245897|NCT00117182|Bromides|bromides|mesh-list
110245898|NCT00117182|Albuterol|albuterol|mesh-list
110245899|NCT00117182|Ipratropium|ipratropium|mesh-list
110245900|NCT00117182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110245901|NCT00117182|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110245902|NCT00117182|Autonomic Agents|autonomic agents|mesh-ancestor
110245903|NCT00117182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110245904|NCT00117182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110245905|NCT00117182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110245906|NCT00117182|Respiratory System Agents|respiratory system agents|mesh-ancestor
110245907|NCT00117182|Glucocorticoids|glucocorticoids|mesh-ancestor
110245908|NCT00117182|Hormones|hormones|mesh-ancestor
110245909|NCT00117182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110245910|NCT00117182|Anticonvulsants|anticonvulsants|mesh-ancestor
110245911|NCT00117182|Tocolytic Agents|tocolytic agents|mesh-ancestor
110245912|NCT00117182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110245913|NCT00117182|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110245914|NCT00117182|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110245915|NCT00117182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110245916|NCT00117182|Adrenergic Agents|adrenergic agents|mesh-ancestor
110245917|NCT00117182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110245918|NCT00117182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110245919|NCT00117182|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110245920|NCT00117182|Diuretics|diuretics|mesh-ancestor
110245921|NCT00117182|Natriuretic Agents|natriuretic agents|mesh-ancestor
110245922|NCT00117182|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110245923|NCT00117182|Cholinergic Agents|cholinergic agents|mesh-ancestor
110245924|NCT00116922|Metformin|metformin|mesh-list
110245925|NCT00116922|Rosiglitazone|rosiglitazone|mesh-list
110245926|NCT00116922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110245927|NCT00116922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110245928|NCT00116961|Dexamethasone|dexamethasone|mesh-list
110245929|NCT00116961|Bortezomib|bortezomib|mesh-list
110245930|NCT00116961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110245931|NCT00116961|Antiemetics|antiemetics|mesh-ancestor
110245932|NCT00116961|Autonomic Agents|autonomic agents|mesh-ancestor
110245933|NCT00116961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110245934|NCT00116961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110245935|NCT00116961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110245936|NCT00116961|Glucocorticoids|glucocorticoids|mesh-ancestor
110245937|NCT00116961|Hormones|hormones|mesh-ancestor
110245938|NCT00116961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110245939|NCT00116961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110245940|NCT00116961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110245941|NCT00474721|Acetaminophen|acetaminophen|mesh-list
110245942|NCT00474721|Ibuprofen|ibuprofen|mesh-list
110245943|NCT00474721|Codeine|codeine|mesh-list
110245944|NCT00474721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110245945|NCT00474721|Analgesics|analgesics|mesh-ancestor
110245946|NCT00474721|Sensory System Agents|sensory system agents|mesh-ancestor
110245947|NCT00474721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110245948|NCT00474721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110245949|NCT00474721|Antipyretics|antipyretics|mesh-ancestor
110245950|NCT00474721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110245951|NCT00474721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110245952|NCT00474721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110245953|NCT00474721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110245954|NCT00474721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110245955|NCT00474721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110245956|NCT00474721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110245957|NCT00474721|Narcotics|narcotics|mesh-ancestor
110245958|NCT00474721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110245959|NCT00474721|Antitussive Agents|antitussive agents|mesh-ancestor
110245960|NCT00474721|Respiratory System Agents|respiratory system agents|mesh-ancestor
110245961|NCT00117260|Levonorgestrel|levonorgestrel|mesh-list
110245962|NCT00117260|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110245963|NCT00117260|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
110245964|NCT00117260|Estradiol|estradiol|mesh-list
110245965|NCT00117260|Estrogens|estrogens|mesh-ancestor
110245966|NCT00117260|Hormones|hormones|mesh-ancestor
110245967|NCT00117260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110245968|NCT00117260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110245969|NCT00117260|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110245970|NCT00117260|Contraceptive Agents|contraceptive agents|mesh-ancestor
110245971|NCT00117260|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110245972|NCT00117260|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110245973|NCT00117260|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110245974|NCT00117260|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110245975|NCT00117260|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110245976|NCT00117260|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110245977|NCT00474838|Metformin|metformin|mesh-list
110245978|NCT00474838|Glimepiride|glimepiride|mesh-list
110245979|NCT00474838|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110245980|NCT00474838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110245981|NCT00474838|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110245982|NCT00474838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110245983|NCT00474838|Immunologic Factors|immunologic factors|mesh-ancestor
110245984|NCT00474916|KRN 5500|krn 5500|mesh-list
110245985|NCT00474916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110245986|NCT00474916|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110245987|NCT00474916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110245988|NCT00474916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110245989|NCT00475072|Ribavirin|ribavirin|mesh-list
110245990|NCT00475072|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110245992|NCT00475072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110245993|NCT00475072|Antiviral Agents|antiviral agents|mesh-ancestor
110245994|NCT00475072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110245995|NCT00117299|Vatalanib|vatalanib|mesh-list
110245996|NCT00117299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110245997|NCT00117299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110245998|NCT00117299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110245999|NCT00117000|Methyltestosterone|methyltestosterone|mesh-list
110246000|NCT00117000|Testosterone|testosterone|mesh-list
110246001|NCT00117000|Testosterone undecanoate|testosterone undecanoate|mesh-list
110246002|NCT00117000|Testosterone enanthate|testosterone enanthate|mesh-list
110246003|NCT00117000|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110246004|NCT00117000|Androgens|androgens|mesh-ancestor
110246005|NCT00117000|Hormones|hormones|mesh-ancestor
110246006|NCT00117000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110246007|NCT00117000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246008|NCT00117000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110246009|NCT00117000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110246010|NCT00117000|Anabolic Agents|anabolic agents|mesh-ancestor
110246011|NCT02956408|Vitamin D|vitamin d|mesh-list
110246012|NCT02956408|Cholecalciferol|cholecalciferol|mesh-list
110246013|NCT02956408|Vitamins|vitamins|mesh-ancestor
110246014|NCT02956408|Micronutrients|micronutrients|mesh-ancestor
110246015|NCT02956408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246016|NCT02956408|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110246017|NCT02956408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110246018|NCT00475189|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
110246019|NCT00475189|Norinyl|norinyl|mesh-list
110246020|NCT00475189|Mestranol|mestranol|mesh-list
110246021|NCT00475189|Norethindrone|norethindrone|mesh-list
110246022|NCT00475189|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110246023|NCT00475189|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110246024|NCT00475189|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110246025|NCT00475189|Contraceptive Agents|contraceptive agents|mesh-ancestor
110246026|NCT00475189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110246027|NCT00475189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246028|NCT00475189|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110246029|NCT00475189|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110246030|NCT00475189|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
110246031|NCT00475189|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110246032|NCT00475189|Estrogens|estrogens|mesh-ancestor
110246034|NCT00475189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110246035|NCT00117377|Pimecrolimus|pimecrolimus|mesh-list
110246036|NCT00117377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110246037|NCT00117377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110246039|NCT00117377|Sensory System Agents|sensory system agents|mesh-ancestor
110246040|NCT00117377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110246041|NCT00117377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246042|NCT00117377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110246043|NCT00117377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110246044|NCT00117377|Dermatologic Agents|dermatologic agents|mesh-ancestor
110246045|NCT00117377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110246046|NCT00117377|Immunologic Factors|immunologic factors|mesh-ancestor
110246047|NCT00117377|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110246048|NCT00117377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110246049|NCT00117377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110246050|NCT02964195|Rifaximin|rifaximin|mesh-list
110246051|NCT02964195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110246052|NCT02964195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110246053|NCT02964195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110246054|NCT00475462|Metoprolol|metoprolol|mesh-list
110246055|NCT00475462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110246056|NCT00475462|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110246057|NCT00475462|Sympatholytics|sympatholytics|mesh-ancestor
110246058|NCT00475462|Autonomic Agents|autonomic agents|mesh-ancestor
110246059|NCT00475462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110246060|NCT00475462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246061|NCT00475462|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110246062|NCT00475462|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110246063|NCT00475462|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110246064|NCT00475462|Adrenergic Agents|adrenergic agents|mesh-ancestor
110246065|NCT00475462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110246066|NCT00475462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110246067|NCT00475618|Fluorides|fluorides|mesh-list
110246068|NCT00475618|Fluorides, Topical|fluorides, topical|mesh-list
110246069|NCT00475618|Cariostatic Agents|cariostatic agents|mesh-ancestor
110246070|NCT00475618|Protective Agents|protective agents|mesh-ancestor
110246071|NCT00475618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246072|NCT00117039|Darbepoetin alfa|darbepoetin alfa|mesh-list
110246073|NCT00117039|Hematinics|hematinics|mesh-ancestor
110246074|NCT00475696|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110246075|NCT00475696|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110246076|NCT00475696|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110246077|NCT00475696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110246078|NCT00475696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110246079|NCT00475696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110246080|NCT00475696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246081|NCT00475696|Analgesics|analgesics|mesh-ancestor
110246082|NCT00475696|Sensory System Agents|sensory system agents|mesh-ancestor
110246083|NCT00475696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110246084|NCT00475696|Antidepressive Agents|antidepressive agents|mesh-ancestor
110246085|NCT00475696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110246086|NCT00475696|Dopamine Agents|dopamine agents|mesh-ancestor
110246087|NCT00117455|Lenograstim|lenograstim|mesh-list
110246088|NCT00117455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110246089|NCT00117455|Immunologic Factors|immunologic factors|mesh-ancestor
110246090|NCT00117455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246091|NCT03270007|Vinorelbine|vinorelbine|mesh-list
110246092|NCT03270007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110246093|NCT03270007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110246094|NCT03270007|Tubulin Modulators|tubulin modulators|mesh-ancestor
110246095|NCT03270007|Antimitotic Agents|antimitotic agents|mesh-ancestor
110246096|NCT03270007|Mitosis Modulators|mitosis modulators|mesh-ancestor
110246097|NCT03270007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110246098|NCT00475813|Fluticasone|fluticasone|mesh-list
110246100|NCT00475813|Formoterol Fumarate|formoterol fumarate|mesh-list
110246101|NCT00475813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110246102|NCT00475813|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110246103|NCT00475813|Autonomic Agents|autonomic agents|mesh-ancestor
110246104|NCT00475813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110246105|NCT00475813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246106|NCT00475813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110246107|NCT00475813|Respiratory System Agents|respiratory system agents|mesh-ancestor
110246108|NCT00475813|Dermatologic Agents|dermatologic agents|mesh-ancestor
110246109|NCT00475813|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110246110|NCT00475813|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110246111|NCT00475813|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110246112|NCT00475813|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110246113|NCT00475813|Adrenergic Agents|adrenergic agents|mesh-ancestor
110246114|NCT00475813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110246115|NCT00475813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110246116|NCT00402038|Methylnaltrexone|methylnaltrexone|mesh-list
110246117|NCT00402038|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110246118|NCT00402038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246119|NCT00402038|Sensory System Agents|sensory system agents|mesh-ancestor
110246120|NCT00402038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110246121|NCT00475930|Chlorhexidine|chlorhexidine|mesh-list
110246122|NCT00475930|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110246123|NCT00475930|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110246124|NCT00475930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110246125|NCT00475930|Disinfectants|disinfectants|mesh-ancestor
110246126|NCT00475930|Dermatologic Agents|dermatologic agents|mesh-ancestor
110246127|NCT00475969|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110246128|NCT00475969|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110246129|NCT00475969|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110246130|NCT00475969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110246131|NCT00475969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110246132|NCT00475969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110246133|NCT00475969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246134|NCT00475969|Analgesics|analgesics|mesh-ancestor
110246135|NCT00475969|Sensory System Agents|sensory system agents|mesh-ancestor
110246136|NCT00475969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110246137|NCT00475969|Antidepressive Agents|antidepressive agents|mesh-ancestor
110246138|NCT00475969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110246139|NCT00475969|Dopamine Agents|dopamine agents|mesh-ancestor
110246140|NCT00476164|Rituximab|rituximab|mesh-list
110246141|NCT00476164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110246142|NCT00476164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110246143|NCT00476164|Immunologic Factors|immunologic factors|mesh-ancestor
110246144|NCT00476164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246145|NCT00476164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110246146|NCT00402077|Pramlintide|pramlintide|mesh-list
110246147|NCT00402077|Phentermine|phentermine|mesh-list
110246148|NCT00402077|Sibutramine|sibutramine|mesh-list
110246149|NCT00402077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110246150|NCT00402077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246151|NCT00402077|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110246152|NCT00402077|Appetite Depressants|appetite depressants|mesh-ancestor
110246153|NCT00402077|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110246154|NCT00402077|Sympathomimetics|sympathomimetics|mesh-ancestor
110246155|NCT00402077|Autonomic Agents|autonomic agents|mesh-ancestor
110246156|NCT00402077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110246157|NCT00402077|Adrenergic Agents|adrenergic agents|mesh-ancestor
110246158|NCT00402077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110246159|NCT00402077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110246160|NCT00402077|Antidepressive Agents|antidepressive agents|mesh-ancestor
110246161|NCT00402077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110246162|NCT00476359|Lopinavir|lopinavir|mesh-list
110246163|NCT00476359|Saquinavir|saquinavir|mesh-list
110246164|NCT00476359|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110246165|NCT00476359|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110246166|NCT00476359|Protease Inhibitors|protease inhibitors|mesh-ancestor
110246167|NCT00476359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110246168|NCT00476359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110246169|NCT00476359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110246170|NCT00476359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110246171|NCT00476359|Antiviral Agents|antiviral agents|mesh-ancestor
110246172|NCT00476359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110246173|NCT00476359|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110246174|NCT00476359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110246175|NCT00117117|Darbepoetin alfa|darbepoetin alfa|mesh-list
110246176|NCT00117117|Hematinics|hematinics|mesh-ancestor
110246177|NCT00476437|Insulin|insulin|mesh-list
110246178|NCT00476437|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110246179|NCT00476437|Insulin Aspart|insulin aspart|mesh-list
110246180|NCT00476437|Biphasic Insulins|biphasic insulins|mesh-list
110246181|NCT00476437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110246182|NCT00476437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246183|NCT00117494|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110246184|NCT00117494|Pravastatin|pravastatin|mesh-list
110246185|NCT00117494|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110246186|NCT00117494|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110246187|NCT00117494|Antimetabolites|antimetabolites|mesh-ancestor
110246188|NCT00117494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110246189|NCT00117494|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110246190|NCT00117494|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110246191|NCT00117494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110246192|NCT00117533|Ribavirin|ribavirin|mesh-list
110246193|NCT00117533|Interferon alpha-2|interferon alpha-2|mesh-list
110246194|NCT00117533|Antimetabolites|antimetabolites|mesh-ancestor
110246195|NCT00117533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110246196|NCT00117533|Antiviral Agents|antiviral agents|mesh-ancestor
110246197|NCT00117533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110246198|NCT00117533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110246199|NCT00117234|Darbepoetin alfa|darbepoetin alfa|mesh-list
110246200|NCT00117234|Hematinics|hematinics|mesh-ancestor
110246202|NCT00117611|Antibodies|antibodies|mesh-list
110246203|NCT00117611|Immunologic Factors|immunologic factors|mesh-ancestor
110246204|NCT00117611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246205|NCT00117611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110246206|NCT00117611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110246207|NCT00117611|Respiratory System Agents|respiratory system agents|mesh-ancestor
110246208|NCT04727684|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110246209|NCT04727684|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110246210|NCT04727684|Cetrorelix|cetrorelix|mesh-list
110246211|NCT04727684|Menotropins|menotropins|mesh-list
110246212|NCT04727684|Luteolytic Agents|luteolytic agents|mesh-ancestor
110246213|NCT04727684|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110246214|NCT04727684|Contraceptive Agents|contraceptive agents|mesh-ancestor
110268632|NCT00551122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110246215|NCT04727684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110246216|NCT04727684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246217|NCT04727684|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110246218|NCT04727684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110246219|NCT04727684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110246220|NCT04727684|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110246221|NCT04727684|Fertility Agents|fertility agents|mesh-ancestor
110246222|NCT04727684|Hormone Antagonists|hormone antagonists|mesh-ancestor
110246223|NCT04727684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110246224|NCT03277261|Teriflunomide|teriflunomide|mesh-list
110246225|NCT03277261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110246226|NCT03277261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110246227|NCT03277261|Analgesics|analgesics|mesh-ancestor
110246228|NCT03277261|Sensory System Agents|sensory system agents|mesh-ancestor
110246229|NCT03277261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110246230|NCT03277261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246231|NCT03277261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110246232|NCT03277261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110246233|NCT03277261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110246234|NCT03277261|Immunologic Factors|immunologic factors|mesh-ancestor
110246235|NCT02273947|BMS-955176|bms-955176|mesh-list
110246236|NCT02273947|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110246237|NCT02273947|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110246238|NCT02273947|Antiviral Agents|antiviral agents|mesh-ancestor
110246239|NCT02273947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110246240|NCT05367336|Fentanyl|fentanyl|mesh-list
110246241|NCT05367336|Morphine|morphine|mesh-list
110246242|NCT05367336|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110246244|NCT05367336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110246245|NCT05367336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246247|NCT05367336|Sensory System Agents|sensory system agents|mesh-ancestor
110246248|NCT05367336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110246249|NCT05367336|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110246250|NCT05367336|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110246251|NCT05367336|Anesthetics, General|anesthetics, general|mesh-ancestor
110246252|NCT05367336|Anesthetics|anesthetics|mesh-ancestor
110246253|NCT00476515|Rituximab|rituximab|mesh-list
110246254|NCT00476515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110246255|NCT00476515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110246256|NCT00476515|Immunologic Factors|immunologic factors|mesh-ancestor
110246257|NCT00476515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246258|NCT00476515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110246259|NCT00117689|Mycophenolic Acid|mycophenolic acid|mesh-list
110246260|NCT00117689|Tacrolimus|tacrolimus|mesh-list
110246261|NCT00117689|Thymoglobulin|thymoglobulin|mesh-list
110246262|NCT00117689|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110246263|NCT00117689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110246264|NCT00117689|Immunologic Factors|immunologic factors|mesh-ancestor
110246265|NCT00117689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246266|NCT00117689|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110246267|NCT00117689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110246268|NCT00117689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110246269|NCT00117689|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110246270|NCT00117689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110246271|NCT00117689|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110246272|NCT00117689|Antitubercular Agents|antitubercular agents|mesh-ancestor
110246273|NCT00117689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110246274|NCT00117689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110246275|NCT00117273|Levonorgestrel|levonorgestrel|mesh-list
110246276|NCT00117273|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110246277|NCT00117273|Estradiol|estradiol|mesh-list
110246278|NCT00117273|Estrogens|estrogens|mesh-ancestor
110246279|NCT00117273|Hormones|hormones|mesh-ancestor
110246280|NCT00117273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110246281|NCT00117273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246282|NCT00117273|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110246283|NCT00117273|Contraceptive Agents|contraceptive agents|mesh-ancestor
110246284|NCT00117273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110246285|NCT00117273|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110246286|NCT00117273|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110246287|NCT00117273|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110246288|NCT00117273|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110246289|NCT00476710|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
110246290|NCT00476710|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110246291|NCT00476710|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110246292|NCT00476710|Antimetabolites|antimetabolites|mesh-ancestor
110246293|NCT00476710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110246294|NCT00476710|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110246295|NCT00117728|Nevirapine|nevirapine|mesh-list
110246296|NCT00117728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110246297|NCT00117728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110246298|NCT00117728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110246299|NCT00117728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110246300|NCT00117728|Antiviral Agents|antiviral agents|mesh-ancestor
110246301|NCT00117728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110246302|NCT00117728|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110246303|NCT00117728|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110246304|NCT00117728|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110246305|NCT00117728|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110246306|NCT00117767|Terbinafine|terbinafine|mesh-list
110246307|NCT00117767|Griseofulvin|griseofulvin|mesh-list
110246309|NCT00117767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110246310|NCT00117767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110246311|NCT00117767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110246312|NCT03277066|Diclofenac|diclofenac|mesh-list
110246313|NCT03277066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110246314|NCT03277066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110246315|NCT03277066|Analgesics|analgesics|mesh-ancestor
110246316|NCT03277066|Sensory System Agents|sensory system agents|mesh-ancestor
110246317|NCT03277066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110246318|NCT03277066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246319|NCT03277066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110246320|NCT03277066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110246321|NCT03277066|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110246322|NCT03277066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110246323|NCT03277066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110246324|NCT00117351|Bortezomib|bortezomib|mesh-list
110246325|NCT00117351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110246326|NCT00118196|Azacitidine|azacitidine|mesh-list
110246327|NCT00118196|Arsenic Trioxide|arsenic trioxide|mesh-list
110246328|NCT00118196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110246329|NCT00118196|Antimetabolites|antimetabolites|mesh-ancestor
110246330|NCT00118196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110246331|NCT00118196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110268672|NCT00551356|Insulin Lispro|insulin lispro|mesh-list
110246332|NCT00118196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110246333|NCT00118235|Bevacizumab|bevacizumab|mesh-list
110246334|NCT00118235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110246335|NCT00118235|Irinotecan|irinotecan|mesh-list
110246336|NCT00118235|Antibodies|antibodies|mesh-list
110246337|NCT00118235|Immunoglobulins|immunoglobulins|mesh-list
110246338|NCT00118235|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110246339|NCT00118235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110246340|NCT00118235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110246341|NCT00118235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110246342|NCT00118235|Growth Substances|growth substances|mesh-ancestor
110246343|NCT00118235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246344|NCT00118235|Growth Inhibitors|growth inhibitors|mesh-ancestor
110246345|NCT00118235|Immunologic Factors|immunologic factors|mesh-ancestor
110246346|NCT00118235|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110246347|NCT00118235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110246348|NCT00118235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110246349|NCT00118235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110246350|NCT00118313|Imiquimod|imiquimod|mesh-list
110246351|NCT00118313|Sargramostim|sargramostim|mesh-list
110246352|NCT00118313|Freund's Adjuvant|freund's adjuvant|mesh-list
110246353|NCT00118313|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
110246354|NCT00118313|Immunologic Factors|immunologic factors|mesh-ancestor
110246355|NCT00118313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246356|NCT00118313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110246357|NCT00118313|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110246358|NCT00118313|Interferon Inducers|interferon inducers|mesh-ancestor
110246359|NCT00118313|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110246360|NCT00118313|Protective Agents|protective agents|mesh-ancestor
110246361|NCT00118313|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110246362|NCT00118313|Antioxidants|antioxidants|mesh-ancestor
110246363|NCT00118313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110246364|NCT03271021|Minocycline|minocycline|mesh-list
110246365|NCT03271021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110246366|NCT03271021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110246367|NCT02273986|Digoxin|digoxin|mesh-list
110246368|NCT02273986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110246369|NCT02273986|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110246370|NCT02273986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110246371|NCT02273986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110246372|NCT02273986|Protective Agents|protective agents|mesh-ancestor
110246373|NCT02273986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246374|NCT00118508|Risedronic Acid|risedronic acid|mesh-list
110246375|NCT00118508|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110246376|NCT00118508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110246377|NCT00118508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110246378|NCT00118508|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110246379|NCT00118508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246380|NCT00118508|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110246381|NCT00476983|Ritonavir|ritonavir|mesh-list
110246382|NCT00476983|Saquinavir|saquinavir|mesh-list
110246383|NCT00476983|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110246384|NCT00476983|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110246385|NCT00476983|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110246386|NCT00476983|Protease Inhibitors|protease inhibitors|mesh-ancestor
110246387|NCT00476983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110246388|NCT00476983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110246389|NCT00476983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110246390|NCT00476983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110246391|NCT00476983|Antiviral Agents|antiviral agents|mesh-ancestor
110246392|NCT00476983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110246393|NCT00476983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110246394|NCT00476983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110246395|NCT00476983|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110246396|NCT00476983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110246398|NCT00477061|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110246399|NCT00477061|Narcotics|narcotics|mesh-ancestor
110246400|NCT00477061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110246401|NCT00477061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246402|NCT00477061|Analgesics|analgesics|mesh-ancestor
110246403|NCT00477061|Sensory System Agents|sensory system agents|mesh-ancestor
110246404|NCT00477061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110246405|NCT00477217|Zoledronic Acid|zoledronic acid|mesh-list
110246406|NCT00477217|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110246407|NCT00477217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246408|NCT00477373|Valproic Acid|valproic acid|mesh-list
110246409|NCT00477373|Anticonvulsants|anticonvulsants|mesh-ancestor
110246410|NCT00477373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110246411|NCT00477373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110246413|NCT00477373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110246414|NCT00477373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246415|NCT00477373|Antimanic Agents|antimanic agents|mesh-ancestor
110246416|NCT00477373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110246417|NCT00477373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110246418|NCT00477373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110246419|NCT00477763|Cyclosporine|cyclosporine|mesh-list
110246420|NCT00477763|Cyclosporins|cyclosporins|mesh-list
110246421|NCT00477763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110246422|NCT00477763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110246423|NCT00477763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110246424|NCT00477763|Immunologic Factors|immunologic factors|mesh-ancestor
110246425|NCT00477763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246426|NCT00477763|Antifungal Agents|antifungal agents|mesh-ancestor
110246427|NCT00477763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110246428|NCT00477763|Dermatologic Agents|dermatologic agents|mesh-ancestor
110246429|NCT00477763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110246430|NCT00477763|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110246431|NCT00477802|Botulinum Toxins|botulinum toxins|mesh-list
110246432|NCT00477802|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110246435|NCT00477802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110246436|NCT00477802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110246437|NCT00477802|Cholinergic Agents|cholinergic agents|mesh-ancestor
110246438|NCT00477802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110246439|NCT00477802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246440|NCT00477802|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110246441|NCT00477802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110246442|NCT00477880|Cetuximab|cetuximab|mesh-list
110246443|NCT00477880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110246444|NCT00477880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110246445|NCT00118820|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110246446|NCT00118820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110246447|NCT00477997|Hormones|hormones|mesh-list
110246448|NCT00477997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110246449|NCT00477997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246450|NCT00478075|Bortezomib|bortezomib|mesh-list
110246451|NCT00478075|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
110246452|NCT00478075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110246453|NCT00478075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110246454|NCT00478075|Analgesics|analgesics|mesh-ancestor
110246455|NCT00478075|Sensory System Agents|sensory system agents|mesh-ancestor
110246456|NCT00478075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110246457|NCT00478075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246458|NCT00117078|Darbepoetin alfa|darbepoetin alfa|mesh-list
110246459|NCT00117078|Hematinics|hematinics|mesh-ancestor
110246460|NCT00478114|Sorafenib|sorafenib|mesh-list
110246461|NCT00478114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110246462|NCT00478114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110246463|NCT00478114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110246464|NCT00478114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110246465|NCT00478270|Ibandronic Acid|ibandronic acid|mesh-list
110246466|NCT00478270|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110246467|NCT00478270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246468|NCT00478504|Letrozole|letrozole|mesh-list
110246469|NCT00478504|Clomiphene|clomiphene|mesh-list
110246470|NCT00478504|Enclomiphene|enclomiphene|mesh-list
110246471|NCT00478504|Zuclomiphene|zuclomiphene|mesh-list
110246472|NCT00478504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110246473|NCT00478504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110246474|NCT00478504|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110246475|NCT00478504|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110246476|NCT00478504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110246477|NCT00478504|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110246478|NCT00478504|Hormone Antagonists|hormone antagonists|mesh-ancestor
110246479|NCT00478504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110246480|NCT00478504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246481|NCT00478504|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110246483|NCT00478504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110246484|NCT00478504|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110246485|NCT00478504|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110246486|NCT00117468|Progesterone|progesterone|mesh-list
110246487|NCT00117468|Progestins|progestins|mesh-ancestor
110246488|NCT00117468|Hormones|hormones|mesh-ancestor
110246489|NCT00117468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110246490|NCT00117468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246491|NCT03271879|Empagliflozin|empagliflozin|mesh-list
110246492|NCT03271879|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110246493|NCT03271879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110246495|NCT03271879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246496|NCT00478543|Furosemide|furosemide|mesh-list
110246497|NCT00478543|Diuretics|diuretics|mesh-ancestor
110246498|NCT00478543|Natriuretic Agents|natriuretic agents|mesh-ancestor
110246499|NCT00478543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246500|NCT00478543|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110246501|NCT00478543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110246502|NCT00478543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110246503|NCT00118937|Metformin|metformin|mesh-list
110246504|NCT00118937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110246505|NCT00118937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246506|NCT00478621|Vaccines|vaccines|mesh-list
110246507|NCT00478621|Immunologic Factors|immunologic factors|mesh-ancestor
110246508|NCT00478621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246509|NCT00478660|Adalimumab|adalimumab|mesh-list
110246510|NCT00478660|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110246511|NCT00478660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110246512|NCT00478660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110246513|NCT00478699|Cisplatin|cisplatin|mesh-list
110246514|NCT00478699|Gemcitabine|gemcitabine|mesh-list
110246515|NCT00478699|Docetaxel|docetaxel|mesh-list
110246516|NCT00478699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110246517|NCT00478699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110246518|NCT00478699|Antimetabolites|antimetabolites|mesh-ancestor
110246519|NCT00478699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110246520|NCT00478699|Tubulin Modulators|tubulin modulators|mesh-ancestor
110246521|NCT00478699|Antimitotic Agents|antimitotic agents|mesh-ancestor
110246522|NCT00478699|Mitosis Modulators|mitosis modulators|mesh-ancestor
110246523|NCT00118976|Lisinopril|lisinopril|mesh-list
110246524|NCT00118976|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110246525|NCT00118976|Protease Inhibitors|protease inhibitors|mesh-ancestor
110246526|NCT00118976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110246527|NCT00118976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110246528|NCT00118976|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110246529|NCT00118976|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110246530|NCT00118976|Protective Agents|protective agents|mesh-ancestor
110246531|NCT00118976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246532|NCT00478816|Vaccines|vaccines|mesh-list
110246533|NCT00478816|Immunologic Factors|immunologic factors|mesh-ancestor
110246534|NCT00478816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246535|NCT00478855|Piperacillin|piperacillin|mesh-list
110246536|NCT00478855|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
110246537|NCT00478855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110246538|NCT00478855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110246539|NCT00478855|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110246540|NCT00478855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110246541|NCT00478855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110246542|NCT00117546|Methyldopa|methyldopa|mesh-list
110246543|NCT00117546|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110246544|NCT00117546|Sympatholytics|sympatholytics|mesh-ancestor
110246545|NCT00117546|Autonomic Agents|autonomic agents|mesh-ancestor
110246546|NCT00117546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110246547|NCT00117546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246548|NCT00117546|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110246549|NCT00117546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110246550|NCT00117546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110246551|NCT00117546|Adrenergic Agents|adrenergic agents|mesh-ancestor
110246552|NCT00117546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110246553|NCT00117546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110246555|NCT00479206|Antimalarials|antimalarials|mesh-ancestor
110246556|NCT00479206|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110246557|NCT00479206|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110246558|NCT00479206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110246559|NCT00479206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110246560|NCT00479206|Antiviral Agents|antiviral agents|mesh-ancestor
110246561|NCT00479206|Schistosomicides|schistosomicides|mesh-ancestor
110246562|NCT00479206|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110246563|NCT00479206|Anthelmintics|anthelmintics|mesh-ancestor
110246564|NCT00119132|Artesunate|artesunate|mesh-list
110246565|NCT00119132|Pyrimethamine|pyrimethamine|mesh-list
110246566|NCT00119132|Sulfadoxine|sulfadoxine|mesh-list
110246567|NCT00119132|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110246568|NCT00119132|Amodiaquine|amodiaquine|mesh-list
110246569|NCT00119132|Antimalarials|antimalarials|mesh-ancestor
110246570|NCT00119132|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110246571|NCT00119132|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110246572|NCT00119132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110246573|NCT00119132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110246574|NCT00119132|Antiviral Agents|antiviral agents|mesh-ancestor
110246575|NCT00119132|Schistosomicides|schistosomicides|mesh-ancestor
110246576|NCT00119132|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110246577|NCT00119132|Anthelmintics|anthelmintics|mesh-ancestor
110246578|NCT00119132|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110246579|NCT00119132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110246580|NCT00119132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110246581|NCT00119132|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110246582|NCT00479323|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110246583|NCT00479323|Immunologic Factors|immunologic factors|mesh-ancestor
110246584|NCT00479323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246586|NCT00479362|Warfarin|warfarin|mesh-list
110246587|NCT00479362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110246588|NCT00479362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110246589|NCT00479362|Analgesics|analgesics|mesh-ancestor
110246590|NCT00479362|Sensory System Agents|sensory system agents|mesh-ancestor
110246591|NCT00479362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110246592|NCT00479362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246593|NCT00479362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110246594|NCT00479362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110246595|NCT00479362|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110246596|NCT00479362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110246597|NCT00479362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110246598|NCT00479362|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110246599|NCT00479362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110246600|NCT00479362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110246601|NCT00479362|Antipyretics|antipyretics|mesh-ancestor
110246602|NCT00479362|Anticoagulants|anticoagulants|mesh-ancestor
110246603|NCT00119171|Capecitabine|capecitabine|mesh-list
110246604|NCT00119171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110246605|NCT00119171|Antimetabolites|antimetabolites|mesh-ancestor
110246606|NCT00119171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110246607|NCT00119171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110246608|NCT00117624|Darbepoetin alfa|darbepoetin alfa|mesh-list
110246609|NCT00117624|Hematinics|hematinics|mesh-ancestor
110246610|NCT00479479|Vitamin B 12|vitamin b 12|mesh-list
110246611|NCT00479479|Hydroxocobalamin|hydroxocobalamin|mesh-list
110246612|NCT00479479|Vitamins|vitamins|mesh-ancestor
110246613|NCT00479479|Micronutrients|micronutrients|mesh-ancestor
110246614|NCT00479479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246615|NCT00479479|Vitamin B Complex|vitamin b complex|mesh-ancestor
110246616|NCT00479479|Hematinics|hematinics|mesh-ancestor
110246617|NCT00119210|Bupropion|bupropion|mesh-list
110246618|NCT00119210|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110246619|NCT00119210|Antidepressive Agents|antidepressive agents|mesh-ancestor
110246620|NCT00119210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110246621|NCT00119210|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110246622|NCT00119210|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110246623|NCT00119210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110246624|NCT00119210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110246625|NCT00119210|Dopamine Agents|dopamine agents|mesh-ancestor
110246627|NCT00119210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246628|NCT00119210|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110246629|NCT00119210|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110246631|NCT00117663|Hormones|hormones|mesh-list
110246632|NCT00117663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110246633|NCT00117663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246634|NCT00479752|Oxaliplatin|oxaliplatin|mesh-list
110246635|NCT00479752|Cetuximab|cetuximab|mesh-list
110246636|NCT00479752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110246637|NCT00479752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110246638|NCT00119249|Sorafenib|sorafenib|mesh-list
110246639|NCT00119249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110246641|NCT00119249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110246642|NCT00119249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110246643|NCT00479908|Sildenafil Citrate|sildenafil citrate|mesh-list
110246644|NCT00479908|Nitroglycerin|nitroglycerin|mesh-list
110246645|NCT00479908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110246646|NCT00479908|Vasodilator Agents|vasodilator agents|mesh-ancestor
110246647|NCT00479908|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110246648|NCT00479908|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110246649|NCT00479908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110246650|NCT00479908|Urological Agents|urological agents|mesh-ancestor
110246651|NCT00479986|Pioglitazone|pioglitazone|mesh-list
110246652|NCT00479986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110246653|NCT00479986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246654|NCT00480064|Cytarabine|cytarabine|mesh-list
110246655|NCT00480064|Lomustine|lomustine|mesh-list
110246656|NCT00480064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110246657|NCT00480064|Antimetabolites|antimetabolites|mesh-ancestor
110246658|NCT00480064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110246659|NCT00480064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110246660|NCT00480064|Antiviral Agents|antiviral agents|mesh-ancestor
110246661|NCT00480064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110246662|NCT00480064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110246663|NCT00480064|Immunologic Factors|immunologic factors|mesh-ancestor
110246664|NCT00480064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246665|NCT00480064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110246666|NCT00480064|Alkylating Agents|alkylating agents|mesh-ancestor
110246667|NCT00480103|Mineral Oil|mineral oil|mesh-list
110246668|NCT00480103|Emollients|emollients|mesh-ancestor
110246669|NCT00480103|Dermatologic Agents|dermatologic agents|mesh-ancestor
110246670|NCT00480142|Oxycodone|oxycodone|mesh-list
110246671|NCT00480142|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110246672|NCT00480142|Narcotics|narcotics|mesh-ancestor
110246673|NCT00480142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110246674|NCT00480142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246675|NCT00480142|Analgesics|analgesics|mesh-ancestor
110246676|NCT00480142|Sensory System Agents|sensory system agents|mesh-ancestor
110246677|NCT00480142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110246678|NCT00119483|Methyltestosterone|methyltestosterone|mesh-list
110246679|NCT00119483|Testosterone|testosterone|mesh-list
110246680|NCT00119483|Testosterone undecanoate|testosterone undecanoate|mesh-list
110246681|NCT00119483|Testosterone enanthate|testosterone enanthate|mesh-list
110246682|NCT00119483|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110246683|NCT00119483|Androgens|androgens|mesh-ancestor
110246684|NCT00119483|Hormones|hormones|mesh-ancestor
110246685|NCT00119483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110246686|NCT00119483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246687|NCT00119483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110246688|NCT00119483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110246689|NCT00119483|Anabolic Agents|anabolic agents|mesh-ancestor
110246690|NCT00480181|Nabilone|nabilone|mesh-list
110246691|NCT00480181|Antiemetics|antiemetics|mesh-ancestor
110246692|NCT00480181|Autonomic Agents|autonomic agents|mesh-ancestor
110246693|NCT00480181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110246694|NCT00480181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246695|NCT00480181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110246696|NCT00480181|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110246697|NCT00480181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110246698|NCT00480181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110246700|NCT00480298|Methylprednisolone|methylprednisolone|mesh-list
110246701|NCT00480298|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110246702|NCT00480298|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110246704|NCT00480298|Prednisolone acetate|prednisolone acetate|mesh-list
110246705|NCT00480298|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110246706|NCT00480298|Prednisolone phosphate|prednisolone phosphate|mesh-list
110246707|NCT00480298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110246708|NCT00480298|Antiemetics|antiemetics|mesh-ancestor
110246709|NCT00480298|Autonomic Agents|autonomic agents|mesh-ancestor
110246710|NCT00480298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110246711|NCT00480298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246712|NCT00480298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110246713|NCT00480298|Glucocorticoids|glucocorticoids|mesh-ancestor
110246715|NCT00480298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110246716|NCT00480298|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110246717|NCT00480298|Protective Agents|protective agents|mesh-ancestor
110246718|NCT00480298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110246719|NCT00480298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110246720|NCT00480376|Gentamicins|gentamicins|mesh-list
110246721|NCT00480376|Ofloxacin|ofloxacin|mesh-list
110246722|NCT00480376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110246723|NCT00480376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110246724|NCT00480376|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110246725|NCT00480376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110246726|NCT00480376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110246727|NCT00480376|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110246728|NCT00480376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110246729|NCT00480376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110246730|NCT00480376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110246731|NCT00480376|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110246732|NCT00480376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110246733|NCT00117702|Everolimus|everolimus|mesh-list
110246734|NCT00117702|Tacrolimus|tacrolimus|mesh-list
110246735|NCT00117702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110246736|NCT00117702|Immunologic Factors|immunologic factors|mesh-ancestor
110246737|NCT00117702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246738|NCT00117702|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110246739|NCT00117702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110246740|NCT00117702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110246741|NCT00117702|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110246742|NCT00117702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110246743|NCT00117702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110246744|NCT00480454|Vaccines|vaccines|mesh-list
110246745|NCT00480454|Immunologic Factors|immunologic factors|mesh-ancestor
110246746|NCT00480454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246747|NCT00480571|Perphenazine|perphenazine|mesh-list
110246748|NCT00480571|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
110246749|NCT00480571|GABA Agents|gaba agents|mesh-ancestor
110246750|NCT00480571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110246751|NCT00480571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110246752|NCT00480571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246753|NCT00480571|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110246754|NCT00480571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110246755|NCT00480571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110246756|NCT00480571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110246757|NCT00480571|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110246758|NCT00480571|Dopamine Agents|dopamine agents|mesh-ancestor
110246759|NCT00480610|Tacrolimus|tacrolimus|mesh-list
110246760|NCT00480610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110246761|NCT00480610|Immunologic Factors|immunologic factors|mesh-ancestor
110246762|NCT00480610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246763|NCT00480610|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110246764|NCT00480610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110246765|NCT00480610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110246766|NCT00480649|Fluticasone|fluticasone|mesh-list
110246767|NCT00480649|Xhance|xhance|mesh-list
110246768|NCT00480649|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110246769|NCT00480649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110246770|NCT00480649|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110246771|NCT00480649|Autonomic Agents|autonomic agents|mesh-ancestor
110246772|NCT00480649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110246773|NCT00480649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246774|NCT00480649|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110246775|NCT00480649|Respiratory System Agents|respiratory system agents|mesh-ancestor
110246776|NCT00480649|Dermatologic Agents|dermatologic agents|mesh-ancestor
110246777|NCT00480649|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110246778|NCT00480649|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110246779|NCT00480649|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110246780|NCT00480649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110246781|NCT00480649|Adrenergic Agents|adrenergic agents|mesh-ancestor
110246782|NCT00480649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110246783|NCT00480649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110246785|NCT00119639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110246786|NCT00119639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110246787|NCT00119639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110246788|NCT00119639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110246790|NCT00480844|Sertindole|sertindole|mesh-list
110246791|NCT00480844|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110246793|NCT00480844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110246794|NCT00480844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110246795|NCT00480844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246796|NCT00480844|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110246797|NCT00480844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110246798|NCT00480844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110246799|NCT00480844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110246800|NCT00480844|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110246801|NCT00480844|Dopamine Agents|dopamine agents|mesh-ancestor
110246802|NCT00480883|Meglumine Antimoniate|meglumine antimoniate|mesh-list
110246803|NCT00480883|Allopurinol|allopurinol|mesh-list
110246805|NCT00480883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110246806|NCT00480883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110246807|NCT00480883|Gout Suppressants|gout suppressants|mesh-ancestor
110246808|NCT00480883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110246809|NCT00480883|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110246810|NCT00480883|Antioxidants|antioxidants|mesh-ancestor
110246811|NCT00480883|Protective Agents|protective agents|mesh-ancestor
110246812|NCT00480883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246813|NCT00480883|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110246814|NCT00480883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110246815|NCT00480883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110246816|NCT05236998|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110246817|NCT05236998|Dapagliflozin|dapagliflozin|mesh-list
110246818|NCT05236998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110246819|NCT05236998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246820|NCT05236998|Incretins|incretins|mesh-ancestor
110246821|NCT05236998|Hormones|hormones|mesh-ancestor
110246822|NCT05236998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110246823|NCT05236998|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110246824|NCT05236998|Protease Inhibitors|protease inhibitors|mesh-ancestor
110246825|NCT05236998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110246826|NCT05236998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110246827|NCT05236998|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110246828|NCT01240096|Mirtazapine|mirtazapine|mesh-list
110246829|NCT01240096|Antidepressive Agents|antidepressive agents|mesh-ancestor
110246830|NCT01240096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110246831|NCT01240096|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110246832|NCT01240096|Histamine Antagonists|histamine antagonists|mesh-ancestor
110246833|NCT01240096|Histamine Agents|histamine agents|mesh-ancestor
110246834|NCT01240096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110246835|NCT01240096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110246836|NCT01240096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246837|NCT01240096|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110246838|NCT01240096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110246839|NCT01240096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110246840|NCT01240096|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110246841|NCT01240096|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110246842|NCT01240096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110246843|NCT01240096|Adrenergic Agents|adrenergic agents|mesh-ancestor
110246844|NCT01240096|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110246845|NCT01240096|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110246846|NCT01240096|Serotonin Agents|serotonin agents|mesh-ancestor
110246847|NCT01240096|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110246848|NCT00119756|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110246849|NCT00119756|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110246850|NCT00119756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110246851|NCT00119756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110246852|NCT00119756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246853|NCT00119756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110246854|NCT00119756|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110246855|NCT00119756|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110246856|NCT00119756|Serotonin Agents|serotonin agents|mesh-ancestor
110246857|NCT00119756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110246858|NCT00119756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110246859|NCT00119756|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110246860|NCT00119756|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110246861|NCT00119756|Dopamine Agents|dopamine agents|mesh-ancestor
110246862|NCT01240174|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110246863|NCT01240174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110246864|NCT01240252|Insulin|insulin|mesh-list
110246865|NCT01240252|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110246866|NCT01240252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110246867|NCT01240252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246868|NCT05233605|Dexmedetomidine|dexmedetomidine|mesh-list
110246869|NCT05233605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110246870|NCT05233605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110246871|NCT05233605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246872|NCT05233605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110246873|NCT05233605|Analgesics|analgesics|mesh-ancestor
110246874|NCT05233605|Sensory System Agents|sensory system agents|mesh-ancestor
110246875|NCT05233605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110246876|NCT05233605|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110246877|NCT05233605|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110246878|NCT05233605|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110246879|NCT05233605|Adrenergic Agents|adrenergic agents|mesh-ancestor
110246880|NCT05233605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110246881|NCT05233605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110246882|NCT00117780|Insulin|insulin|mesh-list
110246883|NCT00117780|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110246884|NCT00117780|Insulin Aspart|insulin aspart|mesh-list
110246885|NCT00117780|Insulin Detemir|insulin detemir|mesh-list
110246886|NCT00117780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110246887|NCT00117780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246888|NCT01240408|Lenvatinib|lenvatinib|mesh-list
110246889|NCT01240408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110246890|NCT01240408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110268769|NCT00185328|Estradiol|estradiol|mesh-list
110246891|NCT01240408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110246892|NCT01240408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110246893|NCT00481273|Azacitidine|azacitidine|mesh-list
110246894|NCT00481273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110246895|NCT00481273|Antimetabolites|antimetabolites|mesh-ancestor
110246896|NCT00481273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110246897|NCT00481273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110246898|NCT00481273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110246899|NCT00481312|Midazolam|midazolam|mesh-list
110246900|NCT00481312|Dexmedetomidine|dexmedetomidine|mesh-list
110246901|NCT00481312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110246902|NCT00481312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110246903|NCT00481312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246904|NCT00481312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110246905|NCT00481312|Analgesics|analgesics|mesh-ancestor
110246906|NCT00481312|Sensory System Agents|sensory system agents|mesh-ancestor
110246907|NCT00481312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110246908|NCT00481312|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110246909|NCT00481312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110246910|NCT00481312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110246911|NCT00481312|Adrenergic Agents|adrenergic agents|mesh-ancestor
110246912|NCT00481312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110246913|NCT00481312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110246914|NCT00481312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110246915|NCT00481312|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110246916|NCT00481312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110246917|NCT00481312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110246918|NCT00481312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110246919|NCT00481312|Anesthetics, General|anesthetics, general|mesh-ancestor
110246920|NCT00481312|Anesthetics|anesthetics|mesh-ancestor
110246921|NCT00481312|GABA Modulators|gaba modulators|mesh-ancestor
110246922|NCT00481312|GABA Agents|gaba agents|mesh-ancestor
110246923|NCT00481429|Rosiglitazone|rosiglitazone|mesh-list
110246924|NCT00481429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110246925|NCT00481429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246926|NCT00119990|Dialysis Solutions|dialysis solutions|mesh-list
110246927|NCT00119990|Icodextrin|icodextrin|mesh-list
110246928|NCT00119990|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110246929|NCT00481624|Epoetin Alfa|epoetin alfa|mesh-list
110246930|NCT00481624|Ferric gluconate|ferric gluconate|mesh-list
110246931|NCT00481624|Hematinics|hematinics|mesh-ancestor
110246932|NCT00117897|Lenograstim|lenograstim|mesh-list
110246933|NCT00117897|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110246934|NCT00117897|Immunologic Factors|immunologic factors|mesh-ancestor
110246935|NCT00117897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246936|NCT00481663|Metformin|metformin|mesh-list
110246937|NCT00481663|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110246938|NCT00481663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110246939|NCT00481663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246940|NCT00481663|Incretins|incretins|mesh-ancestor
110246941|NCT00481663|Hormones|hormones|mesh-ancestor
110246942|NCT00481663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110246943|NCT00481663|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110246944|NCT00481663|Protease Inhibitors|protease inhibitors|mesh-ancestor
110246945|NCT00481663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110246946|NCT00481663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110246947|NCT00481702|Metronidazole|metronidazole|mesh-list
110246948|NCT00481702|Ceftriaxone|ceftriaxone|mesh-list
110246949|NCT00481702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110246950|NCT00481702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110246951|NCT00481702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110246952|NCT00481702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110246953|NCT00481741|Hemostatics|hemostatics|mesh-list
110246954|NCT00481741|Coagulants|coagulants|mesh-ancestor
110246955|NCT00481819|Mycophenolic Acid|mycophenolic acid|mesh-list
110246956|NCT00481819|Methylprednisolone|methylprednisolone|mesh-list
110246958|NCT00481819|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110246959|NCT00481819|Prednisolone|prednisolone|mesh-list
110246960|NCT00481819|Prednisolone acetate|prednisolone acetate|mesh-list
110246961|NCT00481819|Tacrolimus|tacrolimus|mesh-list
110246962|NCT00481819|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110246963|NCT00481819|Prednisolone phosphate|prednisolone phosphate|mesh-list
110246964|NCT00481819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110246965|NCT00481819|Immunologic Factors|immunologic factors|mesh-ancestor
110246966|NCT00481819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246967|NCT00481819|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110246968|NCT00481819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110246969|NCT00481819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110246970|NCT00481819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110246971|NCT00481819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110246972|NCT00481819|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110246973|NCT00481819|Antitubercular Agents|antitubercular agents|mesh-ancestor
110246974|NCT00481819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110246975|NCT00481819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110246976|NCT00481819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110246978|NCT00481819|Autonomic Agents|autonomic agents|mesh-ancestor
110246979|NCT00481819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110246980|NCT00481819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110246981|NCT00481819|Glucocorticoids|glucocorticoids|mesh-ancestor
110246982|NCT00481819|Hormones|hormones|mesh-ancestor
110246983|NCT00481819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110246984|NCT00481819|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110246985|NCT00481819|Protective Agents|protective agents|mesh-ancestor
110246986|NCT00481819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110246987|NCT02958059|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110246988|NCT02958059|Cefoxitin|cefoxitin|mesh-list
110246989|NCT02958059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110246990|NCT00481975|Rimonabant|rimonabant|mesh-list
110246991|NCT00481975|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110246992|NCT00481975|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
110246993|NCT00481975|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110246994|NCT00481975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110246995|NCT00481975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110246997|NCT00481975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110246998|NCT00481975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110246999|NCT00482209|Misoprostol|misoprostol|mesh-list
110247000|NCT00482209|Mifepristone|mifepristone|mesh-list
110247001|NCT00482209|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110247002|NCT00482209|Abortifacient Agents|abortifacient agents|mesh-ancestor
110247003|NCT00482209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110247004|NCT00482209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247005|NCT00482209|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110247006|NCT00482209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110247007|NCT00482209|Oxytocics|oxytocics|mesh-ancestor
110247008|NCT00482209|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110247009|NCT00482209|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110247010|NCT00482209|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110247011|NCT00482209|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110247012|NCT00482209|Contraceptive Agents|contraceptive agents|mesh-ancestor
110247013|NCT00482209|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110247014|NCT00482209|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110247015|NCT00482209|Hormone Antagonists|hormone antagonists|mesh-ancestor
110268804|NCT00162188|Antiviral Agents|antiviral agents|mesh-ancestor
110247016|NCT00482209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110247017|NCT00482209|Luteolytic Agents|luteolytic agents|mesh-ancestor
110247018|NCT00482209|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110247019|NCT00482209|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110247020|NCT00117936|Mitogens|mitogens|mesh-list
110247021|NCT00117936|Mitosis Modulators|mitosis modulators|mesh-ancestor
110247022|NCT00117936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247023|NCT00482248|Omalizumab|omalizumab|mesh-list
110247024|NCT00482248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110247025|NCT00482248|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110247026|NCT00482248|Respiratory System Agents|respiratory system agents|mesh-ancestor
110247027|NCT00120185|Interleukin-2|interleukin-2|mesh-list
110247028|NCT00120185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110247029|NCT00120185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110247030|NCT00120185|Analgesics|analgesics|mesh-ancestor
110247031|NCT00120185|Sensory System Agents|sensory system agents|mesh-ancestor
110247032|NCT00120185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110247033|NCT00120185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247034|NCT01240642|Vadimezan|vadimezan|mesh-list
110247035|NCT01240642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110247037|NCT00117975|Rituximab|rituximab|mesh-list
110247038|NCT00117975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110247039|NCT00117975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110247040|NCT00117975|Immunologic Factors|immunologic factors|mesh-ancestor
110247041|NCT00117975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247042|NCT00117975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110247043|NCT00117975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110247044|NCT00482521|Pomalidomide|pomalidomide|mesh-list
110247045|NCT00482521|Immunologic Factors|immunologic factors|mesh-ancestor
110247046|NCT00482521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247047|NCT00482521|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110247048|NCT00482521|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110247049|NCT00482521|Growth Substances|growth substances|mesh-ancestor
110247050|NCT00482521|Growth Inhibitors|growth inhibitors|mesh-ancestor
110247051|NCT00482521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110247052|NCT00120302|Pimecrolimus|pimecrolimus|mesh-list
110247053|NCT00120302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110247054|NCT00120302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110247055|NCT00120302|Analgesics|analgesics|mesh-ancestor
110247056|NCT00120302|Sensory System Agents|sensory system agents|mesh-ancestor
110247057|NCT00120302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110247058|NCT00120302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247059|NCT00120302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110247060|NCT00120302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110247061|NCT00120302|Dermatologic Agents|dermatologic agents|mesh-ancestor
110247062|NCT00120302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110247063|NCT00120302|Immunologic Factors|immunologic factors|mesh-ancestor
110247064|NCT00120302|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110247065|NCT00120302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110247066|NCT00120302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247068|NCT00482716|Dextrans|dextrans|mesh-list
110247069|NCT00482716|Epoetin Alfa|epoetin alfa|mesh-list
110247070|NCT00482716|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
110247071|NCT00482716|Iron-Dextran Complex|iron-dextran complex|mesh-list
110247072|NCT00482716|Trace Elements|trace elements|mesh-ancestor
110247073|NCT00482716|Micronutrients|micronutrients|mesh-ancestor
110247074|NCT00482716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247076|NCT00482716|Anticoagulants|anticoagulants|mesh-ancestor
110247077|NCT00482716|Plasma Substitutes|plasma substitutes|mesh-ancestor
110247078|NCT00482716|Blood Substitutes|blood substitutes|mesh-ancestor
110247079|NCT00120341|Analgesics|analgesics|mesh-list
110247080|NCT00120341|Sensory System Agents|sensory system agents|mesh-ancestor
110247081|NCT00120341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110247082|NCT00120341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247084|NCT00482989|Immunologic Factors|immunologic factors|mesh-ancestor
110247085|NCT00482989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247086|NCT00120380|Iloprost|iloprost|mesh-list
110247087|NCT00120380|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110247088|NCT00120380|Vasodilator Agents|vasodilator agents|mesh-ancestor
110247089|NCT00483028|Donepezil|donepezil|mesh-list
110247090|NCT00483028|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110247091|NCT00483028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110247092|NCT00483028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247093|NCT00483028|Cholinergic Agents|cholinergic agents|mesh-ancestor
110247094|NCT00483028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110247095|NCT00483028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247096|NCT00483028|Nootropic Agents|nootropic agents|mesh-ancestor
110247097|NCT00118014|Sertraline|sertraline|mesh-list
110247098|NCT00118014|Antidepressive Agents|antidepressive agents|mesh-ancestor
110247099|NCT00118014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110247100|NCT00118014|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110247101|NCT00118014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110247102|NCT00118014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110247103|NCT00118014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247104|NCT00118014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110247105|NCT00118014|Serotonin Agents|serotonin agents|mesh-ancestor
110247106|NCT00118014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247107|NCT00120419|Mycophenolic Acid|mycophenolic acid|mesh-list
110247108|NCT00120419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110247109|NCT00120419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110247110|NCT00120419|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110247111|NCT00120419|Antitubercular Agents|antitubercular agents|mesh-ancestor
110247112|NCT00120419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110247113|NCT00120419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110247114|NCT00120419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110247115|NCT00120419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247116|NCT05176470|Cyclophosphamide|cyclophosphamide|mesh-list
110247117|NCT05176470|Pembrolizumab|pembrolizumab|mesh-list
110247118|NCT05176470|Fludarabine|fludarabine|mesh-list
110247119|NCT05176470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110247120|NCT05176470|Immunologic Factors|immunologic factors|mesh-ancestor
110247121|NCT05176470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247122|NCT05176470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110247123|NCT05176470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110247124|NCT05176470|Alkylating Agents|alkylating agents|mesh-ancestor
110247125|NCT05176470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247126|NCT05176470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110247127|NCT05176470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110247128|NCT05176470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110247129|NCT05176470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110247130|NCT01241032|Udenafil|udenafil|mesh-list
110247131|NCT01241032|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110247132|NCT01241032|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110247133|NCT01241032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110247134|NCT01241032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247135|NCT00483067|Cytarabine|cytarabine|mesh-list
110247136|NCT00483067|Cladribine|cladribine|mesh-list
110247137|NCT00483067|Lenograstim|lenograstim|mesh-list
110247138|NCT00483067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110247139|NCT00483067|Antimetabolites|antimetabolites|mesh-ancestor
110247140|NCT00483067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247141|NCT00483067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110247142|NCT00483067|Antiviral Agents|antiviral agents|mesh-ancestor
110247143|NCT00483067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110247144|NCT00483067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110247145|NCT00483067|Immunologic Factors|immunologic factors|mesh-ancestor
110247146|NCT00483067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247147|NCT00483067|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110247148|NCT00483106|Methylphenidate|methylphenidate|mesh-list
110247149|NCT00483106|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110247150|NCT00483106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247151|NCT00483106|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110247152|NCT00483106|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110247153|NCT00483106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110247154|NCT00483106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247155|NCT00483106|Dopamine Agents|dopamine agents|mesh-ancestor
110247156|NCT00483106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110247157|NCT00118170|Sorafenib|sorafenib|mesh-list
110247158|NCT00118170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110247159|NCT00118170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110247160|NCT00118170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110247161|NCT00118170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247162|NCT00120497|Hormones|hormones|mesh-list
110247163|NCT00120497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110247164|NCT00120497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247165|NCT00483145|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
110247166|NCT00483145|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110247167|NCT00483145|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110247168|NCT00483145|Dermatologic Agents|dermatologic agents|mesh-ancestor
110247169|NCT00483301|Sorafenib|sorafenib|mesh-list
110247170|NCT00483301|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110247171|NCT00483301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110247172|NCT00483301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110247173|NCT00483301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110247174|NCT00483301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247175|NCT00483457|Enzyme Inhibitors|enzyme inhibitors|mesh-list
110247176|NCT00483457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247177|NCT00120536|Vildagliptin|vildagliptin|mesh-list
110247178|NCT00120536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110247179|NCT00120536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247180|NCT00120536|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110247181|NCT00120536|Protease Inhibitors|protease inhibitors|mesh-ancestor
110247182|NCT00120536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110247183|NCT00120536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247184|NCT00483730|Actovegin|actovegin|mesh-list
110247185|NCT00483730|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110247186|NCT00483730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247187|NCT00483730|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110247188|NCT00483730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110247189|NCT00483730|Antioxidants|antioxidants|mesh-ancestor
110247190|NCT00483730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247191|NCT00483730|Protective Agents|protective agents|mesh-ancestor
110247192|NCT00483730|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110247193|NCT00118326|Lenograstim|lenograstim|mesh-list
110247194|NCT00118326|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110247195|NCT00118326|Immunologic Factors|immunologic factors|mesh-ancestor
110247196|NCT00118326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247197|NCT00483769|Insulin Glargine|insulin glargine|mesh-list
110247198|NCT00483769|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110247199|NCT00483769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247200|NCT00405171|Nevirapine|nevirapine|mesh-list
110247201|NCT00405171|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110247202|NCT00405171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110247203|NCT00405171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110247204|NCT00405171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247205|NCT00405171|Antiviral Agents|antiviral agents|mesh-ancestor
110247206|NCT00405171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110247207|NCT00405171|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110247208|NCT00405171|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110247209|NCT00405171|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110247210|NCT00405171|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110247211|NCT00483886|Prucalopride|prucalopride|mesh-list
110247212|NCT00483886|Laxatives|laxatives|mesh-ancestor
110247213|NCT00483886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110247214|NCT00483886|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
110247215|NCT00483886|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110247216|NCT00483886|Serotonin Agents|serotonin agents|mesh-ancestor
110247217|NCT00483886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110247218|NCT00483886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247219|NCT00483886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247220|NCT00483964|Olanzapine|olanzapine|mesh-list
110247221|NCT00483964|Antiemetics|antiemetics|mesh-ancestor
110247222|NCT00483964|Autonomic Agents|autonomic agents|mesh-ancestor
110247223|NCT00483964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110247224|NCT00483964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247225|NCT00483964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110247226|NCT00483964|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110247227|NCT00483964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110247228|NCT00483964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110247229|NCT00483964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110247230|NCT00483964|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110247231|NCT00483964|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110247232|NCT00483964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110247233|NCT00483964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247234|NCT00483964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110247235|NCT00483964|Serotonin Agents|serotonin agents|mesh-ancestor
110247236|NCT00484003|Pimecrolimus|pimecrolimus|mesh-list
110247237|NCT00484003|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110247238|NCT00484003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110247239|NCT00484003|Analgesics|analgesics|mesh-ancestor
110247240|NCT00484003|Sensory System Agents|sensory system agents|mesh-ancestor
110247241|NCT00484003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110247242|NCT00484003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247243|NCT00484003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110247244|NCT00484003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110247245|NCT00484003|Dermatologic Agents|dermatologic agents|mesh-ancestor
110247247|NCT00484003|Immunologic Factors|immunologic factors|mesh-ancestor
110247248|NCT00484003|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110247249|NCT00484003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110247250|NCT00484003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247251|NCT01241110|Ofloxacin|ofloxacin|mesh-list
110247252|NCT01241110|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110247253|NCT01241110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110247254|NCT01241110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110247255|NCT01241110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110247256|NCT01241110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110247257|NCT01241110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110268855|NCT04684498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110247258|NCT01241110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247259|NCT01241110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110247260|NCT01241110|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110247261|NCT01241110|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110247262|NCT00120653|Metoclopramide|metoclopramide|mesh-list
110247263|NCT00120653|Antiemetics|antiemetics|mesh-ancestor
110247264|NCT00120653|Autonomic Agents|autonomic agents|mesh-ancestor
110247265|NCT00120653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110247266|NCT00120653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247267|NCT00120653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110247268|NCT00120653|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110247269|NCT00120653|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110247270|NCT00120653|Dopamine Agents|dopamine agents|mesh-ancestor
110247271|NCT00120653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110247272|NCT00120653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247273|NCT00484120|Diclofenac|diclofenac|mesh-list
110247274|NCT00484120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110247275|NCT00484120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110247276|NCT00484120|Analgesics|analgesics|mesh-ancestor
110247277|NCT00484120|Sensory System Agents|sensory system agents|mesh-ancestor
110247278|NCT00484120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110247279|NCT00484120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247280|NCT00484120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110247281|NCT00484120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110247282|NCT00484120|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110247283|NCT00484120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110247284|NCT00484120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247285|NCT00484237|Etanercept|etanercept|mesh-list
110247286|NCT00484237|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110247287|NCT00484237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110247289|NCT00484237|Sensory System Agents|sensory system agents|mesh-ancestor
110247290|NCT00484237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110247291|NCT00484237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247292|NCT00484237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110247293|NCT00484237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110247294|NCT00484237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110247295|NCT00484237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110247296|NCT00484237|Immunologic Factors|immunologic factors|mesh-ancestor
110247297|NCT00120692|Epoetin Alfa|epoetin alfa|mesh-list
110247298|NCT00120692|Darbepoetin alfa|darbepoetin alfa|mesh-list
110247299|NCT00120692|Hematinics|hematinics|mesh-ancestor
110247300|NCT00484432|Doxorubicin|doxorubicin|mesh-list
110247301|NCT00484432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110247302|NCT00484432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110247303|NCT00484432|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110247304|NCT00484432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110247305|NCT00484432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110247306|NCT00484432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247307|NCT00484510|Ascorbic Acid|ascorbic acid|mesh-list
110247308|NCT00484510|Vitamins|vitamins|mesh-ancestor
110247309|NCT00484510|Micronutrients|micronutrients|mesh-ancestor
110247310|NCT00484510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247311|NCT00484510|Antioxidants|antioxidants|mesh-ancestor
110247312|NCT00484510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247313|NCT00484510|Protective Agents|protective agents|mesh-ancestor
110247314|NCT00120731|Acetazolamide|acetazolamide|mesh-list
110247315|NCT00120731|Potassium Citrate|potassium citrate|mesh-list
110247316|NCT00120731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247317|NCT00120731|Anticonvulsants|anticonvulsants|mesh-ancestor
110247318|NCT00120731|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110247319|NCT00120731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110247320|NCT00120731|Diuretics|diuretics|mesh-ancestor
110247321|NCT00120731|Natriuretic Agents|natriuretic agents|mesh-ancestor
110247322|NCT00120731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247323|NCT00120731|Expectorants|expectorants|mesh-ancestor
110247324|NCT00120731|Respiratory System Agents|respiratory system agents|mesh-ancestor
110268868|NCT04513015|Antioxidants|antioxidants|mesh-list
110247325|NCT00120770|Anti-Infective Agents|anti-infective agents|mesh-list
110247326|NCT00484744|Acetaminophen|acetaminophen|mesh-list
110247327|NCT00484744|Ibuprofen|ibuprofen|mesh-list
110247328|NCT00484744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110247329|NCT00484744|Analgesics|analgesics|mesh-ancestor
110247330|NCT00484744|Sensory System Agents|sensory system agents|mesh-ancestor
110247331|NCT00484744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110247332|NCT00484744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247333|NCT00484744|Antipyretics|antipyretics|mesh-ancestor
110247334|NCT00484744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110247335|NCT00484744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110247336|NCT00484744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110247337|NCT00484744|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110247338|NCT00484744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110247339|NCT00484744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247340|NCT00484822|Heparin|heparin|mesh-list
110247341|NCT00484822|Calcium heparin|calcium heparin|mesh-list
110247342|NCT00484822|Anticoagulants|anticoagulants|mesh-ancestor
110247343|NCT00484822|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110247344|NCT00484822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110247345|NCT00484822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247346|NCT00405210|Docetaxel|docetaxel|mesh-list
110247347|NCT00405210|Sorafenib|sorafenib|mesh-list
110247348|NCT00405210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110247349|NCT00405210|Tubulin Modulators|tubulin modulators|mesh-ancestor
110247350|NCT00405210|Antimitotic Agents|antimitotic agents|mesh-ancestor
110247351|NCT00405210|Mitosis Modulators|mitosis modulators|mesh-ancestor
110247352|NCT00405210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247353|NCT00405210|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110247354|NCT00405210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110247355|NCT00120809|Pyrimethamine|pyrimethamine|mesh-list
110247356|NCT00120809|Sulfadoxine|sulfadoxine|mesh-list
110247357|NCT00120809|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110247358|NCT00120809|Antimalarials|antimalarials|mesh-ancestor
110247359|NCT00120809|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110247360|NCT00120809|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110247361|NCT00120809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110247362|NCT00120809|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110247363|NCT00120809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110247364|NCT00120809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247365|NCT00120809|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110247366|NCT00484900|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110247367|NCT00484900|Antimalarials|antimalarials|mesh-ancestor
110247368|NCT00484900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110247369|NCT00484900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110247370|NCT00484900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110247371|NCT05062356|Ketorolac|ketorolac|mesh-list
110247372|NCT05062356|Epinephrine|epinephrine|mesh-list
110247373|NCT05062356|Bupivacaine|bupivacaine|mesh-list
110247374|NCT05062356|Prilocaine|prilocaine|mesh-list
110247375|NCT05062356|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110247376|NCT05062356|Anesthetics, Local|anesthetics, local|mesh-ancestor
110247377|NCT05062356|Anesthetics|anesthetics|mesh-ancestor
110247378|NCT05062356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110247379|NCT05062356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247380|NCT05062356|Sensory System Agents|sensory system agents|mesh-ancestor
110247381|NCT05062356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110247382|NCT05062356|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110247383|NCT05062356|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110247384|NCT05062356|Adrenergic Agents|adrenergic agents|mesh-ancestor
110247385|NCT05062356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110247386|NCT05062356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247387|NCT05062356|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110247388|NCT05062356|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110247389|NCT05062356|Autonomic Agents|autonomic agents|mesh-ancestor
110247390|NCT05062356|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110247391|NCT05062356|Respiratory System Agents|respiratory system agents|mesh-ancestor
110247392|NCT05062356|Mydriatics|mydriatics|mesh-ancestor
110247393|NCT05062356|Sympathomimetics|sympathomimetics|mesh-ancestor
110247394|NCT05062356|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110247395|NCT05062356|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110247396|NCT05062356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110247397|NCT05062356|Analgesics|analgesics|mesh-ancestor
110247398|NCT05062356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110247399|NCT05062356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110247400|NCT05062356|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110247401|NCT05062356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110247403|NCT01241383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110247404|NCT01241383|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110247405|NCT01241383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247406|NCT00485056|Pioglitazone|pioglitazone|mesh-list
110247407|NCT00485056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110247408|NCT00485056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247409|NCT00120887|Atorvastatin|atorvastatin|mesh-list
110247410|NCT00120887|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110247411|NCT00120887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110247412|NCT00120887|Antimetabolites|antimetabolites|mesh-ancestor
110247413|NCT00120887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247414|NCT00120887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110247415|NCT00120887|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110247416|NCT00120887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110247417|NCT00118638|Darbepoetin alfa|darbepoetin alfa|mesh-list
110247418|NCT00118638|Hematinics|hematinics|mesh-ancestor
110247419|NCT00485368|Perindopril|perindopril|mesh-list
110247420|NCT00485368|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110247421|NCT00485368|Protease Inhibitors|protease inhibitors|mesh-ancestor
110247422|NCT00485368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110247423|NCT00485368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247424|NCT00485368|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110247425|NCT00485407|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110247426|NCT00485407|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110247427|NCT00485407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110247428|NCT00485407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110247429|NCT00485407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247430|NCT00485407|Adrenergic Agents|adrenergic agents|mesh-ancestor
110247431|NCT00485407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110247432|NCT00485407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247433|NCT01241500|ON 01910|on 01910|mesh-list
110247434|NCT01241500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110247435|NCT01241500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110247436|NCT01241500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110247437|NCT01241500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247438|NCT05058612|Midodrine|midodrine|mesh-list
110247439|NCT05058612|Sympathomimetics|sympathomimetics|mesh-ancestor
110247440|NCT05058612|Autonomic Agents|autonomic agents|mesh-ancestor
110247441|NCT05058612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110247442|NCT05058612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247443|NCT05058612|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110247444|NCT05058612|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110247445|NCT05058612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110247446|NCT05058612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110247447|NCT05058612|Adrenergic Agents|adrenergic agents|mesh-ancestor
110247448|NCT05058612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110247449|NCT05058612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247451|NCT02274181|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110247452|NCT02274181|Hormone Antagonists|hormone antagonists|mesh-ancestor
110247453|NCT02274181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110247454|NCT02274181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247455|NCT02274181|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110247456|NCT02274181|Fertility Agents|fertility agents|mesh-ancestor
110247457|NCT02274181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110247458|NCT02274181|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110247459|NCT02274181|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110247460|NCT01241422|Montelukast|montelukast|mesh-list
110247461|NCT01241422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110247462|NCT01241422|Respiratory System Agents|respiratory system agents|mesh-ancestor
110247463|NCT01241422|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110247464|NCT01241422|Hormone Antagonists|hormone antagonists|mesh-ancestor
110247465|NCT01241422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110247466|NCT01241422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247467|NCT01241422|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110247468|NCT01241422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110247469|NCT01241422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247471|NCT05058417|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110247472|NCT05058417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247473|NCT05058417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110247474|NCT05058417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247475|NCT02274337|Abivertinib|abivertinib|mesh-list
110247476|NCT02274337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110247477|NCT02274337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110247478|NCT02274337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247479|NCT00121043|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110247480|NCT00121043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110247482|NCT00485680|Lithium Carbonate|lithium carbonate|mesh-list
110247483|NCT00485680|Antiemetics|antiemetics|mesh-ancestor
110247484|NCT00485680|Autonomic Agents|autonomic agents|mesh-ancestor
110247485|NCT00485680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110247486|NCT00485680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247487|NCT00485680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110247488|NCT00485680|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110247489|NCT00485680|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110247490|NCT00485680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110247491|NCT00485680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110247492|NCT00485680|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110247493|NCT00485680|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110247494|NCT00485680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110247495|NCT00485680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247496|NCT00485680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110247497|NCT00485680|Serotonin Agents|serotonin agents|mesh-ancestor
110247498|NCT00485680|Antidepressive Agents|antidepressive agents|mesh-ancestor
110247499|NCT00485680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110247500|NCT00485680|Antimanic Agents|antimanic agents|mesh-ancestor
110247501|NCT00118794|Lumefantrine|lumefantrine|mesh-list
110247502|NCT00118794|Artemether|artemether|mesh-list
110247503|NCT00118794|Dapsone|dapsone|mesh-list
110247504|NCT00118794|Chlorproguanil|chlorproguanil|mesh-list
110247505|NCT00118794|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110247506|NCT00118794|Antimalarials|antimalarials|mesh-ancestor
110247507|NCT00118794|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110247508|NCT00118794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110247509|NCT00118794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110247510|NCT00118794|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110247511|NCT00118794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110247512|NCT00118794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247513|NCT00118794|Leprostatic Agents|leprostatic agents|mesh-ancestor
110247514|NCT00118794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110247515|NCT01241773|Efavirenz|efavirenz|mesh-list
110061192|NCT06043323|Antiemetics|antiemetics|mesh-ancestor
110247516|NCT01241773|Raltegravir Potassium|raltegravir potassium|mesh-list
110247517|NCT01241773|Simeprevir|simeprevir|mesh-list
110247518|NCT01241773|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110247519|NCT01241773|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110247520|NCT01241773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110247521|NCT01241773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247522|NCT01241773|Antiviral Agents|antiviral agents|mesh-ancestor
110247523|NCT01241773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110247524|NCT01241773|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110247525|NCT01241773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110247526|NCT01241773|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110247527|NCT01241773|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110247528|NCT01241773|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110247529|NCT01241773|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110247530|NCT01241773|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110247531|NCT01241773|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110247532|NCT01241773|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110247533|NCT01241773|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110247534|NCT01241773|Protease Inhibitors|protease inhibitors|mesh-ancestor
110247535|NCT00121277|Capecitabine|capecitabine|mesh-list
110247536|NCT00121277|Vorinostat|vorinostat|mesh-list
110247537|NCT00121277|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110247538|NCT00121277|Antimetabolites|antimetabolites|mesh-ancestor
110247539|NCT00121277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247540|NCT00121277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110247541|NCT00121277|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110247542|NCT00121277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110247543|NCT00485797|Methylphenidate|methylphenidate|mesh-list
110247544|NCT00485797|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110247545|NCT00485797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247546|NCT00485797|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110247547|NCT00485797|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110247548|NCT00485797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110247549|NCT00485797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247550|NCT00485797|Dopamine Agents|dopamine agents|mesh-ancestor
110247551|NCT00485797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110247552|NCT00485875|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110247553|NCT00485875|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110247554|NCT00485875|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110247555|NCT00485875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110247556|NCT00485875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247557|NCT00485875|Adrenergic Agents|adrenergic agents|mesh-ancestor
110247558|NCT00485875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110247559|NCT00485875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247560|NCT00121316|Pimecrolimus|pimecrolimus|mesh-list
110247561|NCT00121316|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110247562|NCT00121316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110247563|NCT00121316|Analgesics|analgesics|mesh-ancestor
110247564|NCT00121316|Sensory System Agents|sensory system agents|mesh-ancestor
110247565|NCT00121316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110247566|NCT00121316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247567|NCT00121316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110247568|NCT00121316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110247569|NCT00121316|Dermatologic Agents|dermatologic agents|mesh-ancestor
110247570|NCT00121316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110247571|NCT00121316|Immunologic Factors|immunologic factors|mesh-ancestor
110247572|NCT00121316|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110247573|NCT00121316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110247574|NCT00121316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247575|NCT00118950|Metformin|metformin|mesh-list
110247576|NCT00118950|Repaglinide|repaglinide|mesh-list
110247577|NCT00118950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110247578|NCT00118950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247579|NCT00486187|Metformin|metformin|mesh-list
110247580|NCT00486187|Rosiglitazone|rosiglitazone|mesh-list
110247581|NCT00486187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110247582|NCT00486187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247583|NCT00121394|Chlorhexidine|chlorhexidine|mesh-list
110247584|NCT00121394|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110247585|NCT00121394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110247586|NCT00121394|Disinfectants|disinfectants|mesh-ancestor
110247587|NCT00486343|Zileuton|zileuton|mesh-list
110247588|NCT00486343|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110247589|NCT00486343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110247590|NCT00486343|Analgesics|analgesics|mesh-ancestor
110247591|NCT00486343|Sensory System Agents|sensory system agents|mesh-ancestor
110247592|NCT00486343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110247593|NCT00486343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247594|NCT00486343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110247595|NCT00486343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110247596|NCT00486343|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110247597|NCT00486343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110247598|NCT00486343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247599|NCT00486343|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110247600|NCT00486343|Hormone Antagonists|hormone antagonists|mesh-ancestor
110247601|NCT00486343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110247603|NCT00486421|Rituximab|rituximab|mesh-list
110247604|NCT00486421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110247605|NCT00486421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110247606|NCT00486421|Immunologic Factors|immunologic factors|mesh-ancestor
110247607|NCT00486421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247608|NCT00486421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110247609|NCT00486421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110247610|NCT00486421|Glucocorticoids|glucocorticoids|mesh-ancestor
110247611|NCT00486421|Hormones|hormones|mesh-ancestor
110247612|NCT00486421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110247613|NCT00486421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110247614|NCT00486460|Curcumin|curcumin|mesh-list
110247615|NCT00486460|Celecoxib|celecoxib|mesh-list
110247616|NCT00486460|Gemcitabine|gemcitabine|mesh-list
110247617|NCT00486460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110247618|NCT00486460|Antimetabolites|antimetabolites|mesh-ancestor
110247619|NCT00486460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247620|NCT00486460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110247621|NCT00486460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110247622|NCT00486460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110247623|NCT00486460|Analgesics|analgesics|mesh-ancestor
110247624|NCT00486460|Sensory System Agents|sensory system agents|mesh-ancestor
110247625|NCT00486460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110247626|NCT00486460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247627|NCT00486460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110247628|NCT00486460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110247629|NCT00486460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110247630|NCT00486460|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110247631|NCT00486460|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110247632|NCT00121511|Fluorouracil|fluorouracil|mesh-list
110247633|NCT00121511|Antimetabolites|antimetabolites|mesh-ancestor
110247634|NCT00121511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247635|NCT00121511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110247636|NCT00121511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110247637|NCT00121511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110247638|NCT00121511|Immunologic Factors|immunologic factors|mesh-ancestor
110247639|NCT00121511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247640|NCT00486694|Artesunate|artesunate|mesh-list
110247641|NCT00486694|Chloroquine|chloroquine|mesh-list
110247642|NCT00486694|Pyrimethamine|pyrimethamine|mesh-list
110247643|NCT00486694|Sulfadoxine|sulfadoxine|mesh-list
110247644|NCT00486694|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110247646|NCT00486694|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110247647|NCT00486694|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110247648|NCT00486694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110247649|NCT00486694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110247650|NCT00486694|Antiviral Agents|antiviral agents|mesh-ancestor
110247651|NCT00486694|Schistosomicides|schistosomicides|mesh-ancestor
110247652|NCT00486694|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110247653|NCT00486694|Anthelmintics|anthelmintics|mesh-ancestor
110247654|NCT00486694|Amebicides|amebicides|mesh-ancestor
110247655|NCT00486694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110247656|NCT00486694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110268904|NCT00162383|Anticonvulsants|anticonvulsants|mesh-ancestor
110247657|NCT00486694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110247658|NCT00486694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247659|NCT00486694|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110247660|NCT00486772|Calcium|calcium|mesh-list
110247661|NCT00486772|Sevelamer|sevelamer|mesh-list
110247662|NCT00486772|Calcium acetate|calcium acetate|mesh-list
110247663|NCT00486772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110247664|NCT00486772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247665|NCT00486772|Chelating Agents|chelating agents|mesh-ancestor
110247666|NCT00486772|Sequestering Agents|sequestering agents|mesh-ancestor
110247667|NCT00486772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247668|NCT00121550|Clarithromycin|clarithromycin|mesh-list
110247669|NCT00121550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110247670|NCT00121550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110247671|NCT00121550|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110247672|NCT00121550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110247673|NCT00121550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247674|NCT00121550|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110247675|NCT00121550|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110247676|NCT01242046|Caffeine|caffeine|mesh-list
110247677|NCT01242046|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110247678|NCT01242046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247679|NCT01242046|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110247680|NCT01242046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110247681|NCT01242046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247682|NCT01242046|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110247683|NCT01242046|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110247684|NCT01242046|Purinergic Agents|purinergic agents|mesh-ancestor
110247685|NCT01242046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110247686|NCT01242202|Acarbose|acarbose|mesh-list
110247687|NCT01242202|Voglibose|voglibose|mesh-list
110247688|NCT01242202|Miglitol|miglitol|mesh-list
110247689|NCT01242202|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
110247690|NCT01242202|Ipragliflozin|ipragliflozin|mesh-list
110247691|NCT01242202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110247692|NCT01242202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247693|NCT01242202|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110247694|NCT01242202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247695|NCT01242202|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110247696|NCT00119145|Artesunate|artesunate|mesh-list
110247697|NCT00119145|Amodiaquine|amodiaquine|mesh-list
110247698|NCT00119145|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110247699|NCT00119145|Antimalarials|antimalarials|mesh-ancestor
110247700|NCT00119145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110247701|NCT00119145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110247702|NCT00119145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110247703|NCT00119145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110247704|NCT00119145|Antiviral Agents|antiviral agents|mesh-ancestor
110247705|NCT00119145|Schistosomicides|schistosomicides|mesh-ancestor
110247706|NCT00119145|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110247707|NCT00119145|Anthelmintics|anthelmintics|mesh-ancestor
110247708|NCT00119184|Anesthetics|anesthetics|mesh-list
110247709|NCT00119184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110247710|NCT00119184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247711|NCT00487123|Valsartan|valsartan|mesh-list
110247712|NCT00487123|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110247713|NCT00487123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110247714|NCT00487123|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110247715|NCT00487123|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110247716|NCT00487123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247717|NCT00487123|Diuretics|diuretics|mesh-ancestor
110247718|NCT00487123|Natriuretic Agents|natriuretic agents|mesh-ancestor
110247719|NCT00487123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247720|NCT00487123|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110247721|NCT00487123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110247722|NCT00487591|Simvastatin|simvastatin|mesh-list
110247723|NCT00487591|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110247724|NCT00487591|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110247725|NCT00487591|Antimetabolites|antimetabolites|mesh-ancestor
110247726|NCT00487591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247727|NCT00487591|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110247728|NCT00487591|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110247729|NCT00487591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110247730|NCT00487786|Docetaxel|docetaxel|mesh-list
110247731|NCT00487786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110247732|NCT00487786|Tubulin Modulators|tubulin modulators|mesh-ancestor
110247733|NCT00487786|Antimitotic Agents|antimitotic agents|mesh-ancestor
110247734|NCT00487786|Mitosis Modulators|mitosis modulators|mesh-ancestor
110247735|NCT00487786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247736|NCT00488137|Prucalopride|prucalopride|mesh-list
110247737|NCT00488137|Laxatives|laxatives|mesh-ancestor
110247738|NCT00488137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110247739|NCT00488137|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
110247740|NCT00488137|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110247741|NCT00488137|Serotonin Agents|serotonin agents|mesh-ancestor
110247743|NCT00488137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247744|NCT00488137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247745|NCT00488176|Cetirizine|cetirizine|mesh-list
110247746|NCT00488176|Montelukast|montelukast|mesh-list
110247747|NCT00488176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110247748|NCT00488176|Respiratory System Agents|respiratory system agents|mesh-ancestor
110247749|NCT00488176|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110247750|NCT00488176|Hormone Antagonists|hormone antagonists|mesh-ancestor
110247751|NCT00488176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110247752|NCT00488176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247753|NCT00488176|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110247754|NCT00488176|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110247755|NCT00488176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247756|NCT00488176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110247757|NCT00488176|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110247758|NCT00488176|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110247759|NCT00488176|Histamine Antagonists|histamine antagonists|mesh-ancestor
110247760|NCT00488176|Histamine Agents|histamine agents|mesh-ancestor
110247761|NCT00488176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110247762|NCT00488215|Prucalopride|prucalopride|mesh-list
110247763|NCT00488215|Laxatives|laxatives|mesh-ancestor
110247764|NCT00488215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110247765|NCT00488215|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
110247766|NCT00488215|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110247767|NCT00488215|Serotonin Agents|serotonin agents|mesh-ancestor
110247768|NCT00488215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110247769|NCT00488215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247771|NCT00121628|Motesanib diphosphate|motesanib diphosphate|mesh-list
110247772|NCT00121628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110247773|NCT00121628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110247774|NCT00121628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247775|NCT00488371|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110247776|NCT00488371|Immunologic Factors|immunologic factors|mesh-ancestor
110247777|NCT00488371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247778|NCT00488527|Insulin Glargine|insulin glargine|mesh-list
110247779|NCT00488527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110247780|NCT00488527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247782|NCT00488566|Anticonvulsants|anticonvulsants|mesh-ancestor
110247783|NCT00488566|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110247784|NCT00488566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110247785|NCT00488566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247786|NCT00488566|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110247787|NCT00488566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247788|NCT00488566|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110247789|NCT00488566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110247790|NCT00488566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110247791|NCT00488566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110247792|NCT00488566|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110247793|NCT00488722|Goserelin|goserelin|mesh-list
110247794|NCT00488722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110247795|NCT00488722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110247796|NCT00488761|Tigecycline|tigecycline|mesh-list
110247797|NCT00488761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110247798|NCT00488761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110247799|NCT00488761|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110247800|NCT00488761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110247801|NCT00488761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247802|NCT00121784|Mycophenolic Acid|mycophenolic acid|mesh-list
110247803|NCT00121784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110247804|NCT00121784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110247805|NCT00121784|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110247806|NCT00121784|Antitubercular Agents|antitubercular agents|mesh-ancestor
110247807|NCT00121784|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110247808|NCT00121784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110247809|NCT00121784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110247810|NCT00121784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247811|NCT00145236|Nebivolol|nebivolol|mesh-list
110247812|NCT00145236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110247813|NCT00145236|Vasodilator Agents|vasodilator agents|mesh-ancestor
110247814|NCT00145236|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110247815|NCT00145236|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110247816|NCT00145236|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110247817|NCT00145236|Adrenergic Agents|adrenergic agents|mesh-ancestor
110247818|NCT00145236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110247819|NCT00145236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247820|NCT00145236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247821|NCT01242592|Antitubercular Agents|antitubercular agents|mesh-list
110247822|NCT01242592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110247823|NCT01242592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110247824|NCT00488800|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110247825|NCT00488800|Immunologic Factors|immunologic factors|mesh-ancestor
110247826|NCT00488800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247827|NCT00145275|Zoledronic Acid|zoledronic acid|mesh-list
110247828|NCT00145275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110247829|NCT00145275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247830|NCT00488995|Tremelimumab|tremelimumab|mesh-list
110247831|NCT00488995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110247832|NCT04911816|Hydroxychloroquine|hydroxychloroquine|mesh-list
110247833|NCT04911816|Antimalarials|antimalarials|mesh-ancestor
110247834|NCT04911816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110247835|NCT04911816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110247836|NCT04911816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110247837|NCT04911816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110247838|NCT04911816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247839|NCT04911816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110247840|NCT00489073|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110247841|NCT00489073|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110268939|NCT04233034|Verapamil|verapamil|mesh-list
110247842|NCT00489073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110247843|NCT00489073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110247844|NCT00489073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247845|NCT00489073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110247846|NCT00489073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247847|NCT00489073|Analgesics|analgesics|mesh-ancestor
110247848|NCT00489073|Sensory System Agents|sensory system agents|mesh-ancestor
110247849|NCT00489073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110247850|NCT00489073|Antidepressive Agents|antidepressive agents|mesh-ancestor
110247851|NCT00489073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110247852|NCT00489073|Dopamine Agents|dopamine agents|mesh-ancestor
110247853|NCT00489151|Lamivudine|lamivudine|mesh-list
110247854|NCT00489151|Adefovir|adefovir|mesh-list
110247855|NCT00489151|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
110247856|NCT00489151|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110247857|NCT00489151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110247858|NCT00489151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110247859|NCT00489151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247860|NCT00489151|Antiviral Agents|antiviral agents|mesh-ancestor
110247861|NCT00489151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110247862|NCT00489151|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110247863|NCT00489151|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110247864|NCT00145314|Leucovorin|leucovorin|mesh-list
110247865|NCT00145314|Folic Acid|folic acid|mesh-list
110247866|NCT00145314|Fluorouracil|fluorouracil|mesh-list
110247867|NCT00145314|Oxaliplatin|oxaliplatin|mesh-list
110247868|NCT00145314|Cetuximab|cetuximab|mesh-list
110247869|NCT00145314|Levoleucovorin|levoleucovorin|mesh-list
110247870|NCT00145314|Antimetabolites|antimetabolites|mesh-ancestor
110247871|NCT00145314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247872|NCT00145314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110247873|NCT00145314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110247874|NCT00145314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110247875|NCT00145314|Immunologic Factors|immunologic factors|mesh-ancestor
110247876|NCT00145314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247877|NCT00145314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110247878|NCT00145314|Antidotes|antidotes|mesh-ancestor
110247879|NCT00145314|Protective Agents|protective agents|mesh-ancestor
110247880|NCT00145314|Vitamin B Complex|vitamin b complex|mesh-ancestor
110247881|NCT00145314|Vitamins|vitamins|mesh-ancestor
110247882|NCT00145314|Micronutrients|micronutrients|mesh-ancestor
110247883|NCT00145314|Hematinics|hematinics|mesh-ancestor
110247884|NCT00489190|Insulin glulisine|insulin glulisine|mesh-list
110247885|NCT00489190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110247886|NCT00489190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247887|NCT00489229|Rosiglitazone|rosiglitazone|mesh-list
110247888|NCT00489229|Ramipril|ramipril|mesh-list
110247889|NCT00489229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110247890|NCT00489229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247891|NCT00489229|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110247892|NCT00489229|Protease Inhibitors|protease inhibitors|mesh-ancestor
110247893|NCT00489229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110247894|NCT00489229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247896|NCT00489385|Ribavirin|ribavirin|mesh-list
110247897|NCT00489385|Antimetabolites|antimetabolites|mesh-ancestor
110247898|NCT00489385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247899|NCT00489385|Antiviral Agents|antiviral agents|mesh-ancestor
110247900|NCT00489385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110247901|NCT01242631|Everolimus|everolimus|mesh-list
110247902|NCT01242631|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110247903|NCT01242631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110247904|NCT01242631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110247905|NCT01242631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247906|NCT01242631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110247907|NCT01242631|Immunologic Factors|immunologic factors|mesh-ancestor
110247908|NCT01242631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247909|NCT01242631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110247911|NCT01242826|Biphasic Insulins|biphasic insulins|mesh-list
110247912|NCT01242826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110247913|NCT01242826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247915|NCT01242904|Dialysis Solutions|dialysis solutions|mesh-ancestor
110247916|NCT01242904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110247917|NCT00145353|Insulin Aspart|insulin aspart|mesh-list
110247918|NCT00145353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110247919|NCT00145353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247920|NCT00121979|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
110247921|NCT00121979|Racivir|racivir|mesh-list
110247922|NCT00121979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110247923|NCT00121979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110247924|NCT00121979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247925|NCT00121979|Antiviral Agents|antiviral agents|mesh-ancestor
110247926|NCT00121979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110247927|NCT00489658|Eflornithine|eflornithine|mesh-list
110247928|NCT00489658|Nifurtimox|nifurtimox|mesh-list
110247929|NCT00489658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110247930|NCT00489658|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110247931|NCT00489658|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110247932|NCT00489658|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110247933|NCT00489658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110247934|NCT00489658|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
110247935|NCT00489658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110247936|NCT00489658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247937|NCT00122018|Acetylcysteine|acetylcysteine|mesh-list
110247938|NCT00122018|Fenoldopam|fenoldopam|mesh-list
110247939|NCT00122018|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110247940|NCT00122018|Antiviral Agents|antiviral agents|mesh-ancestor
110247941|NCT00122018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110247942|NCT00122018|Expectorants|expectorants|mesh-ancestor
110247943|NCT00122018|Respiratory System Agents|respiratory system agents|mesh-ancestor
110247944|NCT00122018|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110247945|NCT00122018|Antioxidants|antioxidants|mesh-ancestor
110247946|NCT00122018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247947|NCT00122018|Protective Agents|protective agents|mesh-ancestor
110247948|NCT00122018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247949|NCT00122018|Antidotes|antidotes|mesh-ancestor
110247950|NCT00122018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110247951|NCT00122018|Vasodilator Agents|vasodilator agents|mesh-ancestor
110247952|NCT00122018|Dopamine Agonists|dopamine agonists|mesh-ancestor
110247953|NCT00122018|Dopamine Agents|dopamine agents|mesh-ancestor
110247954|NCT00122018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110247955|NCT00489775|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110247956|NCT00489775|Paroxetine|paroxetine|mesh-list
110247957|NCT00489775|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110247958|NCT00489775|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110247959|NCT00489775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110247960|NCT00489775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247961|NCT00489775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110247962|NCT00489775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247964|NCT00489775|Sensory System Agents|sensory system agents|mesh-ancestor
110247965|NCT00489775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110247966|NCT00489775|Antidepressive Agents|antidepressive agents|mesh-ancestor
110247967|NCT00489775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110247968|NCT00489775|Dopamine Agents|dopamine agents|mesh-ancestor
110247969|NCT00489775|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110247970|NCT00489775|Serotonin Agents|serotonin agents|mesh-ancestor
110247971|NCT00489775|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110247972|NCT00489775|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110247973|NCT00489775|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110247974|NCT00489775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110247975|NCT00122057|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110247976|NCT00122057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110247977|NCT00489892|Modafinil|modafinil|mesh-list
110247978|NCT00489892|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110247979|NCT00489892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247980|NCT00489892|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110247981|NCT00489892|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110247982|NCT00489892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110247983|NCT00489892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110247984|NCT00490087|Levonorgestrel|levonorgestrel|mesh-list
110247985|NCT00490087|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110247986|NCT00490087|Contraceptive Agents|contraceptive agents|mesh-ancestor
110247987|NCT00490087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110247988|NCT00490087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247989|NCT00490087|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110247990|NCT00490087|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110247991|NCT00490087|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110247992|NCT01243060|Zolpidem|zolpidem|mesh-list
110247993|NCT01243060|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110247994|NCT01243060|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110247995|NCT01243060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110247996|NCT01243060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247997|NCT01243060|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110247998|NCT01243060|GABA Agonists|gaba agonists|mesh-ancestor
110247999|NCT01243060|GABA Agents|gaba agents|mesh-ancestor
110248000|NCT01243060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110248001|NCT01243060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110248002|NCT00490204|Cetirizine|cetirizine|mesh-list
110248003|NCT00490204|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110248004|NCT00490204|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110248005|NCT00490204|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110248006|NCT00490204|Histamine Antagonists|histamine antagonists|mesh-ancestor
110248007|NCT00490204|Histamine Agents|histamine agents|mesh-ancestor
110248008|NCT00490204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110248009|NCT00490204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110248010|NCT00490204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248011|NCT00122096|Valdecoxib|valdecoxib|mesh-list
110248012|NCT00122096|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110248013|NCT00122096|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110248014|NCT00122096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110248015|NCT00122096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110248016|NCT00122096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110248017|NCT00122096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110248019|NCT00122096|Sensory System Agents|sensory system agents|mesh-ancestor
110248020|NCT00122096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110248021|NCT00122096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248022|NCT00122096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110248023|NCT00122096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110248024|NCT00490243|Budesonide|budesonide|mesh-list
110248025|NCT00490243|Formoterol Fumarate|formoterol fumarate|mesh-list
110248026|NCT00490243|Montelukast|montelukast|mesh-list
110248027|NCT00490243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110248028|NCT00490243|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110248030|NCT00490243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110248031|NCT00490243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248032|NCT00490243|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110248033|NCT00490243|Respiratory System Agents|respiratory system agents|mesh-ancestor
110248034|NCT00490243|Glucocorticoids|glucocorticoids|mesh-ancestor
110248035|NCT00490243|Hormones|hormones|mesh-ancestor
110248036|NCT00490243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110248037|NCT00490243|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110248038|NCT00490243|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110248039|NCT00490243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110248040|NCT00490243|Adrenergic Agents|adrenergic agents|mesh-ancestor
110248041|NCT00490243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110248042|NCT00490243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110248043|NCT00490243|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110248044|NCT00490243|Hormone Antagonists|hormone antagonists|mesh-ancestor
110248045|NCT00490243|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110248046|NCT00490243|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110248047|NCT00490360|Gemcitabine|gemcitabine|mesh-list
110248048|NCT00490360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110248049|NCT00490360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110248050|NCT00490360|Antimetabolites|antimetabolites|mesh-ancestor
110248051|NCT00490360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110248052|NCT00490399|Gemcitabine|gemcitabine|mesh-list
110248053|NCT00490399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110248054|NCT00490399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110248055|NCT00490399|Antimetabolites|antimetabolites|mesh-ancestor
110248056|NCT00490399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110248057|NCT04844385|Paclitaxel|paclitaxel|mesh-list
110248058|NCT04844385|Capecitabine|capecitabine|mesh-list
110248059|NCT04844385|Nedaplatin|nedaplatin|mesh-list
110248060|NCT04844385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110248061|NCT04844385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110248062|NCT04844385|Tubulin Modulators|tubulin modulators|mesh-ancestor
110248063|NCT04844385|Antimitotic Agents|antimitotic agents|mesh-ancestor
110248064|NCT04844385|Mitosis Modulators|mitosis modulators|mesh-ancestor
110248065|NCT04844385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110248066|NCT04844385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110248067|NCT04844385|Antimetabolites|antimetabolites|mesh-ancestor
110248068|NCT00490633|Ethanol|ethanol|mesh-list
110248069|NCT00490633|Hand Sanitizers|hand sanitizers|mesh-list
110248070|NCT00490633|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110248071|NCT00490633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110248072|NCT00490633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110248073|NCT00490633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248074|NCT00490633|Disinfectants|disinfectants|mesh-ancestor
110248075|NCT00490711|Paclitaxel|paclitaxel|mesh-list
110248076|NCT00490711|Carboplatin|carboplatin|mesh-list
110248077|NCT00490711|Gemcitabine|gemcitabine|mesh-list
110248078|NCT00490711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110248079|NCT00490711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110248080|NCT00490711|Tubulin Modulators|tubulin modulators|mesh-ancestor
110248081|NCT00490711|Antimitotic Agents|antimitotic agents|mesh-ancestor
110248082|NCT00490711|Mitosis Modulators|mitosis modulators|mesh-ancestor
110248083|NCT00490711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110248084|NCT00490711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110248085|NCT00490711|Antimetabolites|antimetabolites|mesh-ancestor
110248086|NCT00122291|Capecitabine|capecitabine|mesh-list
110248087|NCT00122291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110248088|NCT00122291|Antimetabolites|antimetabolites|mesh-ancestor
110248089|NCT00122291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110248090|NCT00122291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110248091|NCT00490789|Sirolimus|sirolimus|mesh-list
110248092|NCT00490789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110248093|NCT00490789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110248094|NCT00490789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110248095|NCT00490789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110248097|NCT00490789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110248098|NCT00490789|Immunologic Factors|immunologic factors|mesh-ancestor
110248099|NCT00490789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248100|NCT00490828|Hydrocortisone|hydrocortisone|mesh-list
110248101|NCT00490828|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110248102|NCT00490828|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110248103|NCT00490828|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110248104|NCT00490828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110248105|NCT00490867|Thioctic Acid|thioctic acid|mesh-list
110248106|NCT00490867|Antioxidants|antioxidants|mesh-ancestor
110248107|NCT00490867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110248108|NCT00490867|Protective Agents|protective agents|mesh-ancestor
110248109|NCT00490867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248111|NCT00490867|Vitamins|vitamins|mesh-ancestor
110248112|NCT00490867|Micronutrients|micronutrients|mesh-ancestor
110248113|NCT00122330|Eculizumab|eculizumab|mesh-list
110248114|NCT00122330|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110248115|NCT00122330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110248116|NCT00122330|Immunologic Factors|immunologic factors|mesh-ancestor
110248117|NCT00122330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248118|NCT00490906|Interferons|interferons|mesh-list
110248119|NCT00490906|Interferon-beta|interferon-beta|mesh-list
110248120|NCT00490906|Interferon beta-1a|interferon beta-1a|mesh-list
110248121|NCT00490906|Glatiramer Acetate|glatiramer acetate|mesh-list
110248122|NCT00490906|(T,G)-A-L|(t,g)-a-l|mesh-list
110248123|NCT00490906|Interferon beta-1b|interferon beta-1b|mesh-list
110248124|NCT00490906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110248125|NCT00490906|Antiviral Agents|antiviral agents|mesh-ancestor
110248126|NCT00490906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110248127|NCT00490906|Immunologic Factors|immunologic factors|mesh-ancestor
110248128|NCT00490906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248129|NCT00490906|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110248130|NCT00490906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110248131|NCT00490906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110248132|NCT00122486|Tenofovir|tenofovir|mesh-list
110248133|NCT00122486|Antiviral Agents|antiviral agents|mesh-ancestor
110248134|NCT00122486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110248135|NCT00122486|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110248136|NCT00122486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110248137|NCT00122486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110248138|NCT00122486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110248139|NCT00122486|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110248140|NCT00122486|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110248141|NCT00491413|Epoetin Alfa|epoetin alfa|mesh-list
110248142|NCT00491413|Hematinics|hematinics|mesh-ancestor
110248143|NCT00145665|Telbivudine|telbivudine|mesh-list
110248144|NCT00145665|Antiviral Agents|antiviral agents|mesh-ancestor
110248145|NCT00145665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110248146|NCT00145665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110248147|NCT00145665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110248148|NCT00145665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110248149|NCT00491725|Metformin|metformin|mesh-list
110248150|NCT00491725|Repaglinide|repaglinide|mesh-list
110248151|NCT00491725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110248152|NCT00491725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248153|NCT00491803|Sildenafil Citrate|sildenafil citrate|mesh-list
110248154|NCT00491803|Vasodilator Agents|vasodilator agents|mesh-ancestor
110248155|NCT00491803|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110248156|NCT00491803|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110248157|NCT00491803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110248158|NCT00491803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110248159|NCT00491803|Urological Agents|urological agents|mesh-ancestor
110248161|NCT00122603|Fosamprenavir|fosamprenavir|mesh-list
110248162|NCT00122603|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110248163|NCT00122603|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110248164|NCT00122603|Protease Inhibitors|protease inhibitors|mesh-ancestor
110248165|NCT00122603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110248166|NCT00122603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110248168|NCT00122603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110248169|NCT00122603|Antiviral Agents|antiviral agents|mesh-ancestor
110248170|NCT00122603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110248171|NCT00122603|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110248172|NCT00122603|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110248174|NCT00491920|Cholecalciferol|cholecalciferol|mesh-list
110248175|NCT00491920|Vitamins|vitamins|mesh-ancestor
110248176|NCT00491920|Micronutrients|micronutrients|mesh-ancestor
110248177|NCT00491920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248178|NCT00491920|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110248179|NCT00491920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110248180|NCT00491998|Entacapone|entacapone|mesh-list
110248181|NCT00491998|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110248182|NCT00491998|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110248183|NCT00491998|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
110248184|NCT00491998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110248185|NCT00491998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110248186|NCT00492037|Conivaptan|conivaptan|mesh-list
110248187|NCT00492037|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110248188|NCT00492037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110248190|NCT00492037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248191|NCT00402272|Everolimus|everolimus|mesh-list
110248192|NCT00402272|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110248193|NCT00402272|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110248194|NCT00402272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110248195|NCT00402272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110248196|NCT00402272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110248197|NCT00402272|Immunologic Factors|immunologic factors|mesh-ancestor
110248198|NCT00402272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248199|NCT00402272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110248200|NCT00492388|Ketamine|ketamine|mesh-list
110248201|NCT00492388|Analgesics|analgesics|mesh-ancestor
110248202|NCT00492388|Sensory System Agents|sensory system agents|mesh-ancestor
110248203|NCT00492388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110248204|NCT00492388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248205|NCT00492388|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110248206|NCT00492388|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110248207|NCT00492388|Anesthetics, General|anesthetics, general|mesh-ancestor
110248209|NCT00492388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110248210|NCT00492388|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110248211|NCT00492388|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110248212|NCT00492388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110248213|NCT00492388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110248214|NCT01243528|Vitamin D|vitamin d|mesh-list
110248215|NCT01243528|Vitamins|vitamins|mesh-ancestor
110248216|NCT01243528|Micronutrients|micronutrients|mesh-ancestor
110248217|NCT01243528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248218|NCT01243528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110248219|NCT00492427|Epoetin Alfa|epoetin alfa|mesh-list
110248220|NCT00492427|Hematinics|hematinics|mesh-ancestor
110248221|NCT00492466|Interferons|interferons|mesh-list
110248222|NCT00492466|Interferon-beta|interferon-beta|mesh-list
110248223|NCT00492466|Interferon beta-1a|interferon beta-1a|mesh-list
110248225|NCT00492466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110248227|NCT00492466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110248228|NCT00492466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110248229|NCT00492466|Antiemetics|antiemetics|mesh-ancestor
110248230|NCT00492466|Autonomic Agents|autonomic agents|mesh-ancestor
110248231|NCT00492466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110248232|NCT00492466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248233|NCT00492466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110248234|NCT00492466|Glucocorticoids|glucocorticoids|mesh-ancestor
110248235|NCT00492466|Hormones|hormones|mesh-ancestor
110248236|NCT00492466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110248237|NCT00492466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110248238|NCT00492466|Protective Agents|protective agents|mesh-ancestor
110248239|NCT00492466|Immunologic Factors|immunologic factors|mesh-ancestor
110248240|NCT00492466|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110248241|NCT00492505|Tamoxifen|tamoxifen|mesh-list
110248242|NCT00492505|Sorafenib|sorafenib|mesh-list
110248243|NCT00492505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110248244|NCT00492505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110248245|NCT00492505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110248246|NCT00492505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110248247|NCT00492505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110248248|NCT00492505|Hormone Antagonists|hormone antagonists|mesh-ancestor
110248249|NCT00492505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110248250|NCT00492505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248251|NCT00492505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110248252|NCT00492505|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110248253|NCT00492505|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110248254|NCT00492505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110248255|NCT00492661|Tacrolimus|tacrolimus|mesh-list
110248256|NCT00492661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110248257|NCT00492661|Immunologic Factors|immunologic factors|mesh-ancestor
110248258|NCT00492661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248259|NCT00492661|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110248260|NCT00492661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110248261|NCT00492661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110248262|NCT00492700|Rosiglitazone|rosiglitazone|mesh-list
110248263|NCT00492700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110248264|NCT00492700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248265|NCT00402350|Fentanyl|fentanyl|mesh-list
110248266|NCT00402350|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110248268|NCT00402350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110248269|NCT00402350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248270|NCT00402350|Analgesics|analgesics|mesh-ancestor
110248271|NCT00402350|Sensory System Agents|sensory system agents|mesh-ancestor
110248272|NCT00402350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110248273|NCT00402350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110248274|NCT00402350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110248275|NCT00402350|Anesthetics, General|anesthetics, general|mesh-ancestor
110248276|NCT00402350|Anesthetics|anesthetics|mesh-ancestor
110248277|NCT00122720|Darbepoetin alfa|darbepoetin alfa|mesh-list
110248278|NCT00122720|Hematinics|hematinics|mesh-ancestor
110248279|NCT00492934|Menotropins|menotropins|mesh-list
110248280|NCT00492934|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110248281|NCT00492934|Fertility Agents|fertility agents|mesh-ancestor
110248282|NCT00492934|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110248283|NCT00492934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248284|NCT02274454|Oxytocin|oxytocin|mesh-list
110248285|NCT02274454|Calcium|calcium|mesh-list
110248286|NCT02274454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110248287|NCT02274454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248288|NCT02274454|Oxytocics|oxytocics|mesh-ancestor
110248289|NCT02274454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110248291|NCT04760730|Immunologic Factors|immunologic factors|mesh-ancestor
110248292|NCT04760730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248293|NCT00122759|Ketamine|ketamine|mesh-list
110248294|NCT00122759|Analgesics|analgesics|mesh-ancestor
110248295|NCT00122759|Sensory System Agents|sensory system agents|mesh-ancestor
110248296|NCT00122759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110248297|NCT00122759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248298|NCT00122759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110248299|NCT00122759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110248300|NCT00122759|Anesthetics, General|anesthetics, general|mesh-ancestor
110248301|NCT00122759|Anesthetics|anesthetics|mesh-ancestor
110248302|NCT00122759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110248303|NCT00122759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110248304|NCT00122759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110248305|NCT00122759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110248306|NCT00122759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110248307|NCT00493129|Denileukin diftitox|denileukin diftitox|mesh-list
110248308|NCT00493129|Interleukin-2|interleukin-2|mesh-list
110248309|NCT00493129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110248310|NCT00493129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110248311|NCT00493129|Analgesics|analgesics|mesh-ancestor
110248312|NCT00493129|Sensory System Agents|sensory system agents|mesh-ancestor
110248313|NCT00493129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110248314|NCT00493129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248315|NCT00126542|Bevacizumab|bevacizumab|mesh-list
110248316|NCT00126542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110248317|NCT00126542|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110248318|NCT00126542|Antibodies|antibodies|mesh-list
110248319|NCT00126542|Immunoglobulins|immunoglobulins|mesh-list
110248320|NCT00126542|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110248321|NCT00126542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110248322|NCT00126542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110248323|NCT00126542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110248324|NCT00126542|Growth Substances|growth substances|mesh-ancestor
110248325|NCT00126542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248326|NCT00126542|Growth Inhibitors|growth inhibitors|mesh-ancestor
110248327|NCT00126542|Immunologic Factors|immunologic factors|mesh-ancestor
110248328|NCT00126542|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110248329|NCT00126542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110248330|NCT00126542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110248331|NCT00493324|Alefacept|alefacept|mesh-list
110248332|NCT00493324|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110248333|NCT00493324|Immunologic Factors|immunologic factors|mesh-ancestor
110248334|NCT00493324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248335|NCT00493324|Dermatologic Agents|dermatologic agents|mesh-ancestor
110248337|NCT01243801|Analgesics|analgesics|mesh-ancestor
110248338|NCT01243801|Sensory System Agents|sensory system agents|mesh-ancestor
110248339|NCT01243801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110248340|NCT01243801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248341|NCT01243801|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110248342|NCT01243801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110248343|NCT01243801|Anesthetics, General|anesthetics, general|mesh-ancestor
110248344|NCT01243801|Anesthetics|anesthetics|mesh-ancestor
110248345|NCT01243801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110248346|NCT01243801|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110248347|NCT01243801|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110248348|NCT01243801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110248349|NCT01243801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110248350|NCT00126620|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110248351|NCT00126620|Sorafenib|sorafenib|mesh-list
110248352|NCT00126620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110248353|NCT00126620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110248354|NCT00126620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110248355|NCT00126620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110248356|NCT00493363|Artesunate|artesunate|mesh-list
110248357|NCT00493363|Mefloquine|mefloquine|mesh-list
110248358|NCT00493363|Antimalarials|antimalarials|mesh-ancestor
110248359|NCT00493363|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110248360|NCT00493363|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110248361|NCT00493363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110248362|NCT00493363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110248363|NCT00493363|Antiviral Agents|antiviral agents|mesh-ancestor
110248364|NCT00493363|Schistosomicides|schistosomicides|mesh-ancestor
110248365|NCT00493363|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110248366|NCT00493363|Anthelmintics|anthelmintics|mesh-ancestor
110248367|NCT00126698|Ciprofloxacin|ciprofloxacin|mesh-list
110248368|NCT00126698|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110248369|NCT00126698|Trimethoprim|trimethoprim|mesh-list
110248370|NCT00126698|Sulfamethoxazole|sulfamethoxazole|mesh-list
110248371|NCT00126698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110248372|NCT00126698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110248373|NCT00126698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110248374|NCT00126698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110248375|NCT00126698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110248376|NCT00126698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110248377|NCT00126698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110248378|NCT00126698|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110248379|NCT00126698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110248380|NCT00126698|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110248381|NCT00126698|Antimalarials|antimalarials|mesh-ancestor
110248382|NCT00126698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110248383|NCT00126698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110248384|NCT00126698|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110248385|NCT00126698|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110248386|NCT00126698|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110248387|NCT00493402|Chlorotrianisene|chlorotrianisene|mesh-list
110248388|NCT00493402|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110248389|NCT00493402|Estrogens|estrogens|mesh-ancestor
110248390|NCT00493402|Hormones|hormones|mesh-ancestor
110248391|NCT00493402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110248392|NCT00493402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248393|NCT00493402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110248394|NCT00493402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110248395|NCT00145938|Sildenafil Citrate|sildenafil citrate|mesh-list
110248396|NCT00145938|Vasodilator Agents|vasodilator agents|mesh-ancestor
110248397|NCT00145938|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110248398|NCT00145938|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110248399|NCT00145938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110269034|NCT04015414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248400|NCT00145938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110248401|NCT00145938|Urological Agents|urological agents|mesh-ancestor
110248402|NCT00493480|Propranolol|propranolol|mesh-list
110248403|NCT00493480|Carvedilol|carvedilol|mesh-list
110248404|NCT00493480|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110248405|NCT00493480|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110248406|NCT00493480|Adrenergic Agents|adrenergic agents|mesh-ancestor
110248407|NCT00493480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110248408|NCT00493480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110248409|NCT00493480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248411|NCT00493480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110248412|NCT00493480|Vasodilator Agents|vasodilator agents|mesh-ancestor
110248413|NCT00493480|Antioxidants|antioxidants|mesh-ancestor
110248414|NCT00493480|Protective Agents|protective agents|mesh-ancestor
110248415|NCT00493480|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110248416|NCT00493480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110248417|NCT00493480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110248418|NCT00493480|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110248419|NCT00493480|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110248421|NCT01243996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110248422|NCT01243996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110248423|NCT01243996|Analgesics|analgesics|mesh-ancestor
110248424|NCT01243996|Sensory System Agents|sensory system agents|mesh-ancestor
110248425|NCT01243996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110248426|NCT01243996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248427|NCT01243996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110248428|NCT01243996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110248429|NCT01243996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110248430|NCT01243996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110248431|NCT01243996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110248433|NCT01244113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110248434|NCT01244113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110248435|NCT01244113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248436|NCT01244113|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110248437|NCT01244113|Anesthetics, General|anesthetics, general|mesh-ancestor
110248438|NCT01244113|Anesthetics|anesthetics|mesh-ancestor
110248439|NCT00405249|Dexelvucitabine|dexelvucitabine|mesh-list
110248440|NCT00405249|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110248441|NCT00405249|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110248442|NCT00405249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110248443|NCT00405249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110248444|NCT00405249|Antiviral Agents|antiviral agents|mesh-ancestor
110248445|NCT00405249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110248446|NCT00405249|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110248447|NCT00405249|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110248448|NCT00493987|Methyltestosterone|methyltestosterone|mesh-list
110248449|NCT00493987|Testosterone|testosterone|mesh-list
110248450|NCT00493987|Testosterone undecanoate|testosterone undecanoate|mesh-list
110248451|NCT00493987|Testosterone enanthate|testosterone enanthate|mesh-list
110248452|NCT00493987|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110248453|NCT00493987|Dutasteride|dutasteride|mesh-list
110248454|NCT00493987|Androgens|androgens|mesh-ancestor
110248455|NCT00493987|Hormones|hormones|mesh-ancestor
110248456|NCT00493987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110248457|NCT00493987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248458|NCT00493987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110248459|NCT00493987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110248460|NCT00493987|Anabolic Agents|anabolic agents|mesh-ancestor
110248461|NCT00493987|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110248462|NCT00493987|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110248463|NCT00493987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110248464|NCT00493987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110248465|NCT00493987|Hormone Antagonists|hormone antagonists|mesh-ancestor
110248466|NCT00494104|Vitamin D|vitamin d|mesh-list
110248467|NCT00494104|Vitamins|vitamins|mesh-ancestor
110248468|NCT00494104|Micronutrients|micronutrients|mesh-ancestor
110248469|NCT00494104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248470|NCT00494104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110248472|NCT00405366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110248473|NCT00405366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110248474|NCT00405366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110248475|NCT00405366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110248476|NCT00494338|Docetaxel|docetaxel|mesh-list
110248477|NCT00494338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110248478|NCT00494338|Tubulin Modulators|tubulin modulators|mesh-ancestor
110248479|NCT00494338|Antimitotic Agents|antimitotic agents|mesh-ancestor
110248480|NCT00494338|Mitosis Modulators|mitosis modulators|mesh-ancestor
110248481|NCT00494338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110248482|NCT00494377|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110248483|NCT00494377|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110248484|NCT00494377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110248485|NCT00494377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110248486|NCT00494377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110248487|NCT00494377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110248488|NCT00494377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248489|NCT00494377|Analgesics|analgesics|mesh-ancestor
110248490|NCT00494377|Sensory System Agents|sensory system agents|mesh-ancestor
110248491|NCT00494377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110248492|NCT00494377|Antidepressive Agents|antidepressive agents|mesh-ancestor
110248493|NCT00494377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110248494|NCT00494377|Dopamine Agents|dopamine agents|mesh-ancestor
110248496|NCT00146016|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110248497|NCT00146016|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110248498|NCT00146016|Antiviral Agents|antiviral agents|mesh-ancestor
110248499|NCT00146016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110248500|NCT00146016|Dopamine Agents|dopamine agents|mesh-ancestor
110248501|NCT00146016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110248502|NCT00146016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110248503|NCT00146016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248504|NCT00146016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110248505|NCT00146016|Analgesics|analgesics|mesh-ancestor
110248506|NCT00146016|Sensory System Agents|sensory system agents|mesh-ancestor
110248507|NCT00146016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110248508|NCT00126971|Dapsone|dapsone|mesh-list
110248509|NCT00126971|Chlorproguanil|chlorproguanil|mesh-list
110248510|NCT00126971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110248511|NCT00126971|Antimalarials|antimalarials|mesh-ancestor
110248512|NCT00126971|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110248513|NCT00126971|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110248514|NCT00126971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110248515|NCT00126971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110248516|NCT00126971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110248517|NCT00126971|Leprostatic Agents|leprostatic agents|mesh-ancestor
110248518|NCT00126971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110248519|NCT01244230|Fexofenadine|fexofenadine|mesh-list
110248520|NCT01244230|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110248521|NCT01244230|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110248522|NCT01244230|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110248523|NCT01244230|Histamine Antagonists|histamine antagonists|mesh-ancestor
110248524|NCT01244230|Histamine Agents|histamine agents|mesh-ancestor
110248525|NCT01244230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110248526|NCT01244230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110248527|NCT01244230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248528|NCT01244269|Methylphenidate|methylphenidate|mesh-list
110248529|NCT01244269|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110248530|NCT01244269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248531|NCT01244269|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110248532|NCT01244269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110248533|NCT01244269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110248534|NCT01244269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110248535|NCT01244269|Dopamine Agents|dopamine agents|mesh-ancestor
110248536|NCT01244269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110248537|NCT00127010|Vaccines|vaccines|mesh-list
110248538|NCT00127010|Immunologic Factors|immunologic factors|mesh-ancestor
110248539|NCT00127010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248540|NCT00494533|Treprostinil|treprostinil|mesh-list
110248541|NCT00494533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110248542|NCT00494572|Montelukast|montelukast|mesh-list
110248543|NCT00494572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110248544|NCT00494572|Respiratory System Agents|respiratory system agents|mesh-ancestor
110248546|NCT00494572|Hormone Antagonists|hormone antagonists|mesh-ancestor
110248547|NCT00494572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110248548|NCT00494572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248549|NCT00494572|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110248550|NCT00494572|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110248551|NCT00494572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110248552|NCT00494611|Cetuximab|cetuximab|mesh-list
110248553|NCT00494611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110248554|NCT00494611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110248555|NCT00127049|Gemcitabine|gemcitabine|mesh-list
110248556|NCT00127049|Ifosfamide|ifosfamide|mesh-list
110248557|NCT00127049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110248558|NCT00127049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110248559|NCT00127049|Antimetabolites|antimetabolites|mesh-ancestor
110248560|NCT00127049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110248561|NCT00127049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110248562|NCT00127049|Alkylating Agents|alkylating agents|mesh-ancestor
110248563|NCT00494884|Vildagliptin|vildagliptin|mesh-list
110248564|NCT00494884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110248565|NCT00494884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248566|NCT00494884|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110248567|NCT00494884|Protease Inhibitors|protease inhibitors|mesh-ancestor
110248568|NCT00494884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110248569|NCT00494884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110248570|NCT00127088|Docetaxel|docetaxel|mesh-list
110248571|NCT00127088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110248572|NCT00127088|Tubulin Modulators|tubulin modulators|mesh-ancestor
110248573|NCT00127088|Antimitotic Agents|antimitotic agents|mesh-ancestor
110248574|NCT00127088|Mitosis Modulators|mitosis modulators|mesh-ancestor
110248575|NCT00127088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110248576|NCT02957877|Heparin|heparin|mesh-list
110248577|NCT02957877|Calcium heparin|calcium heparin|mesh-list
110248578|NCT02957877|Nadroparin|nadroparin|mesh-list
110248579|NCT02957877|Anticoagulants|anticoagulants|mesh-ancestor
110248580|NCT02957877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110248581|NCT02957877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110248582|NCT02957877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110248583|NCT01244581|Amoxicillin|amoxicillin|mesh-list
110248584|NCT01244581|Clavulanic Acid|clavulanic acid|mesh-list
110248585|NCT01244581|Clavulanic Acids|clavulanic acids|mesh-list
110248586|NCT01244581|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110248587|NCT01244581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110248588|NCT01244581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110248589|NCT01244581|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110248590|NCT01244581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110248591|NCT01244581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110248592|NCT01244659|Tacrolimus|tacrolimus|mesh-list
110269066|NCT03757585|Inositol|inositol|mesh-list
110248593|NCT01244659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110248594|NCT01244659|Immunologic Factors|immunologic factors|mesh-ancestor
110248595|NCT01244659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248596|NCT01244659|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110248597|NCT01244659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110248598|NCT01244659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110248599|NCT01244698|Clindamycin|clindamycin|mesh-list
110248600|NCT01244698|Clindamycin palmitate|clindamycin palmitate|mesh-list
110248601|NCT01244698|Clindamycin phosphate|clindamycin phosphate|mesh-list
110248602|NCT01244698|Cefazolin|cefazolin|mesh-list
110248603|NCT01244698|Cefadroxil|cefadroxil|mesh-list
110248604|NCT01244698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110248605|NCT01244698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110248606|NCT01244698|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110248607|NCT01244698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110248608|NCT01244698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110248609|NCT00495118|Risperidone|risperidone|mesh-list
110248610|NCT00495118|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110248611|NCT00495118|Serotonin Agents|serotonin agents|mesh-ancestor
110248612|NCT00495118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110248613|NCT00495118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110248614|NCT00495118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248615|NCT00495118|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110248616|NCT00495118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110248617|NCT00495118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110248618|NCT00495118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110248619|NCT00495118|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110248620|NCT00495118|Dopamine Agents|dopamine agents|mesh-ancestor
110248621|NCT00495313|Metronidazole|metronidazole|mesh-list
110248622|NCT00495313|Doxycycline|doxycycline|mesh-list
110248623|NCT00495313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110248624|NCT00495313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110248625|NCT00495313|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110248626|NCT00495313|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110248627|NCT00495313|Antimalarials|antimalarials|mesh-ancestor
110248628|NCT00495352|Bupropion|bupropion|mesh-list
110248629|NCT00495352|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110248630|NCT00495352|Antidepressive Agents|antidepressive agents|mesh-ancestor
110248631|NCT00495352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110248632|NCT00495352|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110248633|NCT00495352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110248634|NCT00495352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110248635|NCT00495352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110248636|NCT00495352|Dopamine Agents|dopamine agents|mesh-ancestor
110248637|NCT00495352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110248638|NCT00495352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248639|NCT00495352|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110248640|NCT00495352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110248641|NCT00495352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110248642|NCT00495547|Azacitidine|azacitidine|mesh-list
110248643|NCT00495547|Epoetin Alfa|epoetin alfa|mesh-list
110248644|NCT00495547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110248645|NCT00495547|Antimetabolites|antimetabolites|mesh-ancestor
110248646|NCT00495547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110248647|NCT00495547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110248648|NCT00495547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110248649|NCT00495547|Hematinics|hematinics|mesh-ancestor
110248650|NCT00495781|Iron|iron|mesh-list
110248651|NCT00495781|Trace Elements|trace elements|mesh-ancestor
110248652|NCT00495781|Micronutrients|micronutrients|mesh-ancestor
110248653|NCT00495781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248654|NCT00405405|Bevacizumab|bevacizumab|mesh-list
110248656|NCT00405405|Docetaxel|docetaxel|mesh-list
110248657|NCT00405405|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110248658|NCT00405405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110248659|NCT00405405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110248660|NCT00405405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110248661|NCT00405405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110248662|NCT00405405|Growth Substances|growth substances|mesh-ancestor
110248663|NCT00405405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248664|NCT00405405|Growth Inhibitors|growth inhibitors|mesh-ancestor
110248665|NCT00405405|Tubulin Modulators|tubulin modulators|mesh-ancestor
110248666|NCT00405405|Antimitotic Agents|antimitotic agents|mesh-ancestor
110248667|NCT00405405|Mitosis Modulators|mitosis modulators|mesh-ancestor
110248668|NCT00405405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110248669|NCT00405405|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110248670|NCT00405405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110248671|NCT00495898|Sirolimus|sirolimus|mesh-list
110248672|NCT00495898|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110248673|NCT00495898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110248674|NCT00495898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110248675|NCT00495898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110248676|NCT00495898|Antifungal Agents|antifungal agents|mesh-ancestor
110248677|NCT00495898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110248678|NCT00495898|Immunologic Factors|immunologic factors|mesh-ancestor
110248679|NCT00495898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248680|NCT00496093|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110248681|NCT00496093|Immunologic Factors|immunologic factors|mesh-ancestor
110248682|NCT00496093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248684|NCT00127478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110248685|NCT00127478|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
110248686|NCT00127478|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110248687|NCT00127478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110248688|NCT00146211|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
110248689|NCT00146211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110248690|NCT00146211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110248691|NCT00496405|Bevacizumab|bevacizumab|mesh-list
110248692|NCT00496405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110248693|NCT00496405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110248694|NCT00496405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110248695|NCT00496405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110248696|NCT00496405|Growth Substances|growth substances|mesh-ancestor
110248697|NCT00496405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248698|NCT00496405|Growth Inhibitors|growth inhibitors|mesh-ancestor
110248699|NCT00496444|Azacitidine|azacitidine|mesh-list
110248700|NCT00496444|Valproic Acid|valproic acid|mesh-list
110248701|NCT00496444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110248702|NCT00496444|Antimetabolites|antimetabolites|mesh-ancestor
110248703|NCT00496444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110248704|NCT00496444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110248705|NCT00496444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110248706|NCT00496444|Anticonvulsants|anticonvulsants|mesh-ancestor
110248707|NCT00496444|GABA Agents|gaba agents|mesh-ancestor
110248708|NCT00496444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110248709|NCT00496444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248710|NCT00496444|Antimanic Agents|antimanic agents|mesh-ancestor
110248711|NCT00496444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110248712|NCT00496444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110248713|NCT00496444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110248714|NCT00496561|Immunomodulating Agents|immunomodulating agents|mesh-list
110248715|NCT00496561|Immunologic Factors|immunologic factors|mesh-list
110248716|NCT00496561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248717|NCT00146250|Nitrous Oxide|nitrous oxide|mesh-list
110248718|NCT00146250|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110248719|NCT00146250|Anesthetics, General|anesthetics, general|mesh-ancestor
110248720|NCT00146250|Anesthetics|anesthetics|mesh-ancestor
110248721|NCT00146250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110248722|NCT00146250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248723|NCT00146250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110248724|NCT00146250|Analgesics|analgesics|mesh-ancestor
110248725|NCT00146250|Sensory System Agents|sensory system agents|mesh-ancestor
110248726|NCT00146250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110248727|NCT00496600|Everolimus|everolimus|mesh-list
110248728|NCT00496600|Epothilone B|epothilone b|mesh-list
110248729|NCT00496600|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110248730|NCT00496600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110248731|NCT00496600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110248732|NCT00496600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110248733|NCT00496600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110248734|NCT00496600|Immunologic Factors|immunologic factors|mesh-ancestor
110248735|NCT00496600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248736|NCT00496600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110248737|NCT00496600|Tubulin Modulators|tubulin modulators|mesh-ancestor
110248738|NCT00496600|Antimitotic Agents|antimitotic agents|mesh-ancestor
110248739|NCT00496600|Mitosis Modulators|mitosis modulators|mesh-ancestor
110248740|NCT00127595|Gemcitabine|gemcitabine|mesh-list
110248741|NCT00127595|Oxaliplatin|oxaliplatin|mesh-list
110248742|NCT00127595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110248743|NCT00127595|Antimetabolites|antimetabolites|mesh-ancestor
110248744|NCT00127595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110248745|NCT00127595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110248747|NCT04665765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110248748|NCT04665765|Carboplatin|carboplatin|mesh-list
110248749|NCT04665765|Etoposide|etoposide|mesh-list
110248750|NCT04665765|Etoposide phosphate|etoposide phosphate|mesh-list
110248751|NCT04665765|Ifosfamide|ifosfamide|mesh-list
110248752|NCT04665765|Isophosphamide mustard|isophosphamide mustard|mesh-list
110248753|NCT04665765|Podophyllotoxin|podophyllotoxin|mesh-list
110248754|NCT04665765|Antibodies|antibodies|mesh-list
110248755|NCT04665765|Immunoglobulins|immunoglobulins|mesh-list
110248756|NCT04665765|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110248757|NCT04665765|Immunoconjugates|immunoconjugates|mesh-list
110248758|NCT04665765|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
110248759|NCT04665765|Immunologic Factors|immunologic factors|mesh-ancestor
110248760|NCT04665765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248761|NCT04665765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110248762|NCT04665765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110248763|NCT04665765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110248764|NCT04665765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110248765|NCT04665765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110248766|NCT04665765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110248767|NCT04665765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110248768|NCT04665765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110248769|NCT04665765|Alkylating Agents|alkylating agents|mesh-ancestor
110248770|NCT04665765|Keratolytic Agents|keratolytic agents|mesh-ancestor
110248771|NCT04665765|Dermatologic Agents|dermatologic agents|mesh-ancestor
110248772|NCT04665765|Tubulin Modulators|tubulin modulators|mesh-ancestor
110248773|NCT04665765|Antimitotic Agents|antimitotic agents|mesh-ancestor
110248774|NCT04665765|Mitosis Modulators|mitosis modulators|mesh-ancestor
110248775|NCT00497107|Calcium, Dietary|calcium, dietary|mesh-list
110248777|NCT00497107|Calcium|calcium|mesh-list
110248778|NCT00497107|Levoleucovorin|levoleucovorin|mesh-list
110248779|NCT00497107|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110248780|NCT00497107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248781|NCT00497107|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110248782|NCT00497107|Antidotes|antidotes|mesh-ancestor
110248783|NCT00497107|Protective Agents|protective agents|mesh-ancestor
110248784|NCT00497107|Vitamin B Complex|vitamin b complex|mesh-ancestor
110248785|NCT00497107|Vitamins|vitamins|mesh-ancestor
110248786|NCT00497107|Micronutrients|micronutrients|mesh-ancestor
110248787|NCT00146289|Telmisartan|telmisartan|mesh-list
110248788|NCT00146289|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110248789|NCT00146289|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110248790|NCT00146289|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110248791|NCT00146289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110248792|NCT01244932|Bupivacaine|bupivacaine|mesh-list
110248793|NCT01244932|Anesthetics, Local|anesthetics, local|mesh-ancestor
110248794|NCT01244932|Anesthetics|anesthetics|mesh-ancestor
110248795|NCT01244932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110248796|NCT01244932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248797|NCT01244932|Sensory System Agents|sensory system agents|mesh-ancestor
110248798|NCT01244932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110248799|NCT01244971|Acarbose|acarbose|mesh-list
110248800|NCT01244971|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110248801|NCT01244971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110248802|NCT01244971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110248803|NCT01244971|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110248804|NCT01244971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248805|NCT04599894|Pregabalin|pregabalin|mesh-list
110248806|NCT04599894|Analgesics|analgesics|mesh-ancestor
110248807|NCT04599894|Sensory System Agents|sensory system agents|mesh-ancestor
110248808|NCT04599894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110248809|NCT04599894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248810|NCT04599894|Anticonvulsants|anticonvulsants|mesh-ancestor
110248811|NCT04599894|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110248812|NCT04599894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110248813|NCT04599894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110248814|NCT04599894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110248815|NCT04599894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110248816|NCT04599894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110248817|NCT04599894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110248818|NCT04599894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110248819|NCT00497224|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110248820|NCT00497224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110248821|NCT00497224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110248822|NCT00497224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110248823|NCT00497224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110248825|NCT04726982|Anticonvulsants|anticonvulsants|mesh-ancestor
110248826|NCT04726982|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110248827|NCT04726982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110248828|NCT04726982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110248829|NCT04726982|Diuretics|diuretics|mesh-ancestor
110248830|NCT04726982|Natriuretic Agents|natriuretic agents|mesh-ancestor
110248831|NCT04726982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248832|NCT00497341|Cefuroxime|cefuroxime|mesh-list
110248833|NCT00497341|Cefuroxime axetil|cefuroxime axetil|mesh-list
110248834|NCT00497341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110248835|NCT00497341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110248836|NCT00127829|Gefitinib|gefitinib|mesh-list
110248837|NCT00127829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110248838|NCT00127829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110248839|NCT00127829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110248840|NCT00127829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110248841|NCT00497458|Testosterone|testosterone|mesh-list
110248842|NCT00497458|Androgens|androgens|mesh-ancestor
110248843|NCT00497458|Hormones|hormones|mesh-ancestor
110248844|NCT00497458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110248845|NCT00497458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248846|NCT00497497|Bevacizumab|bevacizumab|mesh-list
110248847|NCT00497497|Cetuximab|cetuximab|mesh-list
110248848|NCT00497497|Irinotecan|irinotecan|mesh-list
110248849|NCT00497497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110248850|NCT00497497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110248851|NCT00497497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110248852|NCT00497497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110248853|NCT00497497|Growth Substances|growth substances|mesh-ancestor
110248854|NCT00497497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248855|NCT00497497|Growth Inhibitors|growth inhibitors|mesh-ancestor
110248856|NCT00497497|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110248857|NCT00497497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110248858|NCT00497497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110248859|NCT00497497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110248860|NCT00127868|Selenium|selenium|mesh-list
110248861|NCT00127868|Ketoconazole|ketoconazole|mesh-list
110248862|NCT00127868|Ciclopirox|ciclopirox|mesh-list
110248863|NCT00127868|Griseofulvin|griseofulvin|mesh-list
110248864|NCT00127868|Selenium disulfide|selenium disulfide|mesh-list
110248865|NCT00127868|Antifungal Agents|antifungal agents|mesh-ancestor
110248866|NCT00127868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110248867|NCT00127868|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110248868|NCT00127868|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110248869|NCT00127868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110248870|NCT00127868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110248871|NCT00127868|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110248872|NCT00127868|Hormone Antagonists|hormone antagonists|mesh-ancestor
110248873|NCT00127868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110248874|NCT00127868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248875|NCT00127868|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110248876|NCT00127868|Antioxidants|antioxidants|mesh-ancestor
110248877|NCT00127868|Protective Agents|protective agents|mesh-ancestor
110248878|NCT00127868|Trace Elements|trace elements|mesh-ancestor
110248879|NCT00127868|Micronutrients|micronutrients|mesh-ancestor
110248880|NCT00127868|Dermatologic Agents|dermatologic agents|mesh-ancestor
110248881|NCT00497536|Insulin|insulin|mesh-list
110248882|NCT00497536|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110248884|NCT00497536|Insulin, Long-Acting|insulin, long-acting|mesh-list
110248885|NCT00497536|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110248886|NCT00497536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110248887|NCT00497536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248889|NCT00497614|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110248890|NCT00497614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110248891|NCT00497614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110248892|NCT00127907|Vasopressins|vasopressins|mesh-list
110248893|NCT00127907|Arginine Vasopressin|arginine vasopressin|mesh-list
110248894|NCT00127907|Epinephrine|epinephrine|mesh-list
110248895|NCT00127907|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110248896|NCT00127907|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110269144|NCT00185991|Gentamicins|gentamicins|mesh-list
110248897|NCT00127907|Adrenergic Agents|adrenergic agents|mesh-ancestor
110248898|NCT00127907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110248899|NCT00127907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110248900|NCT00127907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248901|NCT00127907|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110248902|NCT00127907|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110248903|NCT00127907|Autonomic Agents|autonomic agents|mesh-ancestor
110248904|NCT00127907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110248905|NCT00127907|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110248906|NCT00127907|Respiratory System Agents|respiratory system agents|mesh-ancestor
110248908|NCT00127907|Sympathomimetics|sympathomimetics|mesh-ancestor
110248909|NCT00127907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110248910|NCT00127907|Hemostatics|hemostatics|mesh-ancestor
110248911|NCT00127907|Coagulants|coagulants|mesh-ancestor
110248912|NCT00127907|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110248913|NCT00127907|Natriuretic Agents|natriuretic agents|mesh-ancestor
110248914|NCT00497809|Lenograstim|lenograstim|mesh-list
110248915|NCT00497809|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110248916|NCT00497809|Immunologic Factors|immunologic factors|mesh-ancestor
110248917|NCT00497809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248918|NCT00146484|Insulin|insulin|mesh-list
110248919|NCT00146484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110248920|NCT00146484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248921|NCT00402584|Sibutramine|sibutramine|mesh-list
110248922|NCT00402584|Antidepressive Agents|antidepressive agents|mesh-ancestor
110248923|NCT00402584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110248924|NCT00402584|Appetite Depressants|appetite depressants|mesh-ancestor
110248925|NCT00402584|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110248926|NCT00498004|Risperidone|risperidone|mesh-list
110248927|NCT00498004|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110248928|NCT00498004|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110248929|NCT00498004|Serotonin Agents|serotonin agents|mesh-ancestor
110248930|NCT00498004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110248931|NCT00498004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110248932|NCT00498004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248933|NCT00498004|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110248934|NCT00498004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110248935|NCT00498004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110248936|NCT00498004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110248937|NCT00498004|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110248938|NCT00498004|Dopamine Agents|dopamine agents|mesh-ancestor
110248939|NCT00498004|Antidepressive Agents|antidepressive agents|mesh-ancestor
110248940|NCT00146523|Mifepristone|mifepristone|mesh-list
110248941|NCT00146523|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110248942|NCT00146523|Abortifacient Agents|abortifacient agents|mesh-ancestor
110248943|NCT00146523|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110248944|NCT00146523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248945|NCT00146523|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110248946|NCT00146523|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110248947|NCT00146523|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110248948|NCT00146523|Contraceptive Agents|contraceptive agents|mesh-ancestor
110248949|NCT00146523|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110248950|NCT00146523|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110248951|NCT00146523|Hormone Antagonists|hormone antagonists|mesh-ancestor
110248952|NCT00146523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110248953|NCT00146523|Luteolytic Agents|luteolytic agents|mesh-ancestor
110248954|NCT00146523|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110248955|NCT00146523|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110248957|NCT00402623|Antioxidants|antioxidants|mesh-ancestor
110248958|NCT00402623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110248959|NCT00402623|Protective Agents|protective agents|mesh-ancestor
110248960|NCT00402623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248962|NCT00402662|Imatinib Mesylate|imatinib mesylate|mesh-list
110248963|NCT00402662|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110248964|NCT00402662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110248965|NCT00402662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110248966|NCT00402662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110248967|NCT00402662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110248968|NCT00402662|Immunologic Factors|immunologic factors|mesh-ancestor
110248969|NCT00402662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248970|NCT00402662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110248971|NCT00498316|Mycophenolic Acid|mycophenolic acid|mesh-list
110248972|NCT00498316|Cyclophosphamide|cyclophosphamide|mesh-list
110248973|NCT00498316|Melphalan|melphalan|mesh-list
110248974|NCT00498316|Busulfan|busulfan|mesh-list
110248975|NCT00498316|Rituximab|rituximab|mesh-list
110248976|NCT00498316|Fludarabine|fludarabine|mesh-list
110248977|NCT00498316|Fludarabine phosphate|fludarabine phosphate|mesh-list
110248978|NCT00498316|Clofarabine|clofarabine|mesh-list
110248979|NCT00498316|Tacrolimus|tacrolimus|mesh-list
110248980|NCT00498316|Thymoglobulin|thymoglobulin|mesh-list
110248981|NCT00498316|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110248982|NCT00498316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110248983|NCT00498316|Immunologic Factors|immunologic factors|mesh-ancestor
110248984|NCT00498316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248985|NCT00498316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110248986|NCT00498316|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110248987|NCT00498316|Alkylating Agents|alkylating agents|mesh-ancestor
110248988|NCT00498316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110248989|NCT00498316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110248990|NCT00498316|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110248991|NCT00498316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110248992|NCT00498316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110248993|NCT00498316|Antimetabolites|antimetabolites|mesh-ancestor
110248994|NCT00498316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110248995|NCT00498316|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110248996|NCT00498316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110248997|NCT00498316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110248998|NCT00498316|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110248999|NCT00498316|Antitubercular Agents|antitubercular agents|mesh-ancestor
110249000|NCT00498316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110249001|NCT01245166|Metformin|metformin|mesh-list
110249002|NCT01245166|Acarbose|acarbose|mesh-list
110249003|NCT01245166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110249004|NCT01245166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110249005|NCT01245166|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110249006|NCT01245166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110249007|NCT01245166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110249008|NCT00146601|Fulvestrant|fulvestrant|mesh-list
110249009|NCT00146601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110249010|NCT00146601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110249011|NCT00146601|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110249012|NCT00146601|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110249013|NCT00146601|Hormone Antagonists|hormone antagonists|mesh-ancestor
110249014|NCT00146601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110249015|NCT00146601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110249016|NCT00498589|Methotrexate|methotrexate|mesh-list
110249017|NCT00498589|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110249018|NCT00498589|Abortifacient Agents|abortifacient agents|mesh-ancestor
110249019|NCT00498589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110249020|NCT00498589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110249021|NCT00498589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110249022|NCT00498589|Antimetabolites|antimetabolites|mesh-ancestor
110249023|NCT00498589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110249024|NCT00498589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110249025|NCT00498589|Dermatologic Agents|dermatologic agents|mesh-ancestor
110269163|NCT03318952|Lidocaine|lidocaine|mesh-list
110249026|NCT00498589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110249027|NCT00498589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110249028|NCT00498589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110249029|NCT00498589|Immunologic Factors|immunologic factors|mesh-ancestor
110249030|NCT00498589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110249031|NCT00498589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110249033|NCT00498784|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110249034|NCT00498784|Contraceptive Agents|contraceptive agents|mesh-ancestor
110249035|NCT00498784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110249036|NCT00498784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110249037|NCT00498784|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110249038|NCT00498784|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110249039|NCT00498784|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110249040|NCT00498901|Letrozole|letrozole|mesh-list
110249041|NCT00498901|Leuprolide|leuprolide|mesh-list
110249042|NCT00498901|Goserelin|goserelin|mesh-list
110249043|NCT00498901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110249044|NCT00498901|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110249045|NCT00498901|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110249046|NCT00498901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110249047|NCT00498901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110249048|NCT00498901|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110249049|NCT00498901|Hormone Antagonists|hormone antagonists|mesh-ancestor
110249050|NCT00498901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110249051|NCT00498901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110249052|NCT00498901|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110249053|NCT00498901|Fertility Agents|fertility agents|mesh-ancestor
110249054|NCT00498901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110249055|NCT00498901|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110249056|NCT00498979|Interferons|interferons|mesh-list
110249057|NCT00498979|Interferon-alpha|interferon-alpha|mesh-list
110249058|NCT00498979|Interferon alpha-2|interferon alpha-2|mesh-list
110249059|NCT00498979|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
110249060|NCT00498979|Dacarbazine|dacarbazine|mesh-list
110249061|NCT00498979|Vinblastine|vinblastine|mesh-list
110249062|NCT00498979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110249063|NCT00498979|Antiviral Agents|antiviral agents|mesh-ancestor
110249064|NCT00498979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110249065|NCT00498979|Immunologic Factors|immunologic factors|mesh-ancestor
110249066|NCT00498979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110249067|NCT00498979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110249068|NCT00498979|Alkylating Agents|alkylating agents|mesh-ancestor
110249069|NCT00498979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110249070|NCT00498979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110249071|NCT00498979|Tubulin Modulators|tubulin modulators|mesh-ancestor
110249072|NCT00498979|Antimitotic Agents|antimitotic agents|mesh-ancestor
110249073|NCT00498979|Mitosis Modulators|mitosis modulators|mesh-ancestor
110249074|NCT00498979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110249075|NCT00498979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110249076|NCT00498979|Schistosomicides|schistosomicides|mesh-ancestor
110249077|NCT00498979|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110249078|NCT00498979|Anthelmintics|anthelmintics|mesh-ancestor
110249079|NCT01245205|Lapatinib|lapatinib|mesh-list
110249080|NCT01245205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110249081|NCT01245205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110249083|NCT01245205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110249085|NCT01245244|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110249086|NCT01245244|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110249087|NCT01245244|Narcotics|narcotics|mesh-ancestor
110249088|NCT01245244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110249089|NCT01245244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110249091|NCT01245244|Sensory System Agents|sensory system agents|mesh-ancestor
110249092|NCT01245244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110249093|NCT00405717|Atorvastatin|atorvastatin|mesh-list
110249094|NCT00405717|Pravastatin|pravastatin|mesh-list
110249095|NCT00405717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110249096|NCT00405717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110249097|NCT00405717|Antimetabolites|antimetabolites|mesh-ancestor
110249098|NCT00405717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110249099|NCT00405717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110249100|NCT00405717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110249101|NCT00405717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110249102|NCT00499018|Cytarabine|cytarabine|mesh-list
110249103|NCT00499018|Prednisone|prednisone|mesh-list
110249104|NCT00499018|Rituximab|rituximab|mesh-list
110249105|NCT00499018|Mitoxantrone|mitoxantrone|mesh-list
110249106|NCT00499018|Cyclophosphamide|cyclophosphamide|mesh-list
110249107|NCT00499018|Vincristine|vincristine|mesh-list
110249108|NCT00499018|Doxorubicin|doxorubicin|mesh-list
110249109|NCT00499018|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110249110|NCT00499018|Lenograstim|lenograstim|mesh-list
110249111|NCT00499018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110249112|NCT00499018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110249113|NCT00499018|Immunologic Factors|immunologic factors|mesh-ancestor
110249114|NCT00499018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110249115|NCT00499018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110249116|NCT00499018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110249117|NCT00499018|Glucocorticoids|glucocorticoids|mesh-ancestor
110249118|NCT00499018|Hormones|hormones|mesh-ancestor
110249119|NCT00499018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110249120|NCT00499018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110249121|NCT00499018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110249122|NCT00499018|Antimetabolites|antimetabolites|mesh-ancestor
110249123|NCT00499018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110249124|NCT00499018|Antiviral Agents|antiviral agents|mesh-ancestor
110249125|NCT00499018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110249126|NCT00499018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110249127|NCT00499018|Analgesics|analgesics|mesh-ancestor
110249128|NCT00499018|Sensory System Agents|sensory system agents|mesh-ancestor
110249129|NCT00499018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110249130|NCT00499018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110249131|NCT00499018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110249132|NCT00499018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110249133|NCT00499018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110249134|NCT00499018|Alkylating Agents|alkylating agents|mesh-ancestor
110249135|NCT00499018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110249136|NCT00499018|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110249137|NCT00499018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110249138|NCT00499018|Tubulin Modulators|tubulin modulators|mesh-ancestor
110249139|NCT00499018|Antimitotic Agents|antimitotic agents|mesh-ancestor
110249140|NCT00499018|Mitosis Modulators|mitosis modulators|mesh-ancestor
110249141|NCT00499018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110249142|NCT00127985|Prednisolone|prednisolone|mesh-list
110249143|NCT00127985|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110249144|NCT00127985|Methylprednisolone|methylprednisolone|mesh-list
110249145|NCT00127985|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110249146|NCT00127985|Prednisolone acetate|prednisolone acetate|mesh-list
110249147|NCT00127985|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110249148|NCT00127985|Prednisolone phosphate|prednisolone phosphate|mesh-list
110249149|NCT00127985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110249150|NCT00127985|Glucocorticoids|glucocorticoids|mesh-ancestor
110249151|NCT00127985|Hormones|hormones|mesh-ancestor
110249152|NCT00127985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110269184|NCT00192660|Nevirapine|nevirapine|mesh-list
110249153|NCT00127985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110249154|NCT00127985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110249155|NCT00127985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110249156|NCT00127985|Antiemetics|antiemetics|mesh-ancestor
110249157|NCT00127985|Autonomic Agents|autonomic agents|mesh-ancestor
110249158|NCT00127985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110249159|NCT00127985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110249160|NCT00127985|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110249161|NCT00127985|Protective Agents|protective agents|mesh-ancestor
110249162|NCT00424164|Tamoxifen|tamoxifen|mesh-list
110249163|NCT00424164|Lapatinib|lapatinib|mesh-list
110249164|NCT00424164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110249165|NCT00424164|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110249166|NCT00424164|Hormone Antagonists|hormone antagonists|mesh-ancestor
110249167|NCT00424164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110249168|NCT00424164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110249169|NCT00424164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110249170|NCT00424164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110249171|NCT00424164|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110249172|NCT00424164|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110249173|NCT00424164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110249174|NCT00424164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110249175|NCT00424164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110249176|NCT00499135|Alovudine|alovudine|mesh-list
110249177|NCT00499135|Sunitinib|sunitinib|mesh-list
110249178|NCT00499135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110249179|NCT00499135|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110249180|NCT00499135|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110249181|NCT00499135|Growth Substances|growth substances|mesh-ancestor
110249182|NCT00499135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110249183|NCT00499135|Growth Inhibitors|growth inhibitors|mesh-ancestor
110249184|NCT00499135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110249185|NCT00499135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110249186|NCT00499135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110249187|NCT00499135|Antiviral Agents|antiviral agents|mesh-ancestor
110249188|NCT00499135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110249189|NCT01245361|Infliximab|infliximab|mesh-list
110249190|NCT01245361|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110249191|NCT01245361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110249192|NCT01245361|Dermatologic Agents|dermatologic agents|mesh-ancestor
110249193|NCT01245361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110249194|NCT01245361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110249195|NCT00424203|Cyclophosphamide|cyclophosphamide|mesh-list
110249196|NCT00424203|Doxorubicin|doxorubicin|mesh-list
110249197|NCT00424203|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110249198|NCT00424203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110249199|NCT00424203|Immunologic Factors|immunologic factors|mesh-ancestor
110249200|NCT00424203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110249201|NCT00424203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110249202|NCT00424203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110249203|NCT00424203|Alkylating Agents|alkylating agents|mesh-ancestor
110249204|NCT00424203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110249205|NCT00424203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110249213|NCT01245556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110249214|NCT01245556|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110249215|NCT01245556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110249217|NCT00499525|Sorafenib|sorafenib|mesh-list
110249218|NCT00499525|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110249219|NCT00499525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110249220|NCT00499525|Tubulin Modulators|tubulin modulators|mesh-ancestor
110249221|NCT00499525|Antimitotic Agents|antimitotic agents|mesh-ancestor
110249222|NCT00499525|Mitosis Modulators|mitosis modulators|mesh-ancestor
110249223|NCT00499525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110249224|NCT00499525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110249225|NCT00499525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110249226|NCT00499642|Moxifloxacin|moxifloxacin|mesh-list
110249227|NCT00499642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110249228|NCT00499642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110249229|NCT00499642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110249230|NCT00499642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110249231|NCT00499642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110249232|NCT00499642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110249233|NCT00499642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110249235|NCT00499720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110249236|NCT00499720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110249244|NCT00499837|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
110249245|NCT00499837|Protein C Inhibitor|protein c inhibitor|mesh-list
110249246|NCT00499837|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110249247|NCT00499837|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110249248|NCT00499837|Protease Inhibitors|protease inhibitors|mesh-ancestor
110249249|NCT00499837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110249250|NCT00499837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110249252|NCT00499876|Antimalarials|antimalarials|mesh-ancestor
110249253|NCT00499876|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110249254|NCT00499876|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110249255|NCT00499876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110249256|NCT00146718|Pyrimethamine|pyrimethamine|mesh-list
110249257|NCT00146718|Sulfadoxine|sulfadoxine|mesh-list
110249258|NCT00146718|Amodiaquine|amodiaquine|mesh-list
110249259|NCT00146718|Antimalarials|antimalarials|mesh-ancestor
110249260|NCT00146718|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110249261|NCT00146718|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110249262|NCT00146718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110249263|NCT00146718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110249264|NCT00146718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110249265|NCT00146718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110249266|NCT00146718|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110249267|NCT00499993|Lanreotide|lanreotide|mesh-list
110249268|NCT00499993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110249269|NCT00500188|Imatinib Mesylate|imatinib mesylate|mesh-list
110249270|NCT00500188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110249271|NCT00500188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110249272|NCT00500188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110249273|NCT00500188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110249274|NCT04710914|Midazolam|midazolam|mesh-list
110249275|NCT04710914|Isoflurane|isoflurane|mesh-list
110249276|NCT04710914|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110249277|NCT04710914|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110249278|NCT04710914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110249279|NCT04710914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269215|NCT00163241|Celecoxib|celecoxib|mesh-list
110249280|NCT04710914|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110249281|NCT04710914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110249282|NCT04710914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110249283|NCT04710914|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110249284|NCT04710914|Anesthetics, General|anesthetics, general|mesh-ancestor
110249285|NCT04710914|Anesthetics|anesthetics|mesh-ancestor
110249286|NCT04710914|GABA Modulators|gaba modulators|mesh-ancestor
110249287|NCT04710914|GABA Agents|gaba agents|mesh-ancestor
110249288|NCT04710914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110249289|NCT04710914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110249290|NCT04710914|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110249291|NCT00500344|Ranibizumab|ranibizumab|mesh-list
110249292|NCT00500344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110249293|NCT00500344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110249294|NCT00500344|Growth Substances|growth substances|mesh-ancestor
110249295|NCT00500344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110249296|NCT00500344|Growth Inhibitors|growth inhibitors|mesh-ancestor
110249297|NCT00500344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110249298|NCT00146835|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110249299|NCT00146835|Immunologic Factors|immunologic factors|mesh-ancestor
110249300|NCT00146835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110249302|NCT01245868|Bupivacaine|bupivacaine|mesh-list
110249303|NCT01245868|Anesthetics, Local|anesthetics, local|mesh-ancestor
110249304|NCT01245868|Anesthetics|anesthetics|mesh-ancestor
110249305|NCT01245868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110249306|NCT01245868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110249307|NCT01245868|Sensory System Agents|sensory system agents|mesh-ancestor
110249308|NCT01245868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110249309|NCT01245868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110249310|NCT01245868|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110249311|NCT01245868|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110249312|NCT01245868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110249313|NCT01245868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110249314|NCT00500422|Gemcitabine|gemcitabine|mesh-list
110249315|NCT00500422|Doxorubicin|doxorubicin|mesh-list
110249316|NCT00500422|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110249317|NCT00500422|Bortezomib|bortezomib|mesh-list
110249318|NCT00500422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110249319|NCT00500422|Antimetabolites|antimetabolites|mesh-ancestor
110249320|NCT00500422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110249321|NCT00500422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110249322|NCT00500422|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110249323|NCT00500422|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110249324|NCT00500422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110249325|NCT00500422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110249326|NCT01245946|Doxycycline|doxycycline|mesh-list
110249327|NCT01245946|Adapalene|adapalene|mesh-list
110249328|NCT01245946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110249329|NCT01245946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110249330|NCT01245946|Antimalarials|antimalarials|mesh-ancestor
110249331|NCT01245946|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110249332|NCT01245946|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110249333|NCT01245946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110249334|NCT01245946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110249335|NCT01245946|Analgesics|analgesics|mesh-ancestor
110249336|NCT01245946|Sensory System Agents|sensory system agents|mesh-ancestor
110249338|NCT01245946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110249339|NCT01245946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110249340|NCT01245946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110249341|NCT01245946|Dermatologic Agents|dermatologic agents|mesh-ancestor
110249342|NCT00146913|Interferons|interferons|mesh-list
110249343|NCT00146913|Imatinib Mesylate|imatinib mesylate|mesh-list
110249344|NCT00146913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110249345|NCT00146913|Antiviral Agents|antiviral agents|mesh-ancestor
110249346|NCT00146913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110249347|NCT00146913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110249349|NCT00146913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110249350|NCT00501124|Clevudine|clevudine|mesh-list
110249351|NCT00501124|Antiviral Agents|antiviral agents|mesh-ancestor
110249352|NCT00501124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110249353|NCT00501241|ATI 7505|ati 7505|mesh-list
110249354|NCT00501241|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
110249355|NCT00501241|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110249356|NCT00501241|Serotonin Agents|serotonin agents|mesh-ancestor
110249357|NCT00501241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110249358|NCT00501241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110249359|NCT00501241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110249360|NCT01246180|Diclofenac|diclofenac|mesh-list
110249361|NCT01246180|Amiloride|amiloride|mesh-list
110249362|NCT01246180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110249363|NCT01246180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110249364|NCT01246180|Analgesics|analgesics|mesh-ancestor
110249365|NCT01246180|Sensory System Agents|sensory system agents|mesh-ancestor
110249366|NCT01246180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110249367|NCT01246180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110249368|NCT01246180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110249369|NCT01246180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110249370|NCT01246180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110249371|NCT01246180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110249372|NCT01246180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110249373|NCT01246180|Diuretics|diuretics|mesh-ancestor
110249374|NCT01246180|Natriuretic Agents|natriuretic agents|mesh-ancestor
110249375|NCT01246180|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
110249376|NCT01246180|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110249377|NCT01246180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110249378|NCT01246180|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
110249379|NCT01246180|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110249380|NCT05561972|Hyaluronic Acid|hyaluronic acid|mesh-list
110249381|NCT05561972|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110249382|NCT05561972|Immunologic Factors|immunologic factors|mesh-ancestor
110249383|NCT05561972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110249384|NCT05561972|Viscosupplements|viscosupplements|mesh-ancestor
110249385|NCT05561972|Protective Agents|protective agents|mesh-ancestor
110249386|NCT02274610|Docetaxel|docetaxel|mesh-list
110249387|NCT02274610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110249388|NCT02274610|Tubulin Modulators|tubulin modulators|mesh-ancestor
110249389|NCT02274610|Antimitotic Agents|antimitotic agents|mesh-ancestor
110249390|NCT02274610|Mitosis Modulators|mitosis modulators|mesh-ancestor
110249391|NCT02274610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110249392|NCT00501397|Ketoconazole|ketoconazole|mesh-list
110249393|NCT00501397|Antifungal Agents|antifungal agents|mesh-ancestor
110249394|NCT00501397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110249395|NCT00501397|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110249396|NCT00501397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110249397|NCT00501397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110249398|NCT00501397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110249399|NCT00501397|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110249400|NCT00501397|Hormone Antagonists|hormone antagonists|mesh-ancestor
110249401|NCT00501397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110249403|NCT00501397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110249404|NCT00501514|Hormones|hormones|mesh-list
110249405|NCT00501514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110249406|NCT00501514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110249408|NCT00147186|Viscosupplements|viscosupplements|mesh-ancestor
110249409|NCT00147186|Protective Agents|protective agents|mesh-ancestor
110249410|NCT00147186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110249411|NCT00501748|Rituximab|rituximab|mesh-list
110249412|NCT00501748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110249413|NCT00501748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110249414|NCT00501748|Immunologic Factors|immunologic factors|mesh-ancestor
110249415|NCT00501748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110249416|NCT00501748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110249417|NCT00501787|Metformin|metformin|mesh-list
110249418|NCT00501787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110249419|NCT00501787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110249420|NCT00147264|Telmisartan|telmisartan|mesh-list
110249421|NCT00147264|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110249422|NCT00147264|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110249423|NCT00147264|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110249424|NCT00147264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110249425|NCT00501904|Metformin|metformin|mesh-list
110249426|NCT00501904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110249427|NCT00501904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110249428|NCT00501982|Poractant alfa|poractant alfa|mesh-list
110249429|NCT00501982|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
110249430|NCT00501982|Respiratory System Agents|respiratory system agents|mesh-ancestor
110249431|NCT00147303|Sarpogrelate|sarpogrelate|mesh-list
110249432|NCT00147303|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110249433|NCT00147303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110249434|NCT00147303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110249435|NCT00147303|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110249436|NCT00147303|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110249437|NCT00147303|Serotonin Agents|serotonin agents|mesh-ancestor
110249438|NCT00147303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110249439|NCT00147303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110249441|NCT00502060|Gefitinib|gefitinib|mesh-list
110249442|NCT00502060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110249443|NCT00502060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110249444|NCT00502060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110249445|NCT00502060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110249446|NCT00502099|Interferons|interferons|mesh-list
110249447|NCT00502099|Ribavirin|ribavirin|mesh-list
110249448|NCT00502099|Interferon-alpha|interferon-alpha|mesh-list
110249449|NCT00502099|Interferon alpha-2|interferon alpha-2|mesh-list
110249450|NCT00502099|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110249451|NCT00502099|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110249452|NCT00502099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110249453|NCT00502099|Antiviral Agents|antiviral agents|mesh-ancestor
110249454|NCT00502099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110249455|NCT00502099|Antimetabolites|antimetabolites|mesh-ancestor
110249456|NCT00502099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110249457|NCT00502099|Immunologic Factors|immunologic factors|mesh-ancestor
110249458|NCT00502099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110249459|NCT00502138|Pramlintide|pramlintide|mesh-list
110249460|NCT00502138|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
110249462|NCT00502138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110249463|NCT00502138|Appetite Depressants|appetite depressants|mesh-ancestor
110249464|NCT00502138|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110249465|NCT00502138|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
110249466|NCT00502138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110249467|NCT00502294|Visilizumab|visilizumab|mesh-list
110249468|NCT00502294|Immunologic Factors|immunologic factors|mesh-ancestor
110249469|NCT00502294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110249470|NCT00502411|Doxorubicin|doxorubicin|mesh-list
110249471|NCT00502411|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110249472|NCT00502411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110249473|NCT00502411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110249474|NCT00502411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110249475|NCT00502411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110249476|NCT00502411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110249477|NCT00502411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110249478|NCT00502528|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
110249479|NCT00502528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110249480|NCT00502528|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110249481|NCT00502528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110249482|NCT00147381|Alemtuzumab|alemtuzumab|mesh-list
110249484|NCT00147381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110249485|NCT00147381|Immunologic Factors|immunologic factors|mesh-ancestor
110249486|NCT00147381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110249487|NCT00147381|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110249488|NCT00147381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110249489|NCT00147381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110249490|NCT00147381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110249491|NCT00147381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110249492|NCT00502567|Leucovorin|leucovorin|mesh-list
110249493|NCT00502567|Docetaxel|docetaxel|mesh-list
110249494|NCT00502567|Fluorouracil|fluorouracil|mesh-list
110249495|NCT00502567|Oxaliplatin|oxaliplatin|mesh-list
110249496|NCT00502567|Irinotecan|irinotecan|mesh-list
110249497|NCT00502567|Pemetrexed|pemetrexed|mesh-list
110249498|NCT00502567|Cetuximab|cetuximab|mesh-list
110249499|NCT00502567|Cediranib|cediranib|mesh-list
110249500|NCT00502567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110249501|NCT00502567|Tubulin Modulators|tubulin modulators|mesh-ancestor
110249502|NCT00502567|Antimitotic Agents|antimitotic agents|mesh-ancestor
110249503|NCT00502567|Mitosis Modulators|mitosis modulators|mesh-ancestor
110249504|NCT00502567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110249505|NCT00502567|Antimetabolites|antimetabolites|mesh-ancestor
110249506|NCT00502567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110249507|NCT00502567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110249508|NCT00502567|Immunologic Factors|immunologic factors|mesh-ancestor
110249509|NCT00502567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110249510|NCT00502567|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110249511|NCT00502567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110249513|NCT00502567|Antidotes|antidotes|mesh-ancestor
110249514|NCT00502567|Protective Agents|protective agents|mesh-ancestor
110249515|NCT00502567|Vitamin B Complex|vitamin b complex|mesh-ancestor
110249516|NCT00502567|Vitamins|vitamins|mesh-ancestor
110249517|NCT00502567|Micronutrients|micronutrients|mesh-ancestor
110249518|NCT00502567|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110249519|NCT00502567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110249520|NCT00502567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110249522|NCT05561231|Pyrithione zinc|pyrithione zinc|mesh-list
110249523|NCT05561231|Keratolytic Agents|keratolytic agents|mesh-ancestor
110249524|NCT05561231|Dermatologic Agents|dermatologic agents|mesh-ancestor
110249525|NCT00502684|Etodolac|etodolac|mesh-list
110249526|NCT00502684|Propranolol|propranolol|mesh-list
110249527|NCT00502684|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110249528|NCT00502684|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110249529|NCT00502684|Adrenergic Agents|adrenergic agents|mesh-ancestor
110249530|NCT00502684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110249531|NCT00502684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110249532|NCT00502684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110249534|NCT00502684|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110249535|NCT00502684|Vasodilator Agents|vasodilator agents|mesh-ancestor
110249536|NCT00502684|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110249537|NCT00502684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110249538|NCT00502684|Analgesics|analgesics|mesh-ancestor
110249539|NCT00502684|Sensory System Agents|sensory system agents|mesh-ancestor
110249541|NCT00502684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110249542|NCT00502684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110249543|NCT00502684|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110249544|NCT00502684|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110249545|NCT00502684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110249547|NCT00502762|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110249548|NCT00502762|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110249549|NCT00502762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110249550|NCT00502762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110249551|NCT00502762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110249552|NCT00502879|Etanercept|etanercept|mesh-list
110249553|NCT00502879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110249554|NCT00502879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110249555|NCT00502879|Analgesics|analgesics|mesh-ancestor
110249556|NCT00502879|Sensory System Agents|sensory system agents|mesh-ancestor
110249557|NCT00502879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110249558|NCT00502879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110249559|NCT00502879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110249560|NCT00502879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110249561|NCT00502879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110249562|NCT00502879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110249563|NCT00502879|Immunologic Factors|immunologic factors|mesh-ancestor
110249564|NCT00503152|Valsartan|valsartan|mesh-list
110249565|NCT00503152|Benazepril|benazepril|mesh-list
110249566|NCT00503152|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110249567|NCT00503152|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110249568|NCT00503152|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110249569|NCT00503152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110249570|NCT00503152|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110249571|NCT00503152|Protease Inhibitors|protease inhibitors|mesh-ancestor
110249572|NCT00503152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110249573|NCT00503347|Bavituximab|bavituximab|mesh-list
110249574|NCT00503347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110249575|NCT00503347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110249576|NCT00503386|Palonosetron|palonosetron|mesh-list
110249577|NCT00503386|Granisetron|granisetron|mesh-list
110249578|NCT00503386|Antiemetics|antiemetics|mesh-ancestor
110249579|NCT00503386|Autonomic Agents|autonomic agents|mesh-ancestor
110249580|NCT00503386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110249581|NCT00503386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110249582|NCT00503386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110249583|NCT00503386|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110249584|NCT00503386|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110249585|NCT00503386|Serotonin Agents|serotonin agents|mesh-ancestor
110249586|NCT00503386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110249587|NCT00503386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110249589|NCT00503503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110249590|NCT00503503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110249591|NCT00503503|Analgesics|analgesics|mesh-ancestor
110249592|NCT00503503|Sensory System Agents|sensory system agents|mesh-ancestor
110249593|NCT00503503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110249594|NCT00503503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110249595|NCT00503503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110249596|NCT00503503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110249597|NCT00503503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110249598|NCT00503503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110249599|NCT00503503|Immunologic Factors|immunologic factors|mesh-ancestor
110249602|NCT00503542|Clindamycin palmitate|clindamycin palmitate|mesh-list
110249603|NCT00503542|Clindamycin phosphate|clindamycin phosphate|mesh-list
110249604|NCT00503542|Fluconazole|fluconazole|mesh-list
110249605|NCT00503542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110249606|NCT00503542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110249608|NCT00503542|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110249609|NCT00503542|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110249610|NCT00503542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110249611|NCT00503542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110249613|NCT00503542|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110249614|NCT00503542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110249615|NCT00503542|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110249616|NCT00503542|Hormone Antagonists|hormone antagonists|mesh-ancestor
110249617|NCT00503542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110249618|NCT00503542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110249619|NCT00503542|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110249620|NCT00503542|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110249622|NCT00147615|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110249623|NCT00147615|Hormone Antagonists|hormone antagonists|mesh-ancestor
110249624|NCT00147615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110249625|NCT00147615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110249626|NCT00147615|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110249627|NCT00147615|Diuretics|diuretics|mesh-ancestor
110249628|NCT00147615|Natriuretic Agents|natriuretic agents|mesh-ancestor
110249629|NCT00147615|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110249630|NCT05561036|Doxorubicin|doxorubicin|mesh-list
110249631|NCT05561036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110249632|NCT05561036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110249633|NCT05561036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110249634|NCT05561036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110249635|NCT05561036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110249636|NCT05561036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110249637|NCT01246804|Raltegravir Potassium|raltegravir potassium|mesh-list
110249638|NCT01246804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110249639|NCT01246804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110249640|NCT01246804|Antiviral Agents|antiviral agents|mesh-ancestor
110249642|NCT01246804|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110249643|NCT01246804|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110249644|NCT01246804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110249645|NCT01246804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110249646|NCT00147654|Tamsulosin|tamsulosin|mesh-list
110249647|NCT00147654|Tolterodine Tartrate|tolterodine tartrate|mesh-list
110249648|NCT00147654|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110249649|NCT00147654|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110249650|NCT00147654|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110249651|NCT00147654|Adrenergic Agents|adrenergic agents|mesh-ancestor
110249652|NCT00147654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110249653|NCT00147654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110249654|NCT00147654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110249655|NCT00147654|Urological Agents|urological agents|mesh-ancestor
110249656|NCT00147654|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110249657|NCT00147654|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110249658|NCT00147654|Cholinergic Agents|cholinergic agents|mesh-ancestor
110249659|NCT01246921|Fluticasone|fluticasone|mesh-list
110249660|NCT01246921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110249662|NCT01246921|Autonomic Agents|autonomic agents|mesh-ancestor
110249663|NCT01246921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110249664|NCT01246921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110249665|NCT01246921|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110249666|NCT01246921|Respiratory System Agents|respiratory system agents|mesh-ancestor
110249667|NCT01246921|Dermatologic Agents|dermatologic agents|mesh-ancestor
110249668|NCT01246921|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110249669|NCT04696939|Carboplatin|carboplatin|mesh-list
110249670|NCT04696939|Etoposide|etoposide|mesh-list
110249671|NCT04696939|Atezolizumab|atezolizumab|mesh-list
110249672|NCT04696939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110249673|NCT04696939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110249674|NCT04696939|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110249675|NCT04696939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110249677|NCT04696939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110249678|NCT04696939|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110249679|NCT04696939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110249680|NCT05560919|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
110249681|NCT05560919|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
110249682|NCT05560919|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110249683|NCT05560919|Protective Agents|protective agents|mesh-ancestor
110249684|NCT05560919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110249685|NCT05560919|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110249686|NCT05560919|Antioxidants|antioxidants|mesh-ancestor
110249687|NCT05560919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110249689|NCT05560919|Micronutrients|micronutrients|mesh-ancestor
110249690|NCT05560919|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110249691|NCT00503620|Botulinum Toxins|botulinum toxins|mesh-list
110249692|NCT00503620|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110249693|NCT00503620|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110249694|NCT00503620|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110249695|NCT00503620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110249696|NCT00503620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110249697|NCT00503620|Cholinergic Agents|cholinergic agents|mesh-ancestor
110249698|NCT00503620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110249699|NCT00503620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110249700|NCT00503620|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110249701|NCT00503620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110249702|NCT00503659|Methacholine Chloride|methacholine chloride|mesh-list
110249703|NCT00503659|Miotics|miotics|mesh-ancestor
110249704|NCT00503659|Autonomic Agents|autonomic agents|mesh-ancestor
110249705|NCT00503659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110249706|NCT00503659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110249707|NCT00503659|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110249708|NCT00503659|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
110249709|NCT00503659|Respiratory System Agents|respiratory system agents|mesh-ancestor
110249710|NCT00503659|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110249711|NCT00503659|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110249712|NCT00503659|Cholinergic Agents|cholinergic agents|mesh-ancestor
110249713|NCT00503659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110249714|NCT00503659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110249715|NCT04063163|Carboplatin|carboplatin|mesh-list
110249716|NCT04063163|Etoposide|etoposide|mesh-list
110249717|NCT04063163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110249718|NCT04063163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110249719|NCT04063163|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110249720|NCT04063163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110249721|NCT04063163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110269278|NCT02556931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110249722|NCT04063163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110249723|NCT00503815|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
110249725|NCT00503815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110249727|NCT01247077|Antioxidants|antioxidants|mesh-ancestor
110249728|NCT01247077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110249729|NCT01247077|Protective Agents|protective agents|mesh-ancestor
110249730|NCT01247077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110249731|NCT01247077|Trace Elements|trace elements|mesh-ancestor
110249734|NCT03990467|Piperacillin|piperacillin|mesh-list
110249735|NCT03990467|Amikacin|amikacin|mesh-list
110249736|NCT03990467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110249737|NCT03990467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110249738|NCT03990467|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110249739|NCT03990467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110249740|NCT03990467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110249741|NCT01247311|Vitamin D|vitamin d|mesh-list
110249742|NCT01247311|Ergocalciferols|ergocalciferols|mesh-list
110249743|NCT01247311|Cholecalciferol|cholecalciferol|mesh-list
110249744|NCT01247311|Vitamins|vitamins|mesh-list
110249745|NCT01247311|Micronutrients|micronutrients|mesh-ancestor
110249746|NCT01247311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110249747|NCT01247311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110249748|NCT01247311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110249749|NCT00147771|Imiquimod|imiquimod|mesh-list
110249750|NCT00147771|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110249751|NCT00147771|Immunologic Factors|immunologic factors|mesh-ancestor
110249752|NCT00147771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110249753|NCT00147771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110249754|NCT00147771|Interferon Inducers|interferon inducers|mesh-ancestor
110249755|NCT00503932|Capecitabine|capecitabine|mesh-list
110249756|NCT00503932|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110249757|NCT00503932|Antimetabolites|antimetabolites|mesh-ancestor
110249758|NCT00503932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110249759|NCT00503932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110249760|NCT03981146|Nivolumab|nivolumab|mesh-list
110249761|NCT03981146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110249762|NCT03981146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110249763|NCT03981146|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110249764|NCT03981146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110249765|NCT01247857|Ropivacaine|ropivacaine|mesh-list
110249766|NCT01247857|Anesthetics, Local|anesthetics, local|mesh-ancestor
110249767|NCT01247857|Anesthetics|anesthetics|mesh-ancestor
110249768|NCT01247857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110249769|NCT01247857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110249770|NCT01247857|Sensory System Agents|sensory system agents|mesh-ancestor
110249771|NCT01247857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110249772|NCT04331730|Aflibercept|aflibercept|mesh-list
110249773|NCT04331730|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110249774|NCT04331730|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110249775|NCT04331730|Growth Substances|growth substances|mesh-ancestor
110249776|NCT04331730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110249777|NCT04331730|Growth Inhibitors|growth inhibitors|mesh-ancestor
110249778|NCT04331730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110249780|NCT01248091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110249782|NCT01248091|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110249783|NCT01248091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110249784|NCT00503971|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110249785|NCT00503971|Vorinostat|vorinostat|mesh-list
110249786|NCT00503971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110249787|NCT00503971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110249788|NCT00503971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110249789|NCT00503971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110249790|NCT00503971|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110249791|NCT01248325|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110269288|NCT00163358|Hormones|hormones|mesh-ancestor
110249792|NCT02274961|Pantoprazole|pantoprazole|mesh-list
110249793|NCT02274961|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110249794|NCT02274961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110249795|NCT02274961|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110249796|NCT02274961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110249797|NCT02274961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110249799|NCT02275039|Vaccines|vaccines|mesh-list
110249800|NCT02275039|Immunologic Factors|immunologic factors|mesh-ancestor
110249801|NCT02275039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110249802|NCT02275039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110249803|NCT02275039|Antimetabolites|antimetabolites|mesh-ancestor
110249804|NCT02275039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110249805|NCT02275039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110249807|NCT01248403|Everolimus|everolimus|mesh-list
110249808|NCT01248403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110249809|NCT01248403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110249810|NCT01248403|Tubulin Modulators|tubulin modulators|mesh-ancestor
110249811|NCT01248403|Antimitotic Agents|antimitotic agents|mesh-ancestor
110249812|NCT01248403|Mitosis Modulators|mitosis modulators|mesh-ancestor
110249813|NCT01248403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110249814|NCT01248403|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110249815|NCT01248403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110249816|NCT01248403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110249817|NCT01248403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110249818|NCT01248403|Immunologic Factors|immunologic factors|mesh-ancestor
110249819|NCT01248403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110249820|NCT01248442|Cholecalciferol|cholecalciferol|mesh-list
110249821|NCT01248442|Vitamin D|vitamin d|mesh-list
110249822|NCT01248442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110249823|NCT01248442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110249824|NCT01248442|Vitamins|vitamins|mesh-ancestor
110249825|NCT01248442|Micronutrients|micronutrients|mesh-ancestor
110249826|NCT01248442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110249827|NCT01248481|Acarbose|acarbose|mesh-list
110249828|NCT01248481|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110249829|NCT01248481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110249830|NCT01248481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110249831|NCT01248481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110249832|NCT01248481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110249833|NCT01249339|Lobeline|lobeline|mesh-list
110249835|NCT01249339|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110249836|NCT01249339|Autonomic Agents|autonomic agents|mesh-ancestor
110249837|NCT01249339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110249838|NCT01249339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110249839|NCT01249339|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110249840|NCT01249339|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110249841|NCT01249339|Cholinergic Agents|cholinergic agents|mesh-ancestor
110249842|NCT01249339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110249843|NCT01249339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110249844|NCT01249339|Respiratory System Agents|respiratory system agents|mesh-ancestor
110249846|NCT03809429|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
110249847|NCT03809429|Hormones|hormones|mesh-ancestor
110249848|NCT03809429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110249849|NCT03809429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110249850|NCT03809429|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110249851|NCT03809429|Fertility Agents|fertility agents|mesh-ancestor
110249852|NCT03809429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110249853|NCT03809429|Hormone Antagonists|hormone antagonists|mesh-ancestor
110249855|NCT00504127|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
110249856|NCT00504127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110249857|NCT00504127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110249858|NCT00504127|Analgesics|analgesics|mesh-ancestor
110249859|NCT00504127|Sensory System Agents|sensory system agents|mesh-ancestor
110249860|NCT00504127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110249861|NCT00504127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110249862|NCT00504127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110249864|NCT00504127|Gout Suppressants|gout suppressants|mesh-ancestor
110249865|NCT00504127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110249866|NCT00504127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110249867|NCT00504127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110249868|NCT00504127|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110249869|NCT04088292|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110249870|NCT04088292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110249871|NCT04088292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110249872|NCT04088292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110249873|NCT00504205|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
110249874|NCT00504205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110249875|NCT00504205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110249876|NCT00504205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110249877|NCT04085250|Nivolumab|nivolumab|mesh-list
110249878|NCT04085250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110249879|NCT04085250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110249880|NCT04085250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110249881|NCT04085250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110249882|NCT01249690|Thalidomide|thalidomide|mesh-list
110249883|NCT01249690|Dexamethasone|dexamethasone|mesh-list
110249884|NCT01249690|Dexamethasone acetate|dexamethasone acetate|mesh-list
110249885|NCT01249690|Bortezomib|bortezomib|mesh-list
110249886|NCT01249690|Pirarubicin|pirarubicin|mesh-list
110249887|NCT01249690|Doxorubicin|doxorubicin|mesh-list
110249888|NCT01249690|BB 1101|bb 1101|mesh-list
110249889|NCT01249690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110249890|NCT01249690|Antiemetics|antiemetics|mesh-ancestor
110249892|NCT01249690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110249893|NCT01249690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110249894|NCT01249690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110249895|NCT01249690|Glucocorticoids|glucocorticoids|mesh-ancestor
110249896|NCT01249690|Hormones|hormones|mesh-ancestor
110249897|NCT01249690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110249898|NCT01249690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110249899|NCT01249690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110249900|NCT01249690|Protease Inhibitors|protease inhibitors|mesh-ancestor
110249901|NCT01249690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110249902|NCT01249690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110249903|NCT01249690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110249904|NCT01249690|Immunologic Factors|immunologic factors|mesh-ancestor
110249905|NCT01249690|Leprostatic Agents|leprostatic agents|mesh-ancestor
110249906|NCT01249690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110249907|NCT01249690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110249908|NCT01249690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110249909|NCT01249690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110249910|NCT01249690|Growth Substances|growth substances|mesh-ancestor
110249911|NCT01249690|Growth Inhibitors|growth inhibitors|mesh-ancestor
110249912|NCT01249690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110249913|NCT01249690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110249914|NCT01249690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110249915|NCT03712826|Ustekinumab|ustekinumab|mesh-list
110249916|NCT03712826|Dermatologic Agents|dermatologic agents|mesh-ancestor
110249917|NCT01249846|Chlorhexidine|chlorhexidine|mesh-list
110249918|NCT01249846|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110249919|NCT01249846|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110249920|NCT01249846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110249921|NCT01249846|Disinfectants|disinfectants|mesh-ancestor
110249922|NCT01249846|Dermatologic Agents|dermatologic agents|mesh-ancestor
110249923|NCT00504244|Mycophenolic Acid|mycophenolic acid|mesh-list
110249924|NCT00504244|Azathioprine|azathioprine|mesh-list
110249925|NCT00504244|Antimetabolites|antimetabolites|mesh-ancestor
110249926|NCT00504244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110249927|NCT00504244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110249928|NCT00504244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110249929|NCT00504244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110249930|NCT00504244|Immunologic Factors|immunologic factors|mesh-ancestor
110249931|NCT00504244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110249932|NCT00504244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110249933|NCT00504244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110249934|NCT00504244|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110249935|NCT00504244|Antitubercular Agents|antitubercular agents|mesh-ancestor
110249936|NCT00504244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110249937|NCT00504244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110249938|NCT00504244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110249939|NCT00405444|Fentanyl|fentanyl|mesh-list
110249940|NCT00405444|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110249941|NCT00405444|Narcotics|narcotics|mesh-ancestor
110249942|NCT00405444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110249943|NCT00405444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110249944|NCT00405444|Analgesics|analgesics|mesh-ancestor
110249945|NCT00405444|Sensory System Agents|sensory system agents|mesh-ancestor
110249946|NCT00405444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110249947|NCT00405444|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110249948|NCT00405444|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110249949|NCT00405444|Anesthetics, General|anesthetics, general|mesh-ancestor
110249951|NCT00504283|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110249952|NCT00504283|Morphine|morphine|mesh-list
110249953|NCT00504283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110249954|NCT00504283|Narcotics|narcotics|mesh-ancestor
110249955|NCT00504283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110249956|NCT00504283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110249957|NCT00504283|Analgesics|analgesics|mesh-ancestor
110249958|NCT00504283|Sensory System Agents|sensory system agents|mesh-ancestor
110249959|NCT00504283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110249960|NCT00504283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110249961|NCT00504283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110249962|NCT00504283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110249963|NCT00504283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110249964|NCT00504283|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110249965|NCT00504283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110249966|NCT00504283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110249967|NCT00504400|Ranibizumab|ranibizumab|mesh-list
110249968|NCT00504400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110249969|NCT00504400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110249970|NCT00504400|Growth Substances|growth substances|mesh-ancestor
110249971|NCT00504400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110249972|NCT00504400|Growth Inhibitors|growth inhibitors|mesh-ancestor
110249973|NCT00504400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110249974|NCT00504439|Simvastatin|simvastatin|mesh-list
110249975|NCT00504439|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110249976|NCT00504439|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110249977|NCT00504439|Antimetabolites|antimetabolites|mesh-ancestor
110249978|NCT00504439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110249979|NCT00504439|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110249980|NCT00504439|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110249981|NCT00504439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110249983|NCT04054830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110249984|NCT04054830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110249985|NCT04054830|Analgesics|analgesics|mesh-ancestor
110249986|NCT04054830|Sensory System Agents|sensory system agents|mesh-ancestor
110249987|NCT04054830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110249988|NCT04054830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110249989|NCT04054830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110249990|NCT04054830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110249991|NCT04054830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110249992|NCT04054830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110249993|NCT04054830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110249995|NCT03622775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110249996|NCT01249651|Esomeprazole|esomeprazole|mesh-list
110249997|NCT01249651|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110249998|NCT01249651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110249999|NCT01249651|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110250000|NCT01249651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110250001|NCT01249651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110250004|NCT03999723|Micronutrients|micronutrients|mesh-ancestor
110250005|NCT03999723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110250006|NCT03999723|Antioxidants|antioxidants|mesh-ancestor
110250007|NCT03999723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110250008|NCT03999723|Protective Agents|protective agents|mesh-ancestor
110250009|NCT01249417|Botulinum Toxins|botulinum toxins|mesh-list
110250011|NCT01249417|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110250012|NCT01249417|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110250013|NCT01249417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110250014|NCT01249417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110250015|NCT01249417|Cholinergic Agents|cholinergic agents|mesh-ancestor
110250016|NCT01249417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110250017|NCT01249417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110250018|NCT01249417|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110250019|NCT01249417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110250020|NCT00403325|Ranibizumab|ranibizumab|mesh-list
110250021|NCT00403325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110250022|NCT00403325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110250023|NCT00403325|Growth Substances|growth substances|mesh-ancestor
110250024|NCT00403325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110250025|NCT00403325|Growth Inhibitors|growth inhibitors|mesh-ancestor
110250026|NCT00403325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110250028|NCT04725747|Ketamine|ketamine|mesh-list
110250029|NCT04725747|Analgesics|analgesics|mesh-ancestor
110250030|NCT04725747|Sensory System Agents|sensory system agents|mesh-ancestor
110250031|NCT04725747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110250032|NCT04725747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110250033|NCT04725747|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110250034|NCT04725747|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110250035|NCT04725747|Anesthetics, General|anesthetics, general|mesh-ancestor
110250036|NCT04725747|Anesthetics|anesthetics|mesh-ancestor
110250037|NCT04725747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110250038|NCT04725747|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110250039|NCT04725747|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110250040|NCT04725747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110250041|NCT04725747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110250042|NCT04725747|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110250043|NCT04725747|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110250044|NCT04725747|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110250045|NCT04725747|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110250046|NCT04725747|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110250047|NCT04725747|GABA Modulators|gaba modulators|mesh-ancestor
110250048|NCT04725747|GABA Agents|gaba agents|mesh-ancestor
110250049|NCT03546686|Pembrolizumab|pembrolizumab|mesh-list
110250050|NCT03546686|Nivolumab|nivolumab|mesh-list
110250051|NCT03546686|Ipilimumab|ipilimumab|mesh-list
110250052|NCT03546686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110250053|NCT03546686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110250054|NCT03546686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110250055|NCT03546686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110250056|NCT04725942|Posaconazole|posaconazole|mesh-list
110250057|NCT04725942|Antifungal Agents|antifungal agents|mesh-ancestor
110250059|NCT04725942|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110250060|NCT04725942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110250061|NCT04725942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110250062|NCT04725942|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110250063|NCT04725942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110250064|NCT04725942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110250065|NCT04725942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110250066|NCT04725942|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110250067|NCT04725942|Hormone Antagonists|hormone antagonists|mesh-ancestor
110250068|NCT04725942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110250069|NCT04725942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110250070|NCT01249261|Risedronic Acid|risedronic acid|mesh-list
110250071|NCT01249261|Etidronic Acid|etidronic acid|mesh-list
110250072|NCT01249261|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110250073|NCT01249261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110250074|NCT01249261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110250075|NCT01249261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110250076|NCT01249261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110250077|NCT01249261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110250079|NCT03890952|Nivolumab|nivolumab|mesh-list
110250080|NCT03890952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
110250081|NCT03890952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110250082|NCT03890952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110250083|NCT03890952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110250084|NCT03890952|Growth Substances|growth substances|mesh-ancestor
110250085|NCT03890952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110250086|NCT03890952|Growth Inhibitors|growth inhibitors|mesh-ancestor
110250087|NCT03890952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110250088|NCT03890952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110250089|NCT03868722|Venetoclax|venetoclax|mesh-list
110250090|NCT03868722|Acalabrutinib|acalabrutinib|mesh-list
110250091|NCT03868722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110250092|NCT03761511|Niacinamide|niacinamide|mesh-list
110250094|NCT03761511|Nicotinic Acids|nicotinic acids|mesh-list
110250095|NCT03761511|Vitamin B Complex|vitamin b complex|mesh-ancestor
110250097|NCT03761511|Micronutrients|micronutrients|mesh-ancestor
110250098|NCT03761511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110250099|NCT03761511|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110250100|NCT03761511|Antimetabolites|antimetabolites|mesh-ancestor
110250101|NCT03761511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110250102|NCT03761511|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110250103|NCT03761511|Vasodilator Agents|vasodilator agents|mesh-ancestor
110250104|NCT02952092|Darbepoetin alfa|darbepoetin alfa|mesh-list
110250105|NCT02952092|Hematinics|hematinics|mesh-ancestor
110250106|NCT00139152|Omalizumab|omalizumab|mesh-list
110250107|NCT00139152|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110250108|NCT00139152|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110250109|NCT00139152|Respiratory System Agents|respiratory system agents|mesh-ancestor
110250110|NCT02824523|Aspirin|aspirin|mesh-list
110250111|NCT02824523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110269342|NCT00163553|Analgesics|analgesics|mesh-ancestor
110250112|NCT02824523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110250113|NCT02824523|Analgesics|analgesics|mesh-ancestor
110250114|NCT02824523|Sensory System Agents|sensory system agents|mesh-ancestor
110250115|NCT02824523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110250116|NCT02824523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110250117|NCT02824523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110250118|NCT02824523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110250119|NCT02824523|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110250120|NCT02824523|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110250121|NCT02824523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110250122|NCT02824523|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110250123|NCT02824523|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110250124|NCT02824523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110250127|NCT02736422|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110250128|NCT02736422|Anesthetics, General|anesthetics, general|mesh-ancestor
110250129|NCT02736422|Anesthetics|anesthetics|mesh-ancestor
110250130|NCT02736422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110250131|NCT02736422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110250132|NCT03721497|Methyltestosterone|methyltestosterone|mesh-list
110250133|NCT03721497|Testosterone|testosterone|mesh-list
110250134|NCT03721497|Testosterone undecanoate|testosterone undecanoate|mesh-list
110250135|NCT03721497|Testosterone enanthate|testosterone enanthate|mesh-list
110250136|NCT03721497|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110250137|NCT03721497|Androgens|androgens|mesh-ancestor
110250138|NCT03721497|Hormones|hormones|mesh-ancestor
110250139|NCT03721497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110250140|NCT03721497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110250141|NCT03721497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110250142|NCT03721497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110250143|NCT03721497|Anabolic Agents|anabolic agents|mesh-ancestor
110250144|NCT03682029|Ascorbic Acid|ascorbic acid|mesh-list
110250145|NCT03682029|Vitamins|vitamins|mesh-ancestor
110250146|NCT03682029|Micronutrients|micronutrients|mesh-ancestor
110250147|NCT03682029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110250148|NCT03682029|Antioxidants|antioxidants|mesh-ancestor
110250149|NCT03682029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110250150|NCT03682029|Protective Agents|protective agents|mesh-ancestor
110250151|NCT00139230|Leucovorin|leucovorin|mesh-list
110250152|NCT00139230|Ciprofloxacin|ciprofloxacin|mesh-list
110250153|NCT00139230|Fluorouracil|fluorouracil|mesh-list
110250154|NCT00139230|Docetaxel|docetaxel|mesh-list
110250155|NCT00139230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110250156|NCT00139230|Antimetabolites|antimetabolites|mesh-ancestor
110250157|NCT00139230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110250158|NCT00139230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110250159|NCT00139230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110250160|NCT00139230|Immunologic Factors|immunologic factors|mesh-ancestor
110250161|NCT00139230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110250162|NCT00139230|Antidotes|antidotes|mesh-ancestor
110250163|NCT00139230|Protective Agents|protective agents|mesh-ancestor
110250164|NCT00139230|Vitamin B Complex|vitamin b complex|mesh-ancestor
110250165|NCT00139230|Vitamins|vitamins|mesh-ancestor
110250166|NCT00139230|Micronutrients|micronutrients|mesh-ancestor
110250167|NCT00139230|Tubulin Modulators|tubulin modulators|mesh-ancestor
110250168|NCT00139230|Antimitotic Agents|antimitotic agents|mesh-ancestor
110250169|NCT00139230|Mitosis Modulators|mitosis modulators|mesh-ancestor
110250170|NCT00139230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110250171|NCT00139230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110250172|NCT00139230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110250173|NCT00139230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110250174|NCT00139230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110269348|NCT00163592|Coagulants|coagulants|mesh-ancestor
110250187|NCT00139269|Antimitotic Agents|antimitotic agents|mesh-ancestor
110250188|NCT00139269|Mitosis Modulators|mitosis modulators|mesh-ancestor
110250189|NCT00139269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110250190|NCT00139269|Antimetabolites|antimetabolites|mesh-ancestor
110250191|NCT00139269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110250192|NCT00139269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110250193|NCT00139269|Immunologic Factors|immunologic factors|mesh-ancestor
110250194|NCT00139269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110250195|NCT02065154|Cyclophosphamide|cyclophosphamide|mesh-list
110250196|NCT02065154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110250197|NCT02065154|Immunologic Factors|immunologic factors|mesh-ancestor
110250198|NCT02065154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110250199|NCT02065154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110250200|NCT02065154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110250201|NCT02065154|Alkylating Agents|alkylating agents|mesh-ancestor
110250202|NCT02065154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110250203|NCT02065154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110250204|NCT02065154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110250205|NCT00403364|Amoxicillin|amoxicillin|mesh-list
110250206|NCT00403364|Clarithromycin|clarithromycin|mesh-list
110250208|NCT00403364|Pantoprazole|pantoprazole|mesh-list
110250209|NCT00403364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110250210|NCT00403364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110250211|NCT00403364|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110250212|NCT00403364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110250213|NCT00403364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110250214|NCT00403364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110250215|NCT00403364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110250216|NCT00403364|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110250217|NCT00403364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110250218|NCT00403364|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110250219|NCT00403364|Alkylating Agents|alkylating agents|mesh-ancestor
110250220|NCT00403364|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
110250221|NCT00403364|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110250222|NCT00403364|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110250223|NCT00403442|Bevacizumab|bevacizumab|mesh-list
110250224|NCT00403442|Verteporfin|verteporfin|mesh-list
110250225|NCT00403442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110250226|NCT00403442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110250227|NCT00403442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110250228|NCT00403442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110250229|NCT00403442|Growth Substances|growth substances|mesh-ancestor
110250230|NCT00403442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110250231|NCT00403442|Growth Inhibitors|growth inhibitors|mesh-ancestor
110250232|NCT00403442|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110250233|NCT00403442|Dermatologic Agents|dermatologic agents|mesh-ancestor
110250234|NCT00139386|Candesartan|candesartan|mesh-list
110250235|NCT00139386|Candesartan cilexetil|candesartan cilexetil|mesh-list
110250236|NCT00139386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110269360|NCT00192777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110250237|NCT00139386|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110250239|NCT00139386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110250240|NCT00402974|Vitamin K 2|vitamin k 2|mesh-list
110250241|NCT00402974|Vitamin K|vitamin k|mesh-list
110250242|NCT00402974|Menaquinone 7|menaquinone 7|mesh-list
110250243|NCT00402974|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110250244|NCT00402974|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110250245|NCT00402974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110250246|NCT00402974|Hemostatics|hemostatics|mesh-ancestor
110250247|NCT00402974|Coagulants|coagulants|mesh-ancestor
110250248|NCT00402974|Vitamins|vitamins|mesh-ancestor
110250249|NCT00402974|Micronutrients|micronutrients|mesh-ancestor
110250250|NCT00402974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110250251|NCT01731236|Aspirin|aspirin|mesh-list
110250252|NCT01731236|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110250253|NCT01731236|Vancomycin|vancomycin|mesh-list
110250254|NCT01731236|Ciprofloxacin|ciprofloxacin|mesh-list
110250255|NCT01731236|Neomycin|neomycin|mesh-list
110250256|NCT01731236|Choline|choline|mesh-list
110250257|NCT01731236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110250258|NCT01731236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110250259|NCT01731236|Analgesics|analgesics|mesh-ancestor
110250260|NCT01731236|Sensory System Agents|sensory system agents|mesh-ancestor
110250261|NCT01731236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110250262|NCT01731236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110250263|NCT01731236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110250264|NCT01731236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110250265|NCT01731236|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110250266|NCT01731236|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110250267|NCT01731236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110250268|NCT01731236|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110250269|NCT01731236|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110250270|NCT01731236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110250272|NCT01731236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110250273|NCT01731236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110250274|NCT01731236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110250275|NCT01731236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110250276|NCT01731236|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110250277|NCT01731236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110250278|NCT01731236|Lipotropic Agents|lipotropic agents|mesh-ancestor
110250279|NCT01731236|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110250280|NCT01731236|Antimetabolites|antimetabolites|mesh-ancestor
110250281|NCT01731236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110250282|NCT01731236|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110250283|NCT01731236|Nootropic Agents|nootropic agents|mesh-ancestor
110250284|NCT01731236|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110250286|NCT03510078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110250287|NCT03510078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110250288|NCT00139581|Pimecrolimus|pimecrolimus|mesh-list
110250289|NCT00139581|Tacrolimus|tacrolimus|mesh-list
110250290|NCT00139581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110250291|NCT00139581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110250292|NCT00139581|Analgesics|analgesics|mesh-ancestor
110250293|NCT00139581|Sensory System Agents|sensory system agents|mesh-ancestor
110250294|NCT00139581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110250295|NCT00139581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110250296|NCT00139581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110250297|NCT00139581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110250298|NCT00139581|Dermatologic Agents|dermatologic agents|mesh-ancestor
110250299|NCT00139581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110250300|NCT00139581|Immunologic Factors|immunologic factors|mesh-ancestor
110250302|NCT00139581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110250303|NCT00139581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110250304|NCT03500913|Hormones|hormones|mesh-list
110250305|NCT03500913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110250306|NCT03500913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110250307|NCT00139620|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110250308|NCT00139620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110250309|NCT00139620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110250310|NCT00139620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110250311|NCT00139620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110250312|NCT00130481|Atorvastatin|atorvastatin|mesh-list
110250313|NCT00130481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110250314|NCT00130481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110250315|NCT00130481|Antimetabolites|antimetabolites|mesh-ancestor
110250316|NCT00130481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110250317|NCT00130481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110250318|NCT00130481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110250319|NCT00130481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110250320|NCT00139698|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110250321|NCT00139698|Olmesartan|olmesartan|mesh-list
110250322|NCT00139698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110250323|NCT00139698|Diuretics|diuretics|mesh-ancestor
110250324|NCT00139698|Natriuretic Agents|natriuretic agents|mesh-ancestor
110250325|NCT00139698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110250326|NCT00139698|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110250327|NCT00139698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110250328|NCT00139698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110250329|NCT00139698|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110250330|NCT00139698|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110250331|NCT00130676|Mifepristone|mifepristone|mesh-list
110250332|NCT00130676|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110250333|NCT00130676|Abortifacient Agents|abortifacient agents|mesh-ancestor
110250334|NCT00130676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110250335|NCT00130676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110250336|NCT00130676|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110250337|NCT00130676|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110250338|NCT00130676|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110250339|NCT00130676|Contraceptive Agents|contraceptive agents|mesh-ancestor
110250340|NCT00130676|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110250341|NCT00130676|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110250342|NCT00130676|Hormone Antagonists|hormone antagonists|mesh-ancestor
110250343|NCT00130676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110250344|NCT00130676|Luteolytic Agents|luteolytic agents|mesh-ancestor
110250345|NCT00130676|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110250347|NCT00404274|Casopitant|casopitant|mesh-list
110250348|NCT00404274|Warfarin|warfarin|mesh-list
110250349|NCT00404274|Anticoagulants|anticoagulants|mesh-ancestor
110250350|NCT00404274|Antiemetics|antiemetics|mesh-ancestor
110250351|NCT00404274|Autonomic Agents|autonomic agents|mesh-ancestor
110250352|NCT00404274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110250353|NCT00404274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110250354|NCT00404274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110250355|NCT00404274|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110250356|NCT00404274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110250357|NCT00404274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110250358|NCT00130754|Thymoglobulin|thymoglobulin|mesh-list
110250360|NCT00130754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110250361|NCT00130754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110250362|NCT00130871|Simendan|simendan|mesh-list
110250363|NCT00130871|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110250364|NCT00130871|Vasodilator Agents|vasodilator agents|mesh-ancestor
110250365|NCT00130871|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110250366|NCT00130871|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110250367|NCT00130871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110250368|NCT00130871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110250369|NCT00130871|Protective Agents|protective agents|mesh-ancestor
110250370|NCT00130871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110250371|NCT00130910|Albendazole|albendazole|mesh-list
110250372|NCT00130910|Anthelmintics|anthelmintics|mesh-ancestor
110250373|NCT00130910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110250374|NCT00130910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110250375|NCT00130910|Anticestodal Agents|anticestodal agents|mesh-ancestor
110250376|NCT00130910|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110250377|NCT00130910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110250378|NCT00130910|Tubulin Modulators|tubulin modulators|mesh-ancestor
110250379|NCT00130910|Antimitotic Agents|antimitotic agents|mesh-ancestor
110250380|NCT00130910|Mitosis Modulators|mitosis modulators|mesh-ancestor
110250381|NCT00130910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110250382|NCT00130910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110250383|NCT03226821|Tesamorelin|tesamorelin|mesh-list
110250384|NCT03226821|Growth Substances|growth substances|mesh-ancestor
110250385|NCT03226821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110250386|NCT00139815|Enoxaparin|enoxaparin|mesh-list
110250387|NCT00139815|PENTA|penta|mesh-list
110250388|NCT00139815|Fondaparinux|fondaparinux|mesh-list
110250389|NCT00139815|Anticoagulants|anticoagulants|mesh-ancestor
110250390|NCT00139815|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110250391|NCT00139815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110250392|NCT00139815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110250393|NCT00139815|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110250394|NCT00139815|Antithrombins|antithrombins|mesh-ancestor
110250395|NCT00139815|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110250396|NCT00139815|Protease Inhibitors|protease inhibitors|mesh-ancestor
110250397|NCT00139815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110250399|NCT00131027|Dexamethasone|dexamethasone|mesh-list
110250400|NCT00131027|Prednisolone|prednisolone|mesh-list
110250401|NCT00131027|Cyclophosphamide|cyclophosphamide|mesh-list
110250402|NCT00131027|Doxorubicin|doxorubicin|mesh-list
110250403|NCT00131027|Methotrexate|methotrexate|mesh-list
110250404|NCT00131027|Etoposide|etoposide|mesh-list
110250405|NCT00131027|Vincristine|vincristine|mesh-list
110250406|NCT00131027|Daunorubicin|daunorubicin|mesh-list
110250407|NCT00131027|Asparaginase|asparaginase|mesh-list
110250408|NCT00131027|Mercaptopurine|mercaptopurine|mesh-list
110250409|NCT00131027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110250410|NCT00131027|Immunologic Factors|immunologic factors|mesh-ancestor
110250411|NCT00131027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110250412|NCT00131027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110250413|NCT00131027|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110250414|NCT00131027|Alkylating Agents|alkylating agents|mesh-ancestor
110250415|NCT00131027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110250416|NCT00131027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110250417|NCT00131027|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110250418|NCT00131027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110250419|NCT00131027|Antiemetics|antiemetics|mesh-ancestor
110250420|NCT00131027|Autonomic Agents|autonomic agents|mesh-ancestor
110250421|NCT00131027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110250422|NCT00131027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110250423|NCT00131027|Glucocorticoids|glucocorticoids|mesh-ancestor
110250424|NCT00131027|Hormones|hormones|mesh-ancestor
110250425|NCT00131027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110250426|NCT00131027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110250427|NCT00131027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110250428|NCT00131027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110250429|NCT00131027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110250430|NCT00131027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110250431|NCT00131027|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110250432|NCT00131027|Abortifacient Agents|abortifacient agents|mesh-ancestor
110250433|NCT00131027|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110250434|NCT00131027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110250435|NCT00131027|Antimetabolites|antimetabolites|mesh-ancestor
110250436|NCT00131027|Dermatologic Agents|dermatologic agents|mesh-ancestor
110250437|NCT00131027|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110250438|NCT00131027|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110250439|NCT00131027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110250440|NCT00131027|Antiviral Agents|antiviral agents|mesh-ancestor
110250441|NCT00131027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110250442|NCT00131027|Tubulin Modulators|tubulin modulators|mesh-ancestor
110250443|NCT00131027|Antimitotic Agents|antimitotic agents|mesh-ancestor
110250444|NCT00131027|Mitosis Modulators|mitosis modulators|mesh-ancestor
110250445|NCT00139854|Alprazolam|alprazolam|mesh-list
110250446|NCT00139854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110250447|NCT00139854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110250448|NCT00139854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110250449|NCT00139854|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110250450|NCT00139854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110250451|NCT00139854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110250452|NCT00139854|GABA Modulators|gaba modulators|mesh-ancestor
110250453|NCT00139854|GABA Agents|gaba agents|mesh-ancestor
110250454|NCT00139854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110250455|NCT00139854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110250456|NCT00131144|Octreotide|octreotide|mesh-list
110250457|NCT00131144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110250458|NCT00131144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110250459|NCT00131144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110250460|NCT00139893|Metoclopramide|metoclopramide|mesh-list
110250461|NCT00139893|Antiemetics|antiemetics|mesh-ancestor
110250462|NCT00139893|Autonomic Agents|autonomic agents|mesh-ancestor
110250463|NCT00139893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110250464|NCT00139893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110250465|NCT00139893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110250466|NCT00139893|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110250467|NCT00139893|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110250468|NCT00139893|Dopamine Agents|dopamine agents|mesh-ancestor
110250469|NCT00139893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110250470|NCT00139893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110250471|NCT00131183|Testosterone undecanoate|testosterone undecanoate|mesh-list
110250472|NCT00131183|Androgens|androgens|mesh-ancestor
110250473|NCT00131183|Hormones|hormones|mesh-ancestor
110250474|NCT00131183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110250475|NCT00131183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110250476|NCT00139932|Formoterol Fumarate|formoterol fumarate|mesh-list
110250477|NCT00139932|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110250478|NCT00139932|Autonomic Agents|autonomic agents|mesh-ancestor
110250479|NCT00139932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110250480|NCT00139932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110250481|NCT00139932|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110250482|NCT00139932|Respiratory System Agents|respiratory system agents|mesh-ancestor
110250483|NCT00139932|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110250484|NCT00139932|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110250485|NCT00139932|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110250486|NCT00139932|Adrenergic Agents|adrenergic agents|mesh-ancestor
110250487|NCT00139932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110250488|NCT00139932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110250490|NCT00131261|Belinostat|belinostat|mesh-list
110250491|NCT00131261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110250492|NCT00131261|Antiemetics|antiemetics|mesh-ancestor
110250493|NCT00131261|Autonomic Agents|autonomic agents|mesh-ancestor
110250494|NCT00131261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110250495|NCT00131261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110250496|NCT00131261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110250497|NCT00131261|Glucocorticoids|glucocorticoids|mesh-ancestor
110250498|NCT00131261|Hormones|hormones|mesh-ancestor
110250499|NCT00131261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110250500|NCT00131261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110250501|NCT00131261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110250502|NCT00131261|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110250503|NCT00131261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110250504|NCT00131261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110250506|NCT00131300|Viscosupplements|viscosupplements|mesh-ancestor
110250507|NCT00131300|Protective Agents|protective agents|mesh-ancestor
110250508|NCT00131300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110250509|NCT00131339|Cycloserine|cycloserine|mesh-list
110250510|NCT00131339|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110250511|NCT00131339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110250512|NCT00131339|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110250513|NCT00131339|Antitubercular Agents|antitubercular agents|mesh-ancestor
110250514|NCT00131339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110250515|NCT00131339|Antimetabolites|antimetabolites|mesh-ancestor
110250516|NCT00131339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110250517|NCT00139971|Gemcitabine|gemcitabine|mesh-list
110250518|NCT00139971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110250519|NCT00139971|Antimetabolites|antimetabolites|mesh-ancestor
110250520|NCT00139971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110250521|NCT00139971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110250522|NCT00140010|Epoetin Alfa|epoetin alfa|mesh-list
110250523|NCT00140010|Hematinics|hematinics|mesh-ancestor
110250524|NCT00131495|Testosterone|testosterone|mesh-list
110250525|NCT00131495|Androgens|androgens|mesh-ancestor
110250526|NCT00131495|Hormones|hormones|mesh-ancestor
110250527|NCT00131495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110250528|NCT00131495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110250529|NCT04726631|Insulin|insulin|mesh-list
110250530|NCT04726631|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110250531|NCT04726631|Insulin, Short-Acting|insulin, short-acting|mesh-list
110250532|NCT04726631|Protamines|protamines|mesh-list
110250533|NCT04726631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110250534|NCT04726631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110250535|NCT04726631|Heparin Antagonists|heparin antagonists|mesh-ancestor
110250536|NCT04726631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110250537|NCT04726631|Coagulants|coagulants|mesh-ancestor
110250538|NCT02957760|Hydroxyurea|hydroxyurea|mesh-list
110250539|NCT02957760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110250540|NCT02957760|Antisickling Agents|antisickling agents|mesh-ancestor
110250541|NCT02957760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110250542|NCT02957760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110250543|NCT02957760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110250545|NCT03117309|Ipilimumab|ipilimumab|mesh-list
110250546|NCT03117309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110250547|NCT03117309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110250548|NCT03117309|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110250549|NCT03117309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110250550|NCT00140166|Pyridoxine|pyridoxine|mesh-list
110250551|NCT00140166|Niacinamide|niacinamide|mesh-list
110250553|NCT00140166|Nicotinic Acids|nicotinic acids|mesh-list
110250554|NCT00140166|Vitamin B Complex|vitamin b complex|mesh-ancestor
110250556|NCT00140166|Micronutrients|micronutrients|mesh-ancestor
110250557|NCT00140166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110250558|NCT00140166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110250559|NCT00140166|Antimetabolites|antimetabolites|mesh-ancestor
110250560|NCT00140166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110250561|NCT00140166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110250562|NCT00140166|Vasodilator Agents|vasodilator agents|mesh-ancestor
110250563|NCT03095274|Durvalumab|durvalumab|mesh-list
110250564|NCT03095274|Tremelimumab|tremelimumab|mesh-list
110250565|NCT03095274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110250566|NCT03095274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110250567|NCT00131768|Hylan|hylan|mesh-list
110250568|NCT00131768|Viscosupplements|viscosupplements|mesh-ancestor
110250569|NCT00131768|Protective Agents|protective agents|mesh-ancestor
110250570|NCT00131768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110250571|NCT01248949|Paclitaxel|paclitaxel|mesh-list
110250572|NCT01248949|Bevacizumab|bevacizumab|mesh-list
110250573|NCT01248949|Carboplatin|carboplatin|mesh-list
110250574|NCT01248949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110250575|NCT01248949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110250576|NCT01248949|Tubulin Modulators|tubulin modulators|mesh-ancestor
110250577|NCT01248949|Antimitotic Agents|antimitotic agents|mesh-ancestor
110250578|NCT01248949|Mitosis Modulators|mitosis modulators|mesh-ancestor
110250579|NCT01248949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110250580|NCT01248949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110250581|NCT01248949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110250582|NCT01248949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110250583|NCT01248949|Growth Substances|growth substances|mesh-ancestor
110250584|NCT01248949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110250585|NCT01248949|Growth Inhibitors|growth inhibitors|mesh-ancestor
110250587|NCT00403637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110250588|NCT00403637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110250589|NCT04696666|Hyaluronic Acid|hyaluronic acid|mesh-list
110250590|NCT04696666|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110250591|NCT04696666|Immunologic Factors|immunologic factors|mesh-ancestor
110250592|NCT04696666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110250593|NCT04696666|Viscosupplements|viscosupplements|mesh-ancestor
110250594|NCT04696666|Protective Agents|protective agents|mesh-ancestor
110250595|NCT01248793|Golimumab|golimumab|mesh-list
110250596|NCT01248793|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110250597|NCT01248793|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110250598|NCT01248793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110250599|NCT01248793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110250600|NCT01248793|Immunologic Factors|immunologic factors|mesh-ancestor
110250601|NCT01248793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110250602|NCT00403715|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110250603|NCT00403715|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110250604|NCT01248364|Empagliflozin|empagliflozin|mesh-list
110250605|NCT01248364|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110250606|NCT01248364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110250608|NCT01248364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110250609|NCT00140361|Artesunate|artesunate|mesh-list
110250610|NCT00140361|Lumefantrine|lumefantrine|mesh-list
110250611|NCT00140361|Artemether|artemether|mesh-list
110250612|NCT00140361|Pyrimethamine|pyrimethamine|mesh-list
110250613|NCT00140361|Sulfadoxine|sulfadoxine|mesh-list
110250614|NCT00140361|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110250615|NCT00140361|Antimalarials|antimalarials|mesh-ancestor
110250616|NCT00140361|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110250617|NCT00140361|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110250618|NCT00140361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110250619|NCT00140361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110250620|NCT00140361|Antiviral Agents|antiviral agents|mesh-ancestor
110250621|NCT00140361|Schistosomicides|schistosomicides|mesh-ancestor
110250622|NCT00140361|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110250623|NCT00140361|Anthelmintics|anthelmintics|mesh-ancestor
110250624|NCT00140361|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110250625|NCT00140361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110250626|NCT00140361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110250627|NCT00140361|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110250628|NCT00131846|Diuretics|diuretics|mesh-list
110250629|NCT00131846|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
110250630|NCT00131846|Natriuretic Agents|natriuretic agents|mesh-ancestor
110250631|NCT00131846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110250632|NCT00131846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110250633|NCT00131846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110250634|NCT00131963|Paclitaxel|paclitaxel|mesh-list
110250635|NCT00131963|Cyclophosphamide|cyclophosphamide|mesh-list
110250636|NCT00131963|Doxorubicin|doxorubicin|mesh-list
110250637|NCT00131963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110250638|NCT00131963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110250639|NCT00131963|Tubulin Modulators|tubulin modulators|mesh-ancestor
110250640|NCT00131963|Antimitotic Agents|antimitotic agents|mesh-ancestor
110250641|NCT00131963|Mitosis Modulators|mitosis modulators|mesh-ancestor
110250642|NCT00131963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110250643|NCT00131963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110250644|NCT00131963|Immunologic Factors|immunologic factors|mesh-ancestor
110250645|NCT00131963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110250646|NCT00131963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110250647|NCT00131963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110250648|NCT00131963|Alkylating Agents|alkylating agents|mesh-ancestor
110250649|NCT00131963|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110250650|NCT00131963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110250651|NCT00131963|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110250652|NCT00131963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110250653|NCT00131963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110250654|NCT00140400|Immunomodulating Agents|immunomodulating agents|mesh-list
110250655|NCT00140400|Immunologic Factors|immunologic factors|mesh-ancestor
110250656|NCT00140400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110250657|NCT00132119|Nalmefene|nalmefene|mesh-list
110250658|NCT00132119|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110250659|NCT00132119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110250660|NCT00132119|Sensory System Agents|sensory system agents|mesh-ancestor
110250661|NCT00132119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110250663|NCT00132158|Gefitinib|gefitinib|mesh-list
110250664|NCT00132158|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110250665|NCT00132158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110250666|NCT00132158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110250667|NCT00132158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110250668|NCT00132158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110250669|NCT00132158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110250670|NCT00140478|Mifepristone|mifepristone|mesh-list
110250671|NCT00140478|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110250672|NCT00140478|Abortifacient Agents|abortifacient agents|mesh-ancestor
110250673|NCT00140478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110250674|NCT00140478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110250675|NCT00140478|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110250676|NCT00140478|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110250677|NCT00140478|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110250678|NCT00140478|Contraceptive Agents|contraceptive agents|mesh-ancestor
110250679|NCT00140478|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110250680|NCT00140478|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110250681|NCT00140478|Hormone Antagonists|hormone antagonists|mesh-ancestor
110250682|NCT00140478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110250683|NCT00140478|Luteolytic Agents|luteolytic agents|mesh-ancestor
110250684|NCT00140478|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110250685|NCT00140478|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110250686|NCT00140517|Chloroquine|chloroquine|mesh-list
110250687|NCT00140517|Pyrimethamine|pyrimethamine|mesh-list
110250688|NCT00140517|Sulfadoxine|sulfadoxine|mesh-list
110250689|NCT00140517|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110250690|NCT00140517|Amebicides|amebicides|mesh-ancestor
110250691|NCT00140517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110250692|NCT00140517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110250693|NCT00140517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110250694|NCT00140517|Antimalarials|antimalarials|mesh-ancestor
110250695|NCT00140517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110250696|NCT00140517|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110250697|NCT00140517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110250698|NCT00140517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110250699|NCT00140517|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110250700|NCT00132236|Nicotine|nicotine|mesh-list
110250701|NCT00132236|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110250702|NCT00132236|Autonomic Agents|autonomic agents|mesh-ancestor
110250703|NCT00132236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110250704|NCT00132236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110250705|NCT00132236|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110250706|NCT00132236|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110250707|NCT00132236|Cholinergic Agents|cholinergic agents|mesh-ancestor
110250708|NCT00132236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110250709|NCT00132236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110250710|NCT00132275|Amoxicillin|amoxicillin|mesh-list
110250711|NCT00132275|Clavulanic Acid|clavulanic acid|mesh-list
110250712|NCT00132275|Clavulanic Acids|clavulanic acids|mesh-list
110250713|NCT00132275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110250714|NCT00132275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110250715|NCT00132275|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110250716|NCT00132275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110250717|NCT00132275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110250719|NCT01246999|Immunologic Factors|immunologic factors|mesh-ancestor
110250720|NCT01246999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110250721|NCT00140595|Cyclophosphamide|cyclophosphamide|mesh-list
110250722|NCT00140595|Rituximab|rituximab|mesh-list
110250723|NCT00140595|Doxorubicin|doxorubicin|mesh-list
110250724|NCT00140595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110250725|NCT00140595|Immunologic Factors|immunologic factors|mesh-ancestor
110250726|NCT00140595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110250727|NCT00140595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110250728|NCT00140595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110250729|NCT00140595|Alkylating Agents|alkylating agents|mesh-ancestor
110250730|NCT00140595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110250731|NCT00140595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110250732|NCT00140595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110250733|NCT00140595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110250734|NCT00140595|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110250735|NCT00140595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110250736|NCT00140595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110250737|NCT00140595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110250738|NCT04696783|Esomeprazole|esomeprazole|mesh-list
110250739|NCT04696783|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110250740|NCT04696783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110250742|NCT04696783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110250743|NCT04696783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110250744|NCT00132431|Cinacalcet|cinacalcet|mesh-list
110250745|NCT00132431|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110250746|NCT00132431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110250747|NCT00132431|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
110250748|NCT00132431|Hormone Antagonists|hormone antagonists|mesh-ancestor
110250749|NCT00132431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110250750|NCT00140712|Ropinirole|ropinirole|mesh-list
110017418|NCT03009396|Clarithromycin|clarithromycin|mesh-list
110250751|NCT00140712|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110250752|NCT00140712|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110250753|NCT00140712|Dopamine Agonists|dopamine agonists|mesh-ancestor
110250755|NCT00140712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110250756|NCT00140712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110250757|NCT00140712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110250758|NCT00132548|Artesunate|artesunate|mesh-list
110250759|NCT00132548|Pyrimethamine|pyrimethamine|mesh-list
110250760|NCT00132548|Sulfadoxine|sulfadoxine|mesh-list
110250761|NCT00132548|Amodiaquine|amodiaquine|mesh-list
110250762|NCT00132548|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110250763|NCT00132548|Antimalarials|antimalarials|mesh-ancestor
110250764|NCT00132548|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110250765|NCT00132548|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110250766|NCT00132548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110250767|NCT00132548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110250768|NCT00132548|Antiviral Agents|antiviral agents|mesh-ancestor
110250769|NCT00132548|Schistosomicides|schistosomicides|mesh-ancestor
110250770|NCT00132548|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110250771|NCT00132548|Anthelmintics|anthelmintics|mesh-ancestor
110250772|NCT00132548|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110250773|NCT00132548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110250774|NCT00132548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110250775|NCT00132548|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110250776|NCT00140751|Ritonavir|ritonavir|mesh-list
110250777|NCT00140751|Lopinavir|lopinavir|mesh-list
110250778|NCT00140751|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110250779|NCT00140751|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110250780|NCT00140751|Protease Inhibitors|protease inhibitors|mesh-ancestor
110250781|NCT00140751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110250782|NCT00140751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110250784|NCT00140751|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110250785|NCT00140751|Antiviral Agents|antiviral agents|mesh-ancestor
110250786|NCT00140751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110250787|NCT00140751|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110250788|NCT00140751|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110250789|NCT00132587|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
110250790|NCT00132587|Vasodilator Agents|vasodilator agents|mesh-ancestor
110250791|NCT00132587|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110250792|NCT00132587|Protective Agents|protective agents|mesh-ancestor
110250793|NCT00132587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110250794|NCT00140790|Valsartan|valsartan|mesh-list
110250795|NCT00140790|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110250796|NCT00140790|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110250797|NCT00140790|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110250798|NCT00140790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110250799|NCT01245673|Lenalidomide|lenalidomide|mesh-list
110250800|NCT01245673|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110250801|NCT01245673|Poly ICLC|poly iclc|mesh-list
110250803|NCT01245673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110250804|NCT01245673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110250805|NCT01245673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110250806|NCT01245673|Growth Substances|growth substances|mesh-ancestor
110250807|NCT01245673|Growth Inhibitors|growth inhibitors|mesh-ancestor
110250808|NCT01245673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110250809|NCT01245673|Interferon Inducers|interferon inducers|mesh-ancestor
110250810|NCT02261415|Tranexamic Acid|tranexamic acid|mesh-list
110250811|NCT02261415|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110250812|NCT02261415|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110250813|NCT02261415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110250814|NCT02261415|Hemostatics|hemostatics|mesh-ancestor
110250815|NCT02261415|Coagulants|coagulants|mesh-ancestor
110250816|NCT00132743|Cilostazol|cilostazol|mesh-list
110250817|NCT00132743|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110250818|NCT00132743|Autonomic Agents|autonomic agents|mesh-ancestor
110250819|NCT00132743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110250820|NCT00132743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110250821|NCT00132743|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110250822|NCT00132743|Respiratory System Agents|respiratory system agents|mesh-ancestor
110250823|NCT00132743|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110250824|NCT00132743|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110250825|NCT00132743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110250826|NCT00132743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110250827|NCT00132743|Vasodilator Agents|vasodilator agents|mesh-ancestor
110250828|NCT00132743|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110250829|NCT00132743|Protective Agents|protective agents|mesh-ancestor
110250830|NCT00132743|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110250831|NCT00132743|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110250832|NCT00132743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110250833|NCT00132821|Bupropion|bupropion|mesh-list
110250834|NCT00132821|Nicotine|nicotine|mesh-list
110250835|NCT00132821|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110250836|NCT00132821|Autonomic Agents|autonomic agents|mesh-ancestor
110250837|NCT00132821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110250838|NCT00132821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110250839|NCT00132821|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110250840|NCT00132821|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110250841|NCT00132821|Cholinergic Agents|cholinergic agents|mesh-ancestor
110250842|NCT00132821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110250843|NCT00132821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110250844|NCT00132821|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110250845|NCT00132821|Antidepressive Agents|antidepressive agents|mesh-ancestor
110250846|NCT00132821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110250847|NCT00132821|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110250848|NCT00132821|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110250849|NCT00132821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110250850|NCT00132821|Dopamine Agents|dopamine agents|mesh-ancestor
110250851|NCT00132821|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110250852|NCT00132821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110250853|NCT00132821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110250854|NCT00132860|Azithromycin|azithromycin|mesh-list
110250855|NCT00132860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110250856|NCT00132860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110250857|NCT01244815|Asenapine|asenapine|mesh-list
110250858|NCT01244815|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110250859|NCT01244815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110250860|NCT01244815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110250861|NCT01244815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110250862|NCT01244815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110250863|NCT00132899|Methotrexate|methotrexate|mesh-list
110250864|NCT00132899|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110250865|NCT00132899|Abortifacient Agents|abortifacient agents|mesh-ancestor
110250866|NCT00132899|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110250867|NCT00132899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110250868|NCT00132899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110250869|NCT00132899|Antimetabolites|antimetabolites|mesh-ancestor
110250870|NCT00132899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110250871|NCT00132899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110250872|NCT00132899|Dermatologic Agents|dermatologic agents|mesh-ancestor
110250873|NCT00132899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110250874|NCT00132899|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110250875|NCT00132899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110250876|NCT00132899|Immunologic Factors|immunologic factors|mesh-ancestor
110250877|NCT00132899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110250878|NCT00132899|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110250879|NCT00140868|Phenobarbital|phenobarbital|mesh-list
110250880|NCT00140868|Anticonvulsants|anticonvulsants|mesh-ancestor
110250881|NCT00140868|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110250882|NCT00140868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110250883|NCT00140868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110250884|NCT00140868|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110250885|NCT00140868|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110250886|NCT00140868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110250887|NCT00140868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110250888|NCT00140868|GABA Modulators|gaba modulators|mesh-ancestor
110250889|NCT00140868|GABA Agents|gaba agents|mesh-ancestor
110250890|NCT00140868|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110250891|NCT00140868|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110250892|NCT00140868|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110250893|NCT00132938|Telithromycin|telithromycin|mesh-list
110250894|NCT00132938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110250895|NCT00132938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110250896|NCT02955706|Acetylcarnitine|acetylcarnitine|mesh-list
110250897|NCT02955706|Vitamin B Complex|vitamin b complex|mesh-ancestor
110250899|NCT02955706|Micronutrients|micronutrients|mesh-ancestor
110250900|NCT02955706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110250901|NCT02955706|Nootropic Agents|nootropic agents|mesh-ancestor
110250902|NCT01244425|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110250903|NCT01244425|Hemostatics|hemostatics|mesh-ancestor
110250904|NCT01244425|Coagulants|coagulants|mesh-ancestor
110250905|NCT00141063|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
110250906|NCT00141063|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110250907|NCT00141063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110250908|NCT00141063|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110250909|NCT00141063|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110250910|NCT00141063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110250911|NCT00141063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110250912|NCT00141063|Dopamine Agents|dopamine agents|mesh-ancestor
110250913|NCT00141063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110250915|NCT01154439|Etoposide|etoposide|mesh-list
110250916|NCT01154439|Mitoxantrone|mitoxantrone|mesh-list
110250917|NCT01154439|Idarubicin|idarubicin|mesh-list
110250918|NCT01154439|Etoposide phosphate|etoposide phosphate|mesh-list
110250919|NCT01154439|Everolimus|everolimus|mesh-list
110250920|NCT01154439|Ifosfamide|ifosfamide|mesh-list
110250921|NCT01154439|Carboplatin|carboplatin|mesh-list
110250922|NCT01154439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110250923|NCT01154439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110250924|NCT01154439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110250925|NCT01154439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110250926|NCT01154439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110269497|NCT05781698|Fenofibrate|fenofibrate|mesh-list
110250927|NCT01154439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110250928|NCT01154439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110250930|NCT01154439|Antiviral Agents|antiviral agents|mesh-ancestor
110250931|NCT01154439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110250932|NCT01154439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110250933|NCT01154439|Immunologic Factors|immunologic factors|mesh-ancestor
110250934|NCT01154439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110250935|NCT01154439|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110250936|NCT01154439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110250937|NCT01154439|Analgesics|analgesics|mesh-ancestor
110250938|NCT01154439|Sensory System Agents|sensory system agents|mesh-ancestor
110250939|NCT01154439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110250941|NCT01154439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110250942|NCT01154439|Alkylating Agents|alkylating agents|mesh-ancestor
110250943|NCT00133172|Mycophenolic Acid|mycophenolic acid|mesh-list
110250945|NCT00133172|Tacrolimus|tacrolimus|mesh-list
110250946|NCT00133172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110250947|NCT00133172|Glucocorticoids|glucocorticoids|mesh-ancestor
110250948|NCT00133172|Hormones|hormones|mesh-ancestor
110250949|NCT00133172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110250950|NCT00133172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110250951|NCT00133172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110250952|NCT00133172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110250953|NCT00133172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110250954|NCT00133172|Immunologic Factors|immunologic factors|mesh-ancestor
110250955|NCT00133172|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110250956|NCT00133172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110250957|NCT00133172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110250958|NCT00133172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110250959|NCT00133172|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110250960|NCT00133172|Antitubercular Agents|antitubercular agents|mesh-ancestor
110250961|NCT00133172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110250962|NCT00133172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110250965|NCT00141141|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110250966|NCT00141141|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110250967|NCT00141141|Antimetabolites|antimetabolites|mesh-ancestor
110250968|NCT00141141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110250969|NCT00141141|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110250970|NCT00141141|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110250971|NCT00141141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110250972|NCT00133250|Heparin|heparin|mesh-list
110250973|NCT00133250|Calcium heparin|calcium heparin|mesh-list
110250974|NCT00133250|Abciximab|abciximab|mesh-list
110250975|NCT00133250|Anticoagulants|anticoagulants|mesh-ancestor
110250976|NCT00133250|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110250977|NCT00133250|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110250978|NCT00133250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110250979|NCT00133250|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110250980|NCT00144495|Epoetin Alfa|epoetin alfa|mesh-list
110250981|NCT00144495|Hematinics|hematinics|mesh-ancestor
110250982|NCT00133328|Valsartan|valsartan|mesh-list
110250983|NCT00133328|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110250984|NCT00133328|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110250985|NCT00133328|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110250986|NCT00133328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110250987|NCT00133367|Sirolimus|sirolimus|mesh-list
110250988|NCT00133367|Fludarabine|fludarabine|mesh-list
110250989|NCT00133367|Melphalan|melphalan|mesh-list
110250990|NCT00133367|Tacrolimus|tacrolimus|mesh-list
110250991|NCT00133367|Thymoglobulin|thymoglobulin|mesh-list
110250992|NCT00133367|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110250993|NCT00133367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110250994|NCT00133367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110250995|NCT00133367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110250996|NCT00133367|Immunologic Factors|immunologic factors|mesh-ancestor
110250997|NCT00133367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110250998|NCT00133367|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110250999|NCT00133367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110251000|NCT00133367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110251001|NCT00133367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110251002|NCT00133367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110251003|NCT00133367|Antifungal Agents|antifungal agents|mesh-ancestor
110251004|NCT00133367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110251005|NCT00133367|Alkylating Agents|alkylating agents|mesh-ancestor
110251006|NCT00133367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110251007|NCT00141258|Pregabalin|pregabalin|mesh-list
110251008|NCT00141258|Analgesics|analgesics|mesh-ancestor
110251009|NCT00141258|Sensory System Agents|sensory system agents|mesh-ancestor
110251010|NCT00141258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110251011|NCT00141258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251012|NCT00141258|Anticonvulsants|anticonvulsants|mesh-ancestor
110251013|NCT00141258|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110251014|NCT00141258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110251015|NCT00141258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110251016|NCT00141258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110251017|NCT00141258|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110251018|NCT00141258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110251019|NCT00141258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110251020|NCT00141258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110251021|NCT00403910|Canrenone|canrenone|mesh-list
110251022|NCT00403910|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110251023|NCT00403910|Hormone Antagonists|hormone antagonists|mesh-ancestor
110251024|NCT00403910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110251025|NCT00403910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251026|NCT00403910|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110251027|NCT00403910|Diuretics|diuretics|mesh-ancestor
110251028|NCT00403910|Natriuretic Agents|natriuretic agents|mesh-ancestor
110251029|NCT00141336|Pregabalin|pregabalin|mesh-list
110251030|NCT00141336|Analgesics|analgesics|mesh-ancestor
110251031|NCT00141336|Sensory System Agents|sensory system agents|mesh-ancestor
110251032|NCT00141336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110251033|NCT00141336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251034|NCT00141336|Anticonvulsants|anticonvulsants|mesh-ancestor
110251035|NCT00141336|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110251036|NCT00141336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110251037|NCT00141336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110251038|NCT00141336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110251039|NCT00141336|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110251040|NCT00141336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110251041|NCT00141336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110251042|NCT00141336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110251043|NCT00133406|Vitamin A|vitamin a|mesh-list
110251044|NCT00133406|Glycine|glycine|mesh-list
110251045|NCT00133406|Vitamins|vitamins|mesh-ancestor
110251046|NCT00133406|Micronutrients|micronutrients|mesh-ancestor
110251047|NCT00133406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251048|NCT00133406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110251049|NCT00133406|Glycine Agents|glycine agents|mesh-ancestor
110251050|NCT00133406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110251051|NCT00133445|Vaccines|vaccines|mesh-list
110251052|NCT00133445|Immunologic Factors|immunologic factors|mesh-ancestor
110251053|NCT00133445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251054|NCT00141375|Pregabalin|pregabalin|mesh-list
110251055|NCT00141375|Analgesics|analgesics|mesh-ancestor
110251056|NCT00141375|Sensory System Agents|sensory system agents|mesh-ancestor
110251057|NCT00141375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110251058|NCT00141375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251059|NCT00141375|Anticonvulsants|anticonvulsants|mesh-ancestor
110251060|NCT00141375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110251061|NCT00141375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110251062|NCT00141375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110251063|NCT00141375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110251064|NCT00141375|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110251065|NCT00141375|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110251066|NCT00141375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110251067|NCT00141375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110251068|NCT00133523|Vaccines|vaccines|mesh-list
110251069|NCT00133523|Immunologic Factors|immunologic factors|mesh-ancestor
110251070|NCT00133523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251071|NCT00133562|Glycine|glycine|mesh-list
110251072|NCT00133562|Glycine Agents|glycine agents|mesh-ancestor
110251073|NCT00133562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110251074|NCT00133562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110251075|NCT00133562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251076|NCT00404391|Acetaminophen|acetaminophen|mesh-list
110251077|NCT00404391|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
110251078|NCT00404391|Hydrocodone|hydrocodone|mesh-list
110251079|NCT00404391|Oxycodone|oxycodone|mesh-list
110251080|NCT00404391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110251081|NCT00404391|Analgesics|analgesics|mesh-ancestor
110251082|NCT00404391|Sensory System Agents|sensory system agents|mesh-ancestor
110251083|NCT00404391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110251084|NCT00404391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251085|NCT00404391|Antipyretics|antipyretics|mesh-ancestor
110251086|NCT00404391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110251087|NCT00404391|Narcotics|narcotics|mesh-ancestor
110251088|NCT00404391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110251089|NCT00404391|Antitussive Agents|antitussive agents|mesh-ancestor
110251090|NCT00404391|Respiratory System Agents|respiratory system agents|mesh-ancestor
110251091|NCT00404391|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110251092|NCT00404391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110251093|NCT00404391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110251094|NCT00144807|Cyclophosphamide|cyclophosphamide|mesh-list
110251095|NCT00144807|Rituximab|rituximab|mesh-list
110251096|NCT00144807|Doxorubicin|doxorubicin|mesh-list
110251097|NCT00144807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110251098|NCT00144807|Immunologic Factors|immunologic factors|mesh-ancestor
110251099|NCT00144807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251100|NCT00144807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110251101|NCT00144807|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110251102|NCT00144807|Alkylating Agents|alkylating agents|mesh-ancestor
110251103|NCT00144807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110251104|NCT00144807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110251105|NCT00144807|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110251106|NCT00144807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110251107|NCT00144807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110251108|NCT00144807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110251109|NCT00144807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110251110|NCT00144807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110251111|NCT00133640|Cholecalciferol|cholecalciferol|mesh-list
110251112|NCT00133640|Vitamin D|vitamin d|mesh-list
110251113|NCT00133640|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110269532|NCT05693844|Paclitaxel|paclitaxel|mesh-list
110251114|NCT00133640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251115|NCT00133640|Vitamins|vitamins|mesh-ancestor
110251116|NCT00133640|Micronutrients|micronutrients|mesh-ancestor
110251117|NCT00133640|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110251118|NCT01244191|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110251119|NCT01244191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110251120|NCT01244191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110251121|NCT01244191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110251122|NCT01244191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110251123|NCT00404508|Hydralazine|hydralazine|mesh-list
110251124|NCT00404508|Valproic Acid|valproic acid|mesh-list
110251125|NCT00404508|Anticonvulsants|anticonvulsants|mesh-ancestor
110251126|NCT00404508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110251127|NCT00404508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110251128|NCT00404508|GABA Agents|gaba agents|mesh-ancestor
110251129|NCT00404508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110251130|NCT00404508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251131|NCT00404508|Antimanic Agents|antimanic agents|mesh-ancestor
110251132|NCT00404508|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110251133|NCT00404508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110251134|NCT00404508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110251135|NCT00404508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110251136|NCT00404508|Vasodilator Agents|vasodilator agents|mesh-ancestor
110251137|NCT00133757|Bupropion|bupropion|mesh-list
110251138|NCT00133757|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110251139|NCT00133757|Antidepressive Agents|antidepressive agents|mesh-ancestor
110251140|NCT00133757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110251141|NCT00133757|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110251142|NCT00133757|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110251143|NCT00133757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110251144|NCT00133757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110251145|NCT00133757|Dopamine Agents|dopamine agents|mesh-ancestor
110251146|NCT00133757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110251147|NCT00133757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251148|NCT00133757|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110251149|NCT00133757|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110251150|NCT00133757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110251152|NCT00144846|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110251153|NCT00144846|Autonomic Agents|autonomic agents|mesh-ancestor
110251154|NCT00144846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110251155|NCT00144846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251156|NCT00144846|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110251157|NCT00144846|Respiratory System Agents|respiratory system agents|mesh-ancestor
110251158|NCT00144846|Tocolytic Agents|tocolytic agents|mesh-ancestor
110251159|NCT00144846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110251160|NCT00144846|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110251161|NCT00144846|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110251162|NCT00144846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110251163|NCT00144846|Adrenergic Agents|adrenergic agents|mesh-ancestor
110251164|NCT00144846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110251165|NCT00144846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110251166|NCT00133796|Trastuzumab|trastuzumab|mesh-list
110251167|NCT00133796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110251168|NCT00133796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110251169|NCT00133874|Retapamulin|retapamulin|mesh-list
110251170|NCT00133874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110251171|NCT00133874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110251172|NCT00141414|Pregabalin|pregabalin|mesh-list
110251173|NCT00141414|Analgesics|analgesics|mesh-ancestor
110251174|NCT00141414|Sensory System Agents|sensory system agents|mesh-ancestor
110251175|NCT00141414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110251176|NCT00141414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251177|NCT00141414|Anticonvulsants|anticonvulsants|mesh-ancestor
110251178|NCT00141414|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110251179|NCT00141414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110251180|NCT00141414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110251181|NCT00141414|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110251182|NCT00141414|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110251183|NCT00141414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110251184|NCT00141414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110251185|NCT00141414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110251186|NCT00145002|Lenograstim|lenograstim|mesh-list
110251187|NCT00145002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110251188|NCT00145002|Immunologic Factors|immunologic factors|mesh-ancestor
110251189|NCT00145002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251190|NCT00141492|Testosterone|testosterone|mesh-list
110251191|NCT00141492|Androgens|androgens|mesh-ancestor
110251192|NCT00141492|Hormones|hormones|mesh-ancestor
110251193|NCT00141492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110251194|NCT00141492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251195|NCT00141531|Apaziquone|apaziquone|mesh-list
110251196|NCT00141531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110251197|NCT00134069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110251198|NCT00134069|Cetuximab|cetuximab|mesh-list
110251199|NCT00134069|Irinotecan|irinotecan|mesh-list
110251201|NCT00134069|Antibodies|antibodies|mesh-list
110251202|NCT00134069|Immunoglobulins|immunoglobulins|mesh-list
110251203|NCT00134069|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110251204|NCT00134069|Immunologic Factors|immunologic factors|mesh-ancestor
110251205|NCT00134069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251206|NCT00134069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110251207|NCT00134069|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110251208|NCT00134069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110251209|NCT00134069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110251210|NCT00134069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110251211|NCT00134069|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110251212|NCT00141570|Methyltestosterone|methyltestosterone|mesh-list
110251213|NCT00141570|Estrogens|estrogens|mesh-list
110251214|NCT00141570|Estrogens, Esterified (USP)|estrogens, esterified (usp)|mesh-list
110251215|NCT00141570|Testosterone|testosterone|mesh-list
110251216|NCT00141570|Testosterone undecanoate|testosterone undecanoate|mesh-list
110251217|NCT00141570|Testosterone enanthate|testosterone enanthate|mesh-list
110251218|NCT00141570|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110251219|NCT00141570|Hormones|hormones|mesh-ancestor
110251220|NCT00141570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110251221|NCT00141570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251222|NCT00141570|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110251223|NCT00141570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110251224|NCT00141570|Anabolic Agents|anabolic agents|mesh-ancestor
110251225|NCT00141570|Androgens|androgens|mesh-ancestor
110251226|NCT00134147|Insulin|insulin|mesh-list
110251227|NCT00134147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110251228|NCT00134147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251229|NCT00403988|Oxaliplatin|oxaliplatin|mesh-list
110251230|NCT00403988|Vinorelbine|vinorelbine|mesh-list
110251231|NCT00403988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110251232|NCT00403988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110251233|NCT00403988|Tubulin Modulators|tubulin modulators|mesh-ancestor
110251234|NCT00403988|Antimitotic Agents|antimitotic agents|mesh-ancestor
110251235|NCT00403988|Mitosis Modulators|mitosis modulators|mesh-ancestor
110251236|NCT00403988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110251237|NCT00134186|Motexafin gadolinium|motexafin gadolinium|mesh-list
110251238|NCT00134186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110251239|NCT00134186|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110251240|NCT00134186|Dermatologic Agents|dermatologic agents|mesh-ancestor
110251241|NCT00141648|Prednisolone|prednisolone|mesh-list
110251242|NCT00141648|Cyclophosphamide|cyclophosphamide|mesh-list
110251243|NCT00141648|Doxorubicin|doxorubicin|mesh-list
110251244|NCT00141648|Vincristine|vincristine|mesh-list
110251245|NCT00141648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110251246|NCT00141648|Immunologic Factors|immunologic factors|mesh-ancestor
110251247|NCT00141648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251248|NCT00141648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110251249|NCT00141648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110251250|NCT00141648|Alkylating Agents|alkylating agents|mesh-ancestor
110251251|NCT00141648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110251252|NCT00141648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110251253|NCT00141648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110251254|NCT00141648|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110251255|NCT00141648|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110251256|NCT00141648|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110251257|NCT00141648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110251258|NCT00141648|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110251259|NCT00141648|Tubulin Modulators|tubulin modulators|mesh-ancestor
110251260|NCT00141648|Antimitotic Agents|antimitotic agents|mesh-ancestor
110251261|NCT00141648|Mitosis Modulators|mitosis modulators|mesh-ancestor
110251262|NCT00141648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110251263|NCT00141648|Glucocorticoids|glucocorticoids|mesh-ancestor
110251264|NCT00141648|Hormones|hormones|mesh-ancestor
110251265|NCT00141648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110251266|NCT00141648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110251267|NCT00134420|Clonidine|clonidine|mesh-list
110251269|NCT00134420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251270|NCT00134420|Mitosis Modulators|mitosis modulators|mesh-ancestor
110251271|NCT00134420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110251272|NCT00134420|Analgesics|analgesics|mesh-ancestor
110251273|NCT00134420|Sensory System Agents|sensory system agents|mesh-ancestor
110251274|NCT00134420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110251275|NCT00134420|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110251276|NCT00134420|Sympatholytics|sympatholytics|mesh-ancestor
110251277|NCT00134420|Autonomic Agents|autonomic agents|mesh-ancestor
110251278|NCT00134420|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110251279|NCT00134420|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110251280|NCT00134420|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110251281|NCT00134420|Adrenergic Agents|adrenergic agents|mesh-ancestor
110251282|NCT00134420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110251283|NCT00141804|Sirolimus|sirolimus|mesh-list
110251284|NCT00141804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110251285|NCT00141804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110251286|NCT00141804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110251287|NCT00141804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110251288|NCT00141804|Antifungal Agents|antifungal agents|mesh-ancestor
110251289|NCT00141804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110251290|NCT00141804|Immunologic Factors|immunologic factors|mesh-ancestor
110251291|NCT00141804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251292|NCT00134498|Atorvastatin|atorvastatin|mesh-list
110251293|NCT00134498|Torcetrapib|torcetrapib|mesh-list
110251294|NCT00134498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110251295|NCT00134498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110251296|NCT00134498|Antimetabolites|antimetabolites|mesh-ancestor
110251297|NCT00134498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110251298|NCT00134498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110251299|NCT00134498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110251300|NCT00134498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110251301|NCT00141843|Factor VIII|factor viii|mesh-list
110251302|NCT00141843|Coagulants|coagulants|mesh-ancestor
110251304|NCT00141882|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110251305|NCT00141882|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110251306|NCT00141882|Dopamine Agents|dopamine agents|mesh-ancestor
110251307|NCT00141882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110251308|NCT00141882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110251309|NCT00141882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251310|NCT00141882|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110251311|NCT00141882|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110251312|NCT00152295|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110251313|NCT00152295|Estrogens|estrogens|mesh-ancestor
110251314|NCT00152295|Hormones|hormones|mesh-ancestor
110251315|NCT00152295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110251316|NCT00152295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251317|NCT00152373|Levetiracetam|levetiracetam|mesh-list
110251318|NCT00152373|Anticonvulsants|anticonvulsants|mesh-ancestor
110251319|NCT00152373|Nootropic Agents|nootropic agents|mesh-ancestor
110251320|NCT00134654|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110251321|NCT00134654|Estrogens|estrogens|mesh-ancestor
110251322|NCT00134654|Hormones|hormones|mesh-ancestor
110251323|NCT00134654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110251324|NCT00134654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251325|NCT00141960|Famotidine|famotidine|mesh-list
110251326|NCT00141960|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110251327|NCT00141960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110251328|NCT00141960|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110251329|NCT00141960|Histamine Antagonists|histamine antagonists|mesh-ancestor
110251330|NCT00141960|Histamine Agents|histamine agents|mesh-ancestor
110251331|NCT00141960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110251332|NCT00141960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110251333|NCT00141960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251334|NCT00134693|Prednisolone|prednisolone|mesh-list
110251335|NCT00134693|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110251336|NCT00134693|Methylprednisolone|methylprednisolone|mesh-list
110251337|NCT00134693|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110251338|NCT00134693|Prednisolone acetate|prednisolone acetate|mesh-list
110251339|NCT00134693|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110251340|NCT00134693|Prednisolone phosphate|prednisolone phosphate|mesh-list
110251341|NCT00134693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110251342|NCT00134693|Glucocorticoids|glucocorticoids|mesh-ancestor
110251343|NCT00134693|Hormones|hormones|mesh-ancestor
110251344|NCT00134693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110251345|NCT00134693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251346|NCT00134693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110251347|NCT00134693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110251348|NCT00134693|Antiemetics|antiemetics|mesh-ancestor
110251349|NCT00134693|Autonomic Agents|autonomic agents|mesh-ancestor
110251350|NCT00134693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110251351|NCT00134693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110251352|NCT00134693|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110251353|NCT00134693|Protective Agents|protective agents|mesh-ancestor
110251355|NCT00152412|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110251356|NCT00152412|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110251357|NCT00152412|Histamine Antagonists|histamine antagonists|mesh-ancestor
110251358|NCT00152412|Histamine Agents|histamine agents|mesh-ancestor
110251359|NCT00152412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110251360|NCT00152412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110251361|NCT00152412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251362|NCT00142038|Docetaxel|docetaxel|mesh-list
110251363|NCT00142038|Capecitabine|capecitabine|mesh-list
110251364|NCT00142038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110251365|NCT00142038|Tubulin Modulators|tubulin modulators|mesh-ancestor
110251366|NCT00142038|Antimitotic Agents|antimitotic agents|mesh-ancestor
110251367|NCT00142038|Mitosis Modulators|mitosis modulators|mesh-ancestor
110251368|NCT00142038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110251369|NCT00142038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110251370|NCT00142038|Antimetabolites|antimetabolites|mesh-ancestor
110251371|NCT00134810|Botulinum Toxins|botulinum toxins|mesh-list
110251372|NCT00134810|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110251373|NCT00134810|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110251374|NCT00134810|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110251375|NCT00134810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110251376|NCT00134810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110251377|NCT00134810|Cholinergic Agents|cholinergic agents|mesh-ancestor
110251378|NCT00134810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110251379|NCT00134810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251380|NCT00134810|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110251381|NCT00134810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110251382|NCT02964455|Docetaxel|docetaxel|mesh-list
110251383|NCT02964455|Nedaplatin|nedaplatin|mesh-list
110251384|NCT02964455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110251385|NCT02964455|Tubulin Modulators|tubulin modulators|mesh-ancestor
110251386|NCT02964455|Antimitotic Agents|antimitotic agents|mesh-ancestor
110251387|NCT02964455|Mitosis Modulators|mitosis modulators|mesh-ancestor
110251388|NCT02964455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110251389|NCT00142155|Rituximab|rituximab|mesh-list
110251390|NCT00142155|Antibodies|antibodies|mesh-list
110251391|NCT00142155|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110251392|NCT00142155|Immunologic Factors|immunologic factors|mesh-ancestor
110251393|NCT00142155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251394|NCT00142155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110251395|NCT00142155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110251397|NCT00152490|Certolizumab Pegol|certolizumab pegol|mesh-list
110251398|NCT00152490|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110251399|NCT00152490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110251400|NCT00152490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110251401|NCT00152490|Immunologic Factors|immunologic factors|mesh-ancestor
110251402|NCT00152490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251403|NCT00152490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110251404|NCT00134888|Buprenorphine|buprenorphine|mesh-list
110251405|NCT00134888|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
110251406|NCT00134888|Naloxone|naloxone|mesh-list
110251407|NCT00134888|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110251409|NCT00134888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110251410|NCT00134888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251411|NCT00134888|Analgesics|analgesics|mesh-ancestor
110251412|NCT00134888|Sensory System Agents|sensory system agents|mesh-ancestor
110251413|NCT00134888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110251414|NCT00134888|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110251415|NCT00134966|Levodopa|levodopa|mesh-list
110251416|NCT00134966|Carbidopa|carbidopa|mesh-list
110251417|NCT00134966|Entacapone|entacapone|mesh-list
110251418|NCT00134966|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110251419|NCT00134966|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110251420|NCT00134966|Dopamine Agents|dopamine agents|mesh-ancestor
110269602|NCT05617118|GABA Agents|gaba agents|mesh-ancestor
110251421|NCT00134966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110251422|NCT00134966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110251423|NCT00134966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251424|NCT00134966|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110251425|NCT00134966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110251426|NCT00134966|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
110251427|NCT00135005|Imatinib Mesylate|imatinib mesylate|mesh-list
110251428|NCT00135005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110251429|NCT00135005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110251430|NCT00135005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110251431|NCT00135005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110251432|NCT00142233|N-Methylaspartate|n-methylaspartate|mesh-list
110251433|NCT00142233|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
110251434|NCT00142233|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110251435|NCT00142233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110251436|NCT00142233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110251437|NCT00142233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251438|NCT00135083|Insulin glulisine|insulin glulisine|mesh-list
110251439|NCT00135083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110251440|NCT00135083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251441|NCT04725357|Meloxicam|meloxicam|mesh-list
110251442|NCT04725357|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110251443|NCT04725357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110251444|NCT04725357|Analgesics|analgesics|mesh-ancestor
110251445|NCT04725357|Sensory System Agents|sensory system agents|mesh-ancestor
110251446|NCT04725357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110251447|NCT04725357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251448|NCT04725357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110251449|NCT04725357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110251450|NCT04725357|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110251451|NCT04725357|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110251452|NCT04725357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110251453|NCT04725357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110251454|NCT00135122|Prednisolone|prednisolone|mesh-list
110251455|NCT00135122|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110251456|NCT00135122|Methylprednisolone|methylprednisolone|mesh-list
110251457|NCT00135122|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110251458|NCT00135122|Prednisolone acetate|prednisolone acetate|mesh-list
110251459|NCT00135122|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110251460|NCT00135122|Prednisolone phosphate|prednisolone phosphate|mesh-list
110251461|NCT00135122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110251462|NCT00135122|Glucocorticoids|glucocorticoids|mesh-ancestor
110251463|NCT00135122|Hormones|hormones|mesh-ancestor
110251464|NCT00135122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110251465|NCT00135122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251466|NCT00135122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110251467|NCT00135122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110251468|NCT00135122|Antiemetics|antiemetics|mesh-ancestor
110251469|NCT00135122|Autonomic Agents|autonomic agents|mesh-ancestor
110251470|NCT00135122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110251471|NCT00135122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110251472|NCT00135122|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110251473|NCT00135122|Protective Agents|protective agents|mesh-ancestor
110251474|NCT00142350|Fluorouracil|fluorouracil|mesh-list
110251475|NCT00142350|Irinotecan|irinotecan|mesh-list
110251476|NCT00142350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110251478|NCT00142350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110251479|NCT00142350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110251480|NCT00142350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110251481|NCT00142350|Immunologic Factors|immunologic factors|mesh-ancestor
110251483|NCT00142350|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110251484|NCT00142350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110251485|NCT00142350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110251487|NCT00135317|Hematinics|hematinics|mesh-ancestor
110251488|NCT00152646|Clopidogrel|clopidogrel|mesh-list
110251489|NCT00152646|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110251490|NCT00152646|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110251491|NCT00152646|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110251492|NCT00152646|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110251493|NCT00152646|Purinergic Agents|purinergic agents|mesh-ancestor
110251494|NCT00152646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110251495|NCT00152646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110251496|NCT00152646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251497|NCT00135434|Ritonavir|ritonavir|mesh-list
110251498|NCT00135434|Lopinavir|lopinavir|mesh-list
110251499|NCT00135434|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110251500|NCT00135434|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110251501|NCT00135434|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110251502|NCT00135434|Protease Inhibitors|protease inhibitors|mesh-ancestor
110251503|NCT00135434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110251504|NCT00135434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110251505|NCT00135434|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110251506|NCT00135434|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110251507|NCT00135434|Antiviral Agents|antiviral agents|mesh-ancestor
110251508|NCT00135434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110251509|NCT00135434|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110251510|NCT00135434|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110251512|NCT00135473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110251513|NCT00135473|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
110251514|NCT00135473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110251515|NCT00135473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251516|NCT00135473|Plasma Substitutes|plasma substitutes|mesh-ancestor
110251517|NCT00135473|Blood Substitutes|blood substitutes|mesh-ancestor
110251518|NCT00142428|Cetuximab|cetuximab|mesh-list
110251519|NCT00142428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110251520|NCT00142428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110251521|NCT00135551|Benidipine|benidipine|mesh-list
110251522|NCT00135551|Diuretics|diuretics|mesh-list
110251523|NCT00135551|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
110251524|NCT00135551|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
110251525|NCT00135551|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110251526|NCT00135551|Natriuretic Agents|natriuretic agents|mesh-ancestor
110251527|NCT00135551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251528|NCT00135551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110251529|NCT00135551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110251530|NCT00135551|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110251531|NCT00135551|Adrenergic Agents|adrenergic agents|mesh-ancestor
110251532|NCT00135551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110251533|NCT00135551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110251534|NCT00135551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110251535|NCT00135551|Vasodilator Agents|vasodilator agents|mesh-ancestor
110251536|NCT00152724|Aspirin|aspirin|mesh-list
110251537|NCT00152724|Celecoxib|celecoxib|mesh-list
110251538|NCT00152724|Indomethacin|indomethacin|mesh-list
110251539|NCT00152724|Nitroprusside|nitroprusside|mesh-list
110251540|NCT00152724|Acetylcholine|acetylcholine|mesh-list
110251541|NCT00152724|Capsaicin|capsaicin|mesh-list
110251542|NCT00152724|Clopidogrel|clopidogrel|mesh-list
110251543|NCT00152724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110251544|NCT00152724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110251545|NCT00152724|Analgesics|analgesics|mesh-ancestor
110251546|NCT00152724|Sensory System Agents|sensory system agents|mesh-ancestor
110251547|NCT00152724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110251548|NCT00152724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251549|NCT00152724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110251551|NCT00152724|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110251552|NCT00152724|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110251553|NCT00152724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110251554|NCT00152724|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110251555|NCT00152724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110251556|NCT00152724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110251557|NCT00152724|Antipyretics|antipyretics|mesh-ancestor
110251558|NCT00152724|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110251559|NCT00152724|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110251561|NCT00152724|Purinergic Agents|purinergic agents|mesh-ancestor
110251562|NCT00152724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110251563|NCT00152724|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110251564|NCT00152724|Antipruritics|antipruritics|mesh-ancestor
110251565|NCT00152724|Dermatologic Agents|dermatologic agents|mesh-ancestor
110251566|NCT00152724|Gout Suppressants|gout suppressants|mesh-ancestor
110251567|NCT00152724|Tocolytic Agents|tocolytic agents|mesh-ancestor
110251568|NCT00152724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110251569|NCT00152724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110251571|NCT00152724|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110251572|NCT00152724|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110251573|NCT00152724|Cholinergic Agents|cholinergic agents|mesh-ancestor
110251574|NCT00135668|Nitroprusside|nitroprusside|mesh-list
110251575|NCT00135668|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110251576|NCT00135668|Vasodilator Agents|vasodilator agents|mesh-ancestor
110251577|NCT00135668|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110251578|NCT00135668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110251580|NCT00152802|Immunologic Factors|immunologic factors|mesh-ancestor
110251581|NCT00152802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251582|NCT00135746|Nicotine|nicotine|mesh-list
110251583|NCT00135746|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110251584|NCT00135746|Autonomic Agents|autonomic agents|mesh-ancestor
110251585|NCT00135746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110251586|NCT00135746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251587|NCT00135746|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110251588|NCT00135746|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110251589|NCT00135746|Cholinergic Agents|cholinergic agents|mesh-ancestor
110251590|NCT00135746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110251591|NCT00135746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110251592|NCT00135785|Bupropion|bupropion|mesh-list
110251593|NCT00135785|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110251594|NCT00135785|Antidepressive Agents|antidepressive agents|mesh-ancestor
110251595|NCT00135785|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110251596|NCT00135785|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110251597|NCT00135785|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110251598|NCT00135785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110251599|NCT00135785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110251600|NCT00135785|Dopamine Agents|dopamine agents|mesh-ancestor
110251601|NCT00135785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110251602|NCT00135785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251603|NCT00135785|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110251604|NCT00135785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110251605|NCT00135785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110251606|NCT00159081|Haloperidol|haloperidol|mesh-list
110251607|NCT00159081|Risperidone|risperidone|mesh-list
110251608|NCT00159081|Haloperidol decanoate|haloperidol decanoate|mesh-list
110251609|NCT00159081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110251610|NCT00159081|Serotonin Agents|serotonin agents|mesh-ancestor
110251611|NCT00159081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110251612|NCT00159081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110251613|NCT00159081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251614|NCT00159081|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110251615|NCT00159081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110251616|NCT00159081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110251617|NCT00159081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110251618|NCT00159081|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110251619|NCT00159081|Dopamine Agents|dopamine agents|mesh-ancestor
110251620|NCT00159081|Antiemetics|antiemetics|mesh-ancestor
110251621|NCT00159081|Autonomic Agents|autonomic agents|mesh-ancestor
110251622|NCT00159081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110251623|NCT00159081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110251624|NCT00159081|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110251626|NCT00152841|Vitamins|vitamins|mesh-ancestor
110251627|NCT00152841|Micronutrients|micronutrients|mesh-ancestor
110251628|NCT00152841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251629|NCT00152841|Antioxidants|antioxidants|mesh-ancestor
110251630|NCT00152841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110251631|NCT00152841|Protective Agents|protective agents|mesh-ancestor
110251632|NCT00159120|Antipsychotic Agents|antipsychotic agents|mesh-list
110251633|NCT00159120|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110251634|NCT00159120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110251635|NCT00159120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251636|NCT00159120|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110251638|NCT00159159|Cyclosporins|cyclosporins|mesh-list
110251639|NCT00159159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110251640|NCT00159159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110251641|NCT00159159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110251642|NCT00159159|Immunologic Factors|immunologic factors|mesh-ancestor
110251643|NCT00159159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251644|NCT00159159|Antifungal Agents|antifungal agents|mesh-ancestor
110251645|NCT00159159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110251646|NCT00159159|Dermatologic Agents|dermatologic agents|mesh-ancestor
110251647|NCT00159159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110251648|NCT00159159|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110251649|NCT00135824|Povidone|povidone|mesh-list
110251650|NCT00135824|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110251651|NCT00135824|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110251652|NCT00135824|Plasma Substitutes|plasma substitutes|mesh-ancestor
110251653|NCT00135824|Blood Substitutes|blood substitutes|mesh-ancestor
110251654|NCT00135863|Tinzaparin|tinzaparin|mesh-list
110251655|NCT00135863|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110251656|NCT00135863|Dalteparin|dalteparin|mesh-list
110251658|NCT00135863|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110251659|NCT00135863|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110251660|NCT00135863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110251661|NCT00135902|Progesterone|progesterone|mesh-list
110251662|NCT00135902|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
110251663|NCT00135902|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
110251664|NCT00135902|Progestins|progestins|mesh-ancestor
110251665|NCT00135902|Hormones|hormones|mesh-ancestor
110251666|NCT00135902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110251667|NCT00135902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251668|NCT00135902|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110251669|NCT00135902|Hormone Antagonists|hormone antagonists|mesh-ancestor
110251670|NCT00135941|Insulin|insulin|mesh-list
110251671|NCT00135941|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110251672|NCT00135941|Insulin Glargine|insulin glargine|mesh-list
110251674|NCT00135941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110251675|NCT00135941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251676|NCT00152919|Meloxicam|meloxicam|mesh-list
110251677|NCT00152919|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110251678|NCT00152919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110251679|NCT00152919|Analgesics|analgesics|mesh-ancestor
110251680|NCT00152919|Sensory System Agents|sensory system agents|mesh-ancestor
110251681|NCT00152919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110251682|NCT00152919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251683|NCT00152919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110251684|NCT00152919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110251685|NCT00152919|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110251686|NCT00152919|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110251687|NCT00152919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110251688|NCT00152919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110251689|NCT00406146|Artesunate|artesunate|mesh-list
110251690|NCT00406146|Lumefantrine|lumefantrine|mesh-list
110251691|NCT00406146|Artemether|artemether|mesh-list
110269661|NCT05267873|Vortioxetine|vortioxetine|mesh-list
110251692|NCT00406146|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110251693|NCT00406146|Amodiaquine|amodiaquine|mesh-list
110251694|NCT00406146|Antimalarials|antimalarials|mesh-ancestor
110251695|NCT00406146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110251696|NCT00406146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110251697|NCT00406146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110251698|NCT00406146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110251699|NCT00406146|Antiviral Agents|antiviral agents|mesh-ancestor
110251700|NCT00406146|Schistosomicides|schistosomicides|mesh-ancestor
110251701|NCT00406146|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110251702|NCT00406146|Anthelmintics|anthelmintics|mesh-ancestor
110251703|NCT00136058|Alendronate|alendronate|mesh-list
110251704|NCT00136058|Risedronic Acid|risedronic acid|mesh-list
110251705|NCT00136058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110251706|NCT00136058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251707|NCT00136058|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110251708|NCT00136058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110251709|NCT00136058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110251710|NCT00136058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110251712|NCT00152958|Antioxidants|antioxidants|mesh-ancestor
110251713|NCT00152958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110251714|NCT00152958|Protective Agents|protective agents|mesh-ancestor
110251715|NCT00152958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251716|NCT00152958|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110251717|NCT00152958|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110251718|NCT00152958|Dopamine Agonists|dopamine agonists|mesh-ancestor
110251719|NCT00152958|Dopamine Agents|dopamine agents|mesh-ancestor
110251720|NCT00152958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110251721|NCT00136175|Paclitaxel|paclitaxel|mesh-list
110251722|NCT00136175|Carboplatin|carboplatin|mesh-list
110251723|NCT00136175|Gemcitabine|gemcitabine|mesh-list
110251724|NCT00136175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110251725|NCT00136175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110251726|NCT00136175|Tubulin Modulators|tubulin modulators|mesh-ancestor
110251727|NCT00136175|Antimitotic Agents|antimitotic agents|mesh-ancestor
110251728|NCT00136175|Mitosis Modulators|mitosis modulators|mesh-ancestor
110251729|NCT00136175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110251730|NCT00136175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110251731|NCT00136175|Antimetabolites|antimetabolites|mesh-ancestor
110251732|NCT00152997|Pramipexole|pramipexole|mesh-list
110251733|NCT00152997|Antioxidants|antioxidants|mesh-ancestor
110251734|NCT00152997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110251735|NCT00152997|Protective Agents|protective agents|mesh-ancestor
110251736|NCT00152997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251737|NCT00152997|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110251738|NCT00152997|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110251739|NCT00152997|Dopamine Agonists|dopamine agonists|mesh-ancestor
110251740|NCT00152997|Dopamine Agents|dopamine agents|mesh-ancestor
110251741|NCT00152997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110251743|NCT00136292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110251744|NCT00136292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110251745|NCT00153075|Fenoterol|fenoterol|mesh-list
110251746|NCT00153075|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
110251747|NCT00153075|Ipratropium|ipratropium|mesh-list
110251748|NCT00153075|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110251749|NCT00153075|Autonomic Agents|autonomic agents|mesh-ancestor
110251750|NCT00153075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110251751|NCT00153075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251752|NCT00153075|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110251753|NCT00153075|Respiratory System Agents|respiratory system agents|mesh-ancestor
110251754|NCT00153075|Sympathomimetics|sympathomimetics|mesh-ancestor
110251755|NCT00153075|Tocolytic Agents|tocolytic agents|mesh-ancestor
110251756|NCT00153075|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110251757|NCT00153075|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110251758|NCT00153075|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110251759|NCT00153075|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110251760|NCT00153075|Adrenergic Agents|adrenergic agents|mesh-ancestor
110251761|NCT00153075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110251762|NCT00153075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110251763|NCT00153075|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110251764|NCT00153075|Cholinergic Agents|cholinergic agents|mesh-ancestor
110251765|NCT00159471|Gemcitabine|gemcitabine|mesh-list
110251766|NCT00159471|Capecitabine|capecitabine|mesh-list
110251767|NCT00159471|Docetaxel|docetaxel|mesh-list
110251768|NCT00159471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110251769|NCT00159471|Antimetabolites|antimetabolites|mesh-ancestor
110251770|NCT00159471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110251771|NCT00159471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110251772|NCT00159471|Tubulin Modulators|tubulin modulators|mesh-ancestor
110251773|NCT00159471|Antimitotic Agents|antimitotic agents|mesh-ancestor
110251774|NCT00159471|Mitosis Modulators|mitosis modulators|mesh-ancestor
110251775|NCT00136370|Chlorhexidine|chlorhexidine|mesh-list
110251776|NCT00136370|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110251777|NCT00136370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110251778|NCT00136370|Disinfectants|disinfectants|mesh-ancestor
110251779|NCT00159510|Nitric Oxide|nitric oxide|mesh-list
110251780|NCT00159510|Methylene Blue|methylene blue|mesh-list
110251781|NCT00159510|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110251782|NCT00159510|Autonomic Agents|autonomic agents|mesh-ancestor
110251783|NCT00159510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110251784|NCT00159510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251786|NCT00159510|Respiratory System Agents|respiratory system agents|mesh-ancestor
110251787|NCT00159510|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110251788|NCT00159510|Antioxidants|antioxidants|mesh-ancestor
110251789|NCT00159510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110251790|NCT00159510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110251791|NCT00159510|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110251792|NCT00159510|Vasodilator Agents|vasodilator agents|mesh-ancestor
110251793|NCT00159510|Gasotransmitters|gasotransmitters|mesh-ancestor
110251794|NCT00159510|Protective Agents|protective agents|mesh-ancestor
110251795|NCT00159510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110251796|NCT00136409|Imatinib Mesylate|imatinib mesylate|mesh-list
110251797|NCT00136409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110251798|NCT00136409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110251799|NCT00136409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110251800|NCT00136409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110251801|NCT00153114|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
110251803|NCT00153114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110251805|NCT00136448|Interleukin-2|interleukin-2|mesh-list
110251806|NCT00136448|Daunorubicin|daunorubicin|mesh-list
110251807|NCT00136448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110251808|NCT00136448|Antimetabolites|antimetabolites|mesh-ancestor
110251809|NCT00136448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110251810|NCT00136448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110251811|NCT00136448|Antiviral Agents|antiviral agents|mesh-ancestor
110251812|NCT00136448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110251813|NCT00136448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110251814|NCT00136448|Immunologic Factors|immunologic factors|mesh-ancestor
110251815|NCT00136448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251816|NCT00136448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110251817|NCT00136448|Analgesics|analgesics|mesh-ancestor
110251818|NCT00136448|Sensory System Agents|sensory system agents|mesh-ancestor
110251819|NCT00136448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110251820|NCT00136448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110251821|NCT00136448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110251822|NCT00136448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110251823|NCT00136448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110251824|NCT00153153|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
110251825|NCT00153153|Laxatives|laxatives|mesh-ancestor
110251826|NCT00153153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110251828|NCT00136487|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110251829|NCT00136487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110251830|NCT00136487|Analgesics|analgesics|mesh-ancestor
110251831|NCT00136487|Sensory System Agents|sensory system agents|mesh-ancestor
110251832|NCT00136487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110251833|NCT00136487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251834|NCT00136487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110251835|NCT00136487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110251836|NCT00136487|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110251837|NCT00136487|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110251838|NCT00136487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110251839|NCT00136487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110251840|NCT00153192|Dronabinol|dronabinol|mesh-list
110251841|NCT00153192|Hallucinogens|hallucinogens|mesh-ancestor
110251842|NCT00153192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251843|NCT00153192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110251844|NCT00153192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110251845|NCT00153192|Analgesics|analgesics|mesh-ancestor
110251846|NCT00153192|Sensory System Agents|sensory system agents|mesh-ancestor
110251847|NCT00153192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110251848|NCT00153192|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110251849|NCT00153192|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110251850|NCT00153192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110251851|NCT00153192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110251852|NCT00153192|Hormones|hormones|mesh-ancestor
110251853|NCT00153192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110251854|NCT00136526|Docetaxel|docetaxel|mesh-list
110251855|NCT00136526|Fosfestrol|fosfestrol|mesh-list
110251856|NCT00136526|Diethylstilbestrol|diethylstilbestrol|mesh-list
110251857|NCT00136526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110251858|NCT00136526|Tubulin Modulators|tubulin modulators|mesh-ancestor
110251859|NCT00136526|Antimitotic Agents|antimitotic agents|mesh-ancestor
110251860|NCT00136526|Mitosis Modulators|mitosis modulators|mesh-ancestor
110251861|NCT00136526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110251862|NCT00136526|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110251863|NCT00136526|Estrogens|estrogens|mesh-ancestor
110251864|NCT00136526|Hormones|hormones|mesh-ancestor
110251865|NCT00136526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110251866|NCT00136526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251867|NCT00136526|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110251868|NCT00136565|Prednisone|prednisone|mesh-list
110251869|NCT00136565|Cyclophosphamide|cyclophosphamide|mesh-list
110251870|NCT00136565|Doxorubicin|doxorubicin|mesh-list
110251872|NCT00136565|Bleomycin|bleomycin|mesh-list
110251873|NCT00136565|Vindesine|vindesine|mesh-list
110251874|NCT00136565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110251875|NCT00136565|Immunologic Factors|immunologic factors|mesh-ancestor
110251876|NCT00136565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251877|NCT00136565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110251878|NCT00136565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110251879|NCT00136565|Alkylating Agents|alkylating agents|mesh-ancestor
110251880|NCT00136565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110251881|NCT00136565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110251882|NCT00136565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110251883|NCT00136565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110251884|NCT00136565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110251885|NCT00136565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110251886|NCT00136565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110251887|NCT00136565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110251888|NCT00136565|Glucocorticoids|glucocorticoids|mesh-ancestor
110251889|NCT00136565|Hormones|hormones|mesh-ancestor
110251890|NCT00136565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110251891|NCT00136565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110251892|NCT00136565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110251893|NCT00136565|Tubulin Modulators|tubulin modulators|mesh-ancestor
110251894|NCT00136565|Antimitotic Agents|antimitotic agents|mesh-ancestor
110251895|NCT00136565|Mitosis Modulators|mitosis modulators|mesh-ancestor
110251896|NCT00159627|Rolofylline|rolofylline|mesh-list
110251897|NCT00159627|Diuretics|diuretics|mesh-ancestor
110251898|NCT00159627|Natriuretic Agents|natriuretic agents|mesh-ancestor
110251899|NCT00159627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251901|NCT00159666|Analgesics|analgesics|mesh-ancestor
110251902|NCT00159666|Sensory System Agents|sensory system agents|mesh-ancestor
110251903|NCT00159666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110251904|NCT00159666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251905|NCT00159666|Anticonvulsants|anticonvulsants|mesh-ancestor
110251906|NCT00159666|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110251907|NCT00159666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110251908|NCT00159666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110251909|NCT00159666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110251910|NCT00159666|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110251911|NCT00159666|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110251912|NCT00159666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110251913|NCT00159666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110251914|NCT00153270|Valproic Acid|valproic acid|mesh-list
110251915|NCT00153270|Anticonvulsants|anticonvulsants|mesh-ancestor
110251916|NCT00153270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110251917|NCT00153270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110251918|NCT00153270|GABA Agents|gaba agents|mesh-ancestor
110251919|NCT00153270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110251920|NCT00153270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251921|NCT00153270|Antimanic Agents|antimanic agents|mesh-ancestor
110251922|NCT00153270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110251923|NCT00153270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110251924|NCT00153270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110251925|NCT00159705|Pregabalin|pregabalin|mesh-list
110251926|NCT00159705|Analgesics|analgesics|mesh-ancestor
110251927|NCT00159705|Sensory System Agents|sensory system agents|mesh-ancestor
110251928|NCT00159705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110251929|NCT00159705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251930|NCT00159705|Anticonvulsants|anticonvulsants|mesh-ancestor
110251931|NCT00159705|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110251932|NCT00159705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110251933|NCT00159705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110251934|NCT00159705|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110251936|NCT00159705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110251937|NCT00159705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110251938|NCT00159705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110251940|NCT00136994|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110251941|NCT00136994|Serotonin Agents|serotonin agents|mesh-ancestor
110251942|NCT00136994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110251943|NCT00136994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110251944|NCT00136994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251945|NCT00136994|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110251946|NCT00136994|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110251947|NCT00136994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110251948|NCT00136994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110251949|NCT00136994|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110251950|NCT00136994|Dopamine Agents|dopamine agents|mesh-ancestor
110251952|NCT00137033|Naproxen|naproxen|mesh-list
110251953|NCT00137033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110251954|NCT00137033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110251955|NCT00137033|Analgesics|analgesics|mesh-ancestor
110251956|NCT00137033|Sensory System Agents|sensory system agents|mesh-ancestor
110251957|NCT00137033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110251958|NCT00137033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251959|NCT00137033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110251960|NCT00137033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110251961|NCT00137033|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110251962|NCT00137033|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110251963|NCT00137033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110251964|NCT00137033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110251965|NCT00137033|Gout Suppressants|gout suppressants|mesh-ancestor
110251966|NCT00137072|Sildenafil Citrate|sildenafil citrate|mesh-list
110251967|NCT00137072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110251968|NCT00137072|Vasodilator Agents|vasodilator agents|mesh-ancestor
110251969|NCT00137072|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110251970|NCT00137072|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110251971|NCT00137072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110251972|NCT00137072|Urological Agents|urological agents|mesh-ancestor
110251973|NCT04724538|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
110251974|NCT04724538|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110251975|NCT04724538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110251976|NCT00159900|Sildenafil Citrate|sildenafil citrate|mesh-list
110251977|NCT00159900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110251978|NCT00159900|Vasodilator Agents|vasodilator agents|mesh-ancestor
110251979|NCT00159900|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110251980|NCT00159900|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110251981|NCT00159900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110251982|NCT00159900|Urological Agents|urological agents|mesh-ancestor
110251983|NCT00159978|Alovudine|alovudine|mesh-list
110251984|NCT00159978|Antiviral Agents|antiviral agents|mesh-ancestor
110251985|NCT00159978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110251986|NCT00137345|Sirolimus|sirolimus|mesh-list
110251987|NCT00137345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110251988|NCT00137345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110251989|NCT00137345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110251990|NCT00137345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110251991|NCT00137345|Antifungal Agents|antifungal agents|mesh-ancestor
110251992|NCT00137345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110251993|NCT00137345|Immunologic Factors|immunologic factors|mesh-ancestor
110251994|NCT00137345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251995|NCT00137462|Atorvastatin|atorvastatin|mesh-list
110251996|NCT00137462|Torcetrapib|torcetrapib|mesh-list
110251997|NCT00137462|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110251998|NCT00137462|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110251999|NCT00137462|Antimetabolites|antimetabolites|mesh-ancestor
110252000|NCT00137462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252001|NCT00137462|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110252002|NCT00137462|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110252003|NCT00137462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110252004|NCT00153543|Vaccines|vaccines|mesh-list
110269771|NCT04826562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110252005|NCT00153543|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110252006|NCT00153543|Immunologic Factors|immunologic factors|mesh-ancestor
110252007|NCT00153543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252009|NCT00137501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110252010|NCT00137501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110252011|NCT00137501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252012|NCT00137501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110252013|NCT00137501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252014|NCT00137501|Vasodilator Agents|vasodilator agents|mesh-ancestor
110252015|NCT00137501|Tocolytic Agents|tocolytic agents|mesh-ancestor
110252016|NCT00137501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110252017|NCT00137540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
110252018|NCT00153660|Celecoxib|celecoxib|mesh-list
110252019|NCT00153660|Naproxen|naproxen|mesh-list
110252020|NCT00153660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110252021|NCT00153660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110252022|NCT00153660|Analgesics|analgesics|mesh-ancestor
110252023|NCT00153660|Sensory System Agents|sensory system agents|mesh-ancestor
110252024|NCT00153660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110252025|NCT00153660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252026|NCT00153660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110252028|NCT00153660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110252029|NCT00153660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110252030|NCT00153660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110252031|NCT00153660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252032|NCT00153660|Gout Suppressants|gout suppressants|mesh-ancestor
110252033|NCT00137657|Trimethoprim|trimethoprim|mesh-list
110252034|NCT00137657|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110252035|NCT00137657|Sulfamethoxazole|sulfamethoxazole|mesh-list
110252036|NCT00137657|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110252037|NCT00137657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110252038|NCT00137657|Antimalarials|antimalarials|mesh-ancestor
110252039|NCT00137657|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110252040|NCT00137657|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110252041|NCT00137657|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110252042|NCT00137657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110252043|NCT00137657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252044|NCT00137657|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110252045|NCT00137657|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110252046|NCT00137657|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110252047|NCT00137657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110252048|NCT00153699|Topiramate|topiramate|mesh-list
110252049|NCT00153699|Anticonvulsants|anticonvulsants|mesh-ancestor
110252050|NCT00153699|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110252051|NCT00153699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252052|NCT00160290|Lactulose|lactulose|mesh-list
110252053|NCT00160290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110252054|NCT00137735|Gabapentin|gabapentin|mesh-list
110252055|NCT00137735|Analgesics|analgesics|mesh-ancestor
110252056|NCT00137735|Sensory System Agents|sensory system agents|mesh-ancestor
110252057|NCT00137735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110252058|NCT00137735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252059|NCT00137735|Anticonvulsants|anticonvulsants|mesh-ancestor
110252060|NCT00137735|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110252061|NCT00137735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110252062|NCT00137735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110252063|NCT00137735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110252064|NCT00137735|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110252065|NCT00137735|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110252066|NCT00137735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110269783|NCT04767841|Metformin|metformin|mesh-list
110252067|NCT00137735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252068|NCT00137735|Antimanic Agents|antimanic agents|mesh-ancestor
110252069|NCT00137774|Bevacizumab|bevacizumab|mesh-list
110252070|NCT00137774|Temozolomide|temozolomide|mesh-list
110252071|NCT00137774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110252072|NCT00137774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110252073|NCT00137774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110252074|NCT00137774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110252075|NCT00137774|Growth Substances|growth substances|mesh-ancestor
110252076|NCT00137774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252077|NCT00137774|Growth Inhibitors|growth inhibitors|mesh-ancestor
110252078|NCT00137774|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110252079|NCT00137774|Alkylating Agents|alkylating agents|mesh-ancestor
110252080|NCT00137774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252082|NCT00160329|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110252083|NCT00160329|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110252084|NCT00160329|Protease Inhibitors|protease inhibitors|mesh-ancestor
110252085|NCT00160329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110252086|NCT00160329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252087|NCT00160329|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110252088|NCT00160329|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110252089|NCT00160329|Antiviral Agents|antiviral agents|mesh-ancestor
110252090|NCT00160329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110252091|NCT00137813|Bevacizumab|bevacizumab|mesh-list
110252092|NCT00137813|Docetaxel|docetaxel|mesh-list
110252093|NCT00137813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110252094|NCT00137813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110252095|NCT00137813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110252096|NCT00137813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110252097|NCT00137813|Growth Substances|growth substances|mesh-ancestor
110252098|NCT00137813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252099|NCT00137813|Growth Inhibitors|growth inhibitors|mesh-ancestor
110252100|NCT00137813|Tubulin Modulators|tubulin modulators|mesh-ancestor
110252101|NCT00137813|Antimitotic Agents|antimitotic agents|mesh-ancestor
110252102|NCT00137813|Mitosis Modulators|mitosis modulators|mesh-ancestor
110252103|NCT00137813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252104|NCT00137852|Celecoxib|celecoxib|mesh-list
110252105|NCT00137852|Irinotecan|irinotecan|mesh-list
110252106|NCT00137852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110252107|NCT00137852|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110252108|NCT00137852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110252109|NCT00137852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110252110|NCT00137852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252111|NCT00137852|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110252112|NCT00137852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110252113|NCT00137852|Analgesics|analgesics|mesh-ancestor
110252114|NCT00137852|Sensory System Agents|sensory system agents|mesh-ancestor
110252115|NCT00137852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110252116|NCT00137852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252117|NCT00137852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110252118|NCT00137852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110252119|NCT00137852|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110252120|NCT00137852|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110252121|NCT00160407|Orlistat|orlistat|mesh-list
110252122|NCT00160407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110252123|NCT00160407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252124|NCT00160407|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110252125|NCT00160407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110252126|NCT00153933|Lenalidomide|lenalidomide|mesh-list
110252127|NCT00153933|Bortezomib|bortezomib|mesh-list
110252128|NCT00153933|Immunologic Factors|immunologic factors|mesh-ancestor
110252129|NCT00153933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252130|NCT00153933|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110252131|NCT00153933|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110252132|NCT00153933|Growth Substances|growth substances|mesh-ancestor
110252133|NCT00153933|Growth Inhibitors|growth inhibitors|mesh-ancestor
110252134|NCT00153933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110252135|NCT00138164|Denileukin diftitox|denileukin diftitox|mesh-list
110252136|NCT00138164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110252138|NCT00153972|Cabergoline|cabergoline|mesh-list
110252139|NCT00153972|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110252140|NCT00153972|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110252141|NCT00153972|Dopamine Agents|dopamine agents|mesh-ancestor
110252142|NCT00153972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110252143|NCT00153972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252144|NCT00153972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252145|NCT00153972|Dopamine Agonists|dopamine agonists|mesh-ancestor
110252146|NCT00160485|Glyburide|glyburide|mesh-list
110252147|NCT00160485|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110252148|NCT00160485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252149|NCT00404183|Acetaminophen|acetaminophen|mesh-list
110252150|NCT00404183|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
110252151|NCT00404183|Hydrocodone|hydrocodone|mesh-list
110252152|NCT00404183|Oxycodone|oxycodone|mesh-list
110252153|NCT00404183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110252154|NCT00404183|Analgesics|analgesics|mesh-ancestor
110252155|NCT00404183|Sensory System Agents|sensory system agents|mesh-ancestor
110252156|NCT00404183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110252157|NCT00404183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252158|NCT00404183|Antipyretics|antipyretics|mesh-ancestor
110252159|NCT00404183|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110252160|NCT00404183|Narcotics|narcotics|mesh-ancestor
110252162|NCT00404183|Antitussive Agents|antitussive agents|mesh-ancestor
110252163|NCT00404183|Respiratory System Agents|respiratory system agents|mesh-ancestor
110252164|NCT00404183|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110252165|NCT00404183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110252166|NCT00404183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110252167|NCT00154011|Rosiglitazone|rosiglitazone|mesh-list
110252168|NCT00154011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110252169|NCT00154011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252170|NCT00404222|Acetaminophen|acetaminophen|mesh-list
110252171|NCT00404222|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
110252172|NCT00404222|Hydrocodone|hydrocodone|mesh-list
110252173|NCT00404222|Oxycodone|oxycodone|mesh-list
110252174|NCT00404222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110252175|NCT00404222|Analgesics|analgesics|mesh-ancestor
110252176|NCT00404222|Sensory System Agents|sensory system agents|mesh-ancestor
110252177|NCT00404222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110252178|NCT00404222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252179|NCT00404222|Antipyretics|antipyretics|mesh-ancestor
110252180|NCT00404222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110252181|NCT00404222|Narcotics|narcotics|mesh-ancestor
110252182|NCT00404222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110252183|NCT00404222|Antitussive Agents|antitussive agents|mesh-ancestor
110252184|NCT00404222|Respiratory System Agents|respiratory system agents|mesh-ancestor
110252185|NCT00404222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110252187|NCT00404222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110252188|NCT00160602|Certolizumab Pegol|certolizumab pegol|mesh-list
110252189|NCT00160602|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110252190|NCT00160602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110252191|NCT00160602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110252192|NCT00160602|Immunologic Factors|immunologic factors|mesh-ancestor
110252193|NCT00160602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252195|NCT00138242|Carboplatin|carboplatin|mesh-list
110252196|NCT00138242|Docetaxel|docetaxel|mesh-list
110252197|NCT00138242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110252198|NCT00138242|Tubulin Modulators|tubulin modulators|mesh-ancestor
110252199|NCT00138242|Antimitotic Agents|antimitotic agents|mesh-ancestor
110252200|NCT00138242|Mitosis Modulators|mitosis modulators|mesh-ancestor
110252201|NCT00138242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252202|NCT00154050|Candesartan|candesartan|mesh-list
110252203|NCT00154050|Candesartan cilexetil|candesartan cilexetil|mesh-list
110252204|NCT00154050|Quinapril|quinapril|mesh-list
110252205|NCT00154050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110252206|NCT00154050|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110252207|NCT00154050|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110252208|NCT00154050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252209|NCT00154050|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110252210|NCT00154050|Protease Inhibitors|protease inhibitors|mesh-ancestor
110252211|NCT00154050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110252212|NCT00154089|Masoprocol|masoprocol|mesh-list
110252213|NCT00154089|Antioxidants|antioxidants|mesh-ancestor
110252214|NCT00154089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252215|NCT00154089|Protective Agents|protective agents|mesh-ancestor
110252216|NCT00154089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252217|NCT00154089|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110252218|NCT00154089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110252219|NCT00154089|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110252220|NCT00154089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110252221|NCT00154089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110252223|NCT00154089|Sensory System Agents|sensory system agents|mesh-ancestor
110252224|NCT00154089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110252225|NCT00154089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110252226|NCT00154089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110252228|NCT00138359|Anticestodal Agents|anticestodal agents|mesh-ancestor
110252229|NCT00138359|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110252230|NCT00138359|Anthelmintics|anthelmintics|mesh-ancestor
110252231|NCT00138359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110252232|NCT00138359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110252233|NCT00138359|Antinematodal Agents|antinematodal agents|mesh-ancestor
110252234|NCT00154128|Salicylic Acid|salicylic acid|mesh-list
110252235|NCT00154128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110252237|NCT00154128|Keratolytic Agents|keratolytic agents|mesh-ancestor
110252238|NCT00154128|Dermatologic Agents|dermatologic agents|mesh-ancestor
110252239|NCT00154167|Phentolamine|phentolamine|mesh-list
110252240|NCT00154167|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110252241|NCT00154167|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110252242|NCT00154167|Adrenergic Agents|adrenergic agents|mesh-ancestor
110252243|NCT00154167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110252244|NCT00154167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252245|NCT00154167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252246|NCT00154167|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110252247|NCT00138515|Vildagliptin|vildagliptin|mesh-list
110252248|NCT00138515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110252249|NCT00138515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252250|NCT00138515|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110252251|NCT00138515|Protease Inhibitors|protease inhibitors|mesh-ancestor
110252252|NCT00138515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110252253|NCT00138515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252254|NCT00154206|Mycophenolic Acid|mycophenolic acid|mesh-list
110252255|NCT00154206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110252257|NCT00154206|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110252258|NCT00154206|Antitubercular Agents|antitubercular agents|mesh-ancestor
110252259|NCT00154206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110252260|NCT00154206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110252261|NCT00154206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110252262|NCT00154206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252263|NCT00138554|Pioglitazone|pioglitazone|mesh-list
110252264|NCT00138554|Vildagliptin|vildagliptin|mesh-list
110252265|NCT00138554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110252266|NCT00138554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252267|NCT00138554|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110252268|NCT00138554|Protease Inhibitors|protease inhibitors|mesh-ancestor
110252269|NCT00138554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110252270|NCT00138554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252271|NCT00138593|Vildagliptin|vildagliptin|mesh-list
110252272|NCT00138593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110252273|NCT00138593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252274|NCT00138593|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110252275|NCT00138593|Protease Inhibitors|protease inhibitors|mesh-ancestor
110252276|NCT00138593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110252277|NCT00138593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252278|NCT00154245|Mycophenolic Acid|mycophenolic acid|mesh-list
110252279|NCT00154245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110252280|NCT00154245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110252281|NCT00154245|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110252282|NCT00154245|Antitubercular Agents|antitubercular agents|mesh-ancestor
110252283|NCT00154245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110252284|NCT00154245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110252285|NCT00154245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110252286|NCT00154245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252287|NCT00138632|Vatalanib|vatalanib|mesh-list
110252288|NCT00138632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110252289|NCT00138632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110252290|NCT00138632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252291|NCT00160875|Irinotecan|irinotecan|mesh-list
110252292|NCT00160875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110252293|NCT00160875|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110252294|NCT00160875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110252296|NCT00160875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252297|NCT00138710|Letrozole|letrozole|mesh-list
110252298|NCT00138710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110252299|NCT00138710|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110252300|NCT00138710|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110252301|NCT00138710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110252302|NCT00138710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252303|NCT00138710|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110252304|NCT00138710|Hormone Antagonists|hormone antagonists|mesh-ancestor
110252305|NCT00138710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110252306|NCT00138710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368702|NCT00557934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252307|NCT01243762|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|mesh-list
110252308|NCT01243762|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
110252309|NCT01243762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110252310|NCT01243762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252311|NCT00154323|Oxcarbazepine|oxcarbazepine|mesh-list
110252312|NCT00154323|Anticonvulsants|anticonvulsants|mesh-ancestor
110252313|NCT00154323|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110252314|NCT00154323|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110252315|NCT00154323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110252316|NCT00154323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252317|NCT00154323|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110252318|NCT00154323|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110252320|NCT00138866|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110252321|NCT00138866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110252322|NCT00138866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252323|NCT00138866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110252324|NCT00138866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252325|NCT00138866|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110252326|NCT00154362|Oxcarbazepine|oxcarbazepine|mesh-list
110252327|NCT00154362|Anticonvulsants|anticonvulsants|mesh-ancestor
110252328|NCT00154362|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110252329|NCT00154362|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110252330|NCT00154362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110252331|NCT00154362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252332|NCT00154362|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110252333|NCT00154362|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110252334|NCT00161031|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110252335|NCT00161031|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110252336|NCT00161031|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110252337|NCT00161031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110252338|NCT00161031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252340|NCT00161031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110252341|NCT00161031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252342|NCT00154401|Liraglutide|liraglutide|mesh-list
110252343|NCT00154401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110252344|NCT00154401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252345|NCT00154401|Incretins|incretins|mesh-ancestor
110252347|NCT00154401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110252348|NCT00138944|Eplerenone|eplerenone|mesh-list
110252349|NCT00138944|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110252350|NCT00138944|Hormone Antagonists|hormone antagonists|mesh-ancestor
110252351|NCT00138944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110252352|NCT00138944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252353|NCT00138944|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110252354|NCT00138944|Diuretics|diuretics|mesh-ancestor
110252355|NCT00138944|Natriuretic Agents|natriuretic agents|mesh-ancestor
110252356|NCT00138944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110252357|NCT00161070|Aspirin|aspirin|mesh-list
110252358|NCT00161070|Dipyridamole|dipyridamole|mesh-list
110269838|NCT04577690|Mydriatics|mydriatics|mesh-ancestor
110252359|NCT00161070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110252360|NCT00161070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110252362|NCT00161070|Sensory System Agents|sensory system agents|mesh-ancestor
110252363|NCT00161070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110252364|NCT00161070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252365|NCT00161070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110252366|NCT00161070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110252367|NCT00161070|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110252368|NCT00161070|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110252370|NCT00161070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110252371|NCT00161070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110252372|NCT00161070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110252373|NCT00161070|Antipyretics|antipyretics|mesh-ancestor
110252374|NCT00161070|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110252375|NCT00161070|Vasodilator Agents|vasodilator agents|mesh-ancestor
110252376|NCT00138983|Vitamin D|vitamin d|mesh-list
110252377|NCT00138983|Alendronate|alendronate|mesh-list
110252379|NCT00138983|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
110252380|NCT00138983|Vitamins|vitamins|mesh-ancestor
110252381|NCT00138983|Micronutrients|micronutrients|mesh-ancestor
110252382|NCT00138983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252383|NCT00138983|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110252384|NCT01243177|Lacosamide|lacosamide|mesh-list
110252385|NCT01243177|Carbamazepine|carbamazepine|mesh-list
110252386|NCT01243177|Anticonvulsants|anticonvulsants|mesh-ancestor
110252387|NCT01243177|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110252388|NCT01243177|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110252389|NCT01243177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110252390|NCT01243177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252391|NCT01243177|Antimanic Agents|antimanic agents|mesh-ancestor
110252392|NCT01243177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110252393|NCT01243177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110252394|NCT01243177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252395|NCT01243177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110252396|NCT01243177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110252397|NCT01243177|Analgesics|analgesics|mesh-ancestor
110252398|NCT01243177|Sensory System Agents|sensory system agents|mesh-ancestor
110252399|NCT01243177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110252400|NCT01243177|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110252401|NCT01243177|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110252402|NCT00154440|Amoxicillin|amoxicillin|mesh-list
110252403|NCT00154440|Metronidazole|metronidazole|mesh-list
110252404|NCT00154440|Clarithromycin|clarithromycin|mesh-list
110252405|NCT00154440|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
110252406|NCT00154440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110252407|NCT00154440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110252408|NCT00154440|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110252409|NCT00154440|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110252410|NCT00154440|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110252411|NCT00154440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110252412|NCT00154440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252413|NCT00154440|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110252414|NCT00154440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110252415|NCT00139061|Atorvastatin|atorvastatin|mesh-list
110252416|NCT00139061|Torcetrapib|torcetrapib|mesh-list
110252417|NCT00139061|Fenofibrate|fenofibrate|mesh-list
110252418|NCT00139061|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110252419|NCT00139061|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110252420|NCT00139061|Antimetabolites|antimetabolites|mesh-ancestor
110252421|NCT00139061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252422|NCT00139061|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110252423|NCT00139061|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110252424|NCT00139061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110252425|NCT00139100|Anti-Infective Agents|anti-infective agents|mesh-list
110252426|NCT00139100|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110252427|NCT04705584|Cyclosporine|cyclosporine|mesh-list
110252428|NCT04705584|Prednisolone|prednisolone|mesh-list
110252429|NCT04705584|Cyclosporins|cyclosporins|mesh-list
110252430|NCT04705584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110252431|NCT04705584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252432|NCT04705584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110252433|NCT04705584|Immunologic Factors|immunologic factors|mesh-ancestor
110252434|NCT04705584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252435|NCT04705584|Antifungal Agents|antifungal agents|mesh-ancestor
110252436|NCT04705584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110252437|NCT04705584|Dermatologic Agents|dermatologic agents|mesh-ancestor
110252438|NCT04705584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110252439|NCT04705584|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110252440|NCT04705584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110252441|NCT04705584|Glucocorticoids|glucocorticoids|mesh-ancestor
110252442|NCT04705584|Hormones|hormones|mesh-ancestor
110252443|NCT04705584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110252444|NCT04705584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110252445|NCT04705584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110252446|NCT00139217|Nitric Oxide|nitric oxide|mesh-list
110252447|NCT00139217|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110252448|NCT00139217|Autonomic Agents|autonomic agents|mesh-ancestor
110252449|NCT00139217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110252450|NCT00139217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252451|NCT00139217|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110252452|NCT00139217|Respiratory System Agents|respiratory system agents|mesh-ancestor
110252453|NCT00139217|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110252455|NCT00139217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252456|NCT00139217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110252457|NCT00139217|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110252458|NCT00139217|Vasodilator Agents|vasodilator agents|mesh-ancestor
110252459|NCT00139217|Gasotransmitters|gasotransmitters|mesh-ancestor
110252460|NCT00139217|Protective Agents|protective agents|mesh-ancestor
110252461|NCT00161226|Levonorgestrel|levonorgestrel|mesh-list
110252462|NCT00161226|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110252463|NCT00161226|Contraceptive Agents|contraceptive agents|mesh-ancestor
110252464|NCT00161226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110252465|NCT00161226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252466|NCT00161226|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110252467|NCT00161226|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110252468|NCT00161226|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110252469|NCT00139256|Betamethasone|betamethasone|mesh-list
110252470|NCT00139256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110252471|NCT00139256|Glucocorticoids|glucocorticoids|mesh-ancestor
110252472|NCT00139256|Hormones|hormones|mesh-ancestor
110252473|NCT00139256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110252474|NCT00139256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252475|NCT00139256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110252476|NCT00139256|Respiratory System Agents|respiratory system agents|mesh-ancestor
110252477|NCT00161304|Methyltestosterone|methyltestosterone|mesh-list
110252478|NCT00161304|Testosterone|testosterone|mesh-list
110252479|NCT00161304|Testosterone undecanoate|testosterone undecanoate|mesh-list
110252480|NCT00161304|Testosterone enanthate|testosterone enanthate|mesh-list
110252481|NCT00161304|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110252482|NCT00161304|Androgens|androgens|mesh-ancestor
110252483|NCT00161304|Hormones|hormones|mesh-ancestor
110252484|NCT00161304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110252485|NCT00161304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252486|NCT00161304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110252487|NCT00161304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110252488|NCT00161304|Anabolic Agents|anabolic agents|mesh-ancestor
110252489|NCT01242748|Goserelin|goserelin|mesh-list
110252490|NCT01242748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110252491|NCT01242748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110252493|NCT00139373|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110252494|NCT00139373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110252495|NCT00139373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252496|NCT00139373|Cholinergic Agents|cholinergic agents|mesh-ancestor
110252497|NCT00139373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110252498|NCT00139373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252499|NCT00139373|Nootropic Agents|nootropic agents|mesh-ancestor
110252500|NCT00161421|Leuprolide|leuprolide|mesh-list
110252501|NCT00161421|Testosterone|testosterone|mesh-list
110252502|NCT00161421|Dutasteride|dutasteride|mesh-list
110252503|NCT00161421|Androgens|androgens|mesh-ancestor
110252504|NCT00161421|Hormones|hormones|mesh-ancestor
110252505|NCT00161421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110252506|NCT00161421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252507|NCT00161421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110252509|NCT00161421|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110252510|NCT00161421|Fertility Agents|fertility agents|mesh-ancestor
110252511|NCT00161421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110252512|NCT00161421|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110252513|NCT00161421|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110252514|NCT00161421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110252515|NCT00161421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252516|NCT00161421|Hormone Antagonists|hormone antagonists|mesh-ancestor
110252517|NCT00139568|Tegaserod|tegaserod|mesh-list
110252518|NCT00139568|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110252519|NCT00139568|Serotonin Agents|serotonin agents|mesh-ancestor
110252520|NCT00139568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110252521|NCT00139568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252522|NCT00139568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252523|NCT00139646|Diclofenac|diclofenac|mesh-list
110252524|NCT00139646|Parecoxib|parecoxib|mesh-list
110252525|NCT00139646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110252526|NCT00139646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110252527|NCT00139646|Analgesics|analgesics|mesh-ancestor
110252528|NCT00139646|Sensory System Agents|sensory system agents|mesh-ancestor
110252529|NCT00139646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110252530|NCT00139646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252531|NCT00139646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110252532|NCT00139646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110252533|NCT00139646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110252534|NCT00139646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110252535|NCT00139646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252536|NCT00139646|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110252537|NCT00406302|Docetaxel|docetaxel|mesh-list
110252538|NCT00406302|Oxaliplatin|oxaliplatin|mesh-list
110252539|NCT00406302|Cetuximab|cetuximab|mesh-list
110252540|NCT00406302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110252541|NCT00406302|Tubulin Modulators|tubulin modulators|mesh-ancestor
110252542|NCT00406302|Antimitotic Agents|antimitotic agents|mesh-ancestor
110252543|NCT00406302|Mitosis Modulators|mitosis modulators|mesh-ancestor
110252544|NCT00406302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252545|NCT00406302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110252546|NCT00139685|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110252547|NCT00139685|Contraceptive Agents|contraceptive agents|mesh-list
110252548|NCT00139685|Medroxyprogesterone|medroxyprogesterone|mesh-list
110252549|NCT00139685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110252550|NCT00139685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252551|NCT00139685|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110252552|NCT00139685|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110252553|NCT00139685|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110252554|NCT00139685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110252555|NCT00139685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110252556|NCT00139685|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110252558|NCT00139685|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110252560|NCT00406341|Glucocorticoids|glucocorticoids|mesh-ancestor
110252561|NCT00406341|Hormones|hormones|mesh-ancestor
110252562|NCT00406341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110252563|NCT00406341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252564|NCT00139724|Tolterodine Tartrate|tolterodine tartrate|mesh-list
110252565|NCT00139724|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110252566|NCT00139724|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110252567|NCT00139724|Cholinergic Agents|cholinergic agents|mesh-ancestor
110252568|NCT00139724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110252569|NCT00139724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252570|NCT00139724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252571|NCT00139724|Urological Agents|urological agents|mesh-ancestor
110252572|NCT00161577|Ketorolac|ketorolac|mesh-list
110252573|NCT00161577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110252574|NCT00161577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110252575|NCT00161577|Analgesics|analgesics|mesh-ancestor
110252576|NCT00161577|Sensory System Agents|sensory system agents|mesh-ancestor
110252577|NCT00161577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110252578|NCT00161577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252579|NCT00161577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110252580|NCT00161577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110252581|NCT00161577|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110252582|NCT00161577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110252583|NCT00161577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252584|NCT00404261|Fluticasone|fluticasone|mesh-list
110252585|NCT00404261|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110252586|NCT00404261|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110252587|NCT00404261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110252588|NCT00404261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110252589|NCT00404261|Autonomic Agents|autonomic agents|mesh-ancestor
110252590|NCT00404261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110252591|NCT00404261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252592|NCT00404261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110252593|NCT00404261|Respiratory System Agents|respiratory system agents|mesh-ancestor
110252594|NCT00404261|Dermatologic Agents|dermatologic agents|mesh-ancestor
110252595|NCT00404261|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110252596|NCT00404261|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110252597|NCT00404261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110252598|NCT00404261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110252599|NCT00404261|Adrenergic Agents|adrenergic agents|mesh-ancestor
110252600|NCT00404261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110252601|NCT00404261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252602|NCT00404261|Glucocorticoids|glucocorticoids|mesh-ancestor
110252603|NCT00404261|Hormones|hormones|mesh-ancestor
110252604|NCT00404261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110252605|NCT00404261|Sympathomimetics|sympathomimetics|mesh-ancestor
110252606|NCT00406380|Bevacizumab|bevacizumab|mesh-list
110252607|NCT00406380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110252608|NCT00406380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110252609|NCT00406380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110269953|NCT03544099|Pembrolizumab|pembrolizumab|mesh-list
110252610|NCT00406380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110252611|NCT00406380|Growth Substances|growth substances|mesh-ancestor
110252612|NCT00406380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252613|NCT00406380|Growth Inhibitors|growth inhibitors|mesh-ancestor
110252614|NCT00406497|Difluprednate|difluprednate|mesh-list
110252615|NCT00406497|Glucocorticoids|glucocorticoids|mesh-ancestor
110252616|NCT00406497|Hormones|hormones|mesh-ancestor
110252617|NCT00406497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110252618|NCT00406497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252619|NCT00161655|Etanercept|etanercept|mesh-list
110252620|NCT00161655|Methotrexate|methotrexate|mesh-list
110252621|NCT00161655|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110252623|NCT00161655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110252624|NCT00161655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252625|NCT00161655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110252626|NCT00161655|Antimetabolites|antimetabolites|mesh-ancestor
110252627|NCT00161655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252628|NCT00161655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110252629|NCT00161655|Dermatologic Agents|dermatologic agents|mesh-ancestor
110252630|NCT00161655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110252631|NCT00161655|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110252632|NCT00161655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110252633|NCT00161655|Immunologic Factors|immunologic factors|mesh-ancestor
110252634|NCT00161655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110252635|NCT00161655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110252636|NCT00161655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110252637|NCT00161655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110252639|NCT00161655|Sensory System Agents|sensory system agents|mesh-ancestor
110252640|NCT00161655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110252641|NCT00161655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110252642|NCT00161655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110252643|NCT00161733|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110252644|NCT00161733|Hemostatics|hemostatics|mesh-ancestor
110252645|NCT00161733|Coagulants|coagulants|mesh-ancestor
110252646|NCT00139841|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110252647|NCT00139841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110252648|NCT00139841|Alkylating Agents|alkylating agents|mesh-ancestor
110252649|NCT00139841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252650|NCT00139841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110252651|NCT00139880|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110252652|NCT00139880|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110252653|NCT00139880|Immunologic Factors|immunologic factors|mesh-ancestor
110252654|NCT00139880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252655|NCT00139880|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110252656|NCT00139880|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110252657|NCT00139880|Dopamine Agonists|dopamine agonists|mesh-ancestor
110252658|NCT00139880|Dopamine Agents|dopamine agents|mesh-ancestor
110252659|NCT00139880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110252660|NCT00139880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252661|NCT04724187|Misoprostol|misoprostol|mesh-list
110252662|NCT04724187|Oxytocin|oxytocin|mesh-list
110252663|NCT04724187|Oxytocics|oxytocics|mesh-ancestor
110252664|NCT04724187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110252665|NCT04724187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252666|NCT04724187|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110252667|NCT04724187|Abortifacient Agents|abortifacient agents|mesh-ancestor
110252668|NCT04724187|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110252669|NCT04724187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110252670|NCT04727021|Rivaroxaban|rivaroxaban|mesh-list
110252671|NCT04727021|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110252672|NCT04727021|Antithrombins|antithrombins|mesh-ancestor
110368703|NCT00557934|Protective Agents|protective agents|mesh-ancestor
110252673|NCT04727021|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110252674|NCT04727021|Protease Inhibitors|protease inhibitors|mesh-ancestor
110252675|NCT04727021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110252676|NCT04727021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252677|NCT04727021|Anticoagulants|anticoagulants|mesh-ancestor
110252678|NCT04724226|Apatinib|apatinib|mesh-list
110252679|NCT04724226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110252680|NCT04724226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110252681|NCT04724226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110252682|NCT04724226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252683|NCT04724343|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110252684|NCT04724343|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110252686|NCT04724343|Menotropins|menotropins|mesh-list
110252687|NCT04724343|Luteolytic Agents|luteolytic agents|mesh-ancestor
110252688|NCT04724343|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110252689|NCT04724343|Contraceptive Agents|contraceptive agents|mesh-ancestor
110252690|NCT04724343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110252691|NCT04724343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252692|NCT04724343|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110252693|NCT04724343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110252694|NCT04724343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110252695|NCT04724343|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110252696|NCT04724343|Fertility Agents|fertility agents|mesh-ancestor
110252697|NCT04724343|Hormone Antagonists|hormone antagonists|mesh-ancestor
110252698|NCT04724343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110252699|NCT00140075|Cyclophosphamide|cyclophosphamide|mesh-list
110252700|NCT00140075|Epirubicin|epirubicin|mesh-list
110252701|NCT00140075|Taxane|taxane|mesh-list
110252702|NCT00140075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110252703|NCT00140075|Immunologic Factors|immunologic factors|mesh-ancestor
110252704|NCT00140075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252705|NCT00140075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110252706|NCT00140075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110252707|NCT00140075|Alkylating Agents|alkylating agents|mesh-ancestor
110252708|NCT00140075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252709|NCT00140075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110252710|NCT00140075|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110252711|NCT00140075|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110252712|NCT00140075|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110252713|NCT00140075|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110252714|NCT00140075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110252715|NCT00140114|Misoprostol|misoprostol|mesh-list
110252716|NCT00140114|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110252717|NCT00140114|Abortifacient Agents|abortifacient agents|mesh-ancestor
110252718|NCT00140114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110252719|NCT00140114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252720|NCT00140114|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110252721|NCT00140114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110252722|NCT00140114|Oxytocics|oxytocics|mesh-ancestor
110269989|NCT03406299|Tegafur|tegafur|mesh-list
110252723|NCT00140153|Testosterone|testosterone|mesh-list
110252724|NCT00140153|Androgens|androgens|mesh-ancestor
110252725|NCT00140153|Hormones|hormones|mesh-ancestor
110252726|NCT00140153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110252727|NCT00140153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252728|NCT00140309|Moxifloxacin|moxifloxacin|mesh-list
110252729|NCT00140309|Rifampin|rifampin|mesh-list
110252730|NCT00140309|Isoniazid|isoniazid|mesh-list
110252731|NCT00140309|Pyrazinamide|pyrazinamide|mesh-list
110252732|NCT00140309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110252733|NCT00140309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110252734|NCT00140309|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110252735|NCT00140309|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110252736|NCT00140309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110252737|NCT00140309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252738|NCT00140309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110252739|NCT00140309|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110252740|NCT00140309|Antitubercular Agents|antitubercular agents|mesh-ancestor
110252741|NCT00140309|Leprostatic Agents|leprostatic agents|mesh-ancestor
110252742|NCT00140309|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110252744|NCT00140309|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110252745|NCT00140309|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110252746|NCT00140309|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110368704|NCT00558051|Vaccines|vaccines|mesh-list
110252747|NCT00140309|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110252748|NCT00140309|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110252749|NCT00140309|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110252750|NCT00140309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110252752|NCT00140309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110252754|NCT00161811|Immunologic Factors|immunologic factors|mesh-ancestor
110252755|NCT00161811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252756|NCT01240135|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110252757|NCT00140348|Immunomodulating Agents|immunomodulating agents|mesh-list
110252758|NCT00140348|Immunologic Factors|immunologic factors|mesh-ancestor
110252759|NCT00140348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252760|NCT01240759|Metformin|metformin|mesh-list
110252761|NCT01240759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110252762|NCT01240759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252763|NCT00140387|Immunomodulating Agents|immunomodulating agents|mesh-list
110252764|NCT00140387|Immunologic Factors|immunologic factors|mesh-ancestor
110252765|NCT00140387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252766|NCT00504634|Bortezomib|bortezomib|mesh-list
110252767|NCT00504634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110252768|NCT00140465|Clopidogrel|clopidogrel|mesh-list
110252769|NCT00140465|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110252770|NCT00140465|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110252771|NCT00140465|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110252772|NCT00140465|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110252773|NCT00140465|Purinergic Agents|purinergic agents|mesh-ancestor
110252774|NCT00140465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110252775|NCT00140465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252776|NCT00140465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252777|NCT00504673|Insulin|insulin|mesh-list
110252778|NCT00504673|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110252779|NCT00504673|Insulin Aspart|insulin aspart|mesh-list
110252780|NCT00504673|Insulin Detemir|insulin detemir|mesh-list
110252781|NCT00504673|Isophane Insulin, Human|isophane insulin, human|mesh-list
110252782|NCT00504673|Insulin, Isophane|insulin, isophane|mesh-list
110252783|NCT00504673|Isophane insulin, beef|isophane insulin, beef|mesh-list
110252784|NCT00504673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110252785|NCT00504673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252786|NCT01247701|Cyclophosphamide|cyclophosphamide|mesh-list
110252787|NCT01247701|Busulfan|busulfan|mesh-list
110252788|NCT01247701|Fludarabine|fludarabine|mesh-list
110252789|NCT01247701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110252790|NCT01247701|Immunologic Factors|immunologic factors|mesh-ancestor
110252791|NCT01247701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252792|NCT01247701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110252793|NCT01247701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110252794|NCT01247701|Alkylating Agents|alkylating agents|mesh-ancestor
110252795|NCT01247701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252796|NCT01247701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110252797|NCT01247701|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110252798|NCT00140543|Mycophenolic Acid|mycophenolic acid|mesh-list
110252799|NCT00140543|Sirolimus|sirolimus|mesh-list
110252800|NCT00140543|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110252801|NCT00140543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110252802|NCT00140543|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110252803|NCT00140543|Antitubercular Agents|antitubercular agents|mesh-ancestor
110252804|NCT00140543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110252805|NCT00140543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110252806|NCT00140543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110252807|NCT00140543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252808|NCT00140543|Antifungal Agents|antifungal agents|mesh-ancestor
110252809|NCT00140543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110252810|NCT00140543|Immunologic Factors|immunologic factors|mesh-ancestor
110252811|NCT00140543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252812|NCT00154791|Gemcitabine|gemcitabine|mesh-list
110252813|NCT00154791|Oxaliplatin|oxaliplatin|mesh-list
110252814|NCT00154791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110252815|NCT00154791|Antimetabolites|antimetabolites|mesh-ancestor
110252816|NCT00154791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252817|NCT00154791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110252818|NCT00140582|Rituximab|rituximab|mesh-list
110252819|NCT00140582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110252820|NCT00140582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110252821|NCT00140582|Immunologic Factors|immunologic factors|mesh-ancestor
110252822|NCT00140582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252823|NCT00140582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110252825|NCT00154869|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110252826|NCT00154869|Antimetabolites|antimetabolites|mesh-ancestor
110252827|NCT00154869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252828|NCT00154869|Antiviral Agents|antiviral agents|mesh-ancestor
110252829|NCT00154869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110252830|NCT00140660|Rituximab|rituximab|mesh-list
110252831|NCT00140660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110252832|NCT00140660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110252833|NCT00140660|Immunologic Factors|immunologic factors|mesh-ancestor
110252834|NCT00140660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252835|NCT00140660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110252836|NCT00162006|Immunoglobulins|immunoglobulins|mesh-list
110252837|NCT00162006|Antibodies|antibodies|mesh-list
110252838|NCT00162006|gamma-Globulins|gamma-globulins|mesh-list
110252839|NCT00162006|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110252840|NCT00162006|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110252841|NCT00162006|Immunologic Factors|immunologic factors|mesh-ancestor
110252842|NCT00162006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252843|NCT00162045|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
110252844|NCT00162045|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110252845|NCT00162045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252846|NCT02964572|Empagliflozin|empagliflozin|mesh-list
110252847|NCT02964572|Glimepiride|glimepiride|mesh-list
110252848|NCT02964572|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110252849|NCT02964572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252850|NCT02964572|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110252851|NCT02964572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252852|NCT02964572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110252853|NCT02964572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110252854|NCT02964572|Immunologic Factors|immunologic factors|mesh-ancestor
110252855|NCT00162201|Abatacept|abatacept|mesh-list
110252856|NCT00162201|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110252857|NCT00162201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252858|NCT00162201|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110252859|NCT00162201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110252860|NCT00162201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110252861|NCT00162201|Immunologic Factors|immunologic factors|mesh-ancestor
110252862|NCT00162201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252864|NCT01248247|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110252865|NCT01248247|Sorafenib|sorafenib|mesh-list
110252866|NCT01248247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110252867|NCT01248247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110252868|NCT01248247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110252869|NCT01248247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252871|NCT00140894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252872|NCT00140894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252873|NCT00140894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110252874|NCT00140894|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110252875|NCT00140894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110252877|NCT00140894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110252878|NCT00140894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110252879|NCT00140894|Analgesics|analgesics|mesh-ancestor
110252880|NCT00140894|Sensory System Agents|sensory system agents|mesh-ancestor
110252881|NCT00140894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110252882|NCT00140894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110252883|NCT00155064|Losartan|losartan|mesh-list
110252884|NCT00155064|Captopril|captopril|mesh-list
110252885|NCT00155064|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110252886|NCT00155064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110252887|NCT00155064|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110252888|NCT00155064|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110252889|NCT00155064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252890|NCT00155064|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110252891|NCT00155064|Protease Inhibitors|protease inhibitors|mesh-ancestor
110252892|NCT00155064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110252893|NCT02483260|Ribavirin|ribavirin|mesh-list
110252894|NCT02483260|Antimetabolites|antimetabolites|mesh-ancestor
110252895|NCT02483260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252896|NCT02483260|Antiviral Agents|antiviral agents|mesh-ancestor
110252897|NCT02483260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110252898|NCT00140933|Diclofenac|diclofenac|mesh-list
110252899|NCT00140933|Rofecoxib|rofecoxib|mesh-list
110252900|NCT00140933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110252901|NCT00140933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110252902|NCT00140933|Analgesics|analgesics|mesh-ancestor
110252903|NCT00140933|Sensory System Agents|sensory system agents|mesh-ancestor
110252904|NCT00140933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110252905|NCT00140933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252906|NCT00140933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110252907|NCT00140933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110252908|NCT00140933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110252909|NCT00140933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110252910|NCT00140933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252911|NCT00140933|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110252912|NCT04515628|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110252913|NCT04515628|Branebrutinib|branebrutinib|mesh-list
110252914|NCT04515628|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110252915|NCT04515628|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110252917|NCT04515628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252918|NCT04515628|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110252919|NCT04515628|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110252920|NCT04515628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110252921|NCT04515628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110252922|NCT00407043|Loteprednol Etabonate|loteprednol etabonate|mesh-list
110252923|NCT00407043|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110252925|NCT00141011|Anticoagulants|anticoagulants|mesh-ancestor
110252926|NCT00141011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110252927|NCT00141011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110252928|NCT00141011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252929|NCT00504946|Cholecalciferol|cholecalciferol|mesh-list
110252930|NCT00504946|Vitamin D|vitamin d|mesh-list
110252931|NCT00504946|Prednisone|prednisone|mesh-list
110252932|NCT00504946|Budesonide|budesonide|mesh-list
110252933|NCT00504946|Montelukast|montelukast|mesh-list
110252934|NCT00504946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110252935|NCT00504946|Glucocorticoids|glucocorticoids|mesh-ancestor
110252936|NCT00504946|Hormones|hormones|mesh-ancestor
110252937|NCT00504946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110252938|NCT00504946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252939|NCT00504946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110252940|NCT00504946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110252941|NCT00504946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110252942|NCT00504946|Respiratory System Agents|respiratory system agents|mesh-ancestor
110252943|NCT00504946|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110252944|NCT00504946|Hormone Antagonists|hormone antagonists|mesh-ancestor
110252945|NCT00504946|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110252946|NCT00504946|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110252947|NCT00504946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252948|NCT00504946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110252949|NCT00504946|Autonomic Agents|autonomic agents|mesh-ancestor
110252950|NCT00504946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110252951|NCT00504946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110252952|NCT00504946|Vitamins|vitamins|mesh-ancestor
110252953|NCT00504946|Micronutrients|micronutrients|mesh-ancestor
110252954|NCT00504946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110252955|NCT00141050|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
110252956|NCT00141050|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110252957|NCT00141050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252958|NCT00141050|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110252959|NCT00141050|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110252960|NCT00141050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110252961|NCT00141050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252962|NCT00141050|Dopamine Agents|dopamine agents|mesh-ancestor
110252963|NCT00141050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110252964|NCT04511416|Metformin|metformin|mesh-list
110252965|NCT04511416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110252966|NCT04511416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252968|NCT00407082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110252969|NCT00407082|Glucocorticoids|glucocorticoids|mesh-ancestor
110252970|NCT00407082|Hormones|hormones|mesh-ancestor
110252971|NCT00407082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110252972|NCT00407082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252973|NCT00141089|Tegaserod|tegaserod|mesh-list
110252974|NCT00141089|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110252975|NCT00141089|Serotonin Agents|serotonin agents|mesh-ancestor
110252976|NCT00141089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110252977|NCT00141089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252978|NCT00141089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252979|NCT00407121|Bevacizumab|bevacizumab|mesh-list
110252980|NCT00407121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110252981|NCT00407121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110252982|NCT00407121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110252983|NCT00407121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110252984|NCT00407121|Growth Substances|growth substances|mesh-ancestor
110252985|NCT00407121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252986|NCT00407121|Growth Inhibitors|growth inhibitors|mesh-ancestor
110252987|NCT00141167|Varenicline|varenicline|mesh-list
110252988|NCT00141167|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110252989|NCT00141167|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110252990|NCT00141167|Cholinergic Agents|cholinergic agents|mesh-ancestor
110252991|NCT00141167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110252992|NCT00141167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252993|NCT00141167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110252994|NCT00141206|Varenicline|varenicline|mesh-list
110252995|NCT00141206|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110252996|NCT00141206|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110252997|NCT00141206|Cholinergic Agents|cholinergic agents|mesh-ancestor
110252998|NCT00141206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110252999|NCT00141206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110253000|NCT00141206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253003|NCT00141245|Sensory System Agents|sensory system agents|mesh-ancestor
110253004|NCT00141245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110253005|NCT00141245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253006|NCT00141245|Anticonvulsants|anticonvulsants|mesh-ancestor
110253007|NCT00141245|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110253008|NCT00141245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110253009|NCT00141245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110253010|NCT00141245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110253011|NCT00141245|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110253012|NCT00141245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110253013|NCT00141245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110253015|NCT00141362|Pregabalin|pregabalin|mesh-list
110253016|NCT00141362|Analgesics|analgesics|mesh-ancestor
110253017|NCT00141362|Sensory System Agents|sensory system agents|mesh-ancestor
110253018|NCT00141362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110253019|NCT00141362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253020|NCT00141362|Anticonvulsants|anticonvulsants|mesh-ancestor
110253021|NCT00141362|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110253022|NCT00141362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110253023|NCT00141362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110253024|NCT00141362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110253025|NCT00141362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110253026|NCT00141362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110253027|NCT00141362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110253028|NCT00141362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110253030|NCT00155259|Capecitabine|capecitabine|mesh-list
110253031|NCT00155259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110253032|NCT00155259|Tubulin Modulators|tubulin modulators|mesh-ancestor
110253033|NCT00155259|Antimitotic Agents|antimitotic agents|mesh-ancestor
110253034|NCT00155259|Mitosis Modulators|mitosis modulators|mesh-ancestor
110253035|NCT00155259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110253036|NCT00155259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110253037|NCT00155259|Antimetabolites|antimetabolites|mesh-ancestor
110253039|NCT04518124|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110253040|NCT04518124|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110253041|NCT04518124|Adrenergic Agents|adrenergic agents|mesh-ancestor
110253042|NCT04518124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110253043|NCT04518124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110253044|NCT04518124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253045|NCT04518124|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110253046|NCT04518124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110253047|NCT04518124|Vasodilator Agents|vasodilator agents|mesh-ancestor
110253049|NCT00141401|Analgesics|analgesics|mesh-ancestor
110253050|NCT00141401|Sensory System Agents|sensory system agents|mesh-ancestor
110253051|NCT00141401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110253052|NCT00141401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253053|NCT00141401|Anticonvulsants|anticonvulsants|mesh-ancestor
110253054|NCT00141401|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110253055|NCT00141401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110253056|NCT00141401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110253057|NCT00141401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110253058|NCT00141401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110253059|NCT00141401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110253060|NCT00141401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110253061|NCT00141401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110253062|NCT00505102|Everolimus|everolimus|mesh-list
110253063|NCT00505102|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110253064|NCT00505102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110253065|NCT00505102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110253066|NCT00505102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110253067|NCT00505102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110253068|NCT00505102|Immunologic Factors|immunologic factors|mesh-ancestor
110253069|NCT00505102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253070|NCT00505102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110253071|NCT00404378|Ketoconazole|ketoconazole|mesh-list
110253072|NCT00404378|Casopitant|casopitant|mesh-list
110253073|NCT00404378|Antifungal Agents|antifungal agents|mesh-ancestor
110253074|NCT00404378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110253075|NCT00404378|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110253076|NCT00404378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110253077|NCT00404378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110253078|NCT00404378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110253079|NCT00404378|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110253080|NCT00404378|Hormone Antagonists|hormone antagonists|mesh-ancestor
110253081|NCT00404378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110253082|NCT00404378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253083|NCT00404378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110253084|NCT00404378|Antiemetics|antiemetics|mesh-ancestor
110253085|NCT00404378|Autonomic Agents|autonomic agents|mesh-ancestor
110253086|NCT00404378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110253087|NCT00404378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110253088|NCT00404378|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110253089|NCT00404378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110253090|NCT04511728|Propofol|propofol|mesh-list
110253091|NCT04511728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110253092|NCT04511728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110253093|NCT04511728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253094|NCT04511728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110270068|NCT03311555|Hormones|hormones|mesh-ancestor
110253095|NCT04511728|Anesthetics, General|anesthetics, general|mesh-ancestor
110253096|NCT04511728|Anesthetics|anesthetics|mesh-ancestor
110253098|NCT00162318|Gefitinib|gefitinib|mesh-list
110253099|NCT00162318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110253100|NCT00162318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110253101|NCT00162318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110253102|NCT00162318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110253103|NCT00162318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110253105|NCT00404417|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110253106|NCT00404417|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110253107|NCT00404417|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110253108|NCT00404417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110253109|NCT00404417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110253110|NCT00404417|Cholinergic Agents|cholinergic agents|mesh-ancestor
110253111|NCT00404417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110253112|NCT00404417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253113|NCT00404417|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110253114|NCT00404417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110253115|NCT04519762|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110253116|NCT04519762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110253117|NCT00162357|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
110253118|NCT00162357|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110253119|NCT00162357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110253121|NCT00404456|Antioxidants|antioxidants|mesh-ancestor
110253122|NCT00404456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110253123|NCT00404456|Protective Agents|protective agents|mesh-ancestor
110253124|NCT00404456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253125|NCT00404456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110253126|NCT00404534|Amoxicillin|amoxicillin|mesh-list
110253127|NCT00404534|Clarithromycin|clarithromycin|mesh-list
110253128|NCT00404534|Omeprazole|omeprazole|mesh-list
110253129|NCT00404534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110253130|NCT00404534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110253131|NCT00404534|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110253132|NCT00404534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110253133|NCT00404534|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110253134|NCT00404534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110253135|NCT00404534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110253136|NCT00404534|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110253138|NCT00404534|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110253139|NCT00505258|Ceftobiprole|ceftobiprole|mesh-list
110253140|NCT00505258|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
110253141|NCT00505258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110253142|NCT00505258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110253143|NCT00162396|Albuterol|albuterol|mesh-list
110253144|NCT00162396|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110253145|NCT00162396|Autonomic Agents|autonomic agents|mesh-ancestor
110253146|NCT00162396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110253147|NCT00162396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253148|NCT00162396|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110253149|NCT00162396|Respiratory System Agents|respiratory system agents|mesh-ancestor
110253150|NCT00162396|Tocolytic Agents|tocolytic agents|mesh-ancestor
110253151|NCT00162396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110253152|NCT00162396|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110253155|NCT00162396|Adrenergic Agents|adrenergic agents|mesh-ancestor
110253156|NCT00162396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110253157|NCT00162396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110253158|NCT00162435|Warfarin|warfarin|mesh-list
110253159|NCT00162435|Anticoagulants|anticoagulants|mesh-ancestor
110253160|NCT04518982|Lenalidomide|lenalidomide|mesh-list
110253161|NCT04518982|Immunologic Factors|immunologic factors|mesh-ancestor
110253162|NCT04518982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253163|NCT04518982|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110253164|NCT04518982|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110253165|NCT04518982|Growth Substances|growth substances|mesh-ancestor
110253166|NCT04518982|Growth Inhibitors|growth inhibitors|mesh-ancestor
110253167|NCT04518982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110253168|NCT00155376|Morphine|morphine|mesh-list
110253169|NCT00155376|Glucagon|glucagon|mesh-list
110253170|NCT00155376|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110253171|NCT00155376|Narcotics|narcotics|mesh-ancestor
110253172|NCT00155376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110253173|NCT00155376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253174|NCT00155376|Analgesics|analgesics|mesh-ancestor
110253175|NCT00155376|Sensory System Agents|sensory system agents|mesh-ancestor
110253176|NCT00155376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110253177|NCT00155376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110253178|NCT00155376|Hormones|hormones|mesh-ancestor
110253179|NCT00155376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110253180|NCT00141557|Methyltestosterone|methyltestosterone|mesh-list
110253181|NCT00141557|Estrogens|estrogens|mesh-list
110253182|NCT00141557|Estrogens, Esterified (USP)|estrogens, esterified (usp)|mesh-list
110253183|NCT00141557|Estrone|estrone|mesh-list
110253184|NCT00141557|Testosterone|testosterone|mesh-list
110253185|NCT00141557|Testosterone undecanoate|testosterone undecanoate|mesh-list
110253186|NCT00141557|Testosterone enanthate|testosterone enanthate|mesh-list
110253187|NCT00141557|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110253188|NCT00141557|Hormones|hormones|mesh-ancestor
110253189|NCT00141557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110253190|NCT00141557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253191|NCT00141557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110253192|NCT00141557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110253193|NCT00141557|Anabolic Agents|anabolic agents|mesh-ancestor
110253194|NCT00141557|Androgens|androgens|mesh-ancestor
110253195|NCT00162474|Phenytoin|phenytoin|mesh-list
110253196|NCT00162474|Warfarin|warfarin|mesh-list
110253197|NCT00162474|Anticoagulants|anticoagulants|mesh-ancestor
110253198|NCT00162474|Anticonvulsants|anticonvulsants|mesh-ancestor
110253199|NCT00162474|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110253200|NCT00162474|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110253201|NCT00162474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110253202|NCT00162474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110253203|NCT00162474|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110026847|NCT01270152|Vitamins|vitamins|mesh-ancestor
110253204|NCT00162474|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110253205|NCT04518553|Antiviral Agents|antiviral agents|mesh-list
110253206|NCT04518553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110253207|NCT00505336|Eplerenone|eplerenone|mesh-list
110253208|NCT00505336|Atorvastatin|atorvastatin|mesh-list
110253209|NCT00505336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110253210|NCT00505336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110253211|NCT00505336|Antimetabolites|antimetabolites|mesh-ancestor
110253212|NCT00505336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110253213|NCT00505336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110253214|NCT00505336|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110253215|NCT00505336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110253216|NCT00505336|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110253217|NCT00505336|Hormone Antagonists|hormone antagonists|mesh-ancestor
110253218|NCT00505336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110270103|NCT02992743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110253219|NCT00505336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253220|NCT00505336|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110253221|NCT00505336|Diuretics|diuretics|mesh-ancestor
110253222|NCT00505336|Natriuretic Agents|natriuretic agents|mesh-ancestor
110253223|NCT00505336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110253224|NCT04518202|Lidocaine|lidocaine|mesh-list
110253225|NCT04518202|Anesthetics, Local|anesthetics, local|mesh-ancestor
110253226|NCT04518202|Anesthetics|anesthetics|mesh-ancestor
110253227|NCT04518202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110253228|NCT04518202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253229|NCT04518202|Sensory System Agents|sensory system agents|mesh-ancestor
110253230|NCT04518202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110253231|NCT04518202|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110253232|NCT04518202|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110253233|NCT04518202|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110253234|NCT04518202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110253235|NCT04518202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110253236|NCT04517890|Lidocaine|lidocaine|mesh-list
110253237|NCT04517890|Anesthetics, Local|anesthetics, local|mesh-ancestor
110253238|NCT04517890|Anesthetics|anesthetics|mesh-ancestor
110253239|NCT04517890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110253240|NCT04517890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253241|NCT04517890|Sensory System Agents|sensory system agents|mesh-ancestor
110253242|NCT04517890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110253243|NCT04517890|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110253244|NCT04517890|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110253245|NCT04517890|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110253246|NCT04517890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110253247|NCT04517890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110253248|NCT00141596|Amiloride|amiloride|mesh-list
110253249|NCT00141596|Furosemide|furosemide|mesh-list
110253250|NCT00141596|Diuretics|diuretics|mesh-ancestor
110253251|NCT00141596|Natriuretic Agents|natriuretic agents|mesh-ancestor
110253252|NCT00141596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253253|NCT00141596|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110253254|NCT00141596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110253255|NCT00141596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110253256|NCT00141596|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
110253257|NCT00141596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110253258|NCT00141596|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
110253259|NCT00141596|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110253260|NCT02275663|Cytarabine|cytarabine|mesh-list
110253261|NCT02275663|Fludarabine|fludarabine|mesh-list
110253262|NCT02275663|Azacitidine|azacitidine|mesh-list
110253263|NCT02275663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110253264|NCT02275663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110253265|NCT02275663|Antimetabolites|antimetabolites|mesh-ancestor
110253266|NCT02275663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110253267|NCT02275663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110253268|NCT02275663|Immunologic Factors|immunologic factors|mesh-ancestor
110253269|NCT02275663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253270|NCT02275663|Antiviral Agents|antiviral agents|mesh-ancestor
110253271|NCT02275663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110253272|NCT02275663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110253274|NCT02275702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110253275|NCT02275702|Antiemetics|antiemetics|mesh-ancestor
110253276|NCT02275702|Autonomic Agents|autonomic agents|mesh-ancestor
110253277|NCT02275702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110253278|NCT02275702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253279|NCT02275702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110253280|NCT02275702|Glucocorticoids|glucocorticoids|mesh-ancestor
110253281|NCT02275702|Hormones|hormones|mesh-ancestor
110253282|NCT02275702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110253283|NCT02275702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110253286|NCT04518163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110253287|NCT04518163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110253289|NCT04518163|Hemostatics|hemostatics|mesh-ancestor
110253290|NCT04518163|Coagulants|coagulants|mesh-ancestor
110253291|NCT04517227|Durvalumab|durvalumab|mesh-list
110253292|NCT04517227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110253293|NCT04517227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110253294|NCT00141713|Etanercept|etanercept|mesh-list
110253295|NCT00141713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110253296|NCT00141713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110253297|NCT00141713|Analgesics|analgesics|mesh-ancestor
110253298|NCT00141713|Sensory System Agents|sensory system agents|mesh-ancestor
110253299|NCT00141713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110253300|NCT00141713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253301|NCT00141713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110253302|NCT00141713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110253303|NCT00141713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110253304|NCT00141713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110253305|NCT00141713|Immunologic Factors|immunologic factors|mesh-ancestor
110253306|NCT04517188|Iodine|iodine|mesh-list
110253307|NCT04517188|Povidone-Iodine|povidone-iodine|mesh-list
110253308|NCT04517188|Povidone|povidone|mesh-list
110253309|NCT04517188|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110253310|NCT04517188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110253311|NCT04517188|Trace Elements|trace elements|mesh-ancestor
110253312|NCT04517188|Micronutrients|micronutrients|mesh-ancestor
110253313|NCT04517188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253314|NCT04517188|Plasma Substitutes|plasma substitutes|mesh-ancestor
110253315|NCT04517188|Blood Substitutes|blood substitutes|mesh-ancestor
110253316|NCT00162552|Pentoxifylline|pentoxifylline|mesh-list
110253317|NCT00162552|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110253318|NCT00162552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110253319|NCT00162552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110253320|NCT00162552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110253321|NCT00162552|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110253322|NCT00162552|Protective Agents|protective agents|mesh-ancestor
110253323|NCT00162552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253324|NCT00162552|Vasodilator Agents|vasodilator agents|mesh-ancestor
110253325|NCT00162552|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110253326|NCT00162552|Antioxidants|antioxidants|mesh-ancestor
110253327|NCT04516681|Ascorbic Acid|ascorbic acid|mesh-list
110253328|NCT04516681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253329|NCT04516681|Vitamins|vitamins|mesh-ancestor
110253330|NCT04516681|Micronutrients|micronutrients|mesh-ancestor
110253331|NCT04516681|Antioxidants|antioxidants|mesh-ancestor
110253332|NCT04516681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110027009|NCT03803124|Tolvaptan|tolvaptan|mesh-list
110253333|NCT04516681|Protective Agents|protective agents|mesh-ancestor
110253334|NCT00141791|Etanercept|etanercept|mesh-list
110253335|NCT00141791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110253336|NCT00141791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110253337|NCT00141791|Analgesics|analgesics|mesh-ancestor
110253338|NCT00141791|Sensory System Agents|sensory system agents|mesh-ancestor
110253339|NCT00141791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110253340|NCT00141791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253341|NCT00141791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110253342|NCT00141791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110270120|NCT02675426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110253344|NCT00141791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110253345|NCT00141791|Immunologic Factors|immunologic factors|mesh-ancestor
110253347|NCT04516603|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110253348|NCT04516603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110253349|NCT04516603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110253350|NCT00162591|Remifentanil|remifentanil|mesh-list
110253351|NCT00162591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110253352|NCT00162591|Narcotics|narcotics|mesh-ancestor
110253353|NCT00162591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110253354|NCT00162591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253355|NCT00162591|Analgesics|analgesics|mesh-ancestor
110253356|NCT00162591|Sensory System Agents|sensory system agents|mesh-ancestor
110253357|NCT00162591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110253358|NCT00505492|Paclitaxel|paclitaxel|mesh-list
110253359|NCT00505492|Cisplatin|cisplatin|mesh-list
110253360|NCT00505492|Carboplatin|carboplatin|mesh-list
110253361|NCT00505492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110253362|NCT00505492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110253363|NCT00505492|Tubulin Modulators|tubulin modulators|mesh-ancestor
110253364|NCT00505492|Antimitotic Agents|antimitotic agents|mesh-ancestor
110253365|NCT00505492|Mitosis Modulators|mitosis modulators|mesh-ancestor
110253366|NCT00505492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110253367|NCT00141830|Methotrexate|methotrexate|mesh-list
110253368|NCT00141830|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110253369|NCT00141830|Abortifacient Agents|abortifacient agents|mesh-ancestor
110253370|NCT00141830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110253371|NCT00141830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253372|NCT00141830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110253374|NCT00141830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110253375|NCT00141830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110253376|NCT00141830|Dermatologic Agents|dermatologic agents|mesh-ancestor
110253377|NCT00141830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110253378|NCT00141830|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110253379|NCT00141830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110253380|NCT00141830|Immunologic Factors|immunologic factors|mesh-ancestor
110253381|NCT00141830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110253382|NCT00141830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110253383|NCT04516174|Dexmedetomidine|dexmedetomidine|mesh-list
110253384|NCT04516174|Ropivacaine|ropivacaine|mesh-list
110253385|NCT04516174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110253386|NCT04516174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110253387|NCT04516174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253388|NCT04516174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110253389|NCT04516174|Analgesics|analgesics|mesh-ancestor
110253390|NCT04516174|Sensory System Agents|sensory system agents|mesh-ancestor
110253391|NCT04516174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110253392|NCT04516174|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110253393|NCT04516174|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110253395|NCT04516174|Adrenergic Agents|adrenergic agents|mesh-ancestor
110253396|NCT04516174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110253397|NCT04516174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110253398|NCT04516174|Anesthetics, Local|anesthetics, local|mesh-ancestor
110253399|NCT04516174|Anesthetics|anesthetics|mesh-ancestor
110253400|NCT04515979|Pembrolizumab|pembrolizumab|mesh-list
110253401|NCT04515979|Vactosertib|vactosertib|mesh-list
110253402|NCT04515979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110253403|NCT04515979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110253404|NCT04515979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110253405|NCT04515979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270134|NCT02427620|Doxorubicin|doxorubicin|mesh-list
110253407|NCT04515979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110253408|NCT00505531|Diphenhydramine|diphenhydramine|mesh-list
110253409|NCT00505531|Tramadol|tramadol|mesh-list
110253410|NCT00505531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110253411|NCT00505531|Narcotics|narcotics|mesh-ancestor
110253412|NCT00505531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110253413|NCT00505531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253414|NCT00505531|Analgesics|analgesics|mesh-ancestor
110253415|NCT00505531|Sensory System Agents|sensory system agents|mesh-ancestor
110253416|NCT00505531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110253417|NCT00505531|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110253418|NCT00505531|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110253419|NCT00505531|Anesthetics, Local|anesthetics, local|mesh-ancestor
110253421|NCT00505531|Antiemetics|antiemetics|mesh-ancestor
110253422|NCT00505531|Autonomic Agents|autonomic agents|mesh-ancestor
110253423|NCT00505531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110253424|NCT00505531|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110253425|NCT00505531|Histamine Antagonists|histamine antagonists|mesh-ancestor
110253426|NCT00505531|Histamine Agents|histamine agents|mesh-ancestor
110253427|NCT00505531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110253428|NCT00505531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110253429|NCT00505531|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110253430|NCT00141908|Castor Oil|castor oil|mesh-list
110253431|NCT00141908|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
110253432|NCT00141908|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
110253433|NCT00141908|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110253434|NCT00141908|Hormone Antagonists|hormone antagonists|mesh-ancestor
110253435|NCT00141908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110253436|NCT00141908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253437|NCT00141908|Progestins|progestins|mesh-ancestor
110253438|NCT00141908|Hormones|hormones|mesh-ancestor
110253439|NCT00141908|Cathartics|cathartics|mesh-ancestor
110253440|NCT00141908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110253442|NCT00162669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110253443|NCT00162669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110253444|NCT00162669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110253445|NCT00162669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110253446|NCT00162669|Growth Substances|growth substances|mesh-ancestor
110253447|NCT00162669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253448|NCT00162669|Growth Inhibitors|growth inhibitors|mesh-ancestor
110253450|NCT00141947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110253451|NCT04514770|Misoprostol|misoprostol|mesh-list
110253452|NCT04514770|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110253453|NCT04514770|Abortifacient Agents|abortifacient agents|mesh-ancestor
110253454|NCT04514770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110253455|NCT04514770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253456|NCT04514770|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110253457|NCT04514770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110253458|NCT04514770|Oxytocics|oxytocics|mesh-ancestor
110253459|NCT00141986|Vitamin D|vitamin d|mesh-list
110253460|NCT00141986|Ergocalciferols|ergocalciferols|mesh-list
110253462|NCT00141986|Vitamins|vitamins|mesh-list
110253463|NCT00141986|Micronutrients|micronutrients|mesh-ancestor
110253464|NCT00141986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253465|NCT00141986|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110260208|NCT00530413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110253466|NCT00141986|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110253467|NCT04514731|Magnesium Sulfate|magnesium sulfate|mesh-list
110253469|NCT04514731|Sensory System Agents|sensory system agents|mesh-ancestor
110253470|NCT04514731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110253471|NCT04514731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253472|NCT04514731|Anesthetics|anesthetics|mesh-ancestor
110253473|NCT04514731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110253474|NCT04514731|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110253475|NCT04514731|Anticonvulsants|anticonvulsants|mesh-ancestor
110253476|NCT04514731|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110253477|NCT04514731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110253478|NCT04514731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110253479|NCT04514731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110253480|NCT04514731|Tocolytic Agents|tocolytic agents|mesh-ancestor
110253481|NCT04514731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110253483|NCT04514419|Trastuzumab|trastuzumab|mesh-list
110253485|NCT04514419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110253486|NCT04514419|Tubulin Modulators|tubulin modulators|mesh-ancestor
110253487|NCT04514419|Antimitotic Agents|antimitotic agents|mesh-ancestor
110253488|NCT04514419|Mitosis Modulators|mitosis modulators|mesh-ancestor
110368705|NCT00558051|Immunologic Factors|immunologic factors|mesh-ancestor
110253489|NCT04514419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110253490|NCT04514419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110253492|NCT00142025|Anticonvulsants|anticonvulsants|mesh-ancestor
110253493|NCT00142025|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110253494|NCT00142025|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110253495|NCT00142025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110253496|NCT00142025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110253497|NCT00142025|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110253498|NCT00142025|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110253499|NCT02275897|Methamphetamine|methamphetamine|mesh-list
110253500|NCT02275897|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110253501|NCT02275897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253502|NCT02275897|Sympathomimetics|sympathomimetics|mesh-ancestor
110253503|NCT02275897|Autonomic Agents|autonomic agents|mesh-ancestor
110253504|NCT02275897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110253505|NCT02275897|Dopamine Agents|dopamine agents|mesh-ancestor
110253506|NCT02275897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110253507|NCT02275897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110253508|NCT02275897|Adrenergic Agents|adrenergic agents|mesh-ancestor
110253509|NCT02275897|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110253510|NCT02275897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110253511|NCT02275897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110253512|NCT02275897|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110253514|NCT00162786|Antipruritics|antipruritics|mesh-ancestor
110253516|NCT00162786|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110253517|NCT00162786|Histamine Antagonists|histamine antagonists|mesh-ancestor
110253518|NCT00162786|Histamine Agents|histamine agents|mesh-ancestor
110253519|NCT00162786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110253520|NCT00162786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110253521|NCT00162786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253522|NCT00142181|Alemtuzumab|alemtuzumab|mesh-list
110253523|NCT00142181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110253524|NCT00142181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110253525|NCT00505804|Dexmedetomidine|dexmedetomidine|mesh-list
110253526|NCT00505804|Haloperidol|haloperidol|mesh-list
110253527|NCT00505804|Haloperidol decanoate|haloperidol decanoate|mesh-list
110253528|NCT00505804|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110253529|NCT00505804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110253530|NCT00505804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253531|NCT00505804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110253532|NCT00505804|Analgesics|analgesics|mesh-ancestor
110253533|NCT00505804|Sensory System Agents|sensory system agents|mesh-ancestor
110253534|NCT00505804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110253535|NCT00505804|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110253536|NCT00505804|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110253537|NCT00505804|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110253538|NCT00505804|Adrenergic Agents|adrenergic agents|mesh-ancestor
110253539|NCT00505804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110253540|NCT00505804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110253541|NCT00505804|Antiemetics|antiemetics|mesh-ancestor
110253542|NCT00505804|Autonomic Agents|autonomic agents|mesh-ancestor
110253543|NCT00505804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110253544|NCT00505804|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110253545|NCT00505804|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110253546|NCT00505804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110253547|NCT00505804|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110253548|NCT00505804|Dopamine Agents|dopamine agents|mesh-ancestor
110253549|NCT00505804|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110253551|NCT00505843|Carbidopa|carbidopa|mesh-list
110253552|NCT00505843|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110253553|NCT00505843|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110253554|NCT00505843|Dopamine Agents|dopamine agents|mesh-ancestor
110253555|NCT00505843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110253556|NCT00505843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270199|NCT02401035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110253557|NCT00505843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253558|NCT00505843|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110253559|NCT00505843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110253560|NCT00505882|Pramlintide|pramlintide|mesh-list
110253561|NCT00505882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110253562|NCT00505882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253563|NCT00142337|Zidovudine|zidovudine|mesh-list
110253564|NCT00142337|Didanosine|didanosine|mesh-list
110253565|NCT00142337|Antimetabolites|antimetabolites|mesh-ancestor
110253566|NCT00142337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110253567|NCT00142337|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110253568|NCT00142337|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110253569|NCT00142337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110253570|NCT00142337|Antiviral Agents|antiviral agents|mesh-ancestor
110253571|NCT00142337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110253572|NCT00142337|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110253573|NCT00142337|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110253574|NCT00162864|Montelukast|montelukast|mesh-list
110253575|NCT00162864|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110253576|NCT00162864|Respiratory System Agents|respiratory system agents|mesh-ancestor
110253577|NCT00162864|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110253578|NCT00162864|Hormone Antagonists|hormone antagonists|mesh-ancestor
110253579|NCT00162864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110253580|NCT00162864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253581|NCT00162864|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110253582|NCT00162864|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110253583|NCT00162864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110253584|NCT04512313|Rocuronium|rocuronium|mesh-list
110253585|NCT04512313|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110253586|NCT04512313|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110253587|NCT04512313|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110253588|NCT04512313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110253589|NCT04512313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253590|NCT00142493|Midazolam|midazolam|mesh-list
110253591|NCT00142493|Dexmedetomidine|dexmedetomidine|mesh-list
110253592|NCT00142493|Thiopental|thiopental|mesh-list
110253593|NCT00142493|Propofol|propofol|mesh-list
110253594|NCT00142493|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110253595|NCT00142493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110253596|NCT00142493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253597|NCT00142493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110253598|NCT00142493|Analgesics|analgesics|mesh-ancestor
110253599|NCT00142493|Sensory System Agents|sensory system agents|mesh-ancestor
110253600|NCT00142493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110253601|NCT00142493|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110253602|NCT00142493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110253603|NCT00142493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110253604|NCT00142493|Adrenergic Agents|adrenergic agents|mesh-ancestor
110253605|NCT00142493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110253606|NCT00142493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110253607|NCT00142493|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110253608|NCT00142493|Anesthetics, General|anesthetics, general|mesh-ancestor
110253609|NCT00142493|Anesthetics|anesthetics|mesh-ancestor
110253610|NCT00142493|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110253611|NCT00142493|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110253612|NCT00142493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110253613|NCT00142493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110253614|NCT00142493|GABA Modulators|gaba modulators|mesh-ancestor
110253615|NCT00142493|GABA Agents|gaba agents|mesh-ancestor
110253616|NCT00142493|Anticonvulsants|anticonvulsants|mesh-ancestor
110253617|NCT04511923|Heparin|heparin|mesh-list
110253618|NCT04511923|Anticoagulants|anticoagulants|mesh-ancestor
110253619|NCT04511923|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110253620|NCT04511923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110270219|NCT02153944|Vasodilator Agents|vasodilator agents|mesh-ancestor
110253621|NCT04511923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110253622|NCT04511611|Rivaroxaban|rivaroxaban|mesh-list
110253623|NCT04511611|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110253624|NCT04511611|Antithrombins|antithrombins|mesh-ancestor
110253625|NCT04511611|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110253626|NCT04511611|Protease Inhibitors|protease inhibitors|mesh-ancestor
110253627|NCT04511611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110253628|NCT04511611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110253629|NCT04511611|Anticoagulants|anticoagulants|mesh-ancestor
110253630|NCT04511299|SMOFlipid|smoflipid|mesh-list
110253631|NCT04511299|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
110253632|NCT04511299|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110253633|NCT04511299|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110253634|NCT00142571|Gemcitabine|gemcitabine|mesh-list
110253635|NCT00142571|Docetaxel|docetaxel|mesh-list
110253636|NCT00142571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110253637|NCT00142571|Antimetabolites|antimetabolites|mesh-ancestor
110253638|NCT00142571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110253639|NCT00142571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110253640|NCT00142571|Tubulin Modulators|tubulin modulators|mesh-ancestor
110253641|NCT00142571|Antimitotic Agents|antimitotic agents|mesh-ancestor
110253642|NCT00142571|Mitosis Modulators|mitosis modulators|mesh-ancestor
110253643|NCT00142610|Vitamins|vitamins|mesh-list
110253644|NCT00142610|Vitamin E|vitamin e|mesh-list
110253645|NCT00142610|Micronutrients|micronutrients|mesh-ancestor
110253646|NCT00142610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253648|NCT00142610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110253649|NCT00142610|Protective Agents|protective agents|mesh-ancestor
110253650|NCT04510870|Ferric Compounds|ferric compounds|mesh-list
110253651|NCT04510870|Hematinics|hematinics|mesh-ancestor
110253652|NCT00406575|Methocarbamol|methocarbamol|mesh-list
110253653|NCT00406575|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110253654|NCT00406575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253655|NCT00406575|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110253656|NCT00406575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110253658|NCT02275975|Antifungal Agents|antifungal agents|mesh-ancestor
110253659|NCT02275975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110253660|NCT02275975|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110253661|NCT02275975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110270229|NCT01527149|Doxorubicin|doxorubicin|mesh-list
110253662|NCT02275975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110253663|NCT02275975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110253664|NCT02275975|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110253665|NCT02275975|Hormone Antagonists|hormone antagonists|mesh-ancestor
110253666|NCT02275975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110253667|NCT02275975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253668|NCT02275975|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110253669|NCT02275975|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110253671|NCT02276092|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110253672|NCT00142727|Analgesics, Opioid|analgesics, opioid|mesh-list
110253673|NCT00142727|Methadone|methadone|mesh-list
110253674|NCT00142727|Narcotic Antagonists|narcotic antagonists|mesh-list
110253675|NCT00142727|Narcotics|narcotics|mesh-ancestor
110253676|NCT00142727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110253677|NCT00142727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253678|NCT00142727|Analgesics|analgesics|mesh-ancestor
110253679|NCT00142727|Sensory System Agents|sensory system agents|mesh-ancestor
110253680|NCT00142727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110253681|NCT00142727|Antitussive Agents|antitussive agents|mesh-ancestor
110253682|NCT00142727|Respiratory System Agents|respiratory system agents|mesh-ancestor
110253683|NCT04510402|Povidone-Iodine|povidone-iodine|mesh-list
110253684|NCT04510402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110253685|NCT04510402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110253686|NCT00506194|Gliclazide|gliclazide|mesh-list
110253687|NCT00506194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110253688|NCT00506194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253689|NCT00404573|Cariprazine|cariprazine|mesh-list
110253690|NCT00404573|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110253691|NCT00404573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110253692|NCT00404573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110253693|NCT00404573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253694|NCT00404573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110253695|NCT00506272|Insulin|insulin|mesh-list
110253696|NCT00506272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110253697|NCT00506272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253698|NCT00506311|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110253699|NCT00506311|Hemostatics|hemostatics|mesh-ancestor
110253700|NCT00506311|Coagulants|coagulants|mesh-ancestor
110253701|NCT00406731|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
110253702|NCT00406731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110253703|NCT00406731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110253704|NCT00142844|Naltrexone|naltrexone|mesh-list
110253705|NCT00142844|Disulfiram|disulfiram|mesh-list
110253706|NCT00142844|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110253707|NCT00142844|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110253708|NCT00142844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253709|NCT00142844|Sensory System Agents|sensory system agents|mesh-ancestor
110253710|NCT00142844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110253711|NCT00142844|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
110253712|NCT00142844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110253713|NCT00142844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110253714|NCT00163137|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
110253716|NCT00163137|Hormone Antagonists|hormone antagonists|mesh-ancestor
110253717|NCT00163137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110253718|NCT00163137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253719|NCT00163137|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110253720|NCT00163137|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110253722|NCT00142883|Pregabalin|pregabalin|mesh-list
110253723|NCT00142883|Analgesics|analgesics|mesh-ancestor
110253724|NCT00142883|Sensory System Agents|sensory system agents|mesh-ancestor
110253725|NCT00142883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110253726|NCT00142883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253727|NCT00142883|Anticonvulsants|anticonvulsants|mesh-ancestor
110253728|NCT00142883|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110253729|NCT00142883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110253730|NCT00142883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110253731|NCT00142883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110253732|NCT00142883|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110253733|NCT00142883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110253734|NCT00142883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110253735|NCT00142883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110253736|NCT04515238|Venetoclax|venetoclax|mesh-list
110253737|NCT04515238|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110253738|NCT04515238|Obinutuzumab|obinutuzumab|mesh-list
110253739|NCT04515238|Zanubrutinib|zanubrutinib|mesh-list
110253740|NCT04515238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110253741|NCT04515238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110253742|NCT04515238|Alkylating Agents|alkylating agents|mesh-ancestor
110253743|NCT04515238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110253744|NCT04515238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110253745|NCT04515238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110253746|NCT04515238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110253747|NCT00142961|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110253748|NCT00142961|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110253749|NCT00142961|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110253750|NCT00142961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110253751|NCT00142961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110253752|NCT00142961|Adrenergic Agents|adrenergic agents|mesh-ancestor
110253753|NCT00142961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110253754|NCT00142961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253756|NCT00163254|Anticoagulants|anticoagulants|mesh-ancestor
110253757|NCT00163254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110253758|NCT00143000|Ribavirin|ribavirin|mesh-list
110253759|NCT00143000|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110253760|NCT00143000|Antimetabolites|antimetabolites|mesh-ancestor
110253761|NCT00143000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110253762|NCT00143000|Antiviral Agents|antiviral agents|mesh-ancestor
110253763|NCT00143000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110253764|NCT04514029|Dexamethasone|dexamethasone|mesh-list
110253765|NCT04514029|Simvastatin|simvastatin|mesh-list
110253766|NCT04514029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110253767|NCT04514029|Antiemetics|antiemetics|mesh-ancestor
110253768|NCT04514029|Autonomic Agents|autonomic agents|mesh-ancestor
110253769|NCT04514029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110270277|NCT01359956|Fotemustine|fotemustine|mesh-list
110253770|NCT04514029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253771|NCT04514029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110253774|NCT04514029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110253775|NCT04514029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110027871|NCT01729806|Rituximab|rituximab|mesh-list
110253776|NCT04514029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110253777|NCT04514029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110253778|NCT04514029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110253780|NCT04514029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110253782|NCT04514029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110253783|NCT04514029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110253784|NCT02590393|Nicotine|nicotine|mesh-list
110253785|NCT02590393|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110253786|NCT02590393|Autonomic Agents|autonomic agents|mesh-ancestor
110253787|NCT02590393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110253788|NCT02590393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253789|NCT02590393|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110253790|NCT02590393|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110253791|NCT02590393|Cholinergic Agents|cholinergic agents|mesh-ancestor
110253792|NCT02590393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110253793|NCT02590393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110253794|NCT00506506|Acetylcysteine|acetylcysteine|mesh-list
110253795|NCT00506506|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110253796|NCT00506506|Antiviral Agents|antiviral agents|mesh-ancestor
110253797|NCT00506506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110253798|NCT00506506|Expectorants|expectorants|mesh-ancestor
110253799|NCT00506506|Respiratory System Agents|respiratory system agents|mesh-ancestor
110253800|NCT00506506|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110253801|NCT00506506|Antioxidants|antioxidants|mesh-ancestor
110253802|NCT00506506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110253803|NCT00506506|Protective Agents|protective agents|mesh-ancestor
110253804|NCT00506506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253805|NCT00506506|Antidotes|antidotes|mesh-ancestor
110253806|NCT02594254|Anti-Infective Agents|anti-infective agents|mesh-list
110253807|NCT02594254|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110253808|NCT00163332|Ciclesonide|ciclesonide|mesh-list
110253809|NCT00163332|Glucocorticoids|glucocorticoids|mesh-ancestor
110253810|NCT00163332|Hormones|hormones|mesh-ancestor
110253811|NCT00163332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110253812|NCT00163332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253813|NCT00163332|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110253814|NCT00163371|Ciclesonide|ciclesonide|mesh-list
110253815|NCT00163371|Glucocorticoids|glucocorticoids|mesh-ancestor
110253816|NCT00163371|Hormones|hormones|mesh-ancestor
110253817|NCT00163371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110253818|NCT00163371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253819|NCT00163371|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110253820|NCT00143156|Pregabalin|pregabalin|mesh-list
110253821|NCT00143156|Analgesics|analgesics|mesh-ancestor
110253822|NCT00143156|Sensory System Agents|sensory system agents|mesh-ancestor
110253823|NCT00143156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110253824|NCT00143156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253825|NCT00143156|Anticonvulsants|anticonvulsants|mesh-ancestor
110253826|NCT00143156|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110253827|NCT00143156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110253828|NCT00143156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110253829|NCT00143156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110253830|NCT00143156|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110253831|NCT00143156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110253832|NCT00143156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110253833|NCT00143156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110253834|NCT00163410|Ciclesonide|ciclesonide|mesh-list
110253835|NCT00163410|Glucocorticoids|glucocorticoids|mesh-ancestor
110253836|NCT00163410|Hormones|hormones|mesh-ancestor
110270295|NCT01306045|Growth Substances|growth substances|mesh-ancestor
110253837|NCT00163410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110253838|NCT00163410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253839|NCT00163410|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110253840|NCT00143195|Amlodipine|amlodipine|mesh-list
110253841|NCT00143195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110253842|NCT00143195|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110253843|NCT00143195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110253844|NCT00143195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110253845|NCT00143195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110253846|NCT00143195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253847|NCT00143195|Vasodilator Agents|vasodilator agents|mesh-ancestor
110253848|NCT00163449|Ciclesonide|ciclesonide|mesh-list
110253849|NCT00163449|Glucocorticoids|glucocorticoids|mesh-ancestor
110253851|NCT00163449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110253852|NCT00163449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253853|NCT00163449|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110253854|NCT00143234|Amlodipine|amlodipine|mesh-list
110253855|NCT00143234|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
110253856|NCT00143234|Atorvastatin|atorvastatin|mesh-list
110253857|NCT00143234|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110253858|NCT00143234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110253859|NCT00143234|Antimetabolites|antimetabolites|mesh-ancestor
110253860|NCT00143234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110253861|NCT00143234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110253862|NCT00143234|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110253863|NCT00143234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110253864|NCT00143234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110253865|NCT00143234|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110253866|NCT00143234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110253867|NCT00143234|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110253868|NCT00143234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253869|NCT00143234|Vasodilator Agents|vasodilator agents|mesh-ancestor
110253870|NCT00163488|Ciclesonide|ciclesonide|mesh-list
110253871|NCT00163488|Glucocorticoids|glucocorticoids|mesh-ancestor
110253872|NCT00163488|Hormones|hormones|mesh-ancestor
110253873|NCT00163488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110253874|NCT00163488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253875|NCT00163488|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110253876|NCT00143351|Ziprasidone|ziprasidone|mesh-list
110253877|NCT00143351|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110253878|NCT00143351|Serotonin Agents|serotonin agents|mesh-ancestor
110253879|NCT00143351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110253880|NCT00143351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110253881|NCT00143351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253882|NCT00143351|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110253883|NCT00143351|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110253884|NCT00143351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110253885|NCT00143351|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110253886|NCT00143351|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110253887|NCT00143351|Dopamine Agents|dopamine agents|mesh-ancestor
110253888|NCT00163605|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110253889|NCT00163605|Thrombin|thrombin|mesh-list
110253890|NCT00163605|Calcium|calcium|mesh-list
110253891|NCT00163605|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110253892|NCT00163605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253894|NCT00163605|Coagulants|coagulants|mesh-ancestor
110253895|NCT02598583|Ravulizumab|ravulizumab|mesh-list
110253896|NCT02598583|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110253897|NCT02598583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110253898|NCT02598583|Immunologic Factors|immunologic factors|mesh-ancestor
110253899|NCT02598583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253900|NCT00143429|Latanoprost|latanoprost|mesh-list
110253901|NCT00143429|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110253902|NCT00143429|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110253905|NCT02598895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110253906|NCT02598895|Tubulin Modulators|tubulin modulators|mesh-ancestor
110253907|NCT02598895|Antimitotic Agents|antimitotic agents|mesh-ancestor
110253908|NCT02598895|Mitosis Modulators|mitosis modulators|mesh-ancestor
110253909|NCT02598895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110253910|NCT00143546|Defibrotide|defibrotide|mesh-list
110253911|NCT00143546|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110253912|NCT00143546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110253913|NCT00143546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110253914|NCT00143546|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110253915|NCT00155883|Leucovorin|leucovorin|mesh-list
110253916|NCT00155883|Fluorouracil|fluorouracil|mesh-list
110253917|NCT00155883|Antimetabolites|antimetabolites|mesh-ancestor
110253918|NCT00155883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110253919|NCT00155883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110253920|NCT00155883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110253921|NCT00155883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110253922|NCT00155883|Immunologic Factors|immunologic factors|mesh-ancestor
110253923|NCT00155883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253924|NCT00155883|Antidotes|antidotes|mesh-ancestor
110253925|NCT00155883|Protective Agents|protective agents|mesh-ancestor
110253926|NCT00155883|Vitamin B Complex|vitamin b complex|mesh-ancestor
110253927|NCT00155883|Vitamins|vitamins|mesh-ancestor
110253928|NCT00155883|Micronutrients|micronutrients|mesh-ancestor
110253929|NCT00506545|Rolapitant|rolapitant|mesh-list
110253930|NCT00506545|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110253931|NCT00506545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110253932|NCT00506545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110253933|NCT00506545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253934|NCT04696393|Mitapivat|mitapivat|mesh-list
110253935|NCT04696393|Enzyme Activators|enzyme activators|mesh-ancestor
110253936|NCT04696393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110253937|NCT05143723|Hormones|hormones|mesh-list
110253938|NCT05143723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110253939|NCT05143723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253940|NCT00143624|Rosiglitazone|rosiglitazone|mesh-list
110253941|NCT00143624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110253942|NCT00143624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253943|NCT05142865|Carboplatin|carboplatin|mesh-list
110253944|NCT05142865|Etoposide|etoposide|mesh-list
110253945|NCT05142865|Apatinib|apatinib|mesh-list
110253946|NCT05142865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110253947|NCT05142865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110253948|NCT05142865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110253949|NCT05142865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110253950|NCT05142865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110253951|NCT05142865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110253952|NCT05142865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110253954|NCT00143702|Thiamine|thiamine|mesh-list
110253955|NCT00143702|Abacavir|abacavir|mesh-list
110253956|NCT00143702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110253957|NCT00143702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110253958|NCT00143702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110253959|NCT00143702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110253960|NCT00143702|Antiviral Agents|antiviral agents|mesh-ancestor
110253961|NCT00143702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110253962|NCT00143702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110253963|NCT00143702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110253964|NCT00143702|Vitamin B Complex|vitamin b complex|mesh-ancestor
110253965|NCT00143702|Vitamins|vitamins|mesh-ancestor
110253966|NCT00143702|Micronutrients|micronutrients|mesh-ancestor
110253967|NCT00143702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253968|NCT00143702|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110253969|NCT00143702|Dermatologic Agents|dermatologic agents|mesh-ancestor
110253970|NCT00156078|Pregabalin|pregabalin|mesh-list
110253971|NCT00156078|Analgesics|analgesics|mesh-ancestor
110253972|NCT00156078|Sensory System Agents|sensory system agents|mesh-ancestor
110253973|NCT00156078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110253974|NCT00156078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253975|NCT00156078|Anticonvulsants|anticonvulsants|mesh-ancestor
110253976|NCT00156078|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110253977|NCT00156078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110253978|NCT00156078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110253979|NCT00156078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110253980|NCT00156078|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110253981|NCT00156078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110253982|NCT00156078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110253983|NCT00156078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110253984|NCT00506623|Capecitabine|capecitabine|mesh-list
110253986|NCT00506623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110253987|NCT00506623|Antimetabolites|antimetabolites|mesh-ancestor
110253988|NCT00506623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110253989|NCT00506623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110253990|NCT00506623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110253991|NCT00506623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110253992|NCT00506623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110253993|NCT00143741|Atorvastatin|atorvastatin|mesh-list
110253994|NCT00143741|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110253995|NCT00143741|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110253996|NCT00143741|Antimetabolites|antimetabolites|mesh-ancestor
110253997|NCT00143741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110253998|NCT00143741|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110253999|NCT00143741|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110254001|NCT00143780|Vaccines|vaccines|mesh-list
110254003|NCT00143780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110254004|NCT02276365|Pioglitazone|pioglitazone|mesh-list
110254005|NCT02276365|Empagliflozin|empagliflozin|mesh-list
110254006|NCT02276365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110254007|NCT02276365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110270344|NCT00775749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110254008|NCT02276365|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110368706|NCT00558051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110254009|NCT02276365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110254010|NCT05145634|Anticoagulants|anticoagulants|mesh-list
110254012|NCT00143975|Mitoxantrone|mitoxantrone|mesh-list
110254013|NCT00143975|Gemtuzumab|gemtuzumab|mesh-list
110254014|NCT00143975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110254016|NCT00143975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110254017|NCT00143975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110254018|NCT00143975|Antiviral Agents|antiviral agents|mesh-ancestor
110254019|NCT00143975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110254020|NCT00143975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110254021|NCT00143975|Immunologic Factors|immunologic factors|mesh-ancestor
110254022|NCT00143975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110254023|NCT00143975|Analgesics|analgesics|mesh-ancestor
110254024|NCT00143975|Sensory System Agents|sensory system agents|mesh-ancestor
110254026|NCT00143975|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110254027|NCT00143975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110254028|NCT00143975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110254029|NCT00143975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110254030|NCT00143975|Immunotoxins|immunotoxins|mesh-ancestor
110254031|NCT00143975|Immunoconjugates|immunoconjugates|mesh-ancestor
110254032|NCT00156312|Docetaxel|docetaxel|mesh-list
110254033|NCT00156312|Capecitabine|capecitabine|mesh-list
110254034|NCT00156312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110254035|NCT00156312|Tubulin Modulators|tubulin modulators|mesh-ancestor
110254036|NCT00156312|Antimitotic Agents|antimitotic agents|mesh-ancestor
110254037|NCT00156312|Mitosis Modulators|mitosis modulators|mesh-ancestor
110254038|NCT00156312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110254039|NCT00156312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110254040|NCT00156312|Antimetabolites|antimetabolites|mesh-ancestor
110254041|NCT00506701|Tadalafil|tadalafil|mesh-list
110254042|NCT00506701|Vasodilator Agents|vasodilator agents|mesh-ancestor
110254043|NCT00506701|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110254044|NCT00506701|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110254045|NCT00506701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110254046|NCT00506701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110254047|NCT00506701|Urological Agents|urological agents|mesh-ancestor
110254048|NCT05147857|Misoprostol|misoprostol|mesh-list
110254049|NCT05147857|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110254050|NCT05147857|Abortifacient Agents|abortifacient agents|mesh-ancestor
110254051|NCT05147857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110254052|NCT05147857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110254053|NCT05147857|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110254054|NCT05147857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110254055|NCT05147857|Oxytocics|oxytocics|mesh-ancestor
110254056|NCT00144053|Paclitaxel|paclitaxel|mesh-list
110254057|NCT00144053|Vindesine|vindesine|mesh-list
110254058|NCT00144053|Carboplatin|carboplatin|mesh-list
110254059|NCT00144053|Irinotecan|irinotecan|mesh-list
110254060|NCT00144053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110254061|NCT00144053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110254062|NCT00144053|Tubulin Modulators|tubulin modulators|mesh-ancestor
110254063|NCT00144053|Antimitotic Agents|antimitotic agents|mesh-ancestor
110254064|NCT00144053|Mitosis Modulators|mitosis modulators|mesh-ancestor
110254065|NCT00144053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110254066|NCT00144053|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110254067|NCT00144053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110254068|NCT00144053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110254069|NCT05147194|Trimetazidine|trimetazidine|mesh-list
110254070|NCT05147194|Vasodilator Agents|vasodilator agents|mesh-ancestor
110254071|NCT00144131|Darbepoetin alfa|darbepoetin alfa|mesh-list
110254072|NCT00144131|Hematinics|hematinics|mesh-ancestor
110254073|NCT00144209|Levodopa|levodopa|mesh-list
110254074|NCT00144209|Pramipexole|pramipexole|mesh-list
110254075|NCT00144209|Benserazide|benserazide|mesh-list
110254076|NCT00144209|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110254077|NCT00144209|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110254078|NCT00144209|Dopamine Agents|dopamine agents|mesh-ancestor
110254079|NCT00144209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110254080|NCT00144209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110254081|NCT00144209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110254082|NCT00144209|Antioxidants|antioxidants|mesh-ancestor
110254083|NCT00144209|Protective Agents|protective agents|mesh-ancestor
110254084|NCT00144209|Dopamine Agonists|dopamine agonists|mesh-ancestor
110254085|NCT00144209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110254086|NCT05149339|Cholecalciferol|cholecalciferol|mesh-list
110254088|NCT05149339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110254089|NCT05149339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110254091|NCT05149339|Micronutrients|micronutrients|mesh-ancestor
110254092|NCT05149339|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110254093|NCT00144248|Nevirapine|nevirapine|mesh-list
110254094|NCT00144248|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110254095|NCT00144248|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110254096|NCT00144248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110254097|NCT00144248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110254098|NCT00144248|Antiviral Agents|antiviral agents|mesh-ancestor
110254099|NCT00144248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110254100|NCT00144248|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110254101|NCT00144248|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110254102|NCT00144248|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110254103|NCT00144248|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110254104|NCT00148005|Cholinergic Antagonists|cholinergic antagonists|mesh-list
110254105|NCT00148005|Cholinergic Agents|cholinergic agents|mesh-ancestor
110254106|NCT00148005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110254107|NCT00148005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110254108|NCT00148005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110254109|NCT00144287|Ritonavir|ritonavir|mesh-list
110254110|NCT00144287|Tipranavir|tipranavir|mesh-list
110254111|NCT00144287|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110254112|NCT00144287|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110254113|NCT00144287|Protease Inhibitors|protease inhibitors|mesh-ancestor
110254114|NCT00144287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110254115|NCT00144287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110254117|NCT00144287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110254118|NCT00144287|Antiviral Agents|antiviral agents|mesh-ancestor
110254119|NCT00144287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110254120|NCT00144287|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110254121|NCT00144287|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110254122|NCT00144326|Bromides|bromides|mesh-list
110254123|NCT00144326|Tiotropium Bromide|tiotropium bromide|mesh-list
110254124|NCT00144326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110254125|NCT00144326|Autonomic Agents|autonomic agents|mesh-ancestor
110254126|NCT00144326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110254127|NCT00144326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110254128|NCT00144326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110254129|NCT00144326|Respiratory System Agents|respiratory system agents|mesh-ancestor
110254130|NCT00144326|Parasympatholytics|parasympatholytics|mesh-ancestor
110254131|NCT00144326|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110254132|NCT00144326|Cholinergic Agents|cholinergic agents|mesh-ancestor
110254133|NCT00144326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110254134|NCT00144326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110254135|NCT00144326|Anticonvulsants|anticonvulsants|mesh-ancestor
110254136|NCT02954692|Metformin|metformin|mesh-list
110254137|NCT02954692|Insulin Glargine|insulin glargine|mesh-list
110254139|NCT02954692|Meglitinide|meglitinide|mesh-list
110254140|NCT02954692|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
110254141|NCT02954692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110254142|NCT02954692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110254143|NCT02954692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110254144|NCT02954692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110254145|NCT00506935|Vigabatrin|vigabatrin|mesh-list
110254147|NCT00506935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110254148|NCT00506935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110254150|NCT00506935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110254151|NCT00506935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110254152|NCT00144365|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110254153|NCT00144365|Antiviral Agents|antiviral agents|mesh-ancestor
110254154|NCT00144365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110254155|NCT00506974|Sodium Oxybate|sodium oxybate|mesh-list
110254156|NCT00506974|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110254157|NCT00506974|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110254158|NCT00506974|Anesthetics, General|anesthetics, general|mesh-ancestor
110254159|NCT00506974|Anesthetics|anesthetics|mesh-ancestor
110254160|NCT00506974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110254161|NCT00506974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110254162|NCT00156546|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110254163|NCT00156546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110254164|NCT00507052|Acetylcysteine|acetylcysteine|mesh-list
110254165|NCT00507052|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110254166|NCT00507052|Antiviral Agents|antiviral agents|mesh-ancestor
110254167|NCT00507052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110254168|NCT00507052|Expectorants|expectorants|mesh-ancestor
110254169|NCT00507052|Respiratory System Agents|respiratory system agents|mesh-ancestor
110254170|NCT00507052|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110254171|NCT00507052|Antioxidants|antioxidants|mesh-ancestor
110254172|NCT00507052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110254173|NCT00507052|Protective Agents|protective agents|mesh-ancestor
110254174|NCT00507052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110254175|NCT00507052|Antidotes|antidotes|mesh-ancestor
110254176|NCT00507091|Leucovorin|leucovorin|mesh-list
110254177|NCT00507091|Fluorouracil|fluorouracil|mesh-list
110254178|NCT00507091|Irinotecan|irinotecan|mesh-list
110254179|NCT00507091|Antimetabolites|antimetabolites|mesh-ancestor
110254180|NCT00507091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110254181|NCT00507091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110254182|NCT00507091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110254183|NCT00507091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110254185|NCT00507091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110254186|NCT00507091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110254187|NCT00507091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110254188|NCT00507091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110254189|NCT00507091|Antidotes|antidotes|mesh-ancestor
110254190|NCT00507091|Protective Agents|protective agents|mesh-ancestor
110254191|NCT00507091|Vitamin B Complex|vitamin b complex|mesh-ancestor
110254192|NCT00507091|Vitamins|vitamins|mesh-ancestor
110254193|NCT00507091|Micronutrients|micronutrients|mesh-ancestor
110254195|NCT05148910|Trace Elements|trace elements|mesh-ancestor
110254196|NCT05148910|Micronutrients|micronutrients|mesh-ancestor
110254197|NCT05148910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110254199|NCT00148083|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110254200|NCT00148083|Serotonin Agents|serotonin agents|mesh-ancestor
110254201|NCT00148083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110254202|NCT00148083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110254203|NCT00148083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110254204|NCT00148083|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110254205|NCT00148083|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110254206|NCT00148083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110254207|NCT00148083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110254208|NCT00148083|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110254210|NCT05148403|Glyburide|glyburide|mesh-list
110254211|NCT05148403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110254212|NCT05148403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110254213|NCT05148208|Dialysis Solutions|dialysis solutions|mesh-list
110254214|NCT05148208|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110254215|NCT05148169|Sulforaphane|sulforaphane|mesh-list
110254216|NCT05148169|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
110254217|NCT05148169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110254218|NCT05148169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110254219|NCT05148169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110254220|NCT05148169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110254221|NCT05148169|Serotonin Agents|serotonin agents|mesh-ancestor
110254222|NCT05148169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110254223|NCT05148169|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110254224|NCT05148169|Protective Agents|protective agents|mesh-ancestor
110254225|NCT05148169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110254226|NCT00144482|Epoetin Alfa|epoetin alfa|mesh-list
110254227|NCT00144482|Hematinics|hematinics|mesh-ancestor
110254228|NCT05148754|Elsulfavirine|elsulfavirine|mesh-list
110254229|NCT05148754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110254230|NCT05148754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110254231|NCT05148754|Antiviral Agents|antiviral agents|mesh-ancestor
110254232|NCT05148754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110254233|NCT00404729|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
110254234|NCT00404729|Nootropic Agents|nootropic agents|mesh-ancestor
110254235|NCT05146687|Bevacizumab|bevacizumab|mesh-list
110254236|NCT05146687|Ranibizumab|ranibizumab|mesh-list
110254237|NCT05146687|Aflibercept|aflibercept|mesh-list
110254238|NCT05146687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110368707|NCT00558090|Morphine|morphine|mesh-list
110254239|NCT05146687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110254240|NCT05146687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110254241|NCT05146687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110254242|NCT05146687|Growth Substances|growth substances|mesh-ancestor
110254243|NCT05146687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110254244|NCT05146687|Growth Inhibitors|growth inhibitors|mesh-ancestor
110254245|NCT05141422|Efavirenz|efavirenz|mesh-list
110254246|NCT05141422|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110254247|NCT05141422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110254248|NCT05141422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110254249|NCT05141422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110254250|NCT05141422|Antiviral Agents|antiviral agents|mesh-ancestor
110254251|NCT05141422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110254252|NCT05141422|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110254253|NCT05141422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110254254|NCT05141422|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110254255|NCT05141422|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110254256|NCT05141422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110254257|NCT05141422|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110254259|NCT05148637|Fentanyl|fentanyl|mesh-list
110254260|NCT05148637|Anesthetics|anesthetics|mesh-list
110254261|NCT05148637|Sevoflurane|sevoflurane|mesh-list
110254262|NCT05148637|Desflurane|desflurane|mesh-list
110254263|NCT05148637|Anesthetics, Local|anesthetics, local|mesh-ancestor
110254264|NCT05148637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110254265|NCT05148637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110254266|NCT05148637|Sensory System Agents|sensory system agents|mesh-ancestor
110254267|NCT05148637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110254268|NCT05148637|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110254269|NCT05148637|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110254270|NCT05148637|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110254271|NCT05148637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110254272|NCT05148637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110254273|NCT05148637|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110254275|NCT05148637|Analgesics|analgesics|mesh-ancestor
110254276|NCT05148637|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110254277|NCT05148637|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110254278|NCT05148637|Anesthetics, General|anesthetics, general|mesh-ancestor
110254279|NCT05148637|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110254280|NCT05148637|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110254281|NCT00148278|Dobutamine|dobutamine|mesh-list
110254282|NCT00148278|Epinephrine|epinephrine|mesh-list
110254283|NCT00148278|Norepinephrine|norepinephrine|mesh-list
110254284|NCT00148278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110254285|NCT00148278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110254286|NCT00148278|Adrenergic Agents|adrenergic agents|mesh-ancestor
110254287|NCT00148278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110254288|NCT00148278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110254289|NCT00148278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110254290|NCT00148278|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110254291|NCT00148278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110254292|NCT00148278|Autonomic Agents|autonomic agents|mesh-ancestor
110254293|NCT00148278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110254294|NCT00148278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110254295|NCT00148278|Respiratory System Agents|respiratory system agents|mesh-ancestor
110254296|NCT00148278|Mydriatics|mydriatics|mesh-ancestor
110254297|NCT00148278|Sympathomimetics|sympathomimetics|mesh-ancestor
110254298|NCT00148278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110254299|NCT00148278|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110254300|NCT00148278|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110254301|NCT00148278|Protective Agents|protective agents|mesh-ancestor
110254302|NCT05594849|Budesonide|budesonide|mesh-list
110254303|NCT05594849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110254304|NCT05594849|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110254305|NCT05594849|Autonomic Agents|autonomic agents|mesh-ancestor
110254306|NCT05594849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110254307|NCT05594849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110254308|NCT05594849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110254309|NCT05594849|Respiratory System Agents|respiratory system agents|mesh-ancestor
110254311|NCT05594849|Hormones|hormones|mesh-ancestor
110368708|NCT00558090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110254312|NCT05594849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110254314|NCT00507247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110254315|NCT00507247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110254316|NCT00507286|Alprostadil|alprostadil|mesh-list
110254317|NCT00507286|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110254318|NCT00507286|Vasodilator Agents|vasodilator agents|mesh-ancestor
110254319|NCT00507286|Urological Agents|urological agents|mesh-ancestor
110254320|NCT05143762|Acetaminophen|acetaminophen|mesh-list
110254321|NCT05143762|Dexamethasone|dexamethasone|mesh-list
110254322|NCT05143762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110254323|NCT05143762|Antiemetics|antiemetics|mesh-ancestor
110254324|NCT05143762|Autonomic Agents|autonomic agents|mesh-ancestor
110254325|NCT05143762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110254326|NCT05143762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110254327|NCT05143762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110254328|NCT05143762|Glucocorticoids|glucocorticoids|mesh-ancestor
110254329|NCT05143762|Hormones|hormones|mesh-ancestor
110254330|NCT05143762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110254331|NCT05143762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110254332|NCT05143762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110254333|NCT05143762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110254334|NCT05143762|Analgesics|analgesics|mesh-ancestor
110254335|NCT05143762|Sensory System Agents|sensory system agents|mesh-ancestor
110254336|NCT05143762|Antipyretics|antipyretics|mesh-ancestor
110254337|NCT00148356|Paclitaxel|paclitaxel|mesh-list
110254338|NCT00148356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110254339|NCT00148356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110254341|NCT00148356|Antimitotic Agents|antimitotic agents|mesh-ancestor
110254342|NCT00148356|Mitosis Modulators|mitosis modulators|mesh-ancestor
110254343|NCT00148356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110254345|NCT00424281|Fondaparinux|fondaparinux|mesh-list
110254346|NCT00424281|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110254347|NCT00424281|Antithrombins|antithrombins|mesh-ancestor
110254348|NCT00424281|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110254349|NCT00424281|Protease Inhibitors|protease inhibitors|mesh-ancestor
110254350|NCT00424281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110254351|NCT00424281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110254352|NCT00424281|Anticoagulants|anticoagulants|mesh-ancestor
110254353|NCT00424281|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110254354|NCT00424281|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110254355|NCT00148395|Carboplatin|carboplatin|mesh-list
110254356|NCT00148395|Gemcitabine|gemcitabine|mesh-list
110254357|NCT00148395|Ifosfamide|ifosfamide|mesh-list
110254358|NCT00148395|Mitomycins|mitomycins|mesh-list
110254359|NCT00148395|Mitomycin|mitomycin|mesh-list
110254360|NCT00148395|Vinorelbine|vinorelbine|mesh-list
110254361|NCT00148395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110254362|NCT00148395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110254363|NCT00148395|Antimetabolites|antimetabolites|mesh-ancestor
110254364|NCT00148395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110254365|NCT00148395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110254366|NCT00148395|Alkylating Agents|alkylating agents|mesh-ancestor
110254367|NCT00148395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110254368|NCT00148395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110254369|NCT00148395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110254370|NCT00148395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110254371|NCT00148395|Tubulin Modulators|tubulin modulators|mesh-ancestor
110254372|NCT00148395|Antimitotic Agents|antimitotic agents|mesh-ancestor
110254374|NCT02276677|Oxytocin|oxytocin|mesh-list
110254375|NCT02276677|Oxytocics|oxytocics|mesh-ancestor
110254376|NCT02276677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110254377|NCT02276677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110254378|NCT05141344|Melatonin|melatonin|mesh-list
110254379|NCT05141344|Antioxidants|antioxidants|mesh-ancestor
110254380|NCT05141344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110254381|NCT05141344|Protective Agents|protective agents|mesh-ancestor
110254382|NCT05141344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110254383|NCT05141344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110254384|NCT00156858|Busulfan|busulfan|mesh-list
110254385|NCT00156858|Alkylating Agents|alkylating agents|mesh-ancestor
110254386|NCT00156858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110254387|NCT00156858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110254388|NCT00156858|Immunologic Factors|immunologic factors|mesh-ancestor
110254389|NCT00156858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110254390|NCT00156858|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110254391|NCT00156858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110254392|NCT00156858|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110254393|NCT03451825|Avelumab|avelumab|mesh-list
110254395|NCT03451825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110254396|NCT03451825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110254397|NCT03451825|Immunologic Factors|immunologic factors|mesh-ancestor
110254398|NCT03451825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110254399|NCT00156897|Orlistat|orlistat|mesh-list
110254400|NCT00156897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110254401|NCT00156897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110254402|NCT00156897|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110254403|NCT00156897|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110254404|NCT03459859|Cytarabine|cytarabine|mesh-list
110254405|NCT03459859|Pevonedistat|pevonedistat|mesh-list
110254406|NCT03459859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110254407|NCT03459859|Antimetabolites|antimetabolites|mesh-ancestor
110254408|NCT03459859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110254409|NCT03459859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110254410|NCT03459859|Antiviral Agents|antiviral agents|mesh-ancestor
110254411|NCT03459859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110254412|NCT03459859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110254413|NCT03459859|Immunologic Factors|immunologic factors|mesh-ancestor
110254414|NCT03459859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110254415|NCT03459859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110254416|NCT05594459|Analgesics|analgesics|mesh-list
110254417|NCT05594459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110254418|NCT05594459|Sensory System Agents|sensory system agents|mesh-ancestor
110254419|NCT05594459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110254420|NCT00507403|Infliximab|infliximab|mesh-list
110254421|NCT00507403|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110254422|NCT00507403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110254423|NCT00507403|Dermatologic Agents|dermatologic agents|mesh-ancestor
110254424|NCT00507403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110254425|NCT00507403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110254427|NCT00156975|Oxaliplatin|oxaliplatin|mesh-list
110254428|NCT00156975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110254429|NCT00156975|Antimetabolites|antimetabolites|mesh-ancestor
110254430|NCT00156975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110254431|NCT00156975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110254432|NCT05594381|Oxaliplatin|oxaliplatin|mesh-list
110254433|NCT05594381|Tegafur|tegafur|mesh-list
110254434|NCT05594381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110254435|NCT05594381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110254436|NCT05594381|Antimetabolites|antimetabolites|mesh-ancestor
110254437|NCT05594381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110254438|NCT00148473|Misoprostol|misoprostol|mesh-list
110254439|NCT00148473|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110254440|NCT00148473|Abortifacient Agents|abortifacient agents|mesh-ancestor
110254441|NCT00148473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110254442|NCT00148473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110254443|NCT00148473|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110254444|NCT00148473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110254445|NCT00148473|Oxytocics|oxytocics|mesh-ancestor
110254446|NCT00507637|Botulinum Toxins|botulinum toxins|mesh-list
110254447|NCT00507637|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110254448|NCT00507637|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110254449|NCT00507637|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
110254450|NCT00507637|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110254451|NCT00507637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110254452|NCT00507637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110254453|NCT00507637|Cholinergic Agents|cholinergic agents|mesh-ancestor
110254454|NCT00507637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110254455|NCT00507637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110254456|NCT00507637|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110254457|NCT00507637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110254459|NCT05594342|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110254460|NCT05594342|Sympathomimetics|sympathomimetics|mesh-ancestor
110254461|NCT05594342|Autonomic Agents|autonomic agents|mesh-ancestor
110254462|NCT05594342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110254463|NCT05594342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110254464|NCT05594342|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110254465|NCT05594342|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110254466|NCT05594342|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110254467|NCT05594342|Adrenergic Agents|adrenergic agents|mesh-ancestor
110254468|NCT05594342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110254469|NCT05594342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110254470|NCT05594342|Protective Agents|protective agents|mesh-ancestor
110254471|NCT00157053|Factor VIII|factor viii|mesh-list
110254472|NCT00157053|Coagulants|coagulants|mesh-ancestor
110254473|NCT00507793|Cyclosporine|cyclosporine|mesh-list
110254474|NCT00507793|Sirolimus|sirolimus|mesh-list
110254475|NCT00507793|Cyclosporins|cyclosporins|mesh-list
110254476|NCT00507793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110260209|NCT00530413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110254477|NCT00507793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110254478|NCT00507793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110254479|NCT00507793|Immunologic Factors|immunologic factors|mesh-ancestor
110254480|NCT00507793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110254482|NCT00507793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110254483|NCT00507793|Dermatologic Agents|dermatologic agents|mesh-ancestor
110254484|NCT00507793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110254485|NCT00507793|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110254486|NCT00507793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110254487|NCT00507793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110254488|NCT00507793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110254489|NCT00507832|Hydrocortisone|hydrocortisone|mesh-list
110254490|NCT00507832|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110254491|NCT00507832|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110254492|NCT00507832|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110254493|NCT00507832|Pimecrolimus|pimecrolimus|mesh-list
110254494|NCT00507832|Tacrolimus|tacrolimus|mesh-list
110254495|NCT00507832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110254496|NCT00507832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110254497|NCT00507832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110254498|NCT00507832|Analgesics|analgesics|mesh-ancestor
110254499|NCT00507832|Sensory System Agents|sensory system agents|mesh-ancestor
110254500|NCT00507832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110254501|NCT00507832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110254502|NCT00507832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110254503|NCT00507832|Dermatologic Agents|dermatologic agents|mesh-ancestor
110254504|NCT00507832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110254505|NCT00507832|Immunologic Factors|immunologic factors|mesh-ancestor
110254506|NCT00507832|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110254507|NCT00507832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110254508|NCT00507832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110254509|NCT00507949|Megestrol|megestrol|mesh-list
110254510|NCT00507949|Megestrol Acetate|megestrol acetate|mesh-list
110254511|NCT00507949|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110254512|NCT00507949|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110254513|NCT00507949|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110254514|NCT00507949|Contraceptive Agents|contraceptive agents|mesh-ancestor
110254515|NCT00507949|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110254516|NCT00507949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110254517|NCT00507949|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110254518|NCT00507949|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110254519|NCT00507949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110254520|NCT00507949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110254521|NCT00507949|Appetite Stimulants|appetite stimulants|mesh-ancestor
110254522|NCT00507949|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110254523|NCT00148551|Triamcinolone|triamcinolone|mesh-list
110254524|NCT00148551|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110254525|NCT00148551|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110254526|NCT00148551|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110254527|NCT00148551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110254528|NCT00148551|Glucocorticoids|glucocorticoids|mesh-ancestor
110254530|NCT00148551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110254531|NCT00148551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110254532|NCT00148551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110254533|NCT00148551|Immunologic Factors|immunologic factors|mesh-ancestor
110254534|NCT00148551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110254535|NCT00148551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110254536|NCT05594186|Tranexamic Acid|tranexamic acid|mesh-list
110254537|NCT05594186|Contraceptive Agents|contraceptive agents|mesh-list
110254538|NCT05594186|Levonorgestrel|levonorgestrel|mesh-list
110254539|NCT05594186|Contraceptives, Oral|contraceptives, oral|mesh-list
110254540|NCT05594186|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
110254541|NCT05594186|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110254542|NCT05594186|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110254543|NCT05594186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110254546|NCT05594186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110254547|NCT05594186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110254548|NCT05594186|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110254549|NCT05594186|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110254550|NCT05594186|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110254551|NCT00157092|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
110254552|NCT00157092|Protein C Inhibitor|protein c inhibitor|mesh-list
110035830|NCT01407237|Angiotensin II|angiotensin ii|mesh-list
110254553|NCT00157092|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110254554|NCT00157092|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110254555|NCT00157092|Protease Inhibitors|protease inhibitors|mesh-ancestor
110254556|NCT00157092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110254557|NCT00157092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110254558|NCT00148590|Memantine|memantine|mesh-list
110254559|NCT00148590|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110254560|NCT00148590|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110254561|NCT00148590|Dopamine Agents|dopamine agents|mesh-ancestor
110254562|NCT00148590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110254563|NCT00148590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110254564|NCT00148590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110254565|NCT00148590|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110254566|NCT00148590|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110254567|NCT02954068|Oxytocin|oxytocin|mesh-list
110254568|NCT02954068|Oxytocics|oxytocics|mesh-ancestor
110254569|NCT02954068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110254570|NCT02954068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110254571|NCT00157131|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110254572|NCT00157131|Hemostatics|hemostatics|mesh-ancestor
110254573|NCT00157131|Coagulants|coagulants|mesh-ancestor
110254574|NCT02954029|Hemostatics|hemostatics|mesh-list
110254575|NCT02954029|Coagulants|coagulants|mesh-ancestor
110254576|NCT00508456|Temozolomide|temozolomide|mesh-list
110254577|NCT00508456|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110254578|NCT00508456|Alkylating Agents|alkylating agents|mesh-ancestor
110254579|NCT00508456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110254580|NCT00508456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110254581|NCT00508495|Acetaminophen|acetaminophen|mesh-list
110254582|NCT00508495|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110254583|NCT00508495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110254584|NCT00508495|Analgesics|analgesics|mesh-ancestor
110254585|NCT00508495|Sensory System Agents|sensory system agents|mesh-ancestor
110254586|NCT00508495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110254587|NCT00508495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110254588|NCT00508495|Antipyretics|antipyretics|mesh-ancestor
110254589|NCT00508690|Metronidazole|metronidazole|mesh-list
110254591|NCT00508690|Cefmetazole|cefmetazole|mesh-list
110254592|NCT00508690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110254593|NCT00508690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110254594|NCT00508690|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110254595|NCT00508690|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110254596|NCT00508690|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110254597|NCT00508690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110254598|NCT00508690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110254599|NCT00148707|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
110254600|NCT00148707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110254601|NCT02953522|Folic Acid|folic acid|mesh-list
110254602|NCT02953522|Vitamin B Complex|vitamin b complex|mesh-list
110254603|NCT02953522|Hematinics|hematinics|mesh-ancestor
110254604|NCT02953522|Vitamins|vitamins|mesh-ancestor
110254605|NCT02953522|Micronutrients|micronutrients|mesh-ancestor
110254606|NCT02953522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110254607|NCT00148746|Cyclosporine|cyclosporine|mesh-list
110254608|NCT00148746|Prednisolone|prednisolone|mesh-list
110254609|NCT00148746|Pimecrolimus|pimecrolimus|mesh-list
110254610|NCT00148746|Prednicarbate|prednicarbate|mesh-list
110254611|NCT00148746|Tacrolimus|tacrolimus|mesh-list
110254612|NCT00148746|Cyclosporins|cyclosporins|mesh-list
110254613|NCT00148746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110254614|NCT00148746|Immunologic Factors|immunologic factors|mesh-ancestor
110254615|NCT00148746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110254616|NCT00148746|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110254617|NCT00148746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110254618|NCT00148746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110254619|NCT00148746|Antifungal Agents|antifungal agents|mesh-ancestor
110254620|NCT00148746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110254621|NCT00148746|Dermatologic Agents|dermatologic agents|mesh-ancestor
110254622|NCT00148746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110254623|NCT00148746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110254624|NCT00148746|Glucocorticoids|glucocorticoids|mesh-ancestor
110254626|NCT00148746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110254627|NCT00148746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110254628|NCT00148746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110254629|NCT00148746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110254630|NCT00148746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110254631|NCT00148746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110254633|NCT00148746|Sensory System Agents|sensory system agents|mesh-ancestor
110254634|NCT00148785|Ritonavir|ritonavir|mesh-list
110254635|NCT00148785|Indinavir|indinavir|mesh-list
110254636|NCT00148785|Fosamprenavir|fosamprenavir|mesh-list
110254637|NCT00148785|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110254638|NCT00148785|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110254639|NCT00148785|Protease Inhibitors|protease inhibitors|mesh-ancestor
110254640|NCT00148785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110254641|NCT00148785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110254643|NCT00148785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110254644|NCT00148785|Antiviral Agents|antiviral agents|mesh-ancestor
110254645|NCT00148785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110254646|NCT00148785|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110254647|NCT00148785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110254648|NCT00148824|Vaccines|vaccines|mesh-list
110254649|NCT00148824|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110254650|NCT00148824|Immunologic Factors|immunologic factors|mesh-ancestor
110254651|NCT00148824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110254652|NCT00466570|Moxifloxacin|moxifloxacin|mesh-list
110254653|NCT00466570|Gatifloxacin|gatifloxacin|mesh-list
110254654|NCT00466570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110254655|NCT00466570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110254656|NCT00466570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110254657|NCT00466570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110254658|NCT00466570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110254659|NCT00466570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110254660|NCT00466570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110254661|NCT00466570|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110254662|NCT00466570|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110254663|NCT00466609|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110254664|NCT00466609|Fluoxetine|fluoxetine|mesh-list
110254665|NCT00466609|Clomipramine|clomipramine|mesh-list
110254666|NCT00466609|Antidepressive Agents|antidepressive agents|mesh-ancestor
110254667|NCT00466609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110254668|NCT00466609|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110254669|NCT00466609|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110254670|NCT00466609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110254671|NCT00466609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110254672|NCT00466609|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110254673|NCT00466609|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110254674|NCT00466609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110254675|NCT00466609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110254676|NCT00466609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110254677|NCT00466609|Serotonin Agents|serotonin agents|mesh-ancestor
110254678|NCT00466609|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110254679|NCT00466609|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110254680|NCT00466609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110254681|NCT00466609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110254682|NCT00466609|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110254684|NCT00157326|Vasodilator Agents|vasodilator agents|mesh-ancestor
110254685|NCT00157326|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110254686|NCT00157326|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110254687|NCT00157326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110254688|NCT00157326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110254689|NCT00157326|Urological Agents|urological agents|mesh-ancestor
110254690|NCT00466843|Prednisone|prednisone|mesh-list
110254691|NCT00466843|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110254692|NCT00466843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110254693|NCT00466843|Glucocorticoids|glucocorticoids|mesh-ancestor
110254694|NCT00466843|Hormones|hormones|mesh-ancestor
110254695|NCT00466843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110254696|NCT00466843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110254697|NCT00466843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110254698|NCT00466843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110254699|NCT00466843|Immunologic Factors|immunologic factors|mesh-ancestor
110254700|NCT00466843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110254701|NCT00148863|Interferons|interferons|mesh-list
110254702|NCT00148863|Ribavirin|ribavirin|mesh-list
110254703|NCT00148863|Interferon-alpha|interferon-alpha|mesh-list
110254704|NCT00148863|Interferon alpha-2|interferon alpha-2|mesh-list
110254705|NCT00148863|Interferon-gamma|interferon-gamma|mesh-list
110254706|NCT00148863|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110254707|NCT00148863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110254708|NCT00148863|Antiviral Agents|antiviral agents|mesh-ancestor
110254709|NCT00148863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110254710|NCT00148863|Antimetabolites|antimetabolites|mesh-ancestor
110254711|NCT00148863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110254712|NCT00148863|Immunologic Factors|immunologic factors|mesh-ancestor
110254713|NCT00148863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110254715|NCT00466999|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110254716|NCT00466999|Abortifacient Agents|abortifacient agents|mesh-ancestor
110254717|NCT00466999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110254718|NCT00466999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110254719|NCT00466999|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110254720|NCT00466999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110254721|NCT00466999|Oxytocics|oxytocics|mesh-ancestor
110254723|NCT00467116|Cetuximab|cetuximab|mesh-list
110254724|NCT00467116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110254725|NCT00467116|Antimetabolites|antimetabolites|mesh-ancestor
110254726|NCT00467116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110254727|NCT00467116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110254728|NCT00467116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110254729|NCT00157482|Simvastatin|simvastatin|mesh-list
110254730|NCT00157482|Ezetimibe|ezetimibe|mesh-list
110254731|NCT00157482|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110254732|NCT00157482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110254733|NCT00157482|Antimetabolites|antimetabolites|mesh-ancestor
110254734|NCT00157482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110254735|NCT00157482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110254736|NCT00157482|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110254737|NCT00157482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110254738|NCT00467194|Sirolimus|sirolimus|mesh-list
110254739|NCT00467194|Bevacizumab|bevacizumab|mesh-list
110254740|NCT00467194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110254741|NCT00467194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110254742|NCT00467194|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110254743|NCT00467194|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110254744|NCT00467194|Growth Substances|growth substances|mesh-ancestor
110254745|NCT00467194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110254746|NCT00467194|Growth Inhibitors|growth inhibitors|mesh-ancestor
110270516|NCT05077969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110254747|NCT00467194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110254748|NCT00467194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110254749|NCT00467194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110254751|NCT00467194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110254752|NCT00467194|Immunologic Factors|immunologic factors|mesh-ancestor
110254753|NCT00148902|Docetaxel|docetaxel|mesh-list
110254754|NCT00148902|Lapatinib|lapatinib|mesh-list
110254755|NCT00148902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110254756|NCT00148902|Tubulin Modulators|tubulin modulators|mesh-ancestor
110254757|NCT00148902|Antimitotic Agents|antimitotic agents|mesh-ancestor
110254758|NCT00148902|Mitosis Modulators|mitosis modulators|mesh-ancestor
110254759|NCT00148902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110254760|NCT00148902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110254761|NCT00148902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110254762|NCT05507645|Saruplase|saruplase|mesh-list
110254763|NCT05507645|Anticoagulants|anticoagulants|mesh-list
110254764|NCT05507645|Clopidogrel|clopidogrel|mesh-list
110368709|NCT00558090|Narcotics|narcotics|mesh-ancestor
110254765|NCT05507645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110254766|NCT05507645|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110254767|NCT05507645|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110254768|NCT05507645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110254769|NCT05507645|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110254770|NCT05507645|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110254771|NCT05507645|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110254772|NCT05507645|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110254773|NCT05507645|Purinergic Agents|purinergic agents|mesh-ancestor
110254774|NCT05507645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110254775|NCT03271918|Cabergoline|cabergoline|mesh-list
110254776|NCT03271918|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110254777|NCT03271918|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110254778|NCT03271918|Dopamine Agonists|dopamine agonists|mesh-ancestor
110254779|NCT03271918|Dopamine Agents|dopamine agents|mesh-ancestor
110254780|NCT03271918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110254781|NCT03271918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110254782|NCT03271918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110254783|NCT00467467|Alfuzosin|alfuzosin|mesh-list
110254784|NCT00467467|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110254785|NCT00467467|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110254786|NCT00467467|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110254787|NCT00467467|Adrenergic Agents|adrenergic agents|mesh-ancestor
110254788|NCT00467467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110254789|NCT00467467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110254790|NCT00467467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110254791|NCT00467467|Urological Agents|urological agents|mesh-ancestor
110254792|NCT00406887|Difluprednate|difluprednate|mesh-list
110254793|NCT00406887|Glucocorticoids|glucocorticoids|mesh-ancestor
110254794|NCT00406887|Hormones|hormones|mesh-ancestor
110254795|NCT00406887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110254796|NCT00406887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110254797|NCT00467506|Antibodies|antibodies|mesh-list
110254798|NCT00467506|Antibodies, Bispecific|antibodies, bispecific|mesh-list
110254799|NCT00467506|Immunologic Factors|immunologic factors|mesh-ancestor
110254800|NCT00467506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110254801|NCT00467545|Telbivudine|telbivudine|mesh-list
110254802|NCT00467545|Antiviral Agents|antiviral agents|mesh-ancestor
110254803|NCT00467545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110254804|NCT00467545|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110254805|NCT00467545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110254806|NCT00467545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110254807|NCT00467662|Acyclovir|acyclovir|mesh-list
110254808|NCT00467662|Docosanol|docosanol|mesh-list
110254810|NCT00467662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110254811|NCT05497310|Tretinoin|tretinoin|mesh-list
110254812|NCT05497310|Arsenic Trioxide|arsenic trioxide|mesh-list
110254813|NCT05497310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110254814|NCT05497310|Keratolytic Agents|keratolytic agents|mesh-ancestor
110254815|NCT05497310|Dermatologic Agents|dermatologic agents|mesh-ancestor
110254816|NCT00467935|Ranibizumab|ranibizumab|mesh-list
110254817|NCT00467935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110254818|NCT00467935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110254819|NCT00467935|Growth Substances|growth substances|mesh-ancestor
110254820|NCT00467935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110254821|NCT00467935|Growth Inhibitors|growth inhibitors|mesh-ancestor
110254822|NCT00467935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110254823|NCT00149019|Antibodies|antibodies|mesh-list
110254824|NCT00149019|Antibodies, Bispecific|antibodies, bispecific|mesh-list
110254825|NCT00149019|Immunologic Factors|immunologic factors|mesh-ancestor
110254826|NCT00149019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110254827|NCT00468091|Atropine|atropine|mesh-list
110254828|NCT00468091|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110254829|NCT00468091|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110254830|NCT00468091|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110254831|NCT00468091|Autonomic Agents|autonomic agents|mesh-ancestor
110254832|NCT00468091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110254833|NCT00468091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110254834|NCT00468091|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110254835|NCT00468091|Respiratory System Agents|respiratory system agents|mesh-ancestor
110254836|NCT00468091|Mydriatics|mydriatics|mesh-ancestor
110254837|NCT00468091|Parasympatholytics|parasympatholytics|mesh-ancestor
110254838|NCT00468091|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110254839|NCT00468091|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110254840|NCT00468091|Cholinergic Agents|cholinergic agents|mesh-ancestor
110254841|NCT00468091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110254842|NCT00468091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110254844|NCT00468364|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110254845|NCT00468364|Insulin Glargine|insulin glargine|mesh-list
110254846|NCT00468364|Insulin, Isophane|insulin, isophane|mesh-list
110254847|NCT00468364|Isophane Insulin, Human|isophane insulin, human|mesh-list
110254848|NCT00468364|Isophane insulin, beef|isophane insulin, beef|mesh-list
110254849|NCT00468364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110254850|NCT00468364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110254851|NCT00149058|Epoetin Alfa|epoetin alfa|mesh-list
110254852|NCT00149058|Hematinics|hematinics|mesh-ancestor
110254853|NCT00468520|Oxytocin|oxytocin|mesh-list
110254854|NCT00468520|Oxytocics|oxytocics|mesh-ancestor
110254855|NCT00468520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110254856|NCT00468520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110254857|NCT03271450|Warfarin|warfarin|mesh-list
110254858|NCT03271450|Rivaroxaban|rivaroxaban|mesh-list
110254859|NCT03271450|Dabigatran|dabigatran|mesh-list
110254860|NCT03271450|Apixaban|apixaban|mesh-list
110254861|NCT03271450|Edoxaban|edoxaban|mesh-list
110254862|NCT03271450|Anticoagulants|anticoagulants|mesh-ancestor
110254863|NCT03271450|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110254864|NCT03271450|Antithrombins|antithrombins|mesh-ancestor
110254865|NCT03271450|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110254866|NCT03271450|Protease Inhibitors|protease inhibitors|mesh-ancestor
110254867|NCT03271450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110254868|NCT03271450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110254869|NCT00468754|Insulin|insulin|mesh-list
110254870|NCT00468754|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110254871|NCT00468754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110254872|NCT00468871|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
110254873|NCT00468871|Immunosuppressive Agents|immunosuppressive agents|mesh-list
110254874|NCT00468871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110254875|NCT00468871|Glucocorticoids|glucocorticoids|mesh-ancestor
110254876|NCT00468871|Hormones|hormones|mesh-ancestor
110254877|NCT00468871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110254878|NCT00468871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110254879|NCT00468871|Immunologic Factors|immunologic factors|mesh-ancestor
110254880|NCT00468988|Travoprost|travoprost|mesh-list
110254881|NCT00468988|Latanoprost|latanoprost|mesh-list
110254882|NCT00468988|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110254883|NCT00468988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110254884|NCT00468988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110254885|NCT00149136|Imatinib Mesylate|imatinib mesylate|mesh-list
110254886|NCT00149136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110254888|NCT00149136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110254889|NCT00149136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110254890|NCT00469261|Doxycycline|doxycycline|mesh-list
110254891|NCT00469261|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110254893|NCT00469261|Antimalarials|antimalarials|mesh-ancestor
110254894|NCT00469261|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110254895|NCT00469261|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110254896|NCT00469300|Acyclovir|acyclovir|mesh-list
110254897|NCT00469300|Antiviral Agents|antiviral agents|mesh-ancestor
110254898|NCT00469300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110254899|NCT04697641|Amoxicillin|amoxicillin|mesh-list
110254900|NCT04697641|Clarithromycin|clarithromycin|mesh-list
110254901|NCT04697641|Pantoprazole|pantoprazole|mesh-list
110254902|NCT04697641|Z 338|z 338|mesh-list
110254903|NCT04697641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110254904|NCT04697641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110254905|NCT04697641|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110254906|NCT04697641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110254907|NCT04697641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110254908|NCT04697641|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110254909|NCT04697641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110254910|NCT04697641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110254911|NCT04697641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110254912|NCT04697641|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110254913|NCT04697641|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110254914|NCT04697641|Cholinergic Agents|cholinergic agents|mesh-ancestor
110254915|NCT04697641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110254916|NCT04697641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110254917|NCT00469417|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110254918|NCT00469417|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
110254919|NCT00469417|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110254920|NCT00469417|Dermatologic Agents|dermatologic agents|mesh-ancestor
110254921|NCT00469495|Anthelmintics|anthelmintics|mesh-list
110254922|NCT00469495|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110254923|NCT00469495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110254924|NCT00469651|Vaccines|vaccines|mesh-list
110254925|NCT00469651|Immunologic Factors|immunologic factors|mesh-ancestor
110254926|NCT00469651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110254927|NCT00149253|Etoricoxib|etoricoxib|mesh-list
110254928|NCT00149253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110270563|NCT00409695|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110254929|NCT00149253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110254930|NCT00149253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110254931|NCT00149253|Analgesics|analgesics|mesh-ancestor
110254932|NCT00149253|Sensory System Agents|sensory system agents|mesh-ancestor
110254933|NCT00149253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110254934|NCT00149253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110254935|NCT00149253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110254936|NCT00149253|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110254937|NCT00149253|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110254938|NCT00149253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110254939|NCT00149253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110254940|NCT00469690|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110254941|NCT00469690|Bromfenac|bromfenac|mesh-list
110254942|NCT00469690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110254943|NCT00469690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110254944|NCT00469690|Analgesics|analgesics|mesh-ancestor
110254945|NCT00469690|Sensory System Agents|sensory system agents|mesh-ancestor
110254946|NCT00469690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110254947|NCT00469690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110254948|NCT00469690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110029840|NCT03011021|Liraglutide|liraglutide|mesh-list
110254949|NCT00469690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110254950|NCT00469690|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110254951|NCT00469690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110254952|NCT00469690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110254955|NCT00469768|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110254956|NCT00469768|Antiviral Agents|antiviral agents|mesh-ancestor
110254957|NCT00469768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110254958|NCT00469885|Nicotine|nicotine|mesh-list
110254959|NCT00469885|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110254960|NCT00469885|Autonomic Agents|autonomic agents|mesh-ancestor
110254961|NCT00469885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110254962|NCT00469885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110254963|NCT00469885|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110254964|NCT00469885|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110254965|NCT00469885|Cholinergic Agents|cholinergic agents|mesh-ancestor
110254966|NCT00469885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110254967|NCT00469885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110254968|NCT00469924|Caffeine|caffeine|mesh-list
110254969|NCT00469924|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110254970|NCT00469924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110254971|NCT00469924|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110254972|NCT00469924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110254973|NCT00469924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110254974|NCT00469924|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110254975|NCT00469924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110254976|NCT00469924|Purinergic Agents|purinergic agents|mesh-ancestor
110254977|NCT00469924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110254978|NCT00157677|Fibrin fragment D|fibrin fragment d|mesh-list
110254979|NCT00157677|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110254980|NCT00157677|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110254981|NCT00157677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110254982|NCT00157677|Hemostatics|hemostatics|mesh-ancestor
110254983|NCT00157677|Coagulants|coagulants|mesh-ancestor
110254984|NCT00470041|Lamivudine|lamivudine|mesh-list
110254985|NCT00470041|Zidovudine|zidovudine|mesh-list
110254987|NCT00470041|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110254988|NCT00470041|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110254989|NCT00470041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110254990|NCT00470041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110254991|NCT00470041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110254992|NCT00470041|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110254993|NCT00470041|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110254995|NCT00157716|Pyridoxal|pyridoxal|mesh-list
110254996|NCT00157716|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
110254997|NCT00157716|Vitamin B Complex|vitamin b complex|mesh-ancestor
110254998|NCT00157716|Vitamins|vitamins|mesh-ancestor
110254999|NCT00157716|Micronutrients|micronutrients|mesh-ancestor
110255000|NCT00157716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110255002|NCT00470197|Mitoxantrone|mitoxantrone|mesh-list
110255003|NCT00470197|Alvocidib|alvocidib|mesh-list
110255004|NCT00470197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110255005|NCT00470197|Antimetabolites|antimetabolites|mesh-ancestor
110255006|NCT00470197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110255007|NCT00470197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110255008|NCT00470197|Antiviral Agents|antiviral agents|mesh-ancestor
110255009|NCT00470197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110255010|NCT00470197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110255011|NCT00470197|Immunologic Factors|immunologic factors|mesh-ancestor
110255012|NCT00470197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110255013|NCT00470197|Analgesics|analgesics|mesh-ancestor
110255014|NCT00470197|Sensory System Agents|sensory system agents|mesh-ancestor
110255015|NCT00470197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110255016|NCT00470197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110255017|NCT00470197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110255018|NCT00470197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110255019|NCT00470197|Growth Inhibitors|growth inhibitors|mesh-ancestor
110255020|NCT00470197|Growth Substances|growth substances|mesh-ancestor
110255021|NCT00470197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110255022|NCT00470314|N-Methylaspartate|n-methylaspartate|mesh-list
110255023|NCT00470314|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
110255024|NCT00470314|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110255025|NCT00470314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110255026|NCT00470314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110255027|NCT00470314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110255028|NCT00149292|Olanzapine|olanzapine|mesh-list
110255029|NCT00149292|Antiemetics|antiemetics|mesh-ancestor
110255030|NCT00149292|Autonomic Agents|autonomic agents|mesh-ancestor
110255031|NCT00149292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110255032|NCT00149292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110255033|NCT00149292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110255034|NCT00149292|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110255035|NCT00149292|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110255036|NCT00149292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110255037|NCT00149292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110255038|NCT00149292|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110255039|NCT00149292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110255040|NCT00149292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110255041|NCT00149292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110255042|NCT00149292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110255043|NCT00149292|Serotonin Agents|serotonin agents|mesh-ancestor
110255044|NCT05391893|Diltiazem|diltiazem|mesh-list
110255045|NCT05391893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110255046|NCT05391893|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110255047|NCT05391893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110255048|NCT05391893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110255049|NCT05391893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110255050|NCT05391893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110255052|NCT00470509|Adalimumab|adalimumab|mesh-list
110255053|NCT00470509|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110255054|NCT00470509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110255055|NCT00470509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110255056|NCT05378906|Darunavir|darunavir|mesh-list
110255057|NCT05378906|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110255058|NCT05378906|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110255059|NCT05378906|Protease Inhibitors|protease inhibitors|mesh-ancestor
110255060|NCT05378906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110255061|NCT05378906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110255063|NCT05378906|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110255064|NCT05378906|Antiviral Agents|antiviral agents|mesh-ancestor
110255065|NCT05378906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110255067|NCT00470665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110255068|NCT00470665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110255069|NCT00470665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110255070|NCT00470665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110255071|NCT00470665|Antifungal Agents|antifungal agents|mesh-ancestor
110255072|NCT00470665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110255073|NCT00470665|Immunologic Factors|immunologic factors|mesh-ancestor
110255074|NCT00470665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110255075|NCT00470743|Ibuprofen|ibuprofen|mesh-list
110255077|NCT00470743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110255078|NCT00470743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110255080|NCT00470743|Sensory System Agents|sensory system agents|mesh-ancestor
110255081|NCT00470743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110255082|NCT00470743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110255083|NCT00470743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110255084|NCT00470743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110255085|NCT00470743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110255086|NCT00470743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110255087|NCT00470743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110255088|NCT00470743|Gout Suppressants|gout suppressants|mesh-ancestor
110255089|NCT00470743|Tocolytic Agents|tocolytic agents|mesh-ancestor
110255090|NCT00470743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110255091|NCT00470821|Melatonin|melatonin|mesh-list
110255092|NCT00470821|Antioxidants|antioxidants|mesh-ancestor
110255093|NCT00470821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110255094|NCT00470821|Protective Agents|protective agents|mesh-ancestor
110255095|NCT00470821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110255096|NCT00470821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110255097|NCT00335920|Dexamethasone|dexamethasone|mesh-list
110030289|NCT01385124|Anticonvulsants|anticonvulsants|mesh-ancestor
110255098|NCT00335920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110255099|NCT00335920|Antiemetics|antiemetics|mesh-ancestor
110255100|NCT00335920|Autonomic Agents|autonomic agents|mesh-ancestor
110255101|NCT00335920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110255102|NCT00335920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110255103|NCT00335920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110255104|NCT00335920|Glucocorticoids|glucocorticoids|mesh-ancestor
110255105|NCT00335920|Hormones|hormones|mesh-ancestor
110255106|NCT00335920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110255107|NCT00335920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110255108|NCT00335920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110255109|NCT00335998|Cisplatin|cisplatin|mesh-list
110255110|NCT00335998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110255111|NCT00470977|Ranibizumab|ranibizumab|mesh-list
110270602|NCT00193674|Dydrogesterone|dydrogesterone|mesh-list
110255112|NCT00470977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110255113|NCT00470977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110255114|NCT00470977|Growth Substances|growth substances|mesh-ancestor
110255115|NCT00470977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110255116|NCT00470977|Growth Inhibitors|growth inhibitors|mesh-ancestor
110255117|NCT00470977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110255119|NCT05350592|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110255120|NCT05350592|Sympathomimetics|sympathomimetics|mesh-ancestor
110255121|NCT05350592|Autonomic Agents|autonomic agents|mesh-ancestor
110255122|NCT05350592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110255123|NCT05350592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110255124|NCT05350592|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110255125|NCT05350592|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110255126|NCT05350592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110255127|NCT05350592|Adrenergic Agents|adrenergic agents|mesh-ancestor
110255128|NCT05350592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110255129|NCT05350592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110255130|NCT05350592|Protective Agents|protective agents|mesh-ancestor
110255131|NCT00471055|Capsaicin|capsaicin|mesh-list
110255132|NCT00471055|Antipruritics|antipruritics|mesh-ancestor
110255133|NCT00471055|Dermatologic Agents|dermatologic agents|mesh-ancestor
110255134|NCT00471055|Sensory System Agents|sensory system agents|mesh-ancestor
110255135|NCT00471055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110255136|NCT00471055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110255137|NCT00471094|Lansoprazole|lansoprazole|mesh-list
110255138|NCT00471094|Dexlansoprazole|dexlansoprazole|mesh-list
110255139|NCT00471094|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110255140|NCT00471094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110255141|NCT00471094|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110255142|NCT00471094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110368710|NCT00558090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110255143|NCT00471094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110255146|NCT00157872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110255147|NCT00157872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110255148|NCT00157872|Analgesics|analgesics|mesh-ancestor
110255149|NCT00157872|Sensory System Agents|sensory system agents|mesh-ancestor
110255150|NCT00157872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110255151|NCT00157872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110255152|NCT00157872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110255153|NCT00157872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110255154|NCT00157872|Gout Suppressants|gout suppressants|mesh-ancestor
110255155|NCT00157872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110255156|NCT00157872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110255157|NCT00157872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110255158|NCT00157872|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110255159|NCT03271255|Bevacizumab|bevacizumab|mesh-list
110255160|NCT03271255|Apatinib|apatinib|mesh-list
110255161|NCT03271255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110255162|NCT03271255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110255163|NCT03271255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110255164|NCT03271255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110255165|NCT03271255|Growth Substances|growth substances|mesh-ancestor
110255166|NCT03271255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110255167|NCT03271255|Growth Inhibitors|growth inhibitors|mesh-ancestor
110255168|NCT03271255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110255169|NCT03271255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110255170|NCT03271255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110255171|NCT00471289|Paclitaxel|paclitaxel|mesh-list
110255172|NCT00471289|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110270619|NCT00193869|Dexamethasone|dexamethasone|mesh-list
110255173|NCT00471289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110255174|NCT00471289|Tubulin Modulators|tubulin modulators|mesh-ancestor
110255175|NCT00471289|Antimitotic Agents|antimitotic agents|mesh-ancestor
110255176|NCT00471289|Mitosis Modulators|mitosis modulators|mesh-ancestor
110255177|NCT00471289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110255179|NCT00336154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110255180|NCT00336154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110255181|NCT00336154|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110255182|NCT00336154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110255183|NCT00336154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110255185|NCT00158028|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110255186|NCT00158028|Serotonin Agents|serotonin agents|mesh-ancestor
110255187|NCT00158028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110030435|NCT01386268|Factor VIII|factor viii|mesh-list
110255188|NCT00158028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110255189|NCT00158028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110255190|NCT00158028|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110255191|NCT00158028|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110255192|NCT00158028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110255193|NCT00158028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110255194|NCT00158028|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110255195|NCT00158028|Dopamine Agents|dopamine agents|mesh-ancestor
110255196|NCT00471406|Verteporfin|verteporfin|mesh-list
110255197|NCT00471406|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110255198|NCT00471406|Dermatologic Agents|dermatologic agents|mesh-ancestor
110255199|NCT00149565|Interferon alpha-2|interferon alpha-2|mesh-list
110255200|NCT00149565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110255202|NCT00149565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110255203|NCT00471484|Interferons|interferons|mesh-list
110255204|NCT00471484|Interferon-alpha|interferon-alpha|mesh-list
110255205|NCT00471484|Interferon alpha-2|interferon alpha-2|mesh-list
110255206|NCT00471484|Doxorubicin|doxorubicin|mesh-list
110255207|NCT00471484|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110255208|NCT00471484|Fluorouracil|fluorouracil|mesh-list
110255209|NCT00471484|Oxaliplatin|oxaliplatin|mesh-list
110255210|NCT00471484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110255211|NCT00471484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110255212|NCT00471484|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110255213|NCT00471484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110255214|NCT00471484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110255215|NCT00471484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110255216|NCT00471484|Antimetabolites|antimetabolites|mesh-ancestor
110255217|NCT00471484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110255218|NCT00471484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110255219|NCT00471484|Immunologic Factors|immunologic factors|mesh-ancestor
110255220|NCT00471484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110255221|NCT00471484|Antiviral Agents|antiviral agents|mesh-ancestor
110255222|NCT00471484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110255223|NCT00471523|Metformin|metformin|mesh-list
110255224|NCT00471523|Clomiphene|clomiphene|mesh-list
110255225|NCT00471523|Enclomiphene|enclomiphene|mesh-list
110255226|NCT00471523|Zuclomiphene|zuclomiphene|mesh-list
110255227|NCT00471523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110270630|NCT00193869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110255228|NCT00471523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110255229|NCT00471523|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110255230|NCT00471523|Hormone Antagonists|hormone antagonists|mesh-ancestor
110255231|NCT00471523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110255232|NCT00471523|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110255233|NCT00471523|Fertility Agents|fertility agents|mesh-ancestor
110255234|NCT00471523|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110255235|NCT00471523|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110255236|NCT00471523|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110255237|NCT00471562|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
110255238|NCT00471562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110255239|NCT00471562|Vasodilator Agents|vasodilator agents|mesh-ancestor
110255240|NCT00471640|Dexamethasone|dexamethasone|mesh-list
110255241|NCT00471640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110255242|NCT00471640|Antiemetics|antiemetics|mesh-ancestor
110255243|NCT00471640|Autonomic Agents|autonomic agents|mesh-ancestor
110255244|NCT00471640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110255245|NCT00471640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110255246|NCT00471640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110255247|NCT00471640|Glucocorticoids|glucocorticoids|mesh-ancestor
110255248|NCT00471640|Hormones|hormones|mesh-ancestor
110255249|NCT00471640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110255250|NCT00471640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110255251|NCT00471640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110255252|NCT00471679|Ethanol|ethanol|mesh-list
110255253|NCT00471679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110255254|NCT00471679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110255255|NCT00471679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110255256|NCT00471679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110255257|NCT00149604|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
110255258|NCT00149604|Estrogens|estrogens|mesh-list
110255260|NCT00149604|Hormones|hormones|mesh-ancestor
110255261|NCT00149604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110255262|NCT00149604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110255264|NCT00149604|Hormone Antagonists|hormone antagonists|mesh-ancestor
110255265|NCT00149604|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110255266|NCT00149604|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110255267|NCT00149604|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110255268|NCT00471952|Caffeine|caffeine|mesh-list
110255270|NCT00471952|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110255271|NCT00471952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110255272|NCT00471952|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110255273|NCT00471952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110255274|NCT00471952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110255275|NCT00471952|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110255276|NCT00471952|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110030591|NCT01386879|Methylene Blue|methylene blue|mesh-list
110255277|NCT00471952|Purinergic Agents|purinergic agents|mesh-ancestor
110255278|NCT00471952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110255279|NCT00471952|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110255280|NCT00471952|Serotonin Agents|serotonin agents|mesh-ancestor
110255281|NCT00471991|Dienogest|dienogest|mesh-list
110255282|NCT00471991|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110255283|NCT00471991|Estradiol|estradiol|mesh-list
110255284|NCT00471991|Estrogens|estrogens|mesh-ancestor
110255285|NCT00471991|Hormones|hormones|mesh-ancestor
110255286|NCT00471991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110255287|NCT00471991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110255288|NCT00471991|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110255289|NCT00471991|Contraceptive Agents|contraceptive agents|mesh-ancestor
110255290|NCT00471991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110255291|NCT00471991|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110255292|NCT00471991|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110255293|NCT00471991|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110255294|NCT00471991|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110255295|NCT00471991|Hormone Antagonists|hormone antagonists|mesh-ancestor
110255296|NCT00471991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110255297|NCT00471991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110255298|NCT00472108|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
110255299|NCT00472108|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110255300|NCT00472108|Dermatologic Agents|dermatologic agents|mesh-ancestor
110030689|NCT01387880|Everolimus|everolimus|mesh-list
110255301|NCT00336310|Repaglinide|repaglinide|mesh-list
110255302|NCT00336310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110255303|NCT00336310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110255304|NCT00336349|Botulinum Toxins|botulinum toxins|mesh-list
110255305|NCT00336349|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110255306|NCT00336349|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110255307|NCT00336349|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110255308|NCT00336349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110255309|NCT00336349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110255310|NCT00336349|Cholinergic Agents|cholinergic agents|mesh-ancestor
110255311|NCT00336349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110255312|NCT00336349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110255313|NCT00336349|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110255314|NCT00336349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110255315|NCT00472225|Rituximab|rituximab|mesh-list
110255316|NCT00472225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110255317|NCT00472225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110255319|NCT00472225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110255320|NCT00472225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110255321|NCT00336466|Epoetin Alfa|epoetin alfa|mesh-list
110255323|NCT00472381|Insulin|insulin|mesh-list
110255324|NCT00472381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110255325|NCT00472381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110255326|NCT00472459|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
110255327|NCT00472459|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110255328|NCT00472459|Dermatologic Agents|dermatologic agents|mesh-ancestor
110255329|NCT00336739|Cinacalcet|cinacalcet|mesh-list
110255330|NCT00336739|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110255331|NCT00336739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110255333|NCT00336739|Hormone Antagonists|hormone antagonists|mesh-ancestor
110255334|NCT00336739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110255335|NCT00424151|Rituximab|rituximab|mesh-list
110255336|NCT00424151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110255337|NCT00424151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110255338|NCT00424151|Immunologic Factors|immunologic factors|mesh-ancestor
110255339|NCT00424151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110255340|NCT00424151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110255341|NCT00472810|Mitomycins|mitomycins|mesh-list
110255342|NCT00472810|Mitomycin|mitomycin|mesh-list
110255343|NCT00472810|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110255344|NCT00472810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110255345|NCT00472810|Alkylating Agents|alkylating agents|mesh-ancestor
110255346|NCT00472810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110255347|NCT00472810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110255348|NCT00472810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110255349|NCT00337051|Propofol|propofol|mesh-list
110255350|NCT00337051|Sevoflurane|sevoflurane|mesh-list
110255351|NCT00337051|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110255352|NCT00337051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110255353|NCT00337051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110255354|NCT00337051|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110255355|NCT00337051|Anesthetics, General|anesthetics, general|mesh-ancestor
110255356|NCT00337051|Anesthetics|anesthetics|mesh-ancestor
110255357|NCT00337051|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110255358|NCT00337051|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110255359|NCT00472927|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110255360|NCT00472927|Estrogens|estrogens|mesh-ancestor
110255361|NCT00472927|Hormones|hormones|mesh-ancestor
110255362|NCT00472927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110255363|NCT00472927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110255364|NCT00337090|Mirabegron|mirabegron|mesh-list
110255365|NCT00337090|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110255366|NCT00337090|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110255367|NCT00337090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110255368|NCT00337090|Adrenergic Agents|adrenergic agents|mesh-ancestor
110255369|NCT00337090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110255370|NCT00337090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110255371|NCT00337090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110255372|NCT00337090|Urological Agents|urological agents|mesh-ancestor
110255373|NCT05262452|Folfirinox|folfirinox|mesh-list
110255374|NCT05262452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110255375|NCT00337246|Cyclophosphamide|cyclophosphamide|mesh-list
110255376|NCT00337246|Rituximab|rituximab|mesh-list
110255377|NCT00337246|Fludarabine|fludarabine|mesh-list
110255378|NCT00337246|Fludarabine phosphate|fludarabine phosphate|mesh-list
110255379|NCT00337246|Mitoxantrone|mitoxantrone|mesh-list
110255380|NCT00337246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110255381|NCT00337246|Immunologic Factors|immunologic factors|mesh-ancestor
110255382|NCT00337246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110255383|NCT00337246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110255384|NCT00337246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110255385|NCT00337246|Alkylating Agents|alkylating agents|mesh-ancestor
110255386|NCT00337246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110255387|NCT00337246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110255388|NCT00337246|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110255389|NCT00337246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110255390|NCT00337246|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110255391|NCT00337246|Antimetabolites|antimetabolites|mesh-ancestor
110255392|NCT00337246|Analgesics|analgesics|mesh-ancestor
110255393|NCT00337246|Sensory System Agents|sensory system agents|mesh-ancestor
110255394|NCT00337246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110255395|NCT00337246|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110255396|NCT00337246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110255397|NCT00337246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110255398|NCT00158301|Fluoxetine|fluoxetine|mesh-list
110255399|NCT00158301|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110255400|NCT00158301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110255401|NCT00158301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110255402|NCT00158301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110255403|NCT00158301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110255404|NCT00158301|Serotonin Agents|serotonin agents|mesh-ancestor
110255405|NCT00158301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110255406|NCT00158301|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110255407|NCT00158301|Antidepressive Agents|antidepressive agents|mesh-ancestor
110255408|NCT00158301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110255409|NCT00158301|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110255410|NCT00158301|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110255411|NCT00158301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110255412|NCT00473005|Capecitabine|capecitabine|mesh-list
110255414|NCT00473005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110255415|NCT00473005|Antimetabolites|antimetabolites|mesh-ancestor
110255416|NCT00473005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110255417|NCT00473005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110255418|NCT00473005|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110255419|NCT00473005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110255420|NCT00473005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110255421|NCT00473005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110255422|NCT00473005|Immunologic Factors|immunologic factors|mesh-ancestor
110255423|NCT00473005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110255424|NCT00149877|Tegaserod|tegaserod|mesh-list
110255425|NCT00149877|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110255426|NCT00149877|Serotonin Agents|serotonin agents|mesh-ancestor
110255427|NCT00149877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110255428|NCT00149877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110255429|NCT00149877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110255430|NCT00473239|Vitamin D|vitamin d|mesh-list
110255431|NCT00473239|Cholecalciferol|cholecalciferol|mesh-list
110255432|NCT00473239|Vitamins|vitamins|mesh-ancestor
110255433|NCT00473239|Micronutrients|micronutrients|mesh-ancestor
110255434|NCT00473239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110255435|NCT00473239|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110255436|NCT00473239|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110255437|NCT00149916|Mycophenolic Acid|mycophenolic acid|mesh-list
110255438|NCT00149916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110255439|NCT00149916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110255440|NCT00149916|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110255441|NCT00149916|Antitubercular Agents|antitubercular agents|mesh-ancestor
110255442|NCT00149916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110255443|NCT00149916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110255444|NCT00149916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110255445|NCT00149916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110255447|NCT00337441|Hematinics|hematinics|mesh-ancestor
110255448|NCT05183048|Panitumumab|panitumumab|mesh-list
110255449|NCT05183048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110255450|NCT05183048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110255452|NCT00337519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110255453|NCT00337519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110255454|NCT00337558|Solifenacin Succinate|solifenacin succinate|mesh-list
110255455|NCT00337558|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110255456|NCT00337558|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110255457|NCT00337558|Cholinergic Agents|cholinergic agents|mesh-ancestor
110255458|NCT00337558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110255459|NCT00337558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110255460|NCT00337558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110255462|NCT00508963|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
110255463|NCT00508963|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110255464|NCT00508963|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110255465|NCT00508963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110255466|NCT00508963|Schistosomicides|schistosomicides|mesh-ancestor
110255467|NCT00508963|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110255468|NCT00508963|Anthelmintics|anthelmintics|mesh-ancestor
110255469|NCT02964104|Insulin|insulin|mesh-list
110255470|NCT02964104|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110255471|NCT02964104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110255472|NCT02964104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110255473|NCT00158457|Tenofovir|tenofovir|mesh-list
110255474|NCT00158457|Emtricitabine|emtricitabine|mesh-list
110255475|NCT00158457|Efavirenz|efavirenz|mesh-list
110255476|NCT00158457|Antiviral Agents|antiviral agents|mesh-ancestor
110255477|NCT00158457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110255478|NCT00158457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110255479|NCT00158457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110255480|NCT00158457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110255481|NCT00158457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110255482|NCT00158457|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110255483|NCT00158457|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110255484|NCT00158457|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110255485|NCT00158457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110255486|NCT00158457|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110255487|NCT00158457|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110255488|NCT00158457|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110255489|NCT00158457|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110255490|NCT00509158|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110255491|NCT00509158|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
110255492|NCT00509158|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110255493|NCT00509158|Immunologic Factors|immunologic factors|mesh-ancestor
110255494|NCT00509158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110255496|NCT00509158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110255497|NCT00509158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110255498|NCT00405080|Rifampin|rifampin|mesh-list
110255499|NCT00405080|Casopitant|casopitant|mesh-list
110255500|NCT00405080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110255501|NCT00405080|Antitubercular Agents|antitubercular agents|mesh-ancestor
110255502|NCT00405080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110255503|NCT00405080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110270733|NCT00194064|Serotonin Agents|serotonin agents|mesh-ancestor
110255504|NCT00405080|Leprostatic Agents|leprostatic agents|mesh-ancestor
110255505|NCT00405080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110255506|NCT00405080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110255507|NCT00405080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110255508|NCT00405080|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110255509|NCT00405080|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110255510|NCT00405080|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110255511|NCT00405080|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110255512|NCT00405080|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110255513|NCT00405080|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110255514|NCT00405080|Antiemetics|antiemetics|mesh-ancestor
110255515|NCT00405080|Autonomic Agents|autonomic agents|mesh-ancestor
110255516|NCT00405080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110255517|NCT00405080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110255518|NCT00405080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110255519|NCT00405080|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110255520|NCT00405080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110255521|NCT00158496|Interferons|interferons|mesh-list
110255522|NCT00158496|Ribavirin|ribavirin|mesh-list
110255523|NCT00158496|Interferon-alpha|interferon-alpha|mesh-list
110255524|NCT00158496|Interferon alpha-2|interferon alpha-2|mesh-list
110255525|NCT00158496|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110255526|NCT00158496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110255527|NCT00158496|Antiviral Agents|antiviral agents|mesh-ancestor
110255528|NCT00158496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110255529|NCT00158496|Antimetabolites|antimetabolites|mesh-ancestor
110255530|NCT00158496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110255531|NCT00158496|Immunologic Factors|immunologic factors|mesh-ancestor
110255532|NCT00158496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110255533|NCT00337792|Fentanyl|fentanyl|mesh-list
110255534|NCT00337792|Midazolam|midazolam|mesh-list
110255535|NCT00337792|Oxycodone|oxycodone|mesh-list
110255536|NCT00337792|Lorazepam|lorazepam|mesh-list
110255537|NCT00337792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110255538|NCT00337792|Narcotics|narcotics|mesh-ancestor
110255539|NCT00337792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110255540|NCT00337792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110255541|NCT00337792|Analgesics|analgesics|mesh-ancestor
110255542|NCT00337792|Sensory System Agents|sensory system agents|mesh-ancestor
110255543|NCT00337792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110255544|NCT00337792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110255545|NCT00337792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110255546|NCT00337792|Anesthetics, General|anesthetics, general|mesh-ancestor
110255547|NCT00337792|Anesthetics|anesthetics|mesh-ancestor
110255548|NCT00337792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110255550|NCT00337792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110255551|NCT00337792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110255552|NCT00337792|GABA Modulators|gaba modulators|mesh-ancestor
110255553|NCT00337792|GABA Agents|gaba agents|mesh-ancestor
110255554|NCT00337792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110255555|NCT00337792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110255556|NCT00337792|Anticonvulsants|anticonvulsants|mesh-ancestor
110255557|NCT00337792|Antiemetics|antiemetics|mesh-ancestor
110255558|NCT00337792|Autonomic Agents|autonomic agents|mesh-ancestor
110255559|NCT00337792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110255560|NCT00509353|Irinotecan|irinotecan|mesh-list
110255561|NCT00509353|Vincristine|vincristine|mesh-list
110255562|NCT00509353|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
110255563|NCT00509353|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110255564|NCT00509353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110255565|NCT00509353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110255566|NCT00509353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110255567|NCT00509353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110255568|NCT00509353|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110255569|NCT00509353|Tubulin Modulators|tubulin modulators|mesh-ancestor
110255570|NCT00509353|Antimitotic Agents|antimitotic agents|mesh-ancestor
110255571|NCT00509353|Mitosis Modulators|mitosis modulators|mesh-ancestor
110255572|NCT00509353|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110255574|NCT00405119|Ranitidine|ranitidine|mesh-list
110255575|NCT00405119|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
110255576|NCT00405119|Loxtidine|loxtidine|mesh-list
110255577|NCT00405119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110255578|NCT00405119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110255579|NCT00405119|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110255580|NCT00405119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110255581|NCT00405119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110255582|NCT00405119|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110255583|NCT00405119|Histamine Antagonists|histamine antagonists|mesh-ancestor
110255584|NCT00405119|Histamine Agents|histamine agents|mesh-ancestor
110255585|NCT00405119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110255586|NCT00405119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110255587|NCT04715737|Vasopressins|vasopressins|mesh-list
110255588|NCT04715737|Arginine Vasopressin|arginine vasopressin|mesh-list
110255589|NCT04715737|Oxytocin|oxytocin|mesh-list
110255590|NCT04715737|Oxytocics|oxytocics|mesh-ancestor
110255591|NCT04715737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110255592|NCT04715737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110255593|NCT04715737|Hemostatics|hemostatics|mesh-ancestor
110255595|NCT04715737|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110255596|NCT04715737|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110255597|NCT04715737|Natriuretic Agents|natriuretic agents|mesh-ancestor
110255598|NCT00509431|Sirolimus|sirolimus|mesh-list
110255599|NCT00509431|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110255600|NCT00509431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110255601|NCT00509431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110255602|NCT00509431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110255603|NCT00509431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110255604|NCT00509431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110255605|NCT00509431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110255606|NCT00509431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110255607|NCT00509431|Antifungal Agents|antifungal agents|mesh-ancestor
110255608|NCT00509431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110255609|NCT00509431|Immunologic Factors|immunologic factors|mesh-ancestor
110255610|NCT00509431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110255611|NCT00509470|Amlodipine|amlodipine|mesh-list
110255612|NCT00509470|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110255614|NCT00509470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110255615|NCT00509470|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110255616|NCT00509470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110270769|NCT04307953|Saracatinib|saracatinib|mesh-list
110255617|NCT00509470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110255618|NCT00509470|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110255619|NCT00509470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110255620|NCT00509470|Vasodilator Agents|vasodilator agents|mesh-ancestor
110255622|NCT00509470|Natriuretic Agents|natriuretic agents|mesh-ancestor
110255623|NCT00509470|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110255624|NCT00509470|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110255625|NCT00509470|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110255626|NCT00405158|Acetaminophen|acetaminophen|mesh-list
110255627|NCT00405158|Antipyretics|antipyretics|mesh-list
110255628|NCT00405158|Penicillins|penicillins|mesh-list
110255629|NCT00405158|Floxacillin|floxacillin|mesh-list
110255630|NCT00405158|Cefadroxil|cefadroxil|mesh-list
110255631|NCT00405158|Oxytocin|oxytocin|mesh-list
110255632|NCT00405158|Oxytocics|oxytocics|mesh-ancestor
110255633|NCT00405158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110255634|NCT00405158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110255635|NCT00405158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110255636|NCT00405158|Analgesics|analgesics|mesh-ancestor
110255637|NCT00405158|Sensory System Agents|sensory system agents|mesh-ancestor
110255638|NCT00405158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110255639|NCT00405158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110255640|NCT00405158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110255641|NCT00150072|Imatinib Mesylate|imatinib mesylate|mesh-list
110255642|NCT00150072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110255643|NCT00150072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110255644|NCT00150072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110255645|NCT00150072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110255646|NCT02953366|Mometasone Furoate|mometasone furoate|mesh-list
110255647|NCT02953366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110255648|NCT02953366|Dermatologic Agents|dermatologic agents|mesh-ancestor
110255649|NCT02953366|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110255650|NCT00150111|Rituximab|rituximab|mesh-list
110255651|NCT00150111|Methimazole|methimazole|mesh-list
110255652|NCT00150111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110255653|NCT00150111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110255654|NCT00150111|Immunologic Factors|immunologic factors|mesh-ancestor
110255655|NCT00150111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110255656|NCT00150111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110255657|NCT00150111|Antithyroid Agents|antithyroid agents|mesh-ancestor
110255658|NCT00150111|Hormone Antagonists|hormone antagonists|mesh-ancestor
110255659|NCT00150111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110255660|NCT02953210|Dexamethasone|dexamethasone|mesh-list
110255661|NCT02953210|Ketorolac|ketorolac|mesh-list
110255662|NCT02953210|Lidocaine|lidocaine|mesh-list
110255663|NCT02953210|Clonidine|clonidine|mesh-list
110255664|NCT02953210|Fentanyl|fentanyl|mesh-list
110255665|NCT02953210|Midazolam|midazolam|mesh-list
110255666|NCT02953210|Ketamine|ketamine|mesh-list
110255667|NCT02953210|Ondansetron|ondansetron|mesh-list
110255668|NCT02953210|Bupivacaine|bupivacaine|mesh-list
110255669|NCT02953210|Propofol|propofol|mesh-list
110255670|NCT02953210|Isoflurane|isoflurane|mesh-list
110255672|NCT02953210|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
110255673|NCT02953210|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110255675|NCT02953210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110255676|NCT02953210|Antiemetics|antiemetics|mesh-ancestor
110255677|NCT02953210|Autonomic Agents|autonomic agents|mesh-ancestor
110255678|NCT02953210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110031464|NCT01392430|Antimalarials|antimalarials|mesh-ancestor
110255679|NCT02953210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110255680|NCT02953210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110255681|NCT02953210|Glucocorticoids|glucocorticoids|mesh-ancestor
110255682|NCT02953210|Hormones|hormones|mesh-ancestor
110255683|NCT02953210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110255684|NCT02953210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110255685|NCT02953210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110255686|NCT02953210|Anesthetics, Local|anesthetics, local|mesh-ancestor
110255687|NCT02953210|Anesthetics|anesthetics|mesh-ancestor
110255688|NCT02953210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110255691|NCT02953210|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110255692|NCT02953210|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110255693|NCT02953210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110255694|NCT02953210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110255695|NCT02953210|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110255696|NCT02953210|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110255697|NCT02953210|Anesthetics, General|anesthetics, general|mesh-ancestor
110255698|NCT02953210|Analgesics|analgesics|mesh-ancestor
110255699|NCT02953210|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110255700|NCT02953210|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110255701|NCT02953210|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110255702|NCT02953210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110255703|NCT02953210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110255704|NCT02953210|Narcotics|narcotics|mesh-ancestor
110255705|NCT02953210|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110255706|NCT02953210|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110255707|NCT02953210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110255708|NCT02953210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110255709|NCT02953210|GABA Modulators|gaba modulators|mesh-ancestor
110255710|NCT02953210|GABA Agents|gaba agents|mesh-ancestor
110255711|NCT02953210|Antipruritics|antipruritics|mesh-ancestor
110255712|NCT02953210|Dermatologic Agents|dermatologic agents|mesh-ancestor
110255713|NCT02953210|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110255714|NCT02953210|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110255715|NCT02953210|Serotonin Agents|serotonin agents|mesh-ancestor
110255716|NCT02953210|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110255717|NCT02953210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110255718|NCT02953210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110255719|NCT02953210|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110255720|NCT02953210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110255721|NCT02953210|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110255722|NCT02953210|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110255723|NCT02953210|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110255724|NCT02953210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110255725|NCT02953210|Sympatholytics|sympatholytics|mesh-ancestor
110255726|NCT02953210|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110255727|NCT02953210|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110255728|NCT02953210|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110255729|NCT02953210|Adrenergic Agents|adrenergic agents|mesh-ancestor
110255730|NCT02953210|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110255731|NCT02953210|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110255732|NCT02953210|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110255733|NCT02953210|Histamine Antagonists|histamine antagonists|mesh-ancestor
110255735|NCT00509743|Diclofenac|diclofenac|mesh-list
110255736|NCT00509743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110255737|NCT00509743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110255738|NCT00509743|Analgesics|analgesics|mesh-ancestor
110255739|NCT00509743|Sensory System Agents|sensory system agents|mesh-ancestor
110255740|NCT00509743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110255741|NCT00509743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110255742|NCT00509743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110255743|NCT00509743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110255744|NCT00509743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110255745|NCT00509743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110255746|NCT00509743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110255748|NCT00509860|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110255750|NCT00509860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110255751|NCT00509860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110255752|NCT00509860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110255753|NCT00509938|Lactoferrin|lactoferrin|mesh-list
110255754|NCT00509938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110255755|NCT00337948|Epoetin Alfa|epoetin alfa|mesh-list
110255756|NCT00337948|Hematinics|hematinics|mesh-ancestor
110255757|NCT02958215|Phenylephrine|phenylephrine|mesh-list
110255758|NCT02958215|Oxymetazoline|oxymetazoline|mesh-list
110255759|NCT02958215|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110255760|NCT02958215|Mydriatics|mydriatics|mesh-ancestor
110255761|NCT02958215|Autonomic Agents|autonomic agents|mesh-ancestor
110255762|NCT02958215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110255763|NCT02958215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110255764|NCT02958215|Sympathomimetics|sympathomimetics|mesh-ancestor
110255765|NCT02958215|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110255766|NCT02958215|Nasal Decongestants|nasal decongestants|mesh-ancestor
110255767|NCT02958215|Respiratory System Agents|respiratory system agents|mesh-ancestor
110255768|NCT02958215|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110255769|NCT02958215|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110255770|NCT02958215|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110255771|NCT02958215|Adrenergic Agents|adrenergic agents|mesh-ancestor
110255772|NCT02958215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110255773|NCT02958215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110255774|NCT02958215|Protective Agents|protective agents|mesh-ancestor
110255775|NCT00158574|Pyrimethamine|pyrimethamine|mesh-list
110255776|NCT00158574|Sulfadoxine|sulfadoxine|mesh-list
110255777|NCT00158574|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110255778|NCT00158574|Dapsone|dapsone|mesh-list
110255779|NCT00158574|Mefloquine|mefloquine|mesh-list
110255780|NCT00158574|Chlorproguanil|chlorproguanil|mesh-list
110255781|NCT00158574|Proguanil|proguanil|mesh-list
110255782|NCT00158574|Antimalarials|antimalarials|mesh-ancestor
110255783|NCT00158574|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110255784|NCT00158574|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110255785|NCT00158574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110255786|NCT00158574|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110255787|NCT00158574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110270822|NCT00165308|Tamoxifen|tamoxifen|mesh-list
110255788|NCT00158574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110255789|NCT00158574|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110255790|NCT00158574|Leprostatic Agents|leprostatic agents|mesh-ancestor
110255791|NCT00158574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110255792|NCT00158574|Antimetabolites|antimetabolites|mesh-ancestor
110255794|NCT00338221|Glycine Agents|glycine agents|mesh-ancestor
110255795|NCT00338221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110255796|NCT00338221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110255797|NCT00338221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110255798|NCT00338299|Epoetin Alfa|epoetin alfa|mesh-list
110255799|NCT00338299|Hematinics|hematinics|mesh-ancestor
110255800|NCT00510016|Clonidine|clonidine|mesh-list
110255801|NCT00510016|Analgesics|analgesics|mesh-ancestor
110255802|NCT00510016|Sensory System Agents|sensory system agents|mesh-ancestor
110255803|NCT00510016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110255804|NCT00510016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110255805|NCT00510016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110255806|NCT00510016|Sympatholytics|sympatholytics|mesh-ancestor
110255807|NCT00510016|Autonomic Agents|autonomic agents|mesh-ancestor
110255809|NCT00510016|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110255810|NCT00510016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110255811|NCT00510016|Adrenergic Agents|adrenergic agents|mesh-ancestor
110255812|NCT00510016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110255813|NCT00510016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110255814|NCT00150228|Varenicline|varenicline|mesh-list
110255815|NCT00150228|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110255816|NCT00150228|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110255817|NCT00150228|Cholinergic Agents|cholinergic agents|mesh-ancestor
110255818|NCT00150228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110255819|NCT00150228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110255820|NCT00150228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110255821|NCT00338338|Amlodipine|amlodipine|mesh-list
110255822|NCT00338338|Lacidipine|lacidipine|mesh-list
110255823|NCT00338338|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110255824|NCT00338338|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110255826|NCT00338338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110255827|NCT00338338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110255828|NCT00338338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110255829|NCT00338338|Vasodilator Agents|vasodilator agents|mesh-ancestor
110255830|NCT00338416|Epoetin Alfa|epoetin alfa|mesh-list
110255831|NCT00338416|Hematinics|hematinics|mesh-ancestor
110255832|NCT00338494|Clofarabine|clofarabine|mesh-list
110255833|NCT00338494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110255834|NCT00338494|Antimetabolites|antimetabolites|mesh-ancestor
110255835|NCT00338494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110255836|NCT00338494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110255837|NCT02953015|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110255838|NCT02953015|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110255839|NCT02953015|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110255840|NCT02953015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110255841|NCT02953015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110255842|NCT02953015|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110255843|NCT02953015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110255844|NCT02953015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110255845|NCT02953015|Cholinergic Agents|cholinergic agents|mesh-ancestor
110255846|NCT02953015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110255847|NCT00158652|Carboplatin|carboplatin|mesh-list
110255848|NCT00158652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110255849|NCT00338650|Adalimumab|adalimumab|mesh-list
110255850|NCT00338650|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110255851|NCT00338650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110255852|NCT00338650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110255853|NCT00158691|Amifostine|amifostine|mesh-list
110255854|NCT00158691|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110255855|NCT00158691|Protective Agents|protective agents|mesh-ancestor
110255856|NCT00158691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110255857|NCT00338767|Fluoxetine|fluoxetine|mesh-list
110255858|NCT00338767|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110255859|NCT00338767|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110255860|NCT00338767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110255861|NCT00338767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110255862|NCT00338767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110255863|NCT00338767|Serotonin Agents|serotonin agents|mesh-ancestor
110255864|NCT00338767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110255865|NCT00338767|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110255866|NCT00338767|Antidepressive Agents|antidepressive agents|mesh-ancestor
110255867|NCT00338767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110255868|NCT00338767|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110255869|NCT00338767|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110255870|NCT00338767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110255871|NCT00339001|Epoetin Alfa|epoetin alfa|mesh-list
110255872|NCT00339001|Hematinics|hematinics|mesh-ancestor
110255873|NCT00150306|Sertraline|sertraline|mesh-list
110255874|NCT00150306|Antidepressive Agents|antidepressive agents|mesh-ancestor
110255875|NCT00150306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110255876|NCT00150306|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110255877|NCT00150306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110255878|NCT00150306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110255879|NCT00150306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110255880|NCT00150306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110255881|NCT00150306|Serotonin Agents|serotonin agents|mesh-ancestor
110255882|NCT00150306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110255883|NCT00510172|Epoprostenol|epoprostenol|mesh-list
110255884|NCT00510172|Tezosentan|tezosentan|mesh-list
110255885|NCT00510172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110255886|NCT00510172|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110255887|NCT00510172|Vasodilator Agents|vasodilator agents|mesh-ancestor
110255888|NCT00420901|Sildenafil Citrate|sildenafil citrate|mesh-list
110255889|NCT00420901|Vasodilator Agents|vasodilator agents|mesh-ancestor
110255890|NCT00420901|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110255891|NCT00420901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110255892|NCT00420901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110255893|NCT00420901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110255894|NCT00420901|Urological Agents|urological agents|mesh-ancestor
110255895|NCT00150384|Amlodipine|amlodipine|mesh-list
110255896|NCT00150384|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
110255897|NCT00150384|Atorvastatin|atorvastatin|mesh-list
110255898|NCT00150384|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110255899|NCT00150384|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110255900|NCT00150384|Antimetabolites|antimetabolites|mesh-ancestor
110255901|NCT00150384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110255902|NCT00150384|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110270849|NCT00176670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110255903|NCT00150384|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110255904|NCT00150384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110255905|NCT00150384|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110255906|NCT00150384|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110255907|NCT00150384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110255908|NCT00150384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110255909|NCT00150384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110255910|NCT00150384|Vasodilator Agents|vasodilator agents|mesh-ancestor
110255911|NCT00425191|Gemcitabine|gemcitabine|mesh-list
110255912|NCT00425191|Docetaxel|docetaxel|mesh-list
110255913|NCT00425191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110255914|NCT00425191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110255915|NCT00425191|Antimetabolites|antimetabolites|mesh-ancestor
110255916|NCT00425191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110255917|NCT00425191|Tubulin Modulators|tubulin modulators|mesh-ancestor
110255918|NCT00425191|Antimitotic Agents|antimitotic agents|mesh-ancestor
110255919|NCT00425191|Mitosis Modulators|mitosis modulators|mesh-ancestor
110255920|NCT00339118|Doxorubicin|doxorubicin|mesh-list
110255921|NCT00339118|Cyclophosphamide|cyclophosphamide|mesh-list
110255922|NCT00339118|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110255923|NCT00339118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110255924|NCT00339118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110255925|NCT00339118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110255926|NCT00339118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110255927|NCT00339118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110255928|NCT00339118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110255929|NCT00339118|Immunologic Factors|immunologic factors|mesh-ancestor
110255930|NCT00339118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110255931|NCT00339118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110255932|NCT00339118|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110255933|NCT00339118|Alkylating Agents|alkylating agents|mesh-ancestor
110255934|NCT00339118|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110255935|NCT00339157|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110255936|NCT00339157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110255937|NCT00339196|Azacitidine|azacitidine|mesh-list
110255938|NCT00339196|Tretinoin|tretinoin|mesh-list
110255939|NCT00339196|Valproic Acid|valproic acid|mesh-list
110255940|NCT00339196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110255941|NCT00339196|Antimetabolites|antimetabolites|mesh-ancestor
110255942|NCT00339196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110255944|NCT00339196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110255945|NCT00339196|Keratolytic Agents|keratolytic agents|mesh-ancestor
110255946|NCT00339196|Dermatologic Agents|dermatologic agents|mesh-ancestor
110255947|NCT00339196|Anticonvulsants|anticonvulsants|mesh-ancestor
110255948|NCT00339196|GABA Agents|gaba agents|mesh-ancestor
110255949|NCT00339196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110255950|NCT00339196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110255951|NCT00339196|Antimanic Agents|antimanic agents|mesh-ancestor
110255952|NCT00339196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110255953|NCT00339196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110255954|NCT00339196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110255956|NCT00158730|Antifungal Agents|antifungal agents|mesh-ancestor
110255957|NCT00158730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110255958|NCT00158730|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110255959|NCT00158730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110255960|NCT00510211|Olanzapine|olanzapine|mesh-list
110255961|NCT00510211|Antiemetics|antiemetics|mesh-ancestor
110255962|NCT00510211|Autonomic Agents|autonomic agents|mesh-ancestor
110255963|NCT00510211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110255964|NCT00510211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110255965|NCT00510211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110255966|NCT00510211|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110255967|NCT00510211|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110270863|NCT04082650|Micronutrients|micronutrients|mesh-ancestor
110255968|NCT00510211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110255970|NCT00510211|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110255971|NCT00510211|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110255972|NCT00510211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110255973|NCT00510211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110255974|NCT00510211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110255975|NCT00510211|Serotonin Agents|serotonin agents|mesh-ancestor
110255977|NCT00150423|Analgesics|analgesics|mesh-ancestor
110255978|NCT00150423|Sensory System Agents|sensory system agents|mesh-ancestor
110255979|NCT00150423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110255980|NCT00150423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110255981|NCT00150423|Anticonvulsants|anticonvulsants|mesh-ancestor
110255982|NCT00150423|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110255983|NCT00150423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110255984|NCT00150423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110255985|NCT00150423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110255986|NCT00150423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110255987|NCT00150423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110255988|NCT00150423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110255989|NCT00150423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110255990|NCT04988282|Methylprednisolone|methylprednisolone|mesh-list
110255991|NCT04988282|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110255992|NCT04988282|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110255993|NCT04988282|Prednisolone|prednisolone|mesh-list
110255994|NCT04988282|Prednisolone acetate|prednisolone acetate|mesh-list
110255995|NCT04988282|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110255996|NCT04988282|Prednisolone phosphate|prednisolone phosphate|mesh-list
110255997|NCT04988282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110255998|NCT04988282|Antiemetics|antiemetics|mesh-ancestor
110255999|NCT04988282|Autonomic Agents|autonomic agents|mesh-ancestor
110256000|NCT04988282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110256001|NCT04988282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110256002|NCT04988282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110256003|NCT04988282|Glucocorticoids|glucocorticoids|mesh-ancestor
110256004|NCT04988282|Hormones|hormones|mesh-ancestor
110256005|NCT04988282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110256006|NCT04988282|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110256007|NCT04988282|Protective Agents|protective agents|mesh-ancestor
110256008|NCT04988282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110256009|NCT04988282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110256010|NCT00510250|Sorafenib|sorafenib|mesh-list
110256011|NCT00510250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110256012|NCT00510250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110256013|NCT00510250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110256014|NCT00510250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256015|NCT04981067|Ropivacaine|ropivacaine|mesh-list
110256016|NCT04981067|Anesthetics, Local|anesthetics, local|mesh-ancestor
110256017|NCT04981067|Anesthetics|anesthetics|mesh-ancestor
110256018|NCT04981067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110256019|NCT04981067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110256020|NCT04981067|Sensory System Agents|sensory system agents|mesh-ancestor
110256021|NCT04981067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110256022|NCT00510367|Cyclophosphamide|cyclophosphamide|mesh-list
110256023|NCT00510367|Doxorubicin|doxorubicin|mesh-list
110256024|NCT00510367|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110256025|NCT00510367|Fluorouracil|fluorouracil|mesh-list
110256026|NCT00510367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110256027|NCT00510367|Immunologic Factors|immunologic factors|mesh-ancestor
110256028|NCT00510367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110256029|NCT00510367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110256030|NCT00510367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110256031|NCT00510367|Alkylating Agents|alkylating agents|mesh-ancestor
110256032|NCT00510367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256033|NCT00510367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110256034|NCT00510367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110256035|NCT00510367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110256036|NCT00510367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110256037|NCT00510367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110256038|NCT00510367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110256039|NCT00510367|Antimetabolites|antimetabolites|mesh-ancestor
110256040|NCT00510367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110256041|NCT00158847|Fluticasone|fluticasone|mesh-list
110256042|NCT00158847|Xhance|xhance|mesh-list
110256043|NCT00158847|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110256044|NCT00158847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110256045|NCT00158847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110256046|NCT00158847|Autonomic Agents|autonomic agents|mesh-ancestor
110256047|NCT00158847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110256048|NCT00158847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110256049|NCT00158847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110256050|NCT00158847|Respiratory System Agents|respiratory system agents|mesh-ancestor
110256051|NCT00158847|Dermatologic Agents|dermatologic agents|mesh-ancestor
110256052|NCT00158847|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110256053|NCT00158847|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110256054|NCT00158847|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110256055|NCT00158847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110256056|NCT00158847|Adrenergic Agents|adrenergic agents|mesh-ancestor
110256057|NCT00158847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110256058|NCT00158847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256059|NCT00339586|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110256060|NCT00339586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110256061|NCT00339586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110256062|NCT00339586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110256063|NCT00339586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256064|NCT00158886|Topotecan|topotecan|mesh-list
110256065|NCT00158886|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110256066|NCT00158886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110256067|NCT00158886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110256068|NCT00158886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256069|NCT00158886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110256070|NCT00510406|Tamsulosin|tamsulosin|mesh-list
110256071|NCT00510406|Solifenacin Succinate|solifenacin succinate|mesh-list
110256072|NCT00510406|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110256073|NCT00510406|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110256074|NCT00510406|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110256075|NCT00510406|Adrenergic Agents|adrenergic agents|mesh-ancestor
110256076|NCT00510406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110256077|NCT00510406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256078|NCT00510406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110256079|NCT00510406|Urological Agents|urological agents|mesh-ancestor
110256080|NCT00510406|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110256081|NCT00510406|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110256082|NCT00510406|Cholinergic Agents|cholinergic agents|mesh-ancestor
110256083|NCT00165555|Sodium thiosulfate|sodium thiosulfate|mesh-list
110256084|NCT00165555|Antidotes|antidotes|mesh-ancestor
110256085|NCT00165555|Protective Agents|protective agents|mesh-ancestor
110256086|NCT00165555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110256087|NCT00165555|Antioxidants|antioxidants|mesh-ancestor
110256088|NCT00165555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256089|NCT00165555|Antitubercular Agents|antitubercular agents|mesh-ancestor
110256090|NCT00165555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110256091|NCT00165555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110256092|NCT00165555|Chelating Agents|chelating agents|mesh-ancestor
110256093|NCT00165555|Sequestering Agents|sequestering agents|mesh-ancestor
110256094|NCT00150579|Amphetamine|amphetamine|mesh-list
110256095|NCT00150579|Dextroamphetamine|dextroamphetamine|mesh-list
110256097|NCT00150579|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110256098|NCT00150579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110256099|NCT00150579|Sympathomimetics|sympathomimetics|mesh-ancestor
110256100|NCT00150579|Autonomic Agents|autonomic agents|mesh-ancestor
110256101|NCT00150579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110256102|NCT00150579|Dopamine Agents|dopamine agents|mesh-ancestor
110256103|NCT00150579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110256104|NCT00150579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256105|NCT00150579|Adrenergic Agents|adrenergic agents|mesh-ancestor
110256106|NCT00150579|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110256107|NCT00150579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110256108|NCT00150579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110256109|NCT00150579|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110256110|NCT00511732|Insulin|insulin|mesh-list
110256111|NCT00511732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110256112|NCT00511732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110256113|NCT00510445|Imetelstat|imetelstat|mesh-list
110256114|NCT00510445|Motesanib diphosphate|motesanib diphosphate|mesh-list
110256115|NCT00510445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110256116|NCT00510445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256117|NCT00510445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110256118|NCT00150657|Bevacizumab|bevacizumab|mesh-list
110256119|NCT00150657|Carboplatin|carboplatin|mesh-list
110256120|NCT00150657|Gemcitabine|gemcitabine|mesh-list
110256121|NCT00150657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110256122|NCT00150657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110256123|NCT00150657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110270929|NCT03789916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110256124|NCT00150657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110256125|NCT00150657|Growth Substances|growth substances|mesh-ancestor
110256126|NCT00150657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110256127|NCT00150657|Growth Inhibitors|growth inhibitors|mesh-ancestor
110256128|NCT00150657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110256130|NCT00150657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256132|NCT00511771|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110256133|NCT00511771|Serotonin Agents|serotonin agents|mesh-ancestor
110256134|NCT00511771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110256135|NCT00511771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256136|NCT00511771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110256137|NCT00165594|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
110256138|NCT00165594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110256139|NCT00165594|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110256140|NCT00165594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110256141|NCT00165594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256142|NCT00511849|Paclitaxel|paclitaxel|mesh-list
110256143|NCT00511849|Carboplatin|carboplatin|mesh-list
110256144|NCT00511849|Sunitinib|sunitinib|mesh-list
110256145|NCT00511849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110256146|NCT00511849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110256147|NCT00511849|Tubulin Modulators|tubulin modulators|mesh-ancestor
110256148|NCT00511849|Antimitotic Agents|antimitotic agents|mesh-ancestor
110256149|NCT00511849|Mitosis Modulators|mitosis modulators|mesh-ancestor
110256150|NCT00511849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256151|NCT00511849|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110256152|NCT00511849|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110256153|NCT00511849|Growth Substances|growth substances|mesh-ancestor
110256154|NCT00511849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110256155|NCT00511849|Growth Inhibitors|growth inhibitors|mesh-ancestor
110256156|NCT00511849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110256157|NCT00511849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110256158|NCT00510640|Sunitinib|sunitinib|mesh-list
110256159|NCT00510640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110256160|NCT00510640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110256161|NCT00510640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110256162|NCT00510640|Growth Substances|growth substances|mesh-ancestor
110256163|NCT00510640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110256164|NCT00510640|Growth Inhibitors|growth inhibitors|mesh-ancestor
110256165|NCT00510640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110256166|NCT00510640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110256167|NCT00510640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256168|NCT00150696|Risedronic Acid|risedronic acid|mesh-list
110256169|NCT00150696|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110256170|NCT00150696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110256171|NCT00150696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256172|NCT00150696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110256173|NCT00150696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110256174|NCT00150696|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110256175|NCT00165633|Vitamin K 2|vitamin k 2|mesh-list
110256176|NCT00165633|Menatetrenone|menatetrenone|mesh-list
110256177|NCT00165633|Hemostatics|hemostatics|mesh-ancestor
110256178|NCT00165633|Coagulants|coagulants|mesh-ancestor
110256179|NCT00165633|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110256180|NCT00165633|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110256181|NCT00165633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256182|NCT00165633|Vitamins|vitamins|mesh-ancestor
110256183|NCT00165633|Micronutrients|micronutrients|mesh-ancestor
110256184|NCT00165633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110256185|NCT02952469|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110270939|NCT03789916|Antipyretics|antipyretics|mesh-ancestor
110256186|NCT02952469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256187|NCT02952469|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110256188|NCT00510913|Tacrolimus|tacrolimus|mesh-list
110256189|NCT00510913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110256190|NCT00510913|Immunologic Factors|immunologic factors|mesh-ancestor
110256191|NCT00510913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110256192|NCT00510913|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110256193|NCT00510913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110256194|NCT00510913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256196|NCT00150735|Anticonvulsants|anticonvulsants|mesh-ancestor
110256197|NCT00150735|Nootropic Agents|nootropic agents|mesh-ancestor
110256199|NCT04695925|Pemetrexed|pemetrexed|mesh-list
110256200|NCT04695925|Osimertinib|osimertinib|mesh-list
110256201|NCT04695925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110256202|NCT04695925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110256203|NCT04695925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256204|NCT04695925|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110256205|NCT04695925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110256206|NCT04695925|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110256207|NCT00511069|Bortezomib|bortezomib|mesh-list
110256208|NCT00511069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110256209|NCT00165750|Donepezil|donepezil|mesh-list
110256210|NCT00165750|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110256211|NCT00165750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110256212|NCT00165750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256213|NCT00165750|Cholinergic Agents|cholinergic agents|mesh-ancestor
110256214|NCT00165750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110256215|NCT00165750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110256216|NCT00165750|Nootropic Agents|nootropic agents|mesh-ancestor
110256217|NCT00511225|Cholecalciferol|cholecalciferol|mesh-list
110256218|NCT00511225|Vitamin D|vitamin d|mesh-list
110256219|NCT00511225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110256220|NCT00511225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110256221|NCT00511225|Vitamins|vitamins|mesh-ancestor
110256222|NCT00511225|Micronutrients|micronutrients|mesh-ancestor
110256223|NCT00511225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110256224|NCT00150774|Levetiracetam|levetiracetam|mesh-list
110256225|NCT00150774|Anticonvulsants|anticonvulsants|mesh-ancestor
110256226|NCT00150774|Nootropic Agents|nootropic agents|mesh-ancestor
110256227|NCT04864067|Leucovorin|leucovorin|mesh-list
110256228|NCT04864067|Capecitabine|capecitabine|mesh-list
110256229|NCT04864067|Oxaliplatin|oxaliplatin|mesh-list
110256230|NCT04864067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110256231|NCT04864067|Antimetabolites|antimetabolites|mesh-ancestor
110256232|NCT04864067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256233|NCT04864067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110256234|NCT04864067|Antidotes|antidotes|mesh-ancestor
110256235|NCT04864067|Protective Agents|protective agents|mesh-ancestor
110256236|NCT04864067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110256237|NCT04864067|Vitamin B Complex|vitamin b complex|mesh-ancestor
110256238|NCT04864067|Vitamins|vitamins|mesh-ancestor
110256239|NCT04864067|Micronutrients|micronutrients|mesh-ancestor
110256240|NCT00511303|Imatinib Mesylate|imatinib mesylate|mesh-list
110256241|NCT00511303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110256242|NCT00511303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110256243|NCT00511303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110256244|NCT00511303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256246|NCT00165828|Anticonvulsants|anticonvulsants|mesh-ancestor
110256247|NCT00165828|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110256248|NCT00165828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110256249|NCT00165828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256250|NCT00165828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110256251|NCT00165828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110256252|NCT00511498|Sildenafil Citrate|sildenafil citrate|mesh-list
110256253|NCT00511498|Vasodilator Agents|vasodilator agents|mesh-ancestor
110256254|NCT00511498|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110256255|NCT00511498|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110256256|NCT00511498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110256257|NCT00511498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256258|NCT00511498|Urological Agents|urological agents|mesh-ancestor
110256260|NCT00511576|Mocetinostat|mocetinostat|mesh-list
110256261|NCT00511576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110256262|NCT00511576|Tubulin Modulators|tubulin modulators|mesh-ancestor
110256263|NCT00511576|Antimitotic Agents|antimitotic agents|mesh-ancestor
110256264|NCT00511576|Mitosis Modulators|mitosis modulators|mesh-ancestor
110256265|NCT00511576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256266|NCT00511576|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110256267|NCT00511576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110256268|NCT00511654|Midazolam|midazolam|mesh-list
110256269|NCT00511654|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110256270|NCT00511654|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110256271|NCT00511654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110256272|NCT00511654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110256273|NCT00511654|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110256274|NCT00511654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110256275|NCT00511654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110256276|NCT00511654|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110256277|NCT00511654|Anesthetics, General|anesthetics, general|mesh-ancestor
110256278|NCT00511654|Anesthetics|anesthetics|mesh-ancestor
110256279|NCT00511654|GABA Modulators|gaba modulators|mesh-ancestor
110256280|NCT00511654|GABA Agents|gaba agents|mesh-ancestor
110256281|NCT00511654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110256282|NCT00511654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256283|NCT00150852|Vancomycin|vancomycin|mesh-list
110256284|NCT00150852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110256285|NCT00150852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110256286|NCT02952235|Sunscreening Agents|sunscreening agents|mesh-list
110256287|NCT02952235|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110256288|NCT02952235|Protective Agents|protective agents|mesh-ancestor
110256289|NCT02952235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110256290|NCT02952235|Dermatologic Agents|dermatologic agents|mesh-ancestor
110256291|NCT00165867|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
110256292|NCT00165867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110256293|NCT00165867|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110256294|NCT00165867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110256295|NCT00165867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256296|NCT02951806|Fentanyl|fentanyl|mesh-list
110256297|NCT02951806|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110256298|NCT02951806|Narcotics|narcotics|mesh-ancestor
110256299|NCT02951806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110256300|NCT02951806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110256301|NCT02951806|Analgesics|analgesics|mesh-ancestor
110256302|NCT02951806|Sensory System Agents|sensory system agents|mesh-ancestor
110256303|NCT02951806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110256304|NCT02951806|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110256305|NCT02951806|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110256306|NCT02951806|Anesthetics, General|anesthetics, general|mesh-ancestor
110256307|NCT02951806|Anesthetics|anesthetics|mesh-ancestor
110256308|NCT00512980|Prednisone|prednisone|mesh-list
110256309|NCT00512980|Gemcitabine|gemcitabine|mesh-list
110256310|NCT00512980|Doxorubicin|doxorubicin|mesh-list
110256311|NCT00512980|Vinblastine|vinblastine|mesh-list
110256312|NCT00512980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110256313|NCT00512980|Antimetabolites|antimetabolites|mesh-ancestor
110256314|NCT00512980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256315|NCT00512980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110256316|NCT00512980|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110256317|NCT00512980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110256318|NCT00512980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110256319|NCT00512980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110256320|NCT00512980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110256321|NCT00512980|Glucocorticoids|glucocorticoids|mesh-ancestor
110256323|NCT00512980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110256324|NCT00512980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110256325|NCT00512980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110256326|NCT00512980|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110256327|NCT00512980|Tubulin Modulators|tubulin modulators|mesh-ancestor
110256329|NCT00512980|Mitosis Modulators|mitosis modulators|mesh-ancestor
110256330|NCT00150891|Cyclosporine|cyclosporine|mesh-list
110256331|NCT00150891|Mycophenolic Acid|mycophenolic acid|mesh-list
110256332|NCT00150891|Azathioprine|azathioprine|mesh-list
110256333|NCT00150891|Tacrolimus|tacrolimus|mesh-list
110256334|NCT00150891|Cyclosporins|cyclosporins|mesh-list
110256335|NCT00150891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110256336|NCT00150891|Immunologic Factors|immunologic factors|mesh-ancestor
110256337|NCT00150891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110256338|NCT00150891|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110256339|NCT00150891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110256340|NCT00150891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256341|NCT00150891|Antifungal Agents|antifungal agents|mesh-ancestor
110256342|NCT00150891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110256343|NCT00150891|Dermatologic Agents|dermatologic agents|mesh-ancestor
110256344|NCT00150891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110256345|NCT00150891|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110256346|NCT00150891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110256347|NCT00150891|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110256348|NCT00150891|Antitubercular Agents|antitubercular agents|mesh-ancestor
110256349|NCT00150891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110256350|NCT00150891|Antimetabolites|antimetabolites|mesh-ancestor
110256351|NCT00150891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110256352|NCT00513058|Vinorelbine|vinorelbine|mesh-list
110256353|NCT00513058|Lapatinib|lapatinib|mesh-list
110256354|NCT00513058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110256355|NCT00513058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110256356|NCT00513058|Tubulin Modulators|tubulin modulators|mesh-ancestor
110256357|NCT00513058|Antimitotic Agents|antimitotic agents|mesh-ancestor
110256358|NCT00513058|Mitosis Modulators|mitosis modulators|mesh-ancestor
110256359|NCT00513058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256360|NCT00513058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110256361|NCT00513058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110256363|NCT02951962|Telmisartan|telmisartan|mesh-list
110256364|NCT02951962|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
110256365|NCT02951962|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110256366|NCT02951962|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110256368|NCT02951962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110256369|NCT02951962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256370|NCT02951962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110256371|NCT02951962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110256372|NCT02951962|Vasodilator Agents|vasodilator agents|mesh-ancestor
110256373|NCT02951962|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110256374|NCT02951962|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110256375|NCT02951962|Antimetabolites|antimetabolites|mesh-ancestor
110256376|NCT02951962|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110256377|NCT02951962|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110256378|NCT02951962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110256379|NCT02951962|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110256380|NCT02951962|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110256381|NCT00513253|Lapatinib|lapatinib|mesh-list
110256382|NCT00513253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110256383|NCT00513253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110256384|NCT00513253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110256385|NCT00513253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256386|NCT00513487|Fluticasone|fluticasone|mesh-list
110256387|NCT00513487|Methacholine Chloride|methacholine chloride|mesh-list
110256388|NCT00513487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110256389|NCT00513487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110256390|NCT00513487|Autonomic Agents|autonomic agents|mesh-ancestor
110270966|NCT00177060|Hydromorphone|hydromorphone|mesh-list
110256391|NCT00513487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110256392|NCT00513487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110256393|NCT00513487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110256394|NCT00513487|Respiratory System Agents|respiratory system agents|mesh-ancestor
110256395|NCT00513487|Dermatologic Agents|dermatologic agents|mesh-ancestor
110256396|NCT00513487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110256397|NCT00513487|Miotics|miotics|mesh-ancestor
110256398|NCT00513487|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110256399|NCT00513487|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
110256400|NCT00513487|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110256401|NCT00513487|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110256402|NCT00513487|Cholinergic Agents|cholinergic agents|mesh-ancestor
110256403|NCT00513487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110256404|NCT00513487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256405|NCT00405236|Tiotropium Bromide|tiotropium bromide|mesh-list
110256406|NCT00405236|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110256407|NCT00405236|Autonomic Agents|autonomic agents|mesh-ancestor
110256408|NCT00405236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110256409|NCT00405236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110256410|NCT00405236|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110256411|NCT00405236|Respiratory System Agents|respiratory system agents|mesh-ancestor
110256412|NCT00405236|Parasympatholytics|parasympatholytics|mesh-ancestor
110256413|NCT00405236|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110256414|NCT00405236|Cholinergic Agents|cholinergic agents|mesh-ancestor
110256415|NCT00405236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110256416|NCT00405236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256417|NCT00403949|Azelaic acid|azelaic acid|mesh-list
110256418|NCT00403949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110256419|NCT00403949|Dermatologic Agents|dermatologic agents|mesh-ancestor
110256420|NCT00513643|Insulin|insulin|mesh-list
110256421|NCT00513643|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110256422|NCT00513643|Insulin Aspart|insulin aspart|mesh-list
110256423|NCT00513643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110256425|NCT00151008|Bexarotene|bexarotene|mesh-list
110256426|NCT00151008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110256427|NCT00513877|Bortezomib|bortezomib|mesh-list
110256428|NCT00513877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110256429|NCT04695613|Magnesium Sulfate|magnesium sulfate|mesh-list
110256430|NCT04695613|Analgesics|analgesics|mesh-ancestor
110256431|NCT04695613|Sensory System Agents|sensory system agents|mesh-ancestor
110256432|NCT04695613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110256433|NCT04695613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110256434|NCT04695613|Anesthetics|anesthetics|mesh-ancestor
110256435|NCT04695613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110256436|NCT04695613|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110256437|NCT04695613|Anticonvulsants|anticonvulsants|mesh-ancestor
110256438|NCT04695613|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110256439|NCT04695613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110256440|NCT04695613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256441|NCT04695613|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110256442|NCT04695613|Tocolytic Agents|tocolytic agents|mesh-ancestor
110256443|NCT04695613|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110256444|NCT00151047|Docetaxel|docetaxel|mesh-list
110256445|NCT00151047|Capecitabine|capecitabine|mesh-list
110256446|NCT00151047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110256447|NCT00151047|Tubulin Modulators|tubulin modulators|mesh-ancestor
110256448|NCT00151047|Antimitotic Agents|antimitotic agents|mesh-ancestor
110256449|NCT00151047|Mitosis Modulators|mitosis modulators|mesh-ancestor
110256450|NCT00151047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256451|NCT00151047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110256452|NCT00151047|Antimetabolites|antimetabolites|mesh-ancestor
110256453|NCT00513955|Prednisolone|prednisolone|mesh-list
110256454|NCT00513955|Cyclophosphamide|cyclophosphamide|mesh-list
110256455|NCT00513955|Doxorubicin|doxorubicin|mesh-list
110256456|NCT00513955|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110256457|NCT00513955|Vincristine|vincristine|mesh-list
110256458|NCT00513955|Bortezomib|bortezomib|mesh-list
110256459|NCT00513955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110270974|NCT03421639|Leuprolide|leuprolide|mesh-list
110256460|NCT00513955|Immunologic Factors|immunologic factors|mesh-ancestor
110256461|NCT00513955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110256462|NCT00513955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110256463|NCT00513955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110256464|NCT00513955|Alkylating Agents|alkylating agents|mesh-ancestor
110256465|NCT00513955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256466|NCT00513955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110256467|NCT00513955|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110256468|NCT00513955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110256469|NCT00513955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110256470|NCT00513955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110256471|NCT00513955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110256472|NCT00513955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110256473|NCT00513955|Tubulin Modulators|tubulin modulators|mesh-ancestor
110256474|NCT00513955|Antimitotic Agents|antimitotic agents|mesh-ancestor
110256475|NCT00513955|Mitosis Modulators|mitosis modulators|mesh-ancestor
110256476|NCT00513955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110256477|NCT00513955|Glucocorticoids|glucocorticoids|mesh-ancestor
110256478|NCT00513955|Hormones|hormones|mesh-ancestor
110256479|NCT00513955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110256480|NCT00513955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110256481|NCT00513994|Nitroglycerin|nitroglycerin|mesh-list
110256482|NCT00513994|Vasodilator Agents|vasodilator agents|mesh-ancestor
110256483|NCT00514072|Vaccines|vaccines|mesh-list
110256484|NCT00514072|BCG Vaccine|bcg vaccine|mesh-list
110256485|NCT00514072|Immunologic Factors|immunologic factors|mesh-ancestor
110256486|NCT00514072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110256487|NCT00514072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110256488|NCT00514111|Interferons|interferons|mesh-list
110256489|NCT00514111|Ribavirin|ribavirin|mesh-list
110256490|NCT00514111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110256491|NCT00514111|Antiviral Agents|antiviral agents|mesh-ancestor
110256492|NCT00514111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110256493|NCT00514111|Antimetabolites|antimetabolites|mesh-ancestor
110256494|NCT00514111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256495|NCT00151086|Vinorelbine|vinorelbine|mesh-list
110256496|NCT00151086|Estramustine|estramustine|mesh-list
110256497|NCT00151086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110256498|NCT00151086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110256499|NCT00151086|Tubulin Modulators|tubulin modulators|mesh-ancestor
110256500|NCT00151086|Antimitotic Agents|antimitotic agents|mesh-ancestor
110256501|NCT00151086|Mitosis Modulators|mitosis modulators|mesh-ancestor
110256502|NCT00151086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256503|NCT00151086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110256504|NCT00151086|Alkylating Agents|alkylating agents|mesh-ancestor
110256505|NCT00151086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110256506|NCT00514228|Sunitinib|sunitinib|mesh-list
110256507|NCT00514228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110256508|NCT00514228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110256509|NCT00514228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110256510|NCT00514228|Growth Substances|growth substances|mesh-ancestor
110256511|NCT00514228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110256512|NCT00514228|Growth Inhibitors|growth inhibitors|mesh-ancestor
110256513|NCT00514228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110256514|NCT00514228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110256515|NCT00514228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256516|NCT00151125|Oprelvekin|oprelvekin|mesh-list
110256517|NCT00151125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110256518|NCT00514618|Misoprostol|misoprostol|mesh-list
110256519|NCT00514618|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110256520|NCT00514618|Abortifacient Agents|abortifacient agents|mesh-ancestor
110256521|NCT00514618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110256522|NCT00514618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110256523|NCT00514618|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110256524|NCT00514618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110256526|NCT00514657|Mitogens|mitogens|mesh-list
110256527|NCT00514657|Mitosis Modulators|mitosis modulators|mesh-ancestor
110256528|NCT00514657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256529|NCT00514774|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
110256530|NCT00514774|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110256531|NCT00514774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110256532|NCT02951260|Metformin|metformin|mesh-list
110256533|NCT02951260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110256534|NCT02951260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110256535|NCT02951299|Pentoxifylline|pentoxifylline|mesh-list
110256536|NCT02951299|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110256537|NCT02951299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110256538|NCT02951299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256539|NCT02951299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110256540|NCT02951299|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110256541|NCT02951299|Protective Agents|protective agents|mesh-ancestor
110256542|NCT02951299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110256543|NCT02951299|Vasodilator Agents|vasodilator agents|mesh-ancestor
110256544|NCT02951299|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110256545|NCT02951299|Antioxidants|antioxidants|mesh-ancestor
110256546|NCT00514891|Vitamin A|vitamin a|mesh-list
110256547|NCT00514891|Vitamins|vitamins|mesh-ancestor
110256548|NCT00514891|Micronutrients|micronutrients|mesh-ancestor
110256549|NCT00514891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110256550|NCT00514969|Imatinib Mesylate|imatinib mesylate|mesh-list
110256551|NCT00514969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110256552|NCT00514969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110256553|NCT00514969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110256554|NCT00514969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256555|NCT02950948|Progesterone|progesterone|mesh-list
110256556|NCT02950948|Progestins|progestins|mesh-ancestor
110256557|NCT02950948|Hormones|hormones|mesh-ancestor
110256558|NCT02950948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110256559|NCT02950948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110256560|NCT00515320|Fluoxetine|fluoxetine|mesh-list
110256561|NCT00515320|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110256562|NCT00515320|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110256563|NCT00515320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110256564|NCT00515320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256565|NCT00515320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110256566|NCT00515320|Serotonin Agents|serotonin agents|mesh-ancestor
110256567|NCT00515320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110256568|NCT00515320|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110256569|NCT00515320|Antidepressive Agents|antidepressive agents|mesh-ancestor
110256571|NCT00515320|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110256572|NCT00515320|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110256573|NCT00515320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110256574|NCT00515359|Propofol|propofol|mesh-list
110256575|NCT00515359|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110256576|NCT00515359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110256577|NCT00515359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110256578|NCT00515359|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110256579|NCT00515359|Anesthetics, General|anesthetics, general|mesh-ancestor
110256580|NCT00515359|Anesthetics|anesthetics|mesh-ancestor
110256581|NCT00515554|Rituximab|rituximab|mesh-list
110256582|NCT00515554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110256583|NCT00515554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110256584|NCT00515554|Immunologic Factors|immunologic factors|mesh-ancestor
110256585|NCT00515554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110256586|NCT00515554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110256587|NCT00151203|Clarithromycin|clarithromycin|mesh-list
110256588|NCT00151203|Dexamethasone|dexamethasone|mesh-list
110256589|NCT00151203|Lenalidomide|lenalidomide|mesh-list
110256590|NCT00151203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110256591|NCT00151203|Antiemetics|antiemetics|mesh-ancestor
110256592|NCT00151203|Autonomic Agents|autonomic agents|mesh-ancestor
110256593|NCT00151203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110256594|NCT00151203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110256595|NCT00151203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110256596|NCT00151203|Glucocorticoids|glucocorticoids|mesh-ancestor
110256597|NCT00151203|Hormones|hormones|mesh-ancestor
110256598|NCT00151203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110256599|NCT00151203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110256600|NCT00151203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110256601|NCT00151203|Immunologic Factors|immunologic factors|mesh-ancestor
110256602|NCT00151203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110256603|NCT00151203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110256604|NCT00151203|Growth Substances|growth substances|mesh-ancestor
110256605|NCT00151203|Growth Inhibitors|growth inhibitors|mesh-ancestor
110256606|NCT00151203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110256607|NCT00151203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110256608|NCT00151203|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110256609|NCT00151203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110256610|NCT00151203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256611|NCT00151203|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110256612|NCT00151203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110256613|NCT04620200|Nivolumab|nivolumab|mesh-list
110256614|NCT04620200|Ipilimumab|ipilimumab|mesh-list
110256615|NCT04620200|Immunomodulating Agents|immunomodulating agents|mesh-list
110256616|NCT04620200|Immunologic Factors|immunologic factors|mesh-list
110256617|NCT04620200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110256618|NCT04620200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110256619|NCT04620200|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110256620|NCT04620200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256621|NCT04620200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110256622|NCT00515593|Hormones|hormones|mesh-list
110256623|NCT00515593|Parathyroid Hormone|parathyroid hormone|mesh-list
110256624|NCT00515593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110256625|NCT00515593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110256626|NCT00515593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110256627|NCT00515788|Cytarabine|cytarabine|mesh-list
110256628|NCT00515788|Temozolomide|temozolomide|mesh-list
110256629|NCT00515788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110256630|NCT00515788|Antimetabolites|antimetabolites|mesh-ancestor
110256631|NCT00515788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256632|NCT00515788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110256633|NCT00515788|Antiviral Agents|antiviral agents|mesh-ancestor
110256634|NCT00515788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110256635|NCT00515788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110256636|NCT00515788|Immunologic Factors|immunologic factors|mesh-ancestor
110256637|NCT00515788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110256638|NCT00515788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110256639|NCT00515788|Alkylating Agents|alkylating agents|mesh-ancestor
110256640|NCT02950870|Ritonavir|ritonavir|mesh-list
110256641|NCT02950870|Ribavirin|ribavirin|mesh-list
110256642|NCT02950870|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110256643|NCT02950870|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110256645|NCT02950870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110256646|NCT02950870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256647|NCT02950870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110256648|NCT02950870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110256649|NCT02950870|Antiviral Agents|antiviral agents|mesh-ancestor
110256650|NCT02950870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110256651|NCT02950870|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110256652|NCT02950870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110256653|NCT02950870|Antimetabolites|antimetabolites|mesh-ancestor
110256654|NCT00515866|Gemcitabine|gemcitabine|mesh-list
110256655|NCT00515866|Olaparib|olaparib|mesh-list
110256656|NCT00515866|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
110256657|NCT00515866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110256658|NCT00515866|Antimetabolites|antimetabolites|mesh-ancestor
110256659|NCT00515866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256661|NCT00515866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110256662|NCT00515905|Propofol|propofol|mesh-list
110256663|NCT00515905|Sevoflurane|sevoflurane|mesh-list
110256664|NCT00515905|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110256665|NCT00515905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110256666|NCT00515905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110256667|NCT00515905|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110256668|NCT00515905|Anesthetics, General|anesthetics, general|mesh-ancestor
110256669|NCT00515905|Anesthetics|anesthetics|mesh-ancestor
110256670|NCT00515905|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110256671|NCT00515905|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110256672|NCT00515944|Botulinum Toxins|botulinum toxins|mesh-list
110256673|NCT00515944|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110256674|NCT00515944|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110256675|NCT00515944|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110256676|NCT00515944|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110256677|NCT00515944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256678|NCT00515944|Cholinergic Agents|cholinergic agents|mesh-ancestor
110256679|NCT00515944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110256680|NCT00515944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110256681|NCT00515944|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110256682|NCT00515944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110256683|NCT00151242|Cytarabine|cytarabine|mesh-list
110256684|NCT00151242|Etoposide|etoposide|mesh-list
110256685|NCT00151242|Idarubicin|idarubicin|mesh-list
110256686|NCT00151242|Tretinoin|tretinoin|mesh-list
110256687|NCT00151242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110256688|NCT00151242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110256689|NCT00151242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110256690|NCT00151242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110256691|NCT00151242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110256692|NCT00151242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256693|NCT00151242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110256694|NCT00151242|Antimetabolites|antimetabolites|mesh-ancestor
110256695|NCT00151242|Antiviral Agents|antiviral agents|mesh-ancestor
110256696|NCT00151242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110256697|NCT00151242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110256698|NCT00151242|Immunologic Factors|immunologic factors|mesh-ancestor
110256699|NCT00151242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110256700|NCT00151242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110256701|NCT00151242|Keratolytic Agents|keratolytic agents|mesh-ancestor
110256702|NCT00151242|Dermatologic Agents|dermatologic agents|mesh-ancestor
110256703|NCT00516100|Pemetrexed|pemetrexed|mesh-list
110256704|NCT00516100|Bortezomib|bortezomib|mesh-list
110256705|NCT00516100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110256706|NCT00516100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110256707|NCT00516100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256708|NCT00516100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110256709|NCT00516100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110256710|NCT00166413|Thalidomide|thalidomide|mesh-list
110256711|NCT00166413|Lenalidomide|lenalidomide|mesh-list
110256712|NCT00166413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110256713|NCT00166413|Immunologic Factors|immunologic factors|mesh-ancestor
110256714|NCT00166413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110256715|NCT00166413|Leprostatic Agents|leprostatic agents|mesh-ancestor
110256716|NCT00166413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110256717|NCT00166413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110256718|NCT00166413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110256719|NCT00166413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110256720|NCT00166413|Growth Substances|growth substances|mesh-ancestor
110256721|NCT00166413|Growth Inhibitors|growth inhibitors|mesh-ancestor
110256722|NCT00166413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110256723|NCT02950441|Niacinamide|niacinamide|mesh-list
110256724|NCT02950441|Niacin|niacin|mesh-list
110256725|NCT02950441|Nicotinic Acids|nicotinic acids|mesh-list
110256726|NCT02950441|Vitamin B Complex|vitamin b complex|mesh-ancestor
110256727|NCT02950441|Vitamins|vitamins|mesh-ancestor
110256728|NCT02950441|Micronutrients|micronutrients|mesh-ancestor
110256729|NCT02950441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110256730|NCT02950441|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110256731|NCT02950441|Antimetabolites|antimetabolites|mesh-ancestor
110256732|NCT02950441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256733|NCT02950441|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110256734|NCT02950441|Vasodilator Agents|vasodilator agents|mesh-ancestor
110256735|NCT02950246|Chlorhexidine|chlorhexidine|mesh-list
110256736|NCT02950246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110256737|NCT02950246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110256738|NCT02950246|Disinfectants|disinfectants|mesh-ancestor
110256739|NCT02950168|Edoxaban|edoxaban|mesh-list
110256740|NCT02950168|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110256741|NCT02950168|Antithrombins|antithrombins|mesh-ancestor
110256742|NCT02950168|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110256743|NCT02950168|Protease Inhibitors|protease inhibitors|mesh-ancestor
110256744|NCT02950168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110256745|NCT02950168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256746|NCT02950168|Anticoagulants|anticoagulants|mesh-ancestor
110256747|NCT04695223|Arsenic Trioxide|arsenic trioxide|mesh-list
110256748|NCT04695223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110256749|NCT00166491|Insulin|insulin|mesh-list
110256750|NCT00166491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110256751|NCT00166491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110256752|NCT00508885|Niacinamide|niacinamide|mesh-list
110256754|NCT00508885|Nicotinic Acids|nicotinic acids|mesh-list
110256755|NCT00508885|Vitamin B Complex|vitamin b complex|mesh-ancestor
110256756|NCT00508885|Vitamins|vitamins|mesh-ancestor
110256757|NCT00508885|Micronutrients|micronutrients|mesh-ancestor
110256758|NCT00508885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110256759|NCT00508885|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110256760|NCT00508885|Antimetabolites|antimetabolites|mesh-ancestor
110256761|NCT00508885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256762|NCT00508885|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110256763|NCT00508885|Vasodilator Agents|vasodilator agents|mesh-ancestor
110256764|NCT02953405|Clopidogrel|clopidogrel|mesh-list
110256765|NCT02953405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110271044|NCT00166127|Simendan|simendan|mesh-list
110256766|NCT02953405|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110256767|NCT02953405|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110256768|NCT02953405|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110256769|NCT02953405|Purinergic Agents|purinergic agents|mesh-ancestor
110256770|NCT02953405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110256771|NCT02953405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256772|NCT02953405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110256773|NCT00516802|Olaparib|olaparib|mesh-list
110256774|NCT00516802|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
110256775|NCT00516802|Dacarbazine|dacarbazine|mesh-list
110256776|NCT00516802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110256777|NCT00516802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256778|NCT00516802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110256779|NCT00516802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110256780|NCT00516802|Alkylating Agents|alkylating agents|mesh-ancestor
110256781|NCT05861466|Ranibizumab|ranibizumab|mesh-list
110256783|NCT05861466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110256784|NCT05861466|Growth Substances|growth substances|mesh-ancestor
110256785|NCT05861466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110256786|NCT05861466|Growth Inhibitors|growth inhibitors|mesh-ancestor
110256789|NCT05861336|Gemcitabine|gemcitabine|mesh-list
110256790|NCT05861336|Losartan|losartan|mesh-list
110256791|NCT05861336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110256792|NCT05861336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110256793|NCT05861336|Tubulin Modulators|tubulin modulators|mesh-ancestor
110256794|NCT05861336|Antimitotic Agents|antimitotic agents|mesh-ancestor
110256795|NCT05861336|Mitosis Modulators|mitosis modulators|mesh-ancestor
110256796|NCT05861336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256797|NCT05861336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110256798|NCT05861336|Antimetabolites|antimetabolites|mesh-ancestor
110256799|NCT05861336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110256800|NCT05861336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110256801|NCT05861336|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110256802|NCT05861336|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110256803|NCT05861310|Metronidazole|metronidazole|mesh-list
110256804|NCT05861310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110256805|NCT05861310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110256806|NCT05861310|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110256807|NCT05861310|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110256808|NCT05861297|Dexamethasone|dexamethasone|mesh-list
110256809|NCT05861297|Prednisolone|prednisolone|mesh-list
110256810|NCT05861297|Rituximab|rituximab|mesh-list
110256811|NCT05861297|Azathioprine|azathioprine|mesh-list
110256812|NCT05861297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110256813|NCT05861297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110256814|NCT05861297|Immunologic Factors|immunologic factors|mesh-ancestor
110256815|NCT05861297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110256816|NCT05861297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110256817|NCT05861297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110256818|NCT05861297|Antiemetics|antiemetics|mesh-ancestor
110256819|NCT05861297|Autonomic Agents|autonomic agents|mesh-ancestor
110256820|NCT05861297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110256821|NCT05861297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110256822|NCT05861297|Glucocorticoids|glucocorticoids|mesh-ancestor
110256823|NCT05861297|Hormones|hormones|mesh-ancestor
110256824|NCT05861297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110256825|NCT05861297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110256827|NCT05861297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256828|NCT05861297|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110256829|NCT05861297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110256830|NCT05861271|Capecitabine|capecitabine|mesh-list
110256831|NCT05861271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110256832|NCT05861271|Antimetabolites|antimetabolites|mesh-ancestor
110256833|NCT05861271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256834|NCT05861271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110256835|NCT05861206|Listerine|listerine|mesh-list
110256836|NCT05861206|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110256837|NCT05861206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110256838|NCT05861154|Benzocaine|benzocaine|mesh-list
110256839|NCT05861154|Anesthetics, Local|anesthetics, local|mesh-ancestor
110256840|NCT05861154|Anesthetics|anesthetics|mesh-ancestor
110256841|NCT05861154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110256842|NCT05861154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110256843|NCT05861154|Sensory System Agents|sensory system agents|mesh-ancestor
110256844|NCT05861154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110256845|NCT05861063|Lidocaine|lidocaine|mesh-list
110256847|NCT05861063|Anesthetics, Local|anesthetics, local|mesh-ancestor
110256848|NCT05861063|Anesthetics|anesthetics|mesh-ancestor
110256849|NCT05861063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110256850|NCT05861063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110256851|NCT05861063|Sensory System Agents|sensory system agents|mesh-ancestor
110256852|NCT05861063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110256853|NCT05861063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110256854|NCT05861063|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110256855|NCT05861063|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110256856|NCT05861063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110256857|NCT05861063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256858|NCT05861063|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110256859|NCT05861063|Narcotics|narcotics|mesh-ancestor
110256860|NCT05861063|Analgesics|analgesics|mesh-ancestor
110256861|NCT05860699|Ethanol|ethanol|mesh-list
110256862|NCT05860699|Cannabidiol|cannabidiol|mesh-list
110256863|NCT05860699|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110256864|NCT05860699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110256865|NCT05860699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110256866|NCT05860699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110256867|NCT05860699|Anticonvulsants|anticonvulsants|mesh-ancestor
110256868|NCT05860335|Paclitaxel|paclitaxel|mesh-list
110256869|NCT05860335|Nedaplatin|nedaplatin|mesh-list
110256870|NCT05860335|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110256871|NCT05860335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110256872|NCT05860335|Tubulin Modulators|tubulin modulators|mesh-ancestor
110256873|NCT05860335|Antimitotic Agents|antimitotic agents|mesh-ancestor
110256874|NCT05860335|Mitosis Modulators|mitosis modulators|mesh-ancestor
110256875|NCT05860335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256876|NCT05860244|Albuterol|albuterol|mesh-list
110256877|NCT05860244|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110256878|NCT05860244|Autonomic Agents|autonomic agents|mesh-ancestor
110256879|NCT05860244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110256880|NCT05860244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110256881|NCT05860244|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110256882|NCT05860244|Respiratory System Agents|respiratory system agents|mesh-ancestor
110256883|NCT05860244|Tocolytic Agents|tocolytic agents|mesh-ancestor
110256884|NCT05860244|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110256885|NCT05860244|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110256886|NCT05860244|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110256887|NCT05860244|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110256888|NCT05860244|Adrenergic Agents|adrenergic agents|mesh-ancestor
110256889|NCT05860244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110256890|NCT05860244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256891|NCT05860153|Diazepam|diazepam|mesh-list
110256892|NCT05860153|Levetiracetam|levetiracetam|mesh-list
110256893|NCT05860153|Anticonvulsants|anticonvulsants|mesh-ancestor
110256894|NCT05860153|Nootropic Agents|nootropic agents|mesh-ancestor
110256895|NCT05860153|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110256897|NCT05860153|Autonomic Agents|autonomic agents|mesh-ancestor
110256898|NCT05860153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110256899|NCT05860153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110256900|NCT05860153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110256901|NCT05860153|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110256902|NCT05860153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110256903|NCT05860153|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110256904|NCT05860153|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110256905|NCT05860153|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110256906|NCT05860153|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110256907|NCT05860153|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110256908|NCT05860153|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110256909|NCT05860153|Anesthetics, General|anesthetics, general|mesh-ancestor
110256910|NCT05860153|Anesthetics|anesthetics|mesh-ancestor
110256911|NCT05860153|GABA Modulators|gaba modulators|mesh-ancestor
110256912|NCT05860153|GABA Agents|gaba agents|mesh-ancestor
110256913|NCT05860153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110256914|NCT05860153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256915|NCT05860114|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
110256916|NCT05860114|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110256917|NCT05860114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110256918|NCT05860114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256919|NCT05860062|Vitamin D|vitamin d|mesh-list
110256920|NCT05860062|Calcium|calcium|mesh-list
110256921|NCT05860062|Vitamins|vitamins|mesh-ancestor
110256922|NCT05860062|Micronutrients|micronutrients|mesh-ancestor
110256923|NCT05860062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110256924|NCT05860062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110256925|NCT05860062|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110256926|NCT05860010|Epinephrine|epinephrine|mesh-list
110256927|NCT05860010|Dexmedetomidine|dexmedetomidine|mesh-list
110256929|NCT05860010|Anesthetics, Local|anesthetics, local|mesh-ancestor
110256930|NCT05860010|Anesthetics|anesthetics|mesh-ancestor
110256931|NCT05860010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110256932|NCT05860010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110256933|NCT05860010|Sensory System Agents|sensory system agents|mesh-ancestor
110256934|NCT05860010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110256935|NCT05860010|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110256936|NCT05860010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110256937|NCT05860010|Analgesics|analgesics|mesh-ancestor
110256938|NCT05860010|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110256939|NCT05860010|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110256940|NCT05860010|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110256941|NCT05860010|Adrenergic Agents|adrenergic agents|mesh-ancestor
110256942|NCT05860010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110256943|NCT05860010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256944|NCT05860010|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110256945|NCT05860010|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110256946|NCT05860010|Autonomic Agents|autonomic agents|mesh-ancestor
110256947|NCT05860010|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110256948|NCT05860010|Respiratory System Agents|respiratory system agents|mesh-ancestor
110256949|NCT05860010|Mydriatics|mydriatics|mesh-ancestor
110256950|NCT05860010|Sympathomimetics|sympathomimetics|mesh-ancestor
110256951|NCT05860010|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110256952|NCT05859984|Interferons|interferons|mesh-list
110256953|NCT05859984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110256954|NCT05859984|Antiviral Agents|antiviral agents|mesh-ancestor
110256955|NCT05859984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110256956|NCT05859802|4-Aminopyridine|4-aminopyridine|mesh-list
110256957|NCT05859802|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110256958|NCT05859802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110256959|NCT05859802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256961|NCT05859750|Gemcitabine|gemcitabine|mesh-list
110256962|NCT05859750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110256963|NCT05859750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110256964|NCT05859750|Tubulin Modulators|tubulin modulators|mesh-ancestor
110256965|NCT05859750|Antimitotic Agents|antimitotic agents|mesh-ancestor
110256966|NCT05859750|Mitosis Modulators|mitosis modulators|mesh-ancestor
110256967|NCT05859750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256968|NCT05859750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110256969|NCT05859750|Antimetabolites|antimetabolites|mesh-ancestor
110256970|NCT05859477|Capecitabine|capecitabine|mesh-list
110256971|NCT05859477|Oxaliplatin|oxaliplatin|mesh-list
110256972|NCT05859477|Nivolumab|nivolumab|mesh-list
110256973|NCT05859477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110256974|NCT05859477|Antimetabolites|antimetabolites|mesh-ancestor
110256975|NCT05859477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256976|NCT05859477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110256977|NCT05859477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110256978|NCT05859477|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110256979|NCT05859412|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110256980|NCT05859412|Methylprednisolone|methylprednisolone|mesh-list
110256981|NCT05859412|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110256982|NCT05859412|Prednisolone|prednisolone|mesh-list
110256983|NCT05859412|Prednisolone acetate|prednisolone acetate|mesh-list
110256984|NCT05859412|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110256985|NCT05859412|Prednisolone phosphate|prednisolone phosphate|mesh-list
110256986|NCT05859412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110256987|NCT05859412|Antiemetics|antiemetics|mesh-ancestor
110256988|NCT05859412|Autonomic Agents|autonomic agents|mesh-ancestor
110256989|NCT05859412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110256990|NCT05859412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110256992|NCT05859412|Glucocorticoids|glucocorticoids|mesh-ancestor
110256994|NCT05859412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110256995|NCT05859412|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110256996|NCT05859412|Protective Agents|protective agents|mesh-ancestor
110256997|NCT05859412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110256998|NCT05859412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110256999|NCT05858918|Clopidogrel|clopidogrel|mesh-list
110257000|NCT05858918|Ticagrelor|ticagrelor|mesh-list
110257001|NCT05858918|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110257002|NCT05858918|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110257003|NCT05858918|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110257004|NCT05858918|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110257005|NCT05858918|Purinergic Agents|purinergic agents|mesh-ancestor
110257006|NCT05858918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110257007|NCT05858918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110257008|NCT05858918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110257009|NCT05856877|Insulin|insulin|mesh-list
110257010|NCT05856877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110257011|NCT05856877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110257012|NCT05856864|Ramucirumab|ramucirumab|mesh-list
110257013|NCT05856864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110257014|NCT05829187|Primaquine|primaquine|mesh-list
110257015|NCT05829187|Piperaquine|piperaquine|mesh-list
110257016|NCT05829187|Artenimol|artenimol|mesh-list
110257017|NCT05829187|Antimalarials|antimalarials|mesh-ancestor
110257018|NCT05829187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110257019|NCT05829187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110032250|NCT01396564|Pioglitazone|pioglitazone|mesh-list
110257020|NCT05829187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110257021|NCT05779644|Metformin|metformin|mesh-list
110257022|NCT05779644|Liraglutide|liraglutide|mesh-list
110257023|NCT05779644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110257024|NCT05779644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110257025|NCT05779644|Incretins|incretins|mesh-ancestor
110257026|NCT05779644|Hormones|hormones|mesh-ancestor
110257027|NCT05779644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110257028|NCT05749211|Niraparib|niraparib|mesh-list
110257029|NCT05749211|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110257030|NCT05749211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110257031|NCT05749211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110257032|NCT05749211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110257033|NCT05748093|Cobicistat|cobicistat|mesh-list
110257034|NCT05748093|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110257035|NCT05748093|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110257036|NCT05748093|Antiviral Agents|antiviral agents|mesh-ancestor
110257037|NCT05748093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110257038|NCT05748093|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110257039|NCT05748093|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110257040|NCT05748093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110257041|NCT05748093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110257042|NCT05731596|Ubiquinone|ubiquinone|mesh-list
110257043|NCT05731596|Coenzyme Q10|coenzyme q10|mesh-list
110257044|NCT05731596|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110257045|NCT05731596|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110257046|NCT05731596|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110257047|NCT05731596|Antimetabolites|antimetabolites|mesh-ancestor
110257048|NCT05731596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110257049|NCT05731596|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110257050|NCT05731596|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110257051|NCT05731596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110257052|NCT05731596|Micronutrients|micronutrients|mesh-ancestor
110257053|NCT05731596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110257055|NCT05722782|Acetaminophen|acetaminophen|mesh-list
110257056|NCT05722782|Piroxicam|piroxicam|mesh-list
110257057|NCT05722782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110257058|NCT05722782|Analgesics|analgesics|mesh-ancestor
110257059|NCT05722782|Sensory System Agents|sensory system agents|mesh-ancestor
110257060|NCT05722782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110257061|NCT05722782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110257062|NCT05722782|Antipyretics|antipyretics|mesh-ancestor
110257063|NCT05722782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110257064|NCT05722782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110257065|NCT05722782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110257066|NCT05722782|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110257067|NCT05722782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110257068|NCT05722782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110257069|NCT05710328|Deoxyglucose|deoxyglucose|mesh-list
110257070|NCT05710328|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110257071|NCT05710328|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110257072|NCT05710328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110257075|NCT05710328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110257076|NCT05709990|Vitamin D|vitamin d|mesh-list
110257077|NCT05709990|Cholecalciferol|cholecalciferol|mesh-list
110257078|NCT05709990|Solifenacin Succinate|solifenacin succinate|mesh-list
110257079|NCT05709990|Vitamins|vitamins|mesh-ancestor
110257080|NCT05709990|Micronutrients|micronutrients|mesh-ancestor
110257081|NCT05709990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110257082|NCT05709990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110257083|NCT05709990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110257084|NCT05709990|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110257085|NCT05709990|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110257086|NCT05709990|Cholinergic Agents|cholinergic agents|mesh-ancestor
110257087|NCT05709990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110257088|NCT05709990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110257089|NCT05709990|Urological Agents|urological agents|mesh-ancestor
110257090|NCT05684744|Methotrexate|methotrexate|mesh-list
110257091|NCT05684744|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110257092|NCT05684744|Abortifacient Agents|abortifacient agents|mesh-ancestor
110257093|NCT05684744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110257094|NCT05684744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110257095|NCT05684744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110257096|NCT05684744|Antimetabolites|antimetabolites|mesh-ancestor
110368711|NCT00558090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110257097|NCT05684744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110257098|NCT05684744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110257100|NCT05684744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110257101|NCT05684744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110257102|NCT05684744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110257103|NCT05684744|Immunologic Factors|immunologic factors|mesh-ancestor
110257104|NCT05684744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110257105|NCT05684744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110257107|NCT05678114|Vitamin B Complex|vitamin b complex|mesh-ancestor
110257108|NCT05678114|Vitamins|vitamins|mesh-ancestor
110257109|NCT05678114|Micronutrients|micronutrients|mesh-ancestor
110257110|NCT05678114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110257111|NCT05675787|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110257112|NCT05675787|Atorvastatin|atorvastatin|mesh-list
110257113|NCT05675787|Medroxyprogesterone|medroxyprogesterone|mesh-list
110257114|NCT05675787|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110257115|NCT05675787|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110257116|NCT05675787|Antimetabolites|antimetabolites|mesh-ancestor
110257117|NCT05675787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110257118|NCT05675787|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110257119|NCT05675787|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110257120|NCT05675787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110257121|NCT05675787|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110257122|NCT05675787|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110257123|NCT05675787|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110257124|NCT05675787|Contraceptive Agents|contraceptive agents|mesh-ancestor
110257125|NCT05675787|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110257126|NCT05675787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271124|NCT02042287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110257127|NCT05675787|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110257128|NCT05675787|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110257129|NCT05675787|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110257130|NCT05675787|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110257131|NCT05675787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110257132|NCT05662527|Pembrolizumab|pembrolizumab|mesh-list
110257133|NCT05662527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110257134|NCT05662527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110257135|NCT05662527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110257136|NCT05662527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110257137|NCT05576792|Ranibizumab|ranibizumab|mesh-list
110257138|NCT05576792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110257139|NCT05576792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110257140|NCT05576792|Growth Substances|growth substances|mesh-ancestor
110257141|NCT05576792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110257142|NCT05576792|Growth Inhibitors|growth inhibitors|mesh-ancestor
110257143|NCT05576792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110257144|NCT05501665|Deoxyglucose|deoxyglucose|mesh-list
110257146|NCT05501665|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110257147|NCT05501665|Carboplatin|carboplatin|mesh-list
110257148|NCT05501665|Pembrolizumab|pembrolizumab|mesh-list
110257149|NCT05501665|Pemetrexed|pemetrexed|mesh-list
110257150|NCT05501665|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110257151|NCT05501665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110257152|NCT05501665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110257153|NCT05501665|Tubulin Modulators|tubulin modulators|mesh-ancestor
110257154|NCT05501665|Antimitotic Agents|antimitotic agents|mesh-ancestor
110257155|NCT05501665|Mitosis Modulators|mitosis modulators|mesh-ancestor
110257156|NCT05501665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110257157|NCT05501665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110257158|NCT05501665|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110257159|NCT05501665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110257160|NCT05501665|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110257161|NCT05501665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110257162|NCT05501665|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110257163|NCT05501665|Antimetabolites|antimetabolites|mesh-ancestor
110257164|NCT05501665|Antiviral Agents|antiviral agents|mesh-ancestor
110257165|NCT05501665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110257166|NCT05494398|Acetylcysteine|acetylcysteine|mesh-list
110257167|NCT05494398|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110257168|NCT05494398|Antiviral Agents|antiviral agents|mesh-ancestor
110257169|NCT05494398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110257170|NCT05494398|Expectorants|expectorants|mesh-ancestor
110257171|NCT05494398|Respiratory System Agents|respiratory system agents|mesh-ancestor
110257172|NCT05494398|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110257173|NCT05494398|Antioxidants|antioxidants|mesh-ancestor
110257174|NCT05494398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110257175|NCT05494398|Protective Agents|protective agents|mesh-ancestor
110257176|NCT05494398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110257177|NCT05494398|Antidotes|antidotes|mesh-ancestor
110257178|NCT05491278|Remifentanil|remifentanil|mesh-list
110257179|NCT05491278|Propofol|propofol|mesh-list
110257180|NCT05491278|Fospropofol|fospropofol|mesh-list
110257181|NCT05491278|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110257182|NCT05491278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110257183|NCT05491278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110257184|NCT05491278|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110257185|NCT05491278|Anesthetics, General|anesthetics, general|mesh-ancestor
110257186|NCT05491278|Anesthetics|anesthetics|mesh-ancestor
110257187|NCT05491278|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110257188|NCT05491278|Narcotics|narcotics|mesh-ancestor
110257189|NCT05491278|Analgesics|analgesics|mesh-ancestor
110257190|NCT05491278|Sensory System Agents|sensory system agents|mesh-ancestor
110257191|NCT05491278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110257192|NCT05463783|Tenofovir|tenofovir|mesh-list
110257193|NCT05463783|Emtricitabine|emtricitabine|mesh-list
110257194|NCT05463783|Darunavir|darunavir|mesh-list
110257195|NCT05463783|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110257196|NCT05463783|Cobicistat|cobicistat|mesh-list
110257197|NCT05463783|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
110257198|NCT05463783|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
110257199|NCT05463783|Antiviral Agents|antiviral agents|mesh-ancestor
110257200|NCT05463783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110257201|NCT05463783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110257202|NCT05463783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110257203|NCT05463783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110257204|NCT05463783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110257205|NCT05463783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110257206|NCT05463783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110257207|NCT05463783|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110257208|NCT05463783|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110257209|NCT05463783|Protease Inhibitors|protease inhibitors|mesh-ancestor
110257210|NCT05463783|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110257211|NCT05463783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110257212|NCT05457582|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
110257213|NCT05457582|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
110257214|NCT05457582|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110257215|NCT05457582|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110257216|NCT05457582|Antimetabolites|antimetabolites|mesh-ancestor
110257217|NCT05457582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110257219|NCT05457582|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110257220|NCT05457582|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110257221|NCT05457582|Protease Inhibitors|protease inhibitors|mesh-ancestor
110257222|NCT05375916|Hydromorphone|hydromorphone|mesh-list
110257223|NCT05375916|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110257224|NCT05375916|Narcotics|narcotics|mesh-ancestor
110257225|NCT05375916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110257226|NCT05375916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110257227|NCT05375916|Analgesics|analgesics|mesh-ancestor
110257228|NCT05375916|Sensory System Agents|sensory system agents|mesh-ancestor
110257229|NCT05375916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110257230|NCT05359354|Vaccines|vaccines|mesh-list
110257231|NCT05359354|Immunologic Factors|immunologic factors|mesh-ancestor
110257232|NCT05359354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110257234|NCT05346562|Anticonvulsants|anticonvulsants|mesh-ancestor
110257235|NCT05313529|Metformin|metformin|mesh-list
110257236|NCT05313529|Liraglutide|liraglutide|mesh-list
110257237|NCT05313529|Empagliflozin|empagliflozin|mesh-list
110257238|NCT05313529|Linagliptin|linagliptin|mesh-list
110257239|NCT05313529|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110257240|NCT05313529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110257241|NCT05313529|Incretins|incretins|mesh-ancestor
110257242|NCT05313529|Hormones|hormones|mesh-ancestor
110257243|NCT05313529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110257244|NCT05313529|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110257245|NCT05313529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110257246|NCT05313529|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110257247|NCT05313529|Protease Inhibitors|protease inhibitors|mesh-ancestor
110257248|NCT05313529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110257249|NCT05287633|Esomeprazole|esomeprazole|mesh-list
110257250|NCT05287633|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110257251|NCT05287633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110257252|NCT05287633|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110257253|NCT05287633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110257254|NCT05287633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110257255|NCT05285449|Cannabidiol|cannabidiol|mesh-list
110257256|NCT05285449|Anticonvulsants|anticonvulsants|mesh-ancestor
110257257|NCT05238597|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110257258|NCT05238597|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110257259|NCT05226598|Paclitaxel|paclitaxel|mesh-list
110257260|NCT05226598|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110257261|NCT05226598|Carboplatin|carboplatin|mesh-list
110257262|NCT05226598|Pembrolizumab|pembrolizumab|mesh-list
110257263|NCT05226598|Pemetrexed|pemetrexed|mesh-list
110257264|NCT05226598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110257265|NCT05226598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110257266|NCT05226598|Tubulin Modulators|tubulin modulators|mesh-ancestor
110257267|NCT05226598|Antimitotic Agents|antimitotic agents|mesh-ancestor
110257268|NCT05226598|Mitosis Modulators|mitosis modulators|mesh-ancestor
110257269|NCT05226598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110257270|NCT05226598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110257271|NCT05226598|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110257272|NCT05226598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110257273|NCT05226598|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110257274|NCT05226598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110257275|NCT05221320|Hydroxychloroquine|hydroxychloroquine|mesh-list
110257276|NCT05221320|Antimalarials|antimalarials|mesh-ancestor
110257277|NCT05221320|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110257278|NCT05221320|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110257279|NCT05221320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110257280|NCT05221320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110257281|NCT05221320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110257282|NCT05221320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110257283|NCT05190705|Dexamethasone|dexamethasone|mesh-list
110257284|NCT05190705|Dexamethasone acetate|dexamethasone acetate|mesh-list
110257285|NCT05190705|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
110257287|NCT05190705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110257288|NCT05190705|Antiemetics|antiemetics|mesh-ancestor
110257289|NCT05190705|Autonomic Agents|autonomic agents|mesh-ancestor
110257290|NCT05190705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110257291|NCT05190705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110257292|NCT05190705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110257293|NCT05190705|Glucocorticoids|glucocorticoids|mesh-ancestor
110257295|NCT05190705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110257296|NCT05190705|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110257297|NCT05190705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110257298|NCT05190705|Protease Inhibitors|protease inhibitors|mesh-ancestor
110257299|NCT05190705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110257300|NCT05190705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110257301|NCT05190705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110257302|NCT05188118|Nivolumab|nivolumab|mesh-list
110257303|NCT05188118|Ipilimumab|ipilimumab|mesh-list
110257304|NCT05188118|Everolimus|everolimus|mesh-list
110257305|NCT05188118|Lenvatinib|lenvatinib|mesh-list
110257306|NCT05188118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110257307|NCT05188118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110257308|NCT05188118|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110257309|NCT05188118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110257310|NCT05188118|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110257311|NCT05188118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110257312|NCT05188118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110257313|NCT05188118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110257314|NCT05188118|Immunologic Factors|immunologic factors|mesh-ancestor
110257315|NCT05188118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110257316|NCT05172908|Dexamethasone|dexamethasone|mesh-list
110257317|NCT05172908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110257318|NCT05172908|Antiemetics|antiemetics|mesh-ancestor
110257319|NCT05172908|Autonomic Agents|autonomic agents|mesh-ancestor
110257320|NCT05172908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110257321|NCT05172908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110257322|NCT05172908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110257324|NCT05172908|Hormones|hormones|mesh-ancestor
110257325|NCT05172908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110257326|NCT05172908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110257327|NCT05172908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110257328|NCT05140512|Goserelin|goserelin|mesh-list
110257329|NCT05140512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110257330|NCT05140512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110257331|NCT05110170|Goserelin|goserelin|mesh-list
110257332|NCT05110170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110257333|NCT05110170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110257334|NCT04971499|Dapansutrile|dapansutrile|mesh-list
110257335|NCT04971499|Pembrolizumab|pembrolizumab|mesh-list
110257336|NCT04971499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110257337|NCT04971499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110257338|NCT04971499|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110257339|NCT04971499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110257340|NCT04971499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110257341|NCT04918017|Esomeprazole|esomeprazole|mesh-list
110257342|NCT04918017|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
110257343|NCT04918017|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110257344|NCT04918017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110257345|NCT04918017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110257346|NCT04918017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110257347|NCT04898231|Methylprednisolone|methylprednisolone|mesh-list
110257348|NCT04898231|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110257350|NCT04898231|Prednisolone|prednisolone|mesh-list
110257351|NCT04898231|Prednisolone acetate|prednisolone acetate|mesh-list
110257352|NCT04898231|Infliximab|infliximab|mesh-list
110257353|NCT04898231|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110257354|NCT04898231|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110257355|NCT04898231|Prednisolone phosphate|prednisolone phosphate|mesh-list
110257356|NCT04898231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110257357|NCT04898231|Antiemetics|antiemetics|mesh-ancestor
110257358|NCT04898231|Autonomic Agents|autonomic agents|mesh-ancestor
110257359|NCT04898231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110257360|NCT04898231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110257361|NCT04898231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110257362|NCT04898231|Glucocorticoids|glucocorticoids|mesh-ancestor
110257363|NCT04898231|Hormones|hormones|mesh-ancestor
110257364|NCT04898231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110257365|NCT04898231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110257366|NCT04898231|Protective Agents|protective agents|mesh-ancestor
110257367|NCT04898231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110257368|NCT04898231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110257369|NCT04898231|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110257370|NCT04898231|Dermatologic Agents|dermatologic agents|mesh-ancestor
110257371|NCT04898231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110257372|NCT04849026|Clozapine|clozapine|mesh-list
110257373|NCT04849026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110257374|NCT04849026|Serotonin Agents|serotonin agents|mesh-ancestor
110257375|NCT04849026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110257376|NCT04849026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110257377|NCT04849026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110257379|NCT04849026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110257380|NCT04849026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110257381|NCT04849026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110257382|NCT04849026|GABA Antagonists|gaba antagonists|mesh-ancestor
110257384|NCT04841980|Rifaximin|rifaximin|mesh-list
110257385|NCT04841980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110257386|NCT04841980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110257387|NCT04841980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110257388|NCT04831736|Ketamine|ketamine|mesh-list
110257389|NCT04831736|Analgesics|analgesics|mesh-ancestor
110257390|NCT04831736|Sensory System Agents|sensory system agents|mesh-ancestor
110257391|NCT04831736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110257392|NCT04831736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110257393|NCT04831736|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110257394|NCT04831736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110257395|NCT04831736|Anesthetics, General|anesthetics, general|mesh-ancestor
110257396|NCT04831736|Anesthetics|anesthetics|mesh-ancestor
110257397|NCT04831736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110257398|NCT04831736|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110368712|NCT00558090|Analgesics|analgesics|mesh-ancestor
110257399|NCT04831736|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110257400|NCT04831736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110257401|NCT04831736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110257403|NCT04830462|Isoniazid|isoniazid|mesh-list
110257404|NCT04830462|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110257405|NCT04830462|Antitubercular Agents|antitubercular agents|mesh-ancestor
110257406|NCT04830462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110257407|NCT04830462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110257408|NCT04830462|Leprostatic Agents|leprostatic agents|mesh-ancestor
110257409|NCT04830462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110257410|NCT04830462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110257411|NCT04830462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110257412|NCT04830462|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110257413|NCT04830462|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110257414|NCT04830462|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110257415|NCT04830462|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110257416|NCT04830462|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110257417|NCT04830462|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110257418|NCT04830462|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110257419|NCT04830462|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110257421|NCT04830462|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110257423|NCT04797767|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
110257424|NCT04797767|Venetoclax|venetoclax|mesh-list
110257425|NCT04797767|Mitoxantrone|mitoxantrone|mesh-list
110257426|NCT04797767|Cladribine|cladribine|mesh-list
110257427|NCT04797767|Lenograstim|lenograstim|mesh-list
110257428|NCT04797767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110257429|NCT04797767|Antimetabolites|antimetabolites|mesh-ancestor
110257430|NCT04797767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110257431|NCT04797767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110257432|NCT04797767|Antiviral Agents|antiviral agents|mesh-ancestor
110257433|NCT04797767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110257434|NCT04797767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110257435|NCT04797767|Immunologic Factors|immunologic factors|mesh-ancestor
110257436|NCT04797767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110257437|NCT04797767|Analgesics|analgesics|mesh-ancestor
110257438|NCT04797767|Sensory System Agents|sensory system agents|mesh-ancestor
110257439|NCT04797767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110257440|NCT04797767|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110257441|NCT04797767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110257442|NCT04797767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110257443|NCT04797767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110257444|NCT04787341|Panitumumab|panitumumab|mesh-list
110257445|NCT04787341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110257446|NCT04787341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110257447|NCT04781972|Methylphenidate|methylphenidate|mesh-list
110257448|NCT04781972|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110257449|NCT04781972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110257450|NCT04781972|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110257451|NCT04781972|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110257452|NCT04781972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110257453|NCT04781972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110257454|NCT04781972|Dopamine Agents|dopamine agents|mesh-ancestor
110257455|NCT04781972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110257456|NCT04775381|Vitamin D|vitamin d|mesh-list
110257457|NCT04775381|Vitamins|vitamins|mesh-ancestor
110257458|NCT04775381|Micronutrients|micronutrients|mesh-ancestor
110257459|NCT04775381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110257460|NCT04775381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110257461|NCT04760275|Fluoxetine|fluoxetine|mesh-list
110257462|NCT04760275|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110257463|NCT04760275|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110257464|NCT04760275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110257465|NCT04760275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110257466|NCT04760275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110257467|NCT04760275|Serotonin Agents|serotonin agents|mesh-ancestor
110257468|NCT04760275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110257469|NCT04760275|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110257470|NCT04760275|Antidepressive Agents|antidepressive agents|mesh-ancestor
110257471|NCT04760275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110257472|NCT04760275|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110257473|NCT04760275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110257474|NCT04760275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110257475|NCT04721873|Topiramate|topiramate|mesh-list
110257476|NCT04721873|Phentermine|phentermine|mesh-list
110257477|NCT04721873|Anticonvulsants|anticonvulsants|mesh-ancestor
110257478|NCT04721873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110257479|NCT04721873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110257480|NCT04721873|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110257481|NCT04721873|Appetite Depressants|appetite depressants|mesh-ancestor
110257482|NCT04721873|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110257483|NCT04721873|Sympathomimetics|sympathomimetics|mesh-ancestor
110257484|NCT04721873|Autonomic Agents|autonomic agents|mesh-ancestor
110257485|NCT04721873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110257486|NCT04721873|Adrenergic Agents|adrenergic agents|mesh-ancestor
110257487|NCT04721873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110271207|NCT05124067|Autonomic Agents|autonomic agents|mesh-ancestor
110257488|NCT04721873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110257489|NCT04721015|Docetaxel|docetaxel|mesh-list
110257490|NCT04721015|Osimertinib|osimertinib|mesh-list
110257491|NCT04721015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110257492|NCT04721015|Tubulin Modulators|tubulin modulators|mesh-ancestor
110257493|NCT04721015|Antimitotic Agents|antimitotic agents|mesh-ancestor
110257494|NCT04721015|Mitosis Modulators|mitosis modulators|mesh-ancestor
110257495|NCT04721015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110257496|NCT04721015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110257497|NCT04721015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110257498|NCT04679389|Acetazolamide|acetazolamide|mesh-list
110257499|NCT04679389|Anticonvulsants|anticonvulsants|mesh-ancestor
110257500|NCT04679389|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110257501|NCT04679389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110257502|NCT04679389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110257503|NCT04679389|Diuretics|diuretics|mesh-ancestor
110257504|NCT04679389|Natriuretic Agents|natriuretic agents|mesh-ancestor
110257505|NCT04679389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110257506|NCT04645589|Mycophenolic Acid|mycophenolic acid|mesh-list
110257507|NCT04645589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110257508|NCT04645589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110257509|NCT04645589|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110257510|NCT04645589|Antitubercular Agents|antitubercular agents|mesh-ancestor
110257511|NCT04645589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110257512|NCT04645589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110257513|NCT04645589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110257514|NCT04645589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110257515|NCT04644016|Cyclosporine|cyclosporine|mesh-list
110257516|NCT04644016|Mycophenolic Acid|mycophenolic acid|mesh-list
110257517|NCT04644016|Fludarabine|fludarabine|mesh-list
110257518|NCT04644016|Busulfan|busulfan|mesh-list
110257519|NCT04644016|Clofarabine|clofarabine|mesh-list
110257520|NCT04644016|Cyclosporins|cyclosporins|mesh-list
110257521|NCT04644016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110257522|NCT04644016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110257523|NCT04644016|Antimetabolites|antimetabolites|mesh-ancestor
110257524|NCT04644016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110257525|NCT04644016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110257526|NCT04644016|Immunologic Factors|immunologic factors|mesh-ancestor
110257527|NCT04644016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110257528|NCT04644016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110257529|NCT04644016|Antifungal Agents|antifungal agents|mesh-ancestor
110257530|NCT04644016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110257531|NCT04644016|Dermatologic Agents|dermatologic agents|mesh-ancestor
110257533|NCT04644016|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110257534|NCT04644016|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110257535|NCT04644016|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110257536|NCT04644016|Antitubercular Agents|antitubercular agents|mesh-ancestor
110257537|NCT04644016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110257538|NCT04644016|Alkylating Agents|alkylating agents|mesh-ancestor
110257539|NCT04644016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110257540|NCT04644016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110257542|NCT04634162|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110257543|NCT04634162|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110257544|NCT04634162|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110257545|NCT04634162|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110257546|NCT04634162|Purinergic Agents|purinergic agents|mesh-ancestor
110257547|NCT04634162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110257548|NCT04634162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110257549|NCT04634162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110257550|NCT04616196|Cetuximab|cetuximab|mesh-list
110257551|NCT04616196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110257552|NCT04616196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110257553|NCT04583956|Remdesivir|remdesivir|mesh-list
110257554|NCT04583956|Antimetabolites|antimetabolites|mesh-ancestor
110257555|NCT04583956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110257556|NCT04583956|Antiviral Agents|antiviral agents|mesh-ancestor
110257557|NCT04583956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110257558|NCT04541407|Temozolomide|temozolomide|mesh-list
110257559|NCT04541407|Osimertinib|osimertinib|mesh-list
110257560|NCT04541407|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110257561|NCT04541407|Alkylating Agents|alkylating agents|mesh-ancestor
110257562|NCT04541407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110257563|NCT04541407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110257564|NCT04541407|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110257565|NCT04541407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110257566|NCT04552795|Lamivudine|lamivudine|mesh-list
110257567|NCT04552795|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110257568|NCT04552795|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110257569|NCT04552795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110257570|NCT04552795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110257571|NCT04552795|Antiviral Agents|antiviral agents|mesh-ancestor
110257572|NCT04552795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110257573|NCT04552795|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110257574|NCT04552795|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110257575|NCT04463680|Rifampin|rifampin|mesh-list
110257576|NCT04463680|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110257577|NCT04463680|Antitubercular Agents|antitubercular agents|mesh-ancestor
110257578|NCT04463680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110257580|NCT04463680|Leprostatic Agents|leprostatic agents|mesh-ancestor
110257581|NCT04463680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110257582|NCT04463680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110257583|NCT04463680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110257584|NCT04463680|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110257585|NCT04463680|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110257586|NCT04463680|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110257587|NCT04463680|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110257588|NCT04463680|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110257589|NCT04463680|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110257590|NCT04438655|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110257591|NCT04438655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110257592|NCT04428333|Pembrolizumab|pembrolizumab|mesh-list
110257593|NCT04428333|Fluorouracil|fluorouracil|mesh-list
110257594|NCT04428333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110257595|NCT04428333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110257596|NCT04428333|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110257597|NCT04428333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110257598|NCT04428333|Antimetabolites|antimetabolites|mesh-ancestor
110257599|NCT04428333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110257600|NCT04428333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110257601|NCT04428333|Immunologic Factors|immunologic factors|mesh-ancestor
110257602|NCT04428333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110257603|NCT04395989|Paclitaxel|paclitaxel|mesh-list
110257604|NCT04395989|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110257605|NCT04395989|Capecitabine|capecitabine|mesh-list
110257606|NCT04395989|Everolimus|everolimus|mesh-list
110257607|NCT04395989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110257608|NCT04395989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110257609|NCT04395989|Tubulin Modulators|tubulin modulators|mesh-ancestor
110257610|NCT04395989|Antimitotic Agents|antimitotic agents|mesh-ancestor
110257611|NCT04395989|Mitosis Modulators|mitosis modulators|mesh-ancestor
110257612|NCT04395989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110257613|NCT04395989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110257614|NCT04395989|Antimetabolites|antimetabolites|mesh-ancestor
110257615|NCT04395989|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110257616|NCT04395989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110257617|NCT04395989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110257618|NCT04395989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110257619|NCT04395989|Immunologic Factors|immunologic factors|mesh-ancestor
110257620|NCT04395989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110257621|NCT04393454|Sirolimus|sirolimus|mesh-list
110257622|NCT04393454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110257623|NCT04393454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110257624|NCT04393454|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110257625|NCT04393454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110257626|NCT04393454|Antifungal Agents|antifungal agents|mesh-ancestor
110257627|NCT04393454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110257628|NCT04393454|Immunologic Factors|immunologic factors|mesh-ancestor
110257629|NCT04393454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110257630|NCT04341311|Panobinostat|panobinostat|mesh-list
110257631|NCT04341311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110257632|NCT04341311|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110257633|NCT04341311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110257634|NCT04341311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110257636|NCT04304014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110257637|NCT04304014|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110257638|NCT04304014|Antimalarials|antimalarials|mesh-ancestor
110257639|NCT04304014|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110257640|NCT04304014|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110257641|NCT04300231|Hydromorphone|hydromorphone|mesh-list
110257642|NCT04300231|Bupivacaine|bupivacaine|mesh-list
110257643|NCT04300231|Anesthetics, Local|anesthetics, local|mesh-ancestor
110257644|NCT04300231|Anesthetics|anesthetics|mesh-ancestor
110257645|NCT04300231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110257646|NCT04300231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110257647|NCT04300231|Sensory System Agents|sensory system agents|mesh-ancestor
110257648|NCT04300231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110257649|NCT04300231|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110257650|NCT04300231|Narcotics|narcotics|mesh-ancestor
110257651|NCT04300231|Analgesics|analgesics|mesh-ancestor
110257652|NCT04230148|Triclabendazole|triclabendazole|mesh-list
110257653|NCT04230148|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110257654|NCT04230148|Anthelmintics|anthelmintics|mesh-ancestor
110257655|NCT04230148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110257656|NCT04230148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110257657|NCT04205630|Trastuzumab|trastuzumab|mesh-list
110257658|NCT04205630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110257659|NCT04205630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110257660|NCT04195633|Cyclosporine|cyclosporine|mesh-list
110257661|NCT04195633|Mycophenolic Acid|mycophenolic acid|mesh-list
110257662|NCT04195633|Cyclophosphamide|cyclophosphamide|mesh-list
110257664|NCT04195633|Busulfan|busulfan|mesh-list
110257665|NCT04195633|Fludarabine|fludarabine|mesh-list
110257666|NCT04195633|Cyclosporins|cyclosporins|mesh-list
110257667|NCT04195633|Lenograstim|lenograstim|mesh-list
110257668|NCT04195633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110257669|NCT04195633|Immunologic Factors|immunologic factors|mesh-ancestor
110257670|NCT04195633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110257671|NCT04195633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110257672|NCT04195633|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110257673|NCT04195633|Alkylating Agents|alkylating agents|mesh-ancestor
110257674|NCT04195633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110257675|NCT04195633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110257676|NCT04195633|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110257677|NCT04195633|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110257678|NCT04195633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110257679|NCT04195633|Antifungal Agents|antifungal agents|mesh-ancestor
110257680|NCT04195633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110257681|NCT04195633|Dermatologic Agents|dermatologic agents|mesh-ancestor
110257682|NCT04195633|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110257683|NCT04195633|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110257684|NCT04195633|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110257685|NCT04195633|Antitubercular Agents|antitubercular agents|mesh-ancestor
110257686|NCT04195633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110257687|NCT04171050|Anesthetics|anesthetics|mesh-list
110257688|NCT04171050|Anesthetics, Local|anesthetics, local|mesh-list
110257689|NCT04171050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110257690|NCT04171050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110257691|NCT04171050|Sensory System Agents|sensory system agents|mesh-ancestor
110257692|NCT04171050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110257693|NCT04128696|Pembrolizumab|pembrolizumab|mesh-list
110257694|NCT04128696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110257695|NCT04128696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110257696|NCT04128696|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110257697|NCT04128696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110257699|NCT04098081|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene|mesh-list
110257700|NCT04098081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110257701|NCT04098081|Antimetabolites|antimetabolites|mesh-ancestor
110257702|NCT04098081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110257703|NCT04098081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110257704|NCT04098081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110257705|NCT04039607|Nivolumab|nivolumab|mesh-list
110257706|NCT04039607|Ipilimumab|ipilimumab|mesh-list
110257707|NCT04039607|Sorafenib|sorafenib|mesh-list
110257708|NCT04039607|Lenvatinib|lenvatinib|mesh-list
110257709|NCT04039607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110257710|NCT04039607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110257711|NCT04039607|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110257712|NCT04039607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110257713|NCT04039607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110257714|NCT04039607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110257715|NCT04028986|Ulipristal acetate|ulipristal acetate|mesh-list
110257716|NCT04028986|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110257717|NCT04028986|Contraceptive Agents|contraceptive agents|mesh-ancestor
110257718|NCT04028986|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110257719|NCT04028986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110257720|NCT04028986|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110257721|NCT03914612|Paclitaxel|paclitaxel|mesh-list
110257722|NCT03914612|Carboplatin|carboplatin|mesh-list
110257723|NCT03914612|Pembrolizumab|pembrolizumab|mesh-list
110257724|NCT03914612|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110257725|NCT03914612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110257726|NCT03914612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110257727|NCT03914612|Tubulin Modulators|tubulin modulators|mesh-ancestor
110257728|NCT03914612|Antimitotic Agents|antimitotic agents|mesh-ancestor
110257729|NCT03914612|Mitosis Modulators|mitosis modulators|mesh-ancestor
110257730|NCT03914612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110257731|NCT03914612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110257732|NCT03914612|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110257733|NCT03900793|Sunitinib|sunitinib|mesh-list
110257734|NCT03900793|Losartan|losartan|mesh-list
110257735|NCT03900793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110257736|NCT03900793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110257737|NCT03900793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110257738|NCT03900793|Growth Substances|growth substances|mesh-ancestor
110257739|NCT03900793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110257740|NCT03900793|Growth Inhibitors|growth inhibitors|mesh-ancestor
110257741|NCT03900793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110257742|NCT03900793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110257743|NCT03900793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110257744|NCT03900793|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110257745|NCT03900793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110257746|NCT03900793|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110257747|NCT03900793|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110257748|NCT03897881|Pembrolizumab|pembrolizumab|mesh-list
110257750|NCT03897881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110257751|NCT03897881|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110257752|NCT03897881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110257753|NCT03896880|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110257754|NCT03896880|Clotrimazole|clotrimazole|mesh-list
110257756|NCT03896880|Antifungal Agents|antifungal agents|mesh-list
110257757|NCT03896880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110257758|NCT03896880|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110257759|NCT03896880|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110257760|NCT03896880|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110257761|NCT03896880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110257762|NCT03896880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110257763|NCT03896880|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110257764|NCT03896880|Hormone Antagonists|hormone antagonists|mesh-ancestor
110257765|NCT03896880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110257766|NCT03896880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110257767|NCT03896880|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110257768|NCT03896880|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110257769|NCT03854019|Quinidine|quinidine|mesh-list
110257770|NCT03854019|Dextromethorphan|dextromethorphan|mesh-list
110257771|NCT03854019|Antitussive Agents|antitussive agents|mesh-ancestor
110257772|NCT03854019|Respiratory System Agents|respiratory system agents|mesh-ancestor
110257773|NCT03854019|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110257774|NCT03854019|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110257775|NCT03854019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110257776|NCT03854019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110257777|NCT03854019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110257778|NCT03854019|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110257779|NCT03854019|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110257780|NCT03854019|Adrenergic Agents|adrenergic agents|mesh-ancestor
110257781|NCT03854019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110257782|NCT03854019|Antimalarials|antimalarials|mesh-ancestor
110257783|NCT03854019|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110257784|NCT03854019|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110257785|NCT03854019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110257786|NCT03854019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110257787|NCT03854019|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110257788|NCT03854019|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110257789|NCT03854019|Cholinergic Agents|cholinergic agents|mesh-ancestor
110257790|NCT03854019|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110257791|NCT03854019|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110257792|NCT03854019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110257793|NCT03854019|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110257794|NCT03854019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110257795|NCT03815019|Megestrol|megestrol|mesh-list
110257796|NCT03815019|Megestrol Acetate|megestrol acetate|mesh-list
110257797|NCT03815019|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110257798|NCT03815019|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110257799|NCT03815019|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110257800|NCT03815019|Contraceptive Agents|contraceptive agents|mesh-ancestor
110257801|NCT03815019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110257802|NCT03815019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110257803|NCT03815019|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110257804|NCT03815019|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110257805|NCT03815019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110257807|NCT03815019|Appetite Stimulants|appetite stimulants|mesh-ancestor
110257808|NCT03815019|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110257809|NCT03767218|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110257810|NCT03767218|Hormones|hormones|mesh-ancestor
110257811|NCT03767218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110257812|NCT03767218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110257813|NCT03739645|Metronidazole|metronidazole|mesh-list
110257814|NCT03739645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110257815|NCT03739645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110257816|NCT03739645|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110257817|NCT03739645|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110257818|NCT03705585|Vaccines|vaccines|mesh-list
110257819|NCT03705585|Immunologic Factors|immunologic factors|mesh-ancestor
110257820|NCT03705585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110257821|NCT03695237|Leuprolide|leuprolide|mesh-list
110257822|NCT03695237|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110257823|NCT03695237|Fertility Agents|fertility agents|mesh-ancestor
110257824|NCT03695237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110257825|NCT03695237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110257826|NCT03695237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110257827|NCT03695237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110257828|NCT03603509|Vaccines|vaccines|mesh-list
110257829|NCT03603509|Immunologic Factors|immunologic factors|mesh-ancestor
110257830|NCT03603509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110257831|NCT03361345|Tranexamic Acid|tranexamic acid|mesh-list
110257832|NCT03361345|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110257833|NCT03361345|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110257834|NCT03361345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110257835|NCT03361345|Hemostatics|hemostatics|mesh-ancestor
110257836|NCT03361345|Coagulants|coagulants|mesh-ancestor
110257837|NCT03275285|Dexamethasone|dexamethasone|mesh-list
110257838|NCT03275285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110257839|NCT03275285|Antiemetics|antiemetics|mesh-ancestor
110257840|NCT03275285|Autonomic Agents|autonomic agents|mesh-ancestor
110257841|NCT03275285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110257842|NCT03275285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110257843|NCT03275285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110257844|NCT03275285|Glucocorticoids|glucocorticoids|mesh-ancestor
110257845|NCT03275285|Hormones|hormones|mesh-ancestor
110257846|NCT03275285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110257847|NCT03275285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110257848|NCT03275285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110257849|NCT03216187|Pregabalin|pregabalin|mesh-list
110257850|NCT03216187|Analgesics|analgesics|mesh-ancestor
110257851|NCT03216187|Sensory System Agents|sensory system agents|mesh-ancestor
110257852|NCT03216187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110257853|NCT03216187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110257854|NCT03216187|Anticonvulsants|anticonvulsants|mesh-ancestor
110257855|NCT03216187|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110257856|NCT03216187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110257857|NCT03216187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110257858|NCT03216187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110257860|NCT03216187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110257861|NCT03216187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110257862|NCT03216187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110257863|NCT03195270|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110257864|NCT03195270|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110257865|NCT03195270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110257866|NCT03172754|Nivolumab|nivolumab|mesh-list
110257867|NCT03172754|Axitinib|axitinib|mesh-list
110257868|NCT03172754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110257869|NCT03172754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110257870|NCT03172754|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110257871|NCT03172754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110257872|NCT03172754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110257873|NCT03172754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110257874|NCT03137888|Temozolomide|temozolomide|mesh-list
110257875|NCT03137888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110257876|NCT03137888|Alkylating Agents|alkylating agents|mesh-ancestor
110257877|NCT03137888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110257878|NCT03137888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110257879|NCT03123913|Methyltestosterone|methyltestosterone|mesh-list
110257880|NCT03123913|Testosterone|testosterone|mesh-list
110257881|NCT03123913|Testosterone undecanoate|testosterone undecanoate|mesh-list
110257882|NCT03123913|Testosterone enanthate|testosterone enanthate|mesh-list
110257883|NCT03123913|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110257884|NCT03123913|Androgens|androgens|mesh-ancestor
110257885|NCT03123913|Hormones|hormones|mesh-ancestor
110257886|NCT03123913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110257887|NCT03123913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110257888|NCT03123913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110257889|NCT03123913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110257890|NCT03123913|Anabolic Agents|anabolic agents|mesh-ancestor
110257891|NCT03039985|Lithium Carbonate|lithium carbonate|mesh-list
110257892|NCT03039985|Antidepressive Agents|antidepressive agents|mesh-ancestor
110257893|NCT03039985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110257894|NCT03039985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110257895|NCT03039985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110257896|NCT03039985|Antimanic Agents|antimanic agents|mesh-ancestor
110257897|NCT03039985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110257898|NCT03039985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110257899|NCT03039985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110257900|NCT03007238|Aldesleukin|aldesleukin|mesh-list
110257901|NCT03007238|Interleukin-2|interleukin-2|mesh-list
110257902|NCT03007238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110257903|NCT03007238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110257904|NCT03007238|Analgesics|analgesics|mesh-ancestor
110257905|NCT03007238|Sensory System Agents|sensory system agents|mesh-ancestor
110257906|NCT03007238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110257907|NCT03007238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110257908|NCT03007238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110257909|NCT03007238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110257910|NCT03007238|Antiviral Agents|antiviral agents|mesh-ancestor
110257911|NCT03007238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110257912|NCT02902198|Quinine|quinine|mesh-list
110257913|NCT02902198|Antimalarials|antimalarials|mesh-ancestor
110257914|NCT02902198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110257915|NCT02902198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110257916|NCT02902198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110257917|NCT02902198|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110257918|NCT02902198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110257919|NCT02902198|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110257920|NCT02902198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110257921|NCT02902198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110257922|NCT02902198|Analgesics|analgesics|mesh-ancestor
110257923|NCT02902198|Sensory System Agents|sensory system agents|mesh-ancestor
110257924|NCT02858869|Pembrolizumab|pembrolizumab|mesh-list
110257925|NCT02858869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110257926|NCT02858869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110257927|NCT02858869|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110271290|NCT00177372|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110257928|NCT02858869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110257930|NCT02811523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110257931|NCT02811523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110257932|NCT02811523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110257933|NCT02811523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110257934|NCT02811523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110257935|NCT02811523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110257936|NCT02750319|Acetylcysteine|acetylcysteine|mesh-list
110257938|NCT02750319|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110257939|NCT02750319|Antiviral Agents|antiviral agents|mesh-ancestor
110257940|NCT02750319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110257941|NCT02750319|Expectorants|expectorants|mesh-ancestor
110257942|NCT02750319|Respiratory System Agents|respiratory system agents|mesh-ancestor
110257943|NCT02750319|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110257944|NCT02750319|Antioxidants|antioxidants|mesh-ancestor
110257945|NCT02750319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110257946|NCT02750319|Protective Agents|protective agents|mesh-ancestor
110257947|NCT02750319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110257948|NCT02750319|Antidotes|antidotes|mesh-ancestor
110257949|NCT02750319|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110257950|NCT02750319|Vasodilator Agents|vasodilator agents|mesh-ancestor
110257951|NCT02750319|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110257952|NCT02750319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110257953|NCT02750319|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110257954|NCT02750319|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110257955|NCT02750319|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110257956|NCT02750319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110257957|NCT02750319|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110257958|NCT02750319|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110257959|NCT02750319|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110257960|NCT02636582|Molgramostim|molgramostim|mesh-list
110257962|NCT02636582|Sargramostim|sargramostim|mesh-list
110257963|NCT02636582|Immunologic Factors|immunologic factors|mesh-ancestor
110257964|NCT02636582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110257965|NCT02636582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110257966|NCT02611258|Tadalafil|tadalafil|mesh-list
110257967|NCT02611258|Vasodilator Agents|vasodilator agents|mesh-ancestor
110257968|NCT02611258|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110257969|NCT02611258|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110257970|NCT02611258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110257971|NCT02611258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110257972|NCT02611258|Urological Agents|urological agents|mesh-ancestor
110257973|NCT02367040|Rituximab|rituximab|mesh-list
110257974|NCT02367040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110257975|NCT02367040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110257976|NCT02367040|Immunologic Factors|immunologic factors|mesh-ancestor
110257977|NCT02367040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110257978|NCT02367040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110257979|NCT02172651|Vitamin D|vitamin d|mesh-list
110257980|NCT02172651|Ergocalciferols|ergocalciferols|mesh-list
110257981|NCT02172651|Cholecalciferol|cholecalciferol|mesh-list
110257982|NCT02172651|Vitamins|vitamins|mesh-list
110257983|NCT02172651|Micronutrients|micronutrients|mesh-ancestor
110257984|NCT02172651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110257985|NCT02172651|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110257986|NCT02172651|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110257987|NCT02144857|Cyclosporine|cyclosporine|mesh-list
110257989|NCT02144857|Apremilast|apremilast|mesh-list
110257990|NCT02144857|Ustekinumab|ustekinumab|mesh-list
110257991|NCT02144857|Cyclosporins|cyclosporins|mesh-list
110257992|NCT02144857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110257993|NCT02144857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110257994|NCT02144857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110257995|NCT02144857|Immunologic Factors|immunologic factors|mesh-ancestor
110257996|NCT02144857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110257997|NCT02144857|Antifungal Agents|antifungal agents|mesh-ancestor
110257998|NCT02144857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110257999|NCT02144857|Dermatologic Agents|dermatologic agents|mesh-ancestor
110258000|NCT02144857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110258001|NCT02144857|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110258002|NCT02144857|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110258003|NCT02144857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110258004|NCT02144857|Analgesics|analgesics|mesh-ancestor
110258005|NCT02144857|Sensory System Agents|sensory system agents|mesh-ancestor
110258006|NCT02144857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110258007|NCT02144857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110258008|NCT02144857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110258009|NCT02144857|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110258010|NCT02144857|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110258011|NCT02095184|Letrozole|letrozole|mesh-list
110258012|NCT02095184|Anastrozole|anastrozole|mesh-list
110258013|NCT02095184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110258014|NCT02095184|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110258015|NCT02095184|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110258016|NCT02095184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110258017|NCT02095184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110258018|NCT02095184|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110258019|NCT02095184|Hormone Antagonists|hormone antagonists|mesh-ancestor
110258020|NCT02095184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110258021|NCT02095184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258022|NCT02095184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110258023|NCT01252953|Oxazolidinones|oxazolidinones|mesh-list
110258024|NCT01252953|Anacetrapib|anacetrapib|mesh-list
110258025|NCT01252953|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110258026|NCT01252953|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110258027|NCT01252953|Antimetabolites|antimetabolites|mesh-ancestor
110258028|NCT01252953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110258029|NCT01252953|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110258030|NCT01252953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110258031|NCT01252953|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110258032|NCT01252953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110258033|NCT00937131|Rituximab|rituximab|mesh-list
110258034|NCT00937131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110258036|NCT00937131|Immunologic Factors|immunologic factors|mesh-ancestor
110258037|NCT00937131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258038|NCT00937131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110258039|NCT00837616|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110258040|NCT00837616|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110258041|NCT00837616|Estradiol|estradiol|mesh-list
110258042|NCT00837616|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110258043|NCT00837616|Estrogens|estrogens|mesh-ancestor
110258044|NCT00837616|Hormones|hormones|mesh-ancestor
110258045|NCT00837616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110258046|NCT00837616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258047|NCT00837616|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110258048|NCT00837616|Contraceptive Agents|contraceptive agents|mesh-ancestor
110258049|NCT00837616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110258050|NCT00837616|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110258051|NCT00610051|Alprostadil|alprostadil|mesh-list
110258052|NCT00610051|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110258053|NCT00610051|Vasodilator Agents|vasodilator agents|mesh-ancestor
110258054|NCT00610051|Urological Agents|urological agents|mesh-ancestor
110258055|NCT00176254|Paclitaxel|paclitaxel|mesh-list
110258056|NCT00176254|Carboplatin|carboplatin|mesh-list
110258057|NCT00176254|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110258058|NCT00176254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110258059|NCT00176254|Tubulin Modulators|tubulin modulators|mesh-ancestor
110258060|NCT00176254|Antimitotic Agents|antimitotic agents|mesh-ancestor
110258061|NCT00176254|Mitosis Modulators|mitosis modulators|mesh-ancestor
110258062|NCT00176254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110258063|NCT02949895|Etoposide|etoposide|mesh-list
110258064|NCT02949895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110258065|NCT02949895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110258066|NCT02949895|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110258067|NCT02949895|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110258068|NCT02949895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110258069|NCT02949895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110258070|NCT02949583|Chlorhexidine|chlorhexidine|mesh-list
110258071|NCT02949583|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110258072|NCT02949583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110258073|NCT02949583|Disinfectants|disinfectants|mesh-ancestor
110258074|NCT00516841|Volociximab|volociximab|mesh-list
110258075|NCT00516841|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110258076|NCT00516841|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110258077|NCT00516841|Growth Substances|growth substances|mesh-ancestor
110258078|NCT00516841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258079|NCT00516841|Growth Inhibitors|growth inhibitors|mesh-ancestor
110258080|NCT00516841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110258081|NCT00516880|Rosiglitazone|rosiglitazone|mesh-list
110258082|NCT00516880|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110258083|NCT00516880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258084|NCT04694677|Misoprostol|misoprostol|mesh-list
110258085|NCT04694677|Tranexamic Acid|tranexamic acid|mesh-list
110258086|NCT04694677|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110258087|NCT04694677|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110258088|NCT04694677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110258089|NCT04694677|Hemostatics|hemostatics|mesh-ancestor
110258090|NCT04694677|Coagulants|coagulants|mesh-ancestor
110258091|NCT04694677|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110258092|NCT04694677|Abortifacient Agents|abortifacient agents|mesh-ancestor
110258093|NCT04694677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110258094|NCT04694677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258095|NCT04694677|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110258096|NCT04694677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110258097|NCT04694677|Oxytocics|oxytocics|mesh-ancestor
110258098|NCT00516958|Levofloxacin|levofloxacin|mesh-list
110258099|NCT00516958|Ofloxacin|ofloxacin|mesh-list
110258100|NCT00516958|Sodium Hypochlorite|sodium hypochlorite|mesh-list
110258101|NCT00516958|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110258103|NCT00516958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110258104|NCT00516958|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110258105|NCT00516958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110258106|NCT00516958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110258107|NCT00516958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110258108|NCT00516958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110258109|NCT00516958|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110258110|NCT00516958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110258111|NCT00516958|Disinfectants|disinfectants|mesh-ancestor
110258112|NCT00517114|Rabeprazole|rabeprazole|mesh-list
110258113|NCT00517114|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110258114|NCT00517114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110258115|NCT00517114|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110258116|NCT00517114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110258117|NCT00517114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110258118|NCT00517270|Rabeprazole|rabeprazole|mesh-list
110258119|NCT00517270|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110258120|NCT00517270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110258121|NCT00517270|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110258122|NCT00517270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110258123|NCT00517270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110258124|NCT00517309|Vaccines|vaccines|mesh-list
110258125|NCT00517309|Immunologic Factors|immunologic factors|mesh-ancestor
110258126|NCT00517309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258127|NCT00517387|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110258128|NCT00517387|Antidepressive Agents|antidepressive agents|mesh-ancestor
110258129|NCT00517387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110258130|NCT00517387|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110258131|NCT00517387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110258132|NCT00517387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110258133|NCT00517387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258134|NCT00517426|Acetazolamide|acetazolamide|mesh-list
110258135|NCT00517426|Anticonvulsants|anticonvulsants|mesh-ancestor
110258136|NCT00517426|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110258137|NCT00517426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110258138|NCT00517426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110258139|NCT00517426|Diuretics|diuretics|mesh-ancestor
110258140|NCT00517426|Natriuretic Agents|natriuretic agents|mesh-ancestor
110258141|NCT00517426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258142|NCT00517504|Methylphenidate|methylphenidate|mesh-list
110258143|NCT00517504|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110258144|NCT00517504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258145|NCT00517504|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110258146|NCT00517504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110258147|NCT00517504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110258148|NCT00517504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110258149|NCT00517504|Dopamine Agents|dopamine agents|mesh-ancestor
110258150|NCT00517504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110258151|NCT00517582|Icatibant|icatibant|mesh-list
110258152|NCT00517582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110258153|NCT00517582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110258154|NCT00517582|Analgesics|analgesics|mesh-ancestor
110258155|NCT00517582|Sensory System Agents|sensory system agents|mesh-ancestor
110258156|NCT00517582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110258157|NCT00517582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258158|NCT00517582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110258159|NCT00517582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110258160|NCT00517582|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
110258161|NCT00517582|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
110258162|NCT00517582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110271353|NCT00177567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110258163|NCT00517582|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110258164|NCT00517582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110258165|NCT00517582|Immunologic Factors|immunologic factors|mesh-ancestor
110258167|NCT00517621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110258168|NCT00517621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110258169|NCT00517621|Tubulin Modulators|tubulin modulators|mesh-ancestor
110258170|NCT00517621|Antimitotic Agents|antimitotic agents|mesh-ancestor
110258171|NCT00517621|Mitosis Modulators|mitosis modulators|mesh-ancestor
110258172|NCT00517621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110258173|NCT00151515|Minoxidil|minoxidil|mesh-list
110258174|NCT00151515|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110258175|NCT00151515|Vasodilator Agents|vasodilator agents|mesh-ancestor
110258176|NCT00166686|Clonidine|clonidine|mesh-list
110258177|NCT00166686|Analgesics|analgesics|mesh-ancestor
110258178|NCT00166686|Sensory System Agents|sensory system agents|mesh-ancestor
110258179|NCT00166686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110258180|NCT00166686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258181|NCT00166686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110258182|NCT00166686|Sympatholytics|sympatholytics|mesh-ancestor
110258183|NCT00166686|Autonomic Agents|autonomic agents|mesh-ancestor
110258184|NCT00166686|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110258185|NCT00166686|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110258186|NCT00166686|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110258187|NCT00166686|Adrenergic Agents|adrenergic agents|mesh-ancestor
110258188|NCT00166686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110258189|NCT00166686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110258190|NCT02949778|Ropivacaine|ropivacaine|mesh-list
110258191|NCT02949778|Anesthetics, Local|anesthetics, local|mesh-ancestor
110258192|NCT02949778|Anesthetics|anesthetics|mesh-ancestor
110258193|NCT02949778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110258194|NCT02949778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258195|NCT02949778|Sensory System Agents|sensory system agents|mesh-ancestor
110258196|NCT02949778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110258197|NCT00518245|Enoxaparin|enoxaparin|mesh-list
110258198|NCT00518245|Anticoagulants|anticoagulants|mesh-ancestor
110258199|NCT00518245|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110258200|NCT00518245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110258201|NCT00518245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110258202|NCT02957903|Ropivacaine|ropivacaine|mesh-list
110258203|NCT02957903|Anesthetics, Local|anesthetics, local|mesh-ancestor
110258204|NCT02957903|Anesthetics|anesthetics|mesh-ancestor
110258205|NCT02957903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110258206|NCT02957903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258207|NCT02957903|Sensory System Agents|sensory system agents|mesh-ancestor
110258208|NCT02957903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110258209|NCT00518479|Amlodipine|amlodipine|mesh-list
110258210|NCT00518479|Valsartan|valsartan|mesh-list
110258211|NCT00518479|Moxonidine|moxonidine|mesh-list
110258212|NCT00518479|Bendroflumethiazide|bendroflumethiazide|mesh-list
110258213|NCT00518479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110258214|NCT00518479|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110258216|NCT00518479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110258217|NCT00518479|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110258218|NCT00518479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258220|NCT00518479|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110258221|NCT00518479|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110258222|NCT00518479|Diuretics|diuretics|mesh-ancestor
110258223|NCT00518479|Natriuretic Agents|natriuretic agents|mesh-ancestor
110258224|NCT00518479|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110258225|NCT00166725|Octreotide|octreotide|mesh-list
110258226|NCT00166725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110258227|NCT00166725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110258228|NCT00166725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110258229|NCT00518635|Insulin|insulin|mesh-list
110258230|NCT00518635|Hormones|hormones|mesh-list
110258231|NCT00518635|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110258232|NCT00518635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258233|NCT00518635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110258235|NCT00151632|Tacrolimus|tacrolimus|mesh-list
110258236|NCT00151632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110258237|NCT00151632|Immunologic Factors|immunologic factors|mesh-ancestor
110258238|NCT00151632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258239|NCT00151632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110258240|NCT00151632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110258241|NCT00151632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110258242|NCT00151632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110258243|NCT00151632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110258244|NCT00151632|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110258245|NCT00151632|Antitubercular Agents|antitubercular agents|mesh-ancestor
110258246|NCT00151632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110258247|NCT00151632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110258248|NCT02949232|Prednisolone|prednisolone|mesh-list
110258249|NCT02949232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110258250|NCT02949232|Glucocorticoids|glucocorticoids|mesh-ancestor
110258252|NCT02949232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110258253|NCT02949232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258254|NCT02949232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110258255|NCT02949232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110258256|NCT00518908|Sevoflurane|sevoflurane|mesh-list
110258257|NCT00518908|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110258258|NCT00518908|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110258259|NCT00518908|Anesthetics, General|anesthetics, general|mesh-ancestor
110258261|NCT00518908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110258262|NCT00518908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258263|NCT00518947|Verapamil|verapamil|mesh-list
110258264|NCT00518947|Lithium Carbonate|lithium carbonate|mesh-list
110258265|NCT00518947|Antidepressive Agents|antidepressive agents|mesh-ancestor
110258266|NCT00518947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110258267|NCT00518947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110258268|NCT00518947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110258269|NCT00518947|Antimanic Agents|antimanic agents|mesh-ancestor
110258270|NCT00518947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110258271|NCT00518947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110258272|NCT00518947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258273|NCT00518947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110258274|NCT00518947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110258275|NCT00518947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110258276|NCT00518947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110258277|NCT00518947|Vasodilator Agents|vasodilator agents|mesh-ancestor
110258279|NCT02949466|Hyaluronic Acid|hyaluronic acid|mesh-list
110258280|NCT02949466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110258281|NCT02949466|Glucocorticoids|glucocorticoids|mesh-ancestor
110258283|NCT02949466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110258284|NCT02949466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258285|NCT02949466|Immunologic Factors|immunologic factors|mesh-ancestor
110258286|NCT02949466|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110258287|NCT02949466|Viscosupplements|viscosupplements|mesh-ancestor
110258288|NCT02949466|Protective Agents|protective agents|mesh-ancestor
110258289|NCT00151710|Pioglitazone|pioglitazone|mesh-list
110258290|NCT00151710|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110258291|NCT00151710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258292|NCT00519181|Valproic Acid|valproic acid|mesh-list
110258293|NCT00519181|Anticonvulsants|anticonvulsants|mesh-ancestor
110258294|NCT00519181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110258295|NCT00519181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110258296|NCT00519181|GABA Agents|gaba agents|mesh-ancestor
110258297|NCT00519181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110258298|NCT00519181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258299|NCT00519181|Antimanic Agents|antimanic agents|mesh-ancestor
110258300|NCT00519181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110258301|NCT00519181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110258302|NCT00519181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110258303|NCT00166803|Rosiglitazone|rosiglitazone|mesh-list
110258304|NCT00166803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110258305|NCT00166803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258307|NCT02949310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110258308|NCT02949310|Analgesics|analgesics|mesh-ancestor
110258309|NCT02949310|Sensory System Agents|sensory system agents|mesh-ancestor
110258310|NCT02949310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110258311|NCT02949310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258312|NCT02949349|Mycophenolic Acid|mycophenolic acid|mesh-list
110258313|NCT02949349|Prednisolone|prednisolone|mesh-list
110258314|NCT02949349|Azathioprine|azathioprine|mesh-list
110258315|NCT02949349|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110258316|NCT02949349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110258317|NCT02949349|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110258318|NCT02949349|Antitubercular Agents|antitubercular agents|mesh-ancestor
110258319|NCT02949349|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110258320|NCT02949349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110258321|NCT02949349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110258322|NCT02949349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110258323|NCT02949349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110258324|NCT02949349|Glucocorticoids|glucocorticoids|mesh-ancestor
110258326|NCT02949349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110258327|NCT02949349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258328|NCT02949349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110258329|NCT02949349|Antimetabolites|antimetabolites|mesh-ancestor
110258330|NCT02949349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110258331|NCT02949349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110258332|NCT02949349|Immunologic Factors|immunologic factors|mesh-ancestor
110258333|NCT02949349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110258334|NCT00166842|Cyclosporine|cyclosporine|mesh-list
110258335|NCT00166842|Sirolimus|sirolimus|mesh-list
110258336|NCT00166842|Tacrolimus|tacrolimus|mesh-list
110258337|NCT00166842|Cyclosporins|cyclosporins|mesh-list
110258338|NCT00166842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110258339|NCT00166842|Immunologic Factors|immunologic factors|mesh-ancestor
110258340|NCT00166842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258341|NCT00166842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110258342|NCT00166842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110258343|NCT00166842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110258344|NCT00166842|Antifungal Agents|antifungal agents|mesh-ancestor
110258345|NCT00166842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110258346|NCT00166842|Dermatologic Agents|dermatologic agents|mesh-ancestor
110258347|NCT00166842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110258348|NCT00166842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110258349|NCT00166842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110258350|NCT00166842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110258351|NCT02949193|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110258352|NCT02949193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110258353|NCT02949193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258354|NCT02949193|Incretins|incretins|mesh-ancestor
110258356|NCT02949193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110258357|NCT02949193|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110258358|NCT02949193|Protease Inhibitors|protease inhibitors|mesh-ancestor
110258359|NCT02949193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110258360|NCT02949193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110258361|NCT00519259|Lobeline|lobeline|mesh-list
110258362|NCT00519259|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110258363|NCT00519259|Autonomic Agents|autonomic agents|mesh-ancestor
110258364|NCT00519259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110258365|NCT00519259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258366|NCT00519259|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110258367|NCT00519259|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110258368|NCT00519259|Cholinergic Agents|cholinergic agents|mesh-ancestor
110258369|NCT00519259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110258370|NCT00519259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110258371|NCT00519259|Respiratory System Agents|respiratory system agents|mesh-ancestor
110258373|NCT00519298|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110258374|NCT00519298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110258375|NCT00519298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110258376|NCT00519298|Cholinergic Agents|cholinergic agents|mesh-ancestor
110258377|NCT00519298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110258378|NCT00519298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258379|NCT00519298|Nootropic Agents|nootropic agents|mesh-ancestor
110258380|NCT00519337|Ascorbic Acid|ascorbic acid|mesh-list
110258381|NCT00519337|Vitamins|vitamins|mesh-ancestor
110258382|NCT00519337|Micronutrients|micronutrients|mesh-ancestor
110258383|NCT00519337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258384|NCT00519337|Antioxidants|antioxidants|mesh-ancestor
110258385|NCT00519337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110258386|NCT00519337|Protective Agents|protective agents|mesh-ancestor
110258387|NCT00151749|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
110258388|NCT00151749|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110258389|NCT00151749|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110258390|NCT00151749|Antimetabolites|antimetabolites|mesh-ancestor
110258391|NCT00151749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110258392|NCT00151749|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110258393|NCT00166881|Docetaxel|docetaxel|mesh-list
110258394|NCT00166881|Irinotecan|irinotecan|mesh-list
110258395|NCT00166881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110258396|NCT00166881|Tubulin Modulators|tubulin modulators|mesh-ancestor
110258397|NCT00166881|Antimitotic Agents|antimitotic agents|mesh-ancestor
110258398|NCT00166881|Mitosis Modulators|mitosis modulators|mesh-ancestor
110258399|NCT00166881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110258400|NCT00166881|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110258401|NCT00166881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110258402|NCT00166881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110258403|NCT02948998|Spironolactone|spironolactone|mesh-list
110258404|NCT02948998|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110258405|NCT02948998|Hormone Antagonists|hormone antagonists|mesh-ancestor
110260210|NCT00530413|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110258406|NCT02948998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110258407|NCT02948998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258408|NCT02948998|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110258409|NCT02948998|Diuretics|diuretics|mesh-ancestor
110258410|NCT02948998|Natriuretic Agents|natriuretic agents|mesh-ancestor
110258411|NCT00519688|Thalidomide|thalidomide|mesh-list
110258412|NCT00519688|Tegafur|tegafur|mesh-list
110258413|NCT00519688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110258414|NCT00519688|Immunologic Factors|immunologic factors|mesh-ancestor
110258415|NCT00519688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258416|NCT00519688|Leprostatic Agents|leprostatic agents|mesh-ancestor
110258417|NCT00519688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110258418|NCT00519688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110258419|NCT00519688|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110258420|NCT00519688|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110258421|NCT00519688|Growth Substances|growth substances|mesh-ancestor
110258422|NCT00519688|Growth Inhibitors|growth inhibitors|mesh-ancestor
110258423|NCT00519688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110258424|NCT00519688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110258425|NCT00519688|Antimetabolites|antimetabolites|mesh-ancestor
110258426|NCT00519688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110258427|NCT02948920|Ephedrine|ephedrine|mesh-list
110258428|NCT02948920|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110258429|NCT02948920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258430|NCT02948920|Sympathomimetics|sympathomimetics|mesh-ancestor
110258431|NCT02948920|Autonomic Agents|autonomic agents|mesh-ancestor
110258432|NCT02948920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110258433|NCT02948920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110258434|NCT02948920|Adrenergic Agents|adrenergic agents|mesh-ancestor
110258435|NCT02948920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110258437|NCT00151827|Losartan|losartan|mesh-list
110258438|NCT00151827|Olmesartan|olmesartan|mesh-list
110258439|NCT00151827|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110258440|NCT00151827|Furosemide|furosemide|mesh-list
110258441|NCT00151827|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110258442|NCT00151827|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110258443|NCT00151827|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110258444|NCT00151827|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110258445|NCT00151827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110258446|NCT00151827|Diuretics|diuretics|mesh-ancestor
110258447|NCT00151827|Natriuretic Agents|natriuretic agents|mesh-ancestor
110258448|NCT00151827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258449|NCT00151827|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110258450|NCT00151827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110258451|NCT00519805|Dalteparin|dalteparin|mesh-list
110258452|NCT00519805|Tinzaparin|tinzaparin|mesh-list
110258453|NCT00519805|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110258454|NCT00519805|Anticoagulants|anticoagulants|mesh-ancestor
110258455|NCT00519805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110258456|NCT00519805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110258457|NCT00519805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110258458|NCT02948881|Ibandronic Acid|ibandronic acid|mesh-list
110258459|NCT02948881|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110258460|NCT02948881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258461|NCT04457180|Repaglinide|repaglinide|mesh-list
110258462|NCT04457180|Apatinib|apatinib|mesh-list
110258463|NCT04457180|Bupropion|bupropion|mesh-list
110258464|NCT04457180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110258465|NCT04457180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110258466|NCT04457180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110258467|NCT04457180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110258468|NCT04457180|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110258469|NCT04457180|Antidepressive Agents|antidepressive agents|mesh-ancestor
110258470|NCT04457180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110258471|NCT04457180|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110258472|NCT04457180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110258473|NCT04457180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110258474|NCT04457180|Dopamine Agents|dopamine agents|mesh-ancestor
110258475|NCT04457180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110258476|NCT04457180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258477|NCT04457180|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110258478|NCT04457180|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110258479|NCT04457180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110258480|NCT00520000|Carboplatin|carboplatin|mesh-list
110258481|NCT00520000|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110258482|NCT00520000|Paclitaxel|paclitaxel|mesh-list
110258483|NCT00520000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110258484|NCT00520000|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110258485|NCT00520000|Tubulin Modulators|tubulin modulators|mesh-ancestor
110258486|NCT00520000|Antimitotic Agents|antimitotic agents|mesh-ancestor
110258487|NCT00520000|Mitosis Modulators|mitosis modulators|mesh-ancestor
110258488|NCT00520000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110258489|NCT00151944|Mesalamine|mesalamine|mesh-list
110258490|NCT00151944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110258491|NCT00151944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110258492|NCT00151944|Analgesics|analgesics|mesh-ancestor
110258493|NCT00151944|Sensory System Agents|sensory system agents|mesh-ancestor
110258494|NCT00151944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110258495|NCT00151944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258496|NCT00151944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110258497|NCT00151944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110258498|NCT00520507|Olanzapine|olanzapine|mesh-list
110258499|NCT00520507|Antiemetics|antiemetics|mesh-ancestor
110258500|NCT00520507|Autonomic Agents|autonomic agents|mesh-ancestor
110258501|NCT00520507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110258502|NCT00520507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258503|NCT00520507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110258504|NCT00520507|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110258505|NCT00520507|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110258506|NCT00520507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110258507|NCT00520507|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110258508|NCT00520507|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110258509|NCT00520507|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110258510|NCT00520507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110258511|NCT00520507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110258512|NCT00520507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110258513|NCT00520507|Serotonin Agents|serotonin agents|mesh-ancestor
110258514|NCT04694404|Oxaliplatin|oxaliplatin|mesh-list
110258515|NCT04694404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110258517|NCT04694365|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110258518|NCT04694365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110258519|NCT04694365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110258520|NCT04694365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110258521|NCT00151983|Methylphenidate|methylphenidate|mesh-list
110258522|NCT00151983|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110258523|NCT00151983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258525|NCT00151983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110258526|NCT00151983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110258527|NCT00151983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110258528|NCT00151983|Dopamine Agents|dopamine agents|mesh-ancestor
110258529|NCT00151983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110258530|NCT00520585|Atorvastatin|atorvastatin|mesh-list
110258531|NCT00520585|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110258532|NCT00520585|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110258533|NCT00520585|Antimetabolites|antimetabolites|mesh-ancestor
110258534|NCT00520585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110258535|NCT00520585|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110258536|NCT00520585|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110258537|NCT00520585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110258538|NCT00152022|Amphetamine|amphetamine|mesh-list
110258539|NCT00152022|Dextroamphetamine|dextroamphetamine|mesh-list
110258540|NCT00152022|Adderall|adderall|mesh-list
110258541|NCT00152022|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110258542|NCT00152022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258544|NCT00152022|Autonomic Agents|autonomic agents|mesh-ancestor
110258545|NCT00152022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110258546|NCT00152022|Dopamine Agents|dopamine agents|mesh-ancestor
110258547|NCT00152022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110258548|NCT00152022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110258549|NCT00152022|Adrenergic Agents|adrenergic agents|mesh-ancestor
110258550|NCT00152022|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110258551|NCT00152022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110258552|NCT00152022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110258553|NCT00152022|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110258554|NCT00520819|Antioxidants|antioxidants|mesh-list
110258555|NCT00520819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110258556|NCT00520819|Protective Agents|protective agents|mesh-ancestor
110258557|NCT00520819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258558|NCT00520897|Raltegravir Potassium|raltegravir potassium|mesh-list
110258559|NCT00520897|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110258560|NCT00520897|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110258561|NCT00520897|Antiviral Agents|antiviral agents|mesh-ancestor
110258562|NCT00520897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110258563|NCT00520897|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110258564|NCT00520897|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110258565|NCT00520897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110258566|NCT00520897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110258568|NCT00521092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110258569|NCT00521092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110258570|NCT00521092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110258571|NCT00521092|Growth Substances|growth substances|mesh-ancestor
110258572|NCT00521092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258573|NCT00521092|Growth Inhibitors|growth inhibitors|mesh-ancestor
110258574|NCT00521092|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110258575|NCT00521092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110258576|NCT00521092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110258577|NCT00521131|Levocetirizine|levocetirizine|mesh-list
110258578|NCT00521131|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110258579|NCT00521131|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110258580|NCT00521131|Histamine Antagonists|histamine antagonists|mesh-ancestor
110258581|NCT00521131|Histamine Agents|histamine agents|mesh-ancestor
110258582|NCT00521131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110258583|NCT00521131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110258584|NCT00521131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258585|NCT04694092|Landiolol|landiolol|mesh-list
110271448|NCT04299880|Antimetabolites|antimetabolites|mesh-ancestor
110258586|NCT04694092|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110258587|NCT04694092|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110258588|NCT04694092|Adrenergic Agents|adrenergic agents|mesh-ancestor
110258589|NCT04694092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110258590|NCT04694092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110258591|NCT04694092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258592|NCT04694092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110258593|NCT00521170|Levocetirizine|levocetirizine|mesh-list
110258594|NCT00521170|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110258595|NCT00521170|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110258596|NCT00521170|Histamine Antagonists|histamine antagonists|mesh-ancestor
110258597|NCT00521170|Histamine Agents|histamine agents|mesh-ancestor
110258598|NCT00521170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110258599|NCT00521170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110258600|NCT00521170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258602|NCT00521248|Buprenorphine|buprenorphine|mesh-list
110258603|NCT00521248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110258604|NCT00521248|Narcotics|narcotics|mesh-ancestor
110258605|NCT00521248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110258606|NCT00521248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258607|NCT00521248|Analgesics|analgesics|mesh-ancestor
110258608|NCT00521248|Sensory System Agents|sensory system agents|mesh-ancestor
110258609|NCT00521248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110258610|NCT00521248|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110258611|NCT00167154|Risperidone|risperidone|mesh-list
110258612|NCT00167154|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110258613|NCT00167154|Serotonin Agents|serotonin agents|mesh-ancestor
110258614|NCT00167154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110258615|NCT00167154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110258616|NCT00167154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258617|NCT00167154|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110258618|NCT00167154|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110258619|NCT00167154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110258620|NCT00167154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110258621|NCT00167154|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110258622|NCT00167154|Dopamine Agents|dopamine agents|mesh-ancestor
110258623|NCT00521482|Thalidomide|thalidomide|mesh-list
110258624|NCT00521482|Temozolomide|temozolomide|mesh-list
110258625|NCT00521482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110258626|NCT00521482|Alkylating Agents|alkylating agents|mesh-ancestor
110258627|NCT00521482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110258628|NCT00521482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110258629|NCT00521482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110258630|NCT00521482|Immunologic Factors|immunologic factors|mesh-ancestor
110258631|NCT00521482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258632|NCT00521482|Leprostatic Agents|leprostatic agents|mesh-ancestor
110258633|NCT00521482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110258634|NCT00521482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110258635|NCT00521482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110258636|NCT00521482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110258637|NCT00521482|Growth Substances|growth substances|mesh-ancestor
110258638|NCT00521482|Growth Inhibitors|growth inhibitors|mesh-ancestor
110258639|NCT00521521|Docetaxel|docetaxel|mesh-list
110258640|NCT00521521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110258641|NCT00521521|Tubulin Modulators|tubulin modulators|mesh-ancestor
110258642|NCT00521521|Antimitotic Agents|antimitotic agents|mesh-ancestor
110258643|NCT00521521|Mitosis Modulators|mitosis modulators|mesh-ancestor
110258644|NCT00521521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110258645|NCT00152100|Alemtuzumab|alemtuzumab|mesh-list
110258646|NCT00152100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110271460|NCT00167492|Mycophenolic Acid|mycophenolic acid|mesh-list
110258647|NCT00152100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110258648|NCT00522184|Etanercept|etanercept|mesh-list
110258649|NCT00522184|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110258650|NCT00522184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110258651|NCT00522184|Analgesics|analgesics|mesh-ancestor
110258652|NCT00522184|Sensory System Agents|sensory system agents|mesh-ancestor
110258653|NCT00522184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110258654|NCT00522184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258655|NCT00522184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110258656|NCT00522184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110258657|NCT00522184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110258658|NCT00522184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110258659|NCT00522184|Immunologic Factors|immunologic factors|mesh-ancestor
110258660|NCT03458923|Diclofenac|diclofenac|mesh-list
110258661|NCT03458923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
110258662|NCT03458923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110258663|NCT03458923|Ranibizumab|ranibizumab|mesh-list
110258664|NCT03458923|Endothelial Growth Factors|endothelial growth factors|mesh-list
110258665|NCT03458923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110258666|NCT03458923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110258667|NCT03458923|Growth Substances|growth substances|mesh-ancestor
110258668|NCT03458923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258669|NCT03458923|Growth Inhibitors|growth inhibitors|mesh-ancestor
110258670|NCT03458923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110258671|NCT03458923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110258672|NCT03458923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110258673|NCT03458923|Analgesics|analgesics|mesh-ancestor
110258674|NCT03458923|Sensory System Agents|sensory system agents|mesh-ancestor
110258675|NCT03458923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110258676|NCT03458923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110258677|NCT03458923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110258678|NCT03458923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110258679|NCT04186013|Atezolizumab|atezolizumab|mesh-list
110258680|NCT04186013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110258681|NCT04186013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110258682|NCT04186013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110258683|NCT04186013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110258684|NCT00152139|Antibodies|antibodies|mesh-list
110258685|NCT00152139|Immunologic Factors|immunologic factors|mesh-ancestor
110258686|NCT00152139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258687|NCT04725162|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110258688|NCT04725162|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110258689|NCT04725162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110258690|NCT00405431|Lubricant Eye Drops|lubricant eye drops|mesh-list
110258691|NCT00405431|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110258692|NCT00405431|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110258693|NCT00167232|Naltrexone|naltrexone|mesh-list
110258694|NCT00167232|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110258695|NCT00167232|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110258696|NCT00167232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258697|NCT00167232|Sensory System Agents|sensory system agents|mesh-ancestor
110258698|NCT00167232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110258700|NCT00522886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110258701|NCT00522886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110258703|NCT04083560|Vitamin B 12|vitamin b 12|mesh-list
110258704|NCT04083560|Hematinics|hematinics|mesh-ancestor
110258705|NCT04083560|Vitamin B Complex|vitamin b complex|mesh-ancestor
110258706|NCT04083560|Vitamins|vitamins|mesh-ancestor
110258707|NCT04083560|Micronutrients|micronutrients|mesh-ancestor
110258708|NCT04083560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258709|NCT00511966|Rabeprazole|rabeprazole|mesh-list
110258710|NCT00511966|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110258711|NCT00511966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110258712|NCT00511966|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110258713|NCT00511966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110258714|NCT00511966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110258715|NCT00152178|Tamoxifen|tamoxifen|mesh-list
110258716|NCT00152178|Cyclophosphamide|cyclophosphamide|mesh-list
110258717|NCT00152178|Fluorouracil|fluorouracil|mesh-list
110258718|NCT00152178|Methotrexate|methotrexate|mesh-list
110258719|NCT00152178|Tegafur|tegafur|mesh-list
110258720|NCT00152178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110258721|NCT00152178|Immunologic Factors|immunologic factors|mesh-ancestor
110258722|NCT00152178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258723|NCT00152178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110258724|NCT00152178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110258725|NCT00152178|Alkylating Agents|alkylating agents|mesh-ancestor
110258726|NCT00152178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110258727|NCT00152178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110258728|NCT00152178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110258729|NCT00152178|Antimetabolites|antimetabolites|mesh-ancestor
110258730|NCT00152178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110258731|NCT00152178|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110258732|NCT00152178|Abortifacient Agents|abortifacient agents|mesh-ancestor
110258733|NCT00152178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110258734|NCT00152178|Dermatologic Agents|dermatologic agents|mesh-ancestor
110258735|NCT00152178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110258736|NCT00152178|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110258737|NCT00152178|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110258738|NCT00152178|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110258739|NCT00152178|Hormone Antagonists|hormone antagonists|mesh-ancestor
110258740|NCT00152178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110258741|NCT00152178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110258742|NCT00152178|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110258743|NCT00152178|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110258744|NCT00152178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110258746|NCT00523120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110258747|NCT00523120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110258748|NCT00523120|Analgesics|analgesics|mesh-ancestor
110258749|NCT00523120|Sensory System Agents|sensory system agents|mesh-ancestor
110258750|NCT00523120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110258751|NCT00523120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258752|NCT00523120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110258753|NCT00523120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110258754|NCT00523120|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110258755|NCT00523120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110258756|NCT00523120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110258758|NCT00523159|Immunologic Factors|immunologic factors|mesh-ancestor
110258759|NCT00523159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258760|NCT04693897|Solifenacin Succinate|solifenacin succinate|mesh-list
110258761|NCT04693897|Mirabegron|mirabegron|mesh-list
110258762|NCT04693897|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110258763|NCT04693897|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110258764|NCT04693897|Cholinergic Agents|cholinergic agents|mesh-ancestor
110258765|NCT04693897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110258766|NCT04693897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110258767|NCT04693897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258768|NCT04693897|Urological Agents|urological agents|mesh-ancestor
110258769|NCT04693897|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110258770|NCT04693897|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110258771|NCT04693897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110258772|NCT04693897|Adrenergic Agents|adrenergic agents|mesh-ancestor
110258773|NCT00424242|Pemetrexed|pemetrexed|mesh-list
110258774|NCT00424242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110258775|NCT00424242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110258776|NCT00424242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110258777|NCT00424242|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110258778|NCT00424242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110258779|NCT04726553|Mycophenolic Acid|mycophenolic acid|mesh-list
110258780|NCT04726553|Antimalarials|antimalarials|mesh-list
110258781|NCT04726553|Methotrexate|methotrexate|mesh-list
110258782|NCT04726553|Azathioprine|azathioprine|mesh-list
110258783|NCT04726553|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110258784|NCT04726553|Abortifacient Agents|abortifacient agents|mesh-ancestor
110258785|NCT04726553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110258786|NCT04726553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258787|NCT04726553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110258788|NCT04726553|Antimetabolites|antimetabolites|mesh-ancestor
110258789|NCT04726553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110258790|NCT04726553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110258791|NCT04726553|Dermatologic Agents|dermatologic agents|mesh-ancestor
110258792|NCT04726553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110258793|NCT04726553|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110258794|NCT04726553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110258795|NCT04726553|Immunologic Factors|immunologic factors|mesh-ancestor
110258796|NCT04726553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110258797|NCT04726553|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110258798|NCT04726553|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110258799|NCT04726553|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110258800|NCT04726553|Antitubercular Agents|antitubercular agents|mesh-ancestor
110258801|NCT04726553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110258802|NCT04726553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110258803|NCT04726553|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110258804|NCT04726553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110258805|NCT02947945|Reslizumab|reslizumab|mesh-list
110258806|NCT02947945|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110258807|NCT02947945|Respiratory System Agents|respiratory system agents|mesh-ancestor
110258808|NCT02948101|Cyclophosphamide|cyclophosphamide|mesh-list
110258809|NCT02948101|Antibodies|antibodies|mesh-list
110258810|NCT02948101|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110258811|NCT02948101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110258813|NCT02948101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258814|NCT02948101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110258815|NCT02948101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110258816|NCT02948101|Alkylating Agents|alkylating agents|mesh-ancestor
110258817|NCT02948101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110258818|NCT02948101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110258819|NCT02948101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110258821|NCT02952157|Anesthetics, Local|anesthetics, local|mesh-ancestor
110258822|NCT02952157|Anesthetics|anesthetics|mesh-ancestor
110258823|NCT02952157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110258824|NCT02952157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258825|NCT02952157|Sensory System Agents|sensory system agents|mesh-ancestor
110258826|NCT02952157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110258827|NCT02952157|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110258828|NCT02952157|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110258829|NCT02952157|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110258830|NCT02952157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110258831|NCT02952157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110258832|NCT02951728|Prednisone|prednisone|mesh-list
110258833|NCT02951728|Cyclophosphamide|cyclophosphamide|mesh-list
110258834|NCT02951728|Rituximab|rituximab|mesh-list
110258835|NCT02951728|Doxorubicin|doxorubicin|mesh-list
110258836|NCT02951728|Vincristine|vincristine|mesh-list
110258837|NCT02951728|Decitabine|decitabine|mesh-list
110258838|NCT02951728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110258839|NCT02951728|Immunologic Factors|immunologic factors|mesh-ancestor
110258840|NCT02951728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258841|NCT02951728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110258842|NCT02951728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110258843|NCT02951728|Alkylating Agents|alkylating agents|mesh-ancestor
110258844|NCT02951728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110258845|NCT02951728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110258846|NCT02951728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110258847|NCT02951728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110258848|NCT02951728|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110258849|NCT02951728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110258850|NCT02951728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110258851|NCT02951728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110258852|NCT02951728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110258853|NCT02951728|Glucocorticoids|glucocorticoids|mesh-ancestor
110258855|NCT02951728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110258856|NCT02951728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110258857|NCT02951728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110258858|NCT02951728|Tubulin Modulators|tubulin modulators|mesh-ancestor
110258859|NCT02951728|Antimitotic Agents|antimitotic agents|mesh-ancestor
110258860|NCT02951728|Mitosis Modulators|mitosis modulators|mesh-ancestor
110258861|NCT02951728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110258862|NCT02951728|Antimetabolites|antimetabolites|mesh-ancestor
110258863|NCT04726046|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110258864|NCT04726046|Cefotetan|cefotetan|mesh-list
110258865|NCT04726046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110258866|NCT00523354|Infliximab|infliximab|mesh-list
110258867|NCT00523354|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110258868|NCT00523354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110258869|NCT00523354|Dermatologic Agents|dermatologic agents|mesh-ancestor
110258870|NCT00523354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110258871|NCT00523354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110258872|NCT00523393|Insulin|insulin|mesh-list
110258873|NCT00523393|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110258874|NCT00523393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110258875|NCT00523393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258876|NCT00523432|Sirolimus|sirolimus|mesh-list
110258877|NCT00523432|Topotecan|topotecan|mesh-list
110258878|NCT00523432|Temsirolimus|temsirolimus|mesh-list
110258879|NCT00523432|MTOR Inhibitors|mtor inhibitors|mesh-list
110258880|NCT00523432|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110258881|NCT00523432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110258882|NCT00523432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110258883|NCT00523432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110258884|NCT00523432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110258885|NCT00523432|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110258886|NCT00523432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110258887|NCT00523432|Immunologic Factors|immunologic factors|mesh-ancestor
110271518|NCT00167687|Prazosin|prazosin|mesh-list
110258888|NCT00523432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258889|NCT00523432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110258890|NCT00523432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110258891|NCT00523432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110258892|NCT00523432|Antifungal Agents|antifungal agents|mesh-ancestor
110258893|NCT00512044|Anesthetics|anesthetics|mesh-list
110258894|NCT00512044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110258895|NCT00512044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258896|NCT04726007|Fibrinolytic Agents|fibrinolytic agents|mesh-list
110258897|NCT04726007|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110258898|NCT04726007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110258899|NCT00521950|Mercaptopurine|mercaptopurine|mesh-list
110258900|NCT00521950|Azathioprine|azathioprine|mesh-list
110258901|NCT00521950|Antimetabolites|antimetabolites|mesh-ancestor
110258902|NCT00521950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110258903|NCT00521950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110258904|NCT00521950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110258905|NCT00521950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110258906|NCT00521950|Immunologic Factors|immunologic factors|mesh-ancestor
110258907|NCT00521950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258908|NCT00521950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110258909|NCT00521950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110258910|NCT00521950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110258911|NCT00523666|Galantamine|galantamine|mesh-list
110258912|NCT00523666|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110258913|NCT00523666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110258914|NCT00523666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110258915|NCT00523666|Cholinergic Agents|cholinergic agents|mesh-ancestor
110258916|NCT00523666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110258917|NCT00523666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258918|NCT00523666|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110258919|NCT00523666|Autonomic Agents|autonomic agents|mesh-ancestor
110258920|NCT00523666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110258921|NCT00523666|Nootropic Agents|nootropic agents|mesh-ancestor
110258922|NCT00167583|Interferons|interferons|mesh-list
110258923|NCT00167583|Interferon-alpha|interferon-alpha|mesh-list
110258924|NCT00167583|Interferon alpha-2|interferon alpha-2|mesh-list
110258925|NCT00167583|Cyclosporine|cyclosporine|mesh-list
110258926|NCT00167583|Cyclosporins|cyclosporins|mesh-list
110258927|NCT00167583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110258929|NCT00167583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110258930|NCT00167583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110258931|NCT00167583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110258932|NCT00167583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110258933|NCT00167583|Immunologic Factors|immunologic factors|mesh-ancestor
110258934|NCT00167583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258935|NCT00167583|Antifungal Agents|antifungal agents|mesh-ancestor
110258936|NCT00167583|Dermatologic Agents|dermatologic agents|mesh-ancestor
110258937|NCT00167583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110258938|NCT00167583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110258939|NCT03943511|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110258940|NCT03943511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110258941|NCT00172809|Interferons|interferons|mesh-list
110258942|NCT00172809|Interferon-alpha|interferon-alpha|mesh-list
110258943|NCT00172809|Interferon alpha-2|interferon alpha-2|mesh-list
110258944|NCT00172809|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110258945|NCT00172809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110258946|NCT00172809|Antiviral Agents|antiviral agents|mesh-ancestor
110258947|NCT00172809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110258948|NCT00172809|Immunologic Factors|immunologic factors|mesh-ancestor
110258949|NCT00172809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258951|NCT04696120|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110258952|NCT04696120|Antithrombins|antithrombins|mesh-ancestor
110271540|NCT02906800|Digoxin|digoxin|mesh-list
110258954|NCT04696120|Protease Inhibitors|protease inhibitors|mesh-ancestor
110258955|NCT04696120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110258956|NCT04696120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110258957|NCT04696120|Anticoagulants|anticoagulants|mesh-ancestor
110258958|NCT00512395|Fentanyl|fentanyl|mesh-list
110258959|NCT00512395|Ropivacaine|ropivacaine|mesh-list
110258960|NCT00512395|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110258961|NCT00512395|Narcotics|narcotics|mesh-ancestor
110258962|NCT00512395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110258963|NCT00512395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258964|NCT00512395|Analgesics|analgesics|mesh-ancestor
110258965|NCT00512395|Sensory System Agents|sensory system agents|mesh-ancestor
110258966|NCT00512395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110258967|NCT00512395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110258968|NCT00512395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110258969|NCT00512395|Anesthetics, General|anesthetics, general|mesh-ancestor
110258970|NCT00512395|Anesthetics|anesthetics|mesh-ancestor
110258971|NCT00512395|Anesthetics, Local|anesthetics, local|mesh-ancestor
110258973|NCT00512473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110258974|NCT00512473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258975|NCT00524095|Fluticasone|fluticasone|mesh-list
110258976|NCT00524095|Xhance|xhance|mesh-list
110258977|NCT00524095|Azithromycin|azithromycin|mesh-list
110258978|NCT00524095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110258979|NCT00524095|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110258980|NCT00524095|Autonomic Agents|autonomic agents|mesh-ancestor
110258981|NCT00524095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110258982|NCT00524095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110258983|NCT00524095|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110258984|NCT00524095|Respiratory System Agents|respiratory system agents|mesh-ancestor
110258985|NCT00524095|Dermatologic Agents|dermatologic agents|mesh-ancestor
110258986|NCT00524095|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110258987|NCT00524095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110258988|NCT00524095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110258989|NCT00512629|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
110258990|NCT00512629|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
110258991|NCT00512629|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110258992|NCT00512629|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110258994|NCT00512668|Leuprolide|leuprolide|mesh-list
110258995|NCT00512668|Goserelin|goserelin|mesh-list
110258996|NCT00512668|Flutamide|flutamide|mesh-list
110258997|NCT00512668|Temsirolimus|temsirolimus|mesh-list
110258998|NCT00512668|Bicalutamide|bicalutamide|mesh-list
110258999|NCT00512668|Nilutamide|nilutamide|mesh-list
110259000|NCT00512668|MTOR Inhibitors|mtor inhibitors|mesh-list
110259001|NCT00512668|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110259002|NCT00512668|Fertility Agents|fertility agents|mesh-ancestor
110259003|NCT00512668|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110259004|NCT00512668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259005|NCT00512668|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110259006|NCT00512668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110259007|NCT00512668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110259008|NCT00512668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110259009|NCT00512668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110259010|NCT00512668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110259011|NCT00512668|Immunologic Factors|immunologic factors|mesh-ancestor
110259012|NCT00512668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110259013|NCT00512668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110259014|NCT00512668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110259015|NCT00512668|Antifungal Agents|antifungal agents|mesh-ancestor
110259016|NCT00512668|Androgen Antagonists|androgen antagonists|mesh-ancestor
110259017|NCT00512668|Hormone Antagonists|hormone antagonists|mesh-ancestor
110259018|NCT00512668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110259019|NCT00167739|Pyrimethamine|pyrimethamine|mesh-list
110259020|NCT00167739|Sulfadoxine|sulfadoxine|mesh-list
110259021|NCT00167739|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110259022|NCT00167739|Quinine|quinine|mesh-list
110259023|NCT00167739|Antimalarials|antimalarials|mesh-ancestor
110259024|NCT00167739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110259025|NCT00167739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110259026|NCT00167739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110259027|NCT00167739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110259028|NCT00167739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110259029|NCT00167739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110259030|NCT00167739|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110259031|NCT00167739|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110259032|NCT00167739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259033|NCT00167739|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110259034|NCT00167739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110259035|NCT00167739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110259036|NCT00167739|Analgesics|analgesics|mesh-ancestor
110259037|NCT00167739|Sensory System Agents|sensory system agents|mesh-ancestor
110259038|NCT00524251|Esomeprazole|esomeprazole|mesh-list
110259039|NCT00524251|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110259040|NCT00524251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110259041|NCT00524251|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110259042|NCT00524251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110259043|NCT00524251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110259044|NCT00512824|Calcium Carbonate|calcium carbonate|mesh-list
110259045|NCT00512824|Calcium|calcium|mesh-list
110259046|NCT00512824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110259047|NCT00512824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259048|NCT00512824|Antacids|antacids|mesh-ancestor
110259049|NCT00512824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110259050|NCT00512824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110259051|NCT00512863|Adalimumab|adalimumab|mesh-list
110259052|NCT00512863|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110259053|NCT00512863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110259054|NCT00512863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110259055|NCT00524407|Epoetin Alfa|epoetin alfa|mesh-list
110259056|NCT00524407|Hematinics|hematinics|mesh-ancestor
110259057|NCT00525889|Sirolimus|sirolimus|mesh-list
110259058|NCT00525889|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110259059|NCT00525889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110259060|NCT00525889|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110259061|NCT00525889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110259062|NCT00525889|Antifungal Agents|antifungal agents|mesh-ancestor
110259063|NCT00525889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110259064|NCT00525889|Immunologic Factors|immunologic factors|mesh-ancestor
110259065|NCT00525889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259066|NCT00524524|Beta-lapachone|beta-lapachone|mesh-list
110259067|NCT00524524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110259068|NCT00524524|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110259069|NCT00524524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110259070|NCT00524524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110259071|NCT00524524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110259072|NCT00524524|Antiviral Agents|antiviral agents|mesh-ancestor
110259073|NCT03879122|Docetaxel|docetaxel|mesh-list
110259074|NCT03879122|Nivolumab|nivolumab|mesh-list
110259075|NCT03879122|Ipilimumab|ipilimumab|mesh-list
110259076|NCT03879122|Androgens|androgens|mesh-list
110259077|NCT03879122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110259078|NCT03879122|Tubulin Modulators|tubulin modulators|mesh-ancestor
110259079|NCT03879122|Antimitotic Agents|antimitotic agents|mesh-ancestor
110259080|NCT03879122|Mitosis Modulators|mitosis modulators|mesh-ancestor
110259081|NCT03879122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110259082|NCT03879122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110259083|NCT03879122|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110259085|NCT03879122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110259086|NCT03879122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259087|NCT00525928|Varenicline|varenicline|mesh-list
110259088|NCT00525928|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110259089|NCT00525928|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110259090|NCT00525928|Cholinergic Agents|cholinergic agents|mesh-ancestor
110259091|NCT00525928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110259092|NCT00525928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110259093|NCT00525928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259094|NCT00167817|Aripiprazole|aripiprazole|mesh-list
110259095|NCT00167817|Antidepressive Agents|antidepressive agents|mesh-ancestor
110259096|NCT00167817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110259097|NCT00167817|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110259098|NCT00167817|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110259099|NCT00167817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110259100|NCT00167817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259101|NCT00167817|Dopamine Agonists|dopamine agonists|mesh-ancestor
110259102|NCT00167817|Dopamine Agents|dopamine agents|mesh-ancestor
110259103|NCT00167817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110259104|NCT00167817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110259105|NCT00167817|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110259106|NCT00167817|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110259107|NCT00167817|Serotonin Agents|serotonin agents|mesh-ancestor
110259108|NCT00167817|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110259109|NCT00167817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110259110|NCT00167817|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110259111|NCT00167817|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110259112|NCT02947711|Diltiazem|diltiazem|mesh-list
110259113|NCT02947711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110259114|NCT02947711|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110259115|NCT02947711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110259116|NCT02947711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110259117|NCT02947711|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110259118|NCT02947711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259120|NCT03845348|Ketoconazole|ketoconazole|mesh-list
110259121|NCT03845348|Antifungal Agents|antifungal agents|mesh-ancestor
110259122|NCT03845348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110259123|NCT03845348|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110259124|NCT03845348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110259125|NCT03845348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110259126|NCT03845348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110259127|NCT03845348|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110259128|NCT03845348|Hormone Antagonists|hormone antagonists|mesh-ancestor
110259129|NCT03845348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110259130|NCT03845348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259131|NCT03845348|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110259133|NCT04723563|Anticoagulants|anticoagulants|mesh-ancestor
110259134|NCT04723563|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110259135|NCT04723563|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110259136|NCT04723563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110259138|NCT00525967|Methadone|methadone|mesh-list
110259139|NCT00525967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110259140|NCT00525967|Analgesics|analgesics|mesh-ancestor
110259141|NCT00525967|Sensory System Agents|sensory system agents|mesh-ancestor
110259142|NCT00525967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110259143|NCT00525967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259144|NCT00525967|Antipyretics|antipyretics|mesh-ancestor
110259145|NCT00525967|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110259146|NCT00525967|Narcotics|narcotics|mesh-ancestor
110259147|NCT00525967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110259148|NCT00525967|Antitussive Agents|antitussive agents|mesh-ancestor
110259149|NCT00525967|Respiratory System Agents|respiratory system agents|mesh-ancestor
110259150|NCT00167856|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110259151|NCT00167856|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110259152|NCT00167856|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110259153|NCT00167856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110259154|NCT00167856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110259155|NCT00167856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110259156|NCT00167856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259157|NCT00167856|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110259158|NCT00167856|Antidepressive Agents|antidepressive agents|mesh-ancestor
110259159|NCT00167856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110259160|NCT00526006|Esomeprazole|esomeprazole|mesh-list
110259161|NCT00526006|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110259162|NCT00526006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110259163|NCT00526006|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110259164|NCT00526006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110260211|NCT00530413|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110259165|NCT00526006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110259166|NCT03681275|Tofacitinib|tofacitinib|mesh-list
110259167|NCT03681275|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110259168|NCT03681275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110259169|NCT03681275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110259170|NCT03681275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110259171|NCT02946814|Listerine|listerine|mesh-list
110259172|NCT02946814|Sodium Fluoride|sodium fluoride|mesh-list
110259173|NCT02946814|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110259174|NCT02946814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110259175|NCT02946814|Cariostatic Agents|cariostatic agents|mesh-ancestor
110259176|NCT02946814|Protective Agents|protective agents|mesh-ancestor
110259177|NCT02946814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259178|NCT00524836|Levocetirizine|levocetirizine|mesh-list
110259179|NCT00524836|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110259180|NCT00524836|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110259181|NCT00524836|Histamine Antagonists|histamine antagonists|mesh-ancestor
110259182|NCT00524836|Histamine Agents|histamine agents|mesh-ancestor
110259183|NCT00524836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110259184|NCT00524836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110259185|NCT00524836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259186|NCT00524875|Bevacizumab|bevacizumab|mesh-list
110259187|NCT00524875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110259188|NCT00524875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110259189|NCT00524875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110259190|NCT00524875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110259191|NCT00524875|Growth Substances|growth substances|mesh-ancestor
110259192|NCT00524875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259193|NCT00524875|Growth Inhibitors|growth inhibitors|mesh-ancestor
110259194|NCT00524914|Apomorphine|apomorphine|mesh-list
110259195|NCT00524914|Emetics|emetics|mesh-ancestor
110259196|NCT00524914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259197|NCT00524914|Autonomic Agents|autonomic agents|mesh-ancestor
110259198|NCT00524914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110259199|NCT00524914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110259200|NCT00524914|Dopamine Agonists|dopamine agonists|mesh-ancestor
110259201|NCT00524914|Dopamine Agents|dopamine agents|mesh-ancestor
110259202|NCT00524914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110259203|NCT00524914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110259204|NCT02957864|Tenofovir|tenofovir|mesh-list
110259205|NCT02957864|Abacavir|abacavir|mesh-list
110259206|NCT02957864|Antiviral Agents|antiviral agents|mesh-ancestor
110259207|NCT02957864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110259208|NCT02957864|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110259209|NCT02957864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110259210|NCT02957864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110259211|NCT02957864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110259212|NCT02957864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110259213|NCT02957864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110259214|NCT00168012|Immunoglobulins|immunoglobulins|mesh-list
110259215|NCT00168012|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110259217|NCT00168012|Immunologic Factors|immunologic factors|mesh-ancestor
110259218|NCT00168012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259219|NCT03585452|Dexmedetomidine|dexmedetomidine|mesh-list
110259221|NCT03585452|Anesthetics|anesthetics|mesh-ancestor
110259222|NCT03585452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110259223|NCT03585452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259224|NCT03585452|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110259225|NCT03585452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110259226|NCT03585452|Analgesics|analgesics|mesh-ancestor
110259227|NCT03585452|Sensory System Agents|sensory system agents|mesh-ancestor
110259228|NCT03585452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110259229|NCT03585452|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110259230|NCT03585452|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110259231|NCT03585452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110259232|NCT03585452|Adrenergic Agents|adrenergic agents|mesh-ancestor
110259233|NCT03585452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110259234|NCT03585452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110259235|NCT03585452|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110259236|NCT03585452|Anesthetics, General|anesthetics, general|mesh-ancestor
110259237|NCT02947672|Dexamethasone|dexamethasone|mesh-list
110259238|NCT02947672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110259239|NCT02947672|Antiemetics|antiemetics|mesh-ancestor
110259240|NCT02947672|Autonomic Agents|autonomic agents|mesh-ancestor
110259241|NCT02947672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110259242|NCT02947672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259243|NCT02947672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110259244|NCT02947672|Glucocorticoids|glucocorticoids|mesh-ancestor
110259245|NCT02947672|Hormones|hormones|mesh-ancestor
110259246|NCT02947672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110259247|NCT02947672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110259248|NCT02947672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110259249|NCT03539627|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
110259250|NCT03539627|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110259251|NCT03539627|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110259252|NCT03539627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110259253|NCT02946268|Ropivacaine|ropivacaine|mesh-list
110259254|NCT02946268|Anesthetics, Local|anesthetics, local|mesh-ancestor
110259255|NCT02946268|Anesthetics|anesthetics|mesh-ancestor
110259256|NCT02946268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110259257|NCT02946268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259258|NCT02946268|Sensory System Agents|sensory system agents|mesh-ancestor
110259259|NCT02946268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110259260|NCT00168051|Factor VIII|factor viii|mesh-list
110259261|NCT00168051|Coagulants|coagulants|mesh-ancestor
110259262|NCT00526318|Cyclophosphamide|cyclophosphamide|mesh-list
110259263|NCT00526318|Melphalan|melphalan|mesh-list
110259264|NCT00526318|Ifosfamide|ifosfamide|mesh-list
110259265|NCT00526318|Dacarbazine|dacarbazine|mesh-list
110259266|NCT00526318|Carboplatin|carboplatin|mesh-list
110259267|NCT00526318|Doxorubicin|doxorubicin|mesh-list
110259268|NCT00526318|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110259269|NCT00526318|Etoposide|etoposide|mesh-list
110259270|NCT00526318|Vincristine|vincristine|mesh-list
110259271|NCT00526318|Topotecan|topotecan|mesh-list
110259272|NCT00526318|Etoposide phosphate|etoposide phosphate|mesh-list
110259273|NCT00526318|Vindesine|vindesine|mesh-list
110259274|NCT00526318|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
110259275|NCT00526318|Isotretinoin|isotretinoin|mesh-list
110259276|NCT00526318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110259277|NCT00526318|Immunologic Factors|immunologic factors|mesh-ancestor
110259278|NCT00526318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259279|NCT00526318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110259280|NCT00526318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110259281|NCT00526318|Alkylating Agents|alkylating agents|mesh-ancestor
110259282|NCT00526318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110259283|NCT00526318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110259284|NCT00526318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110259285|NCT00526318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110259286|NCT00526318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110259287|NCT00526318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110259288|NCT00526318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110259289|NCT00526318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110259290|NCT00526318|Tubulin Modulators|tubulin modulators|mesh-ancestor
110259291|NCT00526318|Antimitotic Agents|antimitotic agents|mesh-ancestor
110259292|NCT00526318|Mitosis Modulators|mitosis modulators|mesh-ancestor
110259293|NCT00526318|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110259294|NCT00526318|Dermatologic Agents|dermatologic agents|mesh-ancestor
110259295|NCT00526318|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110259296|NCT04693312|Methylprednisolone|methylprednisolone|mesh-list
110259297|NCT04693312|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110259298|NCT04693312|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110259300|NCT04693312|Prednisolone acetate|prednisolone acetate|mesh-list
110259301|NCT04693312|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110259302|NCT04693312|Prednisolone phosphate|prednisolone phosphate|mesh-list
110259303|NCT04693312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110259304|NCT04693312|Antiemetics|antiemetics|mesh-ancestor
110259305|NCT04693312|Autonomic Agents|autonomic agents|mesh-ancestor
110259306|NCT04693312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110259307|NCT04693312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259308|NCT04693312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110259309|NCT04693312|Glucocorticoids|glucocorticoids|mesh-ancestor
110259310|NCT04693312|Hormones|hormones|mesh-ancestor
110259311|NCT04693312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110259313|NCT04693312|Protective Agents|protective agents|mesh-ancestor
110259314|NCT04693312|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110259315|NCT04693312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110259316|NCT00168090|Factor VIII|factor viii|mesh-list
110259317|NCT00168090|Coagulants|coagulants|mesh-ancestor
110259318|NCT00525382|Levocetirizine|levocetirizine|mesh-list
110259319|NCT00525382|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110259320|NCT00525382|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110259321|NCT00525382|Histamine Antagonists|histamine antagonists|mesh-ancestor
110259322|NCT00525382|Histamine Agents|histamine agents|mesh-ancestor
110259323|NCT00525382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110259324|NCT00525382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110259325|NCT00525382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259326|NCT00526513|Insulin glulisine|insulin glulisine|mesh-list
110259327|NCT00526513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110259328|NCT00526513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259329|NCT00168168|Lenograstim|lenograstim|mesh-list
110259330|NCT00168168|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110259331|NCT00168168|Immunologic Factors|immunologic factors|mesh-ancestor
110259332|NCT00168168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259333|NCT03225755|Hormones|hormones|mesh-list
110259334|NCT03225755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110259335|NCT03225755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259336|NCT00525577|Probucol|probucol|mesh-list
110259337|NCT00525577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110259338|NCT00525577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110259339|NCT00525577|Antimetabolites|antimetabolites|mesh-ancestor
110259340|NCT00525577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110259341|NCT00525577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110259342|NCT00525577|Antioxidants|antioxidants|mesh-ancestor
110259343|NCT00525577|Protective Agents|protective agents|mesh-ancestor
110259344|NCT00525577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259345|NCT03186755|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
110259346|NCT03186755|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110259347|NCT03186755|Hyaluronic Acid|hyaluronic acid|mesh-list
110259348|NCT03186755|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110259349|NCT03186755|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110259350|NCT03186755|Immunologic Factors|immunologic factors|mesh-ancestor
110259351|NCT03186755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259352|NCT03186755|Viscosupplements|viscosupplements|mesh-ancestor
110259353|NCT03186755|Protective Agents|protective agents|mesh-ancestor
110259354|NCT03186755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110259355|NCT03186755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110259356|NCT03186755|Analgesics|analgesics|mesh-ancestor
110259357|NCT03186755|Sensory System Agents|sensory system agents|mesh-ancestor
110259358|NCT03186755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110259359|NCT03186755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110259360|NCT03186755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110259361|NCT03186755|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110259362|NCT03186755|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110259363|NCT03186755|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110259364|NCT03186755|Histamine Antagonists|histamine antagonists|mesh-ancestor
110259365|NCT03186755|Histamine Agents|histamine agents|mesh-ancestor
110259366|NCT03186755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110259367|NCT03186755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110259368|NCT00525616|Rituximab|rituximab|mesh-list
110259369|NCT00525616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110259370|NCT00525616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110259371|NCT00525616|Immunologic Factors|immunologic factors|mesh-ancestor
110259372|NCT00525616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259373|NCT00525616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110259374|NCT00525694|Cocaine|cocaine|mesh-list
110259375|NCT00525694|Anesthetics, Local|anesthetics, local|mesh-ancestor
110259376|NCT00525694|Anesthetics|anesthetics|mesh-ancestor
110259377|NCT00525694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110259378|NCT00525694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259379|NCT00525694|Sensory System Agents|sensory system agents|mesh-ancestor
110259380|NCT00525694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110259381|NCT00525694|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110259382|NCT00525694|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110259383|NCT00525694|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110259384|NCT00525694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110259385|NCT00525694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110259386|NCT00525694|Dopamine Agents|dopamine agents|mesh-ancestor
110259387|NCT00525694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110259388|NCT02947243|Morphine|morphine|mesh-list
110259389|NCT02947243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110259390|NCT02947243|Narcotics|narcotics|mesh-ancestor
110259391|NCT02947243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110259392|NCT02947243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259393|NCT02947243|Analgesics|analgesics|mesh-ancestor
110259394|NCT02947243|Sensory System Agents|sensory system agents|mesh-ancestor
110259395|NCT02947243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110259396|NCT02946970|Quinine|quinine|mesh-list
110259397|NCT02946970|Antimalarials|antimalarials|mesh-ancestor
110259398|NCT02946970|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110259399|NCT02946970|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110259400|NCT02946970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110259401|NCT02946970|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110259402|NCT02946970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259403|NCT02946970|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110259404|NCT02946970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110259405|NCT02946970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110259406|NCT02946970|Analgesics|analgesics|mesh-ancestor
110259407|NCT02946970|Sensory System Agents|sensory system agents|mesh-ancestor
110259408|NCT00527020|Nicotine|nicotine|mesh-list
110259409|NCT00527020|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110259410|NCT00527020|Autonomic Agents|autonomic agents|mesh-ancestor
110259411|NCT00527020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110259412|NCT00527020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259413|NCT00527020|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110259414|NCT00527020|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110259415|NCT00527020|Cholinergic Agents|cholinergic agents|mesh-ancestor
110259416|NCT00527020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110259417|NCT00527020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110259418|NCT00407277|Nicotine|nicotine|mesh-list
110259419|NCT00407277|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110259420|NCT00407277|Autonomic Agents|autonomic agents|mesh-ancestor
110259421|NCT00407277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110259422|NCT00407277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259423|NCT00407277|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110259424|NCT00407277|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110259425|NCT00407277|Cholinergic Agents|cholinergic agents|mesh-ancestor
110259426|NCT00407277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110259427|NCT00407277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110259428|NCT00527059|Simendan|simendan|mesh-list
110259429|NCT00527059|Spironolactone|spironolactone|mesh-list
110259430|NCT00527059|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110259431|NCT00527059|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110259432|NCT00527059|Hormone Antagonists|hormone antagonists|mesh-ancestor
110259433|NCT00527059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110259434|NCT00527059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259435|NCT00527059|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110259437|NCT00527059|Natriuretic Agents|natriuretic agents|mesh-ancestor
110259438|NCT00527059|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110259439|NCT00527059|Adrenergic Agents|adrenergic agents|mesh-ancestor
110259440|NCT00527059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110259441|NCT00527059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110259442|NCT00527059|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110259443|NCT00527059|Vasodilator Agents|vasodilator agents|mesh-ancestor
110259444|NCT00527059|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110259445|NCT00527059|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110259446|NCT00527059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110259447|NCT00527059|Protective Agents|protective agents|mesh-ancestor
110259448|NCT03156452|Mycophenolic Acid|mycophenolic acid|mesh-list
110259449|NCT03156452|Prednisolone|prednisolone|mesh-list
110259450|NCT03156452|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110259451|NCT03156452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110259452|NCT03156452|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110259453|NCT03156452|Antitubercular Agents|antitubercular agents|mesh-ancestor
110259454|NCT03156452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110259455|NCT03156452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110259456|NCT03156452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110259457|NCT03156452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110259458|NCT03156452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110259459|NCT03156452|Glucocorticoids|glucocorticoids|mesh-ancestor
110259460|NCT03156452|Hormones|hormones|mesh-ancestor
110259461|NCT03156452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110259462|NCT03156452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259463|NCT03156452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110259465|NCT00525772|Glucocorticoids|glucocorticoids|mesh-ancestor
110259466|NCT00525772|Hormones|hormones|mesh-ancestor
110259467|NCT00525772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110259468|NCT00525772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259469|NCT00525772|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110259470|NCT02945956|Entecavir|entecavir|mesh-list
110259471|NCT02945956|Antiviral Agents|antiviral agents|mesh-ancestor
110259472|NCT02945956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110259473|NCT03122639|Atorvastatin|atorvastatin|mesh-list
110259474|NCT03122639|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110259475|NCT03122639|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110259476|NCT03122639|Antimetabolites|antimetabolites|mesh-ancestor
110259477|NCT03122639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110259478|NCT03122639|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110259479|NCT03122639|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110259480|NCT03122639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110259481|NCT00527137|Darbepoetin alfa|darbepoetin alfa|mesh-list
110259482|NCT00527137|Hematinics|hematinics|mesh-ancestor
110259483|NCT02945839|Topiramate|topiramate|mesh-list
110259484|NCT02945839|Anticonvulsants|anticonvulsants|mesh-ancestor
110259485|NCT02945839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110259486|NCT02945839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259487|NCT02957786|Varenicline|varenicline|mesh-list
110259488|NCT02957786|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110259489|NCT02957786|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110259490|NCT02957786|Cholinergic Agents|cholinergic agents|mesh-ancestor
110259491|NCT02957786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110259492|NCT02957786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110259493|NCT02957786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259494|NCT00407394|Amoxicillin|amoxicillin|mesh-list
110259495|NCT00407394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110259496|NCT00407394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110259497|NCT03109964|Hemostatics|hemostatics|mesh-list
110259498|NCT03109964|Surgiflo|surgiflo|mesh-list
110259499|NCT03109964|Coagulants|coagulants|mesh-ancestor
110259500|NCT00407433|Gemcitabine|gemcitabine|mesh-list
110259501|NCT00407433|Oxaliplatin|oxaliplatin|mesh-list
110259502|NCT00407433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110259503|NCT00407433|Antimetabolites|antimetabolites|mesh-ancestor
110259504|NCT00407433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110259505|NCT00407433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110259506|NCT00516412|Everolimus|everolimus|mesh-list
110259507|NCT00516412|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110259508|NCT00516412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110259509|NCT00516412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110259510|NCT00516412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110259511|NCT00516412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110259512|NCT00516412|Immunologic Factors|immunologic factors|mesh-ancestor
110259513|NCT00516412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259514|NCT00516412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110259515|NCT03058835|Tenofovir|tenofovir|mesh-list
110259516|NCT03058835|Emtricitabine|emtricitabine|mesh-list
110259517|NCT03058835|Antiviral Agents|antiviral agents|mesh-ancestor
110259518|NCT03058835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110259519|NCT03058835|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110259520|NCT03058835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110259521|NCT03058835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110259522|NCT03058835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110259523|NCT03058835|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110259524|NCT03058835|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110259525|NCT00516490|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110259526|NCT00516490|Luteolytic Agents|luteolytic agents|mesh-ancestor
110259527|NCT00516490|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110259528|NCT00516490|Contraceptive Agents|contraceptive agents|mesh-ancestor
110259529|NCT00516490|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110259530|NCT00516490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259531|NCT00516490|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110259532|NCT00516490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110259534|NCT00516607|Temozolomide|temozolomide|mesh-list
110259535|NCT00516607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110259536|NCT00516607|Alkylating Agents|alkylating agents|mesh-ancestor
110259537|NCT00516607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110259538|NCT00516607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110259539|NCT00173667|Nifedipine|nifedipine|mesh-list
110259540|NCT00173667|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110259541|NCT00173667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110259542|NCT00173667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110259543|NCT00173667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110259544|NCT00173667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259545|NCT00173667|Vasodilator Agents|vasodilator agents|mesh-ancestor
110259546|NCT00173667|Tocolytic Agents|tocolytic agents|mesh-ancestor
110259547|NCT00173667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110259548|NCT00516685|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
110259549|NCT00516685|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110259550|NCT00516685|Immunologic Factors|immunologic factors|mesh-ancestor
110259551|NCT00516685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259552|NCT03016871|Carboplatin|carboplatin|mesh-list
110259553|NCT03016871|Nivolumab|nivolumab|mesh-list
110259554|NCT03016871|Etoposide|etoposide|mesh-list
110259555|NCT03016871|Etoposide phosphate|etoposide phosphate|mesh-list
110259556|NCT03016871|Ifosfamide|ifosfamide|mesh-list
110259557|NCT03016871|Isophosphamide mustard|isophosphamide mustard|mesh-list
110259558|NCT03016871|Podophyllotoxin|podophyllotoxin|mesh-list
110259559|NCT03016871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110259560|NCT03016871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110259561|NCT03016871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110259562|NCT03016871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110259563|NCT03016871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110259564|NCT03016871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110259565|NCT03016871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110259566|NCT03016871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110259567|NCT03016871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110259568|NCT03016871|Alkylating Agents|alkylating agents|mesh-ancestor
110259569|NCT03016871|Keratolytic Agents|keratolytic agents|mesh-ancestor
110259570|NCT03016871|Dermatologic Agents|dermatologic agents|mesh-ancestor
110259571|NCT03016871|Tubulin Modulators|tubulin modulators|mesh-ancestor
110259572|NCT03016871|Antimitotic Agents|antimitotic agents|mesh-ancestor
110259573|NCT03016871|Mitosis Modulators|mitosis modulators|mesh-ancestor
110259574|NCT03458689|Analgesics|analgesics|mesh-list
110259575|NCT03458689|Sensory System Agents|sensory system agents|mesh-ancestor
110259576|NCT03458689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110259577|NCT03458689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259578|NCT00527215|Darbepoetin alfa|darbepoetin alfa|mesh-list
110259579|NCT00527215|Hematinics|hematinics|mesh-ancestor
110259580|NCT00173745|Botulinum Toxins|botulinum toxins|mesh-list
110259581|NCT00173745|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110259582|NCT00173745|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110259583|NCT00173745|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110259584|NCT00173745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110259585|NCT00173745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110259586|NCT00173745|Cholinergic Agents|cholinergic agents|mesh-ancestor
110259588|NCT00173745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259589|NCT00173745|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110259590|NCT00173745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110259591|NCT02945644|Trazodone|trazodone|mesh-list
110259592|NCT02945644|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110259593|NCT02945644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110259594|NCT02945644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110259595|NCT02945644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259596|NCT02945644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110259597|NCT02945644|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110259598|NCT02945644|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110259599|NCT02945644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110259600|NCT02945644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110259601|NCT02945644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110259602|NCT02945644|Serotonin Agents|serotonin agents|mesh-ancestor
110259603|NCT02945644|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110259604|NCT02945644|Antidepressive Agents|antidepressive agents|mesh-ancestor
110259605|NCT02460887|Cisplatin|cisplatin|mesh-list
110259606|NCT02460887|Gemcitabine|gemcitabine|mesh-list
110259607|NCT02460887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110259608|NCT02460887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110259609|NCT02460887|Antimetabolites|antimetabolites|mesh-ancestor
110259610|NCT02460887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110259611|NCT02945527|Dexamethasone|dexamethasone|mesh-list
110259612|NCT02945527|Acetazolamide|acetazolamide|mesh-list
110259613|NCT02945527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110259615|NCT02945527|Autonomic Agents|autonomic agents|mesh-ancestor
110259616|NCT02945527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110259617|NCT02945527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259618|NCT02945527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110259619|NCT02945527|Glucocorticoids|glucocorticoids|mesh-ancestor
110259620|NCT02945527|Hormones|hormones|mesh-ancestor
110259621|NCT02945527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110259622|NCT02945527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110259623|NCT02945527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110259624|NCT02945527|Anticonvulsants|anticonvulsants|mesh-ancestor
110271684|NCT02904772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110259625|NCT02945527|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110259626|NCT02945527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110259627|NCT02945527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110259629|NCT02945527|Natriuretic Agents|natriuretic agents|mesh-ancestor
110259630|NCT00168363|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110259631|NCT00168363|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110259632|NCT00168363|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110259633|NCT00168363|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110259634|NCT00168363|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110259635|NCT00168363|Adrenergic Agents|adrenergic agents|mesh-ancestor
110259636|NCT00168363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110259637|NCT00168363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110259638|NCT00168363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259639|NCT02448095|Ponatinib|ponatinib|mesh-list
110259640|NCT02448095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110259641|NCT02448095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110259642|NCT02448095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110259643|NCT02448095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110259644|NCT00168402|Botulinum Toxins|botulinum toxins|mesh-list
110259645|NCT00168402|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110259646|NCT00168402|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110259647|NCT00168402|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110259648|NCT00168402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110259649|NCT00168402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110259650|NCT00168402|Cholinergic Agents|cholinergic agents|mesh-ancestor
110259651|NCT00168402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110259652|NCT00168402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259653|NCT00168402|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110259654|NCT00168402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110259655|NCT00529594|Etoricoxib|etoricoxib|mesh-list
110259656|NCT00529594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110259657|NCT00529594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110259658|NCT00529594|Analgesics|analgesics|mesh-ancestor
110259659|NCT00529594|Sensory System Agents|sensory system agents|mesh-ancestor
110259660|NCT00529594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110259661|NCT00529594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259662|NCT00529594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110259663|NCT00529594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110259664|NCT00529594|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110259665|NCT00529594|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110259666|NCT00529594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110259667|NCT00529594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110259668|NCT00173862|Gemcitabine|gemcitabine|mesh-list
110259669|NCT00173862|Ifosfamide|ifosfamide|mesh-list
110259670|NCT00173862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110259671|NCT00173862|Antimetabolites|antimetabolites|mesh-ancestor
110259672|NCT00173862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110259673|NCT00173862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110259674|NCT00173862|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110259676|NCT00529750|Atenolol|atenolol|mesh-list
110259677|NCT00529750|Irbesartan|irbesartan|mesh-list
110259678|NCT00529750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110259679|NCT00529750|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110259680|NCT00529750|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110259681|NCT00529750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110259682|NCT00529750|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110259683|NCT00529750|Sympatholytics|sympatholytics|mesh-ancestor
110259684|NCT00529750|Autonomic Agents|autonomic agents|mesh-ancestor
110259685|NCT00529750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110259686|NCT00529750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259687|NCT00529750|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110259688|NCT00529750|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110259689|NCT00529750|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110259690|NCT00529750|Adrenergic Agents|adrenergic agents|mesh-ancestor
110259691|NCT00529750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110259692|NCT00529867|Lumefantrine|lumefantrine|mesh-list
110259693|NCT00529867|Artemether|artemether|mesh-list
110259694|NCT00529867|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110259695|NCT00529867|Antimalarials|antimalarials|mesh-ancestor
110259697|NCT00529867|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110259698|NCT00529867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110259699|NCT00168441|Botulinum Toxins|botulinum toxins|mesh-list
110259700|NCT00168441|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110259701|NCT00168441|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110259702|NCT00168441|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110259703|NCT00168441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110259704|NCT00168441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110259705|NCT00168441|Cholinergic Agents|cholinergic agents|mesh-ancestor
110259706|NCT00168441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110259707|NCT00168441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259708|NCT00168441|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110259709|NCT00168441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110259710|NCT00168480|Botulinum Toxins|botulinum toxins|mesh-list
110259711|NCT00168480|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110259712|NCT00168480|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110259713|NCT00168480|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110259714|NCT00168480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110259715|NCT00168480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110259716|NCT00168480|Cholinergic Agents|cholinergic agents|mesh-ancestor
110259717|NCT00168480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110259718|NCT00168480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259719|NCT00168480|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110259720|NCT00168480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110259721|NCT00527449|Carboplatin|carboplatin|mesh-list
110259722|NCT00527449|Docetaxel|docetaxel|mesh-list
110259723|NCT00527449|Epirubicin|epirubicin|mesh-list
110259724|NCT00527449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110259725|NCT00527449|Tubulin Modulators|tubulin modulators|mesh-ancestor
110259726|NCT00527449|Antimitotic Agents|antimitotic agents|mesh-ancestor
110259727|NCT00527449|Mitosis Modulators|mitosis modulators|mesh-ancestor
110259728|NCT00527449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110259729|NCT00527449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110259730|NCT00527449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110259731|NCT00527449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110259732|NCT00527449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110259733|NCT00168519|Nitroprusside|nitroprusside|mesh-list
110259734|NCT00168519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110259735|NCT00168519|Vasodilator Agents|vasodilator agents|mesh-ancestor
110259736|NCT00168519|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110259737|NCT00168519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110259738|NCT04692376|Cyclosporine|cyclosporine|mesh-list
110259739|NCT04692376|Cyclosporins|cyclosporins|mesh-list
110259740|NCT04692376|Glucocorticoids|glucocorticoids|mesh-list
110259741|NCT04692376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110259742|NCT04692376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110259743|NCT04692376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110259744|NCT04692376|Immunologic Factors|immunologic factors|mesh-ancestor
110259745|NCT04692376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259746|NCT04692376|Antifungal Agents|antifungal agents|mesh-ancestor
110259747|NCT04692376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110259748|NCT04692376|Dermatologic Agents|dermatologic agents|mesh-ancestor
110259749|NCT04692376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110259750|NCT04692376|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110259751|NCT04692376|Hormones|hormones|mesh-ancestor
110259752|NCT04692376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110259753|NCT00527683|Vigabatrin|vigabatrin|mesh-list
110259754|NCT00527683|Anticonvulsants|anticonvulsants|mesh-ancestor
110259755|NCT00527683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110259756|NCT00527683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110259757|NCT00527683|GABA Agents|gaba agents|mesh-ancestor
110259758|NCT00527683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110259759|NCT00527683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259761|NCT00173901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110259762|NCT00173901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110259763|NCT00527761|Cisplatin|cisplatin|mesh-list
110259764|NCT00527761|Docetaxel|docetaxel|mesh-list
110259765|NCT00527761|Temozolomide|temozolomide|mesh-list
110259766|NCT00527761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110259767|NCT00527761|Tubulin Modulators|tubulin modulators|mesh-ancestor
110259768|NCT00527761|Antimitotic Agents|antimitotic agents|mesh-ancestor
110259769|NCT00527761|Mitosis Modulators|mitosis modulators|mesh-ancestor
110259770|NCT00527761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110259771|NCT00527761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110259772|NCT00527761|Alkylating Agents|alkylating agents|mesh-ancestor
110259773|NCT00527800|Lumefantrine|lumefantrine|mesh-list
110259774|NCT00527800|Artemether|artemether|mesh-list
110259775|NCT00527800|Piperaquine|piperaquine|mesh-list
110259776|NCT00527800|Trimethoprim|trimethoprim|mesh-list
110259777|NCT00527800|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110259778|NCT00527800|Artenimol|artenimol|mesh-list
110259779|NCT00527800|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110259780|NCT00527800|Sulfamethoxazole|sulfamethoxazole|mesh-list
110259781|NCT00527800|Antimalarials|antimalarials|mesh-ancestor
110259782|NCT00527800|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110259783|NCT00527800|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110259784|NCT00527800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110259785|NCT00527800|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110259786|NCT00527800|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110259787|NCT00527800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110259788|NCT00527800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110259789|NCT00527800|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110259790|NCT00527800|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110259791|NCT00527800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110259792|NCT00527800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110259793|NCT02945293|Oxycodone|oxycodone|mesh-list
110259794|NCT02945293|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110259795|NCT02945293|Narcotics|narcotics|mesh-ancestor
110259796|NCT02945293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110259797|NCT02945293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259798|NCT02945293|Analgesics|analgesics|mesh-ancestor
110259799|NCT02945293|Sensory System Agents|sensory system agents|mesh-ancestor
110259800|NCT02945293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110259801|NCT04692415|Insulin Glargine|insulin glargine|mesh-list
110259802|NCT04692415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110259803|NCT04692415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259804|NCT02945215|Rituximab|rituximab|mesh-list
110259805|NCT02945215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110259806|NCT02945215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110259807|NCT02945215|Immunologic Factors|immunologic factors|mesh-ancestor
110259808|NCT02945215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259809|NCT02945215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110259810|NCT00144677|Sirolimus|sirolimus|mesh-list
110259811|NCT00144677|Tacrolimus|tacrolimus|mesh-list
110259812|NCT00144677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110259814|NCT00144677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259815|NCT00144677|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110259816|NCT00144677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110259817|NCT00144677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110259818|NCT00144677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110259819|NCT00144677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110259820|NCT00144677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110259821|NCT00144677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110259822|NCT00144677|Antifungal Agents|antifungal agents|mesh-ancestor
110259823|NCT00531076|Bevacizumab|bevacizumab|mesh-list
110259824|NCT00531076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110259825|NCT00531076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110259826|NCT00531076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110259827|NCT00531076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110259828|NCT00531076|Growth Substances|growth substances|mesh-ancestor
110259829|NCT00531076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259830|NCT00531076|Growth Inhibitors|growth inhibitors|mesh-ancestor
110259831|NCT00531115|Cetuximab|cetuximab|mesh-list
110259832|NCT00531115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110259833|NCT00531115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110259834|NCT00144716|Insect Repellents|insect repellents|mesh-list
110259835|NCT00144716|Protective Agents|protective agents|mesh-ancestor
110259836|NCT00144716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259837|NCT00531193|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
110259838|NCT00531193|SCH 442416|sch 442416|mesh-list
110259839|NCT00531193|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
110259840|NCT00531193|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110259841|NCT00531193|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110259842|NCT00531193|Purinergic Agents|purinergic agents|mesh-ancestor
110259843|NCT00531193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110259844|NCT00531193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110259845|NCT00531193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259846|NCT00144755|Darbepoetin alfa|darbepoetin alfa|mesh-list
110259847|NCT00144755|Hematinics|hematinics|mesh-ancestor
110259848|NCT00531271|Docetaxel|docetaxel|mesh-list
110259849|NCT00531271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110259850|NCT00531271|Tubulin Modulators|tubulin modulators|mesh-ancestor
110259851|NCT00531271|Antimitotic Agents|antimitotic agents|mesh-ancestor
110259852|NCT00531271|Mitosis Modulators|mitosis modulators|mesh-ancestor
110259853|NCT00531271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110259854|NCT00531310|Fludarabine|fludarabine|mesh-list
110259855|NCT00531310|Busulfan|busulfan|mesh-list
110259856|NCT00531310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110259857|NCT00531310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110259858|NCT00531310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110259859|NCT00531310|Immunologic Factors|immunologic factors|mesh-ancestor
110259860|NCT00531310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259861|NCT00531310|Alkylating Agents|alkylating agents|mesh-ancestor
110259862|NCT00531310|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110259863|NCT00531310|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110259864|NCT00407862|Losartan|losartan|mesh-list
110259865|NCT00407862|Telmisartan|telmisartan|mesh-list
110259866|NCT00407862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110259867|NCT00407862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110259868|NCT00407862|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110259869|NCT00407862|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110259870|NCT00407862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110259871|NCT00527995|Sildenafil Citrate|sildenafil citrate|mesh-list
110259872|NCT00527995|Vasodilator Agents|vasodilator agents|mesh-ancestor
110259873|NCT00527995|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110259874|NCT00527995|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110259875|NCT00527995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110259876|NCT00527995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110259877|NCT00527995|Urological Agents|urological agents|mesh-ancestor
110259878|NCT00144833|Ritonavir|ritonavir|mesh-list
110259879|NCT00144833|Lopinavir|lopinavir|mesh-list
110259880|NCT00144833|Fosamprenavir|fosamprenavir|mesh-list
110259881|NCT00144833|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110259882|NCT00144833|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110259883|NCT00144833|Protease Inhibitors|protease inhibitors|mesh-ancestor
110259884|NCT00144833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110259885|NCT00144833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110259886|NCT00144833|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110259887|NCT00144833|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110259888|NCT00144833|Antiviral Agents|antiviral agents|mesh-ancestor
110259889|NCT00144833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110259890|NCT00144833|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110259891|NCT00144833|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110259892|NCT02944942|Anesthetics|anesthetics|mesh-list
110259893|NCT02944942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110259894|NCT02944942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259895|NCT00144872|Lamotrigine|lamotrigine|mesh-list
110259896|NCT00144872|Anticonvulsants|anticonvulsants|mesh-ancestor
110259897|NCT00144872|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110259898|NCT00144872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110259899|NCT00144872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110259900|NCT00144872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110259901|NCT00144872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259902|NCT00144872|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110259903|NCT00144872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110259904|NCT00144872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110259905|NCT00144872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110259906|NCT00144872|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110259907|NCT02945020|Simeprevir|simeprevir|mesh-list
110259908|NCT02945020|Odalasvir|odalasvir|mesh-list
110259909|NCT02945020|Dabigatran|dabigatran|mesh-list
110259910|NCT02945020|Antithrombins|antithrombins|mesh-ancestor
110259911|NCT02945020|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110259912|NCT02945020|Protease Inhibitors|protease inhibitors|mesh-ancestor
110259913|NCT02945020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110259914|NCT02945020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110259915|NCT02945020|Anticoagulants|anticoagulants|mesh-ancestor
110259916|NCT02945020|Antiviral Agents|antiviral agents|mesh-ancestor
110259917|NCT02945020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110259918|NCT00528073|Rifaximin|rifaximin|mesh-list
110259919|NCT00528073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110259920|NCT00528073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110259921|NCT00528073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110259922|NCT00528151|Curcumin|curcumin|mesh-list
110259923|NCT00528151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110259925|NCT00528151|Analgesics|analgesics|mesh-ancestor
110259926|NCT00528151|Sensory System Agents|sensory system agents|mesh-ancestor
110259927|NCT00528151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110259928|NCT00528151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259929|NCT00528151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110259930|NCT00528151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110259931|NCT00528151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110259932|NCT00528151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110259933|NCT00528151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110259934|NCT00144911|Fluticasone|fluticasone|mesh-list
110259935|NCT00144911|Xhance|xhance|mesh-list
110259936|NCT00144911|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110259937|NCT00144911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110259938|NCT00144911|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110259939|NCT00144911|Autonomic Agents|autonomic agents|mesh-ancestor
110259940|NCT00144911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110259941|NCT00144911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259942|NCT00144911|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110259943|NCT00144911|Respiratory System Agents|respiratory system agents|mesh-ancestor
110259944|NCT00144911|Dermatologic Agents|dermatologic agents|mesh-ancestor
110259945|NCT00144911|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110259946|NCT00144911|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110259947|NCT00144911|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110259948|NCT00144911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110259949|NCT00144911|Adrenergic Agents|adrenergic agents|mesh-ancestor
110259950|NCT00144911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110259951|NCT00144911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110259952|NCT00168597|Vitamin A|vitamin a|mesh-list
110259953|NCT00168597|Vitamins|vitamins|mesh-ancestor
110259954|NCT00168597|Micronutrients|micronutrients|mesh-ancestor
110259955|NCT00168597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259956|NCT00528385|Spironolactone|spironolactone|mesh-list
110259957|NCT00528385|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110259958|NCT00528385|Hormone Antagonists|hormone antagonists|mesh-ancestor
110259959|NCT00528385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110259960|NCT00528385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259961|NCT00528385|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110259962|NCT00528385|Diuretics|diuretics|mesh-ancestor
110259963|NCT00528385|Natriuretic Agents|natriuretic agents|mesh-ancestor
110259964|NCT02944981|Gabapentin|gabapentin|mesh-list
110259965|NCT02944981|Analgesics|analgesics|mesh-ancestor
110259966|NCT02944981|Sensory System Agents|sensory system agents|mesh-ancestor
110259967|NCT02944981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110259968|NCT02944981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259969|NCT02944981|Anticonvulsants|anticonvulsants|mesh-ancestor
110259970|NCT02944981|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110259971|NCT02944981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110259972|NCT02944981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110259973|NCT02944981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110259974|NCT02944981|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110259975|NCT02944981|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110259976|NCT02944981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110259977|NCT02944981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110259978|NCT02944981|Antimanic Agents|antimanic agents|mesh-ancestor
110259979|NCT00168636|Vitamin A|vitamin a|mesh-list
110259980|NCT00168636|Vitamins|vitamins|mesh-ancestor
110259981|NCT00168636|Micronutrients|micronutrients|mesh-ancestor
110259982|NCT00168636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259984|NCT00144989|Irinotecan|irinotecan|mesh-list
110259985|NCT00144989|Etoposide|etoposide|mesh-list
110259986|NCT00144989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110259987|NCT00144989|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110259988|NCT00144989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110259989|NCT00144989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110259990|NCT00144989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110259991|NCT00144989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110259992|NCT00144989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110259993|NCT00528502|Lidocaine|lidocaine|mesh-list
110259994|NCT00528502|Anesthetics, Local|anesthetics, local|mesh-ancestor
110259995|NCT00528502|Anesthetics|anesthetics|mesh-ancestor
110259996|NCT00528502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110259997|NCT00528502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259998|NCT00528502|Sensory System Agents|sensory system agents|mesh-ancestor
110259999|NCT00528502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110260000|NCT00528502|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110260001|NCT00528502|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110260002|NCT00528502|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110260003|NCT00528502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110260004|NCT00528502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110260006|NCT00528619|Pemetrexed|pemetrexed|mesh-list
110260007|NCT00528619|Sunitinib|sunitinib|mesh-list
110260008|NCT00528619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110260009|NCT00528619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110260010|NCT00528619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110260011|NCT00528619|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110260012|NCT00528619|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110260013|NCT00528619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110260014|NCT00528619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110260015|NCT00528619|Growth Substances|growth substances|mesh-ancestor
110260016|NCT00528619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110260017|NCT00528619|Growth Inhibitors|growth inhibitors|mesh-ancestor
110260018|NCT00528619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110260019|NCT00168714|Interferons|interferons|mesh-list
110260020|NCT00168714|Interferon-beta|interferon-beta|mesh-list
110260021|NCT00168714|Interferon beta-1a|interferon beta-1a|mesh-list
110260022|NCT00168714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110260023|NCT00168714|Antiviral Agents|antiviral agents|mesh-ancestor
110260024|NCT00168714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110260025|NCT00168714|Immunologic Factors|immunologic factors|mesh-ancestor
110260026|NCT00168714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110260027|NCT00168714|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110260028|NCT00528658|Acetaminophen|acetaminophen|mesh-list
110260029|NCT00528658|Ibuprofen|ibuprofen|mesh-list
110260030|NCT00528658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110260031|NCT00528658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110260032|NCT00528658|Analgesics|analgesics|mesh-ancestor
110260033|NCT00528658|Sensory System Agents|sensory system agents|mesh-ancestor
110260034|NCT00528658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110260035|NCT00528658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110260036|NCT00528658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110260037|NCT00528658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110260038|NCT00528658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110260039|NCT00528658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110260040|NCT00528658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110260041|NCT00528658|Antipyretics|antipyretics|mesh-ancestor
110260042|NCT00145028|Carboplatin|carboplatin|mesh-list
110260043|NCT00145028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110260044|NCT00528814|Hand Sanitizers|hand sanitizers|mesh-list
110260045|NCT00528814|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110260046|NCT00528814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110260047|NCT00528814|Disinfectants|disinfectants|mesh-ancestor
110260048|NCT00168753|Alefacept|alefacept|mesh-list
110260049|NCT00168753|Dermatologic Agents|dermatologic agents|mesh-ancestor
110260050|NCT00168753|Immunologic Factors|immunologic factors|mesh-ancestor
110260051|NCT00168753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110260052|NCT00528892|Raltegravir Potassium|raltegravir potassium|mesh-list
110260053|NCT00528892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110271769|NCT00407342|Alefacept|alefacept|mesh-list
110260054|NCT00528892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110260055|NCT00528892|Antiviral Agents|antiviral agents|mesh-ancestor
110260056|NCT00528892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110260057|NCT00528892|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110260058|NCT00528892|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110260059|NCT00528892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110260060|NCT00528892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110260061|NCT00531349|Propofol|propofol|mesh-list
110260062|NCT00531349|Sevoflurane|sevoflurane|mesh-list
110260063|NCT00531349|Anesthetics|anesthetics|mesh-ancestor
110260064|NCT00531349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110260065|NCT00531349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110260066|NCT00531349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110260067|NCT00531349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110260068|NCT00531349|Anesthetics, General|anesthetics, general|mesh-ancestor
110260069|NCT00531349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110260070|NCT00531349|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110260071|NCT00531466|Tolperisone|tolperisone|mesh-list
110260072|NCT00531466|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110260073|NCT00531466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110260074|NCT00531466|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110260075|NCT00531466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110260076|NCT00168792|Tenecteplase|tenecteplase|mesh-list
110260077|NCT00168792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110260078|NCT00168792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110260079|NCT00168792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110260080|NCT00531544|Sunitinib|sunitinib|mesh-list
110260081|NCT00531544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110260082|NCT00531544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110260083|NCT00531544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110260084|NCT00531544|Growth Substances|growth substances|mesh-ancestor
110260085|NCT00531544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110260086|NCT00531544|Growth Inhibitors|growth inhibitors|mesh-ancestor
110260087|NCT00531544|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110260088|NCT00531544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110260089|NCT00531544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110260091|NCT00145106|Tazarotene|tazarotene|mesh-list
110260092|NCT00145106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110260093|NCT00145106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110260094|NCT00145106|Dermatologic Agents|dermatologic agents|mesh-ancestor
110260095|NCT00145106|Keratolytic Agents|keratolytic agents|mesh-ancestor
110260096|NCT00145184|Vitamins|vitamins|mesh-list
110260097|NCT00145184|Vitamin B Complex|vitamin b complex|mesh-list
110260098|NCT00145184|Micronutrients|micronutrients|mesh-ancestor
110260099|NCT00145184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110260100|NCT02944357|Cisplatin|cisplatin|mesh-list
110260101|NCT02944357|Gemcitabine|gemcitabine|mesh-list
110260102|NCT02944357|Vaccines|vaccines|mesh-list
110260103|NCT02944357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110260104|NCT02944357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110260105|NCT02944357|Antimetabolites|antimetabolites|mesh-ancestor
110260106|NCT02944357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110260107|NCT02944357|Immunologic Factors|immunologic factors|mesh-ancestor
110260108|NCT02944357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110260109|NCT02944396|Paclitaxel|paclitaxel|mesh-list
110260110|NCT02944396|Carboplatin|carboplatin|mesh-list
110260111|NCT02944396|Nivolumab|nivolumab|mesh-list
110260112|NCT02944396|Pemetrexed|pemetrexed|mesh-list
110260113|NCT02944396|Veliparib|veliparib|mesh-list
110260114|NCT02944396|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110260115|NCT02944396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110260116|NCT02944396|Tubulin Modulators|tubulin modulators|mesh-ancestor
110260117|NCT02944396|Antimitotic Agents|antimitotic agents|mesh-ancestor
110260118|NCT02944396|Mitosis Modulators|mitosis modulators|mesh-ancestor
110260119|NCT02944396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110260120|NCT02944396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110260121|NCT02944396|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110260122|NCT02944396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110260123|NCT02944396|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110260124|NCT02944396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110260125|NCT02944396|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110260126|NCT00174174|Modafinil|modafinil|mesh-list
110260127|NCT00174174|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110260128|NCT00174174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110260129|NCT00174174|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110260130|NCT00174174|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110260131|NCT00174174|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110260132|NCT00174174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110260133|NCT00530101|Doxorubicin|doxorubicin|mesh-list
110260134|NCT00530101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110260135|NCT00530101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110260136|NCT00530101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110260137|NCT00530101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110260138|NCT00530101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110260139|NCT00530101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110260140|NCT00530140|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
110260141|NCT00530140|Immunologic Factors|immunologic factors|mesh-ancestor
110260143|NCT02944552|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
110260146|NCT02944552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110260147|NCT02944552|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110260148|NCT00145301|Lumiracoxib|lumiracoxib|mesh-list
110260149|NCT00145301|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110260150|NCT00145301|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110260151|NCT00145301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110260152|NCT00145301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110260153|NCT00145301|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110260154|NCT00145301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110260155|NCT00145301|Analgesics|analgesics|mesh-ancestor
110260156|NCT00145301|Sensory System Agents|sensory system agents|mesh-ancestor
110260213|NCT00530413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110260214|NCT00530413|GABA Modulators|gaba modulators|mesh-ancestor
110260215|NCT00530413|GABA Agents|gaba agents|mesh-ancestor
110260216|NCT00530413|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110260217|NCT00530413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110260218|NCT00530413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110260219|NCT00174330|Amlodipine|amlodipine|mesh-list
110260220|NCT00174330|Atorvastatin|atorvastatin|mesh-list
110260221|NCT00174330|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110260222|NCT00174330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110260223|NCT00174330|Antimetabolites|antimetabolites|mesh-ancestor
110260224|NCT00174330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110260225|NCT00174330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110260226|NCT00174330|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110260227|NCT00174330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110260228|NCT00174330|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110260229|NCT00174330|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110260230|NCT00174330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110260231|NCT00174330|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110260232|NCT00174330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110260233|NCT00174330|Vasodilator Agents|vasodilator agents|mesh-ancestor
110260234|NCT00531856|Carbon Monoxide|carbon monoxide|mesh-list
110260235|NCT00531856|Antimetabolites|antimetabolites|mesh-ancestor
110260236|NCT00531856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110260237|NCT00531856|Gasotransmitters|gasotransmitters|mesh-ancestor
110260238|NCT00531856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110260239|NCT00531856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110260240|NCT00531895|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110260241|NCT00531895|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110260242|NCT00531895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110260243|NCT00531895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110260244|NCT00531895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110260245|NCT00531895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110260246|NCT00531895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110260247|NCT00531895|Analgesics|analgesics|mesh-ancestor
110260248|NCT00531895|Sensory System Agents|sensory system agents|mesh-ancestor
110260249|NCT00531895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110260250|NCT00531895|Antidepressive Agents|antidepressive agents|mesh-ancestor
110260251|NCT00531895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110260252|NCT00531895|Dopamine Agents|dopamine agents|mesh-ancestor
110260253|NCT02942914|Insulin Glargine|insulin glargine|mesh-list
110260254|NCT02942914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110260255|NCT02942914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110260256|NCT00169026|Antipsychotic Agents|antipsychotic agents|mesh-list
110260257|NCT00169026|Clozapine|clozapine|mesh-list
110260258|NCT00169026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110260259|NCT00169026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110260260|NCT00169026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110260261|NCT00169026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110260262|NCT00169026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110260263|NCT00169026|Serotonin Agents|serotonin agents|mesh-ancestor
110260264|NCT00169026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110260265|NCT00169026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110260266|NCT00169026|GABA Antagonists|gaba antagonists|mesh-ancestor
110260267|NCT00169026|GABA Agents|gaba agents|mesh-ancestor
110260268|NCT00145613|Antibodies|antibodies|mesh-list
110260269|NCT00145613|Immunologic Factors|immunologic factors|mesh-ancestor
110260270|NCT00145613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110260271|NCT00531973|Doxorubicin|doxorubicin|mesh-list
110260272|NCT00531973|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110260274|NCT00531973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110260275|NCT00531973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110260276|NCT00531973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110260277|NCT00531973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110260278|NCT00531973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110260279|NCT00531973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110260280|NCT00145652|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
110260281|NCT00145652|Hematinics|hematinics|mesh-ancestor
110260282|NCT00174486|Tadalafil|tadalafil|mesh-list
110260283|NCT00174486|Vasodilator Agents|vasodilator agents|mesh-ancestor
110260284|NCT00174486|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110260285|NCT00174486|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110260286|NCT00174486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110260287|NCT00174486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110260288|NCT00174486|Urological Agents|urological agents|mesh-ancestor
110260289|NCT00145691|Oxcarbazepine|oxcarbazepine|mesh-list
110260290|NCT00145691|Anticonvulsants|anticonvulsants|mesh-ancestor
110260291|NCT00145691|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110260292|NCT00145691|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110260293|NCT00145691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110260294|NCT00145691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110260295|NCT00145691|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110260296|NCT00145691|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110260298|NCT05319301|Melatonin|melatonin|mesh-list
110260299|NCT05319301|Antioxidants|antioxidants|mesh-ancestor
110260300|NCT05319301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110260301|NCT05319301|Protective Agents|protective agents|mesh-ancestor
110260302|NCT05319301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110260303|NCT05319301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110260304|NCT00169065|Olanzapine|olanzapine|mesh-list
110260305|NCT00169065|Clozapine|clozapine|mesh-list
110260306|NCT00169065|Antiemetics|antiemetics|mesh-ancestor
110260307|NCT00169065|Autonomic Agents|autonomic agents|mesh-ancestor
110260308|NCT00169065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110260309|NCT00169065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110260310|NCT00169065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110260311|NCT00169065|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110260312|NCT00169065|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110260313|NCT00169065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110260314|NCT00169065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110260315|NCT00169065|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110260316|NCT00169065|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110260317|NCT00169065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110260318|NCT00169065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110260319|NCT00169065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110260320|NCT00169065|Serotonin Agents|serotonin agents|mesh-ancestor
110260321|NCT00169065|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110260322|NCT00169065|GABA Antagonists|gaba antagonists|mesh-ancestor
110260323|NCT00169065|GABA Agents|gaba agents|mesh-ancestor
110260324|NCT00145730|Ibuprofen|ibuprofen|mesh-list
110260325|NCT00145730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110260326|NCT00145730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110260327|NCT00145730|Analgesics|analgesics|mesh-ancestor
110260328|NCT00145730|Sensory System Agents|sensory system agents|mesh-ancestor
110260329|NCT00145730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110260330|NCT00145730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110260331|NCT00145730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110260332|NCT00145730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110260333|NCT00145730|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110260334|NCT00145730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110260335|NCT00145730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110260337|NCT00169143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110260338|NCT00169143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110260339|NCT00169143|Immunologic Factors|immunologic factors|mesh-ancestor
110260340|NCT00169143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110260341|NCT00169143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110260342|NCT02942680|Aspirin|aspirin|mesh-list
110260343|NCT02942680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110260344|NCT02942680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110260345|NCT02942680|Analgesics|analgesics|mesh-ancestor
110260346|NCT02942680|Sensory System Agents|sensory system agents|mesh-ancestor
110260347|NCT02942680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110260348|NCT02942680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110260349|NCT02942680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110260350|NCT02942680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110260351|NCT02942680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110260352|NCT02942680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110260353|NCT02942680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110260354|NCT02942680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110260355|NCT02942680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110260356|NCT02942680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110260357|NCT02942680|Antipyretics|antipyretics|mesh-ancestor
110260358|NCT00174564|Oxaliplatin|oxaliplatin|mesh-list
110271835|NCT02904031|Antidotes|antidotes|mesh-ancestor
110260359|NCT00174564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110260360|NCT02276911|Ibuprofen|ibuprofen|mesh-list
110260361|NCT02276911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110260362|NCT02276911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110260363|NCT02276911|Analgesics|analgesics|mesh-ancestor
110260364|NCT02276911|Sensory System Agents|sensory system agents|mesh-ancestor
110260365|NCT02276911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110260366|NCT02276911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110260367|NCT02276911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110260368|NCT02276911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110260369|NCT02276911|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110260370|NCT02276911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110260371|NCT02276911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110260372|NCT00145847|Naltrexone|naltrexone|mesh-list
110260373|NCT00145847|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110260374|NCT00145847|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110260375|NCT00145847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110260376|NCT00145847|Sensory System Agents|sensory system agents|mesh-ancestor
110260377|NCT00145847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110260378|NCT00169182|Nicotinic Acids|nicotinic acids|mesh-list
110260380|NCT00169182|Docetaxel|docetaxel|mesh-list
110260381|NCT00169182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110260382|NCT00169182|Tubulin Modulators|tubulin modulators|mesh-ancestor
110260383|NCT00169182|Antimitotic Agents|antimitotic agents|mesh-ancestor
110260384|NCT00169182|Mitosis Modulators|mitosis modulators|mesh-ancestor
110260385|NCT00169182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110260386|NCT00169182|Vitamin B Complex|vitamin b complex|mesh-ancestor
110260387|NCT00169182|Vitamins|vitamins|mesh-ancestor
110260388|NCT00169182|Micronutrients|micronutrients|mesh-ancestor
110260389|NCT00169182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110260390|NCT00169182|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110260392|NCT00169182|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110260393|NCT00169182|Vasodilator Agents|vasodilator agents|mesh-ancestor
110260394|NCT02944825|Ciprofloxacin|ciprofloxacin|mesh-list
110260395|NCT02944825|Trimethoprim|trimethoprim|mesh-list
110260396|NCT02944825|Sulfamethoxazole|sulfamethoxazole|mesh-list
110260397|NCT02944825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110260398|NCT02944825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110260399|NCT02944825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110260400|NCT02944825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110260401|NCT02944825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110260402|NCT02944825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110260403|NCT02944825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110260404|NCT02944825|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110260405|NCT02944825|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110260406|NCT02944825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110260407|NCT02944825|Antimalarials|antimalarials|mesh-ancestor
110260408|NCT02944825|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110260409|NCT02944825|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110260410|NCT02944825|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110260411|NCT02944825|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110260412|NCT02944825|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110260413|NCT02942758|Pioglitazone|pioglitazone|mesh-list
110260414|NCT02942758|Azacitidine|azacitidine|mesh-list
110260415|NCT02942758|Tretinoin|tretinoin|mesh-list
110260416|NCT02942758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110260417|NCT02942758|Antimetabolites|antimetabolites|mesh-ancestor
110260418|NCT02942758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110260419|NCT02942758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110260420|NCT02942758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110260421|NCT02942758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110271850|NCT00178113|Antioxidants|antioxidants|mesh-ancestor
110260422|NCT02942758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110260423|NCT02942758|Keratolytic Agents|keratolytic agents|mesh-ancestor
110260424|NCT02942758|Dermatologic Agents|dermatologic agents|mesh-ancestor
110260425|NCT00145886|Parathyroid Hormone|parathyroid hormone|mesh-list
110260426|NCT00145886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110260427|NCT00145886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110260428|NCT00174603|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110260429|NCT00174603|Antidepressive Agents|antidepressive agents|mesh-ancestor
110260430|NCT00174603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110260431|NCT00174603|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110260432|NCT00174603|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110260433|NCT00174603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110260434|NCT00174603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110260435|NCT02942563|Capecitabine|capecitabine|mesh-list
110260436|NCT02942563|Oxaliplatin|oxaliplatin|mesh-list
110260438|NCT02942563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110260439|NCT02942563|Antimetabolites|antimetabolites|mesh-ancestor
110260440|NCT02942563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110260441|NCT02942563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110260442|NCT02942563|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110260443|NCT02942563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110260444|NCT02942563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110260445|NCT00145925|Gliclazide|gliclazide|mesh-list
110260446|NCT00145925|Perindopril|perindopril|mesh-list
110260447|NCT00145925|Indapamide|indapamide|mesh-list
110260448|NCT00145925|Indapamide, perindopril drug combination|indapamide, perindopril drug combination|mesh-list
110260449|NCT00145925|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110260450|NCT00145925|Protease Inhibitors|protease inhibitors|mesh-ancestor
110260451|NCT00145925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110260452|NCT00145925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110260453|NCT00145925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110260454|NCT00145925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110260455|NCT00145925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110260457|NCT00145925|Natriuretic Agents|natriuretic agents|mesh-ancestor
110260458|NCT00145925|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110260459|NCT00145925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110260460|NCT00529321|Immunomodulating Agents|immunomodulating agents|mesh-list
110260461|NCT00529321|Immunologic Factors|immunologic factors|mesh-ancestor
110260462|NCT00529321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110260464|NCT00169221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110260465|NCT00169221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110260466|NCT00169221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110260467|NCT00169221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110260468|NCT00529360|Clofarabine|clofarabine|mesh-list
110260469|NCT00529360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110260470|NCT00529360|Antimetabolites|antimetabolites|mesh-ancestor
110260471|NCT00529360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110260472|NCT00529360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110260473|NCT00174642|Insulin|insulin|mesh-list
110260474|NCT00174642|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110260475|NCT00174642|Metformin|metformin|mesh-list
110260476|NCT00174642|Insulin Glargine|insulin glargine|mesh-list
110260477|NCT00174642|Insulin glulisine|insulin glulisine|mesh-list
110260478|NCT00174642|Secretagogues|secretagogues|mesh-list
110260479|NCT00174642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110260480|NCT00174642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110260481|NCT00174681|Insulin Glargine|insulin glargine|mesh-list
110260482|NCT00174681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110260483|NCT00174681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110260484|NCT00146042|Erythromycin|erythromycin|mesh-list
110260485|NCT00146042|Erythromycin Estolate|erythromycin estolate|mesh-list
110260486|NCT00146042|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
110260487|NCT00146042|Erythromycin stearate|erythromycin stearate|mesh-list
110260488|NCT00146042|Docetaxel|docetaxel|mesh-list
110260489|NCT00146042|Trastuzumab|trastuzumab|mesh-list
110260490|NCT00146042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110260491|NCT00146042|Tubulin Modulators|tubulin modulators|mesh-ancestor
110260492|NCT00146042|Antimitotic Agents|antimitotic agents|mesh-ancestor
110260493|NCT00146042|Mitosis Modulators|mitosis modulators|mesh-ancestor
110260494|NCT00146042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110260495|NCT00146042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110260496|NCT00146042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110260497|NCT00146042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110260498|NCT00146042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110260499|NCT00146042|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110260500|NCT00146042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110260501|NCT00169299|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110260502|NCT00169299|Medroxyprogesterone|medroxyprogesterone|mesh-list
110260504|NCT00169299|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110260505|NCT00169299|Hormones|hormones|mesh-ancestor
110260506|NCT00169299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110260507|NCT00169299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110260508|NCT00169299|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110260509|NCT00169299|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110260510|NCT00169299|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110260511|NCT00169299|Contraceptive Agents|contraceptive agents|mesh-ancestor
110260512|NCT00169299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110260513|NCT00169299|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110260514|NCT00169299|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110260515|NCT00169299|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110260516|NCT00169299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110260517|NCT00169299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110260518|NCT02942602|Atorvastatin|atorvastatin|mesh-list
110260519|NCT02942602|Ezetimibe|ezetimibe|mesh-list
110260520|NCT02942602|Cholestyramine Resin|cholestyramine resin|mesh-list
110260521|NCT02942602|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110260522|NCT02942602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110260523|NCT02942602|Antimetabolites|antimetabolites|mesh-ancestor
110260524|NCT02942602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110260525|NCT02942602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110260526|NCT02942602|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110260528|NCT02942329|Apatinib|apatinib|mesh-list
110260529|NCT02942329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110260530|NCT02942329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110260531|NCT02942329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110260532|NCT02942329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110260533|NCT00174720|Ciclesonide|ciclesonide|mesh-list
110260534|NCT00174720|Glucocorticoids|glucocorticoids|mesh-ancestor
110260535|NCT00174720|Hormones|hormones|mesh-ancestor
110260536|NCT00174720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110260537|NCT00174720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110260538|NCT00174720|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110260539|NCT02942212|Nicotine|nicotine|mesh-list
110260540|NCT02942212|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110260541|NCT02942212|Autonomic Agents|autonomic agents|mesh-ancestor
110260542|NCT02942212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110260543|NCT02942212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110260545|NCT02942212|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110260546|NCT02942212|Cholinergic Agents|cholinergic agents|mesh-ancestor
110260547|NCT02942212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110260548|NCT02942212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110260549|NCT00146120|Etoposide|etoposide|mesh-list
110260550|NCT00146120|Idarubicin|idarubicin|mesh-list
110260551|NCT00146120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110260552|NCT00146120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110260553|NCT00146120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110260554|NCT00146120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110260555|NCT00146120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110260556|NCT00146120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110260557|NCT00146120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110260558|NCT00146159|Mitoxantrone|mitoxantrone|mesh-list
110260559|NCT00146159|Analgesics|analgesics|mesh-ancestor
110260560|NCT00146159|Sensory System Agents|sensory system agents|mesh-ancestor
110260561|NCT00146159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110260562|NCT00146159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110260563|NCT00146159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110260564|NCT00146159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110260565|NCT00146159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110260566|NCT00146159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110260567|NCT00146159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110260568|NCT02276989|Riboflavin|riboflavin|mesh-list
110260569|NCT02276989|Quinine|quinine|mesh-list
110260570|NCT02276989|Acetazolamide|acetazolamide|mesh-list
110260571|NCT02276989|Vitamins|vitamins|mesh-ancestor
110260572|NCT02276989|Micronutrients|micronutrients|mesh-ancestor
110260573|NCT02276989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110260574|NCT02276989|Vitamin B Complex|vitamin b complex|mesh-ancestor
110260575|NCT02276989|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110260576|NCT02276989|Dermatologic Agents|dermatologic agents|mesh-ancestor
110260577|NCT02276989|Anticonvulsants|anticonvulsants|mesh-ancestor
110260578|NCT02276989|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110260579|NCT02276989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110260580|NCT02276989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110260581|NCT02276989|Diuretics|diuretics|mesh-ancestor
110260582|NCT02276989|Natriuretic Agents|natriuretic agents|mesh-ancestor
110260583|NCT02276989|Antimalarials|antimalarials|mesh-ancestor
110260584|NCT02276989|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110260585|NCT02276989|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110260586|NCT02276989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110260587|NCT02276989|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110260588|NCT02276989|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110260589|NCT02276989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110260590|NCT02276989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110260591|NCT02276989|Analgesics|analgesics|mesh-ancestor
110260592|NCT02276989|Sensory System Agents|sensory system agents|mesh-ancestor
110260593|NCT00174759|Clopidogrel|clopidogrel|mesh-list
110260594|NCT00174759|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110260595|NCT00174759|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110260596|NCT00174759|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110260597|NCT00174759|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110260598|NCT00174759|Purinergic Agents|purinergic agents|mesh-ancestor
110260599|NCT00174759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110260600|NCT00174759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110260601|NCT00174759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110260602|NCT00146237|Phenytoin|phenytoin|mesh-list
110260603|NCT00146237|Anticonvulsants|anticonvulsants|mesh-ancestor
110260604|NCT00146237|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110271893|NCT05995912|Analgesics|analgesics|mesh-ancestor
110260605|NCT00146237|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110260606|NCT00146237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110260607|NCT00146237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110260608|NCT00146237|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110260609|NCT00146237|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110260612|NCT02277067|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110260613|NCT02277067|Abortifacient Agents|abortifacient agents|mesh-ancestor
110260614|NCT02277067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110260615|NCT02277067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110260616|NCT02277067|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110260617|NCT02277067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110260618|NCT02277067|Oxytocics|oxytocics|mesh-ancestor
110260619|NCT00146276|Gemcitabine|gemcitabine|mesh-list
110260620|NCT00146276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110260622|NCT00146276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110260623|NCT00146276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110260624|NCT00174798|Tolterodine Tartrate|tolterodine tartrate|mesh-list
110260625|NCT00174798|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110260626|NCT00174798|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110260627|NCT00174798|Cholinergic Agents|cholinergic agents|mesh-ancestor
110260628|NCT00174798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110260629|NCT00174798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110260630|NCT00174798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110260631|NCT00174798|Urological Agents|urological agents|mesh-ancestor
110260633|NCT02940808|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110260634|NCT02940808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110260635|NCT02940808|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110260636|NCT02940808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110260637|NCT02940808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110260638|NCT02940808|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110260639|NCT02940808|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110260640|NCT02940808|Purinergic Agents|purinergic agents|mesh-ancestor
110260641|NCT02940808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110260642|NCT00169416|Valacyclovir|valacyclovir|mesh-list
110260643|NCT00169416|Antiviral Agents|antiviral agents|mesh-ancestor
110260644|NCT00169416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110260645|NCT00174876|Aripiprazole|aripiprazole|mesh-list
110260646|NCT00174876|Antidepressive Agents|antidepressive agents|mesh-ancestor
110260647|NCT00174876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110260648|NCT00174876|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110260649|NCT00174876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110260650|NCT00174876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110260651|NCT00174876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110260652|NCT00174876|Dopamine Agonists|dopamine agonists|mesh-ancestor
110260653|NCT00174876|Dopamine Agents|dopamine agents|mesh-ancestor
110260654|NCT00174876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110260655|NCT00174876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110260656|NCT00174876|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110260657|NCT00174876|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110260658|NCT00174876|Serotonin Agents|serotonin agents|mesh-ancestor
110260659|NCT00174876|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110260660|NCT00174876|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110260661|NCT00174876|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110260662|NCT00174876|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110260663|NCT00146471|Levetiracetam|levetiracetam|mesh-list
110260664|NCT00146471|Anticonvulsants|anticonvulsants|mesh-ancestor
110260665|NCT00146471|Nootropic Agents|nootropic agents|mesh-ancestor
110260666|NCT00174993|Pioglitazone|pioglitazone|mesh-list
110260667|NCT00174993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110260668|NCT00174993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110260669|NCT02940379|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
110260670|NCT02940379|Metoprolol|metoprolol|mesh-list
110260671|NCT02940379|Midazolam|midazolam|mesh-list
110260672|NCT02940379|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110260673|NCT02940379|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110260674|NCT02940379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110260675|NCT02940379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110260676|NCT02940379|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110260677|NCT02940379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110260678|NCT02940379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110260679|NCT02940379|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110260680|NCT02940379|Anesthetics, General|anesthetics, general|mesh-ancestor
110260682|NCT02940379|GABA Modulators|gaba modulators|mesh-ancestor
110260683|NCT02940379|GABA Agents|gaba agents|mesh-ancestor
110260684|NCT02940379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110260685|NCT02940379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110260686|NCT02940379|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110260687|NCT02940379|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110260688|NCT02940379|Sympatholytics|sympatholytics|mesh-ancestor
110260689|NCT02940379|Autonomic Agents|autonomic agents|mesh-ancestor
110260690|NCT02940379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110260691|NCT02940379|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110260692|NCT02940379|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110260693|NCT02940379|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110260694|NCT02940379|Adrenergic Agents|adrenergic agents|mesh-ancestor
110260695|NCT02940379|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110260696|NCT02940379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110260697|NCT00146549|Paclitaxel|paclitaxel|mesh-list
110260698|NCT00146549|Vinorelbine|vinorelbine|mesh-list
110260699|NCT00146549|Docetaxel|docetaxel|mesh-list
110260700|NCT00146549|Trastuzumab|trastuzumab|mesh-list
110260701|NCT00146549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110260702|NCT00146549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110260703|NCT00146549|Tubulin Modulators|tubulin modulators|mesh-ancestor
110260704|NCT00146549|Antimitotic Agents|antimitotic agents|mesh-ancestor
110260705|NCT00146549|Mitosis Modulators|mitosis modulators|mesh-ancestor
110260706|NCT00146549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110260707|NCT00146549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110260708|NCT02940535|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110260709|NCT02940535|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110260710|NCT02940535|Menotropins|menotropins|mesh-list
110260711|NCT02940535|Luteolytic Agents|luteolytic agents|mesh-ancestor
110260712|NCT02940535|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110260713|NCT02940535|Contraceptive Agents|contraceptive agents|mesh-ancestor
110260714|NCT02940535|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110260715|NCT02940535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110260716|NCT02940535|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110260717|NCT02940535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110260718|NCT02940535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110260719|NCT02940535|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110260720|NCT02940535|Fertility Agents|fertility agents|mesh-ancestor
110260721|NCT00146588|Cyclophosphamide|cyclophosphamide|mesh-list
110260722|NCT00146588|Capecitabine|capecitabine|mesh-list
110260723|NCT00146588|Epirubicin|epirubicin|mesh-list
110260724|NCT00146588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110260725|NCT00146588|Immunologic Factors|immunologic factors|mesh-ancestor
110260726|NCT00146588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110260727|NCT00146588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110260728|NCT00146588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110260729|NCT00146588|Alkylating Agents|alkylating agents|mesh-ancestor
110260730|NCT00146588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110260731|NCT00146588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110260732|NCT00146588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110260733|NCT00146588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110260734|NCT00146588|Antimetabolites|antimetabolites|mesh-ancestor
110260735|NCT00146588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110260736|NCT00146588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110260737|NCT00146588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110260738|NCT00146588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110260741|NCT00175032|Naproxen|naproxen|mesh-list
110260742|NCT00175032|Lansoprazole|lansoprazole|mesh-list
110260743|NCT00175032|Dexlansoprazole|dexlansoprazole|mesh-list
110260744|NCT00175032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110260745|NCT00175032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110260746|NCT00175032|Analgesics|analgesics|mesh-ancestor
110260747|NCT00175032|Sensory System Agents|sensory system agents|mesh-ancestor
110260748|NCT00175032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110260749|NCT00175032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110260750|NCT00175032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110260751|NCT00175032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110260753|NCT00175032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110260754|NCT00175032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110260755|NCT00175032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110260756|NCT00175032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110260757|NCT00175032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110260758|NCT00175032|Antipyretics|antipyretics|mesh-ancestor
110260759|NCT00175032|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110260760|NCT00175032|Gout Suppressants|gout suppressants|mesh-ancestor
110260761|NCT00175032|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110260762|NCT00175032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110260763|NCT00175032|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110260764|NCT00146627|Eflornithine|eflornithine|mesh-list
110260765|NCT00146627|Nifurtimox|nifurtimox|mesh-list
110260766|NCT00146627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110260767|NCT00146627|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110260768|NCT00146627|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110260769|NCT00146627|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110260770|NCT00146627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110260771|NCT00146627|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
110260772|NCT00146627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110260773|NCT00146627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110260774|NCT00169533|Lapatinib|lapatinib|mesh-list
110260775|NCT00169533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110260776|NCT00169533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110260777|NCT00169533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110260778|NCT00169533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110260779|NCT00424229|Lenalidomide|lenalidomide|mesh-list
110260780|NCT00424229|Immunologic Factors|immunologic factors|mesh-ancestor
110260781|NCT00424229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110260782|NCT00424229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110260783|NCT00424229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110260784|NCT00424229|Growth Substances|growth substances|mesh-ancestor
110260785|NCT00424229|Growth Inhibitors|growth inhibitors|mesh-ancestor
110260786|NCT00424229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110260787|NCT02944123|Clopidogrel|clopidogrel|mesh-list
110260788|NCT02944123|Ticagrelor|ticagrelor|mesh-list
110260789|NCT02944123|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110260790|NCT02944123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110260791|NCT02944123|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110260792|NCT02944123|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110260793|NCT02944123|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110260794|NCT02944123|Purinergic Agents|purinergic agents|mesh-ancestor
110260795|NCT02944123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110260796|NCT02944123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110260797|NCT02944123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110260798|NCT02944045|Methylprednisolone|methylprednisolone|mesh-list
110260799|NCT02944045|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110260800|NCT02944045|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110260801|NCT02944045|Prednisolone|prednisolone|mesh-list
110260802|NCT02944045|Prednisolone acetate|prednisolone acetate|mesh-list
110260803|NCT02944045|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110260804|NCT02944045|Prednisolone phosphate|prednisolone phosphate|mesh-list
110260805|NCT02944045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110260806|NCT02944045|Antiemetics|antiemetics|mesh-ancestor
110260807|NCT02944045|Autonomic Agents|autonomic agents|mesh-ancestor
110260809|NCT02944045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110260810|NCT02944045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110260811|NCT02944045|Glucocorticoids|glucocorticoids|mesh-ancestor
110260813|NCT02944045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110260814|NCT02944045|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110260815|NCT02944045|Protective Agents|protective agents|mesh-ancestor
110260816|NCT02944045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110260817|NCT02944045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110260818|NCT00169572|Dexamethasone|dexamethasone|mesh-list
110260819|NCT00169572|Ondansetron|ondansetron|mesh-list
110260820|NCT00169572|Aprepitant|aprepitant|mesh-list
110260821|NCT00169572|Fosaprepitant|fosaprepitant|mesh-list
110260822|NCT00169572|Casopitant|casopitant|mesh-list
110260823|NCT00169572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110260824|NCT00169572|Antiemetics|antiemetics|mesh-ancestor
110260825|NCT00169572|Autonomic Agents|autonomic agents|mesh-ancestor
110260826|NCT00169572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110260827|NCT00169572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110260828|NCT00169572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110260829|NCT00169572|Glucocorticoids|glucocorticoids|mesh-ancestor
110260830|NCT00169572|Hormones|hormones|mesh-ancestor
110260831|NCT00169572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110260832|NCT00169572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110260833|NCT00169572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110260834|NCT00169572|Antipruritics|antipruritics|mesh-ancestor
110260835|NCT00169572|Dermatologic Agents|dermatologic agents|mesh-ancestor
110260836|NCT00169572|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110260837|NCT00169572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110260838|NCT00169572|Serotonin Agents|serotonin agents|mesh-ancestor
110260839|NCT00169572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110260840|NCT00169572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110260841|NCT00169572|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110260842|NCT00146783|Pyrimethamine|pyrimethamine|mesh-list
110260843|NCT00146783|Sulfadoxine|sulfadoxine|mesh-list
110260844|NCT00146783|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110260845|NCT00146783|Amodiaquine|amodiaquine|mesh-list
110260846|NCT00146783|Antimalarials|antimalarials|mesh-ancestor
110260847|NCT00146783|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110260848|NCT00146783|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110260849|NCT00146783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110260850|NCT00146783|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110260851|NCT00146783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110260852|NCT00146783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110260853|NCT00146783|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110260854|NCT00169611|Methylphenidate|methylphenidate|mesh-list
110260855|NCT00169611|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110260856|NCT00169611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110260857|NCT00169611|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110260858|NCT00169611|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110260859|NCT00169611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110260860|NCT00169611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110260862|NCT00169611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110260863|NCT02943655|Mefenamic Acid|mefenamic acid|mesh-list
110260864|NCT02943655|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110260865|NCT02943655|Contraceptive Agents|contraceptive agents|mesh-list
110260866|NCT02943655|Medroxyprogesterone|medroxyprogesterone|mesh-list
110260867|NCT02943655|Progesterone|progesterone|mesh-list
110260868|NCT02943655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110260869|NCT02943655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110260870|NCT02943655|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110260871|NCT02943655|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110260872|NCT02943655|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110260873|NCT02943655|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110260874|NCT02943655|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110260875|NCT02943655|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110260876|NCT02943655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110260877|NCT02943655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110260878|NCT02943655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110260879|NCT02943655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110260880|NCT02943655|Analgesics|analgesics|mesh-ancestor
110260881|NCT02943655|Sensory System Agents|sensory system agents|mesh-ancestor
110260882|NCT02943655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110260883|NCT02943655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110260884|NCT02943655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110260885|NCT02943655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110260886|NCT02943655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110260887|NCT02943655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110260888|NCT02943655|Progestins|progestins|mesh-ancestor
110260890|NCT02943655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110260891|NCT05085067|Hyaluronic Acid|hyaluronic acid|mesh-list
110260892|NCT05085067|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110260893|NCT05085067|Immunologic Factors|immunologic factors|mesh-ancestor
110260894|NCT05085067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110260895|NCT05085067|Viscosupplements|viscosupplements|mesh-ancestor
110260896|NCT05085067|Protective Agents|protective agents|mesh-ancestor
110260897|NCT00175227|Furosemide|furosemide|mesh-list
110260898|NCT00175227|Mannitol|mannitol|mesh-list
110260900|NCT00175227|Natriuretic Agents|natriuretic agents|mesh-ancestor
110260901|NCT00175227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110260902|NCT00175227|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110260903|NCT00175227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110260904|NCT00175227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110260905|NCT00175227|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110260906|NCT02940262|Edetic Acid|edetic acid|mesh-list
110260907|NCT02940262|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110260908|NCT02940262|Chelating Agents|chelating agents|mesh-ancestor
110260909|NCT02940262|Sequestering Agents|sequestering agents|mesh-ancestor
110260910|NCT02940262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110260911|NCT02940262|Anticoagulants|anticoagulants|mesh-ancestor
110260912|NCT02940262|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110260913|NCT02940262|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110260914|NCT00146900|Escitalopram|escitalopram|mesh-list
110260915|NCT00146900|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110260916|NCT00146900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110260917|NCT00146900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110260918|NCT00146900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110260919|NCT00146900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110260920|NCT00146900|Serotonin Agents|serotonin agents|mesh-ancestor
110260921|NCT00146900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110260922|NCT02939482|Triamcinolone|triamcinolone|mesh-list
110260923|NCT02939482|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110260924|NCT02939482|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110260925|NCT02939482|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110260926|NCT02939482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110260927|NCT02939482|Glucocorticoids|glucocorticoids|mesh-ancestor
110260929|NCT02939482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110260930|NCT02939482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110260931|NCT02939482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110260932|NCT02939482|Immunologic Factors|immunologic factors|mesh-ancestor
110260933|NCT02939482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110260934|NCT02939482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110260936|NCT00175266|Alemtuzumab|alemtuzumab|mesh-list
110260937|NCT00175266|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110260938|NCT00175266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110260939|NCT00175266|Dermatologic Agents|dermatologic agents|mesh-ancestor
110260940|NCT00175266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110260941|NCT00175266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110260942|NCT00175266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110260943|NCT00175266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110260944|NCT05013892|Memantine|memantine|mesh-list
110260945|NCT05013892|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110260946|NCT05013892|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110260947|NCT05013892|Dopamine Agents|dopamine agents|mesh-ancestor
110260948|NCT05013892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110260949|NCT05013892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110260950|NCT05013892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110260951|NCT05013892|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110260952|NCT05013892|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110260953|NCT02939248|Morphine|morphine|mesh-list
110260954|NCT02939248|Naloxone|naloxone|mesh-list
110260955|NCT02939248|Ticagrelor|ticagrelor|mesh-list
110260956|NCT02939248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110260957|NCT02939248|Narcotics|narcotics|mesh-ancestor
110260958|NCT02939248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110260959|NCT02939248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110260960|NCT02939248|Analgesics|analgesics|mesh-ancestor
110260961|NCT02939248|Sensory System Agents|sensory system agents|mesh-ancestor
110260962|NCT02939248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110260963|NCT02939248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110260964|NCT02939248|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110260965|NCT02939248|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110260966|NCT02939248|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110260967|NCT02939248|Purinergic Agents|purinergic agents|mesh-ancestor
110260968|NCT02939248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110260969|NCT02939248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110260970|NCT02939248|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110260971|NCT02938975|Permethrin|permethrin|mesh-list
110260972|NCT02938975|Insect Repellents|insect repellents|mesh-list
110260973|NCT02938975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110368713|NCT00558090|Sensory System Agents|sensory system agents|mesh-ancestor
110260974|NCT02938975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110260975|NCT02938975|Protective Agents|protective agents|mesh-ancestor
110260976|NCT02938975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110260977|NCT02939092|Chlorhexidine|chlorhexidine|mesh-list
110260978|NCT02939092|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110260979|NCT02939092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110260980|NCT02939092|Disinfectants|disinfectants|mesh-ancestor
110260981|NCT00175305|Octreotide|octreotide|mesh-list
110260982|NCT00175305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110260983|NCT00175305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110260984|NCT00175305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110260985|NCT02938741|Thymoglobulin|thymoglobulin|mesh-list
110260986|NCT02938741|Immunologic Factors|immunologic factors|mesh-ancestor
110260987|NCT02938741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110260988|NCT02938741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110260989|NCT00407589|Besifloxacin|besifloxacin|mesh-list
110260990|NCT00407589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110260991|NCT00407589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110260992|NCT00407589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110260993|NCT00407589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110260994|NCT00407589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110260995|NCT00407589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110260996|NCT00407589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110260997|NCT02938546|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110260998|NCT02938546|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110260999|NCT02938546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261000|NCT00175383|Hormones|hormones|mesh-list
110261001|NCT00175383|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
110261002|NCT00175383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110261003|NCT00175383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110261004|NCT02938468|Dexamethasone|dexamethasone|mesh-list
110261005|NCT02938468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110261006|NCT02938468|Antiemetics|antiemetics|mesh-ancestor
110261007|NCT02938468|Autonomic Agents|autonomic agents|mesh-ancestor
110261008|NCT02938468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110261009|NCT02938468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110261010|NCT02938468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110261011|NCT02938468|Glucocorticoids|glucocorticoids|mesh-ancestor
110261012|NCT02938468|Hormones|hormones|mesh-ancestor
110261013|NCT02938468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110261014|NCT02938468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110261015|NCT02938468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110261016|NCT02938507|Solabegron|solabegron|mesh-list
110261017|NCT02938507|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110261018|NCT02938507|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110261019|NCT02938507|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110261020|NCT02938507|Adrenergic Agents|adrenergic agents|mesh-ancestor
110261021|NCT02938507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110261022|NCT02938507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261023|NCT02938507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110261024|NCT04836910|Metformin|metformin|mesh-list
110261025|NCT04836910|Contraceptive Agents|contraceptive agents|mesh-list
110261026|NCT04836910|Contraceptives, Oral|contraceptives, oral|mesh-list
110261027|NCT04836910|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
110261028|NCT04836910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110261029|NCT04836910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110261030|NCT04836910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110261031|NCT04836910|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110261032|NCT00169728|Vaccines|vaccines|mesh-list
110261033|NCT00169728|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110261034|NCT00169728|Immunologic Factors|immunologic factors|mesh-ancestor
110261035|NCT00169728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110261036|NCT00147524|Quinapril|quinapril|mesh-list
110261037|NCT00147524|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110261038|NCT00147524|Protease Inhibitors|protease inhibitors|mesh-ancestor
110261039|NCT00147524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110261040|NCT00147524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261041|NCT00147524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110261043|NCT00147563|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110261044|NCT00147563|Hormone Antagonists|hormone antagonists|mesh-ancestor
110261045|NCT00147563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110261046|NCT00147563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110261048|NCT00147563|Diuretics|diuretics|mesh-ancestor
110261049|NCT00147563|Natriuretic Agents|natriuretic agents|mesh-ancestor
110261050|NCT00147563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110261051|NCT02938273|Cetuximab|cetuximab|mesh-list
110261052|NCT02938273|Avelumab|avelumab|mesh-list
110261053|NCT02938273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110261054|NCT02938273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110261055|NCT00147602|Atorvastatin|atorvastatin|mesh-list
110261056|NCT00147602|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110261057|NCT00147602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110261058|NCT00147602|Antimetabolites|antimetabolites|mesh-ancestor
110261059|NCT00147602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261060|NCT00147602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110261061|NCT00147602|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110261062|NCT00147602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110261063|NCT02941744|Nivolumab|nivolumab|mesh-list
110261064|NCT02941744|Ipilimumab|ipilimumab|mesh-list
110261065|NCT02941744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110261066|NCT02941744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110261067|NCT02941744|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110261068|NCT02941744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261069|NCT02941822|Ambroxol|ambroxol|mesh-list
110261070|NCT02941822|Expectorants|expectorants|mesh-ancestor
110261071|NCT02941822|Respiratory System Agents|respiratory system agents|mesh-ancestor
110261072|NCT02941510|Budesonide|budesonide|mesh-list
110261073|NCT02941510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110261074|NCT02941510|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110261075|NCT02941510|Autonomic Agents|autonomic agents|mesh-ancestor
110261076|NCT02941510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110261077|NCT02941510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110261078|NCT02941510|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110261079|NCT02941510|Respiratory System Agents|respiratory system agents|mesh-ancestor
110261080|NCT02941510|Glucocorticoids|glucocorticoids|mesh-ancestor
110261081|NCT02941510|Hormones|hormones|mesh-ancestor
110261082|NCT02941510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110261083|NCT00147680|Paclitaxel|paclitaxel|mesh-list
110261084|NCT00147680|Carboplatin|carboplatin|mesh-list
110261085|NCT00147680|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110261086|NCT00147680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110261087|NCT00147680|Tubulin Modulators|tubulin modulators|mesh-ancestor
110261088|NCT00147680|Antimitotic Agents|antimitotic agents|mesh-ancestor
110261089|NCT00147680|Mitosis Modulators|mitosis modulators|mesh-ancestor
110261090|NCT00147680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261091|NCT02940184|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110261092|NCT02940184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110261093|NCT02940184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110261094|NCT02940184|Incretins|incretins|mesh-ancestor
110261095|NCT02940184|Hormones|hormones|mesh-ancestor
110261096|NCT02940184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110261097|NCT02940184|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110261098|NCT02940184|Protease Inhibitors|protease inhibitors|mesh-ancestor
110261099|NCT02940184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110261100|NCT02940184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261101|NCT03458143|Ketamine|ketamine|mesh-list
110261102|NCT03458143|Remifentanil|remifentanil|mesh-list
110261103|NCT03458143|Analgesics|analgesics|mesh-ancestor
110261104|NCT03458143|Sensory System Agents|sensory system agents|mesh-ancestor
110271993|NCT05994742|Vitamins|vitamins|mesh-ancestor
110261105|NCT03458143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110261106|NCT03458143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110261107|NCT03458143|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110261108|NCT03458143|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110261109|NCT03458143|Anesthetics, General|anesthetics, general|mesh-ancestor
110261110|NCT03458143|Anesthetics|anesthetics|mesh-ancestor
110261111|NCT03458143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110261112|NCT03458143|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110261113|NCT03458143|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110261114|NCT03458143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110261115|NCT03458143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261116|NCT03458143|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110261117|NCT03458143|Narcotics|narcotics|mesh-ancestor
110261119|NCT02941198|Trace Elements|trace elements|mesh-ancestor
110261120|NCT02941198|Micronutrients|micronutrients|mesh-ancestor
110261121|NCT02941198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110261122|NCT00147719|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
110261123|NCT00147719|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110261124|NCT00147719|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110261125|NCT00147719|Antimetabolites|antimetabolites|mesh-ancestor
110261126|NCT00147719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261127|NCT00147719|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110261128|NCT05273671|Dexmedetomidine|dexmedetomidine|mesh-list
110261129|NCT05273671|Nalbuphine|nalbuphine|mesh-list
110261130|NCT05273671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110261131|NCT05273671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110261132|NCT05273671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110261133|NCT05273671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110261134|NCT05273671|Analgesics|analgesics|mesh-ancestor
110261135|NCT05273671|Sensory System Agents|sensory system agents|mesh-ancestor
110261136|NCT05273671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110261137|NCT05273671|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110261138|NCT05273671|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110261139|NCT05273671|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110261140|NCT05273671|Adrenergic Agents|adrenergic agents|mesh-ancestor
110261141|NCT05273671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110261142|NCT05273671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261143|NCT05273671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110261144|NCT05273671|Narcotics|narcotics|mesh-ancestor
110261145|NCT00147758|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
110261146|NCT00147758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110261147|NCT00147758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110261148|NCT00147758|Antimetabolites|antimetabolites|mesh-ancestor
110261149|NCT00147758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261150|NCT00147758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110261151|NCT02931526|Tigecycline|tigecycline|mesh-list
110261152|NCT02931526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110261153|NCT02931526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110261154|NCT02931526|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110261155|NCT02931526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110261156|NCT02931526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261157|NCT00169845|Tocopherols|tocopherols|mesh-list
110261158|NCT00169845|Vitamin E|vitamin e|mesh-list
110261159|NCT00169845|alpha-Tocopherol|alpha-tocopherol|mesh-list
110261160|NCT00169845|Beta Carotene|beta carotene|mesh-list
110261161|NCT00169845|Carotenoids|carotenoids|mesh-list
110261162|NCT00169845|Antioxidants|antioxidants|mesh-ancestor
110261163|NCT00169845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261164|NCT00169845|Protective Agents|protective agents|mesh-ancestor
110271996|NCT05994703|Cycloserine|cycloserine|mesh-list
110261165|NCT00169845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110261167|NCT00169845|Micronutrients|micronutrients|mesh-ancestor
110261168|NCT00169845|Provitamins|provitamins|mesh-ancestor
110261169|NCT00147836|Insulin|insulin|mesh-list
110261170|NCT00147836|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110261171|NCT00147836|Metformin|metformin|mesh-list
110261172|NCT00147836|Gliclazide|gliclazide|mesh-list
110261173|NCT00147836|Isophane Insulin, Human|isophane insulin, human|mesh-list
110261174|NCT00147836|Insulin, Isophane|insulin, isophane|mesh-list
110261175|NCT00147836|Isophane insulin, beef|isophane insulin, beef|mesh-list
110261176|NCT00147836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110261177|NCT00147836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110261179|NCT02931136|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110261180|NCT02931136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110261181|NCT02931136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261182|NCT02931136|Cholinergic Agents|cholinergic agents|mesh-ancestor
110261183|NCT02931136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110261184|NCT02931136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110261185|NCT02931136|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110261186|NCT02931136|Protective Agents|protective agents|mesh-ancestor
110261187|NCT02931175|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
110261188|NCT02931175|Hormones|hormones|mesh-ancestor
110261189|NCT02931175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110261190|NCT02931175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110261192|NCT00147875|Gemcitabine|gemcitabine|mesh-list
110261193|NCT00147875|Doxorubicin|doxorubicin|mesh-list
110261194|NCT00147875|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110261195|NCT00147875|Vinblastine|vinblastine|mesh-list
110261196|NCT00147875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110261197|NCT00147875|Antimetabolites|antimetabolites|mesh-ancestor
110261198|NCT00147875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261199|NCT00147875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110261200|NCT00147875|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110261201|NCT00147875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110261202|NCT00147875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110261203|NCT00147875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110261204|NCT00147875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110261205|NCT00147875|Glucocorticoids|glucocorticoids|mesh-ancestor
110261206|NCT00147875|Hormones|hormones|mesh-ancestor
110261207|NCT00147875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110261208|NCT00147875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110261209|NCT00147875|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110261210|NCT00147875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110261211|NCT00147875|Tubulin Modulators|tubulin modulators|mesh-ancestor
110261212|NCT00147875|Antimitotic Agents|antimitotic agents|mesh-ancestor
110261213|NCT00147875|Mitosis Modulators|mitosis modulators|mesh-ancestor
110261214|NCT00169923|Rosiglitazone|rosiglitazone|mesh-list
110261215|NCT00169923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110261216|NCT00169923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110261217|NCT00147914|Amoxicillin|amoxicillin|mesh-list
110261218|NCT00147914|Clavulanic Acid|clavulanic acid|mesh-list
110261219|NCT00147914|Clavulanic Acids|clavulanic acids|mesh-list
110261220|NCT00147914|Cefdinir|cefdinir|mesh-list
110261221|NCT00147914|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110261222|NCT00147914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110261223|NCT00147914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110261224|NCT00147914|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110261225|NCT00147914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110261226|NCT00147914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261228|NCT00147953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110261229|NCT00147953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110261230|NCT00147953|Immunologic Factors|immunologic factors|mesh-ancestor
110261231|NCT00147953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110261232|NCT00147953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110261233|NCT02930551|Lidocaine|lidocaine|mesh-list
110261234|NCT02930551|Anesthetics, Local|anesthetics, local|mesh-ancestor
110261235|NCT02930551|Anesthetics|anesthetics|mesh-ancestor
110261236|NCT02930551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110261237|NCT02930551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110261238|NCT02930551|Sensory System Agents|sensory system agents|mesh-ancestor
110261239|NCT02930551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110261240|NCT02930551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110261241|NCT02930551|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110261242|NCT02930551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110261243|NCT02930551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110261244|NCT02930551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261245|NCT00175617|Minoxidil|minoxidil|mesh-list
110261246|NCT00175617|Spironolactone|spironolactone|mesh-list
110261247|NCT00175617|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110261248|NCT00175617|Hormone Antagonists|hormone antagonists|mesh-ancestor
110261249|NCT00175617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110261250|NCT00175617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110261251|NCT00175617|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110261252|NCT00175617|Diuretics|diuretics|mesh-ancestor
110261253|NCT00175617|Natriuretic Agents|natriuretic agents|mesh-ancestor
110261254|NCT00175617|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110261255|NCT00175617|Vasodilator Agents|vasodilator agents|mesh-ancestor
110261256|NCT02930707|Magnesium Sulfate|magnesium sulfate|mesh-list
110261257|NCT02930707|Bupivacaine|bupivacaine|mesh-list
110261258|NCT02930707|Anesthetics, Local|anesthetics, local|mesh-ancestor
110261259|NCT02930707|Anesthetics|anesthetics|mesh-ancestor
110261260|NCT02930707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110261261|NCT02930707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110261262|NCT02930707|Sensory System Agents|sensory system agents|mesh-ancestor
110261263|NCT02930707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110261264|NCT02930707|Analgesics|analgesics|mesh-ancestor
110261265|NCT02930707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110261266|NCT02930707|Anticonvulsants|anticonvulsants|mesh-ancestor
110261267|NCT02930707|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110261268|NCT02930707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110261269|NCT02930707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261270|NCT02930707|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110261271|NCT02930707|Tocolytic Agents|tocolytic agents|mesh-ancestor
110261272|NCT02930707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110261274|NCT00148031|Ribavirin|ribavirin|mesh-list
110261275|NCT00148031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110261276|NCT00148031|Antiviral Agents|antiviral agents|mesh-ancestor
110261277|NCT00148031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110261278|NCT00148031|Antimetabolites|antimetabolites|mesh-ancestor
110261279|NCT00148031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261280|NCT02930473|Psychotropic Drugs|psychotropic drugs|mesh-list
110261281|NCT02930434|Vitamin D|vitamin d|mesh-list
110261282|NCT02930434|Cholecalciferol|cholecalciferol|mesh-list
110261283|NCT02930434|Vitamins|vitamins|mesh-ancestor
110261284|NCT02930434|Micronutrients|micronutrients|mesh-ancestor
110261285|NCT02930434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110261286|NCT02930434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110261287|NCT02930434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110261288|NCT00148070|Erythromycin|erythromycin|mesh-list
110261289|NCT00148070|Erythromycin Estolate|erythromycin estolate|mesh-list
110261290|NCT00148070|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
110261292|NCT00148070|Docetaxel|docetaxel|mesh-list
110261293|NCT00148070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110261294|NCT00148070|Tubulin Modulators|tubulin modulators|mesh-ancestor
110261295|NCT00148070|Antimitotic Agents|antimitotic agents|mesh-ancestor
110261296|NCT00148070|Mitosis Modulators|mitosis modulators|mesh-ancestor
110261297|NCT00148070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261298|NCT00148070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110261299|NCT00148070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110261300|NCT00148070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110261301|NCT00148070|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110261302|NCT00148070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110261303|NCT00175695|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
110261304|NCT00175695|Protein C|protein c|mesh-list
110261305|NCT00175695|Anticoagulants|anticoagulants|mesh-ancestor
110261306|NCT00175695|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110261307|NCT00175695|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110261308|NCT00175695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261309|NCT00175695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110261310|NCT02930317|Factor VIII|factor viii|mesh-list
110261311|NCT02930317|Coagulants|coagulants|mesh-ancestor
110261312|NCT00148148|Amphotericin B|amphotericin b|mesh-list
110261313|NCT00148148|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110261314|NCT00148148|Caspofungin|caspofungin|mesh-list
110261315|NCT00148148|Amebicides|amebicides|mesh-ancestor
110261316|NCT00148148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110261317|NCT00148148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110261318|NCT00148148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110261319|NCT00148148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110261320|NCT00148148|Antifungal Agents|antifungal agents|mesh-ancestor
110261321|NCT00148148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110261322|NCT00148148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261323|NCT00170001|Esomeprazole|esomeprazole|mesh-list
110261324|NCT00170001|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110261325|NCT00170001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110261326|NCT00170001|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110261327|NCT00170001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110261328|NCT00170001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261329|NCT00148265|Triamcinolone|triamcinolone|mesh-list
110261330|NCT00148265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110261331|NCT00148265|Glucocorticoids|glucocorticoids|mesh-ancestor
110261332|NCT00148265|Hormones|hormones|mesh-ancestor
110261333|NCT00148265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110261334|NCT00148265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110261335|NCT02929693|Gefitinib|gefitinib|mesh-list
110261336|NCT02929693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110261337|NCT02929693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110261338|NCT02929693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110261339|NCT02929693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261340|NCT00175734|Chrysarobin|chrysarobin|mesh-list
110261341|NCT00175734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110261342|NCT00175734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110261344|NCT00175734|Sensory System Agents|sensory system agents|mesh-ancestor
110261345|NCT00175734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110261346|NCT00175734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110272037|NCT05994287|Analgesics|analgesics|mesh-ancestor
110261348|NCT00175734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110261349|NCT00148382|Cetilistat|cetilistat|mesh-list
110261350|NCT00148382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110261351|NCT00148382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261352|NCT00148382|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110261353|NCT00148382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110261354|NCT00148421|Epoetin Alfa|epoetin alfa|mesh-list
110261355|NCT00148421|Darbepoetin alfa|darbepoetin alfa|mesh-list
110261356|NCT00148421|Hematinics|hematinics|mesh-ancestor
110261357|NCT02929888|Aspirin|aspirin|mesh-list
110261358|NCT02929888|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110261359|NCT02929888|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110261360|NCT02929888|Analgesics|analgesics|mesh-ancestor
110261361|NCT02929888|Sensory System Agents|sensory system agents|mesh-ancestor
110261362|NCT02929888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110261363|NCT02929888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110261364|NCT02929888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110261365|NCT02929888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110261366|NCT02929888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110261367|NCT02929888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110261368|NCT02929888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261369|NCT02929888|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110261370|NCT02929888|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110261371|NCT02929888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110261372|NCT02929888|Antipyretics|antipyretics|mesh-ancestor
110261373|NCT04689412|Resveratrol|resveratrol|mesh-list
110261374|NCT04689412|Antioxidants|antioxidants|mesh-ancestor
110261375|NCT04689412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261376|NCT04689412|Protective Agents|protective agents|mesh-ancestor
110261377|NCT04689412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110261378|NCT04689412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110261379|NCT04689412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110261380|NCT00148460|Tenecteplase|tenecteplase|mesh-list
110261381|NCT00148460|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110261382|NCT00148460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110261383|NCT00148460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261384|NCT00170196|Prednisone|prednisone|mesh-list
110261385|NCT00170196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110261386|NCT00170196|Glucocorticoids|glucocorticoids|mesh-ancestor
110261387|NCT00170196|Hormones|hormones|mesh-ancestor
110261388|NCT00170196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110261389|NCT00170196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110261390|NCT00170196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110261391|NCT00170196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110261392|NCT02929459|Vitamins|vitamins|mesh-list
110261393|NCT02929459|Riboflavin|riboflavin|mesh-list
110261394|NCT02929459|Vitamin B Complex|vitamin b complex|mesh-list
110261395|NCT02929459|Micronutrients|micronutrients|mesh-ancestor
110261396|NCT02929459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110261397|NCT02929459|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110261398|NCT02929459|Dermatologic Agents|dermatologic agents|mesh-ancestor
110261400|NCT02929576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110261401|NCT02929576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110261402|NCT02929576|Tubulin Modulators|tubulin modulators|mesh-ancestor
110261403|NCT02929576|Antimitotic Agents|antimitotic agents|mesh-ancestor
110261404|NCT02929576|Mitosis Modulators|mitosis modulators|mesh-ancestor
110261405|NCT02929576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261407|NCT00175812|Theophylline|theophylline|mesh-list
110261408|NCT00175812|Valproic Acid|valproic acid|mesh-list
110261409|NCT00175812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110261410|NCT00175812|Keratolytic Agents|keratolytic agents|mesh-ancestor
110261411|NCT00175812|Dermatologic Agents|dermatologic agents|mesh-ancestor
110261412|NCT00175812|Anticonvulsants|anticonvulsants|mesh-ancestor
110261413|NCT00175812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110261414|NCT00175812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261415|NCT00175812|GABA Agents|gaba agents|mesh-ancestor
110261416|NCT00175812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110261417|NCT00175812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110261418|NCT00175812|Antimanic Agents|antimanic agents|mesh-ancestor
110261419|NCT00175812|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110261420|NCT00175812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110261421|NCT00175812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110261422|NCT00175812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110261423|NCT00175812|Autonomic Agents|autonomic agents|mesh-ancestor
110261424|NCT00175812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110261425|NCT00175812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110261426|NCT00175812|Respiratory System Agents|respiratory system agents|mesh-ancestor
110261427|NCT00175812|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110261428|NCT00175812|Vasodilator Agents|vasodilator agents|mesh-ancestor
110261429|NCT00175812|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110261430|NCT00175812|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110261431|NCT00175812|Purinergic Agents|purinergic agents|mesh-ancestor
110261432|NCT00148499|Benzocaine|benzocaine|mesh-list
110261433|NCT00148499|Ambroxol|ambroxol|mesh-list
110261434|NCT00148499|Anesthetics, Local|anesthetics, local|mesh-ancestor
110261435|NCT00148499|Anesthetics|anesthetics|mesh-ancestor
110261436|NCT00148499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110261437|NCT00148499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110261438|NCT00148499|Sensory System Agents|sensory system agents|mesh-ancestor
110261439|NCT00148499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110261440|NCT00148499|Expectorants|expectorants|mesh-ancestor
110261441|NCT00148499|Respiratory System Agents|respiratory system agents|mesh-ancestor
110261443|NCT03457597|Tolbutamide|tolbutamide|mesh-list
110261444|NCT03457597|Metoprolol|metoprolol|mesh-list
110261445|NCT03457597|Midazolam|midazolam|mesh-list
110261446|NCT03457597|Omeprazole|omeprazole|mesh-list
110261447|NCT03457597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110261448|NCT03457597|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110261449|NCT03457597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110261450|NCT03457597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110261451|NCT03457597|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110261452|NCT03457597|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110261453|NCT03457597|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110261454|NCT03457597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110261455|NCT03457597|Anesthetics, General|anesthetics, general|mesh-ancestor
110261456|NCT03457597|Anesthetics|anesthetics|mesh-ancestor
110261457|NCT03457597|GABA Modulators|gaba modulators|mesh-ancestor
110261458|NCT03457597|GABA Agents|gaba agents|mesh-ancestor
110261459|NCT03457597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110261460|NCT03457597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261461|NCT03457597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110261462|NCT03457597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110261463|NCT03457597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110261464|NCT03457597|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110261465|NCT03457597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110261466|NCT03457597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110261467|NCT03457597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110261468|NCT03457597|Sympatholytics|sympatholytics|mesh-ancestor
110261469|NCT03457597|Autonomic Agents|autonomic agents|mesh-ancestor
110261470|NCT03457597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110261471|NCT03457597|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110261472|NCT03457597|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110261473|NCT03457597|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110261474|NCT03457597|Adrenergic Agents|adrenergic agents|mesh-ancestor
110261475|NCT02929147|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
110261476|NCT02929147|Morphine|morphine|mesh-list
110261477|NCT02929147|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110261478|NCT02929147|Narcotics|narcotics|mesh-ancestor
110261479|NCT02929147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110261480|NCT02929147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110261481|NCT02929147|Analgesics|analgesics|mesh-ancestor
110261482|NCT02929147|Sensory System Agents|sensory system agents|mesh-ancestor
110261483|NCT02929147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110261484|NCT02929147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110261485|NCT02929147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110261486|NCT02929147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110261487|NCT02929147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110261488|NCT00175890|Levetiracetam|levetiracetam|mesh-list
110261489|NCT00175890|Anticonvulsants|anticonvulsants|mesh-ancestor
110261490|NCT00175890|Nootropic Agents|nootropic agents|mesh-ancestor
110261491|NCT00148616|Memantine|memantine|mesh-list
110261492|NCT00148616|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110261493|NCT00148616|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110261494|NCT00148616|Dopamine Agents|dopamine agents|mesh-ancestor
110261495|NCT00148616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110261496|NCT00148616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261497|NCT00148616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110261498|NCT00148616|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110261499|NCT00148616|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110261500|NCT00175929|Brivaracetam|brivaracetam|mesh-list
110261501|NCT00175929|Anticonvulsants|anticonvulsants|mesh-ancestor
110261502|NCT02928679|Liraglutide|liraglutide|mesh-list
110261503|NCT02928679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110261504|NCT02928679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110261505|NCT02928679|Incretins|incretins|mesh-ancestor
110261506|NCT02928679|Hormones|hormones|mesh-ancestor
110261507|NCT02928679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110261508|NCT02928601|Ondansetron|ondansetron|mesh-list
110261509|NCT02928601|Antiemetics|antiemetics|mesh-ancestor
110261510|NCT02928601|Autonomic Agents|autonomic agents|mesh-ancestor
110261511|NCT02928601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110261512|NCT02928601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110261513|NCT02928601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110261514|NCT02928601|Antipruritics|antipruritics|mesh-ancestor
110261515|NCT02928601|Dermatologic Agents|dermatologic agents|mesh-ancestor
110261516|NCT02928601|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110261517|NCT02928601|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110261518|NCT02928601|Serotonin Agents|serotonin agents|mesh-ancestor
110261519|NCT02928601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110261520|NCT02928601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261521|NCT02928328|Lidocaine|lidocaine|mesh-list
110261522|NCT02928328|Lorazepam|lorazepam|mesh-list
110261523|NCT02928328|Capsaicin|capsaicin|mesh-list
110261524|NCT02928328|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
110261525|NCT02928328|Butyric Acid|butyric acid|mesh-list
110261526|NCT02928328|Anesthetics, Local|anesthetics, local|mesh-ancestor
110261528|NCT02928328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110261529|NCT02928328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110261530|NCT02928328|Sensory System Agents|sensory system agents|mesh-ancestor
110261531|NCT02928328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110261532|NCT02928328|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110261533|NCT02928328|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110261534|NCT02928328|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110261535|NCT02928328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110261536|NCT02928328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261537|NCT02928328|Antipruritics|antipruritics|mesh-ancestor
110261538|NCT02928328|Dermatologic Agents|dermatologic agents|mesh-ancestor
110261539|NCT02928328|Anticonvulsants|anticonvulsants|mesh-ancestor
110261540|NCT02928328|Antiemetics|antiemetics|mesh-ancestor
110261541|NCT02928328|Autonomic Agents|autonomic agents|mesh-ancestor
110261542|NCT02928328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110261543|NCT02928328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110261544|NCT02928328|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110261545|NCT02928328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110261546|NCT02928328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110261547|NCT02928328|GABA Modulators|gaba modulators|mesh-ancestor
110261548|NCT02928328|GABA Agents|gaba agents|mesh-ancestor
110261549|NCT02928328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110261550|NCT02928328|Histamine Antagonists|histamine antagonists|mesh-ancestor
110261551|NCT02928328|Histamine Agents|histamine agents|mesh-ancestor
110261552|NCT00148694|Cisplatin|cisplatin|mesh-list
110261553|NCT00148694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110261554|NCT00148772|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110261555|NCT00148772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110261556|NCT00148772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110261557|NCT00148772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110261558|NCT00148772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261559|NCT00176046|Viscum album peptide|viscum album peptide|mesh-list
110261560|NCT00176046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110261561|NCT00176046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110261562|NCT00176046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110261564|NCT00176046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110261565|NCT02927587|Propofol|propofol|mesh-list
110261566|NCT02927587|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110261567|NCT02927587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110261568|NCT02927587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110261569|NCT02927587|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110261570|NCT02927587|Anesthetics, General|anesthetics, general|mesh-ancestor
110261571|NCT02927587|Anesthetics|anesthetics|mesh-ancestor
110261572|NCT00148850|Pioglitazone|pioglitazone|mesh-list
110261573|NCT00148850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110261574|NCT00148850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110261575|NCT02927353|Adalimumab|adalimumab|mesh-list
110261576|NCT02927353|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110261577|NCT02927353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110261578|NCT02927353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110261579|NCT02927509|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
110261580|NCT02927509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110261581|NCT02927509|Adrenergic Agents|adrenergic agents|mesh-ancestor
110261582|NCT02927509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110261583|NCT02927509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261584|NCT02927509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110261585|NCT02926885|Liver Extracts|liver extracts|mesh-list
110261586|NCT02926885|Hematinics|hematinics|mesh-ancestor
110261587|NCT02926846|Vancomycin|vancomycin|mesh-list
110261588|NCT02926846|Gentamicins|gentamicins|mesh-list
110261589|NCT02926846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110261590|NCT02926846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110261591|NCT02926846|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110261592|NCT02926846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110261593|NCT02926846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261594|NCT02926183|Paclitaxel|paclitaxel|mesh-list
110261595|NCT02926183|Gemcitabine|gemcitabine|mesh-list
110261596|NCT02926183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110261597|NCT02926183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110261598|NCT02926183|Tubulin Modulators|tubulin modulators|mesh-ancestor
110261599|NCT02926183|Antimitotic Agents|antimitotic agents|mesh-ancestor
110261600|NCT02926183|Mitosis Modulators|mitosis modulators|mesh-ancestor
110261601|NCT02926183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261602|NCT02926183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110261603|NCT02926183|Antimetabolites|antimetabolites|mesh-ancestor
110261604|NCT02925832|Bupivacaine|bupivacaine|mesh-list
110261605|NCT02925832|Ropivacaine|ropivacaine|mesh-list
110261606|NCT02925832|Anesthetics, Local|anesthetics, local|mesh-list
110261607|NCT02925832|Proxymetacaine|proxymetacaine|mesh-list
110261608|NCT02925832|Anesthetics|anesthetics|mesh-list
110261609|NCT02925832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110261610|NCT02925832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110261611|NCT02925832|Sensory System Agents|sensory system agents|mesh-ancestor
110261612|NCT02925832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110261613|NCT00170430|Fluconazole|fluconazole|mesh-list
110261614|NCT00170430|Antifungal Agents|antifungal agents|mesh-ancestor
110261615|NCT00170430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110261616|NCT00170430|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110261617|NCT00170430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110261618|NCT00170430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110261619|NCT00170430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261620|NCT00170430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110261621|NCT00170430|Hormone Antagonists|hormone antagonists|mesh-ancestor
110261622|NCT00170430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110261623|NCT00170430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110261624|NCT00170430|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110261625|NCT00170430|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110261626|NCT00149084|Amoxicillin|amoxicillin|mesh-list
110261627|NCT00149084|Clarithromycin|clarithromycin|mesh-list
110261628|NCT00149084|Lansoprazole|lansoprazole|mesh-list
110261629|NCT00149084|Dexlansoprazole|dexlansoprazole|mesh-list
110261630|NCT00149084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110261631|NCT00149084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110272123|NCT05880459|Anesthetics|anesthetics|mesh-ancestor
110261632|NCT00149084|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110261633|NCT00149084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110261634|NCT00149084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261635|NCT00149084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110261636|NCT00149084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110261637|NCT00149084|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110261638|NCT00149084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110261639|NCT00149084|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110261640|NCT00170469|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110261641|NCT00170469|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110261642|NCT00170469|Immunologic Factors|immunologic factors|mesh-ancestor
110261643|NCT00170469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110261644|NCT00170469|Antacids|antacids|mesh-ancestor
110261645|NCT00170469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261646|NCT00170469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110261647|NCT00149123|Hydrocortisone|hydrocortisone|mesh-list
110261648|NCT00149123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110261649|NCT00149162|Aldesleukin|aldesleukin|mesh-list
110261650|NCT00149162|Interleukin-2|interleukin-2|mesh-list
110261651|NCT00149162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110261653|NCT00149162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110261654|NCT00149162|Antiviral Agents|antiviral agents|mesh-ancestor
110261655|NCT00149162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110261656|NCT00149162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110261657|NCT00149162|Analgesics|analgesics|mesh-ancestor
110261658|NCT00149162|Sensory System Agents|sensory system agents|mesh-ancestor
110261659|NCT00149162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110261660|NCT00149162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110261661|NCT00170547|Vaccines|vaccines|mesh-list
110261662|NCT00170547|Immunologic Factors|immunologic factors|mesh-ancestor
110261663|NCT00170547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110261664|NCT00149201|Fluorouracil|fluorouracil|mesh-list
110261665|NCT00149201|Antimetabolites|antimetabolites|mesh-ancestor
110261666|NCT00149201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261668|NCT00149201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110261669|NCT00149201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110261670|NCT00149201|Immunologic Factors|immunologic factors|mesh-ancestor
110261671|NCT00149201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110261672|NCT02925559|Dapagliflozin|dapagliflozin|mesh-list
110261673|NCT02925559|Gliclazide|gliclazide|mesh-list
110261674|NCT02925559|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110261675|NCT02925559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261676|NCT02925559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110261677|NCT02925559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110261678|NCT00149240|Botulinum Toxins|botulinum toxins|mesh-list
110261679|NCT00149240|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110261680|NCT00149240|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110261681|NCT00149240|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110261682|NCT00149240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110261683|NCT00149240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261684|NCT00149240|Cholinergic Agents|cholinergic agents|mesh-ancestor
110261685|NCT00149240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110261686|NCT00149240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110261687|NCT00149240|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110261688|NCT00149240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110261689|NCT02925247|Anticoagulants|anticoagulants|mesh-list
110261691|NCT00170664|Carboplatin|carboplatin|mesh-list
110261692|NCT00170664|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110261693|NCT00170664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110261694|NCT00170664|Tubulin Modulators|tubulin modulators|mesh-ancestor
110261695|NCT00170664|Antimitotic Agents|antimitotic agents|mesh-ancestor
110261696|NCT00170664|Mitosis Modulators|mitosis modulators|mesh-ancestor
110261697|NCT00170664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261698|NCT00170742|Octreotide|octreotide|mesh-list
110261699|NCT00170742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110261700|NCT00170742|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110261701|NCT00170742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110261702|NCT02917525|Vitamin K|vitamin k|mesh-list
110261703|NCT02917525|Vitamin K 2|vitamin k 2|mesh-list
110261704|NCT02917525|Vitamins|vitamins|mesh-ancestor
110261705|NCT02917525|Micronutrients|micronutrients|mesh-ancestor
110261706|NCT02917525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110261707|NCT02917525|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110261708|NCT02917525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110261709|NCT02917525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261710|NCT02917525|Hemostatics|hemostatics|mesh-ancestor
110261711|NCT02917525|Coagulants|coagulants|mesh-ancestor
110261712|NCT00170781|Lumiracoxib|lumiracoxib|mesh-list
110261713|NCT00170781|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110261714|NCT00170781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110261715|NCT00170781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110261716|NCT00170781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261717|NCT00170781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110261718|NCT00170781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110261719|NCT00170781|Analgesics|analgesics|mesh-ancestor
110261720|NCT00170781|Sensory System Agents|sensory system agents|mesh-ancestor
110261721|NCT00170781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110261722|NCT00170781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110261724|NCT00170781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110261725|NCT00170820|Everolimus|everolimus|mesh-list
110261726|NCT00170820|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110261727|NCT00170820|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110261728|NCT00170820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110261729|NCT00170820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261730|NCT00170820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110261731|NCT00170820|Immunologic Factors|immunologic factors|mesh-ancestor
110261732|NCT00170820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110261733|NCT00170820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110261734|NCT02917018|Dexmedetomidine|dexmedetomidine|mesh-list
110261735|NCT02917018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110261736|NCT02917018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110261737|NCT02917018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110261738|NCT02917018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110261739|NCT02917018|Analgesics|analgesics|mesh-ancestor
110261740|NCT02917018|Sensory System Agents|sensory system agents|mesh-ancestor
110261741|NCT02917018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110261742|NCT02917018|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110261743|NCT02917018|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110261744|NCT02917018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110261745|NCT02917018|Adrenergic Agents|adrenergic agents|mesh-ancestor
110261746|NCT02917018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110261747|NCT02917018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261748|NCT00170859|Everolimus|everolimus|mesh-list
110261749|NCT00170859|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110261750|NCT00170859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110261751|NCT00170859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110261752|NCT00170859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261753|NCT00170859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110261754|NCT00170859|Immunologic Factors|immunologic factors|mesh-ancestor
110261755|NCT00170859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110261756|NCT00170859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110261757|NCT02917057|Exenatide|exenatide|mesh-list
110261758|NCT02917057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110261759|NCT02917057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110261760|NCT02917057|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110261761|NCT02917057|Incretins|incretins|mesh-ancestor
110261762|NCT02917057|Hormones|hormones|mesh-ancestor
110272157|NCT05844995|Analgesics|analgesics|mesh-ancestor
110261763|NCT02917057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110261764|NCT02916940|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
110261765|NCT02916940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110261766|NCT02916940|Glucocorticoids|glucocorticoids|mesh-ancestor
110261767|NCT02916940|Hormones|hormones|mesh-ancestor
110261768|NCT02916940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110261769|NCT02916940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110261770|NCT00170898|Lumiracoxib|lumiracoxib|mesh-list
110261771|NCT00170898|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110261772|NCT00170898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110261773|NCT00170898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110261774|NCT00170898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261775|NCT00170898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110261776|NCT00170898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110261777|NCT00170898|Analgesics|analgesics|mesh-ancestor
110261778|NCT00170898|Sensory System Agents|sensory system agents|mesh-ancestor
110261779|NCT00170898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110261780|NCT00170898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110261781|NCT00170898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110261782|NCT00170898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110261783|NCT02916355|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110261784|NCT02916355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110261785|NCT02916511|Paclitaxel|paclitaxel|mesh-list
110261786|NCT02916511|Carboplatin|carboplatin|mesh-list
110261787|NCT02916511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110261788|NCT02916511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110261789|NCT02916511|Tubulin Modulators|tubulin modulators|mesh-ancestor
110261790|NCT02916511|Antimitotic Agents|antimitotic agents|mesh-ancestor
110261791|NCT02916511|Mitosis Modulators|mitosis modulators|mesh-ancestor
110261792|NCT02916511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261793|NCT00170937|Valsartan|valsartan|mesh-list
110261794|NCT00170937|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110261795|NCT00170937|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110261796|NCT00170937|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110261797|NCT00170937|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110261798|NCT00170937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261799|NCT00170937|Diuretics|diuretics|mesh-ancestor
110261800|NCT00170937|Natriuretic Agents|natriuretic agents|mesh-ancestor
110261801|NCT00170937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110261802|NCT00170937|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110261803|NCT00170937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110261804|NCT02916238|Fluoxetine|fluoxetine|mesh-list
110261805|NCT02916238|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110261806|NCT02916238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110261807|NCT02916238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110261808|NCT02916238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261809|NCT02916238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110261810|NCT02916238|Serotonin Agents|serotonin agents|mesh-ancestor
110261811|NCT02916238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110261812|NCT02916238|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110261813|NCT02916238|Antidepressive Agents|antidepressive agents|mesh-ancestor
110261814|NCT02916238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110261815|NCT02916238|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110261816|NCT02916238|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110261817|NCT02916238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110261819|NCT00149708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110261820|NCT00149708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110261821|NCT00163761|Gemcitabine|gemcitabine|mesh-list
110261822|NCT00163761|Vinorelbine|vinorelbine|mesh-list
110261823|NCT00163761|Ifosfamide|ifosfamide|mesh-list
110261824|NCT00163761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110261825|NCT00163761|Antimetabolites|antimetabolites|mesh-ancestor
110261826|NCT00163761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261827|NCT00163761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110261828|NCT00163761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110261829|NCT00163761|Tubulin Modulators|tubulin modulators|mesh-ancestor
110261830|NCT00163761|Antimitotic Agents|antimitotic agents|mesh-ancestor
110261831|NCT00163761|Mitosis Modulators|mitosis modulators|mesh-ancestor
110261832|NCT00163761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110261833|NCT00163761|Alkylating Agents|alkylating agents|mesh-ancestor
110261834|NCT02916160|Valsartan|valsartan|mesh-list
110261835|NCT02916160|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110261836|NCT02916160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110261837|NCT02916160|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110261839|NCT02916160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261840|NCT02916121|Folic Acid|folic acid|mesh-list
110261841|NCT02916121|Vitamin B 12|vitamin b 12|mesh-list
110261842|NCT02916121|Vitamins|vitamins|mesh-ancestor
110261843|NCT02916121|Micronutrients|micronutrients|mesh-ancestor
110261844|NCT02916121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110261845|NCT02916121|Hematinics|hematinics|mesh-ancestor
110261846|NCT02916121|Vitamin B Complex|vitamin b complex|mesh-ancestor
110261847|NCT00170976|Amlodipine|amlodipine|mesh-list
110261848|NCT00170976|Valsartan|valsartan|mesh-list
110261849|NCT00170976|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110261850|NCT00170976|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110261851|NCT00170976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110261852|NCT00170976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261853|NCT00170976|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110261854|NCT00170976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110261855|NCT00170976|Vasodilator Agents|vasodilator agents|mesh-ancestor
110261856|NCT00170976|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110261857|NCT00170976|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110261858|NCT00149864|Mycophenolic Acid|mycophenolic acid|mesh-list
110261859|NCT00149864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110261860|NCT00149864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110261861|NCT00149864|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110261862|NCT00149864|Antitubercular Agents|antitubercular agents|mesh-ancestor
110261863|NCT00149864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110261864|NCT00149864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110261865|NCT00149864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110261866|NCT00149864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261867|NCT00149903|Mycophenolic Acid|mycophenolic acid|mesh-list
110261868|NCT00149903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110261869|NCT00149903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110261870|NCT00149903|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110261871|NCT00149903|Antitubercular Agents|antitubercular agents|mesh-ancestor
110261872|NCT00149903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110261874|NCT00149903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110261875|NCT00149903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261877|NCT04688632|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110261878|NCT04688632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110261879|NCT04688632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110261880|NCT04688632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110261881|NCT04688632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110261882|NCT04688632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110261883|NCT04688632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261884|NCT04688632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110261885|NCT04688632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110261886|NCT04688632|Contraceptive Agents|contraceptive agents|mesh-ancestor
110261887|NCT04688632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110261888|NCT04688632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110261889|NCT04688632|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110261890|NCT04688632|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110261891|NCT04688632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110261893|NCT00171015|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110261894|NCT00171015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110261895|NCT00171015|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110261896|NCT00171015|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110261897|NCT00171015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261899|NCT00171015|Natriuretic Agents|natriuretic agents|mesh-ancestor
110261900|NCT00171015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110261901|NCT00171015|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110261902|NCT00171015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110261903|NCT05786677|Serotonin|serotonin|mesh-list
110261904|NCT05786677|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
110261905|NCT05786677|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110261906|NCT05786677|Serotonin Agents|serotonin agents|mesh-ancestor
110261907|NCT05786677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110261908|NCT05786677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261909|NCT05786677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110261910|NCT05786677|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110261911|NCT05786677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110261912|NCT05786612|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110261913|NCT05786612|Laxatives|laxatives|mesh-ancestor
110261914|NCT05786612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110261915|NCT05786495|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110261916|NCT05786495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110261917|NCT05786430|Carboplatin|carboplatin|mesh-list
110261918|NCT05786430|Pemetrexed|pemetrexed|mesh-list
110261919|NCT05786430|Lazertinib|lazertinib|mesh-list
110261920|NCT05786430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110261921|NCT05786430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110261922|NCT05786430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261923|NCT05786430|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110261924|NCT05786430|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110261925|NCT05786430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110261926|NCT05786365|Ketamine|ketamine|mesh-list
110261927|NCT05786365|Analgesics|analgesics|mesh-ancestor
110261928|NCT05786365|Sensory System Agents|sensory system agents|mesh-ancestor
110261930|NCT05786365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110261931|NCT05786365|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110261932|NCT05786365|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110261933|NCT05786365|Anesthetics, General|anesthetics, general|mesh-ancestor
110261934|NCT05786365|Anesthetics|anesthetics|mesh-ancestor
110261935|NCT05786365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110261936|NCT05786365|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110261937|NCT05786365|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110261938|NCT05786365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110261939|NCT05786365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261940|NCT05786339|Irbesartan|irbesartan|mesh-list
110261941|NCT05786339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110261942|NCT05786339|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110261943|NCT05786339|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110261944|NCT05786339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261947|NCT05785585|Vitamin B Complex|vitamin b complex|mesh-ancestor
110261949|NCT05785585|Micronutrients|micronutrients|mesh-ancestor
110261950|NCT05785585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110261951|NCT05785585|Hematinics|hematinics|mesh-ancestor
110261952|NCT05785429|Colchicine|colchicine|mesh-list
110261953|NCT05785429|Gout Suppressants|gout suppressants|mesh-ancestor
110261954|NCT05785429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110261955|NCT05785429|Tubulin Modulators|tubulin modulators|mesh-ancestor
110261956|NCT05785429|Antimitotic Agents|antimitotic agents|mesh-ancestor
110261957|NCT05785429|Mitosis Modulators|mitosis modulators|mesh-ancestor
110261958|NCT05785429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261959|NCT05785429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110261960|NCT05785377|Bupivacaine|bupivacaine|mesh-list
110261961|NCT05785377|Neostigmine|neostigmine|mesh-list
110261962|NCT05785377|Anesthetics, Local|anesthetics, local|mesh-ancestor
110261963|NCT05785377|Anesthetics|anesthetics|mesh-ancestor
110261964|NCT05785377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110261965|NCT05785377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110261966|NCT05785377|Sensory System Agents|sensory system agents|mesh-ancestor
110261967|NCT05785377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110261968|NCT05785377|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110261969|NCT05785377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110261970|NCT05785377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261971|NCT05785377|Cholinergic Agents|cholinergic agents|mesh-ancestor
110261972|NCT05785377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110261973|NCT05785377|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110261974|NCT05785377|Autonomic Agents|autonomic agents|mesh-ancestor
110261975|NCT05785325|Bevacizumab|bevacizumab|mesh-list
110261976|NCT05785325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110261977|NCT05785325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110261978|NCT05785325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110261979|NCT05785325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110261980|NCT05785325|Growth Substances|growth substances|mesh-ancestor
110261981|NCT05785325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110261982|NCT05785325|Growth Inhibitors|growth inhibitors|mesh-ancestor
110261984|NCT05785234|Remifentanil|remifentanil|mesh-list
110261985|NCT05785234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110261986|NCT05785234|Narcotics|narcotics|mesh-ancestor
110261987|NCT05785234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110261988|NCT05785234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110261990|NCT05785234|Sensory System Agents|sensory system agents|mesh-ancestor
110261991|NCT05785234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110261992|NCT05785234|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110261993|NCT05785234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110261994|NCT05785234|Anesthetics, General|anesthetics, general|mesh-ancestor
110261995|NCT05785234|Anesthetics|anesthetics|mesh-ancestor
110261996|NCT05785208|Osimertinib|osimertinib|mesh-list
110261997|NCT05785208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110261998|NCT05785208|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110261999|NCT05785208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110262000|NCT05785208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110262001|NCT05785026|Menthol|menthol|mesh-list
110262002|NCT05785026|Antipruritics|antipruritics|mesh-ancestor
110262003|NCT05785026|Dermatologic Agents|dermatologic agents|mesh-ancestor
110262004|NCT05784987|Rituximab|rituximab|mesh-list
110262005|NCT05784987|Etoposide|etoposide|mesh-list
110262006|NCT05784987|Lenalidomide|lenalidomide|mesh-list
110262007|NCT05784987|Mitoxantrone|mitoxantrone|mesh-list
110262008|NCT05784987|Ifosfamide|ifosfamide|mesh-list
110262009|NCT05784987|Isophosphamide mustard|isophosphamide mustard|mesh-list
110262010|NCT05784987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110262011|NCT05784987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110262012|NCT05784987|Immunologic Factors|immunologic factors|mesh-ancestor
110262013|NCT05784987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262014|NCT05784987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110262015|NCT05784987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110262016|NCT05784987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110262017|NCT05784987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110262018|NCT05784987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110262019|NCT05784987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110262020|NCT05784987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110262021|NCT05784987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110262022|NCT05784987|Growth Substances|growth substances|mesh-ancestor
110262023|NCT05784987|Growth Inhibitors|growth inhibitors|mesh-ancestor
110262025|NCT05784987|Sensory System Agents|sensory system agents|mesh-ancestor
110262026|NCT05784987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110262027|NCT05784987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110262028|NCT05784987|Alkylating Agents|alkylating agents|mesh-ancestor
110262029|NCT05784519|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110262030|NCT05784519|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110262031|NCT05784467|Methamphetamine|methamphetamine|mesh-list
110262032|NCT05784467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110262033|NCT05784467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262034|NCT05784467|Sympathomimetics|sympathomimetics|mesh-ancestor
110262035|NCT05784467|Autonomic Agents|autonomic agents|mesh-ancestor
110262036|NCT05784467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110262037|NCT05784467|Dopamine Agents|dopamine agents|mesh-ancestor
110262038|NCT05784467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110262039|NCT05784467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110262040|NCT05784467|Adrenergic Agents|adrenergic agents|mesh-ancestor
110262041|NCT05784467|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110262042|NCT05784467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110262043|NCT05784467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110262044|NCT05784467|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110262045|NCT05782894|Remifentanil|remifentanil|mesh-list
110262046|NCT05782894|Propofol|propofol|mesh-list
110262047|NCT05782894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110262048|NCT05782894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110262049|NCT05782894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262050|NCT05782894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110262051|NCT05782894|Anesthetics, General|anesthetics, general|mesh-ancestor
110262052|NCT05782894|Anesthetics|anesthetics|mesh-ancestor
110262053|NCT05782894|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110262063|NCT05782712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110262064|NCT05782712|Vasodilator Agents|vasodilator agents|mesh-ancestor
110262065|NCT05782712|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110262066|NCT05782712|Purinergic Agonists|purinergic agonists|mesh-ancestor
110262067|NCT05782712|Purinergic Agents|purinergic agents|mesh-ancestor
110262068|NCT05782712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110262069|NCT05782712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110262070|NCT05781516|Prednisolone|prednisolone|mesh-list
110262071|NCT05781516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110262072|NCT05781516|Glucocorticoids|glucocorticoids|mesh-ancestor
110262073|NCT05781516|Hormones|hormones|mesh-ancestor
110262074|NCT05781516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110262075|NCT05781516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262076|NCT05781516|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110262077|NCT05781516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110262078|NCT05780437|Remdesivir|remdesivir|mesh-list
110262079|NCT05780437|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
110262080|NCT05780437|Antimetabolites|antimetabolites|mesh-ancestor
110262081|NCT05780437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110262083|NCT05780437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110262084|NCT05780424|Remdesivir|remdesivir|mesh-list
110262085|NCT05780424|Antimetabolites|antimetabolites|mesh-ancestor
110262086|NCT05780424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110262087|NCT05780424|Antiviral Agents|antiviral agents|mesh-ancestor
110262088|NCT05780424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110262089|NCT05778266|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110262090|NCT05778266|Laxatives|laxatives|mesh-ancestor
110262091|NCT05778266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110262092|NCT05774405|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110262093|NCT05774405|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110262095|NCT05774405|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110262096|NCT05774405|Estrogens|estrogens|mesh-ancestor
110262097|NCT05774405|Hormones|hormones|mesh-ancestor
110262098|NCT05774405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110262099|NCT05774405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262100|NCT05774405|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110262101|NCT05774405|Contraceptive Agents|contraceptive agents|mesh-ancestor
110262102|NCT05774405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110262103|NCT05774405|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110262116|NCT05764941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110262117|NCT05764941|Tubulin Modulators|tubulin modulators|mesh-ancestor
110262118|NCT05764941|Antimitotic Agents|antimitotic agents|mesh-ancestor
110262119|NCT05764941|Mitosis Modulators|mitosis modulators|mesh-ancestor
110262120|NCT05764941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110262121|NCT05750017|Vaccines|vaccines|mesh-list
110262122|NCT05750017|Immunologic Factors|immunologic factors|mesh-ancestor
110262123|NCT05750017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262124|NCT05724316|Vitamin D|vitamin d|mesh-list
110262125|NCT05724316|Cholecalciferol|cholecalciferol|mesh-list
110262126|NCT05724316|Vitamins|vitamins|mesh-ancestor
110262127|NCT05724316|Micronutrients|micronutrients|mesh-ancestor
110262128|NCT05724316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262129|NCT05724316|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110262130|NCT05724316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110262131|NCT05723705|Liver Extracts|liver extracts|mesh-list
110262132|NCT05723705|Hematinics|hematinics|mesh-ancestor
110262133|NCT05634577|Pembrolizumab|pembrolizumab|mesh-list
110262134|NCT05634577|Mitotane|mitotane|mesh-list
110262135|NCT05634577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110262136|NCT05634577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110262137|NCT05634577|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110262138|NCT05634577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110262139|NCT05634577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110262140|NCT05616260|Acetazolamide|acetazolamide|mesh-list
110262141|NCT05616260|Anticonvulsants|anticonvulsants|mesh-ancestor
110262142|NCT05616260|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110262143|NCT05616260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110262144|NCT05616260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110262145|NCT05616260|Diuretics|diuretics|mesh-ancestor
110262146|NCT05616260|Natriuretic Agents|natriuretic agents|mesh-ancestor
110262147|NCT05616260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262149|NCT05611034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110262150|NCT05592509|Vitamins|vitamins|mesh-list
110262151|NCT05592509|Micronutrients|micronutrients|mesh-ancestor
110262152|NCT05592509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262153|NCT05582213|Anesthetics|anesthetics|mesh-list
110262154|NCT05582213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110262155|NCT05582213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262156|NCT05550597|Fentanyl|fentanyl|mesh-list
110262157|NCT05550597|Bupivacaine|bupivacaine|mesh-list
110262158|NCT05550597|Anesthetics, Local|anesthetics, local|mesh-ancestor
110262159|NCT05550597|Anesthetics|anesthetics|mesh-ancestor
110262160|NCT05550597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110262161|NCT05550597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262162|NCT05550597|Sensory System Agents|sensory system agents|mesh-ancestor
110262163|NCT05550597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110262164|NCT05550597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110262165|NCT05550597|Narcotics|narcotics|mesh-ancestor
110262166|NCT05550597|Analgesics|analgesics|mesh-ancestor
110262167|NCT05550597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110262168|NCT05550597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110262169|NCT05550597|Anesthetics, General|anesthetics, general|mesh-ancestor
110262170|NCT05495269|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110262171|NCT05495269|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110262172|NCT05355935|Moxifloxacin|moxifloxacin|mesh-list
110262173|NCT05355935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110262174|NCT05355935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110262175|NCT05355935|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110262176|NCT05355935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110262177|NCT05355935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110262178|NCT05355935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110262179|NCT05355935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110262181|NCT05334017|Xylometazoline|xylometazoline|mesh-list
110262182|NCT05334017|Anesthetics, Local|anesthetics, local|mesh-ancestor
110262183|NCT05334017|Anesthetics|anesthetics|mesh-ancestor
110262184|NCT05334017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110262185|NCT05334017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262186|NCT05334017|Sensory System Agents|sensory system agents|mesh-ancestor
110262187|NCT05334017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110262188|NCT05334017|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110262189|NCT05334017|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110262190|NCT05334017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110262191|NCT05334017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110262192|NCT05334017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110262193|NCT05334017|Dopamine Agents|dopamine agents|mesh-ancestor
110262194|NCT05334017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110262195|NCT05334017|Nasal Decongestants|nasal decongestants|mesh-ancestor
110262196|NCT05334017|Respiratory System Agents|respiratory system agents|mesh-ancestor
110262197|NCT05292339|Triamcinolone|triamcinolone|mesh-list
110262198|NCT05292339|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110262199|NCT05292339|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110262200|NCT05292339|Ketorolac|ketorolac|mesh-list
110262201|NCT05292339|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110262202|NCT05292339|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110262203|NCT05292339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110262204|NCT05292339|Glucocorticoids|glucocorticoids|mesh-ancestor
110262205|NCT05292339|Hormones|hormones|mesh-ancestor
110262206|NCT05292339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110262207|NCT05292339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262208|NCT05292339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110262210|NCT05292339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110262211|NCT05292339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110262212|NCT05292339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110262213|NCT05292339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110262214|NCT05292339|Analgesics|analgesics|mesh-ancestor
110262215|NCT05292339|Sensory System Agents|sensory system agents|mesh-ancestor
110262216|NCT05292339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110262217|NCT05292339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110262218|NCT05292339|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110262219|NCT05291650|Hyaluronic Acid|hyaluronic acid|mesh-list
110262220|NCT05291650|Glucocorticoids|glucocorticoids|mesh-list
110262221|NCT05291650|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110262222|NCT05291650|Immunologic Factors|immunologic factors|mesh-ancestor
110262223|NCT05291650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262224|NCT05291650|Viscosupplements|viscosupplements|mesh-ancestor
110262225|NCT05291650|Protective Agents|protective agents|mesh-ancestor
110262226|NCT05291650|Hormones|hormones|mesh-ancestor
110262227|NCT05291650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110262228|NCT05266027|Nalbuphine|nalbuphine|mesh-list
110262229|NCT05266027|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110262230|NCT05266027|Narcotics|narcotics|mesh-ancestor
110262231|NCT05266027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110262232|NCT05266027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262233|NCT05266027|Analgesics|analgesics|mesh-ancestor
110262234|NCT05266027|Sensory System Agents|sensory system agents|mesh-ancestor
110262235|NCT05266027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110262236|NCT05157867|Trypsin Inhibitors|trypsin inhibitors|mesh-list
110262237|NCT05157867|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110262238|NCT05157867|Protease Inhibitors|protease inhibitors|mesh-ancestor
110262239|NCT05157867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110262240|NCT05157867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110262241|NCT05131386|Trabectedin|trabectedin|mesh-list
110262242|NCT05131386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110262243|NCT05131386|Alkylating Agents|alkylating agents|mesh-ancestor
110262244|NCT05131386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110262245|NCT05131386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110262246|NCT05129332|Vitamin E|vitamin e|mesh-list
110262247|NCT05129332|Vitamins|vitamins|mesh-ancestor
110262248|NCT05129332|Micronutrients|micronutrients|mesh-ancestor
110262249|NCT05129332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262250|NCT05129332|Antioxidants|antioxidants|mesh-ancestor
110262251|NCT05129332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110262252|NCT05129332|Protective Agents|protective agents|mesh-ancestor
110262254|NCT05111262|Formoterol Fumarate|formoterol fumarate|mesh-list
110262255|NCT05111262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110262256|NCT05111262|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110262257|NCT05111262|Autonomic Agents|autonomic agents|mesh-ancestor
110262258|NCT05111262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110262259|NCT05111262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262260|NCT05111262|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110262261|NCT05111262|Respiratory System Agents|respiratory system agents|mesh-ancestor
110262262|NCT05111262|Glucocorticoids|glucocorticoids|mesh-ancestor
110262263|NCT05111262|Hormones|hormones|mesh-ancestor
110262264|NCT05111262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110262265|NCT05111262|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110262266|NCT05111262|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110262267|NCT05111262|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110262268|NCT05111262|Adrenergic Agents|adrenergic agents|mesh-ancestor
110262269|NCT05111262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110262270|NCT05111262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110262271|NCT05091242|Clonidine|clonidine|mesh-list
110262272|NCT05091242|Analgesics|analgesics|mesh-ancestor
110262273|NCT05091242|Sensory System Agents|sensory system agents|mesh-ancestor
110262274|NCT05091242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110262275|NCT05091242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262276|NCT05091242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110262277|NCT05091242|Sympatholytics|sympatholytics|mesh-ancestor
110262278|NCT05091242|Autonomic Agents|autonomic agents|mesh-ancestor
110262279|NCT05091242|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110262280|NCT05091242|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110262281|NCT05091242|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110262282|NCT05091242|Adrenergic Agents|adrenergic agents|mesh-ancestor
110262283|NCT05091242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110262284|NCT05091242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110262285|NCT05028140|Pioglitazone|pioglitazone|mesh-list
110262286|NCT05028140|Empagliflozin|empagliflozin|mesh-list
110262287|NCT05028140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110262288|NCT05028140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262289|NCT05028140|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110262290|NCT05028140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110262291|NCT05027516|Azithromycin|azithromycin|mesh-list
110262292|NCT05027516|Ceftriaxone|ceftriaxone|mesh-list
110262293|NCT05027516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110262294|NCT05027516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110262295|NCT04992013|Niraparib|niraparib|mesh-list
110262296|NCT04992013|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110262297|NCT04992013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110262298|NCT04992013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110262299|NCT04992013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110262300|NCT04969263|Vaccines|vaccines|mesh-list
110262301|NCT04969263|Immunologic Factors|immunologic factors|mesh-ancestor
110262302|NCT04969263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262303|NCT04947124|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110262304|NCT04947124|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110262305|NCT04933630|Norepinephrine|norepinephrine|mesh-list
110262306|NCT04933630|Serotonin|serotonin|mesh-list
110262307|NCT04933630|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
110262308|NCT04933630|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110262309|NCT04933630|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110262310|NCT04933630|Adrenergic Agents|adrenergic agents|mesh-ancestor
110262311|NCT04933630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110262312|NCT04933630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110262313|NCT04933630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262314|NCT04933630|Sympathomimetics|sympathomimetics|mesh-ancestor
110262315|NCT04933630|Autonomic Agents|autonomic agents|mesh-ancestor
110262316|NCT04933630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110262317|NCT04933630|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110262318|NCT04933630|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110262319|NCT04933630|Serotonin Agents|serotonin agents|mesh-ancestor
110262320|NCT04933630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110262321|NCT04933630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110262322|NCT04923841|Atropine|atropine|mesh-list
110262323|NCT04923841|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110262324|NCT04923841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110262325|NCT04923841|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110262326|NCT04923841|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110262327|NCT04923841|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110262328|NCT04923841|Autonomic Agents|autonomic agents|mesh-ancestor
110262329|NCT04923841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110262330|NCT04923841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262331|NCT04923841|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110262332|NCT04923841|Respiratory System Agents|respiratory system agents|mesh-ancestor
110262333|NCT04923841|Mydriatics|mydriatics|mesh-ancestor
110262334|NCT04923841|Parasympatholytics|parasympatholytics|mesh-ancestor
110262335|NCT04923841|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110262336|NCT04923841|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110262337|NCT04923841|Cholinergic Agents|cholinergic agents|mesh-ancestor
110262338|NCT04923841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110262339|NCT04923841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110262340|NCT04838808|Rivaroxaban|rivaroxaban|mesh-list
110262342|NCT04838808|Antithrombins|antithrombins|mesh-ancestor
110262343|NCT04838808|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110262344|NCT04838808|Protease Inhibitors|protease inhibitors|mesh-ancestor
110262345|NCT04838808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110262346|NCT04838808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110262348|NCT04792502|Lenalidomide|lenalidomide|mesh-list
110262349|NCT04792502|Immunologic Factors|immunologic factors|mesh-ancestor
110262350|NCT04792502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262351|NCT04792502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110262352|NCT04792502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110262353|NCT04792502|Growth Substances|growth substances|mesh-ancestor
110262354|NCT04792502|Growth Inhibitors|growth inhibitors|mesh-ancestor
110262355|NCT04792502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110262356|NCT04777422|Defibrotide|defibrotide|mesh-list
110262357|NCT04777422|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110262358|NCT04777422|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110262359|NCT04777422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110262360|NCT04777422|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110262361|NCT04761198|Nivolumab|nivolumab|mesh-list
110262362|NCT04761198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110262363|NCT04761198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110262364|NCT04761198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110262365|NCT04761198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110262366|NCT04748276|Norepinephrine|norepinephrine|mesh-list
110262367|NCT04748276|Serotonin|serotonin|mesh-list
110262368|NCT04748276|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
110262369|NCT04748276|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110262370|NCT04748276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110262371|NCT04748276|Adrenergic Agents|adrenergic agents|mesh-ancestor
110262372|NCT04748276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110262373|NCT04748276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110262374|NCT04748276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262375|NCT04748276|Sympathomimetics|sympathomimetics|mesh-ancestor
110262376|NCT04748276|Autonomic Agents|autonomic agents|mesh-ancestor
110262377|NCT04748276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110262378|NCT04748276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110262379|NCT04748276|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110262380|NCT04748276|Serotonin Agents|serotonin agents|mesh-ancestor
110262381|NCT04748276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110262382|NCT04748276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110262383|NCT04659811|Pembrolizumab|pembrolizumab|mesh-list
110262384|NCT04659811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110262385|NCT04659811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110262386|NCT04659811|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110262387|NCT04659811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110262389|NCT04610658|Ipilimumab|ipilimumab|mesh-list
110262390|NCT04610658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110262391|NCT04610658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110262392|NCT04610658|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110262393|NCT04610658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110262394|NCT04595994|Gemcitabine|gemcitabine|mesh-list
110262395|NCT04595994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110262396|NCT04595994|Antimetabolites|antimetabolites|mesh-ancestor
110262397|NCT04595994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110262398|NCT04595994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110262399|NCT04587791|Cannabidiol|cannabidiol|mesh-list
110262400|NCT04587791|Anticonvulsants|anticonvulsants|mesh-ancestor
110262401|NCT04538066|Bryostatin 1|bryostatin 1|mesh-list
110262402|NCT04538066|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110262403|NCT04538066|Immunologic Factors|immunologic factors|mesh-ancestor
110262404|NCT04538066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262405|NCT04538066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110262406|NCT04532918|Cyclosporine|cyclosporine|mesh-list
110262407|NCT04532918|Rifampin|rifampin|mesh-list
110262408|NCT04532918|Allopurinol|allopurinol|mesh-list
110262409|NCT04532918|Verinurad|verinurad|mesh-list
110262410|NCT04532918|Cyclosporins|cyclosporins|mesh-list
110262411|NCT04532918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110262412|NCT04532918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110262413|NCT04532918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110262414|NCT04532918|Immunologic Factors|immunologic factors|mesh-ancestor
110262415|NCT04532918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262416|NCT04532918|Antifungal Agents|antifungal agents|mesh-ancestor
110262417|NCT04532918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110262418|NCT04532918|Dermatologic Agents|dermatologic agents|mesh-ancestor
110262419|NCT04532918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110262420|NCT04532918|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110262421|NCT04532918|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110262422|NCT04532918|Antitubercular Agents|antitubercular agents|mesh-ancestor
110262423|NCT04532918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110262424|NCT04532918|Leprostatic Agents|leprostatic agents|mesh-ancestor
110262425|NCT04532918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110262426|NCT04532918|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110262427|NCT04532918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110262428|NCT04532918|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110262429|NCT04532918|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110262430|NCT04532918|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110262431|NCT04532918|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110262432|NCT04532918|Antimetabolites|antimetabolites|mesh-ancestor
110262434|NCT04532918|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110262435|NCT04532918|Antioxidants|antioxidants|mesh-ancestor
110262436|NCT04532918|Protective Agents|protective agents|mesh-ancestor
110262437|NCT04511247|Sirolimus|sirolimus|mesh-list
110262438|NCT04511247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110262439|NCT04511247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110262440|NCT04511247|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110262441|NCT04511247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110262442|NCT04511247|Antifungal Agents|antifungal agents|mesh-ancestor
110272292|NCT05663866|Montelukast|montelukast|mesh-list
110262443|NCT04511247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110262445|NCT04511247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262446|NCT04387084|Pembrolizumab|pembrolizumab|mesh-list
110262447|NCT04387084|Nivolumab|nivolumab|mesh-list
110262448|NCT04387084|Atezolizumab|atezolizumab|mesh-list
110262449|NCT04387084|Durvalumab|durvalumab|mesh-list
110262450|NCT04387084|Avelumab|avelumab|mesh-list
110262451|NCT04387084|Cemiplimab|cemiplimab|mesh-list
110262452|NCT04387084|Immunoglobulins|immunoglobulins|mesh-list
110262453|NCT04387084|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110262454|NCT04387084|Immunoglobulin G|immunoglobulin g|mesh-list
110262455|NCT04387084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110262456|NCT04387084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110262457|NCT04387084|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110262458|NCT04387084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110262459|NCT04387084|Immunologic Factors|immunologic factors|mesh-ancestor
110262460|NCT04387084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262461|NCT04347798|Hydroxychloroquine|hydroxychloroquine|mesh-list
110262462|NCT04347798|Chloroquine|chloroquine|mesh-list
110262463|NCT04347798|Antimalarials|antimalarials|mesh-ancestor
110262464|NCT04347798|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110262465|NCT04347798|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110262466|NCT04347798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110262467|NCT04347798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110262468|NCT04347798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110262469|NCT04347798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110262470|NCT04347798|Amebicides|amebicides|mesh-ancestor
110262471|NCT04335669|Paclitaxel|paclitaxel|mesh-list
110262472|NCT04335669|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110262473|NCT04335669|Cyclophosphamide|cyclophosphamide|mesh-list
110262474|NCT04335669|Carboplatin|carboplatin|mesh-list
110262475|NCT04335669|Pembrolizumab|pembrolizumab|mesh-list
110262476|NCT04335669|Capecitabine|capecitabine|mesh-list
110262477|NCT04335669|Epirubicin|epirubicin|mesh-list
110262478|NCT04335669|Taxane|taxane|mesh-list
110262479|NCT04335669|Antimetabolites|antimetabolites|mesh-list
110262480|NCT04335669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110262481|NCT04335669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110262482|NCT04335669|Tubulin Modulators|tubulin modulators|mesh-ancestor
110262483|NCT04335669|Antimitotic Agents|antimitotic agents|mesh-ancestor
110262484|NCT04335669|Mitosis Modulators|mitosis modulators|mesh-ancestor
110262485|NCT04335669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110262486|NCT04335669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110262487|NCT04335669|Immunologic Factors|immunologic factors|mesh-ancestor
110262488|NCT04335669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262490|NCT04335669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110262491|NCT04335669|Alkylating Agents|alkylating agents|mesh-ancestor
110262492|NCT04335669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110262493|NCT04335669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110262494|NCT04335669|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110262495|NCT04335669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110262496|NCT04335669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110262497|NCT04335669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110262498|NCT04335669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110262499|NCT04335669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110262500|NCT04310176|Bevacizumab|bevacizumab|mesh-list
110262501|NCT04310176|Fluorouracil|fluorouracil|mesh-list
110262502|NCT04310176|Capecitabine|capecitabine|mesh-list
110262503|NCT04310176|Valproic Acid|valproic acid|mesh-list
110262504|NCT04310176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110262505|NCT04310176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110262506|NCT04310176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110262507|NCT04310176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110262508|NCT04310176|Growth Substances|growth substances|mesh-ancestor
110262509|NCT04310176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262510|NCT04310176|Growth Inhibitors|growth inhibitors|mesh-ancestor
110262511|NCT04310176|Antimetabolites|antimetabolites|mesh-ancestor
110262512|NCT04310176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110262513|NCT04310176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110262514|NCT04310176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110262515|NCT04310176|Immunologic Factors|immunologic factors|mesh-ancestor
110262516|NCT04310176|Anticonvulsants|anticonvulsants|mesh-ancestor
110262517|NCT04310176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110262518|NCT04310176|GABA Agents|gaba agents|mesh-ancestor
110262519|NCT04310176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110262520|NCT04310176|Antimanic Agents|antimanic agents|mesh-ancestor
110262521|NCT04310176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110262522|NCT04310176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110262523|NCT04310176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110262525|NCT04298983|Hormones|hormones|mesh-ancestor
110262526|NCT04298983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110262527|NCT04298983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262528|NCT04251416|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
110262529|NCT04251416|Immunoconjugates|immunoconjugates|mesh-ancestor
110262530|NCT04251416|Immunologic Factors|immunologic factors|mesh-ancestor
110262531|NCT04251416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262532|NCT04236609|Sirolimus|sirolimus|mesh-list
110262533|NCT04236609|Everolimus|everolimus|mesh-list
110262534|NCT04236609|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110262535|NCT04236609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110262536|NCT04236609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110262537|NCT04236609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110262538|NCT04236609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110262539|NCT04236609|Immunologic Factors|immunologic factors|mesh-ancestor
110262540|NCT04236609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262541|NCT04236609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110262542|NCT04236609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110262543|NCT04236609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110262544|NCT04236609|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110262545|NCT04236609|Antifungal Agents|antifungal agents|mesh-ancestor
110262546|NCT04232657|Denosumab|denosumab|mesh-list
110262547|NCT04232657|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110262548|NCT04232657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262550|NCT04173585|Gemtuzumab|gemtuzumab|mesh-list
110262551|NCT04173585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110262552|NCT04173585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110262553|NCT04173585|Immunotoxins|immunotoxins|mesh-ancestor
110262554|NCT04173585|Immunoconjugates|immunoconjugates|mesh-ancestor
110262555|NCT04173585|Immunologic Factors|immunologic factors|mesh-ancestor
110262556|NCT04173585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262557|NCT04172987|Tirzepatide|tirzepatide|mesh-list
110262558|NCT04172987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110262559|NCT04172987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262560|NCT04172987|Incretins|incretins|mesh-ancestor
110262561|NCT04172987|Hormones|hormones|mesh-ancestor
110262562|NCT04172987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110262563|NCT04138381|Imatinib Mesylate|imatinib mesylate|mesh-list
110262564|NCT04138381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110262565|NCT04138381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110262566|NCT04138381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110262567|NCT04138381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110262568|NCT04127786|Vaccines|vaccines|mesh-list
110262569|NCT04127786|Immunologic Factors|immunologic factors|mesh-ancestor
110262570|NCT04127786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262571|NCT04049331|Methyltestosterone|methyltestosterone|mesh-list
110262572|NCT04049331|Testosterone|testosterone|mesh-list
110262573|NCT04049331|Testosterone undecanoate|testosterone undecanoate|mesh-list
110262574|NCT04049331|Testosterone enanthate|testosterone enanthate|mesh-list
110262575|NCT04049331|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110262576|NCT04049331|Androgens|androgens|mesh-ancestor
110262577|NCT04049331|Hormones|hormones|mesh-ancestor
110262578|NCT04049331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110262579|NCT04049331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262580|NCT04049331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110262581|NCT04049331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110262582|NCT04049331|Anabolic Agents|anabolic agents|mesh-ancestor
110262583|NCT04033055|Ropivacaine|ropivacaine|mesh-list
110262584|NCT04033055|Anesthetics, Local|anesthetics, local|mesh-ancestor
110262585|NCT04033055|Anesthetics|anesthetics|mesh-ancestor
110262586|NCT04033055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110262587|NCT04033055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262588|NCT04033055|Sensory System Agents|sensory system agents|mesh-ancestor
110262589|NCT04033055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110262590|NCT04015596|Naproxen|naproxen|mesh-list
110262591|NCT04015596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110262592|NCT04015596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110262593|NCT04015596|Analgesics|analgesics|mesh-ancestor
110262594|NCT04015596|Sensory System Agents|sensory system agents|mesh-ancestor
110262595|NCT04015596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110262596|NCT04015596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262597|NCT04015596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110262598|NCT04015596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110262599|NCT04015596|Gout Suppressants|gout suppressants|mesh-ancestor
110262600|NCT04015596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110262601|NCT04015596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110262602|NCT04015596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110262603|NCT03985722|Trabectedin|trabectedin|mesh-list
110262604|NCT03985722|Olaratumab|olaratumab|mesh-list
110262605|NCT03985722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110262606|NCT03985722|Alkylating Agents|alkylating agents|mesh-ancestor
110262607|NCT03985722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110262608|NCT03985722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110262609|NCT03954327|Tenofovir|tenofovir|mesh-list
110262610|NCT03954327|Emtricitabine|emtricitabine|mesh-list
110262611|NCT03954327|Raltegravir Potassium|raltegravir potassium|mesh-list
110262612|NCT03954327|Antiviral Agents|antiviral agents|mesh-ancestor
110262613|NCT03954327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110262614|NCT03954327|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110262615|NCT03954327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110262616|NCT03954327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110262617|NCT03954327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110262618|NCT03954327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110262619|NCT03954327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110262620|NCT03954327|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110262621|NCT03954327|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110262623|NCT03762096|Antioxidants|antioxidants|mesh-ancestor
110262624|NCT03762096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110262625|NCT03762096|Protective Agents|protective agents|mesh-ancestor
110262626|NCT03762096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262627|NCT03762096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110262628|NCT03762096|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110262629|NCT03737955|Gemtuzumab|gemtuzumab|mesh-list
110262630|NCT03737955|Calicheamicins|calicheamicins|mesh-list
110262631|NCT03737955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110262632|NCT03737955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110262633|NCT03737955|Immunotoxins|immunotoxins|mesh-ancestor
110262634|NCT03737955|Immunoconjugates|immunoconjugates|mesh-ancestor
110262635|NCT03737955|Immunologic Factors|immunologic factors|mesh-ancestor
110262636|NCT03737955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262637|NCT03737955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110262638|NCT03736720|Leucovorin|leucovorin|mesh-list
110262639|NCT03736720|Fluorouracil|fluorouracil|mesh-list
110262640|NCT03736720|Irinotecan|irinotecan|mesh-list
110262641|NCT03736720|Antimetabolites|antimetabolites|mesh-ancestor
110262642|NCT03736720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110262643|NCT03736720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110262644|NCT03736720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110262645|NCT03736720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110262646|NCT03736720|Immunologic Factors|immunologic factors|mesh-ancestor
110262647|NCT03736720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262648|NCT03736720|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110262649|NCT03736720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110262650|NCT03736720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110262651|NCT03736720|Antidotes|antidotes|mesh-ancestor
110262652|NCT03736720|Protective Agents|protective agents|mesh-ancestor
110262653|NCT03736720|Vitamin B Complex|vitamin b complex|mesh-ancestor
110262654|NCT03736720|Vitamins|vitamins|mesh-ancestor
110262655|NCT03736720|Micronutrients|micronutrients|mesh-ancestor
110262656|NCT03490344|Lenalidomide|lenalidomide|mesh-list
110262657|NCT03490344|Daratumumab|daratumumab|mesh-list
110262658|NCT03490344|Immunologic Factors|immunologic factors|mesh-ancestor
110262659|NCT03490344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262660|NCT03490344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110262661|NCT03490344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110262662|NCT03490344|Growth Substances|growth substances|mesh-ancestor
110262663|NCT03490344|Growth Inhibitors|growth inhibitors|mesh-ancestor
110262664|NCT03490344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110262665|NCT03460379|Citalopram|citalopram|mesh-list
110262666|NCT03460379|Escitalopram|escitalopram|mesh-list
110262667|NCT03460379|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110262668|NCT03460379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110262669|NCT03460379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110262670|NCT03460379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110262671|NCT03460379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110262672|NCT03460379|Serotonin Agents|serotonin agents|mesh-ancestor
110262673|NCT03460379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262674|NCT03460379|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110262675|NCT03460379|Antidepressive Agents|antidepressive agents|mesh-ancestor
110262676|NCT03460379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110262677|NCT03460366|Enalapril|enalapril|mesh-list
110262678|NCT03460366|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110262679|NCT03460366|Protease Inhibitors|protease inhibitors|mesh-ancestor
110262680|NCT03460366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110262681|NCT03460366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110262682|NCT03460366|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110262683|NCT03460353|Dextroamphetamine|dextroamphetamine|mesh-list
110262684|NCT03460353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110262685|NCT03460353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262686|NCT03460353|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110262687|NCT03460353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110262688|NCT03460353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110262689|NCT03460353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110262690|NCT03460353|Dopamine Agents|dopamine agents|mesh-ancestor
110262691|NCT03460353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110262692|NCT03460327|Candesartan|candesartan|mesh-list
110262693|NCT03460327|Candesartan cilexetil|candesartan cilexetil|mesh-list
110262694|NCT03460327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110262695|NCT03460327|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110262696|NCT03460327|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110262697|NCT03460327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110262699|NCT03460314|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110262700|NCT03460314|Narcotics|narcotics|mesh-ancestor
110262701|NCT03460314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110262702|NCT03460314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262703|NCT03460314|Analgesics|analgesics|mesh-ancestor
110262704|NCT03460314|Sensory System Agents|sensory system agents|mesh-ancestor
110262705|NCT03460314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110262706|NCT03460314|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110262707|NCT03460210|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110262708|NCT03460210|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110262709|NCT03460210|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110262710|NCT03460210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110262711|NCT03460210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110262712|NCT03460210|Adrenergic Agents|adrenergic agents|mesh-ancestor
110262713|NCT03460210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110262714|NCT03460210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262715|NCT03449472|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110262716|NCT03449472|Antidepressive Agents|antidepressive agents|mesh-ancestor
110262717|NCT03449472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110262718|NCT03449472|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110262719|NCT03449472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110262720|NCT03449472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110262721|NCT03449472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262723|NCT03440879|Androgens|androgens|mesh-list
110262724|NCT03440879|Hormones|hormones|mesh-ancestor
110262725|NCT03440879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110262726|NCT03440879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262727|NCT03440879|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110262728|NCT03440879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110262729|NCT03433755|Evolocumab|evolocumab|mesh-list
110262730|NCT03433755|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110262731|NCT03433755|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110262732|NCT03433755|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110262733|NCT03433755|Antimetabolites|antimetabolites|mesh-ancestor
110262734|NCT03433755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110262735|NCT03433755|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110262736|NCT03433755|Protease Inhibitors|protease inhibitors|mesh-ancestor
110262737|NCT03433755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110262738|NCT03433755|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110262739|NCT03406507|Ravulizumab|ravulizumab|mesh-list
110262740|NCT03406507|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110262741|NCT03406507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110262742|NCT03406507|Immunologic Factors|immunologic factors|mesh-ancestor
110262743|NCT03406507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262744|NCT03283150|Dexmedetomidine|dexmedetomidine|mesh-list
110262745|NCT03283150|Remifentanil|remifentanil|mesh-list
110262746|NCT03283150|Propofol|propofol|mesh-list
110262747|NCT03283150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110262748|NCT03283150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110262749|NCT03283150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262750|NCT03283150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110262751|NCT03283150|Analgesics|analgesics|mesh-ancestor
110262752|NCT03283150|Sensory System Agents|sensory system agents|mesh-ancestor
110262753|NCT03283150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110262754|NCT03283150|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110262755|NCT03283150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110262756|NCT03283150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110262757|NCT03283150|Adrenergic Agents|adrenergic agents|mesh-ancestor
110262758|NCT03283150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110262759|NCT03283150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110262760|NCT03283150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110262761|NCT03283150|Anesthetics, General|anesthetics, general|mesh-ancestor
110262763|NCT03283150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110262764|NCT03283150|Narcotics|narcotics|mesh-ancestor
110262765|NCT03249792|Pembrolizumab|pembrolizumab|mesh-list
110262766|NCT03249792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110262767|NCT03249792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110262768|NCT03249792|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110262769|NCT03249792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110262770|NCT03132675|Pembrolizumab|pembrolizumab|mesh-list
110262771|NCT03132675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110262772|NCT03132675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110262773|NCT03132675|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110262774|NCT03132675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110262775|NCT03110744|Palbociclib|palbociclib|mesh-list
110262776|NCT03110744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110262777|NCT03110744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110262778|NCT03110744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110262779|NCT03110744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110262780|NCT03056040|Eculizumab|eculizumab|mesh-list
110262781|NCT03056040|Ravulizumab|ravulizumab|mesh-list
110262782|NCT03056040|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110262783|NCT03056040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110262784|NCT03056040|Immunologic Factors|immunologic factors|mesh-ancestor
110262785|NCT03056040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262786|NCT02924038|Poly ICLC|poly iclc|mesh-list
110262787|NCT02924038|Interferon Inducers|interferon inducers|mesh-ancestor
110262788|NCT02924038|Immunologic Factors|immunologic factors|mesh-ancestor
110262789|NCT02924038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262790|NCT02726581|Dexamethasone|dexamethasone|mesh-list
110262791|NCT02726581|Nivolumab|nivolumab|mesh-list
110262792|NCT02726581|Pomalidomide|pomalidomide|mesh-list
110262793|NCT02726581|Elotuzumab|elotuzumab|mesh-list
110262794|NCT02726581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110262795|NCT02726581|Antiemetics|antiemetics|mesh-ancestor
110262796|NCT02726581|Autonomic Agents|autonomic agents|mesh-ancestor
110262797|NCT02726581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110262798|NCT02726581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262799|NCT02726581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110262800|NCT02726581|Glucocorticoids|glucocorticoids|mesh-ancestor
110262801|NCT02726581|Hormones|hormones|mesh-ancestor
110262802|NCT02726581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110262803|NCT02726581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110262804|NCT02726581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110262805|NCT02726581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110262807|NCT02726581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110262808|NCT02726581|Immunologic Factors|immunologic factors|mesh-ancestor
110262809|NCT02726581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110262810|NCT02726581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110262811|NCT02726581|Growth Substances|growth substances|mesh-ancestor
110262812|NCT02726581|Growth Inhibitors|growth inhibitors|mesh-ancestor
110262813|NCT02700048|Naloxone|naloxone|mesh-list
110262814|NCT02700048|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110262815|NCT02700048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262816|NCT02700048|Sensory System Agents|sensory system agents|mesh-ancestor
110262817|NCT02700048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110262818|NCT02535832|Pioglitazone|pioglitazone|mesh-list
110262819|NCT02535832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110262820|NCT02535832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262821|NCT02425904|Clofarabine|clofarabine|mesh-list
110262822|NCT02425904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110262823|NCT02425904|Antimetabolites|antimetabolites|mesh-ancestor
110262824|NCT02425904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110262825|NCT02425904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110262826|NCT02406209|Prednisolone|prednisolone|mesh-list
110262827|NCT02406209|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110262828|NCT02406209|Methylprednisolone|methylprednisolone|mesh-list
110262829|NCT02406209|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110262830|NCT02406209|Prednisolone acetate|prednisolone acetate|mesh-list
110262831|NCT02406209|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110262832|NCT02406209|Prednisolone phosphate|prednisolone phosphate|mesh-list
110262833|NCT02406209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110262834|NCT02406209|Glucocorticoids|glucocorticoids|mesh-ancestor
110262835|NCT02406209|Hormones|hormones|mesh-ancestor
110262836|NCT02406209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110262837|NCT02406209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262838|NCT02406209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110262839|NCT02406209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110262840|NCT02406209|Antiemetics|antiemetics|mesh-ancestor
110262841|NCT02406209|Autonomic Agents|autonomic agents|mesh-ancestor
110262842|NCT02406209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110262843|NCT02406209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110262844|NCT02406209|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110262845|NCT02406209|Protective Agents|protective agents|mesh-ancestor
110262847|NCT02295722|Melphalan|melphalan|mesh-list
110262848|NCT02295722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110262849|NCT02295722|Antimetabolites|antimetabolites|mesh-ancestor
110262850|NCT02295722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110262851|NCT02295722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110262852|NCT02295722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110262853|NCT02295722|Alkylating Agents|alkylating agents|mesh-ancestor
110262854|NCT02295722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110262855|NCT02295722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110262856|NCT02295722|Immunologic Factors|immunologic factors|mesh-ancestor
110262857|NCT02295722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262858|NCT02282059|Sunitinib|sunitinib|mesh-list
110262859|NCT02282059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110262860|NCT02282059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110262861|NCT02282059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110262862|NCT02282059|Growth Substances|growth substances|mesh-ancestor
110262863|NCT02282059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262864|NCT02282059|Growth Inhibitors|growth inhibitors|mesh-ancestor
110262865|NCT02282059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110262866|NCT02282059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110262867|NCT02282059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110262868|NCT01964989|Vaccines|vaccines|mesh-list
110262869|NCT01964989|Immunologic Factors|immunologic factors|mesh-ancestor
110262870|NCT01964989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262872|NCT01711554|Lenalidomide|lenalidomide|mesh-list
110262873|NCT01711554|Tretinoin|tretinoin|mesh-list
110262874|NCT01711554|Dinutuximab|dinutuximab|mesh-list
110262875|NCT01711554|Isotretinoin|isotretinoin|mesh-list
110262876|NCT01711554|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110262877|NCT01711554|Vitamins|vitamins|mesh-ancestor
110262878|NCT01711554|Micronutrients|micronutrients|mesh-ancestor
110262879|NCT01711554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262880|NCT01711554|Immunologic Factors|immunologic factors|mesh-ancestor
110262881|NCT01711554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110262882|NCT01711554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110262883|NCT01711554|Growth Substances|growth substances|mesh-ancestor
110262884|NCT01711554|Growth Inhibitors|growth inhibitors|mesh-ancestor
110262885|NCT01711554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110262886|NCT01711554|Keratolytic Agents|keratolytic agents|mesh-ancestor
110262887|NCT01711554|Dermatologic Agents|dermatologic agents|mesh-ancestor
110262888|NCT01575860|Lenalidomide|lenalidomide|mesh-list
110262889|NCT01575860|Immunologic Factors|immunologic factors|mesh-ancestor
110262890|NCT01575860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262891|NCT01575860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110262892|NCT01575860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110262893|NCT01575860|Growth Substances|growth substances|mesh-ancestor
110262894|NCT01575860|Growth Inhibitors|growth inhibitors|mesh-ancestor
110262895|NCT01575860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110262896|NCT01416831|Interleukin-2|interleukin-2|mesh-list
110262897|NCT01416831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110262898|NCT01416831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110262899|NCT01416831|Analgesics|analgesics|mesh-ancestor
110262900|NCT01416831|Sensory System Agents|sensory system agents|mesh-ancestor
110262901|NCT01416831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110262902|NCT01416831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262903|NCT01064648|Cisplatin|cisplatin|mesh-list
110262904|NCT01064648|Pemetrexed|pemetrexed|mesh-list
110262905|NCT01064648|Cediranib|cediranib|mesh-list
110262906|NCT01064648|Maleic acid|maleic acid|mesh-list
110262907|NCT01064648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110262908|NCT01064648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110262917|NCT00635700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110262918|NCT00635700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262919|NCT00635700|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110262920|NCT00635700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110262921|NCT00635700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110262922|NCT00635700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110262923|NCT00635700|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110262924|NCT00635700|Dopamine Agents|dopamine agents|mesh-ancestor
110262926|NCT00582075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110262927|NCT00582075|Alkylating Agents|alkylating agents|mesh-ancestor
110262928|NCT00582075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110262929|NCT00582075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110262930|NCT00558961|Imatinib Mesylate|imatinib mesylate|mesh-list
110262931|NCT00558961|Chlorambucil|chlorambucil|mesh-list
110262932|NCT00558961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110262933|NCT00558961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110262934|NCT00558961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110262935|NCT00558961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110262936|NCT00558961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110262937|NCT00558961|Alkylating Agents|alkylating agents|mesh-ancestor
110262947|NCT00382070|Letrozole|letrozole|mesh-list
110262948|NCT00382070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110262949|NCT00382070|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110262950|NCT00382070|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110262951|NCT00382070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110262952|NCT00382070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110262953|NCT00382070|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110262954|NCT00382070|Hormone Antagonists|hormone antagonists|mesh-ancestor
110262955|NCT00382070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110262956|NCT00382070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262957|NCT00326456|Paclitaxel|paclitaxel|mesh-list
110262958|NCT00326456|Carboplatin|carboplatin|mesh-list
110262959|NCT00326456|Doxorubicin|doxorubicin|mesh-list
110262960|NCT00326456|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110262961|NCT00326456|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110262962|NCT00326456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110262963|NCT00326456|Tubulin Modulators|tubulin modulators|mesh-ancestor
110262964|NCT00326456|Antimitotic Agents|antimitotic agents|mesh-ancestor
110262965|NCT00326456|Mitosis Modulators|mitosis modulators|mesh-ancestor
110262966|NCT00326456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110262967|NCT00326456|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110262968|NCT00326456|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110262969|NCT00326456|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110262970|NCT00326456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110262971|NCT00149942|Mycophenolic Acid|mycophenolic acid|mesh-list
110262972|NCT00149942|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110262973|NCT00149942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110262974|NCT00149942|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110262975|NCT00149942|Antitubercular Agents|antitubercular agents|mesh-ancestor
110262976|NCT00149942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110262977|NCT00149942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110262978|NCT00149942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110262979|NCT00149942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110262980|NCT00149981|Everolimus|everolimus|mesh-list
110262981|NCT00149981|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110262982|NCT00149981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110262983|NCT00149981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110262984|NCT00149981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110262985|NCT00149981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110262986|NCT00149981|Immunologic Factors|immunologic factors|mesh-ancestor
110262987|NCT00149981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262988|NCT00149981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110262989|NCT02915731|Vitamin A|vitamin a|mesh-list
110262990|NCT02915731|Vitamins|vitamins|mesh-ancestor
110262991|NCT02915731|Micronutrients|micronutrients|mesh-ancestor
110262992|NCT02915731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262993|NCT02915809|Vaccines|vaccines|mesh-list
110262994|NCT02915809|Immunologic Factors|immunologic factors|mesh-ancestor
110262995|NCT02915809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262996|NCT00405860|Mycophenolic Acid|mycophenolic acid|mesh-list
110262997|NCT00405860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110262998|NCT00405860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110262999|NCT00405860|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110263000|NCT00405860|Antitubercular Agents|antitubercular agents|mesh-ancestor
110263001|NCT00405860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110263002|NCT00405860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110263003|NCT00405860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110263004|NCT00405860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263005|NCT02914678|Fentanyl|fentanyl|mesh-list
110263006|NCT02914678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110263007|NCT02914678|Narcotics|narcotics|mesh-ancestor
110263008|NCT02914678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110263009|NCT02914678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110263010|NCT02914678|Analgesics|analgesics|mesh-ancestor
110263011|NCT02914678|Sensory System Agents|sensory system agents|mesh-ancestor
110263012|NCT02914678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110263013|NCT02914678|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110263014|NCT02914678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110263015|NCT02914678|Anesthetics, General|anesthetics, general|mesh-ancestor
110263016|NCT02914678|Anesthetics|anesthetics|mesh-ancestor
110263017|NCT00405977|Magnesium Sulfate|magnesium sulfate|mesh-list
110263018|NCT00405977|Analgesics|analgesics|mesh-ancestor
110263019|NCT00405977|Sensory System Agents|sensory system agents|mesh-ancestor
110263020|NCT00405977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110263021|NCT00405977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110263022|NCT00405977|Anesthetics|anesthetics|mesh-ancestor
110263023|NCT00405977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110263024|NCT00405977|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110263025|NCT00405977|Anticonvulsants|anticonvulsants|mesh-ancestor
110263026|NCT00405977|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110263027|NCT00405977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110263028|NCT00405977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263029|NCT00405977|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110263030|NCT00405977|Tocolytic Agents|tocolytic agents|mesh-ancestor
110263031|NCT00405977|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110263032|NCT00150020|Mycophenolic Acid|mycophenolic acid|mesh-list
110263033|NCT00150020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110263034|NCT00150020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110263035|NCT00150020|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110263036|NCT00150020|Antitubercular Agents|antitubercular agents|mesh-ancestor
110263037|NCT00150020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110263038|NCT00150020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110263039|NCT00150020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110263040|NCT00150020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263041|NCT02914015|Morphine|morphine|mesh-list
110263042|NCT02914015|Ropivacaine|ropivacaine|mesh-list
110263043|NCT02914015|Anesthetics, Local|anesthetics, local|mesh-list
110263044|NCT02914015|Anesthetics|anesthetics|mesh-list
110263045|NCT02914015|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110263046|NCT02914015|Narcotics|narcotics|mesh-ancestor
110263047|NCT02914015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110263048|NCT02914015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110263049|NCT02914015|Analgesics|analgesics|mesh-ancestor
110263050|NCT02914015|Sensory System Agents|sensory system agents|mesh-ancestor
110263051|NCT02914015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110263052|NCT00171093|Valsartan|valsartan|mesh-list
110263053|NCT00171093|Simvastatin|simvastatin|mesh-list
110263054|NCT00171093|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110263055|NCT00171093|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110263056|NCT00171093|Antimetabolites|antimetabolites|mesh-ancestor
110263057|NCT00171093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263058|NCT00171093|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110263059|NCT00171093|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110263060|NCT00171093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110263061|NCT00171093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110263062|NCT00171093|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110263063|NCT00171093|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110263065|NCT02914054|Prednisone|prednisone|mesh-list
110263066|NCT02914054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110263067|NCT02914054|Antiemetics|antiemetics|mesh-ancestor
110263068|NCT02914054|Autonomic Agents|autonomic agents|mesh-ancestor
110263069|NCT02914054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110263070|NCT02914054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110263071|NCT02914054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110263072|NCT02914054|Glucocorticoids|glucocorticoids|mesh-ancestor
110263073|NCT02914054|Hormones|hormones|mesh-ancestor
110263074|NCT02914054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110263075|NCT02914054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110263076|NCT02914054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110263077|NCT00150059|Pimecrolimus|pimecrolimus|mesh-list
110263078|NCT00150059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110263079|NCT00150059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110263080|NCT00150059|Analgesics|analgesics|mesh-ancestor
110263081|NCT00150059|Sensory System Agents|sensory system agents|mesh-ancestor
110263082|NCT00150059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110263083|NCT00150059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110263084|NCT00150059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110263085|NCT00150059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110263086|NCT00150059|Dermatologic Agents|dermatologic agents|mesh-ancestor
110263087|NCT00150059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110263088|NCT00150059|Immunologic Factors|immunologic factors|mesh-ancestor
110263089|NCT00150059|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110263090|NCT00150059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110272394|NCT05427084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110263091|NCT00150059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263092|NCT00171132|Atenolol|atenolol|mesh-list
110263093|NCT00171132|Valsartan|valsartan|mesh-list
110263094|NCT00171132|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110263095|NCT00171132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110263096|NCT00171132|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110263097|NCT00171132|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110263098|NCT00171132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263099|NCT00171132|Diuretics|diuretics|mesh-ancestor
110263100|NCT00171132|Natriuretic Agents|natriuretic agents|mesh-ancestor
110263101|NCT00171132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110263102|NCT00171132|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110263103|NCT00171132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110263104|NCT00171132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110263105|NCT00171132|Sympatholytics|sympatholytics|mesh-ancestor
110263106|NCT00171132|Autonomic Agents|autonomic agents|mesh-ancestor
110263107|NCT00171132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110263108|NCT00171132|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110263109|NCT00171132|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110263110|NCT00171132|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110263111|NCT00171132|Adrenergic Agents|adrenergic agents|mesh-ancestor
110263112|NCT00171132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110263113|NCT02913859|Androgen Antagonists|androgen antagonists|mesh-list
110263114|NCT02913859|Hormone Antagonists|hormone antagonists|mesh-ancestor
110263115|NCT02913859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110263116|NCT02913859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110263118|NCT00150137|Antithyroid Agents|antithyroid agents|mesh-ancestor
110263119|NCT00150137|Hormone Antagonists|hormone antagonists|mesh-ancestor
110263120|NCT00150137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110263121|NCT00150137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110263123|NCT00150215|Antiemetics|antiemetics|mesh-ancestor
110263124|NCT00150215|Autonomic Agents|autonomic agents|mesh-ancestor
110263125|NCT00150215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110263126|NCT00150215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110263127|NCT00150215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110263128|NCT00150215|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110263129|NCT00150215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110263130|NCT00150215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110263131|NCT00150215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110263132|NCT00150215|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110263133|NCT00150215|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110263134|NCT00150215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110263135|NCT00150215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263136|NCT00150215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110263137|NCT00150215|Serotonin Agents|serotonin agents|mesh-ancestor
110263138|NCT00171171|Deferasirox|deferasirox|mesh-list
110263139|NCT00171171|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110263140|NCT00171171|Chelating Agents|chelating agents|mesh-ancestor
110263141|NCT00171171|Sequestering Agents|sequestering agents|mesh-ancestor
110263142|NCT00171171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263144|NCT02913430|Fulvestrant|fulvestrant|mesh-list
110263145|NCT02913430|Palbociclib|palbociclib|mesh-list
110263146|NCT02913430|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110263147|NCT02913430|Hormone Antagonists|hormone antagonists|mesh-ancestor
110263148|NCT02913430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110263149|NCT02913430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110263150|NCT02913430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110263151|NCT02913430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110263152|NCT02913430|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110263153|NCT02913430|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110263154|NCT02913430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110263155|NCT02913430|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110263156|NCT02913430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110263157|NCT02913430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110263158|NCT02913430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263159|NCT02913469|Morphine|morphine|mesh-list
110263160|NCT02913469|Metoclopramide|metoclopramide|mesh-list
110263161|NCT02913469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110263162|NCT02913469|Narcotics|narcotics|mesh-ancestor
110263163|NCT02913469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110263164|NCT02913469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110263165|NCT02913469|Analgesics|analgesics|mesh-ancestor
110263166|NCT02913469|Sensory System Agents|sensory system agents|mesh-ancestor
110263167|NCT02913469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110263168|NCT02913469|Antiemetics|antiemetics|mesh-ancestor
110263169|NCT02913469|Autonomic Agents|autonomic agents|mesh-ancestor
110263170|NCT02913469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110263171|NCT02913469|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110263172|NCT02913469|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110263173|NCT02913469|Dopamine Agents|dopamine agents|mesh-ancestor
110263174|NCT02913469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110263175|NCT02913469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263176|NCT00150254|Varenicline|varenicline|mesh-list
110263177|NCT00150254|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110263178|NCT00150254|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110263179|NCT00150254|Cholinergic Agents|cholinergic agents|mesh-ancestor
110263180|NCT00150254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110263181|NCT00150254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263182|NCT00150254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110263183|NCT02913508|Vedolizumab|vedolizumab|mesh-list
110263184|NCT02913508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110263185|NCT02913157|Hydroxychloroquine|hydroxychloroquine|mesh-list
110263186|NCT02913157|Antimalarials|antimalarials|mesh-ancestor
110263187|NCT02913157|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110263188|NCT02913157|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110263189|NCT02913157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110263190|NCT02913157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110263191|NCT02913157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263192|NCT02913157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110263194|NCT00150293|Analgesics|analgesics|mesh-ancestor
110263195|NCT00150293|Sensory System Agents|sensory system agents|mesh-ancestor
110263196|NCT00150293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110263197|NCT00150293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110263198|NCT00150293|Anticonvulsants|anticonvulsants|mesh-ancestor
110263199|NCT00150293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110263200|NCT00150293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110263201|NCT00150293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263202|NCT00150293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110263203|NCT00150293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110263204|NCT00150293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110272429|NCT05365451|Metformin|metformin|mesh-list
110263205|NCT00150293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110263207|NCT02913118|Amoxicillin|amoxicillin|mesh-list
110263208|NCT02913118|Azithromycin|azithromycin|mesh-list
110263209|NCT02913118|Doxycycline|doxycycline|mesh-list
110263210|NCT02913118|Minocycline|minocycline|mesh-list
110263211|NCT02913118|Cephalosporins|cephalosporins|mesh-list
110263212|NCT02913118|Fluoroquinolones|fluoroquinolones|mesh-list
110263213|NCT02913118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110263214|NCT02913118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110263215|NCT02913118|Antimalarials|antimalarials|mesh-ancestor
110263216|NCT02913118|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110263217|NCT02913118|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110263218|NCT02913118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110263219|NCT02913118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110263220|NCT02913118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263222|NCT00150332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110263223|NCT00150332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110263224|NCT00150332|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110263225|NCT00150332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110263226|NCT00150332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263227|NCT00150371|Atorvastatin|atorvastatin|mesh-list
110263228|NCT00150371|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110263229|NCT00150371|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110263230|NCT00150371|Antimetabolites|antimetabolites|mesh-ancestor
110263231|NCT00150371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263232|NCT00150371|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110263233|NCT00150371|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110263234|NCT00150371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110263235|NCT02912494|Darbepoetin alfa|darbepoetin alfa|mesh-list
110263237|NCT00150410|Insulin|insulin|mesh-list
110263238|NCT00150410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110263239|NCT00150410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110263240|NCT00171288|Ezetimibe|ezetimibe|mesh-list
110263241|NCT00171288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110263242|NCT00171288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110263244|NCT00171288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263245|NCT00171288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110263246|NCT00150449|Pregabalin|pregabalin|mesh-list
110263247|NCT00150449|Analgesics|analgesics|mesh-ancestor
110263248|NCT00150449|Sensory System Agents|sensory system agents|mesh-ancestor
110263249|NCT00150449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110263250|NCT00150449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110263251|NCT00150449|Anticonvulsants|anticonvulsants|mesh-ancestor
110263252|NCT00150449|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110263253|NCT00150449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110263254|NCT00150449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263255|NCT00150449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110263257|NCT00150449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110263258|NCT00150449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110263259|NCT00150449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110263260|NCT02912182|Prednisolone|prednisolone|mesh-list
110263261|NCT02912182|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110263262|NCT02912182|Methylprednisolone|methylprednisolone|mesh-list
110263263|NCT02912182|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110263264|NCT02912182|Prednisolone acetate|prednisolone acetate|mesh-list
110263265|NCT02912182|Betamethasone|betamethasone|mesh-list
110263266|NCT02912182|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110263267|NCT02912182|Prednisolone phosphate|prednisolone phosphate|mesh-list
110263268|NCT02912182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110263269|NCT02912182|Glucocorticoids|glucocorticoids|mesh-ancestor
110263270|NCT02912182|Hormones|hormones|mesh-ancestor
110263271|NCT02912182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110263272|NCT02912182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110263273|NCT02912182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110263274|NCT02912182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110263276|NCT02912182|Autonomic Agents|autonomic agents|mesh-ancestor
110263277|NCT02912182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110263278|NCT02912182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110263279|NCT02912182|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110263280|NCT02912182|Protective Agents|protective agents|mesh-ancestor
110263281|NCT02912182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110263282|NCT02912182|Respiratory System Agents|respiratory system agents|mesh-ancestor
110263283|NCT02912026|Olorofim|olorofim|mesh-list
110263284|NCT02912026|Antifungal Agents|antifungal agents|mesh-ancestor
110263285|NCT02912026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110263286|NCT02911870|Moxifloxacin|moxifloxacin|mesh-list
110263287|NCT02911870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110263288|NCT02911870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110263289|NCT02911870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110263290|NCT02911870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110263291|NCT02911870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110263292|NCT02911870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263293|NCT02911870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110263294|NCT02843230|Bevacizumab|bevacizumab|mesh-list
110263295|NCT02843230|Temozolomide|temozolomide|mesh-list
110263296|NCT02843230|Lomustine|lomustine|mesh-list
110263297|NCT02843230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110263298|NCT02843230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110263299|NCT02843230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110263300|NCT02843230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110263301|NCT02843230|Growth Substances|growth substances|mesh-ancestor
110263302|NCT02843230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110263303|NCT02843230|Growth Inhibitors|growth inhibitors|mesh-ancestor
110263304|NCT02843230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110263305|NCT02843230|Alkylating Agents|alkylating agents|mesh-ancestor
110263306|NCT02843230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263307|NCT02712814|Estrogens|estrogens|mesh-list
110263308|NCT02712814|Hormones|hormones|mesh-ancestor
110263309|NCT02712814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110263310|NCT02712814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110263311|NCT00150527|Dexamethasone|dexamethasone|mesh-list
110263312|NCT00150527|Citalopram|citalopram|mesh-list
110263313|NCT00150527|Escitalopram|escitalopram|mesh-list
110263314|NCT00150527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110263315|NCT00150527|Antiemetics|antiemetics|mesh-ancestor
110263316|NCT00150527|Autonomic Agents|autonomic agents|mesh-ancestor
110263317|NCT00150527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110263318|NCT00150527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110263319|NCT00150527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110263320|NCT00150527|Glucocorticoids|glucocorticoids|mesh-ancestor
110263321|NCT00150527|Hormones|hormones|mesh-ancestor
110263322|NCT00150527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110263323|NCT00150527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110263324|NCT00150527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110263325|NCT00150527|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110263326|NCT00150527|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110263327|NCT00150527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110263328|NCT00150527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263329|NCT00150527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110263330|NCT00150527|Serotonin Agents|serotonin agents|mesh-ancestor
110263331|NCT00150527|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110263332|NCT00150527|Antidepressive Agents|antidepressive agents|mesh-ancestor
110263333|NCT00150527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110263334|NCT00171327|Valsartan|valsartan|mesh-list
110263335|NCT00171327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110263336|NCT00171327|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110263337|NCT00171327|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110263338|NCT00171327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263339|NCT02911597|Naltrexone|naltrexone|mesh-list
110263340|NCT02911597|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110263341|NCT02911597|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110263342|NCT02911597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110263343|NCT02911597|Sensory System Agents|sensory system agents|mesh-ancestor
110263344|NCT02911597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110263345|NCT02911480|Oxytocin|oxytocin|mesh-list
110263346|NCT02911480|Oxytocics|oxytocics|mesh-ancestor
110263347|NCT02911480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110263348|NCT02911480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110263349|NCT00171366|Amlodipine|amlodipine|mesh-list
110263350|NCT00171366|Benazepril|benazepril|mesh-list
110263351|NCT00171366|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110263352|NCT00171366|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110263353|NCT00171366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110263354|NCT00171366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263355|NCT00171366|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110263356|NCT00171366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110263358|NCT00171366|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110263359|NCT00171366|Protease Inhibitors|protease inhibitors|mesh-ancestor
110263360|NCT00171366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110263361|NCT00150605|Carbamazepine|carbamazepine|mesh-list
110263362|NCT00150605|Anticonvulsants|anticonvulsants|mesh-ancestor
110263363|NCT00150605|Antimanic Agents|antimanic agents|mesh-ancestor
110263364|NCT00150605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110263365|NCT00150605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110263366|NCT00150605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110263367|NCT00150605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110263368|NCT00150605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110263369|NCT00150605|Analgesics|analgesics|mesh-ancestor
110263370|NCT00150605|Sensory System Agents|sensory system agents|mesh-ancestor
110263371|NCT00150605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110263372|NCT00150605|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110263373|NCT00150605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110263374|NCT00150605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263375|NCT00150605|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110263376|NCT00150605|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110263377|NCT02910778|Ticagrelor|ticagrelor|mesh-list
110263378|NCT02910778|Atorvastatin|atorvastatin|mesh-list
110263379|NCT02910778|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110263380|NCT02910778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110263381|NCT02910778|Antimetabolites|antimetabolites|mesh-ancestor
110263382|NCT02910778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263383|NCT02910778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110263384|NCT02910778|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110263385|NCT02910778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110263386|NCT02910778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110263387|NCT02910778|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110263388|NCT02910778|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110263389|NCT02910778|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110263390|NCT02910778|Purinergic Agents|purinergic agents|mesh-ancestor
110263391|NCT02910778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110263392|NCT02910778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110263393|NCT00164112|Azithromycin|azithromycin|mesh-list
110263394|NCT00164112|Levofloxacin|levofloxacin|mesh-list
110263396|NCT00164112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110263397|NCT00164112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110263398|NCT00164112|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110263399|NCT00164112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110263400|NCT00164112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110263401|NCT00164112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110263402|NCT00164112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263403|NCT00164112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110263404|NCT00164112|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110263405|NCT00164112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110263406|NCT02910817|Metformin|metformin|mesh-list
110263407|NCT02910817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110263408|NCT02910817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110263409|NCT00150722|Atorvastatin|atorvastatin|mesh-list
110263410|NCT00150722|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110263411|NCT00150722|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110263412|NCT00150722|Antimetabolites|antimetabolites|mesh-ancestor
110263413|NCT00150722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263414|NCT00150722|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110263415|NCT00150722|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110263416|NCT00150722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110263417|NCT00150761|Levocetirizine|levocetirizine|mesh-list
110263418|NCT00150761|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110263419|NCT00150761|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110263420|NCT00150761|Histamine Antagonists|histamine antagonists|mesh-ancestor
110263422|NCT00150761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110263423|NCT00150761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263424|NCT00150761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110263425|NCT00171483|Tegaserod|tegaserod|mesh-list
110263426|NCT00171483|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110263427|NCT00171483|Serotonin Agents|serotonin agents|mesh-ancestor
110263428|NCT00171483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110263429|NCT00171483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263430|NCT00171483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110263431|NCT03777904|Iron|iron|mesh-list
110263432|NCT03777904|Trace Elements|trace elements|mesh-ancestor
110263433|NCT03777904|Micronutrients|micronutrients|mesh-ancestor
110263434|NCT03777904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110263435|NCT00150839|Mirtazapine|mirtazapine|mesh-list
110263436|NCT00150839|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110368714|NCT00558090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110263437|NCT00150839|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110263438|NCT00150839|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110263439|NCT00150839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110263440|NCT00150839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263441|NCT00150839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110263442|NCT00150839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110263443|NCT00150839|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110263444|NCT00150839|Antidepressive Agents|antidepressive agents|mesh-ancestor
110263445|NCT00150839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110263446|NCT00150839|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110263447|NCT00150839|Histamine Antagonists|histamine antagonists|mesh-ancestor
110263448|NCT00150839|Histamine Agents|histamine agents|mesh-ancestor
110263449|NCT00150839|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110263450|NCT00150839|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110263451|NCT00150839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110263452|NCT00150839|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110263453|NCT00150839|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110263454|NCT00150839|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110263455|NCT00150839|Adrenergic Agents|adrenergic agents|mesh-ancestor
110263456|NCT00150839|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110263457|NCT00150839|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110263458|NCT00150839|Serotonin Agents|serotonin agents|mesh-ancestor
110263459|NCT00150839|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110263460|NCT03782740|Melatonin|melatonin|mesh-list
110263461|NCT03782740|Antioxidants|antioxidants|mesh-ancestor
110263462|NCT03782740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263463|NCT03782740|Protective Agents|protective agents|mesh-ancestor
110263464|NCT03782740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110263465|NCT03782740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110263466|NCT00532168|Ritonavir|ritonavir|mesh-list
110263467|NCT00532168|Lopinavir|lopinavir|mesh-list
110263468|NCT00532168|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110263470|NCT00532168|Emtricitabine|emtricitabine|mesh-list
110263471|NCT00532168|Efavirenz|efavirenz|mesh-list
110263472|NCT00532168|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110263473|NCT00532168|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110263474|NCT00532168|Protease Inhibitors|protease inhibitors|mesh-ancestor
110263475|NCT00532168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110263476|NCT00532168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263477|NCT00532168|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110263478|NCT00532168|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110263479|NCT00532168|Antiviral Agents|antiviral agents|mesh-ancestor
110263480|NCT00532168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110263481|NCT00532168|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110263482|NCT00532168|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110263483|NCT00532168|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110263484|NCT00532168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110263485|NCT00532168|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110263486|NCT00532168|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110263487|NCT00532168|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110263488|NCT00532168|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110263489|NCT00532168|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110263491|NCT00532207|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110263492|NCT00532207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110263493|NCT00532207|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110263494|NCT04723836|Riboflavin|riboflavin|mesh-list
110263495|NCT04723836|Vitamins|vitamins|mesh-ancestor
110263496|NCT04723836|Micronutrients|micronutrients|mesh-ancestor
110263498|NCT04723836|Vitamin B Complex|vitamin b complex|mesh-ancestor
110263499|NCT04723836|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110263500|NCT04723836|Dermatologic Agents|dermatologic agents|mesh-ancestor
110263501|NCT00150995|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
110263502|NCT00150995|Chelating Agents|chelating agents|mesh-ancestor
110263503|NCT00150995|Sequestering Agents|sequestering agents|mesh-ancestor
110263504|NCT00150995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263505|NCT00150995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110263506|NCT00150995|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110263507|NCT00150995|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110263508|NCT00150995|Growth Substances|growth substances|mesh-ancestor
110263509|NCT00150995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110263510|NCT00150995|Growth Inhibitors|growth inhibitors|mesh-ancestor
110263511|NCT00150995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110263512|NCT00532246|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
110263513|NCT00532246|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110263514|NCT00532246|Hormone Antagonists|hormone antagonists|mesh-ancestor
110263515|NCT00532246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110263516|NCT00532246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110263517|NCT00532246|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110263518|NCT00532246|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110263519|NCT00532246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110263520|NCT00532285|Paclitaxel|paclitaxel|mesh-list
110263521|NCT00532285|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110263522|NCT00532285|Gemcitabine|gemcitabine|mesh-list
110263523|NCT00532285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110263525|NCT00532285|Tubulin Modulators|tubulin modulators|mesh-ancestor
110263526|NCT00532285|Antimitotic Agents|antimitotic agents|mesh-ancestor
110263527|NCT00532285|Mitosis Modulators|mitosis modulators|mesh-ancestor
110263528|NCT00532285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263529|NCT00532285|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110263531|NCT00151034|Paclitaxel|paclitaxel|mesh-list
110263532|NCT00151034|Carboplatin|carboplatin|mesh-list
110263533|NCT00151034|Gemcitabine|gemcitabine|mesh-list
110263534|NCT00151034|Trastuzumab|trastuzumab|mesh-list
110263535|NCT00151034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110263536|NCT00151034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110263537|NCT00151034|Tubulin Modulators|tubulin modulators|mesh-ancestor
110263538|NCT00151034|Antimitotic Agents|antimitotic agents|mesh-ancestor
110263539|NCT00151034|Mitosis Modulators|mitosis modulators|mesh-ancestor
110263540|NCT00151034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263541|NCT00151034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110263542|NCT00151034|Antimetabolites|antimetabolites|mesh-ancestor
110263543|NCT00151034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110263544|NCT02817451|Vaccines|vaccines|mesh-list
110263545|NCT02817451|Immunologic Factors|immunologic factors|mesh-ancestor
110263546|NCT02817451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110263547|NCT00171522|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
110263548|NCT00171522|Tegaserod|tegaserod|mesh-list
110263549|NCT00171522|Laxatives|laxatives|mesh-ancestor
110263550|NCT00171522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110263551|NCT00171522|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110263552|NCT00171522|Serotonin Agents|serotonin agents|mesh-ancestor
110263553|NCT00171522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110263554|NCT00171522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263555|NCT00171522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110263556|NCT02716012|Sorafenib|sorafenib|mesh-list
110263557|NCT02716012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110263558|NCT02716012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110263559|NCT02716012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110263560|NCT02716012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263561|NCT00151073|Zoledronic Acid|zoledronic acid|mesh-list
110263562|NCT00151073|Docetaxel|docetaxel|mesh-list
110263563|NCT00151073|Estramustine|estramustine|mesh-list
110263564|NCT00151073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110263565|NCT00151073|Tubulin Modulators|tubulin modulators|mesh-ancestor
110263566|NCT00151073|Antimitotic Agents|antimitotic agents|mesh-ancestor
110263567|NCT00151073|Mitosis Modulators|mitosis modulators|mesh-ancestor
110263568|NCT00151073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263569|NCT00151073|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110263570|NCT00151073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110263571|NCT00151073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110263572|NCT00151073|Alkylating Agents|alkylating agents|mesh-ancestor
110263573|NCT00151073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110263574|NCT00171561|Valsartan|valsartan|mesh-list
110263575|NCT00171561|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110263576|NCT00171561|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110263577|NCT00171561|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110263578|NCT00171561|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110263579|NCT00171561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263580|NCT00171561|Diuretics|diuretics|mesh-ancestor
110263581|NCT00171561|Natriuretic Agents|natriuretic agents|mesh-ancestor
110263582|NCT00171561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110263583|NCT00171561|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110263584|NCT00171561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110263586|NCT00151112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110263587|NCT00151112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110263588|NCT00532324|Chlorhexidine|chlorhexidine|mesh-list
110263589|NCT00532324|Mupirocin|mupirocin|mesh-list
110263590|NCT00532324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110263591|NCT00532324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110263592|NCT00532324|Disinfectants|disinfectants|mesh-ancestor
110263593|NCT00532324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110263594|NCT00532324|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110263595|NCT00532324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110263596|NCT00532324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263597|NCT00171600|Valsartan|valsartan|mesh-list
110263599|NCT00171600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110263600|NCT00171600|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110263601|NCT00171600|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110263602|NCT00171600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263603|NCT00171600|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110263604|NCT00171600|Protease Inhibitors|protease inhibitors|mesh-ancestor
110263605|NCT00171600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110263606|NCT00171600|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110263607|NCT00171600|Protective Agents|protective agents|mesh-ancestor
110263608|NCT00171600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110263610|NCT05467384|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110263611|NCT05467384|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110263612|NCT05467384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110263613|NCT05467384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263614|NCT05467384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110263615|NCT05467384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110263616|NCT05467384|Vasodilator Agents|vasodilator agents|mesh-ancestor
110263618|NCT05467189|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110263619|NCT05467189|Busulfan|busulfan|mesh-list
110263620|NCT05467189|Lapatinib|lapatinib|mesh-list
110263621|NCT05467189|Afatinib|afatinib|mesh-list
110263622|NCT05467189|Crizotinib|crizotinib|mesh-list
110263623|NCT05467189|Ceritinib|ceritinib|mesh-list
110263624|NCT05467189|Antineoplastic Agents|antineoplastic agents|mesh-list
110263625|NCT05467189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110263626|NCT05467189|Tubulin Modulators|tubulin modulators|mesh-ancestor
110263627|NCT05467189|Antimitotic Agents|antimitotic agents|mesh-ancestor
110263628|NCT05467189|Mitosis Modulators|mitosis modulators|mesh-ancestor
110263629|NCT05467189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263630|NCT05467189|Alkylating Agents|alkylating agents|mesh-ancestor
110263631|NCT05467189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110263632|NCT05467189|Immunologic Factors|immunologic factors|mesh-ancestor
110263633|NCT05467189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110263634|NCT05467189|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110263635|NCT05467189|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110263636|NCT05467189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110263637|NCT05467189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110263638|NCT00171639|Zoledronic Acid|zoledronic acid|mesh-list
110263639|NCT00171639|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110263640|NCT00171639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110263641|NCT05466604|Dexamethasone|dexamethasone|mesh-list
110263642|NCT05466604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110263643|NCT05466604|Antiemetics|antiemetics|mesh-ancestor
110263644|NCT05466604|Autonomic Agents|autonomic agents|mesh-ancestor
110263645|NCT05466604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110263646|NCT05466604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110263647|NCT05466604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110263648|NCT05466604|Glucocorticoids|glucocorticoids|mesh-ancestor
110263649|NCT05466604|Hormones|hormones|mesh-ancestor
110263650|NCT05466604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110263651|NCT05466604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110263652|NCT05466604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110263653|NCT04723875|Paclitaxel|paclitaxel|mesh-list
110263654|NCT04723875|Docetaxel|docetaxel|mesh-list
110263655|NCT04723875|Carboplatin|carboplatin|mesh-list
110263656|NCT04723875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110263657|NCT04723875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110263658|NCT04723875|Tubulin Modulators|tubulin modulators|mesh-ancestor
110263659|NCT04723875|Antimitotic Agents|antimitotic agents|mesh-ancestor
110263660|NCT04723875|Mitosis Modulators|mitosis modulators|mesh-ancestor
110263661|NCT04723875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263665|NCT05466019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110263666|NCT05466019|Tubulin Modulators|tubulin modulators|mesh-ancestor
110263667|NCT05466019|Antimitotic Agents|antimitotic agents|mesh-ancestor
110263668|NCT05466019|Mitosis Modulators|mitosis modulators|mesh-ancestor
110263669|NCT05466019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263671|NCT05466019|Protective Agents|protective agents|mesh-ancestor
110263672|NCT05466019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110263673|NCT05466019|Vitamin B Complex|vitamin b complex|mesh-ancestor
110263674|NCT05466019|Vitamins|vitamins|mesh-ancestor
110263675|NCT05466019|Micronutrients|micronutrients|mesh-ancestor
110263676|NCT05465902|Vaccines|vaccines|mesh-list
110263677|NCT05465902|Immunologic Factors|immunologic factors|mesh-ancestor
110263678|NCT05465902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110263679|NCT00151346|Fentanyl|fentanyl|mesh-list
110263680|NCT00151346|Bupivacaine|bupivacaine|mesh-list
110263681|NCT00151346|Anesthetics, Local|anesthetics, local|mesh-ancestor
110263682|NCT00151346|Anesthetics|anesthetics|mesh-ancestor
110263683|NCT00151346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110263684|NCT00151346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110263685|NCT00151346|Sensory System Agents|sensory system agents|mesh-ancestor
110263686|NCT00151346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110263687|NCT00151346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110263688|NCT00151346|Narcotics|narcotics|mesh-ancestor
110263689|NCT00151346|Analgesics|analgesics|mesh-ancestor
110263690|NCT00151346|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110263691|NCT00151346|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110263692|NCT00151346|Anesthetics, General|anesthetics, general|mesh-ancestor
110263693|NCT00164424|Acyclovir|acyclovir|mesh-list
110263694|NCT00164424|Antiviral Agents|antiviral agents|mesh-ancestor
110263695|NCT00164424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110263696|NCT00532519|Citalopram|citalopram|mesh-list
110263697|NCT00532519|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110263698|NCT00532519|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110263699|NCT00532519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110263700|NCT00532519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263701|NCT00532519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110263702|NCT00532519|Serotonin Agents|serotonin agents|mesh-ancestor
110263703|NCT00532519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110263704|NCT00532519|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110263705|NCT00532519|Antidepressive Agents|antidepressive agents|mesh-ancestor
110263706|NCT00532519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110263708|NCT00171678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110263709|NCT00171678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110263710|NCT00171678|Analgesics|analgesics|mesh-ancestor
110263711|NCT00171678|Sensory System Agents|sensory system agents|mesh-ancestor
110263712|NCT00171678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110272515|NCT05194293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110263713|NCT00171678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110263714|NCT00171678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110263715|NCT00171678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110263716|NCT00171678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110263717|NCT00171678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110263718|NCT00171678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263719|NCT00151463|Sildenafil Citrate|sildenafil citrate|mesh-list
110263720|NCT00151463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263721|NCT00151463|Vasodilator Agents|vasodilator agents|mesh-ancestor
110263722|NCT00151463|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110263723|NCT00151463|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110263724|NCT00151463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110263725|NCT00151463|Urological Agents|urological agents|mesh-ancestor
110263727|NCT00171717|Cyclosporins|cyclosporins|mesh-list
110263728|NCT00171717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110263729|NCT00171717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263730|NCT00171717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110263731|NCT00171717|Immunologic Factors|immunologic factors|mesh-ancestor
110263732|NCT00171717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110263733|NCT00171717|Antifungal Agents|antifungal agents|mesh-ancestor
110263734|NCT00171717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110263735|NCT00171717|Dermatologic Agents|dermatologic agents|mesh-ancestor
110263736|NCT00171717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110263737|NCT00171717|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110263739|NCT00151502|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110263740|NCT00151502|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110263741|NCT00151502|Antimetabolites|antimetabolites|mesh-ancestor
110263742|NCT00151502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263743|NCT00151502|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110263744|NCT00151502|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110263745|NCT00151502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110263746|NCT00164463|Moxifloxacin|moxifloxacin|mesh-list
110263747|NCT00164463|Isoniazid|isoniazid|mesh-list
110263748|NCT00164463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110263749|NCT00164463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110263750|NCT00164463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110263751|NCT00164463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110263752|NCT00164463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110263753|NCT00164463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263754|NCT00164463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110263755|NCT00164463|Antitubercular Agents|antitubercular agents|mesh-ancestor
110263756|NCT00164463|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110263757|NCT00164463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110263758|NCT00164463|Antimetabolites|antimetabolites|mesh-ancestor
110263759|NCT00164463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110263760|NCT00171756|Atenolol|atenolol|mesh-list
110263761|NCT00171756|Valsartan|valsartan|mesh-list
110263762|NCT00171756|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110263763|NCT00171756|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110263764|NCT00171756|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110263765|NCT00171756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263766|NCT00171756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110263767|NCT00171756|Sympatholytics|sympatholytics|mesh-ancestor
110263768|NCT00171756|Autonomic Agents|autonomic agents|mesh-ancestor
110263769|NCT00171756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110263770|NCT00171756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110263771|NCT00171756|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110263772|NCT00171756|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110263773|NCT00171756|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110263774|NCT00171756|Adrenergic Agents|adrenergic agents|mesh-ancestor
110263775|NCT00171756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110263776|NCT00171795|Rivastigmine|rivastigmine|mesh-list
110263777|NCT00171795|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110263778|NCT00171795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110263779|NCT00171795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263780|NCT00171795|Cholinergic Agents|cholinergic agents|mesh-ancestor
110263781|NCT00171795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110263782|NCT00171795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110263783|NCT00171795|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110263784|NCT00171795|Protective Agents|protective agents|mesh-ancestor
110263785|NCT00151541|Dapsone|dapsone|mesh-list
110263786|NCT00151541|Adapalene|adapalene|mesh-list
110263787|NCT00151541|Benzoyl Peroxide|benzoyl peroxide|mesh-list
110263788|NCT00151541|Dermatologic Agents|dermatologic agents|mesh-ancestor
110263789|NCT00151541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110263790|NCT00151541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110263791|NCT00151541|Analgesics|analgesics|mesh-ancestor
110263794|NCT00151541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110263795|NCT00151541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110263796|NCT00151541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110263797|NCT00151541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110263798|NCT00151541|Antimalarials|antimalarials|mesh-ancestor
110263799|NCT00151541|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110263800|NCT00151541|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110263801|NCT00151541|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110263802|NCT00151541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110263803|NCT00151541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263804|NCT00151541|Leprostatic Agents|leprostatic agents|mesh-ancestor
110263805|NCT00151541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110263806|NCT00151580|Ribavirin|ribavirin|mesh-list
110263807|NCT00151580|Antimetabolites|antimetabolites|mesh-ancestor
110263808|NCT00151580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263809|NCT00151580|Antiviral Agents|antiviral agents|mesh-ancestor
110263810|NCT00151580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110263811|NCT00171912|Imatinib Mesylate|imatinib mesylate|mesh-list
110263812|NCT00171912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110263813|NCT00171912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110263814|NCT00171912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110263815|NCT00171912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263817|NCT00151619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110263818|NCT00151619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110263819|NCT00151619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110263820|NCT00151619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263821|NCT00151619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110263822|NCT00151619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110263823|NCT00151619|Vasodilator Agents|vasodilator agents|mesh-ancestor
110263824|NCT00532675|Lenalidomide|lenalidomide|mesh-list
110263825|NCT00532675|Panobinostat|panobinostat|mesh-list
110263826|NCT00532675|Immunologic Factors|immunologic factors|mesh-ancestor
110263827|NCT00532675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110263828|NCT00532675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110263829|NCT00532675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110263830|NCT00532675|Growth Substances|growth substances|mesh-ancestor
110263831|NCT00532675|Growth Inhibitors|growth inhibitors|mesh-ancestor
110263832|NCT00532675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110263833|NCT00532675|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110263834|NCT00532675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110263835|NCT00532675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263836|NCT05308030|Aspirin|aspirin|mesh-list
110263837|NCT05308030|Rivaroxaban|rivaroxaban|mesh-list
110263838|NCT05308030|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110263839|NCT05308030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110263841|NCT05308030|Sensory System Agents|sensory system agents|mesh-ancestor
110263842|NCT05308030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110263843|NCT05308030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110263844|NCT05308030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110263845|NCT05308030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110263846|NCT05308030|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110263847|NCT05308030|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110263848|NCT05308030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263849|NCT05308030|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110263850|NCT05308030|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110263851|NCT05308030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110263852|NCT05308030|Antipyretics|antipyretics|mesh-ancestor
110263853|NCT05308030|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110263862|NCT05293600|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110263863|NCT05293600|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110263864|NCT05293600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110263865|NCT05293600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263866|NCT05293600|Adrenergic Agents|adrenergic agents|mesh-ancestor
110263867|NCT05293600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110263868|NCT05293600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110263869|NCT05293600|Anticonvulsants|anticonvulsants|mesh-ancestor
110263870|NCT05293600|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110263871|NCT05293600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110263872|NCT05293600|Diuretics|diuretics|mesh-ancestor
110263873|NCT05293600|Natriuretic Agents|natriuretic agents|mesh-ancestor
110263874|NCT05293600|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110263875|NCT05293600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110263876|NCT05293600|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110263877|NCT05293600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110263878|NCT05293600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110263879|NCT05293600|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110263880|NCT05293600|Serotonin Agents|serotonin agents|mesh-ancestor
110263881|NCT05293600|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110263882|NCT05293600|Antidepressive Agents|antidepressive agents|mesh-ancestor
110263884|NCT00151697|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110263885|NCT00151697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110263886|NCT00151697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110263887|NCT00532714|Capecitabine|capecitabine|mesh-list
110263888|NCT00532714|Irinotecan|irinotecan|mesh-list
110263890|NCT00532714|Antimetabolites|antimetabolites|mesh-ancestor
110272553|NCT05149768|Immunologic Factors|immunologic factors|mesh-ancestor
110263891|NCT00532714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263892|NCT00532714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110263893|NCT00532714|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110263894|NCT00532714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110263895|NCT00532714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110263896|NCT00151736|Etodolac|etodolac|mesh-list
110263897|NCT00151736|Chlorambucil|chlorambucil|mesh-list
110263898|NCT00151736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110263899|NCT00151736|Alkylating Agents|alkylating agents|mesh-ancestor
110263900|NCT00151736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263901|NCT00151736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110263902|NCT00151736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110263903|NCT00151736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110263904|NCT00151736|Analgesics|analgesics|mesh-ancestor
110263905|NCT00151736|Sensory System Agents|sensory system agents|mesh-ancestor
110263906|NCT00151736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110263907|NCT00151736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110263908|NCT00151736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110263911|NCT00151736|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110263912|NCT00151736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110263913|NCT00171990|Famciclovir|famciclovir|mesh-list
110263914|NCT00171990|Antiviral Agents|antiviral agents|mesh-ancestor
110263915|NCT00171990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110263916|NCT00171990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110263917|NCT00171990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110263918|NCT00171990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263919|NCT00406094|Montelukast|montelukast|mesh-list
110263920|NCT00406094|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110263921|NCT00406094|Respiratory System Agents|respiratory system agents|mesh-ancestor
110263922|NCT00406094|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110263923|NCT00406094|Hormone Antagonists|hormone antagonists|mesh-ancestor
110263924|NCT00406094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110263925|NCT00406094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110263926|NCT00406094|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110263927|NCT00406094|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110263928|NCT00406094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263930|NCT00164736|Lopinavir|lopinavir|mesh-list
110263931|NCT00164736|Lamivudine|lamivudine|mesh-list
110263932|NCT00164736|Zidovudine|zidovudine|mesh-list
110263933|NCT00164736|Nevirapine|nevirapine|mesh-list
110263934|NCT00164736|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110263935|NCT00164736|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110263936|NCT00164736|Protease Inhibitors|protease inhibitors|mesh-ancestor
110263937|NCT00164736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110263938|NCT00164736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263940|NCT00164736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110263941|NCT00164736|Antiviral Agents|antiviral agents|mesh-ancestor
110263942|NCT00164736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110263943|NCT00164736|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110263944|NCT00164736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110263945|NCT00164736|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110263946|NCT00164736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110263947|NCT00164736|Antimetabolites|antimetabolites|mesh-ancestor
110263948|NCT00164736|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110263949|NCT00164736|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110263950|NCT00532909|Bevacizumab|bevacizumab|mesh-list
110263951|NCT00532909|Capecitabine|capecitabine|mesh-list
110263952|NCT00532909|Oxaliplatin|oxaliplatin|mesh-list
110263953|NCT00532909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110263954|NCT00532909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110263955|NCT00532909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110263956|NCT00532909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110263957|NCT00532909|Growth Substances|growth substances|mesh-ancestor
110263958|NCT00532909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110263959|NCT00532909|Growth Inhibitors|growth inhibitors|mesh-ancestor
110263960|NCT00532909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110263961|NCT00532909|Antimetabolites|antimetabolites|mesh-ancestor
110263962|NCT00532909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263963|NCT00172068|Vitamin D|vitamin d|mesh-list
110263964|NCT00172068|Zoledronic Acid|zoledronic acid|mesh-list
110263965|NCT00172068|Calcium|calcium|mesh-list
110263966|NCT00172068|Vitamins|vitamins|mesh-ancestor
110263967|NCT00172068|Micronutrients|micronutrients|mesh-ancestor
110263968|NCT00172068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110263969|NCT00172068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110263971|NCT00151970|Methylphenidate|methylphenidate|mesh-list
110263972|NCT00151970|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110263973|NCT00151970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110263974|NCT00151970|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110263975|NCT00151970|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110263976|NCT00151970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110263977|NCT00151970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263979|NCT00151970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110263980|NCT00152048|Eflornithine|eflornithine|mesh-list
110263981|NCT00152048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110263982|NCT00152048|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110263983|NCT00152048|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110263984|NCT00152048|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110263985|NCT00152048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110263986|NCT00152048|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
110263987|NCT00152048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110263988|NCT00152048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263990|NCT04687111|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110263992|NCT04687111|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110263993|NCT04687111|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110263994|NCT04687111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263995|NCT00164775|Imipramine|imipramine|mesh-list
110263996|NCT00164775|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110263997|NCT00164775|Antidepressive Agents|antidepressive agents|mesh-ancestor
110263998|NCT00164775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110263999|NCT00164775|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110264000|NCT00164775|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110264001|NCT00164775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110264002|NCT00164775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110264003|NCT00164775|Adrenergic Agents|adrenergic agents|mesh-ancestor
110264004|NCT00164775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110264005|NCT00164775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264006|NCT00533026|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110264008|NCT00533026|Anticoagulants|anticoagulants|mesh-ancestor
110264009|NCT00533026|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110264010|NCT00533026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110264011|NCT00533026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110264012|NCT00533026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110264013|NCT00533026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110264014|NCT00533026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264015|NCT00533026|Analgesics|analgesics|mesh-ancestor
110264016|NCT00533026|Sensory System Agents|sensory system agents|mesh-ancestor
110264017|NCT00533026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110264018|NCT00533026|Antidepressive Agents|antidepressive agents|mesh-ancestor
110264019|NCT00533026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110264020|NCT00533026|Dopamine Agents|dopamine agents|mesh-ancestor
110264022|NCT00152126|Busulfan|busulfan|mesh-list
110264023|NCT00152126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110264024|NCT00152126|Alkylating Agents|alkylating agents|mesh-ancestor
110368715|NCT04617015|Bromides|bromides|mesh-list
110264025|NCT00152126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110264026|NCT00152126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110264027|NCT00152126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110264028|NCT00152126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110264029|NCT00152126|Immunologic Factors|immunologic factors|mesh-ancestor
110264030|NCT00152126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264032|NCT05039593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110264033|NCT05039593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110264034|NCT05039593|Disinfectants|disinfectants|mesh-ancestor
110264035|NCT00425451|Chlorhexidine|chlorhexidine|mesh-list
110264036|NCT00425451|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110264037|NCT00425451|Flurbiprofen|flurbiprofen|mesh-list
110264038|NCT00425451|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110264039|NCT00425451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110264040|NCT00425451|Disinfectants|disinfectants|mesh-ancestor
110264041|NCT00425451|Dermatologic Agents|dermatologic agents|mesh-ancestor
110264042|NCT00425451|Analgesics|analgesics|mesh-ancestor
110264043|NCT00425451|Sensory System Agents|sensory system agents|mesh-ancestor
110264044|NCT00425451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110264045|NCT00425451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264046|NCT00425451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110264047|NCT00425451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110264048|NCT00425451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110264049|NCT00425451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110264050|NCT00425451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110264051|NCT00425451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110264052|NCT00425451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110264054|NCT00152204|Sulfadoxine|sulfadoxine|mesh-list
110264055|NCT00152204|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110264056|NCT00152204|Antimalarials|antimalarials|mesh-ancestor
110264057|NCT00152204|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110264058|NCT00152204|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110264059|NCT00152204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110264060|NCT00152204|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110264061|NCT00152204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110264062|NCT00152204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110264063|NCT00152204|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110264064|NCT00533065|Donepezil|donepezil|mesh-list
110264065|NCT00533065|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110264066|NCT00533065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110264067|NCT00533065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110264068|NCT00533065|Cholinergic Agents|cholinergic agents|mesh-ancestor
110264069|NCT00533065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110264070|NCT00533065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264071|NCT00533065|Nootropic Agents|nootropic agents|mesh-ancestor
110264072|NCT00152243|Tegafur|tegafur|mesh-list
110264073|NCT00152243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110264074|NCT00152243|Antimetabolites|antimetabolites|mesh-ancestor
110264075|NCT00152243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110264076|NCT00152243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110264077|NCT00172107|Parathyroid Hormone|parathyroid hormone|mesh-list
110264078|NCT00172107|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110264079|NCT00172107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264080|NCT00152282|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110264081|NCT00152282|Estrogens|estrogens|mesh-ancestor
110264082|NCT00152282|Hormones|hormones|mesh-ancestor
110264083|NCT00152282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110264084|NCT00152282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264085|NCT04922983|Botulinum Toxins|botulinum toxins|mesh-list
110264086|NCT04922983|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110264087|NCT04922983|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110264089|NCT04922983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110264090|NCT04922983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110264092|NCT04922983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110264093|NCT04922983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264094|NCT04922983|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110264095|NCT04922983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110264096|NCT00152360|Orlistat|orlistat|mesh-list
110264097|NCT00152360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110368716|NCT04617015|Ipratropium|ipratropium|mesh-list
110264098|NCT00152360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110264099|NCT00152360|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110264100|NCT00152360|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110264101|NCT00164892|Rofecoxib|rofecoxib|mesh-list
110264102|NCT00164892|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110264103|NCT00164892|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110264104|NCT00164892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110264105|NCT00164892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110264106|NCT00164892|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110264107|NCT00164892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110264108|NCT00164892|Analgesics|analgesics|mesh-ancestor
110264109|NCT00164892|Sensory System Agents|sensory system agents|mesh-ancestor
110264110|NCT00164892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110264111|NCT00164892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264112|NCT00164892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110264113|NCT00164892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110264114|NCT00152399|Somatostatin|somatostatin|mesh-list
110264116|NCT00152399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110264117|NCT00152399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264118|NCT00164931|Omeprazole|omeprazole|mesh-list
110264119|NCT00164931|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110264120|NCT00164931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110264121|NCT00164931|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110264122|NCT00164931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110264123|NCT00164931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110264124|NCT00152438|Progesterone|progesterone|mesh-list
110264125|NCT00152438|Progestins|progestins|mesh-ancestor
110264126|NCT00152438|Hormones|hormones|mesh-ancestor
110264127|NCT00152438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110264128|NCT00152438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264129|NCT00164970|Vitamin B 12|vitamin b 12|mesh-list
110264130|NCT00164970|Hydroxocobalamin|hydroxocobalamin|mesh-list
110264131|NCT00164970|Vitamins|vitamins|mesh-ancestor
110264132|NCT00164970|Micronutrients|micronutrients|mesh-ancestor
110264133|NCT00164970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264134|NCT00164970|Vitamin B Complex|vitamin b complex|mesh-ancestor
110264135|NCT00164970|Hematinics|hematinics|mesh-ancestor
110264136|NCT02937844|Cyclophosphamide|cyclophosphamide|mesh-list
110264137|NCT02937844|Fludarabine|fludarabine|mesh-list
110264138|NCT02937844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110264139|NCT02937844|Immunologic Factors|immunologic factors|mesh-ancestor
110264140|NCT02937844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264142|NCT02937844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110264143|NCT02937844|Alkylating Agents|alkylating agents|mesh-ancestor
110264144|NCT02937844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110264145|NCT02937844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110264146|NCT02937844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110264148|NCT02937415|Carbon Monoxide|carbon monoxide|mesh-list
110264149|NCT02937415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110264150|NCT02937415|Protective Agents|protective agents|mesh-ancestor
110264151|NCT02937415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264152|NCT02937415|Antimetabolites|antimetabolites|mesh-ancestor
110264153|NCT02937415|Gasotransmitters|gasotransmitters|mesh-ancestor
110264154|NCT02937415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110264155|NCT00152594|Voriconazole|voriconazole|mesh-list
110264156|NCT00152594|Antifungal Agents|antifungal agents|mesh-ancestor
110264157|NCT00152594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110264158|NCT00152594|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110264159|NCT00152594|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110264160|NCT00152594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110264161|NCT00152594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110264162|NCT00152594|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110264163|NCT00152594|Hormone Antagonists|hormone antagonists|mesh-ancestor
110264164|NCT00152594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110264165|NCT00152594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264166|NCT00152594|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110264167|NCT00407199|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110264168|NCT00407199|Antidepressive Agents|antidepressive agents|mesh-ancestor
110264169|NCT00407199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110264170|NCT00407199|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110264171|NCT00407199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110264172|NCT00407199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110264173|NCT00407199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264175|NCT04725422|Pamidronate|pamidronate|mesh-list
110264176|NCT04725422|Sulfasalazine|sulfasalazine|mesh-list
110264177|NCT04725422|Adalimumab|adalimumab|mesh-list
110264178|NCT04725422|Infliximab|infliximab|mesh-list
110264179|NCT04725422|Golimumab|golimumab|mesh-list
110264180|NCT04725422|Certolizumab Pegol|certolizumab pegol|mesh-list
110264181|NCT04725422|Etanercept|etanercept|mesh-list
110264182|NCT04725422|Methotrexate|methotrexate|mesh-list
110264183|NCT04725422|Leflunomide|leflunomide|mesh-list
110264184|NCT04725422|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110264185|NCT04725422|Abortifacient Agents|abortifacient agents|mesh-ancestor
110264186|NCT04725422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110264187|NCT04725422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264188|NCT04725422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110264189|NCT04725422|Antimetabolites|antimetabolites|mesh-ancestor
110264190|NCT04725422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110264191|NCT04725422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110264192|NCT04725422|Dermatologic Agents|dermatologic agents|mesh-ancestor
110264193|NCT04725422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110264194|NCT04725422|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110264195|NCT04725422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110264196|NCT04725422|Immunologic Factors|immunologic factors|mesh-ancestor
110264197|NCT04725422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110264198|NCT04725422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110264199|NCT04725422|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110264200|NCT04725422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110264201|NCT04725422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110264202|NCT04725422|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110264203|NCT04725422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110264204|NCT04725422|Analgesics|analgesics|mesh-ancestor
110264205|NCT04725422|Sensory System Agents|sensory system agents|mesh-ancestor
110264206|NCT04725422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110264207|NCT04725422|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110264208|NCT04725422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110264211|NCT00152633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110264212|NCT00152633|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110264213|NCT00152633|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110264214|NCT00152633|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110264215|NCT00152633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110264216|NCT00152633|Sympatholytics|sympatholytics|mesh-ancestor
110264218|NCT00152633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110264219|NCT00152633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264220|NCT00152633|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110264221|NCT00152633|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110264222|NCT00152633|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110264223|NCT00152633|Adrenergic Agents|adrenergic agents|mesh-ancestor
110264224|NCT00152633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110264225|NCT02937181|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
110264226|NCT02937181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110264227|NCT02937181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110264228|NCT00425490|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110264229|NCT00425490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110264230|NCT00425490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264231|NCT00425490|Incretins|incretins|mesh-ancestor
110264232|NCT00425490|Hormones|hormones|mesh-ancestor
110264233|NCT00425490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110264234|NCT00425490|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110264235|NCT00425490|Protease Inhibitors|protease inhibitors|mesh-ancestor
110264236|NCT00425490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110264237|NCT00425490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110264238|NCT03457753|Riluzole|riluzole|mesh-list
110264239|NCT03457753|Anticonvulsants|anticonvulsants|mesh-ancestor
110264240|NCT03457753|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110264241|NCT03457753|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110264242|NCT03457753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110264243|NCT03457753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110264244|NCT03457753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264245|NCT03457753|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110264246|NCT03457753|Protective Agents|protective agents|mesh-ancestor
110264247|NCT02936830|Listerine|listerine|mesh-list
110264248|NCT02936830|Fluorides|fluorides|mesh-list
110264249|NCT02936830|Sodium Fluoride|sodium fluoride|mesh-list
110264250|NCT02936830|Fluorides, Topical|fluorides, topical|mesh-list
110264251|NCT02936830|Glycerol|glycerol|mesh-list
110264252|NCT02936830|Cariostatic Agents|cariostatic agents|mesh-ancestor
110264253|NCT02936830|Protective Agents|protective agents|mesh-ancestor
110264254|NCT02936830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264255|NCT02936830|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110264256|NCT02936830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110264257|NCT02936830|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110264258|NCT00165048|Rofecoxib|rofecoxib|mesh-list
110264259|NCT00165048|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110264260|NCT00165048|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110264261|NCT00165048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110264262|NCT00165048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110264263|NCT00165048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110264264|NCT00165048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110264265|NCT00165048|Analgesics|analgesics|mesh-ancestor
110264266|NCT00165048|Sensory System Agents|sensory system agents|mesh-ancestor
110264267|NCT00165048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110264268|NCT00165048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264269|NCT00165048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110264271|NCT04690270|Sumatriptan|sumatriptan|mesh-list
110264272|NCT04690270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110264273|NCT04690270|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110264274|NCT04690270|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110264275|NCT04690270|Serotonin Agents|serotonin agents|mesh-ancestor
110264276|NCT04690270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110264277|NCT04690270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110264278|NCT04690270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264280|NCT00165087|Dexrazoxane|dexrazoxane|mesh-list
110264281|NCT00165087|Asparaginase|asparaginase|mesh-list
110264282|NCT00165087|Razoxane|razoxane|mesh-list
110264283|NCT00165087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110264284|NCT00165087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110264285|NCT00165087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110264286|NCT00165087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110264287|NCT00165087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110264288|NCT00165087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110264289|NCT00165087|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110264290|NCT00165087|Protective Agents|protective agents|mesh-ancestor
110264291|NCT00165087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264292|NCT00165087|Antimitotic Agents|antimitotic agents|mesh-ancestor
110264293|NCT00165087|Mitosis Modulators|mitosis modulators|mesh-ancestor
110264294|NCT00152750|Clonidine|clonidine|mesh-list
110264295|NCT00152750|Analgesics|analgesics|mesh-ancestor
110264296|NCT00152750|Sensory System Agents|sensory system agents|mesh-ancestor
110264297|NCT00152750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110264298|NCT00152750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264299|NCT00152750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110264300|NCT00152750|Sympatholytics|sympatholytics|mesh-ancestor
110264301|NCT00152750|Autonomic Agents|autonomic agents|mesh-ancestor
110264302|NCT00152750|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110264303|NCT00152750|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110264304|NCT00152750|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110264305|NCT00152750|Adrenergic Agents|adrenergic agents|mesh-ancestor
110264306|NCT00152750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110264307|NCT00152750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110264308|NCT02936167|Plasma-lyte 148|plasma-lyte 148|mesh-list
110264309|NCT02936167|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110264310|NCT02936167|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110264311|NCT00152828|Celecoxib|celecoxib|mesh-list
110264312|NCT00152828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110264313|NCT00152828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110264314|NCT00152828|Analgesics|analgesics|mesh-ancestor
110264315|NCT00152828|Sensory System Agents|sensory system agents|mesh-ancestor
110264316|NCT00152828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110264317|NCT00152828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264318|NCT00152828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110264319|NCT00152828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110264320|NCT00152828|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110264321|NCT00152828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110264322|NCT00152828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110264323|NCT00152828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110264325|NCT02935933|Morphine|morphine|mesh-list
110264326|NCT02935933|Bupivacaine|bupivacaine|mesh-list
110264327|NCT02935933|Anesthetics, Local|anesthetics, local|mesh-ancestor
110264328|NCT02935933|Anesthetics|anesthetics|mesh-ancestor
110264329|NCT02935933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110264330|NCT02935933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264331|NCT02935933|Sensory System Agents|sensory system agents|mesh-ancestor
110264332|NCT02935933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110264333|NCT02935933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110264334|NCT02935933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110264335|NCT02935933|Analgesics|analgesics|mesh-ancestor
110264336|NCT02935933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110264337|NCT02935933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110264338|NCT02935933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110264339|NCT02935933|Adrenergic Agents|adrenergic agents|mesh-ancestor
110264340|NCT02935933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110264341|NCT02935933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110264342|NCT02935933|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110264343|NCT02935933|Narcotics|narcotics|mesh-ancestor
110264344|NCT00152867|Dexamethasone|dexamethasone|mesh-list
110264345|NCT00152867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110264346|NCT00152867|Antiemetics|antiemetics|mesh-ancestor
110264347|NCT00152867|Autonomic Agents|autonomic agents|mesh-ancestor
110264348|NCT00152867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110264349|NCT00152867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264350|NCT00152867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110264351|NCT00152867|Glucocorticoids|glucocorticoids|mesh-ancestor
110264353|NCT00152867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110264354|NCT00152867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110264355|NCT00152867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110264356|NCT02935972|Lidocaine|lidocaine|mesh-list
110264357|NCT02935972|Diazepam|diazepam|mesh-list
110264358|NCT02935972|Anesthetics, Local|anesthetics, local|mesh-ancestor
110264359|NCT02935972|Anesthetics|anesthetics|mesh-ancestor
110264360|NCT02935972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110264361|NCT02935972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264362|NCT02935972|Sensory System Agents|sensory system agents|mesh-ancestor
110264363|NCT02935972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110264364|NCT02935972|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110264365|NCT02935972|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110264366|NCT02935972|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110264367|NCT02935972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110264368|NCT02935972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110264369|NCT02935972|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110264370|NCT02935972|Anticonvulsants|anticonvulsants|mesh-ancestor
110264371|NCT02935972|Antiemetics|antiemetics|mesh-ancestor
110264372|NCT02935972|Autonomic Agents|autonomic agents|mesh-ancestor
110264373|NCT02935972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110264375|NCT02935972|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110264376|NCT02935972|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110264377|NCT02935972|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110264378|NCT02935972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110264379|NCT02935972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110264380|NCT02935972|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110264381|NCT02935972|Anesthetics, General|anesthetics, general|mesh-ancestor
110264382|NCT02935972|GABA Modulators|gaba modulators|mesh-ancestor
110264383|NCT02935972|GABA Agents|gaba agents|mesh-ancestor
110264384|NCT02935972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110264385|NCT02935855|Warfarin|warfarin|mesh-list
110264386|NCT02935855|Rivaroxaban|rivaroxaban|mesh-list
110264387|NCT02935855|Dabigatran|dabigatran|mesh-list
110264388|NCT02935855|Apixaban|apixaban|mesh-list
110264389|NCT02935855|Edoxaban|edoxaban|mesh-list
110264390|NCT02935855|Anticoagulants|anticoagulants|mesh-ancestor
110264391|NCT02935855|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110264392|NCT02935855|Antithrombins|antithrombins|mesh-ancestor
110264393|NCT02935855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110264394|NCT02935855|Protease Inhibitors|protease inhibitors|mesh-ancestor
110264395|NCT02935855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110264396|NCT02935855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110264397|NCT02935582|Betamethasone|betamethasone|mesh-list
110264398|NCT02935582|Betamethasone Valerate|betamethasone valerate|mesh-list
110264399|NCT02935582|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
110264400|NCT02935582|Betamethasone benzoate|betamethasone benzoate|mesh-list
110264401|NCT02935582|Calcipotriene|calcipotriene|mesh-list
110264402|NCT02935582|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
110264403|NCT02935582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110264404|NCT02935582|Glucocorticoids|glucocorticoids|mesh-ancestor
110264405|NCT02935582|Hormones|hormones|mesh-ancestor
110264406|NCT02935582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110264407|NCT02935582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264408|NCT02935582|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110264409|NCT02935582|Respiratory System Agents|respiratory system agents|mesh-ancestor
110264410|NCT02935582|Dermatologic Agents|dermatologic agents|mesh-ancestor
110264411|NCT00406172|Bevacizumab|bevacizumab|mesh-list
110264412|NCT00406172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110264413|NCT00406172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110264414|NCT00406172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110264415|NCT00406172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110264416|NCT00406172|Growth Substances|growth substances|mesh-ancestor
110264417|NCT00406172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264418|NCT00406172|Growth Inhibitors|growth inhibitors|mesh-ancestor
110264419|NCT00152945|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
110264420|NCT00152945|Glycerol|glycerol|mesh-list
110264421|NCT00152945|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
110264422|NCT00152945|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110264423|NCT00152945|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110264424|NCT00152945|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110264425|NCT00152945|Protective Agents|protective agents|mesh-ancestor
110264426|NCT00152945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264427|NCT02935114|Hydrogen Peroxide|hydrogen peroxide|mesh-list
110264428|NCT02935114|Carbamide Peroxide|carbamide peroxide|mesh-list
110264429|NCT02935114|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110264430|NCT02935114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110264432|NCT02935231|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110264433|NCT02935231|Autonomic Agents|autonomic agents|mesh-ancestor
110264434|NCT02935231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110264435|NCT02935231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264436|NCT02935231|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110264437|NCT02935231|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110264438|NCT02935231|Cholinergic Agents|cholinergic agents|mesh-ancestor
110264439|NCT02935231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110272674|NCT04820309|Urological Agents|urological agents|mesh-ancestor
110264440|NCT02935231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110264441|NCT00172380|Docetaxel|docetaxel|mesh-list
110264442|NCT00172380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110264443|NCT00172380|Tubulin Modulators|tubulin modulators|mesh-ancestor
110264444|NCT00172380|Antimitotic Agents|antimitotic agents|mesh-ancestor
110264445|NCT00172380|Mitosis Modulators|mitosis modulators|mesh-ancestor
110264446|NCT00172380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110264447|NCT00152984|Tiotropium Bromide|tiotropium bromide|mesh-list
110264448|NCT00152984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110264449|NCT00152984|Autonomic Agents|autonomic agents|mesh-ancestor
110264450|NCT00152984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110264451|NCT00152984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264452|NCT00152984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110264453|NCT00152984|Respiratory System Agents|respiratory system agents|mesh-ancestor
110264454|NCT00152984|Parasympatholytics|parasympatholytics|mesh-ancestor
110264455|NCT00152984|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110264456|NCT00152984|Cholinergic Agents|cholinergic agents|mesh-ancestor
110264457|NCT00152984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110264458|NCT00152984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110264459|NCT02935075|Tenofovir|tenofovir|mesh-list
110264460|NCT02935075|Lamivudine|lamivudine|mesh-list
110264461|NCT02935075|Efavirenz|efavirenz|mesh-list
110264462|NCT02935075|Antiviral Agents|antiviral agents|mesh-ancestor
110264464|NCT02935075|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110264465|NCT02935075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110264466|NCT02935075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110264467|NCT02935075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110264468|NCT02935075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110264469|NCT02935075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110264470|NCT02935075|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110264471|NCT02935075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110368717|NCT04617015|Anticonvulsants|anticonvulsants|mesh-ancestor
110264472|NCT02935075|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110264473|NCT02935075|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110264474|NCT02935075|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110264475|NCT02935075|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110264477|NCT02934919|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110264478|NCT02934919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264479|NCT02934919|Sensory System Agents|sensory system agents|mesh-ancestor
110264480|NCT02934919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110264481|NCT00172419|Atorvastatin|atorvastatin|mesh-list
110264482|NCT00172419|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110264483|NCT00172419|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110264484|NCT00172419|Antimetabolites|antimetabolites|mesh-ancestor
110264485|NCT00172419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110264486|NCT00172419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110264487|NCT00172419|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110264488|NCT00172419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110264490|NCT00153023|Telmisartan|telmisartan|mesh-list
110264491|NCT00153023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110264492|NCT00153023|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110264493|NCT00153023|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110264494|NCT00153023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110264495|NCT00165204|Tibolone|tibolone|mesh-list
110264496|NCT00165204|Androgen Antagonists|androgen antagonists|mesh-ancestor
110264497|NCT00165204|Hormone Antagonists|hormone antagonists|mesh-ancestor
110264498|NCT00165204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110264499|NCT00165204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264500|NCT00165204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110264501|NCT00165204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110264502|NCT00165204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110264503|NCT00165204|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110264504|NCT00165204|Anabolic Agents|anabolic agents|mesh-ancestor
110264505|NCT00165204|Hormones|hormones|mesh-ancestor
110264506|NCT02934763|Propranolol|propranolol|mesh-list
110264507|NCT02934763|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110264508|NCT02934763|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110264509|NCT02934763|Adrenergic Agents|adrenergic agents|mesh-ancestor
110264510|NCT02934763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110264511|NCT02934763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110264512|NCT02934763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264513|NCT02934763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110264514|NCT02934763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110264515|NCT02934763|Vasodilator Agents|vasodilator agents|mesh-ancestor
110264516|NCT04689958|Vitamin D|vitamin d|mesh-list
110264517|NCT04689958|Vitamins|vitamins|mesh-ancestor
110264518|NCT04689958|Micronutrients|micronutrients|mesh-ancestor
110264519|NCT04689958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264521|NCT00153140|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
110264522|NCT00153140|Laxatives|laxatives|mesh-ancestor
110264523|NCT00153140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110264524|NCT04684420|Metformin|metformin|mesh-list
110264525|NCT04684420|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110264526|NCT04684420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264527|NCT02934607|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110264528|NCT02934607|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110264529|NCT02934607|Respiratory System Agents|respiratory system agents|mesh-ancestor
110264530|NCT00153296|Carbamazepine|carbamazepine|mesh-list
110264531|NCT00153296|Anticonvulsants|anticonvulsants|mesh-ancestor
110264532|NCT00153296|Antimanic Agents|antimanic agents|mesh-ancestor
110264533|NCT00153296|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110264534|NCT00153296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110264535|NCT00153296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264536|NCT00153296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110264537|NCT00153296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110264538|NCT00153296|Analgesics|analgesics|mesh-ancestor
110264539|NCT00153296|Sensory System Agents|sensory system agents|mesh-ancestor
110264540|NCT00153296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110264541|NCT00153296|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110264542|NCT00153296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110264543|NCT00153296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110264544|NCT00153296|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110264545|NCT00153296|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110264547|NCT02934295|Immunologic Factors|immunologic factors|mesh-ancestor
110264548|NCT02934295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264549|NCT02934022|Maraviroc|maraviroc|mesh-list
110264550|NCT02934022|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110264551|NCT02934022|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110264552|NCT02934022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110264553|NCT02934022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110264554|NCT02934022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110264555|NCT02934022|Antiviral Agents|antiviral agents|mesh-ancestor
110264556|NCT02934022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110264557|NCT02934022|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110264558|NCT02934061|Tizanidine|tizanidine|mesh-list
110264559|NCT02934061|Analgesics|analgesics|mesh-ancestor
110264560|NCT02934061|Sensory System Agents|sensory system agents|mesh-ancestor
110264561|NCT02934061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110264562|NCT02934061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264563|NCT02934061|Anticonvulsants|anticonvulsants|mesh-ancestor
110264564|NCT02934061|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110264567|NCT02934061|Autonomic Agents|autonomic agents|mesh-ancestor
110264568|NCT02934061|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110264569|NCT02934061|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110264570|NCT02934061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110264571|NCT02934061|Adrenergic Agents|adrenergic agents|mesh-ancestor
110264572|NCT02934061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110264573|NCT02934061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110264575|NCT02934217|Cyclosporins|cyclosporins|mesh-list
110264576|NCT02934217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110264577|NCT02934217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110264578|NCT02934217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110264579|NCT02934217|Immunologic Factors|immunologic factors|mesh-ancestor
110264580|NCT02934217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264581|NCT02934217|Antifungal Agents|antifungal agents|mesh-ancestor
110264582|NCT02934217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110264583|NCT02934217|Dermatologic Agents|dermatologic agents|mesh-ancestor
110264584|NCT02934217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110264585|NCT02934217|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110264586|NCT00165360|Temozolomide|temozolomide|mesh-list
110264587|NCT00165360|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110264588|NCT00165360|Alkylating Agents|alkylating agents|mesh-ancestor
110264589|NCT00165360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110264590|NCT00165360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110264591|NCT02933905|Ranibizumab|ranibizumab|mesh-list
110264592|NCT02933905|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110264593|NCT02933905|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110264594|NCT02933905|Growth Substances|growth substances|mesh-ancestor
110264595|NCT02933905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264596|NCT02933905|Growth Inhibitors|growth inhibitors|mesh-ancestor
110264597|NCT02933905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110264598|NCT02933788|Aspirin|aspirin|mesh-list
110264599|NCT02933788|Cilostazol|cilostazol|mesh-list
110264600|NCT02933788|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110264601|NCT02933788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110264602|NCT02933788|Analgesics|analgesics|mesh-ancestor
110264603|NCT02933788|Sensory System Agents|sensory system agents|mesh-ancestor
110264604|NCT02933788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110264605|NCT02933788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264606|NCT02933788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110264607|NCT02933788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110264608|NCT02933788|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110264609|NCT02933788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110264610|NCT02933788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110264611|NCT02933788|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110264612|NCT02933788|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110264613|NCT02933788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110264614|NCT02933788|Antipyretics|antipyretics|mesh-ancestor
110264615|NCT02933788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110264616|NCT02933788|Autonomic Agents|autonomic agents|mesh-ancestor
110264617|NCT02933788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110264618|NCT02933788|Respiratory System Agents|respiratory system agents|mesh-ancestor
110264619|NCT02933788|Vasodilator Agents|vasodilator agents|mesh-ancestor
110264620|NCT02933788|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110264621|NCT02933788|Protective Agents|protective agents|mesh-ancestor
110264622|NCT02933788|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110264623|NCT02933788|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110264626|NCT00165399|Bicalutamide|bicalutamide|mesh-list
110264627|NCT00165399|Estramustine|estramustine|mesh-list
110264628|NCT00165399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110264629|NCT00165399|Tubulin Modulators|tubulin modulators|mesh-ancestor
110264630|NCT00165399|Antimitotic Agents|antimitotic agents|mesh-ancestor
110264631|NCT00165399|Mitosis Modulators|mitosis modulators|mesh-ancestor
110264632|NCT00165399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110264633|NCT00165399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110264634|NCT00165399|Androgen Antagonists|androgen antagonists|mesh-ancestor
110264635|NCT00165399|Hormone Antagonists|hormone antagonists|mesh-ancestor
110264636|NCT00165399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110264637|NCT00165399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264638|NCT00165399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110264639|NCT00165399|Alkylating Agents|alkylating agents|mesh-ancestor
110264640|NCT02933593|Labetalol|labetalol|mesh-list
110264641|NCT02933593|Hydralazine|hydralazine|mesh-list
110264642|NCT02933593|Nifedipine|nifedipine|mesh-list
110264643|NCT02933593|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110264644|NCT02933593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110264645|NCT02933593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110264646|NCT02933593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110264647|NCT02933593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264648|NCT02933593|Vasodilator Agents|vasodilator agents|mesh-ancestor
110264649|NCT02933593|Tocolytic Agents|tocolytic agents|mesh-ancestor
110264650|NCT02933593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110264651|NCT02933593|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110264652|NCT02933593|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110264653|NCT02933593|Adrenergic Agents|adrenergic agents|mesh-ancestor
110264654|NCT02933593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110264655|NCT02933593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110264656|NCT02933593|Sympathomimetics|sympathomimetics|mesh-ancestor
110264657|NCT02933593|Autonomic Agents|autonomic agents|mesh-ancestor
110264658|NCT02933593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110264659|NCT02933593|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110264660|NCT02933593|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110264661|NCT00153491|Lumefantrine|lumefantrine|mesh-list
110264662|NCT00153491|Artemether|artemether|mesh-list
110264663|NCT00153491|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110264664|NCT00153491|Antimalarials|antimalarials|mesh-ancestor
110264665|NCT00153491|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110264666|NCT00153491|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110264667|NCT00153491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110264668|NCT02933437|Ajmaline|ajmaline|mesh-list
110264669|NCT02933437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110264670|NCT02933437|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110264671|NCT02933437|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110264672|NCT02933437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110264673|NCT02933437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110264674|NCT00153530|Methotrexate|methotrexate|mesh-list
110264675|NCT00153530|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110264676|NCT00153530|Abortifacient Agents|abortifacient agents|mesh-ancestor
110264677|NCT00153530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110264678|NCT00153530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264679|NCT00153530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110264680|NCT00153530|Antimetabolites|antimetabolites|mesh-ancestor
110264681|NCT00153530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110264682|NCT00153530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110264683|NCT00153530|Dermatologic Agents|dermatologic agents|mesh-ancestor
110264684|NCT00153530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110264685|NCT00153530|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110264686|NCT00153530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110264687|NCT00153530|Immunologic Factors|immunologic factors|mesh-ancestor
110264688|NCT00153530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110264689|NCT00153530|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110264691|NCT00165477|Immunologic Factors|immunologic factors|mesh-ancestor
110264692|NCT00165477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264693|NCT00165477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110264694|NCT00165477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110264695|NCT00165477|Growth Substances|growth substances|mesh-ancestor
110264696|NCT00165477|Growth Inhibitors|growth inhibitors|mesh-ancestor
110264697|NCT00165477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110264698|NCT02932930|Ropivacaine|ropivacaine|mesh-list
110264699|NCT02932930|Anesthetics, Local|anesthetics, local|mesh-ancestor
110264700|NCT02932930|Anesthetics|anesthetics|mesh-ancestor
110264701|NCT02932930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110264702|NCT02932930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264703|NCT02932930|Sensory System Agents|sensory system agents|mesh-ancestor
110264704|NCT02932930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110264705|NCT00165516|Sodium thiosulfate|sodium thiosulfate|mesh-list
110264706|NCT00165516|Antidotes|antidotes|mesh-ancestor
110264707|NCT00165516|Protective Agents|protective agents|mesh-ancestor
110264708|NCT00165516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264709|NCT00165516|Antioxidants|antioxidants|mesh-ancestor
110264710|NCT00165516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110264711|NCT00165516|Antitubercular Agents|antitubercular agents|mesh-ancestor
110264712|NCT00165516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110264713|NCT00165516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110264714|NCT00165516|Chelating Agents|chelating agents|mesh-ancestor
110264715|NCT00165516|Sequestering Agents|sequestering agents|mesh-ancestor
110264716|NCT04642378|Insulin|insulin|mesh-list
110264717|NCT04642378|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110264718|NCT04642378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110264719|NCT04642378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264720|NCT00407784|Eplerenone|eplerenone|mesh-list
110264721|NCT00407784|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110264722|NCT00407784|Hormone Antagonists|hormone antagonists|mesh-ancestor
110264723|NCT00407784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110264724|NCT00407784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264725|NCT00407784|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110264726|NCT00407784|Diuretics|diuretics|mesh-ancestor
110264727|NCT00407784|Natriuretic Agents|natriuretic agents|mesh-ancestor
110264728|NCT00407784|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110264729|NCT02932774|Cetirizine|cetirizine|mesh-list
110264730|NCT02932774|Loratadine|loratadine|mesh-list
110264731|NCT02932774|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110264732|NCT02932774|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110264733|NCT02932774|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110264734|NCT02932774|Histamine Antagonists|histamine antagonists|mesh-ancestor
110264735|NCT02932774|Histamine Agents|histamine agents|mesh-ancestor
110264736|NCT02932774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110264737|NCT02932774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110264738|NCT02932774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264739|NCT02932774|Antipruritics|antipruritics|mesh-ancestor
110264740|NCT02932774|Dermatologic Agents|dermatologic agents|mesh-ancestor
110264741|NCT00180063|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
110264742|NCT00180063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110264743|NCT00180063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110264744|NCT00153725|Aspirin|aspirin|mesh-list
110264745|NCT00153725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110264746|NCT00153725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110264747|NCT00153725|Analgesics|analgesics|mesh-ancestor
110264748|NCT00153725|Sensory System Agents|sensory system agents|mesh-ancestor
110264749|NCT00153725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110264750|NCT00153725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264751|NCT00153725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110264752|NCT00153725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110264753|NCT00153725|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110264754|NCT00153725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110264755|NCT00153725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110264756|NCT00153725|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110264757|NCT00153725|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110264758|NCT00153725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110264759|NCT00153725|Antipyretics|antipyretics|mesh-ancestor
110264760|NCT00153764|Vitamins|vitamins|mesh-list
110264761|NCT00153764|Micronutrients|micronutrients|mesh-ancestor
110264762|NCT00153764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264763|NCT00180102|Cytarabine|cytarabine|mesh-list
110264764|NCT00180102|Mitoxantrone|mitoxantrone|mesh-list
110264765|NCT00180102|Amsacrine|amsacrine|mesh-list
110264766|NCT00180102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110264767|NCT00180102|Antimetabolites|antimetabolites|mesh-ancestor
110264768|NCT00180102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110264769|NCT00180102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110264771|NCT00180102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110264772|NCT00180102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110264773|NCT00180102|Immunologic Factors|immunologic factors|mesh-ancestor
110264774|NCT00180102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264775|NCT00180102|Analgesics|analgesics|mesh-ancestor
110264776|NCT00180102|Sensory System Agents|sensory system agents|mesh-ancestor
110264777|NCT00180102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110264778|NCT00180102|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110264779|NCT00180102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110264780|NCT00180102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110264781|NCT04690309|Insulin|insulin|mesh-list
110264782|NCT04690309|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110264783|NCT04690309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110264784|NCT04690309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264785|NCT00153881|Carboplatin|carboplatin|mesh-list
110264786|NCT00153881|Docetaxel|docetaxel|mesh-list
110264787|NCT00153881|Capecitabine|capecitabine|mesh-list
110264788|NCT00153881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110264789|NCT00153881|Tubulin Modulators|tubulin modulators|mesh-ancestor
110264790|NCT00153881|Antimitotic Agents|antimitotic agents|mesh-ancestor
110264791|NCT00153881|Mitosis Modulators|mitosis modulators|mesh-ancestor
110264792|NCT00153881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110264793|NCT00153881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110264794|NCT00153881|Antimetabolites|antimetabolites|mesh-ancestor
110264795|NCT00180141|Pimecrolimus|pimecrolimus|mesh-list
110264796|NCT00180141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110264797|NCT00180141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110264798|NCT00180141|Analgesics|analgesics|mesh-ancestor
110264799|NCT00180141|Sensory System Agents|sensory system agents|mesh-ancestor
110264800|NCT00180141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110264801|NCT00180141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264802|NCT00180141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110264803|NCT00180141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110264804|NCT00180141|Dermatologic Agents|dermatologic agents|mesh-ancestor
110264805|NCT00180141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110264806|NCT00180141|Immunologic Factors|immunologic factors|mesh-ancestor
110264807|NCT00180141|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110264808|NCT00180141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110264809|NCT00180141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110264811|NCT02931877|Sevoflurane|sevoflurane|mesh-list
110264812|NCT02931877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110264813|NCT02931877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110264814|NCT02931877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264815|NCT02931877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110264816|NCT02931877|Anesthetics, General|anesthetics, general|mesh-ancestor
110264817|NCT02931877|Anesthetics|anesthetics|mesh-ancestor
110264818|NCT02931877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110264819|NCT02931877|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110264820|NCT00153998|Leucovorin|leucovorin|mesh-list
110264821|NCT00153998|Folic Acid|folic acid|mesh-list
110264822|NCT00153998|Fluorouracil|fluorouracil|mesh-list
110264823|NCT00153998|Oxaliplatin|oxaliplatin|mesh-list
110264824|NCT00153998|Irinotecan|irinotecan|mesh-list
110264825|NCT00153998|Cetuximab|cetuximab|mesh-list
110264826|NCT00153998|Levoleucovorin|levoleucovorin|mesh-list
110264827|NCT00153998|Antimetabolites|antimetabolites|mesh-ancestor
110264828|NCT00153998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110264829|NCT00153998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110264830|NCT00153998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110272733|NCT04692077|Tenofovir|tenofovir|mesh-list
110264831|NCT00153998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110264832|NCT00153998|Immunologic Factors|immunologic factors|mesh-ancestor
110264833|NCT00153998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264834|NCT00153998|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110264835|NCT00153998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110264836|NCT00153998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110264837|NCT00153998|Antidotes|antidotes|mesh-ancestor
110264838|NCT00153998|Protective Agents|protective agents|mesh-ancestor
110264839|NCT00153998|Vitamin B Complex|vitamin b complex|mesh-ancestor
110264840|NCT00153998|Vitamins|vitamins|mesh-ancestor
110264841|NCT00153998|Micronutrients|micronutrients|mesh-ancestor
110264842|NCT00153998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110264844|NCT02925130|Albuterol|albuterol|mesh-list
110264845|NCT02925130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110264846|NCT02925130|Autonomic Agents|autonomic agents|mesh-ancestor
110264847|NCT02925130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110264848|NCT02925130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264849|NCT02925130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110264850|NCT02925130|Respiratory System Agents|respiratory system agents|mesh-ancestor
110264851|NCT02925130|Tocolytic Agents|tocolytic agents|mesh-ancestor
110264852|NCT02925130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110264853|NCT02925130|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110264854|NCT02925130|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110264855|NCT02925130|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110264856|NCT02925130|Adrenergic Agents|adrenergic agents|mesh-ancestor
110264857|NCT02925130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110264858|NCT02925130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110264859|NCT02924974|Lidocaine|lidocaine|mesh-list
110264860|NCT02924974|Morphine|morphine|mesh-list
110264861|NCT02924974|Anesthetics, Local|anesthetics, local|mesh-ancestor
110264862|NCT02924974|Anesthetics|anesthetics|mesh-ancestor
110264863|NCT02924974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110264864|NCT02924974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264866|NCT02924974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110264867|NCT02924974|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110264868|NCT02924974|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110264869|NCT02924974|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110264870|NCT02924974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110264871|NCT02924974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110264873|NCT02924974|Narcotics|narcotics|mesh-ancestor
110264874|NCT02924974|Analgesics|analgesics|mesh-ancestor
110264875|NCT00154037|Pioglitazone|pioglitazone|mesh-list
110264876|NCT00154037|Candesartan|candesartan|mesh-list
110264877|NCT00154037|Candesartan cilexetil|candesartan cilexetil|mesh-list
110264878|NCT00154037|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110264879|NCT00154037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264880|NCT00154037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110264881|NCT00154037|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110264882|NCT00154037|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110264883|NCT00154037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110264884|NCT02924857|Paclitaxel|paclitaxel|mesh-list
110264885|NCT02924857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110264886|NCT02924857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110264887|NCT02924857|Tubulin Modulators|tubulin modulators|mesh-ancestor
110264888|NCT02924857|Antimitotic Agents|antimitotic agents|mesh-ancestor
110264889|NCT02924857|Mitosis Modulators|mitosis modulators|mesh-ancestor
110264890|NCT02924857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110264891|NCT00154076|Topiramate|topiramate|mesh-list
110264892|NCT00154076|Zonisamide|zonisamide|mesh-list
110264893|NCT00154076|Anticonvulsants|anticonvulsants|mesh-ancestor
110264894|NCT00154076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110264895|NCT00154076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264896|NCT00154076|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110264897|NCT00154076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110264898|NCT00154076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110264899|NCT00154076|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110264900|NCT00154115|Simendan|simendan|mesh-list
110264901|NCT00154115|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110264902|NCT00154115|Vasodilator Agents|vasodilator agents|mesh-ancestor
110264903|NCT00154115|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110264904|NCT00154115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110264905|NCT00154115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110264906|NCT00154115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110264907|NCT00154115|Protective Agents|protective agents|mesh-ancestor
110264908|NCT00154115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264909|NCT02924506|Meloxicam|meloxicam|mesh-list
110264910|NCT02924506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110264911|NCT02924506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110264912|NCT02924506|Analgesics|analgesics|mesh-ancestor
110264913|NCT02924506|Sensory System Agents|sensory system agents|mesh-ancestor
110033983|NCT01940809|Trametinib|trametinib|mesh-list
110264914|NCT02924506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110264915|NCT02924506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264916|NCT02924506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110264917|NCT02924506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110264918|NCT02924506|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110264919|NCT02924506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110264921|NCT02924506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110264923|NCT02924311|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110264924|NCT02924311|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110264925|NCT02924311|Growth Substances|growth substances|mesh-ancestor
110264926|NCT02924311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264927|NCT02924311|Growth Inhibitors|growth inhibitors|mesh-ancestor
110264928|NCT02924311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110264929|NCT02924233|Nivolumab|nivolumab|mesh-list
110264930|NCT02924233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110264931|NCT02924233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110264932|NCT02924233|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110264933|NCT02924233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110264934|NCT02923999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110264935|NCT02923999|Antibodies|antibodies|mesh-list
110264936|NCT02923999|Immunoglobulins|immunoglobulins|mesh-list
110264937|NCT02923999|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110264938|NCT02923999|Immunologic Factors|immunologic factors|mesh-ancestor
110264939|NCT02923999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264940|NCT02923999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110264941|NCT00154193|Cyclosporine|cyclosporine|mesh-list
110264942|NCT00154193|Cyclosporins|cyclosporins|mesh-list
110264943|NCT00154193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110264944|NCT00154193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110264945|NCT00154193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110264946|NCT00154193|Immunologic Factors|immunologic factors|mesh-ancestor
110264947|NCT00154193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264948|NCT00154193|Antifungal Agents|antifungal agents|mesh-ancestor
110264949|NCT00154193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110264950|NCT00154193|Dermatologic Agents|dermatologic agents|mesh-ancestor
110264951|NCT00154193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110264952|NCT00154193|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110264953|NCT00154232|Mycophenolic Acid|mycophenolic acid|mesh-list
110264954|NCT00154232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110264955|NCT00154232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110264956|NCT00154232|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110264957|NCT00154232|Antitubercular Agents|antitubercular agents|mesh-ancestor
110264958|NCT00154232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110264959|NCT00154232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110264960|NCT00154232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110264961|NCT00154232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110264962|NCT00154271|Valsartan|valsartan|mesh-list
110264963|NCT00154271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110264964|NCT00154271|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110264965|NCT00154271|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110264966|NCT00154271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110264967|NCT00154349|Imatinib Mesylate|imatinib mesylate|mesh-list
110264968|NCT00154349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110264969|NCT00154349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110264970|NCT00154349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110264971|NCT00154349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110264972|NCT00187941|Mycophenolic Acid|mycophenolic acid|mesh-list
110264973|NCT00187941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110264974|NCT00187941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110264975|NCT00187941|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110264977|NCT00187941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110264978|NCT00187941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110264979|NCT00187941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110264980|NCT00187941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110264981|NCT02923687|Ketorolac|ketorolac|mesh-list
110264982|NCT02923687|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110264983|NCT02923687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110264984|NCT02923687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110264985|NCT02923687|Analgesics|analgesics|mesh-ancestor
110264986|NCT02923687|Sensory System Agents|sensory system agents|mesh-ancestor
110264987|NCT02923687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110264988|NCT02923687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264989|NCT02923687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110264990|NCT02923687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110264991|NCT02923687|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110264992|NCT02923687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110264993|NCT02923687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110264994|NCT00154388|Imatinib Mesylate|imatinib mesylate|mesh-list
110264995|NCT00154388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110264996|NCT00154388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110264997|NCT00154388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110264998|NCT00154388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110265000|NCT02923258|Cisplatin|cisplatin|mesh-list
110265001|NCT02923258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110265002|NCT02923258|Tubulin Modulators|tubulin modulators|mesh-ancestor
110265003|NCT02923258|Antimitotic Agents|antimitotic agents|mesh-ancestor
110265004|NCT02923258|Mitosis Modulators|mitosis modulators|mesh-ancestor
110265005|NCT02923258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110265006|NCT02923336|Propranolol|propranolol|mesh-list
110265007|NCT02923336|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110265008|NCT02923336|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110265009|NCT02923336|Adrenergic Agents|adrenergic agents|mesh-ancestor
110265011|NCT02923336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110265012|NCT02923336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265013|NCT02923336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110265014|NCT02923336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110265015|NCT02923336|Vasodilator Agents|vasodilator agents|mesh-ancestor
110265016|NCT02922946|Entinostat|entinostat|mesh-list
110265017|NCT02922946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110265018|NCT02922946|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110265019|NCT02922946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110265020|NCT02922946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110265021|NCT02922712|Nimesulide|nimesulide|mesh-list
110265022|NCT02922712|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110265023|NCT02922712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110265024|NCT02922712|Analgesics|analgesics|mesh-ancestor
110265025|NCT02922712|Sensory System Agents|sensory system agents|mesh-ancestor
110265026|NCT02922712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110265027|NCT02922712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265029|NCT02922712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110265030|NCT02922712|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110265031|NCT02922712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110265032|NCT02922712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110265033|NCT02922673|Aspirin|aspirin|mesh-list
110265034|NCT02922673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110265035|NCT02922673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110265036|NCT02922673|Analgesics|analgesics|mesh-ancestor
110265037|NCT02922673|Sensory System Agents|sensory system agents|mesh-ancestor
110265038|NCT02922673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110265039|NCT02922673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265040|NCT02922673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110265041|NCT02922673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110265042|NCT02922673|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110265043|NCT02922673|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110265044|NCT02922673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110265045|NCT02922673|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110265046|NCT02922673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110265047|NCT02922673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110265048|NCT02922673|Antipyretics|antipyretics|mesh-ancestor
110265049|NCT02922283|Interleukin-2|interleukin-2|mesh-list
110265050|NCT02922283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110265052|NCT02922283|Analgesics|analgesics|mesh-ancestor
110265053|NCT02922283|Sensory System Agents|sensory system agents|mesh-ancestor
110265054|NCT02922283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110265055|NCT02922283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265056|NCT04705454|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
110265057|NCT04705454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110265058|NCT04705454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110265060|NCT02922166|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110265061|NCT02922166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110265062|NCT02922166|Natriuretic Agents|natriuretic agents|mesh-ancestor
110265063|NCT02922166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265064|NCT02922127|Contraceptive Agents|contraceptive agents|mesh-list
110265065|NCT02922127|Ulipristal acetate|ulipristal acetate|mesh-list
110265066|NCT02922127|Contraceptives, Oral|contraceptives, oral|mesh-list
110265067|NCT02922127|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
110265068|NCT02922127|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110265069|NCT02922127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265070|NCT02922127|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110265071|NCT02922127|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110265072|NCT02921659|Niacinamide|niacinamide|mesh-list
110265073|NCT02921659|Vitamin B Complex|vitamin b complex|mesh-ancestor
110265074|NCT02921659|Vitamins|vitamins|mesh-ancestor
110265076|NCT02921659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265077|NCT04689100|Leucovorin|leucovorin|mesh-list
110265078|NCT04689100|Fluorouracil|fluorouracil|mesh-list
110265079|NCT04689100|Oxaliplatin|oxaliplatin|mesh-list
110265080|NCT04689100|Irinotecan|irinotecan|mesh-list
110265081|NCT04689100|Calcium|calcium|mesh-list
110265082|NCT04689100|Levoleucovorin|levoleucovorin|mesh-list
110265083|NCT04689100|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110265084|NCT04689100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265086|NCT04689100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110265087|NCT04689100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110265088|NCT04689100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110265089|NCT04689100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110265090|NCT04689100|Immunologic Factors|immunologic factors|mesh-ancestor
110265091|NCT04689100|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110265092|NCT04689100|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110265093|NCT04689100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110265095|NCT04689100|Protective Agents|protective agents|mesh-ancestor
110265096|NCT04689100|Vitamin B Complex|vitamin b complex|mesh-ancestor
110265097|NCT04689100|Vitamins|vitamins|mesh-ancestor
110265098|NCT04689100|Micronutrients|micronutrients|mesh-ancestor
110265099|NCT00188136|Fludarabine|fludarabine|mesh-list
110265100|NCT00188136|Melphalan|melphalan|mesh-list
110265101|NCT00188136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110265102|NCT00188136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110265103|NCT00188136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110265104|NCT00188136|Immunologic Factors|immunologic factors|mesh-ancestor
110265105|NCT00188136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265106|NCT00188136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110265107|NCT00188136|Alkylating Agents|alkylating agents|mesh-ancestor
110265108|NCT00188136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110265109|NCT00406250|Bevacizumab|bevacizumab|mesh-list
110265110|NCT00406250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110265111|NCT00406250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110265112|NCT00406250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110265113|NCT00406250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110265114|NCT00406250|Growth Substances|growth substances|mesh-ancestor
110265115|NCT00406250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265116|NCT00406250|Growth Inhibitors|growth inhibitors|mesh-ancestor
110265117|NCT00406289|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110265118|NCT00406289|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110265119|NCT00406289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110265120|NCT02921269|Bevacizumab|bevacizumab|mesh-list
110265121|NCT02921269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110265122|NCT02921269|Atezolizumab|atezolizumab|mesh-list
110265123|NCT02921269|Endothelial Growth Factors|endothelial growth factors|mesh-list
110265124|NCT02921269|Antibodies|antibodies|mesh-list
110265125|NCT02921269|Immunoglobulins|immunoglobulins|mesh-list
110265126|NCT02921269|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110265127|NCT02921269|Immunoglobulin G|immunoglobulin g|mesh-list
110265128|NCT02921269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110265129|NCT02921269|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110265130|NCT02921269|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110265131|NCT02921269|Growth Substances|growth substances|mesh-ancestor
110265132|NCT02921269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265133|NCT02921269|Growth Inhibitors|growth inhibitors|mesh-ancestor
110265134|NCT02921269|Immunologic Factors|immunologic factors|mesh-ancestor
110265135|NCT02921269|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110265136|NCT02921269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110265138|NCT02920801|Saxagliptin|saxagliptin|mesh-list
110265139|NCT02920801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110265140|NCT02920801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265142|NCT02920801|Hormones|hormones|mesh-ancestor
110265143|NCT02920801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110265144|NCT02920801|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110265145|NCT02920801|Protease Inhibitors|protease inhibitors|mesh-ancestor
110265146|NCT02920801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110265147|NCT02920801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110265149|NCT00180843|Albuterol|albuterol|mesh-list
110265150|NCT00180843|Ipratropium|ipratropium|mesh-list
110265151|NCT00180843|Anticonvulsants|anticonvulsants|mesh-ancestor
110265152|NCT00180843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110265153|NCT00180843|Autonomic Agents|autonomic agents|mesh-ancestor
110265154|NCT00180843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110265155|NCT00180843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265156|NCT00180843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110265157|NCT00180843|Respiratory System Agents|respiratory system agents|mesh-ancestor
110265158|NCT00180843|Tocolytic Agents|tocolytic agents|mesh-ancestor
110265159|NCT00180843|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110265160|NCT00180843|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110265161|NCT00180843|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110265162|NCT00180843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110265163|NCT00180843|Adrenergic Agents|adrenergic agents|mesh-ancestor
110265164|NCT00180843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110265165|NCT00180843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110265166|NCT00180843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110265167|NCT00180843|Cholinergic Agents|cholinergic agents|mesh-ancestor
110265168|NCT02920567|Octreotide|octreotide|mesh-list
110265169|NCT02920567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110265170|NCT02920567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110265171|NCT02920567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110265172|NCT00180882|Rituximab|rituximab|mesh-list
110265173|NCT00180882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110265174|NCT00180882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110265175|NCT00180882|Immunologic Factors|immunologic factors|mesh-ancestor
110265176|NCT00180882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265177|NCT00180882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110265178|NCT00180921|Imatinib Mesylate|imatinib mesylate|mesh-list
110265179|NCT00180921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110265180|NCT00180921|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110265181|NCT00180921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110265182|NCT00180921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110265183|NCT02920489|Sufentanil|sufentanil|mesh-list
110265185|NCT02920489|Ropivacaine|ropivacaine|mesh-list
110265186|NCT02920489|Anesthetics, Local|anesthetics, local|mesh-ancestor
110265187|NCT02920489|Anesthetics|anesthetics|mesh-ancestor
110265188|NCT02920489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110265189|NCT02920489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265190|NCT02920489|Sensory System Agents|sensory system agents|mesh-ancestor
110265191|NCT02920489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110265192|NCT02920489|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110265193|NCT02920489|Narcotics|narcotics|mesh-ancestor
110265194|NCT02920489|Analgesics|analgesics|mesh-ancestor
110265195|NCT02920489|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110265196|NCT02920489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110265197|NCT02920489|Anesthetics, General|anesthetics, general|mesh-ancestor
110265198|NCT02920372|Epoetin Alfa|epoetin alfa|mesh-list
110265199|NCT02920372|Hematinics|hematinics|mesh-ancestor
110265200|NCT00154661|Pentoxifylline|pentoxifylline|mesh-list
110265201|NCT00154661|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110265202|NCT00154661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110265203|NCT00154661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110265204|NCT00154661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110265205|NCT00154661|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110265206|NCT00154661|Protective Agents|protective agents|mesh-ancestor
110265207|NCT00154661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265208|NCT00154661|Vasodilator Agents|vasodilator agents|mesh-ancestor
110265211|NCT00180960|Oxaliplatin|oxaliplatin|mesh-list
110265212|NCT00180960|Irinotecan|irinotecan|mesh-list
110265213|NCT00180960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110265214|NCT00180960|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110265215|NCT00180960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110265216|NCT00180960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110265217|NCT00180960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110265218|NCT00154700|Folic Acid|folic acid|mesh-list
110265219|NCT00154700|Paclitaxel|paclitaxel|mesh-list
110265220|NCT00154700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110265221|NCT00154700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110265222|NCT00154700|Tubulin Modulators|tubulin modulators|mesh-ancestor
110265223|NCT00154700|Antimitotic Agents|antimitotic agents|mesh-ancestor
110265224|NCT00154700|Mitosis Modulators|mitosis modulators|mesh-ancestor
110265225|NCT00154700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110265226|NCT00154700|Hematinics|hematinics|mesh-ancestor
110265227|NCT00154700|Vitamin B Complex|vitamin b complex|mesh-ancestor
110265228|NCT00154700|Vitamins|vitamins|mesh-ancestor
110265229|NCT00154700|Micronutrients|micronutrients|mesh-ancestor
110265230|NCT00154700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265231|NCT04688983|Imatinib Mesylate|imatinib mesylate|mesh-list
110265232|NCT04688983|Blinatumomab|blinatumomab|mesh-list
110265233|NCT04688983|Ponatinib|ponatinib|mesh-list
110265234|NCT04688983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110265235|NCT04688983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110265236|NCT04688983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110265237|NCT04688983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110265238|NCT02920060|Levetiracetam|levetiracetam|mesh-list
110265239|NCT02920060|Valproic Acid|valproic acid|mesh-list
110265240|NCT02920060|Anticonvulsants|anticonvulsants|mesh-ancestor
110265241|NCT02920060|Nootropic Agents|nootropic agents|mesh-ancestor
110265242|NCT02920060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110265243|NCT02920060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110265244|NCT02920060|GABA Agents|gaba agents|mesh-ancestor
110265245|NCT02920060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110265246|NCT02920060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265247|NCT02920060|Antimanic Agents|antimanic agents|mesh-ancestor
110265248|NCT02920060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110265249|NCT02920060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110265250|NCT02920060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110265251|NCT00154739|Gemcitabine|gemcitabine|mesh-list
110265252|NCT00154739|Epirubicin|epirubicin|mesh-list
110265253|NCT00154739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110265254|NCT00154739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110265255|NCT00154739|Antimetabolites|antimetabolites|mesh-ancestor
110265256|NCT00154739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110265258|NCT00154739|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110265259|NCT00154739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110265260|NCT00154739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110265261|NCT00154778|Leucovorin|leucovorin|mesh-list
110265262|NCT00154778|Antidotes|antidotes|mesh-ancestor
110265263|NCT00154778|Protective Agents|protective agents|mesh-ancestor
110265264|NCT00154778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265265|NCT00154778|Vitamin B Complex|vitamin b complex|mesh-ancestor
110265266|NCT00154778|Vitamins|vitamins|mesh-ancestor
110265267|NCT00154778|Micronutrients|micronutrients|mesh-ancestor
110265268|NCT02919202|Listerine|listerine|mesh-list
110265269|NCT02919202|Fluorides|fluorides|mesh-list
110265270|NCT02919202|Sodium Fluoride|sodium fluoride|mesh-list
110265271|NCT02919202|Fluorides, Topical|fluorides, topical|mesh-list
110265272|NCT02919202|Cariostatic Agents|cariostatic agents|mesh-ancestor
110265273|NCT02919202|Protective Agents|protective agents|mesh-ancestor
110265274|NCT02919202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265275|NCT02919202|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110265276|NCT02919202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110265277|NCT00154895|Minocycline|minocycline|mesh-list
110265278|NCT00154895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110265279|NCT00154895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110265280|NCT00181116|Levetiracetam|levetiracetam|mesh-list
110265281|NCT00181116|Anticonvulsants|anticonvulsants|mesh-ancestor
110265282|NCT00181116|Nootropic Agents|nootropic agents|mesh-ancestor
110265283|NCT02918812|Diclofenac|diclofenac|mesh-list
110265284|NCT02918812|Lidocaine|lidocaine|mesh-list
110265285|NCT02918812|Anesthetics, Local|anesthetics, local|mesh-ancestor
110265286|NCT02918812|Anesthetics|anesthetics|mesh-ancestor
110265287|NCT02918812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110265288|NCT02918812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265289|NCT02918812|Sensory System Agents|sensory system agents|mesh-ancestor
110265290|NCT02918812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110265291|NCT02918812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110265292|NCT02918812|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110265293|NCT02918812|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110265294|NCT02918812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110265295|NCT02918812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110265296|NCT02918812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110265297|NCT02918812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110265298|NCT02918812|Analgesics|analgesics|mesh-ancestor
110265299|NCT02918812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110265300|NCT02918812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110265301|NCT02918812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110265302|NCT02918812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110265303|NCT02918110|Misoprostol|misoprostol|mesh-list
110265304|NCT02918110|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110265305|NCT02918110|Abortifacient Agents|abortifacient agents|mesh-ancestor
110265306|NCT02918110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110265307|NCT02918110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265308|NCT02918110|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110265309|NCT02918110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110265311|NCT00181272|Azithromycin|azithromycin|mesh-list
110265312|NCT00181272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110265313|NCT00181272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110265314|NCT02910076|Hydroxychloroquine|hydroxychloroquine|mesh-list
110265315|NCT02910076|Antimalarials|antimalarials|mesh-ancestor
110265316|NCT02910076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110265317|NCT02910076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110265318|NCT02910076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110265319|NCT02910076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110265320|NCT02910076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110265321|NCT02910076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110265322|NCT02910115|Oxytocin|oxytocin|mesh-list
110265323|NCT02910115|Oxytocics|oxytocics|mesh-ancestor
110265324|NCT02910115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110265325|NCT02910115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265327|NCT00188565|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110265328|NCT00188565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110265329|NCT00188565|Analgesics|analgesics|mesh-ancestor
110265330|NCT00188565|Sensory System Agents|sensory system agents|mesh-ancestor
110265331|NCT00188565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110265332|NCT00188565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265333|NCT00188565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110265334|NCT00188565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110265335|NCT00188565|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110265337|NCT00188565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110265338|NCT00188565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110265339|NCT00155246|Pentoxifylline|pentoxifylline|mesh-list
110265340|NCT00155246|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110265341|NCT00155246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110265342|NCT00155246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110265343|NCT00155246|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110265344|NCT00155246|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110265345|NCT00155246|Protective Agents|protective agents|mesh-ancestor
110265346|NCT00155246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265347|NCT00155246|Vasodilator Agents|vasodilator agents|mesh-ancestor
110265348|NCT00155246|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110265349|NCT00155246|Antioxidants|antioxidants|mesh-ancestor
110265350|NCT02909413|Sevoflurane|sevoflurane|mesh-list
110265352|NCT02909413|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110265353|NCT02909413|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110265354|NCT02909413|Anesthetics, General|anesthetics, general|mesh-ancestor
110265355|NCT02909413|Anesthetics|anesthetics|mesh-ancestor
110265356|NCT02909413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110265357|NCT02909413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265358|NCT02909257|Bupivacaine|bupivacaine|mesh-list
110265359|NCT02909257|Anesthetics, Local|anesthetics, local|mesh-ancestor
110265360|NCT02909257|Anesthetics|anesthetics|mesh-ancestor
110265361|NCT02909257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110265362|NCT02909257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265363|NCT02909257|Sensory System Agents|sensory system agents|mesh-ancestor
110265364|NCT02909257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110265365|NCT02908945|Ketamine|ketamine|mesh-list
110265366|NCT02908945|Analgesics|analgesics|mesh-ancestor
110265367|NCT02908945|Sensory System Agents|sensory system agents|mesh-ancestor
110265368|NCT02908945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110265369|NCT02908945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265370|NCT02908945|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110265371|NCT02908945|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110265372|NCT02908945|Anesthetics, General|anesthetics, general|mesh-ancestor
110265374|NCT02908945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110265375|NCT02908945|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110265376|NCT02908945|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110265377|NCT02908945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110265378|NCT02908945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110265380|NCT02939833|Anesthetics, Local|anesthetics, local|mesh-ancestor
110265381|NCT02939833|Anesthetics|anesthetics|mesh-ancestor
110265382|NCT02939833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110265383|NCT02939833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265384|NCT02939833|Sensory System Agents|sensory system agents|mesh-ancestor
110265385|NCT02939833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110265386|NCT00188604|Selenious Acid|selenious acid|mesh-list
110265387|NCT00188604|Sodium Selenite|sodium selenite|mesh-list
110265388|NCT00188604|Trace Elements|trace elements|mesh-ancestor
110265389|NCT00188604|Micronutrients|micronutrients|mesh-ancestor
110265390|NCT00188604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265391|NCT00155402|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110265392|NCT00155402|Hemostatics|hemostatics|mesh-ancestor
110265393|NCT00155402|Coagulants|coagulants|mesh-ancestor
110265395|NCT00188643|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110265396|NCT00188643|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110265397|NCT00188643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110265398|NCT00188643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110265399|NCT00188643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110265400|NCT00188643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110265401|NCT00188643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265402|NCT00188643|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110265403|NCT00188643|Antidepressive Agents|antidepressive agents|mesh-ancestor
110265404|NCT00188643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110265405|NCT00188643|Anticonvulsants|anticonvulsants|mesh-ancestor
110265406|NCT00188643|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110265407|NCT00188643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110265408|NCT00188643|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110265409|NCT00188643|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110265410|NCT00188643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110265411|NCT00188643|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110265413|NCT00533299|Valproic Acid|valproic acid|mesh-list
110265414|NCT00533299|Anticonvulsants|anticonvulsants|mesh-ancestor
110265415|NCT00533299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110265416|NCT00533299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110265417|NCT00533299|GABA Agents|gaba agents|mesh-ancestor
110265418|NCT00533299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110265419|NCT00533299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265420|NCT00533299|Antimanic Agents|antimanic agents|mesh-ancestor
110265421|NCT00533299|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110265422|NCT00533299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110265423|NCT00533299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110265424|NCT00533299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110265425|NCT00533299|Vasodilator Agents|vasodilator agents|mesh-ancestor
110265426|NCT00181584|Zoledronic Acid|zoledronic acid|mesh-list
110265427|NCT00181584|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110265428|NCT00181584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265429|NCT00181662|Curcumin|curcumin|mesh-list
110265430|NCT00181662|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110265431|NCT00181662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110265432|NCT00181662|Analgesics|analgesics|mesh-ancestor
110265433|NCT00181662|Sensory System Agents|sensory system agents|mesh-ancestor
110265434|NCT00181662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110265435|NCT00181662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265436|NCT00181662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110265437|NCT00181662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110265438|NCT00181662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110265439|NCT00181662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110265440|NCT00181662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110265442|NCT00533416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110265443|NCT00533416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110265444|NCT00533416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110272872|NCT04229368|Vitamin D|vitamin d|mesh-list
110265445|NCT00533416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110265447|NCT00155558|Fluorouracil|fluorouracil|mesh-list
110265448|NCT00155558|Antimetabolites|antimetabolites|mesh-ancestor
110265449|NCT00155558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110265450|NCT00155558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110265451|NCT00155558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110265452|NCT00155558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110265453|NCT00155558|Immunologic Factors|immunologic factors|mesh-ancestor
110265454|NCT00155558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265456|NCT00155558|Protective Agents|protective agents|mesh-ancestor
110265457|NCT00155558|Vitamin B Complex|vitamin b complex|mesh-ancestor
110265459|NCT00155558|Micronutrients|micronutrients|mesh-ancestor
110265460|NCT00533455|Gabapentin|gabapentin|mesh-list
110265461|NCT00533455|Analgesics|analgesics|mesh-ancestor
110265462|NCT00533455|Sensory System Agents|sensory system agents|mesh-ancestor
110265463|NCT00533455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110265464|NCT00533455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265465|NCT00533455|Anticonvulsants|anticonvulsants|mesh-ancestor
110265466|NCT00533455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110265467|NCT00533455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110265468|NCT00533455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110265469|NCT00533455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110265470|NCT00533455|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110265471|NCT00533455|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110265472|NCT00533455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110265473|NCT00533455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110265474|NCT00533455|Antimanic Agents|antimanic agents|mesh-ancestor
110265475|NCT00533533|Docetaxel|docetaxel|mesh-list
110265476|NCT00533533|Oxaliplatin|oxaliplatin|mesh-list
110265477|NCT00533533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110265478|NCT00533533|Tubulin Modulators|tubulin modulators|mesh-ancestor
110265479|NCT00533533|Antimitotic Agents|antimitotic agents|mesh-ancestor
110265480|NCT00533533|Mitosis Modulators|mitosis modulators|mesh-ancestor
110265481|NCT00533533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110265482|NCT00533611|Niacin|niacin|mesh-list
110265483|NCT00533611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110265484|NCT00533611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265485|NCT00533611|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110265486|NCT00533611|Antimetabolites|antimetabolites|mesh-ancestor
110265487|NCT00533611|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110265488|NCT00533611|Vasodilator Agents|vasodilator agents|mesh-ancestor
110265489|NCT00533611|Vitamin B Complex|vitamin b complex|mesh-ancestor
110265490|NCT00533611|Vitamins|vitamins|mesh-ancestor
110265491|NCT00533611|Micronutrients|micronutrients|mesh-ancestor
110265492|NCT04575844|Liraglutide|liraglutide|mesh-list
110265493|NCT04575844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110265494|NCT04575844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265495|NCT04575844|Incretins|incretins|mesh-ancestor
110265496|NCT04575844|Hormones|hormones|mesh-ancestor
110265497|NCT04575844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110265498|NCT00155714|Sildenafil Citrate|sildenafil citrate|mesh-list
110265499|NCT00155714|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-list
110265500|NCT00155714|Vasodilator Agents|vasodilator agents|mesh-ancestor
110265502|NCT00155714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110265503|NCT00155714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110265504|NCT00155714|Urological Agents|urological agents|mesh-ancestor
110265505|NCT00181740|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110265506|NCT00181740|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110265507|NCT00181740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110265508|NCT00181740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110265509|NCT00181740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110272884|NCT04169828|Methotrexate|methotrexate|mesh-list
110265510|NCT00181740|Adrenergic Agents|adrenergic agents|mesh-ancestor
110265511|NCT00181740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110265512|NCT00181740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265514|NCT00181779|Antidepressive Agents|antidepressive agents|mesh-ancestor
110265515|NCT00181779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110265516|NCT00181779|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110265517|NCT00181779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110265518|NCT00181779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110265519|NCT00181779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265520|NCT00181779|Dopamine Agonists|dopamine agonists|mesh-ancestor
110265521|NCT00181779|Dopamine Agents|dopamine agents|mesh-ancestor
110265522|NCT00181779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110265523|NCT00181779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110265524|NCT00181779|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110265525|NCT00181779|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110265526|NCT00181779|Serotonin Agents|serotonin agents|mesh-ancestor
110265527|NCT00181779|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110265528|NCT00181779|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110265529|NCT00181779|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110265530|NCT00181779|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110265531|NCT00533923|Cyclosporine|cyclosporine|mesh-list
110265532|NCT00533923|Cyclophosphamide|cyclophosphamide|mesh-list
110265533|NCT00533923|Fludarabine|fludarabine|mesh-list
110265534|NCT00533923|Alemtuzumab|alemtuzumab|mesh-list
110265535|NCT00533923|Cyclosporins|cyclosporins|mesh-list
110265536|NCT00533923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110265537|NCT00533923|Immunologic Factors|immunologic factors|mesh-ancestor
110265538|NCT00533923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265539|NCT00533923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110265540|NCT00533923|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110265541|NCT00533923|Alkylating Agents|alkylating agents|mesh-ancestor
110265542|NCT00533923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110265543|NCT00533923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110265544|NCT00533923|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110265545|NCT00533923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110265546|NCT00533923|Antifungal Agents|antifungal agents|mesh-ancestor
110265547|NCT00533923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110265548|NCT00533923|Dermatologic Agents|dermatologic agents|mesh-ancestor
110265549|NCT00533923|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110265550|NCT00533923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110265551|NCT00409227|Alfuzosin|alfuzosin|mesh-list
110265552|NCT00409227|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
110265553|NCT00409227|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110265554|NCT00409227|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110265555|NCT00409227|Adrenergic Agents|adrenergic agents|mesh-ancestor
110265556|NCT00409227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110265557|NCT00409227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110265559|NCT00409227|Urological Agents|urological agents|mesh-ancestor
110265561|NCT00533962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110265562|NCT00533962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110265563|NCT00533962|Growth Substances|growth substances|mesh-ancestor
110265564|NCT00533962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265565|NCT00533962|Growth Inhibitors|growth inhibitors|mesh-ancestor
110265566|NCT00533962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110265567|NCT00181818|Bupropion|bupropion|mesh-list
110265568|NCT00181818|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110265569|NCT00181818|Antidepressive Agents|antidepressive agents|mesh-ancestor
110265570|NCT00181818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110265571|NCT00181818|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110265572|NCT00181818|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110265573|NCT00181818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110272895|NCT04169828|Dermatologic Agents|dermatologic agents|mesh-ancestor
110265574|NCT00181818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110265575|NCT00181818|Dopamine Agents|dopamine agents|mesh-ancestor
110265576|NCT00181818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110265577|NCT00181818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265578|NCT00181818|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110265579|NCT00181818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110265580|NCT00181818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110265582|NCT04462627|Immunologic Factors|immunologic factors|mesh-ancestor
110265583|NCT04462627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265584|NCT00406601|Sorafenib|sorafenib|mesh-list
110265585|NCT00406601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110265586|NCT00406601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110265587|NCT00406601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110265588|NCT00406601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110265589|NCT00409305|Betahistine|betahistine|mesh-list
110265590|NCT00409305|Vasodilator Agents|vasodilator agents|mesh-ancestor
110265591|NCT00409305|Histamine Agonists|histamine agonists|mesh-ancestor
110265592|NCT00409305|Histamine Agents|histamine agents|mesh-ancestor
110265593|NCT00409305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110368718|NCT04617015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110265594|NCT00409305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110265595|NCT00409305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265597|NCT00406679|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110265598|NCT00406679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110265599|NCT00406679|Analgesics|analgesics|mesh-ancestor
110265600|NCT00406679|Sensory System Agents|sensory system agents|mesh-ancestor
110265601|NCT00406679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110265602|NCT00406679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265603|NCT00406679|Antipyretics|antipyretics|mesh-ancestor
110265604|NCT00181896|Bupropion|bupropion|mesh-list
110265605|NCT00181896|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110265606|NCT00181896|Antidepressive Agents|antidepressive agents|mesh-ancestor
110265607|NCT00181896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110265608|NCT00181896|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110265609|NCT00181896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110265610|NCT00181896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110265611|NCT00181896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110265612|NCT00181896|Dopamine Agents|dopamine agents|mesh-ancestor
110265613|NCT00181896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110265614|NCT00181896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265615|NCT00181896|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110265617|NCT00181896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110265618|NCT04686448|Fentanyl|fentanyl|mesh-list
110265619|NCT04686448|Ketamine|ketamine|mesh-list
110265620|NCT04686448|Propofol|propofol|mesh-list
110265621|NCT04686448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110265622|NCT04686448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110265623|NCT04686448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265624|NCT04686448|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110265625|NCT04686448|Anesthetics, General|anesthetics, general|mesh-ancestor
110265626|NCT04686448|Anesthetics|anesthetics|mesh-ancestor
110265627|NCT04686448|Analgesics|analgesics|mesh-ancestor
110265628|NCT04686448|Sensory System Agents|sensory system agents|mesh-ancestor
110265629|NCT04686448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110265630|NCT04686448|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110265631|NCT04686448|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110265632|NCT04686448|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110265633|NCT04686448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110272904|NCT04169828|Vitamin B Complex|vitamin b complex|mesh-ancestor
110265634|NCT04686448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110265635|NCT04686448|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110265636|NCT04686448|Narcotics|narcotics|mesh-ancestor
110265637|NCT04686448|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110265638|NCT00181935|Olanzapine|olanzapine|mesh-list
110265639|NCT00181935|Risperidone|risperidone|mesh-list
110265640|NCT00181935|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110265641|NCT00181935|Serotonin Agents|serotonin agents|mesh-ancestor
110265642|NCT00181935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110265643|NCT00181935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110265644|NCT00181935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265645|NCT00181935|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110265646|NCT00181935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110265647|NCT00181935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110265648|NCT00181935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110265649|NCT00181935|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110265650|NCT00181935|Dopamine Agents|dopamine agents|mesh-ancestor
110265651|NCT00181935|Antiemetics|antiemetics|mesh-ancestor
110265652|NCT00181935|Autonomic Agents|autonomic agents|mesh-ancestor
110265653|NCT00181935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110265654|NCT00181935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110265655|NCT00181935|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110265656|NCT00181935|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110265657|NCT00181935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110265658|NCT00409383|Paclitaxel|paclitaxel|mesh-list
110265659|NCT00409383|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110265660|NCT00409383|Temozolomide|temozolomide|mesh-list
110265661|NCT00409383|Oblimersen|oblimersen|mesh-list
110265662|NCT00409383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110265663|NCT00409383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110265664|NCT00409383|Tubulin Modulators|tubulin modulators|mesh-ancestor
110265665|NCT00409383|Antimitotic Agents|antimitotic agents|mesh-ancestor
110265666|NCT00409383|Mitosis Modulators|mitosis modulators|mesh-ancestor
110265667|NCT00409383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110265668|NCT00409383|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110265669|NCT00409383|Alkylating Agents|alkylating agents|mesh-ancestor
110265670|NCT04893148|Insulin Glargine|insulin glargine|mesh-list
110265672|NCT04893148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110265673|NCT04893148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265675|NCT04883632|Anesthetics, Local|anesthetics, local|mesh-ancestor
110265676|NCT04883632|Anesthetics|anesthetics|mesh-ancestor
110265677|NCT04883632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110265678|NCT04883632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265680|NCT04883632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110265681|NCT04883632|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110265682|NCT04883632|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110265683|NCT04883632|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110265684|NCT04883632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110265685|NCT04883632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110265686|NCT00181974|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110265687|NCT00181974|Hemostatics|hemostatics|mesh-ancestor
110265688|NCT00181974|Coagulants|coagulants|mesh-ancestor
110265689|NCT02569645|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110265690|NCT02569645|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110265691|NCT02569645|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110265692|NCT02569645|Antimetabolites|antimetabolites|mesh-ancestor
110265693|NCT02569645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110265694|NCT02569645|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110265695|NCT02569645|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110265697|NCT02500147|Metformin|metformin|mesh-list
110265698|NCT02500147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110265699|NCT02500147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265700|NCT00182013|Olanzapine|olanzapine|mesh-list
110265701|NCT00182013|Risperidone|risperidone|mesh-list
110265702|NCT00182013|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110265703|NCT00182013|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110265704|NCT00182013|Serotonin Agents|serotonin agents|mesh-ancestor
110265705|NCT00182013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110265706|NCT00182013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110265707|NCT00182013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265708|NCT00182013|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110265709|NCT00182013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110265710|NCT00182013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110265711|NCT00182013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110265712|NCT00182013|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110265713|NCT00182013|Dopamine Agents|dopamine agents|mesh-ancestor
110265714|NCT00182013|Antiemetics|antiemetics|mesh-ancestor
110265715|NCT00182013|Autonomic Agents|autonomic agents|mesh-ancestor
110265716|NCT00182013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110265717|NCT00182013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110265718|NCT00182013|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110265719|NCT00182013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110265720|NCT00182013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110265721|NCT00182013|Antidepressive Agents|antidepressive agents|mesh-ancestor
110265722|NCT00182052|Rosiglitazone|rosiglitazone|mesh-list
110265723|NCT00182052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110265724|NCT00182052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265725|NCT02081755|Mycophenolic Acid|mycophenolic acid|mesh-list
110265726|NCT02081755|Everolimus|everolimus|mesh-list
110265727|NCT02081755|Azathioprine|azathioprine|mesh-list
110265728|NCT02081755|Tacrolimus|tacrolimus|mesh-list
110265729|NCT02081755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110265730|NCT02081755|Immunologic Factors|immunologic factors|mesh-ancestor
110265731|NCT02081755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265732|NCT02081755|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110265733|NCT02081755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110265734|NCT02081755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110265735|NCT02081755|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110265736|NCT02081755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110265737|NCT02081755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110265738|NCT02081755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110265739|NCT02081755|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110265740|NCT02081755|Antitubercular Agents|antitubercular agents|mesh-ancestor
110265741|NCT02081755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110265742|NCT02081755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110265743|NCT02081755|Antimetabolites|antimetabolites|mesh-ancestor
110265744|NCT02081755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110265745|NCT02081755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110265746|NCT01715974|Molgramostim|molgramostim|mesh-list
110265747|NCT01715974|Sargramostim|sargramostim|mesh-list
110265748|NCT01715974|Immunologic Factors|immunologic factors|mesh-ancestor
110265749|NCT01715974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265750|NCT01715974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110265751|NCT05471479|Charcoal|charcoal|mesh-list
110265752|NCT05471479|Antidotes|antidotes|mesh-ancestor
110265753|NCT05471479|Protective Agents|protective agents|mesh-ancestor
110265754|NCT05471479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265755|NCT00188877|Fluorouracil|fluorouracil|mesh-list
110265756|NCT00188877|Antimetabolites|antimetabolites|mesh-ancestor
110265757|NCT00188877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110272930|NCT03961334|Edoxaban|edoxaban|mesh-list
110265758|NCT00188877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110265759|NCT00188877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110265760|NCT00188877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110265761|NCT00188877|Immunologic Factors|immunologic factors|mesh-ancestor
110265762|NCT00188877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265763|NCT00182169|Hormones|hormones|mesh-list
110265764|NCT00182169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110265765|NCT00182169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265766|NCT05471050|Danazol|danazol|mesh-list
110265767|NCT05471050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110265768|NCT05471050|Hormone Antagonists|hormone antagonists|mesh-ancestor
110265769|NCT05471050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110265770|NCT05471050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265771|NCT05470972|Ethanol|ethanol|mesh-list
110265772|NCT05470972|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110265773|NCT05470972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110265774|NCT05470972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110265775|NCT05470972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265776|NCT04686058|Midazolam|midazolam|mesh-list
110265777|NCT04686058|Meperidine|meperidine|mesh-list
110265779|NCT04686058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110265780|NCT04686058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110265781|NCT04686058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265782|NCT04686058|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110265783|NCT04686058|Anesthetics, General|anesthetics, general|mesh-ancestor
110265784|NCT04686058|Anesthetics|anesthetics|mesh-ancestor
110265785|NCT04686058|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110265786|NCT04686058|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110265787|NCT04686058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110265788|NCT04686058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110265789|NCT04686058|GABA Modulators|gaba modulators|mesh-ancestor
110265790|NCT04686058|GABA Agents|gaba agents|mesh-ancestor
110265791|NCT04686058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110265792|NCT04686058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110265793|NCT04686058|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110265794|NCT04686058|Narcotics|narcotics|mesh-ancestor
110265795|NCT04686058|Analgesics|analgesics|mesh-ancestor
110265796|NCT04686058|Sensory System Agents|sensory system agents|mesh-ancestor
110265797|NCT04686058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110265798|NCT00156299|Dexamethasone|dexamethasone|mesh-list
110265799|NCT00156299|Choline magnesium trisalicylate|choline magnesium trisalicylate|mesh-list
110265800|NCT00156299|Choline|choline|mesh-list
110265801|NCT00156299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110265802|NCT00156299|Antiemetics|antiemetics|mesh-ancestor
110265803|NCT00156299|Autonomic Agents|autonomic agents|mesh-ancestor
110265804|NCT00156299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110265805|NCT00156299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265806|NCT00156299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110265807|NCT00156299|Glucocorticoids|glucocorticoids|mesh-ancestor
110265808|NCT00156299|Hormones|hormones|mesh-ancestor
110265809|NCT00156299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110265810|NCT00156299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110265811|NCT00156299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110265812|NCT00156299|Lipotropic Agents|lipotropic agents|mesh-ancestor
110265813|NCT00156299|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110265814|NCT00156299|Antimetabolites|antimetabolites|mesh-ancestor
110265815|NCT00156299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110265816|NCT00156299|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110265817|NCT00156299|Nootropic Agents|nootropic agents|mesh-ancestor
110265818|NCT00156299|Analgesics|analgesics|mesh-ancestor
110265819|NCT00156299|Sensory System Agents|sensory system agents|mesh-ancestor
110265820|NCT00156299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110265821|NCT00156299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110265822|NCT00156299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110265823|NCT00535951|Panobinostat|panobinostat|mesh-list
110265824|NCT00535951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110265825|NCT00535951|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110265826|NCT00535951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110265827|NCT00535951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110265829|NCT00188955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110265830|NCT00188955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110265831|NCT00188955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110265832|NCT00188955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110265833|NCT00188955|Antifungal Agents|antifungal agents|mesh-ancestor
110265834|NCT00188955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110265835|NCT00188955|Immunologic Factors|immunologic factors|mesh-ancestor
110265836|NCT00188955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265837|NCT00536068|Acetaminophen|acetaminophen|mesh-list
110265838|NCT00536068|Aspirin|aspirin|mesh-list
110265839|NCT00536068|Diclofenac|diclofenac|mesh-list
110265840|NCT00536068|Naproxen|naproxen|mesh-list
110265841|NCT00536068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110265842|NCT00536068|Analgesics|analgesics|mesh-ancestor
110265843|NCT00536068|Sensory System Agents|sensory system agents|mesh-ancestor
110265844|NCT00536068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110265845|NCT00536068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265846|NCT00536068|Antipyretics|antipyretics|mesh-ancestor
110265847|NCT00536068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110265848|NCT00536068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110265849|NCT00536068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110265850|NCT00536068|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110265851|NCT00536068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110265852|NCT00536068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110265853|NCT00536068|Gout Suppressants|gout suppressants|mesh-ancestor
110265854|NCT00536068|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110265855|NCT00536068|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110265856|NCT00536068|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110265857|NCT05470582|Vaccines|vaccines|mesh-list
110265858|NCT05470582|Immunologic Factors|immunologic factors|mesh-ancestor
110265859|NCT05470582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265860|NCT00156377|Mupirocin|mupirocin|mesh-list
110265861|NCT00156377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110265862|NCT00156377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110265863|NCT00156377|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110265864|NCT00156377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110265865|NCT00156377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110265866|NCT00188994|Insulin|insulin|mesh-list
110265867|NCT00188994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110265868|NCT00188994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265869|NCT05469880|Benzoyl Peroxide|benzoyl peroxide|mesh-list
110265870|NCT05469880|Dermatologic Agents|dermatologic agents|mesh-ancestor
110265871|NCT00408525|Donepezil|donepezil|mesh-list
110272970|NCT03930953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110265872|NCT00408525|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110265873|NCT00408525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110265874|NCT00408525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110265875|NCT00408525|Cholinergic Agents|cholinergic agents|mesh-ancestor
110265876|NCT00408525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110265877|NCT00408525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265878|NCT00408525|Nootropic Agents|nootropic agents|mesh-ancestor
110265879|NCT05469529|Dexmedetomidine|dexmedetomidine|mesh-list
110265880|NCT05469529|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110265881|NCT05469529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110265882|NCT05469529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265883|NCT05469529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110265884|NCT05469529|Analgesics|analgesics|mesh-ancestor
110265885|NCT05469529|Sensory System Agents|sensory system agents|mesh-ancestor
110265886|NCT05469529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110265887|NCT05469529|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110265888|NCT05469529|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110265889|NCT05469529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110265890|NCT05469529|Adrenergic Agents|adrenergic agents|mesh-ancestor
110265891|NCT05469529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110265892|NCT05469529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110265893|NCT00189033|Psyllium|psyllium|mesh-list
110265894|NCT00189033|Cathartics|cathartics|mesh-ancestor
110265895|NCT00189033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110265896|NCT05469061|Cisplatin|cisplatin|mesh-list
110265897|NCT05469061|Tislelizumab|tislelizumab|mesh-list
110265898|NCT05469061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110265899|NCT05469061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110265900|NCT05469022|Lazertinib|lazertinib|mesh-list
110265901|NCT05469022|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110265902|NCT05469022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110265903|NCT05469022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110265904|NCT00189072|Gabapentin|gabapentin|mesh-list
110265905|NCT00189072|Analgesics|analgesics|mesh-ancestor
110265906|NCT00189072|Sensory System Agents|sensory system agents|mesh-ancestor
110265907|NCT00189072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110265908|NCT00189072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265909|NCT00189072|Anticonvulsants|anticonvulsants|mesh-ancestor
110265910|NCT00189072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110265911|NCT00189072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110265912|NCT00189072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110265913|NCT00189072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110265914|NCT00189072|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110265915|NCT00189072|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110265916|NCT00189072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110265917|NCT00189072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110265918|NCT00189072|Antimanic Agents|antimanic agents|mesh-ancestor
110265919|NCT00156611|Abciximab|abciximab|mesh-list
110265920|NCT00156611|Anticoagulants|anticoagulants|mesh-ancestor
110265922|NCT00156650|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110265923|NCT00156650|Medroxyprogesterone|medroxyprogesterone|mesh-list
110265924|NCT00156650|Testosterone|testosterone|mesh-list
110265925|NCT00156650|Acyline|acyline|mesh-list
110265927|NCT00156650|Hormones|hormones|mesh-ancestor
110265928|NCT00156650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110265929|NCT00156650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265930|NCT00156650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110265931|NCT00156650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110265932|NCT00156650|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110265933|NCT00156650|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110265934|NCT00156650|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110265935|NCT00156650|Contraceptive Agents|contraceptive agents|mesh-ancestor
110265936|NCT00156650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110265937|NCT00156650|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110265938|NCT00156650|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110265939|NCT00156650|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110265940|NCT00156650|Hormone Antagonists|hormone antagonists|mesh-ancestor
110265941|NCT00536419|Methylphenidate|methylphenidate|mesh-list
110265942|NCT00536419|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110265943|NCT00536419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265944|NCT00536419|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110265945|NCT00536419|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110265946|NCT00536419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110265947|NCT00536419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110265948|NCT00536419|Dopamine Agents|dopamine agents|mesh-ancestor
110265949|NCT00536419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110265950|NCT00189150|Mycophenolic Acid|mycophenolic acid|mesh-list
110265951|NCT00189150|Valganciclovir|valganciclovir|mesh-list
110265952|NCT00189150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110265953|NCT00189150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110265954|NCT00189150|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110265955|NCT00189150|Antitubercular Agents|antitubercular agents|mesh-ancestor
110265956|NCT00189150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110265957|NCT00189150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110265958|NCT00189150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110265959|NCT00189150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110265960|NCT00189150|Antiviral Agents|antiviral agents|mesh-ancestor
110034045|NCT01595620|Hormones|hormones|mesh-ancestor
110265961|NCT00156689|Levetiracetam|levetiracetam|mesh-list
110265964|NCT00536614|Cetuximab|cetuximab|mesh-list
110265965|NCT00536614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110265966|NCT00536614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110265967|NCT05468164|Omeprazole|omeprazole|mesh-list
110265968|NCT05468164|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110265969|NCT05468164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110265970|NCT05468164|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110265971|NCT05468164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110265972|NCT05468164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110265973|NCT05468047|Ketamine|ketamine|mesh-list
110265974|NCT05468047|Analgesics|analgesics|mesh-ancestor
110265975|NCT05468047|Sensory System Agents|sensory system agents|mesh-ancestor
110265977|NCT05468047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265978|NCT05468047|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110265979|NCT05468047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110265980|NCT05468047|Anesthetics, General|anesthetics, general|mesh-ancestor
110265981|NCT05468047|Anesthetics|anesthetics|mesh-ancestor
110265982|NCT05468047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110265983|NCT05468047|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110265984|NCT05468047|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110265985|NCT05468047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110265986|NCT05468047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110265987|NCT00182364|Heparin|heparin|mesh-list
110265988|NCT00182364|Calcium heparin|calcium heparin|mesh-list
110265989|NCT00182364|Dalteparin|dalteparin|mesh-list
110265990|NCT00182364|Tinzaparin|tinzaparin|mesh-list
110265991|NCT00182364|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110265992|NCT00182364|Anticoagulants|anticoagulants|mesh-ancestor
110265993|NCT00182364|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110265994|NCT00182364|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110265995|NCT00182364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110265996|NCT00536653|Calcium, Dietary|calcium, dietary|mesh-list
110265997|NCT00536653|Vitamin D|vitamin d|mesh-list
110265998|NCT00536653|Ergocalciferols|ergocalciferols|mesh-list
110265999|NCT00536653|Cholecalciferol|cholecalciferol|mesh-list
110266001|NCT00536653|Goserelin|goserelin|mesh-list
110266002|NCT00536653|Bicalutamide|bicalutamide|mesh-list
110266003|NCT00536653|Calcium|calcium|mesh-list
110266004|NCT00536653|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
110266005|NCT00536653|Micronutrients|micronutrients|mesh-ancestor
110266006|NCT00536653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110266007|NCT00536653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110266008|NCT00536653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110266009|NCT00536653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110266010|NCT00536653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110266011|NCT00536653|Androgen Antagonists|androgen antagonists|mesh-ancestor
110266012|NCT00536653|Hormone Antagonists|hormone antagonists|mesh-ancestor
110266013|NCT00536653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110266014|NCT00536653|Hormones|hormones|mesh-ancestor
110266015|NCT05467852|Dydrogesterone|dydrogesterone|mesh-list
110266016|NCT05467852|Progestins|progestins|mesh-ancestor
110266017|NCT05467852|Hormones|hormones|mesh-ancestor
110266018|NCT05467852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110266019|NCT05467852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110266020|NCT00536692|Mecamylamine|mecamylamine|mesh-list
110266021|NCT00536692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110266022|NCT00536692|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
110266023|NCT00536692|Autonomic Agents|autonomic agents|mesh-ancestor
110266024|NCT00536692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110266025|NCT00536692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110266026|NCT00536692|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
110266027|NCT00536692|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110266029|NCT00536692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110266030|NCT00536692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110266031|NCT00189345|Catumaxomab|catumaxomab|mesh-list
110266032|NCT00189345|Muromonab-CD3|muromonab-cd3|mesh-list
110266033|NCT00189345|Immunologic Factors|immunologic factors|mesh-ancestor
110266034|NCT00189345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110266035|NCT00189345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110266036|NCT00189345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110266037|NCT00156884|Cisplatin|cisplatin|mesh-list
110266038|NCT00156884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110266039|NCT05464693|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110266040|NCT05464693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110266041|NCT00156962|Epoetin Alfa|epoetin alfa|mesh-list
110266042|NCT00156962|Hematinics|hematinics|mesh-ancestor
110266043|NCT00182442|Olanzapine|olanzapine|mesh-list
110266044|NCT00182442|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110266045|NCT00182442|Antiemetics|antiemetics|mesh-ancestor
110266046|NCT00182442|Autonomic Agents|autonomic agents|mesh-ancestor
110368719|NCT04617015|Autonomic Agents|autonomic agents|mesh-ancestor
110266047|NCT00182442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110266048|NCT00182442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110266049|NCT00182442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110266050|NCT00182442|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110266051|NCT00182442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110266052|NCT00182442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110266053|NCT00182442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110266054|NCT00182442|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110266055|NCT00182442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110266056|NCT00182442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110266057|NCT00182442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110266058|NCT00182442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110266059|NCT00182442|Serotonin Agents|serotonin agents|mesh-ancestor
110266060|NCT00182442|Antidepressive Agents|antidepressive agents|mesh-ancestor
110266062|NCT00536770|Gemcitabine|gemcitabine|mesh-list
110266063|NCT00536770|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110266064|NCT00536770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110266065|NCT00536770|Antimetabolites|antimetabolites|mesh-ancestor
110266066|NCT00536770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110266067|NCT00536770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110266068|NCT00536770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110266069|NCT00536770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110266070|NCT00536770|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110266071|NCT00536770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110266072|NCT00536770|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110266073|NCT00536770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110266074|NCT00536770|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110266075|NCT00536770|Vitamins|vitamins|mesh-ancestor
110266076|NCT00536770|Micronutrients|micronutrients|mesh-ancestor
110266077|NCT00536770|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110266078|NCT04685512|Tenofovir|tenofovir|mesh-list
110266079|NCT04685512|Emtricitabine|emtricitabine|mesh-list
110266080|NCT04685512|Antiviral Agents|antiviral agents|mesh-ancestor
110266081|NCT04685512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110266082|NCT04685512|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110266083|NCT04685512|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110266084|NCT04685512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110266086|NCT04685512|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110266087|NCT04685512|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110266088|NCT00157040|Factor VIII|factor viii|mesh-list
110266089|NCT00157040|Coagulants|coagulants|mesh-ancestor
110266090|NCT00189384|Gentamicins|gentamicins|mesh-list
110266091|NCT00189384|Ceftriaxone|ceftriaxone|mesh-list
110266092|NCT00189384|Penicillins|penicillins|mesh-list
110266093|NCT00189384|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110266094|NCT00189384|Penicillin G Procaine|penicillin g procaine|mesh-list
110266095|NCT00189384|Penicillin G|penicillin g|mesh-list
110266096|NCT00189384|Penicillin G Benzathine|penicillin g benzathine|mesh-list
110266097|NCT00189384|Procaine|procaine|mesh-list
110266098|NCT00189384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110266099|NCT00189384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110266100|NCT00189384|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110266101|NCT00189384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110266102|NCT00189384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110266103|NCT00189384|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110266104|NCT00189384|Antimalarials|antimalarials|mesh-ancestor
110266105|NCT00189384|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110266106|NCT00189384|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110266107|NCT00189384|Anesthetics, Local|anesthetics, local|mesh-ancestor
110266108|NCT00189384|Anesthetics|anesthetics|mesh-ancestor
110266109|NCT00189384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110266110|NCT00189384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110266111|NCT00189384|Sensory System Agents|sensory system agents|mesh-ancestor
110266113|NCT00536848|Metronidazole|metronidazole|mesh-list
110266114|NCT00536848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110266115|NCT00536848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110266116|NCT00536848|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110266117|NCT00536848|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110266118|NCT00157079|Immunoglobulins|immunoglobulins|mesh-list
110266119|NCT00157079|Antibodies|antibodies|mesh-list
110266120|NCT00157079|gamma-Globulins|gamma-globulins|mesh-list
110266121|NCT00157079|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110266122|NCT00157079|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110266123|NCT00157079|Immunologic Factors|immunologic factors|mesh-ancestor
110266124|NCT00157079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110266126|NCT00189501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110266127|NCT00189501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110266128|NCT00189501|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
110266129|NCT00189501|Hormone Antagonists|hormone antagonists|mesh-ancestor
110266130|NCT00189501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110266131|NCT00157118|Protein C|protein c|mesh-list
110266132|NCT00157118|Anticoagulants|anticoagulants|mesh-ancestor
110266133|NCT00157118|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110266134|NCT00157118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110266135|NCT00157118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110266136|NCT00189579|Trastuzumab|trastuzumab|mesh-list
110266137|NCT00189579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110266138|NCT00189579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110266139|NCT00157235|Bromides|bromides|mesh-list
110266140|NCT00157235|Tiotropium Bromide|tiotropium bromide|mesh-list
110266141|NCT00157235|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110266142|NCT00157235|Autonomic Agents|autonomic agents|mesh-ancestor
110266143|NCT00157235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110266144|NCT00157235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110266145|NCT00157235|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110266146|NCT00157235|Respiratory System Agents|respiratory system agents|mesh-ancestor
110266147|NCT00157235|Parasympatholytics|parasympatholytics|mesh-ancestor
110266148|NCT00157235|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110266149|NCT00157235|Cholinergic Agents|cholinergic agents|mesh-ancestor
110266150|NCT00157235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110266151|NCT00157235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110266154|NCT00182520|Anticonvulsants|anticonvulsants|mesh-ancestor
110266155|NCT00182520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110266156|NCT00182520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110266157|NCT00157274|Alemtuzumab|alemtuzumab|mesh-list
110266158|NCT00157274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110266159|NCT00157274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110266160|NCT04257487|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
110266161|NCT04257487|Anticoagulants|anticoagulants|mesh-ancestor
110266162|NCT04257487|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110266163|NCT04257487|Antimetabolites|antimetabolites|mesh-ancestor
110266164|NCT04257487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110266165|NCT04257487|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110266166|NCT04257487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110266167|NCT04257487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110266168|NCT04257487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110266169|NCT04257487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110266170|NCT00182559|Cyclosporine|cyclosporine|mesh-list
110266171|NCT00182559|Tacrolimus|tacrolimus|mesh-list
110266172|NCT00182559|Cyclosporins|cyclosporins|mesh-list
110266173|NCT00182559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110266174|NCT00182559|Immunologic Factors|immunologic factors|mesh-ancestor
110266175|NCT00182559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110266176|NCT00182559|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110266177|NCT00182559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110266178|NCT00182559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110266179|NCT00182559|Antifungal Agents|antifungal agents|mesh-ancestor
110266180|NCT00182559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110266181|NCT00182559|Dermatologic Agents|dermatologic agents|mesh-ancestor
110266182|NCT00182559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110266184|NCT00425568|Androgens|androgens|mesh-ancestor
110266185|NCT00425568|Hormones|hormones|mesh-ancestor
110266186|NCT00425568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110266187|NCT00425568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110266188|NCT00157508|Nitroaspirin|nitroaspirin|mesh-list
110266189|NCT00157508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110266190|NCT00157508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110266191|NCT00157508|Analgesics|analgesics|mesh-ancestor
110266192|NCT00157508|Sensory System Agents|sensory system agents|mesh-ancestor
110266193|NCT00157508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110266194|NCT00157508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110266195|NCT00157508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110266196|NCT00157508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110266197|NCT00157508|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110266198|NCT00157508|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110266199|NCT00157508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110266200|NCT00157508|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110266201|NCT00157508|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
110266202|NCT00157508|Protease Inhibitors|protease inhibitors|mesh-ancestor
110266203|NCT00157508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110266205|NCT00189618|Clopidogrel|clopidogrel|mesh-list
110266206|NCT00189618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110266208|NCT00189618|Analgesics|analgesics|mesh-ancestor
110266209|NCT00189618|Sensory System Agents|sensory system agents|mesh-ancestor
110266210|NCT00189618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110266211|NCT00189618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110266212|NCT00189618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110266213|NCT00189618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110266214|NCT00189618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110266215|NCT00189618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110266216|NCT00189618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110266217|NCT00189618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110266218|NCT00189618|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110266219|NCT00189618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110266220|NCT00189618|Antipyretics|antipyretics|mesh-ancestor
110266221|NCT00189618|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110266222|NCT00189618|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110266223|NCT00189618|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110266224|NCT00189618|Purinergic Agents|purinergic agents|mesh-ancestor
110266225|NCT00189618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110266226|NCT00406796|Ranibizumab|ranibizumab|mesh-list
110266227|NCT00406796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110266228|NCT00406796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110266229|NCT00406796|Growth Substances|growth substances|mesh-ancestor
110266230|NCT00406796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110266231|NCT00406796|Growth Inhibitors|growth inhibitors|mesh-ancestor
110266232|NCT00406796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110266233|NCT00534391|Polymyxins|polymyxins|mesh-list
110266234|NCT00534391|Neomycin|neomycin|mesh-list
110266235|NCT00534391|Polymyxin B|polymyxin b|mesh-list
110266236|NCT00534391|Gramicidin|gramicidin|mesh-list
110266237|NCT00534391|Lubricant Eye Drops|lubricant eye drops|mesh-list
110266238|NCT00534391|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110266239|NCT00534391|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110266240|NCT00534391|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110266241|NCT00534391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110266242|NCT00534391|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110266243|NCT00534391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110266244|NCT00534391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110266245|NCT00534391|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110266246|NCT00534508|Tacrolimus|tacrolimus|mesh-list
110266247|NCT00534508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110266248|NCT00534508|Immunologic Factors|immunologic factors|mesh-ancestor
110266249|NCT00534508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110266250|NCT00534508|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110266251|NCT00534508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110266252|NCT00534508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110266253|NCT00182715|Leucovorin|leucovorin|mesh-list
110266254|NCT00182715|Fluorouracil|fluorouracil|mesh-list
110266255|NCT00182715|Capecitabine|capecitabine|mesh-list
110266256|NCT00182715|Oxaliplatin|oxaliplatin|mesh-list
110266257|NCT00182715|Cetuximab|cetuximab|mesh-list
110266258|NCT00182715|Calcium|calcium|mesh-list
110266259|NCT00182715|Levoleucovorin|levoleucovorin|mesh-list
110266260|NCT00182715|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110266261|NCT00182715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110266262|NCT00182715|Antimetabolites|antimetabolites|mesh-ancestor
110266263|NCT00182715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110266265|NCT00182715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110266266|NCT00182715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110266267|NCT00182715|Immunologic Factors|immunologic factors|mesh-ancestor
110266268|NCT00182715|Antidotes|antidotes|mesh-ancestor
110266269|NCT00182715|Protective Agents|protective agents|mesh-ancestor
110266270|NCT00182715|Vitamin B Complex|vitamin b complex|mesh-ancestor
110266272|NCT00182715|Micronutrients|micronutrients|mesh-ancestor
110266273|NCT00182715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110266274|NCT00534586|Ketamine|ketamine|mesh-list
110266275|NCT00534586|Remifentanil|remifentanil|mesh-list
110266276|NCT00534586|Propofol|propofol|mesh-list
110266278|NCT00534586|Esketamine|esketamine|mesh-list
110266279|NCT00534586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110266280|NCT00534586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110266281|NCT00534586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110266282|NCT00534586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110266283|NCT00534586|Anesthetics, General|anesthetics, general|mesh-ancestor
110266284|NCT00534586|Anesthetics|anesthetics|mesh-ancestor
110266285|NCT00534586|Analgesics|analgesics|mesh-ancestor
110266286|NCT00534586|Sensory System Agents|sensory system agents|mesh-ancestor
110266287|NCT00534586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110266288|NCT00534586|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110266289|NCT00534586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110266290|NCT00534586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110266291|NCT00534586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110266292|NCT00534586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110266293|NCT00534586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110266294|NCT00534586|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110266295|NCT00534586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110266296|NCT00534586|Narcotics|narcotics|mesh-ancestor
110266297|NCT00534586|Antidepressive Agents|antidepressive agents|mesh-ancestor
110266298|NCT00534586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110266300|NCT00534625|Hydroxyurea|hydroxyurea|mesh-list
110266301|NCT00534625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110266302|NCT00534625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110266303|NCT00534625|Analgesics|analgesics|mesh-ancestor
110266304|NCT00534625|Sensory System Agents|sensory system agents|mesh-ancestor
110266305|NCT00534625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110266306|NCT00534625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110266307|NCT00534625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110266308|NCT00534625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110266310|NCT00534625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110266311|NCT00534625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110266312|NCT00534625|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110266313|NCT00534625|Hormone Antagonists|hormone antagonists|mesh-ancestor
110266314|NCT00534625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110266315|NCT00534625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110266339|NCT04106830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110266340|NCT00189657|Irinotecan|irinotecan|mesh-list
110266341|NCT00189657|Fluorouracil|fluorouracil|mesh-list
110266342|NCT00189657|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110266343|NCT00189657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110266344|NCT00189657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110266345|NCT00189657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110266346|NCT00189657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110266347|NCT00189657|Antimetabolites|antimetabolites|mesh-ancestor
110266348|NCT00189657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110266349|NCT00189657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110266350|NCT00189657|Immunologic Factors|immunologic factors|mesh-ancestor
110266351|NCT00189657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110266353|NCT00406913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110266354|NCT00406913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110266355|NCT00406913|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110266356|NCT00406913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110266357|NCT00406913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110266358|NCT00406952|Sertraline|sertraline|mesh-list
110266359|NCT00406952|Antidepressive Agents|antidepressive agents|mesh-ancestor
110266360|NCT00406952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110266361|NCT00406952|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110266362|NCT00406952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110266363|NCT00406952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110266364|NCT00406952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110266365|NCT00406952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110266367|NCT00406952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110266368|NCT00157547|Fluvoxamine|fluvoxamine|mesh-list
110266369|NCT00157547|Citalopram|citalopram|mesh-list
110266370|NCT00157547|Fluoxetine|fluoxetine|mesh-list
110034396|NCT01398501|Sorafenib|sorafenib|mesh-list
110266371|NCT00157547|Paroxetine|paroxetine|mesh-list
110266372|NCT00157547|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110266373|NCT00157547|Sertraline|sertraline|mesh-list
110266374|NCT00157547|Escitalopram|escitalopram|mesh-list
110266375|NCT00157547|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
110266376|NCT00157547|Serotonin|serotonin|mesh-list
110266377|NCT00157547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110266378|NCT00157547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110266379|NCT00157547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110266380|NCT00157547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110266381|NCT00157547|Serotonin Agents|serotonin agents|mesh-ancestor
110266382|NCT00157547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110266383|NCT00157547|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110266384|NCT00157547|Antidepressive Agents|antidepressive agents|mesh-ancestor
110266385|NCT00157547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110266386|NCT00157547|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110266387|NCT00157547|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110266388|NCT00157547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110266389|NCT00157547|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110266390|NCT00157547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110266391|NCT00157547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110266392|NCT00157547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110266393|NCT00157547|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110266394|NCT00157547|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110266395|NCT00157547|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110266397|NCT04061161|Tiotropium Bromide|tiotropium bromide|mesh-list
110266398|NCT04061161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110266399|NCT04061161|Autonomic Agents|autonomic agents|mesh-ancestor
110266400|NCT04061161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110266401|NCT04061161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110266402|NCT04061161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110266403|NCT04061161|Respiratory System Agents|respiratory system agents|mesh-ancestor
110266405|NCT04061161|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110266406|NCT04061161|Cholinergic Agents|cholinergic agents|mesh-ancestor
110266407|NCT04061161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110266408|NCT04061161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110266409|NCT04061161|Anticonvulsants|anticonvulsants|mesh-ancestor
110266412|NCT00157586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110266413|NCT00157586|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110266414|NCT00157586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110266415|NCT00157586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110266416|NCT00157586|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110266417|NCT00157586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110266418|NCT00157586|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110266419|NCT00157586|Protease Inhibitors|protease inhibitors|mesh-ancestor
110266420|NCT00157586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110266424|NCT00182871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110266425|NCT00182871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110266426|NCT00189774|Nateglinide|nateglinide|mesh-list
110266427|NCT00189774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110266428|NCT00189774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110266429|NCT04686643|Niacin|niacin|mesh-list
110266430|NCT04686643|Amlodipine|amlodipine|mesh-list
110266431|NCT04686643|Valsartan|valsartan|mesh-list
110266432|NCT04686643|Indapamide|indapamide|mesh-list
110266433|NCT04686643|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110266434|NCT04686643|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110266435|NCT04686643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110266436|NCT04686643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110266437|NCT04686643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110266438|NCT04686643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110266439|NCT04686643|Vasodilator Agents|vasodilator agents|mesh-ancestor
110266440|NCT04686643|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110266441|NCT04686643|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110266442|NCT04686643|Diuretics|diuretics|mesh-ancestor
110266443|NCT04686643|Natriuretic Agents|natriuretic agents|mesh-ancestor
110266444|NCT04686643|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110266445|NCT04686643|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110266446|NCT04686643|Antimetabolites|antimetabolites|mesh-ancestor
110266447|NCT04686643|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110266448|NCT04686643|Vitamin B Complex|vitamin b complex|mesh-ancestor
110266449|NCT04686643|Vitamins|vitamins|mesh-ancestor
110266450|NCT04686643|Micronutrients|micronutrients|mesh-ancestor
110266451|NCT00534898|Fenretinide|fenretinide|mesh-list
110266452|NCT00534898|Bexarotene|bexarotene|mesh-list
110266453|NCT00534898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110266454|NCT00534898|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110266455|NCT00534898|Protective Agents|protective agents|mesh-ancestor
110266456|NCT00534898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110266457|NCT03748810|Metformin|metformin|mesh-list
110266459|NCT03748810|Empagliflozin|empagliflozin|mesh-list
110266460|NCT03748810|Glimepiride|glimepiride|mesh-list
110266461|NCT03748810|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
110266468|NCT03748810|Immunologic Factors|immunologic factors|mesh-ancestor
110266469|NCT03748810|Protease Inhibitors|protease inhibitors|mesh-ancestor
110266470|NCT03748810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110266472|NCT00157859|Pyrimethamine|pyrimethamine|mesh-list
110266473|NCT00157859|Sulfadoxine|sulfadoxine|mesh-list
110266474|NCT00157859|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110266475|NCT00157859|Amebicides|amebicides|mesh-ancestor
110266476|NCT00157859|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110266477|NCT00157859|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110266478|NCT00157859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110266479|NCT00157859|Antimalarials|antimalarials|mesh-ancestor
110266480|NCT00157859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110266481|NCT00157859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110266482|NCT00157859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110266483|NCT00157859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110266484|NCT00157859|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110266486|NCT00157898|Ceftriaxone|ceftriaxone|mesh-list
110266487|NCT00157898|Ertapenem|ertapenem|mesh-list
110266488|NCT00157898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110266489|NCT00157898|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110266490|NCT00157898|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110266491|NCT00157898|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110266493|NCT03669523|Nivolumab|nivolumab|mesh-list
110266494|NCT03669523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110266495|NCT03669523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110266496|NCT03669523|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110266497|NCT03669523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110266498|NCT03669523|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110266499|NCT03669523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110266500|NCT00157976|Tin etiopurpurin|tin etiopurpurin|mesh-list
110266501|NCT00157976|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110266502|NCT00157976|Dermatologic Agents|dermatologic agents|mesh-ancestor
110266504|NCT00158093|Atenolol|atenolol|mesh-list
110266505|NCT00158093|Nebivolol|nebivolol|mesh-list
110266506|NCT00158093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110266507|NCT00158093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110266508|NCT00158093|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110266509|NCT00158093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110266510|NCT00158093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110266511|NCT00158093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110266512|NCT00158093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110266513|NCT00158093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110266514|NCT00158093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110266515|NCT00158093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110266517|NCT00158093|Autonomic Agents|autonomic agents|mesh-ancestor
110266518|NCT00158093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110266519|NCT00158093|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110266520|NCT00158093|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110266521|NCT00158093|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110266526|NCT00158093|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110266527|NCT00158093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110266528|NCT03429946|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110266529|NCT03429946|Spironolactone|spironolactone|mesh-list
110266530|NCT03429946|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110266531|NCT03429946|Hormone Antagonists|hormone antagonists|mesh-ancestor
110266532|NCT03429946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110266533|NCT03429946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110266534|NCT03429946|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110266535|NCT03429946|Diuretics|diuretics|mesh-ancestor
110266536|NCT03429946|Natriuretic Agents|natriuretic agents|mesh-ancestor
110266537|NCT00189930|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
110266538|NCT00189930|Antiviral Agents|antiviral agents|mesh-ancestor
110266539|NCT00189930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110266540|NCT00158132|Amantadine|amantadine|mesh-list
110266541|NCT00158132|Propranolol|propranolol|mesh-list
110266542|NCT00158132|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110266543|NCT00158132|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110266544|NCT00158132|Adrenergic Agents|adrenergic agents|mesh-ancestor
110266545|NCT00158132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110266546|NCT00158132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110266547|NCT00158132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110266548|NCT00158132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110266549|NCT00158132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110266550|NCT00158132|Vasodilator Agents|vasodilator agents|mesh-ancestor
110266551|NCT00158132|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110266552|NCT00158132|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110266553|NCT00158132|Antiviral Agents|antiviral agents|mesh-ancestor
110266554|NCT00158132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110266555|NCT00158132|Dopamine Agents|dopamine agents|mesh-ancestor
110266556|NCT00158132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110266557|NCT00158132|Analgesics|analgesics|mesh-ancestor
110266558|NCT00158132|Sensory System Agents|sensory system agents|mesh-ancestor
110266559|NCT00158132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110266560|NCT00158171|Folic Acid|folic acid|mesh-list
110266561|NCT00158171|Nicotine|nicotine|mesh-list
110266563|NCT00158171|Autonomic Agents|autonomic agents|mesh-ancestor
110266564|NCT00158171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110266565|NCT00158171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110266566|NCT00158171|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110266567|NCT00158171|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110266568|NCT00158171|Cholinergic Agents|cholinergic agents|mesh-ancestor
110266569|NCT00158171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110368720|NCT04617015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110266570|NCT00158171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110266572|NCT00158171|Vitamin B Complex|vitamin b complex|mesh-ancestor
110266573|NCT00158171|Vitamins|vitamins|mesh-ancestor
110266574|NCT00158171|Micronutrients|micronutrients|mesh-ancestor
110266575|NCT03370783|Ethanol|ethanol|mesh-list
110266576|NCT03370783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110266577|NCT03370783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110266578|NCT03370783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110266581|NCT00158210|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110266582|NCT00158210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110266583|NCT00158210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110266584|NCT00158210|Cholinergic Agents|cholinergic agents|mesh-ancestor
110266585|NCT00158210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110266586|NCT00158210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110266587|NCT00158210|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110266588|NCT00158210|Protective Agents|protective agents|mesh-ancestor
110266589|NCT00190008|Piracetam|piracetam|mesh-list
110266590|NCT00190008|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110266591|NCT00190008|Protective Agents|protective agents|mesh-ancestor
110266592|NCT00190008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110266593|NCT00190008|Nootropic Agents|nootropic agents|mesh-ancestor
110266594|NCT00183222|Naltrexone|naltrexone|mesh-list
110266595|NCT00183222|Ondansetron|ondansetron|mesh-list
110266596|NCT00183222|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110266597|NCT00183222|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110266598|NCT00183222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110266599|NCT00183222|Sensory System Agents|sensory system agents|mesh-ancestor
110266600|NCT00183222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110266601|NCT00183222|Antiemetics|antiemetics|mesh-ancestor
110266602|NCT00183222|Autonomic Agents|autonomic agents|mesh-ancestor
110266603|NCT00183222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110266604|NCT00183222|Antipruritics|antipruritics|mesh-ancestor
110266605|NCT00183222|Dermatologic Agents|dermatologic agents|mesh-ancestor
110266606|NCT00183222|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110266607|NCT00183222|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110266608|NCT00183222|Serotonin Agents|serotonin agents|mesh-ancestor
110266609|NCT00183222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110266610|NCT00183222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110266612|NCT00158405|Indinavir|indinavir|mesh-list
110266613|NCT00158405|Lamivudine|lamivudine|mesh-list
110266614|NCT00158405|Zidovudine|zidovudine|mesh-list
110266615|NCT00158405|Efavirenz|efavirenz|mesh-list
110266616|NCT00158405|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110266617|NCT00158405|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110266618|NCT00158405|Protease Inhibitors|protease inhibitors|mesh-ancestor
110266619|NCT00158405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110266620|NCT00158405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110266621|NCT00158405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110266622|NCT00158405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110266623|NCT00158405|Antiviral Agents|antiviral agents|mesh-ancestor
110266624|NCT00158405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110266625|NCT00158405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110266626|NCT00158405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110266627|NCT00158405|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110266628|NCT00158405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110266629|NCT00158405|Antimetabolites|antimetabolites|mesh-ancestor
110266630|NCT00158405|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110266631|NCT00158405|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110266632|NCT00158405|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110266633|NCT00158405|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110266634|NCT00158405|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110266635|NCT00158483|Acyclovir|acyclovir|mesh-list
110266636|NCT00158483|Antiviral Agents|antiviral agents|mesh-ancestor
110266637|NCT00158483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110266638|NCT00158522|Interferons|interferons|mesh-list
110266639|NCT00158522|Interferon-alpha|interferon-alpha|mesh-list
110266640|NCT00158522|Interferon alpha-2|interferon alpha-2|mesh-list
110266641|NCT00158522|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110266642|NCT00158522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110266643|NCT00158522|Antiviral Agents|antiviral agents|mesh-ancestor
110266644|NCT00158522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110266653|NCT00158561|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110266654|NCT00158561|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110266655|NCT00158561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110266656|NCT00158561|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110266657|NCT00158561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110266658|NCT00158561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110266659|NCT00158561|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110266660|NCT00158561|Leprostatic Agents|leprostatic agents|mesh-ancestor
110266661|NCT00158561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110266664|NCT05169229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110266665|NCT05169229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110266666|NCT00538018|Telithromycin|telithromycin|mesh-list
110266667|NCT00538018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110266668|NCT00538018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110266669|NCT00538096|Blinatumomab|blinatumomab|mesh-list
110266671|NCT00158678|Cisplatin|cisplatin|mesh-list
110266672|NCT00158678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110266673|NCT00538174|Dapagliflozin|dapagliflozin|mesh-list
110266674|NCT00538174|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110266675|NCT00538174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110266676|NCT00538174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110266677|NCT00538174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110266678|NCT04724486|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110266679|NCT04724486|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110266680|NCT04724486|Cetrorelix|cetrorelix|mesh-list
110266681|NCT04724486|Menotropins|menotropins|mesh-list
110266682|NCT04724486|Luteolytic Agents|luteolytic agents|mesh-ancestor
110266683|NCT04724486|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110266684|NCT04724486|Contraceptive Agents|contraceptive agents|mesh-ancestor
110266685|NCT04724486|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110266686|NCT04724486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110266687|NCT04724486|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110266688|NCT04724486|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110266689|NCT04724486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110266690|NCT04724486|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110266691|NCT04724486|Fertility Agents|fertility agents|mesh-ancestor
110266692|NCT04724486|Hormone Antagonists|hormone antagonists|mesh-ancestor
110266693|NCT04724486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110266694|NCT00538330|Tamoxifen|tamoxifen|mesh-list
110266695|NCT00538330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110266696|NCT00538330|Hormone Antagonists|hormone antagonists|mesh-ancestor
110266697|NCT00538330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110266698|NCT00538330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110266699|NCT00538330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110266700|NCT00538330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110273169|NCT02365597|Metformin|metformin|mesh-list
110266701|NCT00538330|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110266702|NCT00538330|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110266703|NCT00538330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110266704|NCT00158717|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
110266706|NCT00158717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110266707|NCT00158717|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110266708|NCT00158717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110266709|NCT00158717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110266710|NCT00158717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110266714|NCT00538486|Candesartan|candesartan|mesh-list
110266715|NCT00538486|Candesartan cilexetil|candesartan cilexetil|mesh-list
110266716|NCT00538486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110266717|NCT00538486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110266718|NCT00538486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110266719|NCT00538486|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110266720|NCT00538486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110266721|NCT00538486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110266722|NCT00538486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110266723|NCT00538486|Vasodilator Agents|vasodilator agents|mesh-ancestor
110266724|NCT00538486|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110266725|NCT00538486|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110266726|NCT00538525|Docetaxel|docetaxel|mesh-list
110266727|NCT00538525|Doxorubicin|doxorubicin|mesh-list
110266728|NCT00538525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110266729|NCT00538525|Tubulin Modulators|tubulin modulators|mesh-ancestor
110266730|NCT00538525|Antimitotic Agents|antimitotic agents|mesh-ancestor
110266731|NCT00538525|Mitosis Modulators|mitosis modulators|mesh-ancestor
110266732|NCT00538525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110266733|NCT00538525|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110266734|NCT00538525|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110266735|NCT00538525|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110266736|NCT00538525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110266738|NCT00538564|Vasodilator Agents|vasodilator agents|mesh-ancestor
110266739|NCT00538564|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110266740|NCT00538564|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110266741|NCT00538564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110266742|NCT00538564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110266743|NCT00538564|Urological Agents|urological agents|mesh-ancestor
110266745|NCT00538603|Carboplatin|carboplatin|mesh-list
110266746|NCT00538603|Doxorubicin|doxorubicin|mesh-list
110266747|NCT00538603|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110266748|NCT00538603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110266749|NCT00538603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110266750|NCT00538603|Tubulin Modulators|tubulin modulators|mesh-ancestor
110266751|NCT00538603|Antimitotic Agents|antimitotic agents|mesh-ancestor
110266752|NCT00538603|Mitosis Modulators|mitosis modulators|mesh-ancestor
110266753|NCT00538603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110266754|NCT00538603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110266755|NCT00538603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110266757|NCT00538603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110266758|NCT00158834|Fluticasone|fluticasone|mesh-list
110266760|NCT00158834|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110266761|NCT00158834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110266762|NCT00158834|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110266763|NCT00158834|Autonomic Agents|autonomic agents|mesh-ancestor
110266764|NCT00158834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110266765|NCT00158834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110266766|NCT00158834|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110266767|NCT00158834|Respiratory System Agents|respiratory system agents|mesh-ancestor
110266768|NCT00158834|Dermatologic Agents|dermatologic agents|mesh-ancestor
110266769|NCT00158834|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110266770|NCT00158834|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110266771|NCT00158834|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110266772|NCT00158834|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110266773|NCT00158834|Adrenergic Agents|adrenergic agents|mesh-ancestor
110266774|NCT00158834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110266775|NCT00158834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110266776|NCT00538720|Vitamin D|vitamin d|mesh-list
110266777|NCT00538720|Ergocalciferols|ergocalciferols|mesh-list
110266778|NCT00538720|Vitamins|vitamins|mesh-ancestor
110266780|NCT00538720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110266781|NCT00538720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110266782|NCT00538720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110266783|NCT00536887|Atorvastatin|atorvastatin|mesh-list
110266784|NCT00536887|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110266785|NCT00536887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110266786|NCT00536887|Antimetabolites|antimetabolites|mesh-ancestor
110266787|NCT00536887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110266788|NCT00536887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110266789|NCT00536887|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110266790|NCT00536887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110266791|NCT00158873|Fentanyl|fentanyl|mesh-list
110266792|NCT00158873|Midazolam|midazolam|mesh-list
110266793|NCT00158873|Morphine|morphine|mesh-list
110266794|NCT00158873|Remifentanil|remifentanil|mesh-list
110266795|NCT00158873|Lorazepam|lorazepam|mesh-list
110266796|NCT00158873|Propofol|propofol|mesh-list
110266797|NCT00158873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110266798|NCT00158873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110266799|NCT00158873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110266800|NCT00158873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110266801|NCT00158873|Anesthetics, General|anesthetics, general|mesh-ancestor
110266802|NCT00158873|Anesthetics|anesthetics|mesh-ancestor
110266803|NCT00158873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110266804|NCT00158873|Narcotics|narcotics|mesh-ancestor
110266805|NCT00158873|Analgesics|analgesics|mesh-ancestor
110266806|NCT00158873|Sensory System Agents|sensory system agents|mesh-ancestor
110266807|NCT00158873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110266808|NCT00158873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110266809|NCT00158873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110266810|NCT00158873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110266811|NCT00158873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110266812|NCT00158873|GABA Modulators|gaba modulators|mesh-ancestor
110266820|NCT00537121|Leucovorin|leucovorin|mesh-list
110266821|NCT00537121|Fluorouracil|fluorouracil|mesh-list
110266822|NCT00537121|Irinotecan|irinotecan|mesh-list
110266823|NCT00537121|Vorinostat|vorinostat|mesh-list
110266824|NCT00537121|Calcium|calcium|mesh-list
110266825|NCT00537121|Levoleucovorin|levoleucovorin|mesh-list
110266826|NCT00537121|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110266828|NCT00537121|Antimetabolites|antimetabolites|mesh-ancestor
110266829|NCT00537121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110266830|NCT00537121|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110266831|NCT00537121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110266832|NCT00537121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110266833|NCT00537121|Immunologic Factors|immunologic factors|mesh-ancestor
110266834|NCT00537121|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110266835|NCT00537121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110266836|NCT00537121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110266837|NCT00537121|Antidotes|antidotes|mesh-ancestor
110266838|NCT00537121|Protective Agents|protective agents|mesh-ancestor
110266839|NCT00537121|Vitamin B Complex|vitamin b complex|mesh-ancestor
110266840|NCT00537121|Vitamins|vitamins|mesh-ancestor
110266841|NCT00537121|Micronutrients|micronutrients|mesh-ancestor
110266842|NCT00537121|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110266843|NCT00406991|Aspirin|aspirin|mesh-list
110266844|NCT00406991|Clopidogrel|clopidogrel|mesh-list
110266845|NCT00406991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110266846|NCT00406991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110266847|NCT00406991|Analgesics|analgesics|mesh-ancestor
110266848|NCT00406991|Sensory System Agents|sensory system agents|mesh-ancestor
110266849|NCT00406991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110266850|NCT00406991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110266851|NCT00406991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110266852|NCT00406991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110266853|NCT00406991|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110266854|NCT00406991|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110266855|NCT00406991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110266856|NCT00406991|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110266857|NCT00406991|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110266858|NCT00406991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110266859|NCT00406991|Antipyretics|antipyretics|mesh-ancestor
110266860|NCT00406991|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110266861|NCT00406991|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110266862|NCT00406991|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110266863|NCT00406991|Purinergic Agents|purinergic agents|mesh-ancestor
110266864|NCT00406991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110266865|NCT05432947|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110266866|NCT05432947|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110266867|NCT05432947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110266871|NCT00158990|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110266872|NCT00158990|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110266873|NCT00158990|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110266874|NCT00158990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110273219|NCT01828112|Tubulin Modulators|tubulin modulators|mesh-ancestor
110266875|NCT00158990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110266876|NCT00158990|Serotonin Agents|serotonin agents|mesh-ancestor
110266877|NCT00158990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110266878|NCT00537355|Histamine|histamine|mesh-list
110266879|NCT00537355|Histamine Agonists|histamine agonists|mesh-ancestor
110266880|NCT00537355|Histamine Agents|histamine agents|mesh-ancestor
110266881|NCT00537355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110266882|NCT00537355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110266883|NCT00537355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110266885|NCT00183612|Antiemetics|antiemetics|mesh-ancestor
110266886|NCT00183612|Autonomic Agents|autonomic agents|mesh-ancestor
110266887|NCT00183612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110266888|NCT00183612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110266889|NCT00183612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110266890|NCT00183612|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110266891|NCT00183612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110266892|NCT00183612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110266893|NCT00183612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110266894|NCT00183612|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110266895|NCT00183612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110266896|NCT00183612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110266897|NCT00183612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110266898|NCT00183612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110266899|NCT00183612|Serotonin Agents|serotonin agents|mesh-ancestor
110266900|NCT05381623|Hemostatics|hemostatics|mesh-list
110266901|NCT05381623|Coagulants|coagulants|mesh-ancestor
110266902|NCT00537472|Bupivacaine|bupivacaine|mesh-list
110266903|NCT00537472|Anesthetics|anesthetics|mesh-list
110266904|NCT00537472|Anesthetics, Local|anesthetics, local|mesh-ancestor
110266905|NCT00537472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110266906|NCT00537472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110266907|NCT00537472|Sensory System Agents|sensory system agents|mesh-ancestor
110266908|NCT00537472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110266910|NCT00159107|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110266911|NCT00537550|Methotrexate|methotrexate|mesh-list
110266912|NCT00537550|Vincristine|vincristine|mesh-list
110266913|NCT00537550|Asparaginase|asparaginase|mesh-list
110266914|NCT00537550|Daunorubicin|daunorubicin|mesh-list
110266915|NCT00537550|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110266916|NCT00537550|Abortifacient Agents|abortifacient agents|mesh-ancestor
110266917|NCT00537550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110266918|NCT00537550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110266919|NCT00537550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110266920|NCT00537550|Antimetabolites|antimetabolites|mesh-ancestor
110266921|NCT00537550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110266923|NCT00537550|Dermatologic Agents|dermatologic agents|mesh-ancestor
110034730|NCT01401036|Immunologic Factors|immunologic factors|mesh-ancestor
110266924|NCT00537550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110266925|NCT00537550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110266926|NCT00537550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110266927|NCT00537550|Immunologic Factors|immunologic factors|mesh-ancestor
110266928|NCT00537550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110266929|NCT00537550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110266930|NCT00537550|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110266931|NCT00537550|Tubulin Modulators|tubulin modulators|mesh-ancestor
110266932|NCT00537550|Antimitotic Agents|antimitotic agents|mesh-ancestor
110266933|NCT00537550|Mitosis Modulators|mitosis modulators|mesh-ancestor
110266934|NCT00537550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110266935|NCT00537550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110266936|NCT00537550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110266938|NCT00159146|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110266939|NCT00159146|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110266940|NCT00159146|Adrenergic Agents|adrenergic agents|mesh-ancestor
110266941|NCT00159146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110266942|NCT00159146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110266943|NCT00159146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110266944|NCT00159146|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110266945|NCT00159146|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110266946|NCT00159146|Serotonin Agents|serotonin agents|mesh-ancestor
110266947|NCT00159146|Vasodilator Agents|vasodilator agents|mesh-ancestor
110266948|NCT00537667|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110266949|NCT00537667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110266951|NCT00538876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110266952|NCT00538876|Antimetabolites|antimetabolites|mesh-ancestor
110266953|NCT00538876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110266954|NCT00538876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110266955|NCT00538876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110266957|NCT00538954|Antacids|antacids|mesh-ancestor
110266958|NCT00538954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110266959|NCT00538954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110266960|NCT00539071|Risperidone|risperidone|mesh-list
110266961|NCT00539071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110266962|NCT00539071|Serotonin Agents|serotonin agents|mesh-ancestor
110266963|NCT00539071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110266964|NCT00539071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110266965|NCT00539071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110266966|NCT00539071|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110266967|NCT00539071|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110266968|NCT00539071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110266969|NCT00539071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110266970|NCT00539071|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110266971|NCT00539071|Dopamine Agents|dopamine agents|mesh-ancestor
110266972|NCT00539149|Amoxicillin|amoxicillin|mesh-list
110266973|NCT00539149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110266974|NCT00539149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110266975|NCT00183807|Celecoxib|celecoxib|mesh-list
110266976|NCT00183807|Irinotecan|irinotecan|mesh-list
110266977|NCT00183807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110266978|NCT00183807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110266979|NCT00183807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110266980|NCT00183807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110266983|NCT00183807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110266984|NCT00183807|Analgesics|analgesics|mesh-ancestor
110266985|NCT00183807|Sensory System Agents|sensory system agents|mesh-ancestor
110266986|NCT00183807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110266987|NCT00183807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110266988|NCT00183807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110266989|NCT00183807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110266990|NCT00183807|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110266991|NCT00183807|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110266993|NCT00539773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110266994|NCT00539773|Antiviral Agents|antiviral agents|mesh-ancestor
110266995|NCT00539773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110266996|NCT00409461|Sirolimus|sirolimus|mesh-list
110266997|NCT00409461|Tacrolimus|tacrolimus|mesh-list
110266998|NCT00409461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110266999|NCT00409461|Immunologic Factors|immunologic factors|mesh-ancestor
110267000|NCT00409461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267001|NCT00409461|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110267002|NCT00409461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110267003|NCT00409461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267004|NCT00409461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110267005|NCT00409461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110267006|NCT00409461|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110267007|NCT00409461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110267008|NCT00409461|Antifungal Agents|antifungal agents|mesh-ancestor
110267010|NCT00539890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110267011|NCT00539890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267013|NCT00539968|Lonafarnib|lonafarnib|mesh-list
110267014|NCT00539968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110267015|NCT00539968|Tubulin Modulators|tubulin modulators|mesh-ancestor
110267016|NCT00539968|Antimitotic Agents|antimitotic agents|mesh-ancestor
110267017|NCT00539968|Mitosis Modulators|mitosis modulators|mesh-ancestor
110267018|NCT00539968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267019|NCT00539968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110267021|NCT00183846|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110267022|NCT00183846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110267023|NCT00183846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110267024|NCT00183846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267025|NCT00183846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110267026|NCT00540085|Rocuronium|rocuronium|mesh-list
110267027|NCT00540085|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110267028|NCT00540085|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110267029|NCT00540085|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110267030|NCT00540085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110267031|NCT00540085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267032|NCT00540202|Lumefantrine|lumefantrine|mesh-list
110267033|NCT00540202|Artemether|artemether|mesh-list
110267034|NCT00540202|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110267035|NCT00540202|Quinine|quinine|mesh-list
110267036|NCT00540202|Antimalarials|antimalarials|mesh-ancestor
110267037|NCT00540202|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110267038|NCT00540202|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110267042|NCT00540202|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110267043|NCT00540202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110267044|NCT00540202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110267045|NCT00540202|Analgesics|analgesics|mesh-ancestor
110267046|NCT00540202|Sensory System Agents|sensory system agents|mesh-ancestor
110267048|NCT00540241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110267049|NCT00540241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110267050|NCT00540241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267051|NCT00540241|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110267052|NCT00540241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110267054|NCT00159224|Lopinavir|lopinavir|mesh-list
110267055|NCT00159224|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110267056|NCT00159224|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110267057|NCT00159224|Protease Inhibitors|protease inhibitors|mesh-ancestor
110267058|NCT00159224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110267059|NCT00159224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267060|NCT00159224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110267061|NCT00159224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110267062|NCT00159224|Antiviral Agents|antiviral agents|mesh-ancestor
110267063|NCT00159224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110273253|NCT01286272|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110267064|NCT00159224|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110267065|NCT00159224|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110267066|NCT00540280|Gemcitabine|gemcitabine|mesh-list
110267067|NCT00540280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110267068|NCT00540280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110267069|NCT00540280|Antimetabolites|antimetabolites|mesh-ancestor
110267070|NCT00540280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267071|NCT00183924|Carboplatin|carboplatin|mesh-list
110267072|NCT00183924|Docetaxel|docetaxel|mesh-list
110267073|NCT00183924|Estramustine|estramustine|mesh-list
110267074|NCT00183924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110267076|NCT00183924|Antimitotic Agents|antimitotic agents|mesh-ancestor
110267077|NCT00183924|Mitosis Modulators|mitosis modulators|mesh-ancestor
110267078|NCT00183924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267079|NCT00183924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110267080|NCT00183924|Alkylating Agents|alkylating agents|mesh-ancestor
110267081|NCT00183924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110267083|NCT00159302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110267084|NCT00159302|Autonomic Agents|autonomic agents|mesh-ancestor
110267085|NCT00159302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110267086|NCT00159302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267087|NCT00159302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110267088|NCT00159302|Respiratory System Agents|respiratory system agents|mesh-ancestor
110267089|NCT00159302|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110267090|NCT00159302|Antioxidants|antioxidants|mesh-ancestor
110267091|NCT00159302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267092|NCT00159302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110267093|NCT00159302|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110267094|NCT00159302|Vasodilator Agents|vasodilator agents|mesh-ancestor
110267095|NCT00159302|Gasotransmitters|gasotransmitters|mesh-ancestor
110267096|NCT00159302|Protective Agents|protective agents|mesh-ancestor
110267097|NCT00540631|Immunomodulating Agents|immunomodulating agents|mesh-list
110267107|NCT00183885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110267108|NCT00540709|Insulin Glargine|insulin glargine|mesh-list
110267109|NCT00540709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110267110|NCT00540709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267113|NCT00540748|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110267114|NCT00540748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267115|NCT00540787|Quinidine|quinidine|mesh-list
110267116|NCT00540787|Amiodarone|amiodarone|mesh-list
110267117|NCT00540787|Sotalol|sotalol|mesh-list
110267118|NCT00540787|Flecainide|flecainide|mesh-list
110267119|NCT00540787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
110267120|NCT00540787|Propafenone|propafenone|mesh-list
110267121|NCT00540787|Dofetilide|dofetilide|mesh-list
110267122|NCT00540787|Cifenline|cifenline|mesh-list
110267123|NCT00540787|Calcium Channel Blockers|calcium channel blockers|mesh-list
110267124|NCT00540787|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110267125|NCT00540787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267126|NCT00540787|Vasodilator Agents|vasodilator agents|mesh-ancestor
110267127|NCT00540787|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110267128|NCT00540787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110267129|NCT00540787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267130|NCT00540787|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110267131|NCT00540787|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110267132|NCT00540787|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110267133|NCT00540787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110267134|NCT00540787|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110267135|NCT00540787|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110267136|NCT00540787|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110267137|NCT00540787|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110267138|NCT00540787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110267139|NCT00540787|Adrenergic Agents|adrenergic agents|mesh-ancestor
110267140|NCT00540787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110267141|NCT00540787|Sympatholytics|sympatholytics|mesh-ancestor
110267142|NCT00540787|Autonomic Agents|autonomic agents|mesh-ancestor
110034864|NCT01402089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110267143|NCT00540787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110267144|NCT00540787|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110267145|NCT00540787|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110267146|NCT00540787|Antimalarials|antimalarials|mesh-ancestor
110267147|NCT00540787|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110267148|NCT00540787|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110267149|NCT00540787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110267150|NCT00540787|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110267152|NCT00540787|Cholinergic Agents|cholinergic agents|mesh-ancestor
110267154|NCT00159380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110267155|NCT00159380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267156|NCT00540826|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110267157|NCT00540826|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110267158|NCT00540826|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110267160|NCT00540826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267161|NCT00540826|Adrenergic Agents|adrenergic agents|mesh-ancestor
110267162|NCT00540826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110267163|NCT00540826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267164|NCT00540943|Irinotecan|irinotecan|mesh-list
110267165|NCT00540943|Cetuximab|cetuximab|mesh-list
110267166|NCT00540943|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110267167|NCT00540943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110267168|NCT00540943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110267169|NCT00540943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267170|NCT00540943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110273276|NCT00980460|Fluorouracil|fluorouracil|mesh-list
110267171|NCT00540943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110267172|NCT00159458|Gemcitabine|gemcitabine|mesh-list
110267174|NCT00159458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110267175|NCT00159458|Antimetabolites|antimetabolites|mesh-ancestor
110267176|NCT00159458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267177|NCT00159458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110267178|NCT00541021|Gemcitabine|gemcitabine|mesh-list
110267179|NCT00541021|Sorafenib|sorafenib|mesh-list
110267180|NCT00541021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110267181|NCT00541021|Antimetabolites|antimetabolites|mesh-ancestor
110267182|NCT00541021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267183|NCT00541021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110267184|NCT00541021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110267185|NCT00541021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110267186|NCT00541138|Tamoxifen|tamoxifen|mesh-list
110267187|NCT00541138|Carboplatin|carboplatin|mesh-list
110267188|NCT00541138|Topotecan|topotecan|mesh-list
110267189|NCT00541138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110267190|NCT00541138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267191|NCT00541138|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110267192|NCT00541138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110267193|NCT00541138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110267194|NCT00541138|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110267195|NCT00541138|Hormone Antagonists|hormone antagonists|mesh-ancestor
110267196|NCT00541138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110267197|NCT00541138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267198|NCT00541138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110267199|NCT00541138|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110267200|NCT00541138|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110267201|NCT00541138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110267203|NCT00541177|Tropicamide|tropicamide|mesh-list
110267204|NCT00541177|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110267205|NCT00541177|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110267206|NCT00541177|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110267207|NCT00541177|Autonomic Agents|autonomic agents|mesh-ancestor
110267208|NCT00541177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110267209|NCT00541177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267210|NCT00541177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110267211|NCT00541177|Respiratory System Agents|respiratory system agents|mesh-ancestor
110267215|NCT00541177|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110267216|NCT00541177|Cholinergic Agents|cholinergic agents|mesh-ancestor
110267217|NCT00541177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110267218|NCT00541177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267219|NCT00541216|Ephedrine|ephedrine|mesh-list
110267220|NCT00541216|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110267221|NCT00541216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267222|NCT00541216|Sympathomimetics|sympathomimetics|mesh-ancestor
110267223|NCT00541216|Autonomic Agents|autonomic agents|mesh-ancestor
110267224|NCT00541216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110267225|NCT00541216|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110267226|NCT00541216|Adrenergic Agents|adrenergic agents|mesh-ancestor
110267227|NCT00541216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110273299|NCT00980460|Tubulin Modulators|tubulin modulators|mesh-ancestor
110267228|NCT00541216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267230|NCT00541333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110267231|NCT00541333|Immunologic Factors|immunologic factors|mesh-ancestor
110267232|NCT00541333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267233|NCT00541333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110267234|NCT00541333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110267235|NCT00541372|Insulin|insulin|mesh-list
110267236|NCT00541372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110267237|NCT00541372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267238|NCT00159536|Metformin|metformin|mesh-list
110267239|NCT00159536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110267240|NCT00159536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267242|NCT00541411|Vincristine|vincristine|mesh-list
110267243|NCT00541411|Ifosfamide|ifosfamide|mesh-list
110267244|NCT00541411|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110267245|NCT00541411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110267246|NCT00541411|Tubulin Modulators|tubulin modulators|mesh-ancestor
110267247|NCT00541411|Antimitotic Agents|antimitotic agents|mesh-ancestor
110267248|NCT00541411|Mitosis Modulators|mitosis modulators|mesh-ancestor
110267249|NCT00541411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267250|NCT00541411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110267251|NCT00541411|Alkylating Agents|alkylating agents|mesh-ancestor
110267252|NCT00541411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110267253|NCT00541411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110267254|NCT00541411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110267255|NCT00541411|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110267256|NCT00541411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110267257|NCT00541411|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110267258|NCT00541489|Naproxen|naproxen|mesh-list
110267259|NCT00541489|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
110267260|NCT00541489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110267261|NCT00541489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110267262|NCT00541489|Analgesics|analgesics|mesh-ancestor
110267263|NCT00541489|Sensory System Agents|sensory system agents|mesh-ancestor
110267264|NCT00541489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110267265|NCT00541489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267266|NCT00541489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110267267|NCT00541489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110267268|NCT00541489|Gout Suppressants|gout suppressants|mesh-ancestor
110267269|NCT00541489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110267270|NCT00541489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110267275|NCT00190437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110267276|NCT00159575|Metformin|metformin|mesh-list
110267277|NCT00159575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110267278|NCT00159575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267280|NCT00541567|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
110267281|NCT00541567|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110267282|NCT00541567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110267283|NCT00541567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267285|NCT00541567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110267286|NCT00541567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267287|NCT00408798|Botulinum Toxins|botulinum toxins|mesh-list
110267288|NCT00408798|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110035052|NCT01403415|BB 1101|bb 1101|mesh-list
110267289|NCT00408798|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110267290|NCT00408798|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110267291|NCT00408798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110267292|NCT00408798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267293|NCT00408798|Cholinergic Agents|cholinergic agents|mesh-ancestor
110267294|NCT00408798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110267295|NCT00408798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267296|NCT00408798|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110267297|NCT00408798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110267298|NCT00541723|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
110267299|NCT00541723|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110267300|NCT00541723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110267301|NCT00541723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267302|NCT00541723|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110267303|NCT00541723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110267304|NCT00541723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267305|NCT00541723|Cholinergic Agents|cholinergic agents|mesh-ancestor
110267306|NCT00541723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110267307|NCT00159614|Rolofylline|rolofylline|mesh-list
110035068|NCT01403415|Antimetabolites|antimetabolites|mesh-ancestor
110267308|NCT00159614|Diuretics|diuretics|mesh-ancestor
110267309|NCT00159614|Natriuretic Agents|natriuretic agents|mesh-ancestor
110267310|NCT00159614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267311|NCT00541840|Sorafenib|sorafenib|mesh-list
110267312|NCT00541840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110267313|NCT00541840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110267314|NCT00541840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110267315|NCT00541840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267316|NCT00190476|Docetaxel|docetaxel|mesh-list
110267317|NCT00190476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110267318|NCT00190476|Tubulin Modulators|tubulin modulators|mesh-ancestor
110267319|NCT00190476|Antimitotic Agents|antimitotic agents|mesh-ancestor
110267320|NCT00190476|Mitosis Modulators|mitosis modulators|mesh-ancestor
110267321|NCT00190476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267322|NCT00159653|Timolol|timolol|mesh-list
110267323|NCT00159653|Latanoprost|latanoprost|mesh-list
110267324|NCT00159653|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110267325|NCT00159653|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110267326|NCT00159653|Adrenergic Agents|adrenergic agents|mesh-ancestor
110267327|NCT00159653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110267328|NCT00159653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267329|NCT00159653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267330|NCT00159653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110267333|NCT00159653|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110267334|NCT00541918|Propofol|propofol|mesh-list
110267335|NCT00541918|Sevoflurane|sevoflurane|mesh-list
110267336|NCT00541918|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110267337|NCT00541918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110267338|NCT00541918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267339|NCT00541918|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110267340|NCT00541918|Anesthetics, General|anesthetics, general|mesh-ancestor
110267341|NCT00541918|Anesthetics|anesthetics|mesh-ancestor
110267342|NCT00541918|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110267343|NCT00541918|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110267344|NCT00190515|Leucovorin|leucovorin|mesh-list
110267345|NCT00190515|Levoleucovorin|levoleucovorin|mesh-list
110267346|NCT00190515|Antidotes|antidotes|mesh-ancestor
110267347|NCT00190515|Protective Agents|protective agents|mesh-ancestor
110267348|NCT00190515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267349|NCT00190515|Vitamin B Complex|vitamin b complex|mesh-ancestor
110267351|NCT00190515|Micronutrients|micronutrients|mesh-ancestor
110267352|NCT00159692|Amlodipine|amlodipine|mesh-list
110267353|NCT00159692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110267354|NCT00159692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110267355|NCT00159692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110267356|NCT00159692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267357|NCT00159692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110267358|NCT00159692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267359|NCT00159692|Vasodilator Agents|vasodilator agents|mesh-ancestor
110267361|NCT00542074|Emollients|emollients|mesh-list
110267362|NCT00542074|Dermatologic Agents|dermatologic agents|mesh-ancestor
110267363|NCT00542074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110267364|NCT00542074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110267365|NCT00542074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110267366|NCT00542074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267367|NCT00542152|Cyclosporine|cyclosporine|mesh-list
110267368|NCT00542152|Infliximab|infliximab|mesh-list
110267369|NCT00542152|Cyclosporins|cyclosporins|mesh-list
110267370|NCT00542152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110267371|NCT00542152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267372|NCT00542152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110267373|NCT00542152|Immunologic Factors|immunologic factors|mesh-ancestor
110267374|NCT00542152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267375|NCT00542152|Antifungal Agents|antifungal agents|mesh-ancestor
110267376|NCT00542152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110267377|NCT00542152|Dermatologic Agents|dermatologic agents|mesh-ancestor
110267378|NCT00542152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110267379|NCT00542152|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110267380|NCT00542152|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110267381|NCT00542152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110267382|NCT00542152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110267383|NCT00159731|Pregabalin|pregabalin|mesh-list
110267384|NCT00159731|Analgesics|analgesics|mesh-ancestor
110267385|NCT00159731|Sensory System Agents|sensory system agents|mesh-ancestor
110267386|NCT00159731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110267387|NCT00159731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267388|NCT00159731|Anticonvulsants|anticonvulsants|mesh-ancestor
110267389|NCT00159731|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110267390|NCT00159731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110267391|NCT00159731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267392|NCT00159731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110267393|NCT00159731|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110267394|NCT00159731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110267395|NCT00159731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110267396|NCT00159731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110267398|NCT00408915|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110267399|NCT00408915|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110267400|NCT00408915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110267401|NCT00408915|Serotonin Agents|serotonin agents|mesh-ancestor
110267402|NCT00408915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110267403|NCT00408915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267404|NCT00408915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267405|NCT00408915|Dopamine Agonists|dopamine agonists|mesh-ancestor
110267406|NCT00408915|Dopamine Agents|dopamine agents|mesh-ancestor
110267407|NCT00542347|Esomeprazole|esomeprazole|mesh-list
110267409|NCT00542347|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110267410|NCT00542347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110267411|NCT00542347|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110267413|NCT00542347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267414|NCT00190554|Cisplatin|cisplatin|mesh-list
110267415|NCT00190554|Fluorouracil|fluorouracil|mesh-list
110267416|NCT00190554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110267417|NCT00190554|Antimetabolites|antimetabolites|mesh-ancestor
110267418|NCT00190554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267419|NCT00190554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110267420|NCT00190554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110267421|NCT00190554|Immunologic Factors|immunologic factors|mesh-ancestor
110267422|NCT00190554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267423|NCT00159770|Olanzapine|olanzapine|mesh-list
110267424|NCT00159770|Risperidone|risperidone|mesh-list
110267425|NCT00159770|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110267426|NCT00159770|Ziprasidone|ziprasidone|mesh-list
110267427|NCT00159770|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110267428|NCT00159770|Serotonin Agents|serotonin agents|mesh-ancestor
110267429|NCT00159770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110267430|NCT00159770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267431|NCT00159770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267432|NCT00159770|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110267433|NCT00159770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110267434|NCT00159770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110267435|NCT00159770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110267436|NCT00159770|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110267437|NCT00159770|Dopamine Agents|dopamine agents|mesh-ancestor
110267438|NCT00159770|Antiemetics|antiemetics|mesh-ancestor
110267439|NCT00159770|Autonomic Agents|autonomic agents|mesh-ancestor
110267440|NCT00159770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110267441|NCT00159770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110267442|NCT00159770|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110267443|NCT00159770|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110267444|NCT00159770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110267446|NCT00190593|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
110267447|NCT00190593|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110267448|NCT00190593|Hormone Antagonists|hormone antagonists|mesh-ancestor
110267449|NCT00190593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110267450|NCT00190593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267451|NCT00190593|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110267452|NCT00190593|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110267453|NCT00190593|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110267454|NCT00542893|Dacarbazine|dacarbazine|mesh-list
110267456|NCT00542893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110267457|NCT00542893|Alkylating Agents|alkylating agents|mesh-ancestor
110267458|NCT00542893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267459|NCT00542893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110267461|NCT00184041|Prednisone|prednisone|mesh-list
110267462|NCT00184041|Methotrexate|methotrexate|mesh-list
110267463|NCT00184041|Cyclophosphamide|cyclophosphamide|mesh-list
110267464|NCT00184041|Vincristine|vincristine|mesh-list
110267465|NCT00184041|Daunorubicin|daunorubicin|mesh-list
110267466|NCT00184041|Asparaginase|asparaginase|mesh-list
110267467|NCT00184041|Mercaptopurine|mercaptopurine|mesh-list
110267468|NCT00184041|Thioguanine|thioguanine|mesh-list
110267470|NCT00184041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110267471|NCT00184041|Glucocorticoids|glucocorticoids|mesh-ancestor
110267472|NCT00184041|Hormones|hormones|mesh-ancestor
110267473|NCT00184041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110267474|NCT00184041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267475|NCT00184041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110267476|NCT00184041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110267477|NCT00184041|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110267479|NCT00184041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110267480|NCT00184041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110267481|NCT00184041|Antimetabolites|antimetabolites|mesh-ancestor
110267482|NCT00184041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267483|NCT00184041|Dermatologic Agents|dermatologic agents|mesh-ancestor
110267484|NCT00184041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110267485|NCT00184041|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110267486|NCT00184041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110267487|NCT00184041|Immunologic Factors|immunologic factors|mesh-ancestor
110267488|NCT00184041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110267489|NCT00184041|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110267490|NCT00184041|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110267491|NCT00184041|Alkylating Agents|alkylating agents|mesh-ancestor
110267492|NCT00184041|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110267493|NCT00184041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110267494|NCT00184041|Tubulin Modulators|tubulin modulators|mesh-ancestor
110267495|NCT00184041|Antimitotic Agents|antimitotic agents|mesh-ancestor
110267496|NCT00184041|Mitosis Modulators|mitosis modulators|mesh-ancestor
110267497|NCT00184041|Antiviral Agents|antiviral agents|mesh-ancestor
110267498|NCT00184041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110267499|NCT00184041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110267500|NCT00184041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110267501|NCT00184041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110267503|NCT00543049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110267504|NCT00543049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110267507|NCT00543049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267508|NCT00543049|Growth Inhibitors|growth inhibitors|mesh-ancestor
110267509|NCT00543049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110267510|NCT00543049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110267511|NCT00543049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267512|NCT04685005|Caffeine|caffeine|mesh-list
110267513|NCT04685005|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110267514|NCT04685005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267515|NCT04685005|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110267516|NCT04685005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110267517|NCT04685005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267518|NCT04685005|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110267519|NCT04685005|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110267520|NCT04685005|Purinergic Agents|purinergic agents|mesh-ancestor
110267521|NCT04685005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110267522|NCT00190632|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110267523|NCT00190632|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110267524|NCT00190632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110267525|NCT00190632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110267526|NCT00190632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267527|NCT00190632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110267528|NCT00190632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267530|NCT00190632|Sensory System Agents|sensory system agents|mesh-ancestor
110267531|NCT00190632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110267532|NCT00190632|Antidepressive Agents|antidepressive agents|mesh-ancestor
110267533|NCT00190632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110267534|NCT00190632|Dopamine Agents|dopamine agents|mesh-ancestor
110267535|NCT00543166|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
110267536|NCT00543166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110267537|NCT00543166|Immunologic Factors|immunologic factors|mesh-ancestor
110267539|NCT00543205|Oblimersen|oblimersen|mesh-list
110267540|NCT00543205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110267541|NCT00159809|Sildenafil Citrate|sildenafil citrate|mesh-list
110267542|NCT00159809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267543|NCT00159809|Vasodilator Agents|vasodilator agents|mesh-ancestor
110267544|NCT00159809|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110267545|NCT00159809|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110267546|NCT00159809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110267547|NCT00159809|Urological Agents|urological agents|mesh-ancestor
110267549|NCT00543244|Ribavirin|ribavirin|mesh-list
110267550|NCT00543244|Interferon-alpha|interferon-alpha|mesh-list
110267551|NCT00543244|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110267552|NCT00543244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110267553|NCT00543244|Antiviral Agents|antiviral agents|mesh-ancestor
110267554|NCT00543244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110267555|NCT00543244|Antimetabolites|antimetabolites|mesh-ancestor
110267556|NCT00543244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267557|NCT00543244|Immunologic Factors|immunologic factors|mesh-ancestor
110267558|NCT00543244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267559|NCT00190710|Carboplatin|carboplatin|mesh-list
110267560|NCT00190710|Gemcitabine|gemcitabine|mesh-list
110267561|NCT00190710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110267562|NCT00190710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110267563|NCT00190710|Antimetabolites|antimetabolites|mesh-ancestor
110267564|NCT00190710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267565|NCT03456661|Dexmedetomidine|dexmedetomidine|mesh-list
110267566|NCT03456661|Levobupivacaine|levobupivacaine|mesh-list
110267567|NCT03456661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110267569|NCT03456661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267570|NCT03456661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110267571|NCT03456661|Analgesics|analgesics|mesh-ancestor
110267572|NCT03456661|Sensory System Agents|sensory system agents|mesh-ancestor
110267573|NCT03456661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110267574|NCT03456661|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110267576|NCT03456661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110267577|NCT03456661|Adrenergic Agents|adrenergic agents|mesh-ancestor
110267578|NCT03456661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110267579|NCT03456661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267580|NCT03456661|Anesthetics, Local|anesthetics, local|mesh-ancestor
110267581|NCT03456661|Anesthetics|anesthetics|mesh-ancestor
110267582|NCT03456544|Vancomycin|vancomycin|mesh-list
110267584|NCT03456544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110267585|NCT00159887|Sildenafil Citrate|sildenafil citrate|mesh-list
110267586|NCT00159887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267587|NCT00159887|Vasodilator Agents|vasodilator agents|mesh-ancestor
110267588|NCT00159887|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110267591|NCT00159887|Urological Agents|urological agents|mesh-ancestor
110267592|NCT00543361|Metformin|metformin|mesh-list
110267593|NCT00543361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110267594|NCT00543361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267595|NCT00190788|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
110267596|NCT00190788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110267597|NCT00543634|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110267598|NCT00543634|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110267599|NCT00543634|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110267600|NCT00543634|Contraceptive Agents|contraceptive agents|mesh-ancestor
110267601|NCT00543634|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110267602|NCT00543634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267603|NCT00543634|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110273446|NCT02902042|Pembrolizumab|pembrolizumab|mesh-list
110267604|NCT00543634|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110267605|NCT00543634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110267606|NCT00543634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110267607|NCT00543634|Estrogens|estrogens|mesh-ancestor
110267608|NCT00543634|Hormones|hormones|mesh-ancestor
110267609|NCT00543634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110267610|NCT00184197|Botulinum Toxins|botulinum toxins|mesh-list
110267611|NCT00184197|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110267612|NCT00184197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110267613|NCT00184197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267614|NCT00184197|Cholinergic Agents|cholinergic agents|mesh-ancestor
110267615|NCT00184197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110267616|NCT00184197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267617|NCT00543829|Tamoxifen|tamoxifen|mesh-list
110267618|NCT00543829|Docetaxel|docetaxel|mesh-list
110267619|NCT00543829|Doxorubicin|doxorubicin|mesh-list
110267620|NCT00543829|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110267621|NCT00543829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110267622|NCT00543829|Tubulin Modulators|tubulin modulators|mesh-ancestor
110267623|NCT00543829|Antimitotic Agents|antimitotic agents|mesh-ancestor
110267624|NCT00543829|Mitosis Modulators|mitosis modulators|mesh-ancestor
110267625|NCT00543829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267626|NCT00543829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110267627|NCT00543829|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110267628|NCT00543829|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110267629|NCT00543829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110267630|NCT00543829|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110267631|NCT00543829|Hormone Antagonists|hormone antagonists|mesh-ancestor
110267632|NCT00543829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110267633|NCT00543829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267634|NCT00543829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110267635|NCT00543829|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110267636|NCT00543829|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110267637|NCT00543829|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110267638|NCT00190827|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110267639|NCT00190827|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110267640|NCT00190827|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110267641|NCT00190827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110267642|NCT00190827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267643|NCT00190827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110267644|NCT00190827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267646|NCT00190827|Sensory System Agents|sensory system agents|mesh-ancestor
110267648|NCT00190827|Antidepressive Agents|antidepressive agents|mesh-ancestor
110267649|NCT00190827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110267650|NCT00190827|Dopamine Agents|dopamine agents|mesh-ancestor
110267651|NCT00160043|Vatalanib|vatalanib|mesh-list
110267652|NCT00160043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110267653|NCT00160043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110267654|NCT00160043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267655|NCT00544063|Oxaliplatin|oxaliplatin|mesh-list
110267656|NCT00544063|Irinotecan|irinotecan|mesh-list
110267657|NCT00544063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110267658|NCT00544063|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110267659|NCT00544063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110267660|NCT00544063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110267661|NCT00544063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267662|NCT00544180|Risedronic Acid|risedronic acid|mesh-list
110273464|NCT00168779|Diuretics|diuretics|mesh-ancestor
110267663|NCT00544180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110267664|NCT00544180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110267665|NCT00544180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267666|NCT00544180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110267667|NCT00544180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267668|NCT00544180|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110267669|NCT00544219|Prednisone|prednisone|mesh-list
110267670|NCT00544219|Cyclophosphamide|cyclophosphamide|mesh-list
110267671|NCT00544219|Rituximab|rituximab|mesh-list
110267672|NCT00544219|Doxorubicin|doxorubicin|mesh-list
110267673|NCT00544219|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110267674|NCT00544219|Vincristine|vincristine|mesh-list
110267675|NCT00544219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110267676|NCT00544219|Immunologic Factors|immunologic factors|mesh-ancestor
110267677|NCT00544219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267678|NCT00544219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110267679|NCT00544219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110267680|NCT00544219|Alkylating Agents|alkylating agents|mesh-ancestor
110267681|NCT00544219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267682|NCT00544219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110267683|NCT00544219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110267684|NCT00544219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110267685|NCT00544219|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110267686|NCT00544219|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110267687|NCT00544219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110267688|NCT00544219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110267689|NCT00544219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110267692|NCT00544219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110267693|NCT00544219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110267694|NCT00544219|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110267697|NCT00544219|Mitosis Modulators|mitosis modulators|mesh-ancestor
110267698|NCT00190866|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110267699|NCT00190866|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110267700|NCT00190866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110267701|NCT00190866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110267702|NCT00190866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267703|NCT00190866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110267704|NCT00190866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267705|NCT00190866|Analgesics|analgesics|mesh-ancestor
110267706|NCT00190866|Sensory System Agents|sensory system agents|mesh-ancestor
110267707|NCT00190866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110267708|NCT00190866|Antidepressive Agents|antidepressive agents|mesh-ancestor
110267710|NCT00190866|Dopamine Agents|dopamine agents|mesh-ancestor
110267711|NCT00160160|Eprosartan|eprosartan|mesh-list
110267712|NCT00160160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110267713|NCT00160160|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
110267714|NCT00160160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110267715|NCT00160160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267716|NCT00544570|Cyclophosphamide|cyclophosphamide|mesh-list
110267717|NCT00544570|Melphalan|melphalan|mesh-list
110267718|NCT00544570|Carmustine|carmustine|mesh-list
110267719|NCT00544570|Etoposide|etoposide|mesh-list
110267720|NCT00544570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110267721|NCT00544570|Immunologic Factors|immunologic factors|mesh-ancestor
110267722|NCT00544570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267723|NCT00544570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110267724|NCT00544570|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110267725|NCT00544570|Alkylating Agents|alkylating agents|mesh-ancestor
110267726|NCT00544570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267727|NCT00544570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110267728|NCT00544570|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110267729|NCT00544570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110267730|NCT00544570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110267731|NCT00544570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110267732|NCT00544570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110267733|NCT00190905|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110267734|NCT00190905|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110267735|NCT00190905|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110267736|NCT00190905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110267737|NCT00190905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267738|NCT00190905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110267739|NCT00190905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267740|NCT00190905|Analgesics|analgesics|mesh-ancestor
110267741|NCT00190905|Sensory System Agents|sensory system agents|mesh-ancestor
110267742|NCT00190905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110267743|NCT00190905|Antidepressive Agents|antidepressive agents|mesh-ancestor
110267744|NCT00190905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110267745|NCT00190905|Dopamine Agents|dopamine agents|mesh-ancestor
110267747|NCT00544609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110267748|NCT00544609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110267749|NCT00544609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110267750|NCT00544609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267751|NCT00544687|Mometasone Furoate|mometasone furoate|mesh-list
110267752|NCT00544687|Nortriptyline|nortriptyline|mesh-list
110267753|NCT00544687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110267754|NCT00544687|Dermatologic Agents|dermatologic agents|mesh-ancestor
110267755|NCT00544687|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110267756|NCT00544687|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110267757|NCT00544687|Antidepressive Agents|antidepressive agents|mesh-ancestor
110267758|NCT00544687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110267759|NCT00544687|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110267760|NCT00544687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110267761|NCT00544687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110267762|NCT00544687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267763|NCT00544687|Adrenergic Agents|adrenergic agents|mesh-ancestor
110267764|NCT00544687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110267765|NCT00544687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267766|NCT00160238|Betahistine|betahistine|mesh-list
110267768|NCT00160238|Histamine Agonists|histamine agonists|mesh-ancestor
110267769|NCT00160238|Histamine Agents|histamine agents|mesh-ancestor
110267770|NCT00160238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110267771|NCT00160238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267772|NCT00160238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267775|NCT00544804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110267776|NCT00544804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110267777|NCT00544804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110273484|NCT00168896|Carboplatin|carboplatin|mesh-list
110267779|NCT00160277|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110267782|NCT02963181|Antioxidants|antioxidants|mesh-ancestor
110267783|NCT02963181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267784|NCT02963181|Protective Agents|protective agents|mesh-ancestor
110267785|NCT02963181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267786|NCT02963181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110267787|NCT02963181|Mydriatics|mydriatics|mesh-ancestor
110267788|NCT02963181|Autonomic Agents|autonomic agents|mesh-ancestor
110267789|NCT02963181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110267790|NCT02963181|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110267791|NCT02963181|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110267792|NCT02963181|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110267793|NCT02963181|Adrenergic Agents|adrenergic agents|mesh-ancestor
110267794|NCT02963181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110267795|NCT02963181|Urological Agents|urological agents|mesh-ancestor
110267796|NCT00544999|Cytarabine|cytarabine|mesh-list
110267797|NCT00544999|Everolimus|everolimus|mesh-list
110267798|NCT00544999|Daunorubicin|daunorubicin|mesh-list
110267799|NCT00544999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110267800|NCT00544999|Antimetabolites|antimetabolites|mesh-ancestor
110267801|NCT00544999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267802|NCT00544999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110267803|NCT00544999|Antiviral Agents|antiviral agents|mesh-ancestor
110267804|NCT00544999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110267805|NCT00544999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110267806|NCT00544999|Immunologic Factors|immunologic factors|mesh-ancestor
110267807|NCT00544999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267808|NCT00544999|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110267809|NCT00544999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110267810|NCT00544999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110267811|NCT00544999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110267812|NCT00544999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110267813|NCT00544999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110267814|NCT00160316|Estradiol|estradiol|mesh-list
110267815|NCT00160316|Dydrogesterone|dydrogesterone|mesh-list
110267816|NCT00160316|Estrogens|estrogens|mesh-ancestor
110267817|NCT00160316|Hormones|hormones|mesh-ancestor
110267818|NCT00160316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110267819|NCT00160316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267820|NCT00160316|Progestins|progestins|mesh-ancestor
110267821|NCT00545194|Dinoprostone|dinoprostone|mesh-list
110267822|NCT00545194|Oxytocics|oxytocics|mesh-ancestor
110267823|NCT00545194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110267824|NCT00545194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267825|NCT00190944|Teriparatide|teriparatide|mesh-list
110267826|NCT00190944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110267827|NCT00190944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110273500|NCT02901379|Antimetabolites|antimetabolites|mesh-ancestor
110267830|NCT03456466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110267831|NCT03456466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110267833|NCT03456466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267834|NCT03456466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110267835|NCT00160355|Fludarabine|fludarabine|mesh-list
110267836|NCT00160355|Melphalan|melphalan|mesh-list
110267837|NCT00160355|Thiotepa|thiotepa|mesh-list
110267838|NCT00160355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110267839|NCT00160355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267841|NCT00160355|Immunologic Factors|immunologic factors|mesh-ancestor
110267842|NCT00160355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267843|NCT00160355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110267844|NCT00160355|Alkylating Agents|alkylating agents|mesh-ancestor
110267845|NCT00160355|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110267846|NCT00545311|Glycopyrrolate|glycopyrrolate|mesh-list
110267847|NCT00545311|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110267848|NCT00545311|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110267849|NCT00545311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110267850|NCT00545311|Cholinergic Agents|cholinergic agents|mesh-ancestor
110267851|NCT00545311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110267852|NCT00545311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267853|NCT00545311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267855|NCT00160394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110267856|NCT00160394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110267857|NCT00160394|Analgesics|analgesics|mesh-ancestor
110267858|NCT00160394|Sensory System Agents|sensory system agents|mesh-ancestor
110267859|NCT00160394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110267860|NCT00160394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267861|NCT00160394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110267862|NCT00160394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110267863|NCT00160394|Dermatologic Agents|dermatologic agents|mesh-ancestor
110267864|NCT00191022|Paroxetine|paroxetine|mesh-list
110267865|NCT00191022|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110267866|NCT00191022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110267867|NCT00191022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110267868|NCT00191022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267869|NCT00191022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110267870|NCT00191022|Serotonin Agents|serotonin agents|mesh-ancestor
110267871|NCT00191022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267872|NCT00191022|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110267874|NCT00191022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110267875|NCT00191022|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110267876|NCT00191022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110267877|NCT00191022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110267878|NCT00545389|Mesalamine|mesalamine|mesh-list
110267879|NCT00545389|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110267880|NCT00545389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110267881|NCT00545389|Analgesics|analgesics|mesh-ancestor
110267882|NCT00545389|Sensory System Agents|sensory system agents|mesh-ancestor
110267883|NCT00545389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110267884|NCT00545389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267885|NCT00545389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110267888|NCT00545467|Antidepressive Agents|antidepressive agents|mesh-ancestor
110267889|NCT00545467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110267890|NCT00545467|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110273524|NCT02901301|Capecitabine|capecitabine|mesh-list
110267891|NCT00545467|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110267892|NCT00545467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110267893|NCT00545467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267894|NCT00545467|Dopamine Agonists|dopamine agonists|mesh-ancestor
110267895|NCT00545467|Dopamine Agents|dopamine agents|mesh-ancestor
110267896|NCT00545467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110267897|NCT00545467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267898|NCT00545467|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110267899|NCT00545467|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110267900|NCT00545467|Serotonin Agents|serotonin agents|mesh-ancestor
110267901|NCT00545467|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110267902|NCT00545467|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110267903|NCT00545467|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110267904|NCT00545467|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110267905|NCT00545857|Pioglitazone|pioglitazone|mesh-list
110267906|NCT00545857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110267907|NCT00545857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267908|NCT00545935|Artesunate|artesunate|mesh-list
110267909|NCT00545935|Amodiaquine|amodiaquine|mesh-list
110267910|NCT00545935|Antimalarials|antimalarials|mesh-ancestor
110267911|NCT00545935|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110267912|NCT00545935|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110267914|NCT00545935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110267915|NCT00545935|Antiviral Agents|antiviral agents|mesh-ancestor
110267916|NCT00545935|Schistosomicides|schistosomicides|mesh-ancestor
110267917|NCT00545935|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110267918|NCT00545935|Anthelmintics|anthelmintics|mesh-ancestor
110267919|NCT00160511|Levetiracetam|levetiracetam|mesh-list
110267920|NCT00160511|Anticonvulsants|anticonvulsants|mesh-ancestor
110267921|NCT00160511|Nootropic Agents|nootropic agents|mesh-ancestor
110267922|NCT00191061|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110267923|NCT00191061|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110267924|NCT00191061|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110267925|NCT00191061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110267926|NCT00191061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267927|NCT00191061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110267928|NCT00191061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267929|NCT00191061|Analgesics|analgesics|mesh-ancestor
110267930|NCT00191061|Sensory System Agents|sensory system agents|mesh-ancestor
110267931|NCT00191061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110267932|NCT00191061|Antidepressive Agents|antidepressive agents|mesh-ancestor
110267933|NCT00191061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110267934|NCT00191061|Dopamine Agents|dopamine agents|mesh-ancestor
110267935|NCT00160550|Levetiracetam|levetiracetam|mesh-list
110267936|NCT00160550|Anticonvulsants|anticonvulsants|mesh-ancestor
110267937|NCT00160550|Nootropic Agents|nootropic agents|mesh-ancestor
110267938|NCT00160589|Levocetirizine|levocetirizine|mesh-list
110267939|NCT00160589|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110267940|NCT00160589|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110267941|NCT00160589|Histamine Antagonists|histamine antagonists|mesh-ancestor
110267943|NCT00160589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110267944|NCT00160589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267945|NCT00160589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267946|NCT00546130|polysaccharide-K|polysaccharide-k|mesh-list
110267947|NCT00546130|Cisplatin|cisplatin|mesh-list
110267952|NCT00546130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110273547|NCT00169091|Haloperidol|haloperidol|mesh-list
110267953|NCT00546130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267954|NCT00546130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110267956|NCT00546130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267957|NCT00546130|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110267959|NCT00546130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110267960|NCT00546130|Interferon Inducers|interferon inducers|mesh-ancestor
110267961|NCT00546130|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110267962|NCT00546130|Protective Agents|protective agents|mesh-ancestor
110267963|NCT00191178|Insulin|insulin|mesh-list
110267964|NCT00191178|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110267965|NCT00191178|Insulin Glargine|insulin glargine|mesh-list
110267966|NCT00191178|Insulin Lispro|insulin lispro|mesh-list
110267967|NCT00191178|Protamines|protamines|mesh-list
110267968|NCT00191178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110267969|NCT00191178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267970|NCT00191178|Heparin Antagonists|heparin antagonists|mesh-ancestor
110267971|NCT00191178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267972|NCT00191178|Coagulants|coagulants|mesh-ancestor
110267973|NCT00546169|Thrombin|thrombin|mesh-list
110267974|NCT00546169|Hemostatics|hemostatics|mesh-ancestor
110267975|NCT00546169|Coagulants|coagulants|mesh-ancestor
110267976|NCT00160628|Levetiracetam|levetiracetam|mesh-list
110267978|NCT00160628|Nootropic Agents|nootropic agents|mesh-ancestor
110267979|NCT00546286|Timolol|timolol|mesh-list
110267980|NCT00546286|Dorzolamide|dorzolamide|mesh-list
110267981|NCT00546286|Maleic acid|maleic acid|mesh-list
110267982|NCT00546286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110267983|NCT00546286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267984|NCT00546286|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110267985|NCT00546286|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110267986|NCT00546286|Adrenergic Agents|adrenergic agents|mesh-ancestor
110267987|NCT00546286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110267988|NCT00546286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267989|NCT00546286|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110267990|NCT00546286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110267991|NCT00546286|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110267993|NCT00546325|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110267994|NCT00546325|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
110267995|NCT00546325|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110267996|NCT00546325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110267997|NCT00546325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267999|NCT00546325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110268000|NCT00546325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110268001|NCT00546403|Modafinil|modafinil|mesh-list
110268002|NCT00546403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110268003|NCT00546403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110268004|NCT00546403|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110268005|NCT00546403|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110268006|NCT00546403|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110268007|NCT00546403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268008|NCT00546442|Metformin|metformin|mesh-list
110268009|NCT00546442|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110268010|NCT00546442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110268011|NCT00191256|Paclitaxel|paclitaxel|mesh-list
110268012|NCT00191256|Carboplatin|carboplatin|mesh-list
110268014|NCT00191256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110268015|NCT00191256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110268016|NCT00191256|Tubulin Modulators|tubulin modulators|mesh-ancestor
110268017|NCT00191256|Antimitotic Agents|antimitotic agents|mesh-ancestor
110268018|NCT00191256|Mitosis Modulators|mitosis modulators|mesh-ancestor
110268019|NCT00191256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268020|NCT00191256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110268021|NCT00191256|Antimetabolites|antimetabolites|mesh-ancestor
110268023|NCT00546520|Glucocorticoids|glucocorticoids|mesh-ancestor
110268024|NCT00546520|Hormones|hormones|mesh-ancestor
110268025|NCT00546520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110268026|NCT00546520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110268027|NCT00546520|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110268028|NCT00546559|Simvastatin|simvastatin|mesh-list
110268029|NCT00546559|Pravastatin|pravastatin|mesh-list
110268030|NCT00546559|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110268031|NCT00546559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110268032|NCT00546559|Antimetabolites|antimetabolites|mesh-ancestor
110268033|NCT00546559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268034|NCT00546559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110268035|NCT00546559|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110268036|NCT00546559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110268037|NCT00160745|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110268038|NCT00160745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110268039|NCT00160745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110268041|NCT00160745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268042|NCT00160745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110268043|NCT00160745|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110268044|NCT00160745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110268045|NCT00546676|Telithromycin|telithromycin|mesh-list
110268046|NCT00546676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110268047|NCT00546676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110268048|NCT00546832|Celecoxib|celecoxib|mesh-list
110268049|NCT00546832|Diclofenac|diclofenac|mesh-list
110268050|NCT00546832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110268051|NCT00546832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110268052|NCT00546832|Analgesics|analgesics|mesh-ancestor
110268053|NCT00546832|Sensory System Agents|sensory system agents|mesh-ancestor
110268054|NCT00546832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110268055|NCT00546832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110268056|NCT00546832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110268057|NCT00546832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110268058|NCT00546832|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110268059|NCT00546832|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110268060|NCT00546832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110268061|NCT00546832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268062|NCT00184587|Candesartan|candesartan|mesh-list
110268063|NCT00184587|Candesartan cilexetil|candesartan cilexetil|mesh-list
110268064|NCT00184587|Angiotensin II|angiotensin ii|mesh-list
110268065|NCT00184587|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
110268066|NCT00184587|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110268067|NCT00184587|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110268068|NCT00184587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268069|NCT00184587|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110268070|NCT00547144|Gemcitabine|gemcitabine|mesh-list
110268071|NCT00547144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110268072|NCT00547144|Antimetabolites|antimetabolites|mesh-ancestor
110268073|NCT00547144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268074|NCT00547144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110268075|NCT00547183|Tadalafil|tadalafil|mesh-list
110268076|NCT00547183|Vasodilator Agents|vasodilator agents|mesh-ancestor
110268077|NCT00547183|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110268080|NCT00547183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268081|NCT00547183|Urological Agents|urological agents|mesh-ancestor
110268083|NCT00184626|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110268084|NCT00184626|Metformin|metformin|mesh-list
110268085|NCT00184626|Insulin Glargine|insulin glargine|mesh-list
110268086|NCT00184626|Insulin Aspart|insulin aspart|mesh-list
110268087|NCT00184626|Biphasic Insulins|biphasic insulins|mesh-list
110268088|NCT00184626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110268089|NCT00184626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110268090|NCT00547417|Tadalafil|tadalafil|mesh-list
110268091|NCT00547417|Vasodilator Agents|vasodilator agents|mesh-ancestor
110268092|NCT00547417|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110268093|NCT00547417|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110268094|NCT00547417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110268095|NCT00547417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268096|NCT00547417|Urological Agents|urological agents|mesh-ancestor
110268097|NCT00191295|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110268098|NCT00191295|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110268099|NCT00191295|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110268100|NCT00191295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110268101|NCT00191295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268102|NCT00191295|Adrenergic Agents|adrenergic agents|mesh-ancestor
110268103|NCT00191295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110268104|NCT00191295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110268105|NCT00547495|Tadalafil|tadalafil|mesh-list
110268106|NCT00547495|Vasodilator Agents|vasodilator agents|mesh-ancestor
110268107|NCT00547495|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110268108|NCT00547495|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110268109|NCT00547495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110268110|NCT00547495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268112|NCT02277223|Curcumin|curcumin|mesh-list
110268113|NCT02277223|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110268114|NCT02277223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110268115|NCT02277223|Analgesics|analgesics|mesh-ancestor
110268116|NCT02277223|Sensory System Agents|sensory system agents|mesh-ancestor
110268117|NCT02277223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110268118|NCT02277223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110268119|NCT02277223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110268120|NCT02277223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110268121|NCT02277223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110268122|NCT02277223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110268123|NCT02277223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268124|NCT00547573|Tadalafil|tadalafil|mesh-list
110268125|NCT00547573|Vasodilator Agents|vasodilator agents|mesh-ancestor
110268126|NCT00547573|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110268127|NCT00547573|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110268128|NCT00547573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110268129|NCT00547573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268130|NCT00547573|Urological Agents|urological agents|mesh-ancestor
110268131|NCT00191373|Gemcitabine|gemcitabine|mesh-list
110268132|NCT00191373|Trastuzumab|trastuzumab|mesh-list
110268134|NCT00191373|Antimetabolites|antimetabolites|mesh-ancestor
110268135|NCT00191373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268136|NCT00191373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110268137|NCT00191373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110268138|NCT00547612|Substance P|substance p|mesh-list
110268139|NCT00547612|Neurokinin A|neurokinin a|mesh-list
110268140|NCT00547612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110268141|NCT00547612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268142|NCT00547612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110268143|NCT00547768|Fexofenadine|fexofenadine|mesh-list
110268144|NCT00547768|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110268145|NCT00547768|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110268146|NCT00547768|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110268147|NCT00547768|Histamine Antagonists|histamine antagonists|mesh-ancestor
110268148|NCT00547768|Histamine Agents|histamine agents|mesh-ancestor
110268149|NCT00547768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110268150|NCT00547768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268151|NCT00547768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110268152|NCT00184665|Insulin|insulin|mesh-list
110268153|NCT00184665|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110268154|NCT00184665|Insulin Aspart|insulin aspart|mesh-list
110268155|NCT00184665|Insulin Detemir|insulin detemir|mesh-list
110268156|NCT00184665|Isophane Insulin, Human|isophane insulin, human|mesh-list
110268157|NCT00184665|Insulin, Isophane|insulin, isophane|mesh-list
110268158|NCT00184665|Isophane insulin, beef|isophane insulin, beef|mesh-list
110268159|NCT00184665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110268160|NCT00184665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110268161|NCT04983238|Sodium thiosulfate|sodium thiosulfate|mesh-list
110268162|NCT04983238|Trastuzumab|trastuzumab|mesh-list
110268163|NCT04983238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110268164|NCT04983238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110268165|NCT04983238|Antidotes|antidotes|mesh-ancestor
110268166|NCT04983238|Protective Agents|protective agents|mesh-ancestor
110268167|NCT04983238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110268168|NCT04983238|Antioxidants|antioxidants|mesh-ancestor
110268169|NCT04983238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268170|NCT04983238|Antitubercular Agents|antitubercular agents|mesh-ancestor
110268171|NCT04983238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110268172|NCT04983238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110268174|NCT04983238|Sequestering Agents|sequestering agents|mesh-ancestor
110268175|NCT04974385|Bupivacaine|bupivacaine|mesh-list
110268176|NCT04974385|Anesthetics, Local|anesthetics, local|mesh-ancestor
110268177|NCT04974385|Anesthetics|anesthetics|mesh-ancestor
110268178|NCT04974385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110268179|NCT04974385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110268180|NCT04974385|Sensory System Agents|sensory system agents|mesh-ancestor
110268181|NCT04974385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110268182|NCT00547885|Dihydrocodeine|dihydrocodeine|mesh-list
110268183|NCT00547885|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110268184|NCT00547885|Narcotics|narcotics|mesh-ancestor
110268185|NCT00547885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110268186|NCT00547885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110268189|NCT00547885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110268190|NCT00161018|Risperidone|risperidone|mesh-list
110268191|NCT00161018|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110268192|NCT00161018|Fluphenazine|fluphenazine|mesh-list
110268193|NCT00161018|Fluphenazine depot|fluphenazine depot|mesh-list
110268194|NCT00161018|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
110268195|NCT00161018|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110268196|NCT00161018|Serotonin Agents|serotonin agents|mesh-ancestor
110268197|NCT00161018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110268198|NCT00161018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268199|NCT00161018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110268200|NCT00161018|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110268201|NCT00161018|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110268202|NCT00161018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110268203|NCT00161018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110268204|NCT00161018|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110268205|NCT00161018|Dopamine Agents|dopamine agents|mesh-ancestor
110268206|NCT00161018|Antidepressive Agents|antidepressive agents|mesh-ancestor
110268208|NCT00191412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110268209|NCT00191412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110268210|NCT00191412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268211|NCT00191412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110268212|NCT00191412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110268213|NCT00548002|Levofloxacin|levofloxacin|mesh-list
110268214|NCT00548002|Trovafloxacin|trovafloxacin|mesh-list
110268215|NCT00548002|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110268216|NCT00548002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110268217|NCT00548002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110268218|NCT00548002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110268219|NCT00548002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110268220|NCT00548002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110268221|NCT00548002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268222|NCT00548002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110268223|NCT00548002|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110268224|NCT00548002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110268226|NCT00191490|Docetaxel|docetaxel|mesh-list
110268227|NCT00191490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110268228|NCT00191490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110268229|NCT00191490|Antimetabolites|antimetabolites|mesh-ancestor
110268230|NCT00191490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268231|NCT00191490|Tubulin Modulators|tubulin modulators|mesh-ancestor
110268232|NCT00191490|Antimitotic Agents|antimitotic agents|mesh-ancestor
110268233|NCT00191490|Mitosis Modulators|mitosis modulators|mesh-ancestor
110268234|NCT00548080|Caspofungin|caspofungin|mesh-list
110268235|NCT00548080|Antifungal Agents|antifungal agents|mesh-ancestor
110268236|NCT00548080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110268237|NCT00548080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110268238|NCT00548080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268239|NCT00161096|Pantoprazole|pantoprazole|mesh-list
110268240|NCT00161096|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110268241|NCT00161096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110268242|NCT00161096|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110268243|NCT00161096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110268244|NCT00161096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268245|NCT00184821|Glyburide|glyburide|mesh-list
110268246|NCT00184821|Adenosine|adenosine|mesh-list
110268247|NCT00184821|Diazoxide|diazoxide|mesh-list
110268248|NCT00184821|Annexin A5|annexin a5|mesh-list
110268249|NCT00184821|Analgesics|analgesics|mesh-ancestor
110268250|NCT00184821|Sensory System Agents|sensory system agents|mesh-ancestor
110268251|NCT00184821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110268255|NCT00184821|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110268256|NCT00184821|Purinergic Agonists|purinergic agonists|mesh-ancestor
110268257|NCT00184821|Purinergic Agents|purinergic agents|mesh-ancestor
110268258|NCT00184821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110268259|NCT00184821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268260|NCT00184821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110268261|NCT00184821|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110268262|NCT00184821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110268263|NCT00548509|Vitamin K|vitamin k|mesh-list
110268264|NCT00548509|Vitamin K 2|vitamin k 2|mesh-list
110268265|NCT00548509|Menatetrenone|menatetrenone|mesh-list
110268266|NCT00548509|Vitamins|vitamins|mesh-ancestor
110268267|NCT00548509|Micronutrients|micronutrients|mesh-ancestor
110268268|NCT00548509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110268269|NCT00548509|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110268270|NCT00548509|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110268271|NCT00548509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268272|NCT00548509|Hemostatics|hemostatics|mesh-ancestor
110268273|NCT00548509|Coagulants|coagulants|mesh-ancestor
110268274|NCT00548704|Dexrazoxane|dexrazoxane|mesh-list
110268275|NCT00548704|Razoxane|razoxane|mesh-list
110268276|NCT00548704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110268277|NCT00548704|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110268278|NCT00548704|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110268279|NCT00548704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110268280|NCT00548704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110268281|NCT00548704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268282|NCT00548704|Protective Agents|protective agents|mesh-ancestor
110268283|NCT00548704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110268284|NCT00548704|Antimitotic Agents|antimitotic agents|mesh-ancestor
110268285|NCT00548704|Mitosis Modulators|mitosis modulators|mesh-ancestor
110268286|NCT00184899|Heparin|heparin|mesh-list
110268287|NCT00184899|Calcium heparin|calcium heparin|mesh-list
110268288|NCT00184899|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
110268290|NCT00184899|Anticoagulants|anticoagulants|mesh-ancestor
110268291|NCT00184899|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110268292|NCT00184899|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110268293|NCT00184899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268294|NCT00184899|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
110268295|NCT00184899|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110268296|NCT00184899|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110268297|NCT00184899|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110268298|NCT00184899|Protective Agents|protective agents|mesh-ancestor
110268299|NCT00184899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110268300|NCT00548821|Cisplatin|cisplatin|mesh-list
110268301|NCT00548821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110268302|NCT00161291|Bevacizumab|bevacizumab|mesh-list
110268303|NCT00161291|Letrozole|letrozole|mesh-list
110273625|NCT02899507|Clavulanic Acids|clavulanic acids|mesh-list
110268304|NCT00161291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110268305|NCT00161291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110268306|NCT00161291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110036015|NCT01408524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110268307|NCT00161291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110268308|NCT00161291|Growth Substances|growth substances|mesh-ancestor
110268309|NCT00161291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110268310|NCT00161291|Growth Inhibitors|growth inhibitors|mesh-ancestor
110268311|NCT00161291|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110268312|NCT00161291|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110268313|NCT00161291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110268314|NCT00161291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268316|NCT00161291|Hormone Antagonists|hormone antagonists|mesh-ancestor
110268317|NCT00161291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110268318|NCT00548899|Sorafenib|sorafenib|mesh-list
110268319|NCT00548899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110268320|NCT00548899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110268321|NCT00548899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110268322|NCT00548899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268323|NCT00191568|Gemcitabine|gemcitabine|mesh-list
110268324|NCT00191568|Oxaliplatin|oxaliplatin|mesh-list
110268325|NCT00191568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110036062|NCT01408849|Omeprazole|omeprazole|mesh-list
110268326|NCT00191568|Antimetabolites|antimetabolites|mesh-ancestor
110268327|NCT00191568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268328|NCT00191568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110268329|NCT00548938|Temozolomide|temozolomide|mesh-list
110268330|NCT00548938|Carmustine|carmustine|mesh-list
110268331|NCT00548938|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110268332|NCT00548938|Alkylating Agents|alkylating agents|mesh-ancestor
110268333|NCT00548938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268334|NCT00548938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110268335|NCT00161330|Amoxicillin|amoxicillin|mesh-list
110268336|NCT00161330|Ceftriaxone|ceftriaxone|mesh-list
110268337|NCT00161330|Clavulanic Acids|clavulanic acids|mesh-list
110268338|NCT00161330|Clavulanic Acid|clavulanic acid|mesh-list
110268339|NCT00161330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110268340|NCT00161330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110268341|NCT00161330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110268342|NCT00161330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268343|NCT00161330|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110268344|NCT00184938|Morphine|morphine|mesh-list
110268345|NCT00184938|Naloxone|naloxone|mesh-list
110268346|NCT00184938|Annexin A5|annexin a5|mesh-list
110268347|NCT00184938|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110268348|NCT00184938|Narcotics|narcotics|mesh-ancestor
110268349|NCT00184938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110268350|NCT00184938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110268351|NCT00184938|Analgesics|analgesics|mesh-ancestor
110268352|NCT00184938|Sensory System Agents|sensory system agents|mesh-ancestor
110268353|NCT00184938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110268354|NCT00184938|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110268355|NCT00184938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110268356|NCT00184938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268357|NCT00549133|Irbesartan|irbesartan|mesh-list
110268358|NCT00549133|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110273642|NCT00178854|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110268359|NCT00549133|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110268360|NCT00549133|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110268361|NCT00549133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268365|NCT00191607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110268367|NCT00191607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268368|NCT00191607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110268369|NCT00191607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110268370|NCT00191607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110268371|NCT00191607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110268372|NCT00191607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110268373|NCT00549289|Cyclosporine|cyclosporine|mesh-list
110268374|NCT00549289|Cyclosporins|cyclosporins|mesh-list
110268375|NCT00549289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110268376|NCT00549289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268378|NCT00549289|Immunologic Factors|immunologic factors|mesh-ancestor
110268379|NCT00549289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110268380|NCT00549289|Antifungal Agents|antifungal agents|mesh-ancestor
110268381|NCT00549289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110268382|NCT00549289|Dermatologic Agents|dermatologic agents|mesh-ancestor
110268383|NCT00549289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110268384|NCT00549289|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110268385|NCT00184977|Fluticasone|fluticasone|mesh-list
110268386|NCT00184977|Xhance|xhance|mesh-list
110268387|NCT00184977|Acetylcysteine|acetylcysteine|mesh-list
110268388|NCT00184977|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110268389|NCT00184977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110268390|NCT00184977|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110268391|NCT00184977|Autonomic Agents|autonomic agents|mesh-ancestor
110268392|NCT00184977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110268393|NCT00184977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110268394|NCT00184977|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110268395|NCT00184977|Respiratory System Agents|respiratory system agents|mesh-ancestor
110268396|NCT00184977|Dermatologic Agents|dermatologic agents|mesh-ancestor
110268397|NCT00184977|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110268398|NCT00184977|Antiviral Agents|antiviral agents|mesh-ancestor
110268399|NCT00184977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110268401|NCT00184977|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110268402|NCT00184977|Antioxidants|antioxidants|mesh-ancestor
110268403|NCT00184977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268404|NCT00184977|Protective Agents|protective agents|mesh-ancestor
110268406|NCT03456154|Salicylic Acid|salicylic acid|mesh-list
110268407|NCT03456154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110268408|NCT03456154|Antifungal Agents|antifungal agents|mesh-ancestor
110268409|NCT03456154|Keratolytic Agents|keratolytic agents|mesh-ancestor
110268410|NCT03456154|Dermatologic Agents|dermatologic agents|mesh-ancestor
110268411|NCT00161447|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110268412|NCT00161447|Medroxyprogesterone|medroxyprogesterone|mesh-list
110268413|NCT00161447|Testosterone|testosterone|mesh-list
110268414|NCT00161447|Acyline|acyline|mesh-list
110268415|NCT00161447|Androgens|androgens|mesh-ancestor
110268416|NCT00161447|Hormones|hormones|mesh-ancestor
110268417|NCT00161447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110268418|NCT00161447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110268419|NCT00161447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110268420|NCT00161447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110268421|NCT00161447|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110268422|NCT00161447|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110268423|NCT00161447|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110268424|NCT00161447|Contraceptive Agents|contraceptive agents|mesh-ancestor
110268425|NCT00161447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110268426|NCT00161447|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110268427|NCT00161447|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110268428|NCT00161447|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110268429|NCT00161447|Hormone Antagonists|hormone antagonists|mesh-ancestor
110268433|NCT00191685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110268434|NCT00191685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268435|NCT00191685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110268436|NCT00191685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110268438|NCT00191685|Sensory System Agents|sensory system agents|mesh-ancestor
110268439|NCT00191685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110268440|NCT00191685|Antidepressive Agents|antidepressive agents|mesh-ancestor
110268441|NCT00191685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110268442|NCT00191685|Dopamine Agents|dopamine agents|mesh-ancestor
110268444|NCT00161486|Testosterone|testosterone|mesh-list
110268445|NCT00161486|Testosterone undecanoate|testosterone undecanoate|mesh-list
110268446|NCT00161486|Testosterone enanthate|testosterone enanthate|mesh-list
110268447|NCT00161486|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110268448|NCT00161486|Acyline|acyline|mesh-list
110268449|NCT00161486|Androgens|androgens|mesh-ancestor
110268450|NCT00161486|Hormones|hormones|mesh-ancestor
110268451|NCT00161486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110268452|NCT00161486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110268453|NCT00161486|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110268454|NCT00161486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110268455|NCT00161486|Anabolic Agents|anabolic agents|mesh-ancestor
110268456|NCT00161486|Hormone Antagonists|hormone antagonists|mesh-ancestor
110268458|NCT00549874|Glyburide|glyburide|mesh-list
110268459|NCT00549874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110268460|NCT00549874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110268461|NCT00191763|Gemcitabine|gemcitabine|mesh-list
110268462|NCT00191763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110268463|NCT00191763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110268464|NCT00191763|Antimetabolites|antimetabolites|mesh-ancestor
110268465|NCT00191763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268467|NCT00161564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110268469|NCT00161564|Immunologic Factors|immunologic factors|mesh-ancestor
110268470|NCT00161564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110268471|NCT00161564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110268472|NCT00185055|Valsartan|valsartan|mesh-list
110268473|NCT00185055|Olmesartan|olmesartan|mesh-list
110268474|NCT00185055|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110268475|NCT00185055|Irbesartan|irbesartan|mesh-list
110268476|NCT00185055|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110268477|NCT00185055|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110268478|NCT00185055|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110268479|NCT00185055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268480|NCT00550108|Ethanol|ethanol|mesh-list
110268481|NCT00550108|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110268482|NCT00550108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110268483|NCT00550108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110268484|NCT00550108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110268485|NCT00185094|Losartan|losartan|mesh-list
110268486|NCT00185094|Atenolol|atenolol|mesh-list
110268487|NCT00185094|Olmesartan|olmesartan|mesh-list
110268488|NCT00185094|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110268489|NCT00185094|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110268490|NCT00185094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110268491|NCT00185094|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110268492|NCT00185094|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110268493|NCT00185094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268494|NCT00185094|Sympatholytics|sympatholytics|mesh-ancestor
110268495|NCT00185094|Autonomic Agents|autonomic agents|mesh-ancestor
110268496|NCT00185094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110268497|NCT00185094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110268498|NCT00185094|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110268499|NCT00185094|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110268501|NCT00185094|Adrenergic Agents|adrenergic agents|mesh-ancestor
110268502|NCT00185094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110268503|NCT00550303|Bazedoxifene|bazedoxifene|mesh-list
110268505|NCT00550303|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110268506|NCT00550303|Hormones|hormones|mesh-ancestor
110268507|NCT00550303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110268508|NCT00550303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110268509|NCT00550303|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110268510|NCT00550303|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110268511|NCT00550303|Hormone Antagonists|hormone antagonists|mesh-ancestor
110268512|NCT00550303|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110268513|NCT00550342|Rituximab|rituximab|mesh-list
110268514|NCT00550342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110268515|NCT00550342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110268516|NCT00550342|Immunologic Factors|immunologic factors|mesh-ancestor
110268517|NCT00550342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110268518|NCT00550342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110268519|NCT00161681|Levonorgestrel|levonorgestrel|mesh-list
110268520|NCT00161681|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110268521|NCT00161681|Estradiol|estradiol|mesh-list
110268522|NCT00161681|Estrogens|estrogens|mesh-ancestor
110268523|NCT00161681|Hormones|hormones|mesh-ancestor
110268524|NCT00161681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110268525|NCT00161681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110268526|NCT00161681|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110268527|NCT00161681|Contraceptive Agents|contraceptive agents|mesh-ancestor
110268528|NCT00161681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110268529|NCT00161681|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110268530|NCT00161681|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110268531|NCT00161681|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110268532|NCT00161681|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110268533|NCT02963454|Simendan|simendan|mesh-list
110268534|NCT02963454|Dobutamine|dobutamine|mesh-list
110268535|NCT02963454|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110268536|NCT02963454|Vasodilator Agents|vasodilator agents|mesh-ancestor
110268537|NCT02963454|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110268538|NCT02963454|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110268539|NCT02963454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110268540|NCT02963454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268541|NCT02963454|Protective Agents|protective agents|mesh-ancestor
110268542|NCT02963454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110268543|NCT02963454|Sympathomimetics|sympathomimetics|mesh-ancestor
110268544|NCT02963454|Autonomic Agents|autonomic agents|mesh-ancestor
110268545|NCT02963454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110268546|NCT02963454|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110268547|NCT02963454|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110268548|NCT02963454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110268549|NCT02963454|Adrenergic Agents|adrenergic agents|mesh-ancestor
110268550|NCT02963454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110268551|NCT00191802|Teriparatide|teriparatide|mesh-list
110268552|NCT00191802|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110268553|NCT00191802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110268554|NCT00191802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110268555|NCT00550693|Chlorhexidine|chlorhexidine|mesh-list
110268556|NCT00550693|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110268557|NCT00550693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110268558|NCT00550693|Disinfectants|disinfectants|mesh-ancestor
110268560|NCT00550810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110268561|NCT00550810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110268562|NCT00550810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110268563|NCT00550810|Growth Substances|growth substances|mesh-ancestor
110268564|NCT00550810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110268565|NCT00550810|Growth Inhibitors|growth inhibitors|mesh-ancestor
110268566|NCT00550810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110268567|NCT00550810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110268568|NCT00550810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268569|NCT00191841|Gemcitabine|gemcitabine|mesh-list
110268570|NCT00191841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110268571|NCT00191841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110268572|NCT00191841|Antimetabolites|antimetabolites|mesh-ancestor
110268573|NCT00191841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268574|NCT00550927|Bevacizumab|bevacizumab|mesh-list
110268575|NCT00550927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110268576|NCT00550927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110268577|NCT00550927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110268578|NCT00550927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110268579|NCT00550927|Growth Substances|growth substances|mesh-ancestor
110268580|NCT00550927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110268581|NCT00550927|Growth Inhibitors|growth inhibitors|mesh-ancestor
110268582|NCT00161720|Protein C|protein c|mesh-list
110268583|NCT00161720|Anticoagulants|anticoagulants|mesh-ancestor
110268584|NCT00161720|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110268585|NCT00161720|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110268586|NCT00161720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268587|NCT00185133|Amlodipine|amlodipine|mesh-list
110268589|NCT00185133|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110268590|NCT00185133|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110268591|NCT00185133|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110268592|NCT00185133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110268593|NCT00185133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268594|NCT00185133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110268595|NCT00185133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110268596|NCT00185133|Vasodilator Agents|vasodilator agents|mesh-ancestor
110268597|NCT00185133|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110268598|NCT00185133|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110268599|NCT00551005|Celecoxib|celecoxib|mesh-list
110268600|NCT00551005|Etoposide|etoposide|mesh-list
110268601|NCT00551005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110268602|NCT00551005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110268603|NCT00551005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110268604|NCT00551005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110268605|NCT00551005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110268606|NCT00551005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268607|NCT00551005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110268608|NCT00551005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110268623|NCT00161759|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110268624|NCT00161759|Thrombin|thrombin|mesh-list
110268625|NCT00161759|Hemostatics|hemostatics|mesh-ancestor
110268626|NCT00161759|Coagulants|coagulants|mesh-ancestor
110268627|NCT00551122|Paclitaxel|paclitaxel|mesh-list
110268628|NCT00551122|Gemcitabine|gemcitabine|mesh-list
110268629|NCT00551122|Ifosfamide|ifosfamide|mesh-list
110268630|NCT00551122|Lenograstim|lenograstim|mesh-list
110268631|NCT00551122|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110268633|NCT00551122|Tubulin Modulators|tubulin modulators|mesh-ancestor
110268634|NCT00551122|Antimitotic Agents|antimitotic agents|mesh-ancestor
110268635|NCT00551122|Mitosis Modulators|mitosis modulators|mesh-ancestor
110268636|NCT00551122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268637|NCT00551122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110268638|NCT00551122|Antimetabolites|antimetabolites|mesh-ancestor
110268639|NCT00551122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110268640|NCT00551122|Immunologic Factors|immunologic factors|mesh-ancestor
110268641|NCT00551122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110268642|NCT00551122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110268643|NCT00551122|Alkylating Agents|alkylating agents|mesh-ancestor
110268644|NCT00551239|Rituximab|rituximab|mesh-list
110268645|NCT00551239|Fludarabine|fludarabine|mesh-list
110268646|NCT00551239|Fludarabine phosphate|fludarabine phosphate|mesh-list
110268647|NCT00551239|Pixantrone|pixantrone|mesh-list
110268648|NCT00551239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110268649|NCT00551239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110268650|NCT00551239|Immunologic Factors|immunologic factors|mesh-ancestor
110268651|NCT00551239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110268652|NCT00551239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110268653|NCT00551239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110268654|NCT00551239|Antimetabolites|antimetabolites|mesh-ancestor
110268655|NCT00551239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268656|NCT00551239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110268657|NCT00551239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110268658|NCT00551239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110268659|NCT00551239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110268660|NCT00191880|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110268661|NCT00191880|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110268662|NCT00191880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110268663|NCT00191880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110268664|NCT00191880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268665|NCT00191880|Adrenergic Agents|adrenergic agents|mesh-ancestor
110268666|NCT00191880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110268667|NCT00191880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110268669|NCT00551317|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
110268670|NCT00551317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110268671|NCT00551317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268673|NCT00551356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110268674|NCT00551356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110268676|NCT02963337|Bupivacaine|bupivacaine|mesh-list
110268677|NCT02963337|Anesthetics, Local|anesthetics, local|mesh-ancestor
110268678|NCT02963337|Anesthetics|anesthetics|mesh-ancestor
110268679|NCT02963337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110268680|NCT02963337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110268681|NCT02963337|Sensory System Agents|sensory system agents|mesh-ancestor
110268682|NCT02963337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110268683|NCT02963337|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110268684|NCT02963337|Narcotics|narcotics|mesh-ancestor
110268685|NCT02963337|Analgesics|analgesics|mesh-ancestor
110268686|NCT00191919|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110268687|NCT00191919|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110268688|NCT00191919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110268689|NCT00191919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110268690|NCT00191919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268691|NCT00191919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110268692|NCT00191919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110268693|NCT00191919|Analgesics|analgesics|mesh-ancestor
110268694|NCT00191919|Sensory System Agents|sensory system agents|mesh-ancestor
110268695|NCT00191919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110268696|NCT00191919|Antidepressive Agents|antidepressive agents|mesh-ancestor
110268697|NCT00191919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110268698|NCT00191919|Dopamine Agents|dopamine agents|mesh-ancestor
110268699|NCT00161837|Vaccines|vaccines|mesh-list
110268700|NCT00161837|Immunologic Factors|immunologic factors|mesh-ancestor
110268701|NCT00161837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110268702|NCT00551512|Cisplatin|cisplatin|mesh-list
110268703|NCT00551512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110268704|NCT00551590|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110268705|NCT00551590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110268706|NCT00551590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110268707|NCT00551590|Incretins|incretins|mesh-ancestor
110268708|NCT00551590|Hormones|hormones|mesh-ancestor
110268709|NCT00551590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110268710|NCT00551590|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110268711|NCT00551590|Protease Inhibitors|protease inhibitors|mesh-ancestor
110268712|NCT00551590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110268713|NCT00551590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268714|NCT00161915|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110268715|NCT00161915|Hemostatics|hemostatics|mesh-ancestor
110268716|NCT00161915|Coagulants|coagulants|mesh-ancestor
110268717|NCT00185172|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110268719|NCT00185172|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110268720|NCT00185172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110268721|NCT00185172|Diuretics|diuretics|mesh-ancestor
110268722|NCT00185172|Natriuretic Agents|natriuretic agents|mesh-ancestor
110268723|NCT00185172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110268724|NCT00185172|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110268726|NCT00185172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268727|NCT00185172|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110268728|NCT00185172|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110268729|NCT00191997|Olanzapine|olanzapine|mesh-list
110268730|NCT00191997|Antiemetics|antiemetics|mesh-ancestor
110268731|NCT00191997|Autonomic Agents|autonomic agents|mesh-ancestor
110268732|NCT00191997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110268733|NCT00191997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110268734|NCT00191997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110268735|NCT00191997|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110268736|NCT00191997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110268737|NCT00191997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110268738|NCT00191997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110268739|NCT00191997|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110268740|NCT00191997|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110268741|NCT00191997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110268742|NCT00191997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268743|NCT00191997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110268744|NCT00191997|Serotonin Agents|serotonin agents|mesh-ancestor
110268746|NCT00551824|Mitomycin|mitomycin|mesh-list
110268747|NCT00551824|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110268748|NCT00551824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110268749|NCT00551824|Alkylating Agents|alkylating agents|mesh-ancestor
110268750|NCT00551824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268751|NCT00551824|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110268752|NCT00551824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110268753|NCT00185250|Interferons|interferons|mesh-list
110268754|NCT00185250|Interferon-beta|interferon-beta|mesh-list
110268755|NCT00185250|Interferon beta-1b|interferon beta-1b|mesh-list
110268756|NCT00185250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110268757|NCT00185250|Antiviral Agents|antiviral agents|mesh-ancestor
110268758|NCT00185250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110268759|NCT00185250|Immunologic Factors|immunologic factors|mesh-ancestor
110268760|NCT00185250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110268761|NCT00185250|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110268764|NCT00161993|gamma-Globulins|gamma-globulins|mesh-list
110268765|NCT00161993|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110268766|NCT00161993|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110268767|NCT00161993|Immunologic Factors|immunologic factors|mesh-ancestor
110268768|NCT00161993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110268772|NCT00185328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110268773|NCT00185328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110268774|NCT00162110|Cetuximab|cetuximab|mesh-list
110268775|NCT00162110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110268776|NCT00162110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110268777|NCT00552370|Insulin Glargine|insulin glargine|mesh-list
110268778|NCT00552370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110268779|NCT00552370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110268780|NCT00162149|Ritonavir|ritonavir|mesh-list
110268781|NCT00162149|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110268782|NCT00162149|Nevirapine|nevirapine|mesh-list
110268783|NCT00162149|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110268784|NCT00162149|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110268785|NCT00162149|Protease Inhibitors|protease inhibitors|mesh-ancestor
110268786|NCT00162149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110268787|NCT00162149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268788|NCT00162149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110268789|NCT00162149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110268790|NCT00162149|Antiviral Agents|antiviral agents|mesh-ancestor
110268791|NCT00162149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110268792|NCT00162149|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110268793|NCT00162149|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110268794|NCT00162149|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110268795|NCT00162149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110268796|NCT00162149|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110268797|NCT00162149|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110268798|NCT00552526|Anticonvulsants|anticonvulsants|mesh-list
110268800|NCT00162188|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110268801|NCT00162188|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110268802|NCT00162188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110268803|NCT00162188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268805|NCT00162188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110268806|NCT00162188|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110268807|NCT00162188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110268808|NCT00162188|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110268809|NCT00162188|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110268810|NCT00162188|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110268811|NCT00162188|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110268812|NCT00162227|Efavirenz|efavirenz|mesh-list
110268813|NCT00162227|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110268814|NCT00162227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110268815|NCT00162227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110268816|NCT00162227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268817|NCT00162227|Antiviral Agents|antiviral agents|mesh-ancestor
110268818|NCT00162227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110268819|NCT00162227|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110268820|NCT00162227|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110268821|NCT00162227|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110268824|NCT00162227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110268825|NCT04701580|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110268826|NCT04701580|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110268827|NCT04701580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268828|NCT00552682|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110268829|NCT00552682|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110268830|NCT00552682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110268831|NCT00552682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110268832|NCT00552682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268833|NCT00552682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110268834|NCT00552682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110268835|NCT00552682|Analgesics|analgesics|mesh-ancestor
110268836|NCT00552682|Sensory System Agents|sensory system agents|mesh-ancestor
110268837|NCT00552682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110268838|NCT00552682|Antidepressive Agents|antidepressive agents|mesh-ancestor
110268839|NCT00552682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110268840|NCT00552682|Dopamine Agents|dopamine agents|mesh-ancestor
110268841|NCT04652089|Simvastatin|simvastatin|mesh-list
110268842|NCT04652089|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110268843|NCT04652089|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110268844|NCT04652089|Antimetabolites|antimetabolites|mesh-ancestor
110268845|NCT04652089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268846|NCT04652089|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110268847|NCT04652089|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110268848|NCT04652089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110268849|NCT04609306|Hydrogen Peroxide|hydrogen peroxide|mesh-list
110268850|NCT04609306|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110268851|NCT04609306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110268853|NCT04684498|Antiviral Agents|antiviral agents|mesh-ancestor
110268854|NCT04684498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110268856|NCT04684498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268857|NCT00552799|Penicillins|penicillins|mesh-list
110268858|NCT00552799|Penicillin V|penicillin v|mesh-list
110268859|NCT00552799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110268860|NCT00552799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110268862|NCT00409071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110268863|NCT00162305|Dapagliflozin|dapagliflozin|mesh-list
110268864|NCT00162305|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110268865|NCT00162305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268866|NCT00162305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110268867|NCT00162305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110268869|NCT04513015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268870|NCT04513015|Protective Agents|protective agents|mesh-ancestor
110268871|NCT04513015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110268872|NCT00162344|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
110268873|NCT00162344|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110268874|NCT00162344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268875|NCT04382326|Vaccines|vaccines|mesh-list
110268876|NCT04382326|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110268877|NCT04382326|Immunologic Factors|immunologic factors|mesh-ancestor
110268878|NCT04382326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110268879|NCT00162383|Dapsone|dapsone|mesh-list
110268881|NCT00162383|Mephenytoin|mephenytoin|mesh-list
110268882|NCT00162383|Caffeine|caffeine|mesh-list
110268883|NCT00162383|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110268884|NCT00162383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110268885|NCT00162383|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110268886|NCT00162383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110268887|NCT00162383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268888|NCT00162383|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110268889|NCT00162383|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110268890|NCT00162383|Purinergic Agents|purinergic agents|mesh-ancestor
110268891|NCT00162383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110268892|NCT00162383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110268893|NCT00162383|Antimalarials|antimalarials|mesh-ancestor
110268894|NCT00162383|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110268895|NCT00162383|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110268896|NCT00162383|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110268897|NCT00162383|Leprostatic Agents|leprostatic agents|mesh-ancestor
110268898|NCT00162383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110268899|NCT00162383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110268900|NCT00162383|Sympatholytics|sympatholytics|mesh-ancestor
110268901|NCT00162383|Autonomic Agents|autonomic agents|mesh-ancestor
110268902|NCT00162383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110268903|NCT00162383|Adrenergic Agents|adrenergic agents|mesh-ancestor
110268905|NCT00162422|Albuterol|albuterol|mesh-list
110268906|NCT00162422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110268907|NCT00162422|Autonomic Agents|autonomic agents|mesh-ancestor
110268908|NCT00162422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110268909|NCT00162422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110268910|NCT00162422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110268911|NCT00162422|Respiratory System Agents|respiratory system agents|mesh-ancestor
110268912|NCT00162422|Tocolytic Agents|tocolytic agents|mesh-ancestor
110268913|NCT00162422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110268914|NCT00162422|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110268915|NCT00162422|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110268916|NCT00162422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110268917|NCT00162422|Adrenergic Agents|adrenergic agents|mesh-ancestor
110268918|NCT00162422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110268919|NCT00162422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268920|NCT04355143|Colchicine|colchicine|mesh-list
110268921|NCT04355143|Gout Suppressants|gout suppressants|mesh-ancestor
110268922|NCT04355143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110268923|NCT04355143|Tubulin Modulators|tubulin modulators|mesh-ancestor
110268924|NCT04355143|Antimitotic Agents|antimitotic agents|mesh-ancestor
110268925|NCT04355143|Mitosis Modulators|mitosis modulators|mesh-ancestor
110268926|NCT04355143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268927|NCT04355143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110268928|NCT00185445|Fludarabine|fludarabine|mesh-list
110268929|NCT00185445|Fludarabine phosphate|fludarabine phosphate|mesh-list
110268930|NCT00185445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110268931|NCT00185445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110268932|NCT00185445|Antimetabolites|antimetabolites|mesh-ancestor
110268934|NCT00185445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110268935|NCT00185445|Immunologic Factors|immunologic factors|mesh-ancestor
110268936|NCT00185445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110268937|NCT00552838|Anti-Infective Agents|anti-infective agents|mesh-list
110268940|NCT04233034|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110268941|NCT04233034|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110268942|NCT04233034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110268943|NCT04233034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268944|NCT04233034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110268945|NCT04233034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110268946|NCT04233034|Vasodilator Agents|vasodilator agents|mesh-ancestor
110268947|NCT04187053|Methylene Blue|methylene blue|mesh-list
110268948|NCT04187053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110268949|NCT04187053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268950|NCT00162461|Phenytoin|phenytoin|mesh-list
110268951|NCT00162461|Anticonvulsants|anticonvulsants|mesh-ancestor
110268952|NCT00162461|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110268953|NCT00162461|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110268954|NCT00162461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110268955|NCT00162461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268956|NCT00162461|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110268957|NCT00162461|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110268959|NCT00185562|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110268960|NCT00185562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110268961|NCT00185562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110268962|NCT04095364|Paclitaxel|paclitaxel|mesh-list
110268963|NCT04095364|Carboplatin|carboplatin|mesh-list
110268964|NCT04095364|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110268965|NCT04095364|Letrozole|letrozole|mesh-list
110268966|NCT04095364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110268967|NCT04095364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110268968|NCT04095364|Tubulin Modulators|tubulin modulators|mesh-ancestor
110268969|NCT04095364|Antimitotic Agents|antimitotic agents|mesh-ancestor
110268970|NCT04095364|Mitosis Modulators|mitosis modulators|mesh-ancestor
110268971|NCT04095364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268972|NCT04095364|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110268975|NCT04095364|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110268976|NCT04095364|Hormone Antagonists|hormone antagonists|mesh-ancestor
110268977|NCT04095364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110268978|NCT04095364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110268979|NCT00162656|Cyclophosphamide|cyclophosphamide|mesh-list
110268980|NCT00162656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110268981|NCT00162656|Immunologic Factors|immunologic factors|mesh-ancestor
110268982|NCT00162656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110268983|NCT00162656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110268984|NCT00162656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110268985|NCT00162656|Alkylating Agents|alkylating agents|mesh-ancestor
110268986|NCT00162656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268987|NCT00162656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110268988|NCT00162656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110268989|NCT00162695|Etoposide|etoposide|mesh-list
110268990|NCT00162695|Vincristine|vincristine|mesh-list
110268991|NCT00162695|Epirubicin|epirubicin|mesh-list
110268992|NCT00162695|Ifosfamide|ifosfamide|mesh-list
110268993|NCT00162695|Carboplatin|carboplatin|mesh-list
110268994|NCT00162695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110268995|NCT00162695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110268996|NCT00162695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110268997|NCT00162695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110268998|NCT00162695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110268999|NCT00162695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110269000|NCT00162695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110269001|NCT00162695|Alkylating Agents|alkylating agents|mesh-ancestor
110269002|NCT00162695|Tubulin Modulators|tubulin modulators|mesh-ancestor
110269003|NCT00162695|Antimitotic Agents|antimitotic agents|mesh-ancestor
110269004|NCT00162695|Mitosis Modulators|mitosis modulators|mesh-ancestor
110269005|NCT00162695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110269006|NCT00162734|Interferons|interferons|mesh-list
110269008|NCT00162734|Interferon alfacon-1|interferon alfacon-1|mesh-list
110269009|NCT00162734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110269010|NCT00162734|Antiviral Agents|antiviral agents|mesh-ancestor
110269011|NCT00162734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110269012|NCT00162734|Antimetabolites|antimetabolites|mesh-ancestor
110269013|NCT00162734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110269014|NCT00185796|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110269015|NCT00185796|Immunologic Factors|immunologic factors|mesh-ancestor
110269016|NCT00185796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269017|NCT00185796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110269019|NCT00162812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110269020|NCT00162812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110269021|NCT00162812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110269022|NCT00162812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110269023|NCT00162812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110269024|NCT00162812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110269026|NCT00162851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110269027|NCT00162851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110269028|NCT04015414|Varenicline|varenicline|mesh-list
110269029|NCT04015414|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110269030|NCT04015414|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110269031|NCT04015414|Cholinergic Agents|cholinergic agents|mesh-ancestor
110269032|NCT04015414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110269033|NCT04015414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110269046|NCT00162968|Serotonin Agents|serotonin agents|mesh-ancestor
110269047|NCT00162968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269048|NCT03970330|Naltrexone|naltrexone|mesh-list
110269049|NCT03970330|Norethindrone|norethindrone|mesh-list
110269050|NCT03970330|Norethindrone Acetate|norethindrone acetate|mesh-list
110269051|NCT03970330|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110269052|NCT03970330|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110269053|NCT03970330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269054|NCT03970330|Sensory System Agents|sensory system agents|mesh-ancestor
110269055|NCT03970330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110269056|NCT03970330|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110269057|NCT03970330|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110269058|NCT03970330|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110269059|NCT03970330|Contraceptive Agents|contraceptive agents|mesh-ancestor
110269060|NCT03970330|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110269061|NCT03970330|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110269062|NCT03970330|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110269063|NCT00185874|Immunomodulating Agents|immunomodulating agents|mesh-list
110269064|NCT00185874|Immunologic Factors|immunologic factors|mesh-ancestor
110269065|NCT00185874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269067|NCT03757585|Acetylcysteine|acetylcysteine|mesh-list
110269068|NCT03757585|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110269069|NCT03757585|Antiviral Agents|antiviral agents|mesh-ancestor
110269070|NCT03757585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110269071|NCT03757585|Expectorants|expectorants|mesh-ancestor
110269072|NCT03757585|Respiratory System Agents|respiratory system agents|mesh-ancestor
110269073|NCT03757585|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110269074|NCT03757585|Antioxidants|antioxidants|mesh-ancestor
110269075|NCT03757585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110269076|NCT03757585|Protective Agents|protective agents|mesh-ancestor
110269077|NCT03757585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269078|NCT03757585|Antidotes|antidotes|mesh-ancestor
110269079|NCT03757585|Vitamin B Complex|vitamin b complex|mesh-ancestor
110269080|NCT03757585|Vitamins|vitamins|mesh-ancestor
110269081|NCT03757585|Micronutrients|micronutrients|mesh-ancestor
110269082|NCT00163046|Gabapentin|gabapentin|mesh-list
110269083|NCT00163046|Analgesics|analgesics|mesh-ancestor
110269084|NCT00163046|Sensory System Agents|sensory system agents|mesh-ancestor
110269085|NCT00163046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110269086|NCT00163046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269087|NCT00163046|Anticonvulsants|anticonvulsants|mesh-ancestor
110269088|NCT00163046|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110269089|NCT00163046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110269090|NCT00163046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110269091|NCT00163046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110269092|NCT00163046|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110269093|NCT00163046|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110269094|NCT00163046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110269095|NCT00163046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110269096|NCT00163046|Antimanic Agents|antimanic agents|mesh-ancestor
110269098|NCT00185952|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110269099|NCT00185952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110269100|NCT00185952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110269101|NCT00185952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110269102|NCT00185952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269104|NCT00185952|Tocolytic Agents|tocolytic agents|mesh-ancestor
110269105|NCT00185952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110269106|NCT03541447|Octreotide|octreotide|mesh-list
110269107|NCT03541447|Tolvaptan|tolvaptan|mesh-list
110269108|NCT03541447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110269109|NCT03541447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110269110|NCT03541447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110269111|NCT03541447|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110269112|NCT03541447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110269113|NCT03541447|Natriuretic Agents|natriuretic agents|mesh-ancestor
110269114|NCT03541447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269115|NCT00192621|Lamivudine|lamivudine|mesh-list
110269116|NCT00192621|Zidovudine|zidovudine|mesh-list
110269117|NCT00192621|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
110269118|NCT00192621|Lopinavir|lopinavir|mesh-list
110269119|NCT00192621|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110269120|NCT00192621|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110269121|NCT00192621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110269122|NCT00192621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110269123|NCT00192621|Antiviral Agents|antiviral agents|mesh-ancestor
110269124|NCT00192621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110269125|NCT00192621|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110269126|NCT00192621|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110269127|NCT00192621|Antimetabolites|antimetabolites|mesh-ancestor
110269128|NCT00192621|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110269129|NCT00192621|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110269130|NCT00192621|Protease Inhibitors|protease inhibitors|mesh-ancestor
110269131|NCT00192621|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110269132|NCT00192621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110269134|NCT03516604|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110269135|NCT03516604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110269136|NCT03516604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110269137|NCT03516604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110269138|NCT03516604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110269140|NCT03516604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269141|NCT03516604|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110269142|NCT03516604|Antidepressive Agents|antidepressive agents|mesh-ancestor
110269143|NCT03516604|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110269145|NCT00185991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110269146|NCT00185991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110269147|NCT00185991|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110269148|NCT00185991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110269149|NCT00185991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110269150|NCT03434158|Olaparib|olaparib|mesh-list
110269151|NCT03434158|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110269152|NCT03434158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110269153|NCT03434158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110269154|NCT03434158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110269155|NCT00163202|Atorvastatin|atorvastatin|mesh-list
110269156|NCT00163202|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110269157|NCT00163202|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110269158|NCT00163202|Antimetabolites|antimetabolites|mesh-ancestor
110269159|NCT00163202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110269160|NCT00163202|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110269161|NCT00163202|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110269162|NCT00163202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110269164|NCT03318952|Anesthetics, Local|anesthetics, local|mesh-list
110269165|NCT03318952|Carticaine|carticaine|mesh-list
110269166|NCT03318952|Anesthetics|anesthetics|mesh-list
110269167|NCT03318952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110269168|NCT03318952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269169|NCT03318952|Sensory System Agents|sensory system agents|mesh-ancestor
110269170|NCT03318952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110269171|NCT03318952|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110269172|NCT03318952|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110269173|NCT03318952|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110269174|NCT03318952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110269175|NCT03318952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110269176|NCT00192660|Ritonavir|ritonavir|mesh-list
110269177|NCT00192660|Nelfinavir|nelfinavir|mesh-list
110269178|NCT00192660|Indinavir|indinavir|mesh-list
110269179|NCT00192660|Saquinavir|saquinavir|mesh-list
110269180|NCT00192660|Amprenavir|amprenavir|mesh-list
110269183|NCT00192660|Zidovudine|zidovudine|mesh-list
110269185|NCT00192660|Abacavir|abacavir|mesh-list
110269186|NCT00192660|Stavudine|stavudine|mesh-list
110269187|NCT00192660|Didanosine|didanosine|mesh-list
110269188|NCT00192660|Tipranavir|tipranavir|mesh-list
110269189|NCT00192660|Enfuvirtide|enfuvirtide|mesh-list
110269191|NCT00192660|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110269192|NCT00192660|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110269193|NCT00192660|Protease Inhibitors|protease inhibitors|mesh-ancestor
110269194|NCT00192660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110269195|NCT00192660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110269196|NCT00192660|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110269197|NCT00192660|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110269198|NCT00192660|Antiviral Agents|antiviral agents|mesh-ancestor
110269199|NCT00192660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110269200|NCT00192660|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110269201|NCT00192660|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110269202|NCT00192660|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110269203|NCT00192660|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110269204|NCT00192660|Antimetabolites|antimetabolites|mesh-ancestor
110269205|NCT00192660|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110269206|NCT00192660|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110269207|NCT00192660|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110269208|NCT00192660|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110269209|NCT00192660|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110269210|NCT00192660|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110269211|NCT00192660|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110269212|NCT00192660|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110269213|NCT00192660|Antitubercular Agents|antitubercular agents|mesh-ancestor
110269214|NCT00192660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110269216|NCT00163241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110269217|NCT00163241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110269218|NCT00163241|Analgesics|analgesics|mesh-ancestor
110269219|NCT00163241|Sensory System Agents|sensory system agents|mesh-ancestor
110269220|NCT00163241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110269221|NCT00163241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269222|NCT00163241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110269223|NCT00163241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110269224|NCT00163241|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110269225|NCT00163241|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110269226|NCT00163241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110269227|NCT00163241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110269228|NCT02916316|Doxorubicin|doxorubicin|mesh-list
110269229|NCT02916316|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110269230|NCT02916316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110269231|NCT02916316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110269232|NCT02916316|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110269233|NCT02916316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110269234|NCT02916316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110269235|NCT02916316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110269236|NCT00186264|Hydrocortisone|hydrocortisone|mesh-list
110269237|NCT00186264|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110269238|NCT00186264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110269239|NCT00186264|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110269240|NCT00186264|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110269241|NCT00186264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110269242|NCT00186264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110269252|NCT00163319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269253|NCT00163319|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110269254|NCT02812420|Durvalumab|durvalumab|mesh-list
110269255|NCT02812420|Ipilimumab|ipilimumab|mesh-list
110269256|NCT02812420|Tremelimumab|tremelimumab|mesh-list
110269257|NCT02812420|Immunoglobulins|immunoglobulins|mesh-list
110269258|NCT02812420|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110269259|NCT02812420|Immunoglobulin G|immunoglobulin g|mesh-list
110269260|NCT02812420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110269261|NCT02812420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110269262|NCT02812420|Immunologic Factors|immunologic factors|mesh-ancestor
110269263|NCT02812420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269264|NCT02812420|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110269265|NCT02812420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110269266|NCT02556931|Mycophenolic Acid|mycophenolic acid|mesh-list
110269267|NCT02556931|Cyclophosphamide|cyclophosphamide|mesh-list
110269268|NCT02556931|Fludarabine|fludarabine|mesh-list
110269269|NCT02556931|Tacrolimus|tacrolimus|mesh-list
110269270|NCT02556931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110269271|NCT02556931|Immunologic Factors|immunologic factors|mesh-ancestor
110269272|NCT02556931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269273|NCT02556931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110269274|NCT02556931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110269275|NCT02556931|Alkylating Agents|alkylating agents|mesh-ancestor
110269276|NCT02556931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110269277|NCT02556931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110269279|NCT02556931|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110269280|NCT02556931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110269281|NCT02556931|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110269282|NCT02556931|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110269283|NCT02556931|Antitubercular Agents|antitubercular agents|mesh-ancestor
110269284|NCT02556931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110269285|NCT02556931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110269286|NCT00163358|Ciclesonide|ciclesonide|mesh-list
110269287|NCT00163358|Glucocorticoids|glucocorticoids|mesh-ancestor
110269289|NCT00163358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110269290|NCT00163358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269291|NCT00163358|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110269292|NCT00163397|Ciclesonide|ciclesonide|mesh-list
110269293|NCT00163397|Glucocorticoids|glucocorticoids|mesh-ancestor
110269294|NCT00163397|Hormones|hormones|mesh-ancestor
110269295|NCT00163397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110269296|NCT00163397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269297|NCT00163397|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110269298|NCT00163436|Ciclesonide|ciclesonide|mesh-list
110269299|NCT00163436|Glucocorticoids|glucocorticoids|mesh-ancestor
110269300|NCT00163436|Hormones|hormones|mesh-ancestor
110269301|NCT00163436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110269302|NCT00163436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269303|NCT00163436|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110269307|NCT00186420|Antimitotic Agents|antimitotic agents|mesh-ancestor
110269308|NCT00186420|Mitosis Modulators|mitosis modulators|mesh-ancestor
110269309|NCT00186420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110269310|NCT00163514|Ciclesonide|ciclesonide|mesh-list
110269311|NCT00163514|Glucocorticoids|glucocorticoids|mesh-ancestor
110269312|NCT00163514|Hormones|hormones|mesh-ancestor
110269313|NCT00163514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110269314|NCT00163514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269315|NCT00163514|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110269316|NCT00717652|Triamcinolone|triamcinolone|mesh-list
110269317|NCT00717652|Tretinoin|tretinoin|mesh-list
110269318|NCT00717652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110269319|NCT00717652|Glucocorticoids|glucocorticoids|mesh-ancestor
110269320|NCT00717652|Hormones|hormones|mesh-ancestor
110269321|NCT00717652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110269322|NCT00717652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269323|NCT00717652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110269324|NCT00717652|Keratolytic Agents|keratolytic agents|mesh-ancestor
110269325|NCT00717652|Dermatologic Agents|dermatologic agents|mesh-ancestor
110269326|NCT00066040|Chlorhexidine|chlorhexidine|mesh-list
110269327|NCT00066040|Chlorhexidine, thymol drug combination|chlorhexidine, thymol drug combination|mesh-list
110269329|NCT00066040|Fluorides, Topical|fluorides, topical|mesh-list
110269330|NCT00066040|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
110269331|NCT00066040|Cariostatic Agents|cariostatic agents|mesh-ancestor
110269332|NCT00066040|Protective Agents|protective agents|mesh-ancestor
110269333|NCT00066040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269334|NCT00066040|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110269335|NCT00066040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110269336|NCT00066040|Disinfectants|disinfectants|mesh-ancestor
110269337|NCT00163553|Meperidine|meperidine|mesh-list
110269338|NCT00163553|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110269339|NCT00163553|Narcotics|narcotics|mesh-ancestor
110269340|NCT00163553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110269341|NCT00163553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269343|NCT00163553|Sensory System Agents|sensory system agents|mesh-ancestor
110269344|NCT00163553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110269345|NCT00163553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110269346|NCT00163592|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110269347|NCT00163592|Hemostatics|hemostatics|mesh-ancestor
110269349|NCT04683445|Pembrolizumab|pembrolizumab|mesh-list
110269350|NCT04683445|Trastuzumab|trastuzumab|mesh-list
110269351|NCT04683445|Pertuzumab|pertuzumab|mesh-list
110269352|NCT04683445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110269353|NCT04683445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110269354|NCT04683445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110269355|NCT04683445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110269356|NCT00192777|Capecitabine|capecitabine|mesh-list
110269357|NCT00192777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110269359|NCT00192777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110269361|NCT00553072|Magnesium Sulfate|magnesium sulfate|mesh-list
110269362|NCT00553072|Analgesics|analgesics|mesh-ancestor
110269363|NCT00553072|Sensory System Agents|sensory system agents|mesh-ancestor
110269365|NCT00553072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269366|NCT00553072|Anesthetics|anesthetics|mesh-ancestor
110269367|NCT00553072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110269368|NCT00553072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110269369|NCT00553072|Anticonvulsants|anticonvulsants|mesh-ancestor
110269370|NCT00553072|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110269371|NCT00553072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110269372|NCT00553072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110269373|NCT00553072|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110269374|NCT00553072|Tocolytic Agents|tocolytic agents|mesh-ancestor
110269375|NCT00553072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110269376|NCT05808387|Resveratrol|resveratrol|mesh-list
110269377|NCT05808387|Antioxidants|antioxidants|mesh-ancestor
110269378|NCT05808387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110269379|NCT05808387|Protective Agents|protective agents|mesh-ancestor
110269380|NCT05808387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269381|NCT05808387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110269382|NCT05808387|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110269383|NCT05808231|Quinine|quinine|mesh-list
110269384|NCT05808231|Antimalarials|antimalarials|mesh-ancestor
110269385|NCT05808231|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110269386|NCT05808231|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110269387|NCT05808231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110269388|NCT05808231|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110269389|NCT05808231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269390|NCT05808231|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110269391|NCT05808231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110269392|NCT05808231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110269393|NCT05808231|Analgesics|analgesics|mesh-ancestor
110269394|NCT05808231|Sensory System Agents|sensory system agents|mesh-ancestor
110269395|NCT05808192|Immunosuppressive Agents|immunosuppressive agents|mesh-list
110269396|NCT05808192|Immunologic Factors|immunologic factors|mesh-ancestor
110269397|NCT05808192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269398|NCT05808049|Antioxidants|antioxidants|mesh-list
110269399|NCT05808049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110269400|NCT05808049|Protective Agents|protective agents|mesh-ancestor
110269401|NCT05808049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269402|NCT05807945|Ropivacaine|ropivacaine|mesh-list
110269403|NCT05807945|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110269404|NCT05807945|Anesthetics, Local|anesthetics, local|mesh-ancestor
110269405|NCT05807945|Anesthetics|anesthetics|mesh-ancestor
110269406|NCT05807945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110269407|NCT05807945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269408|NCT05807945|Sensory System Agents|sensory system agents|mesh-ancestor
110269409|NCT05807945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110269410|NCT05807893|Bevacizumab|bevacizumab|mesh-list
110269411|NCT05807893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110269412|NCT05807893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110269413|NCT05807893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110269414|NCT05807893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110269415|NCT05807893|Growth Substances|growth substances|mesh-ancestor
110269416|NCT05807893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269417|NCT05807893|Growth Inhibitors|growth inhibitors|mesh-ancestor
110269418|NCT05807880|Capecitabine|capecitabine|mesh-list
110269419|NCT05807880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110269420|NCT05807880|Antimetabolites|antimetabolites|mesh-ancestor
110269424|NCT05807776|Tislelizumab|tislelizumab|mesh-list
110269425|NCT05807776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110269426|NCT05807776|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110269427|NCT05807776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110273882|NCT02896582|Antiemetics|antiemetics|mesh-ancestor
110269428|NCT05807776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110269429|NCT05807776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110269430|NCT05807711|Vitamin B 12|vitamin b 12|mesh-list
110269431|NCT05807711|Vitamin B Complex|vitamin b complex|mesh-ancestor
110269432|NCT05807711|Vitamins|vitamins|mesh-ancestor
110269433|NCT05807711|Micronutrients|micronutrients|mesh-ancestor
110269434|NCT05807711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269435|NCT05807659|Busulfan|busulfan|mesh-list
110269436|NCT05807659|Alkylating Agents|alkylating agents|mesh-ancestor
110269437|NCT05807659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110269438|NCT05807659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110269439|NCT05807659|Immunologic Factors|immunologic factors|mesh-ancestor
110269440|NCT05807659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269441|NCT05807659|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110269442|NCT05807659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110269443|NCT05807659|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110269444|NCT05807542|Paclitaxel|paclitaxel|mesh-list
110269445|NCT05807542|Carboplatin|carboplatin|mesh-list
110269446|NCT05807542|Tislelizumab|tislelizumab|mesh-list
110269447|NCT05807542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110269448|NCT05807542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110269449|NCT05807542|Tubulin Modulators|tubulin modulators|mesh-ancestor
110269450|NCT05807542|Antimitotic Agents|antimitotic agents|mesh-ancestor
110269451|NCT05807542|Mitosis Modulators|mitosis modulators|mesh-ancestor
110269452|NCT05807542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110269453|NCT05807542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110269454|NCT05807503|Cerebrolysin|cerebrolysin|mesh-list
110269455|NCT05807503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110269456|NCT05807503|Protective Agents|protective agents|mesh-ancestor
110269457|NCT05807503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269458|NCT05807503|Nootropic Agents|nootropic agents|mesh-ancestor
110269459|NCT05807425|Polidocanol|polidocanol|mesh-list
110269460|NCT05807425|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
110269461|NCT05807425|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110269462|NCT05807347|Cytarabine|cytarabine|mesh-list
110269463|NCT05807347|Azacitidine|azacitidine|mesh-list
110269464|NCT05807347|Venetoclax|venetoclax|mesh-list
110269465|NCT05807347|Aclacinomycins|aclacinomycins|mesh-list
110269466|NCT05807347|Lenograstim|lenograstim|mesh-list
110269467|NCT05807347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110269469|NCT05807347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110269470|NCT05807347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110269471|NCT05807347|Antiviral Agents|antiviral agents|mesh-ancestor
110269472|NCT05807347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110269473|NCT05807347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110269474|NCT05807347|Immunologic Factors|immunologic factors|mesh-ancestor
110269475|NCT05807347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269476|NCT05807347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110269477|NCT05807347|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110269478|NCT05807347|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110269479|NCT05807165|Memantine|memantine|mesh-list
110269480|NCT05807165|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110269482|NCT05807165|Dopamine Agents|dopamine agents|mesh-ancestor
110269483|NCT05807165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110273894|NCT02896582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110269484|NCT05807165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110269485|NCT05807165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269486|NCT05807165|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110269487|NCT05807165|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110269488|NCT05807100|Salicylic Acid|salicylic acid|mesh-list
110269489|NCT05807100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110269490|NCT05807100|Antifungal Agents|antifungal agents|mesh-ancestor
110269491|NCT05807100|Keratolytic Agents|keratolytic agents|mesh-ancestor
110269492|NCT05807100|Dermatologic Agents|dermatologic agents|mesh-ancestor
110269493|NCT05807035|Vaccines|vaccines|mesh-list
110269494|NCT05807035|Immunologic Factors|immunologic factors|mesh-ancestor
110269495|NCT05807035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269496|NCT05781698|Mesalamine|mesalamine|mesh-list
110269498|NCT05781698|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110269499|NCT05781698|Antimetabolites|antimetabolites|mesh-ancestor
110269500|NCT05781698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110269501|NCT05781698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110269502|NCT05781698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110269503|NCT05781698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110269504|NCT05781698|Analgesics|analgesics|mesh-ancestor
110269505|NCT05781698|Sensory System Agents|sensory system agents|mesh-ancestor
110269506|NCT05781698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110269507|NCT05781698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269508|NCT05781698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110269509|NCT05781698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110269510|NCT05709509|Aspirin|aspirin|mesh-list
110269511|NCT05709509|Colchicine|colchicine|mesh-list
110269512|NCT05709509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110269513|NCT05709509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110269514|NCT05709509|Analgesics|analgesics|mesh-ancestor
110269515|NCT05709509|Sensory System Agents|sensory system agents|mesh-ancestor
110269516|NCT05709509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110269517|NCT05709509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269518|NCT05709509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110269519|NCT05709509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110269520|NCT05709509|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110269521|NCT05709509|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110269522|NCT05709509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110269523|NCT05709509|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110269524|NCT05709509|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110269525|NCT05709509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110269526|NCT05709509|Antipyretics|antipyretics|mesh-ancestor
110269527|NCT05709509|Gout Suppressants|gout suppressants|mesh-ancestor
110269528|NCT05709509|Tubulin Modulators|tubulin modulators|mesh-ancestor
110269529|NCT05709509|Antimitotic Agents|antimitotic agents|mesh-ancestor
110269530|NCT05709509|Mitosis Modulators|mitosis modulators|mesh-ancestor
110269531|NCT05709509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110269533|NCT05693844|Cyclophosphamide|cyclophosphamide|mesh-list
110269534|NCT05693844|Fludarabine|fludarabine|mesh-list
110269535|NCT05693844|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110269536|NCT05693844|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110269537|NCT05693844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110269538|NCT05693844|Tubulin Modulators|tubulin modulators|mesh-ancestor
110269539|NCT05693844|Antimitotic Agents|antimitotic agents|mesh-ancestor
110269540|NCT05693844|Mitosis Modulators|mitosis modulators|mesh-ancestor
110269541|NCT05693844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110269544|NCT05693844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269545|NCT05693844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110269546|NCT05693844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110269547|NCT05693844|Alkylating Agents|alkylating agents|mesh-ancestor
110269548|NCT05693844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110269549|NCT05674513|Ulipristal acetate|ulipristal acetate|mesh-list
110269550|NCT05674513|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110269551|NCT05674513|Contraceptive Agents|contraceptive agents|mesh-ancestor
110269553|NCT05674513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269554|NCT05674513|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110269555|NCT05644340|Methamphetamine|methamphetamine|mesh-list
110269556|NCT05644340|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110269557|NCT05644340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269558|NCT05644340|Sympathomimetics|sympathomimetics|mesh-ancestor
110269559|NCT05644340|Autonomic Agents|autonomic agents|mesh-ancestor
110269560|NCT05644340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110269561|NCT05644340|Dopamine Agents|dopamine agents|mesh-ancestor
110269562|NCT05644340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110269563|NCT05644340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110269564|NCT05644340|Adrenergic Agents|adrenergic agents|mesh-ancestor
110269565|NCT05644340|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110269566|NCT05644340|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110269567|NCT05644340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110269568|NCT05644340|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110269569|NCT05627947|Cyclosporine|cyclosporine|mesh-list
110269570|NCT05627947|Mitomycins|mitomycins|mesh-list
110269571|NCT05627947|Mitomycin|mitomycin|mesh-list
110269572|NCT05627947|Cyclosporins|cyclosporins|mesh-list
110269573|NCT05627947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110269574|NCT05627947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110269575|NCT05627947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110269576|NCT05627947|Immunologic Factors|immunologic factors|mesh-ancestor
110269577|NCT05627947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269578|NCT05627947|Antifungal Agents|antifungal agents|mesh-ancestor
110269579|NCT05627947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110269580|NCT05627947|Dermatologic Agents|dermatologic agents|mesh-ancestor
110269581|NCT05627947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110269582|NCT05627947|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110269583|NCT05627947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110269584|NCT05627947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110269585|NCT05627947|Alkylating Agents|alkylating agents|mesh-ancestor
110269586|NCT05627947|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110269587|NCT05617118|Baclofen|baclofen|mesh-list
110269588|NCT05617118|Botulinum Toxins|botulinum toxins|mesh-list
110269589|NCT05617118|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110269590|NCT05617118|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110269591|NCT05617118|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110269592|NCT05617118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110269593|NCT05617118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110269594|NCT05617118|Cholinergic Agents|cholinergic agents|mesh-ancestor
110269595|NCT05617118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110269596|NCT05617118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269597|NCT05617118|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110269598|NCT05617118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110269599|NCT05617118|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110269600|NCT05617118|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110269603|NCT05606341|1018 oligonucleotide|1018 oligonucleotide|mesh-list
110269604|NCT05606341|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110269605|NCT05606341|Immunologic Factors|immunologic factors|mesh-ancestor
110269606|NCT05606341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269607|NCT05591105|Acetaminophen|acetaminophen|mesh-list
110269608|NCT05591105|Dipyrone|dipyrone|mesh-list
110269609|NCT05591105|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
110269610|NCT05591105|Lidocaine|lidocaine|mesh-list
110269611|NCT05591105|Ketamine|ketamine|mesh-list
110269612|NCT05591105|Morphine|morphine|mesh-list
110269613|NCT05591105|Anesthetics, Local|anesthetics, local|mesh-ancestor
110269614|NCT05591105|Anesthetics|anesthetics|mesh-ancestor
110269615|NCT05591105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110269616|NCT05591105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269617|NCT05591105|Sensory System Agents|sensory system agents|mesh-ancestor
110269618|NCT05591105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110269619|NCT05591105|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110269620|NCT05591105|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110269621|NCT05591105|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110269622|NCT05591105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110269623|NCT05591105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110269625|NCT05591105|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110269626|NCT05591105|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110269627|NCT05591105|Anesthetics, General|anesthetics, general|mesh-ancestor
110269628|NCT05591105|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110269629|NCT05591105|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110269630|NCT05591105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110269631|NCT05591105|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110269632|NCT05591105|Narcotics|narcotics|mesh-ancestor
110269633|NCT05591105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110269634|NCT05591105|Antipyretics|antipyretics|mesh-ancestor
110269635|NCT05591105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110269636|NCT05591105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110269637|NCT05591105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110269638|NCT05550662|Xenon|xenon|mesh-list
110269639|NCT05550662|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110269640|NCT05550662|Anesthetics, General|anesthetics, general|mesh-ancestor
110269641|NCT05550662|Anesthetics|anesthetics|mesh-ancestor
110269642|NCT05550662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110269643|NCT05550662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269644|NCT05546658|Psilocybin|psilocybin|mesh-list
110269645|NCT05546658|Hallucinogens|hallucinogens|mesh-ancestor
110269646|NCT05546658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269647|NCT05546658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110269648|NCT05494580|Pamiparib|pamiparib|mesh-list
110269649|NCT05494580|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
110269650|NCT05494580|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
110269651|NCT05494580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110269652|NCT05494580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110269653|NCT05494580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110269654|NCT05494580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110269655|NCT05464654|Estrogens|estrogens|mesh-list
110269656|NCT05464654|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110269657|NCT05464654|Hormones|hormones|mesh-ancestor
110269658|NCT05464654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110269659|NCT05464654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269660|NCT05267873|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110269662|NCT05267873|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110269663|NCT05267873|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110269664|NCT05267873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110269665|NCT05267873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110269666|NCT05267873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110269667|NCT05267873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269668|NCT05267873|Analgesics|analgesics|mesh-ancestor
110269669|NCT05267873|Sensory System Agents|sensory system agents|mesh-ancestor
110269670|NCT05267873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110269671|NCT05267873|Antidepressive Agents|antidepressive agents|mesh-ancestor
110269672|NCT05267873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110269673|NCT05267873|Dopamine Agents|dopamine agents|mesh-ancestor
110269674|NCT05267873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110269675|NCT05267873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110269676|NCT05267873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110269677|NCT05267873|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110269678|NCT05267873|Serotonin Agents|serotonin agents|mesh-ancestor
110269679|NCT05267873|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110269680|NCT05267873|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110269681|NCT05267873|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110269682|NCT05267873|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110269683|NCT05113901|Methylprednisolone|methylprednisolone|mesh-list
110269684|NCT05113901|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110269685|NCT05113901|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110269686|NCT05113901|Prednisolone|prednisolone|mesh-list
110269687|NCT05113901|Prednisolone acetate|prednisolone acetate|mesh-list
110269688|NCT05113901|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110269689|NCT05113901|Prednisolone phosphate|prednisolone phosphate|mesh-list
110269690|NCT05113901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110269691|NCT05113901|Antiemetics|antiemetics|mesh-ancestor
110269692|NCT05113901|Autonomic Agents|autonomic agents|mesh-ancestor
110269693|NCT05113901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110269694|NCT05113901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269695|NCT05113901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110269696|NCT05113901|Glucocorticoids|glucocorticoids|mesh-ancestor
110269697|NCT05113901|Hormones|hormones|mesh-ancestor
110269698|NCT05113901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110269699|NCT05113901|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110269700|NCT05113901|Protective Agents|protective agents|mesh-ancestor
110269701|NCT05113901|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110269702|NCT05113901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110269703|NCT05075603|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
110269704|NCT05075603|Tisagenlecleucel|tisagenlecleucel|mesh-list
110269705|NCT05075603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110269706|NCT05075603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110269707|NCT05024214|Sunitinib|sunitinib|mesh-list
110269708|NCT05024214|Lenvatinib|lenvatinib|mesh-list
110269709|NCT05024214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110269710|NCT05024214|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110269711|NCT05024214|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110269712|NCT05024214|Growth Substances|growth substances|mesh-ancestor
110269713|NCT05024214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269714|NCT05024214|Growth Inhibitors|growth inhibitors|mesh-ancestor
110269715|NCT05024214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110269717|NCT05024214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110269718|NCT05018091|Dexamethasone|dexamethasone|mesh-list
110269719|NCT05018091|Dexamethasone acetate|dexamethasone acetate|mesh-list
110269720|NCT05018091|BB 1101|bb 1101|mesh-list
110269721|NCT05018091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110269722|NCT05018091|Antiemetics|antiemetics|mesh-ancestor
110269723|NCT05018091|Autonomic Agents|autonomic agents|mesh-ancestor
110269724|NCT05018091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110269725|NCT05018091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269726|NCT05018091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110269727|NCT05018091|Glucocorticoids|glucocorticoids|mesh-ancestor
110269728|NCT05018091|Hormones|hormones|mesh-ancestor
110269729|NCT05018091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110269730|NCT05018091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110269731|NCT05018091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110269732|NCT05018091|Protease Inhibitors|protease inhibitors|mesh-ancestor
110273945|NCT00169949|Serotonin Agents|serotonin agents|mesh-ancestor
110269733|NCT05018091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110269734|NCT05018091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110269736|NCT04999644|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110269737|NCT04999644|Autonomic Agents|autonomic agents|mesh-ancestor
110269738|NCT04999644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110269739|NCT04999644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269740|NCT04999644|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110269741|NCT04999644|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110269742|NCT04999644|Cholinergic Agents|cholinergic agents|mesh-ancestor
110269743|NCT04999644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110269744|NCT04999644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110269746|NCT04962503|Dermatologic Agents|dermatologic agents|mesh-ancestor
110269747|NCT04916080|Acetylcysteine|acetylcysteine|mesh-list
110269748|NCT04916080|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110269749|NCT04916080|Antiviral Agents|antiviral agents|mesh-ancestor
110269750|NCT04916080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110269751|NCT04916080|Expectorants|expectorants|mesh-ancestor
110269752|NCT04916080|Respiratory System Agents|respiratory system agents|mesh-ancestor
110269753|NCT04916080|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110269754|NCT04916080|Antioxidants|antioxidants|mesh-ancestor
110269755|NCT04916080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110269756|NCT04916080|Protective Agents|protective agents|mesh-ancestor
110269757|NCT04916080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269758|NCT04916080|Antidotes|antidotes|mesh-ancestor
110269759|NCT04854369|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110269760|NCT04854369|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110269761|NCT04854369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110269762|NCT04833140|Estradiol|estradiol|mesh-list
110269763|NCT04833140|Estrogens|estrogens|mesh-ancestor
110269764|NCT04833140|Hormones|hormones|mesh-ancestor
110269765|NCT04833140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110269766|NCT04833140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269767|NCT04826562|Lamivudine|lamivudine|mesh-list
110269768|NCT04826562|Dolutegravir|dolutegravir|mesh-list
110269769|NCT04826562|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110269770|NCT04826562|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110269772|NCT04826562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110269773|NCT04826562|Antiviral Agents|antiviral agents|mesh-ancestor
110269774|NCT04826562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110269775|NCT04826562|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110269777|NCT04826562|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110269778|NCT04826562|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110269780|NCT04778618|Immunologic Factors|immunologic factors|mesh-ancestor
110269781|NCT04778618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269782|NCT04778618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110269784|NCT04767841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110269785|NCT04767841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269786|NCT04761861|Vildagliptin|vildagliptin|mesh-list
110269787|NCT04761861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110269788|NCT04761861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269789|NCT04761861|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110269790|NCT04761861|Protease Inhibitors|protease inhibitors|mesh-ancestor
110269791|NCT04761861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110269792|NCT04761861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110269793|NCT04716699|Lidocaine|lidocaine|mesh-list
110269794|NCT04716699|Anesthetics, Local|anesthetics, local|mesh-ancestor
110269795|NCT04716699|Anesthetics|anesthetics|mesh-ancestor
110273960|NCT00169988|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110269796|NCT04716699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110269797|NCT04716699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269799|NCT04716699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110269800|NCT04716699|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110269801|NCT04716699|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110269802|NCT04716699|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110269803|NCT04716699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110269804|NCT04716699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110269805|NCT04685980|Morphine|morphine|mesh-list
110269806|NCT04685980|Anesthetics|anesthetics|mesh-list
110269807|NCT04685980|Anesthetics, Local|anesthetics, local|mesh-list
110269808|NCT04685980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110269809|NCT04685980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269810|NCT04685980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110269811|NCT04685980|Narcotics|narcotics|mesh-ancestor
110269812|NCT04685980|Analgesics|analgesics|mesh-ancestor
110269813|NCT04685980|Sensory System Agents|sensory system agents|mesh-ancestor
110269814|NCT04685980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110269815|NCT04657692|Anesthetics|anesthetics|mesh-list
110269816|NCT04657692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110269817|NCT04657692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269818|NCT04577690|Epinephrine|epinephrine|mesh-list
110269819|NCT04577690|Racepinephrine|racepinephrine|mesh-list
110269820|NCT04577690|Bupivacaine|bupivacaine|mesh-list
110269821|NCT04577690|Epinephryl borate|epinephryl borate|mesh-list
110269822|NCT04577690|Anesthetics, Local|anesthetics, local|mesh-ancestor
110269823|NCT04577690|Anesthetics|anesthetics|mesh-ancestor
110269824|NCT04577690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110269825|NCT04577690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269826|NCT04577690|Sensory System Agents|sensory system agents|mesh-ancestor
110269827|NCT04577690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110269828|NCT04577690|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110269829|NCT04577690|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110269830|NCT04577690|Adrenergic Agents|adrenergic agents|mesh-ancestor
110269832|NCT04577690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110269833|NCT04577690|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110269834|NCT04577690|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110269836|NCT04577690|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110269837|NCT04577690|Respiratory System Agents|respiratory system agents|mesh-ancestor
110269839|NCT04577690|Sympathomimetics|sympathomimetics|mesh-ancestor
110269840|NCT04577690|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110269841|NCT04531176|Liraglutide|liraglutide|mesh-list
110269842|NCT04531176|Topiramate|topiramate|mesh-list
110269843|NCT04531176|Orlistat|orlistat|mesh-list
110269844|NCT04531176|Phentermine|phentermine|mesh-list
110269845|NCT04531176|Naltrexone|naltrexone|mesh-list
110269846|NCT04531176|Bupropion|bupropion|mesh-list
110269847|NCT04531176|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110269848|NCT04531176|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110269849|NCT04531176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269850|NCT04531176|Sensory System Agents|sensory system agents|mesh-ancestor
110269851|NCT04531176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110269852|NCT04531176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110269853|NCT04531176|Incretins|incretins|mesh-ancestor
110269854|NCT04531176|Hormones|hormones|mesh-ancestor
110269855|NCT04531176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110269856|NCT04531176|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110269857|NCT04531176|Antidepressive Agents|antidepressive agents|mesh-ancestor
110269858|NCT04531176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110269859|NCT04531176|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110269860|NCT04531176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110269861|NCT04531176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110269862|NCT04531176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110269863|NCT04531176|Dopamine Agents|dopamine agents|mesh-ancestor
110269864|NCT04531176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110269865|NCT04531176|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110269866|NCT04531176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110269867|NCT04531176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110269868|NCT04531176|Anticonvulsants|anticonvulsants|mesh-ancestor
110269869|NCT04531176|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110269870|NCT04531176|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110269871|NCT04531176|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110269872|NCT04531176|Appetite Depressants|appetite depressants|mesh-ancestor
110269873|NCT04531176|Sympathomimetics|sympathomimetics|mesh-ancestor
110269874|NCT04531176|Autonomic Agents|autonomic agents|mesh-ancestor
110269875|NCT04531176|Adrenergic Agents|adrenergic agents|mesh-ancestor
110269876|NCT04472767|Nivolumab|nivolumab|mesh-list
110269877|NCT04472767|Ipilimumab|ipilimumab|mesh-list
110269878|NCT04472767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110269879|NCT04472767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110269880|NCT04472767|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110269881|NCT04472767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110269882|NCT04456946|Salicylic Acid|salicylic acid|mesh-list
110269883|NCT04456946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110269884|NCT04456946|Antifungal Agents|antifungal agents|mesh-ancestor
110269885|NCT04456946|Keratolytic Agents|keratolytic agents|mesh-ancestor
110269886|NCT04456946|Dermatologic Agents|dermatologic agents|mesh-ancestor
110269887|NCT04409860|Paclitaxel|paclitaxel|mesh-list
110269888|NCT04409860|Cisplatin|cisplatin|mesh-list
110269889|NCT04409860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110269890|NCT04409860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110269891|NCT04409860|Tubulin Modulators|tubulin modulators|mesh-ancestor
110269892|NCT04409860|Antimitotic Agents|antimitotic agents|mesh-ancestor
110269893|NCT04409860|Mitosis Modulators|mitosis modulators|mesh-ancestor
110269894|NCT04409860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110269903|NCT04303559|Immunologic Factors|immunologic factors|mesh-ancestor
110269904|NCT04303559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269905|NCT04303390|Cefazolin|cefazolin|mesh-list
110269907|NCT04303390|Cefuroxime axetil|cefuroxime axetil|mesh-list
110269908|NCT04303390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110269909|NCT04303390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110269910|NCT04075110|Montelukast|montelukast|mesh-list
110269911|NCT04075110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110269912|NCT04075110|Respiratory System Agents|respiratory system agents|mesh-ancestor
110269913|NCT04075110|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110269914|NCT04075110|Hormone Antagonists|hormone antagonists|mesh-ancestor
110269915|NCT04075110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110269916|NCT04075110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269917|NCT04075110|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110269918|NCT04075110|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110269919|NCT04075110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110269920|NCT04055909|Nangibotide|nangibotide|mesh-list
110269921|NCT04055909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110269922|NCT03978689|Pembrolizumab|pembrolizumab|mesh-list
110269923|NCT03978689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110269924|NCT03978689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110269925|NCT03978689|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110269926|NCT03978689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110269927|NCT03816553|Apatinib|apatinib|mesh-list
110269928|NCT03816553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110269929|NCT03816553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110269930|NCT03816553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110269931|NCT03816553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110269933|NCT03729245|Sunitinib|sunitinib|mesh-list
110269934|NCT03729245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110269935|NCT03729245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110269936|NCT03729245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110269937|NCT03729245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110269938|NCT03729245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110269939|NCT03729245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110269940|NCT03729245|Growth Substances|growth substances|mesh-ancestor
110269941|NCT03729245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269942|NCT03729245|Growth Inhibitors|growth inhibitors|mesh-ancestor
110269943|NCT03729245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110269944|NCT03729245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110269945|NCT03712397|Irinotecan|irinotecan|mesh-list
110269946|NCT03712397|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110269947|NCT03712397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110269948|NCT03712397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110269949|NCT03712397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110269950|NCT03712397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110269951|NCT03557918|Tremelimumab|tremelimumab|mesh-list
110269952|NCT03557918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110269954|NCT03544099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110269955|NCT03544099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110269956|NCT03544099|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110269957|NCT03544099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110269959|NCT03528408|Ipilimumab|ipilimumab|mesh-list
110269960|NCT03528408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110269961|NCT03528408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110269962|NCT03528408|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110269963|NCT03528408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110269964|NCT03501381|Aldesleukin|aldesleukin|mesh-list
110269965|NCT03501381|Interleukin-2|interleukin-2|mesh-list
110269966|NCT03501381|Entinostat|entinostat|mesh-list
110269967|NCT03501381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110269968|NCT03501381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110269969|NCT03501381|Analgesics|analgesics|mesh-ancestor
110269970|NCT03501381|Sensory System Agents|sensory system agents|mesh-ancestor
110269971|NCT03501381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110269972|NCT03501381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269973|NCT03501381|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110269974|NCT03501381|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110269975|NCT03501381|Antiviral Agents|antiviral agents|mesh-ancestor
110269976|NCT03501381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110273997|NCT00170222|Doxycycline|doxycycline|mesh-list
110269977|NCT03501381|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110269978|NCT03501381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110269979|NCT03501381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110269980|NCT03478488|Gemcitabine|gemcitabine|mesh-list
110269981|NCT03478488|Oxaliplatin|oxaliplatin|mesh-list
110269982|NCT03478488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110269983|NCT03478488|Antimetabolites|antimetabolites|mesh-ancestor
110269984|NCT03478488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110269985|NCT03478488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110269987|NCT03406299|Gemcitabine|gemcitabine|mesh-list
110269988|NCT03406299|Oxaliplatin|oxaliplatin|mesh-list
110269990|NCT03406299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110269991|NCT03406299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110269992|NCT03406299|Antimetabolites|antimetabolites|mesh-ancestor
110269993|NCT03406299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110269994|NCT03406299|Antidotes|antidotes|mesh-ancestor
110269995|NCT03406299|Protective Agents|protective agents|mesh-ancestor
110269996|NCT03406299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269997|NCT03406299|Vitamin B Complex|vitamin b complex|mesh-ancestor
110269998|NCT03406299|Vitamins|vitamins|mesh-ancestor
110269999|NCT03406299|Micronutrients|micronutrients|mesh-ancestor
110270000|NCT03396445|Paclitaxel|paclitaxel|mesh-list
110270001|NCT03396445|Carboplatin|carboplatin|mesh-list
110270002|NCT03396445|Pembrolizumab|pembrolizumab|mesh-list
110270003|NCT03396445|Pemetrexed|pemetrexed|mesh-list
110270004|NCT03396445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110270005|NCT03396445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110270006|NCT03396445|Tubulin Modulators|tubulin modulators|mesh-ancestor
110270007|NCT03396445|Antimitotic Agents|antimitotic agents|mesh-ancestor
110270008|NCT03396445|Mitosis Modulators|mitosis modulators|mesh-ancestor
110270009|NCT03396445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270010|NCT03396445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110270011|NCT03396445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110270013|NCT03396445|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110270014|NCT03396445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110270015|NCT03355469|Metformin|metformin|mesh-list
110270016|NCT03355469|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110270017|NCT03355469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110270018|NCT03330028|Diphenhydramine|diphenhydramine|mesh-list
110270019|NCT03330028|Promethazine|promethazine|mesh-list
110270020|NCT03330028|Dexamethasone|dexamethasone|mesh-list
110270021|NCT03330028|Paclitaxel|paclitaxel|mesh-list
110270022|NCT03330028|Cisplatin|cisplatin|mesh-list
110270023|NCT03330028|Mitomycins|mitomycins|mesh-list
110270024|NCT03330028|Mitomycin|mitomycin|mesh-list
110270025|NCT03330028|Famotidine|famotidine|mesh-list
110270026|NCT03330028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110270027|NCT03330028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110270028|NCT03330028|Tubulin Modulators|tubulin modulators|mesh-ancestor
110270029|NCT03330028|Antimitotic Agents|antimitotic agents|mesh-ancestor
110270030|NCT03330028|Mitosis Modulators|mitosis modulators|mesh-ancestor
110270031|NCT03330028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270032|NCT03330028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110270033|NCT03330028|Antiemetics|antiemetics|mesh-ancestor
110270034|NCT03330028|Autonomic Agents|autonomic agents|mesh-ancestor
110270035|NCT03330028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110270036|NCT03330028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110270037|NCT03330028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110270038|NCT03330028|Glucocorticoids|glucocorticoids|mesh-ancestor
110270040|NCT03330028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110270041|NCT03330028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110270042|NCT03330028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110270043|NCT03330028|Alkylating Agents|alkylating agents|mesh-ancestor
110270044|NCT03330028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110270045|NCT03330028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110270046|NCT03330028|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110270047|NCT03330028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110270048|NCT03330028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110270049|NCT03330028|Anesthetics, Local|anesthetics, local|mesh-ancestor
110270050|NCT03330028|Anesthetics|anesthetics|mesh-ancestor
110270051|NCT03330028|Sensory System Agents|sensory system agents|mesh-ancestor
110270052|NCT03330028|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110270053|NCT03330028|Histamine Antagonists|histamine antagonists|mesh-ancestor
110270054|NCT03330028|Histamine Agents|histamine agents|mesh-ancestor
110270055|NCT03330028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110270056|NCT03330028|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110270057|NCT03330028|Antipruritics|antipruritics|mesh-ancestor
110270058|NCT03330028|Dermatologic Agents|dermatologic agents|mesh-ancestor
110270059|NCT03330028|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110270060|NCT03330028|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110270061|NCT03311555|Docetaxel|docetaxel|mesh-list
110270062|NCT03311555|Androgens|androgens|mesh-list
110270063|NCT03311555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110270064|NCT03311555|Tubulin Modulators|tubulin modulators|mesh-ancestor
110270065|NCT03311555|Antimitotic Agents|antimitotic agents|mesh-ancestor
110270066|NCT03311555|Mitosis Modulators|mitosis modulators|mesh-ancestor
110270067|NCT03311555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270069|NCT03311555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110270070|NCT03311555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110270072|NCT03271866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110270073|NCT03271866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110270075|NCT03217565|Tedizolid phosphate|tedizolid phosphate|mesh-list
110270076|NCT03217565|Oxazolidinones|oxazolidinones|mesh-list
110270077|NCT03217565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110270078|NCT03217565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110270079|NCT03217565|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110270080|NCT03217565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110270081|NCT03217565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270082|NCT03196180|Fluorouracil|fluorouracil|mesh-list
110270083|NCT03196180|Imiquimod|imiquimod|mesh-list
110270084|NCT03196180|Antimetabolites|antimetabolites|mesh-ancestor
110270085|NCT03196180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270086|NCT03196180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110270087|NCT03196180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110270088|NCT03196180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110270089|NCT03196180|Immunologic Factors|immunologic factors|mesh-ancestor
110270090|NCT03196180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110270091|NCT03196180|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110270092|NCT03196180|Interferon Inducers|interferon inducers|mesh-ancestor
110270093|NCT03162627|Olaparib|olaparib|mesh-list
110270094|NCT03162627|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110270095|NCT03162627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110270096|NCT03162627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270098|NCT02992743|Cyclophosphamide|cyclophosphamide|mesh-list
110270099|NCT02992743|Fludarabine|fludarabine|mesh-list
110270100|NCT02992743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110270101|NCT02992743|Immunologic Factors|immunologic factors|mesh-ancestor
110270102|NCT02992743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110270104|NCT02992743|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110270105|NCT02992743|Alkylating Agents|alkylating agents|mesh-ancestor
110270106|NCT02992743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270107|NCT02992743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110270108|NCT02992743|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110270109|NCT02853344|Pembrolizumab|pembrolizumab|mesh-list
110270110|NCT02853344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110270111|NCT02853344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110270112|NCT02853344|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110270113|NCT02853344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270114|NCT02738229|Valacyclovir|valacyclovir|mesh-list
110270115|NCT02738229|Antiviral Agents|antiviral agents|mesh-ancestor
110270116|NCT02738229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110270117|NCT02675426|Upadacitinib|upadacitinib|mesh-list
110270118|NCT02675426|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110270119|NCT02675426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110270121|NCT02675426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270122|NCT02675426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110270123|NCT02579473|Rotigotine|rotigotine|mesh-list
110270124|NCT02579473|Dopamine Agonists|dopamine agonists|mesh-ancestor
110270125|NCT02579473|Dopamine Agents|dopamine agents|mesh-ancestor
110270126|NCT02579473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110270127|NCT02579473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270128|NCT02579473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110270129|NCT02427620|Cytarabine|cytarabine|mesh-list
110270130|NCT02427620|Dexamethasone|dexamethasone|mesh-list
110270131|NCT02427620|Dexamethasone acetate|dexamethasone acetate|mesh-list
110270132|NCT02427620|Cyclophosphamide|cyclophosphamide|mesh-list
110270133|NCT02427620|Rituximab|rituximab|mesh-list
110270135|NCT02427620|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110270136|NCT02427620|Methotrexate|methotrexate|mesh-list
110270137|NCT02427620|Vincristine|vincristine|mesh-list
110270138|NCT02427620|Daunorubicin|daunorubicin|mesh-list
110270139|NCT02427620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110270141|NCT02427620|Immunoglobulins|immunoglobulins|mesh-list
110270142|NCT02427620|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110270143|NCT02427620|BB 1101|bb 1101|mesh-list
110270144|NCT02427620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110270145|NCT02427620|Immunologic Factors|immunologic factors|mesh-ancestor
110270146|NCT02427620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110270147|NCT02427620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110270148|NCT02427620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110270149|NCT02427620|Alkylating Agents|alkylating agents|mesh-ancestor
110270150|NCT02427620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270151|NCT02427620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110270152|NCT02427620|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110270153|NCT02427620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110270154|NCT02427620|Antiemetics|antiemetics|mesh-ancestor
110270155|NCT02427620|Autonomic Agents|autonomic agents|mesh-ancestor
110270156|NCT02427620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110270157|NCT02427620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110270158|NCT02427620|Glucocorticoids|glucocorticoids|mesh-ancestor
110270159|NCT02427620|Hormones|hormones|mesh-ancestor
110270160|NCT02427620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110270164|NCT02427620|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110270165|NCT02427620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110270166|NCT02427620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110270167|NCT02427620|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110270168|NCT02427620|Abortifacient Agents|abortifacient agents|mesh-ancestor
110270169|NCT02427620|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110270170|NCT02427620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110270171|NCT02427620|Antimetabolites|antimetabolites|mesh-ancestor
110270172|NCT02427620|Dermatologic Agents|dermatologic agents|mesh-ancestor
110270173|NCT02427620|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110270174|NCT02427620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110270175|NCT02427620|Antiviral Agents|antiviral agents|mesh-ancestor
110270176|NCT02427620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110270177|NCT02427620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110270178|NCT02427620|Tubulin Modulators|tubulin modulators|mesh-ancestor
110270179|NCT02427620|Antimitotic Agents|antimitotic agents|mesh-ancestor
110270180|NCT02427620|Mitosis Modulators|mitosis modulators|mesh-ancestor
110270181|NCT02415621|Abiraterone Acetate|abiraterone acetate|mesh-list
110270182|NCT02415621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110270183|NCT02415621|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110270184|NCT02415621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110270185|NCT02415621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270186|NCT02415621|Hormone Antagonists|hormone antagonists|mesh-ancestor
110270187|NCT02415621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110270188|NCT02415621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110270189|NCT02415621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110270195|NCT02401035|Pantoprazole|pantoprazole|mesh-list
110270196|NCT02401035|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110270197|NCT02401035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110270198|NCT02401035|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110270200|NCT02401035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270206|NCT02153944|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110270207|NCT02153944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110270208|NCT02153944|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110270209|NCT02153944|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110270210|NCT02153944|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110270211|NCT02153944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270212|NCT02153944|Dopamine Agents|dopamine agents|mesh-ancestor
110270213|NCT02153944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110270214|NCT02153944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110270215|NCT02153944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110270216|NCT02153944|Adrenergic Agents|adrenergic agents|mesh-ancestor
110270217|NCT02153944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110270218|NCT02153944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110270220|NCT02060721|Macitentan|macitentan|mesh-list
110274056|NCT00179244|Bupropion|bupropion|mesh-list
110270221|NCT02060721|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
110270222|NCT02060721|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110270223|NCT02060721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270224|NCT02060721|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
110270226|NCT01527149|Dexamethasone|dexamethasone|mesh-list
110270227|NCT01527149|Dexamethasone acetate|dexamethasone acetate|mesh-list
110270228|NCT01527149|Cyclophosphamide|cyclophosphamide|mesh-list
110270230|NCT01527149|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110270231|NCT01527149|Methotrexate|methotrexate|mesh-list
110270232|NCT01527149|Vincristine|vincristine|mesh-list
110270233|NCT01527149|Ofatumumab|ofatumumab|mesh-list
110270234|NCT01527149|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110270235|NCT01527149|BB 1101|bb 1101|mesh-list
110270236|NCT01527149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110270237|NCT01527149|Immunologic Factors|immunologic factors|mesh-ancestor
110270238|NCT01527149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110270239|NCT01527149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110270240|NCT01527149|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110270241|NCT01527149|Alkylating Agents|alkylating agents|mesh-ancestor
110270242|NCT01527149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270243|NCT01527149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110270244|NCT01527149|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110270245|NCT01527149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110270246|NCT01527149|Antiemetics|antiemetics|mesh-ancestor
110270247|NCT01527149|Autonomic Agents|autonomic agents|mesh-ancestor
110270248|NCT01527149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110270249|NCT01527149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110270250|NCT01527149|Glucocorticoids|glucocorticoids|mesh-ancestor
110270251|NCT01527149|Hormones|hormones|mesh-ancestor
110270252|NCT01527149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110270253|NCT01527149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110270254|NCT01527149|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110270255|NCT01527149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110270258|NCT01527149|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110270260|NCT01527149|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110270261|NCT01527149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110270262|NCT01527149|Antimetabolites|antimetabolites|mesh-ancestor
110270263|NCT01527149|Dermatologic Agents|dermatologic agents|mesh-ancestor
110270264|NCT01527149|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110270265|NCT01527149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110270266|NCT01527149|Antiviral Agents|antiviral agents|mesh-ancestor
110270267|NCT01527149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110274071|NCT00196872|Epirubicin|epirubicin|mesh-list
110270268|NCT01527149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110270269|NCT01527149|Tubulin Modulators|tubulin modulators|mesh-ancestor
110270270|NCT01527149|Antimitotic Agents|antimitotic agents|mesh-ancestor
110270271|NCT01527149|Mitosis Modulators|mitosis modulators|mesh-ancestor
110270272|NCT01527149|Protease Inhibitors|protease inhibitors|mesh-ancestor
110270273|NCT01359956|Interferons|interferons|mesh-list
110270274|NCT01359956|Interferon-alpha|interferon-alpha|mesh-list
110270275|NCT01359956|Interferon alpha-2|interferon alpha-2|mesh-list
110270276|NCT01359956|Dacarbazine|dacarbazine|mesh-list
110270278|NCT01359956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110270279|NCT01359956|Antiviral Agents|antiviral agents|mesh-ancestor
110270280|NCT01359956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110270281|NCT01359956|Immunologic Factors|immunologic factors|mesh-ancestor
110270282|NCT01359956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110270283|NCT01359956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110270284|NCT01359956|Alkylating Agents|alkylating agents|mesh-ancestor
110270285|NCT01359956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270286|NCT01306045|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110270287|NCT01306045|Sunitinib|sunitinib|mesh-list
110270288|NCT01306045|Lapatinib|lapatinib|mesh-list
110270289|NCT01306045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110270290|NCT01306045|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110270291|NCT01306045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110270292|NCT01306045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270293|NCT01306045|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110270294|NCT01306045|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110270296|NCT01306045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110270297|NCT01306045|Growth Inhibitors|growth inhibitors|mesh-ancestor
110270298|NCT01198067|Pomalidomide|pomalidomide|mesh-list
110270299|NCT01198067|Immunologic Factors|immunologic factors|mesh-ancestor
110270300|NCT01198067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110270301|NCT01198067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110270302|NCT01198067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110270303|NCT01198067|Growth Substances|growth substances|mesh-ancestor
110270304|NCT01198067|Growth Inhibitors|growth inhibitors|mesh-ancestor
110270305|NCT01198067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110270306|NCT01196936|Tamoxifen|tamoxifen|mesh-list
110270307|NCT01196936|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110270308|NCT01196936|Hormone Antagonists|hormone antagonists|mesh-ancestor
110270309|NCT01196936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110270310|NCT01196936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110270311|NCT01196936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110270312|NCT01196936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110270313|NCT01196936|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110270314|NCT01196936|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110270315|NCT01196936|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110270316|NCT01192568|Oxybutynin|oxybutynin|mesh-list
110270317|NCT01192568|Parasympatholytics|parasympatholytics|mesh-ancestor
110270318|NCT01192568|Autonomic Agents|autonomic agents|mesh-ancestor
110270319|NCT01192568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110036259|NCT01409694|Vitamin D|vitamin d|mesh-list
110270320|NCT01192568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110270321|NCT01192568|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110270322|NCT01192568|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110270323|NCT01192568|Cholinergic Agents|cholinergic agents|mesh-ancestor
110270324|NCT01192568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110270325|NCT01192568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270326|NCT01192568|Urological Agents|urological agents|mesh-ancestor
110270327|NCT01075971|Buprenorphine|buprenorphine|mesh-list
110270328|NCT01075971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110270329|NCT01075971|Narcotics|narcotics|mesh-ancestor
110270330|NCT01075971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110270331|NCT01075971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110270332|NCT01075971|Analgesics|analgesics|mesh-ancestor
110270333|NCT01075971|Sensory System Agents|sensory system agents|mesh-ancestor
110270334|NCT01075971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110270335|NCT01075971|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110270337|NCT00775749|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110270338|NCT00775749|Autonomic Agents|autonomic agents|mesh-ancestor
110270339|NCT00775749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110270340|NCT00775749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110270341|NCT00775749|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110270342|NCT00775749|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110270343|NCT00775749|Cholinergic Agents|cholinergic agents|mesh-ancestor
110270345|NCT00775749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270346|NCT00324922|Vancomycin|vancomycin|mesh-list
110036290|NCT01410162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110270347|NCT00324922|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110270349|NCT00324922|Sulfamethoxazole|sulfamethoxazole|mesh-list
110270350|NCT00324922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110270351|NCT00324922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110270352|NCT00324922|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110270353|NCT00324922|Antimalarials|antimalarials|mesh-ancestor
110270354|NCT00324922|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110270355|NCT00324922|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110270356|NCT00324922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110270357|NCT00324922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110270358|NCT00324922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270359|NCT00324922|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110270360|NCT00324922|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110270361|NCT00324922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110270362|NCT00192855|Entacapone|entacapone|mesh-list
110270363|NCT00192855|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110270364|NCT00192855|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110270365|NCT00192855|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
110270366|NCT00192855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110270367|NCT00192855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270368|NCT00407186|Cisplatin|cisplatin|mesh-list
110270369|NCT00407186|Capecitabine|capecitabine|mesh-list
110270370|NCT00407186|Epirubicin|epirubicin|mesh-list
110270372|NCT00407186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110270373|NCT00407186|Antimetabolites|antimetabolites|mesh-ancestor
110270374|NCT00407186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270377|NCT00407186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110270378|NCT00407186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110270379|NCT00163748|Gemcitabine|gemcitabine|mesh-list
110270380|NCT00163748|Vinorelbine|vinorelbine|mesh-list
110270381|NCT00163748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110270382|NCT00163748|Antimetabolites|antimetabolites|mesh-ancestor
110270383|NCT00163748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270384|NCT00163748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110270385|NCT00163748|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110270386|NCT00163748|Tubulin Modulators|tubulin modulators|mesh-ancestor
110270387|NCT00163748|Antimitotic Agents|antimitotic agents|mesh-ancestor
110270388|NCT00163748|Mitosis Modulators|mitosis modulators|mesh-ancestor
110270389|NCT00193011|Cyclophosphamide|cyclophosphamide|mesh-list
110270391|NCT00193011|Fluorouracil|fluorouracil|mesh-list
110270392|NCT00193011|Methotrexate|methotrexate|mesh-list
110270393|NCT00193011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110270394|NCT00193011|Immunologic Factors|immunologic factors|mesh-ancestor
110270395|NCT00193011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110270396|NCT00193011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110270397|NCT00193011|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110270398|NCT00193011|Alkylating Agents|alkylating agents|mesh-ancestor
110270399|NCT00193011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270400|NCT00193011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110270401|NCT00193011|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110270402|NCT00193011|Tubulin Modulators|tubulin modulators|mesh-ancestor
110270403|NCT00193011|Antimitotic Agents|antimitotic agents|mesh-ancestor
110270404|NCT00193011|Mitosis Modulators|mitosis modulators|mesh-ancestor
110270405|NCT00193011|Antimetabolites|antimetabolites|mesh-ancestor
110270406|NCT00193011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110270407|NCT00193011|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110270408|NCT00193011|Abortifacient Agents|abortifacient agents|mesh-ancestor
110270409|NCT00193011|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110270410|NCT00193011|Dermatologic Agents|dermatologic agents|mesh-ancestor
110270411|NCT00193011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110270412|NCT00193011|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110270413|NCT00193011|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110270415|NCT00193089|Trastuzumab|trastuzumab|mesh-list
110270416|NCT00193089|Vinorelbine|vinorelbine|mesh-list
110270417|NCT00193089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110270418|NCT00193089|Tubulin Modulators|tubulin modulators|mesh-ancestor
110270419|NCT00193089|Antimitotic Agents|antimitotic agents|mesh-ancestor
110270420|NCT00193089|Mitosis Modulators|mitosis modulators|mesh-ancestor
110270421|NCT00193089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270422|NCT00193089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110270423|NCT00193089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110270424|NCT00193167|Topotecan|topotecan|mesh-list
110270425|NCT00193167|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110270426|NCT00193167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110270427|NCT00193167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110270428|NCT00193167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270429|NCT00193167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110270430|NCT00193245|Docetaxel|docetaxel|mesh-list
110270431|NCT00193245|Topotecan|topotecan|mesh-list
110270432|NCT00193245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110270433|NCT00193245|Tubulin Modulators|tubulin modulators|mesh-ancestor
110270434|NCT00193245|Antimitotic Agents|antimitotic agents|mesh-ancestor
110270435|NCT00193245|Mitosis Modulators|mitosis modulators|mesh-ancestor
110270436|NCT00193245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270437|NCT00193245|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110270438|NCT00193245|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110270439|NCT00193245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110270441|NCT00193284|Docetaxel|docetaxel|mesh-list
110270442|NCT00193284|Fluorouracil|fluorouracil|mesh-list
110270443|NCT00193284|Gefitinib|gefitinib|mesh-list
110270444|NCT00193284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110270445|NCT00193284|Tubulin Modulators|tubulin modulators|mesh-ancestor
110270446|NCT00193284|Antimitotic Agents|antimitotic agents|mesh-ancestor
110270447|NCT00193284|Mitosis Modulators|mitosis modulators|mesh-ancestor
110270448|NCT00193284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270449|NCT00193284|Antimetabolites|antimetabolites|mesh-ancestor
110270450|NCT00193284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110270451|NCT00193284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110270452|NCT00193284|Immunologic Factors|immunologic factors|mesh-ancestor
110270453|NCT00193284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110270454|NCT00193284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110270455|NCT00193284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110270457|NCT00163982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110270458|NCT00163982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110270459|NCT00163982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110270460|NCT00163982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110270461|NCT00163982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110270462|NCT00163982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270463|NCT00163982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110270464|NCT00163982|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110270465|NCT00163982|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110270466|NCT00193323|Gemcitabine|gemcitabine|mesh-list
110270467|NCT00193323|Docetaxel|docetaxel|mesh-list
110270468|NCT00193323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110270469|NCT00193323|Antimetabolites|antimetabolites|mesh-ancestor
110270470|NCT00193323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270471|NCT00193323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110270472|NCT00193323|Tubulin Modulators|tubulin modulators|mesh-ancestor
110270473|NCT00193323|Antimitotic Agents|antimitotic agents|mesh-ancestor
110270474|NCT00193323|Mitosis Modulators|mitosis modulators|mesh-ancestor
110270475|NCT00193362|Paclitaxel|paclitaxel|mesh-list
110270476|NCT00193362|Vinorelbine|vinorelbine|mesh-list
110270477|NCT00193362|Carboplatin|carboplatin|mesh-list
110270478|NCT00193362|Gemcitabine|gemcitabine|mesh-list
110270479|NCT00193362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110270480|NCT00193362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110270481|NCT00193362|Tubulin Modulators|tubulin modulators|mesh-ancestor
110270482|NCT00193362|Antimitotic Agents|antimitotic agents|mesh-ancestor
110270483|NCT00193362|Mitosis Modulators|mitosis modulators|mesh-ancestor
110270484|NCT00193362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270485|NCT00193362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110270486|NCT00193362|Antimetabolites|antimetabolites|mesh-ancestor
110270487|NCT00193401|Topotecan|topotecan|mesh-list
110270488|NCT00193401|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110270489|NCT00193401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110270490|NCT00193401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110270491|NCT00193401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270492|NCT00193401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110270493|NCT00553189|Topotecan|topotecan|mesh-list
110270494|NCT00553189|Veliparib|veliparib|mesh-list
110270495|NCT00553189|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110270497|NCT00553189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110270498|NCT00553189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270499|NCT00553189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110270500|NCT00553189|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110270501|NCT00193440|Rituximab|rituximab|mesh-list
110270502|NCT00193440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110270503|NCT00193440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110270504|NCT00193440|Immunologic Factors|immunologic factors|mesh-ancestor
110270505|NCT00193440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110270506|NCT00193440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110270508|NCT05077969|Famotidine|famotidine|mesh-list
110270509|NCT05077969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110270510|NCT05077969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110270511|NCT05077969|Analgesics|analgesics|mesh-ancestor
110270512|NCT05077969|Sensory System Agents|sensory system agents|mesh-ancestor
110270513|NCT05077969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110270514|NCT05077969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110270515|NCT05077969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110270517|NCT05077969|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110270518|NCT05077969|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110270519|NCT05077969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110270520|NCT05077969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270521|NCT05077969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110270522|NCT05077969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110270523|NCT05077969|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110270524|NCT05077969|Histamine Antagonists|histamine antagonists|mesh-ancestor
110270525|NCT05077969|Histamine Agents|histamine agents|mesh-ancestor
110270526|NCT05077969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110270527|NCT00193518|Arsenic Trioxide|arsenic trioxide|mesh-list
110270528|NCT00193518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110270529|NCT00164216|Artesunate|artesunate|mesh-list
110270530|NCT00164216|Mefloquine|mefloquine|mesh-list
110270531|NCT00164216|Antimalarials|antimalarials|mesh-ancestor
110270532|NCT00164216|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110270533|NCT00164216|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110270534|NCT00164216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110270535|NCT00164216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110270536|NCT00164216|Antiviral Agents|antiviral agents|mesh-ancestor
110270537|NCT00164216|Schistosomicides|schistosomicides|mesh-ancestor
110270538|NCT00164216|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110270539|NCT00164216|Anthelmintics|anthelmintics|mesh-ancestor
110270541|NCT00193557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110270542|NCT00164255|Artesunate|artesunate|mesh-list
110270543|NCT00164255|Pyrimethamine|pyrimethamine|mesh-list
110270544|NCT00164255|Sulfadoxine|sulfadoxine|mesh-list
110270545|NCT00164255|Antimalarials|antimalarials|mesh-ancestor
110270546|NCT00164255|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110270547|NCT00164255|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110270548|NCT00164255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110270549|NCT00164255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110270550|NCT00164255|Antiviral Agents|antiviral agents|mesh-ancestor
110270551|NCT00164255|Schistosomicides|schistosomicides|mesh-ancestor
110270552|NCT00164255|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110270553|NCT00164255|Anthelmintics|anthelmintics|mesh-ancestor
110270554|NCT00164255|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110270555|NCT00164255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110270556|NCT00164255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270557|NCT00164255|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110270558|NCT00409656|Basiliximab|basiliximab|mesh-list
110270559|NCT00409656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110270560|NCT00409656|Immunologic Factors|immunologic factors|mesh-ancestor
110270561|NCT00409656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110270562|NCT00409695|Thymoglobulin|thymoglobulin|mesh-list
110270564|NCT00409695|Immunologic Factors|immunologic factors|mesh-ancestor
110270565|NCT00409695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110270568|NCT04977232|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110270569|NCT04977232|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110270570|NCT04977232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110270571|NCT04977232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270572|NCT04977232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110270573|NCT04977232|Serotonin Agents|serotonin agents|mesh-ancestor
110270574|NCT04977232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110270575|NCT04974814|Atorvastatin|atorvastatin|mesh-list
110270576|NCT04974814|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110270577|NCT04974814|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110270578|NCT04974814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110270579|NCT04974814|Antimetabolites|antimetabolites|mesh-ancestor
110270580|NCT04974814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270581|NCT04974814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110270582|NCT04974814|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110270583|NCT04974814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110270589|NCT00193635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110270590|NCT00193635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110270591|NCT00193635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110270592|NCT00193635|Antitubercular Agents|antitubercular agents|mesh-ancestor
110270593|NCT00193635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110270594|NCT00193635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110270595|NCT00193635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110270596|NCT00193635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270603|NCT00193674|Progestins|progestins|mesh-ancestor
110270604|NCT00193674|Hormones|hormones|mesh-ancestor
110270605|NCT00193674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110270606|NCT00193674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110270607|NCT00164450|Isoniazid|isoniazid|mesh-list
110270608|NCT00164450|Rifapentine|rifapentine|mesh-list
110270609|NCT00164450|Antitubercular Agents|antitubercular agents|mesh-ancestor
110270610|NCT00164450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110270611|NCT00164450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110270612|NCT00164450|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110270613|NCT00164450|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110270614|NCT00164450|Antimetabolites|antimetabolites|mesh-ancestor
110270615|NCT00164450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270616|NCT00164450|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110270617|NCT00164450|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110270618|NCT00164450|Leprostatic Agents|leprostatic agents|mesh-ancestor
110270620|NCT00193869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110270621|NCT00193869|Antiemetics|antiemetics|mesh-ancestor
110270622|NCT00193869|Autonomic Agents|autonomic agents|mesh-ancestor
110270623|NCT00193869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110270624|NCT00193869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110270625|NCT00193869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110270626|NCT00193869|Glucocorticoids|glucocorticoids|mesh-ancestor
110270627|NCT00193869|Hormones|hormones|mesh-ancestor
110270628|NCT00193869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110270629|NCT00193869|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110270631|NCT00176241|Paclitaxel|paclitaxel|mesh-list
110270632|NCT00176241|Gemcitabine|gemcitabine|mesh-list
110270633|NCT00176241|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110270634|NCT00176241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110270635|NCT00176241|Tubulin Modulators|tubulin modulators|mesh-ancestor
110270636|NCT00176241|Antimitotic Agents|antimitotic agents|mesh-ancestor
110270637|NCT00176241|Mitosis Modulators|mitosis modulators|mesh-ancestor
110270638|NCT00176241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270639|NCT00176241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110270642|NCT04742959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110270643|NCT04742959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110270644|NCT04742959|Tubulin Modulators|tubulin modulators|mesh-ancestor
110270645|NCT04742959|Antimitotic Agents|antimitotic agents|mesh-ancestor
110270646|NCT04742959|Mitosis Modulators|mitosis modulators|mesh-ancestor
110274142|NCT03014635|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110270647|NCT04742959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270648|NCT00164801|Diltiazem|diltiazem|mesh-list
110270649|NCT00164801|Baclofen|baclofen|mesh-list
110270650|NCT00164801|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110270651|NCT00164801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110270652|NCT00164801|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110270653|NCT00164801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110270654|NCT00164801|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110270655|NCT00164801|GABA Agonists|gaba agonists|mesh-ancestor
110270656|NCT00164801|GABA Agents|gaba agents|mesh-ancestor
110270657|NCT00164801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110270658|NCT00164801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270659|NCT00164801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110270660|NCT00164801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110270661|NCT00164801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110270662|NCT00164801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110270663|NCT00164801|Vasodilator Agents|vasodilator agents|mesh-ancestor
110270664|NCT00176280|Dexamethasone|dexamethasone|mesh-list
110270665|NCT00176280|Sargramostim|sargramostim|mesh-list
110270666|NCT00176280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110270667|NCT00176280|Antiemetics|antiemetics|mesh-ancestor
110270668|NCT00176280|Autonomic Agents|autonomic agents|mesh-ancestor
110270669|NCT00176280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110270670|NCT00176280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110270671|NCT00176280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110270672|NCT00176280|Glucocorticoids|glucocorticoids|mesh-ancestor
110270673|NCT00176280|Hormones|hormones|mesh-ancestor
110270674|NCT00176280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110270675|NCT00176280|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110270676|NCT00176280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110270677|NCT00176280|Immunologic Factors|immunologic factors|mesh-ancestor
110270678|NCT04723940|Doxycycline|doxycycline|mesh-list
110270679|NCT04723940|Clindamycin|clindamycin|mesh-list
110270680|NCT04723940|Clindamycin palmitate|clindamycin palmitate|mesh-list
110270681|NCT04723940|Clindamycin phosphate|clindamycin phosphate|mesh-list
110368721|NCT04617015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110270682|NCT04723940|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110270684|NCT04723940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110270685|NCT04723940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110270686|NCT04723940|Antimalarials|antimalarials|mesh-ancestor
110270687|NCT04723940|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110270688|NCT04723940|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110270689|NCT04723940|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110270690|NCT04723940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110270691|NCT04723940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270692|NCT04723940|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110270693|NCT00164840|Esomeprazole|esomeprazole|mesh-list
110270694|NCT00164840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110270695|NCT00164840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110270696|NCT00164840|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110270698|NCT00164840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270699|NCT04641247|Niraparib|niraparib|mesh-list
110270700|NCT04641247|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110270701|NCT04641247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110270702|NCT04641247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270703|NCT04641247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110270704|NCT04635007|Misoprostol|misoprostol|mesh-list
110270705|NCT04635007|Tranexamic Acid|tranexamic acid|mesh-list
110270706|NCT04635007|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110270707|NCT04635007|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110270708|NCT04635007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270710|NCT04635007|Coagulants|coagulants|mesh-ancestor
110270711|NCT04635007|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110270712|NCT04635007|Abortifacient Agents|abortifacient agents|mesh-ancestor
110270713|NCT04635007|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110270714|NCT04635007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110270715|NCT04635007|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110270716|NCT04635007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110270717|NCT04635007|Oxytocics|oxytocics|mesh-ancestor
110270719|NCT00194064|Antiemetics|antiemetics|mesh-ancestor
110270720|NCT00194064|Autonomic Agents|autonomic agents|mesh-ancestor
110270721|NCT00194064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110270722|NCT00194064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110270723|NCT00194064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110270724|NCT00194064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110270725|NCT00194064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110270726|NCT00194064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110270727|NCT00194064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110270728|NCT00194064|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110270729|NCT00194064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110270730|NCT00194064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110270731|NCT00194064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270732|NCT00194064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110270734|NCT00164996|Anesthetics|anesthetics|mesh-list
110270735|NCT00164996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110270736|NCT00164996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110270737|NCT04418557|Antibodies|antibodies|mesh-list
110270738|NCT04418557|Immunologic Factors|immunologic factors|mesh-ancestor
110270739|NCT04418557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110270740|NCT04682782|Esketamine|esketamine|mesh-list
110270741|NCT04682782|Antidepressive Agents|antidepressive agents|mesh-ancestor
110270742|NCT04682782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110270743|NCT04682665|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
110270744|NCT04682665|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110270745|NCT04682665|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110270746|NCT00165035|Paclitaxel|paclitaxel|mesh-list
110270747|NCT00165035|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110270748|NCT00165035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110270749|NCT00165035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110270750|NCT00165035|Tubulin Modulators|tubulin modulators|mesh-ancestor
110270751|NCT00165035|Antimitotic Agents|antimitotic agents|mesh-ancestor
110270752|NCT00165035|Mitosis Modulators|mitosis modulators|mesh-ancestor
110270753|NCT00165035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270754|NCT04326673|Methyltestosterone|methyltestosterone|mesh-list
110270755|NCT04326673|Testosterone|testosterone|mesh-list
110270756|NCT04326673|Testosterone undecanoate|testosterone undecanoate|mesh-list
110270758|NCT04326673|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110270759|NCT04326673|Androgens|androgens|mesh-ancestor
110270760|NCT04326673|Hormones|hormones|mesh-ancestor
110270761|NCT04326673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110270762|NCT04326673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110270763|NCT04326673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110270764|NCT04326673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110270765|NCT04326673|Anabolic Agents|anabolic agents|mesh-ancestor
110270766|NCT00165074|Calfactant|calfactant|mesh-list
110270767|NCT00165074|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
110270768|NCT00165074|Respiratory System Agents|respiratory system agents|mesh-ancestor
110270770|NCT04307953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110270771|NCT04307953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110270772|NCT04307953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270773|NCT04297267|Gemcitabine|gemcitabine|mesh-list
110270774|NCT04297267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110270775|NCT04297267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110270776|NCT04297267|Antimetabolites|antimetabolites|mesh-ancestor
110270777|NCT04297267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270778|NCT00176475|Rituximab|rituximab|mesh-list
110270779|NCT00176475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110270780|NCT00176475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110270781|NCT00176475|Immunologic Factors|immunologic factors|mesh-ancestor
110270782|NCT00176475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110270783|NCT00176475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110270784|NCT00165191|Doxorubicin|doxorubicin|mesh-list
110270785|NCT00165191|Fluorouracil|fluorouracil|mesh-list
110270786|NCT00165191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110270787|NCT00165191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110270788|NCT00165191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110270789|NCT00165191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110270790|NCT00165191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110270791|NCT00165191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270792|NCT00165191|Antimetabolites|antimetabolites|mesh-ancestor
110270793|NCT00165191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110270794|NCT00165191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110270795|NCT00165191|Immunologic Factors|immunologic factors|mesh-ancestor
110270796|NCT00165191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110270797|NCT00176514|Antineoplastic Agents|antineoplastic agents|mesh-list
110270798|NCT00165230|Thalidomide|thalidomide|mesh-list
110270799|NCT00165230|Temozolomide|temozolomide|mesh-list
110270800|NCT00165230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110270801|NCT00165230|Immunologic Factors|immunologic factors|mesh-ancestor
110270802|NCT00165230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110270803|NCT00165230|Leprostatic Agents|leprostatic agents|mesh-ancestor
110270804|NCT00165230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110270805|NCT00165230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110270806|NCT00165230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110270807|NCT00165230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110270808|NCT00165230|Growth Substances|growth substances|mesh-ancestor
110270809|NCT00165230|Growth Inhibitors|growth inhibitors|mesh-ancestor
110270810|NCT00165230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110270811|NCT00165230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110270812|NCT00165230|Alkylating Agents|alkylating agents|mesh-ancestor
110270813|NCT00165230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270814|NCT00176553|Dextromethorphan|dextromethorphan|mesh-list
110270815|NCT00176553|Antitussive Agents|antitussive agents|mesh-ancestor
110270816|NCT00176553|Respiratory System Agents|respiratory system agents|mesh-ancestor
110270817|NCT00176553|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110270818|NCT00176553|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110270830|NCT00165308|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110270831|NCT00165308|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110270833|NCT00165347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110270835|NCT00165347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270836|NCT00176670|Midazolam|midazolam|mesh-list
110270837|NCT00176670|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110270838|NCT00176670|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110270839|NCT00176670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110270840|NCT00176670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110270841|NCT00176670|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110270842|NCT00176670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110270843|NCT00176670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110270844|NCT00176670|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110270845|NCT00176670|Anesthetics, General|anesthetics, general|mesh-ancestor
110270846|NCT00176670|Anesthetics|anesthetics|mesh-ancestor
110270847|NCT00176670|GABA Modulators|gaba modulators|mesh-ancestor
110270848|NCT00176670|GABA Agents|gaba agents|mesh-ancestor
110270850|NCT00176670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270851|NCT00165464|Irinotecan|irinotecan|mesh-list
110270853|NCT00165464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110270854|NCT00165464|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110270855|NCT00165464|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110270856|NCT00165464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110270857|NCT00165464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270858|NCT00165464|Tubulin Modulators|tubulin modulators|mesh-ancestor
110270859|NCT00165464|Antimitotic Agents|antimitotic agents|mesh-ancestor
110270860|NCT00165464|Mitosis Modulators|mitosis modulators|mesh-ancestor
110270861|NCT04082650|Vitamin D|vitamin d|mesh-list
110270862|NCT04082650|Vitamins|vitamins|mesh-ancestor
110270864|NCT04082650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110270865|NCT04082650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110270866|NCT00176787|Capecitabine|capecitabine|mesh-list
110270867|NCT00176787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110270868|NCT00176787|Antimetabolites|antimetabolites|mesh-ancestor
110270869|NCT00176787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270870|NCT00176787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110270871|NCT00176943|Imiquimod|imiquimod|mesh-list
110270872|NCT00176943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110270873|NCT00176943|Immunologic Factors|immunologic factors|mesh-ancestor
110270874|NCT00176943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110270875|NCT00176943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110270876|NCT00176943|Interferon Inducers|interferon inducers|mesh-ancestor
110270877|NCT03978208|Naproxen|naproxen|mesh-list
110270878|NCT03978208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110270879|NCT03978208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110270880|NCT03978208|Analgesics|analgesics|mesh-ancestor
110270881|NCT03978208|Sensory System Agents|sensory system agents|mesh-ancestor
110270882|NCT03978208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110270883|NCT03978208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110270884|NCT03978208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110270885|NCT03978208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110270886|NCT03978208|Gout Suppressants|gout suppressants|mesh-ancestor
110270887|NCT03978208|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110270888|NCT03978208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110270889|NCT03978208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270890|NCT00165659|Donepezil|donepezil|mesh-list
110270891|NCT00165659|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110270892|NCT00165659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110270893|NCT00165659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270894|NCT00165659|Cholinergic Agents|cholinergic agents|mesh-ancestor
110270895|NCT00165659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110270896|NCT00165659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110270897|NCT00165659|Nootropic Agents|nootropic agents|mesh-ancestor
110270898|NCT00176982|Hydroxychloroquine|hydroxychloroquine|mesh-list
110270899|NCT00176982|Antimalarials|antimalarials|mesh-ancestor
110270900|NCT00176982|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110270901|NCT00176982|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110270902|NCT00176982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110270903|NCT00176982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110368722|NCT04617015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110270904|NCT00176982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270905|NCT00176982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110270906|NCT00165737|Donepezil|donepezil|mesh-list
110270907|NCT00165737|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110270908|NCT00165737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110270909|NCT00165737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270910|NCT00165737|Cholinergic Agents|cholinergic agents|mesh-ancestor
110270911|NCT00165737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110270912|NCT00165737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110270913|NCT00165737|Nootropic Agents|nootropic agents|mesh-ancestor
110270914|NCT04682899|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110270915|NCT04682899|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110270916|NCT04682899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110270917|NCT04682899|Antitubercular Agents|antitubercular agents|mesh-ancestor
110270918|NCT03789916|Aspirin|aspirin|mesh-list
110270919|NCT03789916|Ticagrelor|ticagrelor|mesh-list
110270920|NCT03789916|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110270921|NCT03789916|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110270922|NCT03789916|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110270923|NCT03789916|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110270924|NCT03789916|Purinergic Agents|purinergic agents|mesh-ancestor
110270925|NCT03789916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110270926|NCT03789916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270927|NCT03789916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110270930|NCT03789916|Analgesics|analgesics|mesh-ancestor
110270931|NCT03789916|Sensory System Agents|sensory system agents|mesh-ancestor
110270932|NCT03789916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110270933|NCT03789916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110270934|NCT03789916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110270935|NCT03789916|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110270936|NCT03789916|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110270937|NCT03789916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110270938|NCT03789916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110270941|NCT00165815|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110270942|NCT00165815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110270943|NCT00165815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270944|NCT00165815|Cholinergic Agents|cholinergic agents|mesh-ancestor
110270945|NCT00165815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110270946|NCT00165815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110270947|NCT00165815|Nootropic Agents|nootropic agents|mesh-ancestor
110270948|NCT00177021|Imiquimod|imiquimod|mesh-list
110270949|NCT00177021|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110270950|NCT00177021|Immunologic Factors|immunologic factors|mesh-ancestor
110270951|NCT00177021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110270952|NCT00177021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110270953|NCT00177021|Interferon Inducers|interferon inducers|mesh-ancestor
110270954|NCT03697603|Brexpiprazole|brexpiprazole|mesh-list
110270955|NCT03697603|Serotonin Agents|serotonin agents|mesh-ancestor
110270956|NCT03697603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110270957|NCT03697603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270958|NCT03697603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110270959|NCT03697603|Dopamine Agonists|dopamine agonists|mesh-ancestor
110270960|NCT03697603|Dopamine Agents|dopamine agents|mesh-ancestor
110270961|NCT00165854|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
110270962|NCT00165854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110270963|NCT00165854|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110270964|NCT00165854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110270965|NCT00165854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270967|NCT00177060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110270968|NCT00177060|Narcotics|narcotics|mesh-ancestor
110270969|NCT00177060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110270970|NCT00177060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110270971|NCT00177060|Analgesics|analgesics|mesh-ancestor
110270972|NCT00177060|Sensory System Agents|sensory system agents|mesh-ancestor
110270973|NCT00177060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110270975|NCT03421639|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
110270977|NCT03421639|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110270978|NCT03421639|Fertility Agents|fertility agents|mesh-ancestor
110270979|NCT03421639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110270980|NCT03421639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110270981|NCT03421639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110270982|NCT03421639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110270983|NCT03421639|Hormones|hormones|mesh-ancestor
110270984|NCT03421639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110270985|NCT03421639|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110270986|NCT03421639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110270987|NCT03421639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270988|NCT03421639|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110270989|NCT03421639|Hormone Antagonists|hormone antagonists|mesh-ancestor
110270990|NCT00177099|Tacrolimus|tacrolimus|mesh-list
110270991|NCT00177099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110270993|NCT00177099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110270994|NCT00177099|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110270995|NCT00177099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110270996|NCT00177099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270997|NCT03413800|Dexamethasone|dexamethasone|mesh-list
110270998|NCT03413800|Lenalidomide|lenalidomide|mesh-list
110270999|NCT03413800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110271000|NCT03413800|Antiemetics|antiemetics|mesh-ancestor
110271001|NCT03413800|Autonomic Agents|autonomic agents|mesh-ancestor
110271002|NCT03413800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110271003|NCT03413800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271004|NCT03413800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110271005|NCT03413800|Glucocorticoids|glucocorticoids|mesh-ancestor
110271006|NCT03413800|Hormones|hormones|mesh-ancestor
110271007|NCT03413800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110271008|NCT03413800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110271009|NCT03413800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110271010|NCT03413800|Immunologic Factors|immunologic factors|mesh-ancestor
110271011|NCT03413800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110271012|NCT03413800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110271013|NCT03413800|Growth Substances|growth substances|mesh-ancestor
110271014|NCT03413800|Growth Inhibitors|growth inhibitors|mesh-ancestor
110271015|NCT00166010|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
110271016|NCT00166010|Natriuretic Agents|natriuretic agents|mesh-ancestor
110271017|NCT00166010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271019|NCT05336812|Obinutuzumab|obinutuzumab|mesh-list
110271020|NCT05336812|Acalabrutinib|acalabrutinib|mesh-list
110271021|NCT05336812|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
110271022|NCT05336812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110271023|NCT05336812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110271024|NCT05336812|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110271025|NCT05336812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110271026|NCT05336812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110271027|NCT00537862|Mycophenolic Acid|mycophenolic acid|mesh-list
110271028|NCT00537862|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110271029|NCT00537862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110271030|NCT00537862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110271031|NCT00537862|Antitubercular Agents|antitubercular agents|mesh-ancestor
110271032|NCT00537862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110271033|NCT00537862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110271034|NCT00537862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110271035|NCT00537862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110271036|NCT00537901|Bevacizumab|bevacizumab|mesh-list
110271037|NCT00537901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110271038|NCT00537901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110271039|NCT00537901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110271040|NCT00537901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110271041|NCT00537901|Growth Substances|growth substances|mesh-ancestor
110271042|NCT00537901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271043|NCT00537901|Growth Inhibitors|growth inhibitors|mesh-ancestor
110271045|NCT00166127|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110271046|NCT00166127|Vasodilator Agents|vasodilator agents|mesh-ancestor
110271047|NCT00166127|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110271048|NCT00166127|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110271049|NCT00166127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110271050|NCT00166127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110271051|NCT00166127|Protective Agents|protective agents|mesh-ancestor
110271052|NCT00166127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271053|NCT00194649|Miglustat|miglustat|mesh-list
110271054|NCT00194649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110271056|NCT00194649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110271057|NCT00194649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110271058|NCT00194649|Antiviral Agents|antiviral agents|mesh-ancestor
110271059|NCT00194649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110271060|NCT00194649|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110271061|NCT00194649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110271062|NCT00194649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271063|NCT00166244|Mycophenolic Acid|mycophenolic acid|mesh-list
110271064|NCT00166244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110271065|NCT00166244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110271066|NCT00166244|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110271067|NCT00166244|Antitubercular Agents|antitubercular agents|mesh-ancestor
110271068|NCT00166244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110271069|NCT00166244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110271070|NCT00166244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110271071|NCT00166244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110271072|NCT00177138|Alemtuzumab|alemtuzumab|mesh-list
110271073|NCT00177138|Tacrolimus|tacrolimus|mesh-list
110271074|NCT00177138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110271075|NCT00177138|Immunologic Factors|immunologic factors|mesh-ancestor
110271076|NCT00177138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271077|NCT00177138|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110271078|NCT00177138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110271079|NCT00177138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110271080|NCT00177138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110271081|NCT00177138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110271082|NCT05311774|Tramadol|tramadol|mesh-list
110271083|NCT05311774|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110271084|NCT05311774|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110271085|NCT05311774|Narcotics|narcotics|mesh-ancestor
110271086|NCT05311774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110271087|NCT05311774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271088|NCT05311774|Analgesics|analgesics|mesh-ancestor
110271089|NCT05311774|Sensory System Agents|sensory system agents|mesh-ancestor
110271090|NCT05311774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110271091|NCT05311774|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110271092|NCT05311774|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110271093|NCT05311774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110271094|NCT05311774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110271095|NCT05311774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110271096|NCT05311774|Antidepressive Agents|antidepressive agents|mesh-ancestor
110036312|NCT01410214|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110271097|NCT05311774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110271098|NCT05311774|Dopamine Agents|dopamine agents|mesh-ancestor
110271099|NCT00194727|Capecitabine|capecitabine|mesh-list
110271100|NCT00194727|Vinorelbine|vinorelbine|mesh-list
110271101|NCT00194727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110271102|NCT00194727|Antimetabolites|antimetabolites|mesh-ancestor
110271103|NCT00194727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110271104|NCT00194727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110271105|NCT00194727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110271106|NCT00194727|Tubulin Modulators|tubulin modulators|mesh-ancestor
110271107|NCT00194727|Antimitotic Agents|antimitotic agents|mesh-ancestor
110271108|NCT00194727|Mitosis Modulators|mitosis modulators|mesh-ancestor
110271109|NCT00166400|Metoprolol|metoprolol|mesh-list
110271110|NCT00166400|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110271111|NCT00166400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110271112|NCT00166400|Sympatholytics|sympatholytics|mesh-ancestor
110271113|NCT00166400|Autonomic Agents|autonomic agents|mesh-ancestor
110271114|NCT00166400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110271115|NCT00166400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271116|NCT00166400|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110271117|NCT00166400|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110271118|NCT00166400|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110271120|NCT00166400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110271121|NCT00166400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110271122|NCT02042287|Metronidazole|metronidazole|mesh-list
110271123|NCT02042287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110271125|NCT02042287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110271126|NCT02042287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110271127|NCT05296213|Calcium|calcium|mesh-list
110271128|NCT05296213|Fluorides|fluorides|mesh-list
110271129|NCT05296213|Caseins|caseins|mesh-list
110271130|NCT05296213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110271131|NCT05296213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271132|NCT05296213|Cariostatic Agents|cariostatic agents|mesh-ancestor
110271133|NCT05296213|Protective Agents|protective agents|mesh-ancestor
110271134|NCT05296213|Chelating Agents|chelating agents|mesh-ancestor
110271135|NCT05296213|Sequestering Agents|sequestering agents|mesh-ancestor
110271136|NCT05296213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110271137|NCT00166478|Sulindac sulfone|sulindac sulfone|mesh-list
110271138|NCT00166478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110271140|NCT00166478|Protective Agents|protective agents|mesh-ancestor
110271141|NCT00166478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271142|NCT00166478|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110271143|NCT00166478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110271144|NCT00166478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110271145|NCT00166478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110271146|NCT00166478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110271147|NCT00166478|Analgesics|analgesics|mesh-ancestor
110271148|NCT00166478|Sensory System Agents|sensory system agents|mesh-ancestor
110271149|NCT00166478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110271150|NCT00166478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110271151|NCT00166478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110271152|NCT05282875|Immunosuppressive Agents|immunosuppressive agents|mesh-list
110271153|NCT05282875|Immunologic Factors|immunologic factors|mesh-ancestor
110271154|NCT05282875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271155|NCT00194766|Temozolomide|temozolomide|mesh-list
110271156|NCT00194766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110271157|NCT00194766|Alkylating Agents|alkylating agents|mesh-ancestor
110271158|NCT00194766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110271159|NCT00194766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110271160|NCT00166556|Alemtuzumab|alemtuzumab|mesh-list
110271161|NCT00166556|Tacrolimus|tacrolimus|mesh-list
110271162|NCT00166556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110271163|NCT00166556|Immunologic Factors|immunologic factors|mesh-ancestor
110271164|NCT00166556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271165|NCT00166556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110271166|NCT00166556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110271167|NCT00166556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110271168|NCT00166556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110271169|NCT00166556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110271170|NCT00166595|Risperidone|risperidone|mesh-list
110271171|NCT00166595|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110271172|NCT00166595|Serotonin Agents|serotonin agents|mesh-ancestor
110271173|NCT00166595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110271174|NCT00166595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110271175|NCT00166595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271176|NCT00166595|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110271178|NCT00166595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110271179|NCT00166595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110271180|NCT00166595|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110271181|NCT00166595|Dopamine Agents|dopamine agents|mesh-ancestor
110271182|NCT05259631|Propofol|propofol|mesh-list
110271183|NCT05259631|Sevoflurane|sevoflurane|mesh-list
110271184|NCT05259631|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110271185|NCT05259631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110271186|NCT05259631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271187|NCT05259631|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110271188|NCT05259631|Anesthetics, General|anesthetics, general|mesh-ancestor
110271189|NCT05259631|Anesthetics|anesthetics|mesh-ancestor
110271190|NCT05259631|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110271191|NCT05259631|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110271194|NCT00408135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110271195|NCT00407225|Difluprednate|difluprednate|mesh-list
110271196|NCT00407225|Glucocorticoids|glucocorticoids|mesh-ancestor
110271197|NCT00407225|Hormones|hormones|mesh-ancestor
110271198|NCT00407225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110271199|NCT00407225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271201|NCT05124067|Dexamethasone acetate|dexamethasone acetate|mesh-list
110271202|NCT05124067|Dexmedetomidine|dexmedetomidine|mesh-list
110271203|NCT05124067|Ondansetron|ondansetron|mesh-list
110271204|NCT05124067|BB 1101|bb 1101|mesh-list
110271205|NCT05124067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110271206|NCT05124067|Antiemetics|antiemetics|mesh-ancestor
110271208|NCT05124067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110271209|NCT05124067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271210|NCT05124067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110271211|NCT05124067|Glucocorticoids|glucocorticoids|mesh-ancestor
110271212|NCT05124067|Hormones|hormones|mesh-ancestor
110271213|NCT05124067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110271214|NCT05124067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110271215|NCT05124067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110271216|NCT05124067|Protease Inhibitors|protease inhibitors|mesh-ancestor
110271217|NCT05124067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110271218|NCT05124067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110271219|NCT05124067|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110271220|NCT05124067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110271221|NCT05124067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110271222|NCT05124067|Analgesics|analgesics|mesh-ancestor
110271223|NCT05124067|Sensory System Agents|sensory system agents|mesh-ancestor
110271224|NCT05124067|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110271225|NCT05124067|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110271226|NCT05124067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110271227|NCT05124067|Adrenergic Agents|adrenergic agents|mesh-ancestor
110271228|NCT05124067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110271229|NCT05124067|Antipruritics|antipruritics|mesh-ancestor
110271230|NCT05124067|Dermatologic Agents|dermatologic agents|mesh-ancestor
110271231|NCT05124067|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110271232|NCT05124067|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110271233|NCT05124067|Serotonin Agents|serotonin agents|mesh-ancestor
110271234|NCT00194883|Hormones|hormones|mesh-list
110271235|NCT00194883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110271236|NCT00194883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271237|NCT02277184|Cisplatin|cisplatin|mesh-list
110271238|NCT02277184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110271239|NCT00166829|Mycophenolic Acid|mycophenolic acid|mesh-list
110271240|NCT00166829|Sirolimus|sirolimus|mesh-list
110271241|NCT00166829|Tacrolimus|tacrolimus|mesh-list
110271242|NCT00166829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110271243|NCT00166829|Immunologic Factors|immunologic factors|mesh-ancestor
110271244|NCT00166829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271245|NCT00166829|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110271246|NCT00166829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110271247|NCT00166829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110271248|NCT00166829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110271249|NCT00166829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110271250|NCT00166829|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110271251|NCT00166829|Antitubercular Agents|antitubercular agents|mesh-ancestor
110271253|NCT00166829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110271254|NCT00166829|Antifungal Agents|antifungal agents|mesh-ancestor
110271255|NCT00177333|Doxycycline|doxycycline|mesh-list
110271256|NCT00177333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110271257|NCT00177333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110271258|NCT00177333|Antimalarials|antimalarials|mesh-ancestor
110271259|NCT00177333|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110271260|NCT00177333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110271261|NCT00166868|Neomycin|neomycin|mesh-list
110271262|NCT00166868|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110271263|NCT00166868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110271264|NCT00166868|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110271265|NCT00166868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110274258|NCT00170963|Vasodilator Agents|vasodilator agents|mesh-ancestor
110271266|NCT00166868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110271268|NCT00194961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110271269|NCT00194961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271270|NCT00177372|Misoprostol|misoprostol|mesh-list
110271271|NCT00177372|Mifepristone|mifepristone|mesh-list
110271272|NCT00177372|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110271273|NCT00177372|Abortifacient Agents|abortifacient agents|mesh-ancestor
110271274|NCT00177372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110271275|NCT00177372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271276|NCT00177372|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110271277|NCT00177372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110271279|NCT00177372|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110271280|NCT00177372|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110271281|NCT00177372|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110271282|NCT00177372|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110271283|NCT00177372|Contraceptive Agents|contraceptive agents|mesh-ancestor
110271284|NCT00177372|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110271285|NCT00177372|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110271286|NCT00177372|Hormone Antagonists|hormone antagonists|mesh-ancestor
110271287|NCT00177372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110271288|NCT00177372|Luteolytic Agents|luteolytic agents|mesh-ancestor
110271289|NCT00177372|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110271291|NCT04819399|Catumaxomab|catumaxomab|mesh-list
110271292|NCT04819399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110271293|NCT00177411|Hormones|hormones|mesh-list
110271294|NCT00177411|Parathyroid Hormone|parathyroid hormone|mesh-list
110271295|NCT00177411|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
110271296|NCT00177411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110271297|NCT00177411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271298|NCT00177411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110271299|NCT00195078|Gefitinib|gefitinib|mesh-list
110271300|NCT00195078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110271301|NCT00195078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110271302|NCT00195078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110271303|NCT00195078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110271304|NCT00167141|Contraceptive Agents|contraceptive agents|mesh-list
110271305|NCT00167141|Contraceptive Agents, Male|contraceptive agents, male|mesh-list
110271306|NCT00167141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110271307|NCT00167141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271308|NCT04660045|Acalabrutinib|acalabrutinib|mesh-list
110271309|NCT04660045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110271310|NCT00177528|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110271311|NCT00177528|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110271312|NCT00177528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110271313|NCT00177528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110271314|NCT00177528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110271315|NCT00177528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110271316|NCT00177528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271317|NCT00177528|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110271318|NCT00177528|Antidepressive Agents|antidepressive agents|mesh-ancestor
110271319|NCT00177528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110271320|NCT04566250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
110271321|NCT04566250|Analgesics|analgesics|mesh-ancestor
110271322|NCT04566250|Sensory System Agents|sensory system agents|mesh-ancestor
110271323|NCT04566250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110271324|NCT04566250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271325|NCT04548583|Remestemcel-l|remestemcel-l|mesh-list
110271326|NCT04548583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110271327|NCT04548583|Antiviral Agents|antiviral agents|mesh-ancestor
110271328|NCT04548583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110271329|NCT00167297|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110271330|NCT00167297|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110271331|NCT00167297|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110271332|NCT00167297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110271333|NCT00167297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110271334|NCT00167297|Adrenergic Agents|adrenergic agents|mesh-ancestor
110271335|NCT00167297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110271336|NCT00167297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271337|NCT00177567|Lamotrigine|lamotrigine|mesh-list
110271338|NCT00177567|Valproic Acid|valproic acid|mesh-list
110271339|NCT00177567|Olanzapine|olanzapine|mesh-list
110271340|NCT00177567|Risperidone|risperidone|mesh-list
110271341|NCT00177567|Lithium Carbonate|lithium carbonate|mesh-list
110271342|NCT00177567|Mirtazapine|mirtazapine|mesh-list
110271343|NCT00177567|Tranylcypromine|tranylcypromine|mesh-list
110271344|NCT00177567|Bupropion|bupropion|mesh-list
110271345|NCT00177567|Paroxetine|paroxetine|mesh-list
110271346|NCT00177567|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110271347|NCT00177567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110271348|NCT00177567|Serotonin Agents|serotonin agents|mesh-ancestor
110271350|NCT00177567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110271351|NCT00177567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271352|NCT00177567|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110271354|NCT00177567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110271355|NCT00177567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110271356|NCT00177567|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110271357|NCT00177567|Dopamine Agents|dopamine agents|mesh-ancestor
110271358|NCT00177567|Antiemetics|antiemetics|mesh-ancestor
110271359|NCT00177567|Autonomic Agents|autonomic agents|mesh-ancestor
110271360|NCT00177567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110271361|NCT00177567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110271362|NCT00177567|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110271363|NCT00177567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110271364|NCT00177567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110271366|NCT00177567|Antidepressive Agents|antidepressive agents|mesh-ancestor
110271367|NCT00177567|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110271368|NCT00177567|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110271369|NCT00177567|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110271370|NCT00177567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110271371|NCT00177567|Antimanic Agents|antimanic agents|mesh-ancestor
110271372|NCT00177567|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110271373|NCT00177567|Anticonvulsants|anticonvulsants|mesh-ancestor
110271374|NCT00177567|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110271375|NCT00177567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110271376|NCT00177567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110271377|NCT00177567|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110271378|NCT00177567|Histamine Antagonists|histamine antagonists|mesh-ancestor
110271379|NCT00177567|Histamine Agents|histamine agents|mesh-ancestor
110271380|NCT00177567|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110271381|NCT00177567|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110271382|NCT00177567|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110271383|NCT00177567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110271384|NCT00177567|Adrenergic Agents|adrenergic agents|mesh-ancestor
110271385|NCT00177567|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110271386|NCT00177567|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110271388|NCT00177567|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110271389|NCT00195156|Valproic Acid|valproic acid|mesh-list
110271390|NCT00195156|Anticonvulsants|anticonvulsants|mesh-ancestor
110271391|NCT00195156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110271392|NCT00195156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110271393|NCT00195156|GABA Agents|gaba agents|mesh-ancestor
110271394|NCT00195156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110271395|NCT00195156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271396|NCT00195156|Antimanic Agents|antimanic agents|mesh-ancestor
110271397|NCT00195156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110271398|NCT00195156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110271399|NCT00195156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110271400|NCT00167375|Eszopiclone|eszopiclone|mesh-list
110271401|NCT00167375|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110271402|NCT00167375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110271403|NCT00167375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271404|NCT00195000|Cytarabine|cytarabine|mesh-list
110271405|NCT00195000|Gemtuzumab|gemtuzumab|mesh-list
110271406|NCT00195000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110271407|NCT00195000|Antimetabolites|antimetabolites|mesh-ancestor
110271408|NCT00195000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110271409|NCT00195000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110271410|NCT00195000|Antiviral Agents|antiviral agents|mesh-ancestor
110271411|NCT00195000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110271412|NCT00195000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110271413|NCT00195000|Immunologic Factors|immunologic factors|mesh-ancestor
110271414|NCT00195000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271415|NCT00195000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110271416|NCT00195000|Immunotoxins|immunotoxins|mesh-ancestor
110271417|NCT00195000|Immunoconjugates|immunoconjugates|mesh-ancestor
110271418|NCT00195195|Sirolimus|sirolimus|mesh-list
110271419|NCT00195195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110271420|NCT00195195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110271421|NCT00195195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110271422|NCT00195195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110271424|NCT00195195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110271425|NCT00195195|Immunologic Factors|immunologic factors|mesh-ancestor
110271426|NCT00195195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271428|NCT04299880|Paclitaxel|paclitaxel|mesh-list
110271429|NCT04299880|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110271430|NCT04299880|Bevacizumab|bevacizumab|mesh-list
110271431|NCT04299880|Gemcitabine|gemcitabine|mesh-list
110271432|NCT04299880|Fluorouracil|fluorouracil|mesh-list
110271433|NCT04299880|Nivolumab|nivolumab|mesh-list
110271434|NCT04299880|Irinotecan|irinotecan|mesh-list
110271435|NCT04299880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110271436|NCT04299880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110271437|NCT04299880|Tubulin Modulators|tubulin modulators|mesh-ancestor
110271438|NCT04299880|Antimitotic Agents|antimitotic agents|mesh-ancestor
110271439|NCT04299880|Mitosis Modulators|mitosis modulators|mesh-ancestor
110271440|NCT04299880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110271441|NCT04299880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110271442|NCT04299880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110271443|NCT04299880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110271444|NCT04299880|Growth Substances|growth substances|mesh-ancestor
110271445|NCT04299880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271446|NCT04299880|Growth Inhibitors|growth inhibitors|mesh-ancestor
110271447|NCT04299880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110271449|NCT04299880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110271450|NCT04299880|Immunologic Factors|immunologic factors|mesh-ancestor
110271451|NCT04299880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110271452|NCT04299880|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110271453|NCT04299880|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110271454|NCT04299880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110271456|NCT04299880|Protective Agents|protective agents|mesh-ancestor
110271457|NCT04299880|Vitamin B Complex|vitamin b complex|mesh-ancestor
110271459|NCT04299880|Micronutrients|micronutrients|mesh-ancestor
110271461|NCT00167492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110271462|NCT00167492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110271463|NCT00167492|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110271464|NCT00167492|Antitubercular Agents|antitubercular agents|mesh-ancestor
110271465|NCT00167492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110271466|NCT00167492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110271467|NCT00167492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110271468|NCT00167492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110271469|NCT04087096|Zoledronic Acid|zoledronic acid|mesh-list
110271470|NCT04087096|Denosumab|denosumab|mesh-list
110271471|NCT04087096|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110271472|NCT04087096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271473|NCT00177684|Amphotericin B|amphotericin b|mesh-list
110271474|NCT00177684|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110271475|NCT00177684|Amebicides|amebicides|mesh-ancestor
110271476|NCT00177684|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110271477|NCT00177684|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110271478|NCT00177684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110271479|NCT00177684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110271480|NCT00177684|Antifungal Agents|antifungal agents|mesh-ancestor
110271481|NCT00532090|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
110271482|NCT00532090|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
110271483|NCT00532090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110271484|NCT00532090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110271485|NCT00195312|Bupivacaine|bupivacaine|mesh-list
110271486|NCT00195312|Anesthetics, Local|anesthetics, local|mesh-ancestor
110271487|NCT00195312|Anesthetics|anesthetics|mesh-ancestor
110271488|NCT00195312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110271489|NCT00195312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271490|NCT00195312|Sensory System Agents|sensory system agents|mesh-ancestor
110271491|NCT00195312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110271492|NCT00167609|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
110271493|NCT00167609|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110271494|NCT00167609|Immunologic Factors|immunologic factors|mesh-ancestor
110271495|NCT00167609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271498|NCT03888079|Anesthetics, General|anesthetics, general|mesh-list
110271499|NCT03888079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110271500|NCT03888079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271501|NCT03888079|Sensory System Agents|sensory system agents|mesh-ancestor
110271502|NCT03888079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110271503|NCT00167648|Leuprolide|leuprolide|mesh-list
110271504|NCT00167648|Goserelin|goserelin|mesh-list
110271505|NCT00167648|Estradiol|estradiol|mesh-list
110271506|NCT00167648|Estrogens|estrogens|mesh-ancestor
110271507|NCT00167648|Hormones|hormones|mesh-ancestor
110271508|NCT00167648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110271509|NCT00167648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271510|NCT00167648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110271511|NCT00167648|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110271512|NCT00167648|Fertility Agents|fertility agents|mesh-ancestor
110271513|NCT00167648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110271514|NCT00167648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110271515|NCT02906722|Colistin|colistin|mesh-list
110271516|NCT02906722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110271517|NCT02906722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110271519|NCT00167687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110271520|NCT00167687|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110271521|NCT00167687|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110271522|NCT00167687|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110271523|NCT00167687|Adrenergic Agents|adrenergic agents|mesh-ancestor
110271524|NCT00167687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110271525|NCT00167687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110271526|NCT00167687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271527|NCT02906995|Nicotine|nicotine|mesh-list
110271528|NCT02906995|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110271529|NCT02906995|Autonomic Agents|autonomic agents|mesh-ancestor
110271530|NCT02906995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110271531|NCT02906995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271532|NCT02906995|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110271533|NCT02906995|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110271534|NCT02906995|Cholinergic Agents|cholinergic agents|mesh-ancestor
110271535|NCT02906995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110271536|NCT02906995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110271537|NCT00195390|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110271538|NCT00195390|Immunologic Factors|immunologic factors|mesh-ancestor
110271539|NCT00195390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271541|NCT02906800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110271542|NCT02906800|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110271543|NCT02906800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110271544|NCT02906800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110271545|NCT02906800|Protective Agents|protective agents|mesh-ancestor
110271546|NCT02906800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271547|NCT00195468|Cyclosporine|cyclosporine|mesh-list
110271548|NCT00195468|Cyclosporins|cyclosporins|mesh-list
110271549|NCT00195468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110271550|NCT00195468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110271551|NCT00195468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110271552|NCT00195468|Immunologic Factors|immunologic factors|mesh-ancestor
110271553|NCT00195468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271554|NCT00195468|Antifungal Agents|antifungal agents|mesh-ancestor
110271555|NCT00195468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110271556|NCT00195468|Dermatologic Agents|dermatologic agents|mesh-ancestor
110271557|NCT00195468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110271558|NCT00195468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110271560|NCT00167765|Anticoagulants|anticoagulants|mesh-ancestor
110271561|NCT00167765|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110271562|NCT02906254|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110271563|NCT02906254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110271564|NCT00167843|Pyrimethamine|pyrimethamine|mesh-list
110271565|NCT00167843|Sulfadoxine|sulfadoxine|mesh-list
110271566|NCT00167843|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110271567|NCT00167843|Antimalarials|antimalarials|mesh-ancestor
110271568|NCT00167843|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110271569|NCT00167843|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110271571|NCT00167843|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110271572|NCT00167843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110271573|NCT00167843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110271574|NCT00167843|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110271575|NCT02906059|Irinotecan|irinotecan|mesh-list
110271576|NCT02906059|Adavosertib|adavosertib|mesh-list
110271577|NCT02906059|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110271578|NCT02906059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110271579|NCT02906059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110271580|NCT02906059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110271581|NCT02906059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110271583|NCT02906176|Antifungal Agents|antifungal agents|mesh-ancestor
110271584|NCT02906176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110271585|NCT02906176|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110271586|NCT02906176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110271587|NCT02906176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110271588|NCT02906176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110271589|NCT02906176|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110271590|NCT02906176|Hormone Antagonists|hormone antagonists|mesh-ancestor
110271591|NCT02906176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110271592|NCT02906176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271593|NCT02906176|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110271594|NCT02905864|Liraglutide|liraglutide|mesh-list
110271595|NCT02905864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110271596|NCT02905864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271597|NCT02905864|Incretins|incretins|mesh-ancestor
110271598|NCT02905864|Hormones|hormones|mesh-ancestor
110271599|NCT02905864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110271600|NCT00167882|Mesalamine|mesalamine|mesh-list
110271601|NCT00167882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110271602|NCT00167882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110271603|NCT00167882|Analgesics|analgesics|mesh-ancestor
110271604|NCT00167882|Sensory System Agents|sensory system agents|mesh-ancestor
110271605|NCT00167882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110271607|NCT00167882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110271608|NCT00167882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110271610|NCT02905708|Antidotes|antidotes|mesh-ancestor
110271611|NCT02905708|Protective Agents|protective agents|mesh-ancestor
110271612|NCT02905708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271613|NCT00167921|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110271614|NCT00167921|Estrogens|estrogens|mesh-ancestor
110271615|NCT00167921|Hormones|hormones|mesh-ancestor
110271616|NCT00167921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110271617|NCT00167921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271618|NCT00167960|Tazobactam|tazobactam|mesh-list
110271619|NCT00167960|Piperacillin|piperacillin|mesh-list
110271620|NCT00167960|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
110271621|NCT00167960|Lactams|lactams|mesh-list
110271622|NCT00167960|beta-Lactams|beta-lactams|mesh-list
110271623|NCT00167960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110271625|NCT00167960|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110271626|NCT00167960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110271627|NCT00167960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110271628|NCT02905513|Contraceptive Agents|contraceptive agents|mesh-list
110271629|NCT02905513|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110271630|NCT02905513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271631|NCT00167999|Tazobactam|tazobactam|mesh-list
110271632|NCT00167999|Piperacillin|piperacillin|mesh-list
110271633|NCT00167999|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
110271634|NCT00167999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110271635|NCT00167999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110271636|NCT00167999|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110271637|NCT00167999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110271638|NCT00167999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110271639|NCT00177996|Sertraline|sertraline|mesh-list
110271640|NCT00177996|Antidepressive Agents|antidepressive agents|mesh-ancestor
110271641|NCT00177996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110271642|NCT00177996|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110271643|NCT00177996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110271644|NCT00177996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110271645|NCT00177996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110271646|NCT00177996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110271647|NCT00177996|Serotonin Agents|serotonin agents|mesh-ancestor
110271648|NCT00177996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271649|NCT00168077|Thrombin|thrombin|mesh-list
110271650|NCT00168077|Hemostatics|hemostatics|mesh-ancestor
110271651|NCT00168077|Coagulants|coagulants|mesh-ancestor
110271652|NCT00195585|Leucovorin|leucovorin|mesh-list
110271653|NCT00195585|Levoleucovorin|levoleucovorin|mesh-list
110271654|NCT00195585|Antidotes|antidotes|mesh-ancestor
110271655|NCT00195585|Protective Agents|protective agents|mesh-ancestor
110271656|NCT00195585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271657|NCT00195585|Vitamin B Complex|vitamin b complex|mesh-ancestor
110271658|NCT00195585|Vitamins|vitamins|mesh-ancestor
110271659|NCT00195585|Micronutrients|micronutrients|mesh-ancestor
110271660|NCT02905045|Ketoprofen|ketoprofen|mesh-list
110271661|NCT02905045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110271662|NCT02905045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110271663|NCT02905045|Analgesics|analgesics|mesh-ancestor
110271664|NCT02905045|Sensory System Agents|sensory system agents|mesh-ancestor
110271665|NCT02905045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110271666|NCT02905045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271667|NCT02905045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110271668|NCT02905045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110271669|NCT02905045|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110271670|NCT02905045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110271671|NCT02905045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110271673|NCT02904772|Mycophenolic Acid|mycophenolic acid|mesh-list
110271674|NCT02904772|Prednisolone|prednisolone|mesh-list
110271675|NCT02904772|Cyclosporins|cyclosporins|mesh-list
110271676|NCT02904772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110271677|NCT02904772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110271678|NCT02904772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110271679|NCT02904772|Immunologic Factors|immunologic factors|mesh-ancestor
110271680|NCT02904772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271681|NCT02904772|Antifungal Agents|antifungal agents|mesh-ancestor
110271682|NCT02904772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110271683|NCT02904772|Dermatologic Agents|dermatologic agents|mesh-ancestor
110271685|NCT02904772|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110271686|NCT02904772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110271687|NCT02904772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110271688|NCT02904772|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110271689|NCT02904772|Antitubercular Agents|antitubercular agents|mesh-ancestor
110271690|NCT02904772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110271691|NCT02904772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110271692|NCT02904772|Glucocorticoids|glucocorticoids|mesh-ancestor
110271693|NCT02904772|Hormones|hormones|mesh-ancestor
110271694|NCT02904772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110271695|NCT02904772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110271696|NCT00195741|Valproic Acid|valproic acid|mesh-list
110271697|NCT00195741|Anticonvulsants|anticonvulsants|mesh-ancestor
110271698|NCT00195741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110271699|NCT00195741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110271700|NCT00195741|GABA Agents|gaba agents|mesh-ancestor
110271701|NCT00195741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110271702|NCT00195741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271703|NCT00195741|Antimanic Agents|antimanic agents|mesh-ancestor
110271704|NCT00195741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110271705|NCT00195741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110271706|NCT00195741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110271707|NCT00178035|Paroxetine|paroxetine|mesh-list
110271708|NCT00178035|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110271709|NCT00178035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110271710|NCT00178035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110271711|NCT00178035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110271712|NCT00178035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110271714|NCT00178035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271715|NCT00178035|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110271716|NCT00178035|Antidepressive Agents|antidepressive agents|mesh-ancestor
110271717|NCT00178035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110271718|NCT00178035|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110271719|NCT00178035|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110271720|NCT00178035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110271721|NCT02904538|Dexamethasone|dexamethasone|mesh-list
110271722|NCT02904538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110271723|NCT02904538|Antiemetics|antiemetics|mesh-ancestor
110271724|NCT02904538|Autonomic Agents|autonomic agents|mesh-ancestor
110271725|NCT02904538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110271726|NCT02904538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271727|NCT02904538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110271728|NCT02904538|Glucocorticoids|glucocorticoids|mesh-ancestor
110271729|NCT02904538|Hormones|hormones|mesh-ancestor
110271731|NCT02904538|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110271732|NCT02904538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110271734|NCT02963103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110271735|NCT02963103|Immunologic Factors|immunologic factors|mesh-ancestor
110271736|NCT02963103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271737|NCT02963103|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110271738|NCT02963103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110271739|NCT02963103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110271740|NCT00407264|Fluticasone|fluticasone|mesh-list
110271741|NCT00407264|Xhance|xhance|mesh-list
110271742|NCT00407264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110271743|NCT00407264|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110271744|NCT00407264|Autonomic Agents|autonomic agents|mesh-ancestor
110271745|NCT00407264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110271746|NCT00407264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271747|NCT00407264|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110271748|NCT00407264|Respiratory System Agents|respiratory system agents|mesh-ancestor
110271749|NCT00407264|Dermatologic Agents|dermatologic agents|mesh-ancestor
110271750|NCT00407264|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110271752|NCT02904499|Antithrombins|antithrombins|mesh-ancestor
110271753|NCT02904499|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110271754|NCT02904499|Protease Inhibitors|protease inhibitors|mesh-ancestor
110271755|NCT02904499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110271756|NCT02904499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110271757|NCT02904499|Anticoagulants|anticoagulants|mesh-ancestor
110271758|NCT00195780|Valproic Acid|valproic acid|mesh-list
110271759|NCT00195780|Anticonvulsants|anticonvulsants|mesh-ancestor
110271760|NCT00195780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110271761|NCT00195780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110271762|NCT00195780|GABA Agents|gaba agents|mesh-ancestor
110271763|NCT00195780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110271764|NCT00195780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271765|NCT00195780|Antimanic Agents|antimanic agents|mesh-ancestor
110271766|NCT00195780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110271767|NCT00195780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110271768|NCT00195780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110271770|NCT00407342|Dermatologic Agents|dermatologic agents|mesh-ancestor
110271771|NCT00407342|Immunologic Factors|immunologic factors|mesh-ancestor
110271772|NCT00407342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271773|NCT00553423|Lactulose|lactulose|mesh-list
110271774|NCT00553423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110271775|NCT02904304|Ibuprofen|ibuprofen|mesh-list
110271776|NCT02904304|Phenylephrine|phenylephrine|mesh-list
110271777|NCT02904304|Oxymetazoline|oxymetazoline|mesh-list
110271778|NCT02904304|Desloratadine|desloratadine|mesh-list
110271779|NCT02904304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110271780|NCT02904304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110271781|NCT02904304|Analgesics|analgesics|mesh-ancestor
110271782|NCT02904304|Sensory System Agents|sensory system agents|mesh-ancestor
110271783|NCT02904304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110271784|NCT02904304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271785|NCT02904304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110271786|NCT02904304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110271787|NCT02904304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110271788|NCT02904304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110271789|NCT02904304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110271790|NCT02904304|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110271791|NCT02904304|Mydriatics|mydriatics|mesh-ancestor
110271792|NCT02904304|Autonomic Agents|autonomic agents|mesh-ancestor
110271793|NCT02904304|Sympathomimetics|sympathomimetics|mesh-ancestor
110271794|NCT02904304|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110271795|NCT02904304|Nasal Decongestants|nasal decongestants|mesh-ancestor
110271796|NCT02904304|Respiratory System Agents|respiratory system agents|mesh-ancestor
110271797|NCT02904304|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110271798|NCT02904304|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110271799|NCT02904304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110271800|NCT02904304|Adrenergic Agents|adrenergic agents|mesh-ancestor
110271801|NCT02904304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110271802|NCT02904304|Protective Agents|protective agents|mesh-ancestor
110271803|NCT02904304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110271804|NCT02904304|Cholinergic Agents|cholinergic agents|mesh-ancestor
110271805|NCT02904304|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110271806|NCT02904304|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110271807|NCT02904304|Histamine Antagonists|histamine antagonists|mesh-ancestor
110271808|NCT02904304|Histamine Agents|histamine agents|mesh-ancestor
110271809|NCT00407459|Bevacizumab|bevacizumab|mesh-list
110271810|NCT00407459|Carboplatin|carboplatin|mesh-list
110271811|NCT00407459|Pemetrexed|pemetrexed|mesh-list
110271812|NCT00407459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110271813|NCT00407459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110271814|NCT00407459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110271815|NCT00407459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110271816|NCT00407459|Growth Substances|growth substances|mesh-ancestor
110271817|NCT00407459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271818|NCT00407459|Growth Inhibitors|growth inhibitors|mesh-ancestor
110271819|NCT00407459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110271820|NCT00407459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110271821|NCT00407459|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110271822|NCT00407459|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110271823|NCT02904031|Leucovorin|leucovorin|mesh-list
110271824|NCT02904031|Fluorouracil|fluorouracil|mesh-list
110271825|NCT02904031|Oxaliplatin|oxaliplatin|mesh-list
110271826|NCT02904031|Panitumumab|panitumumab|mesh-list
110271827|NCT02904031|Levoleucovorin|levoleucovorin|mesh-list
110271828|NCT02904031|Antimetabolites|antimetabolites|mesh-ancestor
110271829|NCT02904031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110271830|NCT02904031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110271831|NCT02904031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110271832|NCT02904031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110271833|NCT02904031|Immunologic Factors|immunologic factors|mesh-ancestor
110271834|NCT02904031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271836|NCT02904031|Protective Agents|protective agents|mesh-ancestor
110271837|NCT02904031|Vitamin B Complex|vitamin b complex|mesh-ancestor
110271838|NCT02904031|Vitamins|vitamins|mesh-ancestor
110271839|NCT02904031|Micronutrients|micronutrients|mesh-ancestor
110271840|NCT02904031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110271842|NCT02904109|Triflusal|triflusal|mesh-list
110271843|NCT02904109|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110271844|NCT02904109|Diuretics|diuretics|mesh-ancestor
110271845|NCT02904109|Natriuretic Agents|natriuretic agents|mesh-ancestor
110271846|NCT02904109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271847|NCT02904109|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110271848|NCT00178113|Lycopene|lycopene|mesh-list
110271849|NCT00178113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110271851|NCT00178113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110271852|NCT00178113|Protective Agents|protective agents|mesh-ancestor
110271853|NCT00178113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271854|NCT00178113|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110271855|NCT00178113|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110271856|NCT00178113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110271857|NCT02903524|Cyclophosphamide|cyclophosphamide|mesh-list
110271858|NCT02903524|Doxorubicin|doxorubicin|mesh-list
110271859|NCT02903524|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110271860|NCT02903524|Pirarubicin|pirarubicin|mesh-list
110271861|NCT02903524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110271862|NCT02903524|Immunologic Factors|immunologic factors|mesh-ancestor
110271863|NCT02903524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271864|NCT02903524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110271865|NCT02903524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110271866|NCT02903524|Alkylating Agents|alkylating agents|mesh-ancestor
110271867|NCT02903524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110271868|NCT02903524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110271869|NCT02903524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110271870|NCT02903524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110271871|NCT02903524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110271872|NCT02903524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110271873|NCT02903524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110271874|NCT00168350|Memantine|memantine|mesh-list
110271875|NCT00168350|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110271876|NCT00168350|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110271877|NCT00168350|Dopamine Agents|dopamine agents|mesh-ancestor
110271878|NCT00168350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110271879|NCT00168350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110271880|NCT00168350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271881|NCT00168350|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110271882|NCT00168350|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110271883|NCT02903485|Anesthetics|anesthetics|mesh-list
110271884|NCT02903485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110271885|NCT02903485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271886|NCT05995912|Naproxen|naproxen|mesh-list
110271887|NCT05995912|Etoricoxib|etoricoxib|mesh-list
110271888|NCT05995912|Tramadol|tramadol|mesh-list
110271889|NCT05995912|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110271890|NCT05995912|Narcotics|narcotics|mesh-ancestor
110271891|NCT05995912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110274372|NCT00171392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110271892|NCT05995912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271894|NCT05995912|Sensory System Agents|sensory system agents|mesh-ancestor
110271895|NCT05995912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110271896|NCT05995912|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110271897|NCT05995912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110271898|NCT05995912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110271899|NCT05995912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110271900|NCT05995912|Gout Suppressants|gout suppressants|mesh-ancestor
110271901|NCT05995912|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110271902|NCT05995912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110271903|NCT05995912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110271906|NCT05995704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110271907|NCT05995704|Analgesics|analgesics|mesh-ancestor
110271908|NCT05995704|Sensory System Agents|sensory system agents|mesh-ancestor
110271909|NCT05995704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110271910|NCT05995704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271911|NCT05995704|Antipyretics|antipyretics|mesh-ancestor
110271912|NCT05995691|Adalimumab|adalimumab|mesh-list
110271913|NCT05995691|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110271914|NCT05995691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110271915|NCT05995691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110271916|NCT05995522|Vitamin K|vitamin k|mesh-list
110271917|NCT05995522|Vitamin K 2|vitamin k 2|mesh-list
110271918|NCT05995522|Vitamins|vitamins|mesh-ancestor
110271919|NCT05995522|Micronutrients|micronutrients|mesh-ancestor
110271920|NCT05995522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271921|NCT05995522|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110271922|NCT05995522|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110271923|NCT05995522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110271924|NCT05995522|Hemostatics|hemostatics|mesh-ancestor
110271925|NCT05995522|Coagulants|coagulants|mesh-ancestor
110271926|NCT05995405|Nimodipine|nimodipine|mesh-list
110271927|NCT05995405|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110271928|NCT05995405|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110271929|NCT05995405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110271930|NCT05995405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110271931|NCT05995405|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110271932|NCT05995405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271933|NCT05995405|Vasodilator Agents|vasodilator agents|mesh-ancestor
110271934|NCT05995353|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110271935|NCT05995353|Immunologic Factors|immunologic factors|mesh-ancestor
110271936|NCT05995353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271937|NCT05995249|Efavirenz|efavirenz|mesh-list
110271938|NCT05995249|Erythromycin|erythromycin|mesh-list
110271939|NCT05995249|Erythromycin Estolate|erythromycin estolate|mesh-list
110271940|NCT05995249|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
110271941|NCT05995249|Erythromycin stearate|erythromycin stearate|mesh-list
110271942|NCT05995249|Phenytoin|phenytoin|mesh-list
110271943|NCT05995249|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110271944|NCT05995249|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110271945|NCT05995249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110271946|NCT05995249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110271947|NCT05995249|Antiviral Agents|antiviral agents|mesh-ancestor
110271948|NCT05995249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110271949|NCT05995249|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110271950|NCT05995249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110271951|NCT05995249|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110271952|NCT05995249|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110271953|NCT05995249|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110271954|NCT05995249|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110271955|NCT05995249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110271956|NCT05995249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110271957|NCT05995249|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110271958|NCT05995249|Anticonvulsants|anticonvulsants|mesh-ancestor
110271959|NCT05995249|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110271960|NCT05995249|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110271961|NCT05995249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110271962|NCT05995249|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110271965|NCT05995054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110271966|NCT05994768|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110271967|NCT05994768|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110271968|NCT05994768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110271970|NCT05994742|Vitamin B 6|vitamin b 6|mesh-list
110271971|NCT05994742|Azithromycin|azithromycin|mesh-list
110271972|NCT05994742|Rifampin|rifampin|mesh-list
110271973|NCT05994742|Isoniazid|isoniazid|mesh-list
110271974|NCT05994742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110271975|NCT05994742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110271976|NCT05994742|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110271977|NCT05994742|Antitubercular Agents|antitubercular agents|mesh-ancestor
110271978|NCT05994742|Leprostatic Agents|leprostatic agents|mesh-ancestor
110271979|NCT05994742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110271980|NCT05994742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110271981|NCT05994742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110271982|NCT05994742|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110271983|NCT05994742|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110271984|NCT05994742|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110271985|NCT05994742|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110271986|NCT05994742|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110271987|NCT05994742|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110271988|NCT05994742|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110271989|NCT05994742|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110271990|NCT05994742|Antimetabolites|antimetabolites|mesh-ancestor
110271991|NCT05994742|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110271992|NCT05994742|Vitamin B Complex|vitamin b complex|mesh-ancestor
110271994|NCT05994742|Micronutrients|micronutrients|mesh-ancestor
110271995|NCT05994742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271997|NCT05994703|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110271998|NCT05994703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110271999|NCT05994703|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110272000|NCT05994703|Antitubercular Agents|antitubercular agents|mesh-ancestor
110272001|NCT05994703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110272002|NCT05994703|Antimetabolites|antimetabolites|mesh-ancestor
110272003|NCT05994703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110272004|NCT05994599|NuvaRing|nuvaring|mesh-list
110272005|NCT05994599|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110272006|NCT05994599|Contraceptive Agents|contraceptive agents|mesh-ancestor
110272007|NCT05994599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110272008|NCT05994599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110272009|NCT05994547|Midazolam|midazolam|mesh-list
110272010|NCT05994547|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110272011|NCT05994547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110272012|NCT05994547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110272013|NCT05994547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110272014|NCT05994547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110272015|NCT05994547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110272016|NCT05994547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110272017|NCT05994547|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110272018|NCT05994547|Anesthetics, General|anesthetics, general|mesh-ancestor
110272019|NCT05994547|Anesthetics|anesthetics|mesh-ancestor
110272020|NCT05994547|GABA Modulators|gaba modulators|mesh-ancestor
110272021|NCT05994547|GABA Agents|gaba agents|mesh-ancestor
110272022|NCT05994547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110272023|NCT05994547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110272024|NCT05994456|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110272025|NCT05994456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110272026|NCT05994456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110272035|NCT05994287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110272036|NCT05994287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110272038|NCT05994287|Sensory System Agents|sensory system agents|mesh-ancestor
110272039|NCT05994287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110272040|NCT05994287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110272041|NCT05994287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110272042|NCT05994287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110272043|NCT05994287|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110272044|NCT05994287|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110272045|NCT05994287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110272046|NCT05994287|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110272047|NCT05994287|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110272048|NCT05994287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110272049|NCT05994287|Antipyretics|antipyretics|mesh-ancestor
110272050|NCT05994287|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110272051|NCT05994131|Aflutinib|aflutinib|mesh-list
110272052|NCT05994131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110272053|NCT05994131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110272054|NCT05994131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110272055|NCT05994001|Antibodies, Bispecific|antibodies, bispecific|mesh-list
110272056|NCT05994001|Immunologic Factors|immunologic factors|mesh-ancestor
110272057|NCT05994001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110272058|NCT05993975|Dexmedetomidine|dexmedetomidine|mesh-list
110272059|NCT05993975|Bupivacaine|bupivacaine|mesh-list
110272060|NCT05993975|Anesthetics, Local|anesthetics, local|mesh-ancestor
110272061|NCT05993975|Anesthetics|anesthetics|mesh-ancestor
110272062|NCT05993975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110272063|NCT05993975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110272064|NCT05993975|Sensory System Agents|sensory system agents|mesh-ancestor
110272065|NCT05993975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110272066|NCT05993975|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110272067|NCT05993975|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110272068|NCT05993975|Analgesics|analgesics|mesh-ancestor
110272069|NCT05993975|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110272070|NCT05993975|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110272071|NCT05993975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110272072|NCT05993975|Adrenergic Agents|adrenergic agents|mesh-ancestor
110272073|NCT05993975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110272074|NCT05993975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110272094|NCT05910801|Venetoclax|venetoclax|mesh-list
110272095|NCT05910801|Immunoglobulins|immunoglobulins|mesh-list
110272096|NCT05910801|Immunologic Factors|immunologic factors|mesh-ancestor
110272097|NCT05910801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110272098|NCT05910801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110272099|NCT05910801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110272100|NCT05910801|Growth Substances|growth substances|mesh-ancestor
110272101|NCT05910801|Growth Inhibitors|growth inhibitors|mesh-ancestor
110272102|NCT05910801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110272103|NCT05909397|Letrozole|letrozole|mesh-list
110272104|NCT05909397|Palbociclib|palbociclib|mesh-list
110272105|NCT05909397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110272106|NCT05909397|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110272107|NCT05909397|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110272108|NCT05909397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110272109|NCT05909397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110272110|NCT05909397|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110272111|NCT05909397|Hormone Antagonists|hormone antagonists|mesh-ancestor
110272112|NCT05909397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110272113|NCT05909397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110272114|NCT05909397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110272115|NCT05880459|Magnesium Sulfate|magnesium sulfate|mesh-list
110272116|NCT05880459|Nalbuphine|nalbuphine|mesh-list
110272117|NCT05880459|Propofol|propofol|mesh-list
110272118|NCT05880459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110272119|NCT05880459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110272120|NCT05880459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110272121|NCT05880459|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110272122|NCT05880459|Anesthetics, General|anesthetics, general|mesh-ancestor
110272124|NCT05880459|Analgesics|analgesics|mesh-ancestor
110272125|NCT05880459|Sensory System Agents|sensory system agents|mesh-ancestor
110272126|NCT05880459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110272127|NCT05880459|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110272128|NCT05880459|Anticonvulsants|anticonvulsants|mesh-ancestor
110272129|NCT05880459|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110272130|NCT05880459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110272131|NCT05880459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110272132|NCT05880459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110272133|NCT05880459|Tocolytic Agents|tocolytic agents|mesh-ancestor
110272134|NCT05880459|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110272135|NCT05880459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110272136|NCT05880459|Narcotics|narcotics|mesh-ancestor
110272137|NCT05864417|Sunscreening Agents|sunscreening agents|mesh-list
110272138|NCT05864417|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110272139|NCT05864417|Protective Agents|protective agents|mesh-ancestor
110272142|NCT05856136|Fentanyl|fentanyl|mesh-list
110272143|NCT05856136|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110272144|NCT05856136|Narcotics|narcotics|mesh-ancestor
110272145|NCT05856136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110272146|NCT05856136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110272147|NCT05856136|Analgesics|analgesics|mesh-ancestor
110272148|NCT05856136|Sensory System Agents|sensory system agents|mesh-ancestor
110272149|NCT05856136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110272150|NCT05856136|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110272151|NCT05856136|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110272152|NCT05856136|Anesthetics, General|anesthetics, general|mesh-ancestor
110272153|NCT05856136|Anesthetics|anesthetics|mesh-ancestor
110272154|NCT05844995|Acetaminophen|acetaminophen|mesh-list
110272155|NCT05844995|Naproxen|naproxen|mesh-list
110272156|NCT05844995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110272158|NCT05844995|Sensory System Agents|sensory system agents|mesh-ancestor
110272159|NCT05844995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110272160|NCT05844995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110272161|NCT05844995|Antipyretics|antipyretics|mesh-ancestor
110272162|NCT05844995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110272163|NCT05844995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110272164|NCT05844995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110272165|NCT05844995|Gout Suppressants|gout suppressants|mesh-ancestor
110272166|NCT05844995|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110272167|NCT05844995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110272168|NCT05844995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110272169|NCT05819853|Metformin|metformin|mesh-list
110272170|NCT05819853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110272171|NCT05819853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110272172|NCT05813288|Pramipexole|pramipexole|mesh-list
110272173|NCT05813288|Antioxidants|antioxidants|mesh-ancestor
110272174|NCT05813288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110272175|NCT05813288|Protective Agents|protective agents|mesh-ancestor
110272176|NCT05813288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110272177|NCT05813288|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110272178|NCT05813288|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110272179|NCT05813288|Dopamine Agonists|dopamine agonists|mesh-ancestor
110272180|NCT05813288|Dopamine Agents|dopamine agents|mesh-ancestor
110272181|NCT05813288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110272182|NCT05812300|Hyaluronic Acid|hyaluronic acid|mesh-list
110272183|NCT05812300|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110272184|NCT05812300|Immunologic Factors|immunologic factors|mesh-ancestor
110272185|NCT05812300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110272186|NCT05812300|Viscosupplements|viscosupplements|mesh-ancestor
110272187|NCT05812300|Protective Agents|protective agents|mesh-ancestor
110272188|NCT05788016|Analgesics, Opioid|analgesics, opioid|mesh-list
110272189|NCT05788016|Narcotics|narcotics|mesh-ancestor
110272190|NCT05788016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110272192|NCT05788016|Analgesics|analgesics|mesh-ancestor
110272193|NCT05788016|Sensory System Agents|sensory system agents|mesh-ancestor
110272194|NCT05788016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110272195|NCT05763121|Pramipexole|pramipexole|mesh-list
110272196|NCT05763121|Antioxidants|antioxidants|mesh-ancestor
110272207|NCT05755048|Maytansine|maytansine|mesh-list
110272208|NCT05755048|Antibodies|antibodies|mesh-list
110272209|NCT05755048|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110272210|NCT05755048|Immunologic Factors|immunologic factors|mesh-ancestor
110272211|NCT05755048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110272213|NCT05755048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110272214|NCT05755048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110272215|NCT05755048|Tubulin Modulators|tubulin modulators|mesh-ancestor
110272216|NCT05755048|Antimitotic Agents|antimitotic agents|mesh-ancestor
110272217|NCT05755048|Mitosis Modulators|mitosis modulators|mesh-ancestor
110272218|NCT05755048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110272219|NCT05755048|Immunotoxins|immunotoxins|mesh-ancestor
110272220|NCT05755048|Immunoconjugates|immunoconjugates|mesh-ancestor
110272221|NCT05750199|Immunomodulating Agents|immunomodulating agents|mesh-list
110272222|NCT05750199|Immunologic Factors|immunologic factors|mesh-ancestor
110272223|NCT05750199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110272224|NCT05748600|Pramipexole|pramipexole|mesh-list
110272225|NCT05748600|Antioxidants|antioxidants|mesh-ancestor
110272226|NCT05748600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110272227|NCT05748600|Protective Agents|protective agents|mesh-ancestor
110272228|NCT05748600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110272229|NCT05748600|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110272230|NCT05748600|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110272231|NCT05748600|Dopamine Agonists|dopamine agonists|mesh-ancestor
110272232|NCT05748600|Dopamine Agents|dopamine agents|mesh-ancestor
110272233|NCT05748600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110272244|NCT05706779|Cetuximab|cetuximab|mesh-list
110272245|NCT05706779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110272246|NCT05706779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110272247|NCT05686356|Acetylcysteine|acetylcysteine|mesh-list
110272248|NCT05686356|Bedaquiline|bedaquiline|mesh-list
110272249|NCT05686356|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110272250|NCT05686356|Antiviral Agents|antiviral agents|mesh-ancestor
110272251|NCT05686356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110272252|NCT05686356|Expectorants|expectorants|mesh-ancestor
110272253|NCT05686356|Respiratory System Agents|respiratory system agents|mesh-ancestor
110272254|NCT05686356|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110272255|NCT05686356|Antioxidants|antioxidants|mesh-ancestor
110272256|NCT05686356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110272257|NCT05686356|Protective Agents|protective agents|mesh-ancestor
110272258|NCT05686356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110272259|NCT05686356|Antidotes|antidotes|mesh-ancestor
110272260|NCT05686356|Antitubercular Agents|antitubercular agents|mesh-ancestor
110272261|NCT05686356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110272262|NCT05676112|Pirfenidone|pirfenidone|mesh-list
110272264|NCT05676112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110272265|NCT05676112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110272266|NCT05676112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110272267|NCT05676112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110272268|NCT05676112|Analgesics|analgesics|mesh-ancestor
110272269|NCT05676112|Sensory System Agents|sensory system agents|mesh-ancestor
110272270|NCT05676112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110272271|NCT05676112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110272272|NCT05676112|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110272273|NCT05676112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110272274|NCT05676112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110272275|NCT05676112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110272277|NCT05668091|Nirmatrelvir|nirmatrelvir|mesh-list
110272278|NCT05668091|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110272279|NCT05668091|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110272280|NCT05668091|Protease Inhibitors|protease inhibitors|mesh-ancestor
110272281|NCT05668091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110272282|NCT05668091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110272283|NCT05668091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110272284|NCT05668091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110272285|NCT05668091|Antiviral Agents|antiviral agents|mesh-ancestor
110272286|NCT05668091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110272287|NCT05668091|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110272288|NCT05668091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110272289|NCT05663866|Dexamethasone|dexamethasone|mesh-list
110272290|NCT05663866|Methotrexate|methotrexate|mesh-list
110272291|NCT05663866|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
110272293|NCT05663866|Lazertinib|lazertinib|mesh-list
110274499|NCT00171782|Valsartan|valsartan|mesh-list
110272294|NCT05663866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110272296|NCT05663866|Autonomic Agents|autonomic agents|mesh-ancestor
110272297|NCT05663866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110272298|NCT05663866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110272299|NCT05663866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110272300|NCT05663866|Glucocorticoids|glucocorticoids|mesh-ancestor
110272301|NCT05663866|Hormones|hormones|mesh-ancestor
110272302|NCT05663866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110272303|NCT05663866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110272304|NCT05663866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110272305|NCT05663866|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110272306|NCT05663866|Abortifacient Agents|abortifacient agents|mesh-ancestor
110272307|NCT05663866|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110272308|NCT05663866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110272309|NCT05663866|Antimetabolites|antimetabolites|mesh-ancestor
110272310|NCT05663866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110272311|NCT05663866|Dermatologic Agents|dermatologic agents|mesh-ancestor
110272312|NCT05663866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110272313|NCT05663866|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110272314|NCT05663866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110272315|NCT05663866|Immunologic Factors|immunologic factors|mesh-ancestor
110272316|NCT05663866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110272317|NCT05663866|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110272318|NCT05663866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110272319|NCT05663866|Respiratory System Agents|respiratory system agents|mesh-ancestor
110272320|NCT05663866|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110272321|NCT05663866|Hormone Antagonists|hormone antagonists|mesh-ancestor
110272322|NCT05663866|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110272323|NCT05663866|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110272324|NCT05663866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110272325|NCT05663866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110272326|NCT05642026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110272327|NCT05642026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
110272329|NCT05642026|Anesthetics, Local|anesthetics, local|mesh-ancestor
110272331|NCT05642026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110272332|NCT05642026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110272333|NCT05642026|Sensory System Agents|sensory system agents|mesh-ancestor
110272334|NCT05642026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110272335|NCT05642026|Analgesics|analgesics|mesh-ancestor
110272336|NCT05642026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110272337|NCT05642026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110272338|NCT05622201|Rituximab|rituximab|mesh-list
110272339|NCT05622201|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110272340|NCT05622201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110272341|NCT05622201|Immunologic Factors|immunologic factors|mesh-ancestor
110272342|NCT05622201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110272343|NCT05622201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110272344|NCT05603754|Lorecivivint|lorecivivint|mesh-list
110272345|NCT05603754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110272346|NCT05583708|Pembrolizumab|pembrolizumab|mesh-list
110272347|NCT05583708|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
110272348|NCT05583708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110274513|NCT00197418|Amoxicillin|amoxicillin|mesh-list
110272359|NCT05525078|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110272360|NCT05525078|Cholinergic Agents|cholinergic agents|mesh-ancestor
110272361|NCT05525078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110272362|NCT05525078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110272363|NCT05515575|Niraparib|niraparib|mesh-list
110272364|NCT05515575|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110272365|NCT05515575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110272366|NCT05515575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110272367|NCT05515575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110272368|NCT05470699|Fluorides|fluorides|mesh-list
110272369|NCT05470699|Cariostatic Agents|cariostatic agents|mesh-ancestor
110272370|NCT05470699|Protective Agents|protective agents|mesh-ancestor
110272371|NCT05470699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110272372|NCT05458453|Esketamine|esketamine|mesh-list
110272373|NCT05458453|Antidepressive Agents|antidepressive agents|mesh-ancestor
110272374|NCT05458453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110272388|NCT05438979|Calcium|calcium|mesh-list
110272389|NCT05438979|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110272390|NCT05438979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110272391|NCT05427084|Canagliflozin|canagliflozin|mesh-list
110272392|NCT05427084|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110272393|NCT05427084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110272395|NCT05427084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110272396|NCT05414136|Trastuzumab|trastuzumab|mesh-list
110272397|NCT05414136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110272398|NCT05414136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110272399|NCT05403580|Olanzapine|olanzapine|mesh-list
110272400|NCT05403580|Antiemetics|antiemetics|mesh-ancestor
110272401|NCT05403580|Autonomic Agents|autonomic agents|mesh-ancestor
110272402|NCT05403580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110272403|NCT05403580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110272404|NCT05403580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110274534|NCT05054023|Piroxicam|piroxicam|mesh-list
110272405|NCT05403580|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110272406|NCT05403580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110272407|NCT05403580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110272408|NCT05403580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110272409|NCT05403580|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110272410|NCT05403580|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110272411|NCT05403580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110272412|NCT05403580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110272413|NCT05403580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110272414|NCT05403580|Serotonin Agents|serotonin agents|mesh-ancestor
110272415|NCT05388669|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
110272416|NCT05388669|Lazertinib|lazertinib|mesh-list
110272417|NCT05388669|Antibodies, Bispecific|antibodies, bispecific|mesh-list
110272418|NCT05388669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110272419|NCT05388669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110272420|NCT05388669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110272421|NCT05388669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110272422|NCT05388669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110272423|NCT05388669|Immunologic Factors|immunologic factors|mesh-ancestor
110272424|NCT05388669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110272425|NCT05379803|Aflutinib|aflutinib|mesh-list
110272426|NCT05379803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110272427|NCT05379803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110272428|NCT05379803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110272430|NCT05365451|Probenecid|probenecid|mesh-list
110272431|NCT05365451|Furosemide|furosemide|mesh-list
110272432|NCT05365451|Cimetidine|cimetidine|mesh-list
110272433|NCT05365451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110272434|NCT05365451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110272435|NCT05365451|Diuretics|diuretics|mesh-ancestor
110272436|NCT05365451|Natriuretic Agents|natriuretic agents|mesh-ancestor
110272437|NCT05365451|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110272438|NCT05365451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110272439|NCT05365451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110272440|NCT05365451|Uricosuric Agents|uricosuric agents|mesh-ancestor
110272441|NCT05365451|Gout Suppressants|gout suppressants|mesh-ancestor
110272442|NCT05365451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110272443|NCT05365451|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110272444|NCT05365451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110272445|NCT05365451|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110272446|NCT05365451|Histamine Antagonists|histamine antagonists|mesh-ancestor
110272447|NCT05365451|Histamine Agents|histamine agents|mesh-ancestor
110272448|NCT05365451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110272449|NCT05365451|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110272450|NCT05365451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110272451|NCT05365451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110272452|NCT05356897|Trifluridine|trifluridine|mesh-list
110272453|NCT05356897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110272454|NCT05356897|Trastuzumab|trastuzumab|mesh-list
110272455|NCT05356897|Tucatinib|tucatinib|mesh-list
110272456|NCT05356897|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
110272457|NCT05356897|Antibodies|antibodies|mesh-list
110272458|NCT05356897|Immunoglobulins|immunoglobulins|mesh-list
110272459|NCT05356897|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110272460|NCT05356897|Immunologic Factors|immunologic factors|mesh-ancestor
110272461|NCT05356897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110272462|NCT05356897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110272463|NCT05356897|Antimetabolites|antimetabolites|mesh-ancestor
110272464|NCT05356897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110272465|NCT05356897|Antiviral Agents|antiviral agents|mesh-ancestor
110272466|NCT05356897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110272467|NCT05356897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110272469|NCT05328297|JNJ-55308942|jnj-55308942|mesh-list
110272470|NCT05328297|Purinergic P2X Receptor Antagonists|purinergic p2x receptor antagonists|mesh-ancestor
110272471|NCT05328297|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110272472|NCT05328297|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110272473|NCT05328297|Purinergic Agents|purinergic agents|mesh-ancestor
110272474|NCT05328297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110272475|NCT05328297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110272476|NCT05328297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110272477|NCT05296070|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
110272478|NCT05296070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110272479|NCT05296070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110272480|NCT05294146|Clofazimine|clofazimine|mesh-list
110272481|NCT05294146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110272482|NCT05294146|Leprostatic Agents|leprostatic agents|mesh-ancestor
110272483|NCT05294146|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110272484|NCT05294146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110272485|NCT05284591|Daratumumab|daratumumab|mesh-list
110272486|NCT05284591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110272487|NCT05246670|Palmidrol|palmidrol|mesh-list
110272488|NCT05246670|Analgesics|analgesics|mesh-ancestor
110272489|NCT05246670|Sensory System Agents|sensory system agents|mesh-ancestor
110272490|NCT05246670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110272491|NCT05246670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110272492|NCT05246670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110272493|NCT05246670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110272494|NCT05246670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110272495|NCT05246670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110272496|NCT05246670|Antiviral Agents|antiviral agents|mesh-ancestor
110272497|NCT05246670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110272498|NCT05246670|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110272499|NCT05246670|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110272500|NCT05246670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110272501|NCT05246670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110272502|NCT05246670|Hormones|hormones|mesh-ancestor
110272503|NCT05246670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110272504|NCT05199285|Nivolumab|nivolumab|mesh-list
110272505|NCT05199285|Ipilimumab|ipilimumab|mesh-list
110272506|NCT05199285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110272507|NCT05199285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110272508|NCT05199285|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110272509|NCT05199285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110272510|NCT05194293|Durvalumab|durvalumab|mesh-list
110272511|NCT05194293|Immunoglobulins|immunoglobulins|mesh-list
110272512|NCT05194293|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110272513|NCT05194293|Immunoglobulin G|immunoglobulin g|mesh-list
110272514|NCT05194293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110272516|NCT05194293|Immunologic Factors|immunologic factors|mesh-ancestor
110272517|NCT05194293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110272518|NCT05154747|Rilpivirine|rilpivirine|mesh-list
110272519|NCT05154747|Cabotegravir|cabotegravir|mesh-list
110272520|NCT05154747|Cabotegravir, rilpivirine drug combination|cabotegravir, rilpivirine drug combination|mesh-list
110272522|NCT05154747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110272523|NCT05154747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110274568|NCT00171938|Imatinib Mesylate|imatinib mesylate|mesh-list
110272524|NCT05154747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110272525|NCT05154747|Antiviral Agents|antiviral agents|mesh-ancestor
110272526|NCT05154747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110272527|NCT05154747|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110272528|NCT05154747|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110272529|NCT05154747|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110272530|NCT05154747|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110272531|NCT05153915|Tacrolimus|tacrolimus|mesh-list
110272532|NCT05153915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110272533|NCT05153915|Immunologic Factors|immunologic factors|mesh-ancestor
110272534|NCT05153915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110272535|NCT05153915|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110272536|NCT05153915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110272537|NCT05153915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110272538|NCT05152927|Parathyroid Hormone|parathyroid hormone|mesh-list
110272539|NCT05152927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110272540|NCT05152927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110272541|NCT05152628|Tacrolimus|tacrolimus|mesh-list
110272542|NCT05152628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110272543|NCT05152628|Immunologic Factors|immunologic factors|mesh-ancestor
110272544|NCT05152628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110272545|NCT05152628|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110272546|NCT05152628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110272547|NCT05152628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110272548|NCT05149768|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110272549|NCT05149768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110272550|NCT05149768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110272551|NCT05149768|Immunotoxins|immunotoxins|mesh-ancestor
110272552|NCT05149768|Immunoconjugates|immunoconjugates|mesh-ancestor
110272554|NCT05149768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110272555|NCT05131204|Eculizumab|eculizumab|mesh-list
110272556|NCT05131204|Ravulizumab|ravulizumab|mesh-list
110272557|NCT05131204|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110272558|NCT05131204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110272559|NCT05131204|Immunologic Factors|immunologic factors|mesh-ancestor
110272560|NCT05131204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110272561|NCT05128487|Pembrolizumab|pembrolizumab|mesh-list
110272562|NCT05128487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110272563|NCT05128487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110272564|NCT05128487|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110272565|NCT05128487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110272566|NCT05112939|Cabotegravir|cabotegravir|mesh-list
110272567|NCT05112939|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110272568|NCT05112939|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110272569|NCT05112939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110272570|NCT05112939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110272571|NCT05112939|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110272572|NCT05112939|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110272573|NCT05112939|Antiviral Agents|antiviral agents|mesh-ancestor
110272574|NCT05112939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110272575|NCT05106335|Docetaxel|docetaxel|mesh-list
110272576|NCT05106335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110272577|NCT05106335|Tubulin Modulators|tubulin modulators|mesh-ancestor
110272578|NCT05106335|Antimitotic Agents|antimitotic agents|mesh-ancestor
110272583|NCT05090085|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110272584|NCT05090085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110272585|NCT05090085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110272586|NCT05090085|Hormone Antagonists|hormone antagonists|mesh-ancestor
110274579|NCT02240407|Diphenhydramine|diphenhydramine|mesh-list
110272587|NCT05090085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110272588|NCT05090085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110272590|NCT05073679|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110272591|NCT05073679|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110272592|NCT05073679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110272593|NCT05073679|Sensory System Agents|sensory system agents|mesh-ancestor
110272594|NCT05073679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110272595|NCT05019027|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110272596|NCT05019027|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110272597|NCT05019027|Adrenergic Agents|adrenergic agents|mesh-ancestor
110272598|NCT05019027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110272599|NCT05019027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110272600|NCT05019027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110272602|NCT05014282|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110272603|NCT05014282|Autonomic Agents|autonomic agents|mesh-ancestor
110272604|NCT05014282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110272605|NCT05014282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110272606|NCT05014282|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110272607|NCT05014282|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110272608|NCT05014282|Cholinergic Agents|cholinergic agents|mesh-ancestor
110272609|NCT05014282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110272610|NCT05014282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110272611|NCT04956094|Uric Acid|uric acid|mesh-list
110272612|NCT04956094|Antioxidants|antioxidants|mesh-ancestor
110272613|NCT04956094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110272615|NCT04956094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110272616|NCT04929392|Paclitaxel|paclitaxel|mesh-list
110272617|NCT04929392|Carboplatin|carboplatin|mesh-list
110272618|NCT04929392|Pembrolizumab|pembrolizumab|mesh-list
110272619|NCT04929392|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110272620|NCT04929392|Lenvatinib|lenvatinib|mesh-list
110272621|NCT04929392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110272622|NCT04929392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110272623|NCT04929392|Tubulin Modulators|tubulin modulators|mesh-ancestor
110272624|NCT04929392|Antimitotic Agents|antimitotic agents|mesh-ancestor
110272625|NCT04929392|Mitosis Modulators|mitosis modulators|mesh-ancestor
110272626|NCT04929392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110272627|NCT04929392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110272628|NCT04929392|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110272629|NCT04929392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110272631|NCT04859946|Cyclophosphamide|cyclophosphamide|mesh-list
110272633|NCT04859946|Thiotepa|thiotepa|mesh-list
110272634|NCT04859946|Fludarabine|fludarabine|mesh-list
110272635|NCT04859946|Tacrolimus|tacrolimus|mesh-list
110272636|NCT04859946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110272637|NCT04859946|Immunologic Factors|immunologic factors|mesh-ancestor
110272638|NCT04859946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110272639|NCT04859946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110272640|NCT04859946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110272641|NCT04859946|Alkylating Agents|alkylating agents|mesh-ancestor
110272642|NCT04859946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110272643|NCT04859946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110272644|NCT04859946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110272645|NCT04859946|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110272646|NCT04859946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110272647|NCT04843904|Rituximab|rituximab|mesh-list
110272648|NCT04843904|Obinutuzumab|obinutuzumab|mesh-list
110272649|NCT04843904|Venetoclax|venetoclax|mesh-list
110272650|NCT04843904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110272651|NCT04843904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110272652|NCT04843904|Immunologic Factors|immunologic factors|mesh-ancestor
110272653|NCT04843904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110272654|NCT04843904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110272655|NCT04831294|Cannabidiol|cannabidiol|mesh-list
110272656|NCT04831294|Anticonvulsants|anticonvulsants|mesh-ancestor
110272657|NCT04828694|Naltrexone|naltrexone|mesh-list
110272658|NCT04828694|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110272659|NCT04828694|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110272660|NCT04828694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110272661|NCT04828694|Sensory System Agents|sensory system agents|mesh-ancestor
110272662|NCT04828694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110272663|NCT04820309|Xanomeline|xanomeline|mesh-list
110272664|NCT04820309|Trospium chloride|trospium chloride|mesh-list
110272665|NCT04820309|Parasympatholytics|parasympatholytics|mesh-ancestor
110272666|NCT04820309|Autonomic Agents|autonomic agents|mesh-ancestor
110272667|NCT04820309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110272668|NCT04820309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110272669|NCT04820309|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110272670|NCT04820309|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110272671|NCT04820309|Cholinergic Agents|cholinergic agents|mesh-ancestor
110272672|NCT04820309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110272673|NCT04820309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110272675|NCT04820309|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110272676|NCT04820309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110272677|NCT04820309|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110272678|NCT04820309|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110272679|NCT04801589|Midazolam|midazolam|mesh-list
110272680|NCT04801589|Dexmedetomidine|dexmedetomidine|mesh-list
110272681|NCT04801589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110272682|NCT04801589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110272683|NCT04801589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110272684|NCT04801589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110272685|NCT04801589|Analgesics|analgesics|mesh-ancestor
110272686|NCT04801589|Sensory System Agents|sensory system agents|mesh-ancestor
110272687|NCT04801589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110272688|NCT04801589|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110272689|NCT04801589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110272690|NCT04801589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110272691|NCT04801589|Adrenergic Agents|adrenergic agents|mesh-ancestor
110272692|NCT04801589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110272693|NCT04801589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110272694|NCT04801589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110272696|NCT04801589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110272697|NCT04801589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110272698|NCT04801589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110272699|NCT04801589|Anesthetics, General|anesthetics, general|mesh-ancestor
110272700|NCT04801589|Anesthetics|anesthetics|mesh-ancestor
110272701|NCT04801589|GABA Modulators|gaba modulators|mesh-ancestor
110272702|NCT04801589|GABA Agents|gaba agents|mesh-ancestor
110272703|NCT04796948|Leucovorin|leucovorin|mesh-list
110272704|NCT04796948|Fluorouracil|fluorouracil|mesh-list
110272705|NCT04796948|Oxaliplatin|oxaliplatin|mesh-list
110272706|NCT04796948|Irinotecan|irinotecan|mesh-list
110272707|NCT04796948|Calcium|calcium|mesh-list
110272708|NCT04796948|Levoleucovorin|levoleucovorin|mesh-list
110272709|NCT04796948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110272710|NCT04796948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110272711|NCT04796948|Antimetabolites|antimetabolites|mesh-ancestor
110272712|NCT04796948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110272713|NCT04796948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110272714|NCT04796948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110272715|NCT04796948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110272717|NCT04796948|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110272718|NCT04796948|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110272719|NCT04796948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110272720|NCT04796948|Antidotes|antidotes|mesh-ancestor
110272721|NCT04796948|Protective Agents|protective agents|mesh-ancestor
110272722|NCT04796948|Vitamin B Complex|vitamin b complex|mesh-ancestor
110272723|NCT04796948|Vitamins|vitamins|mesh-ancestor
110272724|NCT04796948|Micronutrients|micronutrients|mesh-ancestor
110272725|NCT04692467|Amlodipine|amlodipine|mesh-list
110272726|NCT04692467|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110272727|NCT04692467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110272728|NCT04692467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110272729|NCT04692467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110272730|NCT04692467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110272731|NCT04692467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110272732|NCT04692467|Vasodilator Agents|vasodilator agents|mesh-ancestor
110272734|NCT04692077|Emtricitabine|emtricitabine|mesh-list
110272735|NCT04692077|Cabotegravir|cabotegravir|mesh-list
110272736|NCT04692077|Antiviral Agents|antiviral agents|mesh-ancestor
110272738|NCT04692077|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110272739|NCT04692077|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110272740|NCT04692077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110272741|NCT04692077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110272742|NCT04692077|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110272743|NCT04692077|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110272744|NCT04692077|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110272745|NCT04692077|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110272747|NCT04563520|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
110272748|NCT04531982|Pimavanserin|pimavanserin|mesh-list
110272749|NCT04531982|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110272750|NCT04531982|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110272751|NCT04531982|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110272752|NCT04531982|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110272753|NCT04531982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110272754|NCT04531982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110272755|NCT04531982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110272756|NCT04531982|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110272757|NCT04531982|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110272758|NCT04531982|Serotonin Agents|serotonin agents|mesh-ancestor
110272759|NCT04531982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110272760|NCT04531982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110272761|NCT04507503|Futibatinib|futibatinib|mesh-list
110272762|NCT04507503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110272763|NCT04497961|Lenalidomide|lenalidomide|mesh-list
110272764|NCT04497961|Daratumumab|daratumumab|mesh-list
110272765|NCT04497961|Immunologic Factors|immunologic factors|mesh-ancestor
110272766|NCT04497961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110272767|NCT04497961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110272768|NCT04497961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110272769|NCT04497961|Growth Substances|growth substances|mesh-ancestor
110272770|NCT04497961|Growth Inhibitors|growth inhibitors|mesh-ancestor
110272771|NCT04497961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110272772|NCT04497844|Prednisone|prednisone|mesh-list
110272773|NCT04497844|Abiraterone Acetate|abiraterone acetate|mesh-list
110272774|NCT04497844|Niraparib|niraparib|mesh-list
110272775|NCT04497844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110272776|NCT04497844|Glucocorticoids|glucocorticoids|mesh-ancestor
110272777|NCT04497844|Hormones|hormones|mesh-ancestor
110272778|NCT04497844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110272779|NCT04497844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110272780|NCT04497844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110272781|NCT04497844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110272782|NCT04497844|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110272783|NCT04497844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110272784|NCT04497844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110272785|NCT04497844|Hormone Antagonists|hormone antagonists|mesh-ancestor
110272786|NCT04497844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110272787|NCT04497844|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110272788|NCT04464629|Prednisolone|prednisolone|mesh-list
110272789|NCT04464629|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110272790|NCT04464629|Methylprednisolone|methylprednisolone|mesh-list
110272791|NCT04464629|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110272792|NCT04464629|Prednisolone acetate|prednisolone acetate|mesh-list
110272793|NCT04464629|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110272794|NCT04464629|Prednisolone phosphate|prednisolone phosphate|mesh-list
110272797|NCT04464629|Hormones|hormones|mesh-ancestor
110272798|NCT04464629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110272799|NCT04464629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110272800|NCT04464629|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110272801|NCT04464629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110272803|NCT04464629|Autonomic Agents|autonomic agents|mesh-ancestor
110272804|NCT04464629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110272805|NCT04464629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110272806|NCT04464629|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110272807|NCT04464629|Protective Agents|protective agents|mesh-ancestor
110272808|NCT04459416|Analgesics, Opioid|analgesics, opioid|mesh-list
110272809|NCT04459416|Narcotics|narcotics|mesh-ancestor
110274643|NCT00197613|Antimetabolites|antimetabolites|mesh-ancestor
110272810|NCT04459416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110272811|NCT04459416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110272812|NCT04459416|Analgesics|analgesics|mesh-ancestor
110272813|NCT04459416|Sensory System Agents|sensory system agents|mesh-ancestor
110272814|NCT04459416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110272816|NCT04435782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110272817|NCT04432935|Lactoferrin|lactoferrin|mesh-list
110272818|NCT04432935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110272819|NCT04414722|Amoxicillin|amoxicillin|mesh-list
110272820|NCT04414722|Clavulanic Acid|clavulanic acid|mesh-list
110272821|NCT04414722|Clavulanic Acids|clavulanic acids|mesh-list
110272822|NCT04414722|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110272823|NCT04414722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110272824|NCT04414722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110272825|NCT04414722|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110272826|NCT04414722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110272827|NCT04414722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110272828|NCT04392037|Dexamethasone|dexamethasone|mesh-list
110272829|NCT04392037|Cyclophosphamide|cyclophosphamide|mesh-list
110272830|NCT04392037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110272831|NCT04392037|Immunologic Factors|immunologic factors|mesh-ancestor
110272832|NCT04392037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110272833|NCT04392037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110272834|NCT04392037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110272835|NCT04392037|Alkylating Agents|alkylating agents|mesh-ancestor
110272836|NCT04392037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110272837|NCT04392037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110272838|NCT04392037|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110272839|NCT04392037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110272840|NCT04392037|Antiemetics|antiemetics|mesh-ancestor
110272841|NCT04392037|Autonomic Agents|autonomic agents|mesh-ancestor
110272842|NCT04392037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110272843|NCT04392037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110272844|NCT04392037|Glucocorticoids|glucocorticoids|mesh-ancestor
110272845|NCT04392037|Hormones|hormones|mesh-ancestor
110272846|NCT04392037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110272847|NCT04392037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110272848|NCT04287062|Suvorexant|suvorexant|mesh-list
110272849|NCT04287062|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110272850|NCT04287062|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110272851|NCT04287062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110272852|NCT04287062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110272853|NCT04287062|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
110272854|NCT04287062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110272855|NCT04287062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110272856|NCT04273945|Macitentan|macitentan|mesh-list
110272857|NCT04273945|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
110272858|NCT04273945|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110272859|NCT04273945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110272860|NCT04273945|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
110272861|NCT04244552|Doxorubicin|doxorubicin|mesh-list
110272862|NCT04244552|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110272863|NCT04244552|Pembrolizumab|pembrolizumab|mesh-list
110272864|NCT04244552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110272865|NCT04244552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110272866|NCT04244552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110272867|NCT04244552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110272868|NCT04244552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110272869|NCT04244552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110272870|NCT04244552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110272871|NCT04244552|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110272873|NCT04229368|Cholecalciferol|cholecalciferol|mesh-list
110272874|NCT04229368|Vitamins|vitamins|mesh-ancestor
110272875|NCT04229368|Micronutrients|micronutrients|mesh-ancestor
110272876|NCT04229368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110272877|NCT04229368|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110272878|NCT04229368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110272879|NCT04185402|Azithromycin|azithromycin|mesh-list
110272880|NCT04185402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110272881|NCT04185402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110272882|NCT04169828|Leucovorin|leucovorin|mesh-list
110272883|NCT04169828|Folic Acid|folic acid|mesh-list
110272885|NCT04169828|Ondansetron|ondansetron|mesh-list
110272886|NCT04169828|Levoleucovorin|levoleucovorin|mesh-list
110272887|NCT04169828|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110272888|NCT04169828|Abortifacient Agents|abortifacient agents|mesh-ancestor
110272889|NCT04169828|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110272890|NCT04169828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110272891|NCT04169828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110272892|NCT04169828|Antimetabolites|antimetabolites|mesh-ancestor
110272893|NCT04169828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110272894|NCT04169828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110272896|NCT04169828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110272897|NCT04169828|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110272898|NCT04169828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110272899|NCT04169828|Immunologic Factors|immunologic factors|mesh-ancestor
110272900|NCT04169828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110272901|NCT04169828|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110272902|NCT04169828|Antidotes|antidotes|mesh-ancestor
110272903|NCT04169828|Protective Agents|protective agents|mesh-ancestor
110272905|NCT04169828|Vitamins|vitamins|mesh-ancestor
110272906|NCT04169828|Micronutrients|micronutrients|mesh-ancestor
110272907|NCT04169828|Antiemetics|antiemetics|mesh-ancestor
110272908|NCT04169828|Autonomic Agents|autonomic agents|mesh-ancestor
110272909|NCT04169828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110272910|NCT04169828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110272911|NCT04169828|Antipruritics|antipruritics|mesh-ancestor
110272912|NCT04169828|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110272913|NCT04169828|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110272914|NCT04169828|Serotonin Agents|serotonin agents|mesh-ancestor
110272915|NCT04169828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110272916|NCT04169828|Hematinics|hematinics|mesh-ancestor
110272917|NCT04157348|Benralizumab|benralizumab|mesh-list
110272918|NCT04157348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110272919|NCT04157348|Respiratory System Agents|respiratory system agents|mesh-ancestor
110272920|NCT04082533|Hydrocortisone|hydrocortisone|mesh-list
110272923|NCT03989271|Antioxidants|antioxidants|mesh-ancestor
110272924|NCT03989271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110272925|NCT03989271|Protective Agents|protective agents|mesh-ancestor
110272926|NCT03989271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110272927|NCT03961334|Aspirin|aspirin|mesh-list
110272928|NCT03961334|Dabigatran|dabigatran|mesh-list
110272929|NCT03961334|Apixaban|apixaban|mesh-list
110272931|NCT03961334|Clopidogrel|clopidogrel|mesh-list
110272932|NCT03961334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110272933|NCT03961334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110272934|NCT03961334|Analgesics|analgesics|mesh-ancestor
110272935|NCT03961334|Sensory System Agents|sensory system agents|mesh-ancestor
110272936|NCT03961334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110272937|NCT03961334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110272938|NCT03961334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110272939|NCT03961334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110272940|NCT03961334|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110272941|NCT03961334|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110272942|NCT03961334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110272943|NCT03961334|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110272944|NCT03961334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110272945|NCT03961334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110272946|NCT03961334|Antipyretics|antipyretics|mesh-ancestor
110272947|NCT03961334|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110272948|NCT03961334|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110272949|NCT03961334|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110272950|NCT03961334|Purinergic Agents|purinergic agents|mesh-ancestor
110272951|NCT03961334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110272952|NCT03961334|Antithrombins|antithrombins|mesh-ancestor
110272953|NCT03961334|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110272954|NCT03961334|Protease Inhibitors|protease inhibitors|mesh-ancestor
110272955|NCT03961334|Anticoagulants|anticoagulants|mesh-ancestor
110272956|NCT03961334|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110272957|NCT03933163|Resveratrol|resveratrol|mesh-list
110272958|NCT03933163|Antioxidants|antioxidants|mesh-ancestor
110272959|NCT03933163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110272960|NCT03933163|Protective Agents|protective agents|mesh-ancestor
110272961|NCT03933163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110272963|NCT03933163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110272964|NCT03930953|Rituximab|rituximab|mesh-list
110272965|NCT03930953|Obinutuzumab|obinutuzumab|mesh-list
110272966|NCT03930953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110272967|NCT03930953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110272968|NCT03930953|Immunologic Factors|immunologic factors|mesh-ancestor
110272969|NCT03930953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110272971|NCT03913104|Mifepristone|mifepristone|mesh-list
110272972|NCT03913104|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110272973|NCT03913104|Abortifacient Agents|abortifacient agents|mesh-ancestor
110272974|NCT03913104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110272975|NCT03913104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110272976|NCT03913104|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110272977|NCT03913104|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110272978|NCT03913104|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110272979|NCT03913104|Contraceptive Agents|contraceptive agents|mesh-ancestor
110272980|NCT03913104|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110272981|NCT03913104|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110272983|NCT03913104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110272984|NCT03913104|Luteolytic Agents|luteolytic agents|mesh-ancestor
110272985|NCT03913104|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110272986|NCT03913104|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110272988|NCT03854370|Povidone-Iodine|povidone-iodine|mesh-list
110272989|NCT03854370|Povidone|povidone|mesh-list
110272990|NCT03854370|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110272991|NCT03854370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110272992|NCT03854370|Disinfectants|disinfectants|mesh-ancestor
110272993|NCT03854370|Plasma Substitutes|plasma substitutes|mesh-ancestor
110272994|NCT03854370|Blood Substitutes|blood substitutes|mesh-ancestor
110272995|NCT03845517|PF-06700841|pf-06700841|mesh-list
110272996|NCT03845517|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110272997|NCT03845517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110272998|NCT03845517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110272999|NCT03819088|Zinc|zinc|mesh-list
110273000|NCT03819088|Zinc Sulfate|zinc sulfate|mesh-list
110273001|NCT03819088|Trace Elements|trace elements|mesh-ancestor
110273002|NCT03819088|Micronutrients|micronutrients|mesh-ancestor
110273003|NCT03819088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110273005|NCT03819088|Dermatologic Agents|dermatologic agents|mesh-ancestor
110273006|NCT03729349|Golimumab|golimumab|mesh-list
110273007|NCT03729349|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110273008|NCT03729349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110273009|NCT03729349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110273010|NCT03729349|Immunologic Factors|immunologic factors|mesh-ancestor
110273011|NCT03729349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110273012|NCT03598998|Pembrolizumab|pembrolizumab|mesh-list
110273013|NCT03598998|10-deazaaminopterin|10-deazaaminopterin|mesh-list
110273014|NCT03598998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110273015|NCT03598998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110273016|NCT03598998|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110273017|NCT03598998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110273018|NCT03598998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110273019|NCT03598998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110273020|NCT03553186|Tranexamic Acid|tranexamic acid|mesh-list
110273021|NCT03553186|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110273022|NCT03553186|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110273023|NCT03553186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110273024|NCT03553186|Hemostatics|hemostatics|mesh-ancestor
110273025|NCT03553186|Coagulants|coagulants|mesh-ancestor
110273026|NCT03535298|Interferons|interferons|mesh-list
110273027|NCT03535298|Interferon-beta|interferon-beta|mesh-list
110273030|NCT03535298|Ofatumumab|ofatumumab|mesh-list
110273031|NCT03535298|Cladribine|cladribine|mesh-list
110273032|NCT03535298|Glatiramer Acetate|glatiramer acetate|mesh-list
110273033|NCT03535298|Dimethyl Fumarate|dimethyl fumarate|mesh-list
110273034|NCT03535298|Ocrelizumab|ocrelizumab|mesh-list
110273035|NCT03535298|Natalizumab|natalizumab|mesh-list
110273036|NCT03535298|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
110273037|NCT03535298|(T,G)-A-L|(t,g)-a-l|mesh-list
110273038|NCT03535298|Ozanimod|ozanimod|mesh-list
110273039|NCT03535298|Ponesimod|ponesimod|mesh-list
110273040|NCT03535298|Siponimod|siponimod|mesh-list
110273041|NCT03535298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110273042|NCT03535298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110273043|NCT03535298|Immunologic Factors|immunologic factors|mesh-ancestor
110273044|NCT03535298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110273045|NCT03535298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110273046|NCT03535298|Antiviral Agents|antiviral agents|mesh-ancestor
110273047|NCT03535298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110273048|NCT03535298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110273049|NCT03535298|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110273050|NCT03535298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110273051|NCT03535298|Dermatologic Agents|dermatologic agents|mesh-ancestor
110273052|NCT03535298|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110273053|NCT03535298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110273054|NCT03535298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110273055|NCT03535298|Analgesics|analgesics|mesh-ancestor
110273056|NCT03535298|Sensory System Agents|sensory system agents|mesh-ancestor
110273057|NCT03535298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110273058|NCT03535298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110273059|NCT03493178|Acetylcysteine|acetylcysteine|mesh-list
110273060|NCT03493178|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110273061|NCT03493178|Glycine|glycine|mesh-list
110273062|NCT03493178|Antiviral Agents|antiviral agents|mesh-ancestor
110273063|NCT03493178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110273064|NCT03493178|Expectorants|expectorants|mesh-ancestor
110273065|NCT03493178|Respiratory System Agents|respiratory system agents|mesh-ancestor
110273066|NCT03493178|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110273067|NCT03493178|Antioxidants|antioxidants|mesh-ancestor
110273068|NCT03493178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110273069|NCT03493178|Protective Agents|protective agents|mesh-ancestor
110273070|NCT03493178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110273071|NCT03493178|Antidotes|antidotes|mesh-ancestor
110273072|NCT03493178|Glycine Agents|glycine agents|mesh-ancestor
110273073|NCT03493178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110273074|NCT03473743|Carboplatin|carboplatin|mesh-list
110273075|NCT03473743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110273076|NCT03406650|Durvalumab|durvalumab|mesh-list
110273077|NCT03406650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110273078|NCT03406650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110273079|NCT03377725|Decitabine|decitabine|mesh-list
110273080|NCT03377725|Arsenic Trioxide|arsenic trioxide|mesh-list
110273081|NCT03377725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110273082|NCT03377725|Antimetabolites|antimetabolites|mesh-ancestor
110273083|NCT03377725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110273084|NCT03377725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110273085|NCT03377725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110273086|NCT03346135|Melphalan|melphalan|mesh-list
110273087|NCT03346135|Mechlorethamine|mechlorethamine|mesh-list
110273088|NCT03346135|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
110273089|NCT03346135|Daratumumab|daratumumab|mesh-list
110273090|NCT03346135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110273092|NCT03346135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110273093|NCT03346135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110273094|NCT03346135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110273095|NCT03346135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110273096|NCT03346135|Immunologic Factors|immunologic factors|mesh-ancestor
110273097|NCT03346135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110273098|NCT03282916|Valacyclovir|valacyclovir|mesh-list
110273099|NCT03282916|Antiviral Agents|antiviral agents|mesh-ancestor
110273100|NCT03282916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110273101|NCT03229382|Obinutuzumab|obinutuzumab|mesh-list
110273102|NCT03229382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110273103|NCT03229382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110273105|NCT03215693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110273106|NCT03215693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110273107|NCT03215693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110273108|NCT03215693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110273109|NCT03187106|Metronidazole|metronidazole|mesh-list
110273110|NCT03187106|Cephalexin|cephalexin|mesh-list
110273111|NCT03187106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110273112|NCT03187106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110273113|NCT03187106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110273114|NCT03187106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110273115|NCT03159702|Fludarabine|fludarabine|mesh-list
110273117|NCT03159702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110273118|NCT03159702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110273119|NCT03159702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110273120|NCT03159702|Immunologic Factors|immunologic factors|mesh-ancestor
110273121|NCT03159702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110273122|NCT03159702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110273123|NCT03159702|Alkylating Agents|alkylating agents|mesh-ancestor
110273124|NCT03159702|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110273125|NCT03044977|Octreotide|octreotide|mesh-list
110273126|NCT03044977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110273127|NCT03044977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110273128|NCT03044977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110273129|NCT03009201|Doxorubicin|doxorubicin|mesh-list
110273130|NCT03009201|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110273131|NCT03009201|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110273132|NCT03009201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110273133|NCT03009201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110273134|NCT03009201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110273135|NCT03009201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110273136|NCT03009201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110273137|NCT02985749|Oxytocin|oxytocin|mesh-list
110273138|NCT02985749|Oxytocics|oxytocics|mesh-ancestor
110273139|NCT02985749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110273140|NCT02985749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110273141|NCT02905591|Ascorbic Acid|ascorbic acid|mesh-list
110273142|NCT02905591|Paclitaxel|paclitaxel|mesh-list
110273143|NCT02905591|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110273144|NCT02905591|Carboplatin|carboplatin|mesh-list
110273145|NCT02905591|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110273146|NCT02905591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110273147|NCT02905591|Tubulin Modulators|tubulin modulators|mesh-ancestor
110273148|NCT02905591|Antimitotic Agents|antimitotic agents|mesh-ancestor
110273149|NCT02905591|Mitosis Modulators|mitosis modulators|mesh-ancestor
110273151|NCT02905591|Vitamins|vitamins|mesh-ancestor
110273152|NCT02905591|Micronutrients|micronutrients|mesh-ancestor
110273153|NCT02905591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110273154|NCT02905591|Antioxidants|antioxidants|mesh-ancestor
110273155|NCT02905591|Protective Agents|protective agents|mesh-ancestor
110273156|NCT02635672|Pembrolizumab|pembrolizumab|mesh-list
110273157|NCT02635672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110273158|NCT02635672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110273159|NCT02635672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110273160|NCT02635672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110273161|NCT02589600|Vitamin D|vitamin d|mesh-list
110273162|NCT02589600|Zoledronic Acid|zoledronic acid|mesh-list
110273163|NCT02589600|Calcium|calcium|mesh-list
110273164|NCT02589600|Vitamins|vitamins|mesh-ancestor
110273165|NCT02589600|Micronutrients|micronutrients|mesh-ancestor
110273166|NCT02589600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110273167|NCT02589600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110273168|NCT02589600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110273170|NCT02365597|Midazolam|midazolam|mesh-list
110273171|NCT02365597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110273172|NCT02365597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110273173|NCT02365597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110273174|NCT02365597|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110273184|NCT02365597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110273185|NCT02365597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110273196|NCT02222155|Rituximab|rituximab|mesh-list
110273197|NCT02222155|Glucocorticoids|glucocorticoids|mesh-list
110273198|NCT02222155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110273199|NCT02222155|Immunologic Factors|immunologic factors|mesh-ancestor
110273200|NCT02222155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110273201|NCT02222155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110273202|NCT02222155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110273203|NCT02222155|Alkylating Agents|alkylating agents|mesh-ancestor
110273204|NCT02222155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110273205|NCT02222155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110273206|NCT02222155|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110273207|NCT02222155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110273208|NCT02222155|Hormones|hormones|mesh-ancestor
110273209|NCT02222155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110273210|NCT02020070|Ipilimumab|ipilimumab|mesh-list
110273211|NCT02020070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110273212|NCT02020070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110273213|NCT02020070|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110273214|NCT02020070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110273215|NCT01828112|Docetaxel|docetaxel|mesh-list
110273216|NCT01828112|Pemetrexed|pemetrexed|mesh-list
110273217|NCT01828112|Ceritinib|ceritinib|mesh-list
110273218|NCT01828112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110273220|NCT01828112|Antimitotic Agents|antimitotic agents|mesh-ancestor
110273221|NCT01828112|Mitosis Modulators|mitosis modulators|mesh-ancestor
110273222|NCT01828112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110273223|NCT01828112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110273224|NCT01828112|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110273225|NCT01828112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110273226|NCT01828112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110273227|NCT01465100|Liver Extracts|liver extracts|mesh-list
110273228|NCT01465100|Hematinics|hematinics|mesh-ancestor
110273231|NCT01430390|Immunologic Factors|immunologic factors|mesh-ancestor
110273232|NCT01430390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110273233|NCT01430390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110273234|NCT01430390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110273235|NCT01430390|Alkylating Agents|alkylating agents|mesh-ancestor
110273236|NCT01430390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110273237|NCT01430390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110273238|NCT01430390|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110273239|NCT01364857|GTPase-Activating Proteins|gtpase-activating proteins|mesh-list
110273240|NCT01364857|GTP Phosphohydrolase Activators|gtp phosphohydrolase activators|mesh-ancestor
110273241|NCT01364857|Enzyme Activators|enzyme activators|mesh-ancestor
110273242|NCT01364857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110273243|NCT01286272|Deoxyglucose|deoxyglucose|mesh-list
110273244|NCT01286272|Bortezomib|bortezomib|mesh-list
110273245|NCT01286272|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110273246|NCT01286272|Ofatumumab|ofatumumab|mesh-list
110273247|NCT01286272|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110273248|NCT01286272|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110273249|NCT01286272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110273250|NCT01286272|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110273251|NCT01286272|Alkylating Agents|alkylating agents|mesh-ancestor
110273252|NCT01286272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110273254|NCT01286272|Antimetabolites|antimetabolites|mesh-ancestor
110273255|NCT01286272|Antiviral Agents|antiviral agents|mesh-ancestor
110273256|NCT01286272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110273257|NCT01286272|Immunologic Factors|immunologic factors|mesh-ancestor
110273258|NCT01286272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110273259|NCT01029002|Vitamin D|vitamin d|mesh-list
110273260|NCT01029002|Vitamins|vitamins|mesh-ancestor
110273261|NCT01029002|Micronutrients|micronutrients|mesh-ancestor
110273262|NCT01029002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110273263|NCT01029002|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110273264|NCT01011478|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110273266|NCT01011478|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110273267|NCT01011478|Antimetabolites|antimetabolites|mesh-ancestor
110273268|NCT01011478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110273269|NCT01011478|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110273270|NCT01011478|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110273271|NCT01011478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110273272|NCT00980460|Sirolimus|sirolimus|mesh-list
110273273|NCT00980460|Cisplatin|cisplatin|mesh-list
110273274|NCT00980460|Doxorubicin|doxorubicin|mesh-list
110273275|NCT00980460|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110273277|NCT00980460|Irinotecan|irinotecan|mesh-list
110273278|NCT00980460|Vincristine|vincristine|mesh-list
110273279|NCT00980460|Temsirolimus|temsirolimus|mesh-list
110273280|NCT00980460|Camptothecin|camptothecin|mesh-list
110273281|NCT00980460|Dexrazoxane|dexrazoxane|mesh-list
110273282|NCT00980460|Razoxane|razoxane|mesh-list
110273283|NCT00980460|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|mesh-list
110273284|NCT00980460|MTOR Inhibitors|mtor inhibitors|mesh-list
110273285|NCT00980460|Liver Extracts|liver extracts|mesh-list
110273286|NCT00980460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110273287|NCT00980460|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110273288|NCT00980460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110273289|NCT00980460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110273290|NCT00980460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110273291|NCT00980460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110273292|NCT00980460|Antimetabolites|antimetabolites|mesh-ancestor
110273293|NCT00980460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110273294|NCT00980460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110273295|NCT00980460|Immunologic Factors|immunologic factors|mesh-ancestor
110273296|NCT00980460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110273297|NCT00980460|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110273298|NCT00980460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110273300|NCT00980460|Antimitotic Agents|antimitotic agents|mesh-ancestor
110273301|NCT00980460|Mitosis Modulators|mitosis modulators|mesh-ancestor
110273302|NCT00980460|Hematinics|hematinics|mesh-ancestor
110273303|NCT00980460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110273304|NCT00980460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110273306|NCT00980460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110273307|NCT00980460|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110273308|NCT00980460|Protective Agents|protective agents|mesh-ancestor
110273309|NCT00799864|Tenofovir|tenofovir|mesh-list
110273310|NCT00799864|Lamivudine|lamivudine|mesh-list
110273311|NCT00799864|Emtricitabine|emtricitabine|mesh-list
110273312|NCT00799864|Zidovudine|zidovudine|mesh-list
110273313|NCT00799864|Abacavir|abacavir|mesh-list
110273314|NCT00799864|Rilpivirine|rilpivirine|mesh-list
110273315|NCT00799864|Antiviral Agents|antiviral agents|mesh-ancestor
110273316|NCT00799864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110273317|NCT00799864|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110273318|NCT00799864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110273319|NCT00799864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110273320|NCT00799864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110273321|NCT00799864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110273322|NCT00799864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110273323|NCT00799864|Antimetabolites|antimetabolites|mesh-ancestor
110273324|NCT00695279|Vaccines|vaccines|mesh-list
110273325|NCT00695279|Immunologic Factors|immunologic factors|mesh-ancestor
110273326|NCT00695279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110273327|NCT00272714|Afimoxifene|afimoxifene|mesh-list
110273328|NCT00272714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110273329|NCT00272714|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110273330|NCT00272714|Hormone Antagonists|hormone antagonists|mesh-ancestor
110273331|NCT00272714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110273332|NCT00272714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110273333|NCT00272714|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110273334|NCT00272714|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110273335|NCT02903719|Ropivacaine|ropivacaine|mesh-list
110273336|NCT02903719|Anesthetics, Local|anesthetics, local|mesh-ancestor
110273337|NCT02903719|Anesthetics|anesthetics|mesh-ancestor
110273338|NCT02903719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110273339|NCT02903719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110273340|NCT02903719|Sensory System Agents|sensory system agents|mesh-ancestor
110273341|NCT02903719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110273342|NCT00178269|Docetaxel|docetaxel|mesh-list
110273343|NCT00178269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110273344|NCT00178269|Tubulin Modulators|tubulin modulators|mesh-ancestor
110273345|NCT00178269|Antimitotic Agents|antimitotic agents|mesh-ancestor
110273346|NCT00178269|Mitosis Modulators|mitosis modulators|mesh-ancestor
110273347|NCT00178269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110273348|NCT02903251|Oxytocin|oxytocin|mesh-list
110273349|NCT02903251|Oxytocics|oxytocics|mesh-ancestor
110273350|NCT02903251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110273351|NCT02903251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110273352|NCT00168467|Ramipril|ramipril|mesh-list
110273353|NCT00168467|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110273354|NCT00168467|Protease Inhibitors|protease inhibitors|mesh-ancestor
110273355|NCT00168467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110273356|NCT00168467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110273357|NCT00168467|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110273358|NCT00195936|Cinacalcet|cinacalcet|mesh-list
110273359|NCT00195936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110273360|NCT00195936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110273361|NCT00195936|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
110273362|NCT00195936|Hormone Antagonists|hormone antagonists|mesh-ancestor
110273363|NCT00195936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110273364|NCT00168506|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
110273365|NCT00168506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110273366|NCT00168506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110273367|NCT00168506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110273368|NCT00168506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110273369|NCT00168506|Serotonin Agents|serotonin agents|mesh-ancestor
110273370|NCT00168506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110273371|NCT02902861|Methotrexate|methotrexate|mesh-list
110273372|NCT02902861|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110273373|NCT02902861|Abortifacient Agents|abortifacient agents|mesh-ancestor
110273374|NCT02902861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110273375|NCT02902861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110273376|NCT02902861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110273377|NCT02902861|Antimetabolites|antimetabolites|mesh-ancestor
110273378|NCT02902861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110273379|NCT02902861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110273380|NCT02902861|Dermatologic Agents|dermatologic agents|mesh-ancestor
110273381|NCT02902861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110273382|NCT02902861|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110273383|NCT02902861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110273384|NCT02902861|Immunologic Factors|immunologic factors|mesh-ancestor
110273385|NCT02902861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110273386|NCT02902861|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110273387|NCT02903017|Tranexamic Acid|tranexamic acid|mesh-list
110273388|NCT02903017|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110273389|NCT02903017|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110273390|NCT02903017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110273391|NCT02903017|Hemostatics|hemostatics|mesh-ancestor
110273392|NCT02903017|Coagulants|coagulants|mesh-ancestor
110273393|NCT02902744|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
110273394|NCT02902744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110273395|NCT02902744|Glucocorticoids|glucocorticoids|mesh-ancestor
110273397|NCT02902744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110273398|NCT02902744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110273400|NCT00168584|Vitamins|vitamins|mesh-ancestor
110273401|NCT00168584|Micronutrients|micronutrients|mesh-ancestor
110273402|NCT00168584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110273403|NCT02902666|Acetaminophen|acetaminophen|mesh-list
110273404|NCT02902666|Codeine|codeine|mesh-list
110273405|NCT02902666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110273406|NCT02902666|Analgesics|analgesics|mesh-ancestor
110273407|NCT02902666|Sensory System Agents|sensory system agents|mesh-ancestor
110273408|NCT02902666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110273409|NCT02902666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110273410|NCT02902666|Antipyretics|antipyretics|mesh-ancestor
110273411|NCT02902666|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110273412|NCT02902666|Narcotics|narcotics|mesh-ancestor
110273413|NCT02902666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110273414|NCT02902666|Antitussive Agents|antitussive agents|mesh-ancestor
110273415|NCT02902666|Respiratory System Agents|respiratory system agents|mesh-ancestor
110273416|NCT02902354|Nifedipine|nifedipine|mesh-list
110273417|NCT02902354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110273418|NCT02902354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110273419|NCT02902354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110273420|NCT02902354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110273421|NCT02902354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110273422|NCT02902354|Vasodilator Agents|vasodilator agents|mesh-ancestor
110273423|NCT02902354|Tocolytic Agents|tocolytic agents|mesh-ancestor
110273424|NCT02902354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110273425|NCT00168623|Vitamin A|vitamin a|mesh-list
110273426|NCT00168623|Vitamins|vitamins|mesh-ancestor
110273427|NCT00168623|Micronutrients|micronutrients|mesh-ancestor
110273428|NCT00168623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110273429|NCT02902315|Vitamins|vitamins|mesh-list
110273430|NCT02902315|Ascorbic Acid|ascorbic acid|mesh-list
110273431|NCT02902315|Tocopherols|tocopherols|mesh-list
110273432|NCT02902315|alpha-Tocopherol|alpha-tocopherol|mesh-list
110273433|NCT02902315|Micronutrients|micronutrients|mesh-ancestor
110273434|NCT02902315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110273435|NCT02902315|Antioxidants|antioxidants|mesh-ancestor
110273436|NCT02902315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110273437|NCT02902315|Protective Agents|protective agents|mesh-ancestor
110273438|NCT02902432|Endostar protein|endostar protein|mesh-list
110273439|NCT02902432|Endostatins|endostatins|mesh-list
110274794|NCT00198120|Antimetabolites|antimetabolites|mesh-ancestor
110273440|NCT02902432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110273441|NCT02902432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110273442|NCT02902432|Growth Substances|growth substances|mesh-ancestor
110273443|NCT02902432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110273444|NCT02902432|Growth Inhibitors|growth inhibitors|mesh-ancestor
110273445|NCT02902432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110273447|NCT02902042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110273448|NCT02902042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110273449|NCT02902042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110273450|NCT02902042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110273452|NCT00168740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110273453|NCT00168740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110273454|NCT00168740|Immunologic Factors|immunologic factors|mesh-ancestor
110273455|NCT00168740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110273456|NCT00168740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110273457|NCT00168779|Valsartan|valsartan|mesh-list
110273458|NCT00168779|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110273459|NCT00168779|Telmisartan|telmisartan|mesh-list
110273460|NCT00168779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110273461|NCT00168779|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110273462|NCT00168779|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110273463|NCT00168779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110273465|NCT00168779|Natriuretic Agents|natriuretic agents|mesh-ancestor
110273466|NCT00168779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110273467|NCT00168779|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110273468|NCT00168779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110273469|NCT00168857|Losartan|losartan|mesh-list
110273470|NCT00168857|Telmisartan|telmisartan|mesh-list
110273471|NCT00168857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110273472|NCT00168857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110273473|NCT00168857|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110273474|NCT00168857|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110273475|NCT00168857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110273477|NCT00196131|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110273478|NCT00196131|Narcotics|narcotics|mesh-ancestor
110273479|NCT00196131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110273480|NCT00196131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110273481|NCT00196131|Analgesics|analgesics|mesh-ancestor
110273482|NCT00196131|Sensory System Agents|sensory system agents|mesh-ancestor
110273483|NCT00196131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110273486|NCT00168896|Etoposide|etoposide|mesh-list
110273487|NCT00168896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110273488|NCT00168896|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110273489|NCT00168896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110273490|NCT00168896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110273491|NCT00168896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110273492|NCT00168896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110273493|NCT00168896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110273494|NCT02901418|Immunoglobulins|immunoglobulins|mesh-list
110273495|NCT02901418|Immunologic Factors|immunologic factors|mesh-ancestor
110273496|NCT02901418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110273497|NCT02901379|Atorvastatin|atorvastatin|mesh-list
110273498|NCT02901379|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110273499|NCT02901379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110273501|NCT02901379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110273502|NCT02901379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110273503|NCT02901379|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110273504|NCT02901379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110273505|NCT02901106|Dimethyl Fumarate|dimethyl fumarate|mesh-list
110273507|NCT02901106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110273508|NCT02901106|Immunologic Factors|immunologic factors|mesh-ancestor
110273509|NCT02901106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110273510|NCT02901145|Cyclophosphamide|cyclophosphamide|mesh-list
110273511|NCT02901145|Nivolumab|nivolumab|mesh-list
110273512|NCT02901145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110273513|NCT02901145|Immunologic Factors|immunologic factors|mesh-ancestor
110273514|NCT02901145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110273515|NCT02901145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110273516|NCT02901145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110273517|NCT02901145|Alkylating Agents|alkylating agents|mesh-ancestor
110273518|NCT02901145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110273519|NCT02901145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110273520|NCT02901145|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110273521|NCT02901145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110273522|NCT02901145|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110273523|NCT02901301|Pembrolizumab|pembrolizumab|mesh-list
110273525|NCT02901301|Trastuzumab|trastuzumab|mesh-list
110273526|NCT02901301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110273527|NCT02901301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110273528|NCT02901301|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110273529|NCT02901301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110273530|NCT02901301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110273531|NCT02901301|Antimetabolites|antimetabolites|mesh-ancestor
110273532|NCT00169013|Gabapentin|gabapentin|mesh-list
110273533|NCT00169013|Analgesics|analgesics|mesh-ancestor
110273534|NCT00169013|Sensory System Agents|sensory system agents|mesh-ancestor
110273535|NCT00169013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110273536|NCT00169013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110273538|NCT00169013|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110273539|NCT00169013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110273540|NCT00169013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110273541|NCT00169013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110273542|NCT00169013|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110273543|NCT00169013|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110273544|NCT00169013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110273545|NCT00169013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110273546|NCT00169013|Antimanic Agents|antimanic agents|mesh-ancestor
110273548|NCT00169091|Haloperidol decanoate|haloperidol decanoate|mesh-list
110273549|NCT00169091|Clozapine|clozapine|mesh-list
110273550|NCT00169091|Antiemetics|antiemetics|mesh-ancestor
110273551|NCT00169091|Autonomic Agents|autonomic agents|mesh-ancestor
110273552|NCT00169091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110273553|NCT00169091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110273555|NCT00169091|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110273556|NCT00169091|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110273557|NCT00169091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110273558|NCT00169091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110273559|NCT00169091|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110273560|NCT00169091|Dopamine Agents|dopamine agents|mesh-ancestor
110273561|NCT00169091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110273562|NCT00169091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110273563|NCT00169091|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110273564|NCT00169091|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110273565|NCT00169091|Serotonin Agents|serotonin agents|mesh-ancestor
110273566|NCT00169091|GABA Antagonists|gaba antagonists|mesh-ancestor
110273567|NCT00169091|GABA Agents|gaba agents|mesh-ancestor
110273568|NCT00169130|Cyclophosphamide|cyclophosphamide|mesh-list
110273569|NCT00169130|Doxorubicin|doxorubicin|mesh-list
110273570|NCT00169130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110273571|NCT00169130|Immunologic Factors|immunologic factors|mesh-ancestor
110273572|NCT00169130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110273573|NCT00169130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110273574|NCT00169130|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110273575|NCT00169130|Alkylating Agents|alkylating agents|mesh-ancestor
110273576|NCT00169130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110273577|NCT00169130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110273578|NCT00169130|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110273579|NCT00169130|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110273580|NCT00169130|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110273581|NCT00169130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110273582|NCT00169130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110273583|NCT00178620|Reteplase|reteplase|mesh-list
110273584|NCT00178620|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110273585|NCT00178620|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110273586|NCT00178620|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110273587|NCT00178620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110273588|NCT00169169|Rituximab|rituximab|mesh-list
110273589|NCT00169169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110273590|NCT00169169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110273591|NCT00169169|Immunologic Factors|immunologic factors|mesh-ancestor
110273593|NCT00169169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110273594|NCT00169208|Rituximab|rituximab|mesh-list
110273595|NCT00169208|Fludarabine|fludarabine|mesh-list
110273596|NCT00169208|Mitoxantrone|mitoxantrone|mesh-list
110273597|NCT00169208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110273598|NCT00169208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110273599|NCT00169208|Immunologic Factors|immunologic factors|mesh-ancestor
110273600|NCT00169208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110273601|NCT00169208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110273602|NCT00169208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110273604|NCT00169208|Sensory System Agents|sensory system agents|mesh-ancestor
110273605|NCT00169208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110273606|NCT00169208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110273607|NCT00169208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110273608|NCT00169208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110273610|NCT00178698|Gemcitabine|gemcitabine|mesh-list
110273611|NCT00178698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110273612|NCT00178698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110273613|NCT00178698|Antimetabolites|antimetabolites|mesh-ancestor
110273614|NCT00178698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110273615|NCT00178698|Antiviral Agents|antiviral agents|mesh-ancestor
110273616|NCT00178698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110273617|NCT00169247|Cetuximab|cetuximab|mesh-list
110273618|NCT00169247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110273619|NCT00169247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110273620|NCT02899702|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110273621|NCT02899702|Immunologic Factors|immunologic factors|mesh-ancestor
110273622|NCT02899702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110273623|NCT02899507|Amoxicillin|amoxicillin|mesh-list
110273624|NCT02899507|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110273626|NCT02899507|Clavulanic Acid|clavulanic acid|mesh-list
110273627|NCT02899507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110273628|NCT02899507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110273629|NCT02899507|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110273630|NCT02899507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110273631|NCT02899507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110273632|NCT00178854|Risperidone|risperidone|mesh-list
110273633|NCT00178854|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110273634|NCT00178854|Serotonin Agents|serotonin agents|mesh-ancestor
110273635|NCT00178854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110273636|NCT00178854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110273637|NCT00178854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110273638|NCT00178854|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110273639|NCT00178854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110273640|NCT00178854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110273641|NCT00178854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110273643|NCT00178854|Dopamine Agents|dopamine agents|mesh-ancestor
110273644|NCT00196365|Levonorgestrel|levonorgestrel|mesh-list
110273645|NCT00196365|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110273646|NCT00196365|Contraceptive Agents|contraceptive agents|mesh-ancestor
110273647|NCT00196365|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110273648|NCT00196365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110273649|NCT00196365|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110273650|NCT00196365|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110273651|NCT00196365|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110273652|NCT02898961|Gentamicins|gentamicins|mesh-list
110273653|NCT02898961|Amikacin|amikacin|mesh-list
110273654|NCT02898961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110273655|NCT02898961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110273656|NCT02898961|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110273658|NCT02898961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110273659|NCT00553618|Aldesleukin|aldesleukin|mesh-list
110273660|NCT00553618|Dacarbazine|dacarbazine|mesh-list
110273661|NCT00553618|Interleukin-2|interleukin-2|mesh-list
110273662|NCT00553618|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110273663|NCT00553618|Alkylating Agents|alkylating agents|mesh-ancestor
110273664|NCT00553618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110273665|NCT00553618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110273666|NCT00553618|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110273667|NCT00553618|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110273668|NCT00553618|Antiviral Agents|antiviral agents|mesh-ancestor
110273669|NCT00553618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110273670|NCT00553618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110273671|NCT00553618|Analgesics|analgesics|mesh-ancestor
110273672|NCT00553618|Sensory System Agents|sensory system agents|mesh-ancestor
110273673|NCT00553618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110273674|NCT00553618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110273675|NCT02898376|Tocopherols|tocopherols|mesh-list
110273676|NCT02898376|Vitamin E|vitamin e|mesh-list
110273677|NCT02898376|Tocotrienols|tocotrienols|mesh-list
110273678|NCT02898376|alpha-Tocopherol|alpha-tocopherol|mesh-list
110273679|NCT02898376|Pentoxifylline|pentoxifylline|mesh-list
110273680|NCT02898376|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110273681|NCT02898376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110273682|NCT02898376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110273683|NCT02898376|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110273684|NCT02898376|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110273685|NCT02898376|Protective Agents|protective agents|mesh-ancestor
110273686|NCT02898376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110273687|NCT02898376|Vasodilator Agents|vasodilator agents|mesh-ancestor
110273688|NCT02898376|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110273689|NCT02898376|Antioxidants|antioxidants|mesh-ancestor
110273690|NCT02898376|Vitamins|vitamins|mesh-ancestor
110273691|NCT02898376|Micronutrients|micronutrients|mesh-ancestor
110273693|NCT00408174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110273694|NCT00408174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110273695|NCT00408174|Analgesics|analgesics|mesh-ancestor
110273696|NCT00408174|Sensory System Agents|sensory system agents|mesh-ancestor
110273697|NCT00408174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110273698|NCT00408174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110273699|NCT00408174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110273700|NCT00408174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110273701|NCT00408174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110273702|NCT00169520|Docetaxel|docetaxel|mesh-list
110273703|NCT00169520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110273704|NCT00169520|Tubulin Modulators|tubulin modulators|mesh-ancestor
110273705|NCT00169520|Antimitotic Agents|antimitotic agents|mesh-ancestor
110273706|NCT00169520|Mitosis Modulators|mitosis modulators|mesh-ancestor
110273707|NCT00169520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110273709|NCT02897986|Propranolol|propranolol|mesh-list
110273710|NCT02897986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110273711|NCT02897986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110273712|NCT02897986|Tubulin Modulators|tubulin modulators|mesh-ancestor
110273713|NCT02897986|Antimitotic Agents|antimitotic agents|mesh-ancestor
110273714|NCT02897986|Mitosis Modulators|mitosis modulators|mesh-ancestor
110273715|NCT02897986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110273716|NCT02897986|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110273717|NCT02897986|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110273718|NCT02897986|Adrenergic Agents|adrenergic agents|mesh-ancestor
110273719|NCT02897986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110273720|NCT02897986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110273721|NCT02897986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110273722|NCT02897986|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110273723|NCT02897986|Vasodilator Agents|vasodilator agents|mesh-ancestor
110273724|NCT00169559|Fenofibrate|fenofibrate|mesh-list
110273725|NCT00169559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110273726|NCT00169559|Antimetabolites|antimetabolites|mesh-ancestor
110273727|NCT00169559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110273728|NCT00169559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110273729|NCT00408213|Mycophenolic Acid|mycophenolic acid|mesh-list
110273730|NCT00408213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110273731|NCT00408213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110273732|NCT00408213|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110273733|NCT00408213|Antitubercular Agents|antitubercular agents|mesh-ancestor
110273734|NCT00408213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110273735|NCT00408213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110273736|NCT00408213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110273737|NCT00408213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110273738|NCT00408252|Sunitinib|sunitinib|mesh-list
110273739|NCT00408252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110273740|NCT00408252|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110273741|NCT00408252|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110273742|NCT00408252|Growth Substances|growth substances|mesh-ancestor
110273743|NCT00408252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110273745|NCT00408252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110273746|NCT00408252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110273747|NCT00408252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110273748|NCT02897869|Amikacin|amikacin|mesh-list
110273749|NCT02897869|Murepavadin|murepavadin|mesh-list
110273750|NCT02897869|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110273751|NCT02897869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110273752|NCT02897830|Dexamethasone|dexamethasone|mesh-list
110273755|NCT02897830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110273756|NCT02897830|Antiemetics|antiemetics|mesh-ancestor
110273757|NCT02897830|Autonomic Agents|autonomic agents|mesh-ancestor
110273758|NCT02897830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110273759|NCT02897830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110273760|NCT02897830|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110273761|NCT02897830|Glucocorticoids|glucocorticoids|mesh-ancestor
110273762|NCT02897830|Hormones|hormones|mesh-ancestor
110273763|NCT02897830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110273764|NCT02897830|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110273765|NCT02897830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110273766|NCT02897830|Immunologic Factors|immunologic factors|mesh-ancestor
110273767|NCT02897830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110273768|NCT02897830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110273769|NCT02897830|Growth Substances|growth substances|mesh-ancestor
110273770|NCT02897830|Growth Inhibitors|growth inhibitors|mesh-ancestor
110273771|NCT02897830|Protease Inhibitors|protease inhibitors|mesh-ancestor
110273772|NCT02897830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110273773|NCT02897830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110273774|NCT02897557|Pancrelipase|pancrelipase|mesh-list
110273775|NCT02897557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110273776|NCT02897596|Grazoprevir|grazoprevir|mesh-list
110273777|NCT02897596|Antiviral Agents|antiviral agents|mesh-ancestor
110273778|NCT02897596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110273779|NCT04681027|Oxymorphone|oxymorphone|mesh-list
110273780|NCT04681027|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110273781|NCT04681027|Narcotics|narcotics|mesh-ancestor
110273782|NCT04681027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110273783|NCT04681027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110273785|NCT04681027|Sensory System Agents|sensory system agents|mesh-ancestor
110273786|NCT04681027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110273787|NCT04681027|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110273788|NCT00408330|Azelaic acid|azelaic acid|mesh-list
110273789|NCT00408330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110273790|NCT00408330|Dermatologic Agents|dermatologic agents|mesh-ancestor
110273791|NCT00408369|Pafuramidine|pafuramidine|mesh-list
110273792|NCT00408369|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110273793|NCT00408369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110273794|NCT00408369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110273795|NCT00408369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110273796|NCT02897206|Imipenem|imipenem|mesh-list
110273797|NCT02897206|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
110273798|NCT02897206|Cilastatin|cilastatin|mesh-list
110273799|NCT02897206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110273800|NCT02897206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110273801|NCT02897206|Protease Inhibitors|protease inhibitors|mesh-ancestor
110273802|NCT02897206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110273803|NCT02897206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110273804|NCT02897401|Carbon Monoxide|carbon monoxide|mesh-list
110273805|NCT02897401|Antimetabolites|antimetabolites|mesh-ancestor
110273806|NCT02897401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110273807|NCT02897401|Gasotransmitters|gasotransmitters|mesh-ancestor
110273808|NCT02897401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110273809|NCT02897401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110273810|NCT02897011|Methotrexate|methotrexate|mesh-list
110273811|NCT02897011|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110273812|NCT02897011|Abortifacient Agents|abortifacient agents|mesh-ancestor
110273813|NCT02897011|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110273814|NCT02897011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110273815|NCT02897011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110273816|NCT02897011|Antimetabolites|antimetabolites|mesh-ancestor
110273817|NCT02897011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110273818|NCT02897011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110273819|NCT02897011|Dermatologic Agents|dermatologic agents|mesh-ancestor
110273820|NCT02897011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110273821|NCT02897011|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110273822|NCT02897011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110273823|NCT02897011|Immunologic Factors|immunologic factors|mesh-ancestor
110273824|NCT02897011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110273825|NCT02897011|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110273826|NCT00169832|Rosiglitazone|rosiglitazone|mesh-list
110273827|NCT00169832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110273828|NCT00169832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110273829|NCT00196599|Emtricitabine|emtricitabine|mesh-list
110273830|NCT00196599|Efavirenz|efavirenz|mesh-list
110273831|NCT00196599|Didanosine|didanosine|mesh-list
110273832|NCT00196599|Antiviral Agents|antiviral agents|mesh-ancestor
110273833|NCT00196599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110273834|NCT00196599|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110273835|NCT00196599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110273836|NCT00196599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110273837|NCT00196599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110273838|NCT00196599|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110273839|NCT00196599|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110273840|NCT00196599|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110273841|NCT00196599|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110273842|NCT00196599|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110273843|NCT00196599|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110273844|NCT00196599|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110273845|NCT00196599|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110273846|NCT00196599|Antimetabolites|antimetabolites|mesh-ancestor
110273847|NCT00178971|Buspirone|buspirone|mesh-list
110273848|NCT00178971|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110273849|NCT00178971|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110273850|NCT00178971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110273851|NCT00178971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110273852|NCT00178971|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110273853|NCT00178971|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110273854|NCT00178971|Serotonin Agents|serotonin agents|mesh-ancestor
110273855|NCT00178971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110273856|NCT00178971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110273857|NCT02896621|Amlodipine|amlodipine|mesh-list
110273858|NCT02896621|Chlorthalidone|chlorthalidone|mesh-list
110273859|NCT02896621|Amiloride|amiloride|mesh-list
110273860|NCT02896621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110273861|NCT02896621|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110273862|NCT02896621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110273863|NCT02896621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110273864|NCT02896621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110273865|NCT02896621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110273866|NCT02896621|Vasodilator Agents|vasodilator agents|mesh-ancestor
110273867|NCT02896621|Diuretics|diuretics|mesh-ancestor
110273868|NCT02896621|Natriuretic Agents|natriuretic agents|mesh-ancestor
110273869|NCT02896621|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110273870|NCT02896621|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
110273871|NCT02896621|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110273872|NCT02896621|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
110273873|NCT02896621|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110273874|NCT02896582|Cytarabine|cytarabine|mesh-list
110273875|NCT02896582|Dexamethasone|dexamethasone|mesh-list
110273876|NCT02896582|Etoposide|etoposide|mesh-list
110273877|NCT02896582|Melphalan|melphalan|mesh-list
110273878|NCT02896582|Cisplatin|cisplatin|mesh-list
110273879|NCT02896582|Obinutuzumab|obinutuzumab|mesh-list
110273880|NCT02896582|Carmustine|carmustine|mesh-list
110273881|NCT02896582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110273883|NCT02896582|Autonomic Agents|autonomic agents|mesh-ancestor
110273884|NCT02896582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110273885|NCT02896582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110273886|NCT02896582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110273888|NCT02896582|Hormones|hormones|mesh-ancestor
110273889|NCT02896582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110273890|NCT02896582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110273891|NCT02896582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110273892|NCT02896582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110273893|NCT02896582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110273895|NCT02896582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110273896|NCT02896582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110273897|NCT02896582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110273898|NCT02896582|Antimetabolites|antimetabolites|mesh-ancestor
110273899|NCT02896582|Antiviral Agents|antiviral agents|mesh-ancestor
110273900|NCT02896582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110273901|NCT02896582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110273902|NCT02896582|Immunologic Factors|immunologic factors|mesh-ancestor
110273903|NCT02896582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110273904|NCT02896582|Alkylating Agents|alkylating agents|mesh-ancestor
110273905|NCT02896582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110273906|NCT02896582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110273907|NCT00196638|Interferons|interferons|mesh-list
110273908|NCT00196638|Interferon-alpha|interferon-alpha|mesh-list
110273909|NCT00196638|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110273910|NCT00196638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110273911|NCT00196638|Antiviral Agents|antiviral agents|mesh-ancestor
110273912|NCT00196638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110273913|NCT00196638|Immunologic Factors|immunologic factors|mesh-ancestor
110273914|NCT00196638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110273915|NCT02896270|Valproic Acid|valproic acid|mesh-list
110273916|NCT02896270|Anticonvulsants|anticonvulsants|mesh-ancestor
110273917|NCT02896270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110273918|NCT02896270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110273919|NCT02896270|GABA Agents|gaba agents|mesh-ancestor
110273920|NCT02896270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110273921|NCT02896270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110273922|NCT02896270|Antimanic Agents|antimanic agents|mesh-ancestor
110273923|NCT02896270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110273924|NCT02896270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110273925|NCT02896270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110273926|NCT00196677|Vitamins|vitamins|mesh-list
110273927|NCT00196677|Micronutrients|micronutrients|mesh-ancestor
110273928|NCT00196677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110273929|NCT02895958|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
110273930|NCT02895958|Antiviral Agents|antiviral agents|mesh-ancestor
110273931|NCT02895958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110273932|NCT00169949|Aripiprazole|aripiprazole|mesh-list
110273933|NCT00169949|Antidepressive Agents|antidepressive agents|mesh-ancestor
110273934|NCT00169949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110273935|NCT00169949|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110273936|NCT00169949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110273937|NCT00169949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110273938|NCT00169949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110273939|NCT00169949|Dopamine Agonists|dopamine agonists|mesh-ancestor
110273940|NCT00169949|Dopamine Agents|dopamine agents|mesh-ancestor
110273941|NCT00169949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110273942|NCT00169949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110273943|NCT00169949|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110273944|NCT00169949|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110273946|NCT00169949|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110273947|NCT00169949|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110273948|NCT00169949|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110273949|NCT00169949|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110273950|NCT00196755|Calcium|calcium|mesh-list
110273951|NCT00196755|Sevelamer|sevelamer|mesh-list
110273952|NCT00196755|Calcium acetate|calcium acetate|mesh-list
110273953|NCT00196755|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110273954|NCT00196755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110273955|NCT00196755|Chelating Agents|chelating agents|mesh-ancestor
110273956|NCT00196755|Sequestering Agents|sequestering agents|mesh-ancestor
110273957|NCT00196755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110273958|NCT00169988|Risperidone|risperidone|mesh-list
110273959|NCT00169988|Sertraline|sertraline|mesh-list
110273961|NCT00169988|Serotonin Agents|serotonin agents|mesh-ancestor
110273962|NCT00169988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110273963|NCT00169988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110273964|NCT00169988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110273965|NCT00169988|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110273966|NCT00169988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110273967|NCT00169988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110273968|NCT00169988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110273969|NCT00169988|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110273970|NCT00169988|Dopamine Agents|dopamine agents|mesh-ancestor
110273971|NCT00169988|Antidepressive Agents|antidepressive agents|mesh-ancestor
110273972|NCT00169988|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110273973|NCT00169988|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110273974|NCT00169988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110273975|NCT02895529|Itraconazole|itraconazole|mesh-list
110273976|NCT02895529|Caspofungin|caspofungin|mesh-list
110273977|NCT02895529|Antifungal Agents|antifungal agents|mesh-ancestor
110273978|NCT02895529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110273979|NCT02895529|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110273980|NCT02895529|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110273981|NCT02895529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110273982|NCT02895529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110273983|NCT02895529|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110273984|NCT02895529|Hormone Antagonists|hormone antagonists|mesh-ancestor
110273985|NCT02895529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110273986|NCT02895529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110273987|NCT02895529|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110273988|NCT02895061|Alfacalcidol|alfacalcidol|mesh-list
110273989|NCT02895061|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
110273990|NCT02895061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110273991|NCT02895061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110273993|NCT02895061|Micronutrients|micronutrients|mesh-ancestor
110273994|NCT00170183|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
110273995|NCT00170183|Natriuretic Agents|natriuretic agents|mesh-ancestor
110273996|NCT00170183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110273998|NCT00170222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110273999|NCT00170222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110274000|NCT00170222|Antimalarials|antimalarials|mesh-ancestor
110274001|NCT00170222|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110274002|NCT00170222|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110274003|NCT02894983|Calpastatin|calpastatin|mesh-list
110274004|NCT02894983|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
110274005|NCT02894983|Protease Inhibitors|protease inhibitors|mesh-ancestor
110274006|NCT02894983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110274007|NCT02894983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274009|NCT02895022|Anesthetics, Local|anesthetics, local|mesh-ancestor
110274010|NCT02895022|Anesthetics|anesthetics|mesh-ancestor
110274011|NCT02895022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110274012|NCT02895022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110274013|NCT02895022|Sensory System Agents|sensory system agents|mesh-ancestor
110274014|NCT02895022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110274015|NCT02895022|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110274016|NCT02895022|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110274017|NCT02895022|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110274018|NCT02895022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110274019|NCT02895022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274020|NCT00409851|Amlodipine|amlodipine|mesh-list
110274021|NCT00409851|Valsartan|valsartan|mesh-list
110274022|NCT00409851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110274023|NCT00409851|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110274024|NCT00409851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110274025|NCT00409851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274026|NCT00409851|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110274027|NCT00409851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110274028|NCT00409851|Vasodilator Agents|vasodilator agents|mesh-ancestor
110274029|NCT00409851|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110274030|NCT00409851|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110274031|NCT00409890|Scopolamine|scopolamine|mesh-list
110274032|NCT00409890|Bromides|bromides|mesh-list
110274033|NCT00409890|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
110274034|NCT00409890|Anticonvulsants|anticonvulsants|mesh-ancestor
110274035|NCT00409890|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110274036|NCT00409890|Antiemetics|antiemetics|mesh-ancestor
110274037|NCT00409890|Autonomic Agents|autonomic agents|mesh-ancestor
110274038|NCT00409890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110274039|NCT00409890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110274040|NCT00409890|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110274041|NCT00409890|Mydriatics|mydriatics|mesh-ancestor
110274042|NCT00409890|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110274043|NCT00409890|Cholinergic Agents|cholinergic agents|mesh-ancestor
110274044|NCT00409890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110274045|NCT00409890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274046|NCT00409890|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110274047|NCT00409890|Parasympatholytics|parasympatholytics|mesh-ancestor
110274048|NCT05423821|Anesthetics|anesthetics|mesh-list
110274049|NCT05423821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110274050|NCT05423821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110274051|NCT00170378|Enoxaparin|enoxaparin|mesh-list
110274052|NCT00170378|Anticoagulants|anticoagulants|mesh-ancestor
110274053|NCT00170378|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110274054|NCT00170378|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110274904|NCT00202995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110274055|NCT00170378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274058|NCT00179244|Antidepressive Agents|antidepressive agents|mesh-ancestor
110274059|NCT00179244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110274060|NCT00179244|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110274061|NCT00179244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110274062|NCT00179244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110274063|NCT00179244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274064|NCT00179244|Dopamine Agents|dopamine agents|mesh-ancestor
110274065|NCT00179244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110274066|NCT00179244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110274067|NCT00179244|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110274068|NCT00179244|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110274069|NCT00179244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110274070|NCT00196872|Cyclophosphamide|cyclophosphamide|mesh-list
110274072|NCT00196872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110274073|NCT00196872|Immunologic Factors|immunologic factors|mesh-ancestor
110274074|NCT00196872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110274075|NCT00196872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110274076|NCT00196872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110274077|NCT00196872|Alkylating Agents|alkylating agents|mesh-ancestor
110274078|NCT00196872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274079|NCT00196872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110274080|NCT00196872|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110274081|NCT00196872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110274082|NCT00196872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110274083|NCT00196872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110274084|NCT00196872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110274085|NCT00170456|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110274086|NCT00170456|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110274087|NCT00170456|Immunologic Factors|immunologic factors|mesh-ancestor
110274088|NCT00170456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110274089|NCT00170456|Antacids|antacids|mesh-ancestor
110274090|NCT00170456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274091|NCT00170456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110274092|NCT00179283|Sertraline|sertraline|mesh-list
110274093|NCT00179283|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110274094|NCT00179283|Antidepressive Agents|antidepressive agents|mesh-ancestor
110274095|NCT00179283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110274096|NCT00179283|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110274097|NCT00179283|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110274098|NCT00179283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110274099|NCT00179283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274100|NCT00179283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110274101|NCT00179283|Serotonin Agents|serotonin agents|mesh-ancestor
110274102|NCT00179283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110274103|NCT00179283|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110274104|NCT00179283|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110274105|NCT05420350|Lamotrigine|lamotrigine|mesh-list
110274106|NCT05420350|Bupropion|bupropion|mesh-list
110274107|NCT05420350|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110274108|NCT05420350|Antidepressive Agents|antidepressive agents|mesh-ancestor
110274109|NCT05420350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110274110|NCT05420350|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110274111|NCT05420350|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110274112|NCT05420350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110274925|NCT00198393|Antimetabolites|antimetabolites|mesh-ancestor
110274113|NCT05420350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274114|NCT05420350|Dopamine Agents|dopamine agents|mesh-ancestor
110274115|NCT05420350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110274116|NCT05420350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110274117|NCT05420350|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110274118|NCT05420350|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110274119|NCT05420350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110274120|NCT05420350|Anticonvulsants|anticonvulsants|mesh-ancestor
110274121|NCT05420350|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110274122|NCT05420350|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110274123|NCT05420350|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110274124|NCT05420350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110274125|NCT05420350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110274126|NCT05420350|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110274128|NCT03097939|Ipilimumab|ipilimumab|mesh-list
110274129|NCT03097939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110274130|NCT03097939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110274131|NCT03097939|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110274132|NCT03097939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274133|NCT03014635|Botulinum Toxins|botulinum toxins|mesh-list
110274134|NCT03014635|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110274135|NCT03014635|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110274136|NCT03014635|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110274137|NCT03014635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110274138|NCT03014635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274139|NCT03014635|Cholinergic Agents|cholinergic agents|mesh-ancestor
110274140|NCT03014635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110274141|NCT03014635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110274143|NCT03014635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110274144|NCT00170573|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110274145|NCT00170573|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110274146|NCT00170573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110274147|NCT02885272|Deoxyglucose|deoxyglucose|mesh-list
110274148|NCT02885272|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110274149|NCT02885272|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110274150|NCT02885272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274151|NCT02885272|Antimetabolites|antimetabolites|mesh-ancestor
110274152|NCT02885272|Antiviral Agents|antiviral agents|mesh-ancestor
110274153|NCT02885272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110274154|NCT02793583|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110274155|NCT02793583|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110274156|NCT02793583|Alkylating Agents|alkylating agents|mesh-ancestor
110274157|NCT02793583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274158|NCT02793583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110274159|NCT00170612|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110274160|NCT00170612|Immunologic Factors|immunologic factors|mesh-ancestor
110274161|NCT00170612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110274163|NCT00170690|Busulfan|busulfan|mesh-list
110274164|NCT00170690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110274165|NCT00170690|Alkylating Agents|alkylating agents|mesh-ancestor
110274166|NCT00170690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274167|NCT00170690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110274168|NCT00170690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110274169|NCT00170690|Immunologic Factors|immunologic factors|mesh-ancestor
110274170|NCT00170690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110274171|NCT00170690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110274172|NCT00196989|Pioglitazone|pioglitazone|mesh-list
110274173|NCT00196989|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110274174|NCT00196989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110274175|NCT00170729|Prednisolone|prednisolone|mesh-list
110274176|NCT00170729|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110274177|NCT00170729|Methylprednisolone|methylprednisolone|mesh-list
110274178|NCT00170729|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110274179|NCT00170729|Prednisolone acetate|prednisolone acetate|mesh-list
110274180|NCT00170729|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110274181|NCT00170729|Prednisolone phosphate|prednisolone phosphate|mesh-list
110274182|NCT00170729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110274184|NCT00170729|Hormones|hormones|mesh-ancestor
110274185|NCT00170729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110274186|NCT00170729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110274187|NCT00170729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110274188|NCT00170729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110274189|NCT00170729|Antiemetics|antiemetics|mesh-ancestor
110274190|NCT00170729|Autonomic Agents|autonomic agents|mesh-ancestor
110274191|NCT00170729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110274192|NCT00170729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110274193|NCT00170729|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110274194|NCT00170729|Protective Agents|protective agents|mesh-ancestor
110274195|NCT00170768|Oxybutynin|oxybutynin|mesh-list
110274196|NCT00170768|Darifenacin|darifenacin|mesh-list
110274197|NCT00170768|Parasympatholytics|parasympatholytics|mesh-ancestor
110274198|NCT00170768|Autonomic Agents|autonomic agents|mesh-ancestor
110274199|NCT00170768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110274200|NCT00170768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110274201|NCT00170768|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110274202|NCT00170768|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110274203|NCT00170768|Cholinergic Agents|cholinergic agents|mesh-ancestor
110274204|NCT00170768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110274205|NCT00170768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274206|NCT00170768|Urological Agents|urological agents|mesh-ancestor
110274207|NCT02655562|Montelukast|montelukast|mesh-list
110274208|NCT02655562|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110274209|NCT02655562|Respiratory System Agents|respiratory system agents|mesh-ancestor
110274210|NCT02655562|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110274211|NCT02655562|Hormone Antagonists|hormone antagonists|mesh-ancestor
110274212|NCT02655562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110274213|NCT02655562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110274214|NCT02655562|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110274215|NCT02655562|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110274216|NCT02655562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274217|NCT00170885|Everolimus|everolimus|mesh-list
110274218|NCT00170885|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110274219|NCT00170885|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110274220|NCT00170885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110274221|NCT00170885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274222|NCT00170885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110274223|NCT00170885|Immunologic Factors|immunologic factors|mesh-ancestor
110274224|NCT00170885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110274225|NCT00170885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110274226|NCT02607748|Listerine|listerine|mesh-list
110274227|NCT02607748|Fluorides|fluorides|mesh-list
110274228|NCT02607748|Sodium Fluoride|sodium fluoride|mesh-list
110274229|NCT02607748|Cariostatic Agents|cariostatic agents|mesh-ancestor
110274230|NCT02607748|Protective Agents|protective agents|mesh-ancestor
110274231|NCT02607748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110274232|NCT02607748|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110274233|NCT02607748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110274234|NCT02502253|Resveratrol|resveratrol|mesh-list
110274235|NCT02502253|Antioxidants|antioxidants|mesh-ancestor
110274236|NCT02502253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274237|NCT02502253|Protective Agents|protective agents|mesh-ancestor
110274238|NCT02502253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110274239|NCT02502253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110274240|NCT02502253|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110274241|NCT00170924|Valsartan|valsartan|mesh-list
110274242|NCT00170924|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110274243|NCT00170924|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110274244|NCT00170924|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110274245|NCT00170924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274246|NCT01356940|4-Aminopyridine|4-aminopyridine|mesh-list
110274247|NCT01356940|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110274248|NCT01356940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110274249|NCT01356940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274250|NCT00170963|Amlodipine|amlodipine|mesh-list
110274251|NCT00170963|Valsartan|valsartan|mesh-list
110274252|NCT00170963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110274253|NCT00170963|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110274254|NCT00170963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110274255|NCT00170963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274262|NCT02492776|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110274263|NCT02492776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110274264|NCT02492776|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110274265|NCT02492776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110274266|NCT02492776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274267|NCT00171002|Amlodipine|amlodipine|mesh-list
110274268|NCT00171002|Valsartan|valsartan|mesh-list
110274269|NCT00171002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110274270|NCT00171002|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110274271|NCT00171002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110274272|NCT00171002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274273|NCT00171002|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110274274|NCT00171002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110274275|NCT00171002|Vasodilator Agents|vasodilator agents|mesh-ancestor
110274276|NCT00171002|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110274277|NCT00171002|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110274280|NCT00171041|Valsartan|valsartan|mesh-list
110274281|NCT00171041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110274282|NCT00171041|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110274283|NCT00171041|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110274284|NCT00171041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274294|NCT05392699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110274295|NCT05392699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110274296|NCT05392699|Growth Substances|growth substances|mesh-ancestor
110274297|NCT05392699|Growth Inhibitors|growth inhibitors|mesh-ancestor
110274298|NCT05392699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110274299|NCT00171080|Valsartan|valsartan|mesh-list
110274300|NCT00171080|Irbesartan|irbesartan|mesh-list
110274301|NCT00171080|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110274302|NCT00171080|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110274303|NCT00171080|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110274304|NCT00171080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274305|NCT02229877|Omeprazole|omeprazole|mesh-list
110274306|NCT02229877|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110274307|NCT02229877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110274308|NCT02229877|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110274309|NCT02229877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110274310|NCT02229877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274311|NCT00171119|Valsartan|valsartan|mesh-list
110274312|NCT00171119|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110274313|NCT00171119|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110274314|NCT00171119|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110274315|NCT00171119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274323|NCT05349448|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110274324|NCT05349448|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110274325|NCT05349448|Dexmedetomidine|dexmedetomidine|mesh-list
110274326|NCT05349448|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110274327|NCT05349448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110274328|NCT05349448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110274329|NCT05349448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110274330|NCT05349448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110274331|NCT05349448|Analgesics|analgesics|mesh-ancestor
110274332|NCT05349448|Sensory System Agents|sensory system agents|mesh-ancestor
110274333|NCT05349448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110274334|NCT05349448|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110274335|NCT05349448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110274336|NCT05349448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110274337|NCT05349448|Adrenergic Agents|adrenergic agents|mesh-ancestor
110274338|NCT05349448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110274339|NCT05349448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274340|NCT05349448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110274341|NCT05349448|Glucocorticoids|glucocorticoids|mesh-ancestor
110274342|NCT05349448|Hormones|hormones|mesh-ancestor
110274343|NCT05349448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110274345|NCT05349448|Immunologic Factors|immunologic factors|mesh-ancestor
110274346|NCT05349448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110274347|NCT00171353|Valsartan|valsartan|mesh-list
110274348|NCT00171353|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110274349|NCT00171353|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110274350|NCT00171353|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110274351|NCT00171353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274352|NCT01656343|Abatacept|abatacept|mesh-list
110274353|NCT01656343|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
110274354|NCT01656343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110274355|NCT01656343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274356|NCT01656343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110274357|NCT01656343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110274358|NCT01656343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110274359|NCT01656343|Immunologic Factors|immunologic factors|mesh-ancestor
110274360|NCT01656343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110274361|NCT01656343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110274362|NCT01656343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110274363|NCT01539811|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110274364|NCT01539811|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110274365|NCT01539811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110274366|NCT01539811|Antitubercular Agents|antitubercular agents|mesh-ancestor
110274367|NCT00171392|Mycophenolic Acid|mycophenolic acid|mesh-list
110274368|NCT00171392|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110274369|NCT00171392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110274370|NCT00171392|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110274371|NCT00171392|Antitubercular Agents|antitubercular agents|mesh-ancestor
110274373|NCT00171392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110274374|NCT00171392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110274375|NCT00171392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274376|NCT00171431|Tegaserod|tegaserod|mesh-list
110274377|NCT00171431|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110274378|NCT00171431|Serotonin Agents|serotonin agents|mesh-ancestor
110274379|NCT00171431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110274380|NCT00171431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274381|NCT00171431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110274382|NCT01330030|Selegiline|selegiline|mesh-list
110274383|NCT01330030|Antidepressive Agents|antidepressive agents|mesh-ancestor
110274385|NCT01330030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110274386|NCT01330030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110274387|NCT01330030|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110274388|NCT01330030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110274389|NCT01330030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274390|NCT01330030|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110274391|NCT01330030|Protective Agents|protective agents|mesh-ancestor
110274392|NCT01330030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110274393|NCT00171470|Tegaserod|tegaserod|mesh-list
110274394|NCT00171470|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110274395|NCT00171470|Serotonin Agents|serotonin agents|mesh-ancestor
110274396|NCT00171470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110274397|NCT00171470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274398|NCT00171470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110274399|NCT00171509|Cyclosporine|cyclosporine|mesh-list
110274400|NCT00171509|Cyclosporins|cyclosporins|mesh-list
110274401|NCT00171509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110274402|NCT00171509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274403|NCT00171509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110274404|NCT00171509|Immunologic Factors|immunologic factors|mesh-ancestor
110274405|NCT00171509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110274406|NCT00171509|Antifungal Agents|antifungal agents|mesh-ancestor
110274407|NCT00171509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110274408|NCT00171509|Dermatologic Agents|dermatologic agents|mesh-ancestor
110274409|NCT00171509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110274410|NCT00171509|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110274412|NCT00179712|Lenalidomide|lenalidomide|mesh-list
110274413|NCT00179712|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110274414|NCT00179712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110274415|NCT00179712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110274416|NCT00179712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274417|NCT00179712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110274418|NCT00179712|Immunologic Factors|immunologic factors|mesh-ancestor
110274419|NCT00179712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110274420|NCT00179712|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110274421|NCT00179712|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110274422|NCT00179712|Growth Substances|growth substances|mesh-ancestor
110274423|NCT00179712|Growth Inhibitors|growth inhibitors|mesh-ancestor
110274424|NCT00611572|Flumazenil|flumazenil|mesh-list
110274425|NCT00611572|Antidotes|antidotes|mesh-ancestor
110274426|NCT00611572|Protective Agents|protective agents|mesh-ancestor
110274427|NCT00611572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110274428|NCT00611572|GABA Modulators|gaba modulators|mesh-ancestor
110274429|NCT00611572|GABA Agents|gaba agents|mesh-ancestor
110274430|NCT00611572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110274431|NCT00611572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274432|NCT00197340|Ropivacaine|ropivacaine|mesh-list
110274433|NCT00197340|Anesthetics, Local|anesthetics, local|mesh-ancestor
110274434|NCT00197340|Anesthetics|anesthetics|mesh-ancestor
110274435|NCT00197340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110274436|NCT00197340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110274437|NCT00197340|Sensory System Agents|sensory system agents|mesh-ancestor
110274438|NCT00197340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110274439|NCT00171587|Vatalanib|vatalanib|mesh-list
110274440|NCT00171587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110274441|NCT00171587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110274442|NCT00171587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274443|NCT05265052|Oxycodone|oxycodone|mesh-list
110274444|NCT05265052|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110274445|NCT05265052|Narcotics|narcotics|mesh-ancestor
110274446|NCT05265052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110274447|NCT05265052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110274448|NCT05265052|Analgesics|analgesics|mesh-ancestor
110274449|NCT05265052|Sensory System Agents|sensory system agents|mesh-ancestor
110274450|NCT05265052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110274451|NCT00171626|Diclofenac|diclofenac|mesh-list
110274452|NCT00171626|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110274453|NCT00171626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110274454|NCT00171626|Analgesics|analgesics|mesh-ancestor
110274455|NCT00171626|Sensory System Agents|sensory system agents|mesh-ancestor
110274456|NCT00171626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110274457|NCT00171626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110274458|NCT00171626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110274459|NCT00171626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110274460|NCT00171626|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110274461|NCT00171626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110275014|NCT00203112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110274462|NCT00171626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274464|NCT00171665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110274465|NCT00171665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110274466|NCT00171665|Analgesics|analgesics|mesh-ancestor
110274467|NCT00171665|Sensory System Agents|sensory system agents|mesh-ancestor
110274468|NCT00171665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110274469|NCT00171665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110274470|NCT00171665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110274471|NCT00171665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110274472|NCT00171665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110274473|NCT00171665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110274474|NCT00171665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274475|NCT00179751|Gemcitabine|gemcitabine|mesh-list
110274476|NCT00179751|Lenalidomide|lenalidomide|mesh-list
110274477|NCT00179751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110274478|NCT00179751|Antimetabolites|antimetabolites|mesh-ancestor
110274479|NCT00179751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274480|NCT00179751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110274481|NCT00179751|Immunologic Factors|immunologic factors|mesh-ancestor
110274482|NCT00179751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110274483|NCT00179751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110274484|NCT00179751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110274485|NCT00179751|Growth Substances|growth substances|mesh-ancestor
110274486|NCT00179751|Growth Inhibitors|growth inhibitors|mesh-ancestor
110274487|NCT00171743|Cyclosporine|cyclosporine|mesh-list
110274488|NCT00171743|Cyclosporins|cyclosporins|mesh-list
110274489|NCT00171743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110274490|NCT00171743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274491|NCT00171743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110274492|NCT00171743|Immunologic Factors|immunologic factors|mesh-ancestor
110274493|NCT00171743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110274494|NCT00171743|Antifungal Agents|antifungal agents|mesh-ancestor
110274495|NCT00171743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110274496|NCT00171743|Dermatologic Agents|dermatologic agents|mesh-ancestor
110274497|NCT00171743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110274498|NCT00171743|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110274500|NCT00171782|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110274501|NCT00171782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110274502|NCT00171782|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110274503|NCT00171782|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110274504|NCT00171782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274505|NCT00171782|Diuretics|diuretics|mesh-ancestor
110274506|NCT00171782|Natriuretic Agents|natriuretic agents|mesh-ancestor
110274507|NCT00171782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110274508|NCT00171782|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110274509|NCT00171782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110274510|NCT00197379|Roxithromycin|roxithromycin|mesh-list
110274511|NCT00197379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110274512|NCT00197379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110274514|NCT00197418|Metronidazole|metronidazole|mesh-list
110274515|NCT00197418|Clarithromycin|clarithromycin|mesh-list
110274516|NCT00197418|Rabeprazole|rabeprazole|mesh-list
110274517|NCT00197418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110274518|NCT00197418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110274519|NCT00197418|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110274520|NCT00197418|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110275030|NCT02057380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110274521|NCT00197418|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110274522|NCT00197418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110274523|NCT00197418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274524|NCT00197418|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110274525|NCT00197418|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110274526|NCT00197418|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110274527|NCT00197418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110274528|NCT00197418|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110274529|NCT00171821|Deferasirox|deferasirox|mesh-list
110274530|NCT00171821|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110274531|NCT00171821|Chelating Agents|chelating agents|mesh-ancestor
110274532|NCT00171821|Sequestering Agents|sequestering agents|mesh-ancestor
110274533|NCT00171821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274535|NCT05054023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110274536|NCT05054023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110274537|NCT05054023|Analgesics|analgesics|mesh-ancestor
110274538|NCT05054023|Sensory System Agents|sensory system agents|mesh-ancestor
110274539|NCT05054023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110274540|NCT05054023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110274541|NCT05054023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110274542|NCT05054023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110274543|NCT05054023|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110274544|NCT05054023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110274545|NCT05054023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274546|NCT00171860|Imatinib Mesylate|imatinib mesylate|mesh-list
110274547|NCT00171860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110274548|NCT00171860|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110274549|NCT00171860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110274550|NCT00171860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274551|NCT00553930|Interferons|interferons|mesh-list
110274552|NCT00553930|Ribavirin|ribavirin|mesh-list
110274553|NCT00553930|Interferon-alpha|interferon-alpha|mesh-list
110274554|NCT00553930|Interferon alpha-2|interferon alpha-2|mesh-list
110274555|NCT00553930|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110274556|NCT00553930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110274557|NCT00553930|Antiviral Agents|antiviral agents|mesh-ancestor
110274558|NCT00553930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110274559|NCT00553930|Antimetabolites|antimetabolites|mesh-ancestor
110274560|NCT00553930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274561|NCT00553930|Immunologic Factors|immunologic factors|mesh-ancestor
110274562|NCT00553930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110274563|NCT00171899|Imatinib Mesylate|imatinib mesylate|mesh-list
110274564|NCT00171899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110274565|NCT00171899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110274566|NCT00171899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110274567|NCT00171899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274570|NCT00171938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110274571|NCT00171938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110274572|NCT00171938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274573|NCT00171977|Imatinib Mesylate|imatinib mesylate|mesh-list
110274574|NCT00171977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110274575|NCT00171977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110274576|NCT00171977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110274577|NCT00171977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274578|NCT02240407|Acetaminophen|acetaminophen|mesh-list
110274580|NCT02240407|Promethazine|promethazine|mesh-list
110274581|NCT02240407|Sirolimus|sirolimus|mesh-list
110274582|NCT02240407|Rituximab|rituximab|mesh-list
110274583|NCT02240407|Lidocaine|lidocaine|mesh-list
110274584|NCT02240407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110274585|NCT02240407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110274586|NCT02240407|Immunologic Factors|immunologic factors|mesh-ancestor
110274587|NCT02240407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110274588|NCT02240407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110274589|NCT02240407|Anesthetics, Local|anesthetics, local|mesh-ancestor
110274590|NCT02240407|Anesthetics|anesthetics|mesh-ancestor
110274591|NCT02240407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110274592|NCT02240407|Sensory System Agents|sensory system agents|mesh-ancestor
110274593|NCT02240407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110274594|NCT02240407|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110274595|NCT02240407|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110274596|NCT02240407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110274597|NCT02240407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110274598|NCT02240407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274599|NCT02240407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110274600|NCT02240407|Analgesics|analgesics|mesh-ancestor
110274601|NCT02240407|Antipyretics|antipyretics|mesh-ancestor
110274602|NCT02240407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110274603|NCT02240407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110274604|NCT02240407|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110274605|NCT02240407|Antifungal Agents|antifungal agents|mesh-ancestor
110274606|NCT02240407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110274607|NCT02240407|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110274608|NCT02240407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110274609|NCT02240407|Antiemetics|antiemetics|mesh-ancestor
110274610|NCT02240407|Autonomic Agents|autonomic agents|mesh-ancestor
110274611|NCT02240407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110274612|NCT02240407|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110274613|NCT02240407|Histamine Antagonists|histamine antagonists|mesh-ancestor
110274614|NCT02240407|Histamine Agents|histamine agents|mesh-ancestor
110274615|NCT02240407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110274616|NCT02240407|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110274617|NCT02240407|Antipruritics|antipruritics|mesh-ancestor
110274618|NCT02240407|Dermatologic Agents|dermatologic agents|mesh-ancestor
110274619|NCT00172016|Zoledronic Acid|zoledronic acid|mesh-list
110274620|NCT00172016|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110274621|NCT00172016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110274622|NCT04958122|Penicillins|penicillins|mesh-list
110274624|NCT04958122|Penicillin G Benzathine|penicillin g benzathine|mesh-list
110274625|NCT04958122|Penicillin G|penicillin g|mesh-list
110274626|NCT04958122|Penicillin G Procaine|penicillin g procaine|mesh-list
110274627|NCT04958122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110274628|NCT04958122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110274629|NCT00197613|Lamivudine|lamivudine|mesh-list
110274630|NCT00197613|Zidovudine|zidovudine|mesh-list
110274631|NCT00197613|Efavirenz|efavirenz|mesh-list
110274632|NCT00197613|Nevirapine|nevirapine|mesh-list
110274633|NCT00197613|Stavudine|stavudine|mesh-list
110274634|NCT00197613|Didanosine|didanosine|mesh-list
110274635|NCT00197613|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110274636|NCT00197613|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110274637|NCT00197613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110274638|NCT00197613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274639|NCT00197613|Antiviral Agents|antiviral agents|mesh-ancestor
110274640|NCT00197613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110274641|NCT00197613|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110274642|NCT00197613|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110274644|NCT00197613|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110274645|NCT00197613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110274646|NCT00197613|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110274647|NCT00197613|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110274648|NCT00197613|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110274649|NCT00197613|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110274650|NCT00180024|Irbesartan|irbesartan|mesh-list
110274651|NCT00180024|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110274652|NCT00180024|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110274653|NCT00180024|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110274654|NCT00180024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274655|NCT00172055|Zoledronic Acid|zoledronic acid|mesh-list
110274656|NCT00172055|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110274657|NCT00172055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110274658|NCT04934449|Salicylic Acid|salicylic acid|mesh-list
110274659|NCT04934449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110274660|NCT04934449|Antifungal Agents|antifungal agents|mesh-ancestor
110274661|NCT04934449|Keratolytic Agents|keratolytic agents|mesh-ancestor
110274662|NCT04934449|Dermatologic Agents|dermatologic agents|mesh-ancestor
110274663|NCT03455179|Methamphetamine|methamphetamine|mesh-list
110274664|NCT03455179|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110274665|NCT03455179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110274666|NCT03455179|Sympathomimetics|sympathomimetics|mesh-ancestor
110274667|NCT03455179|Autonomic Agents|autonomic agents|mesh-ancestor
110274668|NCT03455179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110274669|NCT03455179|Dopamine Agents|dopamine agents|mesh-ancestor
110274670|NCT03455179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110274671|NCT03455179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274672|NCT03455179|Adrenergic Agents|adrenergic agents|mesh-ancestor
110274673|NCT03455179|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110274674|NCT03455179|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110274675|NCT03455179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110274676|NCT03455179|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110274678|NCT00202293|Chlorpromazine|chlorpromazine|mesh-list
110274679|NCT00202293|Antiemetics|antiemetics|mesh-ancestor
110274680|NCT00202293|Autonomic Agents|autonomic agents|mesh-ancestor
110274681|NCT00202293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110274682|NCT00202293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110274683|NCT00202293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110274684|NCT00202293|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110274685|NCT00202293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110274686|NCT00202293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110274687|NCT00202293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110274688|NCT00202293|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110274689|NCT00202293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110274690|NCT00202293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110274691|NCT00202293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274692|NCT00202293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110274694|NCT00202293|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110274695|NCT00202293|Dopamine Agents|dopamine agents|mesh-ancestor
110274696|NCT00197730|Folic Acid|folic acid|mesh-list
110274697|NCT00197730|Vitamin B Complex|vitamin b complex|mesh-list
110274698|NCT00197730|Vitamins|vitamins|mesh-ancestor
110274699|NCT00197730|Micronutrients|micronutrients|mesh-ancestor
110274700|NCT00197730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110274702|NCT00172172|Calcium|calcium|mesh-list
110274703|NCT00172172|Parathyroid Hormone|parathyroid hormone|mesh-list
110274704|NCT00172172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110274705|NCT00172172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110274706|NCT02908711|Ropivacaine|ropivacaine|mesh-list
110274707|NCT02908711|Anesthetics, Local|anesthetics, local|mesh-ancestor
110274708|NCT02908711|Anesthetics|anesthetics|mesh-ancestor
110274709|NCT02908711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110274710|NCT02908711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110274711|NCT02908711|Sensory System Agents|sensory system agents|mesh-ancestor
110274712|NCT02908711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110274713|NCT04681846|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110274714|NCT04681846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110274715|NCT02908438|Hormones|hormones|mesh-list
110274716|NCT02908438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110274717|NCT02908438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110274718|NCT00172367|Lycopene|lycopene|mesh-list
110274719|NCT00172367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110274720|NCT00172367|Antioxidants|antioxidants|mesh-ancestor
110274721|NCT00172367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274722|NCT00172367|Protective Agents|protective agents|mesh-ancestor
110274723|NCT00172367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110274724|NCT00172367|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110274725|NCT00172367|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110274726|NCT00172367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110274727|NCT04632316|Cyclophosphamide|cyclophosphamide|mesh-list
110274728|NCT04632316|Fludarabine|fludarabine|mesh-list
110274729|NCT04632316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110274730|NCT04632316|Immunologic Factors|immunologic factors|mesh-ancestor
110274731|NCT04632316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110274732|NCT04632316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110274733|NCT04632316|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110274734|NCT04632316|Alkylating Agents|alkylating agents|mesh-ancestor
110274735|NCT04632316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274736|NCT04632316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110274737|NCT04632316|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110274738|NCT00197886|Norepinephrine|norepinephrine|mesh-list
110274739|NCT00197886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110274740|NCT00197886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110274741|NCT00197886|Adrenergic Agents|adrenergic agents|mesh-ancestor
110274742|NCT00197886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110274743|NCT00197886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274744|NCT00197886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110274745|NCT00197886|Sympathomimetics|sympathomimetics|mesh-ancestor
110274746|NCT00197886|Autonomic Agents|autonomic agents|mesh-ancestor
110274747|NCT00197886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110274748|NCT00197886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110274749|NCT02908165|Sorafenib|sorafenib|mesh-list
110274750|NCT02908165|Chlorotrianisene|chlorotrianisene|mesh-list
110274751|NCT02908165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110274752|NCT02908165|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110274753|NCT02908165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110274754|NCT02908165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274755|NCT02908165|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110274756|NCT02908165|Estrogens|estrogens|mesh-ancestor
110274757|NCT02908165|Hormones|hormones|mesh-ancestor
110274758|NCT02908165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110274759|NCT02908165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110274760|NCT02908165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110274762|NCT04534270|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110274763|NCT04534270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274764|NCT04534270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110274765|NCT04534270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110274766|NCT02908282|Povidone|povidone|mesh-list
110274767|NCT02908282|Plasma Substitutes|plasma substitutes|mesh-ancestor
110274768|NCT02908282|Blood Substitutes|blood substitutes|mesh-ancestor
110274769|NCT02908126|Oxytocin|oxytocin|mesh-list
110274770|NCT02908126|Oxytocics|oxytocics|mesh-ancestor
110274771|NCT02908126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110274772|NCT02908126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110274773|NCT00202605|Amphetamine|amphetamine|mesh-list
110274774|NCT00202605|Dextroamphetamine|dextroamphetamine|mesh-list
110274775|NCT00202605|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110274776|NCT00202605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110274777|NCT00202605|Sympathomimetics|sympathomimetics|mesh-ancestor
110274778|NCT00202605|Autonomic Agents|autonomic agents|mesh-ancestor
110274779|NCT00202605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110274780|NCT00202605|Dopamine Agents|dopamine agents|mesh-ancestor
110274781|NCT00202605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110274782|NCT00202605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274783|NCT00202605|Adrenergic Agents|adrenergic agents|mesh-ancestor
110274784|NCT00202605|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110274785|NCT00202605|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110274786|NCT00202605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110274787|NCT00202605|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110274788|NCT00198120|Cycloserine|cycloserine|mesh-list
110274789|NCT00198120|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110274790|NCT00198120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110274791|NCT00198120|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110274792|NCT00198120|Antitubercular Agents|antitubercular agents|mesh-ancestor
110274793|NCT00198120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110274795|NCT00198120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274796|NCT00198159|Gefitinib|gefitinib|mesh-list
110274797|NCT00198159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110274798|NCT00198159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110274799|NCT00198159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110274800|NCT00198159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274801|NCT02907307|Clotrimazole|clotrimazole|mesh-list
110274803|NCT02907307|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110274805|NCT02907307|Antifungal Agents|antifungal agents|mesh-ancestor
110274806|NCT02907307|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110274807|NCT02907307|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110274808|NCT02907307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110274809|NCT02907307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274810|NCT02907307|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110274811|NCT02907307|Hormone Antagonists|hormone antagonists|mesh-ancestor
110274812|NCT02907307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110274813|NCT02907307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110274814|NCT02907307|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110274815|NCT02907307|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110274816|NCT00553345|Vitamin E|vitamin e|mesh-list
110274817|NCT00553345|Selenium|selenium|mesh-list
110274818|NCT00553345|Vitamins|vitamins|mesh-ancestor
110274819|NCT00553345|Micronutrients|micronutrients|mesh-ancestor
110274820|NCT00553345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110274821|NCT00553345|Antioxidants|antioxidants|mesh-ancestor
110274822|NCT00553345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274823|NCT00553345|Protective Agents|protective agents|mesh-ancestor
110274824|NCT00553345|Trace Elements|trace elements|mesh-ancestor
110274825|NCT00407771|Tirofiban|tirofiban|mesh-list
110274826|NCT00407771|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110274827|NCT00407771|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110274828|NCT00407771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274829|NCT00407771|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110274830|NCT00198198|Aripiprazole|aripiprazole|mesh-list
110274831|NCT00198198|Antidepressive Agents|antidepressive agents|mesh-ancestor
110274832|NCT00198198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110274833|NCT00198198|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110274834|NCT00198198|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110274835|NCT00198198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110274836|NCT00198198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110274837|NCT00198198|Dopamine Agonists|dopamine agonists|mesh-ancestor
110274838|NCT00198198|Dopamine Agents|dopamine agents|mesh-ancestor
110274839|NCT00198198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110274840|NCT00198198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274841|NCT00198198|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110274842|NCT00198198|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110274843|NCT00198198|Serotonin Agents|serotonin agents|mesh-ancestor
110274844|NCT00198198|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110274845|NCT00198198|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110274846|NCT00198198|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110274847|NCT00198198|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110274848|NCT02206087|Heparin|heparin|mesh-list
110274849|NCT02206087|Calcium heparin|calcium heparin|mesh-list
110274850|NCT02206087|Anticoagulants|anticoagulants|mesh-ancestor
110274851|NCT02206087|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110274852|NCT02206087|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110274853|NCT02206087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274854|NCT00198237|Docetaxel|docetaxel|mesh-list
110274855|NCT00198237|Capecitabine|capecitabine|mesh-list
110274856|NCT00198237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110274857|NCT00198237|Tubulin Modulators|tubulin modulators|mesh-ancestor
110274858|NCT00198237|Antimitotic Agents|antimitotic agents|mesh-ancestor
110274859|NCT00198237|Mitosis Modulators|mitosis modulators|mesh-ancestor
110274860|NCT00198237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275145|NCT00410553|Antimetabolites|antimetabolites|mesh-ancestor
110274861|NCT00198237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110274863|NCT00198354|Paclitaxel|paclitaxel|mesh-list
110274864|NCT00198354|Gemcitabine|gemcitabine|mesh-list
110274865|NCT00198354|Carboplatin|carboplatin|mesh-list
110274866|NCT00198354|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110274867|NCT00198354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110274868|NCT00198354|Tubulin Modulators|tubulin modulators|mesh-ancestor
110274869|NCT00198354|Antimitotic Agents|antimitotic agents|mesh-ancestor
110274870|NCT00198354|Mitosis Modulators|mitosis modulators|mesh-ancestor
110274871|NCT00198354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274872|NCT00198354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110274873|NCT00198354|Antimetabolites|antimetabolites|mesh-ancestor
110274874|NCT02158585|Lamotrigine|lamotrigine|mesh-list
110274875|NCT02158585|Anticonvulsants|anticonvulsants|mesh-ancestor
110274876|NCT02158585|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110274877|NCT02158585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110274878|NCT02158585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274879|NCT02158585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110274880|NCT02158585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110274881|NCT02158585|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110274882|NCT02158585|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110274883|NCT02158585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110274884|NCT02158585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110274885|NCT02158585|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110274887|NCT00202917|Melphalan|melphalan|mesh-list
110274888|NCT00202917|Thiotepa|thiotepa|mesh-list
110274889|NCT00202917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110274890|NCT00202917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274891|NCT00202917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110274892|NCT00202917|Immunologic Factors|immunologic factors|mesh-ancestor
110274893|NCT00202917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110274894|NCT00202917|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110274895|NCT00202917|Alkylating Agents|alkylating agents|mesh-ancestor
110274896|NCT00202917|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110274897|NCT00202995|Glatiramer Acetate|glatiramer acetate|mesh-list
110274898|NCT00202995|Interferon beta-1b|interferon beta-1b|mesh-list
110274899|NCT00202995|(T,G)-A-L|(t,g)-a-l|mesh-list
110274900|NCT00202995|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110274901|NCT00202995|Immunologic Factors|immunologic factors|mesh-ancestor
110274902|NCT00202995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110274903|NCT00202995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110274905|NCT04677868|Methotrexate|methotrexate|mesh-list
110274906|NCT04677868|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110274907|NCT04677868|Abortifacient Agents|abortifacient agents|mesh-ancestor
110274908|NCT04677868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110274909|NCT04677868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110274910|NCT04677868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110274911|NCT04677868|Antimetabolites|antimetabolites|mesh-ancestor
110274912|NCT04677868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274913|NCT04677868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110274914|NCT04677868|Dermatologic Agents|dermatologic agents|mesh-ancestor
110274915|NCT04677868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110274916|NCT04677868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110274917|NCT04677868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110274918|NCT04677868|Immunologic Factors|immunologic factors|mesh-ancestor
110274919|NCT04677868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110274920|NCT04677868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110274922|NCT00198393|Docetaxel|docetaxel|mesh-list
110274923|NCT00198393|Gefitinib|gefitinib|mesh-list
110274924|NCT00198393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110274926|NCT00198393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274927|NCT00198393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110274928|NCT00198393|Tubulin Modulators|tubulin modulators|mesh-ancestor
110274929|NCT00198393|Antimitotic Agents|antimitotic agents|mesh-ancestor
110274930|NCT00198393|Mitosis Modulators|mitosis modulators|mesh-ancestor
110274931|NCT00198393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110274932|NCT00198393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110274933|NCT02103322|Imatinib Mesylate|imatinib mesylate|mesh-list
110274934|NCT02103322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110274935|NCT02103322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110274936|NCT02103322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110274937|NCT02103322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274938|NCT00554827|Vitamins|vitamins|mesh-list
110274939|NCT00554827|Folic Acid|folic acid|mesh-list
110274940|NCT00554827|Vitamin B 12|vitamin b 12|mesh-list
110274941|NCT00554827|Vitamin B Complex|vitamin b complex|mesh-list
110274942|NCT00554827|10-deazaaminopterin|10-deazaaminopterin|mesh-list
110274943|NCT00554827|Aminopterin|aminopterin|mesh-list
110274944|NCT00554827|Micronutrients|micronutrients|mesh-ancestor
110274945|NCT00554827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110274946|NCT00554827|Hematinics|hematinics|mesh-ancestor
110274947|NCT00554827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110274948|NCT00554827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110274949|NCT00554827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274950|NCT00554827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110274951|NCT00203034|Rasagiline|rasagiline|mesh-list
110274952|NCT00203034|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110274953|NCT00203034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110274954|NCT00203034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274955|NCT00203034|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110274956|NCT00203034|Protective Agents|protective agents|mesh-ancestor
110274957|NCT00203034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110274958|NCT00203073|Mitoxantrone|mitoxantrone|mesh-list
110274959|NCT00203073|Glatiramer Acetate|glatiramer acetate|mesh-list
110274960|NCT00203073|(T,G)-A-L|(t,g)-a-l|mesh-list
110274961|NCT00203073|Analgesics|analgesics|mesh-ancestor
110274962|NCT00203073|Sensory System Agents|sensory system agents|mesh-ancestor
110274963|NCT00203073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110274964|NCT00203073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110274965|NCT00203073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110274966|NCT00203073|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110274967|NCT00203073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110274968|NCT00203073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110274969|NCT00203073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274970|NCT00203073|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110274971|NCT00203073|Immunologic Factors|immunologic factors|mesh-ancestor
110274972|NCT00203073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110274973|NCT00203073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110274975|NCT00198432|Vinorelbine|vinorelbine|mesh-list
110274976|NCT00198432|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110274977|NCT00198432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110274979|NCT00198432|Antimitotic Agents|antimitotic agents|mesh-ancestor
110274980|NCT00198432|Mitosis Modulators|mitosis modulators|mesh-ancestor
110274981|NCT00198432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274982|NCT02072863|Prednisone|prednisone|mesh-list
110274983|NCT02072863|Melphalan|melphalan|mesh-list
110274984|NCT02072863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110274985|NCT02072863|Glucocorticoids|glucocorticoids|mesh-ancestor
110274986|NCT02072863|Hormones|hormones|mesh-ancestor
110274987|NCT02072863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110274988|NCT02072863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110274989|NCT02072863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110274990|NCT02072863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110274991|NCT02072863|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110274992|NCT02072863|Alkylating Agents|alkylating agents|mesh-ancestor
110274993|NCT02072863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274994|NCT02072863|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110274995|NCT02072863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110274997|NCT02072161|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
110274998|NCT02072161|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110274999|NCT02072161|Antimetabolites|antimetabolites|mesh-ancestor
110275000|NCT02072161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275001|NCT02072161|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110275002|NCT02072161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110275003|NCT02072161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110275004|NCT02072161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110275005|NCT00203112|Minocycline|minocycline|mesh-list
110275006|NCT00203112|Glatiramer Acetate|glatiramer acetate|mesh-list
110275007|NCT00203112|(T,G)-A-L|(t,g)-a-l|mesh-list
110275008|NCT00203112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110275009|NCT00203112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110275010|NCT00203112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110275011|NCT00203112|Immunologic Factors|immunologic factors|mesh-ancestor
110275012|NCT00203112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110275013|NCT00203112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110275015|NCT02057380|Dexamethasone|dexamethasone|mesh-list
110275016|NCT02057380|Paclitaxel|paclitaxel|mesh-list
110275017|NCT02057380|Bortezomib|bortezomib|mesh-list
110275018|NCT02057380|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110275019|NCT02057380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110275020|NCT02057380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110275021|NCT02057380|Tubulin Modulators|tubulin modulators|mesh-ancestor
110275022|NCT02057380|Antimitotic Agents|antimitotic agents|mesh-ancestor
110275023|NCT02057380|Mitosis Modulators|mitosis modulators|mesh-ancestor
110275024|NCT02057380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275025|NCT02057380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110275026|NCT02057380|Antiemetics|antiemetics|mesh-ancestor
110275027|NCT02057380|Autonomic Agents|autonomic agents|mesh-ancestor
110275028|NCT02057380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110275029|NCT02057380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110275031|NCT02057380|Glucocorticoids|glucocorticoids|mesh-ancestor
110275032|NCT02057380|Hormones|hormones|mesh-ancestor
110275033|NCT02057380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110275034|NCT02057380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110275035|NCT02057380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110275036|NCT02057380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110275037|NCT02052778|Futibatinib|futibatinib|mesh-list
110275038|NCT02052778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110275039|NCT02050828|Ranibizumab|ranibizumab|mesh-list
110275040|NCT02050828|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110275041|NCT02050828|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110275042|NCT02050828|Growth Substances|growth substances|mesh-ancestor
110275043|NCT02050828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110275044|NCT02050828|Growth Inhibitors|growth inhibitors|mesh-ancestor
110275045|NCT02050828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110275046|NCT02046694|Allopurinol|allopurinol|mesh-list
110275047|NCT02046694|Antimetabolites|antimetabolites|mesh-ancestor
110275048|NCT02046694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275049|NCT02046694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110275050|NCT02046694|Gout Suppressants|gout suppressants|mesh-ancestor
110275051|NCT02046694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110275052|NCT02046694|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110275053|NCT02046694|Antioxidants|antioxidants|mesh-ancestor
110275054|NCT02046694|Protective Agents|protective agents|mesh-ancestor
110275055|NCT02046694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110275056|NCT00203190|Topiramate|topiramate|mesh-list
110275057|NCT00203190|Anticonvulsants|anticonvulsants|mesh-ancestor
110275058|NCT00203190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110275059|NCT00203190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110275060|NCT02019589|Progesterone|progesterone|mesh-list
110275061|NCT02019589|Progestins|progestins|mesh-ancestor
110275062|NCT02019589|Hormones|hormones|mesh-ancestor
110275063|NCT02019589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110275064|NCT02019589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110275065|NCT02018926|Azacitidine|azacitidine|mesh-list
110275066|NCT02018926|Mocetinostat|mocetinostat|mesh-list
110275067|NCT02018926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110275068|NCT02018926|Antimetabolites|antimetabolites|mesh-ancestor
110275069|NCT02018926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275070|NCT02018926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110275071|NCT02018926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110275072|NCT02018926|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110275073|NCT01989325|Dexamethasone|dexamethasone|mesh-list
110275074|NCT01989325|Filanesib|filanesib|mesh-list
110275075|NCT01989325|Lenograstim|lenograstim|mesh-list
110275076|NCT01989325|Proteasome Inhibitors|proteasome inhibitors|mesh-list
110275077|NCT01989325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110275078|NCT01989325|Antiemetics|antiemetics|mesh-ancestor
110275079|NCT01989325|Autonomic Agents|autonomic agents|mesh-ancestor
110275080|NCT01989325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110275081|NCT01989325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110275082|NCT01989325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110275083|NCT01989325|Glucocorticoids|glucocorticoids|mesh-ancestor
110275084|NCT01989325|Hormones|hormones|mesh-ancestor
110275085|NCT01989325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110275086|NCT01989325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110275087|NCT01989325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110275088|NCT01989325|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110275089|NCT01989325|Immunologic Factors|immunologic factors|mesh-ancestor
110275090|NCT01989325|Protease Inhibitors|protease inhibitors|mesh-ancestor
110275091|NCT01989325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110275092|NCT01989325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275093|NCT01989325|Antimitotic Agents|antimitotic agents|mesh-ancestor
110275094|NCT01989325|Mitosis Modulators|mitosis modulators|mesh-ancestor
110275095|NCT01978366|Halofuginone|halofuginone|mesh-list
110275096|NCT01978366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110275097|NCT01978366|Coccidiostats|coccidiostats|mesh-ancestor
110275098|NCT01978366|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110275099|NCT01978366|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110275100|NCT01978366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110275101|NCT01978366|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110275102|NCT01978366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110275103|NCT01978366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275104|NCT01978366|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110275105|NCT01978366|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110275106|NCT01978366|Growth Substances|growth substances|mesh-ancestor
110275107|NCT01978366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110275108|NCT01978366|Growth Inhibitors|growth inhibitors|mesh-ancestor
110275109|NCT02962986|Phenylephrine|phenylephrine|mesh-list
110275110|NCT02962986|Oxymetazoline|oxymetazoline|mesh-list
110275111|NCT02962986|Norepinephrine|norepinephrine|mesh-list
110275112|NCT02962986|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110275113|NCT02962986|Mydriatics|mydriatics|mesh-ancestor
110275114|NCT02962986|Autonomic Agents|autonomic agents|mesh-ancestor
110275115|NCT02962986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110275116|NCT02962986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110275117|NCT02962986|Sympathomimetics|sympathomimetics|mesh-ancestor
110275118|NCT02962986|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110275119|NCT02962986|Nasal Decongestants|nasal decongestants|mesh-ancestor
110275120|NCT02962986|Respiratory System Agents|respiratory system agents|mesh-ancestor
110275121|NCT02962986|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110275122|NCT02962986|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110275123|NCT02962986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110275124|NCT02962986|Adrenergic Agents|adrenergic agents|mesh-ancestor
110275125|NCT02962986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110275126|NCT02962986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275127|NCT02962986|Protective Agents|protective agents|mesh-ancestor
110275128|NCT04677361|Pembrolizumab|pembrolizumab|mesh-list
110275129|NCT04677361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110275130|NCT04677361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110275131|NCT04677361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110275132|NCT04677361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275133|NCT01968733|Moxifloxacin|moxifloxacin|mesh-list
110275134|NCT01968733|Solithromycin|solithromycin|mesh-list
110275135|NCT01968733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110275136|NCT01968733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110275137|NCT01968733|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110275138|NCT01968733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110275139|NCT01968733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110275140|NCT01968733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275141|NCT01968733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110275142|NCT00410553|Gemcitabine|gemcitabine|mesh-list
110275143|NCT00410553|Halichondrin B|halichondrin b|mesh-list
110275144|NCT00410553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110275146|NCT00410553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275147|NCT00410553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110275148|NCT00410553|Tubulin Modulators|tubulin modulators|mesh-ancestor
110275149|NCT00410553|Antimitotic Agents|antimitotic agents|mesh-ancestor
110275150|NCT00410553|Mitosis Modulators|mitosis modulators|mesh-ancestor
110275151|NCT00410592|Esomeprazole|esomeprazole|mesh-list
110275152|NCT00410592|Pantoprazole|pantoprazole|mesh-list
110275153|NCT00410592|Lansoprazole|lansoprazole|mesh-list
110275154|NCT00410592|Dexlansoprazole|dexlansoprazole|mesh-list
110275155|NCT00410592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110275156|NCT00410592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110275157|NCT00410592|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110275158|NCT00410592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110275159|NCT00410592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275160|NCT00410631|Cyclophosphamide|cyclophosphamide|mesh-list
110275161|NCT00410631|Melphalan|melphalan|mesh-list
110275162|NCT00410631|Ifosfamide|ifosfamide|mesh-list
110275163|NCT00410631|Dacarbazine|dacarbazine|mesh-list
110275164|NCT00410631|Carboplatin|carboplatin|mesh-list
110275165|NCT00410631|Doxorubicin|doxorubicin|mesh-list
110275166|NCT00410631|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110275167|NCT00410631|Etoposide|etoposide|mesh-list
110275168|NCT00410631|Vincristine|vincristine|mesh-list
110275169|NCT00410631|Topotecan|topotecan|mesh-list
110275170|NCT00410631|Etoposide phosphate|etoposide phosphate|mesh-list
110275171|NCT00410631|Vindesine|vindesine|mesh-list
110275172|NCT00410631|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
110275173|NCT00410631|Isotretinoin|isotretinoin|mesh-list
110275174|NCT00410631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110275175|NCT00410631|Immunologic Factors|immunologic factors|mesh-ancestor
110275176|NCT00410631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110275177|NCT00410631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110275178|NCT00410631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110275179|NCT00410631|Alkylating Agents|alkylating agents|mesh-ancestor
110275180|NCT00410631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275181|NCT00410631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110275182|NCT00410631|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110275183|NCT00410631|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110275184|NCT00410631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110275185|NCT00410631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110275186|NCT00410631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110275187|NCT00410631|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110275188|NCT00410631|Tubulin Modulators|tubulin modulators|mesh-ancestor
110275189|NCT00410631|Antimitotic Agents|antimitotic agents|mesh-ancestor
110275190|NCT00410631|Mitosis Modulators|mitosis modulators|mesh-ancestor
110275191|NCT00410631|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110275192|NCT00410631|Dermatologic Agents|dermatologic agents|mesh-ancestor
110275193|NCT00410631|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110275195|NCT01930357|Immunologic Factors|immunologic factors|mesh-ancestor
110275196|NCT01930357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110275197|NCT01913158|Hydrocortisone|hydrocortisone|mesh-list
110275198|NCT01913158|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110275199|NCT01913158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110275200|NCT01903954|Ribavirin|ribavirin|mesh-list
110275201|NCT01903954|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110275202|NCT01903954|Antimetabolites|antimetabolites|mesh-ancestor
110275203|NCT01903954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275204|NCT01903954|Antiviral Agents|antiviral agents|mesh-ancestor
110275205|NCT01903954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110275206|NCT01893190|Nimodipine|nimodipine|mesh-list
110275207|NCT01893190|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110275233|NCT01874626|Analgesics|analgesics|mesh-ancestor
110275208|NCT01893190|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110275209|NCT01893190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110275210|NCT01893190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275211|NCT01893190|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110275212|NCT01893190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110275213|NCT01893190|Vasodilator Agents|vasodilator agents|mesh-ancestor
110275214|NCT00198588|Argatroban|argatroban|mesh-list
110275215|NCT00198588|Antithrombins|antithrombins|mesh-ancestor
110275216|NCT00198588|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110275217|NCT00198588|Protease Inhibitors|protease inhibitors|mesh-ancestor
110275218|NCT00198588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110275219|NCT00198588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275220|NCT00198588|Anticoagulants|anticoagulants|mesh-ancestor
110275221|NCT00198588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110275222|NCT01887886|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110275223|NCT01887886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110275224|NCT01887886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110275225|NCT01887886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110275226|NCT01887886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275227|NCT01877395|Vaccines|vaccines|mesh-list
110275228|NCT01877395|Immunologic Factors|immunologic factors|mesh-ancestor
110275229|NCT01877395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110275230|NCT01874626|Ibuprofen|ibuprofen|mesh-list
110275234|NCT01874626|Sensory System Agents|sensory system agents|mesh-ancestor
110275235|NCT01874626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110275236|NCT01874626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110275237|NCT01874626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110275239|NCT01874626|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110275240|NCT01874626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110275241|NCT01874626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275243|NCT00410748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110275244|NCT00410748|Narcotics|narcotics|mesh-ancestor
110275245|NCT00410748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110275246|NCT00410748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110275247|NCT00410748|Analgesics|analgesics|mesh-ancestor
110275248|NCT00410748|Sensory System Agents|sensory system agents|mesh-ancestor
110275249|NCT00410748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110275250|NCT00198627|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110275251|NCT00198627|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110275252|NCT00198627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110275253|NCT00198627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110275254|NCT00198627|Antimalarials|antimalarials|mesh-ancestor
110275255|NCT00198627|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110275256|NCT00198627|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110275257|NCT01862224|Methotrexate|methotrexate|mesh-list
110275258|NCT01862224|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110275259|NCT01862224|Abortifacient Agents|abortifacient agents|mesh-ancestor
110275260|NCT01862224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110275261|NCT01862224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110275262|NCT01862224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110275263|NCT01862224|Antimetabolites|antimetabolites|mesh-ancestor
110275264|NCT01862224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275265|NCT01862224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110275266|NCT01862224|Dermatologic Agents|dermatologic agents|mesh-ancestor
110278334|NCT00180908|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110278335|NCT00180908|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110278336|NCT00180908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110278338|NCT00580450|Thymalfasin|thymalfasin|mesh-list
110278339|NCT00580450|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110278340|NCT00580450|Immunologic Factors|immunologic factors|mesh-ancestor
110278341|NCT00580450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110278358|NCT00581425|Immunologic Factors|immunologic factors|mesh-ancestor
110278359|NCT00581425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110278360|NCT00581425|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110278361|NCT00581425|Interferon Inducers|interferon inducers|mesh-ancestor
110278363|NCT00209079|Imatinib Mesylate|imatinib mesylate|mesh-list
110278364|NCT00209079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110278365|NCT00209079|Tubulin Modulators|tubulin modulators|mesh-ancestor
110278366|NCT00209079|Antimitotic Agents|antimitotic agents|mesh-ancestor
110278367|NCT00209079|Mitosis Modulators|mitosis modulators|mesh-ancestor
110278368|NCT00209079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110278369|NCT00209079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110278370|NCT00209079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110278371|NCT04576975|Dexmedetomidine|dexmedetomidine|mesh-list
110278372|NCT04576975|Ketamine|ketamine|mesh-list
110278373|NCT04576975|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110278374|NCT04576975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110278375|NCT04576975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110278376|NCT04576975|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110278377|NCT04576975|Analgesics|analgesics|mesh-ancestor
110278378|NCT04576975|Sensory System Agents|sensory system agents|mesh-ancestor
110278379|NCT04576975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110278380|NCT04576975|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110275275|NCT01859962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275276|NCT01859962|Antiviral Agents|antiviral agents|mesh-ancestor
110275277|NCT01859962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110275278|NCT00173888|Cisplatin|cisplatin|mesh-list
110278381|NCT04576975|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110278382|NCT04576975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110278383|NCT04576975|Adrenergic Agents|adrenergic agents|mesh-ancestor
110278384|NCT04576975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110280917|NCT00220350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110280919|NCT00190307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110280920|NCT00190307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110280921|NCT00190307|Analgesics|analgesics|mesh-ancestor
110280922|NCT00190307|Sensory System Agents|sensory system agents|mesh-ancestor
110280923|NCT00190307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110281409|NCT00221481|GABA Agents|gaba agents|mesh-ancestor
110281410|NCT00221481|Antimanic Agents|antimanic agents|mesh-ancestor
110281411|NCT00191633|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110281412|NCT00191633|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110275300|NCT00555022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275301|NCT00555022|Anticonvulsants|anticonvulsants|mesh-ancestor
110275302|NCT00203385|Valproic Acid|valproic acid|mesh-list
110275303|NCT00203385|Anticonvulsants|anticonvulsants|mesh-ancestor
110275304|NCT00203385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110275305|NCT00203385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275306|NCT00203385|GABA Agents|gaba agents|mesh-ancestor
110275307|NCT00203385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110275308|NCT00203385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110275309|NCT00203385|Antimanic Agents|antimanic agents|mesh-ancestor
110275310|NCT00203385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110275311|NCT00203385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110275312|NCT00203385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110275313|NCT00555100|Dexamethasone|dexamethasone|mesh-list
110275314|NCT00555100|Lenalidomide|lenalidomide|mesh-list
110275315|NCT00555100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110275316|NCT00555100|Antiemetics|antiemetics|mesh-ancestor
110275317|NCT00555100|Autonomic Agents|autonomic agents|mesh-ancestor
110275318|NCT00555100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110275319|NCT00555100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281413|NCT00191633|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110281414|NCT00191633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110281415|NCT00191633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281416|NCT00191633|Adrenergic Agents|adrenergic agents|mesh-ancestor
110281417|NCT00191633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110281418|NCT00191633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281419|NCT00221520|Midazolam|midazolam|mesh-list
110281420|NCT00221520|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110281421|NCT00221520|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110281422|NCT00221520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110281423|NCT00221520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281424|NCT00221520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110281425|NCT00221520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110281426|NCT00221520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110281427|NCT00221520|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110281428|NCT00221520|Anesthetics, General|anesthetics, general|mesh-ancestor
110281429|NCT00221520|Anesthetics|anesthetics|mesh-ancestor
110281430|NCT00221520|GABA Modulators|gaba modulators|mesh-ancestor
110281432|NCT00221520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110281433|NCT00221520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281434|NCT00191672|Paclitaxel|paclitaxel|mesh-list
110281435|NCT00191672|Docetaxel|docetaxel|mesh-list
110281436|NCT00191672|Gemcitabine|gemcitabine|mesh-list
110281437|NCT00191672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110281438|NCT00191672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110281439|NCT00191672|Tubulin Modulators|tubulin modulators|mesh-ancestor
110281440|NCT00191672|Antimitotic Agents|antimitotic agents|mesh-ancestor
110281442|NCT00191672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281443|NCT00191672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110281446|NCT00214578|Antidepressive Agents|antidepressive agents|mesh-ancestor
110281447|NCT00214578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110281448|NCT00214578|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110275322|NCT00555100|Hormones|hormones|mesh-ancestor
110275323|NCT00555100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110275324|NCT00555100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110275325|NCT00555100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110275326|NCT00555100|Immunologic Factors|immunologic factors|mesh-ancestor
110275327|NCT00555100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110281449|NCT00214578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110281450|NCT00214578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110281451|NCT00214578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281452|NCT00191711|Gemcitabine|gemcitabine|mesh-list
110281453|NCT00191711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110281454|NCT00191711|Antimetabolites|antimetabolites|mesh-ancestor
110281455|NCT00191711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281456|NCT00191711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110281457|NCT00221637|Valproic Acid|valproic acid|mesh-list
110281458|NCT00221637|Anticonvulsants|anticonvulsants|mesh-ancestor
110281459|NCT00221637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110281460|NCT00221637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281461|NCT00221637|GABA Agents|gaba agents|mesh-ancestor
110281462|NCT00221637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110281463|NCT00221637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281464|NCT00221637|Antimanic Agents|antimanic agents|mesh-ancestor
110281465|NCT00221637|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110281466|NCT00221637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110281467|NCT00221637|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110281468|NCT00123656|Fluticasone|fluticasone|mesh-list
110281469|NCT00123656|Esomeprazole|esomeprazole|mesh-list
110281470|NCT00123656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110281471|NCT00123656|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110281472|NCT00123656|Autonomic Agents|autonomic agents|mesh-ancestor
110281473|NCT00123656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110281479|NCT00123656|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110281480|NCT00123656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110281481|NCT00123656|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110281482|NCT00123656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110281483|NCT00123656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281484|NCT00214617|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110281485|NCT00214617|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110281487|NCT00214617|Antimetabolites|antimetabolites|mesh-ancestor
110281488|NCT00214617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281489|NCT00214617|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110281490|NCT00214617|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110281491|NCT00214617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110281492|NCT00191750|Pemetrexed|pemetrexed|mesh-list
110281493|NCT00191750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110281494|NCT00191750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110281495|NCT00191750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281496|NCT00191750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110281497|NCT00191750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110281498|NCT00214695|Dialysis Solutions|dialysis solutions|mesh-list
110281499|NCT00214695|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110281500|NCT00221754|Pravastatin|pravastatin|mesh-list
110281501|NCT00221754|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110281502|NCT00221754|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110281503|NCT00221754|Antimetabolites|antimetabolites|mesh-ancestor
110281504|NCT00221754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281505|NCT00221754|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110281506|NCT00221754|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110281507|NCT00221754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110281508|NCT00191828|Olanzapine|olanzapine|mesh-list
110281509|NCT00191828|Antiemetics|antiemetics|mesh-ancestor
110275328|NCT00555100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110275329|NCT00555100|Growth Substances|growth substances|mesh-ancestor
110275330|NCT00555100|Growth Inhibitors|growth inhibitors|mesh-ancestor
110275331|NCT00555139|Alprazolam|alprazolam|mesh-list
110275332|NCT00555139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110275333|NCT00555139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110275334|NCT00555139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110275335|NCT00555139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110275336|NCT00555139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110275337|NCT00555139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110275338|NCT00555139|GABA Modulators|gaba modulators|mesh-ancestor
110275339|NCT00555139|GABA Agents|gaba agents|mesh-ancestor
110275340|NCT00555139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110275341|NCT00555139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275342|NCT00203463|Topiramate|topiramate|mesh-list
110275343|NCT00203463|Anticonvulsants|anticonvulsants|mesh-ancestor
110275344|NCT00203463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110281510|NCT00191828|Autonomic Agents|autonomic agents|mesh-ancestor
110281511|NCT00191828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110281512|NCT00191828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281513|NCT00191828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110281514|NCT00191828|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110281515|NCT00191828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110281516|NCT00191828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110281517|NCT00191828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110281518|NCT00191828|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110281519|NCT00191828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110281520|NCT00191828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110281521|NCT00191828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281522|NCT00191828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110281523|NCT00191828|Serotonin Agents|serotonin agents|mesh-ancestor
110281524|NCT00191867|Teriparatide|teriparatide|mesh-list
110281525|NCT00191867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110281526|NCT00191867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281527|NCT00191867|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110281529|NCT00123851|Oxaliplatin|oxaliplatin|mesh-list
110281530|NCT00123851|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110281531|NCT00123851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110281532|NCT00123851|Antimetabolites|antimetabolites|mesh-ancestor
110281533|NCT00123851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281534|NCT00123851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110281535|NCT00123851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110281536|NCT00123851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110281537|NCT00123890|Aplaviroc|aplaviroc|mesh-list
110281538|NCT00123890|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110281539|NCT00123890|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110281540|NCT00123890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281548|NCT00412698|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110281549|NCT00412698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110281550|NCT00412698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281551|NCT00412698|Hormones|hormones|mesh-ancestor
110281552|NCT00412698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110281553|NCT00412698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281554|NCT00123929|Docetaxel|docetaxel|mesh-list
110281555|NCT00123929|Doxorubicin|doxorubicin|mesh-list
110275345|NCT00203463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110275346|NCT00407849|Triamcinolone|triamcinolone|mesh-list
110275347|NCT00407849|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110275348|NCT00407849|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110275349|NCT00407849|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110275350|NCT00407849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110275351|NCT00407849|Glucocorticoids|glucocorticoids|mesh-ancestor
110275352|NCT00407849|Hormones|hormones|mesh-ancestor
110275353|NCT00407849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110275354|NCT00407849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110275355|NCT00407849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110275356|NCT00407849|Immunologic Factors|immunologic factors|mesh-ancestor
110275357|NCT00407849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110275358|NCT00407849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275359|NCT00407927|Epinastine|epinastine|mesh-list
110275360|NCT00407927|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110275361|NCT00407927|Histamine Antagonists|histamine antagonists|mesh-ancestor
110275362|NCT00407927|Histamine Agents|histamine agents|mesh-ancestor
110275363|NCT00407927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110275364|NCT00407927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275365|NCT00407927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110275366|NCT01818076|Botulinum Toxins|botulinum toxins|mesh-list
110275368|NCT01818076|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110275369|NCT01818076|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110275370|NCT01818076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110275371|NCT01818076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275372|NCT01818076|Cholinergic Agents|cholinergic agents|mesh-ancestor
110281556|NCT00123929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110281557|NCT00123929|Tubulin Modulators|tubulin modulators|mesh-ancestor
110281558|NCT00123929|Antimitotic Agents|antimitotic agents|mesh-ancestor
110281559|NCT00123929|Mitosis Modulators|mitosis modulators|mesh-ancestor
110281560|NCT00123929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281561|NCT00123929|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110281562|NCT00123929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110281563|NCT00123929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110281564|NCT00123929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110281565|NCT00475033|Vaccines|vaccines|mesh-list
110281566|NCT00475033|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110281567|NCT00475033|Immunologic Factors|immunologic factors|mesh-ancestor
110281568|NCT00475033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281569|NCT00192062|Gemcitabine|gemcitabine|mesh-list
110281570|NCT00192062|Vinorelbine|vinorelbine|mesh-list
110281571|NCT00192062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110275373|NCT01818076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110275374|NCT01818076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110275375|NCT01818076|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110275376|NCT01818076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110275377|NCT01807546|ON 01910|on 01910|mesh-list
110275378|NCT01807546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110275379|NCT01807546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110275380|NCT01807546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110275381|NCT01807546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275382|NCT03454984|Guadecitabine|guadecitabine|mesh-list
110281572|NCT00192062|Antimetabolites|antimetabolites|mesh-ancestor
110281573|NCT00192062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281574|NCT00192062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110281575|NCT00192062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110281576|NCT00192062|Tubulin Modulators|tubulin modulators|mesh-ancestor
110281577|NCT00192062|Antimitotic Agents|antimitotic agents|mesh-ancestor
110281578|NCT00192062|Mitosis Modulators|mitosis modulators|mesh-ancestor
110281579|NCT00192101|Gemcitabine|gemcitabine|mesh-list
110281580|NCT00192101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110281581|NCT00192101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110281582|NCT00192101|Antimetabolites|antimetabolites|mesh-ancestor
110281583|NCT00192101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281584|NCT00215007|Levofloxacin|levofloxacin|mesh-list
110281585|NCT00215007|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110281586|NCT00215007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110281587|NCT00215007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110281588|NCT00215007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110281589|NCT00215007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110281590|NCT00215007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110281591|NCT00215007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281592|NCT00215007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110281593|NCT00215007|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110281594|NCT00215007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110281595|NCT00474994|Sunitinib|sunitinib|mesh-list
110281596|NCT00474994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110281597|NCT00474994|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110281598|NCT00474994|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110281599|NCT00474994|Growth Substances|growth substances|mesh-ancestor
110281600|NCT00474994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281601|NCT00474994|Growth Inhibitors|growth inhibitors|mesh-ancestor
110281602|NCT00474994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110281603|NCT00474994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110281604|NCT00474994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281605|NCT00474955|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110281607|NCT00474955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110281620|NCT00215046|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110281621|NCT00215046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110281622|NCT00215046|Immunologic Factors|immunologic factors|mesh-ancestor
110281623|NCT00215046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110281624|NCT00215046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110281625|NCT00215046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110281626|NCT00215046|Tubulin Modulators|tubulin modulators|mesh-ancestor
110281627|NCT00215046|Antimitotic Agents|antimitotic agents|mesh-ancestor
110281628|NCT00215046|Mitosis Modulators|mitosis modulators|mesh-ancestor
110281629|NCT00474487|Vaccines|vaccines|mesh-list
110281630|NCT00474487|Immunologic Factors|immunologic factors|mesh-ancestor
110281631|NCT00474487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281632|NCT00124124|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
110281633|NCT00124124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110281634|NCT00124124|Immunologic Factors|immunologic factors|mesh-ancestor
110281635|NCT00124124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281636|NCT00474253|Rocuronium|rocuronium|mesh-list
110281637|NCT00474253|Succinylcholine|succinylcholine|mesh-list
110275383|NCT03454984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110275384|NCT01785433|Tiotropium Bromide|tiotropium bromide|mesh-list
110275385|NCT01785433|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110275386|NCT01785433|Autonomic Agents|autonomic agents|mesh-ancestor
110275387|NCT01785433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110275388|NCT01785433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110275389|NCT01785433|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110275390|NCT01785433|Respiratory System Agents|respiratory system agents|mesh-ancestor
110275391|NCT01785433|Parasympatholytics|parasympatholytics|mesh-ancestor
110275392|NCT01785433|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110275393|NCT01785433|Cholinergic Agents|cholinergic agents|mesh-ancestor
110281638|NCT00474253|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110281639|NCT00474253|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110281640|NCT00474253|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110281641|NCT00474253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110281642|NCT00474253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281643|NCT00474253|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
110281644|NCT00221871|Ketamine|ketamine|mesh-list
110281645|NCT00221871|Analgesics|analgesics|mesh-ancestor
110281646|NCT00221871|Sensory System Agents|sensory system agents|mesh-ancestor
110281647|NCT00221871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110281648|NCT00221871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281649|NCT00221871|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110281650|NCT00221871|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110281651|NCT00221871|Anesthetics, General|anesthetics, general|mesh-ancestor
110281653|NCT00221871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110281654|NCT00221871|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110281655|NCT00221871|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110281656|NCT00221871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110281657|NCT00221871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281658|NCT00474058|Rotigotine|rotigotine|mesh-list
110281659|NCT00474058|Dopamine Agonists|dopamine agonists|mesh-ancestor
110281660|NCT00474058|Dopamine Agents|dopamine agents|mesh-ancestor
110281661|NCT00474058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110281662|NCT00474058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281663|NCT00474058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281665|NCT02277730|Oxymetazoline|oxymetazoline|mesh-list
110281666|NCT02277730|Ephedrine|ephedrine|mesh-list
110281667|NCT02277730|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
110281668|NCT02277730|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110281669|NCT02277730|Mydriatics|mydriatics|mesh-ancestor
110281670|NCT02277730|Autonomic Agents|autonomic agents|mesh-ancestor
110281671|NCT02277730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110281694|NCT04571437|Hormone Antagonists|hormone antagonists|mesh-ancestor
110281695|NCT04571437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110281696|NCT04571437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281697|NCT00215124|Lenograstim|lenograstim|mesh-list
110281698|NCT00215124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110281699|NCT00215124|Immunologic Factors|immunologic factors|mesh-ancestor
110281700|NCT00215124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281701|NCT00473824|Immunoglobulins|immunoglobulins|mesh-list
110281702|NCT00473824|Antibodies|antibodies|mesh-list
110281703|NCT00473824|gamma-Globulins|gamma-globulins|mesh-list
110281704|NCT00473824|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110281705|NCT00473824|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110281706|NCT00473824|Immunologic Factors|immunologic factors|mesh-ancestor
110281707|NCT00473824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281708|NCT00215163|Paroxetine|paroxetine|mesh-list
110281709|NCT00215163|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110281710|NCT00215163|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110281711|NCT00215163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110275394|NCT01785433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110275395|NCT01785433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275397|NCT00203580|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110275398|NCT00203580|Dalteparin|dalteparin|mesh-list
110275399|NCT00203580|Anticoagulants|anticoagulants|mesh-ancestor
110275400|NCT00203580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110275401|NCT00203580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110275402|NCT00203580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275404|NCT01777555|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110281712|NCT00215163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281713|NCT00215163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110281714|NCT00215163|Serotonin Agents|serotonin agents|mesh-ancestor
110281715|NCT00215163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281716|NCT00215163|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110281717|NCT00215163|Antidepressive Agents|antidepressive agents|mesh-ancestor
110281718|NCT00215163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110281719|NCT00215163|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110281720|NCT00215163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110281721|NCT00215163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110281722|NCT00215202|Gefitinib|gefitinib|mesh-list
110281743|NCT00215241|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110281745|NCT00124241|Telbivudine|telbivudine|mesh-list
110281746|NCT00124241|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110281747|NCT00124241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110281748|NCT00124241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110281749|NCT00124241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281750|NCT00124241|Antiviral Agents|antiviral agents|mesh-ancestor
110281751|NCT00124241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110281752|NCT00124241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110281753|NCT00124241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110281755|NCT00124280|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110281756|NCT00124280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110281757|NCT00124280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110281758|NCT00124280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281759|NCT00124280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110281760|NCT00124280|Immunologic Factors|immunologic factors|mesh-ancestor
110281761|NCT00124280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281762|NCT00124280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110281763|NCT00215280|Ivermectin|ivermectin|mesh-list
110281764|NCT00215280|Albendazole|albendazole|mesh-list
110281765|NCT00215280|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110281766|NCT00215280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110281767|NCT00215280|Anthelmintics|anthelmintics|mesh-ancestor
110281768|NCT00215280|Anticestodal Agents|anticestodal agents|mesh-ancestor
110281769|NCT00215280|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110281770|NCT00215280|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110281771|NCT00215280|Tubulin Modulators|tubulin modulators|mesh-ancestor
110281772|NCT00215280|Antimitotic Agents|antimitotic agents|mesh-ancestor
110281773|NCT00215280|Mitosis Modulators|mitosis modulators|mesh-ancestor
110281774|NCT00215280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281775|NCT00215280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110281790|NCT00215358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110281791|NCT00215358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281793|NCT00192569|Ribavirin|ribavirin|mesh-list
110281794|NCT00192569|Interferon-alpha|interferon-alpha|mesh-list
110281795|NCT00192569|Interferon alpha-2|interferon alpha-2|mesh-list
110281796|NCT00192569|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110281797|NCT00192569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110281798|NCT00192569|Antiviral Agents|antiviral agents|mesh-ancestor
110281799|NCT00192569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110281800|NCT00192569|Antimetabolites|antimetabolites|mesh-ancestor
110281801|NCT00192569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275405|NCT01777555|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110275406|NCT01777555|Dopamine Agents|dopamine agents|mesh-ancestor
110275407|NCT01777555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110275408|NCT01777555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275409|NCT01777555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110275410|NCT01773928|Vaccines|vaccines|mesh-list
110275411|NCT01773928|Immunologic Factors|immunologic factors|mesh-ancestor
110281802|NCT00192569|Immunologic Factors|immunologic factors|mesh-ancestor
110281803|NCT00192569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281804|NCT00215397|Formoterol Fumarate|formoterol fumarate|mesh-list
110281805|NCT00215397|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110281806|NCT00215397|Autonomic Agents|autonomic agents|mesh-ancestor
110281807|NCT00215397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110281808|NCT00215397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281809|NCT00215397|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110281810|NCT00215397|Respiratory System Agents|respiratory system agents|mesh-ancestor
110281811|NCT00215397|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110281812|NCT00215397|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110281813|NCT00215397|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110281814|NCT00215397|Adrenergic Agents|adrenergic agents|mesh-ancestor
110281815|NCT00215397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110281816|NCT00215397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281817|NCT00192608|Saquinavir|saquinavir|mesh-list
110281818|NCT00192608|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110281819|NCT00192608|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110281820|NCT00192608|Protease Inhibitors|protease inhibitors|mesh-ancestor
110281821|NCT00192608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110281822|NCT00192608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281823|NCT00192608|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110281824|NCT00192608|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110281825|NCT00192608|Antiviral Agents|antiviral agents|mesh-ancestor
110281826|NCT00192608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110281827|NCT00192608|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110281828|NCT00192608|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110281829|NCT00215436|Formoterol Fumarate|formoterol fumarate|mesh-list
110281830|NCT00215436|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110281831|NCT00215436|Autonomic Agents|autonomic agents|mesh-ancestor
110281832|NCT00215436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110281833|NCT00215436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281834|NCT00215436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110281835|NCT00215436|Respiratory System Agents|respiratory system agents|mesh-ancestor
110281841|NCT00215436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281843|NCT00215514|Epirubicin|epirubicin|mesh-list
110281844|NCT00215514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110281845|NCT00215514|Antimetabolites|antimetabolites|mesh-ancestor
110281846|NCT00215514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281847|NCT00215514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110281848|NCT00215514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110281849|NCT00215514|Immunologic Factors|immunologic factors|mesh-ancestor
110281850|NCT00215514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281851|NCT00215514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110281852|NCT00215514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110281853|NCT00215514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110281854|NCT00215514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110281855|NCT00192725|Tryptophan|tryptophan|mesh-list
110281856|NCT00192725|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110281857|NCT00192725|Antidepressive Agents|antidepressive agents|mesh-ancestor
110281858|NCT00192725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110281859|NCT00215592|Zonisamide|zonisamide|mesh-list
110281860|NCT00215592|Anticonvulsants|anticonvulsants|mesh-ancestor
110281861|NCT00215592|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110281862|NCT00215592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110281863|NCT00215592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281864|NCT00215592|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110275412|NCT01773928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110275414|NCT01768975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110275416|NCT01756924|Vancomycin|vancomycin|mesh-list
110275417|NCT01756924|Ciprofloxacin|ciprofloxacin|mesh-list
110275418|NCT01756924|Levofloxacin|levofloxacin|mesh-list
110275419|NCT01756924|Rifampin|rifampin|mesh-list
110275420|NCT01756924|Cefazolin|cefazolin|mesh-list
110281865|NCT00215592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281866|NCT00222144|Docetaxel|docetaxel|mesh-list
110281867|NCT00222144|Imatinib Mesylate|imatinib mesylate|mesh-list
110281868|NCT00222144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110281869|NCT00222144|Tubulin Modulators|tubulin modulators|mesh-ancestor
110281870|NCT00222144|Antimitotic Agents|antimitotic agents|mesh-ancestor
110281871|NCT00222144|Mitosis Modulators|mitosis modulators|mesh-ancestor
110281872|NCT00222144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281873|NCT00222144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110281874|NCT00222144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110281875|NCT00222183|Pimecrolimus|pimecrolimus|mesh-list
110281876|NCT00222183|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110281877|NCT00222183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110281878|NCT00222183|Analgesics|analgesics|mesh-ancestor
110281879|NCT00222183|Sensory System Agents|sensory system agents|mesh-ancestor
110281880|NCT00222183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110281881|NCT00222183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281882|NCT00222183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110281883|NCT00222183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110281884|NCT00222183|Dermatologic Agents|dermatologic agents|mesh-ancestor
110281885|NCT00222183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110281886|NCT00222183|Immunologic Factors|immunologic factors|mesh-ancestor
110281887|NCT00222183|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110281888|NCT00222183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110281889|NCT00222183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281890|NCT00192764|Cyclophosphamide|cyclophosphamide|mesh-list
110281891|NCT00192764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110281892|NCT00192764|Immunologic Factors|immunologic factors|mesh-ancestor
110281893|NCT00192764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281894|NCT00192764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110281895|NCT00192764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110281896|NCT00192764|Alkylating Agents|alkylating agents|mesh-ancestor
110281897|NCT00192764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281898|NCT00192764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110281899|NCT00192764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110281900|NCT00411957|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110281901|NCT00411957|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110281902|NCT00411957|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110281903|NCT00411957|Protease Inhibitors|protease inhibitors|mesh-ancestor
110281908|NCT00411957|Antiviral Agents|antiviral agents|mesh-ancestor
110281909|NCT00411957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110281910|NCT00192803|Candesartan|candesartan|mesh-list
110281911|NCT00192803|Candesartan cilexetil|candesartan cilexetil|mesh-list
110281912|NCT00192803|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110281913|NCT00192803|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110281914|NCT00192803|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110281915|NCT00192803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281917|NCT00192842|Gemcitabine|gemcitabine|mesh-list
110281918|NCT00192842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110281923|NCT00192842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110281924|NCT00192842|Analgesics|analgesics|mesh-ancestor
110281925|NCT00192842|Sensory System Agents|sensory system agents|mesh-ancestor
110281926|NCT00192842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110281927|NCT00192842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110275422|NCT01756924|Linezolid|linezolid|mesh-list
110275423|NCT01756924|Daptomycin|daptomycin|mesh-list
110275424|NCT01756924|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110275425|NCT01756924|Oxacillin|oxacillin|mesh-list
110275426|NCT01756924|Fusidic Acid|fusidic acid|mesh-list
110275427|NCT01756924|Nafcillin|nafcillin|mesh-list
110275428|NCT01756924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110275429|NCT01756924|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110275430|NCT01756924|Antitubercular Agents|antitubercular agents|mesh-ancestor
110275431|NCT01756924|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110275432|NCT01756924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110275433|NCT01756924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110281928|NCT00192842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110281929|NCT00192842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110281930|NCT00192842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110281932|NCT00411996|Indinavir|indinavir|mesh-list
110281933|NCT00411996|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110281934|NCT00411996|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110281935|NCT00411996|Protease Inhibitors|protease inhibitors|mesh-ancestor
110281936|NCT00411996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110281937|NCT00411996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281938|NCT00411996|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110281939|NCT00411996|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110281940|NCT00411996|Antiviral Agents|antiviral agents|mesh-ancestor
110281941|NCT00411996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110281942|NCT00411996|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110281943|NCT00411996|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110281944|NCT00222261|Aspirin|aspirin|mesh-list
110281945|NCT00222261|Clopidogrel|clopidogrel|mesh-list
110281946|NCT00222261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110281947|NCT00222261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110281948|NCT00222261|Analgesics|analgesics|mesh-ancestor
110281949|NCT00222261|Sensory System Agents|sensory system agents|mesh-ancestor
110281950|NCT00222261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110281951|NCT00222261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281952|NCT00222261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110281953|NCT00222261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110281954|NCT00222261|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110281955|NCT00222261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110281956|NCT00222261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281957|NCT00222261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110281958|NCT00222261|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110281959|NCT00222261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110281960|NCT00222261|Antipyretics|antipyretics|mesh-ancestor
110281961|NCT00222261|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110281962|NCT00222261|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110281963|NCT00222261|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110281964|NCT00222261|Purinergic Agents|purinergic agents|mesh-ancestor
110281965|NCT00222261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110281967|NCT00192959|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110275434|NCT01756924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275435|NCT01756924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110275436|NCT01756924|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110275437|NCT01756924|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110275438|NCT01756924|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110275439|NCT01756924|Leprostatic Agents|leprostatic agents|mesh-ancestor
110275440|NCT01756924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110275441|NCT01756924|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110275442|NCT01756924|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110275443|NCT01756924|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110275444|NCT01756924|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110275445|NCT01756924|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110275446|NCT01756924|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110275447|NCT01756924|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110275448|NCT01756924|Antimalarials|antimalarials|mesh-ancestor
110275449|NCT01756924|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110275450|NCT01756924|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110281968|NCT00192959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110281969|NCT00192959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281970|NCT00192959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110281971|NCT00192959|Anesthetics, General|anesthetics, general|mesh-ancestor
110281972|NCT00192959|Anesthetics|anesthetics|mesh-ancestor
110281973|NCT00215631|Tadalafil|tadalafil|mesh-list
110281976|NCT00215631|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110281977|NCT00215631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110281978|NCT00215631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281979|NCT00215631|Urological Agents|urological agents|mesh-ancestor
110281981|NCT00193076|Gemcitabine|gemcitabine|mesh-list
110281982|NCT00193076|Trastuzumab|trastuzumab|mesh-list
110281983|NCT00193076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110281984|NCT00193076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110281985|NCT00193076|Antimetabolites|antimetabolites|mesh-ancestor
110281986|NCT00193076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281987|NCT00193076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110281988|NCT00193115|Cyclophosphamide|cyclophosphamide|mesh-list
110281989|NCT00193115|Docetaxel|docetaxel|mesh-list
110281990|NCT00193115|Doxorubicin|doxorubicin|mesh-list
110281991|NCT00193115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110281992|NCT00193115|Immunologic Factors|immunologic factors|mesh-ancestor
110281993|NCT00193115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281994|NCT00193115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110281995|NCT00193115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110281996|NCT00193115|Alkylating Agents|alkylating agents|mesh-ancestor
110281997|NCT00193115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281998|NCT00193115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110281999|NCT00193115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110282000|NCT00193115|Tubulin Modulators|tubulin modulators|mesh-ancestor
110282001|NCT00193115|Antimitotic Agents|antimitotic agents|mesh-ancestor
110282002|NCT00193115|Mitosis Modulators|mitosis modulators|mesh-ancestor
110282003|NCT00193115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110282004|NCT00193115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110282005|NCT00193115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110282006|NCT00193115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110282007|NCT00193154|Bevacizumab|bevacizumab|mesh-list
110275451|NCT01756339|Moxifloxacin|moxifloxacin|mesh-list
110275452|NCT01756339|Solithromycin|solithromycin|mesh-list
110275453|NCT01756339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110275454|NCT01756339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110275455|NCT01756339|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110275456|NCT01756339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110275457|NCT01756339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110275458|NCT01756339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275459|NCT01756339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110275460|NCT00174200|Risperidone|risperidone|mesh-list
110275461|NCT00174200|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110275462|NCT00174200|Serotonin Agents|serotonin agents|mesh-ancestor
110275463|NCT00174200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110275464|NCT00174200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110282008|NCT00193154|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110282009|NCT00193154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110282010|NCT00193154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110282011|NCT00193154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110282012|NCT00193154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110282013|NCT00193154|Growth Substances|growth substances|mesh-ancestor
110282014|NCT00193154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110282015|NCT00193154|Growth Inhibitors|growth inhibitors|mesh-ancestor
110282016|NCT00193154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110282017|NCT00193154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110282018|NCT00193154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110282021|NCT00193193|Estramustine|estramustine|mesh-list
110282022|NCT00193193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110282023|NCT00193193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110282024|NCT00193193|Tubulin Modulators|tubulin modulators|mesh-ancestor
110282025|NCT00193193|Antimitotic Agents|antimitotic agents|mesh-ancestor
110282026|NCT00193193|Mitosis Modulators|mitosis modulators|mesh-ancestor
110282027|NCT00193193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110282028|NCT00193193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110282029|NCT00193193|Alkylating Agents|alkylating agents|mesh-ancestor
110282030|NCT00193193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110282031|NCT00193232|Docetaxel|docetaxel|mesh-list
110282032|NCT00193232|Bortezomib|bortezomib|mesh-list
110282033|NCT00193232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110282034|NCT00193232|Tubulin Modulators|tubulin modulators|mesh-ancestor
110282035|NCT00193232|Antimitotic Agents|antimitotic agents|mesh-ancestor
110282036|NCT00193232|Mitosis Modulators|mitosis modulators|mesh-ancestor
110282037|NCT00193232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110282039|NCT00222495|Risperidone|risperidone|mesh-list
110282040|NCT00222495|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110282041|NCT00222495|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110282042|NCT00222495|Serotonin Agents|serotonin agents|mesh-ancestor
110282043|NCT00222495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110282044|NCT00222495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110282045|NCT00222495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110282046|NCT00222495|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110282056|NCT00222495|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110282057|NCT00222495|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110282058|NCT00222495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110282060|NCT00193271|Docetaxel|docetaxel|mesh-list
110282061|NCT00193271|Estramustine|estramustine|mesh-list
110275466|NCT00174200|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110275467|NCT00174200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110275468|NCT00174200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110275469|NCT00174200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110275471|NCT00174200|Dopamine Agents|dopamine agents|mesh-ancestor
110275472|NCT00203658|Tinzaparin|tinzaparin|mesh-list
110275473|NCT00203658|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110275474|NCT00203658|Dalteparin|dalteparin|mesh-list
110275475|NCT00203658|Anticoagulants|anticoagulants|mesh-ancestor
110275476|NCT00203658|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110275477|NCT00203658|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110275478|NCT00203658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275479|NCT00174239|Levodopa|levodopa|mesh-list
110275480|NCT00174239|Carbidopa|carbidopa|mesh-list
110275481|NCT00174239|Cabergoline|cabergoline|mesh-list
110275482|NCT00174239|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110275483|NCT00174239|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110275484|NCT00174239|Dopamine Agents|dopamine agents|mesh-ancestor
110275485|NCT00174239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110275486|NCT00174239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275487|NCT00174239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110282062|NCT00193271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110282063|NCT00193271|Tubulin Modulators|tubulin modulators|mesh-ancestor
110282064|NCT00193271|Antimitotic Agents|antimitotic agents|mesh-ancestor
110282065|NCT00193271|Mitosis Modulators|mitosis modulators|mesh-ancestor
110282066|NCT00193271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110282067|NCT00193271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110282068|NCT00193271|Alkylating Agents|alkylating agents|mesh-ancestor
110282069|NCT00193271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110282070|NCT00222534|Acetazolamide|acetazolamide|mesh-list
110282071|NCT00222534|Anticonvulsants|anticonvulsants|mesh-ancestor
110282072|NCT00222534|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110282073|NCT00222534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110282074|NCT00222534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110282075|NCT00222534|Diuretics|diuretics|mesh-ancestor
110282076|NCT00222534|Natriuretic Agents|natriuretic agents|mesh-ancestor
110282077|NCT00222534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110282078|NCT00193310|Paclitaxel|paclitaxel|mesh-list
110282079|NCT00193310|Carboplatin|carboplatin|mesh-list
110282080|NCT00193310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110282081|NCT00193310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110282082|NCT00193310|Tubulin Modulators|tubulin modulators|mesh-ancestor
110282083|NCT00193310|Antimitotic Agents|antimitotic agents|mesh-ancestor
110282084|NCT00193310|Mitosis Modulators|mitosis modulators|mesh-ancestor
110282085|NCT00193310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110282086|NCT00193349|Carboplatin|carboplatin|mesh-list
110282087|NCT00193349|Irinotecan|irinotecan|mesh-list
110282088|NCT00193349|Imatinib Mesylate|imatinib mesylate|mesh-list
110282089|NCT00193349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110282090|NCT00193349|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110282091|NCT00193349|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110275488|NCT00174239|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110275489|NCT00174239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110275490|NCT00174239|Dopamine Agonists|dopamine agonists|mesh-ancestor
110275492|NCT00203697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110275493|NCT00203697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110275494|NCT00174317|Celecoxib|celecoxib|mesh-list
110275495|NCT00174317|Diclofenac|diclofenac|mesh-list
110275496|NCT00174317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110275497|NCT00174317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110282092|NCT00193349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110282093|NCT00193349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110282094|NCT00193349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110282095|NCT00193388|Topotecan|topotecan|mesh-list
110282096|NCT00193388|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110282097|NCT00193388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110282098|NCT00193388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110282099|NCT00193388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110282100|NCT00193388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110282101|NCT00215709|Docetaxel|docetaxel|mesh-list
110282102|NCT00215709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110282103|NCT00215709|Tubulin Modulators|tubulin modulators|mesh-ancestor
110282104|NCT00215709|Antimitotic Agents|antimitotic agents|mesh-ancestor
110282105|NCT00215709|Mitosis Modulators|mitosis modulators|mesh-ancestor
110282106|NCT00215709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110282107|NCT00193466|Rituximab|rituximab|mesh-list
110282108|NCT00193466|Fludarabine|fludarabine|mesh-list
110282109|NCT00193466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110282110|NCT00193466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110282111|NCT00193466|Immunologic Factors|immunologic factors|mesh-ancestor
110282112|NCT00193466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110282123|NCT00215748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110282124|NCT00215748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110282125|NCT00215748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110282126|NCT00215826|Interferon-alpha|interferon-alpha|mesh-list
110282127|NCT00215826|Antiviral Agents|antiviral agents|mesh-ancestor
110282128|NCT00215826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110282129|NCT00215826|Immunologic Factors|immunologic factors|mesh-ancestor
110282130|NCT00215826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110282131|NCT00193544|Thalidomide|thalidomide|mesh-list
110282132|NCT00193544|Arsenic Trioxide|arsenic trioxide|mesh-list
110282133|NCT00193544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110282134|NCT00193544|Immunologic Factors|immunologic factors|mesh-ancestor
110282135|NCT00193544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110282136|NCT00193544|Leprostatic Agents|leprostatic agents|mesh-ancestor
110282137|NCT00193544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110282138|NCT00193544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110282139|NCT00193544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110282140|NCT00193544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110282141|NCT00193544|Growth Substances|growth substances|mesh-ancestor
110282142|NCT00193544|Growth Inhibitors|growth inhibitors|mesh-ancestor
110282143|NCT00193544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110282144|NCT00215865|Ribavirin|ribavirin|mesh-list
110282145|NCT00215865|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110282146|NCT00215865|Antimetabolites|antimetabolites|mesh-ancestor
110282147|NCT00215865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275498|NCT00174317|Analgesics|analgesics|mesh-ancestor
110275499|NCT00174317|Sensory System Agents|sensory system agents|mesh-ancestor
110275500|NCT00174317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110275501|NCT00174317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110275502|NCT00174317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110275503|NCT00174317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110275504|NCT00174317|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110275505|NCT00174317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110275506|NCT00174317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110275507|NCT00174317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275509|NCT01737892|Racepinephrine|racepinephrine|mesh-list
110282148|NCT00215865|Antiviral Agents|antiviral agents|mesh-ancestor
110282149|NCT00215865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110282150|NCT00124358|Buprenorphine|buprenorphine|mesh-list
110282151|NCT00124358|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110282152|NCT00124358|Narcotics|narcotics|mesh-ancestor
110282153|NCT00124358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110282154|NCT00124358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110282155|NCT00124358|Analgesics|analgesics|mesh-ancestor
110282156|NCT00124358|Sensory System Agents|sensory system agents|mesh-ancestor
110282157|NCT00124358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110282158|NCT00124358|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110282159|NCT00193583|Carboplatin|carboplatin|mesh-list
110282160|NCT00193583|Topotecan|topotecan|mesh-list
110282161|NCT00193583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110282162|NCT00193583|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110282163|NCT00193583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110282164|NCT00193583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110282165|NCT00193583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110282166|NCT00215982|Capecitabine|capecitabine|mesh-list
110282167|NCT00215982|Oxaliplatin|oxaliplatin|mesh-list
110282168|NCT00215982|Irinotecan|irinotecan|mesh-list
110282169|NCT00215982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110282170|NCT00215982|Antimetabolites|antimetabolites|mesh-ancestor
110282171|NCT00215982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110282172|NCT00215982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110282173|NCT00215982|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110282174|NCT00215982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110282175|NCT00215982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110282176|NCT00124397|Atorvastatin|atorvastatin|mesh-list
110282177|NCT00124397|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110282178|NCT00124397|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110282179|NCT00124397|Antimetabolites|antimetabolites|mesh-ancestor
110282180|NCT00124397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110282186|NCT00216021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110282187|NCT00216021|Antimetabolites|antimetabolites|mesh-ancestor
110282188|NCT00216021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110282189|NCT00216021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110282190|NCT00409526|Iloprost|iloprost|mesh-list
110282191|NCT00409526|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110282192|NCT00409526|Vasodilator Agents|vasodilator agents|mesh-ancestor
110282193|NCT00216138|Docetaxel|docetaxel|mesh-list
110282194|NCT00216138|Capecitabine|capecitabine|mesh-list
110282195|NCT00216138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110282196|NCT00216138|Tubulin Modulators|tubulin modulators|mesh-ancestor
110282197|NCT00216138|Antimitotic Agents|antimitotic agents|mesh-ancestor
110282198|NCT00216138|Mitosis Modulators|mitosis modulators|mesh-ancestor
110282199|NCT00216138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110282200|NCT00216138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110282201|NCT00216138|Antimetabolites|antimetabolites|mesh-ancestor
110282202|NCT00216177|Adalimumab|adalimumab|mesh-list
110282203|NCT00216177|Infliximab|infliximab|mesh-list
110282204|NCT00216177|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110275511|NCT01737892|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110275512|NCT01737892|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110275513|NCT01737892|Adrenergic Agents|adrenergic agents|mesh-ancestor
110275514|NCT01737892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110275515|NCT01737892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275516|NCT01737892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110275517|NCT01737892|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110275518|NCT01737892|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110275519|NCT01737892|Autonomic Agents|autonomic agents|mesh-ancestor
110275520|NCT01737892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110275521|NCT01737892|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110275522|NCT01737892|Respiratory System Agents|respiratory system agents|mesh-ancestor
110275523|NCT01737892|Mydriatics|mydriatics|mesh-ancestor
110275524|NCT01737892|Sympathomimetics|sympathomimetics|mesh-ancestor
110282205|NCT00216177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110282206|NCT00216177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110282207|NCT00216177|Dermatologic Agents|dermatologic agents|mesh-ancestor
110282208|NCT00216177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110282209|NCT00216216|Pemetrexed|pemetrexed|mesh-list
110282210|NCT00216216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110282211|NCT00216216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110282212|NCT00216216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110282213|NCT00216216|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110282214|NCT00216216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110282215|NCT00473746|Dexamethasone|dexamethasone|mesh-list
110282216|NCT00473746|Prednisone|prednisone|mesh-list
110282217|NCT00473746|Prednisolone|prednisolone|mesh-list
110282218|NCT00473746|Abiraterone Acetate|abiraterone acetate|mesh-list
110282219|NCT00473746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110282220|NCT00473746|Antiemetics|antiemetics|mesh-ancestor
110282221|NCT00473746|Autonomic Agents|autonomic agents|mesh-ancestor
110282222|NCT00473746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110282223|NCT00473746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110282224|NCT00473746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110282225|NCT00473746|Glucocorticoids|glucocorticoids|mesh-ancestor
110282226|NCT00473746|Hormones|hormones|mesh-ancestor
110282227|NCT00473746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110282228|NCT00473746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110282229|NCT00473746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110282230|NCT00473746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110282231|NCT00473746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110282232|NCT00473746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110282233|NCT00473746|Hormone Antagonists|hormone antagonists|mesh-ancestor
110282234|NCT00473746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110282235|NCT00409643|Amlodipine|amlodipine|mesh-list
110282236|NCT00409643|Valsartan|valsartan|mesh-list
110282237|NCT00409643|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110282238|NCT00409643|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110282239|NCT00409643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110282240|NCT00409643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110282241|NCT00409643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110282242|NCT00409643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110282243|NCT00409643|Vasodilator Agents|vasodilator agents|mesh-ancestor
110275525|NCT01737892|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110275526|NCT00203736|Artesunate|artesunate|mesh-list
110275527|NCT00203736|Pyrimethamine|pyrimethamine|mesh-list
110275528|NCT00203736|Sulfadoxine|sulfadoxine|mesh-list
110275529|NCT00203736|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110275530|NCT00203736|Antimalarials|antimalarials|mesh-ancestor
110275531|NCT00203736|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110275532|NCT00203736|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110275533|NCT00203736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110275534|NCT00203736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110275535|NCT00203736|Antiviral Agents|antiviral agents|mesh-ancestor
110275536|NCT00203736|Schistosomicides|schistosomicides|mesh-ancestor
110275537|NCT00203736|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110275538|NCT00203736|Anthelmintics|anthelmintics|mesh-ancestor
110275539|NCT00203736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110275540|NCT00203736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110282244|NCT00409643|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110282245|NCT00409643|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110282246|NCT00216294|Secretin|secretin|mesh-list
110282247|NCT00216294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110282248|NCT00216294|Hormones|hormones|mesh-ancestor
110282249|NCT00216294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110282250|NCT00216294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110282254|NCT00409721|Dopamine Agents|dopamine agents|mesh-ancestor
110282255|NCT00409721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110282256|NCT00409721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110282257|NCT00409721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110282258|NCT00409721|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110282259|NCT00409721|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110282260|NCT00193622|Bevacizumab|bevacizumab|mesh-list
110282261|NCT00193622|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110282262|NCT00193622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110282263|NCT00193622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110282264|NCT00193622|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110282265|NCT00193622|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110282266|NCT00193622|Growth Substances|growth substances|mesh-ancestor
110282267|NCT00193622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110282268|NCT00193622|Growth Inhibitors|growth inhibitors|mesh-ancestor
110282269|NCT00193622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110282270|NCT00193622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110282271|NCT00193622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110282273|NCT00473590|Bortezomib|bortezomib|mesh-list
110282274|NCT00473590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110282275|NCT00473590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110282276|NCT00473590|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110282277|NCT00473590|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110282278|NCT00473590|Growth Substances|growth substances|mesh-ancestor
110282279|NCT00473590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110282280|NCT00473590|Growth Inhibitors|growth inhibitors|mesh-ancestor
110282281|NCT00223275|Naltrexone|naltrexone|mesh-list
110282282|NCT00223275|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110282283|NCT00223275|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110282284|NCT00223275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110282285|NCT00223275|Sensory System Agents|sensory system agents|mesh-ancestor
110282286|NCT00223275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110282287|NCT00124787|Dimenhydrinate|dimenhydrinate|mesh-list
110282288|NCT00124787|Antiemetics|antiemetics|mesh-ancestor
110275541|NCT00203736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275542|NCT00203736|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110275544|NCT01719016|Analgesics|analgesics|mesh-ancestor
110275545|NCT01719016|Sensory System Agents|sensory system agents|mesh-ancestor
110275546|NCT01719016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110275547|NCT01719016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110282290|NCT00124787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110282291|NCT00124787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110282292|NCT00124787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110282293|NCT00124787|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110282294|NCT00124787|Histamine Antagonists|histamine antagonists|mesh-ancestor
110282295|NCT00124787|Histamine Agents|histamine agents|mesh-ancestor
110282296|NCT00124787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110282297|NCT00124787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110282298|NCT00193661|Testosterone|testosterone|mesh-list
110282299|NCT00193661|Androgens|androgens|mesh-ancestor
110282301|NCT00193661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110282302|NCT00193661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110282303|NCT00206232|Spironolactone|spironolactone|mesh-list
110282304|NCT00206232|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110282305|NCT00206232|Hormone Antagonists|hormone antagonists|mesh-ancestor
110282306|NCT00206232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110282307|NCT00206232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110282308|NCT00206232|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110282309|NCT00206232|Diuretics|diuretics|mesh-ancestor
110282310|NCT00206232|Natriuretic Agents|natriuretic agents|mesh-ancestor
110282311|NCT00193700|Testosterone|testosterone|mesh-list
110282312|NCT00193700|Androgens|androgens|mesh-ancestor
110282313|NCT00193700|Hormones|hormones|mesh-ancestor
110282314|NCT00193700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110282315|NCT00193700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110282316|NCT00124826|Insulin|insulin|mesh-list
110282317|NCT00124826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110282318|NCT00124826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110282319|NCT00193739|Paclitaxel|paclitaxel|mesh-list
110282320|NCT00193739|Carboplatin|carboplatin|mesh-list
110282321|NCT00193739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110282326|NCT00193739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110282327|NCT00206310|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110282328|NCT00206310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110282329|NCT00206310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110282330|NCT00206310|Antimetabolites|antimetabolites|mesh-ancestor
110282331|NCT00206310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110282332|NCT00206310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110282333|NCT00206310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110282334|NCT00206310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110282335|NCT00206388|Cyclophosphamide|cyclophosphamide|mesh-list
110282336|NCT00206388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110282337|NCT00206388|Immunologic Factors|immunologic factors|mesh-ancestor
110282338|NCT00206388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110282339|NCT00206388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110282340|NCT00206388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110282341|NCT00206388|Alkylating Agents|alkylating agents|mesh-ancestor
110282342|NCT00206388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110282343|NCT00206388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110282344|NCT00206388|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110282346|NCT00125021|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110282347|NCT00125021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110282348|NCT00125021|Antimetabolites|antimetabolites|mesh-ancestor
110275548|NCT01719016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110275549|NCT01719016|Vasodilator Agents|vasodilator agents|mesh-ancestor
110275550|NCT01719016|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110275551|NCT01719016|Purinergic Agonists|purinergic agonists|mesh-ancestor
110275552|NCT01719016|Purinergic Agents|purinergic agents|mesh-ancestor
110275553|NCT01719016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110275554|NCT01719016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275556|NCT00174356|Carboplatin|carboplatin|mesh-list
110275557|NCT00174356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110275558|NCT00174356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110275559|NCT00174356|Tubulin Modulators|tubulin modulators|mesh-ancestor
110275560|NCT00174356|Antimitotic Agents|antimitotic agents|mesh-ancestor
110275561|NCT00174356|Mitosis Modulators|mitosis modulators|mesh-ancestor
110275562|NCT00174356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275563|NCT01718158|Ribavirin|ribavirin|mesh-list
110275564|NCT01718158|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110275565|NCT01718158|Antimetabolites|antimetabolites|mesh-ancestor
110275566|NCT01718158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110282349|NCT00125021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110282350|NCT00125021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110282351|NCT00125021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110282352|NCT00125021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110282353|NCT00193856|Zoledronic Acid|zoledronic acid|mesh-list
110282354|NCT00193856|Leuprolide|leuprolide|mesh-list
110282355|NCT00193856|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110282356|NCT00193856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110282357|NCT00193856|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110282358|NCT00193856|Fertility Agents|fertility agents|mesh-ancestor
110282359|NCT00193856|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110282360|NCT00193856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110282361|NCT00193856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110282362|NCT00223509|Lamotrigine|lamotrigine|mesh-list
110282363|NCT00223509|Anticonvulsants|anticonvulsants|mesh-ancestor
110282364|NCT00223509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110282365|NCT00223509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110282366|NCT00223509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110282367|NCT00223509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110282368|NCT00223509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110282369|NCT00223509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110282370|NCT00223509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110282371|NCT00223509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110282373|NCT00223509|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110282374|NCT00193895|Carboplatin|carboplatin|mesh-list
110282375|NCT00193895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110282377|NCT00223548|Protective Agents|protective agents|mesh-ancestor
110282378|NCT00223548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110282379|NCT00125060|Simvastatin|simvastatin|mesh-list
110282380|NCT00125060|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110282381|NCT00125060|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110282382|NCT00125060|Antimetabolites|antimetabolites|mesh-ancestor
110282383|NCT00125060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275567|NCT01718158|Antiviral Agents|antiviral agents|mesh-ancestor
110275568|NCT01718158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110275570|NCT00174395|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110275571|NCT00174395|Serotonin Agents|serotonin agents|mesh-ancestor
110275572|NCT00174395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110275573|NCT00174395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275574|NCT00174395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110275575|NCT00203775|Risperidone|risperidone|mesh-list
110275576|NCT00203775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110275577|NCT00203775|Serotonin Agents|serotonin agents|mesh-ancestor
110275578|NCT00203775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110282384|NCT00125060|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110282385|NCT00125060|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110282386|NCT00125060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110282387|NCT00223626|Topiramate|topiramate|mesh-list
110282388|NCT00223626|Anticonvulsants|anticonvulsants|mesh-ancestor
110282389|NCT00223626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110282390|NCT00223626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110282391|NCT00223743|Zonisamide|zonisamide|mesh-list
110282401|NCT00193973|Abortifacient Agents|abortifacient agents|mesh-ancestor
110282402|NCT00193973|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110282403|NCT00193973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110282404|NCT00193973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110282405|NCT00193973|Antimetabolites|antimetabolites|mesh-ancestor
110282406|NCT00193973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110282407|NCT00193973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110282408|NCT00193973|Dermatologic Agents|dermatologic agents|mesh-ancestor
110282409|NCT00193973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110282410|NCT00193973|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110282411|NCT00193973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110282412|NCT00193973|Immunologic Factors|immunologic factors|mesh-ancestor
110282413|NCT00193973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110282414|NCT00193973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110282415|NCT00193973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110282416|NCT00193973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110282417|NCT00193973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110282418|NCT00411879|Vasopressins|vasopressins|mesh-list
110282419|NCT00411879|Arginine Vasopressin|arginine vasopressin|mesh-list
110282420|NCT00411879|Epinephrine|epinephrine|mesh-list
110282421|NCT00411879|Racepinephrine|racepinephrine|mesh-list
110282422|NCT00411879|Epinephryl borate|epinephryl borate|mesh-list
110282423|NCT00411879|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110282424|NCT00411879|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110282425|NCT00411879|Adrenergic Agents|adrenergic agents|mesh-ancestor
110282426|NCT00411879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110282427|NCT00411879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110282428|NCT00411879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110282430|NCT00411879|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110282431|NCT00411879|Autonomic Agents|autonomic agents|mesh-ancestor
110282432|NCT00411879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110282433|NCT00411879|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110282434|NCT00411879|Respiratory System Agents|respiratory system agents|mesh-ancestor
110282435|NCT00411879|Mydriatics|mydriatics|mesh-ancestor
110282436|NCT00411879|Sympathomimetics|sympathomimetics|mesh-ancestor
110282437|NCT00411879|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110282438|NCT00411879|Hemostatics|hemostatics|mesh-ancestor
110282439|NCT00411879|Coagulants|coagulants|mesh-ancestor
110282440|NCT00411879|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110282441|NCT00411879|Natriuretic Agents|natriuretic agents|mesh-ancestor
110282442|NCT00193505|Rituximab|rituximab|mesh-list
110282443|NCT00193505|Carboplatin|carboplatin|mesh-list
110282444|NCT00193505|Etoposide|etoposide|mesh-list
110282445|NCT00193505|Ifosfamide|ifosfamide|mesh-list
110282446|NCT00193505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110275579|NCT00203775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275580|NCT00203775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110275581|NCT00203775|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110275582|NCT00203775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110275583|NCT00203775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110275584|NCT00203775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110275585|NCT00203775|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110275586|NCT00203775|Dopamine Agents|dopamine agents|mesh-ancestor
110275587|NCT00555256|Sirolimus|sirolimus|mesh-list
110275588|NCT00555256|Sunitinib|sunitinib|mesh-list
110275589|NCT00555256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110282447|NCT00193505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110282448|NCT00193505|Immunologic Factors|immunologic factors|mesh-ancestor
110282449|NCT00193505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110282450|NCT00193505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110282451|NCT00193505|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110282452|NCT00193505|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110282453|NCT00193505|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110282454|NCT00193505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110282455|NCT00193505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110282456|NCT00193505|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110282472|NCT00125255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110282473|NCT00125255|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110282474|NCT00125255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110282475|NCT00125255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110282476|NCT00125255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110282477|NCT00223938|Ferric gluconate|ferric gluconate|mesh-list
110282478|NCT00223938|Ferric Compounds|ferric compounds|mesh-list
110282479|NCT00223938|Hematinics|hematinics|mesh-ancestor
110282480|NCT00125294|Methadone|methadone|mesh-list
110282481|NCT00125294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110282482|NCT00125294|Narcotics|narcotics|mesh-ancestor
110282483|NCT00125294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110282484|NCT00125294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110282485|NCT00125294|Analgesics|analgesics|mesh-ancestor
110282486|NCT00125294|Sensory System Agents|sensory system agents|mesh-ancestor
110282487|NCT00125294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110282488|NCT00125294|Antitussive Agents|antitussive agents|mesh-ancestor
110282489|NCT00125294|Respiratory System Agents|respiratory system agents|mesh-ancestor
110282491|NCT00206466|Doxorubicin|doxorubicin|mesh-list
110282492|NCT00206466|Cyclophosphamide|cyclophosphamide|mesh-list
110282494|NCT00206466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110282495|NCT00206466|Tubulin Modulators|tubulin modulators|mesh-ancestor
110282496|NCT00206466|Antimitotic Agents|antimitotic agents|mesh-ancestor
110282497|NCT00206466|Mitosis Modulators|mitosis modulators|mesh-ancestor
110282498|NCT00206466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110282499|NCT00206466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110282500|NCT00206466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110282501|NCT00206466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110282502|NCT00206466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110282503|NCT00206466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110282504|NCT00206466|Immunologic Factors|immunologic factors|mesh-ancestor
110282505|NCT00206466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110282506|NCT00206466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110282507|NCT00206466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110282508|NCT00206466|Alkylating Agents|alkylating agents|mesh-ancestor
110282509|NCT00206466|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110282510|NCT00224094|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110282511|NCT00224094|Estrogens|estrogens|mesh-ancestor
110282512|NCT00224094|Hormones|hormones|mesh-ancestor
110275590|NCT00555256|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110275591|NCT00555256|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110275592|NCT00555256|Growth Substances|growth substances|mesh-ancestor
110275593|NCT00555256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110275594|NCT00555256|Growth Inhibitors|growth inhibitors|mesh-ancestor
110275595|NCT00555256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110275596|NCT00555256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110275597|NCT00555256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275598|NCT00555256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110282513|NCT00224094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110282514|NCT00224094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110282515|NCT00125411|Docetaxel|docetaxel|mesh-list
110282516|NCT00125411|Satraplatin|satraplatin|mesh-list
110282517|NCT00125411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110282521|NCT00125411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110282522|NCT00206505|Docetaxel|docetaxel|mesh-list
110282523|NCT00206505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110282524|NCT00206505|Tubulin Modulators|tubulin modulators|mesh-ancestor
110282525|NCT00206505|Antimitotic Agents|antimitotic agents|mesh-ancestor
110282526|NCT00206505|Mitosis Modulators|mitosis modulators|mesh-ancestor
110282527|NCT00206505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110282528|NCT00206544|Tamoxifen|tamoxifen|mesh-list
110282529|NCT00206544|Progesterone|progesterone|mesh-list
110282530|NCT00206544|Progestins|progestins|mesh-ancestor
110282531|NCT00206544|Hormones|hormones|mesh-ancestor
110282532|NCT00206544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110282533|NCT00206544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110282534|NCT00206544|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110282535|NCT00206544|Hormone Antagonists|hormone antagonists|mesh-ancestor
110282536|NCT00206544|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110282537|NCT00206544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110282538|NCT00206544|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110282539|NCT00206544|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110282540|NCT00206544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110282541|NCT00194324|Miconazole|miconazole|mesh-list
110282542|NCT00194324|Clotrimazole|clotrimazole|mesh-list
110282543|NCT00194324|Antifungal Agents|antifungal agents|mesh-ancestor
110282544|NCT00194324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110282545|NCT00194324|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110282546|NCT00194324|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110282547|NCT00194324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110282548|NCT00194324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110282549|NCT00194324|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110282550|NCT00194324|Hormone Antagonists|hormone antagonists|mesh-ancestor
110282551|NCT00194324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110282552|NCT00194324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110282553|NCT00194324|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110282554|NCT00194324|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110282555|NCT00194324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110282556|NCT00206622|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110282557|NCT00206622|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110282558|NCT00206622|Levonorgestrel|levonorgestrel|mesh-list
110282559|NCT00206622|Estradiol|estradiol|mesh-list
110282560|NCT00206622|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110282561|NCT00206622|Estrogens|estrogens|mesh-ancestor
110282563|NCT00206622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110282564|NCT00206622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110282565|NCT00206622|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110282566|NCT00206622|Contraceptive Agents|contraceptive agents|mesh-ancestor
110282567|NCT00206622|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110282568|NCT00206622|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110275599|NCT00555256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110275600|NCT00555256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110275601|NCT00555256|Antifungal Agents|antifungal agents|mesh-ancestor
110275602|NCT00555256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110275603|NCT00555256|Immunologic Factors|immunologic factors|mesh-ancestor
110275604|NCT00174434|Paclitaxel|paclitaxel|mesh-list
110282569|NCT00206622|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110282570|NCT00206622|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110282571|NCT00194402|Niacin|niacin|mesh-list
110282572|NCT00194402|Niacinamide|niacinamide|mesh-list
110282573|NCT00194402|Nicotinic Acids|nicotinic acids|mesh-list
110282574|NCT00194402|Atorvastatin|atorvastatin|mesh-list
110282575|NCT00194402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110282576|NCT00194402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110282577|NCT00194402|Antimetabolites|antimetabolites|mesh-ancestor
110282578|NCT00194402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110282579|NCT00194402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110282580|NCT00194402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110282581|NCT00194402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110282582|NCT00194402|Vasodilator Agents|vasodilator agents|mesh-ancestor
110282583|NCT00194402|Vitamin B Complex|vitamin b complex|mesh-ancestor
110282584|NCT00194402|Vitamins|vitamins|mesh-ancestor
110282585|NCT00194402|Micronutrients|micronutrients|mesh-ancestor
110282586|NCT00194402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110282587|NCT00473512|Dexamethasone|dexamethasone|mesh-list
110282588|NCT00473512|Abiraterone Acetate|abiraterone acetate|mesh-list
110282589|NCT00473512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110282604|NCT00473512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110282606|NCT00125489|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
110282607|NCT00125489|Pyrimethamine|pyrimethamine|mesh-list
110282608|NCT00125489|Sulfadoxine|sulfadoxine|mesh-list
110282609|NCT00125489|Amebicides|amebicides|mesh-ancestor
110282610|NCT00125489|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110282611|NCT00125489|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110282612|NCT00125489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110282613|NCT00125489|Antimalarials|antimalarials|mesh-ancestor
110282614|NCT00125489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110282615|NCT00125489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110282617|NCT00125489|Analgesics|analgesics|mesh-ancestor
110282618|NCT00125489|Sensory System Agents|sensory system agents|mesh-ancestor
110282619|NCT00125489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110282620|NCT00125489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110282621|NCT00125489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110282622|NCT00125489|Filaricides|filaricides|mesh-ancestor
110282623|NCT00125489|Antinematodal Agents|antinematodal agents|mesh-ancestor
110282624|NCT00125489|Anthelmintics|anthelmintics|mesh-ancestor
110282625|NCT00125489|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110282626|NCT00125489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110282627|NCT00125489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110282628|NCT00125489|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110282629|NCT00206661|Molgramostim|molgramostim|mesh-list
110282630|NCT00206661|Sargramostim|sargramostim|mesh-list
110282631|NCT00206661|Immunologic Factors|immunologic factors|mesh-ancestor
110282632|NCT00206661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110282633|NCT00206661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110282634|NCT00473434|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110282635|NCT00473434|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110282637|NCT00473434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110282638|NCT00473434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110282639|NCT00473434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110282640|NCT00473434|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110282641|NCT00473434|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110282642|NCT00473434|Serotonin Agents|serotonin agents|mesh-ancestor
110282643|NCT00473434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110282644|NCT00473434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110282645|NCT00473434|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110282646|NCT00473434|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110282647|NCT00473434|Dopamine Agents|dopamine agents|mesh-ancestor
110282649|NCT00125567|Carbidopa|carbidopa|mesh-list
110275605|NCT00174434|Sunitinib|sunitinib|mesh-list
110275606|NCT00174434|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110275607|NCT00174434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110275608|NCT00174434|Tubulin Modulators|tubulin modulators|mesh-ancestor
110275609|NCT00174434|Antimitotic Agents|antimitotic agents|mesh-ancestor
110275610|NCT00174434|Mitosis Modulators|mitosis modulators|mesh-ancestor
110275611|NCT00174434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275612|NCT00174434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110275613|NCT00174434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110275615|NCT00174434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110275616|NCT00174434|Growth Inhibitors|growth inhibitors|mesh-ancestor
110275617|NCT00174434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110275618|NCT00174434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110275620|NCT00203814|Pyrimethamine|pyrimethamine|mesh-list
110275621|NCT00203814|Sulfadoxine|sulfadoxine|mesh-list
110275622|NCT00203814|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110282650|NCT00125567|Entacapone|entacapone|mesh-list
110282659|NCT00125567|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
110282661|NCT00473083|Clindamycin|clindamycin|mesh-list
110282662|NCT00473083|Clindamycin palmitate|clindamycin palmitate|mesh-list
110282663|NCT00473083|Clindamycin phosphate|clindamycin phosphate|mesh-list
110282664|NCT00473083|Triamcinolone|triamcinolone|mesh-list
110282665|NCT00473083|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110282666|NCT00473083|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110282667|NCT00473083|Hydrocortisone|hydrocortisone|mesh-list
110282668|NCT00473083|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110282669|NCT00473083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110282670|NCT00473083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110282671|NCT00473083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110282672|NCT00473083|Glucocorticoids|glucocorticoids|mesh-ancestor
110282673|NCT00473083|Hormones|hormones|mesh-ancestor
110282674|NCT00473083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110282675|NCT00473083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110282676|NCT00473083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110282677|NCT00473083|Immunologic Factors|immunologic factors|mesh-ancestor
110282678|NCT00473083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110282679|NCT00473083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110282680|NCT00473083|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110282681|NCT00194480|Interferons|interferons|mesh-list
110282682|NCT00194480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110282683|NCT00194480|Antiviral Agents|antiviral agents|mesh-ancestor
110282684|NCT00194480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110282685|NCT00472420|Rituximab|rituximab|mesh-list
110282686|NCT00472420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110282687|NCT00472420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110282688|NCT00472420|Immunologic Factors|immunologic factors|mesh-ancestor
110282689|NCT00472420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110282690|NCT00472420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110282691|NCT00194519|Acyclovir|acyclovir|mesh-list
110282692|NCT00194519|Antiviral Agents|antiviral agents|mesh-ancestor
110282693|NCT00194519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110282694|NCT00206700|Sargramostim|sargramostim|mesh-list
110282695|NCT00206700|Immunologic Factors|immunologic factors|mesh-ancestor
110282696|NCT00206700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110275623|NCT00203814|Antimalarials|antimalarials|mesh-ancestor
110275624|NCT00203814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110275625|NCT00203814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110275626|NCT00203814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110275627|NCT00203814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110275628|NCT00203814|Antiviral Agents|antiviral agents|mesh-ancestor
110275629|NCT00203814|Schistosomicides|schistosomicides|mesh-ancestor
110275630|NCT00203814|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110275632|NCT00203814|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110275633|NCT00203814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110275634|NCT00203814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275635|NCT00203814|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110275636|NCT00174473|Voriconazole|voriconazole|mesh-list
110275637|NCT00174473|Antifungal Agents|antifungal agents|mesh-ancestor
110275638|NCT00174473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110282698|NCT00125645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110282699|NCT00125645|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110282700|NCT00125645|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110282701|NCT00125645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110282703|NCT00125684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110282704|NCT00125684|Narcotics|narcotics|mesh-ancestor
110282705|NCT00125684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110282706|NCT00125684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110282707|NCT00125684|Analgesics|analgesics|mesh-ancestor
110282708|NCT00125684|Sensory System Agents|sensory system agents|mesh-ancestor
110282709|NCT00125684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110282710|NCT00194597|Sildenafil Citrate|sildenafil citrate|mesh-list
110282711|NCT00194597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110282712|NCT00194597|Vasodilator Agents|vasodilator agents|mesh-ancestor
110282713|NCT00194597|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110282714|NCT00194597|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110282715|NCT00194597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110282716|NCT00194597|Urological Agents|urological agents|mesh-ancestor
110282730|NCT00206778|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110282731|NCT00206778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110282732|NCT00206778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110282733|NCT00206778|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110282734|NCT00206778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110282735|NCT00206778|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110282736|NCT00206778|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110282737|NCT00206778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110282738|NCT00206778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110282739|NCT00206778|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110282740|NCT00206778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110282741|NCT00206778|GABA Agents|gaba agents|mesh-ancestor
110282742|NCT00206778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110282743|NCT00206778|Antimanic Agents|antimanic agents|mesh-ancestor
110282744|NCT00125801|Hydromorphone|hydromorphone|mesh-list
110282745|NCT00125801|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110282746|NCT00125801|Narcotics|narcotics|mesh-ancestor
110282747|NCT00125801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110282748|NCT00125801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110282749|NCT00125801|Analgesics|analgesics|mesh-ancestor
110282750|NCT00125801|Sensory System Agents|sensory system agents|mesh-ancestor
110282751|NCT00125801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110282752|NCT00125840|Clofarabine|clofarabine|mesh-list
110275639|NCT00174473|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110275640|NCT00174473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110275641|NCT00174473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110275642|NCT00174473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275643|NCT00174473|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110275644|NCT00174473|Hormone Antagonists|hormone antagonists|mesh-ancestor
110275645|NCT00174473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110275646|NCT00174473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110275647|NCT00174473|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110282753|NCT00125840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110282754|NCT00125840|Antimetabolites|antimetabolites|mesh-ancestor
110282755|NCT00125840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110282756|NCT00125840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110282757|NCT00224445|Ritonavir|ritonavir|mesh-list
110282758|NCT00224445|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110282759|NCT00224445|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110282760|NCT00224445|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110282761|NCT00224445|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110282762|NCT00224445|Protease Inhibitors|protease inhibitors|mesh-ancestor
110282763|NCT00224445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110282764|NCT00224445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110282765|NCT00224445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110282766|NCT00224445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110282767|NCT00224445|Antiviral Agents|antiviral agents|mesh-ancestor
110282768|NCT00224445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110282769|NCT00224445|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110282770|NCT00224445|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110282771|NCT00224445|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110282772|NCT00224445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110282773|NCT00194753|Paclitaxel|paclitaxel|mesh-list
110282774|NCT00194753|Cyclophosphamide|cyclophosphamide|mesh-list
110282775|NCT00194753|Doxorubicin|doxorubicin|mesh-list
110282776|NCT00194753|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110282777|NCT00194753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110282778|NCT00194753|Tubulin Modulators|tubulin modulators|mesh-ancestor
110282786|NCT00194753|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110282787|NCT00194753|Alkylating Agents|alkylating agents|mesh-ancestor
110282788|NCT00194753|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110282789|NCT00194753|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110282790|NCT00194753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110282791|NCT00194753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110282792|NCT00194753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110282793|NCT00206856|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
110282794|NCT00206856|Natriuretic Agents|natriuretic agents|mesh-ancestor
110282795|NCT00206856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110282797|NCT00125918|Vasodilator Agents|vasodilator agents|mesh-ancestor
110282798|NCT00125918|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110282799|NCT00125918|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110282800|NCT00125918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110282801|NCT00125918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110282802|NCT00125918|Urological Agents|urological agents|mesh-ancestor
110282803|NCT00224523|Mometasone Furoate|mometasone furoate|mesh-list
110282804|NCT00224523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110282805|NCT00224523|Dermatologic Agents|dermatologic agents|mesh-ancestor
110282806|NCT00224523|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110282807|NCT00472303|Morphine|morphine|mesh-list
110282808|NCT00472303|Tapentadol|tapentadol|mesh-list
110282809|NCT00472303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110282810|NCT00472303|Narcotics|narcotics|mesh-ancestor
110282811|NCT00472303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110275649|NCT00174512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110275650|NCT00174512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110275651|NCT00174512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110275652|NCT00174512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110275653|NCT00174512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110275654|NCT00174512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275655|NCT00174512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110275656|NCT00199017|Cytarabine|cytarabine|mesh-list
110275657|NCT00199017|Dexamethasone|dexamethasone|mesh-list
110275658|NCT00199017|Prednisolone|prednisolone|mesh-list
110275659|NCT00199017|Cyclophosphamide|cyclophosphamide|mesh-list
110275660|NCT00199017|Methotrexate|methotrexate|mesh-list
110275661|NCT00199017|Vincristine|vincristine|mesh-list
110282812|NCT00472303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110282813|NCT00472303|Analgesics|analgesics|mesh-ancestor
110282814|NCT00472303|Sensory System Agents|sensory system agents|mesh-ancestor
110282815|NCT00472303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110282816|NCT00472303|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110282817|NCT00472303|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110282818|NCT00472303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110282819|NCT00472303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110282820|NCT00472303|Adrenergic Agents|adrenergic agents|mesh-ancestor
110282821|NCT00472303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110282822|NCT00125996|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
110282823|NCT00125996|Hematinics|hematinics|mesh-ancestor
110282824|NCT00206934|Dexetimide|dexetimide|mesh-list
110282825|NCT00206934|Citalopram|citalopram|mesh-list
110282826|NCT00206934|Escitalopram|escitalopram|mesh-list
110282827|NCT00206934|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110282828|NCT00206934|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110282829|NCT00206934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110282830|NCT00206934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110282831|NCT00206934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110282832|NCT00206934|Serotonin Agents|serotonin agents|mesh-ancestor
110282833|NCT00206934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110282834|NCT00206934|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110282835|NCT00206934|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110282836|NCT00206934|Parasympatholytics|parasympatholytics|mesh-ancestor
110282837|NCT00206934|Autonomic Agents|autonomic agents|mesh-ancestor
110282838|NCT00206934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110282839|NCT00206934|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110282840|NCT00206934|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110282841|NCT00206934|Cholinergic Agents|cholinergic agents|mesh-ancestor
110282842|NCT00206934|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110282843|NCT00206934|Antidepressive Agents|antidepressive agents|mesh-ancestor
110282844|NCT00206934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110282845|NCT00194909|Sildenafil Citrate|sildenafil citrate|mesh-list
110282850|NCT00194909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110282851|NCT00194909|Urological Agents|urological agents|mesh-ancestor
110282852|NCT00224640|Iron Chelating Agents|iron chelating agents|mesh-list
110282853|NCT00224640|Chelating Agents|chelating agents|mesh-ancestor
110282854|NCT00224640|Sequestering Agents|sequestering agents|mesh-ancestor
110282855|NCT00224640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110282857|NCT00194948|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110282858|NCT00194948|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110282859|NCT00194948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110282860|NCT00194948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110282861|NCT00194948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110282862|NCT00194948|Serotonin Agents|serotonin agents|mesh-ancestor
110282863|NCT00194948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110282864|NCT00206973|Mannitol|mannitol|mesh-list
110275662|NCT00199017|Doxorubicin|doxorubicin|mesh-list
110275663|NCT00199017|Daunorubicin|daunorubicin|mesh-list
110275664|NCT00199017|Asparaginase|asparaginase|mesh-list
110275665|NCT00199017|Mercaptopurine|mercaptopurine|mesh-list
110275666|NCT00199017|Cladribine|cladribine|mesh-list
110275667|NCT00199017|Thioguanine|thioguanine|mesh-list
110275668|NCT00199017|Vindesine|vindesine|mesh-list
110275669|NCT00199017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110275670|NCT00199017|Immunologic Factors|immunologic factors|mesh-ancestor
110275671|NCT00199017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110275672|NCT00199017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110275673|NCT00199017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110275674|NCT00199017|Alkylating Agents|alkylating agents|mesh-ancestor
110275675|NCT00199017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275676|NCT00199017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110275677|NCT00199017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110275678|NCT00199017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110282865|NCT00206973|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110282867|NCT00206973|Natriuretic Agents|natriuretic agents|mesh-ancestor
110282868|NCT00206973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110282869|NCT00471445|Ketamine|ketamine|mesh-list
110282870|NCT00471445|Amitriptyline|amitriptyline|mesh-list
110282871|NCT00471445|Analgesics|analgesics|mesh-ancestor
110282872|NCT00471445|Sensory System Agents|sensory system agents|mesh-ancestor
110282873|NCT00471445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110282874|NCT00471445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110282875|NCT00471445|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110282876|NCT00471445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110282877|NCT00471445|Anesthetics, General|anesthetics, general|mesh-ancestor
110282878|NCT00471445|Anesthetics|anesthetics|mesh-ancestor
110282879|NCT00471445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110282880|NCT00471445|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110282881|NCT00471445|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110282882|NCT00471445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110282883|NCT00471445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110282884|NCT00471445|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110282885|NCT00471445|Antidepressive Agents|antidepressive agents|mesh-ancestor
110282887|NCT00471445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110282888|NCT00471445|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110282889|NCT00471445|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110282890|NCT00471445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110282891|NCT00471445|Adrenergic Agents|adrenergic agents|mesh-ancestor
110282892|NCT00207051|Cetuximab|cetuximab|mesh-list
110282893|NCT00207051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110282894|NCT00207051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110282895|NCT00402467|Enoxaparin|enoxaparin|mesh-list
110282896|NCT00402467|Rivaroxaban|rivaroxaban|mesh-list
110282897|NCT00402467|Enoxaparin sodium|enoxaparin sodium|mesh-list
110282898|NCT00402467|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110282899|NCT00402467|Antithrombins|antithrombins|mesh-ancestor
110282900|NCT00402467|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110282901|NCT00402467|Protease Inhibitors|protease inhibitors|mesh-ancestor
110282902|NCT00402467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110282903|NCT00402467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110282904|NCT00402467|Anticoagulants|anticoagulants|mesh-ancestor
110282905|NCT00402467|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110282906|NCT00402467|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110282907|NCT00224679|Aspirin|aspirin|mesh-list
110282908|NCT00224679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110275679|NCT00199017|Antiemetics|antiemetics|mesh-ancestor
110275680|NCT00199017|Autonomic Agents|autonomic agents|mesh-ancestor
110275681|NCT00199017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110275682|NCT00199017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110275683|NCT00199017|Glucocorticoids|glucocorticoids|mesh-ancestor
110275684|NCT00199017|Hormones|hormones|mesh-ancestor
110275685|NCT00199017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110275686|NCT00199017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110275687|NCT00199017|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110275688|NCT00199017|Abortifacient Agents|abortifacient agents|mesh-ancestor
110275689|NCT00199017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110282909|NCT00224679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110282910|NCT00224679|Analgesics|analgesics|mesh-ancestor
110282911|NCT00224679|Sensory System Agents|sensory system agents|mesh-ancestor
110282912|NCT00224679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110282913|NCT00224679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110282914|NCT00224679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110282915|NCT00224679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110282920|NCT00224679|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110282921|NCT00224679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110282922|NCT00224679|Antipyretics|antipyretics|mesh-ancestor
110282923|NCT00402506|Pyridoxal|pyridoxal|mesh-list
110282924|NCT00402506|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
110282925|NCT00402506|Vitamin B Complex|vitamin b complex|mesh-ancestor
110282926|NCT00402506|Vitamins|vitamins|mesh-ancestor
110282927|NCT00402506|Micronutrients|micronutrients|mesh-ancestor
110282928|NCT00402506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110282929|NCT00207129|Capecitabine|capecitabine|mesh-list
110282930|NCT00207129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110282931|NCT00207129|Antimetabolites|antimetabolites|mesh-ancestor
110282932|NCT00207129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110282933|NCT00207129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110282934|NCT00402545|Docetaxel|docetaxel|mesh-list
110282935|NCT00402545|Fluorouracil|fluorouracil|mesh-list
110282936|NCT00402545|Cetuximab|cetuximab|mesh-list
110282937|NCT00402545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110282938|NCT00402545|Tubulin Modulators|tubulin modulators|mesh-ancestor
110282939|NCT00402545|Antimitotic Agents|antimitotic agents|mesh-ancestor
110282940|NCT00402545|Mitosis Modulators|mitosis modulators|mesh-ancestor
110282941|NCT00402545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110282942|NCT00402545|Antimetabolites|antimetabolites|mesh-ancestor
110282943|NCT00402545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110282944|NCT00402545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110282945|NCT00402545|Immunologic Factors|immunologic factors|mesh-ancestor
110282946|NCT00402545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110282947|NCT00402545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110282948|NCT00126074|Tedisamil|tedisamil|mesh-list
110282949|NCT00126074|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110282950|NCT00126074|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110282951|NCT00126074|Protective Agents|protective agents|mesh-ancestor
110282952|NCT00126074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110282953|NCT00195104|Cytarabine|cytarabine|mesh-list
110282954|NCT00195104|Arsenic Trioxide|arsenic trioxide|mesh-list
110282955|NCT00195104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110282957|NCT00195104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110282958|NCT00195104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110282959|NCT00195104|Antiviral Agents|antiviral agents|mesh-ancestor
110282960|NCT00195104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110282961|NCT00195104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110282962|NCT00195104|Immunologic Factors|immunologic factors|mesh-ancestor
110282963|NCT00195104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110282964|NCT00413088|Bemiparin|bemiparin|mesh-list
110282965|NCT00413088|Anticoagulants|anticoagulants|mesh-ancestor
110275691|NCT00199017|Antimetabolites|antimetabolites|mesh-ancestor
110275692|NCT00199017|Dermatologic Agents|dermatologic agents|mesh-ancestor
110275693|NCT00199017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110275694|NCT00199017|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110275695|NCT00199017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110275696|NCT00199017|Antiviral Agents|antiviral agents|mesh-ancestor
110275697|NCT00199017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110275698|NCT00199017|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110282966|NCT00409760|Amlodipine|amlodipine|mesh-list
110282967|NCT00409760|Valsartan|valsartan|mesh-list
110282968|NCT00409760|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110282969|NCT00409760|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110282970|NCT00409760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110282971|NCT00409760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110282972|NCT00409760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110282973|NCT00409760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110282974|NCT00409760|Vasodilator Agents|vasodilator agents|mesh-ancestor
110282975|NCT00409760|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110282976|NCT00409760|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110282977|NCT00413127|Lidocaine|lidocaine|mesh-list
110282978|NCT00413127|Anesthetics, Local|anesthetics, local|mesh-ancestor
110282979|NCT00413127|Anesthetics|anesthetics|mesh-ancestor
110282980|NCT00413127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110282981|NCT00413127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110282982|NCT00413127|Sensory System Agents|sensory system agents|mesh-ancestor
110282983|NCT00413127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110282984|NCT00413127|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110282985|NCT00413127|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110282989|NCT00126230|Docetaxel|docetaxel|mesh-list
110282990|NCT00126230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110282991|NCT00126230|Tubulin Modulators|tubulin modulators|mesh-ancestor
110282992|NCT00126230|Antimitotic Agents|antimitotic agents|mesh-ancestor
110282993|NCT00126230|Mitosis Modulators|mitosis modulators|mesh-ancestor
110282994|NCT00126230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110282995|NCT00207363|Interferons|interferons|mesh-list
110282996|NCT00207363|Ribavirin|ribavirin|mesh-list
110282997|NCT00207363|Interferon-alpha|interferon-alpha|mesh-list
110282998|NCT00207363|Interferon alpha-2|interferon alpha-2|mesh-list
110282999|NCT00207363|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110283000|NCT00207363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110283001|NCT00207363|Antiviral Agents|antiviral agents|mesh-ancestor
110283002|NCT00207363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110283003|NCT00207363|Antimetabolites|antimetabolites|mesh-ancestor
110283004|NCT00207363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110283005|NCT00207363|Immunologic Factors|immunologic factors|mesh-ancestor
110283006|NCT00207363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283007|NCT00126269|Gemcitabine|gemcitabine|mesh-list
110283008|NCT00126269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110283009|NCT00126269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110283010|NCT00126269|Antimetabolites|antimetabolites|mesh-ancestor
110283011|NCT00126269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110283012|NCT00207402|Rosiglitazone|rosiglitazone|mesh-list
110283013|NCT00207402|Interferons|interferons|mesh-list
110283014|NCT00207402|Ribavirin|ribavirin|mesh-list
110283015|NCT00207402|Interferon alfacon-1|interferon alfacon-1|mesh-list
110283016|NCT00207402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110283017|NCT00207402|Antiviral Agents|antiviral agents|mesh-ancestor
110283018|NCT00207402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110283020|NCT00207402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110283021|NCT00207402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110283022|NCT00207402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283023|NCT00195299|Sirolimus|sirolimus|mesh-list
110275699|NCT00199017|Tubulin Modulators|tubulin modulators|mesh-ancestor
110275700|NCT00199017|Antimitotic Agents|antimitotic agents|mesh-ancestor
110275701|NCT00199017|Mitosis Modulators|mitosis modulators|mesh-ancestor
110275702|NCT00199017|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110275703|NCT00199017|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110283024|NCT00195299|Temsirolimus|temsirolimus|mesh-list
110283025|NCT00195299|MTOR Inhibitors|mtor inhibitors|mesh-list
110283026|NCT00195299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110283027|NCT00195299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110283028|NCT00195299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110283029|NCT00195299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110283030|NCT00195299|Immunologic Factors|immunologic factors|mesh-ancestor
110283031|NCT00195299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283032|NCT00195299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110283033|NCT00195299|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110283034|NCT00195299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110283035|NCT00195299|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110283036|NCT00195299|Antifungal Agents|antifungal agents|mesh-ancestor
110283037|NCT00471328|Sunitinib|sunitinib|mesh-list
110283038|NCT00471328|Imatinib Mesylate|imatinib mesylate|mesh-list
110283039|NCT00471328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110283040|NCT00471328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110283041|NCT00471328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110283042|NCT00471328|Growth Substances|growth substances|mesh-ancestor
110283043|NCT00471328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283044|NCT00471328|Growth Inhibitors|growth inhibitors|mesh-ancestor
110283045|NCT00471328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110283046|NCT00471328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110283047|NCT00471328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110283048|NCT00225030|Antihypertensive Agents|antihypertensive agents|mesh-list
110283049|NCT00126308|Mannitol|mannitol|mesh-list
110283050|NCT00126308|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110283051|NCT00126308|Diuretics|diuretics|mesh-ancestor
110283052|NCT00126308|Natriuretic Agents|natriuretic agents|mesh-ancestor
110283053|NCT00126308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283054|NCT00195377|Etanercept|etanercept|mesh-list
110283055|NCT00195377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110283056|NCT00195377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110283057|NCT00195377|Analgesics|analgesics|mesh-ancestor
110283058|NCT00195377|Sensory System Agents|sensory system agents|mesh-ancestor
110283066|NCT00225108|Tinzaparin|tinzaparin|mesh-list
110283067|NCT00225108|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110283068|NCT00225108|Dalteparin|dalteparin|mesh-list
110283069|NCT00225108|Anticoagulants|anticoagulants|mesh-ancestor
110283070|NCT00225108|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110283071|NCT00225108|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110283072|NCT00225108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110283073|NCT00195416|Etanercept|etanercept|mesh-list
110283074|NCT00195416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110283075|NCT00195416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110283076|NCT00195416|Analgesics|analgesics|mesh-ancestor
110283077|NCT00195416|Sensory System Agents|sensory system agents|mesh-ancestor
110283078|NCT00195416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110283079|NCT00195416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283080|NCT00195416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110283081|NCT00195416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110283082|NCT00195416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110283083|NCT00195416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110283084|NCT00195416|Immunologic Factors|immunologic factors|mesh-ancestor
110283085|NCT00195455|Estradiol|estradiol|mesh-list
110283086|NCT00195455|Estrogens|estrogens|mesh-ancestor
110283087|NCT00195455|Hormones|hormones|mesh-ancestor
110283088|NCT00195455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110283089|NCT00195455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283090|NCT00126347|Folic Acid|folic acid|mesh-list
110283091|NCT00126347|Betaine|betaine|mesh-list
110283092|NCT00126347|Hematinics|hematinics|mesh-ancestor
110283093|NCT00126347|Vitamin B Complex|vitamin b complex|mesh-ancestor
110283094|NCT00126347|Vitamins|vitamins|mesh-ancestor
110283095|NCT00126347|Micronutrients|micronutrients|mesh-ancestor
110283096|NCT00126347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283097|NCT00126347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110275704|NCT00199017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110275705|NCT01665391|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110275706|NCT01665391|Immunologic Factors|immunologic factors|mesh-ancestor
110275707|NCT01665391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110275709|NCT01660633|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110275710|NCT01660633|Alkylating Agents|alkylating agents|mesh-ancestor
110275711|NCT01660633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110283098|NCT00126347|Lipotropic Agents|lipotropic agents|mesh-ancestor
110283099|NCT00126347|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110283100|NCT00126347|Antimetabolites|antimetabolites|mesh-ancestor
110283101|NCT00126347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110283102|NCT00126347|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110283103|NCT00225225|Rosiglitazone|rosiglitazone|mesh-list
110283104|NCT00225225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110283105|NCT00225225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283106|NCT00126386|Zoledronic Acid|zoledronic acid|mesh-list
110283107|NCT00126386|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110283108|NCT00126386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283109|NCT00225264|Pioglitazone|pioglitazone|mesh-list
110283110|NCT00225264|Glimepiride|glimepiride|mesh-list
110283111|NCT00225264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110283112|NCT00225264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283113|NCT00225264|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110283114|NCT00225264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110283115|NCT00225264|Immunologic Factors|immunologic factors|mesh-ancestor
110283116|NCT00126464|Tamoxifen|tamoxifen|mesh-list
110283117|NCT00126464|Fulvestrant|fulvestrant|mesh-list
110283118|NCT00126464|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110283119|NCT00126464|Hormone Antagonists|hormone antagonists|mesh-ancestor
110283120|NCT00126464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110283121|NCT00126464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041927|NCT01438866|Fluorides, Topical|fluorides, topical|mesh-list
110283122|NCT00126464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110283123|NCT00126464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110283124|NCT00126464|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110283125|NCT00126464|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110283126|NCT00126464|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110283127|NCT00126464|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110283132|NCT00195533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110283133|NCT00195533|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110283134|NCT00195533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110283135|NCT00195533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110283137|NCT00207558|Hematinics|hematinics|mesh-ancestor
110283138|NCT00207558|Vitamin B Complex|vitamin b complex|mesh-ancestor
110283139|NCT00207558|Vitamins|vitamins|mesh-ancestor
110283140|NCT00207558|Micronutrients|micronutrients|mesh-ancestor
110283141|NCT00207558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283142|NCT00195572|Leucovorin|leucovorin|mesh-list
110283143|NCT00195572|Levoleucovorin|levoleucovorin|mesh-list
110283144|NCT00195572|Antidotes|antidotes|mesh-ancestor
110283145|NCT00195572|Protective Agents|protective agents|mesh-ancestor
110283146|NCT00195572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283147|NCT00195572|Vitamin B Complex|vitamin b complex|mesh-ancestor
110283148|NCT00195572|Vitamins|vitamins|mesh-ancestor
110283149|NCT00195572|Micronutrients|micronutrients|mesh-ancestor
110283150|NCT00202280|Folic Acid|folic acid|mesh-list
110283151|NCT00202280|Vitamin B 12|vitamin b 12|mesh-list
110283152|NCT00202280|Hydroxocobalamin|hydroxocobalamin|mesh-list
110283153|NCT00202280|Vitamins|vitamins|mesh-ancestor
110283154|NCT00202280|Micronutrients|micronutrients|mesh-ancestor
110283155|NCT00202280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283156|NCT00202280|Hematinics|hematinics|mesh-ancestor
110283157|NCT00202280|Vitamin B Complex|vitamin b complex|mesh-ancestor
110283158|NCT00225303|Etravirine|etravirine|mesh-list
110283159|NCT00225303|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110283160|NCT00225303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110283161|NCT00225303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110283162|NCT00225303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275712|NCT01660633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110275713|NCT01660633|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110275714|NCT01660633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110275715|NCT01660633|Immunologic Factors|immunologic factors|mesh-ancestor
110275716|NCT01660633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110275718|NCT00174551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110275719|NCT00174551|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110275720|NCT00174551|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110275721|NCT00174551|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110275722|NCT00174551|Adrenergic Agents|adrenergic agents|mesh-ancestor
110283163|NCT00225303|Antiviral Agents|antiviral agents|mesh-ancestor
110283164|NCT00225303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110283165|NCT00225342|Rosiglitazone|rosiglitazone|mesh-list
110283166|NCT00225342|Gliclazide|gliclazide|mesh-list
110283167|NCT00225342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110283168|NCT00225342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283169|NCT00195611|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110283170|NCT00195611|Immunologic Factors|immunologic factors|mesh-ancestor
110283171|NCT00195611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283172|NCT00470470|Imatinib Mesylate|imatinib mesylate|mesh-list
110283173|NCT00470470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110283174|NCT00470470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110283175|NCT00470470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110283176|NCT00470470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110283177|NCT00195689|Adalimumab|adalimumab|mesh-list
110283178|NCT00195689|Antibodies|antibodies|mesh-list
110283179|NCT00195689|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110283180|NCT00195689|Immunologic Factors|immunologic factors|mesh-ancestor
110283181|NCT00195689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283182|NCT00195689|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110283183|NCT00195689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110283184|NCT00195689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110283185|NCT00470275|Cytarabine|cytarabine|mesh-list
110283186|NCT00470275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110283187|NCT00470275|Antimetabolites|antimetabolites|mesh-ancestor
110283188|NCT00470275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110283189|NCT00470275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110283190|NCT00470275|Antiviral Agents|antiviral agents|mesh-ancestor
110283191|NCT00470275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110283192|NCT00470275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110283193|NCT00470275|Immunologic Factors|immunologic factors|mesh-ancestor
110283194|NCT00470275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283195|NCT00225381|Anesthetics|anesthetics|mesh-list
110283196|NCT00225381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110283197|NCT00225381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283198|NCT00195728|Acetaminophen|acetaminophen|mesh-list
110283199|NCT00195728|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
110283200|NCT00195728|Hydrocodone|hydrocodone|mesh-list
110283201|NCT00195728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110283205|NCT00195728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283206|NCT00195728|Antipyretics|antipyretics|mesh-ancestor
110283207|NCT00195728|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110283208|NCT00195728|Narcotics|narcotics|mesh-ancestor
110283209|NCT00195728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110283210|NCT00195728|Antitussive Agents|antitussive agents|mesh-ancestor
110283211|NCT00195728|Respiratory System Agents|respiratory system agents|mesh-ancestor
110283212|NCT00195728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110283213|NCT00195728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110283214|NCT00195728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110283215|NCT00470158|Iron|iron|mesh-list
110283216|NCT00470158|Zinc|zinc|mesh-list
110283217|NCT00470158|Trace Elements|trace elements|mesh-ancestor
110283218|NCT00470158|Micronutrients|micronutrients|mesh-ancestor
110283219|NCT00470158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110275724|NCT00174551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275725|NCT00174551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110275726|NCT04676659|Tenecteplase|tenecteplase|mesh-list
110275727|NCT04676659|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110275728|NCT04676659|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110275729|NCT04676659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275730|NCT00174590|Risperidone|risperidone|mesh-list
110275731|NCT00174590|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110275732|NCT00174590|Serotonin Agents|serotonin agents|mesh-ancestor
110275733|NCT00174590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110283220|NCT00472186|Lansoprazole|lansoprazole|mesh-list
110283221|NCT00472186|Dexlansoprazole|dexlansoprazole|mesh-list
110283222|NCT00472186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110283223|NCT00472186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110283224|NCT00472186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110283225|NCT00472186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110283226|NCT00472186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110283227|NCT00195767|Valproic Acid|valproic acid|mesh-list
110283228|NCT00195767|Anticonvulsants|anticonvulsants|mesh-ancestor
110283229|NCT00195767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110283230|NCT00195767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110283231|NCT00195767|GABA Agents|gaba agents|mesh-ancestor
110283232|NCT00195767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110283233|NCT00195767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283234|NCT00195767|Antimanic Agents|antimanic agents|mesh-ancestor
110283235|NCT00195767|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110283236|NCT00195767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110283237|NCT00195767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110283238|NCT00207675|Infliximab|infliximab|mesh-list
110283239|NCT00207675|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110283240|NCT00207675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110283241|NCT00207675|Dermatologic Agents|dermatologic agents|mesh-ancestor
110283242|NCT00207675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110283243|NCT00207675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110283244|NCT00202358|Atenolol|atenolol|mesh-list
110283245|NCT00202358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110283246|NCT00202358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110283247|NCT00202358|Sympatholytics|sympatholytics|mesh-ancestor
110283248|NCT00202358|Autonomic Agents|autonomic agents|mesh-ancestor
110283249|NCT00202358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110283250|NCT00202358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283251|NCT00202358|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110283252|NCT00202358|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110283253|NCT00202358|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110283254|NCT00202358|Adrenergic Agents|adrenergic agents|mesh-ancestor
110283255|NCT00202358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110283256|NCT00202358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110283257|NCT00479713|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110283259|NCT00479713|Ezetimibe|ezetimibe|mesh-list
110283260|NCT00479713|Calcium|calcium|mesh-list
110283261|NCT00479713|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110283262|NCT00479713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283263|NCT00479713|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110283264|NCT00479713|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110283265|NCT00479713|Antimetabolites|antimetabolites|mesh-ancestor
110283266|NCT00479713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110283267|NCT00479713|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110283268|NCT00479713|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110283269|NCT00479713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110283270|NCT00207753|Ivermectin|ivermectin|mesh-list
110283271|NCT00207753|Albendazole|albendazole|mesh-list
110283272|NCT00207753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110275734|NCT00174590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275735|NCT00174590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110275736|NCT00174590|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110275737|NCT00174590|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110275738|NCT00174590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110275739|NCT00174590|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110275740|NCT00174590|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110275741|NCT00174590|Dopamine Agents|dopamine agents|mesh-ancestor
110275743|NCT01652482|Fluorouracil|fluorouracil|mesh-list
110275744|NCT01652482|Irinotecan|irinotecan|mesh-list
110283273|NCT00207753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110283274|NCT00207753|Anthelmintics|anthelmintics|mesh-ancestor
110283275|NCT00207753|Anticestodal Agents|anticestodal agents|mesh-ancestor
110283281|NCT00207753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110283282|NCT00207753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110283283|NCT00202397|Riluzole|riluzole|mesh-list
110283284|NCT00202397|Anticonvulsants|anticonvulsants|mesh-ancestor
110283285|NCT00202397|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110283286|NCT00202397|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110283287|NCT00202397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110283288|NCT00202397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110283289|NCT00202397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283290|NCT00202397|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110283291|NCT00202397|Protective Agents|protective agents|mesh-ancestor
110283292|NCT00478972|Rimonabant|rimonabant|mesh-list
110283293|NCT00478972|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110283294|NCT00478972|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
110283295|NCT00478972|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110283296|NCT00478972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110283297|NCT00478972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110283299|NCT00478972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110283300|NCT00478972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283301|NCT00207792|Lenograstim|lenograstim|mesh-list
110283302|NCT00207792|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110283303|NCT00207792|Immunologic Factors|immunologic factors|mesh-ancestor
110283304|NCT00207792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283305|NCT00195806|Valproic Acid|valproic acid|mesh-list
110283306|NCT00195806|Anticonvulsants|anticonvulsants|mesh-ancestor
110283307|NCT00195806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110283308|NCT00195806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110283309|NCT00195806|GABA Agents|gaba agents|mesh-ancestor
110283310|NCT00195806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110283311|NCT00195806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283312|NCT00195806|Antimanic Agents|antimanic agents|mesh-ancestor
110283313|NCT00195806|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110283314|NCT00195806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110283315|NCT00195806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110283316|NCT00477529|Docetaxel|docetaxel|mesh-list
110283317|NCT00477529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110283318|NCT00477529|Tubulin Modulators|tubulin modulators|mesh-ancestor
110283319|NCT00477529|Antimitotic Agents|antimitotic agents|mesh-ancestor
110283320|NCT00477529|Mitosis Modulators|mitosis modulators|mesh-ancestor
110283321|NCT00477529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110283322|NCT00472693|Bevacizumab|bevacizumab|mesh-list
110283323|NCT00472693|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110283324|NCT00472693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110283325|NCT00472693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110283326|NCT00472693|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110283327|NCT00472693|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110283328|NCT00472693|Growth Substances|growth substances|mesh-ancestor
110283329|NCT00472693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283330|NCT00472693|Growth Inhibitors|growth inhibitors|mesh-ancestor
110275745|NCT01652482|Cetuximab|cetuximab|mesh-list
110275746|NCT01652482|Antimetabolites|antimetabolites|mesh-ancestor
110275747|NCT01652482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275748|NCT01652482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110275749|NCT01652482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110275750|NCT01652482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110275751|NCT01652482|Immunologic Factors|immunologic factors|mesh-ancestor
110275752|NCT01652482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110275753|NCT01652482|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110275754|NCT01652482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110275755|NCT01652482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110275756|NCT01652482|Antidotes|antidotes|mesh-ancestor
110275757|NCT01652482|Protective Agents|protective agents|mesh-ancestor
110275758|NCT01652482|Vitamin B Complex|vitamin b complex|mesh-ancestor
110275760|NCT01652482|Micronutrients|micronutrients|mesh-ancestor
110283331|NCT00195845|Galantamine|galantamine|mesh-list
110283332|NCT00195845|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110283333|NCT00195845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110283334|NCT00195845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110283335|NCT00195845|Cholinergic Agents|cholinergic agents|mesh-ancestor
110283336|NCT00195845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110283337|NCT00195845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283338|NCT00195845|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110283339|NCT00195845|Autonomic Agents|autonomic agents|mesh-ancestor
110283340|NCT00195845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110283341|NCT00195845|Nootropic Agents|nootropic agents|mesh-ancestor
110283342|NCT00202514|Valproic Acid|valproic acid|mesh-list
110283343|NCT00202514|Anticonvulsants|anticonvulsants|mesh-ancestor
110283344|NCT00202514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110283368|NCT00195923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110283370|NCT00225615|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110283371|NCT00225615|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110283372|NCT00225615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110283373|NCT00225615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110283374|NCT00225615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110283375|NCT00225615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283376|NCT00225615|Vasodilator Agents|vasodilator agents|mesh-ancestor
110283377|NCT00202553|Perindopril|perindopril|mesh-list
110283378|NCT00202553|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110283379|NCT00202553|Protease Inhibitors|protease inhibitors|mesh-ancestor
110283381|NCT00202553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110283382|NCT00202553|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110283383|NCT00202592|Perindopril|perindopril|mesh-list
110283384|NCT00202592|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110283385|NCT00202592|Protease Inhibitors|protease inhibitors|mesh-ancestor
110283386|NCT00202592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110283387|NCT00202592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110283388|NCT00202592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110283389|NCT00411333|Triamcinolone|triamcinolone|mesh-list
110283390|NCT00411333|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110283391|NCT00411333|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110283392|NCT00411333|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110283393|NCT00411333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110283394|NCT00411333|Glucocorticoids|glucocorticoids|mesh-ancestor
110275761|NCT01652482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110275762|NCT00174629|Gemcitabine|gemcitabine|mesh-list
110275764|NCT00174629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110275765|NCT00174629|Antimetabolites|antimetabolites|mesh-ancestor
110275766|NCT00174629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275767|NCT00174629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110275768|NCT00174629|Tubulin Modulators|tubulin modulators|mesh-ancestor
110275769|NCT00174629|Antimitotic Agents|antimitotic agents|mesh-ancestor
110275771|NCT02962947|Propranolol|propranolol|mesh-list
110275772|NCT02962947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110275773|NCT02962947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110275774|NCT02962947|Adrenergic Agents|adrenergic agents|mesh-ancestor
110275775|NCT02962947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110275776|NCT02962947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275777|NCT02962947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110275778|NCT02962947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110275779|NCT02962947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110275780|NCT02962947|Vasodilator Agents|vasodilator agents|mesh-ancestor
110275781|NCT00555334|Lamivudine|lamivudine|mesh-list
110275782|NCT00555334|Entecavir|entecavir|mesh-list
110275783|NCT00555334|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110275784|NCT00555334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110275785|NCT00555334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110275786|NCT00555334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110283396|NCT00411333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110283397|NCT00411333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283406|NCT00225849|Sensory System Agents|sensory system agents|mesh-ancestor
110283407|NCT00225849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110283408|NCT00225849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283409|NCT00225849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110283410|NCT00225849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110283411|NCT00225849|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110283412|NCT00225849|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110283413|NCT00225849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110283414|NCT00225849|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110283415|NCT00225849|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110283416|NCT00225849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110283420|NCT00202787|Fluorouracil|fluorouracil|mesh-list
110283421|NCT00202787|Oxaliplatin|oxaliplatin|mesh-list
110283422|NCT00202787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110283423|NCT00202787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110283424|NCT00202787|Antimetabolites|antimetabolites|mesh-ancestor
110283425|NCT00202787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275787|NCT00555334|Antiviral Agents|antiviral agents|mesh-ancestor
110275788|NCT00555334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110275789|NCT00555334|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110275790|NCT00555334|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110275791|NCT01640080|Esketamine|esketamine|mesh-list
110275792|NCT01640080|Antidepressive Agents|antidepressive agents|mesh-ancestor
110275793|NCT01640080|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110275794|NCT00174668|Insulin|insulin|mesh-list
110275795|NCT00174668|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110275796|NCT00174668|Insulin Glargine|insulin glargine|mesh-list
110275797|NCT00174668|Insulin glulisine|insulin glulisine|mesh-list
110275798|NCT00174668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110275799|NCT00174668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110275800|NCT00174707|Cyclophosphamide|cyclophosphamide|mesh-list
110275801|NCT00174707|Docetaxel|docetaxel|mesh-list
110275802|NCT00174707|Methotrexate|methotrexate|mesh-list
110275803|NCT00174707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110275804|NCT00174707|Immunologic Factors|immunologic factors|mesh-ancestor
110275805|NCT00174707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110275806|NCT00174707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110275807|NCT00174707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110275808|NCT00174707|Alkylating Agents|alkylating agents|mesh-ancestor
110275809|NCT00174707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275810|NCT00174707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110275811|NCT00174707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110275812|NCT00174707|Tubulin Modulators|tubulin modulators|mesh-ancestor
110283426|NCT00202787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110283427|NCT00202787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110283428|NCT00202787|Immunologic Factors|immunologic factors|mesh-ancestor
110283429|NCT00202787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283430|NCT00202787|Antidotes|antidotes|mesh-ancestor
110283431|NCT00202787|Protective Agents|protective agents|mesh-ancestor
110283432|NCT00202787|Vitamin B Complex|vitamin b complex|mesh-ancestor
110283433|NCT00202787|Vitamins|vitamins|mesh-ancestor
110283434|NCT00202787|Micronutrients|micronutrients|mesh-ancestor
110283435|NCT00424437|Insulin|insulin|mesh-list
110283436|NCT00424437|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110283437|NCT00424437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110283438|NCT00424437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283439|NCT00202865|Infliximab|infliximab|mesh-list
110283440|NCT00202865|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110283441|NCT00202865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110283442|NCT00202865|Dermatologic Agents|dermatologic agents|mesh-ancestor
110283443|NCT00202865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110283444|NCT00202865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110283445|NCT00226005|Vatalanib|vatalanib|mesh-list
110283446|NCT00226005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110283447|NCT00226005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110283448|NCT00226005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110283450|NCT00196352|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110275815|NCT00174707|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110275816|NCT00174707|Abortifacient Agents|abortifacient agents|mesh-ancestor
110275817|NCT00174707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110275818|NCT00174707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110275819|NCT00174707|Antimetabolites|antimetabolites|mesh-ancestor
110275820|NCT00174707|Dermatologic Agents|dermatologic agents|mesh-ancestor
110275821|NCT00174707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110275822|NCT00174707|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110275823|NCT00174707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110275825|NCT01235923|Hematinics|hematinics|mesh-ancestor
110275826|NCT00199134|Letrozole|letrozole|mesh-list
110275833|NCT00199134|Hormone Antagonists|hormone antagonists|mesh-ancestor
110275834|NCT00199134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110275835|NCT00199134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110275836|NCT00174824|Insulin Glargine|insulin glargine|mesh-list
110275837|NCT00174824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110275838|NCT00174824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110275840|NCT00174863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110275841|NCT00174863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110283451|NCT00196352|Contraceptive Agents|contraceptive agents|mesh-ancestor
110283452|NCT00196352|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110283453|NCT00196352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283454|NCT00196352|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110283455|NCT00196352|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110283456|NCT00196352|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110283458|NCT00226044|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110283459|NCT00226044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110283460|NCT00226044|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110283461|NCT00226044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110283462|NCT00226044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110283464|NCT00202982|(T,G)-A-L|(t,g)-a-l|mesh-list
110283480|NCT00207948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110283481|NCT00207948|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110283482|NCT00207948|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110283483|NCT00196391|Progesterone|progesterone|mesh-list
110275842|NCT00174863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110275843|NCT00174863|Immunologic Factors|immunologic factors|mesh-ancestor
110275844|NCT00174863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110275845|NCT00712582|Cyclophosphamide|cyclophosphamide|mesh-list
110275846|NCT00712582|Ifosfamide|ifosfamide|mesh-list
110275847|NCT00712582|Isophosphamide mustard|isophosphamide mustard|mesh-list
110275848|NCT00712582|Carmustine|carmustine|mesh-list
110275849|NCT00712582|Rituximab|rituximab|mesh-list
110275850|NCT00712582|Carboplatin|carboplatin|mesh-list
110275851|NCT00712582|Etoposide|etoposide|mesh-list
110275852|NCT00712582|Etoposide phosphate|etoposide phosphate|mesh-list
110275853|NCT00712582|Mitoxantrone|mitoxantrone|mesh-list
110283486|NCT00196391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110283487|NCT00196391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283488|NCT00203060|Rasagiline|rasagiline|mesh-list
110283489|NCT00203060|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110283490|NCT00203060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110283491|NCT00203060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110283492|NCT00203060|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110283493|NCT00203060|Protective Agents|protective agents|mesh-ancestor
110283494|NCT00203060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283495|NCT00226122|Indomethacin|indomethacin|mesh-list
110283496|NCT00226122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110283497|NCT00226122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110283498|NCT00226122|Analgesics|analgesics|mesh-ancestor
110283499|NCT00226122|Sensory System Agents|sensory system agents|mesh-ancestor
110283500|NCT00226122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110283501|NCT00226122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283502|NCT00226122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110283503|NCT00226122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110283504|NCT00226122|Gout Suppressants|gout suppressants|mesh-ancestor
110283506|NCT00226122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110283507|NCT00226122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110283508|NCT00226122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110283509|NCT00226122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110283511|NCT00196469|Anticoagulants|anticoagulants|mesh-ancestor
110283512|NCT00196469|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110283513|NCT00196469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110283514|NCT00196469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110283515|NCT00208065|Pseudoephedrine|pseudoephedrine|mesh-list
110283516|NCT00208065|Ephedrine|ephedrine|mesh-list
110283517|NCT00208065|Almotriptan|almotriptan|mesh-list
110283518|NCT00208065|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110283519|NCT00208065|Autonomic Agents|autonomic agents|mesh-ancestor
110283520|NCT00208065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110283521|NCT00208065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283522|NCT00208065|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110283523|NCT00208065|Respiratory System Agents|respiratory system agents|mesh-ancestor
110283530|NCT00208065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110283532|NCT00208065|Serotonin Agents|serotonin agents|mesh-ancestor
110283533|NCT00203099|Acetylcysteine|acetylcysteine|mesh-list
110283534|NCT00203099|Glatiramer Acetate|glatiramer acetate|mesh-list
110283535|NCT00203099|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110283537|NCT00203099|Antiviral Agents|antiviral agents|mesh-ancestor
110283538|NCT00203099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110283539|NCT00203099|Expectorants|expectorants|mesh-ancestor
110283540|NCT00203099|Respiratory System Agents|respiratory system agents|mesh-ancestor
110283541|NCT00203099|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110283542|NCT00203099|Antioxidants|antioxidants|mesh-ancestor
110275855|NCT00712582|Immunologic Factors|immunologic factors|mesh-ancestor
110275856|NCT00712582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110275857|NCT00712582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110275858|NCT00712582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110275859|NCT00712582|Alkylating Agents|alkylating agents|mesh-ancestor
110275860|NCT00712582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275861|NCT00712582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110275862|NCT00712582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110275863|NCT00712582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110275864|NCT00712582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110283543|NCT00203099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110283544|NCT00203099|Protective Agents|protective agents|mesh-ancestor
110283545|NCT00203099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283547|NCT00203099|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110283548|NCT00203099|Immunologic Factors|immunologic factors|mesh-ancestor
110283549|NCT00203099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110283550|NCT00203099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110283551|NCT00226200|Omalizumab|omalizumab|mesh-list
110283552|NCT00226200|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110283553|NCT00226200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110283554|NCT00226200|Respiratory System Agents|respiratory system agents|mesh-ancestor
110283555|NCT00203138|Rasagiline|rasagiline|mesh-list
110283556|NCT00203138|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110283557|NCT00203138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110283558|NCT00203138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110283559|NCT00203138|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110283560|NCT00203138|Protective Agents|protective agents|mesh-ancestor
110283561|NCT00203138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283562|NCT00196547|Montelukast|montelukast|mesh-list
110283563|NCT00196547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110283564|NCT00196547|Respiratory System Agents|respiratory system agents|mesh-ancestor
110283565|NCT00196547|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110283566|NCT00196547|Hormone Antagonists|hormone antagonists|mesh-ancestor
110283567|NCT00196547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110283568|NCT00196547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283569|NCT00196547|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110283570|NCT00196547|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110283571|NCT00196547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110283573|NCT00203177|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110283574|NCT00203177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110283575|NCT00203177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110283576|NCT00203177|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110283577|NCT00203177|Protective Agents|protective agents|mesh-ancestor
110283578|NCT00203177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283579|NCT00208143|Risperidone|risperidone|mesh-list
110283580|NCT00208143|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110283582|NCT00208143|Serotonin Agents|serotonin agents|mesh-ancestor
110283583|NCT00208143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110283584|NCT00208143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110283585|NCT00208143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283586|NCT00208143|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110283587|NCT00208143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110283588|NCT00208143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110283589|NCT00208143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110283590|NCT00208143|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110283591|NCT00208143|Dopamine Agents|dopamine agents|mesh-ancestor
110283592|NCT00208143|Antidepressive Agents|antidepressive agents|mesh-ancestor
110283600|NCT00196586|Antiviral Agents|antiviral agents|mesh-ancestor
110283601|NCT00196586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110275866|NCT00712582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110275867|NCT00712582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110275869|NCT00712582|Sensory System Agents|sensory system agents|mesh-ancestor
110275870|NCT00712582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110275871|NCT00174902|Aspirin|aspirin|mesh-list
110275872|NCT00174902|Propranolol|propranolol|mesh-list
110275873|NCT00174902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110275874|NCT00174902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110275875|NCT00174902|Analgesics|analgesics|mesh-ancestor
110275876|NCT00174902|Sensory System Agents|sensory system agents|mesh-ancestor
110275877|NCT00174902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110283602|NCT00196586|Antimetabolites|antimetabolites|mesh-ancestor
110283603|NCT00196586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110283604|NCT00196586|Immunologic Factors|immunologic factors|mesh-ancestor
110283605|NCT00196586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283606|NCT00196586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110283607|NCT00196586|Analgesics|analgesics|mesh-ancestor
110283608|NCT00196586|Sensory System Agents|sensory system agents|mesh-ancestor
110283609|NCT00196586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110283610|NCT00226317|Aripiprazole|aripiprazole|mesh-list
110283611|NCT00226317|Antidepressive Agents|antidepressive agents|mesh-ancestor
110283612|NCT00226317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110283613|NCT00226317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110283614|NCT00226317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110283615|NCT00226317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110283616|NCT00226317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283617|NCT00226317|Dopamine Agonists|dopamine agonists|mesh-ancestor
110283618|NCT00226317|Dopamine Agents|dopamine agents|mesh-ancestor
110283619|NCT00226317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110283620|NCT00226317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110283621|NCT00226317|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110283622|NCT00226317|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110283623|NCT00226317|Serotonin Agents|serotonin agents|mesh-ancestor
110283624|NCT00226317|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110283626|NCT00226317|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110283627|NCT00226317|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110283629|NCT00226356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110283630|NCT00226356|Lipotropic Agents|lipotropic agents|mesh-ancestor
110283631|NCT00226356|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110283632|NCT00226356|Antimetabolites|antimetabolites|mesh-ancestor
110283633|NCT00226356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110283634|NCT00226356|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110283635|NCT00208182|Risperidone|risperidone|mesh-list
110283636|NCT00208182|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110283637|NCT00208182|Serotonin Agents|serotonin agents|mesh-ancestor
110283638|NCT00208182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110283639|NCT00208182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275878|NCT00174902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110275880|NCT00174902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110275881|NCT00174902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110275882|NCT00174902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110275883|NCT00174902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275884|NCT00174902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110275886|NCT00174902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110275887|NCT00174902|Antipyretics|antipyretics|mesh-ancestor
110275888|NCT00174902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110275889|NCT00174902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110275890|NCT00174902|Adrenergic Agents|adrenergic agents|mesh-ancestor
110275891|NCT00174902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110275892|NCT00174902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110283640|NCT00208182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283641|NCT00208182|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110283642|NCT00208182|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110283643|NCT00208182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110283644|NCT00208182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110283645|NCT00208182|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110283646|NCT00208182|Dopamine Agents|dopamine agents|mesh-ancestor
110283647|NCT00226395|Oxymorphone|oxymorphone|mesh-list
110283648|NCT00226395|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110283650|NCT00226395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110283651|NCT00226395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283653|NCT00226395|Sensory System Agents|sensory system agents|mesh-ancestor
110283654|NCT00226395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110283655|NCT00226395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110283657|NCT00208221|Ramipril|ramipril|mesh-list
110283658|NCT00208221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110283659|NCT00208221|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110283660|NCT00208221|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110283661|NCT00208221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110283668|NCT00196625|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110283670|NCT00196625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110283671|NCT00196625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110283673|NCT00196625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110283674|NCT00196625|Antiviral Agents|antiviral agents|mesh-ancestor
110283675|NCT00196625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110283676|NCT00196625|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110283677|NCT00196625|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110283678|NCT00196625|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110283679|NCT00196625|Antitubercular Agents|antitubercular agents|mesh-ancestor
110283680|NCT00196625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110283681|NCT00226434|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110283682|NCT00226434|Antiviral Agents|antiviral agents|mesh-ancestor
110283683|NCT00226434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110283684|NCT00208260|Leucovorin|leucovorin|mesh-list
110283685|NCT00208260|Fluorouracil|fluorouracil|mesh-list
110283686|NCT00208260|Oxaliplatin|oxaliplatin|mesh-list
110283687|NCT00208260|Folfirinox|folfirinox|mesh-list
110283688|NCT00208260|Antimetabolites|antimetabolites|mesh-ancestor
110283689|NCT00208260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275893|NCT00174902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110275894|NCT00174902|Vasodilator Agents|vasodilator agents|mesh-ancestor
110275895|NCT00373711|Iodine|iodine|mesh-list
110275896|NCT00373711|Cadexomer iodine|cadexomer iodine|mesh-list
110275897|NCT00373711|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110275898|NCT00373711|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110275899|NCT00373711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110275900|NCT00373711|Trace Elements|trace elements|mesh-ancestor
110275901|NCT00373711|Micronutrients|micronutrients|mesh-ancestor
110275902|NCT00373711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110275903|NCT00373711|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110275904|NCT00373711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275905|NCT00199212|Trastuzumab|trastuzumab|mesh-list
110275906|NCT00199212|Bortezomib|bortezomib|mesh-list
110283690|NCT00208260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110283691|NCT00208260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110283692|NCT00208260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110283693|NCT00208260|Immunologic Factors|immunologic factors|mesh-ancestor
110283694|NCT00208260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283695|NCT00208260|Antidotes|antidotes|mesh-ancestor
110283696|NCT00208260|Protective Agents|protective agents|mesh-ancestor
110283697|NCT00208260|Vitamin B Complex|vitamin b complex|mesh-ancestor
110283698|NCT00208260|Vitamins|vitamins|mesh-ancestor
110283699|NCT00208260|Micronutrients|micronutrients|mesh-ancestor
110283700|NCT00226473|Dacarbazine|dacarbazine|mesh-list
110283701|NCT00226473|Vindesine|vindesine|mesh-list
110283702|NCT00226473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110283703|NCT00226473|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110283704|NCT00226473|Alkylating Agents|alkylating agents|mesh-ancestor
110283705|NCT00226473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110283706|NCT00226473|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110283707|NCT00226473|Tubulin Modulators|tubulin modulators|mesh-ancestor
110283708|NCT00226473|Antimitotic Agents|antimitotic agents|mesh-ancestor
110283709|NCT00226473|Mitosis Modulators|mitosis modulators|mesh-ancestor
110283710|NCT00208299|Adenosine|adenosine|mesh-list
110283711|NCT00208299|Regadenoson|regadenoson|mesh-list
110283712|NCT00208299|Analgesics|analgesics|mesh-ancestor
110283713|NCT00208299|Sensory System Agents|sensory system agents|mesh-ancestor
110283714|NCT00208299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110283715|NCT00208299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283716|NCT00208299|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110283717|NCT00208299|Vasodilator Agents|vasodilator agents|mesh-ancestor
110283718|NCT00208299|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110283719|NCT00208299|Purinergic Agonists|purinergic agonists|mesh-ancestor
110283720|NCT00208299|Purinergic Agents|purinergic agents|mesh-ancestor
110283721|NCT00208299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110283722|NCT00208299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110283723|NCT00208299|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
110283725|NCT00196664|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110283726|NCT00196664|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110283727|NCT00196664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110283729|NCT00196664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110283730|NCT00196664|Serotonin Agents|serotonin agents|mesh-ancestor
110283733|NCT00196664|Antidepressive Agents|antidepressive agents|mesh-ancestor
110283734|NCT00196664|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110283735|NCT00196664|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110283736|NCT00196664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110283737|NCT00196664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110283739|NCT00196703|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110283740|NCT00196703|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110275907|NCT00199212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110275908|NCT00199212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110275910|NCT00555373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110275911|NCT00555373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110275912|NCT00555373|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110275913|NCT00555373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110275914|NCT00555373|Antifungal Agents|antifungal agents|mesh-ancestor
110275915|NCT00555373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110275916|NCT00555373|Immunologic Factors|immunologic factors|mesh-ancestor
110275917|NCT00555373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110275919|NCT00555412|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110275920|NCT00555412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110275921|NCT00555412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110275922|NCT00555412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110275923|NCT00555412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110275924|NCT00555412|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110275925|NCT00555412|Dopamine Agents|dopamine agents|mesh-ancestor
110275926|NCT00555412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110275927|NCT00555412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275928|NCT04676776|Levonorgestrel|levonorgestrel|mesh-list
110275929|NCT04676776|Mifepristone|mifepristone|mesh-list
110283741|NCT00196703|Dopamine Agents|dopamine agents|mesh-ancestor
110283742|NCT00196703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110283743|NCT00196703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110283744|NCT00196703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283745|NCT00196703|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110283746|NCT00196703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110283747|NCT00413322|Fluorouracil|fluorouracil|mesh-list
110283748|NCT00413322|Belinostat|belinostat|mesh-list
110283750|NCT00413322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110283751|NCT00413322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110283752|NCT00413322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110283753|NCT00413322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110283754|NCT00413322|Immunologic Factors|immunologic factors|mesh-ancestor
110283755|NCT00413322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283756|NCT00413322|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110283757|NCT00413322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110283758|NCT00413361|Hydroxychloroquine|hydroxychloroquine|mesh-list
110283759|NCT00413361|Antimalarials|antimalarials|mesh-ancestor
110283760|NCT00413361|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110283761|NCT00413361|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110283762|NCT00413361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110283763|NCT00413361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110283764|NCT00413361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110283765|NCT00413361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110283766|NCT00410657|Prednisone|prednisone|mesh-list
110283767|NCT00410657|Methylprednisolone|methylprednisolone|mesh-list
110283768|NCT00410657|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110283769|NCT00410657|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110283770|NCT00410657|Prednisolone|prednisolone|mesh-list
110275930|NCT04676776|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110275931|NCT04676776|Contraceptive Agents|contraceptive agents|mesh-ancestor
110275932|NCT04676776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110275933|NCT04676776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110275934|NCT04676776|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110275935|NCT04676776|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110275936|NCT04676776|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110275937|NCT04676776|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110275938|NCT04676776|Abortifacient Agents|abortifacient agents|mesh-ancestor
110275939|NCT04676776|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110275940|NCT04676776|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110275941|NCT04676776|Hormone Antagonists|hormone antagonists|mesh-ancestor
110275942|NCT04676776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110275943|NCT04676776|Luteolytic Agents|luteolytic agents|mesh-ancestor
110275944|NCT04676776|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110275945|NCT00175253|Alemtuzumab|alemtuzumab|mesh-list
110275946|NCT00175253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110275947|NCT00175253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110275948|NCT00199329|Ondansetron|ondansetron|mesh-list
110283771|NCT00410657|Prednisolone acetate|prednisolone acetate|mesh-list
110283772|NCT00410657|Alemtuzumab|alemtuzumab|mesh-list
110283773|NCT00410657|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110283774|NCT00410657|Prednisolone phosphate|prednisolone phosphate|mesh-list
110283775|NCT00410657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110283776|NCT00410657|Glucocorticoids|glucocorticoids|mesh-ancestor
110283777|NCT00410657|Hormones|hormones|mesh-ancestor
110283778|NCT00410657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110283779|NCT00410657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283780|NCT00410657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110283781|NCT00410657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110283782|NCT00410657|Antiemetics|antiemetics|mesh-ancestor
110283783|NCT00410657|Autonomic Agents|autonomic agents|mesh-ancestor
110283784|NCT00410657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110283785|NCT00410657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110283786|NCT00410657|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110283787|NCT00410657|Protective Agents|protective agents|mesh-ancestor
110283788|NCT00410657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110283789|NCT00196820|Capecitabine|capecitabine|mesh-list
110283790|NCT00196820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110283791|NCT00196820|Antimetabolites|antimetabolites|mesh-ancestor
110283792|NCT00196820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110283793|NCT00196820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110283794|NCT00410696|Lenograstim|lenograstim|mesh-list
110283795|NCT00410696|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110283796|NCT00410696|Immunologic Factors|immunologic factors|mesh-ancestor
110283797|NCT00410696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283798|NCT00226512|Alemtuzumab|alemtuzumab|mesh-list
110283799|NCT00226512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110283800|NCT00226512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110283801|NCT00410735|Pranlukast|pranlukast|mesh-list
110283802|NCT00410735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110283807|NCT00410735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283808|NCT00203372|Cyclophosphamide|cyclophosphamide|mesh-list
110283809|NCT00203372|Bevacizumab|bevacizumab|mesh-list
110283810|NCT00203372|Docetaxel|docetaxel|mesh-list
110275949|NCT00199329|Antiemetics|antiemetics|mesh-ancestor
110275950|NCT00199329|Autonomic Agents|autonomic agents|mesh-ancestor
110275951|NCT00199329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110275952|NCT00199329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110275953|NCT00199329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110275954|NCT00199329|Antipruritics|antipruritics|mesh-ancestor
110275955|NCT00199329|Dermatologic Agents|dermatologic agents|mesh-ancestor
110275956|NCT00199329|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110275957|NCT00199329|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110275958|NCT00199329|Serotonin Agents|serotonin agents|mesh-ancestor
110275959|NCT00199329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110283811|NCT00203372|Doxorubicin|doxorubicin|mesh-list
110283812|NCT00203372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110283813|NCT00203372|Immunologic Factors|immunologic factors|mesh-ancestor
110283814|NCT00203372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283816|NCT00203372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110283817|NCT00203372|Alkylating Agents|alkylating agents|mesh-ancestor
110283818|NCT00203372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110283819|NCT00203372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110283820|NCT00203372|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110283821|NCT00203372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110283822|NCT00203372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110283823|NCT00203372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110283824|NCT00203372|Growth Substances|growth substances|mesh-ancestor
110283825|NCT00203372|Growth Inhibitors|growth inhibitors|mesh-ancestor
110283826|NCT00203372|Tubulin Modulators|tubulin modulators|mesh-ancestor
110283827|NCT00203372|Antimitotic Agents|antimitotic agents|mesh-ancestor
110283828|NCT00203372|Mitosis Modulators|mitosis modulators|mesh-ancestor
110283829|NCT00203372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110283830|NCT00203372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110283831|NCT00203372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110283832|NCT00203372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110283833|NCT00226551|Isoproterenol|isoproterenol|mesh-list
110283834|NCT00226551|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110283835|NCT00226551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110283836|NCT00226551|Adrenergic Agents|adrenergic agents|mesh-ancestor
110283837|NCT00226551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110283838|NCT00226551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110283839|NCT00226551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283840|NCT00226551|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110283842|NCT00226551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110283843|NCT00226551|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110283844|NCT00226551|Respiratory System Agents|respiratory system agents|mesh-ancestor
110283846|NCT00226551|Sympathomimetics|sympathomimetics|mesh-ancestor
110283847|NCT00226551|Protective Agents|protective agents|mesh-ancestor
110283848|NCT00196859|Ibandronic Acid|ibandronic acid|mesh-list
110283850|NCT00196859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110283851|NCT00196859|Antimetabolites|antimetabolites|mesh-ancestor
110283852|NCT00196859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110283853|NCT00196859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110283854|NCT00196859|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110283855|NCT00196859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283856|NCT00208533|Aripiprazole|aripiprazole|mesh-list
110283857|NCT00208533|Antidepressive Agents|antidepressive agents|mesh-ancestor
110283859|NCT00208533|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110283860|NCT00208533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110283861|NCT00208533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110283862|NCT00208533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283863|NCT00208533|Dopamine Agonists|dopamine agonists|mesh-ancestor
110283864|NCT00208533|Dopamine Agents|dopamine agents|mesh-ancestor
110275960|NCT00199329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275962|NCT00555607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110275963|NCT00555607|Glucocorticoids|glucocorticoids|mesh-ancestor
110275964|NCT00555607|Hormones|hormones|mesh-ancestor
110275965|NCT00555607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110275966|NCT00555607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110275967|NCT00555607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110275969|NCT00199368|Istradefylline|istradefylline|mesh-list
110283865|NCT00208533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110283866|NCT00208533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110283867|NCT00208533|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110283868|NCT00208533|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110283870|NCT00208533|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110283871|NCT00208533|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110283876|NCT00203450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110283877|NCT00203450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110283878|NCT00203450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110283879|NCT00203450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110283880|NCT00203450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283881|NCT00226668|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
110283882|NCT00226668|Hormones|hormones|mesh-ancestor
110283883|NCT00226668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110283884|NCT00226668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283886|NCT00208572|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110283887|NCT00208572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110283888|NCT00208572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110283889|NCT00208572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110283890|NCT00208572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110283891|NCT00208572|Serotonin Agents|serotonin agents|mesh-ancestor
110283892|NCT00208572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283893|NCT00208572|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110283894|NCT00208572|Antidepressive Agents|antidepressive agents|mesh-ancestor
110283895|NCT00208572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110283897|NCT00226707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110283898|NCT00226707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110283899|NCT00226707|Analgesics|analgesics|mesh-ancestor
110283900|NCT00226707|Sensory System Agents|sensory system agents|mesh-ancestor
110283901|NCT00226707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110283902|NCT00226707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283903|NCT00226707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110283904|NCT00226707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110283905|NCT00226707|Dermatologic Agents|dermatologic agents|mesh-ancestor
110283906|NCT00226707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110283907|NCT00226707|Immunologic Factors|immunologic factors|mesh-ancestor
110283908|NCT00226707|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110283909|NCT00226707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110283910|NCT00226707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110283911|NCT00203528|Valproic Acid|valproic acid|mesh-list
110283912|NCT00203528|Risperidone|risperidone|mesh-list
110283913|NCT00203528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110283914|NCT00203528|Serotonin Agents|serotonin agents|mesh-ancestor
110283915|NCT00203528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110283916|NCT00203528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110283917|NCT00203528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110275970|NCT00199368|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
110275971|NCT00199368|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110275972|NCT00199368|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110275973|NCT00199368|Purinergic Agents|purinergic agents|mesh-ancestor
110275974|NCT00199368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110275975|NCT00199368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275976|NCT00199368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110275977|NCT04675528|Paclitaxel|paclitaxel|mesh-list
110275978|NCT04675528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110275979|NCT04675528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110275980|NCT04675528|Tubulin Modulators|tubulin modulators|mesh-ancestor
110275981|NCT04675528|Antimitotic Agents|antimitotic agents|mesh-ancestor
110275982|NCT04675528|Mitosis Modulators|mitosis modulators|mesh-ancestor
110275983|NCT04675528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275984|NCT04675177|Polidocanol|polidocanol|mesh-list
110275985|NCT04675177|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
110275986|NCT04675177|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110283918|NCT00203528|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110283919|NCT00203528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110283920|NCT00203528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110283921|NCT00203528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110283922|NCT00203528|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110283923|NCT00203528|Dopamine Agents|dopamine agents|mesh-ancestor
110283924|NCT00203528|Anticonvulsants|anticonvulsants|mesh-ancestor
110283925|NCT00203528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110283926|NCT00203528|GABA Agents|gaba agents|mesh-ancestor
110283927|NCT00203528|Antimanic Agents|antimanic agents|mesh-ancestor
110283928|NCT00208611|Vitamins|vitamins|mesh-list
110283929|NCT00208611|Vitamin B 12|vitamin b 12|mesh-list
110283930|NCT00208611|Hydroxocobalamin|hydroxocobalamin|mesh-list
110283931|NCT00208611|Vitamin B Complex|vitamin b complex|mesh-list
110283932|NCT00208611|Micronutrients|micronutrients|mesh-ancestor
110283933|NCT00208611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283934|NCT00208611|Hematinics|hematinics|mesh-ancestor
110283935|NCT00203567|Carbamazepine|carbamazepine|mesh-list
110283936|NCT00203567|Anticonvulsants|anticonvulsants|mesh-ancestor
110283937|NCT00203567|Antimanic Agents|antimanic agents|mesh-ancestor
110283938|NCT00203567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110283939|NCT00203567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110283940|NCT00203567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283941|NCT00203567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110283943|NCT00203567|Analgesics|analgesics|mesh-ancestor
110283947|NCT00203567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110283948|NCT00203567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110283949|NCT00203567|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110283950|NCT00203567|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110283952|NCT00226746|Gemcitabine|gemcitabine|mesh-list
110283953|NCT00226746|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110283954|NCT00226746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110283955|NCT00226746|Tubulin Modulators|tubulin modulators|mesh-ancestor
110283956|NCT00226746|Antimitotic Agents|antimitotic agents|mesh-ancestor
110283957|NCT00226746|Mitosis Modulators|mitosis modulators|mesh-ancestor
110283958|NCT00226746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110283959|NCT00226746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110283960|NCT00226746|Antimetabolites|antimetabolites|mesh-ancestor
110283961|NCT00203606|Interferons|interferons|mesh-list
110283962|NCT00203606|Ribavirin|ribavirin|mesh-list
110275987|NCT00175370|Vancomycin|vancomycin|mesh-list
110275988|NCT00175370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110275989|NCT00175370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110275990|NCT00204243|Naltrexone|naltrexone|mesh-list
110275991|NCT00204243|Methadone|methadone|mesh-list
110275992|NCT00204243|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110275993|NCT00204243|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110275994|NCT00204243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283963|NCT00203606|Interferon-alpha|interferon-alpha|mesh-list
110283964|NCT00203606|Interferon alpha-2|interferon alpha-2|mesh-list
110283965|NCT00203606|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110283966|NCT00203606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110283967|NCT00203606|Antiviral Agents|antiviral agents|mesh-ancestor
110283968|NCT00203606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110283969|NCT00203606|Antimetabolites|antimetabolites|mesh-ancestor
110283970|NCT00203606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110283971|NCT00203606|Immunologic Factors|immunologic factors|mesh-ancestor
110283972|NCT00203606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283973|NCT00203684|Flunisolide|flunisolide|mesh-list
110283974|NCT00203684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110283975|NCT00203684|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110283976|NCT00203684|Respiratory System Agents|respiratory system agents|mesh-ancestor
110283977|NCT00226785|Dexmedetomidine|dexmedetomidine|mesh-list
110283978|NCT00226785|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110283979|NCT00226785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110283980|NCT00226785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283981|NCT00226785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110283982|NCT00226785|Analgesics|analgesics|mesh-ancestor
110283983|NCT00226785|Sensory System Agents|sensory system agents|mesh-ancestor
110283984|NCT00226785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110283985|NCT00226785|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110283986|NCT00226785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110283987|NCT00226785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110283988|NCT00226785|Adrenergic Agents|adrenergic agents|mesh-ancestor
110283989|NCT00226785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110283990|NCT00226785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110283991|NCT00197132|Rosiglitazone|rosiglitazone|mesh-list
110283992|NCT00197132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110283993|NCT00197132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283994|NCT00226824|Galantamine|galantamine|mesh-list
110283995|NCT00226824|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110283996|NCT00226824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110283997|NCT00226824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110283998|NCT00226824|Cholinergic Agents|cholinergic agents|mesh-ancestor
110283999|NCT00226824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110284000|NCT00226824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284001|NCT00226824|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110284003|NCT00226824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110284004|NCT00226824|Nootropic Agents|nootropic agents|mesh-ancestor
110284005|NCT00197249|Vaccines|vaccines|mesh-list
110284006|NCT00197249|Immunologic Factors|immunologic factors|mesh-ancestor
110284007|NCT00197249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284008|NCT00203723|Risperidone|risperidone|mesh-list
110284009|NCT00203723|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110284010|NCT00203723|Serotonin Agents|serotonin agents|mesh-ancestor
110284011|NCT00203723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110284012|NCT00203723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110284013|NCT00203723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284014|NCT00203723|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110284020|NCT00226902|Chrysarobin|chrysarobin|mesh-list
110284021|NCT00226902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110284022|NCT00226902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110284023|NCT00226902|Analgesics|analgesics|mesh-ancestor
110284024|NCT00226902|Sensory System Agents|sensory system agents|mesh-ancestor
110284025|NCT00226902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110284026|NCT00226902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284027|NCT00226902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110275995|NCT00204243|Sensory System Agents|sensory system agents|mesh-ancestor
110275996|NCT00204243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110275997|NCT00204243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110275998|NCT00204243|Narcotics|narcotics|mesh-ancestor
110275999|NCT00204243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110276000|NCT00204243|Analgesics|analgesics|mesh-ancestor
110276001|NCT00204243|Antitussive Agents|antitussive agents|mesh-ancestor
110276002|NCT00204243|Respiratory System Agents|respiratory system agents|mesh-ancestor
110276004|NCT04675372|Dexmedetomidine|dexmedetomidine|mesh-list
110276005|NCT04675372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110276006|NCT04675372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110276007|NCT04675372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276008|NCT04675372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110276009|NCT04675372|Analgesics|analgesics|mesh-ancestor
110284028|NCT00226902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110284029|NCT00203762|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110284030|NCT00203762|Antiviral Agents|antiviral agents|mesh-ancestor
110284031|NCT00203762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110284032|NCT00226980|Thalidomide|thalidomide|mesh-list
110284033|NCT00226980|Capecitabine|capecitabine|mesh-list
110284034|NCT00226980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110284035|NCT00226980|Antimetabolites|antimetabolites|mesh-ancestor
110284036|NCT00226980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110284037|NCT00226980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110284038|NCT00226980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110284039|NCT00226980|Immunologic Factors|immunologic factors|mesh-ancestor
110284040|NCT00226980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284041|NCT00226980|Leprostatic Agents|leprostatic agents|mesh-ancestor
110284042|NCT00226980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110284043|NCT00226980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110284044|NCT00226980|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110284045|NCT00226980|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110284046|NCT00226980|Growth Substances|growth substances|mesh-ancestor
110284047|NCT00226980|Growth Inhibitors|growth inhibitors|mesh-ancestor
110284049|NCT00203801|Lumefantrine|lumefantrine|mesh-list
110284050|NCT00203801|Artemether|artemether|mesh-list
110284051|NCT00203801|Pyrimethamine|pyrimethamine|mesh-list
110284052|NCT00203801|Sulfadoxine|sulfadoxine|mesh-list
110284053|NCT00203801|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110284054|NCT00203801|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110284055|NCT00203801|Antimalarials|antimalarials|mesh-ancestor
110284056|NCT00203801|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110284057|NCT00203801|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110284058|NCT00203801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110284059|NCT00203801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110284060|NCT00203801|Antiviral Agents|antiviral agents|mesh-ancestor
110284061|NCT00203801|Schistosomicides|schistosomicides|mesh-ancestor
110284062|NCT00203801|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110284063|NCT00203801|Anthelmintics|anthelmintics|mesh-ancestor
110284064|NCT00203801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110284065|NCT00203801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110284066|NCT00203801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110284068|NCT00197327|Bupivacaine|bupivacaine|mesh-list
110284069|NCT00197327|Anesthetics, Local|anesthetics, local|mesh-ancestor
110284070|NCT00197327|Anesthetics|anesthetics|mesh-ancestor
110284071|NCT00197327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110284072|NCT00197327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276011|NCT04675372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110276012|NCT04675372|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110276013|NCT04675372|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110276014|NCT04675372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110276015|NCT04675372|Adrenergic Agents|adrenergic agents|mesh-ancestor
110276016|NCT04675372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110276017|NCT04675372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276018|NCT04675372|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110276019|NCT04675372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110276020|NCT04675372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110276021|NCT04675372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110276022|NCT04675372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110276023|NCT04675372|Anesthetics, General|anesthetics, general|mesh-ancestor
110276025|NCT04675372|GABA Modulators|gaba modulators|mesh-ancestor
110276026|NCT04675372|GABA Agents|gaba agents|mesh-ancestor
110284073|NCT00197327|Sensory System Agents|sensory system agents|mesh-ancestor
110284074|NCT00197327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110284075|NCT00227097|Anticoagulants|anticoagulants|mesh-list
110284076|NCT00208923|Cyclophosphamide|cyclophosphamide|mesh-list
110284078|NCT00208923|Fludarabine|fludarabine|mesh-list
110284079|NCT00208923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110284080|NCT00208923|Immunologic Factors|immunologic factors|mesh-ancestor
110284081|NCT00208923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284082|NCT00208923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110284083|NCT00208923|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110284084|NCT00208923|Alkylating Agents|alkylating agents|mesh-ancestor
110284085|NCT00208923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110284086|NCT00208923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110284445|NCT00204620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110284446|NCT02962518|Triamcinolone|triamcinolone|mesh-list
110284447|NCT02962518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110284448|NCT02962518|Glucocorticoids|glucocorticoids|mesh-ancestor
110284449|NCT02962518|Hormones|hormones|mesh-ancestor
110284450|NCT02962518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110284451|NCT02962518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284452|NCT00204659|Rituximab|rituximab|mesh-list
110284453|NCT00204659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110284454|NCT00204659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110284926|NCT00205751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110368783|NCT05125796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110285279|NCT00233025|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110285280|NCT00233025|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110285281|NCT00233025|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110285282|NCT00233025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110285283|NCT00233025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110285285|NCT00233025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285286|NCT00233025|Analgesics|analgesics|mesh-ancestor
110285287|NCT00233025|Sensory System Agents|sensory system agents|mesh-ancestor
110276029|NCT04424602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110276030|NCT04424602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110276031|NCT04424602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276032|NCT04424602|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110276033|NCT04424602|Cholinergic Agents|cholinergic agents|mesh-ancestor
110276034|NCT04424602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110285288|NCT00233025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110285289|NCT00233025|Antidepressive Agents|antidepressive agents|mesh-ancestor
110285290|NCT00233025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110285291|NCT00233025|Dopamine Agents|dopamine agents|mesh-ancestor
110285292|NCT00207428|Carbamazepine|carbamazepine|mesh-list
110285293|NCT00207428|Anticonvulsants|anticonvulsants|mesh-ancestor
110285294|NCT00207428|Antimanic Agents|antimanic agents|mesh-ancestor
110285295|NCT00207428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110285296|NCT00207428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110285297|NCT00207428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285298|NCT00207428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110285299|NCT00207428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110285300|NCT00207428|Analgesics|analgesics|mesh-ancestor
110285301|NCT00207428|Sensory System Agents|sensory system agents|mesh-ancestor
110285302|NCT00207428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110285303|NCT00207428|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110285304|NCT00207428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110285305|NCT00207428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110285306|NCT00207428|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110285307|NCT00207428|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110285309|NCT00230334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110285310|NCT00230334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110285311|NCT00230334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110285312|NCT00230334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110285313|NCT00207584|Doxycycline|doxycycline|mesh-list
110285314|NCT00207584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110285315|NCT00207584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110285317|NCT00207584|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110285318|NCT00207584|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110285319|NCT00207662|Infliximab|infliximab|mesh-list
110285320|NCT00207662|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110285327|NCT00207701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110285328|NCT00207701|Dermatologic Agents|dermatologic agents|mesh-ancestor
110285329|NCT00207701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110285330|NCT00207701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110285331|NCT00207779|Heparin|heparin|mesh-list
110285332|NCT00207779|Anticoagulants|anticoagulants|mesh-ancestor
110285333|NCT00207779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110285334|NCT00207779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110276035|NCT04424602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276036|NCT04424602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110276037|NCT04424602|Immunologic Factors|immunologic factors|mesh-ancestor
110276038|NCT04424602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110276039|NCT04424602|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110276040|NCT04424602|Alkylating Agents|alkylating agents|mesh-ancestor
110276041|NCT04424602|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110285335|NCT00207779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110285336|NCT00230373|Imiquimod|imiquimod|mesh-list
110285337|NCT00230373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110285338|NCT00230373|Immunologic Factors|immunologic factors|mesh-ancestor
110285339|NCT00230373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285340|NCT00230373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110285341|NCT00230373|Interferon Inducers|interferon inducers|mesh-ancestor
110285342|NCT00230451|Paclitaxel|paclitaxel|mesh-list
110285343|NCT00230451|Fluorouracil|fluorouracil|mesh-list
110285344|NCT00230451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110285345|NCT00230451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110285346|NCT00230451|Tubulin Modulators|tubulin modulators|mesh-ancestor
110285347|NCT00230451|Antimitotic Agents|antimitotic agents|mesh-ancestor
110285348|NCT00230451|Mitosis Modulators|mitosis modulators|mesh-ancestor
110285349|NCT00230451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110285350|NCT00230451|Antimetabolites|antimetabolites|mesh-ancestor
110285351|NCT00230451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110285352|NCT00230451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110285353|NCT00230451|Immunologic Factors|immunologic factors|mesh-ancestor
110285354|NCT00230451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285355|NCT00411320|Dexamethasone|dexamethasone|mesh-list
110285356|NCT00411320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110285357|NCT00411320|Antiemetics|antiemetics|mesh-ancestor
110285358|NCT00411320|Autonomic Agents|autonomic agents|mesh-ancestor
110285359|NCT00411320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110285360|NCT00411320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285361|NCT00411320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110285362|NCT00411320|Glucocorticoids|glucocorticoids|mesh-ancestor
110285364|NCT00411320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110285365|NCT00411320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110285366|NCT00411320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110285368|NCT00233337|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110285369|NCT00233337|Antimalarials|antimalarials|mesh-ancestor
110285370|NCT00233337|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110285371|NCT00233337|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110285372|NCT00233337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110285374|NCT00230490|Pradefovir|pradefovir|mesh-list
110285375|NCT00230490|Antiviral Agents|antiviral agents|mesh-ancestor
110285376|NCT00230490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110285377|NCT00230490|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110285378|NCT00230490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110285379|NCT00230490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110285380|NCT00230490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110285381|NCT00230490|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110285382|NCT01089556|Pregabalin|pregabalin|mesh-list
110285383|NCT01089556|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110276043|NCT00199407|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
110276044|NCT00199407|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110276045|NCT00199407|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110276046|NCT00199407|Purinergic Agents|purinergic agents|mesh-ancestor
110276047|NCT00199407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110276048|NCT00199407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276049|NCT00199407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276050|NCT00199446|Istradefylline|istradefylline|mesh-list
110276051|NCT00199446|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
110285384|NCT01089556|Analgesics|analgesics|mesh-ancestor
110285385|NCT01089556|Sensory System Agents|sensory system agents|mesh-ancestor
110285386|NCT01089556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110285387|NCT01089556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285388|NCT01089556|Anticonvulsants|anticonvulsants|mesh-ancestor
110285389|NCT01089556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110285409|NCT01089127|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110285410|NCT01089127|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110285411|NCT01089127|Autonomic Agents|autonomic agents|mesh-ancestor
110285412|NCT01089127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110285413|NCT01089127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285414|NCT01089127|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110285415|NCT01089127|Respiratory System Agents|respiratory system agents|mesh-ancestor
110285416|NCT01089127|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110285418|NCT01089127|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110285419|NCT01089127|Adrenergic Agents|adrenergic agents|mesh-ancestor
110285420|NCT01089127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110285421|NCT01089127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110285422|NCT00424580|Montelukast|montelukast|mesh-list
110285423|NCT00424580|Desloratadine|desloratadine|mesh-list
110285424|NCT00424580|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110285425|NCT00424580|Respiratory System Agents|respiratory system agents|mesh-ancestor
110285426|NCT00424580|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110285427|NCT00424580|Hormone Antagonists|hormone antagonists|mesh-ancestor
110285428|NCT00424580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110285429|NCT00424580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285430|NCT00424580|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110285431|NCT00424580|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110285432|NCT00424580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110285433|NCT00424580|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110285435|NCT00424580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110285436|NCT00424580|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110285437|NCT00424580|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110285438|NCT00424580|Histamine Antagonists|histamine antagonists|mesh-ancestor
110285439|NCT00424580|Histamine Agents|histamine agents|mesh-ancestor
110285441|NCT00233532|Trandolapril|trandolapril|mesh-list
110285442|NCT00233532|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110285466|NCT00237198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285467|NCT00233610|Tamoxifen|tamoxifen|mesh-list
110285468|NCT00233610|Bicalutamide|bicalutamide|mesh-list
110285469|NCT00233610|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110285470|NCT00233610|Hormone Antagonists|hormone antagonists|mesh-ancestor
110285471|NCT00233610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110285472|NCT00233610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285473|NCT00233610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110285474|NCT00233610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110285475|NCT00233610|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110276052|NCT00199446|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110276053|NCT00199446|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110276055|NCT00199446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110276056|NCT00199446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276057|NCT00199446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276058|NCT04306393|Nitric Oxide|nitric oxide|mesh-list
110276059|NCT04306393|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110276060|NCT04306393|Autonomic Agents|autonomic agents|mesh-ancestor
110276061|NCT04306393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110276062|NCT04306393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276063|NCT04306393|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110285476|NCT00233610|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110285477|NCT00233610|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110285478|NCT00233610|Androgen Antagonists|androgen antagonists|mesh-ancestor
110285479|NCT00208130|Topiramate|topiramate|mesh-list
110285480|NCT00208130|Anticonvulsants|anticonvulsants|mesh-ancestor
110285481|NCT00208130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110285482|NCT00208130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285483|NCT00237237|Vildagliptin|vildagliptin|mesh-list
110285484|NCT00237237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110285485|NCT00237237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285486|NCT00237237|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110285487|NCT00237237|Protease Inhibitors|protease inhibitors|mesh-ancestor
110285488|NCT00237237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110285489|NCT00237237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110285490|NCT00208169|Aripiprazole|aripiprazole|mesh-list
110285491|NCT00208169|Antidepressive Agents|antidepressive agents|mesh-ancestor
110285509|NCT01087723|Bivalirudin|bivalirudin|mesh-list
110285510|NCT01087723|Anticoagulants|anticoagulants|mesh-ancestor
110285512|NCT01087723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110285513|NCT01087723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110285514|NCT01087723|Antithrombins|antithrombins|mesh-ancestor
110285515|NCT01087723|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110285516|NCT01087723|Protease Inhibitors|protease inhibitors|mesh-ancestor
110285517|NCT01087723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110285518|NCT00208208|Ziprasidone|ziprasidone|mesh-list
110285519|NCT00208208|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110285520|NCT00208208|Serotonin Agents|serotonin agents|mesh-ancestor
110285521|NCT00208208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110285522|NCT00208208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110285523|NCT00208208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285524|NCT00208208|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110285525|NCT00208208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110285526|NCT00208208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110285527|NCT00208208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110276064|NCT04306393|Respiratory System Agents|respiratory system agents|mesh-ancestor
110276065|NCT04306393|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110276066|NCT04306393|Antioxidants|antioxidants|mesh-ancestor
110276067|NCT04306393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276068|NCT04306393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110276069|NCT04306393|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110276070|NCT04306393|Vasodilator Agents|vasodilator agents|mesh-ancestor
110276072|NCT04306393|Protective Agents|protective agents|mesh-ancestor
110276074|NCT00204321|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110276075|NCT00204321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110276076|NCT00204321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110276077|NCT00204321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110276078|NCT00204321|Antifungal Agents|antifungal agents|mesh-ancestor
110276079|NCT00204321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110276080|NCT00204321|Immunologic Factors|immunologic factors|mesh-ancestor
110276081|NCT00204321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285528|NCT00208208|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110285530|NCT01085812|Milnacipran|milnacipran|mesh-list
110285531|NCT01085812|Levomilnacipran|levomilnacipran|mesh-list
110285532|NCT01085812|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110285533|NCT01085812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110285535|NCT01085812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110285536|NCT01085812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110285537|NCT01085812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285538|NCT01085812|Antidepressive Agents|antidepressive agents|mesh-ancestor
110285539|NCT01085812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110285540|NCT01085812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110285541|NCT01085812|Analgesics|analgesics|mesh-ancestor
110285542|NCT01085812|Sensory System Agents|sensory system agents|mesh-ancestor
110285543|NCT01085812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110285544|NCT01085734|Bevacizumab|bevacizumab|mesh-list
110285545|NCT01085734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110285546|NCT01085734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110285547|NCT01085734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110285548|NCT01085734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110285563|NCT01084603|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110285564|NCT01084603|Cholinergic Agents|cholinergic agents|mesh-ancestor
110285565|NCT01084603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110285566|NCT01084603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110285567|NCT00208442|Methyclothiazide|methyclothiazide|mesh-list
110285569|NCT00208442|Natriuretic Agents|natriuretic agents|mesh-ancestor
110285570|NCT00208442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285571|NCT00208442|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110285572|NCT00208442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110285573|NCT00208442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110285574|NCT00233766|Sirolimus|sirolimus|mesh-list
110285575|NCT00233766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110285576|NCT00233766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110285577|NCT00233766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110285578|NCT00233766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110285579|NCT00233766|Antifungal Agents|antifungal agents|mesh-ancestor
110285580|NCT00233766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110285581|NCT00233766|Immunologic Factors|immunologic factors|mesh-ancestor
110276082|NCT00175565|Fluticasone|fluticasone|mesh-list
110276083|NCT00175565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110276084|NCT00175565|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110276085|NCT00175565|Autonomic Agents|autonomic agents|mesh-ancestor
110276086|NCT00175565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110276087|NCT00175565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276088|NCT00175565|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110276089|NCT00175565|Respiratory System Agents|respiratory system agents|mesh-ancestor
110276090|NCT00175565|Dermatologic Agents|dermatologic agents|mesh-ancestor
110276091|NCT00175565|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110276092|NCT04230187|Leucovorin|leucovorin|mesh-list
110276093|NCT04230187|Bevacizumab|bevacizumab|mesh-list
110276094|NCT04230187|Fluorouracil|fluorouracil|mesh-list
110276095|NCT04230187|Oxaliplatin|oxaliplatin|mesh-list
110276096|NCT04230187|Irinotecan|irinotecan|mesh-list
110276097|NCT04230187|Levoleucovorin|levoleucovorin|mesh-list
110276099|NCT04230187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110276100|NCT04230187|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110276101|NCT04230187|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110285582|NCT00233766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285583|NCT00208520|Lamotrigine|lamotrigine|mesh-list
110285584|NCT00208520|Carbamazepine|carbamazepine|mesh-list
110285585|NCT00208520|Levetiracetam|levetiracetam|mesh-list
110285586|NCT00208520|Anticonvulsants|anticonvulsants|mesh-ancestor
110285587|NCT00208520|Nootropic Agents|nootropic agents|mesh-ancestor
110285588|NCT00208520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110285589|NCT00208520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110285590|NCT00208520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110285591|NCT00208520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110285592|NCT00208520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285593|NCT00208520|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110285594|NCT00208520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110285595|NCT00208520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110285596|NCT00208520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110285597|NCT00208520|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110285598|NCT00208520|Antimanic Agents|antimanic agents|mesh-ancestor
110285599|NCT00208520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110285600|NCT00208520|Analgesics|analgesics|mesh-ancestor
110285601|NCT00208520|Sensory System Agents|sensory system agents|mesh-ancestor
110285602|NCT00208520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110285603|NCT00208520|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110285604|NCT00208520|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110285605|NCT00237393|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110285606|NCT00237393|Antidepressive Agents|antidepressive agents|mesh-ancestor
110285607|NCT00237393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110285608|NCT00237393|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110285609|NCT00237393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110285619|NCT00208559|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110285620|NCT00208559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110285621|NCT00208559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110285622|NCT00208559|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110285623|NCT00208559|Dopamine Agents|dopamine agents|mesh-ancestor
110285624|NCT00233805|Sirolimus|sirolimus|mesh-list
110285625|NCT00233805|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110285626|NCT00233805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110285627|NCT00233805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110285628|NCT00233805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110276102|NCT04230187|Growth Substances|growth substances|mesh-ancestor
110276103|NCT04230187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276104|NCT04230187|Growth Inhibitors|growth inhibitors|mesh-ancestor
110276105|NCT04230187|Antimetabolites|antimetabolites|mesh-ancestor
110276106|NCT04230187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276107|NCT04230187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110276108|NCT04230187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110276109|NCT04230187|Immunologic Factors|immunologic factors|mesh-ancestor
110276110|NCT04230187|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110276111|NCT04230187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110276112|NCT04230187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110276114|NCT04230187|Protective Agents|protective agents|mesh-ancestor
110276115|NCT04230187|Vitamin B Complex|vitamin b complex|mesh-ancestor
110276117|NCT04230187|Micronutrients|micronutrients|mesh-ancestor
110285629|NCT00233805|Antifungal Agents|antifungal agents|mesh-ancestor
110285630|NCT00233805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110285632|NCT00233805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285633|NCT01084135|Rivastigmine|rivastigmine|mesh-list
110285634|NCT01084135|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110285635|NCT01084135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110285636|NCT01084135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110285637|NCT01084135|Cholinergic Agents|cholinergic agents|mesh-ancestor
110285638|NCT01084135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110285639|NCT01084135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285640|NCT01084135|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110285641|NCT01084135|Protective Agents|protective agents|mesh-ancestor
110285642|NCT01083316|Dexamethasone|dexamethasone|mesh-list
110285643|NCT01083316|Bortezomib|bortezomib|mesh-list
110285644|NCT01083316|Melphalan|melphalan|mesh-list
110285645|NCT01083316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110285647|NCT01083316|Autonomic Agents|autonomic agents|mesh-ancestor
110285648|NCT01083316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110285649|NCT01083316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285651|NCT01083316|Glucocorticoids|glucocorticoids|mesh-ancestor
110285652|NCT01083316|Hormones|hormones|mesh-ancestor
110285653|NCT01083316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110285654|NCT01083316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110285655|NCT01083316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110285656|NCT01083316|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110285657|NCT01083316|Alkylating Agents|alkylating agents|mesh-ancestor
110285658|NCT01083316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110285659|NCT01083316|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110285660|NCT01083316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110285662|NCT00208715|Modafinil|modafinil|mesh-list
110285663|NCT00208715|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110285664|NCT00208715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285665|NCT00208715|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110285666|NCT00208715|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110285667|NCT00208715|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110285668|NCT00208715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110285670|NCT00208793|Vitamin D|vitamin d|mesh-list
110285671|NCT00208793|Ergocalciferols|ergocalciferols|mesh-list
110285672|NCT00208793|Cholecalciferol|cholecalciferol|mesh-list
110276119|NCT00175643|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110276120|NCT00175643|Immunologic Factors|immunologic factors|mesh-ancestor
110276121|NCT00175643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276122|NCT00175643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110276123|NCT00175643|Interferon Inducers|interferon inducers|mesh-ancestor
110276124|NCT00204438|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110276125|NCT00204438|Desogestrel|desogestrel|mesh-list
110276126|NCT00204438|Estradiol|estradiol|mesh-list
110276127|NCT00204438|Estrogens|estrogens|mesh-ancestor
110276128|NCT00204438|Hormones|hormones|mesh-ancestor
110285673|NCT00208793|Vitamins|vitamins|mesh-list
110285674|NCT00208793|Calcium|calcium|mesh-list
110285675|NCT00208793|Micronutrients|micronutrients|mesh-ancestor
110285692|NCT01081873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110285694|NCT00237471|Insulin|insulin|mesh-list
110285695|NCT00237471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110285696|NCT00237471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285697|NCT00237510|Terazosin|terazosin|mesh-list
110285698|NCT00237510|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110285699|NCT00237510|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110285700|NCT00237510|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110285701|NCT00237510|Adrenergic Agents|adrenergic agents|mesh-ancestor
110285702|NCT00237510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110285703|NCT00237510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110285704|NCT00237510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285705|NCT00237510|Urological Agents|urological agents|mesh-ancestor
110285706|NCT01081795|Topiramate|topiramate|mesh-list
110285707|NCT01081795|Anticonvulsants|anticonvulsants|mesh-ancestor
110285708|NCT01081795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110285710|NCT00233961|Lenograstim|lenograstim|mesh-list
110285711|NCT00233961|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110285712|NCT00233961|Immunologic Factors|immunologic factors|mesh-ancestor
110285714|NCT00234000|Azacitidine|azacitidine|mesh-list
110285715|NCT00234000|Arsenic Trioxide|arsenic trioxide|mesh-list
110285716|NCT00234000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110285717|NCT00234000|Antimetabolites|antimetabolites|mesh-ancestor
110285718|NCT00234000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110285719|NCT00234000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110285720|NCT00234000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110285721|NCT00234117|Rabeprazole|rabeprazole|mesh-list
110285722|NCT00234117|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110285723|NCT00234117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110285724|NCT00234117|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110285725|NCT00234117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110285726|NCT00234117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110285728|NCT00209144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110285729|NCT00209144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285731|NCT00209222|Dexamethasone|dexamethasone|mesh-list
110285732|NCT00209222|Prednisone|prednisone|mesh-list
110285733|NCT00209222|Cyclophosphamide|cyclophosphamide|mesh-list
110285746|NCT00209222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110285747|NCT00209222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110276129|NCT00204438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110276130|NCT00204438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276131|NCT00204438|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110276132|NCT00204438|Contraceptive Agents|contraceptive agents|mesh-ancestor
110276133|NCT00204438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110276134|NCT00204438|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110276135|NCT00204438|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110276136|NCT00204438|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110276137|NCT00204438|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110285749|NCT00209222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110285750|NCT00209222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110285751|NCT00209222|Antiemetics|antiemetics|mesh-ancestor
110285752|NCT00209222|Autonomic Agents|autonomic agents|mesh-ancestor
110285754|NCT00209222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110285755|NCT00209222|Glucocorticoids|glucocorticoids|mesh-ancestor
110285757|NCT00209222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110285758|NCT00209222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110285759|NCT00209222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110285760|NCT00209222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110285763|NCT00209222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110285764|NCT00209222|Tubulin Modulators|tubulin modulators|mesh-ancestor
110285765|NCT00209222|Antimitotic Agents|antimitotic agents|mesh-ancestor
110285766|NCT00209222|Mitosis Modulators|mitosis modulators|mesh-ancestor
110285767|NCT00209222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110285768|NCT00209222|Antimetabolites|antimetabolites|mesh-ancestor
110285769|NCT00209222|Antiviral Agents|antiviral agents|mesh-ancestor
110285770|NCT00209222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110285771|NCT00234195|Bupropion|bupropion|mesh-list
110285772|NCT00234195|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110285773|NCT00234195|Antidepressive Agents|antidepressive agents|mesh-ancestor
110285775|NCT00234195|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110285776|NCT00234195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110285777|NCT00234195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110285778|NCT00234195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110285779|NCT00234195|Dopamine Agents|dopamine agents|mesh-ancestor
110285780|NCT00234195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110285781|NCT00234195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285782|NCT00234195|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110285783|NCT00234195|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110285784|NCT00234195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110285785|NCT00209261|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
110285786|NCT00209261|Hemostatics|hemostatics|mesh-ancestor
110285787|NCT00209261|Coagulants|coagulants|mesh-ancestor
110285788|NCT00209261|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110285789|NCT00209261|Natriuretic Agents|natriuretic agents|mesh-ancestor
110285790|NCT00209261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285792|NCT00209300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110285793|NCT00209300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110285795|NCT00209300|Sensory System Agents|sensory system agents|mesh-ancestor
110285796|NCT00209300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110285820|NCT00411437|Cholinergic Agents|cholinergic agents|mesh-ancestor
110276139|NCT00175682|Prazosin|prazosin|mesh-list
110276140|NCT00175682|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110276141|NCT00175682|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110276142|NCT00175682|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110276143|NCT00175682|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110276144|NCT00175682|Adrenergic Agents|adrenergic agents|mesh-ancestor
110276145|NCT00175682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110285822|NCT00411437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110285823|NCT00411437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285824|NCT00411437|Urological Agents|urological agents|mesh-ancestor
110285825|NCT00411437|Parasympatholytics|parasympatholytics|mesh-ancestor
110285826|NCT00411437|Autonomic Agents|autonomic agents|mesh-ancestor
110285827|NCT00411437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110285828|NCT00234312|Sertraline|sertraline|mesh-list
110285829|NCT00234312|Escitalopram|escitalopram|mesh-list
110285830|NCT00234312|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110285831|NCT00234312|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110285832|NCT00234312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110285833|NCT00234312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110285834|NCT00234312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110285836|NCT00234312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285837|NCT00234312|Antidepressive Agents|antidepressive agents|mesh-ancestor
110285838|NCT00234312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110285839|NCT00411515|Mycophenolic Acid|mycophenolic acid|mesh-list
110285840|NCT00411515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110285841|NCT00411515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110285842|NCT00411515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110285843|NCT00411515|Antitubercular Agents|antitubercular agents|mesh-ancestor
110285844|NCT00411515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110285845|NCT00411515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110285846|NCT00411515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110285847|NCT00411515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110285848|NCT00237627|Doxorubicin|doxorubicin|mesh-list
110285849|NCT00237627|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110285850|NCT00237627|Bortezomib|bortezomib|mesh-list
110285851|NCT00237627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110285870|NCT00209495|Analgesics|analgesics|mesh-ancestor
110276146|NCT00175682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276147|NCT00175682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276148|NCT00554086|Bicalutamide|bicalutamide|mesh-list
110276149|NCT00554086|Androgen Antagonists|androgen antagonists|mesh-ancestor
110276150|NCT00554086|Hormone Antagonists|hormone antagonists|mesh-ancestor
110276151|NCT00554086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110276152|NCT00554086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276153|NCT00554086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110276155|NCT04173364|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110276156|NCT04173364|Anesthetics, Local|anesthetics, local|mesh-ancestor
110276157|NCT04173364|Anesthetics|anesthetics|mesh-ancestor
110276158|NCT04173364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110276159|NCT04173364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276160|NCT04173364|Sensory System Agents|sensory system agents|mesh-ancestor
110285871|NCT00209495|Sensory System Agents|sensory system agents|mesh-ancestor
110285872|NCT00209495|Anticonvulsants|anticonvulsants|mesh-ancestor
110285873|NCT00209495|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110285874|NCT00209495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110285875|NCT00209495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110285876|NCT00209495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110285877|NCT00209495|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110285878|NCT00209495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110285879|NCT00209495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110285880|NCT00209495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110285882|NCT00234390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110285883|NCT00234390|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110285884|NCT00234390|Autonomic Agents|autonomic agents|mesh-ancestor
110285885|NCT00234390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110285886|NCT00234390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285887|NCT00234390|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110285888|NCT00234390|Respiratory System Agents|respiratory system agents|mesh-ancestor
110285889|NCT00234390|Glucocorticoids|glucocorticoids|mesh-ancestor
110285890|NCT00234390|Hormones|hormones|mesh-ancestor
110285891|NCT00234390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110285892|NCT00209534|Fospropofol|fospropofol|mesh-list
110285893|NCT00209534|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110285895|NCT00209534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285896|NCT00209573|Fospropofol|fospropofol|mesh-list
110285897|NCT00209573|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110285898|NCT00209573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110285899|NCT00209573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285900|NCT00209612|Paclitaxel|paclitaxel|mesh-list
110285901|NCT00209612|Irinotecan|irinotecan|mesh-list
110285902|NCT00209612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110285903|NCT00209612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110285904|NCT00209612|Tubulin Modulators|tubulin modulators|mesh-ancestor
110285905|NCT00209612|Antimitotic Agents|antimitotic agents|mesh-ancestor
110285906|NCT00209612|Mitosis Modulators|mitosis modulators|mesh-ancestor
110285907|NCT00209612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110285908|NCT00209612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110285921|NCT00234429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110285922|NCT00234429|Antimetabolites|antimetabolites|mesh-ancestor
110285923|NCT00234429|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110285924|NCT00209651|Irinotecan|irinotecan|mesh-list
110285925|NCT00209651|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110285926|NCT00209651|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110285927|NCT00209651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110276161|NCT04173364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110276162|NCT04171453|Pregabalin|pregabalin|mesh-list
110276164|NCT04171453|Sensory System Agents|sensory system agents|mesh-ancestor
110276165|NCT04171453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110276166|NCT04171453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276167|NCT04171453|Anticonvulsants|anticonvulsants|mesh-ancestor
110276168|NCT04171453|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110276169|NCT04171453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110285928|NCT00209651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110285929|NCT00209651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110285930|NCT02961855|Diclofenac|diclofenac|mesh-list
110285931|NCT02961855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110285932|NCT02961855|Lidocaine|lidocaine|mesh-list
110285933|NCT02961855|Anesthetics, Local|anesthetics, local|mesh-ancestor
110285934|NCT02961855|Anesthetics|anesthetics|mesh-ancestor
110285935|NCT02961855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110285936|NCT02961855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285937|NCT02961855|Sensory System Agents|sensory system agents|mesh-ancestor
110285938|NCT02961855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110285939|NCT02961855|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110285940|NCT02961855|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110285941|NCT02961855|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110285942|NCT02961855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110285943|NCT02961855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110285944|NCT02961855|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110285945|NCT02961855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110285946|NCT02961855|Analgesics|analgesics|mesh-ancestor
110285947|NCT02961855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110285948|NCT02961855|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110285949|NCT02961855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110285950|NCT00209690|Cisplatin|cisplatin|mesh-list
110285951|NCT00209690|Docetaxel|docetaxel|mesh-list
110285952|NCT00209690|Fluorouracil|fluorouracil|mesh-list
110285953|NCT00209690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110285954|NCT00209690|Tubulin Modulators|tubulin modulators|mesh-ancestor
110285955|NCT00209690|Antimitotic Agents|antimitotic agents|mesh-ancestor
110285956|NCT00209690|Mitosis Modulators|mitosis modulators|mesh-ancestor
110285957|NCT00209690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110285958|NCT00209690|Antimetabolites|antimetabolites|mesh-ancestor
110285959|NCT00209690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110285960|NCT00209690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110285961|NCT00209690|Immunologic Factors|immunologic factors|mesh-ancestor
110285962|NCT00209690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285964|NCT01081132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110285965|NCT01081132|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110285966|NCT01081132|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110285967|NCT01081132|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110285968|NCT01081132|Adrenergic Agents|adrenergic agents|mesh-ancestor
110285969|NCT01081132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110285970|NCT01081132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110285980|NCT01080625|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110285981|NCT01080625|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110285982|NCT01080625|Adrenergic Agents|adrenergic agents|mesh-ancestor
110285983|NCT01080625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110285984|NCT01080625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110285985|NCT01080625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285986|NCT01080625|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110285987|NCT01080625|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110285988|NCT01080625|Autonomic Agents|autonomic agents|mesh-ancestor
110285989|NCT01080625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110285990|NCT01080625|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110276170|NCT04171453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276171|NCT04171453|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110276172|NCT04171453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110276173|NCT04171453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110276174|NCT04171453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110276175|NCT04171453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110285991|NCT01080625|Respiratory System Agents|respiratory system agents|mesh-ancestor
110285992|NCT01080625|Mydriatics|mydriatics|mesh-ancestor
110285993|NCT01080625|Sympathomimetics|sympathomimetics|mesh-ancestor
110285994|NCT01080625|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110285995|NCT01080625|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110285996|NCT01080625|Nasal Decongestants|nasal decongestants|mesh-ancestor
110285997|NCT01080625|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110285998|NCT01080625|Protective Agents|protective agents|mesh-ancestor
110285999|NCT00209729|Docetaxel|docetaxel|mesh-list
110286000|NCT00209729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110286001|NCT00209729|Tubulin Modulators|tubulin modulators|mesh-ancestor
110286002|NCT00209729|Antimitotic Agents|antimitotic agents|mesh-ancestor
110286003|NCT00209729|Mitosis Modulators|mitosis modulators|mesh-ancestor
110286004|NCT00209729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110286005|NCT00414180|Bupropion|bupropion|mesh-list
110286006|NCT00414180|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110286007|NCT00414180|Antidepressive Agents|antidepressive agents|mesh-ancestor
110286008|NCT00414180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110286009|NCT00414180|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110286010|NCT00414180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110286011|NCT00414180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110286012|NCT00414180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110286013|NCT00414180|Dopamine Agents|dopamine agents|mesh-ancestor
110286014|NCT00414180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110286015|NCT00414180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110286016|NCT00414180|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110286017|NCT00414180|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110286018|NCT00414180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110286019|NCT01089790|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110286020|NCT01089790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110286021|NCT01089790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110286023|NCT01089790|Hormones|hormones|mesh-ancestor
110286024|NCT01089790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110286025|NCT01089790|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110286026|NCT01089790|Protease Inhibitors|protease inhibitors|mesh-ancestor
110286027|NCT01089790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110286028|NCT01089790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110286029|NCT00234507|Botulinum Toxins|botulinum toxins|mesh-list
110286030|NCT00234507|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110286031|NCT00234507|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110286032|NCT00234507|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110286033|NCT00234507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110286034|NCT00234507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110286035|NCT00234507|Cholinergic Agents|cholinergic agents|mesh-ancestor
110286047|NCT01084330|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110286048|NCT01084330|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110286049|NCT01084330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110286050|NCT00209807|Reboxetine|reboxetine|mesh-list
110286051|NCT00209807|Escitalopram|escitalopram|mesh-list
110286052|NCT00209807|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110286053|NCT00209807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110286054|NCT00209807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110286055|NCT00209807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110286056|NCT00209807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110286057|NCT00209807|Serotonin Agents|serotonin agents|mesh-ancestor
110286058|NCT00209807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110286059|NCT00209807|Antidepressive Agents|antidepressive agents|mesh-ancestor
110276177|NCT04111315|Ibuprofen|ibuprofen|mesh-list
110276178|NCT04111315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110276179|NCT04111315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110276180|NCT04111315|Analgesics|analgesics|mesh-ancestor
110276181|NCT04111315|Sensory System Agents|sensory system agents|mesh-ancestor
110276182|NCT04111315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110276183|NCT04111315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276184|NCT04111315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110286060|NCT00209807|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110286061|NCT00209807|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110286062|NCT00209807|Adrenergic Agents|adrenergic agents|mesh-ancestor
110286063|NCT00209846|Gaboxadol|gaboxadol|mesh-list
110286064|NCT00209846|Analgesics|analgesics|mesh-ancestor
110286065|NCT00209846|Sensory System Agents|sensory system agents|mesh-ancestor
110286066|NCT00209846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110286067|NCT00209846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110286068|NCT00209846|Anticonvulsants|anticonvulsants|mesh-ancestor
110286069|NCT00209846|GABA Agonists|gaba agonists|mesh-ancestor
110286070|NCT00209846|GABA Agents|gaba agents|mesh-ancestor
110286071|NCT00209846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110286072|NCT00209846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110286073|NCT01082068|Letrozole|letrozole|mesh-list
110286074|NCT01082068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110286075|NCT01082068|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110286076|NCT01082068|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110286077|NCT01082068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110286078|NCT01082068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110286079|NCT01082068|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110286080|NCT01082068|Hormone Antagonists|hormone antagonists|mesh-ancestor
110286081|NCT01082068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110286082|NCT01082068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110286083|NCT01086748|Risperidone|risperidone|mesh-list
110286084|NCT01086748|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110286085|NCT01086748|Serotonin Agents|serotonin agents|mesh-ancestor
110286086|NCT01086748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110286087|NCT01086748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110286088|NCT01086748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110286089|NCT01086748|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110286090|NCT01086748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110286091|NCT01086748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110286092|NCT01086748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110286093|NCT01086748|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110286094|NCT01086748|Dopamine Agents|dopamine agents|mesh-ancestor
110286095|NCT00237705|Metoclopramide|metoclopramide|mesh-list
110286096|NCT00237705|Antiemetics|antiemetics|mesh-ancestor
110286097|NCT00237705|Autonomic Agents|autonomic agents|mesh-ancestor
110286098|NCT00237705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110286099|NCT00237705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110286103|NCT00237705|Dopamine Agents|dopamine agents|mesh-ancestor
110286104|NCT00237705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110286105|NCT00237705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110286106|NCT00209885|Lidocaine|lidocaine|mesh-list
110286107|NCT00209885|Droperidol|droperidol|mesh-list
110286108|NCT00209885|Ketamine|ketamine|mesh-list
110286109|NCT00209885|Gabapentin|gabapentin|mesh-list
110286110|NCT00209885|Esketamine|esketamine|mesh-list
110286111|NCT00209885|Anesthetics, Local|anesthetics, local|mesh-ancestor
110286112|NCT00209885|Anesthetics|anesthetics|mesh-ancestor
110286113|NCT00209885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110286114|NCT00209885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110286115|NCT00209885|Sensory System Agents|sensory system agents|mesh-ancestor
110286116|NCT00209885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110286117|NCT00209885|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110286118|NCT00209885|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110286119|NCT00209885|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110286120|NCT00209885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110286121|NCT00209885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276185|NCT04111315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110276186|NCT04111315|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110276187|NCT04111315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110276188|NCT04111315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276189|NCT04111315|Antipyretics|antipyretics|mesh-ancestor
110276190|NCT00199563|Sildenafil Citrate|sildenafil citrate|mesh-list
110276191|NCT00199563|Vasodilator Agents|vasodilator agents|mesh-ancestor
110276192|NCT00199563|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110276193|NCT00199563|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110276194|NCT00199563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110276195|NCT00199563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276196|NCT00199563|Urological Agents|urological agents|mesh-ancestor
110286122|NCT00209885|Analgesics|analgesics|mesh-ancestor
110286123|NCT00209885|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110286124|NCT00209885|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110286125|NCT00209885|Anesthetics, General|anesthetics, general|mesh-ancestor
110286126|NCT00209885|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110286127|NCT00209885|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110286128|NCT00209885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110286129|NCT00209885|Anticonvulsants|anticonvulsants|mesh-ancestor
110286130|NCT00209885|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110286131|NCT00209885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110286132|NCT00209885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110286133|NCT00209885|Antimanic Agents|antimanic agents|mesh-ancestor
110286134|NCT00209885|Antidepressive Agents|antidepressive agents|mesh-ancestor
110286135|NCT00209885|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110286136|NCT00209885|Antiemetics|antiemetics|mesh-ancestor
110286137|NCT00209885|Autonomic Agents|autonomic agents|mesh-ancestor
110286138|NCT00209885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110286139|NCT00209885|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110286140|NCT00209885|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110286141|NCT00209885|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110286142|NCT00209885|Dopamine Agents|dopamine agents|mesh-ancestor
110286143|NCT00234546|Botulinum Toxins|botulinum toxins|mesh-list
110286144|NCT00234546|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110286145|NCT00234546|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110286146|NCT00234546|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110286147|NCT00234546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110286148|NCT00234546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110286149|NCT00234546|Cholinergic Agents|cholinergic agents|mesh-ancestor
110286150|NCT00234546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110286151|NCT00234546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110286152|NCT00234546|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110286153|NCT00234546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110286154|NCT00209924|Gaboxadol|gaboxadol|mesh-list
110286155|NCT00209924|Analgesics|analgesics|mesh-ancestor
110286156|NCT00209924|Sensory System Agents|sensory system agents|mesh-ancestor
110286157|NCT00209924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110286158|NCT00209924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110286159|NCT00209924|Anticonvulsants|anticonvulsants|mesh-ancestor
110276199|NCT04679506|Cladribine|cladribine|mesh-list
110276200|NCT04679506|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110276201|NCT04679506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110276202|NCT04679506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110276203|NCT04679506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110276204|NCT04679506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110276205|NCT04679506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110286160|NCT00209924|GABA Agonists|gaba agonists|mesh-ancestor
110286161|NCT00209924|GABA Agents|gaba agents|mesh-ancestor
110286163|NCT00209924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110286164|NCT00209963|Gaboxadol|gaboxadol|mesh-list
110286165|NCT00209963|Analgesics|analgesics|mesh-ancestor
110286166|NCT00209963|Sensory System Agents|sensory system agents|mesh-ancestor
110286167|NCT00209963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110286168|NCT00209963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110286169|NCT00209963|Anticonvulsants|anticonvulsants|mesh-ancestor
110286170|NCT00209963|GABA Agonists|gaba agonists|mesh-ancestor
110286171|NCT00209963|GABA Agents|gaba agents|mesh-ancestor
110286172|NCT00209963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110286178|NCT02277886|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110286179|NCT02277886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110286180|NCT02277886|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110286181|NCT02277886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110286182|NCT02277886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110286183|NCT00413751|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110286184|NCT00413751|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110286185|NCT00413751|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110286186|NCT00413751|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110286187|NCT00413751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110286188|NCT00413751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110286189|NCT00413751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110286190|NCT00413751|Adrenergic Agents|adrenergic agents|mesh-ancestor
110286191|NCT00413751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110286192|NCT00413751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110286193|NCT00413751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110286194|NCT00210041|Gemcitabine|gemcitabine|mesh-list
110286195|NCT00210041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110286196|NCT00210041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110286197|NCT00210041|Antimetabolites|antimetabolites|mesh-ancestor
110286198|NCT00210041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110286199|NCT04990804|Analgesics, Opioid|analgesics, opioid|mesh-list
110286200|NCT04990804|Analgesics|analgesics|mesh-list
110286201|NCT04990804|Narcotics|narcotics|mesh-ancestor
110286202|NCT04990804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110286203|NCT04990804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110286204|NCT04990804|Sensory System Agents|sensory system agents|mesh-ancestor
110286205|NCT04990804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110286206|NCT00237783|Dialysis Solutions|dialysis solutions|mesh-list
110286207|NCT00237783|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110286208|NCT04991662|Phenylephrine|phenylephrine|mesh-list
110286209|NCT04991662|Oxymetazoline|oxymetazoline|mesh-list
110286211|NCT04991662|Metaraminol|metaraminol|mesh-list
110286212|NCT04991662|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110286213|NCT04991662|Mydriatics|mydriatics|mesh-ancestor
110286214|NCT04991662|Autonomic Agents|autonomic agents|mesh-ancestor
110286215|NCT04991662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110286216|NCT04991662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110286217|NCT04991662|Sympathomimetics|sympathomimetics|mesh-ancestor
110286218|NCT04991662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110276207|NCT04679506|Antimetabolites|antimetabolites|mesh-ancestor
110276208|NCT04679506|Antiviral Agents|antiviral agents|mesh-ancestor
110276209|NCT04679506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110276210|NCT04679506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110276211|NCT04679506|Immunologic Factors|immunologic factors|mesh-ancestor
110276212|NCT04679506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276214|NCT02962830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110276215|NCT02962830|Narcotics|narcotics|mesh-ancestor
110276216|NCT02962830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110286219|NCT04991662|Nasal Decongestants|nasal decongestants|mesh-ancestor
110286220|NCT04991662|Respiratory System Agents|respiratory system agents|mesh-ancestor
110286221|NCT04991662|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110286222|NCT04991662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110286223|NCT04991662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110286224|NCT04991662|Adrenergic Agents|adrenergic agents|mesh-ancestor
110286225|NCT04991662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110286226|NCT04991662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110286227|NCT04991662|Protective Agents|protective agents|mesh-ancestor
110286228|NCT04997941|Tamoxifen|tamoxifen|mesh-list
110286229|NCT04997941|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110286230|NCT04997941|Hormone Antagonists|hormone antagonists|mesh-ancestor
110286231|NCT04997941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110286232|NCT04997941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110286233|NCT04997941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110286234|NCT04997941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110286235|NCT04997941|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110286236|NCT04997941|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110286237|NCT04997941|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110286238|NCT00210158|Nitrous Oxide|nitrous oxide|mesh-list
110286239|NCT00210158|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110286240|NCT00210158|Anesthetics, General|anesthetics, general|mesh-ancestor
110286241|NCT00210158|Anesthetics|anesthetics|mesh-ancestor
110286245|NCT00210158|Analgesics|analgesics|mesh-ancestor
110286246|NCT00210158|Sensory System Agents|sensory system agents|mesh-ancestor
110286247|NCT00210158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110286248|NCT00413790|Tolterodine Tartrate|tolterodine tartrate|mesh-list
110286249|NCT00413790|Darifenacin|darifenacin|mesh-list
110286250|NCT00413790|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110286251|NCT00413790|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110286252|NCT00413790|Cholinergic Agents|cholinergic agents|mesh-ancestor
110286253|NCT00413790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110286254|NCT00413790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110286255|NCT00413790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110286257|NCT01059903|Rotigotine|rotigotine|mesh-list
110286258|NCT01059903|Dopamine Agonists|dopamine agonists|mesh-ancestor
110286259|NCT01059903|Dopamine Agents|dopamine agents|mesh-ancestor
110286260|NCT01059903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110286261|NCT01059903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110286262|NCT01059903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110286263|NCT04996771|Cisplatin|cisplatin|mesh-list
110286264|NCT04996771|Etoposide|etoposide|mesh-list
110286265|NCT04996771|Etoposide phosphate|etoposide phosphate|mesh-list
110286266|NCT04996771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110286267|NCT04996771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110286268|NCT04996771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110286269|NCT04996771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110286270|NCT04996771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110286271|NCT04996771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110286272|NCT00210314|Cytarabine|cytarabine|mesh-list
110276217|NCT02962830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276218|NCT02962830|Analgesics|analgesics|mesh-ancestor
110276219|NCT02962830|Sensory System Agents|sensory system agents|mesh-ancestor
110276220|NCT02962830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110276221|NCT02962830|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110276222|NCT02962830|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110276223|NCT02962830|Anesthetics, General|anesthetics, general|mesh-ancestor
110276224|NCT02962830|Anesthetics|anesthetics|mesh-ancestor
110276226|NCT00199602|Anticoagulants|anticoagulants|mesh-ancestor
110276227|NCT00199602|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110276228|NCT00199602|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110276229|NCT00199602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110286273|NCT00210314|Methotrexate|methotrexate|mesh-list
110286274|NCT00210314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110286275|NCT00210314|Abortifacient Agents|abortifacient agents|mesh-ancestor
110286276|NCT00210314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110286277|NCT00210314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110286278|NCT00210314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110286279|NCT00210314|Antimetabolites|antimetabolites|mesh-ancestor
110286280|NCT00210314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110286281|NCT00210314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110286282|NCT00210314|Dermatologic Agents|dermatologic agents|mesh-ancestor
110286283|NCT00210314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110286284|NCT00210314|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110286285|NCT00210314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110286286|NCT00210314|Immunologic Factors|immunologic factors|mesh-ancestor
110286287|NCT00210314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110286288|NCT00210314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110286289|NCT00210314|Antiviral Agents|antiviral agents|mesh-ancestor
110286290|NCT00210314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110286292|NCT00210392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110286293|NCT00413829|Ranibizumab|ranibizumab|mesh-list
110286294|NCT00413829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110286295|NCT00413829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110286296|NCT00413829|Growth Substances|growth substances|mesh-ancestor
110286297|NCT00413829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110286298|NCT00413829|Growth Inhibitors|growth inhibitors|mesh-ancestor
110286299|NCT00413829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110286300|NCT02210104|Cyclophosphamide|cyclophosphamide|mesh-list
110286301|NCT02210104|Ipilimumab|ipilimumab|mesh-list
110286302|NCT02210104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110286303|NCT02210104|Immunologic Factors|immunologic factors|mesh-ancestor
110286304|NCT02210104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110286305|NCT02210104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110286306|NCT02210104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110286307|NCT02210104|Alkylating Agents|alkylating agents|mesh-ancestor
110286308|NCT02210104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110286309|NCT02210104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110286310|NCT02210104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110286311|NCT02210104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110286324|NCT00210509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110286325|NCT02210260|Heroin|heroin|mesh-list
110286326|NCT02210260|Bupivacaine|bupivacaine|mesh-list
110286327|NCT02210260|Anesthetics, Local|anesthetics, local|mesh-list
110286328|NCT02210260|Anesthetics|anesthetics|mesh-list
110286329|NCT02210260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110286330|NCT02210260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110286331|NCT02210260|Sensory System Agents|sensory system agents|mesh-ancestor
110286332|NCT02210260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110286333|NCT02210260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110286334|NCT02210260|Narcotics|narcotics|mesh-ancestor
110286335|NCT02210260|Analgesics|analgesics|mesh-ancestor
110276231|NCT00554125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110276232|NCT00554125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110276233|NCT00554125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110276234|NCT00554125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110276235|NCT00554125|Antifungal Agents|antifungal agents|mesh-ancestor
110276236|NCT00554125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110276237|NCT00554125|Immunologic Factors|immunologic factors|mesh-ancestor
110276238|NCT00554125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276239|NCT00175838|Aspirin|aspirin|mesh-list
110276240|NCT00175838|Hydroxyurea|hydroxyurea|mesh-list
110276241|NCT00175838|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110276242|NCT00175838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110286336|NCT00210548|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110286337|NCT00210548|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110286338|NCT00210548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110286339|NCT00210548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110286340|NCT00210548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110286341|NCT00210548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110286342|NCT00210548|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110286343|NCT00210548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110286344|NCT00210548|Serotonin Agents|serotonin agents|mesh-ancestor
110286345|NCT00210548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110286346|NCT00210548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110286347|NCT00210548|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110286348|NCT00210548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110286349|NCT00210548|Dopamine Agents|dopamine agents|mesh-ancestor
110286350|NCT00210587|Epoetin Alfa|epoetin alfa|mesh-list
110286351|NCT00210587|Hematinics|hematinics|mesh-ancestor
110286352|NCT00210665|Trabectedin|trabectedin|mesh-list
110286353|NCT00210665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110286354|NCT00210665|Alkylating Agents|alkylating agents|mesh-ancestor
110286355|NCT00210665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110286356|NCT00210665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110286357|NCT04570345|Aspirin|aspirin|mesh-list
110286358|NCT04570345|Ticagrelor|ticagrelor|mesh-list
110286359|NCT04570345|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110286360|NCT04570345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110286362|NCT04570345|Sensory System Agents|sensory system agents|mesh-ancestor
110286363|NCT04570345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110286364|NCT04570345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110286365|NCT04570345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110286366|NCT04570345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110286367|NCT04570345|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110286368|NCT04570345|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110286369|NCT04570345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110286370|NCT04570345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110286371|NCT04570345|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110286372|NCT04570345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110286373|NCT04570345|Antipyretics|antipyretics|mesh-ancestor
110286374|NCT04570345|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110286375|NCT04570345|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110286386|NCT00234819|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110286387|NCT00234819|Hormone Antagonists|hormone antagonists|mesh-ancestor
110286388|NCT00234819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110286389|NCT04570306|Belimumab|belimumab|mesh-list
110286390|NCT04570306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110286391|NCT04570306|Immunologic Factors|immunologic factors|mesh-ancestor
110286392|NCT04570306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110286393|NCT04570033|Parathyroid Hormone|parathyroid hormone|mesh-list
110286394|NCT04570033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110276244|NCT00175838|Sensory System Agents|sensory system agents|mesh-ancestor
110276245|NCT00175838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110276246|NCT00175838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276247|NCT00175838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110276248|NCT00175838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110276249|NCT00175838|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110276250|NCT00175838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110286395|NCT04570033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110286396|NCT00234858|Losartan|losartan|mesh-list
110286397|NCT00234858|Verapamil|verapamil|mesh-list
110286398|NCT00234858|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110286399|NCT00234858|Trandolapril|trandolapril|mesh-list
110286400|NCT00234858|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110286401|NCT00234858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110286402|NCT00234858|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110286403|NCT00234858|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110286404|NCT00234858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110286405|NCT00234858|Diuretics|diuretics|mesh-ancestor
110286406|NCT00234858|Natriuretic Agents|natriuretic agents|mesh-ancestor
110286407|NCT00234858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110286408|NCT00234858|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110286409|NCT00234858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110286410|NCT00234858|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110286411|NCT00234858|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110286412|NCT00234858|Vasodilator Agents|vasodilator agents|mesh-ancestor
110286413|NCT00234858|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110286414|NCT00234858|Protease Inhibitors|protease inhibitors|mesh-ancestor
110286415|NCT00234858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110286416|NCT04569838|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110286417|NCT04569838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110286418|NCT04569838|Alkylating Agents|alkylating agents|mesh-ancestor
110286419|NCT04569838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110286420|NCT04569838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110286421|NCT00210743|Epoetin Alfa|epoetin alfa|mesh-list
110286422|NCT00210743|Hematinics|hematinics|mesh-ancestor
110286423|NCT04569916|Irinotecan|irinotecan|mesh-list
110286424|NCT04569916|Apatinib|apatinib|mesh-list
110286425|NCT04569916|Antibodies|antibodies|mesh-list
110286426|NCT04569916|Immunologic Factors|immunologic factors|mesh-ancestor
110286427|NCT04569916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110286428|NCT04569916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110286429|NCT04569916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110286430|NCT04569916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110286431|NCT04569916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110286432|NCT04569916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110286433|NCT04569916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110286434|NCT00210782|Topiramate|topiramate|mesh-list
110286435|NCT00210782|Phenytoin|phenytoin|mesh-list
110286436|NCT00210782|Anticonvulsants|anticonvulsants|mesh-ancestor
110286437|NCT00210782|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110286438|NCT00210782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110286450|NCT00237861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110286451|NCT00237861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110286452|NCT00237861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110286453|NCT00237861|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110286454|NCT00237861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110286455|NCT00237861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110286456|NCT00237861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110286457|NCT00237861|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110286458|NCT00237861|Dopamine Agents|dopamine agents|mesh-ancestor
110286459|NCT00237861|Antiemetics|antiemetics|mesh-ancestor
110286460|NCT00237861|Autonomic Agents|autonomic agents|mesh-ancestor
110286461|NCT00237861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110276251|NCT00175838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276252|NCT00175838|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110276253|NCT00175838|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110276254|NCT00175838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110276255|NCT00175838|Antipyretics|antipyretics|mesh-ancestor
110276256|NCT00175838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110276257|NCT00175838|Antisickling Agents|antisickling agents|mesh-ancestor
110276258|NCT00175838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110276260|NCT00204555|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110276261|NCT00204555|Immunologic Factors|immunologic factors|mesh-ancestor
110276262|NCT00204555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276263|NCT00204555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110276264|NCT00204555|Interferon Inducers|interferon inducers|mesh-ancestor
110286462|NCT00237861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110286463|NCT00237861|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110286464|NCT00237861|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110286465|NCT00237861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110286466|NCT00237861|Antidepressive Agents|antidepressive agents|mesh-ancestor
110286467|NCT00237900|Leucovorin|leucovorin|mesh-list
110286468|NCT00237900|Fluorouracil|fluorouracil|mesh-list
110286469|NCT00237900|Gefitinib|gefitinib|mesh-list
110286470|NCT00237900|Antimetabolites|antimetabolites|mesh-ancestor
110286471|NCT00237900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110286472|NCT00237900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110286473|NCT00237900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110286474|NCT00237900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110286475|NCT00237900|Immunologic Factors|immunologic factors|mesh-ancestor
110286476|NCT00237900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110286477|NCT00237900|Antidotes|antidotes|mesh-ancestor
110286478|NCT00237900|Protective Agents|protective agents|mesh-ancestor
110286479|NCT00237900|Vitamin B Complex|vitamin b complex|mesh-ancestor
110286480|NCT00237900|Vitamins|vitamins|mesh-ancestor
110286481|NCT00237900|Micronutrients|micronutrients|mesh-ancestor
110286482|NCT00237900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110286483|NCT00237900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110286484|NCT00210821|Topiramate|topiramate|mesh-list
110286485|NCT00210821|Anticonvulsants|anticonvulsants|mesh-ancestor
110286486|NCT00210821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110286487|NCT00210821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110286488|NCT00237939|Aripiprazole|aripiprazole|mesh-list
110286489|NCT00237939|Antidepressive Agents|antidepressive agents|mesh-ancestor
110286490|NCT00237939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110286491|NCT00237939|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110286492|NCT00237939|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110286493|NCT00237939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110286494|NCT00237939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110286495|NCT00237939|Dopamine Agonists|dopamine agonists|mesh-ancestor
110286496|NCT00237939|Dopamine Agents|dopamine agents|mesh-ancestor
110286497|NCT00237939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110286498|NCT00237939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110286499|NCT00237939|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110286500|NCT00237939|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110286501|NCT00237939|Serotonin Agents|serotonin agents|mesh-ancestor
110286528|NCT02278081|Lansoprazole|lansoprazole|mesh-list
110286529|NCT02278081|Dexlansoprazole|dexlansoprazole|mesh-list
110286530|NCT02278081|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110286531|NCT02278081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110286532|NCT02278081|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110286533|NCT02278081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110286534|NCT02278081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276266|NCT00175955|Anticonvulsants|anticonvulsants|mesh-ancestor
110276267|NCT00175955|Nootropic Agents|nootropic agents|mesh-ancestor
110276268|NCT03758287|Gefitinib|gefitinib|mesh-list
110276269|NCT03758287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110276270|NCT03758287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110276271|NCT03758287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110276272|NCT03758287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276273|NCT00204633|Darbepoetin alfa|darbepoetin alfa|mesh-list
110276274|NCT00204633|Hematinics|hematinics|mesh-ancestor
110276275|NCT00199719|Ribavirin|ribavirin|mesh-list
110276276|NCT00199719|Antimetabolites|antimetabolites|mesh-ancestor
110286535|NCT00211016|Doripenem|doripenem|mesh-list
110286536|NCT00211016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110286537|NCT00211016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110286538|NCT00238017|Artesunate|artesunate|mesh-list
110286539|NCT00238017|Amodiaquine|amodiaquine|mesh-list
110286540|NCT00238017|Antimalarials|antimalarials|mesh-ancestor
110286541|NCT00238017|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110286542|NCT00238017|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110286543|NCT00238017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110286544|NCT00238017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110286545|NCT00238017|Antiviral Agents|antiviral agents|mesh-ancestor
110286546|NCT00238017|Schistosomicides|schistosomicides|mesh-ancestor
110286547|NCT00238017|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110286548|NCT00238017|Anthelmintics|anthelmintics|mesh-ancestor
110286549|NCT04567576|Antirheumatic Agents|antirheumatic agents|mesh-list
110286551|NCT00238056|Antiemetics|antiemetics|mesh-ancestor
110286552|NCT00238056|Autonomic Agents|autonomic agents|mesh-ancestor
110286553|NCT00238056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110286554|NCT00238056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110286555|NCT00238056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110286556|NCT00238056|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110286564|NCT04566952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110286566|NCT04567069|Immunologic Factors|immunologic factors|mesh-ancestor
110286567|NCT04567069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110286568|NCT04566796|Neostigmine|neostigmine|mesh-list
110286569|NCT04566796|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110286570|NCT04566796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110286571|NCT04566796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110286572|NCT04566796|Cholinergic Agents|cholinergic agents|mesh-ancestor
110286573|NCT04566796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110286574|NCT04566796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110286575|NCT04566796|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110286576|NCT04566796|Autonomic Agents|autonomic agents|mesh-ancestor
110286577|NCT04566796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110286578|NCT00238173|Acetylcysteine|acetylcysteine|mesh-list
110286579|NCT00238173|Sodium thiosulfate|sodium thiosulfate|mesh-list
110286580|NCT00238173|Cyclophosphamide|cyclophosphamide|mesh-list
110286581|NCT00238173|Carboplatin|carboplatin|mesh-list
110286582|NCT00238173|Etoposide|etoposide|mesh-list
110286583|NCT00238173|Etoposide phosphate|etoposide phosphate|mesh-list
110286584|NCT00238173|Mannitol|mannitol|mesh-list
110286585|NCT00238173|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110286586|NCT00238173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110286587|NCT00238173|Immunologic Factors|immunologic factors|mesh-ancestor
110286588|NCT00238173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110286589|NCT00238173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110286590|NCT00238173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110286591|NCT00238173|Alkylating Agents|alkylating agents|mesh-ancestor
110286592|NCT00238173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110286593|NCT00238173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110286594|NCT00238173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110286595|NCT00238173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110276277|NCT00199719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276279|NCT00199719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110276281|NCT03430882|Carboplatin|carboplatin|mesh-list
110276282|NCT03430882|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110276283|NCT03430882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110276284|NCT03430882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110276285|NCT03430882|Tubulin Modulators|tubulin modulators|mesh-ancestor
110276286|NCT03430882|Antimitotic Agents|antimitotic agents|mesh-ancestor
110276287|NCT03430882|Mitosis Modulators|mitosis modulators|mesh-ancestor
110286596|NCT00238173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110286597|NCT00238173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110286598|NCT00238173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110286599|NCT00238173|Antiviral Agents|antiviral agents|mesh-ancestor
110286600|NCT00238173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110286601|NCT00238173|Expectorants|expectorants|mesh-ancestor
110286602|NCT00238173|Respiratory System Agents|respiratory system agents|mesh-ancestor
110286603|NCT00238173|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110286604|NCT00238173|Antioxidants|antioxidants|mesh-ancestor
110286605|NCT00238173|Protective Agents|protective agents|mesh-ancestor
110286606|NCT00238173|Antidotes|antidotes|mesh-ancestor
110286607|NCT00238173|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110286608|NCT00238173|Diuretics|diuretics|mesh-ancestor
110286609|NCT00238173|Natriuretic Agents|natriuretic agents|mesh-ancestor
110286610|NCT00238173|Antitubercular Agents|antitubercular agents|mesh-ancestor
110286611|NCT00238173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110286612|NCT00238173|Chelating Agents|chelating agents|mesh-ancestor
110286613|NCT00238173|Sequestering Agents|sequestering agents|mesh-ancestor
110286614|NCT00211133|Epoetin Alfa|epoetin alfa|mesh-list
110286615|NCT00211133|Hematinics|hematinics|mesh-ancestor
110286616|NCT00238212|Sorafenib|sorafenib|mesh-list
110286617|NCT00238212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110286618|NCT00238212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110286619|NCT00238212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110286620|NCT00238212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110286621|NCT00211250|Valproic Acid|valproic acid|mesh-list
110286622|NCT00211250|Anticonvulsants|anticonvulsants|mesh-ancestor
110286623|NCT00211250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110286624|NCT00211250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110286625|NCT00211250|GABA Agents|gaba agents|mesh-ancestor
110286634|NCT00238251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110286636|NCT00238251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110286637|NCT00238251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110286638|NCT00238251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110286639|NCT00238251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110286640|NCT04566718|Metformin|metformin|mesh-list
110286641|NCT04566718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110286642|NCT04566718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110286643|NCT02210884|Vitamin D|vitamin d|mesh-list
110286644|NCT02210884|Ergocalciferols|ergocalciferols|mesh-list
110286645|NCT02210884|Cholecalciferol|cholecalciferol|mesh-list
110286646|NCT02210884|Vitamins|vitamins|mesh-list
110286647|NCT02210884|Micronutrients|micronutrients|mesh-ancestor
110286648|NCT02210884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110286649|NCT02210884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110286650|NCT02210884|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110286651|NCT00238290|Trastuzumab|trastuzumab|mesh-list
110286652|NCT00238290|Letrozole|letrozole|mesh-list
110286653|NCT00238290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110286654|NCT00238290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110286655|NCT00238290|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110286656|NCT00238290|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110286657|NCT00238290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110286658|NCT00238290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110286659|NCT00238290|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110286660|NCT00238290|Hormone Antagonists|hormone antagonists|mesh-ancestor
110276288|NCT03430882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276290|NCT00199758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110276291|NCT00199758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110276292|NCT00199758|Antimetabolites|antimetabolites|mesh-ancestor
110276293|NCT00199758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276295|NCT03291886|Entinostat|entinostat|mesh-list
110276296|NCT03291886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110276297|NCT03291886|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110276298|NCT03291886|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110276299|NCT03291886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110276300|NCT03291886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276301|NCT03291886|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110286661|NCT00238290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110286662|NCT00238290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110286664|NCT00211328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110286665|NCT00211328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110286666|NCT00211328|Growth Substances|growth substances|mesh-ancestor
110286667|NCT00211328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110286668|NCT00211328|Growth Inhibitors|growth inhibitors|mesh-ancestor
110286669|NCT00211328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110286670|NCT00238329|Interferons|interferons|mesh-list
110286671|NCT00238329|Interferon-alpha|interferon-alpha|mesh-list
110286672|NCT00238329|Interferon alpha-2|interferon alpha-2|mesh-list
110286673|NCT00238329|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110286674|NCT00238329|Thalidomide|thalidomide|mesh-list
110286675|NCT00238329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110286676|NCT00238329|Antiviral Agents|antiviral agents|mesh-ancestor
110286677|NCT00238329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110286678|NCT00238329|Immunologic Factors|immunologic factors|mesh-ancestor
110286679|NCT00238329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110286680|NCT00238329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110286681|NCT00238329|Leprostatic Agents|leprostatic agents|mesh-ancestor
110286682|NCT00238329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110286683|NCT00238329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110286684|NCT00238329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110286685|NCT00238329|Growth Substances|growth substances|mesh-ancestor
110286686|NCT00238329|Growth Inhibitors|growth inhibitors|mesh-ancestor
110286687|NCT02894905|Adafosbuvir|adafosbuvir|mesh-list
110286688|NCT02894905|Antiviral Agents|antiviral agents|mesh-ancestor
110286689|NCT02894905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110286690|NCT00211367|Anecortave|anecortave|mesh-list
110286691|NCT00211367|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110286692|NCT00211367|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110286693|NCT00211367|Growth Substances|growth substances|mesh-ancestor
110286694|NCT00211367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110286695|NCT00211367|Growth Inhibitors|growth inhibitors|mesh-ancestor
110286701|NCT00238368|Busulfan|busulfan|mesh-list
110286702|NCT00238368|Rituximab|rituximab|mesh-list
110286703|NCT00238368|Doxorubicin|doxorubicin|mesh-list
110286704|NCT00238368|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110286706|NCT00238368|Vincristine|vincristine|mesh-list
110286707|NCT00238368|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110286708|NCT00238368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110286709|NCT00238368|Immunologic Factors|immunologic factors|mesh-ancestor
110286710|NCT00238368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110286711|NCT00238368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110286712|NCT00238368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110286713|NCT00238368|Alkylating Agents|alkylating agents|mesh-ancestor
110286714|NCT00238368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276303|NCT03291886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110276304|NCT03291886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276305|NCT03291886|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110276306|NCT03252808|Paclitaxel|paclitaxel|mesh-list
110276307|NCT03252808|Gemcitabine|gemcitabine|mesh-list
110276308|NCT03252808|Tegafur|tegafur|mesh-list
110276309|NCT03252808|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110276310|NCT03252808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110276311|NCT03252808|Tubulin Modulators|tubulin modulators|mesh-ancestor
110276312|NCT03252808|Antimitotic Agents|antimitotic agents|mesh-ancestor
110276313|NCT03252808|Mitosis Modulators|mitosis modulators|mesh-ancestor
110286715|NCT00238368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110286716|NCT00238368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110286717|NCT00238368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110286718|NCT00238368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110286719|NCT00238368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110286720|NCT00238368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110286721|NCT00238368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110286722|NCT00238368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110286723|NCT00238368|Glucocorticoids|glucocorticoids|mesh-ancestor
110286724|NCT00238368|Hormones|hormones|mesh-ancestor
110286725|NCT00238368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110286726|NCT00238368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110286727|NCT00238368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110286728|NCT00238368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110286729|NCT00238368|Antimetabolites|antimetabolites|mesh-ancestor
110286730|NCT00238368|Antiviral Agents|antiviral agents|mesh-ancestor
110286731|NCT00238368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110286732|NCT00238368|Tubulin Modulators|tubulin modulators|mesh-ancestor
110286733|NCT00238368|Antimitotic Agents|antimitotic agents|mesh-ancestor
110286734|NCT00238368|Mitosis Modulators|mitosis modulators|mesh-ancestor
110286735|NCT00238368|Antiemetics|antiemetics|mesh-ancestor
110286736|NCT00238368|Autonomic Agents|autonomic agents|mesh-ancestor
110286737|NCT00238368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110286738|NCT00238368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110286739|NCT00238368|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110286740|NCT00238368|Protective Agents|protective agents|mesh-ancestor
110286741|NCT00238368|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110286742|NCT02894593|Ethanol|ethanol|mesh-list
110286743|NCT02894593|Chlorhexidine|chlorhexidine|mesh-list
110286744|NCT02894593|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110286745|NCT02894593|Listerine|listerine|mesh-list
110286746|NCT02894593|Sodium Fluoride|sodium fluoride|mesh-list
110286747|NCT02894593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110286748|NCT02894593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110286749|NCT02894593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110286750|NCT02894593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110286751|NCT02894593|Disinfectants|disinfectants|mesh-ancestor
110286752|NCT02894593|Dermatologic Agents|dermatologic agents|mesh-ancestor
110286753|NCT02894593|Cariostatic Agents|cariostatic agents|mesh-ancestor
110286754|NCT02894593|Protective Agents|protective agents|mesh-ancestor
110286755|NCT00211406|Anecortave|anecortave|mesh-list
110286756|NCT00211406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110286757|NCT00211406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110286758|NCT00211406|Growth Substances|growth substances|mesh-ancestor
110286759|NCT00211406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110286760|NCT00211406|Growth Inhibitors|growth inhibitors|mesh-ancestor
110286761|NCT00211406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110286762|NCT02894554|Lamivudine|lamivudine|mesh-list
110286763|NCT02894554|Telbivudine|telbivudine|mesh-list
110286764|NCT02894554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110276314|NCT03252808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276315|NCT03252808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110276316|NCT03252808|Antimetabolites|antimetabolites|mesh-ancestor
110276317|NCT03191461|Adenosine|adenosine|mesh-list
110276318|NCT03191461|Analgesics|analgesics|mesh-ancestor
110276319|NCT03191461|Sensory System Agents|sensory system agents|mesh-ancestor
110276320|NCT03191461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110276321|NCT03191461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276322|NCT03191461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110286765|NCT02894554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110286766|NCT02894554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110286767|NCT02894554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110286768|NCT02894554|Antiviral Agents|antiviral agents|mesh-ancestor
110286769|NCT02894554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110286770|NCT02894554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110286773|NCT00238407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110286774|NCT00238407|Tubulin Modulators|tubulin modulators|mesh-ancestor
110286775|NCT00238407|Antimitotic Agents|antimitotic agents|mesh-ancestor
110286776|NCT00238407|Mitosis Modulators|mitosis modulators|mesh-ancestor
110286777|NCT00238407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110286778|NCT02894515|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
110286779|NCT02894515|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110286781|NCT02894515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110286782|NCT02894515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110286783|NCT02894515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110286784|NCT00211445|Verteporfin|verteporfin|mesh-list
110286785|NCT00211445|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110286786|NCT00211445|Dermatologic Agents|dermatologic agents|mesh-ancestor
110286788|NCT02894710|Anesthetics, Local|anesthetics, local|mesh-ancestor
110286789|NCT02894710|Anesthetics|anesthetics|mesh-ancestor
110286790|NCT02894710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110286791|NCT02894710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110286792|NCT02894710|Sensory System Agents|sensory system agents|mesh-ancestor
110286793|NCT02894710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110286794|NCT02894710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110286795|NCT02894710|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110286796|NCT02894710|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110286797|NCT02894710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110286798|NCT02894710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110286799|NCT00211484|Anecortave|anecortave|mesh-list
110286800|NCT00211484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110286801|NCT00211484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110286802|NCT00211484|Growth Substances|growth substances|mesh-ancestor
110286803|NCT00211484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110286804|NCT00211484|Growth Inhibitors|growth inhibitors|mesh-ancestor
110286805|NCT00211484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110286806|NCT05428072|Aspirin|aspirin|mesh-list
110286807|NCT05428072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110286808|NCT05428072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110286809|NCT05428072|Analgesics|analgesics|mesh-ancestor
110286810|NCT05428072|Sensory System Agents|sensory system agents|mesh-ancestor
110286811|NCT05428072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110286812|NCT05428072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110286813|NCT05428072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110286814|NCT05428072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110286815|NCT05428072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110286816|NCT05428072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110286817|NCT05428072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110286818|NCT05428072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110286819|NCT05428072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110286820|NCT05428072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110286821|NCT05428072|Antipyretics|antipyretics|mesh-ancestor
110276323|NCT03191461|Vasodilator Agents|vasodilator agents|mesh-ancestor
110276324|NCT03191461|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110276325|NCT03191461|Purinergic Agonists|purinergic agonists|mesh-ancestor
110276326|NCT03191461|Purinergic Agents|purinergic agents|mesh-ancestor
110276327|NCT03191461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110276328|NCT03191461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276329|NCT00199953|Rabeprazole|rabeprazole|mesh-list
110276330|NCT00199953|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110276331|NCT00199953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110276332|NCT00199953|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110276334|NCT00199953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276335|NCT03184090|Palbociclib|palbociclib|mesh-list
110286822|NCT00211523|Omiganan pentahydrochloride|omiganan pentahydrochloride|mesh-list
110286823|NCT00211523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110286824|NCT00211562|Vitamin E|vitamin e|mesh-list
110286825|NCT00211562|Olanzapine|olanzapine|mesh-list
110286826|NCT00211562|Vitamins|vitamins|mesh-ancestor
110286827|NCT00211562|Micronutrients|micronutrients|mesh-ancestor
110286828|NCT00211562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110286829|NCT00211562|Antiemetics|antiemetics|mesh-ancestor
110286830|NCT00211562|Autonomic Agents|autonomic agents|mesh-ancestor
110286831|NCT00211562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110286832|NCT00211562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110286833|NCT00211562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110286834|NCT00211562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110286835|NCT00211562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110286836|NCT00211562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110286837|NCT00211562|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110286838|NCT00211562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110286839|NCT00211562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110286840|NCT00211562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110286841|NCT00211562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110286842|NCT00211562|Serotonin Agents|serotonin agents|mesh-ancestor
110286843|NCT00211562|Antioxidants|antioxidants|mesh-ancestor
110286853|NCT00238641|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110286854|NCT00238641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110286855|NCT00238641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110286856|NCT00238641|Cholinergic Agents|cholinergic agents|mesh-ancestor
110286857|NCT00238641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110286858|NCT00238641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110286859|NCT00238641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110286860|NCT00238641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110286861|NCT00238641|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110286862|NCT05427175|Methotrexate|methotrexate|mesh-list
110286863|NCT05427175|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110286864|NCT05427175|Abortifacient Agents|abortifacient agents|mesh-ancestor
110286865|NCT05427175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110286866|NCT05427175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110286867|NCT05427175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110286868|NCT05427175|Antimetabolites|antimetabolites|mesh-ancestor
110286869|NCT05427175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110286870|NCT05427175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110286871|NCT05427175|Dermatologic Agents|dermatologic agents|mesh-ancestor
110286872|NCT05427175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110286873|NCT05427175|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110286874|NCT05427175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110286875|NCT05427175|Immunologic Factors|immunologic factors|mesh-ancestor
110286876|NCT05427175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110286877|NCT05427175|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110286878|NCT00211679|Botulinum Toxins|botulinum toxins|mesh-list
110276336|NCT03184090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110276337|NCT03184090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110276338|NCT03184090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110276339|NCT03184090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276340|NCT03160846|Milrinone|milrinone|mesh-list
110276341|NCT03160846|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110276342|NCT03160846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110276344|NCT03160846|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110276345|NCT03160846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110276346|NCT03160846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110276347|NCT03160846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276348|NCT03160846|Protective Agents|protective agents|mesh-ancestor
110276349|NCT03160846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276350|NCT00204789|Eflornithine|eflornithine|mesh-list
110286879|NCT00211679|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110286880|NCT00211679|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110286881|NCT00211679|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110286882|NCT00211679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110286883|NCT00211679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110286884|NCT00211679|Cholinergic Agents|cholinergic agents|mesh-ancestor
110286885|NCT00211679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110286886|NCT00211679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110286887|NCT00211679|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110286888|NCT00211679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110286889|NCT04680091|Efavirenz|efavirenz|mesh-list
110286890|NCT04680091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110286891|NCT04680091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110286892|NCT04680091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110286893|NCT04680091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110286894|NCT04680091|Antiviral Agents|antiviral agents|mesh-ancestor
110286895|NCT04680091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110286896|NCT04680091|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110286897|NCT04680091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110286898|NCT04680091|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110286899|NCT04680091|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110286900|NCT04680091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110286901|NCT04680091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110286902|NCT00211718|Botulinum Toxins|botulinum toxins|mesh-list
110286903|NCT00211718|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110286904|NCT00211718|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110286905|NCT00211718|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110286906|NCT00211718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110286917|NCT00238719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110286918|NCT00238719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110286919|NCT00238719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110286920|NCT00238719|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110286921|NCT00238719|Antidepressive Agents|antidepressive agents|mesh-ancestor
110286922|NCT00238719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110286923|NCT04680208|Anesthetics|anesthetics|mesh-list
110286924|NCT04680208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110286925|NCT04680208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110286926|NCT00211796|Valproic Acid|valproic acid|mesh-list
110286927|NCT00211796|Anticonvulsants|anticonvulsants|mesh-ancestor
110286928|NCT00211796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110286929|NCT00211796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276351|NCT00204789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110276352|NCT00204789|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110276353|NCT00204789|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110276354|NCT00204789|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110276355|NCT00204789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110276356|NCT00204789|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
110276357|NCT00204789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110276358|NCT00204789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276359|NCT00176540|Dextromethorphan|dextromethorphan|mesh-list
110286930|NCT00211796|GABA Agents|gaba agents|mesh-ancestor
110286931|NCT00211796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110286932|NCT00211796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110286933|NCT00211796|Antimanic Agents|antimanic agents|mesh-ancestor
110286934|NCT00211796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110286935|NCT00211796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110286936|NCT00211796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110286937|NCT05426824|Pegaspargase|pegaspargase|mesh-list
110286938|NCT05426824|Asparaginase|asparaginase|mesh-list
110286939|NCT05426824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110286940|NCT00238797|Gefitinib|gefitinib|mesh-list
110286941|NCT00238797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110286942|NCT00238797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110286943|NCT00238797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110286944|NCT00238797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110286945|NCT05426044|Metformin|metformin|mesh-list
110286946|NCT05426044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110286947|NCT05426044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110286948|NCT05425654|Cyclophosphamide|cyclophosphamide|mesh-list
110286949|NCT05425654|Busulfan|busulfan|mesh-list
110286950|NCT05425654|Carmustine|carmustine|mesh-list
110286951|NCT05425654|Rituximab|rituximab|mesh-list
110286952|NCT05425654|Methotrexate|methotrexate|mesh-list
110286953|NCT05425654|Vincristine|vincristine|mesh-list
110286954|NCT05425654|Lenalidomide|lenalidomide|mesh-list
110286955|NCT05425654|Procarbazine|procarbazine|mesh-list
110286956|NCT05425654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110286957|NCT05425654|Immunologic Factors|immunologic factors|mesh-ancestor
110286958|NCT05425654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110286959|NCT05425654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110286960|NCT05425654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110286961|NCT05425654|Alkylating Agents|alkylating agents|mesh-ancestor
110286962|NCT05425654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110286963|NCT05425654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110286964|NCT05425654|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110286965|NCT05425654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110286966|NCT05425654|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110286967|NCT05425654|Abortifacient Agents|abortifacient agents|mesh-ancestor
110286968|NCT05425654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110286969|NCT05425654|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110286974|NCT05425654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110286975|NCT05425654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110286976|NCT05425654|Tubulin Modulators|tubulin modulators|mesh-ancestor
110286977|NCT05425654|Antimitotic Agents|antimitotic agents|mesh-ancestor
110286978|NCT05425654|Mitosis Modulators|mitosis modulators|mesh-ancestor
110286979|NCT05425654|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110286980|NCT05425654|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110286981|NCT05425654|Growth Substances|growth substances|mesh-ancestor
110286982|NCT05425654|Growth Inhibitors|growth inhibitors|mesh-ancestor
110286983|NCT05425576|Pembrolizumab|pembrolizumab|mesh-list
110286984|NCT05425576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110286985|NCT05425576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110286986|NCT05425576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110286987|NCT05425576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110286988|NCT00238914|Naltrexone|naltrexone|mesh-list
110286989|NCT00238914|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110276360|NCT00176540|Antitussive Agents|antitussive agents|mesh-ancestor
110276361|NCT00176540|Respiratory System Agents|respiratory system agents|mesh-ancestor
110276362|NCT00176540|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110276363|NCT00176540|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110276364|NCT00176540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110276365|NCT00176540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276366|NCT00176540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276367|NCT02827435|Bromides|bromides|mesh-list
110276368|NCT02827435|Rocuronium|rocuronium|mesh-list
110276369|NCT02827435|Anticonvulsants|anticonvulsants|mesh-ancestor
110276370|NCT02827435|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110276371|NCT02827435|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110276372|NCT02827435|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110276373|NCT02827435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110276374|NCT02827435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276376|NCT00176618|Sulindac|sulindac|mesh-list
110276377|NCT00176618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110276378|NCT00176618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110286990|NCT00238914|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110286991|NCT00238914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110286992|NCT00238914|Sensory System Agents|sensory system agents|mesh-ancestor
110286993|NCT00238914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110286994|NCT04668976|Gemcitabine|gemcitabine|mesh-list
110286995|NCT04668976|Fluorouracil|fluorouracil|mesh-list
110286996|NCT04668976|Floxuridine|floxuridine|mesh-list
110286997|NCT04668976|Oxaliplatin|oxaliplatin|mesh-list
110286998|NCT04668976|Irinotecan|irinotecan|mesh-list
110286999|NCT04668976|Cetuximab|cetuximab|mesh-list
110287000|NCT04668976|Panitumumab|panitumumab|mesh-list
110287001|NCT04668976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110287002|NCT04668976|Antimetabolites|antimetabolites|mesh-ancestor
110287003|NCT04668976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287004|NCT04668976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110287005|NCT04668976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110287006|NCT04668976|Immunologic Factors|immunologic factors|mesh-ancestor
110287007|NCT04668976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110287008|NCT04668976|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110287009|NCT04668976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110287010|NCT04668976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110287011|NCT04668976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110287012|NCT00238953|Mycophenolic Acid|mycophenolic acid|mesh-list
110287013|NCT00238953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110287014|NCT00238953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110287015|NCT00238953|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110287016|NCT00238953|Antitubercular Agents|antitubercular agents|mesh-ancestor
110287017|NCT00238953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110287018|NCT00238953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110287019|NCT00238953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110287020|NCT00238953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287021|NCT04669366|Sunitinib|sunitinib|mesh-list
110287022|NCT04669366|Axitinib|axitinib|mesh-list
110287023|NCT04669366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110287024|NCT04669366|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110287025|NCT04669366|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110287026|NCT04669366|Growth Substances|growth substances|mesh-ancestor
110287027|NCT04669366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276379|NCT00176618|Analgesics|analgesics|mesh-ancestor
110276380|NCT00176618|Sensory System Agents|sensory system agents|mesh-ancestor
110276381|NCT00176618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110276382|NCT00176618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276383|NCT00176618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110276384|NCT00176618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110276385|NCT00176618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110276386|NCT00176618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110276387|NCT00176618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287028|NCT04669366|Growth Inhibitors|growth inhibitors|mesh-ancestor
110287029|NCT04669366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110287030|NCT04669366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110287031|NCT04669366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287032|NCT04721301|Maraviroc|maraviroc|mesh-list
110287033|NCT04721301|Nivolumab|nivolumab|mesh-list
110287034|NCT04721301|Ipilimumab|ipilimumab|mesh-list
110287035|NCT04721301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110287036|NCT04721301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110287037|NCT04721301|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110287038|NCT04721301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287040|NCT04721301|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110287041|NCT04721301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110287050|NCT00238992|Antitubercular Agents|antitubercular agents|mesh-ancestor
110287051|NCT00238992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110287052|NCT00238992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110287053|NCT00238992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110287054|NCT00238992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287055|NCT00556465|Acetylcysteine|acetylcysteine|mesh-list
110287056|NCT00556465|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110287057|NCT00556465|Antiviral Agents|antiviral agents|mesh-ancestor
110287058|NCT00556465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110287059|NCT00556465|Expectorants|expectorants|mesh-ancestor
110287060|NCT00556465|Respiratory System Agents|respiratory system agents|mesh-ancestor
110287061|NCT00556465|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110287062|NCT00556465|Antioxidants|antioxidants|mesh-ancestor
110287063|NCT00556465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287064|NCT00556465|Protective Agents|protective agents|mesh-ancestor
110287065|NCT00556465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110287066|NCT00556465|Antidotes|antidotes|mesh-ancestor
110287067|NCT04668469|Acetaminophen|acetaminophen|mesh-list
110287069|NCT04668469|Ascorbic Acid|ascorbic acid|mesh-list
110287070|NCT04668469|Zinc|zinc|mesh-list
110287071|NCT04668469|Azithromycin|azithromycin|mesh-list
110287072|NCT04668469|Hydroxychloroquine|hydroxychloroquine|mesh-list
110287073|NCT04668469|Ivermectin|ivermectin|mesh-list
110287074|NCT04668469|Lactoferrin|lactoferrin|mesh-list
110287075|NCT04668469|Fibrin fragment D|fibrin fragment d|mesh-list
110287076|NCT04668469|Micronutrients|micronutrients|mesh-ancestor
110287077|NCT04668469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110287078|NCT04668469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110287080|NCT04668469|Sensory System Agents|sensory system agents|mesh-ancestor
110287081|NCT04668469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110287082|NCT04668469|Antipyretics|antipyretics|mesh-ancestor
110287083|NCT04668469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110287084|NCT04668469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110287085|NCT04668469|Antimalarials|antimalarials|mesh-ancestor
110287086|NCT04668469|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110287087|NCT04668469|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110287088|NCT04668469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110287089|NCT04668469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287090|NCT04668469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110287091|NCT04668469|Trace Elements|trace elements|mesh-ancestor
110287092|NCT04668469|Antioxidants|antioxidants|mesh-ancestor
110287093|NCT04668469|Protective Agents|protective agents|mesh-ancestor
110287094|NCT04668469|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110287095|NCT04668469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110276388|NCT00176618|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110276389|NCT02675959|Defibrotide|defibrotide|mesh-list
110276390|NCT02675959|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110276391|NCT02675959|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110276392|NCT02675959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276393|NCT02675959|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110276394|NCT00410787|Hydromorphone|hydromorphone|mesh-list
110276395|NCT00410787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110276396|NCT00410787|Narcotics|narcotics|mesh-ancestor
110276397|NCT00410787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110276398|NCT00410787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110287096|NCT04668469|Hemostatics|hemostatics|mesh-ancestor
110287097|NCT04668469|Coagulants|coagulants|mesh-ancestor
110287098|NCT00239031|Mycophenolic Acid|mycophenolic acid|mesh-list
110287099|NCT00239031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110287100|NCT00239031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110287101|NCT00239031|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110287102|NCT00239031|Antitubercular Agents|antitubercular agents|mesh-ancestor
110287103|NCT00239031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110287104|NCT00239031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110287105|NCT00239031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110287106|NCT00239031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287107|NCT00239070|Mycophenolic Acid|mycophenolic acid|mesh-list
110287108|NCT00239070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110287109|NCT00239070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110287110|NCT00239070|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110287111|NCT00239070|Antitubercular Agents|antitubercular agents|mesh-ancestor
110287112|NCT00239070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110287126|NCT00211952|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110287127|NCT00211952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110287128|NCT00211952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287129|NCT00239109|Olanzapine|olanzapine|mesh-list
110287130|NCT00239109|Ziprasidone|ziprasidone|mesh-list
110287131|NCT00239109|Antiemetics|antiemetics|mesh-ancestor
110287132|NCT00239109|Autonomic Agents|autonomic agents|mesh-ancestor
110287133|NCT00239109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110287134|NCT00239109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110287135|NCT00239109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110287136|NCT00239109|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110287137|NCT00239109|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110287138|NCT00239109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110287139|NCT00239109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110287140|NCT00239109|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110287141|NCT00239109|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110287142|NCT00239109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110287143|NCT00239109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287144|NCT00239109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110287145|NCT00239109|Serotonin Agents|serotonin agents|mesh-ancestor
110287146|NCT00239109|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110287147|NCT00239109|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110287148|NCT00239109|Dopamine Agents|dopamine agents|mesh-ancestor
110287149|NCT00212030|Nicorandil|nicorandil|mesh-list
110287150|NCT00212030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110287151|NCT00212030|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110287152|NCT00212030|Vasodilator Agents|vasodilator agents|mesh-ancestor
110287153|NCT00212030|Vitamin B Complex|vitamin b complex|mesh-ancestor
110287154|NCT00212030|Vitamins|vitamins|mesh-ancestor
110287155|NCT00212030|Micronutrients|micronutrients|mesh-ancestor
110287156|NCT00212030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110287157|NCT00212069|Carboplatin|carboplatin|mesh-list
110287158|NCT00212069|Gemcitabine|gemcitabine|mesh-list
110287159|NCT00212069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110287160|NCT00212069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110276399|NCT00410787|Analgesics|analgesics|mesh-ancestor
110276400|NCT00410787|Sensory System Agents|sensory system agents|mesh-ancestor
110276401|NCT00410787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110276402|NCT00554164|Prednisone|prednisone|mesh-list
110276403|NCT00554164|Cyclophosphamide|cyclophosphamide|mesh-list
110276404|NCT00554164|Doxorubicin|doxorubicin|mesh-list
110276405|NCT00554164|Vincristine|vincristine|mesh-list
110276406|NCT00554164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110276407|NCT00554164|Immunologic Factors|immunologic factors|mesh-ancestor
110276408|NCT00554164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276410|NCT00554164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110287161|NCT00212069|Antimetabolites|antimetabolites|mesh-ancestor
110287162|NCT00212069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287164|NCT00212108|Gefitinib|gefitinib|mesh-list
110287165|NCT00212108|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110287166|NCT00212108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110287167|NCT00212108|Analgesics|analgesics|mesh-ancestor
110287168|NCT00212108|Sensory System Agents|sensory system agents|mesh-ancestor
110287169|NCT00212108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110287170|NCT00212108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110287171|NCT00212108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110287172|NCT00212108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110287173|NCT00212108|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110287174|NCT00212108|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110287180|NCT00212186|Antioxidants|antioxidants|mesh-ancestor
110287181|NCT00212186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287182|NCT00212186|Protective Agents|protective agents|mesh-ancestor
110287183|NCT00212186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110287184|NCT00212186|Trace Elements|trace elements|mesh-ancestor
110287185|NCT00212186|Micronutrients|micronutrients|mesh-ancestor
110287186|NCT00414336|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110287187|NCT00414336|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110287188|NCT00414336|Immunologic Factors|immunologic factors|mesh-ancestor
110287189|NCT00414336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110287190|NCT00414336|Antacids|antacids|mesh-ancestor
110287191|NCT00414336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287192|NCT00414336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110287193|NCT00212342|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110287194|NCT00212342|Norethindrone|norethindrone|mesh-list
110287195|NCT00212342|Norethindrone Acetate|norethindrone acetate|mesh-list
110287196|NCT00212342|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110287197|NCT00212342|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110287198|NCT00212342|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110287199|NCT00212342|Contraceptive Agents|contraceptive agents|mesh-ancestor
110287200|NCT00212342|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110287201|NCT00212342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110287202|NCT00212342|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110287203|NCT00212342|Estrogens|estrogens|mesh-ancestor
110287204|NCT00212342|Hormones|hormones|mesh-ancestor
110287205|NCT00212342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110287206|NCT00212342|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110287207|NCT00414414|Prednisone|prednisone|mesh-list
110287208|NCT00414414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110287209|NCT00414414|Glucocorticoids|glucocorticoids|mesh-ancestor
110287210|NCT00414414|Hormones|hormones|mesh-ancestor
110287211|NCT00414414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110287212|NCT00414414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110287213|NCT00414414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110287214|NCT00414414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110287215|NCT00239304|Gefitinib|gefitinib|mesh-list
110287216|NCT00239304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110276411|NCT00554164|Alkylating Agents|alkylating agents|mesh-ancestor
110276412|NCT00554164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276413|NCT00554164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110276414|NCT00554164|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110276415|NCT00554164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110276417|NCT00554164|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110276418|NCT00554164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110276419|NCT00554164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110276420|NCT00554164|Glucocorticoids|glucocorticoids|mesh-ancestor
110276421|NCT00554164|Hormones|hormones|mesh-ancestor
110276422|NCT00554164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110276423|NCT00554164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110276424|NCT00554164|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110276425|NCT00554164|Tubulin Modulators|tubulin modulators|mesh-ancestor
110276426|NCT00554164|Antimitotic Agents|antimitotic agents|mesh-ancestor
110276427|NCT00554164|Mitosis Modulators|mitosis modulators|mesh-ancestor
110276428|NCT02572141|Leucovorin|leucovorin|mesh-list
110276429|NCT02572141|Fluorouracil|fluorouracil|mesh-list
110276430|NCT02572141|Capecitabine|capecitabine|mesh-list
110276431|NCT02572141|Oxaliplatin|oxaliplatin|mesh-list
110276432|NCT02572141|Levoleucovorin|levoleucovorin|mesh-list
110276433|NCT02572141|Antimetabolites|antimetabolites|mesh-ancestor
110287217|NCT00239304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110287218|NCT00239304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110287219|NCT00239304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287220|NCT00239343|Gefitinib|gefitinib|mesh-list
110287221|NCT00239343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110287222|NCT00239343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110287223|NCT00239343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110287224|NCT00239343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287225|NCT00411593|Bevacizumab|bevacizumab|mesh-list
110287226|NCT00411593|Bortezomib|bortezomib|mesh-list
110287227|NCT00411593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110287228|NCT00411593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110287229|NCT00411593|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110287230|NCT00411593|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110287231|NCT00411593|Growth Substances|growth substances|mesh-ancestor
110287232|NCT00411593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110287233|NCT00411593|Growth Inhibitors|growth inhibitors|mesh-ancestor
110287234|NCT00239382|Meloxicam|meloxicam|mesh-list
110287235|NCT00239382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110287236|NCT00239382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110287237|NCT00239382|Analgesics|analgesics|mesh-ancestor
110287238|NCT00239382|Sensory System Agents|sensory system agents|mesh-ancestor
110287239|NCT00239382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110287240|NCT00239382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110287241|NCT00239382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110287242|NCT00239382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110287243|NCT00239382|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110287249|NCT00239421|Formoterol Fumarate|formoterol fumarate|mesh-list
110287250|NCT00239421|Tiotropium Bromide|tiotropium bromide|mesh-list
110287251|NCT00239421|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110276434|NCT02572141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276435|NCT02572141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110276436|NCT02572141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110276437|NCT02572141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110276438|NCT02572141|Immunologic Factors|immunologic factors|mesh-ancestor
110276439|NCT02572141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276440|NCT02572141|Antidotes|antidotes|mesh-ancestor
110276441|NCT02572141|Protective Agents|protective agents|mesh-ancestor
110276442|NCT02572141|Vitamin B Complex|vitamin b complex|mesh-ancestor
110276443|NCT02572141|Vitamins|vitamins|mesh-ancestor
110276444|NCT02572141|Micronutrients|micronutrients|mesh-ancestor
110276445|NCT02470039|Insulin|insulin|mesh-list
110276446|NCT02470039|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110276447|NCT02470039|Insulin Glargine|insulin glargine|mesh-list
110276448|NCT02470039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110276450|NCT00554203|Sulfasalazine|sulfasalazine|mesh-list
110276451|NCT00554203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110276452|NCT00554203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110276453|NCT00554203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110276454|NCT00554203|Analgesics|analgesics|mesh-ancestor
110287252|NCT00239421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110287253|NCT00239421|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110287254|NCT00239421|Autonomic Agents|autonomic agents|mesh-ancestor
110287255|NCT00239421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110287256|NCT00239421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110287257|NCT00239421|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110287258|NCT00239421|Respiratory System Agents|respiratory system agents|mesh-ancestor
110287259|NCT00239421|Dermatologic Agents|dermatologic agents|mesh-ancestor
110287260|NCT00239421|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110287261|NCT00239421|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110287262|NCT00239421|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110287263|NCT00239421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110287264|NCT00239421|Adrenergic Agents|adrenergic agents|mesh-ancestor
110287265|NCT00239421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110287266|NCT00239421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287267|NCT00239421|Parasympatholytics|parasympatholytics|mesh-ancestor
110287268|NCT00239421|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110287269|NCT00239421|Cholinergic Agents|cholinergic agents|mesh-ancestor
110287270|NCT00239460|Tiotropium Bromide|tiotropium bromide|mesh-list
110287271|NCT00239460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110287272|NCT00239460|Autonomic Agents|autonomic agents|mesh-ancestor
110287273|NCT00239460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110287274|NCT00239460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110287275|NCT00239460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110287276|NCT00239460|Respiratory System Agents|respiratory system agents|mesh-ancestor
110287277|NCT00239460|Parasympatholytics|parasympatholytics|mesh-ancestor
110287278|NCT00239460|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110287279|NCT00239460|Cholinergic Agents|cholinergic agents|mesh-ancestor
110287280|NCT00239460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110287281|NCT00239460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287282|NCT00239499|Fluticasone|fluticasone|mesh-list
110287283|NCT00239499|Tiotropium Bromide|tiotropium bromide|mesh-list
110287284|NCT00239499|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110287285|NCT00239499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110287286|NCT00239499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110287287|NCT00239499|Autonomic Agents|autonomic agents|mesh-ancestor
110287288|NCT00239499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110276455|NCT00554203|Sensory System Agents|sensory system agents|mesh-ancestor
110276456|NCT00554203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110276457|NCT00554203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276458|NCT00554203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110276459|NCT00554203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110276460|NCT00554203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110276461|NCT00554242|Ascorbic Acid|ascorbic acid|mesh-list
110276462|NCT00554242|Grape Seed Extract|grape seed extract|mesh-list
110276463|NCT00554242|Antioxidants|antioxidants|mesh-ancestor
110276464|NCT00554242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276465|NCT00554242|Protective Agents|protective agents|mesh-ancestor
110276466|NCT00554242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276467|NCT00554242|Vitamins|vitamins|mesh-ancestor
110276468|NCT00554242|Micronutrients|micronutrients|mesh-ancestor
110276469|NCT00554242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110287289|NCT00239499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110287290|NCT00239499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110287291|NCT00239499|Respiratory System Agents|respiratory system agents|mesh-ancestor
110287292|NCT00239499|Dermatologic Agents|dermatologic agents|mesh-ancestor
110287293|NCT00239499|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110287294|NCT00239499|Parasympatholytics|parasympatholytics|mesh-ancestor
110287295|NCT00239499|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110287296|NCT00239499|Cholinergic Agents|cholinergic agents|mesh-ancestor
110287297|NCT00239499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110287298|NCT00239499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287299|NCT00239499|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110287300|NCT00239499|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110287301|NCT00239499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110287302|NCT00239499|Adrenergic Agents|adrenergic agents|mesh-ancestor
110287304|NCT00212615|Oxaliplatin|oxaliplatin|mesh-list
110287305|NCT00212615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110287306|NCT00212615|Antimetabolites|antimetabolites|mesh-ancestor
110287307|NCT00212615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287308|NCT00212615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110287309|NCT00222573|Metoprolol|metoprolol|mesh-list
110287310|NCT00222573|Clopidogrel|clopidogrel|mesh-list
110287311|NCT00222573|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110287312|NCT00222573|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110287313|NCT00222573|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110287314|NCT00222573|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110287323|NCT00222573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110287324|NCT00222573|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110287325|NCT00222573|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110287326|NCT00222573|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110287327|NCT00222573|Adrenergic Agents|adrenergic agents|mesh-ancestor
110287329|NCT00212654|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110287330|NCT00212654|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110287331|NCT00212654|Adrenergic Agents|adrenergic agents|mesh-ancestor
110287332|NCT00212654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110287333|NCT00212654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287334|NCT00212654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110287335|NCT00212654|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110287336|NCT00239538|Valsartan|valsartan|mesh-list
110287337|NCT00239538|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110287338|NCT00239538|Telmisartan|telmisartan|mesh-list
110287339|NCT00239538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110287340|NCT00239538|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110287341|NCT00239538|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110276470|NCT00554242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110276471|NCT00176735|Capecitabine|capecitabine|mesh-list
110276472|NCT00176735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110276473|NCT00176735|Antimetabolites|antimetabolites|mesh-ancestor
110276474|NCT00176735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276475|NCT00176735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110276476|NCT00410943|Hydromorphone|hydromorphone|mesh-list
110287342|NCT00239538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287343|NCT00239538|Diuretics|diuretics|mesh-ancestor
110287344|NCT00239538|Natriuretic Agents|natriuretic agents|mesh-ancestor
110045608|NCT06039540|Expectorants|expectorants|mesh-ancestor
110287345|NCT00239538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110287346|NCT00239538|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110287347|NCT00239538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110287349|NCT00212810|Anticonvulsants|anticonvulsants|mesh-ancestor
110287350|NCT00212810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110287351|NCT00212810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110287352|NCT00222651|Tenecteplase|tenecteplase|mesh-list
110287353|NCT00222651|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110287354|NCT00222651|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110287355|NCT00222651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287356|NCT00239616|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
110287357|NCT00239616|Hematinics|hematinics|mesh-ancestor
110287359|NCT00213122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110287360|NCT00213122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287361|NCT00213122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110287362|NCT00213122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110287363|NCT00213122|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110287364|NCT00213200|Morphine|morphine|mesh-list
110287365|NCT00213200|Tetracaine|tetracaine|mesh-list
110287366|NCT00213200|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110287367|NCT00213200|Narcotics|narcotics|mesh-ancestor
110287368|NCT00213200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110287369|NCT00213200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110287370|NCT00213200|Analgesics|analgesics|mesh-ancestor
110287371|NCT00213200|Sensory System Agents|sensory system agents|mesh-ancestor
110287372|NCT00213200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110287373|NCT00213200|Anesthetics, Local|anesthetics, local|mesh-ancestor
110287374|NCT00213200|Anesthetics|anesthetics|mesh-ancestor
110287375|NCT00239811|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
110018218|NCT03574818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110287376|NCT00239811|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110287377|NCT00239811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287378|NCT00239811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110287379|NCT00239811|Immunologic Factors|immunologic factors|mesh-ancestor
110287385|NCT00213278|Antimitotic Agents|antimitotic agents|mesh-ancestor
110287386|NCT00213278|Mitosis Modulators|mitosis modulators|mesh-ancestor
110287387|NCT00213278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287389|NCT00239889|Salmon calcitonin|salmon calcitonin|mesh-list
110287390|NCT00239889|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
110287391|NCT00239889|Katacalcin|katacalcin|mesh-list
110287392|NCT00239889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110287393|NCT00239889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110287394|NCT00239889|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110287395|NCT00239889|Vasodilator Agents|vasodilator agents|mesh-ancestor
110287396|NCT00239967|Rimonabant|rimonabant|mesh-list
110287397|NCT00239967|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110287398|NCT00239967|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
110287399|NCT00239967|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110287400|NCT00239967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110287401|NCT00239967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287402|NCT00239967|Hormones|hormones|mesh-ancestor
110287403|NCT00239967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110287404|NCT00239967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110287405|NCT00223002|Chlorhexidine|chlorhexidine|mesh-list
110287406|NCT00223002|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110276477|NCT00410943|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110276478|NCT00410943|Narcotics|narcotics|mesh-ancestor
110276479|NCT00410943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110276480|NCT00410943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276481|NCT00410943|Analgesics|analgesics|mesh-ancestor
110276482|NCT00410943|Sensory System Agents|sensory system agents|mesh-ancestor
110276483|NCT00410943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110276484|NCT00176774|Leucovorin|leucovorin|mesh-list
110276485|NCT00176774|Fluorouracil|fluorouracil|mesh-list
110276486|NCT00176774|Irinotecan|irinotecan|mesh-list
110276487|NCT00176774|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
110276488|NCT00176774|Antimetabolites|antimetabolites|mesh-ancestor
110276489|NCT00176774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276490|NCT00176774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110276491|NCT00176774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110276492|NCT00176774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110287407|NCT00223002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110287408|NCT00223002|Disinfectants|disinfectants|mesh-ancestor
110287409|NCT00213512|Rituximab|rituximab|mesh-list
110287410|NCT00213512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110287412|NCT00213512|Immunologic Factors|immunologic factors|mesh-ancestor
110287413|NCT00213512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110287414|NCT00213512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110287415|NCT00213551|Antioxidants|antioxidants|mesh-list
110287416|NCT00213551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287417|NCT00213551|Protective Agents|protective agents|mesh-ancestor
110287418|NCT00213551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110287419|NCT00240006|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110287420|NCT00213590|Cyclosporine|cyclosporine|mesh-list
110287421|NCT00213590|Cyclosporins|cyclosporins|mesh-list
110287422|NCT00213590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110287423|NCT00213590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287424|NCT00213590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110287425|NCT00213590|Immunologic Factors|immunologic factors|mesh-ancestor
110287426|NCT00213590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110287427|NCT00213590|Antifungal Agents|antifungal agents|mesh-ancestor
110287428|NCT00213590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110287429|NCT00213590|Dermatologic Agents|dermatologic agents|mesh-ancestor
110287430|NCT00213590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110287431|NCT00213590|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110287432|NCT00240045|Octreotide|octreotide|mesh-list
110287433|NCT00240045|Midodrine|midodrine|mesh-list
110287434|NCT00240045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110287435|NCT00240045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110287436|NCT00240045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110287437|NCT00240045|Sympathomimetics|sympathomimetics|mesh-ancestor
110287438|NCT00240045|Autonomic Agents|autonomic agents|mesh-ancestor
110287439|NCT00240045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110287440|NCT00240045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110287441|NCT00240045|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110287442|NCT00240045|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110287443|NCT00240045|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110287444|NCT00240045|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110287445|NCT00240045|Adrenergic Agents|adrenergic agents|mesh-ancestor
110287446|NCT00240045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110287447|NCT00240045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287448|NCT00243672|Atorvastatin|atorvastatin|mesh-list
110287460|NCT00240084|Natriuretic Agents|natriuretic agents|mesh-ancestor
110287461|NCT00240084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276494|NCT00176774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276495|NCT00176774|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110276496|NCT00176774|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110276497|NCT00176774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110276498|NCT00176774|Antidotes|antidotes|mesh-ancestor
110276499|NCT00176774|Protective Agents|protective agents|mesh-ancestor
110276500|NCT00176774|Vitamin B Complex|vitamin b complex|mesh-ancestor
110276501|NCT00176774|Vitamins|vitamins|mesh-ancestor
110276502|NCT00176774|Micronutrients|micronutrients|mesh-ancestor
110276503|NCT00176774|Chelating Agents|chelating agents|mesh-ancestor
110276504|NCT00176774|Sequestering Agents|sequestering agents|mesh-ancestor
110276505|NCT00176774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110276506|NCT00176774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110276507|NCT00176774|Growth Substances|growth substances|mesh-ancestor
110287462|NCT00243711|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110287463|NCT00243711|Glycerol|glycerol|mesh-list
110287464|NCT00243711|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110287465|NCT00243711|Protective Agents|protective agents|mesh-ancestor
110287466|NCT00243711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110287467|NCT00243711|Laxatives|laxatives|mesh-ancestor
110287468|NCT00243711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110287469|NCT00240123|Diphenhydramine|diphenhydramine|mesh-list
110287470|NCT00240123|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110287471|NCT00240123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110287472|NCT00240123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110287473|NCT00240123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110287474|NCT00240123|Anesthetics, Local|anesthetics, local|mesh-ancestor
110287475|NCT00240123|Anesthetics|anesthetics|mesh-ancestor
110287476|NCT00240123|Sensory System Agents|sensory system agents|mesh-ancestor
110287477|NCT00240123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110287478|NCT00240123|Antiemetics|antiemetics|mesh-ancestor
110287479|NCT00240123|Autonomic Agents|autonomic agents|mesh-ancestor
110287480|NCT00240123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110287481|NCT00240123|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110287482|NCT00240123|Histamine Antagonists|histamine antagonists|mesh-ancestor
110287483|NCT00240123|Histamine Agents|histamine agents|mesh-ancestor
110287484|NCT00240123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110287485|NCT00240123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287486|NCT00240123|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110287487|NCT00240279|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110287488|NCT00240279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110287489|NCT00240279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110287490|NCT00240279|Antimetabolites|antimetabolites|mesh-ancestor
110287491|NCT00240279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287492|NCT00240279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110287493|NCT00240279|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110287494|NCT00240279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110287495|NCT00243750|Methotrexate|methotrexate|mesh-list
110287496|NCT00243750|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110287497|NCT00243750|Abortifacient Agents|abortifacient agents|mesh-ancestor
110287498|NCT00243750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110287499|NCT00243750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110287500|NCT00243750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110287501|NCT00243750|Antimetabolites|antimetabolites|mesh-ancestor
110287502|NCT00243750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287503|NCT00243750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110287504|NCT00243750|Dermatologic Agents|dermatologic agents|mesh-ancestor
110287505|NCT00243750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110287506|NCT00243750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110287507|NCT00243750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110276508|NCT00176774|Growth Inhibitors|growth inhibitors|mesh-ancestor
110276509|NCT02434744|Metformin|metformin|mesh-list
110276510|NCT02434744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110276511|NCT02434744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276512|NCT02421679|Cyclobenzaprine|cyclobenzaprine|mesh-list
110276513|NCT02421679|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110276514|NCT02421679|Antidepressive Agents|antidepressive agents|mesh-ancestor
110276515|NCT02421679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110276517|NCT02421679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276518|NCT02421679|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110276519|NCT02421679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110276520|NCT02421679|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110276521|NCT02421679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110276522|NCT00410982|Rituximab|rituximab|mesh-list
110276523|NCT00410982|Gemcitabine|gemcitabine|mesh-list
110276524|NCT00410982|Melphalan|melphalan|mesh-list
110276525|NCT00410982|Busulfan|busulfan|mesh-list
110276526|NCT00410982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110276527|NCT00410982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110276528|NCT00410982|Immunologic Factors|immunologic factors|mesh-ancestor
110276529|NCT00410982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276530|NCT00410982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110276531|NCT00410982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110276532|NCT00410982|Antimetabolites|antimetabolites|mesh-ancestor
110276533|NCT00410982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287508|NCT00243750|Immunologic Factors|immunologic factors|mesh-ancestor
110287509|NCT00243750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110287515|NCT00243789|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110287516|NCT00243789|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110287517|NCT00243789|Protective Agents|protective agents|mesh-ancestor
110287518|NCT00243789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110287519|NCT00243789|Vasodilator Agents|vasodilator agents|mesh-ancestor
110287520|NCT00243789|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110287521|NCT00243789|Antioxidants|antioxidants|mesh-ancestor
110287522|NCT00214058|Carboplatin|carboplatin|mesh-list
110287524|NCT00214058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110287525|NCT00214058|Tubulin Modulators|tubulin modulators|mesh-ancestor
110287526|NCT00214058|Antimitotic Agents|antimitotic agents|mesh-ancestor
110287527|NCT00214058|Mitosis Modulators|mitosis modulators|mesh-ancestor
110287528|NCT00214058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287529|NCT00240318|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110287530|NCT00240318|Calcium|calcium|mesh-list
110287531|NCT00240318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110287532|NCT00240318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110287533|NCT00240318|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110287534|NCT00240318|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110287535|NCT00240318|Antimetabolites|antimetabolites|mesh-ancestor
110287536|NCT00240318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276534|NCT00410982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110276535|NCT00410982|Alkylating Agents|alkylating agents|mesh-ancestor
110276536|NCT00410982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110276537|NCT00410982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110276538|NCT02372578|Pregabalin|pregabalin|mesh-list
110276539|NCT02372578|Analgesics|analgesics|mesh-ancestor
110276540|NCT02372578|Sensory System Agents|sensory system agents|mesh-ancestor
110276541|NCT02372578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110276542|NCT02372578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276543|NCT02372578|Anticonvulsants|anticonvulsants|mesh-ancestor
110276544|NCT02372578|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110276545|NCT02372578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110276546|NCT02372578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276547|NCT02372578|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110276548|NCT02372578|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110276549|NCT02372578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110276550|NCT02372578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110276551|NCT02372578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110276552|NCT00554398|Raltegravir Potassium|raltegravir potassium|mesh-list
110276553|NCT00554398|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110276554|NCT00554398|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110287537|NCT00240318|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110287538|NCT00240318|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110287539|NCT00240318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110287540|NCT00243945|Rotigotine|rotigotine|mesh-list
110287541|NCT00243945|Dopamine Agonists|dopamine agonists|mesh-ancestor
110287542|NCT00243945|Dopamine Agents|dopamine agents|mesh-ancestor
110287543|NCT00243945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110287544|NCT00243945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287545|NCT00243945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110287546|NCT00214214|Alemtuzumab|alemtuzumab|mesh-list
110287547|NCT00214214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110287548|NCT00214214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110287549|NCT00214253|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
110287550|NCT00214253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110287551|NCT00214253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110287552|NCT00240396|Narcotics|narcotics|mesh-list
110287553|NCT00240396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110287554|NCT00240396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110287555|NCT00240396|Analgesics|analgesics|mesh-ancestor
110287556|NCT00240396|Sensory System Agents|sensory system agents|mesh-ancestor
110287557|NCT00240396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110287558|NCT00214331|Azithromycin|azithromycin|mesh-list
110287559|NCT00214331|Ciprofloxacin|ciprofloxacin|mesh-list
110287560|NCT00214331|Gentamicins|gentamicins|mesh-list
110287561|NCT00214331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110287562|NCT00214331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110287563|NCT00214331|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110287564|NCT00214331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110287565|NCT00214331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110287566|NCT00214331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287567|NCT00214331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110276555|NCT00554398|Antiviral Agents|antiviral agents|mesh-ancestor
110276556|NCT00554398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110276557|NCT00554398|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110276558|NCT00554398|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110276559|NCT00554398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110276560|NCT00554398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276561|NCT00554476|Triamcinolone|triamcinolone|mesh-list
110276562|NCT00554476|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110276563|NCT00554476|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110276564|NCT00554476|Indomethacin|indomethacin|mesh-list
110276565|NCT00554476|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110276566|NCT00554476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110287568|NCT00214331|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110287569|NCT00214331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110287570|NCT00214331|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110287571|NCT00243984|Topiramate|topiramate|mesh-list
110287572|NCT00243984|Anticonvulsants|anticonvulsants|mesh-ancestor
110287573|NCT00243984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110287574|NCT00243984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110287575|NCT00214370|Fentanyl|fentanyl|mesh-list
110287577|NCT00214370|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110287578|NCT00214370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110287586|NCT00214370|Sensory System Agents|sensory system agents|mesh-ancestor
110287587|NCT00214370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110287588|NCT00214370|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110287589|NCT00240435|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110287590|NCT00240435|Tiotropium Bromide|tiotropium bromide|mesh-list
110287591|NCT00240435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110287592|NCT00240435|Autonomic Agents|autonomic agents|mesh-ancestor
110287593|NCT00240435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110287594|NCT00240435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110287595|NCT00240435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110287596|NCT00240435|Respiratory System Agents|respiratory system agents|mesh-ancestor
110287597|NCT00240435|Parasympatholytics|parasympatholytics|mesh-ancestor
110287598|NCT00240435|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110287599|NCT00240435|Cholinergic Agents|cholinergic agents|mesh-ancestor
110287600|NCT00240435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110287601|NCT00240435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287602|NCT00244023|Methyltestosterone|methyltestosterone|mesh-list
110287603|NCT00244023|Testosterone|testosterone|mesh-list
110287604|NCT00244023|Testosterone undecanoate|testosterone undecanoate|mesh-list
110287605|NCT00244023|Testosterone enanthate|testosterone enanthate|mesh-list
110287606|NCT00244023|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110287607|NCT00244023|Androgens|androgens|mesh-ancestor
110287609|NCT00244023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110287610|NCT00244023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110287611|NCT00244023|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110287612|NCT00244023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110287613|NCT00244023|Anabolic Agents|anabolic agents|mesh-ancestor
110287614|NCT00240474|Amlodipine|amlodipine|mesh-list
110287615|NCT00240474|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110287616|NCT00240474|Telmisartan|telmisartan|mesh-list
110287617|NCT00240474|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110287618|NCT00240474|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110287619|NCT00240474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110287620|NCT00240474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287621|NCT00240474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110287622|NCT00240474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110287623|NCT00240474|Vasodilator Agents|vasodilator agents|mesh-ancestor
110287624|NCT00240474|Diuretics|diuretics|mesh-ancestor
110287625|NCT00240474|Natriuretic Agents|natriuretic agents|mesh-ancestor
110287626|NCT00240474|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110276567|NCT00554476|Glucocorticoids|glucocorticoids|mesh-ancestor
110276569|NCT00554476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110276570|NCT00554476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276571|NCT00554476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110276572|NCT00554476|Immunologic Factors|immunologic factors|mesh-ancestor
110276573|NCT00554476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110276574|NCT00554476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276575|NCT00554476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110276576|NCT00554476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110276577|NCT00554476|Analgesics|analgesics|mesh-ancestor
110276578|NCT00554476|Sensory System Agents|sensory system agents|mesh-ancestor
110276579|NCT00554476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110276580|NCT00554476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110276581|NCT00554476|Gout Suppressants|gout suppressants|mesh-ancestor
110276582|NCT00554476|Tocolytic Agents|tocolytic agents|mesh-ancestor
110276583|NCT00554476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110276584|NCT00554476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110287627|NCT00240474|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110287628|NCT00240474|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110287629|NCT00214604|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110287630|NCT00214604|Pravastatin|pravastatin|mesh-list
110287631|NCT00214604|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110287632|NCT00214604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110287633|NCT00214604|Antimetabolites|antimetabolites|mesh-ancestor
110287634|NCT00214604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287635|NCT00214604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110287636|NCT00214604|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110287637|NCT00214604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110287638|NCT00214643|Clindamycin|clindamycin|mesh-list
110287639|NCT00214643|Clindamycin palmitate|clindamycin palmitate|mesh-list
110287640|NCT00214643|Clindamycin phosphate|clindamycin phosphate|mesh-list
110287641|NCT00214643|Fosmidomycin|fosmidomycin|mesh-list
110287642|NCT00214643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110287643|NCT00214643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110287644|NCT00214643|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110287645|NCT00214643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110287646|NCT00214643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287652|NCT00414531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110287653|NCT00414531|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110287654|NCT00414531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110287655|NCT00214682|Vitamin B 12|vitamin b 12|mesh-list
110287656|NCT00214682|Hydroxocobalamin|hydroxocobalamin|mesh-list
110287658|NCT00214682|Micronutrients|micronutrients|mesh-ancestor
110287659|NCT00214682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110287660|NCT00214682|Vitamin B Complex|vitamin b complex|mesh-ancestor
110287661|NCT00214682|Hematinics|hematinics|mesh-ancestor
110287662|NCT00214721|Dialysis Solutions|dialysis solutions|mesh-list
110287663|NCT00214721|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110287664|NCT00240513|Minocycline|minocycline|mesh-list
110287665|NCT00240513|Tretinoin|tretinoin|mesh-list
110287666|NCT00240513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110287667|NCT00240513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110287668|NCT00240513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110287669|NCT00240513|Keratolytic Agents|keratolytic agents|mesh-ancestor
110287670|NCT00240513|Dermatologic Agents|dermatologic agents|mesh-ancestor
110276585|NCT02336698|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110276586|NCT02336698|Immunologic Factors|immunologic factors|mesh-ancestor
110276587|NCT02336698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276588|NCT00204906|Vitamin D|vitamin d|mesh-list
110276589|NCT00204906|Vitamins|vitamins|mesh-ancestor
110276590|NCT00204906|Micronutrients|micronutrients|mesh-ancestor
110276591|NCT00204906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276592|NCT00204906|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110276593|NCT02335918|Nivolumab|nivolumab|mesh-list
110276594|NCT02335918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110276595|NCT02335918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110287671|NCT00240552|Fosamprenavir|fosamprenavir|mesh-list
110287672|NCT00240552|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110287673|NCT00240552|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110287674|NCT00240552|Protease Inhibitors|protease inhibitors|mesh-ancestor
110287675|NCT00240552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110287676|NCT00240552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287677|NCT00240552|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110287678|NCT00240552|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110287679|NCT00240552|Antiviral Agents|antiviral agents|mesh-ancestor
110287680|NCT00240552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110287681|NCT00214877|Methylene Blue|methylene blue|mesh-list
110287682|NCT00214877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110287683|NCT00214877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287684|NCT00214955|Fentanyl|fentanyl|mesh-list
110287685|NCT00214955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110287686|NCT00214955|Narcotics|narcotics|mesh-ancestor
110287687|NCT00214955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110287688|NCT00214955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110287689|NCT00214955|Analgesics|analgesics|mesh-ancestor
110287690|NCT00214955|Sensory System Agents|sensory system agents|mesh-ancestor
110287691|NCT00214955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110287692|NCT00214955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110287693|NCT00214955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110287694|NCT00214955|Anesthetics, General|anesthetics, general|mesh-ancestor
110287695|NCT00214955|Anesthetics|anesthetics|mesh-ancestor
110287696|NCT00244179|Interferons|interferons|mesh-list
110287697|NCT00244179|Interferon-gamma|interferon-gamma|mesh-list
110287698|NCT00244179|Infliximab|infliximab|mesh-list
110287699|NCT00244179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110287700|NCT00244179|Antiviral Agents|antiviral agents|mesh-ancestor
110287701|NCT00244179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110287702|NCT00244179|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110287703|NCT00244179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110287704|NCT00244179|Dermatologic Agents|dermatologic agents|mesh-ancestor
110287705|NCT00244179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110287706|NCT00244179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110287707|NCT00214994|Tiagabine|tiagabine|mesh-list
110287708|NCT00214994|Anticonvulsants|anticonvulsants|mesh-ancestor
110287709|NCT00214994|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
110287710|NCT00214994|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110287711|NCT00214994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110287712|NCT00214994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287713|NCT00214994|GABA Agents|gaba agents|mesh-ancestor
110287714|NCT00214994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110287715|NCT00214994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110287716|NCT00240630|Naproxen|naproxen|mesh-list
110287717|NCT00240630|Sumatriptan|sumatriptan|mesh-list
110287718|NCT00240630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110287719|NCT00240630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110287725|NCT00240630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110287726|NCT00240630|Gout Suppressants|gout suppressants|mesh-ancestor
110287727|NCT00240630|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110287729|NCT00240630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287730|NCT00240630|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110276596|NCT02335918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110276597|NCT02335918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276598|NCT00176813|Celecoxib|celecoxib|mesh-list
110276599|NCT00176813|Gemcitabine|gemcitabine|mesh-list
110276600|NCT00176813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110276601|NCT00176813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110276602|NCT00176813|Antimetabolites|antimetabolites|mesh-ancestor
110287731|NCT00240630|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110287732|NCT00240630|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110287733|NCT00240630|Serotonin Agents|serotonin agents|mesh-ancestor
110287734|NCT00240630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110287735|NCT00244296|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110287736|NCT00244296|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110287737|NCT00244296|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110287738|NCT00244296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110287739|NCT00244296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287740|NCT00244296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110287741|NCT00244296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110287742|NCT00244296|Analgesics|analgesics|mesh-ancestor
110287743|NCT00244296|Sensory System Agents|sensory system agents|mesh-ancestor
110287744|NCT00244296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110287745|NCT00244296|Antidepressive Agents|antidepressive agents|mesh-ancestor
110287746|NCT00244296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110287747|NCT00244296|Dopamine Agents|dopamine agents|mesh-ancestor
110287748|NCT00215228|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110287750|NCT00215228|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110287751|NCT00215228|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110287752|NCT00215228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110287753|NCT00215228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287754|NCT00215228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110287755|NCT00215228|Serotonin Agents|serotonin agents|mesh-ancestor
110287756|NCT00215228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110287757|NCT00215228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110287758|NCT00215228|Antidepressive Agents|antidepressive agents|mesh-ancestor
110287759|NCT00215228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110287760|NCT00215228|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110287761|NCT00215228|Analgesics|analgesics|mesh-ancestor
110287762|NCT00215228|Sensory System Agents|sensory system agents|mesh-ancestor
110287763|NCT00215228|Dopamine Agents|dopamine agents|mesh-ancestor
110287764|NCT00215267|Praziquantel|praziquantel|mesh-list
110287765|NCT00215267|Anthelmintics|anthelmintics|mesh-ancestor
110287766|NCT00215267|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110287767|NCT00215267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110287768|NCT00240708|Risperidone|risperidone|mesh-list
110287769|NCT00240708|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110287770|NCT00240708|Serotonin Agents|serotonin agents|mesh-ancestor
110287771|NCT00240708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110287772|NCT00240708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287773|NCT00240708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110287774|NCT00240708|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110287775|NCT00240708|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110287776|NCT00240708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110287777|NCT00240708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110287778|NCT00240708|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110287779|NCT00240708|Dopamine Agents|dopamine agents|mesh-ancestor
110287781|NCT00215345|Docetaxel|docetaxel|mesh-list
110287782|NCT00215345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110287783|NCT00215345|Tubulin Modulators|tubulin modulators|mesh-ancestor
110287784|NCT00215345|Antimitotic Agents|antimitotic agents|mesh-ancestor
110287785|NCT00215345|Mitosis Modulators|mitosis modulators|mesh-ancestor
110287786|NCT00215345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287787|NCT00215345|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110287803|NCT00240747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276603|NCT00176813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276604|NCT00176813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110276605|NCT00176813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110276607|NCT00176813|Sensory System Agents|sensory system agents|mesh-ancestor
110276608|NCT00176813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110276609|NCT00176813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276610|NCT00176813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110276611|NCT00176813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110276612|NCT00176813|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110276613|NCT00176813|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110287804|NCT00215384|Formoterol Fumarate|formoterol fumarate|mesh-list
110287805|NCT00215384|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110287806|NCT00215384|Autonomic Agents|autonomic agents|mesh-ancestor
110287807|NCT00215384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110287808|NCT00215384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110287809|NCT00215384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110287810|NCT00215384|Respiratory System Agents|respiratory system agents|mesh-ancestor
110287811|NCT00215384|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110287812|NCT00215384|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110287813|NCT00215384|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110287814|NCT00215384|Adrenergic Agents|adrenergic agents|mesh-ancestor
110287815|NCT00215384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110287816|NCT00215384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287817|NCT00215423|Formoterol Fumarate|formoterol fumarate|mesh-list
110287818|NCT00215423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110287819|NCT00215423|Autonomic Agents|autonomic agents|mesh-ancestor
110287820|NCT00215423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110287821|NCT00215423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110287822|NCT00215423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110287823|NCT00215423|Respiratory System Agents|respiratory system agents|mesh-ancestor
110287824|NCT00215423|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110287825|NCT00215423|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110287826|NCT00215423|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110287827|NCT00215423|Adrenergic Agents|adrenergic agents|mesh-ancestor
110287828|NCT00215423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110287829|NCT00215423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287831|NCT04668352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110287832|NCT00215462|Vinorelbine|vinorelbine|mesh-list
110287833|NCT00215462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110287834|NCT00215462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110287835|NCT00215462|Tubulin Modulators|tubulin modulators|mesh-ancestor
110287836|NCT00215462|Antimitotic Agents|antimitotic agents|mesh-ancestor
110287837|NCT00215462|Mitosis Modulators|mitosis modulators|mesh-ancestor
110287838|NCT00215462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287839|NCT00215501|Fluorouracil|fluorouracil|mesh-list
110287840|NCT00215501|Capecitabine|capecitabine|mesh-list
110287842|NCT00215501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110287843|NCT00215501|Antimetabolites|antimetabolites|mesh-ancestor
110287844|NCT00215501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287845|NCT00215501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110287846|NCT00215501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110287850|NCT00215501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110287851|NCT00215501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110287852|NCT00240786|Acetaminophen|acetaminophen|mesh-list
110287853|NCT00240786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110287854|NCT00240786|Analgesics|analgesics|mesh-ancestor
110287855|NCT00240786|Sensory System Agents|sensory system agents|mesh-ancestor
110287856|NCT00240786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110276614|NCT00176813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110276615|NCT04678531|Tea Tree Oil|tea tree oil|mesh-list
110276616|NCT04678531|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110276617|NCT04678531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110276618|NCT02320708|Acetaminophen|acetaminophen|mesh-list
110276619|NCT02320708|Ibuprofen|ibuprofen|mesh-list
110276620|NCT02320708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110276621|NCT02320708|Analgesics|analgesics|mesh-ancestor
110287857|NCT00240786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110287858|NCT00240786|Antipyretics|antipyretics|mesh-ancestor
110287859|NCT00215579|Risperidone|risperidone|mesh-list
110287860|NCT00215579|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110287861|NCT00215579|Serotonin Agents|serotonin agents|mesh-ancestor
110287862|NCT00215579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110287863|NCT00215579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287864|NCT00215579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110287865|NCT00215579|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110287866|NCT00215579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110287867|NCT00215579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110287868|NCT00215579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110287869|NCT00215579|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110287870|NCT00215579|Dopamine Agents|dopamine agents|mesh-ancestor
110287871|NCT00556621|Gemcitabine|gemcitabine|mesh-list
110287872|NCT00556621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110287873|NCT00556621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110287874|NCT00556621|Antimetabolites|antimetabolites|mesh-ancestor
110287875|NCT00556621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287876|NCT00244452|Cetrorelix|cetrorelix|mesh-list
110287877|NCT00244452|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110287878|NCT00244452|Fertility Agents|fertility agents|mesh-ancestor
110287879|NCT00244452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110287880|NCT00244452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110287881|NCT00244452|Hormone Antagonists|hormone antagonists|mesh-ancestor
110287882|NCT00244452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110287883|NCT00556699|Rituximab|rituximab|mesh-list
110287884|NCT00556699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110287885|NCT00556699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110287886|NCT00556699|Immunologic Factors|immunologic factors|mesh-ancestor
110287887|NCT00556699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110287888|NCT00556699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110287889|NCT00411866|Ketoconazole|ketoconazole|mesh-list
110287890|NCT00411866|Antifungal Agents|antifungal agents|mesh-ancestor
110287891|NCT00411866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110287892|NCT00411866|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110287893|NCT00411866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110287894|NCT00411866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110287895|NCT00411866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287896|NCT00411866|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110287897|NCT00411866|Hormone Antagonists|hormone antagonists|mesh-ancestor
110287898|NCT00411866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110287899|NCT00411866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110287900|NCT00411866|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110287901|NCT04667299|Amoxicillin|amoxicillin|mesh-list
110287902|NCT04667299|Metronidazole|metronidazole|mesh-list
110287903|NCT04667299|Potassium Citrate|potassium citrate|mesh-list
110287904|NCT04667299|Rabeprazole|rabeprazole|mesh-list
110287905|NCT04667299|Bismuth|bismuth|mesh-list
110287906|NCT04667299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287907|NCT04667299|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110287908|NCT04667299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110287909|NCT04667299|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110287910|NCT04667299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110287911|NCT04667299|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110287912|NCT04667299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110287913|NCT04667299|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110287914|NCT04667299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110287915|NCT04667299|Antacids|antacids|mesh-ancestor
110287916|NCT04667299|Diuretics|diuretics|mesh-ancestor
110287917|NCT04667299|Natriuretic Agents|natriuretic agents|mesh-ancestor
110276622|NCT02320708|Sensory System Agents|sensory system agents|mesh-ancestor
110276623|NCT02320708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110276624|NCT02320708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276625|NCT02320708|Antipyretics|antipyretics|mesh-ancestor
110276626|NCT02320708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110276627|NCT02320708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110276628|NCT02320708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110276629|NCT02320708|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110276630|NCT02320708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110276631|NCT02320708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276632|NCT02309671|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110287918|NCT04667299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110287934|NCT00240825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110287935|NCT00240825|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110287936|NCT00240825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110287937|NCT00240825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287939|NCT04666675|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110287940|NCT04666675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110287941|NCT04666675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110287942|NCT04666675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287943|NCT04666675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110287945|NCT00244530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110287946|NCT00244530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110287947|NCT00244530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287948|NCT00244530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110287949|NCT00244530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110287950|NCT00244530|Vasodilator Agents|vasodilator agents|mesh-ancestor
110287951|NCT00244530|Tocolytic Agents|tocolytic agents|mesh-ancestor
110287952|NCT00244530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110287953|NCT00411905|Bortezomib|bortezomib|mesh-list
110287954|NCT00411905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110287955|NCT00240864|Acetaminophen|acetaminophen|mesh-list
110287956|NCT00240864|Ibuprofen|ibuprofen|mesh-list
110287957|NCT00240864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110287958|NCT00240864|Analgesics|analgesics|mesh-ancestor
110287959|NCT00240864|Sensory System Agents|sensory system agents|mesh-ancestor
110287960|NCT00240864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110287961|NCT00240864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110287962|NCT00240864|Antipyretics|antipyretics|mesh-ancestor
110287963|NCT00240864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110287964|NCT00240864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110287965|NCT00240864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110287966|NCT00240864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110287967|NCT00240864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110287968|NCT00240864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287969|NCT00557011|Amphetamine|amphetamine|mesh-list
110287971|NCT00557011|Adderall|adderall|mesh-list
110018821|NCT01800162|Antimetabolites|antimetabolites|mesh-ancestor
110287972|NCT00557011|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110287973|NCT00557011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110287975|NCT00557011|Autonomic Agents|autonomic agents|mesh-ancestor
110287976|NCT00557011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110287977|NCT00557011|Dopamine Agents|dopamine agents|mesh-ancestor
110287978|NCT00557011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110287983|NCT00557011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110287984|NCT00557011|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110287985|NCT04666324|Simethicone|simethicone|mesh-list
110287986|NCT04666324|Antifoaming Agents|antifoaming agents|mesh-ancestor
110287987|NCT04666324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276633|NCT02309671|Hormones|hormones|mesh-ancestor
110276634|NCT02309671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110276635|NCT02309671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276636|NCT02296645|Ethanol|ethanol|mesh-list
110276637|NCT02296645|Chlorhexidine|chlorhexidine|mesh-list
110276638|NCT02296645|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110276639|NCT02296645|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110276640|NCT02296645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110276641|NCT02296645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110276642|NCT02296645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276643|NCT02296645|Disinfectants|disinfectants|mesh-ancestor
110276644|NCT02296645|Dermatologic Agents|dermatologic agents|mesh-ancestor
110287988|NCT04666324|Emollients|emollients|mesh-ancestor
110287989|NCT04666324|Dermatologic Agents|dermatologic agents|mesh-ancestor
110287990|NCT04720833|Vitamin D|vitamin d|mesh-list
110287991|NCT04720833|Calcium|calcium|mesh-list
110287992|NCT04720833|Vitamins|vitamins|mesh-ancestor
110287993|NCT04720833|Micronutrients|micronutrients|mesh-ancestor
110287994|NCT04720833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110287995|NCT04720833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110287996|NCT04720833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110287997|NCT00244608|Budesonide|budesonide|mesh-list
110287998|NCT00244608|Terbutaline|terbutaline|mesh-list
110287999|NCT00244608|Formoterol Fumarate|formoterol fumarate|mesh-list
110288000|NCT00244608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110288001|NCT00244608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110288002|NCT00244608|Autonomic Agents|autonomic agents|mesh-ancestor
110288003|NCT00244608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110288004|NCT00244608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110288005|NCT00244608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110288006|NCT00244608|Respiratory System Agents|respiratory system agents|mesh-ancestor
110288007|NCT00244608|Glucocorticoids|glucocorticoids|mesh-ancestor
110288008|NCT00244608|Hormones|hormones|mesh-ancestor
110288009|NCT00244608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110288010|NCT00244608|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110288011|NCT00244608|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110045670|NCT06039280|Hormones|hormones|mesh-ancestor
110288012|NCT00244608|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110288013|NCT00244608|Adrenergic Agents|adrenergic agents|mesh-ancestor
110288014|NCT00244608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110288015|NCT00244608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110288016|NCT00244608|Sympathomimetics|sympathomimetics|mesh-ancestor
110288017|NCT00244608|Tocolytic Agents|tocolytic agents|mesh-ancestor
110288018|NCT00244608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110288019|NCT04666168|Cyclophosphamide|cyclophosphamide|mesh-list
110288020|NCT04666168|Fludarabine|fludarabine|mesh-list
110288021|NCT04666168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110288022|NCT04666168|Immunologic Factors|immunologic factors|mesh-ancestor
110288023|NCT04666168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110288024|NCT04666168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110288025|NCT04666168|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110288026|NCT04666168|Alkylating Agents|alkylating agents|mesh-ancestor
110288027|NCT04666168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110288028|NCT04666168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110288029|NCT04666168|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110288030|NCT00215774|Flecainide|flecainide|mesh-list
110288031|NCT00215774|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110288032|NCT00215774|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110288033|NCT00215774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110288034|NCT00215774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110288035|NCT00215774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110288036|NCT00240942|Letrozole|letrozole|mesh-list
110288037|NCT00240942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110288038|NCT00240942|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110276646|NCT02295865|Histamine Antagonists|histamine antagonists|mesh-ancestor
110276647|NCT02295865|Histamine Agents|histamine agents|mesh-ancestor
110276648|NCT02295865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110276649|NCT02295865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276650|NCT02295865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276651|NCT02282215|Lenograstim|lenograstim|mesh-list
110276652|NCT02282215|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110276653|NCT02282215|Immunologic Factors|immunologic factors|mesh-ancestor
110276654|NCT02282215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276655|NCT00176969|Capsaicin|capsaicin|mesh-list
110276656|NCT00176969|Antipruritics|antipruritics|mesh-ancestor
110276657|NCT00176969|Dermatologic Agents|dermatologic agents|mesh-ancestor
110276658|NCT00176969|Sensory System Agents|sensory system agents|mesh-ancestor
110288039|NCT00240942|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110288040|NCT00240942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110288041|NCT00240942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110288042|NCT00240942|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110288043|NCT00240942|Hormone Antagonists|hormone antagonists|mesh-ancestor
110288044|NCT00240942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110288045|NCT00240942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110288046|NCT00215891|Interferons|interferons|mesh-list
110288047|NCT00215891|Ribavirin|ribavirin|mesh-list
110288051|NCT00215891|Antimetabolites|antimetabolites|mesh-ancestor
110288052|NCT00215891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110288053|NCT02961816|Pyridoxine|pyridoxine|mesh-list
110288054|NCT02961816|Dexamethasone|dexamethasone|mesh-list
110288055|NCT02961816|Rituximab|rituximab|mesh-list
110288056|NCT02961816|Gemcitabine|gemcitabine|mesh-list
110288057|NCT02961816|Melphalan|melphalan|mesh-list
110288058|NCT02961816|Busulfan|busulfan|mesh-list
110288059|NCT02961816|Panobinostat|panobinostat|mesh-list
110288060|NCT02961816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110288061|NCT02961816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110288062|NCT02961816|Immunologic Factors|immunologic factors|mesh-ancestor
110288063|NCT02961816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110288064|NCT02961816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110288065|NCT02961816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110288066|NCT02961816|Antiemetics|antiemetics|mesh-ancestor
110288067|NCT02961816|Autonomic Agents|autonomic agents|mesh-ancestor
110288068|NCT02961816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110288069|NCT02961816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110288070|NCT02961816|Glucocorticoids|glucocorticoids|mesh-ancestor
110288071|NCT02961816|Hormones|hormones|mesh-ancestor
110288072|NCT02961816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110288073|NCT02961816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110288074|NCT02961816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110288075|NCT02961816|Antimetabolites|antimetabolites|mesh-ancestor
110288076|NCT02961816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110288077|NCT02961816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110288078|NCT02961816|Alkylating Agents|alkylating agents|mesh-ancestor
110288079|NCT02961816|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110288080|NCT02961816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110288081|NCT02961816|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110288082|NCT02961816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110288083|NCT02961816|Vitamin B Complex|vitamin b complex|mesh-ancestor
110288085|NCT02961816|Micronutrients|micronutrients|mesh-ancestor
110288086|NCT04665232|Progesterone|progesterone|mesh-list
110288087|NCT04665232|Progestins|progestins|mesh-ancestor
110288088|NCT04665232|Hormones|hormones|mesh-ancestor
110288089|NCT04665232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110276659|NCT00176969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110276660|NCT00176969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276661|NCT00204945|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
110276662|NCT00204945|Natriuretic Agents|natriuretic agents|mesh-ancestor
110276663|NCT00204945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276664|NCT00177008|Aripiprazole|aripiprazole|mesh-list
110276665|NCT00177008|Antidepressive Agents|antidepressive agents|mesh-ancestor
110276666|NCT00177008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110276667|NCT00177008|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110276668|NCT00177008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110288090|NCT04665232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110288091|NCT00216008|Docetaxel|docetaxel|mesh-list
110288092|NCT00216008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110288093|NCT00216008|Tubulin Modulators|tubulin modulators|mesh-ancestor
110288094|NCT00216008|Antimitotic Agents|antimitotic agents|mesh-ancestor
110288095|NCT00216008|Mitosis Modulators|mitosis modulators|mesh-ancestor
110288096|NCT00216008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110288097|NCT04665076|Cyclophosphamide|cyclophosphamide|mesh-list
110288098|NCT04665076|Fludarabine|fludarabine|mesh-list
110288099|NCT04665076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110288100|NCT04665076|Immunologic Factors|immunologic factors|mesh-ancestor
110288101|NCT04665076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110288102|NCT04665076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110288103|NCT04665076|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110288104|NCT04665076|Alkylating Agents|alkylating agents|mesh-ancestor
110288105|NCT04665076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110288106|NCT04665076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110288107|NCT04665076|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110288108|NCT00241020|Octreotide|octreotide|mesh-list
110288109|NCT00241020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110288110|NCT00241020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110288111|NCT00241020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110288112|NCT00216047|Trastuzumab|trastuzumab|mesh-list
110288113|NCT00216047|Vatalanib|vatalanib|mesh-list
110288114|NCT00216047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110288115|NCT00216047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110288116|NCT00216047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110288117|NCT00216047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110288118|NCT00216047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110288119|NCT04665310|Tacrolimus|tacrolimus|mesh-list
110288120|NCT04665310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110288121|NCT04665310|Immunologic Factors|immunologic factors|mesh-ancestor
110288130|NCT00241059|Antitubercular Agents|antitubercular agents|mesh-ancestor
110288131|NCT00241059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110288132|NCT00241059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110288133|NCT00241059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110288134|NCT00241059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110288136|NCT00216164|Gemcitabine|gemcitabine|mesh-list
110288137|NCT00216164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110288138|NCT00216164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110288139|NCT00216164|Immunologic Factors|immunologic factors|mesh-ancestor
110288140|NCT00216164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110288141|NCT00216164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110288142|NCT00216164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110288144|NCT00216164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110288145|NCT04664803|Cefdinir|cefdinir|mesh-list
110288146|NCT04664803|Cefetamet|cefetamet|mesh-list
110288147|NCT04664803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110288148|NCT04664803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110288149|NCT04664725|Repaglinide|repaglinide|mesh-list
110288150|NCT04664725|Bupropion|bupropion|mesh-list
110288151|NCT04664725|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110276669|NCT00177008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110276670|NCT00177008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276672|NCT00177008|Dopamine Agents|dopamine agents|mesh-ancestor
110276673|NCT00177008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110276674|NCT00177008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276675|NCT00177008|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110276676|NCT00177008|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110276677|NCT00177008|Serotonin Agents|serotonin agents|mesh-ancestor
110288152|NCT04664725|Antidepressive Agents|antidepressive agents|mesh-ancestor
110288153|NCT04664725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110288154|NCT04664725|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110288155|NCT04664725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110288156|NCT04664725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110288157|NCT04664725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110288158|NCT04664725|Dopamine Agents|dopamine agents|mesh-ancestor
110288159|NCT04664725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110288160|NCT04664725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110288161|NCT04664725|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110288162|NCT04664725|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110288163|NCT04664725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110288164|NCT04664725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110288165|NCT04664764|Insulin, Isophane|insulin, isophane|mesh-list
110288166|NCT04664764|Isophane Insulin, Human|isophane insulin, human|mesh-list
110288167|NCT04664764|Isophane insulin, beef|isophane insulin, beef|mesh-list
110288168|NCT04664764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110288169|NCT04664764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110288170|NCT00241098|Valsartan|valsartan|mesh-list
110288171|NCT00241098|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110288172|NCT00241098|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110288173|NCT00241098|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110288174|NCT00241098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110288175|NCT00216281|Clozapine|clozapine|mesh-list
110288176|NCT00216281|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110288177|NCT00216281|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110288178|NCT00216281|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110288179|NCT00216281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110288180|NCT00216281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110288181|NCT00216281|Adrenergic Agents|adrenergic agents|mesh-ancestor
110288182|NCT00216281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110288183|NCT00216281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110288184|NCT00216281|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110288185|NCT00216281|Serotonin Agents|serotonin agents|mesh-ancestor
110288186|NCT00216281|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110288193|NCT00241137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110288194|NCT00241137|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110288195|NCT00241137|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110288196|NCT00241137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110288197|NCT00216359|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110288198|NCT00216359|Enfuvirtide|enfuvirtide|mesh-list
110288199|NCT00216359|Antiviral Agents|antiviral agents|mesh-ancestor
110288200|NCT00216359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110288201|NCT00216359|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110288202|NCT00216359|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110288203|NCT00216359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110288204|NCT00216359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110288205|NCT04664530|Esketamine|esketamine|mesh-list
110288206|NCT04664530|Antidepressive Agents|antidepressive agents|mesh-ancestor
110288207|NCT04664530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110288208|NCT00216398|Lanreotide|lanreotide|mesh-list
110288209|NCT00216398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110288210|NCT00241215|Botulinum Toxins|botulinum toxins|mesh-list
110276678|NCT00177008|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110276679|NCT00177008|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110276680|NCT00177008|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110276681|NCT00177008|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110276682|NCT04677985|Analgesics|analgesics|mesh-list
110276683|NCT04677985|Menthol|menthol|mesh-list
110276684|NCT04677985|Sensory System Agents|sensory system agents|mesh-ancestor
110276685|NCT04677985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110276686|NCT04677985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276687|NCT04677985|Antipruritics|antipruritics|mesh-ancestor
110276688|NCT04677985|Dermatologic Agents|dermatologic agents|mesh-ancestor
110276689|NCT00554632|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110276690|NCT00554632|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110276691|NCT00554632|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110276692|NCT00554632|Norgestimate|norgestimate|mesh-list
110276693|NCT00554632|Norelgestromin|norelgestromin|mesh-list
110276694|NCT00554632|Ortho Evra|ortho evra|mesh-list
110276695|NCT00554632|Estradiol|estradiol|mesh-list
110276696|NCT00554632|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110288211|NCT00241215|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110288212|NCT00241215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110288213|NCT00241215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110288214|NCT00241215|Cholinergic Agents|cholinergic agents|mesh-ancestor
110288215|NCT00241215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110288216|NCT00241215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110288217|NCT00216437|Capecitabine|capecitabine|mesh-list
110288218|NCT00216437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110288219|NCT00216437|Antimetabolites|antimetabolites|mesh-ancestor
110288221|NCT00216437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110288223|NCT00244920|Leuprolide|leuprolide|mesh-list
110288224|NCT00244920|Bicalutamide|bicalutamide|mesh-list
110288225|NCT00244920|Hormones|hormones|mesh-list
110288226|NCT00244920|Androgen Antagonists|androgen antagonists|mesh-list
110288227|NCT00244920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110288228|NCT00244920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110288229|NCT00244920|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110288230|NCT00244920|Fertility Agents|fertility agents|mesh-ancestor
110288231|NCT00244920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110288232|NCT00244920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110288233|NCT00244920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110288234|NCT00244920|Hormone Antagonists|hormone antagonists|mesh-ancestor
110288235|NCT00244920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110288236|NCT00244920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110288237|NCT00244920|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110288238|NCT00244920|Protective Agents|protective agents|mesh-ancestor
110288239|NCT00244920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110288240|NCT00244920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110288241|NCT00244920|Growth Substances|growth substances|mesh-ancestor
110288242|NCT00244920|Growth Inhibitors|growth inhibitors|mesh-ancestor
110288243|NCT04663438|Antineoplastic Agents|antineoplastic agents|mesh-list
110288244|NCT00216515|Galantamine|galantamine|mesh-list
110288245|NCT00216515|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110288246|NCT00216515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110288247|NCT00216515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110288248|NCT00216515|Cholinergic Agents|cholinergic agents|mesh-ancestor
110288249|NCT00216515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110276697|NCT00554632|Estrogens|estrogens|mesh-ancestor
110276698|NCT00554632|Hormones|hormones|mesh-ancestor
110276699|NCT00554632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110276700|NCT00554632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276701|NCT00554632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110276702|NCT00554632|Contraceptive Agents|contraceptive agents|mesh-ancestor
110276703|NCT00554632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110276704|NCT00554632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110276705|NCT00554632|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110276706|NCT00554632|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110276707|NCT00554632|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110288250|NCT00216515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110288251|NCT00216515|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110288252|NCT00216515|Autonomic Agents|autonomic agents|mesh-ancestor
110288253|NCT00216515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110288254|NCT00216515|Nootropic Agents|nootropic agents|mesh-ancestor
110288255|NCT00244959|Anastrozole|anastrozole|mesh-list
110288256|NCT00244959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110288268|NCT00244998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110288269|NCT00244998|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110288270|NCT00244998|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110288271|NCT00244998|Hormone Antagonists|hormone antagonists|mesh-ancestor
110288272|NCT00244998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110288273|NCT00244998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110288275|NCT00216554|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110288276|NCT00216554|Serotonin Agents|serotonin agents|mesh-ancestor
110288277|NCT00216554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110288278|NCT00216554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110288279|NCT00216554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110288280|NCT00216554|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110288281|NCT00216554|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110288282|NCT00216554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110288283|NCT00216554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110288284|NCT00216554|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110288285|NCT00216554|Dopamine Agents|dopamine agents|mesh-ancestor
110288286|NCT00241254|Methylprednisolone|methylprednisolone|mesh-list
110288287|NCT00241254|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110288288|NCT00241254|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110288289|NCT00241254|Prednisolone|prednisolone|mesh-list
110288290|NCT00241254|Prednisolone acetate|prednisolone acetate|mesh-list
110288291|NCT00241254|Cyclophosphamide|cyclophosphamide|mesh-list
110288292|NCT00241254|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110288293|NCT00241254|Prednisolone phosphate|prednisolone phosphate|mesh-list
110288294|NCT00241254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110288295|NCT00241254|Immunologic Factors|immunologic factors|mesh-ancestor
110288296|NCT00241254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110288297|NCT00241254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110288298|NCT00241254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110288299|NCT00241254|Alkylating Agents|alkylating agents|mesh-ancestor
110288300|NCT00241254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110288301|NCT00241254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110288302|NCT00241254|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110288303|NCT00241254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110288304|NCT00241254|Antiemetics|antiemetics|mesh-ancestor
110288305|NCT00241254|Autonomic Agents|autonomic agents|mesh-ancestor
110288306|NCT00241254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110288307|NCT00241254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110288308|NCT00241254|Glucocorticoids|glucocorticoids|mesh-ancestor
110288309|NCT00241254|Hormones|hormones|mesh-ancestor
110288310|NCT00241254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110288311|NCT00241254|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110276708|NCT00204984|Hydralazine|hydralazine|mesh-list
110276709|NCT00204984|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
110276710|NCT00204984|Natriuretic Agents|natriuretic agents|mesh-ancestor
110276711|NCT00204984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276712|NCT00204984|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110276713|NCT00204984|Vasodilator Agents|vasodilator agents|mesh-ancestor
110276714|NCT02236195|Mocetinostat|mocetinostat|mesh-list
110276715|NCT02236195|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110276716|NCT02236195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110276717|NCT02236195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276718|NCT02236156|Metronidazole|metronidazole|mesh-list
110276719|NCT02236156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110276720|NCT02236156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110276721|NCT02236156|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110276722|NCT02236156|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110276723|NCT00177086|Alfuzosin|alfuzosin|mesh-list
110276724|NCT00177086|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110276725|NCT00177086|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110276726|NCT00177086|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110276727|NCT00177086|Adrenergic Agents|adrenergic agents|mesh-ancestor
110288312|NCT00241254|Protective Agents|protective agents|mesh-ancestor
110288313|NCT00241254|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110288314|NCT00216632|Risperidone|risperidone|mesh-list
110288315|NCT00216632|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110288316|NCT00216632|Serotonin Agents|serotonin agents|mesh-ancestor
110288317|NCT00216632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110288325|NCT00216632|Dopamine Agents|dopamine agents|mesh-ancestor
110288326|NCT04662736|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110288328|NCT04662736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110288330|NCT04662658|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110288331|NCT04662658|Anesthetics, General|anesthetics, general|mesh-ancestor
110288333|NCT04662658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110288334|NCT04662658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110288335|NCT00216788|Esomeprazole|esomeprazole|mesh-list
110288336|NCT00216788|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110288337|NCT00216788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110288338|NCT00216788|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110288339|NCT00216788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110288340|NCT00216788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110288341|NCT00245115|Cyclophosphamide|cyclophosphamide|mesh-list
110288342|NCT00245115|Busulfan|busulfan|mesh-list
110288343|NCT00245115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110288344|NCT00245115|Immunologic Factors|immunologic factors|mesh-ancestor
110288345|NCT00245115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110288346|NCT00245115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110288347|NCT00245115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110288348|NCT00245115|Alkylating Agents|alkylating agents|mesh-ancestor
110288349|NCT00245115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110288350|NCT00245115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110288351|NCT00245115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110288352|NCT04662385|Listerine|listerine|mesh-list
110288353|NCT04662385|Sodium Fluoride|sodium fluoride|mesh-list
110288354|NCT04662385|Cariostatic Agents|cariostatic agents|mesh-ancestor
110288355|NCT04662385|Protective Agents|protective agents|mesh-ancestor
110288356|NCT04662385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276728|NCT00177086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110276729|NCT00177086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276730|NCT00177086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276731|NCT00177086|Urological Agents|urological agents|mesh-ancestor
110276732|NCT02207257|Edoxaban|edoxaban|mesh-list
110276733|NCT02207257|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110276734|NCT02207257|Antithrombins|antithrombins|mesh-ancestor
110276735|NCT02207257|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110276736|NCT02207257|Protease Inhibitors|protease inhibitors|mesh-ancestor
110276737|NCT02207257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110276738|NCT02207257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276739|NCT02207257|Anticoagulants|anticoagulants|mesh-ancestor
110276740|NCT00554710|Methylprednisolone|methylprednisolone|mesh-list
110276741|NCT00554710|Budesonide|budesonide|mesh-list
110276742|NCT00554710|Infliximab|infliximab|mesh-list
110276743|NCT00554710|Azathioprine|azathioprine|mesh-list
110276744|NCT00554710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110276745|NCT00554710|Antiemetics|antiemetics|mesh-ancestor
110276746|NCT00554710|Autonomic Agents|autonomic agents|mesh-ancestor
110276747|NCT00554710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110276748|NCT00554710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110288357|NCT04662385|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110288358|NCT04662385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110288359|NCT00216827|Betamethasone|betamethasone|mesh-list
110288360|NCT00216827|Betamethasone Valerate|betamethasone valerate|mesh-list
110288361|NCT00216827|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
110288362|NCT00216827|Betamethasone benzoate|betamethasone benzoate|mesh-list
110288363|NCT00216827|Calcipotriene|calcipotriene|mesh-list
110288364|NCT00216827|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
110288365|NCT00216827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110288366|NCT00216827|Glucocorticoids|glucocorticoids|mesh-ancestor
110288368|NCT00216827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110288370|NCT00216827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110288371|NCT00216827|Respiratory System Agents|respiratory system agents|mesh-ancestor
110288372|NCT00216827|Dermatologic Agents|dermatologic agents|mesh-ancestor
110288374|NCT00241332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110288375|NCT00241332|Narcotics|narcotics|mesh-ancestor
110288376|NCT00241332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110288377|NCT00241332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110288378|NCT00241332|Analgesics|analgesics|mesh-ancestor
110288379|NCT00241332|Sensory System Agents|sensory system agents|mesh-ancestor
110288380|NCT00241332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110288381|NCT00241332|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110288382|NCT00241332|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110288383|NCT00241332|Anesthetics, General|anesthetics, general|mesh-ancestor
110288384|NCT00241332|Anesthetics|anesthetics|mesh-ancestor
110288385|NCT00216866|Dalteparin|dalteparin|mesh-list
110288386|NCT00216866|Tinzaparin|tinzaparin|mesh-list
110288398|NCT00557206|Mitosis Modulators|mitosis modulators|mesh-ancestor
110288399|NCT00557206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110288400|NCT00241371|Clofarabine|clofarabine|mesh-list
110288401|NCT00241371|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110288402|NCT00241371|Antimetabolites|antimetabolites|mesh-ancestor
110276749|NCT00554710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110276750|NCT00554710|Glucocorticoids|glucocorticoids|mesh-ancestor
110276752|NCT00554710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110276753|NCT00554710|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110276754|NCT00554710|Protective Agents|protective agents|mesh-ancestor
110288403|NCT00241371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110288404|NCT00241371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110288405|NCT04660786|Vitamin D|vitamin d|mesh-list
110288406|NCT04660786|Triamcinolone|triamcinolone|mesh-list
110288407|NCT04660786|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110288408|NCT04660786|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110288409|NCT04660786|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110288410|NCT04660786|Vitamins|vitamins|mesh-ancestor
110288411|NCT04660786|Micronutrients|micronutrients|mesh-ancestor
110288412|NCT04660786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110288413|NCT04660786|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110288414|NCT04660786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110288415|NCT04660786|Glucocorticoids|glucocorticoids|mesh-ancestor
110288416|NCT04660786|Hormones|hormones|mesh-ancestor
110288417|NCT04660786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110288418|NCT04660786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110288419|NCT04660786|Immunologic Factors|immunologic factors|mesh-ancestor
110288420|NCT04660786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110288421|NCT04660786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110288422|NCT00217178|Folic Acid|folic acid|mesh-list
110288423|NCT00217178|Vitamins|vitamins|mesh-ancestor
110288424|NCT00217178|Micronutrients|micronutrients|mesh-ancestor
110288425|NCT00217178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110288426|NCT00217178|Hematinics|hematinics|mesh-ancestor
110288427|NCT00217178|Vitamin B Complex|vitamin b complex|mesh-ancestor
110288428|NCT00241449|Tamoxifen|tamoxifen|mesh-list
110288429|NCT00241449|Fulvestrant|fulvestrant|mesh-list
110288430|NCT00241449|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110288431|NCT00241449|Hormone Antagonists|hormone antagonists|mesh-ancestor
110288432|NCT00241449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110288433|NCT00241449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110288434|NCT00241449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110288435|NCT00241449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110288436|NCT00241449|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110288437|NCT00241449|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110288438|NCT00241449|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110288439|NCT00241449|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110288440|NCT00412100|Oxycodone|oxycodone|mesh-list
110288441|NCT00412100|Naloxone|naloxone|mesh-list
110288442|NCT00412100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110288443|NCT00412100|Narcotics|narcotics|mesh-ancestor
110288444|NCT00412100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110288445|NCT00412100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110288446|NCT00412100|Analgesics|analgesics|mesh-ancestor
110288447|NCT00412100|Sensory System Agents|sensory system agents|mesh-ancestor
110288448|NCT00412100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110288449|NCT00412100|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110288450|NCT00241488|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110288451|NCT00241488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110288452|NCT00241488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110288478|NCT04648813|Respiratory System Agents|respiratory system agents|mesh-ancestor
110288479|NCT04648813|Parasympatholytics|parasympatholytics|mesh-ancestor
110288480|NCT04648813|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110288481|NCT04648813|Cholinergic Agents|cholinergic agents|mesh-ancestor
110288482|NCT04648813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110288483|NCT04648813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110288484|NCT04648813|Anticonvulsants|anticonvulsants|mesh-ancestor
110288486|NCT04648423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110288487|NCT04648423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110288488|NCT04648423|Anesthetics, General|anesthetics, general|mesh-ancestor
110288489|NCT04648423|Anesthetics|anesthetics|mesh-ancestor
110288490|NCT04648423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110288491|NCT04648423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276755|NCT00554710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110276756|NCT00554710|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110276757|NCT00554710|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110276758|NCT00554710|Respiratory System Agents|respiratory system agents|mesh-ancestor
110276759|NCT00554710|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110276760|NCT00554710|Dermatologic Agents|dermatologic agents|mesh-ancestor
110276761|NCT00554710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110276762|NCT00554710|Antimetabolites|antimetabolites|mesh-ancestor
110276763|NCT00554710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276764|NCT00554710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110276765|NCT00554710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110276766|NCT00554710|Immunologic Factors|immunologic factors|mesh-ancestor
110276767|NCT00200187|Anesthetics|anesthetics|mesh-list
110276768|NCT00200187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110276769|NCT00200187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276770|NCT04659109|Glenzocimab|glenzocimab|mesh-list
110276771|NCT04659109|Anticoagulants|anticoagulants|mesh-ancestor
110276773|NCT00177242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110276774|NCT00177242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110276775|NCT00177242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110276776|NCT00177242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276777|NCT04659070|Telmisartan|telmisartan|mesh-list
110276778|NCT04659070|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110276779|NCT04659070|Ezetimibe|ezetimibe|mesh-list
110276780|NCT04659070|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110276781|NCT04659070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110276783|NCT04659070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276784|NCT04659070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110288492|NCT00558181|Methylprednisolone|methylprednisolone|mesh-list
110288493|NCT00558181|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110288494|NCT00558181|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110288495|NCT00558181|Prednisolone|prednisolone|mesh-list
110288496|NCT00558181|Prednisolone acetate|prednisolone acetate|mesh-list
110288497|NCT00558181|Rituximab|rituximab|mesh-list
110288498|NCT00558181|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110288499|NCT00558181|Prednisolone phosphate|prednisolone phosphate|mesh-list
110288500|NCT00558181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110288501|NCT00558181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110288518|NCT00558220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110288519|NCT00217295|Topiramate|topiramate|mesh-list
110288520|NCT00217295|Anticonvulsants|anticonvulsants|mesh-ancestor
110288521|NCT00217295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110288522|NCT00217295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110288523|NCT00245427|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110276785|NCT04659070|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110276786|NCT04659070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110276787|NCT04659070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110288525|NCT00245427|beta-Lactams|beta-lactams|mesh-list
110288526|NCT00245427|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110288527|NCT00245427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110288528|NCT00245427|Antitubercular Agents|antitubercular agents|mesh-ancestor
110288529|NCT00558298|Risperidone|risperidone|mesh-list
110288530|NCT00558298|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110288531|NCT00558298|Serotonin Agents|serotonin agents|mesh-ancestor
110288532|NCT00558298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110288533|NCT00558298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110288534|NCT00558298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110288535|NCT00558298|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110288536|NCT00558298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110288537|NCT00558298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110288538|NCT00558298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110288539|NCT00558298|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110288540|NCT00558298|Dopamine Agents|dopamine agents|mesh-ancestor
110288541|NCT00245505|Mesalamine|mesalamine|mesh-list
110288542|NCT00245505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110288543|NCT00245505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110288544|NCT00245505|Analgesics|analgesics|mesh-ancestor
110288545|NCT00245505|Sensory System Agents|sensory system agents|mesh-ancestor
110288546|NCT00245505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110288547|NCT00245505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110288548|NCT00245505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110288549|NCT00245505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110288550|NCT04647838|Tepotinib|tepotinib|mesh-list
110288551|NCT04647838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110288552|NCT00217373|Interferons|interferons|mesh-list
110288553|NCT00217373|Interferon-alpha|interferon-alpha|mesh-list
110288554|NCT00217373|Interferon alpha-2|interferon alpha-2|mesh-list
110288555|NCT00217373|Metronidazole|metronidazole|mesh-list
110288556|NCT00217373|Vaccines|vaccines|mesh-list
110288557|NCT00217373|Sargramostim|sargramostim|mesh-list
110288558|NCT00217373|Immunologic Factors|immunologic factors|mesh-ancestor
110288559|NCT00217373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110288560|NCT00217373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110288561|NCT00217373|Antiviral Agents|antiviral agents|mesh-ancestor
110288562|NCT00217373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110288563|NCT00217373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110288568|NCT00241605|Rosiglitazone|rosiglitazone|mesh-list
110288569|NCT00241605|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110288570|NCT00241605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110288571|NCT00217412|Vorinostat|vorinostat|mesh-list
110288572|NCT00217412|Isotretinoin|isotretinoin|mesh-list
110288573|NCT00217412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110288574|NCT00217412|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110288575|NCT00217412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110288576|NCT00217412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110288577|NCT00217412|Dermatologic Agents|dermatologic agents|mesh-ancestor
110288579|NCT04646824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110288580|NCT04646824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110288581|NCT04646824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110288582|NCT04646824|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110288583|NCT04646824|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110288584|NCT00217451|Clindamycin|clindamycin|mesh-list
110288585|NCT00217451|Clindamycin palmitate|clindamycin palmitate|mesh-list
110288586|NCT00217451|Clindamycin phosphate|clindamycin phosphate|mesh-list
110288587|NCT00217451|Fosmidomycin|fosmidomycin|mesh-list
110288588|NCT00217451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110288589|NCT00217451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110288590|NCT00217451|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110288591|NCT00217451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110288592|NCT00217451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110288593|NCT00217529|Carboplatin|carboplatin|mesh-list
110288594|NCT00217529|Docetaxel|docetaxel|mesh-list
110288595|NCT00217529|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110288596|NCT00217529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110288597|NCT00217529|Tubulin Modulators|tubulin modulators|mesh-ancestor
110276789|NCT04659070|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110276790|NCT00177281|Belotecan|belotecan|mesh-list
110276791|NCT00177281|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110276792|NCT00177281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110276793|NCT00177281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110276794|NCT00177281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276795|NCT00177281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110276796|NCT00200226|Vitamin B 6|vitamin b 6|mesh-list
110276797|NCT00200226|Pyridoxal|pyridoxal|mesh-list
110276798|NCT00200226|Pyridoxine|pyridoxine|mesh-list
110276799|NCT00200226|Misoprostol|misoprostol|mesh-list
110276800|NCT00200226|Vitamins|vitamins|mesh-ancestor
110276801|NCT00200226|Micronutrients|micronutrients|mesh-ancestor
110276802|NCT00200226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276803|NCT00200226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110276804|NCT00200226|Abortifacient Agents|abortifacient agents|mesh-ancestor
110276805|NCT00200226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110276806|NCT00200226|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110276807|NCT00200226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110276808|NCT00200226|Oxytocics|oxytocics|mesh-ancestor
110276809|NCT00200226|Vitamin B Complex|vitamin b complex|mesh-ancestor
110288598|NCT00217529|Antimitotic Agents|antimitotic agents|mesh-ancestor
110288599|NCT00217529|Mitosis Modulators|mitosis modulators|mesh-ancestor
110288600|NCT00217529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110288601|NCT00217529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110288602|NCT00217529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110288603|NCT00245661|Temazepam|temazepam|mesh-list
110288604|NCT00245661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110288605|NCT00245661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110288606|NCT00245661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110288607|NCT00245661|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110288608|NCT00245661|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110288609|NCT00245661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110288610|NCT00245661|GABA Modulators|gaba modulators|mesh-ancestor
110288611|NCT00245661|GABA Agents|gaba agents|mesh-ancestor
110288612|NCT00245661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110288613|NCT00245661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110288615|NCT04646317|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110288616|NCT04646317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110288617|NCT04646317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110288618|NCT04646317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110288619|NCT04646317|Analgesics|analgesics|mesh-ancestor
110288620|NCT04646317|Sensory System Agents|sensory system agents|mesh-ancestor
110288621|NCT04646317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110288622|NCT04646317|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110288623|NCT04646317|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110288624|NCT04646317|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110288625|NCT04646317|Adrenergic Agents|adrenergic agents|mesh-ancestor
110288626|NCT04646317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110288627|NCT04646317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110288628|NCT00217568|Carboplatin|carboplatin|mesh-list
110288629|NCT00217568|Docetaxel|docetaxel|mesh-list
110276810|NCT04658329|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110276811|NCT04658329|Antiviral Agents|antiviral agents|mesh-ancestor
110276812|NCT04658329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110276813|NCT00557557|Oxaliplatin|oxaliplatin|mesh-list
110276814|NCT00557557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110276815|NCT04658134|Glycine|glycine|mesh-list
110276816|NCT04658134|Glycine Agents|glycine agents|mesh-ancestor
110276817|NCT04658134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110276818|NCT04658134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276819|NCT04658134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276820|NCT00200382|Bortezomib|bortezomib|mesh-list
110276821|NCT00200382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110276822|NCT04657744|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
110276823|NCT04657744|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110276824|NCT04657744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276825|NCT04657744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110276826|NCT04657744|Immunologic Factors|immunologic factors|mesh-ancestor
110276827|NCT04657744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110288630|NCT00217568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110288631|NCT00217568|Tubulin Modulators|tubulin modulators|mesh-ancestor
110288632|NCT00217568|Antimitotic Agents|antimitotic agents|mesh-ancestor
110288633|NCT00217568|Mitosis Modulators|mitosis modulators|mesh-ancestor
110288634|NCT00217568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110288635|NCT04646161|Misoprostol|misoprostol|mesh-list
110288652|NCT00558337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110288653|NCT00558337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110288654|NCT00558337|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110288655|NCT00558337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110288656|NCT00558337|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110288657|NCT00558337|Immunologic Factors|immunologic factors|mesh-ancestor
110288658|NCT00558337|Dopamine Agonists|dopamine agonists|mesh-ancestor
110288659|NCT00558376|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
110288661|NCT00558376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110288662|NCT00217646|Sorafenib|sorafenib|mesh-list
110288663|NCT00217646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110288664|NCT00217646|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110288665|NCT00217646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110288666|NCT00217646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110288667|NCT00558454|Ferrous succinate|ferrous succinate|mesh-list
110288668|NCT00558454|Hematinics|hematinics|mesh-ancestor
110288669|NCT00558493|Clevudine|clevudine|mesh-list
110288670|NCT00558493|Antiviral Agents|antiviral agents|mesh-ancestor
110288671|NCT00558493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110288672|NCT04645303|Triamcinolone|triamcinolone|mesh-list
110288673|NCT04645303|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110288674|NCT04645303|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110288675|NCT04645303|Hyaluronic Acid|hyaluronic acid|mesh-list
110288676|NCT04645303|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110288677|NCT04645303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110288678|NCT04645303|Glucocorticoids|glucocorticoids|mesh-ancestor
110288679|NCT04645303|Hormones|hormones|mesh-ancestor
110288680|NCT04645303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110288681|NCT04645303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110288682|NCT04645303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110288683|NCT04645303|Immunologic Factors|immunologic factors|mesh-ancestor
110276828|NCT00177398|Insulin|insulin|mesh-list
110276829|NCT00177398|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110276830|NCT00177398|Insulin Glargine|insulin glargine|mesh-list
110276831|NCT00177398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110276832|NCT00177398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276833|NCT00200421|Atenolol|atenolol|mesh-list
110276834|NCT00200421|Nebivolol|nebivolol|mesh-list
110276835|NCT00200421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110276836|NCT00200421|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110276837|NCT00200421|Sympatholytics|sympatholytics|mesh-ancestor
110276838|NCT00200421|Autonomic Agents|autonomic agents|mesh-ancestor
110276839|NCT00200421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110276840|NCT00200421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276841|NCT00200421|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110288684|NCT04645303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110288685|NCT04645303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110288686|NCT04645303|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110288687|NCT04645303|Viscosupplements|viscosupplements|mesh-ancestor
110288688|NCT04645303|Protective Agents|protective agents|mesh-ancestor
110288689|NCT00217607|Paclitaxel|paclitaxel|mesh-list
110288690|NCT00217607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110288691|NCT00217607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110288692|NCT00217607|Tubulin Modulators|tubulin modulators|mesh-ancestor
110288693|NCT00217607|Antimitotic Agents|antimitotic agents|mesh-ancestor
110288694|NCT00217607|Mitosis Modulators|mitosis modulators|mesh-ancestor
110288695|NCT00217607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110288696|NCT04644484|Vaccines|vaccines|mesh-list
110288697|NCT04644484|Immunoglobulins|immunoglobulins|mesh-list
110288698|NCT04644484|Antibodies|antibodies|mesh-list
110288699|NCT04644484|gamma-Globulins|gamma-globulins|mesh-list
110288702|NCT04644484|Immunologic Factors|immunologic factors|mesh-ancestor
110288703|NCT04644484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110288704|NCT04644250|Paclitaxel|paclitaxel|mesh-list
110288705|NCT04644250|Carboplatin|carboplatin|mesh-list
110288706|NCT04644250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110288707|NCT04644250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110288708|NCT04644250|Tubulin Modulators|tubulin modulators|mesh-ancestor
110288709|NCT04644250|Antimitotic Agents|antimitotic agents|mesh-ancestor
110288710|NCT04644250|Mitosis Modulators|mitosis modulators|mesh-ancestor
110288711|NCT04644250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110288712|NCT00245739|Darunavir|darunavir|mesh-list
110288713|NCT00245739|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110288714|NCT00245739|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110288715|NCT00245739|Protease Inhibitors|protease inhibitors|mesh-ancestor
110288716|NCT00245739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110288717|NCT00245739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110288718|NCT00245739|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110288719|NCT00245739|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110288720|NCT00245739|Antiviral Agents|antiviral agents|mesh-ancestor
110288721|NCT00245739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110288722|NCT00558883|Acarbose|acarbose|mesh-list
110288723|NCT00558883|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110288724|NCT00558883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110288725|NCT00558883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110288726|NCT00558883|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110288727|NCT00558883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110288728|NCT04644094|Dexamethasone|dexamethasone|mesh-list
110288729|NCT04644094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110288730|NCT04644094|Antiemetics|antiemetics|mesh-ancestor
110288731|NCT04644094|Autonomic Agents|autonomic agents|mesh-ancestor
110288732|NCT04644094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110288733|NCT04644094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110288734|NCT04644094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110276842|NCT00200421|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110276843|NCT00200421|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110276844|NCT00200421|Adrenergic Agents|adrenergic agents|mesh-ancestor
110276845|NCT00200421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110276846|NCT00200421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276847|NCT00200421|Vasodilator Agents|vasodilator agents|mesh-ancestor
110276848|NCT00200421|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110276849|NCT00200421|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110276850|NCT00200421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110276851|NCT04656106|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110288735|NCT04644094|Glucocorticoids|glucocorticoids|mesh-ancestor
110288736|NCT04644094|Hormones|hormones|mesh-ancestor
110288737|NCT04644094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110288738|NCT04644094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110288739|NCT04644094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110288740|NCT04644406|Trastuzumab|trastuzumab|mesh-list
110288741|NCT04644406|Pertuzumab|pertuzumab|mesh-list
110288742|NCT04644406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110288743|NCT04644406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110288744|NCT04643821|Calcitriol|calcitriol|mesh-list
110288745|NCT04643821|Acetylcysteine|acetylcysteine|mesh-list
110288747|NCT04643821|Antiviral Agents|antiviral agents|mesh-ancestor
110288748|NCT04643821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110288749|NCT04643821|Expectorants|expectorants|mesh-ancestor
110288750|NCT04643821|Respiratory System Agents|respiratory system agents|mesh-ancestor
110288751|NCT04643821|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110288752|NCT04643821|Antioxidants|antioxidants|mesh-ancestor
110288753|NCT04643821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110288754|NCT04643821|Protective Agents|protective agents|mesh-ancestor
110288755|NCT04643821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110288756|NCT04643821|Antidotes|antidotes|mesh-ancestor
110288757|NCT04643821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110288758|NCT04643821|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110288759|NCT04643821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110288760|NCT04643821|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110288761|NCT04643821|Vitamins|vitamins|mesh-ancestor
110288762|NCT04643821|Micronutrients|micronutrients|mesh-ancestor
110288763|NCT04643821|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110288764|NCT00218075|Levodopa|levodopa|mesh-list
110288765|NCT00218075|Carbidopa|carbidopa|mesh-list
110288766|NCT00218075|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110288767|NCT00218075|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110288768|NCT00218075|Dopamine Agents|dopamine agents|mesh-ancestor
110288769|NCT00218075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110288770|NCT00218075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110288771|NCT00218075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110288772|NCT00218075|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110288773|NCT00218075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110288779|NCT00218114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110288780|NCT00218114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110288782|NCT00218114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110288783|NCT00218114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110288784|NCT00218114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110288785|NCT00424788|Natalizumab|natalizumab|mesh-list
110288786|NCT00424788|Immunologic Factors|immunologic factors|mesh-ancestor
110288787|NCT00424788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110288788|NCT00218153|Naltrexone|naltrexone|mesh-list
110288789|NCT00218153|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110288790|NCT00218153|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110288791|NCT00218153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110288792|NCT00218153|Sensory System Agents|sensory system agents|mesh-ancestor
110288793|NCT00218153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110276852|NCT04656106|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110276853|NCT04656106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276854|NCT04656262|Cyclophosphamide|cyclophosphamide|mesh-list
110276855|NCT04656262|Doxorubicin|doxorubicin|mesh-list
110276856|NCT04656262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110276857|NCT04656262|Immunologic Factors|immunologic factors|mesh-ancestor
110276858|NCT04656262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276859|NCT04656262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110276860|NCT04656262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110276861|NCT04656262|Alkylating Agents|alkylating agents|mesh-ancestor
110288794|NCT04642846|Fluorides|fluorides|mesh-list
110288795|NCT04642846|Cariostatic Agents|cariostatic agents|mesh-ancestor
110288796|NCT04642846|Protective Agents|protective agents|mesh-ancestor
110288797|NCT04642846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110288798|NCT00245895|Darbepoetin alfa|darbepoetin alfa|mesh-list
110288799|NCT00245895|Hematinics|hematinics|mesh-ancestor
110288800|NCT00559195|Epoetin Alfa|epoetin alfa|mesh-list
110288801|NCT00559195|Hematinics|hematinics|mesh-ancestor
110288802|NCT00245934|Etanercept|etanercept|mesh-list
110288803|NCT00245934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110288804|NCT00245934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110288805|NCT00245934|Analgesics|analgesics|mesh-ancestor
110288806|NCT00245934|Sensory System Agents|sensory system agents|mesh-ancestor
110288807|NCT00245934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110288808|NCT00245934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110288809|NCT00245934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110288810|NCT00245934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110288811|NCT00245934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110288812|NCT00245934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110288813|NCT00245934|Immunologic Factors|immunologic factors|mesh-ancestor
110288814|NCT00218231|Bupropion|bupropion|mesh-list
110288815|NCT00218231|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110288816|NCT00218231|Antidepressive Agents|antidepressive agents|mesh-ancestor
110288817|NCT00218231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110288818|NCT00218231|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110288819|NCT00218231|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110288820|NCT00218231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110288821|NCT00218231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110288823|NCT00218231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110288824|NCT00218231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110288825|NCT00218231|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110288826|NCT00218231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110288827|NCT00218231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110288828|NCT00241995|Anticonvulsants|anticonvulsants|mesh-list
110288829|NCT00218309|Hydromorphone|hydromorphone|mesh-list
110288830|NCT00218309|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110288831|NCT00218309|Narcotics|narcotics|mesh-ancestor
110288832|NCT00218309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110288833|NCT00218309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110288834|NCT00218309|Analgesics|analgesics|mesh-ancestor
110288835|NCT00218309|Sensory System Agents|sensory system agents|mesh-ancestor
110288836|NCT00218309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110288837|NCT00218348|Amphetamine|amphetamine|mesh-list
110288838|NCT00218348|Dextroamphetamine|dextroamphetamine|mesh-list
110288839|NCT00218348|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110288840|NCT00218348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110288841|NCT00218348|Sympathomimetics|sympathomimetics|mesh-ancestor
110288842|NCT00218348|Autonomic Agents|autonomic agents|mesh-ancestor
110288843|NCT00218348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110288844|NCT00218348|Dopamine Agents|dopamine agents|mesh-ancestor
110288865|NCT00559312|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110288866|NCT00559312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110288867|NCT00559312|Adrenergic Agents|adrenergic agents|mesh-ancestor
110276862|NCT04656262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276863|NCT04656262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110276864|NCT04656262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110276865|NCT04656262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110276866|NCT04656262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110276867|NCT04656262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110276868|NCT04656262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110276869|NCT00200460|Nebivolol|nebivolol|mesh-list
110276870|NCT00200460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110276871|NCT00200460|Vasodilator Agents|vasodilator agents|mesh-ancestor
110288868|NCT00559312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110288869|NCT00559312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110288871|NCT00559312|Hormones|hormones|mesh-ancestor
110288872|NCT00559312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110288873|NCT00559312|Sympathomimetics|sympathomimetics|mesh-ancestor
110288874|NCT00559351|Fluorouracil|fluorouracil|mesh-list
110019725|NCT00000372|Clozapine|clozapine|mesh-list
110288875|NCT00559351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110288876|NCT00559351|Antimetabolites|antimetabolites|mesh-ancestor
110288877|NCT00559351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110288878|NCT00559351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110288879|NCT00559351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110288880|NCT00559351|Immunologic Factors|immunologic factors|mesh-ancestor
110288881|NCT00559351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110288882|NCT00218504|Dronabinol|dronabinol|mesh-list
110288883|NCT00218504|Hallucinogens|hallucinogens|mesh-ancestor
110288884|NCT00218504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110288885|NCT00218504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110288886|NCT00218504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110288887|NCT00218504|Analgesics|analgesics|mesh-ancestor
110288888|NCT00218504|Sensory System Agents|sensory system agents|mesh-ancestor
110288889|NCT00218504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110288890|NCT00218504|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110288891|NCT00218504|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110288892|NCT00218504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110288893|NCT00218504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110288894|NCT00218504|Hormones|hormones|mesh-ancestor
110288895|NCT00218504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110288900|NCT00559429|Antimitotic Agents|antimitotic agents|mesh-ancestor
110288901|NCT00559429|Mitosis Modulators|mitosis modulators|mesh-ancestor
110288902|NCT00559429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110288903|NCT00559429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110288905|NCT00559429|Sensory System Agents|sensory system agents|mesh-ancestor
110288906|NCT00559429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110288907|NCT00559429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110288908|NCT00218621|Buprenorphine|buprenorphine|mesh-list
110288909|NCT00218621|Methadone|methadone|mesh-list
110288910|NCT00218621|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110288911|NCT00218621|Narcotics|narcotics|mesh-ancestor
110288912|NCT00218621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110288913|NCT00218621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110288914|NCT00218621|Analgesics|analgesics|mesh-ancestor
110288915|NCT00218621|Sensory System Agents|sensory system agents|mesh-ancestor
110288916|NCT00218621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110288917|NCT00218621|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110288918|NCT00218621|Antitussive Agents|antitussive agents|mesh-ancestor
110288919|NCT00218621|Respiratory System Agents|respiratory system agents|mesh-ancestor
110288920|NCT00246168|Acetaminophen|acetaminophen|mesh-list
110288921|NCT00246168|Tramadol|tramadol|mesh-list
110288922|NCT00246168|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110288923|NCT00246168|Analgesics|analgesics|mesh-ancestor
110288924|NCT00246168|Sensory System Agents|sensory system agents|mesh-ancestor
110288925|NCT00246168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110276872|NCT00200460|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110276873|NCT00200460|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110276874|NCT00200460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110276875|NCT00200460|Adrenergic Agents|adrenergic agents|mesh-ancestor
110276876|NCT00200460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110276877|NCT00200460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276878|NCT00200460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276879|NCT00200499|Nebivolol|nebivolol|mesh-list
110276880|NCT00200499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110276881|NCT00200499|Vasodilator Agents|vasodilator agents|mesh-ancestor
110276882|NCT00200499|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110288926|NCT00246168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110288927|NCT00246168|Antipyretics|antipyretics|mesh-ancestor
110288928|NCT00246168|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110288929|NCT00246168|Narcotics|narcotics|mesh-ancestor
110288930|NCT00246168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110288931|NCT00218660|Naltrexone|naltrexone|mesh-list
110288932|NCT00218660|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110288933|NCT00218660|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110288934|NCT00218660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110288935|NCT00218660|Sensory System Agents|sensory system agents|mesh-ancestor
110288936|NCT00218660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110288937|NCT00559546|Montelukast|montelukast|mesh-list
110288938|NCT00559546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110288939|NCT00559546|Respiratory System Agents|respiratory system agents|mesh-ancestor
110288940|NCT00559546|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110288941|NCT00559546|Hormone Antagonists|hormone antagonists|mesh-ancestor
110288942|NCT00559546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110288943|NCT00559546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110288944|NCT00559546|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110288945|NCT00559546|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110288946|NCT00559546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110288947|NCT00246207|Methylphenidate|methylphenidate|mesh-list
110288948|NCT00246207|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110288949|NCT00246207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110288950|NCT00246207|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110288951|NCT00246207|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110288952|NCT00246207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110288953|NCT00246207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110288954|NCT00246207|Dopamine Agents|dopamine agents|mesh-ancestor
110288955|NCT00246207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110288956|NCT04639804|Celecoxib|celecoxib|mesh-list
110288957|NCT04639804|Naproxen|naproxen|mesh-list
110288958|NCT04639804|Aceclofenac|aceclofenac|mesh-list
110288959|NCT04639804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110288960|NCT04639804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110288961|NCT04639804|Analgesics|analgesics|mesh-ancestor
110288962|NCT04639804|Sensory System Agents|sensory system agents|mesh-ancestor
110288963|NCT04639804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110288964|NCT04639804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110288965|NCT04639804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110288966|NCT04639804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110288970|NCT04639804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110288972|NCT00218855|Thalidomide|thalidomide|mesh-list
110288973|NCT00218855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110288974|NCT00218855|Immunologic Factors|immunologic factors|mesh-ancestor
110288975|NCT00218855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110288976|NCT00218855|Leprostatic Agents|leprostatic agents|mesh-ancestor
110288977|NCT00218855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110288978|NCT00218855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110288979|NCT00218855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110276883|NCT00200499|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110276884|NCT00200499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110276885|NCT00200499|Adrenergic Agents|adrenergic agents|mesh-ancestor
110276886|NCT00200499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110276887|NCT00200499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276888|NCT00200499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276889|NCT00200538|Memantine|memantine|mesh-list
110276890|NCT00200538|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110288980|NCT00218855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110288981|NCT00218855|Growth Substances|growth substances|mesh-ancestor
110288983|NCT00218855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110288984|NCT00246246|Risperidone|risperidone|mesh-list
110288985|NCT00246246|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110288986|NCT00246246|Serotonin Agents|serotonin agents|mesh-ancestor
110288987|NCT00246246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110288988|NCT00246246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110288989|NCT00246246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110288990|NCT00246246|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110288991|NCT00246246|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110288992|NCT00246246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110288993|NCT00246246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110288994|NCT00246246|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110288995|NCT00246246|Dopamine Agents|dopamine agents|mesh-ancestor
110288996|NCT00242190|Gemcitabine|gemcitabine|mesh-list
110288997|NCT00242190|Oxaliplatin|oxaliplatin|mesh-list
110288998|NCT00242190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110288999|NCT00242190|Antimetabolites|antimetabolites|mesh-ancestor
110289000|NCT00242190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110289001|NCT00242190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110289003|NCT04628884|Anticoagulants|anticoagulants|mesh-ancestor
110289004|NCT04628884|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110289005|NCT04628884|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110289006|NCT04628884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110289007|NCT00412334|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110289008|NCT00412334|Interferon-alpha|interferon-alpha|mesh-list
110289009|NCT00412334|Ribavirin|ribavirin|mesh-list
110289010|NCT00412334|Antiviral Agents|antiviral agents|mesh-ancestor
110289011|NCT00412334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110289012|NCT00412334|Immunologic Factors|immunologic factors|mesh-ancestor
110289013|NCT00412334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289014|NCT00412334|Antimetabolites|antimetabolites|mesh-ancestor
110289015|NCT00412334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110289016|NCT00561379|Rituximab|rituximab|mesh-list
110289017|NCT00561379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110289018|NCT00561379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110289019|NCT00561379|Immunologic Factors|immunologic factors|mesh-ancestor
110289020|NCT00561379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289021|NCT00561379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110289022|NCT04629118|Sirolimus|sirolimus|mesh-list
110289023|NCT04629118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110019866|NCT00000702|Zidovudine|zidovudine|mesh-list
110289025|NCT04629118|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110289026|NCT04629118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110289027|NCT04629118|Antifungal Agents|antifungal agents|mesh-ancestor
110289028|NCT04629118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110289029|NCT04629118|Immunologic Factors|immunologic factors|mesh-ancestor
110289030|NCT04629118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289031|NCT00561496|Tenofovir|tenofovir|mesh-list
110289032|NCT00561496|Antiviral Agents|antiviral agents|mesh-ancestor
110289033|NCT00561496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110289034|NCT00561496|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110289035|NCT00561496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110289036|NCT00561496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110289037|NCT00561496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110289038|NCT00561496|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110276891|NCT00200538|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110276892|NCT00200538|Dopamine Agents|dopamine agents|mesh-ancestor
110276893|NCT00200538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110276894|NCT00200538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276895|NCT00200538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276896|NCT00200538|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110276897|NCT00200538|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110276898|NCT00177710|Amphotericin B|amphotericin b|mesh-list
110276899|NCT00177710|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110276900|NCT00177710|Amebicides|amebicides|mesh-ancestor
110276901|NCT00177710|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110289044|NCT00246285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110289045|NCT00246285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289046|NCT00246285|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110289047|NCT00246285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110289048|NCT00246285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110289049|NCT00246285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110289050|NCT00246285|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110289051|NCT00246285|Dopamine Agents|dopamine agents|mesh-ancestor
110289052|NCT00242268|Simvastatin|simvastatin|mesh-list
110289053|NCT00242268|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110289054|NCT00242268|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110289055|NCT00242268|Antimetabolites|antimetabolites|mesh-ancestor
110289056|NCT00242268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110289057|NCT00242268|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110289058|NCT00242268|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110289059|NCT00242268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110289060|NCT00246363|Silymarin|silymarin|mesh-list
110289061|NCT00246363|Antioxidants|antioxidants|mesh-ancestor
110289062|NCT00246363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110289063|NCT00246363|Protective Agents|protective agents|mesh-ancestor
110289064|NCT00246363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289065|NCT04628533|Oxymetazoline|oxymetazoline|mesh-list
110289066|NCT04628533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110289067|NCT04628533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110289068|NCT04628533|Adrenergic Agents|adrenergic agents|mesh-ancestor
110289069|NCT04628533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110289070|NCT04628533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110289071|NCT04628533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289072|NCT04628533|Sympathomimetics|sympathomimetics|mesh-ancestor
110289073|NCT04628533|Autonomic Agents|autonomic agents|mesh-ancestor
110289074|NCT04628533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110289075|NCT04628533|Nasal Decongestants|nasal decongestants|mesh-ancestor
110289076|NCT04628533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110289077|NCT04628533|Respiratory System Agents|respiratory system agents|mesh-ancestor
110289078|NCT00246402|Acipimox|acipimox|mesh-list
110289079|NCT00246402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110289080|NCT00246402|Antimetabolites|antimetabolites|mesh-ancestor
110289081|NCT00246402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110289082|NCT00246402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110289083|NCT00561613|Spermatocidal Agents|spermatocidal agents|mesh-list
110289084|NCT00561613|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
110289085|NCT00561613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289086|NCT00561613|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110289087|NCT00561613|Contraceptive Agents|contraceptive agents|mesh-ancestor
110289088|NCT00561613|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110289090|NCT00561691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110289091|NCT00561691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110289092|NCT04628143|Nafamostat|nafamostat|mesh-list
110289093|NCT04628143|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110289094|NCT04628143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110289095|NCT04628143|Analgesics|analgesics|mesh-ancestor
110276902|NCT00177710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110276903|NCT00177710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110276904|NCT00177710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110276905|NCT00177710|Antifungal Agents|antifungal agents|mesh-ancestor
110276907|NCT00177749|Antifungal Agents|antifungal agents|mesh-ancestor
110276908|NCT00177749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110276909|NCT00177749|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110276910|NCT00177749|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110276911|NCT00177749|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110276912|NCT00177749|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110276913|NCT00177749|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110276914|NCT00177749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110276915|NCT00177749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276916|NCT00177749|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110276917|NCT00177749|Hormone Antagonists|hormone antagonists|mesh-ancestor
110276918|NCT00177749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110276919|NCT00177749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276920|NCT00205491|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110276921|NCT00205491|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110276922|NCT00205491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110289096|NCT04628143|Sensory System Agents|sensory system agents|mesh-ancestor
110019940|NCT00000750|Antiviral Agents|antiviral agents|mesh-ancestor
110289097|NCT04628143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110289098|NCT04628143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289099|NCT04628143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110289100|NCT04628143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110289101|NCT04628143|Anticoagulants|anticoagulants|mesh-ancestor
110289102|NCT04628143|Protease Inhibitors|protease inhibitors|mesh-ancestor
110289103|NCT04628143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110289104|NCT04628143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110289105|NCT04628143|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110289106|NCT04628143|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110289110|NCT00242346|Candesartan|candesartan|mesh-list
110289111|NCT00242346|Candesartan cilexetil|candesartan cilexetil|mesh-list
110289112|NCT00242346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110289113|NCT00242346|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110289114|NCT00242346|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110289115|NCT00242346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110289116|NCT00219245|Rivastigmine|rivastigmine|mesh-list
110289117|NCT00219245|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110289118|NCT00219245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110289119|NCT00219245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110289120|NCT00219245|Cholinergic Agents|cholinergic agents|mesh-ancestor
110289121|NCT00219245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110289122|NCT00219245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289123|NCT00219245|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110289124|NCT00219245|Protective Agents|protective agents|mesh-ancestor
110289125|NCT04627363|Bevacizumab|bevacizumab|mesh-list
110276923|NCT00205491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110276924|NCT00205491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276925|NCT00205491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110276926|NCT00205491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276927|NCT00205491|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110276928|NCT00205491|Antidepressive Agents|antidepressive agents|mesh-ancestor
110276930|NCT04654819|Anesthetics|anesthetics|mesh-list
110276931|NCT04654819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110276932|NCT04654819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289126|NCT04627363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110289127|NCT04627363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110289128|NCT04627363|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110289129|NCT04627363|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110289130|NCT04627363|Growth Substances|growth substances|mesh-ancestor
110289131|NCT04627363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289132|NCT04627363|Growth Inhibitors|growth inhibitors|mesh-ancestor
110289133|NCT00219323|Omalizumab|omalizumab|mesh-list
110289134|NCT00219323|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110289135|NCT00219323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110289136|NCT00219323|Respiratory System Agents|respiratory system agents|mesh-ancestor
110289137|NCT00246597|Epoetin Alfa|epoetin alfa|mesh-list
110289138|NCT00246597|Hematinics|hematinics|mesh-ancestor
110289139|NCT04626739|Cyclophosphamide|cyclophosphamide|mesh-list
110289140|NCT04626739|Fludarabine|fludarabine|mesh-list
110289141|NCT04626739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110289142|NCT04626739|Immunologic Factors|immunologic factors|mesh-ancestor
110289143|NCT04626739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289144|NCT04626739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110289145|NCT04626739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110289146|NCT04626739|Alkylating Agents|alkylating agents|mesh-ancestor
110289147|NCT04626739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110289148|NCT04626739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110289149|NCT04626739|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110289150|NCT00219401|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110289151|NCT00219401|Immunologic Factors|immunologic factors|mesh-ancestor
110289152|NCT00219401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289154|NCT04627129|Antifungal Agents|antifungal agents|mesh-ancestor
110289155|NCT04627129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110289156|NCT04627129|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110289157|NCT04627129|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110289158|NCT04627129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110289159|NCT04627129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110289160|NCT04627129|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110289161|NCT04627129|Hormone Antagonists|hormone antagonists|mesh-ancestor
110289162|NCT04627129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110289163|NCT04627129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289164|NCT04627129|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110289165|NCT00246636|Fenofibrate|fenofibrate|mesh-list
110289166|NCT00246636|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110289167|NCT00246636|Antimetabolites|antimetabolites|mesh-ancestor
110368784|NCT05125796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110020014|NCT00000894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110289168|NCT00246636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110289169|NCT00246636|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110289171|NCT00219440|Pioglitazone|pioglitazone|mesh-list
110289172|NCT00219440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110289173|NCT00219440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289174|NCT00246675|Furosemide|furosemide|mesh-list
110289175|NCT00246675|Diuretics|diuretics|mesh-ancestor
110289176|NCT00246675|Natriuretic Agents|natriuretic agents|mesh-ancestor
110276933|NCT04654741|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110276934|NCT04654741|Medroxyprogesterone|medroxyprogesterone|mesh-list
110276936|NCT04654741|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110276937|NCT04654741|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110289178|NCT00246675|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110289179|NCT00246675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110289180|NCT00246675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110289182|NCT00219479|Anticonvulsants|anticonvulsants|mesh-ancestor
110289183|NCT00219479|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110289184|NCT00219479|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110289185|NCT00219479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110289186|NCT00219479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110289187|NCT00219479|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110289188|NCT00219479|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110289189|NCT04626778|Hydrogen Peroxide|hydrogen peroxide|mesh-list
110289190|NCT04626778|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110289191|NCT04626778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110289192|NCT04626973|Ezetimibe|ezetimibe|mesh-list
110289193|NCT04626973|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
110289194|NCT04626973|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110289195|NCT04626973|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110289196|NCT04626973|Antimetabolites|antimetabolites|mesh-ancestor
110289197|NCT04626973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110289198|NCT04626973|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110289199|NCT04626973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110289200|NCT00242463|Nandrolone Decanoate|nandrolone decanoate|mesh-list
110289201|NCT00242463|Nandrolone|nandrolone|mesh-list
110289202|NCT00242463|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
110289203|NCT00242463|Anabolic Androgenic Steroids|anabolic androgenic steroids|mesh-list
110289204|NCT00242463|Androgens|androgens|mesh-ancestor
110289205|NCT00242463|Hormones|hormones|mesh-ancestor
110289206|NCT00242463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110289207|NCT00242463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289208|NCT00242463|Anabolic Agents|anabolic agents|mesh-ancestor
110289209|NCT00242463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110289210|NCT00242463|Performance-Enhancing Substances|performance-enhancing substances|mesh-ancestor
110289211|NCT00561886|Formoterol Fumarate|formoterol fumarate|mesh-list
110289212|NCT00561886|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110289213|NCT00561886|Autonomic Agents|autonomic agents|mesh-ancestor
110289214|NCT00561886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110289215|NCT00561886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289216|NCT00561886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110289217|NCT00561886|Respiratory System Agents|respiratory system agents|mesh-ancestor
110289218|NCT00561886|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110289219|NCT00561886|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110289220|NCT00561886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110289221|NCT00561886|Adrenergic Agents|adrenergic agents|mesh-ancestor
110289222|NCT00561886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110289223|NCT00561886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110289224|NCT00561964|Irbesartan|irbesartan|mesh-list
110289225|NCT00561964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110289226|NCT00561964|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110289227|NCT00561964|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110289228|NCT00561964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110289229|NCT00219596|Timolol|timolol|mesh-list
110289230|NCT00219596|Latanoprost|latanoprost|mesh-list
110289231|NCT00219596|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110289232|NCT00219596|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110289233|NCT00219596|Adrenergic Agents|adrenergic agents|mesh-ancestor
110289234|NCT00219596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110289235|NCT00219596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110289236|NCT00219596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289237|NCT00219596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110289238|NCT00219596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110020096|NCT00000924|Antimetabolites|antimetabolites|mesh-ancestor
110276938|NCT04654741|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110276939|NCT04654741|Contraceptive Agents|contraceptive agents|mesh-ancestor
110276940|NCT04654741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110276941|NCT04654741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276942|NCT04654741|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110276943|NCT04654741|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110276944|NCT04654741|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110276945|NCT04654741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110276946|NCT04654741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110276947|NCT04654741|Hormone Antagonists|hormone antagonists|mesh-ancestor
110276948|NCT04654741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110276949|NCT04654195|Cyclophosphamide|cyclophosphamide|mesh-list
110276950|NCT04654195|Doxorubicin|doxorubicin|mesh-list
110276951|NCT04654195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110276952|NCT04654195|Immunologic Factors|immunologic factors|mesh-ancestor
110276953|NCT04654195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276954|NCT04654195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110276955|NCT04654195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110276956|NCT04654195|Alkylating Agents|alkylating agents|mesh-ancestor
110276957|NCT04654195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276958|NCT04654195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110276959|NCT04654195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110276960|NCT04654195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110276961|NCT04654195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110289239|NCT00219596|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110289240|NCT00219596|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110289241|NCT04626193|Amoxicillin|amoxicillin|mesh-list
110289242|NCT04626193|Doxycycline|doxycycline|mesh-list
110289243|NCT04626193|Levofloxacin|levofloxacin|mesh-list
110289244|NCT04626193|Esomeprazole|esomeprazole|mesh-list
110289245|NCT04626193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110289246|NCT04626193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110289265|NCT04625608|Acetaminophen|acetaminophen|mesh-list
110289266|NCT04625608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110289267|NCT04625608|Analgesics|analgesics|mesh-ancestor
110289268|NCT04625608|Sensory System Agents|sensory system agents|mesh-ancestor
110289269|NCT04625608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110289270|NCT04625608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289271|NCT04625608|Antipyretics|antipyretics|mesh-ancestor
110289272|NCT00219713|Nitrous Oxide|nitrous oxide|mesh-list
110289273|NCT00219713|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110289274|NCT00219713|Anesthetics, General|anesthetics, general|mesh-ancestor
110289275|NCT00219713|Anesthetics|anesthetics|mesh-ancestor
110289276|NCT00219713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110289277|NCT00219713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289278|NCT00219713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110289279|NCT00219713|Analgesics|analgesics|mesh-ancestor
110289280|NCT00219713|Sensory System Agents|sensory system agents|mesh-ancestor
110289281|NCT00219713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110289282|NCT00219752|Imatinib Mesylate|imatinib mesylate|mesh-list
110276962|NCT04654195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110276963|NCT04654195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110276964|NCT00200616|Anti-Infective Agents|anti-infective agents|mesh-list
110276965|NCT00200616|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110276967|NCT03454789|Anesthetics, Local|anesthetics, local|mesh-ancestor
110276968|NCT03454789|Anesthetics|anesthetics|mesh-ancestor
110276969|NCT03454789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110276970|NCT03454789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276971|NCT03454789|Sensory System Agents|sensory system agents|mesh-ancestor
110276972|NCT03454789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110276973|NCT03454789|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110276974|NCT03454789|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110276975|NCT03454789|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110276976|NCT03454789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110289283|NCT00219752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110289284|NCT00219752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110289285|NCT00219752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110289286|NCT00219752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110289287|NCT00242697|Anesthetics|anesthetics|mesh-list
110289288|NCT00242697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110289289|NCT00242697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289290|NCT04625179|Melatonin|melatonin|mesh-list
110289291|NCT04625179|Hyaluronic Acid|hyaluronic acid|mesh-list
110289292|NCT04625179|Antioxidants|antioxidants|mesh-ancestor
110289293|NCT04625179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110289294|NCT04625179|Protective Agents|protective agents|mesh-ancestor
110289295|NCT04625179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289296|NCT04625179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110289297|NCT04625179|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110289298|NCT04625179|Immunologic Factors|immunologic factors|mesh-ancestor
110289299|NCT04625179|Viscosupplements|viscosupplements|mesh-ancestor
110289300|NCT02962232|Paclitaxel|paclitaxel|mesh-list
110289301|NCT02962232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110289302|NCT02962232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110289303|NCT02962232|Tubulin Modulators|tubulin modulators|mesh-ancestor
110289310|NCT00246909|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110289311|NCT00246909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110289312|NCT00246909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020169|NCT00000996|Doxorubicin|doxorubicin|mesh-list
110289313|NCT00219869|Galantamine|galantamine|mesh-list
110289314|NCT00219869|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110289315|NCT00219869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110289316|NCT00219869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110289317|NCT00219869|Cholinergic Agents|cholinergic agents|mesh-ancestor
110289318|NCT00219869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110289319|NCT00219869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289320|NCT00219869|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110289322|NCT00219869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110289323|NCT00219869|Nootropic Agents|nootropic agents|mesh-ancestor
110289324|NCT04624360|Dexamethasone|dexamethasone|mesh-list
110289325|NCT04624360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110289326|NCT04624360|Antiemetics|antiemetics|mesh-ancestor
110289327|NCT04624360|Autonomic Agents|autonomic agents|mesh-ancestor
110289328|NCT04624360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110289329|NCT04624360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276977|NCT03454789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276979|NCT00200655|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110276980|NCT00200655|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110276981|NCT00200655|Antimetabolites|antimetabolites|mesh-ancestor
110276982|NCT00200655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276983|NCT00200655|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110276984|NCT00200655|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110276985|NCT00200655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110276986|NCT04653493|Cyclophosphamide|cyclophosphamide|mesh-list
110289331|NCT04624360|Glucocorticoids|glucocorticoids|mesh-ancestor
110289332|NCT04624360|Hormones|hormones|mesh-ancestor
110289333|NCT04624360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110289334|NCT04624360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110289335|NCT04624360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110289336|NCT00219908|Mitoxantrone|mitoxantrone|mesh-list
110289337|NCT00219908|Analgesics|analgesics|mesh-ancestor
110289338|NCT00219908|Sensory System Agents|sensory system agents|mesh-ancestor
110289339|NCT00219908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110289340|NCT00219908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289341|NCT00219908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110289342|NCT00219908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110289343|NCT00219908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110289344|NCT00219908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110289345|NCT00219908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110289346|NCT00242736|Esomeprazole|esomeprazole|mesh-list
110289347|NCT00242736|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110289348|NCT00242736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110289349|NCT00242736|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110289350|NCT00242736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110289351|NCT00242736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110289352|NCT00242775|Fluticasone|fluticasone|mesh-list
110289353|NCT00242775|Budesonide|budesonide|mesh-list
110289354|NCT00242775|Formoterol Fumarate|formoterol fumarate|mesh-list
110289355|NCT00242775|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110289356|NCT00242775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110289357|NCT00242775|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110289358|NCT00242775|Autonomic Agents|autonomic agents|mesh-ancestor
110289359|NCT00242775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110289360|NCT00242775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289361|NCT00242775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110289362|NCT00242775|Respiratory System Agents|respiratory system agents|mesh-ancestor
110289363|NCT00242775|Dermatologic Agents|dermatologic agents|mesh-ancestor
110289364|NCT00242775|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110289365|NCT00242775|Glucocorticoids|glucocorticoids|mesh-ancestor
110289366|NCT00242775|Hormones|hormones|mesh-ancestor
110289367|NCT00242775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110289368|NCT00242775|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110289369|NCT00242775|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110289370|NCT00242775|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110289371|NCT00242775|Adrenergic Agents|adrenergic agents|mesh-ancestor
110289372|NCT00242775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110289381|NCT00562198|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110289382|NCT00562198|Entacapone|entacapone|mesh-list
110289383|NCT00562198|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110289384|NCT00562198|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110289385|NCT00562198|Dopamine Agents|dopamine agents|mesh-ancestor
110289386|NCT00562198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110289387|NCT00562198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020266|NCT00001296|Melphalan|melphalan|mesh-list
110289388|NCT00562198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289389|NCT00562198|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110289390|NCT00562198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110276988|NCT04653493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110276989|NCT04653493|Immunologic Factors|immunologic factors|mesh-ancestor
110276990|NCT04653493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276991|NCT04653493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110276992|NCT04653493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110276993|NCT04653493|Alkylating Agents|alkylating agents|mesh-ancestor
110276994|NCT04653493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276995|NCT04653493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110276996|NCT04653493|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110289391|NCT00562198|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110289392|NCT00562198|Immunologic Factors|immunologic factors|mesh-ancestor
110289393|NCT00562198|Dopamine Agonists|dopamine agonists|mesh-ancestor
110289394|NCT00562198|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
110289396|NCT00220064|Fluorouracil|fluorouracil|mesh-list
110289398|NCT00220064|Antimetabolites|antimetabolites|mesh-ancestor
110289399|NCT00220064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110289400|NCT00220064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110289401|NCT00220064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110289402|NCT00220064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110289403|NCT00220064|Immunologic Factors|immunologic factors|mesh-ancestor
110289404|NCT00220064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289405|NCT00220064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110289406|NCT00220064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110289407|NCT00220064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110289408|NCT00220064|Antidotes|antidotes|mesh-ancestor
110289409|NCT00220064|Protective Agents|protective agents|mesh-ancestor
110289410|NCT00220064|Vitamin B Complex|vitamin b complex|mesh-ancestor
110289411|NCT00220064|Vitamins|vitamins|mesh-ancestor
110289412|NCT00220064|Micronutrients|micronutrients|mesh-ancestor
110289413|NCT00220103|Capecitabine|capecitabine|mesh-list
110289414|NCT00220103|Epirubicin|epirubicin|mesh-list
110289415|NCT00220103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110289416|NCT00220103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110289417|NCT00220103|Antimetabolites|antimetabolites|mesh-ancestor
110289418|NCT00220103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110289419|NCT00220103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110289420|NCT00220103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110289421|NCT00220103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110289422|NCT00220103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110289423|NCT00247026|Ubiquinone|ubiquinone|mesh-list
110289424|NCT00247026|Coenzyme Q10|coenzyme q10|mesh-list
110289425|NCT00247026|Curcumin|curcumin|mesh-list
110289426|NCT00247026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110289427|NCT00247026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110289428|NCT00247026|Analgesics|analgesics|mesh-ancestor
110289429|NCT00247026|Sensory System Agents|sensory system agents|mesh-ancestor
110289430|NCT00247026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110289431|NCT00247026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289432|NCT00247026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110289433|NCT00247026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110289434|NCT00247026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110289435|NCT00247026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110289436|NCT00247026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110289437|NCT00247026|Micronutrients|micronutrients|mesh-ancestor
110289438|NCT00247026|Vitamins|vitamins|mesh-ancestor
110289439|NCT01580683|Ascorbic Acid|ascorbic acid|mesh-list
110289440|NCT01580683|Vitamins|vitamins|mesh-ancestor
110289441|NCT01580683|Micronutrients|micronutrients|mesh-ancestor
110289442|NCT01580683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289448|NCT00242814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110289449|NCT00242814|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110289450|NCT00242814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110289451|NCT00242814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276999|NCT00200694|Furosemide|furosemide|mesh-list
110277000|NCT00200694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110277001|NCT00200694|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110277002|NCT00200694|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110277003|NCT00200694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110277004|NCT00200694|Diuretics|diuretics|mesh-ancestor
110277005|NCT00200694|Natriuretic Agents|natriuretic agents|mesh-ancestor
110277006|NCT00200694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277007|NCT00200694|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110277008|NCT00200694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110277009|NCT00200694|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110277010|NCT00200694|Protease Inhibitors|protease inhibitors|mesh-ancestor
110277011|NCT00200694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110277012|NCT00557713|Bevacizumab|bevacizumab|mesh-list
110277013|NCT00557713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110277014|NCT00557713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110277015|NCT00557713|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110277016|NCT00557713|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110289452|NCT00242814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110289453|NCT00242814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289454|NCT00242814|Vasodilator Agents|vasodilator agents|mesh-ancestor
110289455|NCT00242814|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110289456|NCT00242814|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110289458|NCT04623385|Isotretinoin|isotretinoin|mesh-list
110289459|NCT04623385|Testosterone|testosterone|mesh-list
110289460|NCT04623385|Androgens|androgens|mesh-ancestor
110289461|NCT04623385|Hormones|hormones|mesh-ancestor
110289462|NCT04623385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110289463|NCT04623385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289464|NCT04623385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110289465|NCT04623385|Keratolytic Agents|keratolytic agents|mesh-ancestor
110289466|NCT04623385|Dermatologic Agents|dermatologic agents|mesh-ancestor
110289467|NCT00220220|Amlodipine|amlodipine|mesh-list
110289468|NCT00220220|Olmesartan|olmesartan|mesh-list
110289469|NCT00220220|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110289470|NCT00220220|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110289471|NCT00220220|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110289472|NCT00220220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110289473|NCT00220220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110289474|NCT00220220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110289475|NCT00220220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289476|NCT00220220|Vasodilator Agents|vasodilator agents|mesh-ancestor
110289477|NCT00220220|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110289478|NCT00220220|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110289479|NCT00242853|Nitric Oxide|nitric oxide|mesh-list
110289480|NCT00242853|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110289481|NCT00242853|Autonomic Agents|autonomic agents|mesh-ancestor
110289482|NCT00242853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110289483|NCT00242853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289484|NCT00242853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110277018|NCT00557713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277019|NCT00557713|Growth Inhibitors|growth inhibitors|mesh-ancestor
110277021|NCT00178100|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110277022|NCT00178100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110277023|NCT00178100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110277024|NCT00178100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110277025|NCT00178100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110277026|NCT00178100|Serotonin Agents|serotonin agents|mesh-ancestor
110277027|NCT00178100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277028|NCT00178100|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110277029|NCT00178100|Antidepressive Agents|antidepressive agents|mesh-ancestor
110277030|NCT00178100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110277031|NCT00178100|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110277032|NCT00178100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110277033|NCT00178100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110277034|NCT04653415|Methylprednisolone|methylprednisolone|mesh-list
110277035|NCT04653415|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110277036|NCT04653415|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110277037|NCT04653415|Prednisolone|prednisolone|mesh-list
110277038|NCT04653415|Prednisolone acetate|prednisolone acetate|mesh-list
110277039|NCT04653415|Gabapentin|gabapentin|mesh-list
110277040|NCT04653415|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110277041|NCT04653415|Prednisolone phosphate|prednisolone phosphate|mesh-list
110289485|NCT00242853|Respiratory System Agents|respiratory system agents|mesh-ancestor
110289486|NCT00242853|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110289487|NCT00242853|Antioxidants|antioxidants|mesh-ancestor
110289488|NCT00242853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110289489|NCT00242853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110289490|NCT00242853|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110289491|NCT00242853|Vasodilator Agents|vasodilator agents|mesh-ancestor
110289492|NCT00242853|Gasotransmitters|gasotransmitters|mesh-ancestor
110289493|NCT00242853|Protective Agents|protective agents|mesh-ancestor
110289494|NCT00220259|Fluticasone|fluticasone|mesh-list
110289495|NCT00220259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110289496|NCT00220259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110289497|NCT00220259|Autonomic Agents|autonomic agents|mesh-ancestor
110289498|NCT00220259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110289499|NCT00220259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289500|NCT00220259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110289501|NCT00220259|Respiratory System Agents|respiratory system agents|mesh-ancestor
110289502|NCT00220259|Dermatologic Agents|dermatologic agents|mesh-ancestor
110289503|NCT00220259|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110289504|NCT04622956|Methotrexate|methotrexate|mesh-list
110289505|NCT04622956|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110289506|NCT04622956|Abortifacient Agents|abortifacient agents|mesh-ancestor
110277042|NCT04653415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110277044|NCT04653415|Autonomic Agents|autonomic agents|mesh-ancestor
110277045|NCT04653415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110277046|NCT04653415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277047|NCT04653415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110277048|NCT04653415|Glucocorticoids|glucocorticoids|mesh-ancestor
110277050|NCT04653415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110277051|NCT04653415|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110277052|NCT04653415|Protective Agents|protective agents|mesh-ancestor
110277053|NCT04653415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110277054|NCT04653415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110277055|NCT04653415|Analgesics|analgesics|mesh-ancestor
110277056|NCT04653415|Sensory System Agents|sensory system agents|mesh-ancestor
110277057|NCT04653415|Anticonvulsants|anticonvulsants|mesh-ancestor
110277058|NCT04653415|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110277059|NCT04653415|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110277060|NCT04653415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110277061|NCT04653415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110277062|NCT04653415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110277063|NCT04653415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110277064|NCT04653415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110277065|NCT04653415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110277066|NCT04653415|Antimanic Agents|antimanic agents|mesh-ancestor
110277067|NCT00557791|Ranibizumab|ranibizumab|mesh-list
110289507|NCT04622956|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110289508|NCT04622956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289509|NCT04622956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110289510|NCT04622956|Antimetabolites|antimetabolites|mesh-ancestor
110289528|NCT04622488|Diclofenac|diclofenac|mesh-list
110289529|NCT04622488|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110289530|NCT04622488|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110289531|NCT04622488|Analgesics|analgesics|mesh-ancestor
110289532|NCT04622488|Sensory System Agents|sensory system agents|mesh-ancestor
110289533|NCT04622488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110289534|NCT04622488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289535|NCT04622488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110289536|NCT04622488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110289537|NCT04622488|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110289538|NCT04622488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110289539|NCT04622488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110289540|NCT00220298|Methyltestosterone|methyltestosterone|mesh-list
110289541|NCT00220298|Testosterone|testosterone|mesh-list
110289542|NCT00220298|Testosterone undecanoate|testosterone undecanoate|mesh-list
110289543|NCT00220298|Testosterone enanthate|testosterone enanthate|mesh-list
110289544|NCT00220298|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110289545|NCT00220298|Androgens|androgens|mesh-ancestor
110289546|NCT00220298|Hormones|hormones|mesh-ancestor
110277068|NCT00557791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110277069|NCT00557791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110277070|NCT00557791|Growth Substances|growth substances|mesh-ancestor
110277071|NCT00557791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277072|NCT00557791|Growth Inhibitors|growth inhibitors|mesh-ancestor
110277073|NCT00557791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110277074|NCT04652284|Amoxicillin|amoxicillin|mesh-list
110277075|NCT04652284|Clarithromycin|clarithromycin|mesh-list
110277076|NCT04652284|Rifabutin|rifabutin|mesh-list
110277077|NCT04652284|Tinidazole|tinidazole|mesh-list
110277078|NCT04652284|Esomeprazole|esomeprazole|mesh-list
110277079|NCT04652284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110289547|NCT00220298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110289548|NCT00220298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289549|NCT00220298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110289550|NCT00220298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110289551|NCT00220298|Anabolic Agents|anabolic agents|mesh-ancestor
110289552|NCT00412412|Trastuzumab|trastuzumab|mesh-list
110289553|NCT00412412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110289554|NCT00412412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110289555|NCT04621669|Metformin|metformin|mesh-list
110289556|NCT04621669|Digoxin|digoxin|mesh-list
110289557|NCT04621669|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110289558|NCT04621669|Calcium|calcium|mesh-list
110289559|NCT04621669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110289560|NCT04621669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289561|NCT04621669|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110289562|NCT04621669|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110289563|NCT04621669|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110289564|NCT04621669|Antimetabolites|antimetabolites|mesh-ancestor
110289565|NCT04621669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110289566|NCT04621669|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110289574|NCT00412646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110289575|NCT00412646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110289576|NCT00412646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110289577|NCT00412646|Antiviral Agents|antiviral agents|mesh-ancestor
110289578|NCT00412646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110289579|NCT00243009|Cyclosporine|cyclosporine|mesh-list
110289580|NCT00243009|Mycophenolic Acid|mycophenolic acid|mesh-list
110289581|NCT00243009|Fludarabine|fludarabine|mesh-list
110289582|NCT00243009|Fludarabine phosphate|fludarabine phosphate|mesh-list
110289583|NCT00243009|Cyclosporins|cyclosporins|mesh-list
110289584|NCT00243009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110289585|NCT00243009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110289586|NCT00243009|Antimetabolites|antimetabolites|mesh-ancestor
110289587|NCT00243009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110289588|NCT00243009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110289589|NCT00243009|Immunologic Factors|immunologic factors|mesh-ancestor
110289590|NCT00243009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289591|NCT00243009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110289592|NCT00243009|Antifungal Agents|antifungal agents|mesh-ancestor
110289593|NCT00243009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110289594|NCT00243009|Dermatologic Agents|dermatologic agents|mesh-ancestor
110289595|NCT00243009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110289596|NCT00243009|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110289597|NCT00243009|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110289598|NCT00243009|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110289599|NCT00243009|Antitubercular Agents|antitubercular agents|mesh-ancestor
110289600|NCT00243009|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110289601|NCT00562510|Raltegravir Potassium|raltegravir potassium|mesh-list
110289602|NCT00562510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110289603|NCT00562510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110289604|NCT00562510|Antiviral Agents|antiviral agents|mesh-ancestor
110289605|NCT00562510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110289606|NCT00562510|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110277080|NCT04652284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110277081|NCT04652284|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110277082|NCT04652284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110277083|NCT04652284|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110277084|NCT04652284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110277085|NCT04652284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110277086|NCT04652284|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110277087|NCT04652284|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110277088|NCT04652284|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110277089|NCT04652284|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110277090|NCT04652284|Antitubercular Agents|antitubercular agents|mesh-ancestor
110277091|NCT04652284|Alkylating Agents|alkylating agents|mesh-ancestor
110277092|NCT04652284|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
110277093|NCT04652284|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110277094|NCT04652284|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110277095|NCT04652323|Calcium|calcium|mesh-list
110277096|NCT04652323|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110277097|NCT04652323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277098|NCT04652011|Analgesics|analgesics|mesh-list
110277099|NCT04652011|Sensory System Agents|sensory system agents|mesh-ancestor
110277100|NCT04652011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110277101|NCT04652011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277102|NCT04652128|Zoledronic Acid|zoledronic acid|mesh-list
110289607|NCT00562510|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110289608|NCT00562510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110289609|NCT00562510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110289610|NCT04621513|Montelukast|montelukast|mesh-list
110289611|NCT04621513|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110289612|NCT04621513|Respiratory System Agents|respiratory system agents|mesh-ancestor
110289613|NCT04621513|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110289614|NCT04621513|Hormone Antagonists|hormone antagonists|mesh-ancestor
110289615|NCT04621513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110289616|NCT04621513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289617|NCT04621513|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110289618|NCT04621513|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110289619|NCT04621513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110289621|NCT00220454|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110289622|NCT00220454|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110289623|NCT00220454|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110289624|NCT00220454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110289625|NCT00562705|Hormones|hormones|mesh-list
110289626|NCT00562705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110289627|NCT00562705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289628|NCT04620967|Insulin|insulin|mesh-list
110289629|NCT04620967|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110289630|NCT04620967|Insulin Aspart|insulin aspart|mesh-list
110289631|NCT04620967|Insulin, Long-Acting|insulin, long-acting|mesh-list
110289632|NCT04620967|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110289633|NCT04620967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110277103|NCT04652128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110277104|NCT04652128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277106|NCT00205725|Ziprasidone|ziprasidone|mesh-list
110277107|NCT00205725|Antiemetics|antiemetics|mesh-ancestor
110277108|NCT00205725|Autonomic Agents|autonomic agents|mesh-ancestor
110277109|NCT00205725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110277110|NCT00205725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277111|NCT00205725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110277112|NCT00205725|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110277113|NCT00205725|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110277114|NCT00205725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110277115|NCT00205725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110277116|NCT00205725|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110277117|NCT00205725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110277118|NCT00205725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110277119|NCT00205725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110277120|NCT00205725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110277121|NCT00205725|Serotonin Agents|serotonin agents|mesh-ancestor
110277122|NCT00205725|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110289634|NCT04620967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289636|NCT00220493|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110289637|NCT00220493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289638|NCT00220493|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110289639|NCT00220493|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110289640|NCT00220493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110289641|NCT00220493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110289642|NCT00220493|Dopamine Agents|dopamine agents|mesh-ancestor
110289643|NCT00220493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110289644|NCT04620616|Menthol|menthol|mesh-list
110289645|NCT04620616|Antipruritics|antipruritics|mesh-ancestor
110289646|NCT04620616|Dermatologic Agents|dermatologic agents|mesh-ancestor
110289647|NCT00220532|Folic Acid|folic acid|mesh-list
110289648|NCT00220532|Riboflavin|riboflavin|mesh-list
110289649|NCT00220532|Hematinics|hematinics|mesh-ancestor
110289650|NCT00220532|Vitamin B Complex|vitamin b complex|mesh-ancestor
110289651|NCT00220532|Vitamins|vitamins|mesh-ancestor
110289652|NCT00220532|Micronutrients|micronutrients|mesh-ancestor
110289653|NCT00220532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289654|NCT00220532|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110289655|NCT00220532|Dermatologic Agents|dermatologic agents|mesh-ancestor
110289656|NCT04620772|Cyclophosphamide|cyclophosphamide|mesh-list
110289657|NCT04620772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110289658|NCT04620772|Immunologic Factors|immunologic factors|mesh-ancestor
110289659|NCT04620772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289660|NCT04620772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110289661|NCT04620772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110289662|NCT04620772|Alkylating Agents|alkylating agents|mesh-ancestor
110289663|NCT04620772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110289664|NCT04620772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110289665|NCT04620772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110289666|NCT00243204|Docetaxel|docetaxel|mesh-list
110277123|NCT00205725|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110277124|NCT00205725|Dopamine Agents|dopamine agents|mesh-ancestor
110277125|NCT00178373|Modafinil|modafinil|mesh-list
110277126|NCT00178373|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110277127|NCT00178373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277128|NCT00178373|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110277129|NCT00178373|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110277130|NCT00178373|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110277131|NCT00178373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110277133|NCT00205764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110277134|NCT00205764|Alkylating Agents|alkylating agents|mesh-ancestor
110277135|NCT00205764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110277136|NCT00205764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110277137|NCT00205764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110277138|NCT00205764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110277139|NCT00205764|Immunologic Factors|immunologic factors|mesh-ancestor
110277140|NCT00205764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277141|NCT00558142|Acetylcysteine|acetylcysteine|mesh-list
110277142|NCT00558142|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110277143|NCT00558142|Antiviral Agents|antiviral agents|mesh-ancestor
110289668|NCT00243204|Tubulin Modulators|tubulin modulators|mesh-ancestor
110289669|NCT00243204|Antimitotic Agents|antimitotic agents|mesh-ancestor
110289670|NCT00243204|Mitosis Modulators|mitosis modulators|mesh-ancestor
110289671|NCT00243204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110289672|NCT04620577|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110289673|NCT04620577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110289674|NCT04620031|Propofol|propofol|mesh-list
110289675|NCT04620031|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110289676|NCT04620031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110289677|NCT04620031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289678|NCT04620031|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110289679|NCT04620031|Anesthetics, General|anesthetics, general|mesh-ancestor
110289680|NCT04620031|Anesthetics|anesthetics|mesh-ancestor
110289681|NCT04620109|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110289682|NCT04620109|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110289683|NCT00220649|Leucovorin|leucovorin|mesh-list
110289684|NCT00220649|Gemcitabine|gemcitabine|mesh-list
110289685|NCT00220649|Fluorouracil|fluorouracil|mesh-list
110289686|NCT00220649|Oxaliplatin|oxaliplatin|mesh-list
110289687|NCT00220649|Irinotecan|irinotecan|mesh-list
110289688|NCT00220649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110289690|NCT00220649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110289691|NCT00220649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110289692|NCT00220649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110277149|NCT00558142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110277150|NCT00558142|Protective Agents|protective agents|mesh-ancestor
110277151|NCT00558142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277152|NCT00558142|Antidotes|antidotes|mesh-ancestor
110277153|NCT00205842|Alvimopan|alvimopan|mesh-list
110277154|NCT00205842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110277155|NCT00178451|Abciximab|abciximab|mesh-list
110277156|NCT00178451|Anticoagulants|anticoagulants|mesh-ancestor
110277157|NCT00178451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110277158|NCT00206115|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110277159|NCT00206115|Antidepressive Agents|antidepressive agents|mesh-ancestor
110277160|NCT00206115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110289693|NCT00220649|Immunologic Factors|immunologic factors|mesh-ancestor
110289694|NCT00220649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289695|NCT00220649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110289696|NCT00220649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110289697|NCT00220649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110289698|NCT00220649|Antidotes|antidotes|mesh-ancestor
110289699|NCT00220649|Protective Agents|protective agents|mesh-ancestor
110289700|NCT00220649|Vitamin B Complex|vitamin b complex|mesh-ancestor
110289701|NCT00220649|Vitamins|vitamins|mesh-ancestor
110289702|NCT00220649|Micronutrients|micronutrients|mesh-ancestor
110289703|NCT04619758|Emollients|emollients|mesh-list
110289704|NCT04619758|Dermatologic Agents|dermatologic agents|mesh-ancestor
110289705|NCT04619914|Letrozole|letrozole|mesh-list
110289706|NCT04619914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110289707|NCT04619914|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110289708|NCT04619914|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110289709|NCT04619914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110289710|NCT04619914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110289711|NCT04619914|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110289715|NCT00220766|Immunoglobulins|immunoglobulins|mesh-list
110289716|NCT00220766|Antibodies|antibodies|mesh-list
110289717|NCT00220766|gamma-Globulins|gamma-globulins|mesh-list
110289718|NCT00220766|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110289719|NCT00220766|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110289720|NCT00220766|Immunoglobulin G|immunoglobulin g|mesh-list
110289721|NCT00220766|Immunologic Factors|immunologic factors|mesh-ancestor
110289722|NCT00220766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289723|NCT04619875|Lactulose|lactulose|mesh-list
110289724|NCT04619875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110289725|NCT04619290|Methylene Blue|methylene blue|mesh-list
110289726|NCT04619290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110289727|NCT04619290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110289728|NCT04619563|Docetaxel|docetaxel|mesh-list
110289729|NCT04619563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110289730|NCT04619563|Tubulin Modulators|tubulin modulators|mesh-ancestor
110289731|NCT04619563|Antimitotic Agents|antimitotic agents|mesh-ancestor
110289732|NCT04619563|Mitosis Modulators|mitosis modulators|mesh-ancestor
110289733|NCT04619563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110289734|NCT00220844|Amitriptyline|amitriptyline|mesh-list
110289735|NCT00220844|Desipramine|desipramine|mesh-list
110289736|NCT00220844|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110289737|NCT00220844|Antidepressive Agents|antidepressive agents|mesh-ancestor
110289738|NCT00220844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110289739|NCT00220844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110289740|NCT00220844|Analgesics|analgesics|mesh-ancestor
110289741|NCT00220844|Sensory System Agents|sensory system agents|mesh-ancestor
110289742|NCT00220844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110289743|NCT00220844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289744|NCT00220844|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110289745|NCT00220844|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110289746|NCT00220844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110289747|NCT00220844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110277161|NCT00206115|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110277162|NCT00206115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110277163|NCT00206115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110277164|NCT00206115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277165|NCT00206154|Budesonide|budesonide|mesh-list
110277166|NCT00206154|Formoterol Fumarate|formoterol fumarate|mesh-list
110277167|NCT00206154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110277168|NCT00206154|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110277169|NCT00206154|Autonomic Agents|autonomic agents|mesh-ancestor
110277170|NCT00206154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110277171|NCT00206154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277172|NCT00206154|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110277173|NCT00206154|Respiratory System Agents|respiratory system agents|mesh-ancestor
110277174|NCT00206154|Glucocorticoids|glucocorticoids|mesh-ancestor
110277175|NCT00206154|Hormones|hormones|mesh-ancestor
110277176|NCT00206154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110277177|NCT00206154|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110277178|NCT00206154|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110277179|NCT00206154|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110277180|NCT00206154|Adrenergic Agents|adrenergic agents|mesh-ancestor
110277181|NCT00206154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110277182|NCT00206154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110277183|NCT00559702|Natalizumab|natalizumab|mesh-list
110277184|NCT00559702|Immunologic Factors|immunologic factors|mesh-ancestor
110277185|NCT00559702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277186|NCT00559741|Leucovorin|leucovorin|mesh-list
110289748|NCT00220844|Adrenergic Agents|adrenergic agents|mesh-ancestor
110289749|NCT00220844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110289750|NCT00220844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110289751|NCT00247494|Mycophenolic Acid|mycophenolic acid|mesh-list
110289752|NCT00247494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110289753|NCT00247494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110289754|NCT00247494|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110289755|NCT00247494|Antitubercular Agents|antitubercular agents|mesh-ancestor
110289757|NCT00247494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110289758|NCT00247494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110289759|NCT00247494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110289760|NCT04619251|Itraconazole|itraconazole|mesh-list
110289761|NCT04619251|Antifungal Agents|antifungal agents|mesh-ancestor
110289762|NCT04619251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110289763|NCT04619251|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110289764|NCT04619251|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110289765|NCT04619251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110289766|NCT04619251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110289767|NCT04619251|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110289768|NCT04619251|Hormone Antagonists|hormone antagonists|mesh-ancestor
110277187|NCT00559741|Fluorouracil|fluorouracil|mesh-list
110277188|NCT00559741|Irinotecan|irinotecan|mesh-list
110277189|NCT00559741|Cetuximab|cetuximab|mesh-list
110277190|NCT00559741|Calcium|calcium|mesh-list
110277191|NCT00559741|Levoleucovorin|levoleucovorin|mesh-list
110277192|NCT00559741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110277193|NCT00559741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277194|NCT00559741|Antimetabolites|antimetabolites|mesh-ancestor
110277195|NCT00559741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110277196|NCT00559741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110277197|NCT00559741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110289769|NCT04619251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110289770|NCT04619251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289771|NCT04619251|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110289772|NCT00243399|Oxandrolone|oxandrolone|mesh-list
110289773|NCT00243399|Androgens|androgens|mesh-ancestor
110289774|NCT00243399|Hormones|hormones|mesh-ancestor
110289775|NCT00243399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110289776|NCT00243399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289777|NCT00243399|Anabolic Agents|anabolic agents|mesh-ancestor
110289778|NCT00220922|Ethanol|ethanol|mesh-list
110289779|NCT00220922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110289780|NCT00220922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110289781|NCT00220922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110289786|NCT00243477|Escitalopram|escitalopram|mesh-list
110289787|NCT00243477|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110289788|NCT00243477|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110289789|NCT00243477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110289790|NCT00243477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110289791|NCT00243477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110289792|NCT00243477|Serotonin Agents|serotonin agents|mesh-ancestor
110289793|NCT00243477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289794|NCT00221039|Methoxsalen|methoxsalen|mesh-list
110289795|NCT00221039|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110289796|NCT00221039|Dermatologic Agents|dermatologic agents|mesh-ancestor
110289797|NCT00562939|Vaccines|vaccines|mesh-list
110289798|NCT00562939|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110289799|NCT00562939|Immunologic Factors|immunologic factors|mesh-ancestor
110289800|NCT00562939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289801|NCT00221156|Acarbose|acarbose|mesh-list
110289802|NCT00221156|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110289803|NCT00221156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110289804|NCT00221156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110289805|NCT00221156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110289806|NCT00221156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289807|NCT04617613|Amoxicillin|amoxicillin|mesh-list
110289809|NCT04617613|Clarithromycin|clarithromycin|mesh-list
110289810|NCT04617613|Omeprazole|omeprazole|mesh-list
110289811|NCT04617613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110289812|NCT04617613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110289813|NCT04617613|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110289814|NCT04617613|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110289815|NCT04617613|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110289816|NCT04617613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110289817|NCT04617613|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110289818|NCT04617613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110289819|NCT04617613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110289820|NCT04617613|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110289821|NCT04617613|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110289822|NCT04617613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110289823|NCT04617652|Magnesium Sulfate|magnesium sulfate|mesh-list
110289824|NCT04617652|Analgesics|analgesics|mesh-ancestor
110289825|NCT04617652|Sensory System Agents|sensory system agents|mesh-ancestor
110277198|NCT00559741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110277199|NCT00559741|Immunologic Factors|immunologic factors|mesh-ancestor
110277200|NCT00559741|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110277201|NCT00559741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110277202|NCT00559741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110277204|NCT00559741|Protective Agents|protective agents|mesh-ancestor
110277205|NCT00559741|Vitamin B Complex|vitamin b complex|mesh-ancestor
110277206|NCT00559741|Vitamins|vitamins|mesh-ancestor
110289826|NCT04617652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110289827|NCT04617652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289828|NCT04617652|Anesthetics|anesthetics|mesh-ancestor
110289829|NCT04617652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110289830|NCT04617652|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110289831|NCT04617652|Anticonvulsants|anticonvulsants|mesh-ancestor
110289832|NCT04617652|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110289833|NCT04617652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110289834|NCT04617652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110289835|NCT04617652|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110289836|NCT04617652|Tocolytic Agents|tocolytic agents|mesh-ancestor
110289837|NCT04617652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110289838|NCT00247572|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
110289839|NCT00247572|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110289840|NCT00247572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289841|NCT00247572|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110289842|NCT00247572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110289843|NCT00247572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110289844|NCT00247572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110289845|NCT00247572|Dopamine Agents|dopamine agents|mesh-ancestor
110289846|NCT00247572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110289847|NCT00221312|Alendronate|alendronate|mesh-list
110289851|NCT04616872|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110289852|NCT04616872|Abortifacient Agents|abortifacient agents|mesh-ancestor
110289853|NCT04616872|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110289854|NCT04616872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289855|NCT04616872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110289856|NCT04616872|Antimetabolites|antimetabolites|mesh-ancestor
110289857|NCT04616872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110289858|NCT04616872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110289859|NCT04616872|Dermatologic Agents|dermatologic agents|mesh-ancestor
110289860|NCT04616872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110289861|NCT04616872|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110289862|NCT04616872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110289863|NCT04616872|Immunologic Factors|immunologic factors|mesh-ancestor
110289864|NCT04616872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110289865|NCT04616872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110289866|NCT00221390|Ropinirole|ropinirole|mesh-list
110289867|NCT00221390|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110289868|NCT00221390|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110289869|NCT00221390|Dopamine Agonists|dopamine agonists|mesh-ancestor
110289870|NCT00221390|Dopamine Agents|dopamine agents|mesh-ancestor
110289871|NCT00221390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110289872|NCT00221390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110289873|NCT00221390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289874|NCT00247650|Zoledronic Acid|zoledronic acid|mesh-list
110289875|NCT00247650|Letrozole|letrozole|mesh-list
110289876|NCT00247650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110289877|NCT00247650|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110289878|NCT00247650|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110289879|NCT00247650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110289880|NCT00247650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110289881|NCT00247650|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110277207|NCT00559741|Micronutrients|micronutrients|mesh-ancestor
110277208|NCT00559741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110277209|NCT00178763|Interferons|interferons|mesh-list
110277210|NCT00178763|Interferon-alpha|interferon-alpha|mesh-list
110277211|NCT00178763|Cisplatin|cisplatin|mesh-list
110277212|NCT00178763|Gemcitabine|gemcitabine|mesh-list
110277213|NCT00178763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110277214|NCT00178763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110277215|NCT00178763|Antimetabolites|antimetabolites|mesh-ancestor
110277216|NCT00178763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110277217|NCT00178763|Antiviral Agents|antiviral agents|mesh-ancestor
110277218|NCT00178763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110277219|NCT00178763|Immunologic Factors|immunologic factors|mesh-ancestor
110277220|NCT00178763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277221|NCT00559858|Pyridoxine|pyridoxine|mesh-list
110277222|NCT00559858|Vitamin B 6|vitamin b 6|mesh-list
110277223|NCT00559858|Vitamin B Complex|vitamin b complex|mesh-ancestor
110277224|NCT00559858|Vitamins|vitamins|mesh-ancestor
110289882|NCT00247650|Hormone Antagonists|hormone antagonists|mesh-ancestor
110289883|NCT00247650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110289884|NCT00247650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289885|NCT00247650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110289886|NCT00221429|Valproic Acid|valproic acid|mesh-list
110289887|NCT00221429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110289888|NCT00221429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110289889|NCT00221429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110289890|NCT00221429|Antimanic Agents|antimanic agents|mesh-ancestor
110289891|NCT00221429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110289892|NCT00221429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110289893|NCT00221429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289894|NCT00221429|Anticonvulsants|anticonvulsants|mesh-ancestor
110289895|NCT00221429|GABA Agents|gaba agents|mesh-ancestor
110289896|NCT00221429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110289897|NCT00563017|Risperidone|risperidone|mesh-list
110289898|NCT00563017|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110289899|NCT00563017|Serotonin Agents|serotonin agents|mesh-ancestor
110289900|NCT00563017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110289901|NCT00563017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110289902|NCT00563017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289903|NCT00563017|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110289904|NCT00563017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110289905|NCT00563017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110289906|NCT00563017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110289907|NCT00563017|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110289908|NCT00563017|Dopamine Agents|dopamine agents|mesh-ancestor
110289909|NCT00563056|Fluticasone|fluticasone|mesh-list
110289910|NCT00563056|Formoterol Fumarate|formoterol fumarate|mesh-list
110289911|NCT00563056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110289912|NCT00563056|Autonomic Agents|autonomic agents|mesh-ancestor
110289913|NCT00563056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110289914|NCT00563056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289915|NCT00563056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110289918|NCT00563056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110289919|NCT00563056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110289920|NCT00563056|Adrenergic Agents|adrenergic agents|mesh-ancestor
110277225|NCT00559858|Micronutrients|micronutrients|mesh-ancestor
110277226|NCT00559858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277227|NCT00559975|Vaccines|vaccines|mesh-list
110277228|NCT00559975|Immunologic Factors|immunologic factors|mesh-ancestor
110277229|NCT00559975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277230|NCT00206193|Misoprostol|misoprostol|mesh-list
110277231|NCT00206193|Sulprostone|sulprostone|mesh-list
110277232|NCT00206193|Mifepristone|mifepristone|mesh-list
110277233|NCT00206193|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110277234|NCT00206193|Abortifacient Agents|abortifacient agents|mesh-ancestor
110277235|NCT00206193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110277236|NCT00206193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277237|NCT00206193|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110289921|NCT00563056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110289922|NCT00563056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110289923|NCT00563056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110289924|NCT00563056|Dermatologic Agents|dermatologic agents|mesh-ancestor
110289925|NCT00563056|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110289926|NCT00563095|Interferons|interferons|mesh-list
110289927|NCT00563095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110289928|NCT00563095|Antiviral Agents|antiviral agents|mesh-ancestor
110289929|NCT00563095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110289930|NCT00221468|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110289931|NCT00221468|Antidepressive Agents|antidepressive agents|mesh-ancestor
110289932|NCT00221468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110289933|NCT00221468|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110289934|NCT00221468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110289935|NCT00221468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110289936|NCT00221468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289937|NCT00563212|Interferons|interferons|mesh-list
110289938|NCT00563212|Interferon-gamma|interferon-gamma|mesh-list
110289939|NCT00563212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110289940|NCT00563212|Antiviral Agents|antiviral agents|mesh-ancestor
110289941|NCT00563212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110289942|NCT00563251|Azithromycin|azithromycin|mesh-list
110289943|NCT00563251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110289944|NCT00563251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110289945|NCT00251082|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110289946|NCT00251082|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110289947|NCT00251082|Estradiol|estradiol|mesh-list
110289948|NCT00251082|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110289949|NCT00251082|Dydrogesterone|dydrogesterone|mesh-list
110289950|NCT00251082|Estrogens|estrogens|mesh-ancestor
110289951|NCT00251082|Hormones|hormones|mesh-ancestor
110289952|NCT00251082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110289953|NCT00251082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289954|NCT00251082|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110289955|NCT00251082|Contraceptive Agents|contraceptive agents|mesh-ancestor
110289956|NCT00251082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110289957|NCT00251082|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110289958|NCT00251082|Progestins|progestins|mesh-ancestor
110289959|NCT00221624|Ribavirin|ribavirin|mesh-list
110289960|NCT00221624|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110289961|NCT00221624|Amantadine|amantadine|mesh-list
110289962|NCT00221624|Antimetabolites|antimetabolites|mesh-ancestor
110289963|NCT00221624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110289965|NCT00221624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110289966|NCT00221624|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110289967|NCT00221624|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110289968|NCT00221624|Dopamine Agents|dopamine agents|mesh-ancestor
110289969|NCT00221624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110289970|NCT00221624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289971|NCT00221624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110289972|NCT00221624|Analgesics|analgesics|mesh-ancestor
110277238|NCT00206193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110277239|NCT00206193|Oxytocics|oxytocics|mesh-ancestor
110277240|NCT00206193|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110277241|NCT00206193|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110277242|NCT00206193|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110277243|NCT00206193|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110277244|NCT00206193|Contraceptive Agents|contraceptive agents|mesh-ancestor
110277245|NCT00206193|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110277246|NCT00206193|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110277247|NCT00206193|Hormone Antagonists|hormone antagonists|mesh-ancestor
110289973|NCT00221624|Sensory System Agents|sensory system agents|mesh-ancestor
110289974|NCT00221624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110289975|NCT04720092|Rivaroxaban|rivaroxaban|mesh-list
110289976|NCT04720092|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110289977|NCT04720092|Antithrombins|antithrombins|mesh-ancestor
110289978|NCT04720092|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110289979|NCT04720092|Protease Inhibitors|protease inhibitors|mesh-ancestor
110289980|NCT04720092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110289981|NCT04720092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110289982|NCT04720092|Anticoagulants|anticoagulants|mesh-ancestor
110289983|NCT00221702|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110289984|NCT00221702|Antiviral Agents|antiviral agents|mesh-ancestor
110289985|NCT00221702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110289986|NCT04615702|Acetaminophen|acetaminophen|mesh-list
110289987|NCT04615702|Metronidazole|metronidazole|mesh-list
110289988|NCT04615702|Ciprofloxacin|ciprofloxacin|mesh-list
110289989|NCT04615702|Imipenem|imipenem|mesh-list
110289990|NCT04615702|Diclofenac|diclofenac|mesh-list
110289991|NCT04615702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
110289998|NCT04615702|Sensory System Agents|sensory system agents|mesh-ancestor
110289999|NCT04615702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110290000|NCT04615702|Antipyretics|antipyretics|mesh-ancestor
110290001|NCT04615702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110290002|NCT04615702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110290003|NCT04615702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110290004|NCT04615702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110290005|NCT04615702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110290006|NCT04615702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110290007|NCT04615702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110290008|NCT04615702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110290009|NCT04615702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290010|NCT04615702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110290011|NCT04615702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110290012|NCT04615702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110290013|NCT04615702|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110290014|NCT04615702|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110290015|NCT04615702|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110290016|NCT04615702|Narcotics|narcotics|mesh-ancestor
110290017|NCT04615702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110290018|NCT04615702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110290020|NCT04615702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110290022|NCT04615702|Protective Agents|protective agents|mesh-ancestor
110290023|NCT04615351|Metformin|metformin|mesh-list
110290024|NCT04615351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110290025|NCT04615351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110290026|NCT04615156|Deoxyglucose|deoxyglucose|mesh-list
110290027|NCT04615156|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110290028|NCT04615156|Antimetabolites|antimetabolites|mesh-ancestor
110290029|NCT04615156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110277248|NCT00206193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110277249|NCT00206193|Luteolytic Agents|luteolytic agents|mesh-ancestor
110277250|NCT00206193|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110277251|NCT00206193|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110277252|NCT04638439|Entecavir|entecavir|mesh-list
110277253|NCT04638439|Nivolumab|nivolumab|mesh-list
110277254|NCT04638439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110277255|NCT04638439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110277256|NCT04638439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110277257|NCT04638439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290030|NCT04615156|Antiviral Agents|antiviral agents|mesh-ancestor
110290031|NCT04615156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110290032|NCT04615156|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110290033|NCT04614727|Calcium|calcium|mesh-list
110290034|NCT04614727|Fluorides|fluorides|mesh-list
110290035|NCT04614727|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110290036|NCT04614727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110290037|NCT04614727|Cariostatic Agents|cariostatic agents|mesh-ancestor
110290038|NCT04614727|Protective Agents|protective agents|mesh-ancestor
110290039|NCT04614298|Brodalumab|brodalumab|mesh-list
110290040|NCT04614298|Dermatologic Agents|dermatologic agents|mesh-ancestor
110290041|NCT04614259|Bupivacaine|bupivacaine|mesh-list
110290042|NCT04614259|Anesthetics, Local|anesthetics, local|mesh-ancestor
110290043|NCT04614259|Anesthetics|anesthetics|mesh-ancestor
110290044|NCT04614259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110290045|NCT04614259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110290046|NCT04614259|Sensory System Agents|sensory system agents|mesh-ancestor
110290047|NCT04614259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110290048|NCT00412763|Silymarin|silymarin|mesh-list
110290049|NCT00412763|Antioxidants|antioxidants|mesh-ancestor
110290050|NCT00412763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290051|NCT00412763|Protective Agents|protective agents|mesh-ancestor
110290052|NCT00412763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110290053|NCT00563446|Darbepoetin alfa|darbepoetin alfa|mesh-list
110290054|NCT00563446|Hematinics|hematinics|mesh-ancestor
110290055|NCT00563485|Doxazosin|doxazosin|mesh-list
110290056|NCT00563485|Terazosin|terazosin|mesh-list
110290057|NCT00563485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110290058|NCT00563485|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110290059|NCT00563485|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110290060|NCT00563485|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110290061|NCT00563485|Adrenergic Agents|adrenergic agents|mesh-ancestor
110290062|NCT00563485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110290074|NCT00412802|Anticoagulants|anticoagulants|mesh-ancestor
110290075|NCT00412802|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110290076|NCT00412802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110290077|NCT00412802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290079|NCT00563524|Dermatologic Agents|dermatologic agents|mesh-ancestor
110290080|NCT04613869|Hydromorphone|hydromorphone|mesh-list
110290082|NCT04613869|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110290083|NCT04613869|Narcotics|narcotics|mesh-ancestor
110290084|NCT04613869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110290085|NCT04613869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110290086|NCT04613869|Analgesics|analgesics|mesh-ancestor
110290087|NCT04613869|Sensory System Agents|sensory system agents|mesh-ancestor
110290088|NCT04613869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110290089|NCT04613869|Antidepressive Agents|antidepressive agents|mesh-ancestor
110290090|NCT04613869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110290091|NCT00251355|Gemcitabine|gemcitabine|mesh-list
110290092|NCT00251355|Fluorouracil|fluorouracil|mesh-list
110290093|NCT00251355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110290094|NCT00251355|Antimetabolites|antimetabolites|mesh-ancestor
110290095|NCT00251355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290096|NCT00251355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110277258|NCT04638439|Antiviral Agents|antiviral agents|mesh-ancestor
110277259|NCT04638439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110277260|NCT00178802|Interferons|interferons|mesh-list
110277261|NCT00178802|Doxorubicin|doxorubicin|mesh-list
110277262|NCT00178802|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110277263|NCT00178802|Fluorouracil|fluorouracil|mesh-list
110277264|NCT00178802|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110277265|NCT00178802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110277266|NCT00178802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110277267|NCT00178802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110277268|NCT00178802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110277269|NCT00178802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110277270|NCT00178802|Antimetabolites|antimetabolites|mesh-ancestor
110290097|NCT00251355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110290098|NCT00251355|Immunologic Factors|immunologic factors|mesh-ancestor
110290099|NCT00251355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110290100|NCT02962388|Anagrelide|anagrelide|mesh-list
110290101|NCT02962388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110290102|NCT02962388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110290103|NCT02962388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290104|NCT02962388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110290105|NCT04613167|Evolocumab|evolocumab|mesh-list
110290106|NCT04613167|Alirocumab|alirocumab|mesh-list
110290107|NCT04613167|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110290108|NCT04613167|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110290109|NCT04613167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110290110|NCT04613167|Antimetabolites|antimetabolites|mesh-ancestor
110290111|NCT04613167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290112|NCT04613167|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110290113|NCT04613167|Protease Inhibitors|protease inhibitors|mesh-ancestor
110290114|NCT04613167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110290115|NCT04613167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110290116|NCT04613284|Durvalumab|durvalumab|mesh-list
110290117|NCT04613284|Endostar protein|endostar protein|mesh-list
110290118|NCT04613284|Endostatins|endostatins|mesh-list
110290119|NCT04613284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110290120|NCT04613284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110290121|NCT04613284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110290122|NCT04613284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110290123|NCT04613284|Growth Substances|growth substances|mesh-ancestor
110290124|NCT04613284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110290125|NCT04613284|Growth Inhibitors|growth inhibitors|mesh-ancestor
110290126|NCT00563641|Pulmonary Surfactants|pulmonary surfactants|mesh-list
110290127|NCT00563641|Respiratory System Agents|respiratory system agents|mesh-ancestor
110290128|NCT00248118|Bupropion|bupropion|mesh-list
110290143|NCT04612894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110290144|NCT04612894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110290145|NCT04612894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110290146|NCT04612894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290147|NCT00251394|Rituximab|rituximab|mesh-list
110290148|NCT00251394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110290149|NCT00251394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110290150|NCT00251394|Immunologic Factors|immunologic factors|mesh-ancestor
110290151|NCT00251394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110290152|NCT00251394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110290153|NCT00221975|Lamotrigine|lamotrigine|mesh-list
110290154|NCT00221975|Valproic Acid|valproic acid|mesh-list
110290155|NCT00221975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110290156|NCT00221975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110290157|NCT00221975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290158|NCT00221975|Antimanic Agents|antimanic agents|mesh-ancestor
110290159|NCT00221975|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110277271|NCT00178802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110277272|NCT00178802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110277273|NCT00178802|Immunologic Factors|immunologic factors|mesh-ancestor
110277274|NCT00178802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277275|NCT00178802|Antiviral Agents|antiviral agents|mesh-ancestor
110277276|NCT00178802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110277277|NCT00408239|Enoxaparin|enoxaparin|mesh-list
110277278|NCT00408239|Anticoagulants|anticoagulants|mesh-ancestor
110277279|NCT00408239|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110290160|NCT00221975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110290161|NCT00221975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110290162|NCT00221975|Anticonvulsants|anticonvulsants|mesh-ancestor
110290163|NCT00221975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110290164|NCT00221975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110290165|NCT00221975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110290166|NCT00221975|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110290167|NCT00221975|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110290169|NCT00221975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110290170|NCT04612582|Thalidomide|thalidomide|mesh-list
110290171|NCT04612582|Cyclophosphamide|cyclophosphamide|mesh-list
110290172|NCT04612582|Bortezomib|bortezomib|mesh-list
110290173|NCT04612582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110290174|NCT04612582|Immunologic Factors|immunologic factors|mesh-ancestor
110290175|NCT04612582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110290176|NCT04612582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110290177|NCT04612582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110290178|NCT04612582|Alkylating Agents|alkylating agents|mesh-ancestor
110290179|NCT04612582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290180|NCT04612582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110290181|NCT04612582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110290182|NCT04612582|Leprostatic Agents|leprostatic agents|mesh-ancestor
110290183|NCT04612582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110290184|NCT04612582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110290185|NCT04612582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110290188|NCT04612582|Growth Inhibitors|growth inhibitors|mesh-ancestor
110290190|NCT00248157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110290191|NCT00248157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110290192|NCT00248157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110290193|NCT00251472|Paclitaxel|paclitaxel|mesh-list
110290194|NCT00251472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110290195|NCT00251472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110290196|NCT00251472|Tubulin Modulators|tubulin modulators|mesh-ancestor
110290197|NCT00251472|Antimitotic Agents|antimitotic agents|mesh-ancestor
110290198|NCT00251472|Mitosis Modulators|mitosis modulators|mesh-ancestor
110290199|NCT00251472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290201|NCT00222053|Thalidomide|thalidomide|mesh-list
110290202|NCT00222053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110290203|NCT00222053|Immunologic Factors|immunologic factors|mesh-ancestor
110290204|NCT00222053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110290205|NCT00222053|Leprostatic Agents|leprostatic agents|mesh-ancestor
110290206|NCT00222053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110290207|NCT00222053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110290208|NCT00222053|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110290209|NCT00222053|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110290210|NCT00222053|Growth Substances|growth substances|mesh-ancestor
110290211|NCT00222053|Growth Inhibitors|growth inhibitors|mesh-ancestor
110290212|NCT00222053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110290213|NCT00222053|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110290214|NCT00251511|Arsenic Trioxide|arsenic trioxide|mesh-list
110290215|NCT00251511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110290216|NCT04611958|Bupivacaine|bupivacaine|mesh-list
110290217|NCT04611958|Anesthetics, Local|anesthetics, local|mesh-ancestor
110290218|NCT04611958|Anesthetics|anesthetics|mesh-ancestor
110290219|NCT04611958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110277280|NCT00408239|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110277281|NCT00408239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110277282|NCT04637464|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110277283|NCT04637464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110277284|NCT00408278|Mitoxantrone|mitoxantrone|mesh-list
110277285|NCT00408278|Analgesics|analgesics|mesh-ancestor
110277286|NCT00408278|Sensory System Agents|sensory system agents|mesh-ancestor
110290220|NCT04611958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110290221|NCT04611958|Sensory System Agents|sensory system agents|mesh-ancestor
110290222|NCT04611958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110290223|NCT00412919|Azacitidine|azacitidine|mesh-list
110290224|NCT00412919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110290225|NCT00412919|Antimetabolites|antimetabolites|mesh-ancestor
110290226|NCT00412919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290227|NCT00412919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110290228|NCT00412919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110290229|NCT00222170|Rabeprazole|rabeprazole|mesh-list
110290230|NCT00222170|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110290231|NCT00222170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110290232|NCT00222170|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110290233|NCT00222170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110290234|NCT00222170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290235|NCT04611724|Folfirinox|folfirinox|mesh-list
110290236|NCT04611724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110290237|NCT00563758|Tegaserod|tegaserod|mesh-list
110290238|NCT00563758|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110290239|NCT00563758|Serotonin Agents|serotonin agents|mesh-ancestor
110290240|NCT00563758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110290241|NCT00563758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290242|NCT00563758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110290243|NCT00563836|Catumaxomab|catumaxomab|mesh-list
110290244|NCT00563836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110290245|NCT00563875|Aspirin|aspirin|mesh-list
110290246|NCT00563875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110290247|NCT00563875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110290248|NCT00563875|Analgesics|analgesics|mesh-ancestor
110290249|NCT00563875|Sensory System Agents|sensory system agents|mesh-ancestor
110290250|NCT00563875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110290251|NCT00563875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110290252|NCT00563875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110290254|NCT00563875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110290255|NCT00563875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110290256|NCT00563875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290257|NCT00563875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110290262|NCT04611685|Loxoprofen|loxoprofen|mesh-list
110290263|NCT04611685|Tramadol|tramadol|mesh-list
110290264|NCT04611685|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110290265|NCT04611685|Narcotics|narcotics|mesh-ancestor
110290266|NCT04611685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110290267|NCT04611685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110290268|NCT04611685|Analgesics|analgesics|mesh-ancestor
110290269|NCT04611685|Sensory System Agents|sensory system agents|mesh-ancestor
110290270|NCT04611685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110290271|NCT04611685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110290272|NCT04611685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110290273|NCT04611685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110290274|NCT04611685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290275|NCT04611685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110290276|NCT04611685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110290277|NCT04611685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110290278|NCT04611685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110290279|NCT00563914|Amodiaquine|amodiaquine|mesh-list
110290280|NCT00563914|Ferroquine|ferroquine|mesh-list
110290281|NCT00563914|Antimalarials|antimalarials|mesh-ancestor
110290282|NCT00563914|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110290283|NCT00563914|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110277287|NCT00408278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110277288|NCT00408278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277289|NCT00408278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110277290|NCT00408278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110277291|NCT00408278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110277292|NCT00408278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110277293|NCT00408278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110277295|NCT00560092|Analgesics|analgesics|mesh-ancestor
110277296|NCT00560092|Sensory System Agents|sensory system agents|mesh-ancestor
110277297|NCT00560092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110290284|NCT00563914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110290285|NCT00563953|Doxorubicin|doxorubicin|mesh-list
110290286|NCT00563953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110290287|NCT00563953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110290288|NCT00563953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110290289|NCT00563953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110290290|NCT00563953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110290291|NCT00563953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290292|NCT00563992|Valproic Acid|valproic acid|mesh-list
110290293|NCT00563992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110290294|NCT00563992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110290295|NCT00563992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290296|NCT00563992|Antimanic Agents|antimanic agents|mesh-ancestor
110290297|NCT00563992|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110290298|NCT00563992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110290299|NCT00563992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110290300|NCT00563992|Anticonvulsants|anticonvulsants|mesh-ancestor
110290301|NCT00563992|GABA Agents|gaba agents|mesh-ancestor
110290302|NCT00563992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110290303|NCT00251550|Pemetrexed|pemetrexed|mesh-list
110290304|NCT00251550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110290305|NCT00251550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110290306|NCT00251550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290308|NCT00251550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110290309|NCT04611373|Levamisole|levamisole|mesh-list
110290310|NCT04611373|Acetazolamide|acetazolamide|mesh-list
110290311|NCT04611373|Anticonvulsants|anticonvulsants|mesh-ancestor
110290312|NCT04611373|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110290313|NCT04611373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110290314|NCT04611373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290315|NCT04611373|Diuretics|diuretics|mesh-ancestor
110290316|NCT04611373|Natriuretic Agents|natriuretic agents|mesh-ancestor
110290317|NCT04611373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110290318|NCT04611373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110290319|NCT04611373|Immunologic Factors|immunologic factors|mesh-ancestor
110290320|NCT04611373|Antinematodal Agents|antinematodal agents|mesh-ancestor
110290321|NCT04611373|Anthelmintics|anthelmintics|mesh-ancestor
110290322|NCT04611373|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110290323|NCT04611373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110290324|NCT04611373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110290325|NCT00564031|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110290326|NCT00564031|Medroxyprogesterone|medroxyprogesterone|mesh-list
110290327|NCT00564031|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110290328|NCT00564031|Contraceptive Agents|contraceptive agents|mesh-ancestor
110290329|NCT00564031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110290330|NCT00564031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110290333|NCT00564031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110290334|NCT00564031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110290335|NCT00564031|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110290336|NCT00564031|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110277298|NCT00560092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277299|NCT00560092|Anesthetics|anesthetics|mesh-ancestor
110277300|NCT00560092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110277301|NCT00560092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110277302|NCT00560092|Anticonvulsants|anticonvulsants|mesh-ancestor
110277303|NCT00560092|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110277304|NCT00560092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110277305|NCT00560092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290337|NCT00564031|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110290339|NCT02961426|Antiviral Agents|antiviral agents|mesh-ancestor
110290340|NCT02961426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110290341|NCT04610164|Tranexamic Acid|tranexamic acid|mesh-list
110290342|NCT04610164|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110290343|NCT04610164|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110290344|NCT04610164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290345|NCT04610164|Hemostatics|hemostatics|mesh-ancestor
110290346|NCT04610164|Coagulants|coagulants|mesh-ancestor
110290347|NCT00222443|Irinotecan|irinotecan|mesh-list
110290348|NCT00222443|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110290349|NCT00222443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110290350|NCT00222443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110290351|NCT00222443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290352|NCT00222443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110290353|NCT00222482|Valproic Acid|valproic acid|mesh-list
110290354|NCT00222482|Anticonvulsants|anticonvulsants|mesh-ancestor
110290355|NCT00222482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110290356|NCT00222482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290357|NCT00222482|GABA Agents|gaba agents|mesh-ancestor
110290358|NCT00222482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110290359|NCT00222482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110290360|NCT00222482|Antimanic Agents|antimanic agents|mesh-ancestor
110290361|NCT00222482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110290362|NCT00222482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110290363|NCT00222482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110290364|NCT04610125|Cyclophosphamide|cyclophosphamide|mesh-list
110290365|NCT04610125|Fludarabine|fludarabine|mesh-list
110290367|NCT04610125|Immunologic Factors|immunologic factors|mesh-ancestor
110290368|NCT04610125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110290369|NCT04610125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110290370|NCT04610125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110290371|NCT04610125|Alkylating Agents|alkylating agents|mesh-ancestor
110290372|NCT04610125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290373|NCT04610125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110290374|NCT04610125|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110290376|NCT00564148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110290377|NCT00564148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110290378|NCT00564148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110290379|NCT00564148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110290380|NCT00564148|Growth Substances|growth substances|mesh-ancestor
110290381|NCT00564148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110290382|NCT00564148|Growth Inhibitors|growth inhibitors|mesh-ancestor
110290383|NCT00222521|Insulin Glargine|insulin glargine|mesh-list
110290384|NCT00222521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110290385|NCT00222521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110290386|NCT04609540|Trastuzumab|trastuzumab|mesh-list
110290387|NCT04609540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110290388|NCT04609540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110290389|NCT00564187|Irbesartan|irbesartan|mesh-list
110290390|NCT00564187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110290391|NCT00564187|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110290392|NCT00564187|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110290393|NCT00564187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290394|NCT00222677|Aspirin|aspirin|mesh-list
110277306|NCT00560092|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110277307|NCT00560092|Tocolytic Agents|tocolytic agents|mesh-ancestor
110277308|NCT00560092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110277309|NCT00560170|Simvastatin|simvastatin|mesh-list
110277310|NCT00560170|Ezetimibe|ezetimibe|mesh-list
110277311|NCT00560170|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
110277312|NCT00560170|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110277313|NCT00560170|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110277314|NCT00560170|Antimetabolites|antimetabolites|mesh-ancestor
110277315|NCT00560170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110277316|NCT00560170|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110290395|NCT00222677|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110290396|NCT00222677|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110290397|NCT00222677|Analgesics|analgesics|mesh-ancestor
110290398|NCT00222677|Sensory System Agents|sensory system agents|mesh-ancestor
110290399|NCT00222677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110290400|NCT00222677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110290401|NCT00222677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110290402|NCT00222677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110290416|NCT00564460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110290417|NCT00564460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110290418|NCT00564460|Urological Agents|urological agents|mesh-ancestor
110290420|NCT04609033|Morphine|morphine|mesh-list
110290421|NCT04609033|Bupivacaine|bupivacaine|mesh-list
110290422|NCT04609033|Anesthetics, Local|anesthetics, local|mesh-ancestor
110290423|NCT04609033|Anesthetics|anesthetics|mesh-ancestor
110290424|NCT04609033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110290425|NCT04609033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110290426|NCT04609033|Sensory System Agents|sensory system agents|mesh-ancestor
110290427|NCT04609033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110290428|NCT04609033|Analgesics|analgesics|mesh-ancestor
110290429|NCT04609033|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110290430|NCT04609033|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110290431|NCT04609033|Anesthetics, General|anesthetics, general|mesh-ancestor
110290432|NCT04609033|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110290433|NCT04609033|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110290434|NCT04609033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110290435|NCT04609033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290436|NCT04609033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110290437|NCT04609033|Narcotics|narcotics|mesh-ancestor
110290438|NCT00248313|Sirolimus|sirolimus|mesh-list
110290439|NCT00248313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110290440|NCT00248313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110290441|NCT00248313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110290442|NCT00248313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110290443|NCT00248313|Antifungal Agents|antifungal agents|mesh-ancestor
110290444|NCT00248313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110290445|NCT00248313|Immunologic Factors|immunologic factors|mesh-ancestor
110290446|NCT00248313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110290447|NCT00222794|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110290448|NCT00222794|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110290449|NCT00222794|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110290450|NCT00222794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110290451|NCT00222794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290452|NCT00222794|Adrenergic Agents|adrenergic agents|mesh-ancestor
110290453|NCT00222794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110290454|NCT00222794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110290455|NCT04608253|Choline|choline|mesh-list
110290456|NCT04608253|Lipotropic Agents|lipotropic agents|mesh-ancestor
110290457|NCT04608253|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110290458|NCT04608253|Antimetabolites|antimetabolites|mesh-ancestor
110277317|NCT00560170|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110277318|NCT00560170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110277320|NCT04637152|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110277321|NCT04637152|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110277322|NCT04637152|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110277323|NCT04637152|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110277324|NCT04637152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110277325|NCT04636918|Cyclosporine|cyclosporine|mesh-list
110277326|NCT04636918|Cyclosporins|cyclosporins|mesh-list
110277327|NCT04636918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110277328|NCT04636918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110277329|NCT04636918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110277330|NCT04636918|Immunologic Factors|immunologic factors|mesh-ancestor
110277331|NCT04636918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277332|NCT04636918|Antifungal Agents|antifungal agents|mesh-ancestor
110277333|NCT04636918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110277334|NCT04636918|Dermatologic Agents|dermatologic agents|mesh-ancestor
110290459|NCT04608253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290460|NCT04608253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110290461|NCT04608253|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110290462|NCT04608253|Nootropic Agents|nootropic agents|mesh-ancestor
110290470|NCT00222833|Dopamine Agonists|dopamine agonists|mesh-ancestor
110290471|NCT00222833|Dopamine Agents|dopamine agents|mesh-ancestor
110290472|NCT00222833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110290473|NCT00222833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290474|NCT00222833|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110290475|NCT00222833|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110290476|NCT00222833|Serotonin Agents|serotonin agents|mesh-ancestor
110290477|NCT00222833|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110290478|NCT00222833|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110290479|NCT00222833|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110290480|NCT00222833|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110290481|NCT00564538|Tacrolimus|tacrolimus|mesh-list
110290482|NCT00564538|Thymoglobulin|thymoglobulin|mesh-list
110290484|NCT00564538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110290485|NCT00564538|Immunologic Factors|immunologic factors|mesh-ancestor
110290486|NCT00564538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110290487|NCT00564538|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110290488|NCT00564538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110290489|NCT00564538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290490|NCT00251706|Amiodarone|amiodarone|mesh-list
110290491|NCT00251706|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110290492|NCT00251706|Vasodilator Agents|vasodilator agents|mesh-ancestor
110290493|NCT00251706|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110290494|NCT00251706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110290495|NCT00251706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290496|NCT00251706|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110290497|NCT00251706|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110290498|NCT00251706|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110277335|NCT04636918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110277336|NCT04636918|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110277337|NCT00560209|Landiolol|landiolol|mesh-list
110277338|NCT00560209|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110277339|NCT00560209|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110277340|NCT00560209|Adrenergic Agents|adrenergic agents|mesh-ancestor
110277341|NCT00560209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110277342|NCT00560209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110277343|NCT00560209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277344|NCT00560209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110277345|NCT04636957|Ciprofloxacin|ciprofloxacin|mesh-list
110277346|NCT04636957|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
110277347|NCT04636957|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110277348|NCT04636957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110277349|NCT04636957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110277350|NCT04636957|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110277351|NCT04636957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110277352|NCT04636957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110277353|NCT04636957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290499|NCT00251706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110290500|NCT00251706|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110290501|NCT00251706|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110290502|NCT00251706|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110290504|NCT00199121|Antimetabolites|antimetabolites|mesh-ancestor
110290505|NCT00199121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290506|NCT00199121|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110290507|NCT00199121|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110290508|NCT00199121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110290509|NCT00199121|Antiviral Agents|antiviral agents|mesh-ancestor
110290510|NCT00199121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110290511|NCT00199121|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110290512|NCT00199121|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110290513|NCT04607785|Chlorhexidine|chlorhexidine|mesh-list
110290514|NCT04607785|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110290515|NCT04607785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110290516|NCT04607785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110290517|NCT04607785|Disinfectants|disinfectants|mesh-ancestor
110290518|NCT04607785|Dermatologic Agents|dermatologic agents|mesh-ancestor
110290519|NCT00199160|Sorafenib|sorafenib|mesh-list
110290521|NCT00199160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110290522|NCT00199160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110290523|NCT00199160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290524|NCT04607629|Omalizumab|omalizumab|mesh-list
110290525|NCT04607629|Budesonide|budesonide|mesh-list
110290526|NCT04607629|Formoterol Fumarate|formoterol fumarate|mesh-list
110290527|NCT04607629|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110290528|NCT04607629|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110290529|NCT04607629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110290535|NCT04607629|Respiratory System Agents|respiratory system agents|mesh-ancestor
110290536|NCT04607629|Glucocorticoids|glucocorticoids|mesh-ancestor
110290537|NCT04607629|Hormones|hormones|mesh-ancestor
110277360|NCT04636957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110277361|NCT04636957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277363|NCT00560326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110277364|NCT00560326|Immunologic Factors|immunologic factors|mesh-ancestor
110277365|NCT00560326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277366|NCT00560326|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110277367|NCT00560326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110290538|NCT04607629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110290539|NCT04607629|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110290540|NCT04607629|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110290541|NCT04607629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110290542|NCT04607629|Adrenergic Agents|adrenergic agents|mesh-ancestor
110290543|NCT04607629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110290544|NCT04607629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290545|NCT04607629|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110290546|NCT04607629|Immunologic Factors|immunologic factors|mesh-ancestor
110290547|NCT00251784|Sildenafil Citrate|sildenafil citrate|mesh-list
110290548|NCT00251784|Vasodilator Agents|vasodilator agents|mesh-ancestor
110290549|NCT00251784|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110290550|NCT00251784|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110290551|NCT00251784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110290552|NCT00251784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290553|NCT00251784|Urological Agents|urological agents|mesh-ancestor
110290554|NCT00248430|Aldesleukin|aldesleukin|mesh-list
110290555|NCT00248430|Melphalan|melphalan|mesh-list
110290556|NCT00248430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110290557|NCT00248430|Alkylating Agents|alkylating agents|mesh-ancestor
110290558|NCT00248430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290559|NCT00248430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110290560|NCT00248430|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110290561|NCT00248430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110290562|NCT00248430|Immunologic Factors|immunologic factors|mesh-ancestor
110290563|NCT00248430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110290564|NCT00248430|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110290565|NCT00248430|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110290566|NCT00248430|Antiviral Agents|antiviral agents|mesh-ancestor
110290567|NCT00248430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110290575|NCT00564655|Epinephrine|epinephrine|mesh-list
110290576|NCT00564655|Racepinephrine|racepinephrine|mesh-list
110290577|NCT00564655|Bupivacaine|bupivacaine|mesh-list
110290578|NCT00564655|Epinephryl borate|epinephryl borate|mesh-list
110290579|NCT00564655|Anesthetics, Local|anesthetics, local|mesh-ancestor
110290580|NCT00564655|Anesthetics|anesthetics|mesh-ancestor
110290581|NCT00564655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110277368|NCT00560326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110277369|NCT00560443|Ketorolac|ketorolac|mesh-list
110277370|NCT00560443|Tramadol|tramadol|mesh-list
110277371|NCT00560443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110277372|NCT00560443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110277373|NCT00560443|Analgesics|analgesics|mesh-ancestor
110277374|NCT00560443|Sensory System Agents|sensory system agents|mesh-ancestor
110277375|NCT00560443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110290582|NCT00564655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110290583|NCT00564655|Sensory System Agents|sensory system agents|mesh-ancestor
110290584|NCT00564655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110290585|NCT00564655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110290586|NCT00564655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110290587|NCT00564655|Adrenergic Agents|adrenergic agents|mesh-ancestor
110290588|NCT00564655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110021460|NCT00002598|Cytarabine|cytarabine|mesh-list
110290589|NCT00564655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290590|NCT00564655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110290591|NCT00564655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110290592|NCT00564655|Autonomic Agents|autonomic agents|mesh-ancestor
110290593|NCT00564655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110290594|NCT00564655|Respiratory System Agents|respiratory system agents|mesh-ancestor
110290595|NCT00564655|Mydriatics|mydriatics|mesh-ancestor
110290596|NCT00564655|Sympathomimetics|sympathomimetics|mesh-ancestor
110290597|NCT00564655|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110290598|NCT04606537|Itraconazole|itraconazole|mesh-list
110290599|NCT04606537|Rifampin|rifampin|mesh-list
110290604|NCT04606537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110290605|NCT04606537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290606|NCT04606537|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110290607|NCT04606537|Hormone Antagonists|hormone antagonists|mesh-ancestor
110290608|NCT04606537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110290609|NCT04606537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110290610|NCT04606537|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110290611|NCT04606537|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110290612|NCT04606537|Antitubercular Agents|antitubercular agents|mesh-ancestor
110290613|NCT04606537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110290614|NCT04606537|Leprostatic Agents|leprostatic agents|mesh-ancestor
110290615|NCT04606537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110290616|NCT04606537|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110290617|NCT04606537|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110290618|NCT04606537|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110290619|NCT04606537|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110290620|NCT04606537|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110290621|NCT04606537|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110290622|NCT00251823|Eptifibatide|eptifibatide|mesh-list
110290623|NCT00251823|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110290625|NCT04606225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110290626|NCT04606225|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110290627|NCT04606225|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110290628|NCT04606225|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110290629|NCT04606225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290630|NCT04606108|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110290631|NCT04606108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290632|NCT04606108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110290633|NCT04606108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110290634|NCT04719507|Meperidine|meperidine|mesh-list
110290635|NCT04719507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110290636|NCT04719507|Narcotics|narcotics|mesh-ancestor
110290637|NCT04719507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110290638|NCT04719507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277376|NCT00560443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277377|NCT00560443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110277378|NCT00560443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110277379|NCT00560443|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110277380|NCT00560443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110277381|NCT00560443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110277382|NCT00560443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110277383|NCT00560443|Narcotics|narcotics|mesh-ancestor
110277384|NCT00560443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110290639|NCT04719507|Analgesics|analgesics|mesh-ancestor
110290640|NCT04719507|Sensory System Agents|sensory system agents|mesh-ancestor
110290641|NCT04719507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110290642|NCT04719507|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110290643|NCT04605952|Antibodies|antibodies|mesh-list
110290644|NCT04605952|Immunoglobulin G|immunoglobulin g|mesh-list
110290645|NCT04605952|Immunologic Factors|immunologic factors|mesh-ancestor
110290646|NCT04605952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110290647|NCT04605562|Palbociclib|palbociclib|mesh-list
110290648|NCT04605562|Antibodies|antibodies|mesh-list
110290649|NCT04605562|Antibodies, Blocking|antibodies, blocking|mesh-list
110290650|NCT04605562|Immunologic Factors|immunologic factors|mesh-ancestor
110290651|NCT04605562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110290652|NCT04605562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110290653|NCT04605562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110290654|NCT04605562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110290655|NCT04605562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290656|NCT00251901|Esomeprazole|esomeprazole|mesh-list
110290657|NCT00251901|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110290658|NCT00251901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110290659|NCT00251901|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110290660|NCT00251901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110021532|NCT00002616|Thiotepa|thiotepa|mesh-list
110290661|NCT00251901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290662|NCT05517278|Anti-Infective Agents|anti-infective agents|mesh-list
110290663|NCT05517278|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110290664|NCT00564772|Ritonavir|ritonavir|mesh-list
110290665|NCT00564772|Lopinavir|lopinavir|mesh-list
110290666|NCT00564772|Raltegravir Potassium|raltegravir potassium|mesh-list
110290667|NCT00564772|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110290671|NCT00564772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290672|NCT00564772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110290673|NCT00564772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110290674|NCT00564772|Antiviral Agents|antiviral agents|mesh-ancestor
110290675|NCT00564772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110290676|NCT00564772|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110290677|NCT00564772|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110290678|NCT00564772|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110290681|NCT00251940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110290682|NCT00251940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110290683|NCT04604938|Losartan|losartan|mesh-list
110290684|NCT04604938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110290685|NCT04604938|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110290686|NCT04604938|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110290687|NCT04604938|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110290688|NCT04604938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290689|NCT00565006|Anacetrapib|anacetrapib|mesh-list
110290690|NCT00565006|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110290691|NCT00565006|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110290692|NCT00565006|Antimetabolites|antimetabolites|mesh-ancestor
110290693|NCT00565006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290694|NCT00565006|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110290695|NCT00565123|Levofloxacin|levofloxacin|mesh-list
110290696|NCT00565123|Ofloxacin|ofloxacin|mesh-list
110290697|NCT00565123|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110290698|NCT00565123|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110277385|NCT00179114|Baclofen|baclofen|mesh-list
110277386|NCT00179114|Botulinum Toxins|botulinum toxins|mesh-list
110277387|NCT00179114|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110277388|NCT00179114|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110277389|NCT00179114|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110277390|NCT00179114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110277391|NCT00179114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110277392|NCT00179114|Cholinergic Agents|cholinergic agents|mesh-ancestor
110277393|NCT00179114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110277394|NCT00179114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277395|NCT00179114|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110290699|NCT00565123|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110290700|NCT00565123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110290701|NCT00565123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110290702|NCT00565123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110290703|NCT00565123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110290704|NCT00565123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110290705|NCT00565123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290706|NCT00565123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110290707|NCT00565123|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110290708|NCT00565123|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110290709|NCT04604509|Bupropion|bupropion|mesh-list
110290710|NCT04604509|Nicotine|nicotine|mesh-list
110290711|NCT04604509|Varenicline|varenicline|mesh-list
110290712|NCT04604509|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110290713|NCT04604509|Autonomic Agents|autonomic agents|mesh-ancestor
110290714|NCT04604509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110290715|NCT04604509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110290716|NCT04604509|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110290717|NCT04604509|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110290718|NCT04604509|Cholinergic Agents|cholinergic agents|mesh-ancestor
110290719|NCT04604509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110290720|NCT04604509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290721|NCT04604509|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110290722|NCT04604509|Antidepressive Agents|antidepressive agents|mesh-ancestor
110290723|NCT04604509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110290724|NCT04604509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110290725|NCT04604509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110290726|NCT04604509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110290727|NCT04604509|Dopamine Agents|dopamine agents|mesh-ancestor
110290728|NCT04604509|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110290729|NCT04604509|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110290730|NCT04604509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110290731|NCT00565162|Insulin Glargine|insulin glargine|mesh-list
110290732|NCT00565162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110290733|NCT00565162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110290734|NCT04603729|Dexamethasone|dexamethasone|mesh-list
110290735|NCT04603729|Methylprednisolone|methylprednisolone|mesh-list
110290736|NCT04603729|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110290737|NCT04603729|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110290738|NCT04603729|Prednisolone|prednisolone|mesh-list
110290746|NCT04603729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110290747|NCT04603729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110290748|NCT04603729|Glucocorticoids|glucocorticoids|mesh-ancestor
110290750|NCT04603729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110290751|NCT04603729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110290752|NCT04603729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110290753|NCT04603729|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110290754|NCT04603729|Protective Agents|protective agents|mesh-ancestor
110290755|NCT04603924|Niclosamide|niclosamide|mesh-list
110290756|NCT04603924|Anticestodal Agents|anticestodal agents|mesh-ancestor
110290757|NCT04603924|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110290758|NCT04603924|Anthelmintics|anthelmintics|mesh-ancestor
110277396|NCT00179114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110277397|NCT00179114|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110277398|NCT00179114|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110277399|NCT00179114|GABA Agonists|gaba agonists|mesh-ancestor
110277400|NCT00179114|GABA Agents|gaba agents|mesh-ancestor
110277401|NCT00201318|Lamivudine|lamivudine|mesh-list
110277402|NCT00201318|Cyclophosphamide|cyclophosphamide|mesh-list
110277403|NCT00201318|Doxorubicin|doxorubicin|mesh-list
110290759|NCT04603924|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110290760|NCT04603924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110290761|NCT04603924|Antinematodal Agents|antinematodal agents|mesh-ancestor
110290762|NCT04603573|Listerine|listerine|mesh-list
110290763|NCT04603573|Fluorides|fluorides|mesh-list
110290764|NCT04603573|Sodium Fluoride|sodium fluoride|mesh-list
110290765|NCT04603573|Fluorides, Topical|fluorides, topical|mesh-list
110290766|NCT04603573|Cariostatic Agents|cariostatic agents|mesh-ancestor
110290767|NCT04603573|Protective Agents|protective agents|mesh-ancestor
110290768|NCT04603573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110290769|NCT04603573|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110290770|NCT04603573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110290771|NCT05361824|Acetaminophen|acetaminophen|mesh-list
110290772|NCT05361824|Ketorolac|ketorolac|mesh-list
110290773|NCT05361824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110290774|NCT05361824|Analgesics|analgesics|mesh-ancestor
110290775|NCT05361824|Sensory System Agents|sensory system agents|mesh-ancestor
110290776|NCT05361824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110290777|NCT05361824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110290778|NCT05361824|Antipyretics|antipyretics|mesh-ancestor
110290779|NCT05361824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110290780|NCT05361824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110290781|NCT05361824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110290782|NCT05361824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110290783|NCT05361824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110290784|NCT05361824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290785|NCT04603456|Calcium Carbonate|calcium carbonate|mesh-list
110290786|NCT04603456|Antacids|antacids|mesh-ancestor
110290787|NCT04603456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290788|NCT04603456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110290789|NCT00252291|Methacholine Chloride|methacholine chloride|mesh-list
110290791|NCT00252291|Autonomic Agents|autonomic agents|mesh-ancestor
110290792|NCT00252291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110290793|NCT00252291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110290794|NCT00252291|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110290795|NCT00252291|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
110290796|NCT00252291|Respiratory System Agents|respiratory system agents|mesh-ancestor
110290797|NCT00252291|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110290798|NCT00252291|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110290799|NCT00252291|Cholinergic Agents|cholinergic agents|mesh-ancestor
110290800|NCT00252291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110290801|NCT00252291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290802|NCT00565240|Letrozole|letrozole|mesh-list
110290803|NCT00565240|NuvaRing|nuvaring|mesh-list
110290804|NCT00565240|Desogestrel|desogestrel|mesh-list
110290805|NCT00565240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110290806|NCT00565240|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110290807|NCT00565240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110290808|NCT00565240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110290809|NCT00565240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290813|NCT00565240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110290814|NCT00565240|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110290815|NCT00565240|Contraceptive Agents|contraceptive agents|mesh-ancestor
110290816|NCT00565240|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110290817|NCT00565240|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110290818|NCT00565240|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110290819|NCT00565240|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110290820|NCT00565240|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110290821|NCT00565240|Progestins|progestins|mesh-ancestor
110290822|NCT00565240|Hormones|hormones|mesh-ancestor
110290823|NCT04602247|Fesoterodine|fesoterodine|mesh-list
110277404|NCT00201318|Vincristine|vincristine|mesh-list
110277405|NCT00201318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110277406|NCT00201318|Immunologic Factors|immunologic factors|mesh-ancestor
110277407|NCT00201318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277408|NCT00201318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110277409|NCT00201318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110277410|NCT00201318|Alkylating Agents|alkylating agents|mesh-ancestor
110277411|NCT00201318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110277412|NCT00201318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110277413|NCT00201318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110277414|NCT00201318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110277415|NCT00201318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110290824|NCT04602247|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110290825|NCT04602247|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110290826|NCT04602247|Cholinergic Agents|cholinergic agents|mesh-ancestor
110290827|NCT04602247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110290828|NCT04602247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290829|NCT04602247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110290830|NCT04602247|Urological Agents|urological agents|mesh-ancestor
110290832|NCT00252330|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
110290833|NCT00252330|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110290834|NCT00252330|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110290835|NCT00252330|Adrenergic Agents|adrenergic agents|mesh-ancestor
110290836|NCT00252330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110290837|NCT00252330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290838|NCT00252330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110290839|NCT00252330|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110290840|NCT04602013|Paclitaxel|paclitaxel|mesh-list
110290841|NCT04602013|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110290842|NCT04602013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110290843|NCT04602013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110290844|NCT04602013|Tubulin Modulators|tubulin modulators|mesh-ancestor
110290845|NCT04602013|Antimitotic Agents|antimitotic agents|mesh-ancestor
110290846|NCT04602013|Mitosis Modulators|mitosis modulators|mesh-ancestor
110290847|NCT04602013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290848|NCT04601701|Dexamethasone|dexamethasone|mesh-list
110290849|NCT04601701|Bevacizumab|bevacizumab|mesh-list
110290850|NCT04601701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110290851|NCT04601701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110290852|NCT04601701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110290853|NCT04601701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110290854|NCT04601701|Growth Substances|growth substances|mesh-ancestor
110290855|NCT04601701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110290856|NCT04601701|Growth Inhibitors|growth inhibitors|mesh-ancestor
110290857|NCT04601701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110290858|NCT04601701|Antiemetics|antiemetics|mesh-ancestor
110290859|NCT04601701|Autonomic Agents|autonomic agents|mesh-ancestor
110290860|NCT04601701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110290861|NCT04601701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110290862|NCT04601701|Glucocorticoids|glucocorticoids|mesh-ancestor
110290863|NCT04601701|Hormones|hormones|mesh-ancestor
110290864|NCT04601701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110290865|NCT04601701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110290866|NCT00252369|Infliximab|infliximab|mesh-list
110290867|NCT00252369|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110290868|NCT00252369|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110290869|NCT00252369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110290870|NCT00252369|Dermatologic Agents|dermatologic agents|mesh-ancestor
110277417|NCT00201318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110277418|NCT00201318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110277419|NCT00201318|Tubulin Modulators|tubulin modulators|mesh-ancestor
110277420|NCT00201318|Antimitotic Agents|antimitotic agents|mesh-ancestor
110277421|NCT00201318|Mitosis Modulators|mitosis modulators|mesh-ancestor
110277422|NCT00201318|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110277423|NCT00201318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110277424|NCT00201318|Antiviral Agents|antiviral agents|mesh-ancestor
110277425|NCT00201318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110277426|NCT00201318|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110277427|NCT00201318|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110277428|NCT00201357|Thalidomide|thalidomide|mesh-list
110277429|NCT00201357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110277430|NCT00201357|Immunologic Factors|immunologic factors|mesh-ancestor
110277431|NCT00201357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277432|NCT00201357|Leprostatic Agents|leprostatic agents|mesh-ancestor
110277433|NCT00201357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110277434|NCT00201357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110290871|NCT00252369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110290872|NCT00252369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110290873|NCT00252369|Hemostatics|hemostatics|mesh-ancestor
110290874|NCT00252369|Coagulants|coagulants|mesh-ancestor
110290875|NCT00565318|Benphothiamine|benphothiamine|mesh-list
110290876|NCT00565318|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110290877|NCT00565318|Immunologic Factors|immunologic factors|mesh-ancestor
110290878|NCT00565318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110290879|NCT00565318|Chelating Agents|chelating agents|mesh-ancestor
110290880|NCT00565318|Sequestering Agents|sequestering agents|mesh-ancestor
110290893|NCT04601389|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110290894|NCT04601389|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110290895|NCT04601389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110290896|NCT04601389|Respiratory System Agents|respiratory system agents|mesh-ancestor
110290897|NCT04601389|Immunologic Factors|immunologic factors|mesh-ancestor
110290898|NCT04601389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110290899|NCT00565396|Losartan|losartan|mesh-list
110290900|NCT00565396|Fosinopril|fosinopril|mesh-list
110290901|NCT00565396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110290902|NCT00565396|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110290903|NCT00565396|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110290904|NCT00565396|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110290905|NCT00565396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290906|NCT00565396|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110290907|NCT00565396|Protease Inhibitors|protease inhibitors|mesh-ancestor
110290908|NCT00565396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110290909|NCT04601116|Atorvastatin|atorvastatin|mesh-list
110290910|NCT04601116|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110290911|NCT04601116|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110290912|NCT04601116|Antimetabolites|antimetabolites|mesh-ancestor
110290913|NCT04601116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290914|NCT04601116|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110290915|NCT04601116|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110290916|NCT04601116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110290917|NCT00249132|Risperidone|risperidone|mesh-list
110290918|NCT00249132|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110290919|NCT00249132|Serotonin Agents|serotonin agents|mesh-ancestor
110290920|NCT00249132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110290921|NCT00249132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110277435|NCT00201357|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110277436|NCT00201357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110277437|NCT00201357|Growth Substances|growth substances|mesh-ancestor
110277438|NCT00201357|Growth Inhibitors|growth inhibitors|mesh-ancestor
110277439|NCT00201357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110277441|NCT00201396|Fluorouracil|fluorouracil|mesh-list
110277442|NCT00201396|Epirubicin|epirubicin|mesh-list
110277443|NCT00201396|Mitomycins|mitomycins|mesh-list
110277444|NCT00201396|Mitomycin|mitomycin|mesh-list
110277445|NCT00201396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110277446|NCT00201396|Antimetabolites|antimetabolites|mesh-ancestor
110277447|NCT00201396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110277448|NCT00201396|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110290922|NCT00249132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110290923|NCT00249132|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110290924|NCT00249132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110290925|NCT00249132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110290926|NCT00249132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110290927|NCT00249132|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110290928|NCT00249132|Dopamine Agents|dopamine agents|mesh-ancestor
110290929|NCT04600492|Riociguat|riociguat|mesh-list
110290930|NCT04600492|Enzyme Activators|enzyme activators|mesh-ancestor
110290931|NCT04600492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290932|NCT04599712|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
110290933|NCT04599712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110290934|NCT04599712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110290935|NCT00414648|Sirolimus|sirolimus|mesh-list
110290936|NCT00414648|Temsirolimus|temsirolimus|mesh-list
110290937|NCT00414648|MTOR Inhibitors|mtor inhibitors|mesh-list
110290938|NCT00414648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110290939|NCT00414648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110290940|NCT00414648|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110290941|NCT00414648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110290942|NCT00414648|Antifungal Agents|antifungal agents|mesh-ancestor
110290950|NCT00414687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110290952|NCT04599205|Tranexamic Acid|tranexamic acid|mesh-list
110290954|NCT04599205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110290955|NCT04599205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290956|NCT04599205|Hemostatics|hemostatics|mesh-ancestor
110290957|NCT04599205|Coagulants|coagulants|mesh-ancestor
110290958|NCT04598737|Lithium Carbonate|lithium carbonate|mesh-list
110290959|NCT04598737|Antidepressive Agents|antidepressive agents|mesh-ancestor
110290960|NCT04598737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110290961|NCT04598737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110290962|NCT04598737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290963|NCT04598737|Antimanic Agents|antimanic agents|mesh-ancestor
110290964|NCT04598737|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110290965|NCT04598737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110290966|NCT04598737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110290967|NCT05055128|Lansoprazole|lansoprazole|mesh-list
110290968|NCT05055128|Dexlansoprazole|dexlansoprazole|mesh-list
110290969|NCT05055128|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110290970|NCT05055128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110290971|NCT05055128|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110290972|NCT05055128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110290973|NCT05055128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290974|NCT00565591|Albuterol|albuterol|mesh-list
110290975|NCT00565591|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110290976|NCT00565591|Autonomic Agents|autonomic agents|mesh-ancestor
110290977|NCT00565591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110290978|NCT00565591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277449|NCT00201396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110277450|NCT00201396|Immunologic Factors|immunologic factors|mesh-ancestor
110277451|NCT00201396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277452|NCT00201396|Antidotes|antidotes|mesh-ancestor
110277453|NCT00201396|Protective Agents|protective agents|mesh-ancestor
110277454|NCT00201396|Vitamin B Complex|vitamin b complex|mesh-ancestor
110277455|NCT00201396|Vitamins|vitamins|mesh-ancestor
110277456|NCT00201396|Micronutrients|micronutrients|mesh-ancestor
110277457|NCT00201396|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110277458|NCT00201396|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110277459|NCT00201396|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110277460|NCT00201396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110277461|NCT00201396|Alkylating Agents|alkylating agents|mesh-ancestor
110277462|NCT00201396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110290979|NCT00565591|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110290980|NCT00565591|Respiratory System Agents|respiratory system agents|mesh-ancestor
110290981|NCT00565591|Tocolytic Agents|tocolytic agents|mesh-ancestor
110290982|NCT00565591|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110290983|NCT00565591|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110290984|NCT00565591|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110290985|NCT00565591|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110290986|NCT00565591|Adrenergic Agents|adrenergic agents|mesh-ancestor
110290987|NCT00565591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110290988|NCT00565591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290989|NCT00252603|Galantamine|galantamine|mesh-list
110290990|NCT00252603|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110290991|NCT00252603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110290992|NCT00252603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290993|NCT00252603|Cholinergic Agents|cholinergic agents|mesh-ancestor
110290994|NCT00252603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110290995|NCT00252603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110290996|NCT00252603|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110290997|NCT00252603|Autonomic Agents|autonomic agents|mesh-ancestor
110290998|NCT00252603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110290999|NCT00252603|Nootropic Agents|nootropic agents|mesh-ancestor
110291000|NCT00565630|Moxifloxacin|moxifloxacin|mesh-list
110291001|NCT00565630|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110291002|NCT00565630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110291003|NCT00565630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110291004|NCT00565630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110291005|NCT00565630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110291006|NCT00565630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110291007|NCT00565630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110291008|NCT00565630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110291013|NCT00565630|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110291014|NCT00565630|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110291015|NCT00565630|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110291017|NCT00565708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110291018|NCT00565708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110291019|NCT00565708|Analgesics|analgesics|mesh-ancestor
110291020|NCT00565708|Sensory System Agents|sensory system agents|mesh-ancestor
110291021|NCT00565708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110291022|NCT00565708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110291023|NCT00565708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110291024|NCT00565708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110291025|NCT00565708|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110291026|NCT00565708|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110291027|NCT00565708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110291028|NCT00565708|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110277463|NCT00201435|Paclitaxel|paclitaxel|mesh-list
110277464|NCT00201435|Docetaxel|docetaxel|mesh-list
110277465|NCT00201435|Capecitabine|capecitabine|mesh-list
110277466|NCT00201435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110277467|NCT00201435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110277468|NCT00201435|Tubulin Modulators|tubulin modulators|mesh-ancestor
110277469|NCT00201435|Antimitotic Agents|antimitotic agents|mesh-ancestor
110277470|NCT00201435|Mitosis Modulators|mitosis modulators|mesh-ancestor
110277471|NCT00201435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110291029|NCT00565708|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110291030|NCT00565708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110291031|NCT00565708|Antipyretics|antipyretics|mesh-ancestor
110291032|NCT00252642|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110021914|NCT00002784|Doxorubicin|doxorubicin|mesh-list
110291033|NCT00252642|Antiviral Agents|antiviral agents|mesh-ancestor
110291034|NCT00252642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110291035|NCT04598542|Triamcinolone|triamcinolone|mesh-list
110291036|NCT04598542|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110291037|NCT04598542|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110291038|NCT04598542|Lorecivivint|lorecivivint|mesh-list
110291039|NCT04598542|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110291040|NCT04598542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110291041|NCT04598542|Glucocorticoids|glucocorticoids|mesh-ancestor
110291042|NCT04598542|Hormones|hormones|mesh-ancestor
110291043|NCT04598542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110291044|NCT04598542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110291045|NCT04598542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110291046|NCT04598542|Immunologic Factors|immunologic factors|mesh-ancestor
110291047|NCT04598542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110291048|NCT04598542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110291049|NCT04995263|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
110291050|NCT04995263|Caffeine|caffeine|mesh-list
110291051|NCT04995263|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110291052|NCT04995263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110291053|NCT04995263|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110291054|NCT04995263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110291055|NCT04995263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110291056|NCT04995263|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110291057|NCT04995263|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110291058|NCT04995263|Purinergic Agents|purinergic agents|mesh-ancestor
110291059|NCT04995263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110291060|NCT04995263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110291061|NCT04598191|Iloprost|iloprost|mesh-list
110291062|NCT04598191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110291063|NCT04598191|Vasodilator Agents|vasodilator agents|mesh-ancestor
110291064|NCT00249171|Risperidone|risperidone|mesh-list
110291065|NCT00249171|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110291066|NCT00249171|Serotonin Agents|serotonin agents|mesh-ancestor
110291067|NCT00249171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110291068|NCT00249171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110291069|NCT00249171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110291070|NCT00249171|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110291071|NCT00249171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110291072|NCT00249171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110291073|NCT00249171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110291074|NCT00249171|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110291075|NCT00249171|Dopamine Agents|dopamine agents|mesh-ancestor
110291076|NCT00565981|Fludarabine|fludarabine|mesh-list
110291077|NCT00565981|Fludarabine phosphate|fludarabine phosphate|mesh-list
110291090|NCT04952519|Antiviral Agents|antiviral agents|mesh-ancestor
110291091|NCT04952519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110291092|NCT04952519|Dopamine Agents|dopamine agents|mesh-ancestor
110291093|NCT04952519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110291094|NCT04952519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110291095|NCT04952519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277472|NCT00201435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110277473|NCT00201435|Antimetabolites|antimetabolites|mesh-ancestor
110277474|NCT00560599|Chlorhexidine|chlorhexidine|mesh-list
110277475|NCT00560599|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110277476|NCT00560599|Mupirocin|mupirocin|mesh-list
110277477|NCT00560599|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110277478|NCT00560599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110277479|NCT00560599|Disinfectants|disinfectants|mesh-ancestor
110277480|NCT00560599|Dermatologic Agents|dermatologic agents|mesh-ancestor
110277481|NCT00560599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110277482|NCT00560599|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110277483|NCT00560599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110277484|NCT00560599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110277485|NCT04635553|Praziquantel|praziquantel|mesh-list
110291096|NCT04952519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110291097|NCT04952519|Analgesics|analgesics|mesh-ancestor
110291098|NCT04952519|Sensory System Agents|sensory system agents|mesh-ancestor
110291099|NCT04952519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110291100|NCT00414921|Clonidine|clonidine|mesh-list
110291101|NCT00414921|Methylphenidate|methylphenidate|mesh-list
110291102|NCT00414921|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110291103|NCT00414921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110291104|NCT00414921|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110291105|NCT00414921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110291106|NCT00414921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110291107|NCT00414921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110291108|NCT00414921|Dopamine Agents|dopamine agents|mesh-ancestor
110291109|NCT00414921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110291110|NCT00414921|Analgesics|analgesics|mesh-ancestor
110291111|NCT00414921|Sensory System Agents|sensory system agents|mesh-ancestor
110291112|NCT00414921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110291113|NCT00414921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110291114|NCT00414921|Sympatholytics|sympatholytics|mesh-ancestor
110291115|NCT00414921|Autonomic Agents|autonomic agents|mesh-ancestor
110291116|NCT00414921|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110291117|NCT00414921|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110291118|NCT00414921|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110291119|NCT00414921|Adrenergic Agents|adrenergic agents|mesh-ancestor
110291120|NCT04597762|Cyclosporine|cyclosporine|mesh-list
110291121|NCT04597762|Hydrocortisone|hydrocortisone|mesh-list
110291122|NCT04597762|Cyclosporins|cyclosporins|mesh-list
110291123|NCT04597762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110291124|NCT04597762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110291125|NCT04597762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110291126|NCT04597762|Immunologic Factors|immunologic factors|mesh-ancestor
110291127|NCT04597762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110291128|NCT04597762|Antifungal Agents|antifungal agents|mesh-ancestor
110291129|NCT04597762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110291130|NCT04597762|Dermatologic Agents|dermatologic agents|mesh-ancestor
110291131|NCT04597762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110291132|NCT04597762|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110291133|NCT04597762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110291134|NCT00249210|Levofloxacin|levofloxacin|mesh-list
110291135|NCT00249210|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110291136|NCT00249210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110291137|NCT00249210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110291138|NCT00249210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110291139|NCT00249210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110291140|NCT00249210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110291149|NCT00252798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110291150|NCT00252798|Tubulin Modulators|tubulin modulators|mesh-ancestor
110291151|NCT00252798|Antimitotic Agents|antimitotic agents|mesh-ancestor
110277486|NCT04635553|Anthelmintics|anthelmintics|mesh-ancestor
110277487|NCT04635553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110277488|NCT04635553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110277489|NCT00560638|Loteprednol Etabonate|loteprednol etabonate|mesh-list
110277490|NCT00560638|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110277491|NCT04634656|Lidocaine|lidocaine|mesh-list
110277492|NCT04634656|Anesthetics, Local|anesthetics, local|mesh-ancestor
110277493|NCT04634656|Anesthetics|anesthetics|mesh-ancestor
110277494|NCT04634656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110277495|NCT04634656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277496|NCT04634656|Sensory System Agents|sensory system agents|mesh-ancestor
110277497|NCT04634656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110291152|NCT00252798|Mitosis Modulators|mitosis modulators|mesh-ancestor
110291153|NCT00252798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110291154|NCT00252798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110291155|NCT00252798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110291156|NCT02961660|Odalasvir|odalasvir|mesh-list
110291157|NCT02961660|Antiviral Agents|antiviral agents|mesh-ancestor
110291158|NCT02961660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110291159|NCT00403013|Anesthetics|anesthetics|mesh-list
110291160|NCT00403013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110291161|NCT00403013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110291162|NCT00566332|Fludarabine|fludarabine|mesh-list
110291163|NCT00566332|Chlorambucil|chlorambucil|mesh-list
110291164|NCT00566332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110291165|NCT00566332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110291166|NCT00566332|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110291167|NCT00566332|Alkylating Agents|alkylating agents|mesh-ancestor
110291168|NCT00403052|1018 oligonucleotide|1018 oligonucleotide|mesh-list
110291169|NCT00403052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110291170|NCT00403052|Immunologic Factors|immunologic factors|mesh-ancestor
110291171|NCT00403052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110291172|NCT00566371|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110291173|NCT00566371|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110291174|NCT00566371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110291175|NCT00566371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110291176|NCT00566371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110291177|NCT00566371|Adrenergic Agents|adrenergic agents|mesh-ancestor
110291178|NCT00566371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110291179|NCT00566371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110291180|NCT04595929|Leucovorin|leucovorin|mesh-list
110291181|NCT04595929|Docetaxel|docetaxel|mesh-list
110291182|NCT04595929|Fluorouracil|fluorouracil|mesh-list
110291183|NCT04595929|Oxaliplatin|oxaliplatin|mesh-list
110291184|NCT04595929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110291185|NCT04595929|Tubulin Modulators|tubulin modulators|mesh-ancestor
110291186|NCT04595929|Antimitotic Agents|antimitotic agents|mesh-ancestor
110291187|NCT04595929|Mitosis Modulators|mitosis modulators|mesh-ancestor
110291188|NCT04595929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110291189|NCT04595929|Antimetabolites|antimetabolites|mesh-ancestor
110291190|NCT04595929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110291191|NCT04595929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110291192|NCT04595929|Immunologic Factors|immunologic factors|mesh-ancestor
110291193|NCT04595929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110291194|NCT04595929|Antidotes|antidotes|mesh-ancestor
110291195|NCT04595929|Protective Agents|protective agents|mesh-ancestor
110291196|NCT04595929|Vitamin B Complex|vitamin b complex|mesh-ancestor
110291197|NCT04595929|Vitamins|vitamins|mesh-ancestor
110291198|NCT04595929|Micronutrients|micronutrients|mesh-ancestor
110291199|NCT00252954|Levetiracetam|levetiracetam|mesh-list
110291200|NCT00252954|Anticonvulsants|anticonvulsants|mesh-ancestor
110291201|NCT00252954|Nootropic Agents|nootropic agents|mesh-ancestor
110291202|NCT04595812|Misoprostol|misoprostol|mesh-list
110291203|NCT04595812|Hemostatics|hemostatics|mesh-list
110291204|NCT04595812|Oxytocin|oxytocin|mesh-list
110291205|NCT04595812|Carbetocin|carbetocin|mesh-list
110277498|NCT04634656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110277499|NCT04634656|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110277500|NCT04634656|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110277501|NCT04634656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110277502|NCT04634656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110277503|NCT04634500|Dapagliflozin|dapagliflozin|mesh-list
110277504|NCT04634500|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110277505|NCT04634500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110277506|NCT04634500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110277507|NCT04634500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277508|NCT04633954|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110277509|NCT04633954|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110277510|NCT04633954|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110277511|NCT04633954|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110277512|NCT04633954|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110277513|NCT04633954|Adrenergic Agents|adrenergic agents|mesh-ancestor
110291206|NCT04595812|Oxytocics|oxytocics|mesh-ancestor
110291207|NCT04595812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110291208|NCT04595812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110291211|NCT04595812|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110291212|NCT04595812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110291213|NCT04595812|Coagulants|coagulants|mesh-ancestor
110291214|NCT00249366|Lorazepam|lorazepam|mesh-list
110291215|NCT00249366|Anticonvulsants|anticonvulsants|mesh-ancestor
110291216|NCT00249366|Antiemetics|antiemetics|mesh-ancestor
110291217|NCT00249366|Autonomic Agents|autonomic agents|mesh-ancestor
110291218|NCT00249366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110291219|NCT00249366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110291220|NCT00249366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110291221|NCT00249366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110291222|NCT00249366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110291223|NCT00249366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110291224|NCT00249366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110291225|NCT00249366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110291226|NCT00249366|GABA Modulators|gaba modulators|mesh-ancestor
110291228|NCT00249366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110291229|NCT00249366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110291230|NCT04635683|Lenalidomide|lenalidomide|mesh-list
110291231|NCT04635683|Immunologic Factors|immunologic factors|mesh-ancestor
110291232|NCT04635683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110291233|NCT04635683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110291234|NCT04635683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110291235|NCT04635683|Growth Substances|growth substances|mesh-ancestor
110291236|NCT04635683|Growth Inhibitors|growth inhibitors|mesh-ancestor
110291237|NCT04635683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110291238|NCT00249405|Citalopram|citalopram|mesh-list
110291239|NCT00249405|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110291240|NCT00249405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110291241|NCT00249405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110291242|NCT00249405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110291243|NCT00249405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110291244|NCT00249405|Serotonin Agents|serotonin agents|mesh-ancestor
110291245|NCT00249405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110291246|NCT00249405|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110277514|NCT04633954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110277515|NCT04633954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110277516|NCT04633954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277517|NCT00201630|Alfuzosin|alfuzosin|mesh-list
110277518|NCT00201630|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110277519|NCT00201630|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110277520|NCT00201630|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110277521|NCT00201630|Adrenergic Agents|adrenergic agents|mesh-ancestor
110291247|NCT00249405|Antidepressive Agents|antidepressive agents|mesh-ancestor
110291248|NCT00249405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110291249|NCT00566644|Levonorgestrel|levonorgestrel|mesh-list
110291250|NCT00566644|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110291251|NCT00566644|Contraceptive Agents|contraceptive agents|mesh-ancestor
110291252|NCT00566644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110291253|NCT00566644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110291254|NCT00566644|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110291255|NCT00566644|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110291256|NCT00566644|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110291257|NCT00253110|Haloperidol|haloperidol|mesh-list
110291258|NCT00253110|Risperidone|risperidone|mesh-list
110291259|NCT00253110|Haloperidol decanoate|haloperidol decanoate|mesh-list
110291260|NCT00253110|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110291261|NCT00253110|Serotonin Agents|serotonin agents|mesh-ancestor
110291262|NCT00253110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110291263|NCT00253110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110291264|NCT00253110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110291265|NCT00253110|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110291266|NCT00253110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110291267|NCT00253110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110291268|NCT00253110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110291269|NCT00253110|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110291270|NCT00253110|Dopamine Agents|dopamine agents|mesh-ancestor
110291271|NCT00253110|Antiemetics|antiemetics|mesh-ancestor
110291272|NCT00253110|Autonomic Agents|autonomic agents|mesh-ancestor
110291273|NCT00253110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110291274|NCT00253110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110291275|NCT00253110|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110291276|NCT00566683|Meperidine|meperidine|mesh-list
110291277|NCT00566683|Diazepam|diazepam|mesh-list
110291278|NCT00566683|Alfentanil|alfentanil|mesh-list
110291279|NCT00566683|Propofol|propofol|mesh-list
110291280|NCT00566683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110291281|NCT00566683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110291282|NCT00566683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110291293|NCT00566683|Antiemetics|antiemetics|mesh-ancestor
110291294|NCT00566683|Autonomic Agents|autonomic agents|mesh-ancestor
110291295|NCT00566683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110291296|NCT00566683|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110291297|NCT00566683|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110291298|NCT00566683|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110291299|NCT00566683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110291300|NCT00566683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110291301|NCT00566683|GABA Modulators|gaba modulators|mesh-ancestor
110291302|NCT00566683|GABA Agents|gaba agents|mesh-ancestor
110291303|NCT00566683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110291304|NCT00566683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110291305|NCT00566761|Triamcinolone|triamcinolone|mesh-list
110291306|NCT00566761|Bevacizumab|bevacizumab|mesh-list
110291307|NCT00566761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110291308|NCT00566761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110291309|NCT00566761|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110291310|NCT00566761|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110291311|NCT00566761|Growth Substances|growth substances|mesh-ancestor
110291312|NCT00566761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110291313|NCT00566761|Growth Inhibitors|growth inhibitors|mesh-ancestor
110291314|NCT00566761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110291315|NCT00566761|Glucocorticoids|glucocorticoids|mesh-ancestor
110277522|NCT00201630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110277523|NCT00201630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110277524|NCT00201630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277525|NCT00201630|Urological Agents|urological agents|mesh-ancestor
110277527|NCT00179231|Clozapine|clozapine|mesh-list
110277528|NCT00179231|Antiemetics|antiemetics|mesh-ancestor
110277529|NCT00179231|Autonomic Agents|autonomic agents|mesh-ancestor
110277530|NCT00179231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110277531|NCT00179231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110291317|NCT00566761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110291318|NCT00566800|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110291319|NCT00566800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110291320|NCT00566800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110291321|NCT00566800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110291322|NCT00566800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110291323|NCT04593706|Dexamethasone|dexamethasone|mesh-list
110291324|NCT04593706|Methylprednisolone|methylprednisolone|mesh-list
110291325|NCT04593706|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110291326|NCT04593706|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110291327|NCT04593706|Prednisolone|prednisolone|mesh-list
110291328|NCT04593706|Prednisolone acetate|prednisolone acetate|mesh-list
110291329|NCT04593706|Triamcinolone|triamcinolone|mesh-list
110291330|NCT04593706|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110291331|NCT04593706|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110291332|NCT04593706|Betamethasone|betamethasone|mesh-list
110291333|NCT04593706|Betamethasone Valerate|betamethasone valerate|mesh-list
110291334|NCT04593706|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
110291335|NCT04593706|Betamethasone benzoate|betamethasone benzoate|mesh-list
110291336|NCT04593706|Dexamethasone acetate|dexamethasone acetate|mesh-list
110291337|NCT04593706|Betamethasone acetate|betamethasone acetate|mesh-list
110291338|NCT04593706|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110291339|NCT04593706|Prednisolone phosphate|prednisolone phosphate|mesh-list
110291340|NCT04593706|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
110291341|NCT04593706|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
110291342|NCT04593706|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110291343|NCT04593706|BB 1101|bb 1101|mesh-list
110291344|NCT04593706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110291345|NCT04593706|Antiemetics|antiemetics|mesh-ancestor
110291346|NCT04593706|Autonomic Agents|autonomic agents|mesh-ancestor
110291347|NCT04593706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110291348|NCT04593706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110291349|NCT04593706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110291350|NCT04593706|Glucocorticoids|glucocorticoids|mesh-ancestor
110291351|NCT04593706|Hormones|hormones|mesh-ancestor
110291355|NCT04593706|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110291357|NCT04593706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110291358|NCT04593706|Immunologic Factors|immunologic factors|mesh-ancestor
110291359|NCT04593706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110291360|NCT04593706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110291361|NCT04593706|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110291362|NCT04593706|Respiratory System Agents|respiratory system agents|mesh-ancestor
110291363|NCT04593706|Protease Inhibitors|protease inhibitors|mesh-ancestor
110291364|NCT04593238|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110291365|NCT04593238|Calcium|calcium|mesh-list
110291366|NCT04593238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110291367|NCT04593238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110291368|NCT04593238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110291369|NCT04593160|Acetaminophen|acetaminophen|mesh-list
110291370|NCT04593160|Diclofenac|diclofenac|mesh-list
110291371|NCT04593160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110291372|NCT04593160|Analgesics|analgesics|mesh-ancestor
110291373|NCT04593160|Sensory System Agents|sensory system agents|mesh-ancestor
110291374|NCT04593160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110291375|NCT04593160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110291376|NCT04593160|Antipyretics|antipyretics|mesh-ancestor
110277532|NCT00179231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110277533|NCT00179231|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110277534|NCT00179231|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110277535|NCT00179231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110277536|NCT00179231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110277537|NCT00179231|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110277538|NCT00179231|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110277539|NCT00179231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110277540|NCT00179231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110277541|NCT00179231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110277542|NCT00179231|Serotonin Agents|serotonin agents|mesh-ancestor
110277543|NCT00179231|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110277544|NCT00179231|GABA Antagonists|gaba antagonists|mesh-ancestor
110277545|NCT00179231|GABA Agents|gaba agents|mesh-ancestor
110277546|NCT00201669|Clofarabine|clofarabine|mesh-list
110277547|NCT00201669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110277548|NCT00201669|Antimetabolites|antimetabolites|mesh-ancestor
110277549|NCT00201669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110277550|NCT00201669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110277551|NCT00201708|Cyclophosphamide|cyclophosphamide|mesh-list
110277552|NCT00201708|Docetaxel|docetaxel|mesh-list
110277553|NCT00201708|Doxorubicin|doxorubicin|mesh-list
110277554|NCT00201708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110277555|NCT00201708|Immunologic Factors|immunologic factors|mesh-ancestor
110277556|NCT00201708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277557|NCT00201708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110277558|NCT00201708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110277559|NCT00201708|Alkylating Agents|alkylating agents|mesh-ancestor
110291377|NCT04593160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110291378|NCT04593160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110291379|NCT04593160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110291380|NCT04593160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110291381|NCT04593160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110291382|NCT04593160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110291383|NCT00253149|Risperidone|risperidone|mesh-list
110291384|NCT00253149|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110291385|NCT00253149|Serotonin Agents|serotonin agents|mesh-ancestor
110291386|NCT00253149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110291387|NCT00253149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110291388|NCT00253149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110291389|NCT00253149|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110291390|NCT00253149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110291391|NCT00253149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110291392|NCT00253149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110277560|NCT00201708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110277562|NCT00201708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110277563|NCT00201708|Tubulin Modulators|tubulin modulators|mesh-ancestor
110277564|NCT00201708|Antimitotic Agents|antimitotic agents|mesh-ancestor
110277565|NCT00201708|Mitosis Modulators|mitosis modulators|mesh-ancestor
110277566|NCT00201708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110277567|NCT00201708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110277568|NCT00201708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110277569|NCT00201708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110277570|NCT04632121|Nicorandil|nicorandil|mesh-list
110277571|NCT04632121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110277572|NCT04632121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110277573|NCT04632121|Vasodilator Agents|vasodilator agents|mesh-ancestor
110277574|NCT04632121|Vitamin B Complex|vitamin b complex|mesh-ancestor
110277575|NCT04632121|Vitamins|vitamins|mesh-ancestor
110277576|NCT04632121|Micronutrients|micronutrients|mesh-ancestor
110277577|NCT04632121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110291393|NCT00253149|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110291394|NCT00253149|Dopamine Agents|dopamine agents|mesh-ancestor
110291395|NCT04539236|Lenalidomide|lenalidomide|mesh-list
110291396|NCT04539236|Luspatercept|luspatercept|mesh-list
110291397|NCT04539236|Immunologic Factors|immunologic factors|mesh-ancestor
110291398|NCT04539236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110291399|NCT04539236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110291400|NCT04539236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110291401|NCT04539236|Growth Substances|growth substances|mesh-ancestor
110291402|NCT04539236|Growth Inhibitors|growth inhibitors|mesh-ancestor
110291403|NCT04539236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110291404|NCT04539236|Hematinics|hematinics|mesh-ancestor
110291405|NCT00249483|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110291406|NCT00249483|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110291407|NCT00249483|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110291408|NCT00249483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110291409|NCT00249483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110291410|NCT00249483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110291411|NCT00249483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110291412|NCT00249483|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110291413|NCT00249483|Antidepressive Agents|antidepressive agents|mesh-ancestor
110291414|NCT00249483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110291415|NCT00567034|Naltrexone|naltrexone|mesh-list
110291416|NCT00567034|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110291417|NCT00567034|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110291418|NCT00567034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110291419|NCT00567034|Sensory System Agents|sensory system agents|mesh-ancestor
110291420|NCT00567034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110291428|NCT04592380|Clevidipine|clevidipine|mesh-list
110291429|NCT04592380|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
110291430|NCT04592380|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
110291431|NCT04592380|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110291432|NCT04592380|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110291433|NCT04592380|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110291434|NCT04592380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110291435|NCT04592380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110291436|NCT04592380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110277580|NCT00179699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110277581|NCT00179699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110277582|NCT00179699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110277583|NCT00179699|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110277584|NCT00179699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110277585|NCT00179699|Immunologic Factors|immunologic factors|mesh-ancestor
110277586|NCT00179699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110291437|NCT04592380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110291438|NCT00253188|Galantamine|galantamine|mesh-list
110291439|NCT00253188|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110291440|NCT00253188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110291441|NCT00253188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110291442|NCT00253188|Cholinergic Agents|cholinergic agents|mesh-ancestor
110291443|NCT00253188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110291444|NCT00253188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110291445|NCT00253188|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110291446|NCT00253188|Autonomic Agents|autonomic agents|mesh-ancestor
110291447|NCT00253188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110291448|NCT00253188|Nootropic Agents|nootropic agents|mesh-ancestor
110291449|NCT04591990|Hydrocortisone|hydrocortisone|mesh-list
110291450|NCT04591990|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110291451|NCT04591990|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110291452|NCT04591990|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110291453|NCT04591990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110291454|NCT04438265|Levobupivacaine|levobupivacaine|mesh-list
110291455|NCT04438265|Anesthetics, Local|anesthetics, local|mesh-ancestor
110291456|NCT04438265|Anesthetics|anesthetics|mesh-ancestor
110291457|NCT04438265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110291458|NCT04438265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110291459|NCT04438265|Sensory System Agents|sensory system agents|mesh-ancestor
110291460|NCT04438265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110291461|NCT04591795|Diclofenac|diclofenac|mesh-list
110291462|NCT04591795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110291463|NCT04591795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110291464|NCT04591795|Analgesics|analgesics|mesh-ancestor
110291465|NCT04591795|Sensory System Agents|sensory system agents|mesh-ancestor
110291466|NCT04591795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110291467|NCT04591795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110291468|NCT04591795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110291469|NCT04591795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110291470|NCT04591795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110291471|NCT04591795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110291472|NCT04591795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110291473|NCT04591639|Dapagliflozin|dapagliflozin|mesh-list
110291474|NCT04591639|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110291475|NCT04591639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110291476|NCT04591639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110291477|NCT04591639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110291478|NCT04719585|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110291479|NCT04719585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110291480|NCT04719585|Analgesics|analgesics|mesh-ancestor
110291481|NCT04719585|Sensory System Agents|sensory system agents|mesh-ancestor
110291482|NCT04719585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110291483|NCT04719585|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110291484|NCT04719585|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110291485|NCT04719585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110291490|NCT04719585|Dopamine Agents|dopamine agents|mesh-ancestor
110291491|NCT04592029|Bevacizumab|bevacizumab|mesh-list
110291492|NCT04592029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110291493|NCT04592029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110277587|NCT00179699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110277588|NCT00179699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110277589|NCT00179699|Growth Substances|growth substances|mesh-ancestor
110277590|NCT00179699|Growth Inhibitors|growth inhibitors|mesh-ancestor
110277591|NCT00201747|Mitomycins|mitomycins|mesh-list
110277592|NCT00201747|Mitomycin|mitomycin|mesh-list
110277593|NCT00201747|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110277594|NCT00201747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110277595|NCT00201747|Alkylating Agents|alkylating agents|mesh-ancestor
110277596|NCT00201747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110277597|NCT00201747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110277598|NCT00201747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110277599|NCT00179738|Lenalidomide|lenalidomide|mesh-list
110277600|NCT00179738|Immunologic Factors|immunologic factors|mesh-ancestor
110277601|NCT00179738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277602|NCT00179738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110277603|NCT00179738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110277604|NCT00179738|Growth Substances|growth substances|mesh-ancestor
110277605|NCT00179738|Growth Inhibitors|growth inhibitors|mesh-ancestor
110277606|NCT00179738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110291494|NCT04592029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110291495|NCT04592029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110291496|NCT04592029|Growth Substances|growth substances|mesh-ancestor
110291497|NCT04592029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110291498|NCT04592029|Growth Inhibitors|growth inhibitors|mesh-ancestor
110291499|NCT04409873|Hydrogen Peroxide|hydrogen peroxide|mesh-list
110291500|NCT04409873|Listerine|listerine|mesh-list
110291501|NCT04409873|Cetylpyridinium|cetylpyridinium|mesh-list
110291502|NCT04409873|Chlorine dioxide|chlorine dioxide|mesh-list
110291503|NCT04409873|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110291504|NCT04409873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110291505|NCT04409873|Dental Disinfectants|dental disinfectants|mesh-ancestor
110291506|NCT04409873|Disinfectants|disinfectants|mesh-ancestor
110291507|NCT00253227|Galantamine|galantamine|mesh-list
110291508|NCT00253227|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110291509|NCT00253227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110291510|NCT00253227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110291511|NCT00253227|Cholinergic Agents|cholinergic agents|mesh-ancestor
110291512|NCT00253227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110291513|NCT00253227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110291514|NCT00253227|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110291515|NCT00253227|Autonomic Agents|autonomic agents|mesh-ancestor
110291516|NCT00253227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110291517|NCT00253227|Nootropic Agents|nootropic agents|mesh-ancestor
110291518|NCT04591444|Fluorides|fluorides|mesh-list
110291519|NCT04591444|Fluorides, Topical|fluorides, topical|mesh-list
110291520|NCT04591444|Cariostatic Agents|cariostatic agents|mesh-ancestor
110291521|NCT04591444|Protective Agents|protective agents|mesh-ancestor
110291522|NCT04591444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110291523|NCT04591327|Anesthetics|anesthetics|mesh-list
110291524|NCT04591327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110291525|NCT04591327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110291526|NCT00253266|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110291527|NCT00253266|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110291528|NCT00253266|Antidepressive Agents|antidepressive agents|mesh-ancestor
110291529|NCT00253266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110291530|NCT00253266|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110277607|NCT04631341|Melatonin|melatonin|mesh-list
110277608|NCT04631341|Antioxidants|antioxidants|mesh-ancestor
110277609|NCT04631341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110277610|NCT04631341|Protective Agents|protective agents|mesh-ancestor
110277611|NCT04631341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277612|NCT04631341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110277613|NCT04723238|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110277614|NCT04723238|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110277615|NCT04723238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110291531|NCT00253266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110291532|NCT00253266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110291533|NCT00253266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110291534|NCT00253266|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110291535|NCT00253266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110291536|NCT00253266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110291537|NCT00253266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110291538|NCT00253266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110291539|NCT00253266|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110291540|NCT00253305|Terbinafine|terbinafine|mesh-list
110291541|NCT00253305|Naftifine|naftifine|mesh-list
110291542|NCT00253305|Antifungal Agents|antifungal agents|mesh-ancestor
110291543|NCT00253305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110291544|NCT00253305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110291545|NCT00253305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110291546|NCT04591600|Ivermectin|ivermectin|mesh-list
110291547|NCT04591600|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110291548|NCT04591600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110291549|NCT04591405|Vaccines|vaccines|mesh-list
110291550|NCT04591405|Immunologic Factors|immunologic factors|mesh-ancestor
110291551|NCT04591405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110291552|NCT04590742|Melatonin|melatonin|mesh-list
110291553|NCT04590742|Antioxidants|antioxidants|mesh-ancestor
110291554|NCT04590742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110291555|NCT04590742|Protective Agents|protective agents|mesh-ancestor
110291556|NCT04590742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110291558|NCT00253344|Docetaxel|docetaxel|mesh-list
110291559|NCT00253344|Lenalidomide|lenalidomide|mesh-list
110291560|NCT00253344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110291561|NCT00253344|Tubulin Modulators|tubulin modulators|mesh-ancestor
110291562|NCT00253344|Antimitotic Agents|antimitotic agents|mesh-ancestor
110291563|NCT00253344|Mitosis Modulators|mitosis modulators|mesh-ancestor
110291564|NCT00253344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110291565|NCT00253344|Immunologic Factors|immunologic factors|mesh-ancestor
110291566|NCT00253344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110291567|NCT00253344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110291568|NCT00253344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110291569|NCT00253344|Growth Substances|growth substances|mesh-ancestor
110291570|NCT00253344|Growth Inhibitors|growth inhibitors|mesh-ancestor
110291571|NCT00567463|Fluticasone|fluticasone|mesh-list
110291572|NCT00567463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110291573|NCT00567463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110291574|NCT00567463|Autonomic Agents|autonomic agents|mesh-ancestor
110291575|NCT00567463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110291576|NCT00567463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110291577|NCT00567463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110291578|NCT00567463|Respiratory System Agents|respiratory system agents|mesh-ancestor
110291579|NCT00567463|Dermatologic Agents|dermatologic agents|mesh-ancestor
110291580|NCT00567463|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110291582|NCT00253422|Anastrozole|anastrozole|mesh-list
110291583|NCT00253422|Exemestane|exemestane|mesh-list
110291584|NCT00253422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110291585|NCT00253422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110291586|NCT00253422|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110277616|NCT04723238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110277617|NCT04723238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110277618|NCT04723238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110277619|NCT04723238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277620|NCT04723238|Analgesics|analgesics|mesh-ancestor
110277621|NCT04723238|Sensory System Agents|sensory system agents|mesh-ancestor
110277622|NCT04723238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110277623|NCT04723238|Antidepressive Agents|antidepressive agents|mesh-ancestor
110277624|NCT04723238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110291587|NCT00253422|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110291588|NCT00253422|Hormone Antagonists|hormone antagonists|mesh-ancestor
110291589|NCT00253422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110291590|NCT00253422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110291591|NCT00253422|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110291592|NCT00253422|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110291593|NCT00253422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110291594|NCT00253422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110291595|NCT04590625|Carboplatin|carboplatin|mesh-list
110291596|NCT04590625|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110291597|NCT04590625|Apatinib|apatinib|mesh-list
110291598|NCT04590625|Cisplatin|cisplatin|mesh-list
110291599|NCT04590625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110291600|NCT04590625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110291601|NCT04590625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110291602|NCT04590625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110291603|NCT00253461|Topotecan|topotecan|mesh-list
110291604|NCT00253461|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110291605|NCT00253461|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110291606|NCT00253461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110291607|NCT00253461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110291608|NCT00253461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110291609|NCT00253461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110291610|NCT00253461|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110291611|NCT00567658|Esomeprazole|esomeprazole|mesh-list
110291612|NCT00567658|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110291613|NCT00567658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110291614|NCT00567658|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110291615|NCT00567658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110291616|NCT00567658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110291617|NCT00567697|Ranibizumab|ranibizumab|mesh-list
110291618|NCT00567697|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110291619|NCT00567697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110291620|NCT00567697|Growth Substances|growth substances|mesh-ancestor
110291621|NCT00567697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110291622|NCT00567697|Growth Inhibitors|growth inhibitors|mesh-ancestor
110291623|NCT00567697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110291624|NCT04589494|Morphine|morphine|mesh-list
110291625|NCT04589494|Tramadol|tramadol|mesh-list
110291626|NCT04589494|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110291627|NCT04589494|Narcotics|narcotics|mesh-ancestor
110291628|NCT04589494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110291629|NCT04589494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110291639|NCT00253500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110291640|NCT00253500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110291641|NCT00253500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110291642|NCT00253500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110291643|NCT00253500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110291644|NCT00253500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110291645|NCT04589143|Agomelatine|agomelatine|mesh-list
110291646|NCT04589143|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110291647|NCT04589143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110291648|NCT04589143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110291649|NCT04588987|Apatinib|apatinib|mesh-list
110291650|NCT04588987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110277625|NCT04723238|Dopamine Agents|dopamine agents|mesh-ancestor
110277626|NCT00201786|Pentostatin|pentostatin|mesh-list
110277627|NCT00201786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110277628|NCT00201786|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
110277629|NCT00201786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110277630|NCT00201786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110277632|NCT04630522|Calcium, Dietary|calcium, dietary|mesh-list
110277633|NCT04630522|Calcium|calcium|mesh-list
110277634|NCT04630522|Vitamins|vitamins|mesh-ancestor
110277635|NCT04630522|Micronutrients|micronutrients|mesh-ancestor
110277636|NCT04630522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277637|NCT04630522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110291651|NCT04588987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110291652|NCT04588987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110291653|NCT04588987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110291655|NCT00253539|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110291656|NCT00253539|Hormone Antagonists|hormone antagonists|mesh-ancestor
110291657|NCT00253539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110291658|NCT00253539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110291659|NCT00253539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110291660|NCT00253539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110291661|NCT00253539|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110291662|NCT00253539|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110291663|NCT00253539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110291664|NCT04588636|Salicylic Acid|salicylic acid|mesh-list
110291665|NCT04588636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110291666|NCT04588636|Antifungal Agents|antifungal agents|mesh-ancestor
110291667|NCT04588636|Keratolytic Agents|keratolytic agents|mesh-ancestor
110291668|NCT04588636|Dermatologic Agents|dermatologic agents|mesh-ancestor
110291669|NCT00567775|Insulin|insulin|mesh-list
110291670|NCT00567775|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110291671|NCT00567775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110291672|NCT00567775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110291673|NCT00567814|Oxazepam|oxazepam|mesh-list
110291674|NCT00567814|Metyrapone|metyrapone|mesh-list
110291675|NCT00567814|Antimetabolites|antimetabolites|mesh-ancestor
110291676|NCT00567814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110291677|NCT00567814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110291678|NCT00567814|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110291679|NCT00567814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110291680|NCT00567814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110291681|NCT00567814|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110291682|NCT00567814|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110291683|NCT00567814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110291684|NCT00567814|GABA Modulators|gaba modulators|mesh-ancestor
110291685|NCT00567814|GABA Agents|gaba agents|mesh-ancestor
110291686|NCT00567814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110291687|NCT04588090|Cisplatin|cisplatin|mesh-list
110291688|NCT04588090|Paclitaxel|paclitaxel|mesh-list
110291689|NCT04588090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110291690|NCT04588090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110291691|NCT04588090|Tubulin Modulators|tubulin modulators|mesh-ancestor
110291692|NCT04588090|Antimitotic Agents|antimitotic agents|mesh-ancestor
110291693|NCT04588090|Mitosis Modulators|mitosis modulators|mesh-ancestor
110291694|NCT04588090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110291695|NCT00253578|Sorafenib|sorafenib|mesh-list
110291696|NCT00253578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110291697|NCT00253578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110291698|NCT00253578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110291709|NCT04153565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110291710|NCT04153565|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110291711|NCT04153565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110277638|NCT04630522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110277639|NCT00179816|Cyclophosphamide|cyclophosphamide|mesh-list
110277640|NCT00179816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110277641|NCT00179816|Immunologic Factors|immunologic factors|mesh-ancestor
110277642|NCT00179816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277643|NCT00179816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110277644|NCT00179816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110277645|NCT00179816|Alkylating Agents|alkylating agents|mesh-ancestor
110291712|NCT04588324|Antineoplastic Agents|antineoplastic agents|mesh-list
110291713|NCT00253617|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
110291714|NCT00253617|Trioxsalen|trioxsalen|mesh-list
110291715|NCT00253617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110291716|NCT00253617|Dermatologic Agents|dermatologic agents|mesh-ancestor
110291717|NCT00253617|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110291718|NCT04587778|Ketamine|ketamine|mesh-list
110291719|NCT04587778|Esketamine|esketamine|mesh-list
110291720|NCT04587778|Analgesics|analgesics|mesh-ancestor
110291721|NCT04587778|Sensory System Agents|sensory system agents|mesh-ancestor
110291722|NCT04587778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110291723|NCT04587778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110291724|NCT04587778|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110291725|NCT04587778|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110291726|NCT04587778|Anesthetics, General|anesthetics, general|mesh-ancestor
110291727|NCT04587778|Anesthetics|anesthetics|mesh-ancestor
110291728|NCT04587778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110291729|NCT04587778|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110291730|NCT04587778|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110291731|NCT04587778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110291732|NCT04587778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110291733|NCT04587778|Antidepressive Agents|antidepressive agents|mesh-ancestor
110291734|NCT04587778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110291735|NCT04587505|Morphine|morphine|mesh-list
110291736|NCT04587505|Tramadol|tramadol|mesh-list
110291737|NCT04587505|Anesthetics|anesthetics|mesh-list
110291738|NCT04587505|Ropivacaine|ropivacaine|mesh-list
110291739|NCT04587505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110291740|NCT04587505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110291741|NCT04587505|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110291742|NCT04587505|Narcotics|narcotics|mesh-ancestor
110291743|NCT04587505|Analgesics|analgesics|mesh-ancestor
110291744|NCT04587505|Sensory System Agents|sensory system agents|mesh-ancestor
110291745|NCT04587505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110291746|NCT04587505|Anesthetics, Local|anesthetics, local|mesh-ancestor
110291747|NCT04587115|Oxycodone|oxycodone|mesh-list
110291748|NCT04587115|Risperidone|risperidone|mesh-list
110291749|NCT04587115|Ziprasidone|ziprasidone|mesh-list
110291750|NCT04587115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110291751|NCT04587115|Narcotics|narcotics|mesh-ancestor
110291753|NCT04587115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110291754|NCT04587115|Analgesics|analgesics|mesh-ancestor
110291755|NCT04587115|Sensory System Agents|sensory system agents|mesh-ancestor
110291756|NCT04587115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110291757|NCT04587115|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110291758|NCT04587115|Serotonin Agents|serotonin agents|mesh-ancestor
110291759|NCT04587115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110291760|NCT04587115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110291761|NCT04587115|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110291762|NCT04587115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110291774|NCT00253773|Acetaminophen|acetaminophen|mesh-list
110291775|NCT00253773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110291776|NCT00253773|Analgesics|analgesics|mesh-ancestor
110291777|NCT00253773|Sensory System Agents|sensory system agents|mesh-ancestor
110291778|NCT00253773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110291779|NCT00253773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110291780|NCT00253773|Antipyretics|antipyretics|mesh-ancestor
110291781|NCT00403286|Fluticasone|fluticasone|mesh-list
110277646|NCT00179816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110277647|NCT00179816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110277648|NCT00179816|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110277649|NCT04630444|Riluzole|riluzole|mesh-list
110277650|NCT04630444|Anticonvulsants|anticonvulsants|mesh-ancestor
110277651|NCT04630444|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110277652|NCT04630444|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110277653|NCT04630444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110277654|NCT04630444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110022665|NCT00003012|Dermatologic Agents|dermatologic agents|mesh-ancestor
110291783|NCT00403286|Formoterol Fumarate|formoterol fumarate|mesh-list
110291784|NCT00403286|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110291785|NCT00403286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110291786|NCT00403286|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110291787|NCT00403286|Autonomic Agents|autonomic agents|mesh-ancestor
110291788|NCT00403286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110291789|NCT00403286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110291790|NCT00403286|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110291791|NCT00403286|Respiratory System Agents|respiratory system agents|mesh-ancestor
110291792|NCT00403286|Dermatologic Agents|dermatologic agents|mesh-ancestor
110291793|NCT00403286|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110291794|NCT00403286|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110291795|NCT00403286|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110291796|NCT00403286|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110291797|NCT00403286|Adrenergic Agents|adrenergic agents|mesh-ancestor
110291798|NCT00403286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110291799|NCT00403286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110291800|NCT04586491|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110291801|NCT04586218|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
110291802|NCT04585867|Bupivacaine|bupivacaine|mesh-list
110291803|NCT04585867|Anesthetics, Local|anesthetics, local|mesh-ancestor
110291804|NCT04585867|Anesthetics|anesthetics|mesh-ancestor
110291805|NCT04585867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110291806|NCT04585867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110291807|NCT04585867|Sensory System Agents|sensory system agents|mesh-ancestor
110291808|NCT04585867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110291809|NCT00253851|Heparin|heparin|mesh-list
110291810|NCT00253851|Calcium heparin|calcium heparin|mesh-list
110291811|NCT00253851|Anticoagulants|anticoagulants|mesh-ancestor
110291812|NCT00253851|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110291813|NCT00253851|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110291814|NCT00253851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110291815|NCT00249912|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110291816|NCT00249912|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110291817|NCT00249912|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110291818|NCT00249912|Antimetabolites|antimetabolites|mesh-ancestor
110291819|NCT00249912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110291820|NCT00249912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110291821|NCT00249912|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110291822|NCT00249912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110291823|NCT04585438|Diclofenac|diclofenac|mesh-list
110291824|NCT04585438|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110291825|NCT04585438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110291826|NCT04585438|Analgesics|analgesics|mesh-ancestor
110291827|NCT04585438|Sensory System Agents|sensory system agents|mesh-ancestor
110291828|NCT04585438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110291829|NCT04585438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110291838|NCT00567931|Tryptophan|tryptophan|mesh-list
110291839|NCT00567931|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110291840|NCT00567931|Antidepressive Agents|antidepressive agents|mesh-ancestor
110291841|NCT00567931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110291842|NCT00223301|Mycophenolic Acid|mycophenolic acid|mesh-list
110277655|NCT04630444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277656|NCT04630444|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110277657|NCT04630444|Protective Agents|protective agents|mesh-ancestor
110277658|NCT00186810|Cyclophosphamide|cyclophosphamide|mesh-list
110277659|NCT00186810|Busulfan|busulfan|mesh-list
110277660|NCT00186810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110277661|NCT00186810|Immunologic Factors|immunologic factors|mesh-ancestor
110277662|NCT00186810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277663|NCT00186810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110277664|NCT00186810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110291843|NCT00223301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110291844|NCT00223301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110291845|NCT00223301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110291846|NCT00223301|Antitubercular Agents|antitubercular agents|mesh-ancestor
110291847|NCT00223301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110291848|NCT00223301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110291849|NCT00223301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110291850|NCT00223301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110291851|NCT04585321|Diclofenac|diclofenac|mesh-list
110291852|NCT04585321|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
110291853|NCT04585321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110291854|NCT04585321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110291855|NCT04585321|Analgesics|analgesics|mesh-ancestor
110291856|NCT04585321|Sensory System Agents|sensory system agents|mesh-ancestor
110291857|NCT04585321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110291858|NCT04585321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110291859|NCT04585321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110291860|NCT04585321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110291861|NCT04585321|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110291862|NCT04585321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110291863|NCT04585321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110291865|NCT00412997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110291866|NCT00412997|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110291867|NCT00412997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110291868|NCT00412997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110291869|NCT00253929|Adenosine|adenosine|mesh-list
110291870|NCT00253929|Nitroprusside|nitroprusside|mesh-list
110291871|NCT00253929|Acetylcholine|acetylcholine|mesh-list
110291872|NCT00253929|Caffeine|caffeine|mesh-list
110291873|NCT00253929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110291874|NCT00253929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110291875|NCT00253929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110291876|NCT00253929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110291877|NCT00253929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110291878|NCT00253929|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110291879|NCT00253929|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110291880|NCT00253929|Purinergic Agents|purinergic agents|mesh-ancestor
110291881|NCT00253929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110291882|NCT00253929|Analgesics|analgesics|mesh-ancestor
110291883|NCT00253929|Sensory System Agents|sensory system agents|mesh-ancestor
110291884|NCT00253929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110291885|NCT00253929|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110291886|NCT00253929|Vasodilator Agents|vasodilator agents|mesh-ancestor
110291887|NCT00253929|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110291888|NCT00253929|Purinergic Agonists|purinergic agonists|mesh-ancestor
110291889|NCT00253929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110291890|NCT00253929|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110291891|NCT00253929|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110291892|NCT00253929|Cholinergic Agents|cholinergic agents|mesh-ancestor
110291893|NCT00568048|Bevacizumab|bevacizumab|mesh-list
110291894|NCT00568048|Temozolomide|temozolomide|mesh-list
110291895|NCT00568048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110291896|NCT00568048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110291905|NCT04584580|Heparin|heparin|mesh-list
110277665|NCT00186810|Alkylating Agents|alkylating agents|mesh-ancestor
110277666|NCT00186810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110277667|NCT00186810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110277669|NCT04630288|Clopidogrel|clopidogrel|mesh-list
110277670|NCT04630288|Ticagrelor|ticagrelor|mesh-list
110277671|NCT04630288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110277672|NCT04630288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110277673|NCT04630288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110291906|NCT04584580|Enoxaparin|enoxaparin|mesh-list
110291907|NCT04584580|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110291908|NCT04584580|Tinzaparin|tinzaparin|mesh-list
110291909|NCT04584580|Dalteparin|dalteparin|mesh-list
110291910|NCT04584580|Anticoagulants|anticoagulants|mesh-ancestor
110291911|NCT04584580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110291912|NCT04584580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110291913|NCT04584580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110291914|NCT00250029|Capecitabine|capecitabine|mesh-list
110291915|NCT00250029|Oxaliplatin|oxaliplatin|mesh-list
110291916|NCT00250029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110291917|NCT00250029|Antimetabolites|antimetabolites|mesh-ancestor
110291918|NCT00250029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110291919|NCT00250029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110291920|NCT00223418|Aripiprazole|aripiprazole|mesh-list
110291921|NCT00223418|Antidepressive Agents|antidepressive agents|mesh-ancestor
110291922|NCT00223418|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110291923|NCT00223418|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110291924|NCT00223418|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110291925|NCT00223418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110291926|NCT00223418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110291927|NCT00223418|Dopamine Agonists|dopamine agonists|mesh-ancestor
110291928|NCT00223418|Dopamine Agents|dopamine agents|mesh-ancestor
110291929|NCT00223418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110291930|NCT00223418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110291931|NCT00223418|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110291932|NCT00223418|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110291934|NCT00223418|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110291935|NCT00223418|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110291936|NCT00223418|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110291937|NCT00223418|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110291938|NCT04584736|Ezetimibe|ezetimibe|mesh-list
110291939|NCT04584736|Pitavastatin|pitavastatin|mesh-list
110291940|NCT04584736|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110291941|NCT04584736|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110291942|NCT04584736|Antimetabolites|antimetabolites|mesh-ancestor
110291943|NCT04584736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110291944|NCT04584736|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110291945|NCT04584736|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110291946|NCT04584736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110291947|NCT00250068|Rubitecan|rubitecan|mesh-list
110291948|NCT00250068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110291949|NCT00250068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110291950|NCT00250068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110291951|NCT00250068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110291952|NCT00250068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110291953|NCT04584307|Pomalidomide|pomalidomide|mesh-list
110291954|NCT04584307|Elotuzumab|elotuzumab|mesh-list
110291955|NCT04584307|Immunologic Factors|immunologic factors|mesh-ancestor
110291956|NCT04584307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110291957|NCT04584307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110291958|NCT04584307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110291959|NCT04584307|Growth Substances|growth substances|mesh-ancestor
110291960|NCT04584307|Growth Inhibitors|growth inhibitors|mesh-ancestor
110291961|NCT04584307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110291962|NCT04584034|Albuterol|albuterol|mesh-list
110277674|NCT04630288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110277675|NCT04630288|Purinergic Agents|purinergic agents|mesh-ancestor
110277676|NCT04630288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110277677|NCT04630288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110277678|NCT04630288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277680|NCT00561028|Immunologic Factors|immunologic factors|mesh-ancestor
110277681|NCT00561028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277682|NCT00561067|Methylprednisolone|methylprednisolone|mesh-list
110277683|NCT00561067|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110277684|NCT00561067|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110291963|NCT04584034|Bronchodilator Agents|bronchodilator agents|mesh-list
110291973|NCT04584034|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110291974|NCT04584034|Adrenergic Agents|adrenergic agents|mesh-ancestor
110291975|NCT04584034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110291976|NCT04584034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110291977|NCT04583410|Nicotine|nicotine|mesh-list
110291978|NCT04583410|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110291979|NCT04583410|Autonomic Agents|autonomic agents|mesh-ancestor
110291980|NCT04583410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110291981|NCT04583410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110291982|NCT04583410|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110291983|NCT04583410|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110291984|NCT04583410|Cholinergic Agents|cholinergic agents|mesh-ancestor
110291985|NCT04583410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110291986|NCT04583410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110291987|NCT00254007|Citalopram|citalopram|mesh-list
110291988|NCT00254007|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110291989|NCT00254007|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110291990|NCT00254007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110291991|NCT00254007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110291992|NCT00254007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110291993|NCT00254007|Serotonin Agents|serotonin agents|mesh-ancestor
110291994|NCT00254007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110291995|NCT00254007|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110291996|NCT00254007|Antidepressive Agents|antidepressive agents|mesh-ancestor
110291997|NCT00254007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110291998|NCT00223613|Insulin|insulin|mesh-list
110291999|NCT00223613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110292000|NCT00223613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110292001|NCT04583137|Lidocaine|lidocaine|mesh-list
110292002|NCT04583137|Anesthetics, Local|anesthetics, local|mesh-ancestor
110292003|NCT04583137|Anesthetics|anesthetics|mesh-ancestor
110292004|NCT04583137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110292005|NCT04583137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110292006|NCT04583137|Sensory System Agents|sensory system agents|mesh-ancestor
110292007|NCT04583137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110292008|NCT04583137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110292009|NCT04583137|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110022892|NCT00003018|Alkylating Agents|alkylating agents|mesh-ancestor
110292010|NCT04583137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110292011|NCT04583137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110292012|NCT04583137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110292014|NCT00223691|Diphenhydramine|diphenhydramine|mesh-list
110292015|NCT00223691|Promethazine|promethazine|mesh-list
110292016|NCT00223691|Ibuprofen|ibuprofen|mesh-list
110292017|NCT00223691|Celecoxib|celecoxib|mesh-list
110292018|NCT00223691|Indomethacin|indomethacin|mesh-list
110292019|NCT00223691|Octreotide|octreotide|mesh-list
110292020|NCT00223691|Phenylephrine|phenylephrine|mesh-list
110292021|NCT00223691|Acetazolamide|acetazolamide|mesh-list
110292022|NCT00223691|Midodrine|midodrine|mesh-list
110292023|NCT00223691|Pseudoephedrine|pseudoephedrine|mesh-list
110292024|NCT00223691|Ephedrine|ephedrine|mesh-list
110292025|NCT00223691|Oxymetazoline|oxymetazoline|mesh-list
110277685|NCT00561067|Prednisolone|prednisolone|mesh-list
110277686|NCT00561067|Prednisolone acetate|prednisolone acetate|mesh-list
110277687|NCT00561067|Epoetin Alfa|epoetin alfa|mesh-list
110277688|NCT00561067|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110277689|NCT00561067|Prednisolone phosphate|prednisolone phosphate|mesh-list
110277690|NCT00561067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110277691|NCT00561067|Antiemetics|antiemetics|mesh-ancestor
110277692|NCT00561067|Autonomic Agents|autonomic agents|mesh-ancestor
110277693|NCT00561067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110277694|NCT00561067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277695|NCT00561067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110277696|NCT00561067|Glucocorticoids|glucocorticoids|mesh-ancestor
110277697|NCT00561067|Hormones|hormones|mesh-ancestor
110292026|NCT00223691|Ergotamine|ergotamine|mesh-list
110292027|NCT00223691|Bromides|bromides|mesh-list
110292028|NCT00223691|Levodopa|levodopa|mesh-list
110292029|NCT00223691|Carbidopa|carbidopa|mesh-list
110292030|NCT00223691|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110292038|NCT00223691|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
110292039|NCT00223691|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110292040|NCT00223691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110292041|NCT00223691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110292042|NCT00223691|Analgesics|analgesics|mesh-ancestor
110292043|NCT00223691|Sensory System Agents|sensory system agents|mesh-ancestor
110292044|NCT00223691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110292045|NCT00223691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110292046|NCT00223691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110292047|NCT00223691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110292048|NCT00223691|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110292049|NCT00223691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110292050|NCT00223691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110292051|NCT00223691|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110292052|NCT00223691|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110292053|NCT00223691|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110292054|NCT00223691|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110292055|NCT00223691|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110292056|NCT00223691|Purinergic Agents|purinergic agents|mesh-ancestor
110292057|NCT00223691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110292058|NCT00223691|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110292059|NCT00223691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110292060|NCT00223691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110292061|NCT00223691|Dopamine Agents|dopamine agents|mesh-ancestor
110292062|NCT00223691|Anticonvulsants|anticonvulsants|mesh-ancestor
110292063|NCT00223691|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110292064|NCT00223691|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110292065|NCT00223691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110292066|NCT00223691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110292067|NCT00223691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110292068|NCT00223691|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110292069|NCT00223691|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110292070|NCT00223691|Adrenergic Agents|adrenergic agents|mesh-ancestor
110292071|NCT00223691|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110292072|NCT00223691|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110292073|NCT00223691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110292074|NCT00223691|Anesthetics, Local|anesthetics, local|mesh-ancestor
110292075|NCT00223691|Anesthetics|anesthetics|mesh-ancestor
110292076|NCT00223691|Antiemetics|antiemetics|mesh-ancestor
110292077|NCT00223691|Autonomic Agents|autonomic agents|mesh-ancestor
110292078|NCT00223691|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110292079|NCT00223691|Histamine Antagonists|histamine antagonists|mesh-ancestor
110292080|NCT00223691|Histamine Agents|histamine agents|mesh-ancestor
110292081|NCT00223691|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110292082|NCT00223691|Antipruritics|antipruritics|mesh-ancestor
110292083|NCT00223691|Dermatologic Agents|dermatologic agents|mesh-ancestor
110277698|NCT00561067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110277699|NCT00561067|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110277700|NCT00561067|Protective Agents|protective agents|mesh-ancestor
110277701|NCT00561067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110277702|NCT00561067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110277703|NCT00561067|Hematinics|hematinics|mesh-ancestor
110277704|NCT00561106|Valacyclovir|valacyclovir|mesh-list
110277706|NCT00561106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110277707|NCT00561106|Glucocorticoids|glucocorticoids|mesh-ancestor
110277708|NCT00561106|Hormones|hormones|mesh-ancestor
110277709|NCT00561106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110277710|NCT00561106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277711|NCT00561106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110292084|NCT00223691|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110292085|NCT00223691|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110292086|NCT00223691|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110292087|NCT00223691|Gout Suppressants|gout suppressants|mesh-ancestor
110292088|NCT00223691|Tocolytic Agents|tocolytic agents|mesh-ancestor
110292089|NCT00223691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110292090|NCT00223691|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110292092|NCT00223691|Natriuretic Agents|natriuretic agents|mesh-ancestor
110292093|NCT00223691|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110292094|NCT00223691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110292095|NCT00223691|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110292096|NCT00223691|Cholinergic Agents|cholinergic agents|mesh-ancestor
110292097|NCT00223691|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110292098|NCT00223691|Protective Agents|protective agents|mesh-ancestor
110292099|NCT00223691|Sympathomimetics|sympathomimetics|mesh-ancestor
110292100|NCT00223691|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110292101|NCT00223691|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110292108|NCT00223691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110292109|NCT00223691|Respiratory System Agents|respiratory system agents|mesh-ancestor
110292110|NCT00223691|Nasal Decongestants|nasal decongestants|mesh-ancestor
110292111|NCT00223691|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110292112|NCT00223691|Mydriatics|mydriatics|mesh-ancestor
110292113|NCT00223691|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110292114|NCT00223691|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110292115|NCT00223691|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110292116|NCT00223691|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110292117|NCT00223691|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110292118|NCT00223691|Urological Agents|urological agents|mesh-ancestor
110292119|NCT00223691|Antidepressive Agents|antidepressive agents|mesh-ancestor
110292120|NCT00223691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110292121|NCT00223691|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110292122|NCT00223691|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110292123|NCT00223691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110292124|NCT00223691|Oxytocics|oxytocics|mesh-ancestor
110292125|NCT00223691|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110292126|NCT00223691|Serotonin Agents|serotonin agents|mesh-ancestor
110292127|NCT04583020|Temozolomide|temozolomide|mesh-list
110292128|NCT04583020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110292129|NCT04583020|Alkylating Agents|alkylating agents|mesh-ancestor
110292130|NCT04583020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110292131|NCT04583020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110292132|NCT04582552|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
110292133|NCT04582552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110292134|NCT04582552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110292135|NCT04582552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110292136|NCT04582786|Morphine|morphine|mesh-list
110277712|NCT00561106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110277714|NCT00561106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110277715|NCT00561184|Vaccines|vaccines|mesh-list
110277716|NCT00561184|Immunologic Factors|immunologic factors|mesh-ancestor
110277717|NCT00561184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277718|NCT00186849|Cyclophosphamide|cyclophosphamide|mesh-list
110277719|NCT00186849|Ifosfamide|ifosfamide|mesh-list
110277720|NCT00186849|Carboplatin|carboplatin|mesh-list
110277721|NCT00186849|Doxorubicin|doxorubicin|mesh-list
110277722|NCT00186849|Etoposide|etoposide|mesh-list
110277723|NCT00186849|Topotecan|topotecan|mesh-list
110292137|NCT04582786|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110292138|NCT04582786|Narcotics|narcotics|mesh-ancestor
110292139|NCT04582786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110292140|NCT04582786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110292141|NCT04582786|Analgesics|analgesics|mesh-ancestor
110292142|NCT04582786|Sensory System Agents|sensory system agents|mesh-ancestor
110292143|NCT04582786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110292144|NCT00223769|Oxandrolone|oxandrolone|mesh-list
110292145|NCT00223769|Androgens|androgens|mesh-ancestor
110292146|NCT00223769|Hormones|hormones|mesh-ancestor
110292147|NCT00223769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110292148|NCT00223769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110292149|NCT00223769|Anabolic Agents|anabolic agents|mesh-ancestor
110292150|NCT04582084|Etanercept|etanercept|mesh-list
110292151|NCT04582084|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110292152|NCT04582084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110292153|NCT04582084|Analgesics|analgesics|mesh-ancestor
110292154|NCT04582084|Sensory System Agents|sensory system agents|mesh-ancestor
110292155|NCT04582084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110292156|NCT04582084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110292157|NCT04582084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110292158|NCT04582084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110292159|NCT04582084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110292160|NCT04582084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110292161|NCT04582084|Immunologic Factors|immunologic factors|mesh-ancestor
110292162|NCT00254046|Etravirine|etravirine|mesh-list
110292163|NCT00254046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110292164|NCT00254046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110292165|NCT00254046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110292166|NCT00254046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110292167|NCT00254046|Antiviral Agents|antiviral agents|mesh-ancestor
110292168|NCT00254046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110292169|NCT00223925|Maribavir|maribavir|mesh-list
110292170|NCT00223925|Antiviral Agents|antiviral agents|mesh-ancestor
110292171|NCT00223925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110292177|NCT04581967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110292178|NCT04581967|Immunologic Factors|immunologic factors|mesh-ancestor
110292179|NCT04581967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110292180|NCT04581967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110292181|NCT04581967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110292182|NCT04581967|Alkylating Agents|alkylating agents|mesh-ancestor
110292183|NCT04581967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110292184|NCT04581967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110292185|NCT04581967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110292186|NCT04581967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110292187|NCT04581967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110292188|NCT04581967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110292189|NCT04581967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110292190|NCT00223964|Ferric gluconate|ferric gluconate|mesh-list
110292191|NCT00223964|Hematinics|hematinics|mesh-ancestor
110292192|NCT00224081|Ferric gluconate|ferric gluconate|mesh-list
110292193|NCT00224081|Hematinics|hematinics|mesh-ancestor
110292194|NCT04581265|Paclitaxel|paclitaxel|mesh-list
110292195|NCT04581265|Ifosfamide|ifosfamide|mesh-list
110277724|NCT00186849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110277725|NCT00186849|Immunologic Factors|immunologic factors|mesh-ancestor
110277726|NCT00186849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277727|NCT00186849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110277728|NCT00186849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110277729|NCT00186849|Alkylating Agents|alkylating agents|mesh-ancestor
110277730|NCT00186849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110277731|NCT00186849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110292196|NCT04581265|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110292197|NCT04581265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110292198|NCT04581265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110292199|NCT04581265|Tubulin Modulators|tubulin modulators|mesh-ancestor
110292200|NCT04581265|Antimitotic Agents|antimitotic agents|mesh-ancestor
110292201|NCT04581265|Mitosis Modulators|mitosis modulators|mesh-ancestor
110292202|NCT04581265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110292203|NCT04581265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110292204|NCT04581265|Alkylating Agents|alkylating agents|mesh-ancestor
110292205|NCT04580797|PF-06700841|pf-06700841|mesh-list
110292206|NCT04580797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110292207|NCT04580797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110292208|NCT04580797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110292209|NCT00568477|Rituximab|rituximab|mesh-list
110292210|NCT00568477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110292211|NCT00568477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110292212|NCT00568477|Immunologic Factors|immunologic factors|mesh-ancestor
110292213|NCT00568477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110292214|NCT00568477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110292215|NCT00568711|Doxycycline|doxycycline|mesh-list
110292216|NCT00568711|Rifampin|rifampin|mesh-list
110292217|NCT00568711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110292218|NCT00568711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110292219|NCT00568711|Antimalarials|antimalarials|mesh-ancestor
110292220|NCT00568711|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110292221|NCT00568711|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110292222|NCT00568711|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110292223|NCT00568711|Antitubercular Agents|antitubercular agents|mesh-ancestor
110292224|NCT00568711|Leprostatic Agents|leprostatic agents|mesh-ancestor
110292225|NCT00568711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110292226|NCT00568711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110292227|NCT00568711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110292228|NCT00568711|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110292229|NCT00568711|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110292230|NCT00568711|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110292231|NCT00568711|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110292232|NCT00568711|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110292233|NCT00568711|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110292235|NCT00415116|Docetaxel|docetaxel|mesh-list
110292236|NCT00415116|Lenalidomide|lenalidomide|mesh-list
110292237|NCT00415116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110292238|NCT00415116|Tubulin Modulators|tubulin modulators|mesh-ancestor
110292239|NCT00415116|Antimitotic Agents|antimitotic agents|mesh-ancestor
110292240|NCT00415116|Mitosis Modulators|mitosis modulators|mesh-ancestor
110292241|NCT00415116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110292245|NCT00415116|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110292246|NCT00415116|Growth Substances|growth substances|mesh-ancestor
110292247|NCT00415116|Growth Inhibitors|growth inhibitors|mesh-ancestor
110292248|NCT00568750|Dasatinib|dasatinib|mesh-list
110292249|NCT00568750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110292250|NCT00568750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110292251|NCT00568750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110292252|NCT00568750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110292253|NCT00568789|Zolpidem|zolpidem|mesh-list
110277732|NCT00186849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110277733|NCT00186849|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110277734|NCT00186849|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110277735|NCT00186849|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110277737|NCT00186849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110277738|NCT00186849|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110277739|NCT00201981|Rebamipide|rebamipide|mesh-list
110277740|NCT00201981|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110277741|NCT00201981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110277742|NCT00201981|Antioxidants|antioxidants|mesh-ancestor
110277743|NCT00201981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110277744|NCT00201981|Protective Agents|protective agents|mesh-ancestor
110277745|NCT00201981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110292254|NCT00568789|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110292255|NCT00568789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110292256|NCT00568789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110292257|NCT00568789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110292258|NCT00568789|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110292259|NCT00568789|GABA Agonists|gaba agonists|mesh-ancestor
110292260|NCT00568789|GABA Agents|gaba agents|mesh-ancestor
110292261|NCT00568789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110292262|NCT00568789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110292263|NCT00254202|Iloperidone|iloperidone|mesh-list
110292264|NCT00254202|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110292265|NCT00254202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110292266|NCT00254202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110292267|NCT00254202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110292268|NCT00254202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110292269|NCT00568984|Metformin|metformin|mesh-list
110292270|NCT00568984|Repaglinide|repaglinide|mesh-list
110292271|NCT00568984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110292272|NCT00568984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110292273|NCT00254241|Risperidone|risperidone|mesh-list
110292274|NCT00254241|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110292275|NCT00254241|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110292276|NCT00254241|Serotonin Agents|serotonin agents|mesh-ancestor
110292277|NCT00254241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110292278|NCT00254241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110292279|NCT00254241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110292280|NCT00254241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110292281|NCT00254241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110292282|NCT00254241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110292283|NCT00254241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110292284|NCT00254241|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110292285|NCT00254241|Dopamine Agents|dopamine agents|mesh-ancestor
110292286|NCT00254241|Antidepressive Agents|antidepressive agents|mesh-ancestor
110292288|NCT00224315|Ziprasidone|ziprasidone|mesh-list
110292289|NCT00224315|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110292290|NCT00224315|Serotonin Agents|serotonin agents|mesh-ancestor
110292291|NCT00224315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110292292|NCT00224315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110292293|NCT00224315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110292294|NCT00224315|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110292295|NCT00224315|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110292296|NCT00224315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110292297|NCT00224315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110292298|NCT00224315|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110292299|NCT00224315|Dopamine Agents|dopamine agents|mesh-ancestor
110292300|NCT00569101|Tacrolimus|tacrolimus|mesh-list
110277746|NCT00201981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110277748|NCT00561223|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110277749|NCT00561223|Vasodilator Agents|vasodilator agents|mesh-ancestor
110277750|NCT00180011|Omalizumab|omalizumab|mesh-list
110277751|NCT00180011|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110277752|NCT00180011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110277753|NCT00180011|Respiratory System Agents|respiratory system agents|mesh-ancestor
110277754|NCT00186966|Cytarabine|cytarabine|mesh-list
110277755|NCT00186966|Cyclophosphamide|cyclophosphamide|mesh-list
110277756|NCT00186966|Melphalan|melphalan|mesh-list
110277757|NCT00186966|Busulfan|busulfan|mesh-list
110277758|NCT00186966|Fludarabine|fludarabine|mesh-list
110277759|NCT00186966|Etoposide|etoposide|mesh-list
110277760|NCT00186966|Daunorubicin|daunorubicin|mesh-list
110277761|NCT00186966|Thioguanine|thioguanine|mesh-list
110277762|NCT00186966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110277763|NCT00186966|Immunologic Factors|immunologic factors|mesh-ancestor
110277764|NCT00186966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277765|NCT00186966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110292301|NCT00569101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110292302|NCT00569101|Immunologic Factors|immunologic factors|mesh-ancestor
110292303|NCT00569101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110292304|NCT00569101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110292305|NCT00569101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110292306|NCT00569101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110292307|NCT00224354|Interleukin-2|interleukin-2|mesh-list
110292308|NCT00224354|Denileukin diftitox|denileukin diftitox|mesh-list
110292309|NCT00224354|Immunotoxins|immunotoxins|mesh-list
110292310|NCT00224354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110292311|NCT00224354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110292312|NCT00224354|Analgesics|analgesics|mesh-ancestor
110292313|NCT00224354|Sensory System Agents|sensory system agents|mesh-ancestor
110023194|NCT00003528|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110292323|NCT00569296|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110292324|NCT00569296|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110292325|NCT00569296|Antiviral Agents|antiviral agents|mesh-ancestor
110292326|NCT00569296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110292327|NCT00569335|Bevacizumab|bevacizumab|mesh-list
110292328|NCT00569335|Irinotecan|irinotecan|mesh-list
110036136|NCT01409174|Ipilimumab|ipilimumab|mesh-list
110292329|NCT00569335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110292330|NCT00569335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110292331|NCT00569335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110292332|NCT00569335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110292333|NCT00569335|Growth Substances|growth substances|mesh-ancestor
110292334|NCT00569335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110292335|NCT00569335|Growth Inhibitors|growth inhibitors|mesh-ancestor
110292336|NCT00569335|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110292337|NCT00569335|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110292338|NCT00569335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110292339|NCT00569335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110292340|NCT00254319|Bevacizumab|bevacizumab|mesh-list
110292341|NCT00254319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110292342|NCT00254319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110292343|NCT00254319|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110292344|NCT00254319|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110292345|NCT00254319|Growth Substances|growth substances|mesh-ancestor
110292346|NCT00254319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110292347|NCT00254319|Growth Inhibitors|growth inhibitors|mesh-ancestor
110277766|NCT00186966|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110277767|NCT00186966|Alkylating Agents|alkylating agents|mesh-ancestor
110277768|NCT00186966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110277769|NCT00186966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110277770|NCT00186966|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110277771|NCT00186966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110277772|NCT00186966|Antimetabolites|antimetabolites|mesh-ancestor
110277773|NCT00186966|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110277774|NCT00186966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110277775|NCT00186966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110277776|NCT00186966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110277777|NCT00186966|Antiviral Agents|antiviral agents|mesh-ancestor
110277778|NCT00186966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110292348|NCT00569452|Insulin|insulin|mesh-list
110292349|NCT00569452|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110292350|NCT00569452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110292351|NCT00569452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110292352|NCT00569881|Moxifloxacin|moxifloxacin|mesh-list
110292353|NCT00569881|Gatifloxacin|gatifloxacin|mesh-list
110292354|NCT00569881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110292355|NCT00569881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110292356|NCT00569881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110292357|NCT00569881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110292358|NCT00569881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110292359|NCT00569881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110292360|NCT00569881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110292361|NCT00569881|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110292362|NCT00569881|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110292363|NCT00224471|Vaccines|vaccines|mesh-list
110292364|NCT00224471|Immunologic Factors|immunologic factors|mesh-ancestor
110292365|NCT00224471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110292366|NCT00569920|Dexamethasone|dexamethasone|mesh-list
110292367|NCT00569920|Dexamethasone acetate|dexamethasone acetate|mesh-list
110292368|NCT00569920|BB 1101|bb 1101|mesh-list
110292369|NCT00569920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110292370|NCT00569920|Antiemetics|antiemetics|mesh-ancestor
110292371|NCT00569920|Autonomic Agents|autonomic agents|mesh-ancestor
110292372|NCT00569920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110292373|NCT00569920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110292374|NCT00569920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110292375|NCT00569920|Glucocorticoids|glucocorticoids|mesh-ancestor
110292376|NCT00569920|Hormones|hormones|mesh-ancestor
110292377|NCT00569920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110292378|NCT00569920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110292379|NCT00569920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110292380|NCT00569920|Protease Inhibitors|protease inhibitors|mesh-ancestor
110292381|NCT00569920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110292382|NCT00569920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110292387|NCT00224510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110292388|NCT00224510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110292389|NCT00224510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110292391|NCT00224510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110292392|NCT00224510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110292393|NCT00224510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110292394|NCT00224510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110292395|NCT00570193|Ranibizumab|ranibizumab|mesh-list
110292396|NCT00570193|Verteporfin|verteporfin|mesh-list
110292397|NCT00570193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110292398|NCT00570193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110292399|NCT00570193|Growth Substances|growth substances|mesh-ancestor
110292400|NCT00570193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277779|NCT00186966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110277781|NCT00180050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110277782|NCT00180050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110277783|NCT00180050|Autonomic Agents|autonomic agents|mesh-ancestor
110277784|NCT00180050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110277785|NCT00180050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277786|NCT00180050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110277787|NCT00180050|Respiratory System Agents|respiratory system agents|mesh-ancestor
110277788|NCT00180050|Glucocorticoids|glucocorticoids|mesh-ancestor
110277789|NCT00180050|Hormones|hormones|mesh-ancestor
110277790|NCT00180050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110292401|NCT00570193|Growth Inhibitors|growth inhibitors|mesh-ancestor
110292402|NCT00570193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110292403|NCT00570193|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110292404|NCT00570193|Dermatologic Agents|dermatologic agents|mesh-ancestor
110292405|NCT00224549|Amlodipine|amlodipine|mesh-list
110292406|NCT00224549|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110292407|NCT00224549|Irbesartan|irbesartan|mesh-list
110292408|NCT00224549|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110292409|NCT00224549|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110292410|NCT00224549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110292411|NCT00224549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110292412|NCT00224549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110292413|NCT00224549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110292414|NCT00224549|Vasodilator Agents|vasodilator agents|mesh-ancestor
110292415|NCT00224549|Diuretics|diuretics|mesh-ancestor
110292416|NCT00224549|Natriuretic Agents|natriuretic agents|mesh-ancestor
110292417|NCT00224549|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110292418|NCT00224549|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110292419|NCT00224549|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110292420|NCT00570544|Tiotropium Bromide|tiotropium bromide|mesh-list
110292421|NCT00570544|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110292422|NCT00570544|Autonomic Agents|autonomic agents|mesh-ancestor
110292423|NCT00570544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110292424|NCT00570544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110292425|NCT00570544|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110292426|NCT00570544|Respiratory System Agents|respiratory system agents|mesh-ancestor
110292427|NCT00570544|Parasympatholytics|parasympatholytics|mesh-ancestor
110292428|NCT00570544|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110292429|NCT00570544|Cholinergic Agents|cholinergic agents|mesh-ancestor
110292430|NCT00570544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110292431|NCT00570544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110292432|NCT00254436|Epoetin Alfa|epoetin alfa|mesh-list
110292433|NCT00254436|Hematinics|hematinics|mesh-ancestor
110292434|NCT00224588|Ketamine|ketamine|mesh-list
110292435|NCT00224588|Analgesics|analgesics|mesh-ancestor
110292436|NCT00224588|Sensory System Agents|sensory system agents|mesh-ancestor
110292437|NCT00224588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110292438|NCT00224588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110292439|NCT00224588|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110292440|NCT00224588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110292442|NCT00224588|Anesthetics|anesthetics|mesh-ancestor
110292443|NCT00224588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110292444|NCT00224588|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110292445|NCT00224588|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110292446|NCT00224588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110292447|NCT00224588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110292448|NCT00570622|Pioglitazone|pioglitazone|mesh-list
110292449|NCT00570622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110292450|NCT00570622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277791|NCT00575302|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110277793|NCT00575302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110277794|NCT00575302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277795|NCT00575341|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
110277796|NCT00575341|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110277797|NCT00575341|Immunologic Factors|immunologic factors|mesh-ancestor
110277798|NCT00575341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277799|NCT00180089|Budesonide|budesonide|mesh-list
110277800|NCT00180089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110292451|NCT00254475|Valsartan|valsartan|mesh-list
110292452|NCT00254475|Simvastatin|simvastatin|mesh-list
110292456|NCT00254475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110292458|NCT00254475|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110292459|NCT00254475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110292460|NCT00254475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110292461|NCT00254475|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110292462|NCT00254475|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110292463|NCT00570856|Folic Acid|folic acid|mesh-list
110292464|NCT00570856|Hematinics|hematinics|mesh-ancestor
110292465|NCT00570856|Vitamin B Complex|vitamin b complex|mesh-ancestor
110292466|NCT00570856|Vitamins|vitamins|mesh-ancestor
110292467|NCT00570856|Micronutrients|micronutrients|mesh-ancestor
110292468|NCT00570856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110292469|NCT00570934|Calcium, Dietary|calcium, dietary|mesh-list
110292470|NCT00570934|Cholecalciferol|cholecalciferol|mesh-list
110292471|NCT00570934|Vitamin D|vitamin d|mesh-list
110292472|NCT00570934|Calcium|calcium|mesh-list
110292473|NCT00570934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110292474|NCT00570934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110292475|NCT00570934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110292476|NCT00570934|Vitamins|vitamins|mesh-ancestor
110292477|NCT00570934|Micronutrients|micronutrients|mesh-ancestor
110292478|NCT00254553|Methyltestosterone|methyltestosterone|mesh-list
110292479|NCT00254553|Testosterone|testosterone|mesh-list
110292480|NCT00254553|Testosterone undecanoate|testosterone undecanoate|mesh-list
110292481|NCT00254553|Testosterone enanthate|testosterone enanthate|mesh-list
110292482|NCT00254553|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110292483|NCT00254553|Androgens|androgens|mesh-ancestor
110292484|NCT00254553|Hormones|hormones|mesh-ancestor
110292485|NCT00254553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110292486|NCT00254553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110292487|NCT00254553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110292488|NCT00254553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110292489|NCT00254553|Anabolic Agents|anabolic agents|mesh-ancestor
110292490|NCT00571129|Mitomycins|mitomycins|mesh-list
110292491|NCT00571129|Mitomycin|mitomycin|mesh-list
110292492|NCT00571129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110292493|NCT00571129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110292494|NCT00571129|Alkylating Agents|alkylating agents|mesh-ancestor
110292495|NCT00571129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110292496|NCT00571129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110292497|NCT00571129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110292498|NCT03453931|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110292499|NCT03453931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110292500|NCT03453931|Glucocorticoids|glucocorticoids|mesh-ancestor
110292502|NCT03453931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110292503|NCT03453931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110292504|NCT03453931|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110292505|NCT03453931|Protective Agents|protective agents|mesh-ancestor
110292506|NCT03453931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110292507|NCT03453931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110292508|NCT00571246|Topiramate|topiramate|mesh-list
110292509|NCT00571246|Lamotrigine|lamotrigine|mesh-list
110292510|NCT00571246|Anticonvulsants|anticonvulsants|mesh-ancestor
110277801|NCT00180089|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110277802|NCT00180089|Autonomic Agents|autonomic agents|mesh-ancestor
110277803|NCT00180089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110277804|NCT00180089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277805|NCT00180089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110277806|NCT00180089|Respiratory System Agents|respiratory system agents|mesh-ancestor
110277807|NCT00180089|Glucocorticoids|glucocorticoids|mesh-ancestor
110277808|NCT00180089|Hormones|hormones|mesh-ancestor
110277809|NCT00180089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110292511|NCT00571246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110292512|NCT00571246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110292513|NCT00571246|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110292514|NCT00571246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110292515|NCT00571246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110292516|NCT00571246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110292517|NCT00571246|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110292518|NCT00571246|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110292519|NCT00571246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110292520|NCT00571246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110292521|NCT00571246|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110292522|NCT00254631|Oxycodone|oxycodone|mesh-list
110292523|NCT00254631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110292524|NCT00254631|Narcotics|narcotics|mesh-ancestor
110292529|NCT00254631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110292531|NCT00571285|Ergocalciferols|ergocalciferols|mesh-list
110292532|NCT00571285|Cholecalciferol|cholecalciferol|mesh-list
110292534|NCT00571285|Micronutrients|micronutrients|mesh-ancestor
110292535|NCT00571285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110292536|NCT00571285|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110292537|NCT00571285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110292538|NCT00571558|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110292539|NCT00571558|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110292540|NCT00571558|Dermatologic Agents|dermatologic agents|mesh-ancestor
110292541|NCT00571636|Fentanyl|fentanyl|mesh-list
110292542|NCT00571636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110292543|NCT00571636|Narcotics|narcotics|mesh-ancestor
110292544|NCT00571636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110292545|NCT00571636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110292546|NCT00571636|Analgesics|analgesics|mesh-ancestor
110292547|NCT00571636|Sensory System Agents|sensory system agents|mesh-ancestor
110292548|NCT00571636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110292549|NCT00571636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110292550|NCT00571636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110292551|NCT00571636|Anesthetics, General|anesthetics, general|mesh-ancestor
110292553|NCT00571675|Prednisone|prednisone|mesh-list
110292554|NCT00571675|Docetaxel|docetaxel|mesh-list
110292555|NCT00571675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110292556|NCT00571675|Tubulin Modulators|tubulin modulators|mesh-ancestor
110292557|NCT00571675|Antimitotic Agents|antimitotic agents|mesh-ancestor
110292558|NCT00571675|Mitosis Modulators|mitosis modulators|mesh-ancestor
110292559|NCT00571675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110292560|NCT00571675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110292561|NCT00571675|Glucocorticoids|glucocorticoids|mesh-ancestor
110292562|NCT00571675|Hormones|hormones|mesh-ancestor
110292563|NCT00571675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110292564|NCT00571675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110292565|NCT00571675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110292566|NCT00571753|Isoniazid|isoniazid|mesh-list
110292567|NCT00571753|Antitubercular Agents|antitubercular agents|mesh-ancestor
110292568|NCT00571753|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110292569|NCT00571753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110292570|NCT00571753|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110292571|NCT00571753|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110292572|NCT00571753|Antimetabolites|antimetabolites|mesh-ancestor
110277810|NCT00575419|Acetylcysteine|acetylcysteine|mesh-list
110277811|NCT00575419|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110277812|NCT00575419|Antiviral Agents|antiviral agents|mesh-ancestor
110277813|NCT00575419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110277814|NCT00575419|Expectorants|expectorants|mesh-ancestor
110277815|NCT00575419|Respiratory System Agents|respiratory system agents|mesh-ancestor
110277816|NCT00575419|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110277817|NCT00575419|Antioxidants|antioxidants|mesh-ancestor
110277818|NCT00575419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110277819|NCT00575419|Protective Agents|protective agents|mesh-ancestor
110277820|NCT00575419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277821|NCT00575419|Antidotes|antidotes|mesh-ancestor
110277822|NCT00180128|Cytarabine|cytarabine|mesh-list
110277823|NCT00180128|Daunorubicin|daunorubicin|mesh-list
110277824|NCT00180128|Mitoxantrone|mitoxantrone|mesh-list
110277825|NCT00180128|Idarubicin|idarubicin|mesh-list
110277826|NCT00180128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110277827|NCT00180128|Antimetabolites|antimetabolites|mesh-ancestor
110292573|NCT00571753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110292574|NCT00571753|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110292575|NCT00254709|Sirolimus|sirolimus|mesh-list
110292576|NCT00254709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110292577|NCT00254709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110292578|NCT00254709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110292579|NCT00254709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110292580|NCT00254709|Antifungal Agents|antifungal agents|mesh-ancestor
110292581|NCT00254709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110292582|NCT00254709|Immunologic Factors|immunologic factors|mesh-ancestor
110292583|NCT00254709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110292584|NCT00224822|Aripiprazole|aripiprazole|mesh-list
110292585|NCT00224822|Antidepressive Agents|antidepressive agents|mesh-ancestor
110292586|NCT00224822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110292587|NCT00224822|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110292588|NCT00224822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110292589|NCT00224822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110292590|NCT00224822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110292591|NCT00224822|Dopamine Agonists|dopamine agonists|mesh-ancestor
110292592|NCT00224822|Dopamine Agents|dopamine agents|mesh-ancestor
110292593|NCT00224822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110292594|NCT00224822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110292595|NCT00224822|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110292606|NCT00571870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110292608|NCT00571870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110292609|NCT00254748|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110292610|NCT00254748|Antidepressive Agents|antidepressive agents|mesh-ancestor
110292611|NCT00254748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110292612|NCT00254748|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110292613|NCT00254748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110292614|NCT00254748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110292615|NCT00254748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110292616|NCT00572026|Methylphenidate|methylphenidate|mesh-list
110292617|NCT00572026|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110292618|NCT00572026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110292619|NCT00572026|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110292620|NCT00572026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110292621|NCT00572026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110292622|NCT00572026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110292623|NCT00572026|Dopamine Agents|dopamine agents|mesh-ancestor
110277828|NCT00180128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110277829|NCT00180128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110277830|NCT00180128|Antiviral Agents|antiviral agents|mesh-ancestor
110277831|NCT00180128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110277832|NCT00180128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110277833|NCT00180128|Immunologic Factors|immunologic factors|mesh-ancestor
110277834|NCT00180128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277835|NCT00180128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110277836|NCT00180128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110277837|NCT00180128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110292624|NCT00572026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110292625|NCT00572065|Cytarabine|cytarabine|mesh-list
110292626|NCT00572065|Arsenic Trioxide|arsenic trioxide|mesh-list
110292627|NCT00572065|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110292628|NCT00572065|Antimetabolites|antimetabolites|mesh-ancestor
110292629|NCT00572065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110292630|NCT00572065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110292631|NCT00572065|Antiviral Agents|antiviral agents|mesh-ancestor
110292632|NCT00572065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110292633|NCT00572065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110292634|NCT00572065|Immunologic Factors|immunologic factors|mesh-ancestor
110292635|NCT00572065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110292636|NCT00234897|Adalimumab|adalimumab|mesh-list
110292637|NCT00234897|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110292638|NCT00234897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110292639|NCT00234897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110292640|NCT00572182|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|mesh-list
110292641|NCT00572182|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
110292642|NCT00572182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110292643|NCT00572182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110292644|NCT00572299|Alendronate|alendronate|mesh-list
110292645|NCT00572299|Prednisone|prednisone|mesh-list
110292646|NCT00572299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110292647|NCT00572299|Glucocorticoids|glucocorticoids|mesh-ancestor
110292648|NCT00572299|Hormones|hormones|mesh-ancestor
110292649|NCT00572299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110292650|NCT00572299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110292651|NCT00572299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110292652|NCT00572299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110292653|NCT00572299|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110292654|NCT00234936|Adalimumab|adalimumab|mesh-list
110292655|NCT00234936|Methotrexate|methotrexate|mesh-list
110292656|NCT00234936|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110292657|NCT00234936|Abortifacient Agents|abortifacient agents|mesh-ancestor
110292662|NCT00234936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110292663|NCT00234936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110292664|NCT00234936|Dermatologic Agents|dermatologic agents|mesh-ancestor
110292665|NCT00234936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110292666|NCT00234936|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110292667|NCT00234936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110292668|NCT00234936|Immunologic Factors|immunologic factors|mesh-ancestor
110292669|NCT00234936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110292670|NCT00234936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110292671|NCT00234936|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110292672|NCT00234936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110292674|NCT00413075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110292675|NCT00413075|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110292676|NCT00413075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110292677|NCT00413075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110292678|NCT00572650|Vildagliptin|vildagliptin|mesh-list
110292679|NCT00572650|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110292680|NCT00572650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277839|NCT00180128|Analgesics|analgesics|mesh-ancestor
110277840|NCT00180128|Sensory System Agents|sensory system agents|mesh-ancestor
110277841|NCT00180128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110277842|NCT00575614|Prucalopride|prucalopride|mesh-list
110277843|NCT00575614|Laxatives|laxatives|mesh-ancestor
110277844|NCT00575614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110277845|NCT00575614|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
110292681|NCT00572650|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110292682|NCT00572650|Protease Inhibitors|protease inhibitors|mesh-ancestor
110292683|NCT00572650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110292684|NCT00572650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110292686|NCT00572689|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110292687|NCT00572689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110292688|NCT00572689|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110292689|NCT00572689|Incretins|incretins|mesh-ancestor
110292690|NCT00572689|Hormones|hormones|mesh-ancestor
110292691|NCT00572689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110292692|NCT00572806|Insulin Aspart|insulin aspart|mesh-list
110292693|NCT00572806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110292694|NCT00572806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110292695|NCT00224978|Chloroquine|chloroquine|mesh-list
110292696|NCT00224978|Amebicides|amebicides|mesh-ancestor
110292697|NCT00224978|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110292698|NCT00224978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110292699|NCT00224978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110292700|NCT00224978|Antimalarials|antimalarials|mesh-ancestor
110292701|NCT00224978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110292702|NCT00572884|Permethrin|permethrin|mesh-list
110292703|NCT00572884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110292704|NCT00572884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110292705|NCT00573001|Ritonavir|ritonavir|mesh-list
110292706|NCT00573001|Lopinavir|lopinavir|mesh-list
110292707|NCT00573001|Tenofovir|tenofovir|mesh-list
110292708|NCT00573001|Emtricitabine|emtricitabine|mesh-list
110292709|NCT00573001|Zidovudine|zidovudine|mesh-list
110292710|NCT00573001|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110292711|NCT00573001|Nevirapine|nevirapine|mesh-list
110292712|NCT00573001|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110292713|NCT00573001|Efavirenz|efavirenz|mesh-list
110292714|NCT00573001|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110292715|NCT00573001|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110292716|NCT00573001|Protease Inhibitors|protease inhibitors|mesh-ancestor
110292717|NCT00573001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110292718|NCT00573001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110292719|NCT00573001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110292720|NCT00573001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110292721|NCT00573001|Antiviral Agents|antiviral agents|mesh-ancestor
110292722|NCT00573001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110292723|NCT00573001|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110292724|NCT00573001|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110292725|NCT00573001|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110292726|NCT00573001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110292727|NCT00573001|Antimetabolites|antimetabolites|mesh-ancestor
110292735|NCT00254787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110292736|NCT00254787|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110292737|NCT00254787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110292738|NCT00254787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110292739|NCT00254787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110292740|NCT00225056|Docetaxel|docetaxel|mesh-list
110292741|NCT00225056|Capecitabine|capecitabine|mesh-list
110292742|NCT00225056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110292743|NCT00225056|Tubulin Modulators|tubulin modulators|mesh-ancestor
110292744|NCT00225056|Antimitotic Agents|antimitotic agents|mesh-ancestor
110292745|NCT00225056|Mitosis Modulators|mitosis modulators|mesh-ancestor
110292746|NCT00225056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110277846|NCT00575614|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110277847|NCT00575614|Serotonin Agents|serotonin agents|mesh-ancestor
110277848|NCT00575614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110277849|NCT00575614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110277850|NCT00575614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277852|NCT00575848|Glycine Agents|glycine agents|mesh-ancestor
110277853|NCT00575848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110277854|NCT00575848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110277855|NCT00575848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277856|NCT00576238|Betamethasone|betamethasone|mesh-list
110277857|NCT00576238|Betamethasone Valerate|betamethasone valerate|mesh-list
110277858|NCT00576238|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
110292747|NCT00225056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110292748|NCT00225056|Antimetabolites|antimetabolites|mesh-ancestor
110292749|NCT00225173|Prednisone|prednisone|mesh-list
110292750|NCT00225173|Cyclophosphamide|cyclophosphamide|mesh-list
110292751|NCT00225173|Gemcitabine|gemcitabine|mesh-list
110292752|NCT00225173|Doxorubicin|doxorubicin|mesh-list
110292753|NCT00225173|Etoposide|etoposide|mesh-list
110292754|NCT00225173|Etoposide phosphate|etoposide phosphate|mesh-list
110292755|NCT00225173|Vincristine|vincristine|mesh-list
110292756|NCT00225173|Vinorelbine|vinorelbine|mesh-list
110292758|NCT00225173|Vinblastine|vinblastine|mesh-list
110292759|NCT00225173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110292760|NCT00225173|Immunologic Factors|immunologic factors|mesh-ancestor
110292761|NCT00225173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110292762|NCT00225173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110292763|NCT00225173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110292764|NCT00225173|Alkylating Agents|alkylating agents|mesh-ancestor
110292765|NCT00225173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110292766|NCT00225173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110292767|NCT00225173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110292768|NCT00225173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110292769|NCT00225173|Antimetabolites|antimetabolites|mesh-ancestor
110292770|NCT00225173|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110292771|NCT00225173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110292772|NCT00225173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110292773|NCT00225173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110292774|NCT00225173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110292775|NCT00225173|Glucocorticoids|glucocorticoids|mesh-ancestor
110292777|NCT00225173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110292778|NCT00225173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110292779|NCT00225173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110292780|NCT00225173|Tubulin Modulators|tubulin modulators|mesh-ancestor
110292781|NCT00225173|Antimitotic Agents|antimitotic agents|mesh-ancestor
110292782|NCT00225173|Mitosis Modulators|mitosis modulators|mesh-ancestor
110292783|NCT00234975|Ritonavir|ritonavir|mesh-list
110292784|NCT00234975|Lopinavir|lopinavir|mesh-list
110292785|NCT00234975|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110292786|NCT00234975|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110292787|NCT00234975|Protease Inhibitors|protease inhibitors|mesh-ancestor
110292788|NCT00234975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110292789|NCT00234975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110292790|NCT00234975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110292791|NCT00234975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110292792|NCT00234975|Antiviral Agents|antiviral agents|mesh-ancestor
110292793|NCT00234975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110292794|NCT00234975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110292795|NCT00234975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110292796|NCT00235014|Verapamil|verapamil|mesh-list
110292813|NCT00225290|Leprostatic Agents|leprostatic agents|mesh-ancestor
110277859|NCT00576238|Betamethasone benzoate|betamethasone benzoate|mesh-list
110277860|NCT00576238|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
110277861|NCT00576238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110277862|NCT00576238|Glucocorticoids|glucocorticoids|mesh-ancestor
110277863|NCT00576238|Hormones|hormones|mesh-ancestor
110277864|NCT00576238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110277865|NCT00576238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277866|NCT00576238|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110277867|NCT00576238|Respiratory System Agents|respiratory system agents|mesh-ancestor
110277868|NCT00576394|Insulin|insulin|mesh-list
110277869|NCT00576394|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110277870|NCT00576394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110292814|NCT00225290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110292815|NCT00225290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110292816|NCT00225290|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110292818|NCT00225290|Growth Substances|growth substances|mesh-ancestor
110292819|NCT00225290|Growth Inhibitors|growth inhibitors|mesh-ancestor
110292820|NCT00225290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110292822|NCT00573547|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110292823|NCT00573547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110292824|NCT00573547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110292825|NCT00573547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110292826|NCT00573547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110292827|NCT00573547|Serotonin Agents|serotonin agents|mesh-ancestor
110292828|NCT00573547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110292829|NCT00573547|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110292830|NCT00573547|Antidepressive Agents|antidepressive agents|mesh-ancestor
110292831|NCT00573547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110292832|NCT00573547|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110292833|NCT00573547|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110292834|NCT00573547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110292835|NCT00573664|Gabapentin|gabapentin|mesh-list
110292836|NCT00573664|Analgesics|analgesics|mesh-ancestor
110292837|NCT00573664|Sensory System Agents|sensory system agents|mesh-ancestor
110292838|NCT00573664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110292839|NCT00573664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110292840|NCT00573664|Anticonvulsants|anticonvulsants|mesh-ancestor
110292841|NCT00573664|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110292842|NCT00573664|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110292843|NCT00573664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110292844|NCT00573664|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110292845|NCT00573664|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110292846|NCT00573664|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110292847|NCT00573664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110292848|NCT00573664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110292849|NCT00573664|Antimanic Agents|antimanic agents|mesh-ancestor
110292850|NCT00573742|Candesartan|candesartan|mesh-list
110292851|NCT00573742|Candesartan cilexetil|candesartan cilexetil|mesh-list
110292852|NCT00573742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110292865|NCT00254865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110292866|NCT00254865|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110292867|NCT00254865|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110292868|NCT00254865|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110292869|NCT00235053|Fluticasone|fluticasone|mesh-list
110292870|NCT00235053|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110292871|NCT00235053|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110292872|NCT00235053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110292873|NCT00235053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110292874|NCT00235053|Autonomic Agents|autonomic agents|mesh-ancestor
110277871|NCT00576394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277873|NCT00576433|Methotrexate|methotrexate|mesh-list
110277874|NCT00576433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110277875|NCT00576433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110277876|NCT00576433|Immunologic Factors|immunologic factors|mesh-ancestor
110277877|NCT00576433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277878|NCT00576433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110277879|NCT00576433|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110277880|NCT00576433|Abortifacient Agents|abortifacient agents|mesh-ancestor
110277881|NCT00576433|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110277882|NCT00576433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110277883|NCT00576433|Antimetabolites|antimetabolites|mesh-ancestor
110277884|NCT00576433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110292875|NCT00235053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110292876|NCT00235053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110292877|NCT00235053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110292878|NCT00235053|Respiratory System Agents|respiratory system agents|mesh-ancestor
110292879|NCT00235053|Dermatologic Agents|dermatologic agents|mesh-ancestor
110292880|NCT00235053|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110292881|NCT00235053|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110292882|NCT00235053|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110292883|NCT00235053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110292884|NCT00235053|Adrenergic Agents|adrenergic agents|mesh-ancestor
110292885|NCT00235053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110292886|NCT00235053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110292887|NCT00235053|Glucocorticoids|glucocorticoids|mesh-ancestor
110292888|NCT00235053|Hormones|hormones|mesh-ancestor
110292889|NCT00235053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110292890|NCT00235053|Sympathomimetics|sympathomimetics|mesh-ancestor
110292891|NCT00574015|Acetaminophen|acetaminophen|mesh-list
110292892|NCT00574015|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
110292893|NCT00574015|Hydrocodone|hydrocodone|mesh-list
110292894|NCT00574015|Bupivacaine|bupivacaine|mesh-list
110292895|NCT00574015|Anesthetics, Local|anesthetics, local|mesh-ancestor
110292896|NCT00574015|Anesthetics|anesthetics|mesh-ancestor
110292897|NCT00574015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110292898|NCT00574015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110292899|NCT00574015|Sensory System Agents|sensory system agents|mesh-ancestor
110292900|NCT00574015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110292901|NCT00574015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110292902|NCT00574015|Analgesics|analgesics|mesh-ancestor
110292903|NCT00574015|Antipyretics|antipyretics|mesh-ancestor
110292904|NCT00574015|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110292905|NCT00574015|Narcotics|narcotics|mesh-ancestor
110292906|NCT00574015|Antitussive Agents|antitussive agents|mesh-ancestor
110292907|NCT00574015|Respiratory System Agents|respiratory system agents|mesh-ancestor
110292908|NCT00574015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110292909|NCT00574015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110292910|NCT00574015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110292911|NCT00225485|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110292912|NCT00225485|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110292913|NCT00225485|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110292918|NCT00225485|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110292919|NCT00225485|Antidepressive Agents|antidepressive agents|mesh-ancestor
110292920|NCT00225485|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110292921|NCT00574093|Ranibizumab|ranibizumab|mesh-list
110292922|NCT00574093|Verteporfin|verteporfin|mesh-list
110292923|NCT00574093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110277885|NCT00576433|Dermatologic Agents|dermatologic agents|mesh-ancestor
110277886|NCT00576433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110277887|NCT00576433|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110277888|NCT00576433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110277889|NCT00576433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110277890|NCT00576511|Prucalopride|prucalopride|mesh-list
110277891|NCT00576511|Laxatives|laxatives|mesh-ancestor
110277892|NCT00576511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110292924|NCT00574093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110292925|NCT00574093|Growth Substances|growth substances|mesh-ancestor
110292926|NCT00574093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110292927|NCT00574093|Growth Inhibitors|growth inhibitors|mesh-ancestor
110292928|NCT00574093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110292929|NCT00574093|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110292930|NCT00574093|Dermatologic Agents|dermatologic agents|mesh-ancestor
110292932|NCT00574366|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110292933|NCT00574366|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110292934|NCT00574366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110292935|NCT00574366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110292936|NCT00574366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110292937|NCT00574366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110292938|NCT00574366|Immunologic Factors|immunologic factors|mesh-ancestor
110292939|NCT00574366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110292940|NCT00574366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110292941|NCT00225524|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110292942|NCT00225524|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110292943|NCT00225524|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110292944|NCT00225524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110292945|NCT00225524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110292946|NCT00225524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110292947|NCT00225524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110292948|NCT00225524|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110292949|NCT00225524|Antidepressive Agents|antidepressive agents|mesh-ancestor
110292950|NCT00225524|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110292951|NCT00574483|Quinacrine|quinacrine|mesh-list
110292952|NCT00574483|Anticestodal Agents|anticestodal agents|mesh-ancestor
110292953|NCT00574483|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110292955|NCT00574483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110292956|NCT00574483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110292957|NCT00574483|Antimalarials|antimalarials|mesh-ancestor
110292958|NCT00574483|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110292959|NCT00574483|Antinematodal Agents|antinematodal agents|mesh-ancestor
110292960|NCT00574483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110292961|NCT00574483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110292962|NCT00574483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110292963|NCT00235092|Sirolimus|sirolimus|mesh-list
110292964|NCT00235092|Paclitaxel|paclitaxel|mesh-list
110292965|NCT00235092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110292966|NCT00235092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110292967|NCT00235092|Tubulin Modulators|tubulin modulators|mesh-ancestor
110292968|NCT00235092|Antimitotic Agents|antimitotic agents|mesh-ancestor
110292969|NCT00235092|Mitosis Modulators|mitosis modulators|mesh-ancestor
110292970|NCT00235092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110292971|NCT00235092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110292972|NCT00235092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110292973|NCT00235092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110292974|NCT00235092|Antifungal Agents|antifungal agents|mesh-ancestor
110292975|NCT00235092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110292976|NCT00235092|Immunologic Factors|immunologic factors|mesh-ancestor
110292977|NCT00235092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110292978|NCT00574600|Vaccines|vaccines|mesh-list
110292979|NCT00574600|Immunologic Factors|immunologic factors|mesh-ancestor
110292980|NCT00574600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277893|NCT00576511|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
110277894|NCT00576511|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110277895|NCT00576511|Serotonin Agents|serotonin agents|mesh-ancestor
110277896|NCT00576511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110277897|NCT00576511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110277898|NCT00576511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277899|NCT00576550|Betamethasone|betamethasone|mesh-list
110277900|NCT00576550|Betamethasone Valerate|betamethasone valerate|mesh-list
110277901|NCT00576550|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
110277902|NCT00576550|Betamethasone benzoate|betamethasone benzoate|mesh-list
110277903|NCT00576550|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
110277904|NCT00576550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110277905|NCT00576550|Glucocorticoids|glucocorticoids|mesh-ancestor
110277907|NCT00576550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110292981|NCT00574639|Alprazolam|alprazolam|mesh-list
110292982|NCT00574639|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110292988|NCT00574639|GABA Modulators|gaba modulators|mesh-ancestor
110292989|NCT00574639|GABA Agents|gaba agents|mesh-ancestor
110292990|NCT00574639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110292991|NCT00574639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110292992|NCT00255255|Budesonide|budesonide|mesh-list
110292993|NCT00255255|Formoterol Fumarate|formoterol fumarate|mesh-list
110292994|NCT00255255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110292995|NCT00255255|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110292996|NCT00255255|Autonomic Agents|autonomic agents|mesh-ancestor
110292997|NCT00255255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110292998|NCT00255255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110292999|NCT00255255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110293000|NCT00255255|Respiratory System Agents|respiratory system agents|mesh-ancestor
110293001|NCT00255255|Glucocorticoids|glucocorticoids|mesh-ancestor
110293002|NCT00255255|Hormones|hormones|mesh-ancestor
110293003|NCT00255255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110293004|NCT00255255|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110293005|NCT00255255|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110293006|NCT00255255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110293007|NCT00255255|Adrenergic Agents|adrenergic agents|mesh-ancestor
110293008|NCT00255255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110293009|NCT00255255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293010|NCT00574756|Ranolazine|ranolazine|mesh-list
110293011|NCT00574756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110293012|NCT00574756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110293013|NCT00574756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293014|NCT03453346|Ribavirin|ribavirin|mesh-list
110293015|NCT03453346|Sofosbuvir|sofosbuvir|mesh-list
110293016|NCT03453346|Antimetabolites|antimetabolites|mesh-ancestor
110293017|NCT03453346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293018|NCT03453346|Antiviral Agents|antiviral agents|mesh-ancestor
110293019|NCT03453346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110293020|NCT00575068|Galiximab|galiximab|mesh-list
110293021|NCT00575068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110293022|NCT00575068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110293023|NCT00575224|Interferons|interferons|mesh-list
110293024|NCT00575224|Ribavirin|ribavirin|mesh-list
110293025|NCT00575224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110293026|NCT00575224|Antiviral Agents|antiviral agents|mesh-ancestor
110293027|NCT00575224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110293028|NCT00575224|Antimetabolites|antimetabolites|mesh-ancestor
110293029|NCT00575224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110277908|NCT00576550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277909|NCT00576550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110277910|NCT00576550|Respiratory System Agents|respiratory system agents|mesh-ancestor
110277911|NCT00576706|Misoprostol|misoprostol|mesh-list
110277912|NCT00576706|Rebamipide|rebamipide|mesh-list
110277913|NCT00576706|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110277914|NCT00576706|Abortifacient Agents|abortifacient agents|mesh-ancestor
110277915|NCT00576706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110277916|NCT00576706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277917|NCT00576706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110277918|NCT00576706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110293030|NCT00225797|Oxymorphone|oxymorphone|mesh-list
110293031|NCT00225797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110293032|NCT00225797|Narcotics|narcotics|mesh-ancestor
110293033|NCT00225797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110293034|NCT00225797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110293035|NCT00225797|Analgesics|analgesics|mesh-ancestor
110293036|NCT00225797|Sensory System Agents|sensory system agents|mesh-ancestor
110293037|NCT00225797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110293038|NCT00225797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110293039|NCT00235209|Anti-Infective Agents|anti-infective agents|mesh-list
110293040|NCT00235209|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110293041|NCT00591487|Lidocaine|lidocaine|mesh-list
110293042|NCT00591487|Anesthetics, Local|anesthetics, local|mesh-ancestor
110293043|NCT00591487|Anesthetics|anesthetics|mesh-ancestor
110293044|NCT00591487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110293045|NCT00591487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110293046|NCT00591487|Sensory System Agents|sensory system agents|mesh-ancestor
110293047|NCT00591487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110293048|NCT00591487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110293049|NCT00591487|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110293050|NCT00591487|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110293051|NCT00591487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110293055|NCT00225875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110293056|NCT00225875|Immunologic Factors|immunologic factors|mesh-ancestor
110293057|NCT00225875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110293058|NCT00225875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110293059|NCT03451981|Chlorhexidine|chlorhexidine|mesh-list
110293060|NCT03451981|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110293061|NCT03451981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110293062|NCT03451981|Disinfectants|disinfectants|mesh-ancestor
110293064|NCT00255372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110293065|NCT00225914|Paroxetine|paroxetine|mesh-list
110293066|NCT00225914|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110293067|NCT00225914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110293068|NCT00225914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110293069|NCT00225914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293070|NCT00225914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110293071|NCT00225914|Serotonin Agents|serotonin agents|mesh-ancestor
110293072|NCT00225914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110293073|NCT00225914|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110293074|NCT00225914|Antidepressive Agents|antidepressive agents|mesh-ancestor
110293075|NCT00225914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110293076|NCT00225914|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110293077|NCT00225914|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110293078|NCT00225914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110293079|NCT03451903|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110293080|NCT03451903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110293081|NCT03451903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110293082|NCT03451903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110277920|NCT00576706|Antioxidants|antioxidants|mesh-ancestor
110277921|NCT00576706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110277923|NCT00576706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110277924|NCT00576784|Pioglitazone|pioglitazone|mesh-list
110277925|NCT00576784|Glimepiride|glimepiride|mesh-list
110277926|NCT00576784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110277927|NCT00576784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277928|NCT00576784|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110277929|NCT00576784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110277930|NCT00576784|Immunologic Factors|immunologic factors|mesh-ancestor
110277931|NCT00576862|Insulin Glargine|insulin glargine|mesh-list
110277932|NCT00576862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110277933|NCT00576862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277935|NCT00202020|Cilostazol|cilostazol|mesh-list
110277936|NCT00202020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110277937|NCT00202020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110293083|NCT00235248|Aspirin|aspirin|mesh-list
110293084|NCT00235248|Warfarin|warfarin|mesh-list
110293085|NCT00235248|Clopidogrel|clopidogrel|mesh-list
110293086|NCT00235248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110293087|NCT00235248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110293088|NCT00235248|Analgesics|analgesics|mesh-ancestor
110293089|NCT00235248|Sensory System Agents|sensory system agents|mesh-ancestor
110293090|NCT00235248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110293091|NCT00235248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110293092|NCT00235248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110293093|NCT00235248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110293094|NCT00235248|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110293095|NCT00235248|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110293096|NCT00235248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293097|NCT00235248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110293098|NCT00235248|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110293099|NCT00235248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110293100|NCT00235248|Antipyretics|antipyretics|mesh-ancestor
110293101|NCT00235248|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110293102|NCT00235248|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110293103|NCT00235248|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110293104|NCT00235248|Purinergic Agents|purinergic agents|mesh-ancestor
110293105|NCT00235248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110293106|NCT00235248|Anticoagulants|anticoagulants|mesh-ancestor
110293107|NCT00225992|Arsenic Trioxide|arsenic trioxide|mesh-list
110293108|NCT00225992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110293109|NCT03451435|Acetylcysteine|acetylcysteine|mesh-list
110293110|NCT03451435|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110293111|NCT03451435|Antiviral Agents|antiviral agents|mesh-ancestor
110293112|NCT03451435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110293113|NCT03451435|Expectorants|expectorants|mesh-ancestor
110293114|NCT03451435|Respiratory System Agents|respiratory system agents|mesh-ancestor
110293115|NCT03451435|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110293116|NCT03451435|Antioxidants|antioxidants|mesh-ancestor
110293117|NCT03451435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293118|NCT03451435|Protective Agents|protective agents|mesh-ancestor
110293119|NCT03451435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110293120|NCT03451435|Antidotes|antidotes|mesh-ancestor
110293121|NCT04575064|Remdesivir|remdesivir|mesh-list
110293122|NCT04575064|Antimetabolites|antimetabolites|mesh-ancestor
110293140|NCT00226109|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110293141|NCT00226109|Hormone Antagonists|hormone antagonists|mesh-ancestor
110277938|NCT00202020|Analgesics|analgesics|mesh-ancestor
110277939|NCT00202020|Sensory System Agents|sensory system agents|mesh-ancestor
110277940|NCT00202020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110277941|NCT00202020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277942|NCT00202020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110277943|NCT00202020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110277944|NCT00202020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110293142|NCT00226109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110293143|NCT00226109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110293144|NCT00226109|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110293145|NCT00226109|Diuretics|diuretics|mesh-ancestor
110293146|NCT00226109|Natriuretic Agents|natriuretic agents|mesh-ancestor
110293147|NCT04573426|Acetaminophen|acetaminophen|mesh-list
110293148|NCT04573426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110293149|NCT04573426|Analgesics|analgesics|mesh-ancestor
110293150|NCT04573426|Sensory System Agents|sensory system agents|mesh-ancestor
110293151|NCT04573426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110293152|NCT04573426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110293153|NCT04573426|Antipyretics|antipyretics|mesh-ancestor
110293154|NCT00235287|Candesartan|candesartan|mesh-list
110293155|NCT00235287|Candesartan cilexetil|candesartan cilexetil|mesh-list
110293157|NCT00235287|Enalaprilat|enalaprilat|mesh-list
110293158|NCT00235287|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110293159|NCT00235287|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110293160|NCT00235287|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110293161|NCT00235287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293162|NCT00235287|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110293163|NCT00235287|Protease Inhibitors|protease inhibitors|mesh-ancestor
110293164|NCT00235287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110293165|NCT00255489|Gefitinib|gefitinib|mesh-list
110293166|NCT00255489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110293167|NCT00255489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110293168|NCT00255489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110293169|NCT00255489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293170|NCT04573153|Hydroxychloroquine|hydroxychloroquine|mesh-list
110293171|NCT04573153|Sorbitol|sorbitol|mesh-list
110293172|NCT04573153|Antimalarials|antimalarials|mesh-ancestor
110293173|NCT04573153|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110293174|NCT04573153|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110293175|NCT04573153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110293176|NCT04573153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110293177|NCT04573153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293178|NCT04573153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110293180|NCT04573153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110293181|NCT00255528|Metoprolol|metoprolol|mesh-list
110293189|NCT00255528|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110293190|NCT00255528|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110293192|NCT00255528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110293193|NCT00255528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293194|NCT04572685|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110293195|NCT04572685|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110293196|NCT04572685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110293197|NCT04572685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110293198|NCT04572685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110293199|NCT04572685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110293200|NCT04572685|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110293201|NCT04572685|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110293202|NCT04572685|Serotonin Agents|serotonin agents|mesh-ancestor
110293203|NCT04572685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110293204|NCT04572685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293205|NCT04572685|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110293206|NCT04572685|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110293207|NCT04572685|Dopamine Agents|dopamine agents|mesh-ancestor
110277945|NCT00202020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110277946|NCT00202020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110277947|NCT00202020|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110277948|NCT00202020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110277949|NCT00202020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110277950|NCT00202020|Antipyretics|antipyretics|mesh-ancestor
110277951|NCT00202020|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110277952|NCT00202020|Autonomic Agents|autonomic agents|mesh-ancestor
110277953|NCT00202020|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110277954|NCT00202020|Respiratory System Agents|respiratory system agents|mesh-ancestor
110277955|NCT00202020|Vasodilator Agents|vasodilator agents|mesh-ancestor
110277956|NCT00202020|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110277957|NCT00202020|Protective Agents|protective agents|mesh-ancestor
110293209|NCT04572724|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110293210|NCT04572724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110293211|NCT04572724|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110293212|NCT04572724|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110293213|NCT04572724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293214|NCT00255567|Paromomycin|paromomycin|mesh-list
110293215|NCT00255567|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
110293216|NCT00255567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110293217|NCT00255567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110293218|NCT00255567|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110293219|NCT00255567|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110293220|NCT00255567|Schistosomicides|schistosomicides|mesh-ancestor
110293221|NCT00255567|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110293222|NCT00255567|Anthelmintics|anthelmintics|mesh-ancestor
110293223|NCT03450967|Durvalumab|durvalumab|mesh-list
110293224|NCT03450967|Tremelimumab|tremelimumab|mesh-list
110293225|NCT03450967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110293226|NCT03450967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110293227|NCT00255606|Prednisone|prednisone|mesh-list
110293228|NCT00255606|Docetaxel|docetaxel|mesh-list
110293229|NCT00255606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110293230|NCT00255606|Tubulin Modulators|tubulin modulators|mesh-ancestor
110293231|NCT00255606|Antimitotic Agents|antimitotic agents|mesh-ancestor
110293232|NCT00255606|Mitosis Modulators|mitosis modulators|mesh-ancestor
110293233|NCT00255606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293234|NCT00255606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110293235|NCT00255606|Glucocorticoids|glucocorticoids|mesh-ancestor
110293236|NCT00255606|Hormones|hormones|mesh-ancestor
110293237|NCT00255606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110293238|NCT00255606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110293239|NCT00255606|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110293240|NCT00226343|Valproic Acid|valproic acid|mesh-list
110293241|NCT00226343|Anticonvulsants|anticonvulsants|mesh-ancestor
110293242|NCT00226343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110293243|NCT00226343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293244|NCT00226343|GABA Agents|gaba agents|mesh-ancestor
110293245|NCT00226343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110293246|NCT00226343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110293247|NCT00226343|Antimanic Agents|antimanic agents|mesh-ancestor
110293260|NCT03450499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110293261|NCT03450499|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110293262|NCT03450499|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110293264|NCT03450499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293265|NCT00226382|Interferons|interferons|mesh-list
110293266|NCT00226382|Interferon-alpha|interferon-alpha|mesh-list
110293267|NCT00226382|Interferon alpha-2|interferon alpha-2|mesh-list
110293268|NCT00226382|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110277958|NCT00202020|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110277959|NCT00202020|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110277960|NCT00577018|Prucalopride|prucalopride|mesh-list
110277961|NCT00577018|Laxatives|laxatives|mesh-ancestor
110277962|NCT00577018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110277963|NCT00577018|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
110277964|NCT00577018|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110277965|NCT00577018|Serotonin Agents|serotonin agents|mesh-ancestor
110277966|NCT00577018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110293269|NCT00226382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110293270|NCT00226382|Antiviral Agents|antiviral agents|mesh-ancestor
110293271|NCT00226382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110293272|NCT00226382|Immunologic Factors|immunologic factors|mesh-ancestor
110293273|NCT00226382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110293274|NCT01580839|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110293275|NCT01580839|Plasminogen|plasminogen|mesh-list
110293276|NCT01580839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110293277|NCT01580839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110293278|NCT01580839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293279|NCT03450226|Bupivacaine|bupivacaine|mesh-list
110293280|NCT03450226|Anesthetics, Local|anesthetics, local|mesh-ancestor
110293281|NCT03450226|Anesthetics|anesthetics|mesh-ancestor
110293282|NCT03450226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110024181|NCT00004344|Leuprolide|leuprolide|mesh-list
110293283|NCT03450226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110293284|NCT03450226|Sensory System Agents|sensory system agents|mesh-ancestor
110293285|NCT03450226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110293286|NCT00226421|Oxymorphone|oxymorphone|mesh-list
110293287|NCT00226421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110293288|NCT00226421|Narcotics|narcotics|mesh-ancestor
110293289|NCT00226421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110293290|NCT00226421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110293291|NCT00226421|Analgesics|analgesics|mesh-ancestor
110293292|NCT00226421|Sensory System Agents|sensory system agents|mesh-ancestor
110293293|NCT00226421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110293294|NCT00226421|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110293295|NCT04572373|SMOFlipid|smoflipid|mesh-list
110293296|NCT04572373|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
110293297|NCT04572373|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110293298|NCT04572373|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110293299|NCT03450109|Goserelin|goserelin|mesh-list
110293300|NCT03450109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110293301|NCT03450109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110293302|NCT00413387|Budesonide|budesonide|mesh-list
110293303|NCT00413387|Beclomethasone|beclomethasone|mesh-list
110293304|NCT00413387|Formoterol Fumarate|formoterol fumarate|mesh-list
110293305|NCT00413387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110293306|NCT00413387|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110293307|NCT00413387|Autonomic Agents|autonomic agents|mesh-ancestor
110293308|NCT00413387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110293318|NCT00413387|Adrenergic Agents|adrenergic agents|mesh-ancestor
110293319|NCT00413387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110293320|NCT00413387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293321|NCT00413426|Darifenacin|darifenacin|mesh-list
110293322|NCT00413426|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110293323|NCT00413426|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110293324|NCT00413426|Cholinergic Agents|cholinergic agents|mesh-ancestor
110293325|NCT00413426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110293326|NCT00413426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293327|NCT00413426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110293328|NCT00413426|Urological Agents|urological agents|mesh-ancestor
110293329|NCT00255762|Paclitaxel|paclitaxel|mesh-list
110293330|NCT00255762|Bevacizumab|bevacizumab|mesh-list
110293331|NCT00255762|Carboplatin|carboplatin|mesh-list
110277967|NCT00577018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110277968|NCT00577018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277969|NCT04578847|Imatinib Mesylate|imatinib mesylate|mesh-list
110277970|NCT04578847|Dasatinib|dasatinib|mesh-list
110277971|NCT04578847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110277972|NCT04578847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110277973|NCT04578847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110277974|NCT04578847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110277975|NCT00577057|Fluorouracil|fluorouracil|mesh-list
110277976|NCT00577057|Capecitabine|capecitabine|mesh-list
110277977|NCT00577057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110277978|NCT00577057|Antimetabolites|antimetabolites|mesh-ancestor
110293332|NCT00255762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110293333|NCT00255762|Antibodies|antibodies|mesh-list
110293334|NCT00255762|Immunoglobulins|immunoglobulins|mesh-list
110293335|NCT00255762|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110293336|NCT00255762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110293337|NCT00255762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110293338|NCT00255762|Tubulin Modulators|tubulin modulators|mesh-ancestor
110293339|NCT00255762|Antimitotic Agents|antimitotic agents|mesh-ancestor
110293340|NCT00255762|Mitosis Modulators|mitosis modulators|mesh-ancestor
110293341|NCT00255762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293342|NCT00255762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110293343|NCT00255762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110293344|NCT00255762|Growth Substances|growth substances|mesh-ancestor
110293345|NCT00255762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110293346|NCT00255762|Growth Inhibitors|growth inhibitors|mesh-ancestor
110293347|NCT00255762|Immunologic Factors|immunologic factors|mesh-ancestor
110293348|NCT02277457|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110293349|NCT02277457|Crizotinib|crizotinib|mesh-list
110293350|NCT02277457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110293351|NCT02277457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110293352|NCT02277457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110293353|NCT02277457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293354|NCT00255879|Olanzapine|olanzapine|mesh-list
110293355|NCT00255879|Risperidone|risperidone|mesh-list
110293356|NCT00255879|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110293357|NCT00255879|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110293358|NCT00255879|Serotonin Agents|serotonin agents|mesh-ancestor
110293359|NCT00255879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110293360|NCT00255879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293361|NCT00255879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110293362|NCT00255879|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110293363|NCT00255879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110293364|NCT00255879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110293365|NCT00255879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110293366|NCT00255879|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110293367|NCT00255879|Dopamine Agents|dopamine agents|mesh-ancestor
110293368|NCT00255879|Antiemetics|antiemetics|mesh-ancestor
110293369|NCT00255879|Autonomic Agents|autonomic agents|mesh-ancestor
110293370|NCT00255879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110293371|NCT00255879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110293372|NCT00255879|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110293373|NCT00255879|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110293386|NCT00413504|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110293387|NCT04721223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110293388|NCT04721223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293389|NCT04721223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110293390|NCT04721223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110293391|NCT04710498|Atezolizumab|atezolizumab|mesh-list
110293392|NCT04710498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110293393|NCT04710498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110277979|NCT00577057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110277980|NCT00577057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110277981|NCT00577057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110277982|NCT00577057|Immunologic Factors|immunologic factors|mesh-ancestor
110277983|NCT00577057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277984|NCT00187005|Cytarabine|cytarabine|mesh-list
110277985|NCT00187005|Dexamethasone|dexamethasone|mesh-list
110277986|NCT00187005|Prednisone|prednisone|mesh-list
110277987|NCT00187005|Cyclophosphamide|cyclophosphamide|mesh-list
110277988|NCT00187005|Methotrexate|methotrexate|mesh-list
110277989|NCT00187005|Etoposide|etoposide|mesh-list
110277990|NCT00187005|Vincristine|vincristine|mesh-list
110277991|NCT00187005|Daunorubicin|daunorubicin|mesh-list
110277992|NCT00187005|Asparaginase|asparaginase|mesh-list
110277993|NCT00187005|Mercaptopurine|mercaptopurine|mesh-list
110293394|NCT04710498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110293395|NCT04710498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110293396|NCT00226538|Rifampin|rifampin|mesh-list
110293397|NCT00226538|Fluconazole|fluconazole|mesh-list
110293398|NCT00226538|Diclofenac|diclofenac|mesh-list
110293399|NCT00226538|Phenytoin|phenytoin|mesh-list
110293400|NCT00226538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110293401|NCT00226538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110293402|NCT00226538|Analgesics|analgesics|mesh-ancestor
110293403|NCT00226538|Sensory System Agents|sensory system agents|mesh-ancestor
110293404|NCT00226538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110293405|NCT00226538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110293406|NCT00226538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110293407|NCT00226538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110293408|NCT00226538|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110293409|NCT00226538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110293410|NCT00226538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293411|NCT00226538|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110293412|NCT00226538|Antitubercular Agents|antitubercular agents|mesh-ancestor
110293413|NCT00226538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110293414|NCT00226538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110293415|NCT00226538|Leprostatic Agents|leprostatic agents|mesh-ancestor
110293416|NCT00226538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110293417|NCT00226538|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110293418|NCT00226538|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110293419|NCT00226538|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110293420|NCT00226538|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110293421|NCT00226538|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110293422|NCT00226538|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110293423|NCT00226538|Antifungal Agents|antifungal agents|mesh-ancestor
110293424|NCT00226538|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110293425|NCT00226538|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110293426|NCT00226538|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110293427|NCT00226538|Hormone Antagonists|hormone antagonists|mesh-ancestor
110293428|NCT00226538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110293429|NCT00226538|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110293430|NCT00226538|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110293431|NCT00226538|Anticonvulsants|anticonvulsants|mesh-ancestor
110293432|NCT00226538|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110293433|NCT00226538|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110293439|NCT00255918|Cholinergic Agents|cholinergic agents|mesh-ancestor
110293440|NCT00255918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110293441|NCT00255918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293442|NCT00255918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110293443|NCT00226694|Citalopram|citalopram|mesh-list
110277995|NCT00187005|Pegaspargase|pegaspargase|mesh-list
110277996|NCT00187005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110277997|NCT00187005|Immunologic Factors|immunologic factors|mesh-ancestor
110277998|NCT00187005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277999|NCT00187005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110278000|NCT00187005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110278001|NCT00187005|Alkylating Agents|alkylating agents|mesh-ancestor
110278002|NCT00187005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110278003|NCT00187005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110278004|NCT00187005|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110278005|NCT00187005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110278006|NCT00187005|Antiemetics|antiemetics|mesh-ancestor
110293444|NCT00226694|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110293445|NCT00226694|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110293446|NCT00226694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110293447|NCT00226694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293448|NCT00226694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110293449|NCT00226694|Serotonin Agents|serotonin agents|mesh-ancestor
110293450|NCT00226694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110293451|NCT00226694|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110293452|NCT00226694|Antidepressive Agents|antidepressive agents|mesh-ancestor
110293453|NCT00226694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110293455|NCT00255996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110293456|NCT00255996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110293457|NCT00255996|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110293458|NCT00255996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110293459|NCT00255996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293461|NCT00226889|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110293462|NCT00226889|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110293463|NCT00226889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293464|NCT00226967|Octreotide|octreotide|mesh-list
110293465|NCT00226967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110293466|NCT00226967|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110293467|NCT00226967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110293468|NCT00199381|Istradefylline|istradefylline|mesh-list
110293469|NCT00199381|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
110293470|NCT00199381|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110293471|NCT00199381|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110293472|NCT00199381|Purinergic Agents|purinergic agents|mesh-ancestor
110293473|NCT00199381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110293474|NCT00199381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293475|NCT00199381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110293476|NCT00227084|Hemostatics|hemostatics|mesh-list
110293477|NCT00227084|Coagulants|coagulants|mesh-ancestor
110293478|NCT00227123|Risperidone|risperidone|mesh-list
110293479|NCT00227123|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110293480|NCT00227123|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110293481|NCT00227123|Serotonin Agents|serotonin agents|mesh-ancestor
110293482|NCT00227123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110293483|NCT00227123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293484|NCT00227123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110293485|NCT00227123|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110293486|NCT00227123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110293487|NCT00227123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110293488|NCT00227123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110293489|NCT00227123|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110293490|NCT00227123|Dopamine Agents|dopamine agents|mesh-ancestor
110278007|NCT00187005|Autonomic Agents|autonomic agents|mesh-ancestor
110278008|NCT00187005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110278009|NCT00187005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110278010|NCT00187005|Glucocorticoids|glucocorticoids|mesh-ancestor
110278012|NCT00187005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110278013|NCT00187005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110278014|NCT00187005|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110278015|NCT00187005|Abortifacient Agents|abortifacient agents|mesh-ancestor
110278016|NCT00187005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110278017|NCT00187005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110278018|NCT00187005|Antimetabolites|antimetabolites|mesh-ancestor
110278019|NCT00187005|Dermatologic Agents|dermatologic agents|mesh-ancestor
110278020|NCT00187005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110278021|NCT00187005|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110278022|NCT00187005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110278023|NCT00187005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110278024|NCT00187005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110293491|NCT00227123|Antidepressive Agents|antidepressive agents|mesh-ancestor
110293492|NCT00235521|Iloprost|iloprost|mesh-list
110293493|NCT00235521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110293494|NCT00235521|Vasodilator Agents|vasodilator agents|mesh-ancestor
110293495|NCT00235560|Sirolimus|sirolimus|mesh-list
110293496|NCT00235560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110293497|NCT00235560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110293498|NCT00235560|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110293499|NCT00235560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110293500|NCT00235560|Antifungal Agents|antifungal agents|mesh-ancestor
110293501|NCT00235560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110293505|NCT00227318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110293506|NCT00227318|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110293507|NCT00227318|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110293508|NCT00227318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293509|NCT00227357|Buprenorphine|buprenorphine|mesh-list
110293510|NCT00227357|Methadone|methadone|mesh-list
110293511|NCT00227357|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
110293512|NCT00227357|Naloxone|naloxone|mesh-list
110293513|NCT00227357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110293514|NCT00227357|Narcotics|narcotics|mesh-ancestor
110293515|NCT00227357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110293516|NCT00227357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110293517|NCT00227357|Analgesics|analgesics|mesh-ancestor
110293518|NCT00227357|Sensory System Agents|sensory system agents|mesh-ancestor
110293519|NCT00227357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110293520|NCT00227357|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110293521|NCT00227357|Antitussive Agents|antitussive agents|mesh-ancestor
110293522|NCT00227357|Respiratory System Agents|respiratory system agents|mesh-ancestor
110293523|NCT00198133|Pemetrexed|pemetrexed|mesh-list
110293524|NCT00198133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110293525|NCT00198133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110293526|NCT00198133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293527|NCT00198133|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110293528|NCT00198133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110278025|NCT00187005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110278026|NCT00187005|Antiviral Agents|antiviral agents|mesh-ancestor
110278027|NCT00187005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110278028|NCT00187005|Tubulin Modulators|tubulin modulators|mesh-ancestor
110278029|NCT00187005|Antimitotic Agents|antimitotic agents|mesh-ancestor
110278030|NCT00187005|Mitosis Modulators|mitosis modulators|mesh-ancestor
110278031|NCT00187005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110278032|NCT00202059|Zoledronic Acid|zoledronic acid|mesh-list
110278033|NCT00202059|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110278034|NCT00202059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110278035|NCT00577369|Desflurane|desflurane|mesh-list
110293530|NCT00227474|Immunologic Factors|immunologic factors|mesh-ancestor
110293531|NCT00227474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110293532|NCT00227513|Bortezomib|bortezomib|mesh-list
110293533|NCT00227513|Vorinostat|vorinostat|mesh-list
110293534|NCT00227513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110293535|NCT00227513|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110293536|NCT00227513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110293537|NCT00227513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293538|NCT00227630|Pemetrexed|pemetrexed|mesh-list
110293539|NCT00227630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110293540|NCT00227630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110293541|NCT00227630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293542|NCT00227630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110293543|NCT00227630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110293544|NCT00256230|Disulfiram|disulfiram|mesh-list
110293545|NCT00256230|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110293546|NCT00256230|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
110293547|NCT00256230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110293548|NCT00256230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293549|NCT00227669|Gemcitabine|gemcitabine|mesh-list
110293550|NCT00227669|Docetaxel|docetaxel|mesh-list
110293551|NCT00227669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110293552|NCT00227669|Antimetabolites|antimetabolites|mesh-ancestor
110293553|NCT00227669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293554|NCT00227669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110293555|NCT00227669|Tubulin Modulators|tubulin modulators|mesh-ancestor
110293556|NCT00227669|Antimitotic Agents|antimitotic agents|mesh-ancestor
110293557|NCT00227669|Mitosis Modulators|mitosis modulators|mesh-ancestor
110293558|NCT00235794|Sirolimus|sirolimus|mesh-list
110293560|NCT00235794|MTOR Inhibitors|mtor inhibitors|mesh-list
110293561|NCT00235794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110293562|NCT00235794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110293563|NCT00235794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293564|NCT00235794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110293565|NCT00235794|Immunologic Factors|immunologic factors|mesh-ancestor
110293566|NCT00235794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110293567|NCT00235794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110293568|NCT00235794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110293569|NCT00235794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110293570|NCT00235794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110293571|NCT00235794|Antifungal Agents|antifungal agents|mesh-ancestor
110293572|NCT00256269|Oxaliplatin|oxaliplatin|mesh-list
110293578|NCT00256269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293579|NCT00197002|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110293580|NCT00197002|Immunologic Factors|immunologic factors|mesh-ancestor
110293581|NCT00197002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110293582|NCT00227708|Docetaxel|docetaxel|mesh-list
110293583|NCT00227708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110293584|NCT00227708|Tubulin Modulators|tubulin modulators|mesh-ancestor
110293585|NCT00227708|Antimitotic Agents|antimitotic agents|mesh-ancestor
110293586|NCT00227708|Mitosis Modulators|mitosis modulators|mesh-ancestor
110278036|NCT00577369|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110278037|NCT00577369|Anesthetics, General|anesthetics, general|mesh-ancestor
110278038|NCT00577369|Anesthetics|anesthetics|mesh-ancestor
110278039|NCT00577369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110278040|NCT00577369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110278041|NCT00577681|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110278042|NCT00577681|Antiviral Agents|antiviral agents|mesh-ancestor
110278043|NCT00577681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110278044|NCT00577798|Doxorubicin|doxorubicin|mesh-list
110278045|NCT00577798|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110278046|NCT00577798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110278047|NCT00577798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110278048|NCT00577798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110293587|NCT00227708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293588|NCT00235911|Budesonide|budesonide|mesh-list
110293589|NCT00235911|Formoterol Fumarate|formoterol fumarate|mesh-list
110293590|NCT00235911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110293591|NCT00235911|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110293592|NCT00235911|Autonomic Agents|autonomic agents|mesh-ancestor
110293593|NCT00235911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110293594|NCT00235911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110293595|NCT00235911|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110293596|NCT00235911|Respiratory System Agents|respiratory system agents|mesh-ancestor
110293597|NCT00235911|Glucocorticoids|glucocorticoids|mesh-ancestor
110293598|NCT00235911|Hormones|hormones|mesh-ancestor
110293599|NCT00235911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110293600|NCT00235911|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110293601|NCT00235911|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110293602|NCT00235911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110293603|NCT00235911|Adrenergic Agents|adrenergic agents|mesh-ancestor
110293604|NCT00235911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110293605|NCT00235911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293606|NCT00256347|Morphine|morphine|mesh-list
110293607|NCT00256347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110293608|NCT00256347|Narcotics|narcotics|mesh-ancestor
110293609|NCT00256347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110293610|NCT00256347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110293611|NCT00256347|Analgesics|analgesics|mesh-ancestor
110293612|NCT00256347|Sensory System Agents|sensory system agents|mesh-ancestor
110293613|NCT00256347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110293614|NCT00227747|Capecitabine|capecitabine|mesh-list
110293615|NCT00227747|Oxaliplatin|oxaliplatin|mesh-list
110293616|NCT00227747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110293617|NCT00227747|Antimetabolites|antimetabolites|mesh-ancestor
110293618|NCT00227747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293619|NCT00227747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110293620|NCT00235950|Clopidogrel|clopidogrel|mesh-list
110293621|NCT00235950|Atorvastatin|atorvastatin|mesh-list
110293622|NCT00235950|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110293623|NCT00235950|Simvastatin|simvastatin|mesh-list
110293624|NCT00235950|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110293625|NCT00235950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110293626|NCT00235950|Antimetabolites|antimetabolites|mesh-ancestor
110293627|NCT00235950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293628|NCT00235950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110293629|NCT00235950|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110293630|NCT00235950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110293631|NCT00235950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110293632|NCT00235950|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110293633|NCT00235950|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110293634|NCT00235950|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110293635|NCT00235950|Purinergic Agents|purinergic agents|mesh-ancestor
110278049|NCT00577798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110278050|NCT00577798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110278051|NCT00577798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110278052|NCT00187083|Dexamethasone|dexamethasone|mesh-list
110278053|NCT00187083|Methotrexate|methotrexate|mesh-list
110278054|NCT00187083|Fludarabine|fludarabine|mesh-list
110278055|NCT00187083|Etoposide|etoposide|mesh-list
110278056|NCT00187083|Vincristine|vincristine|mesh-list
110278057|NCT00187083|Topotecan|topotecan|mesh-list
110278058|NCT00187083|Asparaginase|asparaginase|mesh-list
110278059|NCT00187083|Mercaptopurine|mercaptopurine|mesh-list
110278060|NCT00187083|Idarubicin|idarubicin|mesh-list
110278061|NCT00187083|Pegaspargase|pegaspargase|mesh-list
110278062|NCT00187083|Teniposide|teniposide|mesh-list
110293636|NCT00235950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110293637|NCT00235950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110293638|NCT00227942|Zolpidem|zolpidem|mesh-list
110293639|NCT00227942|Estrogens|estrogens|mesh-list
110293640|NCT00227942|Hormones|hormones|mesh-ancestor
110293641|NCT00227942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110293645|NCT00227942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110293646|NCT00227942|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110293647|NCT00227942|GABA Agonists|gaba agonists|mesh-ancestor
110293648|NCT00227942|GABA Agents|gaba agents|mesh-ancestor
110293649|NCT00227942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110293650|NCT00227942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293651|NCT00227981|Fluoxetine|fluoxetine|mesh-list
110293652|NCT00227981|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110293653|NCT00227981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110293654|NCT00227981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110293655|NCT00227981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293657|NCT00227981|Serotonin Agents|serotonin agents|mesh-ancestor
110293658|NCT00227981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110293659|NCT00227981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110293660|NCT00227981|Antidepressive Agents|antidepressive agents|mesh-ancestor
110293661|NCT00227981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110293662|NCT00227981|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110293663|NCT00227981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110293664|NCT00227981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110293665|NCT00236028|Infliximab|infliximab|mesh-list
110293666|NCT00236028|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110293667|NCT00236028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110293668|NCT00236028|Dermatologic Agents|dermatologic agents|mesh-ancestor
110293669|NCT00236028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110293670|NCT00236028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110293671|NCT00256542|Lidocaine|lidocaine|mesh-list
110293672|NCT00256542|Heparin|heparin|mesh-list
110293673|NCT00256542|Anesthetics, Local|anesthetics, local|mesh-ancestor
110293674|NCT00256542|Anesthetics|anesthetics|mesh-ancestor
110293675|NCT00256542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110293676|NCT00256542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110293677|NCT00256542|Sensory System Agents|sensory system agents|mesh-ancestor
110293678|NCT00256542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110293679|NCT00256542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110293680|NCT00256542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110293681|NCT00256542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110293682|NCT00256542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110293683|NCT00256542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293684|NCT00256542|Anticoagulants|anticoagulants|mesh-ancestor
110293685|NCT00256542|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110293686|NCT00256542|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110293687|NCT00228020|Cyclosporine|cyclosporine|mesh-list
110293688|NCT00228020|Mycophenolic Acid|mycophenolic acid|mesh-list
110278063|NCT00187083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110278064|NCT00187083|Antiemetics|antiemetics|mesh-ancestor
110278065|NCT00187083|Autonomic Agents|autonomic agents|mesh-ancestor
110278066|NCT00187083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110278067|NCT00187083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110278068|NCT00187083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110278069|NCT00187083|Glucocorticoids|glucocorticoids|mesh-ancestor
110278070|NCT00187083|Hormones|hormones|mesh-ancestor
110278071|NCT00187083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110278072|NCT00187083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110278073|NCT00187083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110278074|NCT00187083|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110293689|NCT00228020|Prednisone|prednisone|mesh-list
110293690|NCT00228020|Cyclosporins|cyclosporins|mesh-list
110293691|NCT00228020|Basiliximab|basiliximab|mesh-list
110293692|NCT00228020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110293693|NCT00228020|Glucocorticoids|glucocorticoids|mesh-ancestor
110293694|NCT00228020|Hormones|hormones|mesh-ancestor
110293695|NCT00228020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110293696|NCT00228020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110293697|NCT00228020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110293698|NCT00228020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110293699|NCT00228020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110293700|NCT00228020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293701|NCT00228020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110293702|NCT00228020|Immunologic Factors|immunologic factors|mesh-ancestor
110293703|NCT00228020|Antifungal Agents|antifungal agents|mesh-ancestor
110293704|NCT00228020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110293705|NCT00228020|Dermatologic Agents|dermatologic agents|mesh-ancestor
110293706|NCT00228020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110293707|NCT00228020|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110293708|NCT00228020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110293709|NCT00228020|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110293710|NCT00228020|Antitubercular Agents|antitubercular agents|mesh-ancestor
110293711|NCT00228020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110293712|NCT00236067|Tiagabine|tiagabine|mesh-list
110293730|NCT00236106|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110293731|NCT00236106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110293732|NCT00236106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293733|NCT00236106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110293734|NCT00236106|Dermatologic Agents|dermatologic agents|mesh-ancestor
110293735|NCT00236106|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110293736|NCT00236145|Fentanyl|fentanyl|mesh-list
110293737|NCT00236145|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110293738|NCT00236145|Narcotics|narcotics|mesh-ancestor
110293739|NCT00236145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110293740|NCT00236145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110293741|NCT00236145|Analgesics|analgesics|mesh-ancestor
110293742|NCT00236145|Sensory System Agents|sensory system agents|mesh-ancestor
110293743|NCT00236145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110293744|NCT00236145|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110293745|NCT00236145|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110293746|NCT00236145|Anesthetics, General|anesthetics, general|mesh-ancestor
110293747|NCT00236145|Anesthetics|anesthetics|mesh-ancestor
110293748|NCT00228254|Vitamin A|vitamin a|mesh-list
110293749|NCT00228254|Vitamins|vitamins|mesh-ancestor
110293750|NCT00228254|Micronutrients|micronutrients|mesh-ancestor
110293751|NCT00228254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110293752|NCT00195676|Adalimumab|adalimumab|mesh-list
110293753|NCT00195676|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110293754|NCT00195676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110293755|NCT00195676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110293756|NCT00194077|Aripiprazole|aripiprazole|mesh-list
110293757|NCT00194077|Antidepressive Agents|antidepressive agents|mesh-ancestor
110278075|NCT00187083|Abortifacient Agents|abortifacient agents|mesh-ancestor
110278076|NCT00187083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110278077|NCT00187083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110278078|NCT00187083|Antimetabolites|antimetabolites|mesh-ancestor
110278079|NCT00187083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110278080|NCT00187083|Dermatologic Agents|dermatologic agents|mesh-ancestor
110278081|NCT00187083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110278082|NCT00187083|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110278083|NCT00187083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110278084|NCT00187083|Immunologic Factors|immunologic factors|mesh-ancestor
110278085|NCT00187083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110293758|NCT00194077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110293759|NCT00194077|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110293760|NCT00194077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110293761|NCT00194077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110293762|NCT00194077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110293763|NCT00194077|Dopamine Agonists|dopamine agonists|mesh-ancestor
110293764|NCT00194077|Dopamine Agents|dopamine agents|mesh-ancestor
110293765|NCT00194077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110293766|NCT00194077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293767|NCT00194077|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110293768|NCT00194077|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110293769|NCT00194077|Serotonin Agents|serotonin agents|mesh-ancestor
110293770|NCT00194077|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110293786|NCT00228410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110293787|NCT00228410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293789|NCT00193180|Imatinib Mesylate|imatinib mesylate|mesh-list
110293790|NCT00193180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110293791|NCT00193180|Tubulin Modulators|tubulin modulators|mesh-ancestor
110293792|NCT00193180|Antimitotic Agents|antimitotic agents|mesh-ancestor
110293793|NCT00193180|Mitosis Modulators|mitosis modulators|mesh-ancestor
110293794|NCT00193180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293795|NCT00193180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110293796|NCT00193180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110293798|NCT00193063|Trastuzumab|trastuzumab|mesh-list
110293799|NCT00193063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110293800|NCT00193063|Antimetabolites|antimetabolites|mesh-ancestor
110293801|NCT00193063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293802|NCT00193063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110293803|NCT00193063|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110293805|NCT00228488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110293806|NCT00228488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110293807|NCT00228488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110293808|NCT00228488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293809|NCT00228527|Esomeprazole|esomeprazole|mesh-list
110293810|NCT00228527|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110293811|NCT00228527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110293812|NCT00228527|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110293813|NCT00228527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110293814|NCT00228527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293815|NCT00191854|Paclitaxel|paclitaxel|mesh-list
110293816|NCT00191854|Carboplatin|carboplatin|mesh-list
110293817|NCT00191854|Gemcitabine|gemcitabine|mesh-list
110293818|NCT00191854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110293819|NCT00191854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110293820|NCT00191854|Tubulin Modulators|tubulin modulators|mesh-ancestor
110293821|NCT00191854|Antimitotic Agents|antimitotic agents|mesh-ancestor
110293822|NCT00191854|Mitosis Modulators|mitosis modulators|mesh-ancestor
110293823|NCT00191854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293824|NCT00191854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110293825|NCT00191854|Antimetabolites|antimetabolites|mesh-ancestor
110278086|NCT00187083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110278087|NCT00187083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110278088|NCT00187083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110278089|NCT00187083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110278090|NCT00187083|Tubulin Modulators|tubulin modulators|mesh-ancestor
110278091|NCT00187083|Antimitotic Agents|antimitotic agents|mesh-ancestor
110278092|NCT00187083|Mitosis Modulators|mitosis modulators|mesh-ancestor
110278093|NCT00187083|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110278094|NCT00187083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110278095|NCT00577837|Risedronic Acid|risedronic acid|mesh-list
110278097|NCT00577837|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110278098|NCT00577837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110278099|NCT00577837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293826|NCT00228605|Fentanyl|fentanyl|mesh-list
110293827|NCT00228605|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110293828|NCT00228605|Narcotics|narcotics|mesh-ancestor
110293829|NCT00228605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110293830|NCT00228605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110293831|NCT00228605|Analgesics|analgesics|mesh-ancestor
110293832|NCT00228605|Sensory System Agents|sensory system agents|mesh-ancestor
110293836|NCT00228605|Anesthetics, General|anesthetics, general|mesh-ancestor
110293837|NCT00228605|Anesthetics|anesthetics|mesh-ancestor
110293838|NCT00191815|Gemcitabine|gemcitabine|mesh-list
110293839|NCT00191815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110293840|NCT00191815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110293841|NCT00191815|Antimetabolites|antimetabolites|mesh-ancestor
110293842|NCT00191815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293843|NCT00191386|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110293844|NCT00191386|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110293845|NCT00191386|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110293846|NCT00191386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110293847|NCT00191386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293848|NCT00191386|Adrenergic Agents|adrenergic agents|mesh-ancestor
110293849|NCT00191386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110293850|NCT00191386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110293851|NCT00191308|Pemetrexed|pemetrexed|mesh-list
110293852|NCT00191308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110293853|NCT00191308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110293854|NCT00191308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293855|NCT00191308|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110293856|NCT00191308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110293857|NCT00228839|Infliximab|infliximab|mesh-list
110293858|NCT00228839|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110293859|NCT00228839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110293860|NCT00228839|Dermatologic Agents|dermatologic agents|mesh-ancestor
110293861|NCT00228839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110293862|NCT00228839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110293863|NCT00191269|Gemcitabine|gemcitabine|mesh-list
110293864|NCT00191269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110293865|NCT00191269|Antimetabolites|antimetabolites|mesh-ancestor
110293866|NCT00191269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293867|NCT00191269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110293868|NCT00228878|Insulin|insulin|mesh-list
110293869|NCT00228878|Insulin Aspart|insulin aspart|mesh-list
110293870|NCT00228878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110278100|NCT00577837|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110278101|NCT00577837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110278102|NCT00577837|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110278104|NCT00578149|Bevacizumab|bevacizumab|mesh-list
110278105|NCT00578149|Carboplatin|carboplatin|mesh-list
110278106|NCT00578149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110278107|NCT00578149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110278108|NCT00578149|Tubulin Modulators|tubulin modulators|mesh-ancestor
110278109|NCT00578149|Antimitotic Agents|antimitotic agents|mesh-ancestor
110278110|NCT00578149|Mitosis Modulators|mitosis modulators|mesh-ancestor
110293871|NCT00228878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110293872|NCT00228995|Epoetin Alfa|epoetin alfa|mesh-list
110293873|NCT00228995|Hematinics|hematinics|mesh-ancestor
110293874|NCT00413946|Epoetin Alfa|epoetin alfa|mesh-list
110293875|NCT00413946|Hematinics|hematinics|mesh-ancestor
110293876|NCT00229112|Tazobactam|tazobactam|mesh-list
110293877|NCT00229112|Piperacillin|piperacillin|mesh-list
110293878|NCT00229112|Ertapenem|ertapenem|mesh-list
110293879|NCT00229112|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
110293880|NCT00229112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293882|NCT00229112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110293883|NCT00229112|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110293884|NCT00229112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110293886|NCT00256737|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110293887|NCT00256737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110293888|NCT00256737|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110293889|NCT00256737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110293890|NCT00256737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293891|NCT00191191|Pemetrexed|pemetrexed|mesh-list
110293892|NCT00191191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110293893|NCT00191191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110293894|NCT00191191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293895|NCT00191191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110293896|NCT00191191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110293897|NCT00414024|Tegaserod|tegaserod|mesh-list
110293898|NCT00414024|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110293899|NCT00414024|Serotonin Agents|serotonin agents|mesh-ancestor
110293900|NCT00414024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110293901|NCT00414024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293902|NCT00414024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110293903|NCT00256893|Ropinirole|ropinirole|mesh-list
110293904|NCT00256893|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110293905|NCT00256893|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110293913|NCT00229385|Serotonin Agents|serotonin agents|mesh-ancestor
110293914|NCT00229385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110293915|NCT00229385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293916|NCT00229385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110293917|NCT00229385|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110293918|NCT00229385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110293919|NCT00229385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110293920|NCT00229385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110293921|NCT00229385|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110293922|NCT00229385|Dopamine Agents|dopamine agents|mesh-ancestor
110293923|NCT00236223|Dexamethasone|dexamethasone|mesh-list
110293925|NCT00236223|Gabapentin|gabapentin|mesh-list
110293926|NCT00236223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110293927|NCT00236223|Antiemetics|antiemetics|mesh-ancestor
110293928|NCT00236223|Autonomic Agents|autonomic agents|mesh-ancestor
110293929|NCT00236223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110293930|NCT00236223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110293931|NCT00236223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110293932|NCT00236223|Glucocorticoids|glucocorticoids|mesh-ancestor
110278111|NCT00578149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110278112|NCT00578149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110278113|NCT00578149|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110278114|NCT00578149|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110278115|NCT00578149|Growth Substances|growth substances|mesh-ancestor
110278116|NCT00578149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110278117|NCT00578149|Growth Inhibitors|growth inhibitors|mesh-ancestor
110278118|NCT00187122|Cytarabine|cytarabine|mesh-list
110278119|NCT00187122|Dexamethasone|dexamethasone|mesh-list
110278120|NCT00187122|Prednisone|prednisone|mesh-list
110293933|NCT00236223|Hormones|hormones|mesh-ancestor
110293934|NCT00236223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110293935|NCT00236223|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110293936|NCT00236223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110293937|NCT00236223|Analgesics|analgesics|mesh-ancestor
110293938|NCT00236223|Sensory System Agents|sensory system agents|mesh-ancestor
110293939|NCT00236223|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110293940|NCT00236223|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110293941|NCT00236223|Anesthetics, General|anesthetics, general|mesh-ancestor
110293942|NCT00236223|Anesthetics|anesthetics|mesh-ancestor
110293943|NCT00236223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110293944|NCT00236223|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110293945|NCT00236223|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110293946|NCT00236223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110293947|NCT00236223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293948|NCT00236223|Anticonvulsants|anticonvulsants|mesh-ancestor
110293949|NCT00236223|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110293950|NCT00236223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110293951|NCT00236223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110293952|NCT00236223|Antimanic Agents|antimanic agents|mesh-ancestor
110293953|NCT00229424|Famotidine|famotidine|mesh-list
110293954|NCT00229424|Lafutidine|lafutidine|mesh-list
110293955|NCT00229424|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110293956|NCT00229424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110293957|NCT00229424|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110293958|NCT00229424|Histamine Antagonists|histamine antagonists|mesh-ancestor
110293959|NCT00229424|Histamine Agents|histamine agents|mesh-ancestor
110293960|NCT00229424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110293961|NCT00229424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293962|NCT00229424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110293963|NCT00256932|Alvimopan|alvimopan|mesh-list
110293964|NCT00256932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110293965|NCT00191152|Gemcitabine|gemcitabine|mesh-list
110293966|NCT00191152|Capecitabine|capecitabine|mesh-list
110293967|NCT00191152|Docetaxel|docetaxel|mesh-list
110293968|NCT00191152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110293969|NCT00191152|Antimetabolites|antimetabolites|mesh-ancestor
110293970|NCT00191152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293971|NCT00191152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110293972|NCT00191152|Tubulin Modulators|tubulin modulators|mesh-ancestor
110293973|NCT00191152|Antimitotic Agents|antimitotic agents|mesh-ancestor
110293974|NCT00191152|Mitosis Modulators|mitosis modulators|mesh-ancestor
110293978|NCT00257049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110293979|NCT00257049|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110293980|NCT00257049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110293981|NCT00257049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110293982|NCT00257049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293983|NCT00257049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110293984|NCT00257049|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110293985|NCT00257049|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110293987|NCT01059188|Cetuximab|cetuximab|mesh-list
110293988|NCT01059188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110293989|NCT01059188|Tubulin Modulators|tubulin modulators|mesh-ancestor
110293990|NCT01059188|Antimitotic Agents|antimitotic agents|mesh-ancestor
110293991|NCT01059188|Mitosis Modulators|mitosis modulators|mesh-ancestor
110278121|NCT00187122|Cyclophosphamide|cyclophosphamide|mesh-list
110278122|NCT00187122|Methotrexate|methotrexate|mesh-list
110278123|NCT00187122|Etoposide|etoposide|mesh-list
110278124|NCT00187122|Vincristine|vincristine|mesh-list
110278125|NCT00187122|Asparaginase|asparaginase|mesh-list
110278126|NCT00187122|Mercaptopurine|mercaptopurine|mesh-list
110278127|NCT00187122|Daunorubicin|daunorubicin|mesh-list
110278128|NCT00187122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110278129|NCT00187122|Immunologic Factors|immunologic factors|mesh-ancestor
110293992|NCT01059188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293993|NCT01059188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110293994|NCT00236301|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110293995|NCT00236301|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110293997|NCT00236301|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110293998|NCT00236301|Estrogens|estrogens|mesh-ancestor
110293999|NCT00236301|Hormones|hormones|mesh-ancestor
110294000|NCT00236301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110294001|NCT00236301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294002|NCT00236301|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110294003|NCT00236301|Contraceptive Agents|contraceptive agents|mesh-ancestor
110294004|NCT00236301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110294005|NCT00236301|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110294006|NCT00229697|Tamoxifen|tamoxifen|mesh-list
110294007|NCT00229697|Gefitinib|gefitinib|mesh-list
110294008|NCT00229697|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110294009|NCT00229697|Hormone Antagonists|hormone antagonists|mesh-ancestor
110294010|NCT00229697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110294011|NCT00229697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294012|NCT00229697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110294013|NCT00229697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110294014|NCT00229697|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110294015|NCT00229697|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110294016|NCT00229697|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110294017|NCT00229697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110294018|NCT00229697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110294019|NCT00229697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110294020|NCT00236379|Olanzapine|olanzapine|mesh-list
110294021|NCT00236379|Risperidone|risperidone|mesh-list
110294022|NCT00236379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110294024|NCT00236379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110294025|NCT00236379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110294026|NCT00236379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294027|NCT00236379|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110294028|NCT00236379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110294029|NCT00236379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110294030|NCT00236379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110294031|NCT00236379|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110294032|NCT00236379|Dopamine Agents|dopamine agents|mesh-ancestor
110294033|NCT00236379|Antiemetics|antiemetics|mesh-ancestor
110294034|NCT00236379|Autonomic Agents|autonomic agents|mesh-ancestor
110294035|NCT00236379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110294036|NCT00236379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110294037|NCT00236379|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110294038|NCT00236379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110294039|NCT00236379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110294040|NCT00229775|Chloroquine|chloroquine|mesh-list
110294041|NCT00229775|Artemether|artemether|mesh-list
110294042|NCT00229775|Pyrimethamine|pyrimethamine|mesh-list
110294043|NCT00229775|Sulfadoxine|sulfadoxine|mesh-list
110294056|NCT00257127|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110294057|NCT00257127|Immunologic Factors|immunologic factors|mesh-ancestor
110294058|NCT00257127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294059|NCT00190684|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110294060|NCT00190684|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110278130|NCT00187122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110278131|NCT00187122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110278132|NCT00187122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110278133|NCT00187122|Alkylating Agents|alkylating agents|mesh-ancestor
110278134|NCT00187122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110278135|NCT00187122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110278136|NCT00187122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110294061|NCT00190684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110294062|NCT00190684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110294063|NCT00190684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110294064|NCT00190684|Adrenergic Agents|adrenergic agents|mesh-ancestor
110294065|NCT00190684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110294066|NCT00190684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294067|NCT00236418|Topiramate|topiramate|mesh-list
110294068|NCT00236418|Anticonvulsants|anticonvulsants|mesh-ancestor
110294069|NCT00236418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110294070|NCT00236418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294071|NCT00236457|Risperidone|risperidone|mesh-list
110294072|NCT00236457|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110294073|NCT00236457|Serotonin Agents|serotonin agents|mesh-ancestor
110294074|NCT00236457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110294075|NCT00236457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110294076|NCT00236457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294077|NCT00236457|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110294078|NCT00236457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110294079|NCT00236457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110294080|NCT00236457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110294081|NCT00236457|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110294082|NCT00236457|Dopamine Agents|dopamine agents|mesh-ancestor
110294083|NCT00236496|Topiramate|topiramate|mesh-list
110294084|NCT00236496|Anticonvulsants|anticonvulsants|mesh-ancestor
110294085|NCT00236496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110294086|NCT00236496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294088|NCT00199277|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
110294089|NCT00199277|Trace Elements|trace elements|mesh-ancestor
110294090|NCT00199277|Micronutrients|micronutrients|mesh-ancestor
110294091|NCT00199277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294092|NCT00199277|Hematinics|hematinics|mesh-ancestor
110294093|NCT00236535|Acetaminophen|acetaminophen|mesh-list
110294094|NCT00236535|Tramadol|tramadol|mesh-list
110294095|NCT00236535|Hydrocodone|hydrocodone|mesh-list
110294096|NCT00236535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110294097|NCT00236535|Analgesics|analgesics|mesh-ancestor
110294098|NCT00236535|Sensory System Agents|sensory system agents|mesh-ancestor
110294099|NCT00236535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110294100|NCT00236535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294101|NCT00236535|Antipyretics|antipyretics|mesh-ancestor
110294102|NCT00236535|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110294103|NCT00236535|Narcotics|narcotics|mesh-ancestor
110294104|NCT00236535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110294105|NCT00236535|Antitussive Agents|antitussive agents|mesh-ancestor
110294106|NCT00236535|Respiratory System Agents|respiratory system agents|mesh-ancestor
110294107|NCT00193219|Leucovorin|leucovorin|mesh-list
110294108|NCT00193219|Bevacizumab|bevacizumab|mesh-list
110294113|NCT00193219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110294114|NCT00193219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110294115|NCT00193219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110294117|NCT00193219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294118|NCT00193219|Growth Inhibitors|growth inhibitors|mesh-ancestor
110294120|NCT00193219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110294121|NCT00193219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110294122|NCT00193219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110294123|NCT00193219|Immunologic Factors|immunologic factors|mesh-ancestor
110294124|NCT00193219|Antidotes|antidotes|mesh-ancestor
110294125|NCT00193219|Protective Agents|protective agents|mesh-ancestor
110294126|NCT00193219|Vitamin B Complex|vitamin b complex|mesh-ancestor
110278137|NCT00187122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110278138|NCT00187122|Antiemetics|antiemetics|mesh-ancestor
110278139|NCT00187122|Autonomic Agents|autonomic agents|mesh-ancestor
110278140|NCT00187122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110278141|NCT00187122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110278143|NCT00187122|Hormones|hormones|mesh-ancestor
110278144|NCT00187122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110278145|NCT00187122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110294127|NCT00193219|Vitamins|vitamins|mesh-ancestor
110294128|NCT00193219|Micronutrients|micronutrients|mesh-ancestor
110294129|NCT00199316|Morphine|morphine|mesh-list
110294130|NCT00199316|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110294131|NCT00199316|Narcotics|narcotics|mesh-ancestor
110294132|NCT00199316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110294133|NCT00199316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294134|NCT00199316|Analgesics|analgesics|mesh-ancestor
110294135|NCT00199316|Sensory System Agents|sensory system agents|mesh-ancestor
110294136|NCT00199316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110294137|NCT00196339|Cyproterone Acetate|cyproterone acetate|mesh-list
110294138|NCT00196339|Cyproterone|cyproterone|mesh-list
110294139|NCT00196339|Androgen Antagonists|androgen antagonists|mesh-ancestor
110294140|NCT00196339|Hormone Antagonists|hormone antagonists|mesh-ancestor
110294141|NCT00196339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110294142|NCT00196339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294143|NCT00196339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110294144|NCT00196339|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110294145|NCT00196339|Contraceptive Agents|contraceptive agents|mesh-ancestor
110294146|NCT00196339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110294147|NCT00257361|Cycloserine|cycloserine|mesh-list
110294148|NCT00257361|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110294149|NCT00257361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110294150|NCT00257361|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110294151|NCT00257361|Antitubercular Agents|antitubercular agents|mesh-ancestor
110294152|NCT00257361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110294153|NCT00257361|Antimetabolites|antimetabolites|mesh-ancestor
110294154|NCT00257361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110294155|NCT00199355|Istradefylline|istradefylline|mesh-list
110294156|NCT00199355|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
110294157|NCT00199355|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110294158|NCT00199355|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110294159|NCT00199355|Purinergic Agents|purinergic agents|mesh-ancestor
110294160|NCT00199355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110294161|NCT00199355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110294162|NCT00199355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294163|NCT00179959|Mupirocin|mupirocin|mesh-list
110294164|NCT00179959|Sodium Hypochlorite|sodium hypochlorite|mesh-list
110294165|NCT00179959|Eusol|eusol|mesh-list
110294166|NCT00179959|Petrolatum|petrolatum|mesh-list
110294167|NCT00179959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110294168|NCT00179959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110294169|NCT00179959|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110294170|NCT00179959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110294171|NCT00179959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110294172|NCT00179959|Disinfectants|disinfectants|mesh-ancestor
110294173|NCT00179959|Emollients|emollients|mesh-ancestor
110294174|NCT00179959|Dermatologic Agents|dermatologic agents|mesh-ancestor
110294175|NCT00199394|Istradefylline|istradefylline|mesh-list
110294176|NCT00199394|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
110294177|NCT00199394|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110294178|NCT00199394|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110294179|NCT00199394|Purinergic Agents|purinergic agents|mesh-ancestor
110025093|NCT00357474|Ethanol|ethanol|mesh-list
110294181|NCT00199394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110294182|NCT00199394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110278146|NCT00187122|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110278147|NCT00187122|Abortifacient Agents|abortifacient agents|mesh-ancestor
110278148|NCT00187122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110278149|NCT00187122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110278150|NCT00187122|Antimetabolites|antimetabolites|mesh-ancestor
110278151|NCT00187122|Dermatologic Agents|dermatologic agents|mesh-ancestor
110278152|NCT00187122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110278153|NCT00187122|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110278154|NCT00187122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110278155|NCT00187122|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110278156|NCT00187122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110278157|NCT00187122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110294184|NCT00236574|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110294185|NCT00236574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110294186|NCT00236574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110294187|NCT00236574|Cholinergic Agents|cholinergic agents|mesh-ancestor
110294188|NCT00236574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110294189|NCT00236574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294190|NCT00236574|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110294191|NCT00236574|Autonomic Agents|autonomic agents|mesh-ancestor
110294192|NCT00236574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110294193|NCT00236574|Nootropic Agents|nootropic agents|mesh-ancestor
110294194|NCT00199433|Istradefylline|istradefylline|mesh-list
110294195|NCT00199433|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
110294196|NCT00199433|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110294197|NCT00199433|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110294198|NCT00199433|Purinergic Agents|purinergic agents|mesh-ancestor
110294199|NCT00199433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110294200|NCT00199433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110294201|NCT00199433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294202|NCT00199472|Diuretics|diuretics|mesh-list
110294203|NCT00199472|Natriuretic Agents|natriuretic agents|mesh-ancestor
110294204|NCT00199472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294205|NCT00199511|Mannitol|mannitol|mesh-list
110294206|NCT00199511|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110294207|NCT00199511|Diuretics|diuretics|mesh-ancestor
110294208|NCT00199511|Natriuretic Agents|natriuretic agents|mesh-ancestor
110294209|NCT00199511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294210|NCT00236613|Topiramate|topiramate|mesh-list
110294211|NCT00236613|Anticonvulsants|anticonvulsants|mesh-ancestor
110294212|NCT00236613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110294213|NCT00236613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294214|NCT00236652|Levofloxacin|levofloxacin|mesh-list
110294215|NCT00236652|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110294216|NCT00236652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110294217|NCT00236652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110294218|NCT00236652|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110294219|NCT00236652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110294220|NCT00236652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110294221|NCT00236652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110294222|NCT00236652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110294223|NCT00236652|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110294224|NCT00236652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110294225|NCT00257595|Cetirizine|cetirizine|mesh-list
110294226|NCT00257595|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110294227|NCT00257595|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110294228|NCT00257595|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110294229|NCT00257595|Histamine Antagonists|histamine antagonists|mesh-ancestor
110294230|NCT00257595|Histamine Agents|histamine agents|mesh-ancestor
110294231|NCT00257595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110294232|NCT00257595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110278158|NCT00187122|Antiviral Agents|antiviral agents|mesh-ancestor
110278159|NCT00187122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110278160|NCT00187122|Tubulin Modulators|tubulin modulators|mesh-ancestor
110278161|NCT00187122|Antimitotic Agents|antimitotic agents|mesh-ancestor
110278162|NCT00187122|Mitosis Modulators|mitosis modulators|mesh-ancestor
110278163|NCT00187122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110278164|NCT00180635|Pimagedine|pimagedine|mesh-list
110278165|NCT00180635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110278166|NCT00180635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110278167|NCT00578266|Cyclophosphamide|cyclophosphamide|mesh-list
110278168|NCT00578266|Alemtuzumab|alemtuzumab|mesh-list
110294233|NCT00257595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294234|NCT00199667|Mycophenolic Acid|mycophenolic acid|mesh-list
110294235|NCT00199667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110294236|NCT00199667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110294237|NCT00199667|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110294238|NCT00199667|Antitubercular Agents|antitubercular agents|mesh-ancestor
110294239|NCT00199667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110294240|NCT00199667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110294241|NCT00199667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110294242|NCT00199667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110294244|NCT00236691|Anticonvulsants|anticonvulsants|mesh-ancestor
110294245|NCT00236691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110294246|NCT00236691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294247|NCT00236730|Topiramate|topiramate|mesh-list
110294248|NCT00236730|Anticonvulsants|anticonvulsants|mesh-ancestor
110294249|NCT00236730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110294250|NCT00236730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294251|NCT00199745|Atorvastatin|atorvastatin|mesh-list
110294252|NCT00199745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110294253|NCT00199745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110294283|NCT00236769|Estradiol|estradiol|mesh-list
110294284|NCT00236769|Estrogens|estrogens|mesh-ancestor
110294285|NCT00236769|Hormones|hormones|mesh-ancestor
110294286|NCT00236769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110294287|NCT00236769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294288|NCT00236769|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110294289|NCT00236769|Contraceptive Agents|contraceptive agents|mesh-ancestor
110294290|NCT00236769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110294291|NCT00236769|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110294292|NCT00236769|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110294293|NCT00236769|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110294294|NCT00415311|Lectins|lectins|mesh-list
110294295|NCT00415311|Agglutinins|agglutinins|mesh-ancestor
110294296|NCT00415311|Immunologic Factors|immunologic factors|mesh-ancestor
110294297|NCT00415311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294298|NCT00415311|Coagulants|coagulants|mesh-ancestor
110294299|NCT00199940|Ziprasidone|ziprasidone|mesh-list
110294300|NCT00199940|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110294301|NCT00199940|Serotonin Agents|serotonin agents|mesh-ancestor
110294320|NCT00236808|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110294321|NCT00236808|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110294322|NCT00199979|Nevirapine|nevirapine|mesh-list
110294323|NCT00199979|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110294324|NCT00199979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110294325|NCT00199979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110294326|NCT00199979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110294327|NCT00199979|Antiviral Agents|antiviral agents|mesh-ancestor
110025235|NCT00360048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294328|NCT00199979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110294329|NCT00199979|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110294330|NCT00199979|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110294331|NCT00199979|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110278169|NCT00578266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110278170|NCT00578266|Immunologic Factors|immunologic factors|mesh-ancestor
110278171|NCT00578266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110278172|NCT00578266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110278173|NCT00578266|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110278174|NCT00578266|Alkylating Agents|alkylating agents|mesh-ancestor
110278175|NCT00578266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110278176|NCT00578266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110278177|NCT00578266|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110278178|NCT00578266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110278179|NCT04578496|Afamelanotide|afamelanotide|mesh-list
110278180|NCT04578496|Dermatologic Agents|dermatologic agents|mesh-ancestor
110278181|NCT00579046|Darbepoetin alfa|darbepoetin alfa|mesh-list
110278182|NCT00579046|Hematinics|hematinics|mesh-ancestor
110278183|NCT00579085|Ketamine|ketamine|mesh-list
110278184|NCT00579085|Analgesics|analgesics|mesh-ancestor
110278185|NCT00579085|Sensory System Agents|sensory system agents|mesh-ancestor
110278186|NCT00579085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110278187|NCT00579085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110278188|NCT00579085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110278189|NCT00579085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110278190|NCT00579085|Anesthetics, General|anesthetics, general|mesh-ancestor
110278191|NCT00579085|Anesthetics|anesthetics|mesh-ancestor
110278192|NCT00579085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110294332|NCT00199979|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110294333|NCT00257634|Dexamethasone|dexamethasone|mesh-list
110294334|NCT00257634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110294335|NCT00257634|Antiemetics|antiemetics|mesh-ancestor
110294336|NCT00257634|Autonomic Agents|autonomic agents|mesh-ancestor
110294337|NCT00257634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110294338|NCT00257634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294339|NCT00257634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110294340|NCT00257634|Glucocorticoids|glucocorticoids|mesh-ancestor
110294341|NCT00257634|Hormones|hormones|mesh-ancestor
110294342|NCT00257634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110294343|NCT00257634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110294344|NCT00257634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110294345|NCT00236847|Topiramate|topiramate|mesh-list
110294346|NCT00236847|Anticonvulsants|anticonvulsants|mesh-ancestor
110294347|NCT00236847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110294348|NCT00236847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294349|NCT00410306|Methyltestosterone|methyltestosterone|mesh-list
110294350|NCT00410306|Testosterone|testosterone|mesh-list
110294351|NCT00410306|Testosterone undecanoate|testosterone undecanoate|mesh-list
110294352|NCT00410306|Testosterone enanthate|testosterone enanthate|mesh-list
110294353|NCT00410306|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110294354|NCT00410306|Androgens|androgens|mesh-ancestor
110294355|NCT00410306|Hormones|hormones|mesh-ancestor
110278193|NCT00579085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110278194|NCT00579085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110278195|NCT00579085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110278196|NCT00579085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110278197|NCT00187161|Cytarabine|cytarabine|mesh-list
110278198|NCT00187161|Cyclophosphamide|cyclophosphamide|mesh-list
110278199|NCT00187161|Doxorubicin|doxorubicin|mesh-list
110278200|NCT00187161|Methotrexate|methotrexate|mesh-list
110278201|NCT00187161|Etoposide|etoposide|mesh-list
110278202|NCT00187161|Vincristine|vincristine|mesh-list
110278203|NCT00187161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110278204|NCT00187161|Immunologic Factors|immunologic factors|mesh-ancestor
110278205|NCT00187161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110278206|NCT00187161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110278207|NCT00187161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110278208|NCT00187161|Alkylating Agents|alkylating agents|mesh-ancestor
110278209|NCT00187161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110278210|NCT00187161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110294368|NCT00179647|Lenalidomide|lenalidomide|mesh-list
110294369|NCT00179647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110294370|NCT00179647|Antiemetics|antiemetics|mesh-ancestor
110294371|NCT00179647|Autonomic Agents|autonomic agents|mesh-ancestor
110294372|NCT00179647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110294373|NCT00179647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294374|NCT00179647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110294375|NCT00179647|Glucocorticoids|glucocorticoids|mesh-ancestor
110294376|NCT00179647|Hormones|hormones|mesh-ancestor
110294377|NCT00179647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110294378|NCT00179647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110294379|NCT00179647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110294380|NCT00179647|Immunologic Factors|immunologic factors|mesh-ancestor
110294381|NCT00179647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110294382|NCT00179647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110294383|NCT00179647|Growth Substances|growth substances|mesh-ancestor
110294384|NCT00179647|Growth Inhibitors|growth inhibitors|mesh-ancestor
110294385|NCT00257751|Aprotinin|aprotinin|mesh-list
110294386|NCT00257751|Hemostatics|hemostatics|mesh-ancestor
110294387|NCT00257751|Coagulants|coagulants|mesh-ancestor
110294388|NCT00257751|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110294389|NCT00257751|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110294390|NCT00257751|Protease Inhibitors|protease inhibitors|mesh-ancestor
110294391|NCT00257751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110294392|NCT00257751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110294393|NCT00179413|Interferons|interferons|mesh-list
110294394|NCT00179413|Interferon-alpha|interferon-alpha|mesh-list
110294395|NCT00179413|Interferon alpha-2|interferon alpha-2|mesh-list
110294396|NCT00179413|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110294397|NCT00179413|Colchicine|colchicine|mesh-list
110294398|NCT00179413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110294399|NCT00179413|Antiviral Agents|antiviral agents|mesh-ancestor
110294400|NCT00179413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110294401|NCT00179413|Immunologic Factors|immunologic factors|mesh-ancestor
110294402|NCT00179413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294403|NCT00179413|Gout Suppressants|gout suppressants|mesh-ancestor
110294404|NCT00179413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110294405|NCT00179413|Tubulin Modulators|tubulin modulators|mesh-ancestor
110294406|NCT00179413|Antimitotic Agents|antimitotic agents|mesh-ancestor
110294407|NCT00179413|Mitosis Modulators|mitosis modulators|mesh-ancestor
110294408|NCT00179413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110278211|NCT00187161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110278212|NCT00187161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110278213|NCT00187161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110278214|NCT00187161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110278215|NCT00187161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110278216|NCT00187161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110278217|NCT00187161|Abortifacient Agents|abortifacient agents|mesh-ancestor
110278218|NCT00187161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110278219|NCT00187161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110278220|NCT00187161|Antimetabolites|antimetabolites|mesh-ancestor
110294409|NCT00236886|Topiramate|topiramate|mesh-list
110294410|NCT00236886|Anticonvulsants|anticonvulsants|mesh-ancestor
110294411|NCT00236886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110294412|NCT00236886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294413|NCT00257790|Tobramycin|tobramycin|mesh-list
110294414|NCT00257790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110294415|NCT00257790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110294416|NCT00236925|Hydrocortisone|hydrocortisone|mesh-list
110294417|NCT00236925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110294424|NCT00200252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294425|NCT00177307|Bevacizumab|bevacizumab|mesh-list
110294426|NCT00177307|Capecitabine|capecitabine|mesh-list
110294427|NCT00177307|Oxaliplatin|oxaliplatin|mesh-list
110294428|NCT00177307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110294429|NCT00177307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110294430|NCT00177307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110294431|NCT00177307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110294432|NCT00177307|Growth Substances|growth substances|mesh-ancestor
110294433|NCT00177307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294434|NCT00177307|Growth Inhibitors|growth inhibitors|mesh-ancestor
110294435|NCT00177307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110294436|NCT00177307|Antimetabolites|antimetabolites|mesh-ancestor
110294437|NCT00177307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110294438|NCT00257829|Methazolamide|methazolamide|mesh-list
110294439|NCT00257829|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110294440|NCT00257829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110294441|NCT00257829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110294442|NCT00257829|Diuretics|diuretics|mesh-ancestor
110294443|NCT00257829|Natriuretic Agents|natriuretic agents|mesh-ancestor
110294444|NCT00257829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294445|NCT02484664|Celecoxib|celecoxib|mesh-list
110294446|NCT02484664|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110294447|NCT02484664|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110294448|NCT02484664|Analgesics|analgesics|mesh-ancestor
110294449|NCT02484664|Sensory System Agents|sensory system agents|mesh-ancestor
110294450|NCT02484664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110294451|NCT02484664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294452|NCT02484664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110294453|NCT02484664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110294454|NCT02484664|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110294455|NCT02484664|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110294456|NCT02484664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110294457|NCT02484664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110294458|NCT00257868|Rivastigmine|rivastigmine|mesh-list
110294459|NCT00257868|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110294460|NCT00257868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110294461|NCT00257868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110294462|NCT00257868|Cholinergic Agents|cholinergic agents|mesh-ancestor
110294463|NCT00257868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110294464|NCT00257868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294465|NCT00257868|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110278221|NCT00187161|Dermatologic Agents|dermatologic agents|mesh-ancestor
110278222|NCT00187161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110278223|NCT00187161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110278224|NCT00187161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110278226|NCT00187161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110278227|NCT00187161|Tubulin Modulators|tubulin modulators|mesh-ancestor
110278228|NCT00187161|Antimitotic Agents|antimitotic agents|mesh-ancestor
110278229|NCT00187161|Mitosis Modulators|mitosis modulators|mesh-ancestor
110278230|NCT00579475|Mifepristone|mifepristone|mesh-list
110278231|NCT00579475|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110278232|NCT00579475|Abortifacient Agents|abortifacient agents|mesh-ancestor
110278233|NCT00579475|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110278234|NCT00579475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110278235|NCT00579475|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110278236|NCT00579475|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110278237|NCT00579475|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110278238|NCT00579475|Contraceptive Agents|contraceptive agents|mesh-ancestor
110278239|NCT00579475|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110278240|NCT00579475|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110294466|NCT00257868|Protective Agents|protective agents|mesh-ancestor
110294467|NCT00176605|Cyclophosphamide|cyclophosphamide|mesh-list
110294468|NCT00176605|Etoposide|etoposide|mesh-list
110294469|NCT00176605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110294470|NCT00176605|Immunologic Factors|immunologic factors|mesh-ancestor
110294471|NCT00176605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294472|NCT00176605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110294473|NCT00176605|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110294474|NCT00176605|Alkylating Agents|alkylating agents|mesh-ancestor
110294475|NCT00176605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110294476|NCT00176605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110294477|NCT00176605|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110294478|NCT00176605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110294479|NCT00176605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110294480|NCT00176605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110294481|NCT00176605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110294483|NCT00176488|Epirubicin|epirubicin|mesh-list
110294484|NCT00176488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110294485|NCT00176488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110294486|NCT00176488|Tubulin Modulators|tubulin modulators|mesh-ancestor
110294487|NCT00176488|Antimitotic Agents|antimitotic agents|mesh-ancestor
110294488|NCT00176488|Mitosis Modulators|mitosis modulators|mesh-ancestor
110294495|NCT00200447|Levodopa|levodopa|mesh-list
110294496|NCT00200447|Entacapone|entacapone|mesh-list
110294497|NCT00200447|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
110294498|NCT00200447|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110294499|NCT00200447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110294500|NCT00200447|Dopamine Agents|dopamine agents|mesh-ancestor
110294501|NCT00200447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110294502|NCT00200447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110294503|NCT00200447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294504|NCT00200447|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110294505|NCT00200447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110294506|NCT00200447|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
110278241|NCT00579475|Hormone Antagonists|hormone antagonists|mesh-ancestor
110278242|NCT00579475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110278243|NCT00579475|Luteolytic Agents|luteolytic agents|mesh-ancestor
110278244|NCT00579475|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110278245|NCT00579475|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110278246|NCT00579592|Mycophenolic Acid|mycophenolic acid|mesh-list
110278247|NCT00579592|Rituximab|rituximab|mesh-list
110278248|NCT00579592|Alemtuzumab|alemtuzumab|mesh-list
110278249|NCT00579592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110278250|NCT00579592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110278251|NCT00579592|Immunologic Factors|immunologic factors|mesh-ancestor
110278252|NCT00579592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110278253|NCT00579592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110278254|NCT00579592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110278255|NCT00579592|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110278256|NCT00579592|Antitubercular Agents|antitubercular agents|mesh-ancestor
110294507|NCT00237120|Imatinib Mesylate|imatinib mesylate|mesh-list
110294508|NCT00237120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110294509|NCT00237120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110294510|NCT00237120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110294511|NCT00237120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110294512|NCT00175825|Brivaracetam|brivaracetam|mesh-list
110294513|NCT00175825|Anticonvulsants|anticonvulsants|mesh-ancestor
110294514|NCT04710329|Ascorbic Acid|ascorbic acid|mesh-list
110294515|NCT04710329|Antioxidants|antioxidants|mesh-ancestor
110294516|NCT04710329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110294517|NCT04710329|Protective Agents|protective agents|mesh-ancestor
110294518|NCT04710329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294519|NCT04710329|Vitamins|vitamins|mesh-ancestor
110294520|NCT04710329|Micronutrients|micronutrients|mesh-ancestor
110294521|NCT00200525|Apomorphine|apomorphine|mesh-list
110294522|NCT00200525|Emetics|emetics|mesh-ancestor
110294523|NCT00200525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294524|NCT00200525|Autonomic Agents|autonomic agents|mesh-ancestor
110294525|NCT00200525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110294526|NCT00200525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110294527|NCT00200525|Dopamine Agonists|dopamine agonists|mesh-ancestor
110294528|NCT00200525|Dopamine Agents|dopamine agents|mesh-ancestor
110294529|NCT00200525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110294530|NCT00200525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110294531|NCT00174967|Febuxostat|febuxostat|mesh-list
110294532|NCT00174967|Gout Suppressants|gout suppressants|mesh-ancestor
110294533|NCT00174967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110294534|NCT00200564|Ketamine|ketamine|mesh-list
110294535|NCT00200564|Analgesics|analgesics|mesh-ancestor
110294536|NCT00200564|Sensory System Agents|sensory system agents|mesh-ancestor
110294537|NCT00200564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110294538|NCT00200564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294539|NCT00200564|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110294540|NCT00200564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110294541|NCT00200564|Anesthetics, General|anesthetics, general|mesh-ancestor
110294542|NCT00200564|Anesthetics|anesthetics|mesh-ancestor
110294543|NCT00200564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110294544|NCT00200564|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110294545|NCT00200564|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110294546|NCT00200564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110294547|NCT00200564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110294548|NCT00174265|Olanzapine|olanzapine|mesh-list
110278257|NCT00579592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110278258|NCT00579592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110278259|NCT00579592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110278260|NCT00579592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110278262|NCT00180791|Etoposide|etoposide|mesh-list
110278263|NCT00180791|Melphalan|melphalan|mesh-list
110278264|NCT00180791|Thiotepa|thiotepa|mesh-list
110278265|NCT00180791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110294549|NCT00174265|Asenapine|asenapine|mesh-list
110294550|NCT00174265|Antiemetics|antiemetics|mesh-ancestor
110294551|NCT00174265|Autonomic Agents|autonomic agents|mesh-ancestor
110294552|NCT00174265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110294553|NCT00174265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025465|NCT00366834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110294554|NCT00174265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110294555|NCT00174265|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110294556|NCT00174265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110294557|NCT00174265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110294561|NCT00174265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110294562|NCT00174265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110294563|NCT00174265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110294564|NCT00174265|Serotonin Agents|serotonin agents|mesh-ancestor
110294565|NCT00200603|Calcium|calcium|mesh-list
110294566|NCT00200603|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110294567|NCT00200603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294568|NCT00200681|Bortezomib|bortezomib|mesh-list
110294569|NCT00200681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110294570|NCT00258063|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110294571|NCT00258063|Norelgestromin|norelgestromin|mesh-list
110294572|NCT00258063|Contraceptive Agents|contraceptive agents|mesh-list
110294573|NCT00258063|Estradiol|estradiol|mesh-list
110294574|NCT00258063|Estrogens|estrogens|mesh-ancestor
110294575|NCT00258063|Hormones|hormones|mesh-ancestor
110294576|NCT00258063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110294577|NCT00258063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294578|NCT00258063|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110294579|NCT00258063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110294580|NCT00258063|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110294581|NCT00258063|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110294582|NCT00258063|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110294583|NCT00258102|Levofloxacin|levofloxacin|mesh-list
110294584|NCT00258102|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110294585|NCT00258102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110294586|NCT00258102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110294587|NCT00258102|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110294588|NCT00258102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110294589|NCT00258102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110294590|NCT00258102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110294591|NCT00258102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110294592|NCT00258102|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110294593|NCT00258102|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110294594|NCT00265278|Modafinil|modafinil|mesh-list
110294595|NCT00265278|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110294596|NCT00265278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294597|NCT00265278|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110294598|NCT00265278|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110294599|NCT00265278|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110294600|NCT00265278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110294601|NCT00258258|Zoledronic Acid|zoledronic acid|mesh-list
110294602|NCT00258258|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110294603|NCT00258258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294604|NCT00172042|Zoledronic Acid|zoledronic acid|mesh-list
110294605|NCT00172042|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110294606|NCT00172042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110278266|NCT00180791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110278267|NCT00180791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110278268|NCT00180791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110278269|NCT00180791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110278270|NCT00180791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110278271|NCT00180791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110294608|NCT00258297|Enzyme Inhibitors|enzyme inhibitors|mesh-list
110294609|NCT00258297|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
110294610|NCT00258297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110294611|NCT00258297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110294612|NCT00258297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110294613|NCT00258336|Rituximab|rituximab|mesh-list
110294614|NCT00258336|Immunoglobulins|immunoglobulins|mesh-list
110294615|NCT00258336|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110294616|NCT00258336|Antibodies|antibodies|mesh-list
110294617|NCT00258336|Sargramostim|sargramostim|mesh-list
110294618|NCT00258336|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
110294619|NCT00258336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110294620|NCT00258336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110294621|NCT00258336|Immunologic Factors|immunologic factors|mesh-ancestor
110294622|NCT00258336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294623|NCT00258336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110294624|NCT00171925|Vitamin D|vitamin d|mesh-list
110294625|NCT00171925|Zoledronic Acid|zoledronic acid|mesh-list
110294626|NCT00171925|Calcium|calcium|mesh-list
110294627|NCT00171925|Vitamins|vitamins|mesh-ancestor
110294628|NCT00171925|Micronutrients|micronutrients|mesh-ancestor
110294633|NCT00201305|Gemcitabine|gemcitabine|mesh-list
110294634|NCT00201305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110294635|NCT00201305|Antimetabolites|antimetabolites|mesh-ancestor
110294636|NCT00201305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110294637|NCT00201305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110294638|NCT00201305|Antidotes|antidotes|mesh-ancestor
110294639|NCT00201305|Protective Agents|protective agents|mesh-ancestor
110294640|NCT00201305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294641|NCT00201305|Vitamin B Complex|vitamin b complex|mesh-ancestor
110294642|NCT00201305|Vitamins|vitamins|mesh-ancestor
110294643|NCT00201305|Micronutrients|micronutrients|mesh-ancestor
110294644|NCT00265551|Olanzapine|olanzapine|mesh-list
110294645|NCT00265551|Antiemetics|antiemetics|mesh-ancestor
110294646|NCT00265551|Autonomic Agents|autonomic agents|mesh-ancestor
110294647|NCT00265551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110294648|NCT00265551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294649|NCT00265551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110294650|NCT00265551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110294651|NCT00265551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110294652|NCT00265551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110294653|NCT00265551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110294654|NCT00265551|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110294655|NCT00265551|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110294656|NCT00265551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110294657|NCT00265551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110294658|NCT00265551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110294659|NCT00265551|Serotonin Agents|serotonin agents|mesh-ancestor
110294660|NCT00201344|Leucovorin|leucovorin|mesh-list
110294661|NCT00201344|Antidotes|antidotes|mesh-ancestor
110294662|NCT00201344|Protective Agents|protective agents|mesh-ancestor
110294663|NCT00201344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294664|NCT00201344|Vitamin B Complex|vitamin b complex|mesh-ancestor
110294665|NCT00201344|Vitamins|vitamins|mesh-ancestor
110294666|NCT00201344|Micronutrients|micronutrients|mesh-ancestor
110294667|NCT00201383|Cisplatin|cisplatin|mesh-list
110294668|NCT00201383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110294669|NCT00201422|Amoxicillin|amoxicillin|mesh-list
110294670|NCT00201422|Clarithromycin|clarithromycin|mesh-list
110294671|NCT00201422|Omeprazole|omeprazole|mesh-list
110294672|NCT00201422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110294673|NCT00201422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110294674|NCT00201422|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110278272|NCT00180791|Alkylating Agents|alkylating agents|mesh-ancestor
110278273|NCT00180791|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110278274|NCT00180791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110278275|NCT00180791|Immunologic Factors|immunologic factors|mesh-ancestor
110278276|NCT00180791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110278277|NCT01054248|Artesunate|artesunate|mesh-list
110278278|NCT01054248|Piperaquine|piperaquine|mesh-list
110278279|NCT01054248|Artenimol|artenimol|mesh-list
110278280|NCT01054248|Mefloquine|mefloquine|mesh-list
110278281|NCT01054248|Antimalarials|antimalarials|mesh-ancestor
110278282|NCT01054248|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110278283|NCT01054248|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110278284|NCT01054248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110294675|NCT00201422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110294676|NCT00201422|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110294677|NCT00201422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110294678|NCT00201422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110294679|NCT00201422|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110294680|NCT00201422|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110294681|NCT00201422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110294682|NCT00258609|Botulinum Toxins|botulinum toxins|mesh-list
110294683|NCT00258609|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110294684|NCT00258609|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110294685|NCT00258609|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110294686|NCT00258609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110294687|NCT00258609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110294688|NCT00258609|Cholinergic Agents|cholinergic agents|mesh-ancestor
110294689|NCT00258609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110294690|NCT00258609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294691|NCT00258609|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110294692|NCT00258609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110294693|NCT00265746|Metformin|metformin|mesh-list
110294694|NCT00265746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110294695|NCT00265746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294696|NCT00201539|Morphine|morphine|mesh-list
110294697|NCT00201539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110294698|NCT00201539|Narcotics|narcotics|mesh-ancestor
110294699|NCT00201539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110294707|NCT00265824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110294708|NCT00265824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110294709|NCT00265824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110294710|NCT00265824|Growth Substances|growth substances|mesh-ancestor
110294711|NCT00265824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294712|NCT00265824|Growth Inhibitors|growth inhibitors|mesh-ancestor
110294713|NCT00265824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110294714|NCT00265824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110294715|NCT00265824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110294716|NCT00201695|Dexamethasone|dexamethasone|mesh-list
110294717|NCT00201695|Doxorubicin|doxorubicin|mesh-list
110294718|NCT00201695|Vincristine|vincristine|mesh-list
110294719|NCT00201695|Arsenic Trioxide|arsenic trioxide|mesh-list
110294722|NCT00201695|Autonomic Agents|autonomic agents|mesh-ancestor
110294723|NCT00201695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110294724|NCT00201695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294725|NCT00201695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110294726|NCT00201695|Glucocorticoids|glucocorticoids|mesh-ancestor
110294727|NCT00201695|Hormones|hormones|mesh-ancestor
110294728|NCT00201695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110294729|NCT00201695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110278285|NCT01054248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110278286|NCT01054248|Antiviral Agents|antiviral agents|mesh-ancestor
110278287|NCT01054248|Schistosomicides|schistosomicides|mesh-ancestor
110278288|NCT01054248|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110278289|NCT01054248|Anthelmintics|anthelmintics|mesh-ancestor
110278290|NCT00180830|Imatinib Mesylate|imatinib mesylate|mesh-list
110278291|NCT00180830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110278292|NCT00180830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110278293|NCT00180830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110278294|NCT00180830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110278295|NCT00202176|Bromides|bromides|mesh-list
110294730|NCT00201695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110294731|NCT00201695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110294732|NCT00201695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110294733|NCT00201695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110294734|NCT00201695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110294735|NCT00201695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110294736|NCT00201695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110294737|NCT00201695|Tubulin Modulators|tubulin modulators|mesh-ancestor
110294738|NCT00201695|Antimitotic Agents|antimitotic agents|mesh-ancestor
110294739|NCT00201695|Mitosis Modulators|mitosis modulators|mesh-ancestor
110294740|NCT00410345|Mifepristone|mifepristone|mesh-list
110294741|NCT00410345|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110294742|NCT00410345|Abortifacient Agents|abortifacient agents|mesh-ancestor
110294743|NCT00410345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110294744|NCT00410345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294745|NCT00410345|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110294746|NCT00410345|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110294747|NCT00410345|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110294748|NCT00410345|Contraceptive Agents|contraceptive agents|mesh-ancestor
110294749|NCT00410345|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110294750|NCT00410345|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110294751|NCT00410345|Hormone Antagonists|hormone antagonists|mesh-ancestor
110294752|NCT00410345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110294753|NCT00410345|Luteolytic Agents|luteolytic agents|mesh-ancestor
110294754|NCT00410345|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110294755|NCT00410345|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110294757|NCT00265863|Mitomycin|mitomycin|mesh-list
110294758|NCT00265863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110294759|NCT00265863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110294760|NCT00265863|Alkylating Agents|alkylating agents|mesh-ancestor
110294761|NCT00265863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110294762|NCT00265863|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110294763|NCT00265863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110294764|NCT00410462|Doxorubicin|doxorubicin|mesh-list
110294771|NCT00410462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110294772|NCT00258765|Zoledronic Acid|zoledronic acid|mesh-list
110294773|NCT00258765|Docetaxel|docetaxel|mesh-list
110294774|NCT00258765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110294775|NCT00258765|Tubulin Modulators|tubulin modulators|mesh-ancestor
110294776|NCT00258765|Antimitotic Agents|antimitotic agents|mesh-ancestor
110294777|NCT00258765|Mitosis Modulators|mitosis modulators|mesh-ancestor
110294778|NCT00258765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110294779|NCT00258765|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110294780|NCT00258765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294782|NCT00410540|Hydromorphone|hydromorphone|mesh-list
110294783|NCT00410540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110294784|NCT00410540|Narcotics|narcotics|mesh-ancestor
110294785|NCT00410540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110294786|NCT00410540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294787|NCT00410540|Analgesics|analgesics|mesh-ancestor
110294788|NCT00410540|Sensory System Agents|sensory system agents|mesh-ancestor
110278296|NCT00202176|Ipratropium|ipratropium|mesh-list
110278297|NCT00202176|Anticonvulsants|anticonvulsants|mesh-ancestor
110278298|NCT00202176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110278299|NCT00202176|Autonomic Agents|autonomic agents|mesh-ancestor
110278300|NCT00202176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110278301|NCT00202176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110278302|NCT00202176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110278303|NCT00202176|Respiratory System Agents|respiratory system agents|mesh-ancestor
110278304|NCT00202176|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110278305|NCT00202176|Cholinergic Agents|cholinergic agents|mesh-ancestor
110278306|NCT00202176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110278307|NCT00202176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110278308|NCT00580060|Molgramostim|molgramostim|mesh-list
110278309|NCT00580060|Sargramostim|sargramostim|mesh-list
110278310|NCT00580060|Immunologic Factors|immunologic factors|mesh-ancestor
110294789|NCT00410540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110294790|NCT00258804|Insulin Glargine|insulin glargine|mesh-list
110294791|NCT00258804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110294792|NCT00258804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294793|NCT00201812|Dexamethasone|dexamethasone|mesh-list
110294794|NCT00201812|Etanercept|etanercept|mesh-list
110294795|NCT00201812|Docetaxel|docetaxel|mesh-list
110294796|NCT00201812|Glucocorticoids|glucocorticoids|mesh-list
110294797|NCT00201812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110294798|NCT00201812|Antiemetics|antiemetics|mesh-ancestor
110294799|NCT00201812|Autonomic Agents|autonomic agents|mesh-ancestor
110294800|NCT00201812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110294801|NCT00201812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294802|NCT00201812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110294803|NCT00201812|Hormones|hormones|mesh-ancestor
110294804|NCT00201812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110294805|NCT00201812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110294806|NCT00201812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110294807|NCT00201812|Tubulin Modulators|tubulin modulators|mesh-ancestor
110294808|NCT00201812|Antimitotic Agents|antimitotic agents|mesh-ancestor
110294809|NCT00201812|Mitosis Modulators|mitosis modulators|mesh-ancestor
110294810|NCT00201812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110294811|NCT00201812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110294813|NCT00201812|Analgesics|analgesics|mesh-ancestor
110294814|NCT00201812|Sensory System Agents|sensory system agents|mesh-ancestor
110294815|NCT00201812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110294816|NCT00201812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110294817|NCT00201812|Immunologic Factors|immunologic factors|mesh-ancestor
110294818|NCT00258843|Vaccines|vaccines|mesh-list
110294819|NCT00258843|Immunologic Factors|immunologic factors|mesh-ancestor
110294820|NCT00258843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294821|NCT04709094|Bupropion|bupropion|mesh-list
110294822|NCT04709094|Warfarin|warfarin|mesh-list
110294823|NCT04709094|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110294824|NCT04709094|Norethindrone|norethindrone|mesh-list
110294825|NCT04709094|Norethindrone Acetate|norethindrone acetate|mesh-list
110294826|NCT04709094|Norinyl|norinyl|mesh-list
110294827|NCT04709094|Estradiol|estradiol|mesh-list
110294828|NCT04709094|Estrogens|estrogens|mesh-ancestor
110294829|NCT04709094|Hormones|hormones|mesh-ancestor
110294830|NCT04709094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110294831|NCT04709094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294832|NCT04709094|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110294833|NCT04709094|Contraceptive Agents|contraceptive agents|mesh-ancestor
110294834|NCT04709094|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110294835|NCT04709094|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110294836|NCT04709094|Anticoagulants|anticoagulants|mesh-ancestor
110278311|NCT00580060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110278312|NCT00580060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110278313|NCT00180908|Doxorubicin|doxorubicin|mesh-list
110278314|NCT00180908|Etoposide|etoposide|mesh-list
110278315|NCT00180908|Methotrexate|methotrexate|mesh-list
110278316|NCT00180908|Ifosfamide|ifosfamide|mesh-list
110278317|NCT00180908|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110278318|NCT00180908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110278319|NCT00180908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110278320|NCT00180908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110278321|NCT00180908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110278322|NCT00180908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110294848|NCT04709094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110294849|NCT04709094|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110294850|NCT04709094|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110294851|NCT04709094|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110294852|NCT04709094|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110294853|NCT00171340|Zoledronic Acid|zoledronic acid|mesh-list
110294854|NCT00171340|Letrozole|letrozole|mesh-list
110294855|NCT00171340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110294856|NCT00171340|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110294857|NCT00171340|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110294858|NCT00171340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110294859|NCT00171340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110294860|NCT00171340|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110294861|NCT00171340|Hormone Antagonists|hormone antagonists|mesh-ancestor
110294862|NCT00171340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110294863|NCT00171340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294864|NCT00171340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110294865|NCT00202007|Risperidone|risperidone|mesh-list
110294866|NCT00202007|Aripiprazole|aripiprazole|mesh-list
110294867|NCT00202007|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110294869|NCT00202007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110294870|NCT00202007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110294872|NCT00202007|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110294873|NCT00202007|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110294874|NCT00202007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110294875|NCT00202007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110294876|NCT00202007|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110294877|NCT00202007|Dopamine Agents|dopamine agents|mesh-ancestor
110294878|NCT00202007|Antidepressive Agents|antidepressive agents|mesh-ancestor
110294879|NCT00202007|Dopamine Agonists|dopamine agonists|mesh-ancestor
110294880|NCT00202007|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110294881|NCT00202007|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110294882|NCT00202007|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110294883|NCT00202007|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110294884|NCT00171301|Deferasirox|deferasirox|mesh-list
110294885|NCT00171301|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110294886|NCT00171301|Chelating Agents|chelating agents|mesh-ancestor
110294887|NCT00171301|Sequestering Agents|sequestering agents|mesh-ancestor
110294888|NCT00171301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110294889|NCT00266058|Ritonavir|ritonavir|mesh-list
110294890|NCT00266058|Lopinavir|lopinavir|mesh-list
110294891|NCT00266058|Efavirenz|efavirenz|mesh-list
110294892|NCT00266058|Lumefantrine|lumefantrine|mesh-list
110294893|NCT00266058|Artemether|artemether|mesh-list
110294894|NCT00266058|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110294895|NCT00266058|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110294896|NCT00266058|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110278323|NCT00180908|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110278324|NCT00180908|Abortifacient Agents|abortifacient agents|mesh-ancestor
110278325|NCT00180908|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110278326|NCT00180908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110278327|NCT00180908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110278328|NCT00180908|Antimetabolites|antimetabolites|mesh-ancestor
110278329|NCT00180908|Dermatologic Agents|dermatologic agents|mesh-ancestor
110278330|NCT00180908|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110278331|NCT00180908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110278332|NCT00180908|Immunologic Factors|immunologic factors|mesh-ancestor
110278333|NCT00180908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110278337|NCT00180908|Alkylating Agents|alkylating agents|mesh-ancestor
110278385|NCT04576975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110278386|NCT04576975|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110278387|NCT04576975|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110278388|NCT04576975|Anesthetics, General|anesthetics, general|mesh-ancestor
110278389|NCT04576975|Anesthetics|anesthetics|mesh-ancestor
110278390|NCT04576975|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110278391|NCT04576975|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110278393|NCT00209118|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110278394|NCT00209118|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110278395|NCT00209118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110278396|NCT00209118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110278397|NCT00209118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110278398|NCT00209118|Serotonin Agents|serotonin agents|mesh-ancestor
110278399|NCT00209118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294908|NCT00266058|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110294909|NCT00266058|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110294910|NCT00266058|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110294911|NCT00266058|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110294912|NCT00266058|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110294914|NCT00266058|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110294915|NCT00266058|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110294916|NCT00171223|Imatinib Mesylate|imatinib mesylate|mesh-list
110294917|NCT00171223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110294918|NCT00171223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110294919|NCT00171223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110294920|NCT00171223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110294921|NCT00202124|Tryptophan|tryptophan|mesh-list
110294922|NCT00202124|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110294923|NCT00202124|Antidepressive Agents|antidepressive agents|mesh-ancestor
110294924|NCT00202124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110294925|NCT00266097|Gemcitabine|gemcitabine|mesh-list
110294926|NCT00266097|Oxaliplatin|oxaliplatin|mesh-list
110294927|NCT00266097|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110294928|NCT00266097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110294929|NCT00266097|Antimetabolites|antimetabolites|mesh-ancestor
110294930|NCT00266097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110294931|NCT00266097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110294932|NCT00266097|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110294933|NCT00266097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110294934|NCT00202163|Testosterone|testosterone|mesh-list
110294935|NCT00202163|Androgens|androgens|mesh-ancestor
110294936|NCT00202163|Hormones|hormones|mesh-ancestor
110294937|NCT00202163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110294938|NCT00202163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294939|NCT00476554|Sapacitabine|sapacitabine|mesh-list
110294940|NCT00476554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110294941|NCT04709289|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110294942|NCT04709289|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110294943|NCT04709289|Dermatologic Agents|dermatologic agents|mesh-ancestor
110294944|NCT00202241|Testosterone|testosterone|mesh-list
110294945|NCT00202241|Androgens|androgens|mesh-ancestor
110294946|NCT00202241|Hormones|hormones|mesh-ancestor
110278400|NCT00209118|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110278401|NCT00209118|Antidepressive Agents|antidepressive agents|mesh-ancestor
110278402|NCT00209118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110278403|NCT00209118|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110278404|NCT00209118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110278405|NCT00209118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110278407|NCT00181025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110278408|NCT00181025|Alkylating Agents|alkylating agents|mesh-ancestor
110278409|NCT00181025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110278410|NCT00181025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110278411|NCT00181025|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110294947|NCT00202241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110294948|NCT00202241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294949|NCT00266136|Cytarabine|cytarabine|mesh-list
110294950|NCT00266136|Cyclophosphamide|cyclophosphamide|mesh-list
110294951|NCT00266136|Daunorubicin|daunorubicin|mesh-list
110294952|NCT00266136|Thioguanine|thioguanine|mesh-list
110294953|NCT00266136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110294954|NCT00266136|Immunologic Factors|immunologic factors|mesh-ancestor
110294955|NCT00266136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294956|NCT00266136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110294957|NCT00266136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110294958|NCT00266136|Alkylating Agents|alkylating agents|mesh-ancestor
110294961|NCT00266136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110294962|NCT00266136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110294965|NCT00266136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110294966|NCT00266136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110294967|NCT00266136|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110294968|NCT00266136|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110294969|NCT00266136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110294970|NCT00230594|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
110294971|NCT00230594|Hemostatics|hemostatics|mesh-ancestor
110294972|NCT00230594|Coagulants|coagulants|mesh-ancestor
110294973|NCT00230594|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110294974|NCT00230594|Natriuretic Agents|natriuretic agents|mesh-ancestor
110294975|NCT00230594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294976|NCT00259077|Omeprazole|omeprazole|mesh-list
110294977|NCT00259077|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110294978|NCT00259077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110294979|NCT00259077|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110294980|NCT00259077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110294981|NCT00259077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110294982|NCT00479674|Paclitaxel|paclitaxel|mesh-list
110294983|NCT00479674|Bevacizumab|bevacizumab|mesh-list
110294984|NCT00479674|Carboplatin|carboplatin|mesh-list
110294985|NCT00479674|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110294986|NCT00479674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110294987|NCT00479674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110294988|NCT00479674|Tubulin Modulators|tubulin modulators|mesh-ancestor
110294989|NCT00479674|Antimitotic Agents|antimitotic agents|mesh-ancestor
110294990|NCT00479674|Mitosis Modulators|mitosis modulators|mesh-ancestor
110294991|NCT00479674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110294992|NCT00479674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110294993|NCT00479674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110294994|NCT00479674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110294995|NCT00479674|Growth Substances|growth substances|mesh-ancestor
110294996|NCT00479674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294997|NCT00479674|Growth Inhibitors|growth inhibitors|mesh-ancestor
110294998|NCT02962310|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110278412|NCT00181025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110278413|NCT00181025|Immunologic Factors|immunologic factors|mesh-ancestor
110278414|NCT00181025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110278416|NCT00209313|Antiviral Agents|antiviral agents|mesh-ancestor
110278417|NCT00209313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110278418|NCT00582634|Docetaxel|docetaxel|mesh-list
110278419|NCT00582634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110278420|NCT00582634|Tubulin Modulators|tubulin modulators|mesh-ancestor
110278421|NCT00582634|Antimitotic Agents|antimitotic agents|mesh-ancestor
110278422|NCT00582634|Mitosis Modulators|mitosis modulators|mesh-ancestor
110278423|NCT00582634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110278424|NCT00209352|Acyclovir|acyclovir|mesh-list
110278425|NCT00209352|Antiviral Agents|antiviral agents|mesh-ancestor
110278426|NCT00209352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110278427|NCT00181142|Daclizumab|daclizumab|mesh-list
110278428|NCT00181142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110278429|NCT00181142|Immunologic Factors|immunologic factors|mesh-ancestor
110278430|NCT00181142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110278431|NCT00582985|Antibodies|antibodies|mesh-list
110278432|NCT00582985|Immunologic Factors|immunologic factors|mesh-ancestor
110278433|NCT00582985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110278434|NCT00187551|Enfuvirtide|enfuvirtide|mesh-list
110278435|NCT00187551|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110278436|NCT00187551|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110278437|NCT00187551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110294999|NCT02962310|Calcium|calcium|mesh-list
110295000|NCT02962310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110295001|NCT02962310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295002|NCT02962310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110295003|NCT02962310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110295004|NCT02962310|Antimetabolites|antimetabolites|mesh-ancestor
110295005|NCT02962310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110295006|NCT02962310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110295007|NCT02962310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110295008|NCT02962310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110295009|NCT00259116|Methocarbamol|methocarbamol|mesh-list
110295010|NCT00259116|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110295011|NCT00259116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295012|NCT00259116|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110295013|NCT00259116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110295014|NCT00415779|Zoledronic Acid|zoledronic acid|mesh-list
110295015|NCT00415779|Docetaxel|docetaxel|mesh-list
110295016|NCT00415779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110295017|NCT00415779|Tubulin Modulators|tubulin modulators|mesh-ancestor
110295018|NCT00415779|Antimitotic Agents|antimitotic agents|mesh-ancestor
110295019|NCT00415779|Mitosis Modulators|mitosis modulators|mesh-ancestor
110295020|NCT00415779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110295021|NCT00415779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110295022|NCT00415779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110278438|NCT00187551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110278439|NCT00187551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110278440|NCT00187551|Antiviral Agents|antiviral agents|mesh-ancestor
110278441|NCT00187551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110278442|NCT00181181|Atorvastatin|atorvastatin|mesh-list
110278443|NCT00181181|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110278444|NCT00181181|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110278445|NCT00181181|Antimetabolites|antimetabolites|mesh-ancestor
110295023|NCT00259155|Rifaximin|rifaximin|mesh-list
110295024|NCT00259155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110295025|NCT00259155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110295026|NCT00259155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110295027|NCT00479401|Pramipexole|pramipexole|mesh-list
110295028|NCT00479401|Antioxidants|antioxidants|mesh-ancestor
110295034|NCT00479401|Dopamine Agonists|dopamine agonists|mesh-ancestor
110295035|NCT00479401|Dopamine Agents|dopamine agents|mesh-ancestor
110295036|NCT00479401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110295037|NCT00230789|Tolterodine Tartrate|tolterodine tartrate|mesh-list
110295038|NCT00230789|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110295039|NCT00230789|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110295040|NCT00230789|Cholinergic Agents|cholinergic agents|mesh-ancestor
110295041|NCT00230789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110295042|NCT00230789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110295043|NCT00230789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295044|NCT00230789|Urological Agents|urological agents|mesh-ancestor
110295045|NCT00478777|Dexamethasone|dexamethasone|mesh-list
110295046|NCT00478777|Lenalidomide|lenalidomide|mesh-list
110295047|NCT00478777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110295048|NCT00478777|Antiemetics|antiemetics|mesh-ancestor
110295049|NCT00478777|Autonomic Agents|autonomic agents|mesh-ancestor
110295050|NCT00478777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110295051|NCT00478777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295052|NCT00478777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110295053|NCT00478777|Glucocorticoids|glucocorticoids|mesh-ancestor
110295054|NCT00478777|Hormones|hormones|mesh-ancestor
110295055|NCT00478777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110295056|NCT00478777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110295057|NCT00478777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110295058|NCT00478777|Immunologic Factors|immunologic factors|mesh-ancestor
110295060|NCT00478777|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110295061|NCT00478777|Growth Substances|growth substances|mesh-ancestor
110295062|NCT00478777|Growth Inhibitors|growth inhibitors|mesh-ancestor
110295063|NCT00477607|Thioctic Acid|thioctic acid|mesh-list
110295064|NCT00477607|Antioxidants|antioxidants|mesh-ancestor
110295065|NCT00477607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110295066|NCT00477607|Protective Agents|protective agents|mesh-ancestor
110295067|NCT00477607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295068|NCT00477607|Vitamin B Complex|vitamin b complex|mesh-ancestor
110295069|NCT00477607|Vitamins|vitamins|mesh-ancestor
110295070|NCT00477607|Micronutrients|micronutrients|mesh-ancestor
110295071|NCT00230867|Acyclovir|acyclovir|mesh-list
110295072|NCT00230867|Antiviral Agents|antiviral agents|mesh-ancestor
110295073|NCT00230867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110295074|NCT00266214|Lidocaine|lidocaine|mesh-list
110295075|NCT00266214|Anesthetics, Local|anesthetics, local|mesh-ancestor
110295077|NCT00266214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110295078|NCT00266214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295079|NCT00266214|Sensory System Agents|sensory system agents|mesh-ancestor
110295080|NCT00266214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110295081|NCT00266214|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110295082|NCT00266214|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110295083|NCT00266214|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110295084|NCT00266214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110278446|NCT00181181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110278447|NCT00181181|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110278448|NCT00181181|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110278449|NCT00181181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110278451|NCT00181220|Anticonvulsants|anticonvulsants|mesh-ancestor
110278452|NCT00181220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110278453|NCT00181220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110278454|NCT00181220|GABA Agents|gaba agents|mesh-ancestor
110278455|NCT00181220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110295085|NCT00266214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110295086|NCT00266253|Metformin|metformin|mesh-list
110295087|NCT00266253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110295088|NCT00266253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295089|NCT00230984|Methyltestosterone|methyltestosterone|mesh-list
110295090|NCT00230984|Testosterone|testosterone|mesh-list
110295091|NCT00230984|Testosterone undecanoate|testosterone undecanoate|mesh-list
110295092|NCT00230984|Testosterone enanthate|testosterone enanthate|mesh-list
110295093|NCT00230984|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110295094|NCT00230984|Androgens|androgens|mesh-ancestor
110295095|NCT00230984|Hormones|hormones|mesh-ancestor
110295096|NCT00230984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110295097|NCT00230984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295104|NCT00231023|Triamcinolone|triamcinolone|mesh-list
110295105|NCT00231023|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110295106|NCT00231023|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110295107|NCT00231023|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110295108|NCT00231023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110295109|NCT00231023|Glucocorticoids|glucocorticoids|mesh-ancestor
110295110|NCT00231023|Hormones|hormones|mesh-ancestor
110295111|NCT00231023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110295112|NCT00231023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295113|NCT00231023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110295114|NCT00231023|Immunologic Factors|immunologic factors|mesh-ancestor
110295115|NCT00231023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110295116|NCT00231023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110295117|NCT00231101|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110295118|NCT00231101|Antidepressive Agents|antidepressive agents|mesh-ancestor
110295119|NCT00231101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110295120|NCT00231101|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110295121|NCT00231101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110295122|NCT00231101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110295123|NCT00231101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295124|NCT00231140|Thalidomide|thalidomide|mesh-list
110295125|NCT00231140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110295126|NCT00231140|Immunologic Factors|immunologic factors|mesh-ancestor
110295127|NCT00231140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295128|NCT00231140|Leprostatic Agents|leprostatic agents|mesh-ancestor
110295129|NCT00231140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110295130|NCT00231140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110295131|NCT00231140|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110295132|NCT00231140|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110295133|NCT00231140|Growth Substances|growth substances|mesh-ancestor
110295134|NCT00231140|Growth Inhibitors|growth inhibitors|mesh-ancestor
110295135|NCT00231140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110295136|NCT00231218|Propolis|propolis|mesh-list
110295137|NCT00231218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110295138|NCT00266448|Chlorhexidine|chlorhexidine|mesh-list
110295139|NCT00266448|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110295140|NCT00266448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110295141|NCT00266448|Disinfectants|disinfectants|mesh-ancestor
110295142|NCT00231335|Escitalopram|escitalopram|mesh-list
110295143|NCT00231335|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110278456|NCT00181220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110278457|NCT00181220|Antimanic Agents|antimanic agents|mesh-ancestor
110278458|NCT00181220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110278459|NCT00181220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110278460|NCT00181220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110278461|NCT00583063|Sirolimus|sirolimus|mesh-list
110278462|NCT00583063|Sunitinib|sunitinib|mesh-list
110278463|NCT00583063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110278464|NCT00583063|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110278465|NCT00583063|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110278466|NCT00583063|Growth Substances|growth substances|mesh-ancestor
110278467|NCT00583063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110278468|NCT00583063|Growth Inhibitors|growth inhibitors|mesh-ancestor
110278469|NCT00583063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110278470|NCT00583063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110295144|NCT00231335|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110295145|NCT00231335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110295146|NCT00231335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110295147|NCT00231335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110295148|NCT00231335|Serotonin Agents|serotonin agents|mesh-ancestor
110295149|NCT00231335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295150|NCT00266487|Vitamins|vitamins|mesh-list
110295151|NCT00266487|Folic Acid|folic acid|mesh-list
110295152|NCT00266487|Vitamin B 12|vitamin b 12|mesh-list
110295153|NCT00266487|Vitamin B 6|vitamin b 6|mesh-list
110295154|NCT00266487|Pyridoxal|pyridoxal|mesh-list
110295156|NCT00266487|Vitamin B Complex|vitamin b complex|mesh-list
110295157|NCT00266487|Micronutrients|micronutrients|mesh-ancestor
110295158|NCT00266487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295159|NCT00266487|Hematinics|hematinics|mesh-ancestor
110295160|NCT00231452|Artesunate|artesunate|mesh-list
110295161|NCT00231452|Pyrimethamine|pyrimethamine|mesh-list
110295162|NCT00231452|Sulfadoxine|sulfadoxine|mesh-list
110295163|NCT00231452|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110295164|NCT00231452|Antimalarials|antimalarials|mesh-ancestor
110295165|NCT00231452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110295166|NCT00231452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110295167|NCT00231452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110295168|NCT00231452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110295169|NCT00231452|Antiviral Agents|antiviral agents|mesh-ancestor
110295180|NCT00231491|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110295181|NCT00231491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110295182|NCT00231491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110295184|NCT00231491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110295185|NCT00231491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295186|NCT00231491|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110295187|NCT00231491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110295188|NCT00477490|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
110295189|NCT00477490|Hemostatics|hemostatics|mesh-ancestor
110295190|NCT00477490|Coagulants|coagulants|mesh-ancestor
110295191|NCT00477490|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110295192|NCT00477490|Natriuretic Agents|natriuretic agents|mesh-ancestor
110295193|NCT00477490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295194|NCT00231530|Topiramate|topiramate|mesh-list
110295195|NCT00231530|Anticonvulsants|anticonvulsants|mesh-ancestor
110295196|NCT00231530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110295197|NCT00231530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295198|NCT00231569|Mipomersen|mipomersen|mesh-list
110295199|NCT00231569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110295200|NCT00231569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110278471|NCT00583063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110278472|NCT00583063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110278473|NCT00583063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110278474|NCT00583063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110278475|NCT00583063|Antifungal Agents|antifungal agents|mesh-ancestor
110278476|NCT00583063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110278477|NCT00583063|Immunologic Factors|immunologic factors|mesh-ancestor
110278479|NCT00181298|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110278480|NCT00181298|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110278481|NCT00181298|Dopamine Agents|dopamine agents|mesh-ancestor
110278482|NCT00181298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110278483|NCT00181298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110278484|NCT00181298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110278485|NCT00181298|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110278486|NCT00181298|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110278487|NCT00583180|Capsaicin|capsaicin|mesh-list
110278488|NCT00583180|Antipruritics|antipruritics|mesh-ancestor
110278489|NCT00583180|Dermatologic Agents|dermatologic agents|mesh-ancestor
110278490|NCT00583180|Sensory System Agents|sensory system agents|mesh-ancestor
110278491|NCT00583180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110295201|NCT00231569|Antimetabolites|antimetabolites|mesh-ancestor
110295202|NCT00231569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110295203|NCT00231569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110295204|NCT00477334|Famciclovir|famciclovir|mesh-list
110295205|NCT00477334|Antiviral Agents|antiviral agents|mesh-ancestor
110295206|NCT00477334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110295207|NCT00477334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110295208|NCT00477334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110295209|NCT00477334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110295210|NCT00231608|Topiramate|topiramate|mesh-list
110295211|NCT00231608|Anticonvulsants|anticonvulsants|mesh-ancestor
110295212|NCT00231608|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110295213|NCT00231608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295214|NCT00266604|Topiramate|topiramate|mesh-list
110295215|NCT00266604|Anticonvulsants|anticonvulsants|mesh-ancestor
110295216|NCT00266604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110295217|NCT00266604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295218|NCT04561336|Cetuximab|cetuximab|mesh-list
110295219|NCT04561336|Avelumab|avelumab|mesh-list
110295220|NCT04561336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110295222|NCT00259428|Dronedarone|dronedarone|mesh-list
110295223|NCT00259428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110295224|NCT00231647|Topiramate|topiramate|mesh-list
110295225|NCT00231647|Anticonvulsants|anticonvulsants|mesh-ancestor
110295226|NCT00231647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110295227|NCT00231647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295228|NCT04560751|Lenvatinib|lenvatinib|mesh-list
110295229|NCT04560751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110295230|NCT04560751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110026133|NCT00384540|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110295231|NCT04560751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110295232|NCT04560751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110278492|NCT00583180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110278494|NCT00583258|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110278495|NCT00583258|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110278496|NCT00583258|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110278497|NCT00583258|Adrenergic Agents|adrenergic agents|mesh-ancestor
110278498|NCT00583258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110278499|NCT00583258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110278500|NCT00583258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110278501|NCT00583258|Urological Agents|urological agents|mesh-ancestor
110278502|NCT00181532|Celecoxib|celecoxib|mesh-list
110278503|NCT00181532|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110278504|NCT00181532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110278505|NCT00181532|Analgesics|analgesics|mesh-ancestor
110278506|NCT00181532|Sensory System Agents|sensory system agents|mesh-ancestor
110278507|NCT00181532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110278508|NCT00181532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110278509|NCT00181532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110278510|NCT00181532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110278511|NCT00181532|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110278512|NCT00181532|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110278513|NCT00181532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110278514|NCT00181532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110278515|NCT04576390|Ondansetron|ondansetron|mesh-list
110278516|NCT04576390|Palonosetron|palonosetron|mesh-list
110295233|NCT00266643|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110295234|NCT00266643|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110295270|NCT04559425|Protease Inhibitors|protease inhibitors|mesh-ancestor
110295271|NCT04559425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110295272|NCT04559425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110295273|NCT00231764|Daclizumab|daclizumab|mesh-list
110295274|NCT00231764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110295281|NCT04559308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110295282|NCT04559308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110295283|NCT04559308|Tubulin Modulators|tubulin modulators|mesh-ancestor
110295284|NCT04559308|Antimitotic Agents|antimitotic agents|mesh-ancestor
110295285|NCT04559308|Mitosis Modulators|mitosis modulators|mesh-ancestor
110295287|NCT04559308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110295288|NCT04559308|Immunologic Factors|immunologic factors|mesh-ancestor
110295289|NCT04559308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295290|NCT04559308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110295291|NCT04559308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110295292|NCT04559308|Alkylating Agents|alkylating agents|mesh-ancestor
110295293|NCT04559308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110278518|NCT04576390|Autonomic Agents|autonomic agents|mesh-ancestor
110278519|NCT04576390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110278520|NCT04576390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110278521|NCT04576390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110278522|NCT04576390|Antipruritics|antipruritics|mesh-ancestor
110278523|NCT04576390|Dermatologic Agents|dermatologic agents|mesh-ancestor
110278524|NCT04576390|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110295294|NCT04559308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110295295|NCT04559308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110295296|NCT04559308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110295297|NCT04559308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110295298|NCT04559308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110295299|NCT04559113|Methylprednisolone|methylprednisolone|mesh-list
110295300|NCT04559113|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110295301|NCT04559113|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110295302|NCT04559113|Prednisolone|prednisolone|mesh-list
110295303|NCT04559113|Prednisolone acetate|prednisolone acetate|mesh-list
110295304|NCT04559113|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110295305|NCT04559113|Prednisolone phosphate|prednisolone phosphate|mesh-list
110295306|NCT04559113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110295307|NCT04559113|Antiemetics|antiemetics|mesh-ancestor
110295308|NCT04559113|Autonomic Agents|autonomic agents|mesh-ancestor
110295309|NCT04559113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110295310|NCT04559113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295311|NCT04559113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110295312|NCT04559113|Glucocorticoids|glucocorticoids|mesh-ancestor
110295314|NCT04559113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110295315|NCT04559113|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110295316|NCT04559113|Protective Agents|protective agents|mesh-ancestor
110295317|NCT04559113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110295318|NCT04559113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110295319|NCT00266721|Pancrelipase|pancrelipase|mesh-list
110295320|NCT00266721|Pancreatin|pancreatin|mesh-list
110295321|NCT00266721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110295322|NCT04559074|Amlodipine|amlodipine|mesh-list
110295323|NCT04559074|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110295324|NCT04559074|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110295325|NCT04559074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110295326|NCT04559074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110295327|NCT04559074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110295328|NCT04559074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295329|NCT04559074|Vasodilator Agents|vasodilator agents|mesh-ancestor
110295330|NCT02211976|Bisacodyl|bisacodyl|mesh-list
110295331|NCT02211976|Cathartics|cathartics|mesh-ancestor
110295332|NCT02211976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110295333|NCT02211976|Laxatives|laxatives|mesh-ancestor
110295334|NCT04558684|Immunomodulating Agents|immunomodulating agents|mesh-list
110295335|NCT04558684|Immunologic Factors|immunologic factors|mesh-ancestor
110295336|NCT04558684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295337|NCT00231959|Pramipexole|pramipexole|mesh-list
110295338|NCT00231959|Antioxidants|antioxidants|mesh-ancestor
110295339|NCT00231959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110295340|NCT00231959|Protective Agents|protective agents|mesh-ancestor
110295341|NCT00231959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295342|NCT00231959|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110295343|NCT00231959|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110295344|NCT00231959|Dopamine Agonists|dopamine agonists|mesh-ancestor
110295345|NCT00231959|Dopamine Agents|dopamine agents|mesh-ancestor
110295346|NCT00231959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110295349|NCT00231998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110295350|NCT00231998|Analgesics|analgesics|mesh-ancestor
110295351|NCT00231998|Sensory System Agents|sensory system agents|mesh-ancestor
110295352|NCT00231998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110295353|NCT00231998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295354|NCT00231998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110295355|NCT00231998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110295356|NCT00231998|Dermatologic Agents|dermatologic agents|mesh-ancestor
110278525|NCT04576390|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110278526|NCT04576390|Serotonin Agents|serotonin agents|mesh-ancestor
110278527|NCT04576390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110278528|NCT04576390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110278529|NCT00181571|Methylphenidate|methylphenidate|mesh-list
110278530|NCT00181571|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110278531|NCT00181571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110278532|NCT00181571|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110278533|NCT00181571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110278534|NCT00181571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110278535|NCT00181571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110278536|NCT00181571|Dopamine Agents|dopamine agents|mesh-ancestor
110278537|NCT00181571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110295357|NCT00231998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110295358|NCT00231998|Immunologic Factors|immunologic factors|mesh-ancestor
110295359|NCT00231998|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110295360|NCT00231998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110295361|NCT00231998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110295362|NCT00266838|Dexamethasone|dexamethasone|mesh-list
110295363|NCT00266838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110295364|NCT00266838|Antiemetics|antiemetics|mesh-ancestor
110295365|NCT00266838|Autonomic Agents|autonomic agents|mesh-ancestor
110295366|NCT00266838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110295367|NCT00266838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295368|NCT00266838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110295369|NCT00266838|Glucocorticoids|glucocorticoids|mesh-ancestor
110295370|NCT00266838|Hormones|hormones|mesh-ancestor
110295371|NCT00266838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110295372|NCT00266838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110295373|NCT00266838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110295374|NCT00232037|Tegaserod|tegaserod|mesh-list
110295375|NCT00232037|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110295376|NCT00232037|Serotonin Agents|serotonin agents|mesh-ancestor
110295377|NCT00232037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110295378|NCT00232037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110295379|NCT00232037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295380|NCT02212210|Methylprednisolone|methylprednisolone|mesh-list
110295381|NCT02212210|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110295382|NCT02212210|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110295383|NCT02212210|Prednisolone|prednisolone|mesh-list
110295384|NCT02212210|Prednisolone acetate|prednisolone acetate|mesh-list
110295385|NCT02212210|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110295386|NCT02212210|Prednisolone phosphate|prednisolone phosphate|mesh-list
110295387|NCT02212210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110295388|NCT02212210|Antiemetics|antiemetics|mesh-ancestor
110295389|NCT02212210|Autonomic Agents|autonomic agents|mesh-ancestor
110295390|NCT02212210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110295391|NCT02212210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295392|NCT02212210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110295393|NCT02212210|Glucocorticoids|glucocorticoids|mesh-ancestor
110295394|NCT02212210|Hormones|hormones|mesh-ancestor
110295395|NCT02212210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110295396|NCT02212210|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110295397|NCT02212210|Protective Agents|protective agents|mesh-ancestor
110295398|NCT02212210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110295399|NCT02212210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110295400|NCT00232076|Cyclosporine|cyclosporine|mesh-list
110295401|NCT00232076|Cyclosporins|cyclosporins|mesh-list
110295402|NCT00232076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110278538|NCT00187707|Gabapentin|gabapentin|mesh-list
110278539|NCT00187707|Analgesics|analgesics|mesh-ancestor
110278540|NCT00187707|Sensory System Agents|sensory system agents|mesh-ancestor
110278541|NCT00187707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110278542|NCT00187707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110278543|NCT00187707|Anticonvulsants|anticonvulsants|mesh-ancestor
110278544|NCT00187707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110278545|NCT00187707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110278546|NCT00187707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110278547|NCT00187707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110295403|NCT00232076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110295404|NCT00232076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110295405|NCT00232076|Immunologic Factors|immunologic factors|mesh-ancestor
110295406|NCT00232076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295407|NCT00232076|Antifungal Agents|antifungal agents|mesh-ancestor
110295408|NCT00232076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110295409|NCT00232076|Dermatologic Agents|dermatologic agents|mesh-ancestor
110295410|NCT00232076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110295411|NCT00232076|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110295412|NCT00232115|Pimecrolimus|pimecrolimus|mesh-list
110295413|NCT00232115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110295414|NCT00232115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110295415|NCT00232115|Analgesics|analgesics|mesh-ancestor
110295416|NCT00232115|Sensory System Agents|sensory system agents|mesh-ancestor
110295417|NCT00232115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110295418|NCT00232115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295423|NCT00232115|Immunologic Factors|immunologic factors|mesh-ancestor
110295424|NCT00232115|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110295425|NCT00232115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110295426|NCT00232115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110295428|NCT04558021|Anticestodal Agents|anticestodal agents|mesh-ancestor
110295429|NCT04558021|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110295430|NCT04558021|Anthelmintics|anthelmintics|mesh-ancestor
110295431|NCT04558021|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110295432|NCT04558021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110295433|NCT04558021|Antinematodal Agents|antinematodal agents|mesh-ancestor
110295434|NCT00232154|Azithromycin|azithromycin|mesh-list
110295435|NCT00232154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110295436|NCT00232154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110295437|NCT00259662|Atorvastatin|atorvastatin|mesh-list
110295438|NCT00259662|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110295439|NCT00259662|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110295440|NCT00259662|Antimetabolites|antimetabolites|mesh-ancestor
110295441|NCT00259662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110295442|NCT00259662|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110295443|NCT00259662|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110295445|NCT04557943|Hyaluronic Acid|hyaluronic acid|mesh-list
110295446|NCT04557943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110295447|NCT04557943|Immunologic Factors|immunologic factors|mesh-ancestor
110295448|NCT04557943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295449|NCT04557943|Viscosupplements|viscosupplements|mesh-ancestor
110295450|NCT04557943|Protective Agents|protective agents|mesh-ancestor
110295451|NCT04557475|Aspirin|aspirin|mesh-list
110295452|NCT04557475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110295453|NCT04557475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110295454|NCT04557475|Analgesics|analgesics|mesh-ancestor
110295455|NCT04557475|Sensory System Agents|sensory system agents|mesh-ancestor
110295456|NCT04557475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110295457|NCT04557475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295458|NCT04557475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110295459|NCT04557475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110295460|NCT04557475|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110295461|NCT04557475|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110278548|NCT00187707|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110278549|NCT00187707|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110278550|NCT00187707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110278551|NCT00187707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110278552|NCT00187707|Antimanic Agents|antimanic agents|mesh-ancestor
110278553|NCT00187746|Adefovir|adefovir|mesh-list
110278554|NCT00187746|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
110278555|NCT00187746|Antiviral Agents|antiviral agents|mesh-ancestor
110278556|NCT00187746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110278557|NCT00187746|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110278558|NCT00187746|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110295462|NCT04557475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110295463|NCT04557475|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110295464|NCT04557475|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110295465|NCT04557475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110295466|NCT04557475|Antipyretics|antipyretics|mesh-ancestor
110295467|NCT00232271|Enoxaparin|enoxaparin|mesh-list
110295468|NCT00232271|Anticoagulants|anticoagulants|mesh-ancestor
110295469|NCT00232271|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110295470|NCT00232271|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110295471|NCT00232271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110295472|NCT04557397|Itraconazole|itraconazole|mesh-list
110295473|NCT04557397|Rifampin|rifampin|mesh-list
110295474|NCT04557397|Antifungal Agents|antifungal agents|mesh-ancestor
110295475|NCT04557397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110295476|NCT04557397|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110295477|NCT04557397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110295478|NCT04557397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110295479|NCT04557397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110295480|NCT04557397|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110295481|NCT04557397|Hormone Antagonists|hormone antagonists|mesh-ancestor
110295482|NCT04557397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110295483|NCT04557397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295484|NCT04557397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110295485|NCT04557397|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110295486|NCT04557397|Antitubercular Agents|antitubercular agents|mesh-ancestor
110295487|NCT04557397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110295488|NCT04557397|Leprostatic Agents|leprostatic agents|mesh-ancestor
110295496|NCT04557202|Tamsulosin|tamsulosin|mesh-list
110295497|NCT04557202|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110295498|NCT04557202|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110295499|NCT04557202|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110295500|NCT04557202|Adrenergic Agents|adrenergic agents|mesh-ancestor
110295501|NCT04557202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110295502|NCT04557202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110295503|NCT04557202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295504|NCT04557202|Urological Agents|urological agents|mesh-ancestor
110295505|NCT00232349|Galantamine|galantamine|mesh-list
110295506|NCT00232349|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110295507|NCT00232349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110295508|NCT00232349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110295509|NCT00232349|Cholinergic Agents|cholinergic agents|mesh-ancestor
110295510|NCT00232349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110295511|NCT00232349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295512|NCT00232349|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110295513|NCT00232349|Autonomic Agents|autonomic agents|mesh-ancestor
110295514|NCT00232349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110295515|NCT00232349|Nootropic Agents|nootropic agents|mesh-ancestor
110295516|NCT00259701|Nitroglycerin|nitroglycerin|mesh-list
110295517|NCT00259701|Acetylcholine|acetylcholine|mesh-list
110295518|NCT00259701|Vasodilator Agents|vasodilator agents|mesh-ancestor
110295519|NCT00259701|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110278559|NCT00187746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110278560|NCT00187746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110278562|NCT00181688|Gefitinib|gefitinib|mesh-list
110278563|NCT00181688|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110278564|NCT00181688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110278565|NCT00181688|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110278566|NCT00181688|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110295521|NCT00259701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110295522|NCT00259701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110295523|NCT00259701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295524|NCT04556929|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110295525|NCT04556929|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110295526|NCT04556929|Dermatologic Agents|dermatologic agents|mesh-ancestor
110295527|NCT04566211|Amoxicillin|amoxicillin|mesh-list
110295528|NCT04566211|Metronidazole|metronidazole|mesh-list
110295529|NCT04566211|Clarithromycin|clarithromycin|mesh-list
110026435|NCT02993094|Carboplatin|carboplatin|mesh-list
110295530|NCT04566211|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
110295531|NCT04566211|Pantoprazole|pantoprazole|mesh-list
110295533|NCT04566211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110295534|NCT04566211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110295535|NCT04566211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110295536|NCT04566211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110295537|NCT04566211|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110295538|NCT04566211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110295539|NCT04566211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110295540|NCT04566211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110295541|NCT04566211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110295542|NCT04566211|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110295543|NCT04566211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110295544|NCT04566211|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110295546|NCT00259779|Prednisolone|prednisolone|mesh-list
110295547|NCT00259779|Budesonide|budesonide|mesh-list
110295548|NCT00259779|Formoterol Fumarate|formoterol fumarate|mesh-list
110295549|NCT00259779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110295550|NCT00259779|Glucocorticoids|glucocorticoids|mesh-ancestor
110295551|NCT00259779|Hormones|hormones|mesh-ancestor
110295552|NCT00259779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110295553|NCT00259779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295554|NCT00259779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110295561|NCT00259779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110295562|NCT00259779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110295563|NCT00259779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110295564|NCT00259779|Adrenergic Agents|adrenergic agents|mesh-ancestor
110295565|NCT00259779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110295566|NCT00259779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110295567|NCT02211079|Tolbutamide|tolbutamide|mesh-list
110295568|NCT02211079|Midazolam|midazolam|mesh-list
110295569|NCT02211079|Caffeine|caffeine|mesh-list
110295570|NCT02211079|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110295571|NCT02211079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110295572|NCT02211079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110295573|NCT02211079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295574|NCT02211079|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110295575|NCT02211079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110295576|NCT02211079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110295577|NCT02211079|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110295578|NCT02211079|Anesthetics, General|anesthetics, general|mesh-ancestor
110295579|NCT02211079|Anesthetics|anesthetics|mesh-ancestor
110295580|NCT02211079|GABA Modulators|gaba modulators|mesh-ancestor
110295581|NCT02211079|GABA Agents|gaba agents|mesh-ancestor
110295582|NCT02211079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110295583|NCT02211079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110295584|NCT02211079|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110278568|NCT00181688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110278569|NCT00181688|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110278570|NCT00181688|Hormone Antagonists|hormone antagonists|mesh-ancestor
110278571|NCT00181688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110278572|NCT00181688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110278573|NCT00181688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110278574|NCT00209469|Alendronate|alendronate|mesh-list
110278575|NCT00209469|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110278576|NCT00209469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110278577|NCT00181727|Valproic Acid|valproic acid|mesh-list
110278578|NCT00181727|Anticonvulsants|anticonvulsants|mesh-ancestor
110278579|NCT00181727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110278580|NCT00181727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110278581|NCT00181727|GABA Agents|gaba agents|mesh-ancestor
110295585|NCT02211079|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110295586|NCT02211079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110295587|NCT02211079|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110295588|NCT02211079|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110295589|NCT02211079|Purinergic Agents|purinergic agents|mesh-ancestor
110295590|NCT02211079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110295591|NCT00232622|Streptokinase|streptokinase|mesh-list
110295592|NCT00232622|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110295593|NCT00232622|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110295594|NCT00232622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110295595|NCT00232661|Tamoxifen|tamoxifen|mesh-list
110295596|NCT00232661|Anastrozole|anastrozole|mesh-list
110295597|NCT00232661|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110295598|NCT00232661|Hormone Antagonists|hormone antagonists|mesh-ancestor
110295599|NCT00232661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110295600|NCT00232661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295601|NCT00232661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110295602|NCT00232661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110295603|NCT00232661|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110295604|NCT00232661|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110295605|NCT00232661|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110295606|NCT00232661|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110295607|NCT00232661|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110295608|NCT00232661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110295609|NCT00232661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110295610|NCT00267267|Atorvastatin|atorvastatin|mesh-list
110295611|NCT00267267|Simvastatin|simvastatin|mesh-list
110295613|NCT00267267|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
110295614|NCT00267267|Torcetrapib|torcetrapib|mesh-list
110295615|NCT00267267|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110295616|NCT00267267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110295617|NCT00267267|Antimetabolites|antimetabolites|mesh-ancestor
110295618|NCT00267267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110295619|NCT00267267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110295620|NCT00267267|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110295621|NCT00267267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110295622|NCT04564690|Vitamin E|vitamin e|mesh-list
110295633|NCT00232700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110295634|NCT00232700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110295635|NCT00232700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110278582|NCT00181727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110278583|NCT00181727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110278584|NCT00181727|Antimanic Agents|antimanic agents|mesh-ancestor
110278585|NCT00181727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110278586|NCT00181727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110278587|NCT00181727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110278588|NCT00584155|Ofloxacin|ofloxacin|mesh-list
110278589|NCT00584155|Levofloxacin|levofloxacin|mesh-list
110278590|NCT00584155|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110278591|NCT00584155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110278592|NCT00584155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110278593|NCT00584155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110278594|NCT00584155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110278595|NCT00584155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110278596|NCT00584155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110278597|NCT00584155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110278598|NCT00584155|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110278599|NCT00584155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110278600|NCT00411372|Fluticasone|fluticasone|mesh-list
110278601|NCT00411372|Xhance|xhance|mesh-list
110278602|NCT00411372|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110278603|NCT00411372|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110278604|NCT00411372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110278605|NCT00411372|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110278606|NCT00411372|Autonomic Agents|autonomic agents|mesh-ancestor
110278607|NCT00411372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110278608|NCT00411372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295636|NCT00232700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110295637|NCT00232700|Serotonin Agents|serotonin agents|mesh-ancestor
110295638|NCT00232700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295639|NCT04564456|Fluticasone|fluticasone|mesh-list
110295641|NCT04564456|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110295642|NCT04564456|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110295643|NCT04564456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110295644|NCT04564456|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110295645|NCT04564456|Autonomic Agents|autonomic agents|mesh-ancestor
110295646|NCT04564456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110295647|NCT04564456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295648|NCT04564456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110295649|NCT04564456|Respiratory System Agents|respiratory system agents|mesh-ancestor
110295650|NCT04564456|Dermatologic Agents|dermatologic agents|mesh-ancestor
110295651|NCT04564456|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110295652|NCT04564456|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110295653|NCT04564456|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110295654|NCT04564456|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110295655|NCT04564456|Adrenergic Agents|adrenergic agents|mesh-ancestor
110278609|NCT00411372|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110278610|NCT00411372|Respiratory System Agents|respiratory system agents|mesh-ancestor
110278612|NCT00411372|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110278613|NCT00411372|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110278614|NCT00411372|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110278615|NCT00411372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110278616|NCT00411372|Adrenergic Agents|adrenergic agents|mesh-ancestor
110278617|NCT00411372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110278618|NCT00411372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110278619|NCT00411372|Glucocorticoids|glucocorticoids|mesh-ancestor
110278620|NCT00411372|Hormones|hormones|mesh-ancestor
110278621|NCT00411372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110278622|NCT00411372|Sympathomimetics|sympathomimetics|mesh-ancestor
110278623|NCT00181922|Ziprasidone|ziprasidone|mesh-list
110278624|NCT00181922|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110278625|NCT00181922|Serotonin Agents|serotonin agents|mesh-ancestor
110278626|NCT00181922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110278627|NCT00181922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110278628|NCT00181922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110278629|NCT00181922|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110278630|NCT00181922|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110278631|NCT00181922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110278632|NCT00181922|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110295656|NCT04564456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110295657|NCT04564456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110295658|NCT04564456|Glucocorticoids|glucocorticoids|mesh-ancestor
110295659|NCT04564456|Hormones|hormones|mesh-ancestor
110295660|NCT04564456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110295661|NCT04564456|Sympathomimetics|sympathomimetics|mesh-ancestor
110295662|NCT04564144|Meclizine|meclizine|mesh-list
110295663|NCT04564144|Antiemetics|antiemetics|mesh-ancestor
110295664|NCT04564144|Autonomic Agents|autonomic agents|mesh-ancestor
110295665|NCT04564144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110295666|NCT04564144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295667|NCT04564144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110295668|NCT04564144|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110295669|NCT04564144|Histamine Antagonists|histamine antagonists|mesh-ancestor
110295670|NCT04564144|Histamine Agents|histamine agents|mesh-ancestor
110295671|NCT04564144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110295672|NCT04564144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110295673|NCT04564144|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110295674|NCT04564144|Cholinergic Agents|cholinergic agents|mesh-ancestor
110295675|NCT04564144|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110295676|NCT00267306|Visilizumab|visilizumab|mesh-list
110295677|NCT00267306|Immunologic Factors|immunologic factors|mesh-ancestor
110295678|NCT00267306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295679|NCT00259896|Exenatide|exenatide|mesh-list
110295680|NCT00259896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110278634|NCT00181922|Dopamine Agents|dopamine agents|mesh-ancestor
110278635|NCT00182039|Metoprolol|metoprolol|mesh-list
110278636|NCT00182039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110278637|NCT00182039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110278638|NCT00182039|Sympatholytics|sympatholytics|mesh-ancestor
110278639|NCT00182039|Autonomic Agents|autonomic agents|mesh-ancestor
110278640|NCT00182039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110278641|NCT00182039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110278642|NCT00182039|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110278643|NCT00182039|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110278644|NCT00182039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110278645|NCT00182039|Adrenergic Agents|adrenergic agents|mesh-ancestor
110278647|NCT00182039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110295681|NCT00259896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295682|NCT00259896|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110295683|NCT00259896|Incretins|incretins|mesh-ancestor
110295684|NCT00259896|Hormones|hormones|mesh-ancestor
110295685|NCT00259896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110295686|NCT04721795|Antitubercular Agents|antitubercular agents|mesh-list
110295687|NCT04721795|Atorvastatin|atorvastatin|mesh-list
110295688|NCT04721795|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110295693|NCT04721795|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110295694|NCT04721795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110295695|NCT04721795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110295696|NCT04721795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110295697|NCT04675021|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110295698|NCT04564222|Micronutrients|micronutrients|mesh-list
110295699|NCT04564222|Trace Elements|trace elements|mesh-list
110295700|NCT04564222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295701|NCT00232817|Nicotine|nicotine|mesh-list
110295702|NCT00232817|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110295703|NCT00232817|Autonomic Agents|autonomic agents|mesh-ancestor
110295704|NCT00232817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110295705|NCT00232817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295707|NCT00232817|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110295708|NCT00232817|Cholinergic Agents|cholinergic agents|mesh-ancestor
110295709|NCT00232817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110295710|NCT00232817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110295711|NCT00267384|Acetylcysteine|acetylcysteine|mesh-list
110295712|NCT00267384|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110295713|NCT00267384|Antiviral Agents|antiviral agents|mesh-ancestor
110295714|NCT00267384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110295715|NCT00267384|Expectorants|expectorants|mesh-ancestor
110295716|NCT00267384|Respiratory System Agents|respiratory system agents|mesh-ancestor
110295717|NCT00267384|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110295718|NCT00267384|Antioxidants|antioxidants|mesh-ancestor
110295719|NCT00267384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110295720|NCT00267384|Protective Agents|protective agents|mesh-ancestor
110295721|NCT00267384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295722|NCT00267384|Antidotes|antidotes|mesh-ancestor
110295723|NCT00259935|Topotecan|topotecan|mesh-list
110295724|NCT00259935|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110295725|NCT00259935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110295726|NCT00259935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110295727|NCT00259935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110295728|NCT00259935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110278648|NCT00584389|Rimonabant|rimonabant|mesh-list
110278649|NCT00584389|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110278650|NCT00584389|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
110278651|NCT00584389|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110278652|NCT00584389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110278653|NCT00584389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110278655|NCT00584389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110278656|NCT00584389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110278657|NCT00216372|Lanreotide|lanreotide|mesh-list
110278658|NCT00216372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110278659|NCT00584662|Phenylephrine|phenylephrine|mesh-list
110295729|NCT00232856|Sirolimus|sirolimus|mesh-list
110295730|NCT00232856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110295731|NCT00232856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110295732|NCT00232856|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110295733|NCT00232856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110295734|NCT00232856|Antifungal Agents|antifungal agents|mesh-ancestor
110295735|NCT00232856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110295736|NCT00232856|Immunologic Factors|immunologic factors|mesh-ancestor
110295737|NCT00232856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295738|NCT00259974|Rituximab|rituximab|mesh-list
110295739|NCT00259974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110295740|NCT00259974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110295741|NCT00259974|Immunologic Factors|immunologic factors|mesh-ancestor
110295742|NCT00259974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295743|NCT00259974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110295744|NCT00232895|Propofol|propofol|mesh-list
110295745|NCT00232895|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110295746|NCT00232895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110295747|NCT00232895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295748|NCT00232895|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110295749|NCT00232895|Anesthetics, General|anesthetics, general|mesh-ancestor
110295751|NCT00232934|Thalidomide|thalidomide|mesh-list
110295752|NCT00232934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110295753|NCT00232934|Immunologic Factors|immunologic factors|mesh-ancestor
110295754|NCT00232934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295755|NCT00232934|Leprostatic Agents|leprostatic agents|mesh-ancestor
110295756|NCT00232934|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110295757|NCT00232934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110295758|NCT00232934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110295759|NCT00232934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110295760|NCT00232934|Growth Substances|growth substances|mesh-ancestor
110295767|NCT04673812|Anesthetics|anesthetics|mesh-ancestor
110295768|NCT04673812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110295769|NCT04673812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295770|NCT04673812|Sensory System Agents|sensory system agents|mesh-ancestor
110295771|NCT04673812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110295772|NCT04673812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110295773|NCT04673812|Narcotics|narcotics|mesh-ancestor
110295774|NCT04673812|Analgesics|analgesics|mesh-ancestor
110295775|NCT04673812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110295776|NCT04673812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110295777|NCT04673812|Anesthetics, General|anesthetics, general|mesh-ancestor
110295778|NCT04673812|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110295779|NCT00260052|Epoetin Alfa|epoetin alfa|mesh-list
110295780|NCT00260052|Hematinics|hematinics|mesh-ancestor
110295781|NCT04673500|Lidocaine|lidocaine|mesh-list
110295782|NCT04673500|Propofol|propofol|mesh-list
110295783|NCT04673500|Anesthetics, Local|anesthetics, local|mesh-ancestor
110295785|NCT04673500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110278660|NCT00584662|Oxymetazoline|oxymetazoline|mesh-list
110278661|NCT00584662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110278662|NCT00584662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110278663|NCT00584662|Adrenergic Agents|adrenergic agents|mesh-ancestor
110278664|NCT00584662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110278665|NCT00584662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110278666|NCT00584662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110278667|NCT00584662|Sympathomimetics|sympathomimetics|mesh-ancestor
110278668|NCT00584662|Autonomic Agents|autonomic agents|mesh-ancestor
110278669|NCT00584662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110278670|NCT00584662|Nasal Decongestants|nasal decongestants|mesh-ancestor
110278671|NCT00584662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110278672|NCT00584662|Respiratory System Agents|respiratory system agents|mesh-ancestor
110278673|NCT00584662|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110278675|NCT00584662|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110278676|NCT00584662|Protective Agents|protective agents|mesh-ancestor
110278677|NCT00584779|Gabapentin|gabapentin|mesh-list
110278678|NCT00584779|Analgesics|analgesics|mesh-ancestor
110278679|NCT00584779|Sensory System Agents|sensory system agents|mesh-ancestor
110278680|NCT00584779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110278681|NCT00584779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110278682|NCT00584779|Anticonvulsants|anticonvulsants|mesh-ancestor
110278683|NCT00584779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110278684|NCT00584779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110278685|NCT00584779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110278686|NCT00584779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110278687|NCT00584779|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110278688|NCT00584779|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110278689|NCT00584779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110295786|NCT04673500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295787|NCT04673500|Sensory System Agents|sensory system agents|mesh-ancestor
110295788|NCT04673500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110295789|NCT04673500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110295790|NCT04673500|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110295791|NCT04673500|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110295792|NCT04673500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110295793|NCT04673500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110295794|NCT04673500|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110295795|NCT04673500|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110295796|NCT04673500|Anesthetics, General|anesthetics, general|mesh-ancestor
110295797|NCT00233012|Topiramate|topiramate|mesh-list
110278691|NCT00584779|Antimanic Agents|antimanic agents|mesh-ancestor
110278692|NCT00216411|Botulinum Toxins|botulinum toxins|mesh-list
110278693|NCT00216411|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110278694|NCT00216411|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110278695|NCT00216411|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110278696|NCT00216411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110278697|NCT00216411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110278698|NCT00216411|Cholinergic Agents|cholinergic agents|mesh-ancestor
110278699|NCT00216411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110278700|NCT00216411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295798|NCT00233012|Anticonvulsants|anticonvulsants|mesh-ancestor
110295799|NCT00233012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110295800|NCT00233012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295801|NCT00267540|Cholecalciferol|cholecalciferol|mesh-list
110295803|NCT00267540|Vitamins|vitamins|mesh-ancestor
110295804|NCT00267540|Micronutrients|micronutrients|mesh-ancestor
110295805|NCT00267540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295806|NCT00267540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110295807|NCT00267540|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110295808|NCT00233051|Fluticasone|fluticasone|mesh-list
110295809|NCT00233051|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110295810|NCT00233051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110295811|NCT00233051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110295812|NCT00233051|Autonomic Agents|autonomic agents|mesh-ancestor
110295813|NCT00233051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110295814|NCT00233051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295815|NCT00233051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110295816|NCT00233051|Respiratory System Agents|respiratory system agents|mesh-ancestor
110295817|NCT00233051|Dermatologic Agents|dermatologic agents|mesh-ancestor
110295818|NCT00233051|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110295819|NCT00233051|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110295820|NCT00233051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110295821|NCT00233051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110295822|NCT00233051|Adrenergic Agents|adrenergic agents|mesh-ancestor
110295823|NCT00233051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110295824|NCT00233051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110295825|NCT04672759|Durvalumab|durvalumab|mesh-list
110295826|NCT04672759|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110295827|NCT04672759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110295828|NCT04672759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110295829|NCT04672759|Immunologic Factors|immunologic factors|mesh-ancestor
110295830|NCT04672759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026738|NCT01279902|Rituximab|rituximab|mesh-list
110295831|NCT04672330|Tislelizumab|tislelizumab|mesh-list
110295832|NCT04672330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110295833|NCT04672330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110295838|NCT00260247|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110295839|NCT00260247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110295840|NCT00260247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295841|NCT00260247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110295842|NCT00260247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110295843|NCT00260247|Analgesics|analgesics|mesh-ancestor
110295844|NCT00260247|Sensory System Agents|sensory system agents|mesh-ancestor
110295845|NCT00260247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110295846|NCT00260247|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110295847|NCT00260247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110295848|NCT00260247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110295849|NCT00260247|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110278701|NCT00216411|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110278702|NCT00216411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110278704|NCT00585091|Oxymetazoline|oxymetazoline|mesh-list
110278705|NCT00585091|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110278706|NCT00585091|Mydriatics|mydriatics|mesh-ancestor
110278707|NCT00585091|Autonomic Agents|autonomic agents|mesh-ancestor
110278708|NCT00585091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110278709|NCT00585091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110278710|NCT00585091|Sympathomimetics|sympathomimetics|mesh-ancestor
110278711|NCT00585091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110278712|NCT00585091|Nasal Decongestants|nasal decongestants|mesh-ancestor
110278713|NCT00585091|Respiratory System Agents|respiratory system agents|mesh-ancestor
110278714|NCT00585091|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110278715|NCT00585091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110278716|NCT00585091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110295850|NCT00260247|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110295851|NCT00260247|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110295852|NCT04671589|Meropenem|meropenem|mesh-list
110295854|NCT04671589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110295855|NCT00260325|Valdecoxib|valdecoxib|mesh-list
110295856|NCT00260325|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110295857|NCT00260325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110295858|NCT00260325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110295859|NCT00260325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110295860|NCT00260325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110295861|NCT00260325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110295862|NCT00260325|Analgesics|analgesics|mesh-ancestor
110295863|NCT00260325|Sensory System Agents|sensory system agents|mesh-ancestor
110295864|NCT00260325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110295865|NCT00260325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295866|NCT00260325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110295867|NCT00260325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110295868|NCT04671160|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110295869|NCT04671160|Dalteparin|dalteparin|mesh-list
110295870|NCT04671160|Anticoagulants|anticoagulants|mesh-ancestor
110295871|NCT04671160|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110295872|NCT04671160|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110295873|NCT04671160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110295874|NCT04671394|Photosensitizing Agents|photosensitizing agents|mesh-list
110295875|NCT04671394|Dermatologic Agents|dermatologic agents|mesh-ancestor
110295876|NCT00233558|Adalimumab|adalimumab|mesh-list
110295877|NCT00233558|Methotrexate|methotrexate|mesh-list
110295878|NCT00233558|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110295879|NCT00233558|Abortifacient Agents|abortifacient agents|mesh-ancestor
110295880|NCT00233558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110295881|NCT00233558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295882|NCT00233558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110295883|NCT00233558|Antimetabolites|antimetabolites|mesh-ancestor
110295884|NCT00233558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110295885|NCT00233558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110295886|NCT00233558|Dermatologic Agents|dermatologic agents|mesh-ancestor
110295887|NCT00233558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110295888|NCT00233558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110295889|NCT00233558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110295890|NCT00233558|Immunologic Factors|immunologic factors|mesh-ancestor
110295891|NCT00233558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110295892|NCT00233558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110295893|NCT00233558|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110295894|NCT00233558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110278717|NCT00585091|Adrenergic Agents|adrenergic agents|mesh-ancestor
110278718|NCT00585091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110278719|NCT00585091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110278720|NCT00585091|Protective Agents|protective agents|mesh-ancestor
110278721|NCT00216450|Rabeprazole|rabeprazole|mesh-list
110278722|NCT00216450|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110278723|NCT00216450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110278724|NCT00216450|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110278725|NCT00216450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110278726|NCT00216450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110295895|NCT00233636|Gefitinib|gefitinib|mesh-list
110295896|NCT00233636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110295897|NCT00233636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110295898|NCT00233636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110295899|NCT00233636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110295900|NCT00267657|Reserpine|reserpine|mesh-list
110295901|NCT00267657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110295902|NCT00267657|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110295904|NCT00267657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110295910|NCT00267657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110295911|NCT00267657|Adrenergic Agents|adrenergic agents|mesh-ancestor
110295912|NCT00267657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110295913|NCT04670809|Clevidipine|clevidipine|mesh-list
110295914|NCT04670809|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110295915|NCT04670809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110295916|NCT04670809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110295917|NCT04670809|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110295918|NCT04670809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295920|NCT00233714|Temsirolimus|temsirolimus|mesh-list
110295921|NCT00233714|MTOR Inhibitors|mtor inhibitors|mesh-list
110295922|NCT00233714|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110295923|NCT00233714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110295924|NCT00233714|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110295925|NCT00233714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110295926|NCT00233714|Antifungal Agents|antifungal agents|mesh-ancestor
110295927|NCT00233714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110295928|NCT00233714|Immunologic Factors|immunologic factors|mesh-ancestor
110295929|NCT00233714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295930|NCT00233714|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110295931|NCT00233714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110295932|NCT00233714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110295933|NCT04670497|Epinephrine|epinephrine|mesh-list
110295934|NCT04670497|Racepinephrine|racepinephrine|mesh-list
110295935|NCT04670497|Bupivacaine|bupivacaine|mesh-list
110295936|NCT04670497|Epinephryl borate|epinephryl borate|mesh-list
110295937|NCT04670497|Anesthetics, Local|anesthetics, local|mesh-ancestor
110295938|NCT04670497|Anesthetics|anesthetics|mesh-ancestor
110295939|NCT04670497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110295940|NCT04670497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295941|NCT04670497|Sensory System Agents|sensory system agents|mesh-ancestor
110295942|NCT04670497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110295943|NCT04670497|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110295944|NCT04670497|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110295945|NCT04670497|Adrenergic Agents|adrenergic agents|mesh-ancestor
110295946|NCT04670497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110295947|NCT04670497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110295948|NCT04670497|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110295949|NCT04670497|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110295950|NCT04670497|Autonomic Agents|autonomic agents|mesh-ancestor
110295951|NCT04670497|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110295952|NCT04670497|Respiratory System Agents|respiratory system agents|mesh-ancestor
110295953|NCT04670497|Mydriatics|mydriatics|mesh-ancestor
110278728|NCT00585442|Calcitriol|calcitriol|mesh-list
110278729|NCT00585442|Vitamins|vitamins|mesh-ancestor
110278730|NCT00585442|Micronutrients|micronutrients|mesh-ancestor
110278731|NCT00585442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110278732|NCT00585442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110278733|NCT00585442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110278734|NCT00585442|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110278735|NCT00585442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110278736|NCT00585442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110278737|NCT00585442|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110278738|NCT00585520|Progesterone|progesterone|mesh-list
110278739|NCT00585520|Progestins|progestins|mesh-ancestor
110278740|NCT00585520|Hormones|hormones|mesh-ancestor
110278741|NCT00585520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110278742|NCT00585520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110278743|NCT00216489|Rabeprazole|rabeprazole|mesh-list
110278744|NCT00216489|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110278745|NCT00216489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110278746|NCT00216489|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110295954|NCT04670497|Sympathomimetics|sympathomimetics|mesh-ancestor
110295955|NCT04670497|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110295956|NCT04670107|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110295957|NCT04670107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110295958|NCT04670107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110295959|NCT04670107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110295960|NCT00260364|Bevacizumab|bevacizumab|mesh-list
110295961|NCT00260364|Gemcitabine|gemcitabine|mesh-list
110295962|NCT00260364|Capecitabine|capecitabine|mesh-list
110295963|NCT00260364|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110295964|NCT00260364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110295965|NCT00260364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110295966|NCT00260364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110295967|NCT00260364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110295968|NCT00260364|Growth Substances|growth substances|mesh-ancestor
110295969|NCT00260364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295970|NCT00260364|Growth Inhibitors|growth inhibitors|mesh-ancestor
110295971|NCT00260364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110295972|NCT00260364|Antimetabolites|antimetabolites|mesh-ancestor
110295973|NCT00260364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110295991|NCT00233792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295992|NCT00233792|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110295993|NCT00233792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110295994|NCT00233792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110295995|NCT00556153|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
110295996|NCT00556153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110295997|NCT00556192|Rituximab|rituximab|mesh-list
110295998|NCT00556192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110295999|NCT00556192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110296000|NCT00556192|Immunologic Factors|immunologic factors|mesh-ancestor
110296001|NCT00556192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296002|NCT00556192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110278747|NCT00216489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110278748|NCT00216489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110278749|NCT00585754|Guanfacine|guanfacine|mesh-list
110278750|NCT00585754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110278751|NCT00585754|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110278752|NCT00585754|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110278753|NCT00585754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110278754|NCT00585754|Adrenergic Agents|adrenergic agents|mesh-ancestor
110278755|NCT00585754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110278756|NCT00585754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110278757|NCT00585754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296003|NCT00556270|Fentanyl|fentanyl|mesh-list
110296004|NCT00556270|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110296005|NCT00556270|Narcotics|narcotics|mesh-ancestor
110296006|NCT00556270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110296007|NCT00556270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296008|NCT00556270|Analgesics|analgesics|mesh-ancestor
110296009|NCT00556270|Sensory System Agents|sensory system agents|mesh-ancestor
110296010|NCT00556270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110296011|NCT00556270|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110296012|NCT00556270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110296013|NCT00556270|Anesthetics, General|anesthetics, general|mesh-ancestor
110296014|NCT00556270|Anesthetics|anesthetics|mesh-ancestor
110296015|NCT00260520|Dalteparin|dalteparin|mesh-list
110296017|NCT00260520|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110296019|NCT00260520|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110296020|NCT00260520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110296021|NCT00260520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110296022|NCT00233909|Gemtuzumab|gemtuzumab|mesh-list
110296023|NCT00233909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110296024|NCT00233909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110296025|NCT00233909|Immunotoxins|immunotoxins|mesh-ancestor
110296026|NCT00233909|Immunoconjugates|immunoconjugates|mesh-ancestor
110296027|NCT00233909|Immunologic Factors|immunologic factors|mesh-ancestor
110296028|NCT00233909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296029|NCT00267813|Bupropion|bupropion|mesh-list
110296030|NCT00267813|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110296031|NCT00267813|Antidepressive Agents|antidepressive agents|mesh-ancestor
110296032|NCT00267813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110296039|NCT00267813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296040|NCT00267813|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110296041|NCT00267813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110296042|NCT00267813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110296043|NCT00234026|Gemcitabine|gemcitabine|mesh-list
110296044|NCT00234026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110296045|NCT00234026|Antimetabolites|antimetabolites|mesh-ancestor
110296046|NCT00234026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110296047|NCT00234026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110296048|NCT00234143|Darbepoetin alfa|darbepoetin alfa|mesh-list
110296049|NCT00234143|Hematinics|hematinics|mesh-ancestor
110296050|NCT00234182|Interferons|interferons|mesh-list
110296051|NCT00234182|Interferon-alpha|interferon-alpha|mesh-list
110026967|NCT00241644|Vaccines|vaccines|mesh-list
110296052|NCT00234182|Interferon alpha-2|interferon alpha-2|mesh-list
110296053|NCT00234182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110296054|NCT00234182|Antiviral Agents|antiviral agents|mesh-ancestor
110296055|NCT00234182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110296056|NCT00234182|Immunologic Factors|immunologic factors|mesh-ancestor
110296057|NCT00234182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296058|NCT04669990|Remdesivir|remdesivir|mesh-list
110296059|NCT04669990|Antimetabolites|antimetabolites|mesh-ancestor
110296060|NCT04669990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110296061|NCT04669990|Antiviral Agents|antiviral agents|mesh-ancestor
110278758|NCT00209547|Fospropofol|fospropofol|mesh-list
110278759|NCT00209547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110278760|NCT00209547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110278761|NCT00209547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110278762|NCT00585871|Metoprolol|metoprolol|mesh-list
110278763|NCT00585871|Clonidine|clonidine|mesh-list
110278764|NCT00585871|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110278765|NCT00585871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110278766|NCT00585871|Sympatholytics|sympatholytics|mesh-ancestor
110278767|NCT00585871|Autonomic Agents|autonomic agents|mesh-ancestor
110278768|NCT00585871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110278769|NCT00585871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110278770|NCT00585871|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110278771|NCT00585871|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110296062|NCT04669990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110296063|NCT00556348|Bevacizumab|bevacizumab|mesh-list
110296064|NCT00556348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110296065|NCT00556348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110296066|NCT00556348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110296068|NCT00556348|Growth Substances|growth substances|mesh-ancestor
110296069|NCT00556348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296070|NCT00556348|Growth Inhibitors|growth inhibitors|mesh-ancestor
110296071|NCT00556387|Ketamine|ketamine|mesh-list
110296072|NCT00556387|Analgesics|analgesics|mesh-ancestor
110296073|NCT00556387|Sensory System Agents|sensory system agents|mesh-ancestor
110296074|NCT00556387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110296075|NCT00556387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296076|NCT00556387|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110296077|NCT00556387|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110296078|NCT00556387|Anesthetics, General|anesthetics, general|mesh-ancestor
110296079|NCT00556387|Anesthetics|anesthetics|mesh-ancestor
110296080|NCT00556387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110296081|NCT00556387|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110296082|NCT00556387|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110296083|NCT00556387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110296084|NCT00556387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110296085|NCT04552093|Floxuridine|floxuridine|mesh-list
110296086|NCT04552093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110296087|NCT04552093|Antimetabolites|antimetabolites|mesh-ancestor
110296088|NCT04552093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110296089|NCT04552093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110296090|NCT04556110|Perindopril|perindopril|mesh-list
110296091|NCT04556110|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110296092|NCT04556110|Protease Inhibitors|protease inhibitors|mesh-ancestor
110296093|NCT04556110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110296094|NCT04556110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110296095|NCT04556110|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110296096|NCT00234299|Aspirin|aspirin|mesh-list
110296097|NCT00234299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110296098|NCT00234299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110296105|NCT00234299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110296106|NCT00234299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110296107|NCT00234299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110296108|NCT00234299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110296109|NCT00234299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110296110|NCT00234299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110296111|NCT00234299|Antipyretics|antipyretics|mesh-ancestor
110296112|NCT04556032|Ergothioneine|ergothioneine|mesh-list
110296113|NCT04556032|Antioxidants|antioxidants|mesh-ancestor
110278773|NCT00585871|Adrenergic Agents|adrenergic agents|mesh-ancestor
110278774|NCT00585871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110278775|NCT00585871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110278776|NCT00585871|Analgesics|analgesics|mesh-ancestor
110278777|NCT00585871|Sensory System Agents|sensory system agents|mesh-ancestor
110278778|NCT00585871|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110278779|NCT00585871|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110278780|NCT00585871|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110296114|NCT04556032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110296115|NCT04556032|Protective Agents|protective agents|mesh-ancestor
110296116|NCT04556032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296117|NCT04556071|Bevacizumab|bevacizumab|mesh-list
110296118|NCT04556071|Niraparib|niraparib|mesh-list
110296119|NCT04556071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110296120|NCT04556071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110296121|NCT04556071|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110296122|NCT04556071|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110296123|NCT04556071|Growth Substances|growth substances|mesh-ancestor
110296124|NCT04556071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296125|NCT04556071|Growth Inhibitors|growth inhibitors|mesh-ancestor
110296126|NCT04556071|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110296127|NCT04556071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110296128|NCT04556071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110296129|NCT04563871|Osimertinib|osimertinib|mesh-list
110296130|NCT04563871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110296131|NCT04563871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110296132|NCT04563871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110296133|NCT04563871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110296134|NCT00234377|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110296137|NCT00234377|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110296138|NCT00234377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110296139|NCT00234377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110296140|NCT00234377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296141|NCT02211118|Dexmedetomidine|dexmedetomidine|mesh-list
110296142|NCT02211118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110296143|NCT02211118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110296144|NCT02211118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296145|NCT02211118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110296146|NCT02211118|Analgesics|analgesics|mesh-ancestor
110296147|NCT02211118|Sensory System Agents|sensory system agents|mesh-ancestor
110296148|NCT02211118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110296149|NCT02211118|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110296150|NCT02211118|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110296151|NCT02211118|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110296152|NCT02211118|Adrenergic Agents|adrenergic agents|mesh-ancestor
110296153|NCT02211118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110296154|NCT02211118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110296155|NCT00234416|Gemcitabine|gemcitabine|mesh-list
110296156|NCT00234416|Gefitinib|gefitinib|mesh-list
110296157|NCT00234416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110296158|NCT00234416|Antimetabolites|antimetabolites|mesh-ancestor
110296159|NCT00234416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110296160|NCT00234416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110296161|NCT00234416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110296162|NCT00234416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110296163|NCT00234455|Sirolimus|sirolimus|mesh-list
110296164|NCT00234455|Temsirolimus|temsirolimus|mesh-list
110296165|NCT00234455|MTOR Inhibitors|mtor inhibitors|mesh-list
110296166|NCT00234455|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110296176|NCT00234455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110296178|NCT00234572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110278782|NCT03452722|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110278783|NCT03452722|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110278784|NCT03452722|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110278785|NCT03452722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110278786|NCT00408551|Leucovorin|leucovorin|mesh-list
110278787|NCT00408551|Fluorouracil|fluorouracil|mesh-list
110278788|NCT00408551|Floxuridine|floxuridine|mesh-list
110278789|NCT00408551|Oxaliplatin|oxaliplatin|mesh-list
110278790|NCT00408551|Irinotecan|irinotecan|mesh-list
110278791|NCT00408551|Calcium|calcium|mesh-list
110278792|NCT00408551|Levoleucovorin|levoleucovorin|mesh-list
110278793|NCT00408551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110278794|NCT00408551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110278795|NCT00408551|Antimetabolites|antimetabolites|mesh-ancestor
110278796|NCT00408551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110278797|NCT00408551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110278798|NCT00408551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110278799|NCT00408551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110278801|NCT00408551|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110278802|NCT00408551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110278803|NCT00408551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110278804|NCT00408551|Antidotes|antidotes|mesh-ancestor
110278805|NCT00408551|Protective Agents|protective agents|mesh-ancestor
110278806|NCT00408551|Vitamin B Complex|vitamin b complex|mesh-ancestor
110278808|NCT00408551|Micronutrients|micronutrients|mesh-ancestor
110296179|NCT00260793|Ropinirole|ropinirole|mesh-list
110296180|NCT00260793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110296181|NCT00260793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110296182|NCT00260793|Dopamine Agonists|dopamine agonists|mesh-ancestor
110296183|NCT00260793|Dopamine Agents|dopamine agents|mesh-ancestor
110296184|NCT00260793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110296185|NCT00260793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110296186|NCT00260793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296187|NCT00415935|Methotrexate|methotrexate|mesh-list
110296188|NCT00415935|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110296189|NCT00415935|Abortifacient Agents|abortifacient agents|mesh-ancestor
110296190|NCT00415935|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110296191|NCT00415935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296192|NCT00415935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110296193|NCT00415935|Antimetabolites|antimetabolites|mesh-ancestor
110296194|NCT00415935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110296195|NCT00415935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110296196|NCT00415935|Dermatologic Agents|dermatologic agents|mesh-ancestor
110296197|NCT00415935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110296198|NCT00415935|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110296199|NCT00415935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110296200|NCT00415935|Immunologic Factors|immunologic factors|mesh-ancestor
110027117|NCT02017704|Vitamins|vitamins|mesh-ancestor
110296201|NCT00415935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110278810|NCT04575415|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110278811|NCT04575415|Gefitinib|gefitinib|mesh-list
110278812|NCT04575415|Osimertinib|osimertinib|mesh-list
110278813|NCT04575415|Afatinib|afatinib|mesh-list
110278814|NCT04575415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110278815|NCT04575415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110278816|NCT04575415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110278817|NCT04575415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110278818|NCT04575415|Growth Substances|growth substances|mesh-ancestor
110278819|NCT04575415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110278820|NCT04575415|Growth Inhibitors|growth inhibitors|mesh-ancestor
110278821|NCT04575415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110278822|NCT04575415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110278823|NCT04575415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110278824|NCT00209625|Leucovorin|leucovorin|mesh-list
110278825|NCT00209625|Fluorouracil|fluorouracil|mesh-list
110296202|NCT00415935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110296203|NCT00413738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
110296204|NCT00413738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110296205|NCT02211391|Caseins|caseins|mesh-list
110296206|NCT02211391|Chelating Agents|chelating agents|mesh-ancestor
110296207|NCT02211391|Sequestering Agents|sequestering agents|mesh-ancestor
110296208|NCT02211391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110296209|NCT04562311|Tislelizumab|tislelizumab|mesh-list
110296210|NCT04562311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110296211|NCT04562311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110296212|NCT00234689|Naltrexone|naltrexone|mesh-list
110296213|NCT00234689|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110296214|NCT00234689|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110296215|NCT00234689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296216|NCT00234689|Sensory System Agents|sensory system agents|mesh-ancestor
110296217|NCT00234689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110296218|NCT04561960|Fluorides|fluorides|mesh-list
110296219|NCT04561960|Cariostatic Agents|cariostatic agents|mesh-ancestor
110296220|NCT04561960|Protective Agents|protective agents|mesh-ancestor
110296221|NCT04561960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296222|NCT04561921|Magnesium Sulfate|magnesium sulfate|mesh-list
110296223|NCT04561921|Nordefrin|nordefrin|mesh-list
110296224|NCT04561921|Mepivacaine|mepivacaine|mesh-list
110296225|NCT04561921|Analgesics|analgesics|mesh-ancestor
110296226|NCT04561921|Sensory System Agents|sensory system agents|mesh-ancestor
110296227|NCT04561921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110296228|NCT04561921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296229|NCT04561921|Anesthetics|anesthetics|mesh-ancestor
110296230|NCT04561921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110296242|NCT04561687|Budesonide|budesonide|mesh-list
110296243|NCT04561687|Montelukast|montelukast|mesh-list
110296244|NCT04561687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110296245|NCT04561687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110296246|NCT04561687|Autonomic Agents|autonomic agents|mesh-ancestor
110296247|NCT04561687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110296248|NCT04561687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296249|NCT04561687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110296250|NCT04561687|Respiratory System Agents|respiratory system agents|mesh-ancestor
110296251|NCT04561687|Glucocorticoids|glucocorticoids|mesh-ancestor
110296252|NCT04561687|Hormones|hormones|mesh-ancestor
110296253|NCT04561687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110296254|NCT04561687|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110296255|NCT04561687|Hormone Antagonists|hormone antagonists|mesh-ancestor
110278826|NCT00209625|Irinotecan|irinotecan|mesh-list
110278827|NCT00209625|Antimetabolites|antimetabolites|mesh-ancestor
110278828|NCT00209625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110278829|NCT00209625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110278830|NCT00209625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110278831|NCT00209625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110278832|NCT00209625|Immunologic Factors|immunologic factors|mesh-ancestor
110278833|NCT00209625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110278834|NCT00209625|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110278835|NCT00209625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110278836|NCT00209625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110278838|NCT00209625|Protective Agents|protective agents|mesh-ancestor
110296256|NCT04561687|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110296257|NCT04561687|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110296258|NCT04561687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110296259|NCT04561687|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110296260|NCT04561687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110296261|NCT04561687|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110296262|NCT04561687|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110296263|NCT04561687|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110296264|NCT04561687|Histamine Antagonists|histamine antagonists|mesh-ancestor
110296265|NCT04561687|Histamine Agents|histamine agents|mesh-ancestor
110296266|NCT04561687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110296267|NCT04561219|Nitazoxanide|nitazoxanide|mesh-list
110296268|NCT04561219|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110296269|NCT04561219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110296270|NCT00234845|Adalimumab|adalimumab|mesh-list
110296271|NCT00234845|Methotrexate|methotrexate|mesh-list
110296272|NCT00234845|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110296273|NCT00234845|Abortifacient Agents|abortifacient agents|mesh-ancestor
110027185|NCT03218514|Anticoagulants|anticoagulants|mesh-ancestor
110296274|NCT00234845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110296275|NCT00234845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296276|NCT00234845|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110296277|NCT00234845|Antimetabolites|antimetabolites|mesh-ancestor
110296278|NCT00234845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110296279|NCT00234845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110296280|NCT00234845|Dermatologic Agents|dermatologic agents|mesh-ancestor
110296282|NCT00234845|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110296283|NCT00234845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110296284|NCT00234845|Immunologic Factors|immunologic factors|mesh-ancestor
110296285|NCT00234845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110296286|NCT00234845|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110296287|NCT00234845|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110296288|NCT00234845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110296290|NCT02211625|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110296291|NCT02211625|Narcotics|narcotics|mesh-ancestor
110296292|NCT02211625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110296293|NCT02211625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296301|NCT00234923|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
110296303|NCT00234923|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110296304|NCT00234923|Protease Inhibitors|protease inhibitors|mesh-ancestor
110296305|NCT00234923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110296306|NCT00234923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110296307|NCT00234923|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110296308|NCT00234923|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110296309|NCT00234923|Antiviral Agents|antiviral agents|mesh-ancestor
110296310|NCT00234923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110296311|NCT00234923|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110278839|NCT00209625|Vitamin B Complex|vitamin b complex|mesh-ancestor
110278841|NCT00209625|Micronutrients|micronutrients|mesh-ancestor
110278842|NCT00216528|Risperidone|risperidone|mesh-list
110278843|NCT00216528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110278844|NCT00216528|Serotonin Agents|serotonin agents|mesh-ancestor
110278845|NCT00216528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110296312|NCT00234923|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110296313|NCT00234923|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110296314|NCT00234923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110296315|NCT00234923|Antimetabolites|antimetabolites|mesh-ancestor
110296316|NCT02213887|Pantoprazole|pantoprazole|mesh-list
110296317|NCT02213887|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110296318|NCT02213887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110296319|NCT02213887|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110296320|NCT02213887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110296323|NCT00234962|Lopinavir|lopinavir|mesh-list
110296324|NCT00234962|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110296325|NCT00234962|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110296326|NCT00234962|Protease Inhibitors|protease inhibitors|mesh-ancestor
110296327|NCT00234962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110296328|NCT00234962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110296329|NCT00234962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110296330|NCT00234962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110296331|NCT00234962|Antiviral Agents|antiviral agents|mesh-ancestor
110296332|NCT00234962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110296333|NCT00234962|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110296334|NCT00234962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110296335|NCT04551703|Epinephrine|epinephrine|mesh-list
110296336|NCT04551703|Racepinephrine|racepinephrine|mesh-list
110296337|NCT04551703|Epinephryl borate|epinephryl borate|mesh-list
110296338|NCT04551703|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110296339|NCT04551703|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110296340|NCT04551703|Adrenergic Agents|adrenergic agents|mesh-ancestor
110296341|NCT04551703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110296342|NCT04551703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110296343|NCT04551703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296344|NCT04551703|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110296345|NCT04551703|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110296346|NCT04551703|Autonomic Agents|autonomic agents|mesh-ancestor
110296347|NCT04551703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110296348|NCT04551703|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110296349|NCT04551703|Respiratory System Agents|respiratory system agents|mesh-ancestor
110296350|NCT04551703|Mydriatics|mydriatics|mesh-ancestor
110296351|NCT04551703|Sympathomimetics|sympathomimetics|mesh-ancestor
110296352|NCT04551703|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110296353|NCT00235001|Verapamil|verapamil|mesh-list
110296354|NCT00235001|Trandolapril|trandolapril|mesh-list
110296355|NCT00235001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110296356|NCT00235001|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110296357|NCT00235001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110296358|NCT00235001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110296359|NCT00235001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110296360|NCT00235001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296361|NCT00235001|Vasodilator Agents|vasodilator agents|mesh-ancestor
110296379|NCT02214004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110296380|NCT02214004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110296381|NCT02214004|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110296382|NCT02214004|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110296383|NCT02214004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110296384|NCT02214004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110296385|NCT02214004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110296386|NCT02214004|Hormone Antagonists|hormone antagonists|mesh-ancestor
110296387|NCT02214004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110296388|NCT02214004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296389|NCT00235079|Colchicine|colchicine|mesh-list
110278846|NCT00216528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110278847|NCT00216528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110278848|NCT00216528|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110278849|NCT00216528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110278850|NCT00216528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110278851|NCT00216528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110278852|NCT00216528|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110278853|NCT00216528|Dopamine Agents|dopamine agents|mesh-ancestor
110278854|NCT00182312|Caffeine|caffeine|mesh-list
110278855|NCT00182312|Caffeine citrate|caffeine citrate|mesh-list
110278856|NCT00182312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110278857|NCT00182312|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110278858|NCT00182312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110278859|NCT00182312|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110278860|NCT00182312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110278861|NCT00182312|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110278862|NCT00182312|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110278863|NCT00182312|Purinergic Agents|purinergic agents|mesh-ancestor
110278864|NCT00182312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110278865|NCT00209664|Irinotecan|irinotecan|mesh-list
110278866|NCT00209664|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110296390|NCT00235079|Gout Suppressants|gout suppressants|mesh-ancestor
110296391|NCT00235079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110296393|NCT00235079|Antimitotic Agents|antimitotic agents|mesh-ancestor
110296394|NCT00235079|Mitosis Modulators|mitosis modulators|mesh-ancestor
110296395|NCT00235079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110296396|NCT00235079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110296397|NCT00260988|Dalteparin|dalteparin|mesh-list
110296398|NCT00260988|Tinzaparin|tinzaparin|mesh-list
110296399|NCT00260988|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110296400|NCT00260988|Anticoagulants|anticoagulants|mesh-ancestor
110296401|NCT00260988|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110296402|NCT00260988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110296403|NCT00260988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110296404|NCT00235157|Sirolimus|sirolimus|mesh-list
110296405|NCT00235157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110296406|NCT00235157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110296407|NCT00235157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110296408|NCT00235157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110296409|NCT00235157|Antifungal Agents|antifungal agents|mesh-ancestor
110296410|NCT00235157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110296411|NCT00235157|Immunologic Factors|immunologic factors|mesh-ancestor
110296412|NCT00235157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296413|NCT04550338|Tranexamic Acid|tranexamic acid|mesh-list
110296414|NCT04550338|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110296415|NCT04550338|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110296416|NCT04550338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110296417|NCT04550338|Hemostatics|hemostatics|mesh-ancestor
110296418|NCT04550338|Coagulants|coagulants|mesh-ancestor
110296419|NCT04550611|Immunoglobulins|immunoglobulins|mesh-list
110296420|NCT04550611|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110296428|NCT00261027|Exemestane|exemestane|mesh-list
110296429|NCT00261027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110278867|NCT00209664|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110278868|NCT00209664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110278869|NCT00209664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110278870|NCT00209664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110278871|NCT04575493|Ciprofloxacin|ciprofloxacin|mesh-list
110278872|NCT04575493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110278873|NCT04575493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110278874|NCT04575493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110278875|NCT04575493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110278876|NCT04575493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110278877|NCT04575493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110278878|NCT04575493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110296430|NCT00261027|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110296431|NCT00261027|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110296432|NCT00261027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110296433|NCT00261027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110296434|NCT00261027|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110296435|NCT00261027|Hormone Antagonists|hormone antagonists|mesh-ancestor
110296436|NCT00261027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110296437|NCT00261027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296438|NCT00235235|Cyclophosphamide|cyclophosphamide|mesh-list
110296440|NCT00235235|Doxorubicin|doxorubicin|mesh-list
110296441|NCT00235235|Capecitabine|capecitabine|mesh-list
110296442|NCT00235235|Vinorelbine|vinorelbine|mesh-list
110296443|NCT00235235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110296444|NCT00235235|Immunologic Factors|immunologic factors|mesh-ancestor
110296445|NCT00235235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296446|NCT00235235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110296447|NCT00235235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110296448|NCT00235235|Alkylating Agents|alkylating agents|mesh-ancestor
110296449|NCT00235235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110296450|NCT00235235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110296451|NCT00235235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110296452|NCT00235235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110296453|NCT00235235|Antimetabolites|antimetabolites|mesh-ancestor
110296454|NCT00235235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110296455|NCT00235235|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110296456|NCT00235235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110296457|NCT00235235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110296458|NCT00235235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110296459|NCT00235235|Tubulin Modulators|tubulin modulators|mesh-ancestor
110296460|NCT00235235|Antimitotic Agents|antimitotic agents|mesh-ancestor
110296461|NCT00235235|Mitosis Modulators|mitosis modulators|mesh-ancestor
110296462|NCT00268359|Bevacizumab|bevacizumab|mesh-list
110296463|NCT00268359|Irinotecan|irinotecan|mesh-list
110296464|NCT00268359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110296465|NCT00268359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110296466|NCT00268359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110296467|NCT00268359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110296468|NCT00268359|Growth Substances|growth substances|mesh-ancestor
110296469|NCT00268359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296470|NCT00268359|Growth Inhibitors|growth inhibitors|mesh-ancestor
110296471|NCT00268359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110296472|NCT00268359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110296473|NCT00268359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110296474|NCT00268359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110296475|NCT00235274|Secretin|secretin|mesh-list
110296476|NCT00235274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110296477|NCT00235274|Hormones|hormones|mesh-ancestor
110278879|NCT04575493|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110278880|NCT04575493|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110278885|NCT00587119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110278886|NCT00587119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110278887|NCT00587119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110278888|NCT00587119|Respiratory System Agents|respiratory system agents|mesh-ancestor
110278889|NCT00587119|Glucocorticoids|glucocorticoids|mesh-ancestor
110278890|NCT00587119|Hormones|hormones|mesh-ancestor
110278891|NCT00587119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110278892|NCT00216567|Topiramate|topiramate|mesh-list
110278893|NCT00216567|Anticonvulsants|anticonvulsants|mesh-ancestor
110278894|NCT00216567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110278895|NCT00216567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110278896|NCT00182351|Fibrin fragment D|fibrin fragment d|mesh-list
110278897|NCT00182351|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110278898|NCT00182351|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110296478|NCT00235274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110296479|NCT00235274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296480|NCT00268398|Leucovorin|leucovorin|mesh-list
110296481|NCT00268398|Folic Acid|folic acid|mesh-list
110296482|NCT00268398|Fluorouracil|fluorouracil|mesh-list
110296483|NCT00268398|Oxaliplatin|oxaliplatin|mesh-list
110296484|NCT00268398|Irinotecan|irinotecan|mesh-list
110296485|NCT00268398|Levoleucovorin|levoleucovorin|mesh-list
110296486|NCT00268398|Antimetabolites|antimetabolites|mesh-ancestor
110296487|NCT00268398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110296488|NCT00268398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110296498|NCT00268398|Vitamin B Complex|vitamin b complex|mesh-ancestor
110296500|NCT00268398|Micronutrients|micronutrients|mesh-ancestor
110296501|NCT00268398|Hematinics|hematinics|mesh-ancestor
110296502|NCT00235313|Nicotine|nicotine|mesh-list
110296503|NCT00235313|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110296504|NCT00235313|Autonomic Agents|autonomic agents|mesh-ancestor
110296505|NCT00235313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110296506|NCT00235313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296507|NCT00235313|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110296508|NCT00235313|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110296509|NCT00235313|Cholinergic Agents|cholinergic agents|mesh-ancestor
110296510|NCT00235313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110296511|NCT00235313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110296512|NCT04549012|Tranexamic Acid|tranexamic acid|mesh-list
110296513|NCT04549012|Oxytocin|oxytocin|mesh-list
110296514|NCT04549012|Oxytocics|oxytocics|mesh-ancestor
110296515|NCT04549012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110296516|NCT04549012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296517|NCT04549012|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110278899|NCT00182351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110278901|NCT00182351|Coagulants|coagulants|mesh-ancestor
110278902|NCT00587470|Candesartan|candesartan|mesh-list
110278903|NCT00587470|Candesartan cilexetil|candesartan cilexetil|mesh-list
110278912|NCT00209703|Antimetabolites|antimetabolites|mesh-ancestor
110278913|NCT00209703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110278914|NCT00209703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110278915|NCT00209703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110296518|NCT04549012|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110296519|NCT04549012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110296520|NCT04549012|Hemostatics|hemostatics|mesh-ancestor
110296521|NCT04549012|Coagulants|coagulants|mesh-ancestor
110296522|NCT00261105|Telithromycin|telithromycin|mesh-list
110296523|NCT00261105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110296524|NCT00261105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110296525|NCT00235508|Eszopiclone|eszopiclone|mesh-list
110296526|NCT00235508|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110296534|NCT00268515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110296535|NCT00268515|Glucocorticoids|glucocorticoids|mesh-ancestor
110296536|NCT00268515|Hormones|hormones|mesh-ancestor
110296537|NCT00268515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110296538|NCT00268515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296539|NCT00268515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110296540|NCT00268515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110296541|NCT00268515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110278916|NCT00209703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110278917|NCT00209703|Immunologic Factors|immunologic factors|mesh-ancestor
110278918|NCT00209703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110278921|NCT00209703|Vitamin B Complex|vitamin b complex|mesh-ancestor
110278923|NCT00209703|Micronutrients|micronutrients|mesh-ancestor
110278924|NCT04575103|Antipsychotic Agents|antipsychotic agents|mesh-list
110296542|NCT00268515|Immunologic Factors|immunologic factors|mesh-ancestor
110296543|NCT00268515|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110296544|NCT00268515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110296545|NCT00268515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110296546|NCT00268515|Antifungal Agents|antifungal agents|mesh-ancestor
110296547|NCT00268515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110296548|NCT00268515|Dermatologic Agents|dermatologic agents|mesh-ancestor
110296549|NCT00268515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110296550|NCT00268515|Antimetabolites|antimetabolites|mesh-ancestor
110296551|NCT00268515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110296552|NCT04548700|Prednisone|prednisone|mesh-list
110296553|NCT04548700|Cyclophosphamide|cyclophosphamide|mesh-list
110296554|NCT04548700|Vincristine|vincristine|mesh-list
110296555|NCT04548700|Mitoxantrone|mitoxantrone|mesh-list
110296556|NCT04548700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110296557|NCT04548700|Immunologic Factors|immunologic factors|mesh-ancestor
110296558|NCT04548700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296559|NCT04548700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110296560|NCT04548700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110296561|NCT04548700|Alkylating Agents|alkylating agents|mesh-ancestor
110296562|NCT04548700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110296563|NCT04548700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110296564|NCT04548700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110296565|NCT04548700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110296571|NCT04548700|Tubulin Modulators|tubulin modulators|mesh-ancestor
110296572|NCT04548700|Antimitotic Agents|antimitotic agents|mesh-ancestor
110296573|NCT04548700|Mitosis Modulators|mitosis modulators|mesh-ancestor
110296574|NCT04548700|Analgesics|analgesics|mesh-ancestor
110296575|NCT04548700|Sensory System Agents|sensory system agents|mesh-ancestor
110296576|NCT04548700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110296577|NCT04548700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110296578|NCT04548700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110296579|NCT04548700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110296580|NCT02214433|Pantoprazole|pantoprazole|mesh-list
110296581|NCT02214433|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110296582|NCT02214433|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110296583|NCT02214433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110296584|NCT02214433|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110296585|NCT02214433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110296586|NCT02214433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110296587|NCT02212561|Cytarabine|cytarabine|mesh-list
110296588|NCT02212561|Hydrocortisone|hydrocortisone|mesh-list
110296589|NCT02212561|Methotrexate|methotrexate|mesh-list
110296590|NCT02212561|Fludarabine phosphate|fludarabine phosphate|mesh-list
110296591|NCT02212561|Fludarabine|fludarabine|mesh-list
110296592|NCT02212561|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110296593|NCT02212561|Abortifacient Agents|abortifacient agents|mesh-ancestor
110278931|NCT00587548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110278932|NCT00216606|Topiramate|topiramate|mesh-list
110278933|NCT00216606|Anticonvulsants|anticonvulsants|mesh-ancestor
110278934|NCT00216606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110278935|NCT00216606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110278936|NCT00587665|Ketamine|ketamine|mesh-list
110278937|NCT00587665|Analgesics|analgesics|mesh-ancestor
110278938|NCT00587665|Sensory System Agents|sensory system agents|mesh-ancestor
110278939|NCT00587665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110296594|NCT02212561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110296595|NCT02212561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296596|NCT02212561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110296597|NCT02212561|Antimetabolites|antimetabolites|mesh-ancestor
110296598|NCT02212561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110296599|NCT02212561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110296600|NCT02212561|Dermatologic Agents|dermatologic agents|mesh-ancestor
110296601|NCT02212561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110296602|NCT02212561|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110296603|NCT02212561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110296604|NCT02212561|Immunologic Factors|immunologic factors|mesh-ancestor
110296605|NCT02212561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110296606|NCT02212561|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110296616|NCT00268554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110296617|NCT00268554|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110296618|NCT00268554|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110296619|NCT00268554|Purinergic Agents|purinergic agents|mesh-ancestor
110296620|NCT00268554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110296621|NCT00268554|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110296622|NCT00268554|Vasodilator Agents|vasodilator agents|mesh-ancestor
110296623|NCT00268593|Prednisone|prednisone|mesh-list
110296624|NCT00268593|Docetaxel|docetaxel|mesh-list
110296625|NCT00268593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110296626|NCT00268593|Tubulin Modulators|tubulin modulators|mesh-ancestor
110278945|NCT00587665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110278946|NCT00587665|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110278947|NCT00587665|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110278948|NCT00587665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110278949|NCT00587665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110278950|NCT00182429|Metronidazole|metronidazole|mesh-list
110278951|NCT00182429|Rifampin|rifampin|mesh-list
110278952|NCT00182429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110278953|NCT00182429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110278954|NCT00182429|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110278955|NCT00182429|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110278956|NCT00182429|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110296628|NCT00268593|Mitosis Modulators|mitosis modulators|mesh-ancestor
110296629|NCT00268593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110296630|NCT00268593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110296631|NCT00268593|Glucocorticoids|glucocorticoids|mesh-ancestor
110296632|NCT00268593|Hormones|hormones|mesh-ancestor
110296633|NCT00268593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110296634|NCT00268593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296642|NCT00261183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110296643|NCT00261183|Protective Agents|protective agents|mesh-ancestor
110296644|NCT00261183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296645|NCT00261183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110296648|NCT00268632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110296649|NCT00268632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110296650|NCT00268632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110296651|NCT00268632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296652|NCT00268632|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110296653|NCT04554979|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110296654|NCT04554979|Hydroxychloroquine|hydroxychloroquine|mesh-list
110278965|NCT00182429|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110278966|NCT00182429|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110278967|NCT00182429|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110278969|NCT00216645|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110296655|NCT04554979|Anticoagulants|anticoagulants|mesh-list
110296656|NCT04554979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110296657|NCT04554979|Antimalarials|antimalarials|mesh-ancestor
110296658|NCT04554979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110296659|NCT04554979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110296660|NCT04554979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110296661|NCT04554979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110296662|NCT04554979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110296663|NCT00235703|Anti-Infective Agents|anti-infective agents|mesh-list
110296664|NCT00235703|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110296665|NCT00261222|Amodiaquine|amodiaquine|mesh-list
110296666|NCT00261222|Antimalarials|antimalarials|mesh-ancestor
110296667|NCT00261222|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110296668|NCT00261222|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110296669|NCT00261222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110296670|NCT00235781|Thymoglobulin|thymoglobulin|mesh-list
110296671|NCT00235781|Immunologic Factors|immunologic factors|mesh-ancestor
110296672|NCT00235781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296673|NCT00235781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110296674|NCT04554589|Glycopyrrolate|glycopyrrolate|mesh-list
110296675|NCT04554589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110296676|NCT04554589|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110296677|NCT04554589|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110296678|NCT04554589|Cholinergic Agents|cholinergic agents|mesh-ancestor
110278977|NCT00588016|Antifungal Agents|antifungal agents|mesh-ancestor
110278978|NCT00588016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110278979|NCT00588016|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110278980|NCT00588016|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110278981|NCT00588016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110278982|NCT00588016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110278983|NCT00588016|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110278984|NCT00588016|Hormone Antagonists|hormone antagonists|mesh-ancestor
110278985|NCT00588016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110278986|NCT00588016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296684|NCT00268671|Tubulin Modulators|tubulin modulators|mesh-ancestor
110296685|NCT00268671|Antimitotic Agents|antimitotic agents|mesh-ancestor
110296686|NCT00268671|Mitosis Modulators|mitosis modulators|mesh-ancestor
110296687|NCT00268671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110296688|NCT04554433|Ethanol|ethanol|mesh-list
110296689|NCT04554433|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110278999|NCT00216684|Anesthetics|anesthetics|mesh-ancestor
110279000|NCT00588133|Tranexamic Acid|tranexamic acid|mesh-list
110279001|NCT00588133|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110279002|NCT00588133|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110279003|NCT00588133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110279004|NCT00588133|Hemostatics|hemostatics|mesh-ancestor
110279005|NCT00588133|Coagulants|coagulants|mesh-ancestor
110279006|NCT00588172|Metformin|metformin|mesh-list
110279008|NCT00588172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110279009|NCT00182507|Olanzapine|olanzapine|mesh-list
110279010|NCT00182507|Antiemetics|antiemetics|mesh-ancestor
110279011|NCT00182507|Autonomic Agents|autonomic agents|mesh-ancestor
110279012|NCT00182507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110279013|NCT00182507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110279014|NCT00182507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110279015|NCT00182507|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110279016|NCT00182507|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110279017|NCT00182507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110279018|NCT00182507|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110279019|NCT00182507|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110279021|NCT00182507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110279022|NCT00182507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110279023|NCT00182507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110279024|NCT00182507|Serotonin Agents|serotonin agents|mesh-ancestor
110279025|NCT00209742|Leucovorin|leucovorin|mesh-list
110279026|NCT00209742|polysaccharide-K|polysaccharide-k|mesh-list
110279027|NCT00209742|Tegafur|tegafur|mesh-list
110279085|NCT00182663|Hormones|hormones|mesh-ancestor
110279086|NCT00182663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110279097|NCT00182663|Immunologic Factors|immunologic factors|mesh-ancestor
110279098|NCT00182663|Leprostatic Agents|leprostatic agents|mesh-ancestor
110279099|NCT00182663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110296692|NCT04554433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296693|NCT04721054|Lidocaine|lidocaine|mesh-list
110296694|NCT04721054|Bupivacaine|bupivacaine|mesh-list
110296695|NCT04721054|Anesthetics|anesthetics|mesh-list
110296696|NCT04721054|Anesthetics, Local|anesthetics, local|mesh-ancestor
110279106|NCT00216762|Immunologic Factors|immunologic factors|mesh-ancestor
110279107|NCT00216762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110279108|NCT00216762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110279110|NCT00182702|Epothilone B|epothilone b|mesh-list
110279111|NCT00182702|Tubulin Modulators|tubulin modulators|mesh-ancestor
110279112|NCT00182702|Antimitotic Agents|antimitotic agents|mesh-ancestor
110279113|NCT00182702|Mitosis Modulators|mitosis modulators|mesh-ancestor
110279114|NCT00182702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110296715|NCT02212756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296716|NCT02212795|Levofloxacin|levofloxacin|mesh-list
110296718|NCT02212795|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110296719|NCT02212795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110296720|NCT02212795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110296721|NCT02212795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110296722|NCT02212795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110296723|NCT02212795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110296724|NCT02212795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110296725|NCT02212795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110279127|NCT00588835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110296727|NCT02212795|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110027631|NCT01720212|Urological Agents|urological agents|mesh-ancestor
110296728|NCT02212795|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110296730|NCT00261261|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110296731|NCT00261261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110296732|NCT00261261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110296733|NCT00261261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296734|NCT00261261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110296735|NCT00261261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110296736|NCT00261261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110296737|NCT00261261|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110296738|NCT00261261|Anesthetics, General|anesthetics, general|mesh-ancestor
110296739|NCT00261261|Anesthetics|anesthetics|mesh-ancestor
110296740|NCT00261261|GABA Modulators|gaba modulators|mesh-ancestor
110296741|NCT00261261|GABA Agents|gaba agents|mesh-ancestor
110296742|NCT00261261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110296743|NCT00261261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110296744|NCT00235820|Adalimumab|adalimumab|mesh-list
110296745|NCT00235820|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110279130|NCT00588835|Antipruritics|antipruritics|mesh-ancestor
110279131|NCT00588835|Dermatologic Agents|dermatologic agents|mesh-ancestor
110279132|NCT00588835|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110279133|NCT00588835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110279134|NCT00588835|Serotonin Agents|serotonin agents|mesh-ancestor
110279135|NCT00588835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110279136|NCT00588835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110279137|NCT00588835|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110017305|NCT02956044|Metformin|metformin|mesh-list
110279177|NCT00182741|Mitoxantrone|mitoxantrone|mesh-list
110296746|NCT00235820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110296747|NCT00235820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110296748|NCT00268710|Docetaxel|docetaxel|mesh-list
110296749|NCT00268710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110296750|NCT00268710|Tubulin Modulators|tubulin modulators|mesh-ancestor
110296751|NCT00268710|Antimitotic Agents|antimitotic agents|mesh-ancestor
110296752|NCT00268710|Mitosis Modulators|mitosis modulators|mesh-ancestor
110296753|NCT00268710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110296754|NCT00261300|Pantoprazole|pantoprazole|mesh-list
110296755|NCT00261300|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110296756|NCT00261300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110296757|NCT00261300|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110296758|NCT00261300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110296759|NCT00261300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110296760|NCT02212990|Acetaminophen|acetaminophen|mesh-list
110296761|NCT02212990|Ibuprofen|ibuprofen|mesh-list
110296762|NCT02212990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110296763|NCT02212990|Analgesics|analgesics|mesh-ancestor
110296764|NCT02212990|Sensory System Agents|sensory system agents|mesh-ancestor
110296765|NCT02212990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110296766|NCT02212990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296767|NCT02212990|Antipyretics|antipyretics|mesh-ancestor
110296782|NCT00235859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110296783|NCT00235859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110296784|NCT00235859|Dermatologic Agents|dermatologic agents|mesh-ancestor
110296785|NCT00235859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110017343|NCT02956122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110296786|NCT00235859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110296787|NCT00235859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110296788|NCT00235859|Immunologic Factors|immunologic factors|mesh-ancestor
110296789|NCT00235859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110296790|NCT00235859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110296791|NCT00235859|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110296792|NCT00235859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110296793|NCT02213029|Oxytocin|oxytocin|mesh-list
110296794|NCT02213029|Oxytocics|oxytocics|mesh-ancestor
110296795|NCT02213029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110296796|NCT02213029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296797|NCT02213146|Insulin|insulin|mesh-list
110296798|NCT02213146|Insulin Lispro|insulin lispro|mesh-list
110296799|NCT02213146|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110279178|NCT00182741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110279179|NCT00182741|Glucocorticoids|glucocorticoids|mesh-ancestor
110279180|NCT00182741|Hormones|hormones|mesh-ancestor
110279181|NCT00182741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110279182|NCT00182741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110279183|NCT00182741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110279184|NCT00182741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110279185|NCT00182741|Analgesics|analgesics|mesh-ancestor
110279186|NCT00182741|Sensory System Agents|sensory system agents|mesh-ancestor
110279187|NCT00182741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110279188|NCT00182741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110279189|NCT00182741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110279190|NCT00182741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110279191|NCT00182741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110296800|NCT02213146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110296801|NCT02213146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296802|NCT00268749|Glycine|glycine|mesh-list
110296803|NCT00268749|Glycine Agents|glycine agents|mesh-ancestor
110296804|NCT00268749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110017373|NCT02968368|Ferric maltol|ferric maltol|mesh-list
110296805|NCT00268749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110296806|NCT00268749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296807|NCT00235898|Leucovorin|leucovorin|mesh-list
110296808|NCT00235898|Fluorouracil|fluorouracil|mesh-list
110296809|NCT00235898|Antimetabolites|antimetabolites|mesh-ancestor
110296810|NCT00235898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110296811|NCT00235898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110296812|NCT00235898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110296813|NCT00235898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110296814|NCT00235898|Immunologic Factors|immunologic factors|mesh-ancestor
110296815|NCT00235898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296816|NCT00235898|Antidotes|antidotes|mesh-ancestor
110296817|NCT00235898|Protective Agents|protective agents|mesh-ancestor
110296818|NCT00235898|Vitamin B Complex|vitamin b complex|mesh-ancestor
110296819|NCT00235898|Vitamins|vitamins|mesh-ancestor
110296820|NCT00235898|Micronutrients|micronutrients|mesh-ancestor
110296821|NCT02213224|Amlodipine|amlodipine|mesh-list
110296822|NCT02213224|Telmisartan|telmisartan|mesh-list
110296823|NCT02213224|Perindopril|perindopril|mesh-list
110296824|NCT02213224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110296825|NCT02213224|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110296826|NCT02213224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110296827|NCT02213224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110296828|NCT02213224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110296849|NCT00235937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110296850|NCT00235937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110296851|NCT00235937|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110296852|NCT00235937|Hormone Antagonists|hormone antagonists|mesh-ancestor
110296853|NCT00235937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110296854|NCT00235937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296855|NCT00261339|Pantoprazole|pantoprazole|mesh-list
110296856|NCT00261339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110296857|NCT00261339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110296858|NCT00261339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110296859|NCT00261339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110296860|NCT00261339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110296861|NCT04553380|Insulin|insulin|mesh-list
110296862|NCT04553380|Insulin Glargine|insulin glargine|mesh-list
110296863|NCT04553380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110296864|NCT04553380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296865|NCT00236015|Tiagabine|tiagabine|mesh-list
110279192|NCT00182741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110279193|NCT00182741|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110279194|NCT00182741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110279195|NCT00182741|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110279196|NCT00182741|Vitamins|vitamins|mesh-ancestor
110279197|NCT00182741|Micronutrients|micronutrients|mesh-ancestor
110279198|NCT00182741|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110279199|NCT00589186|Celecoxib|celecoxib|mesh-list
110279200|NCT00589186|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110279201|NCT00589186|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110279202|NCT00589186|Analgesics|analgesics|mesh-ancestor
110296866|NCT00236015|Anticonvulsants|anticonvulsants|mesh-ancestor
110017413|NCT03009162|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110296867|NCT00236015|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
110296868|NCT00236015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110296869|NCT00236015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110296870|NCT00236015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110296871|NCT00236015|GABA Agents|gaba agents|mesh-ancestor
110296873|NCT00236015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296874|NCT00261378|Doxorubicin|doxorubicin|mesh-list
110296875|NCT00261378|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110296876|NCT00261378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110296877|NCT00261378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110296878|NCT00261378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110296879|NCT00261378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110296880|NCT00261378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110296881|NCT00261378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110296883|NCT04553458|Sorafenib|sorafenib|mesh-list
110296884|NCT04553458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110296906|NCT04552951|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110296907|NCT04552951|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110296908|NCT02213419|Ethanol|ethanol|mesh-list
110296909|NCT02213419|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110296910|NCT02213419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110296911|NCT02213419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110296912|NCT02213419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296913|NCT00236093|Fentanyl|fentanyl|mesh-list
110296914|NCT00236093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110296915|NCT00236093|Narcotics|narcotics|mesh-ancestor
110296916|NCT00236093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110296917|NCT00236093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296918|NCT00236093|Analgesics|analgesics|mesh-ancestor
110296919|NCT00236093|Sensory System Agents|sensory system agents|mesh-ancestor
110296920|NCT00236093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110296921|NCT00236093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110296922|NCT00236093|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110296923|NCT00236093|Anesthetics, General|anesthetics, general|mesh-ancestor
110296924|NCT00236093|Anesthetics|anesthetics|mesh-ancestor
110296925|NCT04552483|Nitazoxanide|nitazoxanide|mesh-list
110296926|NCT04552483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110296927|NCT04552483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110296928|NCT02213614|Lithium Carbonate|lithium carbonate|mesh-list
110296929|NCT02213614|Antidepressive Agents|antidepressive agents|mesh-ancestor
110296930|NCT02213614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110296931|NCT02213614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110296932|NCT02213614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110296933|NCT02213614|Antimanic Agents|antimanic agents|mesh-ancestor
110296935|NCT02213614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110296936|NCT02213614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296937|NCT02213653|Iron|iron|mesh-list
110017443|NCT03020004|Ritonavir|ritonavir|mesh-list
110296938|NCT02213653|Trace Elements|trace elements|mesh-ancestor
110296942|NCT04552444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110296943|NCT00236171|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
110279203|NCT00589186|Sensory System Agents|sensory system agents|mesh-ancestor
110279204|NCT00589186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110279205|NCT00589186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110279206|NCT00589186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110279207|NCT00589186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110279208|NCT00589186|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110279209|NCT00589186|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110279210|NCT00589186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110279211|NCT00589186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110279213|NCT00589264|Trace Elements|trace elements|mesh-ancestor
110279214|NCT00589264|Micronutrients|micronutrients|mesh-ancestor
110279215|NCT00589264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110279216|NCT00589381|Fenretinide|fenretinide|mesh-list
110279217|NCT00589381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110279218|NCT00589381|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110296944|NCT00236171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110296945|NCT04552405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110296947|NCT02213848|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110296948|NCT02213848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296949|NCT00261573|Galantamine|galantamine|mesh-list
110296950|NCT00261573|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110296951|NCT00261573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110296952|NCT00261573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110296953|NCT00261573|Cholinergic Agents|cholinergic agents|mesh-ancestor
110296954|NCT00261573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110296955|NCT00261573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296956|NCT00261573|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110296957|NCT00261573|Autonomic Agents|autonomic agents|mesh-ancestor
110296958|NCT00261573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110296959|NCT00261573|Nootropic Agents|nootropic agents|mesh-ancestor
110296960|NCT04548271|Apatinib|apatinib|mesh-list
110296961|NCT04548271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110296962|NCT04548271|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110296963|NCT04548271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110296964|NCT04548271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110296965|NCT04541719|Remifentanil|remifentanil|mesh-list
110296966|NCT04541719|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110296967|NCT04541719|Narcotics|narcotics|mesh-ancestor
110296968|NCT04541719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110296969|NCT04541719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296970|NCT04541719|Analgesics|analgesics|mesh-ancestor
110296971|NCT04541719|Sensory System Agents|sensory system agents|mesh-ancestor
110296972|NCT04541719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110296973|NCT00414089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110296974|NCT00414089|Immunologic Factors|immunologic factors|mesh-ancestor
110296975|NCT00414089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296976|NCT00261612|Dexamethasone|dexamethasone|mesh-list
110296977|NCT00261612|Rituximab|rituximab|mesh-list
110296978|NCT00261612|Bortezomib|bortezomib|mesh-list
110296979|NCT00261612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110296980|NCT00261612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110296981|NCT00261612|Immunologic Factors|immunologic factors|mesh-ancestor
110296982|NCT00261612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296983|NCT00261612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110017461|NCT03020082|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110296985|NCT00261612|Antiemetics|antiemetics|mesh-ancestor
110296986|NCT00261612|Autonomic Agents|autonomic agents|mesh-ancestor
110296987|NCT00261612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110296988|NCT00261612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110279219|NCT00589381|Protective Agents|protective agents|mesh-ancestor
110279220|NCT00589381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110279221|NCT00182819|Temozolomide|temozolomide|mesh-list
110279222|NCT00182819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110279223|NCT00182819|Alkylating Agents|alkylating agents|mesh-ancestor
110279224|NCT00182819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110279225|NCT00182819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110279226|NCT00216840|Betamethasone|betamethasone|mesh-list
110279227|NCT00216840|Betamethasone Valerate|betamethasone valerate|mesh-list
110279228|NCT00216840|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
110279229|NCT00216840|Betamethasone benzoate|betamethasone benzoate|mesh-list
110279230|NCT00216840|Calcipotriene|calcipotriene|mesh-list
110279231|NCT00216840|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
110279232|NCT00216840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110279233|NCT00216840|Glucocorticoids|glucocorticoids|mesh-ancestor
110279234|NCT00216840|Hormones|hormones|mesh-ancestor
110279235|NCT00216840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110279236|NCT00216840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110279237|NCT00216840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110296989|NCT00261612|Glucocorticoids|glucocorticoids|mesh-ancestor
110296990|NCT00261612|Hormones|hormones|mesh-ancestor
110296991|NCT00261612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110296992|NCT00261612|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110296993|NCT04547764|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110296994|NCT04547764|Calcium|calcium|mesh-list
110296995|NCT04547764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110296996|NCT04547764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296997|NCT04547764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110296998|NCT04547608|Propofol|propofol|mesh-list
110296999|NCT04547608|Rocuronium|rocuronium|mesh-list
110297000|NCT04547608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110297001|NCT04547608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110297002|NCT04547608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297003|NCT04547608|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110297004|NCT04547608|Anesthetics, General|anesthetics, general|mesh-ancestor
110297005|NCT04547608|Anesthetics|anesthetics|mesh-ancestor
110297006|NCT04547608|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110297007|NCT04547608|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110297008|NCT04547608|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110297009|NCT04547608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110297010|NCT00236249|Lidocaine|lidocaine|mesh-list
110297011|NCT00236249|Anesthetics, Local|anesthetics, local|mesh-ancestor
110027931|NCT01048866|Analgesics|analgesics|mesh-ancestor
110297028|NCT04547335|Voriconazole|voriconazole|mesh-list
110297029|NCT04547335|Antifungal Agents|antifungal agents|mesh-ancestor
110297030|NCT04547335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110297031|NCT04547335|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110297032|NCT04547335|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110297033|NCT04547335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110297034|NCT04547335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110297035|NCT04547335|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110297036|NCT04547335|Hormone Antagonists|hormone antagonists|mesh-ancestor
110297037|NCT04547335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110279238|NCT00216840|Respiratory System Agents|respiratory system agents|mesh-ancestor
110279239|NCT00216840|Dermatologic Agents|dermatologic agents|mesh-ancestor
110279240|NCT00589732|Valsartan|valsartan|mesh-list
110279241|NCT00589732|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110279242|NCT00589732|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110279243|NCT00589732|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110279244|NCT00589732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110279245|NCT00216879|Betamethasone|betamethasone|mesh-list
110279246|NCT00216879|Betamethasone Valerate|betamethasone valerate|mesh-list
110279247|NCT00216879|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
110279248|NCT00216879|Betamethasone benzoate|betamethasone benzoate|mesh-list
110297038|NCT04547335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297039|NCT04547335|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110297040|NCT00236288|Bupropion|bupropion|mesh-list
110297041|NCT00236288|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110297042|NCT00236288|Antidepressive Agents|antidepressive agents|mesh-ancestor
110297043|NCT00236288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110297044|NCT00236288|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110297045|NCT00236288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110297046|NCT00236288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110017507|NCT03040362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110297047|NCT00236288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110297048|NCT00236288|Dopamine Agents|dopamine agents|mesh-ancestor
110297049|NCT00236288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110297050|NCT00236288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297051|NCT00236288|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110297052|NCT00236288|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110297053|NCT00236288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110297054|NCT04547296|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110297056|NCT00236327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110297057|NCT00236327|Narcotics|narcotics|mesh-ancestor
110297058|NCT00236327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110297059|NCT00236327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297060|NCT00236327|Analgesics|analgesics|mesh-ancestor
110297061|NCT00236327|Sensory System Agents|sensory system agents|mesh-ancestor
110297062|NCT00236327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110297063|NCT00236327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110297064|NCT00236327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110297065|NCT00236327|Anesthetics, General|anesthetics, general|mesh-ancestor
110297072|NCT00236366|Analgesics|analgesics|mesh-ancestor
110297073|NCT00236366|Sensory System Agents|sensory system agents|mesh-ancestor
110297074|NCT00236366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110297075|NCT00236366|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110297076|NCT00236366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110297077|NCT00236366|Anesthetics, General|anesthetics, general|mesh-ancestor
110297078|NCT00236366|Anesthetics|anesthetics|mesh-ancestor
110297080|NCT04547179|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
110297081|NCT04547179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110297082|NCT04547179|Analgesics|analgesics|mesh-ancestor
110297083|NCT04547179|Sensory System Agents|sensory system agents|mesh-ancestor
110297084|NCT04547179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110297085|NCT04547179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297086|NCT00236405|Epoetin Alfa|epoetin alfa|mesh-list
110297087|NCT00236405|Hematinics|hematinics|mesh-ancestor
110297088|NCT00236444|Risperidone|risperidone|mesh-list
110297089|NCT00236444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110297090|NCT00236444|Serotonin Agents|serotonin agents|mesh-ancestor
110297091|NCT00236444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110297092|NCT00236444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110297093|NCT00236444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110279249|NCT00216879|Calcipotriene|calcipotriene|mesh-list
110279250|NCT00216879|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
110279251|NCT00216879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110279252|NCT00216879|Glucocorticoids|glucocorticoids|mesh-ancestor
110279253|NCT00216879|Hormones|hormones|mesh-ancestor
110279254|NCT00216879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110279255|NCT00216879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110279256|NCT00216879|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110279257|NCT00216879|Respiratory System Agents|respiratory system agents|mesh-ancestor
110279258|NCT00216879|Dermatologic Agents|dermatologic agents|mesh-ancestor
110279259|NCT00589927|Cilostazol|cilostazol|mesh-list
110279260|NCT00589927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110279261|NCT00589927|Autonomic Agents|autonomic agents|mesh-ancestor
110279262|NCT00589927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110279263|NCT00589927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110279264|NCT00589927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110297094|NCT00236444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110297095|NCT00236444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110297096|NCT00236444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110297097|NCT00236444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110017547|NCT03061812|Topotecan|topotecan|mesh-list
110017548|NCT03061812|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
110017550|NCT03061812|Antiemetics|antiemetics|mesh-ancestor
110297098|NCT00236444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110297099|NCT00236444|Dopamine Agents|dopamine agents|mesh-ancestor
110297101|NCT00269217|Niacinamide|niacinamide|mesh-list
110297102|NCT00269217|Nicotinic Acids|nicotinic acids|mesh-list
110297104|NCT00269217|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110297105|NCT00269217|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110297106|NCT00269217|Antimetabolites|antimetabolites|mesh-ancestor
110297107|NCT00269217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110297108|NCT00269217|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110297109|NCT00269217|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110297110|NCT00269217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110297111|NCT00269217|Vasodilator Agents|vasodilator agents|mesh-ancestor
110297112|NCT00269217|Vitamin B Complex|vitamin b complex|mesh-ancestor
110297113|NCT00269217|Vitamins|vitamins|mesh-ancestor
110297114|NCT00269217|Micronutrients|micronutrients|mesh-ancestor
110297115|NCT00269217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297116|NCT04546282|Osimertinib|osimertinib|mesh-list
110297117|NCT04546282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110297118|NCT04546282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110297119|NCT04546282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110297120|NCT04546282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110297121|NCT00236483|Acetaminophen|acetaminophen|mesh-list
110297122|NCT00236483|Tramadol|tramadol|mesh-list
110297123|NCT00236483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110297124|NCT00236483|Analgesics|analgesics|mesh-ancestor
110297125|NCT00236483|Sensory System Agents|sensory system agents|mesh-ancestor
110297126|NCT00236483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110297127|NCT00236483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297128|NCT00236483|Antipyretics|antipyretics|mesh-ancestor
110297129|NCT00236483|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110297130|NCT00236483|Narcotics|narcotics|mesh-ancestor
110297131|NCT00236483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110297132|NCT04545970|Sunscreening Agents|sunscreening agents|mesh-list
110297133|NCT04545970|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110297134|NCT04545970|Protective Agents|protective agents|mesh-ancestor
110297135|NCT04545970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297136|NCT04545970|Dermatologic Agents|dermatologic agents|mesh-ancestor
110297137|NCT04545931|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
110297146|NCT00236522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110297147|NCT00236522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110279265|NCT00589927|Respiratory System Agents|respiratory system agents|mesh-ancestor
110279266|NCT00589927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110279267|NCT00589927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110279268|NCT00589927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110279269|NCT00589927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110279270|NCT00589927|Vasodilator Agents|vasodilator agents|mesh-ancestor
110279271|NCT00589927|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110279272|NCT00589927|Protective Agents|protective agents|mesh-ancestor
110279273|NCT00589927|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110279274|NCT00589927|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110279275|NCT00589927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110279277|NCT00209937|Analgesics|analgesics|mesh-ancestor
110279278|NCT00209937|Sensory System Agents|sensory system agents|mesh-ancestor
110017558|NCT03061812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110017560|NCT03061812|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110017561|NCT03061812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110017562|NCT03061812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110017563|NCT03061812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110017564|NCT03061812|Immunoconjugates|immunoconjugates|mesh-ancestor
110017565|NCT03061812|Immunologic Factors|immunologic factors|mesh-ancestor
110017566|NCT03070470|Ritonavir|ritonavir|mesh-list
110279279|NCT00209937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110279280|NCT00209937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110279281|NCT00209937|Anticonvulsants|anticonvulsants|mesh-ancestor
110279282|NCT00209937|GABA Agonists|gaba agonists|mesh-ancestor
110279283|NCT00209937|GABA Agents|gaba agents|mesh-ancestor
110279284|NCT00209937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110279285|NCT00209937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110279286|NCT00590278|Raltitrexed|raltitrexed|mesh-list
110279287|NCT00590278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110279288|NCT00590278|Antimetabolites|antimetabolites|mesh-ancestor
110279289|NCT00590278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110297148|NCT00236522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110297149|NCT00236522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110297150|NCT00236522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110297151|NCT00236522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110297152|NCT00236522|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110297153|NCT00236522|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110297154|NCT00261729|Prazosin|prazosin|mesh-list
110297155|NCT00261729|Paroxetine|paroxetine|mesh-list
110297156|NCT00261729|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110297157|NCT00261729|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110297158|NCT00261729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110297159|NCT00261729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110297160|NCT00261729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110297161|NCT00261729|Serotonin Agents|serotonin agents|mesh-ancestor
110297162|NCT00261729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297163|NCT00261729|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110297164|NCT00261729|Antidepressive Agents|antidepressive agents|mesh-ancestor
110297165|NCT00261729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110297166|NCT00261729|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110297167|NCT00261729|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110297168|NCT00261729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110279290|NCT00590278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110279291|NCT00590278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110279292|NCT00590278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110279293|NCT00216918|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110279294|NCT00216918|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110279295|NCT00216918|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110279296|NCT00216918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110297169|NCT00261729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110297170|NCT00261729|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110297171|NCT00261729|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110297172|NCT00261729|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110297173|NCT00261729|Adrenergic Agents|adrenergic agents|mesh-ancestor
110297174|NCT00236561|Topiramate|topiramate|mesh-list
110297175|NCT00236561|Propranolol|propranolol|mesh-list
110297176|NCT00236561|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110297178|NCT00236561|Adrenergic Agents|adrenergic agents|mesh-ancestor
110297179|NCT00236561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110297180|NCT00236561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110297181|NCT00236561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297182|NCT00236561|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110297183|NCT00236561|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110297184|NCT00236561|Vasodilator Agents|vasodilator agents|mesh-ancestor
110297185|NCT00236561|Anticonvulsants|anticonvulsants|mesh-ancestor
110297186|NCT00236561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110297187|NCT02215330|Eplerenone|eplerenone|mesh-list
110297188|NCT02215330|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110297189|NCT02215330|Hormone Antagonists|hormone antagonists|mesh-ancestor
110297190|NCT02215330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110297191|NCT02215330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297192|NCT02215330|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110297193|NCT02215330|Diuretics|diuretics|mesh-ancestor
110297194|NCT02215330|Natriuretic Agents|natriuretic agents|mesh-ancestor
110297195|NCT02215330|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110297196|NCT02278510|Topotecan|topotecan|mesh-list
110297197|NCT02278510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110297198|NCT02278510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110297199|NCT02278510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110297200|NCT02278510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110297201|NCT02278510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110297202|NCT04545892|Capsaicin|capsaicin|mesh-list
110297203|NCT04545892|Antipruritics|antipruritics|mesh-ancestor
110297204|NCT04545892|Dermatologic Agents|dermatologic agents|mesh-ancestor
110297210|NCT02214706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110297211|NCT02214706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110297212|NCT02214706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110297213|NCT02214706|Antifungal Agents|antifungal agents|mesh-ancestor
110297214|NCT02214706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110297215|NCT02214706|Immunologic Factors|immunologic factors|mesh-ancestor
110297216|NCT02214706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297218|NCT00236600|Anticonvulsants|anticonvulsants|mesh-ancestor
110297219|NCT00236600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110297220|NCT00236600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297221|NCT00236639|Topiramate|topiramate|mesh-list
110297222|NCT00236639|Anticonvulsants|anticonvulsants|mesh-ancestor
110297223|NCT00236639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110297224|NCT00236639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297225|NCT04545463|Psyllium|psyllium|mesh-list
110297226|NCT04545463|Cathartics|cathartics|mesh-ancestor
110297227|NCT04545463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110297228|NCT00236678|Epoetin Alfa|epoetin alfa|mesh-list
110297229|NCT00236678|Hematinics|hematinics|mesh-ancestor
110297230|NCT00269334|Paroxetine|paroxetine|mesh-list
110297231|NCT00269334|Citalopram|citalopram|mesh-list
110017603|NCT03080142|Bupivacaine|bupivacaine|mesh-list
110297232|NCT00269334|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110297233|NCT00269334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110297234|NCT00269334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110297235|NCT00269334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110297236|NCT00269334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110279297|NCT00216918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110279298|NCT00216918|Adrenergic Agents|adrenergic agents|mesh-ancestor
110279299|NCT00216918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110279300|NCT00216918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110279302|NCT04574791|Analgesics|analgesics|mesh-ancestor
110279303|NCT04574791|Sensory System Agents|sensory system agents|mesh-ancestor
110279304|NCT04574791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110279305|NCT04574791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110279306|NCT04574791|Anticonvulsants|anticonvulsants|mesh-ancestor
110279307|NCT04574791|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110279308|NCT04574791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110279309|NCT04574791|Parasympatholytics|parasympatholytics|mesh-ancestor
110279310|NCT04574791|Autonomic Agents|autonomic agents|mesh-ancestor
110279311|NCT04574791|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110279312|NCT04574791|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110297237|NCT00269334|Serotonin Agents|serotonin agents|mesh-ancestor
110297238|NCT00269334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297239|NCT00269334|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110297240|NCT00269334|Antidepressive Agents|antidepressive agents|mesh-ancestor
110297241|NCT00269334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110297242|NCT00269334|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110297243|NCT00269334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110297244|NCT00269334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110297246|NCT04541251|Carboplatin|carboplatin|mesh-list
110297247|NCT04541251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110297248|NCT04541251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110297249|NCT04541251|Tubulin Modulators|tubulin modulators|mesh-ancestor
110297250|NCT04541251|Antimitotic Agents|antimitotic agents|mesh-ancestor
110297251|NCT04541251|Mitosis Modulators|mitosis modulators|mesh-ancestor
110297252|NCT04541251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110297253|NCT00236717|Topiramate|topiramate|mesh-list
110297254|NCT00236717|Carbamazepine|carbamazepine|mesh-list
110297255|NCT00236717|Valproic Acid|valproic acid|mesh-list
110297256|NCT00236717|Anticonvulsants|anticonvulsants|mesh-ancestor
110297257|NCT00236717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110297258|NCT00236717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297259|NCT00236717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110297260|NCT00236717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110297261|NCT00236717|GABA Agents|gaba agents|mesh-ancestor
110297262|NCT00236717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110297263|NCT00236717|Antimanic Agents|antimanic agents|mesh-ancestor
110297264|NCT00236717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110297265|NCT00236717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110297266|NCT00236717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110297267|NCT00236717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110297268|NCT00236717|Analgesics|analgesics|mesh-ancestor
110297269|NCT00236717|Sensory System Agents|sensory system agents|mesh-ancestor
110297270|NCT00236717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110297271|NCT00236717|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110297272|NCT00236717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110297273|NCT00236717|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110297274|NCT00236717|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110297275|NCT00236756|Topiramate|topiramate|mesh-list
110297279|NCT00269412|Rifaximin|rifaximin|mesh-list
110297280|NCT00269412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110297281|NCT00269412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110297282|NCT00269412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110297283|NCT00236795|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110297284|NCT00236795|Norelgestromin|norelgestromin|mesh-list
110279314|NCT04574791|Adrenergic Agents|adrenergic agents|mesh-ancestor
110279315|NCT04574791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110279316|NCT04574791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110279317|NCT00590629|Niacin|niacin|mesh-list
110279318|NCT00590629|Nicotinic Acids|nicotinic acids|mesh-list
110279319|NCT00590629|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110279320|NCT00590629|Antimetabolites|antimetabolites|mesh-ancestor
110279321|NCT00590629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110279322|NCT00590629|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110279323|NCT00590629|Vasodilator Agents|vasodilator agents|mesh-ancestor
110279324|NCT00590629|Vitamin B Complex|vitamin b complex|mesh-ancestor
110279325|NCT00590629|Vitamins|vitamins|mesh-ancestor
110279326|NCT00590629|Micronutrients|micronutrients|mesh-ancestor
110279327|NCT00590629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297285|NCT00236795|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
110297286|NCT00236795|Estradiol|estradiol|mesh-list
110297287|NCT00236795|Estrogens|estrogens|mesh-ancestor
110297288|NCT00236795|Hormones|hormones|mesh-ancestor
110297289|NCT00236795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110297290|NCT00236795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297291|NCT00236795|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110297292|NCT00236795|Contraceptive Agents|contraceptive agents|mesh-ancestor
110297293|NCT00236795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110297294|NCT00236795|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110297295|NCT00236795|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110297296|NCT00236795|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110297297|NCT00236795|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110297298|NCT00236795|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110297299|NCT00236795|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
110297300|NCT00236795|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110297301|NCT00236795|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110297302|NCT04540627|Palivizumab|palivizumab|mesh-list
110297303|NCT04540627|Antiviral Agents|antiviral agents|mesh-ancestor
110297304|NCT04540627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110297305|NCT00236834|Levofloxacin|levofloxacin|mesh-list
110297306|NCT00236834|Imipenem|imipenem|mesh-list
110297307|NCT00236834|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110297308|NCT00236834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110297309|NCT00236834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110297310|NCT00236834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110297311|NCT00236834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110297312|NCT00236834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110297313|NCT00236834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110017638|NCT03096444|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110297314|NCT00236834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110297315|NCT00236834|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110297316|NCT00236834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110297317|NCT00236873|Topiramate|topiramate|mesh-list
110297318|NCT00236873|Anticonvulsants|anticonvulsants|mesh-ancestor
110297319|NCT00236873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110297320|NCT00236873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297321|NCT00236912|Metronidazole|metronidazole|mesh-list
110297322|NCT00236912|Levofloxacin|levofloxacin|mesh-list
110297323|NCT00236912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110297324|NCT00236912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110297325|NCT00236912|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110297326|NCT00236912|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110028238|NCT02242812|Metoprolol|metoprolol|mesh-list
110297327|NCT00236912|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110297328|NCT00236912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110279328|NCT00590785|Tamoxifen|tamoxifen|mesh-list
110279329|NCT00590785|Ciprofloxacin|ciprofloxacin|mesh-list
110279330|NCT00590785|Cyclophosphamide|cyclophosphamide|mesh-list
110279331|NCT00590785|Doxorubicin|doxorubicin|mesh-list
110279332|NCT00590785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110279333|NCT00590785|Immunologic Factors|immunologic factors|mesh-ancestor
110279334|NCT00590785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110279335|NCT00590785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110279336|NCT00590785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110279337|NCT00590785|Alkylating Agents|alkylating agents|mesh-ancestor
110279338|NCT00590785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110279339|NCT00590785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110279340|NCT00590785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110279341|NCT00590785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110279342|NCT00590785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110279343|NCT00590785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110297329|NCT00236912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110297330|NCT00236912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110297331|NCT00236912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110297332|NCT00236912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110297333|NCT00236912|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110297334|NCT00236912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110297336|NCT02215447|Carboplatin|carboplatin|mesh-list
110297337|NCT02215447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110297338|NCT02215447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110297339|NCT02215447|Tubulin Modulators|tubulin modulators|mesh-ancestor
110297340|NCT02215447|Antimitotic Agents|antimitotic agents|mesh-ancestor
110297341|NCT02215447|Mitosis Modulators|mitosis modulators|mesh-ancestor
110017661|NCT03107754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110297342|NCT02215447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110297343|NCT00236990|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
110297344|NCT00236990|Anticoagulants|anticoagulants|mesh-ancestor
110297345|NCT00237068|Lansoprazole|lansoprazole|mesh-list
110297346|NCT00237068|Dexlansoprazole|dexlansoprazole|mesh-list
110297347|NCT00237068|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110297380|NCT04544059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110297381|NCT04544059|Growth Substances|growth substances|mesh-ancestor
110297382|NCT04544059|Growth Inhibitors|growth inhibitors|mesh-ancestor
110297383|NCT04544059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110297385|NCT00269607|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110297386|NCT00269607|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110297387|NCT00269607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297388|NCT00269607|Sensory System Agents|sensory system agents|mesh-ancestor
110297393|NCT00237224|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110297394|NCT00237224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110297395|NCT00237224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110297396|NCT00237224|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110297397|NCT00237224|Hormone Antagonists|hormone antagonists|mesh-ancestor
110297398|NCT00237224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110028303|NCT02243826|Analgesics|analgesics|mesh-ancestor
110297399|NCT00237224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297401|NCT00237263|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110297402|NCT00237263|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110297403|NCT00237263|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
110297404|NCT00237263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110297405|NCT00237263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110297406|NCT00237302|Topiramate|topiramate|mesh-list
110297407|NCT00237302|Anticonvulsants|anticonvulsants|mesh-ancestor
110279344|NCT00590785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110279345|NCT00590785|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110279346|NCT00590785|Hormone Antagonists|hormone antagonists|mesh-ancestor
110279347|NCT00590785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110279348|NCT00590785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110279349|NCT00590785|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110279350|NCT00590785|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110279351|NCT00590785|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110279352|NCT00590785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110279353|NCT00590785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110279354|NCT00590785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110279355|NCT00590785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110279356|NCT00477295|Carbamazepine|carbamazepine|mesh-list
110279357|NCT00477295|Zonisamide|zonisamide|mesh-list
110017690|NCT03177798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110279358|NCT00477295|Anticonvulsants|anticonvulsants|mesh-ancestor
110279359|NCT00477295|Antimanic Agents|antimanic agents|mesh-ancestor
110279360|NCT00477295|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110279361|NCT00477295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110279362|NCT00477295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110279363|NCT00477295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110279364|NCT00477295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110279365|NCT00477295|Analgesics|analgesics|mesh-ancestor
110297408|NCT00237302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110297409|NCT00237302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297410|NCT00262275|Aspirin|aspirin|mesh-list
110297411|NCT00262275|Clopidogrel|clopidogrel|mesh-list
110297412|NCT00262275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110297413|NCT00262275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110297414|NCT00262275|Analgesics|analgesics|mesh-ancestor
110297415|NCT00262275|Sensory System Agents|sensory system agents|mesh-ancestor
110297416|NCT00262275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110297417|NCT00262275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297418|NCT00262275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110297419|NCT00262275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110297420|NCT00262275|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110297421|NCT00262275|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110297422|NCT00262275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110297423|NCT00262275|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110297424|NCT00262275|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110297425|NCT00262275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110297426|NCT00262275|Antipyretics|antipyretics|mesh-ancestor
110297427|NCT00262275|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110297428|NCT00262275|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110297429|NCT00262275|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110297430|NCT00262275|Purinergic Agents|purinergic agents|mesh-ancestor
110297431|NCT00262275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110297432|NCT02214979|Telmisartan|telmisartan|mesh-list
110297433|NCT02214979|Ramipril|ramipril|mesh-list
110297434|NCT02214979|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110297435|NCT02214979|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110297436|NCT02214979|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110279366|NCT00477295|Sensory System Agents|sensory system agents|mesh-ancestor
110279367|NCT00477295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110279368|NCT00477295|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110279369|NCT00477295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110279370|NCT00477295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110279371|NCT00477295|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110279372|NCT00477295|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110279373|NCT00477295|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110279374|NCT00477295|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110279375|NCT00476593|Dexamethasone|dexamethasone|mesh-list
110279376|NCT00476593|Diclofenac|diclofenac|mesh-list
110017718|NCT05093790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110017719|NCT04933344|Daptomycin|daptomycin|mesh-list
110279378|NCT00476593|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110279379|NCT00476593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110279380|NCT00476593|Antiemetics|antiemetics|mesh-ancestor
110297437|NCT02214979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110297438|NCT02214979|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110297439|NCT02214979|Protease Inhibitors|protease inhibitors|mesh-ancestor
110297440|NCT02214979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110297441|NCT00237341|Fentanyl|fentanyl|mesh-list
110297442|NCT00237341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110297443|NCT00237341|Narcotics|narcotics|mesh-ancestor
110297444|NCT00237341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110297445|NCT00237341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297446|NCT00237341|Analgesics|analgesics|mesh-ancestor
110297447|NCT00237341|Sensory System Agents|sensory system agents|mesh-ancestor
110297448|NCT00237341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110297449|NCT00237341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110297450|NCT00237341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110297451|NCT00237341|Anesthetics, General|anesthetics, general|mesh-ancestor
110297452|NCT00237341|Anesthetics|anesthetics|mesh-ancestor
110297453|NCT04539301|Anticoagulants|anticoagulants|mesh-list
110297454|NCT00237419|Infliximab|infliximab|mesh-list
110297455|NCT00237419|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110297456|NCT00237419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110297457|NCT00237419|Dermatologic Agents|dermatologic agents|mesh-ancestor
110297458|NCT00237419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110297459|NCT00237419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110297462|NCT04539106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110297463|NCT04539106|Growth Substances|growth substances|mesh-ancestor
110297464|NCT04539106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297465|NCT04539106|Growth Inhibitors|growth inhibitors|mesh-ancestor
110297466|NCT04539106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110297467|NCT00237497|Zopiclone|zopiclone|mesh-list
110297468|NCT00237497|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110297469|NCT00237497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110297470|NCT00237497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297471|NCT00416130|Vorinostat|vorinostat|mesh-list
110028378|NCT02247414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110297472|NCT00416130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110297473|NCT00416130|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110297474|NCT00416130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110297475|NCT00416130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110297477|NCT00416169|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110297478|NCT00416169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110297479|NCT00416169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110297480|NCT00416169|Cholinergic Agents|cholinergic agents|mesh-ancestor
110297481|NCT00416169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110279381|NCT00476593|Autonomic Agents|autonomic agents|mesh-ancestor
110279382|NCT00476593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110279383|NCT00476593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110279384|NCT00476593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110279385|NCT00476593|Glucocorticoids|glucocorticoids|mesh-ancestor
110279386|NCT00476593|Hormones|hormones|mesh-ancestor
110279387|NCT00476593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110279388|NCT00476593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110279389|NCT00476593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110279390|NCT00476593|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110279391|NCT00476593|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110279392|NCT00476593|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110279393|NCT00476593|Analgesics|analgesics|mesh-ancestor
110279394|NCT00476593|Sensory System Agents|sensory system agents|mesh-ancestor
110297482|NCT00416169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297483|NCT00416169|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110297484|NCT00416169|Autonomic Agents|autonomic agents|mesh-ancestor
110297485|NCT00416169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110297486|NCT00416169|Nootropic Agents|nootropic agents|mesh-ancestor
110297487|NCT00237536|Lonidamine|lonidamine|mesh-list
110297488|NCT00237536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110297489|NCT00237536|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
110297490|NCT00237536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297491|NCT00237536|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110297492|NCT00237536|Contraceptive Agents|contraceptive agents|mesh-ancestor
110297493|NCT00237536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110297494|NCT00237536|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110297495|NCT00237536|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110297496|NCT00237536|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110297497|NCT00237536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110297498|NCT02215720|Sirolimus|sirolimus|mesh-list
110297499|NCT02215720|Cetuximab|cetuximab|mesh-list
110297500|NCT02215720|Temsirolimus|temsirolimus|mesh-list
110297501|NCT02215720|MTOR Inhibitors|mtor inhibitors|mesh-list
110297502|NCT02215720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110297503|NCT02215720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110297504|NCT02215720|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110297505|NCT02215720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110297506|NCT02215720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110297507|NCT02215720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110297508|NCT02215720|Immunologic Factors|immunologic factors|mesh-ancestor
110297509|NCT02215720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297510|NCT02215720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110297511|NCT02215720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110297512|NCT02215720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110297513|NCT02215720|Antifungal Agents|antifungal agents|mesh-ancestor
110297514|NCT00416208|Bortezomib|bortezomib|mesh-list
110297515|NCT00416208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110297516|NCT02215798|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110297517|NCT02215798|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110297518|NCT02215798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110297519|NCT02215798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110297520|NCT02215798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110297521|NCT02215798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110297522|NCT02215798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297523|NCT02215798|Analgesics|analgesics|mesh-ancestor
110297524|NCT02215798|Sensory System Agents|sensory system agents|mesh-ancestor
110297525|NCT02215798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110297526|NCT02215798|Antidepressive Agents|antidepressive agents|mesh-ancestor
110297527|NCT02215798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110279395|NCT00476593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110279396|NCT00476593|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110279397|NCT00476593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110279398|NCT00476593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110279399|NCT00476593|Cathartics|cathartics|mesh-ancestor
110279400|NCT00210132|Ropivacaine|ropivacaine|mesh-list
110279401|NCT00210132|Anesthetics, Local|anesthetics, local|mesh-ancestor
110279402|NCT00210132|Anesthetics|anesthetics|mesh-ancestor
110279403|NCT00210132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110279404|NCT00210132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110279405|NCT00210132|Sensory System Agents|sensory system agents|mesh-ancestor
110279406|NCT00210132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110279408|NCT00183404|Antiemetics|antiemetics|mesh-ancestor
110279409|NCT00183404|Autonomic Agents|autonomic agents|mesh-ancestor
110279410|NCT00183404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110279411|NCT00183404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110279412|NCT00183404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110279413|NCT00183404|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110297528|NCT02215798|Dopamine Agents|dopamine agents|mesh-ancestor
110297529|NCT02215018|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110297530|NCT02215057|Lidocaine|lidocaine|mesh-list
110297531|NCT02215057|Anesthetics|anesthetics|mesh-list
110297532|NCT02215057|Anesthetics, Local|anesthetics, local|mesh-ancestor
110297535|NCT02215057|Sensory System Agents|sensory system agents|mesh-ancestor
110297536|NCT02215057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110297537|NCT02215057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110297538|NCT02215057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110297539|NCT02215057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110297540|NCT02215057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110297541|NCT02215057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110297542|NCT00269685|Vasopressins|vasopressins|mesh-list
110297543|NCT00269685|Arginine Vasopressin|arginine vasopressin|mesh-list
110297545|NCT00269685|Coagulants|coagulants|mesh-ancestor
110028451|NCT02248896|Telmisartan|telmisartan|mesh-list
110297546|NCT00269685|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110297547|NCT00269685|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110297548|NCT00269685|Natriuretic Agents|natriuretic agents|mesh-ancestor
110297549|NCT00269685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297550|NCT04543123|Antidepressive Agents|antidepressive agents|mesh-list
110297551|NCT04543123|Escitalopram|escitalopram|mesh-list
110297552|NCT04543123|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110297553|NCT04543123|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110297554|NCT04543123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110297555|NCT04543123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110297556|NCT04543123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110297557|NCT04543123|Serotonin Agents|serotonin agents|mesh-ancestor
110297558|NCT04543123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297559|NCT04543123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110297560|NCT04539418|Vitamin K|vitamin k|mesh-list
110297561|NCT04539418|Vitamin K 2|vitamin k 2|mesh-list
110017789|NCT03883074|Viscosupplements|viscosupplements|mesh-ancestor
110297563|NCT04539418|Micronutrients|micronutrients|mesh-ancestor
110297564|NCT04539418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297565|NCT04539418|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110279414|NCT00183404|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110279415|NCT00183404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110279416|NCT00183404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110279417|NCT00183404|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110279418|NCT00183404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110279419|NCT00183404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110279420|NCT00183404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110279421|NCT00183404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110279422|NCT00183404|Serotonin Agents|serotonin agents|mesh-ancestor
110279423|NCT00476476|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110279424|NCT00476476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110279425|NCT00476476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110279426|NCT00476476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110279427|NCT00476476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110279428|NCT00183560|Antidepressive Agents|antidepressive agents|mesh-list
110279429|NCT00183560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110279430|NCT00217152|Mycophenolic Acid|mycophenolic acid|mesh-list
110279431|NCT00217152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110297566|NCT04539418|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110297567|NCT04539418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110297568|NCT04539418|Hemostatics|hemostatics|mesh-ancestor
110297569|NCT04539418|Coagulants|coagulants|mesh-ancestor
110297570|NCT00269724|Oxybutynin|oxybutynin|mesh-list
110297571|NCT00269724|Parasympatholytics|parasympatholytics|mesh-ancestor
110297572|NCT00269724|Autonomic Agents|autonomic agents|mesh-ancestor
110297573|NCT00269724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110297574|NCT00269724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297575|NCT00269724|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110297576|NCT00269724|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110297577|NCT00269724|Cholinergic Agents|cholinergic agents|mesh-ancestor
110297578|NCT00269724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110297579|NCT00269724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110297580|NCT00269724|Urological Agents|urological agents|mesh-ancestor
110297581|NCT04710017|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110297582|NCT04710017|Tranexamic Acid|tranexamic acid|mesh-list
110297583|NCT04710017|Medroxyprogesterone|medroxyprogesterone|mesh-list
110297584|NCT04710017|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110297585|NCT04710017|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110297586|NCT04710017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110297587|NCT04710017|Hemostatics|hemostatics|mesh-ancestor
110297588|NCT04710017|Coagulants|coagulants|mesh-ancestor
110297589|NCT04710017|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110297590|NCT04710017|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110297591|NCT04710017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110297592|NCT04710017|Contraceptive Agents|contraceptive agents|mesh-ancestor
110297593|NCT04710017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110297594|NCT04710017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297595|NCT04710017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110297596|NCT04710017|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110297597|NCT04710017|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110297598|NCT04710017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110297599|NCT04710017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110279433|NCT00217152|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110279434|NCT00217152|Antitubercular Agents|antitubercular agents|mesh-ancestor
110279435|NCT00217152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110279437|NCT00217152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110279438|NCT00217152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110279439|NCT00210210|Ketamine|ketamine|mesh-list
110279440|NCT00210210|Analgesics|analgesics|mesh-ancestor
110279441|NCT00210210|Sensory System Agents|sensory system agents|mesh-ancestor
110279442|NCT00210210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110279443|NCT00210210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110279444|NCT00210210|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110279445|NCT00210210|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110279446|NCT00210210|Anesthetics, General|anesthetics, general|mesh-ancestor
110279447|NCT00210210|Anesthetics|anesthetics|mesh-ancestor
110297600|NCT04538521|Niacin|niacin|mesh-list
110297601|NCT04538521|Nicotinic Acids|nicotinic acids|mesh-list
110297602|NCT04538521|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110297603|NCT04538521|Antimetabolites|antimetabolites|mesh-ancestor
110297607|NCT04538521|Vitamin B Complex|vitamin b complex|mesh-ancestor
110297608|NCT04538521|Vitamins|vitamins|mesh-ancestor
110297609|NCT04538521|Micronutrients|micronutrients|mesh-ancestor
110297610|NCT04538521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297611|NCT00269763|Fentanyl|fentanyl|mesh-list
110297612|NCT00269763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110297613|NCT00269763|Narcotics|narcotics|mesh-ancestor
110297614|NCT00269763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110297615|NCT00269763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297616|NCT00269763|Analgesics|analgesics|mesh-ancestor
110297617|NCT00269763|Sensory System Agents|sensory system agents|mesh-ancestor
110297618|NCT00269763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110297619|NCT00269763|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110297620|NCT00269763|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110297621|NCT00269763|Anesthetics, General|anesthetics, general|mesh-ancestor
110297622|NCT00269763|Anesthetics|anesthetics|mesh-ancestor
110297623|NCT00237575|Gemcitabine|gemcitabine|mesh-list
110297624|NCT00237575|Sargramostim|sargramostim|mesh-list
110297625|NCT00237575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110297626|NCT00237575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110297627|NCT00237575|Antimetabolites|antimetabolites|mesh-ancestor
110297628|NCT00237575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110297629|NCT00237575|Immunologic Factors|immunologic factors|mesh-ancestor
110297630|NCT00237575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297631|NCT00269802|Methylphenidate|methylphenidate|mesh-list
110297632|NCT00269802|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110297633|NCT00269802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297634|NCT00269802|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110297635|NCT00269802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110297636|NCT00269802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110297637|NCT00269802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110297638|NCT00269802|Dopamine Agents|dopamine agents|mesh-ancestor
110297639|NCT00269802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110297640|NCT02215174|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110297641|NCT02215174|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110297642|NCT02215174|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110297643|NCT02215174|Antimetabolites|antimetabolites|mesh-ancestor
110279448|NCT00210210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110279449|NCT00210210|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110279450|NCT00210210|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110279451|NCT00210210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110297644|NCT02215174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110297645|NCT02215174|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110297646|NCT02215174|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110297647|NCT02215174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110297648|NCT00237614|Acetylcysteine|acetylcysteine|mesh-list
110297649|NCT00237614|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110297650|NCT00237614|Antiviral Agents|antiviral agents|mesh-ancestor
110297651|NCT00237614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110297652|NCT00237614|Expectorants|expectorants|mesh-ancestor
110297653|NCT00237614|Respiratory System Agents|respiratory system agents|mesh-ancestor
110297654|NCT00237614|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110297655|NCT00237614|Antioxidants|antioxidants|mesh-ancestor
110297656|NCT00237614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110297657|NCT00237614|Protective Agents|protective agents|mesh-ancestor
110297658|NCT00237614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297659|NCT00237614|Antidotes|antidotes|mesh-ancestor
110297660|NCT00269841|Infliximab|infliximab|mesh-list
110297661|NCT00269841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110297662|NCT00269841|Antibodies|antibodies|mesh-list
110297663|NCT00269841|Immunoglobulins|immunoglobulins|mesh-list
110297664|NCT00269841|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110297665|NCT00269841|Immunologic Factors|immunologic factors|mesh-ancestor
110297666|NCT00269841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297667|NCT00269841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110297668|NCT00269841|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110297669|NCT00269841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110297670|NCT00269841|Dermatologic Agents|dermatologic agents|mesh-ancestor
110297671|NCT00269841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110297672|NCT00269841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110297673|NCT00414128|Mycophenolic Acid|mycophenolic acid|mesh-list
110297674|NCT00414128|Cyclophosphamide|cyclophosphamide|mesh-list
110297675|NCT00414128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110297681|NCT00414128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110297682|NCT00414128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110297683|NCT00414128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110297684|NCT00414128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110297685|NCT00414128|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110297686|NCT00414128|Antitubercular Agents|antitubercular agents|mesh-ancestor
110297687|NCT00414128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110297688|NCT00414128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110297689|NCT00414128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110297690|NCT04538365|Triclosan|triclosan|mesh-list
110297691|NCT04538365|Propranolol|propranolol|mesh-list
110297692|NCT04538365|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110297693|NCT04538365|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110297694|NCT04538365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110028598|NCT00558636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110297695|NCT04538365|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110297698|NCT04538365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110297699|NCT04538365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110297700|NCT04538365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110297701|NCT04538365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110297702|NCT04538365|Adrenergic Agents|adrenergic agents|mesh-ancestor
110297703|NCT04538365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110297704|NCT04538365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297705|NCT04538365|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110297706|NCT04538365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110297707|NCT04538365|Vasodilator Agents|vasodilator agents|mesh-ancestor
110297708|NCT00414245|Metformin|metformin|mesh-list
110297709|NCT00414245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110297710|NCT00414245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297711|NCT00269880|Heparin|heparin|mesh-list
110297712|NCT00269880|Abciximab|abciximab|mesh-list
110297713|NCT00269880|Anticoagulants|anticoagulants|mesh-ancestor
110279452|NCT00210210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110279453|NCT00476086|Gemcitabine|gemcitabine|mesh-list
110279454|NCT00476086|Oxaliplatin|oxaliplatin|mesh-list
110279455|NCT00476086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110279456|NCT00476086|Antimetabolites|antimetabolites|mesh-ancestor
110279457|NCT00476086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110279458|NCT00476086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110279459|NCT00476047|Tositumomab I-131|tositumomab i-131|mesh-list
110279460|NCT00476047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110279461|NCT00217191|Ibuprofen|ibuprofen|mesh-list
110297714|NCT00269880|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110297715|NCT00269880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110297716|NCT00269880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110297717|NCT00269880|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110297718|NCT00237653|Valganciclovir|valganciclovir|mesh-list
110297719|NCT00237653|Antiviral Agents|antiviral agents|mesh-ancestor
110297720|NCT00237653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110297721|NCT00269958|Epoetin Alfa|epoetin alfa|mesh-list
110297722|NCT00269958|Hematinics|hematinics|mesh-ancestor
110297723|NCT02215876|Cyclophosphamide|cyclophosphamide|mesh-list
110297724|NCT02215876|Doxorubicin|doxorubicin|mesh-list
110297725|NCT02215876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110297726|NCT02215876|Immunologic Factors|immunologic factors|mesh-ancestor
110297727|NCT02215876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297728|NCT02215876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110297729|NCT02215876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110297730|NCT02215876|Alkylating Agents|alkylating agents|mesh-ancestor
110297731|NCT02215876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110297732|NCT02215876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110297733|NCT02215876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110297734|NCT02215876|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110297735|NCT02215876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110297736|NCT02215876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110297737|NCT02215876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110297738|NCT00269997|Epoetin Alfa|epoetin alfa|mesh-list
110297739|NCT00269997|Hematinics|hematinics|mesh-ancestor
110297740|NCT00237731|Morphine|morphine|mesh-list
110297741|NCT00237731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110297742|NCT00237731|Narcotics|narcotics|mesh-ancestor
110297743|NCT00237731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110297744|NCT00237731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297746|NCT00237731|Sensory System Agents|sensory system agents|mesh-ancestor
110297758|NCT04537780|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110297759|NCT04537780|Hormone Antagonists|hormone antagonists|mesh-ancestor
110297760|NCT04537780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110297761|NCT04537780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297762|NCT04537780|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110297763|NCT04537780|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110297764|NCT04537780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110297765|NCT00237887|Adalimumab|adalimumab|mesh-list
110297766|NCT00237887|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110297767|NCT00237887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110297768|NCT00237887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110297769|NCT02215993|Ticagrelor|ticagrelor|mesh-list
110297770|NCT02215993|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110297771|NCT02215993|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110297772|NCT02215993|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110297773|NCT02215993|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110297774|NCT02215993|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110297775|NCT02215993|Purinergic Agents|purinergic agents|mesh-ancestor
110297776|NCT02215993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110279462|NCT00217191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110279463|NCT00217191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110279464|NCT00217191|Analgesics|analgesics|mesh-ancestor
110279465|NCT00217191|Sensory System Agents|sensory system agents|mesh-ancestor
110279466|NCT00217191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110297777|NCT02215993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110297778|NCT02215993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297780|NCT02216149|Tegafur|tegafur|mesh-list
110297781|NCT02216149|Oxaliplatin|oxaliplatin|mesh-list
110297782|NCT02216149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110297783|NCT02216149|Antimetabolites|antimetabolites|mesh-ancestor
110297784|NCT02216149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110297785|NCT02216149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110297786|NCT00238004|Nicotinic Acids|nicotinic acids|mesh-list
110297788|NCT00238004|Niacinamide|niacinamide|mesh-list
110297789|NCT00238004|Vitamin B Complex|vitamin b complex|mesh-ancestor
110297790|NCT00238004|Vitamins|vitamins|mesh-ancestor
110297791|NCT00238004|Micronutrients|micronutrients|mesh-ancestor
110297792|NCT00238004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297793|NCT00238004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110297794|NCT00238004|Antimetabolites|antimetabolites|mesh-ancestor
110297795|NCT00238004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110297796|NCT00238004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110297797|NCT00238004|Vasodilator Agents|vasodilator agents|mesh-ancestor
110297798|NCT00262548|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110297799|NCT00262548|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110297800|NCT00262548|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110297801|NCT00262548|Antimetabolites|antimetabolites|mesh-ancestor
110017885|NCT03219294|Bromides|bromides|mesh-list
110297802|NCT00262548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110297803|NCT00262548|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110297804|NCT00262548|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110297805|NCT00262548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110297806|NCT00238043|Epoetin Alfa|epoetin alfa|mesh-list
110297807|NCT00238043|Hematinics|hematinics|mesh-ancestor
110297808|NCT00415584|Cinacalcet|cinacalcet|mesh-list
110297809|NCT00415584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110297810|NCT00415584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297811|NCT00415584|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
110297812|NCT00415584|Hormone Antagonists|hormone antagonists|mesh-ancestor
110297815|NCT04536922|Cyclophosphamide|cyclophosphamide|mesh-list
110297816|NCT04536922|Pembrolizumab|pembrolizumab|mesh-list
110297817|NCT04536922|Fludarabine|fludarabine|mesh-list
110297818|NCT04536922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110297819|NCT04536922|Immunologic Factors|immunologic factors|mesh-ancestor
110297820|NCT04536922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297821|NCT04536922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110297822|NCT04536922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110297823|NCT04536922|Alkylating Agents|alkylating agents|mesh-ancestor
110297824|NCT04536922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110297825|NCT04536922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110297826|NCT04536922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110297827|NCT04536922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110297828|NCT04536922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110297829|NCT04536922|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110297830|NCT04536922|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110297831|NCT04536922|Antiviral Agents|antiviral agents|mesh-ancestor
110297832|NCT04536922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110297833|NCT04536961|Deucravacitinib|deucravacitinib|mesh-list
110297834|NCT04536961|Famotidine|famotidine|mesh-list
110017904|NCT03223272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110297836|NCT04536961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110297837|NCT04536961|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110297838|NCT04536961|Histamine Antagonists|histamine antagonists|mesh-ancestor
110297839|NCT04536961|Histamine Agents|histamine agents|mesh-ancestor
110297840|NCT04536961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110297841|NCT04536961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110297842|NCT04536961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297843|NCT04536961|Dermatologic Agents|dermatologic agents|mesh-ancestor
110297844|NCT04536961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110279467|NCT00217191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110279468|NCT00217191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110279469|NCT00217191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110279470|NCT00217191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110279471|NCT00217191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110279472|NCT00217191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110279474|NCT00476008|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110279475|NCT00476008|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110279476|NCT00476008|Dopamine Agents|dopamine agents|mesh-ancestor
110279477|NCT00476008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110279478|NCT00476008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110279479|NCT00476008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297845|NCT04536961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110297846|NCT00238160|Fluorouracil|fluorouracil|mesh-list
110297847|NCT00238160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110297848|NCT00238160|Antimetabolites|antimetabolites|mesh-ancestor
110297849|NCT00238160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110297850|NCT00238160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110297851|NCT00238160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110297852|NCT00238160|Immunologic Factors|immunologic factors|mesh-ancestor
110297853|NCT00238160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297854|NCT00415701|Hydrocortisone|hydrocortisone|mesh-list
110297855|NCT00415701|Propofol|propofol|mesh-list
110297856|NCT00415701|Etomidate|etomidate|mesh-list
110297857|NCT00415701|Cosyntropin|cosyntropin|mesh-list
110297858|NCT00415701|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110297859|NCT00415701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110297860|NCT00415701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297861|NCT00415701|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110297862|NCT00415701|Anesthetics, General|anesthetics, general|mesh-ancestor
110297863|NCT00415701|Anesthetics|anesthetics|mesh-ancestor
110297864|NCT00415701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110297865|NCT00415701|Hormones|hormones|mesh-ancestor
110297866|NCT00415701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110297867|NCT02961998|Celecoxib|celecoxib|mesh-list
110297868|NCT02961998|Sorafenib|sorafenib|mesh-list
110297869|NCT02961998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110297870|NCT02961998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110297871|NCT02961998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110297872|NCT02961998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110297873|NCT02961998|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110297874|NCT02961998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110297875|NCT02961998|Analgesics|analgesics|mesh-ancestor
110297876|NCT02961998|Sensory System Agents|sensory system agents|mesh-ancestor
110297877|NCT02961998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110017948|NCT03285984|Fluorides|fluorides|mesh-list
110017949|NCT03285984|Sodium Fluoride|sodium fluoride|mesh-list
110297878|NCT02961998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297879|NCT02961998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110297880|NCT02961998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110297881|NCT02961998|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110297882|NCT02961998|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110297884|NCT04536415|Antiviral Agents|antiviral agents|mesh-ancestor
110297885|NCT04536415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110297890|NCT00262587|Autonomic Agents|autonomic agents|mesh-ancestor
110297891|NCT00262587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110297892|NCT00262587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297893|NCT00262587|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110297894|NCT00262587|Respiratory System Agents|respiratory system agents|mesh-ancestor
110297895|NCT00262587|Glucocorticoids|glucocorticoids|mesh-ancestor
110279480|NCT00476008|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110279481|NCT00476008|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110279482|NCT00412035|Botulinum Toxins|botulinum toxins|mesh-list
110279483|NCT00412035|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110279484|NCT00412035|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110279485|NCT00412035|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110279486|NCT00412035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110279487|NCT00412035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110279488|NCT00412035|Cholinergic Agents|cholinergic agents|mesh-ancestor
110279489|NCT00412035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110279490|NCT00412035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110279491|NCT00412035|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110279492|NCT00412035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110297896|NCT00262587|Hormones|hormones|mesh-ancestor
110297897|NCT00262587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110297898|NCT00262587|Sympathomimetics|sympathomimetics|mesh-ancestor
110297900|NCT00238199|Docetaxel|docetaxel|mesh-list
110297901|NCT00238199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110297902|NCT00238199|Tubulin Modulators|tubulin modulators|mesh-ancestor
110297903|NCT00238199|Antimitotic Agents|antimitotic agents|mesh-ancestor
110297904|NCT00238199|Mitosis Modulators|mitosis modulators|mesh-ancestor
110297905|NCT00238199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110297906|NCT00238199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110297907|NCT00238199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297908|NCT00238199|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110297909|NCT00238199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110297910|NCT00238199|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110297911|NCT00238199|Vitamins|vitamins|mesh-ancestor
110297912|NCT00238199|Micronutrients|micronutrients|mesh-ancestor
110297913|NCT00238199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110297914|NCT04536493|Lidocaine|lidocaine|mesh-list
110297915|NCT04536493|Epinephrine|epinephrine|mesh-list
110297916|NCT04536493|Racepinephrine|racepinephrine|mesh-list
110297917|NCT04536493|Tetracaine|tetracaine|mesh-list
110297918|NCT04536493|Epinephryl borate|epinephryl borate|mesh-list
110297919|NCT04536493|Anesthetics, Local|anesthetics, local|mesh-ancestor
110297920|NCT04536493|Anesthetics|anesthetics|mesh-ancestor
110297921|NCT04536493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110297922|NCT04536493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297924|NCT04536493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110297925|NCT04536493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110297926|NCT04536493|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110297927|NCT04536493|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110297928|NCT04536493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110297929|NCT04536493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110017965|NCT03287310|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110297930|NCT04536493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110297931|NCT04536493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110297932|NCT04536493|Adrenergic Agents|adrenergic agents|mesh-ancestor
110297933|NCT04536493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110297934|NCT04536493|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110297935|NCT04536493|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110297936|NCT04536493|Autonomic Agents|autonomic agents|mesh-ancestor
110297937|NCT04536493|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110297938|NCT04536493|Respiratory System Agents|respiratory system agents|mesh-ancestor
110297939|NCT04536493|Mydriatics|mydriatics|mesh-ancestor
110297940|NCT04536493|Sympathomimetics|sympathomimetics|mesh-ancestor
110297941|NCT04536493|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110297942|NCT04536181|Prednisone|prednisone|mesh-list
110297943|NCT04536181|Prednisolone|prednisolone|mesh-list
110297944|NCT04536181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110297945|NCT04536181|Glucocorticoids|glucocorticoids|mesh-ancestor
110279493|NCT00183833|Capecitabine|capecitabine|mesh-list
110279494|NCT00183833|Imatinib Mesylate|imatinib mesylate|mesh-list
110279495|NCT00183833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110279496|NCT00183833|Antimetabolites|antimetabolites|mesh-ancestor
110279497|NCT00183833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110279498|NCT00183833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110279499|NCT00183833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110279500|NCT00183833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110279501|NCT00183911|Leucovorin|leucovorin|mesh-list
110279502|NCT00183911|Fluorouracil|fluorouracil|mesh-list
110279503|NCT00183911|Floxuridine|floxuridine|mesh-list
110279504|NCT00183911|Antimetabolites|antimetabolites|mesh-ancestor
110279505|NCT00183911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110279506|NCT00183911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110279507|NCT00183911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110279508|NCT00183911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110279509|NCT00183911|Immunologic Factors|immunologic factors|mesh-ancestor
110279510|NCT00183911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110279511|NCT00183911|Antidotes|antidotes|mesh-ancestor
110279512|NCT00183911|Protective Agents|protective agents|mesh-ancestor
110279513|NCT00183911|Vitamin B Complex|vitamin b complex|mesh-ancestor
110297946|NCT04536181|Hormones|hormones|mesh-ancestor
110297947|NCT04536181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110297948|NCT04536181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297949|NCT04536181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110297950|NCT04536181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110297951|NCT04535869|Sofosbuvir|sofosbuvir|mesh-list
110297952|NCT04535869|Antiviral Agents|antiviral agents|mesh-ancestor
110297953|NCT04535869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110297955|NCT02216227|Chlorhexidine|chlorhexidine|mesh-list
110297956|NCT02216227|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110297957|NCT02216227|Povidone-Iodine|povidone-iodine|mesh-list
110297958|NCT02216227|Vancomycin|vancomycin|mesh-list
110297965|NCT02216227|Dermatologic Agents|dermatologic agents|mesh-ancestor
110297967|NCT02216227|Micronutrients|micronutrients|mesh-ancestor
110297968|NCT02216227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297969|NCT02216227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110297970|NCT02216227|Plasma Substitutes|plasma substitutes|mesh-ancestor
110297971|NCT02216227|Blood Substitutes|blood substitutes|mesh-ancestor
110297972|NCT02216227|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110297973|NCT02216227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110297974|NCT02216227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110297976|NCT00238277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110297977|NCT00238277|Alkylating Agents|alkylating agents|mesh-ancestor
110297978|NCT00238277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110297979|NCT00238277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110297980|NCT02216266|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110297981|NCT02216266|Physostigmine|physostigmine|mesh-list
110297982|NCT02216266|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110297983|NCT02216266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110297984|NCT02216266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110297985|NCT02216266|Cholinergic Agents|cholinergic agents|mesh-ancestor
110279515|NCT00183911|Micronutrients|micronutrients|mesh-ancestor
110279516|NCT00412152|Oxycodone|oxycodone|mesh-list
110279517|NCT00412152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110279518|NCT00412152|Narcotics|narcotics|mesh-ancestor
110279519|NCT00412152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110279520|NCT00412152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110279521|NCT00412152|Analgesics|analgesics|mesh-ancestor
110279522|NCT00412152|Sensory System Agents|sensory system agents|mesh-ancestor
110279523|NCT00412152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110279525|NCT02963402|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110279526|NCT02963402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110279527|NCT02963402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110297986|NCT02216266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110297987|NCT02216266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297988|NCT02216266|Miotics|miotics|mesh-ancestor
110297989|NCT02216266|Autonomic Agents|autonomic agents|mesh-ancestor
110297990|NCT02216266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110297991|NCT00238316|Letrozole|letrozole|mesh-list
110297992|NCT00238316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110297993|NCT00238316|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110297994|NCT00238316|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110297995|NCT00238316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110297996|NCT00238316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110297997|NCT00238316|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110297998|NCT00238316|Hormone Antagonists|hormone antagonists|mesh-ancestor
110297999|NCT00238316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110298000|NCT00238316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110298001|NCT04535518|Aspirin|aspirin|mesh-list
110298002|NCT04535518|Infliximab|infliximab|mesh-list
110298003|NCT04535518|Immunoglobulins|immunoglobulins|mesh-list
110298004|NCT04535518|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110298005|NCT04535518|gamma-Globulins|gamma-globulins|mesh-list
110298006|NCT04535518|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110298007|NCT04535518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110298008|NCT04535518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110298009|NCT04535518|Analgesics|analgesics|mesh-ancestor
110298010|NCT04535518|Sensory System Agents|sensory system agents|mesh-ancestor
110298011|NCT04535518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110298012|NCT04535518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110298013|NCT04535518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110298014|NCT04535518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110298015|NCT04535518|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110298016|NCT04535518|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110298017|NCT04535518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110298018|NCT04535518|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110017998|NCT03336450|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110298019|NCT04535518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110298020|NCT04535518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110298021|NCT04535518|Antipyretics|antipyretics|mesh-ancestor
110298022|NCT04535518|Immunologic Factors|immunologic factors|mesh-ancestor
110298023|NCT04535518|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110298024|NCT04535518|Dermatologic Agents|dermatologic agents|mesh-ancestor
110298025|NCT04535518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110298026|NCT02216383|Oxytocin|oxytocin|mesh-list
110298027|NCT02216383|Carbetocin|carbetocin|mesh-list
110298028|NCT02216383|Syntometrine|syntometrine|mesh-list
110298029|NCT02216383|Ergonovine|ergonovine|mesh-list
110298032|NCT02216383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110298033|NCT00262782|Fludarabine|fludarabine|mesh-list
110298034|NCT00262782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110298036|NCT00238394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110298037|NCT00238394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110298038|NCT00238394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110279528|NCT00210327|Bortezomib|bortezomib|mesh-list
110279529|NCT00210327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110279530|NCT00425516|Cyclophosphamide|cyclophosphamide|mesh-list
110279531|NCT00425516|Docetaxel|docetaxel|mesh-list
110279532|NCT00425516|Fluorouracil|fluorouracil|mesh-list
110279533|NCT00425516|Epirubicin|epirubicin|mesh-list
110279534|NCT00425516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110279535|NCT00425516|Immunologic Factors|immunologic factors|mesh-ancestor
110279536|NCT00425516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110279537|NCT00425516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110279538|NCT00425516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110279539|NCT00425516|Alkylating Agents|alkylating agents|mesh-ancestor
110279540|NCT00425516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110279541|NCT00425516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110279542|NCT00425516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110279543|NCT00425516|Tubulin Modulators|tubulin modulators|mesh-ancestor
110279544|NCT00425516|Antimitotic Agents|antimitotic agents|mesh-ancestor
110279545|NCT00425516|Mitosis Modulators|mitosis modulators|mesh-ancestor
110279546|NCT00425516|Antimetabolites|antimetabolites|mesh-ancestor
110279547|NCT00425516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110279548|NCT00425516|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110279549|NCT00425516|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110279550|NCT00425516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110279551|NCT00425516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110298039|NCT00238394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110298040|NCT00238472|Nateglinide|nateglinide|mesh-list
110298041|NCT00238472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110298042|NCT00238472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110298043|NCT00238628|Bexarotene|bexarotene|mesh-list
110298044|NCT00238628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110298045|NCT02216617|Docetaxel|docetaxel|mesh-list
110298046|NCT02216617|Afatinib|afatinib|mesh-list
110298047|NCT02216617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110298048|NCT02216617|Tubulin Modulators|tubulin modulators|mesh-ancestor
110298049|NCT02216617|Antimitotic Agents|antimitotic agents|mesh-ancestor
110298050|NCT02216617|Mitosis Modulators|mitosis modulators|mesh-ancestor
110298051|NCT02216617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110298052|NCT02216617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110298053|NCT02216617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110298054|NCT00262977|Aspirin|aspirin|mesh-list
110298055|NCT00262977|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110298056|NCT00262977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110298057|NCT00262977|Analgesics|analgesics|mesh-ancestor
110298058|NCT00262977|Sensory System Agents|sensory system agents|mesh-ancestor
110018016|NCT03341910|Vitamins|vitamins|mesh-ancestor
110298059|NCT00262977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110298060|NCT00262977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110298061|NCT00262977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110298062|NCT00262977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110298063|NCT00262977|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110298064|NCT00262977|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110298065|NCT00262977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110298066|NCT00262977|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110298067|NCT00262977|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110279553|NCT00412191|Anticonvulsants|anticonvulsants|mesh-ancestor
110279554|NCT00412191|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110279555|NCT00412191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110279556|NCT00412191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110279557|NCT00412191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110279558|NCT00412191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110279559|NCT00412191|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110279560|NCT00412191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110279561|NCT00412191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110279562|NCT00412191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110279563|NCT00412191|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110298068|NCT00262977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110298069|NCT00262977|Antipyretics|antipyretics|mesh-ancestor
110298070|NCT00238667|Aspirin|aspirin|mesh-list
110298071|NCT00238667|Heparin|heparin|mesh-list
110298072|NCT00238667|Calcium heparin|calcium heparin|mesh-list
110298073|NCT00238667|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110298074|NCT00238667|Dalteparin|dalteparin|mesh-list
110298075|NCT00238667|Dipyridamole|dipyridamole|mesh-list
110298076|NCT00238667|Warfarin|warfarin|mesh-list
110298077|NCT00238667|Anticoagulants|anticoagulants|mesh-list
110298078|NCT00238667|Clopidogrel|clopidogrel|mesh-list
110298079|NCT00238667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110298080|NCT00238667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110298081|NCT00238667|Analgesics|analgesics|mesh-ancestor
110298082|NCT00238667|Sensory System Agents|sensory system agents|mesh-ancestor
110298083|NCT00238667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110298084|NCT00238667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110298085|NCT00238667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110298086|NCT00238667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110298087|NCT00238667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110298088|NCT00238667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110298089|NCT00238667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110298090|NCT00238667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110298091|NCT00238667|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110298092|NCT00238667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110298093|NCT00238667|Antipyretics|antipyretics|mesh-ancestor
110298094|NCT00238667|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110298095|NCT00238667|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110298096|NCT00238667|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110298097|NCT00238667|Purinergic Agents|purinergic agents|mesh-ancestor
110298098|NCT00238667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110298099|NCT00238667|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110298100|NCT00238667|Vasodilator Agents|vasodilator agents|mesh-ancestor
110298101|NCT00263016|Docetaxel|docetaxel|mesh-list
110298102|NCT00263016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110298103|NCT00263016|Tubulin Modulators|tubulin modulators|mesh-ancestor
110298104|NCT00263016|Antimitotic Agents|antimitotic agents|mesh-ancestor
110298109|NCT04534465|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110298110|NCT04534465|Diuretics|diuretics|mesh-ancestor
110298111|NCT04534465|Natriuretic Agents|natriuretic agents|mesh-ancestor
110298112|NCT04534465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110298113|NCT04534465|Laxatives|laxatives|mesh-ancestor
110298114|NCT04534465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110298115|NCT02216656|Cinacalcet|cinacalcet|mesh-list
110298116|NCT02216656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110298117|NCT02216656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110298118|NCT02216656|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
110298119|NCT02216656|Hormone Antagonists|hormone antagonists|mesh-ancestor
110298120|NCT02216656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110298121|NCT00263055|Oxaliplatin|oxaliplatin|mesh-list
110298122|NCT00263055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110298123|NCT00238745|Bazedoxifene|bazedoxifene|mesh-list
110279565|NCT00183950|Antitussive Agents|antitussive agents|mesh-ancestor
110279566|NCT00183950|Respiratory System Agents|respiratory system agents|mesh-ancestor
110279567|NCT00210366|Idarubicin|idarubicin|mesh-list
110279568|NCT00210366|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110279569|NCT00210366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110279570|NCT00210366|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110279571|NCT00210366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110279572|NCT00210366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110279573|NCT00210366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110279574|NCT00408785|Botulinum Toxins|botulinum toxins|mesh-list
110279575|NCT00408785|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110279576|NCT00408785|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110279577|NCT00408785|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110279578|NCT00408785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110279579|NCT00408785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110279580|NCT00408785|Cholinergic Agents|cholinergic agents|mesh-ancestor
110298124|NCT00238745|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110298125|NCT00238745|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110298126|NCT00238745|Hormone Antagonists|hormone antagonists|mesh-ancestor
110298127|NCT00238745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110298128|NCT00238745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110298129|NCT00238745|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110298131|NCT04534231|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110298132|NCT04534231|Autonomic Agents|autonomic agents|mesh-ancestor
110298133|NCT04534231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110018041|NCT03395808|Tramadol|tramadol|mesh-list
110298134|NCT04534231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110298136|NCT04534231|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110298137|NCT04534231|Cholinergic Agents|cholinergic agents|mesh-ancestor
110298138|NCT04534231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110298139|NCT04534231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110298140|NCT00263094|Rofecoxib|rofecoxib|mesh-list
110298141|NCT00263094|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110298142|NCT00263094|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110298143|NCT00263094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110298144|NCT00263094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110298145|NCT00263094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110298146|NCT00263094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110298147|NCT00263094|Analgesics|analgesics|mesh-ancestor
110298148|NCT00263094|Sensory System Agents|sensory system agents|mesh-ancestor
110298149|NCT00263094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110029045|NCT05767515|Vitamins|vitamins|mesh-ancestor
110298150|NCT00263094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110298151|NCT00263094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110298152|NCT00263094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110298153|NCT00238784|Budesonide|budesonide|mesh-list
110298154|NCT00238784|Formoterol Fumarate|formoterol fumarate|mesh-list
110298155|NCT00238784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110298156|NCT00238784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110298157|NCT00238784|Autonomic Agents|autonomic agents|mesh-ancestor
110298158|NCT00238784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110298159|NCT00238784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110298160|NCT00238784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110298161|NCT00238784|Respiratory System Agents|respiratory system agents|mesh-ancestor
110279581|NCT00408785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110279582|NCT00408785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110279583|NCT00408785|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110279584|NCT00408785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110279585|NCT00475735|Methylphenidate|methylphenidate|mesh-list
110279586|NCT00475735|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110279587|NCT00475735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110279588|NCT00475735|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110279589|NCT00475735|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110298162|NCT00238784|Glucocorticoids|glucocorticoids|mesh-ancestor
110298163|NCT00238784|Hormones|hormones|mesh-ancestor
110298164|NCT00238784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110298165|NCT00238784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110298166|NCT00238784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110298167|NCT00238784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110298168|NCT00238784|Adrenergic Agents|adrenergic agents|mesh-ancestor
110298169|NCT00238784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110298170|NCT00238784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110298171|NCT00263133|Sertraline|sertraline|mesh-list
110018085|NCT03448068|Ketamine|ketamine|mesh-list
110298172|NCT00263133|Antidepressive Agents|antidepressive agents|mesh-ancestor
110298173|NCT00263133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110298177|NCT00263133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110298179|NCT00263133|Serotonin Agents|serotonin agents|mesh-ancestor
110298180|NCT00263133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110298181|NCT04533724|Amisulpride|amisulpride|mesh-list
110298182|NCT04533724|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110298183|NCT04533724|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110298184|NCT04533724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110298185|NCT04533724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110298186|NCT04533724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110298187|NCT04533724|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110298188|NCT04533724|Dopamine Agents|dopamine agents|mesh-ancestor
110298189|NCT04533724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110298190|NCT04533724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110298191|NCT04533724|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110298192|NCT04533724|Antidepressive Agents|antidepressive agents|mesh-ancestor
110298193|NCT00238901|Basiliximab|basiliximab|mesh-list
110298194|NCT00238901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110298195|NCT00238901|Immunologic Factors|immunologic factors|mesh-ancestor
110298196|NCT00238901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110298197|NCT00238940|Mycophenolic Acid|mycophenolic acid|mesh-list
110298198|NCT00238940|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110298199|NCT00238940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110298200|NCT00238940|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110298201|NCT00238940|Antitubercular Agents|antitubercular agents|mesh-ancestor
110298202|NCT00238940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110298203|NCT00238940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110298204|NCT00238940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110298205|NCT00238940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110298206|NCT00238979|Mycophenolic Acid|mycophenolic acid|mesh-list
110298207|NCT00238979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110298208|NCT00238979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110298209|NCT00238979|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110298210|NCT00238979|Antitubercular Agents|antitubercular agents|mesh-ancestor
110298211|NCT00238979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110298212|NCT00238979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110298213|NCT00238979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110298214|NCT00238979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110298215|NCT00239018|Mycophenolic Acid|mycophenolic acid|mesh-list
110298216|NCT00239018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110279590|NCT00475735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110018103|NCT03459612|Promethazine|promethazine|mesh-list
110279591|NCT00475735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110279592|NCT00475735|Dopamine Agents|dopamine agents|mesh-ancestor
110279593|NCT00475735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110279594|NCT00475657|Pemetrexed|pemetrexed|mesh-list
110279595|NCT00475657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110279596|NCT00475657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110279597|NCT00475657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110279598|NCT00475657|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110279599|NCT00475657|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110279600|NCT00210405|Micronutrients|micronutrients|mesh-list
110279601|NCT00210405|Trace Elements|trace elements|mesh-list
110279602|NCT00210405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110279603|NCT00408941|Propofol|propofol|mesh-list
110279604|NCT00408941|Prilocaine|prilocaine|mesh-list
110279605|NCT00408941|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110279606|NCT00408941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110279607|NCT00408941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110279608|NCT00408941|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110298217|NCT00239018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110298218|NCT00239018|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110298219|NCT00239018|Antitubercular Agents|antitubercular agents|mesh-ancestor
110298220|NCT00239018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110298221|NCT00239018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110298222|NCT00239018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110298223|NCT00239018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110298225|NCT04532671|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110298226|NCT04532671|Anesthetics, General|anesthetics, general|mesh-ancestor
110298227|NCT04532671|Anesthetics|anesthetics|mesh-ancestor
110298228|NCT04532671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110298229|NCT04532671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110298230|NCT00239057|Mycophenolic Acid|mycophenolic acid|mesh-list
110298231|NCT00239057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110298232|NCT00239057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110298233|NCT00239057|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110298234|NCT00239057|Antitubercular Agents|antitubercular agents|mesh-ancestor
110298235|NCT00239057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110298236|NCT00239057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110298237|NCT00239057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110298238|NCT00239057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110298239|NCT00238082|Beclomethasone|beclomethasone|mesh-list
110298240|NCT00238082|Norflurane|norflurane|mesh-list
110298241|NCT00238082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110298242|NCT00238082|Glucocorticoids|glucocorticoids|mesh-ancestor
110298244|NCT00238082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110298245|NCT00238082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110298247|NCT00238082|Respiratory System Agents|respiratory system agents|mesh-ancestor
110298248|NCT00238082|Anesthetics|anesthetics|mesh-ancestor
110298249|NCT00238082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110298250|NCT02217007|Calcium, Dietary|calcium, dietary|mesh-list
110298251|NCT02217007|Acamprosate|acamprosate|mesh-list
110298252|NCT02217007|Calcium|calcium|mesh-list
110298253|NCT02217007|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110298254|NCT02217007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110279609|NCT00408941|Anesthetics, General|anesthetics, general|mesh-ancestor
110279610|NCT00408941|Anesthetics|anesthetics|mesh-ancestor
110279611|NCT00408941|Anesthetics, Local|anesthetics, local|mesh-ancestor
110279612|NCT00408941|Sensory System Agents|sensory system agents|mesh-ancestor
110279613|NCT00408941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110279614|NCT00475423|Rituximab|rituximab|mesh-list
110279615|NCT00475423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110018137|NCT03496974|Antibodies|antibodies|mesh-list
110279616|NCT00475423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110279617|NCT00475423|Immunologic Factors|immunologic factors|mesh-ancestor
110279618|NCT00475423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110279619|NCT00475423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110279620|NCT00210444|Botulinum Toxins|botulinum toxins|mesh-list
110279621|NCT00210444|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110279622|NCT00210444|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110298255|NCT02217007|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110298256|NCT02217007|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110298257|NCT05897385|Lidocaine|lidocaine|mesh-list
110298258|NCT05897385|Anesthetics, Local|anesthetics, local|mesh-ancestor
110298259|NCT05897385|Anesthetics|anesthetics|mesh-ancestor
110298260|NCT05897385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110298261|NCT05897385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110298262|NCT05897385|Sensory System Agents|sensory system agents|mesh-ancestor
110298263|NCT05897385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110298264|NCT05897385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110298265|NCT05897385|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110298266|NCT05897385|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110298267|NCT05897385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110298268|NCT05897385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110298269|NCT05897372|Pentoxifylline|pentoxifylline|mesh-list
110298270|NCT05897372|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110298271|NCT05897372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110298272|NCT05897372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110298273|NCT05897372|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110298274|NCT05897372|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110298275|NCT05897372|Protective Agents|protective agents|mesh-ancestor
110298276|NCT05897372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110298277|NCT05897372|Vasodilator Agents|vasodilator agents|mesh-ancestor
110298278|NCT05897372|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110298279|NCT05897372|Antioxidants|antioxidants|mesh-ancestor
110298280|NCT05897294|Voriconazole|voriconazole|mesh-list
110298281|NCT05897294|Antifungal Agents|antifungal agents|mesh-ancestor
110298282|NCT05897294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110298283|NCT05897294|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110298284|NCT05897294|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110298285|NCT05897294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110298286|NCT05897294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110298287|NCT05897294|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110298288|NCT05897294|Hormone Antagonists|hormone antagonists|mesh-ancestor
110298289|NCT05897294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110298290|NCT05897294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110298291|NCT05897294|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110298292|NCT05896943|Ustekinumab|ustekinumab|mesh-list
110298293|NCT05896943|Dermatologic Agents|dermatologic agents|mesh-ancestor
110018151|NCT03503292|Dermatologic Agents|dermatologic agents|mesh-ancestor
110018157|NCT03506724|Labetalol|labetalol|mesh-list
110298294|NCT05896930|Amoxicillin|amoxicillin|mesh-list
110298295|NCT05896930|Rifampin|rifampin|mesh-list
110298296|NCT05896930|Meropenem|meropenem|mesh-list
110298298|NCT05896930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110298299|NCT05896930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110298300|NCT05896930|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110298301|NCT05896930|Antitubercular Agents|antitubercular agents|mesh-ancestor
110298302|NCT05896930|Leprostatic Agents|leprostatic agents|mesh-ancestor
110279623|NCT00210444|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110279624|NCT00210444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110279625|NCT00210444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110279627|NCT00210444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110279628|NCT00210444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110279629|NCT00210444|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110279630|NCT00210444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110279631|NCT00475306|Diphenhydramine|diphenhydramine|mesh-list
110279632|NCT00475306|Promethazine|promethazine|mesh-list
110298303|NCT05896930|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110298304|NCT05896930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110298305|NCT05896930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110298306|NCT05896930|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110298307|NCT05896930|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110298308|NCT05896930|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110298309|NCT05896930|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110298310|NCT05896930|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110298311|NCT05896930|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110298312|NCT05896800|Nitric Oxide|nitric oxide|mesh-list
110298313|NCT05896800|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110298314|NCT05896800|Autonomic Agents|autonomic agents|mesh-ancestor
110298318|NCT05896800|Respiratory System Agents|respiratory system agents|mesh-ancestor
110298319|NCT05896800|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110298320|NCT05896800|Antioxidants|antioxidants|mesh-ancestor
110298321|NCT05896800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110298322|NCT05896800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110298323|NCT05896800|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110298324|NCT05896800|Vasodilator Agents|vasodilator agents|mesh-ancestor
110298325|NCT05896800|Gasotransmitters|gasotransmitters|mesh-ancestor
110018176|NCT03506724|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110298328|NCT05896787|Carboplatin|carboplatin|mesh-list
110298329|NCT05896787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110298330|NCT05896787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110298331|NCT05896787|Tubulin Modulators|tubulin modulators|mesh-ancestor
110298332|NCT05896787|Antimitotic Agents|antimitotic agents|mesh-ancestor
110298333|NCT05896787|Mitosis Modulators|mitosis modulators|mesh-ancestor
110298334|NCT05896787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110298335|NCT05896748|Rilpivirine|rilpivirine|mesh-list
110298336|NCT05896748|Cabotegravir|cabotegravir|mesh-list
110298337|NCT05896748|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110298338|NCT05896748|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110298339|NCT05896748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110298340|NCT05896748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110298341|NCT05896748|Antiviral Agents|antiviral agents|mesh-ancestor
110298342|NCT05896748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110298343|NCT05896748|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110298344|NCT05896748|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110298345|NCT05896748|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110298346|NCT05896748|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110298347|NCT05896631|Bupivacaine|bupivacaine|mesh-list
110298348|NCT05896631|Anesthetics, Local|anesthetics, local|mesh-ancestor
110298349|NCT05896631|Anesthetics|anesthetics|mesh-ancestor
110298350|NCT05896631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110298351|NCT05896631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110298352|NCT05896631|Sensory System Agents|sensory system agents|mesh-ancestor
110298353|NCT05896631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110298354|NCT05896605|Azathioprine|azathioprine|mesh-list
110298355|NCT05896605|Antimetabolites|antimetabolites|mesh-ancestor
110298356|NCT05896605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110298357|NCT05896605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110279634|NCT00475306|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110279635|NCT00475306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110279636|NCT00475306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110279637|NCT00475306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110279638|NCT00475306|Anesthetics, Local|anesthetics, local|mesh-ancestor
110279639|NCT00475306|Anesthetics|anesthetics|mesh-ancestor
110279640|NCT00475306|Sensory System Agents|sensory system agents|mesh-ancestor
110279641|NCT00475306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110279642|NCT00475306|Antiemetics|antiemetics|mesh-ancestor
110279643|NCT00475306|Autonomic Agents|autonomic agents|mesh-ancestor
110279644|NCT00475306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110298358|NCT05896605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110298359|NCT05896605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110298360|NCT05896605|Immunologic Factors|immunologic factors|mesh-ancestor
110298361|NCT05896605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110298362|NCT05896605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110298363|NCT05896553|Oxytocin|oxytocin|mesh-list
110298364|NCT05896553|Oxytocics|oxytocics|mesh-ancestor
110298365|NCT05896553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110298366|NCT05896553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110298367|NCT05896462|Povidone-Iodine|povidone-iodine|mesh-list
110298368|NCT05896462|Povidone|povidone|mesh-list
110298369|NCT05896462|Plasma Substitutes|plasma substitutes|mesh-ancestor
110298370|NCT05896462|Blood Substitutes|blood substitutes|mesh-ancestor
110298371|NCT05896462|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110298372|NCT05896462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110298373|NCT05896449|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110298374|NCT05896449|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110298375|NCT05896449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110298376|NCT05896319|Hyaluronic Acid|hyaluronic acid|mesh-list
110298377|NCT05896319|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110298381|NCT05896319|Protective Agents|protective agents|mesh-ancestor
110298382|NCT05896059|Tislelizumab|tislelizumab|mesh-list
110298383|NCT05896059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110298384|NCT05896059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110298385|NCT05896033|Menthol|menthol|mesh-list
110298386|NCT05896033|Antipruritics|antipruritics|mesh-ancestor
110298414|NCT05893771|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110298415|NCT05893771|Protective Agents|protective agents|mesh-ancestor
110298416|NCT05893771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110298417|NCT05893771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110298418|NCT05876715|Nivolumab|nivolumab|mesh-list
110298419|NCT05876715|Ipilimumab|ipilimumab|mesh-list
110298420|NCT05876715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110298421|NCT05876715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110298422|NCT05876715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110298423|NCT05876715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110298426|NCT05853120|Doxycycline|doxycycline|mesh-list
110298427|NCT05853120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110298428|NCT05853120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110298429|NCT05853120|Antimalarials|antimalarials|mesh-ancestor
110298430|NCT05853120|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110298431|NCT05853120|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110298432|NCT05841160|Moxifloxacin|moxifloxacin|mesh-list
110298433|NCT05841160|Ecopipam|ecopipam|mesh-list
110298434|NCT05841160|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110298435|NCT05841160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110298436|NCT05841160|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110298463|NCT05815758|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110279646|NCT00475306|Histamine Antagonists|histamine antagonists|mesh-ancestor
110279647|NCT00475306|Histamine Agents|histamine agents|mesh-ancestor
110279648|NCT00475306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110279649|NCT00475306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110279650|NCT00475306|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110279651|NCT00475306|Antipruritics|antipruritics|mesh-ancestor
110279652|NCT00475306|Dermatologic Agents|dermatologic agents|mesh-ancestor
110279653|NCT00475306|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110279654|NCT00475306|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110279655|NCT00475306|Dopamine Agents|dopamine agents|mesh-ancestor
110279656|NCT00475228|Levonorgestrel|levonorgestrel|mesh-list
110279657|NCT00475228|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110279658|NCT00475228|Contraceptive Agents|contraceptive agents|mesh-ancestor
110279659|NCT00475228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110298464|NCT05815758|Histamine Antagonists|histamine antagonists|mesh-ancestor
110298465|NCT05815758|Histamine Agents|histamine agents|mesh-ancestor
110018229|NCT03610464|Sympathomimetics|sympathomimetics|mesh-ancestor
110298466|NCT05815758|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110298467|NCT05724849|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110298468|NCT05724849|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110298469|NCT05724849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110298470|NCT05724849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110298471|NCT05724849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110298472|NCT05724849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110298473|NCT05724849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110298474|NCT05724849|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110298475|NCT05724849|Antidepressive Agents|antidepressive agents|mesh-ancestor
110298476|NCT05724849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110298478|NCT05694533|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110298479|NCT05694533|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110298480|NCT05694533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110298481|NCT05694533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110298488|NCT05694533|GABA Modulators|gaba modulators|mesh-ancestor
110298489|NCT05694533|GABA Agents|gaba agents|mesh-ancestor
110298490|NCT05694533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110298491|NCT05694533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110298492|NCT05681390|Tislelizumab|tislelizumab|mesh-list
110018254|NCT03630198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110018255|NCT03630198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110298507|NCT05669079|Immunologic Factors|immunologic factors|mesh-ancestor
110298508|NCT05669079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110298509|NCT05669079|Hematinics|hematinics|mesh-ancestor
110279660|NCT00475228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110279661|NCT00475228|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110279662|NCT00475228|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110279663|NCT00475228|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110279665|NCT00183989|Fludarabine|fludarabine|mesh-list
110279666|NCT00183989|Mitoxantrone|mitoxantrone|mesh-list
110279667|NCT00183989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110279668|NCT00183989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110279669|NCT00183989|Immunologic Factors|immunologic factors|mesh-ancestor
110279670|NCT00183989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110279671|NCT00183989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110279672|NCT00183989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110279673|NCT00183989|Analgesics|analgesics|mesh-ancestor
110298524|NCT05611905|Probenecid|probenecid|mesh-list
110298525|NCT05611905|Uricosuric Agents|uricosuric agents|mesh-ancestor
110298526|NCT05611905|Gout Suppressants|gout suppressants|mesh-ancestor
110018304|NCT03716076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110298527|NCT05611905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110298529|NCT05586373|Ibuprofen|ibuprofen|mesh-list
110298530|NCT05586373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110298531|NCT05586373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110298532|NCT05586373|Analgesics|analgesics|mesh-ancestor
110298533|NCT05586373|Sensory System Agents|sensory system agents|mesh-ancestor
110298534|NCT05586373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110298535|NCT05586373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110298536|NCT05586373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110298537|NCT05586373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110298538|NCT05586373|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110298539|NCT05586373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110298540|NCT05586373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110298541|NCT05586373|Antipyretics|antipyretics|mesh-ancestor
110298542|NCT05579626|Ezetimibe|ezetimibe|mesh-list
110298543|NCT05579626|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
110298544|NCT05579626|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110298545|NCT05579626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110298546|NCT05579626|Antimetabolites|antimetabolites|mesh-ancestor
110298547|NCT05579626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110298548|NCT05579626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110298549|NCT05579626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110298550|NCT05442567|Vedolizumab|vedolizumab|mesh-list
110298551|NCT05442567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110298567|NCT05400122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110298568|NCT05400122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110298569|NCT05400122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110298570|NCT05400122|Antimetabolites|antimetabolites|mesh-ancestor
110298571|NCT05400122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110298572|NCT05400122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110279674|NCT00183989|Sensory System Agents|sensory system agents|mesh-ancestor
110279675|NCT00183989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110279676|NCT00183989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110279677|NCT00183989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110279678|NCT00183989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110279679|NCT00184067|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
110279680|NCT00184067|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110279681|NCT00184067|Immunologic Factors|immunologic factors|mesh-ancestor
110279682|NCT00184067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110279684|NCT00184106|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110279685|NCT00184106|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110279686|NCT00184106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110279687|NCT00184106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110056899|NCT01505088|Prednisolone|prednisolone|mesh-list
110279688|NCT00184106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110298573|NCT05386472|Ritonavir|ritonavir|mesh-list
110298574|NCT05386472|Nirmatrelvir|nirmatrelvir|mesh-list
110298575|NCT05386472|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110298576|NCT05386472|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110298577|NCT05386472|Protease Inhibitors|protease inhibitors|mesh-ancestor
110298578|NCT05386472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110298579|NCT05386472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110298580|NCT05386472|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110298581|NCT05386472|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110298582|NCT05386472|Antiviral Agents|antiviral agents|mesh-ancestor
110298583|NCT05386472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110298584|NCT05386472|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110298585|NCT05386472|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110298586|NCT05359939|Choline|choline|mesh-list
110298587|NCT05359939|Lipotropic Agents|lipotropic agents|mesh-ancestor
110298588|NCT05359939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110298589|NCT05359939|Antimetabolites|antimetabolites|mesh-ancestor
110298590|NCT05359939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110298591|NCT05359939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110298592|NCT05359939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110298593|NCT05359939|Nootropic Agents|nootropic agents|mesh-ancestor
110298594|NCT05251909|Benralizumab|benralizumab|mesh-list
110298595|NCT05251909|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110298596|NCT05251909|Respiratory System Agents|respiratory system agents|mesh-ancestor
110298597|NCT05250791|Lidocaine|lidocaine|mesh-list
110298598|NCT05250791|Anesthetics, Local|anesthetics, local|mesh-ancestor
110298599|NCT05250791|Anesthetics|anesthetics|mesh-ancestor
110298600|NCT05250791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110298601|NCT05250791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110298602|NCT05250791|Sensory System Agents|sensory system agents|mesh-ancestor
110298603|NCT05250791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110298604|NCT05250791|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110298605|NCT05250791|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110298606|NCT05250791|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110298607|NCT05250791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110298608|NCT05250791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110298609|NCT05241873|Carboplatin|carboplatin|mesh-list
110298610|NCT05241873|Pemetrexed|pemetrexed|mesh-list
110298611|NCT05241873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110298612|NCT05241873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110298636|NCT05085496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110298637|NCT05085496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110279689|NCT00184106|Serotonin Agents|serotonin agents|mesh-ancestor
110279690|NCT00184106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110279691|NCT00184106|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110279692|NCT00184106|Antidepressive Agents|antidepressive agents|mesh-ancestor
110279693|NCT00184106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110279694|NCT00184106|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110279695|NCT00184106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110279696|NCT00184106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110279697|NCT00210483|Almotriptan|almotriptan|mesh-list
110298638|NCT05085496|Immunologic Factors|immunologic factors|mesh-ancestor
110298639|NCT05085496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110298640|NCT05028062|Naltrexone|naltrexone|mesh-list
110298641|NCT05028062|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110298642|NCT05028062|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110298643|NCT05028062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110298644|NCT05028062|Sensory System Agents|sensory system agents|mesh-ancestor
110298645|NCT05028062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110298647|NCT04983836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110298648|NCT04983836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110298649|NCT04933383|Budesonide|budesonide|mesh-list
110298650|NCT04933383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110298651|NCT04933383|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110298652|NCT04933383|Autonomic Agents|autonomic agents|mesh-ancestor
110298653|NCT04933383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110298654|NCT04933383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110298655|NCT04933383|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110298656|NCT04933383|Respiratory System Agents|respiratory system agents|mesh-ancestor
110298657|NCT04933383|Glucocorticoids|glucocorticoids|mesh-ancestor
110298658|NCT04933383|Hormones|hormones|mesh-ancestor
110298659|NCT04933383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110298660|NCT04923776|Carboplatin|carboplatin|mesh-list
110298666|NCT04923776|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110298667|NCT04923776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110298668|NCT04923776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110298669|NCT04923776|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110298670|NCT04923776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110298671|NCT04899583|Sirolimus|sirolimus|mesh-list
110298672|NCT04899583|Paclitaxel|paclitaxel|mesh-list
110298673|NCT04899583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110298674|NCT04899583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110298676|NCT04899583|Antimitotic Agents|antimitotic agents|mesh-ancestor
110298677|NCT04899583|Mitosis Modulators|mitosis modulators|mesh-ancestor
110298678|NCT04899583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110298679|NCT04899583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110298680|NCT04899583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110298681|NCT04899583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110298682|NCT04899583|Antifungal Agents|antifungal agents|mesh-ancestor
110298683|NCT04899583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110298684|NCT04899583|Immunologic Factors|immunologic factors|mesh-ancestor
110298685|NCT04899583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110298686|NCT04884308|BCG Vaccine|bcg vaccine|mesh-list
110298687|NCT04884308|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110298688|NCT04884308|Immunologic Factors|immunologic factors|mesh-ancestor
110298689|NCT04884308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110298690|NCT04868565|Caffeine|caffeine|mesh-list
110298691|NCT04868565|Caffeine citrate|caffeine citrate|mesh-list
110298692|NCT04868565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110298693|NCT04868565|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110298694|NCT04868565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110298695|NCT04868565|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110298696|NCT04868565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110298697|NCT04868565|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110279698|NCT00210483|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110279699|NCT00210483|Serotonin Agents|serotonin agents|mesh-ancestor
110279700|NCT00210483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110279701|NCT00210483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110279702|NCT00210483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110279703|NCT00210561|Acetaminophen|acetaminophen|mesh-list
110279705|NCT00210561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110279706|NCT00210561|Analgesics|analgesics|mesh-ancestor
110279707|NCT00210561|Sensory System Agents|sensory system agents|mesh-ancestor
110279708|NCT00210561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110279709|NCT00210561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110279710|NCT00210561|Antipyretics|antipyretics|mesh-ancestor
110279711|NCT00210561|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110279712|NCT00210561|Narcotics|narcotics|mesh-ancestor
110279713|NCT00210561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110279714|NCT00210600|Epoetin Alfa|epoetin alfa|mesh-list
110279715|NCT00210600|Hematinics|hematinics|mesh-ancestor
110279716|NCT00217386|Etanercept|etanercept|mesh-list
110279717|NCT00217386|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110279718|NCT00217386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110279719|NCT00217386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110279720|NCT00217386|Analgesics|analgesics|mesh-ancestor
110279721|NCT00217386|Sensory System Agents|sensory system agents|mesh-ancestor
110279722|NCT00217386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110298698|NCT04868565|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110298699|NCT04868565|Purinergic Agents|purinergic agents|mesh-ancestor
110018369|NCT04284930|Bupivacaine|bupivacaine|mesh-list
110298700|NCT04868565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110298702|NCT04716881|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110298703|NCT04716881|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110298704|NCT04716881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110298705|NCT04716881|Sensory System Agents|sensory system agents|mesh-ancestor
110298706|NCT04716881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110298707|NCT04711824|Paclitaxel|paclitaxel|mesh-list
110298708|NCT04711824|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110298709|NCT04711824|Cisplatin|cisplatin|mesh-list
110298710|NCT04711824|Carboplatin|carboplatin|mesh-list
110298711|NCT04711824|Gemcitabine|gemcitabine|mesh-list
110298712|NCT04711824|Capecitabine|capecitabine|mesh-list
110298713|NCT04711824|Durvalumab|durvalumab|mesh-list
110298714|NCT04711824|Olaparib|olaparib|mesh-list
110298715|NCT04711824|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110298716|NCT04711824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110298717|NCT04711824|Tubulin Modulators|tubulin modulators|mesh-ancestor
110298718|NCT04711824|Antimitotic Agents|antimitotic agents|mesh-ancestor
110298719|NCT04711824|Mitosis Modulators|mitosis modulators|mesh-ancestor
110298720|NCT04711824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110298721|NCT04711824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110298722|NCT04711824|Antimetabolites|antimetabolites|mesh-ancestor
110298723|NCT04711824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110298724|NCT04711824|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110298725|NCT04711824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110279723|NCT00217386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110279724|NCT00217386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110279726|NCT00217386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110279727|NCT00217386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110279728|NCT00217386|Immunologic Factors|immunologic factors|mesh-ancestor
110279729|NCT00217503|Zidovudine|zidovudine|mesh-list
110279730|NCT00217503|Valganciclovir|valganciclovir|mesh-list
110279731|NCT00217503|Ganciclovir|ganciclovir|mesh-list
110279732|NCT00217503|Cyclophosphamide|cyclophosphamide|mesh-list
110279733|NCT00217503|Bevacizumab|bevacizumab|mesh-list
110279734|NCT00217503|Doxorubicin|doxorubicin|mesh-list
110279735|NCT00217503|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110279736|NCT00217503|Etoposide|etoposide|mesh-list
110279737|NCT00217503|Bortezomib|bortezomib|mesh-list
110279738|NCT00217503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110279739|NCT00217503|Immunologic Factors|immunologic factors|mesh-ancestor
110279740|NCT00217503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110279741|NCT00217503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110279742|NCT00217503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110279743|NCT00217503|Alkylating Agents|alkylating agents|mesh-ancestor
110279744|NCT00217503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110279745|NCT00217503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110279746|NCT00217503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110279747|NCT00217503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110279748|NCT00217503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110279749|NCT00217503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110279750|NCT00217503|Growth Substances|growth substances|mesh-ancestor
110279751|NCT00217503|Growth Inhibitors|growth inhibitors|mesh-ancestor
110298726|NCT04582266|Remdesivir|remdesivir|mesh-list
110298727|NCT04582266|Antimetabolites|antimetabolites|mesh-ancestor
110298728|NCT04582266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110298729|NCT04582266|Antiviral Agents|antiviral agents|mesh-ancestor
110298730|NCT04582266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110298731|NCT04528134|Listerine|listerine|mesh-list
110298749|NCT04482621|Decitabine|decitabine|mesh-list
110298750|NCT04482621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110298751|NCT04482621|Antimetabolites|antimetabolites|mesh-ancestor
110298752|NCT04482621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110298753|NCT04482621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110298754|NCT04482621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110298755|NCT04452877|Trametinib|trametinib|mesh-list
110298756|NCT04452877|Dabrafenib|dabrafenib|mesh-list
110298757|NCT04452877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110018377|NCT04267770|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110298759|NCT04452877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110298760|NCT04452877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110298761|NCT04613596|Pembrolizumab|pembrolizumab|mesh-list
110279752|NCT00217503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110279753|NCT00217503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110279754|NCT00217503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110279755|NCT00217503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110279756|NCT00217503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110279757|NCT00217503|Antimetabolites|antimetabolites|mesh-ancestor
110279758|NCT00217503|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110279759|NCT00217503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110279760|NCT00217503|Antiviral Agents|antiviral agents|mesh-ancestor
110279761|NCT00217503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110279762|NCT00217503|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110279763|NCT00217503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110279764|NCT00217542|Interferons|interferons|mesh-list
110279765|NCT00217542|Interferon-alpha|interferon-alpha|mesh-list
110279766|NCT00217542|Interferon alpha-2|interferon alpha-2|mesh-list
110279767|NCT00217542|Azacitidine|azacitidine|mesh-list
110279768|NCT00217542|Amifostine|amifostine|mesh-list
110279769|NCT00217542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110279770|NCT00217542|Antiviral Agents|antiviral agents|mesh-ancestor
110279771|NCT00217542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110279772|NCT00217542|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110298762|NCT04613596|Pemetrexed|pemetrexed|mesh-list
110298763|NCT04613596|Adagrasib|adagrasib|mesh-list
110298764|NCT04613596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110298765|NCT04613596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110298766|NCT04613596|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110298767|NCT04613596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110298768|NCT04613596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110298769|NCT04613596|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110298770|NCT04613596|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110298771|NCT04381143|Aspirin|aspirin|mesh-list
110298772|NCT04381143|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110298773|NCT04381143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110298774|NCT04381143|Analgesics|analgesics|mesh-ancestor
110298775|NCT04381143|Sensory System Agents|sensory system agents|mesh-ancestor
110298776|NCT04381143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110298777|NCT04381143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110298778|NCT04381143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110298779|NCT04381143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110298780|NCT04381143|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110298781|NCT04381143|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110298782|NCT04381143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110298783|NCT04381143|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110298784|NCT04381143|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110298785|NCT04381143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110298786|NCT04381143|Antipyretics|antipyretics|mesh-ancestor
110298787|NCT04370093|Pioglitazone|pioglitazone|mesh-list
110298788|NCT04370093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110298789|NCT04370093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110298790|NCT04298229|Dapagliflozin|dapagliflozin|mesh-list
110298791|NCT04298229|Diuretics|diuretics|mesh-list
110298792|NCT04298229|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110298797|NCT04177433|Methylprednisolone|methylprednisolone|mesh-list
110298798|NCT04177433|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110279773|NCT00217542|Antimetabolites|antimetabolites|mesh-ancestor
110279774|NCT00217542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110279775|NCT00217542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110279776|NCT00217542|Immunologic Factors|immunologic factors|mesh-ancestor
110279777|NCT00217542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110279778|NCT00217542|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110279779|NCT00217542|Protective Agents|protective agents|mesh-ancestor
110279781|NCT00210717|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110279782|NCT00210717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110279783|NCT00210717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110279784|NCT00210717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110279785|NCT00210717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110298799|NCT04177433|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110298800|NCT04177433|Prednisolone|prednisolone|mesh-list
110298801|NCT04177433|Prednisolone acetate|prednisolone acetate|mesh-list
110298802|NCT04177433|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110298803|NCT04177433|Prednisolone phosphate|prednisolone phosphate|mesh-list
110298804|NCT04177433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110298805|NCT04177433|Antiemetics|antiemetics|mesh-ancestor
110298806|NCT04177433|Autonomic Agents|autonomic agents|mesh-ancestor
110298807|NCT04177433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110298808|NCT04177433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110298809|NCT04177433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110298810|NCT04177433|Glucocorticoids|glucocorticoids|mesh-ancestor
110298812|NCT04177433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110298813|NCT04177433|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110298814|NCT04177433|Protective Agents|protective agents|mesh-ancestor
110298815|NCT04177433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110298816|NCT04177433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110298817|NCT04166383|Nivolumab|nivolumab|mesh-list
110298818|NCT04166383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110298819|NCT04166383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110298820|NCT04166383|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110298821|NCT04166383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110298823|NCT04108897|Ivermectin|ivermectin|mesh-list
110298824|NCT04108897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110298825|NCT04108897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110298826|NCT04108897|Antimalarials|antimalarials|mesh-ancestor
110298827|NCT04108897|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110298828|NCT04108897|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110298829|NCT04101877|Bevacizumab|bevacizumab|mesh-list
110298830|NCT04101877|Aflibercept|aflibercept|mesh-list
110298831|NCT04101877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110298832|NCT04101877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110298833|NCT04101877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110298834|NCT04101877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110298835|NCT04101877|Growth Substances|growth substances|mesh-ancestor
110298836|NCT04101877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110298837|NCT04101877|Growth Inhibitors|growth inhibitors|mesh-ancestor
110298838|NCT04101838|Vaccines|vaccines|mesh-list
110298839|NCT04101838|Immunologic Factors|immunologic factors|mesh-ancestor
110298840|NCT04101838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110298841|NCT04054648|Antihypertensive Agents|antihypertensive agents|mesh-list
110298842|NCT04026958|Clarithromycin|clarithromycin|mesh-list
110298843|NCT04026958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110298844|NCT04026958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110298845|NCT04026958|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110298846|NCT04026958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110298847|NCT04026958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110279786|NCT00210717|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110279787|NCT00210717|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110279788|NCT00210717|Serotonin Agents|serotonin agents|mesh-ancestor
110018394|NCT04150224|Macozinone|macozinone|mesh-list
110279789|NCT00210717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110279790|NCT00210717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110279791|NCT00210717|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110279792|NCT00210717|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110279793|NCT00210717|Dopamine Agents|dopamine agents|mesh-ancestor
110279794|NCT00184496|Methadone|methadone|mesh-list
110279795|NCT00184496|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110279796|NCT00184496|Narcotics|narcotics|mesh-ancestor
110279797|NCT00184496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110279798|NCT00184496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110279799|NCT00184496|Analgesics|analgesics|mesh-ancestor
110279800|NCT00184496|Sensory System Agents|sensory system agents|mesh-ancestor
110279801|NCT00184496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110279802|NCT00184496|Antitussive Agents|antitussive agents|mesh-ancestor
110279803|NCT00184496|Respiratory System Agents|respiratory system agents|mesh-ancestor
110279804|NCT00210756|Epoetin Alfa|epoetin alfa|mesh-list
110279805|NCT00210756|Hematinics|hematinics|mesh-ancestor
110279806|NCT00217659|Anastrozole|anastrozole|mesh-list
110279807|NCT00217659|Goserelin|goserelin|mesh-list
110279808|NCT00217659|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110279809|NCT00217659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110279810|NCT00217659|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110279811|NCT00217659|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110279812|NCT00217659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110298848|NCT04026958|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110298849|NCT04026958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110298850|NCT04024254|Folic Acid|folic acid|mesh-list
110298851|NCT04024254|Hematinics|hematinics|mesh-ancestor
110298852|NCT04024254|Vitamin B Complex|vitamin b complex|mesh-ancestor
110298853|NCT04024254|Vitamins|vitamins|mesh-ancestor
110298854|NCT04024254|Micronutrients|micronutrients|mesh-ancestor
110298855|NCT04024254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110298857|NCT04023331|Trace Elements|trace elements|mesh-ancestor
110298858|NCT04023331|Micronutrients|micronutrients|mesh-ancestor
110298859|NCT04023331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110298860|NCT03939182|Abexinostat|abexinostat|mesh-list
110298861|NCT03939182|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110298862|NCT03939182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110298863|NCT03939182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110298864|NCT03887702|Tenofovir|tenofovir|mesh-list
110298865|NCT03887702|Entecavir|entecavir|mesh-list
110298880|NCT03875287|Antimetabolites|antimetabolites|mesh-ancestor
110018413|NCT04102956|Fertility Agents|fertility agents|mesh-ancestor
110298882|NCT03875287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110298883|NCT03875287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110298884|NCT03832010|Triamcinolone|triamcinolone|mesh-list
110298885|NCT03832010|Hydrocortisone|hydrocortisone|mesh-list
110279814|NCT00217659|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110279815|NCT00217659|Hormone Antagonists|hormone antagonists|mesh-ancestor
110279816|NCT00217659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110279817|NCT00217659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110279819|NCT00184574|Insulin Aspart|insulin aspart|mesh-list
110279820|NCT00184574|Biphasic Insulins|biphasic insulins|mesh-list
110279821|NCT00184574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110279822|NCT00184574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110279823|NCT00210795|Epoetin Alfa|epoetin alfa|mesh-list
110279824|NCT00210795|Hematinics|hematinics|mesh-ancestor
110279825|NCT00217698|Gemcitabine|gemcitabine|mesh-list
110279826|NCT00217698|Gefitinib|gefitinib|mesh-list
110279827|NCT00217698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110279828|NCT00217698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110279829|NCT00217698|Antimetabolites|antimetabolites|mesh-ancestor
110279830|NCT00217698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110298886|NCT03832010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110298888|NCT03832010|Hormones|hormones|mesh-ancestor
110298889|NCT03832010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110298890|NCT03832010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110298891|NCT03813836|Pembrolizumab|pembrolizumab|mesh-list
110298892|NCT03813836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110298893|NCT03813836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110298894|NCT03813836|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110298895|NCT03813836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110298896|NCT03730649|Sulforaphane|sulforaphane|mesh-list
110298898|NCT03730649|Protective Agents|protective agents|mesh-ancestor
110298899|NCT03730649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110298900|NCT03730649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110298901|NCT03683355|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110298902|NCT03683355|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110298903|NCT03683355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110298904|NCT03632720|Vaccines|vaccines|mesh-list
110298905|NCT03632720|Immunologic Factors|immunologic factors|mesh-ancestor
110298906|NCT03632720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110298907|NCT03598426|Dexamethasone|dexamethasone|mesh-list
110298908|NCT03598426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110298909|NCT03598426|Antiemetics|antiemetics|mesh-ancestor
110298910|NCT03598426|Autonomic Agents|autonomic agents|mesh-ancestor
110298911|NCT03598426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110298912|NCT03598426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110298913|NCT03598426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110298914|NCT03598426|Glucocorticoids|glucocorticoids|mesh-ancestor
110298916|NCT03598426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110298917|NCT03598426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110298918|NCT03598426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110298919|NCT03568890|Aspirin|aspirin|mesh-list
110298920|NCT03568890|Rivaroxaban|rivaroxaban|mesh-list
110298921|NCT03568890|Apixaban|apixaban|mesh-list
110298922|NCT03568890|Edoxaban|edoxaban|mesh-list
110298923|NCT03568890|Dabigatran|dabigatran|mesh-list
110298924|NCT03568890|Clopidogrel|clopidogrel|mesh-list
110279831|NCT00217698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110279832|NCT00217698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110279833|NCT00184613|Insulin|insulin|mesh-list
110279834|NCT00184613|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110279836|NCT00184613|Insulin Aspart|insulin aspart|mesh-list
110279837|NCT00184613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110279838|NCT00184613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110279839|NCT00210834|Epoetin Alfa|epoetin alfa|mesh-list
110279840|NCT00210834|Hematinics|hematinics|mesh-ancestor
110279841|NCT00217815|Efungumab|efungumab|mesh-list
110279842|NCT00217815|Docetaxel|docetaxel|mesh-list
110279843|NCT00217815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110279844|NCT00217815|Tubulin Modulators|tubulin modulators|mesh-ancestor
110279845|NCT00217815|Antimitotic Agents|antimitotic agents|mesh-ancestor
110018473|NCT03933618|Fertility Agents|fertility agents|mesh-ancestor
110279847|NCT00217815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110279848|NCT00217815|Antifungal Agents|antifungal agents|mesh-ancestor
110279849|NCT00217815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110279850|NCT04722471|Progesterone|progesterone|mesh-list
110279851|NCT04722471|Progestins|progestins|mesh-ancestor
110279853|NCT04722471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110279854|NCT04722471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110279855|NCT00210873|Topiramate|topiramate|mesh-list
110279856|NCT00210873|Anticonvulsants|anticonvulsants|mesh-ancestor
110279857|NCT00210873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110279858|NCT00210873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110279859|NCT00210912|Topiramate|topiramate|mesh-list
110279860|NCT00210912|Anticonvulsants|anticonvulsants|mesh-ancestor
110279861|NCT00210912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110279862|NCT00210912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110279863|NCT00184847|Adenosine|adenosine|mesh-list
110279864|NCT00184847|Acetylcholine|acetylcholine|mesh-list
110279865|NCT00184847|Caffeine|caffeine|mesh-list
110279866|NCT00184847|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110298925|NCT03568890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110298926|NCT03568890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110298927|NCT03568890|Analgesics|analgesics|mesh-ancestor
110298928|NCT03568890|Sensory System Agents|sensory system agents|mesh-ancestor
110298938|NCT03568890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110298939|NCT03568890|Antipyretics|antipyretics|mesh-ancestor
110298940|NCT03568890|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110279875|NCT00184847|Analgesics|analgesics|mesh-ancestor
110279876|NCT00184847|Sensory System Agents|sensory system agents|mesh-ancestor
110279877|NCT00184847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110279878|NCT00184847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110279879|NCT00184847|Vasodilator Agents|vasodilator agents|mesh-ancestor
110279880|NCT00184847|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110298941|NCT03568890|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110018526|NCT03796260|Entrectinib|entrectinib|mesh-list
110018527|NCT03796260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110298942|NCT03568890|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110298943|NCT03568890|Purinergic Agents|purinergic agents|mesh-ancestor
110298944|NCT03568890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110298945|NCT03568890|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110298946|NCT03568890|Antithrombins|antithrombins|mesh-ancestor
110298947|NCT03568890|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110298948|NCT03568890|Protease Inhibitors|protease inhibitors|mesh-ancestor
110298949|NCT03568890|Anticoagulants|anticoagulants|mesh-ancestor
110298950|NCT03521037|Rucaparib|rucaparib|mesh-list
110298951|NCT03521037|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110298952|NCT03521037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110298953|NCT03521037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110298954|NCT03521037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110298955|NCT03499444|Rucaparib|rucaparib|mesh-list
110298956|NCT03499444|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110298957|NCT03499444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110298958|NCT03499444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110298959|NCT03499444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110298960|NCT03494322|Cetuximab|cetuximab|mesh-list
110298961|NCT03494322|Avelumab|avelumab|mesh-list
110298962|NCT03494322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110298963|NCT03494322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110298964|NCT03480191|Daptomycin|daptomycin|mesh-list
110298965|NCT03480191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110298966|NCT03480191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110298978|NCT03441633|Apixaban|apixaban|mesh-list
110298979|NCT03441633|Dabigatran|dabigatran|mesh-list
110298980|NCT03441633|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110298981|NCT03441633|Antithrombins|antithrombins|mesh-ancestor
110298982|NCT03441633|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110298983|NCT03441633|Protease Inhibitors|protease inhibitors|mesh-ancestor
110298984|NCT03441633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110298985|NCT03441633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110298986|NCT03441633|Anticoagulants|anticoagulants|mesh-ancestor
110298987|NCT03436862|Nivolumab|nivolumab|mesh-list
110298988|NCT03436862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110279881|NCT00184847|Purinergic Agonists|purinergic agonists|mesh-ancestor
110279882|NCT00184847|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110279883|NCT00184847|Cholinergic Agents|cholinergic agents|mesh-ancestor
110279884|NCT00184886|Methotrexate|methotrexate|mesh-list
110279885|NCT00184886|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110279886|NCT00184886|Abortifacient Agents|abortifacient agents|mesh-ancestor
110279887|NCT00184886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110279888|NCT00184886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110279889|NCT00184886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110279890|NCT00184886|Antimetabolites|antimetabolites|mesh-ancestor
110279891|NCT00184886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110279892|NCT00184886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110279893|NCT00184886|Dermatologic Agents|dermatologic agents|mesh-ancestor
110279894|NCT00184886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110279895|NCT00184886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110279896|NCT00184886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110279897|NCT00184886|Immunologic Factors|immunologic factors|mesh-ancestor
110018609|NCT02974686|Immunologic Factors|immunologic factors|mesh-ancestor
110018610|NCT02974686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018611|NCT02974686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110018612|NCT02974686|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110018613|NCT02974686|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110018614|NCT02974686|Antitubercular Agents|antitubercular agents|mesh-ancestor
110018615|NCT02974686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110018617|NCT02966184|Albuterol|albuterol|mesh-list
110279898|NCT00184886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110279899|NCT00184886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110279900|NCT00217932|Valproic Acid|valproic acid|mesh-list
110279901|NCT00217932|Anticonvulsants|anticonvulsants|mesh-ancestor
110298989|NCT03436862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110298990|NCT03436862|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110298991|NCT03436862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110298992|NCT03424005|Bevacizumab|bevacizumab|mesh-list
110298993|NCT03424005|Carboplatin|carboplatin|mesh-list
110298994|NCT03424005|Gemcitabine|gemcitabine|mesh-list
110298995|NCT03424005|Capecitabine|capecitabine|mesh-list
110298996|NCT03424005|Trastuzumab|trastuzumab|mesh-list
110299015|NCT03424005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110299016|NCT03424005|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110299017|NCT03424005|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110299018|NCT03424005|Hormone Antagonists|hormone antagonists|mesh-ancestor
110299019|NCT03424005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110299020|NCT03424005|Immunoconjugates|immunoconjugates|mesh-ancestor
110299021|NCT03424005|Immunologic Factors|immunologic factors|mesh-ancestor
110299022|NCT03424005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110299023|NCT03424005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110299024|NCT03424005|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
110299026|NCT03397394|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110299027|NCT03397394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110299028|NCT03397394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110299029|NCT03397394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110299030|NCT03373760|Durvalumab|durvalumab|mesh-list
110299031|NCT03373760|Ipilimumab|ipilimumab|mesh-list
110299032|NCT03373760|Tremelimumab|tremelimumab|mesh-list
110299033|NCT03373760|Immunoglobulins|immunoglobulins|mesh-list
110299034|NCT03373760|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110299035|NCT03373760|Immunoglobulin G|immunoglobulin g|mesh-list
110299036|NCT03373760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110299037|NCT03373760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110299038|NCT03373760|Immunologic Factors|immunologic factors|mesh-ancestor
110299039|NCT03373760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110299040|NCT03373760|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110279904|NCT00217932|GABA Agents|gaba agents|mesh-ancestor
110279905|NCT00217932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110279906|NCT00217932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110279907|NCT00217932|Antimanic Agents|antimanic agents|mesh-ancestor
110279908|NCT00217932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110279909|NCT00217932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110279910|NCT00217932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110279911|NCT00210990|Doripenem|doripenem|mesh-list
110279912|NCT00210990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110279913|NCT00210990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110279914|NCT00185003|Tolbutamide|tolbutamide|mesh-list
110279915|NCT00185003|Potassium Channel Blockers|potassium channel blockers|mesh-list
110279916|NCT00185003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110279917|NCT00185003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110279918|NCT00185003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110279919|NCT00185003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110279920|NCT00185120|Amlodipine|amlodipine|mesh-list
110279921|NCT00185120|Olmesartan|olmesartan|mesh-list
110279922|NCT00185120|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110279923|NCT00185120|Benazepril|benazepril|mesh-list
110279924|NCT00185120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110299041|NCT03373760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018661|NCT02514252|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110299047|NCT03290794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110299048|NCT03290794|Growth Substances|growth substances|mesh-ancestor
110299049|NCT03290794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110299050|NCT03290794|Growth Inhibitors|growth inhibitors|mesh-ancestor
110299051|NCT03290794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110299052|NCT03053440|Zanubrutinib|zanubrutinib|mesh-list
110299053|NCT03053440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110299059|NCT02986100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110299060|NCT02986100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110299061|NCT02986100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110299063|NCT02965027|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110299064|NCT02965027|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110299065|NCT02965027|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110299066|NCT02965027|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110299067|NCT02965027|Adrenergic Agents|adrenergic agents|mesh-ancestor
110299068|NCT02965027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110299069|NCT02965027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110299070|NCT02965027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110299071|NCT02952534|Rucaparib|rucaparib|mesh-list
110299072|NCT02952534|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110299073|NCT02952534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110279925|NCT00185120|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110279926|NCT00185120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110279927|NCT00185120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110279928|NCT00185120|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110279929|NCT00185120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110279930|NCT00185120|Vasodilator Agents|vasodilator agents|mesh-ancestor
110279931|NCT00185120|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110279932|NCT00185120|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110279933|NCT00185120|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110279934|NCT00185120|Protease Inhibitors|protease inhibitors|mesh-ancestor
110279935|NCT00185120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110279937|NCT00218049|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110279938|NCT00218049|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110279939|NCT00218049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110279940|NCT00218049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110279941|NCT00218049|Dopamine Agents|dopamine agents|mesh-ancestor
110279942|NCT00218049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110279943|NCT00218049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110279944|NCT00185159|Olmesartan|olmesartan|mesh-list
110279945|NCT00185159|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110279946|NCT00185159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110279947|NCT00185159|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110279948|NCT00185159|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110279949|NCT00185159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110279950|NCT00218127|Methadyl Acetate|methadyl acetate|mesh-list
110279951|NCT00218127|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110279952|NCT00218127|Narcotics|narcotics|mesh-ancestor
110018678|NCT02434146|Adrenergic Agents|adrenergic agents|mesh-ancestor
110018682|NCT02382588|Ganciclovir|ganciclovir|mesh-list
110279953|NCT00218127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110279954|NCT00218127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110279955|NCT00218127|Analgesics|analgesics|mesh-ancestor
110299074|NCT02952534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110299075|NCT02952534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110299076|NCT02949934|Tolcapone|tolcapone|mesh-list
110299077|NCT02949934|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110299078|NCT02949934|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110299079|NCT02949934|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
110299080|NCT02949934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110299081|NCT02949934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110279956|NCT00218127|Sensory System Agents|sensory system agents|mesh-ancestor
110279957|NCT00218127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110279958|NCT00185198|Testosterone|testosterone|mesh-list
110279959|NCT00185198|Androgens|androgens|mesh-ancestor
110279960|NCT00185198|Hormones|hormones|mesh-ancestor
110279961|NCT00185198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110279962|NCT00185198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110279963|NCT00185237|Estradiol|estradiol|mesh-list
110279964|NCT00185237|Estrogens|estrogens|mesh-ancestor
110279965|NCT00185237|Hormones|hormones|mesh-ancestor
110279966|NCT00185237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110279967|NCT00185237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110279968|NCT00218166|Triazolam|triazolam|mesh-list
110279969|NCT00218166|Tiagabine|tiagabine|mesh-list
110279970|NCT00218166|Baclofen|baclofen|mesh-list
110299082|NCT02935634|Nivolumab|nivolumab|mesh-list
110299083|NCT02935634|Ipilimumab|ipilimumab|mesh-list
110299084|NCT02935634|Relatlimab|relatlimab|mesh-list
110299086|NCT02935634|Linrodostat|linrodostat|mesh-list
110299087|NCT02935634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110299088|NCT02935634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110299089|NCT02935634|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110299090|NCT02935634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110299091|NCT02935634|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110299092|NCT02935634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110299093|NCT02864992|Tepotinib|tepotinib|mesh-list
110299094|NCT02864992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110299095|NCT02807636|Carboplatin|carboplatin|mesh-list
110299096|NCT02807636|Gemcitabine|gemcitabine|mesh-list
110299097|NCT02807636|Atezolizumab|atezolizumab|mesh-list
110299098|NCT02807636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110299099|NCT02807636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110018695|NCT02345460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110299100|NCT02807636|Antimetabolites|antimetabolites|mesh-ancestor
110299101|NCT02807636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110299102|NCT02807636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110299103|NCT02807636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110299104|NCT02740712|Vitamin K|vitamin k|mesh-list
110299105|NCT02740712|Rucaparib|rucaparib|mesh-list
110299106|NCT02740712|Digoxin|digoxin|mesh-list
110299108|NCT02740712|Caffeine|caffeine|mesh-list
110299109|NCT02740712|Omeprazole|omeprazole|mesh-list
110299110|NCT02740712|Warfarin|warfarin|mesh-list
110299111|NCT02740712|Vitamins|vitamins|mesh-ancestor
110299112|NCT02740712|Micronutrients|micronutrients|mesh-ancestor
110299113|NCT02740712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110299114|NCT02740712|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110299115|NCT02740712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110299116|NCT02740712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110299117|NCT02740712|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110299118|NCT02740712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110299119|NCT02740712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110299120|NCT02740712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110299121|NCT02740712|Anesthetics, General|anesthetics, general|mesh-ancestor
110299122|NCT02740712|Anesthetics|anesthetics|mesh-ancestor
110030037|NCT01992653|Doxorubicin|doxorubicin|mesh-list
110299123|NCT02740712|GABA Modulators|gaba modulators|mesh-ancestor
110299124|NCT02740712|GABA Agents|gaba agents|mesh-ancestor
110299128|NCT02740712|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110299129|NCT02740712|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110299130|NCT02740712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110299131|NCT02740712|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110299132|NCT02740712|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110299133|NCT02740712|Purinergic Agents|purinergic agents|mesh-ancestor
110279971|NCT00218166|GABA Agonists|gaba agonists|mesh-list
110279972|NCT00218166|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110279973|NCT00218166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110279974|NCT00218166|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110279975|NCT00218166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110279976|NCT00218166|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110279977|NCT00218166|GABA Agents|gaba agents|mesh-ancestor
110279978|NCT00218166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110279979|NCT00218166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110279980|NCT00218166|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110279981|NCT00218166|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110279982|NCT00218166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110279983|NCT00218166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110279984|NCT00218166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110279985|NCT00218166|GABA Modulators|gaba modulators|mesh-ancestor
110279986|NCT00218166|Anticonvulsants|anticonvulsants|mesh-ancestor
110279987|NCT00218166|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
110279988|NCT00218166|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110299134|NCT02740712|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110299135|NCT02740712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110299136|NCT02740712|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110299137|NCT02740712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110299138|NCT02740712|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110299139|NCT02740712|Protective Agents|protective agents|mesh-ancestor
110299140|NCT02740712|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110299141|NCT02740712|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110299142|NCT02740712|Hemostatics|hemostatics|mesh-ancestor
110299144|NCT02740712|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110299145|NCT02740712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110299146|NCT02684578|Metformin|metformin|mesh-list
110299147|NCT02684578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110299148|NCT02684578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110299149|NCT02580305|Memantine|memantine|mesh-list
110299150|NCT02580305|Donepezil|donepezil|mesh-list
110299151|NCT02580305|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1H-indole dimesylate monohydrate|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1h-indole dimesylate monohydrate|mesh-list
110299152|NCT02580305|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110299153|NCT02580305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110299154|NCT02580305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110299155|NCT02580305|Cholinergic Agents|cholinergic agents|mesh-ancestor
110299156|NCT02580305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110299157|NCT02580305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110299158|NCT02580305|Nootropic Agents|nootropic agents|mesh-ancestor
110299159|NCT02580305|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110299160|NCT02580305|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110299161|NCT02580305|Dopamine Agents|dopamine agents|mesh-ancestor
110299162|NCT02580305|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110299163|NCT02580305|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110299164|NCT02580305|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110018761|NCT01980342|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110299165|NCT02580305|Serotonin Agents|serotonin agents|mesh-ancestor
110299166|NCT02279394|Dexamethasone|dexamethasone|mesh-list
110299167|NCT02279394|Lenalidomide|lenalidomide|mesh-list
110299168|NCT02279394|Elotuzumab|elotuzumab|mesh-list
110299169|NCT02279394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110299170|NCT02279394|Antiemetics|antiemetics|mesh-ancestor
110299171|NCT02279394|Autonomic Agents|autonomic agents|mesh-ancestor
110279989|NCT00218166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110279990|NCT00185315|Iloprost|iloprost|mesh-list
110279991|NCT00185315|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110279992|NCT00185315|Vasodilator Agents|vasodilator agents|mesh-ancestor
110279993|NCT00409019|Tenofovir|tenofovir|mesh-list
110279994|NCT00409019|Adefovir|adefovir|mesh-list
110279995|NCT00409019|Telbivudine|telbivudine|mesh-list
110279996|NCT00409019|Antiviral Agents|antiviral agents|mesh-ancestor
110279997|NCT00409019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110279998|NCT00409019|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110279999|NCT00409019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110280000|NCT00409019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110280001|NCT00409019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110299172|NCT02279394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110299173|NCT02279394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110299174|NCT02279394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110299175|NCT02279394|Glucocorticoids|glucocorticoids|mesh-ancestor
110299176|NCT02279394|Hormones|hormones|mesh-ancestor
110299177|NCT02279394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110299178|NCT02279394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110299179|NCT02279394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110299180|NCT02279394|Immunologic Factors|immunologic factors|mesh-ancestor
110299181|NCT02279394|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110299182|NCT02279394|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110299183|NCT02279394|Growth Substances|growth substances|mesh-ancestor
110299184|NCT02279394|Growth Inhibitors|growth inhibitors|mesh-ancestor
110299185|NCT02229578|Lidocaine|lidocaine|mesh-list
110299186|NCT02229578|Anesthetics, Local|anesthetics, local|mesh-ancestor
110299187|NCT02229578|Anesthetics|anesthetics|mesh-ancestor
110018796|NCT01846182|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110018797|NCT01846182|Analgesics|analgesics|mesh-ancestor
110299188|NCT02229578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110299189|NCT02229578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110299190|NCT02229578|Sensory System Agents|sensory system agents|mesh-ancestor
110299191|NCT02229578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110299192|NCT02229578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110299193|NCT02229578|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110299194|NCT02229578|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110299202|NCT01821781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110299204|NCT01821781|Immunologic Factors|immunologic factors|mesh-ancestor
110299205|NCT01821781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110299206|NCT01821781|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110299207|NCT01821781|Alkylating Agents|alkylating agents|mesh-ancestor
110299208|NCT01821781|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110299209|NCT01821781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110299210|NCT01555463|Azelaic acid|azelaic acid|mesh-list
110299211|NCT01555463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110299212|NCT01555463|Dermatologic Agents|dermatologic agents|mesh-ancestor
110299213|NCT01482715|Rucaparib|rucaparib|mesh-list
110299214|NCT01482715|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110299215|NCT01482715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110299216|NCT01482715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110299217|NCT01482715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110299218|NCT01257919|Azelaic acid|azelaic acid|mesh-list
110299219|NCT01257919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110299220|NCT01257919|Dermatologic Agents|dermatologic agents|mesh-ancestor
110299221|NCT01081951|Paclitaxel|paclitaxel|mesh-list
110299222|NCT01081951|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110299223|NCT01081951|Carboplatin|carboplatin|mesh-list
110299224|NCT01081951|Olaparib|olaparib|mesh-list
110299225|NCT01081951|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110299226|NCT01081951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110299227|NCT01081951|Tubulin Modulators|tubulin modulators|mesh-ancestor
110280002|NCT00409019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110018845|NCT01738698|Dopamine Agents|dopamine agents|mesh-ancestor
110280003|NCT00409019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110280006|NCT00211224|Riluzole|riluzole|mesh-list
110280007|NCT00211224|Anticonvulsants|anticonvulsants|mesh-ancestor
110280008|NCT00211224|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110280009|NCT00211224|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110280010|NCT00211224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110280011|NCT00211224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280012|NCT00211224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280013|NCT00211224|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110280014|NCT00211224|Protective Agents|protective agents|mesh-ancestor
110280015|NCT00409097|Rosiglitazone|rosiglitazone|mesh-list
110280016|NCT00409097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110280017|NCT00409097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280018|NCT00218205|Celecoxib|celecoxib|mesh-list
110280019|NCT00218205|Epirubicin|epirubicin|mesh-list
110280020|NCT00218205|Estramustine|estramustine|mesh-list
110280021|NCT00218205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110280022|NCT00218205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110280023|NCT00218205|Analgesics|analgesics|mesh-ancestor
110280024|NCT00218205|Sensory System Agents|sensory system agents|mesh-ancestor
110280025|NCT00218205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110280026|NCT00218205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280027|NCT00218205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110280028|NCT00218205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110280029|NCT00218205|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110299228|NCT01081951|Antimitotic Agents|antimitotic agents|mesh-ancestor
110299229|NCT01081951|Mitosis Modulators|mitosis modulators|mesh-ancestor
110299230|NCT01081951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110299231|NCT01081951|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110299232|NCT01081951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110299233|NCT00915837|Triamcinolone|triamcinolone|mesh-list
110018875|NCT01545648|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110018876|NCT01545648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018877|NCT01527942|Acetaminophen|acetaminophen|mesh-list
110299234|NCT00915837|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110299235|NCT00915837|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110299236|NCT00915837|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110299237|NCT00915837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110299239|NCT00915837|Hormones|hormones|mesh-ancestor
110299240|NCT00915837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110299241|NCT00915837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110299242|NCT00915837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110299243|NCT00915837|Immunologic Factors|immunologic factors|mesh-ancestor
110299244|NCT00915837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110299245|NCT00915837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280030|NCT00218205|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110280031|NCT00218205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110280032|NCT00218205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280033|NCT00218205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110280034|NCT00218205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110280035|NCT00218205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110280036|NCT00218205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110280037|NCT00218205|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110280038|NCT00218205|Alkylating Agents|alkylating agents|mesh-ancestor
110280039|NCT00218205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110280040|NCT00185510|Methylprednisolone|methylprednisolone|mesh-list
110280041|NCT00185510|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110280042|NCT00185510|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110299247|NCT00239096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110299248|NCT00239096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110299249|NCT00239096|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110299250|NCT00239096|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110018921|NCT01350258|Fludarabine|fludarabine|mesh-list
110299251|NCT00239096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110299252|NCT04532554|Hormones|hormones|mesh-list
110299253|NCT04532554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110299254|NCT04532554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110299255|NCT04532281|Carbamide Peroxide|carbamide peroxide|mesh-list
110299256|NCT04532281|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110299257|NCT04532281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110299258|NCT02217163|Dexamethasone|dexamethasone|mesh-list
110299259|NCT02217163|Cyclophosphamide|cyclophosphamide|mesh-list
110299260|NCT02217163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110299261|NCT02217163|Immunologic Factors|immunologic factors|mesh-ancestor
110299265|NCT02217163|Alkylating Agents|alkylating agents|mesh-ancestor
110299266|NCT02217163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110299267|NCT02217163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110299268|NCT02217163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110299269|NCT02217163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110299270|NCT02217163|Antiemetics|antiemetics|mesh-ancestor
110299271|NCT02217163|Autonomic Agents|autonomic agents|mesh-ancestor
110299272|NCT02217163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110299273|NCT02217163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110299275|NCT02217163|Hormones|hormones|mesh-ancestor
110299276|NCT02217163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110299277|NCT02217163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110299278|NCT02217202|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110299279|NCT02217202|Laxatives|laxatives|mesh-ancestor
110299280|NCT02217202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110299281|NCT00239174|Surinabant|surinabant|mesh-list
110299282|NCT00239174|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
110299283|NCT00239174|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110299284|NCT00239174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110299285|NCT00239174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110299286|NCT00239174|Hormones|hormones|mesh-ancestor
110299287|NCT00239174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110299288|NCT00239174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110299289|NCT04531423|Golimumab|golimumab|mesh-list
110299290|NCT04531423|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
110299291|NCT04531423|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110299292|NCT04531423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110299293|NCT04531423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110280044|NCT00185510|Prednisolone acetate|prednisolone acetate|mesh-list
110280045|NCT00185510|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
110280046|NCT00185510|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110280048|NCT00185510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110280049|NCT00185510|Antiemetics|antiemetics|mesh-ancestor
110280050|NCT00185510|Autonomic Agents|autonomic agents|mesh-ancestor
110280051|NCT00185510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110280052|NCT00185510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280053|NCT00185510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110280054|NCT00185510|Glucocorticoids|glucocorticoids|mesh-ancestor
110280055|NCT00185510|Hormones|hormones|mesh-ancestor
110280056|NCT00185510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110280057|NCT00185510|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110280058|NCT00185510|Protective Agents|protective agents|mesh-ancestor
110280059|NCT00185510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110280060|NCT00185510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110280061|NCT00218244|Lobeline|lobeline|mesh-list
110280062|NCT00218244|Nicotine|nicotine|mesh-list
110299294|NCT04531423|Immunologic Factors|immunologic factors|mesh-ancestor
110299295|NCT04531423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110299296|NCT04531423|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110299297|NCT04531423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110299298|NCT04531423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110299299|NCT04531423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110299300|NCT04531423|Serotonin Agents|serotonin agents|mesh-ancestor
110299301|NCT00239252|Interferons|interferons|mesh-list
110299302|NCT00239252|Interferon alfacon-1|interferon alfacon-1|mesh-list
110299303|NCT00239252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110299304|NCT00239252|Antiviral Agents|antiviral agents|mesh-ancestor
110299305|NCT00239252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110299306|NCT00263406|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110299307|NCT00263406|Protease Inhibitors|protease inhibitors|mesh-ancestor
110299308|NCT00263406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110299309|NCT00263406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110299310|NCT04531267|Calcium|calcium|mesh-list
110299311|NCT04531267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110299312|NCT04531267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110299314|NCT04531228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110299315|NCT04531228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110299316|NCT04531228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110299317|NCT04531228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110299318|NCT04531072|Ritonavir|ritonavir|mesh-list
110299319|NCT04531072|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110299320|NCT04531072|Lumefantrine|lumefantrine|mesh-list
110299321|NCT04531072|Artemether|artemether|mesh-list
110299322|NCT04531072|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110299323|NCT04531072|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110299324|NCT04531072|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110299325|NCT04531072|Protease Inhibitors|protease inhibitors|mesh-ancestor
110299326|NCT04531072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110299327|NCT04531072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110299328|NCT04531072|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110299329|NCT04531072|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110299330|NCT04531072|Antiviral Agents|antiviral agents|mesh-ancestor
110299331|NCT04531072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110280064|NCT00218244|Autonomic Agents|autonomic agents|mesh-ancestor
110280065|NCT00218244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110280066|NCT00218244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280068|NCT00218244|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110280069|NCT00218244|Cholinergic Agents|cholinergic agents|mesh-ancestor
110280070|NCT00218244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110280071|NCT00218244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280072|NCT00218244|Respiratory System Agents|respiratory system agents|mesh-ancestor
110299345|NCT00414323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110299346|NCT00414323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110299347|NCT00414323|Antidepressive Agents|antidepressive agents|mesh-ancestor
110299349|NCT00414323|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110299350|NCT00414323|Analgesics|analgesics|mesh-ancestor
110299351|NCT00414323|Sensory System Agents|sensory system agents|mesh-ancestor
110299352|NCT00414323|Dopamine Agents|dopamine agents|mesh-ancestor
110299353|NCT00263484|Zoledronic Acid|zoledronic acid|mesh-list
110299354|NCT00263484|Thalidomide|thalidomide|mesh-list
110299355|NCT00263484|Dexamethasone|dexamethasone|mesh-list
110299356|NCT00263484|Dexamethasone acetate|dexamethasone acetate|mesh-list
110299358|NCT00263484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110299359|NCT00263484|Antiemetics|antiemetics|mesh-ancestor
110299360|NCT00263484|Autonomic Agents|autonomic agents|mesh-ancestor
110299361|NCT00263484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110299362|NCT00263484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110299363|NCT00263484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110299364|NCT00263484|Glucocorticoids|glucocorticoids|mesh-ancestor
110299365|NCT00263484|Hormones|hormones|mesh-ancestor
110299366|NCT00263484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110299367|NCT00263484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110299368|NCT00263484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110299369|NCT00263484|Protease Inhibitors|protease inhibitors|mesh-ancestor
110299370|NCT00263484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110299371|NCT00263484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110299372|NCT00263484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110299373|NCT00263484|Immunologic Factors|immunologic factors|mesh-ancestor
110299374|NCT00263484|Leprostatic Agents|leprostatic agents|mesh-ancestor
110299375|NCT00263484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110299376|NCT00263484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110299377|NCT00263484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110299378|NCT00263484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110299379|NCT00263484|Growth Substances|growth substances|mesh-ancestor
110299380|NCT00263484|Growth Inhibitors|growth inhibitors|mesh-ancestor
110299381|NCT00263484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110299382|NCT02217319|Sevoflurane|sevoflurane|mesh-list
110299383|NCT02217319|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110299384|NCT02217319|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110299385|NCT02217319|Anesthetics, General|anesthetics, general|mesh-ancestor
110299386|NCT02217319|Anesthetics|anesthetics|mesh-ancestor
110299387|NCT02217319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110299388|NCT02217319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110299389|NCT00263601|Immunomodulating Agents|immunomodulating agents|mesh-list
110299390|NCT00263601|Immunologic Factors|immunologic factors|mesh-ancestor
110299391|NCT00263601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110299392|NCT02217514|Midazolam|midazolam|mesh-list
110299399|NCT02217514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110299400|NCT02217514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110299401|NCT02217514|Anesthetics, General|anesthetics, general|mesh-ancestor
110299402|NCT02217514|Anesthetics|anesthetics|mesh-ancestor
110299403|NCT02217514|GABA Modulators|gaba modulators|mesh-ancestor
110299404|NCT02217514|GABA Agents|gaba agents|mesh-ancestor
110299405|NCT02217514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110299406|NCT02217514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280074|NCT00211302|Antidepressive Agents|antidepressive agents|mesh-ancestor
110280075|NCT00211302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110280076|NCT00211302|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110280077|NCT00211302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110280078|NCT00211302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110280079|NCT00211302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280080|NCT00211302|Dopamine Agonists|dopamine agonists|mesh-ancestor
110280081|NCT00211302|Dopamine Agents|dopamine agents|mesh-ancestor
110280082|NCT00211302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110280083|NCT00211302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280084|NCT00211302|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110280085|NCT00211302|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110280086|NCT00211302|Serotonin Agents|serotonin agents|mesh-ancestor
110280087|NCT00211302|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110280088|NCT00211302|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110280089|NCT00211302|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110280090|NCT00211302|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110280091|NCT00218283|Nicotine|nicotine|mesh-list
110280092|NCT00218283|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110280093|NCT00218283|Autonomic Agents|autonomic agents|mesh-ancestor
110280094|NCT00218283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110280095|NCT00218283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280096|NCT00218283|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110280097|NCT00218283|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110280098|NCT00218283|Cholinergic Agents|cholinergic agents|mesh-ancestor
110280099|NCT00218283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110280100|NCT00218283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280102|NCT00185705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110280103|NCT00185705|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110280104|NCT00185705|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110280105|NCT00185705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280106|NCT00211341|Vitamin A|vitamin a|mesh-list
110280107|NCT00211341|Vitamins|vitamins|mesh-ancestor
110280108|NCT00211341|Micronutrients|micronutrients|mesh-ancestor
110280109|NCT00211341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280110|NCT00185783|Hydrocortisone|hydrocortisone|mesh-list
110280111|NCT00185783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110280112|NCT00185861|Arsenic Trioxide|arsenic trioxide|mesh-list
110280113|NCT00185861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110280114|NCT00211380|Aripiprazole|aripiprazole|mesh-list
110280115|NCT00211380|Antidepressive Agents|antidepressive agents|mesh-ancestor
110280116|NCT00211380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110280118|NCT00211380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110019099|NCT00738972|Valsartan|valsartan|mesh-list
110280119|NCT00211380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110280120|NCT00211380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280121|NCT00211380|Dopamine Agonists|dopamine agonists|mesh-ancestor
110280122|NCT00211380|Dopamine Agents|dopamine agents|mesh-ancestor
110280123|NCT00211380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110280124|NCT00211380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280125|NCT00211380|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110280126|NCT00211380|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110280127|NCT00211380|Serotonin Agents|serotonin agents|mesh-ancestor
110280128|NCT00211380|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110280129|NCT00211380|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110280130|NCT00211380|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110280131|NCT00211380|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110280132|NCT00185939|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110299407|NCT02217553|Cholecalciferol|cholecalciferol|mesh-list
110299408|NCT02217553|Vitamin D|vitamin d|mesh-list
110299409|NCT02217553|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110299410|NCT02217553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110299411|NCT02217553|Vitamins|vitamins|mesh-ancestor
110299412|NCT02217553|Micronutrients|micronutrients|mesh-ancestor
110299413|NCT02217553|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110299415|NCT02217631|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110299416|NCT02217631|Methylprednisolone|methylprednisolone|mesh-list
110299417|NCT02217631|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110299418|NCT02217631|Prednisolone acetate|prednisolone acetate|mesh-list
110299419|NCT02217631|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110299420|NCT02217631|Prednisolone phosphate|prednisolone phosphate|mesh-list
110299421|NCT02217631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110299422|NCT02217631|Glucocorticoids|glucocorticoids|mesh-ancestor
110299423|NCT02217631|Hormones|hormones|mesh-ancestor
110299424|NCT02217631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110299425|NCT02217631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110299426|NCT02217631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110299427|NCT02217631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110299428|NCT02217631|Antiemetics|antiemetics|mesh-ancestor
110019131|NCT00692094|Melatonin|melatonin|mesh-list
110299429|NCT02217631|Autonomic Agents|autonomic agents|mesh-ancestor
110299430|NCT02217631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110299431|NCT02217631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110299432|NCT02217631|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110299433|NCT02217631|Protective Agents|protective agents|mesh-ancestor
110299434|NCT02217670|Metformin|metformin|mesh-list
110299435|NCT02217670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110280133|NCT00185939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110280134|NCT00185939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110280135|NCT00185939|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110280136|NCT00185939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110280137|NCT00185939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280138|NCT00218322|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110280139|NCT00218322|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110280140|NCT00218322|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110280141|NCT00218322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110280142|NCT00218322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280143|NCT00218322|Adrenergic Agents|adrenergic agents|mesh-ancestor
110280144|NCT00218322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110280145|NCT00218322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110299436|NCT02217670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110299437|NCT00239291|Gefitinib|gefitinib|mesh-list
110299438|NCT00239291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110299439|NCT00239291|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110299440|NCT00239291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110299441|NCT00239291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110299442|NCT00263640|Immunomodulating Agents|immunomodulating agents|mesh-list
110299443|NCT00263640|Immunologic Factors|immunologic factors|mesh-ancestor
110299444|NCT00263640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110299445|NCT02217826|Octreotide|octreotide|mesh-list
110299446|NCT02217826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110299447|NCT02217826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110299448|NCT02217826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110299449|NCT00239330|Atorvastatin|atorvastatin|mesh-list
110299450|NCT00239330|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110299451|NCT00239330|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110299452|NCT00239330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110299453|NCT00239330|Antimetabolites|antimetabolites|mesh-ancestor
110299454|NCT00239330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110299455|NCT00239330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110299456|NCT00239330|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110299457|NCT00239330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110299458|NCT02218021|Oxycodone|oxycodone|mesh-list
110299459|NCT02218021|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110299460|NCT02218021|Narcotics|narcotics|mesh-ancestor
110299461|NCT02218021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110299462|NCT02218021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110299470|NCT00239369|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110299471|NCT00239369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110299472|NCT00239369|Diuretics|diuretics|mesh-ancestor
110299473|NCT00239369|Natriuretic Agents|natriuretic agents|mesh-ancestor
110299474|NCT00239369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110299475|NCT00239369|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110299476|NCT00239369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110299477|NCT04529668|Vitamin D|vitamin d|mesh-list
110299478|NCT04529668|Vitamins|vitamins|mesh-ancestor
110299479|NCT04529668|Micronutrients|micronutrients|mesh-ancestor
110299480|NCT04529668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110299481|NCT04529668|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110299482|NCT00239408|Bromides|bromides|mesh-list
110299483|NCT00239408|Tiotropium Bromide|tiotropium bromide|mesh-list
110299484|NCT00239408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110299485|NCT00239408|Autonomic Agents|autonomic agents|mesh-ancestor
110299486|NCT00239408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110280147|NCT00218361|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110280148|NCT00218361|Narcotics|narcotics|mesh-ancestor
110280149|NCT00218361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110280150|NCT00218361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280151|NCT00218361|Analgesics|analgesics|mesh-ancestor
110280152|NCT00218361|Sensory System Agents|sensory system agents|mesh-ancestor
110280153|NCT00218361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110280154|NCT00218517|Selegiline|selegiline|mesh-list
110280155|NCT00218517|Antidepressive Agents|antidepressive agents|mesh-ancestor
110280156|NCT00218517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110280157|NCT00218517|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110280158|NCT00218517|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110280159|NCT00218517|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110280160|NCT00218517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110299487|NCT00239408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110299488|NCT00239408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110299489|NCT00239408|Respiratory System Agents|respiratory system agents|mesh-ancestor
110299490|NCT00239408|Parasympatholytics|parasympatholytics|mesh-ancestor
110299491|NCT00239408|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110299492|NCT00239408|Cholinergic Agents|cholinergic agents|mesh-ancestor
110299493|NCT00239408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110019202|NCT00570258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110299494|NCT00239408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110299495|NCT00239408|Anticonvulsants|anticonvulsants|mesh-ancestor
110299496|NCT02218177|Ranibizumab|ranibizumab|mesh-list
110299497|NCT02218177|Aflibercept|aflibercept|mesh-list
110299498|NCT02218177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110299499|NCT02218177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110299500|NCT02218177|Growth Substances|growth substances|mesh-ancestor
110299501|NCT02218177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110299502|NCT02218177|Growth Inhibitors|growth inhibitors|mesh-ancestor
110299503|NCT02218177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110299504|NCT00263718|Betamethasone|betamethasone|mesh-list
110299505|NCT00263718|Betamethasone Valerate|betamethasone valerate|mesh-list
110299506|NCT00263718|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
110299507|NCT00263718|Betamethasone benzoate|betamethasone benzoate|mesh-list
110299508|NCT00263718|Calcipotriene|calcipotriene|mesh-list
110299509|NCT00263718|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
110299510|NCT00263718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110299511|NCT00263718|Glucocorticoids|glucocorticoids|mesh-ancestor
110299512|NCT00263718|Hormones|hormones|mesh-ancestor
110299513|NCT00263718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110299514|NCT00263718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110299515|NCT00263718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110299516|NCT00263718|Respiratory System Agents|respiratory system agents|mesh-ancestor
110299517|NCT00263718|Dermatologic Agents|dermatologic agents|mesh-ancestor
110299518|NCT02218645|Brotizolam|brotizolam|mesh-list
110299519|NCT02218645|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110299520|NCT02218645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110299521|NCT02218645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110299523|NCT02218684|Lacidipine|lacidipine|mesh-list
110299524|NCT02218684|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110299525|NCT02218684|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110299526|NCT02218684|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110299527|NCT02218684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110299528|NCT02218684|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110299529|NCT02218684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110299539|NCT02278861|Protective Agents|protective agents|mesh-ancestor
110299540|NCT02278861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110299541|NCT01642030|Buprenorphine|buprenorphine|mesh-list
110299542|NCT01642030|Hydromorphone|hydromorphone|mesh-list
110280161|NCT00218517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280162|NCT00218517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110280163|NCT00218517|Protective Agents|protective agents|mesh-ancestor
110019224|NCT05599230|Ivacaftor|ivacaftor|mesh-list
110280165|NCT00211419|Triamcinolone|triamcinolone|mesh-list
110280166|NCT00211419|Anecortave|anecortave|mesh-list
110280167|NCT00211419|Verteporfin|verteporfin|mesh-list
110280168|NCT00211419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110280169|NCT00211419|Glucocorticoids|glucocorticoids|mesh-ancestor
110280170|NCT00211419|Hormones|hormones|mesh-ancestor
110280171|NCT00211419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110280172|NCT00211419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280173|NCT00211419|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110280174|NCT00211419|Dermatologic Agents|dermatologic agents|mesh-ancestor
110280175|NCT00211419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110280176|NCT00211419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110280177|NCT00211419|Growth Substances|growth substances|mesh-ancestor
110299543|NCT01642030|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110299544|NCT01642030|Narcotics|narcotics|mesh-ancestor
110299545|NCT01642030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110299546|NCT01642030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110299547|NCT01642030|Analgesics|analgesics|mesh-ancestor
110299548|NCT01642030|Sensory System Agents|sensory system agents|mesh-ancestor
110299549|NCT01642030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110299550|NCT01642030|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110299551|NCT00239447|Tiotropium Bromide|tiotropium bromide|mesh-list
110299552|NCT00239447|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110299554|NCT00239447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110299555|NCT00239447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110299556|NCT00239447|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110299557|NCT00239447|Respiratory System Agents|respiratory system agents|mesh-ancestor
110299558|NCT00239447|Parasympatholytics|parasympatholytics|mesh-ancestor
110299559|NCT00239447|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110299560|NCT00239447|Cholinergic Agents|cholinergic agents|mesh-ancestor
110299561|NCT00239447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110299562|NCT00239447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110299564|NCT00263796|Oxytocics|oxytocics|mesh-ancestor
110299565|NCT00263796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110299566|NCT00263796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110030491|NCT01386567|Androgens|androgens|mesh-ancestor
110299567|NCT01642108|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110299568|NCT01642108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110299569|NCT01642108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110299570|NCT01642108|Incretins|incretins|mesh-ancestor
110299571|NCT01642108|Hormones|hormones|mesh-ancestor
110299572|NCT01642108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110299573|NCT01642108|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110299574|NCT01642108|Protease Inhibitors|protease inhibitors|mesh-ancestor
110299575|NCT01642108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110299576|NCT01642108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110299577|NCT00250185|Acetylcholine|acetylcholine|mesh-list
110299578|NCT00250185|Vasodilator Agents|vasodilator agents|mesh-ancestor
110299579|NCT00250185|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110299580|NCT00250185|Cholinergic Agents|cholinergic agents|mesh-ancestor
110299581|NCT00250185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110299582|NCT00250185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280179|NCT00211419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110280180|NCT00211458|Anecortave|anecortave|mesh-list
110280181|NCT00211458|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110280182|NCT00211458|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110280183|NCT00211458|Growth Substances|growth substances|mesh-ancestor
110280184|NCT00211458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280185|NCT00211458|Growth Inhibitors|growth inhibitors|mesh-ancestor
110280186|NCT00211458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110280187|NCT00211497|Omiganan pentahydrochloride|omiganan pentahydrochloride|mesh-list
110280188|NCT00211497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110280189|NCT00186329|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
110280190|NCT00186329|Natriuretic Agents|natriuretic agents|mesh-ancestor
110280191|NCT00186329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280192|NCT00211614|Lansoprazole|lansoprazole|mesh-list
110280193|NCT00211614|Dexlansoprazole|dexlansoprazole|mesh-list
110280194|NCT00211614|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110280195|NCT00211614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110280196|NCT00211614|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110280197|NCT00211614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110280198|NCT00211614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280199|NCT00218790|Dialysis Solutions|dialysis solutions|mesh-list
110280200|NCT00218790|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110280201|NCT00186797|Cyclophosphamide|cyclophosphamide|mesh-list
110280202|NCT00186797|Fludarabine|fludarabine|mesh-list
110299583|NCT00250185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110299584|NCT00239486|Pramipexole|pramipexole|mesh-list
110299585|NCT00239486|Antioxidants|antioxidants|mesh-ancestor
110299586|NCT00239486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110299587|NCT00239486|Protective Agents|protective agents|mesh-ancestor
110299588|NCT00239486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110299590|NCT00239486|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110299591|NCT00239486|Dopamine Agonists|dopamine agonists|mesh-ancestor
110299592|NCT00239486|Dopamine Agents|dopamine agents|mesh-ancestor
110299593|NCT00239486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110299594|NCT01642966|Ticagrelor|ticagrelor|mesh-list
110299601|NCT01642966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110299602|NCT01642966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110299603|NCT01642966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110299605|NCT01643083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110299606|NCT01643083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110299607|NCT01643083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110299608|NCT01643278|Ipilimumab|ipilimumab|mesh-list
110299609|NCT01643278|Dasatinib|dasatinib|mesh-list
110299610|NCT01643278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110299611|NCT01643278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110299612|NCT01643278|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110299613|NCT01643278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280204|NCT00186797|Immunologic Factors|immunologic factors|mesh-ancestor
110280211|NCT00186797|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110280212|NCT00211653|Acetylcysteine|acetylcysteine|mesh-list
110280213|NCT00211653|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110280214|NCT00211653|Antiviral Agents|antiviral agents|mesh-ancestor
110280215|NCT00211653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110280216|NCT00211653|Expectorants|expectorants|mesh-ancestor
110299614|NCT01643278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110299615|NCT01643278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110299616|NCT01643629|Minoxidil|minoxidil|mesh-list
110299617|NCT01643629|Finasteride|finasteride|mesh-list
110299618|NCT01643629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110299619|NCT01643629|Vasodilator Agents|vasodilator agents|mesh-ancestor
110299620|NCT01643629|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110299621|NCT01643629|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110299622|NCT01643629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110299623|NCT01643629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110299624|NCT01643629|Hormone Antagonists|hormone antagonists|mesh-ancestor
110299625|NCT01643629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110299626|NCT01643629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110299627|NCT01643629|Urological Agents|urological agents|mesh-ancestor
110299628|NCT01644253|Rituximab|rituximab|mesh-list
110299629|NCT01644253|Obinutuzumab|obinutuzumab|mesh-list
110299630|NCT01644253|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110299631|NCT01644253|Idelalisib|idelalisib|mesh-list
110299632|NCT01644253|Immunoglobulin G|immunoglobulin g|mesh-list
110019375|NCT00475332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110299633|NCT01644253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110299634|NCT01644253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110299635|NCT01644253|Immunologic Factors|immunologic factors|mesh-ancestor
110299636|NCT01644253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110299637|NCT01644253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110299638|NCT01644253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110299639|NCT01644253|Alkylating Agents|alkylating agents|mesh-ancestor
110299640|NCT01644253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110299641|NCT01644253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110299642|NCT01644799|Lenalidomide|lenalidomide|mesh-list
110299643|NCT01644799|Idelalisib|idelalisib|mesh-list
110299644|NCT01644799|Immunologic Factors|immunologic factors|mesh-ancestor
110299645|NCT01644799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280218|NCT00211653|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110280219|NCT00211653|Antioxidants|antioxidants|mesh-ancestor
110280220|NCT00211653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280221|NCT00211653|Protective Agents|protective agents|mesh-ancestor
110280222|NCT00211653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280223|NCT00211653|Antidotes|antidotes|mesh-ancestor
110280224|NCT00187031|Topotecan|topotecan|mesh-list
110280225|NCT00187031|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110280226|NCT00187031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110280227|NCT00187031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110299646|NCT01644799|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110299647|NCT01644799|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110299648|NCT01644799|Growth Substances|growth substances|mesh-ancestor
110299649|NCT01644799|Growth Inhibitors|growth inhibitors|mesh-ancestor
110299650|NCT01644799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110299651|NCT01644799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110299652|NCT01644799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110299653|NCT01644838|Promethazine|promethazine|mesh-list
110299654|NCT01644838|Diphenhydramine|diphenhydramine|mesh-list
110299655|NCT01644838|Scopolamine|scopolamine|mesh-list
110299656|NCT01644838|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110299657|NCT01644838|Antiemetics|antiemetics|mesh-ancestor
110299658|NCT01644838|Autonomic Agents|autonomic agents|mesh-ancestor
110299659|NCT01644838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110299660|NCT01644838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110299661|NCT01644838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110299662|NCT01644838|Mydriatics|mydriatics|mesh-ancestor
110299669|NCT01644838|Dermatologic Agents|dermatologic agents|mesh-ancestor
110299670|NCT01644838|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110299671|NCT01644838|Histamine Antagonists|histamine antagonists|mesh-ancestor
110299672|NCT01644838|Histamine Agents|histamine agents|mesh-ancestor
110299673|NCT01644838|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110299674|NCT01644838|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110299675|NCT01644838|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110299676|NCT01644838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110299677|NCT01644838|Anesthetics, Local|anesthetics, local|mesh-ancestor
110299679|NCT01644838|Sensory System Agents|sensory system agents|mesh-ancestor
110299680|NCT01644955|Carboplatin|carboplatin|mesh-list
110299681|NCT01644955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110299682|NCT01644994|Cisplatin|cisplatin|mesh-list
110299683|NCT01644994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110299684|NCT04528888|Methylprednisolone|methylprednisolone|mesh-list
110299685|NCT04528888|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110299686|NCT04528888|Heparin|heparin|mesh-list
110299687|NCT04528888|Enoxaparin|enoxaparin|mesh-list
110299688|NCT04528888|Calcium heparin|calcium heparin|mesh-list
110299689|NCT04528888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110299690|NCT04528888|Antiemetics|antiemetics|mesh-ancestor
110299691|NCT04528888|Autonomic Agents|autonomic agents|mesh-ancestor
110299692|NCT04528888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110299693|NCT04528888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110299694|NCT04528888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110299695|NCT04528888|Glucocorticoids|glucocorticoids|mesh-ancestor
110299696|NCT04528888|Hormones|hormones|mesh-ancestor
110299697|NCT04528888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110299698|NCT04528888|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110299699|NCT04528888|Protective Agents|protective agents|mesh-ancestor
110299700|NCT04528888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110299701|NCT04528888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110299702|NCT04528888|Anticoagulants|anticoagulants|mesh-ancestor
110299703|NCT04528888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110299704|NCT04528888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110299705|NCT04528888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110299706|NCT01645384|Atorvastatin|atorvastatin|mesh-list
110299707|NCT01645384|Calcium|calcium|mesh-list
110280228|NCT00187031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280229|NCT00187031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110280230|NCT00187070|Cytarabine|cytarabine|mesh-list
110280231|NCT00187070|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110280232|NCT00187070|Dexamethasone|dexamethasone|mesh-list
110280233|NCT00187070|Prednisone|prednisone|mesh-list
110280234|NCT00187070|Cyclophosphamide|cyclophosphamide|mesh-list
110280235|NCT00187070|Ifosfamide|ifosfamide|mesh-list
110280236|NCT00187070|Carboplatin|carboplatin|mesh-list
110280237|NCT00187070|Doxorubicin|doxorubicin|mesh-list
110280238|NCT00187070|Methotrexate|methotrexate|mesh-list
110280239|NCT00187070|Etoposide|etoposide|mesh-list
110299708|NCT01645384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110299709|NCT01645384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110299710|NCT01645384|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110299711|NCT01645384|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110299712|NCT01645384|Antimetabolites|antimetabolites|mesh-ancestor
110299713|NCT01645384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110299714|NCT01645384|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110299715|NCT01645384|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110299716|NCT01645384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110299717|NCT00239798|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
110299718|NCT00239798|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110299719|NCT00239798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110299720|NCT00239798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110299721|NCT00239798|Immunologic Factors|immunologic factors|mesh-ancestor
110299722|NCT00239798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110299723|NCT01645423|Atorvastatin|atorvastatin|mesh-list
110299724|NCT01645423|Calcium|calcium|mesh-list
110299725|NCT01645423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110299726|NCT01645423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110299727|NCT01645423|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110299728|NCT01645423|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110299729|NCT01645423|Antimetabolites|antimetabolites|mesh-ancestor
110299730|NCT01645423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110299739|NCT01645774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110299741|NCT01645774|Sympathomimetics|sympathomimetics|mesh-ancestor
110299742|NCT01645774|Autonomic Agents|autonomic agents|mesh-ancestor
110299743|NCT01645774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110299744|NCT01645774|Nasal Decongestants|nasal decongestants|mesh-ancestor
110299745|NCT01645774|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110299746|NCT01645774|Respiratory System Agents|respiratory system agents|mesh-ancestor
110299747|NCT00239876|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
110299748|NCT00239876|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110299749|NCT00239876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110299750|NCT00239876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110299751|NCT00239876|Immunologic Factors|immunologic factors|mesh-ancestor
110299752|NCT00239876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110299753|NCT02961075|Anesthetics|anesthetics|mesh-list
110299754|NCT02961075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110299755|NCT02961075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110299756|NCT01646281|Flecainide|flecainide|mesh-list
110299757|NCT01646281|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110299758|NCT01646281|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110299759|NCT01646281|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110299760|NCT01646281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110299761|NCT01646281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110299762|NCT01646554|Oxaliplatin|oxaliplatin|mesh-list
110299763|NCT01646554|Aflibercept|aflibercept|mesh-list
110299764|NCT01646554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110299765|NCT01646554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110299766|NCT01646554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110280240|NCT00187070|Vincristine|vincristine|mesh-list
110280241|NCT00187070|Vinblastine|vinblastine|mesh-list
110280242|NCT00187070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110280243|NCT00187070|Immunologic Factors|immunologic factors|mesh-ancestor
110280244|NCT00187070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280245|NCT00187070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110019473|NCT04422210|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110280247|NCT00187070|Alkylating Agents|alkylating agents|mesh-ancestor
110280248|NCT00187070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280249|NCT00187070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110280250|NCT00187070|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110280251|NCT00187070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110280252|NCT00187070|Antiemetics|antiemetics|mesh-ancestor
110280253|NCT00187070|Autonomic Agents|autonomic agents|mesh-ancestor
110280254|NCT00187070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110280255|NCT00187070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110280257|NCT00187070|Hormones|hormones|mesh-ancestor
110280258|NCT00187070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110280259|NCT00187070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110280260|NCT00187070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110299767|NCT01646554|Growth Substances|growth substances|mesh-ancestor
110299768|NCT01646554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110299769|NCT01646554|Growth Inhibitors|growth inhibitors|mesh-ancestor
110299770|NCT00250263|Immunomodulating Agents|immunomodulating agents|mesh-list
110299771|NCT00250263|Immunologic Factors|immunologic factors|mesh-ancestor
110299772|NCT00250263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110299773|NCT00264069|Antipsychotic Agents|antipsychotic agents|mesh-list
110299774|NCT00264069|Antidepressive Agents|antidepressive agents|mesh-list
110299775|NCT00264069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110299776|NCT00264069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110299777|NCT00264069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110299778|NCT00264069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110299779|NCT01646788|Paclitaxel|paclitaxel|mesh-list
110299780|NCT01646788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110299781|NCT01646788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110299782|NCT01646788|Tubulin Modulators|tubulin modulators|mesh-ancestor
110299783|NCT01646788|Antimitotic Agents|antimitotic agents|mesh-ancestor
110299784|NCT01646788|Mitosis Modulators|mitosis modulators|mesh-ancestor
110299785|NCT01646788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110299786|NCT01647256|Nikkomycin|nikkomycin|mesh-list
110299787|NCT01647256|Antifungal Agents|antifungal agents|mesh-ancestor
110299788|NCT01647256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110299789|NCT01647256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110299790|NCT01647256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110299791|NCT00239954|Escitalopram|escitalopram|mesh-list
110299792|NCT00239954|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110299793|NCT00239954|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110299803|NCT04528927|Antimalarials|antimalarials|mesh-ancestor
110299804|NCT04528927|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110299805|NCT04528927|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110280261|NCT00187070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110280262|NCT00187070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110019497|NCT00000138|Hormones|hormones|mesh-ancestor
110280263|NCT00187070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110280264|NCT00187070|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110280265|NCT00187070|Abortifacient Agents|abortifacient agents|mesh-ancestor
110280266|NCT00187070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110280267|NCT00187070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110280268|NCT00187070|Antimetabolites|antimetabolites|mesh-ancestor
110280269|NCT00187070|Dermatologic Agents|dermatologic agents|mesh-ancestor
110280270|NCT00187070|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110280271|NCT00187070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110280272|NCT00187070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110280274|NCT00187070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110280275|NCT00187070|Tubulin Modulators|tubulin modulators|mesh-ancestor
110280276|NCT00187070|Antimitotic Agents|antimitotic agents|mesh-ancestor
110280277|NCT00187070|Mitosis Modulators|mitosis modulators|mesh-ancestor
110280278|NCT00187070|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110280279|NCT00187070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110299806|NCT04720287|Bupivacaine|bupivacaine|mesh-list
110299807|NCT04720287|Neostigmine|neostigmine|mesh-list
110299808|NCT04720287|Anesthetics, Local|anesthetics, local|mesh-ancestor
110299809|NCT04720287|Anesthetics|anesthetics|mesh-ancestor
110299810|NCT04720287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110299811|NCT04720287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110299812|NCT04720287|Sensory System Agents|sensory system agents|mesh-ancestor
110299813|NCT04720287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110299814|NCT04720287|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110299815|NCT04720287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110299816|NCT04720287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110299817|NCT04720287|Cholinergic Agents|cholinergic agents|mesh-ancestor
110299818|NCT04720287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110299819|NCT04720287|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110299821|NCT00239993|Glatiramer Acetate|glatiramer acetate|mesh-list
110299822|NCT00239993|(T,G)-A-L|(t,g)-a-l|mesh-list
110299823|NCT00239993|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110299824|NCT00239993|Immunologic Factors|immunologic factors|mesh-ancestor
110299825|NCT00239993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110299826|NCT00239993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110299827|NCT00239993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110299828|NCT00264108|Epoetin Alfa|epoetin alfa|mesh-list
110299829|NCT00264108|Darbepoetin alfa|darbepoetin alfa|mesh-list
110299830|NCT00264108|Hematinics|hematinics|mesh-ancestor
110299831|NCT01647412|Curcumin|curcumin|mesh-list
110299832|NCT01647412|Hormones|hormones|mesh-list
110299833|NCT01647412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110299834|NCT01647412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110299835|NCT01647412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110299836|NCT01647412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110299837|NCT01647412|Analgesics|analgesics|mesh-ancestor
110019518|NCT00000174|Protective Agents|protective agents|mesh-ancestor
110299838|NCT01647412|Sensory System Agents|sensory system agents|mesh-ancestor
110299839|NCT01647412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110280280|NCT00187070|Antimalarials|antimalarials|mesh-ancestor
110280281|NCT00187070|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110280282|NCT00187070|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110280283|NCT00211848|Interferons|interferons|mesh-list
110280284|NCT00211848|Ribavirin|ribavirin|mesh-list
110280285|NCT00211848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110280286|NCT00211848|Antiviral Agents|antiviral agents|mesh-ancestor
110280287|NCT00211848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110280288|NCT00211848|Antimetabolites|antimetabolites|mesh-ancestor
110280289|NCT00211848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280290|NCT00412347|Insulin|insulin|mesh-list
110280291|NCT00412347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110299840|NCT01647412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110299841|NCT01647412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110299842|NCT01647412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110299843|NCT01647412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110299844|NCT01647412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110299845|NCT01647529|Ganciclovir|ganciclovir|mesh-list
110299846|NCT01647529|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
110299847|NCT01647529|Antiviral Agents|antiviral agents|mesh-ancestor
110299848|NCT01647529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110299849|NCT01647529|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110299850|NCT01647529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110299851|NCT01647529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110299852|NCT00240032|Cetirizine|cetirizine|mesh-list
110299853|NCT00240032|Glatiramer Acetate|glatiramer acetate|mesh-list
110299854|NCT00240032|(T,G)-A-L|(t,g)-a-l|mesh-list
110299855|NCT00240032|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110299856|NCT00240032|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110299857|NCT00240032|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110299858|NCT00240032|Histamine Antagonists|histamine antagonists|mesh-ancestor
110299859|NCT00240032|Histamine Agents|histamine agents|mesh-ancestor
110299860|NCT00240032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110299880|NCT01647646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110299882|NCT01647685|Methylprednisolone|methylprednisolone|mesh-list
110299883|NCT01647685|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110299884|NCT01647685|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110299885|NCT01647685|Prednisolone|prednisolone|mesh-list
110299886|NCT01647685|Prednisolone acetate|prednisolone acetate|mesh-list
110299887|NCT01647685|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110299888|NCT01647685|Prednisolone phosphate|prednisolone phosphate|mesh-list
110299889|NCT01647685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110299890|NCT01647685|Antiemetics|antiemetics|mesh-ancestor
110299891|NCT01647685|Autonomic Agents|autonomic agents|mesh-ancestor
110299892|NCT01647685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110299893|NCT01647685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110299894|NCT01647685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110299895|NCT01647685|Glucocorticoids|glucocorticoids|mesh-ancestor
110299896|NCT01647685|Hormones|hormones|mesh-ancestor
110299897|NCT01647685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110299898|NCT01647685|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110299899|NCT01647685|Protective Agents|protective agents|mesh-ancestor
110299900|NCT01647685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110299901|NCT01647685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110299902|NCT00240266|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110019541|NCT00000204|Analgesics|analgesics|mesh-ancestor
110299903|NCT00240266|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110299904|NCT00240266|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110299905|NCT00240266|Antimetabolites|antimetabolites|mesh-ancestor
110299906|NCT00240266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110299907|NCT00240266|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110299908|NCT00240266|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110299909|NCT00240266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110299910|NCT01648036|Heparin|heparin|mesh-list
110299911|NCT01648036|Calcium heparin|calcium heparin|mesh-list
110299912|NCT01648036|Dalteparin|dalteparin|mesh-list
110299913|NCT01648036|Tinzaparin|tinzaparin|mesh-list
110280292|NCT00412347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280293|NCT00187499|Fluticasone|fluticasone|mesh-list
110280294|NCT00187499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110280295|NCT00187499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110280296|NCT00187499|Autonomic Agents|autonomic agents|mesh-ancestor
110280297|NCT00187499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110280298|NCT00187499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280299|NCT00187499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110280300|NCT00187499|Respiratory System Agents|respiratory system agents|mesh-ancestor
110280301|NCT00187499|Dermatologic Agents|dermatologic agents|mesh-ancestor
110280302|NCT00187499|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110280303|NCT00212004|Pioglitazone|pioglitazone|mesh-list
110280304|NCT00212004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110280305|NCT00212004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280306|NCT00187577|Bimatoprost|bimatoprost|mesh-list
110280307|NCT00187577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110280308|NCT00187577|Latanoprost|latanoprost|mesh-list
110280309|NCT00187577|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110280310|NCT00187577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110280311|NCT00212043|Carboplatin|carboplatin|mesh-list
110280312|NCT00212043|Gemcitabine|gemcitabine|mesh-list
110280313|NCT00212043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110280314|NCT00212043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110280315|NCT00212043|Antimetabolites|antimetabolites|mesh-ancestor
110280316|NCT00212043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280317|NCT00212082|Docetaxel|docetaxel|mesh-list
110280318|NCT00212082|Doxorubicin|doxorubicin|mesh-list
110280319|NCT00212082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110280320|NCT00212082|Tubulin Modulators|tubulin modulators|mesh-ancestor
110280321|NCT00212082|Antimitotic Agents|antimitotic agents|mesh-ancestor
110280322|NCT00212082|Mitosis Modulators|mitosis modulators|mesh-ancestor
110280323|NCT00212082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280324|NCT00212082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110280325|NCT00212082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110280326|NCT00212082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110280327|NCT00212082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110299914|NCT01648036|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110299915|NCT01648036|Anticoagulants|anticoagulants|mesh-ancestor
110299916|NCT01648036|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110299917|NCT01648036|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110299935|NCT01648231|Vasodilator Agents|vasodilator agents|mesh-ancestor
110280328|NCT00219219|Zoledronic Acid|zoledronic acid|mesh-list
110280329|NCT00219219|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110280330|NCT00219219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280331|NCT00187928|Topiramate|topiramate|mesh-list
110280332|NCT00187928|Anticonvulsants|anticonvulsants|mesh-ancestor
110280333|NCT00187928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110280334|NCT00187928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280335|NCT00212199|Orlistat|orlistat|mesh-list
110280336|NCT00212199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110280337|NCT00212199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280339|NCT00212199|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110280340|NCT00219258|Zoledronic Acid|zoledronic acid|mesh-list
110299936|NCT01648231|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110299937|NCT01648231|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110299938|NCT01648231|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110299939|NCT00264186|Norepinephrine|norepinephrine|mesh-list
110299940|NCT00264186|Nitroglycerin|nitroglycerin|mesh-list
110299941|NCT00264186|Acetylcholine|acetylcholine|mesh-list
110299942|NCT00264186|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110299943|NCT00264186|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110299944|NCT00264186|Adrenergic Agents|adrenergic agents|mesh-ancestor
110299945|NCT00264186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110299946|NCT00264186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110299947|NCT00264186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110299948|NCT00264186|Sympathomimetics|sympathomimetics|mesh-ancestor
110299949|NCT00264186|Autonomic Agents|autonomic agents|mesh-ancestor
110299950|NCT00264186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110299951|NCT00264186|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110299952|NCT00264186|Vasodilator Agents|vasodilator agents|mesh-ancestor
110299953|NCT00264186|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110299954|NCT00264186|Cholinergic Agents|cholinergic agents|mesh-ancestor
110299955|NCT00240422|Telmisartan|telmisartan|mesh-list
110299957|NCT00240422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110299958|NCT00240422|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110299959|NCT00240422|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110299960|NCT00240422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110299961|NCT00240422|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110299962|NCT00240422|Protease Inhibitors|protease inhibitors|mesh-ancestor
110299963|NCT00240422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110299964|NCT00264225|Codeine|codeine|mesh-list
110299965|NCT00264225|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110299966|NCT00264225|Narcotics|narcotics|mesh-ancestor
110299967|NCT00264225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110299968|NCT00264225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110299969|NCT00264225|Analgesics|analgesics|mesh-ancestor
110299970|NCT00264225|Sensory System Agents|sensory system agents|mesh-ancestor
110299971|NCT00264225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110299972|NCT00264225|Antitussive Agents|antitussive agents|mesh-ancestor
110299978|NCT02279563|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110299979|NCT02279563|Autonomic Agents|autonomic agents|mesh-ancestor
110299980|NCT02279563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110299981|NCT02279563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110299982|NCT02279563|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110299983|NCT02279563|Respiratory System Agents|respiratory system agents|mesh-ancestor
110299984|NCT02279563|Dermatologic Agents|dermatologic agents|mesh-ancestor
110299985|NCT02279563|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110299986|NCT02279563|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110299987|NCT02279563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110299988|NCT02279563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280341|NCT00219258|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110280342|NCT00219258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280344|NCT00188006|Anticoagulants|anticoagulants|mesh-ancestor
110280345|NCT00188006|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110280346|NCT00188006|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110280347|NCT00188006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280349|NCT00188045|Spironolactone|spironolactone|mesh-list
110280350|NCT00188045|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110280351|NCT00188045|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110280352|NCT00188045|Adrenergic Agents|adrenergic agents|mesh-ancestor
110280353|NCT00188045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110280354|NCT00188045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280355|NCT00188045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280356|NCT00188045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110280357|NCT00188045|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110280358|NCT00188045|Vasodilator Agents|vasodilator agents|mesh-ancestor
110299989|NCT02279563|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110299990|NCT02279563|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110299991|NCT02279563|Histamine Antagonists|histamine antagonists|mesh-ancestor
110299992|NCT02279563|Histamine Agents|histamine agents|mesh-ancestor
110299993|NCT02279563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110299995|NCT02279758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110299996|NCT02279758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110299997|NCT01649245|Interferons|interferons|mesh-list
110299998|NCT01649245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110299999|NCT01649245|Antiviral Agents|antiviral agents|mesh-ancestor
110300000|NCT01649245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110300001|NCT01649284|Afatinib|afatinib|mesh-list
110300002|NCT01649284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110300003|NCT01649284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110300004|NCT01649284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110300005|NCT01649284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110300007|NCT00415740|Carbidopa|carbidopa|mesh-list
110300008|NCT00415740|Entacapone|entacapone|mesh-list
110300009|NCT00415740|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110300010|NCT00415740|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110300011|NCT00415740|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110300012|NCT00415740|Dopamine Agents|dopamine agents|mesh-ancestor
110300013|NCT00415740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110300014|NCT00415740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110300015|NCT00415740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110300016|NCT00415740|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110300017|NCT00415740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110030934|NCT01389388|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110300018|NCT00415740|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
110300019|NCT00415740|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110300020|NCT00415740|Immunologic Factors|immunologic factors|mesh-ancestor
110300021|NCT00415740|Dopamine Agonists|dopamine agonists|mesh-ancestor
110300022|NCT01649479|Antibodies|antibodies|mesh-list
110300023|NCT01649479|Antibodies, Antiphospholipid|antibodies, antiphospholipid|mesh-list
110300024|NCT01649479|Immunologic Factors|immunologic factors|mesh-ancestor
110300025|NCT01649479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110300026|NCT01649635|Ciprofloxacin|ciprofloxacin|mesh-list
110300027|NCT01649635|Prednisone|prednisone|mesh-list
110280360|NCT00188045|Hormone Antagonists|hormone antagonists|mesh-ancestor
110280361|NCT00188045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110280362|NCT00188045|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110280363|NCT00188045|Diuretics|diuretics|mesh-ancestor
110280364|NCT00188045|Natriuretic Agents|natriuretic agents|mesh-ancestor
110280365|NCT00212277|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110280366|NCT00212277|Norethindrone|norethindrone|mesh-list
110280367|NCT00212277|Norethindrone Acetate|norethindrone acetate|mesh-list
110280368|NCT00212277|Estradiol|estradiol|mesh-list
110280369|NCT00212277|Estrogens|estrogens|mesh-ancestor
110280370|NCT00212277|Hormones|hormones|mesh-ancestor
110280371|NCT00212277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110280372|NCT00212277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280373|NCT00212277|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110300028|NCT01649635|Lenograstim|lenograstim|mesh-list
110300029|NCT01649635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110300030|NCT01649635|Glucocorticoids|glucocorticoids|mesh-ancestor
110300031|NCT01649635|Hormones|hormones|mesh-ancestor
110300032|NCT01649635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110300033|NCT01649635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110300034|NCT01649635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110300035|NCT01649635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110300036|NCT01649635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110300037|NCT01649635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110300038|NCT01649635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110300039|NCT01649635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110300040|NCT01649635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110300041|NCT01649635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110300042|NCT01649635|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110300048|NCT00250536|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
110300049|NCT00250536|Androgens|androgens|mesh-ancestor
110300050|NCT00250536|Hormones|hormones|mesh-ancestor
110300051|NCT00250536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110300052|NCT00250536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110300053|NCT00250536|Anabolic Agents|anabolic agents|mesh-ancestor
110300054|NCT00250536|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110300055|NCT00240617|Naproxen|naproxen|mesh-list
110300056|NCT00240617|Sumatriptan|sumatriptan|mesh-list
110300057|NCT00240617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110300058|NCT00240617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110300059|NCT00240617|Analgesics|analgesics|mesh-ancestor
110300060|NCT00240617|Sensory System Agents|sensory system agents|mesh-ancestor
110300061|NCT00240617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110300062|NCT00240617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110300063|NCT00240617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110300064|NCT00240617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110300065|NCT00240617|Gout Suppressants|gout suppressants|mesh-ancestor
110300066|NCT00240617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110300067|NCT00240617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110300068|NCT00240617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110300069|NCT00240617|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110300070|NCT00240617|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110300071|NCT00240617|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110300072|NCT00240617|Serotonin Agents|serotonin agents|mesh-ancestor
110300073|NCT00240617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110300074|NCT01649830|Temozolomide|temozolomide|mesh-list
110280374|NCT00212277|Contraceptive Agents|contraceptive agents|mesh-ancestor
110280375|NCT00212277|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110280376|NCT00212277|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110280377|NCT00212277|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110280378|NCT00212277|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110280379|NCT00212277|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110280380|NCT00212316|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
110280381|NCT00212316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110280384|NCT00219375|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110280385|NCT00219375|Protease Inhibitors|protease inhibitors|mesh-ancestor
110300075|NCT01649830|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110300076|NCT01649830|Alkylating Agents|alkylating agents|mesh-ancestor
110300077|NCT01649830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110300078|NCT01649830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110300079|NCT00240656|Carvedilol|carvedilol|mesh-list
110300080|NCT00240656|Captopril|captopril|mesh-list
110300081|NCT00240656|Spironolactone|spironolactone|mesh-list
110300082|NCT00240656|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110300083|NCT00240656|Hormone Antagonists|hormone antagonists|mesh-ancestor
110300084|NCT00240656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110300085|NCT00240656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110300086|NCT00240656|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110300087|NCT00240656|Diuretics|diuretics|mesh-ancestor
110300088|NCT00240656|Natriuretic Agents|natriuretic agents|mesh-ancestor
110300089|NCT00240656|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110300090|NCT00240656|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110031009|NCT01389544|Protease Inhibitors|protease inhibitors|mesh-ancestor
110300092|NCT00240656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110300093|NCT00240656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110300094|NCT00240656|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110300095|NCT00240656|Antioxidants|antioxidants|mesh-ancestor
110300096|NCT00240656|Protective Agents|protective agents|mesh-ancestor
110300097|NCT00240656|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110300098|NCT00240656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110300099|NCT00240656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110300100|NCT00240656|Vasodilator Agents|vasodilator agents|mesh-ancestor
110300101|NCT00240656|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110300102|NCT00240656|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110300103|NCT00240656|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110300104|NCT00240656|Protease Inhibitors|protease inhibitors|mesh-ancestor
110300105|NCT00240656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110300106|NCT00250575|Clozapine|clozapine|mesh-list
110300107|NCT00250575|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110300108|NCT00250575|Serotonin Agents|serotonin agents|mesh-ancestor
110300109|NCT00250575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110300110|NCT00250575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110300111|NCT00250575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110300112|NCT00250575|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110300120|NCT00240695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110300121|NCT00240695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110300122|NCT00240695|Cholinergic Agents|cholinergic agents|mesh-ancestor
110300123|NCT00240695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110300124|NCT00240695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110300125|NCT00240695|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110300126|NCT00240695|Autonomic Agents|autonomic agents|mesh-ancestor
110300127|NCT00240695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110300128|NCT00240695|Nootropic Agents|nootropic agents|mesh-ancestor
110300129|NCT00240734|Epoetin Alfa|epoetin alfa|mesh-list
110300130|NCT00240734|Hematinics|hematinics|mesh-ancestor
110280386|NCT00219375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110280387|NCT00219375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280388|NCT00219375|Glycine Agents|glycine agents|mesh-ancestor
110280389|NCT00219375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110280390|NCT00219375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280391|NCT00188240|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110280392|NCT00188240|Antiviral Agents|antiviral agents|mesh-ancestor
110280393|NCT00188240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110300131|NCT04720248|Dipyrone|dipyrone|mesh-list
110300132|NCT04720248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110300133|NCT04720248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110300134|NCT04720248|Analgesics|analgesics|mesh-ancestor
110300135|NCT04720248|Sensory System Agents|sensory system agents|mesh-ancestor
110300136|NCT04720248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110300137|NCT04720248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110300138|NCT04720248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110300139|NCT04720248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110300140|NCT04720248|Antipyretics|antipyretics|mesh-ancestor
110300141|NCT01646515|Udenafil|udenafil|mesh-list
110300142|NCT01646515|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110300143|NCT01646515|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110300144|NCT01646515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110300145|NCT01646515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110300146|NCT00240773|Acetaminophen|acetaminophen|mesh-list
110300147|NCT00240773|Naproxen|naproxen|mesh-list
110300148|NCT00240773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110300149|NCT00240773|Analgesics|analgesics|mesh-ancestor
110300150|NCT00240773|Sensory System Agents|sensory system agents|mesh-ancestor
110300151|NCT00240773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110300152|NCT00240773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110300153|NCT00240773|Antipyretics|antipyretics|mesh-ancestor
110300154|NCT00240773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110300155|NCT00240773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110300156|NCT00240773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110300157|NCT00240773|Gout Suppressants|gout suppressants|mesh-ancestor
110300158|NCT00240773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110300159|NCT00240773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110300160|NCT00240773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110300161|NCT01688401|Melphalan|melphalan|mesh-list
110300162|NCT01688401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110300163|NCT01688401|Alkylating Agents|alkylating agents|mesh-ancestor
110019665|NCT00000306|Dopamine Agents|dopamine agents|mesh-ancestor
110300164|NCT01688401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110300165|NCT01688401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110300166|NCT01688401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110300167|NCT01688401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110300168|NCT01688401|Immunologic Factors|immunologic factors|mesh-ancestor
110300169|NCT01688401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110300170|NCT04708821|Loteprednol Etabonate|loteprednol etabonate|mesh-list
110300171|NCT04708821|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
110300172|NCT04708821|Dexamethasone|dexamethasone|mesh-list
110300173|NCT04708821|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110300174|NCT04708821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110300176|NCT04708821|Autonomic Agents|autonomic agents|mesh-ancestor
110300177|NCT04708821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110300178|NCT04708821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110300179|NCT04708821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110300180|NCT04708821|Glucocorticoids|glucocorticoids|mesh-ancestor
110300186|NCT04708821|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110300187|NCT04708821|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110300188|NCT04708821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110300189|NCT04708821|Analgesics|analgesics|mesh-ancestor
110300190|NCT04708821|Sensory System Agents|sensory system agents|mesh-ancestor
110280395|NCT00188396|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110280396|NCT00188396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110280397|NCT00188396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110280398|NCT00188396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280399|NCT00188396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110280401|NCT00188396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280402|NCT00188396|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110280403|NCT00188396|Antidepressive Agents|antidepressive agents|mesh-ancestor
110280404|NCT00188396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110280405|NCT00219570|Clindamycin|clindamycin|mesh-list
110280406|NCT00219570|Clindamycin palmitate|clindamycin palmitate|mesh-list
110280407|NCT00219570|Clindamycin phosphate|clindamycin phosphate|mesh-list
110280408|NCT00219570|Nadifloxacin|nadifloxacin|mesh-list
110280409|NCT00219570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110300191|NCT04708821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110300192|NCT04708821|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110300193|NCT04708821|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110300194|NCT04708821|Histamine Antagonists|histamine antagonists|mesh-ancestor
110300195|NCT04708821|Histamine Agents|histamine agents|mesh-ancestor
110300196|NCT04708821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110300197|NCT04708821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110300198|NCT00240812|Ibuprofen|ibuprofen|mesh-list
110300199|NCT00240812|Pseudoephedrine|pseudoephedrine|mesh-list
110300200|NCT00240812|Ephedrine|ephedrine|mesh-list
110300201|NCT00240812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110300202|NCT00240812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110300203|NCT00240812|Analgesics|analgesics|mesh-ancestor
110300204|NCT00240812|Sensory System Agents|sensory system agents|mesh-ancestor
110300205|NCT00240812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110300206|NCT00240812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110300207|NCT00240812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110300208|NCT00240812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110300209|NCT00240812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110300210|NCT00240812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110300211|NCT00240812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110300212|NCT00240812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110300213|NCT00240812|Autonomic Agents|autonomic agents|mesh-ancestor
110300214|NCT00240812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110300215|NCT00240812|Respiratory System Agents|respiratory system agents|mesh-ancestor
110300216|NCT00240812|Nasal Decongestants|nasal decongestants|mesh-ancestor
110019675|NCT00000318|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110300217|NCT00240812|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110300218|NCT00240812|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110300220|NCT00240812|Adrenergic Agents|adrenergic agents|mesh-ancestor
110300221|NCT00240812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110300222|NCT01688518|Lidocaine|lidocaine|mesh-list
110300223|NCT01688518|Tetracaine|tetracaine|mesh-list
110300224|NCT01688518|Anesthetics, Local|anesthetics, local|mesh-ancestor
110300225|NCT01688518|Anesthetics|anesthetics|mesh-ancestor
110300226|NCT01688518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110300227|NCT01688518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110300228|NCT01688518|Sensory System Agents|sensory system agents|mesh-ancestor
110300229|NCT01688518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110300230|NCT01688518|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110300231|NCT01688518|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110300232|NCT01688518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110300233|NCT01688518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110280410|NCT00219570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110280411|NCT00219570|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110280412|NCT00219570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110280413|NCT00219570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280414|NCT00219570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110280415|NCT00219570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110280416|NCT00219570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110280418|NCT00212472|Coagulants|coagulants|mesh-ancestor
110280419|NCT00188552|Tocopherols|tocopherols|mesh-list
110280420|NCT00188552|Vitamin E|vitamin e|mesh-list
110280421|NCT00188552|Tocotrienols|tocotrienols|mesh-list
110280422|NCT00188552|alpha-Tocopherol|alpha-tocopherol|mesh-list
110280423|NCT00188552|Pentoxifylline|pentoxifylline|mesh-list
110280424|NCT00188552|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110280425|NCT00188552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110280426|NCT00188552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280427|NCT00188552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110280428|NCT00188552|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110300234|NCT01688518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110300235|NCT00240851|Acetaminophen|acetaminophen|mesh-list
110300236|NCT00240851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110300237|NCT00240851|Analgesics|analgesics|mesh-ancestor
110300238|NCT00240851|Sensory System Agents|sensory system agents|mesh-ancestor
110300239|NCT00240851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110300240|NCT00240851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110300241|NCT00240851|Antipyretics|antipyretics|mesh-ancestor
110300242|NCT00240929|Palivizumab|palivizumab|mesh-list
110300243|NCT00240929|Antiviral Agents|antiviral agents|mesh-ancestor
110300244|NCT00240929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110300245|NCT00250692|Nitrous Oxide|nitrous oxide|mesh-list
110300246|NCT00250692|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110300247|NCT00250692|Anesthetics, General|anesthetics, general|mesh-ancestor
110300248|NCT00250692|Anesthetics|anesthetics|mesh-ancestor
110300249|NCT00250692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110300250|NCT00250692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110300251|NCT00250692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110300263|NCT01688947|Pregabalin|pregabalin|mesh-list
110300264|NCT01688947|Analgesics|analgesics|mesh-ancestor
110300265|NCT01688947|Sensory System Agents|sensory system agents|mesh-ancestor
110300266|NCT01688947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110300267|NCT01688947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110300268|NCT01688947|Anticonvulsants|anticonvulsants|mesh-ancestor
110300269|NCT01688947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110300270|NCT01688947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110300271|NCT01688947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110300273|NCT01688947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110300274|NCT01688947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110300275|NCT01688947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110300276|NCT01688947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110300277|NCT00241007|Valsartan|valsartan|mesh-list
110300278|NCT00241007|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110300279|NCT00241007|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110300280|NCT00241007|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110300281|NCT00241007|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110280429|NCT00188552|Protective Agents|protective agents|mesh-ancestor
110280430|NCT00188552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280431|NCT00188552|Vasodilator Agents|vasodilator agents|mesh-ancestor
110280432|NCT00188552|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110280433|NCT00188552|Antioxidants|antioxidants|mesh-ancestor
110280434|NCT00188552|Vitamins|vitamins|mesh-ancestor
110280436|NCT00188630|Acetylcysteine|acetylcysteine|mesh-list
110280437|NCT00188630|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110280438|NCT00188630|Antiviral Agents|antiviral agents|mesh-ancestor
110300282|NCT00241007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110300283|NCT00241007|Diuretics|diuretics|mesh-ancestor
110300284|NCT00241007|Natriuretic Agents|natriuretic agents|mesh-ancestor
110300285|NCT00241007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110300286|NCT00241007|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110300287|NCT00241007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110300288|NCT01689142|Insulin|insulin|mesh-list
110300289|NCT01689142|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110300290|NCT01689142|Insulin Glargine|insulin glargine|mesh-list
110300291|NCT01689142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110300292|NCT01689142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110300293|NCT00241046|Letrozole|letrozole|mesh-list
110300294|NCT00241046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110300295|NCT00241046|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110300296|NCT00241046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110300297|NCT00241046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110300298|NCT00241046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110300299|NCT00241046|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110300300|NCT00241046|Hormone Antagonists|hormone antagonists|mesh-ancestor
110300301|NCT00241046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110300302|NCT00241046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110300303|NCT01689259|Cyclobenzaprine|cyclobenzaprine|mesh-list
110300304|NCT01689259|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110300305|NCT01689259|Antidepressive Agents|antidepressive agents|mesh-ancestor
110300306|NCT01689259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110300307|NCT01689259|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110300308|NCT01689259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110300309|NCT01689259|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110300310|NCT01689259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110300311|NCT01689259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110300312|NCT01689259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110300314|NCT01689298|Carbetocin|carbetocin|mesh-list
110300322|NCT00241085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110300324|NCT00241124|Lisinopril|lisinopril|mesh-list
110300325|NCT00241124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110300326|NCT00241124|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110300327|NCT00241124|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110300328|NCT00241124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110300329|NCT00241124|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110300330|NCT00241124|Protease Inhibitors|protease inhibitors|mesh-ancestor
110300331|NCT00241124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110300332|NCT00241124|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110300333|NCT00241124|Protective Agents|protective agents|mesh-ancestor
110300334|NCT00241124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110300335|NCT00241163|Thrombin|thrombin|mesh-list
110300336|NCT00241163|Hemostatics|hemostatics|mesh-ancestor
110300337|NCT00241163|Coagulants|coagulants|mesh-ancestor
110300338|NCT02277106|Brexanolone|brexanolone|mesh-list
110300339|NCT02277106|Neurosteroids|neurosteroids|mesh-ancestor
110300340|NCT02277106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110300341|NCT02277106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110300342|NCT02277106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110300343|NCT02277106|GABA Modulators|gaba modulators|mesh-ancestor
110300344|NCT02277106|GABA Agents|gaba agents|mesh-ancestor
110300345|NCT00241241|Interferons|interferons|mesh-list
110300346|NCT00241241|Interferon-alpha|interferon-alpha|mesh-list
110280440|NCT00188630|Expectorants|expectorants|mesh-ancestor
110280441|NCT00188630|Respiratory System Agents|respiratory system agents|mesh-ancestor
110280442|NCT00188630|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110280443|NCT00188630|Antioxidants|antioxidants|mesh-ancestor
110280444|NCT00188630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280445|NCT00188630|Protective Agents|protective agents|mesh-ancestor
110280446|NCT00188630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280447|NCT00188630|Antidotes|antidotes|mesh-ancestor
110280448|NCT00188669|Tocopherols|tocopherols|mesh-list
110280450|NCT00188669|Tocotrienols|tocotrienols|mesh-list
110280451|NCT00188669|alpha-Tocopherol|alpha-tocopherol|mesh-list
110280452|NCT00188669|Pentoxifylline|pentoxifylline|mesh-list
110280453|NCT00188669|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110280454|NCT00188669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110300347|NCT00241241|Interferon alpha-2|interferon alpha-2|mesh-list
110300348|NCT00241241|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110300349|NCT00241241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110300350|NCT00241241|Antiviral Agents|antiviral agents|mesh-ancestor
110300351|NCT00241241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110300352|NCT00241241|Immunologic Factors|immunologic factors|mesh-ancestor
110300353|NCT00241241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110300354|NCT02279602|Fosbretabulin|fosbretabulin|mesh-list
110300355|NCT02279602|Combretastatin|combretastatin|mesh-list
110300356|NCT02279602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110300357|NCT02279602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110300358|NCT02279602|Tubulin Modulators|tubulin modulators|mesh-ancestor
110300359|NCT02279602|Antimitotic Agents|antimitotic agents|mesh-ancestor
110300360|NCT02279602|Mitosis Modulators|mitosis modulators|mesh-ancestor
110300361|NCT02279602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110300362|NCT00241436|Anastrozole|anastrozole|mesh-list
110300363|NCT00241436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110300364|NCT00241436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110300365|NCT00241436|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110300366|NCT00241436|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110300367|NCT00241436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110300368|NCT00241436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110300369|NCT00241436|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110300370|NCT00241436|Hormone Antagonists|hormone antagonists|mesh-ancestor
110300371|NCT00241436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110300372|NCT00241436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110300373|NCT00264420|Zoledronic Acid|zoledronic acid|mesh-list
110300374|NCT00264420|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110300375|NCT00264420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110300376|NCT00241475|Gefitinib|gefitinib|mesh-list
110300377|NCT00241475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110300378|NCT00241475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110300379|NCT00241475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110300380|NCT00241475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280459|NCT00188669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280460|NCT00188669|Vasodilator Agents|vasodilator agents|mesh-ancestor
110280461|NCT00188669|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110280462|NCT00188669|Antioxidants|antioxidants|mesh-ancestor
110280463|NCT00188669|Vitamins|vitamins|mesh-ancestor
110280464|NCT00188669|Micronutrients|micronutrients|mesh-ancestor
110280465|NCT00409214|Talaporfin|talaporfin|mesh-list
110280466|NCT00409214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110280467|NCT00409214|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110300396|NCT02218762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110300397|NCT02218762|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110300398|NCT02218762|Respiratory System Agents|respiratory system agents|mesh-ancestor
110300399|NCT02218762|Dermatologic Agents|dermatologic agents|mesh-ancestor
110300400|NCT02218762|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110300401|NCT02218762|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110300402|NCT02218762|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110300403|NCT02218762|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110300404|NCT02218762|Adrenergic Agents|adrenergic agents|mesh-ancestor
110300405|NCT02218762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110300406|NCT02218762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110300407|NCT02218762|Glucocorticoids|glucocorticoids|mesh-ancestor
110300408|NCT02218762|Hormones|hormones|mesh-ancestor
110300409|NCT02218762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110300410|NCT02218762|Sympathomimetics|sympathomimetics|mesh-ancestor
110300411|NCT00264459|Immunomodulating Agents|immunomodulating agents|mesh-list
110300412|NCT00264459|Immunologic Factors|immunologic factors|mesh-list
110300413|NCT00264459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280468|NCT00409214|Dermatologic Agents|dermatologic agents|mesh-ancestor
110280470|NCT02963051|Disulfiram|disulfiram|mesh-list
110280471|NCT02963051|Trace Elements|trace elements|mesh-ancestor
110280472|NCT02963051|Micronutrients|micronutrients|mesh-ancestor
110280473|NCT02963051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280474|NCT02963051|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110280475|NCT02963051|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
110280476|NCT02963051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110280477|NCT02963051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280478|NCT00219726|Imatinib Mesylate|imatinib mesylate|mesh-list
110280479|NCT00219726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110280480|NCT00219726|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110280481|NCT00219726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110280482|NCT00219726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280483|NCT00409253|Nicardipine|nicardipine|mesh-list
110280484|NCT00409253|Urapidil|urapidil|mesh-list
110280485|NCT00409253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110300414|NCT00241514|Esomeprazole|esomeprazole|mesh-list
110300415|NCT00241514|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110300416|NCT00241514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110300417|NCT00241514|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110300418|NCT00241514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110300419|NCT00241514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110300420|NCT02218879|Dimethyl Fumarate|dimethyl fumarate|mesh-list
110300421|NCT02218879|Dermatologic Agents|dermatologic agents|mesh-ancestor
110300422|NCT02218879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110300423|NCT02218879|Immunologic Factors|immunologic factors|mesh-ancestor
110300424|NCT02218879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110300425|NCT00241553|Esomeprazole|esomeprazole|mesh-list
110300426|NCT00241553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110300427|NCT00241553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110300428|NCT00241553|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110300429|NCT00241553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110300430|NCT00241553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110300431|NCT02219152|Tranexamic Acid|tranexamic acid|mesh-list
110300432|NCT02219152|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110300433|NCT02219152|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110300434|NCT02219152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110300435|NCT02219152|Hemostatics|hemostatics|mesh-ancestor
110300436|NCT02219152|Coagulants|coagulants|mesh-ancestor
110300437|NCT00264615|Lamotrigine|lamotrigine|mesh-list
110300438|NCT00264615|Anticonvulsants|anticonvulsants|mesh-ancestor
110300439|NCT00264615|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110300440|NCT00264615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110300441|NCT00264615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110300442|NCT00264615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110300443|NCT00264615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110300444|NCT00264615|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110300445|NCT00264615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110300446|NCT00264615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110300447|NCT00264615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110300448|NCT00264615|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110300449|NCT02219191|Puerarin|puerarin|mesh-list
110300450|NCT02219191|Atorvastatin|atorvastatin|mesh-list
110300451|NCT02219191|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110300452|NCT02219191|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110280487|NCT00409253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110280488|NCT00409253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280489|NCT00409253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110280490|NCT00409253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280491|NCT00409253|Vasodilator Agents|vasodilator agents|mesh-ancestor
110280492|NCT00409253|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110280493|NCT00409253|Serotonin Agents|serotonin agents|mesh-ancestor
110300453|NCT02219191|Antimetabolites|antimetabolites|mesh-ancestor
110300458|NCT02219191|Vasodilator Agents|vasodilator agents|mesh-ancestor
110019745|NCT00000384|Sertraline|sertraline|mesh-list
110300459|NCT04529512|Dexamethasone|dexamethasone|mesh-list
110300460|NCT04529512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110300461|NCT04529512|Antiemetics|antiemetics|mesh-ancestor
110300462|NCT04529512|Autonomic Agents|autonomic agents|mesh-ancestor
110031385|NCT01391845|Ulipristal acetate|ulipristal acetate|mesh-list
110300463|NCT04529512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110300464|NCT04529512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110300465|NCT04529512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110300467|NCT04529512|Hormones|hormones|mesh-ancestor
110300468|NCT04529512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110300469|NCT04529512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110300470|NCT04529512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110300471|NCT04720131|Capecitabine|capecitabine|mesh-list
110300472|NCT04720131|Apatinib|apatinib|mesh-list
110300473|NCT04720131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110300474|NCT04720131|Antimetabolites|antimetabolites|mesh-ancestor
110300475|NCT04720131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110300476|NCT04720131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110300477|NCT04720131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110300478|NCT04720131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110300479|NCT00241670|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110300480|NCT00241670|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110300481|NCT00241670|Dermatologic Agents|dermatologic agents|mesh-ancestor
110300482|NCT02219737|Rituximab|rituximab|mesh-list
110300483|NCT02219737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110300484|NCT02219737|Carboplatin|carboplatin|mesh-list
110300485|NCT02219737|Etoposide|etoposide|mesh-list
110300486|NCT02219737|Etoposide phosphate|etoposide phosphate|mesh-list
110300487|NCT02219737|Ifosfamide|ifosfamide|mesh-list
110300488|NCT02219737|Isophosphamide mustard|isophosphamide mustard|mesh-list
110300489|NCT02219737|Podophyllotoxin|podophyllotoxin|mesh-list
110300490|NCT02219737|Antibodies|antibodies|mesh-list
110300491|NCT02219737|Immunoglobulins|immunoglobulins|mesh-list
110300492|NCT02219737|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110300493|NCT02219737|Immunologic Factors|immunologic factors|mesh-ancestor
110300494|NCT02219737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110300495|NCT02219737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110300496|NCT02219737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110300497|NCT02219737|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110300498|NCT02219737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110300499|NCT02219737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110300500|NCT02219737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110300501|NCT02219737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110300502|NCT02219737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110300503|NCT02219737|Alkylating Agents|alkylating agents|mesh-ancestor
110300504|NCT02219737|Keratolytic Agents|keratolytic agents|mesh-ancestor
110300505|NCT02219737|Dermatologic Agents|dermatologic agents|mesh-ancestor
110300506|NCT02219737|Tubulin Modulators|tubulin modulators|mesh-ancestor
110300507|NCT02219737|Antimitotic Agents|antimitotic agents|mesh-ancestor
110300508|NCT02219737|Mitosis Modulators|mitosis modulators|mesh-ancestor
110300509|NCT02219893|Immunotoxins|immunotoxins|mesh-list
110300510|NCT02219893|MOC31PE immunotoxin|moc31pe immunotoxin|mesh-list
110300511|NCT02219893|Immunoconjugates|immunoconjugates|mesh-ancestor
110300512|NCT02219893|Immunologic Factors|immunologic factors|mesh-ancestor
110300513|NCT02219893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110300514|NCT02212951|Insulin Lispro|insulin lispro|mesh-list
110300515|NCT02212951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110300516|NCT02212951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280494|NCT00409253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110280495|NCT00409253|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110280496|NCT00409253|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110280497|NCT00409253|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110280498|NCT00409253|Adrenergic Agents|adrenergic agents|mesh-ancestor
110280501|NCT00219765|Daunorubicin|daunorubicin|mesh-list
110280502|NCT00219765|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110280503|NCT00219765|Antimetabolites|antimetabolites|mesh-ancestor
110280504|NCT00219765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280505|NCT00219765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110280506|NCT00219765|Antiviral Agents|antiviral agents|mesh-ancestor
110280507|NCT00219765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110300517|NCT02210806|Albuterol|albuterol|mesh-list
110300518|NCT02210806|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110300519|NCT02210806|Autonomic Agents|autonomic agents|mesh-ancestor
110300520|NCT02210806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110300521|NCT02210806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110300522|NCT02210806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110300523|NCT02210806|Respiratory System Agents|respiratory system agents|mesh-ancestor
110300524|NCT02210806|Tocolytic Agents|tocolytic agents|mesh-ancestor
110300525|NCT02210806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110300534|NCT00264654|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110300535|NCT00264654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110031458|NCT01392430|Hormone Antagonists|hormone antagonists|mesh-ancestor
110300536|NCT00264654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110300537|NCT00264654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110300538|NCT00264654|Serotonin Agents|serotonin agents|mesh-ancestor
110300539|NCT00264654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110300540|NCT00264654|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110300541|NCT00264654|Antidepressive Agents|antidepressive agents|mesh-ancestor
110300542|NCT00264654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110300543|NCT00264654|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110300544|NCT00264654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110300545|NCT00264654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110300547|NCT02219659|Midazolam|midazolam|mesh-list
110300548|NCT02219659|Propofol|propofol|mesh-list
110300549|NCT02219659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110300550|NCT02219659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110300551|NCT02219659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110300552|NCT02219659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110300553|NCT02219659|Anesthetics, General|anesthetics, general|mesh-ancestor
110300554|NCT02219659|Anesthetics|anesthetics|mesh-ancestor
110300555|NCT02219659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110300556|NCT02219659|Narcotics|narcotics|mesh-ancestor
110300558|NCT02219659|Sensory System Agents|sensory system agents|mesh-ancestor
110300559|NCT02219659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110300560|NCT02219659|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110300561|NCT02219659|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110300562|NCT02219659|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110300563|NCT02219659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110300564|NCT02219659|GABA Modulators|gaba modulators|mesh-ancestor
110300565|NCT02219659|GABA Agents|gaba agents|mesh-ancestor
110300566|NCT02219659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110300567|NCT02219659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110300568|NCT00241982|Prednisolone|prednisolone|mesh-list
110300571|NCT00241982|Hormones|hormones|mesh-ancestor
110280508|NCT00219765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110280509|NCT00219765|Immunologic Factors|immunologic factors|mesh-ancestor
110280510|NCT00219765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280511|NCT00219765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110280512|NCT00219765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110280513|NCT00219765|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110280514|NCT00219765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110280515|NCT00219765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110280516|NCT00212589|Leucovorin|leucovorin|mesh-list
110280517|NCT00212589|Folic Acid|folic acid|mesh-list
110280518|NCT00212589|Fluorouracil|fluorouracil|mesh-list
110280520|NCT00212589|Levoleucovorin|levoleucovorin|mesh-list
110280521|NCT00212589|Antimetabolites|antimetabolites|mesh-ancestor
110300572|NCT00241982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110300573|NCT00241982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110300574|NCT00241982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110300575|NCT00241982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110300576|NCT02212015|Paclitaxel|paclitaxel|mesh-list
110300577|NCT02212015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110300578|NCT02212015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110300579|NCT02212015|Tubulin Modulators|tubulin modulators|mesh-ancestor
110300580|NCT02212015|Antimitotic Agents|antimitotic agents|mesh-ancestor
110300581|NCT02212015|Mitosis Modulators|mitosis modulators|mesh-ancestor
110300582|NCT02212015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110300583|NCT04720859|Canagliflozin|canagliflozin|mesh-list
110300584|NCT04720859|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110300585|NCT04720859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110300586|NCT04720859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110300587|NCT04720859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110300588|NCT02961842|Ephedrine|ephedrine|mesh-list
110300589|NCT02961842|Fentanyl|fentanyl|mesh-list
110300590|NCT02961842|Bupivacaine|bupivacaine|mesh-list
110300601|NCT02961842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110300602|NCT02961842|Anesthetics, General|anesthetics, general|mesh-ancestor
110300603|NCT02961842|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110300604|NCT02961842|Sympathomimetics|sympathomimetics|mesh-ancestor
110300605|NCT02961842|Autonomic Agents|autonomic agents|mesh-ancestor
110300606|NCT02961842|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110300607|NCT02961842|Adrenergic Agents|adrenergic agents|mesh-ancestor
110300608|NCT02961842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110300609|NCT02961842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110031533|NCT01392807|Naloxegol|naloxegol|mesh-list
110300611|NCT00272805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110300612|NCT00272805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110300613|NCT00272805|Adrenergic Agents|adrenergic agents|mesh-ancestor
110300614|NCT00272805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110300615|NCT00272805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110300617|NCT00272805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110300618|NCT00272805|Antioxidants|antioxidants|mesh-ancestor
110300619|NCT00272805|Protective Agents|protective agents|mesh-ancestor
110300620|NCT00272805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110300621|NCT00272805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110300622|NCT00272805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110300623|NCT00272805|Vasodilator Agents|vasodilator agents|mesh-ancestor
110300624|NCT00272805|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110300625|NCT00272805|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110300626|NCT00242177|Pioglitazone|pioglitazone|mesh-list
110300627|NCT00242177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110280522|NCT00212589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280523|NCT00212589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110280525|NCT00212589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110280526|NCT00212589|Immunologic Factors|immunologic factors|mesh-ancestor
110280527|NCT00212589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280528|NCT00212589|Antidotes|antidotes|mesh-ancestor
110280529|NCT00212589|Protective Agents|protective agents|mesh-ancestor
110280530|NCT00212589|Vitamin B Complex|vitamin b complex|mesh-ancestor
110280531|NCT00212589|Vitamins|vitamins|mesh-ancestor
110280532|NCT00212589|Micronutrients|micronutrients|mesh-ancestor
110280533|NCT00212589|Hematinics|hematinics|mesh-ancestor
110280534|NCT00188825|Basiliximab|basiliximab|mesh-list
110280535|NCT00188825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110280536|NCT00188825|Immunologic Factors|immunologic factors|mesh-ancestor
110300628|NCT00242177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110300629|NCT00264927|Satavaptan|satavaptan|mesh-list
110300630|NCT00264927|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110300631|NCT00264927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110300632|NCT00264927|Natriuretic Agents|natriuretic agents|mesh-ancestor
110300633|NCT00264927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110300634|NCT00242372|Insulin|insulin|mesh-list
110300635|NCT00242372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110300636|NCT00242372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110300637|NCT00265005|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110300638|NCT00265005|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110300639|NCT00265005|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110300640|NCT00265005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110300641|NCT00242411|Budesonide|budesonide|mesh-list
110300642|NCT00242411|Formoterol Fumarate|formoterol fumarate|mesh-list
110300643|NCT00242411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110300644|NCT00242411|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110300645|NCT00242411|Autonomic Agents|autonomic agents|mesh-ancestor
110300646|NCT00242411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110300647|NCT00242411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110300648|NCT00242411|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110300649|NCT00242411|Respiratory System Agents|respiratory system agents|mesh-ancestor
110300650|NCT00242411|Glucocorticoids|glucocorticoids|mesh-ancestor
110300651|NCT00242411|Hormones|hormones|mesh-ancestor
110300652|NCT00242411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110300653|NCT00242411|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110300678|NCT00242450|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110300679|NCT00242450|Dopamine Agents|dopamine agents|mesh-ancestor
110300680|NCT00242450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110300681|NCT00242450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110300682|NCT00273039|Paroxetine|paroxetine|mesh-list
110300683|NCT00273039|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110031618|NCT01393145|Hormones|hormones|mesh-ancestor
110300684|NCT00273039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110300685|NCT00273039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110300686|NCT00273039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110300687|NCT00273039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110300688|NCT00273039|Serotonin Agents|serotonin agents|mesh-ancestor
110300689|NCT00273039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110300690|NCT00273039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110300691|NCT00273039|Antidepressive Agents|antidepressive agents|mesh-ancestor
110300692|NCT00273039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110300693|NCT00273039|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110300694|NCT00273039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110280537|NCT00188825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280538|NCT00219804|Tetrabenazine|tetrabenazine|mesh-list
110280539|NCT00219804|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110280540|NCT00219804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110280541|NCT00219804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110280542|NCT00219804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280543|NCT00219804|Adrenergic Agents|adrenergic agents|mesh-ancestor
110280544|NCT00219804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110280545|NCT00219804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280546|NCT00188864|Dexamethasone|dexamethasone|mesh-list
110280547|NCT00188864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110280548|NCT00188864|Antiemetics|antiemetics|mesh-ancestor
110280549|NCT00188864|Autonomic Agents|autonomic agents|mesh-ancestor
110300695|NCT00273039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110300696|NCT00242528|Zoledronic Acid|zoledronic acid|mesh-list
110300697|NCT00242528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110300698|NCT00242528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110300699|NCT00242606|Lamotrigine|lamotrigine|mesh-list
110300700|NCT00242606|Levetiracetam|levetiracetam|mesh-list
110300701|NCT00242606|Anticonvulsants|anticonvulsants|mesh-ancestor
110300705|NCT00242606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110300706|NCT00242606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110300707|NCT00242606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110300708|NCT00242606|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110300709|NCT00242606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110300710|NCT00242606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110300711|NCT00242606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110300712|NCT00242606|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110300713|NCT00242762|Docetaxel|docetaxel|mesh-list
110300714|NCT00242762|Gefitinib|gefitinib|mesh-list
110300715|NCT00242762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110300716|NCT00242762|Tubulin Modulators|tubulin modulators|mesh-ancestor
110300717|NCT00242762|Antimitotic Agents|antimitotic agents|mesh-ancestor
110300718|NCT00242762|Mitosis Modulators|mitosis modulators|mesh-ancestor
110300719|NCT00242762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110300720|NCT00242762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110300721|NCT00242762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110300722|NCT00242801|Gefitinib|gefitinib|mesh-list
110300723|NCT00242801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110300724|NCT00242801|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110300725|NCT00242801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110300726|NCT00242801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110300727|NCT00242879|Ritonavir|ritonavir|mesh-list
110300728|NCT00242879|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110300729|NCT00242879|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110300731|NCT00242879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110300732|NCT00242879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110300733|NCT00242879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110300734|NCT00242879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110300735|NCT00242879|Antiviral Agents|antiviral agents|mesh-ancestor
110300736|NCT00242879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110300737|NCT00242879|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110300738|NCT00242879|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110300740|NCT00282594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110300741|NCT00282594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110300742|NCT00242918|Docetaxel|docetaxel|mesh-list
110300743|NCT00242918|Gefitinib|gefitinib|mesh-list
110300744|NCT00242918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110300745|NCT00242918|Tubulin Modulators|tubulin modulators|mesh-ancestor
110280550|NCT00188864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110280551|NCT00188864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280552|NCT00188864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110280553|NCT00188864|Glucocorticoids|glucocorticoids|mesh-ancestor
110280555|NCT00188864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110280556|NCT00188864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110280557|NCT00188864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110280558|NCT00188942|Olanzapine|olanzapine|mesh-list
110280559|NCT00188942|Fluoxetine|fluoxetine|mesh-list
110280560|NCT00188942|Antiemetics|antiemetics|mesh-ancestor
110280561|NCT00188942|Autonomic Agents|autonomic agents|mesh-ancestor
110280562|NCT00188942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110300746|NCT00242918|Antimitotic Agents|antimitotic agents|mesh-ancestor
110300747|NCT00242918|Mitosis Modulators|mitosis modulators|mesh-ancestor
110300748|NCT00242918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110300749|NCT00242918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110300750|NCT00242918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110300751|NCT00273312|Epothilone B|epothilone b|mesh-list
110300752|NCT00273312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110300753|NCT00273312|Tubulin Modulators|tubulin modulators|mesh-ancestor
110300754|NCT00273312|Antimitotic Agents|antimitotic agents|mesh-ancestor
110300755|NCT00273312|Mitosis Modulators|mitosis modulators|mesh-ancestor
110300756|NCT00273312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110300757|NCT00242996|Cyclophosphamide|cyclophosphamide|mesh-list
110300758|NCT00242996|Carmustine|carmustine|mesh-list
110300759|NCT00242996|Rituximab|rituximab|mesh-list
110300760|NCT00242996|Etoposide|etoposide|mesh-list
110300761|NCT00242996|Sargramostim|sargramostim|mesh-list
110300762|NCT00242996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110300763|NCT00242996|Immunologic Factors|immunologic factors|mesh-ancestor
110300764|NCT00242996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110300765|NCT00242996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110300766|NCT00242996|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110300767|NCT00242996|Alkylating Agents|alkylating agents|mesh-ancestor
110300768|NCT00242996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110300769|NCT00242996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110300770|NCT00242996|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110300771|NCT00242996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110300772|NCT00242996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110300773|NCT00242996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110300795|NCT00273429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110300796|NCT00273429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110300797|NCT00273429|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110300798|NCT00273429|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110300799|NCT00273429|Adrenergic Agents|adrenergic agents|mesh-ancestor
110300800|NCT00273429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110300801|NCT00273429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110300802|NCT00273429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110300803|NCT00273429|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110300804|NCT00273429|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110300805|NCT00273429|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110300806|NCT00273429|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110300808|NCT00273468|Antiemetics|antiemetics|mesh-ancestor
110300809|NCT00273468|Autonomic Agents|autonomic agents|mesh-ancestor
110300810|NCT00273468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110300811|NCT00273468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110300812|NCT00273468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110300813|NCT00273468|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110300814|NCT00273468|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110280563|NCT00188942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280564|NCT00188942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110280565|NCT00188942|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110280566|NCT00188942|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110280567|NCT00188942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110280568|NCT00188942|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110280569|NCT00188942|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110280570|NCT00188942|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110280571|NCT00188942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110300815|NCT00273468|Serotonin Agents|serotonin agents|mesh-ancestor
110300816|NCT00273468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110300817|NCT00273468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110300818|NCT00243464|Betamethasone|betamethasone|mesh-list
110300819|NCT00243464|Betamethasone Valerate|betamethasone valerate|mesh-list
110300820|NCT00243464|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
110300821|NCT00243464|Betamethasone benzoate|betamethasone benzoate|mesh-list
110300822|NCT00243464|Calcipotriene|calcipotriene|mesh-list
110300823|NCT00243464|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
110300824|NCT00243464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110300825|NCT00243464|Glucocorticoids|glucocorticoids|mesh-ancestor
110300826|NCT00243464|Hormones|hormones|mesh-ancestor
110300827|NCT00243464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110300828|NCT00243464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110300829|NCT00243464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110300830|NCT00243464|Respiratory System Agents|respiratory system agents|mesh-ancestor
110300836|NCT00273507|Tubulin Modulators|tubulin modulators|mesh-ancestor
110300837|NCT00273507|Antimitotic Agents|antimitotic agents|mesh-ancestor
110300838|NCT00273507|Mitosis Modulators|mitosis modulators|mesh-ancestor
110300839|NCT00273507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110300841|NCT00282945|Rosiglitazone|rosiglitazone|mesh-list
110300842|NCT00282945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110300843|NCT00282945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110300844|NCT00273546|Docetaxel|docetaxel|mesh-list
110300845|NCT00273546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110300846|NCT00273546|Tubulin Modulators|tubulin modulators|mesh-ancestor
110300847|NCT00273546|Antimitotic Agents|antimitotic agents|mesh-ancestor
110300848|NCT00273546|Mitosis Modulators|mitosis modulators|mesh-ancestor
110019859|NCT00000660|Etoposide|etoposide|mesh-list
110300851|NCT00283101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110300852|NCT00283101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110300853|NCT00243737|Artesunate|artesunate|mesh-list
110300854|NCT00243737|Mefloquine|mefloquine|mesh-list
110300855|NCT00243737|Antimalarials|antimalarials|mesh-ancestor
110300856|NCT00243737|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110300857|NCT00243737|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110300858|NCT00243737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110300859|NCT00243737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110300860|NCT00243737|Antiviral Agents|antiviral agents|mesh-ancestor
110300861|NCT00243737|Schistosomicides|schistosomicides|mesh-ancestor
110300862|NCT00243737|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110300863|NCT00243737|Anthelmintics|anthelmintics|mesh-ancestor
110300864|NCT00273702|Acetylcysteine|acetylcysteine|mesh-list
110300865|NCT00273702|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110300866|NCT00273702|Antiviral Agents|antiviral agents|mesh-ancestor
110300867|NCT00273702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110300868|NCT00273702|Expectorants|expectorants|mesh-ancestor
110300869|NCT00273702|Respiratory System Agents|respiratory system agents|mesh-ancestor
110300870|NCT00273702|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110300871|NCT00273702|Antioxidants|antioxidants|mesh-ancestor
110300872|NCT00273702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110300873|NCT00273702|Protective Agents|protective agents|mesh-ancestor
110300874|NCT00273702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110300875|NCT00273702|Antidotes|antidotes|mesh-ancestor
110300876|NCT00243815|Ibuprofen|ibuprofen|mesh-list
110300877|NCT00243815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110280572|NCT00188942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280573|NCT00188942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110280575|NCT00188942|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110280576|NCT00188942|Antidepressive Agents|antidepressive agents|mesh-ancestor
110280577|NCT00188942|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110280578|NCT00188942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110280579|NCT00188942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110280580|NCT00219882|Turmeric extract|turmeric extract|mesh-list
110280581|NCT00219882|Antioxidants|antioxidants|mesh-ancestor
110300878|NCT00243815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110300879|NCT00243815|Analgesics|analgesics|mesh-ancestor
110300880|NCT00243815|Sensory System Agents|sensory system agents|mesh-ancestor
110300881|NCT00243815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110300882|NCT00243815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110300883|NCT00243815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110300884|NCT00243815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110300885|NCT00243815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110300886|NCT00243815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110300887|NCT00243815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110300888|NCT00283179|Risperidone|risperidone|mesh-list
110300889|NCT00283179|Aripiprazole|aripiprazole|mesh-list
110300890|NCT00283179|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110300891|NCT00283179|Serotonin Agents|serotonin agents|mesh-ancestor
110300892|NCT00283179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110300893|NCT00283179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110300894|NCT00283179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110300895|NCT00283179|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110300896|NCT00283179|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110300897|NCT00283179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110300898|NCT00283179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110300899|NCT00283179|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110300900|NCT00283179|Dopamine Agents|dopamine agents|mesh-ancestor
110019876|NCT00000714|Leucovorin|leucovorin|mesh-list
110300902|NCT00283179|Dopamine Agonists|dopamine agonists|mesh-ancestor
110300903|NCT00283179|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110300913|NCT00273741|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110300914|NCT00273741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110300915|NCT00273741|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110300916|NCT00273741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110300917|NCT00273741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110300918|NCT00273741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110300919|NCT00273741|Dopamine Agents|dopamine agents|mesh-ancestor
110300920|NCT00273741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110300921|NCT02279134|Paclitaxel|paclitaxel|mesh-list
110300922|NCT02279134|Nedaplatin|nedaplatin|mesh-list
110300923|NCT02279134|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110300924|NCT02279134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110300925|NCT02279134|Tubulin Modulators|tubulin modulators|mesh-ancestor
110300926|NCT02279134|Antimitotic Agents|antimitotic agents|mesh-ancestor
110300927|NCT02279134|Mitosis Modulators|mitosis modulators|mesh-ancestor
110300928|NCT02279134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110300929|NCT00243893|Doxycycline|doxycycline|mesh-list
110300930|NCT00243893|Minocycline|minocycline|mesh-list
110300931|NCT00243893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110300932|NCT00243893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110300933|NCT00243893|Antimalarials|antimalarials|mesh-ancestor
110300934|NCT00243893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110300935|NCT00243893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110300936|NCT00283218|Insulin Aspart|insulin aspart|mesh-list
110300937|NCT00283218|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110300938|NCT00283218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110280582|NCT00219882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280583|NCT00219882|Protective Agents|protective agents|mesh-ancestor
110280584|NCT00219882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280585|NCT00189020|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110280586|NCT00189020|Immunologic Factors|immunologic factors|mesh-ancestor
110280587|NCT00189020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280588|NCT00219921|Morphine|morphine|mesh-list
110280589|NCT00219921|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110280590|NCT00219921|Narcotics|narcotics|mesh-ancestor
110280591|NCT00219921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110280592|NCT00219921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110300939|NCT00283218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110300940|NCT00244127|Prednisone|prednisone|mesh-list
110300941|NCT00244127|Cyclophosphamide|cyclophosphamide|mesh-list
110300942|NCT00244127|Rituximab|rituximab|mesh-list
110300943|NCT00244127|Vincristine|vincristine|mesh-list
110300944|NCT00244127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110300945|NCT00244127|Immunologic Factors|immunologic factors|mesh-ancestor
110300946|NCT00244127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110300947|NCT00244127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110300948|NCT00244127|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110300949|NCT00244127|Alkylating Agents|alkylating agents|mesh-ancestor
110300950|NCT00244127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110300951|NCT00244127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110300952|NCT00244127|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110300953|NCT00244127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110300954|NCT00244127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110300955|NCT00244127|Glucocorticoids|glucocorticoids|mesh-ancestor
110300957|NCT00244127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110300958|NCT00244127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110019887|NCT00000714|Antifungal Agents|antifungal agents|mesh-ancestor
110300959|NCT00244127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110300960|NCT00244127|Tubulin Modulators|tubulin modulators|mesh-ancestor
110300961|NCT00244127|Antimitotic Agents|antimitotic agents|mesh-ancestor
110300962|NCT00244127|Mitosis Modulators|mitosis modulators|mesh-ancestor
110300963|NCT00244166|Prednisolone|prednisolone|mesh-list
110300964|NCT00244166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110300965|NCT00244166|Glucocorticoids|glucocorticoids|mesh-ancestor
110300966|NCT00244166|Hormones|hormones|mesh-ancestor
110300967|NCT00244166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110300972|NCT00273975|Zidovudine|zidovudine|mesh-list
110300973|NCT00273975|Nevirapine|nevirapine|mesh-list
110300974|NCT00273975|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110300975|NCT00273975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110300976|NCT00273975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110300977|NCT00273975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110300978|NCT00273975|Antiviral Agents|antiviral agents|mesh-ancestor
110300979|NCT00273975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110300980|NCT00273975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110300981|NCT00273975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110300982|NCT00273975|Antimetabolites|antimetabolites|mesh-ancestor
110300983|NCT00273975|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110300984|NCT00273975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110300985|NCT00244283|Sevoflurane|sevoflurane|mesh-list
110300986|NCT00244283|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110300987|NCT00244283|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110300988|NCT00244283|Anesthetics, General|anesthetics, general|mesh-ancestor
110300989|NCT00244283|Anesthetics|anesthetics|mesh-ancestor
110300990|NCT00244283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110300991|NCT00244283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110300992|NCT00283335|Gemfibrozil|gemfibrozil|mesh-list
110280593|NCT00219921|Analgesics|analgesics|mesh-ancestor
110280594|NCT00219921|Sensory System Agents|sensory system agents|mesh-ancestor
110280595|NCT00219921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110280596|NCT00212823|Almotriptan|almotriptan|mesh-list
110280597|NCT00212823|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110280598|NCT00212823|Serotonin Agents|serotonin agents|mesh-ancestor
110280599|NCT00212823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110280600|NCT00212823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280601|NCT00212823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280602|NCT00189059|Amitriptyline|amitriptyline|mesh-list
110280603|NCT00189059|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110300993|NCT00283335|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110300994|NCT00283335|Antimetabolites|antimetabolites|mesh-ancestor
110300995|NCT00283335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110300996|NCT00283335|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110300997|NCT00283335|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110300998|NCT00283335|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110300999|NCT00283335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110301000|NCT00244322|N2-((2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-N1-((7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-L-alaninamide|n2-((2s)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-n1-((7s)-5-methyl-6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-l-alaninamide|mesh-list
110301001|NCT00244322|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
110301002|NCT00244322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110301003|NCT00244322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110301005|NCT00244361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110301006|NCT00244361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110301007|NCT00244361|Immunologic Factors|immunologic factors|mesh-ancestor
110301008|NCT00244361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110301010|NCT00274014|Tiotropium Bromide|tiotropium bromide|mesh-list
110301011|NCT00274014|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110301012|NCT00274014|Autonomic Agents|autonomic agents|mesh-ancestor
110301013|NCT00274014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110301014|NCT00274014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110301015|NCT00274014|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110301016|NCT00274014|Respiratory System Agents|respiratory system agents|mesh-ancestor
110301017|NCT00274014|Parasympatholytics|parasympatholytics|mesh-ancestor
110301018|NCT00274014|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110301019|NCT00274014|Cholinergic Agents|cholinergic agents|mesh-ancestor
110301020|NCT00274014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110301021|NCT00274014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110301022|NCT00244439|Permethrin|permethrin|mesh-list
110301023|NCT00244439|Malathion|malathion|mesh-list
110301024|NCT00244439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110301025|NCT00244439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110301026|NCT00244439|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110301027|NCT00244439|Cholinergic Agents|cholinergic agents|mesh-ancestor
110301028|NCT00244439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110301029|NCT00244439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110301030|NCT00417144|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110301031|NCT00417144|Ganirelix|ganirelix|mesh-list
110301032|NCT00417144|Luteolytic Agents|luteolytic agents|mesh-ancestor
110301033|NCT00417144|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110301034|NCT00417144|Contraceptive Agents|contraceptive agents|mesh-ancestor
110301035|NCT00417144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110301041|NCT00417144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110301043|NCT00274053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110301044|NCT00274053|Autonomic Agents|autonomic agents|mesh-ancestor
110301045|NCT00274053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110301046|NCT00274053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280604|NCT00189059|Antidepressive Agents|antidepressive agents|mesh-ancestor
110280605|NCT00189059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110280606|NCT00189059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110280607|NCT00189059|Analgesics|analgesics|mesh-ancestor
110280608|NCT00189059|Sensory System Agents|sensory system agents|mesh-ancestor
110280609|NCT00189059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110280610|NCT00189059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280611|NCT00189059|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110280612|NCT00189059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110301047|NCT00274053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110301048|NCT00274053|Respiratory System Agents|respiratory system agents|mesh-ancestor
110301049|NCT00274053|Parasympatholytics|parasympatholytics|mesh-ancestor
110301050|NCT00274053|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110301051|NCT00274053|Cholinergic Agents|cholinergic agents|mesh-ancestor
110301052|NCT00274053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110301053|NCT00274053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110301054|NCT00417183|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110301056|NCT00417183|Luteolytic Agents|luteolytic agents|mesh-ancestor
110301057|NCT00417183|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110301058|NCT00417183|Contraceptive Agents|contraceptive agents|mesh-ancestor
110301059|NCT00417183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110301060|NCT00417183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110301061|NCT00417183|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110301062|NCT00417183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110301063|NCT00417183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110301064|NCT00417183|Hormone Antagonists|hormone antagonists|mesh-ancestor
110301065|NCT00417183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110301066|NCT00244517|Remifentanil|remifentanil|mesh-list
110301067|NCT00244517|Sevoflurane|sevoflurane|mesh-list
110301068|NCT00244517|Desflurane|desflurane|mesh-list
110301069|NCT00244517|Isoflurane|isoflurane|mesh-list
110301070|NCT00244517|Anesthetics|anesthetics|mesh-ancestor
110301071|NCT00244517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110301072|NCT00244517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110301073|NCT00244517|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110301074|NCT00244517|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110301075|NCT00244517|Anesthetics, General|anesthetics, general|mesh-ancestor
110301076|NCT00244517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110301077|NCT00244517|Narcotics|narcotics|mesh-ancestor
110301078|NCT00244517|Analgesics|analgesics|mesh-ancestor
110301079|NCT00244517|Sensory System Agents|sensory system agents|mesh-ancestor
110301080|NCT00244517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110301081|NCT00274092|Tiotropium Bromide|tiotropium bromide|mesh-list
110301082|NCT00274092|Ipratropium|ipratropium|mesh-list
110301083|NCT00274092|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110301084|NCT00274092|Autonomic Agents|autonomic agents|mesh-ancestor
110301085|NCT00274092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110301086|NCT00274092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110301087|NCT00274092|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110301088|NCT00274092|Respiratory System Agents|respiratory system agents|mesh-ancestor
110301089|NCT00274092|Parasympatholytics|parasympatholytics|mesh-ancestor
110301090|NCT00274092|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110301091|NCT00274092|Cholinergic Agents|cholinergic agents|mesh-ancestor
110301092|NCT00274092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110301093|NCT00274092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110301094|NCT00244556|Etanercept|etanercept|mesh-list
110301095|NCT00244556|Methotrexate|methotrexate|mesh-list
110301096|NCT00244556|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110301097|NCT00244556|Abortifacient Agents|abortifacient agents|mesh-ancestor
110301098|NCT00244556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110301099|NCT00244556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110301100|NCT00244556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110301101|NCT00244556|Antimetabolites|antimetabolites|mesh-ancestor
110301102|NCT00244556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280613|NCT00189059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110280614|NCT00189059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280615|NCT00189059|Adrenergic Agents|adrenergic agents|mesh-ancestor
110280616|NCT00189059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110280617|NCT00189176|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
110280618|NCT00189176|Chelating Agents|chelating agents|mesh-ancestor
110280619|NCT00189176|Sequestering Agents|sequestering agents|mesh-ancestor
110280620|NCT00189176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280621|NCT00189176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110280622|NCT00189176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110019944|NCT00000804|Indinavir|indinavir|mesh-list
110280623|NCT00189176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110280624|NCT00189176|Growth Substances|growth substances|mesh-ancestor
110301103|NCT00244556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110301113|NCT00244556|Analgesics|analgesics|mesh-ancestor
110301114|NCT00244556|Sensory System Agents|sensory system agents|mesh-ancestor
110301115|NCT00244556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110301116|NCT00244556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110301117|NCT00244556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110301118|NCT00274131|Pramipexole|pramipexole|mesh-list
110301119|NCT00274131|Antioxidants|antioxidants|mesh-ancestor
110301120|NCT00274131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110301121|NCT00274131|Protective Agents|protective agents|mesh-ancestor
110301122|NCT00274131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110301123|NCT00274131|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110301124|NCT00274131|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110301125|NCT00274131|Dopamine Agonists|dopamine agonists|mesh-ancestor
110301127|NCT00274131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110301128|NCT00274170|Octreotide|octreotide|mesh-list
110301129|NCT00274170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110301130|NCT00274170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110301131|NCT00274170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110301132|NCT00244829|Imatinib Mesylate|imatinib mesylate|mesh-list
110301133|NCT00244829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110301134|NCT00244829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110301135|NCT00244829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110301136|NCT00244829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110301137|NCT00244907|Risedronic Acid|risedronic acid|mesh-list
110301138|NCT00244907|Genistein|genistein|mesh-list
110301139|NCT00244907|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110301140|NCT00244907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110301141|NCT00244907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110301142|NCT00244907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110301143|NCT00244907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110301144|NCT00244907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110301145|NCT00244907|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110301146|NCT00244907|Protective Agents|protective agents|mesh-ancestor
110301147|NCT00244907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110301148|NCT00244907|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110301149|NCT00244907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110301150|NCT00244907|Phytoestrogens|phytoestrogens|mesh-ancestor
110301151|NCT00244907|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110301152|NCT00244907|Estrogens|estrogens|mesh-ancestor
110301153|NCT00244907|Hormones|hormones|mesh-ancestor
110301154|NCT00244907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110301155|NCT00244946|Cytarabine|cytarabine|mesh-list
110301156|NCT00244946|Etoposide|etoposide|mesh-list
110301157|NCT00244946|Melphalan|melphalan|mesh-list
110301158|NCT00244946|Carmustine|carmustine|mesh-list
110301159|NCT00244946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110301160|NCT00244946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110301161|NCT00244946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110280625|NCT00189176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280626|NCT00189176|Growth Inhibitors|growth inhibitors|mesh-ancestor
110280627|NCT00189176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110280628|NCT00189371|Paclitaxel|paclitaxel|mesh-list
110280629|NCT00189371|Carboplatin|carboplatin|mesh-list
110280630|NCT00189371|Epoetin Alfa|epoetin alfa|mesh-list
110280631|NCT00189371|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110280632|NCT00189371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110280633|NCT00189371|Tubulin Modulators|tubulin modulators|mesh-ancestor
110301162|NCT00244946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110301163|NCT00244946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110301164|NCT00244946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110301165|NCT00244946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110301166|NCT00244946|Antimetabolites|antimetabolites|mesh-ancestor
110301167|NCT00244946|Antiviral Agents|antiviral agents|mesh-ancestor
110301168|NCT00244946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110301169|NCT00244946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110301173|NCT00244946|Alkylating Agents|alkylating agents|mesh-ancestor
110301174|NCT00244946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110301175|NCT00245024|Sulindac|sulindac|mesh-list
110301176|NCT00245024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110301177|NCT00245024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110301178|NCT00245024|Analgesics|analgesics|mesh-ancestor
110301179|NCT00245024|Sensory System Agents|sensory system agents|mesh-ancestor
110301180|NCT00245024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110301181|NCT00245024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110301182|NCT00245024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110301183|NCT00245024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110301184|NCT00245024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110301185|NCT00245024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110301186|NCT00245024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110301187|NCT00245024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110301188|NCT00274326|Satavaptan|satavaptan|mesh-list
110301189|NCT00274326|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110301190|NCT00274326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110301191|NCT00274326|Natriuretic Agents|natriuretic agents|mesh-ancestor
110301192|NCT00274326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110301194|NCT00245141|Cyclophosphamide|cyclophosphamide|mesh-list
110301195|NCT00245141|Vincristine|vincristine|mesh-list
110301196|NCT00245141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110301197|NCT00245141|Immunologic Factors|immunologic factors|mesh-ancestor
110301198|NCT00245141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110301199|NCT00245141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110301200|NCT00245141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110301201|NCT00245141|Alkylating Agents|alkylating agents|mesh-ancestor
110301202|NCT00245141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110301203|NCT00245141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110032167|NCT01395875|Xhance|xhance|mesh-list
110301205|NCT00245141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110301206|NCT00245141|Tubulin Modulators|tubulin modulators|mesh-ancestor
110301207|NCT00245141|Antimitotic Agents|antimitotic agents|mesh-ancestor
110301208|NCT00245141|Mitosis Modulators|mitosis modulators|mesh-ancestor
110301209|NCT00245141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110301210|NCT00245141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110301211|NCT00245141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110301212|NCT00245141|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110301213|NCT00245141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110301214|NCT00245141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110301215|NCT00416637|Bevacizumab|bevacizumab|mesh-list
110301216|NCT00416637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110301217|NCT00416637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110301218|NCT00416637|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110301220|NCT00416637|Growth Substances|growth substances|mesh-ancestor
110301221|NCT00416637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280634|NCT00189371|Antimitotic Agents|antimitotic agents|mesh-ancestor
110280635|NCT00189371|Mitosis Modulators|mitosis modulators|mesh-ancestor
110280636|NCT00189371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280637|NCT00189371|Hematinics|hematinics|mesh-ancestor
110280638|NCT00189410|Carboplatin|carboplatin|mesh-list
110280639|NCT00189410|Doxorubicin|doxorubicin|mesh-list
110280640|NCT00189410|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110280641|NCT00189410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110280642|NCT00189410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110301222|NCT00416637|Growth Inhibitors|growth inhibitors|mesh-ancestor
110301223|NCT00245258|Sildenafil Citrate|sildenafil citrate|mesh-list
110301224|NCT00245258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110301225|NCT00245258|Vasodilator Agents|vasodilator agents|mesh-ancestor
110301226|NCT00245258|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110301227|NCT00245258|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110301228|NCT00245258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110301229|NCT00245258|Urological Agents|urological agents|mesh-ancestor
110301231|NCT02961803|Vitamin B Complex|vitamin b complex|mesh-ancestor
110301232|NCT02961803|Vitamins|vitamins|mesh-ancestor
110301233|NCT02961803|Micronutrients|micronutrients|mesh-ancestor
110301234|NCT02961803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110301235|NCT00245297|Factor VIII|factor viii|mesh-list
110301236|NCT00245297|Coagulants|coagulants|mesh-ancestor
110301237|NCT00274404|Valacyclovir|valacyclovir|mesh-list
110301238|NCT00274404|Antiviral Agents|antiviral agents|mesh-ancestor
110301239|NCT00274404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110301240|NCT00283764|Latanoprost|latanoprost|mesh-list
110301241|NCT00283764|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110301249|NCT00245375|Acetaminophen|acetaminophen|mesh-list
110301250|NCT00245375|Ibuprofen|ibuprofen|mesh-list
110301251|NCT00245375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110301252|NCT00245375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110301253|NCT00245375|Analgesics|analgesics|mesh-ancestor
110301254|NCT00245375|Sensory System Agents|sensory system agents|mesh-ancestor
110301255|NCT00245375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110301256|NCT00245375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110301257|NCT00245375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110301258|NCT00245375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110301259|NCT00245375|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110301260|NCT00245375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110301261|NCT00245375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110301262|NCT00245375|Antipyretics|antipyretics|mesh-ancestor
110301263|NCT00245414|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110301264|NCT00245414|Interferon-alpha|interferon-alpha|mesh-list
110301265|NCT00245414|Antiviral Agents|antiviral agents|mesh-ancestor
110301266|NCT00245414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110301267|NCT00245414|Immunologic Factors|immunologic factors|mesh-ancestor
110301268|NCT00245414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110301270|NCT00274521|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110301271|NCT00274521|Autonomic Agents|autonomic agents|mesh-ancestor
110301272|NCT00274521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110301273|NCT00274521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110301274|NCT00274521|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110301275|NCT00274521|Respiratory System Agents|respiratory system agents|mesh-ancestor
110301276|NCT00274521|Parasympatholytics|parasympatholytics|mesh-ancestor
110301277|NCT00274521|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110301278|NCT00274521|Cholinergic Agents|cholinergic agents|mesh-ancestor
110032206|NCT01395953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110301279|NCT00274521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110301280|NCT00274521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110301282|NCT00245453|Clarithromycin|clarithromycin|mesh-list
110301283|NCT00245453|Telithromycin|telithromycin|mesh-list
110301284|NCT00245453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110301285|NCT00245453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110280643|NCT00189410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110280644|NCT00189410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110280645|NCT00189410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110280646|NCT00189410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280647|NCT00189566|Paclitaxel|paclitaxel|mesh-list
110280648|NCT00189566|Carboplatin|carboplatin|mesh-list
110280649|NCT00189566|Topotecan|topotecan|mesh-list
110280650|NCT00189566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110280651|NCT00189566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110280652|NCT00189566|Tubulin Modulators|tubulin modulators|mesh-ancestor
110280653|NCT00189566|Antimitotic Agents|antimitotic agents|mesh-ancestor
110280654|NCT00189566|Mitosis Modulators|mitosis modulators|mesh-ancestor
110280655|NCT00189566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280656|NCT00189566|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110280657|NCT00189566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110280658|NCT00189566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110280659|NCT00220116|Capecitabine|capecitabine|mesh-list
110280660|NCT00220116|Oxaliplatin|oxaliplatin|mesh-list
110280661|NCT00220116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110280663|NCT00220116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280664|NCT00220116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110280665|NCT02963129|Mupirocin|mupirocin|mesh-list
110280666|NCT02963129|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110280667|NCT02963129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110280668|NCT02963129|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110280669|NCT02963129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110280670|NCT02963129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280671|NCT00220155|Gemcitabine|gemcitabine|mesh-list
110280672|NCT00220155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110280673|NCT00220155|Antimetabolites|antimetabolites|mesh-ancestor
110280674|NCT00220155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280675|NCT00220155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110280676|NCT00189644|Cyclophosphamide|cyclophosphamide|mesh-list
110280677|NCT00189644|Fluorouracil|fluorouracil|mesh-list
110280678|NCT00189644|Epirubicin|epirubicin|mesh-list
110301286|NCT00245453|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110301287|NCT00245453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110280679|NCT00189644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110280680|NCT00189644|Immunologic Factors|immunologic factors|mesh-ancestor
110280681|NCT00189644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280682|NCT00189644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110280683|NCT00189644|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110280684|NCT00189644|Alkylating Agents|alkylating agents|mesh-ancestor
110280685|NCT00189644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280686|NCT00189644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110280687|NCT00189644|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110280688|NCT00189644|Antimetabolites|antimetabolites|mesh-ancestor
110280689|NCT00189644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110280690|NCT00189644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110280691|NCT00189644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110280692|NCT00189644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110301288|NCT00245453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110301289|NCT00245453|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110301290|NCT00245453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110301291|NCT00274560|Tiotropium Bromide|tiotropium bromide|mesh-list
110301292|NCT00274560|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110301293|NCT00274560|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110301294|NCT00274560|Autonomic Agents|autonomic agents|mesh-ancestor
110301296|NCT00274560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110301297|NCT00274560|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110301298|NCT00274560|Respiratory System Agents|respiratory system agents|mesh-ancestor
110301299|NCT00274560|Parasympatholytics|parasympatholytics|mesh-ancestor
110301300|NCT00274560|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110301301|NCT00274560|Cholinergic Agents|cholinergic agents|mesh-ancestor
110301302|NCT00274560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110301303|NCT00274560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110301304|NCT00274560|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110301305|NCT00274560|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110301306|NCT00274560|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110301307|NCT00274560|Adrenergic Agents|adrenergic agents|mesh-ancestor
110301309|NCT00245609|Alprazolam|alprazolam|mesh-list
110301310|NCT00245609|Analgesics|analgesics|mesh-ancestor
110301311|NCT00245609|Sensory System Agents|sensory system agents|mesh-ancestor
110301315|NCT00245609|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110301316|NCT00245609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110301317|NCT00245609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110301318|NCT00245609|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110301319|NCT00245609|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110301320|NCT00245609|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110301321|NCT00245609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110301322|NCT00245609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110301323|NCT00245609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110301324|NCT00245609|GABA Modulators|gaba modulators|mesh-ancestor
110301325|NCT00245609|GABA Agents|gaba agents|mesh-ancestor
110301326|NCT00245609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110301327|NCT00274599|Telmisartan|telmisartan|mesh-list
110301328|NCT00274599|Ramipril|ramipril|mesh-list
110301329|NCT00274599|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110301330|NCT00274599|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110301331|NCT00274599|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110301332|NCT00274599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110301333|NCT00274599|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110301334|NCT00274599|Protease Inhibitors|protease inhibitors|mesh-ancestor
110280693|NCT00189644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110280695|NCT00189683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110280696|NCT00189683|Antimetabolites|antimetabolites|mesh-ancestor
110280697|NCT00189683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280698|NCT00189683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110280699|NCT00189722|Tacrolimus|tacrolimus|mesh-list
110280700|NCT00189722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110280701|NCT00189722|Immunologic Factors|immunologic factors|mesh-ancestor
110280702|NCT00189722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280703|NCT00189722|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110280704|NCT00189722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110280705|NCT00189722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280706|NCT00220194|Leuprolide|leuprolide|mesh-list
110280707|NCT00220194|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110301335|NCT00274599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110301336|NCT00274638|Losartan|losartan|mesh-list
110301337|NCT00274638|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110301338|NCT00274638|Telmisartan|telmisartan|mesh-list
110301339|NCT00274638|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110301340|NCT00274638|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110301341|NCT00274638|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110301342|NCT00274638|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110301343|NCT00274638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110301344|NCT00274638|Diuretics|diuretics|mesh-ancestor
110301345|NCT00274638|Natriuretic Agents|natriuretic agents|mesh-ancestor
110301346|NCT00274638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110301347|NCT00274638|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110301348|NCT00274638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110301349|NCT00274677|Lamotrigine|lamotrigine|mesh-list
110301350|NCT00274677|Anticonvulsants|anticonvulsants|mesh-ancestor
110301351|NCT00274677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110301352|NCT00274677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110301353|NCT00274677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110301354|NCT00274677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110301355|NCT00274677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110301356|NCT00274677|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110301357|NCT00274677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110301358|NCT00274677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110301359|NCT00274677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110301360|NCT00274677|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110301361|NCT00245921|Levonorgestrel|levonorgestrel|mesh-list
110301362|NCT00245921|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110301363|NCT00245921|Estradiol|estradiol|mesh-list
110301364|NCT00245921|Estrogens|estrogens|mesh-ancestor
110301365|NCT00245921|Hormones|hormones|mesh-ancestor
110301366|NCT00245921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110301367|NCT00245921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110301368|NCT00245921|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110301369|NCT00245921|Contraceptive Agents|contraceptive agents|mesh-ancestor
110301370|NCT00245921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110301371|NCT00245921|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110301372|NCT00245921|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110301373|NCT00245921|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110301374|NCT00245921|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110301375|NCT00274794|Rituximab|rituximab|mesh-list
110301376|NCT00274794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110301377|NCT00274794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110301378|NCT00274794|Immunologic Factors|immunologic factors|mesh-ancestor
110280708|NCT00220194|Fertility Agents|fertility agents|mesh-ancestor
110280709|NCT00220194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110280710|NCT00220194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280711|NCT00220194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110280712|NCT00220194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110280713|NCT00189761|Tacrolimus|tacrolimus|mesh-list
110280714|NCT00189761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110280715|NCT00189761|Immunologic Factors|immunologic factors|mesh-ancestor
110280716|NCT00189761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280717|NCT00189761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110280718|NCT00189761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110280719|NCT00189761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110301379|NCT00274794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110301380|NCT00274794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110301381|NCT00246155|Botulinum Toxins|botulinum toxins|mesh-list
110301392|NCT00284193|Thrombin|thrombin|mesh-list
110301393|NCT00284193|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
110301394|NCT00284193|Factor VIII|factor viii|mesh-list
110301395|NCT00284193|Hemostatics|hemostatics|mesh-ancestor
110301396|NCT00284193|Coagulants|coagulants|mesh-ancestor
110301397|NCT00246194|Risperidone|risperidone|mesh-list
110301398|NCT00246194|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110301399|NCT00246194|Serotonin Agents|serotonin agents|mesh-ancestor
110301400|NCT00246194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110301401|NCT00246194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110301402|NCT00246194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110301403|NCT00246194|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110301404|NCT00246194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110301405|NCT00246194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110301406|NCT00246194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110301407|NCT00246194|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110301408|NCT00246194|Dopamine Agents|dopamine agents|mesh-ancestor
110301409|NCT00284232|Insulin|insulin|mesh-list
110301410|NCT00284232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110301411|NCT00284232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110301412|NCT00246233|Methylphenidate|methylphenidate|mesh-list
110301413|NCT00246233|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110301414|NCT00246233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110301415|NCT00246233|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110301416|NCT00246233|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110301417|NCT00246233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110301418|NCT00246233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110301419|NCT00246233|Dopamine Agents|dopamine agents|mesh-ancestor
110301420|NCT00246233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110301421|NCT00274833|Temozolomide|temozolomide|mesh-list
110301422|NCT00274833|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110301423|NCT00274833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110301424|NCT00274833|Alkylating Agents|alkylating agents|mesh-ancestor
110301425|NCT00274833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110032368|NCT01397305|Pemetrexed|pemetrexed|mesh-list
110301427|NCT00274833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110301428|NCT00274833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110301429|NCT00274872|Leucovorin|leucovorin|mesh-list
110301430|NCT00274872|Fluorouracil|fluorouracil|mesh-list
110301431|NCT00274872|Oxaliplatin|oxaliplatin|mesh-list
110301432|NCT00274872|Calcium|calcium|mesh-list
110301433|NCT00274872|Levoleucovorin|levoleucovorin|mesh-list
110301434|NCT00274872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110301435|NCT00274872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110301436|NCT00274872|Antimetabolites|antimetabolites|mesh-ancestor
110301437|NCT00274872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280720|NCT00213096|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110280721|NCT00213096|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110280722|NCT00213096|Levonorgestrel|levonorgestrel|mesh-list
110280723|NCT00213096|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110280724|NCT00213096|ST 1435|st 1435|mesh-list
110280725|NCT00213096|Contraceptive Agents|contraceptive agents|mesh-list
110280726|NCT00213096|Contraceptives, Oral|contraceptives, oral|mesh-list
110280727|NCT00213096|Estradiol|estradiol|mesh-list
110280728|NCT00213096|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110280729|NCT00213096|Estrogens|estrogens|mesh-ancestor
110280730|NCT00213096|Hormones|hormones|mesh-ancestor
110280731|NCT00213096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110280732|NCT00213096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280733|NCT00213096|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110280734|NCT00213096|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110280735|NCT00213096|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110280736|NCT00213096|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110280737|NCT00213096|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110280738|NCT00189800|Solifenacin Succinate|solifenacin succinate|mesh-list
110301438|NCT00274872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110301439|NCT00274872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110301440|NCT00274872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110301441|NCT00274872|Immunologic Factors|immunologic factors|mesh-ancestor
110301442|NCT00274872|Antidotes|antidotes|mesh-ancestor
110301443|NCT00274872|Protective Agents|protective agents|mesh-ancestor
110301444|NCT00274872|Vitamin B Complex|vitamin b complex|mesh-ancestor
110301445|NCT00274872|Vitamins|vitamins|mesh-ancestor
110301446|NCT00274872|Micronutrients|micronutrients|mesh-ancestor
110301465|NCT00284271|Immunologic Factors|immunologic factors|mesh-ancestor
110301466|NCT00284271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110301467|NCT00284271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110301468|NCT00284271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110301469|NCT00284271|Alkylating Agents|alkylating agents|mesh-ancestor
110301470|NCT00284271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110301471|NCT00284271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110301472|NCT00284271|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110301473|NCT00284271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110301475|NCT00284271|Hormones|hormones|mesh-ancestor
110301476|NCT00284271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110301477|NCT00284271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110301478|NCT00284271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110301480|NCT00284271|Antimitotic Agents|antimitotic agents|mesh-ancestor
110301481|NCT00284271|Mitosis Modulators|mitosis modulators|mesh-ancestor
110301482|NCT00284271|Hematinics|hematinics|mesh-ancestor
110301483|NCT00284271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110301484|NCT00246389|Cyclobenzaprine|cyclobenzaprine|mesh-list
110301485|NCT00246389|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110301486|NCT00246389|Antidepressive Agents|antidepressive agents|mesh-ancestor
110301487|NCT00246389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110301489|NCT00246389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110301490|NCT00246389|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110301491|NCT00246389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110301492|NCT00246389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110280739|NCT00189800|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110280740|NCT00189800|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110280741|NCT00189800|Cholinergic Agents|cholinergic agents|mesh-ancestor
110280742|NCT00189800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110280743|NCT00189800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280744|NCT00189800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280745|NCT00189800|Urological Agents|urological agents|mesh-ancestor
110280746|NCT00220233|Amlodipine|amlodipine|mesh-list
110280747|NCT00220233|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110280748|NCT00220233|Olmesartan|olmesartan|mesh-list
110280749|NCT00220233|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110301493|NCT00246389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110301494|NCT00274911|Vincristine|vincristine|mesh-list
110301495|NCT00274911|Lomustine|lomustine|mesh-list
110301496|NCT00274911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110301497|NCT00274911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110301498|NCT00274911|Tubulin Modulators|tubulin modulators|mesh-ancestor
110301499|NCT00274911|Antimitotic Agents|antimitotic agents|mesh-ancestor
110301500|NCT00274911|Mitosis Modulators|mitosis modulators|mesh-ancestor
110301501|NCT00274911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110301502|NCT00274911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110301504|NCT00246467|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110301505|NCT00246467|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110301513|NCT00277251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110301514|NCT00416676|Cyclophosphamide|cyclophosphamide|mesh-list
110301515|NCT00416676|Carboplatin|carboplatin|mesh-list
110301516|NCT00416676|Etoposide|etoposide|mesh-list
110301517|NCT00416676|Vincristine|vincristine|mesh-list
110301518|NCT00416676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110301519|NCT00416676|Immunologic Factors|immunologic factors|mesh-ancestor
110301520|NCT00416676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110301521|NCT00416676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110301522|NCT00416676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110301523|NCT00416676|Alkylating Agents|alkylating agents|mesh-ancestor
110301524|NCT00416676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110301525|NCT00416676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110301526|NCT00416676|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110301527|NCT00416676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110301528|NCT00416676|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110301529|NCT00416676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110301530|NCT00416676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110301531|NCT00416676|Tubulin Modulators|tubulin modulators|mesh-ancestor
110301532|NCT00416676|Antimitotic Agents|antimitotic agents|mesh-ancestor
110301533|NCT00416676|Mitosis Modulators|mitosis modulators|mesh-ancestor
110301534|NCT00246623|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110301535|NCT00246623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110301536|NCT00284427|Ascorbic Acid|ascorbic acid|mesh-list
110301538|NCT00284427|Micronutrients|micronutrients|mesh-ancestor
110301539|NCT00284427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110301540|NCT00284427|Antioxidants|antioxidants|mesh-ancestor
110301541|NCT00284427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110301542|NCT00284427|Protective Agents|protective agents|mesh-ancestor
110301543|NCT00246701|Simvastatin|simvastatin|mesh-list
110301544|NCT00246701|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110301545|NCT00246701|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110301546|NCT00246701|Antimetabolites|antimetabolites|mesh-ancestor
110301547|NCT00246701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110301548|NCT00246701|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110301549|NCT00246701|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110301550|NCT00246701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110301551|NCT00284505|Thalidomide|thalidomide|mesh-list
110301552|NCT00284505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110301553|NCT00284505|Immunologic Factors|immunologic factors|mesh-ancestor
110280750|NCT00220233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110280751|NCT00220233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110280752|NCT00220233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110280753|NCT00220233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280754|NCT00220233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110280755|NCT00220233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280756|NCT00220233|Vasodilator Agents|vasodilator agents|mesh-ancestor
110280758|NCT00220233|Natriuretic Agents|natriuretic agents|mesh-ancestor
110280759|NCT00220233|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110280760|NCT00220233|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110280761|NCT00220233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110280762|NCT00189839|Tacrolimus|tacrolimus|mesh-list
110280763|NCT00189839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110280764|NCT00189839|Immunologic Factors|immunologic factors|mesh-ancestor
110301554|NCT00284505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110301555|NCT00284505|Leprostatic Agents|leprostatic agents|mesh-ancestor
110301556|NCT00284505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110301557|NCT00284505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110301558|NCT00284505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110301559|NCT00284505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110301560|NCT00284505|Growth Substances|growth substances|mesh-ancestor
110301561|NCT00284505|Growth Inhibitors|growth inhibitors|mesh-ancestor
110301562|NCT00284505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110301563|NCT00246974|Gemcitabine|gemcitabine|mesh-list
110301564|NCT00246974|Gefitinib|gefitinib|mesh-list
110301565|NCT00246974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110301566|NCT00246974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110301567|NCT00246974|Antimetabolites|antimetabolites|mesh-ancestor
110301568|NCT00246974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110301569|NCT00246974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110301570|NCT00246974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110301571|NCT00284583|Lidocaine|lidocaine|mesh-list
110301572|NCT00284583|Anesthetics, Local|anesthetics, local|mesh-ancestor
110301573|NCT00284583|Anesthetics|anesthetics|mesh-ancestor
110301574|NCT00284583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110301589|NCT00247052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110301590|NCT00247052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110301591|NCT00247052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110301592|NCT00247052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110301593|NCT00247052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110301594|NCT00247052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110301595|NCT00277602|Riluzole|riluzole|mesh-list
110301596|NCT00277602|Anticonvulsants|anticonvulsants|mesh-ancestor
110301597|NCT00277602|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110301598|NCT00277602|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110301599|NCT00277602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110301600|NCT00277602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110301601|NCT00277602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110301602|NCT00277602|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110301603|NCT00277602|Protective Agents|protective agents|mesh-ancestor
110301604|NCT00277641|Lamotrigine|lamotrigine|mesh-list
110301605|NCT00277641|Anticonvulsants|anticonvulsants|mesh-ancestor
110020118|NCT00000942|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110301606|NCT00277641|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110301607|NCT00277641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110301608|NCT00277641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110301609|NCT00277641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110280765|NCT00189839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280766|NCT00189839|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110280768|NCT00189839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280769|NCT00189878|Methotrexate|methotrexate|mesh-list
110280770|NCT00189878|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110280771|NCT00189878|Abortifacient Agents|abortifacient agents|mesh-ancestor
110280772|NCT00189878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110280773|NCT00189878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280774|NCT00189878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110280775|NCT00189878|Antimetabolites|antimetabolites|mesh-ancestor
110280776|NCT00189878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280777|NCT00189878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110301610|NCT00277641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110301611|NCT00277641|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110301612|NCT00277641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110301613|NCT00277641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110301614|NCT00277641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110301615|NCT00277641|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110301616|NCT00247130|Omeprazole|omeprazole|mesh-list
110301617|NCT00247130|Ranitidine|ranitidine|mesh-list
110301618|NCT00247130|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
110301619|NCT00247130|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110301620|NCT00247130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110301621|NCT00247130|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110301622|NCT00247130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110301623|NCT00247130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110301624|NCT00247130|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110301625|NCT00247130|Histamine Antagonists|histamine antagonists|mesh-ancestor
110301626|NCT00247130|Histamine Agents|histamine agents|mesh-ancestor
110301627|NCT00247130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110301628|NCT00247130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110301629|NCT00247169|Progesterone|progesterone|mesh-list
110301630|NCT00247169|Progestins|progestins|mesh-ancestor
110301631|NCT00247169|Hormones|hormones|mesh-ancestor
110301632|NCT00247169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110301633|NCT00247169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110301640|NCT00247208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110301641|NCT00284778|Docetaxel|docetaxel|mesh-list
110301643|NCT00284778|Tubulin Modulators|tubulin modulators|mesh-ancestor
110301644|NCT00284778|Antimitotic Agents|antimitotic agents|mesh-ancestor
110301645|NCT00284778|Mitosis Modulators|mitosis modulators|mesh-ancestor
110301646|NCT00284778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110301647|NCT00247247|Entacapone|entacapone|mesh-list
110301648|NCT00247247|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110032579|NCT02420912|Nivolumab|nivolumab|mesh-list
110301649|NCT00247247|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110301650|NCT00247247|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
110301651|NCT00247247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110301652|NCT00247247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110301653|NCT00277758|Interferons|interferons|mesh-list
110301654|NCT00277758|Ribavirin|ribavirin|mesh-list
110301655|NCT00277758|Interferon-alpha|interferon-alpha|mesh-list
110301656|NCT00277758|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110301657|NCT00277758|Interleukin-2|interleukin-2|mesh-list
110301658|NCT00277758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110301659|NCT00277758|Antiviral Agents|antiviral agents|mesh-ancestor
110301660|NCT00277758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110301661|NCT00277758|Antimetabolites|antimetabolites|mesh-ancestor
110280778|NCT00189878|Dermatologic Agents|dermatologic agents|mesh-ancestor
110280779|NCT00189878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110280780|NCT00189878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110280781|NCT00189878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110280782|NCT00189878|Immunologic Factors|immunologic factors|mesh-ancestor
110280783|NCT00189878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110280784|NCT00189878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110280785|NCT00220311|Fludarabine|fludarabine|mesh-list
110280786|NCT00220311|Fludarabine phosphate|fludarabine phosphate|mesh-list
110280787|NCT00220311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110280788|NCT00220311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110020164|NCT00000990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110301662|NCT00277758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110301663|NCT00277758|Immunologic Factors|immunologic factors|mesh-ancestor
110301664|NCT00277758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110301665|NCT00277758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110301667|NCT00277758|Sensory System Agents|sensory system agents|mesh-ancestor
110301668|NCT00277758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110301669|NCT00247364|Levetiracetam|levetiracetam|mesh-list
110301670|NCT00247364|Anticonvulsants|anticonvulsants|mesh-ancestor
110301671|NCT00247364|Nootropic Agents|nootropic agents|mesh-ancestor
110301672|NCT00247403|Deoxyglucose|deoxyglucose|mesh-list
110301673|NCT00247403|Antimetabolites|antimetabolites|mesh-ancestor
110301674|NCT00247403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110301675|NCT00247403|Antiviral Agents|antiviral agents|mesh-ancestor
110301676|NCT00247403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110301677|NCT00424814|Ritonavir|ritonavir|mesh-list
110301678|NCT00424814|Lopinavir|lopinavir|mesh-list
110301679|NCT00424814|Lamivudine|lamivudine|mesh-list
110301680|NCT00424814|Zidovudine|zidovudine|mesh-list
110301681|NCT00424814|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
110301682|NCT00424814|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110301683|NCT00424814|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110301684|NCT00424814|Protease Inhibitors|protease inhibitors|mesh-ancestor
110301685|NCT00424814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110301686|NCT00424814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110301687|NCT00424814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110301688|NCT00424814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110301689|NCT00424814|Antiviral Agents|antiviral agents|mesh-ancestor
110301690|NCT00424814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110301691|NCT00424814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110301692|NCT00424814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110301693|NCT00424814|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110301694|NCT00424814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110301695|NCT00424814|Antimetabolites|antimetabolites|mesh-ancestor
110301696|NCT00284973|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
110301697|NCT00284973|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110301698|NCT00284973|Immunologic Factors|immunologic factors|mesh-ancestor
110301699|NCT00284973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110301700|NCT00247481|Docetaxel|docetaxel|mesh-list
110301701|NCT00247481|Gefitinib|gefitinib|mesh-list
110301702|NCT00247481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110301703|NCT00247481|Tubulin Modulators|tubulin modulators|mesh-ancestor
110301704|NCT00247481|Antimitotic Agents|antimitotic agents|mesh-ancestor
110301707|NCT00247481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110301708|NCT00247481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110301709|NCT00247559|Botulinum Toxins|botulinum toxins|mesh-list
110301710|NCT00247559|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110301711|NCT00247559|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110301712|NCT00247559|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110301713|NCT00247559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110301714|NCT00247559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110301715|NCT00247559|Cholinergic Agents|cholinergic agents|mesh-ancestor
110301716|NCT00247559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110301717|NCT00247559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280789|NCT00220311|Antimetabolites|antimetabolites|mesh-ancestor
110280790|NCT00220311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280791|NCT00220311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110280792|NCT00220311|Immunologic Factors|immunologic factors|mesh-ancestor
110280793|NCT00220311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280794|NCT00189917|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
110280796|NCT00189917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110280797|NCT00189956|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
110301718|NCT00247559|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110301719|NCT00247559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110301720|NCT00285051|Ondansetron|ondansetron|mesh-list
110301721|NCT00285051|Antiemetics|antiemetics|mesh-ancestor
110301722|NCT00285051|Autonomic Agents|autonomic agents|mesh-ancestor
110301723|NCT00285051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110301724|NCT00285051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110301725|NCT00285051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110301727|NCT00285051|Dermatologic Agents|dermatologic agents|mesh-ancestor
110301728|NCT00285051|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110301729|NCT00285051|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110301730|NCT00285051|Serotonin Agents|serotonin agents|mesh-ancestor
110301731|NCT00285051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110301732|NCT00285051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110301733|NCT00247715|Pantoprazole|pantoprazole|mesh-list
110301734|NCT00247715|Ranitidine|ranitidine|mesh-list
110301735|NCT00247715|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
110301736|NCT00247715|Magnesium Oxide|magnesium oxide|mesh-list
110301737|NCT00247715|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110301738|NCT00247715|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110301739|NCT00247715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110301740|NCT00247715|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110301741|NCT00247715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110301742|NCT00247715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110301743|NCT00247715|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110301744|NCT00247715|Histamine Antagonists|histamine antagonists|mesh-ancestor
110301745|NCT00247715|Histamine Agents|histamine agents|mesh-ancestor
110301746|NCT00247715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110301747|NCT00247715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110301748|NCT00247715|Antacids|antacids|mesh-ancestor
110301749|NCT00247715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110301750|NCT00247715|Immunologic Factors|immunologic factors|mesh-ancestor
110301751|NCT00285090|Calcium, Dietary|calcium, dietary|mesh-list
110301752|NCT00285090|Vitamin D|vitamin d|mesh-list
110301753|NCT00285090|Ergocalciferols|ergocalciferols|mesh-list
110301754|NCT00285090|Cholecalciferol|cholecalciferol|mesh-list
110301755|NCT00285090|Vitamins|vitamins|mesh-list
110301756|NCT00285090|Calcium|calcium|mesh-list
110301757|NCT00285090|Micronutrients|micronutrients|mesh-ancestor
110301758|NCT00285090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110301759|NCT00285090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110301760|NCT00285090|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110301761|NCT00417222|Olmesartan|olmesartan|mesh-list
110301762|NCT00417222|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110301763|NCT00417222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110301764|NCT00417222|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110301765|NCT00417222|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110301766|NCT00417222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110301767|NCT00278070|Vinorelbine|vinorelbine|mesh-list
110301768|NCT00278070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110301769|NCT00278070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110301770|NCT00278070|Tubulin Modulators|tubulin modulators|mesh-ancestor
110301771|NCT00278070|Antimitotic Agents|antimitotic agents|mesh-ancestor
110301772|NCT00278070|Mitosis Modulators|mitosis modulators|mesh-ancestor
110280798|NCT00189956|Antiviral Agents|antiviral agents|mesh-ancestor
110280799|NCT00189956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110280800|NCT00213252|Prednisolone|prednisolone|mesh-list
110280801|NCT00213252|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110280802|NCT00213252|Methylprednisolone|methylprednisolone|mesh-list
110280803|NCT00213252|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110280804|NCT00213252|Prednisolone acetate|prednisolone acetate|mesh-list
110280806|NCT00213252|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110280807|NCT00213252|Prednisolone phosphate|prednisolone phosphate|mesh-list
110301773|NCT00278070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110301774|NCT00424983|Zoledronic Acid|zoledronic acid|mesh-list
110301775|NCT00424983|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110301776|NCT00424983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110301777|NCT00247910|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110301778|NCT00247910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110301788|NCT00278187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110301789|NCT00278187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110301790|NCT00278187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110301791|NCT00278187|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110301792|NCT00278187|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110301793|NCT00278187|Growth Substances|growth substances|mesh-ancestor
110301794|NCT00278187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110301795|NCT00278187|Growth Inhibitors|growth inhibitors|mesh-ancestor
110301796|NCT00247988|Carboplatin|carboplatin|mesh-list
110301798|NCT00247988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110301799|NCT00247988|Tubulin Modulators|tubulin modulators|mesh-ancestor
110301800|NCT00247988|Antimitotic Agents|antimitotic agents|mesh-ancestor
110301801|NCT00247988|Mitosis Modulators|mitosis modulators|mesh-ancestor
110301802|NCT00247988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110301803|NCT00248144|Famciclovir|famciclovir|mesh-list
110301804|NCT00248144|Antiviral Agents|antiviral agents|mesh-ancestor
110301805|NCT00248144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110301806|NCT00248144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110301807|NCT00248144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110301808|NCT00248144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110301809|NCT00278265|Methotrexate|methotrexate|mesh-list
110301810|NCT00278265|Fludarabine phosphate|fludarabine phosphate|mesh-list
110301811|NCT00278265|Fludarabine|fludarabine|mesh-list
110301812|NCT00278265|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110301813|NCT00278265|Abortifacient Agents|abortifacient agents|mesh-ancestor
110301814|NCT00278265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110301815|NCT00278265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110301816|NCT00278265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110301817|NCT00278265|Antimetabolites|antimetabolites|mesh-ancestor
110301818|NCT00278265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110301819|NCT00278265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110301820|NCT00278265|Dermatologic Agents|dermatologic agents|mesh-ancestor
110301821|NCT00278265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110301822|NCT00278265|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110301823|NCT00278265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110301824|NCT00278265|Immunologic Factors|immunologic factors|mesh-ancestor
110301825|NCT00278265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110301826|NCT00278265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110301827|NCT00248183|Naluzotan|naluzotan|mesh-list
110301828|NCT00248183|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110301829|NCT00248183|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110301830|NCT00248183|Serotonin Agents|serotonin agents|mesh-ancestor
110301831|NCT00248183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110301832|NCT00248183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110301833|NCT00248183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110301834|NCT00278343|Cediranib|cediranib|mesh-list
110301835|NCT00278343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110301836|NCT00278343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280808|NCT00213252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110280810|NCT00213252|Hormones|hormones|mesh-ancestor
110280811|NCT00213252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110280812|NCT00213252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280813|NCT00213252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110280814|NCT00213252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110280815|NCT00213252|Antiemetics|antiemetics|mesh-ancestor
110280816|NCT00213252|Autonomic Agents|autonomic agents|mesh-ancestor
110280817|NCT00213252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110280818|NCT00213252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110280819|NCT00213252|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110280820|NCT00213252|Protective Agents|protective agents|mesh-ancestor
110301837|NCT00278343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110301838|NCT00278343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110301839|NCT00248261|Ziprasidone|ziprasidone|mesh-list
110301840|NCT00248261|Sertraline|sertraline|mesh-list
110301841|NCT00248261|Antidepressive Agents|antidepressive agents|mesh-ancestor
110301842|NCT00248261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110301857|NCT00248300|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110301858|NCT00248300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110301859|NCT00248300|Disinfectants|disinfectants|mesh-ancestor
110301860|NCT00278382|Sorafenib|sorafenib|mesh-list
110301861|NCT00278382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110301862|NCT00278382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110301863|NCT00278382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110301864|NCT00278382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110301865|NCT00248339|Ribavirin|ribavirin|mesh-list
110301866|NCT00248339|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110301867|NCT00248339|Epoetin Alfa|epoetin alfa|mesh-list
110301868|NCT00248339|Antimetabolites|antimetabolites|mesh-ancestor
110301869|NCT00248339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110301870|NCT00248339|Antiviral Agents|antiviral agents|mesh-ancestor
110301871|NCT00248339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110301872|NCT00248339|Hematinics|hematinics|mesh-ancestor
110301873|NCT00278421|Prednisone|prednisone|mesh-list
110032811|NCT05270434|Antipyretics|antipyretics|mesh-ancestor
110301875|NCT00278421|Rituximab|rituximab|mesh-list
110301876|NCT00278421|Doxorubicin|doxorubicin|mesh-list
110301877|NCT00278421|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110301878|NCT00278421|Vincristine|vincristine|mesh-list
110301879|NCT00278421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110301880|NCT00278421|Immunologic Factors|immunologic factors|mesh-ancestor
110301881|NCT00278421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110301882|NCT00278421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110301883|NCT00278421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110301884|NCT00278421|Alkylating Agents|alkylating agents|mesh-ancestor
110301885|NCT00278421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110301886|NCT00278421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110301887|NCT00278421|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110020250|NCT00001128|Paromomycin|paromomycin|mesh-list
110301889|NCT00278421|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110301890|NCT00278421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110301891|NCT00278421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110301892|NCT00278421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110301893|NCT00278421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110301894|NCT00278421|Glucocorticoids|glucocorticoids|mesh-ancestor
110301895|NCT00278421|Hormones|hormones|mesh-ancestor
110301896|NCT00278421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110301897|NCT00278421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110301898|NCT00278421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110301899|NCT00278421|Tubulin Modulators|tubulin modulators|mesh-ancestor
110280821|NCT00213252|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110280822|NCT00213252|Respiratory System Agents|respiratory system agents|mesh-ancestor
110280823|NCT00213252|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110280824|NCT00213252|Hormone Antagonists|hormone antagonists|mesh-ancestor
110280825|NCT00213252|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110280826|NCT00213252|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110280827|NCT00213252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280828|NCT00189995|Haloperidol|haloperidol|mesh-list
110280829|NCT00189995|Haloperidol decanoate|haloperidol decanoate|mesh-list
110280830|NCT00189995|Clozapine|clozapine|mesh-list
110280831|NCT00189995|Antiemetics|antiemetics|mesh-ancestor
110280832|NCT00189995|Autonomic Agents|autonomic agents|mesh-ancestor
110280833|NCT00189995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110301900|NCT00278421|Antimitotic Agents|antimitotic agents|mesh-ancestor
110301901|NCT00278421|Mitosis Modulators|mitosis modulators|mesh-ancestor
110301902|NCT00248456|Betamethasone|betamethasone|mesh-list
110301903|NCT00248456|Betamethasone Valerate|betamethasone valerate|mesh-list
110301913|NCT00248456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110301914|NCT00248456|Respiratory System Agents|respiratory system agents|mesh-ancestor
110301915|NCT00248456|Dermatologic Agents|dermatologic agents|mesh-ancestor
110301916|NCT00278460|Gemcitabine|gemcitabine|mesh-list
110301918|NCT00278460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110301919|NCT00278460|Antimetabolites|antimetabolites|mesh-ancestor
110301920|NCT00278460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110301921|NCT00278460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110301922|NCT00278460|Tubulin Modulators|tubulin modulators|mesh-ancestor
110301923|NCT00278460|Antimitotic Agents|antimitotic agents|mesh-ancestor
110301924|NCT00278460|Mitosis Modulators|mitosis modulators|mesh-ancestor
110301925|NCT00248729|Midazolam|midazolam|mesh-list
110301926|NCT00248729|Etomidate|etomidate|mesh-list
110301927|NCT00248729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110301928|NCT00248729|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110301929|NCT00248729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110301930|NCT00248729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110301931|NCT00248729|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110301932|NCT00248729|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110301933|NCT00248729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110301934|NCT00248729|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110301935|NCT00248729|Anesthetics, General|anesthetics, general|mesh-ancestor
110301936|NCT00248729|Anesthetics|anesthetics|mesh-ancestor
110301937|NCT00248729|GABA Modulators|gaba modulators|mesh-ancestor
110301938|NCT00248729|GABA Agents|gaba agents|mesh-ancestor
110301939|NCT00248729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110301940|NCT00248729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110301941|NCT00278694|Oxaliplatin|oxaliplatin|mesh-list
110301942|NCT00278694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110301943|NCT00248963|Levonorgestrel|levonorgestrel|mesh-list
110301944|NCT00248963|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110301945|NCT00248963|Estradiol|estradiol|mesh-list
110301946|NCT00248963|Estrogens|estrogens|mesh-ancestor
110301947|NCT00248963|Hormones|hormones|mesh-ancestor
110301948|NCT00248963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110301949|NCT00248963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110301950|NCT00248963|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110301951|NCT00248963|Contraceptive Agents|contraceptive agents|mesh-ancestor
110301952|NCT00248963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110301953|NCT00248963|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110301954|NCT00248963|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110301955|NCT00248963|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110301956|NCT00248963|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110301957|NCT00249041|Etanercept|etanercept|mesh-list
110301958|NCT00249041|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110280834|NCT00189995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280835|NCT00189995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110280836|NCT00189995|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110280837|NCT00189995|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110280838|NCT00189995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110280839|NCT00189995|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110280840|NCT00189995|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110280841|NCT00189995|Dopamine Agents|dopamine agents|mesh-ancestor
110280842|NCT00189995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110280843|NCT00189995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280844|NCT00189995|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110280845|NCT00189995|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110280846|NCT00189995|Serotonin Agents|serotonin agents|mesh-ancestor
110301959|NCT00249041|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110301960|NCT00249041|Analgesics|analgesics|mesh-ancestor
110301961|NCT00249041|Sensory System Agents|sensory system agents|mesh-ancestor
110301962|NCT00249041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110301963|NCT00249041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110301964|NCT00249041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110301965|NCT00249041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110301966|NCT00249041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110301967|NCT00249041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110301968|NCT00249041|Immunologic Factors|immunologic factors|mesh-ancestor
110301969|NCT00285519|Doxazosin|doxazosin|mesh-list
110301970|NCT00285519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110301978|NCT00278772|Valproic Acid|valproic acid|mesh-list
110301979|NCT00278772|Anticonvulsants|anticonvulsants|mesh-ancestor
110301980|NCT00278772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110301981|NCT00278772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110301982|NCT00278772|GABA Agents|gaba agents|mesh-ancestor
110301983|NCT00278772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110301984|NCT00278772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110301985|NCT00278772|Antimanic Agents|antimanic agents|mesh-ancestor
110301986|NCT00278772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110301987|NCT00278772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110301988|NCT00278772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110301989|NCT00249119|Risperidone|risperidone|mesh-list
110301990|NCT00249119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110301992|NCT00249119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110301993|NCT00249119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110301994|NCT00249119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110301995|NCT00249119|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110301996|NCT00249119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110301997|NCT00249119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110301998|NCT00249119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110301999|NCT00249119|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110302000|NCT00249119|Dopamine Agents|dopamine agents|mesh-ancestor
110302001|NCT00285597|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
110302002|NCT00285597|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110302003|NCT00285597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110302004|NCT00249158|Risperidone|risperidone|mesh-list
110302005|NCT00249158|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110302006|NCT00249158|Serotonin Agents|serotonin agents|mesh-ancestor
110302007|NCT00249158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110302008|NCT00249158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110302009|NCT00249158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110302010|NCT00249158|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110302011|NCT00249158|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110302012|NCT00249158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110302013|NCT00249158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110302014|NCT00249158|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110280848|NCT00189995|GABA Agents|gaba agents|mesh-ancestor
110280849|NCT00213291|Darbepoetin alfa|darbepoetin alfa|mesh-list
110280850|NCT00213291|Hematinics|hematinics|mesh-ancestor
110280851|NCT00190034|Acetylcysteine|acetylcysteine|mesh-list
110280852|NCT00190034|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110280853|NCT00190034|Antiviral Agents|antiviral agents|mesh-ancestor
110280854|NCT00190034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110280855|NCT00190034|Expectorants|expectorants|mesh-ancestor
110280856|NCT00190034|Respiratory System Agents|respiratory system agents|mesh-ancestor
110280857|NCT00190034|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110280858|NCT00190034|Antioxidants|antioxidants|mesh-ancestor
110280859|NCT00190034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280860|NCT00190034|Protective Agents|protective agents|mesh-ancestor
110280861|NCT00190034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280862|NCT00190034|Antidotes|antidotes|mesh-ancestor
110280863|NCT00412503|Temozolomide|temozolomide|mesh-list
110280864|NCT00412503|Topotecan|topotecan|mesh-list
110280865|NCT00412503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110280866|NCT00412503|Alkylating Agents|alkylating agents|mesh-ancestor
110302015|NCT00249158|Dopamine Agents|dopamine agents|mesh-ancestor
110302016|NCT00278928|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
110302017|NCT00278928|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
110302018|NCT00278928|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110302019|NCT00278928|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110302020|NCT00249197|Levofloxacin|levofloxacin|mesh-list
110302021|NCT00249197|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110302022|NCT00249197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110302023|NCT00249197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110302024|NCT00249197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110302025|NCT00249197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110302026|NCT00249197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110302027|NCT00249197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110302028|NCT00249197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110302029|NCT00249197|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110302030|NCT00249197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110302032|NCT00278967|Cathartics|cathartics|mesh-ancestor
110302033|NCT00278967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110302034|NCT00278967|Laxatives|laxatives|mesh-ancestor
110302035|NCT00249236|Risperidone|risperidone|mesh-list
110302036|NCT00249236|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110302047|NCT00285675|Calcitriol|calcitriol|mesh-list
110302048|NCT00285675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110302049|NCT00285675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110302050|NCT00285675|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110302051|NCT00285675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110302052|NCT00285675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110302053|NCT00285675|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110302054|NCT00285675|Vitamins|vitamins|mesh-ancestor
110302055|NCT00285675|Micronutrients|micronutrients|mesh-ancestor
110302056|NCT00285675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110302057|NCT02215096|GSK2636771|gsk2636771|mesh-list
110302058|NCT02215096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110302059|NCT02215096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110302060|NCT02215096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110280867|NCT00412503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280868|NCT00412503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110280869|NCT00412503|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110280870|NCT00412503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110280871|NCT00412503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110280873|NCT00412581|Dacarbazine|dacarbazine|mesh-list
110280874|NCT00412581|Immunologic Factors|immunologic factors|mesh-ancestor
110280875|NCT00412581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280876|NCT00412581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110280877|NCT00412581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110280878|NCT00412581|Growth Substances|growth substances|mesh-ancestor
110280879|NCT00412581|Growth Inhibitors|growth inhibitors|mesh-ancestor
110302061|NCT02215096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110302062|NCT00279045|Metformin|metformin|mesh-list
110302063|NCT00279045|Rosiglitazone|rosiglitazone|mesh-list
110302064|NCT00279045|Glyburide|glyburide|mesh-list
110302065|NCT00279045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110302066|NCT00279045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110302067|NCT00249353|Methylphenidate|methylphenidate|mesh-list
110302068|NCT00249353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110302069|NCT00249353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110302070|NCT00249353|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110302071|NCT00249353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110302072|NCT00249353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110302073|NCT00249353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110302074|NCT00249353|Dopamine Agents|dopamine agents|mesh-ancestor
110302075|NCT00249353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110302077|NCT00249431|Antidepressive Agents|antidepressive agents|mesh-ancestor
110302078|NCT00249431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110302079|NCT00249431|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110302080|NCT00249431|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110302081|NCT00249431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110302082|NCT00249431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110302083|NCT00249431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110302084|NCT00249431|Serotonin Agents|serotonin agents|mesh-ancestor
110020328|NCT00001680|Thalidomide|thalidomide|mesh-list
110302085|NCT00249431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110302086|NCT00249509|Bupropion|bupropion|mesh-list
110302087|NCT00249509|Nefazodone|nefazodone|mesh-list
110302088|NCT00249509|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110302089|NCT00249509|Antidepressive Agents|antidepressive agents|mesh-ancestor
110302090|NCT00249509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110302091|NCT00249509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110302092|NCT00249509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110302093|NCT00249509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110302094|NCT00249509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110302095|NCT00249509|Dopamine Agents|dopamine agents|mesh-ancestor
110302096|NCT00249509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110302097|NCT00249509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110302098|NCT00249509|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110302099|NCT00249509|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110302102|NCT00249509|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110302103|NCT00249509|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110302104|NCT00249509|Serotonin Agents|serotonin agents|mesh-ancestor
110302105|NCT00279084|Chrysarobin|chrysarobin|mesh-list
110302106|NCT00279084|Epoetin Alfa|epoetin alfa|mesh-list
110302107|NCT00279084|Hematinics|hematinics|mesh-ancestor
110280880|NCT00412581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110280881|NCT00412581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110280882|NCT00412581|Alkylating Agents|alkylating agents|mesh-ancestor
110280883|NCT00412581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280884|NCT00190151|Ciprofloxacin|ciprofloxacin|mesh-list
110280885|NCT00190151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110280886|NCT00190151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110280887|NCT00190151|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110280888|NCT00190151|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110280889|NCT00190151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110280890|NCT00190151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280891|NCT00190151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110280892|NCT00190151|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110280893|NCT00190151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110280894|NCT00190229|Cyclophosphamide|cyclophosphamide|mesh-list
110280895|NCT00190229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110280896|NCT00190229|Immunologic Factors|immunologic factors|mesh-ancestor
110280897|NCT00190229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280899|NCT00190229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110280900|NCT00190229|Alkylating Agents|alkylating agents|mesh-ancestor
110280901|NCT00190229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280902|NCT00190229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110280903|NCT00190229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110280904|NCT00190268|Amifampridine|amifampridine|mesh-list
110280905|NCT00190268|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110280906|NCT00190268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110280911|NCT00220350|Leuprolide|leuprolide|mesh-list
110280924|NCT00190307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280925|NCT00190307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110280926|NCT00190307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110280927|NCT00190307|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110280928|NCT00190307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110280929|NCT00190307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280930|NCT00190307|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110020352|NCT00001716|Nitric Oxide|nitric oxide|mesh-list
110280931|NCT00190307|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110280933|NCT00190307|Antipyretics|antipyretics|mesh-ancestor
110280934|NCT02963168|Docetaxel|docetaxel|mesh-list
110280935|NCT02963168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110280936|NCT02963168|Tubulin Modulators|tubulin modulators|mesh-ancestor
110302108|NCT00279084|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110302109|NCT00279084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110302110|NCT00279084|Analgesics|analgesics|mesh-ancestor
110302111|NCT00279084|Sensory System Agents|sensory system agents|mesh-ancestor
110302112|NCT00279084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110302113|NCT00279084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110302114|NCT00279084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110302115|NCT00279084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110302116|NCT00249587|Methadone|methadone|mesh-list
110302117|NCT00249587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110302118|NCT00249587|Narcotics|narcotics|mesh-ancestor
110302119|NCT00249587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110302120|NCT00249587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110302121|NCT00249587|Analgesics|analgesics|mesh-ancestor
110302122|NCT00249587|Sensory System Agents|sensory system agents|mesh-ancestor
110302123|NCT00249587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110302124|NCT00249587|Antitussive Agents|antitussive agents|mesh-ancestor
110302125|NCT00249587|Respiratory System Agents|respiratory system agents|mesh-ancestor
110302126|NCT00279123|Pantoprazole|pantoprazole|mesh-list
110302127|NCT00279123|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110302128|NCT00279123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110302129|NCT00279123|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110302130|NCT00279123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110302131|NCT00279123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110302132|NCT00279162|Betamethasone|betamethasone|mesh-list
110302133|NCT00279162|Calcipotriene|calcipotriene|mesh-list
110302134|NCT00279162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110302135|NCT00279162|Glucocorticoids|glucocorticoids|mesh-ancestor
110302136|NCT00279162|Hormones|hormones|mesh-ancestor
110302137|NCT00279162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110302138|NCT00279162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110302139|NCT00279162|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110302140|NCT00279162|Respiratory System Agents|respiratory system agents|mesh-ancestor
110302141|NCT00279162|Dermatologic Agents|dermatologic agents|mesh-ancestor
110302142|NCT00249704|Vitamin D|vitamin d|mesh-list
110302143|NCT00249704|Ergocalciferols|ergocalciferols|mesh-list
110302144|NCT00249704|Cholecalciferol|cholecalciferol|mesh-list
110302145|NCT00249704|Vitamins|vitamins|mesh-list
110302146|NCT00249704|Micronutrients|micronutrients|mesh-ancestor
110302147|NCT00249704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110302148|NCT00249704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110302149|NCT00249704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110302150|NCT00249782|Metronidazole|metronidazole|mesh-list
110302151|NCT00249782|Dapsone|dapsone|mesh-list
110302152|NCT00249782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110302153|NCT00249782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110302154|NCT00249782|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110302155|NCT00249782|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110302156|NCT00249782|Antimalarials|antimalarials|mesh-ancestor
110280937|NCT02963168|Antimitotic Agents|antimitotic agents|mesh-ancestor
110280938|NCT02963168|Mitosis Modulators|mitosis modulators|mesh-ancestor
110280939|NCT02963168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280940|NCT00190424|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
110280941|NCT00190424|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110280942|NCT00190424|Immunologic Factors|immunologic factors|mesh-ancestor
110280943|NCT00190424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280944|NCT00190463|Amphotericin B|amphotericin b|mesh-list
110280945|NCT00190463|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110280946|NCT00190463|Amebicides|amebicides|mesh-ancestor
110280947|NCT00190463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110280949|NCT00190463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110280950|NCT00190463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110280951|NCT00190463|Antifungal Agents|antifungal agents|mesh-ancestor
110280952|NCT00213486|Irinotecan|irinotecan|mesh-list
110280953|NCT00213486|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110302157|NCT00249782|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110302158|NCT00249782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110302159|NCT00249782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110302160|NCT00249782|Leprostatic Agents|leprostatic agents|mesh-ancestor
110302161|NCT00279240|Metformin|metformin|mesh-list
110302162|NCT00279240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110302163|NCT00279240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110302164|NCT00249860|Interferons|interferons|mesh-list
110302165|NCT00249860|Ribavirin|ribavirin|mesh-list
110302166|NCT00249860|Interferon-beta|interferon-beta|mesh-list
110302167|NCT00249860|Interferon beta-1a|interferon beta-1a|mesh-list
110302168|NCT00249860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110302169|NCT00249860|Antiviral Agents|antiviral agents|mesh-ancestor
110302170|NCT00249860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110302171|NCT00249860|Antimetabolites|antimetabolites|mesh-ancestor
110302172|NCT00249860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110302173|NCT00249860|Immunologic Factors|immunologic factors|mesh-ancestor
110302187|NCT00249938|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110302188|NCT00249938|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110302189|NCT00249938|Antimetabolites|antimetabolites|mesh-ancestor
110302190|NCT00249938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110302191|NCT00249938|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110302192|NCT00249977|Capecitabine|capecitabine|mesh-list
110302194|NCT00249977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110302195|NCT00249977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110302196|NCT00249977|Antimetabolites|antimetabolites|mesh-ancestor
110302197|NCT00249977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110302198|NCT00249977|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110302199|NCT00249977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110302200|NCT00249977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110302201|NCT00250094|Topotecan|topotecan|mesh-list
110302202|NCT00250094|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110302203|NCT00250094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110302204|NCT00250094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110302205|NCT00250094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110302206|NCT00250094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110302207|NCT00279435|Visilizumab|visilizumab|mesh-list
110302208|NCT00279435|Immunologic Factors|immunologic factors|mesh-ancestor
110302209|NCT00279435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110302210|NCT00286026|Azithromycin|azithromycin|mesh-list
110280954|NCT00213486|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110280955|NCT00213486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110280956|NCT00213486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280957|NCT00213486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110280958|NCT00190502|Antibodies|antibodies|mesh-list
110280959|NCT00190502|Immunologic Factors|immunologic factors|mesh-ancestor
110280960|NCT00190502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280961|NCT00122837|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110280962|NCT00122837|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110302211|NCT00286026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110302212|NCT00286026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110302213|NCT00250172|Rolipram|rolipram|mesh-list
110302214|NCT00250172|Antidepressive Agents|antidepressive agents|mesh-ancestor
110302215|NCT00250172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110302216|NCT00250172|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110302217|NCT00250172|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110302218|NCT00250172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110302219|NCT00250172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110302220|NCT02961608|Tacrolimus|tacrolimus|mesh-list
110302221|NCT02961608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110302222|NCT02961608|Immunologic Factors|immunologic factors|mesh-ancestor
110302223|NCT02961608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110302224|NCT02961608|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110302225|NCT02961608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110302226|NCT02961608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110302227|NCT00286104|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110302228|NCT00286104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110302229|NCT00286143|Fentanyl|fentanyl|mesh-list
110302230|NCT00286143|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110302231|NCT00286143|Narcotics|narcotics|mesh-ancestor
110302232|NCT00286143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110302233|NCT00286143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110302234|NCT00286143|Analgesics|analgesics|mesh-ancestor
110302235|NCT00286143|Sensory System Agents|sensory system agents|mesh-ancestor
110302242|NCT00286260|Anticonvulsants|anticonvulsants|mesh-ancestor
110302243|NCT00286260|Nootropic Agents|nootropic agents|mesh-ancestor
110302244|NCT00250367|Risperidone|risperidone|mesh-list
110302245|NCT00250367|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110302246|NCT00250367|Serotonin Agents|serotonin agents|mesh-ancestor
110302247|NCT00250367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110302248|NCT00250367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110302249|NCT00250367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110302251|NCT00250367|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110302252|NCT00250367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110302253|NCT00250367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110302254|NCT00250367|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110302255|NCT00250367|Dopamine Agents|dopamine agents|mesh-ancestor
110302256|NCT00250562|Valsartan|valsartan|mesh-list
110302257|NCT00250562|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110302258|NCT00250562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110302259|NCT00250562|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110302260|NCT00250562|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110302261|NCT00250562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110302262|NCT00250562|Diuretics|diuretics|mesh-ancestor
110302263|NCT00250562|Natriuretic Agents|natriuretic agents|mesh-ancestor
110302264|NCT00250562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110302265|NCT00250562|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110302266|NCT00250562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110302267|NCT02960880|Rivaroxaban|rivaroxaban|mesh-list
110302268|NCT02960880|Phenprocoumon|phenprocoumon|mesh-list
110302269|NCT02960880|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110302270|NCT02960880|Antithrombins|antithrombins|mesh-ancestor
110302271|NCT02960880|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110280963|NCT00122837|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110280964|NCT00122837|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110280965|NCT00122837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110280966|NCT00122837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280967|NCT00122837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110280968|NCT00122837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280969|NCT00122837|Analgesics|analgesics|mesh-ancestor
110280970|NCT00122837|Sensory System Agents|sensory system agents|mesh-ancestor
110280971|NCT00122837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110280972|NCT00122837|Antidepressive Agents|antidepressive agents|mesh-ancestor
110280973|NCT00122837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110280974|NCT00122837|Dopamine Agents|dopamine agents|mesh-ancestor
110280975|NCT00122837|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110280977|NCT00190580|Antihypertensive Agents|antihypertensive agents|mesh-list
110302272|NCT02960880|Protease Inhibitors|protease inhibitors|mesh-ancestor
110302273|NCT02960880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110302274|NCT02960880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110302275|NCT02960880|Anticoagulants|anticoagulants|mesh-ancestor
110302276|NCT00279747|Naproxen|naproxen|mesh-list
110302277|NCT00279747|Meloxicam|meloxicam|mesh-list
110302278|NCT00279747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110302279|NCT00279747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110302280|NCT00279747|Analgesics|analgesics|mesh-ancestor
110302281|NCT00279747|Sensory System Agents|sensory system agents|mesh-ancestor
110302282|NCT00279747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110302283|NCT00279747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110302284|NCT00279747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110302285|NCT00279747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110302286|NCT00279747|Gout Suppressants|gout suppressants|mesh-ancestor
110020430|NCT00001968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110302287|NCT00279747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110302288|NCT00279747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110302289|NCT00279747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110302290|NCT00279747|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110302292|NCT00250640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110302293|NCT00250640|Vasodilator Agents|vasodilator agents|mesh-ancestor
110302294|NCT00250796|Interferons|interferons|mesh-list
110302295|NCT00250796|Interferon-alpha|interferon-alpha|mesh-list
110302296|NCT00250796|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
110302297|NCT00250796|Thalidomide|thalidomide|mesh-list
110302298|NCT00250796|Octreotide|octreotide|mesh-list
110302299|NCT00250796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110302300|NCT00250796|Antiviral Agents|antiviral agents|mesh-ancestor
110302301|NCT00250796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110302302|NCT00250796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110302303|NCT00250796|Immunologic Factors|immunologic factors|mesh-ancestor
110302304|NCT00250796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110302305|NCT00250796|Leprostatic Agents|leprostatic agents|mesh-ancestor
110302306|NCT00250796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110302313|NCT00286416|Omalizumab|omalizumab|mesh-list
110302314|NCT00286416|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110302315|NCT00286416|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110302316|NCT00286416|Respiratory System Agents|respiratory system agents|mesh-ancestor
110302317|NCT00250874|Docetaxel|docetaxel|mesh-list
110302318|NCT00250874|Doxorubicin|doxorubicin|mesh-list
110302319|NCT00250874|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110302320|NCT00250874|Trastuzumab|trastuzumab|mesh-list
110302321|NCT00250874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110302322|NCT00250874|Tubulin Modulators|tubulin modulators|mesh-ancestor
110280978|NCT00190580|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110280979|NCT00190580|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110280980|NCT00190580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280981|NCT00220506|Modafinil|modafinil|mesh-list
110280982|NCT00220506|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110280983|NCT00220506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280984|NCT00220506|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110280985|NCT00220506|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110280986|NCT00220506|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110280987|NCT00220506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280988|NCT00190619|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110280989|NCT00190619|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110280990|NCT00190619|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110280991|NCT00190619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110020459|NCT00002022|Hematinics|hematinics|mesh-ancestor
110302324|NCT00250874|Mitosis Modulators|mitosis modulators|mesh-ancestor
110302325|NCT00250874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110302326|NCT00250874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110302327|NCT00250874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110302328|NCT00250874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110302330|NCT00250874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110302331|NCT00279825|Levodopa|levodopa|mesh-list
110302332|NCT00279825|Carbidopa|carbidopa|mesh-list
110302333|NCT00279825|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110302334|NCT00279825|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110302335|NCT00279825|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110302336|NCT00279825|Dopamine Agents|dopamine agents|mesh-ancestor
110302337|NCT00279825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110302338|NCT00279825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110302339|NCT00279825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110302340|NCT00279825|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110302341|NCT00279825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110302342|NCT00279825|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110302343|NCT00279825|Immunologic Factors|immunologic factors|mesh-ancestor
110302344|NCT00279825|Dopamine Agonists|dopamine agonists|mesh-ancestor
110302345|NCT00250952|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110302346|NCT00250952|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110302347|NCT00250952|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110302348|NCT00250952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110020482|NCT00002040|Fluconazole|fluconazole|mesh-list
110302350|NCT00250952|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110302351|NCT00250952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110302352|NCT00250952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110302353|NCT00250952|Cholinergic Agents|cholinergic agents|mesh-ancestor
110302354|NCT00250952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110302355|NCT00250991|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110302356|NCT00250991|Eptifibatide|eptifibatide|mesh-list
110302357|NCT00250991|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110302358|NCT00250991|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110302359|NCT00250991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110302360|NCT00250991|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110302361|NCT00286611|Amifostine|amifostine|mesh-list
110302362|NCT00286611|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110302363|NCT00286611|Protective Agents|protective agents|mesh-ancestor
110280992|NCT00190619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280993|NCT00190619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110280994|NCT00190619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280996|NCT00190619|Sensory System Agents|sensory system agents|mesh-ancestor
110280997|NCT00190619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110280998|NCT00190619|Antidepressive Agents|antidepressive agents|mesh-ancestor
110280999|NCT00190619|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110281000|NCT00190619|Dopamine Agents|dopamine agents|mesh-ancestor
110281002|NCT00213564|Methotrexate|methotrexate|mesh-list
110281003|NCT00213564|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110281004|NCT00213564|Abortifacient Agents|abortifacient agents|mesh-ancestor
110281005|NCT00213564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110281006|NCT00213564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281007|NCT00213564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110281008|NCT00213564|Antimetabolites|antimetabolites|mesh-ancestor
110302364|NCT00286611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110302365|NCT00416832|Prednisone|prednisone|mesh-list
110302366|NCT00416832|Cyclophosphamide|cyclophosphamide|mesh-list
110302367|NCT00416832|Dacarbazine|dacarbazine|mesh-list
110302368|NCT00416832|Doxorubicin|doxorubicin|mesh-list
110302369|NCT00416832|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110302371|NCT00416832|Vincristine|vincristine|mesh-list
110302372|NCT00416832|Procarbazine|procarbazine|mesh-list
110302373|NCT00416832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110302374|NCT00416832|Immunologic Factors|immunologic factors|mesh-ancestor
110302375|NCT00416832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110302376|NCT00416832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110302380|NCT00416832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110302381|NCT00416832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110302382|NCT00416832|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110302383|NCT00416832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110302384|NCT00416832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110302385|NCT00416832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110302386|NCT00416832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110302387|NCT00416832|Glucocorticoids|glucocorticoids|mesh-ancestor
110302388|NCT00416832|Hormones|hormones|mesh-ancestor
110302389|NCT00416832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110302390|NCT00416832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110302391|NCT00416832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110302392|NCT00416832|Tubulin Modulators|tubulin modulators|mesh-ancestor
110302393|NCT00416832|Antimitotic Agents|antimitotic agents|mesh-ancestor
110302394|NCT00416832|Mitosis Modulators|mitosis modulators|mesh-ancestor
110302395|NCT00251030|Nelfinavir|nelfinavir|mesh-list
110302396|NCT00251030|Omeprazole|omeprazole|mesh-list
110302397|NCT00251030|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110302398|NCT00251030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110302399|NCT00251030|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110302400|NCT00251030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110033337|NCT03974243|Chiauranib|chiauranib|mesh-list
110302401|NCT00251030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110302402|NCT00251030|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110302403|NCT00251030|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110302404|NCT00251030|Protease Inhibitors|protease inhibitors|mesh-ancestor
110302405|NCT00251030|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110281009|NCT00213564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281010|NCT00213564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110281011|NCT00213564|Dermatologic Agents|dermatologic agents|mesh-ancestor
110281012|NCT00213564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110281013|NCT00213564|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110281014|NCT00213564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110281015|NCT00213564|Immunologic Factors|immunologic factors|mesh-ancestor
110281016|NCT00213564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110281017|NCT00213564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110281018|NCT00213564|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110281019|NCT00213564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110281020|NCT00213564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110302406|NCT00251030|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110302407|NCT00251030|Antiviral Agents|antiviral agents|mesh-ancestor
110302408|NCT00251030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110302410|NCT00286689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110302411|NCT00286689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110302412|NCT02961491|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
110302413|NCT02961491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110020566|NCT00002100|Antiviral Agents|antiviral agents|mesh-ancestor
110302414|NCT02961491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110302415|NCT02961491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110302416|NCT02961491|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110302417|NCT01640002|Bromides|bromides|mesh-list
110302418|NCT01640002|Propantheline|propantheline|mesh-list
110302419|NCT01640002|Anticonvulsants|anticonvulsants|mesh-ancestor
110302420|NCT01640002|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110302421|NCT01640002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110302422|NCT01640002|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110302423|NCT01640002|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110302424|NCT01640002|Cholinergic Agents|cholinergic agents|mesh-ancestor
110302425|NCT01640002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110302426|NCT01640002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110302427|NCT01640002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110302428|NCT00279903|Cortisone|cortisone|mesh-list
110302429|NCT00279903|Botulinum Toxins|botulinum toxins|mesh-list
110302430|NCT00279903|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110302431|NCT00279903|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110302432|NCT00279903|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110302433|NCT00279903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110302434|NCT00279903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110302435|NCT00279903|Cholinergic Agents|cholinergic agents|mesh-ancestor
110302436|NCT00279903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110302437|NCT00279903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110302438|NCT00279903|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110302439|NCT00279903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110302440|NCT00279903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110302442|NCT01640275|Isoflurane|isoflurane|mesh-list
110302443|NCT01640275|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110302444|NCT01640275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110302445|NCT01640275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110302446|NCT01640275|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110302467|NCT01640782|Fluorouracil|fluorouracil|mesh-list
110302468|NCT01640782|Irinotecan|irinotecan|mesh-list
110302469|NCT01640782|Levoleucovorin|levoleucovorin|mesh-list
110302470|NCT01640782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110302471|NCT01640782|Tubulin Modulators|tubulin modulators|mesh-ancestor
110302472|NCT01640782|Antimitotic Agents|antimitotic agents|mesh-ancestor
110302473|NCT01640782|Mitosis Modulators|mitosis modulators|mesh-ancestor
110302474|NCT01640782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281022|NCT00122876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110281023|NCT00122876|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110281024|NCT00122876|Dermatologic Agents|dermatologic agents|mesh-ancestor
110281025|NCT00190736|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110281026|NCT00190736|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110281027|NCT00190736|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110281028|NCT00190736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110281029|NCT00190736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281030|NCT00190736|Adrenergic Agents|adrenergic agents|mesh-ancestor
110281031|NCT00190736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110302475|NCT01640782|Antimetabolites|antimetabolites|mesh-ancestor
110302476|NCT01640782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110302477|NCT01640782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110302478|NCT01640782|Immunologic Factors|immunologic factors|mesh-ancestor
110302479|NCT01640782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110302480|NCT01640782|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110302481|NCT01640782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110302482|NCT01640782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110302483|NCT01640782|Antidotes|antidotes|mesh-ancestor
110302484|NCT01640782|Protective Agents|protective agents|mesh-ancestor
110302485|NCT01640782|Vitamin B Complex|vitamin b complex|mesh-ancestor
110302486|NCT01640782|Vitamins|vitamins|mesh-ancestor
110302487|NCT01640782|Micronutrients|micronutrients|mesh-ancestor
110302488|NCT00251186|Capecitabine|capecitabine|mesh-list
110302489|NCT00251186|Cetuximab|cetuximab|mesh-list
110302490|NCT00251186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110302491|NCT00251186|Antimetabolites|antimetabolites|mesh-ancestor
110302492|NCT00251186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110302493|NCT00251186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110302494|NCT00251186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110302495|NCT01641250|Cytarabine|cytarabine|mesh-list
110302496|NCT01641250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110302497|NCT01641250|Antimetabolites|antimetabolites|mesh-ancestor
110302498|NCT01641250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110302499|NCT01641250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110302500|NCT01641250|Antiviral Agents|antiviral agents|mesh-ancestor
110302501|NCT01641250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110302502|NCT01641250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110302503|NCT01641250|Immunologic Factors|immunologic factors|mesh-ancestor
110302504|NCT01641250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110302523|NCT01641406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110302525|NCT01641406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110302526|NCT01641406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110302527|NCT01641406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110302528|NCT01641406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110302529|NCT01641406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110302530|NCT01641406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110302531|NCT01641406|Growth Substances|growth substances|mesh-ancestor
110302532|NCT01641406|Growth Inhibitors|growth inhibitors|mesh-ancestor
110302533|NCT01641406|Tubulin Modulators|tubulin modulators|mesh-ancestor
110302534|NCT01641406|Antimitotic Agents|antimitotic agents|mesh-ancestor
110302535|NCT01641406|Mitosis Modulators|mitosis modulators|mesh-ancestor
110302536|NCT01641406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110302537|NCT01641406|Antimetabolites|antimetabolites|mesh-ancestor
110302538|NCT01641406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110302539|NCT01641406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110302540|NCT01641406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110020603|NCT00002118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110302541|NCT01641406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110302542|NCT01641406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110302543|NCT01641523|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
110302544|NCT01641523|Vasodilator Agents|vasodilator agents|mesh-ancestor
110281032|NCT00190736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281034|NCT00220584|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110281035|NCT00220584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110281036|NCT00220584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281037|NCT00220584|Cholinergic Agents|cholinergic agents|mesh-ancestor
110281038|NCT00220584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110281039|NCT00220584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281040|NCT00220584|Nootropic Agents|nootropic agents|mesh-ancestor
110281041|NCT00190814|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110302545|NCT01641523|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110302546|NCT01641523|Protective Agents|protective agents|mesh-ancestor
110302547|NCT01641523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110302549|NCT01641796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110302550|NCT01641796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110302551|NCT01641796|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110302552|NCT01641796|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110302554|NCT00280098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110302555|NCT00280098|Tubulin Modulators|tubulin modulators|mesh-ancestor
110302556|NCT00280098|Antimitotic Agents|antimitotic agents|mesh-ancestor
110302557|NCT00280098|Mitosis Modulators|mitosis modulators|mesh-ancestor
110302558|NCT00280098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110302559|NCT00251381|Cetuximab|cetuximab|mesh-list
110302560|NCT00251381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110302561|NCT00251381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110302562|NCT01685827|Eflornithine|eflornithine|mesh-list
110302563|NCT01685827|Nifurtimox|nifurtimox|mesh-list
110302564|NCT01685827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110302565|NCT01685827|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110302586|NCT05140096|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110302587|NCT05140096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110302588|NCT00251459|Ranibizumab|ranibizumab|mesh-list
110302589|NCT00251459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110302590|NCT00251459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110302591|NCT00251459|Growth Substances|growth substances|mesh-ancestor
110302592|NCT00251459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110302593|NCT00251459|Growth Inhibitors|growth inhibitors|mesh-ancestor
110302594|NCT00251459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110302595|NCT04823065|Scopolamine|scopolamine|mesh-list
110302596|NCT04823065|Loperamide|loperamide|mesh-list
110302597|NCT04823065|Antidiarrheals|antidiarrheals|mesh-list
110302598|NCT04823065|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
110302599|NCT04823065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110302600|NCT04823065|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110302601|NCT04823065|Antiemetics|antiemetics|mesh-ancestor
110302602|NCT04823065|Autonomic Agents|autonomic agents|mesh-ancestor
110302603|NCT04823065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110302604|NCT04823065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110302605|NCT04823065|Mydriatics|mydriatics|mesh-ancestor
110302606|NCT04823065|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110302607|NCT04823065|Cholinergic Agents|cholinergic agents|mesh-ancestor
110302608|NCT04823065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110302609|NCT04823065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020637|NCT00002148|OPC 14117|opc 14117|mesh-list
110302611|NCT04823065|Parasympatholytics|parasympatholytics|mesh-ancestor
110302612|NCT00280176|Fluorouracil|fluorouracil|mesh-list
110302614|NCT00280176|Antimetabolites|antimetabolites|mesh-ancestor
110302615|NCT00280176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110302616|NCT00280176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110302617|NCT00280176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110302618|NCT00280176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110281042|NCT00190814|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110281043|NCT00190814|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110281044|NCT00190814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110281045|NCT00190814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281046|NCT00190814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110281047|NCT00190814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281048|NCT00190814|Analgesics|analgesics|mesh-ancestor
110281049|NCT00190814|Sensory System Agents|sensory system agents|mesh-ancestor
110281050|NCT00190814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110281051|NCT00190814|Antidepressive Agents|antidepressive agents|mesh-ancestor
110281052|NCT00190814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110281053|NCT00190814|Dopamine Agents|dopamine agents|mesh-ancestor
110281054|NCT00220623|Antidepressive Agents|antidepressive agents|mesh-list
110281055|NCT00220623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110281056|NCT00220818|Lansoprazole|lansoprazole|mesh-list
110281057|NCT00220818|Dexlansoprazole|dexlansoprazole|mesh-list
110281058|NCT00220818|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110281059|NCT00220818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110281060|NCT00220818|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110302659|NCT00280371|Formoterol Fumarate|formoterol fumarate|mesh-list
110302660|NCT00280371|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110302661|NCT00280371|Autonomic Agents|autonomic agents|mesh-ancestor
110302662|NCT00280371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110302663|NCT00280371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110302664|NCT00280371|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110302665|NCT00280371|Respiratory System Agents|respiratory system agents|mesh-ancestor
110302666|NCT00280371|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110302667|NCT00280371|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110302668|NCT00280371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110302669|NCT00280371|Adrenergic Agents|adrenergic agents|mesh-ancestor
110302670|NCT00280371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110302671|NCT00280371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110302672|NCT04455139|Melphalan|melphalan|mesh-list
110302673|NCT04455139|Topotecan|topotecan|mesh-list
110302674|NCT04455139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110302675|NCT04455139|Alkylating Agents|alkylating agents|mesh-ancestor
110302676|NCT04455139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110302677|NCT04455139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110302678|NCT04455139|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110302679|NCT04455139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110302680|NCT04455139|Immunologic Factors|immunologic factors|mesh-ancestor
110302681|NCT04455139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110302682|NCT04455139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110302683|NCT04455139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110302684|NCT04455139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110302685|NCT00251654|Anesthetics|anesthetics|mesh-list
110302686|NCT00251654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110302687|NCT00251654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110302688|NCT00286923|Topiramate|topiramate|mesh-list
110302689|NCT00286923|Anticonvulsants|anticonvulsants|mesh-ancestor
110302690|NCT00286923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110302691|NCT00286923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110302692|NCT00251732|Antidepressive Agents|antidepressive agents|mesh-list
110281062|NCT00220818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281063|NCT00213759|Lenograstim|lenograstim|mesh-list
110281064|NCT00213759|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110281065|NCT00213759|Immunologic Factors|immunologic factors|mesh-ancestor
110281066|NCT00213759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281067|NCT00190853|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110281068|NCT00190853|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110281069|NCT00190853|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110281070|NCT00190853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110281071|NCT00190853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281072|NCT00190853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110281073|NCT00190853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110302693|NCT00251732|Nortriptyline|nortriptyline|mesh-list
110302694|NCT00251732|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
110302695|NCT00251732|Rabeprazole|rabeprazole|mesh-list
110302696|NCT00251732|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110302697|NCT00251732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110302698|NCT00251732|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110302699|NCT00251732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110302700|NCT00251732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110302701|NCT00251732|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110033635|NCT03012672|Antiviral Agents|antiviral agents|mesh-ancestor
110302702|NCT00251732|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110302703|NCT00251732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110302704|NCT00251732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110302705|NCT00251732|Adrenergic Agents|adrenergic agents|mesh-ancestor
110302706|NCT00251732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110302707|NCT00251732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110302708|NCT00286962|Insulin|insulin|mesh-list
110302709|NCT00286962|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110302710|NCT00286962|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110302711|NCT00286962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110302712|NCT04719650|Zoledronic Acid|zoledronic acid|mesh-list
110302713|NCT04719650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110302714|NCT04719650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110302715|NCT00251849|KRM 1648|krm 1648|mesh-list
110302716|NCT00251849|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110302717|NCT00251849|Antitubercular Agents|antitubercular agents|mesh-ancestor
110302718|NCT00251849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110302719|NCT00251849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110302720|NCT00251849|Leprostatic Agents|leprostatic agents|mesh-ancestor
110302721|NCT00251888|Irinotecan|irinotecan|mesh-list
110302722|NCT00251888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110302737|NCT00252044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110302738|NCT00252044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110302739|NCT01805284|Linezolid|linezolid|mesh-list
110302740|NCT01805284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110302741|NCT01805284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110302742|NCT01805284|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110302743|NCT01805284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110302744|NCT01805284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110302745|NCT00280605|Alfuzosin|alfuzosin|mesh-list
110302746|NCT00280605|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110302747|NCT00280605|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110302748|NCT00280605|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110302749|NCT00280605|Adrenergic Agents|adrenergic agents|mesh-ancestor
110302750|NCT00280605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110281074|NCT00190853|Analgesics|analgesics|mesh-ancestor
110281075|NCT00190853|Sensory System Agents|sensory system agents|mesh-ancestor
110281076|NCT00190853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110281077|NCT00190853|Antidepressive Agents|antidepressive agents|mesh-ancestor
110281078|NCT00190853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110281079|NCT00190853|Dopamine Agents|dopamine agents|mesh-ancestor
110281081|NCT00190892|Olanzapine|olanzapine|mesh-list
110281082|NCT00190892|Antiemetics|antiemetics|mesh-ancestor
110281083|NCT00190892|Autonomic Agents|autonomic agents|mesh-ancestor
110281084|NCT00190892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110281085|NCT00190892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281086|NCT00190892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110281087|NCT00190892|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110281088|NCT00190892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110281089|NCT00190892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110281090|NCT00190892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110281091|NCT00190892|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110281092|NCT00190892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110281093|NCT00190892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110302751|NCT00280605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110302752|NCT00280605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110302753|NCT00280605|Urological Agents|urological agents|mesh-ancestor
110302754|NCT01134601|Capecitabine|capecitabine|mesh-list
110302755|NCT01134601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110302756|NCT01134601|Antimetabolites|antimetabolites|mesh-ancestor
110302757|NCT01134601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110302758|NCT01134601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110302759|NCT00252122|Ketamine|ketamine|mesh-list
110302760|NCT00252122|Analgesics|analgesics|mesh-ancestor
110302761|NCT00252122|Sensory System Agents|sensory system agents|mesh-ancestor
110302762|NCT00252122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110302763|NCT00252122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110302764|NCT00252122|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110302765|NCT00252122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110302766|NCT00252122|Anesthetics, General|anesthetics, general|mesh-ancestor
110302767|NCT00252122|Anesthetics|anesthetics|mesh-ancestor
110302768|NCT00252122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110302769|NCT00252122|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110302770|NCT00252122|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110302771|NCT00252122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110302772|NCT00252122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110302773|NCT00287157|Tizanidine|tizanidine|mesh-list
110302774|NCT00287157|Analgesics|analgesics|mesh-ancestor
110033712|NCT02924064|Metformin|metformin|mesh-list
110302775|NCT00287157|Sensory System Agents|sensory system agents|mesh-ancestor
110302776|NCT00287157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110302777|NCT00287157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110302778|NCT00287157|Anticonvulsants|anticonvulsants|mesh-ancestor
110302779|NCT00287157|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110302780|NCT00287157|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110302791|NCT00280644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110302793|NCT00280644|Immunologic Factors|immunologic factors|mesh-ancestor
110302794|NCT00280644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110302795|NCT00252200|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
110281094|NCT00190892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281095|NCT00190892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110281096|NCT00190892|Serotonin Agents|serotonin agents|mesh-ancestor
110281097|NCT00190892|Anticonvulsants|anticonvulsants|mesh-ancestor
110281098|NCT00190892|Antimanic Agents|antimanic agents|mesh-ancestor
110281099|NCT00190892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110281101|NCT00190892|Sensory System Agents|sensory system agents|mesh-ancestor
110281102|NCT00190892|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110281103|NCT00190892|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110281104|NCT00190892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110281105|NCT00220857|Rabeprazole|rabeprazole|mesh-list
110281106|NCT00220857|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110281107|NCT00220857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110281108|NCT00220857|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110281109|NCT00220857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110281110|NCT00220857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281111|NCT00190931|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110302796|NCT00252200|Natriuretic Agents|natriuretic agents|mesh-ancestor
110302797|NCT00252200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110302798|NCT00252278|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110302799|NCT00252278|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110302800|NCT00252278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110302801|NCT00252278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110302802|NCT00252278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110302803|NCT00252278|Adrenergic Agents|adrenergic agents|mesh-ancestor
110302804|NCT00252278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110302805|NCT00252278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110302806|NCT00252317|Captopril|captopril|mesh-list
110302807|NCT00252317|Trandolapril|trandolapril|mesh-list
110302808|NCT00252317|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110302809|NCT00252317|Protease Inhibitors|protease inhibitors|mesh-ancestor
110302810|NCT00252317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110302811|NCT00252317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110302812|NCT00252317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110302813|NCT00252356|Amibegron|amibegron|mesh-list
110302814|NCT00252356|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
110302815|NCT00252356|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110302816|NCT00252356|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110302817|NCT00252356|Adrenergic Agents|adrenergic agents|mesh-ancestor
110302818|NCT00252356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110302819|NCT00252356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110302820|NCT00252356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110302821|NCT00252356|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110302822|NCT02753998|Paclitaxel|paclitaxel|mesh-list
110302823|NCT02753998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110302824|NCT02753998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110302825|NCT02753998|Tubulin Modulators|tubulin modulators|mesh-ancestor
110302826|NCT02753998|Antimitotic Agents|antimitotic agents|mesh-ancestor
110302827|NCT02753998|Mitosis Modulators|mitosis modulators|mesh-ancestor
110302828|NCT02753998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110302830|NCT02754154|Rivaroxaban|rivaroxaban|mesh-list
110302831|NCT02754154|Dabigatran|dabigatran|mesh-list
110302832|NCT02754154|Apixaban|apixaban|mesh-list
110302833|NCT02754154|Anticoagulants|anticoagulants|mesh-ancestor
110302834|NCT02754154|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110281112|NCT00190931|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110281113|NCT00190931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110281114|NCT00190931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110281115|NCT00190931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281116|NCT00190931|Adrenergic Agents|adrenergic agents|mesh-ancestor
110281117|NCT00190931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110281118|NCT00190931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110302835|NCT02754154|Antithrombins|antithrombins|mesh-ancestor
110302836|NCT02754154|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110302837|NCT02754154|Protease Inhibitors|protease inhibitors|mesh-ancestor
110302838|NCT02754154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110302839|NCT02754154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110302840|NCT00252434|Methamphetamine|methamphetamine|mesh-list
110302841|NCT00252434|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110302842|NCT00252434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110302843|NCT00252434|Sympathomimetics|sympathomimetics|mesh-ancestor
110302887|NCT02758717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110302889|NCT00287313|Vitamin K|vitamin k|mesh-list
110302890|NCT00287313|Vitamins|vitamins|mesh-ancestor
110302891|NCT00287313|Micronutrients|micronutrients|mesh-ancestor
110302892|NCT00287313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110302893|NCT00287313|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110302894|NCT00287313|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110302895|NCT00287313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110302896|NCT00287313|Hemostatics|hemostatics|mesh-ancestor
110302897|NCT00287313|Coagulants|coagulants|mesh-ancestor
110302898|NCT01680250|Sirolimus|sirolimus|mesh-list
110302899|NCT01680250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110302900|NCT01680250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110302901|NCT01680250|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110302902|NCT01680250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110302903|NCT01680250|Antifungal Agents|antifungal agents|mesh-ancestor
110302904|NCT01680250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110302905|NCT01680250|Immunologic Factors|immunologic factors|mesh-ancestor
110302906|NCT01680250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110302907|NCT00280956|Natalizumab|natalizumab|mesh-list
110302908|NCT00280956|Immunologic Factors|immunologic factors|mesh-ancestor
110302909|NCT00280956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110302910|NCT02279875|Rifampin|rifampin|mesh-list
110302911|NCT02279875|Isoniazid|isoniazid|mesh-list
110302912|NCT02279875|Linezolid|linezolid|mesh-list
110302913|NCT02279875|Pyrazinamide|pyrazinamide|mesh-list
110302914|NCT02279875|Ethambutol|ethambutol|mesh-list
110302915|NCT02279875|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110302916|NCT02279875|Antitubercular Agents|antitubercular agents|mesh-ancestor
110302917|NCT02279875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110302918|NCT02279875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110302919|NCT02279875|Leprostatic Agents|leprostatic agents|mesh-ancestor
110302920|NCT02279875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110302921|NCT02279875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110302922|NCT02279875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110302923|NCT02279875|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110302924|NCT02279875|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110033872|NCT02516657|Hormones|hormones|mesh-ancestor
110302925|NCT02279875|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110302926|NCT02279875|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110302927|NCT02279875|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110302928|NCT02279875|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110302929|NCT02279875|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110302930|NCT02279875|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110302931|NCT02279875|Antimetabolites|antimetabolites|mesh-ancestor
110302932|NCT02279875|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110302933|NCT02279875|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110302934|NCT00280995|Mipomersen|mipomersen|mesh-list
110302935|NCT00280995|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110302936|NCT00280995|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110302937|NCT00280995|Antimetabolites|antimetabolites|mesh-ancestor
110281120|NCT00220896|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110281121|NCT00220896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110281122|NCT00220896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281123|NCT00220896|Cholinergic Agents|cholinergic agents|mesh-ancestor
110281124|NCT00220896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110281125|NCT00220896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281126|NCT00220896|Nootropic Agents|nootropic agents|mesh-ancestor
110281127|NCT00190970|Ruboxistaurin|ruboxistaurin|mesh-list
110281128|NCT00190970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110281129|NCT00190970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281130|NCT00191009|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110281131|NCT00191009|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110281132|NCT00191009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110281133|NCT00191009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110302938|NCT00280995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110302939|NCT00280995|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110302940|NCT05139667|Tacrolimus|tacrolimus|mesh-list
110302941|NCT05139667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110302942|NCT05139667|Immunologic Factors|immunologic factors|mesh-ancestor
110302943|NCT05139667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110302944|NCT05139667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110302956|NCT00287352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110302957|NCT00287352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110302958|NCT00287352|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110302959|NCT00287352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110302960|NCT00287352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110302961|NCT00287352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110302962|NCT00287352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110302963|NCT00287352|Serotonin Agents|serotonin agents|mesh-ancestor
110302964|NCT00287352|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110302965|NCT00287352|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110302966|NCT00287352|Antiviral Agents|antiviral agents|mesh-ancestor
110302967|NCT00287352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110302968|NCT00287352|Dopamine Agents|dopamine agents|mesh-ancestor
110020744|NCT00002202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110302969|NCT00287352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110302970|NCT00287352|Analgesics|analgesics|mesh-ancestor
110302971|NCT00287352|Sensory System Agents|sensory system agents|mesh-ancestor
110302972|NCT04823962|Molgramostim|molgramostim|mesh-list
110302973|NCT04823962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110302974|NCT00252668|Etanercept|etanercept|mesh-list
110302975|NCT00252668|Methotrexate|methotrexate|mesh-list
110302976|NCT00252668|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110302977|NCT00252668|Abortifacient Agents|abortifacient agents|mesh-ancestor
110302978|NCT00252668|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110302979|NCT00252668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110302980|NCT00252668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110302981|NCT00252668|Antimetabolites|antimetabolites|mesh-ancestor
110302982|NCT00252668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110302983|NCT00252668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110302985|NCT00252668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110302986|NCT00252668|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110302987|NCT00252668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110302988|NCT00252668|Immunologic Factors|immunologic factors|mesh-ancestor
110302989|NCT00252668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110302990|NCT00252668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110302991|NCT00252668|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110281135|NCT00191009|Adrenergic Agents|adrenergic agents|mesh-ancestor
110281136|NCT00191009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110281137|NCT00191009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281138|NCT00191048|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110281139|NCT00191048|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110281140|NCT00191048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110281141|NCT00191048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110281142|NCT00191048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281143|NCT00191048|Adrenergic Agents|adrenergic agents|mesh-ancestor
110302992|NCT00252668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110302993|NCT00252668|Analgesics|analgesics|mesh-ancestor
110302994|NCT00252668|Sensory System Agents|sensory system agents|mesh-ancestor
110302995|NCT00252668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110302996|NCT00252668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110302997|NCT00252668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110302998|NCT02271997|Ferrous fumarate|ferrous fumarate|mesh-list
110302999|NCT02271997|Ferrous gluconate|ferrous gluconate|mesh-list
110303001|NCT02271997|Micronutrients|micronutrients|mesh-ancestor
110303002|NCT02271997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110303003|NCT02271997|Hematinics|hematinics|mesh-ancestor
110303004|NCT00287391|Rabeprazole|rabeprazole|mesh-list
110303005|NCT00287391|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110303006|NCT00287391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110303007|NCT00287391|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110303008|NCT00287391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110303009|NCT00287391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110303010|NCT00252707|Docetaxel|docetaxel|mesh-list
110303016|NCT00252707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110303017|NCT00252707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110303018|NCT00252707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110303019|NCT01680406|Chloroquine|chloroquine|mesh-list
110303020|NCT01680406|Lumefantrine|lumefantrine|mesh-list
110303021|NCT01680406|Artemether|artemether|mesh-list
110303022|NCT01680406|Primaquine|primaquine|mesh-list
110303023|NCT01680406|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110303024|NCT01680406|Amebicides|amebicides|mesh-ancestor
110303025|NCT01680406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110303026|NCT01680406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110303027|NCT01680406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110303028|NCT01680406|Antimalarials|antimalarials|mesh-ancestor
110303029|NCT01680406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110303030|NCT00287430|Hormones|hormones|mesh-list
110303031|NCT00287430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110303032|NCT00287430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110303033|NCT01680679|Vaccines|vaccines|mesh-list
110303034|NCT01680679|Immunologic Factors|immunologic factors|mesh-ancestor
110303035|NCT01680679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110303036|NCT01680718|Vasopressins|vasopressins|mesh-list
110303037|NCT01680718|Arginine Vasopressin|arginine vasopressin|mesh-list
110303038|NCT01680718|Oxytocin|oxytocin|mesh-list
110303039|NCT01680718|Oxytocics|oxytocics|mesh-ancestor
110303040|NCT01680718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110303041|NCT01680718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110303042|NCT01680718|Hemostatics|hemostatics|mesh-ancestor
110303043|NCT01680718|Coagulants|coagulants|mesh-ancestor
110303044|NCT01680718|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110303045|NCT01680718|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110303046|NCT01680718|Natriuretic Agents|natriuretic agents|mesh-ancestor
110303047|NCT01680796|Dexamethasone|dexamethasone|mesh-list
110303048|NCT01680796|Bortezomib|bortezomib|mesh-list
110303049|NCT01680796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110303050|NCT01680796|Antiemetics|antiemetics|mesh-ancestor
110303051|NCT01680796|Autonomic Agents|autonomic agents|mesh-ancestor
110281144|NCT00191048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110281145|NCT00191048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281146|NCT00123149|Epoetin Alfa|epoetin alfa|mesh-list
110281147|NCT00123149|Hematinics|hematinics|mesh-ancestor
110281148|NCT00191087|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110281149|NCT00191087|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110281150|NCT00191087|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110281151|NCT00191087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110281152|NCT00191087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281153|NCT00191087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110281154|NCT00191087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281155|NCT00191087|Analgesics|analgesics|mesh-ancestor
110281156|NCT00191087|Sensory System Agents|sensory system agents|mesh-ancestor
110281157|NCT00191087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110281158|NCT00191087|Antidepressive Agents|antidepressive agents|mesh-ancestor
110303052|NCT01680796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110303053|NCT01680796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110303054|NCT01680796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110303055|NCT01680796|Glucocorticoids|glucocorticoids|mesh-ancestor
110303057|NCT01680796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110303058|NCT01680796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110303059|NCT01680796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110303060|NCT00252785|Budesonide|budesonide|mesh-list
110303061|NCT00252785|Theophylline|theophylline|mesh-list
110303062|NCT00252785|Formoterol Fumarate|formoterol fumarate|mesh-list
110303063|NCT00252785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110303064|NCT00252785|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110303065|NCT00252785|Autonomic Agents|autonomic agents|mesh-ancestor
110303066|NCT00252785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110303067|NCT00252785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110303068|NCT00252785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110303069|NCT00252785|Respiratory System Agents|respiratory system agents|mesh-ancestor
110303070|NCT00252785|Glucocorticoids|glucocorticoids|mesh-ancestor
110303072|NCT00252785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110303073|NCT00252785|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110303074|NCT00252785|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110303075|NCT00252785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110303076|NCT00252785|Adrenergic Agents|adrenergic agents|mesh-ancestor
110303077|NCT00252785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110303078|NCT00252785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110303079|NCT00252785|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110303080|NCT00252785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110303081|NCT00252785|Vasodilator Agents|vasodilator agents|mesh-ancestor
110303082|NCT00252785|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110303083|NCT00252785|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110303108|NCT00252824|Autonomic Agents|autonomic agents|mesh-ancestor
110303109|NCT00252824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110303110|NCT00252824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110303111|NCT00252824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110303112|NCT00252824|Respiratory System Agents|respiratory system agents|mesh-ancestor
110303113|NCT00252824|Glucocorticoids|glucocorticoids|mesh-ancestor
110303114|NCT00252824|Hormones|hormones|mesh-ancestor
110303115|NCT00252824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110281159|NCT00191087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110281160|NCT00191087|Dopamine Agents|dopamine agents|mesh-ancestor
110281161|NCT00191126|Gemcitabine|gemcitabine|mesh-list
110281162|NCT00191126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110281163|NCT00191126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110281164|NCT00191126|Antimetabolites|antimetabolites|mesh-ancestor
110281165|NCT00191126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281166|NCT00221052|Diclofenac|diclofenac|mesh-list
110281167|NCT00221052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110281168|NCT00221052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110281169|NCT00221052|Analgesics|analgesics|mesh-ancestor
110281170|NCT00221052|Sensory System Agents|sensory system agents|mesh-ancestor
110303116|NCT00252824|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110303117|NCT00252824|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110303118|NCT00252824|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110303119|NCT00252824|Adrenergic Agents|adrenergic agents|mesh-ancestor
110303120|NCT00252824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110303121|NCT00252824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110303122|NCT00281190|Dimercaprol|dimercaprol|mesh-list
110303123|NCT00281190|Chelating Agents|chelating agents|mesh-ancestor
110303124|NCT00281190|Sequestering Agents|sequestering agents|mesh-ancestor
110303125|NCT00281190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110303126|NCT00252863|Fluticasone|fluticasone|mesh-list
110303127|NCT00252863|Xhance|xhance|mesh-list
110303128|NCT00252863|Budesonide|budesonide|mesh-list
110303129|NCT00252863|Theophylline|theophylline|mesh-list
110303130|NCT00252863|Albuterol|albuterol|mesh-list
110303131|NCT00252863|Terbutaline|terbutaline|mesh-list
110303132|NCT00252863|Formoterol Fumarate|formoterol fumarate|mesh-list
110303133|NCT00252863|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110020796|NCT00002220|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110303134|NCT00252863|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110303135|NCT00252863|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110303136|NCT00252863|Montelukast|montelukast|mesh-list
110303137|NCT00252863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110303159|NCT00252863|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110303160|NCT00252863|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110303161|NCT00252863|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110303162|NCT00252863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110303163|NCT00252863|Vasodilator Agents|vasodilator agents|mesh-ancestor
110303164|NCT00252863|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110303165|NCT00252863|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110303166|NCT00252863|Purinergic Agents|purinergic agents|mesh-ancestor
110303167|NCT00252863|Sympathomimetics|sympathomimetics|mesh-ancestor
110303168|NCT01681537|Cytarabine|cytarabine|mesh-list
110303169|NCT01681537|Etoposide|etoposide|mesh-list
110303170|NCT01681537|Mitoxantrone|mitoxantrone|mesh-list
110303171|NCT01681537|Lenalidomide|lenalidomide|mesh-list
110303172|NCT01681537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110303173|NCT01681537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110303174|NCT01681537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110303175|NCT01681537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110303176|NCT01681537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110303177|NCT01681537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110303178|NCT01681537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110303179|NCT01681537|Antimetabolites|antimetabolites|mesh-ancestor
110303180|NCT01681537|Antiviral Agents|antiviral agents|mesh-ancestor
110303181|NCT01681537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110303182|NCT01681537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110303183|NCT01681537|Immunologic Factors|immunologic factors|mesh-ancestor
110303184|NCT01681537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110303185|NCT01681537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110303186|NCT01681537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110303187|NCT01681537|Growth Substances|growth substances|mesh-ancestor
110303188|NCT01681537|Growth Inhibitors|growth inhibitors|mesh-ancestor
110303189|NCT01681537|Analgesics|analgesics|mesh-ancestor
110281171|NCT00221052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110281172|NCT00221052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281173|NCT00221052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110281174|NCT00221052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110281175|NCT00221052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110281176|NCT00221052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110281177|NCT00221052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281178|NCT00191204|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110281179|NCT00191204|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110303201|NCT01681966|Sensory System Agents|sensory system agents|mesh-ancestor
110303202|NCT01681966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110303203|NCT01682161|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110303204|NCT01682161|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110303205|NCT01682161|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110303206|NCT01682161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110303207|NCT01682161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110303208|NCT01682161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110303209|NCT01682161|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110303210|NCT01682161|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110303212|NCT01682161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110303213|NCT01682161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110303214|NCT01682161|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110303216|NCT01682161|Dopamine Agents|dopamine agents|mesh-ancestor
110303217|NCT02279914|Misoprostol|misoprostol|mesh-list
110303218|NCT02279914|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110303219|NCT02279914|Abortifacient Agents|abortifacient agents|mesh-ancestor
110303220|NCT02279914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110303221|NCT02279914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110303222|NCT02279914|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110303223|NCT02279914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110303224|NCT02279914|Oxytocics|oxytocics|mesh-ancestor
110303225|NCT00281307|Tocopherols|tocopherols|mesh-list
110303226|NCT00281307|Vitamin E|vitamin e|mesh-list
110303227|NCT00281307|Tocotrienols|tocotrienols|mesh-list
110303228|NCT00281307|alpha-Tocopherol|alpha-tocopherol|mesh-list
110303229|NCT00281307|Antioxidants|antioxidants|mesh-ancestor
110303230|NCT00281307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110303231|NCT00281307|Protective Agents|protective agents|mesh-ancestor
110303232|NCT00281307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110303233|NCT00281307|Vitamins|vitamins|mesh-ancestor
110303234|NCT00281307|Micronutrients|micronutrients|mesh-ancestor
110303235|NCT01682746|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
110303236|NCT01682746|Trioxsalen|trioxsalen|mesh-list
110303237|NCT01682746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110303238|NCT01682746|Dermatologic Agents|dermatologic agents|mesh-ancestor
110303239|NCT01682746|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110303240|NCT00287664|Terlipressin|terlipressin|mesh-list
110303241|NCT00287664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110303242|NCT00287664|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110303243|NCT01682902|Insulin|insulin|mesh-list
110303244|NCT01682902|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110303245|NCT01682902|Insulin Aspart|insulin aspart|mesh-list
110303246|NCT01682902|Insulin, Long-Acting|insulin, long-acting|mesh-list
110303247|NCT01682902|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110303248|NCT01682902|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110303249|NCT01682902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110303250|NCT01683175|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110303251|NCT01683175|Cisplatin|cisplatin|mesh-list
110303252|NCT01683175|Vinorelbine|vinorelbine|mesh-list
110303253|NCT01683175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110303254|NCT01683175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110303255|NCT01683175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110303273|NCT01683253|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110303274|NCT01683253|Sympathomimetics|sympathomimetics|mesh-ancestor
110303275|NCT01683253|Autonomic Agents|autonomic agents|mesh-ancestor
110281180|NCT00191204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110281181|NCT00191204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110281182|NCT00191204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281184|NCT00191204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281185|NCT00191204|Analgesics|analgesics|mesh-ancestor
110281186|NCT00191204|Sensory System Agents|sensory system agents|mesh-ancestor
110281187|NCT00191204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110281188|NCT00191204|Antidepressive Agents|antidepressive agents|mesh-ancestor
110281189|NCT00191204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110281191|NCT00123227|Rosiglitazone|rosiglitazone|mesh-list
110281192|NCT00123227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110281193|NCT00123227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281194|NCT00191243|Gemcitabine|gemcitabine|mesh-list
110281195|NCT00191243|Docetaxel|docetaxel|mesh-list
110281196|NCT00191243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110281197|NCT00191243|Antimetabolites|antimetabolites|mesh-ancestor
110281198|NCT00191243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281199|NCT00191243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110281200|NCT00191243|Tubulin Modulators|tubulin modulators|mesh-ancestor
110281201|NCT00191243|Antimitotic Agents|antimitotic agents|mesh-ancestor
110281202|NCT00191243|Mitosis Modulators|mitosis modulators|mesh-ancestor
110281203|NCT00214032|Pycnogenols|pycnogenols|mesh-list
110281204|NCT00214032|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110281205|NCT00214032|Immunologic Factors|immunologic factors|mesh-ancestor
110281206|NCT00214032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281207|NCT00214032|Antioxidants|antioxidants|mesh-ancestor
110303276|NCT01683253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110303277|NCT01683253|Protective Agents|protective agents|mesh-ancestor
110303278|NCT01683292|Apomorphine|apomorphine|mesh-list
110303279|NCT01683292|Emetics|emetics|mesh-ancestor
110303280|NCT01683292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110303281|NCT01683292|Autonomic Agents|autonomic agents|mesh-ancestor
110303282|NCT01683292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110303283|NCT01683292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110303284|NCT01683292|Dopamine Agonists|dopamine agonists|mesh-ancestor
110303285|NCT01683292|Dopamine Agents|dopamine agents|mesh-ancestor
110303286|NCT01683292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110303287|NCT01683292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110303288|NCT00253058|Cetirizine|cetirizine|mesh-list
110303289|NCT00253058|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110303290|NCT00253058|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110303291|NCT00253058|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110303292|NCT00253058|Histamine Antagonists|histamine antagonists|mesh-ancestor
110303293|NCT00253058|Histamine Agents|histamine agents|mesh-ancestor
110281208|NCT00214032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281209|NCT00214032|Protective Agents|protective agents|mesh-ancestor
110281210|NCT00214032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110281211|NCT00123266|Plasminogen|plasminogen|mesh-list
110281212|NCT00123266|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110281213|NCT00123266|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110281214|NCT00123266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281215|NCT00191321|Teriparatide|teriparatide|mesh-list
110303294|NCT00253058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110303295|NCT00253058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020862|NCT00002286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110303296|NCT00253058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110303297|NCT01683682|Carboplatin|carboplatin|mesh-list
110303298|NCT01683682|Vinorelbine|vinorelbine|mesh-list
110303299|NCT01683682|Nintedanib|nintedanib|mesh-list
110303300|NCT01683682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110303301|NCT01683682|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110303302|NCT01683682|Tubulin Modulators|tubulin modulators|mesh-ancestor
110303303|NCT01683682|Antimitotic Agents|antimitotic agents|mesh-ancestor
110303304|NCT01683682|Mitosis Modulators|mitosis modulators|mesh-ancestor
110034238|NCT01397513|Antipyretics|antipyretics|mesh-ancestor
110303305|NCT01683682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110303306|NCT01683682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110303307|NCT01683682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110303309|NCT00287742|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110303310|NCT00287742|Serotonin Agents|serotonin agents|mesh-ancestor
110303311|NCT00287742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110303312|NCT00287742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110303313|NCT00287742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110303325|NCT04527562|Mitosis Modulators|mitosis modulators|mesh-ancestor
110303326|NCT04527562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110303327|NCT04527562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110303329|NCT01684072|Immunologic Factors|immunologic factors|mesh-ancestor
110303330|NCT01684072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110303331|NCT01684111|Vinorelbine|vinorelbine|mesh-list
110303332|NCT01684111|Nintedanib|nintedanib|mesh-list
110303333|NCT01684111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110303334|NCT01684111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110303335|NCT01684111|Tubulin Modulators|tubulin modulators|mesh-ancestor
110303336|NCT01684111|Antimitotic Agents|antimitotic agents|mesh-ancestor
110303337|NCT01684111|Mitosis Modulators|mitosis modulators|mesh-ancestor
110303338|NCT01684111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110303339|NCT01684111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110303340|NCT01684111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110303341|NCT00253136|Risperidone|risperidone|mesh-list
110303342|NCT00253136|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110303343|NCT00253136|Serotonin Agents|serotonin agents|mesh-ancestor
110303344|NCT00253136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110303345|NCT00253136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110303346|NCT00253136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110303347|NCT00253136|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110303348|NCT00253136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110303349|NCT00253136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110303350|NCT00253136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110303351|NCT00253136|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110303352|NCT00253136|Dopamine Agents|dopamine agents|mesh-ancestor
110303353|NCT01684306|Modafinil|modafinil|mesh-list
110303354|NCT01684306|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110303355|NCT01684306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110303356|NCT01684306|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110303357|NCT01684306|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110303358|NCT01684306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110303359|NCT01684306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110303360|NCT00287781|Lidocaine|lidocaine|mesh-list
110303361|NCT00287781|Anesthetics, Local|anesthetics, local|mesh-ancestor
110281216|NCT00191321|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110281217|NCT00191321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281218|NCT00191321|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110281220|NCT00123305|Fibrinolysin|fibrinolysin|mesh-list
110281221|NCT00123305|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110281222|NCT00123305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110281223|NCT00123305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281224|NCT00214110|Tamoxifen|tamoxifen|mesh-list
110281225|NCT00214110|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110281226|NCT00214110|Hormone Antagonists|hormone antagonists|mesh-ancestor
110281227|NCT00214110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110281228|NCT00214110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281229|NCT00214110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110281230|NCT00214110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110281231|NCT00214110|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110281232|NCT00214110|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110281233|NCT00214110|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110281234|NCT00191399|Olanzapine|olanzapine|mesh-list
110281235|NCT00191399|Fluoxetine|fluoxetine|mesh-list
110281236|NCT00191399|Antiemetics|antiemetics|mesh-ancestor
110281237|NCT00191399|Autonomic Agents|autonomic agents|mesh-ancestor
110303362|NCT00287781|Anesthetics|anesthetics|mesh-ancestor
110303363|NCT00287781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110303364|NCT00287781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110303365|NCT00287781|Sensory System Agents|sensory system agents|mesh-ancestor
110303366|NCT00287781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110303367|NCT00287781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110303368|NCT00287781|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110303369|NCT00287781|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110303370|NCT00287781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110303371|NCT00287781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110303372|NCT00416871|Interferons|interferons|mesh-list
110303373|NCT00416871|Interferon-alpha|interferon-alpha|mesh-list
110303374|NCT00416871|Aldesleukin|aldesleukin|mesh-list
110303375|NCT00416871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110303376|NCT00416871|Antiviral Agents|antiviral agents|mesh-ancestor
110303377|NCT00416871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110303378|NCT00416871|Immunologic Factors|immunologic factors|mesh-ancestor
110303408|NCT01684774|Anesthetics|anesthetics|mesh-ancestor
110303409|NCT01684774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110303410|NCT01684774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110303411|NCT01684774|Sensory System Agents|sensory system agents|mesh-ancestor
110303412|NCT01684774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110303413|NCT02279992|Carboplatin|carboplatin|mesh-list
110303414|NCT02279992|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110303415|NCT02279992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110303416|NCT02279992|Vasodilator Agents|vasodilator agents|mesh-ancestor
110303417|NCT02279992|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110303418|NCT02279992|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110303419|NCT02279992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110281238|NCT00191399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110281239|NCT00191399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281240|NCT00191399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110281241|NCT00191399|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110281242|NCT00191399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110281243|NCT00191399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110303420|NCT02279992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110303421|NCT02279992|Urological Agents|urological agents|mesh-ancestor
110303423|NCT00253175|Anticonvulsants|anticonvulsants|mesh-ancestor
110303424|NCT00253175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110303425|NCT00253175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110303426|NCT00287820|Olanzapine|olanzapine|mesh-list
110303442|NCT00287820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110303443|NCT00287820|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110303444|NCT00287820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110303445|NCT00287820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110303446|NCT02272348|Insulin|insulin|mesh-list
110303447|NCT02272348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110303448|NCT02272348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110303449|NCT00253214|Galantamine|galantamine|mesh-list
110303450|NCT00253214|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110303451|NCT00253214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110303452|NCT00253214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110303453|NCT00253214|Cholinergic Agents|cholinergic agents|mesh-ancestor
110303454|NCT00253214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110303455|NCT00253214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110303456|NCT00253214|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110303457|NCT00253214|Autonomic Agents|autonomic agents|mesh-ancestor
110303458|NCT00253214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110303459|NCT00253214|Nootropic Agents|nootropic agents|mesh-ancestor
110303460|NCT00287859|Topotecan|topotecan|mesh-list
110303461|NCT00287859|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110303462|NCT00287859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110303463|NCT00287859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110303464|NCT00287859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110303465|NCT00287859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110303466|NCT01684969|Haloperidol|haloperidol|mesh-list
110303467|NCT01684969|Haloperidol decanoate|haloperidol decanoate|mesh-list
110303468|NCT01684969|Antiemetics|antiemetics|mesh-ancestor
110303469|NCT01684969|Autonomic Agents|autonomic agents|mesh-ancestor
110303470|NCT01684969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110303471|NCT01684969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110303472|NCT01684969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110303473|NCT01684969|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110303474|NCT01684969|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110303475|NCT01684969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110303476|NCT01684969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110303477|NCT01684969|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110303478|NCT01684969|Dopamine Agents|dopamine agents|mesh-ancestor
110303479|NCT01684969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110303480|NCT01684969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110303481|NCT01684969|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110303482|NCT01685125|Prednisone|prednisone|mesh-list
110303483|NCT01685125|Dasatinib|dasatinib|mesh-list
110303484|NCT01685125|Abiraterone Acetate|abiraterone acetate|mesh-list
110303485|NCT01685125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110303486|NCT01685125|Glucocorticoids|glucocorticoids|mesh-ancestor
110303488|NCT01685125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110303510|NCT00417066|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110303511|NCT00417066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110303512|NCT00417066|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110303513|NCT00417066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110303514|NCT00417066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110303515|NCT00417066|Hormone Antagonists|hormone antagonists|mesh-ancestor
110303516|NCT00417066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110303517|NCT01685398|Timolol|timolol|mesh-list
110281244|NCT00191399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110281245|NCT00191399|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110281246|NCT00191399|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110281247|NCT00191399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110020918|NCT00002334|Antimetabolites|antimetabolites|mesh-ancestor
110281248|NCT00191399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281249|NCT00191399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110281250|NCT00191399|Serotonin Agents|serotonin agents|mesh-ancestor
110281251|NCT00191399|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110281252|NCT00191399|Antidepressive Agents|antidepressive agents|mesh-ancestor
110281253|NCT00191399|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110303518|NCT01685398|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110303519|NCT01685398|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110303520|NCT01685398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110303521|NCT01685398|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110303522|NCT01685398|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110303523|NCT01685398|Adrenergic Agents|adrenergic agents|mesh-ancestor
110303524|NCT01685398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110303525|NCT01685398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110303526|NCT01685398|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110303527|NCT01685398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110303529|NCT01685515|Tetrahydrouridine|tetrahydrouridine|mesh-list
110303530|NCT01685515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110303531|NCT01685515|Antimetabolites|antimetabolites|mesh-ancestor
110303532|NCT01685515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110303533|NCT01685515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110303534|NCT01685515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110303535|NCT00281502|Rifaximin|rifaximin|mesh-list
110303536|NCT00281502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110303537|NCT00281502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110303538|NCT00281502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110303539|NCT00253331|Nitroglycerin|nitroglycerin|mesh-list
110303540|NCT00253331|Vasodilator Agents|vasodilator agents|mesh-ancestor
110303541|NCT00253487|Temozolomide|temozolomide|mesh-list
110303571|NCT00253526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110303572|NCT00253526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110303573|NCT00253526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110303574|NCT00253526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110303575|NCT00253526|Growth Substances|growth substances|mesh-ancestor
110303576|NCT00253526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110303577|NCT00253526|Growth Inhibitors|growth inhibitors|mesh-ancestor
110303578|NCT00253526|Immunologic Factors|immunologic factors|mesh-ancestor
110303579|NCT00253526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110303580|NCT00253526|Antimetabolites|antimetabolites|mesh-ancestor
110303581|NCT00253526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110303582|NCT00253526|Mitosis Modulators|mitosis modulators|mesh-ancestor
110303583|NCT01686217|Niacinamide|niacinamide|mesh-list
110303584|NCT01686217|Peficitinib|peficitinib|mesh-list
110020932|NCT00002340|Atovaquone|atovaquone|mesh-list
110303586|NCT01686217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110303587|NCT01686217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110303588|NCT01686217|Immunologic Factors|immunologic factors|mesh-ancestor
110303602|NCT01686529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110303603|NCT01686529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110303604|NCT01686529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110303605|NCT01686529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110303606|NCT01686529|Growth Substances|growth substances|mesh-ancestor
110303607|NCT01686529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110303608|NCT01686529|Growth Inhibitors|growth inhibitors|mesh-ancestor
110303609|NCT01686607|Itraconazole|itraconazole|mesh-list
110303610|NCT01686607|Fluconazole|fluconazole|mesh-list
110281254|NCT00191399|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110281255|NCT00191399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110281257|NCT00191438|Capecitabine|capecitabine|mesh-list
110281258|NCT00191438|Docetaxel|docetaxel|mesh-list
110281259|NCT00191438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110281260|NCT00191438|Antimetabolites|antimetabolites|mesh-ancestor
110281261|NCT00191438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281262|NCT00191438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110281263|NCT00191438|Tubulin Modulators|tubulin modulators|mesh-ancestor
110303611|NCT01686607|Voriconazole|voriconazole|mesh-list
110303612|NCT01686607|Amphotericin B|amphotericin b|mesh-list
110303613|NCT01686607|Caspofungin|caspofungin|mesh-list
110303615|NCT01686607|Antifungal Agents|antifungal agents|mesh-list
110303616|NCT01686607|Clotrimazole|clotrimazole|mesh-list
110303617|NCT01686607|Miconazole|miconazole|mesh-list
110303618|NCT01686607|Anidulafungin|anidulafungin|mesh-list
110303619|NCT01686607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110303620|NCT01686607|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110303621|NCT01686607|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110303622|NCT01686607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110303623|NCT01686607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110303624|NCT01686607|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110303625|NCT01686607|Hormone Antagonists|hormone antagonists|mesh-ancestor
110303626|NCT01686607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110303627|NCT01686607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110303628|NCT01686607|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110303629|NCT01686607|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110303630|NCT01686607|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110303631|NCT01686607|Amebicides|amebicides|mesh-ancestor
110303632|NCT01686607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110303633|NCT01686607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110303634|NCT01686607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110303635|NCT01686607|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110303636|NCT01686802|Ibuprofen|ibuprofen|mesh-list
110303637|NCT01686802|Morphine|morphine|mesh-list
110303638|NCT01686802|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110303639|NCT01686802|Narcotics|narcotics|mesh-ancestor
110303640|NCT01686802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110303641|NCT01686802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110303642|NCT01686802|Analgesics|analgesics|mesh-ancestor
110303643|NCT01686802|Sensory System Agents|sensory system agents|mesh-ancestor
110303644|NCT01686802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110303645|NCT01686802|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110303646|NCT01686802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110303647|NCT01686802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110303648|NCT01686802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110303650|NCT01686802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110303651|NCT01686802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110303652|NCT00253721|Melphalan|melphalan|mesh-list
110303666|NCT00281892|Antimetabolites|antimetabolites|mesh-ancestor
110303667|NCT00281892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110303668|NCT00281892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110303669|NCT00281892|Immunologic Factors|immunologic factors|mesh-ancestor
110303670|NCT00281892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110303671|NCT00281892|Antiviral Agents|antiviral agents|mesh-ancestor
110303672|NCT00281892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110303673|NCT02274571|Estrogens|estrogens|mesh-list
110303674|NCT02274571|Hormones|hormones|mesh-ancestor
110303675|NCT02274571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110303676|NCT02274571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110303677|NCT00253799|Hylan|hylan|mesh-list
110303678|NCT00253799|Viscosupplements|viscosupplements|mesh-ancestor
110303679|NCT00253799|Protective Agents|protective agents|mesh-ancestor
110303680|NCT00253799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281265|NCT00191438|Mitosis Modulators|mitosis modulators|mesh-ancestor
110281266|NCT00221286|Interferons|interferons|mesh-list
110281267|NCT00221286|Tenofovir|tenofovir|mesh-list
110281268|NCT00221286|Interferon-alpha|interferon-alpha|mesh-list
110281269|NCT00221286|Interferon alpha-2|interferon alpha-2|mesh-list
110281270|NCT00221286|Emtricitabine|emtricitabine|mesh-list
110281271|NCT00221286|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110281272|NCT00221286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110281273|NCT00221286|Antiviral Agents|antiviral agents|mesh-ancestor
110281274|NCT00221286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110281275|NCT00221286|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110281276|NCT00221286|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110281277|NCT00221286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110281278|NCT00221286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110303682|NCT00281931|Rituximab|rituximab|mesh-list
110303683|NCT00281931|Fludarabine|fludarabine|mesh-list
110303684|NCT00281931|Fludarabine phosphate|fludarabine phosphate|mesh-list
110303685|NCT00281931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110303686|NCT00281931|Immunologic Factors|immunologic factors|mesh-ancestor
110303687|NCT00281931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110303688|NCT00281931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110303689|NCT00281931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110303690|NCT00281931|Alkylating Agents|alkylating agents|mesh-ancestor
110303691|NCT00281931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110303692|NCT00281931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110303693|NCT00281931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110303694|NCT00281931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110303695|NCT00281931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110303696|NCT00281931|Antimetabolites|antimetabolites|mesh-ancestor
110303697|NCT01687348|Lidocaine|lidocaine|mesh-list
110303698|NCT01687348|Anesthetics, Local|anesthetics, local|mesh-ancestor
110303699|NCT01687348|Anesthetics|anesthetics|mesh-ancestor
110303700|NCT01687348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110303701|NCT01687348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110303702|NCT01687348|Sensory System Agents|sensory system agents|mesh-ancestor
110303703|NCT01687348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110303704|NCT01687348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110303705|NCT01687348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110303706|NCT01687348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110303707|NCT01687348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110303708|NCT01687348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110303709|NCT01687426|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110303710|NCT01687426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110303711|NCT01687426|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110303712|NCT01687426|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110303713|NCT01687426|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110303714|NCT01687426|Adrenergic Agents|adrenergic agents|mesh-ancestor
110303746|NCT01687894|Arginine Vasopressin|arginine vasopressin|mesh-list
110303747|NCT01687894|Propofol|propofol|mesh-list
110303748|NCT01687894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
110303749|NCT01687894|Anesthetics|anesthetics|mesh-list
110303750|NCT01687894|Sevoflurane|sevoflurane|mesh-list
110303751|NCT01687894|Anesthetics, General|anesthetics, general|mesh-list
110303752|NCT01687894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110303753|NCT01687894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110303754|NCT01687894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110303755|NCT01687894|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110303757|NCT01687894|Hemostatics|hemostatics|mesh-ancestor
110281279|NCT00221286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110281280|NCT00221286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110281281|NCT00221286|Immunologic Factors|immunologic factors|mesh-ancestor
110281282|NCT00221286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281283|NCT00123383|Modafinil|modafinil|mesh-list
110281284|NCT00123383|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110281285|NCT00123383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281286|NCT00123383|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110281287|NCT00123383|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110281288|NCT00123383|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110303758|NCT01687894|Coagulants|coagulants|mesh-ancestor
110303759|NCT01687894|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110303760|NCT01687894|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110303761|NCT01687894|Natriuretic Agents|natriuretic agents|mesh-ancestor
110303777|NCT01688089|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110303778|NCT01688089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110303779|NCT01688089|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
110303780|NCT01688206|Atezolizumab|atezolizumab|mesh-list
110303781|NCT01688206|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110303782|NCT01688206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110303783|NCT01688206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110303784|NCT01688206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110303785|NCT00288171|Allopurinol|allopurinol|mesh-list
110303786|NCT00288171|Antimetabolites|antimetabolites|mesh-ancestor
110303787|NCT00288171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110303789|NCT00288171|Gout Suppressants|gout suppressants|mesh-ancestor
110303790|NCT00288171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110303791|NCT00288171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110303792|NCT00288171|Antioxidants|antioxidants|mesh-ancestor
110303793|NCT00288171|Protective Agents|protective agents|mesh-ancestor
110303794|NCT00288171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110303795|NCT00253955|Levofloxacin|levofloxacin|mesh-list
110303796|NCT00253955|Tazobactam|tazobactam|mesh-list
110303797|NCT00253955|Piperacillin|piperacillin|mesh-list
110303798|NCT00253955|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
110303799|NCT00253955|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110303800|NCT00253955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110303801|NCT00253955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110303802|NCT00253955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110303803|NCT00253955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110303804|NCT00253955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110303805|NCT00253955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110303806|NCT00253955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110303807|NCT00253955|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110303808|NCT00253955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110303809|NCT00253955|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110303810|NCT00288249|Sagopilone|sagopilone|mesh-list
110303811|NCT00288249|Epothilones|epothilones|mesh-list
110303812|NCT00288249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110303813|NCT00288249|Tubulin Modulators|tubulin modulators|mesh-ancestor
110303814|NCT00288249|Antimitotic Agents|antimitotic agents|mesh-ancestor
110303815|NCT00288249|Mitosis Modulators|mitosis modulators|mesh-ancestor
110303816|NCT00288249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110303817|NCT00254033|Methylphenidate|methylphenidate|mesh-list
110303818|NCT00254033|Dextroamphetamine|dextroamphetamine|mesh-list
110303819|NCT00254033|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110303820|NCT00254033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110303821|NCT00254033|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110303824|NCT00254033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034763|NCT01401192|Pemetrexed|pemetrexed|mesh-list
110281289|NCT00123383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281290|NCT00214266|Mycophenolic Acid|mycophenolic acid|mesh-list
110281291|NCT00214266|Rituximab|rituximab|mesh-list
110281292|NCT00214266|Alemtuzumab|alemtuzumab|mesh-list
110281293|NCT00214266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110281294|NCT00214266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110303826|NCT00254033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110303827|NCT01600573|Topotecan|topotecan|mesh-list
110303828|NCT01600573|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110303829|NCT01600573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110303830|NCT01600573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110303831|NCT01600573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110303832|NCT01600573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110303834|NCT01600612|Carbetocin|carbetocin|mesh-list
110303835|NCT01600612|Oxytocics|oxytocics|mesh-ancestor
110303836|NCT01600612|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110303837|NCT01600612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110303838|NCT01600768|Lactams|lactams|mesh-list
110303839|NCT01600768|beta-Lactams|beta-lactams|mesh-list
110303840|NCT01600768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110303841|NCT01600768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110303842|NCT00414947|Vildagliptin|vildagliptin|mesh-list
110303843|NCT00414947|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110021022|NCT00002394|Terbinafine|terbinafine|mesh-list
110303844|NCT00414947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110303845|NCT00414947|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110303846|NCT00414947|Protease Inhibitors|protease inhibitors|mesh-ancestor
110303847|NCT00414947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110303848|NCT00414947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110303850|NCT00288444|Lonafarnib|lonafarnib|mesh-list
110303851|NCT00288444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110303852|NCT00288444|Tubulin Modulators|tubulin modulators|mesh-ancestor
110303853|NCT00288444|Antimitotic Agents|antimitotic agents|mesh-ancestor
110303854|NCT00288444|Mitosis Modulators|mitosis modulators|mesh-ancestor
110303855|NCT00288444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110303856|NCT00288444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110303857|NCT00417573|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110303858|NCT00417573|Immunologic Factors|immunologic factors|mesh-ancestor
110303859|NCT00417573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110303861|NCT00415064|Lenalidomide|lenalidomide|mesh-list
110303862|NCT00415064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110303863|NCT00415064|Antiemetics|antiemetics|mesh-ancestor
110303864|NCT00415064|Autonomic Agents|autonomic agents|mesh-ancestor
110303865|NCT00415064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110303866|NCT00415064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110303867|NCT00415064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110303868|NCT00415064|Glucocorticoids|glucocorticoids|mesh-ancestor
110303869|NCT00415064|Hormones|hormones|mesh-ancestor
110303870|NCT00415064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110303871|NCT00415064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110303872|NCT00415064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110303873|NCT00415064|Immunologic Factors|immunologic factors|mesh-ancestor
110303874|NCT00415064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110303875|NCT00415064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110303876|NCT00415064|Growth Substances|growth substances|mesh-ancestor
110303877|NCT00415064|Growth Inhibitors|growth inhibitors|mesh-ancestor
110303878|NCT00415103|Aprepitant|aprepitant|mesh-list
110303879|NCT00415103|Palonosetron|palonosetron|mesh-list
110303880|NCT00415103|Granisetron|granisetron|mesh-list
110303881|NCT00415103|Antiemetics|antiemetics|mesh-ancestor
110303882|NCT00415103|Autonomic Agents|autonomic agents|mesh-ancestor
110303883|NCT00415103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110303884|NCT00415103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110303885|NCT00415103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110303886|NCT00415103|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110303887|NCT00415103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110303888|NCT00415103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110303889|NCT00415103|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110303890|NCT00415103|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110281295|NCT00214266|Immunologic Factors|immunologic factors|mesh-ancestor
110281296|NCT00214266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281297|NCT00214266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110281298|NCT00214266|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110281299|NCT00214266|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110281300|NCT00214266|Antitubercular Agents|antitubercular agents|mesh-ancestor
110281301|NCT00214266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110281302|NCT00214266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110281303|NCT00214266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110281304|NCT00214266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281305|NCT00221325|Rituximab|rituximab|mesh-list
110281306|NCT00221325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110281307|NCT00221325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110281308|NCT00221325|Immunologic Factors|immunologic factors|mesh-ancestor
110281309|NCT00221325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281310|NCT00221325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110281311|NCT00123461|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
110281312|NCT00123461|Vitamins|vitamins|mesh-ancestor
110281313|NCT00123461|Micronutrients|micronutrients|mesh-ancestor
110281314|NCT00123461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281315|NCT00123461|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110281316|NCT00191516|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110281317|NCT00191516|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110281318|NCT00191516|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110281319|NCT00191516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110281320|NCT00191516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110303891|NCT00415103|Serotonin Agents|serotonin agents|mesh-ancestor
110303892|NCT00417690|Aminosalicylic Acid|aminosalicylic acid|mesh-list
110303893|NCT00417690|Antitubercular Agents|antitubercular agents|mesh-ancestor
110303894|NCT00417690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110303969|NCT00288561|Growth Inhibitors|growth inhibitors|mesh-ancestor
110303970|NCT00288561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110303971|NCT01607086|Lamotrigine|lamotrigine|mesh-list
110303972|NCT01607086|Anticonvulsants|anticonvulsants|mesh-ancestor
110303973|NCT01607086|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110303974|NCT01607086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110303975|NCT01607086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110303976|NCT01607086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110303977|NCT01607086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110303978|NCT01607086|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110303979|NCT01607086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110303980|NCT01607086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110303981|NCT01607086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110303982|NCT01607086|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110303983|NCT01607125|Vortioxetine|vortioxetine|mesh-list
110281321|NCT00191516|Adrenergic Agents|adrenergic agents|mesh-ancestor
110281322|NCT00191516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110281323|NCT00191516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281324|NCT00191555|Haloperidol|haloperidol|mesh-list
110281326|NCT00191555|Haloperidol decanoate|haloperidol decanoate|mesh-list
110281327|NCT00191555|Antiemetics|antiemetics|mesh-ancestor
110281328|NCT00191555|Autonomic Agents|autonomic agents|mesh-ancestor
110281329|NCT00191555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110281330|NCT00191555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281331|NCT00191555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110281332|NCT00191555|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110281333|NCT00191555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110281334|NCT00191555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110281335|NCT00191555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110281336|NCT00191555|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110281337|NCT00191555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110281338|NCT00191555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110281339|NCT00191555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281340|NCT00191555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110281341|NCT00191555|Serotonin Agents|serotonin agents|mesh-ancestor
110303984|NCT01607125|Antidepressive Agents|antidepressive agents|mesh-ancestor
110303985|NCT01607125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110303986|NCT01607125|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110303987|NCT01607125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110303988|NCT01607125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110303989|NCT01607125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110303990|NCT01607125|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110303991|NCT01607125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110303992|NCT01607125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110303993|NCT01607125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110303994|NCT01607125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110303995|NCT01607125|Serotonin Agents|serotonin agents|mesh-ancestor
110303996|NCT01607125|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110303997|NCT01607125|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110303998|NCT01607125|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110303999|NCT01607125|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110304000|NCT00254345|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
110304001|NCT00254345|Vasodilator Agents|vasodilator agents|mesh-ancestor
110304002|NCT00254345|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110304003|NCT00254345|Protective Agents|protective agents|mesh-ancestor
110304004|NCT00254345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110304006|NCT00254618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110304007|NCT00254618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110304008|NCT00254618|Analgesics|analgesics|mesh-ancestor
110304009|NCT00254618|Sensory System Agents|sensory system agents|mesh-ancestor
110304010|NCT00254618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110304011|NCT00254618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110304012|NCT00254618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110304013|NCT00254618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110304014|NCT00288717|Telmisartan|telmisartan|mesh-list
110281342|NCT00191555|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110281343|NCT00191555|Dopamine Agents|dopamine agents|mesh-ancestor
110281344|NCT00191555|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110281345|NCT00221364|Azithromycin|azithromycin|mesh-list
110281346|NCT00221364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110281347|NCT00221364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110281348|NCT00123539|Estrogens|estrogens|mesh-list
110281349|NCT00123539|Hormones|hormones|mesh-ancestor
110281350|NCT00123539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110281351|NCT00123539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281352|NCT00191594|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110281353|NCT00191594|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110281354|NCT00191594|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110281355|NCT00191594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110281356|NCT00191594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110304016|NCT00288717|Candesartan cilexetil|candesartan cilexetil|mesh-list
110304017|NCT00288717|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110021086|NCT00002424|Lamivudine|lamivudine|mesh-list
110304018|NCT00288717|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110304019|NCT00288717|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110304020|NCT00288717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110304021|NCT01601314|Magnesium Sulfate|magnesium sulfate|mesh-list
110304022|NCT01601314|Analgesics|analgesics|mesh-ancestor
110304023|NCT01601314|Sensory System Agents|sensory system agents|mesh-ancestor
110304033|NCT01601314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110304035|NCT01601314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110304036|NCT00254657|Levetiracetam|levetiracetam|mesh-list
110304037|NCT00254657|Anticonvulsants|anticonvulsants|mesh-ancestor
110304038|NCT00254657|Nootropic Agents|nootropic agents|mesh-ancestor
110304039|NCT02482753|Exemestane|exemestane|mesh-list
110304040|NCT02482753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110304041|NCT02482753|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110304042|NCT02482753|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110304043|NCT02482753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110304044|NCT02482753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110304045|NCT02482753|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110304046|NCT02482753|Hormone Antagonists|hormone antagonists|mesh-ancestor
110304047|NCT02482753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110304048|NCT02482753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110304049|NCT00254735|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110304050|NCT00254735|Clomipramine|clomipramine|mesh-list
110304051|NCT00254735|Antidepressive Agents|antidepressive agents|mesh-ancestor
110304052|NCT00254735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110304053|NCT00254735|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110304054|NCT00254735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110304055|NCT00254735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110304056|NCT00254735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110304057|NCT00254735|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110304058|NCT00254735|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110304059|NCT00254735|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110304060|NCT00254735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110304061|NCT00254735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110304062|NCT00254735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110304063|NCT00254735|Serotonin Agents|serotonin agents|mesh-ancestor
110304064|NCT00288873|Cholecalciferol|cholecalciferol|mesh-list
110304065|NCT00288873|Vitamin D|vitamin d|mesh-list
110304066|NCT00288873|Ergocalciferols|ergocalciferols|mesh-list
110281357|NCT00191594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110281358|NCT00191594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281359|NCT00191594|Analgesics|analgesics|mesh-ancestor
110281360|NCT00191594|Sensory System Agents|sensory system agents|mesh-ancestor
110281361|NCT00191594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110281362|NCT00191594|Antidepressive Agents|antidepressive agents|mesh-ancestor
110281363|NCT00191594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110281364|NCT00191594|Dopamine Agents|dopamine agents|mesh-ancestor
110281365|NCT00221442|Zonisamide|zonisamide|mesh-list
110281366|NCT00221442|Anticonvulsants|anticonvulsants|mesh-ancestor
110281367|NCT00221442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110281368|NCT00221442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110304067|NCT00288873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110304068|NCT00288873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110304069|NCT00288873|Vitamins|vitamins|mesh-ancestor
110304070|NCT00288873|Micronutrients|micronutrients|mesh-ancestor
110304071|NCT00288873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110304072|NCT01608139|Curcumin|curcumin|mesh-list
110304073|NCT01608139|Sorafenib|sorafenib|mesh-list
110304074|NCT01608139|Vorinostat|vorinostat|mesh-list
110304075|NCT01608139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110304076|NCT01608139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110304077|NCT01608139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110304078|NCT01608139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110304079|NCT01608139|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110304080|NCT01608139|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110304081|NCT01608139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110304083|NCT01608139|Sensory System Agents|sensory system agents|mesh-ancestor
110304084|NCT01608139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110304085|NCT01608139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110304086|NCT01608139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110304092|NCT01607671|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110304094|NCT01607671|Adrenergic Agents|adrenergic agents|mesh-ancestor
110304095|NCT01607671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110304096|NCT01607671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110304097|NCT01607671|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110304098|NCT01607671|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110304099|NCT00288951|Travoprost|travoprost|mesh-list
110304100|NCT00288951|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110304101|NCT00254774|Valproic Acid|valproic acid|mesh-list
110304102|NCT00254774|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110304103|NCT00254774|Antidepressive Agents|antidepressive agents|mesh-ancestor
110304104|NCT00254774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110304105|NCT00254774|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110304106|NCT00254774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110304107|NCT00254774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110304108|NCT00254774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110304109|NCT00254774|Anticonvulsants|anticonvulsants|mesh-ancestor
110304110|NCT00254774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110304111|NCT00254774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110304112|NCT00254774|GABA Agents|gaba agents|mesh-ancestor
110304113|NCT00254774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110304114|NCT00254774|Antimanic Agents|antimanic agents|mesh-ancestor
110304115|NCT01608334|Fentanyl|fentanyl|mesh-list
110304116|NCT01608334|Sufentanil|sufentanil|mesh-list
110304117|NCT01608334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110304118|NCT01608334|Narcotics|narcotics|mesh-ancestor
110304119|NCT01608334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110304120|NCT01608334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110304121|NCT01608334|Analgesics|analgesics|mesh-ancestor
110304122|NCT01608334|Sensory System Agents|sensory system agents|mesh-ancestor
110304123|NCT01608334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110304124|NCT01608334|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110304125|NCT01608334|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110281369|NCT00221442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281370|NCT00221442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110281371|NCT00221442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281372|NCT00123578|Pentobarbital|pentobarbital|mesh-list
110281373|NCT00123578|Lorazepam|lorazepam|mesh-list
110281374|NCT00123578|Anticonvulsants|anticonvulsants|mesh-ancestor
110281375|NCT00123578|Antiemetics|antiemetics|mesh-ancestor
110281376|NCT00123578|Autonomic Agents|autonomic agents|mesh-ancestor
110281377|NCT00123578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110281378|NCT00123578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281379|NCT00123578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110281380|NCT00123578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110281381|NCT00123578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110304126|NCT01608334|Anesthetics, General|anesthetics, general|mesh-ancestor
110304127|NCT01608334|Anesthetics|anesthetics|mesh-ancestor
110304128|NCT01608373|Lidocaine|lidocaine|mesh-list
110304129|NCT01608373|Anesthetics, Local|anesthetics, local|mesh-ancestor
110304130|NCT01608373|Anesthetics|anesthetics|mesh-ancestor
110304131|NCT01608373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110304132|NCT01608373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110304133|NCT01608373|Sensory System Agents|sensory system agents|mesh-ancestor
110304134|NCT01608373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110304135|NCT01608373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110304136|NCT01608373|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110304137|NCT01608373|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110304138|NCT01608373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110304139|NCT01608373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110304140|NCT01608412|Everolimus|everolimus|mesh-list
110304141|NCT01608412|Tacrolimus|tacrolimus|mesh-list
110304142|NCT01608412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110304143|NCT01608412|Immunologic Factors|immunologic factors|mesh-ancestor
110304144|NCT01608412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110304145|NCT01608412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110304146|NCT01608412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110304147|NCT01608412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110304148|NCT01608412|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110304149|NCT01608412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110304150|NCT01608412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110304151|NCT00254813|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110304152|NCT00254813|Antidepressive Agents|antidepressive agents|mesh-ancestor
110304153|NCT00254813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110304154|NCT00254813|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110304155|NCT00254813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110304156|NCT00254813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110304217|NCT04719104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110304219|NCT01588795|Cholecalciferol|cholecalciferol|mesh-list
110304221|NCT01588795|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
110304222|NCT01588795|Vitamins|vitamins|mesh-ancestor
110304223|NCT01588795|Micronutrients|micronutrients|mesh-ancestor
110304224|NCT01588795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110304225|NCT01588795|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110304226|NCT01588795|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110304227|NCT01588795|Natriuretic Agents|natriuretic agents|mesh-ancestor
110304228|NCT01588795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110304229|NCT00107614|Rituximab|rituximab|mesh-list
110304230|NCT00107614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110304231|NCT00107614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110304232|NCT00107614|Immunologic Factors|immunologic factors|mesh-ancestor
110304233|NCT00107614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281383|NCT00123578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110021134|NCT00002442|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110281384|NCT00123578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110281385|NCT00123578|GABA Modulators|gaba modulators|mesh-ancestor
110281387|NCT00123578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110281388|NCT00123578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281389|NCT00123578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110281390|NCT00221481|Valproic Acid|valproic acid|mesh-list
110281391|NCT00221481|Olanzapine|olanzapine|mesh-list
110281392|NCT00221481|Antiemetics|antiemetics|mesh-ancestor
110281393|NCT00221481|Autonomic Agents|autonomic agents|mesh-ancestor
110281394|NCT00221481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110281395|NCT00221481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281396|NCT00221481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110281397|NCT00221481|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110281398|NCT00221481|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110281399|NCT00221481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110281400|NCT00221481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110281401|NCT00221481|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110281402|NCT00221481|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110281403|NCT00221481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110304234|NCT00107614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110304235|NCT00255242|Simvastatin|simvastatin|mesh-list
110304236|NCT00255242|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110304237|NCT00255242|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110304238|NCT00255242|Antimetabolites|antimetabolites|mesh-ancestor
110304239|NCT00255242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110304240|NCT00255242|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110304241|NCT00255242|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110304242|NCT00255242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110304243|NCT00270114|Epoetin Alfa|epoetin alfa|mesh-list
110304244|NCT00270114|Hematinics|hematinics|mesh-ancestor
110304245|NCT00107380|Prednisone|prednisone|mesh-list
110304246|NCT00107380|Cyclophosphamide|cyclophosphamide|mesh-list
110304247|NCT00107380|Rituximab|rituximab|mesh-list
110304248|NCT00107380|Doxorubicin|doxorubicin|mesh-list
110304249|NCT00107380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110304250|NCT00107380|Vincristine|vincristine|mesh-list
110304251|NCT00107380|Tositumomab I-131|tositumomab i-131|mesh-list
110304252|NCT00107380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110304253|NCT00107380|Immunologic Factors|immunologic factors|mesh-ancestor
110304254|NCT00107380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110304255|NCT00107380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110304256|NCT00107380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110304257|NCT00107380|Alkylating Agents|alkylating agents|mesh-ancestor
110304258|NCT00107380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110304259|NCT00107380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110304260|NCT00107380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110304261|NCT00107380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110304262|NCT00107380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110304263|NCT00107380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110304264|NCT00107380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110304265|NCT00107380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110281404|NCT00221481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281405|NCT00221481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110281406|NCT00221481|Serotonin Agents|serotonin agents|mesh-ancestor
110281407|NCT00221481|Anticonvulsants|anticonvulsants|mesh-ancestor
110281408|NCT00221481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110281474|NCT00123656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281475|NCT00123656|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110281476|NCT00123656|Respiratory System Agents|respiratory system agents|mesh-ancestor
110281477|NCT00123656|Dermatologic Agents|dermatologic agents|mesh-ancestor
110281478|NCT00123656|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110281541|NCT00123890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110281542|NCT00123890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110281543|NCT00123890|Antiviral Agents|antiviral agents|mesh-ancestor
110281544|NCT00123890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110281546|NCT00412698|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110281547|NCT00412698|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
110281608|NCT00215046|Methotrexate|methotrexate|mesh-list
110281609|NCT00215046|Vinblastine|vinblastine|mesh-list
110281610|NCT00215046|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110281611|NCT00215046|Abortifacient Agents|abortifacient agents|mesh-ancestor
110281612|NCT00215046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110281613|NCT00215046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281614|NCT00215046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110281615|NCT00215046|Antimetabolites|antimetabolites|mesh-ancestor
110281616|NCT00215046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281617|NCT00215046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110281618|NCT00215046|Dermatologic Agents|dermatologic agents|mesh-ancestor
110281619|NCT00215046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110281672|NCT02277730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281673|NCT02277730|Sympathomimetics|sympathomimetics|mesh-ancestor
110281674|NCT02277730|Nasal Decongestants|nasal decongestants|mesh-ancestor
110281675|NCT02277730|Respiratory System Agents|respiratory system agents|mesh-ancestor
110281676|NCT02277730|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110281677|NCT02277730|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110281678|NCT02277730|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110281679|NCT02277730|Adrenergic Agents|adrenergic agents|mesh-ancestor
110281680|NCT02277730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110281681|NCT02277730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281682|NCT02277730|Protective Agents|protective agents|mesh-ancestor
110281683|NCT02277730|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110281684|NCT04571437|Capecitabine|capecitabine|mesh-list
110281686|NCT04571437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110281687|NCT04571437|Antimetabolites|antimetabolites|mesh-ancestor
110281688|NCT04571437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281689|NCT04571437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110281690|NCT04571437|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110281691|NCT04571437|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110281692|NCT04571437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110281693|NCT04571437|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110281723|NCT00215202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110021177|NCT00002466|Cyclophosphamide|cyclophosphamide|mesh-list
110281724|NCT00215202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110281725|NCT00215202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110281726|NCT00215202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281727|NCT00215241|Risperidone|risperidone|mesh-list
110281728|NCT00215241|Sertraline|sertraline|mesh-list
110281729|NCT00215241|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110281730|NCT00215241|Serotonin Agents|serotonin agents|mesh-ancestor
110281731|NCT00215241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110281732|NCT00215241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281733|NCT00215241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281734|NCT00215241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110281735|NCT00215241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110281736|NCT00215241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110281737|NCT00215241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110281738|NCT00215241|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110281739|NCT00215241|Dopamine Agents|dopamine agents|mesh-ancestor
110281740|NCT00215241|Antidepressive Agents|antidepressive agents|mesh-ancestor
110281741|NCT00215241|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110281742|NCT00215241|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110281754|NCT00124280|Everolimus|everolimus|mesh-list
110281776|NCT00192413|Vaccines|vaccines|mesh-list
110281777|NCT00192413|Immunologic Factors|immunologic factors|mesh-ancestor
110281778|NCT00192413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281779|NCT00215358|Formoterol Fumarate|formoterol fumarate|mesh-list
110281780|NCT00215358|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110281781|NCT00215358|Autonomic Agents|autonomic agents|mesh-ancestor
110281782|NCT00215358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110281783|NCT00215358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281784|NCT00215358|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110281785|NCT00215358|Respiratory System Agents|respiratory system agents|mesh-ancestor
110281786|NCT00215358|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110281787|NCT00215358|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110281788|NCT00215358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110281789|NCT00215358|Adrenergic Agents|adrenergic agents|mesh-ancestor
110281792|NCT00192569|Interferons|interferons|mesh-list
110281836|NCT00215436|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110281837|NCT00215436|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110281838|NCT00215436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110281839|NCT00215436|Adrenergic Agents|adrenergic agents|mesh-ancestor
110281840|NCT00215436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110281904|NCT00411957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110281905|NCT00411957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281906|NCT00411957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110281907|NCT00411957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110281916|NCT00192842|Curcumin|curcumin|mesh-list
110281974|NCT00215631|Vasodilator Agents|vasodilator agents|mesh-ancestor
110281975|NCT00215631|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110282047|NCT00222495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110021207|NCT00002478|Etoposide|etoposide|mesh-list
110282048|NCT00222495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110282049|NCT00222495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110282050|NCT00222495|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110282051|NCT00222495|Dopamine Agents|dopamine agents|mesh-ancestor
110282052|NCT00222495|Antiemetics|antiemetics|mesh-ancestor
110282053|NCT00222495|Autonomic Agents|autonomic agents|mesh-ancestor
110282054|NCT00222495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110282055|NCT00222495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110282059|NCT00222495|Antidepressive Agents|antidepressive agents|mesh-ancestor
110282113|NCT00193466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110282114|NCT00215748|Dexamethasone|dexamethasone|mesh-list
110282115|NCT00215748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110282116|NCT00215748|Antiemetics|antiemetics|mesh-ancestor
110282117|NCT00215748|Autonomic Agents|autonomic agents|mesh-ancestor
110282118|NCT00215748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110282119|NCT00215748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110282120|NCT00215748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110282121|NCT00215748|Glucocorticoids|glucocorticoids|mesh-ancestor
110282122|NCT00215748|Hormones|hormones|mesh-ancestor
110282181|NCT00124397|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110282182|NCT00124397|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110282183|NCT00124397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110282184|NCT00216021|Capecitabine|capecitabine|mesh-list
110282185|NCT00216021|Oxaliplatin|oxaliplatin|mesh-list
110282251|NCT00409721|Memantine|memantine|mesh-list
110282252|NCT00409721|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110282253|NCT00409721|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110282323|NCT00193739|Tubulin Modulators|tubulin modulators|mesh-ancestor
110282324|NCT00193739|Antimitotic Agents|antimitotic agents|mesh-ancestor
110282325|NCT00193739|Mitosis Modulators|mitosis modulators|mesh-ancestor
110282392|NCT00223743|Anticonvulsants|anticonvulsants|mesh-ancestor
110282393|NCT00223743|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110282394|NCT00223743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110282395|NCT00223743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110282396|NCT00223743|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110282397|NCT00223743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110282398|NCT00193973|Methotrexate|methotrexate|mesh-list
110282399|NCT00193973|Idarubicin|idarubicin|mesh-list
110282400|NCT00193973|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110282457|NCT00193505|Alkylating Agents|alkylating agents|mesh-ancestor
110282458|NCT00223860|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110282459|NCT00223860|Hormones|hormones|mesh-list
110282460|NCT00223860|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
110282461|NCT00223860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110282462|NCT00223860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110282463|NCT00223860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110282464|NCT00125255|Lidocaine|lidocaine|mesh-list
110282465|NCT00125255|Tetracaine|tetracaine|mesh-list
110282466|NCT00125255|Anesthetics, Local|anesthetics, local|mesh-ancestor
110282467|NCT00125255|Anesthetics|anesthetics|mesh-ancestor
110282468|NCT00125255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110282469|NCT00125255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110282470|NCT00125255|Sensory System Agents|sensory system agents|mesh-ancestor
110282471|NCT00125255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110282518|NCT00125411|Tubulin Modulators|tubulin modulators|mesh-ancestor
110282519|NCT00125411|Antimitotic Agents|antimitotic agents|mesh-ancestor
110282590|NCT00473512|Antiemetics|antiemetics|mesh-ancestor
110282591|NCT00473512|Autonomic Agents|autonomic agents|mesh-ancestor
110282592|NCT00473512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110282593|NCT00473512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110282594|NCT00473512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110282595|NCT00473512|Glucocorticoids|glucocorticoids|mesh-ancestor
110282597|NCT00473512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110282598|NCT00473512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110282599|NCT00473512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110282600|NCT00473512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110282601|NCT00473512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110282602|NCT00473512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110282603|NCT00473512|Hormone Antagonists|hormone antagonists|mesh-ancestor
110282605|NCT00125489|Chloroquine|chloroquine|mesh-list
110282651|NCT00125567|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110282652|NCT00125567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110282653|NCT00125567|Dopamine Agents|dopamine agents|mesh-ancestor
110282654|NCT00125567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110282655|NCT00125567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110282656|NCT00125567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110282657|NCT00125567|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110282658|NCT00125567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110282660|NCT00473083|Minocycline|minocycline|mesh-list
110282717|NCT00206739|Pyrimethamine|pyrimethamine|mesh-list
110282718|NCT00206739|Sulfadoxine|sulfadoxine|mesh-list
110282719|NCT00206739|Antimalarials|antimalarials|mesh-ancestor
110282720|NCT00206739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110282721|NCT00206739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110282722|NCT00206739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110282723|NCT00206739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110282724|NCT00206739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110282725|NCT00206739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110282726|NCT00206739|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110282727|NCT00206778|Lamotrigine|lamotrigine|mesh-list
110282728|NCT00206778|Valproic Acid|valproic acid|mesh-list
110282729|NCT00206778|Anticonvulsants|anticonvulsants|mesh-ancestor
110282779|NCT00194753|Antimitotic Agents|antimitotic agents|mesh-ancestor
110282780|NCT00194753|Mitosis Modulators|mitosis modulators|mesh-ancestor
110282781|NCT00194753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110282782|NCT00194753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110282783|NCT00194753|Immunologic Factors|immunologic factors|mesh-ancestor
110282784|NCT00194753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110282785|NCT00194753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110282796|NCT00125918|Tadalafil|tadalafil|mesh-list
110282846|NCT00194909|Vasodilator Agents|vasodilator agents|mesh-ancestor
110282847|NCT00194909|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110282848|NCT00194909|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110282849|NCT00194909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110282916|NCT00224679|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110282917|NCT00224679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110282918|NCT00224679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110282919|NCT00224679|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110282986|NCT00413127|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110282987|NCT00413127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110282988|NCT00413127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110021247|NCT00002502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110283060|NCT00195377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283061|NCT00195377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110283062|NCT00195377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110283063|NCT00195377|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110283064|NCT00195377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110283065|NCT00195377|Immunologic Factors|immunologic factors|mesh-ancestor
110283128|NCT00195533|Tazobactam|tazobactam|mesh-list
110283129|NCT00195533|Piperacillin|piperacillin|mesh-list
110283130|NCT00195533|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
110283131|NCT00195533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110283136|NCT00207558|Folic Acid|folic acid|mesh-list
110283202|NCT00195728|Analgesics|analgesics|mesh-ancestor
110283203|NCT00195728|Sensory System Agents|sensory system agents|mesh-ancestor
110283204|NCT00195728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110283276|NCT00207753|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110283277|NCT00207753|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110283278|NCT00207753|Tubulin Modulators|tubulin modulators|mesh-ancestor
110283279|NCT00207753|Antimitotic Agents|antimitotic agents|mesh-ancestor
110283280|NCT00207753|Mitosis Modulators|mitosis modulators|mesh-ancestor
110283345|NCT00202514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110283346|NCT00202514|GABA Agents|gaba agents|mesh-ancestor
110283347|NCT00202514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110283348|NCT00202514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283349|NCT00202514|Antimanic Agents|antimanic agents|mesh-ancestor
110283350|NCT00202514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110283351|NCT00202514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110283352|NCT00202514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110283353|NCT00207831|Tegafur|tegafur|mesh-list
110283354|NCT00207831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110283355|NCT00207831|Antimetabolites|antimetabolites|mesh-ancestor
110283356|NCT00207831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110283357|NCT00207831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110283358|NCT00195923|Clindamycin|clindamycin|mesh-list
110283359|NCT00195923|Clindamycin palmitate|clindamycin palmitate|mesh-list
110283360|NCT00195923|Clindamycin phosphate|clindamycin phosphate|mesh-list
110283361|NCT00195923|Gentamicins|gentamicins|mesh-list
110283362|NCT00195923|Ceftazidime|ceftazidime|mesh-list
110283363|NCT00195923|Ampicillin|ampicillin|mesh-list
110283364|NCT00195923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110283365|NCT00195923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110283367|NCT00195923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110283398|NCT00411333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110283399|NCT00411333|Immunologic Factors|immunologic factors|mesh-ancestor
110283400|NCT00411333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110283401|NCT00411333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110283402|NCT00225849|Aspirin|aspirin|mesh-list
110283403|NCT00225849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110283404|NCT00225849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110283405|NCT00225849|Analgesics|analgesics|mesh-ancestor
110283417|NCT00225849|Antipyretics|antipyretics|mesh-ancestor
110283465|NCT00202982|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110283466|NCT00202982|Immunologic Factors|immunologic factors|mesh-ancestor
110283467|NCT00202982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283468|NCT00202982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110283469|NCT00202982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110283470|NCT00207948|Ritonavir|ritonavir|mesh-list
110283471|NCT00207948|Lopinavir|lopinavir|mesh-list
110283472|NCT00207948|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110283473|NCT00207948|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110283474|NCT00207948|Protease Inhibitors|protease inhibitors|mesh-ancestor
110283475|NCT00207948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110283476|NCT00207948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110283477|NCT00207948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110283478|NCT00207948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110283479|NCT00207948|Antiviral Agents|antiviral agents|mesh-ancestor
110283525|NCT00208065|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110283526|NCT00208065|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110283527|NCT00208065|Sympathomimetics|sympathomimetics|mesh-ancestor
110283528|NCT00208065|Adrenergic Agents|adrenergic agents|mesh-ancestor
110283529|NCT00208065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110283531|NCT00208065|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110283594|NCT00196586|Ribavirin|ribavirin|mesh-list
110283595|NCT00196586|Interferon-alpha|interferon-alpha|mesh-list
110283596|NCT00196586|Interferon alpha-2|interferon alpha-2|mesh-list
110283597|NCT00196586|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110283598|NCT00196586|Interleukin-2|interleukin-2|mesh-list
110283599|NCT00196586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110283662|NCT00208221|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110283663|NCT00208221|Protease Inhibitors|protease inhibitors|mesh-ancestor
110283664|NCT00208221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110283665|NCT00196625|Ritonavir|ritonavir|mesh-list
110283666|NCT00196625|Amprenavir|amprenavir|mesh-list
110283667|NCT00196625|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110283672|NCT00196625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110283731|NCT00196664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283732|NCT00196664|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110283738|NCT00196703|Memantine|memantine|mesh-list
110283803|NCT00410735|Respiratory System Agents|respiratory system agents|mesh-ancestor
110283804|NCT00410735|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110283805|NCT00410735|Hormone Antagonists|hormone antagonists|mesh-ancestor
110283806|NCT00410735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110283872|NCT00208533|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110283873|NCT00208533|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110283874|NCT00203450|Zonisamide|zonisamide|mesh-list
110283945|NCT00203567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110283946|NCT00203567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110283951|NCT00226746|Paclitaxel|paclitaxel|mesh-list
110284015|NCT00203723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110284016|NCT00203723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110284017|NCT00203723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110284018|NCT00203723|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110284087|NCT00208923|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110284088|NCT00227136|Serotonin|serotonin|mesh-list
110284089|NCT00227136|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110284090|NCT00227136|Serotonin Agents|serotonin agents|mesh-ancestor
110284091|NCT00227136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110284092|NCT00227136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110284093|NCT00227136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284094|NCT00203957|Istradefylline|istradefylline|mesh-list
110284095|NCT00203957|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
110284096|NCT00203957|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110284097|NCT00203957|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110284098|NCT00203957|Purinergic Agents|purinergic agents|mesh-ancestor
110284099|NCT00203957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110284100|NCT00203957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110284101|NCT00203957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284102|NCT00197444|Nedaplatin|nedaplatin|mesh-list
110304266|NCT00107380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110304267|NCT00107380|Glucocorticoids|glucocorticoids|mesh-ancestor
110304268|NCT00107380|Hormones|hormones|mesh-ancestor
110304269|NCT00107380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110304270|NCT00107380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110304271|NCT00107380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110304272|NCT00107380|Tubulin Modulators|tubulin modulators|mesh-ancestor
110304273|NCT00107380|Antimitotic Agents|antimitotic agents|mesh-ancestor
110304274|NCT00107380|Mitosis Modulators|mitosis modulators|mesh-ancestor
110304276|NCT00270153|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110304277|NCT00270153|Protease Inhibitors|protease inhibitors|mesh-ancestor
110304292|NCT04054531|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110304294|NCT00289263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110304295|NCT00289263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110304296|NCT00289263|Tubulin Modulators|tubulin modulators|mesh-ancestor
110304297|NCT00289263|Antimitotic Agents|antimitotic agents|mesh-ancestor
110304298|NCT00289263|Mitosis Modulators|mitosis modulators|mesh-ancestor
110304299|NCT00289263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110304300|NCT00255437|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
110021338|NCT00002550|Etoposide|etoposide|mesh-list
110304302|NCT00255437|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110304303|NCT00255437|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110304305|NCT00255476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110304306|NCT00255476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110304307|NCT00255476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110304308|NCT00255476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110304309|NCT00270270|Epoetin Alfa|epoetin alfa|mesh-list
110304310|NCT00270270|Hematinics|hematinics|mesh-ancestor
110304311|NCT04512118|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110304312|NCT04512118|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110304313|NCT04512118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110304314|NCT00255515|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110304315|NCT00255515|Antidepressive Agents|antidepressive agents|mesh-ancestor
110304316|NCT00255515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110304317|NCT00255515|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110304318|NCT00255515|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110304319|NCT00255515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110304320|NCT00255515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110304321|NCT00289419|Ketorolac|ketorolac|mesh-list
110284103|NCT00197444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110284104|NCT00204074|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110284105|NCT00204074|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110284106|NCT00204074|Estradiol|estradiol|mesh-list
110284107|NCT00204074|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110284108|NCT00204074|Estrogens|estrogens|mesh-ancestor
110284109|NCT00204074|Hormones|hormones|mesh-ancestor
110284110|NCT00204074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110284111|NCT00204074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284112|NCT00204074|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110284113|NCT00204074|Contraceptive Agents|contraceptive agents|mesh-ancestor
110284114|NCT00204074|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110284115|NCT00204074|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110304322|NCT00289419|Epinephrine|epinephrine|mesh-list
110304323|NCT00289419|Racepinephrine|racepinephrine|mesh-list
110304324|NCT00289419|Morphine|morphine|mesh-list
110304325|NCT00289419|Ropivacaine|ropivacaine|mesh-list
110304326|NCT00289419|Epinephryl borate|epinephryl borate|mesh-list
110304327|NCT00289419|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110304328|NCT00289419|Narcotics|narcotics|mesh-ancestor
110304329|NCT00289419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110304330|NCT00289419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110304331|NCT00289419|Analgesics|analgesics|mesh-ancestor
110304332|NCT00289419|Sensory System Agents|sensory system agents|mesh-ancestor
110304333|NCT00289419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110304334|NCT00289419|Anesthetics, Local|anesthetics, local|mesh-ancestor
110304335|NCT00289419|Anesthetics|anesthetics|mesh-ancestor
110304336|NCT00289419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110304337|NCT00289419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110304338|NCT00289419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110304339|NCT00289419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110304348|NCT00289419|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110304349|NCT00289419|Autonomic Agents|autonomic agents|mesh-ancestor
110304350|NCT00289419|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110304351|NCT00289419|Respiratory System Agents|respiratory system agents|mesh-ancestor
110304352|NCT00289419|Mydriatics|mydriatics|mesh-ancestor
110304353|NCT00289419|Sympathomimetics|sympathomimetics|mesh-ancestor
110304354|NCT00289419|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110304356|NCT00255554|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110304357|NCT00255554|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110304358|NCT00255554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110304359|NCT00255554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110304360|NCT00255554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110304361|NCT00255554|Serotonin Agents|serotonin agents|mesh-ancestor
110304362|NCT00255554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110304363|NCT00270348|Ciclesonide|ciclesonide|mesh-list
110304364|NCT00270348|Glucocorticoids|glucocorticoids|mesh-ancestor
110304366|NCT00270348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110304367|NCT00270348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110304368|NCT00270348|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110304369|NCT00255593|Rituximab|rituximab|mesh-list
110304370|NCT00255593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110304371|NCT00255593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110304372|NCT00255593|Immunologic Factors|immunologic factors|mesh-ancestor
110304373|NCT00255593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110304374|NCT00255593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110304375|NCT00270387|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
110304376|NCT00270387|Natriuretic Agents|natriuretic agents|mesh-ancestor
110304377|NCT00270387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110304379|NCT00255710|Cyclophosphamide|cyclophosphamide|mesh-list
110304380|NCT00255710|Fludarabine|fludarabine|mesh-list
110284116|NCT00227292|Escitalopram|escitalopram|mesh-list
110284117|NCT00227292|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110284118|NCT00227292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110284119|NCT00227292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110284120|NCT00227292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110284121|NCT00227292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110284122|NCT00227292|Serotonin Agents|serotonin agents|mesh-ancestor
110284123|NCT00227292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284124|NCT00197483|Pergolide|pergolide|mesh-list
110284125|NCT00197483|Dopamine Agonists|dopamine agonists|mesh-ancestor
110284126|NCT00197483|Dopamine Agents|dopamine agents|mesh-ancestor
110284127|NCT00197483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110284128|NCT00197483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110284129|NCT00197483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284130|NCT00230529|Infliximab|infliximab|mesh-list
110284131|NCT00230529|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110284132|NCT00230529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110284133|NCT00230529|Dermatologic Agents|dermatologic agents|mesh-ancestor
110021373|NCT00002562|Paclitaxel|paclitaxel|mesh-list
110284134|NCT00230529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110304382|NCT00255710|Tacrolimus|tacrolimus|mesh-list
110304383|NCT00255710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110304384|NCT00255710|Immunologic Factors|immunologic factors|mesh-ancestor
110304385|NCT00255710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110304386|NCT00255710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110304387|NCT00255710|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110304388|NCT00255710|Alkylating Agents|alkylating agents|mesh-ancestor
110304389|NCT00255710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110304390|NCT00255710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110304391|NCT00255710|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110304392|NCT00255710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110304393|NCT00255710|Antimetabolites|antimetabolites|mesh-ancestor
110304394|NCT00255710|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110304395|NCT00255710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110304396|NCT00255710|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110304397|NCT00255710|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110304398|NCT00255710|Antitubercular Agents|antitubercular agents|mesh-ancestor
110304399|NCT00255710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110304400|NCT00255710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110304401|NCT00270426|Benazepril|benazepril|mesh-list
110304402|NCT00270426|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110304403|NCT00270426|Protease Inhibitors|protease inhibitors|mesh-ancestor
110304404|NCT00270426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110304405|NCT00270426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110304406|NCT00270426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110304418|NCT00270543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110304419|NCT00270543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110304420|NCT00270543|Immunologic Factors|immunologic factors|mesh-ancestor
110304421|NCT00270543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110304422|NCT00270543|Antidotes|antidotes|mesh-ancestor
110304423|NCT00270543|Protective Agents|protective agents|mesh-ancestor
110304424|NCT00270543|Vitamin B Complex|vitamin b complex|mesh-ancestor
110304425|NCT00270543|Vitamins|vitamins|mesh-ancestor
110304426|NCT00270543|Micronutrients|micronutrients|mesh-ancestor
110304427|NCT00270543|Tubulin Modulators|tubulin modulators|mesh-ancestor
110284135|NCT00230529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110284136|NCT00230568|Donepezil|donepezil|mesh-list
110284137|NCT00230568|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110284138|NCT00230568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110284139|NCT00230568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110284141|NCT00230568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110284143|NCT00230568|Nootropic Agents|nootropic agents|mesh-ancestor
110284144|NCT00227331|Amoxicillin|amoxicillin|mesh-list
110284145|NCT00227331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110284146|NCT00227331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110284147|NCT00197561|Selenium|selenium|mesh-list
110284148|NCT00197561|Antioxidants|antioxidants|mesh-ancestor
110284149|NCT00197561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110304428|NCT00270543|Antimitotic Agents|antimitotic agents|mesh-ancestor
110304429|NCT00270543|Mitosis Modulators|mitosis modulators|mesh-ancestor
110304430|NCT02960919|Amoxicillin|amoxicillin|mesh-list
110304431|NCT02960919|Gentamicins|gentamicins|mesh-list
110304432|NCT02960919|Penicillins|penicillins|mesh-list
110304434|NCT02960919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110304435|NCT02960919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110304436|NCT02960919|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110304437|NCT02960919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110304438|NCT02960919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110304439|NCT00270582|Gemcitabine|gemcitabine|mesh-list
110304440|NCT00270582|Docetaxel|docetaxel|mesh-list
110304441|NCT00270582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110304442|NCT00270582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110304443|NCT00270582|Antimetabolites|antimetabolites|mesh-ancestor
110304444|NCT00270582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110304445|NCT00270582|Tubulin Modulators|tubulin modulators|mesh-ancestor
110304446|NCT00270582|Antimitotic Agents|antimitotic agents|mesh-ancestor
110304447|NCT00270582|Mitosis Modulators|mitosis modulators|mesh-ancestor
110304448|NCT01600456|Sertraline|sertraline|mesh-list
110304449|NCT01600456|Antidepressive Agents|antidepressive agents|mesh-ancestor
110304450|NCT01600456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110304451|NCT01600456|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110304452|NCT01600456|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110304453|NCT01600456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110304454|NCT01600456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110304455|NCT01600456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110304456|NCT01600456|Serotonin Agents|serotonin agents|mesh-ancestor
110304457|NCT01600456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110304458|NCT00289809|Ifosfamide|ifosfamide|mesh-list
110304459|NCT00289809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110304460|NCT00289809|Alkylating Agents|alkylating agents|mesh-ancestor
110304461|NCT00289809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110304462|NCT00289809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110304463|NCT00256100|PENTA|penta|mesh-list
110304464|NCT00256100|Fondaparinux|fondaparinux|mesh-list
110304465|NCT00256100|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110304466|NCT00256100|Antithrombins|antithrombins|mesh-ancestor
110304467|NCT00256100|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110304468|NCT00256100|Protease Inhibitors|protease inhibitors|mesh-ancestor
110304469|NCT00256100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110304470|NCT00256100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110304471|NCT00256100|Anticoagulants|anticoagulants|mesh-ancestor
110304472|NCT00256100|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110304473|NCT00256100|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110304474|NCT00289926|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
110304483|NCT01609192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110284151|NCT00197561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284152|NCT00197561|Trace Elements|trace elements|mesh-ancestor
110284153|NCT00197561|Micronutrients|micronutrients|mesh-ancestor
110284154|NCT00227409|Edetic Acid|edetic acid|mesh-list
110284155|NCT00227409|Calcium|calcium|mesh-list
110284156|NCT00227409|Pentetic Acid|pentetic acid|mesh-list
110284157|NCT00227409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110284158|NCT00227409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284159|NCT00227409|Anticoagulants|anticoagulants|mesh-ancestor
110284160|NCT00227409|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110284161|NCT00227409|Chelating Agents|chelating agents|mesh-ancestor
110284162|NCT00227409|Sequestering Agents|sequestering agents|mesh-ancestor
110284163|NCT00227409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110284164|NCT00227409|Antidotes|antidotes|mesh-ancestor
110304485|NCT01609387|Antioxidants|antioxidants|mesh-ancestor
110304486|NCT01609387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110304487|NCT01609387|Protective Agents|protective agents|mesh-ancestor
110304488|NCT01609387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110304489|NCT01609387|Vitamins|vitamins|mesh-ancestor
110304490|NCT01609387|Micronutrients|micronutrients|mesh-ancestor
110304491|NCT00256178|Simvastatin|simvastatin|mesh-list
110304492|NCT00256178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110304493|NCT00256178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110304494|NCT00256178|Antimetabolites|antimetabolites|mesh-ancestor
110304495|NCT00256178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110304496|NCT00256178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110304497|NCT00256178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110304498|NCT00256178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110304500|NCT02488408|Decitabine|decitabine|mesh-list
110304501|NCT02488408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110035450|NCT01405079|Gefitinib|gefitinib|mesh-list
110304502|NCT02488408|Antimetabolites|antimetabolites|mesh-ancestor
110304503|NCT02488408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110304504|NCT02488408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110304505|NCT02488408|Antiviral Agents|antiviral agents|mesh-ancestor
110304506|NCT02488408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110304507|NCT02488408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110304508|NCT02488408|Immunologic Factors|immunologic factors|mesh-ancestor
110304509|NCT02488408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110304510|NCT02488408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110304511|NCT00270777|Promethazine|promethazine|mesh-list
110304512|NCT00270777|Diphenhydramine|diphenhydramine|mesh-list
110304513|NCT00270777|Hydrocortisone|hydrocortisone|mesh-list
110304514|NCT00270777|Epinephrine|epinephrine|mesh-list
110304515|NCT00270777|Racepinephrine|racepinephrine|mesh-list
110304516|NCT00270777|Epinephryl borate|epinephryl borate|mesh-list
110304517|NCT00270777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110304518|NCT00270777|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110304519|NCT00270777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110304520|NCT00270777|Adrenergic Agents|adrenergic agents|mesh-ancestor
110304521|NCT00270777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110304522|NCT00270777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110304523|NCT00270777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110304524|NCT00270777|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110304525|NCT00270777|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110304526|NCT00270777|Autonomic Agents|autonomic agents|mesh-ancestor
110304527|NCT00270777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110304528|NCT00270777|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110304529|NCT00270777|Respiratory System Agents|respiratory system agents|mesh-ancestor
110304530|NCT00270777|Mydriatics|mydriatics|mesh-ancestor
110304531|NCT00270777|Sympathomimetics|sympathomimetics|mesh-ancestor
110284165|NCT00227409|Protective Agents|protective agents|mesh-ancestor
110284166|NCT00227409|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110284167|NCT00197639|Ritonavir|ritonavir|mesh-list
110284168|NCT00197639|Indinavir|indinavir|mesh-list
110284169|NCT00197639|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110284170|NCT00197639|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110284171|NCT00197639|Protease Inhibitors|protease inhibitors|mesh-ancestor
110284172|NCT00197639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110284173|NCT00197639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110284174|NCT00197639|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110284175|NCT00197639|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110284176|NCT00197639|Antiviral Agents|antiviral agents|mesh-ancestor
110284177|NCT00197639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110304532|NCT00270777|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110304533|NCT00270777|Antipruritics|antipruritics|mesh-ancestor
110304534|NCT00270777|Dermatologic Agents|dermatologic agents|mesh-ancestor
110304535|NCT00270777|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110304536|NCT00270777|Histamine Antagonists|histamine antagonists|mesh-ancestor
110304537|NCT00270777|Histamine Agents|histamine agents|mesh-ancestor
110304538|NCT00270777|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110304539|NCT00270777|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110304540|NCT00270777|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110304541|NCT00270777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110304560|NCT00256334|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110304561|NCT01609855|Scopolamine|scopolamine|mesh-list
110304562|NCT01609855|Bromides|bromides|mesh-list
110304563|NCT01609855|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
110304564|NCT01609855|Anticonvulsants|anticonvulsants|mesh-ancestor
110304565|NCT01609855|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110304566|NCT01609855|Antiemetics|antiemetics|mesh-ancestor
110304567|NCT01609855|Autonomic Agents|autonomic agents|mesh-ancestor
110304568|NCT01609855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110304569|NCT01609855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110304570|NCT01609855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110304571|NCT01609855|Mydriatics|mydriatics|mesh-ancestor
110304572|NCT01609855|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110304573|NCT01609855|Cholinergic Agents|cholinergic agents|mesh-ancestor
110304574|NCT01609855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110304575|NCT01609855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110304576|NCT01609855|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110035514|NCT01405157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110304577|NCT01609855|Parasympatholytics|parasympatholytics|mesh-ancestor
110304578|NCT00270816|Interferons|interferons|mesh-list
110304579|NCT00270816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110304580|NCT00270816|Antiviral Agents|antiviral agents|mesh-ancestor
110304581|NCT00270816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110304582|NCT00290004|Motexafin gadolinium|motexafin gadolinium|mesh-list
110304583|NCT00290004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110304584|NCT00290004|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110304585|NCT00290004|Dermatologic Agents|dermatologic agents|mesh-ancestor
110304586|NCT01609816|Dasatinib|dasatinib|mesh-list
110304587|NCT01609816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110304588|NCT01609816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110304589|NCT01609816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110304590|NCT01609816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110304591|NCT00290043|Insulin glulisine|insulin glulisine|mesh-list
110304592|NCT00290043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110304593|NCT00290043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110304594|NCT00290082|Midazolam|midazolam|mesh-list
110304595|NCT00290082|Loxapine|loxapine|mesh-list
110304596|NCT00290082|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110304597|NCT00290082|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110304598|NCT00290082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110304599|NCT00290082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110304600|NCT00290082|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110284178|NCT00197639|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110284179|NCT00197639|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110284180|NCT00227448|Phenylephrine|phenylephrine|mesh-list
110284181|NCT00227448|Oxymetazoline|oxymetazoline|mesh-list
110284182|NCT00227448|Midodrine|midodrine|mesh-list
110284183|NCT00227448|Norepinephrine|norepinephrine|mesh-list
110284184|NCT00227448|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110284185|NCT00227448|Mydriatics|mydriatics|mesh-ancestor
110284186|NCT00227448|Autonomic Agents|autonomic agents|mesh-ancestor
110284187|NCT00227448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110284188|NCT00227448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284189|NCT00227448|Sympathomimetics|sympathomimetics|mesh-ancestor
110284190|NCT00227448|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110284191|NCT00227448|Nasal Decongestants|nasal decongestants|mesh-ancestor
110304624|NCT02270437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110304625|NCT02270437|Sensory System Agents|sensory system agents|mesh-ancestor
110304626|NCT02270437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110304627|NCT02270437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110304628|NCT02270437|Narcotics|narcotics|mesh-ancestor
110304629|NCT02270437|Analgesics|analgesics|mesh-ancestor
110304630|NCT02270437|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110304631|NCT02270437|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110304632|NCT02270437|Anesthetics, General|anesthetics, general|mesh-ancestor
110304633|NCT02270437|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110304634|NCT02270437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110304635|NCT02270437|Adrenergic Agents|adrenergic agents|mesh-ancestor
110304636|NCT02270437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110304637|NCT02270437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110304638|NCT02270437|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110304639|NCT02270437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110304640|NCT02270437|Autonomic Agents|autonomic agents|mesh-ancestor
110304641|NCT02270437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110304642|NCT02270437|Respiratory System Agents|respiratory system agents|mesh-ancestor
110304643|NCT02270437|Mydriatics|mydriatics|mesh-ancestor
110304644|NCT02270437|Sympathomimetics|sympathomimetics|mesh-ancestor
110304645|NCT02270437|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110304646|NCT02270749|Vitamin B 12|vitamin b 12|mesh-list
110304647|NCT02270749|Hydroxocobalamin|hydroxocobalamin|mesh-list
110304648|NCT02270749|Vitamins|vitamins|mesh-ancestor
110304649|NCT02270749|Micronutrients|micronutrients|mesh-ancestor
110035591|NCT01405573|Sorafenib|sorafenib|mesh-list
110304650|NCT02270749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110304651|NCT02270749|Vitamin B Complex|vitamin b complex|mesh-ancestor
110304652|NCT02270749|Hematinics|hematinics|mesh-ancestor
110304653|NCT02270788|Leucovorin|leucovorin|mesh-list
110304654|NCT02270788|Cytarabine|cytarabine|mesh-list
110304655|NCT02270788|Hydrocortisone|hydrocortisone|mesh-list
110304656|NCT02270788|Methotrexate|methotrexate|mesh-list
110304657|NCT02270788|Sorafenib|sorafenib|mesh-list
110304658|NCT02270788|Crenolanib|crenolanib|mesh-list
110304668|NCT02270788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110304669|NCT02270788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110304670|NCT02270788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110304671|NCT02270788|Immunologic Factors|immunologic factors|mesh-ancestor
110304672|NCT02270788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110304673|NCT02270788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110304674|NCT02270788|Antiviral Agents|antiviral agents|mesh-ancestor
110304675|NCT02270788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110304676|NCT02270788|Antidotes|antidotes|mesh-ancestor
110304677|NCT02270788|Protective Agents|protective agents|mesh-ancestor
110304678|NCT02270788|Vitamin B Complex|vitamin b complex|mesh-ancestor
110304680|NCT02270788|Micronutrients|micronutrients|mesh-ancestor
110304681|NCT02270788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110304682|NCT02270788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110304683|NCT02270827|Hydrocortisone|hydrocortisone|mesh-list
110304684|NCT02270827|Aminophylline|aminophylline|mesh-list
110284192|NCT00227448|Respiratory System Agents|respiratory system agents|mesh-ancestor
110284194|NCT00227448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110284195|NCT00227448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110284196|NCT00227448|Adrenergic Agents|adrenergic agents|mesh-ancestor
110284197|NCT00227448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110284198|NCT00227448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110284199|NCT00227448|Protective Agents|protective agents|mesh-ancestor
110284201|NCT00204191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110304685|NCT02270827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110304686|NCT02270827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110304687|NCT02270827|Autonomic Agents|autonomic agents|mesh-ancestor
110304688|NCT02270827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110304689|NCT02270827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110304691|NCT02270827|Respiratory System Agents|respiratory system agents|mesh-ancestor
110304692|NCT02270827|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110304693|NCT02270827|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110304694|NCT02270827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110304695|NCT02270827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110304696|NCT02270827|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110304697|NCT02270827|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110304698|NCT02270827|Purinergic Agents|purinergic agents|mesh-ancestor
110304699|NCT02270827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110304700|NCT02270827|Protective Agents|protective agents|mesh-ancestor
110304701|NCT00290121|Olanzapine|olanzapine|mesh-list
110304702|NCT00290121|Antiemetics|antiemetics|mesh-ancestor
110304703|NCT00290121|Autonomic Agents|autonomic agents|mesh-ancestor
110304704|NCT00290121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110304705|NCT00290121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110304706|NCT00290121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110304707|NCT00290121|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110304708|NCT00290121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110304710|NCT00290121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110304711|NCT00290121|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110304712|NCT00290121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110304713|NCT00290121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110304714|NCT00290121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110304715|NCT00290121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110304716|NCT00290121|Serotonin Agents|serotonin agents|mesh-ancestor
110304717|NCT04709744|Vitamin D|vitamin d|mesh-list
110304718|NCT04709744|Ergocalciferols|ergocalciferols|mesh-list
110304719|NCT04709744|Cholecalciferol|cholecalciferol|mesh-list
110304720|NCT04709744|Vitamins|vitamins|mesh-list
110304721|NCT04709744|Micronutrients|micronutrients|mesh-ancestor
110304722|NCT04709744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110304723|NCT04709744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110304729|NCT02271295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110304731|NCT02271412|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110035665|NCT01406080|Adapalene|adapalene|mesh-list
110304732|NCT02271412|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110304733|NCT02271412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110304734|NCT02271412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110304735|NCT02271412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110304736|NCT02271412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110304737|NCT02271412|Antidepressive Agents|antidepressive agents|mesh-ancestor
110304738|NCT02271412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110304739|NCT00271050|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110304740|NCT00271050|Immunologic Factors|immunologic factors|mesh-ancestor
110304741|NCT00271050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284202|NCT00204191|Immunologic Factors|immunologic factors|mesh-ancestor
110284203|NCT00204191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284204|NCT00204191|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110284205|NCT00204191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110284206|NCT00204191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110284208|NCT00204230|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110284209|NCT00204230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110284210|NCT00204230|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110284211|NCT00204230|Antitubercular Agents|antitubercular agents|mesh-ancestor
110284212|NCT00204230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110284213|NCT00204230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110284214|NCT00204230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110304742|NCT02271646|Bupivacaine|bupivacaine|mesh-list
110304743|NCT02271646|Anesthetics, Local|anesthetics, local|mesh-ancestor
110304744|NCT02271646|Anesthetics|anesthetics|mesh-ancestor
110304745|NCT02271646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110304746|NCT02271646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110304747|NCT02271646|Sensory System Agents|sensory system agents|mesh-ancestor
110304748|NCT02271646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110304749|NCT02271802|Butyric Acid|butyric acid|mesh-list
110304750|NCT02271802|Histamine Antagonists|histamine antagonists|mesh-ancestor
110304751|NCT02271802|Histamine Agents|histamine agents|mesh-ancestor
110304752|NCT02271802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110304753|NCT02271802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110304754|NCT02271802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110304756|NCT02271958|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110304757|NCT02271958|Abortifacient Agents|abortifacient agents|mesh-ancestor
110304758|NCT02271958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110304759|NCT02271958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110304760|NCT02271958|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110304761|NCT02271958|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110304762|NCT02271958|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110304763|NCT02271958|Contraceptive Agents|contraceptive agents|mesh-ancestor
110304764|NCT02271958|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110304765|NCT02271958|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110304766|NCT02271958|Hormone Antagonists|hormone antagonists|mesh-ancestor
110304767|NCT02271958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110304768|NCT02271958|Luteolytic Agents|luteolytic agents|mesh-ancestor
110304769|NCT02271958|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110304770|NCT02271958|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110304771|NCT00257036|Levofloxacin|levofloxacin|mesh-list
110304772|NCT00257036|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110304773|NCT00257036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110304774|NCT00257036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110304775|NCT00257036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110304776|NCT00257036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110304777|NCT00257036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110304778|NCT00257036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110304779|NCT00257036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110304780|NCT00257036|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110304781|NCT00257036|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110304782|NCT00257075|Risperidone|risperidone|mesh-list
110304783|NCT00257075|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110304784|NCT00257075|Serotonin Agents|serotonin agents|mesh-ancestor
110304785|NCT00257075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110304786|NCT00257075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110284215|NCT00204230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110284216|NCT00204269|Testosterone|testosterone|mesh-list
110284217|NCT00204269|Androgens|androgens|mesh-ancestor
110284218|NCT00204269|Hormones|hormones|mesh-ancestor
110284219|NCT00204269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110284220|NCT00204269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284221|NCT00197756|Vitamins|vitamins|mesh-list
110284222|NCT00197756|Vitamin A|vitamin a|mesh-list
110284223|NCT00197756|Retinol palmitate|retinol palmitate|mesh-list
110284224|NCT00197756|Micronutrients|micronutrients|mesh-ancestor
110304787|NCT00257075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110304788|NCT00257075|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110304796|NCT02272270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110304797|NCT02272270|Alkylating Agents|alkylating agents|mesh-ancestor
110304798|NCT02272270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110304799|NCT02272270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110304800|NCT02272270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110304801|NCT02272270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110304802|NCT02272387|Vitamin D|vitamin d|mesh-list
110304803|NCT02272387|Cholecalciferol|cholecalciferol|mesh-list
110304804|NCT02272387|Vitamins|vitamins|mesh-ancestor
110304805|NCT02272387|Micronutrients|micronutrients|mesh-ancestor
110304806|NCT02272387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110304807|NCT02272387|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110304808|NCT02272387|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110304809|NCT00257114|Bortezomib|bortezomib|mesh-list
110304810|NCT00257114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110304811|NCT00271206|Progesterone|progesterone|mesh-list
110304812|NCT00271206|Progestins|progestins|mesh-ancestor
110304813|NCT00271206|Hormones|hormones|mesh-ancestor
110304814|NCT00271206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110304815|NCT00271206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110304816|NCT02272582|Heparin|heparin|mesh-list
110304817|NCT02272582|Anticoagulants|anticoagulants|mesh-ancestor
110304818|NCT02272582|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110304819|NCT02272582|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110021632|NCT00002670|Cobalt|cobalt|mesh-list
110304821|NCT02272660|Parecoxib|parecoxib|mesh-list
110304822|NCT02272660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110304823|NCT02272660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110304824|NCT02272660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110304825|NCT02272660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110304826|NCT02272660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110304827|NCT02272660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110304828|NCT02272660|Analgesics|analgesics|mesh-ancestor
110304829|NCT02272660|Sensory System Agents|sensory system agents|mesh-ancestor
110304830|NCT02272660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110304831|NCT02272660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110304832|NCT02272660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110304833|NCT02272660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110304834|NCT02272699|Paclitaxel|paclitaxel|mesh-list
110304835|NCT02272699|Nimotuzumab|nimotuzumab|mesh-list
110304836|NCT02272699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110304837|NCT02272699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110304838|NCT02272699|Tubulin Modulators|tubulin modulators|mesh-ancestor
110304839|NCT02272699|Antimitotic Agents|antimitotic agents|mesh-ancestor
110304840|NCT02272699|Mitosis Modulators|mitosis modulators|mesh-ancestor
110304841|NCT02272699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110304842|NCT02272699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110304843|NCT02272738|Paclitaxel|paclitaxel|mesh-list
110304844|NCT02272738|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110304845|NCT02272738|Gemcitabine|gemcitabine|mesh-list
110304846|NCT02272738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110304847|NCT02272738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110304849|NCT02272738|Antimitotic Agents|antimitotic agents|mesh-ancestor
110284225|NCT00197756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284226|NCT00197756|Antioxidants|antioxidants|mesh-ancestor
110284227|NCT00197756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110284228|NCT00197756|Protective Agents|protective agents|mesh-ancestor
110284229|NCT00197756|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110284230|NCT00197756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110284231|NCT00227565|Carboplatin|carboplatin|mesh-list
110284232|NCT00227565|Pemetrexed|pemetrexed|mesh-list
110284233|NCT00227565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110284234|NCT00227565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110284235|NCT00227565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110284236|NCT00227565|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110284237|NCT00227565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110284238|NCT00204308|Tenofovir|tenofovir|mesh-list
110284239|NCT00204308|Emtricitabine|emtricitabine|mesh-list
110284240|NCT00204308|Antiviral Agents|antiviral agents|mesh-ancestor
110284241|NCT00204308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110284242|NCT00204308|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110284243|NCT00204308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110284244|NCT00204308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110304850|NCT02272738|Mitosis Modulators|mitosis modulators|mesh-ancestor
110304852|NCT02272738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110304853|NCT02272738|Antimetabolites|antimetabolites|mesh-ancestor
110304854|NCT00271245|Selenium|selenium|mesh-list
110304855|NCT00271245|Selenic Acid|selenic acid|mesh-list
110304856|NCT00271245|Antioxidants|antioxidants|mesh-ancestor
110304857|NCT00271245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110304860|NCT00271245|Trace Elements|trace elements|mesh-ancestor
110304861|NCT00271245|Micronutrients|micronutrients|mesh-ancestor
110304862|NCT02272855|Ipilimumab|ipilimumab|mesh-list
110304863|NCT02272855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110304864|NCT02272855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110304865|NCT02272855|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110304866|NCT02272855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110304867|NCT00257270|Gabapentin|gabapentin|mesh-list
110304868|NCT00257270|Analgesics|analgesics|mesh-ancestor
110304869|NCT00257270|Sensory System Agents|sensory system agents|mesh-ancestor
110304870|NCT00257270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110304871|NCT00257270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110304872|NCT00257270|Anticonvulsants|anticonvulsants|mesh-ancestor
110304873|NCT00257270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110304874|NCT00257270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110304875|NCT00257270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110304876|NCT00257270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110304877|NCT00257270|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110304878|NCT00257270|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110304879|NCT00257270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110304880|NCT00257270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110304881|NCT00257270|Antimanic Agents|antimanic agents|mesh-ancestor
110304882|NCT00290394|Rosiglitazone|rosiglitazone|mesh-list
110304883|NCT00290394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110304884|NCT00290394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284245|NCT00204308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110284247|NCT00204308|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110284249|NCT00204347|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110284250|NCT00204347|Serotonin Agents|serotonin agents|mesh-ancestor
110284251|NCT00204347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110284252|NCT00204347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110284253|NCT00204347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284254|NCT00204347|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110284255|NCT00204347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110284256|NCT00204347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110284257|NCT00204347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110284258|NCT00204347|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110284259|NCT00204347|Dopamine Agents|dopamine agents|mesh-ancestor
110284260|NCT00227682|Ascorbic Acid|ascorbic acid|mesh-list
110284261|NCT00227682|Thalidomide|thalidomide|mesh-list
110284262|NCT00227682|Dexamethasone|dexamethasone|mesh-list
110304885|NCT00257348|Docetaxel|docetaxel|mesh-list
110304886|NCT00257348|Capecitabine|capecitabine|mesh-list
110304887|NCT00257348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110304888|NCT00257348|Tubulin Modulators|tubulin modulators|mesh-ancestor
110304889|NCT00257348|Antimitotic Agents|antimitotic agents|mesh-ancestor
110304890|NCT00257348|Mitosis Modulators|mitosis modulators|mesh-ancestor
110304891|NCT00257348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110304892|NCT00257348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110304893|NCT00257348|Antimetabolites|antimetabolites|mesh-ancestor
110304894|NCT02273128|Calcitonin|calcitonin|mesh-list
110304895|NCT02273128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110304896|NCT02273128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110304897|NCT02273128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110304898|NCT00257387|Cyclosporine|cyclosporine|mesh-list
110304899|NCT00257387|Cyclosporins|cyclosporins|mesh-list
110304900|NCT00257387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110304901|NCT00257387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110304902|NCT00257387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110304903|NCT00257387|Immunologic Factors|immunologic factors|mesh-ancestor
110304904|NCT00257387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110304905|NCT00257387|Antifungal Agents|antifungal agents|mesh-ancestor
110304906|NCT00257387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110304907|NCT00257387|Dermatologic Agents|dermatologic agents|mesh-ancestor
110304908|NCT00257387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110304909|NCT00257387|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110304910|NCT00257426|Octreotide|octreotide|mesh-list
110304911|NCT00257426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110304912|NCT00257426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110304913|NCT00257426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110304914|NCT01601509|Tramazoline|tramazoline|mesh-list
110304915|NCT01601509|Sympathomimetics|sympathomimetics|mesh-ancestor
110304916|NCT01601509|Autonomic Agents|autonomic agents|mesh-ancestor
110304917|NCT01601509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110304918|NCT01601509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110304919|NCT00416325|Lycopene|lycopene|mesh-list
110304920|NCT00416325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110304921|NCT00416325|Antioxidants|antioxidants|mesh-ancestor
110304922|NCT00416325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110304923|NCT00416325|Protective Agents|protective agents|mesh-ancestor
110304924|NCT00416325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284263|NCT00227682|Arsenic Trioxide|arsenic trioxide|mesh-list
110284264|NCT00227682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110284265|NCT00227682|Antiemetics|antiemetics|mesh-ancestor
110284266|NCT00227682|Autonomic Agents|autonomic agents|mesh-ancestor
110284267|NCT00227682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110284268|NCT00227682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284269|NCT00227682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110284270|NCT00227682|Glucocorticoids|glucocorticoids|mesh-ancestor
110284271|NCT00227682|Hormones|hormones|mesh-ancestor
110284272|NCT00227682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110284273|NCT00227682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110284274|NCT00227682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110284275|NCT00227682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110304925|NCT00416325|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110304926|NCT00416325|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110304927|NCT00416325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110304929|NCT00257465|Immunologic Factors|immunologic factors|mesh-ancestor
110304930|NCT00257465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110304931|NCT01601899|Tenofovir|tenofovir|mesh-list
110304937|NCT01601899|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110304938|NCT01601899|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110304940|NCT01601899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110304941|NCT01601899|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110304942|NCT01601899|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110304943|NCT01601899|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110304944|NCT01601899|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110304945|NCT01601899|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110304946|NCT01601899|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110304947|NCT01601899|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110304948|NCT01601899|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110304949|NCT01601899|Antimetabolites|antimetabolites|mesh-ancestor
110304950|NCT01601938|Selenium|selenium|mesh-list
110304951|NCT01601938|Antioxidants|antioxidants|mesh-ancestor
110304952|NCT01601938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110304953|NCT01601938|Protective Agents|protective agents|mesh-ancestor
110304954|NCT01601938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110304955|NCT01601938|Trace Elements|trace elements|mesh-ancestor
110304956|NCT01601938|Micronutrients|micronutrients|mesh-ancestor
110304957|NCT01602055|Azithromycin|azithromycin|mesh-list
110304958|NCT01602055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110304959|NCT01602055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110304960|NCT01602250|Ropivacaine|ropivacaine|mesh-list
110304961|NCT01602250|Levobupivacaine|levobupivacaine|mesh-list
110304962|NCT01602250|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
110304963|NCT01602250|Anesthetics, Local|anesthetics, local|mesh-ancestor
110304964|NCT01602250|Anesthetics|anesthetics|mesh-ancestor
110304965|NCT01602250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110304966|NCT01602250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110304967|NCT01602250|Sensory System Agents|sensory system agents|mesh-ancestor
110304968|NCT01602250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110304969|NCT01602250|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
110304970|NCT01602250|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110304971|NCT01602250|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110304972|NCT00257582|Cetirizine|cetirizine|mesh-list
110304973|NCT00257582|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110304974|NCT00257582|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110304975|NCT00257582|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110304976|NCT00257582|Histamine Antagonists|histamine antagonists|mesh-ancestor
110304977|NCT00257582|Histamine Agents|histamine agents|mesh-ancestor
110304978|NCT00257582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110284277|NCT00227682|Leprostatic Agents|leprostatic agents|mesh-ancestor
110284278|NCT00227682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110284279|NCT00227682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110284280|NCT00227682|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110284281|NCT00227682|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110284282|NCT00227682|Growth Substances|growth substances|mesh-ancestor
110284283|NCT00227682|Growth Inhibitors|growth inhibitors|mesh-ancestor
110284284|NCT00227682|Antioxidants|antioxidants|mesh-ancestor
110284285|NCT00227682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110284286|NCT00227682|Protective Agents|protective agents|mesh-ancestor
110284288|NCT00227682|Micronutrients|micronutrients|mesh-ancestor
110284289|NCT00230763|Timolol|timolol|mesh-list
110284290|NCT00230763|Latanoprost|latanoprost|mesh-list
110304979|NCT00257582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110304980|NCT00257582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110304981|NCT01602289|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110304982|NCT01602289|Gefitinib|gefitinib|mesh-list
110304983|NCT01602289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110304984|NCT01602289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110304985|NCT01602289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110304986|NCT01602289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110304987|NCT00257621|Ritonavir|ritonavir|mesh-list
110304988|NCT00257621|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110304989|NCT00257621|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110304990|NCT00257621|Protease Inhibitors|protease inhibitors|mesh-ancestor
110304991|NCT00257621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110304992|NCT00257621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110304993|NCT00257621|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110304994|NCT00257621|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110304995|NCT00257621|Antiviral Agents|antiviral agents|mesh-ancestor
110304996|NCT00257621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110304997|NCT00257621|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110304998|NCT00257621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110304999|NCT01602406|Trastuzumab|trastuzumab|mesh-list
110305000|NCT01602406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110305005|NCT00290628|Cyclophosphamide|cyclophosphamide|mesh-list
110305006|NCT00290628|Melphalan|melphalan|mesh-list
110305007|NCT00290628|Busulfan|busulfan|mesh-list
110305008|NCT00290628|Cyclosporins|cyclosporins|mesh-list
110305009|NCT00290628|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110305010|NCT00290628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110305011|NCT00290628|Immunologic Factors|immunologic factors|mesh-ancestor
110305012|NCT00290628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110305013|NCT00290628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110305014|NCT00290628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110305015|NCT00290628|Alkylating Agents|alkylating agents|mesh-ancestor
110305016|NCT00290628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110305017|NCT00290628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110305018|NCT00290628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110305019|NCT00290628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110305020|NCT00290628|Antifungal Agents|antifungal agents|mesh-ancestor
110305021|NCT00290628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110305022|NCT00290628|Dermatologic Agents|dermatologic agents|mesh-ancestor
110305023|NCT00290628|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110305024|NCT00290628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110305025|NCT00290628|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110305026|NCT00290628|Antitubercular Agents|antitubercular agents|mesh-ancestor
110305027|NCT00290628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110305028|NCT00290628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110284291|NCT00230763|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110284292|NCT00230763|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110284294|NCT00230763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110284295|NCT00230763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110284296|NCT00230763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110305029|NCT00290628|Antiemetics|antiemetics|mesh-ancestor
110305030|NCT00290628|Autonomic Agents|autonomic agents|mesh-ancestor
110305031|NCT00290628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110305032|NCT00290628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110305033|NCT00290628|Glucocorticoids|glucocorticoids|mesh-ancestor
110305035|NCT00290628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110305036|NCT00290628|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110305037|NCT00290628|Protective Agents|protective agents|mesh-ancestor
110305038|NCT01602523|Budesonide|budesonide|mesh-list
110305039|NCT01602523|Formoterol Fumarate|formoterol fumarate|mesh-list
110305040|NCT01602523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110305041|NCT01602523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110305042|NCT01602523|Autonomic Agents|autonomic agents|mesh-ancestor
110305043|NCT01602523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110305044|NCT01602523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110305045|NCT01602523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110305046|NCT01602523|Respiratory System Agents|respiratory system agents|mesh-ancestor
110305047|NCT01602523|Glucocorticoids|glucocorticoids|mesh-ancestor
110305048|NCT01602523|Hormones|hormones|mesh-ancestor
110305049|NCT01602523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110305050|NCT01602523|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110305051|NCT01602523|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110305052|NCT01602523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110305053|NCT01602523|Adrenergic Agents|adrenergic agents|mesh-ancestor
110305054|NCT01602523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110305055|NCT01602523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110305056|NCT00415298|Oxaliplatin|oxaliplatin|mesh-list
110305057|NCT00415298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110305058|NCT01602640|Fentanyl|fentanyl|mesh-list
110305059|NCT01602640|Midazolam|midazolam|mesh-list
110305060|NCT01602640|Morphine|morphine|mesh-list
110305061|NCT01602640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110305062|NCT01602640|Narcotics|narcotics|mesh-ancestor
110305063|NCT01602640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110305064|NCT01602640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110305065|NCT01602640|Analgesics|analgesics|mesh-ancestor
110305066|NCT01602640|Sensory System Agents|sensory system agents|mesh-ancestor
110305067|NCT01602640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110305068|NCT01602640|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110305069|NCT01602640|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110305070|NCT01602640|Anesthetics, General|anesthetics, general|mesh-ancestor
110305071|NCT01602640|Anesthetics|anesthetics|mesh-ancestor
110305072|NCT01602640|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110305073|NCT01602640|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110305074|NCT01602640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110305091|NCT00290667|Alkylating Agents|alkylating agents|mesh-ancestor
110305092|NCT00290667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110305093|NCT00290667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110305094|NCT00290667|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110305095|NCT00290667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110305096|NCT00290667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110305097|NCT00290667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110305098|NCT00290667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110305099|NCT00290667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110305100|NCT00290667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110305101|NCT00290667|Glucocorticoids|glucocorticoids|mesh-ancestor
110305102|NCT00290667|Hormones|hormones|mesh-ancestor
110305103|NCT00290667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110305104|NCT00290667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110036042|NCT01408836|Prednisolone|prednisolone|mesh-list
110284297|NCT00230763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110284298|NCT00230763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110284299|NCT00230763|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110284300|NCT00230763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110284301|NCT00204386|Topiramate|topiramate|mesh-list
110284302|NCT00204386|Anticonvulsants|anticonvulsants|mesh-ancestor
110284303|NCT00204386|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110284304|NCT00204386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284305|NCT04721964|Ferrous fumarate|ferrous fumarate|mesh-list
110284306|NCT04721964|Trace Elements|trace elements|mesh-ancestor
110284307|NCT04721964|Micronutrients|micronutrients|mesh-ancestor
110305105|NCT00290667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110305106|NCT00290667|Tubulin Modulators|tubulin modulators|mesh-ancestor
110305107|NCT00290667|Antimitotic Agents|antimitotic agents|mesh-ancestor
110305108|NCT00290667|Mitosis Modulators|mitosis modulators|mesh-ancestor
110305109|NCT01602757|Lidocaine|lidocaine|mesh-list
110305110|NCT01602757|Tetracaine|tetracaine|mesh-list
110305111|NCT01602757|Anesthetics, Local|anesthetics, local|mesh-ancestor
110305112|NCT01602757|Anesthetics|anesthetics|mesh-ancestor
110305113|NCT01602757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110305114|NCT01602757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110305115|NCT01602757|Sensory System Agents|sensory system agents|mesh-ancestor
110305116|NCT01602757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110305117|NCT01602757|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110305118|NCT01602757|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110305119|NCT01602757|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110305120|NCT01602757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110305121|NCT01602757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110305122|NCT02961101|Decitabine|decitabine|mesh-list
110305123|NCT02961101|Antibodies|antibodies|mesh-list
110305124|NCT02961101|Immunologic Factors|immunologic factors|mesh-ancestor
110305125|NCT02961101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110305126|NCT02961101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110305127|NCT02961101|Antimetabolites|antimetabolites|mesh-ancestor
110305128|NCT02961101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110305129|NCT02961101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110305130|NCT02961101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110305131|NCT01602913|Paroxetine|paroxetine|mesh-list
110305132|NCT01602913|Pravastatin|pravastatin|mesh-list
110305133|NCT01602913|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110305139|NCT01602913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110305140|NCT01602913|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110021786|NCT00002700|Sensory System Agents|sensory system agents|mesh-ancestor
110305141|NCT01602913|Antidepressive Agents|antidepressive agents|mesh-ancestor
110305142|NCT01602913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110305143|NCT01602913|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110305144|NCT01602913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110305145|NCT01602913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110305146|NCT01602913|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110305147|NCT01602913|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110305148|NCT01602913|Antimetabolites|antimetabolites|mesh-ancestor
110305149|NCT01602913|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110305150|NCT01602913|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110305151|NCT00257699|Metronidazole|metronidazole|mesh-list
110305152|NCT00257699|Ciprofloxacin|ciprofloxacin|mesh-list
110305153|NCT00257699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110305154|NCT00257699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110305155|NCT00257699|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110305156|NCT00257699|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110305157|NCT00257699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110305158|NCT00257699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110305159|NCT00257699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110305160|NCT00257699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110305161|NCT00257699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110305162|NCT00257699|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110284308|NCT04721964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284309|NCT00197834|Valproic Acid|valproic acid|mesh-list
110284310|NCT00197834|Anticonvulsants|anticonvulsants|mesh-ancestor
110284311|NCT00197834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110284312|NCT00197834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110284313|NCT00197834|GABA Agents|gaba agents|mesh-ancestor
110284314|NCT00197834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110284315|NCT00197834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284316|NCT00197834|Antimanic Agents|antimanic agents|mesh-ancestor
110284317|NCT00197834|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110284318|NCT00197834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110284319|NCT00197834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110284320|NCT00197912|Celecoxib|celecoxib|mesh-list
110284321|NCT00197912|Cyclophosphamide|cyclophosphamide|mesh-list
110284322|NCT00197912|Interleukin-2|interleukin-2|mesh-list
110284323|NCT00197912|Immunologic Factors|immunologic factors|mesh-ancestor
110284324|NCT00197912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284325|NCT00197912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110284326|NCT00197912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110284327|NCT00197912|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110284328|NCT00197912|Alkylating Agents|alkylating agents|mesh-ancestor
110284329|NCT00197912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110305163|NCT00257699|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110305164|NCT01603030|Moxifloxacin|moxifloxacin|mesh-list
110305165|NCT01603030|Prednisolone|prednisolone|mesh-list
110305166|NCT01603030|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110305167|NCT01603030|Methylprednisolone|methylprednisolone|mesh-list
110305168|NCT01603030|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110305169|NCT01603030|Prednisolone acetate|prednisolone acetate|mesh-list
110305170|NCT01603030|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110305171|NCT01603030|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110305172|NCT01603030|Prednisolone phosphate|prednisolone phosphate|mesh-list
110305173|NCT01603030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110305174|NCT01603030|Glucocorticoids|glucocorticoids|mesh-ancestor
110305175|NCT01603030|Hormones|hormones|mesh-ancestor
110305176|NCT01603030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110305177|NCT01603030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110305178|NCT01603030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110305179|NCT01603030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110305181|NCT01603030|Autonomic Agents|autonomic agents|mesh-ancestor
110305182|NCT01603030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110305183|NCT01603030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110305184|NCT01603030|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110305185|NCT01603030|Protective Agents|protective agents|mesh-ancestor
110305186|NCT01603030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110305187|NCT01603030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110305189|NCT01603030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110305190|NCT01603030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110305191|NCT01603030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110305192|NCT01603030|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110305193|NCT01603030|Contraceptive Agents|contraceptive agents|mesh-ancestor
110284330|NCT00197912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110284331|NCT00197912|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110284332|NCT00197912|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110284333|NCT00197912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110284334|NCT00197912|Analgesics|analgesics|mesh-ancestor
110284335|NCT00197912|Sensory System Agents|sensory system agents|mesh-ancestor
110284336|NCT00197912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110284337|NCT00197912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110284338|NCT00197912|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110284339|NCT00197912|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110284340|NCT00197912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110284341|NCT02962323|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110284342|NCT02962323|Calcium|calcium|mesh-list
110284343|NCT02962323|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110284344|NCT02962323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284345|NCT02962323|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110284346|NCT02962323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110284347|NCT02962323|Antimetabolites|antimetabolites|mesh-ancestor
110284348|NCT02962323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110305194|NCT01603030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110305195|NCT01603030|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110305196|NCT01603030|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110305197|NCT01603030|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110305198|NCT01603108|Rifaximin|rifaximin|mesh-list
110305199|NCT01603108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110305200|NCT01603108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110305201|NCT01603108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110305207|NCT00290823|Autonomic Agents|autonomic agents|mesh-ancestor
110305208|NCT00290823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110305209|NCT00290823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110305210|NCT00290823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110305211|NCT00290823|Glucocorticoids|glucocorticoids|mesh-ancestor
110305212|NCT00290823|Hormones|hormones|mesh-ancestor
110305213|NCT00290823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110305214|NCT00290823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110305215|NCT00290823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110305216|NCT00290823|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110305217|NCT00290823|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110305219|NCT00290823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110305220|NCT00290823|Anthelmintics|anthelmintics|mesh-ancestor
110305221|NCT00290823|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110305222|NCT00290823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110305223|NCT00290823|Anticestodal Agents|anticestodal agents|mesh-ancestor
110305224|NCT00290823|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110305225|NCT00290823|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110305226|NCT00290823|Tubulin Modulators|tubulin modulators|mesh-ancestor
110305227|NCT00290823|Antimitotic Agents|antimitotic agents|mesh-ancestor
110305228|NCT00290823|Mitosis Modulators|mitosis modulators|mesh-ancestor
110305229|NCT01603186|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110305230|NCT01603186|Antidepressive Agents|antidepressive agents|mesh-ancestor
110305231|NCT01603186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110305232|NCT01603186|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110305233|NCT01603186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110305234|NCT01603186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110284349|NCT02962323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110284350|NCT02962323|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110284351|NCT02962323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110284352|NCT00204503|Valproic Acid|valproic acid|mesh-list
110284353|NCT00204503|Anticonvulsants|anticonvulsants|mesh-ancestor
110284354|NCT00204503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110284355|NCT00204503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110284356|NCT00204503|GABA Agents|gaba agents|mesh-ancestor
110284357|NCT00204503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110284358|NCT00204503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284359|NCT00204503|Antimanic Agents|antimanic agents|mesh-ancestor
110284360|NCT00204503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110305235|NCT01603186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110305236|NCT00271284|Insulin|insulin|mesh-list
110305237|NCT00271284|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110305238|NCT00271284|Insulin Glargine|insulin glargine|mesh-list
110305239|NCT00271284|Insulin Detemir|insulin detemir|mesh-list
110305240|NCT00271284|Insulin glulisine|insulin glulisine|mesh-list
110305241|NCT00271284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110305242|NCT00271284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110305243|NCT00257816|Topotecan|topotecan|mesh-list
110305244|NCT00257816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110305245|NCT00257816|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110305246|NCT00257816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110305247|NCT00257816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110305248|NCT00257816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110305249|NCT00271323|Docetaxel|docetaxel|mesh-list
110305250|NCT00271323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110305251|NCT00271323|Tubulin Modulators|tubulin modulators|mesh-ancestor
110305252|NCT00271323|Antimitotic Agents|antimitotic agents|mesh-ancestor
110305253|NCT00271323|Mitosis Modulators|mitosis modulators|mesh-ancestor
110305254|NCT00271323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110305255|NCT01603342|Clopidogrel|clopidogrel|mesh-list
110305256|NCT01603342|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110305257|NCT01603342|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110305258|NCT01603342|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110305259|NCT01603342|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110305260|NCT01603342|Purinergic Agents|purinergic agents|mesh-ancestor
110305261|NCT01603342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110305262|NCT01603342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110305263|NCT01603342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110305264|NCT00257855|Lamotrigine|lamotrigine|mesh-list
110305265|NCT00257855|Anticonvulsants|anticonvulsants|mesh-ancestor
110305266|NCT00257855|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110305267|NCT00257855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110305268|NCT00257855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110305269|NCT00257855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110305270|NCT00257855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110305271|NCT00257855|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110305272|NCT00257855|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110305279|NCT01603498|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110305280|NCT01603498|Prednisolone|prednisolone|mesh-list
110305281|NCT01603498|Prednisolone acetate|prednisolone acetate|mesh-list
110305282|NCT01603498|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110305283|NCT01603498|Prednisolone phosphate|prednisolone phosphate|mesh-list
110305284|NCT01603498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110305285|NCT01603498|Antiemetics|antiemetics|mesh-ancestor
110305286|NCT01603498|Autonomic Agents|autonomic agents|mesh-ancestor
110305287|NCT01603498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110305288|NCT01603498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110305289|NCT01603498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110305290|NCT01603498|Glucocorticoids|glucocorticoids|mesh-ancestor
110305291|NCT01603498|Hormones|hormones|mesh-ancestor
110021884|NCT00002772|Carmustine|carmustine|mesh-list
110284362|NCT00204503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110284363|NCT00204542|Diclofenac|diclofenac|mesh-list
110284364|NCT00204542|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110284365|NCT00204542|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110284366|NCT00204542|Analgesics|analgesics|mesh-ancestor
110284367|NCT00204542|Sensory System Agents|sensory system agents|mesh-ancestor
110284368|NCT00204542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110284369|NCT00204542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284370|NCT00204542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110284371|NCT00204542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110284372|NCT00204542|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110284373|NCT00204542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110305292|NCT01603498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110305293|NCT01603498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110305295|NCT01603498|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110305296|NCT01603498|Protective Agents|protective agents|mesh-ancestor
110305297|NCT01603654|Ascorbic Acid|ascorbic acid|mesh-list
110305298|NCT01603654|Magnesium citrate|magnesium citrate|mesh-list
110305299|NCT01603654|Picosulfate sodium|picosulfate sodium|mesh-list
110305300|NCT01603654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110305301|NCT01603654|Antioxidants|antioxidants|mesh-ancestor
110305302|NCT01603654|Protective Agents|protective agents|mesh-ancestor
110305303|NCT01603654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110305304|NCT01603654|Vitamins|vitamins|mesh-ancestor
110305305|NCT01603654|Micronutrients|micronutrients|mesh-ancestor
110305306|NCT01603654|Cathartics|cathartics|mesh-ancestor
110305307|NCT01603654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110305308|NCT00257972|Aripiprazole|aripiprazole|mesh-list
110305309|NCT00257972|Antidepressive Agents|antidepressive agents|mesh-ancestor
110305310|NCT00257972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110305311|NCT00257972|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110305312|NCT00257972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110305313|NCT00257972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110305314|NCT00257972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110305315|NCT00257972|Dopamine Agonists|dopamine agonists|mesh-ancestor
110305316|NCT00257972|Dopamine Agents|dopamine agents|mesh-ancestor
110305317|NCT00257972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110305318|NCT00257972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110305319|NCT00257972|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110305320|NCT00257972|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110305321|NCT00257972|Serotonin Agents|serotonin agents|mesh-ancestor
110305322|NCT00257972|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110305323|NCT00257972|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110305324|NCT00257972|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110305325|NCT00257972|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110305326|NCT01603693|Calcium|calcium|mesh-list
110305327|NCT01603693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110305328|NCT01603693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110305329|NCT00258050|Lapatinib|lapatinib|mesh-list
110305330|NCT00258050|Midazolam|midazolam|mesh-list
110305332|NCT00258050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110305333|NCT00258050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110305334|NCT00258050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110305335|NCT00258050|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110305336|NCT00258050|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110305337|NCT00258050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110305338|NCT00258050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110284374|NCT00204542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110284376|NCT00230958|Ribavirin|ribavirin|mesh-list
110284377|NCT00230958|Interferon-alpha|interferon-alpha|mesh-list
110284378|NCT00230958|Interferon alpha-2|interferon alpha-2|mesh-list
110284379|NCT00230958|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110284380|NCT00230958|Taribavirin|taribavirin|mesh-list
110284381|NCT00230958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110284382|NCT00230958|Antiviral Agents|antiviral agents|mesh-ancestor
110284383|NCT00230958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110284384|NCT00230958|Antimetabolites|antimetabolites|mesh-ancestor
110284385|NCT00230958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110284386|NCT00230958|Immunologic Factors|immunologic factors|mesh-ancestor
110284387|NCT00230958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284388|NCT00227955|Imipramine|imipramine|mesh-list
110305340|NCT00258050|Anesthetics|anesthetics|mesh-ancestor
110305341|NCT00258050|GABA Modulators|gaba modulators|mesh-ancestor
110305342|NCT00258050|GABA Agents|gaba agents|mesh-ancestor
110305343|NCT00258050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110305350|NCT00271401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110305351|NCT00271401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110305352|NCT00271401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110305353|NCT00258089|Levofloxacin|levofloxacin|mesh-list
110305354|NCT00258089|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110305355|NCT00258089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110305356|NCT00258089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110305357|NCT00258089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110305358|NCT00258089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110305359|NCT00258089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110305360|NCT00258089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110305361|NCT00258089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110305362|NCT00258089|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110305363|NCT00258089|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110305364|NCT00290901|Celecoxib|celecoxib|mesh-list
110305365|NCT00290901|Tramadol|tramadol|mesh-list
110305366|NCT00290901|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110305367|NCT00290901|Narcotics|narcotics|mesh-ancestor
110305368|NCT00290901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110305369|NCT00290901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110305370|NCT00290901|Analgesics|analgesics|mesh-ancestor
110305371|NCT00290901|Sensory System Agents|sensory system agents|mesh-ancestor
110305372|NCT00290901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110305373|NCT00290901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110305374|NCT00290901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110305375|NCT00290901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110305376|NCT00290901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110305377|NCT00290901|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110305378|NCT00290901|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110305379|NCT00290901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110305380|NCT00290901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110305382|NCT00258245|Vitamins|vitamins|mesh-list
110305383|NCT00258245|Ascorbic Acid|ascorbic acid|mesh-list
110305384|NCT00258245|Thalidomide|thalidomide|mesh-list
110305385|NCT00258245|Dexamethasone|dexamethasone|mesh-list
110305386|NCT00258245|Dexamethasone acetate|dexamethasone acetate|mesh-list
110305387|NCT00258245|Aspirin, aluminum hydroxide, magnesium hydroxide drug combination|aspirin, aluminum hydroxide, magnesium hydroxide drug combination|mesh-list
110305388|NCT00258245|Bortezomib|bortezomib|mesh-list
110305389|NCT00258245|Arsenic Trioxide|arsenic trioxide|mesh-list
110305390|NCT00258245|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
110305391|NCT00258245|BB 1101|bb 1101|mesh-list
110305392|NCT00258245|Micronutrients|micronutrients|mesh-ancestor
110284389|NCT00227955|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110284390|NCT00227955|Antidepressive Agents|antidepressive agents|mesh-ancestor
110284391|NCT00227955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110284392|NCT00227955|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110284393|NCT00227955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110284394|NCT00227955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110284395|NCT00227955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110284396|NCT00227955|Adrenergic Agents|adrenergic agents|mesh-ancestor
110284397|NCT00227955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110284398|NCT00227955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284399|NCT00228033|Calcium Carbonate|calcium carbonate|mesh-list
110284400|NCT00228033|Calcium|calcium|mesh-list
110284401|NCT00228033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110284402|NCT00228033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284404|NCT00228033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110284405|NCT00228033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110284406|NCT00230997|Galantamine|galantamine|mesh-list
110284407|NCT00230997|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110284408|NCT00230997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110284409|NCT00230997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110284410|NCT00230997|Cholinergic Agents|cholinergic agents|mesh-ancestor
110284411|NCT00230997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110305393|NCT00258245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110305394|NCT00258245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110305395|NCT00258245|Antiemetics|antiemetics|mesh-ancestor
110305396|NCT00258245|Autonomic Agents|autonomic agents|mesh-ancestor
110305397|NCT00258245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110305398|NCT00258245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110305399|NCT00258245|Glucocorticoids|glucocorticoids|mesh-ancestor
110305400|NCT00258245|Hormones|hormones|mesh-ancestor
110305401|NCT00258245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110305402|NCT00258245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110305403|NCT00258245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110305404|NCT00258245|Protease Inhibitors|protease inhibitors|mesh-ancestor
110305405|NCT00258245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110305406|NCT00258245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110305407|NCT00258245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110305410|NCT00258245|Sensory System Agents|sensory system agents|mesh-ancestor
110305411|NCT00258245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110305412|NCT00258245|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110305413|NCT00258245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110305416|NCT00258245|Antipyretics|antipyretics|mesh-ancestor
110305417|NCT00258245|Antioxidants|antioxidants|mesh-ancestor
110305418|NCT00258245|Protective Agents|protective agents|mesh-ancestor
110305419|NCT00258245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110305420|NCT00258245|Immunologic Factors|immunologic factors|mesh-ancestor
110305421|NCT00258245|Leprostatic Agents|leprostatic agents|mesh-ancestor
110284412|NCT00230997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284413|NCT00230997|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110284414|NCT00230997|Autonomic Agents|autonomic agents|mesh-ancestor
110284415|NCT00230997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110284416|NCT00230997|Nootropic Agents|nootropic agents|mesh-ancestor
110284417|NCT00204581|Aldesleukin|aldesleukin|mesh-list
110284418|NCT00204581|Interleukin-2|interleukin-2|mesh-list
110284419|NCT00204581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110284420|NCT00204581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110284421|NCT00204581|Analgesics|analgesics|mesh-ancestor
110284422|NCT00204581|Sensory System Agents|sensory system agents|mesh-ancestor
110284423|NCT00204581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110284424|NCT00204581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284426|NCT00204581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110284427|NCT00204581|Antiviral Agents|antiviral agents|mesh-ancestor
110284428|NCT00204581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110284429|NCT00231075|Paclitaxel|paclitaxel|mesh-list
110284430|NCT00231075|Carboplatin|carboplatin|mesh-list
110284431|NCT00231075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110284432|NCT00231075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110284433|NCT00231075|Tubulin Modulators|tubulin modulators|mesh-ancestor
110284434|NCT00231075|Antimitotic Agents|antimitotic agents|mesh-ancestor
110284435|NCT00231075|Mitosis Modulators|mitosis modulators|mesh-ancestor
110284436|NCT00231075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110284437|NCT00198146|Daclizumab|daclizumab|mesh-list
110284438|NCT00198146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110284439|NCT00198146|Immunologic Factors|immunologic factors|mesh-ancestor
110284440|NCT00198146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284441|NCT00204620|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110284442|NCT00204620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110284443|NCT00204620|Alkylating Agents|alkylating agents|mesh-ancestor
110284444|NCT00204620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110284455|NCT00204659|Immunologic Factors|immunologic factors|mesh-ancestor
110284456|NCT00204659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284457|NCT00204659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110284458|NCT00231192|Repaglinide|repaglinide|mesh-list
110284459|NCT00231192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110284460|NCT00231192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284461|NCT00204698|Rabeprazole|rabeprazole|mesh-list
110284462|NCT00204698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110284463|NCT00204698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110284464|NCT00204698|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110284465|NCT00204698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110284466|NCT00204698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110284467|NCT00204737|Prednisone|prednisone|mesh-list
110284468|NCT00204737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110284469|NCT00204737|Glucocorticoids|glucocorticoids|mesh-ancestor
110284470|NCT00204737|Hormones|hormones|mesh-ancestor
110284471|NCT00204737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110284472|NCT00204737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284473|NCT00204737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110284474|NCT00204737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110284475|NCT00198380|Gefitinib|gefitinib|mesh-list
110284476|NCT00198380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110284477|NCT00198380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110284478|NCT00198380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110284479|NCT00198380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110284480|NCT00228267|Propofol|propofol|mesh-list
110284481|NCT00228267|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110284482|NCT00228267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110284483|NCT00228267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110305422|NCT00258245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110305423|NCT00258245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110305424|NCT00258245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110305425|NCT00258245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110305426|NCT00258245|Growth Substances|growth substances|mesh-ancestor
110305427|NCT00258245|Growth Inhibitors|growth inhibitors|mesh-ancestor
110305428|NCT00271440|Chlorhexidine|chlorhexidine|mesh-list
110305429|NCT00271440|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110305430|NCT00271440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110305431|NCT00271440|Disinfectants|disinfectants|mesh-ancestor
110305432|NCT01604629|Adalimumab|adalimumab|mesh-list
110305433|NCT01604629|Infliximab|infliximab|mesh-list
110305434|NCT01604629|Golimumab|golimumab|mesh-list
110305435|NCT01604629|Etanercept|etanercept|mesh-list
110305436|NCT01604629|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110305437|NCT01604629|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110305438|NCT01604629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110305439|NCT01604629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110284484|NCT00228267|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110284485|NCT00228267|Anesthetics, General|anesthetics, general|mesh-ancestor
110284486|NCT00228267|Anesthetics|anesthetics|mesh-ancestor
110284487|NCT00231348|Nefazodone|nefazodone|mesh-list
110284488|NCT00231348|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110284489|NCT00231348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110284490|NCT00231348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110284491|NCT00231348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110284492|NCT00231348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110284493|NCT00231348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284494|NCT00231348|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110284495|NCT00231348|Antidepressive Agents|antidepressive agents|mesh-ancestor
110284496|NCT00231348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110284497|NCT00231348|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110305440|NCT01604629|Dermatologic Agents|dermatologic agents|mesh-ancestor
110305441|NCT01604629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110305442|NCT01604629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110305443|NCT01604629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110305444|NCT01604629|Analgesics|analgesics|mesh-ancestor
110305445|NCT01604629|Sensory System Agents|sensory system agents|mesh-ancestor
110305446|NCT01604629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110305447|NCT01604629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110305448|NCT01604629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110305449|NCT01604629|Immunologic Factors|immunologic factors|mesh-ancestor
110305450|NCT00258284|Docetaxel|docetaxel|mesh-list
110305451|NCT00258284|Capecitabine|capecitabine|mesh-list
110305452|NCT00258284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110305453|NCT00258284|Tubulin Modulators|tubulin modulators|mesh-ancestor
110305454|NCT00258284|Antimitotic Agents|antimitotic agents|mesh-ancestor
110305455|NCT00258284|Mitosis Modulators|mitosis modulators|mesh-ancestor
110305456|NCT00258284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110305457|NCT00258284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110305458|NCT00258284|Antimetabolites|antimetabolites|mesh-ancestor
110305459|NCT00290940|Metformin|metformin|mesh-list
110305460|NCT00290940|Pioglitazone|pioglitazone|mesh-list
110305461|NCT00290940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110305462|NCT00290940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110305463|NCT00258323|Fluorouracil|fluorouracil|mesh-list
110305464|NCT00258323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110305465|NCT00258323|Antimetabolites|antimetabolites|mesh-ancestor
110305466|NCT00258323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110305467|NCT00258323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110305468|NCT00258323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110305469|NCT00258323|Immunologic Factors|immunologic factors|mesh-ancestor
110305470|NCT00258323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110305471|NCT01604863|Paclitaxel|paclitaxel|mesh-list
110305472|NCT01604863|Etoposide|etoposide|mesh-list
110305473|NCT01604863|Docetaxel|docetaxel|mesh-list
110305474|NCT01604863|Carboplatin|carboplatin|mesh-list
110305475|NCT01604863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110305476|NCT01604863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110305477|NCT01604863|Tubulin Modulators|tubulin modulators|mesh-ancestor
110305478|NCT01604863|Antimitotic Agents|antimitotic agents|mesh-ancestor
110305479|NCT01604863|Mitosis Modulators|mitosis modulators|mesh-ancestor
110305480|NCT01604863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110305481|NCT01604863|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110305482|NCT01604863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110305483|NCT01604863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110305484|NCT00290979|Insulin glulisine|insulin glulisine|mesh-list
110284499|NCT00231348|Serotonin Agents|serotonin agents|mesh-ancestor
110284500|NCT00231387|Rosiglitazone|rosiglitazone|mesh-list
110022071|NCT05497674|Leprostatic Agents|leprostatic agents|mesh-ancestor
110022072|NCT05497674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110022073|NCT05497674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110022074|NCT05497674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110022081|NCT05497674|Uricosuric Agents|uricosuric agents|mesh-ancestor
110284502|NCT00231387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284503|NCT00198536|Ecabet|ecabet|mesh-list
110284504|NCT00198536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110284505|NCT00198536|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110284506|NCT00198536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110284507|NCT00198536|Protease Inhibitors|protease inhibitors|mesh-ancestor
110284508|NCT00198536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110284509|NCT00198536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110284510|NCT00198536|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110284511|NCT00198536|Protective Agents|protective agents|mesh-ancestor
110284512|NCT00198536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284513|NCT00198536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110284514|NCT00409994|Sirolimus|sirolimus|mesh-list
110284515|NCT00409994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110284516|NCT00409994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110284517|NCT00409994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110284518|NCT00409994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110284519|NCT00409994|Antifungal Agents|antifungal agents|mesh-ancestor
110284520|NCT00409994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110284521|NCT00409994|Immunologic Factors|immunologic factors|mesh-ancestor
110284522|NCT00409994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284523|NCT00410033|Insulin|insulin|mesh-list
110284524|NCT00410033|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110284525|NCT00410033|Insulin Aspart|insulin aspart|mesh-list
110284526|NCT00410033|Isophane Insulin, Human|isophane insulin, human|mesh-list
110284527|NCT00410033|Insulin, Isophane|insulin, isophane|mesh-list
110284528|NCT00410033|Isophane insulin, beef|isophane insulin, beef|mesh-list
110284529|NCT00410033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110284530|NCT00410033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284531|NCT00228462|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110284532|NCT00228462|Antidepressive Agents|antidepressive agents|mesh-ancestor
110305485|NCT00290979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110305486|NCT00290979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110305487|NCT00258479|Modafinil|modafinil|mesh-list
110305491|NCT00258479|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110305492|NCT00258479|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110305493|NCT00258479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110284533|NCT00228462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110284534|NCT00228462|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110284535|NCT00228462|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110284536|NCT00228462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110284537|NCT00228462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284538|NCT00198614|Metoprolol|metoprolol|mesh-list
110284539|NCT00198614|Carvedilol|carvedilol|mesh-list
110284540|NCT00198614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110284541|NCT00198614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110284542|NCT00198614|Sympatholytics|sympatholytics|mesh-ancestor
110284543|NCT00198614|Autonomic Agents|autonomic agents|mesh-ancestor
110284544|NCT00198614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110284546|NCT00198614|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110284547|NCT00198614|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110284548|NCT00198614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110284549|NCT00198614|Adrenergic Agents|adrenergic agents|mesh-ancestor
110284550|NCT00198614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110284551|NCT00198614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110284552|NCT00198614|Antioxidants|antioxidants|mesh-ancestor
110284553|NCT00198614|Protective Agents|protective agents|mesh-ancestor
110284554|NCT00198614|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110284555|NCT00198614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110284556|NCT00198614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110284557|NCT00198614|Vasodilator Agents|vasodilator agents|mesh-ancestor
110284558|NCT00198614|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110284559|NCT00198614|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110284561|NCT00231582|Etoposide|etoposide|mesh-list
110284562|NCT00231582|Carboplatin|carboplatin|mesh-list
110284563|NCT00231582|Epirubicin|epirubicin|mesh-list
110284564|NCT00231582|Ifosfamide|ifosfamide|mesh-list
110284565|NCT00231582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110284566|NCT00231582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110284567|NCT00231582|Tubulin Modulators|tubulin modulators|mesh-ancestor
110305495|NCT00271518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110305496|NCT00271518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110305497|NCT01340014|Timolol|timolol|mesh-list
110305498|NCT01340014|Dorzolamide|dorzolamide|mesh-list
110305499|NCT01340014|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110284568|NCT00231582|Antimitotic Agents|antimitotic agents|mesh-ancestor
110284569|NCT00231582|Mitosis Modulators|mitosis modulators|mesh-ancestor
110284570|NCT00231582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110284571|NCT00231582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110284572|NCT00231582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110284573|NCT00231582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110284574|NCT00231582|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110284575|NCT00231582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110284576|NCT00231582|Alkylating Agents|alkylating agents|mesh-ancestor
110284577|NCT02963324|Ivermectin|ivermectin|mesh-list
110284578|NCT02963324|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110284579|NCT02963324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110284580|NCT00228540|Modafinil|modafinil|mesh-list
110284581|NCT00228540|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110284582|NCT00228540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284583|NCT00228540|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110284584|NCT00228540|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110305500|NCT01340014|Brinzolamide|brinzolamide|mesh-list
110305501|NCT01340014|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110305502|NCT01340014|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110305503|NCT01340014|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110305504|NCT01340014|Adrenergic Agents|adrenergic agents|mesh-ancestor
110305505|NCT01340014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110305506|NCT01340014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110305507|NCT01340014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110305508|NCT01340014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110022142|NCT04740294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110305509|NCT01340014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110305510|NCT01340014|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110305511|NCT01340014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110305512|NCT00258557|Darunavir|darunavir|mesh-list
110305513|NCT00258557|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110305514|NCT00258557|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110305515|NCT00258557|Protease Inhibitors|protease inhibitors|mesh-ancestor
110305516|NCT00258557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110305517|NCT00258557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110305518|NCT00258557|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110305519|NCT00258557|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110305520|NCT00258557|Antiviral Agents|antiviral agents|mesh-ancestor
110305521|NCT00258557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110305522|NCT00271557|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
110305523|NCT00271557|Natriuretic Agents|natriuretic agents|mesh-ancestor
110305524|NCT00271557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110305525|NCT00271635|Ascorbic Acid|ascorbic acid|mesh-list
110305526|NCT00271635|Vitamins|vitamins|mesh-ancestor
110305528|NCT00271635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110305529|NCT00271635|Antioxidants|antioxidants|mesh-ancestor
110305530|NCT00271635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110305531|NCT00271635|Protective Agents|protective agents|mesh-ancestor
110305532|NCT00258596|Sirolimus|sirolimus|mesh-list
110305533|NCT00258596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110305534|NCT00258596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110305535|NCT00258596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110305536|NCT00258596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110305537|NCT00258596|Antifungal Agents|antifungal agents|mesh-ancestor
110305538|NCT00258596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110305539|NCT00258596|Immunologic Factors|immunologic factors|mesh-ancestor
110305540|NCT00258596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284585|NCT00228540|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110284586|NCT00228540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110284587|NCT00231621|Topiramate|topiramate|mesh-list
110284588|NCT00231621|Anticonvulsants|anticonvulsants|mesh-ancestor
110284589|NCT00231621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110284590|NCT00231621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284591|NCT00474526|Vaccines|vaccines|mesh-list
110284592|NCT00474526|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110284593|NCT00474526|Immunologic Factors|immunologic factors|mesh-ancestor
110284594|NCT00474526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284595|NCT00231660|Topiramate|topiramate|mesh-list
110284596|NCT00231660|Anticonvulsants|anticonvulsants|mesh-ancestor
110284597|NCT00231660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110284598|NCT00231660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284599|NCT00231738|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
110284600|NCT00231738|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110284601|NCT00231738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110284602|NCT00198848|Folic Acid|folic acid|mesh-list
110284603|NCT00198848|Hematinics|hematinics|mesh-ancestor
110305541|NCT01339273|Anesthetics|anesthetics|mesh-list
110305542|NCT01339273|Anesthetics, Local|anesthetics, local|mesh-list
110305543|NCT01339273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110305544|NCT01339273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110305545|NCT01339273|Sensory System Agents|sensory system agents|mesh-ancestor
110305546|NCT01339273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110305547|NCT04709315|Choline|choline|mesh-list
110305548|NCT04709315|Rocuronium|rocuronium|mesh-list
110305549|NCT04709315|Succinylcholine|succinylcholine|mesh-list
110305550|NCT04709315|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110305551|NCT04709315|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110305553|NCT04709315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110305554|NCT04709315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110305555|NCT04709315|Lipotropic Agents|lipotropic agents|mesh-ancestor
110305556|NCT04709315|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110305557|NCT04709315|Antimetabolites|antimetabolites|mesh-ancestor
110305565|NCT01334710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110305566|NCT01334710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110305567|NCT01334710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110305568|NCT00271713|Calcium, Dietary|calcium, dietary|mesh-list
110305569|NCT00271713|Vitamin D|vitamin d|mesh-list
110305570|NCT00271713|Ergocalciferols|ergocalciferols|mesh-list
110305571|NCT00271713|Cholecalciferol|cholecalciferol|mesh-list
110305572|NCT00271713|Ibandronic Acid|ibandronic acid|mesh-list
110305573|NCT00271713|Vitamins|vitamins|mesh-list
110305574|NCT00271713|Calcium|calcium|mesh-list
110305575|NCT00271713|Micronutrients|micronutrients|mesh-ancestor
110305576|NCT00271713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110305577|NCT00271713|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110305578|NCT00271713|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110305579|NCT01334554|Sildenafil Citrate|sildenafil citrate|mesh-list
110305580|NCT01334554|Vasodilator Agents|vasodilator agents|mesh-ancestor
110305581|NCT01334554|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110305582|NCT01334554|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110305583|NCT01334554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110305584|NCT01334554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110284604|NCT00198848|Vitamin B Complex|vitamin b complex|mesh-ancestor
110284605|NCT00198848|Vitamins|vitamins|mesh-ancestor
110284606|NCT00198848|Micronutrients|micronutrients|mesh-ancestor
110284607|NCT00198848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284608|NCT00478426|Sunitinib|sunitinib|mesh-list
110284609|NCT00478426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110284610|NCT00478426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110284611|NCT00478426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110284612|NCT00478426|Growth Substances|growth substances|mesh-ancestor
110284613|NCT00478426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284614|NCT00478426|Growth Inhibitors|growth inhibitors|mesh-ancestor
110284615|NCT00478426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110284616|NCT00478426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110284617|NCT00478426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110284619|NCT00231855|Topotecan|topotecan|mesh-list
110284620|NCT00231855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110284621|NCT00231855|Tubulin Modulators|tubulin modulators|mesh-ancestor
110284622|NCT00231855|Antimitotic Agents|antimitotic agents|mesh-ancestor
110284623|NCT00231855|Mitosis Modulators|mitosis modulators|mesh-ancestor
110284624|NCT00231855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110284625|NCT00231855|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110284626|NCT00231855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110284627|NCT00231855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110284628|NCT00199004|Cytarabine|cytarabine|mesh-list
110284629|NCT00199004|Dexamethasone|dexamethasone|mesh-list
110305585|NCT01334554|Urological Agents|urological agents|mesh-ancestor
110305586|NCT00291213|Levetiracetam|levetiracetam|mesh-list
110305587|NCT00291213|Anticonvulsants|anticonvulsants|mesh-ancestor
110305588|NCT00291213|Nootropic Agents|nootropic agents|mesh-ancestor
110305589|NCT01332799|Allopurinol|allopurinol|mesh-list
110305590|NCT01332799|Antimetabolites|antimetabolites|mesh-ancestor
110022174|NCT04519164|Diuretics|diuretics|mesh-ancestor
110305591|NCT01332799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110305592|NCT01332799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110305593|NCT01332799|Gout Suppressants|gout suppressants|mesh-ancestor
110305594|NCT01332799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110305595|NCT01332799|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110305597|NCT01332799|Protective Agents|protective agents|mesh-ancestor
110305598|NCT01332799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110305600|NCT00258791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110305601|NCT00258791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110305602|NCT00258791|Analgesics|analgesics|mesh-ancestor
110305603|NCT00258791|Sensory System Agents|sensory system agents|mesh-ancestor
110305604|NCT00258791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110305605|NCT00258791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110305606|NCT00258791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110305607|NCT00258791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110305608|NCT00258791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110305609|NCT00258791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110305610|NCT00258791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110284630|NCT00199004|Prednisolone|prednisolone|mesh-list
110284631|NCT00199004|Cyclophosphamide|cyclophosphamide|mesh-list
110284632|NCT00199004|Rituximab|rituximab|mesh-list
110284633|NCT00199004|Methotrexate|methotrexate|mesh-list
110284634|NCT00199004|Vincristine|vincristine|mesh-list
110284635|NCT00199004|Doxorubicin|doxorubicin|mesh-list
110284636|NCT00199004|Daunorubicin|daunorubicin|mesh-list
110284637|NCT00199004|Asparaginase|asparaginase|mesh-list
110284638|NCT00199004|Mercaptopurine|mercaptopurine|mesh-list
110284639|NCT00199004|Thioguanine|thioguanine|mesh-list
110284640|NCT00199004|Vindesine|vindesine|mesh-list
110284641|NCT00199004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110284642|NCT00199004|Immunologic Factors|immunologic factors|mesh-ancestor
110284643|NCT00199004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284644|NCT00199004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110284645|NCT00199004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110284646|NCT00199004|Alkylating Agents|alkylating agents|mesh-ancestor
110284647|NCT00199004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110284648|NCT00199004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110284649|NCT00199004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110305611|NCT00291369|Interferons|interferons|mesh-list
110305612|NCT00291369|Interferon-alpha|interferon-alpha|mesh-list
110305613|NCT00291369|Interleukin-2|interleukin-2|mesh-list
110305614|NCT00291369|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110305615|NCT00291369|Medroxyprogesterone|medroxyprogesterone|mesh-list
110305616|NCT00291369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110305617|NCT00291369|Antiviral Agents|antiviral agents|mesh-ancestor
110022190|NCT04331652|Anesthetics|anesthetics|mesh-list
110022191|NCT04331652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110022192|NCT04331652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110022201|NCT03915366|Valganciclovir|valganciclovir|mesh-list
110022202|NCT03915366|Antitubercular Agents|antitubercular agents|mesh-list
110022203|NCT03915366|Antiviral Agents|antiviral agents|mesh-ancestor
110022204|NCT03915366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110022205|NCT03915366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110022206|NCT03874338|Colchicine|colchicine|mesh-list
110305618|NCT00291369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110305619|NCT00291369|Immunologic Factors|immunologic factors|mesh-ancestor
110305620|NCT00291369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110305621|NCT00291369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110305622|NCT00291369|Analgesics|analgesics|mesh-ancestor
110305623|NCT00291369|Sensory System Agents|sensory system agents|mesh-ancestor
110305624|NCT00291369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110305625|NCT00291369|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110305626|NCT00291369|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110305631|NCT00291369|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110305632|NCT00291369|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110305633|NCT00291369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110305634|NCT00291408|Nitric Oxide|nitric oxide|mesh-list
110305635|NCT00291408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110305636|NCT00291408|Autonomic Agents|autonomic agents|mesh-ancestor
110305637|NCT00291408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110305638|NCT00291408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110305639|NCT00291408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110305640|NCT00291408|Respiratory System Agents|respiratory system agents|mesh-ancestor
110305641|NCT00291408|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110305642|NCT00291408|Antioxidants|antioxidants|mesh-ancestor
110305643|NCT00291408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110305644|NCT00291408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110305645|NCT00291408|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110305646|NCT00291408|Vasodilator Agents|vasodilator agents|mesh-ancestor
110305647|NCT00291408|Gasotransmitters|gasotransmitters|mesh-ancestor
110305648|NCT00291408|Protective Agents|protective agents|mesh-ancestor
110305649|NCT00271791|Prednisone|prednisone|mesh-list
110305650|NCT00271791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110305651|NCT00271791|Glucocorticoids|glucocorticoids|mesh-ancestor
110305652|NCT00271791|Hormones|hormones|mesh-ancestor
110305653|NCT00271791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110284650|NCT00199004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110284651|NCT00199004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110284653|NCT00199004|Autonomic Agents|autonomic agents|mesh-ancestor
110284654|NCT00199004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110284655|NCT00199004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110284656|NCT00199004|Glucocorticoids|glucocorticoids|mesh-ancestor
110284657|NCT00199004|Hormones|hormones|mesh-ancestor
110284658|NCT00199004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110284659|NCT00199004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110284660|NCT00199004|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110284661|NCT00199004|Abortifacient Agents|abortifacient agents|mesh-ancestor
110284662|NCT00199004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110284663|NCT00199004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110284664|NCT00199004|Antimetabolites|antimetabolites|mesh-ancestor
110284665|NCT00199004|Dermatologic Agents|dermatologic agents|mesh-ancestor
110284666|NCT00199004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110022220|NCT03846570|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110284667|NCT00199004|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110284668|NCT00199004|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110284671|NCT00199004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110305654|NCT00271791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110305655|NCT00271791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110305656|NCT00271791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110305657|NCT01332331|Ambrisentan|ambrisentan|mesh-list
110305658|NCT01332331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110305659|NCT00259064|Gefitinib|gefitinib|mesh-list
110305660|NCT00259064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110305661|NCT00259064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110305662|NCT00259064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110305663|NCT00259064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110305664|NCT01332292|Fluticasone|fluticasone|mesh-list
110305665|NCT01332292|Xhance|xhance|mesh-list
110305666|NCT01332292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110305667|NCT01332292|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110305668|NCT01332292|Autonomic Agents|autonomic agents|mesh-ancestor
110305669|NCT01332292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110305670|NCT01332292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110305671|NCT01332292|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110305672|NCT01332292|Respiratory System Agents|respiratory system agents|mesh-ancestor
110305673|NCT01332292|Dermatologic Agents|dermatologic agents|mesh-ancestor
110305674|NCT01332292|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110305675|NCT00259142|Chloroquine|chloroquine|mesh-list
110305676|NCT00259142|Pyrimethamine|pyrimethamine|mesh-list
110305677|NCT00259142|Sulfadoxine|sulfadoxine|mesh-list
110305678|NCT00259142|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110305679|NCT00259142|Amebicides|amebicides|mesh-ancestor
110305680|NCT00259142|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110305681|NCT00259142|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110305682|NCT00259142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110305683|NCT00259142|Antimalarials|antimalarials|mesh-ancestor
110305684|NCT00259142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110284672|NCT00199004|Tubulin Modulators|tubulin modulators|mesh-ancestor
110284673|NCT00199004|Antimitotic Agents|antimitotic agents|mesh-ancestor
110284674|NCT00199004|Mitosis Modulators|mitosis modulators|mesh-ancestor
110284675|NCT00199004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110284676|NCT00199004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110284677|NCT00199004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110284678|NCT00228852|Fludarabine|fludarabine|mesh-list
110284680|NCT00228852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110284681|NCT00228852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110305685|NCT00259142|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110305686|NCT00259142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110305687|NCT00259142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110305688|NCT00259142|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110305689|NCT00259181|Chlorhexidine|chlorhexidine|mesh-list
110305690|NCT00259181|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110305691|NCT00259181|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
110305692|NCT00259181|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110305693|NCT00259181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110305694|NCT00259181|Disinfectants|disinfectants|mesh-ancestor
110305695|NCT00259181|Dermatologic Agents|dermatologic agents|mesh-ancestor
110305696|NCT00259181|Vasodilator Agents|vasodilator agents|mesh-ancestor
110305697|NCT00259181|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110022246|NCT03745170|Capecitabine|capecitabine|mesh-list
110305698|NCT00259181|Protective Agents|protective agents|mesh-ancestor
110305713|NCT00259220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110305714|NCT00259220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110305715|NCT00259220|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110305716|NCT00259220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110305717|NCT00259220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110305718|NCT00291759|Tamoxifen|tamoxifen|mesh-list
110305719|NCT00291759|Anastrozole|anastrozole|mesh-list
110305720|NCT00291759|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110305721|NCT00291759|Hormone Antagonists|hormone antagonists|mesh-ancestor
110305722|NCT00291759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110305723|NCT00291759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110305724|NCT00291759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110305725|NCT00291759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110305726|NCT00291759|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110305727|NCT00291759|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110305728|NCT00291759|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110305729|NCT00291759|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110305730|NCT00291759|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110305731|NCT00291759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110305732|NCT00291759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110305733|NCT00272025|Escitalopram|escitalopram|mesh-list
110305734|NCT00272025|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110305735|NCT00272025|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110305736|NCT00272025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110305737|NCT00272025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110305738|NCT00272025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110305739|NCT00272025|Serotonin Agents|serotonin agents|mesh-ancestor
110305740|NCT00272025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110305741|NCT04709081|Itraconazole|itraconazole|mesh-list
110305742|NCT04709081|Digoxin|digoxin|mesh-list
110305743|NCT04709081|Midazolam|midazolam|mesh-list
110305744|NCT04709081|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110305745|NCT04709081|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110305746|NCT04709081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110305747|NCT04709081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110305748|NCT04709081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110305749|NCT04709081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110305750|NCT04709081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110284682|NCT00228852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110284683|NCT00228852|Immunologic Factors|immunologic factors|mesh-ancestor
110284684|NCT00228852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284685|NCT00228852|Alkylating Agents|alkylating agents|mesh-ancestor
110284686|NCT00228852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110284687|NCT00228852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110284688|NCT00204776|Capecitabine|capecitabine|mesh-list
110284689|NCT00204776|Oxaliplatin|oxaliplatin|mesh-list
110284690|NCT00204776|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110284692|NCT00204776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110284693|NCT00204776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110284694|NCT00228891|Insulin|insulin|mesh-list
110284695|NCT00228891|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110305751|NCT04709081|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110305752|NCT04709081|Anesthetics, General|anesthetics, general|mesh-ancestor
110305753|NCT04709081|Anesthetics|anesthetics|mesh-ancestor
110305754|NCT04709081|GABA Modulators|gaba modulators|mesh-ancestor
110305755|NCT04709081|GABA Agents|gaba agents|mesh-ancestor
110305756|NCT04709081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110305761|NCT04709081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110305763|NCT04709081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110305764|NCT04709081|Hormone Antagonists|hormone antagonists|mesh-ancestor
110305765|NCT04709081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110305766|NCT04709081|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110305767|NCT04709081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110305768|NCT04709081|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110305769|NCT04709081|Protective Agents|protective agents|mesh-ancestor
110305770|NCT00272064|Insulin|insulin|mesh-list
110305771|NCT00272064|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110305772|NCT00272064|Metformin|metformin|mesh-list
110305773|NCT00272064|Insulin Glargine|insulin glargine|mesh-list
110305774|NCT00272064|Insulin glulisine|insulin glulisine|mesh-list
110305775|NCT00272064|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110305776|NCT00272064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110305777|NCT00259376|Dronedarone|dronedarone|mesh-list
110305778|NCT00259376|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110305779|NCT01332019|Interferons|interferons|mesh-list
110305780|NCT01332019|Interferon-beta|interferon-beta|mesh-list
110305781|NCT01332019|Interferon beta-1a|interferon beta-1a|mesh-list
110305782|NCT01332019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110305783|NCT01332019|Antiviral Agents|antiviral agents|mesh-ancestor
110305784|NCT01332019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110305785|NCT01332019|Immunologic Factors|immunologic factors|mesh-ancestor
110305786|NCT01332019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110305787|NCT01332019|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110305788|NCT00415376|Levetiracetam|levetiracetam|mesh-list
110305789|NCT00415376|Anticonvulsants|anticonvulsants|mesh-ancestor
110305790|NCT00415376|Nootropic Agents|nootropic agents|mesh-ancestor
110305791|NCT00291915|Adalimumab|adalimumab|mesh-list
110305792|NCT00291915|Methotrexate|methotrexate|mesh-list
110305793|NCT00291915|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110305794|NCT00291915|Abortifacient Agents|abortifacient agents|mesh-ancestor
110305795|NCT00291915|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110305796|NCT00291915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110305797|NCT00291915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110305798|NCT00291915|Antimetabolites|antimetabolites|mesh-ancestor
110305799|NCT00291915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110305800|NCT00291915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110305801|NCT00291915|Dermatologic Agents|dermatologic agents|mesh-ancestor
110305802|NCT00291915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110305803|NCT00291915|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110284696|NCT00228891|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110284697|NCT00228891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284698|NCT00477412|Cytarabine|cytarabine|mesh-list
110022287|NCT02972034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110284699|NCT00477412|Dexamethasone|dexamethasone|mesh-list
110284700|NCT00477412|Dexamethasone acetate|dexamethasone acetate|mesh-list
110284701|NCT00477412|Cyclophosphamide|cyclophosphamide|mesh-list
110284702|NCT00477412|Rituximab|rituximab|mesh-list
110284703|NCT00477412|Doxorubicin|doxorubicin|mesh-list
110284704|NCT00477412|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110284705|NCT00477412|Methotrexate|methotrexate|mesh-list
110284706|NCT00477412|Vincristine|vincristine|mesh-list
110284707|NCT00477412|Bortezomib|bortezomib|mesh-list
110284708|NCT00477412|Daunorubicin|daunorubicin|mesh-list
110284709|NCT00477412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110305804|NCT00291915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110305805|NCT00291915|Immunologic Factors|immunologic factors|mesh-ancestor
110305806|NCT00291915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110305807|NCT00291915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110305808|NCT00291915|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110305809|NCT00291915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110305810|NCT00259766|Budesonide|budesonide|mesh-list
110305811|NCT00259766|Terbutaline|terbutaline|mesh-list
110305812|NCT00259766|Formoterol Fumarate|formoterol fumarate|mesh-list
110305813|NCT00259766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110305814|NCT00259766|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110305815|NCT00259766|Autonomic Agents|autonomic agents|mesh-ancestor
110305816|NCT00259766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110305817|NCT00259766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110305818|NCT00259766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110305819|NCT00259766|Respiratory System Agents|respiratory system agents|mesh-ancestor
110305820|NCT00259766|Glucocorticoids|glucocorticoids|mesh-ancestor
110305821|NCT00259766|Hormones|hormones|mesh-ancestor
110305822|NCT00259766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110305823|NCT00259766|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110305824|NCT00259766|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110305825|NCT00259766|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110305826|NCT00259766|Adrenergic Agents|adrenergic agents|mesh-ancestor
110305831|NCT00259766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110305832|NCT00292071|Caspofungin|caspofungin|mesh-list
110305833|NCT00292071|Antifungal Agents|antifungal agents|mesh-ancestor
110305834|NCT00292071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110305835|NCT00292071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110305836|NCT00292071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110305838|NCT00292110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110305839|NCT00292110|Narcotics|narcotics|mesh-ancestor
110305840|NCT00292110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110305841|NCT00292110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110305842|NCT00292110|Analgesics|analgesics|mesh-ancestor
110305843|NCT00292110|Sensory System Agents|sensory system agents|mesh-ancestor
110305844|NCT00292110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110305845|NCT00292110|Antitussive Agents|antitussive agents|mesh-ancestor
110305846|NCT00292110|Respiratory System Agents|respiratory system agents|mesh-ancestor
110305848|NCT00259805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110305849|NCT00259805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110305850|NCT00259805|Immunologic Factors|immunologic factors|mesh-ancestor
110305851|NCT00259805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110305852|NCT00259805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110305853|NCT00259883|Paroxetine|paroxetine|mesh-list
110305854|NCT00259883|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110305855|NCT00259883|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110305856|NCT00259883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110305857|NCT00259883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110305859|NCT00259883|Serotonin Agents|serotonin agents|mesh-ancestor
110284710|NCT00477412|Antibodies|antibodies|mesh-list
110284711|NCT00477412|Immunoglobulins|immunoglobulins|mesh-list
110284712|NCT00477412|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110284713|NCT00477412|BB 1101|bb 1101|mesh-list
110284714|NCT00477412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110284715|NCT00477412|Immunologic Factors|immunologic factors|mesh-ancestor
110284716|NCT00477412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284717|NCT00477412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110284718|NCT00477412|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110284719|NCT00477412|Alkylating Agents|alkylating agents|mesh-ancestor
110284720|NCT00477412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110284721|NCT00477412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110284722|NCT00477412|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110284723|NCT00477412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110284724|NCT00477412|Antiemetics|antiemetics|mesh-ancestor
110284725|NCT00477412|Autonomic Agents|autonomic agents|mesh-ancestor
110284726|NCT00477412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110284727|NCT00477412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110284728|NCT00477412|Glucocorticoids|glucocorticoids|mesh-ancestor
110305860|NCT00259883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110305861|NCT00259883|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110305862|NCT00259883|Antidepressive Agents|antidepressive agents|mesh-ancestor
110305863|NCT00259883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110305864|NCT00259883|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110305865|NCT00259883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110305866|NCT00259883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110305867|NCT04718376|Mitoxantrone|mitoxantrone|mesh-list
110305868|NCT04718376|Analgesics|analgesics|mesh-ancestor
110305869|NCT04718376|Sensory System Agents|sensory system agents|mesh-ancestor
110305870|NCT04718376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110305871|NCT04718376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110305872|NCT04718376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110305873|NCT04718376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110305874|NCT04718376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110305875|NCT04718376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110305876|NCT04718376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110305878|NCT00272415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110305879|NCT00272415|Alkylating Agents|alkylating agents|mesh-ancestor
110305880|NCT00272415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110305881|NCT00272415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110305882|NCT00259922|Alvimopan|alvimopan|mesh-list
110305883|NCT00259922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110305884|NCT00272454|Aspirin|aspirin|mesh-list
110305885|NCT00272454|Cilostazol|cilostazol|mesh-list
110305886|NCT00272454|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110305887|NCT00272454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110305888|NCT00272454|Analgesics|analgesics|mesh-ancestor
110305889|NCT00272454|Sensory System Agents|sensory system agents|mesh-ancestor
110305890|NCT00272454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110305891|NCT00272454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110305892|NCT00272454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110305893|NCT00272454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110305894|NCT00272454|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110305895|NCT00272454|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110305896|NCT00272454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110284729|NCT00477412|Hormones|hormones|mesh-ancestor
110284730|NCT00477412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110284731|NCT00477412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110284732|NCT00477412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110284733|NCT00477412|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110284734|NCT00477412|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110284736|NCT00477412|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110284737|NCT00477412|Abortifacient Agents|abortifacient agents|mesh-ancestor
110284738|NCT00477412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110284739|NCT00477412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110284740|NCT00477412|Antimetabolites|antimetabolites|mesh-ancestor
110284741|NCT00477412|Dermatologic Agents|dermatologic agents|mesh-ancestor
110305900|NCT00272454|Antipyretics|antipyretics|mesh-ancestor
110305901|NCT00272454|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110305902|NCT00272454|Autonomic Agents|autonomic agents|mesh-ancestor
110305903|NCT00272454|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110305904|NCT00272454|Respiratory System Agents|respiratory system agents|mesh-ancestor
110305905|NCT00272454|Vasodilator Agents|vasodilator agents|mesh-ancestor
110305906|NCT00272454|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110305907|NCT00272454|Protective Agents|protective agents|mesh-ancestor
110305908|NCT00272454|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110305909|NCT00272454|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110305910|NCT00272493|Vaccines|vaccines|mesh-list
110305911|NCT00272493|Immunologic Factors|immunologic factors|mesh-ancestor
110305912|NCT00272493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110305913|NCT00292266|Interferon beta-1a|interferon beta-1a|mesh-list
110305914|NCT00292266|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110305915|NCT00292266|Immunologic Factors|immunologic factors|mesh-ancestor
110305916|NCT00292266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110305917|NCT00292266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110305918|NCT00292266|Antiviral Agents|antiviral agents|mesh-ancestor
110305919|NCT00292266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110305920|NCT00260039|Vaccines|vaccines|mesh-list
110305921|NCT00260039|Immunologic Factors|immunologic factors|mesh-ancestor
110305922|NCT00260039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110305923|NCT00292344|Rifaximin|rifaximin|mesh-list
110305924|NCT00292344|Loperamide|loperamide|mesh-list
110305925|NCT00292344|Antidiarrheals|antidiarrheals|mesh-list
110305926|NCT00292344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110305927|NCT00292344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110305928|NCT00292344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110305929|NCT00417768|Plasminogen|plasminogen|mesh-list
110305930|NCT00417768|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110305931|NCT00417768|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110305932|NCT00417768|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110305933|NCT00417768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110305935|NCT00272610|Vitamins|vitamins|mesh-ancestor
110305936|NCT00272610|Micronutrients|micronutrients|mesh-ancestor
110305937|NCT00272610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110305939|NCT00260351|Immunologic Factors|immunologic factors|mesh-ancestor
110305940|NCT00260351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110305941|NCT00272688|Levodopa|levodopa|mesh-list
110305942|NCT00272688|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110305943|NCT00272688|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110305944|NCT00272688|Dopamine Agents|dopamine agents|mesh-ancestor
110305945|NCT00272688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110305946|NCT00272688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110305947|NCT00272688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110305948|NCT00260390|Methyltestosterone|methyltestosterone|mesh-list
110305949|NCT00260390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110305950|NCT00260390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110284742|NCT00477412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110284743|NCT00477412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110284745|NCT00477412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110284746|NCT00477412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110284747|NCT00477412|Tubulin Modulators|tubulin modulators|mesh-ancestor
110284748|NCT00477412|Antimitotic Agents|antimitotic agents|mesh-ancestor
110284749|NCT00477412|Mitosis Modulators|mitosis modulators|mesh-ancestor
110284750|NCT00477412|Protease Inhibitors|protease inhibitors|mesh-ancestor
110284752|NCT00410774|Gemcitabine|gemcitabine|mesh-list
110284753|NCT00410774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110284754|NCT00410774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110284755|NCT00410774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110284756|NCT00410774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110284757|NCT00410774|Growth Substances|growth substances|mesh-ancestor
110284758|NCT00410774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284759|NCT00410774|Growth Inhibitors|growth inhibitors|mesh-ancestor
110284760|NCT00410774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110284762|NCT00410774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110284763|NCT00228930|Tamoxifen|tamoxifen|mesh-list
110284764|NCT00228930|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110284765|NCT00228930|Hormone Antagonists|hormone antagonists|mesh-ancestor
110284766|NCT00228930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110284767|NCT00228930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284768|NCT00228930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110284769|NCT00228930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110284770|NCT00228930|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110284771|NCT00228930|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110284772|NCT00228930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110284773|NCT00410852|Insulin|insulin|mesh-list
110284774|NCT00410852|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110305951|NCT00260390|Anabolic Agents|anabolic agents|mesh-ancestor
110305952|NCT00260390|Hormones|hormones|mesh-ancestor
110305953|NCT00260390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110305954|NCT00260390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110305955|NCT00260624|Escitalopram|escitalopram|mesh-list
110305956|NCT00260624|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110305957|NCT00260624|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110305958|NCT00260624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110284775|NCT00410852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110284776|NCT00410852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284777|NCT01086982|Octreotide|octreotide|mesh-list
110284778|NCT01086982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110284779|NCT01086982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110284780|NCT01086982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110022371|NCT00577200|GABA Agents|gaba agents|mesh-ancestor
110284781|NCT00410930|Immunomodulating Agents|immunomodulating agents|mesh-list
110284782|NCT00410930|Immunologic Factors|immunologic factors|mesh-ancestor
110284783|NCT00410930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284785|NCT00204893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110305959|NCT00260624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110305960|NCT00260624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110305961|NCT00260624|Serotonin Agents|serotonin agents|mesh-ancestor
110305962|NCT00260624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110305963|NCT00292695|Ifosfamide|ifosfamide|mesh-list
110305964|NCT00292695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110305965|NCT00292695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110305966|NCT00292695|Alkylating Agents|alkylating agents|mesh-ancestor
110305967|NCT00292695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110305968|NCT00292734|Zolpidem|zolpidem|mesh-list
110305969|NCT00292734|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110305970|NCT00292734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110305972|NCT00292734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110305974|NCT00292734|GABA Agonists|gaba agonists|mesh-ancestor
110305975|NCT00292734|GABA Agents|gaba agents|mesh-ancestor
110305976|NCT00292734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110305977|NCT00292734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110305978|NCT00260702|Omalizumab|omalizumab|mesh-list
110305979|NCT00260702|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110305980|NCT00260702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110305981|NCT00260702|Respiratory System Agents|respiratory system agents|mesh-ancestor
110305982|NCT00260819|Bosentan|bosentan|mesh-list
110305983|NCT00260819|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110305984|NCT00260819|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110305985|NCT00260819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110305986|NCT00298350|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-list
110305987|NCT00298350|Integrase Inhibitors|integrase inhibitors|mesh-list
110305988|NCT00298350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110305989|NCT00298350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110305990|NCT00298350|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110305991|NCT00298350|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110305992|NCT00298350|Antiviral Agents|antiviral agents|mesh-ancestor
110305993|NCT00298350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110305994|NCT00292890|Insulin|insulin|mesh-list
110305995|NCT00292890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110305996|NCT00292890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110305997|NCT00292929|Artesunate|artesunate|mesh-list
110305998|NCT00292929|Antimalarials|antimalarials|mesh-ancestor
110305999|NCT00292929|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110306000|NCT00292929|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110306001|NCT00292929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110022405|NCT00002802|Cobalt|cobalt|mesh-list
110306002|NCT00292929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110306003|NCT00292929|Antiviral Agents|antiviral agents|mesh-ancestor
110306004|NCT00292929|Schistosomicides|schistosomicides|mesh-ancestor
110306005|NCT00292929|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110306006|NCT00292929|Anthelmintics|anthelmintics|mesh-ancestor
110306007|NCT00424853|Cisplatin|cisplatin|mesh-list
110306008|NCT00424853|Gemcitabine|gemcitabine|mesh-list
110306009|NCT00424853|Docetaxel|docetaxel|mesh-list
110306010|NCT00424853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110306011|NCT00424853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110306012|NCT00424853|Antimetabolites|antimetabolites|mesh-ancestor
110306013|NCT00424853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110284786|NCT00204893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284788|NCT00232011|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110284789|NCT00232011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110284790|NCT00232011|Analgesics|analgesics|mesh-ancestor
110284791|NCT00232011|Sensory System Agents|sensory system agents|mesh-ancestor
110284792|NCT00232011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110284793|NCT00232011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284794|NCT00232011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110284795|NCT00232011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110284796|NCT00232011|Dermatologic Agents|dermatologic agents|mesh-ancestor
110284797|NCT00232011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110284798|NCT00232011|Immunologic Factors|immunologic factors|mesh-ancestor
110306014|NCT00424853|Tubulin Modulators|tubulin modulators|mesh-ancestor
110306015|NCT00424853|Antimitotic Agents|antimitotic agents|mesh-ancestor
110306016|NCT00424853|Mitosis Modulators|mitosis modulators|mesh-ancestor
110306017|NCT00298506|Mycophenolic Acid|mycophenolic acid|mesh-list
110306018|NCT00298506|Tacrolimus|tacrolimus|mesh-list
110306019|NCT00298506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110306020|NCT00298506|Immunologic Factors|immunologic factors|mesh-ancestor
110306021|NCT00298506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306022|NCT00298506|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110306023|NCT00298506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110306024|NCT00298506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110306025|NCT00298506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110306026|NCT00298506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110306027|NCT00298506|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110306028|NCT00298506|Antitubercular Agents|antitubercular agents|mesh-ancestor
110306029|NCT00298506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110306030|NCT00298506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110306031|NCT00424892|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
110306032|NCT00424892|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110306033|NCT00424892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110306034|NCT00424892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110306035|NCT00424892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110306036|NCT00424892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110306037|NCT00424892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306038|NCT00424892|Antidepressive Agents|antidepressive agents|mesh-ancestor
110306039|NCT00424892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110306040|NCT00424931|Modafinil|modafinil|mesh-list
110306041|NCT00424931|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110306042|NCT00424931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306043|NCT00424931|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110306047|NCT00298545|Calcitriol|calcitriol|mesh-list
110306048|NCT00298545|Calcium|calcium|mesh-list
110306049|NCT00298545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110306050|NCT00298545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306051|NCT00298545|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110306052|NCT00298545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110306053|NCT00298545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110306054|NCT00298545|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110306055|NCT00298545|Vitamins|vitamins|mesh-ancestor
110306056|NCT00298545|Micronutrients|micronutrients|mesh-ancestor
110306057|NCT00298545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110306058|NCT01331161|Vaccines|vaccines|mesh-list
110306059|NCT01331161|Immunologic Factors|immunologic factors|mesh-ancestor
110306060|NCT01331161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306061|NCT00424970|Acetazolamide|acetazolamide|mesh-list
110306062|NCT00424970|Anticonvulsants|anticonvulsants|mesh-ancestor
110306063|NCT00424970|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110306064|NCT00424970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110284799|NCT00232011|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110284800|NCT00232011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110284801|NCT00232011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110284802|NCT00232050|Omalizumab|omalizumab|mesh-list
110284803|NCT00232050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110284804|NCT00232050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110284805|NCT00232050|Respiratory System Agents|respiratory system agents|mesh-ancestor
110284806|NCT00232089|Tegaserod|tegaserod|mesh-list
110284807|NCT00232089|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110284808|NCT00232089|Serotonin Agents|serotonin agents|mesh-ancestor
110284809|NCT00232089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110284810|NCT00232089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110284811|NCT00232089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306065|NCT00424970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110306066|NCT00424970|Diuretics|diuretics|mesh-ancestor
110306067|NCT00424970|Natriuretic Agents|natriuretic agents|mesh-ancestor
110306068|NCT00424970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306069|NCT01331005|Nepafenac|nepafenac|mesh-list
110306070|NCT01331005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110306071|NCT01331005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110306072|NCT01331005|Analgesics|analgesics|mesh-ancestor
110306073|NCT01331005|Sensory System Agents|sensory system agents|mesh-ancestor
110306074|NCT01331005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110306075|NCT01331005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306076|NCT01331005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110306077|NCT01331005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110306078|NCT01330459|Acetaminophen|acetaminophen|mesh-list
110306079|NCT01330459|Ibuprofen|ibuprofen|mesh-list
110306080|NCT01330459|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
110306081|NCT01330459|Lidocaine|lidocaine|mesh-list
110306082|NCT01330459|Hydrocodone|hydrocodone|mesh-list
110306083|NCT01330459|Lorazepam|lorazepam|mesh-list
110306084|NCT01330459|Anesthetics, Local|anesthetics, local|mesh-ancestor
110306086|NCT01330459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110306087|NCT01330459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306088|NCT01330459|Sensory System Agents|sensory system agents|mesh-ancestor
110306089|NCT01330459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110306090|NCT01330459|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110306091|NCT01330459|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110306092|NCT01330459|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110306093|NCT01330459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110306094|NCT01330459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110306095|NCT01330459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110306096|NCT01330459|Analgesics|analgesics|mesh-ancestor
110306097|NCT01330459|Antipyretics|antipyretics|mesh-ancestor
110306098|NCT01330459|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110306099|NCT01330459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110306100|NCT01330459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110306101|NCT01330459|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110306102|NCT01330459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110306103|NCT01330459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110306104|NCT01330459|Narcotics|narcotics|mesh-ancestor
110306105|NCT01330459|Antitussive Agents|antitussive agents|mesh-ancestor
110306106|NCT01330459|Respiratory System Agents|respiratory system agents|mesh-ancestor
110306107|NCT01330459|Anticonvulsants|anticonvulsants|mesh-ancestor
110306108|NCT01330459|Antiemetics|antiemetics|mesh-ancestor
110306109|NCT01330459|Autonomic Agents|autonomic agents|mesh-ancestor
110306110|NCT01330459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110306111|NCT01330459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110306112|NCT01330459|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110306113|NCT01330459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110284812|NCT00205166|Caffeine|caffeine|mesh-list
110284813|NCT00205166|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110284814|NCT00205166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284815|NCT00205166|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110284816|NCT00205166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110022490|NCT00002880|Etoposide|etoposide|mesh-list
110284817|NCT00205166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110284818|NCT00205166|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110284819|NCT00205166|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110284820|NCT00205166|Purinergic Agents|purinergic agents|mesh-ancestor
110284821|NCT00205166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110284822|NCT00229125|Gabapentin|gabapentin|mesh-list
110284823|NCT00229125|Lorazepam|lorazepam|mesh-list
110284824|NCT00229125|Analgesics|analgesics|mesh-ancestor
110284825|NCT00229125|Sensory System Agents|sensory system agents|mesh-ancestor
110284826|NCT00229125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110284827|NCT00229125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306114|NCT01330459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110306115|NCT01330459|GABA Modulators|gaba modulators|mesh-ancestor
110306125|NCT00261053|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110306126|NCT00261053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110306128|NCT00261053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306129|NCT00298662|Interferons|interferons|mesh-list
110306130|NCT00298662|Interferon-beta|interferon-beta|mesh-list
110306131|NCT00298662|Tacrolimus|tacrolimus|mesh-list
110306133|NCT00298662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110306134|NCT00298662|Antiviral Agents|antiviral agents|mesh-ancestor
110306135|NCT00298662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110306136|NCT00298662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110306137|NCT00298662|Immunologic Factors|immunologic factors|mesh-ancestor
110306138|NCT00298662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306139|NCT00298662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110306140|NCT00298662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110306141|NCT00298662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110306142|NCT00298662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110306143|NCT01330381|Prucalopride|prucalopride|mesh-list
110306144|NCT01330381|Laxatives|laxatives|mesh-ancestor
110306145|NCT01330381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110306146|NCT01330381|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
110306147|NCT01330381|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110306148|NCT01330381|Serotonin Agents|serotonin agents|mesh-ancestor
110306149|NCT01330381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110306150|NCT01330381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110306151|NCT01330381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306152|NCT00261092|Oxaliplatin|oxaliplatin|mesh-list
110306153|NCT00261092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110306154|NCT00293124|Imatinib Mesylate|imatinib mesylate|mesh-list
110306155|NCT00293124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110306156|NCT00293124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110306157|NCT00293124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110306158|NCT00293124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110306160|NCT01330108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110306161|NCT00261131|Botulinum Toxins|botulinum toxins|mesh-list
110306162|NCT00261131|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110306163|NCT00261131|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110306164|NCT00261131|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110306165|NCT00261131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110284829|NCT00229125|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110284830|NCT00229125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110284831|NCT00229125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110284832|NCT00229125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110022505|NCT00002898|Dactinomycin|dactinomycin|mesh-list
110284834|NCT00229125|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110284835|NCT00229125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110284836|NCT00229125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110284837|NCT00229125|Antimanic Agents|antimanic agents|mesh-ancestor
110284838|NCT00229125|Antiemetics|antiemetics|mesh-ancestor
110284839|NCT00229125|Autonomic Agents|autonomic agents|mesh-ancestor
110284840|NCT00229125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110284841|NCT00229125|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110284842|NCT00229125|GABA Modulators|gaba modulators|mesh-ancestor
110284843|NCT00229125|GABA Agents|gaba agents|mesh-ancestor
110284844|NCT00205283|Nelfinavir|nelfinavir|mesh-list
110284845|NCT00205283|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110284846|NCT00205283|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110284847|NCT00205283|Protease Inhibitors|protease inhibitors|mesh-ancestor
110284848|NCT00205283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110284849|NCT00205283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110284850|NCT00205283|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110284851|NCT00205283|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110284852|NCT00205283|Antiviral Agents|antiviral agents|mesh-ancestor
110284853|NCT00205283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110284854|NCT00232167|Indiplon|indiplon|mesh-list
110284855|NCT00232167|Sertraline|sertraline|mesh-list
110284856|NCT00232167|Antidepressive Agents|antidepressive agents|mesh-ancestor
110284857|NCT00232167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110284858|NCT00232167|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110284859|NCT00232167|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110306166|NCT00261131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110306167|NCT00261131|Cholinergic Agents|cholinergic agents|mesh-ancestor
110306168|NCT00261131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110306169|NCT00261131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306170|NCT00261131|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110306171|NCT00261131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110306172|NCT00261170|Bupropion|bupropion|mesh-list
110306173|NCT00261170|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110306174|NCT00261170|Antidepressive Agents|antidepressive agents|mesh-ancestor
110306175|NCT00261170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110284861|NCT00232167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110284862|NCT00232167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110284863|NCT00232167|Serotonin Agents|serotonin agents|mesh-ancestor
110284864|NCT00232167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284865|NCT00232167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110284866|NCT00232167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110284867|NCT00232167|GABA Modulators|gaba modulators|mesh-ancestor
110284868|NCT00232167|GABA Agents|gaba agents|mesh-ancestor
110284869|NCT00205322|Leucovorin|leucovorin|mesh-list
110284870|NCT00205322|Capecitabine|capecitabine|mesh-list
110284871|NCT00205322|Oxaliplatin|oxaliplatin|mesh-list
110306176|NCT00261170|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110306177|NCT00261170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110306178|NCT00261170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110306179|NCT00261170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110306201|NCT00293163|Viscosupplements|viscosupplements|mesh-ancestor
110306202|NCT00293163|Protective Agents|protective agents|mesh-ancestor
110306203|NCT00293163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306204|NCT00261365|Ipilimumab|ipilimumab|mesh-list
110306205|NCT00261365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110306206|NCT00261365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110306207|NCT00261365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110306208|NCT00261365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110306209|NCT00293280|Lomustine|lomustine|mesh-list
110306210|NCT00293280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110306211|NCT00293280|Alkylating Agents|alkylating agents|mesh-ancestor
110306212|NCT00293280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110306213|NCT00293280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110306214|NCT00298779|Bortezomib|bortezomib|mesh-list
110306215|NCT00298779|Omeprazole|omeprazole|mesh-list
110306216|NCT00298779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110306217|NCT00298779|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110306218|NCT00298779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110306219|NCT00298779|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110306220|NCT00298779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110306221|NCT00298779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110306222|NCT00261482|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110306223|NCT00261482|Norelgestromin|norelgestromin|mesh-list
110306224|NCT00261482|Estradiol|estradiol|mesh-list
110306225|NCT00261482|Estrogens|estrogens|mesh-ancestor
110306226|NCT00261482|Hormones|hormones|mesh-ancestor
110306227|NCT00261482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110306228|NCT00261482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306229|NCT00261482|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110306230|NCT00261482|Contraceptive Agents|contraceptive agents|mesh-ancestor
110306231|NCT00261482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110306232|NCT00261482|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110306239|NCT00298857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110306240|NCT00298857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110306241|NCT00298857|GABA Agents|gaba agents|mesh-ancestor
110306242|NCT00298857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110306243|NCT00298857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306244|NCT00298857|Antimanic Agents|antimanic agents|mesh-ancestor
110306245|NCT00298857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110306246|NCT00298857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110306247|NCT00298857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110306248|NCT00261560|Acetaminophen|acetaminophen|mesh-list
110306249|NCT00261560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110306250|NCT00261560|Analgesics|analgesics|mesh-ancestor
110284872|NCT00205322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110284874|NCT00205322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110284875|NCT00205322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110284876|NCT00205322|Antidotes|antidotes|mesh-ancestor
110284877|NCT00205322|Protective Agents|protective agents|mesh-ancestor
110284878|NCT00205322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284879|NCT00205322|Vitamin B Complex|vitamin b complex|mesh-ancestor
110284880|NCT00205322|Vitamins|vitamins|mesh-ancestor
110284881|NCT00205322|Micronutrients|micronutrients|mesh-ancestor
110284882|NCT00232206|Docetaxel|docetaxel|mesh-list
110284883|NCT00232206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110284884|NCT00232206|Tubulin Modulators|tubulin modulators|mesh-ancestor
110284885|NCT00232206|Antimitotic Agents|antimitotic agents|mesh-ancestor
110284886|NCT00232206|Mitosis Modulators|mitosis modulators|mesh-ancestor
110284887|NCT00232206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110284888|NCT00229242|Diuretics|diuretics|mesh-list
110284889|NCT00229242|Natriuretic Agents|natriuretic agents|mesh-ancestor
110306251|NCT00261560|Sensory System Agents|sensory system agents|mesh-ancestor
110306252|NCT00261560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110306253|NCT00261560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306254|NCT00261560|Antipyretics|antipyretics|mesh-ancestor
110306255|NCT00261599|Midazolam|midazolam|mesh-list
110306256|NCT00261599|Fospropofol|fospropofol|mesh-list
110306257|NCT00261599|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110306258|NCT00261599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110306259|NCT00261599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110306260|NCT00261599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306261|NCT00261599|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110306262|NCT00261599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110306263|NCT00261599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110306264|NCT00261599|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110306265|NCT00261599|Anesthetics, General|anesthetics, general|mesh-ancestor
110306266|NCT00261599|Anesthetics|anesthetics|mesh-ancestor
110306267|NCT00261599|GABA Modulators|gaba modulators|mesh-ancestor
110306268|NCT00261599|GABA Agents|gaba agents|mesh-ancestor
110306269|NCT00261599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110306270|NCT00261599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110306271|NCT00293319|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
110306272|NCT00293319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110306273|NCT00293319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110306274|NCT00293319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110306275|NCT00293319|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110306276|NCT00293358|Carboplatin|carboplatin|mesh-list
110306277|NCT00293358|Etoposide|etoposide|mesh-list
110306278|NCT00293358|Ifosfamide|ifosfamide|mesh-list
110306279|NCT00293358|Etoposide phosphate|etoposide phosphate|mesh-list
110306280|NCT00293358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110306281|NCT00293358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110306282|NCT00293358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110306283|NCT00293358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110306284|NCT00293358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110306285|NCT00293358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110306286|NCT00293358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110306287|NCT00293358|Alkylating Agents|alkylating agents|mesh-ancestor
110306288|NCT00261677|Epoetin Alfa|epoetin alfa|mesh-list
110306289|NCT00261677|Hematinics|hematinics|mesh-ancestor
110306290|NCT00298974|Acetaminophen|acetaminophen|mesh-list
110306291|NCT00298974|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
110284890|NCT00229242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284891|NCT00232284|Sertraline|sertraline|mesh-list
110284892|NCT00232284|Antidepressive Agents|antidepressive agents|mesh-ancestor
110284893|NCT00232284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110284894|NCT00232284|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110284895|NCT00232284|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110284896|NCT00232284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110284897|NCT00232284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110284898|NCT00232284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110284899|NCT00232284|Serotonin Agents|serotonin agents|mesh-ancestor
110284900|NCT00232284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284901|NCT00205634|Clarithromycin|clarithromycin|mesh-list
110284902|NCT00205634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110284903|NCT00205634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110284904|NCT00205634|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110284905|NCT00205634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110284906|NCT00205634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110284907|NCT00205634|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110284908|NCT00205634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110284909|NCT00232362|Pioglitazone|pioglitazone|mesh-list
110284910|NCT00232362|Rosiglitazone|rosiglitazone|mesh-list
110284911|NCT00232362|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110284912|NCT00232362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284914|NCT00205751|Dexamethasone|dexamethasone|mesh-list
110284915|NCT00205751|Prednisone|prednisone|mesh-list
110284916|NCT00205751|Melphalan|melphalan|mesh-list
110284917|NCT00205751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110284918|NCT00205751|Antiemetics|antiemetics|mesh-ancestor
110284919|NCT00205751|Autonomic Agents|autonomic agents|mesh-ancestor
110284920|NCT00205751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110284921|NCT00205751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284922|NCT00205751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110284923|NCT00205751|Glucocorticoids|glucocorticoids|mesh-ancestor
110284924|NCT00205751|Hormones|hormones|mesh-ancestor
110284925|NCT00205751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110284927|NCT00205751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110284928|NCT00205751|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110284929|NCT00205751|Alkylating Agents|alkylating agents|mesh-ancestor
110284930|NCT00205751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110284931|NCT00205751|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110284932|NCT00205751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110284933|NCT00205751|Immunologic Factors|immunologic factors|mesh-ancestor
110284934|NCT00205751|Leprostatic Agents|leprostatic agents|mesh-ancestor
110284935|NCT00205751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110284936|NCT00205751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110284937|NCT00205751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110284938|NCT00205751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110284939|NCT00205751|Growth Substances|growth substances|mesh-ancestor
110284940|NCT00205751|Growth Inhibitors|growth inhibitors|mesh-ancestor
110284941|NCT00229476|Sertraline|sertraline|mesh-list
110284942|NCT00229476|Antidepressive Agents|antidepressive agents|mesh-ancestor
110284943|NCT00229476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110284944|NCT00229476|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110284945|NCT00229476|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110306293|NCT00298974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110306294|NCT00298974|Analgesics|analgesics|mesh-ancestor
110306295|NCT00298974|Sensory System Agents|sensory system agents|mesh-ancestor
110306296|NCT00298974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110306297|NCT00298974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306298|NCT00298974|Antipyretics|antipyretics|mesh-ancestor
110306299|NCT00298974|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110306300|NCT00298974|Narcotics|narcotics|mesh-ancestor
110306301|NCT00298974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110306302|NCT00298974|Antitussive Agents|antitussive agents|mesh-ancestor
110306303|NCT00298974|Respiratory System Agents|respiratory system agents|mesh-ancestor
110306304|NCT00298974|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110306309|NCT00293436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110306310|NCT00293436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110306311|NCT00293436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110306312|NCT00293436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110306313|NCT00293436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110306314|NCT00293436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110306315|NCT00293436|Analgesics|analgesics|mesh-ancestor
110306316|NCT00293436|Sensory System Agents|sensory system agents|mesh-ancestor
110306317|NCT00293436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110306318|NCT00293436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306319|NCT00293436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110306320|NCT00293436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110306321|NCT00293436|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110306324|NCT00261872|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110306325|NCT00261872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306326|NCT00261872|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110306327|NCT00261872|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110306328|NCT00261872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110306329|NCT00261872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110306330|NCT00261872|Dopamine Agents|dopamine agents|mesh-ancestor
110284946|NCT00229476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110284947|NCT00229476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110284948|NCT00229476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110284950|NCT00229476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284951|NCT00205946|Bupropion|bupropion|mesh-list
110284952|NCT00205946|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110284953|NCT00205946|Antidepressive Agents|antidepressive agents|mesh-ancestor
110284954|NCT00205946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110284955|NCT00205946|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110284956|NCT00205946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110284957|NCT00205946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110284958|NCT00205946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110284959|NCT00205946|Dopamine Agents|dopamine agents|mesh-ancestor
110284960|NCT00205946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110284961|NCT00205946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284962|NCT00205946|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110284963|NCT00205946|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110284964|NCT00205946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110284965|NCT00229515|Sirolimus|sirolimus|mesh-list
110284966|NCT00229515|polysaccharide-K|polysaccharide-k|mesh-list
110284967|NCT00229515|Temsirolimus|temsirolimus|mesh-list
110284968|NCT00229515|MTOR Inhibitors|mtor inhibitors|mesh-list
110284969|NCT00229515|Tirofiban|tirofiban|mesh-list
110284970|NCT00229515|Abciximab|abciximab|mesh-list
110284971|NCT00229515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110284972|NCT00229515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110284973|NCT00229515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110284974|NCT00229515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110284975|NCT00229515|Antifungal Agents|antifungal agents|mesh-ancestor
110284976|NCT00229515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110306331|NCT00261872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110306332|NCT00293475|Sodium thiosulfate|sodium thiosulfate|mesh-list
110306334|NCT00293475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110306335|NCT00293475|Carboplatin|carboplatin|mesh-list
110306336|NCT00293475|Methotrexate|methotrexate|mesh-list
110306337|NCT00293475|Mannitol|mannitol|mesh-list
110306338|NCT00293475|Antibodies|antibodies|mesh-list
110306339|NCT00293475|Immunoglobulins|immunoglobulins|mesh-list
110306340|NCT00293475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110284978|NCT00229515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284979|NCT00229515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110284980|NCT00229515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110284981|NCT00229515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110284982|NCT00229515|Anticoagulants|anticoagulants|mesh-ancestor
110284983|NCT00229515|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110284984|NCT00229515|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110284985|NCT00229515|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110284986|NCT00229515|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110284987|NCT00229515|Antiviral Agents|antiviral agents|mesh-ancestor
110284988|NCT00229515|Interferon Inducers|interferon inducers|mesh-ancestor
110306341|NCT00293475|Antidotes|antidotes|mesh-list
110306342|NCT00293475|Immunologic Factors|immunologic factors|mesh-ancestor
110306343|NCT00293475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306344|NCT00293475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110306345|NCT00293475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110306346|NCT00293475|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110306347|NCT00293475|Abortifacient Agents|abortifacient agents|mesh-ancestor
110306348|NCT00293475|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110306349|NCT00293475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110306350|NCT00293475|Antimetabolites|antimetabolites|mesh-ancestor
110306351|NCT00293475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110306352|NCT00293475|Dermatologic Agents|dermatologic agents|mesh-ancestor
110306353|NCT00293475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110306354|NCT00293475|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110306355|NCT00293475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110306356|NCT00293475|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110306357|NCT00293475|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110306358|NCT00293475|Diuretics|diuretics|mesh-ancestor
110306359|NCT00293475|Natriuretic Agents|natriuretic agents|mesh-ancestor
110306360|NCT00293475|Protective Agents|protective agents|mesh-ancestor
110306361|NCT00293475|Antioxidants|antioxidants|mesh-ancestor
110306362|NCT00293475|Antitubercular Agents|antitubercular agents|mesh-ancestor
110306363|NCT00293475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110306364|NCT00293475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110306365|NCT00293475|Chelating Agents|chelating agents|mesh-ancestor
110306366|NCT00293475|Sequestering Agents|sequestering agents|mesh-ancestor
110306367|NCT00261911|Sibutramine|sibutramine|mesh-list
110306368|NCT00261911|Antidepressive Agents|antidepressive agents|mesh-ancestor
110306369|NCT00261911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110306370|NCT00261911|Appetite Depressants|appetite depressants|mesh-ancestor
110306371|NCT00261911|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110306372|NCT00299013|Prednisolone|prednisolone|mesh-list
110306373|NCT00299013|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110306374|NCT00299013|Methylprednisolone|methylprednisolone|mesh-list
110306375|NCT00299013|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110306376|NCT00299013|Prednisolone acetate|prednisolone acetate|mesh-list
110306377|NCT00299013|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110306380|NCT00299013|Glucocorticoids|glucocorticoids|mesh-ancestor
110306381|NCT00299013|Hormones|hormones|mesh-ancestor
110306382|NCT00299013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110306383|NCT00299013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306384|NCT00299013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110306385|NCT00299013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110306387|NCT00299013|Autonomic Agents|autonomic agents|mesh-ancestor
110306388|NCT00299013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110306389|NCT00299013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110306390|NCT00299013|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110306391|NCT00299013|Protective Agents|protective agents|mesh-ancestor
110306393|NCT00293514|Hemostatics|hemostatics|mesh-ancestor
110306394|NCT00293514|Coagulants|coagulants|mesh-ancestor
110306395|NCT00299091|Efavirenz|efavirenz|mesh-list
110284989|NCT00229515|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110284990|NCT00229515|Protective Agents|protective agents|mesh-ancestor
110284992|NCT00206024|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110284993|NCT00206024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110284994|NCT00206024|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110284995|NCT00206024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110284996|NCT00206024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110284997|NCT00206063|Ximelagatran|ximelagatran|mesh-list
110284998|NCT00206063|Antithrombins|antithrombins|mesh-ancestor
110284999|NCT00206063|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110285000|NCT00206063|Protease Inhibitors|protease inhibitors|mesh-ancestor
110285001|NCT00206063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110285002|NCT00206063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110285003|NCT00206063|Anticoagulants|anticoagulants|mesh-ancestor
110285004|NCT00206141|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110285005|NCT00206141|Antidepressive Agents|antidepressive agents|mesh-ancestor
110285006|NCT00206141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110285007|NCT00206141|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110285008|NCT00206141|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110285009|NCT00206141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110285010|NCT00206141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285011|NCT00229593|ST 1435|st 1435|mesh-list
110285012|NCT00229593|Testosterone|testosterone|mesh-list
110285013|NCT00229593|Androgens|androgens|mesh-ancestor
110285014|NCT00229593|Hormones|hormones|mesh-ancestor
110285015|NCT00229593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110285016|NCT00229593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285017|NCT00229593|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110285018|NCT00229593|Contraceptive Agents|contraceptive agents|mesh-ancestor
110306396|NCT00299091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110306397|NCT00299091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110306398|NCT00299091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110306399|NCT00299091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110306400|NCT00299091|Antiviral Agents|antiviral agents|mesh-ancestor
110306401|NCT00299091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110306402|NCT00299091|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110306403|NCT00299091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110306404|NCT00299091|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110306405|NCT00299091|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110306406|NCT00299091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110306407|NCT00299091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110306408|NCT00299208|Azithromycin|azithromycin|mesh-list
110306409|NCT00299208|Artesunate|artesunate|mesh-list
110285019|NCT00229593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110285020|NCT00229593|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110285021|NCT00229632|Idebenone|idebenone|mesh-list
110285022|NCT00229632|Antioxidants|antioxidants|mesh-ancestor
110285023|NCT00229632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110285024|NCT00229632|Protective Agents|protective agents|mesh-ancestor
110285025|NCT00229632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285026|NCT00206180|Esomeprazole|esomeprazole|mesh-list
110285027|NCT00206180|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110285028|NCT00206180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110285029|NCT00206180|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110285030|NCT00206180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110306411|NCT00299208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110306412|NCT00299208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110306413|NCT00299208|Antimalarials|antimalarials|mesh-ancestor
110306414|NCT00299208|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110306415|NCT00299208|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110306416|NCT00299208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110306417|NCT00299208|Antiviral Agents|antiviral agents|mesh-ancestor
110306418|NCT00299208|Schistosomicides|schistosomicides|mesh-ancestor
110306419|NCT00299208|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110306420|NCT00299208|Anthelmintics|anthelmintics|mesh-ancestor
110306421|NCT00299208|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110306422|NCT00299208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306423|NCT00299208|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110306424|NCT00299208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110306425|NCT00299208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110306426|NCT00299208|Analgesics|analgesics|mesh-ancestor
110306427|NCT00299208|Sensory System Agents|sensory system agents|mesh-ancestor
110306428|NCT00418119|Epoetin Alfa|epoetin alfa|mesh-list
110306429|NCT00418119|Hematinics|hematinics|mesh-ancestor
110306430|NCT00293592|Dexamethasone|dexamethasone|mesh-list
110306431|NCT00293592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110306432|NCT00293592|Antiemetics|antiemetics|mesh-ancestor
110306433|NCT00293592|Autonomic Agents|autonomic agents|mesh-ancestor
110306434|NCT00293592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110306435|NCT00293592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306436|NCT00293592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110306437|NCT00293592|Glucocorticoids|glucocorticoids|mesh-ancestor
110306438|NCT00293592|Hormones|hormones|mesh-ancestor
110306439|NCT00293592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110306440|NCT00293592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110306441|NCT00293592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110306442|NCT00293631|Ketorolac|ketorolac|mesh-list
110306443|NCT00293631|Lornoxicam|lornoxicam|mesh-list
110306444|NCT00293631|Piroxicam|piroxicam|mesh-list
110306445|NCT00293631|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110306446|NCT00293631|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110306447|NCT00293631|Analgesics|analgesics|mesh-ancestor
110306448|NCT00293631|Sensory System Agents|sensory system agents|mesh-ancestor
110306449|NCT00293631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110306450|NCT00293631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306451|NCT00293631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110306452|NCT00293631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110306457|NCT00262262|Anticonvulsants|anticonvulsants|mesh-ancestor
110306458|NCT00262262|Nootropic Agents|nootropic agents|mesh-ancestor
110306459|NCT00293670|Goserelin|goserelin|mesh-list
110306460|NCT00293670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110306461|NCT00293670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110306462|NCT00262379|Epoetin Alfa|epoetin alfa|mesh-list
110306463|NCT00262379|Hematinics|hematinics|mesh-ancestor
110306464|NCT00299247|Pyrimethamine|pyrimethamine|mesh-list
110306465|NCT00299247|Sulfadoxine|sulfadoxine|mesh-list
110306466|NCT00299247|Antimalarials|antimalarials|mesh-ancestor
110306467|NCT00299247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110306468|NCT00299247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110285031|NCT00206180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110285032|NCT00206219|Methotrexate|methotrexate|mesh-list
110285033|NCT00206219|Gefitinib|gefitinib|mesh-list
110285034|NCT00206219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110285035|NCT00206219|Abortifacient Agents|abortifacient agents|mesh-ancestor
110285036|NCT00206219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110285037|NCT00206219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285038|NCT00206219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110285039|NCT00206219|Antimetabolites|antimetabolites|mesh-ancestor
110285040|NCT00206219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110022707|NCT00003060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110285041|NCT00206219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110285042|NCT00206219|Dermatologic Agents|dermatologic agents|mesh-ancestor
110285043|NCT00206219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110285044|NCT00206219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110285045|NCT00206219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110285046|NCT00206219|Immunologic Factors|immunologic factors|mesh-ancestor
110285047|NCT00206219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110306469|NCT00299247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110306470|NCT00299247|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110306471|NCT00299247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110306472|NCT00299247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110306473|NCT00299247|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110306475|NCT00262418|Permethrin|permethrin|mesh-list
110306476|NCT00262418|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110306477|NCT00262418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110306478|NCT00262418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110306479|NCT00262418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110306480|NCT00299286|Lapatinib|lapatinib|mesh-list
110306481|NCT00299286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110306482|NCT00299286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110306483|NCT00299286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110306484|NCT00299286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110306485|NCT00293787|Timolol|timolol|mesh-list
110306486|NCT00293787|Travoprost|travoprost|mesh-list
110306487|NCT00293787|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110306488|NCT00293787|Latanoprost|latanoprost|mesh-list
110306489|NCT00293787|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110306490|NCT00293787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110306491|NCT00293787|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110306492|NCT00293787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110306493|NCT00293787|Adrenergic Agents|adrenergic agents|mesh-ancestor
110306494|NCT00293787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110306495|NCT00293787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306496|NCT00293787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110306497|NCT00293787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110306498|NCT00299364|Tibolone|tibolone|mesh-list
110306499|NCT00299364|Androgen Antagonists|androgen antagonists|mesh-ancestor
110306500|NCT00299364|Hormone Antagonists|hormone antagonists|mesh-ancestor
110306501|NCT00299364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110306502|NCT00299364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306503|NCT00299364|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110306504|NCT00299364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110306505|NCT00299364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110306506|NCT00299364|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110285048|NCT00206219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110285049|NCT00206219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110285050|NCT00206258|Pramlintide|pramlintide|mesh-list
110285051|NCT00206258|Glucagon|glucagon|mesh-list
110285052|NCT00206258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110285053|NCT00206258|Hormones|hormones|mesh-ancestor
110285054|NCT00206258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110285055|NCT00206258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285056|NCT00206258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110022731|NCT00003078|Fluorouracil|fluorouracil|mesh-list
110285057|NCT00206297|Pramlintide|pramlintide|mesh-list
110285058|NCT00206297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110285059|NCT00206297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285061|NCT00411047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110285062|NCT00411047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110306507|NCT00299364|Anabolic Agents|anabolic agents|mesh-ancestor
110306508|NCT00299364|Hormones|hormones|mesh-ancestor
110306509|NCT00293826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110306510|NCT00293826|Immunologic Factors|immunologic factors|mesh-ancestor
110306511|NCT00293826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306512|NCT00262574|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
110306513|NCT00262574|Natriuretic Agents|natriuretic agents|mesh-ancestor
110306514|NCT00262574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306515|NCT00262769|Cisplatin|cisplatin|mesh-list
110306516|NCT00262769|Gemcitabine|gemcitabine|mesh-list
110306517|NCT00262769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110306518|NCT00262769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110306519|NCT00262769|Antimetabolites|antimetabolites|mesh-ancestor
110306520|NCT00262769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110306521|NCT00299520|Linezolid|linezolid|mesh-list
110306522|NCT00299520|Iclaprim|iclaprim|mesh-list
110306523|NCT00299520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110306524|NCT00299520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110306525|NCT00299520|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110306529|NCT00261755|Analgesics|analgesics|mesh-list
110306530|NCT00261755|Sensory System Agents|sensory system agents|mesh-ancestor
110306531|NCT00261755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110306532|NCT00261755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306533|NCT00262808|Leucovorin|leucovorin|mesh-list
110306535|NCT00262808|Oxaliplatin|oxaliplatin|mesh-list
110306536|NCT00262808|Calcium|calcium|mesh-list
110306537|NCT00262808|Sargramostim|sargramostim|mesh-list
110306538|NCT00262808|Levoleucovorin|levoleucovorin|mesh-list
110306539|NCT00262808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110306540|NCT00262808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306541|NCT00262808|Antimetabolites|antimetabolites|mesh-ancestor
110306542|NCT00262808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110306543|NCT00262808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110306544|NCT00262808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110306545|NCT00262808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110306546|NCT00262808|Immunologic Factors|immunologic factors|mesh-ancestor
110306547|NCT00262808|Antidotes|antidotes|mesh-ancestor
110306548|NCT00262808|Protective Agents|protective agents|mesh-ancestor
110306549|NCT00262808|Vitamin B Complex|vitamin b complex|mesh-ancestor
110306550|NCT00262808|Vitamins|vitamins|mesh-ancestor
110306551|NCT00262808|Micronutrients|micronutrients|mesh-ancestor
110306552|NCT00262886|Mycophenolic Acid|mycophenolic acid|mesh-list
110306553|NCT00262886|Cyclophosphamide|cyclophosphamide|mesh-list
110306554|NCT00262886|Fludarabine|fludarabine|mesh-list
110306556|NCT00262886|Tacrolimus|tacrolimus|mesh-list
110306557|NCT00262886|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110285063|NCT00411047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110285064|NCT00411047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110285065|NCT00411125|Calcitonin|calcitonin|mesh-list
110285066|NCT00411125|Salmon calcitonin|salmon calcitonin|mesh-list
110285067|NCT00411125|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
110285068|NCT00411125|Katacalcin|katacalcin|mesh-list
110285069|NCT00411125|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110285070|NCT00411125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285071|NCT00411125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110285072|NCT00411125|Vasodilator Agents|vasodilator agents|mesh-ancestor
110285073|NCT00411164|Hydromorphone|hydromorphone|mesh-list
110285074|NCT00411164|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110285075|NCT00411164|Narcotics|narcotics|mesh-ancestor
110285076|NCT00411164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110306558|NCT00262886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110306559|NCT00262886|Immunologic Factors|immunologic factors|mesh-ancestor
110306560|NCT00262886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306561|NCT00262886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110306562|NCT00262886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110306563|NCT00262886|Alkylating Agents|alkylating agents|mesh-ancestor
110306564|NCT00262886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110306565|NCT00262886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110306566|NCT00262886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110306567|NCT00262886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110306568|NCT00262886|Antimetabolites|antimetabolites|mesh-ancestor
110306569|NCT00262886|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110306570|NCT00262886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110306571|NCT00262886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110306572|NCT00262886|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110306573|NCT00262886|Antitubercular Agents|antitubercular agents|mesh-ancestor
110306574|NCT00262886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110306575|NCT00262886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110306576|NCT00263003|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110306577|NCT00263003|Irbesartan|irbesartan|mesh-list
110306578|NCT00263003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110306579|NCT00263003|Diuretics|diuretics|mesh-ancestor
110306580|NCT00263003|Natriuretic Agents|natriuretic agents|mesh-ancestor
110306581|NCT00263003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306582|NCT00263003|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110306583|NCT00263003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110306584|NCT00263003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110306585|NCT00263003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110306586|NCT00263003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110306587|NCT00299559|Camphor|camphor|mesh-list
110306588|NCT00299559|Menthol|menthol|mesh-list
110306589|NCT00299559|Antipruritics|antipruritics|mesh-ancestor
110306590|NCT00299559|Dermatologic Agents|dermatologic agents|mesh-ancestor
110306591|NCT00299559|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110306592|NCT00299559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110306593|NCT00299598|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110306594|NCT00299598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110306595|NCT00263198|Letrozole|letrozole|mesh-list
110306597|NCT00263198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110306598|NCT00263198|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110306599|NCT00263198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110306616|NCT00299676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110306617|NCT00299676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110306618|NCT00299676|Cholinergic Agents|cholinergic agents|mesh-ancestor
110285077|NCT00411164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285079|NCT00411164|Sensory System Agents|sensory system agents|mesh-ancestor
110285080|NCT00411164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110285081|NCT00411203|Tamoxifen|tamoxifen|mesh-list
110285082|NCT00411203|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110285083|NCT00411203|Hormone Antagonists|hormone antagonists|mesh-ancestor
110285084|NCT00411203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110285085|NCT00411203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285086|NCT00411203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110285087|NCT00411203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110285088|NCT00411203|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110285089|NCT00411203|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110285090|NCT00411203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110285091|NCT00411281|Cytarabine|cytarabine|mesh-list
110285092|NCT00411281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110285093|NCT00411281|Antimetabolites|antimetabolites|mesh-ancestor
110285094|NCT00411281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110306619|NCT00299676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110306620|NCT00299676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306621|NCT00299676|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110306622|NCT00299676|Autonomic Agents|autonomic agents|mesh-ancestor
110306623|NCT00299676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110306624|NCT00299676|Nootropic Agents|nootropic agents|mesh-ancestor
110306625|NCT00263276|Metformin|metformin|mesh-list
110306626|NCT00263276|Dapagliflozin|dapagliflozin|mesh-list
110306627|NCT00263276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110306628|NCT00263276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306629|NCT00263276|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110306631|NCT00299754|Misoprostol|misoprostol|mesh-list
110306632|NCT00299754|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110306633|NCT00299754|Abortifacient Agents|abortifacient agents|mesh-ancestor
110306634|NCT00299754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110306635|NCT00299754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306636|NCT00299754|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110306637|NCT00299754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110306638|NCT00299754|Oxytocics|oxytocics|mesh-ancestor
110306639|NCT00263315|Amphotericin B|amphotericin b|mesh-list
110306640|NCT00263315|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110306641|NCT00263315|Amebicides|amebicides|mesh-ancestor
110306642|NCT00263315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110306643|NCT00263315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110306644|NCT00263315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110306645|NCT00263315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110306646|NCT00263315|Antifungal Agents|antifungal agents|mesh-ancestor
110306647|NCT00417807|Imatinib Mesylate|imatinib mesylate|mesh-list
110306648|NCT00417807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110306649|NCT00417807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110306650|NCT00417807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110306651|NCT00417807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110306652|NCT00263354|Oxaliplatin|oxaliplatin|mesh-list
110306653|NCT00263354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110306654|NCT00263393|Atenolol|atenolol|mesh-list
110285096|NCT00411281|Antiviral Agents|antiviral agents|mesh-ancestor
110285097|NCT00411281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110285098|NCT00411281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110285099|NCT00411281|Immunologic Factors|immunologic factors|mesh-ancestor
110285100|NCT00411281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285101|NCT00206414|Gefitinib|gefitinib|mesh-list
110285102|NCT00206414|Fulvestrant|fulvestrant|mesh-list
110285103|NCT00206414|Anastrozole|anastrozole|mesh-list
110285104|NCT00206414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110285105|NCT00206414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110285106|NCT00206414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110285107|NCT00206414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110285108|NCT00206414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110285109|NCT00206414|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110285110|NCT00206414|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110285111|NCT00206414|Hormone Antagonists|hormone antagonists|mesh-ancestor
110285112|NCT00206414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110285113|NCT00206414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285114|NCT00206414|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110285115|NCT00206414|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110285116|NCT00232674|Budesonide|budesonide|mesh-list
110285117|NCT00232674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110285118|NCT00232674|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110285119|NCT00232674|Autonomic Agents|autonomic agents|mesh-ancestor
110285120|NCT00232674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110285121|NCT00232674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306655|NCT00263393|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110306656|NCT00263393|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110306657|NCT00263393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110306658|NCT00263393|Diuretics|diuretics|mesh-ancestor
110306659|NCT00263393|Natriuretic Agents|natriuretic agents|mesh-ancestor
110306667|NCT00263393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110022826|NCT00003144|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110306668|NCT00263393|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110306670|NCT00263393|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110306671|NCT00263393|Adrenergic Agents|adrenergic agents|mesh-ancestor
110306672|NCT00263393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110306673|NCT00263393|Protease Inhibitors|protease inhibitors|mesh-ancestor
110306674|NCT00263393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110306675|NCT00299871|Lixisenatide|lixisenatide|mesh-list
110306676|NCT00299871|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110306677|NCT00299871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306678|NCT00299910|Montelukast|montelukast|mesh-list
110306679|NCT00299910|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110306680|NCT00299910|Respiratory System Agents|respiratory system agents|mesh-ancestor
110285122|NCT00232674|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110285123|NCT00232674|Respiratory System Agents|respiratory system agents|mesh-ancestor
110285124|NCT00232674|Glucocorticoids|glucocorticoids|mesh-ancestor
110285125|NCT00232674|Hormones|hormones|mesh-ancestor
110285126|NCT00232674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110285127|NCT00206453|Docetaxel|docetaxel|mesh-list
110285128|NCT00206453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110285129|NCT00206453|Tubulin Modulators|tubulin modulators|mesh-ancestor
110285130|NCT00206453|Antimitotic Agents|antimitotic agents|mesh-ancestor
110285131|NCT00206453|Mitosis Modulators|mitosis modulators|mesh-ancestor
110285132|NCT00206453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110285133|NCT00206492|Tamoxifen|tamoxifen|mesh-list
110285134|NCT00206492|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110285135|NCT00206492|Hormone Antagonists|hormone antagonists|mesh-ancestor
110285136|NCT00206492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110285137|NCT00206492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285138|NCT00206492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110306681|NCT00299910|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110306682|NCT00299910|Hormone Antagonists|hormone antagonists|mesh-ancestor
110306683|NCT00299910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110306684|NCT00299910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306685|NCT00299910|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110306686|NCT00299910|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110306687|NCT00299910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110306688|NCT00263627|Immunomodulating Agents|immunomodulating agents|mesh-list
110306690|NCT00263627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306691|NCT00425594|Bisacodyl|bisacodyl|mesh-list
110306692|NCT00425594|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
110306693|NCT00425594|Cathartics|cathartics|mesh-ancestor
110306694|NCT00425594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110306695|NCT00425594|Laxatives|laxatives|mesh-ancestor
110306696|NCT00294255|Risperidone|risperidone|mesh-list
110306697|NCT00294255|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110306698|NCT00294255|Serotonin Agents|serotonin agents|mesh-ancestor
110306699|NCT00294255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110306700|NCT00294255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110306701|NCT00294255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306702|NCT00294255|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110306703|NCT00294255|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110306704|NCT00294255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110306705|NCT00294255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110306706|NCT00294255|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110306707|NCT00294255|Dopamine Agents|dopamine agents|mesh-ancestor
110306708|NCT00263705|Capecitabine|capecitabine|mesh-list
110306710|NCT00263705|Antimetabolites|antimetabolites|mesh-ancestor
110306711|NCT00263705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110306712|NCT00263705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110306713|NCT00263744|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110306714|NCT00263744|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110306715|NCT00263744|Immunologic Factors|immunologic factors|mesh-ancestor
110306716|NCT00263744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306717|NCT00263744|Antacids|antacids|mesh-ancestor
110306718|NCT00263744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110306719|NCT00263744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110285139|NCT00206492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110285140|NCT00206492|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110285141|NCT00206492|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110285142|NCT00206492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110285143|NCT00206570|Estradiol|estradiol|mesh-list
110285144|NCT00206570|Estrogens|estrogens|mesh-ancestor
110285145|NCT00206570|Hormones|hormones|mesh-ancestor
110285146|NCT00206570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110285147|NCT00206570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285148|NCT00206648|Interferon beta-1b|interferon beta-1b|mesh-list
110285149|NCT00206648|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110285150|NCT00206648|Immunologic Factors|immunologic factors|mesh-ancestor
110285151|NCT00206648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285152|NCT01056159|Albuterol|albuterol|mesh-list
110285153|NCT01056159|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110285154|NCT01056159|Autonomic Agents|autonomic agents|mesh-ancestor
110285155|NCT01056159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110285156|NCT01056159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306720|NCT00294294|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110306721|NCT00294294|Immunologic Factors|immunologic factors|mesh-ancestor
110306722|NCT00294294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306723|NCT00263822|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110306724|NCT00263822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110306735|NCT00263978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110306736|NCT00263978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110306737|NCT00263978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110306738|NCT00263978|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110306739|NCT00264134|Carboplatin|carboplatin|mesh-list
110306740|NCT00264134|Docetaxel|docetaxel|mesh-list
110306741|NCT00264134|Irinotecan|irinotecan|mesh-list
110306742|NCT00264134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110306743|NCT00264134|Tubulin Modulators|tubulin modulators|mesh-ancestor
110306744|NCT00264134|Antimitotic Agents|antimitotic agents|mesh-ancestor
110306745|NCT00264134|Mitosis Modulators|mitosis modulators|mesh-ancestor
110306746|NCT00264134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110306747|NCT00264134|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110306748|NCT00264134|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110306749|NCT00264134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110306750|NCT00300339|Clopidogrel|clopidogrel|mesh-list
110306751|NCT00300339|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110306752|NCT00300339|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110306753|NCT00300339|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110306754|NCT00300339|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110306755|NCT00300339|Purinergic Agents|purinergic agents|mesh-ancestor
110306756|NCT00300339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110306757|NCT00300339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110306758|NCT00300339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306759|NCT00264173|Valproic Acid|valproic acid|mesh-list
110306760|NCT00264173|Anticonvulsants|anticonvulsants|mesh-ancestor
110306761|NCT00264173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110306762|NCT00264173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110306763|NCT00264173|GABA Agents|gaba agents|mesh-ancestor
110306764|NCT00264173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110306765|NCT00264173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306766|NCT00264173|Antimanic Agents|antimanic agents|mesh-ancestor
110285157|NCT01056159|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110285158|NCT01056159|Respiratory System Agents|respiratory system agents|mesh-ancestor
110285159|NCT01056159|Tocolytic Agents|tocolytic agents|mesh-ancestor
110285160|NCT01056159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110285161|NCT01056159|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110285162|NCT01056159|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110285163|NCT01056159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110285164|NCT01056159|Adrenergic Agents|adrenergic agents|mesh-ancestor
110285165|NCT01056159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110285166|NCT01056159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110285167|NCT00206765|Risperidone|risperidone|mesh-list
110285168|NCT00206765|Paroxetine|paroxetine|mesh-list
110285169|NCT00206765|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110285170|NCT00206765|Serotonin Agents|serotonin agents|mesh-ancestor
110285171|NCT00206765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110285172|NCT00206765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110285173|NCT00206765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285174|NCT00206765|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110285175|NCT00206765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110285176|NCT00206765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110285177|NCT00206765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110285178|NCT00206765|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110285179|NCT00206765|Dopamine Agents|dopamine agents|mesh-ancestor
110285180|NCT00206765|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110285181|NCT00206765|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110285182|NCT00206765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110306767|NCT00264173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110306768|NCT00264173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110306769|NCT00264173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110306770|NCT00264212|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110306771|NCT00264212|Irbesartan|irbesartan|mesh-list
110306772|NCT00264212|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110306773|NCT00264212|Diuretics|diuretics|mesh-ancestor
110306774|NCT00264212|Natriuretic Agents|natriuretic agents|mesh-ancestor
110306775|NCT00264212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306776|NCT00264212|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110306777|NCT00264212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110306778|NCT00264212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110306779|NCT00264212|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110306780|NCT00264212|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110306781|NCT00300378|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
110306782|NCT00300378|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110022867|NCT00003174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110306783|NCT00300378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110306784|NCT00300378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110306785|NCT00300378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110285183|NCT00206765|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110285184|NCT00206765|Antidepressive Agents|antidepressive agents|mesh-ancestor
110285185|NCT00206765|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110285186|NCT00206765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110285189|NCT00424710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110285190|NCT00424710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110285191|NCT00424710|Growth Substances|growth substances|mesh-ancestor
110285192|NCT00424710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285193|NCT00424710|Growth Inhibitors|growth inhibitors|mesh-ancestor
110285194|NCT00424710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110285195|NCT00206960|Risperidone|risperidone|mesh-list
110285196|NCT00206960|Clopenthixol|clopenthixol|mesh-list
110285197|NCT00206960|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110285198|NCT00206960|Serotonin Agents|serotonin agents|mesh-ancestor
110285199|NCT00206960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110285200|NCT00206960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110285201|NCT00206960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285202|NCT00206960|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110285203|NCT00206960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110285204|NCT00206960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110285205|NCT00206960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110285206|NCT00206960|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110285207|NCT00206960|Dopamine Agents|dopamine agents|mesh-ancestor
110285208|NCT00206999|Imipramine|imipramine|mesh-list
110285209|NCT00206999|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110285210|NCT00206999|Antidepressive Agents|antidepressive agents|mesh-ancestor
110285211|NCT00206999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110306786|NCT00300378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110306795|NCT00294567|Calcium|calcium|mesh-list
110306796|NCT00294567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110306797|NCT00294567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306798|NCT00294567|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110306799|NCT00294567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110306800|NCT00294567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110306801|NCT00294567|Vasodilator Agents|vasodilator agents|mesh-ancestor
110306802|NCT00294606|Phenylephrine|phenylephrine|mesh-list
110306803|NCT00294606|Oxymetazoline|oxymetazoline|mesh-list
110306804|NCT00294606|Norepinephrine|norepinephrine|mesh-list
110306805|NCT00294606|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110306806|NCT00294606|Mydriatics|mydriatics|mesh-ancestor
110306807|NCT00294606|Autonomic Agents|autonomic agents|mesh-ancestor
110306808|NCT00294606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110306809|NCT00294606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285212|NCT00206999|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110285213|NCT00206999|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110285214|NCT00206999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110285215|NCT00206999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110285216|NCT00206999|Adrenergic Agents|adrenergic agents|mesh-ancestor
110285217|NCT00206999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110285218|NCT00206999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285219|NCT00229944|Azithromycin|azithromycin|mesh-list
110285220|NCT00229944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110306810|NCT00294606|Sympathomimetics|sympathomimetics|mesh-ancestor
110306811|NCT00294606|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110306812|NCT00294606|Nasal Decongestants|nasal decongestants|mesh-ancestor
110306813|NCT00294606|Respiratory System Agents|respiratory system agents|mesh-ancestor
110306814|NCT00294606|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110306815|NCT00294606|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110306816|NCT00294606|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110306817|NCT00294606|Adrenergic Agents|adrenergic agents|mesh-ancestor
110306818|NCT00294606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110306819|NCT00294606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110306820|NCT00294606|Protective Agents|protective agents|mesh-ancestor
110306821|NCT04708964|Flurbiprofen|flurbiprofen|mesh-list
110306822|NCT04708964|Analgesics|analgesics|mesh-ancestor
110306823|NCT04708964|Sensory System Agents|sensory system agents|mesh-ancestor
110306824|NCT04708964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110306825|NCT04708964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306826|NCT04708964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110306827|NCT04708964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110306828|NCT04708964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110306829|NCT04708964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110306830|NCT04708964|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110306831|NCT04708964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110306832|NCT04708964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110306833|NCT00264368|Ganciclovir|ganciclovir|mesh-list
110306834|NCT00264368|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
110306835|NCT00264368|Antiviral Agents|antiviral agents|mesh-ancestor
110306836|NCT00264368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110306837|NCT00264368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110306838|NCT00264368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110306839|NCT00264368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110306840|NCT00264407|Hormones|hormones|mesh-list
110306841|NCT00264407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110306842|NCT00264407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306843|NCT00300573|Dexelvucitabine|dexelvucitabine|mesh-list
110306844|NCT00300573|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110306845|NCT00300573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110306846|NCT00300573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110306847|NCT00300573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110306848|NCT00300573|Antiviral Agents|antiviral agents|mesh-ancestor
110306849|NCT00300573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110306850|NCT00300573|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110306851|NCT00300573|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110306852|NCT00264446|Eniluracil|eniluracil|mesh-list
110306876|NCT00264680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110306877|NCT00264680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110306878|NCT00264680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306879|NCT00264680|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110306880|NCT00264680|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110306881|NCT00264680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110306882|NCT00264680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110306883|NCT00264680|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110306884|NCT00264680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110285221|NCT00229944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110285223|NCT00207077|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110285224|NCT00207077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110285225|NCT00207077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110285226|NCT00207077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110285227|NCT00207077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110285228|NCT00207077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110285229|NCT00207116|Cetuximab|cetuximab|mesh-list
110285230|NCT00207116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110285231|NCT00207116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110285232|NCT00232908|Enfuvirtide|enfuvirtide|mesh-list
110285233|NCT00232908|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110285234|NCT00232908|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110285235|NCT00232908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110285236|NCT00232908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110285237|NCT00232908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110285238|NCT00232908|Antiviral Agents|antiviral agents|mesh-ancestor
110285239|NCT00232908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110285240|NCT00207155|Cetuximab|cetuximab|mesh-list
110285241|NCT00207155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110285242|NCT00207155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110285243|NCT00232947|Vaccines|vaccines|mesh-list
110285244|NCT00232947|Immunologic Factors|immunologic factors|mesh-ancestor
110285245|NCT00232947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285246|NCT00413712|Adenosine|adenosine|mesh-list
110285247|NCT00413712|Calcium Channel Blockers|calcium channel blockers|mesh-list
110285248|NCT00413712|Calcium|calcium|mesh-list
110285249|NCT00413712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110285250|NCT00413712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285251|NCT00413712|Analgesics|analgesics|mesh-ancestor
110285252|NCT00413712|Sensory System Agents|sensory system agents|mesh-ancestor
110306886|NCT00264680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110306887|NCT00264680|Antimanic Agents|antimanic agents|mesh-ancestor
110306888|NCT00300729|Celecoxib|celecoxib|mesh-list
110306889|NCT00300729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110306890|NCT00300729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110306891|NCT00300729|Analgesics|analgesics|mesh-ancestor
110022944|NCT00003216|Fluorouracil|fluorouracil|mesh-list
110306892|NCT00300729|Sensory System Agents|sensory system agents|mesh-ancestor
110306893|NCT00300729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110306894|NCT00300729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306895|NCT00300729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110306896|NCT00300729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110306897|NCT00300729|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110285253|NCT00413712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110285254|NCT00413712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110285255|NCT00413712|Vasodilator Agents|vasodilator agents|mesh-ancestor
110285256|NCT00413712|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110285257|NCT00413712|Purinergic Agonists|purinergic agonists|mesh-ancestor
110285259|NCT00413712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110285260|NCT00413712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110285261|NCT00413712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110285263|NCT00230217|Gout Suppressants|gout suppressants|mesh-ancestor
110285264|NCT00230217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110285266|NCT00207311|Interferon-alpha|interferon-alpha|mesh-list
110285267|NCT00207311|Interferon alpha-2|interferon alpha-2|mesh-list
110285268|NCT00207311|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110285269|NCT00207311|Orlistat|orlistat|mesh-list
110306898|NCT00300729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110306899|NCT00300729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110306900|NCT00300729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110306901|NCT00264719|Metoclopramide|metoclopramide|mesh-list
110306902|NCT00264719|Antiemetics|antiemetics|mesh-ancestor
110306903|NCT00264719|Autonomic Agents|autonomic agents|mesh-ancestor
110306904|NCT00264719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110306905|NCT00264719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306924|NCT00264953|Procarbazine|procarbazine|mesh-list
110306925|NCT00264953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110306926|NCT00264953|Glucocorticoids|glucocorticoids|mesh-ancestor
110306928|NCT00264953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110306929|NCT00264953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306930|NCT00264953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110306931|NCT00264953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110306932|NCT00264953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110306933|NCT00264953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110306934|NCT00264953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110306935|NCT00264953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110306936|NCT00264953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110306937|NCT00264953|Tubulin Modulators|tubulin modulators|mesh-ancestor
110306938|NCT00264953|Antimitotic Agents|antimitotic agents|mesh-ancestor
110306939|NCT00264953|Mitosis Modulators|mitosis modulators|mesh-ancestor
110306940|NCT00264953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110306941|NCT00300846|Aripiprazole|aripiprazole|mesh-list
110306942|NCT00300846|Antidepressive Agents|antidepressive agents|mesh-ancestor
110306943|NCT00300846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110306944|NCT00300846|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110306945|NCT00300846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110306946|NCT00300846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110022976|NCT00003252|Amifostine|amifostine|mesh-list
110306947|NCT00300846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306948|NCT00300846|Dopamine Agonists|dopamine agonists|mesh-ancestor
110306949|NCT00300846|Dopamine Agents|dopamine agents|mesh-ancestor
110306950|NCT00300846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110306951|NCT00300846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110306952|NCT00300846|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110306953|NCT00300846|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110306954|NCT00300846|Serotonin Agents|serotonin agents|mesh-ancestor
110306955|NCT00300846|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110306956|NCT00300846|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110306957|NCT00300846|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110285270|NCT00207311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110285271|NCT00207311|Antiviral Agents|antiviral agents|mesh-ancestor
110285272|NCT00207311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110285273|NCT00207311|Immunologic Factors|immunologic factors|mesh-ancestor
110285274|NCT00207311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285275|NCT00207311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110285276|NCT00207311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110285277|NCT00207311|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110285278|NCT00207311|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110368723|NCT04617015|Respiratory System Agents|respiratory system agents|mesh-ancestor
110368724|NCT04617015|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110368725|NCT04617015|Cholinergic Agents|cholinergic agents|mesh-ancestor
110306958|NCT00300846|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110306960|NCT00294996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110306961|NCT00294996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110306962|NCT00294996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110306977|NCT00265031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110306978|NCT00265031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110306979|NCT00265031|Alkylating Agents|alkylating agents|mesh-ancestor
110306980|NCT00265031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110306981|NCT00265031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110306982|NCT00265031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110306983|NCT00265031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110306984|NCT00265031|Glucocorticoids|glucocorticoids|mesh-ancestor
110306986|NCT00265031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110306987|NCT00265031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110306988|NCT00265031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110306989|NCT00265031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110306990|NCT00265031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110306991|NCT00265031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110306992|NCT00265031|Tubulin Modulators|tubulin modulators|mesh-ancestor
110306993|NCT00265031|Antimitotic Agents|antimitotic agents|mesh-ancestor
110306994|NCT00265031|Mitosis Modulators|mitosis modulators|mesh-ancestor
110306995|NCT00265031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110306996|NCT00300924|Acetaminophen|acetaminophen|mesh-list
110306997|NCT00300924|Rizatriptan|rizatriptan|mesh-list
110306998|NCT00300924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110306999|NCT00300924|Analgesics|analgesics|mesh-ancestor
110307000|NCT00300924|Sensory System Agents|sensory system agents|mesh-ancestor
110307001|NCT00300924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110022991|NCT00003288|Cyclophosphamide|cyclophosphamide|mesh-list
110307002|NCT00300924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110307003|NCT00300924|Antipyretics|antipyretics|mesh-ancestor
110307004|NCT00300924|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110307005|NCT00300924|Serotonin Agents|serotonin agents|mesh-ancestor
110307006|NCT00300924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110307007|NCT00300924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307008|NCT00265070|Gefitinib|gefitinib|mesh-list
110307009|NCT00265070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110307010|NCT00265070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110307011|NCT00265070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110307012|NCT00265070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307013|NCT00295035|Celecoxib|celecoxib|mesh-list
110307014|NCT00295035|Curcumin|curcumin|mesh-list
110307015|NCT00295035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110307016|NCT00295035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110307017|NCT00295035|Analgesics|analgesics|mesh-ancestor
110307018|NCT00295035|Sensory System Agents|sensory system agents|mesh-ancestor
110307019|NCT00295035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110307020|NCT00295035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110307021|NCT00295035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110307022|NCT00295035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110368727|NCT04617015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110368728|NCT04650828|Tenofovir|tenofovir|mesh-list
110368729|NCT04650828|Antiviral Agents|antiviral agents|mesh-ancestor
110368730|NCT04650828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110368731|NCT04650828|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110368732|NCT04650828|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110368733|NCT04650828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110368734|NCT04650828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110368735|NCT04650828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110368736|NCT04650828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110368737|NCT04650555|Genistein|genistein|mesh-list
110368738|NCT04650555|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110368739|NCT04650555|Protective Agents|protective agents|mesh-ancestor
110368740|NCT04650555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368741|NCT04650555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110368742|NCT04650555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110368743|NCT04650555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110368744|NCT04650555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110368745|NCT04650555|Phytoestrogens|phytoestrogens|mesh-ancestor
110368746|NCT04650555|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110368747|NCT04650555|Estrogens|estrogens|mesh-ancestor
110307023|NCT00295035|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110307024|NCT00295035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110307025|NCT00295035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110307031|NCT00265265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110307032|NCT00265265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307033|NCT00265265|Adrenergic Agents|adrenergic agents|mesh-ancestor
110307034|NCT00265265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110307035|NCT00265265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110307036|NCT00418275|Plasminogen|plasminogen|mesh-list
110307037|NCT00418275|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110307038|NCT00418275|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110307039|NCT00418275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307041|NCT00265304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110307042|NCT00265304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110307043|NCT00265304|Analgesics|analgesics|mesh-ancestor
110023014|NCT00003330|Interleukin-12|interleukin-12|mesh-list
110307044|NCT00265304|Sensory System Agents|sensory system agents|mesh-ancestor
110307045|NCT00265304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110307046|NCT00265304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110307047|NCT00265304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110307048|NCT00265304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110307049|NCT00265304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110307050|NCT00265304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110307051|NCT00265304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307052|NCT00295191|Dialysis Solutions|dialysis solutions|mesh-list
110307053|NCT00295191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110307054|NCT00265460|Lobeline|lobeline|mesh-list
110307055|NCT00265460|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110307056|NCT00265460|Autonomic Agents|autonomic agents|mesh-ancestor
110368749|NCT04650555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110368750|NCT05181683|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
110368751|NCT05181683|Antiviral Agents|antiviral agents|mesh-ancestor
110368752|NCT05181683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110368753|NCT04650321|Ocrelizumab|ocrelizumab|mesh-list
110368754|NCT04650321|Immunologic Factors|immunologic factors|mesh-ancestor
110368755|NCT04650321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368756|NCT05153525|Cisatracurium|cisatracurium|mesh-list
110368757|NCT05153525|Atracurium|atracurium|mesh-list
110368758|NCT05153525|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110368759|NCT05153525|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110368760|NCT05153525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110368761|NCT05153525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368762|NCT05153525|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110368763|NCT05153525|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
110368764|NCT05153525|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110368765|NCT05153525|Cholinergic Agents|cholinergic agents|mesh-ancestor
110368766|NCT05153525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110307057|NCT00265460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110307058|NCT00265460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110307059|NCT00265460|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110307060|NCT00265460|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110307061|NCT00265460|Cholinergic Agents|cholinergic agents|mesh-ancestor
110307062|NCT00265460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110307063|NCT00265460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307064|NCT00265460|Respiratory System Agents|respiratory system agents|mesh-ancestor
110307065|NCT00301002|Alefacept|alefacept|mesh-list
110307066|NCT00301002|Dermatologic Agents|dermatologic agents|mesh-ancestor
110307067|NCT00301002|Immunologic Factors|immunologic factors|mesh-ancestor
110307068|NCT00301002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110307069|NCT00265694|Carboplatin|carboplatin|mesh-list
110307070|NCT00265694|Gemcitabine|gemcitabine|mesh-list
110307071|NCT00265694|Vinorelbine|vinorelbine|mesh-list
110307072|NCT00265694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110307073|NCT00265694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110307074|NCT00265694|Antimetabolites|antimetabolites|mesh-ancestor
110307075|NCT00265694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110023029|NCT00003336|Immunologic Factors|immunologic factors|mesh-ancestor
110307076|NCT00265694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110307077|NCT00265694|Tubulin Modulators|tubulin modulators|mesh-ancestor
110307078|NCT00265694|Antimitotic Agents|antimitotic agents|mesh-ancestor
110307079|NCT00265694|Mitosis Modulators|mitosis modulators|mesh-ancestor
110307080|NCT00265733|Paclitaxel|paclitaxel|mesh-list
110307081|NCT00265733|Capecitabine|capecitabine|mesh-list
110307082|NCT00265733|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
110307083|NCT00265733|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110307084|NCT00265733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110307085|NCT00265733|Tubulin Modulators|tubulin modulators|mesh-ancestor
110307086|NCT00265733|Antimitotic Agents|antimitotic agents|mesh-ancestor
110307087|NCT00265733|Mitosis Modulators|mitosis modulators|mesh-ancestor
110307088|NCT00265733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307089|NCT00265733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110307090|NCT00265733|Antimetabolites|antimetabolites|mesh-ancestor
110368767|NCT05153525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110368769|NCT04649892|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110368770|NCT04649892|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110368771|NCT04649892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368772|NCT04649892|Sensory System Agents|sensory system agents|mesh-ancestor
110368773|NCT04649892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110368774|NCT05125796|Acetaminophen|acetaminophen|mesh-list
110368775|NCT05125796|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
110368776|NCT05125796|Ketoprofen|ketoprofen|mesh-list
110368777|NCT05125796|Lidocaine|lidocaine|mesh-list
110368778|NCT05125796|Anesthetics, Local|anesthetics, local|mesh-ancestor
110368779|NCT05125796|Anesthetics|anesthetics|mesh-ancestor
110368780|NCT05125796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110368781|NCT05125796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368782|NCT05125796|Sensory System Agents|sensory system agents|mesh-ancestor
110285321|NCT00207662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110285322|NCT00207662|Dermatologic Agents|dermatologic agents|mesh-ancestor
110285323|NCT00207662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110285324|NCT00207662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110285325|NCT00207701|Infliximab|infliximab|mesh-list
110285326|NCT00207701|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110285391|NCT01089556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110285392|NCT01089556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110285394|NCT01089556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110285395|NCT01089556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110285396|NCT01089556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110285397|NCT01089556|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110285398|NCT01089556|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110285399|NCT01089556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110285400|NCT01089556|Antidepressive Agents|antidepressive agents|mesh-ancestor
110285401|NCT01089556|Dopamine Agents|dopamine agents|mesh-ancestor
110285403|NCT00233376|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110285404|NCT00233376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110285405|NCT00233376|Antitubercular Agents|antitubercular agents|mesh-ancestor
110285406|NCT00237159|Zoledronic Acid|zoledronic acid|mesh-list
110285407|NCT00237159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110285408|NCT00237159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285443|NCT00233532|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110285444|NCT00233532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110285445|NCT00233532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110285446|NCT00233532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110285447|NCT00233532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285448|NCT00233532|Vasodilator Agents|vasodilator agents|mesh-ancestor
110285449|NCT00233532|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110285450|NCT00233532|Protease Inhibitors|protease inhibitors|mesh-ancestor
110285451|NCT00233532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110285452|NCT00233532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110285453|NCT00233571|Adalimumab|adalimumab|mesh-list
110285454|NCT00233571|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110285455|NCT00233571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110285456|NCT00233571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110285457|NCT00237198|Letrozole|letrozole|mesh-list
110285458|NCT00237198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110285459|NCT00237198|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110285460|NCT00237198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110285461|NCT00237198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110285462|NCT00237198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110285463|NCT00237198|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110285464|NCT00237198|Hormone Antagonists|hormone antagonists|mesh-ancestor
110285465|NCT00237198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110285492|NCT00208169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110285493|NCT00208169|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110285494|NCT00208169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110285495|NCT00208169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110285496|NCT00208169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285497|NCT00208169|Dopamine Agonists|dopamine agonists|mesh-ancestor
110285498|NCT00208169|Dopamine Agents|dopamine agents|mesh-ancestor
110285499|NCT00208169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110285500|NCT00208169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110285501|NCT00208169|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110285502|NCT00208169|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110285504|NCT00208169|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110285505|NCT00208169|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110285506|NCT00208169|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110285507|NCT00208169|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110285549|NCT01085734|Growth Substances|growth substances|mesh-ancestor
110285550|NCT01085734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285551|NCT01085734|Growth Inhibitors|growth inhibitors|mesh-ancestor
110285552|NCT00208403|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
110285553|NCT00208403|Vasodilator Agents|vasodilator agents|mesh-ancestor
110285554|NCT00208403|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110285555|NCT00208403|Protective Agents|protective agents|mesh-ancestor
110285556|NCT00208403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285558|NCT01084603|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110285559|NCT01084603|Autonomic Agents|autonomic agents|mesh-ancestor
110285560|NCT01084603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110285561|NCT01084603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285562|NCT01084603|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110285568|NCT00208442|Diuretics|diuretics|mesh-ancestor
110285610|NCT00237393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110285611|NCT00237393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285612|NCT00208559|Ziprasidone|ziprasidone|mesh-list
110285613|NCT00208559|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110285614|NCT00208559|Serotonin Agents|serotonin agents|mesh-ancestor
110285615|NCT00208559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110285616|NCT00208559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110285617|NCT00208559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285618|NCT00208559|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110285676|NCT00208793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285677|NCT00208793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110285678|NCT00208793|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110285679|NCT00233883|Enfuvirtide|enfuvirtide|mesh-list
110285680|NCT00233883|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110285681|NCT00233883|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110285682|NCT00233883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110285683|NCT00233883|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110285684|NCT00233883|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110285685|NCT00233883|Antiviral Agents|antiviral agents|mesh-ancestor
110285686|NCT00233883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110285687|NCT01081873|Leuprolide|leuprolide|mesh-list
110285688|NCT01081873|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110285689|NCT01081873|Fertility Agents|fertility agents|mesh-ancestor
110285690|NCT01081873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110285691|NCT01081873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285693|NCT01081873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110285734|NCT00209222|Melphalan|melphalan|mesh-list
110285735|NCT00209222|Rituximab|rituximab|mesh-list
110285736|NCT00209222|Doxorubicin|doxorubicin|mesh-list
110285737|NCT00209222|Etoposide|etoposide|mesh-list
110285738|NCT00209222|Vincristine|vincristine|mesh-list
110285739|NCT00209222|Cisplatin|cisplatin|mesh-list
110285740|NCT00209222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110285741|NCT00209222|Immunologic Factors|immunologic factors|mesh-ancestor
110285742|NCT00209222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285743|NCT00209222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110285744|NCT00209222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110285745|NCT00209222|Alkylating Agents|alkylating agents|mesh-ancestor
110285798|NCT00209300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110285801|NCT00234234|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110285802|NCT00234234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110285803|NCT00234234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110285804|NCT00237588|Losartan|losartan|mesh-list
110285805|NCT00237588|Amlodipine|amlodipine|mesh-list
110285806|NCT00237588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110285807|NCT00237588|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110285808|NCT00237588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110285809|NCT00237588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110285810|NCT00237588|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110285811|NCT00237588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285812|NCT00237588|Vasodilator Agents|vasodilator agents|mesh-ancestor
110285813|NCT00237588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110285814|NCT00237588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110285815|NCT00237588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110285816|NCT00411437|Tolterodine Tartrate|tolterodine tartrate|mesh-list
110285817|NCT00411437|Oxybutynin|oxybutynin|mesh-list
110285818|NCT00411437|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110285819|NCT00411437|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110285852|NCT00237627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110285853|NCT00237627|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110285854|NCT00237627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110285855|NCT00237627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110285856|NCT00237627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110285857|NCT00209495|Dexamethasone|dexamethasone|mesh-list
110285858|NCT00209495|Pregabalin|pregabalin|mesh-list
110285859|NCT00209495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110285860|NCT00209495|Antiemetics|antiemetics|mesh-ancestor
110285861|NCT00209495|Autonomic Agents|autonomic agents|mesh-ancestor
110285862|NCT00209495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110285863|NCT00209495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285864|NCT00209495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110285865|NCT00209495|Glucocorticoids|glucocorticoids|mesh-ancestor
110285866|NCT00209495|Hormones|hormones|mesh-ancestor
110285867|NCT00209495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110285868|NCT00209495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110285869|NCT00209495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110285909|NCT00209612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110285910|NCT00209612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110285911|NCT01081249|Oxytocin|oxytocin|mesh-list
110285912|NCT01081249|Oxytocics|oxytocics|mesh-ancestor
110285913|NCT01081249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110285914|NCT01081249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285915|NCT00234429|Gefitinib|gefitinib|mesh-list
110285916|NCT00234429|Raltitrexed|raltitrexed|mesh-list
110285917|NCT00234429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110285918|NCT00234429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110285919|NCT00234429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110285920|NCT00234429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110285971|NCT01081132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285973|NCT00234468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110285974|NCT00234468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110285975|NCT00234468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110285976|NCT00234468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110285977|NCT01080625|Phenylephrine|phenylephrine|mesh-list
110285978|NCT01080625|Epinephrine|epinephrine|mesh-list
110285979|NCT01080625|Oxymetazoline|oxymetazoline|mesh-list
110286037|NCT00234507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110286038|NCT00234507|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110286039|NCT00234507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110286040|NCT01084330|Docetaxel|docetaxel|mesh-list
110286042|NCT01084330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110286043|NCT01084330|Tubulin Modulators|tubulin modulators|mesh-ancestor
110286044|NCT01084330|Antimitotic Agents|antimitotic agents|mesh-ancestor
110286045|NCT01084330|Mitosis Modulators|mitosis modulators|mesh-ancestor
110286046|NCT01084330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110286100|NCT00237705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110286101|NCT00237705|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110286102|NCT00237705|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110286173|NCT00209963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110286174|NCT00210002|Darbepoetin alfa|darbepoetin alfa|mesh-list
110286175|NCT00210002|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
110286176|NCT00210002|Hematinics|hematinics|mesh-ancestor
110286177|NCT02277886|Esomeprazole|esomeprazole|mesh-list
110286243|NCT00210158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110286244|NCT00210158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110286312|NCT02210104|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110286314|NCT02210182|Antifungal Agents|antifungal agents|mesh-ancestor
110023179|NCT00003426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110286315|NCT02210182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110286316|NCT02210182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110286317|NCT02210182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110286318|NCT02210182|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110286319|NCT00210509|Almotriptan|almotriptan|mesh-list
110286320|NCT00210509|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110286321|NCT00210509|Serotonin Agents|serotonin agents|mesh-ancestor
110286322|NCT00210509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110286323|NCT00210509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110286376|NCT04570345|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110286377|NCT04570345|Purinergic Agents|purinergic agents|mesh-ancestor
110286378|NCT04570345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110286379|NCT00234819|Bazedoxifene|bazedoxifene|mesh-list
110286380|NCT00234819|Estrogens|estrogens|mesh-list
110286381|NCT00234819|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110286382|NCT00234819|Hormones|hormones|mesh-ancestor
110286383|NCT00234819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110286384|NCT00234819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110286385|NCT00234819|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110286439|NCT00210782|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110286440|NCT00210782|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110286441|NCT00210782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110286442|NCT00210782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110286443|NCT00210782|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110286444|NCT00210782|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110286445|NCT00237861|Olanzapine|olanzapine|mesh-list
110286446|NCT00237861|Risperidone|risperidone|mesh-list
110286447|NCT00237861|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110286448|NCT00237861|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110286449|NCT00237861|Serotonin Agents|serotonin agents|mesh-ancestor
110286502|NCT00237939|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110286503|NCT00237939|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110286504|NCT00237939|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110286505|NCT00237939|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110286507|NCT04569214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110286508|NCT04569214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110286510|NCT00210860|Anticonvulsants|anticonvulsants|mesh-ancestor
110286511|NCT00210860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110286512|NCT00210860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110286513|NCT00210899|Vancomycin|vancomycin|mesh-list
110286514|NCT00210899|Ceftazidime|ceftazidime|mesh-list
110286515|NCT00210899|Ceftobiprole|ceftobiprole|mesh-list
110286516|NCT00210899|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
110286517|NCT00210899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110286518|NCT00210899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110286519|NCT04568863|Melatonin|melatonin|mesh-list
110286520|NCT04568863|Antioxidants|antioxidants|mesh-ancestor
110286521|NCT04568863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110286522|NCT04568863|Protective Agents|protective agents|mesh-ancestor
110286523|NCT04568863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110286524|NCT04568863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110286525|NCT00210938|Doripenem|doripenem|mesh-list
110286526|NCT00210938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110286527|NCT00210938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110286557|NCT00238056|Dopamine Agents|dopamine agents|mesh-ancestor
110286559|NCT00238056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110286560|NCT04566952|Olaparib|olaparib|mesh-list
110286561|NCT04566952|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110286562|NCT04566952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110286563|NCT04566952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110286565|NCT04567069|Vaccines|vaccines|mesh-list
110286626|NCT00211250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110286627|NCT00211250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110286629|NCT00211250|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110286630|NCT00211250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110286631|NCT00211250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110286633|NCT00238251|Gefitinib|gefitinib|mesh-list
110286635|NCT00238251|Alkylating Agents|alkylating agents|mesh-ancestor
110286696|NCT00211367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110286697|NCT00238368|Cytarabine|cytarabine|mesh-list
110286698|NCT00238368|Prednisone|prednisone|mesh-list
110286699|NCT00238368|Methylprednisolone|methylprednisolone|mesh-list
110286700|NCT00238368|Cyclophosphamide|cyclophosphamide|mesh-list
110286771|NCT02894554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110286844|NCT00211562|Protective Agents|protective agents|mesh-ancestor
110286845|NCT05427721|Thymol|thymol|mesh-list
110286846|NCT05427721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110286847|NCT05427721|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110286848|NCT05427721|Antifungal Agents|antifungal agents|mesh-ancestor
110286849|NCT00238641|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
110286850|NCT00238641|Botulinum Toxins|botulinum toxins|mesh-list
110286851|NCT00238641|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110286852|NCT00238641|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110017697|NCT05093790|Aspirin|aspirin|mesh-list
110286907|NCT00211718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110286908|NCT00211718|Cholinergic Agents|cholinergic agents|mesh-ancestor
110286909|NCT00211718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110286910|NCT00211718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110286911|NCT00211718|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110286912|NCT00211718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110286913|NCT00238719|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110286914|NCT00238719|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110286915|NCT00238719|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110286916|NCT00238719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110286971|NCT05425654|Dermatologic Agents|dermatologic agents|mesh-ancestor
110286972|NCT05425654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110286973|NCT05425654|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110287042|NCT04721301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110287043|NCT04721301|Antiviral Agents|antiviral agents|mesh-ancestor
110287044|NCT04721301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110287045|NCT04721301|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110287046|NCT00238992|Mycophenolic Acid|mycophenolic acid|mesh-list
110287047|NCT00238992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110287048|NCT00238992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110287049|NCT00238992|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110287113|NCT00239070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110287114|NCT00239070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110287115|NCT00239070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287117|NCT00211952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110287118|NCT00211952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110287120|NCT00211952|Sensory System Agents|sensory system agents|mesh-ancestor
110287121|NCT00211952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110287122|NCT00211952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110287123|NCT00211952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110287124|NCT00211952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110287125|NCT00211952|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110287175|NCT00212108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110287176|NCT00212108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287177|NCT00212108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110287178|NCT00212108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110287179|NCT00212186|Selenium|selenium|mesh-list
110287244|NCT00239382|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110287245|NCT00239382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110287246|NCT00239382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287247|NCT00239421|Fluticasone|fluticasone|mesh-list
110287248|NCT00239421|Xhance|xhance|mesh-list
110287315|NCT00222573|Purinergic Agents|purinergic agents|mesh-ancestor
110287316|NCT00222573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110287317|NCT00222573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287318|NCT00222573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110287319|NCT00222573|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110287320|NCT00222573|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110287321|NCT00222573|Sympatholytics|sympatholytics|mesh-ancestor
110287322|NCT00222573|Autonomic Agents|autonomic agents|mesh-ancestor
110287380|NCT00239811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110287381|NCT00213278|Vinblastine|vinblastine|mesh-list
110287382|NCT00213278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110287383|NCT00213278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110287384|NCT00213278|Tubulin Modulators|tubulin modulators|mesh-ancestor
110287388|NCT00239889|Calcitonin|calcitonin|mesh-list
110287449|NCT00243672|Gemfibrozil|gemfibrozil|mesh-list
110287450|NCT00243672|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110287451|NCT00243672|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110287452|NCT00243672|Antimetabolites|antimetabolites|mesh-ancestor
110287453|NCT00243672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287454|NCT00243672|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110287455|NCT00243672|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110287456|NCT00243672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110287457|NCT00243672|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110287458|NCT00243672|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110287459|NCT00240084|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
110287510|NCT00243750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110287511|NCT00243789|Pentoxifylline|pentoxifylline|mesh-list
110287512|NCT00243789|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110287513|NCT00243789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110287514|NCT00243789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287523|NCT00214058|Docetaxel|docetaxel|mesh-list
110287579|NCT00214370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110023243|NCT00003558|Vitamins|vitamins|mesh-ancestor
110287580|NCT00214370|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110287581|NCT00214370|Anesthetics, General|anesthetics, general|mesh-ancestor
110287582|NCT00214370|Anesthetics|anesthetics|mesh-ancestor
110287583|NCT00214370|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110287584|NCT00214370|Narcotics|narcotics|mesh-ancestor
110287608|NCT00244023|Hormones|hormones|mesh-ancestor
110287647|NCT00414531|Atorvastatin|atorvastatin|mesh-list
110287648|NCT00414531|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110287649|NCT00414531|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110287650|NCT00414531|Antimetabolites|antimetabolites|mesh-ancestor
110287651|NCT00414531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287720|NCT00240630|Analgesics|analgesics|mesh-ancestor
110287721|NCT00240630|Sensory System Agents|sensory system agents|mesh-ancestor
110287722|NCT00240630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110287723|NCT00240630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110287724|NCT00240630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110287788|NCT00215345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110287789|NCT00215345|Analgesics|analgesics|mesh-ancestor
110287790|NCT00215345|Sensory System Agents|sensory system agents|mesh-ancestor
110287791|NCT00215345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110287792|NCT00215345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110287793|NCT00215345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110287794|NCT00215345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110287795|NCT00215345|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110287796|NCT00215345|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110287797|NCT00215345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110287798|NCT00240747|Quinupristin-dalfopristin|quinupristin-dalfopristin|mesh-list
110287799|NCT00240747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110287800|NCT00240747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110287801|NCT00240747|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110287802|NCT00240747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110287847|NCT00215501|Immunologic Factors|immunologic factors|mesh-ancestor
110287848|NCT00215501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110287849|NCT00215501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110287920|NCT04667299|Respiratory System Agents|respiratory system agents|mesh-ancestor
110287921|NCT04667143|Metformin|metformin|mesh-list
110287922|NCT04667143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110287923|NCT04667143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110287924|NCT00240825|Acetaminophen|acetaminophen|mesh-list
110287925|NCT00240825|Ibuprofen|ibuprofen|mesh-list
110287926|NCT00240825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110287927|NCT00240825|Analgesics|analgesics|mesh-ancestor
110287928|NCT00240825|Sensory System Agents|sensory system agents|mesh-ancestor
110287929|NCT00240825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110287930|NCT00240825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110287931|NCT00240825|Antipyretics|antipyretics|mesh-ancestor
110287932|NCT00240825|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110287933|NCT00240825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110287944|NCT00244530|Nifedipine|nifedipine|mesh-list
110287979|NCT00557011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287981|NCT00557011|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110287982|NCT00557011|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110288048|NCT00215891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110288049|NCT00215891|Antiviral Agents|antiviral agents|mesh-ancestor
110288050|NCT00215891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110288122|NCT04665310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110288123|NCT04665310|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110288124|NCT04665310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110288125|NCT04665310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110288126|NCT00241059|Mycophenolic Acid|mycophenolic acid|mesh-list
110288127|NCT00241059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110288128|NCT00241059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110288129|NCT00241059|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110288187|NCT00216281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110288188|NCT00216281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110288189|NCT00216281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110288191|NCT00216281|GABA Agents|gaba agents|mesh-ancestor
110288257|NCT00244959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110288258|NCT00244959|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110288259|NCT00244959|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110288260|NCT00244959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110288261|NCT00244959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110288262|NCT00244959|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110288263|NCT00244959|Hormone Antagonists|hormone antagonists|mesh-ancestor
110288264|NCT00244959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110288265|NCT00244959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110288267|NCT00244998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110019116|NCT00704496|Pseudoephedrine|pseudoephedrine|mesh-list
110288318|NCT00216632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110288319|NCT00216632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110288321|NCT00216632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110288322|NCT00216632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110288323|NCT00216632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110288324|NCT00216632|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110288327|NCT04662736|Tedizolid|tedizolid|mesh-list
110288387|NCT00216866|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110288388|NCT00216866|Warfarin|warfarin|mesh-list
110288389|NCT00216866|Anticoagulants|anticoagulants|mesh-ancestor
110288390|NCT00216866|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110288391|NCT00216866|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110288392|NCT00216866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110288393|NCT00557206|Docetaxel|docetaxel|mesh-list
110288394|NCT00557206|Oxaliplatin|oxaliplatin|mesh-list
110288395|NCT00557206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110288396|NCT00557206|Tubulin Modulators|tubulin modulators|mesh-ancestor
110288397|NCT00557206|Antimitotic Agents|antimitotic agents|mesh-ancestor
110288453|NCT00241488|Antimetabolites|antimetabolites|mesh-ancestor
110288454|NCT00241488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110288455|NCT00241488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110288456|NCT00241488|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110288457|NCT00241488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110288458|NCT04659499|Paclitaxel|paclitaxel|mesh-list
110288459|NCT04659499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110288460|NCT04659499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110288461|NCT04659499|Tubulin Modulators|tubulin modulators|mesh-ancestor
110288462|NCT04659499|Antimitotic Agents|antimitotic agents|mesh-ancestor
110288463|NCT04659499|Mitosis Modulators|mitosis modulators|mesh-ancestor
110288464|NCT04659499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110288465|NCT00241527|Esomeprazole|esomeprazole|mesh-list
110288466|NCT00241527|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110288467|NCT00241527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110288468|NCT00241527|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110288469|NCT00241527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110288470|NCT00241527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110288471|NCT04648813|Bromides|bromides|mesh-list
110288472|NCT04648813|Tiotropium Bromide|tiotropium bromide|mesh-list
110288473|NCT04648813|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110288474|NCT04648813|Autonomic Agents|autonomic agents|mesh-ancestor
110288475|NCT04648813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110288476|NCT04648813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110288477|NCT04648813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110288485|NCT04648423|Sodium Oxybate|sodium oxybate|mesh-list
110288502|NCT00558181|Immunologic Factors|immunologic factors|mesh-ancestor
110288503|NCT00558181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110288504|NCT00558181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110288505|NCT00558181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110288507|NCT00558181|Autonomic Agents|autonomic agents|mesh-ancestor
110288508|NCT00558181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110288509|NCT00558181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110288510|NCT00558181|Glucocorticoids|glucocorticoids|mesh-ancestor
110288511|NCT00558181|Hormones|hormones|mesh-ancestor
110288512|NCT00558181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110288513|NCT00558181|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110288514|NCT00558181|Protective Agents|protective agents|mesh-ancestor
110288515|NCT00558181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110288516|NCT00558220|Immunomodulating Agents|immunomodulating agents|mesh-list
110288517|NCT00558220|Immunologic Factors|immunologic factors|mesh-ancestor
110288564|NCT00217373|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110288565|NCT00217373|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110288566|NCT04647292|Antihypertensive Agents|antihypertensive agents|mesh-list
110288636|NCT04646161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110288638|NCT04646161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110288639|NCT04646161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110288640|NCT04646161|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110288641|NCT04646161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110288642|NCT04646161|Oxytocics|oxytocics|mesh-ancestor
110288643|NCT00241722|Alvimopan|alvimopan|mesh-list
110288644|NCT00241722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110288645|NCT00558337|Levodopa|levodopa|mesh-list
110288646|NCT00558337|Carbidopa|carbidopa|mesh-list
110288647|NCT00558337|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110288648|NCT00558337|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110288650|NCT00558337|Dopamine Agents|dopamine agents|mesh-ancestor
110288651|NCT00558337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110288700|NCT04644484|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110288774|NCT00218114|Valproic Acid|valproic acid|mesh-list
110288775|NCT00218114|Anticonvulsants|anticonvulsants|mesh-ancestor
110288776|NCT00218114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110288777|NCT00218114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110288778|NCT00218114|GABA Agents|gaba agents|mesh-ancestor
110288781|NCT00218114|Antimanic Agents|antimanic agents|mesh-ancestor
110288845|NCT00218348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110288846|NCT00218348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110288847|NCT00218348|Adrenergic Agents|adrenergic agents|mesh-ancestor
110288848|NCT00218348|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110288849|NCT00218348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110288850|NCT00218348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110288851|NCT00218348|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110288853|NCT00559312|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110288854|NCT00559312|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110288855|NCT00559312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110288857|NCT00559312|Autonomic Agents|autonomic agents|mesh-ancestor
110288858|NCT00559312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110288859|NCT00559312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110288860|NCT00559312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110288861|NCT00559312|Respiratory System Agents|respiratory system agents|mesh-ancestor
110288862|NCT00559312|Dermatologic Agents|dermatologic agents|mesh-ancestor
110288863|NCT00559312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110288864|NCT00559312|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110288896|NCT00559429|Docetaxel|docetaxel|mesh-list
110288897|NCT00559429|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
110288898|NCT00559429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110288899|NCT00559429|Tubulin Modulators|tubulin modulators|mesh-ancestor
110288904|NCT00559429|Analgesics|analgesics|mesh-ancestor
110288967|NCT04639804|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110288968|NCT04639804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110288969|NCT04639804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110288971|NCT04639804|Gout Suppressants|gout suppressants|mesh-ancestor
110289039|NCT00561496|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110289040|NCT00246285|Risperidone|risperidone|mesh-list
110289041|NCT00246285|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110289042|NCT00246285|Serotonin Agents|serotonin agents|mesh-ancestor
110289043|NCT00246285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110289107|NCT04628143|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110289108|NCT04628143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110289109|NCT04628143|Immunologic Factors|immunologic factors|mesh-ancestor
110289177|NCT00246675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289247|NCT04626193|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110289248|NCT04626193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110289249|NCT04626193|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110289250|NCT04626193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110289251|NCT04626193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110289252|NCT04626193|Antimalarials|antimalarials|mesh-ancestor
110289253|NCT04626193|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110289254|NCT04626193|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110289255|NCT04626193|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110289256|NCT04626193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110289257|NCT04626193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110289258|NCT04626193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110289259|NCT04626193|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110289260|NCT04626193|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110289262|NCT00242541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110289263|NCT00242541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110289264|NCT00242541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110289304|NCT02962232|Antimitotic Agents|antimitotic agents|mesh-ancestor
110289305|NCT02962232|Mitosis Modulators|mitosis modulators|mesh-ancestor
110023417|NCT00003714|NSC 366140|nsc 366140|mesh-list
110289306|NCT02962232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110289307|NCT00246909|Pantoprazole|pantoprazole|mesh-list
110289308|NCT00246909|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110289309|NCT00246909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110289373|NCT00242775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110289374|NCT04623619|Acetylcarnitine|acetylcarnitine|mesh-list
110289375|NCT04623619|Vitamin B Complex|vitamin b complex|mesh-ancestor
110289376|NCT04623619|Vitamins|vitamins|mesh-ancestor
110289377|NCT04623619|Micronutrients|micronutrients|mesh-ancestor
110289378|NCT04623619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289379|NCT04623619|Nootropic Agents|nootropic agents|mesh-ancestor
110289380|NCT00562198|Carbidopa|carbidopa|mesh-list
110289444|NCT01580683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110289445|NCT01580683|Protective Agents|protective agents|mesh-ancestor
110289446|NCT00242814|Amlodipine|amlodipine|mesh-list
110289447|NCT00242814|Telmisartan|telmisartan|mesh-list
110289457|NCT04623385|Tretinoin|tretinoin|mesh-list
110289511|NCT04622956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110289512|NCT04622956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110289513|NCT04622956|Dermatologic Agents|dermatologic agents|mesh-ancestor
110289514|NCT04622956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110289515|NCT04622956|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110289516|NCT04622956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110289517|NCT04622956|Immunologic Factors|immunologic factors|mesh-ancestor
110289518|NCT04622956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110289519|NCT04622956|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110289520|NCT04622566|Pembrolizumab|pembrolizumab|mesh-list
110289521|NCT04622566|Lenvatinib|lenvatinib|mesh-list
110289522|NCT04622566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110289523|NCT04622566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110289524|NCT04622566|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110289525|NCT04622566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110289526|NCT04622566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110289527|NCT04622566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110289567|NCT04621669|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110289568|NCT04621669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110289569|NCT04621669|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110289570|NCT04621669|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110289571|NCT04621669|Protective Agents|protective agents|mesh-ancestor
110289573|NCT00412646|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110289635|NCT00220493|Methylphenidate|methylphenidate|mesh-list
110289712|NCT04619914|Hormone Antagonists|hormone antagonists|mesh-ancestor
110289713|NCT04619914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110289714|NCT04619914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289782|NCT00220922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289783|NCT00221000|Methoxsalen|methoxsalen|mesh-list
110289784|NCT00221000|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110289785|NCT00221000|Dermatologic Agents|dermatologic agents|mesh-ancestor
110289848|NCT00221312|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110289849|NCT00221312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289850|NCT04616872|Methotrexate|methotrexate|mesh-list
110289916|NCT00563056|Respiratory System Agents|respiratory system agents|mesh-ancestor
110289917|NCT00563056|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110289992|NCT04615702|Opiate Alkaloids|opiate alkaloids|mesh-list
110289993|NCT04615702|Secretin|secretin|mesh-list
110289994|NCT04615702|Bilirubin|bilirubin|mesh-list
110289995|NCT04615702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289996|NCT04615702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110289997|NCT04615702|Analgesics|analgesics|mesh-ancestor
110290019|NCT04615702|Hormones|hormones|mesh-ancestor
110290063|NCT00563485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290064|NCT00563485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110290065|NCT00563485|Urological Agents|urological agents|mesh-ancestor
110290067|NCT00251277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110290068|NCT00251277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110290069|NCT00251277|Immunologic Factors|immunologic factors|mesh-ancestor
110290070|NCT00251277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110290071|NCT00251277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110290072|NCT00412802|Enoxaparin|enoxaparin|mesh-list
110290073|NCT00412802|Enoxaparin sodium|enoxaparin sodium|mesh-list
110290078|NCT00563524|Fezakinumab|fezakinumab|mesh-list
110290129|NCT00248118|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110290130|NCT00248118|Antidepressive Agents|antidepressive agents|mesh-ancestor
110290131|NCT00248118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110290132|NCT00248118|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110290133|NCT00248118|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110290134|NCT00248118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110290135|NCT00248118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290136|NCT00248118|Dopamine Agents|dopamine agents|mesh-ancestor
110290137|NCT00248118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110290138|NCT00248118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110290139|NCT00248118|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110021001|NCT00002382|Saquinavir|saquinavir|mesh-list
110290140|NCT00248118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110290141|NCT00248118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110290142|NCT04612894|Apatinib|apatinib|mesh-list
110290186|NCT04612582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110290187|NCT04612582|Growth Substances|growth substances|mesh-ancestor
110290189|NCT00248157|Octreotide|octreotide|mesh-list
110290258|NCT00563875|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110290259|NCT00563875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110290260|NCT00563875|Antipyretics|antipyretics|mesh-ancestor
110290261|NCT04611685|Parecoxib|parecoxib|mesh-list
110290331|NCT00564031|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110290332|NCT00564031|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110290338|NCT02961426|Sofosbuvir|sofosbuvir|mesh-list
110290403|NCT00222677|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110290404|NCT00222677|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110290405|NCT00222677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290406|NCT00222677|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110290407|NCT00222677|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110290408|NCT00222677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110290410|NCT00564460|Finasteride|finasteride|mesh-list
110290411|NCT00564460|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110290412|NCT00564460|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110290413|NCT00564460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110290414|NCT00564460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290415|NCT00564460|Hormone Antagonists|hormone antagonists|mesh-ancestor
110290419|NCT04609033|Ketamine|ketamine|mesh-list
110290463|NCT00222833|Aripiprazole|aripiprazole|mesh-list
110290464|NCT00222833|Antidepressive Agents|antidepressive agents|mesh-ancestor
110290465|NCT00222833|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110290466|NCT00222833|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110290467|NCT00222833|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110290468|NCT00222833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110290469|NCT00222833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110290530|NCT04607629|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110290531|NCT04607629|Autonomic Agents|autonomic agents|mesh-ancestor
110290532|NCT04607629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110290533|NCT04607629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110290534|NCT04607629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110290600|NCT04606537|Antifungal Agents|antifungal agents|mesh-ancestor
110290601|NCT04606537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110290602|NCT04606537|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110290603|NCT04606537|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110290668|NCT00564772|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110290669|NCT00564772|Protease Inhibitors|protease inhibitors|mesh-ancestor
110290670|NCT00564772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110290740|NCT04603729|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110290741|NCT04603729|Prednisolone phosphate|prednisolone phosphate|mesh-list
110290742|NCT04603729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110290743|NCT04603729|Antiemetics|antiemetics|mesh-ancestor
110290744|NCT04603729|Autonomic Agents|autonomic agents|mesh-ancestor
110290745|NCT04603729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110290810|NCT00565240|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110290811|NCT00565240|Hormone Antagonists|hormone antagonists|mesh-ancestor
110290812|NCT00565240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110290881|NCT00565318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290882|NCT05201144|Sildenafil Citrate|sildenafil citrate|mesh-list
110290883|NCT05201144|Vasodilator Agents|vasodilator agents|mesh-ancestor
110290884|NCT05201144|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110290885|NCT05201144|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110290886|NCT05201144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110290887|NCT05201144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290888|NCT05201144|Urological Agents|urological agents|mesh-ancestor
110290890|NCT00252408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110290891|NCT00252408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110290892|NCT04601389|Omalizumab|omalizumab|mesh-list
110290943|NCT00414648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110290944|NCT00414648|Immunologic Factors|immunologic factors|mesh-ancestor
110290945|NCT00414648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110290946|NCT00414648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110290947|NCT00414648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110290948|NCT00414648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110290949|NCT00414687|Iloprost|iloprost|mesh-list
110290951|NCT00414687|Vasodilator Agents|vasodilator agents|mesh-ancestor
110291009|NCT00565630|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110291010|NCT00565630|Contraceptive Agents|contraceptive agents|mesh-ancestor
110291011|NCT00565630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110291012|NCT00565630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110291079|NCT00565981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110291080|NCT00565981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110291081|NCT00565981|Antimetabolites|antimetabolites|mesh-ancestor
110291082|NCT00565981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110291083|NCT00565981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110291084|NCT00565981|Immunologic Factors|immunologic factors|mesh-ancestor
110291085|NCT00565981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110291086|NCT00565981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110291087|NCT04952519|Amantadine|amantadine|mesh-list
110291088|NCT04952519|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110291089|NCT04952519|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110291141|NCT00249210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110291142|NCT00249210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110291143|NCT00249210|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110291144|NCT00249210|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110291146|NCT00252798|Carboplatin|carboplatin|mesh-list
110291147|NCT00252798|Gefitinib|gefitinib|mesh-list
110291148|NCT00252798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110291209|NCT04595812|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110291210|NCT04595812|Abortifacient Agents|abortifacient agents|mesh-ancestor
110291283|NCT00566683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110291284|NCT00566683|Anesthetics, General|anesthetics, general|mesh-ancestor
110291285|NCT00566683|Anesthetics|anesthetics|mesh-ancestor
110291286|NCT00566683|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110291287|NCT00566683|Narcotics|narcotics|mesh-ancestor
110291288|NCT00566683|Analgesics|analgesics|mesh-ancestor
110291289|NCT00566683|Sensory System Agents|sensory system agents|mesh-ancestor
110291290|NCT00566683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110291291|NCT00566683|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110291292|NCT00566683|Anticonvulsants|anticonvulsants|mesh-ancestor
110291352|NCT04593706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110291353|NCT04593706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110291354|NCT04593706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110291356|NCT04593706|Protective Agents|protective agents|mesh-ancestor
110291421|NCT04484363|Azacitidine|azacitidine|mesh-list
110291422|NCT04484363|Pevonedistat|pevonedistat|mesh-list
110291423|NCT04484363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110291424|NCT04484363|Antimetabolites|antimetabolites|mesh-ancestor
110291425|NCT04484363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110291426|NCT04484363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110291427|NCT04484363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110291486|NCT04719585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110291487|NCT04719585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110291488|NCT04719585|Antidepressive Agents|antidepressive agents|mesh-ancestor
110291489|NCT04719585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110291557|NCT04590742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110291631|NCT04589494|Sensory System Agents|sensory system agents|mesh-ancestor
110291632|NCT04589494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110291633|NCT04589299|Immunoglobulins|immunoglobulins|mesh-list
110291634|NCT04589299|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110291636|NCT04589299|Immunologic Factors|immunologic factors|mesh-ancestor
110291637|NCT04589299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110291638|NCT00253500|Epirubicin|epirubicin|mesh-list
110291699|NCT00253578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110291701|NCT04588285|Expectorants|expectorants|mesh-ancestor
110291702|NCT04588285|Respiratory System Agents|respiratory system agents|mesh-ancestor
110291703|NCT04153565|Pembrolizumab|pembrolizumab|mesh-list
110291704|NCT04153565|Pemetrexed|pemetrexed|mesh-list
110291705|NCT04153565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110291706|NCT04153565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110291707|NCT04153565|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110291708|NCT04153565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110291763|NCT04587115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110291764|NCT04587115|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110291765|NCT04587115|Dopamine Agents|dopamine agents|mesh-ancestor
110291766|NCT00403247|Vitamin B 12|vitamin b 12|mesh-list
110291767|NCT00403247|Hydroxocobalamin|hydroxocobalamin|mesh-list
110291768|NCT00403247|Pyridoxine|pyridoxine|mesh-list
110291769|NCT00403247|Vitamins|vitamins|mesh-ancestor
110291770|NCT00403247|Micronutrients|micronutrients|mesh-ancestor
110291771|NCT00403247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110291772|NCT00403247|Vitamin B Complex|vitamin b complex|mesh-ancestor
110291773|NCT00403247|Hematinics|hematinics|mesh-ancestor
110291830|NCT04585438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110291831|NCT04585438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110291832|NCT04585438|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110291833|NCT04585438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110291834|NCT04585438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110291835|NCT00223223|Levetiracetam|levetiracetam|mesh-list
110291836|NCT00223223|Anticonvulsants|anticonvulsants|mesh-ancestor
110291837|NCT00223223|Nootropic Agents|nootropic agents|mesh-ancestor
110291897|NCT00568048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110291898|NCT00568048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110291899|NCT00568048|Growth Substances|growth substances|mesh-ancestor
110291900|NCT00568048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110291901|NCT00568048|Growth Inhibitors|growth inhibitors|mesh-ancestor
110291902|NCT00568048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110291903|NCT00568048|Alkylating Agents|alkylating agents|mesh-ancestor
110291904|NCT00568048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110291965|NCT04584034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110291966|NCT04584034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110291967|NCT04584034|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110291968|NCT04584034|Respiratory System Agents|respiratory system agents|mesh-ancestor
110291969|NCT04584034|Tocolytic Agents|tocolytic agents|mesh-ancestor
110291970|NCT04584034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110291971|NCT04584034|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110291972|NCT04584034|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110292031|NCT00223691|Tranylcypromine|tranylcypromine|mesh-list
110292032|NCT00223691|Caffeine|caffeine|mesh-list
110292033|NCT00223691|Methylphenidate|methylphenidate|mesh-list
110292034|NCT00223691|Modafinil|modafinil|mesh-list
110292035|NCT00223691|Rivastigmine|rivastigmine|mesh-list
110292036|NCT00223691|Ranitidine|ranitidine|mesh-list
110292037|NCT00223691|Yohimbine|yohimbine|mesh-list
110292102|NCT00223691|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110292103|NCT00223691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110292104|NCT00223691|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110292105|NCT00223691|Immunologic Factors|immunologic factors|mesh-ancestor
110292106|NCT00223691|Dopamine Agonists|dopamine agonists|mesh-ancestor
110292107|NCT00223691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110292172|NCT00254085|Insulin Aspart|insulin aspart|mesh-list
110292173|NCT00254085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110292174|NCT00254085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110292175|NCT04581967|Cyclophosphamide|cyclophosphamide|mesh-list
110292176|NCT04581967|Doxorubicin|doxorubicin|mesh-list
110292242|NCT00415116|Immunologic Factors|immunologic factors|mesh-ancestor
110292243|NCT00415116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110292244|NCT00415116|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110292314|NCT00224354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110292315|NCT00224354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110292317|NCT00224354|Immunologic Factors|immunologic factors|mesh-ancestor
110292318|NCT00569296|Aldesleukin|aldesleukin|mesh-list
110292319|NCT00569296|Sargramostim|sargramostim|mesh-list
110292320|NCT00569296|Immunologic Factors|immunologic factors|mesh-ancestor
110292321|NCT00569296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110292322|NCT00569296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110292383|NCT00224510|Lamotrigine|lamotrigine|mesh-list
110292384|NCT00224510|Anticonvulsants|anticonvulsants|mesh-ancestor
110292385|NCT00224510|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110292386|NCT00224510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110292390|NCT00224510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110292453|NCT00254475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110292454|NCT00254475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110292455|NCT00254475|Antimetabolites|antimetabolites|mesh-ancestor
110292457|NCT00254475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110292526|NCT00254631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110292527|NCT00254631|Analgesics|analgesics|mesh-ancestor
110292528|NCT00254631|Sensory System Agents|sensory system agents|mesh-ancestor
110292530|NCT00571285|Vitamin D|vitamin d|mesh-list
110292596|NCT00224822|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110292597|NCT00224822|Serotonin Agents|serotonin agents|mesh-ancestor
110292598|NCT00224822|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110292599|NCT00224822|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110292600|NCT00224822|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110292601|NCT00224822|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110292602|NCT00571870|Cetrorelix|cetrorelix|mesh-list
110292603|NCT00571870|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110292604|NCT00571870|Fertility Agents|fertility agents|mesh-ancestor
110292605|NCT00571870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110292607|NCT00571870|Hormone Antagonists|hormone antagonists|mesh-ancestor
110292658|NCT00234936|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110292659|NCT00234936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110292660|NCT00234936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110292661|NCT00234936|Antimetabolites|antimetabolites|mesh-ancestor
110292673|NCT00413075|Belinostat|belinostat|mesh-list
110292728|NCT00573001|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110292729|NCT00573001|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110292730|NCT00573001|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110292731|NCT00573001|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110292732|NCT00573001|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110292733|NCT00254787|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110292734|NCT00254787|Antidepressive Agents|antidepressive agents|mesh-ancestor
110292797|NCT00235014|Trandolapril|trandolapril|mesh-list
110292798|NCT00235014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110292799|NCT00235014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110292800|NCT00235014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110292801|NCT00235014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110292802|NCT00235014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110292803|NCT00235014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110292804|NCT00235014|Vasodilator Agents|vasodilator agents|mesh-ancestor
110292805|NCT00235014|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110292806|NCT00235014|Protease Inhibitors|protease inhibitors|mesh-ancestor
110292807|NCT00235014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110292808|NCT00235014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110292809|NCT00225290|Thalidomide|thalidomide|mesh-list
110292810|NCT00225290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110292811|NCT00225290|Immunologic Factors|immunologic factors|mesh-ancestor
110292812|NCT00225290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110023588|NCT00003876|Carmustine|carmustine|mesh-list
110292853|NCT00573742|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110292854|NCT00573742|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110292855|NCT00573742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110292856|NCT00254865|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110292857|NCT00254865|Norelgestromin|norelgestromin|mesh-list
110292858|NCT00254865|Contraceptive Agents|contraceptive agents|mesh-list
110292860|NCT00254865|Estrogens|estrogens|mesh-ancestor
110292861|NCT00254865|Hormones|hormones|mesh-ancestor
110292862|NCT00254865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110292863|NCT00254865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110292864|NCT00254865|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110292914|NCT00225485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110292915|NCT00225485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110292916|NCT00225485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110292917|NCT00225485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110292983|NCT00574639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110292984|NCT00574639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110292985|NCT00574639|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110292986|NCT00574639|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110292987|NCT00574639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110293052|NCT00591487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293053|NCT00225875|Rituximab|rituximab|mesh-list
110293054|NCT00225875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110293063|NCT00255372|Lactulose|lactulose|mesh-list
110293123|NCT04575064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293124|NCT04575064|Antiviral Agents|antiviral agents|mesh-ancestor
110293125|NCT04575064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110293126|NCT03451318|Mometasone Furoate|mometasone furoate|mesh-list
110293127|NCT03451318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110293128|NCT03451318|Dermatologic Agents|dermatologic agents|mesh-ancestor
110293129|NCT03451318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110293130|NCT00255450|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
110293131|NCT00255450|Hematinics|hematinics|mesh-ancestor
110293132|NCT00255450|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110293133|NCT00255450|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110293134|NCT04573855|Immunoglobulins|immunoglobulins|mesh-list
110293135|NCT04573855|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110293136|NCT04573855|Antibodies|antibodies|mesh-list
110293137|NCT04573855|Immunologic Factors|immunologic factors|mesh-ancestor
110293138|NCT04573855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110293139|NCT00226109|Spironolactone|spironolactone|mesh-list
110293182|NCT00255528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110293183|NCT00255528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110293184|NCT00255528|Sympatholytics|sympatholytics|mesh-ancestor
110293185|NCT00255528|Autonomic Agents|autonomic agents|mesh-ancestor
110293186|NCT00255528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110293187|NCT00255528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110293188|NCT00255528|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110293191|NCT00255528|Adrenergic Agents|adrenergic agents|mesh-ancestor
110293248|NCT00226343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110293249|NCT00226343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110293250|NCT00226343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110293252|NCT03450499|Analgesics|analgesics|mesh-ancestor
110293253|NCT03450499|Sensory System Agents|sensory system agents|mesh-ancestor
110293254|NCT03450499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110293255|NCT03450499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110293256|NCT03450499|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110293257|NCT03450499|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110293258|NCT03450499|Anesthetics, General|anesthetics, general|mesh-ancestor
110293259|NCT03450499|Anesthetics|anesthetics|mesh-ancestor
110293263|NCT03450499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110293309|NCT00413387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110293310|NCT00413387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110293311|NCT00413387|Respiratory System Agents|respiratory system agents|mesh-ancestor
110293312|NCT00413387|Glucocorticoids|glucocorticoids|mesh-ancestor
110293313|NCT00413387|Hormones|hormones|mesh-ancestor
110293314|NCT00413387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110293315|NCT00413387|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110293316|NCT00413387|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110293317|NCT00413387|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110293374|NCT00255879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110293375|NCT00255879|Antidepressive Agents|antidepressive agents|mesh-ancestor
110293377|NCT00413504|Fondaparinux|fondaparinux|mesh-list
110293378|NCT00413504|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110293379|NCT00413504|Antithrombins|antithrombins|mesh-ancestor
110293380|NCT00413504|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110293381|NCT00413504|Protease Inhibitors|protease inhibitors|mesh-ancestor
110293382|NCT00413504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110293383|NCT00413504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293384|NCT00413504|Anticoagulants|anticoagulants|mesh-ancestor
110293385|NCT00413504|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110293435|NCT00226538|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110293436|NCT00255918|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
110023638|NCT00003912|Carboplatin|carboplatin|mesh-list
110293437|NCT00255918|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110293438|NCT00255918|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110293502|NCT00235560|Immunologic Factors|immunologic factors|mesh-ancestor
110293503|NCT00235560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110293504|NCT00227318|Candesartan cilexetil|candesartan cilexetil|mesh-list
110293573|NCT00256269|Irinotecan|irinotecan|mesh-list
110293574|NCT00256269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110293575|NCT00256269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110293576|NCT00256269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110293577|NCT00256269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110293642|NCT00227942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110293643|NCT00227942|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110293644|NCT00227942|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110293714|NCT00236067|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
110293715|NCT00236067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110293716|NCT00236067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110293717|NCT00236067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293718|NCT00236067|GABA Agents|gaba agents|mesh-ancestor
110293719|NCT00236067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110293720|NCT00236067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110293721|NCT00195715|Adalimumab|adalimumab|mesh-list
110293722|NCT00195715|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110293723|NCT00195715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110293724|NCT00195715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110293725|NCT00236106|Mometasone Furoate|mometasone furoate|mesh-list
110293726|NCT00236106|Tacrolimus|tacrolimus|mesh-list
110293727|NCT00236106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110293728|NCT00236106|Immunologic Factors|immunologic factors|mesh-ancestor
110293729|NCT00236106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110293771|NCT00194077|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110293772|NCT00194077|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110293773|NCT00194077|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110293774|NCT00193609|Capecitabine|capecitabine|mesh-list
110293775|NCT00193609|Oxaliplatin|oxaliplatin|mesh-list
110293776|NCT00193609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110293777|NCT00193609|Antimetabolites|antimetabolites|mesh-ancestor
110293778|NCT00193609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293779|NCT00193609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110293780|NCT00228410|Vancomycin|vancomycin|mesh-list
110293781|NCT00228410|Tigecycline|tigecycline|mesh-list
110293782|NCT00228410|Aztreonam|aztreonam|mesh-list
110293783|NCT00228410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110293784|NCT00228410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110293785|NCT00228410|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110293788|NCT00193180|Docetaxel|docetaxel|mesh-list
110293833|NCT00228605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110293834|NCT00228605|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110293835|NCT00228605|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110293906|NCT00256893|Dopamine Agonists|dopamine agonists|mesh-ancestor
110293907|NCT00256893|Dopamine Agents|dopamine agents|mesh-ancestor
110293908|NCT00256893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110293909|NCT00256893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293910|NCT00256893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110293911|NCT00229385|Ziprasidone|ziprasidone|mesh-list
110293912|NCT00229385|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110293924|NCT00236223|Ketamine|ketamine|mesh-list
110293975|NCT00257049|Levofloxacin|levofloxacin|mesh-list
110293976|NCT00257049|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110293977|NCT00257049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110293986|NCT01059188|Docetaxel|docetaxel|mesh-list
110294044|NCT00229775|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110294045|NCT00229775|Amebicides|amebicides|mesh-ancestor
110294046|NCT00229775|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110294047|NCT00229775|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110294048|NCT00229775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110294049|NCT00229775|Antimalarials|antimalarials|mesh-ancestor
110294050|NCT00229775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110294051|NCT00229775|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110294052|NCT00229775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110294053|NCT00229775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110294054|NCT00229775|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110294055|NCT00257127|Vaccines|vaccines|mesh-list
110294109|NCT00193219|Cetuximab|cetuximab|mesh-list
110294110|NCT00193219|Fluorouracil|fluorouracil|mesh-list
110294111|NCT00193219|Oxaliplatin|oxaliplatin|mesh-list
110294112|NCT00193219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110294180|NCT00199394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110294254|NCT00199745|Antimetabolites|antimetabolites|mesh-ancestor
110294255|NCT00199745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110294256|NCT00199745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110294257|NCT00199745|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110294258|NCT00199745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110294261|NCT04709172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110294262|NCT04709172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110294263|NCT00199784|Phenylephrine|phenylephrine|mesh-list
110294264|NCT00199784|Oxymetazoline|oxymetazoline|mesh-list
110294265|NCT00199784|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110294266|NCT00199784|Mydriatics|mydriatics|mesh-ancestor
110294267|NCT00199784|Autonomic Agents|autonomic agents|mesh-ancestor
110294268|NCT00199784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110294269|NCT00199784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294270|NCT00199784|Sympathomimetics|sympathomimetics|mesh-ancestor
110294271|NCT00199784|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110294272|NCT00199784|Nasal Decongestants|nasal decongestants|mesh-ancestor
110294273|NCT00199784|Respiratory System Agents|respiratory system agents|mesh-ancestor
110294274|NCT00199784|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110294275|NCT00199784|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110294276|NCT00199784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110294277|NCT00199784|Adrenergic Agents|adrenergic agents|mesh-ancestor
110294278|NCT00199784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110294279|NCT00199784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110294280|NCT00199784|Protective Agents|protective agents|mesh-ancestor
110294281|NCT00236769|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110294282|NCT00236769|Norelgestromin|norelgestromin|mesh-list
110294302|NCT00199940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110294303|NCT00199940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110294304|NCT00199940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294305|NCT00199940|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110294306|NCT00199940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110294307|NCT00199940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110023691|NCT00003960|Methylprednisolone|methylprednisolone|mesh-list
110294308|NCT00199940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110294309|NCT00199940|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110294310|NCT00199940|Dopamine Agents|dopamine agents|mesh-ancestor
110294312|NCT00236808|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110294313|NCT00236808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110294314|NCT00236808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110294315|NCT00236808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110294316|NCT00236808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110294317|NCT00236808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110294318|NCT00236808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110294319|NCT00236808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110294356|NCT00410306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110294357|NCT00410306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294358|NCT00410306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110294359|NCT00410306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110294360|NCT00410306|Anabolic Agents|anabolic agents|mesh-ancestor
110294361|NCT00257712|Hormones|hormones|mesh-list
110294362|NCT00257712|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
110294363|NCT00257712|Tesamorelin|tesamorelin|mesh-list
110294364|NCT00257712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110294365|NCT00257712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294366|NCT00257712|Growth Substances|growth substances|mesh-ancestor
110294367|NCT00179647|Dexamethasone|dexamethasone|mesh-list
110294418|NCT00236964|Epoetin Alfa|epoetin alfa|mesh-list
110294419|NCT00236964|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
110294420|NCT00236964|Hematinics|hematinics|mesh-ancestor
110294421|NCT00200252|Oxytocin|oxytocin|mesh-list
110294422|NCT00200252|Oxytocics|oxytocics|mesh-ancestor
110294423|NCT00200252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110294489|NCT00176488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110294490|NCT00176488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110294491|NCT00176488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110294493|NCT00176488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110294494|NCT00200447|Carbidopa|carbidopa|mesh-list
110294558|NCT00174265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110294559|NCT00174265|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110294560|NCT00174265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110294629|NCT00171925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294630|NCT00171925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110294631|NCT00171925|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110294632|NCT00201305|Leucovorin|leucovorin|mesh-list
110294700|NCT00201539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110294701|NCT00201539|Analgesics|analgesics|mesh-ancestor
110025626|NCT00370422|Hormones|hormones|mesh-ancestor
110294702|NCT00201539|Sensory System Agents|sensory system agents|mesh-ancestor
110294703|NCT00201539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110294704|NCT00265824|Bevacizumab|bevacizumab|mesh-list
110294705|NCT00265824|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110294706|NCT00265824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110294765|NCT00410462|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110294766|NCT00410462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110294767|NCT00410462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110294768|NCT00410462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110294769|NCT00410462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110294770|NCT00410462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110294837|NCT04709094|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110294838|NCT04709094|Antidepressive Agents|antidepressive agents|mesh-ancestor
110294839|NCT04709094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110294840|NCT04709094|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110294841|NCT04709094|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110294842|NCT04709094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110294843|NCT04709094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110294844|NCT04709094|Dopamine Agents|dopamine agents|mesh-ancestor
110294845|NCT04709094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110294846|NCT04709094|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110294847|NCT04709094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110294897|NCT00266058|Protease Inhibitors|protease inhibitors|mesh-ancestor
110294898|NCT00266058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110294899|NCT00266058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110294900|NCT00266058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110294901|NCT00266058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110294902|NCT00266058|Antiviral Agents|antiviral agents|mesh-ancestor
110294903|NCT00266058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110294904|NCT00266058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110294905|NCT00266058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110294906|NCT00266058|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110294907|NCT00266058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110294959|NCT00266136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110294960|NCT00266136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110294963|NCT00266136|Antimetabolites|antimetabolites|mesh-ancestor
110295029|NCT00479401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110295030|NCT00479401|Protective Agents|protective agents|mesh-ancestor
110295031|NCT00479401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295032|NCT00479401|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110295033|NCT00479401|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110295098|NCT00230984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110295099|NCT00230984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110295100|NCT00230984|Anabolic Agents|anabolic agents|mesh-ancestor
110295101|NCT00415350|Azithromycin|azithromycin|mesh-list
110295102|NCT00415350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110295103|NCT00415350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110295170|NCT00231452|Schistosomicides|schistosomicides|mesh-ancestor
110023741|NCT00003972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110023756|NCT00003996|Etoposide|etoposide|mesh-list
110295171|NCT00231452|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110295172|NCT00231452|Anthelmintics|anthelmintics|mesh-ancestor
110295173|NCT00231452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110295174|NCT00231452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110295175|NCT00231452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110295176|NCT00231452|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110295177|NCT00231491|Botulinum Toxins|botulinum toxins|mesh-list
110295178|NCT00231491|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110295179|NCT00231491|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110295236|NCT00266643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110295237|NCT00266643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110295238|NCT00266643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110295239|NCT00266643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295240|NCT00266643|Analgesics|analgesics|mesh-ancestor
110295241|NCT00266643|Sensory System Agents|sensory system agents|mesh-ancestor
110295242|NCT00266643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110295243|NCT00266643|Antidepressive Agents|antidepressive agents|mesh-ancestor
110295244|NCT00266643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110295245|NCT00266643|Dopamine Agents|dopamine agents|mesh-ancestor
110295246|NCT00231725|Insulin Lispro|insulin lispro|mesh-list
110295247|NCT00231725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110295248|NCT00231725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295251|NCT04560049|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110295252|NCT04560049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110295253|NCT04560049|Disinfectants|disinfectants|mesh-ancestor
110295254|NCT04560049|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
110295255|NCT04560049|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110295256|NCT04559425|Dexamethasone|dexamethasone|mesh-list
110295257|NCT04559425|Dexamethasone acetate|dexamethasone acetate|mesh-list
110295258|NCT04559425|BB 1101|bb 1101|mesh-list
110295259|NCT04559425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110295260|NCT04559425|Antiemetics|antiemetics|mesh-ancestor
110295261|NCT04559425|Autonomic Agents|autonomic agents|mesh-ancestor
110295262|NCT04559425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110295263|NCT04559425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295264|NCT04559425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110295265|NCT04559425|Glucocorticoids|glucocorticoids|mesh-ancestor
110295266|NCT04559425|Hormones|hormones|mesh-ancestor
110295267|NCT04559425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110295268|NCT04559425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110295269|NCT04559425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110295275|NCT00231764|Immunologic Factors|immunologic factors|mesh-ancestor
110295276|NCT00231764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295277|NCT04559308|Metformin|metformin|mesh-list
110295278|NCT04559308|Paclitaxel|paclitaxel|mesh-list
110295279|NCT04559308|Cyclophosphamide|cyclophosphamide|mesh-list
110295280|NCT04559308|Doxorubicin|doxorubicin|mesh-list
110023766|NCT00004002|Bortezomib|bortezomib|mesh-list
110295348|NCT00231998|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110295419|NCT00232115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110295420|NCT00232115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110295421|NCT00232115|Dermatologic Agents|dermatologic agents|mesh-ancestor
110295422|NCT00232115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110295427|NCT04558021|Niclosamide|niclosamide|mesh-list
110295489|NCT04557397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110295490|NCT04557397|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110295491|NCT04557397|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110295492|NCT04557397|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110295493|NCT04557397|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110295494|NCT04557397|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110295495|NCT04557397|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110295555|NCT00259779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110295556|NCT00259779|Autonomic Agents|autonomic agents|mesh-ancestor
110295557|NCT00259779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110295558|NCT00259779|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110295559|NCT00259779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110295560|NCT00259779|Respiratory System Agents|respiratory system agents|mesh-ancestor
110295623|NCT04564690|Selenium|selenium|mesh-list
110295624|NCT04564690|Vitamins|vitamins|mesh-ancestor
110295625|NCT04564690|Micronutrients|micronutrients|mesh-ancestor
110295626|NCT04564690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110295627|NCT04564690|Antioxidants|antioxidants|mesh-ancestor
110295628|NCT04564690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110295629|NCT04564690|Protective Agents|protective agents|mesh-ancestor
110295630|NCT04564690|Trace Elements|trace elements|mesh-ancestor
110295631|NCT00232700|Escitalopram|escitalopram|mesh-list
110295632|NCT00232700|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110295689|NCT04721795|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110295690|NCT04721795|Antimetabolites|antimetabolites|mesh-ancestor
110295691|NCT04721795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110295692|NCT04721795|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110295761|NCT00232934|Growth Inhibitors|growth inhibitors|mesh-ancestor
110295762|NCT00232934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110295764|NCT04673812|Bupivacaine|bupivacaine|mesh-list
110295765|NCT04673812|Naloxone|naloxone|mesh-list
110295766|NCT04673812|Anesthetics, Local|anesthetics, local|mesh-ancestor
110295834|NCT00260247|Carbamazepine|carbamazepine|mesh-list
110295835|NCT00260247|Oxcarbazepine|oxcarbazepine|mesh-list
110295836|NCT00260247|Anticonvulsants|anticonvulsants|mesh-ancestor
110295837|NCT00260247|Antimanic Agents|antimanic agents|mesh-ancestor
110295907|NCT00267657|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110295908|NCT00267657|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110295909|NCT00267657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110295974|NCT00260364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110295975|NCT00260364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110295976|NCT04557007|Pembrolizumab|pembrolizumab|mesh-list
110295977|NCT04557007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110295978|NCT04557007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110295979|NCT04557007|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110295980|NCT04557007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110295981|NCT00233792|Sirolimus|sirolimus|mesh-list
110295982|NCT00233792|Temsirolimus|temsirolimus|mesh-list
110295983|NCT00233792|MTOR Inhibitors|mtor inhibitors|mesh-list
110295984|NCT00233792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110295985|NCT00233792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110295986|NCT00233792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110295987|NCT00233792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110295988|NCT00233792|Antifungal Agents|antifungal agents|mesh-ancestor
110295989|NCT00233792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110295990|NCT00233792|Immunologic Factors|immunologic factors|mesh-ancestor
110296033|NCT00267813|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110296034|NCT00267813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110296035|NCT00267813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110296036|NCT00267813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110296037|NCT00267813|Dopamine Agents|dopamine agents|mesh-ancestor
110296038|NCT00267813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110296099|NCT00234299|Analgesics|analgesics|mesh-ancestor
110296100|NCT00234299|Sensory System Agents|sensory system agents|mesh-ancestor
110296101|NCT00234299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110296102|NCT00234299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296103|NCT00234299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110296104|NCT00234299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110296167|NCT00234455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110296168|NCT00234455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110296169|NCT00234455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110296170|NCT00234455|Antifungal Agents|antifungal agents|mesh-ancestor
110296171|NCT00234455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110296172|NCT00234455|Immunologic Factors|immunologic factors|mesh-ancestor
110296173|NCT00234455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296174|NCT00234455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110296175|NCT00234455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110296231|NCT04561921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110296232|NCT04561921|Anticonvulsants|anticonvulsants|mesh-ancestor
110296233|NCT04561921|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110296234|NCT04561921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110296235|NCT04561921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110296236|NCT04561921|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110296237|NCT04561921|Tocolytic Agents|tocolytic agents|mesh-ancestor
110296238|NCT04561921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110296239|NCT04561921|Anesthetics, Local|anesthetics, local|mesh-ancestor
110296240|NCT04561921|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110296241|NCT04561687|Azelastine|azelastine|mesh-list
110296295|NCT02211625|Sensory System Agents|sensory system agents|mesh-ancestor
110296296|NCT02211625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110296297|NCT00234923|Ritonavir|ritonavir|mesh-list
110296298|NCT00234923|Lopinavir|lopinavir|mesh-list
110296299|NCT00234923|Lamivudine|lamivudine|mesh-list
110296300|NCT00234923|Zidovudine|zidovudine|mesh-list
110296302|NCT00234923|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110296362|NCT00235001|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110296363|NCT00235001|Protease Inhibitors|protease inhibitors|mesh-ancestor
110296364|NCT00235001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110296365|NCT00235001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110296366|NCT04551781|Prednisone|prednisone|mesh-list
110296367|NCT04551781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110296368|NCT04551781|Glucocorticoids|glucocorticoids|mesh-ancestor
110296369|NCT04551781|Hormones|hormones|mesh-ancestor
110296370|NCT04551781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110296371|NCT04551781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296372|NCT04551781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110296373|NCT04551781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110296375|NCT00424944|Immunologic Factors|immunologic factors|mesh-ancestor
110296376|NCT00424944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296377|NCT02214004|Trastuzumab|trastuzumab|mesh-list
110296378|NCT02214004|Letrozole|letrozole|mesh-list
110296421|NCT04550611|Antibodies|antibodies|mesh-list
110296422|NCT04550611|gamma-Globulins|gamma-globulins|mesh-list
110296423|NCT04550611|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110296424|NCT04550611|Immunologic Factors|immunologic factors|mesh-ancestor
110296425|NCT04550611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296426|NCT00235196|Anti-Infective Agents|anti-infective agents|mesh-list
110296427|NCT00235196|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110296492|NCT00268398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296494|NCT00268398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110296566|NCT04548700|Glucocorticoids|glucocorticoids|mesh-ancestor
110296567|NCT04548700|Hormones|hormones|mesh-ancestor
110296568|NCT04548700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110296569|NCT04548700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110296570|NCT04548700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110296635|NCT00268593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110296637|NCT04555525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110296638|NCT04555525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110296639|NCT04555525|Dermatologic Agents|dermatologic agents|mesh-ancestor
110296640|NCT00261183|Melatonin|melatonin|mesh-list
110296641|NCT00261183|Antioxidants|antioxidants|mesh-ancestor
110296703|NCT04721054|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110296704|NCT04721054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110296705|NCT04721054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110296706|NCT02212639|Digoxin|digoxin|mesh-list
110296707|NCT02212639|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110296708|NCT02212639|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110296709|NCT02212639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110296710|NCT02212639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110296711|NCT02212639|Protective Agents|protective agents|mesh-ancestor
110296713|NCT02212756|Metformin|metformin|mesh-list
110296768|NCT02212990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110296769|NCT02212990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110296770|NCT02212990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110296771|NCT02212990|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110296772|NCT02212990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110296773|NCT02212990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110296774|NCT00235859|Adalimumab|adalimumab|mesh-list
110296775|NCT00235859|Methotrexate|methotrexate|mesh-list
110296776|NCT00235859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110296777|NCT00235859|Abortifacient Agents|abortifacient agents|mesh-ancestor
110296778|NCT00235859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110296779|NCT00235859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296780|NCT00235859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110296781|NCT00235859|Antimetabolites|antimetabolites|mesh-ancestor
110296829|NCT02213224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296830|NCT02213224|Vasodilator Agents|vasodilator agents|mesh-ancestor
110296831|NCT02213224|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110296832|NCT02213224|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110296833|NCT02213224|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110296834|NCT02213224|Protease Inhibitors|protease inhibitors|mesh-ancestor
110296835|NCT02213224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110296836|NCT00268788|Immunoglobulins|immunoglobulins|mesh-list
110296837|NCT00268788|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110296838|NCT00268788|Antibodies|antibodies|mesh-list
110296839|NCT00268788|gamma-Globulins|gamma-globulins|mesh-list
110296840|NCT00268788|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110296841|NCT00268788|Immunologic Factors|immunologic factors|mesh-ancestor
110296842|NCT00268788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296843|NCT00235937|Anastrozole|anastrozole|mesh-list
110296844|NCT00235937|Goserelin|goserelin|mesh-list
110296845|NCT00235937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110296846|NCT00235937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110296847|NCT00235937|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110296848|NCT00235937|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110296885|NCT04553458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110296886|NCT04553458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110296887|NCT04553458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110296888|NCT04553458|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110296889|NCT04553458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110296890|NCT04553458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110296891|NCT04553458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296892|NCT00236054|Tiagabine|tiagabine|mesh-list
110296893|NCT00236054|Anticonvulsants|anticonvulsants|mesh-ancestor
110296894|NCT00236054|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
110296895|NCT00236054|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110296896|NCT00236054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110296897|NCT00236054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110296898|NCT00236054|GABA Agents|gaba agents|mesh-ancestor
110296899|NCT00236054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110296900|NCT00236054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296901|NCT04552951|Vitamin D|vitamin d|mesh-list
110296902|NCT04552951|Cholecalciferol|cholecalciferol|mesh-list
110296903|NCT04552951|Vitamins|vitamins|mesh-ancestor
110296904|NCT04552951|Micronutrients|micronutrients|mesh-ancestor
110296905|NCT04552951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296939|NCT02213653|Micronutrients|micronutrients|mesh-ancestor
110296940|NCT02213653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296941|NCT04552444|Biapenem|biapenem|mesh-list
110296946|NCT02213848|Calcium|calcium|mesh-list
110297013|NCT00236249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110297014|NCT00236249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297015|NCT00236249|Sensory System Agents|sensory system agents|mesh-ancestor
110297016|NCT00236249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110297017|NCT00236249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110297018|NCT00236249|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110023856|NCT00004086|Antiviral Agents|antiviral agents|mesh-ancestor
110297019|NCT00236249|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110297020|NCT00236249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110297021|NCT00236249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110297022|NCT00269061|Pioglitazone|pioglitazone|mesh-list
110297023|NCT00269061|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110297024|NCT00269061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297025|NCT04547452|Antibodies|antibodies|mesh-list
110297026|NCT04547452|Immunologic Factors|immunologic factors|mesh-ancestor
110297027|NCT04547452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297066|NCT00236327|Anesthetics|anesthetics|mesh-ancestor
110297067|NCT00236366|Fentanyl|fentanyl|mesh-list
110297068|NCT00236366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110297069|NCT00236366|Narcotics|narcotics|mesh-ancestor
110297070|NCT00236366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110297071|NCT00236366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297100|NCT00269217|Niacin|niacin|mesh-list
110297138|NCT04545931|Hemostatics|hemostatics|mesh-ancestor
110297139|NCT04545931|Coagulants|coagulants|mesh-ancestor
110297140|NCT04545931|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110297141|NCT04545931|Natriuretic Agents|natriuretic agents|mesh-ancestor
110297142|NCT04545931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297143|NCT00236522|Levofloxacin|levofloxacin|mesh-list
110297144|NCT00236522|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110297145|NCT00236522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110297205|NCT04545892|Sensory System Agents|sensory system agents|mesh-ancestor
110297206|NCT04545892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110297207|NCT04545892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297208|NCT02214706|Sirolimus|sirolimus|mesh-list
110297209|NCT02214706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110297217|NCT00236600|Topiramate|topiramate|mesh-list
110297276|NCT00236756|Anticonvulsants|anticonvulsants|mesh-ancestor
110297277|NCT00236756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110297278|NCT00236756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297348|NCT00237068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110297349|NCT00237068|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110297350|NCT00237068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110297351|NCT00237068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110297353|NCT00269568|Mifepristone|mifepristone|mesh-list
110297354|NCT00269568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110297355|NCT00269568|Abortifacient Agents|abortifacient agents|mesh-ancestor
110297356|NCT00269568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110297357|NCT00269568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297358|NCT00269568|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110297359|NCT00269568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110297360|NCT00269568|Oxytocics|oxytocics|mesh-ancestor
110297361|NCT00269568|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110023879|NCT00004110|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110297362|NCT00269568|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110297363|NCT00269568|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110297364|NCT00269568|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110297365|NCT00269568|Contraceptive Agents|contraceptive agents|mesh-ancestor
110297366|NCT00269568|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110297367|NCT00269568|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110297368|NCT00269568|Hormone Antagonists|hormone antagonists|mesh-ancestor
110297369|NCT00269568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110297370|NCT00269568|Luteolytic Agents|luteolytic agents|mesh-ancestor
110297371|NCT00269568|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110297372|NCT00269568|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110297373|NCT00237146|Zoledronic Acid|zoledronic acid|mesh-list
110297374|NCT00237146|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110297375|NCT00237146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297376|NCT04544059|Lenalidomide|lenalidomide|mesh-list
110297377|NCT04544059|Immunologic Factors|immunologic factors|mesh-ancestor
110297378|NCT04544059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297379|NCT04544059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110297389|NCT00269607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110297391|NCT00237224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110297392|NCT00237224|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110297460|NCT04539106|Ranibizumab|ranibizumab|mesh-list
110297461|NCT04539106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110297533|NCT02215057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110297534|NCT02215057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297604|NCT04538521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110297605|NCT04538521|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110297606|NCT04538521|Vasodilator Agents|vasodilator agents|mesh-ancestor
110297676|NCT00414128|Immunologic Factors|immunologic factors|mesh-ancestor
110297677|NCT00414128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297678|NCT00414128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110297679|NCT00414128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110297680|NCT00414128|Alkylating Agents|alkylating agents|mesh-ancestor
110297747|NCT00237731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110297749|NCT04542226|Anticonvulsants|anticonvulsants|mesh-ancestor
110297750|NCT00270036|Epoetin Alfa|epoetin alfa|mesh-list
110297751|NCT00270036|Hematinics|hematinics|mesh-ancestor
110297752|NCT00262392|Pamidronate|pamidronate|mesh-list
110297753|NCT00262392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110297754|NCT00262392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110297755|NCT04537780|Montelukast|montelukast|mesh-list
110297756|NCT04537780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110297757|NCT04537780|Respiratory System Agents|respiratory system agents|mesh-ancestor
110297813|NCT00415584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110297814|NCT04536922|Aldesleukin|aldesleukin|mesh-list
110297886|NCT04536415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110297887|NCT04536415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110297888|NCT00262587|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110297889|NCT00262587|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110297959|NCT02216227|Cefazolin|cefazolin|mesh-list
110297960|NCT02216227|Mupirocin|mupirocin|mesh-list
110297961|NCT02216227|Povidone|povidone|mesh-list
110297962|NCT02216227|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110297963|NCT02216227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110297964|NCT02216227|Disinfectants|disinfectants|mesh-ancestor
110297966|NCT02216227|Trace Elements|trace elements|mesh-ancestor
110298030|NCT02216383|Oxytocics|oxytocics|mesh-ancestor
110298031|NCT02216383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110298105|NCT00263016|Mitosis Modulators|mitosis modulators|mesh-ancestor
110298106|NCT00263016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110298107|NCT04534465|Mannitol|mannitol|mesh-list
110298108|NCT04534465|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
110298174|NCT00263133|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110298175|NCT00263133|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110298176|NCT00263133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110298178|NCT00263133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110298243|NCT00238082|Hormones|hormones|mesh-ancestor
110298246|NCT00238082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110298315|NCT05896800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110298316|NCT05896800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110298317|NCT05896800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110298387|NCT05896033|Dermatologic Agents|dermatologic agents|mesh-ancestor
110298388|NCT05895942|Imatinib Mesylate|imatinib mesylate|mesh-list
110298389|NCT05895942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110298390|NCT05895942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110298391|NCT05895942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110298392|NCT05895942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110298393|NCT05893771|Methylprednisolone|methylprednisolone|mesh-list
110298394|NCT05893771|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110298395|NCT05893771|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110298396|NCT05893771|Prednisolone|prednisolone|mesh-list
110298397|NCT05893771|Prednisolone acetate|prednisolone acetate|mesh-list
110298398|NCT05893771|Bupivacaine|bupivacaine|mesh-list
110298399|NCT05893771|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110298400|NCT05893771|Prednisolone phosphate|prednisolone phosphate|mesh-list
110298401|NCT05893771|Anesthetics, Local|anesthetics, local|mesh-ancestor
110298402|NCT05893771|Anesthetics|anesthetics|mesh-ancestor
110298403|NCT05893771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110298404|NCT05893771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110298405|NCT05893771|Sensory System Agents|sensory system agents|mesh-ancestor
110298406|NCT05893771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110298407|NCT05893771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110298408|NCT05893771|Antiemetics|antiemetics|mesh-ancestor
110298409|NCT05893771|Autonomic Agents|autonomic agents|mesh-ancestor
110298410|NCT05893771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110298411|NCT05893771|Glucocorticoids|glucocorticoids|mesh-ancestor
110298413|NCT05893771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110298437|NCT05841160|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110298438|NCT05841160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110298439|NCT05841160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110298440|NCT05841160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110298441|NCT05841160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110298442|NCT05841160|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110298443|NCT05841160|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110298444|NCT05841160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110298445|NCT05841160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110029350|NCT05019638|Morphine|morphine|mesh-list
110298446|NCT05841160|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110298447|NCT05841160|Dopamine Agents|dopamine agents|mesh-ancestor
110023936|NCT00004164|Leucovorin|leucovorin|mesh-list
110298451|NCT05815758|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110298452|NCT05815758|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110298453|NCT05815758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110298454|NCT05815758|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110298455|NCT05815758|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110298456|NCT05815758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110298457|NCT05815758|Adrenergic Agents|adrenergic agents|mesh-ancestor
110298458|NCT05815758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110298459|NCT05815758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110298460|NCT05815758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110298462|NCT05815758|Dermatologic Agents|dermatologic agents|mesh-ancestor
110298482|NCT05694533|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110298483|NCT05694533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110298484|NCT05694533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110298485|NCT05694533|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110298486|NCT05694533|Anesthetics, General|anesthetics, general|mesh-ancestor
110298553|NCT05434546|Anesthetics|anesthetics|mesh-ancestor
110298554|NCT05434546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110298555|NCT05434546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110298556|NCT05400122|Cyclophosphamide|cyclophosphamide|mesh-list
110298557|NCT05400122|Fludarabine|fludarabine|mesh-list
110298558|NCT05400122|Fludarabine phosphate|fludarabine phosphate|mesh-list
110298559|NCT05400122|Vactosertib|vactosertib|mesh-list
110298560|NCT05400122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110298561|NCT05400122|Immunologic Factors|immunologic factors|mesh-ancestor
110298562|NCT05400122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110298563|NCT05400122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110298564|NCT05400122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110298565|NCT05400122|Alkylating Agents|alkylating agents|mesh-ancestor
110298566|NCT05400122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110298613|NCT05241873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110298614|NCT05241873|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110298615|NCT05241873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110298616|NCT05197322|Pembrolizumab|pembrolizumab|mesh-list
110298617|NCT05197322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110298618|NCT05197322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110298619|NCT05197322|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110298620|NCT05197322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110298624|NCT05145764|Suvorexant|suvorexant|mesh-list
110298625|NCT05145764|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110298626|NCT05145764|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110298627|NCT05145764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110023955|NCT00004164|Vitamins|vitamins|mesh-ancestor
110298628|NCT05145764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110298629|NCT05145764|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
110298630|NCT05145764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110298631|NCT05145764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110298633|NCT05085496|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110298634|NCT05085496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110298635|NCT05085496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110298662|NCT04923776|Atezolizumab|atezolizumab|mesh-list
110298663|NCT04923776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110298664|NCT04923776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110298665|NCT04923776|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110298732|NCT04528134|Fluorides|fluorides|mesh-list
110298733|NCT04528134|Sodium Fluoride|sodium fluoride|mesh-list
110298734|NCT04528134|Fluorides, Topical|fluorides, topical|mesh-list
110298735|NCT04528134|Cariostatic Agents|cariostatic agents|mesh-ancestor
110298736|NCT04528134|Protective Agents|protective agents|mesh-ancestor
110298737|NCT04528134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110298738|NCT04528134|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110298739|NCT04528134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110298740|NCT04521920|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
110298741|NCT04521920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110298742|NCT04521920|Narcotics|narcotics|mesh-ancestor
110298743|NCT04521920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110298744|NCT04521920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110298745|NCT04521920|Analgesics|analgesics|mesh-ancestor
110298746|NCT04521920|Sensory System Agents|sensory system agents|mesh-ancestor
110298748|NCT04521920|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110298793|NCT04298229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110298794|NCT04298229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110298795|NCT04298229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110298796|NCT04298229|Natriuretic Agents|natriuretic agents|mesh-ancestor
110298866|NCT03887702|Antiviral Agents|antiviral agents|mesh-ancestor
110298867|NCT03887702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110298868|NCT03887702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110298869|NCT03887702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110298870|NCT03887702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110298871|NCT03887702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110298872|NCT03887702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110298873|NCT03887702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110298874|NCT03878589|Oxytocin|oxytocin|mesh-list
110298875|NCT03878589|Oxytocics|oxytocics|mesh-ancestor
110298876|NCT03878589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110298877|NCT03878589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110298878|NCT03875287|Decitabine|decitabine|mesh-list
110298879|NCT03875287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110298929|NCT03568890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110298930|NCT03568890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110298931|NCT03568890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110298932|NCT03568890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110298933|NCT03568890|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110298934|NCT03568890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110298935|NCT03568890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110298936|NCT03568890|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110298937|NCT03568890|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110298997|NCT03424005|Atezolizumab|atezolizumab|mesh-list
110298998|NCT03424005|Fulvestrant|fulvestrant|mesh-list
110298999|NCT03424005|Ipatasertib|ipatasertib|mesh-list
110299000|NCT03424005|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
110299001|NCT03424005|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
110299002|NCT03424005|SGN-LIV1A|sgn-liv1a|mesh-list
110299003|NCT03424005|Inavolisib|inavolisib|mesh-list
110299004|NCT03424005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110299005|NCT03424005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110299006|NCT03424005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110299007|NCT03424005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110299008|NCT03424005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110299009|NCT03424005|Growth Substances|growth substances|mesh-ancestor
110299010|NCT03424005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110299011|NCT03424005|Growth Inhibitors|growth inhibitors|mesh-ancestor
110299012|NCT03424005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110299013|NCT03424005|Antimetabolites|antimetabolites|mesh-ancestor
110299014|NCT03424005|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110299025|NCT03397394|Rucaparib|rucaparib|mesh-list
110299054|NCT03053440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110299055|NCT03053440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110299056|NCT03053440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110299057|NCT02986100|Rucaparib|rucaparib|mesh-list
110299058|NCT02986100|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110299125|NCT02740712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110299126|NCT02740712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110299127|NCT02740712|Anticoagulants|anticoagulants|mesh-ancestor
110299195|NCT02229578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110299196|NCT02229578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110299197|NCT01821781|Fludarabine|fludarabine|mesh-list
110299198|NCT01821781|Melphalan|melphalan|mesh-list
110299199|NCT01821781|Alemtuzumab|alemtuzumab|mesh-list
110299200|NCT01821781|Thiotepa|thiotepa|mesh-list
110299201|NCT01821781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110299203|NCT01821781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110299262|NCT02217163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110299263|NCT02217163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110299264|NCT02217163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110299332|NCT04531072|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110299333|NCT04531072|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110299334|NCT04531072|Antimalarials|antimalarials|mesh-ancestor
110299335|NCT04531072|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110299336|NCT04531072|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110299337|NCT00414323|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110299338|NCT00414323|Escitalopram|escitalopram|mesh-list
110299339|NCT00414323|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110299340|NCT00414323|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110299341|NCT00414323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110299342|NCT00414323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110299343|NCT00414323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110299344|NCT00414323|Serotonin Agents|serotonin agents|mesh-ancestor
110299348|NCT00414323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110299393|NCT02217514|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110299394|NCT02217514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110299395|NCT02217514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110299396|NCT02217514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110299397|NCT02217514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110299398|NCT02217514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110299463|NCT02218021|Analgesics|analgesics|mesh-ancestor
110299464|NCT02218021|Sensory System Agents|sensory system agents|mesh-ancestor
110299465|NCT02218021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110299466|NCT00239369|Telmisartan|telmisartan|mesh-list
110024000|NCT00004194|Fludarabine|fludarabine|mesh-list
110299467|NCT00239369|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110299468|NCT00239369|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110299469|NCT00239369|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110299530|NCT02218684|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110299531|NCT02218684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110299532|NCT02278861|Tretinoin|tretinoin|mesh-list
110299533|NCT02278861|Isotretinoin|isotretinoin|mesh-list
110299534|NCT02278861|Sunscreening Agents|sunscreening agents|mesh-list
110299535|NCT02278861|Dermatologic Agents|dermatologic agents|mesh-ancestor
110299536|NCT02278861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110299537|NCT02278861|Keratolytic Agents|keratolytic agents|mesh-ancestor
110299538|NCT02278861|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110299563|NCT00263796|Oxytocin|oxytocin|mesh-list
110299595|NCT01642966|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110299596|NCT01642966|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110299597|NCT01642966|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110299598|NCT01642966|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110299599|NCT01642966|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110299600|NCT01642966|Purinergic Agents|purinergic agents|mesh-ancestor
110299604|NCT01643083|Rifaximin|rifaximin|mesh-list
110299663|NCT01644838|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110299664|NCT01644838|Cholinergic Agents|cholinergic agents|mesh-ancestor
110299665|NCT01644838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110299666|NCT01644838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110299667|NCT01644838|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110299668|NCT01644838|Antipruritics|antipruritics|mesh-ancestor
110299678|NCT01644838|Anesthetics|anesthetics|mesh-ancestor
110299731|NCT01645423|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110299732|NCT01645423|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110299733|NCT01645423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110299734|NCT01645774|Oxymetazoline|oxymetazoline|mesh-list
110299735|NCT01645774|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110299736|NCT01645774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110299737|NCT01645774|Adrenergic Agents|adrenergic agents|mesh-ancestor
110299738|NCT01645774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110299740|NCT01645774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110299794|NCT00239954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110299795|NCT00239954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110299796|NCT00239954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110299798|NCT00239954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110299799|NCT04528927|Azithromycin|azithromycin|mesh-list
110299800|NCT04528927|Doxycycline|doxycycline|mesh-list
110299801|NCT04528927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110299802|NCT04528927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110299861|NCT00240032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110299862|NCT00240032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110299863|NCT00240032|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110299864|NCT00240032|Immunologic Factors|immunologic factors|mesh-ancestor
110299865|NCT00240032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110299866|NCT00240032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110299868|NCT00240149|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110299869|NCT00240149|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110299870|NCT00240149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110299871|NCT01647646|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110299872|NCT01647646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110299873|NCT01647646|Respiratory System Agents|respiratory system agents|mesh-ancestor
110299874|NCT01647646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110299875|NCT01647646|Autonomic Agents|autonomic agents|mesh-ancestor
110299876|NCT01647646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110299877|NCT01647646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110299881|NCT01647646|Sympathomimetics|sympathomimetics|mesh-ancestor
110299918|NCT01648036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110299920|NCT00240305|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110299921|NCT00240305|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110299922|NCT00240305|Antimetabolites|antimetabolites|mesh-ancestor
110299923|NCT00240305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110299924|NCT00240305|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110299925|NCT00240305|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110299926|NCT00240305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110299927|NCT01648231|Losartan|losartan|mesh-list
110299928|NCT01648231|Amlodipine|amlodipine|mesh-list
110299929|NCT01648231|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110299930|NCT01648231|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110299931|NCT01648231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110299932|NCT01648231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110299933|NCT01648231|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110299934|NCT01648231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110299956|NCT00240422|Ramipril|ramipril|mesh-list
110299973|NCT00264225|Respiratory System Agents|respiratory system agents|mesh-ancestor
110299974|NCT02279563|Fluticasone|fluticasone|mesh-list
110299976|NCT02279563|Azelastine|azelastine|mesh-list
110299977|NCT02279563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110299994|NCT02279758|Metformin|metformin|mesh-list
110300043|NCT01649635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110300044|NCT01649635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110300045|NCT01649635|Immunologic Factors|immunologic factors|mesh-ancestor
110300113|NCT00250575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110300114|NCT00250575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110300115|NCT00250575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110300116|NCT00250575|GABA Antagonists|gaba antagonists|mesh-ancestor
110300117|NCT00250575|GABA Agents|gaba agents|mesh-ancestor
110300118|NCT00240695|Galantamine|galantamine|mesh-list
110300119|NCT00240695|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110300182|NCT04708821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110300183|NCT04708821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110300184|NCT04708821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110300185|NCT04708821|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110300253|NCT00250692|Sensory System Agents|sensory system agents|mesh-ancestor
110300254|NCT00250692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110300255|NCT01688791|Paclitaxel|paclitaxel|mesh-list
110300256|NCT01688791|Carboplatin|carboplatin|mesh-list
110300257|NCT01688791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110300258|NCT01688791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110300259|NCT01688791|Tubulin Modulators|tubulin modulators|mesh-ancestor
110300260|NCT01688791|Antimitotic Agents|antimitotic agents|mesh-ancestor
110300261|NCT01688791|Mitosis Modulators|mitosis modulators|mesh-ancestor
110300262|NCT01688791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110300316|NCT01689298|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110300317|NCT01689298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110300319|NCT00241085|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110300320|NCT00241085|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110300321|NCT00241085|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110300323|NCT00241124|Valsartan|valsartan|mesh-list
110300382|NCT01685359|Hematinics|hematinics|mesh-ancestor
110300383|NCT02278978|Nintedanib|nintedanib|mesh-list
110300384|NCT02278978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110300385|NCT02278978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110300454|NCT02219191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110300455|NCT02219191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110300456|NCT02219191|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110300457|NCT02219191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110300526|NCT02210806|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110300527|NCT02210806|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110300528|NCT02210806|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110300529|NCT02210806|Adrenergic Agents|adrenergic agents|mesh-ancestor
110300530|NCT02210806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110300531|NCT02210806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110300533|NCT00264654|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110300591|NCT02961842|Anesthetics, Local|anesthetics, local|mesh-ancestor
110300593|NCT02961842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110300594|NCT02961842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110300595|NCT02961842|Sensory System Agents|sensory system agents|mesh-ancestor
110300596|NCT02961842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110300597|NCT02961842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110300598|NCT02961842|Narcotics|narcotics|mesh-ancestor
110300599|NCT02961842|Analgesics|analgesics|mesh-ancestor
110300600|NCT02961842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110300654|NCT00242411|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110300655|NCT00242411|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110300656|NCT00242411|Adrenergic Agents|adrenergic agents|mesh-ancestor
110300657|NCT00242411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110300658|NCT00242411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110300659|NCT02962037|Melatonin|melatonin|mesh-list
110300660|NCT02962037|Antioxidants|antioxidants|mesh-ancestor
110300661|NCT02962037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110300662|NCT02962037|Protective Agents|protective agents|mesh-ancestor
110300663|NCT02962037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110300664|NCT02962037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110300665|NCT00282399|Decitabine|decitabine|mesh-list
110300666|NCT00282399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110300667|NCT00282399|Antimetabolites|antimetabolites|mesh-ancestor
110300668|NCT00282399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110300669|NCT00282399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110300670|NCT00282399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110300671|NCT00242450|Metoclopramide|metoclopramide|mesh-list
110300672|NCT00242450|Antiemetics|antiemetics|mesh-ancestor
110300673|NCT00242450|Autonomic Agents|autonomic agents|mesh-ancestor
110300674|NCT00242450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110300675|NCT00242450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110300676|NCT00242450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110300677|NCT00242450|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110300703|NCT00242606|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110300704|NCT00242606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110300774|NCT00242996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110300775|NCT00242996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110300776|NCT00273390|Infliximab|infliximab|mesh-list
110300777|NCT00273390|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110300778|NCT00273390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110300779|NCT00273390|Dermatologic Agents|dermatologic agents|mesh-ancestor
110300780|NCT00273390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110300781|NCT00273390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110300782|NCT00243035|Bortezomib|bortezomib|mesh-list
110300783|NCT00243035|Tipifarnib|tipifarnib|mesh-list
110300784|NCT00243035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110300785|NCT00243113|Docetaxel|docetaxel|mesh-list
110300786|NCT00243113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110300787|NCT00243113|Tubulin Modulators|tubulin modulators|mesh-ancestor
110300788|NCT00243113|Antimitotic Agents|antimitotic agents|mesh-ancestor
110300789|NCT00243113|Mitosis Modulators|mitosis modulators|mesh-ancestor
110300790|NCT00243113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110300791|NCT00273429|Timolol|timolol|mesh-list
110300792|NCT00273429|Dorzolamide|dorzolamide|mesh-list
110300793|NCT00273429|Latanoprost|latanoprost|mesh-list
110300794|NCT00273429|Maleic acid|maleic acid|mesh-list
110300807|NCT00273468|Granisetron|granisetron|mesh-list
110300832|NCT00273507|Paclitaxel|paclitaxel|mesh-list
110300833|NCT00273507|Carboplatin|carboplatin|mesh-list
110300834|NCT00273507|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110300835|NCT00273507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110300904|NCT00283179|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110300905|NCT00283179|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110300906|NCT00283179|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110300907|NCT00243854|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110300908|NCT00243854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110300909|NCT00243854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110300910|NCT00243854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110300911|NCT00243854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110300912|NCT00273741|Methylphenidate|methylphenidate|mesh-list
110300968|NCT00244166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110300969|NCT00244166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110300970|NCT00244166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110301036|NCT00417144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110301037|NCT00417144|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110301038|NCT00417144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110301039|NCT00417144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110301040|NCT00417144|Hormone Antagonists|hormone antagonists|mesh-ancestor
110301042|NCT00274053|Tiotropium Bromide|tiotropium bromide|mesh-list
110301104|NCT00244556|Dermatologic Agents|dermatologic agents|mesh-ancestor
110301105|NCT00244556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110301106|NCT00244556|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110301107|NCT00244556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110301108|NCT00244556|Immunologic Factors|immunologic factors|mesh-ancestor
110301109|NCT00244556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110301110|NCT00244556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110301111|NCT00244556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110301112|NCT00244556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110301170|NCT00244946|Immunologic Factors|immunologic factors|mesh-ancestor
110301171|NCT00244946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110301172|NCT00244946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110301242|NCT00283764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110301243|NCT00245336|Thrombin|thrombin|mesh-list
110301244|NCT00245336|Hemostatics|hemostatics|mesh-ancestor
110301245|NCT00245336|Coagulants|coagulants|mesh-ancestor
110301246|NCT00274443|Carboplatin|carboplatin|mesh-list
110301247|NCT00274443|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110301248|NCT00274443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110301312|NCT00245609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110024064|NCT00004218|Antimetabolites|antimetabolites|mesh-ancestor
110301313|NCT00245609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110301314|NCT00245609|Anticonvulsants|anticonvulsants|mesh-ancestor
110301382|NCT00246155|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110301383|NCT00246155|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110301384|NCT00246155|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110301385|NCT00246155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110301386|NCT00246155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110301388|NCT00246155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110301389|NCT00246155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110301390|NCT00246155|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110301391|NCT00246155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110301447|NCT00246272|Risperidone|risperidone|mesh-list
110301448|NCT00246272|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110301449|NCT00246272|Serotonin Agents|serotonin agents|mesh-ancestor
110301450|NCT00246272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110301451|NCT00246272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110301452|NCT00246272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110301453|NCT00246272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110301454|NCT00246272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110301455|NCT00246272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110301456|NCT00246272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110301457|NCT00246272|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110301458|NCT00246272|Dopamine Agents|dopamine agents|mesh-ancestor
110301459|NCT00284271|Prednisone|prednisone|mesh-list
110301460|NCT00284271|Cyclophosphamide|cyclophosphamide|mesh-list
110301461|NCT00284271|Vincristine|vincristine|mesh-list
110301462|NCT00284271|Bleomycin|bleomycin|mesh-list
110301463|NCT00284271|Epoetin Alfa|epoetin alfa|mesh-list
110301464|NCT00284271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110301474|NCT00284271|Glucocorticoids|glucocorticoids|mesh-ancestor
110301506|NCT00246467|Immunologic Factors|immunologic factors|mesh-ancestor
110301507|NCT00246467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110301508|NCT00246467|Antacids|antacids|mesh-ancestor
110301509|NCT00246467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110301510|NCT00246467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110301511|NCT00277251|Alendronate|alendronate|mesh-list
110301512|NCT00277251|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110301575|NCT00284583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110301576|NCT00284583|Sensory System Agents|sensory system agents|mesh-ancestor
110301577|NCT00284583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110301578|NCT00284583|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110301579|NCT00284583|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110301580|NCT00284583|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110301581|NCT00284583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110301582|NCT00284583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110301584|NCT00247052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110301585|NCT00247052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110301587|NCT00247052|Sensory System Agents|sensory system agents|mesh-ancestor
110301588|NCT00247052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110301634|NCT00247208|Paclitaxel|paclitaxel|mesh-list
110301635|NCT00247208|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110301636|NCT00247208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110301637|NCT00247208|Tubulin Modulators|tubulin modulators|mesh-ancestor
110301638|NCT00247208|Antimitotic Agents|antimitotic agents|mesh-ancestor
110301639|NCT00247208|Mitosis Modulators|mitosis modulators|mesh-ancestor
110301705|NCT00247481|Mitosis Modulators|mitosis modulators|mesh-ancestor
110301706|NCT00247481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110301780|NCT00247910|Natriuretic Agents|natriuretic agents|mesh-ancestor
110301781|NCT00247910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110301782|NCT00247910|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110301783|NCT00247910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110301784|NCT00247910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110301785|NCT00278187|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110301786|NCT00278187|Volociximab|volociximab|mesh-list
110301787|NCT00278187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110301843|NCT00248261|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110301844|NCT00248261|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110301845|NCT00248261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110301846|NCT00248261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110301847|NCT00248261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110301848|NCT00248261|Serotonin Agents|serotonin agents|mesh-ancestor
110301849|NCT00248261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110301850|NCT00248261|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110301851|NCT00248261|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110301852|NCT00248261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110301853|NCT00248261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110301854|NCT00248261|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110301855|NCT00248261|Dopamine Agents|dopamine agents|mesh-ancestor
110301856|NCT00248300|Chlorhexidine|chlorhexidine|mesh-list
110301904|NCT00248456|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
110301905|NCT00248456|Betamethasone benzoate|betamethasone benzoate|mesh-list
110301906|NCT00248456|Calcipotriene|calcipotriene|mesh-list
110301907|NCT00248456|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
110301908|NCT00248456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110301909|NCT00248456|Glucocorticoids|glucocorticoids|mesh-ancestor
110301911|NCT00248456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110301912|NCT00248456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110301917|NCT00278460|Docetaxel|docetaxel|mesh-list
110301971|NCT00285519|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110301972|NCT00285519|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110301973|NCT00285519|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110301974|NCT00285519|Adrenergic Agents|adrenergic agents|mesh-ancestor
110301975|NCT00285519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110301976|NCT00285519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110301977|NCT00285519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110302031|NCT00278967|Bisacodyl|bisacodyl|mesh-list
110302037|NCT00249236|Serotonin Agents|serotonin agents|mesh-ancestor
110302038|NCT00249236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110302039|NCT00249236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110302040|NCT00249236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110302041|NCT00249236|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110302042|NCT00249236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110302043|NCT00249236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110302044|NCT00249236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110302045|NCT00249236|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110302100|NCT00249509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110302101|NCT00249509|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110302174|NCT00249860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110024093|NCT00004236|Doxorubicin|doxorubicin|mesh-list
110302175|NCT00249860|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110302176|NCT00249899|Atorvastatin|atorvastatin|mesh-list
110302177|NCT00249899|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110302178|NCT00249899|Simvastatin|simvastatin|mesh-list
110302179|NCT00249899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
110302180|NCT00249899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110302181|NCT00249899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110302182|NCT00249899|Antimetabolites|antimetabolites|mesh-ancestor
110302183|NCT00249899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110302184|NCT00249899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110302185|NCT00249899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110302186|NCT00249938|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
110302236|NCT00286143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110302237|NCT00286143|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110302238|NCT00286143|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110302239|NCT00286143|Anesthetics, General|anesthetics, general|mesh-ancestor
110302240|NCT00286143|Anesthetics|anesthetics|mesh-ancestor
110302241|NCT00286260|Levetiracetam|levetiracetam|mesh-list
110302307|NCT00250796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110302308|NCT00250796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110302309|NCT00250796|Growth Substances|growth substances|mesh-ancestor
110302310|NCT00250796|Growth Inhibitors|growth inhibitors|mesh-ancestor
110302311|NCT00250796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110302312|NCT00250796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110302377|NCT00416832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110302378|NCT00416832|Alkylating Agents|alkylating agents|mesh-ancestor
110302379|NCT00416832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110302447|NCT01640275|Anesthetics, General|anesthetics, general|mesh-ancestor
110302448|NCT01640275|Anesthetics|anesthetics|mesh-ancestor
110302449|NCT01640275|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110302450|NCT04529356|Acetaminophen|acetaminophen|mesh-list
110302451|NCT04529356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110302452|NCT04529356|Analgesics|analgesics|mesh-ancestor
110302453|NCT04529356|Sensory System Agents|sensory system agents|mesh-ancestor
110302454|NCT04529356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110302455|NCT04529356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110302456|NCT04529356|Antipyretics|antipyretics|mesh-ancestor
110302457|NCT01640665|Capecitabine|capecitabine|mesh-list
110302458|NCT01640665|Sorafenib|sorafenib|mesh-list
110302459|NCT01640665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110302460|NCT01640665|Antimetabolites|antimetabolites|mesh-ancestor
110302461|NCT01640665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110302462|NCT01640665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110302463|NCT01640665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110302464|NCT01640665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110302465|NCT01640782|Leucovorin|leucovorin|mesh-list
110302466|NCT01640782|Docetaxel|docetaxel|mesh-list
110302505|NCT01641289|Acetaminophen|acetaminophen|mesh-list
110302506|NCT01641289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110302507|NCT01641289|Analgesics|analgesics|mesh-ancestor
110302508|NCT01641289|Sensory System Agents|sensory system agents|mesh-ancestor
110302509|NCT01641289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110302510|NCT01641289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110302511|NCT01641289|Antipyretics|antipyretics|mesh-ancestor
110302512|NCT01641406|Cyclophosphamide|cyclophosphamide|mesh-list
110302513|NCT01641406|Bevacizumab|bevacizumab|mesh-list
110302514|NCT01641406|Docetaxel|docetaxel|mesh-list
110302515|NCT01641406|Capecitabine|capecitabine|mesh-list
110302516|NCT01641406|Trastuzumab|trastuzumab|mesh-list
110302517|NCT01641406|Epirubicin|epirubicin|mesh-list
110024107|NCT00004242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110302518|NCT01641406|Vinorelbine|vinorelbine|mesh-list
110302519|NCT01641406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110302520|NCT01641406|Immunologic Factors|immunologic factors|mesh-ancestor
110302521|NCT01641406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110302522|NCT01641406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110302524|NCT01641406|Alkylating Agents|alkylating agents|mesh-ancestor
110302566|NCT01685827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110302567|NCT01685827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110302568|NCT01685827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110302569|NCT01685827|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
110302570|NCT01685827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110302571|NCT01685827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110302573|NCT05140096|Isavuconazole|isavuconazole|mesh-list
110302574|NCT05140096|Acalabrutinib|acalabrutinib|mesh-list
110302575|NCT05140096|Antifungal Agents|antifungal agents|mesh-ancestor
110302576|NCT05140096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110302577|NCT05140096|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110302578|NCT05140096|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110302579|NCT05140096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110302580|NCT05140096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110302581|NCT05140096|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110302582|NCT05140096|Hormone Antagonists|hormone antagonists|mesh-ancestor
110302583|NCT05140096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110302584|NCT05140096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110302585|NCT05140096|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110302619|NCT00280176|Immunologic Factors|immunologic factors|mesh-ancestor
110302620|NCT00280176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110302622|NCT00280215|Lisinopril|lisinopril|mesh-list
110302623|NCT00280215|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
110302624|NCT00280215|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110302625|NCT00280215|Enzyme Inhibitors|enzyme inhibitors|mesh-list
110302626|NCT00280215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110302627|NCT00280215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110302628|NCT00280215|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110033559|NCT03180294|Dopamine Agents|dopamine agents|mesh-ancestor
110302629|NCT00280215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110302631|NCT00280215|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110302632|NCT00280215|Protective Agents|protective agents|mesh-ancestor
110302633|NCT00280215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110302634|NCT00251498|Cetuximab|cetuximab|mesh-list
110302635|NCT00251498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110302636|NCT00251498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110302637|NCT02271334|Albuterol|albuterol|mesh-list
110302638|NCT02271334|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110302639|NCT02271334|Autonomic Agents|autonomic agents|mesh-ancestor
110302640|NCT02271334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110302641|NCT02271334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110302642|NCT02271334|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110302643|NCT02271334|Respiratory System Agents|respiratory system agents|mesh-ancestor
110302644|NCT02271334|Tocolytic Agents|tocolytic agents|mesh-ancestor
110302645|NCT02271334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110302646|NCT02271334|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110302647|NCT02271334|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110302648|NCT02271334|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110302649|NCT02271334|Adrenergic Agents|adrenergic agents|mesh-ancestor
110302650|NCT02271334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110302651|NCT02271334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110302652|NCT02276755|Vitamin D|vitamin d|mesh-list
110302653|NCT02276755|Cholecalciferol|cholecalciferol|mesh-list
110307091|NCT00265772|Prednisolone|prednisolone|mesh-list
110307092|NCT00265772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110307093|NCT00265772|Glucocorticoids|glucocorticoids|mesh-ancestor
110307094|NCT00265772|Hormones|hormones|mesh-ancestor
110307106|NCT00295308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110302654|NCT02276755|Vitamins|vitamins|mesh-ancestor
110302655|NCT02276755|Micronutrients|micronutrients|mesh-ancestor
110302656|NCT02276755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110302657|NCT02276755|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110302658|NCT02276755|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110302723|NCT00251888|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110302724|NCT00251888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110302725|NCT00251888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110302726|NCT00251888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110302727|NCT00251966|Esomeprazole|esomeprazole|mesh-list
110302728|NCT00251966|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110302729|NCT00251966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110302730|NCT00251966|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110302731|NCT00251966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110302732|NCT00251966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110302733|NCT00252044|Pergolide|pergolide|mesh-list
110302734|NCT00252044|Dopamine Agonists|dopamine agonists|mesh-ancestor
110302735|NCT00252044|Dopamine Agents|dopamine agents|mesh-ancestor
110302736|NCT00252044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110302781|NCT00287157|Parasympatholytics|parasympatholytics|mesh-ancestor
110302782|NCT00287157|Autonomic Agents|autonomic agents|mesh-ancestor
110302783|NCT00287157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110302784|NCT00287157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110302785|NCT00287157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110302786|NCT00287157|Adrenergic Agents|adrenergic agents|mesh-ancestor
110302787|NCT00287157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110302788|NCT00287157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110302789|NCT00280644|Leflunomide|leflunomide|mesh-list
110302790|NCT00280644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110302792|NCT00280644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110302844|NCT00252434|Autonomic Agents|autonomic agents|mesh-ancestor
110302845|NCT00252434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110302846|NCT00252434|Dopamine Agents|dopamine agents|mesh-ancestor
110302847|NCT00252434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110302848|NCT00252434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110302850|NCT00252434|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110302851|NCT00252434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110302852|NCT00252434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110302853|NCT00252434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110302854|NCT00280839|Topiramate|topiramate|mesh-list
110302855|NCT00280839|Anticonvulsants|anticonvulsants|mesh-ancestor
110302856|NCT00280839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110302857|NCT00280839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110302858|NCT00280878|Rituximab|rituximab|mesh-list
110302859|NCT00280878|Gemcitabine|gemcitabine|mesh-list
110302860|NCT00280878|Vinorelbine|vinorelbine|mesh-list
110302861|NCT00280878|Ifosfamide|ifosfamide|mesh-list
110302862|NCT00280878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110302863|NCT00280878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110302864|NCT00280878|Immunologic Factors|immunologic factors|mesh-ancestor
110302865|NCT00280878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110302866|NCT00280878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110302867|NCT00280878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110302868|NCT00280878|Antimetabolites|antimetabolites|mesh-ancestor
110302869|NCT00280878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110302870|NCT00280878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110302871|NCT00280878|Tubulin Modulators|tubulin modulators|mesh-ancestor
110302872|NCT00280878|Antimitotic Agents|antimitotic agents|mesh-ancestor
110302873|NCT00280878|Mitosis Modulators|mitosis modulators|mesh-ancestor
110302874|NCT00280878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110302875|NCT00280878|Alkylating Agents|alkylating agents|mesh-ancestor
110302876|NCT02758717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110302877|NCT02758717|Nivolumab|nivolumab|mesh-list
110307107|NCT00295308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110307108|NCT00295308|Sympatholytics|sympatholytics|mesh-ancestor
110307109|NCT00295308|Autonomic Agents|autonomic agents|mesh-ancestor
110307110|NCT00295308|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110307111|NCT00295308|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110307112|NCT00295308|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110307113|NCT00295308|Adrenergic Agents|adrenergic agents|mesh-ancestor
110307114|NCT00295308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110307115|NCT00295308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110302878|NCT02758717|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110302879|NCT02758717|Antibodies|antibodies|mesh-list
110302880|NCT02758717|Immunoglobulins|immunoglobulins|mesh-list
110302881|NCT02758717|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110302882|NCT02758717|Immunoconjugates|immunoconjugates|mesh-list
110302883|NCT02758717|Immunologic Factors|immunologic factors|mesh-ancestor
110302884|NCT02758717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110302885|NCT02758717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110302886|NCT02758717|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110302888|NCT02758717|Immunotoxins|immunotoxins|mesh-ancestor
110302945|NCT05139667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110302946|NCT05139667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110302947|NCT00287352|Amantadine|amantadine|mesh-list
110302948|NCT00287352|Olanzapine|olanzapine|mesh-list
110302949|NCT00287352|Antiemetics|antiemetics|mesh-ancestor
110302950|NCT00287352|Autonomic Agents|autonomic agents|mesh-ancestor
110302951|NCT00287352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110302952|NCT00287352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110302953|NCT00287352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110302954|NCT00287352|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110302955|NCT00287352|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110303011|NCT00252707|Gefitinib|gefitinib|mesh-list
110303012|NCT00252707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110303013|NCT00252707|Tubulin Modulators|tubulin modulators|mesh-ancestor
110303014|NCT00252707|Antimitotic Agents|antimitotic agents|mesh-ancestor
110303015|NCT00252707|Mitosis Modulators|mitosis modulators|mesh-ancestor
110303084|NCT00252785|Purinergic Agents|purinergic agents|mesh-ancestor
110303086|NCT01680913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110303087|NCT01680913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110303088|NCT01680952|Mycophenolic Acid|mycophenolic acid|mesh-list
110303089|NCT01680952|Sirolimus|sirolimus|mesh-list
110303090|NCT01680952|Tacrolimus|tacrolimus|mesh-list
110303091|NCT01680952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110303092|NCT01680952|Immunologic Factors|immunologic factors|mesh-ancestor
110303093|NCT01680952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110303094|NCT01680952|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110303095|NCT01680952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110303096|NCT01680952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110303097|NCT01680952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110303098|NCT01680952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110303099|NCT01680952|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110303100|NCT01680952|Antitubercular Agents|antitubercular agents|mesh-ancestor
110303101|NCT01680952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110303102|NCT01680952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110303103|NCT01680952|Antifungal Agents|antifungal agents|mesh-ancestor
110303104|NCT00252824|Budesonide|budesonide|mesh-list
110303105|NCT00252824|Formoterol Fumarate|formoterol fumarate|mesh-list
110303106|NCT00252824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110303107|NCT00252824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110303138|NCT00252863|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110303139|NCT00252863|Autonomic Agents|autonomic agents|mesh-ancestor
110303140|NCT00252863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110303141|NCT00252863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110303142|NCT00252863|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110303143|NCT00252863|Respiratory System Agents|respiratory system agents|mesh-ancestor
110303144|NCT00252863|Dermatologic Agents|dermatologic agents|mesh-ancestor
110303145|NCT00252863|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110303146|NCT00252863|Glucocorticoids|glucocorticoids|mesh-ancestor
110303147|NCT00252863|Hormones|hormones|mesh-ancestor
110303148|NCT00252863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110303149|NCT00252863|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110303150|NCT00252863|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110034102|NCT01334606|Insulin|insulin|mesh-list
110303151|NCT00252863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110303152|NCT00252863|Adrenergic Agents|adrenergic agents|mesh-ancestor
110303153|NCT00252863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110303154|NCT00252863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110303155|NCT00252863|Tocolytic Agents|tocolytic agents|mesh-ancestor
110303156|NCT00252863|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110303157|NCT00252863|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110303158|NCT00252863|Hormone Antagonists|hormone antagonists|mesh-ancestor
110303190|NCT01681537|Sensory System Agents|sensory system agents|mesh-ancestor
110303191|NCT01681537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110303192|NCT01681693|Metformin|metformin|mesh-list
110303193|NCT01681693|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110303194|NCT01681693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110303195|NCT01681966|Ropivacaine|ropivacaine|mesh-list
110303196|NCT01681966|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110303197|NCT01681966|Anesthetics, Local|anesthetics, local|mesh-ancestor
110024200|NCT00004380|Methocarbamol|methocarbamol|mesh-list
110303199|NCT01681966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110303200|NCT01681966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110303211|NCT01682161|Serotonin Agents|serotonin agents|mesh-ancestor
110303256|NCT01683175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110303257|NCT01683175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110303258|NCT01683175|Tubulin Modulators|tubulin modulators|mesh-ancestor
110303259|NCT01683175|Antimitotic Agents|antimitotic agents|mesh-ancestor
110303260|NCT01683175|Mitosis Modulators|mitosis modulators|mesh-ancestor
110303261|NCT01683253|Dopamine|dopamine|mesh-list
110303262|NCT01683253|Levodopa|levodopa|mesh-list
110303263|NCT01683253|Carbidopa|carbidopa|mesh-list
110303264|NCT01683253|Dopamine Agonists|dopamine agonists|mesh-list
110303265|NCT01683253|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110303266|NCT01683253|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110303267|NCT01683253|Dopamine Agents|dopamine agents|mesh-ancestor
110303268|NCT01683253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110303269|NCT01683253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110303270|NCT01683253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110303271|NCT01683253|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110303272|NCT01683253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110303314|NCT00287742|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110303315|NCT00287742|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110303316|NCT00287742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110303317|NCT00287742|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110303318|NCT00287742|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110303320|NCT04527562|Colchicine|colchicine|mesh-list
110303321|NCT04527562|Gout Suppressants|gout suppressants|mesh-ancestor
110303322|NCT04527562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110303323|NCT04527562|Tubulin Modulators|tubulin modulators|mesh-ancestor
110303324|NCT04527562|Antimitotic Agents|antimitotic agents|mesh-ancestor
110303379|NCT00416871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110303381|NCT00416871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110303382|NCT01684657|Asenapine|asenapine|mesh-list
110303383|NCT01684657|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110303384|NCT01684657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110303385|NCT01684657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110303386|NCT01684657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110303387|NCT01684657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110303388|NCT00416910|Cyclophosphamide|cyclophosphamide|mesh-list
110303389|NCT00416910|Fludarabine|fludarabine|mesh-list
110303390|NCT00416910|Mitoxantrone|mitoxantrone|mesh-list
110303391|NCT00416910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110303392|NCT00416910|Immunologic Factors|immunologic factors|mesh-ancestor
110303393|NCT00416910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110303394|NCT00416910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110303395|NCT00416910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110303396|NCT00416910|Alkylating Agents|alkylating agents|mesh-ancestor
110303397|NCT00416910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110303398|NCT00416910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110303399|NCT00416910|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110303401|NCT00416910|Sensory System Agents|sensory system agents|mesh-ancestor
110303402|NCT00416910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110303403|NCT00416910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110303404|NCT00416910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110303405|NCT00416910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110303406|NCT01684774|Bupivacaine|bupivacaine|mesh-list
110303407|NCT01684774|Anesthetics, Local|anesthetics, local|mesh-ancestor
110303422|NCT00253175|Topiramate|topiramate|mesh-list
110303428|NCT00287820|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110303429|NCT00287820|Serotonin Agents|serotonin agents|mesh-ancestor
110303430|NCT00287820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110303431|NCT00287820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110303432|NCT00287820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110303433|NCT00287820|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110303434|NCT00287820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110303435|NCT00287820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110303436|NCT00287820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110303437|NCT00287820|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110303438|NCT00287820|Dopamine Agents|dopamine agents|mesh-ancestor
110303439|NCT00287820|Antiemetics|antiemetics|mesh-ancestor
110303440|NCT00287820|Autonomic Agents|autonomic agents|mesh-ancestor
110303441|NCT00287820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110303489|NCT01685125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110303490|NCT01685125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110303491|NCT01685125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110303492|NCT01685125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110303493|NCT01685125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110303494|NCT01685125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110303495|NCT01685125|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110303496|NCT01685125|Hormone Antagonists|hormone antagonists|mesh-ancestor
110303497|NCT01685125|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110303498|NCT04527679|Lenvatinib|lenvatinib|mesh-list
110303499|NCT04527679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110303500|NCT04527679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110303501|NCT04527679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110303502|NCT04527679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110303503|NCT01685281|Metadoxine|metadoxine|mesh-list
110303504|NCT01685281|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110303505|NCT00417066|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110303506|NCT00417066|Ganirelix|ganirelix|mesh-list
110303507|NCT00417066|Luteolytic Agents|luteolytic agents|mesh-ancestor
110303508|NCT00417066|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110303509|NCT00417066|Contraceptive Agents|contraceptive agents|mesh-ancestor
110303542|NCT00253487|Busulfan|busulfan|mesh-list
110303543|NCT00253487|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
110303544|NCT00253487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110303545|NCT00253487|Alkylating Agents|alkylating agents|mesh-ancestor
110303546|NCT00253487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110303547|NCT00253487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110303548|NCT00253487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110303549|NCT00253487|Immunologic Factors|immunologic factors|mesh-ancestor
110303550|NCT00253487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110303551|NCT00253487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110303552|NCT00253487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110303554|NCT00281619|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110303555|NCT00281619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110303556|NCT00281619|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110303557|NCT00281619|Antitubercular Agents|antitubercular agents|mesh-ancestor
110303558|NCT00281619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110303559|NCT00281619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110303560|NCT00281619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110303561|NCT00281619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110303562|NCT04527211|Ivermectin|ivermectin|mesh-list
110303563|NCT04527211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110303564|NCT04527211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110303565|NCT00253526|Bevacizumab|bevacizumab|mesh-list
110303566|NCT00253526|Gemcitabine|gemcitabine|mesh-list
110303567|NCT00253526|Antibodies|antibodies|mesh-list
110303568|NCT00253526|Immunoglobulins|immunoglobulins|mesh-list
110303569|NCT00253526|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110303570|NCT00253526|Mitogens|mitogens|mesh-list
110303589|NCT01686217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110303590|NCT01686217|Vitamin B Complex|vitamin b complex|mesh-ancestor
110303591|NCT01686217|Vitamins|vitamins|mesh-ancestor
110303592|NCT01686217|Micronutrients|micronutrients|mesh-ancestor
110303593|NCT00253565|Capecitabine|capecitabine|mesh-list
110303594|NCT00253565|Imatinib Mesylate|imatinib mesylate|mesh-list
110303595|NCT00253565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110303596|NCT00253565|Antimetabolites|antimetabolites|mesh-ancestor
110303597|NCT00253565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110303598|NCT00253565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110303599|NCT00253565|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110303600|NCT00253565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110303614|NCT01686607|Micafungin|micafungin|mesh-list
110303653|NCT00253721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110303654|NCT00253721|Alkylating Agents|alkylating agents|mesh-ancestor
110303655|NCT00253721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110303656|NCT00253721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110303657|NCT00253721|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110303658|NCT00253721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110303659|NCT00253721|Immunologic Factors|immunologic factors|mesh-ancestor
110303660|NCT00253721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110303661|NCT00281892|Vidarabine|vidarabine|mesh-list
110303662|NCT00281892|Fludarabine|fludarabine|mesh-list
110303663|NCT00281892|Fludarabine phosphate|fludarabine phosphate|mesh-list
110303664|NCT00281892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110303665|NCT00281892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110303715|NCT01687426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110303716|NCT01687426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110303717|NCT01687426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110303719|NCT01687582|Exenatide|exenatide|mesh-list
110303720|NCT01687582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110303721|NCT01687582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110303722|NCT01687582|Incretins|incretins|mesh-ancestor
110303723|NCT01687582|Hormones|hormones|mesh-ancestor
110303724|NCT01687582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110303725|NCT01687582|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110303726|NCT01687699|Spironolactone|spironolactone|mesh-list
110303727|NCT01687699|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110303728|NCT01687699|Hormone Antagonists|hormone antagonists|mesh-ancestor
110303729|NCT01687699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110303730|NCT01687699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110303731|NCT01687699|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110303732|NCT01687699|Diuretics|diuretics|mesh-ancestor
110303733|NCT01687699|Natriuretic Agents|natriuretic agents|mesh-ancestor
110303734|NCT00287937|Paclitaxel|paclitaxel|mesh-list
110303735|NCT00287937|Carboplatin|carboplatin|mesh-list
110303736|NCT00287937|Vorinostat|vorinostat|mesh-list
110303737|NCT00287937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110303738|NCT00287937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110303739|NCT00287937|Tubulin Modulators|tubulin modulators|mesh-ancestor
110303740|NCT00287937|Antimitotic Agents|antimitotic agents|mesh-ancestor
110303741|NCT00287937|Mitosis Modulators|mitosis modulators|mesh-ancestor
110303742|NCT00287937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110303743|NCT00287937|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110303744|NCT00287937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110303763|NCT00287976|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110024244|NCT00004422|Antibodies|antibodies|mesh-list
110303764|NCT00287976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110303765|NCT00287976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110303766|NCT00287976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110303767|NCT00287976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110303768|NCT01688089|Levodopa|levodopa|mesh-list
110303769|NCT01688089|Carbidopa|carbidopa|mesh-list
110303770|NCT01688089|Entacapone|entacapone|mesh-list
110303771|NCT01688089|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110303772|NCT01688089|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110303773|NCT01688089|Dopamine Agents|dopamine agents|mesh-ancestor
110303774|NCT01688089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110303775|NCT01688089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110303776|NCT01688089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110303822|NCT00254033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110303823|NCT00254033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110303825|NCT00254033|Dopamine Agents|dopamine agents|mesh-ancestor
110303895|NCT00417690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110303897|NCT00417729|Glyburide|glyburide|mesh-list
110303898|NCT00417729|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110303899|NCT00417729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110303900|NCT00417729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110303901|NCT00417729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110034835|NCT01402076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110303902|NCT00417729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110303903|NCT00254189|Levonorgestrel|levonorgestrel|mesh-list
110303904|NCT00254189|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110303905|NCT00254189|Estradiol|estradiol|mesh-list
110303906|NCT00254189|Estrogens|estrogens|mesh-ancestor
110303907|NCT00254189|Hormones|hormones|mesh-ancestor
110303908|NCT00254189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110303909|NCT00254189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110303910|NCT00254189|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110303911|NCT00254189|Contraceptive Agents|contraceptive agents|mesh-ancestor
110303912|NCT00254189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110303913|NCT00254189|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110303914|NCT00254189|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110303915|NCT00254189|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110303916|NCT00254189|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110303917|NCT01600807|Gemcitabine|gemcitabine|mesh-list
110303918|NCT01600807|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110303919|NCT01600807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110303920|NCT01600807|Antimetabolites|antimetabolites|mesh-ancestor
110303921|NCT01600807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110303922|NCT01600807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110303923|NCT01600807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110303924|NCT01600807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110303925|NCT00288483|Policosanol|policosanol|mesh-list
110307117|NCT00265928|Bortezomib|bortezomib|mesh-list
110307118|NCT00265928|Antibodies|antibodies|mesh-list
110307119|NCT00265928|Immunoglobulins|immunoglobulins|mesh-list
110307120|NCT00265928|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110307122|NCT00265928|Immunologic Factors|immunologic factors|mesh-ancestor
110307123|NCT00265928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110307124|NCT00265928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110307125|NCT00265928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110307126|NCT00265928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110307127|NCT00265928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307128|NCT00295347|Fludrocortisone|fludrocortisone|mesh-list
110303926|NCT00288483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110303927|NCT00288483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110303928|NCT00288483|Antimetabolites|antimetabolites|mesh-ancestor
110303929|NCT00288483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110303930|NCT00288483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110303931|NCT00288483|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110303932|NCT01600963|Bedaquiline|bedaquiline|mesh-list
110303933|NCT01600963|Diarylquinolines|diarylquinolines|mesh-list
110303934|NCT01600963|Antitubercular Agents|antitubercular agents|mesh-ancestor
110303935|NCT01600963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110303936|NCT01600963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110303937|NCT01606969|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110303938|NCT00288522|Lanreotide|lanreotide|mesh-list
110303939|NCT00288522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110303940|NCT00254267|Motesanib diphosphate|motesanib diphosphate|mesh-list
110303941|NCT00254267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110303942|NCT00254267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110303943|NCT00254267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110303944|NCT01601002|Mirtazapine|mirtazapine|mesh-list
110303945|NCT01601002|Antidepressive Agents|antidepressive agents|mesh-ancestor
110303946|NCT01601002|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110303947|NCT01601002|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110303948|NCT01601002|Histamine Antagonists|histamine antagonists|mesh-ancestor
110303949|NCT01601002|Histamine Agents|histamine agents|mesh-ancestor
110303950|NCT01601002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110303951|NCT01601002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110303952|NCT01601002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110303953|NCT01601002|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110303954|NCT01601002|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110303955|NCT01601002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110303956|NCT01601002|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110303957|NCT01601002|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110303958|NCT01601002|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110303959|NCT01601002|Adrenergic Agents|adrenergic agents|mesh-ancestor
110307129|NCT00295347|Spironolactone|spironolactone|mesh-list
110307130|NCT00295347|Escitalopram|escitalopram|mesh-list
110307131|NCT00295347|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110307132|NCT00295347|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110303960|NCT01601002|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110303961|NCT01601002|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110303962|NCT01601002|Serotonin Agents|serotonin agents|mesh-ancestor
110303963|NCT01601002|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110303964|NCT00288561|Ranibizumab|ranibizumab|mesh-list
110303965|NCT00288561|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110303966|NCT00288561|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110303967|NCT00288561|Growth Substances|growth substances|mesh-ancestor
110303968|NCT00288561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110304024|NCT01601314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110304025|NCT01601314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110304026|NCT01601314|Anesthetics|anesthetics|mesh-ancestor
110304027|NCT01601314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110304028|NCT01601314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110304029|NCT01601314|Anticonvulsants|anticonvulsants|mesh-ancestor
110304030|NCT01601314|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110304031|NCT01601314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110304032|NCT01601314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110304034|NCT01601314|Tocolytic Agents|tocolytic agents|mesh-ancestor
110304087|NCT01608139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110304088|NCT01607671|Timolol|timolol|mesh-list
110304089|NCT01607671|Maleic acid|maleic acid|mesh-list
110304090|NCT01607671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110304091|NCT01607671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110304093|NCT01607671|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110304157|NCT00254813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110304158|NCT01608646|Oxaliplatin|oxaliplatin|mesh-list
110304159|NCT01608646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110304160|NCT01608841|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110304161|NCT01608841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110304162|NCT01608841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110304163|NCT01608841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110304164|NCT01608841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110304165|NCT00254930|Risperidone|risperidone|mesh-list
110304166|NCT00254930|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110304167|NCT00254930|Serotonin Agents|serotonin agents|mesh-ancestor
110304168|NCT00254930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110304169|NCT00254930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110304170|NCT00254930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110304171|NCT00254930|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110304172|NCT00254930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110304173|NCT00254930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110304174|NCT00254930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110304175|NCT00254930|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110304176|NCT00254930|Dopamine Agents|dopamine agents|mesh-ancestor
110304177|NCT02273440|Theophylline|theophylline|mesh-list
110304178|NCT02273440|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110304179|NCT02273440|Autonomic Agents|autonomic agents|mesh-ancestor
110304180|NCT02273440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110304181|NCT02273440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110304182|NCT02273440|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110304183|NCT02273440|Respiratory System Agents|respiratory system agents|mesh-ancestor
110304184|NCT02273440|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110304185|NCT02273440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110307133|NCT00295347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110307134|NCT00295347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307135|NCT00295347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110307136|NCT00295347|Serotonin Agents|serotonin agents|mesh-ancestor
110307137|NCT00295347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110307138|NCT00295347|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110307139|NCT00295347|Hormone Antagonists|hormone antagonists|mesh-ancestor
110307140|NCT00295347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110307141|NCT00295347|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110307142|NCT00295347|Diuretics|diuretics|mesh-ancestor
110307143|NCT00295347|Natriuretic Agents|natriuretic agents|mesh-ancestor
110307144|NCT00295347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110307145|NCT00265967|Irbesartan|irbesartan|mesh-list
110307146|NCT00265967|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110304186|NCT02273440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110304187|NCT02273440|Vasodilator Agents|vasodilator agents|mesh-ancestor
110304189|NCT02273440|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110304190|NCT02273440|Purinergic Agents|purinergic agents|mesh-ancestor
110304191|NCT02273440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110304192|NCT01588717|Glycopyrrolate|glycopyrrolate|mesh-list
110304193|NCT01588717|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110304194|NCT01588717|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110304195|NCT01588717|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110304196|NCT01588717|Cholinergic Agents|cholinergic agents|mesh-ancestor
110304197|NCT01588717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110304198|NCT01588717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110035138|NCT01403818|Calcium|calcium|mesh-list
110304199|NCT01588717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110304200|NCT00270075|Epoetin Alfa|epoetin alfa|mesh-list
110304201|NCT00270075|Hematinics|hematinics|mesh-ancestor
110304202|NCT01588756|Mechlorethamine|mechlorethamine|mesh-list
110304203|NCT01588756|Goralatide|goralatide|mesh-list
110304204|NCT01588756|Alkylating Agents|alkylating agents|mesh-ancestor
110304205|NCT01588756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110304206|NCT01588756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110304207|NCT01588756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110304208|NCT01588756|Growth Inhibitors|growth inhibitors|mesh-ancestor
110304209|NCT01588756|Growth Substances|growth substances|mesh-ancestor
110307147|NCT00265967|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110307148|NCT00265967|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110307149|NCT00265967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307150|NCT00295386|Zopiclone|zopiclone|mesh-list
110307151|NCT00295386|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110307152|NCT00295386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110307153|NCT00295386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110307154|NCT00301236|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
110307155|NCT00301236|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110307161|NCT00301236|Dopamine Agents|dopamine agents|mesh-ancestor
110307162|NCT00301236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110307163|NCT00295425|Cyclosporine|cyclosporine|mesh-list
110307164|NCT00295425|Mycophenolic Acid|mycophenolic acid|mesh-list
110307165|NCT00295425|Cyclosporins|cyclosporins|mesh-list
110307166|NCT00295425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110307167|NCT00295425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307168|NCT00295425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110307169|NCT00295425|Immunologic Factors|immunologic factors|mesh-ancestor
110307170|NCT00295425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110307171|NCT00295425|Antifungal Agents|antifungal agents|mesh-ancestor
110307172|NCT00295425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110307173|NCT00295425|Dermatologic Agents|dermatologic agents|mesh-ancestor
110307174|NCT00295425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110304210|NCT01588756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110304211|NCT01588756|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110304212|NCT01588756|Protective Agents|protective agents|mesh-ancestor
110304213|NCT04719104|Bilirubin|bilirubin|mesh-list
110304214|NCT04719104|Antioxidants|antioxidants|mesh-ancestor
110304215|NCT04719104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110304216|NCT04719104|Protective Agents|protective agents|mesh-ancestor
110304218|NCT01588795|Vitamin D|vitamin d|mesh-list
110304278|NCT00270153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110304279|NCT00270153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110304280|NCT00270153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110304281|NCT04054531|Paclitaxel|paclitaxel|mesh-list
110304282|NCT04054531|Carboplatin|carboplatin|mesh-list
110304283|NCT04054531|Pemetrexed|pemetrexed|mesh-list
110304284|NCT04054531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110304285|NCT04054531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110304286|NCT04054531|Tubulin Modulators|tubulin modulators|mesh-ancestor
110304287|NCT04054531|Antimitotic Agents|antimitotic agents|mesh-ancestor
110304288|NCT04054531|Mitosis Modulators|mitosis modulators|mesh-ancestor
110304289|NCT04054531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110304290|NCT04054531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110304291|NCT04054531|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110304293|NCT00289263|Paclitaxel|paclitaxel|mesh-list
110304340|NCT00289419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110304341|NCT00289419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110304342|NCT00289419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110304343|NCT00289419|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110304344|NCT00289419|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110304345|NCT00289419|Adrenergic Agents|adrenergic agents|mesh-ancestor
110304346|NCT00289419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110304347|NCT00289419|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110304407|NCT00255749|Epoetin Alfa|epoetin alfa|mesh-list
110304408|NCT00255749|Hematinics|hematinics|mesh-ancestor
110304409|NCT04482361|Antibodies|antibodies|mesh-list
110304410|NCT04482361|Immunologic Factors|immunologic factors|mesh-ancestor
110304411|NCT04482361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110304412|NCT00270543|Leucovorin|leucovorin|mesh-list
110304413|NCT00270543|Fluorouracil|fluorouracil|mesh-list
110304414|NCT00270543|Docetaxel|docetaxel|mesh-list
110304415|NCT00270543|Antimetabolites|antimetabolites|mesh-ancestor
110304416|NCT00270543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110304417|NCT00270543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110304475|NCT00289926|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110304476|NCT00289926|Immunologic Factors|immunologic factors|mesh-ancestor
110304477|NCT00289926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110304478|NCT01609192|Hydroxyurea|hydroxyurea|mesh-list
110304479|NCT01609192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110304480|NCT01609192|Antisickling Agents|antisickling agents|mesh-ancestor
110304481|NCT01609192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110304482|NCT01609192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110304484|NCT01609387|Tocopherols|tocopherols|mesh-list
110304542|NCT00270777|Anesthetics, Local|anesthetics, local|mesh-ancestor
110304543|NCT00270777|Anesthetics|anesthetics|mesh-ancestor
110304544|NCT00270777|Sensory System Agents|sensory system agents|mesh-ancestor
110304545|NCT00270777|Antiemetics|antiemetics|mesh-ancestor
110304546|NCT00270777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110304547|NCT00256256|Glucagon|glucagon|mesh-list
110304548|NCT00256256|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110304549|NCT00256256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110304550|NCT00256256|Hormones|hormones|mesh-ancestor
110304551|NCT00256256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110304552|NCT00256256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110304553|NCT00256256|Incretins|incretins|mesh-ancestor
110304554|NCT00256334|Resveratrol|resveratrol|mesh-list
110304555|NCT00256334|Antioxidants|antioxidants|mesh-ancestor
110304556|NCT00256334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110304557|NCT00256334|Protective Agents|protective agents|mesh-ancestor
110304558|NCT00256334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110304559|NCT00256334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110304602|NCT00290082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110304603|NCT00290082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110304604|NCT00290082|Anesthetics, General|anesthetics, general|mesh-ancestor
110304605|NCT00290082|Anesthetics|anesthetics|mesh-ancestor
110304606|NCT00290082|GABA Modulators|gaba modulators|mesh-ancestor
110304607|NCT00290082|GABA Agents|gaba agents|mesh-ancestor
110304608|NCT00290082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110304609|NCT00290082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110304610|NCT00290082|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110304611|NCT00290082|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110304612|NCT00290082|Dopamine Agents|dopamine agents|mesh-ancestor
110304613|NCT00256646|Rosiglitazone|rosiglitazone|mesh-list
110304614|NCT00256646|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110304615|NCT00256646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110304616|NCT02270437|Epinephrine|epinephrine|mesh-list
110024314|NCT00004488|Vitamin D|vitamin d|mesh-list
110304617|NCT02270437|Racepinephrine|racepinephrine|mesh-list
110304618|NCT02270437|Fentanyl|fentanyl|mesh-list
110304619|NCT02270437|Ropivacaine|ropivacaine|mesh-list
110304620|NCT02270437|Epinephryl borate|epinephryl borate|mesh-list
110304621|NCT02270437|Anesthetics, Local|anesthetics, local|mesh-ancestor
110304622|NCT02270437|Anesthetics|anesthetics|mesh-ancestor
110304623|NCT02270437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110304659|NCT02270788|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110304660|NCT02270788|Abortifacient Agents|abortifacient agents|mesh-ancestor
110304661|NCT02270788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110304662|NCT02270788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110304663|NCT02270788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110304664|NCT02270788|Antimetabolites|antimetabolites|mesh-ancestor
110304665|NCT02270788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110304666|NCT02270788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110304667|NCT02270788|Dermatologic Agents|dermatologic agents|mesh-ancestor
110304724|NCT04709744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110304725|NCT02271295|Enoxaparin|enoxaparin|mesh-list
110304726|NCT02271295|Anticoagulants|anticoagulants|mesh-ancestor
110304727|NCT02271295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110304728|NCT02271295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110304730|NCT02271412|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
110304789|NCT00257075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110304790|NCT00257075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110304791|NCT00257075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110304792|NCT00257075|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110304793|NCT00257075|Dopamine Agents|dopamine agents|mesh-ancestor
110304794|NCT02272270|Minocycline|minocycline|mesh-list
110304795|NCT02272270|Temozolomide|temozolomide|mesh-list
110304859|NCT00271245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110304932|NCT01601899|Lamivudine|lamivudine|mesh-list
110304933|NCT01601899|Efavirenz|efavirenz|mesh-list
110304934|NCT01601899|Stavudine|stavudine|mesh-list
110304935|NCT01601899|Antiviral Agents|antiviral agents|mesh-ancestor
110304936|NCT01601899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110304939|NCT01601899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110305001|NCT01602406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110305002|NCT00290628|Cyclosporine|cyclosporine|mesh-list
110305003|NCT00290628|Mycophenolic Acid|mycophenolic acid|mesh-list
110305004|NCT00290628|Methylprednisolone|methylprednisolone|mesh-list
110305075|NCT01602640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110305076|NCT01602640|GABA Modulators|gaba modulators|mesh-ancestor
110305077|NCT01602640|GABA Agents|gaba agents|mesh-ancestor
110305078|NCT01602640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110305079|NCT01602640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110305080|NCT00290667|Prednisone|prednisone|mesh-list
110305081|NCT00290667|Cyclophosphamide|cyclophosphamide|mesh-list
110305082|NCT00290667|Rituximab|rituximab|mesh-list
110305083|NCT00290667|Doxorubicin|doxorubicin|mesh-list
110305084|NCT00290667|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110305085|NCT00290667|Vincristine|vincristine|mesh-list
110305086|NCT00290667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110305087|NCT00290667|Immunologic Factors|immunologic factors|mesh-ancestor
110305088|NCT00290667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110305089|NCT00290667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110305090|NCT00290667|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110305134|NCT01602913|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110305135|NCT01602913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110305136|NCT01602913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110305137|NCT01602913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110305138|NCT01602913|Serotonin Agents|serotonin agents|mesh-ancestor
110305202|NCT00290823|Albendazole|albendazole|mesh-list
110305203|NCT00290823|Dexamethasone|dexamethasone|mesh-list
110305204|NCT00290823|Omeprazole|omeprazole|mesh-list
110305205|NCT00290823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110305206|NCT00290823|Antiemetics|antiemetics|mesh-ancestor
110305273|NCT00257855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110305274|NCT00257855|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110305275|NCT00257855|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110305276|NCT01603498|Dexamethasone|dexamethasone|mesh-list
110305277|NCT01603498|Methylprednisolone|methylprednisolone|mesh-list
110305278|NCT01603498|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110305344|NCT00258050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110305345|NCT00258050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110305346|NCT00258050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110305347|NCT00258050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110305348|NCT00271401|Heparin|heparin|mesh-list
110305349|NCT00271401|Anticoagulants|anticoagulants|mesh-ancestor
110305414|NCT00258245|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110305415|NCT00258245|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110305488|NCT00258479|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110305489|NCT00258479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110305490|NCT00258479|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110305558|NCT04709315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110305560|NCT04709315|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110305561|NCT04709315|Nootropic Agents|nootropic agents|mesh-ancestor
110305562|NCT04709315|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
110305564|NCT01334710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110305627|NCT00291369|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110305628|NCT00291369|Contraceptive Agents|contraceptive agents|mesh-ancestor
110305629|NCT00291369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110305630|NCT00291369|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110305699|NCT00259181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110305700|NCT00291720|Spironolactone|spironolactone|mesh-list
110305701|NCT00291720|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110305702|NCT00291720|Hormone Antagonists|hormone antagonists|mesh-ancestor
110305703|NCT00291720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110305704|NCT00291720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110305705|NCT00291720|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110305706|NCT00291720|Diuretics|diuretics|mesh-ancestor
110305707|NCT00291720|Natriuretic Agents|natriuretic agents|mesh-ancestor
110305708|NCT00259220|Erythromycin|erythromycin|mesh-list
110305709|NCT00259220|Erythromycin Estolate|erythromycin estolate|mesh-list
110305710|NCT00259220|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
110305711|NCT00259220|Erythromycin stearate|erythromycin stearate|mesh-list
110305712|NCT00259220|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110305757|NCT04709081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110305758|NCT04709081|Antifungal Agents|antifungal agents|mesh-ancestor
110305759|NCT04709081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110305760|NCT04709081|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110305762|NCT04709081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110305827|NCT00259766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110305828|NCT00259766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110305829|NCT00259766|Sympathomimetics|sympathomimetics|mesh-ancestor
110305830|NCT00259766|Tocolytic Agents|tocolytic agents|mesh-ancestor
110305837|NCT00292110|Methadone|methadone|mesh-list
110305897|NCT00272454|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110305898|NCT00272454|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110305899|NCT00272454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110305971|NCT00292734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110305973|NCT00292734|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110306044|NCT00424931|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110306045|NCT00424931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110306046|NCT00424931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110306116|NCT01330459|GABA Agents|gaba agents|mesh-ancestor
110306117|NCT01330459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110306118|NCT00293085|Docetaxel|docetaxel|mesh-list
110306119|NCT00293085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110306120|NCT00293085|Tubulin Modulators|tubulin modulators|mesh-ancestor
110306121|NCT00293085|Antimitotic Agents|antimitotic agents|mesh-ancestor
110306122|NCT00293085|Mitosis Modulators|mitosis modulators|mesh-ancestor
110306123|NCT00293085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110306124|NCT00261053|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
110306127|NCT00261053|Immunologic Factors|immunologic factors|mesh-ancestor
110306180|NCT00261170|Dopamine Agents|dopamine agents|mesh-ancestor
110306181|NCT00261170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110306182|NCT00261170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306183|NCT00261170|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110306184|NCT00261170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110306185|NCT00261170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110306187|NCT00261287|Glucocorticoids|glucocorticoids|mesh-ancestor
110306188|NCT00261287|Hormones|hormones|mesh-ancestor
110306189|NCT00261287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110306190|NCT00261287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306191|NCT00261287|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110306192|NCT00261326|Simvastatin|simvastatin|mesh-list
110306193|NCT00261326|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110306194|NCT00261326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110306195|NCT00261326|Antimetabolites|antimetabolites|mesh-ancestor
110306196|NCT00261326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110306197|NCT00261326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110306198|NCT00261326|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110306199|NCT00261326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110306200|NCT00293163|Hylan|hylan|mesh-list
110306233|NCT00261482|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110306234|NCT00261482|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110306235|NCT00261521|Epoetin Alfa|epoetin alfa|mesh-list
110306236|NCT00261521|Hematinics|hematinics|mesh-ancestor
110306237|NCT00298857|Valproic Acid|valproic acid|mesh-list
110306238|NCT00298857|Anticonvulsants|anticonvulsants|mesh-ancestor
110306305|NCT00298974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110306307|NCT00293436|Celecoxib|celecoxib|mesh-list
110306308|NCT00293436|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110306378|NCT00299013|Prednisolone phosphate|prednisolone phosphate|mesh-list
110306379|NCT00299013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110306453|NCT00293631|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110306454|NCT00293631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110306455|NCT00293631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110306456|NCT00262262|Levetiracetam|levetiracetam|mesh-list
110306526|NCT00299520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110306527|NCT00299520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110306528|NCT00299520|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110306600|NCT00263198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110306601|NCT00263198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110306602|NCT00263198|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110306603|NCT00263198|Hormone Antagonists|hormone antagonists|mesh-ancestor
110306604|NCT00263198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110306605|NCT00263198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306606|NCT00263198|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110306607|NCT00294099|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110306608|NCT00294099|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110306609|NCT00294099|Immunologic Factors|immunologic factors|mesh-ancestor
110306611|NCT00294099|Antacids|antacids|mesh-ancestor
110306612|NCT00294099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110306613|NCT00294099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110306614|NCT00299676|Galantamine|galantamine|mesh-list
110306615|NCT00299676|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110306660|NCT00263393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306661|NCT00263393|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110306662|NCT00263393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110306663|NCT00263393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110306665|NCT00263393|Sympatholytics|sympatholytics|mesh-ancestor
110306666|NCT00263393|Autonomic Agents|autonomic agents|mesh-ancestor
110306725|NCT00263822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110306726|NCT00263822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110306727|NCT00263822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110306729|NCT00300222|Antipruritics|antipruritics|mesh-ancestor
110306730|NCT00300222|Dermatologic Agents|dermatologic agents|mesh-ancestor
110306731|NCT00300222|Sensory System Agents|sensory system agents|mesh-ancestor
110306732|NCT00300222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110306733|NCT00300222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306787|NCT00300378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306788|NCT00300378|Antidepressive Agents|antidepressive agents|mesh-ancestor
110306789|NCT00300378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110306791|NCT00264251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110306792|NCT00264251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306793|NCT00294567|Amlodipine|amlodipine|mesh-list
110306794|NCT00294567|Calcium Channel Blockers|calcium channel blockers|mesh-list
110306854|NCT00264446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110306855|NCT00264485|Fentanyl|fentanyl|mesh-list
110306856|NCT00264485|Morphine|morphine|mesh-list
110306857|NCT00264485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110306858|NCT00264485|Narcotics|narcotics|mesh-ancestor
110306859|NCT00264485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110306860|NCT00264485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306861|NCT00264485|Analgesics|analgesics|mesh-ancestor
110306862|NCT00264485|Sensory System Agents|sensory system agents|mesh-ancestor
110306863|NCT00264485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110306864|NCT00264485|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110306865|NCT00264485|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110306866|NCT00264485|Anesthetics, General|anesthetics, general|mesh-ancestor
110306867|NCT00264485|Anesthetics|anesthetics|mesh-ancestor
110306868|NCT00294918|Hormones|hormones|mesh-list
110306869|NCT00294918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110306870|NCT00294918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306871|NCT00264680|Lamotrigine|lamotrigine|mesh-list
110306872|NCT00264680|Anticonvulsants|anticonvulsants|mesh-list
110306873|NCT00264680|Valproic Acid|valproic acid|mesh-list
110306874|NCT00264680|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110306875|NCT00264680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110306906|NCT00264719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110306907|NCT00264719|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110306908|NCT00264719|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110306909|NCT00264719|Dopamine Agents|dopamine agents|mesh-ancestor
110306910|NCT00264719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110306911|NCT00264719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110306912|NCT00264914|Satavaptan|satavaptan|mesh-list
110306913|NCT00264914|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110306914|NCT00264914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110306915|NCT00264914|Natriuretic Agents|natriuretic agents|mesh-ancestor
110306916|NCT00264914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306917|NCT00264953|Prednisone|prednisone|mesh-list
110306918|NCT00264953|Etoposide|etoposide|mesh-list
110306919|NCT00264953|Vincristine|vincristine|mesh-list
110306920|NCT00264953|Doxorubicin|doxorubicin|mesh-list
110306921|NCT00264953|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110306922|NCT00264953|Bleomycin|bleomycin|mesh-list
110306923|NCT00264953|Vinblastine|vinblastine|mesh-list
110306927|NCT00264953|Hormones|hormones|mesh-ancestor
110306963|NCT00294996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110306964|NCT00294996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110306965|NCT00294996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110306966|NCT00265031|Prednisone|prednisone|mesh-list
110306967|NCT00265031|Cyclophosphamide|cyclophosphamide|mesh-list
110306968|NCT00265031|Etoposide|etoposide|mesh-list
110306969|NCT00265031|Vincristine|vincristine|mesh-list
110306970|NCT00265031|Doxorubicin|doxorubicin|mesh-list
110306971|NCT00265031|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110306972|NCT00265031|Bleomycin|bleomycin|mesh-list
110306973|NCT00265031|Procarbazine|procarbazine|mesh-list
110306974|NCT00265031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110306975|NCT00265031|Immunologic Factors|immunologic factors|mesh-ancestor
110306976|NCT00265031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306985|NCT00265031|Hormones|hormones|mesh-ancestor
110307026|NCT00295035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307027|NCT00295035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110307028|NCT00265265|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110307029|NCT00265265|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110307030|NCT00265265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110307095|NCT00265772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110307096|NCT00265772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110307097|NCT00265772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110307098|NCT00265772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110307099|NCT00265811|Cetuximab|cetuximab|mesh-list
110307100|NCT00265811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110307101|NCT00265811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110307102|NCT00295308|Clonidine|clonidine|mesh-list
110307103|NCT00295308|Analgesics|analgesics|mesh-ancestor
110307104|NCT00295308|Sensory System Agents|sensory system agents|mesh-ancestor
110307105|NCT00295308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110024421|NCT00004728|Antipyretics|antipyretics|mesh-ancestor
110307116|NCT00265928|Rituximab|rituximab|mesh-list
110307156|NCT00301236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110307157|NCT00301236|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110307158|NCT00301236|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110307159|NCT00301236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110307160|NCT00301236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307175|NCT00295425|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110307176|NCT00295425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110307177|NCT00295425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110307178|NCT00295425|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110307224|NCT00415844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110307179|NCT00295425|Antitubercular Agents|antitubercular agents|mesh-ancestor
110307180|NCT00295425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110307182|NCT00266123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110307183|NCT00266123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110307297|NCT00266357|GABA Agents|gaba agents|mesh-ancestor
110307184|NCT00266123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110307185|NCT00266123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110307186|NCT00266123|Antifungal Agents|antifungal agents|mesh-ancestor
110307187|NCT00266123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110307188|NCT00266123|Immunologic Factors|immunologic factors|mesh-ancestor
110307189|NCT00266123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110307190|NCT00266162|Bosentan|bosentan|mesh-list
110307191|NCT00266162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110307192|NCT00266162|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110307193|NCT00266162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307194|NCT00295464|Betamethasone|betamethasone|mesh-list
110307195|NCT00295464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110307196|NCT00295464|Glucocorticoids|glucocorticoids|mesh-ancestor
110307197|NCT00295464|Hormones|hormones|mesh-ancestor
110307198|NCT00295464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110307199|NCT00295464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110307200|NCT00295464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110307201|NCT00295464|Respiratory System Agents|respiratory system agents|mesh-ancestor
110307202|NCT00415766|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110307203|NCT00415766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110307204|NCT00415766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110307205|NCT00301392|Pitavastatin|pitavastatin|mesh-list
110307206|NCT00301392|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110307207|NCT00301392|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110307208|NCT00301392|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110307209|NCT00301392|Antimetabolites|antimetabolites|mesh-ancestor
110307210|NCT00301392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307211|NCT00301392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110307212|NCT00301392|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110307213|NCT00415844|Levodopa|levodopa|mesh-list
110307214|NCT00415844|Carbidopa|carbidopa|mesh-list
110307215|NCT00415844|Entacapone|entacapone|mesh-list
110307216|NCT00415844|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110307217|NCT00415844|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110307218|NCT00415844|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110307219|NCT00415844|Dopamine Agents|dopamine agents|mesh-ancestor
110307220|NCT00415844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110307221|NCT00415844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307222|NCT00415844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110307429|NCT00267176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110307223|NCT00415844|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110307225|NCT00415844|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
110307226|NCT00415844|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110307227|NCT00415844|Immunologic Factors|immunologic factors|mesh-ancestor
110307228|NCT00415844|Dopamine Agonists|dopamine agonists|mesh-ancestor
110307229|NCT00415883|Valsartan|valsartan|mesh-list
110307230|NCT00415883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110307231|NCT00415883|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110307232|NCT00415883|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110307233|NCT00415883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307234|NCT00295542|Atenolol|atenolol|mesh-list
110307235|NCT00295542|Valsartan|valsartan|mesh-list
110307236|NCT00295542|Telmisartan|telmisartan|mesh-list
110307237|NCT00295542|Carvedilol|carvedilol|mesh-list
110307238|NCT00295542|Olmesartan|olmesartan|mesh-list
110307239|NCT00295542|Enalapril|enalapril|mesh-list
110307240|NCT00295542|Lisinopril|lisinopril|mesh-list
110307241|NCT00295542|Nebivolol|nebivolol|mesh-list
110307242|NCT00295542|Antihypertensive Agents|antihypertensive agents|mesh-list
110307243|NCT00295542|Doxazosin|doxazosin|mesh-list
110307244|NCT00295542|Indapamide|indapamide|mesh-list
110307245|NCT00295542|Quinapril|quinapril|mesh-list
110307246|NCT00295542|Torsemide|torsemide|mesh-list
110307247|NCT00295542|Spirapril|spirapril|mesh-list
110307248|NCT00295542|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110307249|NCT00295542|Diuretics|diuretics|mesh-list
110307250|NCT00295542|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110307251|NCT00295542|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110307252|NCT00295542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307253|NCT00295542|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110307254|NCT00295542|Adrenergic Agents|adrenergic agents|mesh-ancestor
110307255|NCT00295542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110307256|NCT00295542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110307257|NCT00295542|Antioxidants|antioxidants|mesh-ancestor
110307258|NCT00295542|Protective Agents|protective agents|mesh-ancestor
110307259|NCT00295542|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110307260|NCT00295542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110307261|NCT00295542|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110307262|NCT00295542|Vasodilator Agents|vasodilator agents|mesh-ancestor
110307263|NCT00295542|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110307264|NCT00295542|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110307265|NCT00295542|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110307266|NCT00295542|Protease Inhibitors|protease inhibitors|mesh-ancestor
110307267|NCT00295542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110307268|NCT00295542|Natriuretic Agents|natriuretic agents|mesh-ancestor
110307270|NCT00295542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110307271|NCT00295542|Sympatholytics|sympatholytics|mesh-ancestor
110307272|NCT00295542|Autonomic Agents|autonomic agents|mesh-ancestor
110307273|NCT00295542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110307274|NCT00295542|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110368880|NCT04615962|Dermatologic Agents|dermatologic agents|mesh-ancestor
110307275|NCT00295542|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110307277|NCT00295542|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110307278|NCT00295542|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110307279|NCT00295542|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110307280|NCT00266318|Interferons|interferons|mesh-list
110307281|NCT00266318|Ribavirin|ribavirin|mesh-list
110307282|NCT00266318|Interferon alfacon-1|interferon alfacon-1|mesh-list
110307283|NCT00266318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110307284|NCT00266318|Antiviral Agents|antiviral agents|mesh-ancestor
110369025|NCT04612998|Cholinergic Agents|cholinergic agents|mesh-ancestor
110307285|NCT00266318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110307286|NCT00266318|Antimetabolites|antimetabolites|mesh-ancestor
110307287|NCT00266318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307289|NCT00266357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110369095|NCT02179151|CKD732|ckd732|mesh-list
110307290|NCT00266357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307291|NCT00266357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110307292|NCT00266357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110307293|NCT00266357|Analgesics|analgesics|mesh-ancestor
110307294|NCT00266357|Sensory System Agents|sensory system agents|mesh-ancestor
110307295|NCT00266357|Anticonvulsants|anticonvulsants|mesh-ancestor
110307296|NCT00266357|GABA Agonists|gaba agonists|mesh-ancestor
110307298|NCT00301509|Ribavirin|ribavirin|mesh-list
110307299|NCT00301509|Antimetabolites|antimetabolites|mesh-ancestor
110307300|NCT00301509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307301|NCT00301509|Antiviral Agents|antiviral agents|mesh-ancestor
110307302|NCT00301509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110369168|NCT02092454|Benzocaine|benzocaine|mesh-list
110307304|NCT00295698|Filaricides|filaricides|mesh-ancestor
110307305|NCT00295698|Antinematodal Agents|antinematodal agents|mesh-ancestor
110307306|NCT00295698|Anthelmintics|anthelmintics|mesh-ancestor
110307307|NCT00295698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110307308|NCT00295698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110369228|NCT02057315|Analgesics|analgesics|mesh-ancestor
110307309|NCT00295698|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110307310|NCT00295698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110307311|NCT00295698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307312|NCT00266552|Risperidone|risperidone|mesh-list
110307313|NCT00266552|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110307314|NCT00266552|Serotonin Agents|serotonin agents|mesh-ancestor
110307315|NCT00266552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110307316|NCT00266552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307317|NCT00266552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110307318|NCT00266552|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110307319|NCT00266552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110307320|NCT00266552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110307321|NCT00266552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110369374|NCT01967810|Bevacizumab|bevacizumab|mesh-list
110307322|NCT00266552|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110307323|NCT00266552|Dopamine Agents|dopamine agents|mesh-ancestor
110307324|NCT00301587|Folic Acid|folic acid|mesh-list
110307326|NCT00301587|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110307327|NCT00301587|Norgestimate|norgestimate|mesh-list
110307328|NCT00301587|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110307329|NCT00301587|Estradiol|estradiol|mesh-list
110307330|NCT00301587|Estrogens|estrogens|mesh-ancestor
110307331|NCT00301587|Hormones|hormones|mesh-ancestor
110307332|NCT00301587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110307333|NCT00301587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110307334|NCT00301587|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110307335|NCT00301587|Contraceptive Agents|contraceptive agents|mesh-ancestor
110307336|NCT00301587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110369515|NCT01941836|Antimetabolites|antimetabolites|mesh-ancestor
110307337|NCT00301587|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110307338|NCT00301587|Hematinics|hematinics|mesh-ancestor
110307339|NCT00301587|Vitamin B Complex|vitamin b complex|mesh-ancestor
110307340|NCT00301587|Vitamins|vitamins|mesh-ancestor
110307341|NCT00301587|Micronutrients|micronutrients|mesh-ancestor
110307342|NCT00301587|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110307343|NCT00301587|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110307344|NCT00301587|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110307345|NCT00301587|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110307346|NCT00301587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110307347|NCT00301587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110307348|NCT00301587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110307349|NCT00301587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110307350|NCT00301587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307351|NCT00301587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110307352|NCT00301587|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110307354|NCT00266591|Anticonvulsants|anticonvulsants|mesh-ancestor
110307355|NCT00266591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110307356|NCT00266591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110307357|NCT00301665|Botulinum Toxins|botulinum toxins|mesh-list
110307358|NCT00301665|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110307359|NCT00301665|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110307360|NCT00301665|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110307361|NCT00301665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110307362|NCT00301665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307363|NCT00301665|Cholinergic Agents|cholinergic agents|mesh-ancestor
110307364|NCT00301665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110307365|NCT00301665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110307366|NCT00301665|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110307367|NCT00301665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110307368|NCT00295776|Lamotrigine|lamotrigine|mesh-list
110307369|NCT00295776|Anticonvulsants|anticonvulsants|mesh-ancestor
110307370|NCT00295776|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110307371|NCT00295776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110307372|NCT00295776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307373|NCT00295776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110307374|NCT00295776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110307375|NCT00295776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110307376|NCT00295776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110307377|NCT00295776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110307378|NCT00295776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110307379|NCT00295776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110307381|NCT00266669|Vasodilator Agents|vasodilator agents|mesh-ancestor
110307382|NCT00266747|Amibegron|amibegron|mesh-list
110307383|NCT00266747|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
110307384|NCT00266747|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110307385|NCT00266747|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110307386|NCT00266747|Adrenergic Agents|adrenergic agents|mesh-ancestor
110307387|NCT00266747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110307388|NCT00266747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307389|NCT00266747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110307390|NCT00266747|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110307391|NCT00266786|Ketorolac|ketorolac|mesh-list
110307392|NCT00266786|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110307393|NCT00266786|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110307394|NCT00266786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110307395|NCT00266786|Analgesics|analgesics|mesh-ancestor
110307396|NCT00266786|Sensory System Agents|sensory system agents|mesh-ancestor
110307397|NCT00266786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110307398|NCT00266786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110307399|NCT00266786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110307400|NCT00266786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110307401|NCT00266786|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110307402|NCT00266786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110307403|NCT00266786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307404|NCT00295815|Lomustine|lomustine|mesh-list
110307405|NCT00295815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110307406|NCT00295815|Alkylating Agents|alkylating agents|mesh-ancestor
110307407|NCT00295815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307408|NCT00295815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110307409|NCT00295971|Fludarabine|fludarabine|mesh-list
110307410|NCT00295971|Fludarabine phosphate|fludarabine phosphate|mesh-list
110307411|NCT00295971|Thiotepa|thiotepa|mesh-list
110307412|NCT00295971|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110307413|NCT00295971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110307414|NCT00295971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110307415|NCT00295971|Antimetabolites|antimetabolites|mesh-ancestor
110369809|NCT01773785|Docetaxel|docetaxel|mesh-list
110307416|NCT00295971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307417|NCT00295971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110307418|NCT00295971|Immunologic Factors|immunologic factors|mesh-ancestor
110307419|NCT00295971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110307420|NCT00295971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110307421|NCT00295971|Alkylating Agents|alkylating agents|mesh-ancestor
110307422|NCT00295971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110307423|NCT00267176|Lumiracoxib|lumiracoxib|mesh-list
110369889|NCT04600089|Ketamine|ketamine|mesh-list
110307424|NCT00267176|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110307425|NCT00267176|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110307426|NCT00267176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110307427|NCT00267176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307428|NCT00267176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110307430|NCT00267176|Analgesics|analgesics|mesh-ancestor
110307431|NCT00267176|Sensory System Agents|sensory system agents|mesh-ancestor
110307432|NCT00267176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110307433|NCT00267176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110307434|NCT00267176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110307435|NCT00267176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110307436|NCT00296010|Cyclophosphamide|cyclophosphamide|mesh-list
110307437|NCT00296010|Doxorubicin|doxorubicin|mesh-list
110307438|NCT00296010|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110307439|NCT00296010|Methotrexate|methotrexate|mesh-list
110307440|NCT00296010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110307441|NCT00296010|Immunologic Factors|immunologic factors|mesh-ancestor
110307442|NCT00296010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110307443|NCT00296010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110307444|NCT00296010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110307445|NCT00296010|Alkylating Agents|alkylating agents|mesh-ancestor
110307446|NCT00296010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307447|NCT00296010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110307448|NCT00296010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110307449|NCT00296010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110307450|NCT00296010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110307451|NCT00296010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110307452|NCT00296010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110307453|NCT00296010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110307454|NCT00296010|Abortifacient Agents|abortifacient agents|mesh-ancestor
110024581|NCT00004926|Vitamin D|vitamin d|mesh-list
110307455|NCT00296010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110307456|NCT00296010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110307457|NCT00296010|Antimetabolites|antimetabolites|mesh-ancestor
110307458|NCT00296010|Dermatologic Agents|dermatologic agents|mesh-ancestor
110307459|NCT00296010|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110307460|NCT00296010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110307461|NCT00267215|Lumiracoxib|lumiracoxib|mesh-list
110307462|NCT00267215|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110307463|NCT00267215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110307464|NCT00267215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110307465|NCT00267215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307466|NCT00267215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110307467|NCT00267215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110307468|NCT00267215|Analgesics|analgesics|mesh-ancestor
110307469|NCT00267215|Sensory System Agents|sensory system agents|mesh-ancestor
110307470|NCT00267215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110307471|NCT00267215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110307472|NCT00267215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110307473|NCT00267215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110307474|NCT00296049|Vancomycin|vancomycin|mesh-list
110307475|NCT00296049|Daptomycin|daptomycin|mesh-list
110307476|NCT00296049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110307477|NCT00296049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110307478|NCT00267254|Atorvastatin|atorvastatin|mesh-list
110307479|NCT00267254|Simvastatin|simvastatin|mesh-list
110307480|NCT00267254|Torcetrapib|torcetrapib|mesh-list
110307481|NCT00267254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110307482|NCT00267254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110307483|NCT00267254|Antimetabolites|antimetabolites|mesh-ancestor
110307484|NCT00267254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307485|NCT00267254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110307486|NCT00267254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110307487|NCT00267254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110307488|NCT00301782|Carboplatin|carboplatin|mesh-list
110307489|NCT00301782|Etoposide|etoposide|mesh-list
110307490|NCT00301782|Vincristine|vincristine|mesh-list
110307491|NCT00301782|Bleomycin|bleomycin|mesh-list
110307492|NCT00301782|Etoposide phosphate|etoposide phosphate|mesh-list
110307493|NCT00301782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110307494|NCT00301782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110307495|NCT00301782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110307496|NCT00301782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110307497|NCT00301782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110307498|NCT00301782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307499|NCT00301782|Tubulin Modulators|tubulin modulators|mesh-ancestor
110307500|NCT00301782|Antimitotic Agents|antimitotic agents|mesh-ancestor
110307501|NCT00301782|Mitosis Modulators|mitosis modulators|mesh-ancestor
110307502|NCT00301782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110307503|NCT00267332|Modafinil|modafinil|mesh-list
110307504|NCT00267332|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110307505|NCT00267332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370302|NCT01161628|Rituximab|rituximab|mesh-list
110307506|NCT00267332|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110307507|NCT00267332|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110307508|NCT00267332|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110307509|NCT00267332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307510|NCT04718649|Celecoxib|celecoxib|mesh-list
110307511|NCT04718649|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110307512|NCT04718649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110307513|NCT04718649|Analgesics|analgesics|mesh-ancestor
110307514|NCT04718649|Sensory System Agents|sensory system agents|mesh-ancestor
110307515|NCT04718649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110307516|NCT04718649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110307517|NCT04718649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110307518|NCT04718649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110307519|NCT04718649|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110307520|NCT04718649|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110307521|NCT04718649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110307522|NCT04718649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307523|NCT00301860|Cyclosporine|cyclosporine|mesh-list
110307524|NCT00301860|Methotrexate|methotrexate|mesh-list
110307525|NCT00301860|Fludarabine phosphate|fludarabine phosphate|mesh-list
110307526|NCT00301860|Fludarabine|fludarabine|mesh-list
110307528|NCT00301860|Cyclosporins|cyclosporins|mesh-list
110307529|NCT00301860|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110307530|NCT00301860|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110307531|NCT00301860|Abortifacient Agents|abortifacient agents|mesh-ancestor
110307532|NCT00301860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110307533|NCT00301860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110307534|NCT00301860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110307535|NCT00301860|Antimetabolites|antimetabolites|mesh-ancestor
110370568|NCT01158118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110307536|NCT00301860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307537|NCT00301860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110307538|NCT00301860|Dermatologic Agents|dermatologic agents|mesh-ancestor
110307539|NCT00301860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110307540|NCT00301860|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110307541|NCT00301860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110307542|NCT00301860|Immunologic Factors|immunologic factors|mesh-ancestor
110307543|NCT00301860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110307544|NCT00301860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110307546|NCT00301860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110307547|NCT00301860|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110307548|NCT00301860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110370698|NCT01156792|Montelukast|montelukast|mesh-list
110307549|NCT00301860|Alkylating Agents|alkylating agents|mesh-ancestor
110307550|NCT00301860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110307552|NCT00301899|Pertuzumab|pertuzumab|mesh-list
110307553|NCT00301899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110307554|NCT00301899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110307555|NCT00296127|Celecoxib|celecoxib|mesh-list
110307556|NCT00296127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110368826|NCT00563160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110368827|NCT00563238|Metoprolol|metoprolol|mesh-list
110368828|NCT00563238|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110368829|NCT00563238|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110368830|NCT00563238|Sympatholytics|sympatholytics|mesh-ancestor
110368831|NCT00563238|Autonomic Agents|autonomic agents|mesh-ancestor
110368832|NCT00563238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110368833|NCT00563238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368834|NCT00563238|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110368835|NCT00563238|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110368836|NCT00563238|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110368837|NCT00563238|Adrenergic Agents|adrenergic agents|mesh-ancestor
110368838|NCT00563238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110368839|NCT00563238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110368840|NCT04679558|Chlorhexidine|chlorhexidine|mesh-list
110368841|NCT04679558|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110368842|NCT04679558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110368843|NCT04679558|Disinfectants|disinfectants|mesh-ancestor
110368844|NCT04934228|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110368845|NCT04934228|Clonidine|clonidine|mesh-list
110368846|NCT04934228|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110368847|NCT04934228|Diuretics|diuretics|mesh-ancestor
110368848|NCT04934228|Natriuretic Agents|natriuretic agents|mesh-ancestor
110368849|NCT04934228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368850|NCT04934228|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110368851|NCT04934228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110368852|NCT04934228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110368853|NCT04934228|Analgesics|analgesics|mesh-ancestor
110368855|NCT04934228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110368856|NCT04934228|Sympatholytics|sympatholytics|mesh-ancestor
110368857|NCT04934228|Autonomic Agents|autonomic agents|mesh-ancestor
110368858|NCT04934228|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110368859|NCT04934228|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110368860|NCT04934228|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110368861|NCT04934228|Adrenergic Agents|adrenergic agents|mesh-ancestor
110368862|NCT04934228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110368863|NCT03454503|Imatinib Mesylate|imatinib mesylate|mesh-list
110368864|NCT03454503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110368865|NCT03454503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110368866|NCT03454503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110368867|NCT03454503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110368868|NCT04616391|Insulin|insulin|mesh-list
110368869|NCT04616391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110368870|NCT04616391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368871|NCT04890236|Tisagenlecleucel|tisagenlecleucel|mesh-list
110368872|NCT04890236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110368873|NCT04890236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110368874|NCT04615962|Mometasone Furoate|mometasone furoate|mesh-list
110368875|NCT04615962|Hydrocortisone|hydrocortisone|mesh-list
110368876|NCT04615962|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110368877|NCT04615962|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110368878|NCT04615962|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110368879|NCT04615962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110368881|NCT04615962|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110368882|NCT04881929|Docetaxel|docetaxel|mesh-list
110368883|NCT04881929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110368884|NCT04881929|Tubulin Modulators|tubulin modulators|mesh-ancestor
110368885|NCT04881929|Antimitotic Agents|antimitotic agents|mesh-ancestor
110368886|NCT04881929|Mitosis Modulators|mitosis modulators|mesh-ancestor
110368887|NCT04881929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110368888|NCT04615767|Inositol|inositol|mesh-list
110368889|NCT04615767|Vitamin B Complex|vitamin b complex|mesh-ancestor
110368890|NCT04615767|Vitamins|vitamins|mesh-ancestor
110368891|NCT04615767|Micronutrients|micronutrients|mesh-ancestor
110368892|NCT04615767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368893|NCT04615611|Albuterol|albuterol|mesh-list
110368894|NCT04615611|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110368895|NCT04615611|Autonomic Agents|autonomic agents|mesh-ancestor
110368896|NCT04615611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110368897|NCT04615611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368898|NCT04615611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110368899|NCT04615611|Respiratory System Agents|respiratory system agents|mesh-ancestor
110368900|NCT04615611|Tocolytic Agents|tocolytic agents|mesh-ancestor
110368901|NCT04615611|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110368902|NCT04615611|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110368903|NCT04615611|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110368904|NCT04615611|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110368905|NCT04615611|Adrenergic Agents|adrenergic agents|mesh-ancestor
110368906|NCT04615611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110368907|NCT04615611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110368908|NCT04615728|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110368909|NCT04615728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110368911|NCT04725812|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110368912|NCT04725812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110368913|NCT04725812|Immunologic Factors|immunologic factors|mesh-ancestor
110368914|NCT04725812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368915|NCT04713371|Cyclophosphamide|cyclophosphamide|mesh-list
110368916|NCT04713371|Pembrolizumab|pembrolizumab|mesh-list
110368917|NCT04713371|Ipilimumab|ipilimumab|mesh-list
110368918|NCT04713371|Sargramostim|sargramostim|mesh-list
110368919|NCT04713371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110368920|NCT04713371|Immunologic Factors|immunologic factors|mesh-ancestor
110373465|NCT01145755|Analgesics|analgesics|mesh-ancestor
110368921|NCT04713371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368922|NCT04713371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110368923|NCT04713371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110373547|NCT00583518|Hormones|hormones|mesh-list
110368925|NCT04713371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110368926|NCT04713371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110368927|NCT04713371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110368928|NCT04713371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110368929|NCT04713371|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110368930|NCT04683614|Norepinephrine|norepinephrine|mesh-list
110368931|NCT04683614|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110368932|NCT04683614|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110368933|NCT04683614|Adrenergic Agents|adrenergic agents|mesh-ancestor
110368934|NCT04683614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110368935|NCT04683614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110368936|NCT04683614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368937|NCT04683614|Sympathomimetics|sympathomimetics|mesh-ancestor
110373604|NCT04575675|Diuretics|diuretics|mesh-ancestor
110368938|NCT04683614|Autonomic Agents|autonomic agents|mesh-ancestor
110373673|NCT03451695|Morphine|morphine|mesh-list
110368940|NCT04683614|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110368941|NCT04613895|Fexuprazan|fexuprazan|mesh-list
110368942|NCT04613895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110368943|NCT04613700|Secretin|secretin|mesh-list
110373740|NCT00570245|Antioxidants|antioxidants|mesh-ancestor
110368944|NCT04613700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110368945|NCT04613700|Hormones|hormones|mesh-ancestor
110368946|NCT04613700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110368947|NCT04613700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368948|NCT00563355|Epoetin Alfa|epoetin alfa|mesh-list
110368949|NCT00563355|Hematinics|hematinics|mesh-ancestor
110368950|NCT00563394|Ofloxacin|ofloxacin|mesh-list
110368951|NCT00563394|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110368952|NCT00563394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110368953|NCT00563394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110368954|NCT00563394|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110368955|NCT00563394|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110368956|NCT00563394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110368957|NCT00563394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110368958|NCT00563394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110368959|NCT00563394|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110368961|NCT00563433|Ofloxacin|ofloxacin|mesh-list
110368962|NCT00563433|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110368963|NCT00563433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110368964|NCT00563433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110368965|NCT00563433|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110368966|NCT00563433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110368967|NCT00563433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110368968|NCT00563433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110368969|NCT00563433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110368970|NCT00563433|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110368971|NCT00563433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110368973|NCT00563472|Progesterone|progesterone|mesh-list
110368974|NCT00563472|Progestins|progestins|mesh-ancestor
110368975|NCT00563472|Hormones|hormones|mesh-ancestor
110374223|NCT01138150|Gout Suppressants|gout suppressants|mesh-ancestor
110368976|NCT00563472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110368977|NCT00563472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368978|NCT00563472|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110368979|NCT00563472|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110368980|NCT00563472|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110368981|NCT00563472|Contraceptive Agents|contraceptive agents|mesh-ancestor
110368982|NCT00563472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110368983|NCT00563472|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110368984|NCT00563472|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110368986|NCT04679597|Oxaliplatin|oxaliplatin|mesh-list
110368987|NCT04679597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110368988|NCT04679597|Antimetabolites|antimetabolites|mesh-ancestor
110368989|NCT04679597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110368990|NCT04679597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110368991|NCT04615910|Exenatide|exenatide|mesh-list
110368992|NCT04615910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110374439|NCT00199797|Leucovorin|leucovorin|mesh-list
110368993|NCT04615910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368994|NCT04615910|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110368995|NCT04615910|Incretins|incretins|mesh-ancestor
110368997|NCT04615910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110368998|NCT04609397|Hemay005|hemay005|mesh-list
110368999|NCT04609397|Dermatologic Agents|dermatologic agents|mesh-ancestor
110369000|NCT04609397|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110369001|NCT04609397|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110369002|NCT04609397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110369003|NCT04609397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110369004|NCT04587947|Valsartan|valsartan|mesh-list
110369005|NCT04587947|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110369006|NCT04587947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110369007|NCT04587947|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110369008|NCT04587947|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110374582|NCT04673396|Norcantharidin|norcantharidin|mesh-list
110369009|NCT04587947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110369011|NCT04612998|Ephedrine|ephedrine|mesh-list
110369012|NCT04612998|Metoclopramide|metoclopramide|mesh-list
110369013|NCT04612998|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110369014|NCT04612998|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110369015|NCT04612998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110369016|NCT04612998|Autonomic Agents|autonomic agents|mesh-ancestor
110374674|NCT02883439|Xhance|xhance|mesh-list
110369017|NCT04612998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110369018|NCT04612998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369019|NCT04612998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110369020|NCT04612998|Respiratory System Agents|respiratory system agents|mesh-ancestor
110369021|NCT04612998|Mydriatics|mydriatics|mesh-ancestor
110369022|NCT04612998|Parasympatholytics|parasympatholytics|mesh-ancestor
110369023|NCT04612998|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110369024|NCT04612998|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110369026|NCT04612998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110369027|NCT04612998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110369028|NCT04612998|Antiemetics|antiemetics|mesh-ancestor
110369029|NCT04612998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110369030|NCT04612998|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110369031|NCT04612998|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110369032|NCT04612998|Dopamine Agents|dopamine agents|mesh-ancestor
110369033|NCT04612998|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110369034|NCT04612998|Sympathomimetics|sympathomimetics|mesh-ancestor
110369035|NCT04612998|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110369036|NCT04612998|Adrenergic Agents|adrenergic agents|mesh-ancestor
110369038|NCT00563589|Mycophenolic Acid|mycophenolic acid|mesh-list
110369040|NCT00563589|Cyclosporins|cyclosporins|mesh-list
110369041|NCT00563589|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110369042|NCT00563589|Abortifacient Agents|abortifacient agents|mesh-ancestor
110369043|NCT00563589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110369044|NCT00563589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369045|NCT00563589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110369047|NCT00563589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110369048|NCT00563589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110369049|NCT00563589|Dermatologic Agents|dermatologic agents|mesh-ancestor
110369050|NCT00563589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110369051|NCT00563589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110369052|NCT00563589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110369053|NCT00563589|Immunologic Factors|immunologic factors|mesh-ancestor
110369054|NCT00563589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110369055|NCT00563589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110369056|NCT00563589|Antifungal Agents|antifungal agents|mesh-ancestor
110369057|NCT00563589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110369058|NCT00563589|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110369059|NCT00563589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110369060|NCT00563589|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110369061|NCT00563589|Antitubercular Agents|antitubercular agents|mesh-ancestor
110369062|NCT00563589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110369063|NCT04612803|Histamine Antagonists|histamine antagonists|mesh-list
110369064|NCT04612803|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
110369065|NCT04612803|Histamine Agents|histamine agents|mesh-ancestor
110369066|NCT04612803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110369067|NCT04612803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110369068|NCT04612803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369069|NCT02204345|Paclitaxel|paclitaxel|mesh-list
110369070|NCT02204345|Carboplatin|carboplatin|mesh-list
110369071|NCT02204345|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110369072|NCT02204345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110369073|NCT02204345|Tubulin Modulators|tubulin modulators|mesh-ancestor
110369074|NCT02204345|Antimitotic Agents|antimitotic agents|mesh-ancestor
110369075|NCT02204345|Mitosis Modulators|mitosis modulators|mesh-ancestor
110369076|NCT02204345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110369077|NCT02187302|Bevacizumab|bevacizumab|mesh-list
110369078|NCT02187302|Sunitinib|sunitinib|mesh-list
110369079|NCT02187302|Everolimus|everolimus|mesh-list
110369080|NCT02187302|Sorafenib|sorafenib|mesh-list
110369081|NCT02187302|Axitinib|axitinib|mesh-list
110369082|NCT02187302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110369083|NCT02187302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110369084|NCT02187302|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110369086|NCT02187302|Growth Substances|growth substances|mesh-ancestor
110369087|NCT02187302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369088|NCT02187302|Growth Inhibitors|growth inhibitors|mesh-ancestor
110369089|NCT02187302|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110369090|NCT02187302|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110369091|NCT02187302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110369092|NCT02187302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110369093|NCT02187302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110024866|NCT00005802|Aldesleukin|aldesleukin|mesh-list
110369094|NCT02187302|Immunologic Factors|immunologic factors|mesh-ancestor
110369096|NCT02179151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110369097|NCT02179151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110369098|NCT02179151|Growth Substances|growth substances|mesh-ancestor
110369099|NCT02179151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369100|NCT02179151|Growth Inhibitors|growth inhibitors|mesh-ancestor
110369101|NCT02179151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110369103|NCT02160665|Dermatologic Agents|dermatologic agents|mesh-ancestor
110369104|NCT02160665|Keratolytic Agents|keratolytic agents|mesh-ancestor
110369105|NCT02138630|Capsaicin|capsaicin|mesh-list
110369106|NCT02138630|Antipruritics|antipruritics|mesh-ancestor
110369107|NCT02138630|Dermatologic Agents|dermatologic agents|mesh-ancestor
110369108|NCT02138630|Sensory System Agents|sensory system agents|mesh-ancestor
110369109|NCT02138630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110369110|NCT02138630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369111|NCT02137343|Capecitabine|capecitabine|mesh-list
110369112|NCT02137343|Rilotumumab|rilotumumab|mesh-list
110369113|NCT02137343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110369114|NCT02137343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110369115|NCT02137343|Antimetabolites|antimetabolites|mesh-ancestor
110369116|NCT02137343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110369117|NCT02137343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110369118|NCT02125253|Mometasone Furoate|mometasone furoate|mesh-list
110369119|NCT02125253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110369120|NCT02125253|Dermatologic Agents|dermatologic agents|mesh-ancestor
110369121|NCT02125253|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110369122|NCT02114060|Vaccines|vaccines|mesh-list
110369123|NCT02114060|Immunologic Factors|immunologic factors|mesh-ancestor
110369124|NCT02114060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369125|NCT00560898|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110369126|NCT02104388|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110369127|NCT02104388|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110369128|NCT04633044|Betaine|betaine|mesh-list
110369129|NCT04633044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110369130|NCT04633044|Lipotropic Agents|lipotropic agents|mesh-ancestor
110369131|NCT04633044|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110369132|NCT04633044|Antimetabolites|antimetabolites|mesh-ancestor
110369133|NCT04633044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110369134|NCT04633044|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110369135|NCT04611438|Cannabidiol|cannabidiol|mesh-list
110369136|NCT04611438|Anticonvulsants|anticonvulsants|mesh-ancestor
110369137|NCT00563823|Vatalanib|vatalanib|mesh-list
110369138|NCT00563823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110369140|NCT00563823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110369141|NCT00563862|Fluorouracil|fluorouracil|mesh-list
110369142|NCT00563862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110369143|NCT00563862|Antimetabolites|antimetabolites|mesh-ancestor
110369144|NCT00563862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110369145|NCT00563862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110369146|NCT00563862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110369147|NCT00563862|Immunologic Factors|immunologic factors|mesh-ancestor
110369148|NCT00563862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369150|NCT04611711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110024905|NCT00005814|Cetuximab|cetuximab|mesh-list
110369152|NCT04611711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110369153|NCT04611711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110369154|NCT04611711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110369155|NCT04632537|BCG Vaccine|bcg vaccine|mesh-list
110369156|NCT04632537|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110369157|NCT04632537|Immunologic Factors|immunologic factors|mesh-ancestor
110369158|NCT04632537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369159|NCT02092922|Filanesib|filanesib|mesh-list
110369160|NCT02092922|Lenograstim|lenograstim|mesh-list
110369161|NCT02092922|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110369162|NCT02092922|Immunologic Factors|immunologic factors|mesh-ancestor
110375394|NCT00473694|Neostigmine|neostigmine|mesh-list
110369164|NCT02092922|Antimitotic Agents|antimitotic agents|mesh-ancestor
110369165|NCT02092922|Mitosis Modulators|mitosis modulators|mesh-ancestor
110369166|NCT02092922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110369167|NCT02092922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110369169|NCT02092454|Anesthetics, Local|anesthetics, local|mesh-ancestor
110369170|NCT02092454|Anesthetics|anesthetics|mesh-ancestor
110369171|NCT02092454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110369172|NCT02092454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369173|NCT02092454|Sensory System Agents|sensory system agents|mesh-ancestor
110369174|NCT02092454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110369175|NCT02083289|Latanoprost|latanoprost|mesh-list
110369176|NCT02083289|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110369177|NCT02083289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110369178|NCT02081300|Methyltestosterone|methyltestosterone|mesh-list
110369179|NCT02081300|Testosterone|testosterone|mesh-list
110369180|NCT02081300|Testosterone undecanoate|testosterone undecanoate|mesh-list
110369181|NCT02081300|Testosterone enanthate|testosterone enanthate|mesh-list
110369182|NCT02081300|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110369183|NCT02081300|Androgens|androgens|mesh-ancestor
110369184|NCT02081300|Hormones|hormones|mesh-ancestor
110369185|NCT02081300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110369186|NCT02081300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369187|NCT02081300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110369188|NCT02081300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110369189|NCT02081300|Anabolic Agents|anabolic agents|mesh-ancestor
110369190|NCT02074007|Benzocaine|benzocaine|mesh-list
110369191|NCT02074007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369192|NCT02074007|Anesthetics, Local|anesthetics, local|mesh-ancestor
110369193|NCT02074007|Anesthetics|anesthetics|mesh-ancestor
110369194|NCT02074007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110369195|NCT02074007|Sensory System Agents|sensory system agents|mesh-ancestor
110369196|NCT02074007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110369197|NCT02072954|Asenapine|asenapine|mesh-list
110369198|NCT02072954|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110369199|NCT02072954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110369200|NCT02072954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110369201|NCT02072954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369202|NCT02072954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110369203|NCT00554918|Zoledronic Acid|zoledronic acid|mesh-list
110369204|NCT00554918|Prednisolone|prednisolone|mesh-list
110369205|NCT00554918|Docetaxel|docetaxel|mesh-list
110369206|NCT00554918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110369207|NCT00554918|Tubulin Modulators|tubulin modulators|mesh-ancestor
110024916|NCT00355290|Vitamin K|vitamin k|mesh-list
110369208|NCT00554918|Antimitotic Agents|antimitotic agents|mesh-ancestor
110369209|NCT00554918|Mitosis Modulators|mitosis modulators|mesh-ancestor
110369210|NCT00554918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110369211|NCT00554918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110369213|NCT00554918|Hormones|hormones|mesh-ancestor
110369214|NCT00554918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110369216|NCT00554918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110369217|NCT00554918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110369218|NCT04631874|Varenicline|varenicline|mesh-list
110369219|NCT04631874|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110369220|NCT04631874|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110369221|NCT04631874|Cholinergic Agents|cholinergic agents|mesh-ancestor
110369222|NCT04631874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110375697|NCT04570254|Antidotes|antidotes|mesh-ancestor
110369223|NCT04631874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110369224|NCT04631874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369225|NCT02057315|Ketoprofen|ketoprofen|mesh-list
110369226|NCT02057315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110369227|NCT02057315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110369229|NCT02057315|Sensory System Agents|sensory system agents|mesh-ancestor
110369230|NCT02057315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110369231|NCT02057315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369232|NCT02057315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110369233|NCT02057315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110369234|NCT02057315|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110369235|NCT02057315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110369236|NCT02057315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110369237|NCT02047214|Bevacizumab|bevacizumab|mesh-list
110369238|NCT02047214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110369239|NCT02047214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110369240|NCT02047214|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110369241|NCT02047214|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110369242|NCT02047214|Growth Substances|growth substances|mesh-ancestor
110369243|NCT02047214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369244|NCT02047214|Growth Inhibitors|growth inhibitors|mesh-ancestor
110369245|NCT02032277|Paclitaxel|paclitaxel|mesh-list
110369246|NCT02032277|Cyclophosphamide|cyclophosphamide|mesh-list
110369247|NCT02032277|Carboplatin|carboplatin|mesh-list
110369248|NCT02032277|Doxorubicin|doxorubicin|mesh-list
110369249|NCT02032277|Veliparib|veliparib|mesh-list
110369250|NCT02032277|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110369251|NCT02032277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110369252|NCT02032277|Tubulin Modulators|tubulin modulators|mesh-ancestor
110369253|NCT02032277|Antimitotic Agents|antimitotic agents|mesh-ancestor
110369254|NCT02032277|Mitosis Modulators|mitosis modulators|mesh-ancestor
110369255|NCT02032277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110369256|NCT02032277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110369257|NCT02032277|Immunologic Factors|immunologic factors|mesh-ancestor
110369258|NCT02032277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369259|NCT02032277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110369260|NCT02032277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110369261|NCT02032277|Alkylating Agents|alkylating agents|mesh-ancestor
110369262|NCT02032277|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110369263|NCT02032277|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110369264|NCT02032277|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110369265|NCT02032277|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110369266|NCT02032277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110369267|NCT02032277|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110369268|NCT00560976|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
110369269|NCT00560976|Ferric gluconate|ferric gluconate|mesh-list
110369270|NCT00560976|Hematinics|hematinics|mesh-ancestor
110369271|NCT02026349|Favipiravir|favipiravir|mesh-list
110369272|NCT02026349|Antiviral Agents|antiviral agents|mesh-ancestor
110369273|NCT02026349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110369274|NCT04611126|Cyclophosphamide|cyclophosphamide|mesh-list
110369276|NCT04611126|Fludarabine|fludarabine|mesh-list
110369277|NCT04611126|Fludarabine phosphate|fludarabine phosphate|mesh-list
110369278|NCT04611126|Ipilimumab|ipilimumab|mesh-list
110369279|NCT04611126|Relatlimab|relatlimab|mesh-list
110369280|NCT04611126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110369281|NCT04611126|Immunologic Factors|immunologic factors|mesh-ancestor
110369282|NCT04611126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369283|NCT04611126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110369284|NCT04611126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110369285|NCT04611126|Alkylating Agents|alkylating agents|mesh-ancestor
110369286|NCT04611126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110369287|NCT04611126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110369288|NCT04611126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110369289|NCT04611126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110369290|NCT04611126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110369291|NCT04611126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110369292|NCT04611126|Antimetabolites|antimetabolites|mesh-ancestor
110369293|NCT02026232|Hydroxychloroquine|hydroxychloroquine|mesh-list
110369294|NCT02026232|Antimalarials|antimalarials|mesh-ancestor
110369295|NCT02026232|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110369296|NCT02026232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110369297|NCT02026232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110369298|NCT02026232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110369299|NCT02026232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110369300|NCT02026232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110369301|NCT04611165|Nivolumab|nivolumab|mesh-list
110369302|NCT04611165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110369303|NCT04611165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110369304|NCT04611165|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110376066|NCT01085136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110369305|NCT04611165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110369307|NCT02014649|Zanamivir|zanamivir|mesh-list
110369308|NCT02014649|Antiviral Agents|antiviral agents|mesh-ancestor
110369309|NCT02014649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110369310|NCT02014649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110369311|NCT02014649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110369312|NCT02014142|Latanoprost|latanoprost|mesh-list
110369313|NCT02014142|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110369314|NCT02014142|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110369315|NCT04610580|Choline|choline|mesh-list
110369316|NCT04610580|Lipotropic Agents|lipotropic agents|mesh-ancestor
110369317|NCT04610580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110369318|NCT04610580|Antimetabolites|antimetabolites|mesh-ancestor
110376137|NCT01083810|Ritonavir|ritonavir|mesh-list
110369319|NCT04610580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110369320|NCT04610580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110369321|NCT04610580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110369323|NCT04631250|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110369324|NCT04631250|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110164780|NCT00021346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110164782|NCT00021385|Carboplatin|carboplatin|mesh-list
110164783|NCT00021385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110164784|NCT00021385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110164785|NCT00021385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110164786|NCT00021385|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110164787|NCT00021385|Protective Agents|protective agents|mesh-ancestor
110164788|NCT00021385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110164789|NCT00021385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110164790|NCT00021385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110164791|NCT00021385|Growth Substances|growth substances|mesh-ancestor
110164792|NCT00021385|Growth Inhibitors|growth inhibitors|mesh-ancestor
110164793|NCT00021463|Lamivudine|lamivudine|mesh-list
110164794|NCT00021463|Zidovudine|zidovudine|mesh-list
110164795|NCT00021463|Efavirenz|efavirenz|mesh-list
110164796|NCT00021463|Nevirapine|nevirapine|mesh-list
110164797|NCT00021463|Abacavir|abacavir|mesh-list
110164799|NCT00021463|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110164800|NCT00021463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110164801|NCT00021463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110164802|NCT00021463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110164803|NCT00021463|Antiviral Agents|antiviral agents|mesh-ancestor
110164804|NCT00021463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110164805|NCT00021463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110164806|NCT00021463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110164807|NCT00021463|Antimetabolites|antimetabolites|mesh-ancestor
110164808|NCT00021463|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110164809|NCT00021463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110164810|NCT00021463|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110164811|NCT00021463|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110164812|NCT00021463|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110164813|NCT00021463|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110164814|NCT00021502|Chrysarobin|chrysarobin|mesh-list
110164815|NCT00021502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110164816|NCT00021502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110164817|NCT00021502|Analgesics|analgesics|mesh-ancestor
110164818|NCT00021502|Sensory System Agents|sensory system agents|mesh-ancestor
110164819|NCT00021502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110164820|NCT00021502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110164821|NCT00021502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110164822|NCT00021502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110164823|NCT00000134|Ganciclovir|ganciclovir|mesh-list
110164824|NCT00000134|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
110164825|NCT00000134|Foscarnet|foscarnet|mesh-list
110164826|NCT00000134|Antiviral Agents|antiviral agents|mesh-ancestor
110164827|NCT00000134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110164828|NCT00000134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110164829|NCT00000134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110164830|NCT00000134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110164831|NCT00000134|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110164832|NCT00010413|Cyclophosphamide|cyclophosphamide|mesh-list
110164833|NCT00010413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110164834|NCT00010413|Immunologic Factors|immunologic factors|mesh-ancestor
110164835|NCT00010413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110164836|NCT00010413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110164837|NCT00010413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110164838|NCT00010413|Alkylating Agents|alkylating agents|mesh-ancestor
110164839|NCT00010413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110164840|NCT00010413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110164841|NCT00010413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110164842|NCT00010452|Picibanil|picibanil|mesh-list
110164843|NCT00010452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110164844|NCT00394693|Interferons|interferons|mesh-list
110164845|NCT00394693|Interferon-gamma|interferon-gamma|mesh-list
110164846|NCT00394693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110164847|NCT00394693|Antiviral Agents|antiviral agents|mesh-ancestor
110164848|NCT00394693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110164849|NCT00394810|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
110164850|NCT00394810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110164851|NCT00394810|Tubulin Modulators|tubulin modulators|mesh-ancestor
110164852|NCT00394810|Antimitotic Agents|antimitotic agents|mesh-ancestor
110164853|NCT00394810|Mitosis Modulators|mitosis modulators|mesh-ancestor
110164854|NCT00394810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110164855|NCT00021814|Doxazosin|doxazosin|mesh-list
110164856|NCT00021814|Finasteride|finasteride|mesh-list
110164857|NCT00021814|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110164858|NCT00021814|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110164859|NCT00021814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110164860|NCT00021814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110164861|NCT00021814|Hormone Antagonists|hormone antagonists|mesh-ancestor
110164862|NCT00021814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110164863|NCT00021814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110164864|NCT00021814|Urological Agents|urological agents|mesh-ancestor
110164865|NCT00021814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110164866|NCT00021814|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110164868|NCT00021814|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110164869|NCT00021814|Adrenergic Agents|adrenergic agents|mesh-ancestor
110164870|NCT00021814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110164872|NCT00019318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110164873|NCT00019318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110164874|NCT00019318|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110164875|NCT00019318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110164876|NCT00019318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110164877|NCT00022009|Gemcitabine|gemcitabine|mesh-list
110164878|NCT00022009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110376767|NCT00194792|Paclitaxel|paclitaxel|mesh-list
110164879|NCT00022009|Antimetabolites|antimetabolites|mesh-ancestor
110164880|NCT00022009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110164881|NCT00022009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110164883|NCT00388661|Antioxidants|antioxidants|mesh-ancestor
110164884|NCT00388661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110164885|NCT00388661|Protective Agents|protective agents|mesh-ancestor
110164886|NCT00388661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110164887|NCT00388661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110164888|NCT00022048|Bevacizumab|bevacizumab|mesh-list
110164889|NCT00022048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110164890|NCT00022048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110164891|NCT00022048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110164892|NCT00022048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110164893|NCT00022048|Growth Substances|growth substances|mesh-ancestor
110164894|NCT00022048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110164895|NCT00022048|Growth Inhibitors|growth inhibitors|mesh-ancestor
110164896|NCT00022087|Vitamin D|vitamin d|mesh-list
110164897|NCT00022087|Cholecalciferol|cholecalciferol|mesh-list
110164898|NCT00022087|Zoledronic Acid|zoledronic acid|mesh-list
110164899|NCT00022087|Calcium|calcium|mesh-list
110164900|NCT00022087|Vitamins|vitamins|mesh-ancestor
110164901|NCT00022087|Micronutrients|micronutrients|mesh-ancestor
110164902|NCT00022087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110164903|NCT00022087|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110164904|NCT00022087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110164905|NCT00388700|Leucovorin|leucovorin|mesh-list
110164906|NCT00388700|Bevacizumab|bevacizumab|mesh-list
110164907|NCT00388700|Fluorouracil|fluorouracil|mesh-list
110164908|NCT00388700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110164909|NCT00388700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110164910|NCT00388700|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110164911|NCT00388700|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110377118|NCT00171158|Imatinib Mesylate|imatinib mesylate|mesh-list
110164912|NCT00388700|Growth Substances|growth substances|mesh-ancestor
110164913|NCT00388700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110164914|NCT00388700|Growth Inhibitors|growth inhibitors|mesh-ancestor
110164915|NCT00388700|Antimetabolites|antimetabolites|mesh-ancestor
110164916|NCT00388700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110164917|NCT00388700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110164918|NCT00388700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110164919|NCT00388700|Immunologic Factors|immunologic factors|mesh-ancestor
110164920|NCT00388700|Antidotes|antidotes|mesh-ancestor
110164921|NCT00388700|Protective Agents|protective agents|mesh-ancestor
110164922|NCT00388700|Vitamin B Complex|vitamin b complex|mesh-ancestor
110164924|NCT00388700|Micronutrients|micronutrients|mesh-ancestor
110164925|NCT00022126|Cytarabine|cytarabine|mesh-list
110164926|NCT00022126|Cyclosporine|cyclosporine|mesh-list
110164927|NCT00022126|Dexamethasone|dexamethasone|mesh-list
110164928|NCT00022126|Methylprednisolone|methylprednisolone|mesh-list
110164931|NCT00022126|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110164932|NCT00022126|Methotrexate|methotrexate|mesh-list
110164933|NCT00022126|Vincristine|vincristine|mesh-list
110164934|NCT00022126|Daunorubicin|daunorubicin|mesh-list
110164935|NCT00022126|Asparaginase|asparaginase|mesh-list
110164936|NCT00022126|Mercaptopurine|mercaptopurine|mesh-list
110164938|NCT00022126|Thioguanine|thioguanine|mesh-list
110164939|NCT00022126|Cyclosporins|cyclosporins|mesh-list
110164940|NCT00022126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110164941|NCT00022126|Immunologic Factors|immunologic factors|mesh-ancestor
110164942|NCT00022126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110164943|NCT00022126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110164944|NCT00022126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110164945|NCT00022126|Alkylating Agents|alkylating agents|mesh-ancestor
110369325|NCT04631250|Dermatologic Agents|dermatologic agents|mesh-ancestor
110164946|NCT00022126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110164947|NCT00022126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110164948|NCT00022126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110164949|NCT00022126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110164951|NCT00022126|Autonomic Agents|autonomic agents|mesh-ancestor
110164952|NCT00022126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110164953|NCT00022126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110164954|NCT00022126|Glucocorticoids|glucocorticoids|mesh-ancestor
110164956|NCT00022126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110164957|NCT00022126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110164958|NCT00022126|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110369326|NCT01998035|Azacitidine|azacitidine|mesh-list
110164959|NCT00022126|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110164960|NCT00022126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110164961|NCT00022126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110164962|NCT00022126|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110164963|NCT00022126|Abortifacient Agents|abortifacient agents|mesh-ancestor
110164964|NCT00022126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110164965|NCT00022126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110164966|NCT00022126|Antimetabolites|antimetabolites|mesh-ancestor
110164967|NCT00022126|Dermatologic Agents|dermatologic agents|mesh-ancestor
110164968|NCT00022126|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110164969|NCT00022126|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110164971|NCT00022126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110164972|NCT00022126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110164973|NCT00022126|Tubulin Modulators|tubulin modulators|mesh-ancestor
110164974|NCT00022126|Antimitotic Agents|antimitotic agents|mesh-ancestor
110164975|NCT00022126|Mitosis Modulators|mitosis modulators|mesh-ancestor
110164976|NCT00022126|Antifungal Agents|antifungal agents|mesh-ancestor
110164977|NCT00022126|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110164978|NCT00022126|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110164979|NCT00022126|Protective Agents|protective agents|mesh-ancestor
110164980|NCT00022165|Selenium|selenium|mesh-list
110164981|NCT00022165|Antioxidants|antioxidants|mesh-ancestor
110164982|NCT00022165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110164983|NCT00022165|Protective Agents|protective agents|mesh-ancestor
110164984|NCT00022165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110164985|NCT00022165|Trace Elements|trace elements|mesh-ancestor
110164986|NCT00022165|Micronutrients|micronutrients|mesh-ancestor
110164987|NCT00022204|Vitamin E|vitamin e|mesh-list
110164988|NCT00022204|Pentoxifylline|pentoxifylline|mesh-list
110164989|NCT00022204|Vitamins|vitamins|mesh-ancestor
110164990|NCT00022204|Micronutrients|micronutrients|mesh-ancestor
110369327|NCT01998035|Romidepsin|romidepsin|mesh-list
110164991|NCT00022204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110164993|NCT00022204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110164994|NCT00022204|Protective Agents|protective agents|mesh-ancestor
110164995|NCT00022204|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110164996|NCT00022204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110164997|NCT00022204|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110164998|NCT00022204|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110164999|NCT00022204|Vasodilator Agents|vasodilator agents|mesh-ancestor
110165000|NCT00022204|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110165001|NCT00388739|Prednisolone|prednisolone|mesh-list
110165002|NCT00388739|Budesonide|budesonide|mesh-list
110165004|NCT00388739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110165005|NCT00388739|Glucocorticoids|glucocorticoids|mesh-ancestor
110165006|NCT00388739|Hormones|hormones|mesh-ancestor
110165007|NCT00388739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110165008|NCT00388739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110165009|NCT00388739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110165010|NCT00388739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110165011|NCT00388739|Autonomic Agents|autonomic agents|mesh-ancestor
110165012|NCT00388739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110165013|NCT00388739|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110165014|NCT00388739|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110165015|NCT00388739|Respiratory System Agents|respiratory system agents|mesh-ancestor
110165016|NCT00388739|Tocolytic Agents|tocolytic agents|mesh-ancestor
110165017|NCT00388739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110165018|NCT00388739|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110165020|NCT00388739|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110165021|NCT00388739|Adrenergic Agents|adrenergic agents|mesh-ancestor
110165022|NCT00388739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110165023|NCT00388739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110165024|NCT00022321|Gemtuzumab|gemtuzumab|mesh-list
110165025|NCT00022321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110165026|NCT00022321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110165028|NCT00022321|Immunoconjugates|immunoconjugates|mesh-ancestor
110165029|NCT00022321|Immunologic Factors|immunologic factors|mesh-ancestor
110165030|NCT00022321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110165031|NCT00022360|Taurolidine|taurolidine|mesh-list
110165032|NCT00022360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110165033|NCT00022360|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110165034|NCT00022360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110165035|NCT00022399|Celecoxib|celecoxib|mesh-list
110165036|NCT00022399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110378405|NCT04570592|Antiemetics|antiemetics|mesh-ancestor
110165037|NCT00022399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110165038|NCT00022399|Analgesics|analgesics|mesh-ancestor
110165039|NCT00022399|Sensory System Agents|sensory system agents|mesh-ancestor
110165040|NCT00022399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110165041|NCT00022399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110165042|NCT00022399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110165043|NCT00022399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110165044|NCT00022399|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110165045|NCT00022399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110165046|NCT00022399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110165047|NCT00022399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110165048|NCT00000143|Ganciclovir|ganciclovir|mesh-list
110165049|NCT00000143|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
110165050|NCT00000143|Cidofovir|cidofovir|mesh-list
110165051|NCT00000143|Antiviral Agents|antiviral agents|mesh-ancestor
110165052|NCT00000143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110165053|NCT00000143|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110165054|NCT00000143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110165055|NCT00000143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110165056|NCT00022438|Aldesleukin|aldesleukin|mesh-list
110165057|NCT00022438|Freund's Adjuvant|freund's adjuvant|mesh-list
110165058|NCT00022438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110165059|NCT00022438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110165060|NCT00022438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110165061|NCT00022438|Antiviral Agents|antiviral agents|mesh-ancestor
110165062|NCT00022438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110165063|NCT00022438|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110165064|NCT00022438|Immunologic Factors|immunologic factors|mesh-ancestor
110165065|NCT00022438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110165066|NCT00010686|Phytoestrogens|phytoestrogens|mesh-list
110165067|NCT00010686|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110165068|NCT00010686|Estrogens|estrogens|mesh-ancestor
110165070|NCT00010686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110165071|NCT00010686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378679|NCT04558580|Rufinamide|rufinamide|mesh-list
110165073|NCT00022555|Bryostatin 1|bryostatin 1|mesh-list
110165074|NCT00022555|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110165075|NCT00022555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110165076|NCT00022555|Tubulin Modulators|tubulin modulators|mesh-ancestor
110165077|NCT00022555|Antimitotic Agents|antimitotic agents|mesh-ancestor
110165078|NCT00022555|Mitosis Modulators|mitosis modulators|mesh-ancestor
110165079|NCT00022555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110165080|NCT00022555|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110165081|NCT00022555|Immunologic Factors|immunologic factors|mesh-ancestor
110165082|NCT00022555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110165083|NCT00000146|Prednisone|prednisone|mesh-list
110165084|NCT00000146|Methylprednisolone|methylprednisolone|mesh-list
110165085|NCT00000146|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110165086|NCT00000146|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110378900|NCT04545801|Ketamine|ketamine|mesh-list
110165087|NCT00000146|Prednisolone|prednisolone|mesh-list
110165088|NCT00000146|Prednisolone acetate|prednisolone acetate|mesh-list
110165089|NCT00000146|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110165090|NCT00000146|Prednisolone phosphate|prednisolone phosphate|mesh-list
110165091|NCT00000146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110165093|NCT00000146|Hormones|hormones|mesh-ancestor
110379033|NCT04205890|Ketamine|ketamine|mesh-list
110165094|NCT00000146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110165095|NCT00000146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110165096|NCT00000146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110165097|NCT00000146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110165098|NCT00000146|Antiemetics|antiemetics|mesh-ancestor
110165099|NCT00000146|Autonomic Agents|autonomic agents|mesh-ancestor
110165100|NCT00000146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110165101|NCT00000146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110165102|NCT00000146|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110165103|NCT00000146|Protective Agents|protective agents|mesh-ancestor
110165105|NCT00010725|Micronutrients|micronutrients|mesh-ancestor
110165106|NCT00010725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110165107|NCT00022594|Lurtotecan|lurtotecan|mesh-list
110165108|NCT00022594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110165109|NCT00000149|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110165110|NCT00000149|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110165111|NCT00000149|Adrenergic Agents|adrenergic agents|mesh-ancestor
110165112|NCT00000149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110165113|NCT00000149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110165114|NCT00000149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110165115|NCT00022711|Temozolomide|temozolomide|mesh-list
110165116|NCT00022711|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110165117|NCT00022711|Alkylating Agents|alkylating agents|mesh-ancestor
110165118|NCT00022711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110165119|NCT00022711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110165120|NCT00010842|Vitamin E|vitamin e|mesh-list
110165121|NCT00010842|Thioctic Acid|thioctic acid|mesh-list
110165122|NCT00010842|Selenium|selenium|mesh-list
110165123|NCT00010842|Vitamins|vitamins|mesh-ancestor
110165124|NCT00010842|Micronutrients|micronutrients|mesh-ancestor
110165125|NCT00010842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110165126|NCT00010842|Antioxidants|antioxidants|mesh-ancestor
110165127|NCT00010842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110165128|NCT00010842|Protective Agents|protective agents|mesh-ancestor
110165129|NCT00010842|Trace Elements|trace elements|mesh-ancestor
110165130|NCT00010842|Vitamin B Complex|vitamin b complex|mesh-ancestor
110165131|NCT00000152|Aspirin|aspirin|mesh-list
110165132|NCT00000152|Beta Carotene|beta carotene|mesh-list
110165133|NCT00000152|Carotenoids|carotenoids|mesh-list
110165134|NCT00000152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110165135|NCT00000152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110165136|NCT00000152|Analgesics|analgesics|mesh-ancestor
110165137|NCT00000152|Sensory System Agents|sensory system agents|mesh-ancestor
110165138|NCT00000152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110165139|NCT00000152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110165140|NCT00000152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110165141|NCT00000152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110165142|NCT00000152|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110165143|NCT00000152|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110165144|NCT00000152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110165145|NCT00000152|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110379426|NCT04542252|Cyclosporine|cyclosporine|mesh-list
110165146|NCT00000152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110165147|NCT00000152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110165148|NCT00000152|Antipyretics|antipyretics|mesh-ancestor
110165149|NCT00000152|Antioxidants|antioxidants|mesh-ancestor
110165150|NCT00000152|Protective Agents|protective agents|mesh-ancestor
110165151|NCT00000152|Provitamins|provitamins|mesh-ancestor
110165152|NCT00000152|Vitamins|vitamins|mesh-ancestor
110165153|NCT00000152|Micronutrients|micronutrients|mesh-ancestor
110165154|NCT00010881|Antioxidants|antioxidants|mesh-list
110165155|NCT00010881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110165156|NCT00010881|Protective Agents|protective agents|mesh-ancestor
110165157|NCT00010881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110165158|NCT00022906|Tositumomab I-131|tositumomab i-131|mesh-list
110165159|NCT00022906|Antibodies|antibodies|mesh-list
110165160|NCT00022906|Immunologic Factors|immunologic factors|mesh-ancestor
110165161|NCT00022906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110165162|NCT00022906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110165163|NCT00022945|Prednisone|prednisone|mesh-list
110165164|NCT00022945|Cyclophosphamide|cyclophosphamide|mesh-list
110165165|NCT00022945|Doxorubicin|doxorubicin|mesh-list
110165166|NCT00022945|Vincristine|vincristine|mesh-list
110165167|NCT00022945|Tositumomab I-131|tositumomab i-131|mesh-list
110165168|NCT00022945|Antibodies|antibodies|mesh-list
110165169|NCT00022945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110165170|NCT00022945|Immunologic Factors|immunologic factors|mesh-ancestor
110165171|NCT00022945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110165172|NCT00022945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110165173|NCT00022945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110165174|NCT00022945|Alkylating Agents|alkylating agents|mesh-ancestor
110165175|NCT00022945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110165176|NCT00022945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110165177|NCT00022945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110165178|NCT00022945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110165179|NCT00022945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110165180|NCT00022945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110165181|NCT00022945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110165182|NCT00022945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110165183|NCT00022945|Glucocorticoids|glucocorticoids|mesh-ancestor
110165184|NCT00022945|Hormones|hormones|mesh-ancestor
110165185|NCT00022945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110165186|NCT00022945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110165187|NCT00022945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110165188|NCT00022945|Tubulin Modulators|tubulin modulators|mesh-ancestor
110165189|NCT00022945|Antimitotic Agents|antimitotic agents|mesh-ancestor
110165190|NCT00022945|Mitosis Modulators|mitosis modulators|mesh-ancestor
110165192|NCT00023218|Lopinavir|lopinavir|mesh-list
110165193|NCT00023218|Efavirenz|efavirenz|mesh-list
110165194|NCT00023218|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110165195|NCT00023218|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110165196|NCT00023218|Protease Inhibitors|protease inhibitors|mesh-ancestor
110165197|NCT00023218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110165198|NCT00023218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110165200|NCT00023218|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110165201|NCT00023218|Antiviral Agents|antiviral agents|mesh-ancestor
110165202|NCT00023218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110165203|NCT00023218|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110165204|NCT00023218|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110165205|NCT00023218|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110165206|NCT00023218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110165207|NCT00023218|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110165208|NCT00023218|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110165210|NCT00023218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110165211|NCT00023218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110165213|NCT00394966|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110165214|NCT00394966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110165215|NCT00394966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110165216|NCT00394966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110165217|NCT00000170|Atropine|atropine|mesh-list
110165218|NCT00000170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110165219|NCT00000170|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110165220|NCT00000170|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110165221|NCT00000170|Autonomic Agents|autonomic agents|mesh-ancestor
110165222|NCT00000170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110165223|NCT00000170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110165224|NCT00000170|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110165225|NCT00000170|Respiratory System Agents|respiratory system agents|mesh-ancestor
110165226|NCT00000170|Mydriatics|mydriatics|mesh-ancestor
110165227|NCT00000170|Parasympatholytics|parasympatholytics|mesh-ancestor
110165228|NCT00000170|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110165229|NCT00000170|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110165230|NCT00000170|Cholinergic Agents|cholinergic agents|mesh-ancestor
110165231|NCT00000170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110165232|NCT00000170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110165233|NCT02024607|Leucovorin|leucovorin|mesh-list
110165234|NCT02024607|Bevacizumab|bevacizumab|mesh-list
110165235|NCT02024607|Fluorouracil|fluorouracil|mesh-list
110165236|NCT02024607|Capecitabine|capecitabine|mesh-list
110165237|NCT02024607|Oxaliplatin|oxaliplatin|mesh-list
110165238|NCT02024607|Irinotecan|irinotecan|mesh-list
110165239|NCT02024607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110165240|NCT02024607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110165241|NCT02024607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110165242|NCT02024607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110165243|NCT02024607|Growth Substances|growth substances|mesh-ancestor
110165244|NCT02024607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110165245|NCT02024607|Growth Inhibitors|growth inhibitors|mesh-ancestor
110165246|NCT02024607|Antimetabolites|antimetabolites|mesh-ancestor
110165247|NCT02024607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110165248|NCT02024607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110165249|NCT02024607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110165250|NCT02024607|Immunologic Factors|immunologic factors|mesh-ancestor
110165251|NCT02024607|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110165252|NCT02024607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110165253|NCT02024607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110165254|NCT02024607|Antidotes|antidotes|mesh-ancestor
110165255|NCT02024607|Protective Agents|protective agents|mesh-ancestor
110165256|NCT02024607|Vitamin B Complex|vitamin b complex|mesh-ancestor
110165258|NCT02024607|Micronutrients|micronutrients|mesh-ancestor
110165259|NCT00023296|Nitric Oxide|nitric oxide|mesh-list
110165260|NCT00023296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110165261|NCT00023296|Autonomic Agents|autonomic agents|mesh-ancestor
110165262|NCT00023296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110165263|NCT00023296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110165264|NCT00023296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110165265|NCT00023296|Respiratory System Agents|respiratory system agents|mesh-ancestor
110165266|NCT00023296|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110165267|NCT00023296|Antioxidants|antioxidants|mesh-ancestor
110379982|NCT02218827|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110165268|NCT00023296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110165269|NCT00023296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110165270|NCT00023296|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110165273|NCT00023296|Protective Agents|protective agents|mesh-ancestor
110165275|NCT00023335|Rifapentine|rifapentine|mesh-list
110165276|NCT00023335|Antitubercular Agents|antitubercular agents|mesh-ancestor
110165277|NCT00023335|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110165278|NCT00023335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110165279|NCT00023335|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110165280|NCT00023335|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110165281|NCT00023335|Antimetabolites|antimetabolites|mesh-ancestor
110165282|NCT00023335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110165283|NCT00023335|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110165284|NCT00023335|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110165285|NCT00023335|Leprostatic Agents|leprostatic agents|mesh-ancestor
110165286|NCT00000173|Vitamin E|vitamin e|mesh-list
110165287|NCT00000173|Donepezil|donepezil|mesh-list
110165288|NCT00000173|Vitamins|vitamins|mesh-ancestor
110165289|NCT00000173|Micronutrients|micronutrients|mesh-ancestor
110165290|NCT00000173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110165291|NCT00000173|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110165292|NCT00000173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110165293|NCT00000173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110165294|NCT00000173|Cholinergic Agents|cholinergic agents|mesh-ancestor
110165295|NCT00000173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110165296|NCT00000173|Nootropic Agents|nootropic agents|mesh-ancestor
110165297|NCT00000173|Antioxidants|antioxidants|mesh-ancestor
110165298|NCT00000173|Protective Agents|protective agents|mesh-ancestor
110165299|NCT00023374|Rifampin|rifampin|mesh-list
110165301|NCT00023374|Ethambutol|ethambutol|mesh-list
110165302|NCT00023374|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110165303|NCT00023374|Antitubercular Agents|antitubercular agents|mesh-ancestor
110165304|NCT00023374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110165305|NCT00023374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110165306|NCT00023374|Leprostatic Agents|leprostatic agents|mesh-ancestor
110165307|NCT00023374|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110025172|NCT00358488|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110025173|NCT00358488|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110165308|NCT00023374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110165309|NCT00023374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110165310|NCT00023374|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110165311|NCT00023374|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110380537|NCT01644084|Plasma Substitutes|plasma substitutes|mesh-ancestor
110165312|NCT00023374|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110165313|NCT00023374|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110165314|NCT00023374|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110165316|NCT00023413|Efavirenz|efavirenz|mesh-list
110165317|NCT00023413|Rifabutin|rifabutin|mesh-list
110165318|NCT00023413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110165319|NCT00023413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110165320|NCT00023413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110165321|NCT00023413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110165322|NCT00023413|Antiviral Agents|antiviral agents|mesh-ancestor
110165323|NCT00023413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110165324|NCT00023413|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110165325|NCT00023413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110165326|NCT00023413|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110165327|NCT00023413|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110165328|NCT00023413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110165329|NCT00023413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110165330|NCT00023413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110165331|NCT00023413|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110380685|NCT01644864|Ropivacaine|ropivacaine|mesh-list
110165332|NCT00023413|Antitubercular Agents|antitubercular agents|mesh-ancestor
110165333|NCT00023530|Thalidomide|thalidomide|mesh-list
110165334|NCT00023530|Fluconazole|fluconazole|mesh-list
110165335|NCT00023530|Voriconazole|voriconazole|mesh-list
110165336|NCT00023530|Dexamethasone|dexamethasone|mesh-list
110165337|NCT00023530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110165338|NCT00023530|Antiemetics|antiemetics|mesh-ancestor
110165339|NCT00023530|Autonomic Agents|autonomic agents|mesh-ancestor
110165340|NCT00023530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110165341|NCT00023530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110165342|NCT00023530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110165343|NCT00023530|Glucocorticoids|glucocorticoids|mesh-ancestor
110165344|NCT00023530|Hormones|hormones|mesh-ancestor
110165345|NCT00023530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110165346|NCT00023530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110165347|NCT00023530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110165348|NCT00023530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110165349|NCT00023530|Immunologic Factors|immunologic factors|mesh-ancestor
110165350|NCT00023530|Leprostatic Agents|leprostatic agents|mesh-ancestor
110165351|NCT00023530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110165352|NCT00023530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110165353|NCT00023530|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110165354|NCT00023530|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110165355|NCT00023530|Growth Substances|growth substances|mesh-ancestor
110165356|NCT00023530|Growth Inhibitors|growth inhibitors|mesh-ancestor
110165357|NCT00023530|Antifungal Agents|antifungal agents|mesh-ancestor
110165358|NCT00023530|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110165359|NCT00023530|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110165360|NCT00023530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110165361|NCT00023530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110165362|NCT00023530|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110165363|NCT00023530|Hormone Antagonists|hormone antagonists|mesh-ancestor
110165364|NCT00023530|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110165365|NCT00023530|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110165366|NCT00023530|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110165367|NCT00000176|Progesterone|progesterone|mesh-list
110165368|NCT00000176|Estrogens|estrogens|mesh-list
110165369|NCT00000176|Progestins|progestins|mesh-ancestor
110165370|NCT00000176|Hormones|hormones|mesh-ancestor
110165371|NCT00000176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110165372|NCT00000176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110165374|NCT00000179|Haloperidol decanoate|haloperidol decanoate|mesh-list
110165376|NCT00000179|Antiemetics|antiemetics|mesh-ancestor
110165377|NCT00000179|Autonomic Agents|autonomic agents|mesh-ancestor
110165378|NCT00000179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110165379|NCT00000179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110165380|NCT00000179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110165381|NCT00000179|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110165382|NCT00000179|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110165383|NCT00000179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110165384|NCT00000179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110165385|NCT00000179|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110165386|NCT00000179|Dopamine Agents|dopamine agents|mesh-ancestor
110165387|NCT00000179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110165388|NCT00000179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110165389|NCT00000179|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110165390|NCT00000179|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110165391|NCT00000179|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110165392|NCT00000179|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110165393|NCT00000179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110165394|NCT00000179|Serotonin Agents|serotonin agents|mesh-ancestor
110165395|NCT00000179|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110165396|NCT00000179|Antidepressive Agents|antidepressive agents|mesh-ancestor
110165398|NCT00023725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110165399|NCT00023725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110165400|NCT00023725|Growth Substances|growth substances|mesh-ancestor
110165401|NCT00023725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110165402|NCT00023725|Growth Inhibitors|growth inhibitors|mesh-ancestor
110165403|NCT00023725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110165404|NCT00023725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110165405|NCT00023725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110165406|NCT00023725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110165407|NCT00391404|Alendronate|alendronate|mesh-list
110165408|NCT00391404|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110165409|NCT00391404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110165410|NCT00000191|Carbamazepine|carbamazepine|mesh-list
110165411|NCT00000191|Anticonvulsants|anticonvulsants|mesh-ancestor
110165412|NCT00000191|Antimanic Agents|antimanic agents|mesh-ancestor
110165413|NCT00000191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110165414|NCT00000191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110165415|NCT00000191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110165417|NCT00000191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110165418|NCT00000191|Analgesics|analgesics|mesh-ancestor
110165419|NCT00000191|Sensory System Agents|sensory system agents|mesh-ancestor
110165420|NCT00000191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110165421|NCT00000191|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110165422|NCT00000191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110165423|NCT00000191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110165424|NCT00000191|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110165425|NCT00000191|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110165426|NCT00023842|Mitomycins|mitomycins|mesh-list
110165427|NCT00023842|Mitomycin|mitomycin|mesh-list
110165428|NCT00023842|BCG Vaccine|bcg vaccine|mesh-list
110165429|NCT00023842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110165430|NCT00023842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110165431|NCT00023842|Alkylating Agents|alkylating agents|mesh-ancestor
110165432|NCT00023842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110165433|NCT00023842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110165434|NCT00023842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110165435|NCT00023842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110165436|NCT00023842|Immunologic Factors|immunologic factors|mesh-ancestor
110165437|NCT00023842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110165438|NCT00000221|Buprenorphine|buprenorphine|mesh-list
110165439|NCT00000221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110165440|NCT00000221|Narcotics|narcotics|mesh-ancestor
110165441|NCT00000221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110165442|NCT00000221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110165444|NCT00000221|Sensory System Agents|sensory system agents|mesh-ancestor
110165445|NCT00000221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110165446|NCT00000221|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110165447|NCT00023881|Bortezomib|bortezomib|mesh-list
110165448|NCT00023881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110165449|NCT00023920|Cytarabine|cytarabine|mesh-list
110165450|NCT00023920|Bevacizumab|bevacizumab|mesh-list
110165451|NCT00023920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110025249|NCT00360750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110025261|NCT00360984|Insulin|insulin|mesh-list
110165453|NCT00023920|Antibodies|antibodies|mesh-list
110165454|NCT00023920|Immunoglobulins|immunoglobulins|mesh-list
110165455|NCT00023920|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110165456|NCT00023920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110165457|NCT00023920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110165458|NCT00023920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110165459|NCT00023920|Growth Substances|growth substances|mesh-ancestor
110165460|NCT00023920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110165462|NCT00023920|Immunologic Factors|immunologic factors|mesh-ancestor
110165463|NCT00023920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110165465|NCT00023920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110165466|NCT00023920|Antiviral Agents|antiviral agents|mesh-ancestor
110165467|NCT00023920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110165468|NCT00023920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110165469|NCT00023920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110165470|NCT00023920|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110165472|NCT00023920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110165473|NCT00023959|Bevacizumab|bevacizumab|mesh-list
110165474|NCT00023959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110165475|NCT00023959|Fluorouracil|fluorouracil|mesh-list
110165476|NCT00023959|Hydroxyurea|hydroxyurea|mesh-list
110165477|NCT00023959|Antibodies|antibodies|mesh-list
110165478|NCT00023959|Immunoglobulins|immunoglobulins|mesh-list
110165479|NCT00023959|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110165480|NCT00023959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110165481|NCT00023959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110165482|NCT00023959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110165483|NCT00023959|Growth Substances|growth substances|mesh-ancestor
110165484|NCT00023959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110165485|NCT00023959|Growth Inhibitors|growth inhibitors|mesh-ancestor
110165486|NCT00023959|Immunologic Factors|immunologic factors|mesh-ancestor
110165487|NCT00023959|Antimetabolites|antimetabolites|mesh-ancestor
110165488|NCT00023959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110165489|NCT00023959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110165490|NCT00023959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110165492|NCT00023959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110165493|NCT00023959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110165495|NCT00023998|Doxorubicin|doxorubicin|mesh-list
110165496|NCT00023998|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110165497|NCT00023998|Methotrexate|methotrexate|mesh-list
110165498|NCT00023998|Trastuzumab|trastuzumab|mesh-list
110165499|NCT00023998|Etoposide|etoposide|mesh-list
110165500|NCT00023998|Etoposide phosphate|etoposide phosphate|mesh-list
110165501|NCT00023998|Ifosfamide|ifosfamide|mesh-list
110165502|NCT00023998|Levoleucovorin|levoleucovorin|mesh-list
110165503|NCT00023998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110165504|NCT00023998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110165505|NCT00023998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110165506|NCT00023998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110165507|NCT00023998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110165508|NCT00023998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110165509|NCT00023998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110165510|NCT00023998|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110381615|NCT04532333|Heparin|heparin|mesh-list
110165511|NCT00023998|Abortifacient Agents|abortifacient agents|mesh-ancestor
110165512|NCT00023998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110165513|NCT00023998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110165514|NCT00023998|Antimetabolites|antimetabolites|mesh-ancestor
110165515|NCT00023998|Dermatologic Agents|dermatologic agents|mesh-ancestor
110165516|NCT00023998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110165517|NCT00023998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110381685|NCT01177813|Hormones|hormones|mesh-ancestor
110165519|NCT00023998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110165520|NCT00023998|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110165521|NCT00023998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110165522|NCT00023998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110165523|NCT00023998|Antidotes|antidotes|mesh-ancestor
110381815|NCT04530500|Androgens|androgens|mesh-list
110165524|NCT00023998|Protective Agents|protective agents|mesh-ancestor
110165525|NCT00023998|Vitamin B Complex|vitamin b complex|mesh-ancestor
110165526|NCT00023998|Vitamins|vitamins|mesh-ancestor
110165527|NCT00023998|Micronutrients|micronutrients|mesh-ancestor
110165528|NCT00023998|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110165529|NCT00023998|Alkylating Agents|alkylating agents|mesh-ancestor
110165530|NCT00024115|Antibodies|antibodies|mesh-list
110165531|NCT00024115|Immunotoxins|immunotoxins|mesh-list
110165532|NCT00024115|Immunologic Factors|immunologic factors|mesh-list
110165533|NCT00024115|Immunomodulating Agents|immunomodulating agents|mesh-list
110165534|NCT00024115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110165535|NCT00024115|Immunoconjugates|immunoconjugates|mesh-ancestor
110165536|NCT00024154|Trastuzumab|trastuzumab|mesh-list
110165537|NCT00024154|Gefitinib|gefitinib|mesh-list
110165538|NCT00024154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110165539|NCT00024154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110165540|NCT00024154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110165541|NCT00024154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110165542|NCT00024154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110165544|NCT00011076|Analgesics|analgesics|mesh-ancestor
110165545|NCT00011076|Sensory System Agents|sensory system agents|mesh-ancestor
110165546|NCT00011076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110165547|NCT00011076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110165548|NCT00011076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110165549|NCT00011076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110382013|NCT01687140|Antimetabolites|antimetabolites|mesh-ancestor
110165550|NCT00011076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110165551|NCT00011076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110165552|NCT00011076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110165553|NCT00000248|Pergolide|pergolide|mesh-list
110165554|NCT00000248|Dopamine Agonists|dopamine agonists|mesh-ancestor
110165555|NCT00000248|Dopamine Agents|dopamine agents|mesh-ancestor
110382084|NCT01688349|Hormones|hormones|mesh-ancestor
110165556|NCT00000248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110165557|NCT00000248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110382153|NCT01198873|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110165558|NCT00000248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110165559|NCT00024193|Cyclophosphamide|cyclophosphamide|mesh-list
110165560|NCT00024193|Melphalan|melphalan|mesh-list
110165561|NCT00024193|Busulfan|busulfan|mesh-list
110165562|NCT00024193|Doxorubicin|doxorubicin|mesh-list
110165563|NCT00024193|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110165564|NCT00024193|Etoposide|etoposide|mesh-list
110165565|NCT00024193|Vincristine|vincristine|mesh-list
110165566|NCT00024193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110165567|NCT00024193|Immunologic Factors|immunologic factors|mesh-ancestor
110165568|NCT00024193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110165569|NCT00024193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110165570|NCT00024193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110165571|NCT00024193|Alkylating Agents|alkylating agents|mesh-ancestor
110165572|NCT00024193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110165573|NCT00024193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110165574|NCT00024193|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110165575|NCT00024193|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110165577|NCT00024193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110165578|NCT00024193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110165579|NCT00024193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110165580|NCT00024193|Tubulin Modulators|tubulin modulators|mesh-ancestor
110165582|NCT00024193|Mitosis Modulators|mitosis modulators|mesh-ancestor
110165583|NCT00024232|Antibodies|antibodies|mesh-list
110165584|NCT00024232|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110165585|NCT00024232|Immunologic Factors|immunologic factors|mesh-ancestor
110165586|NCT00024232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110165587|NCT00024271|Interferons|interferons|mesh-list
110165588|NCT00024271|Interferon-gamma|interferon-gamma|mesh-list
110165589|NCT00024271|Gemcitabine|gemcitabine|mesh-list
110165591|NCT00024271|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110165592|NCT00024271|Mitomycins|mitomycins|mesh-list
110165593|NCT00024271|Mitomycin|mitomycin|mesh-list
110165594|NCT00024271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110382646|NCT01642745|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110165595|NCT00024271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110165596|NCT00024271|Antimetabolites|antimetabolites|mesh-ancestor
110165597|NCT00024271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110165598|NCT00024271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110165599|NCT00024271|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110165600|NCT00024271|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110165601|NCT00024271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110165603|NCT00024271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110165605|NCT00024271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110165607|NCT00024310|Paclitaxel|paclitaxel|mesh-list
110165608|NCT00024310|Lometrexol|lometrexol|mesh-list
110165609|NCT00024310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110165610|NCT00024310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110165611|NCT00024310|Tubulin Modulators|tubulin modulators|mesh-ancestor
110165612|NCT00024310|Antimitotic Agents|antimitotic agents|mesh-ancestor
110025323|NCT00362700|Antiviral Agents|antiviral agents|mesh-ancestor
110165614|NCT00024310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110165615|NCT00024310|Hematinics|hematinics|mesh-ancestor
110165616|NCT00024310|Vitamin B Complex|vitamin b complex|mesh-ancestor
110165617|NCT00024310|Vitamins|vitamins|mesh-ancestor
110165618|NCT00024310|Micronutrients|micronutrients|mesh-ancestor
110165619|NCT00024310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110165620|NCT00024310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110165621|NCT00024310|Antimetabolites|antimetabolites|mesh-ancestor
110165622|NCT00024310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110165623|NCT00024310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110165625|NCT00024349|Mitomycins|mitomycins|mesh-list
110165626|NCT00024349|Mitomycin|mitomycin|mesh-list
110165627|NCT00024349|Antimetabolites|antimetabolites|mesh-ancestor
110165628|NCT00024349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110165629|NCT00024349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110165630|NCT00024349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110165631|NCT00024349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110165632|NCT00024349|Immunologic Factors|immunologic factors|mesh-ancestor
110165633|NCT00024349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110165634|NCT00024349|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110165635|NCT00024349|Alkylating Agents|alkylating agents|mesh-ancestor
110165636|NCT00024349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110165637|NCT00024349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110165638|NCT00000251|Isoflurane|isoflurane|mesh-list
110165639|NCT00000251|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110165640|NCT00000251|Anesthetics, General|anesthetics, general|mesh-ancestor
110165641|NCT00000251|Anesthetics|anesthetics|mesh-ancestor
110165642|NCT00000251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110165643|NCT00000251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110165645|NCT00024388|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110165646|NCT00024388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110383260|NCT06045754|Adalimumab|adalimumab|mesh-list
110025351|NCT00363090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110165647|NCT00024388|Tubulin Modulators|tubulin modulators|mesh-ancestor
110165648|NCT00024388|Antimitotic Agents|antimitotic agents|mesh-ancestor
110165649|NCT00024388|Mitosis Modulators|mitosis modulators|mesh-ancestor
110165650|NCT00024388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110165651|NCT00024427|Gemcitabine|gemcitabine|mesh-list
110165652|NCT00024427|Fluorouracil|fluorouracil|mesh-list
110165653|NCT00024427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110165654|NCT00024427|Antimetabolites|antimetabolites|mesh-ancestor
110165655|NCT00024427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110165656|NCT00024427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110165657|NCT00024427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110165658|NCT00024427|Immunologic Factors|immunologic factors|mesh-ancestor
110165659|NCT00024427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110165660|NCT00000257|Nitrous Oxide|nitrous oxide|mesh-list
110165661|NCT00000257|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110165662|NCT00000257|Anesthetics, General|anesthetics, general|mesh-ancestor
110165663|NCT00000257|Anesthetics|anesthetics|mesh-ancestor
110383474|NCT06044493|Mycophenolic Acid|mycophenolic acid|mesh-list
110165664|NCT00000257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110165665|NCT00000257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110165666|NCT00000257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110165667|NCT00000257|Analgesics|analgesics|mesh-ancestor
110165668|NCT00000257|Sensory System Agents|sensory system agents|mesh-ancestor
110165669|NCT00000257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110165670|NCT00024466|Vaccines|vaccines|mesh-list
110165671|NCT00024466|Immunologic Factors|immunologic factors|mesh-ancestor
110165672|NCT00024466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110165673|NCT04733131|Abatacept|abatacept|mesh-list
110165674|NCT04733131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110165675|NCT04733131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110165676|NCT04733131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110383542|NCT06043908|Dermatologic Agents|dermatologic agents|mesh-ancestor
110165677|NCT04733131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110165678|NCT04733131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110165679|NCT04733131|Immunologic Factors|immunologic factors|mesh-ancestor
110165680|NCT04733131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110165681|NCT04733131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110165683|NCT00024544|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110165684|NCT00024544|Immunologic Factors|immunologic factors|mesh-ancestor
110165685|NCT00024544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110383678|NCT06042855|Metformin|metformin|mesh-list
110165687|NCT00395239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110165688|NCT00395239|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110165689|NCT00395239|Autonomic Agents|autonomic agents|mesh-ancestor
110165690|NCT00395239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110165691|NCT00395239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110165692|NCT00395239|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110165693|NCT00395239|Respiratory System Agents|respiratory system agents|mesh-ancestor
110165694|NCT00395239|Glucocorticoids|glucocorticoids|mesh-ancestor
110165696|NCT00395239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110165697|NCT00025012|Isotretinoin|isotretinoin|mesh-list
110165698|NCT00025012|Dermatologic Agents|dermatologic agents|mesh-ancestor
110165699|NCT00025051|Celecoxib|celecoxib|mesh-list
110165700|NCT00025051|Mitogens|mitogens|mesh-list
110165701|NCT00025051|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110165702|NCT00025051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110165703|NCT00025051|Analgesics|analgesics|mesh-ancestor
110165704|NCT00025051|Sensory System Agents|sensory system agents|mesh-ancestor
110165705|NCT00025051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110165706|NCT00025051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110165707|NCT00025051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110165708|NCT00025051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110165709|NCT00025051|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110165710|NCT00025051|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110383873|NCT06018688|Antipyretics|antipyretics|mesh-ancestor
110165711|NCT00025051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110165712|NCT00025051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110165713|NCT00025051|Mitosis Modulators|mitosis modulators|mesh-ancestor
110165715|NCT00025090|Mitomycins|mitomycins|mesh-list
110165716|NCT00025090|Mitomycin|mitomycin|mesh-list
110165717|NCT00025090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110165718|NCT00025090|Antimetabolites|antimetabolites|mesh-ancestor
110165719|NCT00025090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110165720|NCT00025090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110165721|NCT00025090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110165722|NCT00025090|Immunologic Factors|immunologic factors|mesh-ancestor
110165723|NCT00025090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110165724|NCT00025090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110165725|NCT00025090|Alkylating Agents|alkylating agents|mesh-ancestor
110165726|NCT00025090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110165727|NCT00025090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110165728|NCT00000368|Paroxetine|paroxetine|mesh-list
110165729|NCT00000368|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110165730|NCT00000368|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110165731|NCT00000368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110165732|NCT00000368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110165733|NCT00000368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110165734|NCT00000368|Serotonin Agents|serotonin agents|mesh-ancestor
110165735|NCT00000368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110165736|NCT00000368|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110165737|NCT00000368|Antidepressive Agents|antidepressive agents|mesh-ancestor
110165738|NCT00000368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110165739|NCT00000368|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110165740|NCT00000368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110165741|NCT00000368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110165742|NCT00025168|Gemcitabine|gemcitabine|mesh-list
110165743|NCT00025168|Irinotecan|irinotecan|mesh-list
110165744|NCT00025168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110165745|NCT00025168|Antimetabolites|antimetabolites|mesh-ancestor
110165746|NCT00025168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110165747|NCT00025168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110384215|NCT05885932|Antipyretics|antipyretics|mesh-ancestor
110165748|NCT00025168|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110165749|NCT00025168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110165751|NCT00025207|Gefitinib|gefitinib|mesh-list
110165752|NCT00025207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110165753|NCT00025207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110165754|NCT00025207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110384347|NCT05802225|Pertuzumab|pertuzumab|mesh-list
110165755|NCT00025207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110165756|NCT00025246|Imatinib Mesylate|imatinib mesylate|mesh-list
110165757|NCT00025246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110165758|NCT00025246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110165759|NCT00025246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110165760|NCT00025246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110165761|NCT00025285|Thalidomide|thalidomide|mesh-list
110165762|NCT00025285|Carboplatin|carboplatin|mesh-list
110165763|NCT00025285|Irinotecan|irinotecan|mesh-list
110165764|NCT00025285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110165765|NCT00025285|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110165766|NCT00025285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110165767|NCT00025285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110165768|NCT00025285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110025472|NCT00366834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110165769|NCT00025285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110165770|NCT00025285|Immunologic Factors|immunologic factors|mesh-ancestor
110384478|NCT05752734|Hormones|hormones|mesh-ancestor
110165771|NCT00025285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110165772|NCT00025285|Leprostatic Agents|leprostatic agents|mesh-ancestor
110165773|NCT00025285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110165774|NCT00025285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110165775|NCT00025285|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110165776|NCT00025285|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110165777|NCT00025285|Growth Substances|growth substances|mesh-ancestor
110165778|NCT00025285|Growth Inhibitors|growth inhibitors|mesh-ancestor
110165779|NCT00025324|Cyclophosphamide|cyclophosphamide|mesh-list
110165780|NCT00025324|Thiotepa|thiotepa|mesh-list
110165781|NCT00025324|Carboplatin|carboplatin|mesh-list
110165782|NCT00025324|Etoposide|etoposide|mesh-list
110165783|NCT00025324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110165784|NCT00025324|Immunologic Factors|immunologic factors|mesh-ancestor
110165785|NCT00025324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110165786|NCT00025324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110165787|NCT00025324|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110165788|NCT00025324|Alkylating Agents|alkylating agents|mesh-ancestor
110165789|NCT00025324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110165790|NCT00025324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110165791|NCT00025324|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110165792|NCT00025324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110165793|NCT00025324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110165794|NCT00025324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110165795|NCT00025324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110165796|NCT00025363|Cyclophosphamide|cyclophosphamide|mesh-list
110165797|NCT00025363|Ifosfamide|ifosfamide|mesh-list
110165798|NCT00025363|Doxorubicin|doxorubicin|mesh-list
110165799|NCT00025363|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110165801|NCT00025363|Etoposide|etoposide|mesh-list
110165802|NCT00025363|Vincristine|vincristine|mesh-list
110165803|NCT00025363|Etoposide phosphate|etoposide phosphate|mesh-list
110165804|NCT00025363|Tirapazamine|tirapazamine|mesh-list
110165805|NCT00025363|Sargramostim|sargramostim|mesh-list
110165806|NCT00025363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110165807|NCT00025363|Immunologic Factors|immunologic factors|mesh-ancestor
110165808|NCT00025363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110165809|NCT00025363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110165810|NCT00025363|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110165811|NCT00025363|Alkylating Agents|alkylating agents|mesh-ancestor
110165812|NCT00025363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110165813|NCT00025363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110165814|NCT00025363|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110165815|NCT00025363|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110165816|NCT00025363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110165817|NCT00025363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110165818|NCT00025363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110025494|NCT00367302|Narcotics|narcotics|mesh-ancestor
110165820|NCT00025363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110165821|NCT00025363|Tubulin Modulators|tubulin modulators|mesh-ancestor
110165822|NCT00025363|Antimitotic Agents|antimitotic agents|mesh-ancestor
110165823|NCT00025363|Mitosis Modulators|mitosis modulators|mesh-ancestor
110165825|NCT00025402|Cytarabine|cytarabine|mesh-list
110165826|NCT00025402|Interferon-alpha|interferon-alpha|mesh-list
110165827|NCT00025402|Cyclophosphamide|cyclophosphamide|mesh-list
110165829|NCT00025402|Etoposide|etoposide|mesh-list
110165830|NCT00025402|Idarubicin|idarubicin|mesh-list
110165831|NCT00025402|Hydroxyurea|hydroxyurea|mesh-list
110165832|NCT00025402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110165833|NCT00025402|Immunologic Factors|immunologic factors|mesh-ancestor
110165834|NCT00025402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110165835|NCT00025402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110165836|NCT00025402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110165837|NCT00025402|Alkylating Agents|alkylating agents|mesh-ancestor
110165838|NCT00025402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110165839|NCT00025402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110165840|NCT00025402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110165841|NCT00025402|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110384851|NCT05600114|Cannabidiol|cannabidiol|mesh-list
110165842|NCT00025402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110165843|NCT00025402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110165844|NCT00025402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110165845|NCT00025402|Antiviral Agents|antiviral agents|mesh-ancestor
110165846|NCT00025402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110165848|NCT00025402|Antimetabolites|antimetabolites|mesh-ancestor
110165849|NCT00025402|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110165850|NCT00025402|Antisickling Agents|antisickling agents|mesh-ancestor
110165851|NCT00025402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110165853|NCT00025441|Cyclophosphamide|cyclophosphamide|mesh-list
110165855|NCT00025441|Carboplatin|carboplatin|mesh-list
110165856|NCT00025441|Doxorubicin|doxorubicin|mesh-list
110165857|NCT00025441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110165858|NCT00025441|Etoposide|etoposide|mesh-list
110165859|NCT00025441|Vincristine|vincristine|mesh-list
110165860|NCT00025441|Epirubicin|epirubicin|mesh-list
110165861|NCT00025441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110385282|NCT05403385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110165863|NCT00025441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110165864|NCT00025441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110165865|NCT00025441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110165866|NCT00025441|Alkylating Agents|alkylating agents|mesh-ancestor
110165867|NCT00025441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110165868|NCT00025441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110165869|NCT00025441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110165870|NCT00025441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110165871|NCT00025441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110165872|NCT00025441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110165873|NCT00025441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110165874|NCT00025441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110385434|NCT05358704|Antidotes|antidotes|mesh-ancestor
110165875|NCT00025441|Tubulin Modulators|tubulin modulators|mesh-ancestor
110165876|NCT00025441|Antimitotic Agents|antimitotic agents|mesh-ancestor
110165877|NCT00025441|Mitosis Modulators|mitosis modulators|mesh-ancestor
110165878|NCT00025441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110165879|NCT00025441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110165880|NCT00025441|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110165881|NCT00025441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110165883|NCT00000395|Leucovorin|leucovorin|mesh-list
110165885|NCT00000395|Levoleucovorin|levoleucovorin|mesh-list
110165886|NCT00000395|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110165887|NCT00000395|Abortifacient Agents|abortifacient agents|mesh-ancestor
110165888|NCT00000395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110165889|NCT00000395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110165890|NCT00000395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110165891|NCT00000395|Antimetabolites|antimetabolites|mesh-ancestor
110165892|NCT00000395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110165893|NCT00000395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110165894|NCT00000395|Dermatologic Agents|dermatologic agents|mesh-ancestor
110165895|NCT00000395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110165896|NCT00000395|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110165897|NCT00000395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110165898|NCT00000395|Immunologic Factors|immunologic factors|mesh-ancestor
110165899|NCT00000395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110165900|NCT00000395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110165901|NCT00000395|Hematinics|hematinics|mesh-ancestor
110165902|NCT00000395|Vitamin B Complex|vitamin b complex|mesh-ancestor
110165903|NCT00000395|Vitamins|vitamins|mesh-ancestor
110165904|NCT00000395|Micronutrients|micronutrients|mesh-ancestor
110165905|NCT00000395|Antidotes|antidotes|mesh-ancestor
110165906|NCT00000395|Protective Agents|protective agents|mesh-ancestor
110165907|NCT00025480|Paclitaxel|paclitaxel|mesh-list
110165909|NCT00025480|Tipifarnib|tipifarnib|mesh-list
110165910|NCT00025480|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110165911|NCT00025480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110165912|NCT00025480|Tubulin Modulators|tubulin modulators|mesh-ancestor
110165913|NCT00025480|Antimitotic Agents|antimitotic agents|mesh-ancestor
110165914|NCT00025480|Mitosis Modulators|mitosis modulators|mesh-ancestor
110165915|NCT00025480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110165916|NCT00025519|Mycophenolic Acid|mycophenolic acid|mesh-list
110165917|NCT00025519|Thalidomide|thalidomide|mesh-list
110165919|NCT00025519|Fludarabine phosphate|fludarabine phosphate|mesh-list
110165920|NCT00025519|Tacrolimus|tacrolimus|mesh-list
110165922|NCT00025519|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110165923|NCT00025519|Antimetabolites|antimetabolites|mesh-ancestor
110165924|NCT00025519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110165925|NCT00025519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110165926|NCT00025519|Immunologic Factors|immunologic factors|mesh-ancestor
110165927|NCT00025519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110165928|NCT00025519|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110165929|NCT00025519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110165930|NCT00025519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110165931|NCT00025519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110165932|NCT00025519|Antitubercular Agents|antitubercular agents|mesh-ancestor
110165933|NCT00025519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110165934|NCT00025519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110165935|NCT00025519|Leprostatic Agents|leprostatic agents|mesh-ancestor
110165936|NCT00025519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110165937|NCT00025519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110165938|NCT00025519|Growth Substances|growth substances|mesh-ancestor
110165939|NCT00025519|Growth Inhibitors|growth inhibitors|mesh-ancestor
110165942|NCT00025558|Thiotepa|thiotepa|mesh-list
110165943|NCT00025558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110165944|NCT00025558|Immunologic Factors|immunologic factors|mesh-ancestor
110165945|NCT00025558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110165946|NCT00025558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110165947|NCT00025558|Alkylating Agents|alkylating agents|mesh-ancestor
110165948|NCT00025558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110025599|NCT00369954|Carboplatin|carboplatin|mesh-list
110165949|NCT00025558|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110165950|NCT00025558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110165951|NCT00025597|Cyclophosphamide|cyclophosphamide|mesh-list
110165952|NCT00025597|Carboplatin|carboplatin|mesh-list
110165953|NCT00025597|Doxorubicin|doxorubicin|mesh-list
110165954|NCT00025597|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110165955|NCT00025597|Etoposide|etoposide|mesh-list
110165956|NCT00025597|Vincristine|vincristine|mesh-list
110165957|NCT00025597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110165958|NCT00025597|Immunologic Factors|immunologic factors|mesh-ancestor
110165959|NCT00025597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110165960|NCT00025597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110165961|NCT00025597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110165962|NCT00025597|Alkylating Agents|alkylating agents|mesh-ancestor
110165963|NCT00025597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110165964|NCT00025597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110165965|NCT00025597|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110165966|NCT00025597|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110165967|NCT00025597|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110165968|NCT00025597|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110165969|NCT00025597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110165970|NCT00025597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110165971|NCT00025597|Tubulin Modulators|tubulin modulators|mesh-ancestor
110165972|NCT00025597|Antimitotic Agents|antimitotic agents|mesh-ancestor
110165973|NCT00025597|Mitosis Modulators|mitosis modulators|mesh-ancestor
110165974|NCT00025636|Cytarabine|cytarabine|mesh-list
110165975|NCT00025636|Dexamethasone|dexamethasone|mesh-list
110165976|NCT00025636|Cyclophosphamide|cyclophosphamide|mesh-list
110165977|NCT00025636|Melphalan|melphalan|mesh-list
110165978|NCT00025636|Carmustine|carmustine|mesh-list
110165979|NCT00025636|Methotrexate|methotrexate|mesh-list
110165980|NCT00025636|Etoposide|etoposide|mesh-list
110165981|NCT00025636|Vincristine|vincristine|mesh-list
110165982|NCT00025636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110165983|NCT00025636|Immunologic Factors|immunologic factors|mesh-ancestor
110165984|NCT00025636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110165985|NCT00025636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110165986|NCT00025636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110165987|NCT00025636|Alkylating Agents|alkylating agents|mesh-ancestor
110165988|NCT00025636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110165989|NCT00025636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110165991|NCT00025636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110165992|NCT00025636|Antiemetics|antiemetics|mesh-ancestor
110165993|NCT00025636|Autonomic Agents|autonomic agents|mesh-ancestor
110165994|NCT00025636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110386080|NCT05032183|Mesna|mesna|mesh-list
110165996|NCT00025636|Glucocorticoids|glucocorticoids|mesh-ancestor
110165997|NCT00025636|Hormones|hormones|mesh-ancestor
110165998|NCT00025636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110165999|NCT00025636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110166000|NCT00025636|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110166001|NCT00025636|Abortifacient Agents|abortifacient agents|mesh-ancestor
110166002|NCT00025636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110166003|NCT00025636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110166004|NCT00025636|Antimetabolites|antimetabolites|mesh-ancestor
110166005|NCT00025636|Dermatologic Agents|dermatologic agents|mesh-ancestor
110166006|NCT00025636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110166007|NCT00025636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110166008|NCT00025636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110166009|NCT00025636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110166010|NCT00025636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110386210|NCT04964947|Tobramycin|tobramycin|mesh-list
110166011|NCT00025636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110166012|NCT00025636|Antiviral Agents|antiviral agents|mesh-ancestor
110166013|NCT00025636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110166014|NCT00025636|Tubulin Modulators|tubulin modulators|mesh-ancestor
110166016|NCT00025636|Mitosis Modulators|mitosis modulators|mesh-ancestor
110166018|NCT00025675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110166019|NCT00025675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110166020|NCT00025675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110166021|NCT00025675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110166022|NCT00025753|Rosiglitazone|rosiglitazone|mesh-list
110166023|NCT00025753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110166024|NCT00025753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110166026|NCT00025792|Antioxidants|antioxidants|mesh-ancestor
110166027|NCT00025792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110166028|NCT00025792|Protective Agents|protective agents|mesh-ancestor
110166029|NCT00025792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110166030|NCT00025792|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110166031|NCT00025792|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110166032|NCT00025792|Dopamine Agonists|dopamine agonists|mesh-ancestor
110386574|NCT04721132|Antibodies|antibodies|mesh-list
110166033|NCT00025792|Dopamine Agents|dopamine agents|mesh-ancestor
110166034|NCT00025792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110166035|NCT00000419|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110166036|NCT00000419|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110166037|NCT00000419|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110166038|NCT00000419|Contraceptive Agents|contraceptive agents|mesh-ancestor
110166039|NCT00000419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110166040|NCT00000419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110166041|NCT00000419|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110166042|NCT00000419|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110166043|NCT00000419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110166044|NCT00000419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110166045|NCT00000419|Estrogens|estrogens|mesh-ancestor
110166046|NCT00000419|Hormones|hormones|mesh-ancestor
110166047|NCT00000419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110166048|NCT00026104|Paclitaxel|paclitaxel|mesh-list
110166049|NCT00026104|Gemcitabine|gemcitabine|mesh-list
110166050|NCT00026104|Tipifarnib|tipifarnib|mesh-list
110166051|NCT00026104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110166052|NCT00026104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110166053|NCT00026104|Tubulin Modulators|tubulin modulators|mesh-ancestor
110166054|NCT00026104|Antimitotic Agents|antimitotic agents|mesh-ancestor
110166055|NCT00026104|Mitosis Modulators|mitosis modulators|mesh-ancestor
110166056|NCT00026104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110166057|NCT00026104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110166060|NCT00026143|Interferon-alpha|interferon-alpha|mesh-list
110166062|NCT00026143|Interleukin-12|interleukin-12|mesh-list
110166063|NCT00026143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110166064|NCT00026143|Antiviral Agents|antiviral agents|mesh-ancestor
110166065|NCT00026143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110166066|NCT00026143|Immunologic Factors|immunologic factors|mesh-ancestor
110166067|NCT00026143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110166068|NCT00026143|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110166069|NCT00026143|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110166070|NCT00026143|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110166072|NCT00026143|Growth Inhibitors|growth inhibitors|mesh-ancestor
110166075|NCT00026182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110166076|NCT00026182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110166077|NCT00026182|Immunologic Factors|immunologic factors|mesh-ancestor
110166078|NCT00026182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110166079|NCT00026182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110166080|NCT00026182|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110166081|NCT00026182|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110166082|NCT00026182|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110166083|NCT00026182|Growth Substances|growth substances|mesh-ancestor
110166084|NCT00026182|Growth Inhibitors|growth inhibitors|mesh-ancestor
110166086|NCT00026260|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110166087|NCT00026260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110166088|NCT00026260|Growth Substances|growth substances|mesh-ancestor
110166089|NCT00026260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110387117|NCT04387201|Vitamin B 12|vitamin b 12|mesh-list
110166091|NCT00026260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110166092|NCT00026260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110387186|NCT04329650|Dexamethasone|dexamethasone|mesh-list
110166093|NCT00026260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110166094|NCT00026260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110166095|NCT00026299|Oxaliplatin|oxaliplatin|mesh-list
110166096|NCT00026299|Gefitinib|gefitinib|mesh-list
110166097|NCT00026299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110166098|NCT00026299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110166099|NCT00026299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110166100|NCT00026299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110166101|NCT00026338|Gemcitabine|gemcitabine|mesh-list
110166102|NCT00026338|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110166103|NCT00026338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110387261|NCT04257500|Etonogestrel|etonogestrel|mesh-list
110166104|NCT00026338|Antimetabolites|antimetabolites|mesh-ancestor
110166105|NCT00026338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110166106|NCT00026338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110166107|NCT00026338|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110166108|NCT00026338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110166109|NCT00026377|Leuprolide|leuprolide|mesh-list
110166110|NCT00026377|Goserelin|goserelin|mesh-list
110166111|NCT00026377|Flutamide|flutamide|mesh-list
110166112|NCT00026377|Bicalutamide|bicalutamide|mesh-list
110166113|NCT00026377|Semaxinib|semaxinib|mesh-list
110166114|NCT00026377|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110166115|NCT00026377|Fertility Agents|fertility agents|mesh-ancestor
110166116|NCT00026377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110166117|NCT00026377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110166118|NCT00026377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110166119|NCT00026377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110166120|NCT00026377|Androgen Antagonists|androgen antagonists|mesh-ancestor
110166121|NCT00026377|Hormone Antagonists|hormone antagonists|mesh-ancestor
110369328|NCT01998035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110166122|NCT00026377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110166123|NCT00026377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110166124|NCT00026377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110166125|NCT00026377|Growth Substances|growth substances|mesh-ancestor
110166126|NCT00026377|Growth Inhibitors|growth inhibitors|mesh-ancestor
110166127|NCT00026377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110166128|NCT00026377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110166129|NCT00026377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110166131|NCT00026416|Interferon-alpha|interferon-alpha|mesh-list
110166132|NCT00026416|Thalidomide|thalidomide|mesh-list
110166133|NCT00026416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110166134|NCT00026416|Antiviral Agents|antiviral agents|mesh-ancestor
110166135|NCT00026416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110166136|NCT00026416|Immunologic Factors|immunologic factors|mesh-ancestor
110166137|NCT00026416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110166138|NCT00026416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110166139|NCT00026416|Leprostatic Agents|leprostatic agents|mesh-ancestor
110166141|NCT00026416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110166142|NCT00026416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110166143|NCT00026416|Growth Substances|growth substances|mesh-ancestor
110166144|NCT00026416|Growth Inhibitors|growth inhibitors|mesh-ancestor
110166145|NCT00026533|Thalidomide|thalidomide|mesh-list
110166146|NCT00026533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110166147|NCT00026533|Immunologic Factors|immunologic factors|mesh-ancestor
110166148|NCT00026533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110166149|NCT00026533|Leprostatic Agents|leprostatic agents|mesh-ancestor
110166150|NCT00026533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110166151|NCT00026533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110166152|NCT00026533|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110166153|NCT00026533|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110166154|NCT00026533|Growth Substances|growth substances|mesh-ancestor
110166155|NCT00026533|Growth Inhibitors|growth inhibitors|mesh-ancestor
110166156|NCT00026533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110166157|NCT00026962|Estradiol|estradiol|mesh-list
110166158|NCT00026962|Progesterone|progesterone|mesh-list
110166159|NCT00026962|Estrogens|estrogens|mesh-ancestor
110166160|NCT00026962|Hormones|hormones|mesh-ancestor
110166161|NCT00026962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110166162|NCT00026962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110166164|NCT00027040|Selegiline|selegiline|mesh-list
110166165|NCT00027040|Antidepressive Agents|antidepressive agents|mesh-ancestor
110166166|NCT00027040|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110025693|NCT00371592|Acyclovir|acyclovir|mesh-list
110166167|NCT00027040|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110166168|NCT00027040|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110166169|NCT00027040|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110166170|NCT00027040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110166171|NCT00027040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110166172|NCT00027040|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110166173|NCT00027040|Protective Agents|protective agents|mesh-ancestor
110166174|NCT00027040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110166176|NCT00027079|Ondansetron|ondansetron|mesh-list
110166177|NCT00027079|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110166178|NCT00027079|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110166179|NCT00027079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110166180|NCT00027079|Sensory System Agents|sensory system agents|mesh-ancestor
110166181|NCT00027079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110166182|NCT00027079|Antiemetics|antiemetics|mesh-ancestor
110166183|NCT00027079|Autonomic Agents|autonomic agents|mesh-ancestor
110166184|NCT00027079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110166185|NCT00027079|Antipruritics|antipruritics|mesh-ancestor
110166186|NCT00027079|Dermatologic Agents|dermatologic agents|mesh-ancestor
110166187|NCT00027079|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110166188|NCT00027079|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110166189|NCT00027079|Serotonin Agents|serotonin agents|mesh-ancestor
110166190|NCT00027079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110166191|NCT00027079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110166193|NCT00011778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110166194|NCT00000425|Acetaminophen|acetaminophen|mesh-list
110166195|NCT00000425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110166196|NCT00000425|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
110166197|NCT00000425|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110166198|NCT00000425|Analgesics|analgesics|mesh-ancestor
110166199|NCT00000425|Sensory System Agents|sensory system agents|mesh-ancestor
110166200|NCT00000425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110166201|NCT00000425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110166202|NCT00000425|Antipyretics|antipyretics|mesh-ancestor
110166203|NCT00000425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110166204|NCT00000428|Amitriptyline|amitriptyline|mesh-list
110166205|NCT00000428|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110166206|NCT00000428|Antidepressive Agents|antidepressive agents|mesh-ancestor
110166207|NCT00000428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110166208|NCT00000428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110166209|NCT00000428|Analgesics|analgesics|mesh-ancestor
110166210|NCT00000428|Sensory System Agents|sensory system agents|mesh-ancestor
110166211|NCT00000428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110166212|NCT00000428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110166213|NCT00000428|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110166214|NCT00000428|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110166215|NCT00000428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110166216|NCT00000428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110166217|NCT00000428|Adrenergic Agents|adrenergic agents|mesh-ancestor
110166218|NCT00000428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110166220|NCT00027391|Oxandrolone|oxandrolone|mesh-list
110166221|NCT00027391|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110166222|NCT00027391|Autonomic Agents|autonomic agents|mesh-ancestor
110166223|NCT00027391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110166224|NCT00027391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110166225|NCT00027391|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110166226|NCT00027391|Respiratory System Agents|respiratory system agents|mesh-ancestor
110166227|NCT00027391|Tocolytic Agents|tocolytic agents|mesh-ancestor
110166228|NCT00027391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110166229|NCT00027391|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110166230|NCT00027391|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110166231|NCT00027391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110166232|NCT00027391|Adrenergic Agents|adrenergic agents|mesh-ancestor
110166233|NCT00027391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110166234|NCT00027391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110166237|NCT00027391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110166238|NCT00027391|Anabolic Agents|anabolic agents|mesh-ancestor
110166240|NCT00000461|Pravastatin|pravastatin|mesh-list
110166241|NCT00000461|Gemfibrozil|gemfibrozil|mesh-list
110166242|NCT00000461|Cholestyramine Resin|cholestyramine resin|mesh-list
110166243|NCT00000461|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110166244|NCT00000461|Antimetabolites|antimetabolites|mesh-ancestor
110166245|NCT00000461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110166246|NCT00000461|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110166247|NCT00000461|Vasodilator Agents|vasodilator agents|mesh-ancestor
110166248|NCT00000461|Vitamin B Complex|vitamin b complex|mesh-ancestor
110166249|NCT00000461|Vitamins|vitamins|mesh-ancestor
110166250|NCT00000461|Micronutrients|micronutrients|mesh-ancestor
110166251|NCT00000461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110166252|NCT00000461|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110166253|NCT00000461|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110166254|NCT00000461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110166255|NCT00000461|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110166256|NCT00000461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110166257|NCT00027508|Trabectedin|trabectedin|mesh-list
110166258|NCT00027508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110166259|NCT00027508|Alkylating Agents|alkylating agents|mesh-ancestor
110166260|NCT00027508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110166261|NCT00027508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110166262|NCT00027547|Cytarabine|cytarabine|mesh-list
110166263|NCT00027547|Cyclosporine|cyclosporine|mesh-list
110166264|NCT00027547|Mycophenolic Acid|mycophenolic acid|mesh-list
110166265|NCT00027547|Methotrexate|methotrexate|mesh-list
110166266|NCT00027547|Fludarabine phosphate|fludarabine phosphate|mesh-list
110166267|NCT00027547|Fludarabine|fludarabine|mesh-list
110166268|NCT00027547|Cyclosporins|cyclosporins|mesh-list
110166269|NCT00027547|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110166270|NCT00027547|Abortifacient Agents|abortifacient agents|mesh-ancestor
110166271|NCT00027547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110166272|NCT00027547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110166273|NCT00027547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110166274|NCT00027547|Antimetabolites|antimetabolites|mesh-ancestor
110166275|NCT00027547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110166276|NCT00027547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110166277|NCT00027547|Dermatologic Agents|dermatologic agents|mesh-ancestor
110166278|NCT00027547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110166279|NCT00027547|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110166280|NCT00027547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110166281|NCT00027547|Immunologic Factors|immunologic factors|mesh-ancestor
110166282|NCT00027547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110166283|NCT00027547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110388362|NCT03202628|Ixazomib|ixazomib|mesh-list
110166285|NCT00027547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110166286|NCT00027547|Antifungal Agents|antifungal agents|mesh-ancestor
110166287|NCT00027547|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110166288|NCT00027547|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110388435|NCT03164057|Antiviral Agents|antiviral agents|mesh-ancestor
110166289|NCT00027547|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110166290|NCT00027547|Antitubercular Agents|antitubercular agents|mesh-ancestor
110025727|NCT00372294|Glucocorticoids|glucocorticoids|mesh-ancestor
110166291|NCT00027547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110166292|NCT00011895|Lamivudine|lamivudine|mesh-list
110166293|NCT00011895|Zidovudine|zidovudine|mesh-list
110166294|NCT00011895|Efavirenz|efavirenz|mesh-list
110166295|NCT00011895|Abacavir|abacavir|mesh-list
110166296|NCT00011895|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110369329|NCT01998035|Antimetabolites|antimetabolites|mesh-ancestor
110166297|NCT00011895|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110166298|NCT00011895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110166299|NCT00011895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110166300|NCT00011895|Antiviral Agents|antiviral agents|mesh-ancestor
110166301|NCT00011895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110388570|NCT02964182|Nicotine|nicotine|mesh-list
110166302|NCT00011895|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110166303|NCT00011895|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110166304|NCT00011895|Antimetabolites|antimetabolites|mesh-ancestor
110166305|NCT00011895|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110166306|NCT00011895|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110166307|NCT00011895|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110166308|NCT00011895|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110166309|NCT00011895|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110166310|NCT00011895|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110166311|NCT00027586|Imatinib Mesylate|imatinib mesylate|mesh-list
110166312|NCT00027586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110166313|NCT00027586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110166314|NCT00027586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110166315|NCT00027586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110166316|NCT00000464|Quinidine|quinidine|mesh-list
110166317|NCT00000464|Amiodarone|amiodarone|mesh-list
110166318|NCT00000464|Sotalol|sotalol|mesh-list
110166319|NCT00000464|Propafenone|propafenone|mesh-list
110166320|NCT00000464|Mexiletine|mexiletine|mesh-list
110166321|NCT00000464|Procainamide|procainamide|mesh-list
110166322|NCT00000464|Imipramine|imipramine|mesh-list
110166323|NCT00000464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110166324|NCT00000464|Vasodilator Agents|vasodilator agents|mesh-ancestor
110166325|NCT00000464|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110166326|NCT00000464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110166327|NCT00000464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110166328|NCT00000464|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110166329|NCT00000464|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110166330|NCT00000464|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110166331|NCT00000464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110166332|NCT00000464|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110166333|NCT00000464|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110166334|NCT00000464|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110166335|NCT00000464|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110166336|NCT00000464|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110166337|NCT00000464|Adrenergic Agents|adrenergic agents|mesh-ancestor
110166338|NCT00000464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110166339|NCT00000464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025750|NCT00372762|Bumetanide|bumetanide|mesh-list
110166340|NCT00000464|Sympatholytics|sympatholytics|mesh-ancestor
110166341|NCT00000464|Autonomic Agents|autonomic agents|mesh-ancestor
110388762|NCT02831933|Valacyclovir|valacyclovir|mesh-list
110166342|NCT00000464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110166343|NCT00000464|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110166344|NCT00000464|Antidepressive Agents|antidepressive agents|mesh-ancestor
110166345|NCT00000464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110166346|NCT00000464|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110166347|NCT00000464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110166348|NCT00000464|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110166350|NCT00000464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110166351|NCT00000464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110166352|NCT00000464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110166353|NCT00000464|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110166354|NCT00000464|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110166355|NCT00000464|Cholinergic Agents|cholinergic agents|mesh-ancestor
110166356|NCT00000464|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110166357|NCT00027625|Temozolomide|temozolomide|mesh-list
110166358|NCT00027625|Gefitinib|gefitinib|mesh-list
110166359|NCT00027625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110166360|NCT00027625|Alkylating Agents|alkylating agents|mesh-ancestor
110166361|NCT00027625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110166362|NCT00027625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110166363|NCT00027625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110166365|NCT00027664|Interferons|interferons|mesh-list
110166366|NCT00027664|Interferon-alpha|interferon-alpha|mesh-list
110166367|NCT00027664|Thalidomide|thalidomide|mesh-list
110166368|NCT00027664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110166369|NCT00027664|Antiviral Agents|antiviral agents|mesh-ancestor
110166370|NCT00027664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110166371|NCT00027664|Immunologic Factors|immunologic factors|mesh-ancestor
110166372|NCT00027664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110166373|NCT00027664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110166374|NCT00027664|Leprostatic Agents|leprostatic agents|mesh-ancestor
110166375|NCT00027664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110166376|NCT00027664|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110166377|NCT00027664|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110166378|NCT00027664|Growth Substances|growth substances|mesh-ancestor
110166379|NCT00027664|Growth Inhibitors|growth inhibitors|mesh-ancestor
110166380|NCT00027703|Bevacizumab|bevacizumab|mesh-list
110166381|NCT00027703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110389337|NCT02199184|Hormones|hormones|mesh-ancestor
110166382|NCT00027703|Gemcitabine|gemcitabine|mesh-list
110166383|NCT00027703|Antibodies|antibodies|mesh-list
110166384|NCT00027703|Immunoglobulins|immunoglobulins|mesh-list
110025770|NCT00373620|Paclitaxel|paclitaxel|mesh-list
110166385|NCT00027703|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110166386|NCT00027703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110166387|NCT00027703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110166388|NCT00027703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110166389|NCT00027703|Growth Substances|growth substances|mesh-ancestor
110166390|NCT00027703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110166391|NCT00027703|Growth Inhibitors|growth inhibitors|mesh-ancestor
110166392|NCT00027703|Immunologic Factors|immunologic factors|mesh-ancestor
110166393|NCT00027703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110166394|NCT00027703|Antimetabolites|antimetabolites|mesh-ancestor
110166395|NCT00027703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110166396|NCT00011934|Interferons|interferons|mesh-list
110166397|NCT00011934|Interferon-alpha|interferon-alpha|mesh-list
110166398|NCT00011934|Sargramostim|sargramostim|mesh-list
110166399|NCT00011934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110166400|NCT00011934|Antiviral Agents|antiviral agents|mesh-ancestor
110166401|NCT00011934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110166402|NCT00011934|Immunologic Factors|immunologic factors|mesh-ancestor
110166403|NCT00011934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110166404|NCT00027742|Interferons|interferons|mesh-list
110166405|NCT00027742|Interferon-alpha|interferon-alpha|mesh-list
110166406|NCT00027742|Temozolomide|temozolomide|mesh-list
110166407|NCT00027742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110166408|NCT00027742|Antiviral Agents|antiviral agents|mesh-ancestor
110166409|NCT00027742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110166410|NCT00027742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110166411|NCT00027742|Alkylating Agents|alkylating agents|mesh-ancestor
110389614|NCT01308203|Niacin|niacin|mesh-list
110389621|NCT01308203|Vitamins|vitamins|mesh-ancestor
110166412|NCT00027742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110166414|NCT00027742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110166415|NCT00027820|Cyclosporine|cyclosporine|mesh-list
110166416|NCT00027820|Mycophenolic Acid|mycophenolic acid|mesh-list
110166417|NCT00027820|Fludarabine|fludarabine|mesh-list
110166418|NCT00027820|Fludarabine phosphate|fludarabine phosphate|mesh-list
110166419|NCT00027820|Cyclosporins|cyclosporins|mesh-list
110166420|NCT00027820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110166421|NCT00027820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110166422|NCT00027820|Antimetabolites|antimetabolites|mesh-ancestor
110166423|NCT00027820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110166424|NCT00027820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110166425|NCT00027820|Immunologic Factors|immunologic factors|mesh-ancestor
110166426|NCT00027820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110166427|NCT00027820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110166428|NCT00027820|Antifungal Agents|antifungal agents|mesh-ancestor
110166429|NCT00027820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110166430|NCT00027820|Dermatologic Agents|dermatologic agents|mesh-ancestor
110166431|NCT00027820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110166432|NCT00027820|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110166433|NCT00027820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110166434|NCT00027820|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110166435|NCT00027820|Antitubercular Agents|antitubercular agents|mesh-ancestor
110166436|NCT00027820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110166438|NCT00011973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110025793|NCT00374478|Cholinergic Agents|cholinergic agents|mesh-ancestor
110166439|NCT00011973|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110166440|NCT00011973|Protective Agents|protective agents|mesh-ancestor
110166441|NCT00011973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110166442|NCT00027898|Carboplatin|carboplatin|mesh-list
110166443|NCT00027898|Etoposide|etoposide|mesh-list
110166444|NCT00027898|Etoposide phosphate|etoposide phosphate|mesh-list
110166446|NCT00027898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110166447|NCT00027898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110166448|NCT00027898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110166449|NCT00027898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110166450|NCT00027898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110389949|NCT06031376|Growth Substances|growth substances|mesh-ancestor
110166451|NCT00027898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110166452|NCT00027937|Aldesleukin|aldesleukin|mesh-list
110166453|NCT00027937|Paclitaxel|paclitaxel|mesh-list
110166454|NCT00027937|Cyclophosphamide|cyclophosphamide|mesh-list
110166455|NCT00027937|Melphalan|melphalan|mesh-list
110166456|NCT00027937|Busulfan|busulfan|mesh-list
110166457|NCT00027937|Thiotepa|thiotepa|mesh-list
110166458|NCT00027937|Sargramostim|sargramostim|mesh-list
110166459|NCT00027937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110166460|NCT00027937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110166461|NCT00027937|Tubulin Modulators|tubulin modulators|mesh-ancestor
110166462|NCT00027937|Antimitotic Agents|antimitotic agents|mesh-ancestor
110166463|NCT00027937|Mitosis Modulators|mitosis modulators|mesh-ancestor
110166464|NCT00027937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110166465|NCT00027937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110166466|NCT00027937|Immunologic Factors|immunologic factors|mesh-ancestor
110166467|NCT00027937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110166468|NCT00027937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110166469|NCT00027937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110166470|NCT00027937|Alkylating Agents|alkylating agents|mesh-ancestor
110166471|NCT00027937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110166472|NCT00027937|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110166473|NCT00027937|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110166474|NCT00027937|Antiviral Agents|antiviral agents|mesh-ancestor
110166475|NCT00027937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110166477|NCT00012051|Dexamethasone|dexamethasone|mesh-list
110166478|NCT00012051|Rituximab|rituximab|mesh-list
110166479|NCT00012051|Methotrexate|methotrexate|mesh-list
110166480|NCT00012051|Etoposide|etoposide|mesh-list
110166481|NCT00012051|Melphalan|melphalan|mesh-list
110166482|NCT00012051|Ifosfamide|ifosfamide|mesh-list
110166483|NCT00012051|Carmustine|carmustine|mesh-list
110166484|NCT00012051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110166485|NCT00012051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110166486|NCT00012051|Immunologic Factors|immunologic factors|mesh-ancestor
110166487|NCT00012051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110166488|NCT00012051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110166489|NCT00012051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110166490|NCT00012051|Antiemetics|antiemetics|mesh-ancestor
110166491|NCT00012051|Autonomic Agents|autonomic agents|mesh-ancestor
110166492|NCT00012051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110166493|NCT00012051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110166496|NCT00012051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110166497|NCT00012051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110166498|NCT00012051|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110166499|NCT00012051|Abortifacient Agents|abortifacient agents|mesh-ancestor
110166500|NCT00012051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110166501|NCT00012051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110166502|NCT00012051|Antimetabolites|antimetabolites|mesh-ancestor
110166503|NCT00012051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110166504|NCT00012051|Dermatologic Agents|dermatologic agents|mesh-ancestor
110166505|NCT00012051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110166506|NCT00012051|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110166507|NCT00012051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110166508|NCT00012051|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110166509|NCT00012051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110166510|NCT00012051|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110166511|NCT00012051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110166513|NCT00012051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110166514|NCT00012051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110166515|NCT00012051|Alkylating Agents|alkylating agents|mesh-ancestor
110166516|NCT00012051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110166518|NCT00027976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110166519|NCT00027976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110166520|NCT00027976|Analgesics|analgesics|mesh-ancestor
110166521|NCT00027976|Sensory System Agents|sensory system agents|mesh-ancestor
110166522|NCT00027976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110166523|NCT00027976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110166524|NCT00027976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110166525|NCT00027976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110166526|NCT00027976|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110166527|NCT00027976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110166528|NCT00027976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110166529|NCT00027976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110166530|NCT00000479|Aspirin|aspirin|mesh-list
110166531|NCT00000479|Vitamin E|vitamin e|mesh-list
110166532|NCT00000479|Vitamins|vitamins|mesh-ancestor
110166533|NCT00000479|Micronutrients|micronutrients|mesh-ancestor
110166534|NCT00000479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110166535|NCT00000479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110166536|NCT00000479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110166537|NCT00000479|Analgesics|analgesics|mesh-ancestor
110166538|NCT00000479|Sensory System Agents|sensory system agents|mesh-ancestor
110166539|NCT00000479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110166540|NCT00000479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110166541|NCT00000479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110166542|NCT00000479|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110166543|NCT00000479|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110166544|NCT00000479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110166545|NCT00000479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110390763|NCT05094336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110166546|NCT00000479|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110166547|NCT00000479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110166548|NCT00000479|Antipyretics|antipyretics|mesh-ancestor
110166549|NCT00000479|Antioxidants|antioxidants|mesh-ancestor
110166550|NCT00000479|Protective Agents|protective agents|mesh-ancestor
110166551|NCT00028132|Tenofovir|tenofovir|mesh-list
110390907|NCT04751370|Nivolumab|nivolumab|mesh-list
110166552|NCT00028132|Antiviral Agents|antiviral agents|mesh-ancestor
110166553|NCT00028132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110166554|NCT00028132|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110166555|NCT00028132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110166556|NCT00028132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110166557|NCT00028132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110166558|NCT00028132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110166559|NCT00028132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110166560|NCT00028171|Tacrolimus|tacrolimus|mesh-list
110166561|NCT00028171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110166562|NCT00028171|Immunologic Factors|immunologic factors|mesh-ancestor
110166563|NCT00028171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110166564|NCT00028171|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110166565|NCT00028171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110166566|NCT00028171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110166567|NCT00012090|Goserelin|goserelin|mesh-list
110166568|NCT00012090|Bicalutamide|bicalutamide|mesh-list
110166569|NCT00012090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110166570|NCT00012090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110166571|NCT00012090|Androgen Antagonists|androgen antagonists|mesh-ancestor
110166572|NCT00012090|Hormone Antagonists|hormone antagonists|mesh-ancestor
110166573|NCT00012090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110166574|NCT00012090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110166575|NCT00395395|Calcitonin|calcitonin|mesh-list
110166576|NCT00395395|Salmon calcitonin|salmon calcitonin|mesh-list
110166577|NCT00395395|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
110166578|NCT00395395|Katacalcin|katacalcin|mesh-list
110166579|NCT00395395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110166580|NCT00395395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110391105|NCT04441138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110166581|NCT00395395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110166582|NCT00395395|Vasodilator Agents|vasodilator agents|mesh-ancestor
110166583|NCT00395434|Bevacizumab|bevacizumab|mesh-list
110166584|NCT00395434|Combretastatin|combretastatin|mesh-list
110166585|NCT00395434|Fosbretabulin|fosbretabulin|mesh-list
110166586|NCT00395434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110166587|NCT00395434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110166588|NCT00395434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110166589|NCT00395434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110391177|NCT04267939|Niraparib|niraparib|mesh-list
110166590|NCT00395434|Growth Substances|growth substances|mesh-ancestor
110166591|NCT00395434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110166592|NCT00395434|Growth Inhibitors|growth inhibitors|mesh-ancestor
110166593|NCT00395434|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110166595|NCT00395434|Antimitotic Agents|antimitotic agents|mesh-ancestor
110166596|NCT00395434|Mitosis Modulators|mitosis modulators|mesh-ancestor
110166597|NCT00395434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110166598|NCT00395551|Ranibizumab|ranibizumab|mesh-list
110166599|NCT00395551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110391240|NCT04187105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110166600|NCT00395551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110166601|NCT00395551|Growth Substances|growth substances|mesh-ancestor
110166602|NCT00395551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110166603|NCT00395551|Growth Inhibitors|growth inhibitors|mesh-ancestor
110166604|NCT00395551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110025858|NCT00377910|Lidocaine|lidocaine|mesh-list
110166606|NCT00012129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110166607|NCT00012129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110166608|NCT00028288|Daclizumab|daclizumab|mesh-list
110166609|NCT00028288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110166610|NCT00028288|Immunologic Factors|immunologic factors|mesh-ancestor
110166611|NCT00028288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110166613|NCT00012168|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110166614|NCT00012168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110166616|NCT00000482|Clofibrate|clofibrate|mesh-list
110166617|NCT00000482|Estrogens|estrogens|mesh-list
110166618|NCT00000482|Hormones|hormones|mesh-ancestor
110166619|NCT00000482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110166620|NCT00000482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110166621|NCT00000482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110166622|NCT00000482|Antimetabolites|antimetabolites|mesh-ancestor
110166623|NCT00000482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110166624|NCT00000482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110166625|NCT00000482|Vasodilator Agents|vasodilator agents|mesh-ancestor
110391447|NCT03779854|Vidarabine|vidarabine|mesh-list
110166626|NCT00000482|Vitamin B Complex|vitamin b complex|mesh-ancestor
110166628|NCT00000482|Micronutrients|micronutrients|mesh-ancestor
110166629|NCT00000482|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110166630|NCT00028327|Lamivudine|lamivudine|mesh-list
110166631|NCT00028327|Zidovudine|zidovudine|mesh-list
110166632|NCT00028327|Efavirenz|efavirenz|mesh-list
110166633|NCT00028327|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
110166634|NCT00028327|Nelfinavir|nelfinavir|mesh-list
110166635|NCT00028327|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110166636|NCT00028327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110166637|NCT00028327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110166638|NCT00028327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110166640|NCT00028327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110166642|NCT00028327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110166643|NCT00028327|Antimetabolites|antimetabolites|mesh-ancestor
110166644|NCT00028327|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110166645|NCT00028327|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110166646|NCT00028327|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110166647|NCT00028327|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110166648|NCT00028327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110166649|NCT00028327|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110166650|NCT00028327|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110166651|NCT00028327|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110166652|NCT00028327|Protease Inhibitors|protease inhibitors|mesh-ancestor
110166654|NCT00028366|Lopinavir|lopinavir|mesh-list
110166655|NCT00028366|Fosamprenavir|fosamprenavir|mesh-list
110166656|NCT00028366|Tenofovir|tenofovir|mesh-list
110166657|NCT00028366|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110166658|NCT00028366|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110166659|NCT00028366|Protease Inhibitors|protease inhibitors|mesh-ancestor
110166660|NCT00028366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110166661|NCT00028366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110166662|NCT00028366|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110166663|NCT00028366|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110166664|NCT00028366|Antiviral Agents|antiviral agents|mesh-ancestor
110166665|NCT00028366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110166666|NCT00028366|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110166667|NCT00028366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110166668|NCT00028366|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110166669|NCT00028366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110166670|NCT00028405|Talaporfin|talaporfin|mesh-list
110166671|NCT00028405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110166672|NCT00028405|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110166673|NCT00028405|Dermatologic Agents|dermatologic agents|mesh-ancestor
110166674|NCT00012207|Aldesleukin|aldesleukin|mesh-list
110166675|NCT00012207|Prednisone|prednisone|mesh-list
110166676|NCT00012207|Cyclophosphamide|cyclophosphamide|mesh-list
110166677|NCT00012207|Vincristine|vincristine|mesh-list
110166678|NCT00012207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110166679|NCT00012207|Immunologic Factors|immunologic factors|mesh-ancestor
110166680|NCT00012207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110166682|NCT00012207|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110166683|NCT00012207|Alkylating Agents|alkylating agents|mesh-ancestor
110166684|NCT00012207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391825|NCT01951885|Dermatologic Agents|dermatologic agents|mesh-ancestor
110166685|NCT00012207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110166686|NCT00012207|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110166687|NCT00012207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110166688|NCT00012207|Glucocorticoids|glucocorticoids|mesh-ancestor
110166690|NCT00012207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110166691|NCT00012207|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110166692|NCT00012207|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110166693|NCT00012207|Tubulin Modulators|tubulin modulators|mesh-ancestor
110166694|NCT00012207|Antimitotic Agents|antimitotic agents|mesh-ancestor
110166695|NCT00012207|Mitosis Modulators|mitosis modulators|mesh-ancestor
110166696|NCT00012207|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110166697|NCT00012207|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110166698|NCT00012207|Antiviral Agents|antiviral agents|mesh-ancestor
110166699|NCT00012207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110166700|NCT00028483|Docetaxel|docetaxel|mesh-list
110166701|NCT00028483|Doxorubicin|doxorubicin|mesh-list
110166702|NCT00028483|Immunoconjugates|immunoconjugates|mesh-list
110166703|NCT00028483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110166704|NCT00028483|Tubulin Modulators|tubulin modulators|mesh-ancestor
110166705|NCT00028483|Antimitotic Agents|antimitotic agents|mesh-ancestor
110166706|NCT00028483|Mitosis Modulators|mitosis modulators|mesh-ancestor
110166707|NCT00028483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110166708|NCT00028483|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110166709|NCT00028483|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110166710|NCT00028483|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110166711|NCT00028483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110166712|NCT00028483|Immunologic Factors|immunologic factors|mesh-ancestor
110166713|NCT00028483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110166714|NCT00000485|Antihypertensive Agents|antihypertensive agents|mesh-list
110166715|NCT00000485|Diuretics|diuretics|mesh-list
110166716|NCT00000485|Natriuretic Agents|natriuretic agents|mesh-ancestor
110166717|NCT00000485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110166718|NCT00028561|Carboplatin|carboplatin|mesh-list
110166719|NCT00028561|Epothilone B|epothilone b|mesh-list
110166720|NCT00028561|Epothilones|epothilones|mesh-list
110166721|NCT00028561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110166722|NCT00028561|Tubulin Modulators|tubulin modulators|mesh-ancestor
110392095|NCT01602003|Incretins|incretins|mesh-ancestor
110166723|NCT00028561|Antimitotic Agents|antimitotic agents|mesh-ancestor
110166724|NCT00028561|Mitosis Modulators|mitosis modulators|mesh-ancestor
110166725|NCT00028561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110166726|NCT00028600|Cyclophosphamide|cyclophosphamide|mesh-list
110166727|NCT00028600|Melphalan|melphalan|mesh-list
110166728|NCT00028600|Methotrexate|methotrexate|mesh-list
110166729|NCT00028600|Fludarabine|fludarabine|mesh-list
110166730|NCT00028600|Fludarabine phosphate|fludarabine phosphate|mesh-list
110166731|NCT00028600|Tacrolimus|tacrolimus|mesh-list
110166732|NCT00028600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110166733|NCT00028600|Immunologic Factors|immunologic factors|mesh-ancestor
110166734|NCT00028600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110166735|NCT00028600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110166736|NCT00028600|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110166737|NCT00028600|Alkylating Agents|alkylating agents|mesh-ancestor
110166738|NCT00028600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110166739|NCT00028600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110166740|NCT00028600|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110166741|NCT00028600|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110166742|NCT00028600|Abortifacient Agents|abortifacient agents|mesh-ancestor
110166743|NCT00028600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110166744|NCT00028600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110166745|NCT00028600|Antimetabolites|antimetabolites|mesh-ancestor
110166746|NCT00028600|Dermatologic Agents|dermatologic agents|mesh-ancestor
110166747|NCT00028600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110166748|NCT00028600|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110166749|NCT00028600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110166750|NCT00028600|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110166752|NCT00388778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110166753|NCT00388778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110166754|NCT00388778|Antimalarials|antimalarials|mesh-ancestor
110166755|NCT00388778|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110166756|NCT00388778|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110166757|NCT00012246|Sargramostim|sargramostim|mesh-list
110166758|NCT00012246|Freund's Adjuvant|freund's adjuvant|mesh-list
110166759|NCT00012246|Immunologic Factors|immunologic factors|mesh-ancestor
110166760|NCT00012246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110166761|NCT00012246|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110166762|NCT00028717|Prednisone|prednisone|mesh-list
110166763|NCT00028717|Cyclophosphamide|cyclophosphamide|mesh-list
110166764|NCT00028717|Rituximab|rituximab|mesh-list
110166765|NCT00028717|Doxorubicin|doxorubicin|mesh-list
110166766|NCT00028717|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110166767|NCT00028717|Vincristine|vincristine|mesh-list
110166768|NCT00028717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110166769|NCT00028717|Immunologic Factors|immunologic factors|mesh-ancestor
110166770|NCT00028717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110166771|NCT00028717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110166772|NCT00028717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110166774|NCT00028717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110166775|NCT00028717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110392499|NCT01648010|Mitomycins|mitomycins|mesh-list
110166776|NCT00028717|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110166777|NCT00028717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110166778|NCT00028717|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110166779|NCT00028717|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110166780|NCT00028717|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110166782|NCT00028717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110166783|NCT00028717|Glucocorticoids|glucocorticoids|mesh-ancestor
110166785|NCT00028717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110166786|NCT00028717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110166787|NCT00028717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110166788|NCT00028717|Tubulin Modulators|tubulin modulators|mesh-ancestor
110166789|NCT00028717|Antimitotic Agents|antimitotic agents|mesh-ancestor
110166790|NCT00028717|Mitosis Modulators|mitosis modulators|mesh-ancestor
110166791|NCT00028756|Gemcitabine|gemcitabine|mesh-list
110166792|NCT00028756|Doxorubicin|doxorubicin|mesh-list
110166793|NCT00028756|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110166794|NCT00028756|Methotrexate|methotrexate|mesh-list
110166795|NCT00028756|Vinblastine|vinblastine|mesh-list
110166796|NCT00028756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110166797|NCT00028756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110166798|NCT00028756|Antimetabolites|antimetabolites|mesh-ancestor
110166799|NCT00028756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110166800|NCT00028756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110166801|NCT00028756|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110166802|NCT00028756|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110166803|NCT00028756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110166804|NCT00028756|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110166805|NCT00028756|Abortifacient Agents|abortifacient agents|mesh-ancestor
110166806|NCT00028756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110166807|NCT00028756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110166808|NCT00028756|Dermatologic Agents|dermatologic agents|mesh-ancestor
110166809|NCT00028756|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110166810|NCT00028756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110166811|NCT00028756|Immunologic Factors|immunologic factors|mesh-ancestor
110166812|NCT00028756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110166813|NCT00028756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110166814|NCT00028756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110166816|NCT00028756|Antimitotic Agents|antimitotic agents|mesh-ancestor
110166817|NCT00028756|Mitosis Modulators|mitosis modulators|mesh-ancestor
110166818|NCT00012324|Doxorubicin|doxorubicin|mesh-list
110166819|NCT00012324|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110166821|NCT00012324|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110166822|NCT00012324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110166823|NCT00012324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110166824|NCT00012324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110166825|NCT00012324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110166826|NCT00012324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110166827|NCT00012324|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110166829|NCT00012324|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110166830|NCT00028795|Temozolomide|temozolomide|mesh-list
110166831|NCT00028795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110166832|NCT00028795|Alkylating Agents|alkylating agents|mesh-ancestor
110166833|NCT00028795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110166834|NCT00028795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110166835|NCT00012363|Gemcitabine|gemcitabine|mesh-list
110166836|NCT00012363|Irinotecan|irinotecan|mesh-list
110166837|NCT00012363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110166838|NCT00012363|Antimetabolites|antimetabolites|mesh-ancestor
110166839|NCT00012363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110166840|NCT00012363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110166841|NCT00012363|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110166842|NCT00012363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110166843|NCT00012363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110166844|NCT00388895|Imatinib Mesylate|imatinib mesylate|mesh-list
110166845|NCT00388895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110166846|NCT00388895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110166847|NCT00388895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110166848|NCT00388895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110166849|NCT00028834|Bevacizumab|bevacizumab|mesh-list
110166850|NCT00028834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110166852|NCT00028834|Antibodies|antibodies|mesh-list
110166853|NCT00028834|Immunoglobulins|immunoglobulins|mesh-list
110166854|NCT00028834|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110166855|NCT00028834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110166856|NCT00028834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110166857|NCT00028834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110166859|NCT00028834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110166860|NCT00028834|Growth Inhibitors|growth inhibitors|mesh-ancestor
110166861|NCT00028834|Immunologic Factors|immunologic factors|mesh-ancestor
110166862|NCT00028834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110166863|NCT00028834|Antimetabolites|antimetabolites|mesh-ancestor
110393152|NCT02271126|Hemostatics|hemostatics|mesh-ancestor
110166864|NCT00028834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110166866|NCT00028873|Docetaxel|docetaxel|mesh-list
110166867|NCT00028873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110166868|NCT00028873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110166869|NCT00028873|Tubulin Modulators|tubulin modulators|mesh-ancestor
110166870|NCT00028873|Antimitotic Agents|antimitotic agents|mesh-ancestor
110166871|NCT00028873|Mitosis Modulators|mitosis modulators|mesh-ancestor
110166872|NCT00028873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110166873|NCT00028912|Carboplatin|carboplatin|mesh-list
110166874|NCT00028912|Bortezomib|bortezomib|mesh-list
110166876|NCT00028951|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110166877|NCT00028951|Hemostatics|hemostatics|mesh-ancestor
110166878|NCT00028951|Coagulants|coagulants|mesh-ancestor
110166879|NCT01803555|Budesonide|budesonide|mesh-list
110166880|NCT01803555|Formoterol Fumarate|formoterol fumarate|mesh-list
110166881|NCT01803555|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110166882|NCT01803555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110166883|NCT01803555|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110166885|NCT01803555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110166886|NCT01803555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110166887|NCT01803555|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110166888|NCT01803555|Respiratory System Agents|respiratory system agents|mesh-ancestor
110166889|NCT01803555|Glucocorticoids|glucocorticoids|mesh-ancestor
110166890|NCT01803555|Hormones|hormones|mesh-ancestor
110393645|NCT01357980|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110166891|NCT01803555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110166892|NCT01803555|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110393712|NCT01331109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110166893|NCT01803555|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110166894|NCT01803555|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110166895|NCT01803555|Adrenergic Agents|adrenergic agents|mesh-ancestor
110166896|NCT01803555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110166897|NCT01803555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110166898|NCT00000488|Cholestyramine Resin|cholestyramine resin|mesh-list
110166899|NCT00000488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110166900|NCT00000488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110166902|NCT00000488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110166903|NCT00000488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110166904|NCT00029224|Zoledronic Acid|zoledronic acid|mesh-list
110166905|NCT00029224|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110166906|NCT00029224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110166907|NCT00000491|Aspirin|aspirin|mesh-list
110393846|NCT01340196|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110166908|NCT00000491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110166909|NCT00000491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110166910|NCT00000491|Analgesics|analgesics|mesh-ancestor
110166911|NCT00000491|Sensory System Agents|sensory system agents|mesh-ancestor
110166912|NCT00000491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110166913|NCT00000491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110166914|NCT00000491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110166915|NCT00000491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110166916|NCT00000491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110166917|NCT00000491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110166918|NCT00000491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110166919|NCT00000491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110166920|NCT00000491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110166921|NCT00000491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110166922|NCT00000491|Antipyretics|antipyretics|mesh-ancestor
110166923|NCT00029380|Cyclosporine|cyclosporine|mesh-list
110166924|NCT00029380|Mycophenolic Acid|mycophenolic acid|mesh-list
110166925|NCT00029380|Cyclophosphamide|cyclophosphamide|mesh-list
110166926|NCT00029380|Busulfan|busulfan|mesh-list
110166927|NCT00029380|Cyclosporins|cyclosporins|mesh-list
110166928|NCT00029380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110166929|NCT00029380|Immunologic Factors|immunologic factors|mesh-ancestor
110166930|NCT00029380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110166931|NCT00029380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110166932|NCT00029380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110166933|NCT00029380|Alkylating Agents|alkylating agents|mesh-ancestor
110166934|NCT00029380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110166935|NCT00029380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110166936|NCT00029380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110166937|NCT00029380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110166938|NCT00029380|Antifungal Agents|antifungal agents|mesh-ancestor
110166939|NCT00029380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110166940|NCT00029380|Dermatologic Agents|dermatologic agents|mesh-ancestor
110166941|NCT00029380|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110166942|NCT00029380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110166943|NCT00029380|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110166944|NCT00029380|Antitubercular Agents|antitubercular agents|mesh-ancestor
110166945|NCT00029380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110166947|NCT00029458|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110166948|NCT00029458|Serotonin Agents|serotonin agents|mesh-ancestor
110166949|NCT00029458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110166950|NCT00029458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110166951|NCT00029458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110166952|NCT00029458|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110166953|NCT00029458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110166954|NCT00029458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110166955|NCT00029458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110166956|NCT00029458|GABA Antagonists|gaba antagonists|mesh-ancestor
110394329|NCT01175824|Insulin|insulin|mesh-list
110166957|NCT00029458|GABA Agents|gaba agents|mesh-ancestor
110166958|NCT00029497|Amitriptyline|amitriptyline|mesh-list
110166959|NCT00029497|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110166960|NCT00029497|Antidepressive Agents|antidepressive agents|mesh-ancestor
110166961|NCT00029497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110166962|NCT00029497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110166963|NCT00029497|Analgesics|analgesics|mesh-ancestor
110166964|NCT00029497|Sensory System Agents|sensory system agents|mesh-ancestor
110166965|NCT00029497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110166966|NCT00029497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110166967|NCT00029497|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110166968|NCT00029497|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110166969|NCT00029497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110166970|NCT00029497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110166971|NCT00029497|Adrenergic Agents|adrenergic agents|mesh-ancestor
110166972|NCT00029497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110166973|NCT00000494|Indomethacin|indomethacin|mesh-list
110166974|NCT00000494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110166975|NCT00000494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110166976|NCT00000494|Analgesics|analgesics|mesh-ancestor
110166977|NCT00000494|Sensory System Agents|sensory system agents|mesh-ancestor
110166978|NCT00000494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110166979|NCT00000494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110394525|NCT01111552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110166980|NCT00000494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110166981|NCT00000494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110166982|NCT00000494|Gout Suppressants|gout suppressants|mesh-ancestor
110166983|NCT00000494|Tocolytic Agents|tocolytic agents|mesh-ancestor
110166984|NCT00000494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110166985|NCT00000494|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110166986|NCT00000494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110166987|NCT00000494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110166989|NCT00012519|Indinavir|indinavir|mesh-list
110394598|NCT01608464|Cisplatin|cisplatin|mesh-list
110166990|NCT00012519|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110166991|NCT00012519|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110166992|NCT00012519|Protease Inhibitors|protease inhibitors|mesh-ancestor
110166993|NCT00012519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110166994|NCT00012519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110166995|NCT00012519|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110166996|NCT00012519|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110166997|NCT00012519|Antiviral Agents|antiviral agents|mesh-ancestor
110166998|NCT00012519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110166999|NCT00012519|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110167000|NCT00012519|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110167001|NCT00029614|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110167002|NCT00029614|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110167003|NCT00029614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110167004|NCT00029614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110167005|NCT00029614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110167006|NCT00029614|Adrenergic Agents|adrenergic agents|mesh-ancestor
110167007|NCT00029614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110167008|NCT00029614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110167009|NCT00029770|Acetaminophen|acetaminophen|mesh-list
110167010|NCT00029770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110167011|NCT00029770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
110167012|NCT00029770|Codeine|codeine|mesh-list
110394814|NCT01173055|Analgesics|analgesics|mesh-ancestor
110167013|NCT00029770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110167014|NCT00029770|Analgesics|analgesics|mesh-ancestor
110167015|NCT00029770|Sensory System Agents|sensory system agents|mesh-ancestor
110167016|NCT00029770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110167017|NCT00029770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110167018|NCT00029770|Antipyretics|antipyretics|mesh-ancestor
110167019|NCT00029770|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110167020|NCT00029770|Narcotics|narcotics|mesh-ancestor
110167021|NCT00029770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110167022|NCT00029770|Antitussive Agents|antitussive agents|mesh-ancestor
110167023|NCT00029770|Respiratory System Agents|respiratory system agents|mesh-ancestor
110167024|NCT00029770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110167025|NCT00012558|Inositol|inositol|mesh-list
110167026|NCT00012558|Lamotrigine|lamotrigine|mesh-list
110167027|NCT00012558|Valproic Acid|valproic acid|mesh-list
110167028|NCT00012558|Risperidone|risperidone|mesh-list
110167029|NCT00012558|Tranylcypromine|tranylcypromine|mesh-list
110167030|NCT00012558|Bupropion|bupropion|mesh-list
110167031|NCT00012558|Paroxetine|paroxetine|mesh-list
110167032|NCT00012558|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110167033|NCT00012558|Serotonin Agents|serotonin agents|mesh-ancestor
110167034|NCT00012558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110167035|NCT00012558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110167036|NCT00012558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110167037|NCT00012558|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110167038|NCT00012558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110394870|NCT00593658|Antioxidants|antioxidants|mesh-ancestor
110167039|NCT00012558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110167040|NCT00012558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110167041|NCT00012558|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110167042|NCT00012558|Dopamine Agents|dopamine agents|mesh-ancestor
110394913|NCT00594087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110167043|NCT00012558|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110026079|NCT00383526|Vaccines|vaccines|mesh-list
110167044|NCT00012558|Antidepressive Agents|antidepressive agents|mesh-ancestor
110167045|NCT00012558|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110167046|NCT00012558|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110167047|NCT00012558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110167048|NCT00012558|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110167049|NCT00012558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110167050|NCT00012558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110167051|NCT00012558|Antimanic Agents|antimanic agents|mesh-ancestor
110167052|NCT00012558|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110167053|NCT00012558|Anticonvulsants|anticonvulsants|mesh-ancestor
110167054|NCT00012558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110395064|NCT01605968|Laxatives|laxatives|mesh-ancestor
110167055|NCT00012558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110167056|NCT00012558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110167057|NCT00012558|GABA Agents|gaba agents|mesh-ancestor
110167058|NCT00012558|Vitamin B Complex|vitamin b complex|mesh-ancestor
110167060|NCT00012558|Micronutrients|micronutrients|mesh-ancestor
110167061|NCT00012558|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110167062|NCT00012558|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110167063|NCT00395707|Ranibizumab|ranibizumab|mesh-list
110167064|NCT00395707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110167065|NCT00395707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110167066|NCT00395707|Growth Substances|growth substances|mesh-ancestor
110167067|NCT00395707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110167068|NCT00395707|Growth Inhibitors|growth inhibitors|mesh-ancestor
110167069|NCT00395707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110167071|NCT00000500|Carotenoids|carotenoids|mesh-list
110167072|NCT00000500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110167073|NCT00000500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110167074|NCT00000500|Analgesics|analgesics|mesh-ancestor
110167075|NCT00000500|Sensory System Agents|sensory system agents|mesh-ancestor
110167076|NCT00000500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110167077|NCT00000500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110167079|NCT00000500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110167080|NCT00000500|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110167081|NCT00000500|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110167082|NCT00000500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110167083|NCT00000500|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110167084|NCT00000500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110167085|NCT00000500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110167086|NCT00000500|Antipyretics|antipyretics|mesh-ancestor
110167087|NCT00000500|Antioxidants|antioxidants|mesh-ancestor
110395175|NCT02271347|Brincidofovir|brincidofovir|mesh-list
110167088|NCT00000500|Protective Agents|protective agents|mesh-ancestor
110167089|NCT00395902|Cinacalcet|cinacalcet|mesh-list
110167090|NCT00395902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110167091|NCT00395902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110167092|NCT00395902|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
110167093|NCT00395902|Hormone Antagonists|hormone antagonists|mesh-ancestor
110167094|NCT00395902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110167095|NCT00029848|Rimonabant|rimonabant|mesh-list
110167096|NCT00029848|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110167097|NCT00029848|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
110167098|NCT00029848|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110167099|NCT00029848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110167100|NCT00029848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110167101|NCT00029848|Hormones|hormones|mesh-ancestor
110395252|NCT02892357|Omeprazole|omeprazole|mesh-list
110167102|NCT00029848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110167103|NCT00029848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110167104|NCT00000503|Streptokinase|streptokinase|mesh-list
110167105|NCT00000503|Nitroglycerin|nitroglycerin|mesh-list
110167106|NCT00000503|Vasodilator Agents|vasodilator agents|mesh-ancestor
110167107|NCT00000503|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110167109|NCT00000503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110167110|NCT00030004|Midazolam|midazolam|mesh-list
110167111|NCT00030004|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110167112|NCT00030004|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110395370|NCT02272829|Analgesics|analgesics|mesh-ancestor
110167113|NCT00030004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110167114|NCT00030004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110167115|NCT00030004|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110167116|NCT00030004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110167117|NCT00030004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110167118|NCT00030004|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110167119|NCT00030004|Anesthetics, General|anesthetics, general|mesh-ancestor
110167120|NCT00030004|Anesthetics|anesthetics|mesh-ancestor
110167121|NCT00030004|GABA Modulators|gaba modulators|mesh-ancestor
110167122|NCT00030004|GABA Agents|gaba agents|mesh-ancestor
110167123|NCT00030004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110167124|NCT00030004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110167125|NCT00030082|Melphalan|melphalan|mesh-list
110167126|NCT00030082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110167127|NCT00030082|Alkylating Agents|alkylating agents|mesh-ancestor
110167128|NCT00030082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110167129|NCT00030082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110167130|NCT00030082|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110167131|NCT00030082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110167132|NCT00030082|Immunologic Factors|immunologic factors|mesh-ancestor
110167133|NCT00030082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110167134|NCT00000518|Quinidine|quinidine|mesh-list
110167135|NCT00000518|Sotalol|sotalol|mesh-list
110167136|NCT00000518|Mexiletine|mexiletine|mesh-list
110167137|NCT00000518|Procainamide|procainamide|mesh-list
110167138|NCT00000518|Imipramine|imipramine|mesh-list
110395500|NCT00107900|Edoxaban|edoxaban|mesh-list
110167139|NCT00000518|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110167140|NCT00000518|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110167141|NCT00000518|Adrenergic Agents|adrenergic agents|mesh-ancestor
110167142|NCT00000518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110167143|NCT00000518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110167144|NCT00000518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110167145|NCT00000518|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110167146|NCT00000518|Sympatholytics|sympatholytics|mesh-ancestor
110167147|NCT00000518|Autonomic Agents|autonomic agents|mesh-ancestor
110026123|NCT00384306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110167148|NCT00000518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110167149|NCT00000518|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110167150|NCT00000518|Antidepressive Agents|antidepressive agents|mesh-ancestor
110167151|NCT00000518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110167152|NCT00000518|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110167153|NCT00000518|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110167154|NCT00000518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110167155|NCT00000518|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110167156|NCT00000518|Antimalarials|antimalarials|mesh-ancestor
110167157|NCT00000518|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110167158|NCT00000518|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110167159|NCT00000518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110167160|NCT00000518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110167161|NCT00000518|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110167162|NCT00000518|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110167163|NCT00000518|Cholinergic Agents|cholinergic agents|mesh-ancestor
110167164|NCT00000518|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110167165|NCT00000518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110167166|NCT00000518|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110167167|NCT00000518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110167168|NCT00030121|Cardiodilatin|cardiodilatin|mesh-list
110167169|NCT00030121|Vasodilator Agents|vasodilator agents|mesh-ancestor
110167170|NCT00030238|Calcium|calcium|mesh-list
110167171|NCT00030238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110167172|NCT00030238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110167174|NCT00030355|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110395832|NCT01357616|Brinzolamide|brinzolamide|mesh-list
110167175|NCT00030355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110167176|NCT00030355|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110167177|NCT00030355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110167178|NCT00030355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110167179|NCT00030394|Imatinib Mesylate|imatinib mesylate|mesh-list
110167180|NCT00030394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110167181|NCT00030394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110167182|NCT00030394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110167183|NCT00030394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110167184|NCT00395941|Pioglitazone|pioglitazone|mesh-list
110167185|NCT00395941|Acitretin|acitretin|mesh-list
110167186|NCT00395941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110167187|NCT00395941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110167188|NCT00395941|Keratolytic Agents|keratolytic agents|mesh-ancestor
110167189|NCT00395941|Dermatologic Agents|dermatologic agents|mesh-ancestor
110167190|NCT00030433|Gemcitabine|gemcitabine|mesh-list
110167191|NCT00030433|Irinotecan|irinotecan|mesh-list
110167192|NCT00030433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110167194|NCT00030433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110167195|NCT00030433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110026147|NCT00384618|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110167196|NCT00030433|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110167197|NCT00030433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110167199|NCT00030472|Doxorubicin|doxorubicin|mesh-list
110167200|NCT00030472|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110167201|NCT00030472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110167202|NCT00030472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110167203|NCT00030472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110167204|NCT00030472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110167205|NCT00030472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110167206|NCT00030472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110167209|NCT00000527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110395941|NCT01340768|Hormones|hormones|mesh-ancestor
110167210|NCT00000527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110167211|NCT00000527|Analgesics|analgesics|mesh-ancestor
110167212|NCT00000527|Sensory System Agents|sensory system agents|mesh-ancestor
110167213|NCT00000527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110167214|NCT00000527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110167215|NCT00000527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110167216|NCT00000527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110167217|NCT00000527|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110396009|NCT00600054|Antibodies|antibodies|mesh-list
110167219|NCT00000527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110167220|NCT00000527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110167221|NCT00000527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110167222|NCT00000527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110167223|NCT00000527|Antipyretics|antipyretics|mesh-ancestor
110167224|NCT00000527|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110167225|NCT00000527|Vasodilator Agents|vasodilator agents|mesh-ancestor
110167226|NCT00030511|Fluorouracil|fluorouracil|mesh-list
110167227|NCT00030511|Antimetabolites|antimetabolites|mesh-ancestor
110167228|NCT00030511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110167229|NCT00030511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110167230|NCT00030511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110167231|NCT00030511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110167232|NCT00030511|Immunologic Factors|immunologic factors|mesh-ancestor
110167233|NCT00030511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396151|NCT01167907|Ropivacaine|ropivacaine|mesh-list
110167235|NCT00030550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110167236|NCT00030550|Immunologic Factors|immunologic factors|mesh-ancestor
110167237|NCT00030550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110167238|NCT00030550|Leprostatic Agents|leprostatic agents|mesh-ancestor
110167239|NCT00030550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110167240|NCT00030550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110167241|NCT00030550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110167242|NCT00030550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110167243|NCT00030550|Growth Substances|growth substances|mesh-ancestor
110167244|NCT00030550|Growth Inhibitors|growth inhibitors|mesh-ancestor
110396352|NCT02893280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110167245|NCT00030550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110167247|NCT00030589|Methoxsalen|methoxsalen|mesh-list
110167248|NCT00030589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110167249|NCT00030589|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110167251|NCT00000530|Nifedipine|nifedipine|mesh-list
110167252|NCT00000530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110167253|NCT00000530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110026173|NCT00385554|UC-781|uc-781|mesh-list
110167254|NCT00000530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110167255|NCT00000530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110167256|NCT00000530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110167257|NCT00000530|Vasodilator Agents|vasodilator agents|mesh-ancestor
110167258|NCT00000530|Tocolytic Agents|tocolytic agents|mesh-ancestor
110167259|NCT00000530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110167260|NCT00030667|Imatinib Mesylate|imatinib mesylate|mesh-list
110167261|NCT00030667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110167262|NCT00030667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110167263|NCT00030667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110167264|NCT00030667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110167266|NCT00030745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110167267|NCT00030745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110167268|NCT00030745|Antimetabolites|antimetabolites|mesh-ancestor
110167269|NCT00030745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110167270|NCT00030784|Doxorubicin|doxorubicin|mesh-list
110167271|NCT00030784|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110167272|NCT00030784|Ifosfamide|ifosfamide|mesh-list
110167273|NCT00030784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110167274|NCT00030784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110167275|NCT00030784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110167276|NCT00030784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110167277|NCT00030784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110167278|NCT00030784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110167279|NCT00030784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110396466|NCT00596414|Midazolam|midazolam|mesh-list
110167282|NCT00030862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110167283|NCT00030862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110167284|NCT00030862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110167285|NCT00030862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110167286|NCT00030862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110167288|NCT00000539|Vitamin E|vitamin e|mesh-list
110167289|NCT00000539|Beta Carotene|beta carotene|mesh-list
110167290|NCT00000539|Warfarin|warfarin|mesh-list
110167291|NCT00000539|Pravastatin|pravastatin|mesh-list
110167292|NCT00000539|Carotenoids|carotenoids|mesh-list
110167293|NCT00000539|Micronutrients|micronutrients|mesh-ancestor
110167294|NCT00000539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110167295|NCT00000539|Anticoagulants|anticoagulants|mesh-ancestor
110167296|NCT00000539|Antioxidants|antioxidants|mesh-ancestor
110167297|NCT00000539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110167298|NCT00000539|Protective Agents|protective agents|mesh-ancestor
110167299|NCT00000539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110167300|NCT00000539|Antimetabolites|antimetabolites|mesh-ancestor
110167301|NCT00000539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110167302|NCT00000539|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110167303|NCT00000539|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110167304|NCT00000539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110167305|NCT00000539|Provitamins|provitamins|mesh-ancestor
110167306|NCT00030979|Donepezil|donepezil|mesh-list
110167307|NCT00030979|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110167308|NCT00030979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110167309|NCT00030979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110167310|NCT00030979|Cholinergic Agents|cholinergic agents|mesh-ancestor
110167311|NCT00030979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110167312|NCT00030979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110167313|NCT00030979|Nootropic Agents|nootropic agents|mesh-ancestor
110167314|NCT00031018|Interferon alpha-2|interferon alpha-2|mesh-list
110167315|NCT00031018|Donepezil|donepezil|mesh-list
110396731|NCT04908865|Belimumab|belimumab|mesh-list
110167316|NCT00031018|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110167317|NCT00031018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110167318|NCT00031018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110167319|NCT00031018|Cholinergic Agents|cholinergic agents|mesh-ancestor
110167320|NCT00031018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110167321|NCT00031018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110167322|NCT00031018|Nootropic Agents|nootropic agents|mesh-ancestor
110167323|NCT00031018|Antiviral Agents|antiviral agents|mesh-ancestor
110167324|NCT00031018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110167325|NCT00031018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110167328|NCT00031057|Vitamin B Complex|vitamin b complex|mesh-ancestor
110167329|NCT00031057|Vitamins|vitamins|mesh-ancestor
110167330|NCT00031057|Micronutrients|micronutrients|mesh-ancestor
110167331|NCT00031057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110167332|NCT00031057|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110167333|NCT00031057|Dermatologic Agents|dermatologic agents|mesh-ancestor
110167334|NCT00000554|Dobutamine|dobutamine|mesh-list
110167335|NCT00000554|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110167336|NCT00000554|Sympathomimetics|sympathomimetics|mesh-ancestor
110167337|NCT00000554|Autonomic Agents|autonomic agents|mesh-ancestor
110167338|NCT00000554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110167339|NCT00000554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110167340|NCT00000554|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110167341|NCT00000554|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110167342|NCT00000554|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110167343|NCT00000554|Adrenergic Agents|adrenergic agents|mesh-ancestor
110167344|NCT00000554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110167345|NCT00000554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110167346|NCT00000554|Protective Agents|protective agents|mesh-ancestor
110167347|NCT00012909|Hormones|hormones|mesh-list
110167348|NCT00012909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110167349|NCT00012909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110167350|NCT00031096|Azelaic acid|azelaic acid|mesh-list
110167351|NCT00031096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110167352|NCT00031096|Dermatologic Agents|dermatologic agents|mesh-ancestor
110167354|NCT00031135|Lipotropic Agents|lipotropic agents|mesh-ancestor
110167355|NCT00031135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110167356|NCT00031135|Antimetabolites|antimetabolites|mesh-ancestor
110167357|NCT00031135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110167358|NCT00031135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110167359|NCT00031135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110167360|NCT00031135|Nootropic Agents|nootropic agents|mesh-ancestor
110167361|NCT00031291|Immunoglobulins|immunoglobulins|mesh-list
110167362|NCT00031291|Antibodies|antibodies|mesh-list
110167363|NCT00031291|gamma-Globulins|gamma-globulins|mesh-list
110167364|NCT00031291|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110167365|NCT00031291|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110397001|NCT01324323|Rifampin|rifampin|mesh-list
110167366|NCT00031291|Immunologic Factors|immunologic factors|mesh-ancestor
110167367|NCT00031291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110167368|NCT00000560|Adrenergic Agents|adrenergic agents|mesh-list
110167370|NCT00000560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110167371|NCT00000560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110167372|NCT00000560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110167373|NCT00000560|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110167374|NCT00396058|Methylphenidate|methylphenidate|mesh-list
110167375|NCT00396058|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110167376|NCT00396058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110167377|NCT00396058|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110167378|NCT00396058|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110167379|NCT00396058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110167380|NCT00396058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110167382|NCT00396058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110167383|NCT00396214|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110167384|NCT00396214|Antidepressive Agents|antidepressive agents|mesh-ancestor
110167385|NCT00396214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110167386|NCT00396214|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110167387|NCT00396214|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110167388|NCT00396214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110167389|NCT00396214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110167390|NCT00000563|Dexamethasone|dexamethasone|mesh-list
110167391|NCT00000563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110167392|NCT00000563|Antiemetics|antiemetics|mesh-ancestor
110167393|NCT00000563|Autonomic Agents|autonomic agents|mesh-ancestor
110167394|NCT00000563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110167395|NCT00000563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110167396|NCT00000563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110167397|NCT00000563|Glucocorticoids|glucocorticoids|mesh-ancestor
110167398|NCT00000563|Hormones|hormones|mesh-ancestor
110167399|NCT00000563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110167400|NCT00000563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110167401|NCT00000563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110167402|NCT00031564|Aldesleukin|aldesleukin|mesh-list
110167403|NCT00031564|Interleukin-2|interleukin-2|mesh-list
110167404|NCT00031564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110167405|NCT00031564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110167406|NCT00031564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110167407|NCT00031564|Analgesics|analgesics|mesh-ancestor
110167408|NCT00031564|Sensory System Agents|sensory system agents|mesh-ancestor
110167409|NCT00031564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110167410|NCT00031564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110167411|NCT00031564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110167412|NCT00031564|Antiviral Agents|antiviral agents|mesh-ancestor
110167413|NCT00031564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110167414|NCT00031642|Rituximab|rituximab|mesh-list
110167415|NCT00031642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110167416|NCT00031642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110167417|NCT00031642|Immunologic Factors|immunologic factors|mesh-ancestor
110167418|NCT00031642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110167419|NCT00031642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110167420|NCT00031681|Irinotecan|irinotecan|mesh-list
110167421|NCT00031681|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
110167422|NCT00031681|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110167423|NCT00031681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110167424|NCT00031681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110167425|NCT00031681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110167426|NCT00031681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110167427|NCT00031681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110167428|NCT00031720|Tamoxifen|tamoxifen|mesh-list
110167429|NCT00031720|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110167430|NCT00031720|Hormone Antagonists|hormone antagonists|mesh-ancestor
110167431|NCT00031720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110167432|NCT00031720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110167433|NCT00031720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110167434|NCT00031720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110167435|NCT00031720|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110397218|NCT01312467|Metformin|metformin|mesh-list
110167436|NCT00031720|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110167437|NCT00031720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110167438|NCT00000569|Triamcinolone|triamcinolone|mesh-list
110167439|NCT00000569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110167440|NCT00000569|Glucocorticoids|glucocorticoids|mesh-ancestor
110167441|NCT00000569|Hormones|hormones|mesh-ancestor
110167442|NCT00000569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110167443|NCT00000569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110167444|NCT00031759|Imiquimod|imiquimod|mesh-list
110167445|NCT00031759|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110167446|NCT00031759|Immunologic Factors|immunologic factors|mesh-ancestor
110167447|NCT00031759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110167448|NCT00031759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110167449|NCT00031759|Interferon Inducers|interferon inducers|mesh-ancestor
110167450|NCT01791816|Phenylephrine|phenylephrine|mesh-list
110167451|NCT01791816|Oxymetazoline|oxymetazoline|mesh-list
110167452|NCT01791816|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
110167453|NCT01791816|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110167454|NCT01791816|Mydriatics|mydriatics|mesh-ancestor
110167455|NCT01791816|Autonomic Agents|autonomic agents|mesh-ancestor
110167456|NCT01791816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110397417|NCT01114204|Hematinics|hematinics|mesh-ancestor
110167457|NCT01791816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110167458|NCT01791816|Sympathomimetics|sympathomimetics|mesh-ancestor
110167459|NCT01791816|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110167460|NCT01791816|Nasal Decongestants|nasal decongestants|mesh-ancestor
110167461|NCT01791816|Respiratory System Agents|respiratory system agents|mesh-ancestor
110167462|NCT01791816|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110167463|NCT01791816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110167464|NCT01791816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110167465|NCT01791816|Adrenergic Agents|adrenergic agents|mesh-ancestor
110167467|NCT01791816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110167468|NCT01791816|Protective Agents|protective agents|mesh-ancestor
110167469|NCT01791816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110167471|NCT00031798|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110167472|NCT00031798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110167473|NCT00031798|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110167474|NCT00031798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110167475|NCT00031798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110167476|NCT00031798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110167478|NCT00031798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110167479|NCT00031837|Gemcitabine|gemcitabine|mesh-list
110167480|NCT00031837|Dalteparin|dalteparin|mesh-list
110167481|NCT00031837|Tinzaparin|tinzaparin|mesh-list
110167482|NCT00031837|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110167483|NCT00031837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110167484|NCT00031837|Antimetabolites|antimetabolites|mesh-ancestor
110167485|NCT00031837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110167486|NCT00031837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110167487|NCT00031837|Anticoagulants|anticoagulants|mesh-ancestor
110167488|NCT00031837|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110167489|NCT00031837|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110167490|NCT00031876|Paclitaxel|paclitaxel|mesh-list
110167491|NCT00031876|Capecitabine|capecitabine|mesh-list
110167492|NCT00031876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110167493|NCT00031876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110167494|NCT00031876|Tubulin Modulators|tubulin modulators|mesh-ancestor
110026308|NCT01799460|Cyclosporine|cyclosporine|mesh-list
110167496|NCT00031876|Mitosis Modulators|mitosis modulators|mesh-ancestor
110167497|NCT00031876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110167498|NCT00031876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110167499|NCT00031876|Antimetabolites|antimetabolites|mesh-ancestor
110167500|NCT00031915|Imatinib Mesylate|imatinib mesylate|mesh-list
110167501|NCT00031915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110167502|NCT00031915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110167503|NCT00031915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110167504|NCT00031915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110167505|NCT00031954|Paclitaxel|paclitaxel|mesh-list
110167507|NCT00031954|Gemcitabine|gemcitabine|mesh-list
110167508|NCT00031954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110397956|NCT01080391|Autonomic Agents|autonomic agents|mesh-ancestor
110167509|NCT00031954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110167510|NCT00031954|Tubulin Modulators|tubulin modulators|mesh-ancestor
110167511|NCT00031954|Antimitotic Agents|antimitotic agents|mesh-ancestor
110167512|NCT00031954|Mitosis Modulators|mitosis modulators|mesh-ancestor
110167513|NCT00031954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110167514|NCT00031954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110167515|NCT00031954|Antimetabolites|antimetabolites|mesh-ancestor
110167516|NCT00031993|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110167517|NCT00031993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110167518|NCT00031993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110167519|NCT00031993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110167520|NCT00031993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110167522|NCT00000575|Budesonide|budesonide|mesh-list
110167523|NCT00000575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110167524|NCT00000575|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110167525|NCT00000575|Autonomic Agents|autonomic agents|mesh-ancestor
110167526|NCT00000575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110398240|NCT00598091|Antimetabolites|antimetabolites|mesh-ancestor
110167527|NCT00000575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110167528|NCT00000575|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110167529|NCT00000575|Respiratory System Agents|respiratory system agents|mesh-ancestor
110167531|NCT00000575|Hormones|hormones|mesh-ancestor
110167532|NCT00000575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110167533|NCT00000575|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
110167534|NCT00000575|Immunologic Factors|immunologic factors|mesh-ancestor
110167535|NCT00000575|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110167536|NCT00032032|Paclitaxel|paclitaxel|mesh-list
110167537|NCT00032032|Carboplatin|carboplatin|mesh-list
110167538|NCT00032032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110167539|NCT00032032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110167540|NCT00032032|Tubulin Modulators|tubulin modulators|mesh-ancestor
110167541|NCT00032032|Antimitotic Agents|antimitotic agents|mesh-ancestor
110167542|NCT00032032|Mitosis Modulators|mitosis modulators|mesh-ancestor
110167543|NCT00032032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110167544|NCT00032110|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110167545|NCT00032110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110167546|NCT00032110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110167547|NCT00032110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110167548|NCT00032110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110167549|NCT00032149|Prednisolone|prednisolone|mesh-list
110167550|NCT00032149|Cyclophosphamide|cyclophosphamide|mesh-list
110167551|NCT00032149|Etoposide|etoposide|mesh-list
110167552|NCT00032149|Vincristine|vincristine|mesh-list
110167554|NCT00032149|Bleomycin|bleomycin|mesh-list
110167555|NCT00032149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110167556|NCT00032149|Immunologic Factors|immunologic factors|mesh-ancestor
110398365|NCT00599573|Antipruritics|antipruritics|mesh-ancestor
110167557|NCT00032149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026327|NCT01799460|Hormones|hormones|mesh-ancestor
110167558|NCT00032149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110398433|NCT00600587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110167559|NCT00032149|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110167560|NCT00032149|Alkylating Agents|alkylating agents|mesh-ancestor
110167561|NCT00032149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110398513|NCT05643651|Aspirin|aspirin|mesh-list
110167562|NCT00032149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110167563|NCT00032149|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110167564|NCT00032149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110398586|NCT04303819|Exenatide|exenatide|mesh-list
110167565|NCT00032149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110167566|NCT00032149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110167567|NCT00032149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110167568|NCT00032149|Tubulin Modulators|tubulin modulators|mesh-ancestor
110167569|NCT00032149|Antimitotic Agents|antimitotic agents|mesh-ancestor
110167570|NCT00032149|Mitosis Modulators|mitosis modulators|mesh-ancestor
110167571|NCT00032149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110167572|NCT00032149|Glucocorticoids|glucocorticoids|mesh-ancestor
110167574|NCT00032149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110167575|NCT00032149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110167576|NCT00032149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110167577|NCT00032149|Analgesics|analgesics|mesh-ancestor
110167578|NCT00032149|Sensory System Agents|sensory system agents|mesh-ancestor
110167579|NCT00032149|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110167580|NCT00032188|Aldesleukin|aldesleukin|mesh-list
110167581|NCT00032188|Interleukin-2|interleukin-2|mesh-list
110167582|NCT00032188|Bryostatin 1|bryostatin 1|mesh-list
110167583|NCT00032188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110167584|NCT00032188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110167585|NCT00032188|Analgesics|analgesics|mesh-ancestor
110167586|NCT00032188|Sensory System Agents|sensory system agents|mesh-ancestor
110167587|NCT00032188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110167588|NCT00032188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110167589|NCT00032188|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110167590|NCT00032188|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110167591|NCT00032188|Antiviral Agents|antiviral agents|mesh-ancestor
110167592|NCT00032188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110167593|NCT00032188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110167594|NCT00032188|Immunologic Factors|immunologic factors|mesh-ancestor
110167596|NCT00032305|Immunologic Factors|immunologic factors|mesh-ancestor
110167597|NCT00032305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110167599|NCT00000596|Prednisone|prednisone|mesh-list
110167600|NCT00000596|Cyclophosphamide|cyclophosphamide|mesh-list
110167601|NCT00000596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110167602|NCT00000596|Immunologic Factors|immunologic factors|mesh-ancestor
110167603|NCT00000596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110167604|NCT00000596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110167605|NCT00000596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110167606|NCT00000596|Alkylating Agents|alkylating agents|mesh-ancestor
110167607|NCT00000596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110398838|NCT01095094|Ritonavir|ritonavir|mesh-list
110167608|NCT00000596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110167609|NCT00000596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110167610|NCT00000596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110167611|NCT00000596|Glucocorticoids|glucocorticoids|mesh-ancestor
110167612|NCT00000596|Hormones|hormones|mesh-ancestor
110167613|NCT00000596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110167614|NCT00000596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110398910|NCT01320683|Vitamins|vitamins|mesh-ancestor
110167615|NCT00000596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110167617|NCT00000596|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110167618|NCT00000596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110167619|NCT00000596|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110167620|NCT00000596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110167621|NCT00000596|Leprostatic Agents|leprostatic agents|mesh-ancestor
110167622|NCT00000596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110167624|NCT00000599|Colestipol|colestipol|mesh-list
110167625|NCT00000599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110167626|NCT00000599|Antimetabolites|antimetabolites|mesh-ancestor
110167627|NCT00000599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110167629|NCT00000599|Vasodilator Agents|vasodilator agents|mesh-ancestor
110167630|NCT00000599|Vitamin B Complex|vitamin b complex|mesh-ancestor
110167631|NCT00000599|Vitamins|vitamins|mesh-ancestor
110167632|NCT00000599|Micronutrients|micronutrients|mesh-ancestor
110167633|NCT00000599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110167634|NCT00000599|Sequestering Agents|sequestering agents|mesh-ancestor
110167635|NCT00000602|Hydroxyurea|hydroxyurea|mesh-list
110167636|NCT00000602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110167637|NCT00000602|Antisickling Agents|antisickling agents|mesh-ancestor
110167638|NCT00000602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110167639|NCT00000602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110167640|NCT00000602|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110167641|NCT00032734|Satavaptan|satavaptan|mesh-list
110167642|NCT00032734|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110167643|NCT00032734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110167644|NCT00032734|Natriuretic Agents|natriuretic agents|mesh-ancestor
110167645|NCT00032734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110167646|NCT00032773|Pentostatin|pentostatin|mesh-list
110167647|NCT00032773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110167648|NCT00032773|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
110167649|NCT00032773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110167650|NCT00032773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110167651|NCT00032812|Raclopride|raclopride|mesh-list
110167652|NCT00032812|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110026359|NCT02998320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110167653|NCT00032812|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110167654|NCT00032812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110167655|NCT00032812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110167656|NCT00032812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110167657|NCT00032812|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110167658|NCT00032812|Dopamine Agents|dopamine agents|mesh-ancestor
110167659|NCT00032812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110167660|NCT00032812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110167661|NCT00032890|Celecoxib|celecoxib|mesh-list
110167662|NCT00032890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110167663|NCT00032890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110167664|NCT00032890|Analgesics|analgesics|mesh-ancestor
110167665|NCT00032890|Sensory System Agents|sensory system agents|mesh-ancestor
110167666|NCT00032890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110167667|NCT00032890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110167668|NCT00032890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110167669|NCT00032890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110167670|NCT00032890|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110167671|NCT00032890|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110167672|NCT00032890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110167673|NCT00032890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110167674|NCT00032929|Selegiline|selegiline|mesh-list
110167675|NCT00032929|Antidepressive Agents|antidepressive agents|mesh-ancestor
110167676|NCT00032929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110167677|NCT00032929|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110167678|NCT00032929|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110167679|NCT00032929|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110399123|NCT02890745|Empagliflozin|empagliflozin|mesh-list
110167680|NCT00032929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110167681|NCT00032929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110167682|NCT00032929|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110167683|NCT00032929|Protective Agents|protective agents|mesh-ancestor
110167684|NCT00032929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110167685|NCT00000611|Vitamin D|vitamin d|mesh-list
110167686|NCT00000611|Calcium|calcium|mesh-list
110167687|NCT00000611|Hormones|hormones|mesh-list
110167688|NCT00000611|Estrogens|estrogens|mesh-list
110167689|NCT00000611|Progestins|progestins|mesh-list
110167690|NCT00000611|Vitamins|vitamins|mesh-ancestor
110167691|NCT00000611|Micronutrients|micronutrients|mesh-ancestor
110167692|NCT00000611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110167693|NCT00000611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110167694|NCT00000611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110167695|NCT00000611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110167696|NCT00032968|Buprenorphine|buprenorphine|mesh-list
110167697|NCT00032968|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
110167698|NCT00032968|Naloxone|naloxone|mesh-list
110167699|NCT00032968|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110167700|NCT00032968|Narcotics|narcotics|mesh-ancestor
110167701|NCT00032968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110167702|NCT00032968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110167703|NCT00032968|Analgesics|analgesics|mesh-ancestor
110167704|NCT00032968|Sensory System Agents|sensory system agents|mesh-ancestor
110167705|NCT00032968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110167706|NCT00032968|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110167708|NCT00033046|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110167709|NCT00033046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110167710|NCT00033046|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110399261|NCT01096186|Dopamine Agents|dopamine agents|mesh-ancestor
110167711|NCT00033046|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110167712|NCT00033046|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110167713|NCT00033046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110167714|NCT00033085|Ondansetron|ondansetron|mesh-list
110167715|NCT00033085|Antiemetics|antiemetics|mesh-ancestor
110167716|NCT00033085|Autonomic Agents|autonomic agents|mesh-ancestor
110167717|NCT00033085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110167718|NCT00033085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110167719|NCT00033085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110167720|NCT00033085|Antipruritics|antipruritics|mesh-ancestor
110167721|NCT00033085|Dermatologic Agents|dermatologic agents|mesh-ancestor
110167722|NCT00033085|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110167723|NCT00033085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110167725|NCT00033085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110167726|NCT00033085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110167727|NCT00033163|Tenofovir|tenofovir|mesh-list
110167728|NCT00033163|Adefovir|adefovir|mesh-list
110167729|NCT00033163|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
110167730|NCT00033163|Antiviral Agents|antiviral agents|mesh-ancestor
110167731|NCT00033163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110167732|NCT00033163|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110167733|NCT00033163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110167734|NCT00033163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110167735|NCT00033163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110167737|NCT00033163|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110167738|NCT00033241|Gemcitabine|gemcitabine|mesh-list
110167739|NCT00033241|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110167740|NCT00033241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110167741|NCT00033241|Antimetabolites|antimetabolites|mesh-ancestor
110167742|NCT00033241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110167743|NCT00033241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110167744|NCT00033241|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110167745|NCT00033241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110167746|NCT00000620|Insulin|insulin|mesh-list
110167747|NCT00000620|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110167748|NCT00000620|Metformin|metformin|mesh-list
110167749|NCT00000620|Insulin Glargine|insulin glargine|mesh-list
110167750|NCT00000620|Pioglitazone|pioglitazone|mesh-list
110167752|NCT00000620|Glimepiride|glimepiride|mesh-list
110167753|NCT00000620|Rosiglitazone|rosiglitazone|mesh-list
110167754|NCT00000620|Insulin Detemir|insulin detemir|mesh-list
110167755|NCT00000620|Acarbose|acarbose|mesh-list
110167756|NCT00000620|Repaglinide|repaglinide|mesh-list
110167757|NCT00000620|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110167758|NCT00000620|Metoprolol|metoprolol|mesh-list
110167759|NCT00000620|Felodipine|felodipine|mesh-list
110167760|NCT00000620|Amlodipine|amlodipine|mesh-list
110167761|NCT00000620|Valsartan|valsartan|mesh-list
110167762|NCT00000620|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110167763|NCT00000620|Carvedilol|carvedilol|mesh-list
110167764|NCT00000620|Candesartan|candesartan|mesh-list
110167765|NCT00000620|Candesartan cilexetil|candesartan cilexetil|mesh-list
110167766|NCT00000620|Lisinopril|lisinopril|mesh-list
110167767|NCT00000620|Chlorthalidone|chlorthalidone|mesh-list
110167768|NCT00000620|Diltiazem|diltiazem|mesh-list
110167769|NCT00000620|Benazepril|benazepril|mesh-list
110167770|NCT00000620|Hydralazine|hydralazine|mesh-list
110167771|NCT00000620|Antihypertensive Agents|antihypertensive agents|mesh-list
110167772|NCT00000620|Reserpine|reserpine|mesh-list
110167773|NCT00000620|Hydrochlorothiazide, lisinopril drug combination|hydrochlorothiazide, lisinopril drug combination|mesh-list
110167774|NCT00000620|Hydrochlorothiazide-triamterene|hydrochlorothiazide-triamterene|mesh-list
110167775|NCT00000620|Triamterene|triamterene|mesh-list
110167777|NCT00000620|Simvastatin|simvastatin|mesh-list
110167778|NCT00000620|Fenofibrate|fenofibrate|mesh-list
110167779|NCT00000620|Terazosin|terazosin|mesh-list
110167780|NCT00000620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110167781|NCT00000620|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110167782|NCT00000620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110026406|NCT02994888|Cetuximab|cetuximab|mesh-list
110167783|NCT00000620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110167784|NCT00000620|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110400089|NCT01011673|Analgesics|analgesics|mesh-ancestor
110167785|NCT00000620|Vasodilator Agents|vasodilator agents|mesh-ancestor
110167786|NCT00000620|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110167787|NCT00000620|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110167788|NCT00000620|Antimetabolites|antimetabolites|mesh-ancestor
110167789|NCT00000620|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110167790|NCT00000620|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110167791|NCT00000620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110167792|NCT00000620|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110167793|NCT00000620|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110167794|NCT00000620|Diuretics|diuretics|mesh-ancestor
110167795|NCT00000620|Natriuretic Agents|natriuretic agents|mesh-ancestor
110167796|NCT00000620|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110167797|NCT00000620|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110167798|NCT00000620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110167799|NCT00000620|Sympatholytics|sympatholytics|mesh-ancestor
110167800|NCT00000620|Autonomic Agents|autonomic agents|mesh-ancestor
110167801|NCT00000620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110167802|NCT00000620|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110167803|NCT00000620|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110167804|NCT00000620|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110167805|NCT00000620|Adrenergic Agents|adrenergic agents|mesh-ancestor
110167806|NCT00000620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110167807|NCT00000620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110167808|NCT00000620|Immunologic Factors|immunologic factors|mesh-ancestor
110167809|NCT00000620|Antioxidants|antioxidants|mesh-ancestor
110167810|NCT00000620|Protective Agents|protective agents|mesh-ancestor
110167811|NCT00000620|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110167812|NCT00000620|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110167813|NCT00000620|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110167814|NCT00000620|Protease Inhibitors|protease inhibitors|mesh-ancestor
110167815|NCT00000620|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110167816|NCT00000620|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110167817|NCT00000620|Urological Agents|urological agents|mesh-ancestor
110167818|NCT00000620|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110167819|NCT00000620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110400355|NCT01003639|Antipyretics|antipyretics|mesh-ancestor
110167820|NCT00000620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110167821|NCT00000620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110167822|NCT00000620|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110167823|NCT00000620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110167824|NCT00000620|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
110167825|NCT00000620|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110167826|NCT00000620|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110167828|NCT00033280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110167829|NCT00033280|Alkylating Agents|alkylating agents|mesh-ancestor
110167830|NCT00033280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110167831|NCT00033280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110167832|NCT00033319|Aspirin|aspirin|mesh-list
110167833|NCT00033319|Folic Acid|folic acid|mesh-list
110167834|NCT00033319|Hematinics|hematinics|mesh-ancestor
110167835|NCT00033319|Vitamin B Complex|vitamin b complex|mesh-ancestor
110167836|NCT00033319|Vitamins|vitamins|mesh-ancestor
110167837|NCT00033319|Micronutrients|micronutrients|mesh-ancestor
110167838|NCT00033319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110167839|NCT00033319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110167840|NCT00033319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110167842|NCT00033319|Sensory System Agents|sensory system agents|mesh-ancestor
110167843|NCT00033319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110167844|NCT00033319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110167845|NCT00033319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110167846|NCT00033319|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110167847|NCT00033319|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110400561|NCT04479267|Glucocorticoids|glucocorticoids|mesh-ancestor
110167848|NCT00033319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110167849|NCT00033319|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110167850|NCT00033319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110167851|NCT00033319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110167852|NCT00033319|Antipyretics|antipyretics|mesh-ancestor
110167853|NCT00033358|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110167854|NCT00033358|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110167855|NCT00033358|Medroxyprogesterone|medroxyprogesterone|mesh-list
110167856|NCT00033358|Norgestrel|norgestrel|mesh-list
110167857|NCT00033358|Estradiol|estradiol|mesh-list
110167859|NCT00033358|Hormones|hormones|mesh-ancestor
110167860|NCT00033358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110167861|NCT00033358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110167862|NCT00033358|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110167863|NCT00033358|Contraceptive Agents|contraceptive agents|mesh-ancestor
110167864|NCT00033358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110167865|NCT00033358|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110167866|NCT00033358|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110167867|NCT00033358|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110167868|NCT00033358|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110167869|NCT00033358|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110167870|NCT00033358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110167871|NCT00033358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110167872|NCT02971696|Sorafenib|sorafenib|mesh-list
110167873|NCT02971696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110167874|NCT02971696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110167875|NCT02971696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110167876|NCT02971696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110167877|NCT00033436|Niacinamide|niacinamide|mesh-list
110167878|NCT00033436|Niacin|niacin|mesh-list
110167879|NCT00033436|Nicotinic Acids|nicotinic acids|mesh-list
110167880|NCT00033436|Vitamin B Complex|vitamin b complex|mesh-ancestor
110167882|NCT00033436|Micronutrients|micronutrients|mesh-ancestor
110167883|NCT00033436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110167884|NCT00033436|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110167886|NCT00033436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110167887|NCT00033436|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110167889|NCT00000635|Trifluridine|trifluridine|mesh-list
110167890|NCT00000635|Polymyxins|polymyxins|mesh-list
110167891|NCT00000635|Bacitracin|bacitracin|mesh-list
110167892|NCT00000635|Polymyxin B|polymyxin b|mesh-list
110167893|NCT00000635|Antimetabolites|antimetabolites|mesh-ancestor
110167894|NCT00000635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110167895|NCT00000635|Antiviral Agents|antiviral agents|mesh-ancestor
110167896|NCT00000635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110026425|NCT02993718|Anesthetics, General|anesthetics, general|mesh-ancestor
110167897|NCT00000635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110167898|NCT00000635|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110167900|NCT00033553|Carboplatin|carboplatin|mesh-list
110167902|NCT00033553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110167903|NCT00033553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110401036|NCT04306042|Nivolumab|nivolumab|mesh-list
110167904|NCT00033553|Tubulin Modulators|tubulin modulators|mesh-ancestor
110167905|NCT00033553|Antimitotic Agents|antimitotic agents|mesh-ancestor
110167906|NCT00033553|Mitosis Modulators|mitosis modulators|mesh-ancestor
110167907|NCT00033553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110167908|NCT00033553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110167910|NCT00033592|Bupropion|bupropion|mesh-list
110167911|NCT00033592|Nicotine|nicotine|mesh-list
110167912|NCT00033592|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110167913|NCT00033592|Autonomic Agents|autonomic agents|mesh-ancestor
110167914|NCT00033592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110167915|NCT00033592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110167916|NCT00033592|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110167917|NCT00033592|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110167919|NCT00033592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110167920|NCT00033592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110167921|NCT00033592|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110167922|NCT00033592|Antidepressive Agents|antidepressive agents|mesh-ancestor
110167923|NCT00033592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110167924|NCT00033592|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110167925|NCT00033592|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110167926|NCT00033592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110167927|NCT00033592|Dopamine Agents|dopamine agents|mesh-ancestor
110167928|NCT00033592|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110167929|NCT00033592|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110167930|NCT00033592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110167931|NCT00013689|Pyrimethamine|pyrimethamine|mesh-list
110167932|NCT00013689|Sulfadoxine|sulfadoxine|mesh-list
110167933|NCT00013689|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110167934|NCT00013689|Antimalarials|antimalarials|mesh-ancestor
110167935|NCT00013689|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110167936|NCT00013689|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110167937|NCT00013689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110167938|NCT00013689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110167939|NCT00013689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110167940|NCT00013689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110167941|NCT00013689|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110167942|NCT00033709|Thalidomide|thalidomide|mesh-list
110167943|NCT00033709|Temozolomide|temozolomide|mesh-list
110167944|NCT00033709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110167945|NCT00033709|Alkylating Agents|alkylating agents|mesh-ancestor
110167946|NCT00033709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110167947|NCT00033709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110167948|NCT00033709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110167949|NCT00033709|Immunologic Factors|immunologic factors|mesh-ancestor
110167950|NCT00033709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026446|NCT02992938|Diuretics|diuretics|mesh-ancestor
110167951|NCT00033709|Leprostatic Agents|leprostatic agents|mesh-ancestor
110167952|NCT00033709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110167953|NCT00033709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110167954|NCT00033709|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110167955|NCT00033709|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110167956|NCT00033709|Growth Substances|growth substances|mesh-ancestor
110167957|NCT00033709|Growth Inhibitors|growth inhibitors|mesh-ancestor
110167958|NCT00033748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110167959|NCT00033748|Antibodies|antibodies|mesh-list
110167960|NCT00033748|Immunoglobulins|immunoglobulins|mesh-list
110167961|NCT00033748|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110167962|NCT00033748|Immunologic Factors|immunologic factors|mesh-ancestor
110167963|NCT00033748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110167964|NCT00033748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110167965|NCT00000641|Azithromycin|azithromycin|mesh-list
110167966|NCT00000641|Ciprofloxacin|ciprofloxacin|mesh-list
110167968|NCT00000641|Amikacin|amikacin|mesh-list
110167969|NCT00000641|Ethambutol|ethambutol|mesh-list
110167971|NCT00000641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110167972|NCT00000641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110167973|NCT00000641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110167974|NCT00000641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110167976|NCT00000641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110167977|NCT00000641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110167978|NCT00000641|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110167980|NCT00000641|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110167981|NCT00000641|Antitubercular Agents|antitubercular agents|mesh-ancestor
110167982|NCT00000641|Leprostatic Agents|leprostatic agents|mesh-ancestor
110167983|NCT00000641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110167984|NCT00000641|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110167985|NCT00000641|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110167986|NCT00000641|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110167987|NCT00000641|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110167988|NCT00000641|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110167989|NCT00000641|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110167990|NCT00000641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110167991|NCT00000644|Clarithromycin|clarithromycin|mesh-list
110167992|NCT00000644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110167993|NCT00000644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110167994|NCT00000644|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110167995|NCT00000644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110167996|NCT00000644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110167997|NCT00000644|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110167998|NCT00000644|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110167999|NCT02971423|Imipenem|imipenem|mesh-list
110168000|NCT02971423|Sulbactam|sulbactam|mesh-list
110168001|NCT02971423|Durlobactam|durlobactam|mesh-list
110168002|NCT02971423|Cilastatin|cilastatin|mesh-list
110168003|NCT02971423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110168005|NCT02971423|Protease Inhibitors|protease inhibitors|mesh-ancestor
110168006|NCT02971423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110168007|NCT02971423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110168008|NCT02971423|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110168009|NCT00389051|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110168010|NCT00389051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110168011|NCT00389051|Alkylating Agents|alkylating agents|mesh-ancestor
110401851|NCT06054815|Hormones|hormones|mesh-ancestor
110168012|NCT00389051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110168013|NCT00389051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110168015|NCT00389090|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
110168016|NCT00389090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110168018|NCT00389090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110168019|NCT00389090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110168020|NCT00389090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110168022|NCT00033982|Antifungal Agents|antifungal agents|mesh-ancestor
110168023|NCT00033982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110168024|NCT00033982|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110168025|NCT00033982|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110168026|NCT00033982|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110168027|NCT00033982|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110168028|NCT00033982|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110168029|NCT00033982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110168030|NCT00033982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110168031|NCT00033982|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110168032|NCT00033982|Hormone Antagonists|hormone antagonists|mesh-ancestor
110168033|NCT00033982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110168034|NCT00033982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110168036|NCT00034060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110168037|NCT00034060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110168038|NCT00034060|Analgesics|analgesics|mesh-ancestor
110168039|NCT00034060|Sensory System Agents|sensory system agents|mesh-ancestor
110168040|NCT00034060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110168041|NCT00034060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110168042|NCT00034060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110168043|NCT00034060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110168044|NCT00034060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110168045|NCT00034060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110168047|NCT00034138|Oregovomab|oregovomab|mesh-list
110168048|NCT00034138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110168049|NCT00034138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110168050|NCT00034177|Paclitaxel|paclitaxel|mesh-list
110168051|NCT00034177|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110168052|NCT00034177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110168053|NCT00034177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110168054|NCT00034177|Tubulin Modulators|tubulin modulators|mesh-ancestor
110168055|NCT00034177|Antimitotic Agents|antimitotic agents|mesh-ancestor
110168056|NCT00034177|Mitosis Modulators|mitosis modulators|mesh-ancestor
110168057|NCT00034177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110168058|NCT00389129|Aspirin|aspirin|mesh-list
110168059|NCT00389129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110168060|NCT00389129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110168061|NCT00389129|Analgesics|analgesics|mesh-ancestor
110168062|NCT00389129|Sensory System Agents|sensory system agents|mesh-ancestor
110168063|NCT00389129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110026485|NCT02990286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110026486|NCT02990286|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110168064|NCT00389129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110168065|NCT00389129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110168066|NCT00389129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110168067|NCT00389129|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110168068|NCT00389129|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110168069|NCT00389129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110168070|NCT00389129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110168071|NCT00389129|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110168073|NCT00389129|Antipyretics|antipyretics|mesh-ancestor
110168076|NCT00013962|Micronutrients|micronutrients|mesh-ancestor
110168077|NCT00013962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110168078|NCT00013962|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110168079|NCT00000665|Ganciclovir|ganciclovir|mesh-list
110168080|NCT00000665|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
110168082|NCT00000665|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
110168083|NCT00000665|Antiviral Agents|antiviral agents|mesh-ancestor
110168084|NCT00000665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110402452|NCT05852769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110168085|NCT00000665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110168086|NCT00000665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110168087|NCT00000665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110168088|NCT00000665|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110168089|NCT00034372|Oregovomab|oregovomab|mesh-list
110402522|NCT05843643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110168090|NCT00034372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110168091|NCT00034372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110168092|NCT00014001|Olanzapine|olanzapine|mesh-list
110168093|NCT00014001|Risperidone|risperidone|mesh-list
110168094|NCT00014001|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110168095|NCT00014001|Ziprasidone|ziprasidone|mesh-list
110168096|NCT00014001|Clozapine|clozapine|mesh-list
110168097|NCT00014001|Perphenazine|perphenazine|mesh-list
110168099|NCT00014001|Fluphenazine depot|fluphenazine depot|mesh-list
110168100|NCT00014001|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
110168101|NCT00014001|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110168102|NCT00014001|Serotonin Agents|serotonin agents|mesh-ancestor
110168103|NCT00014001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110168104|NCT00014001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110168105|NCT00014001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110168106|NCT00014001|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110168107|NCT00014001|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110168108|NCT00014001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110168109|NCT00014001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110168110|NCT00014001|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110168111|NCT00014001|Dopamine Agents|dopamine agents|mesh-ancestor
110168112|NCT00014001|Antiemetics|antiemetics|mesh-ancestor
110168113|NCT00014001|Autonomic Agents|autonomic agents|mesh-ancestor
110168114|NCT00014001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110168115|NCT00014001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110168116|NCT00014001|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110168117|NCT00014001|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110168118|NCT00014001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110168119|NCT00014001|Antidepressive Agents|antidepressive agents|mesh-ancestor
110168120|NCT00014001|GABA Antagonists|gaba antagonists|mesh-ancestor
110026510|NCT02999958|Antidotes|antidotes|mesh-ancestor
110168122|NCT00000671|Zidovudine|zidovudine|mesh-list
110168123|NCT00000671|Didanosine|didanosine|mesh-list
110168124|NCT00000671|Antimetabolites|antimetabolites|mesh-ancestor
110168125|NCT00000671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110168126|NCT00000671|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110168127|NCT00000671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110168128|NCT00000671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110168129|NCT00000671|Antiviral Agents|antiviral agents|mesh-ancestor
110168130|NCT00000671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110168131|NCT00000671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110168132|NCT00000671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110168133|NCT02971540|Dipyrone|dipyrone|mesh-list
110168134|NCT02971540|Tramadol|tramadol|mesh-list
110168135|NCT02971540|Bupivacaine|bupivacaine|mesh-list
110168136|NCT02971540|Ropivacaine|ropivacaine|mesh-list
110168137|NCT02971540|Anesthetics, Local|anesthetics, local|mesh-ancestor
110168138|NCT02971540|Anesthetics|anesthetics|mesh-ancestor
110168139|NCT02971540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110168140|NCT02971540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110168141|NCT02971540|Sensory System Agents|sensory system agents|mesh-ancestor
110168142|NCT02971540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110168143|NCT02971540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110168144|NCT02971540|Narcotics|narcotics|mesh-ancestor
110168145|NCT02971540|Analgesics|analgesics|mesh-ancestor
110168146|NCT02971540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110168147|NCT02971540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110168148|NCT02971540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110168149|NCT02971540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110168150|NCT02971540|Antipyretics|antipyretics|mesh-ancestor
110168151|NCT00034489|Gemcitabine|gemcitabine|mesh-list
110168152|NCT00034489|Pemetrexed|pemetrexed|mesh-list
110168153|NCT00034489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110168154|NCT00034489|Antimetabolites|antimetabolites|mesh-ancestor
110168155|NCT00034489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110168156|NCT00034489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110168157|NCT00034489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110168158|NCT00034489|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110168159|NCT00034489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110168162|NCT00396487|Irinotecan|irinotecan|mesh-list
110168163|NCT00396487|Antimetabolites|antimetabolites|mesh-ancestor
110168164|NCT00396487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110168165|NCT00396487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110168166|NCT00396487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110168167|NCT00396487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110168168|NCT00396487|Immunologic Factors|immunologic factors|mesh-ancestor
110168169|NCT00396487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110168170|NCT00396487|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110168171|NCT00396487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110168172|NCT00396487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110168174|NCT00000674|Clindamycin|clindamycin|mesh-list
110168175|NCT00000674|Clindamycin palmitate|clindamycin palmitate|mesh-list
110168176|NCT00000674|Clindamycin phosphate|clindamycin phosphate|mesh-list
110168178|NCT00000674|Calcium|calcium|mesh-list
110168179|NCT00000674|Levoleucovorin|levoleucovorin|mesh-list
110168180|NCT00000674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110402883|NCT05518929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110168181|NCT00000674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110168182|NCT00000674|Antidotes|antidotes|mesh-ancestor
110168183|NCT00000674|Protective Agents|protective agents|mesh-ancestor
110168184|NCT00000674|Vitamin B Complex|vitamin b complex|mesh-ancestor
110168185|NCT00000674|Vitamins|vitamins|mesh-ancestor
110168186|NCT00000674|Micronutrients|micronutrients|mesh-ancestor
110168187|NCT00000674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110168188|NCT00000674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110168189|NCT00000674|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110168190|NCT00000674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110168191|NCT00000674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110168192|NCT00000674|Antimalarials|antimalarials|mesh-ancestor
110168193|NCT00000674|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110168194|NCT00000674|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110403021|NCT05357833|Hematinics|hematinics|mesh-ancestor
110168196|NCT00014040|Nitric Oxide|nitric oxide|mesh-list
110168197|NCT00014040|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110168198|NCT00014040|Autonomic Agents|autonomic agents|mesh-ancestor
110168199|NCT00014040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110168200|NCT00014040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110168202|NCT00014040|Respiratory System Agents|respiratory system agents|mesh-ancestor
110168203|NCT00014040|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110168204|NCT00014040|Antioxidants|antioxidants|mesh-ancestor
110168205|NCT00014040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110168206|NCT00014040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110168207|NCT00014040|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110168208|NCT00014040|Vasodilator Agents|vasodilator agents|mesh-ancestor
110168209|NCT00014040|Gasotransmitters|gasotransmitters|mesh-ancestor
110168210|NCT00014040|Protective Agents|protective agents|mesh-ancestor
110168212|NCT00034528|Fludarabine|fludarabine|mesh-list
110168213|NCT00034528|Busulfan|busulfan|mesh-list
110168214|NCT00034528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110168215|NCT00034528|Glucocorticoids|glucocorticoids|mesh-ancestor
110168216|NCT00034528|Hormones|hormones|mesh-ancestor
110168217|NCT00034528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110168218|NCT00034528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110168219|NCT00034528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110168220|NCT00034528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110168221|NCT00034528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110168222|NCT00034528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110168223|NCT00034528|Immunologic Factors|immunologic factors|mesh-ancestor
110168224|NCT00034528|Alkylating Agents|alkylating agents|mesh-ancestor
110168225|NCT00034528|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110168226|NCT00034528|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110168227|NCT00000677|Sch 39304|sch 39304|mesh-list
110168228|NCT00000677|Antifungal Agents|antifungal agents|mesh-ancestor
110168229|NCT00000677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110168230|NCT04711642|Hyaluronic Acid|hyaluronic acid|mesh-list
110168231|NCT04711642|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110168232|NCT04711642|Immunologic Factors|immunologic factors|mesh-ancestor
110168233|NCT04711642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110168234|NCT04711642|Viscosupplements|viscosupplements|mesh-ancestor
110168235|NCT04711642|Protective Agents|protective agents|mesh-ancestor
110168236|NCT00034606|Gemcitabine|gemcitabine|mesh-list
110168237|NCT00034606|Pemetrexed|pemetrexed|mesh-list
110168238|NCT00034606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110168239|NCT00034606|Antimetabolites|antimetabolites|mesh-ancestor
110168240|NCT00034606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110168241|NCT00034606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110168242|NCT00034606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110168243|NCT00034606|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110168244|NCT00034606|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110168245|NCT00034645|Posaconazole|posaconazole|mesh-list
110168246|NCT00034645|Antifungal Agents|antifungal agents|mesh-ancestor
110168247|NCT00034645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110168248|NCT00034645|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110168249|NCT00034645|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110168250|NCT00034645|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110168251|NCT00034645|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110168252|NCT00034645|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110168253|NCT00034645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110168254|NCT00034645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110168255|NCT00034645|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110168256|NCT00034645|Hormone Antagonists|hormone antagonists|mesh-ancestor
110168257|NCT00034645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110168258|NCT00034645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110168259|NCT00034762|Risperidone|risperidone|mesh-list
110168260|NCT00034762|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110168261|NCT00034762|Serotonin Agents|serotonin agents|mesh-ancestor
110403489|NCT04740918|Maytansine|maytansine|mesh-list
110168262|NCT00034762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110168263|NCT00034762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110168264|NCT00034762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110168265|NCT00034762|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110168266|NCT00034762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110168267|NCT00034762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110168268|NCT00034762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110168269|NCT00034762|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110168270|NCT00034762|Dopamine Agents|dopamine agents|mesh-ancestor
110168271|NCT00000686|Stavudine|stavudine|mesh-list
110168272|NCT00000686|Antimetabolites|antimetabolites|mesh-ancestor
110403553|NCT04577755|Growth Inhibitors|growth inhibitors|mesh-ancestor
110168273|NCT00000686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110168274|NCT00000686|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110168275|NCT00000686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110168276|NCT00000686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110168277|NCT00000686|Antiviral Agents|antiviral agents|mesh-ancestor
110168278|NCT00000686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110168279|NCT00000686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110168280|NCT00000686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110168281|NCT00034801|Olanzapine|olanzapine|mesh-list
110168282|NCT00034801|Ziprasidone|ziprasidone|mesh-list
110168284|NCT00034801|Autonomic Agents|autonomic agents|mesh-ancestor
110168285|NCT00034801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110168286|NCT00034801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110168287|NCT00034801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110168289|NCT00034801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110168290|NCT00034801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110168291|NCT00034801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110403754|NCT04334941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110168292|NCT00034801|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110168293|NCT00034801|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110168294|NCT00034801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110168295|NCT00034801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110168296|NCT00034801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110168297|NCT00034801|Serotonin Agents|serotonin agents|mesh-ancestor
110168298|NCT00034801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110168299|NCT00034801|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110168300|NCT00034801|Dopamine Agents|dopamine agents|mesh-ancestor
110168301|NCT00014196|Docetaxel|docetaxel|mesh-list
110168302|NCT00014196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110168303|NCT00014196|Tubulin Modulators|tubulin modulators|mesh-ancestor
110168304|NCT00014196|Antimitotic Agents|antimitotic agents|mesh-ancestor
110403827|NCT04278729|Apixaban|apixaban|mesh-list
110168305|NCT00014196|Mitosis Modulators|mitosis modulators|mesh-ancestor
110168306|NCT00014196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110026558|NCT01270932|BB 1101|bb 1101|mesh-list
110026566|NCT01270932|Hormones|hormones|mesh-ancestor
110168309|NCT00034840|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110168310|NCT00034840|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110168311|NCT00034840|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110168312|NCT00034840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110168313|NCT00000689|Leucovorin|leucovorin|mesh-list
110168314|NCT00000689|Cytarabine|cytarabine|mesh-list
110168315|NCT00000689|Dexamethasone|dexamethasone|mesh-list
110168316|NCT00000689|Cyclophosphamide|cyclophosphamide|mesh-list
110168317|NCT00000689|Doxorubicin|doxorubicin|mesh-list
110168318|NCT00000689|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110168319|NCT00000689|Methotrexate|methotrexate|mesh-list
110168321|NCT00000689|Bleomycin|bleomycin|mesh-list
110168322|NCT00000689|Sargramostim|sargramostim|mesh-list
110168323|NCT00000689|Levoleucovorin|levoleucovorin|mesh-list
110168324|NCT00000689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110168325|NCT00000689|Immunologic Factors|immunologic factors|mesh-ancestor
110404093|NCT03918850|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110168327|NCT00000689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110168328|NCT00000689|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110168329|NCT00000689|Alkylating Agents|alkylating agents|mesh-ancestor
110168330|NCT00000689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110168331|NCT00000689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110168332|NCT00000689|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110168333|NCT00000689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110168334|NCT00000689|Antiemetics|antiemetics|mesh-ancestor
110404319|NCT03763162|Glycine Agents|glycine agents|mesh-ancestor
110168336|NCT00000689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110168337|NCT00000689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110168338|NCT00000689|Glucocorticoids|glucocorticoids|mesh-ancestor
110168340|NCT00000689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110168341|NCT00000689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110168342|NCT00000689|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110168343|NCT00000689|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110168344|NCT00000689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110168345|NCT00000689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110168346|NCT00000689|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110168347|NCT00000689|Abortifacient Agents|abortifacient agents|mesh-ancestor
110168348|NCT00000689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110168350|NCT00000689|Antimetabolites|antimetabolites|mesh-ancestor
110168351|NCT00000689|Dermatologic Agents|dermatologic agents|mesh-ancestor
110168352|NCT00000689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110168353|NCT00000689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110168354|NCT00000689|Antiviral Agents|antiviral agents|mesh-ancestor
110168355|NCT00000689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110168356|NCT00000689|Antidotes|antidotes|mesh-ancestor
110168357|NCT00000689|Protective Agents|protective agents|mesh-ancestor
110168358|NCT00000689|Vitamin B Complex|vitamin b complex|mesh-ancestor
110168359|NCT00000689|Vitamins|vitamins|mesh-ancestor
110168360|NCT00000689|Micronutrients|micronutrients|mesh-ancestor
110168361|NCT00000689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110168362|NCT00000689|Tubulin Modulators|tubulin modulators|mesh-ancestor
110168363|NCT00000689|Antimitotic Agents|antimitotic agents|mesh-ancestor
110168364|NCT00000689|Mitosis Modulators|mitosis modulators|mesh-ancestor
110168365|NCT00034879|Gefitinib|gefitinib|mesh-list
110168366|NCT00034879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110168367|NCT00034879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110168368|NCT00034879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110168369|NCT00034879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110168372|NCT00000707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110168373|NCT00000707|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110026571|NCT01270932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110168374|NCT00000707|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110168375|NCT00000707|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110168377|NCT00014235|Mycophenolic Acid|mycophenolic acid|mesh-list
110168378|NCT00014235|Fludarabine|fludarabine|mesh-list
110168379|NCT00014235|Fludarabine phosphate|fludarabine phosphate|mesh-list
110168380|NCT00014235|Cyclosporins|cyclosporins|mesh-list
110168381|NCT00014235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110168382|NCT00014235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110168383|NCT00014235|Antimetabolites|antimetabolites|mesh-ancestor
110168384|NCT00014235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110168385|NCT00014235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110168386|NCT00014235|Immunologic Factors|immunologic factors|mesh-ancestor
110168387|NCT00014235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110168388|NCT00014235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110168389|NCT00014235|Antifungal Agents|antifungal agents|mesh-ancestor
110168390|NCT00014235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110168391|NCT00014235|Dermatologic Agents|dermatologic agents|mesh-ancestor
110168392|NCT00014235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110168393|NCT00014235|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110168394|NCT00014235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110168395|NCT00014235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110168396|NCT00014235|Antitubercular Agents|antitubercular agents|mesh-ancestor
110168397|NCT00014235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110168398|NCT00000710|Didanosine|didanosine|mesh-list
110168399|NCT00000710|Antimetabolites|antimetabolites|mesh-ancestor
110168400|NCT00000710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110168401|NCT00000710|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110168402|NCT00000710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110168403|NCT00000710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110168405|NCT00000710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110168406|NCT00000710|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110168407|NCT00000710|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110168408|NCT00000716|Zidovudine|zidovudine|mesh-list
110168409|NCT00000716|Antimetabolites|antimetabolites|mesh-ancestor
110168410|NCT00000716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110168411|NCT00000716|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110168412|NCT00000716|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110168413|NCT00000716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110168414|NCT00000716|Antiviral Agents|antiviral agents|mesh-ancestor
110168415|NCT00000716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110168416|NCT00000716|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110168417|NCT00000716|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110168418|NCT00014274|Carboplatin|carboplatin|mesh-list
110168419|NCT00014274|Gemcitabine|gemcitabine|mesh-list
110168420|NCT00014274|Methotrexate|methotrexate|mesh-list
110168421|NCT00014274|Vinblastine|vinblastine|mesh-list
110168422|NCT00014274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110168423|NCT00014274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110168424|NCT00014274|Antimetabolites|antimetabolites|mesh-ancestor
110168425|NCT00014274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110168426|NCT00014274|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110168427|NCT00014274|Abortifacient Agents|abortifacient agents|mesh-ancestor
110168428|NCT00014274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110168429|NCT00014274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110168430|NCT00014274|Dermatologic Agents|dermatologic agents|mesh-ancestor
110168431|NCT00014274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110168432|NCT00014274|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110168433|NCT00014274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110168434|NCT00014274|Immunologic Factors|immunologic factors|mesh-ancestor
110168435|NCT00014274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110168436|NCT00014274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110168437|NCT00014274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110168438|NCT00014274|Tubulin Modulators|tubulin modulators|mesh-ancestor
110404602|NCT03367741|Nivolumab|nivolumab|mesh-list
110168439|NCT00014274|Antimitotic Agents|antimitotic agents|mesh-ancestor
110168440|NCT00014274|Mitosis Modulators|mitosis modulators|mesh-ancestor
110168441|NCT00035035|Gemcitabine|gemcitabine|mesh-list
110168443|NCT00035035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110168444|NCT00035035|Antimetabolites|antimetabolites|mesh-ancestor
110168445|NCT00035035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110168446|NCT00035035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110168447|NCT00035035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110168448|NCT00035035|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110168449|NCT00035035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110168451|NCT00000719|Zalcitabine|zalcitabine|mesh-list
110168452|NCT00000719|Antimetabolites|antimetabolites|mesh-ancestor
110168453|NCT00000719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110168454|NCT00000719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110168455|NCT00000719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110168456|NCT00000719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110168457|NCT00000719|Antiviral Agents|antiviral agents|mesh-ancestor
110168458|NCT00000719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110168459|NCT00000719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110168460|NCT00000719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110168461|NCT00014313|Etoposide|etoposide|mesh-list
110168462|NCT00014313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110168463|NCT00014313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110168464|NCT00014313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110168465|NCT00014313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110168466|NCT00014313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110168467|NCT00014313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110168468|NCT00035074|Methotrexate|methotrexate|mesh-list
110168469|NCT00035074|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110168471|NCT00035074|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110168472|NCT00035074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110168473|NCT00035074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110168475|NCT00035074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110168476|NCT00035074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110168477|NCT00035074|Dermatologic Agents|dermatologic agents|mesh-ancestor
110168478|NCT00035074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110168479|NCT00035074|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110168480|NCT00035074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110168481|NCT00035074|Immunologic Factors|immunologic factors|mesh-ancestor
110026603|NCT01271166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110168482|NCT00035074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110168483|NCT00035074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110168484|NCT00035113|Epothilones|epothilones|mesh-list
110168485|NCT00035113|Epothilone B|epothilone b|mesh-list
110168486|NCT00035113|Tubulin Modulators|tubulin modulators|mesh-ancestor
110168487|NCT00035113|Antimitotic Agents|antimitotic agents|mesh-ancestor
110168488|NCT00035113|Mitosis Modulators|mitosis modulators|mesh-ancestor
110405162|NCT02496663|Osimertinib|osimertinib|mesh-list
110168489|NCT00035113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110168490|NCT00035113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110168491|NCT00000722|Pentamidine|pentamidine|mesh-list
110168492|NCT00000722|Antifungal Agents|antifungal agents|mesh-ancestor
110168493|NCT00000722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110168494|NCT00000722|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110168495|NCT00000722|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110168496|NCT00000722|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110168498|NCT00035152|Carboplatin|carboplatin|mesh-list
110168499|NCT00035152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110168500|NCT00035152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110168501|NCT00035152|Tubulin Modulators|tubulin modulators|mesh-ancestor
110168502|NCT00035152|Antimitotic Agents|antimitotic agents|mesh-ancestor
110168503|NCT00035152|Mitosis Modulators|mitosis modulators|mesh-ancestor
110168504|NCT00035152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110168505|NCT00014352|Ketoconazole|ketoconazole|mesh-list
110168507|NCT00014352|Doxorubicin|doxorubicin|mesh-list
110168508|NCT00014352|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110168510|NCT00014352|Warfarin|warfarin|mesh-list
110168511|NCT00014352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110168512|NCT00014352|Tubulin Modulators|tubulin modulators|mesh-ancestor
110168513|NCT00014352|Antimitotic Agents|antimitotic agents|mesh-ancestor
110168514|NCT00014352|Mitosis Modulators|mitosis modulators|mesh-ancestor
110168515|NCT00014352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110168516|NCT00014352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110168517|NCT00014352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110168518|NCT00014352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110168519|NCT00014352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110168520|NCT00014352|Anticoagulants|anticoagulants|mesh-ancestor
110168521|NCT00014352|Antifungal Agents|antifungal agents|mesh-ancestor
110168522|NCT00014352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110168523|NCT00014352|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110168524|NCT00014352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110168525|NCT00014352|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110168526|NCT00014352|Hormone Antagonists|hormone antagonists|mesh-ancestor
110168527|NCT00014352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110168528|NCT00014352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110168529|NCT00014352|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110168530|NCT00014352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110168531|NCT00014352|Alkylating Agents|alkylating agents|mesh-ancestor
110168532|NCT00014352|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110168533|NCT00035191|Galantamine|galantamine|mesh-list
110168534|NCT00035191|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110168535|NCT00035191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110168536|NCT00035191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110168537|NCT00035191|Cholinergic Agents|cholinergic agents|mesh-ancestor
110168538|NCT00035191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110168539|NCT00035191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110168540|NCT00035191|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110168541|NCT00035191|Autonomic Agents|autonomic agents|mesh-ancestor
110026627|NCT01272258|Leronlimab|leronlimab|mesh-list
110168542|NCT00035191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110168545|NCT00035230|Anticonvulsants|anticonvulsants|mesh-ancestor
110405485|NCT01833715|Morphine|morphine|mesh-list
110168546|NCT00035230|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110168547|NCT00035230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110168548|NCT00035269|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110168549|NCT00035269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110168551|NCT00014391|Palivizumab|palivizumab|mesh-list
110168552|NCT00014391|Antimetabolites|antimetabolites|mesh-ancestor
110168553|NCT00014391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110168554|NCT00014391|Antiviral Agents|antiviral agents|mesh-ancestor
110168555|NCT00014391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110168557|NCT00035308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110168558|NCT00035308|Immunologic Factors|immunologic factors|mesh-ancestor
110168559|NCT00035308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110168560|NCT00035347|Azithromycin|azithromycin|mesh-list
110168561|NCT00035347|Levofloxacin|levofloxacin|mesh-list
110168562|NCT00035347|Ofloxacin|ofloxacin|mesh-list
110168563|NCT00035347|Ceftriaxone|ceftriaxone|mesh-list
110168564|NCT00035347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110168565|NCT00035347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110168566|NCT00035347|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110168567|NCT00035347|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110168568|NCT00035347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110168569|NCT00035347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110168570|NCT00035347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110168571|NCT00035347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110168572|NCT00035347|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110168573|NCT00035347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110168574|NCT00014430|Trastuzumab|trastuzumab|mesh-list
110168575|NCT00014430|Vinorelbine|vinorelbine|mesh-list
110168576|NCT00014430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110168577|NCT00014430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110168578|NCT00014430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110168580|NCT00014430|Antimitotic Agents|antimitotic agents|mesh-ancestor
110168581|NCT00014430|Mitosis Modulators|mitosis modulators|mesh-ancestor
110168582|NCT00014430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110168584|NCT00035425|Linezolid|linezolid|mesh-list
110168585|NCT00035425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110168586|NCT00035425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110168587|NCT00035425|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110168588|NCT00035425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110168589|NCT00035425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110168590|NCT00000752|Cefuroxime|cefuroxime|mesh-list
110168591|NCT00000752|Cefuroxime axetil|cefuroxime axetil|mesh-list
110168592|NCT00000752|Beclomethasone|beclomethasone|mesh-list
110168593|NCT00000752|Phenylpropanolamine|phenylpropanolamine|mesh-list
110168594|NCT00000752|Pseudoephedrine|pseudoephedrine|mesh-list
110168595|NCT00000752|Ephedrine|ephedrine|mesh-list
110168596|NCT00000752|Guaifenesin|guaifenesin|mesh-list
110168597|NCT00000752|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
110168598|NCT00000752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110168599|NCT00000752|Glucocorticoids|glucocorticoids|mesh-ancestor
110168600|NCT00000752|Hormones|hormones|mesh-ancestor
110026640|NCT01272414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110168601|NCT00000752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110168602|NCT00000752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110168603|NCT00000752|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110168604|NCT00000752|Respiratory System Agents|respiratory system agents|mesh-ancestor
110168605|NCT00000752|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110168606|NCT00000752|Autonomic Agents|autonomic agents|mesh-ancestor
110168607|NCT00000752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110168608|NCT00000752|Nasal Decongestants|nasal decongestants|mesh-ancestor
110168609|NCT00000752|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110168610|NCT00000752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110168611|NCT00000752|Sympathomimetics|sympathomimetics|mesh-ancestor
110168612|NCT00000752|Adrenergic Agents|adrenergic agents|mesh-ancestor
110168613|NCT00000752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110168614|NCT00000752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110168615|NCT00000752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110168616|NCT00000752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110168617|NCT00000752|Expectorants|expectorants|mesh-ancestor
110168618|NCT00000752|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110168619|NCT00000752|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110168620|NCT00000752|Appetite Depressants|appetite depressants|mesh-ancestor
110168621|NCT00000752|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110168623|NCT00035464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110168624|NCT00035464|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110168625|NCT00035464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110168626|NCT00035464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110168627|NCT00035464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110168628|NCT00035464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110168629|NCT00014469|Methotrexate|methotrexate|mesh-list
110168630|NCT00014469|Melphalan|melphalan|mesh-list
110168631|NCT00014469|Busulfan|busulfan|mesh-list
110168632|NCT00014469|Tacrolimus|tacrolimus|mesh-list
110168633|NCT00014469|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110168634|NCT00014469|Abortifacient Agents|abortifacient agents|mesh-ancestor
110168635|NCT00014469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110168636|NCT00014469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110168637|NCT00014469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110168638|NCT00014469|Antimetabolites|antimetabolites|mesh-ancestor
110168639|NCT00014469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110168640|NCT00014469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110168641|NCT00014469|Dermatologic Agents|dermatologic agents|mesh-ancestor
110168642|NCT00014469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110168643|NCT00014469|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110168644|NCT00014469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110168645|NCT00014469|Immunologic Factors|immunologic factors|mesh-ancestor
110168646|NCT00014469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110168647|NCT00014469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110168648|NCT00014469|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110168649|NCT00014469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110168650|NCT00014469|Alkylating Agents|alkylating agents|mesh-ancestor
110168651|NCT00014469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110168652|NCT00000755|Zidovudine|zidovudine|mesh-list
110168653|NCT00000755|Antimetabolites|antimetabolites|mesh-ancestor
110168654|NCT00000755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110168655|NCT00000755|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110168656|NCT00000755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110168657|NCT00000755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110168658|NCT00000755|Antiviral Agents|antiviral agents|mesh-ancestor
110168659|NCT00000755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110168660|NCT00000755|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110168661|NCT00000755|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110026659|NCT01273506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110168662|NCT00035581|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
110168663|NCT00035581|Poly I-C|poly i-c|mesh-list
110168664|NCT00035581|Antiviral Agents|antiviral agents|mesh-ancestor
110168665|NCT00035581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110168666|NCT00035581|Interferon Inducers|interferon inducers|mesh-ancestor
110168667|NCT00035581|Immunologic Factors|immunologic factors|mesh-ancestor
110168668|NCT00035581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110168669|NCT00000758|Fluorouracil|fluorouracil|mesh-list
110168670|NCT00000758|Antimetabolites|antimetabolites|mesh-ancestor
110168671|NCT00000758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110168672|NCT00000758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110168673|NCT00000758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110168674|NCT00000758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110168676|NCT00000758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110168678|NCT00035620|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110168679|NCT00035620|Immunologic Factors|immunologic factors|mesh-ancestor
110168680|NCT00035620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110168681|NCT00014547|BBR 3464|bbr 3464|mesh-list
110168682|NCT00014547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110168683|NCT02971306|Acetylcysteine|acetylcysteine|mesh-list
110168684|NCT02971306|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110168685|NCT02971306|Antiviral Agents|antiviral agents|mesh-ancestor
110168686|NCT02971306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110168687|NCT02971306|Expectorants|expectorants|mesh-ancestor
110168688|NCT02971306|Respiratory System Agents|respiratory system agents|mesh-ancestor
110168689|NCT02971306|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110168690|NCT02971306|Antioxidants|antioxidants|mesh-ancestor
110168691|NCT02971306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110168692|NCT02971306|Protective Agents|protective agents|mesh-ancestor
110168693|NCT02971306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110168694|NCT02971306|Antidotes|antidotes|mesh-ancestor
110168695|NCT00000761|Interferons|interferons|mesh-list
110168696|NCT00000761|Interferon-gamma|interferon-gamma|mesh-list
110168697|NCT00000761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110168698|NCT00000761|Antiviral Agents|antiviral agents|mesh-ancestor
110168699|NCT00000761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110168700|NCT00014586|Goserelin|goserelin|mesh-list
110168701|NCT00014586|Bicalutamide|bicalutamide|mesh-list
110168702|NCT00014586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110168703|NCT00014586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110168705|NCT00014586|Hormone Antagonists|hormone antagonists|mesh-ancestor
110168706|NCT00014586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110168707|NCT00014586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110168709|NCT04732390|Bupivacaine|bupivacaine|mesh-list
110168710|NCT04732390|Anesthetics, Local|anesthetics, local|mesh-ancestor
110168711|NCT04732390|Anesthetics|anesthetics|mesh-ancestor
110168712|NCT04732390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110168713|NCT04732390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110168714|NCT04732390|Sensory System Agents|sensory system agents|mesh-ancestor
110168715|NCT04732390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110168716|NCT04732390|Analgesics|analgesics|mesh-ancestor
110168717|NCT04732390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110168718|NCT04732390|Anticonvulsants|anticonvulsants|mesh-ancestor
110168719|NCT04732390|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110168720|NCT04732390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110168721|NCT04732390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110168722|NCT04732390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110026669|NCT01274130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110168723|NCT04732390|Tocolytic Agents|tocolytic agents|mesh-ancestor
110168724|NCT04732390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110168725|NCT00035854|Linezolid|linezolid|mesh-list
110168726|NCT00035854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110168727|NCT00035854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110168728|NCT00035854|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110168729|NCT00035854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110168730|NCT00035854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110168731|NCT00000779|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110168732|NCT00000779|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110168733|NCT00000779|Immunologic Factors|immunologic factors|mesh-ancestor
110168734|NCT00000779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110168736|NCT00000779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110168737|NCT00000779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110168738|NCT00035893|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
110168739|NCT00035893|Poly I-C|poly i-c|mesh-list
110168740|NCT00035893|Antiviral Agents|antiviral agents|mesh-ancestor
110168741|NCT00035893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110168742|NCT00035893|Interferon Inducers|interferon inducers|mesh-ancestor
110168743|NCT00035893|Immunologic Factors|immunologic factors|mesh-ancestor
110168744|NCT00035893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110168745|NCT00035971|Alendronate|alendronate|mesh-list
110168746|NCT00035971|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
110168747|NCT00035971|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110168748|NCT00035971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110168750|NCT00035971|Hormone Antagonists|hormone antagonists|mesh-ancestor
110168751|NCT00035971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110168752|NCT00035971|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110168754|NCT00014625|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
110168755|NCT00014625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110168756|NCT00014625|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110168757|NCT00014625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110168758|NCT00014625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110168761|NCT02971345|Epirubicin|epirubicin|mesh-list
110168762|NCT02971345|Ethiodized Oil|ethiodized oil|mesh-list
110168763|NCT02971345|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110168764|NCT02971345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110168765|NCT02971345|Trace Elements|trace elements|mesh-ancestor
110168766|NCT02971345|Micronutrients|micronutrients|mesh-ancestor
110168767|NCT02971345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110168768|NCT02971345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110168769|NCT02971345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110168770|NCT02971345|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110168771|NCT02971345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110168772|NCT02971345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110168773|NCT02971345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110168774|NCT00036088|Olanzapine|olanzapine|mesh-list
110168775|NCT00036088|Antiemetics|antiemetics|mesh-ancestor
110168776|NCT00036088|Autonomic Agents|autonomic agents|mesh-ancestor
110168777|NCT00036088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110168778|NCT00036088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026687|NCT01277172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110168779|NCT00036088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110168781|NCT00036088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110168782|NCT00036088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110168783|NCT00036088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110168784|NCT00036088|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110168785|NCT00036088|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110168786|NCT00036088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110168787|NCT00036088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110168790|NCT00036127|Aripiprazole|aripiprazole|mesh-list
110168791|NCT00036127|Antidepressive Agents|antidepressive agents|mesh-ancestor
110168792|NCT00036127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110168793|NCT00036127|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110168794|NCT00036127|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110168795|NCT00036127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110168796|NCT00036127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110168797|NCT00036127|Dopamine Agonists|dopamine agonists|mesh-ancestor
110168798|NCT00036127|Dopamine Agents|dopamine agents|mesh-ancestor
110168799|NCT00036127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110168800|NCT00036127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110168801|NCT00036127|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110168802|NCT00036127|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110168803|NCT00036127|Serotonin Agents|serotonin agents|mesh-ancestor
110168804|NCT00036127|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110168805|NCT00036127|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110168806|NCT00036127|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110168807|NCT00036127|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110168808|NCT00000788|Fluconazole|fluconazole|mesh-list
110168809|NCT00000788|Methadone|methadone|mesh-list
110168810|NCT00000788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110168811|NCT00000788|Narcotics|narcotics|mesh-ancestor
110168812|NCT00000788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110168813|NCT00000788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110168814|NCT00000788|Analgesics|analgesics|mesh-ancestor
110168815|NCT00000788|Sensory System Agents|sensory system agents|mesh-ancestor
110168816|NCT00000788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110168817|NCT00000788|Antitussive Agents|antitussive agents|mesh-ancestor
110168818|NCT00000788|Respiratory System Agents|respiratory system agents|mesh-ancestor
110168819|NCT00000788|Antifungal Agents|antifungal agents|mesh-ancestor
110168820|NCT00000788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110168821|NCT00000788|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110168822|NCT00000788|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110168823|NCT00000788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110168824|NCT00000788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110168825|NCT00000788|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110168826|NCT00000788|Hormone Antagonists|hormone antagonists|mesh-ancestor
110168827|NCT00000788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110168828|NCT00000788|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110168829|NCT00000788|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110168831|NCT00036166|Antifungal Agents|antifungal agents|mesh-ancestor
110168832|NCT00036166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110168833|NCT00000794|Leucovorin|leucovorin|mesh-list
110168834|NCT00000794|Clarithromycin|clarithromycin|mesh-list
110168835|NCT00000794|Sulfadiazine|sulfadiazine|mesh-list
110168837|NCT00000794|Atovaquone|atovaquone|mesh-list
110168838|NCT00000794|Calcium|calcium|mesh-list
110168839|NCT00000794|Levoleucovorin|levoleucovorin|mesh-list
110168840|NCT00000794|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110168841|NCT00000794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110168842|NCT00000794|Antidotes|antidotes|mesh-ancestor
110168843|NCT00000794|Protective Agents|protective agents|mesh-ancestor
110168844|NCT00000794|Vitamin B Complex|vitamin b complex|mesh-ancestor
110168845|NCT00000794|Vitamins|vitamins|mesh-ancestor
110168846|NCT00000794|Micronutrients|micronutrients|mesh-ancestor
110168847|NCT00000794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110168848|NCT00000794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110168849|NCT00000794|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110168850|NCT00000794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110168851|NCT00000794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110168852|NCT00000794|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110168853|NCT00000794|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110168854|NCT00000794|Antimalarials|antimalarials|mesh-ancestor
110168855|NCT00000794|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110168856|NCT00000794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110168857|NCT00000794|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110168858|NCT00000794|Coccidiostats|coccidiostats|mesh-ancestor
110168859|NCT00036244|Secretin|secretin|mesh-list
110168860|NCT00036244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110168861|NCT00036244|Hormones|hormones|mesh-ancestor
110168862|NCT00036244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110168863|NCT00036244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110168864|NCT00036283|Celecoxib|celecoxib|mesh-list
110168865|NCT00036283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110168866|NCT00036283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110168867|NCT00036283|Analgesics|analgesics|mesh-ancestor
110168868|NCT00036283|Sensory System Agents|sensory system agents|mesh-ancestor
110168869|NCT00036283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110168870|NCT00036283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110168871|NCT00036283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110168872|NCT00036283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110168873|NCT00036283|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110168874|NCT00036283|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110168875|NCT00036283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110168876|NCT00036283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110168877|NCT00391638|Interferons|interferons|mesh-list
110168878|NCT00391638|Tenofovir|tenofovir|mesh-list
110168879|NCT00391638|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110168880|NCT00391638|Emtricitabine|emtricitabine|mesh-list
110168881|NCT00391638|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110168882|NCT00391638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110168883|NCT00391638|Antiviral Agents|antiviral agents|mesh-ancestor
110168884|NCT00391638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110168885|NCT00391638|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110168886|NCT00391638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110168887|NCT00391638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110168888|NCT00391638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110168889|NCT00391638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110168890|NCT00391638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110168891|NCT00036361|Aripiprazole|aripiprazole|mesh-list
110168892|NCT00036361|Antidepressive Agents|antidepressive agents|mesh-ancestor
110168893|NCT00036361|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110168894|NCT00036361|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110168895|NCT00036361|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110168896|NCT00036361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110168897|NCT00036361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110168898|NCT00036361|Dopamine Agonists|dopamine agonists|mesh-ancestor
110168899|NCT00036361|Dopamine Agents|dopamine agents|mesh-ancestor
110168900|NCT00036361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110168901|NCT00036361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110168902|NCT00036361|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110168903|NCT00036361|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110168904|NCT00036361|Serotonin Agents|serotonin agents|mesh-ancestor
110168905|NCT00036361|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110168906|NCT00036361|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110168907|NCT00036361|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110168908|NCT00036361|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110168909|NCT00036400|Epoetin Alfa|epoetin alfa|mesh-list
110168910|NCT00036400|Hematinics|hematinics|mesh-ancestor
110168912|NCT00036439|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110168913|NCT00036439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110168914|NCT00036439|Dermatologic Agents|dermatologic agents|mesh-ancestor
110168915|NCT00036439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110168916|NCT00036439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110168917|NCT00000821|Aldesleukin|aldesleukin|mesh-list
110168918|NCT00000821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110168919|NCT00000821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110168920|NCT00000821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110168921|NCT00000821|Antiviral Agents|antiviral agents|mesh-ancestor
110168922|NCT00000821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110168924|NCT00036556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110168925|NCT00036556|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
110168926|NCT00036556|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110168927|NCT00036556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110168930|NCT00000827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110168931|NCT00036634|Tenofovir|tenofovir|mesh-list
110168932|NCT00036634|Antiviral Agents|antiviral agents|mesh-ancestor
110168933|NCT00036634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110168934|NCT00036634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110168935|NCT00036634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110168936|NCT00036634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110168937|NCT00036634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110168938|NCT00036634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110168939|NCT00036634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110168940|NCT00000851|Stavudine|stavudine|mesh-list
110168941|NCT00000851|Didanosine|didanosine|mesh-list
110168942|NCT00000851|Antimetabolites|antimetabolites|mesh-ancestor
110168943|NCT00000851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110168944|NCT00000851|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110026729|NCT01279668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110026744|NCT01278342|Octreotide|octreotide|mesh-list
110168945|NCT00000851|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110168946|NCT00000851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110168947|NCT00000851|Antiviral Agents|antiviral agents|mesh-ancestor
110168948|NCT00000851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110168949|NCT00000851|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110168950|NCT00000851|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110168951|NCT00036751|Imatinib Mesylate|imatinib mesylate|mesh-list
110168952|NCT00036751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110168953|NCT00036751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110168955|NCT00036751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110168956|NCT00036790|Doxorubicin|doxorubicin|mesh-list
110168957|NCT00036790|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110168958|NCT00036790|Motexafin gadolinium|motexafin gadolinium|mesh-list
110168959|NCT00036790|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110168960|NCT00036790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110168961|NCT00036790|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110168962|NCT00036790|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110168964|NCT00036790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110168965|NCT00036790|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110168966|NCT00036790|Dermatologic Agents|dermatologic agents|mesh-ancestor
110168968|NCT00000857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110168969|NCT00000857|Immunologic Factors|immunologic factors|mesh-ancestor
110168970|NCT00000857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110168971|NCT00000857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110168972|NCT00000857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110168973|NCT00000857|Growth Substances|growth substances|mesh-ancestor
110168974|NCT00000857|Growth Inhibitors|growth inhibitors|mesh-ancestor
110168975|NCT00000857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110168976|NCT00036868|Cyclophosphamide|cyclophosphamide|mesh-list
110168977|NCT00036868|Fluorouracil|fluorouracil|mesh-list
110168978|NCT00036868|Methotrexate|methotrexate|mesh-list
110168979|NCT00036868|Trastuzumab|trastuzumab|mesh-list
110168980|NCT00036868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110168981|NCT00036868|Immunologic Factors|immunologic factors|mesh-ancestor
110168982|NCT00036868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110168983|NCT00036868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110168984|NCT00036868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110168985|NCT00036868|Alkylating Agents|alkylating agents|mesh-ancestor
110168986|NCT00036868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110168987|NCT00036868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110168988|NCT00036868|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110168990|NCT00036868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110026757|NCT01277718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110026758|NCT01277718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110026762|NCT01276236|Maraviroc|maraviroc|mesh-list
110168991|NCT00036868|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110168992|NCT00036868|Abortifacient Agents|abortifacient agents|mesh-ancestor
110168993|NCT00036868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110168994|NCT00036868|Dermatologic Agents|dermatologic agents|mesh-ancestor
110168995|NCT00036868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110168996|NCT00036868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110168997|NCT00036868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110168998|NCT00036868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110169000|NCT00036946|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110169001|NCT00036946|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110169002|NCT00036946|Growth Substances|growth substances|mesh-ancestor
110169003|NCT00036946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110169004|NCT00036946|Growth Inhibitors|growth inhibitors|mesh-ancestor
110169005|NCT00036946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110169006|NCT00036985|Cyclophosphamide|cyclophosphamide|mesh-list
110169007|NCT00036985|Doxorubicin|doxorubicin|mesh-list
110169008|NCT00036985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110169009|NCT00036985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110169010|NCT00036985|Immunologic Factors|immunologic factors|mesh-ancestor
110169011|NCT00036985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110169012|NCT00036985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110169013|NCT00036985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110169014|NCT00036985|Alkylating Agents|alkylating agents|mesh-ancestor
110169015|NCT00036985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110169016|NCT00036985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110169017|NCT00036985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110169018|NCT00036985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110169019|NCT00036985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110169020|NCT00036985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110169021|NCT00036985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110169022|NCT00037063|Ascorbic Acid|ascorbic acid|mesh-list
110169023|NCT00037063|Vitamin E|vitamin e|mesh-list
110169024|NCT00037063|Riboflavin|riboflavin|mesh-list
110169025|NCT00037063|Thiamine|thiamine|mesh-list
110169026|NCT00037063|Vitamins|vitamins|mesh-ancestor
110169027|NCT00037063|Micronutrients|micronutrients|mesh-ancestor
110169028|NCT00037063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110169029|NCT00037063|Antioxidants|antioxidants|mesh-ancestor
110169030|NCT00037063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110169031|NCT00037063|Protective Agents|protective agents|mesh-ancestor
110169032|NCT00037063|Vitamin B Complex|vitamin b complex|mesh-ancestor
110169033|NCT00037063|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110169034|NCT00037063|Dermatologic Agents|dermatologic agents|mesh-ancestor
110169036|NCT00000869|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110169037|NCT00000869|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110169038|NCT00000869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110169039|NCT00000869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110169040|NCT00000869|Antiviral Agents|antiviral agents|mesh-ancestor
110169043|NCT00000869|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110169044|NCT00000869|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110169045|NCT00000869|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110169046|NCT00037102|Interferons|interferons|mesh-list
110169047|NCT00037102|Interferon-beta|interferon-beta|mesh-list
110169048|NCT00037102|Interferon beta-1a|interferon beta-1a|mesh-list
110169049|NCT00037102|Methotrexate|methotrexate|mesh-list
110169050|NCT00037102|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110169051|NCT00037102|Abortifacient Agents|abortifacient agents|mesh-ancestor
110169052|NCT00037102|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110169053|NCT00037102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110169054|NCT00037102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110169055|NCT00037102|Antimetabolites|antimetabolites|mesh-ancestor
110169056|NCT00037102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110169057|NCT00037102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110169058|NCT00037102|Dermatologic Agents|dermatologic agents|mesh-ancestor
110169059|NCT00037102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110169060|NCT00037102|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110169061|NCT00037102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110169062|NCT00037102|Immunologic Factors|immunologic factors|mesh-ancestor
110169063|NCT00037102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110169064|NCT00037102|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110169065|NCT00037102|Antiviral Agents|antiviral agents|mesh-ancestor
110169066|NCT00037102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110169067|NCT00037102|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110169069|NCT00037141|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110169070|NCT00037141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110169071|NCT00037141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110169072|NCT00037141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110169073|NCT00037180|Leucovorin|leucovorin|mesh-list
110169074|NCT00037180|Celecoxib|celecoxib|mesh-list
110169075|NCT00037180|Fluorouracil|fluorouracil|mesh-list
110169078|NCT00037180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110169079|NCT00037180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110169080|NCT00037180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110169081|NCT00037180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110169082|NCT00037180|Immunologic Factors|immunologic factors|mesh-ancestor
110169083|NCT00037180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110169084|NCT00037180|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110169085|NCT00037180|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110169086|NCT00037180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110169087|NCT00037180|Antidotes|antidotes|mesh-ancestor
110169088|NCT00037180|Protective Agents|protective agents|mesh-ancestor
110391619|NCT03222531|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
110391621|NCT03222531|Antiviral Agents|antiviral agents|mesh-ancestor
110391622|NCT03222531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110391623|NCT03208452|Magnesium Sulfate|magnesium sulfate|mesh-list
110391624|NCT03208452|Analgesics|analgesics|mesh-ancestor
110391625|NCT03208452|Sensory System Agents|sensory system agents|mesh-ancestor
110026808|NCT01271010|Alkylating Agents|alkylating agents|mesh-ancestor
110026809|NCT01271010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110026810|NCT01271010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110026811|NCT01271010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110026812|NCT01271010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110026813|NCT01270620|Propofol|propofol|mesh-list
110026814|NCT01270620|Desflurane|desflurane|mesh-list
110026815|NCT01270620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110391630|NCT03208452|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110391632|NCT03208452|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110391633|NCT03208452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110391634|NCT03208452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391635|NCT03208452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110391636|NCT03208452|Tocolytic Agents|tocolytic agents|mesh-ancestor
110391637|NCT03208452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110391638|NCT03190265|Cyclophosphamide|cyclophosphamide|mesh-list
110391640|NCT03190265|Ipilimumab|ipilimumab|mesh-list
110391641|NCT03190265|Pancrelipase|pancrelipase|mesh-list
110391642|NCT03190265|Vaccines|vaccines|mesh-list
110391643|NCT03190265|Immunologic Factors|immunologic factors|mesh-ancestor
110391644|NCT03190265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110391645|NCT03190265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110391646|NCT03190265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110391647|NCT03190265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110391648|NCT03190265|Alkylating Agents|alkylating agents|mesh-ancestor
110391649|NCT03190265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391650|NCT03190265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110391651|NCT03190265|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110391652|NCT03190265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110391653|NCT03190265|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110391654|NCT03190265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110391655|NCT03180502|Temozolomide|temozolomide|mesh-list
110391656|NCT03180502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110391657|NCT03180502|Alkylating Agents|alkylating agents|mesh-ancestor
110391658|NCT03180502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391659|NCT03180502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110391660|NCT03150329|Pembrolizumab|pembrolizumab|mesh-list
110391661|NCT03150329|Vorinostat|vorinostat|mesh-list
110391662|NCT03150329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110391663|NCT03150329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110391664|NCT03150329|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110391665|NCT03150329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391666|NCT03150329|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110391667|NCT03150329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110391674|NCT02882282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110391675|NCT02882282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110391676|NCT02882282|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110391677|NCT02882282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391678|NCT02872116|Leucovorin|leucovorin|mesh-list
110391679|NCT02872116|Fluorouracil|fluorouracil|mesh-list
110391680|NCT02872116|Capecitabine|capecitabine|mesh-list
110391681|NCT02872116|Oxaliplatin|oxaliplatin|mesh-list
110391682|NCT02872116|Nivolumab|nivolumab|mesh-list
110391683|NCT02872116|Ipilimumab|ipilimumab|mesh-list
110391684|NCT02872116|Antimetabolites|antimetabolites|mesh-ancestor
110391685|NCT02872116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391686|NCT02872116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110391687|NCT02872116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110391688|NCT02872116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110391689|NCT02872116|Immunologic Factors|immunologic factors|mesh-ancestor
110391690|NCT02872116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110391691|NCT02872116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110391692|NCT02872116|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110391693|NCT02872116|Antidotes|antidotes|mesh-ancestor
110391694|NCT02872116|Protective Agents|protective agents|mesh-ancestor
110391695|NCT02872116|Vitamin B Complex|vitamin b complex|mesh-ancestor
110391696|NCT02872116|Vitamins|vitamins|mesh-ancestor
110391698|NCT02668666|Tamoxifen|tamoxifen|mesh-list
110391699|NCT02668666|Palbociclib|palbociclib|mesh-list
110391700|NCT02668666|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110391701|NCT02668666|Hormone Antagonists|hormone antagonists|mesh-ancestor
110391702|NCT02668666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110391703|NCT02668666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110391704|NCT02668666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110391705|NCT02668666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110391706|NCT02668666|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110391707|NCT02668666|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110391708|NCT02668666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110391709|NCT02668666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110391710|NCT02668666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110391711|NCT02668666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391712|NCT02615691|Factor VIII|factor viii|mesh-list
110391713|NCT02615691|BAX 855|bax 855|mesh-list
110391714|NCT02615691|Coagulants|coagulants|mesh-ancestor
110391715|NCT02530463|Nivolumab|nivolumab|mesh-list
110391716|NCT02530463|Ipilimumab|ipilimumab|mesh-list
110391717|NCT02530463|Azacitidine|azacitidine|mesh-list
110026842|NCT01270152|Ascorbic Acid|ascorbic acid|mesh-list
110391718|NCT02530463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110391719|NCT02530463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110391720|NCT02530463|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110391721|NCT02530463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391722|NCT02530463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110391723|NCT02530463|Antimetabolites|antimetabolites|mesh-ancestor
110391724|NCT02530463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110391725|NCT02446964|Mycophenolic Acid|mycophenolic acid|mesh-list
110391726|NCT02446964|Cyclophosphamide|cyclophosphamide|mesh-list
110391727|NCT02446964|Fludarabine|fludarabine|mesh-list
110391728|NCT02446964|Fludarabine phosphate|fludarabine phosphate|mesh-list
110391729|NCT02446964|Tacrolimus|tacrolimus|mesh-list
110391730|NCT02446964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110391731|NCT02446964|Immunologic Factors|immunologic factors|mesh-ancestor
110391732|NCT02446964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110391733|NCT02446964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110391734|NCT02446964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110391735|NCT02446964|Alkylating Agents|alkylating agents|mesh-ancestor
110391736|NCT02446964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391737|NCT02446964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110391738|NCT02446964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110391739|NCT02446964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110391740|NCT02446964|Antimetabolites|antimetabolites|mesh-ancestor
110391741|NCT02446964|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110391742|NCT02446964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110391743|NCT02446964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110391744|NCT02446964|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110391745|NCT02446964|Antitubercular Agents|antitubercular agents|mesh-ancestor
110391746|NCT02446964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110391747|NCT02446964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110391748|NCT02429570|Meclofenamic Acid|meclofenamic acid|mesh-list
110391749|NCT02429570|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110391750|NCT02429570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110391751|NCT02429570|Analgesics|analgesics|mesh-ancestor
110391752|NCT02429570|Sensory System Agents|sensory system agents|mesh-ancestor
110391753|NCT02429570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110391754|NCT02429570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110391755|NCT02429570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110391756|NCT02429570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110391757|NCT02429570|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110391758|NCT02429570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110391759|NCT02429570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391760|NCT02159495|Cyclophosphamide|cyclophosphamide|mesh-list
110391761|NCT02159495|Fludarabine|fludarabine|mesh-list
110391762|NCT02159495|Fludarabine phosphate|fludarabine phosphate|mesh-list
110391763|NCT02159495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110391764|NCT02159495|Immunologic Factors|immunologic factors|mesh-ancestor
110391765|NCT02159495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110391766|NCT02159495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110391767|NCT02159495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110391768|NCT02159495|Alkylating Agents|alkylating agents|mesh-ancestor
110391769|NCT02159495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391770|NCT02159495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110391771|NCT02159495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110391772|NCT02159495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110391773|NCT02159495|Antimetabolites|antimetabolites|mesh-ancestor
110391774|NCT01977417|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
110391775|NCT01977417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110391776|NCT01977417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110391777|NCT01977417|Analgesics|analgesics|mesh-ancestor
110391778|NCT01977417|Sensory System Agents|sensory system agents|mesh-ancestor
110391779|NCT01977417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110391780|NCT01977417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110391781|NCT01977417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110391782|NCT01977417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110391783|NCT01972919|Gemcitabine|gemcitabine|mesh-list
110391784|NCT01972919|Capecitabine|capecitabine|mesh-list
110391785|NCT01972919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110391786|NCT01972919|Antimetabolites|antimetabolites|mesh-ancestor
110391787|NCT01972919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391788|NCT01972919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110391789|NCT01969578|Paclitaxel|paclitaxel|mesh-list
110391790|NCT01969578|Carboplatin|carboplatin|mesh-list
110391791|NCT01969578|Doxorubicin|doxorubicin|mesh-list
110391792|NCT01969578|Bicalutamide|bicalutamide|mesh-list
110391793|NCT01969578|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110391794|NCT01969578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110391795|NCT01969578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110391796|NCT01969578|Tubulin Modulators|tubulin modulators|mesh-ancestor
110391797|NCT01969578|Antimitotic Agents|antimitotic agents|mesh-ancestor
110391798|NCT01969578|Mitosis Modulators|mitosis modulators|mesh-ancestor
110391799|NCT01969578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391800|NCT01969578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110391801|NCT01969578|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110391802|NCT01969578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110391803|NCT01969578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110391804|NCT01969578|Androgen Antagonists|androgen antagonists|mesh-ancestor
110391805|NCT01969578|Hormone Antagonists|hormone antagonists|mesh-ancestor
110391806|NCT01969578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110391807|NCT01969578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110391808|NCT01969578|Luteolytic Agents|luteolytic agents|mesh-ancestor
110391809|NCT01969578|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110391810|NCT01969578|Contraceptive Agents|contraceptive agents|mesh-ancestor
110391811|NCT01969578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110391812|NCT01969578|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110391813|NCT01969578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110391814|NCT01951885|Mycophenolic Acid|mycophenolic acid|mesh-list
110391815|NCT01951885|Methotrexate|methotrexate|mesh-list
110391816|NCT01951885|Tacrolimus|tacrolimus|mesh-list
110391817|NCT01951885|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110391818|NCT01951885|Abortifacient Agents|abortifacient agents|mesh-ancestor
110391819|NCT01951885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110391820|NCT01951885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110391822|NCT01951885|Antimetabolites|antimetabolites|mesh-ancestor
110391823|NCT01951885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391824|NCT01951885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110391826|NCT01951885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110391827|NCT01951885|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110391828|NCT01951885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110391829|NCT01951885|Immunologic Factors|immunologic factors|mesh-ancestor
110391830|NCT01951885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110391831|NCT01951885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110391832|NCT01951885|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110391833|NCT01951885|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110391834|NCT01951885|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110391835|NCT01951885|Antitubercular Agents|antitubercular agents|mesh-ancestor
110391836|NCT01951885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110391837|NCT01951885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110391838|NCT01810588|Mycophenolic Acid|mycophenolic acid|mesh-list
110391840|NCT01810588|Fludarabine|fludarabine|mesh-list
110391841|NCT01810588|Fludarabine phosphate|fludarabine phosphate|mesh-list
110391842|NCT01810588|Melphalan|melphalan|mesh-list
110391843|NCT01810588|Tacrolimus|tacrolimus|mesh-list
110391844|NCT01810588|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110391845|NCT01810588|Thymoglobulin|thymoglobulin|mesh-list
110391846|NCT01810588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110391847|NCT01810588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110391848|NCT01810588|Immunologic Factors|immunologic factors|mesh-ancestor
110391849|NCT01810588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110391850|NCT01810588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110391851|NCT01810588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110391852|NCT01810588|Antimetabolites|antimetabolites|mesh-ancestor
110391853|NCT01810588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391854|NCT01810588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110391855|NCT01810588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110391856|NCT01810588|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110391857|NCT01810588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110391858|NCT01810588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110391859|NCT01810588|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110391860|NCT01810588|Antitubercular Agents|antitubercular agents|mesh-ancestor
110391861|NCT01810588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110391862|NCT01810588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110391863|NCT01810588|Alkylating Agents|alkylating agents|mesh-ancestor
110391864|NCT01810588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110391865|NCT01698840|Vitamin D|vitamin d|mesh-list
110391866|NCT01698840|Vitamins|vitamins|mesh-ancestor
110391867|NCT01698840|Micronutrients|micronutrients|mesh-ancestor
110391868|NCT01698840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110391869|NCT01698840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110391870|NCT01500551|Tofacitinib|tofacitinib|mesh-list
110391871|NCT01500551|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110391872|NCT01500551|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110391873|NCT01500551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110391874|NCT01500551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391875|NCT01499888|Sirolimus|sirolimus|mesh-list
110391876|NCT01499888|Alemtuzumab|alemtuzumab|mesh-list
110026920|NCT00247416|Carboplatin|carboplatin|mesh-list
110026921|NCT00247416|Gemcitabine|gemcitabine|mesh-list
110391877|NCT01499888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110391878|NCT01499888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110391879|NCT01499888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110391880|NCT01499888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110391881|NCT01499888|Antifungal Agents|antifungal agents|mesh-ancestor
110391882|NCT01499888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110391883|NCT01499888|Immunologic Factors|immunologic factors|mesh-ancestor
110391884|NCT01499888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110391885|NCT01499888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110391887|NCT00745316|Adenosine A1 Receptor Antagonists|adenosine a1 receptor antagonists|mesh-list
110391888|NCT00745316|Analgesics|analgesics|mesh-ancestor
110391889|NCT00745316|Sensory System Agents|sensory system agents|mesh-ancestor
110391890|NCT00745316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110391891|NCT00745316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110391892|NCT00745316|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110391893|NCT00745316|Vasodilator Agents|vasodilator agents|mesh-ancestor
110391894|NCT00745316|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110391895|NCT00745316|Purinergic Agonists|purinergic agonists|mesh-ancestor
110391896|NCT00745316|Purinergic Agents|purinergic agents|mesh-ancestor
110391897|NCT00745316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110391898|NCT00745316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391899|NCT00745316|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110391900|NCT00745316|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110391901|NCT00709865|1,3-dipropyl-8-(2-(5,6-epoxy)norbornyl)xanthine|1,3-dipropyl-8-(2-(5,6-epoxy)norbornyl)xanthine|mesh-list
110391902|NCT00709865|Adenosine A1 Receptor Antagonists|adenosine a1 receptor antagonists|mesh-ancestor
110391903|NCT00709865|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110046042|NCT05785767|Cemiplimab|cemiplimab|mesh-list
110391905|NCT00709865|Purinergic Agents|purinergic agents|mesh-ancestor
110391906|NCT00709865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110391907|NCT00709865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391908|NCT00709865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110391909|NCT00682318|Ethanol|ethanol|mesh-list
110391910|NCT00682318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110391911|NCT00682318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110391912|NCT00682318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110391913|NCT00682318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110391914|NCT00626990|Temozolomide|temozolomide|mesh-list
110391915|NCT00626990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110391917|NCT00626990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391918|NCT00626990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110391919|NCT00107198|Prednisone|prednisone|mesh-list
110391920|NCT00107198|Cortisone|cortisone|mesh-list
110391921|NCT00107198|Cyclophosphamide|cyclophosphamide|mesh-list
110391922|NCT00107198|Doxorubicin|doxorubicin|mesh-list
110391923|NCT00107198|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110391924|NCT00107198|Vincristine|vincristine|mesh-list
110391925|NCT00107198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110391926|NCT00107198|Immunologic Factors|immunologic factors|mesh-ancestor
110391927|NCT00107198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110391928|NCT00107198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110026939|NCT00246012|Alkylating Agents|alkylating agents|mesh-ancestor
110391929|NCT00107198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110391930|NCT00107198|Alkylating Agents|alkylating agents|mesh-ancestor
110391931|NCT00107198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391932|NCT00107198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110391933|NCT00107198|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110391934|NCT00107198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110391935|NCT00107198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110391936|NCT00107198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110391937|NCT00107198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110391938|NCT00107198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110391939|NCT00107198|Glucocorticoids|glucocorticoids|mesh-ancestor
110391941|NCT00107198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110391942|NCT00107198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110391943|NCT00107198|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110391944|NCT00107198|Tubulin Modulators|tubulin modulators|mesh-ancestor
110391945|NCT00107198|Antimitotic Agents|antimitotic agents|mesh-ancestor
110391946|NCT00107198|Mitosis Modulators|mitosis modulators|mesh-ancestor
110391947|NCT01601106|Prednisolone|prednisolone|mesh-list
110391948|NCT01601106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110391949|NCT01601106|Glucocorticoids|glucocorticoids|mesh-ancestor
110391950|NCT01601106|Hormones|hormones|mesh-ancestor
110391951|NCT01601106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110391952|NCT01601106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110391953|NCT01601106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110391954|NCT01601106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110391955|NCT02750540|Tenofovir|tenofovir|mesh-list
110391956|NCT02750540|Antiviral Agents|antiviral agents|mesh-ancestor
110391957|NCT02750540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110391958|NCT02750540|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110391959|NCT02750540|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110391960|NCT02750540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110391961|NCT02750540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391962|NCT02750540|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110391963|NCT02750540|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110391964|NCT01601184|Temozolomide|temozolomide|mesh-list
110391965|NCT01601184|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110391966|NCT01601184|Alkylating Agents|alkylating agents|mesh-ancestor
110391967|NCT01601184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391968|NCT01601184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110391969|NCT01643759|Buprenorphine|buprenorphine|mesh-list
110391970|NCT01643759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110391971|NCT01643759|Narcotics|narcotics|mesh-ancestor
110391972|NCT01643759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110391973|NCT01643759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110391974|NCT01643759|Analgesics|analgesics|mesh-ancestor
110391975|NCT01643759|Sensory System Agents|sensory system agents|mesh-ancestor
110391976|NCT01643759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110391977|NCT01643759|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110391978|NCT04488237|Vitamin D|vitamin d|mesh-list
110391981|NCT04488237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110391982|NCT04488237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110391983|NCT04528628|Norepinephrine|norepinephrine|mesh-list
110391984|NCT04528628|Serotonin|serotonin|mesh-list
110391985|NCT04528628|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
110026960|NCT00242580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110391986|NCT04528628|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
110391987|NCT04528628|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110391988|NCT04528628|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110391989|NCT04528628|Adrenergic Agents|adrenergic agents|mesh-ancestor
110391990|NCT04528628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110391991|NCT04528628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391992|NCT04528628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110391993|NCT04528628|Sympathomimetics|sympathomimetics|mesh-ancestor
110391994|NCT04528628|Autonomic Agents|autonomic agents|mesh-ancestor
110391995|NCT04528628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110391996|NCT04528628|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110391997|NCT04528628|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110391998|NCT04528628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110391999|NCT04528628|Serotonin Agents|serotonin agents|mesh-ancestor
110392000|NCT04528628|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110392001|NCT01641341|Nitazoxanide|nitazoxanide|mesh-list
110392002|NCT01641341|Pancrelipase|pancrelipase|mesh-list
110392003|NCT01641341|Pancreatin|pancreatin|mesh-list
110392004|NCT01641341|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110392005|NCT01641341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110392006|NCT01641341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110392007|NCT01680107|Cycloserine|cycloserine|mesh-list
110392008|NCT01680107|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110392009|NCT01680107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110392010|NCT01680107|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110392011|NCT01680107|Antitubercular Agents|antitubercular agents|mesh-ancestor
110392012|NCT01680107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110392013|NCT01680107|Antimetabolites|antimetabolites|mesh-ancestor
110392014|NCT01680107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110392015|NCT01680146|Caseins|caseins|mesh-list
110392016|NCT01680146|Chelating Agents|chelating agents|mesh-ancestor
110392017|NCT01680146|Sequestering Agents|sequestering agents|mesh-ancestor
110392018|NCT01680146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110392019|NCT01680185|Insulin|insulin|mesh-list
110392020|NCT01680185|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110392021|NCT01680185|Insulin Lispro|insulin lispro|mesh-list
110392022|NCT01680185|Isophane Insulin, Human|isophane insulin, human|mesh-list
110392023|NCT01680185|Insulin, Isophane|insulin, isophane|mesh-list
110392024|NCT01680185|Isophane insulin, beef|isophane insulin, beef|mesh-list
110392025|NCT01680185|Insulin, Short-Acting|insulin, short-acting|mesh-list
110392026|NCT01680185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110392027|NCT01680185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110392028|NCT01680263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110392029|NCT01680263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
110392030|NCT01680263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110392031|NCT01680263|Analgesics|analgesics|mesh-ancestor
110392032|NCT01680263|Sensory System Agents|sensory system agents|mesh-ancestor
110392033|NCT01680263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110392034|NCT01680263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110392035|NCT01680263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110392036|NCT01601730|Dexetimide|dexetimide|mesh-list
110392037|NCT01601730|Modafinil|modafinil|mesh-list
110392038|NCT01601730|Citalopram|citalopram|mesh-list
110392039|NCT01601730|Escitalopram|escitalopram|mesh-list
110392040|NCT01601730|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110392041|NCT01601730|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110026980|NCT03804840|Dronabinol|dronabinol|mesh-list
110392042|NCT01601730|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110392043|NCT01601730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110392044|NCT01601730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110392046|NCT01601730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110392047|NCT01601730|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110392048|NCT01601730|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110392049|NCT01601730|Parasympatholytics|parasympatholytics|mesh-ancestor
110392050|NCT01601730|Autonomic Agents|autonomic agents|mesh-ancestor
110392051|NCT01601730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110392052|NCT01601730|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110392053|NCT01601730|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110392054|NCT01601730|Cholinergic Agents|cholinergic agents|mesh-ancestor
110392055|NCT01601730|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110392056|NCT01601730|Antidepressive Agents|antidepressive agents|mesh-ancestor
110392057|NCT01601730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110392058|NCT01601730|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110392059|NCT01601730|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110392060|NCT01601730|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110392061|NCT01601730|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110392063|NCT01644071|Citalopram|citalopram|mesh-list
110392064|NCT01644071|Escitalopram|escitalopram|mesh-list
110392065|NCT01644071|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110392066|NCT01644071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110392067|NCT01644071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110392068|NCT01644071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110392069|NCT01644071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110392070|NCT01644071|Serotonin Agents|serotonin agents|mesh-ancestor
110392071|NCT01644071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110392072|NCT01644071|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110392073|NCT01644071|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110392074|NCT01644071|Parasympatholytics|parasympatholytics|mesh-ancestor
110392075|NCT01644071|Autonomic Agents|autonomic agents|mesh-ancestor
110026996|NCT03804372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110026997|NCT03804372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110392076|NCT01644071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110392077|NCT01644071|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110392078|NCT01644071|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110392079|NCT01644071|Cholinergic Agents|cholinergic agents|mesh-ancestor
110392080|NCT01644071|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110392081|NCT01644071|Antidepressive Agents|antidepressive agents|mesh-ancestor
110392082|NCT01644071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110392083|NCT01680536|Maraviroc|maraviroc|mesh-list
110392084|NCT01680536|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110392085|NCT01680536|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110392086|NCT01680536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110392087|NCT01680536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110392088|NCT01680536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110392089|NCT01680536|Antiviral Agents|antiviral agents|mesh-ancestor
110392090|NCT01680536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110392091|NCT01680536|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110392092|NCT01602003|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110392093|NCT01602003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110392094|NCT01602003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110392096|NCT01602003|Hormones|hormones|mesh-ancestor
110392097|NCT01602003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110392098|NCT01602003|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110392099|NCT01602003|Protease Inhibitors|protease inhibitors|mesh-ancestor
110392100|NCT01602003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110392101|NCT01602003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110392102|NCT01193920|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110392103|NCT01193920|Vaccines|vaccines|mesh-list
110392104|NCT01193920|Immunologic Factors|immunologic factors|mesh-ancestor
110392105|NCT01193920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110392106|NCT01644773|Dasatinib|dasatinib|mesh-list
110392107|NCT01644773|Crizotinib|crizotinib|mesh-list
110392108|NCT01644773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110392109|NCT01644773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110392110|NCT01644773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110392111|NCT01644773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110392112|NCT01602588|Hydroxychloroquine|hydroxychloroquine|mesh-list
110392113|NCT01602588|Antimalarials|antimalarials|mesh-ancestor
110392114|NCT01602588|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110392115|NCT01602588|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110392116|NCT01602588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110392117|NCT01602588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110392118|NCT01602588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110392119|NCT01602588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110392120|NCT01681550|Incretins|incretins|mesh-list
110392121|NCT01681550|Hormones|hormones|mesh-ancestor
110392122|NCT01681550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110392123|NCT01681550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110392124|NCT01645085|Mannitol|mannitol|mesh-list
110392125|NCT01645085|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110392126|NCT01645085|Diuretics|diuretics|mesh-ancestor
110392127|NCT01645085|Natriuretic Agents|natriuretic agents|mesh-ancestor
110392128|NCT01645085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110392130|NCT01645124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110392131|NCT01645124|Antisickling Agents|antisickling agents|mesh-ancestor
110392132|NCT01645124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110392133|NCT01645124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110392134|NCT01645124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110392136|NCT01602861|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110392137|NCT01602861|Hormone Antagonists|hormone antagonists|mesh-ancestor
110392138|NCT01602861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110392139|NCT01602861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110392140|NCT01602861|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110392141|NCT01602861|Diuretics|diuretics|mesh-ancestor
110392142|NCT01602861|Natriuretic Agents|natriuretic agents|mesh-ancestor
110392144|NCT01681667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110392145|NCT01681667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110392146|NCT01681667|Analgesics|analgesics|mesh-ancestor
110392147|NCT01681667|Sensory System Agents|sensory system agents|mesh-ancestor
110392148|NCT01681667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110392149|NCT01681667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110392150|NCT01681667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110392151|NCT01681667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110392152|NCT01681667|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110392153|NCT01681667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110392154|NCT01681667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110392155|NCT01600365|Ganciclovir|ganciclovir|mesh-list
110392156|NCT01600365|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
110392157|NCT01600365|Lubricant Eye Drops|lubricant eye drops|mesh-list
110392158|NCT01600365|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110392159|NCT01600365|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110392160|NCT01600365|Antiviral Agents|antiviral agents|mesh-ancestor
110392161|NCT01600365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110392162|NCT01600365|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110392163|NCT01600365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110392164|NCT01600365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110392165|NCT01602900|Rolipram|rolipram|mesh-list
110392166|NCT01602900|Antidepressive Agents|antidepressive agents|mesh-ancestor
110392167|NCT01602900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110392168|NCT01602900|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110392169|NCT01602900|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110392170|NCT01602900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110392171|NCT01602900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110392172|NCT01645241|Ganirelix|ganirelix|mesh-list
110392173|NCT01645241|Hormone Antagonists|hormone antagonists|mesh-ancestor
110392174|NCT01645241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110392175|NCT01645241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110392176|NCT01602939|Cladribine|cladribine|mesh-list
110392177|NCT01602939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110392178|NCT01602939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110392179|NCT01602939|Immunologic Factors|immunologic factors|mesh-ancestor
110392180|NCT01602939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110392181|NCT01600404|Muscarinic Antagonists|muscarinic antagonists|mesh-list
110392182|NCT01600404|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110392183|NCT01600404|Cholinergic Agents|cholinergic agents|mesh-ancestor
110392184|NCT01600404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110392185|NCT01600404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110392186|NCT01600404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110392187|NCT01603134|Allopurinol|allopurinol|mesh-list
110392188|NCT01603134|Antimetabolites|antimetabolites|mesh-ancestor
110392189|NCT01603134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110392190|NCT01603134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110392191|NCT01603134|Gout Suppressants|gout suppressants|mesh-ancestor
110392192|NCT01603134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110392193|NCT01603134|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110392194|NCT01603134|Antioxidants|antioxidants|mesh-ancestor
110392195|NCT01603134|Protective Agents|protective agents|mesh-ancestor
110392196|NCT01603134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110392197|NCT01603173|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110392198|NCT01603173|Antidepressive Agents|antidepressive agents|mesh-ancestor
110392199|NCT01603173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110392200|NCT01603173|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110392201|NCT01603173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110392202|NCT01603173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110392203|NCT01603173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110392204|NCT01603212|Interferons|interferons|mesh-list
110392205|NCT01603212|Interferon-alpha|interferon-alpha|mesh-list
110392206|NCT01603212|Interferon alpha-2|interferon alpha-2|mesh-list
110392207|NCT01603212|Aldesleukin|aldesleukin|mesh-list
110392208|NCT01603212|Interleukin-2|interleukin-2|mesh-list
110392209|NCT01603212|Vemurafenib|vemurafenib|mesh-list
110392210|NCT01603212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110392211|NCT01603212|Antiviral Agents|antiviral agents|mesh-ancestor
110392212|NCT01603212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110392213|NCT01603212|Immunologic Factors|immunologic factors|mesh-ancestor
110392214|NCT01603212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110392215|NCT01603212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110392216|NCT01603212|Analgesics|analgesics|mesh-ancestor
110392217|NCT01603212|Sensory System Agents|sensory system agents|mesh-ancestor
110392218|NCT01603212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110392219|NCT01603212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110392220|NCT01603212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110392221|NCT01603212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110392222|NCT01603212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110392223|NCT01603212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110392224|NCT01645748|Cisplatin|cisplatin|mesh-list
110392225|NCT01645748|Docetaxel|docetaxel|mesh-list
110392226|NCT01645748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110392227|NCT01645748|Tubulin Modulators|tubulin modulators|mesh-ancestor
110392228|NCT01645748|Antimitotic Agents|antimitotic agents|mesh-ancestor
110392229|NCT01645748|Mitosis Modulators|mitosis modulators|mesh-ancestor
110392230|NCT01645748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110392232|NCT02484924|Ticagrelor|ticagrelor|mesh-list
110392233|NCT02484924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110392234|NCT02484924|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110392235|NCT02484924|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110392236|NCT02484924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110392237|NCT02484924|Purinergic Agents|purinergic agents|mesh-ancestor
110392238|NCT02484924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110392239|NCT02484924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110392240|NCT02484924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110392241|NCT01645826|Diltiazem|diltiazem|mesh-list
110392242|NCT01645826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110392243|NCT01645826|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110392244|NCT01645826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110392245|NCT01645826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110027074|NCT03467256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110392246|NCT01645826|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110392247|NCT01645826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110392248|NCT01645826|Vasodilator Agents|vasodilator agents|mesh-ancestor
110392249|NCT01607034|Pramipexole|pramipexole|mesh-list
110392250|NCT01607034|Antioxidants|antioxidants|mesh-ancestor
110392251|NCT01607034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110392252|NCT01607034|Protective Agents|protective agents|mesh-ancestor
110392253|NCT01607034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110392254|NCT01607034|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110392255|NCT01607034|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110392256|NCT01607034|Dopamine Agonists|dopamine agonists|mesh-ancestor
110392257|NCT01607034|Dopamine Agents|dopamine agents|mesh-ancestor
110392258|NCT01607034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110392259|NCT01603251|Ivermectin|ivermectin|mesh-list
110392260|NCT01603251|Lumefantrine|lumefantrine|mesh-list
110392261|NCT01603251|Artemether|artemether|mesh-list
110392262|NCT01603251|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110392263|NCT01603251|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110392264|NCT01603251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110392265|NCT01603251|Antimalarials|antimalarials|mesh-ancestor
110392266|NCT01603251|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110392267|NCT01646294|Mirabegron|mirabegron|mesh-list
110392268|NCT01646294|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110392269|NCT01646294|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110392270|NCT01646294|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110392271|NCT01646294|Adrenergic Agents|adrenergic agents|mesh-ancestor
110392272|NCT01646294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110392273|NCT01646294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110392274|NCT01646294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110392275|NCT01646294|Urological Agents|urological agents|mesh-ancestor
110392276|NCT01603758|Ezetimibe|ezetimibe|mesh-list
110392278|NCT01603758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110392279|NCT01603758|Antimetabolites|antimetabolites|mesh-ancestor
110392280|NCT01603758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110392281|NCT01603758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110392282|NCT01177228|Vedolizumab|vedolizumab|mesh-list
110392283|NCT01177228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110392284|NCT02279342|Febuxostat|febuxostat|mesh-list
110392285|NCT02279342|Gout Suppressants|gout suppressants|mesh-ancestor
110392286|NCT02279342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110392287|NCT01607307|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110392288|NCT02279381|Chlorhexidine|chlorhexidine|mesh-list
110392289|NCT02279381|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110392290|NCT02279381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110392291|NCT02279381|Disinfectants|disinfectants|mesh-ancestor
110392292|NCT01646567|Betamethasone|betamethasone|mesh-list
110392293|NCT01646567|Betamethasone Valerate|betamethasone valerate|mesh-list
110392294|NCT01646567|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
110392295|NCT01646567|Betamethasone benzoate|betamethasone benzoate|mesh-list
110392296|NCT01646567|Calcipotriene|calcipotriene|mesh-list
110392297|NCT01646567|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
110392298|NCT01646567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110392299|NCT01646567|Glucocorticoids|glucocorticoids|mesh-ancestor
110392300|NCT01646567|Hormones|hormones|mesh-ancestor
110392301|NCT01646567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110392302|NCT01646567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110392303|NCT01646567|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110392304|NCT01646567|Respiratory System Agents|respiratory system agents|mesh-ancestor
110392305|NCT01646567|Dermatologic Agents|dermatologic agents|mesh-ancestor
110392306|NCT01681979|Fluticasone|fluticasone|mesh-list
110392307|NCT01681979|Xhance|xhance|mesh-list
110392308|NCT01681979|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110392309|NCT01681979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110392310|NCT01681979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110392311|NCT01681979|Autonomic Agents|autonomic agents|mesh-ancestor
110392312|NCT01681979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110392313|NCT01681979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110392314|NCT01681979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110392315|NCT01681979|Respiratory System Agents|respiratory system agents|mesh-ancestor
110392316|NCT01681979|Dermatologic Agents|dermatologic agents|mesh-ancestor
110392317|NCT01681979|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110392318|NCT01681979|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110392319|NCT01681979|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110392320|NCT01681979|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110392321|NCT01681979|Adrenergic Agents|adrenergic agents|mesh-ancestor
110392322|NCT01681979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110392323|NCT01681979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110392324|NCT01646684|Pasireotide|pasireotide|mesh-list
110392325|NCT01646684|Hormones|hormones|mesh-ancestor
110392326|NCT01646684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110392327|NCT01646684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110392328|NCT01607580|Methylprednisolone|methylprednisolone|mesh-list
110392329|NCT01607580|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110392330|NCT01607580|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110392331|NCT01607580|Prednisolone|prednisolone|mesh-list
110392332|NCT01607580|Prednisolone acetate|prednisolone acetate|mesh-list
110392333|NCT01607580|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110392334|NCT01607580|Prednisolone phosphate|prednisolone phosphate|mesh-list
110392335|NCT01607580|Glucocorticoids|glucocorticoids|mesh-list
110392336|NCT01607580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110392337|NCT01607580|Antiemetics|antiemetics|mesh-ancestor
110392338|NCT01607580|Autonomic Agents|autonomic agents|mesh-ancestor
110392339|NCT01607580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110392340|NCT01607580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110392341|NCT01607580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110392342|NCT01607580|Hormones|hormones|mesh-ancestor
110392343|NCT01607580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110392344|NCT01607580|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110392345|NCT01607580|Protective Agents|protective agents|mesh-ancestor
110392347|NCT01607580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110392348|NCT01647152|Ustekinumab|ustekinumab|mesh-list
110392349|NCT01647152|Dermatologic Agents|dermatologic agents|mesh-ancestor
110392350|NCT01604187|Fentanyl|fentanyl|mesh-list
110392351|NCT01604187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110392352|NCT01604187|Narcotics|narcotics|mesh-ancestor
110392353|NCT01604187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110392354|NCT01604187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110392355|NCT01604187|Analgesics|analgesics|mesh-ancestor
110392356|NCT01604187|Sensory System Agents|sensory system agents|mesh-ancestor
110392357|NCT01604187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110392358|NCT01604187|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110392359|NCT01604187|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110392360|NCT01604187|Anesthetics, General|anesthetics, general|mesh-ancestor
110392361|NCT01604187|Anesthetics|anesthetics|mesh-ancestor
110392362|NCT01604382|Remifentanil|remifentanil|mesh-list
110392363|NCT01604382|Bupivacaine|bupivacaine|mesh-list
110392364|NCT01604382|Anesthetics|anesthetics|mesh-list
110392365|NCT01604382|Propofol|propofol|mesh-list
110392366|NCT01604382|Anesthetics, Local|anesthetics, local|mesh-ancestor
110392367|NCT01604382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110392368|NCT01604382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110392369|NCT01604382|Sensory System Agents|sensory system agents|mesh-ancestor
110392370|NCT01604382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110392371|NCT01604382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110392372|NCT01604382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110392373|NCT01604382|Anesthetics, General|anesthetics, general|mesh-ancestor
110392374|NCT01604382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110392375|NCT01604382|Narcotics|narcotics|mesh-ancestor
110392376|NCT01604382|Analgesics|analgesics|mesh-ancestor
110392377|NCT01682408|Mannitol|mannitol|mesh-list
110392378|NCT01682408|Ranitidine|ranitidine|mesh-list
110392379|NCT01682408|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
110392380|NCT01682408|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110392381|NCT01682408|Diuretics|diuretics|mesh-ancestor
110392382|NCT01682408|Natriuretic Agents|natriuretic agents|mesh-ancestor
110392383|NCT01682408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110392384|NCT01682408|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110392385|NCT01682408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110392386|NCT01682408|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110027160|NCT03215940|Dronabinol|dronabinol|mesh-list
110392387|NCT01682408|Histamine Antagonists|histamine antagonists|mesh-ancestor
110392388|NCT01682408|Histamine Agents|histamine agents|mesh-ancestor
110392389|NCT01682408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110392390|NCT01682408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110392391|NCT01607970|Oxytocin|oxytocin|mesh-list
110392392|NCT01607970|Oxytocics|oxytocics|mesh-ancestor
110392393|NCT01607970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110392394|NCT01607970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110392395|NCT01608009|Paclitaxel|paclitaxel|mesh-list
110392396|NCT01608009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110392397|NCT01608009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110392398|NCT01608009|Tubulin Modulators|tubulin modulators|mesh-ancestor
110392399|NCT01608009|Antimitotic Agents|antimitotic agents|mesh-ancestor
110392400|NCT01608009|Mitosis Modulators|mitosis modulators|mesh-ancestor
110392401|NCT01608009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110392402|NCT01647347|Povidone-Iodine|povidone-iodine|mesh-list
110392403|NCT01647347|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110392404|NCT01647347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110392405|NCT01604031|Lenalidomide|lenalidomide|mesh-list
110392406|NCT01604031|Immunologic Factors|immunologic factors|mesh-ancestor
110392407|NCT01604031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110392408|NCT01604031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110392409|NCT01604031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110392410|NCT01604031|Growth Substances|growth substances|mesh-ancestor
110392411|NCT01604031|Growth Inhibitors|growth inhibitors|mesh-ancestor
110392412|NCT01604031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110392413|NCT01682564|Candesartan cilexetil|candesartan cilexetil|mesh-list
110392414|NCT01682564|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110392415|NCT01682564|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110392416|NCT01682564|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110392417|NCT01682564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110392418|NCT01608360|Lidocaine|lidocaine|mesh-list
110392420|NCT01608360|Anesthetics|anesthetics|mesh-ancestor
110392421|NCT01608360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110392422|NCT01608360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110392423|NCT01608360|Sensory System Agents|sensory system agents|mesh-ancestor
110392424|NCT01608360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110392425|NCT01608360|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110392426|NCT01608360|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110392427|NCT01608360|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110392428|NCT01608360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110392429|NCT01608360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110392431|NCT01647659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110392432|NCT01647659|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110392434|NCT01647659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110392436|NCT01604811|Saw palmetto extract|saw palmetto extract|mesh-list
110392437|NCT01604811|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110392438|NCT01604811|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110392439|NCT01604811|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110392440|NCT01604811|Adrenergic Agents|adrenergic agents|mesh-ancestor
110392441|NCT01604811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110392442|NCT01604811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110392443|NCT01604811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110392444|NCT01604811|Urological Agents|urological agents|mesh-ancestor
110392445|NCT01683032|Methylphenidate|methylphenidate|mesh-list
110392446|NCT01683032|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110392447|NCT01683032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110392448|NCT01683032|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110392449|NCT01683032|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110392450|NCT01683032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110392451|NCT01683032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110392452|NCT01683032|Dopamine Agents|dopamine agents|mesh-ancestor
110392453|NCT01683032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110392454|NCT01604928|Mirabegron|mirabegron|mesh-list
110392455|NCT01604928|Tolterodine Tartrate|tolterodine tartrate|mesh-list
110392456|NCT01604928|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110392457|NCT01604928|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110392458|NCT01604928|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110392459|NCT01604928|Adrenergic Agents|adrenergic agents|mesh-ancestor
110392460|NCT01604928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110392461|NCT01604928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110392462|NCT01604928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110392463|NCT01604928|Urological Agents|urological agents|mesh-ancestor
110392464|NCT01604928|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110392465|NCT01604928|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110392466|NCT01604928|Cholinergic Agents|cholinergic agents|mesh-ancestor
110392468|NCT01683149|Topotecan|topotecan|mesh-list
110392469|NCT01683149|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-list
110392470|NCT01683149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110392471|NCT01683149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110392472|NCT01683149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110392473|NCT01683149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110392474|NCT01683149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110392476|NCT01608555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110392477|NCT01608555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110392478|NCT01605084|Ritonavir|ritonavir|mesh-list
110392479|NCT01605084|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110392480|NCT01605084|Darunavir|darunavir|mesh-list
110392481|NCT01605084|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110027205|NCT03217734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110392482|NCT01605084|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110392483|NCT01605084|Protease Inhibitors|protease inhibitors|mesh-ancestor
110392484|NCT01605084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110392485|NCT01605084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110392486|NCT01605084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110392487|NCT01605084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110392488|NCT01605084|Antiviral Agents|antiviral agents|mesh-ancestor
110392489|NCT01605084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110392490|NCT01605084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110392491|NCT01605084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110392492|NCT01647893|Bivalirudin|bivalirudin|mesh-list
110392493|NCT01647893|Antithrombins|antithrombins|mesh-ancestor
110392494|NCT01647893|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110392496|NCT01647893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110392497|NCT01647893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110392498|NCT01647893|Anticoagulants|anticoagulants|mesh-ancestor
110392500|NCT01648010|Mitomycin|mitomycin|mesh-list
110392501|NCT01648010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110392502|NCT01648010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110392503|NCT01648010|Alkylating Agents|alkylating agents|mesh-ancestor
110392504|NCT01648010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110392505|NCT01648010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110392506|NCT01648010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110392507|NCT01605318|Irinotecan|irinotecan|mesh-list
110392508|NCT01605318|Labetuzumab|labetuzumab|mesh-list
110392509|NCT01605318|Immunoconjugates|immunoconjugates|mesh-list
110392510|NCT01605318|Immunologic Factors|immunologic factors|mesh-ancestor
110392511|NCT01605318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110392512|NCT01605318|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110392513|NCT01605318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110392514|NCT01605318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110392515|NCT01605318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110392516|NCT01605318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110392517|NCT01605318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110392518|NCT01608711|Gemcitabine|gemcitabine|mesh-list
110392519|NCT01608711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110392520|NCT01608711|Antimetabolites|antimetabolites|mesh-ancestor
110392521|NCT01608711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110392522|NCT01608711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110392523|NCT01605357|Mannitol|mannitol|mesh-list
110392524|NCT01605357|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110392525|NCT01605357|Diuretics|diuretics|mesh-ancestor
110392526|NCT01605357|Natriuretic Agents|natriuretic agents|mesh-ancestor
110392527|NCT01605357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110392528|NCT01648127|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
110392529|NCT01648127|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110392530|NCT01648127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110392531|NCT01608750|Folic Acid|folic acid|mesh-list
110392532|NCT01608750|Hematinics|hematinics|mesh-ancestor
110392533|NCT01608750|Vitamin B Complex|vitamin b complex|mesh-ancestor
110392534|NCT01608750|Vitamins|vitamins|mesh-ancestor
110392535|NCT01608750|Micronutrients|micronutrients|mesh-ancestor
110392536|NCT01608750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110392537|NCT01605513|Interferons|interferons|mesh-list
110392538|NCT01605513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110392539|NCT01605513|Antiviral Agents|antiviral agents|mesh-ancestor
110392540|NCT01605513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110392541|NCT04528277|Isoniazid|isoniazid|mesh-list
110392542|NCT04528277|Rifapentine|rifapentine|mesh-list
110392543|NCT04528277|Antitubercular Agents|antitubercular agents|mesh-ancestor
110392544|NCT04528277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110392545|NCT04528277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110392546|NCT04528277|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110392547|NCT04528277|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110392548|NCT04528277|Antimetabolites|antimetabolites|mesh-ancestor
110392549|NCT04528277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110392550|NCT04528277|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110392551|NCT04528277|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110392552|NCT04528277|Leprostatic Agents|leprostatic agents|mesh-ancestor
110392554|NCT01683656|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110392555|NCT01683656|Antimetabolites|antimetabolites|mesh-ancestor
110392556|NCT01683656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110392557|NCT01683656|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110392558|NCT01683656|Vasodilator Agents|vasodilator agents|mesh-ancestor
110392559|NCT01683656|Vitamin B Complex|vitamin b complex|mesh-ancestor
110392560|NCT01683656|Vitamins|vitamins|mesh-ancestor
110392561|NCT01683656|Micronutrients|micronutrients|mesh-ancestor
110392562|NCT01683656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110392563|NCT01605864|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
110392564|NCT01605864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110392565|NCT01605864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110392566|NCT01608945|Hydrocortisone|hydrocortisone|mesh-list
110392567|NCT01608945|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110392568|NCT01608945|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110392569|NCT01608945|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110392570|NCT01608945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110392571|NCT01608984|Sufentanil|sufentanil|mesh-list
110392572|NCT01608984|Isoflurane|isoflurane|mesh-list
110392573|NCT01608984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110392574|NCT01608984|Narcotics|narcotics|mesh-ancestor
110392575|NCT01608984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110392576|NCT01608984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110392577|NCT01608984|Analgesics|analgesics|mesh-ancestor
110392578|NCT01608984|Sensory System Agents|sensory system agents|mesh-ancestor
110392579|NCT01608984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110046731|NCT05011188|Antibodies|antibodies|mesh-list
110027254|NCT03216564|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110392580|NCT01608984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110392584|NCT01608984|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110392585|NCT01648517|Carboplatin|carboplatin|mesh-list
110392586|NCT01648517|Gemcitabine|gemcitabine|mesh-list
110392587|NCT01648517|Docetaxel|docetaxel|mesh-list
110392588|NCT01648517|Vinorelbine|vinorelbine|mesh-list
110392589|NCT01648517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110392590|NCT01648517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110392591|NCT01648517|Antimetabolites|antimetabolites|mesh-ancestor
110392592|NCT01648517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110392593|NCT01648517|Tubulin Modulators|tubulin modulators|mesh-ancestor
110392594|NCT01648517|Antimitotic Agents|antimitotic agents|mesh-ancestor
110392595|NCT01648517|Mitosis Modulators|mitosis modulators|mesh-ancestor
110392596|NCT01648517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110392597|NCT01609101|Cobalt|cobalt|mesh-list
110392598|NCT01609101|Trace Elements|trace elements|mesh-ancestor
110392599|NCT01609101|Micronutrients|micronutrients|mesh-ancestor
110392600|NCT01609101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110392601|NCT01648556|Prednisone|prednisone|mesh-list
110392602|NCT01648556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110392603|NCT01648556|Glucocorticoids|glucocorticoids|mesh-ancestor
110392604|NCT01648556|Hormones|hormones|mesh-ancestor
110392605|NCT01648556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110392606|NCT01648556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110392607|NCT01648556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110392608|NCT01648556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110392609|NCT01648595|Fentanyl|fentanyl|mesh-list
110392610|NCT01648595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110392611|NCT01648595|Narcotics|narcotics|mesh-ancestor
110392612|NCT01648595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110392613|NCT01648595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110392615|NCT01648595|Sensory System Agents|sensory system agents|mesh-ancestor
110392616|NCT01648595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110392617|NCT01648595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110392618|NCT01648595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110392619|NCT01648595|Anesthetics, General|anesthetics, general|mesh-ancestor
110392620|NCT01648595|Anesthetics|anesthetics|mesh-ancestor
110392621|NCT01648634|Nebivolol|nebivolol|mesh-list
110392622|NCT01648634|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110392623|NCT01648634|Vasodilator Agents|vasodilator agents|mesh-ancestor
110392624|NCT01648634|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110392625|NCT01648634|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110392626|NCT01648634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110392627|NCT01648634|Adrenergic Agents|adrenergic agents|mesh-ancestor
110027288|NCT03212820|Sympathomimetics|sympathomimetics|mesh-ancestor
110392629|NCT01648634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110392630|NCT01648634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110392631|NCT01606059|Acetaminophen|acetaminophen|mesh-list
110392632|NCT01606059|Tramadol|tramadol|mesh-list
110392633|NCT01606059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110392634|NCT01606059|Analgesics|analgesics|mesh-ancestor
110392635|NCT01606059|Sensory System Agents|sensory system agents|mesh-ancestor
110392636|NCT01606059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110392637|NCT01606059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110392638|NCT01606059|Antipyretics|antipyretics|mesh-ancestor
110392639|NCT01606059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110392640|NCT01606059|Narcotics|narcotics|mesh-ancestor
110392641|NCT01606059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110392642|NCT01648712|Heparin|heparin|mesh-list
110392643|NCT01648712|Anticoagulants|anticoagulants|mesh-ancestor
110392644|NCT01648712|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110392645|NCT01648712|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110392646|NCT01648712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110392647|NCT01688544|Benzimidazole|benzimidazole|mesh-list
110392648|NCT01688544|Anthelmintics|anthelmintics|mesh-ancestor
110392649|NCT01688544|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110392650|NCT01688544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110392651|NCT01688583|Fentanyl|fentanyl|mesh-list
110392652|NCT01688583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110392653|NCT01688583|Narcotics|narcotics|mesh-ancestor
110392654|NCT01688583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110392655|NCT01688583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110392656|NCT01688583|Analgesics|analgesics|mesh-ancestor
110392657|NCT01688583|Sensory System Agents|sensory system agents|mesh-ancestor
110392658|NCT01688583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110392659|NCT01688583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110392660|NCT01688583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110392661|NCT01688583|Anesthetics, General|anesthetics, general|mesh-ancestor
110392663|NCT01648829|Atorvastatin|atorvastatin|mesh-list
110392664|NCT01648829|Pitavastatin|pitavastatin|mesh-list
110392665|NCT01648829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110392666|NCT01648829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110392667|NCT01648829|Antimetabolites|antimetabolites|mesh-ancestor
110392668|NCT01648829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110392669|NCT01648829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110392670|NCT01648829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110392671|NCT01648829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110392672|NCT01688700|Paclitaxel|paclitaxel|mesh-list
110392673|NCT01688700|Nimotuzumab|nimotuzumab|mesh-list
110392674|NCT01688700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110392675|NCT01688700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110392676|NCT01688700|Tubulin Modulators|tubulin modulators|mesh-ancestor
110392677|NCT01688700|Antimitotic Agents|antimitotic agents|mesh-ancestor
110392678|NCT01688700|Mitosis Modulators|mitosis modulators|mesh-ancestor
110392679|NCT01688700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110392680|NCT01688700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110392682|NCT01684085|Anticonvulsants|anticonvulsants|mesh-ancestor
110392683|NCT01684085|Antiemetics|antiemetics|mesh-ancestor
110392684|NCT01684085|Autonomic Agents|autonomic agents|mesh-ancestor
110392685|NCT01684085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110392686|NCT01684085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110392687|NCT01684085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110392688|NCT01684085|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110392689|NCT01684085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110392690|NCT01684085|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110392691|NCT01684085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110392692|NCT01684085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110392693|NCT01684085|GABA Modulators|gaba modulators|mesh-ancestor
110392694|NCT01684085|GABA Agents|gaba agents|mesh-ancestor
110392695|NCT01684085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110392696|NCT01684085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110392697|NCT01684241|Vaccines|vaccines|mesh-list
110392698|NCT01684241|Immunologic Factors|immunologic factors|mesh-ancestor
110392699|NCT01684241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110392701|NCT01688934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110392702|NCT01688934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110027342|NCT03211104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110392703|NCT01688934|Analgesics|analgesics|mesh-ancestor
110392705|NCT01688934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110392706|NCT01688934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110392707|NCT01688934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110392708|NCT01688934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110392709|NCT01688934|Gout Suppressants|gout suppressants|mesh-ancestor
110392710|NCT01688934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110392711|NCT01688934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110392712|NCT01688934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110392713|NCT01684319|Caseins|caseins|mesh-list
110392714|NCT01684319|Chelating Agents|chelating agents|mesh-ancestor
110392715|NCT01684319|Sequestering Agents|sequestering agents|mesh-ancestor
110392716|NCT01684319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110392717|NCT02279576|Paclitaxel|paclitaxel|mesh-list
110392718|NCT02279576|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110392719|NCT02279576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110392720|NCT02279576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110392721|NCT02279576|Tubulin Modulators|tubulin modulators|mesh-ancestor
110392722|NCT02279576|Antimitotic Agents|antimitotic agents|mesh-ancestor
110392723|NCT02279576|Mitosis Modulators|mitosis modulators|mesh-ancestor
110392724|NCT02279576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110392725|NCT02279615|Tamsulosin|tamsulosin|mesh-list
110392726|NCT02279615|Mirabegron|mirabegron|mesh-list
110392727|NCT02279615|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110392728|NCT02279615|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110392729|NCT02279615|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110392731|NCT02279615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110392732|NCT02279615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110392734|NCT02279615|Urological Agents|urological agents|mesh-ancestor
110392735|NCT02279615|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110392736|NCT02279615|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110392737|NCT02279615|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110392738|NCT01689051|Glucagon|glucagon|mesh-list
110392739|NCT01689051|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110392740|NCT01689051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110392741|NCT01689051|Hormones|hormones|mesh-ancestor
110392742|NCT01689051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110392743|NCT01689051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110392745|NCT01689090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
110392746|NCT01689090|Citric Acid|citric acid|mesh-list
110392747|NCT01689090|Sodium Citrate|sodium citrate|mesh-list
110392748|NCT01689090|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
110392749|NCT01689090|Anticoagulants|anticoagulants|mesh-ancestor
110392750|NCT01689090|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110392751|NCT01689090|Chelating Agents|chelating agents|mesh-ancestor
110392752|NCT01689090|Sequestering Agents|sequestering agents|mesh-ancestor
110392753|NCT01689090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110392754|NCT01689090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110392755|NCT01689090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110392757|NCT01689090|Sensory System Agents|sensory system agents|mesh-ancestor
110392758|NCT01689090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110392759|NCT01689090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110392760|NCT01689090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110392761|NCT01689090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110392762|NCT01689090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110392763|NCT01689129|Insulin|insulin|mesh-list
110392764|NCT01689129|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110392766|NCT01689129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110392767|NCT01689129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110392768|NCT01689285|Valacyclovir|valacyclovir|mesh-list
110392769|NCT01689285|Antiviral Agents|antiviral agents|mesh-ancestor
110392770|NCT01689285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110392771|NCT01606527|Ibuprofen|ibuprofen|mesh-list
110392772|NCT01606527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110392773|NCT01606527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110392774|NCT01606527|Analgesics|analgesics|mesh-ancestor
110392775|NCT01606527|Sensory System Agents|sensory system agents|mesh-ancestor
110392776|NCT01606527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110392777|NCT01606527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110392778|NCT01606527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110392779|NCT01606527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110392780|NCT01606527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110392781|NCT01606527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110392782|NCT01606527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110392783|NCT01609335|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110392784|NCT01609335|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110392785|NCT01609335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110392786|NCT01609413|Calcium Carbonate|calcium carbonate|mesh-list
110392788|NCT01609413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110392789|NCT01609413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110392790|NCT02279966|Vortioxetine|vortioxetine|mesh-list
110392791|NCT02279966|Paroxetine|paroxetine|mesh-list
110392792|NCT02279966|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110392793|NCT02279966|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110392794|NCT02279966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110392795|NCT02279966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110392797|NCT02279966|Serotonin Agents|serotonin agents|mesh-ancestor
110392798|NCT02279966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110392799|NCT02279966|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110392800|NCT02279966|Antidepressive Agents|antidepressive agents|mesh-ancestor
110392801|NCT02279966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110392802|NCT02279966|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110392803|NCT02279966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110392804|NCT02279966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110392805|NCT02279966|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110392806|NCT02279966|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110392807|NCT02279966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110392808|NCT02279966|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110392809|NCT02279966|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110392810|NCT02279966|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110392811|NCT02279966|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110392812|NCT01684787|Ribavirin|ribavirin|mesh-list
110392813|NCT01684787|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110392814|NCT01684787|Interferon-alpha|interferon-alpha|mesh-list
110392815|NCT01684787|Antimetabolites|antimetabolites|mesh-ancestor
110392817|NCT01684787|Antiviral Agents|antiviral agents|mesh-ancestor
110392818|NCT01684787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110392819|NCT01684787|Immunologic Factors|immunologic factors|mesh-ancestor
110392820|NCT01684787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110392821|NCT01649258|Granisetron|granisetron|mesh-list
110392822|NCT01649258|Fosaprepitant|fosaprepitant|mesh-list
110392823|NCT01649258|Aprepitant|aprepitant|mesh-list
110392824|NCT01649258|Antiemetics|antiemetics|mesh-ancestor
110392825|NCT01649258|Autonomic Agents|autonomic agents|mesh-ancestor
110392826|NCT01649258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110392827|NCT01649258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110392828|NCT01649258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110392829|NCT01649258|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110392830|NCT01649258|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110392831|NCT01649258|Serotonin Agents|serotonin agents|mesh-ancestor
110392832|NCT01649258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110392833|NCT01649258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110392834|NCT01649258|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110392835|NCT01649336|Paclitaxel|paclitaxel|mesh-list
110392836|NCT01649336|Antimitotic Agents|antimitotic agents|mesh-list
110392837|NCT01649336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110392838|NCT01649336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110392839|NCT01649336|Tubulin Modulators|tubulin modulators|mesh-ancestor
110392840|NCT01649336|Mitosis Modulators|mitosis modulators|mesh-ancestor
110392841|NCT01649336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110392842|NCT01609491|Phenylephrine|phenylephrine|mesh-list
110392843|NCT01609491|Oxymetazoline|oxymetazoline|mesh-list
110392844|NCT01609491|Norepinephrine|norepinephrine|mesh-list
110392845|NCT01609491|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110392846|NCT01609491|Mydriatics|mydriatics|mesh-ancestor
110392847|NCT01609491|Autonomic Agents|autonomic agents|mesh-ancestor
110392848|NCT01609491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110392849|NCT01609491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110392850|NCT01609491|Sympathomimetics|sympathomimetics|mesh-ancestor
110392851|NCT01609491|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110392852|NCT01609491|Nasal Decongestants|nasal decongestants|mesh-ancestor
110392853|NCT01609491|Respiratory System Agents|respiratory system agents|mesh-ancestor
110392854|NCT01609491|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110392855|NCT01609491|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110392856|NCT01609491|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110392857|NCT01609491|Adrenergic Agents|adrenergic agents|mesh-ancestor
110392858|NCT01609491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110392859|NCT01609491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110392860|NCT01609491|Protective Agents|protective agents|mesh-ancestor
110392862|NCT01606878|Doxorubicin|doxorubicin|mesh-list
110392863|NCT01606878|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110392864|NCT01606878|Vincristine|vincristine|mesh-list
110392865|NCT01606878|Topotecan|topotecan|mesh-list
110392866|NCT01606878|Crizotinib|crizotinib|mesh-list
110392867|NCT01606878|Dexrazoxane|dexrazoxane|mesh-list
110392868|NCT01606878|Razoxane|razoxane|mesh-list
110392869|NCT01606878|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
110392870|NCT01606878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110392871|NCT01606878|Immunologic Factors|immunologic factors|mesh-ancestor
110392872|NCT01606878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110392873|NCT01606878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110392874|NCT01606878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110392875|NCT01606878|Alkylating Agents|alkylating agents|mesh-ancestor
110392876|NCT01606878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110392877|NCT01606878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110392878|NCT01606878|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110392879|NCT01606878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110392880|NCT01606878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110392881|NCT01606878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110392882|NCT01606878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110392883|NCT01606878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110392884|NCT01606878|Tubulin Modulators|tubulin modulators|mesh-ancestor
110392885|NCT01606878|Antimitotic Agents|antimitotic agents|mesh-ancestor
110392887|NCT01606878|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110392888|NCT01606878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110392889|NCT01606878|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110392890|NCT01606878|Protective Agents|protective agents|mesh-ancestor
110392891|NCT01684865|Rituximab|rituximab|mesh-list
110392892|NCT01684865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110392893|NCT01684865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110392894|NCT01684865|Immunologic Factors|immunologic factors|mesh-ancestor
110392895|NCT01684865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110392896|NCT01684865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110392897|NCT01580163|Methadone|methadone|mesh-list
110392898|NCT01580163|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110392899|NCT01580163|Narcotics|narcotics|mesh-ancestor
110392900|NCT01580163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110392901|NCT01580163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110392902|NCT01580163|Analgesics|analgesics|mesh-ancestor
110392903|NCT01580163|Sensory System Agents|sensory system agents|mesh-ancestor
110392904|NCT01580163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110392905|NCT01580163|Antitussive Agents|antitussive agents|mesh-ancestor
110392906|NCT01580163|Respiratory System Agents|respiratory system agents|mesh-ancestor
110392908|NCT01609647|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110392909|NCT01609647|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110392910|NCT01609647|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110392911|NCT01609647|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110392912|NCT01609647|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110392913|NCT01609647|Purinergic Agents|purinergic agents|mesh-ancestor
110392914|NCT01609647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110392915|NCT01609647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110392916|NCT01609647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110392917|NCT01580202|Lamivudine|lamivudine|mesh-list
110392918|NCT01580202|Entecavir|entecavir|mesh-list
110392920|NCT01580202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110392921|NCT01580202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110392922|NCT01580202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110392923|NCT01580202|Antiviral Agents|antiviral agents|mesh-ancestor
110392924|NCT01580202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110392925|NCT01580202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110392926|NCT01580202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110392927|NCT01649570|Insulin Aspart|insulin aspart|mesh-list
110392928|NCT01649570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110392929|NCT01649570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110392930|NCT01609881|Ketorolac|ketorolac|mesh-list
110392931|NCT01609881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110392932|NCT01609881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110392934|NCT01609881|Sensory System Agents|sensory system agents|mesh-ancestor
110392935|NCT01609881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110392936|NCT01609881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110392937|NCT01609881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110392938|NCT01609881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110027442|NCT01835340|Propofol|propofol|mesh-list
110392939|NCT01609881|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110392940|NCT01609881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110392941|NCT01609881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110392942|NCT01609959|Valsartan|valsartan|mesh-list
110392943|NCT01609959|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
110392944|NCT01609959|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110392945|NCT01609959|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110392946|NCT01609959|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110392947|NCT01609959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110392948|NCT01609998|Vaccines|vaccines|mesh-list
110392949|NCT01609998|Immunologic Factors|immunologic factors|mesh-ancestor
110392950|NCT01609998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110392951|NCT01649921|Interferons|interferons|mesh-list
110392952|NCT01649921|Interferon-gamma|interferon-gamma|mesh-list
110392953|NCT01649921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110392954|NCT01649921|Antiviral Agents|antiviral agents|mesh-ancestor
110392955|NCT01649921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110392956|NCT01606566|Bleomycin|bleomycin|mesh-list
110392957|NCT01606566|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110392958|NCT01606566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110392959|NCT01605162|10-((4-hydroxypiperidin-1-yl)methyl)chromeno(4,3,2-de)phthalazin-3(2H)-one|10-((4-hydroxypiperidin-1-yl)methyl)chromeno(4,3,2-de)phthalazin-3(2h)-one|mesh-list
110392960|NCT01605162|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110392961|NCT01605162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110392963|NCT01605162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110392964|NCT01649999|Peficitinib|peficitinib|mesh-list
110392965|NCT01649999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110392966|NCT01649999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110392967|NCT01649999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110392968|NCT01649999|Immunologic Factors|immunologic factors|mesh-ancestor
110392969|NCT01649999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110392971|NCT01604889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110392972|NCT01604889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110392973|NCT01604889|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110392974|NCT01604889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110392975|NCT01685762|Metformin|metformin|mesh-list
110392976|NCT01685762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110392977|NCT01685762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110392978|NCT01602822|Ritonavir|ritonavir|mesh-list
110392979|NCT01602822|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110392980|NCT01602822|Tenofovir|tenofovir|mesh-list
110392981|NCT01602822|Emtricitabine|emtricitabine|mesh-list
110392982|NCT01602822|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110392983|NCT01602822|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110392984|NCT01602822|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110392985|NCT01602822|Protease Inhibitors|protease inhibitors|mesh-ancestor
110392986|NCT01602822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110392987|NCT01602822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110392988|NCT01602822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110392989|NCT01602822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110392990|NCT01602822|Antiviral Agents|antiviral agents|mesh-ancestor
110392991|NCT01602822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110392992|NCT01602822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110392993|NCT01602822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110392994|NCT01602822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110392995|NCT01602822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110392996|NCT02273154|Buspirone|buspirone|mesh-list
110392997|NCT02273154|Paroxetine|paroxetine|mesh-list
110392998|NCT02273154|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110392999|NCT02273154|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110393000|NCT02273154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110393001|NCT02273154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110393002|NCT02273154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110393003|NCT02273154|Serotonin Agents|serotonin agents|mesh-ancestor
110393004|NCT02273154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110393005|NCT02273154|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110393006|NCT02273154|Antidepressive Agents|antidepressive agents|mesh-ancestor
110393007|NCT02273154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110393008|NCT02273154|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110393009|NCT02273154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110393010|NCT02273154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110393011|NCT02273154|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110393012|NCT02273154|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110393013|NCT02273154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110393014|NCT02273154|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110393015|NCT01602393|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|mesh-list
110393016|NCT01602393|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
110393017|NCT01602393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110393018|NCT01602393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110393020|NCT01645787|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110393022|NCT01645787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110393024|NCT02270034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110393025|NCT02270034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110393026|NCT02270034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110393027|NCT02270034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110393028|NCT02273271|Alovudine|alovudine|mesh-list
110393029|NCT02273271|Antiviral Agents|antiviral agents|mesh-ancestor
110393030|NCT02273271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110393031|NCT02270307|Cyclophosphamide|cyclophosphamide|mesh-list
110393032|NCT02270307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110393033|NCT02270307|Immunologic Factors|immunologic factors|mesh-ancestor
110393034|NCT02270307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110393035|NCT02270307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110393036|NCT02270307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110393037|NCT02270307|Alkylating Agents|alkylating agents|mesh-ancestor
110393038|NCT02270307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110393039|NCT02270307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110393040|NCT02270307|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110393041|NCT02270424|Fluticasone|fluticasone|mesh-list
110393042|NCT02270424|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110393043|NCT02270424|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110393044|NCT02270424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110393045|NCT02270424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110393046|NCT02270424|Autonomic Agents|autonomic agents|mesh-ancestor
110393047|NCT02270424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110393048|NCT02270424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110393049|NCT02270424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110393050|NCT02270424|Respiratory System Agents|respiratory system agents|mesh-ancestor
110393051|NCT02270424|Dermatologic Agents|dermatologic agents|mesh-ancestor
110393052|NCT02270424|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110393053|NCT02270424|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110393054|NCT02270424|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110393055|NCT02270424|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110393056|NCT02270424|Adrenergic Agents|adrenergic agents|mesh-ancestor
110393057|NCT02270424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110393058|NCT02270424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110393059|NCT02270424|Glucocorticoids|glucocorticoids|mesh-ancestor
110393061|NCT02270424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110393062|NCT02270424|Sympathomimetics|sympathomimetics|mesh-ancestor
110393063|NCT01686347|Ropivacaine|ropivacaine|mesh-list
110393064|NCT01686347|Anesthetics, Local|anesthetics, local|mesh-ancestor
110393065|NCT01686347|Anesthetics|anesthetics|mesh-ancestor
110393066|NCT01686347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110027503|NCT01838772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110027505|NCT01838928|Anesthetics, Local|anesthetics, local|mesh-ancestor
110393067|NCT01686347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110393068|NCT01686347|Sensory System Agents|sensory system agents|mesh-ancestor
110393069|NCT01686347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110393070|NCT05140655|Fulvestrant|fulvestrant|mesh-list
110393071|NCT05140655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110393072|NCT05140655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110393073|NCT05140655|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110393074|NCT05140655|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110393075|NCT05140655|Hormone Antagonists|hormone antagonists|mesh-ancestor
110393076|NCT05140655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110393077|NCT05140655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110393078|NCT01688570|Cyproheptadine|cyproheptadine|mesh-list
110393079|NCT01688570|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110393080|NCT01688570|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110393081|NCT01688570|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110393082|NCT01688570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110393083|NCT01688570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110393084|NCT01688570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110393085|NCT01688570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110393086|NCT01688570|Analgesics|analgesics|mesh-ancestor
110393087|NCT01688570|Sensory System Agents|sensory system agents|mesh-ancestor
110393088|NCT01688570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110393089|NCT01688570|Antidepressive Agents|antidepressive agents|mesh-ancestor
110393090|NCT01688570|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110393091|NCT01688570|Dopamine Agents|dopamine agents|mesh-ancestor
110393092|NCT01688570|Antipruritics|antipruritics|mesh-ancestor
110393093|NCT01688570|Dermatologic Agents|dermatologic agents|mesh-ancestor
110393094|NCT01688570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110393095|NCT01688570|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110393096|NCT01688570|Histamine Antagonists|histamine antagonists|mesh-ancestor
110393097|NCT01688570|Histamine Agents|histamine agents|mesh-ancestor
110393098|NCT01688570|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110393099|NCT01688570|Serotonin Agents|serotonin agents|mesh-ancestor
110393100|NCT01688570|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110393101|NCT01686464|Valacyclovir|valacyclovir|mesh-list
110393103|NCT01686464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110393104|NCT01686464|Glucocorticoids|glucocorticoids|mesh-ancestor
110393105|NCT01686464|Hormones|hormones|mesh-ancestor
110393106|NCT01686464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110393107|NCT01686464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110393108|NCT01686464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110393109|NCT01686464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110393110|NCT01686464|Antiviral Agents|antiviral agents|mesh-ancestor
110393111|NCT01686464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110393112|NCT02270970|Belimumab|belimumab|mesh-list
110393113|NCT02270970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110393114|NCT02270970|Immunologic Factors|immunologic factors|mesh-ancestor
110393115|NCT02270970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110393116|NCT01688648|Lidocaine|lidocaine|mesh-list
110393117|NCT01688648|Dexmedetomidine|dexmedetomidine|mesh-list
110393118|NCT01688648|Anesthetics, Local|anesthetics, local|mesh-ancestor
110393119|NCT01688648|Anesthetics|anesthetics|mesh-ancestor
110393120|NCT01688648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110393121|NCT01688648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110393122|NCT01688648|Sensory System Agents|sensory system agents|mesh-ancestor
110393123|NCT01688648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110393124|NCT01688648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110393125|NCT01688648|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110393126|NCT01688648|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110393127|NCT01688648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110393128|NCT01688648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110393129|NCT01688648|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110393130|NCT01688648|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110393131|NCT01688648|Analgesics|analgesics|mesh-ancestor
110393132|NCT01688648|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110393133|NCT01688648|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110393134|NCT01688648|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110393135|NCT01688648|Adrenergic Agents|adrenergic agents|mesh-ancestor
110393136|NCT01688648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110393137|NCT01686659|Chrysarobin|chrysarobin|mesh-list
110393138|NCT01686659|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110393139|NCT01686659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110393140|NCT01686659|Analgesics|analgesics|mesh-ancestor
110393141|NCT01686659|Sensory System Agents|sensory system agents|mesh-ancestor
110393142|NCT01686659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110393143|NCT01686659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110393144|NCT01686659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110393145|NCT01686659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110393146|NCT02271126|Heparin|heparin|mesh-list
110393147|NCT02271126|Thromboplastin|thromboplastin|mesh-list
110393148|NCT02271126|Anticoagulants|anticoagulants|mesh-ancestor
110393149|NCT02271126|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110393150|NCT02271126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110393151|NCT02271126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110393153|NCT02271126|Coagulants|coagulants|mesh-ancestor
110393154|NCT02271165|Immunoglobulins|immunoglobulins|mesh-list
110393155|NCT02271165|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110393156|NCT02271165|Antibodies|antibodies|mesh-list
110393157|NCT02271165|Immunologic Factors|immunologic factors|mesh-ancestor
110393158|NCT02271165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110393159|NCT02271204|Ibandronic Acid|ibandronic acid|mesh-list
110393160|NCT02271204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110393161|NCT02271204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110393162|NCT02271282|Toremifene|toremifene|mesh-list
110393163|NCT02271282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110393164|NCT02271282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110393165|NCT02271282|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110393166|NCT02271282|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110393167|NCT02271282|Hormone Antagonists|hormone antagonists|mesh-ancestor
110393168|NCT02271282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110393169|NCT02271282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110393170|NCT02271282|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110393171|NCT01688960|Aflibercept|aflibercept|mesh-list
110393172|NCT01688960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110393173|NCT01688960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110393174|NCT01688960|Growth Substances|growth substances|mesh-ancestor
110393175|NCT01688960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110393176|NCT01688960|Growth Inhibitors|growth inhibitors|mesh-ancestor
110393177|NCT01688960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110393178|NCT02271360|Cabergoline|cabergoline|mesh-list
110393179|NCT02271360|Calcium Dobesilate|calcium dobesilate|mesh-list
110393180|NCT02271360|Calcium|calcium|mesh-list
110393181|NCT02271360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110393182|NCT02271360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110393183|NCT02271360|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110393184|NCT02271360|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110393185|NCT02271360|Dopamine Agonists|dopamine agonists|mesh-ancestor
110393187|NCT02271360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110393188|NCT02271360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110393189|NCT02271360|Hemostatics|hemostatics|mesh-ancestor
110393190|NCT02271360|Coagulants|coagulants|mesh-ancestor
110393191|NCT01687049|Red yeast rice|red yeast rice|mesh-list
110393192|NCT01687049|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110393193|NCT01687049|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110393194|NCT01687049|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110393195|NCT01687049|Antimetabolites|antimetabolites|mesh-ancestor
110393196|NCT01687049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110393197|NCT01687049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110393198|NCT01687049|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110393199|NCT02271399|Aspirin|aspirin|mesh-list
110393200|NCT02271399|Rivaroxaban|rivaroxaban|mesh-list
110393201|NCT02271399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110393202|NCT02271399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110393203|NCT02271399|Analgesics|analgesics|mesh-ancestor
110393204|NCT02271399|Sensory System Agents|sensory system agents|mesh-ancestor
110393205|NCT02271399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110393206|NCT02271399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110393207|NCT02271399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110393208|NCT02271399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110393209|NCT02271399|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110393210|NCT02271399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110393211|NCT02271399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110393212|NCT02271399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110393213|NCT02271399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110393214|NCT02271399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110393215|NCT02271399|Antipyretics|antipyretics|mesh-ancestor
110393216|NCT02271399|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110393217|NCT02271399|Antithrombins|antithrombins|mesh-ancestor
110393218|NCT02271399|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110393219|NCT02271399|Protease Inhibitors|protease inhibitors|mesh-ancestor
110393220|NCT02271399|Anticoagulants|anticoagulants|mesh-ancestor
110393221|NCT02271438|Moxifloxacin|moxifloxacin|mesh-list
110393222|NCT02271438|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110393223|NCT02271438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110393224|NCT02271438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110393225|NCT02271438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110393226|NCT02271438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110393227|NCT02271438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110393228|NCT02271438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110393229|NCT02271438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110393230|NCT02271438|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110393231|NCT02271438|Contraceptive Agents|contraceptive agents|mesh-ancestor
110393232|NCT02271438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110393233|NCT02271438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110393234|NCT02271438|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110393235|NCT02271438|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110393236|NCT02271438|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110393237|NCT02271555|Remifentanil|remifentanil|mesh-list
110393238|NCT02271555|Sevoflurane|sevoflurane|mesh-list
110393239|NCT02271555|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110393240|NCT02271555|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110393241|NCT02271555|Anesthetics, General|anesthetics, general|mesh-ancestor
110393242|NCT02271555|Anesthetics|anesthetics|mesh-ancestor
110393243|NCT02271555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110393244|NCT02271555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110393245|NCT02271555|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110393246|NCT02271555|Narcotics|narcotics|mesh-ancestor
110393247|NCT02271555|Analgesics|analgesics|mesh-ancestor
110393248|NCT02271555|Sensory System Agents|sensory system agents|mesh-ancestor
110393249|NCT02271555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110393250|NCT01687205|Tenofovir|tenofovir|mesh-list
110393251|NCT01687205|Antiviral Agents|antiviral agents|mesh-ancestor
110393252|NCT01687205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110393253|NCT01687205|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110393254|NCT01687205|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110393255|NCT01687205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110393256|NCT01687205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110393257|NCT01687205|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110393258|NCT01687205|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110393259|NCT01689116|Moxifloxacin|moxifloxacin|mesh-list
110393260|NCT01689116|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110393261|NCT01689116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110393262|NCT01689116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110393263|NCT01689116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110393264|NCT01689116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110393265|NCT01689116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110393266|NCT01689116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110393267|NCT01689116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110393268|NCT01689116|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110393269|NCT01689116|Contraceptive Agents|contraceptive agents|mesh-ancestor
110393270|NCT01689116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110393271|NCT01689116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110393272|NCT01689116|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110393273|NCT01689116|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110393274|NCT01689116|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110393275|NCT01689194|genexol-PM|genexol-pm|mesh-list
110393276|NCT01689194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110393277|NCT01689194|Tubulin Modulators|tubulin modulators|mesh-ancestor
110393278|NCT01689194|Antimitotic Agents|antimitotic agents|mesh-ancestor
110393279|NCT01689194|Mitosis Modulators|mitosis modulators|mesh-ancestor
110393280|NCT01689194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110393281|NCT01687439|Vinorelbine|vinorelbine|mesh-list
110393283|NCT01687439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110393284|NCT01687439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110393285|NCT01687439|Tubulin Modulators|tubulin modulators|mesh-ancestor
110393286|NCT01687439|Antimitotic Agents|antimitotic agents|mesh-ancestor
110393287|NCT01687439|Mitosis Modulators|mitosis modulators|mesh-ancestor
110393288|NCT01687439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110393289|NCT01687439|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110393290|NCT01687439|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110393291|NCT01687439|Growth Substances|growth substances|mesh-ancestor
110393292|NCT01687439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110393293|NCT01687439|Growth Inhibitors|growth inhibitors|mesh-ancestor
110393294|NCT01588704|Bevacizumab|bevacizumab|mesh-list
110393295|NCT01588704|Pemetrexed|pemetrexed|mesh-list
110393296|NCT01588704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110393297|NCT01588704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110393298|NCT01588704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110393299|NCT01588704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110393300|NCT01588704|Growth Substances|growth substances|mesh-ancestor
110393301|NCT01588704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110393302|NCT01588704|Growth Inhibitors|growth inhibitors|mesh-ancestor
110393303|NCT01588704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110393304|NCT01588704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110393305|NCT01588704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110393306|NCT01588704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110393307|NCT01588743|Insulin Aspart|insulin aspart|mesh-list
110393308|NCT01588743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110393309|NCT01588743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110393310|NCT01689311|Alprostadil|alprostadil|mesh-list
110393311|NCT01689311|Misoprostol|misoprostol|mesh-list
110393312|NCT01689311|Oxytocin|oxytocin|mesh-list
110393313|NCT01689311|Ergonovine|ergonovine|mesh-list
110393314|NCT01689311|Dinoprost|dinoprost|mesh-list
110393315|NCT01689311|Dinoprost tromethamine|dinoprost tromethamine|mesh-list
110393316|NCT01689311|Oxytocics|oxytocics|mesh-ancestor
110393317|NCT01689311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110393318|NCT01689311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110393319|NCT01689311|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110393321|NCT01689311|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110393322|NCT01689311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110393323|NCT01689311|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110393325|NCT01689311|Urological Agents|urological agents|mesh-ancestor
110393326|NCT01588782|Ketoconazole|ketoconazole|mesh-list
110393327|NCT01588782|Antifungal Agents|antifungal agents|mesh-ancestor
110393328|NCT01588782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110393329|NCT01588782|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110393330|NCT01588782|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110393331|NCT01588782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110393332|NCT01588782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110393333|NCT01588782|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110393334|NCT01588782|Hormone Antagonists|hormone antagonists|mesh-ancestor
110393335|NCT01588782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110393336|NCT01588782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110393337|NCT01588782|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110393339|NCT02272101|Vitamins|vitamins|mesh-ancestor
110393340|NCT02272101|Micronutrients|micronutrients|mesh-ancestor
110393341|NCT02272101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110393342|NCT02272101|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110393343|NCT02278133|Cetuximab|cetuximab|mesh-list
110393344|NCT02278133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110393345|NCT02278133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110393346|NCT01687868|Dexmedetomidine|dexmedetomidine|mesh-list
110393347|NCT01687868|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110393348|NCT01687868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110393349|NCT01687868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110393350|NCT01687868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110393352|NCT01687868|Sensory System Agents|sensory system agents|mesh-ancestor
110393353|NCT01687868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110393354|NCT01687868|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110393355|NCT01687868|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110393356|NCT01687868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110393357|NCT01687868|Adrenergic Agents|adrenergic agents|mesh-ancestor
110393358|NCT01687868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110393359|NCT01687868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110393360|NCT01688024|Mitomycins|mitomycins|mesh-list
110393361|NCT01688024|Mitomycin|mitomycin|mesh-list
110393362|NCT01688024|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110393363|NCT01688024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110393364|NCT01688024|Alkylating Agents|alkylating agents|mesh-ancestor
110393365|NCT01688024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110393366|NCT01688024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110393367|NCT01688024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110393368|NCT01689623|Simeprevir|simeprevir|mesh-list
110393369|NCT01689623|Atorvastatin|atorvastatin|mesh-list
110393370|NCT01689623|Simvastatin|simvastatin|mesh-list
110393371|NCT01689623|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110393372|NCT01689623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110393373|NCT01689623|Antimetabolites|antimetabolites|mesh-ancestor
110393374|NCT01689623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110393375|NCT01689623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110393376|NCT01689623|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110393377|NCT01689623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110393378|NCT01689623|Antiviral Agents|antiviral agents|mesh-ancestor
110393379|NCT01689623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110393380|NCT01689623|Protease Inhibitors|protease inhibitors|mesh-ancestor
110393381|NCT04055142|Cidofovir|cidofovir|mesh-list
110393382|NCT04055142|Antiviral Agents|antiviral agents|mesh-ancestor
110393383|NCT04055142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110393384|NCT04055142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110393385|NCT04055142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110393386|NCT02272647|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110393387|NCT02272647|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110393388|NCT02272647|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110393389|NCT02272647|Medroxyprogesterone|medroxyprogesterone|mesh-list
110393390|NCT02272647|Estradiol|estradiol|mesh-list
110393391|NCT02272647|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110393392|NCT02272647|Progesterone|progesterone|mesh-list
110393393|NCT02272647|Estrogens|estrogens|mesh-ancestor
110047534|NCT03765229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110393394|NCT02272647|Hormones|hormones|mesh-ancestor
110393395|NCT02272647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110393396|NCT02272647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110393397|NCT02272647|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110393398|NCT02272647|Contraceptive Agents|contraceptive agents|mesh-ancestor
110393399|NCT02272647|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110393400|NCT02272647|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110393401|NCT02272647|Progestins|progestins|mesh-ancestor
110393402|NCT02272647|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110393403|NCT02272647|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110393405|NCT02272647|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110393406|NCT02272647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110393407|NCT02272647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110393408|NCT02272764|Itraconazole|itraconazole|mesh-list
110393409|NCT02272764|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
110393410|NCT02272764|Antifungal Agents|antifungal agents|mesh-ancestor
110393411|NCT02272764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110393412|NCT02272764|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110393413|NCT02272764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110393414|NCT02272764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110393415|NCT02272764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110393416|NCT02272764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110393417|NCT02272764|Hormone Antagonists|hormone antagonists|mesh-ancestor
110393418|NCT02272764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110393419|NCT02272764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110393420|NCT02272764|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110393421|NCT01689896|Testosterone|testosterone|mesh-list
110393422|NCT01689896|Androgens|androgens|mesh-ancestor
110393423|NCT01689896|Hormones|hormones|mesh-ancestor
110393424|NCT01689896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110393425|NCT01689896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110393426|NCT01316094|Ipragliflozin|ipragliflozin|mesh-list
110393427|NCT01316094|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110393428|NCT01316094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110393429|NCT01316094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110393430|NCT01316094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110393431|NCT01689935|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110393432|NCT01689935|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110393433|NCT01689935|Dermatologic Agents|dermatologic agents|mesh-ancestor
110393434|NCT01316133|Tacrolimus|tacrolimus|mesh-list
110393435|NCT01316133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110393436|NCT01316133|Immunologic Factors|immunologic factors|mesh-ancestor
110393437|NCT01316133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110393438|NCT01316133|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110393439|NCT01316133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110393440|NCT01316133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110393441|NCT05654064|Fentanyl|fentanyl|mesh-list
110393442|NCT05654064|Dexmedetomidine|dexmedetomidine|mesh-list
110393443|NCT05654064|Remifentanil|remifentanil|mesh-list
110393444|NCT05654064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110393445|NCT05654064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110393446|NCT05654064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110393447|NCT05654064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110393448|NCT05654064|Analgesics|analgesics|mesh-ancestor
110027670|NCT01722942|Amiodarone|amiodarone|mesh-list
110393449|NCT05654064|Sensory System Agents|sensory system agents|mesh-ancestor
110393450|NCT05654064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110393451|NCT05654064|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110393452|NCT05654064|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110393453|NCT05654064|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110393454|NCT05654064|Adrenergic Agents|adrenergic agents|mesh-ancestor
110393455|NCT05654064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110393456|NCT05654064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110393457|NCT05654064|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110393458|NCT05654064|Narcotics|narcotics|mesh-ancestor
110393459|NCT05654064|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110393460|NCT05654064|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110393461|NCT05654064|Anesthetics, General|anesthetics, general|mesh-ancestor
110393462|NCT05654064|Anesthetics|anesthetics|mesh-ancestor
110393463|NCT01687985|Laxatives|laxatives|mesh-list
110393464|NCT01687985|Cathartics|cathartics|mesh-list
110393465|NCT01687985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110393466|NCT01686620|Insulin Lispro|insulin lispro|mesh-list
110393467|NCT01686620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110393468|NCT01686620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110393469|NCT01685255|Tamoxifen|tamoxifen|mesh-list
110393470|NCT01685255|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110393471|NCT01685255|Hormone Antagonists|hormone antagonists|mesh-ancestor
110393472|NCT01685255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110393473|NCT01685255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110393474|NCT01685255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110393475|NCT01685255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110393476|NCT01685255|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110393477|NCT01685255|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110393478|NCT01685255|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110393479|NCT01680965|Ofatumumab|ofatumumab|mesh-list
110393480|NCT01680965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110393481|NCT01683188|Vemurafenib|vemurafenib|mesh-list
110393482|NCT01683188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110393483|NCT01683188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110393484|NCT01683188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110393485|NCT01683188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110393486|NCT01339923|Vaccines|vaccines|mesh-list
110393487|NCT01339923|Immunologic Factors|immunologic factors|mesh-ancestor
110393488|NCT01339923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110393489|NCT04417088|Carboplatin|carboplatin|mesh-list
110393490|NCT04417088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110393491|NCT01380093|Naltrexone|naltrexone|mesh-list
110393492|NCT01380093|Morphine|morphine|mesh-list
110393493|NCT01380093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110393494|NCT01380093|Narcotics|narcotics|mesh-ancestor
110393495|NCT01380093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110393496|NCT01380093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110393497|NCT01380093|Analgesics|analgesics|mesh-ancestor
110393498|NCT01380093|Sensory System Agents|sensory system agents|mesh-ancestor
110393499|NCT01380093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110393500|NCT01380093|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110393501|NCT01380093|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110393502|NCT01379937|Vaccines|vaccines|mesh-list
110393503|NCT01379937|Immunologic Factors|immunologic factors|mesh-ancestor
110393504|NCT01379937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027683|NCT01723800|Carboplatin|carboplatin|mesh-list
110393505|NCT04820972|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
110393507|NCT03558854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110393508|NCT03558854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110393509|NCT03558854|Analgesics|analgesics|mesh-ancestor
110393510|NCT03558854|Sensory System Agents|sensory system agents|mesh-ancestor
110393511|NCT03558854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110393512|NCT03558854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110393513|NCT03558854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110393514|NCT03558854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110393515|NCT03558854|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110393516|NCT03558854|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110393517|NCT03558854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110393518|NCT03558854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110393519|NCT03558854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110393520|NCT03558854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110393521|NCT03558854|Antipyretics|antipyretics|mesh-ancestor
110393522|NCT01335477|Nintedanib|nintedanib|mesh-list
110393523|NCT01335477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110393524|NCT01335477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110393525|NCT01335477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110393526|NCT01335477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110393527|NCT03389438|Immunomodulating Agents|immunomodulating agents|mesh-list
110393528|NCT03389438|Immunologic Factors|immunologic factors|mesh-ancestor
110393529|NCT03389438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110393530|NCT01371747|Losartan|losartan|mesh-list
110393531|NCT01371747|Spironolactone|spironolactone|mesh-list
110393532|NCT01371747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110393533|NCT01371747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110393534|NCT01371747|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110393535|NCT01371747|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110393536|NCT01371747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110393537|NCT01371747|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110393538|NCT01371747|Hormone Antagonists|hormone antagonists|mesh-ancestor
110393539|NCT01371747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110393540|NCT01371747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110393541|NCT01371747|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110393542|NCT01371747|Diuretics|diuretics|mesh-ancestor
110393543|NCT01371747|Natriuretic Agents|natriuretic agents|mesh-ancestor
110393544|NCT01335399|Dexamethasone|dexamethasone|mesh-list
110393545|NCT01335399|Dexamethasone acetate|dexamethasone acetate|mesh-list
110393546|NCT01335399|Lenalidomide|lenalidomide|mesh-list
110393547|NCT01335399|Elotuzumab|elotuzumab|mesh-list
110393548|NCT01335399|BB 1101|bb 1101|mesh-list
110393549|NCT01335399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110393550|NCT01335399|Antiemetics|antiemetics|mesh-ancestor
110393551|NCT01335399|Autonomic Agents|autonomic agents|mesh-ancestor
110393552|NCT01335399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110393553|NCT01335399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027699|NCT01724268|Methamphetamine|methamphetamine|mesh-list
110393554|NCT01335399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110393556|NCT01335399|Hormones|hormones|mesh-ancestor
110393557|NCT01335399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110393558|NCT01335399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110393559|NCT01335399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110393560|NCT01335399|Protease Inhibitors|protease inhibitors|mesh-ancestor
110393561|NCT01335399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110393562|NCT01335399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110393564|NCT01335399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110393565|NCT01335399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110393566|NCT01335399|Growth Substances|growth substances|mesh-ancestor
110393567|NCT01335399|Growth Inhibitors|growth inhibitors|mesh-ancestor
110393568|NCT04825262|Tacrolimus|tacrolimus|mesh-list
110393569|NCT04825262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110393570|NCT04825262|Immunologic Factors|immunologic factors|mesh-ancestor
110393571|NCT04825262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110393572|NCT04825262|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110393573|NCT04825262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110393574|NCT04825262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110393576|NCT01335009|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110393577|NCT01335009|Immunologic Factors|immunologic factors|mesh-ancestor
110393578|NCT01335009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110393579|NCT01332630|Diphenhydramine|diphenhydramine|mesh-list
110393580|NCT01332630|Dexamethasone|dexamethasone|mesh-list
110393581|NCT01332630|Ranitidine|ranitidine|mesh-list
110393582|NCT01332630|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
110393583|NCT01332630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110393584|NCT01332630|Antiemetics|antiemetics|mesh-ancestor
110393585|NCT01332630|Autonomic Agents|autonomic agents|mesh-ancestor
110393586|NCT01332630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110393587|NCT01332630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110393588|NCT01332630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110393589|NCT01332630|Glucocorticoids|glucocorticoids|mesh-ancestor
110393590|NCT01332630|Hormones|hormones|mesh-ancestor
110393591|NCT01332630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110393592|NCT01332630|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110393593|NCT01332630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110393594|NCT01332630|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110393595|NCT01332630|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110393596|NCT01332630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110393597|NCT01332630|Anesthetics, Local|anesthetics, local|mesh-ancestor
110393598|NCT01332630|Anesthetics|anesthetics|mesh-ancestor
110393599|NCT01332630|Sensory System Agents|sensory system agents|mesh-ancestor
110393600|NCT01332630|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110393601|NCT01332630|Histamine Antagonists|histamine antagonists|mesh-ancestor
110393602|NCT01332630|Histamine Agents|histamine agents|mesh-ancestor
110393603|NCT01332630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110393604|NCT01332630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110393605|NCT01332630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110393606|NCT01332630|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110393607|NCT01332630|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110393608|NCT01366209|Pirfenidone|pirfenidone|mesh-list
110393609|NCT01366209|Analgesics|analgesics|mesh-ancestor
110393610|NCT01366209|Sensory System Agents|sensory system agents|mesh-ancestor
110393611|NCT01366209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110393612|NCT01366209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110393613|NCT01366209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110393614|NCT01366209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110393615|NCT01366209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110393616|NCT01366209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110393617|NCT01366209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110393618|NCT01365507|Insulin|insulin|mesh-list
110393619|NCT01365507|Insulin Aspart|insulin aspart|mesh-list
110393620|NCT01365507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110393621|NCT01365507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110393622|NCT02995694|Estradiol|estradiol|mesh-list
110393623|NCT02995694|Estrogens|estrogens|mesh-ancestor
110393624|NCT02995694|Hormones|hormones|mesh-ancestor
110393625|NCT02995694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110393626|NCT02995694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110393627|NCT01365468|Everolimus|everolimus|mesh-list
110393628|NCT01365468|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110393629|NCT01365468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110393630|NCT01365468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110393631|NCT01365468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110393632|NCT01365468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110393633|NCT01365468|Immunologic Factors|immunologic factors|mesh-ancestor
110393634|NCT01365468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110393635|NCT01365468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110393636|NCT04827836|Povidone-Iodine|povidone-iodine|mesh-list
110393637|NCT04827836|Povidone|povidone|mesh-list
110393638|NCT04827836|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110393639|NCT04827836|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110393640|NCT04827836|Plasma Substitutes|plasma substitutes|mesh-ancestor
110393641|NCT04827836|Blood Substitutes|blood substitutes|mesh-ancestor
110393642|NCT04827836|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110393643|NCT04827836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110393644|NCT01357980|Botulinum Toxins|botulinum toxins|mesh-list
110393646|NCT01357980|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110393647|NCT01357980|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110393648|NCT01357980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110393649|NCT01357980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110393650|NCT01357980|Cholinergic Agents|cholinergic agents|mesh-ancestor
110393651|NCT01357980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110393652|NCT01357980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110393654|NCT01357980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110393655|NCT01332318|Diphenhydramine|diphenhydramine|mesh-list
110393656|NCT01332318|Promethazine|promethazine|mesh-list
110393657|NCT01332318|Gabapentin|gabapentin|mesh-list
110393658|NCT01332318|Analgesics|analgesics|mesh-ancestor
110393659|NCT01332318|Sensory System Agents|sensory system agents|mesh-ancestor
110393660|NCT01332318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110393661|NCT01332318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110393662|NCT01332318|Anticonvulsants|anticonvulsants|mesh-ancestor
110393663|NCT01332318|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110393664|NCT01332318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110393665|NCT01332318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110393666|NCT01332318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110393667|NCT01332318|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110393668|NCT01332318|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110393669|NCT01332318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110393670|NCT01332318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110393672|NCT01332318|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110393673|NCT01332318|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110393674|NCT01332318|Anesthetics, Local|anesthetics, local|mesh-ancestor
110393675|NCT01332318|Anesthetics|anesthetics|mesh-ancestor
110393676|NCT01332318|Antiemetics|antiemetics|mesh-ancestor
110393677|NCT01332318|Autonomic Agents|autonomic agents|mesh-ancestor
110393678|NCT01332318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110393679|NCT01332318|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110393680|NCT01332318|Histamine Antagonists|histamine antagonists|mesh-ancestor
110393681|NCT01332318|Histamine Agents|histamine agents|mesh-ancestor
110393682|NCT01332318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110393683|NCT01332318|Antipruritics|antipruritics|mesh-ancestor
110393684|NCT01332318|Dermatologic Agents|dermatologic agents|mesh-ancestor
110393685|NCT04828226|Clonidine|clonidine|mesh-list
110393686|NCT04828226|Analgesics|analgesics|mesh-ancestor
110393687|NCT04828226|Sensory System Agents|sensory system agents|mesh-ancestor
110393688|NCT04828226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110393689|NCT04828226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110393690|NCT04828226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110393691|NCT04828226|Sympatholytics|sympatholytics|mesh-ancestor
110393692|NCT04828226|Autonomic Agents|autonomic agents|mesh-ancestor
110393693|NCT04828226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110393694|NCT04828226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110047836|NCT03067181|Carboplatin|carboplatin|mesh-list
110393695|NCT04828226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110393696|NCT04828226|Adrenergic Agents|adrenergic agents|mesh-ancestor
110393697|NCT04828226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110393698|NCT04828226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110393699|NCT01331109|Milnacipran|milnacipran|mesh-list
110393700|NCT01331109|Levomilnacipran|levomilnacipran|mesh-list
110393701|NCT01331109|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110393702|NCT01331109|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110393703|NCT01331109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110393704|NCT01331109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110393705|NCT01331109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110027780|NCT01725672|Metformin|metformin|mesh-list
110393707|NCT01331109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110393709|NCT01331109|Sensory System Agents|sensory system agents|mesh-ancestor
110393710|NCT01331109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110393711|NCT01331109|Antidepressive Agents|antidepressive agents|mesh-ancestor
110393713|NCT01351350|Paclitaxel|paclitaxel|mesh-list
110393714|NCT01351350|Trastuzumab|trastuzumab|mesh-list
110393715|NCT01351350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110393716|NCT01351350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110393717|NCT01351350|Tubulin Modulators|tubulin modulators|mesh-ancestor
110393718|NCT01351350|Antimitotic Agents|antimitotic agents|mesh-ancestor
110393719|NCT01351350|Mitosis Modulators|mitosis modulators|mesh-ancestor
110393720|NCT01351350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110393721|NCT01351350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110393722|NCT02271503|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110393723|NCT02271503|Carbidopa|carbidopa|mesh-list
110393724|NCT02271503|Levodopa|levodopa|mesh-list
110393725|NCT02271503|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110393726|NCT02271503|Immunologic Factors|immunologic factors|mesh-ancestor
110393727|NCT02271503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110393728|NCT02271503|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110393729|NCT02271503|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110393730|NCT02271503|Dopamine Agonists|dopamine agonists|mesh-ancestor
110393731|NCT02271503|Dopamine Agents|dopamine agents|mesh-ancestor
110393732|NCT02271503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110393733|NCT02271503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110393734|NCT02271503|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110393735|NCT02271503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110393736|NCT01350804|Abatacept|abatacept|mesh-list
110393737|NCT01350804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110393738|NCT01350804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110393739|NCT01350804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110393740|NCT01350804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110393741|NCT01350804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110393742|NCT01350804|Immunologic Factors|immunologic factors|mesh-ancestor
110393743|NCT01350804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110393744|NCT01350804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110393745|NCT02270957|Abatacept|abatacept|mesh-list
110393746|NCT02270957|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110393747|NCT02270957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110393748|NCT02270957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110393749|NCT02270957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110393750|NCT02270957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110393751|NCT02270957|Immunologic Factors|immunologic factors|mesh-ancestor
110393752|NCT02270957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110393753|NCT02270957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110393755|NCT01348542|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110393756|NCT01348542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110393757|NCT01348542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110393758|NCT01348542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110393759|NCT01348542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110393760|NCT01348542|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110393761|NCT01348542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110393762|NCT01348542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110393763|NCT01348542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110393764|NCT01348542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110393765|NCT01348542|Serotonin Agents|serotonin agents|mesh-ancestor
110393766|NCT01348542|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110393767|NCT01348542|Antidepressive Agents|antidepressive agents|mesh-ancestor
110393768|NCT01346592|Vaccines|vaccines|mesh-list
110393769|NCT01346592|Immunologic Factors|immunologic factors|mesh-ancestor
110393770|NCT01346592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110393771|NCT01193335|Vaccines|vaccines|mesh-list
110393772|NCT01193335|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110393773|NCT01193335|Immunologic Factors|immunologic factors|mesh-ancestor
110393774|NCT01193335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110393775|NCT02893995|Treprostinil|treprostinil|mesh-list
110393776|NCT02893995|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110393777|NCT01342887|Cyclosporine|cyclosporine|mesh-list
110393778|NCT01342887|Etoposide|etoposide|mesh-list
110393779|NCT01342887|Mitoxantrone|mitoxantrone|mesh-list
110393780|NCT01342887|Etoposide phosphate|etoposide phosphate|mesh-list
110393781|NCT01342887|Pravastatin|pravastatin|mesh-list
110393782|NCT01342887|Cyclosporins|cyclosporins|mesh-list
110393783|NCT01342887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110393784|NCT01342887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110393785|NCT01342887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110393786|NCT01342887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110393787|NCT01342887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110393788|NCT01342887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110393789|NCT01342887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110393790|NCT01342887|Immunologic Factors|immunologic factors|mesh-ancestor
110393791|NCT01342887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110393792|NCT01342887|Antifungal Agents|antifungal agents|mesh-ancestor
110393793|NCT01342887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110393794|NCT01342887|Dermatologic Agents|dermatologic agents|mesh-ancestor
110393795|NCT01342887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110393796|NCT01342887|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110393797|NCT01342887|Analgesics|analgesics|mesh-ancestor
110393798|NCT01342887|Sensory System Agents|sensory system agents|mesh-ancestor
110393799|NCT01342887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110393800|NCT01342887|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110393802|NCT01342887|Antimetabolites|antimetabolites|mesh-ancestor
110393803|NCT01342887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110393804|NCT01342887|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110393805|NCT04445415|Antibodies|antibodies|mesh-list
110393807|NCT04445415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110393808|NCT01342341|Chlorzoxazone|chlorzoxazone|mesh-list
110393809|NCT01342341|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110393810|NCT01342341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110393811|NCT01342341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110393812|NCT01342341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110393813|NCT01340664|Metformin|metformin|mesh-list
110393814|NCT01340664|Canagliflozin|canagliflozin|mesh-list
110393815|NCT01340664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110393816|NCT01340664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110393817|NCT01340664|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110393818|NCT01340664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110393819|NCT01340625|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110393820|NCT01340625|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110393821|NCT01340625|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110393822|NCT01340625|Norethindrone|norethindrone|mesh-list
110393824|NCT01340625|Estradiol|estradiol|mesh-list
110393825|NCT01340625|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110393826|NCT01340625|Estrogens|estrogens|mesh-ancestor
110393827|NCT01340625|Hormones|hormones|mesh-ancestor
110393828|NCT01340625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110393829|NCT01340625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110393830|NCT01340625|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110393831|NCT01340625|Contraceptive Agents|contraceptive agents|mesh-ancestor
110393832|NCT01340625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110393833|NCT01340625|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110393834|NCT01340625|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110393835|NCT01340625|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110393836|NCT01340625|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110393837|NCT04823468|Cisplatin|cisplatin|mesh-list
110393838|NCT04823468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110393839|NCT01340196|Tenofovir|tenofovir|mesh-list
110393840|NCT01340196|Antiviral Agents|antiviral agents|mesh-ancestor
110393841|NCT01340196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110393842|NCT01340196|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110393843|NCT01340196|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110393844|NCT01340196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110393845|NCT01340196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110393847|NCT01340196|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110393848|NCT02893332|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110393849|NCT02893332|Gefitinib|gefitinib|mesh-list
110393850|NCT02893332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110393851|NCT02893332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110393852|NCT02893332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110393853|NCT02893332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110393854|NCT04328493|Chloroquine|chloroquine|mesh-list
110393855|NCT04328493|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
110393856|NCT04328493|Amebicides|amebicides|mesh-ancestor
110393857|NCT04328493|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110393858|NCT04328493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110393859|NCT04328493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110393860|NCT04328493|Antimalarials|antimalarials|mesh-ancestor
110393861|NCT04328493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110393862|NCT04328493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110393863|NCT04328493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110393865|NCT04328493|Sensory System Agents|sensory system agents|mesh-ancestor
110393866|NCT04328493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110393867|NCT04328493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110393868|NCT04328493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110393869|NCT04328493|Filaricides|filaricides|mesh-ancestor
110393870|NCT04328493|Antinematodal Agents|antinematodal agents|mesh-ancestor
110393871|NCT04328493|Anthelmintics|anthelmintics|mesh-ancestor
110393872|NCT04396587|Sufentanil|sufentanil|mesh-list
110393873|NCT04396587|Oxycodone|oxycodone|mesh-list
110393874|NCT04396587|Hydromorphone|hydromorphone|mesh-list
110393875|NCT04396587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110393876|NCT04396587|Narcotics|narcotics|mesh-ancestor
110393877|NCT04396587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110393878|NCT04396587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110393879|NCT04396587|Analgesics|analgesics|mesh-ancestor
110393880|NCT04396587|Sensory System Agents|sensory system agents|mesh-ancestor
110393881|NCT04396587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110393882|NCT04396587|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110393883|NCT04396587|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110393884|NCT04396587|Anesthetics, General|anesthetics, general|mesh-ancestor
110393885|NCT04396587|Anesthetics|anesthetics|mesh-ancestor
110393886|NCT05139524|Immunoglobulin G|immunoglobulin g|mesh-list
110393887|NCT05139524|Immunologic Factors|immunologic factors|mesh-ancestor
110393888|NCT05139524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110393889|NCT01327599|Timolol|timolol|mesh-list
110393890|NCT01327599|Travoprost|travoprost|mesh-list
110393891|NCT01327599|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110393892|NCT01327599|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110393893|NCT01327599|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110393894|NCT01327599|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110393895|NCT01327599|Adrenergic Agents|adrenergic agents|mesh-ancestor
110393896|NCT01327599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110393897|NCT01327599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110393898|NCT01327599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110393899|NCT01327599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110393900|NCT01327599|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110393901|NCT01193257|Prednisone|prednisone|mesh-list
110393902|NCT01193257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110393903|NCT01193257|Glucocorticoids|glucocorticoids|mesh-ancestor
110393904|NCT01193257|Hormones|hormones|mesh-ancestor
110393905|NCT01193257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110393906|NCT01193257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110393907|NCT01193257|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110393908|NCT01193257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110393909|NCT02893371|Lamotrigine|lamotrigine|mesh-list
110393910|NCT02893371|Carbamazepine|carbamazepine|mesh-list
110393911|NCT02893371|Oxcarbazepine|oxcarbazepine|mesh-list
110027865|NCT01729260|Tubulin Modulators|tubulin modulators|mesh-ancestor
110393912|NCT02893371|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110393913|NCT02893371|Valproic Acid|valproic acid|mesh-list
110393914|NCT02893371|Haloperidol|haloperidol|mesh-list
110393915|NCT02893371|Olanzapine|olanzapine|mesh-list
110393916|NCT02893371|Risperidone|risperidone|mesh-list
110393917|NCT02893371|Aripiprazole|aripiprazole|mesh-list
110393918|NCT02893371|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110393919|NCT02893371|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110393920|NCT02893371|Ziprasidone|ziprasidone|mesh-list
110393921|NCT02893371|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
110393922|NCT02893371|Clozapine|clozapine|mesh-list
110393923|NCT02893371|Asenapine|asenapine|mesh-list
110393924|NCT02893371|Perphenazine|perphenazine|mesh-list
110393925|NCT02893371|Lithium Carbonate|lithium carbonate|mesh-list
110393926|NCT02893371|Mirtazapine|mirtazapine|mesh-list
110393927|NCT02893371|Fluvoxamine|fluvoxamine|mesh-list
110393928|NCT02893371|Doxepin|doxepin|mesh-list
110393929|NCT02893371|Citalopram|citalopram|mesh-list
110393930|NCT02893371|Bupropion|bupropion|mesh-list
110393931|NCT02893371|Sertraline|sertraline|mesh-list
110393932|NCT02893371|Fluoxetine|fluoxetine|mesh-list
110393933|NCT02893371|Paroxetine|paroxetine|mesh-list
110393934|NCT02893371|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110393935|NCT02893371|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
110393936|NCT02893371|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
110393937|NCT02893371|Escitalopram|escitalopram|mesh-list
110393938|NCT02893371|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110393939|NCT02893371|Serotonin Agents|serotonin agents|mesh-ancestor
110393940|NCT02893371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110393941|NCT02893371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110393942|NCT02893371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110393943|NCT02893371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110393944|NCT02893371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110393945|NCT02893371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110393946|NCT02893371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110393947|NCT02893371|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110393948|NCT02893371|Dopamine Agents|dopamine agents|mesh-ancestor
110393949|NCT02893371|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110393950|NCT02893371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110393951|NCT02893371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110393952|NCT02893371|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110393953|NCT02893371|Autonomic Agents|autonomic agents|mesh-ancestor
110393954|NCT02893371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110393955|NCT02893371|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110393956|NCT02893371|Antidepressive Agents|antidepressive agents|mesh-ancestor
110393957|NCT02893371|Antiemetics|antiemetics|mesh-ancestor
110393958|NCT02893371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110393959|NCT02893371|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110393960|NCT02893371|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110393961|NCT02893371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110393962|NCT02893371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110393964|NCT02893371|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110393965|NCT02893371|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110393966|NCT02893371|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110393967|NCT02893371|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110393968|NCT02893371|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110393969|NCT02893371|Analgesics|analgesics|mesh-ancestor
110393970|NCT02893371|Sensory System Agents|sensory system agents|mesh-ancestor
110393971|NCT02893371|Antimanic Agents|antimanic agents|mesh-ancestor
110393972|NCT02893371|Anticonvulsants|anticonvulsants|mesh-ancestor
110393973|NCT02893371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110393974|NCT02893371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110393975|NCT02893371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110393976|NCT02893371|GABA Agents|gaba agents|mesh-ancestor
110393977|NCT02893371|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110393978|NCT02893371|Histamine Antagonists|histamine antagonists|mesh-ancestor
110393979|NCT02893371|Histamine Agents|histamine agents|mesh-ancestor
110393980|NCT02893371|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110393981|NCT02893371|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110393982|NCT02893371|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110393983|NCT02893371|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110393984|NCT02893371|Adrenergic Agents|adrenergic agents|mesh-ancestor
110393985|NCT02893371|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110393986|NCT02893371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110393987|NCT02893371|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110393988|NCT02893371|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110393989|NCT02893371|GABA Antagonists|gaba antagonists|mesh-ancestor
110393990|NCT02893371|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110393991|NCT02893371|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110393992|NCT02893371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110393994|NCT02893371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110393995|NCT02893371|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110393997|NCT05138978|Sodium Fluoride|sodium fluoride|mesh-list
110393998|NCT05138978|Cariostatic Agents|cariostatic agents|mesh-ancestor
110048133|NCT02131597|Guadecitabine|guadecitabine|mesh-list
110393999|NCT05138978|Protective Agents|protective agents|mesh-ancestor
110394000|NCT05138978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110394001|NCT05138978|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110394002|NCT05138978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110394003|NCT05138861|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110394004|NCT05138861|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110394005|NCT02893176|Macitentan|macitentan|mesh-list
110394006|NCT02893176|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
110394007|NCT02893176|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110394008|NCT02893176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110394009|NCT02893176|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
110394010|NCT01193218|Empagliflozin|empagliflozin|mesh-list
110394011|NCT01193218|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110394012|NCT01193218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110394013|NCT01193218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110394014|NCT01193218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110394015|NCT01193101|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110394016|NCT01193101|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110394017|NCT01193101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110394018|NCT04328805|Ibuprofen|ibuprofen|mesh-list
110394019|NCT04328805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110394020|NCT04328805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110394021|NCT04328805|Analgesics|analgesics|mesh-ancestor
110394022|NCT04328805|Sensory System Agents|sensory system agents|mesh-ancestor
110394023|NCT04328805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110394024|NCT04328805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110394025|NCT04328805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110394026|NCT04328805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110394027|NCT04328805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110394028|NCT04328805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110394029|NCT04328805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110394030|NCT04329000|Esomeprazole|esomeprazole|mesh-list
110394031|NCT04329000|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110394032|NCT04329000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110394033|NCT04329000|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110394034|NCT04329000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110394035|NCT04329000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110394036|NCT01192399|Eculizumab|eculizumab|mesh-list
110394037|NCT01192399|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110394038|NCT01192399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110394039|NCT01192399|Immunologic Factors|immunologic factors|mesh-ancestor
110394040|NCT01192399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110394041|NCT04389294|Antibodies|antibodies|mesh-list
110394042|NCT04389294|Immunologic Factors|immunologic factors|mesh-ancestor
110394043|NCT04389294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110394045|NCT01176916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110394046|NCT01176916|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110394047|NCT01176916|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110394048|NCT01176916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110394049|NCT01176916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110394050|NCT01176916|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110394051|NCT01176916|Hormone Antagonists|hormone antagonists|mesh-ancestor
110394052|NCT01176916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110394053|NCT01176916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110394054|NCT02894268|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110394056|NCT02894268|Furazolidone|furazolidone|mesh-list
110394057|NCT02894268|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
110394058|NCT02894268|Esomeprazole|esomeprazole|mesh-list
110394059|NCT02894268|Bismuth|bismuth|mesh-list
110394060|NCT02894268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110394061|NCT02894268|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110394062|NCT02894268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110394063|NCT02894268|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110394064|NCT02894268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110394065|NCT02894268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110394066|NCT02894268|Antimalarials|antimalarials|mesh-ancestor
110394067|NCT02894268|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110394068|NCT02894268|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110394069|NCT02894268|Antacids|antacids|mesh-ancestor
110394070|NCT02894268|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110394071|NCT02894268|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110394072|NCT02894268|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
110394073|NCT02894268|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110394074|NCT01600625|Minocycline|minocycline|mesh-list
110394075|NCT01600625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110394076|NCT01600625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110394077|NCT01600742|Vorinostat|vorinostat|mesh-list
110394078|NCT01600742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110394079|NCT01600742|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110394080|NCT01600742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110394081|NCT01600742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110394082|NCT01327482|Raltegravir Potassium|raltegravir potassium|mesh-list
110394083|NCT01327482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110394084|NCT01327482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110394085|NCT01327482|Antiviral Agents|antiviral agents|mesh-ancestor
110394086|NCT01327482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110394087|NCT01327482|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110394088|NCT01327482|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110394089|NCT01327482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110394090|NCT01327482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110394091|NCT02893488|Lamivudine|lamivudine|mesh-list
110394092|NCT02893488|Dolutegravir|dolutegravir|mesh-list
110394093|NCT02893488|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110394094|NCT02893488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110394095|NCT02893488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110394096|NCT02893488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110394097|NCT02893488|Antiviral Agents|antiviral agents|mesh-ancestor
110394098|NCT02893488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110394099|NCT02893488|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110394100|NCT02893488|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110394101|NCT02893488|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110394102|NCT02893488|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110394103|NCT04328883|Aspirin|aspirin|mesh-list
110394104|NCT04328883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110394105|NCT04328883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110394106|NCT04328883|Analgesics|analgesics|mesh-ancestor
110394107|NCT04328883|Sensory System Agents|sensory system agents|mesh-ancestor
110394108|NCT04328883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110394109|NCT04328883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110394110|NCT04328883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110394111|NCT04328883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110394112|NCT04328883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110394113|NCT04328883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110394114|NCT04328883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110394115|NCT04328883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110394116|NCT04328883|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110394117|NCT04328883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110394118|NCT04328883|Antipyretics|antipyretics|mesh-ancestor
110394119|NCT01600235|Phenylephrine|phenylephrine|mesh-list
110394120|NCT01600235|Oxymetazoline|oxymetazoline|mesh-list
110394121|NCT01600235|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110394122|NCT01600235|Mydriatics|mydriatics|mesh-ancestor
110394123|NCT01600235|Autonomic Agents|autonomic agents|mesh-ancestor
110394124|NCT01600235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110394125|NCT01600235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110394126|NCT01600235|Sympathomimetics|sympathomimetics|mesh-ancestor
110394127|NCT01600235|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110394129|NCT01600235|Respiratory System Agents|respiratory system agents|mesh-ancestor
110394130|NCT01600235|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110394131|NCT01600235|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110394132|NCT01600235|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110394133|NCT01600235|Adrenergic Agents|adrenergic agents|mesh-ancestor
110394134|NCT01600235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110394135|NCT01600235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110394136|NCT01600235|Protective Agents|protective agents|mesh-ancestor
110394138|NCT02893254|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110394139|NCT02893254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110394140|NCT02893254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110394141|NCT00592137|Calcium, Dietary|calcium, dietary|mesh-list
110394142|NCT00592137|Calcium|calcium|mesh-list
110394143|NCT00592137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110394144|NCT00592137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110394145|NCT00592137|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110394146|NCT04455776|Propofol|propofol|mesh-list
110048286|NCT00781612|Paclitaxel|paclitaxel|mesh-list
110394147|NCT04455776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110394148|NCT04455776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110394149|NCT04455776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110394150|NCT04455776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110394151|NCT04455776|Anesthetics, General|anesthetics, general|mesh-ancestor
110394152|NCT04455776|Anesthetics|anesthetics|mesh-ancestor
110394153|NCT04135092|Aldesleukin|aldesleukin|mesh-list
110394154|NCT04135092|Cyclophosphamide|cyclophosphamide|mesh-list
110394155|NCT04135092|Pembrolizumab|pembrolizumab|mesh-list
110394156|NCT04135092|Fludarabine|fludarabine|mesh-list
110394157|NCT04135092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110394158|NCT04135092|Immunologic Factors|immunologic factors|mesh-ancestor
110394159|NCT04135092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110394160|NCT04135092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110394161|NCT04135092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110394162|NCT04135092|Alkylating Agents|alkylating agents|mesh-ancestor
110394163|NCT04135092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110394164|NCT04135092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110394165|NCT04135092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110394166|NCT04135092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110394167|NCT04135092|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110394168|NCT04135092|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110394169|NCT04135092|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110394170|NCT04135092|Antiviral Agents|antiviral agents|mesh-ancestor
110394171|NCT04135092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110394172|NCT00592215|Misoprostol|misoprostol|mesh-list
110394173|NCT00592215|Mifepristone|mifepristone|mesh-list
110394174|NCT00592215|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110394175|NCT00592215|Abortifacient Agents|abortifacient agents|mesh-ancestor
110394176|NCT00592215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110394177|NCT00592215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110394178|NCT00592215|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110394179|NCT00592215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110394180|NCT00592215|Oxytocics|oxytocics|mesh-ancestor
110394181|NCT00592215|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110394182|NCT00592215|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110394183|NCT00592215|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110394184|NCT00592215|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110394185|NCT00592215|Contraceptive Agents|contraceptive agents|mesh-ancestor
110394186|NCT00592215|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110394187|NCT00592215|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110394188|NCT00592215|Hormone Antagonists|hormone antagonists|mesh-ancestor
110394189|NCT00592215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110394190|NCT00592215|Luteolytic Agents|luteolytic agents|mesh-ancestor
110394191|NCT00592215|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110394192|NCT00592215|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110394194|NCT00592332|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110394195|NCT00592332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110394196|NCT00592332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110394197|NCT00592332|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110394198|NCT00592332|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110394199|NCT00592332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110394200|NCT00592332|GABA Modulators|gaba modulators|mesh-ancestor
110394201|NCT00592332|GABA Agents|gaba agents|mesh-ancestor
110394202|NCT00592332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110394203|NCT00592332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110394205|NCT04477382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110394206|NCT04477382|Keratolytic Agents|keratolytic agents|mesh-ancestor
110394207|NCT04477382|Dermatologic Agents|dermatologic agents|mesh-ancestor
110394208|NCT01600274|Dienogest|dienogest|mesh-list
110394209|NCT01600274|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110394210|NCT01600274|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110394211|NCT01600274|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110394212|NCT01600274|Estradiol|estradiol|mesh-list
110394213|NCT01600274|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110394214|NCT01600274|Nandrolone|nandrolone|mesh-list
110394215|NCT01600274|Estrogens|estrogens|mesh-ancestor
110394216|NCT01600274|Hormones|hormones|mesh-ancestor
110394217|NCT01600274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110394218|NCT01600274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110394219|NCT01600274|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110048358|NCT04787289|Growth Substances|growth substances|mesh-ancestor
110394220|NCT01600274|Contraceptive Agents|contraceptive agents|mesh-ancestor
110394221|NCT01600274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110394222|NCT01600274|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110394223|NCT01600274|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110394225|NCT01600274|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110394226|NCT01600274|Hormone Antagonists|hormone antagonists|mesh-ancestor
110394227|NCT01600274|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110394228|NCT01600274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110394229|NCT01600274|Androgens|androgens|mesh-ancestor
110394230|NCT01600274|Anabolic Agents|anabolic agents|mesh-ancestor
110394231|NCT01176565|Nicardipine|nicardipine|mesh-list
110394232|NCT01176565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110394233|NCT01176565|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110394234|NCT01176565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110394235|NCT01176565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110394236|NCT01176565|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110394237|NCT01176565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110394238|NCT01176565|Vasodilator Agents|vasodilator agents|mesh-ancestor
110394239|NCT04374123|Antibodies|antibodies|mesh-list
110394240|NCT04374123|Immunoglobulin M|immunoglobulin m|mesh-list
110394241|NCT04374123|Immunologic Factors|immunologic factors|mesh-ancestor
110394242|NCT04374123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110394243|NCT01113541|Ziprasidone|ziprasidone|mesh-list
110394244|NCT01113541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110394245|NCT01113541|Serotonin Agents|serotonin agents|mesh-ancestor
110394246|NCT01113541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110394247|NCT01113541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110394248|NCT01113541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110394249|NCT01113541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110394250|NCT01113541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110394251|NCT01113541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110394252|NCT01113541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110394253|NCT01113541|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110394254|NCT01113541|Dopamine Agents|dopamine agents|mesh-ancestor
110394255|NCT00591708|Calcium, Dietary|calcium, dietary|mesh-list
110394256|NCT00591708|Citric Acid|citric acid|mesh-list
110394257|NCT00591708|Sodium Citrate|sodium citrate|mesh-list
110394259|NCT00591708|Calcium citrate malate|calcium citrate malate|mesh-list
110394260|NCT00591708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110394261|NCT00591708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110394262|NCT00591708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110394263|NCT00591708|Anticoagulants|anticoagulants|mesh-ancestor
110394264|NCT00591708|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110394265|NCT00591708|Chelating Agents|chelating agents|mesh-ancestor
110394266|NCT00591708|Sequestering Agents|sequestering agents|mesh-ancestor
110394267|NCT00591708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110394268|NCT01176058|Fluconazole|fluconazole|mesh-list
110394269|NCT01176058|Anidulafungin|anidulafungin|mesh-list
110394270|NCT01176058|Antifungal Agents|antifungal agents|mesh-ancestor
110394271|NCT01176058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110394272|NCT01176058|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110394273|NCT01176058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110394274|NCT01176058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110394275|NCT01176058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110394276|NCT01176058|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110394277|NCT01176058|Hormone Antagonists|hormone antagonists|mesh-ancestor
110394278|NCT01176058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110394279|NCT01176058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110394280|NCT01176058|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110394281|NCT01176058|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110394282|NCT04328766|Fexuprazan|fexuprazan|mesh-list
110394283|NCT04328766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110394284|NCT02273765|Tenofovir|tenofovir|mesh-list
110394285|NCT02273765|Lamivudine|lamivudine|mesh-list
110394286|NCT02273765|Efavirenz|efavirenz|mesh-list
110394287|NCT02273765|Raltegravir Potassium|raltegravir potassium|mesh-list
110394288|NCT02273765|Antiviral Agents|antiviral agents|mesh-ancestor
110394289|NCT02273765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110394290|NCT02273765|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110028065|NCT03402438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110394291|NCT02273765|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110394293|NCT02273765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110394294|NCT02273765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110394295|NCT02273765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110394296|NCT02273765|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110394297|NCT02273765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110394298|NCT02273765|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110394299|NCT02273765|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110394300|NCT02273765|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110394301|NCT02273765|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110394302|NCT02273765|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110394303|NCT02273765|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110394304|NCT01607333|Lamotrigine|lamotrigine|mesh-list
110394305|NCT01607333|Anticonvulsants|anticonvulsants|mesh-ancestor
110394306|NCT01607333|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110394307|NCT01607333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110394308|NCT01607333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110394309|NCT01607333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110394310|NCT01607333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110394311|NCT01607333|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110394312|NCT01607333|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110394313|NCT01607333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110394314|NCT01607333|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110394315|NCT01607333|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110394317|NCT01601093|Cefoperazone|cefoperazone|mesh-list
110394318|NCT01601093|Sulperazone|sulperazone|mesh-list
110394319|NCT01601093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110394320|NCT01601093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110394321|NCT01601093|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110394322|NCT01601093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110394323|NCT01601093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110394324|NCT01601093|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110394326|NCT04366830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110394327|NCT04366830|Antiviral Agents|antiviral agents|mesh-ancestor
110394328|NCT04366830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110394330|NCT01175824|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110394331|NCT01175824|Insulin Glargine|insulin glargine|mesh-list
110394333|NCT01175824|Protamines|protamines|mesh-list
110394334|NCT01175824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110394335|NCT01175824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110394336|NCT01175824|Heparin Antagonists|heparin antagonists|mesh-ancestor
110394337|NCT01175824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110394338|NCT01175824|Coagulants|coagulants|mesh-ancestor
110394339|NCT01175707|Vancomycin|vancomycin|mesh-list
110394340|NCT01175707|Daptomycin|daptomycin|mesh-list
110394341|NCT01175707|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110394342|NCT01175707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110394343|NCT01112059|Doxycycline|doxycycline|mesh-list
110394344|NCT01112059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110394345|NCT01112059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110028102|NCT03401502|Ranolazine|ranolazine|mesh-list
110394346|NCT01112059|Antimalarials|antimalarials|mesh-ancestor
110394347|NCT01112059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110394348|NCT01112059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110394349|NCT01175668|Clonidine|clonidine|mesh-list
110394350|NCT01175668|Phenobarbital|phenobarbital|mesh-list
110394351|NCT01175668|Analgesics|analgesics|mesh-ancestor
110394352|NCT01175668|Sensory System Agents|sensory system agents|mesh-ancestor
110394353|NCT01175668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110394354|NCT01175668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110394355|NCT01175668|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110394356|NCT01175668|Sympatholytics|sympatholytics|mesh-ancestor
110394357|NCT01175668|Autonomic Agents|autonomic agents|mesh-ancestor
110394358|NCT01175668|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110394359|NCT01175668|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110394360|NCT01175668|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110394361|NCT01175668|Adrenergic Agents|adrenergic agents|mesh-ancestor
110394362|NCT01175668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110394363|NCT01175668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110394364|NCT01175668|Anticonvulsants|anticonvulsants|mesh-ancestor
110394365|NCT01175668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110394366|NCT01175668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110394367|NCT01175668|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110394368|NCT01175668|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110394369|NCT01175668|GABA Modulators|gaba modulators|mesh-ancestor
110394370|NCT01175668|GABA Agents|gaba agents|mesh-ancestor
110394371|NCT01175668|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110394372|NCT01175668|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110394373|NCT01175668|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110394374|NCT01601327|Methyltestosterone|methyltestosterone|mesh-list
110394375|NCT01601327|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110394377|NCT01601327|Testosterone undecanoate|testosterone undecanoate|mesh-list
110394378|NCT01601327|Testosterone enanthate|testosterone enanthate|mesh-list
110394379|NCT01601327|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110394381|NCT01601327|Hormones|hormones|mesh-ancestor
110394382|NCT01601327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110394383|NCT01601327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110394384|NCT01601327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110394385|NCT01601327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110394386|NCT01601327|Anabolic Agents|anabolic agents|mesh-ancestor
110394387|NCT01601327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110394388|NCT01601366|Contraceptive Agents|contraceptive agents|mesh-list
110394389|NCT01601366|Contraceptives, Oral|contraceptives, oral|mesh-list
110394390|NCT01601366|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
110394391|NCT01601366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110394392|NCT01601366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110394393|NCT01601366|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110394395|NCT01607762|Risperidone|risperidone|mesh-list
110394396|NCT01607762|Aripiprazole|aripiprazole|mesh-list
110394397|NCT01607762|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110394398|NCT01607762|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110394399|NCT01607762|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110394400|NCT01607762|Serotonin Agents|serotonin agents|mesh-ancestor
110394401|NCT01607762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110394402|NCT01607762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110394403|NCT01607762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110394404|NCT01607762|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110394405|NCT01607762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110394406|NCT01607762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110394407|NCT01607762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110394408|NCT01607762|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110394409|NCT01607762|Dopamine Agents|dopamine agents|mesh-ancestor
110394410|NCT01607762|Antiemetics|antiemetics|mesh-ancestor
110394411|NCT01607762|Autonomic Agents|autonomic agents|mesh-ancestor
110394412|NCT01607762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110394413|NCT01607762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110394414|NCT01607762|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110394415|NCT01607762|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110394416|NCT01607762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110394417|NCT01607762|Antidepressive Agents|antidepressive agents|mesh-ancestor
110394418|NCT01607762|Dopamine Agonists|dopamine agonists|mesh-ancestor
110394419|NCT01607762|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110394420|NCT01607762|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110394421|NCT01607762|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110394422|NCT01607762|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110394423|NCT04327947|Hyaluronic Acid|hyaluronic acid|mesh-list
110394424|NCT04327947|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110394425|NCT04327947|Immunologic Factors|immunologic factors|mesh-ancestor
110394426|NCT04327947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110394427|NCT04327947|Viscosupplements|viscosupplements|mesh-ancestor
110394428|NCT04327947|Protective Agents|protective agents|mesh-ancestor
110394429|NCT01607918|Amoxicillin|amoxicillin|mesh-list
110394430|NCT01607918|Metronidazole|metronidazole|mesh-list
110394431|NCT01607918|Clarithromycin|clarithromycin|mesh-list
110394432|NCT01607918|Lansoprazole|lansoprazole|mesh-list
110394433|NCT01607918|Dexlansoprazole|dexlansoprazole|mesh-list
110394434|NCT01607918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110394435|NCT01607918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110394436|NCT01607918|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110394437|NCT01607918|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110394438|NCT01607918|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110394439|NCT01607918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110394440|NCT01607918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110394441|NCT01607918|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110394442|NCT01607918|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110394443|NCT01607918|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110394444|NCT01607918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110394445|NCT01607918|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110394447|NCT01607996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110394448|NCT01607996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110394449|NCT01601561|Insulin|insulin|mesh-list
110394450|NCT01601561|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110394451|NCT01601561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110394452|NCT01601561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110394453|NCT01601795|Sevoflurane|sevoflurane|mesh-list
110394454|NCT01601795|Isoflurane|isoflurane|mesh-list
110394455|NCT01601795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110394456|NCT01601795|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110394457|NCT01601795|Anesthetics, General|anesthetics, general|mesh-ancestor
110394458|NCT01601795|Anesthetics|anesthetics|mesh-ancestor
110394459|NCT01601795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110394460|NCT01601795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110394462|NCT01601912|Citalopram|citalopram|mesh-list
110394464|NCT01601912|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110394465|NCT01601912|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110394466|NCT01601912|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110394467|NCT01601912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110394468|NCT01601912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110394469|NCT01601912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110394470|NCT01601912|Serotonin Agents|serotonin agents|mesh-ancestor
110394471|NCT01601912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110394472|NCT01601912|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110394473|NCT01601912|Antidepressive Agents|antidepressive agents|mesh-ancestor
110394474|NCT01601912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110394475|NCT01601912|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110394476|NCT01601912|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110394477|NCT01601912|Parasympatholytics|parasympatholytics|mesh-ancestor
110394479|NCT01601912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110394480|NCT01601912|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110394481|NCT01601912|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110394482|NCT01601912|Cholinergic Agents|cholinergic agents|mesh-ancestor
110394483|NCT01601912|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110394484|NCT01601912|Adrenergic Agents|adrenergic agents|mesh-ancestor
110394485|NCT01111825|Sirolimus|sirolimus|mesh-list
110394486|NCT01111825|Temsirolimus|temsirolimus|mesh-list
110394487|NCT01111825|MTOR Inhibitors|mtor inhibitors|mesh-list
110394488|NCT01111825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110394489|NCT01111825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110028176|NCT02241174|Sodium Hypochlorite|sodium hypochlorite|mesh-list
110394490|NCT01111825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110394493|NCT01111825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110394494|NCT01111825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110394495|NCT01111825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110394496|NCT01111825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110394497|NCT01111825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110394498|NCT01111825|Antifungal Agents|antifungal agents|mesh-ancestor
110394499|NCT01175590|Besifloxacin|besifloxacin|mesh-list
110394500|NCT01175590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110394501|NCT01175590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110394502|NCT01175590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110394503|NCT01175590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110394504|NCT01175590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110394505|NCT01175590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110394506|NCT01175590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110394507|NCT01175473|Metformin|metformin|mesh-list
110394508|NCT01175473|Liraglutide|liraglutide|mesh-list
110394509|NCT01175473|Lixisenatide|lixisenatide|mesh-list
110394510|NCT01175473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110394511|NCT01175473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110394512|NCT01175473|Incretins|incretins|mesh-ancestor
110394513|NCT01175473|Hormones|hormones|mesh-ancestor
110394514|NCT01175473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110394515|NCT01111552|Aripiprazole|aripiprazole|mesh-list
110394516|NCT01111552|Escitalopram|escitalopram|mesh-list
110394517|NCT01111552|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110394518|NCT01111552|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110394519|NCT01111552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110394520|NCT01111552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110394521|NCT01111552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110394522|NCT01111552|Serotonin Agents|serotonin agents|mesh-ancestor
110394523|NCT01111552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110394524|NCT01111552|Antidepressive Agents|antidepressive agents|mesh-ancestor
110394526|NCT01111552|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110394527|NCT01111552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110394528|NCT01111552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110394529|NCT01111552|Dopamine Agonists|dopamine agonists|mesh-ancestor
110394530|NCT01111552|Dopamine Agents|dopamine agents|mesh-ancestor
110394531|NCT01111552|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110394532|NCT01111552|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110394533|NCT01111552|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110394534|NCT01111552|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110394535|NCT01111552|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110394536|NCT01111552|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110394537|NCT01602185|Memantine|memantine|mesh-list
110394538|NCT01602185|Dextromethorphan|dextromethorphan|mesh-list
110394539|NCT01602185|Antitussive Agents|antitussive agents|mesh-list
110394540|NCT01602185|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110394541|NCT01602185|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110394542|NCT01602185|Dopamine Agents|dopamine agents|mesh-ancestor
110394543|NCT01602185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110394544|NCT01602185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110394545|NCT01602185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110394546|NCT01602185|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110394547|NCT01602185|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110394548|NCT01602185|Respiratory System Agents|respiratory system agents|mesh-ancestor
110394549|NCT01602302|Adalimumab|adalimumab|mesh-list
110394550|NCT01602302|Infliximab|infliximab|mesh-list
110394551|NCT01602302|Golimumab|golimumab|mesh-list
110394552|NCT01602302|Certolizumab Pegol|certolizumab pegol|mesh-list
110394553|NCT01602302|Etanercept|etanercept|mesh-list
110394554|NCT01602302|Abatacept|abatacept|mesh-list
110394555|NCT01602302|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110394556|NCT01602302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110394557|NCT01602302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110394558|NCT01602302|Dermatologic Agents|dermatologic agents|mesh-ancestor
110394559|NCT01602302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110394560|NCT01602302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110394561|NCT01602302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110394562|NCT01602302|Analgesics|analgesics|mesh-ancestor
110394563|NCT01602302|Sensory System Agents|sensory system agents|mesh-ancestor
110394564|NCT01602302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110394565|NCT01602302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110394566|NCT01602302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110394567|NCT01602302|Immunologic Factors|immunologic factors|mesh-ancestor
110394568|NCT01602302|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110394569|NCT01602302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110394570|NCT01602302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110394571|NCT01602302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110394572|NCT02893722|Oxytocin|oxytocin|mesh-list
110394573|NCT02893722|Atosiban|atosiban|mesh-list
110394574|NCT02893722|Oxytocics|oxytocics|mesh-ancestor
110394575|NCT02893722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110394576|NCT02893722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110394577|NCT02893722|Hormone Antagonists|hormone antagonists|mesh-ancestor
110394578|NCT02893722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110394579|NCT02893722|Tocolytic Agents|tocolytic agents|mesh-ancestor
110394580|NCT01608269|Lamivudine|lamivudine|mesh-list
110394581|NCT01608269|Abacavir|abacavir|mesh-list
110394582|NCT01608269|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110394583|NCT01608269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110394584|NCT01608269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110394585|NCT01608269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110394586|NCT01608269|Antiviral Agents|antiviral agents|mesh-ancestor
110028231|NCT02242656|Analgesics|analgesics|mesh-ancestor
110394587|NCT01608269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110394588|NCT01608269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110394589|NCT01608269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110394591|NCT01608347|Vitamin B Complex|vitamin b complex|mesh-list
110394593|NCT01608347|Vitamins|vitamins|mesh-ancestor
110394594|NCT01608347|Micronutrients|micronutrients|mesh-ancestor
110394595|NCT01608347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110394596|NCT04405284|Disinfectants|disinfectants|mesh-list
110394597|NCT04405284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110394599|NCT01608464|Docetaxel|docetaxel|mesh-list
110394600|NCT01608464|Fluorouracil|fluorouracil|mesh-list
110394601|NCT01608464|Irinotecan|irinotecan|mesh-list
110394602|NCT01608464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110394603|NCT01608464|Tubulin Modulators|tubulin modulators|mesh-ancestor
110394604|NCT01608464|Antimitotic Agents|antimitotic agents|mesh-ancestor
110394605|NCT01608464|Mitosis Modulators|mitosis modulators|mesh-ancestor
110394606|NCT01608464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110394607|NCT01608464|Antimetabolites|antimetabolites|mesh-ancestor
110394608|NCT01608464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110394609|NCT01608464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110394610|NCT01608464|Immunologic Factors|immunologic factors|mesh-ancestor
110394611|NCT01608464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110394612|NCT01608464|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110394613|NCT01608464|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110394614|NCT01608464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110394615|NCT01608698|Drospirenone|drospirenone|mesh-list
110394616|NCT01608698|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110394617|NCT01608698|Chlormadinone Acetate|chlormadinone acetate|mesh-list
110394618|NCT01608698|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110394619|NCT01608698|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110394620|NCT01608698|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110394621|NCT01608698|Contraceptive Agents|contraceptive agents|mesh-ancestor
110394622|NCT01608698|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110394623|NCT01608698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110394624|NCT01608698|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110394625|NCT01608698|Estrogens|estrogens|mesh-ancestor
110394626|NCT01608698|Hormones|hormones|mesh-ancestor
110394627|NCT01608698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110394628|NCT01608698|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110394629|NCT01608698|Hormone Antagonists|hormone antagonists|mesh-ancestor
110028249|NCT02242812|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110394630|NCT01608698|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110394631|NCT01608698|Diuretics|diuretics|mesh-ancestor
110394632|NCT01608698|Natriuretic Agents|natriuretic agents|mesh-ancestor
110394633|NCT01608698|Androgen Antagonists|androgen antagonists|mesh-ancestor
110394634|NCT01608698|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110394636|NCT04310254|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110394637|NCT04310254|Pentetic Acid|pentetic acid|mesh-list
110394638|NCT04310254|Anticoagulants|anticoagulants|mesh-ancestor
110394639|NCT04310254|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110394640|NCT04310254|Chelating Agents|chelating agents|mesh-ancestor
110394641|NCT04310254|Sequestering Agents|sequestering agents|mesh-ancestor
110394642|NCT04310254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110394643|NCT04310254|Antidotes|antidotes|mesh-ancestor
110394644|NCT04310254|Protective Agents|protective agents|mesh-ancestor
110394645|NCT04310254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110394646|NCT04310254|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110394648|NCT01603511|Antidotes|antidotes|mesh-ancestor
110394649|NCT01603511|Protective Agents|protective agents|mesh-ancestor
110394650|NCT01603511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110394651|NCT01603745|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
110394652|NCT01603745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110394653|NCT01603745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110394655|NCT01174186|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110394656|NCT01174186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110394657|NCT01174186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110394658|NCT01609049|Ribavirin|ribavirin|mesh-list
110394659|NCT01609049|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110394660|NCT01609049|Antimetabolites|antimetabolites|mesh-ancestor
110394661|NCT01609049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110394663|NCT01609049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110394664|NCT01609088|Erythritol|erythritol|mesh-list
110394665|NCT01609088|Vasodilator Agents|vasodilator agents|mesh-ancestor
110394666|NCT01609127|Capecitabine|capecitabine|mesh-list
110394667|NCT01609127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110394668|NCT01609127|Antimetabolites|antimetabolites|mesh-ancestor
110394669|NCT01609127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110394670|NCT01609127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110394671|NCT01609166|Allopurinol|allopurinol|mesh-list
110394672|NCT01609166|Antimetabolites|antimetabolites|mesh-ancestor
110394673|NCT01609166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110394674|NCT01609166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110394675|NCT01609166|Gout Suppressants|gout suppressants|mesh-ancestor
110394676|NCT01609166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110394677|NCT01609166|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110394678|NCT01609166|Antioxidants|antioxidants|mesh-ancestor
110394679|NCT01609166|Protective Agents|protective agents|mesh-ancestor
110394680|NCT01609166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110394682|NCT01609205|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110394683|NCT01609205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110394684|NCT01609205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110394685|NCT01604057|Teriparatide|teriparatide|mesh-list
110394686|NCT01604057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110394687|NCT01604057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110394688|NCT01604057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110394689|NCT00592566|Dexamethasone|dexamethasone|mesh-list
110394690|NCT00592566|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
110394691|NCT00592566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110394692|NCT00592566|Antiemetics|antiemetics|mesh-ancestor
110394693|NCT00592566|Autonomic Agents|autonomic agents|mesh-ancestor
110394694|NCT00592566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110394695|NCT00592566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110394696|NCT00592566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110394697|NCT00592566|Glucocorticoids|glucocorticoids|mesh-ancestor
110394698|NCT00592566|Hormones|hormones|mesh-ancestor
110394699|NCT00592566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110394700|NCT00592566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110394701|NCT00592566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110394702|NCT00592566|Hemostatics|hemostatics|mesh-ancestor
110394703|NCT00592566|Coagulants|coagulants|mesh-ancestor
110394704|NCT00592566|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110394705|NCT00592566|Natriuretic Agents|natriuretic agents|mesh-ancestor
110394706|NCT01111123|Halobetasol|halobetasol|mesh-list
110394707|NCT01111123|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110394708|NCT01604330|Baclofen|baclofen|mesh-list
110394709|NCT01604330|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110394710|NCT01604330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110394711|NCT01604330|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110394712|NCT01604330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110394713|NCT01604330|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110394714|NCT01604330|GABA Agonists|gaba agonists|mesh-ancestor
110394715|NCT01604330|GABA Agents|gaba agents|mesh-ancestor
110394716|NCT01604330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110394717|NCT01604330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110394718|NCT00622830|Darapladib|darapladib|mesh-list
110394719|NCT00622830|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
110394720|NCT00622830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110394721|NCT00622830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110394722|NCT01173679|Rituximab|rituximab|mesh-list
110394723|NCT01173679|Fludarabine|fludarabine|mesh-list
110394724|NCT01173679|Dasatinib|dasatinib|mesh-list
110394725|NCT01173679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110394726|NCT01173679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110394727|NCT01173679|Immunologic Factors|immunologic factors|mesh-ancestor
110394728|NCT01173679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110394729|NCT01173679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110394730|NCT01173679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110394731|NCT01173679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110394732|NCT01173679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110394733|NCT02881528|Metformin|metformin|mesh-list
110394734|NCT02881528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110394735|NCT02881528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110394736|NCT01609439|Vitamin D|vitamin d|mesh-list
110394737|NCT01609439|Vitamins|vitamins|mesh-ancestor
110394738|NCT01609439|Micronutrients|micronutrients|mesh-ancestor
110394739|NCT01609439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110394740|NCT01609439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110394742|NCT01110382|Meropenem|meropenem|mesh-list
110394743|NCT01110382|Clavulanic Acid|clavulanic acid|mesh-list
110394744|NCT01110382|Clavulanic Acids|clavulanic acids|mesh-list
110394745|NCT01110382|Doripenem|doripenem|mesh-list
110394746|NCT01110382|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110394747|NCT01110382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110394748|NCT01110382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110394749|NCT01110382|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110394750|NCT01110382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110394751|NCT01110382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110394752|NCT00592917|Cholecalciferol|cholecalciferol|mesh-list
110394753|NCT00592917|Vitamin D|vitamin d|mesh-list
110394754|NCT00592917|Calcium Carbonate|calcium carbonate|mesh-list
110394755|NCT00592917|Calcium|calcium|mesh-list
110394756|NCT00592917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110394757|NCT00592917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110394758|NCT00592917|Vitamins|vitamins|mesh-ancestor
110394759|NCT00592917|Micronutrients|micronutrients|mesh-ancestor
110394760|NCT00592917|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110394761|NCT00592917|Antacids|antacids|mesh-ancestor
110394762|NCT00592917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110394763|NCT00592917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110394764|NCT01609517|Bupivacaine|bupivacaine|mesh-list
110394765|NCT01609517|Anesthetics|anesthetics|mesh-list
110394766|NCT01609517|Anesthetics, Local|anesthetics, local|mesh-ancestor
110394767|NCT01609517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110394768|NCT01609517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110394769|NCT01609517|Sensory System Agents|sensory system agents|mesh-ancestor
110394770|NCT01609517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110394771|NCT05265325|Epoetin Alfa|epoetin alfa|mesh-list
110394772|NCT05265325|Hematinics|hematinics|mesh-ancestor
110394773|NCT00593151|Interferons|interferons|mesh-list
110394774|NCT00593151|Interferon-alpha|interferon-alpha|mesh-list
110394775|NCT00593151|Interferon alpha-2|interferon alpha-2|mesh-list
110394776|NCT00593151|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110394777|NCT00593151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110394778|NCT00593151|Antiviral Agents|antiviral agents|mesh-ancestor
110394779|NCT00593151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110394780|NCT00593151|Immunologic Factors|immunologic factors|mesh-ancestor
110394781|NCT00593151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110394782|NCT02489006|Olaparib|olaparib|mesh-list
110394783|NCT02489006|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110394784|NCT02489006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110394785|NCT02489006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110394786|NCT02489006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110394787|NCT01173601|Serotonin|serotonin|mesh-list
110394788|NCT01173601|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
110394789|NCT01173601|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110394790|NCT01173601|Serotonin Agents|serotonin agents|mesh-ancestor
110394791|NCT01173601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110394792|NCT01173601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110394793|NCT01173601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110394794|NCT01173601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110394795|NCT01173601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110394796|NCT01609673|Everolimus|everolimus|mesh-list
110394797|NCT01609673|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110394798|NCT01609673|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110394799|NCT01609673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110394800|NCT01609673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110394801|NCT01609673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110394802|NCT01609673|Immunologic Factors|immunologic factors|mesh-ancestor
110394803|NCT01609673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110394804|NCT01609673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110394806|NCT01173055|Levomilnacipran|levomilnacipran|mesh-list
110394807|NCT01173055|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110394808|NCT01173055|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110394809|NCT01173055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110394810|NCT01173055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110394811|NCT01173055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110394812|NCT01173055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110394813|NCT01173055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110394815|NCT01173055|Sensory System Agents|sensory system agents|mesh-ancestor
110394816|NCT01173055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110394817|NCT01173055|Antidepressive Agents|antidepressive agents|mesh-ancestor
110394818|NCT01173055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110394820|NCT00593502|Antiviral Agents|antiviral agents|mesh-ancestor
110394821|NCT00593502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110394822|NCT00593502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110394823|NCT00593502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110394824|NCT01609907|Valsartan|valsartan|mesh-list
110394825|NCT01609907|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110394826|NCT01609907|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110394827|NCT01609907|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110394828|NCT01609907|Antimetabolites|antimetabolites|mesh-ancestor
110394829|NCT01609907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110394830|NCT01609907|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110394831|NCT01609907|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110394832|NCT01609907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110394833|NCT01609907|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110394834|NCT01609907|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110394835|NCT01609907|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110394836|NCT00593580|Cholecalciferol|cholecalciferol|mesh-list
110394838|NCT00593580|Alendronate|alendronate|mesh-list
110394839|NCT00593580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110394842|NCT00593580|Micronutrients|micronutrients|mesh-ancestor
110394843|NCT00593580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110394844|NCT04327011|Flucytosine|flucytosine|mesh-list
110394845|NCT04327011|Antifungal Agents|antifungal agents|mesh-ancestor
110394846|NCT04327011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110394847|NCT04327011|Antimetabolites|antimetabolites|mesh-ancestor
110394848|NCT04327011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110394849|NCT00593619|Iron|iron|mesh-list
110394850|NCT00593619|Dextrans|dextrans|mesh-list
110394851|NCT00593619|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
110394852|NCT00593619|Iron-Dextran Complex|iron-dextran complex|mesh-list
110394853|NCT00593619|Trace Elements|trace elements|mesh-ancestor
110394854|NCT00593619|Micronutrients|micronutrients|mesh-ancestor
110394855|NCT00593619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110394857|NCT00593619|Anticoagulants|anticoagulants|mesh-ancestor
110394858|NCT00593619|Plasma Substitutes|plasma substitutes|mesh-ancestor
110394859|NCT00593619|Blood Substitutes|blood substitutes|mesh-ancestor
110394860|NCT00593658|Pentoxifylline|pentoxifylline|mesh-list
110394861|NCT00593658|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110394862|NCT00593658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110394863|NCT00593658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110394865|NCT00593658|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110394866|NCT00593658|Protective Agents|protective agents|mesh-ancestor
110394867|NCT00593658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110394868|NCT00593658|Vasodilator Agents|vasodilator agents|mesh-ancestor
110394869|NCT00593658|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110394871|NCT00593697|Docetaxel|docetaxel|mesh-list
110394872|NCT00593697|Trastuzumab|trastuzumab|mesh-list
110394873|NCT00593697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110394874|NCT00593697|Tubulin Modulators|tubulin modulators|mesh-ancestor
110394875|NCT00593697|Antimitotic Agents|antimitotic agents|mesh-ancestor
110394876|NCT00593697|Mitosis Modulators|mitosis modulators|mesh-ancestor
110394877|NCT00593697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110394878|NCT00593697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110394879|NCT01601522|Ranitidine|ranitidine|mesh-list
110394880|NCT01601522|Desloratadine|desloratadine|mesh-list
110394881|NCT01601522|Histamine Antagonists|histamine antagonists|mesh-list
110394882|NCT01601522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
110394883|NCT01601522|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110394884|NCT01601522|Cholinergic Agents|cholinergic agents|mesh-ancestor
110394885|NCT01601522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110394886|NCT01601522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110394887|NCT01601522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110394888|NCT01601522|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110394889|NCT01601522|Histamine Agents|histamine agents|mesh-ancestor
110394890|NCT01601522|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110394891|NCT01601522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110394892|NCT01601522|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110394893|NCT00593853|Methylphenidate|methylphenidate|mesh-list
110394894|NCT00593853|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110394895|NCT00593853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110394896|NCT00593853|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110394897|NCT00593853|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110394898|NCT00593853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110394899|NCT00593853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110394900|NCT00593853|Dopamine Agents|dopamine agents|mesh-ancestor
110394901|NCT00593853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110394902|NCT01607294|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
110394903|NCT01607294|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110394904|NCT01607294|Antimetabolites|antimetabolites|mesh-ancestor
110394905|NCT01607294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110394906|NCT01607294|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110394907|NCT01607294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110394908|NCT01607294|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110394909|NCT01607294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110394910|NCT00594087|Eszopiclone|eszopiclone|mesh-list
110394911|NCT00594087|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110394912|NCT00594087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110394915|NCT00594126|Motesanib diphosphate|motesanib diphosphate|mesh-list
110394916|NCT00594126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110394917|NCT00594126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110394918|NCT00594126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110394919|NCT01605344|Leucovorin|leucovorin|mesh-list
110394920|NCT01605344|Fluorouracil|fluorouracil|mesh-list
110394921|NCT01605344|Irinotecan|irinotecan|mesh-list
110394922|NCT01605344|Atorvastatin|atorvastatin|mesh-list
110394923|NCT01605344|Antimetabolites|antimetabolites|mesh-ancestor
110394924|NCT01605344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110394925|NCT01605344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110394926|NCT01605344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110394927|NCT01605344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110394928|NCT01605344|Immunologic Factors|immunologic factors|mesh-ancestor
110394929|NCT01605344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110394930|NCT01605344|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110394931|NCT01605344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110394932|NCT01605344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110394933|NCT01605344|Antidotes|antidotes|mesh-ancestor
110394935|NCT01605344|Vitamin B Complex|vitamin b complex|mesh-ancestor
110394936|NCT01605344|Vitamins|vitamins|mesh-ancestor
110394937|NCT01605344|Micronutrients|micronutrients|mesh-ancestor
110394938|NCT01605344|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110394939|NCT01605344|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110394940|NCT01605344|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110394941|NCT01605344|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110394942|NCT00593463|Cycloserine|cycloserine|mesh-list
110394943|NCT00593463|Verapamil|verapamil|mesh-list
110394944|NCT00593463|Diltiazem|diltiazem|mesh-list
110394945|NCT00593463|Isradipine|isradipine|mesh-list
110394946|NCT00593463|Nifedipine|nifedipine|mesh-list
110394947|NCT00593463|Gabapentin|gabapentin|mesh-list
110394948|NCT00593463|Naloxone|naloxone|mesh-list
110394949|NCT00593463|Analgesics|analgesics|mesh-ancestor
110394950|NCT00593463|Sensory System Agents|sensory system agents|mesh-ancestor
110394951|NCT00593463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110394952|NCT00593463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110394954|NCT00593463|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110394955|NCT00593463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110394956|NCT00593463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110394957|NCT00593463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110394958|NCT00593463|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110394959|NCT00593463|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110394960|NCT00593463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110394961|NCT00593463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110394962|NCT00593463|Antimanic Agents|antimanic agents|mesh-ancestor
110394963|NCT00593463|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110394964|NCT00593463|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110394965|NCT00593463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110394966|NCT00593463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110394967|NCT00593463|Vasodilator Agents|vasodilator agents|mesh-ancestor
110394968|NCT00593463|Tocolytic Agents|tocolytic agents|mesh-ancestor
110394969|NCT00593463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110394970|NCT00593463|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110394971|NCT00593463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110394972|NCT00593463|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110394973|NCT00593463|Antitubercular Agents|antitubercular agents|mesh-ancestor
110394974|NCT00593463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110394975|NCT00593463|Antimetabolites|antimetabolites|mesh-ancestor
110394976|NCT00593463|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110394977|NCT00593463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110394978|NCT00592410|Insulin|insulin|mesh-list
110394980|NCT00592410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110394981|NCT00592410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110394982|NCT04328064|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110394983|NCT04328064|Calcium|calcium|mesh-list
110394984|NCT04328064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110394985|NCT04328064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110394986|NCT04328064|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110394987|NCT04328064|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110394988|NCT04328064|Antimetabolites|antimetabolites|mesh-ancestor
110394989|NCT04328064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110394990|NCT04328064|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110394991|NCT04328064|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110394992|NCT04328064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110394993|NCT01605734|Sorafenib|sorafenib|mesh-list
110394994|NCT01605734|Chlorotrianisene|chlorotrianisene|mesh-list
110394995|NCT01605734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110394996|NCT01605734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110394997|NCT01605734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110394998|NCT01605734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110394999|NCT01605734|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110395000|NCT01605734|Estrogens|estrogens|mesh-ancestor
110395001|NCT01605734|Hormones|hormones|mesh-ancestor
110395002|NCT01605734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110395003|NCT01605734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110395004|NCT01605734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110395006|NCT01605773|Repaglinide|repaglinide|mesh-list
110395007|NCT01605773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110395008|NCT01605773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110395009|NCT00592527|Insulin Detemir|insulin detemir|mesh-list
110395010|NCT00592527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110395011|NCT00592527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110395013|NCT00594555|Imatinib Mesylate|imatinib mesylate|mesh-list
110395014|NCT00594555|Cladribine|cladribine|mesh-list
110395015|NCT00594555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110395016|NCT00594555|Antimetabolites|antimetabolites|mesh-ancestor
110395017|NCT00594555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110395018|NCT00594555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110395019|NCT00594555|Antiviral Agents|antiviral agents|mesh-ancestor
110395020|NCT00594555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110395021|NCT00594555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110395022|NCT00594555|Immunologic Factors|immunologic factors|mesh-ancestor
110395023|NCT00594555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110395024|NCT00594555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110395025|NCT00594555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110395026|NCT01605929|Mepivacaine|mepivacaine|mesh-list
110395027|NCT01605929|Anesthetics, Local|anesthetics, local|mesh-ancestor
110395028|NCT01605929|Anesthetics|anesthetics|mesh-ancestor
110395029|NCT01605929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110395030|NCT01605929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110395031|NCT01605929|Sensory System Agents|sensory system agents|mesh-ancestor
110395032|NCT01605929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110395033|NCT02270606|Calcium, Dietary|calcium, dietary|mesh-list
110395034|NCT02270606|Leucovorin|leucovorin|mesh-list
110395035|NCT02270606|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
110395036|NCT02270606|Tetrahydrofolates|tetrahydrofolates|mesh-list
110395037|NCT02270606|Fluorouracil|fluorouracil|mesh-list
110395038|NCT02270606|Oxaliplatin|oxaliplatin|mesh-list
110395039|NCT02270606|Calcium|calcium|mesh-list
110395040|NCT02270606|Levoleucovorin|levoleucovorin|mesh-list
110395041|NCT02270606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110395042|NCT02270606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110395043|NCT02270606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110395044|NCT02270606|Antimetabolites|antimetabolites|mesh-ancestor
110395045|NCT02270606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110395046|NCT02270606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110395047|NCT02270606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110395048|NCT02270606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110395049|NCT02270606|Immunologic Factors|immunologic factors|mesh-ancestor
110395050|NCT02270606|Antidotes|antidotes|mesh-ancestor
110395051|NCT02270606|Protective Agents|protective agents|mesh-ancestor
110395052|NCT02270606|Vitamin B Complex|vitamin b complex|mesh-ancestor
110395053|NCT02270606|Vitamins|vitamins|mesh-ancestor
110395054|NCT02270606|Micronutrients|micronutrients|mesh-ancestor
110395055|NCT00594633|Donepezil|donepezil|mesh-list
110395056|NCT00594633|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110395057|NCT00594633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110395058|NCT00594633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110395059|NCT00594633|Cholinergic Agents|cholinergic agents|mesh-ancestor
110395060|NCT00594633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110395061|NCT00594633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110395062|NCT00594633|Nootropic Agents|nootropic agents|mesh-ancestor
110395063|NCT01605968|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110028441|NCT02248506|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110395065|NCT01605968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110395067|NCT01606046|Ethyl Chloride|ethyl chloride|mesh-list
110395068|NCT01606046|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
110395069|NCT01606046|Anesthetics, Local|anesthetics, local|mesh-list
110395070|NCT01606046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110395071|NCT01606046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110395072|NCT01606046|Sensory System Agents|sensory system agents|mesh-ancestor
110395073|NCT01606046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110395074|NCT01606046|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
110395075|NCT02892942|Cetrorelix|cetrorelix|mesh-list
110395076|NCT02892942|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110395077|NCT02892942|Fertility Agents|fertility agents|mesh-ancestor
110395078|NCT02892942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110395079|NCT02892942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110395080|NCT02892942|Hormone Antagonists|hormone antagonists|mesh-ancestor
110395081|NCT02892942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110395082|NCT00594867|Aspirin|aspirin|mesh-list
110395083|NCT00594867|Acetaminophen|acetaminophen|mesh-list
110395084|NCT00594867|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110395085|NCT00594867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110395086|NCT00594867|Analgesics|analgesics|mesh-ancestor
110395087|NCT00594867|Sensory System Agents|sensory system agents|mesh-ancestor
110395088|NCT00594867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110395089|NCT00594867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110395090|NCT00594867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110395091|NCT00594867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110395092|NCT00594867|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110395093|NCT00594867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110395094|NCT00594867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110395095|NCT00594867|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110395096|NCT00594867|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110395097|NCT00594867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110395098|NCT00594867|Antipyretics|antipyretics|mesh-ancestor
110395099|NCT01606241|Cyclophosphamide|cyclophosphamide|mesh-list
110395101|NCT01606241|Immunologic Factors|immunologic factors|mesh-ancestor
110395102|NCT01606241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110395103|NCT01606241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110395104|NCT01606241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110395105|NCT01606241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110395106|NCT01606241|Alkylating Agents|alkylating agents|mesh-ancestor
110395107|NCT01606241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110395108|NCT01606241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110395109|NCT01606241|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110395110|NCT02270918|Apixaban|apixaban|mesh-list
110395111|NCT02270918|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110395112|NCT02270918|Antithrombins|antithrombins|mesh-ancestor
110395113|NCT02270918|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110395114|NCT02270918|Protease Inhibitors|protease inhibitors|mesh-ancestor
110395115|NCT02270918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110395116|NCT02270918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110395117|NCT02270918|Anticoagulants|anticoagulants|mesh-ancestor
110395118|NCT02270996|Anti-Infective Agents|anti-infective agents|mesh-list
110395119|NCT02270996|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110395120|NCT00595140|Octreotide|octreotide|mesh-list
110395121|NCT00595140|Dopamine|dopamine|mesh-list
110395122|NCT00595140|Cabergoline|cabergoline|mesh-list
110395124|NCT00595140|Dopamine Agonists|dopamine agonists|mesh-list
110395125|NCT00595140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110395126|NCT00595140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110395127|NCT00595140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110395128|NCT00595140|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110395129|NCT00595140|Sympathomimetics|sympathomimetics|mesh-ancestor
110395130|NCT00595140|Autonomic Agents|autonomic agents|mesh-ancestor
110395131|NCT00595140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110395132|NCT00595140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110395133|NCT00595140|Dopamine Agents|dopamine agents|mesh-ancestor
110395134|NCT00595140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110395135|NCT00595140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110395136|NCT00595140|Protective Agents|protective agents|mesh-ancestor
110395138|NCT00595140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110395139|NCT00595140|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110395140|NCT00595140|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110395141|NCT02271035|Hyaluronic Acid|hyaluronic acid|mesh-list
110395142|NCT02271035|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110395143|NCT02271035|Immunologic Factors|immunologic factors|mesh-ancestor
110395144|NCT02271035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110395145|NCT02271035|Viscosupplements|viscosupplements|mesh-ancestor
110395146|NCT02271035|Protective Agents|protective agents|mesh-ancestor
110395148|NCT01606358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110395149|NCT02271113|Enoxaparin|enoxaparin|mesh-list
110395150|NCT02271113|Enoxaparin sodium|enoxaparin sodium|mesh-list
110395151|NCT02271113|Anticoagulants|anticoagulants|mesh-ancestor
110395152|NCT02271113|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110395153|NCT02271113|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110395154|NCT02271113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110395155|NCT02271191|Nicardipine|nicardipine|mesh-list
110395156|NCT02271191|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110395157|NCT02271191|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110395158|NCT02271191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110395159|NCT02271191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110395160|NCT02271191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110395161|NCT02271191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110395163|NCT00595374|Insulin|insulin|mesh-list
110395164|NCT00595374|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110395165|NCT00595374|Insulin Aspart|insulin aspart|mesh-list
110395166|NCT00595374|Insulin Detemir|insulin detemir|mesh-list
110395167|NCT00595374|Isophane Insulin, Human|isophane insulin, human|mesh-list
110395168|NCT00595374|Insulin, Isophane|insulin, isophane|mesh-list
110395169|NCT00595374|Isophane insulin, beef|isophane insulin, beef|mesh-list
110395170|NCT00595374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110395171|NCT00595374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110395172|NCT00595569|Insulin|insulin|mesh-list
110395173|NCT00595569|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110395174|NCT00595569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110395176|NCT02271347|Antiviral Agents|antiviral agents|mesh-ancestor
110395177|NCT02271347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110395178|NCT01172938|Thalidomide|thalidomide|mesh-list
110395179|NCT01172938|Apremilast|apremilast|mesh-list
110028478|NCT02249130|Antimetabolites|antimetabolites|mesh-ancestor
110395180|NCT01172938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110395181|NCT01172938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110395183|NCT01172938|Sensory System Agents|sensory system agents|mesh-ancestor
110395184|NCT01172938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110395185|NCT01172938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110395186|NCT01172938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110395188|NCT01172938|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110395189|NCT01172938|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110395190|NCT01172938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110395191|NCT01172938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110395192|NCT01172938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110395193|NCT01172938|Immunologic Factors|immunologic factors|mesh-ancestor
110395194|NCT01172938|Leprostatic Agents|leprostatic agents|mesh-ancestor
110395195|NCT01172938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110395196|NCT01172938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110395197|NCT01172938|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110395198|NCT01172938|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110395199|NCT01172938|Growth Substances|growth substances|mesh-ancestor
110395200|NCT01172938|Growth Inhibitors|growth inhibitors|mesh-ancestor
110395201|NCT01172938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110395203|NCT02271464|Bevacizumab|bevacizumab|mesh-list
110395204|NCT02271464|Capecitabine|capecitabine|mesh-list
110395205|NCT02271464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110395206|NCT02271464|Immunologic Factors|immunologic factors|mesh-ancestor
110395207|NCT02271464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110395208|NCT02271464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110395209|NCT02271464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110395210|NCT02271464|Alkylating Agents|alkylating agents|mesh-ancestor
110395211|NCT02271464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110395212|NCT02271464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110395214|NCT02271464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110395215|NCT02271464|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110395216|NCT02271464|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110395217|NCT02271464|Growth Substances|growth substances|mesh-ancestor
110395218|NCT02271464|Growth Inhibitors|growth inhibitors|mesh-ancestor
110395219|NCT02271464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110395220|NCT02271464|Antimetabolites|antimetabolites|mesh-ancestor
110395221|NCT04326894|Methotrexate|methotrexate|mesh-list
110395222|NCT04326894|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110395223|NCT04326894|Abortifacient Agents|abortifacient agents|mesh-ancestor
110395224|NCT04326894|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110395225|NCT04326894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110395226|NCT04326894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110395227|NCT04326894|Antimetabolites|antimetabolites|mesh-ancestor
110395228|NCT04326894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110395229|NCT04326894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110395230|NCT04326894|Dermatologic Agents|dermatologic agents|mesh-ancestor
110395231|NCT04326894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110395232|NCT04326894|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110395233|NCT04326894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110395234|NCT04326894|Immunologic Factors|immunologic factors|mesh-ancestor
110395235|NCT04326894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110395236|NCT04326894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110395237|NCT02271542|Propofol|propofol|mesh-list
110395238|NCT02271542|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110395239|NCT02271542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110395240|NCT02271542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110395241|NCT02271542|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110395242|NCT02271542|Anesthetics, General|anesthetics, general|mesh-ancestor
110395243|NCT02271542|Anesthetics|anesthetics|mesh-ancestor
110395244|NCT01109992|Regadenoson|regadenoson|mesh-list
110395245|NCT01109992|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
110395246|NCT01109992|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110395247|NCT01109992|Purinergic Agonists|purinergic agonists|mesh-ancestor
110395248|NCT01109992|Purinergic Agents|purinergic agents|mesh-ancestor
110395249|NCT01109992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110395250|NCT01109992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110395251|NCT01109992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110395253|NCT02892357|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110395254|NCT02892357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110395255|NCT02892357|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110395256|NCT02892357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110395257|NCT02892357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110395259|NCT01109524|Vinorelbine|vinorelbine|mesh-list
110395260|NCT01109524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110395261|NCT01109524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110395262|NCT01109524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110395263|NCT01109524|Tubulin Modulators|tubulin modulators|mesh-ancestor
110395264|NCT01109524|Antimitotic Agents|antimitotic agents|mesh-ancestor
110395265|NCT01109524|Mitosis Modulators|mitosis modulators|mesh-ancestor
110395266|NCT01109524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110395267|NCT01109173|Nepafenac|nepafenac|mesh-list
110395268|NCT01109173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110395269|NCT01109173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110395270|NCT01109173|Analgesics|analgesics|mesh-ancestor
110395271|NCT01109173|Sensory System Agents|sensory system agents|mesh-ancestor
110395272|NCT01109173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110395273|NCT01109173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110395274|NCT01109173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110395275|NCT01109173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110395276|NCT02271971|Vitamin D|vitamin d|mesh-list
110395277|NCT02271971|Cholecalciferol|cholecalciferol|mesh-list
110395278|NCT02271971|Vitamins|vitamins|mesh-ancestor
110395279|NCT02271971|Micronutrients|micronutrients|mesh-ancestor
110395280|NCT02271971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110395281|NCT02271971|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110395282|NCT02271971|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110395283|NCT01172821|Tiotropium Bromide|tiotropium bromide|mesh-list
110395284|NCT01172821|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110395285|NCT01172821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110395286|NCT01172821|Autonomic Agents|autonomic agents|mesh-ancestor
110395287|NCT01172821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110395288|NCT01172821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110395289|NCT01172821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110395290|NCT01172821|Respiratory System Agents|respiratory system agents|mesh-ancestor
110395291|NCT01172821|Parasympatholytics|parasympatholytics|mesh-ancestor
110395292|NCT01172821|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110395293|NCT01172821|Cholinergic Agents|cholinergic agents|mesh-ancestor
110395294|NCT01172821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110395295|NCT01172821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110028517|NCT02242734|Antitussive Agents|antitussive agents|mesh-ancestor
110395296|NCT01172821|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110395297|NCT01172821|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110395298|NCT01172821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110395299|NCT01172821|Adrenergic Agents|adrenergic agents|mesh-ancestor
110395300|NCT01172275|Acetylcysteine|acetylcysteine|mesh-list
110395301|NCT01172275|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110395302|NCT01172275|Antiviral Agents|antiviral agents|mesh-ancestor
110395303|NCT01172275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110395304|NCT01172275|Expectorants|expectorants|mesh-ancestor
110395305|NCT01172275|Respiratory System Agents|respiratory system agents|mesh-ancestor
110395306|NCT01172275|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110395307|NCT01172275|Antioxidants|antioxidants|mesh-ancestor
110395308|NCT01172275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110395309|NCT01172275|Protective Agents|protective agents|mesh-ancestor
110395310|NCT01172275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110395311|NCT01172275|Antidotes|antidotes|mesh-ancestor
110395312|NCT05034952|Acetaminophen|acetaminophen|mesh-list
110395313|NCT05034952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110395314|NCT05034952|Analgesics|analgesics|mesh-ancestor
110395315|NCT05034952|Sensory System Agents|sensory system agents|mesh-ancestor
110395316|NCT05034952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110395317|NCT05034952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110395318|NCT05034952|Antipyretics|antipyretics|mesh-ancestor
110395320|NCT00596037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110395321|NCT00596037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110395322|NCT02273102|Tretinoin|tretinoin|mesh-list
110395323|NCT02273102|Tranylcypromine|tranylcypromine|mesh-list
110395324|NCT02273102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110395325|NCT02273102|Keratolytic Agents|keratolytic agents|mesh-ancestor
110395326|NCT02273102|Dermatologic Agents|dermatologic agents|mesh-ancestor
110395327|NCT02273102|Antidepressive Agents|antidepressive agents|mesh-ancestor
110395328|NCT02273102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110395329|NCT02273102|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110395330|NCT02273102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110395331|NCT02273102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110395333|NCT02273102|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110395334|NCT02273102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110395335|NCT02273102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110395336|NCT02272478|Decitabine|decitabine|mesh-list
110395337|NCT02272478|Gemtuzumab|gemtuzumab|mesh-list
110395338|NCT02272478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110395339|NCT02272478|Antimetabolites|antimetabolites|mesh-ancestor
110395340|NCT02272478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110395341|NCT02272478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110395342|NCT02272478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110395343|NCT02272478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110395344|NCT02272478|Immunotoxins|immunotoxins|mesh-ancestor
110395345|NCT02272478|Immunoconjugates|immunoconjugates|mesh-ancestor
110395346|NCT02272478|Immunologic Factors|immunologic factors|mesh-ancestor
110395347|NCT02272478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110395349|NCT02272517|Escitalopram|escitalopram|mesh-list
110395350|NCT02272517|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110395351|NCT02272517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110395352|NCT02272517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110028527|NCT02244606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110395353|NCT02272517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110395354|NCT02272517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110395355|NCT02272517|Serotonin Agents|serotonin agents|mesh-ancestor
110049489|NCT02220426|Xenon|xenon|mesh-list
110395356|NCT02272517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110395357|NCT02272517|Antidepressive Agents|antidepressive agents|mesh-ancestor
110395358|NCT02272517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110395359|NCT02272517|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110395360|NCT02272517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110395361|NCT02272517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110395362|NCT02272517|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110395363|NCT02272517|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110395364|NCT02272517|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110395365|NCT02272517|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110395366|NCT02272829|Analgesics, Opioid|analgesics, opioid|mesh-list
110395367|NCT02272829|Narcotics|narcotics|mesh-ancestor
110395368|NCT02272829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110395369|NCT02272829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110395371|NCT02272829|Sensory System Agents|sensory system agents|mesh-ancestor
110395372|NCT02272829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110395373|NCT00596115|Pramipexole|pramipexole|mesh-list
110395374|NCT00596115|Antioxidants|antioxidants|mesh-ancestor
110395375|NCT00596115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110395376|NCT00596115|Protective Agents|protective agents|mesh-ancestor
110395377|NCT00596115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110395378|NCT00596115|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110395379|NCT00596115|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110395380|NCT00596115|Dopamine Agonists|dopamine agonists|mesh-ancestor
110395381|NCT00596115|Dopamine Agents|dopamine agents|mesh-ancestor
110395382|NCT00596115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110395383|NCT02272868|Rifaximin|rifaximin|mesh-list
110395384|NCT02272868|Omeprazole|omeprazole|mesh-list
110395385|NCT02272868|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
110395386|NCT02272868|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110395387|NCT02272868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110395388|NCT02272868|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110395389|NCT02272868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110395390|NCT02272868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110395391|NCT02272868|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110395392|NCT02272868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110395394|NCT02273453|Oxazepam|oxazepam|mesh-list
110395395|NCT02273453|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110395396|NCT02273453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110395397|NCT02273453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110395399|NCT02273453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110395400|NCT02273453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110395401|NCT02273453|GABA Modulators|gaba modulators|mesh-ancestor
110395402|NCT02273453|GABA Agents|gaba agents|mesh-ancestor
110395403|NCT02273453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110395404|NCT02273453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110395405|NCT01108510|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110395406|NCT01108510|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110395407|NCT01108510|Cobicistat|cobicistat|mesh-list
110028551|NCT02245308|Dopamine Agents|dopamine agents|mesh-ancestor
110395408|NCT01108510|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110395409|NCT01108510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110395410|NCT01108510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110395411|NCT01108510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110395412|NCT01108510|Antiviral Agents|antiviral agents|mesh-ancestor
110395413|NCT01108510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110395414|NCT01108510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110395415|NCT01108510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110395416|NCT01108510|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110395417|NCT01108510|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110395418|NCT01108510|Protease Inhibitors|protease inhibitors|mesh-ancestor
110395419|NCT01108510|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110395420|NCT01108510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110395423|NCT02273258|Insulin Lispro|insulin lispro|mesh-list
110395424|NCT02273258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110395425|NCT02273258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110395427|NCT05015686|Immunologic Factors|immunologic factors|mesh-ancestor
110395428|NCT05015686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110049556|NCT01772420|Lenalidomide|lenalidomide|mesh-list
110395429|NCT04327245|Tagatose|tagatose|mesh-list
110395430|NCT04327245|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110395432|NCT04327245|Sequestering Agents|sequestering agents|mesh-ancestor
110395433|NCT04327245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110395434|NCT01588769|Immunomodulating Agents|immunomodulating agents|mesh-list
110395435|NCT01588769|Immunologic Factors|immunologic factors|mesh-ancestor
110395436|NCT01588769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110395437|NCT04327401|Dexamethasone|dexamethasone|mesh-list
110395438|NCT04327401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110395439|NCT04327401|Antiemetics|antiemetics|mesh-ancestor
110395440|NCT04327401|Autonomic Agents|autonomic agents|mesh-ancestor
110395441|NCT04327401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110395442|NCT04327401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110395443|NCT04327401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110395444|NCT04327401|Glucocorticoids|glucocorticoids|mesh-ancestor
110395445|NCT04327401|Hormones|hormones|mesh-ancestor
110395446|NCT04327401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110395447|NCT04327401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110395448|NCT04327401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110395449|NCT01340027|Solifenacin Succinate|solifenacin succinate|mesh-list
110395451|NCT01340027|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110395452|NCT01340027|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110395453|NCT01340027|Cholinergic Agents|cholinergic agents|mesh-ancestor
110395454|NCT01340027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110395455|NCT01340027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110395456|NCT01340027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110395457|NCT01340027|Urological Agents|urological agents|mesh-ancestor
110395458|NCT01340027|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110395459|NCT01340027|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110395460|NCT01340027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110395461|NCT01340027|Adrenergic Agents|adrenergic agents|mesh-ancestor
110028564|NCT00559962|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110395463|NCT01107925|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110395464|NCT01107925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110395465|NCT01107925|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110395466|NCT01107925|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110395467|NCT01107925|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110395468|NCT01107925|Purinergic Agents|purinergic agents|mesh-ancestor
110395469|NCT01107925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110395470|NCT01107925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110395471|NCT01107925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110395472|NCT04310293|Hormones|hormones|mesh-list
110395473|NCT04310293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110395474|NCT04310293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110395476|NCT01339559|Anticonvulsants|anticonvulsants|mesh-ancestor
110395477|NCT01588847|Sufentanil|sufentanil|mesh-list
110395478|NCT01588847|Bupivacaine|bupivacaine|mesh-list
110395479|NCT01588847|Anesthetics|anesthetics|mesh-list
110395480|NCT01588847|Propofol|propofol|mesh-list
110395481|NCT01588847|Sevoflurane|sevoflurane|mesh-list
110395482|NCT01588847|Rocuronium|rocuronium|mesh-list
110395483|NCT01588847|Anesthetics, Local|anesthetics, local|mesh-ancestor
110395484|NCT01588847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110395485|NCT01588847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110395486|NCT01588847|Sensory System Agents|sensory system agents|mesh-ancestor
110395487|NCT01588847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110395488|NCT01588847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110395489|NCT01588847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110395490|NCT01588847|Anesthetics, General|anesthetics, general|mesh-ancestor
110395491|NCT01588847|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110395492|NCT01588847|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110395493|NCT01588847|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110395494|NCT01588847|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110395495|NCT01588847|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110395496|NCT01588847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110395497|NCT01588847|Narcotics|narcotics|mesh-ancestor
110395498|NCT01588847|Analgesics|analgesics|mesh-ancestor
110395499|NCT01588847|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110395501|NCT00107900|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110395502|NCT00107900|Antithrombins|antithrombins|mesh-ancestor
110395503|NCT00107900|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110395504|NCT00107900|Protease Inhibitors|protease inhibitors|mesh-ancestor
110395505|NCT00107900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110395506|NCT00107900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110395508|NCT00107315|Bevacizumab|bevacizumab|mesh-list
110395509|NCT00107315|Capecitabine|capecitabine|mesh-list
110395510|NCT00107315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110395511|NCT00107315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110395512|NCT00107315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110395513|NCT00107315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110395514|NCT00107315|Growth Substances|growth substances|mesh-ancestor
110395515|NCT00107315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110395516|NCT00107315|Growth Inhibitors|growth inhibitors|mesh-ancestor
110028586|NCT00559104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110395517|NCT00107315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110395518|NCT00107315|Antimetabolites|antimetabolites|mesh-ancestor
110395519|NCT00107315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110395520|NCT01335971|Sulforaphane|sulforaphane|mesh-list
110395521|NCT01335971|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110395522|NCT01335971|Protective Agents|protective agents|mesh-ancestor
110395523|NCT01335971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110395524|NCT01335971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110395525|NCT00107276|Cyclophosphamide|cyclophosphamide|mesh-list
110395526|NCT00107276|Capecitabine|capecitabine|mesh-list
110395527|NCT00107276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110395528|NCT00107276|Immunologic Factors|immunologic factors|mesh-ancestor
110395529|NCT00107276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110395530|NCT00107276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110395531|NCT00107276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110395532|NCT00107276|Alkylating Agents|alkylating agents|mesh-ancestor
110395533|NCT00107276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110395534|NCT00107276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110395535|NCT00107276|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110395536|NCT00107276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110395537|NCT00107276|Antimetabolites|antimetabolites|mesh-ancestor
110395538|NCT01335698|Ritonavir|ritonavir|mesh-list
110395539|NCT01335698|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110395540|NCT01335698|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110395541|NCT01335698|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110395542|NCT01335698|Protease Inhibitors|protease inhibitors|mesh-ancestor
110395543|NCT01335698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110395544|NCT01335698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110395545|NCT01335698|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110395546|NCT01335698|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110395547|NCT01335698|Antiviral Agents|antiviral agents|mesh-ancestor
110395548|NCT01335698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110395549|NCT01335698|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110395550|NCT01335698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110395552|NCT00107120|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110395553|NCT00107120|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110395554|NCT00107120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110395555|NCT00107120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110395556|NCT00107120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110395557|NCT00107120|Serotonin Agents|serotonin agents|mesh-ancestor
110395558|NCT00107120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110395559|NCT01335464|Nintedanib|nintedanib|mesh-list
110395560|NCT01335464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110395561|NCT01335464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110395562|NCT01335464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110395563|NCT01335464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110395564|NCT00106184|Rituximab|rituximab|mesh-list
110395565|NCT00106184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110395567|NCT00106184|Immunologic Factors|immunologic factors|mesh-ancestor
110028608|NCT00557622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110395569|NCT00106184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110395571|NCT00598923|Phenytoin|phenytoin|mesh-list
110395572|NCT00598923|Anticonvulsants|anticonvulsants|mesh-ancestor
110395573|NCT00598923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110395574|NCT00598923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110395575|NCT00598923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110395576|NCT00598923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110395577|NCT00598923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110395578|NCT00598923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110395579|NCT00598923|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110395580|NCT00598923|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110395582|NCT02892318|Guadecitabine|guadecitabine|mesh-list
110395583|NCT02892318|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110395584|NCT02892318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110395585|NCT02892318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110395586|NCT02892318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110395587|NCT01334918|Regadenoson|regadenoson|mesh-list
110395588|NCT01334918|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
110395589|NCT01334918|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
110395590|NCT01334918|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110395591|NCT01334918|Purinergic Agonists|purinergic agonists|mesh-ancestor
110395592|NCT01334918|Purinergic Agents|purinergic agents|mesh-ancestor
110395593|NCT01334918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110395594|NCT01334918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110395595|NCT01334918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110395596|NCT01334918|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110395597|NCT00598962|Azithromycin|azithromycin|mesh-list
110395598|NCT00598962|Rifampin|rifampin|mesh-list
110395599|NCT00598962|Rifabutin|rifabutin|mesh-list
110395600|NCT00598962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110395601|NCT00598962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110395602|NCT00598962|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110395603|NCT00598962|Antitubercular Agents|antitubercular agents|mesh-ancestor
110395604|NCT00598962|Leprostatic Agents|leprostatic agents|mesh-ancestor
110395605|NCT00598962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110395606|NCT00598962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110395607|NCT00598962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110395608|NCT00598962|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110395609|NCT00598962|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110395610|NCT00598962|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110395611|NCT00598962|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110395612|NCT00598962|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110395613|NCT00598962|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110395614|NCT01332968|Prednisone|prednisone|mesh-list
110395615|NCT01332968|Cyclophosphamide|cyclophosphamide|mesh-list
110395616|NCT01332968|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110395617|NCT01332968|Rituximab|rituximab|mesh-list
110395618|NCT01332968|Doxorubicin|doxorubicin|mesh-list
110395619|NCT01332968|Vincristine|vincristine|mesh-list
110395620|NCT01332968|Obinutuzumab|obinutuzumab|mesh-list
110395621|NCT01332968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110395622|NCT01332968|Immunologic Factors|immunologic factors|mesh-ancestor
110395623|NCT01332968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110395624|NCT01332968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110395625|NCT01332968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110395626|NCT01332968|Alkylating Agents|alkylating agents|mesh-ancestor
110395627|NCT01332968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110395628|NCT01332968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110395629|NCT01332968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110395630|NCT01332968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110395631|NCT01332968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110395632|NCT01332968|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110395633|NCT01332968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110395634|NCT01332968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110395635|NCT01332968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110395636|NCT01332968|Glucocorticoids|glucocorticoids|mesh-ancestor
110395638|NCT01332968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110395639|NCT01332968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110395640|NCT01332968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110395641|NCT01332968|Tubulin Modulators|tubulin modulators|mesh-ancestor
110395642|NCT01332968|Antimitotic Agents|antimitotic agents|mesh-ancestor
110395643|NCT01332968|Mitosis Modulators|mitosis modulators|mesh-ancestor
110395644|NCT00599079|Azithromycin|azithromycin|mesh-list
110395645|NCT00599079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110395646|NCT00599079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110395647|NCT00599235|Hydralazine|hydralazine|mesh-list
110395648|NCT00599235|Sildenafil Citrate|sildenafil citrate|mesh-list
110395649|NCT00599235|Vasodilator Agents|vasodilator agents|mesh-ancestor
110395650|NCT00599235|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110049786|NCT01455636|Micronutrients|micronutrients|mesh-list
110395651|NCT00599235|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110395652|NCT00599235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110395653|NCT00599235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110395654|NCT00599235|Urological Agents|urological agents|mesh-ancestor
110395655|NCT00599235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110395657|NCT00599274|Interferon-beta|interferon-beta|mesh-list
110395658|NCT00599274|Interferon beta-1a|interferon beta-1a|mesh-list
110395659|NCT00599274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110395660|NCT00599274|Antiviral Agents|antiviral agents|mesh-ancestor
110395661|NCT00599274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110395662|NCT00599274|Immunologic Factors|immunologic factors|mesh-ancestor
110395663|NCT00599274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110395664|NCT00599274|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110395665|NCT01332227|Ritonavir|ritonavir|mesh-list
110395666|NCT01332227|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110395667|NCT01332227|Tenofovir|tenofovir|mesh-list
110395668|NCT01332227|Emtricitabine|emtricitabine|mesh-list
110395669|NCT01332227|Raltegravir Potassium|raltegravir potassium|mesh-list
110395670|NCT01332227|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110395671|NCT01332227|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110395672|NCT01332227|Protease Inhibitors|protease inhibitors|mesh-ancestor
110395673|NCT01332227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110395674|NCT01332227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110395675|NCT01332227|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110395676|NCT01332227|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110395677|NCT01332227|Antiviral Agents|antiviral agents|mesh-ancestor
110395678|NCT01332227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110395679|NCT01332227|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110395680|NCT01332227|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110395681|NCT01332227|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110395682|NCT01332227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110395683|NCT01332227|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110395684|NCT01332227|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110395685|NCT01332149|Pregabalin|pregabalin|mesh-list
110395686|NCT01332149|Analgesics|analgesics|mesh-ancestor
110395687|NCT01332149|Sensory System Agents|sensory system agents|mesh-ancestor
110395688|NCT01332149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110395689|NCT01332149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110395690|NCT01332149|Anticonvulsants|anticonvulsants|mesh-ancestor
110395691|NCT01332149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110395692|NCT01332149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110395693|NCT01332149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110395694|NCT01332149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110395696|NCT01332149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110395697|NCT01332149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110395698|NCT01332149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110395699|NCT01326702|Rituximab|rituximab|mesh-list
110395700|NCT01326702|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110395701|NCT01326702|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110395702|NCT01326702|Veliparib|veliparib|mesh-list
110395703|NCT01326702|Antibodies|antibodies|mesh-list
110395704|NCT01326702|Immunoglobulins|immunoglobulins|mesh-list
110395705|NCT01326702|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110395706|NCT01326702|Immunologic Factors|immunologic factors|mesh-ancestor
110395707|NCT01326702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110395708|NCT01326702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110395709|NCT01326702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110395710|NCT01326702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110395711|NCT01326702|Alkylating Agents|alkylating agents|mesh-ancestor
110395712|NCT01326702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110395713|NCT01326702|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110395714|NCT01326702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110395715|NCT00599625|Pravastatin|pravastatin|mesh-list
110395716|NCT00599625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110395717|NCT00599625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110395718|NCT00599625|Antimetabolites|antimetabolites|mesh-ancestor
110395719|NCT00599625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110395720|NCT00599625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110395721|NCT00599625|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110395722|NCT00599625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110395723|NCT05650697|Cannabidiol|cannabidiol|mesh-list
110395724|NCT05650697|Anticonvulsants|anticonvulsants|mesh-ancestor
110049854|NCT01459445|Estrogens|estrogens|mesh-ancestor
110395725|NCT05649878|Methylprednisolone|methylprednisolone|mesh-list
110395726|NCT05649878|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110395727|NCT05649878|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110395728|NCT05649878|Prednisolone|prednisolone|mesh-list
110395729|NCT05649878|Prednisolone acetate|prednisolone acetate|mesh-list
110395730|NCT05649878|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110395731|NCT05649878|Prednisolone phosphate|prednisolone phosphate|mesh-list
110395732|NCT05649878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110395733|NCT05649878|Antiemetics|antiemetics|mesh-ancestor
110028662|NCT00552240|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110395734|NCT05649878|Autonomic Agents|autonomic agents|mesh-ancestor
110395735|NCT05649878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110395736|NCT05649878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110395737|NCT05649878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110395738|NCT05649878|Glucocorticoids|glucocorticoids|mesh-ancestor
110395739|NCT05649878|Hormones|hormones|mesh-ancestor
110395740|NCT05649878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110395741|NCT05649878|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110395742|NCT05649878|Protective Agents|protective agents|mesh-ancestor
110395743|NCT05649878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110395744|NCT05649878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110395746|NCT01327703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110395747|NCT01380080|Efavirenz|efavirenz|mesh-list
110395748|NCT01380080|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110395749|NCT01380080|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110395750|NCT01380080|Rifampin|rifampin|mesh-list
110395751|NCT01380080|Isoniazid|isoniazid|mesh-list
110395752|NCT01380080|Pyrazinamide|pyrazinamide|mesh-list
110395753|NCT01380080|Ethambutol|ethambutol|mesh-list
110395754|NCT01380080|Isoniazid, pyrazinamide, rifampin drug combination|isoniazid, pyrazinamide, rifampin drug combination|mesh-list
110395755|NCT01380080|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110395756|NCT01380080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110395757|NCT01380080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110395758|NCT01380080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110395759|NCT01380080|Antiviral Agents|antiviral agents|mesh-ancestor
110395760|NCT01380080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110395761|NCT01380080|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110395762|NCT01380080|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110395763|NCT01380080|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110395764|NCT01380080|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110395765|NCT01380080|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110395766|NCT01380080|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110395767|NCT01380080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110395768|NCT01380080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110395769|NCT01380080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110395770|NCT01380080|Antitubercular Agents|antitubercular agents|mesh-ancestor
110395771|NCT01380080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110395772|NCT01380080|Leprostatic Agents|leprostatic agents|mesh-ancestor
110395773|NCT01380080|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110395774|NCT01380080|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110395775|NCT01380080|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110395776|NCT01380080|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110395777|NCT01380080|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110395778|NCT01380080|Antimetabolites|antimetabolites|mesh-ancestor
110395779|NCT01380080|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110395780|NCT01379573|Hydroxychloroquine|hydroxychloroquine|mesh-list
110395781|NCT01379573|Antimalarials|antimalarials|mesh-ancestor
110395782|NCT01379573|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110395783|NCT01379573|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110395784|NCT01379573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110395785|NCT01379573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110395786|NCT01379573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110395788|NCT01371851|Doxazosin|doxazosin|mesh-list
110395789|NCT01371851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110395790|NCT01371851|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110395791|NCT01371851|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110395792|NCT01371851|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110395793|NCT01371851|Adrenergic Agents|adrenergic agents|mesh-ancestor
110395794|NCT01371851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110395795|NCT01371851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110395796|NCT01371851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110049925|NCT01460498|Antimetabolites|antimetabolites|mesh-ancestor
110395797|NCT01371734|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
110395798|NCT01371734|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110395799|NCT01371734|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110395800|NCT01371734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110395801|NCT01371734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110395802|NCT01371734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110395803|NCT01371734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110395805|NCT01371734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110395806|NCT04328870|Oxytocin|oxytocin|mesh-list
110395807|NCT04328870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110395808|NCT04328870|Oxytocics|oxytocics|mesh-ancestor
110395809|NCT04328870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110395810|NCT00591617|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
110395811|NCT00591617|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110395812|NCT00591617|Narcotics|narcotics|mesh-ancestor
110395813|NCT00591617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110395814|NCT00591617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110395815|NCT00591617|Analgesics|analgesics|mesh-ancestor
110395816|NCT00591617|Sensory System Agents|sensory system agents|mesh-ancestor
110395817|NCT00591617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110395818|NCT00591617|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110395819|NCT01357889|rGLP-1 protein|rglp-1 protein|mesh-list
110395820|NCT01357889|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110395821|NCT01357889|Incretins|incretins|mesh-ancestor
110395822|NCT01357889|Hormones|hormones|mesh-ancestor
110395823|NCT01357889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110395824|NCT01357889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110395825|NCT01357655|Dasatinib|dasatinib|mesh-list
110395826|NCT01357655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110395827|NCT01357655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110395828|NCT01357655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110395829|NCT01357655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110395830|NCT01357616|Timolol|timolol|mesh-list
110395831|NCT01357616|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110395833|NCT01357616|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110395834|NCT01357616|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110395835|NCT01357616|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110395836|NCT01357616|Adrenergic Agents|adrenergic agents|mesh-ancestor
110395837|NCT01357616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110395838|NCT01357616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110395839|NCT01357616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110395840|NCT01357616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110395841|NCT01357616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110028692|NCT00556920|Adrenergic Agents|adrenergic agents|mesh-ancestor
110028705|NCT00552708|Lisinopril|lisinopril|mesh-list
110395842|NCT01357616|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110395843|NCT01357616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110395845|NCT01351025|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110395846|NCT01351025|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110395847|NCT01351025|Antimetabolites|antimetabolites|mesh-ancestor
110395848|NCT01351025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110395849|NCT01351025|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110395850|NCT01351025|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110395851|NCT01351025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110395852|NCT01348763|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110395853|NCT01348763|Maraviroc|maraviroc|mesh-list
110395854|NCT01348763|Darunavir|darunavir|mesh-list
110395855|NCT01348763|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110395856|NCT01348763|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110395857|NCT01348763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110395858|NCT01348763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110395859|NCT01348763|Antiviral Agents|antiviral agents|mesh-ancestor
110395860|NCT01348763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110395861|NCT01348763|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110395862|NCT01348763|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110395863|NCT01348763|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110395864|NCT01348763|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110395865|NCT01348763|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110395866|NCT01348763|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110395867|NCT01348763|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110395868|NCT01348763|Protease Inhibitors|protease inhibitors|mesh-ancestor
110395869|NCT01346540|Nintedanib|nintedanib|mesh-list
110395870|NCT01346540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110395871|NCT01346540|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110395872|NCT01346540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110395873|NCT01346540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110395874|NCT01342913|Fluticasone|fluticasone|mesh-list
110395876|NCT01342913|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110395877|NCT01342913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110395878|NCT01342913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110395879|NCT01342913|Autonomic Agents|autonomic agents|mesh-ancestor
110395880|NCT01342913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110395881|NCT01342913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110395882|NCT01342913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110028711|NCT00552708|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110028727|NCT00556374|Denosumab|denosumab|mesh-list
110395883|NCT01342913|Respiratory System Agents|respiratory system agents|mesh-ancestor
110395884|NCT01342913|Dermatologic Agents|dermatologic agents|mesh-ancestor
110395885|NCT01342913|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110395886|NCT01342913|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110395887|NCT01342913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110395888|NCT01342913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110395889|NCT01342913|Adrenergic Agents|adrenergic agents|mesh-ancestor
110395890|NCT01342913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110395891|NCT01342913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110395893|NCT01342796|Immunologic Factors|immunologic factors|mesh-ancestor
110395894|NCT01342796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110395895|NCT01342640|Epoetin Alfa|epoetin alfa|mesh-list
110395896|NCT01342640|Hematinics|hematinics|mesh-ancestor
110395897|NCT01342484|Linagliptin|linagliptin|mesh-list
110395898|NCT01342484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110395899|NCT01342484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110395900|NCT01342484|Incretins|incretins|mesh-ancestor
110395901|NCT01342484|Hormones|hormones|mesh-ancestor
110395902|NCT01342484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110395903|NCT01342484|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110395904|NCT01342484|Protease Inhibitors|protease inhibitors|mesh-ancestor
110395905|NCT01342484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110395906|NCT01342484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110395907|NCT01342445|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
110395908|NCT01342445|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110395909|NCT01342445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110395910|NCT01342445|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110395911|NCT01342445|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110395912|NCT01342445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110395913|NCT01342445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110395914|NCT01342445|Dopamine Agents|dopamine agents|mesh-ancestor
110395915|NCT01342445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110395916|NCT01342211|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
110395917|NCT01342211|Bococizumab|bococizumab|mesh-list
110395918|NCT01342211|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110395919|NCT01342211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110395920|NCT01342211|Antimetabolites|antimetabolites|mesh-ancestor
110395921|NCT01342211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110395922|NCT01342211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110395923|NCT01342211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110395924|NCT01342094|Timolol|timolol|mesh-list
110395925|NCT01342094|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110395926|NCT01342094|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110395927|NCT01342094|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110395928|NCT01342094|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110028743|NCT03029676|Narcotics|narcotics|mesh-ancestor
110395929|NCT01342094|Adrenergic Agents|adrenergic agents|mesh-ancestor
110395930|NCT01342094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110395931|NCT01342094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110395932|NCT01342094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110395933|NCT01342094|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110395934|NCT01342094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110395935|NCT01340768|Metformin|metformin|mesh-list
110395936|NCT01340768|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110395937|NCT01340768|Glimepiride|glimepiride|mesh-list
110395938|NCT01340768|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110395939|NCT01340768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110395940|NCT01340768|Incretins|incretins|mesh-ancestor
110395942|NCT01340768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110395943|NCT01340768|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110395944|NCT01340768|Protease Inhibitors|protease inhibitors|mesh-ancestor
110395946|NCT01340768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110395947|NCT01340768|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110395948|NCT01340768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110395949|NCT01340768|Immunologic Factors|immunologic factors|mesh-ancestor
110395950|NCT01340300|Metformin|metformin|mesh-list
110395951|NCT01340300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110395952|NCT01340300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110395953|NCT01107535|Palivizumab|palivizumab|mesh-list
110395954|NCT01107535|Antibodies|antibodies|mesh-list
110395955|NCT01107535|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110395956|NCT01107535|Immunologic Factors|immunologic factors|mesh-ancestor
110395957|NCT01107535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110395958|NCT01107535|Antiviral Agents|antiviral agents|mesh-ancestor
110395959|NCT01107535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110395960|NCT02880943|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
110395961|NCT02880943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110395962|NCT04207632|Botulinum Toxins|botulinum toxins|mesh-list
110395963|NCT04207632|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110395964|NCT04207632|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110395965|NCT04207632|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110395966|NCT04207632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110395967|NCT04207632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110395968|NCT04207632|Cholinergic Agents|cholinergic agents|mesh-ancestor
110395969|NCT04207632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110395970|NCT04207632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110395971|NCT04207632|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110395972|NCT04207632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110395973|NCT00598338|Prucalopride|prucalopride|mesh-list
110395974|NCT00598338|Laxatives|laxatives|mesh-ancestor
110395975|NCT00598338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110395976|NCT00598338|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
110395977|NCT00598338|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110395978|NCT00598338|Serotonin Agents|serotonin agents|mesh-ancestor
110395979|NCT00598338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110395980|NCT00598338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110395981|NCT00598338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110395982|NCT00598572|Deferoxamine|deferoxamine|mesh-list
110395983|NCT00598572|Siderophores|siderophores|mesh-ancestor
110395984|NCT00598572|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110395985|NCT00598572|Chelating Agents|chelating agents|mesh-ancestor
110395986|NCT00598572|Sequestering Agents|sequestering agents|mesh-ancestor
110395987|NCT00598572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110395988|NCT00599820|Bevacizumab|bevacizumab|mesh-list
110395989|NCT00599820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110395990|NCT00599820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110395991|NCT00599820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110395992|NCT00599820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110395993|NCT00599820|Growth Substances|growth substances|mesh-ancestor
110395994|NCT00599820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110395995|NCT00599820|Growth Inhibitors|growth inhibitors|mesh-ancestor
110395996|NCT00599898|Nifedipine|nifedipine|mesh-list
110395997|NCT00599898|Atosiban|atosiban|mesh-list
110395998|NCT00599898|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110395999|NCT00599898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110396000|NCT00599898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110396001|NCT00599898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110396002|NCT00599898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396003|NCT00599898|Vasodilator Agents|vasodilator agents|mesh-ancestor
110396004|NCT00599898|Tocolytic Agents|tocolytic agents|mesh-ancestor
110396005|NCT00599898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110396006|NCT00599898|Hormone Antagonists|hormone antagonists|mesh-ancestor
110396007|NCT00599898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110396010|NCT00600054|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110396011|NCT00600054|Immunologic Factors|immunologic factors|mesh-ancestor
110396012|NCT00600054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396013|NCT00600054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110396014|NCT00600054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110396015|NCT00600210|Bevacizumab|bevacizumab|mesh-list
110396016|NCT00600210|Carboplatin|carboplatin|mesh-list
110396017|NCT00600210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110396018|NCT00600210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110396019|NCT00600210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110396020|NCT00600210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110396021|NCT00600210|Growth Substances|growth substances|mesh-ancestor
110396022|NCT00600210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396023|NCT00600210|Growth Inhibitors|growth inhibitors|mesh-ancestor
110396024|NCT00600366|Insulin Aspart|insulin aspart|mesh-list
110396025|NCT00600366|Biphasic Insulins|biphasic insulins|mesh-list
110396026|NCT00600366|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110396027|NCT00600366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110396028|NCT00600366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396031|NCT01326546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110396032|NCT00600600|Tigecycline|tigecycline|mesh-list
110396033|NCT00600600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110396034|NCT00600600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110396035|NCT00600600|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110396036|NCT00600600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110396037|NCT00600600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110396038|NCT00623064|Gemcitabine|gemcitabine|mesh-list
110396039|NCT00623064|Lapatinib|lapatinib|mesh-list
110396040|NCT00623064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110396041|NCT00623064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110396042|NCT00623064|Antimetabolites|antimetabolites|mesh-ancestor
110396043|NCT00623064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110396044|NCT00623064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110396045|NCT00623064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110396046|NCT00623220|Nitrous Oxide|nitrous oxide|mesh-list
110396047|NCT00623220|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110396048|NCT00623220|Anesthetics, General|anesthetics, general|mesh-ancestor
110396049|NCT00623220|Anesthetics|anesthetics|mesh-ancestor
110396050|NCT00623220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110396051|NCT00623220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396052|NCT00623220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110396053|NCT00623220|Analgesics|analgesics|mesh-ancestor
110396054|NCT00623220|Sensory System Agents|sensory system agents|mesh-ancestor
110396055|NCT00623220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110396056|NCT00600912|SMOFlipid|smoflipid|mesh-list
110396057|NCT00600912|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
110396058|NCT00600912|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110396059|NCT00600912|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110396061|NCT00600990|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110396062|NCT00600990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110396063|NCT00600990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110396064|NCT00600990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396065|NCT00601302|Amlodipine|amlodipine|mesh-list
110396066|NCT00601302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110396067|NCT00601302|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110396068|NCT00601302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110396069|NCT00601302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110396070|NCT00601302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110396071|NCT00601302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396072|NCT00601302|Vasodilator Agents|vasodilator agents|mesh-ancestor
110396073|NCT00601536|Lithium Carbonate|lithium carbonate|mesh-list
110396074|NCT00601536|Antidepressive Agents|antidepressive agents|mesh-ancestor
110396075|NCT00601536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110396076|NCT00601536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110028820|NCT03838068|Procaine|procaine|mesh-list
110028821|NCT03838068|Anesthetics, Local|anesthetics, local|mesh-list
110396077|NCT00601536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110396078|NCT00601536|Antimanic Agents|antimanic agents|mesh-ancestor
110396079|NCT00601536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110396080|NCT00601536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110396081|NCT00601536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396082|NCT00601614|Temozolomide|temozolomide|mesh-list
110396083|NCT00601614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110396084|NCT00601614|Alkylating Agents|alkylating agents|mesh-ancestor
110396085|NCT00601614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110396086|NCT00601614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110396087|NCT00601692|Docetaxel|docetaxel|mesh-list
110396088|NCT00601692|Irinotecan|irinotecan|mesh-list
110396089|NCT00601692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110396090|NCT00601692|Tubulin Modulators|tubulin modulators|mesh-ancestor
110396091|NCT00601692|Antimitotic Agents|antimitotic agents|mesh-ancestor
110396092|NCT00601692|Mitosis Modulators|mitosis modulators|mesh-ancestor
110396093|NCT00601692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110396094|NCT00601692|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110396095|NCT00601692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110396096|NCT00601692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110396098|NCT00602004|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110396099|NCT00602004|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110396100|NCT00602004|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110396101|NCT00602004|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110396102|NCT00602004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110396103|NCT00602082|Capecitabine|capecitabine|mesh-list
110396104|NCT00602082|Streptozocin|streptozocin|mesh-list
110396105|NCT00602082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110396106|NCT00602082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110396107|NCT00602082|Antimetabolites|antimetabolites|mesh-ancestor
110396108|NCT00602082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110396109|NCT00602082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110396110|NCT04327752|Dermatologic Agents|dermatologic agents|mesh-list
110396111|NCT01171963|Vaccines|vaccines|mesh-list
110396112|NCT01171963|Immunologic Factors|immunologic factors|mesh-ancestor
110396113|NCT01171963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396114|NCT01171183|Carvedilol|carvedilol|mesh-list
110396115|NCT01171183|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110396116|NCT01171183|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110396117|NCT01171183|Adrenergic Agents|adrenergic agents|mesh-ancestor
110396118|NCT01171183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110396119|NCT01171183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110396120|NCT01171183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396121|NCT01171183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110396123|NCT01171183|Protective Agents|protective agents|mesh-ancestor
110396124|NCT01171183|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110396125|NCT01171183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110396126|NCT01171183|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110396127|NCT01171183|Vasodilator Agents|vasodilator agents|mesh-ancestor
110396128|NCT01171183|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110396129|NCT01171183|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110396130|NCT01169779|Metformin|metformin|mesh-list
110396131|NCT01169779|Lixisenatide|lixisenatide|mesh-list
110396132|NCT01169779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110396133|NCT01169779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396134|NCT01169701|Mycophenolic Acid|mycophenolic acid|mesh-list
110396135|NCT01169701|Everolimus|everolimus|mesh-list
110396136|NCT01169701|Tacrolimus|tacrolimus|mesh-list
110396137|NCT01169701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110396138|NCT01169701|Immunologic Factors|immunologic factors|mesh-ancestor
110396139|NCT01169701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396140|NCT01169701|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110396141|NCT01169701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110396142|NCT01169701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110396143|NCT01169701|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110396144|NCT01169701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110396145|NCT01169701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110396146|NCT01169701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110396147|NCT01169701|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110396148|NCT01169701|Antitubercular Agents|antitubercular agents|mesh-ancestor
110396149|NCT01169701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110396150|NCT01169701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110396152|NCT01167907|Anesthetics, Local|anesthetics, local|mesh-ancestor
110396154|NCT01167907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110396155|NCT01167907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396156|NCT01167907|Sensory System Agents|sensory system agents|mesh-ancestor
110396157|NCT01167907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110396158|NCT01115491|Bevacizumab|bevacizumab|mesh-list
110396159|NCT01115491|Temozolomide|temozolomide|mesh-list
110396160|NCT01115491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110396161|NCT01115491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110396162|NCT01115491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110396163|NCT01115491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110396164|NCT01115491|Growth Substances|growth substances|mesh-ancestor
110396165|NCT01115491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396166|NCT01115491|Growth Inhibitors|growth inhibitors|mesh-ancestor
110396167|NCT01115491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110396169|NCT01115491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110396170|NCT01113931|Doxycycline|doxycycline|mesh-list
110396171|NCT01113931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110396172|NCT01113931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110396173|NCT01113931|Antimalarials|antimalarials|mesh-ancestor
110396174|NCT01113931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110396175|NCT01113931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110396177|NCT02881177|Oxytocics|oxytocics|mesh-ancestor
110396178|NCT02881177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110396179|NCT02881177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396180|NCT02880787|Rocuronium|rocuronium|mesh-list
110396181|NCT02880787|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110396182|NCT02880787|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110396183|NCT02880787|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110396184|NCT02880787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110396185|NCT02880787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396186|NCT01106677|Metformin|metformin|mesh-list
110396187|NCT01106677|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110396188|NCT01106677|Canagliflozin|canagliflozin|mesh-list
110396189|NCT01106677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110396190|NCT01106677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396191|NCT01106677|Incretins|incretins|mesh-ancestor
110396192|NCT01106677|Hormones|hormones|mesh-ancestor
110396193|NCT01106677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110396194|NCT01106677|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110396195|NCT01106677|Protease Inhibitors|protease inhibitors|mesh-ancestor
110396196|NCT01106677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110396197|NCT01106677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110396198|NCT01106677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110396199|NCT04309357|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110396201|NCT04309357|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110396202|NCT04309357|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110396203|NCT04309357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110396204|NCT04308343|Methotrexate|methotrexate|mesh-list
110396205|NCT04308343|Letrozole|letrozole|mesh-list
110396206|NCT04308343|Cetrorelix|cetrorelix|mesh-list
110396207|NCT04308343|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110396208|NCT04308343|Abortifacient Agents|abortifacient agents|mesh-ancestor
110396209|NCT04308343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110396210|NCT04308343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396211|NCT04308343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110396212|NCT04308343|Antimetabolites|antimetabolites|mesh-ancestor
110396213|NCT04308343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110396214|NCT04308343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110396215|NCT04308343|Dermatologic Agents|dermatologic agents|mesh-ancestor
110396216|NCT04308343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110396217|NCT04308343|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110396218|NCT04308343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110396219|NCT04308343|Immunologic Factors|immunologic factors|mesh-ancestor
110396220|NCT04308343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110396221|NCT04308343|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110396222|NCT04308343|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110396223|NCT04308343|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110396224|NCT04308343|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110396225|NCT04308343|Hormone Antagonists|hormone antagonists|mesh-ancestor
110396226|NCT04308343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110396227|NCT04308343|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110396228|NCT04308343|Fertility Agents|fertility agents|mesh-ancestor
110396229|NCT01099579|Ritonavir|ritonavir|mesh-list
110396230|NCT01099579|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110396231|NCT01099579|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110396232|NCT01099579|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110396233|NCT01099579|Protease Inhibitors|protease inhibitors|mesh-ancestor
110396234|NCT01099579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110396235|NCT01099579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110396236|NCT01099579|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110396237|NCT01099579|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110396238|NCT01099579|Antiviral Agents|antiviral agents|mesh-ancestor
110396239|NCT01099579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110050375|NCT01466608|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110396240|NCT01099579|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110396241|NCT01099579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110396242|NCT01103713|Azithromycin|azithromycin|mesh-list
110396243|NCT01103713|Chloroquine|chloroquine|mesh-list
110396244|NCT01103713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110396245|NCT01103713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110396246|NCT01103713|Amebicides|amebicides|mesh-ancestor
110396247|NCT01103713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110396248|NCT01103713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110396249|NCT01103713|Antimalarials|antimalarials|mesh-ancestor
110396250|NCT01103713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110396251|NCT01103245|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110028876|NCT05440578|Bevacizumab|bevacizumab|mesh-list
110396252|NCT01103245|Spironolactone|spironolactone|mesh-list
110396253|NCT01103245|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110396254|NCT01103245|Diuretics|diuretics|mesh-ancestor
110396255|NCT01103245|Natriuretic Agents|natriuretic agents|mesh-ancestor
110396256|NCT01103245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396257|NCT01103245|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110396258|NCT01103245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110396259|NCT01103245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110396260|NCT01103245|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110396261|NCT01103245|Hormone Antagonists|hormone antagonists|mesh-ancestor
110396262|NCT01103245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110396263|NCT01103245|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110396264|NCT02878837|Midazolam|midazolam|mesh-list
110396265|NCT02878837|Dexmedetomidine|dexmedetomidine|mesh-list
110396266|NCT02878837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110396267|NCT02878837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110396268|NCT02878837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396270|NCT02878837|Analgesics|analgesics|mesh-ancestor
110396271|NCT02878837|Sensory System Agents|sensory system agents|mesh-ancestor
110396272|NCT02878837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110396273|NCT02878837|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110396274|NCT02878837|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110396275|NCT02878837|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110396276|NCT02878837|Adrenergic Agents|adrenergic agents|mesh-ancestor
110396277|NCT02878837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110396278|NCT02878837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110396279|NCT02878837|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110396280|NCT02878837|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110396281|NCT02878837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110396282|NCT02878837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110396283|NCT02878837|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110396284|NCT02878837|Anesthetics, General|anesthetics, general|mesh-ancestor
110396285|NCT02878837|Anesthetics|anesthetics|mesh-ancestor
110396286|NCT02878837|GABA Modulators|gaba modulators|mesh-ancestor
110396287|NCT02878837|GABA Agents|gaba agents|mesh-ancestor
110396288|NCT02880007|Cisplatin|cisplatin|mesh-list
110396289|NCT02880007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110396290|NCT04982029|Cannabidiol|cannabidiol|mesh-list
110396291|NCT04982029|Anticonvulsants|anticonvulsants|mesh-ancestor
110396292|NCT02880085|Lidocaine|lidocaine|mesh-list
110396293|NCT02880085|Anesthetics, Local|anesthetics, local|mesh-list
110396294|NCT02880085|Anesthetics|anesthetics|mesh-list
110396295|NCT02880085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110396296|NCT02880085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396297|NCT02880085|Sensory System Agents|sensory system agents|mesh-ancestor
110396298|NCT02880085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110396299|NCT02880085|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110396300|NCT02880085|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110396301|NCT02880085|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110396302|NCT02880085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110396303|NCT02880085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110396304|NCT01098097|Ribavirin|ribavirin|mesh-list
110396305|NCT01098097|Antimetabolites|antimetabolites|mesh-ancestor
110396306|NCT01098097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110396307|NCT01098097|Antiviral Agents|antiviral agents|mesh-ancestor
110396308|NCT01098097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110396309|NCT04407572|Vitamin D|vitamin d|mesh-list
110396310|NCT04407572|Vitamins|vitamins|mesh-list
110396311|NCT04407572|Vitamin B 12|vitamin b 12|mesh-list
110396312|NCT04407572|Hydroxocobalamin|hydroxocobalamin|mesh-list
110396313|NCT04407572|Micronutrients|micronutrients|mesh-ancestor
110396314|NCT04407572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396315|NCT04407572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110396316|NCT04407572|Vitamin B Complex|vitamin b complex|mesh-ancestor
110396317|NCT04407572|Hematinics|hematinics|mesh-ancestor
110396318|NCT04328636|Magnesium Sulfate|magnesium sulfate|mesh-list
110396319|NCT04328636|Analgesics|analgesics|mesh-ancestor
110396320|NCT04328636|Sensory System Agents|sensory system agents|mesh-ancestor
110396321|NCT04328636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110396322|NCT04328636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396323|NCT04328636|Anesthetics|anesthetics|mesh-ancestor
110396324|NCT04328636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110396325|NCT04328636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110396326|NCT04328636|Anticonvulsants|anticonvulsants|mesh-ancestor
110396328|NCT04328636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110396329|NCT04328636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110396330|NCT04328636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110396331|NCT04328636|Tocolytic Agents|tocolytic agents|mesh-ancestor
110396332|NCT04328636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110396333|NCT02893826|Nimodipine|nimodipine|mesh-list
110396334|NCT02893826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110396335|NCT02893826|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110396336|NCT02893826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110396337|NCT02893826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110396338|NCT02893826|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110396339|NCT02893826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396340|NCT02893826|Vasodilator Agents|vasodilator agents|mesh-ancestor
110396341|NCT02893280|Aspirin|aspirin|mesh-list
110396342|NCT02893280|Enoxaparin|enoxaparin|mesh-list
110396343|NCT02893280|Streptokinase|streptokinase|mesh-list
110396344|NCT02893280|Clopidogrel|clopidogrel|mesh-list
110396345|NCT02893280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110396346|NCT02893280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110396347|NCT02893280|Analgesics|analgesics|mesh-ancestor
110396348|NCT02893280|Sensory System Agents|sensory system agents|mesh-ancestor
110396349|NCT02893280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110396350|NCT02893280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396351|NCT02893280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110396353|NCT02893280|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110396354|NCT02893280|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110396355|NCT02893280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110396356|NCT02893280|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110396357|NCT02893280|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110396358|NCT02893280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110396359|NCT02893280|Antipyretics|antipyretics|mesh-ancestor
110396360|NCT02893280|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110396361|NCT02893280|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110396362|NCT02893280|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110396363|NCT02893280|Purinergic Agents|purinergic agents|mesh-ancestor
110396364|NCT02893280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110396365|NCT02893280|Anticoagulants|anticoagulants|mesh-ancestor
110396366|NCT04390802|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110396367|NCT04390802|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110396368|NCT04390802|Dermatologic Agents|dermatologic agents|mesh-ancestor
110396370|NCT04328480|Gout Suppressants|gout suppressants|mesh-ancestor
110396371|NCT04328480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110396372|NCT04328480|Tubulin Modulators|tubulin modulators|mesh-ancestor
110396373|NCT04328480|Antimitotic Agents|antimitotic agents|mesh-ancestor
110396374|NCT04328480|Mitosis Modulators|mitosis modulators|mesh-ancestor
110396375|NCT04328480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110396376|NCT04328480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110396377|NCT02893124|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110396378|NCT02893124|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110396379|NCT02893124|Antiviral Agents|antiviral agents|mesh-ancestor
110396380|NCT02893124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110396381|NCT02892812|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110396382|NCT02892812|Immunologic Factors|immunologic factors|mesh-ancestor
110396383|NCT02892812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396384|NCT00592670|Fluoxetine|fluoxetine|mesh-list
110396385|NCT00592670|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110396386|NCT00592670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110396387|NCT00592670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110396388|NCT00592670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110396389|NCT00592670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110396391|NCT00592670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396392|NCT00592670|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110396393|NCT00592670|Antidepressive Agents|antidepressive agents|mesh-ancestor
110396394|NCT00592670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110396395|NCT00592670|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110396396|NCT00592670|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110396397|NCT00592670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110396398|NCT04327232|Spironolactone|spironolactone|mesh-list
110396399|NCT04327232|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110396400|NCT04327232|Hormone Antagonists|hormone antagonists|mesh-ancestor
110396401|NCT04327232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110396402|NCT04327232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396403|NCT04327232|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110396404|NCT04327232|Diuretics|diuretics|mesh-ancestor
110396405|NCT04327232|Natriuretic Agents|natriuretic agents|mesh-ancestor
110396406|NCT00593138|Methylphenidate|methylphenidate|mesh-list
110396407|NCT00593138|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
110396408|NCT00593138|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110396409|NCT00593138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396410|NCT00593138|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110396411|NCT00593138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110396412|NCT00593138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110396413|NCT00593138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110396414|NCT00593138|Dopamine Agents|dopamine agents|mesh-ancestor
110396415|NCT00593138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110396416|NCT00593294|Drospirenone|drospirenone|mesh-list
110396417|NCT00593294|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110396418|NCT00593294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396419|NCT00593294|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110396420|NCT00593294|Hormone Antagonists|hormone antagonists|mesh-ancestor
110396421|NCT00593294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110396422|NCT00593294|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110396423|NCT00593294|Diuretics|diuretics|mesh-ancestor
110396424|NCT00593294|Natriuretic Agents|natriuretic agents|mesh-ancestor
110396425|NCT00593294|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110396426|NCT00593294|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110396427|NCT00593294|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110396428|NCT00593294|Contraceptive Agents|contraceptive agents|mesh-ancestor
110396429|NCT00593294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110396430|NCT00593294|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110396431|NCT00593294|Estrogens|estrogens|mesh-ancestor
110396432|NCT00593294|Hormones|hormones|mesh-ancestor
110396433|NCT00593996|Vitamin D|vitamin d|mesh-list
110396435|NCT00593996|Vitamins|vitamins|mesh-ancestor
110396436|NCT00593996|Micronutrients|micronutrients|mesh-ancestor
110396437|NCT00593996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396438|NCT00593996|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110396439|NCT00593996|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110396440|NCT00594542|Lidocaine|lidocaine|mesh-list
110396441|NCT00594542|Anesthetics, Local|anesthetics, local|mesh-ancestor
110396442|NCT00594542|Anesthetics|anesthetics|mesh-ancestor
110396443|NCT00594542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110396444|NCT00594542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396445|NCT00594542|Sensory System Agents|sensory system agents|mesh-ancestor
110396446|NCT00594542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110396447|NCT00594542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110396448|NCT00594542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110396449|NCT00594542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110396450|NCT00594542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110396451|NCT00594542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110396452|NCT00595322|Bevacizumab|bevacizumab|mesh-list
110396453|NCT00595322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110396454|NCT00595322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110396455|NCT00595322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110396456|NCT00595322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110396457|NCT00595322|Growth Substances|growth substances|mesh-ancestor
110396458|NCT00595322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396459|NCT00595322|Growth Inhibitors|growth inhibitors|mesh-ancestor
110396460|NCT00596336|Imiquimod|imiquimod|mesh-list
110396461|NCT00596336|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110396462|NCT00596336|Immunologic Factors|immunologic factors|mesh-ancestor
110396463|NCT00596336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396464|NCT00596336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110396465|NCT00596336|Interferon Inducers|interferon inducers|mesh-ancestor
110396467|NCT00596414|Meperidine|meperidine|mesh-list
110396468|NCT00596414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110396469|NCT00596414|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110396470|NCT00596414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110396471|NCT00596414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396472|NCT00596414|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110396473|NCT00596414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110396474|NCT00596414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110396475|NCT00596414|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110396476|NCT00596414|Anesthetics, General|anesthetics, general|mesh-ancestor
110396477|NCT00596414|Anesthetics|anesthetics|mesh-ancestor
110396478|NCT00596414|GABA Modulators|gaba modulators|mesh-ancestor
110396479|NCT00596414|GABA Agents|gaba agents|mesh-ancestor
110396480|NCT00596414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110396481|NCT00596414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110396482|NCT00596414|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110396483|NCT00596414|Narcotics|narcotics|mesh-ancestor
110396484|NCT00596414|Analgesics|analgesics|mesh-ancestor
110396485|NCT00596414|Sensory System Agents|sensory system agents|mesh-ancestor
110396486|NCT00596414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110396487|NCT00596648|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110396488|NCT00596648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110396489|NCT00596648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110396490|NCT00596648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110396491|NCT00596648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110396492|NCT00596804|Veltuzumab|veltuzumab|mesh-list
110396493|NCT00596804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110396494|NCT00622934|Epoetin Alfa|epoetin alfa|mesh-list
110396495|NCT00622934|Hematinics|hematinics|mesh-ancestor
110396496|NCT00597662|Icodextrin|icodextrin|mesh-list
110396497|NCT00597662|Dialysis Solutions|dialysis solutions|mesh-ancestor
110396498|NCT00597662|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110396499|NCT00598052|Escitalopram|escitalopram|mesh-list
110396501|NCT00598052|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110396502|NCT00598052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110396503|NCT00598052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110396504|NCT00598052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110396505|NCT00598052|Serotonin Agents|serotonin agents|mesh-ancestor
110396506|NCT00598052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396507|NCT04326296|Lenalidomide|lenalidomide|mesh-list
110396508|NCT04326296|Antibodies|antibodies|mesh-list
110396509|NCT04326296|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110396510|NCT04326296|Immunologic Factors|immunologic factors|mesh-ancestor
110396511|NCT04326296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396512|NCT04326296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110396513|NCT04326296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110396514|NCT04326296|Growth Substances|growth substances|mesh-ancestor
110396515|NCT04326296|Growth Inhibitors|growth inhibitors|mesh-ancestor
110396516|NCT04326296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110396518|NCT00598676|Everolimus|everolimus|mesh-list
110396519|NCT00598676|MTOR Inhibitors|mtor inhibitors|mesh-list
110396520|NCT00598676|Temsirolimus|temsirolimus|mesh-list
110396521|NCT00598676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110396522|NCT00598676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110396523|NCT00598676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110396524|NCT00598676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110396525|NCT00598676|Immunologic Factors|immunologic factors|mesh-ancestor
110396526|NCT00598676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396527|NCT00598676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110028958|NCT05768126|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110396528|NCT00598676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110396529|NCT00598676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110396530|NCT00598676|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110396531|NCT00598676|Antifungal Agents|antifungal agents|mesh-ancestor
110396532|NCT00599222|Ranibizumab|ranibizumab|mesh-list
110396533|NCT00599222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110396534|NCT00599222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110396535|NCT00599222|Growth Substances|growth substances|mesh-ancestor
110396536|NCT00599222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396537|NCT00599222|Growth Inhibitors|growth inhibitors|mesh-ancestor
110396538|NCT00599222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110396539|NCT00599534|Montelukast|montelukast|mesh-list
110396540|NCT00599534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110396541|NCT00599534|Respiratory System Agents|respiratory system agents|mesh-ancestor
110396542|NCT00599534|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110396543|NCT00599534|Hormone Antagonists|hormone antagonists|mesh-ancestor
110396544|NCT00599534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110396545|NCT00599534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396546|NCT00599534|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110396547|NCT00599534|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110396548|NCT00599534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110396550|NCT00600158|Hydromorphone|hydromorphone|mesh-list
110396551|NCT00600158|Bupivacaine|bupivacaine|mesh-list
110396552|NCT00600158|Anesthetics, Local|anesthetics, local|mesh-ancestor
110396553|NCT00600158|Anesthetics|anesthetics|mesh-ancestor
110396554|NCT00600158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110396555|NCT00600158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396556|NCT00600158|Sensory System Agents|sensory system agents|mesh-ancestor
110396557|NCT00600158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110396558|NCT00600158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110396559|NCT00600158|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110396560|NCT00600158|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110396561|NCT00600158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110396562|NCT00600158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110396563|NCT00600158|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110396564|NCT00600158|Narcotics|narcotics|mesh-ancestor
110396565|NCT00600158|Analgesics|analgesics|mesh-ancestor
110396566|NCT04325984|Dexamethasone|dexamethasone|mesh-list
110396567|NCT04325984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110396568|NCT04325984|Antiemetics|antiemetics|mesh-ancestor
110396569|NCT04325984|Autonomic Agents|autonomic agents|mesh-ancestor
110396570|NCT04325984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110396571|NCT04325984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396572|NCT04325984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110396573|NCT04325984|Glucocorticoids|glucocorticoids|mesh-ancestor
110396574|NCT04325984|Hormones|hormones|mesh-ancestor
110396575|NCT04325984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110396576|NCT04325984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110396577|NCT04325984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110396578|NCT00600548|Miltefosine|miltefosine|mesh-list
110396579|NCT00600548|Meglumine Antimoniate|meglumine antimoniate|mesh-list
110396580|NCT00600548|Antifungal Agents|antifungal agents|mesh-ancestor
110396581|NCT00600548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110396582|NCT00600548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110396583|NCT00600548|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110396584|NCT00600548|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110396585|NCT00600626|Insulin|insulin|mesh-list
110396586|NCT00600626|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110396587|NCT00600626|Insulin Aspart|insulin aspart|mesh-list
110396588|NCT00600626|Insulin, Long-Acting|insulin, long-acting|mesh-list
110396589|NCT00600626|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110396590|NCT00600626|Biphasic Insulins|biphasic insulins|mesh-list
110396591|NCT00600626|Isophane Insulin, Human|isophane insulin, human|mesh-list
110396592|NCT00600626|Insulin, Isophane|insulin, isophane|mesh-list
110396593|NCT00600626|Isophane insulin, beef|isophane insulin, beef|mesh-list
110396594|NCT00600626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110396595|NCT00600626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396598|NCT00623168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110396599|NCT00623168|Antiviral Agents|antiviral agents|mesh-ancestor
110396600|NCT00623168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110396601|NCT00601016|Imiquimod|imiquimod|mesh-list
110396602|NCT00601016|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110396603|NCT00601016|Immunologic Factors|immunologic factors|mesh-ancestor
110396604|NCT00601016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396605|NCT00601016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110396606|NCT00601016|Interferon Inducers|interferon inducers|mesh-ancestor
110396607|NCT00601328|Calcitriol|calcitriol|mesh-list
110396608|NCT00601328|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110396609|NCT00601328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396610|NCT00601328|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110396611|NCT00601328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110396612|NCT00601328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110396613|NCT00601328|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110396614|NCT00601328|Vitamins|vitamins|mesh-ancestor
110396615|NCT00601328|Micronutrients|micronutrients|mesh-ancestor
110396616|NCT00601328|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110396617|NCT00601562|Zidovudine|zidovudine|mesh-list
110396618|NCT00601562|Antimetabolites|antimetabolites|mesh-ancestor
110396619|NCT00601562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110396620|NCT00601562|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110396621|NCT00601562|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110396622|NCT00601562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110396623|NCT00601562|Antiviral Agents|antiviral agents|mesh-ancestor
110396624|NCT00601562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110396626|NCT00601562|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110396627|NCT00601874|Pilocarpine|pilocarpine|mesh-list
110396628|NCT00601874|Miotics|miotics|mesh-ancestor
110396629|NCT00601874|Autonomic Agents|autonomic agents|mesh-ancestor
110396630|NCT00601874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110396631|NCT00601874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396632|NCT00601874|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110396634|NCT00601874|Cholinergic Agents|cholinergic agents|mesh-ancestor
110396635|NCT00601874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110028998|NCT05767827|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110396636|NCT00601874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110396637|NCT01326026|Insulin|insulin|mesh-list
110396638|NCT01326026|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110396639|NCT01326026|Insulin, Long-Acting|insulin, long-acting|mesh-list
110396640|NCT01326026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110396641|NCT01326026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396642|NCT01097629|Suvorexant|suvorexant|mesh-list
110396644|NCT01097629|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110396645|NCT01097629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110396646|NCT01097629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396647|NCT01097629|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
110396648|NCT01097629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110396649|NCT01097629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110396650|NCT04308031|Digoxin|digoxin|mesh-list
110396651|NCT04308031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110396652|NCT04308031|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110396653|NCT04308031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110396654|NCT04308031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110396655|NCT04308031|Protective Agents|protective agents|mesh-ancestor
110396656|NCT04308031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396657|NCT01096849|Levofloxacin|levofloxacin|mesh-list
110396658|NCT01096849|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110396659|NCT01096849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110396660|NCT01096849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110396661|NCT01096849|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110396662|NCT01096849|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110396663|NCT01096849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110396664|NCT01096849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110396665|NCT01096849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110396666|NCT01096849|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110396667|NCT01096849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110396668|NCT01324388|Dulaglutide|dulaglutide|mesh-list
110396670|NCT01324388|Lisinopril|lisinopril|mesh-list
110396671|NCT01324388|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110396672|NCT01324388|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110396673|NCT01324388|Sympatholytics|sympatholytics|mesh-ancestor
110396674|NCT01324388|Autonomic Agents|autonomic agents|mesh-ancestor
110396675|NCT01324388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110396676|NCT01324388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396677|NCT01324388|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110396678|NCT01324388|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110396679|NCT01324388|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110396680|NCT01324388|Adrenergic Agents|adrenergic agents|mesh-ancestor
110396681|NCT01324388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110396682|NCT01324388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110396683|NCT01324388|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110396684|NCT01324388|Protease Inhibitors|protease inhibitors|mesh-ancestor
110396685|NCT01324388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110396686|NCT01324388|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110396687|NCT01324388|Protective Agents|protective agents|mesh-ancestor
110396688|NCT01324388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110396689|NCT02878681|Ranibizumab|ranibizumab|mesh-list
110396690|NCT02878681|Aflibercept|aflibercept|mesh-list
110396691|NCT02878681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110396692|NCT02878681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110396693|NCT02878681|Growth Substances|growth substances|mesh-ancestor
110029016|NCT05767723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110396694|NCT02878681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396695|NCT02878681|Growth Inhibitors|growth inhibitors|mesh-ancestor
110396696|NCT02878681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110396697|NCT01324310|Ketoconazole|ketoconazole|mesh-list
110396698|NCT01324310|Romidepsin|romidepsin|mesh-list
110396699|NCT01324310|Antifungal Agents|antifungal agents|mesh-ancestor
110396700|NCT01324310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110396701|NCT01324310|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110396702|NCT01324310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110396703|NCT01324310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110396704|NCT01324310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110396705|NCT01324310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110396706|NCT01324310|Hormone Antagonists|hormone antagonists|mesh-ancestor
110396707|NCT01324310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110396708|NCT01324310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396709|NCT01324310|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110396710|NCT01324310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110396711|NCT01324310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110396712|NCT01324310|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110396714|NCT01102231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110396715|NCT01102231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110396716|NCT01095835|Interferons|interferons|mesh-list
110396717|NCT01095835|Lamivudine|lamivudine|mesh-list
110396718|NCT01095835|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110396719|NCT01095835|Interferon-alpha|interferon-alpha|mesh-list
110396720|NCT01095835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110396721|NCT01095835|Antiviral Agents|antiviral agents|mesh-ancestor
110396722|NCT01095835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110396723|NCT01095835|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110396724|NCT01095835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110396725|NCT01095835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110396726|NCT01095835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110396727|NCT01095835|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110396728|NCT01095835|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110396729|NCT01095835|Immunologic Factors|immunologic factors|mesh-ancestor
110396730|NCT01095835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396732|NCT04908865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110396733|NCT04908865|Immunologic Factors|immunologic factors|mesh-ancestor
110396734|NCT04908865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396736|NCT01324232|Dextromethorphan|dextromethorphan|mesh-list
110396737|NCT01324232|Antitussive Agents|antitussive agents|mesh-ancestor
110396738|NCT01324232|Respiratory System Agents|respiratory system agents|mesh-ancestor
110396739|NCT01324232|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110396740|NCT01324232|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110396741|NCT01324232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110396742|NCT01324232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110396743|NCT01324232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396744|NCT01324232|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110396746|NCT01324232|Adrenergic Agents|adrenergic agents|mesh-ancestor
110396747|NCT01324232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110396748|NCT01324232|Antimalarials|antimalarials|mesh-ancestor
110396749|NCT01324232|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110396750|NCT01324232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110396751|NCT01324232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110396752|NCT01324232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110396753|NCT01324232|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110396754|NCT01324232|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110396755|NCT01324232|Cholinergic Agents|cholinergic agents|mesh-ancestor
110396756|NCT01324232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110396757|NCT01324232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110396758|NCT01324232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110396759|NCT01324232|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110396760|NCT01324232|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110396761|NCT02878291|Vaccines|vaccines|mesh-list
110396762|NCT02878291|Immunologic Factors|immunologic factors|mesh-ancestor
110396763|NCT02878291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396764|NCT05350891|Immunomodulating Agents|immunomodulating agents|mesh-list
110396765|NCT05350891|Immunologic Factors|immunologic factors|mesh-ancestor
110396766|NCT05350891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396767|NCT01323920|Methotrexate|methotrexate|mesh-list
110396769|NCT01323920|Tacrolimus|tacrolimus|mesh-list
110396770|NCT01323920|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110396771|NCT01323920|Abortifacient Agents|abortifacient agents|mesh-ancestor
110396772|NCT01323920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110396774|NCT01323920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110396775|NCT01323920|Antimetabolites|antimetabolites|mesh-ancestor
110396776|NCT01323920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110396777|NCT01323920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110396778|NCT01323920|Dermatologic Agents|dermatologic agents|mesh-ancestor
110396779|NCT01323920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110396780|NCT01323920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110396781|NCT01323920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110396782|NCT01323920|Immunologic Factors|immunologic factors|mesh-ancestor
110396783|NCT01323920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110396784|NCT01323920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110396785|NCT01323920|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110396786|NCT01093885|Ambrisentan|ambrisentan|mesh-list
110396787|NCT01093885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110396788|NCT00597597|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110396789|NCT00597597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110396790|NCT00597597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110396791|NCT00597597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110396792|NCT00597597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110396794|NCT02891967|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110396795|NCT02891967|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110396796|NCT02891967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110396797|NCT02891967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110396798|NCT02891967|Hormone Antagonists|hormone antagonists|mesh-ancestor
110396799|NCT02891967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110396800|NCT02891967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396801|NCT00598377|Cosyntropin|cosyntropin|mesh-list
110396803|NCT00598377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110396804|NCT00598377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396805|NCT00598533|Sirolimus|sirolimus|mesh-list
110396806|NCT00598533|Probucol|probucol|mesh-list
110396807|NCT00598533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110396808|NCT00598533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110396809|NCT00598533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110396810|NCT00598533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110396811|NCT00598533|Antifungal Agents|antifungal agents|mesh-ancestor
110396812|NCT00598533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110396813|NCT00598533|Immunologic Factors|immunologic factors|mesh-ancestor
110396814|NCT00598533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396815|NCT00598533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110396816|NCT00598533|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110396817|NCT00598533|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110396818|NCT00598533|Antimetabolites|antimetabolites|mesh-ancestor
110396819|NCT00598533|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110396820|NCT00598533|Antioxidants|antioxidants|mesh-ancestor
110396821|NCT00598533|Protective Agents|protective agents|mesh-ancestor
110396822|NCT00599937|Tretinoin|tretinoin|mesh-list
110396823|NCT00599937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110396824|NCT00599937|Keratolytic Agents|keratolytic agents|mesh-ancestor
110396825|NCT00599937|Dermatologic Agents|dermatologic agents|mesh-ancestor
110396826|NCT00600093|Amantadine|amantadine|mesh-list
110396827|NCT00600093|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110396828|NCT00600093|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110396829|NCT00600093|Antiviral Agents|antiviral agents|mesh-ancestor
110396830|NCT00600093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110396831|NCT00600093|Dopamine Agents|dopamine agents|mesh-ancestor
110396832|NCT00600093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110050974|NCT01470092|Hormones|hormones|mesh-ancestor
110396833|NCT00600093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110396834|NCT00600093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396835|NCT00600093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110396837|NCT00600093|Sensory System Agents|sensory system agents|mesh-ancestor
110396838|NCT00600093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110396839|NCT00600249|Docetaxel|docetaxel|mesh-list
110396840|NCT00600249|Cetuximab|cetuximab|mesh-list
110396841|NCT00600249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110396842|NCT00600249|Tubulin Modulators|tubulin modulators|mesh-ancestor
110396843|NCT00600249|Antimitotic Agents|antimitotic agents|mesh-ancestor
110396844|NCT00600249|Mitosis Modulators|mitosis modulators|mesh-ancestor
110396845|NCT00600249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110396846|NCT00600249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110396847|NCT00600405|Ibuprofen|ibuprofen|mesh-list
110396848|NCT00600405|Oxycodone|oxycodone|mesh-list
110396849|NCT00600405|Tamsulosin|tamsulosin|mesh-list
110396850|NCT00600405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110396851|NCT00600405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110396852|NCT00600405|Analgesics|analgesics|mesh-ancestor
110396853|NCT00600405|Sensory System Agents|sensory system agents|mesh-ancestor
110396854|NCT00600405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110396855|NCT00600405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029072|NCT05767229|Vasodilator Agents|vasodilator agents|mesh-ancestor
110396856|NCT00600405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110396857|NCT00600405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110396858|NCT00600405|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110396859|NCT00600405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110396860|NCT00600405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110396861|NCT00600405|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110396863|NCT00600405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110396864|NCT00600405|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110396865|NCT00600405|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110396866|NCT00600405|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110396867|NCT00600405|Adrenergic Agents|adrenergic agents|mesh-ancestor
110396868|NCT00600405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110396869|NCT00600405|Urological Agents|urological agents|mesh-ancestor
110396870|NCT00600639|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110396871|NCT00600639|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110396872|NCT00600639|Prednisolone|prednisolone|mesh-list
110396873|NCT00600639|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110396874|NCT00600639|Methylprednisolone|methylprednisolone|mesh-list
110396875|NCT00600639|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110396876|NCT00600639|Prednisolone acetate|prednisolone acetate|mesh-list
110396877|NCT00600639|Albuterol|albuterol|mesh-list
110396878|NCT00600639|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110396879|NCT00600639|Prednisolone phosphate|prednisolone phosphate|mesh-list
110396880|NCT00600639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110396881|NCT00600639|Antitubercular Agents|antitubercular agents|mesh-ancestor
110396882|NCT00600639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110396883|NCT00600639|Glucocorticoids|glucocorticoids|mesh-ancestor
110396884|NCT00600639|Hormones|hormones|mesh-ancestor
110396885|NCT00600639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110396886|NCT00600639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396887|NCT00600639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110396888|NCT00600639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110396889|NCT00600639|Antiemetics|antiemetics|mesh-ancestor
110396890|NCT00600639|Autonomic Agents|autonomic agents|mesh-ancestor
110396891|NCT00600639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110396892|NCT00600639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110396893|NCT00600639|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110396894|NCT00600639|Protective Agents|protective agents|mesh-ancestor
110396895|NCT00600639|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110396896|NCT00600639|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110396897|NCT00600639|Respiratory System Agents|respiratory system agents|mesh-ancestor
110396898|NCT00600639|Tocolytic Agents|tocolytic agents|mesh-ancestor
110396899|NCT00600639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110396900|NCT00600639|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110396901|NCT00600639|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110396902|NCT00600639|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110396903|NCT00600639|Adrenergic Agents|adrenergic agents|mesh-ancestor
110396904|NCT00600639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110396905|NCT00600639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110396907|NCT00600873|Antioxidants|antioxidants|mesh-ancestor
110396908|NCT00600873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110396909|NCT00600873|Protective Agents|protective agents|mesh-ancestor
110396910|NCT00600873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396911|NCT00600873|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110396912|NCT00600873|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110396913|NCT00600873|Dopamine Agonists|dopamine agonists|mesh-ancestor
110396914|NCT00600873|Dopamine Agents|dopamine agents|mesh-ancestor
110396915|NCT00600873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110396916|NCT00598611|Loratadine|loratadine|mesh-list
110396917|NCT00598611|Desloratadine|desloratadine|mesh-list
110396918|NCT00598611|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110396919|NCT00598611|Cholinergic Agents|cholinergic agents|mesh-ancestor
110396920|NCT00598611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110396921|NCT00598611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110396922|NCT00598611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396923|NCT00598611|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110396924|NCT00598611|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110396925|NCT00598611|Histamine Antagonists|histamine antagonists|mesh-ancestor
110396926|NCT00598611|Histamine Agents|histamine agents|mesh-ancestor
110396927|NCT00598611|Antipruritics|antipruritics|mesh-ancestor
110396928|NCT00598611|Dermatologic Agents|dermatologic agents|mesh-ancestor
110396929|NCT00598611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110396930|NCT04325724|Dermatologic Agents|dermatologic agents|mesh-list
110396931|NCT04325490|Hydrocortisone|hydrocortisone|mesh-list
110396932|NCT04325490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110396933|NCT00601575|Lithium Carbonate|lithium carbonate|mesh-list
110396934|NCT00601575|Antidepressive Agents|antidepressive agents|mesh-ancestor
110396935|NCT00601575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110396936|NCT00601575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110396937|NCT00601575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110396938|NCT00601575|Antimanic Agents|antimanic agents|mesh-ancestor
110396939|NCT00601575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110396940|NCT00601575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110396941|NCT00601575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396942|NCT00601887|Meloxicam|meloxicam|mesh-list
110396943|NCT00601887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110396944|NCT00601887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110396945|NCT00601887|Analgesics|analgesics|mesh-ancestor
110396946|NCT00601887|Sensory System Agents|sensory system agents|mesh-ancestor
110396947|NCT00601887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110396948|NCT00601887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396949|NCT00601887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110396950|NCT00601887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110396951|NCT00601887|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110396952|NCT00601887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110396953|NCT00601887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110396954|NCT00601887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110396955|NCT01325493|Ketamine|ketamine|mesh-list
110396956|NCT01325493|Analgesics|analgesics|mesh-ancestor
110396957|NCT01325493|Sensory System Agents|sensory system agents|mesh-ancestor
110396958|NCT01325493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110396959|NCT01325493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396960|NCT01325493|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110396961|NCT01325493|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110396962|NCT01325493|Anesthetics, General|anesthetics, general|mesh-ancestor
110396964|NCT01325493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110396965|NCT01325493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110396967|NCT01325493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110396968|NCT01325493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110396969|NCT01325337|Bimatoprost|bimatoprost|mesh-list
110396970|NCT01325337|Minoxidil|minoxidil|mesh-list
110396971|NCT01325337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110396972|NCT01325337|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110396973|NCT01325337|Vasodilator Agents|vasodilator agents|mesh-ancestor
110396974|NCT01324947|Pomalidomide|pomalidomide|mesh-list
110396975|NCT01324947|Immunologic Factors|immunologic factors|mesh-ancestor
110396976|NCT01324947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396977|NCT01324947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110396978|NCT01324947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110396979|NCT01324947|Growth Substances|growth substances|mesh-ancestor
110396980|NCT01324947|Growth Inhibitors|growth inhibitors|mesh-ancestor
110396981|NCT01324947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110396982|NCT01101841|Paroxetine|paroxetine|mesh-list
110396983|NCT01101841|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110396984|NCT01101841|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110396985|NCT01101841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110029105|NCT05751343|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110396986|NCT01101841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110396987|NCT01101841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110396989|NCT01101841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396990|NCT01101841|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110396991|NCT01101841|Antidepressive Agents|antidepressive agents|mesh-ancestor
110396992|NCT01101841|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110396993|NCT01101841|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110396994|NCT01101841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110396995|NCT01101841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110396996|NCT02877511|Sunscreening Agents|sunscreening agents|mesh-list
110396997|NCT02877511|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110396998|NCT02877511|Protective Agents|protective agents|mesh-ancestor
110396999|NCT02877511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110397000|NCT02877511|Dermatologic Agents|dermatologic agents|mesh-ancestor
110397003|NCT01324323|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110397004|NCT01324323|Antitubercular Agents|antitubercular agents|mesh-ancestor
110397005|NCT01324323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110397006|NCT01324323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110397007|NCT01324323|Leprostatic Agents|leprostatic agents|mesh-ancestor
110397008|NCT01324323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110397009|NCT01324323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110397010|NCT01324323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110397011|NCT01324323|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110397012|NCT01324323|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110397013|NCT01324323|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110397014|NCT01324323|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110397015|NCT01324323|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110397016|NCT01324323|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110397017|NCT01324323|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110397018|NCT01324323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110397019|NCT01324323|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110397020|NCT05344963|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
110397021|NCT05344963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110397022|NCT05344963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110397023|NCT05344963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110397025|NCT02879227|Oxaliplatin|oxaliplatin|mesh-list
110397026|NCT02879227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110397027|NCT01323582|Azithromycin|azithromycin|mesh-list
110397028|NCT01323582|Erythromycin|erythromycin|mesh-list
110397029|NCT01323582|Erythromycin Estolate|erythromycin estolate|mesh-list
110397031|NCT01323582|Erythromycin stearate|erythromycin stearate|mesh-list
110397032|NCT01323582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110397033|NCT01323582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110397034|NCT01323582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110397035|NCT01323582|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110397036|NCT01323582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110397037|NCT01323582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110397038|NCT05367765|Imatinib Mesylate|imatinib mesylate|mesh-list
110397039|NCT05367765|Flumatinib|flumatinib|mesh-list
110397040|NCT05367765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110397041|NCT05367765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110397042|NCT05367765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110397043|NCT05367765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110397044|NCT01323621|Fluticasone|fluticasone|mesh-list
110397046|NCT01323621|Albuterol|albuterol|mesh-list
110397047|NCT01323621|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110397048|NCT01323621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110397049|NCT01323621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110397050|NCT01323621|Autonomic Agents|autonomic agents|mesh-ancestor
110397051|NCT01323621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110397052|NCT01323621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110397053|NCT01323621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110397054|NCT01323621|Respiratory System Agents|respiratory system agents|mesh-ancestor
110397055|NCT01323621|Dermatologic Agents|dermatologic agents|mesh-ancestor
110397056|NCT01323621|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110397057|NCT01323621|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110397058|NCT01323621|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110397059|NCT01323621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110397060|NCT01323621|Adrenergic Agents|adrenergic agents|mesh-ancestor
110397061|NCT01323621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110397062|NCT01323621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110397064|NCT01323621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110397065|NCT05645289|Alendronate|alendronate|mesh-list
110397066|NCT05645289|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110397067|NCT05645289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110397069|NCT01320033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110397070|NCT01320033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110397071|NCT01320033|Antimalarials|antimalarials|mesh-ancestor
110397072|NCT01320033|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110397073|NCT01320033|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110397075|NCT05644743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110397076|NCT05644743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110397077|NCT05644743|Antimetabolites|antimetabolites|mesh-ancestor
110397078|NCT05644743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110397079|NCT01317615|Paclitaxel|paclitaxel|mesh-list
110397080|NCT01317615|Carboplatin|carboplatin|mesh-list
110397081|NCT01317615|Everolimus|everolimus|mesh-list
110397082|NCT01317615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110397083|NCT01317615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110397084|NCT01317615|Tubulin Modulators|tubulin modulators|mesh-ancestor
110397085|NCT01317615|Antimitotic Agents|antimitotic agents|mesh-ancestor
110397086|NCT01317615|Mitosis Modulators|mitosis modulators|mesh-ancestor
110397087|NCT01317615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110397088|NCT01317615|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110397089|NCT01317615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110397091|NCT01317615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110397092|NCT01317615|Immunologic Factors|immunologic factors|mesh-ancestor
110397093|NCT01317615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110397094|NCT01078675|Calcium, Dietary|calcium, dietary|mesh-list
110397095|NCT01078675|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110397096|NCT01078675|Calcium|calcium|mesh-list
110397097|NCT01078675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110397098|NCT01078675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110397099|NCT01078675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110397100|NCT01078675|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110397101|NCT01078675|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110397102|NCT01078675|Antimetabolites|antimetabolites|mesh-ancestor
110397103|NCT01078675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110397104|NCT01078675|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110397105|NCT01078675|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110397107|NCT01100437|Naltrexone|naltrexone|mesh-list
110397109|NCT01100437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110397110|NCT01100437|Narcotics|narcotics|mesh-ancestor
110397111|NCT01100437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110397112|NCT01100437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110397113|NCT01100437|Analgesics|analgesics|mesh-ancestor
110397114|NCT01100437|Sensory System Agents|sensory system agents|mesh-ancestor
110397115|NCT01100437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110397116|NCT01100437|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110397117|NCT01100437|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110397118|NCT01322490|Molgramostim|molgramostim|mesh-list
110397119|NCT01322490|Sargramostim|sargramostim|mesh-list
110397120|NCT01322490|Immunologic Factors|immunologic factors|mesh-ancestor
110397121|NCT01322490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110397122|NCT01322490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110397128|NCT01314261|Antimetabolites|antimetabolites|mesh-ancestor
110397129|NCT01314261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110397130|NCT02891616|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110397131|NCT02891616|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110397132|NCT02891616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110397137|NCT01321710|Acetaminophen|acetaminophen|mesh-list
110397138|NCT01321710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110397139|NCT01321710|Analgesics|analgesics|mesh-ancestor
110397140|NCT01321710|Sensory System Agents|sensory system agents|mesh-ancestor
110397141|NCT01321710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110397142|NCT01321710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110397143|NCT01321710|Antipyretics|antipyretics|mesh-ancestor
110397144|NCT01321008|Prednisone|prednisone|mesh-list
110397145|NCT01321008|Cyclophosphamide|cyclophosphamide|mesh-list
110397146|NCT01321008|Doxorubicin|doxorubicin|mesh-list
110397147|NCT01321008|Vincristine|vincristine|mesh-list
110397148|NCT01321008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110397149|NCT01321008|Immunologic Factors|immunologic factors|mesh-ancestor
110397150|NCT01321008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110397151|NCT01321008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110397152|NCT01321008|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110397153|NCT01321008|Alkylating Agents|alkylating agents|mesh-ancestor
110397154|NCT01321008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110397155|NCT01321008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110397156|NCT01321008|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110397157|NCT01321008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110397158|NCT01321008|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110029163|NCT05604599|Anesthetics|anesthetics|mesh-ancestor
110397159|NCT01321008|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110397160|NCT01321008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110397161|NCT01321008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110397162|NCT01321008|Glucocorticoids|glucocorticoids|mesh-ancestor
110397163|NCT01321008|Hormones|hormones|mesh-ancestor
110397164|NCT01321008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110397165|NCT01321008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110397166|NCT01321008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110397167|NCT01321008|Tubulin Modulators|tubulin modulators|mesh-ancestor
110397168|NCT01321008|Antimitotic Agents|antimitotic agents|mesh-ancestor
110397169|NCT01321008|Mitosis Modulators|mitosis modulators|mesh-ancestor
110397170|NCT01323530|Capecitabine|capecitabine|mesh-list
110397171|NCT01323530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110397172|NCT01323530|Antimetabolites|antimetabolites|mesh-ancestor
110397173|NCT01323530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110397174|NCT01323530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110397175|NCT01313637|Bromides|bromides|mesh-list
110397176|NCT01313637|Anticonvulsants|anticonvulsants|mesh-ancestor
110397177|NCT01320722|Vitamin D|vitamin d|mesh-list
110397178|NCT01320722|Ergocalciferols|ergocalciferols|mesh-list
110397179|NCT01320722|Cholecalciferol|cholecalciferol|mesh-list
110397180|NCT01320722|Vitamins|vitamins|mesh-list
110397181|NCT01320722|Allopurinol|allopurinol|mesh-list
110397183|NCT01320722|Micronutrients|micronutrients|mesh-ancestor
110397184|NCT01320722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110397185|NCT01320722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110397186|NCT01320722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110397187|NCT01320722|Antimetabolites|antimetabolites|mesh-ancestor
110397188|NCT01320722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110397189|NCT01320722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110397190|NCT01320722|Gout Suppressants|gout suppressants|mesh-ancestor
110397191|NCT01320722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110397192|NCT01320722|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110397193|NCT01320722|Antioxidants|antioxidants|mesh-ancestor
110397194|NCT01320722|Protective Agents|protective agents|mesh-ancestor
110397195|NCT01320722|Uricosuric Agents|uricosuric agents|mesh-ancestor
110397196|NCT01313559|Everolimus|everolimus|mesh-list
110397197|NCT01313559|Pasireotide|pasireotide|mesh-list
110397198|NCT01313559|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110397199|NCT01313559|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110397200|NCT01313559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110397201|NCT01313559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110397202|NCT01313559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110397203|NCT01313559|Immunologic Factors|immunologic factors|mesh-ancestor
110397204|NCT01313559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110397205|NCT01313559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110397206|NCT01313559|Hormones|hormones|mesh-ancestor
110397207|NCT01313559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110397208|NCT02890875|Ethanol|ethanol|mesh-list
110029176|NCT05543837|Dermatologic Agents|dermatologic agents|mesh-ancestor
110029189|NCT05486026|Analgesics|analgesics|mesh-ancestor
110397209|NCT02890875|Heparin|heparin|mesh-list
110397210|NCT02890875|Anticoagulants|anticoagulants|mesh-ancestor
110397211|NCT02890875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110397212|NCT02890875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110397213|NCT02890875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110397214|NCT02890875|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110397215|NCT02890875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110397216|NCT02890875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110397217|NCT02890875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110397219|NCT01312467|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110397220|NCT01312467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110397222|NCT01310127|Bromfenac|bromfenac|mesh-list
110397223|NCT01310127|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110397224|NCT01310127|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110397225|NCT01310127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110397226|NCT01310127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110397227|NCT01310127|Analgesics|analgesics|mesh-ancestor
110397228|NCT01310127|Sensory System Agents|sensory system agents|mesh-ancestor
110397229|NCT01310127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110397230|NCT01310127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110397231|NCT01310127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110397232|NCT01310127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110397233|NCT01318902|Dexamethasone|dexamethasone|mesh-list
110397234|NCT01318902|Ixazomib|ixazomib|mesh-list
110397235|NCT01318902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110397236|NCT01318902|Antiemetics|antiemetics|mesh-ancestor
110397237|NCT01318902|Autonomic Agents|autonomic agents|mesh-ancestor
110397238|NCT01318902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110397239|NCT01318902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110397240|NCT01318902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110397241|NCT01318902|Glucocorticoids|glucocorticoids|mesh-ancestor
110397242|NCT01318902|Hormones|hormones|mesh-ancestor
110397243|NCT01318902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110397244|NCT01318902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110397245|NCT01318902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110397246|NCT01318902|Protease Inhibitors|protease inhibitors|mesh-ancestor
110397247|NCT01318902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110397248|NCT01318902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110397250|NCT01313858|Methotrexate|methotrexate|mesh-list
110397251|NCT01313858|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110397252|NCT01313858|Abortifacient Agents|abortifacient agents|mesh-ancestor
110397253|NCT01313858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110397254|NCT01313858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110397255|NCT01313858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110397256|NCT01313858|Antimetabolites|antimetabolites|mesh-ancestor
110397257|NCT01313858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110397258|NCT01313858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110397259|NCT01313858|Dermatologic Agents|dermatologic agents|mesh-ancestor
110397260|NCT01313858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110397261|NCT01313858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110397262|NCT01313858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110397264|NCT01313858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110397265|NCT01313858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110397266|NCT01313858|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110397267|NCT01313858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110397268|NCT01313780|Oxycodone|oxycodone|mesh-list
110397269|NCT01313780|Naloxone|naloxone|mesh-list
110397270|NCT01313780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110397271|NCT01313780|Narcotics|narcotics|mesh-ancestor
110397272|NCT01313780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110397273|NCT01313780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110397274|NCT01313780|Analgesics|analgesics|mesh-ancestor
110397275|NCT01313780|Sensory System Agents|sensory system agents|mesh-ancestor
110397276|NCT01313780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110397277|NCT01313780|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110397278|NCT01090453|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110397279|NCT01090453|Immunologic Factors|immunologic factors|mesh-ancestor
110397280|NCT01090453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110397281|NCT01170364|Sibutramine|sibutramine|mesh-list
110397282|NCT01170364|Antidepressive Agents|antidepressive agents|mesh-ancestor
110397283|NCT01170364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110397284|NCT01170364|Appetite Depressants|appetite depressants|mesh-ancestor
110397285|NCT01170364|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110397286|NCT01170208|Insulin|insulin|mesh-list
110397287|NCT01170208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110397288|NCT01170208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110397289|NCT02891018|Paclitaxel|paclitaxel|mesh-list
110397290|NCT02891018|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110397291|NCT02891018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110397292|NCT02891018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110397293|NCT02891018|Tubulin Modulators|tubulin modulators|mesh-ancestor
110397294|NCT02891018|Antimitotic Agents|antimitotic agents|mesh-ancestor
110397295|NCT02891018|Mitosis Modulators|mitosis modulators|mesh-ancestor
110397296|NCT02891018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110397297|NCT01169350|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110397299|NCT01169350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110397300|NCT01169038|Azithromycin|azithromycin|mesh-list
110397301|NCT01169038|Rifampin|rifampin|mesh-list
110397302|NCT01169038|Ethambutol|ethambutol|mesh-list
110397303|NCT01169038|Levofloxacin|levofloxacin|mesh-list
110397304|NCT01169038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110397305|NCT01169038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110397306|NCT01169038|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110397307|NCT01169038|Antitubercular Agents|antitubercular agents|mesh-ancestor
110397308|NCT01169038|Leprostatic Agents|leprostatic agents|mesh-ancestor
110397309|NCT01169038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110397310|NCT01169038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110397311|NCT01169038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110397312|NCT01169038|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110397313|NCT01169038|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110397314|NCT01169038|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110397315|NCT01169038|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110397316|NCT01169038|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110397317|NCT01169038|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110397318|NCT01169038|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110397319|NCT01169038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110397320|NCT01169038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110397321|NCT01169038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110397322|NCT01169038|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110397323|NCT01169038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110397324|NCT00624754|Budesonide|budesonide|mesh-list
110397325|NCT00624754|Formoterol Fumarate|formoterol fumarate|mesh-list
110397326|NCT00624754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110397327|NCT00624754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110397328|NCT00624754|Autonomic Agents|autonomic agents|mesh-ancestor
110397329|NCT00624754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110397330|NCT00624754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110397331|NCT00624754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110397332|NCT00624754|Respiratory System Agents|respiratory system agents|mesh-ancestor
110397333|NCT00624754|Glucocorticoids|glucocorticoids|mesh-ancestor
110397334|NCT00624754|Hormones|hormones|mesh-ancestor
110397335|NCT00624754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110397336|NCT00624754|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110397337|NCT00624754|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110397338|NCT00624754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110397339|NCT00624754|Adrenergic Agents|adrenergic agents|mesh-ancestor
110397340|NCT00624754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110397341|NCT00624754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110397342|NCT01114828|Tolvaptan|tolvaptan|mesh-list
110397343|NCT01114828|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110397344|NCT01114828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110397345|NCT01114828|Natriuretic Agents|natriuretic agents|mesh-ancestor
110397346|NCT01114828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110397347|NCT01313312|Botulinum Toxins|botulinum toxins|mesh-list
110397348|NCT01313312|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110397349|NCT01313312|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110397350|NCT01313312|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110397351|NCT01313312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110397352|NCT01313312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110397353|NCT01313312|Cholinergic Agents|cholinergic agents|mesh-ancestor
110397354|NCT01313312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110397355|NCT01313312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110397356|NCT01313312|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110397357|NCT01313312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110397358|NCT01114672|Ergocalciferols|ergocalciferols|mesh-list
110397359|NCT01114672|Vitamin D|vitamin d|mesh-list
110397360|NCT01114672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110397362|NCT01114672|Vitamins|vitamins|mesh-ancestor
110397363|NCT01114672|Micronutrients|micronutrients|mesh-ancestor
110397364|NCT01114672|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110029252|NCT05199714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110029253|NCT05199714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110397365|NCT01114516|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110397366|NCT01114516|Clindamycin|clindamycin|mesh-list
110397367|NCT01114516|Clindamycin palmitate|clindamycin palmitate|mesh-list
110397368|NCT01114516|Clindamycin phosphate|clindamycin phosphate|mesh-list
110397370|NCT01114516|Indomethacin|indomethacin|mesh-list
110397371|NCT01114516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110397372|NCT01114516|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110397373|NCT01114516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110397374|NCT01114516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110397375|NCT01114516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110397376|NCT01114516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110397377|NCT01114516|Analgesics|analgesics|mesh-ancestor
110397378|NCT01114516|Sensory System Agents|sensory system agents|mesh-ancestor
110397379|NCT01114516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110397380|NCT01114516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110397381|NCT01114516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110397382|NCT01114516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110397383|NCT01114516|Gout Suppressants|gout suppressants|mesh-ancestor
110397384|NCT01114516|Tocolytic Agents|tocolytic agents|mesh-ancestor
110397385|NCT01114516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110397386|NCT01114516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110397387|NCT01313078|Asparaginase|asparaginase|mesh-list
110397388|NCT01313078|Pegaspargase|pegaspargase|mesh-list
110397389|NCT01313078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110397390|NCT01114360|Melatonin|melatonin|mesh-list
110397391|NCT01114360|Antioxidants|antioxidants|mesh-ancestor
110397392|NCT01114360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110397393|NCT01114360|Protective Agents|protective agents|mesh-ancestor
110397394|NCT01114360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110397395|NCT01114360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110397396|NCT01310036|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110397397|NCT01310036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110397398|NCT01310036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110397399|NCT01310036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110397400|NCT01310036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110397401|NCT01075321|Lenalidomide|lenalidomide|mesh-list
110397402|NCT01075321|Everolimus|everolimus|mesh-list
110397403|NCT01075321|Immunologic Factors|immunologic factors|mesh-ancestor
110397404|NCT01075321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110397405|NCT01075321|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110397406|NCT01075321|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110397407|NCT01075321|Growth Substances|growth substances|mesh-ancestor
110397408|NCT01075321|Growth Inhibitors|growth inhibitors|mesh-ancestor
110397409|NCT01075321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110397410|NCT01075321|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110397411|NCT01075321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110397412|NCT01075321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110397413|NCT01075321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110397414|NCT01075321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110397415|NCT01114204|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
110397416|NCT01114204|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
110029271|NCT05172947|Antioxidants|antioxidants|mesh-ancestor
110029272|NCT05172947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110029273|NCT05172947|Protective Agents|protective agents|mesh-ancestor
110029274|NCT05172947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029275|NCT05172947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110397418|NCT01114204|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110397419|NCT01114204|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110397421|NCT01075243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110397422|NCT01075243|Analgesics|analgesics|mesh-ancestor
110397423|NCT01075243|Sensory System Agents|sensory system agents|mesh-ancestor
110397424|NCT01075243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110397425|NCT01075243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110397426|NCT01075243|Antipyretics|antipyretics|mesh-ancestor
110397427|NCT01078441|Dexamethasone|dexamethasone|mesh-list
110397428|NCT01078441|Cyclophosphamide|cyclophosphamide|mesh-list
110397429|NCT01078441|Doxorubicin|doxorubicin|mesh-list
110397430|NCT01078441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110397431|NCT01078441|Bortezomib|bortezomib|mesh-list
110397432|NCT01078441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110397433|NCT01078441|Immunologic Factors|immunologic factors|mesh-ancestor
110397434|NCT01078441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110397435|NCT01078441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110397436|NCT01078441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110397437|NCT01078441|Alkylating Agents|alkylating agents|mesh-ancestor
110397438|NCT01078441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110397439|NCT01078441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110397440|NCT01078441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110397441|NCT01078441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110397443|NCT01078441|Autonomic Agents|autonomic agents|mesh-ancestor
110397444|NCT01078441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110397445|NCT01078441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110397446|NCT01078441|Glucocorticoids|glucocorticoids|mesh-ancestor
110397447|NCT01078441|Hormones|hormones|mesh-ancestor
110397448|NCT01078441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110397449|NCT01078441|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110397450|NCT01078441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110397451|NCT01078441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110397452|NCT01078441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110397453|NCT01078441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110397454|NCT00626665|Tadalafil|tadalafil|mesh-list
110397455|NCT00626665|Vasodilator Agents|vasodilator agents|mesh-ancestor
110397456|NCT00626665|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110397457|NCT00626665|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110397458|NCT00626665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110397459|NCT00626665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110397460|NCT00626665|Urological Agents|urological agents|mesh-ancestor
110397461|NCT01090063|Ustekinumab|ustekinumab|mesh-list
110397462|NCT01090063|Dermatologic Agents|dermatologic agents|mesh-ancestor
110397463|NCT01306214|Empagliflozin|empagliflozin|mesh-list
110397464|NCT01306214|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110397465|NCT01306214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110397466|NCT01306214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110397467|NCT01306214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110397468|NCT00623402|Interferons|interferons|mesh-list
110397469|NCT00623402|Sorafenib|sorafenib|mesh-list
110397470|NCT00623402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110397471|NCT00623402|Antiviral Agents|antiviral agents|mesh-ancestor
110397472|NCT00623402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110397473|NCT00623402|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110397474|NCT00623402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110397475|NCT00623402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110397476|NCT01077739|Leucovorin|leucovorin|mesh-list
110397477|NCT01077739|Bevacizumab|bevacizumab|mesh-list
110397478|NCT01077739|Fluorouracil|fluorouracil|mesh-list
110397479|NCT01077739|Capecitabine|capecitabine|mesh-list
110397480|NCT01077739|Oxaliplatin|oxaliplatin|mesh-list
110397481|NCT01077739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110397482|NCT01077739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110397483|NCT01077739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110397484|NCT01077739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110397485|NCT01077739|Growth Substances|growth substances|mesh-ancestor
110397486|NCT01077739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110397487|NCT01077739|Growth Inhibitors|growth inhibitors|mesh-ancestor
110397488|NCT01077739|Antimetabolites|antimetabolites|mesh-ancestor
110397489|NCT01077739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110397490|NCT01077739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110397491|NCT01077739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110397492|NCT01077739|Immunologic Factors|immunologic factors|mesh-ancestor
110397494|NCT01077739|Protective Agents|protective agents|mesh-ancestor
110397495|NCT01077739|Vitamin B Complex|vitamin b complex|mesh-ancestor
110397496|NCT01077739|Vitamins|vitamins|mesh-ancestor
110397497|NCT01077739|Micronutrients|micronutrients|mesh-ancestor
110397498|NCT01306058|Sorafenib|sorafenib|mesh-list
110397499|NCT01306058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110397500|NCT01306058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110397501|NCT01306058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110397502|NCT01306058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110397504|NCT00626509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110397505|NCT00626509|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110397506|NCT00626509|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110397507|NCT00626509|Growth Substances|growth substances|mesh-ancestor
110397508|NCT00626509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110397509|NCT00626509|Growth Inhibitors|growth inhibitors|mesh-ancestor
110397510|NCT00626509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110397511|NCT00626509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110397512|NCT00626509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110397513|NCT02877901|Tolterodine Tartrate|tolterodine tartrate|mesh-list
110397514|NCT02877901|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110397515|NCT02877901|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110397516|NCT02877901|Cholinergic Agents|cholinergic agents|mesh-ancestor
110397517|NCT02877901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110397518|NCT02877901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110397519|NCT02877901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110397520|NCT02877901|Urological Agents|urological agents|mesh-ancestor
110397521|NCT04306159|Anesthetics|anesthetics|mesh-list
110397522|NCT04306159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110397523|NCT04306159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029295|NCT05078827|Fluorouracil|fluorouracil|mesh-list
110397525|NCT01305200|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110397526|NCT01305200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110397527|NCT01304498|Vaccines|vaccines|mesh-list
110397528|NCT01304498|Immunologic Factors|immunologic factors|mesh-ancestor
110397529|NCT01304498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110397531|NCT01074931|Lopinavir|lopinavir|mesh-list
110397532|NCT01074931|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110397533|NCT01074931|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110397534|NCT01074931|Protease Inhibitors|protease inhibitors|mesh-ancestor
110397535|NCT01074931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110397536|NCT01074931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110397537|NCT01074931|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110397538|NCT01074931|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110397539|NCT01074931|Antiviral Agents|antiviral agents|mesh-ancestor
110397540|NCT01074931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110397541|NCT01074931|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110397542|NCT01074931|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110397543|NCT04774159|Colchicine|colchicine|mesh-list
110397544|NCT04774159|Gout Suppressants|gout suppressants|mesh-ancestor
110397545|NCT04774159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110397546|NCT04774159|Tubulin Modulators|tubulin modulators|mesh-ancestor
110397547|NCT04774159|Antimitotic Agents|antimitotic agents|mesh-ancestor
110397548|NCT04774159|Mitosis Modulators|mitosis modulators|mesh-ancestor
110397549|NCT04774159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110397550|NCT04774159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110397551|NCT01303172|Gemcitabine|gemcitabine|mesh-list
110397552|NCT01303172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110397553|NCT01303172|Antimetabolites|antimetabolites|mesh-ancestor
110397554|NCT01303172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110397556|NCT01302938|Tolterodine Tartrate|tolterodine tartrate|mesh-list
110397557|NCT01302938|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110397558|NCT01302938|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110397559|NCT01302938|Cholinergic Agents|cholinergic agents|mesh-ancestor
110397560|NCT01302938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110397561|NCT01302938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110397562|NCT01302938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110397563|NCT01302938|Urological Agents|urological agents|mesh-ancestor
110397565|NCT01076647|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110397566|NCT01076647|Insulin Glargine|insulin glargine|mesh-list
110397567|NCT01076647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110397568|NCT01076647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110397569|NCT04306081|Evolocumab|evolocumab|mesh-list
110397570|NCT04306081|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110397571|NCT04306081|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110397572|NCT04306081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110397573|NCT04306081|Antimetabolites|antimetabolites|mesh-ancestor
110397574|NCT04306081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110397575|NCT04306081|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110397576|NCT04306081|Protease Inhibitors|protease inhibitors|mesh-ancestor
110397578|NCT04306081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110397580|NCT01074307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110397581|NCT01074307|Sympatholytics|sympatholytics|mesh-ancestor
110397582|NCT01074307|Autonomic Agents|autonomic agents|mesh-ancestor
110397583|NCT01074307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110397584|NCT01074307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110397585|NCT01074307|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110397586|NCT01074307|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110397587|NCT01074307|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110397588|NCT01074307|Adrenergic Agents|adrenergic agents|mesh-ancestor
110397589|NCT01074307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110397590|NCT01074307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110397592|NCT01076335|Leuprolide|leuprolide|mesh-list
110397593|NCT01076335|Goserelin|goserelin|mesh-list
110397594|NCT01076335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110397595|NCT01076335|Tubulin Modulators|tubulin modulators|mesh-ancestor
110397596|NCT01076335|Antimitotic Agents|antimitotic agents|mesh-ancestor
110397597|NCT01076335|Mitosis Modulators|mitosis modulators|mesh-ancestor
110397598|NCT01076335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110397599|NCT01076335|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110397600|NCT01076335|Fertility Agents|fertility agents|mesh-ancestor
110397601|NCT01076335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110397602|NCT01076335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110397603|NCT01076335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110397604|NCT01309737|Tofacitinib|tofacitinib|mesh-list
110397605|NCT01309737|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110397606|NCT01309737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110397607|NCT01309737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110397608|NCT01309737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110397610|NCT01074229|Anesthetics, Local|anesthetics, local|mesh-ancestor
110397611|NCT01074229|Anesthetics|anesthetics|mesh-ancestor
110397612|NCT01074229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110397613|NCT01074229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110397614|NCT01074229|Sensory System Agents|sensory system agents|mesh-ancestor
110397615|NCT01074229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110397616|NCT01106014|Selexipag|selexipag|mesh-list
110397617|NCT01106014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110397618|NCT01105936|Acetaminophen|acetaminophen|mesh-list
110397619|NCT01105936|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110397620|NCT01105936|Analgesics|analgesics|mesh-ancestor
110397621|NCT01105936|Sensory System Agents|sensory system agents|mesh-ancestor
110397622|NCT01105936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110397623|NCT01105936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110397624|NCT01105936|Antipyretics|antipyretics|mesh-ancestor
110397625|NCT01309659|Iron|iron|mesh-list
110397626|NCT01309659|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
110397627|NCT01309659|Trace Elements|trace elements|mesh-ancestor
110397628|NCT01309659|Micronutrients|micronutrients|mesh-ancestor
110397629|NCT01309659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110397630|NCT01309659|Hematinics|hematinics|mesh-ancestor
110397631|NCT04989166|Curcumin|curcumin|mesh-list
110397632|NCT04989166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110397633|NCT04989166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110397634|NCT04989166|Analgesics|analgesics|mesh-ancestor
110397635|NCT04989166|Sensory System Agents|sensory system agents|mesh-ancestor
110397636|NCT04989166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110397637|NCT04989166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110397638|NCT04989166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110397639|NCT04989166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110397640|NCT04989166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110397641|NCT04989166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110397642|NCT04989166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110397643|NCT05320705|Dexmedetomidine|dexmedetomidine|mesh-list
110397644|NCT05320705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110397645|NCT05320705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110397646|NCT05320705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110397647|NCT05320705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110397649|NCT05320705|Sensory System Agents|sensory system agents|mesh-ancestor
110397650|NCT05320705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110397651|NCT05320705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110397652|NCT05320705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110397653|NCT05320705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110397654|NCT05320705|Adrenergic Agents|adrenergic agents|mesh-ancestor
110397655|NCT05320705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110397656|NCT05320705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110397657|NCT01104766|Aripiprazole|aripiprazole|mesh-list
110397658|NCT01104766|Cariprazine|cariprazine|mesh-list
110397659|NCT01104766|Antidepressive Agents|antidepressive agents|mesh-ancestor
110397660|NCT01104766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110397661|NCT01104766|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110397662|NCT01104766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110397663|NCT01104766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110397664|NCT01104766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110397665|NCT01104766|Dopamine Agonists|dopamine agonists|mesh-ancestor
110029367|NCT05019638|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110397666|NCT01104766|Dopamine Agents|dopamine agents|mesh-ancestor
110397667|NCT01104766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110397668|NCT01104766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110397669|NCT01104766|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110397670|NCT01104766|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110397671|NCT01104766|Serotonin Agents|serotonin agents|mesh-ancestor
110397672|NCT01104766|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110397673|NCT01104766|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110397674|NCT01104766|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110397675|NCT01104766|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110397676|NCT02880280|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110397677|NCT02880280|Menotropins|menotropins|mesh-list
110397678|NCT02880280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110397679|NCT02880280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110397680|NCT02880280|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110397681|NCT02880280|Fertility Agents|fertility agents|mesh-ancestor
110397682|NCT04862455|Pembrolizumab|pembrolizumab|mesh-list
110397683|NCT04862455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110397684|NCT04862455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110397685|NCT04862455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110397686|NCT04862455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110397689|NCT01104376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110397690|NCT01104376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110397692|NCT01104376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110397693|NCT01104376|Antiviral Agents|antiviral agents|mesh-ancestor
110397694|NCT01104376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110397695|NCT01104376|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110397696|NCT01104376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110397697|NCT01104376|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110397698|NCT01104376|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110397699|NCT01104376|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110397700|NCT01104376|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110397701|NCT01104376|Antifungal Agents|antifungal agents|mesh-ancestor
110397702|NCT01104376|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110397703|NCT01104376|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110397704|NCT01104376|Hormone Antagonists|hormone antagonists|mesh-ancestor
110397705|NCT01104376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110397706|NCT01104376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110397707|NCT01104376|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110397708|NCT02875873|Methamphetamine|methamphetamine|mesh-list
110029398|NCT04804072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110397709|NCT02875873|Plasma-lyte 148|plasma-lyte 148|mesh-list
110397710|NCT02875873|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110397711|NCT02875873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110397712|NCT02875873|Sympathomimetics|sympathomimetics|mesh-ancestor
110397713|NCT02875873|Autonomic Agents|autonomic agents|mesh-ancestor
110397714|NCT02875873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110397715|NCT02875873|Dopamine Agents|dopamine agents|mesh-ancestor
110397716|NCT02875873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110397717|NCT02875873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110397718|NCT02875873|Adrenergic Agents|adrenergic agents|mesh-ancestor
110397719|NCT02875873|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110397720|NCT02875873|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110397721|NCT02875873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110397722|NCT02875873|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110397723|NCT02875873|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110397724|NCT02875873|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110397725|NCT01072357|Bevacizumab|bevacizumab|mesh-list
110397726|NCT01072357|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110397727|NCT01072357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110397728|NCT01072357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110397729|NCT01072357|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110397730|NCT01072357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110397731|NCT01072357|Growth Substances|growth substances|mesh-ancestor
110397732|NCT01072357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110397733|NCT01072357|Growth Inhibitors|growth inhibitors|mesh-ancestor
110397734|NCT01072357|Laxatives|laxatives|mesh-ancestor
110397735|NCT01072357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110397736|NCT01072201|Triclosan|triclosan|mesh-list
110397737|NCT01072201|Fluorides|fluorides|mesh-list
110397738|NCT01072201|Cariostatic Agents|cariostatic agents|mesh-ancestor
110397739|NCT01072201|Protective Agents|protective agents|mesh-ancestor
110397740|NCT01072201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110397741|NCT01072201|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110397742|NCT01072201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110397743|NCT01072201|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110397744|NCT01072201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110397745|NCT01072201|Antimetabolites|antimetabolites|mesh-ancestor
110397746|NCT01072201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110397747|NCT01072201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110397748|NCT02893709|Omeprazole|omeprazole|mesh-list
110397749|NCT02893709|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110397750|NCT02893709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110397751|NCT02893709|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110397752|NCT02893709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110397753|NCT02893709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110397754|NCT04972396|Metformin|metformin|mesh-list
110397755|NCT04972396|Digoxin|digoxin|mesh-list
110397756|NCT04972396|Warfarin|warfarin|mesh-list
110397757|NCT04972396|Atorvastatin|atorvastatin|mesh-list
110397758|NCT04972396|Levonorgestrel|levonorgestrel|mesh-list
110397759|NCT04972396|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110397760|NCT04972396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110397761|NCT04972396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110397762|NCT04972396|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110397763|NCT04972396|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110397764|NCT04972396|Antimetabolites|antimetabolites|mesh-ancestor
110397765|NCT04972396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110397766|NCT04972396|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110397767|NCT04972396|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110397768|NCT04972396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110029424|NCT04724031|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
110029425|NCT04724031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110029428|NCT04679376|Atorvastatin|atorvastatin|mesh-list
110397769|NCT04972396|Anticoagulants|anticoagulants|mesh-ancestor
110397770|NCT04972396|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110397771|NCT04972396|Contraceptive Agents|contraceptive agents|mesh-ancestor
110397772|NCT04972396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110397773|NCT04972396|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110397774|NCT04972396|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110397775|NCT04972396|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110397776|NCT04972396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110397777|NCT04972396|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110397778|NCT04972396|Protective Agents|protective agents|mesh-ancestor
110397779|NCT04972396|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110397780|NCT04972396|Estrogens|estrogens|mesh-ancestor
110397781|NCT04972396|Hormones|hormones|mesh-ancestor
110397782|NCT04972396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110397783|NCT01089361|Ketamine|ketamine|mesh-list
110397784|NCT01089361|Analgesics|analgesics|mesh-ancestor
110397785|NCT01089361|Sensory System Agents|sensory system agents|mesh-ancestor
110397786|NCT01089361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110397787|NCT01089361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110397788|NCT01089361|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110397789|NCT01089361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110397790|NCT01089361|Anesthetics, General|anesthetics, general|mesh-ancestor
110397791|NCT01089361|Anesthetics|anesthetics|mesh-ancestor
110397792|NCT01089361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110397793|NCT01089361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110397794|NCT01089361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110397795|NCT01089361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110397796|NCT01089361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110397797|NCT01102972|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110397798|NCT01102972|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110397799|NCT01102972|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110397801|NCT01102972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110397802|NCT01102972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110397803|NCT01102972|Antiviral Agents|antiviral agents|mesh-ancestor
110397804|NCT01102972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110397805|NCT01102972|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110397806|NCT01102972|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110397807|NCT01102972|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110397808|NCT01102972|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110397809|NCT01102972|Protease Inhibitors|protease inhibitors|mesh-ancestor
110397810|NCT04328753|Chlorhexidine|chlorhexidine|mesh-list
110397811|NCT04328753|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110397812|NCT04328753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110397813|NCT04328753|Disinfectants|disinfectants|mesh-ancestor
110397814|NCT01087489|Lidocaine|lidocaine|mesh-list
110397815|NCT01087489|Anesthetics, Local|anesthetics, local|mesh-ancestor
110397816|NCT01087489|Anesthetics|anesthetics|mesh-ancestor
110397817|NCT01087489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110397818|NCT01087489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110397819|NCT01087489|Sensory System Agents|sensory system agents|mesh-ancestor
110397820|NCT01087489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110397822|NCT01087489|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110397823|NCT01087489|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110397824|NCT01087489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110397825|NCT01087489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110397826|NCT04306627|Amlodipine|amlodipine|mesh-list
110397827|NCT04306627|Perindopril|perindopril|mesh-list
110397828|NCT04306627|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
110397829|NCT04306627|Atorvastatin|atorvastatin|mesh-list
110029434|NCT04679376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110029435|NCT04679376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110397830|NCT04306627|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110397831|NCT04306627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110397832|NCT04306627|Antimetabolites|antimetabolites|mesh-ancestor
110397833|NCT04306627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110397834|NCT04306627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110397835|NCT04306627|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110397836|NCT04306627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110397837|NCT04306627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110397838|NCT04306627|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110397839|NCT04306627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110397840|NCT04306627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110397841|NCT04306627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110397842|NCT04306627|Vasodilator Agents|vasodilator agents|mesh-ancestor
110397843|NCT04306627|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110397844|NCT04306627|Protease Inhibitors|protease inhibitors|mesh-ancestor
110397846|NCT04306471|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110397847|NCT04306471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110397848|NCT04306471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110397849|NCT04306471|Antimetabolites|antimetabolites|mesh-ancestor
110397850|NCT04306471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110397851|NCT04306471|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110397852|NCT04306471|Protease Inhibitors|protease inhibitors|mesh-ancestor
110397853|NCT04306471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110397854|NCT04306471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110397855|NCT04296253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110397856|NCT04296253|Mitogens|mitogens|mesh-list
110397857|NCT04296253|Mitosis Modulators|mitosis modulators|mesh-ancestor
110397858|NCT04296253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110397859|NCT01082965|Donepezil|donepezil|mesh-list
110397860|NCT01082965|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110397861|NCT01082965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110397862|NCT01082965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110397863|NCT01082965|Cholinergic Agents|cholinergic agents|mesh-ancestor
110397864|NCT01082965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110397865|NCT01082965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110397866|NCT01082965|Nootropic Agents|nootropic agents|mesh-ancestor
110397867|NCT01102426|Dexamethasone|dexamethasone|mesh-list
110397868|NCT01102426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110397869|NCT01102426|Antiemetics|antiemetics|mesh-ancestor
110397870|NCT01102426|Autonomic Agents|autonomic agents|mesh-ancestor
110397871|NCT01102426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110397872|NCT01102426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110397873|NCT01102426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110397874|NCT01102426|Glucocorticoids|glucocorticoids|mesh-ancestor
110397876|NCT01102426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110029436|NCT04677959|Fluticasone|fluticasone|mesh-list
110397877|NCT01102426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110397878|NCT01102426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110397879|NCT04308850|Vitamin D|vitamin d|mesh-list
110397880|NCT04308850|Vitamins|vitamins|mesh-ancestor
110397881|NCT04308850|Micronutrients|micronutrients|mesh-ancestor
110397882|NCT04308850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110397883|NCT04308850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110397884|NCT01101334|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110397885|NCT01101334|Efatutazone|efatutazone|mesh-list
110397886|NCT01101334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110397887|NCT01101334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110397888|NCT01101334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110397889|NCT01101334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110397891|NCT01327547|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110397892|NCT01327547|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110397893|NCT01327547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110397895|NCT01327547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110397896|NCT01327547|Antiviral Agents|antiviral agents|mesh-ancestor
110397897|NCT01327547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110397898|NCT01327547|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110397899|NCT01308567|Prednisone|prednisone|mesh-list
110397900|NCT01308567|Docetaxel|docetaxel|mesh-list
110397901|NCT01308567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110397902|NCT01308567|Tubulin Modulators|tubulin modulators|mesh-ancestor
110397903|NCT01308567|Antimitotic Agents|antimitotic agents|mesh-ancestor
110397904|NCT01308567|Mitosis Modulators|mitosis modulators|mesh-ancestor
110397905|NCT01308567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110397906|NCT01308567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110397907|NCT01308567|Glucocorticoids|glucocorticoids|mesh-ancestor
110397909|NCT01308567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110397910|NCT01308567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110397911|NCT01308567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110397912|NCT00592241|Insulin|insulin|mesh-list
110397913|NCT00592241|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110397914|NCT00592241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110397915|NCT00592241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110397916|NCT02890719|Ribavirin|ribavirin|mesh-list
110397917|NCT02890719|Grazoprevir|grazoprevir|mesh-list
110397918|NCT02890719|Antimetabolites|antimetabolites|mesh-ancestor
110397919|NCT02890719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110397920|NCT02890719|Antiviral Agents|antiviral agents|mesh-ancestor
110397921|NCT02890719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110397922|NCT04325061|Dexamethasone|dexamethasone|mesh-list
110397923|NCT04325061|Dexamethasone acetate|dexamethasone acetate|mesh-list
110397924|NCT04325061|BB 1101|bb 1101|mesh-list
110397925|NCT04325061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110397926|NCT04325061|Antiemetics|antiemetics|mesh-ancestor
110397927|NCT04325061|Autonomic Agents|autonomic agents|mesh-ancestor
110397928|NCT04325061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110397929|NCT04325061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110397930|NCT04325061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110397931|NCT04325061|Glucocorticoids|glucocorticoids|mesh-ancestor
110397932|NCT04325061|Hormones|hormones|mesh-ancestor
110397933|NCT04325061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110397934|NCT04325061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110397935|NCT04325061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110397936|NCT04325061|Protease Inhibitors|protease inhibitors|mesh-ancestor
110397937|NCT04325061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110397938|NCT04325061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110397939|NCT01307319|Beclomethasone|beclomethasone|mesh-list
110397940|NCT01307319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110397941|NCT01307319|Glucocorticoids|glucocorticoids|mesh-ancestor
110397942|NCT01307319|Hormones|hormones|mesh-ancestor
110397943|NCT01307319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110397944|NCT01307319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110397945|NCT01307319|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110397946|NCT01307319|Respiratory System Agents|respiratory system agents|mesh-ancestor
110397947|NCT04365725|Remdesivir|remdesivir|mesh-list
110397948|NCT04365725|Antimetabolites|antimetabolites|mesh-ancestor
110397949|NCT04365725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110397950|NCT04365725|Antiviral Agents|antiviral agents|mesh-ancestor
110397951|NCT04365725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110052075|NCT01477840|Oxytocics|oxytocics|mesh-ancestor
110397952|NCT01080391|Dexamethasone|dexamethasone|mesh-list
110397953|NCT01080391|Lenalidomide|lenalidomide|mesh-list
110397954|NCT01080391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110397955|NCT01080391|Antiemetics|antiemetics|mesh-ancestor
110397957|NCT01080391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110397958|NCT01080391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110397959|NCT01080391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110397960|NCT01080391|Glucocorticoids|glucocorticoids|mesh-ancestor
110397961|NCT01080391|Hormones|hormones|mesh-ancestor
110397962|NCT01080391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110397963|NCT01080391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110397964|NCT01080391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110397965|NCT01080391|Immunologic Factors|immunologic factors|mesh-ancestor
110397966|NCT01080391|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110397967|NCT01080391|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110397968|NCT01080391|Growth Substances|growth substances|mesh-ancestor
110397969|NCT01080391|Growth Inhibitors|growth inhibitors|mesh-ancestor
110397970|NCT01070329|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110397971|NCT01070329|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110397972|NCT01070329|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110397973|NCT01070329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110397974|NCT01070329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110029485|NCT04570293|Lidocaine|lidocaine|mesh-list
110029487|NCT04570293|Anesthetics|anesthetics|mesh-ancestor
110397976|NCT01070329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110397977|NCT01070329|Analgesics|analgesics|mesh-ancestor
110397978|NCT01070329|Sensory System Agents|sensory system agents|mesh-ancestor
110397979|NCT01070329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110397980|NCT01070329|Antidepressive Agents|antidepressive agents|mesh-ancestor
110397981|NCT01070329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110397982|NCT01070329|Dopamine Agents|dopamine agents|mesh-ancestor
110397983|NCT04327427|Aspirin|aspirin|mesh-list
110397984|NCT04327427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110397985|NCT04327427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110397986|NCT04327427|Analgesics|analgesics|mesh-ancestor
110397987|NCT04327427|Sensory System Agents|sensory system agents|mesh-ancestor
110397988|NCT04327427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110397989|NCT04327427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110397990|NCT04327427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110397991|NCT04327427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110397992|NCT04327427|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110397993|NCT04327427|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110397994|NCT04327427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110397995|NCT04327427|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110397996|NCT04327427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110397997|NCT04327427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110397998|NCT04327427|Antipyretics|antipyretics|mesh-ancestor
110397999|NCT02875717|Aspirin|aspirin|mesh-list
110398000|NCT02875717|Heparin|heparin|mesh-list
110398001|NCT02875717|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110398002|NCT02875717|Tinzaparin|tinzaparin|mesh-list
110398003|NCT02875717|Dalteparin|dalteparin|mesh-list
110398004|NCT02875717|Anticoagulants|anticoagulants|mesh-ancestor
110398005|NCT02875717|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110398006|NCT02875717|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110398007|NCT02875717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110398008|NCT02875717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110398009|NCT02875717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110398011|NCT02875717|Sensory System Agents|sensory system agents|mesh-ancestor
110398012|NCT02875717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110398013|NCT02875717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398014|NCT02875717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110398015|NCT02875717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110398016|NCT02875717|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110398017|NCT02875717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110398018|NCT02875717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110398020|NCT04334837|Copper|copper|mesh-list
110398021|NCT04334837|Trace Elements|trace elements|mesh-ancestor
110398022|NCT04334837|Micronutrients|micronutrients|mesh-ancestor
110398023|NCT04334837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398024|NCT00593099|Bupropion|bupropion|mesh-list
110398025|NCT00593099|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110398026|NCT00593099|Antidepressive Agents|antidepressive agents|mesh-ancestor
110398027|NCT00593099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110398028|NCT00593099|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110398029|NCT00593099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110398031|NCT00593099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110398033|NCT00593099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110398034|NCT00593099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398035|NCT00593099|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110398036|NCT00593099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110398037|NCT00593099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110398038|NCT00593177|Parathyroid Hormone|parathyroid hormone|mesh-list
110398039|NCT00593177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110398040|NCT00593177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398041|NCT00593255|Insulin|insulin|mesh-list
110398042|NCT00593255|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110398043|NCT00593255|Insulin Aspart|insulin aspart|mesh-list
110398044|NCT00593255|Isophane Insulin, Human|isophane insulin, human|mesh-list
110398045|NCT00593255|Insulin, Isophane|insulin, isophane|mesh-list
110398046|NCT00593255|Isophane insulin, beef|isophane insulin, beef|mesh-list
110398047|NCT00593255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110398048|NCT00593255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398050|NCT00593801|Hematinics|hematinics|mesh-ancestor
110398051|NCT00593879|Mecamylamine|mecamylamine|mesh-list
110398052|NCT00593879|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110398053|NCT00593879|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
110398054|NCT00593879|Autonomic Agents|autonomic agents|mesh-ancestor
110398055|NCT00593879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110398056|NCT00593879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398057|NCT00593879|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
110398058|NCT00593879|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110398059|NCT00593879|Cholinergic Agents|cholinergic agents|mesh-ancestor
110398060|NCT00593879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110398061|NCT00593879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110398062|NCT00594191|Simvastatin|simvastatin|mesh-list
110398063|NCT00594191|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110398064|NCT00594191|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110398065|NCT00594191|Antimetabolites|antimetabolites|mesh-ancestor
110398066|NCT00594191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110398067|NCT00594191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110398068|NCT00594191|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110398069|NCT00594191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110398070|NCT00594269|Risperidone|risperidone|mesh-list
110398071|NCT00594269|Citalopram|citalopram|mesh-list
110398072|NCT00594269|Sertraline|sertraline|mesh-list
110398073|NCT00594269|Paroxetine|paroxetine|mesh-list
110398074|NCT00594269|Escitalopram|escitalopram|mesh-list
110398075|NCT00594269|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110398076|NCT00594269|Serotonin Agents|serotonin agents|mesh-ancestor
110398077|NCT00594269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110398078|NCT00594269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110398079|NCT00594269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398080|NCT00594269|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110398081|NCT00594269|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110398082|NCT00594269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110398083|NCT00594269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110398084|NCT00594269|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110398086|NCT00594269|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110398087|NCT00594269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110398088|NCT00594269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110398089|NCT00594269|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110398090|NCT00594269|Antidepressive Agents|antidepressive agents|mesh-ancestor
110398091|NCT00594269|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110398092|NCT00594269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110398093|NCT00594269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110398094|NCT00594347|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110398095|NCT00594347|Immunologic Factors|immunologic factors|mesh-ancestor
110398096|NCT00594347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398097|NCT04326959|Triamcinolone|triamcinolone|mesh-list
110398098|NCT04326959|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110398099|NCT04326959|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110398100|NCT04326959|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110398101|NCT04326959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110398103|NCT04326959|Hormones|hormones|mesh-ancestor
110398104|NCT04326959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110398105|NCT04326959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398106|NCT04326959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110398107|NCT04326959|Immunologic Factors|immunologic factors|mesh-ancestor
110398108|NCT04326959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110398109|NCT04326959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110398110|NCT00594737|Memantine|memantine|mesh-list
110398111|NCT00594737|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110398112|NCT00594737|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110398113|NCT00594737|Dopamine Agents|dopamine agents|mesh-ancestor
110398114|NCT00594737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110398115|NCT00594737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110398116|NCT00594737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398117|NCT00594737|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110398118|NCT00594737|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110398119|NCT00595049|Bosentan|bosentan|mesh-list
110398120|NCT00595049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110398121|NCT00595049|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110398122|NCT00595049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110398123|NCT00595985|Sorafenib|sorafenib|mesh-list
110398124|NCT00595985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110398125|NCT00595985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110398126|NCT00595985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110398127|NCT00595985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110398128|NCT00596063|Insulin|insulin|mesh-list
110398129|NCT00596063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110398130|NCT00596063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398131|NCT00596219|Celecoxib|celecoxib|mesh-list
110398132|NCT00596219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110398133|NCT00596219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110398134|NCT00596219|Analgesics|analgesics|mesh-ancestor
110029554|NCT04477317|Sensory System Agents|sensory system agents|mesh-ancestor
110398135|NCT00596219|Sensory System Agents|sensory system agents|mesh-ancestor
110398136|NCT00596219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110398137|NCT00596219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398138|NCT00596219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110398139|NCT00596219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110398140|NCT00596219|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110398141|NCT00596219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110398142|NCT00596219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110398143|NCT00596219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110398144|NCT00596297|Bevacizumab|bevacizumab|mesh-list
110398145|NCT00596297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110398146|NCT00596297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110398147|NCT00596297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110398148|NCT00596297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110398149|NCT00596297|Growth Substances|growth substances|mesh-ancestor
110398150|NCT00596297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398151|NCT00596297|Growth Inhibitors|growth inhibitors|mesh-ancestor
110398152|NCT00596375|Lidocaine|lidocaine|mesh-list
110398153|NCT00596375|Anesthetics, Local|anesthetics, local|mesh-ancestor
110398154|NCT00596375|Anesthetics|anesthetics|mesh-ancestor
110398155|NCT00596375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110398156|NCT00596375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398157|NCT00596375|Sensory System Agents|sensory system agents|mesh-ancestor
110398158|NCT00596375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110398159|NCT00596375|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110398160|NCT00596375|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110398161|NCT00596375|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110398162|NCT00596375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110398163|NCT00596375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110398165|NCT00596531|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110398166|NCT00596609|Morphine|morphine|mesh-list
110398167|NCT00596609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110398168|NCT00596609|Narcotics|narcotics|mesh-ancestor
110398169|NCT00596609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110398170|NCT00596609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398171|NCT00596609|Analgesics|analgesics|mesh-ancestor
110398172|NCT00596609|Sensory System Agents|sensory system agents|mesh-ancestor
110398173|NCT00596609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110398174|NCT04326803|Vaccines|vaccines|mesh-list
110398175|NCT04326803|Immunologic Factors|immunologic factors|mesh-ancestor
110398176|NCT04326803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398178|NCT00597233|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110398179|NCT00597233|Insulin Aspart|insulin aspart|mesh-list
110398180|NCT00597233|Isophane Insulin, Human|isophane insulin, human|mesh-list
110398181|NCT00597233|Insulin, Isophane|insulin, isophane|mesh-list
110398182|NCT00597233|Isophane insulin, beef|isophane insulin, beef|mesh-list
110398183|NCT00597233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110398184|NCT00597233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398185|NCT01064401|Interferons|interferons|mesh-list
110398186|NCT01064401|Interferon-beta|interferon-beta|mesh-list
110029574|NCT04344262|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110398187|NCT01064401|Interferon beta-1a|interferon beta-1a|mesh-list
110398188|NCT01064401|Daclizumab|daclizumab|mesh-list
110398189|NCT01064401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110398190|NCT01064401|Antiviral Agents|antiviral agents|mesh-ancestor
110398192|NCT01064401|Immunologic Factors|immunologic factors|mesh-ancestor
110398193|NCT01064401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398194|NCT01064401|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110398195|NCT01064401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110398196|NCT00597389|Propranolol|propranolol|mesh-list
110398197|NCT00597389|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110398198|NCT00597389|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110398199|NCT00597389|Adrenergic Agents|adrenergic agents|mesh-ancestor
110398200|NCT00597389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110398201|NCT00597389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110398202|NCT00597389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398203|NCT00597389|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110398204|NCT00597389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110398205|NCT00597389|Vasodilator Agents|vasodilator agents|mesh-ancestor
110398206|NCT01306617|Ritonavir|ritonavir|mesh-list
110398207|NCT01306617|Ribavirin|ribavirin|mesh-list
110398208|NCT01306617|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110398209|NCT01306617|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110398210|NCT01306617|Protease Inhibitors|protease inhibitors|mesh-ancestor
110398211|NCT01306617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110398212|NCT01306617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110398213|NCT01306617|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110398214|NCT01306617|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110398215|NCT01306617|Antiviral Agents|antiviral agents|mesh-ancestor
110398216|NCT01306617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110398217|NCT01306617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110398218|NCT01306617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110398219|NCT01306617|Antimetabolites|antimetabolites|mesh-ancestor
110398221|NCT00597623|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110398222|NCT00597623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110398223|NCT00597623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110398224|NCT00597857|Hydrocortisone|hydrocortisone|mesh-list
110398225|NCT00597857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110398226|NCT00627133|Levetiracetam|levetiracetam|mesh-list
110398227|NCT00627133|Anticonvulsants|anticonvulsants|mesh-ancestor
110398228|NCT00627133|Nootropic Agents|nootropic agents|mesh-ancestor
110398230|NCT00598013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110398231|NCT00598013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398232|NCT04303429|Capecitabine|capecitabine|mesh-list
110398233|NCT04303429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110398234|NCT04303429|Antimetabolites|antimetabolites|mesh-ancestor
110398235|NCT04303429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110398236|NCT04303429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110398237|NCT00598091|Gemcitabine|gemcitabine|mesh-list
110398238|NCT00598091|Dasatinib|dasatinib|mesh-list
110398239|NCT00598091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110398241|NCT00598091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110398242|NCT00598091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110398243|NCT00598091|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110398244|NCT00598091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110398245|NCT00623415|Flupirtine|flupirtine|mesh-list
110398246|NCT00623415|Analgesics|analgesics|mesh-ancestor
110052370|NCT01479556|Anticonvulsants|anticonvulsants|mesh-ancestor
110398247|NCT00623415|Sensory System Agents|sensory system agents|mesh-ancestor
110398248|NCT00623415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110398249|NCT00623415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398250|NCT04326725|Hydroxychloroquine|hydroxychloroquine|mesh-list
110398251|NCT04326725|Antimalarials|antimalarials|mesh-ancestor
110398252|NCT04326725|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110398253|NCT04326725|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110398254|NCT04326725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110398255|NCT04326725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110398256|NCT04326725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110398258|NCT01038427|Mometasone Furoate|mometasone furoate|mesh-list
110398259|NCT01038427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110398260|NCT01038427|Dermatologic Agents|dermatologic agents|mesh-ancestor
110398261|NCT01038427|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110398262|NCT00598169|Dexamethasone|dexamethasone|mesh-list
110398264|NCT00598169|Carboplatin|carboplatin|mesh-list
110398265|NCT00598169|Etoposide|etoposide|mesh-list
110398266|NCT00598169|Bortezomib|bortezomib|mesh-list
110398267|NCT00598169|Ifosfamide|ifosfamide|mesh-list
110398268|NCT00598169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110398269|NCT00598169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110398270|NCT00598169|Immunologic Factors|immunologic factors|mesh-ancestor
110398271|NCT00598169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398272|NCT00598169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110398273|NCT00598169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110398274|NCT00598169|Antiemetics|antiemetics|mesh-ancestor
110398275|NCT00598169|Autonomic Agents|autonomic agents|mesh-ancestor
110398276|NCT00598169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110398277|NCT00598169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110398278|NCT00598169|Glucocorticoids|glucocorticoids|mesh-ancestor
110398279|NCT00598169|Hormones|hormones|mesh-ancestor
110398280|NCT00598169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110398281|NCT00598169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110398282|NCT00598169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110398283|NCT00598169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110398284|NCT00598169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110398285|NCT00598169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110398286|NCT00598169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110398287|NCT00598169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110398288|NCT00598169|Alkylating Agents|alkylating agents|mesh-ancestor
110398289|NCT00598247|Paclitaxel|paclitaxel|mesh-list
110398290|NCT00598247|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
110398291|NCT00598247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110398292|NCT00598247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110398293|NCT00598247|Tubulin Modulators|tubulin modulators|mesh-ancestor
110398294|NCT00598247|Antimitotic Agents|antimitotic agents|mesh-ancestor
110398295|NCT00598247|Mitosis Modulators|mitosis modulators|mesh-ancestor
110398296|NCT00598247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110398297|NCT00598403|Ciprofloxacin|ciprofloxacin|mesh-list
110398298|NCT00598403|Cefditoren pivoxil|cefditoren pivoxil|mesh-list
110398299|NCT00598403|Cefditoren|cefditoren|mesh-list
110398300|NCT00598403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110398301|NCT00598403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110398302|NCT00598403|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110398303|NCT00598403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110398304|NCT00598403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110398305|NCT00598403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110398306|NCT00598403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110398307|NCT00598403|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110029611|NCT04288427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398308|NCT00598403|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110398310|NCT00598637|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110398311|NCT00598637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110398312|NCT00598637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110398313|NCT00598637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110398314|NCT00598637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110398315|NCT00598637|Immunologic Factors|immunologic factors|mesh-ancestor
110398316|NCT00598637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398317|NCT00598637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110398318|NCT00598715|Sirolimus|sirolimus|mesh-list
110398319|NCT00598715|Paclitaxel|paclitaxel|mesh-list
110398320|NCT00598715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110398321|NCT00598715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110398322|NCT00598715|Tubulin Modulators|tubulin modulators|mesh-ancestor
110398323|NCT00598715|Antimitotic Agents|antimitotic agents|mesh-ancestor
110398324|NCT00598715|Mitosis Modulators|mitosis modulators|mesh-ancestor
110398325|NCT00598715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110398326|NCT00598715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110398327|NCT00598715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110398328|NCT00598715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110398329|NCT00598715|Antifungal Agents|antifungal agents|mesh-ancestor
110398330|NCT00598715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110398331|NCT00598715|Immunologic Factors|immunologic factors|mesh-ancestor
110398332|NCT00598715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398334|NCT00598793|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110398336|NCT00598793|Insulin Glargine|insulin glargine|mesh-list
110398337|NCT00598793|Pioglitazone|pioglitazone|mesh-list
110398338|NCT00598793|Insulin Aspart|insulin aspart|mesh-list
110398339|NCT00598793|Biphasic Insulins|biphasic insulins|mesh-list
110398340|NCT00598793|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110398341|NCT00598793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398342|NCT01326845|Deferasirox|deferasirox|mesh-list
110398343|NCT01326845|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110398344|NCT01326845|Chelating Agents|chelating agents|mesh-ancestor
110398345|NCT01326845|Sequestering Agents|sequestering agents|mesh-ancestor
110398346|NCT01326845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110398347|NCT01062763|Spironolactone|spironolactone|mesh-list
110398348|NCT01062763|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110398349|NCT01062763|Hormone Antagonists|hormone antagonists|mesh-ancestor
110398350|NCT01062763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110398351|NCT01062763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398352|NCT01062763|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110398354|NCT01062763|Natriuretic Agents|natriuretic agents|mesh-ancestor
110398355|NCT00599417|Broncho-Vaxom|broncho-vaxom|mesh-list
110398356|NCT00599417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110398357|NCT00599417|Immunologic Factors|immunologic factors|mesh-ancestor
110398358|NCT00599417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398359|NCT00599573|Ondansetron|ondansetron|mesh-list
110398360|NCT00599573|Antiemetics|antiemetics|mesh-ancestor
110398361|NCT00599573|Autonomic Agents|autonomic agents|mesh-ancestor
110398362|NCT00599573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110398363|NCT00599573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398364|NCT00599573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110029628|NCT04263064|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110398366|NCT00599573|Dermatologic Agents|dermatologic agents|mesh-ancestor
110398367|NCT00599573|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110398368|NCT00599573|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110398369|NCT00599573|Serotonin Agents|serotonin agents|mesh-ancestor
110398370|NCT00599573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110398371|NCT00599573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110398372|NCT00599651|Pulmonary Surfactants|pulmonary surfactants|mesh-list
110398373|NCT00599651|Respiratory System Agents|respiratory system agents|mesh-ancestor
110398375|NCT01048099|Pertuzumab|pertuzumab|mesh-list
110398376|NCT01048099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110398377|NCT01048099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110398378|NCT00599807|Vitamin D|vitamin d|mesh-list
110398379|NCT00599807|Cholecalciferol|cholecalciferol|mesh-list
110398380|NCT00599807|Vitamins|vitamins|mesh-ancestor
110398381|NCT00599807|Micronutrients|micronutrients|mesh-ancestor
110398382|NCT00599807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398383|NCT00599807|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110398384|NCT00599807|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110398385|NCT00599885|Valsartan|valsartan|mesh-list
110398386|NCT00599885|Telmisartan|telmisartan|mesh-list
110398387|NCT00599885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110398388|NCT00599885|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110398389|NCT00599885|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110398390|NCT00599885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110398391|NCT01303965|Sirolimus|sirolimus|mesh-list
110398392|NCT01303965|Lenalidomide|lenalidomide|mesh-list
110398393|NCT01303965|Tacrolimus|tacrolimus|mesh-list
110398394|NCT01303965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110398395|NCT01303965|Immunologic Factors|immunologic factors|mesh-ancestor
110398396|NCT01303965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398397|NCT01303965|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110398398|NCT01303965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110398399|NCT01303965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110398400|NCT01303965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110398401|NCT01303965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110398402|NCT01303965|Growth Substances|growth substances|mesh-ancestor
110398403|NCT01303965|Growth Inhibitors|growth inhibitors|mesh-ancestor
110398404|NCT01303965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110398406|NCT01303965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110398407|NCT01303965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110398408|NCT01303965|Antifungal Agents|antifungal agents|mesh-ancestor
110398409|NCT00600041|Pantoprazole|pantoprazole|mesh-list
110398410|NCT00600041|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110398411|NCT00600041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110398412|NCT00600041|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110398413|NCT00600041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110398414|NCT00600041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110398415|NCT01045993|Analgesics|analgesics|mesh-list
110398416|NCT01045993|Sensory System Agents|sensory system agents|mesh-ancestor
110398417|NCT01045993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110398418|NCT01045993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398419|NCT00600509|Levetiracetam|levetiracetam|mesh-list
110398420|NCT00600509|Anticonvulsants|anticonvulsants|mesh-ancestor
110398421|NCT00600509|Nootropic Agents|nootropic agents|mesh-ancestor
110398422|NCT01326533|Hydroxychloroquine|hydroxychloroquine|mesh-list
110398423|NCT01326533|Antimalarials|antimalarials|mesh-ancestor
110398424|NCT01326533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110398425|NCT01326533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110398426|NCT01326533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110398427|NCT01326533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110398428|NCT01326533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110029651|NCT04090567|Cediranib|cediranib|mesh-list
110398429|NCT01326533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110398430|NCT00600587|Carboplatin|carboplatin|mesh-list
110398431|NCT00600587|Gemcitabine|gemcitabine|mesh-list
110398432|NCT00600587|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110398434|NCT00600587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110398435|NCT00600587|Antimetabolites|antimetabolites|mesh-ancestor
110398436|NCT00600587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110398437|NCT00600587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110398438|NCT00600587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110398439|NCT01045447|Insulin|insulin|mesh-list
110398440|NCT01045447|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110398441|NCT01045447|Insulin Glargine|insulin glargine|mesh-list
110398442|NCT01045447|Insulin Aspart|insulin aspart|mesh-list
110398443|NCT01045447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110398444|NCT01045447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398445|NCT00623207|Atropine|atropine|mesh-list
110398446|NCT00623207|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110398447|NCT00623207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110398448|NCT00623207|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110398449|NCT00623207|Autonomic Agents|autonomic agents|mesh-ancestor
110398450|NCT00623207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110398451|NCT00623207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398452|NCT00623207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110398453|NCT00623207|Respiratory System Agents|respiratory system agents|mesh-ancestor
110398454|NCT00623207|Mydriatics|mydriatics|mesh-ancestor
110398455|NCT00623207|Parasympatholytics|parasympatholytics|mesh-ancestor
110398456|NCT00623207|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110398457|NCT00623207|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110398458|NCT00623207|Cholinergic Agents|cholinergic agents|mesh-ancestor
110398459|NCT00623207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110398460|NCT00623207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110398461|NCT00600977|Doxorubicin|doxorubicin|mesh-list
110398462|NCT00600977|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110398463|NCT00600977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110398464|NCT00600977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110398465|NCT00600977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110398466|NCT00600977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110398467|NCT00600977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110398468|NCT00600977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110398469|NCT00601211|Pilocarpine|pilocarpine|mesh-list
110398470|NCT00601211|Miotics|miotics|mesh-ancestor
110398471|NCT00601211|Autonomic Agents|autonomic agents|mesh-ancestor
110398472|NCT00601211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110398473|NCT00601211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398474|NCT00601211|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110398475|NCT00601211|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110398476|NCT00601211|Cholinergic Agents|cholinergic agents|mesh-ancestor
110398477|NCT00601211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110398478|NCT00601211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110052584|NCT01480791|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110398480|NCT00601289|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110398481|NCT00601289|Alkylating Agents|alkylating agents|mesh-ancestor
110398482|NCT00601289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110398483|NCT00601289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110398484|NCT00601913|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110398485|NCT00601913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110029656|NCT04061746|Plasma-lyte 148|plasma-lyte 148|mesh-list
110398486|NCT00601913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110398487|NCT00601913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110398488|NCT00601913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110398490|NCT00601991|Endothelial Growth Factors|endothelial growth factors|mesh-list
110398491|NCT00601991|Growth Substances|growth substances|mesh-ancestor
110398492|NCT00601991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398493|NCT00601991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110398494|NCT00601991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110398495|NCT00601991|Growth Inhibitors|growth inhibitors|mesh-ancestor
110398496|NCT00601991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110398497|NCT01301391|Maleic acid|maleic acid|mesh-list
110398498|NCT01301391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110398499|NCT01301391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110398500|NCT04325633|Naproxen|naproxen|mesh-list
110398501|NCT04325633|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110398502|NCT04325633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110398503|NCT04325633|Analgesics|analgesics|mesh-ancestor
110398504|NCT04325633|Sensory System Agents|sensory system agents|mesh-ancestor
110398505|NCT04325633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110398506|NCT04325633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398507|NCT04325633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110398508|NCT04325633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110398509|NCT04325633|Gout Suppressants|gout suppressants|mesh-ancestor
110398510|NCT04325633|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110398511|NCT04325633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110398512|NCT04325633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110398515|NCT05643651|Warfarin|warfarin|mesh-list
110398516|NCT05643651|Rivaroxaban|rivaroxaban|mesh-list
110398517|NCT05643651|Clopidogrel|clopidogrel|mesh-list
110398518|NCT05643651|Vitamins|vitamins|mesh-ancestor
110398519|NCT05643651|Micronutrients|micronutrients|mesh-ancestor
110398520|NCT05643651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398521|NCT05643651|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110398522|NCT05643651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110398524|NCT05643651|Sensory System Agents|sensory system agents|mesh-ancestor
110398525|NCT05643651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110398526|NCT05643651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110398528|NCT05643651|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110398529|NCT05643651|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110398530|NCT05643651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110398531|NCT05643651|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110398532|NCT05643651|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110398533|NCT05643651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110398534|NCT05643651|Antipyretics|antipyretics|mesh-ancestor
110398535|NCT05643651|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110398536|NCT05643651|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110398537|NCT05643651|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110398538|NCT05643651|Purinergic Agents|purinergic agents|mesh-ancestor
110398539|NCT05643651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110398540|NCT05643651|Anticoagulants|anticoagulants|mesh-ancestor
110398541|NCT05643651|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110398542|NCT05643651|Antithrombins|antithrombins|mesh-ancestor
110398543|NCT05643651|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110398544|NCT05643651|Protease Inhibitors|protease inhibitors|mesh-ancestor
110398545|NCT05643651|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110398546|NCT05643651|Hemostatics|hemostatics|mesh-ancestor
110398548|NCT01061359|Epirubicin|epirubicin|mesh-list
110398549|NCT01061359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110398550|NCT01061359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110398551|NCT01061359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110398552|NCT01061359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110398553|NCT01061359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110398554|NCT01061359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110398556|NCT05643417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110398557|NCT05643417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110398558|NCT05643417|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110398559|NCT05643417|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110398560|NCT05643417|Growth Substances|growth substances|mesh-ancestor
110398561|NCT05643417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398562|NCT05643417|Growth Inhibitors|growth inhibitors|mesh-ancestor
110398564|NCT04303741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110398565|NCT04303741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110398566|NCT04303741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110398567|NCT04303741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110398568|NCT00626977|Clonidine|clonidine|mesh-list
110398569|NCT00626977|Ropivacaine|ropivacaine|mesh-list
110398570|NCT00626977|Anesthetics, Local|anesthetics, local|mesh-ancestor
110398571|NCT00626977|Anesthetics|anesthetics|mesh-ancestor
110398572|NCT00626977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110398573|NCT00626977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398574|NCT00626977|Sensory System Agents|sensory system agents|mesh-ancestor
110398575|NCT00626977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110398576|NCT00626977|Analgesics|analgesics|mesh-ancestor
110398577|NCT00626977|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110398578|NCT00626977|Sympatholytics|sympatholytics|mesh-ancestor
110398579|NCT00626977|Autonomic Agents|autonomic agents|mesh-ancestor
110398580|NCT00626977|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110398581|NCT00626977|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110398582|NCT00626977|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110398583|NCT00626977|Adrenergic Agents|adrenergic agents|mesh-ancestor
110398584|NCT00626977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110398585|NCT00626977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110398587|NCT04303819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110398588|NCT04303819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398589|NCT04303819|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110398591|NCT04303819|Hormones|hormones|mesh-ancestor
110398592|NCT04303819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110398593|NCT01301079|Ketamine|ketamine|mesh-list
110398594|NCT01301079|Analgesics|analgesics|mesh-ancestor
110029693|NCT03835065|Calpastatin|calpastatin|mesh-list
110398595|NCT01301079|Sensory System Agents|sensory system agents|mesh-ancestor
110398596|NCT01301079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110398597|NCT01301079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398598|NCT01301079|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110398599|NCT01301079|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110398600|NCT01301079|Anesthetics, General|anesthetics, general|mesh-ancestor
110398601|NCT01301079|Anesthetics|anesthetics|mesh-ancestor
110398602|NCT01301079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110398603|NCT01301079|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110398604|NCT01301079|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110398605|NCT01301079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110398606|NCT01301079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110398607|NCT05271721|Dexamethasone|dexamethasone|mesh-list
110398608|NCT05271721|Dexamethasone acetate|dexamethasone acetate|mesh-list
110398609|NCT05271721|BB 1101|bb 1101|mesh-list
110398610|NCT05271721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110398611|NCT05271721|Antiemetics|antiemetics|mesh-ancestor
110398612|NCT05271721|Autonomic Agents|autonomic agents|mesh-ancestor
110398613|NCT05271721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110398614|NCT05271721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398615|NCT05271721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110398616|NCT05271721|Glucocorticoids|glucocorticoids|mesh-ancestor
110398617|NCT05271721|Hormones|hormones|mesh-ancestor
110398618|NCT05271721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110398619|NCT05271721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110398620|NCT05271721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110398621|NCT05271721|Protease Inhibitors|protease inhibitors|mesh-ancestor
110398622|NCT05271721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110398623|NCT05271721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110398624|NCT01301001|Gabapentin|gabapentin|mesh-list
110398625|NCT01301001|Analgesics|analgesics|mesh-ancestor
110398626|NCT01301001|Sensory System Agents|sensory system agents|mesh-ancestor
110398627|NCT01301001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110398628|NCT01301001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110052749|NCT01481844|Tinidazole|tinidazole|mesh-list
110398629|NCT01301001|Anticonvulsants|anticonvulsants|mesh-ancestor
110398630|NCT01301001|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110398631|NCT01301001|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110398632|NCT01301001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110398633|NCT01301001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110398634|NCT01301001|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110398635|NCT01301001|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110398636|NCT01301001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110398637|NCT01301001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110398638|NCT01301001|Antimanic Agents|antimanic agents|mesh-ancestor
110398639|NCT01035463|Cytarabine|cytarabine|mesh-list
110398640|NCT01035463|Rituximab|rituximab|mesh-list
110398641|NCT01035463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110398642|NCT01035463|Etoposide|etoposide|mesh-list
110398643|NCT01035463|Lenalidomide|lenalidomide|mesh-list
110398644|NCT01035463|Etoposide phosphate|etoposide phosphate|mesh-list
110029716|NCT03786783|Dexrazoxane|dexrazoxane|mesh-list
110398645|NCT01035463|Melphalan|melphalan|mesh-list
110398646|NCT01035463|Mechlorethamine|mechlorethamine|mesh-list
110398647|NCT01035463|Carmustine|carmustine|mesh-list
110398648|NCT01035463|Podophyllotoxin|podophyllotoxin|mesh-list
110398649|NCT01035463|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
110398650|NCT01035463|Antibodies|antibodies|mesh-list
110398651|NCT01035463|Immunoglobulins|immunoglobulins|mesh-list
110398652|NCT01035463|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110398653|NCT01035463|Immunologic Factors|immunologic factors|mesh-ancestor
110398654|NCT01035463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398655|NCT01035463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110398656|NCT01035463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110398657|NCT01035463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110398658|NCT01035463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110398659|NCT01035463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110398660|NCT01035463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110398661|NCT01035463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110398662|NCT01035463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110398663|NCT01035463|Antimetabolites|antimetabolites|mesh-ancestor
110398664|NCT01035463|Antiviral Agents|antiviral agents|mesh-ancestor
110398665|NCT01035463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110398666|NCT01035463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110398667|NCT01035463|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110398668|NCT01035463|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110398669|NCT01035463|Growth Substances|growth substances|mesh-ancestor
110398670|NCT01035463|Growth Inhibitors|growth inhibitors|mesh-ancestor
110398671|NCT01035463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110398672|NCT01035463|Alkylating Agents|alkylating agents|mesh-ancestor
110398673|NCT01035463|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110398674|NCT01035463|Keratolytic Agents|keratolytic agents|mesh-ancestor
110398675|NCT01035463|Dermatologic Agents|dermatologic agents|mesh-ancestor
110398676|NCT01035463|Tubulin Modulators|tubulin modulators|mesh-ancestor
110398677|NCT01035463|Antimitotic Agents|antimitotic agents|mesh-ancestor
110398678|NCT01035463|Mitosis Modulators|mitosis modulators|mesh-ancestor
110398679|NCT01300923|Acamprosate|acamprosate|mesh-list
110398680|NCT01300923|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110398681|NCT01300767|Contact Lens Solutions|contact lens solutions|mesh-list
110398682|NCT01300767|Disinfectants|disinfectants|mesh-ancestor
110398683|NCT01300767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110398684|NCT02890173|Eplerenone|eplerenone|mesh-list
110398685|NCT02890173|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110398686|NCT02890173|Hormone Antagonists|hormone antagonists|mesh-ancestor
110398687|NCT02890173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110398689|NCT02890173|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110398690|NCT02890173|Diuretics|diuretics|mesh-ancestor
110398691|NCT02890173|Natriuretic Agents|natriuretic agents|mesh-ancestor
110398692|NCT02890173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110398693|NCT01300455|Suvorexant|suvorexant|mesh-list
110398694|NCT01300455|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110398695|NCT01300455|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110398696|NCT01300455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110398697|NCT01300455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398698|NCT01300455|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
110398699|NCT01300455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110398700|NCT01300455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110398701|NCT01101178|Oxycodone|oxycodone|mesh-list
110398702|NCT01101178|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110053101|NCT01484990|Levodopa|levodopa|mesh-list
110398703|NCT01101178|Narcotics|narcotics|mesh-ancestor
110029739|NCT03786783|Mitosis Modulators|mitosis modulators|mesh-ancestor
110029741|NCT03786783|Keratolytic Agents|keratolytic agents|mesh-ancestor
110398704|NCT01101178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110398705|NCT01101178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398706|NCT01101178|Analgesics|analgesics|mesh-ancestor
110398707|NCT01101178|Sensory System Agents|sensory system agents|mesh-ancestor
110398708|NCT01101178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110398709|NCT05637645|Bupivacaine|bupivacaine|mesh-list
110398710|NCT05637645|Anesthetics, Local|anesthetics, local|mesh-ancestor
110398711|NCT05637645|Anesthetics|anesthetics|mesh-ancestor
110398712|NCT05637645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110398713|NCT05637645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398714|NCT05637645|Sensory System Agents|sensory system agents|mesh-ancestor
110398716|NCT01101022|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
110398717|NCT01101022|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110398718|NCT01101022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398719|NCT01101022|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110398720|NCT01101022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110398721|NCT01101022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110398722|NCT01101022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110398723|NCT01101022|Dopamine Agents|dopamine agents|mesh-ancestor
110398724|NCT01101022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110398725|NCT02879110|Sulforaphane|sulforaphane|mesh-list
110398726|NCT02879110|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110398727|NCT02879110|Protective Agents|protective agents|mesh-ancestor
110398728|NCT02879110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398729|NCT02879110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110398731|NCT04207515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110398732|NCT04207515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398733|NCT01100944|Cyclophosphamide|cyclophosphamide|mesh-list
110398735|NCT01100944|Belinostat|belinostat|mesh-list
110398736|NCT01100944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110398737|NCT01100944|Immunologic Factors|immunologic factors|mesh-ancestor
110398738|NCT01100944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398739|NCT01100944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110398740|NCT01100944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110398741|NCT01100944|Alkylating Agents|alkylating agents|mesh-ancestor
110398742|NCT01100944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110398743|NCT01100944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110398744|NCT01100944|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110398745|NCT01100944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110398746|NCT01100944|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110398747|NCT01100944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110398748|NCT01100944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110398749|NCT01100944|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110398750|NCT01100320|Oxycodone|oxycodone|mesh-list
110398751|NCT01100320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110398752|NCT01100320|Narcotics|narcotics|mesh-ancestor
110398753|NCT01100320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110398754|NCT01100320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398755|NCT01100320|Analgesics|analgesics|mesh-ancestor
110398756|NCT01100320|Sensory System Agents|sensory system agents|mesh-ancestor
110398757|NCT01100320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110398758|NCT04309708|Nimodipine|nimodipine|mesh-list
110398759|NCT04309708|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110398760|NCT04309708|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110398761|NCT04309708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110029753|NCT03670056|Nivolumab|nivolumab|mesh-list
110029754|NCT03670056|Ipilimumab|ipilimumab|mesh-list
110029755|NCT03670056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110398762|NCT04309708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110398763|NCT04309708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110398764|NCT04309708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398765|NCT04309708|Vasodilator Agents|vasodilator agents|mesh-ancestor
110398766|NCT01100086|Oxycodone|oxycodone|mesh-list
110398767|NCT01100086|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110398768|NCT01100086|Narcotics|narcotics|mesh-ancestor
110398769|NCT01100086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110398770|NCT01100086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398771|NCT01100086|Analgesics|analgesics|mesh-ancestor
110398772|NCT01100086|Sensory System Agents|sensory system agents|mesh-ancestor
110398773|NCT01100086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110398774|NCT01297959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110398775|NCT00626080|Insulin|insulin|mesh-list
110398776|NCT00626080|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110398777|NCT00626080|Insulin Detemir|insulin detemir|mesh-list
110398778|NCT00626080|Isophane Insulin, Human|isophane insulin, human|mesh-list
110398779|NCT00626080|Insulin, Isophane|insulin, isophane|mesh-list
110398780|NCT00626080|Isophane insulin, beef|isophane insulin, beef|mesh-list
110398781|NCT00626080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110398782|NCT00626080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398784|NCT04309240|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110398785|NCT04309240|Antithrombins|antithrombins|mesh-ancestor
110398786|NCT04309240|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110398787|NCT04309240|Protease Inhibitors|protease inhibitors|mesh-ancestor
110398788|NCT04309240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110398789|NCT04309240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110398790|NCT04309240|Anticoagulants|anticoagulants|mesh-ancestor
110398791|NCT01035229|Everolimus|everolimus|mesh-list
110398792|NCT01035229|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110398793|NCT01035229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110398794|NCT01035229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110398795|NCT01035229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110398796|NCT01035229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110398797|NCT01035229|Immunologic Factors|immunologic factors|mesh-ancestor
110398798|NCT01035229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398799|NCT01035229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110398800|NCT01059799|Insulin|insulin|mesh-list
110398801|NCT01059799|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110398802|NCT01059799|Insulin Glargine|insulin glargine|mesh-list
110398803|NCT01059799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110398804|NCT01059799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398805|NCT04301869|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110398806|NCT04301869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110398808|NCT04301479|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110398809|NCT04301479|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110398810|NCT04301479|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110398811|NCT04301479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110398812|NCT01106092|Vaccines|vaccines|mesh-list
110398813|NCT01106092|Immunologic Factors|immunologic factors|mesh-ancestor
110398814|NCT01106092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398815|NCT04307290|Dexmedetomidine|dexmedetomidine|mesh-list
110398816|NCT04307290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110029776|NCT03635333|Nicotine|nicotine|mesh-list
110398817|NCT04307290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110398818|NCT04307290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398819|NCT04307290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110398820|NCT04307290|Analgesics|analgesics|mesh-ancestor
110398821|NCT04307290|Sensory System Agents|sensory system agents|mesh-ancestor
110398822|NCT04307290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110398823|NCT04307290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110398824|NCT04307290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110398825|NCT04307290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110398826|NCT04307290|Adrenergic Agents|adrenergic agents|mesh-ancestor
110398827|NCT04307290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110398828|NCT04307290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110398829|NCT01325207|Trastuzumab|trastuzumab|mesh-list
110398830|NCT01325207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110398831|NCT01325207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110398832|NCT01324349|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110398833|NCT01324349|Hemostatics|hemostatics|mesh-list
110398834|NCT01324349|Coagulants|coagulants|mesh-ancestor
110398835|NCT01095250|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110398836|NCT01095250|Immunologic Factors|immunologic factors|mesh-ancestor
110398837|NCT01095250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398840|NCT01095094|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110398841|NCT01095094|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110398842|NCT01095094|Protease Inhibitors|protease inhibitors|mesh-ancestor
110398843|NCT01095094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110398844|NCT01095094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110398845|NCT01095094|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110398846|NCT01095094|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110398847|NCT01095094|Antiviral Agents|antiviral agents|mesh-ancestor
110398848|NCT01095094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110398849|NCT01095094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110398850|NCT01095094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110398851|NCT00623285|Pregabalin|pregabalin|mesh-list
110398852|NCT00623285|Analgesics|analgesics|mesh-ancestor
110398853|NCT00623285|Sensory System Agents|sensory system agents|mesh-ancestor
110398854|NCT00623285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110398855|NCT00623285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398856|NCT00623285|Anticonvulsants|anticonvulsants|mesh-ancestor
110398857|NCT00623285|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110398858|NCT00623285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110398859|NCT00623285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110398860|NCT00623285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110398861|NCT00623285|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110398862|NCT00623285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110398863|NCT00623285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110398864|NCT00623285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110398865|NCT01097044|Afamelanotide|afamelanotide|mesh-list
110398866|NCT01097044|Dermatologic Agents|dermatologic agents|mesh-ancestor
110398867|NCT01322009|Acetylcysteine|acetylcysteine|mesh-list
110398868|NCT01322009|Probenecid|probenecid|mesh-list
110398869|NCT01322009|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110398870|NCT01322009|Antiviral Agents|antiviral agents|mesh-ancestor
110398871|NCT01322009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110398872|NCT01322009|Expectorants|expectorants|mesh-ancestor
110398873|NCT01322009|Respiratory System Agents|respiratory system agents|mesh-ancestor
110398874|NCT01322009|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110398875|NCT01322009|Antioxidants|antioxidants|mesh-ancestor
110398876|NCT01322009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110398877|NCT01322009|Protective Agents|protective agents|mesh-ancestor
110398878|NCT01322009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398880|NCT01322009|Uricosuric Agents|uricosuric agents|mesh-ancestor
110398881|NCT01322009|Gout Suppressants|gout suppressants|mesh-ancestor
110398882|NCT01322009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110398883|NCT01320683|Leucovorin|leucovorin|mesh-list
110398884|NCT01320683|Bevacizumab|bevacizumab|mesh-list
110398885|NCT01320683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110398886|NCT01320683|Fluorouracil|fluorouracil|mesh-list
110398887|NCT01320683|Oxaliplatin|oxaliplatin|mesh-list
110398888|NCT01320683|Irinotecan|irinotecan|mesh-list
110398889|NCT01320683|Antibodies|antibodies|mesh-list
110398890|NCT01320683|Immunoglobulins|immunoglobulins|mesh-list
110398891|NCT01320683|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110398892|NCT01320683|Levoleucovorin|levoleucovorin|mesh-list
110398893|NCT01320683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110398894|NCT01320683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110398895|NCT01320683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110398896|NCT01320683|Growth Substances|growth substances|mesh-ancestor
110398897|NCT01320683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398898|NCT01320683|Growth Inhibitors|growth inhibitors|mesh-ancestor
110398899|NCT01320683|Immunologic Factors|immunologic factors|mesh-ancestor
110398900|NCT01320683|Antimetabolites|antimetabolites|mesh-ancestor
110398901|NCT01320683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110398902|NCT01320683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110398903|NCT01320683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110398904|NCT01320683|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110398905|NCT01320683|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110398906|NCT01320683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110398907|NCT01320683|Antidotes|antidotes|mesh-ancestor
110398908|NCT01320683|Protective Agents|protective agents|mesh-ancestor
110398909|NCT01320683|Vitamin B Complex|vitamin b complex|mesh-ancestor
110398911|NCT01320683|Micronutrients|micronutrients|mesh-ancestor
110398912|NCT01320293|Adalimumab|adalimumab|mesh-list
110398913|NCT01320293|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110398914|NCT01320293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110398915|NCT01320293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110398917|NCT01318811|Calcium heparin|calcium heparin|mesh-list
110398918|NCT01318811|Anticoagulants|anticoagulants|mesh-ancestor
110398919|NCT01318811|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110398920|NCT01318811|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110398921|NCT01318811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110398922|NCT05644769|Lisinopril|lisinopril|mesh-list
110398923|NCT05644769|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110398924|NCT05644769|Protease Inhibitors|protease inhibitors|mesh-ancestor
110398925|NCT05644769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110398926|NCT05644769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110398927|NCT05644769|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110398928|NCT05644769|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110398929|NCT05644769|Protective Agents|protective agents|mesh-ancestor
110398930|NCT05644769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398932|NCT05644691|Dermatologic Agents|dermatologic agents|mesh-ancestor
110398933|NCT01093846|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110398934|NCT01093846|Immunologic Factors|immunologic factors|mesh-ancestor
110398935|NCT01093846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398936|NCT01093534|Solifenacin Succinate|solifenacin succinate|mesh-list
110398937|NCT01093534|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110398938|NCT01093534|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110398939|NCT01093534|Cholinergic Agents|cholinergic agents|mesh-ancestor
110398940|NCT01093534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110398941|NCT01093534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110398942|NCT01093534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398943|NCT01093534|Urological Agents|urological agents|mesh-ancestor
110398945|NCT01314911|Antiviral Agents|antiviral agents|mesh-ancestor
110398946|NCT01314911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110398947|NCT01314911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110398948|NCT01314911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110398949|NCT01093222|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110398950|NCT01093222|Sorafenib|sorafenib|mesh-list
110398951|NCT01093222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110398952|NCT01093222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110398953|NCT01093222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110398954|NCT01093222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110398955|NCT02878018|Hormones|hormones|mesh-list
110398956|NCT02878018|Adrenergic Agents|adrenergic agents|mesh-list
110398957|NCT02878018|Immunosuppressive Agents|immunosuppressive agents|mesh-list
110398958|NCT02878018|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110398959|NCT02878018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110398960|NCT02878018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398961|NCT02878018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110398962|NCT02878018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110398963|NCT02878018|Immunologic Factors|immunologic factors|mesh-ancestor
110398964|NCT02878018|Protease Inhibitors|protease inhibitors|mesh-ancestor
110398965|NCT02878018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110398966|NCT01313663|Pemetrexed|pemetrexed|mesh-list
110398967|NCT01313663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110398968|NCT01313663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110398969|NCT01313663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110398970|NCT01313663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110398971|NCT01313663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110398972|NCT01092832|Voriconazole|voriconazole|mesh-list
110398973|NCT01092832|Antifungal Agents|antifungal agents|mesh-ancestor
110398974|NCT01092832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110398975|NCT01092832|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110398976|NCT01092832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110398977|NCT01092832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110398978|NCT01092832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110398979|NCT01092832|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110398980|NCT01092832|Hormone Antagonists|hormone antagonists|mesh-ancestor
110398981|NCT01092832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110398982|NCT01092832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398983|NCT01092832|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110398984|NCT02878564|Praziquantel|praziquantel|mesh-list
110398985|NCT02878564|Anthelmintics|anthelmintics|mesh-ancestor
110398986|NCT02878564|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110398987|NCT02878564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110398988|NCT04308070|Hemostatics|hemostatics|mesh-list
110398989|NCT04308070|Coagulants|coagulants|mesh-ancestor
110398990|NCT01313273|Ascorbic Acid|ascorbic acid|mesh-list
110398991|NCT01313273|Methyltestosterone|methyltestosterone|mesh-list
110398992|NCT01313273|Lanreotide|lanreotide|mesh-list
110398993|NCT01313273|Androgens|androgens|mesh-list
110398994|NCT01313273|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110398995|NCT01313273|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
110398996|NCT01313273|Androgen Antagonists|androgen antagonists|mesh-list
110398997|NCT01313273|Nonsteroidal Anti-Androgens|nonsteroidal anti-androgens|mesh-list
110398998|NCT01313273|Hormones|hormones|mesh-ancestor
110398999|NCT01313273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110399000|NCT01313273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399001|NCT01313273|Antioxidants|antioxidants|mesh-ancestor
110029814|NCT03287778|Pyridoxine|pyridoxine|mesh-list
110399002|NCT01313273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110399003|NCT01313273|Protective Agents|protective agents|mesh-ancestor
110399005|NCT01313273|Micronutrients|micronutrients|mesh-ancestor
110399006|NCT01313273|Estrogens|estrogens|mesh-ancestor
110399007|NCT01313273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110399009|NCT01313273|Anabolic Agents|anabolic agents|mesh-ancestor
110399010|NCT01313273|Hormone Antagonists|hormone antagonists|mesh-ancestor
110399011|NCT01091974|Modafinil|modafinil|mesh-list
110399012|NCT01091974|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110399013|NCT01091974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399014|NCT01091974|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110399015|NCT01091974|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110399016|NCT01091974|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110399017|NCT01091974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110399018|NCT01313117|Thioctic Acid|thioctic acid|mesh-list
110399019|NCT01313117|Antioxidants|antioxidants|mesh-ancestor
110399020|NCT01313117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110399021|NCT01313117|Protective Agents|protective agents|mesh-ancestor
110399022|NCT01313117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399023|NCT01313117|Vitamin B Complex|vitamin b complex|mesh-ancestor
110399024|NCT01313117|Vitamins|vitamins|mesh-ancestor
110399025|NCT01313117|Micronutrients|micronutrients|mesh-ancestor
110399026|NCT01091662|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
110399027|NCT01091662|Anticonvulsants|anticonvulsants|mesh-ancestor
110399028|NCT01091662|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110399029|NCT01091662|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110399030|NCT01091662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110399031|NCT01091662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110399032|NCT01312961|Fluticasone|fluticasone|mesh-list
110399035|NCT01312961|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110399036|NCT01312961|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110399037|NCT01312961|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110399038|NCT01312961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110399039|NCT01312961|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110399040|NCT01312961|Autonomic Agents|autonomic agents|mesh-ancestor
110399041|NCT01312961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110399042|NCT01312961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399043|NCT01312961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110399044|NCT01312961|Respiratory System Agents|respiratory system agents|mesh-ancestor
110399045|NCT01312961|Dermatologic Agents|dermatologic agents|mesh-ancestor
110399046|NCT01312961|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110399047|NCT01312961|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110399048|NCT01312961|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110399049|NCT01312961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110399050|NCT01312961|Adrenergic Agents|adrenergic agents|mesh-ancestor
110399051|NCT01312961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110399052|NCT01312961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110399053|NCT01312961|Tocolytic Agents|tocolytic agents|mesh-ancestor
110399054|NCT01312961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110399055|NCT01312961|Immunologic Factors|immunologic factors|mesh-ancestor
110399056|NCT01312961|Glucocorticoids|glucocorticoids|mesh-ancestor
110399057|NCT01312961|Hormones|hormones|mesh-ancestor
110399058|NCT01312961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110399059|NCT01312961|Sympathomimetics|sympathomimetics|mesh-ancestor
110399060|NCT00626158|Gemcitabine|gemcitabine|mesh-list
110399061|NCT00626158|Capecitabine|capecitabine|mesh-list
110399062|NCT00626158|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110399063|NCT00626158|Antimetabolites|antimetabolites|mesh-ancestor
110399064|NCT00626158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110399065|NCT00626158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110399066|NCT01310777|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110399067|NCT01310777|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110399069|NCT01310777|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110399070|NCT01310777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110399071|NCT01310777|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110399072|NCT01310777|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110399073|NCT01310777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110399074|NCT01310777|Adrenergic Agents|adrenergic agents|mesh-ancestor
110399075|NCT01310777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110399076|NCT01310777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110399077|NCT01310777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399078|NCT01310777|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110399079|NCT01310777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110399080|NCT01309997|Rituximab|rituximab|mesh-list
110399081|NCT01309997|Imatinib Mesylate|imatinib mesylate|mesh-list
110399082|NCT01309997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110399083|NCT01309997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110399084|NCT01309997|Immunologic Factors|immunologic factors|mesh-ancestor
110399085|NCT01309997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399086|NCT01309997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110399087|NCT01309997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110399088|NCT01309997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110399089|NCT01309997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110399090|NCT01309841|Naloxegol|naloxegol|mesh-list
110399091|NCT01309841|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110399092|NCT01309841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399093|NCT01309841|Sensory System Agents|sensory system agents|mesh-ancestor
110399094|NCT01309841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110399095|NCT01308749|Oxytocin|oxytocin|mesh-list
110399096|NCT01308749|Oxytocics|oxytocics|mesh-ancestor
110399097|NCT01308749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110399098|NCT01308749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399099|NCT01307891|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110399101|NCT01307891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110399102|NCT01307891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110399103|NCT01307891|Tubulin Modulators|tubulin modulators|mesh-ancestor
110399104|NCT01307891|Antimitotic Agents|antimitotic agents|mesh-ancestor
110399105|NCT01307891|Mitosis Modulators|mitosis modulators|mesh-ancestor
110399106|NCT01307891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110399107|NCT05644301|Minocycline|minocycline|mesh-list
110399108|NCT05644301|Celecoxib|celecoxib|mesh-list
110399109|NCT05644301|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110399110|NCT05644301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110399111|NCT05644301|Analgesics|analgesics|mesh-ancestor
110399112|NCT05644301|Sensory System Agents|sensory system agents|mesh-ancestor
110399113|NCT05644301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110399114|NCT05644301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399115|NCT05644301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110399116|NCT05644301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110399117|NCT05644301|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110399118|NCT05644301|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110399119|NCT05644301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110399120|NCT05644301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110399121|NCT05644301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110399122|NCT05644301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110029856|NCT02995252|Hematinics|hematinics|mesh-ancestor
110399124|NCT02890745|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110399125|NCT02890745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110399126|NCT02890745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110399127|NCT02890745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399128|NCT01307579|Fluconazole|fluconazole|mesh-list
110399129|NCT01307579|Caspofungin|caspofungin|mesh-list
110399130|NCT01307579|Antifungal Agents|antifungal agents|mesh-ancestor
110399131|NCT01307579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110399132|NCT01307579|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110399133|NCT01307579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110399134|NCT01307579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110399135|NCT01307579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110399136|NCT01307579|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110399137|NCT01307579|Hormone Antagonists|hormone antagonists|mesh-ancestor
110399138|NCT01307579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110399139|NCT01307579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399140|NCT01307579|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110399141|NCT01307579|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110399142|NCT01057693|Pregabalin|pregabalin|mesh-list
110399143|NCT01057693|Analgesics|analgesics|mesh-ancestor
110399144|NCT01057693|Sensory System Agents|sensory system agents|mesh-ancestor
110399145|NCT01057693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110399146|NCT01057693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399147|NCT01057693|Anticonvulsants|anticonvulsants|mesh-ancestor
110399148|NCT01057693|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110399149|NCT01057693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110399150|NCT01057693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110399151|NCT01057693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110399152|NCT01057693|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110399153|NCT01057693|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110399154|NCT01057693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110399155|NCT01057693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110399157|NCT04325009|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110399159|NCT04325009|Antimetabolites|antimetabolites|mesh-ancestor
110399160|NCT04325009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110399161|NCT04325009|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110399162|NCT04325009|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110399163|NCT04325009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110399164|NCT01034137|Methotrexate|methotrexate|mesh-list
110399165|NCT01034137|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110399166|NCT01034137|Abortifacient Agents|abortifacient agents|mesh-ancestor
110399167|NCT01034137|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110399168|NCT01034137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399169|NCT01034137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110399170|NCT01034137|Antimetabolites|antimetabolites|mesh-ancestor
110399171|NCT01034137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110399172|NCT01034137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110399173|NCT01034137|Dermatologic Agents|dermatologic agents|mesh-ancestor
110399174|NCT01034137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110399175|NCT01034137|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110399176|NCT01034137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110399177|NCT01034137|Immunologic Factors|immunologic factors|mesh-ancestor
110399178|NCT01034137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110399179|NCT01034137|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110399180|NCT04302805|Thymoglobulin|thymoglobulin|mesh-list
110399181|NCT04302805|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110399182|NCT04302805|Immunologic Factors|immunologic factors|mesh-ancestor
110029871|NCT02817360|Losartan|losartan|mesh-list
110399183|NCT04302805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399184|NCT04302805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110399185|NCT01056289|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
110399186|NCT01056289|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110399187|NCT01056289|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110399188|NCT01056289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110399189|NCT01056289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110399190|NCT01056289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110399192|NCT01056289|Antidepressive Agents|antidepressive agents|mesh-ancestor
110399194|NCT02875093|Cytarabine|cytarabine|mesh-list
110399195|NCT02875093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110399196|NCT02875093|Antimetabolites|antimetabolites|mesh-ancestor
110399197|NCT02875093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110399198|NCT02875093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110399199|NCT02875093|Antiviral Agents|antiviral agents|mesh-ancestor
110399200|NCT02875093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110399201|NCT02875093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110399202|NCT02875093|Immunologic Factors|immunologic factors|mesh-ancestor
110399203|NCT02875093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399205|NCT01033825|Dexamethasone|dexamethasone|mesh-list
110399206|NCT01033825|Dexamethasone acetate|dexamethasone acetate|mesh-list
110399207|NCT01033825|BB 1101|bb 1101|mesh-list
110399208|NCT01033825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110399209|NCT01033825|Antiemetics|antiemetics|mesh-ancestor
110399210|NCT01033825|Autonomic Agents|autonomic agents|mesh-ancestor
110399211|NCT01033825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110399212|NCT01033825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399213|NCT01033825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110399214|NCT01033825|Glucocorticoids|glucocorticoids|mesh-ancestor
110399215|NCT01033825|Hormones|hormones|mesh-ancestor
110399216|NCT01033825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110399217|NCT01033825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110399218|NCT01033825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110399219|NCT01033825|Protease Inhibitors|protease inhibitors|mesh-ancestor
110399220|NCT01033825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110399221|NCT01033825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110399222|NCT01033825|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110399223|NCT01033747|Deferasirox|deferasirox|mesh-list
110399224|NCT01033747|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110399225|NCT01033747|Chelating Agents|chelating agents|mesh-ancestor
110053627|NCT01487512|Analgesics|analgesics|mesh-ancestor
110399226|NCT01033747|Sequestering Agents|sequestering agents|mesh-ancestor
110399227|NCT01033747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110399228|NCT02875015|Lidocaine|lidocaine|mesh-list
110399230|NCT02875015|Anesthetics, Local|anesthetics, local|mesh-ancestor
110399231|NCT02875015|Anesthetics|anesthetics|mesh-ancestor
110399232|NCT02875015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110399233|NCT02875015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399234|NCT02875015|Sensory System Agents|sensory system agents|mesh-ancestor
110399235|NCT02875015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110399236|NCT02875015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110399237|NCT02875015|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110399238|NCT02875015|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110399239|NCT02875015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110399240|NCT02875015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110399241|NCT01091428|Paclitaxel|paclitaxel|mesh-list
110399242|NCT01091428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110399243|NCT01091428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110399244|NCT01091428|Tubulin Modulators|tubulin modulators|mesh-ancestor
110399245|NCT01091428|Antimitotic Agents|antimitotic agents|mesh-ancestor
110399246|NCT01091428|Mitosis Modulators|mitosis modulators|mesh-ancestor
110399247|NCT01091428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110399248|NCT01096342|Cyclin-Dependent Kinase Inhibitor Proteins|cyclin-dependent kinase inhibitor proteins|mesh-list
110399249|NCT01096342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110399250|NCT01096342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110399251|NCT01096342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110399252|NCT01096186|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110399254|NCT01096186|Levodopa|levodopa|mesh-list
110399255|NCT01096186|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110399256|NCT01096186|Immunologic Factors|immunologic factors|mesh-ancestor
110399257|NCT01096186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399258|NCT01096186|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110399259|NCT01096186|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110399260|NCT01096186|Dopamine Agonists|dopamine agonists|mesh-ancestor
110399262|NCT01096186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110399263|NCT01096186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110399264|NCT01096186|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110399265|NCT01096186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110399266|NCT01032889|Deoxycholic Acid|deoxycholic acid|mesh-list
110399267|NCT01032889|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110399268|NCT01032889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110399269|NCT01049503|Fluorides|fluorides|mesh-list
110399270|NCT01049503|Cariostatic Agents|cariostatic agents|mesh-ancestor
110399271|NCT01049503|Protective Agents|protective agents|mesh-ancestor
110399272|NCT01049503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399273|NCT04302649|Dialysis Solutions|dialysis solutions|mesh-list
110399274|NCT04302649|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110399275|NCT04301557|Capecitabine|capecitabine|mesh-list
110399276|NCT04301557|Oxaliplatin|oxaliplatin|mesh-list
110399277|NCT04301557|Antibodies|antibodies|mesh-list
110399279|NCT04301557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399280|NCT04301557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110399281|NCT04301557|Antimetabolites|antimetabolites|mesh-ancestor
110399282|NCT04301557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110399283|NCT04301557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110399284|NCT02874313|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110399285|NCT02874313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399286|NCT01029535|Hyaluronic Acid|hyaluronic acid|mesh-list
110399287|NCT01029535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110399288|NCT01029535|Immunologic Factors|immunologic factors|mesh-ancestor
110399289|NCT01029535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399290|NCT01029535|Viscosupplements|viscosupplements|mesh-ancestor
110399291|NCT01029535|Protective Agents|protective agents|mesh-ancestor
110399292|NCT01028053|Flutemetamol|flutemetamol|mesh-list
110399293|NCT01028053|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110399294|NCT01028053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110399295|NCT01023217|Lamivudine|lamivudine|mesh-list
110399296|NCT01023217|Adefovir|adefovir|mesh-list
110399297|NCT01023217|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
110399298|NCT01023217|Entecavir|entecavir|mesh-list
110399299|NCT01023217|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110399300|NCT01023217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110399301|NCT01023217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110399302|NCT01023217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110399303|NCT01023217|Antiviral Agents|antiviral agents|mesh-ancestor
110399304|NCT01023217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110399305|NCT01023217|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110399306|NCT01023217|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110399307|NCT01095796|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110029900|NCT02817360|Antioxidants|antioxidants|mesh-ancestor
110399308|NCT01095796|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110399309|NCT01095796|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110399310|NCT01095796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110399312|NCT01095796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110399313|NCT01095796|Antiviral Agents|antiviral agents|mesh-ancestor
110399314|NCT01095796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110399315|NCT01095796|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110399316|NCT01095796|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110399318|NCT01023061|Leuprolide|leuprolide|mesh-list
110399319|NCT01023061|Goserelin|goserelin|mesh-list
110399320|NCT01023061|Abiraterone Acetate|abiraterone acetate|mesh-list
110399321|NCT01023061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110399322|NCT01023061|Glucocorticoids|glucocorticoids|mesh-ancestor
110399323|NCT01023061|Hormones|hormones|mesh-ancestor
110399324|NCT01023061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110399325|NCT01023061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399326|NCT01023061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110399327|NCT01023061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110399328|NCT01023061|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110399329|NCT01023061|Fertility Agents|fertility agents|mesh-ancestor
110399330|NCT01023061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110399331|NCT01023061|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110399332|NCT01023061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110399333|NCT01023061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110399334|NCT01023061|Hormone Antagonists|hormone antagonists|mesh-ancestor
110399335|NCT01023061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110399336|NCT01027897|Doripenem|doripenem|mesh-list
110399337|NCT01027897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110399338|NCT01027897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110399339|NCT01027351|Vaccines|vaccines|mesh-list
110399340|NCT01027351|Immunologic Factors|immunologic factors|mesh-ancestor
110399341|NCT01027351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399343|NCT05661045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110399344|NCT05661045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399345|NCT01294683|Niacin|niacin|mesh-list
110399347|NCT01294683|Nicotinic Acids|nicotinic acids|mesh-list
110399348|NCT01294683|Simvastatin|simvastatin|mesh-list
110399349|NCT01294683|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110399350|NCT01294683|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110399351|NCT01294683|Antimetabolites|antimetabolites|mesh-ancestor
110399352|NCT01294683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110399353|NCT01294683|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110399354|NCT01294683|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110399355|NCT01294683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110399356|NCT01294683|Vasodilator Agents|vasodilator agents|mesh-ancestor
110399357|NCT01294683|Vitamin B Complex|vitamin b complex|mesh-ancestor
110399358|NCT01294683|Vitamins|vitamins|mesh-ancestor
110399359|NCT01294683|Micronutrients|micronutrients|mesh-ancestor
110399360|NCT01294683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399362|NCT01294449|Dexamethasone|dexamethasone|mesh-list
110399363|NCT01294449|Methotrexate|methotrexate|mesh-list
110399364|NCT01294449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110399365|NCT01294449|Antimetabolites|antimetabolites|mesh-ancestor
110029906|NCT02817360|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110399366|NCT01294449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110399367|NCT01294449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110399368|NCT01294449|Antiviral Agents|antiviral agents|mesh-ancestor
110399369|NCT01294449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110399370|NCT01294449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110399371|NCT01294449|Immunologic Factors|immunologic factors|mesh-ancestor
110399372|NCT01294449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399373|NCT01294449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110399374|NCT01294449|Antiemetics|antiemetics|mesh-ancestor
110399375|NCT01294449|Autonomic Agents|autonomic agents|mesh-ancestor
110399376|NCT01294449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110399377|NCT01294449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110399378|NCT01294449|Glucocorticoids|glucocorticoids|mesh-ancestor
110399379|NCT01294449|Hormones|hormones|mesh-ancestor
110399380|NCT01294449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110399381|NCT01294449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110399382|NCT01294449|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110399383|NCT01294449|Abortifacient Agents|abortifacient agents|mesh-ancestor
110399384|NCT01294449|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110399385|NCT01294449|Dermatologic Agents|dermatologic agents|mesh-ancestor
110399386|NCT01294449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110399387|NCT01294449|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110399388|NCT01294449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110399389|NCT01294449|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110399391|NCT01293123|Emtricitabine|emtricitabine|mesh-list
110399392|NCT01293123|Efavirenz|efavirenz|mesh-list
110399393|NCT01293123|Raltegravir Potassium|raltegravir potassium|mesh-list
110399394|NCT01293123|Antiviral Agents|antiviral agents|mesh-ancestor
110399395|NCT01293123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110399396|NCT01293123|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110399397|NCT01293123|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110399398|NCT01293123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110399399|NCT01293123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110399400|NCT01293123|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110399401|NCT01293123|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110399402|NCT01293123|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110399403|NCT01293123|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110399404|NCT01293123|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110399405|NCT01293123|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110399406|NCT01293123|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110399407|NCT01293123|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110399408|NCT01293123|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110399409|NCT01293123|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110399410|NCT01292187|Calcitonin|calcitonin|mesh-list
110399411|NCT01292187|Salmon calcitonin|salmon calcitonin|mesh-list
110399412|NCT01292187|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
110399414|NCT01292187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110399415|NCT01292187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399416|NCT01292187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110399417|NCT01292187|Vasodilator Agents|vasodilator agents|mesh-ancestor
110399418|NCT01026493|Temozolomide|temozolomide|mesh-list
110399419|NCT01026493|Veliparib|veliparib|mesh-list
110399420|NCT01026493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110399421|NCT01026493|Alkylating Agents|alkylating agents|mesh-ancestor
110399422|NCT01026493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110399423|NCT01026493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110029920|NCT02743806|Vedolizumab|vedolizumab|mesh-list
110399424|NCT01026493|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110399425|NCT01026493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110399426|NCT01291173|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
110399427|NCT01291173|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110399428|NCT01291173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399429|NCT01291173|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110399430|NCT01291173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110399431|NCT01291173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110399432|NCT01291173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110399433|NCT01291173|Dopamine Agents|dopamine agents|mesh-ancestor
110399434|NCT01291173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110399435|NCT01291017|Palbociclib|palbociclib|mesh-list
110399436|NCT01291017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110399437|NCT01291017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110399438|NCT01291017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110399439|NCT01291017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110399440|NCT01290315|Dextrans|dextrans|mesh-list
110399441|NCT01290315|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
110399442|NCT01290315|Iron-Dextran Complex|iron-dextran complex|mesh-list
110399443|NCT01290315|Hematinics|hematinics|mesh-ancestor
110399444|NCT01290315|Anticoagulants|anticoagulants|mesh-ancestor
110399445|NCT01290315|Plasma Substitutes|plasma substitutes|mesh-ancestor
110399446|NCT01290315|Blood Substitutes|blood substitutes|mesh-ancestor
110399447|NCT01289847|gamma-Globulins|gamma-globulins|mesh-list
110053852|NCT01489059|Ipilimumab|ipilimumab|mesh-list
110399448|NCT01289847|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110399449|NCT01289847|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110399450|NCT01289847|Immunologic Factors|immunologic factors|mesh-ancestor
110399451|NCT01289847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399452|NCT01021813|Suvorexant|suvorexant|mesh-list
110399453|NCT01021813|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110399454|NCT01021813|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110399455|NCT01021813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110399456|NCT01021813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399457|NCT01021813|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
110399458|NCT01021813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110399459|NCT01021813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110399460|NCT01025635|Azelaic acid|azelaic acid|mesh-list
110399461|NCT01025635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110399462|NCT01025635|Dermatologic Agents|dermatologic agents|mesh-ancestor
110399464|NCT01021423|Immunologic Factors|immunologic factors|mesh-ancestor
110399465|NCT01021423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399466|NCT01021423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110399467|NCT01021423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110399468|NCT01021423|Growth Substances|growth substances|mesh-ancestor
110399469|NCT01021423|Growth Inhibitors|growth inhibitors|mesh-ancestor
110399470|NCT01021423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110399471|NCT01020877|Metronidazole|metronidazole|mesh-list
110399472|NCT01020877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110399473|NCT01020877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110399474|NCT01020877|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110399475|NCT01020877|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110399476|NCT01020799|Escitalopram|escitalopram|mesh-list
110399477|NCT01020799|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110399478|NCT01020799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110399479|NCT01020799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110399480|NCT01020799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110399481|NCT01020799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110399482|NCT01020799|Serotonin Agents|serotonin agents|mesh-ancestor
110399483|NCT01020799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399484|NCT02872597|Dexamethasone|dexamethasone|mesh-list
110399485|NCT02872597|Prednisone|prednisone|mesh-list
110399486|NCT02872597|Methylprednisolone|methylprednisolone|mesh-list
110399487|NCT02872597|Prednisolone|prednisolone|mesh-list
110399488|NCT02872597|Albuterol|albuterol|mesh-list
110399489|NCT02872597|Ipratropium|ipratropium|mesh-list
110399490|NCT02872597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110399491|NCT02872597|Antiemetics|antiemetics|mesh-ancestor
110399492|NCT02872597|Autonomic Agents|autonomic agents|mesh-ancestor
110399493|NCT02872597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110399494|NCT02872597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399495|NCT02872597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110399496|NCT02872597|Glucocorticoids|glucocorticoids|mesh-ancestor
110399497|NCT02872597|Hormones|hormones|mesh-ancestor
110399498|NCT02872597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110399499|NCT02872597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110399500|NCT02872597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110399501|NCT02872597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110399502|NCT02872597|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110399503|NCT02872597|Protective Agents|protective agents|mesh-ancestor
110399504|NCT02872597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110399505|NCT02872597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110399506|NCT02872597|Respiratory System Agents|respiratory system agents|mesh-ancestor
110399507|NCT02872597|Tocolytic Agents|tocolytic agents|mesh-ancestor
110399508|NCT02872597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110399509|NCT02872597|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110399510|NCT02872597|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110399511|NCT02872597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110399512|NCT02872597|Adrenergic Agents|adrenergic agents|mesh-ancestor
110399513|NCT02872597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110399514|NCT02872597|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110399515|NCT02872597|Cholinergic Agents|cholinergic agents|mesh-ancestor
110399516|NCT02873065|Amoxicillin|amoxicillin|mesh-list
110399517|NCT02873065|Clarithromycin|clarithromycin|mesh-list
110399518|NCT02873065|Potassium Citrate|potassium citrate|mesh-list
110399519|NCT02873065|Bismuth|bismuth|mesh-list
110399520|NCT02873065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110399521|NCT02873065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110399522|NCT02873065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110399523|NCT02873065|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110399524|NCT02873065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110399525|NCT02873065|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110399526|NCT02873065|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110399527|NCT02873065|Antacids|antacids|mesh-ancestor
110399528|NCT02873065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110399529|NCT02873065|Diuretics|diuretics|mesh-ancestor
110399530|NCT02873065|Natriuretic Agents|natriuretic agents|mesh-ancestor
110399531|NCT02873065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399532|NCT02873065|Expectorants|expectorants|mesh-ancestor
110399533|NCT02873065|Respiratory System Agents|respiratory system agents|mesh-ancestor
110399534|NCT00628225|Bupropion|bupropion|mesh-list
110399535|NCT00628225|Nicotine|nicotine|mesh-list
110399536|NCT00628225|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110399537|NCT00628225|Autonomic Agents|autonomic agents|mesh-ancestor
110399538|NCT00628225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110399539|NCT00628225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399540|NCT00628225|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110399541|NCT00628225|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110399542|NCT00628225|Cholinergic Agents|cholinergic agents|mesh-ancestor
110399543|NCT00628225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110399544|NCT00628225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110399545|NCT00628225|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110399546|NCT00628225|Antidepressive Agents|antidepressive agents|mesh-ancestor
110399547|NCT00628225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110399548|NCT00628225|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110399549|NCT00628225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110399550|NCT00628225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110399551|NCT00628225|Dopamine Agents|dopamine agents|mesh-ancestor
110399552|NCT00628225|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110399553|NCT00628225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110399554|NCT00628225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110399555|NCT01014013|Ceftriaxone|ceftriaxone|mesh-list
110399556|NCT01014013|Ertapenem|ertapenem|mesh-list
110399557|NCT01014013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110399558|NCT01014013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110399559|NCT01013701|Fluticasone|fluticasone|mesh-list
110399560|NCT01013701|Xhance|xhance|mesh-list
110399561|NCT01013701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110399562|NCT01013701|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110399563|NCT01013701|Autonomic Agents|autonomic agents|mesh-ancestor
110399564|NCT01013701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110399565|NCT01013701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399566|NCT01013701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110399567|NCT01013701|Respiratory System Agents|respiratory system agents|mesh-ancestor
110399568|NCT01013701|Dermatologic Agents|dermatologic agents|mesh-ancestor
110399569|NCT01013701|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110399570|NCT01020019|Lofexidine|lofexidine|mesh-list
110399571|NCT01020019|Dronabinol|dronabinol|mesh-list
110399572|NCT01020019|Hallucinogens|hallucinogens|mesh-ancestor
110399573|NCT01020019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399574|NCT01020019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110399575|NCT01020019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110399576|NCT01020019|Analgesics|analgesics|mesh-ancestor
110399577|NCT01020019|Sensory System Agents|sensory system agents|mesh-ancestor
110399578|NCT01020019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110399579|NCT01020019|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110399580|NCT01020019|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110399581|NCT01020019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110399582|NCT01020019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110399583|NCT01020019|Hormones|hormones|mesh-ancestor
110399584|NCT01020019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110399585|NCT01020019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110399586|NCT01020019|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110399587|NCT01020019|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110399588|NCT01020019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110399590|NCT01020019|Adrenergic Agents|adrenergic agents|mesh-ancestor
110399591|NCT00627835|Cisplatin|cisplatin|mesh-list
110399592|NCT00627835|Sorafenib|sorafenib|mesh-list
110399593|NCT00627835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110399594|NCT00627835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110399595|NCT00627835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110399596|NCT00627835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110399597|NCT01019317|Cytarabine|cytarabine|mesh-list
110399599|NCT01019317|Fludarabine phosphate|fludarabine phosphate|mesh-list
110399600|NCT01019317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110399601|NCT01019317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110399602|NCT01019317|Antimetabolites|antimetabolites|mesh-ancestor
110399603|NCT01019317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110399604|NCT01019317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110399605|NCT01019317|Immunologic Factors|immunologic factors|mesh-ancestor
110399606|NCT01019317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399607|NCT01019317|Antiviral Agents|antiviral agents|mesh-ancestor
110399608|NCT01019317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110399609|NCT02877238|Sevoflurane|sevoflurane|mesh-list
110399610|NCT02877238|Anesthetics|anesthetics|mesh-ancestor
110399611|NCT02877238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110399612|NCT02877238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399613|NCT02877238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110399614|NCT02877238|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110399615|NCT02877238|Anesthetics, General|anesthetics, general|mesh-ancestor
110399616|NCT01288911|Bicalutamide|bicalutamide|mesh-list
110399617|NCT01288911|Androgen Antagonists|androgen antagonists|mesh-ancestor
110399618|NCT01288911|Hormone Antagonists|hormone antagonists|mesh-ancestor
110399619|NCT01288911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110399620|NCT01288911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399621|NCT01288911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110399622|NCT01288443|Atorvastatin|atorvastatin|mesh-list
110399623|NCT01288443|Alirocumab|alirocumab|mesh-list
110399624|NCT01288443|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110399625|NCT01288443|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110399626|NCT01288443|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110399627|NCT01288443|Antimetabolites|antimetabolites|mesh-ancestor
110399628|NCT01288443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110399629|NCT01288443|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110399630|NCT01288443|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110399631|NCT01288443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110399633|NCT01288443|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110399634|NCT01288443|Protease Inhibitors|protease inhibitors|mesh-ancestor
110399635|NCT01288443|Immunologic Factors|immunologic factors|mesh-ancestor
110399636|NCT01288443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399637|NCT01288209|Ribavirin|ribavirin|mesh-list
110399638|NCT01288209|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110399639|NCT01288209|Simeprevir|simeprevir|mesh-list
110399640|NCT01288209|Antimetabolites|antimetabolites|mesh-ancestor
110399641|NCT01288209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110399642|NCT01288209|Antiviral Agents|antiviral agents|mesh-ancestor
110399643|NCT01288209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110399644|NCT01288209|Protease Inhibitors|protease inhibitors|mesh-ancestor
110399645|NCT01288209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110399647|NCT01287195|Muromonab-CD3|muromonab-cd3|mesh-list
110399648|NCT01287195|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110399649|NCT01287195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110399650|NCT01287195|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110399651|NCT01287195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110399652|NCT01287195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110399653|NCT01287195|Immunologic Factors|immunologic factors|mesh-ancestor
110399654|NCT01287195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399655|NCT01287195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110399657|NCT01287117|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110399658|NCT01287117|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110399659|NCT01287117|Respiratory System Agents|respiratory system agents|mesh-ancestor
110399660|NCT01287039|Reslizumab|reslizumab|mesh-list
110399661|NCT01287039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110399662|NCT01287039|Respiratory System Agents|respiratory system agents|mesh-ancestor
110399663|NCT05572203|Caseins|caseins|mesh-list
110399664|NCT05572203|Chelating Agents|chelating agents|mesh-ancestor
110399665|NCT05572203|Sequestering Agents|sequestering agents|mesh-ancestor
110399666|NCT05572203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110399667|NCT01285401|Interferons|interferons|mesh-list
110399668|NCT01285401|Interferon-beta|interferon-beta|mesh-list
110399669|NCT01285401|Interferon beta-1a|interferon beta-1a|mesh-list
110399670|NCT01285401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110399671|NCT01285401|Antiviral Agents|antiviral agents|mesh-ancestor
110399672|NCT01285401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110399673|NCT01285401|Immunologic Factors|immunologic factors|mesh-ancestor
110399674|NCT01285401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399675|NCT01285401|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110399676|NCT01285323|Reslizumab|reslizumab|mesh-list
110399677|NCT01285323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110399678|NCT01285323|Respiratory System Agents|respiratory system agents|mesh-ancestor
110399679|NCT01284621|Empagliflozin|empagliflozin|mesh-list
110399680|NCT01284621|Ramipril|ramipril|mesh-list
110399681|NCT01284621|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110399682|NCT01284621|Protease Inhibitors|protease inhibitors|mesh-ancestor
110399683|NCT01284621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110399684|NCT01284621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110399685|NCT01284621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110399686|NCT01284621|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110399687|NCT01284621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110399688|NCT01284621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399689|NCT01283139|Sifalimumab|sifalimumab|mesh-list
110399690|NCT01283139|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110399691|NCT01283139|Immunologic Factors|immunologic factors|mesh-ancestor
110399692|NCT01283139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399693|NCT01281969|Immunoglobulins|immunoglobulins|mesh-list
110399694|NCT01281969|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110399695|NCT01281969|Antibodies|antibodies|mesh-list
110399696|NCT01281969|gamma-Globulins|gamma-globulins|mesh-list
110399697|NCT01281969|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110399698|NCT01281969|Immunologic Factors|immunologic factors|mesh-ancestor
110399699|NCT01281969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399700|NCT01281813|Ritonavir|ritonavir|mesh-list
110399701|NCT01281813|Darunavir|darunavir|mesh-list
110399703|NCT01281813|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110399704|NCT01281813|Protease Inhibitors|protease inhibitors|mesh-ancestor
110399705|NCT01281813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110399706|NCT01281813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110399707|NCT01281813|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110399708|NCT01281813|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110399709|NCT01281813|Antiviral Agents|antiviral agents|mesh-ancestor
110399710|NCT01281813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110399711|NCT01281813|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110399712|NCT01281813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110399713|NCT01090414|Idelalisib|idelalisib|mesh-list
110399714|NCT01090414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110399715|NCT01090414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110399716|NCT01090414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110399717|NCT01090102|Aminosalicylic Acid|aminosalicylic acid|mesh-list
110399718|NCT01090102|Mesalamine|mesalamine|mesh-list
110399719|NCT01090102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110399720|NCT01090102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110399721|NCT01090102|Analgesics|analgesics|mesh-ancestor
110399722|NCT01090102|Sensory System Agents|sensory system agents|mesh-ancestor
110399723|NCT01090102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110399724|NCT01090102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399725|NCT01090102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110399726|NCT01090102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110399727|NCT01090102|Antitubercular Agents|antitubercular agents|mesh-ancestor
110399728|NCT01090102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110399729|NCT01090102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110399730|NCT01281189|Pramipexole|pramipexole|mesh-list
110399731|NCT01281189|Antioxidants|antioxidants|mesh-ancestor
110399732|NCT01281189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110399733|NCT01281189|Protective Agents|protective agents|mesh-ancestor
110399734|NCT01281189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399735|NCT01281189|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110399736|NCT01281189|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110399737|NCT01281189|Dopamine Agonists|dopamine agonists|mesh-ancestor
110399738|NCT01281189|Dopamine Agents|dopamine agents|mesh-ancestor
110399739|NCT01281189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110399740|NCT04306666|Anesthetics|anesthetics|mesh-list
110399741|NCT04306666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110399742|NCT04306666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399743|NCT01280955|Plerixafor|plerixafor|mesh-list
110399744|NCT01280955|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110399745|NCT01280955|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110399746|NCT01280955|Antiviral Agents|antiviral agents|mesh-ancestor
110399747|NCT01280955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110399748|NCT01280721|Tolvaptan|tolvaptan|mesh-list
110054145|NCT01490203|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110399749|NCT01280721|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110399750|NCT01280721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110399751|NCT01280721|Natriuretic Agents|natriuretic agents|mesh-ancestor
110399752|NCT01280721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399753|NCT01087762|Certolizumab Pegol|certolizumab pegol|mesh-list
110399754|NCT01087762|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110399755|NCT01087762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110399757|NCT01087762|Immunologic Factors|immunologic factors|mesh-ancestor
110399758|NCT01087762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399759|NCT01087762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110399760|NCT04306354|Oxytocin|oxytocin|mesh-list
110399761|NCT04306354|Oxytocics|oxytocics|mesh-ancestor
110399762|NCT04306354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110399763|NCT04306354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399764|NCT04306276|Dienogest|dienogest|mesh-list
110399765|NCT04306276|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110399766|NCT04306276|Contraceptive Agents|contraceptive agents|mesh-ancestor
110399767|NCT04306276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110399768|NCT04306276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399769|NCT04306276|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110399770|NCT04306276|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110399771|NCT04306276|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110399772|NCT04306276|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110399773|NCT04306276|Hormone Antagonists|hormone antagonists|mesh-ancestor
110399774|NCT04306276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110399775|NCT04306276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110399776|NCT04306276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110399777|NCT01078168|Acitretin|acitretin|mesh-list
110399778|NCT01078168|Keratolytic Agents|keratolytic agents|mesh-ancestor
110399779|NCT01078168|Dermatologic Agents|dermatologic agents|mesh-ancestor
110399780|NCT01086358|Naproxen|naproxen|mesh-list
110399781|NCT01086358|Sumatriptan|sumatriptan|mesh-list
110399782|NCT01086358|Naratriptan|naratriptan|mesh-list
110399783|NCT01086358|Zolmitriptan|zolmitriptan|mesh-list
110399784|NCT01086358|Rizatriptan|rizatriptan|mesh-list
110399785|NCT01086358|Eletriptan|eletriptan|mesh-list
110399786|NCT01086358|Almotriptan|almotriptan|mesh-list
110399787|NCT01086358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110399788|NCT01086358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110399789|NCT01086358|Analgesics|analgesics|mesh-ancestor
110399790|NCT01086358|Sensory System Agents|sensory system agents|mesh-ancestor
110399791|NCT01086358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110399792|NCT01086358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399793|NCT01086358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110399794|NCT01086358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110399795|NCT01086358|Gout Suppressants|gout suppressants|mesh-ancestor
110399796|NCT01086358|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110399797|NCT01086358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110399798|NCT01086358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110399799|NCT01086358|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110399800|NCT01086358|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110399801|NCT01086358|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110399802|NCT01086358|Serotonin Agents|serotonin agents|mesh-ancestor
110399803|NCT01086358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110399804|NCT01277601|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110399805|NCT01277601|Antiviral Agents|antiviral agents|mesh-ancestor
110399806|NCT01277601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110399807|NCT01277523|Tiotropium Bromide|tiotropium bromide|mesh-list
110399808|NCT01277523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110399809|NCT01277523|Autonomic Agents|autonomic agents|mesh-ancestor
110399810|NCT01277523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110399811|NCT01277523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399812|NCT01277523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110399813|NCT01277523|Respiratory System Agents|respiratory system agents|mesh-ancestor
110399814|NCT01277523|Parasympatholytics|parasympatholytics|mesh-ancestor
110399815|NCT01277523|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110399816|NCT01277523|Cholinergic Agents|cholinergic agents|mesh-ancestor
110399817|NCT01277523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110399818|NCT01277523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110399820|NCT01081834|Canagliflozin|canagliflozin|mesh-list
110399821|NCT01081834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110399822|NCT01081834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399823|NCT01081834|Incretins|incretins|mesh-ancestor
110399824|NCT01081834|Hormones|hormones|mesh-ancestor
110399825|NCT01081834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110399826|NCT01081834|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110399827|NCT01081834|Protease Inhibitors|protease inhibitors|mesh-ancestor
110399828|NCT01081834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110399829|NCT01081834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110399830|NCT01081834|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110399831|NCT01079962|Atenolol|atenolol|mesh-list
110399832|NCT01079962|Bisoprolol|bisoprolol|mesh-list
110399833|NCT01079962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110399834|NCT01079962|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110399835|NCT01079962|Sympatholytics|sympatholytics|mesh-ancestor
110399836|NCT01079962|Autonomic Agents|autonomic agents|mesh-ancestor
110399837|NCT01079962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110399838|NCT01079962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399839|NCT01079962|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110399840|NCT01079962|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110399841|NCT01079962|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110399842|NCT01079962|Adrenergic Agents|adrenergic agents|mesh-ancestor
110399843|NCT01079962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110399844|NCT01079962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110399845|NCT01274637|Dalteparin|dalteparin|mesh-list
110399846|NCT01274637|Tinzaparin|tinzaparin|mesh-list
110399847|NCT01274637|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110399848|NCT01274637|Anticoagulants|anticoagulants|mesh-ancestor
110399849|NCT01274637|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110399850|NCT01274637|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110399851|NCT01274637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110399852|NCT01079806|Entecavir|entecavir|mesh-list
110399853|NCT01079806|Antiviral Agents|antiviral agents|mesh-ancestor
110399854|NCT01079806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110399855|NCT02876770|Melatonin|melatonin|mesh-list
110399856|NCT02876770|Antioxidants|antioxidants|mesh-ancestor
110399857|NCT02876770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110399858|NCT02876770|Protective Agents|protective agents|mesh-ancestor
110399859|NCT02876770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399860|NCT02876770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110399861|NCT01077622|Ofatumumab|ofatumumab|mesh-list
110399862|NCT01077622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110399863|NCT01313676|Fluticasone|fluticasone|mesh-list
110399864|NCT01313676|Xhance|xhance|mesh-list
110399865|NCT01313676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110399867|NCT01313676|Autonomic Agents|autonomic agents|mesh-ancestor
110399868|NCT01313676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110399869|NCT01313676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399870|NCT01313676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110399871|NCT01313676|Respiratory System Agents|respiratory system agents|mesh-ancestor
110399872|NCT01313676|Dermatologic Agents|dermatologic agents|mesh-ancestor
110399873|NCT01313676|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110030056|NCT01992653|Hormones|hormones|mesh-ancestor
110030061|NCT01850303|Pemetrexed|pemetrexed|mesh-list
110399874|NCT00623376|Dronabinol|dronabinol|mesh-list
110399875|NCT00623376|Nabilone|nabilone|mesh-list
110399876|NCT00623376|Antiemetics|antiemetics|mesh-ancestor
110399877|NCT00623376|Autonomic Agents|autonomic agents|mesh-ancestor
110399878|NCT00623376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110399879|NCT00623376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399880|NCT00623376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110399881|NCT00623376|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110399882|NCT00623376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110399883|NCT00623376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110399884|NCT00623376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110399885|NCT00623376|Hallucinogens|hallucinogens|mesh-ancestor
110399886|NCT00623376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110399887|NCT00623376|Analgesics|analgesics|mesh-ancestor
110399888|NCT00623376|Sensory System Agents|sensory system agents|mesh-ancestor
110399889|NCT00623376|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110399890|NCT00623376|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110399891|NCT00623376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110399892|NCT00623376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110399893|NCT00623376|Hormones|hormones|mesh-ancestor
110399894|NCT00623376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110399896|NCT01313286|Enzyme Activators|enzyme activators|mesh-ancestor
110399897|NCT01313286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110399898|NCT01313208|Etanercept|etanercept|mesh-list
110399899|NCT01313208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110399900|NCT01313208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110399901|NCT01313208|Analgesics|analgesics|mesh-ancestor
110399902|NCT01313208|Sensory System Agents|sensory system agents|mesh-ancestor
110399903|NCT01313208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110399904|NCT01313208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399905|NCT01313208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110399906|NCT01313208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110399907|NCT01313208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110399908|NCT01313208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110399909|NCT01313208|Immunologic Factors|immunologic factors|mesh-ancestor
110399910|NCT01075984|Posaconazole|posaconazole|mesh-list
110399911|NCT01075984|Antifungal Agents|antifungal agents|mesh-ancestor
110399912|NCT01075984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110399913|NCT01075984|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110399914|NCT01075984|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110399915|NCT01075984|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110399916|NCT01075984|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110399917|NCT01075984|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110399918|NCT01075984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110399919|NCT01075984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110399920|NCT01075984|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110399921|NCT01075984|Hormone Antagonists|hormone antagonists|mesh-ancestor
110399922|NCT01075984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110399923|NCT01075984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399924|NCT01024231|Nivolumab|nivolumab|mesh-list
110399925|NCT01024231|Ipilimumab|ipilimumab|mesh-list
110399926|NCT01024231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110030072|NCT01763671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110399927|NCT01024231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110399928|NCT01024231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110399929|NCT01024231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110399930|NCT01012999|Sufentanil|sufentanil|mesh-list
110399931|NCT01012999|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110399932|NCT01012999|Narcotics|narcotics|mesh-ancestor
110399933|NCT01012999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110399934|NCT01012999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399935|NCT01012999|Analgesics|analgesics|mesh-ancestor
110399936|NCT01012999|Sensory System Agents|sensory system agents|mesh-ancestor
110399937|NCT01012999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110399938|NCT01012999|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110399939|NCT01012999|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110399940|NCT01012999|Anesthetics, General|anesthetics, general|mesh-ancestor
110399941|NCT01012999|Anesthetics|anesthetics|mesh-ancestor
110399942|NCT00637663|Lamivudine|lamivudine|mesh-list
110399943|NCT00637663|Entecavir|entecavir|mesh-list
110399944|NCT00637663|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110399945|NCT00637663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110399946|NCT00637663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110399947|NCT00637663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110399948|NCT00637663|Antiviral Agents|antiviral agents|mesh-ancestor
110399949|NCT00637663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110399950|NCT00637663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110399951|NCT00637663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110399952|NCT01016977|Nicotinic Acids|nicotinic acids|mesh-list
110399953|NCT01016977|Clindamycin|clindamycin|mesh-list
110399954|NCT01016977|Clindamycin palmitate|clindamycin palmitate|mesh-list
110399955|NCT01016977|Clindamycin phosphate|clindamycin phosphate|mesh-list
110399956|NCT01016977|Benzoyl Peroxide|benzoyl peroxide|mesh-list
110399957|NCT01016977|Tazarotene|tazarotene|mesh-list
110399958|NCT01016977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110399959|NCT01016977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110399960|NCT01016977|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110399961|NCT01016977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110399962|NCT01016977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110399963|NCT01016977|Dermatologic Agents|dermatologic agents|mesh-ancestor
110399964|NCT01016977|Keratolytic Agents|keratolytic agents|mesh-ancestor
110399965|NCT01016977|Vitamin B Complex|vitamin b complex|mesh-ancestor
110399966|NCT01016977|Vitamins|vitamins|mesh-ancestor
110399967|NCT01016977|Micronutrients|micronutrients|mesh-ancestor
110399968|NCT01016977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399969|NCT02871661|Amitriptyline|amitriptyline|mesh-list
110399970|NCT02871661|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110399971|NCT02871661|Antidepressive Agents|antidepressive agents|mesh-ancestor
110399972|NCT02871661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110399973|NCT02871661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110399974|NCT02871661|Analgesics|analgesics|mesh-ancestor
110399975|NCT02871661|Sensory System Agents|sensory system agents|mesh-ancestor
110399976|NCT02871661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110399977|NCT02871661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399978|NCT02871661|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110399979|NCT02871661|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110399980|NCT02871661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110399981|NCT02871661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110399982|NCT02871661|Adrenergic Agents|adrenergic agents|mesh-ancestor
110399983|NCT02871661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110399984|NCT01012765|Tiotropium Bromide|tiotropium bromide|mesh-list
110399985|NCT01012765|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110399986|NCT01012765|Autonomic Agents|autonomic agents|mesh-ancestor
110399987|NCT01012765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110399988|NCT01012765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399989|NCT01012765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110030092|NCT01681264|Guanfacine|guanfacine|mesh-list
110399990|NCT01012765|Respiratory System Agents|respiratory system agents|mesh-ancestor
110399991|NCT01012765|Parasympatholytics|parasympatholytics|mesh-ancestor
110399992|NCT01012765|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110399993|NCT01012765|Cholinergic Agents|cholinergic agents|mesh-ancestor
110399994|NCT01012765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110399995|NCT01012765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110399996|NCT00628459|Micronutrients|micronutrients|mesh-list
110399997|NCT00628459|Trace Elements|trace elements|mesh-list
110399998|NCT00628459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399999|NCT00627913|Anesthetics|anesthetics|mesh-list
110400000|NCT00627913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110400001|NCT00627913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400002|NCT00627991|Valsartan|valsartan|mesh-list
110400003|NCT00627991|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110400004|NCT00627991|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110400005|NCT00627991|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110400006|NCT00627991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110400007|NCT01006291|Insulin|insulin|mesh-list
110400008|NCT01006291|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110400009|NCT01006291|Insulin Glargine|insulin glargine|mesh-list
110400010|NCT01006291|Insulin, Long-Acting|insulin, long-acting|mesh-list
110400011|NCT01006291|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110400012|NCT01006291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400013|NCT04296175|Paclitaxel|paclitaxel|mesh-list
110400014|NCT04296175|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110400015|NCT04296175|Carboplatin|carboplatin|mesh-list
110400016|NCT04296175|Epirubicin|epirubicin|mesh-list
110400017|NCT04296175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110400018|NCT04296175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110400019|NCT04296175|Tubulin Modulators|tubulin modulators|mesh-ancestor
110400020|NCT04296175|Antimitotic Agents|antimitotic agents|mesh-ancestor
110400021|NCT04296175|Mitosis Modulators|mitosis modulators|mesh-ancestor
110400022|NCT04296175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110400023|NCT04296175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110400024|NCT04296175|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110400025|NCT04296175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110400026|NCT04296175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110400027|NCT02871349|Propranolol|propranolol|mesh-list
110400028|NCT02871349|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110400029|NCT02871349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110400030|NCT02871349|Adrenergic Agents|adrenergic agents|mesh-ancestor
110400031|NCT02871349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110400032|NCT02871349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110400033|NCT02871349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400034|NCT02871349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110400035|NCT02871349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110400036|NCT02871349|Vasodilator Agents|vasodilator agents|mesh-ancestor
110400037|NCT01012609|Irinotecan|irinotecan|mesh-list
110400038|NCT01012609|Cetuximab|cetuximab|mesh-list
110400039|NCT01012609|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110400040|NCT01012609|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110400041|NCT01012609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110400042|NCT01012609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110400043|NCT01012609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110400044|NCT01012609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110400045|NCT04297501|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110400046|NCT04297501|Antiviral Agents|antiviral agents|mesh-ancestor
110400047|NCT04297501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110400048|NCT01012219|Aspirin|aspirin|mesh-list
110400049|NCT01012219|Niacin|niacin|mesh-list
110400050|NCT01012219|Clopidogrel|clopidogrel|mesh-list
110400051|NCT01012219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110054442|NCT01491711|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
110400052|NCT01012219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110400054|NCT01012219|Sensory System Agents|sensory system agents|mesh-ancestor
110400055|NCT01012219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110400056|NCT01012219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400057|NCT01012219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110400058|NCT01012219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110400059|NCT01012219|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110400060|NCT01012219|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110400061|NCT01012219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110400062|NCT01012219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110400063|NCT01012219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110400065|NCT01012219|Antipyretics|antipyretics|mesh-ancestor
110400066|NCT01012219|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110400067|NCT01012219|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110400068|NCT01012219|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110400069|NCT01012219|Purinergic Agents|purinergic agents|mesh-ancestor
110400070|NCT01012219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110400071|NCT01012219|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110400072|NCT01012219|Antimetabolites|antimetabolites|mesh-ancestor
110400073|NCT01012219|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110400074|NCT01012219|Vasodilator Agents|vasodilator agents|mesh-ancestor
110400075|NCT01012219|Vitamin B Complex|vitamin b complex|mesh-ancestor
110400076|NCT01012219|Vitamins|vitamins|mesh-ancestor
110400077|NCT01012219|Micronutrients|micronutrients|mesh-ancestor
110400078|NCT01011907|Varenicline|varenicline|mesh-list
110400079|NCT01011907|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110400080|NCT01011907|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110400081|NCT01011907|Cholinergic Agents|cholinergic agents|mesh-ancestor
110400082|NCT01011907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110400083|NCT01011907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110400084|NCT01011907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400085|NCT01011673|Ketorolac|ketorolac|mesh-list
110400086|NCT01011673|Metoclopramide|metoclopramide|mesh-list
110400087|NCT01011673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110400088|NCT01011673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110400090|NCT01011673|Sensory System Agents|sensory system agents|mesh-ancestor
110400091|NCT01011673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110400092|NCT01011673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400093|NCT01011673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110400094|NCT01011673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110400095|NCT01011673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110400096|NCT01011673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110400097|NCT01011673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110400098|NCT01011673|Antiemetics|antiemetics|mesh-ancestor
110400099|NCT01011673|Autonomic Agents|autonomic agents|mesh-ancestor
110400100|NCT01011673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110400101|NCT01011673|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110400102|NCT01011673|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110400103|NCT01011673|Dopamine Agents|dopamine agents|mesh-ancestor
110400104|NCT01011673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110400105|NCT01311648|Factor VIII|factor viii|mesh-list
110400106|NCT01311648|Coagulants|coagulants|mesh-ancestor
110400107|NCT01011439|Maleic acid|maleic acid|mesh-list
110400108|NCT01011439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110400109|NCT01011439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110400110|NCT04406857|Capecitabine|capecitabine|mesh-list
110400111|NCT04406857|Ropidoxuridine|ropidoxuridine|mesh-list
110400112|NCT04406857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110400113|NCT04406857|Antimetabolites|antimetabolites|mesh-ancestor
110400114|NCT04406857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110400115|NCT04406857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110400117|NCT01311024|Immunologic Factors|immunologic factors|mesh-ancestor
110400118|NCT01311024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400119|NCT02871193|Dexamethasone|dexamethasone|mesh-list
110400120|NCT02871193|Ropivacaine|ropivacaine|mesh-list
110400121|NCT02871193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110400122|NCT02871193|Antiemetics|antiemetics|mesh-ancestor
110400123|NCT02871193|Autonomic Agents|autonomic agents|mesh-ancestor
110400125|NCT02871193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400126|NCT02871193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110400127|NCT02871193|Glucocorticoids|glucocorticoids|mesh-ancestor
110400128|NCT02871193|Hormones|hormones|mesh-ancestor
110400129|NCT02871193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110400130|NCT02871193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110400131|NCT02871193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110400132|NCT02871193|Anesthetics, Local|anesthetics, local|mesh-ancestor
110400134|NCT02871193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110400135|NCT02871193|Sensory System Agents|sensory system agents|mesh-ancestor
110400136|NCT01310868|Carmustine|carmustine|mesh-list
110400137|NCT01310868|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110400138|NCT01310868|Levulinic acid|levulinic acid|mesh-list
110400139|NCT01310868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110400140|NCT01310868|Alkylating Agents|alkylating agents|mesh-ancestor
110400141|NCT01310868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110400142|NCT01310868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110400143|NCT01310868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110400144|NCT01310868|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110400145|NCT01310868|Dermatologic Agents|dermatologic agents|mesh-ancestor
110400146|NCT01273155|Belinostat|belinostat|mesh-list
110400147|NCT01273155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110400148|NCT01273155|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110400149|NCT01273155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110400150|NCT01273155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110400151|NCT05557851|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
110400152|NCT05557851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110400153|NCT05557851|Alkylating Agents|alkylating agents|mesh-ancestor
110400154|NCT05557851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110400155|NCT05557851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110400156|NCT01005901|Glycopyrrolate|glycopyrrolate|mesh-list
110400157|NCT01005901|Bromides|bromides|mesh-list
110400158|NCT01005901|Anticonvulsants|anticonvulsants|mesh-ancestor
110400159|NCT01005901|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110400160|NCT01005901|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110400161|NCT01005901|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110400162|NCT01005901|Cholinergic Agents|cholinergic agents|mesh-ancestor
110400164|NCT01005901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110400165|NCT01005901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400166|NCT02889549|Clopidogrel|clopidogrel|mesh-list
110400168|NCT02889549|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110400169|NCT02889549|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110400170|NCT02889549|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110400171|NCT02889549|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110400173|NCT02889549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110400174|NCT02889549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110400175|NCT02889549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400176|NCT05549037|Immunomodulating Agents|immunomodulating agents|mesh-list
110400177|NCT05549037|Immunologic Factors|immunologic factors|mesh-ancestor
110400178|NCT05549037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400179|NCT01309386|Morphine|morphine|mesh-list
110400180|NCT01309386|Tapentadol|tapentadol|mesh-list
110400181|NCT01309386|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110400182|NCT01309386|Narcotics|narcotics|mesh-ancestor
110400183|NCT01309386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110400184|NCT01309386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400185|NCT01309386|Analgesics|analgesics|mesh-ancestor
110400186|NCT01309386|Sensory System Agents|sensory system agents|mesh-ancestor
110400187|NCT01309386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110400188|NCT01309386|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110400189|NCT01309386|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110400190|NCT01309386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110400191|NCT01309386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110400192|NCT01309386|Adrenergic Agents|adrenergic agents|mesh-ancestor
110400193|NCT01309386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110400195|NCT04295317|Antibodies|antibodies|mesh-list
110400196|NCT04295317|Antibodies, Blocking|antibodies, blocking|mesh-list
110400197|NCT04295317|Immunologic Factors|immunologic factors|mesh-ancestor
110400198|NCT04295317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400199|NCT04295317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110400200|NCT04295317|Antimetabolites|antimetabolites|mesh-ancestor
110054609|NCT01493115|Insulin|insulin|mesh-list
110400201|NCT04295317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110400202|NCT04295317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110400203|NCT01266603|Aldesleukin|aldesleukin|mesh-list
110400204|NCT01266603|Interleukin-2|interleukin-2|mesh-list
110400205|NCT01266603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110400206|NCT01266603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110400207|NCT01266603|Analgesics|analgesics|mesh-ancestor
110400208|NCT01266603|Sensory System Agents|sensory system agents|mesh-ancestor
110400209|NCT01266603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110400210|NCT01266603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400211|NCT01266603|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110400212|NCT01266603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110400213|NCT01266603|Antiviral Agents|antiviral agents|mesh-ancestor
110400214|NCT01266603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110400215|NCT04295551|Ritonavir|ritonavir|mesh-list
110400216|NCT04295551|Lopinavir|lopinavir|mesh-list
110400217|NCT04295551|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110400218|NCT04295551|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110400219|NCT04295551|Protease Inhibitors|protease inhibitors|mesh-ancestor
110400220|NCT04295551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110400221|NCT04295551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110400222|NCT04295551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110400223|NCT04295551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110400224|NCT04295551|Antiviral Agents|antiviral agents|mesh-ancestor
110400225|NCT04295551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110400226|NCT04295551|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110400227|NCT04295551|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110400228|NCT01266291|Vigabatrin|vigabatrin|mesh-list
110400229|NCT01266291|Anticonvulsants|anticonvulsants|mesh-ancestor
110400230|NCT01266291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110400231|NCT01266291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110400232|NCT01266291|GABA Agents|gaba agents|mesh-ancestor
110400233|NCT01266291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110400234|NCT01266291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400235|NCT01004263|Rizatriptan|rizatriptan|mesh-list
110400236|NCT01004263|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110400237|NCT01004263|Serotonin Agents|serotonin agents|mesh-ancestor
110400238|NCT01004263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110400239|NCT01004263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110400240|NCT01004263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400241|NCT01265823|Adalimumab|adalimumab|mesh-list
110400242|NCT01265823|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110400243|NCT01265823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110400244|NCT01265823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110400245|NCT01004185|Aminosalicylic Acid|aminosalicylic acid|mesh-list
110400246|NCT01004185|Mesalamine|mesalamine|mesh-list
110400247|NCT01004185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110400248|NCT01004185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110400249|NCT01004185|Analgesics|analgesics|mesh-ancestor
110400250|NCT01004185|Sensory System Agents|sensory system agents|mesh-ancestor
110400251|NCT01004185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110400252|NCT01004185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400253|NCT01004185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110400254|NCT01004185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110400255|NCT01004185|Antitubercular Agents|antitubercular agents|mesh-ancestor
110400256|NCT01004185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110400257|NCT01004185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110400258|NCT01265511|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110400259|NCT01265511|Antiviral Agents|antiviral agents|mesh-ancestor
110400260|NCT01265511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110400261|NCT01264965|Acetaminophen|acetaminophen|mesh-list
110400262|NCT01264965|Oxycodone|oxycodone|mesh-list
110400263|NCT01264965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110400265|NCT01264965|Sensory System Agents|sensory system agents|mesh-ancestor
110400266|NCT01264965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110400267|NCT01264965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400268|NCT01264965|Antipyretics|antipyretics|mesh-ancestor
110400269|NCT01264965|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110400270|NCT01264965|Narcotics|narcotics|mesh-ancestor
110400271|NCT01264965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110400272|NCT01264887|Tapentadol|tapentadol|mesh-list
110400273|NCT01264887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110400274|NCT01264887|Narcotics|narcotics|mesh-ancestor
110400275|NCT01264887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110400276|NCT01264887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400279|NCT01264887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110400280|NCT01264887|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110400281|NCT01264887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110400282|NCT01264887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110400283|NCT01264887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110400284|NCT01264887|Adrenergic Agents|adrenergic agents|mesh-ancestor
110400285|NCT01264887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110400286|NCT01011283|Azacitidine|azacitidine|mesh-list
110400287|NCT01011283|Decitabine|decitabine|mesh-list
110400288|NCT01011283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110400289|NCT01011283|Antimetabolites|antimetabolites|mesh-ancestor
110400290|NCT01011283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110400291|NCT01011283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110400292|NCT01011283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110400293|NCT01263483|Inositol|inositol|mesh-list
110400294|NCT01263483|Alogliptin|alogliptin|mesh-list
110400295|NCT01263483|Voglibose|voglibose|mesh-list
110400296|NCT01263483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110400297|NCT01263483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400298|NCT01263483|Incretins|incretins|mesh-ancestor
110400299|NCT01263483|Hormones|hormones|mesh-ancestor
110400300|NCT01263483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110400301|NCT01263483|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110400302|NCT01263483|Protease Inhibitors|protease inhibitors|mesh-ancestor
110400303|NCT01263483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110400304|NCT01263483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110400305|NCT01263483|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110400306|NCT01263483|Vitamin B Complex|vitamin b complex|mesh-ancestor
110400307|NCT01263483|Vitamins|vitamins|mesh-ancestor
110400308|NCT01263483|Micronutrients|micronutrients|mesh-ancestor
110400309|NCT01011049|Vaccines|vaccines|mesh-list
110400310|NCT01011049|Immunologic Factors|immunologic factors|mesh-ancestor
110400311|NCT01011049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400312|NCT01263093|Clopidogrel|clopidogrel|mesh-list
110400313|NCT01263093|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110400314|NCT01263093|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110400315|NCT01263093|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110400316|NCT01263093|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110400317|NCT01263093|Purinergic Agents|purinergic agents|mesh-ancestor
110400318|NCT01263093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110400319|NCT01263093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110400320|NCT01263093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400321|NCT01010971|Ciclesonide|ciclesonide|mesh-list
110400322|NCT01010971|Glucocorticoids|glucocorticoids|mesh-ancestor
110400323|NCT01010971|Hormones|hormones|mesh-ancestor
110400324|NCT01010971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110400325|NCT01010971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400326|NCT01010971|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110400327|NCT01306656|Vitamin D|vitamin d|mesh-list
110400328|NCT01306656|Ergocalciferols|ergocalciferols|mesh-list
110400329|NCT01306656|Cholecalciferol|cholecalciferol|mesh-list
110400330|NCT01306656|Vitamins|vitamins|mesh-list
110400331|NCT01306656|Micronutrients|micronutrients|mesh-ancestor
110400332|NCT01306656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400333|NCT01306656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110400334|NCT01306656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110400335|NCT01003639|Aspirin|aspirin|mesh-list
110400336|NCT01003639|Acetaminophen|acetaminophen|mesh-list
110400337|NCT01003639|Ibuprofen|ibuprofen|mesh-list
110400338|NCT01003639|Naproxen|naproxen|mesh-list
110400339|NCT01003639|Acetazolamide|acetazolamide|mesh-list
110400340|NCT01003639|Codeine|codeine|mesh-list
110400341|NCT01003639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110400342|NCT01003639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110400343|NCT01003639|Analgesics|analgesics|mesh-ancestor
110400344|NCT01003639|Sensory System Agents|sensory system agents|mesh-ancestor
110400345|NCT01003639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110400346|NCT01003639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400347|NCT01003639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110400348|NCT01003639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110400349|NCT01003639|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110400350|NCT01003639|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110400351|NCT01003639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110400352|NCT01003639|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110400353|NCT01003639|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110400354|NCT01003639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110400356|NCT01003639|Gout Suppressants|gout suppressants|mesh-ancestor
110400358|NCT01003639|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110400359|NCT01003639|Diuretics|diuretics|mesh-ancestor
110400360|NCT01003639|Natriuretic Agents|natriuretic agents|mesh-ancestor
110400361|NCT01003639|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110400362|NCT01003639|Narcotics|narcotics|mesh-ancestor
110400363|NCT01003639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110400364|NCT01003639|Antitussive Agents|antitussive agents|mesh-ancestor
110400365|NCT01003639|Respiratory System Agents|respiratory system agents|mesh-ancestor
110400367|NCT01003249|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110400368|NCT01003249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400369|NCT01003249|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110400370|NCT01003249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110400371|NCT01003249|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110400372|NCT01003249|GABA Agonists|gaba agonists|mesh-ancestor
110400373|NCT01003249|GABA Agents|gaba agents|mesh-ancestor
110400374|NCT01003249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110400375|NCT01003249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110400376|NCT04297033|Lovastatin|lovastatin|mesh-list
110400377|NCT04297033|L 647318|l 647318|mesh-list
110400378|NCT04297033|Dihydromevinolin|dihydromevinolin|mesh-list
110400379|NCT04297033|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110400380|NCT04297033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110400381|NCT04297033|Antimetabolites|antimetabolites|mesh-ancestor
110400382|NCT04297033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110400383|NCT04297033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110400384|NCT04297033|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110400385|NCT04297033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110400386|NCT04294537|Anesthetics|anesthetics|mesh-list
110400387|NCT04294537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110400388|NCT04294537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400389|NCT04295629|Anesthetics|anesthetics|mesh-list
110400390|NCT04295629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110400391|NCT04295629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400392|NCT01306032|Cyclophosphamide|cyclophosphamide|mesh-list
110400393|NCT01306032|Veliparib|veliparib|mesh-list
110400394|NCT01306032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110400395|NCT01306032|Immunologic Factors|immunologic factors|mesh-ancestor
110400396|NCT01306032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400397|NCT01306032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110400398|NCT01306032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110400399|NCT01306032|Alkylating Agents|alkylating agents|mesh-ancestor
110400400|NCT01306032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110400401|NCT01306032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110400402|NCT01306032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110400403|NCT01306032|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110400404|NCT01306032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110400405|NCT01263015|Lamivudine|lamivudine|mesh-list
110400406|NCT01263015|Abacavir|abacavir|mesh-list
110400407|NCT01263015|Dideoxynucleosides|dideoxynucleosides|mesh-list
110400408|NCT01263015|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110400409|NCT01263015|Dolutegravir|dolutegravir|mesh-list
110400410|NCT01263015|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110400411|NCT01263015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110400412|NCT01263015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110400413|NCT01263015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110400415|NCT01263015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110400416|NCT01263015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110400417|NCT01263015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110400418|NCT01263015|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110400419|NCT01263015|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110400420|NCT01263015|Antimetabolites|antimetabolites|mesh-ancestor
110400421|NCT04322955|Nivolumab|nivolumab|mesh-list
110400422|NCT04322955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110400423|NCT04322955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110400424|NCT04322955|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110400425|NCT04322955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110400426|NCT04322175|Meloxicam|meloxicam|mesh-list
110400427|NCT04322175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110400428|NCT04322175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110400430|NCT04322175|Sensory System Agents|sensory system agents|mesh-ancestor
110400431|NCT04322175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110400432|NCT04322175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400433|NCT04322175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110400434|NCT04322175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110400435|NCT04322175|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110400436|NCT04322175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110400437|NCT04322175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110400438|NCT04322175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110400439|NCT04321785|Caffeine|caffeine|mesh-list
110400440|NCT04321785|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110400441|NCT04321785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400442|NCT04321785|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110400443|NCT04321785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110400444|NCT04321785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110400445|NCT04321785|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110400446|NCT04321785|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110400447|NCT04321785|Purinergic Agents|purinergic agents|mesh-ancestor
110400449|NCT01305408|Modafinil|modafinil|mesh-list
110400450|NCT01305408|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110400451|NCT01305408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400452|NCT01305408|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110400453|NCT01305408|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110400454|NCT01305408|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110400455|NCT01305408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110400456|NCT01261611|Botulinum Toxins|botulinum toxins|mesh-list
110400457|NCT01261611|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110400458|NCT01261611|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110400459|NCT01261611|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110400460|NCT01261611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110400461|NCT01261611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110400462|NCT01261611|Cholinergic Agents|cholinergic agents|mesh-ancestor
110030208|NCT01384578|Tocotrienols|tocotrienols|mesh-list
110400463|NCT01261611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110400464|NCT01261611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400465|NCT01261611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110400467|NCT04207125|Psychotropic Drugs|psychotropic drugs|mesh-list
110400468|NCT04320693|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
110400469|NCT04320693|Immunoconjugates|immunoconjugates|mesh-ancestor
110400470|NCT04320693|Immunologic Factors|immunologic factors|mesh-ancestor
110400471|NCT04320693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400472|NCT00624039|Pilocarpine|pilocarpine|mesh-list
110400473|NCT00624039|Miotics|miotics|mesh-ancestor
110400474|NCT00624039|Autonomic Agents|autonomic agents|mesh-ancestor
110400475|NCT00624039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110400476|NCT00624039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400477|NCT00624039|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110400478|NCT00624039|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110400479|NCT00624039|Cholinergic Agents|cholinergic agents|mesh-ancestor
110400480|NCT00624039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110400481|NCT00624039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110400482|NCT01304706|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
110400483|NCT01304706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110400484|NCT01304706|Glucocorticoids|glucocorticoids|mesh-ancestor
110400485|NCT01304706|Hormones|hormones|mesh-ancestor
110400486|NCT01304706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110400487|NCT01304706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400488|NCT05661240|Docetaxel|docetaxel|mesh-list
110400489|NCT05661240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110400490|NCT05661240|Tubulin Modulators|tubulin modulators|mesh-ancestor
110400491|NCT05661240|Antimitotic Agents|antimitotic agents|mesh-ancestor
110400492|NCT05661240|Mitosis Modulators|mitosis modulators|mesh-ancestor
110400493|NCT05661240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110400494|NCT02889003|Pioglitazone|pioglitazone|mesh-list
110400495|NCT02889003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110400496|NCT02889003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400497|NCT01008553|Fentanyl|fentanyl|mesh-list
110400498|NCT01008553|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110400499|NCT01008553|Narcotics|narcotics|mesh-ancestor
110400500|NCT01008553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110400501|NCT01008553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400502|NCT01008553|Analgesics|analgesics|mesh-ancestor
110400503|NCT01008553|Sensory System Agents|sensory system agents|mesh-ancestor
110400504|NCT01008553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110400505|NCT01008553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110400506|NCT01008553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110400507|NCT01008553|Anesthetics, General|anesthetics, general|mesh-ancestor
110400508|NCT01008553|Anesthetics|anesthetics|mesh-ancestor
110400509|NCT05141877|Anesthetics|anesthetics|mesh-list
110400510|NCT05141877|Propofol|propofol|mesh-list
110400511|NCT05141877|Sevoflurane|sevoflurane|mesh-list
110400512|NCT05141877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110400513|NCT05141877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400514|NCT05141877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110400515|NCT05141877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110400516|NCT05141877|Anesthetics, General|anesthetics, general|mesh-ancestor
110400517|NCT05141877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110400518|NCT05141877|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110400519|NCT04901169|Angiotensin II|angiotensin ii|mesh-list
110400520|NCT04901169|Giapreza|giapreza|mesh-list
110400521|NCT04901169|Angiotensinogen|angiotensinogen|mesh-list
110030230|NCT01384682|Maraviroc|maraviroc|mesh-list
110400522|NCT04901169|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110400523|NCT04901169|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110400524|NCT04901169|Protease Inhibitors|protease inhibitors|mesh-ancestor
110400525|NCT04901169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110400526|NCT04901169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110400527|NCT04479267|Prednisone|prednisone|mesh-list
110400528|NCT04479267|Methylprednisolone|methylprednisolone|mesh-list
110400529|NCT04479267|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110400530|NCT04479267|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110400531|NCT04479267|Prednisolone|prednisolone|mesh-list
110400532|NCT04479267|Prednisolone acetate|prednisolone acetate|mesh-list
110400533|NCT04479267|Hydrocortisone|hydrocortisone|mesh-list
110400534|NCT04479267|Cortisone|cortisone|mesh-list
110400535|NCT04479267|Cyclophosphamide|cyclophosphamide|mesh-list
110400536|NCT04479267|Rituximab|rituximab|mesh-list
110400537|NCT04479267|Doxorubicin|doxorubicin|mesh-list
110400538|NCT04479267|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110400539|NCT04479267|Antibodies|antibodies|mesh-list
110400540|NCT04479267|Immunoglobulins|immunoglobulins|mesh-list
110400541|NCT04479267|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110400542|NCT04479267|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110400543|NCT04479267|Prednisolone phosphate|prednisolone phosphate|mesh-list
110400544|NCT04479267|Immunoconjugates|immunoconjugates|mesh-list
110400545|NCT04479267|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
110400546|NCT04479267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110400548|NCT04479267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400549|NCT04479267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110400550|NCT04479267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110400551|NCT04479267|Alkylating Agents|alkylating agents|mesh-ancestor
110400552|NCT04479267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110400553|NCT04479267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110400554|NCT04479267|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110400555|NCT04479267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110400556|NCT04479267|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110400557|NCT04479267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110400558|NCT04479267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110400559|NCT04479267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110400560|NCT04479267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110400562|NCT04479267|Hormones|hormones|mesh-ancestor
110400563|NCT04479267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110400564|NCT04479267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110400566|NCT04479267|Autonomic Agents|autonomic agents|mesh-ancestor
110400567|NCT04479267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110400568|NCT04479267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110400569|NCT04479267|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110400570|NCT04479267|Protective Agents|protective agents|mesh-ancestor
110400571|NCT04439799|Methyltestosterone|methyltestosterone|mesh-list
110400572|NCT04439799|Testosterone|testosterone|mesh-list
110400573|NCT04439799|Testosterone undecanoate|testosterone undecanoate|mesh-list
110400574|NCT04439799|Testosterone enanthate|testosterone enanthate|mesh-list
110400575|NCT04439799|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110400576|NCT04439799|Androgens|androgens|mesh-ancestor
110400577|NCT04439799|Hormones|hormones|mesh-ancestor
110400578|NCT04439799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110400579|NCT04439799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400580|NCT04439799|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110400581|NCT04439799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110400582|NCT04439799|Anabolic Agents|anabolic agents|mesh-ancestor
110400583|NCT04021017|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110400584|NCT04021017|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110400585|NCT04021017|Estradiol|estradiol|mesh-list
110400586|NCT04021017|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110030243|NCT01384708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110400587|NCT04021017|Estrogens|estrogens|mesh-ancestor
110400588|NCT04021017|Hormones|hormones|mesh-ancestor
110400589|NCT04021017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110400590|NCT04021017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400591|NCT04021017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110400592|NCT04021017|Contraceptive Agents|contraceptive agents|mesh-ancestor
110400593|NCT04021017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110400594|NCT04021017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110400595|NCT03916185|Vaccines|vaccines|mesh-list
110400596|NCT03916185|Immunologic Factors|immunologic factors|mesh-ancestor
110400597|NCT03916185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400598|NCT03764553|Leucovorin|leucovorin|mesh-list
110400599|NCT03764553|Carboplatin|carboplatin|mesh-list
110400600|NCT03764553|Fluorouracil|fluorouracil|mesh-list
110400601|NCT03764553|Capecitabine|capecitabine|mesh-list
110400602|NCT03764553|Oxaliplatin|oxaliplatin|mesh-list
110400603|NCT03764553|Irinotecan|irinotecan|mesh-list
110400604|NCT03764553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110400605|NCT03764553|Antimetabolites|antimetabolites|mesh-ancestor
110400606|NCT03764553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110400607|NCT03764553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110400608|NCT03764553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110400609|NCT03764553|Immunologic Factors|immunologic factors|mesh-ancestor
110400610|NCT03764553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400611|NCT03764553|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110400612|NCT03764553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110400613|NCT03764553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110400614|NCT03764553|Antidotes|antidotes|mesh-ancestor
110400615|NCT03764553|Protective Agents|protective agents|mesh-ancestor
110400616|NCT03764553|Vitamin B Complex|vitamin b complex|mesh-ancestor
110400617|NCT03764553|Vitamins|vitamins|mesh-ancestor
110400618|NCT03764553|Micronutrients|micronutrients|mesh-ancestor
110400619|NCT04320225|Dexamethasone|dexamethasone|mesh-list
110400620|NCT04320225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110400621|NCT04320225|Antiemetics|antiemetics|mesh-ancestor
110400622|NCT04320225|Autonomic Agents|autonomic agents|mesh-ancestor
110400623|NCT04320225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110400624|NCT04320225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400625|NCT04320225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110400626|NCT04320225|Glucocorticoids|glucocorticoids|mesh-ancestor
110400627|NCT04320225|Hormones|hormones|mesh-ancestor
110400628|NCT04320225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110400629|NCT04320225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110400630|NCT04320225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110400631|NCT03221751|Prazosin|prazosin|mesh-list
110400632|NCT03221751|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110400633|NCT03221751|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110400634|NCT03221751|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110400635|NCT03221751|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110400636|NCT03221751|Adrenergic Agents|adrenergic agents|mesh-ancestor
110400637|NCT03221751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110400638|NCT03221751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110400639|NCT03221751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400641|NCT03219177|Narcotics|narcotics|mesh-ancestor
110400642|NCT03219177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110400643|NCT03219177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400644|NCT03219177|Analgesics|analgesics|mesh-ancestor
110400645|NCT03219177|Sensory System Agents|sensory system agents|mesh-ancestor
110400646|NCT03219177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110400648|NCT01302834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110030256|NCT01384903|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110400649|NCT01302834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110400650|NCT02866071|Ketamine|ketamine|mesh-list
110400651|NCT02866071|Analgesics|analgesics|mesh-ancestor
110400652|NCT02866071|Sensory System Agents|sensory system agents|mesh-ancestor
110400653|NCT02866071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110400654|NCT02866071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400655|NCT02866071|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110400656|NCT02866071|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110400657|NCT02866071|Anesthetics, General|anesthetics, general|mesh-ancestor
110400658|NCT02866071|Anesthetics|anesthetics|mesh-ancestor
110400659|NCT02866071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110400660|NCT02866071|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110400661|NCT02866071|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110400662|NCT02866071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110400663|NCT02866071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110400664|NCT02890602|Prednisolone|prednisolone|mesh-list
110400665|NCT02890602|Cyclophosphamide|cyclophosphamide|mesh-list
110400666|NCT02890602|Vincristine|vincristine|mesh-list
110400667|NCT02890602|Darbepoetin alfa|darbepoetin alfa|mesh-list
110400668|NCT02890602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110400669|NCT02890602|Immunologic Factors|immunologic factors|mesh-ancestor
110400670|NCT02890602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400671|NCT02890602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110400672|NCT02890602|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110400673|NCT02890602|Alkylating Agents|alkylating agents|mesh-ancestor
110400674|NCT02890602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110400675|NCT02890602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110400676|NCT02890602|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110400677|NCT02890602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110400678|NCT02890602|Tubulin Modulators|tubulin modulators|mesh-ancestor
110400679|NCT02890602|Antimitotic Agents|antimitotic agents|mesh-ancestor
110400680|NCT02890602|Mitosis Modulators|mitosis modulators|mesh-ancestor
110400681|NCT02890602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110400682|NCT02890602|Glucocorticoids|glucocorticoids|mesh-ancestor
110400684|NCT02890602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110400685|NCT02890602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110400686|NCT02890602|Hematinics|hematinics|mesh-ancestor
110400687|NCT01259115|Ketoconazole|ketoconazole|mesh-list
110400688|NCT01259115|Buprenorphine|buprenorphine|mesh-list
110400689|NCT01259115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110400690|NCT01259115|Narcotics|narcotics|mesh-ancestor
110400691|NCT01259115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110400693|NCT01259115|Analgesics|analgesics|mesh-ancestor
110400694|NCT01259115|Sensory System Agents|sensory system agents|mesh-ancestor
110400695|NCT01259115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110400696|NCT01259115|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110400697|NCT01259115|Antifungal Agents|antifungal agents|mesh-ancestor
110400698|NCT01259115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110400699|NCT01259115|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110400700|NCT01259115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110400701|NCT01259115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110030270|NCT01384994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110400702|NCT01259115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110400703|NCT01259115|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110400704|NCT01259115|Hormone Antagonists|hormone antagonists|mesh-ancestor
110400705|NCT01259115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110400706|NCT01259115|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110400708|NCT01302054|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110400709|NCT01302054|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110400710|NCT01302054|Cholinergic Agents|cholinergic agents|mesh-ancestor
110400711|NCT01302054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110400712|NCT01302054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110400713|NCT01302054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400714|NCT01302054|Urological Agents|urological agents|mesh-ancestor
110400715|NCT05642910|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
110400716|NCT05642910|Antiviral Agents|antiviral agents|mesh-ancestor
110400717|NCT05642910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110400718|NCT01300650|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110400719|NCT01300650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110400720|NCT01300572|Cyclosporine|cyclosporine|mesh-list
110400721|NCT01300572|Mycophenolic Acid|mycophenolic acid|mesh-list
110400722|NCT01300572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110400723|NCT01300572|Fludarabine|fludarabine|mesh-list
110400724|NCT01300572|Fludarabine phosphate|fludarabine phosphate|mesh-list
110400725|NCT01300572|Antibodies|antibodies|mesh-list
110400726|NCT01300572|Immunoglobulins|immunoglobulins|mesh-list
110400727|NCT01300572|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110400728|NCT01300572|Cyclosporins|cyclosporins|mesh-list
110400729|NCT01300572|Immunologic Factors|immunologic factors|mesh-ancestor
110400730|NCT01300572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400732|NCT01300572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110400733|NCT01300572|Antimetabolites|antimetabolites|mesh-ancestor
110400734|NCT01300572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110400735|NCT01300572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110400736|NCT01300572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110400737|NCT01300572|Antifungal Agents|antifungal agents|mesh-ancestor
110400738|NCT01300572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110400739|NCT01300572|Dermatologic Agents|dermatologic agents|mesh-ancestor
110400740|NCT01300572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110400741|NCT01300572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110400743|NCT01300572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110400744|NCT01300572|Antitubercular Agents|antitubercular agents|mesh-ancestor
110400745|NCT01300572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110400746|NCT01077154|Denosumab|denosumab|mesh-list
110400747|NCT01077154|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110400748|NCT01077154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400749|NCT01258101|Ribavirin|ribavirin|mesh-list
110400750|NCT01258101|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110400751|NCT01258101|Interferon-alpha|interferon-alpha|mesh-list
110400752|NCT01258101|Antimetabolites|antimetabolites|mesh-ancestor
110400753|NCT01258101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110400754|NCT01258101|Antiviral Agents|antiviral agents|mesh-ancestor
110400755|NCT01258101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110400756|NCT01258101|Immunologic Factors|immunologic factors|mesh-ancestor
110400757|NCT01258101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400758|NCT05640804|Dasatinib|dasatinib|mesh-list
110400759|NCT05640804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110400760|NCT05640804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110400761|NCT05640804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110400762|NCT05640804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110400763|NCT00623688|Imidacloprid|imidacloprid|mesh-list
110400764|NCT00623688|Cholinergic Agents|cholinergic agents|mesh-ancestor
110400765|NCT00623688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110030290|NCT01385228|Prednisone|prednisone|mesh-list
110400766|NCT00623688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110400767|NCT00623688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400768|NCT01300260|Dulaglutide|dulaglutide|mesh-list
110400770|NCT01300260|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110400771|NCT01300260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110400772|NCT01300260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400773|NCT01300260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110400774|NCT01300260|Hormones|hormones|mesh-ancestor
110400775|NCT01300260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110400776|NCT01300260|Incretins|incretins|mesh-ancestor
110400777|NCT01256385|Sirolimus|sirolimus|mesh-list
110400778|NCT01256385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110400779|NCT01256385|Cetuximab|cetuximab|mesh-list
110400780|NCT01256385|Temsirolimus|temsirolimus|mesh-list
110400781|NCT01256385|MTOR Inhibitors|mtor inhibitors|mesh-list
110400782|NCT01256385|Antibodies|antibodies|mesh-list
110400783|NCT01256385|Immunoglobulins|immunoglobulins|mesh-list
110400784|NCT01256385|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110400785|NCT01256385|Immunologic Factors|immunologic factors|mesh-ancestor
110400786|NCT01256385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400787|NCT01256385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110400788|NCT01256385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110400789|NCT01256385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110400790|NCT01256385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110400791|NCT01256385|Antifungal Agents|antifungal agents|mesh-ancestor
110400792|NCT01256385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110400793|NCT01256385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110400794|NCT01256385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110400795|NCT01256385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110400796|NCT00637182|Anastrozole|anastrozole|mesh-list
110400798|NCT00637182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110400799|NCT00637182|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110400800|NCT00637182|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110400801|NCT00637182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110400802|NCT00637182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110400803|NCT00637182|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110400804|NCT00637182|Hormone Antagonists|hormone antagonists|mesh-ancestor
110400805|NCT00637182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110400806|NCT00637182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400807|NCT01298778|Acetaminophen|acetaminophen|mesh-list
110400810|NCT01298778|Analgesics|analgesics|mesh-ancestor
110400811|NCT01298778|Sensory System Agents|sensory system agents|mesh-ancestor
110400812|NCT01298778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110400813|NCT01298778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400814|NCT01298778|Antipyretics|antipyretics|mesh-ancestor
110400815|NCT01298778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110400816|NCT01298778|Narcotics|narcotics|mesh-ancestor
110400817|NCT01298778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110400818|NCT01298700|Bimatoprost|bimatoprost|mesh-list
110400819|NCT01298700|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110400820|NCT01298700|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110400821|NCT01298700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110400822|NCT01297920|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110400823|NCT01297920|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110400824|NCT01297920|Brinzolamide|brinzolamide|mesh-list
110030303|NCT01385345|Vitamin D|vitamin d|mesh-list
110400825|NCT01297920|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110400826|NCT01297920|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110400827|NCT01297920|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110400828|NCT01297920|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110400829|NCT01297920|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110400830|NCT01297920|Adrenergic Agents|adrenergic agents|mesh-ancestor
110400831|NCT01297920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110400832|NCT01297920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110400833|NCT01297920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400834|NCT01297920|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110400835|NCT01297920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110400836|NCT01255761|Certolizumab Pegol|certolizumab pegol|mesh-list
110400837|NCT01255761|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110400838|NCT01255761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110400839|NCT01255761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110400840|NCT01255761|Immunologic Factors|immunologic factors|mesh-ancestor
110400841|NCT01255761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400842|NCT01255761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110400843|NCT01297062|Exenatide|exenatide|mesh-list
110400844|NCT01297062|Moxifloxacin|moxifloxacin|mesh-list
110400845|NCT01297062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110400846|NCT01297062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110400847|NCT01297062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110400848|NCT01297062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110400849|NCT01297062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110400850|NCT01297062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110400851|NCT01297062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110400852|NCT01297062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400853|NCT01297062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110400854|NCT01297062|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110400855|NCT01297062|Incretins|incretins|mesh-ancestor
110400856|NCT01297062|Hormones|hormones|mesh-ancestor
110400857|NCT01297062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110400858|NCT01296672|Finasteride|finasteride|mesh-list
110400859|NCT01296672|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110400860|NCT01296672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110400861|NCT01296672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110400862|NCT01296672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110400863|NCT01296672|Hormone Antagonists|hormone antagonists|mesh-ancestor
110400864|NCT01296672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110400865|NCT01296672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400866|NCT01296672|Urological Agents|urological agents|mesh-ancestor
110400867|NCT01254669|Vaccines|vaccines|mesh-list
110400868|NCT01254669|Immunologic Factors|immunologic factors|mesh-ancestor
110400869|NCT01254669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400870|NCT04324476|Bevacizumab|bevacizumab|mesh-list
110400871|NCT04324476|Capecitabine|capecitabine|mesh-list
110400873|NCT04324476|Irinotecan|irinotecan|mesh-list
110400874|NCT04324476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110400875|NCT04324476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110400876|NCT04324476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110400877|NCT04324476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110400878|NCT04324476|Growth Substances|growth substances|mesh-ancestor
110400879|NCT04324476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400880|NCT04324476|Growth Inhibitors|growth inhibitors|mesh-ancestor
110030319|NCT01385631|Antimetabolites|antimetabolites|mesh-ancestor
110030323|NCT01385683|Dabigatran|dabigatran|mesh-list
110400881|NCT04324476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110400882|NCT04324476|Antimetabolites|antimetabolites|mesh-ancestor
110400883|NCT04324476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110400884|NCT04324476|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110400885|NCT04324476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110400886|NCT04324476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110400887|NCT01295814|Adalimumab|adalimumab|mesh-list
110400888|NCT01295814|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110400889|NCT01295814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110400890|NCT01295814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110400891|NCT01254045|Oxytocin|oxytocin|mesh-list
110400892|NCT01254045|Oxytocics|oxytocics|mesh-ancestor
110400893|NCT01254045|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110400894|NCT01254045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400895|NCT01075282|Metformin|metformin|mesh-list
110400896|NCT01075282|Insulin Glargine|insulin glargine|mesh-list
110400897|NCT01075282|Glimepiride|glimepiride|mesh-list
110400898|NCT01075282|Dulaglutide|dulaglutide|mesh-list
110400899|NCT01075282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110400900|NCT01075282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400901|NCT01075282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110400902|NCT01075282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110400903|NCT01075282|Immunologic Factors|immunologic factors|mesh-ancestor
110400904|NCT04324086|Calcium, Dietary|calcium, dietary|mesh-list
110400905|NCT04324086|Calcium|calcium|mesh-list
110400906|NCT04324086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110400907|NCT04324086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400908|NCT04324086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110400909|NCT01295034|Vitamin D|vitamin d|mesh-list
110400910|NCT01295034|Ergocalciferols|ergocalciferols|mesh-list
110400911|NCT01295034|Cholecalciferol|cholecalciferol|mesh-list
110400912|NCT01295034|Vitamins|vitamins|mesh-list
110400913|NCT01295034|Micronutrients|micronutrients|mesh-ancestor
110400914|NCT01295034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400915|NCT01295034|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110400916|NCT01295034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110400917|NCT01253421|Amisulpride|amisulpride|mesh-list
110400918|NCT01253421|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110400919|NCT01253421|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110400920|NCT01253421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110400921|NCT01253421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400922|NCT01253421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110400923|NCT01253421|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110400924|NCT01253421|Dopamine Agents|dopamine agents|mesh-ancestor
110400925|NCT01253421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110400926|NCT01253421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110400927|NCT01253421|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110400928|NCT01253421|Antidepressive Agents|antidepressive agents|mesh-ancestor
110400930|NCT01077076|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
110400931|NCT01077076|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110400932|NCT01077076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110400933|NCT01077076|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110400934|NCT01077076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110400935|NCT01077076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110400936|NCT02876224|Bevacizumab|bevacizumab|mesh-list
110400937|NCT02876224|Atezolizumab|atezolizumab|mesh-list
110030332|NCT01385683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110400938|NCT02876224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110400939|NCT02876224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110400940|NCT02876224|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110400941|NCT02876224|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110400942|NCT02876224|Growth Substances|growth substances|mesh-ancestor
110400943|NCT02876224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400944|NCT02876224|Growth Inhibitors|growth inhibitors|mesh-ancestor
110400945|NCT02876224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110400946|NCT02876224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110400947|NCT01294644|Deoxycholic Acid|deoxycholic acid|mesh-list
110400948|NCT01294644|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110400949|NCT01294644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110400951|NCT01253265|Dermatologic Agents|dermatologic agents|mesh-ancestor
110400953|NCT01293006|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110400954|NCT01293006|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110400955|NCT01293006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110400956|NCT01293006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400957|NCT01293006|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
110400958|NCT01293006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110400959|NCT01293006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110400960|NCT01253187|Tetrahydrofolates|tetrahydrofolates|mesh-list
110400961|NCT01253187|Drospirenone|drospirenone|mesh-list
110400962|NCT01253187|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110400963|NCT01253187|Hormone Antagonists|hormone antagonists|mesh-ancestor
110400964|NCT01253187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110400965|NCT01253187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400966|NCT01253187|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110400967|NCT01253187|Diuretics|diuretics|mesh-ancestor
110400968|NCT01253187|Natriuretic Agents|natriuretic agents|mesh-ancestor
110400969|NCT01253187|Vitamin B Complex|vitamin b complex|mesh-ancestor
110400970|NCT01253187|Vitamins|vitamins|mesh-ancestor
110400971|NCT01253187|Micronutrients|micronutrients|mesh-ancestor
110400972|NCT01252563|Amlodipine|amlodipine|mesh-list
110400973|NCT01252563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110400974|NCT01252563|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110400975|NCT01252563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110400976|NCT01252563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110400977|NCT01252563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110400978|NCT01252563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400979|NCT01252563|Vasodilator Agents|vasodilator agents|mesh-ancestor
110400980|NCT01292226|Cyclosporine|cyclosporine|mesh-list
110400981|NCT01292226|Mycophenolic Acid|mycophenolic acid|mesh-list
110400982|NCT01292226|Antibodies|antibodies|mesh-list
110400983|NCT01292226|Cyclosporins|cyclosporins|mesh-list
110400984|NCT01292226|Immunologic Factors|immunologic factors|mesh-ancestor
110400985|NCT01292226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400986|NCT01292226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110400987|NCT01292226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110400989|NCT01292226|Antifungal Agents|antifungal agents|mesh-ancestor
110400990|NCT01292226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110400991|NCT01292226|Dermatologic Agents|dermatologic agents|mesh-ancestor
110400992|NCT01292226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110400993|NCT01292226|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110400994|NCT01292226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110400995|NCT01292226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110400996|NCT01292226|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110400997|NCT01292226|Antitubercular Agents|antitubercular agents|mesh-ancestor
110400998|NCT01292226|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110401000|NCT01075048|Cetuximab|cetuximab|mesh-list
110401001|NCT01075048|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110401002|NCT01075048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110401003|NCT01075048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110401004|NCT01075048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110401005|NCT01075048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110401006|NCT01075048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110401007|NCT01252251|Everolimus|everolimus|mesh-list
110401008|NCT01252251|Pasireotide|pasireotide|mesh-list
110401009|NCT01252251|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110401010|NCT01252251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110401011|NCT01252251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110401012|NCT01252251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110401013|NCT01252251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110401014|NCT01252251|Immunologic Factors|immunologic factors|mesh-ancestor
110401015|NCT01252251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110401016|NCT01252251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110401017|NCT01252251|Hormones|hormones|mesh-ancestor
110401018|NCT01252251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110401019|NCT02888301|Clofarabine|clofarabine|mesh-list
110401020|NCT02888301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110401021|NCT02888301|Antimetabolites|antimetabolites|mesh-ancestor
110401022|NCT02888301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110401023|NCT02888301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110401024|NCT00624273|Sildenafil Citrate|sildenafil citrate|mesh-list
110401025|NCT00624273|Vasodilator Agents|vasodilator agents|mesh-ancestor
110401026|NCT00624273|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110401027|NCT00624273|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110401028|NCT00624273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110055416|NCT01497626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110401029|NCT00624273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110401030|NCT00624273|Urological Agents|urological agents|mesh-ancestor
110401032|NCT04305964|Trace Elements|trace elements|mesh-ancestor
110401033|NCT04305964|Micronutrients|micronutrients|mesh-ancestor
110401034|NCT04305964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110401035|NCT04306042|Pembrolizumab|pembrolizumab|mesh-list
110401037|NCT04306042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110030368|NCT01386086|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110030383|NCT01386151|Mitogens|mitogens|mesh-list
110401039|NCT04306042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110401040|NCT04306042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110401041|NCT01074502|Apremilast|apremilast|mesh-list
110401042|NCT01074502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110401043|NCT01074502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110401044|NCT01074502|Analgesics|analgesics|mesh-ancestor
110401045|NCT01074502|Sensory System Agents|sensory system agents|mesh-ancestor
110401046|NCT01074502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110401047|NCT01074502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110401048|NCT01074502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110401049|NCT01074502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110401050|NCT01074502|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110401051|NCT01074502|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110401052|NCT01074502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110401053|NCT01074502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110401054|NCT04303312|Benzydamine|benzydamine|mesh-list
110401055|NCT04303312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110401056|NCT01285908|Norepinephrine|norepinephrine|mesh-list
110401057|NCT01285908|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110401058|NCT01285908|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110401059|NCT01285908|Adrenergic Agents|adrenergic agents|mesh-ancestor
110401060|NCT01285908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110401061|NCT01285908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110401062|NCT01285908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110401063|NCT01285908|Sympathomimetics|sympathomimetics|mesh-ancestor
110401064|NCT01285908|Autonomic Agents|autonomic agents|mesh-ancestor
110401065|NCT01285908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110401066|NCT01285908|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110401067|NCT01074268|Insulin|insulin|mesh-list
110401068|NCT01074268|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110401069|NCT01074268|Insulin Aspart|insulin aspart|mesh-list
110401070|NCT01074268|Insulin Detemir|insulin detemir|mesh-list
110401071|NCT01074268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110401072|NCT01074268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110401074|NCT01074190|Bupivacaine|bupivacaine|mesh-list
110401075|NCT01074190|Anesthetics, Local|anesthetics, local|mesh-ancestor
110401076|NCT01074190|Anesthetics|anesthetics|mesh-ancestor
110401077|NCT01074190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110401078|NCT01074190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110401079|NCT01074190|Sensory System Agents|sensory system agents|mesh-ancestor
110401080|NCT01074190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110401081|NCT01074190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110401082|NCT01074190|Narcotics|narcotics|mesh-ancestor
110401083|NCT01074190|Analgesics|analgesics|mesh-ancestor
110401084|NCT01074190|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110401085|NCT01074190|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110401086|NCT01074190|Anesthetics, General|anesthetics, general|mesh-ancestor
110401087|NCT01073566|Insulin|insulin|mesh-list
110401088|NCT01073566|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110401089|NCT01073566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110401090|NCT01073566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110401091|NCT01072396|Tiotropium Bromide|tiotropium bromide|mesh-list
110401092|NCT01072396|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110401093|NCT01072396|Autonomic Agents|autonomic agents|mesh-ancestor
110401094|NCT01072396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110401095|NCT01072396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110401096|NCT01072396|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110030405|NCT01386229|Ketamine|ketamine|mesh-list
110401097|NCT01072396|Respiratory System Agents|respiratory system agents|mesh-ancestor
110401098|NCT01072396|Parasympatholytics|parasympatholytics|mesh-ancestor
110401099|NCT01072396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110401100|NCT01072396|Cholinergic Agents|cholinergic agents|mesh-ancestor
110401101|NCT01072396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110401102|NCT01072396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110401103|NCT01045096|Dexlansoprazole|dexlansoprazole|mesh-list
110401104|NCT01045096|Lansoprazole|lansoprazole|mesh-list
110401105|NCT01045096|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110401106|NCT01045096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110401107|NCT01045096|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110401108|NCT01045096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110401109|NCT01045096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110401110|NCT02876146|Albendazole|albendazole|mesh-list
110401111|NCT02876146|Benzimidazole|benzimidazole|mesh-list
110401112|NCT02876146|Anthelmintics|anthelmintics|mesh-ancestor
110401113|NCT02876146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110401114|NCT02876146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110401115|NCT02876146|Anticestodal Agents|anticestodal agents|mesh-ancestor
110401116|NCT02876146|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110401117|NCT02876146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110401118|NCT02876146|Tubulin Modulators|tubulin modulators|mesh-ancestor
110401119|NCT02876146|Antimitotic Agents|antimitotic agents|mesh-ancestor
110401120|NCT02876146|Mitosis Modulators|mitosis modulators|mesh-ancestor
110401121|NCT02876146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110401122|NCT02876146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110401123|NCT02874586|Immunosuppressive Agents|immunosuppressive agents|mesh-list
110401124|NCT02874586|Immunologic Factors|immunologic factors|mesh-ancestor
110401125|NCT02874586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110401126|NCT02875756|Ivermectin|ivermectin|mesh-list
110401127|NCT02875756|Selamectin|selamectin|mesh-list
110401128|NCT02875756|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110401129|NCT02875756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110401130|NCT02874820|Idazoxan|idazoxan|mesh-list
110401131|NCT02874820|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110401132|NCT02874820|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110401133|NCT02874820|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110401134|NCT02874820|Adrenergic Agents|adrenergic agents|mesh-ancestor
110401135|NCT02874820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110401136|NCT02874820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110401137|NCT02874820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110401138|NCT04305028|Aspirin|aspirin|mesh-list
110055576|NCT01498900|Repaglinide|repaglinide|mesh-list
110401139|NCT04305028|Rivaroxaban|rivaroxaban|mesh-list
110401140|NCT04305028|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110401141|NCT04305028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110401142|NCT04305028|Analgesics|analgesics|mesh-ancestor
110401143|NCT04305028|Sensory System Agents|sensory system agents|mesh-ancestor
110401144|NCT04305028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110401145|NCT04305028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110401146|NCT04305028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110401147|NCT04305028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110401148|NCT04305028|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110401149|NCT04305028|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110401150|NCT04305028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110401151|NCT04305028|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110401152|NCT04305028|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110401153|NCT04305028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110401154|NCT04305028|Antipyretics|antipyretics|mesh-ancestor
110401155|NCT04305028|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110401156|NCT04305028|Antithrombins|antithrombins|mesh-ancestor
110401157|NCT04305028|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110401158|NCT04305028|Protease Inhibitors|protease inhibitors|mesh-ancestor
110030428|NCT01386255|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110401159|NCT04305028|Anticoagulants|anticoagulants|mesh-ancestor
110401160|NCT04304794|Antithyroid Agents|antithyroid agents|mesh-list
110401161|NCT04304794|Hormone Antagonists|hormone antagonists|mesh-ancestor
110401162|NCT04304794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110401163|NCT04304794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110401164|NCT02874664|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
110401165|NCT02874664|Immunoconjugates|immunoconjugates|mesh-ancestor
110401166|NCT02874664|Immunologic Factors|immunologic factors|mesh-ancestor
110401167|NCT02874664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110401168|NCT01284114|Renin Inhibitors|renin inhibitors|mesh-list
110401169|NCT01284114|Protease Inhibitors|protease inhibitors|mesh-ancestor
110401170|NCT01284114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110401171|NCT01284114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110401172|NCT01283334|Carboplatin|carboplatin|mesh-list
110401173|NCT01283334|Cetuximab|cetuximab|mesh-list
110401174|NCT01283334|Everolimus|everolimus|mesh-list
110401175|NCT01283334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110401176|NCT01283334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110401177|NCT01283334|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110401178|NCT01283334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110401179|NCT01283334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110401180|NCT01283334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110401181|NCT01283334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110401182|NCT01283334|Immunologic Factors|immunologic factors|mesh-ancestor
110401183|NCT01283334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110401184|NCT04304716|Anesthetics|anesthetics|mesh-list
110401185|NCT04304716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110401186|NCT04304716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110401187|NCT01282476|Rituximab|rituximab|mesh-list
110401188|NCT01282476|Panobinostat|panobinostat|mesh-list
110401189|NCT01282476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110401190|NCT01282476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110401192|NCT01282476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110401193|NCT01282476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110401194|NCT01282476|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110401195|NCT01282476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110401196|NCT01282476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110401197|NCT02889822|Alprostadil|alprostadil|mesh-list
110401198|NCT02889822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110401199|NCT02889822|Vasodilator Agents|vasodilator agents|mesh-ancestor
110401200|NCT02889822|Urological Agents|urological agents|mesh-ancestor
110401201|NCT01282164|Insulin|insulin|mesh-list
110401202|NCT01282164|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110401203|NCT01282164|Glucagon|glucagon|mesh-list
110401204|NCT01282164|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110401205|NCT01282164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110401206|NCT01282164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110401207|NCT01282164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110401208|NCT01282164|Hormones|hormones|mesh-ancestor
110401209|NCT01282164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110401210|NCT01282164|Incretins|incretins|mesh-ancestor
110401211|NCT01250379|Bevacizumab|bevacizumab|mesh-list
110401212|NCT01250379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110401213|NCT01250379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110055595|NCT01499069|Solifenacin Succinate|solifenacin succinate|mesh-list
110401214|NCT01250379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110401215|NCT01250379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110401216|NCT01250379|Growth Substances|growth substances|mesh-ancestor
110401217|NCT01250379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110401218|NCT01250379|Growth Inhibitors|growth inhibitors|mesh-ancestor
110401219|NCT01072630|Modafinil|modafinil|mesh-list
110030457|NCT01386346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110401220|NCT01072630|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110401221|NCT01072630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110401222|NCT01072630|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110401223|NCT01072630|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110401224|NCT01072630|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110401225|NCT01072630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110401227|NCT04302532|Coenzyme Q10|coenzyme q10|mesh-list
110401228|NCT04302532|Clomiphene|clomiphene|mesh-list
110401229|NCT04302532|Enclomiphene|enclomiphene|mesh-list
110401230|NCT04302532|Zuclomiphene|zuclomiphene|mesh-list
110401231|NCT04302532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110401232|NCT04302532|Hormone Antagonists|hormone antagonists|mesh-ancestor
110401233|NCT04302532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110401234|NCT04302532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110401235|NCT04302532|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110401237|NCT04302532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110401238|NCT04302532|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110401239|NCT04302532|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110401240|NCT04302532|Micronutrients|micronutrients|mesh-ancestor
110401241|NCT04302532|Vitamins|vitamins|mesh-ancestor
110401242|NCT01281306|Valsartan|valsartan|mesh-list
110401243|NCT01281306|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110401244|NCT01281306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110401245|NCT01281306|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110401247|NCT01281306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110401248|NCT04304560|Dapagliflozin|dapagliflozin|mesh-list
110401249|NCT04304560|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110401250|NCT04304560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110401251|NCT04304560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110401252|NCT04304560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110401253|NCT04643470|Zanubrutinib|zanubrutinib|mesh-list
110401254|NCT04643470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110401255|NCT04643470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110401256|NCT04643470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110401257|NCT04643470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110401258|NCT01250145|Teriparatide|teriparatide|mesh-list
110401259|NCT01250145|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110401260|NCT01250145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110401261|NCT01250145|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110401262|NCT04319601|Rituximab|rituximab|mesh-list
110401263|NCT04319601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110401264|NCT04319601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110401265|NCT04319601|Immunologic Factors|immunologic factors|mesh-ancestor
110401266|NCT04319601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110401267|NCT04319601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110401268|NCT04640896|Lidocaine|lidocaine|mesh-list
110401269|NCT04640896|Bupivacaine|bupivacaine|mesh-list
110401270|NCT04640896|Anesthetics, Local|anesthetics, local|mesh-ancestor
110401271|NCT04640896|Anesthetics|anesthetics|mesh-ancestor
110401272|NCT04640896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110401273|NCT04640896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110401274|NCT04640896|Sensory System Agents|sensory system agents|mesh-ancestor
110401275|NCT04640896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110401276|NCT04640896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110401277|NCT04640896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110401278|NCT04640896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110401279|NCT04640896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110401280|NCT04640896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110401281|NCT01273818|Gentamicins|gentamicins|mesh-list
110401282|NCT01273818|Cefazolin|cefazolin|mesh-list
110401283|NCT01273818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110401284|NCT01273818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110401285|NCT01273818|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110055669|NCT01499602|Norethindrone|norethindrone|mesh-list
110401286|NCT01273818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110401287|NCT01273818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110401289|NCT01037218|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110401290|NCT01037218|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110401291|NCT01037218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110401292|NCT01037218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110401293|NCT01038856|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110401294|NCT01038856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110401295|NCT01038856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110401296|NCT01038856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110401297|NCT01038856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110401298|NCT01269918|Dexmedetomidine|dexmedetomidine|mesh-list
110401299|NCT01269918|Remifentanil|remifentanil|mesh-list
110401300|NCT01269918|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110401301|NCT01269918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110401302|NCT01269918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110401303|NCT01269918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110401304|NCT01269918|Analgesics|analgesics|mesh-ancestor
110401305|NCT01269918|Sensory System Agents|sensory system agents|mesh-ancestor
110401306|NCT01269918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110401307|NCT01269918|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110401308|NCT01269918|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110401309|NCT01269918|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110401310|NCT01269918|Adrenergic Agents|adrenergic agents|mesh-ancestor
110401311|NCT01269918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110401312|NCT01269918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110401313|NCT01269918|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110401315|NCT01036594|Ketoconazole|ketoconazole|mesh-list
110401316|NCT01036594|Dexamethasone|dexamethasone|mesh-list
110401317|NCT01036594|Dexamethasone acetate|dexamethasone acetate|mesh-list
110401318|NCT01036594|Hydrocortisone|hydrocortisone|mesh-list
110401319|NCT01036594|BB 1101|bb 1101|mesh-list
110401320|NCT01036594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110401322|NCT01036594|Autonomic Agents|autonomic agents|mesh-ancestor
110401323|NCT01036594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110401324|NCT01036594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110401325|NCT01036594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110401326|NCT01036594|Glucocorticoids|glucocorticoids|mesh-ancestor
110401327|NCT01036594|Hormones|hormones|mesh-ancestor
110401328|NCT01036594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110401329|NCT01036594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110401330|NCT01036594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110401331|NCT01036594|Protease Inhibitors|protease inhibitors|mesh-ancestor
110401332|NCT01036594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110401333|NCT01036594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110401334|NCT01036594|Antifungal Agents|antifungal agents|mesh-ancestor
110401335|NCT01036594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110401336|NCT01036594|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110401337|NCT01036594|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110401338|NCT01036594|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110401339|NCT01036594|Hormone Antagonists|hormone antagonists|mesh-ancestor
110401340|NCT01036594|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110401341|NCT04301908|Interferons|interferons|mesh-list
110401342|NCT04301908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110401344|NCT04301908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110401345|NCT04304248|Paclitaxel|paclitaxel|mesh-list
110401346|NCT04304248|Carboplatin|carboplatin|mesh-list
110401347|NCT04304248|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110401348|NCT04304248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110401349|NCT04304248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110401350|NCT04304248|Tubulin Modulators|tubulin modulators|mesh-ancestor
110401351|NCT04304248|Antimitotic Agents|antimitotic agents|mesh-ancestor
110401352|NCT04304248|Mitosis Modulators|mitosis modulators|mesh-ancestor
110401353|NCT04304248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110401354|NCT01268046|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110401355|NCT01268046|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110401357|NCT01268046|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110401358|NCT01268046|Estrogens|estrogens|mesh-list
110401359|NCT01268046|Hormones|hormones|mesh-ancestor
110401360|NCT01268046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110401361|NCT01268046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110401362|NCT01268046|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110401363|NCT01268046|Contraceptive Agents|contraceptive agents|mesh-ancestor
110401364|NCT01268046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110401365|NCT01268046|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110401366|NCT04732000|Acetylcysteine|acetylcysteine|mesh-list
110401367|NCT04732000|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110401368|NCT04732000|Antiviral Agents|antiviral agents|mesh-ancestor
110401369|NCT04732000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110401370|NCT04732000|Expectorants|expectorants|mesh-ancestor
110401371|NCT04732000|Respiratory System Agents|respiratory system agents|mesh-ancestor
110401372|NCT04732000|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110401373|NCT04732000|Antioxidants|antioxidants|mesh-ancestor
110401374|NCT04732000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110401375|NCT04732000|Protective Agents|protective agents|mesh-ancestor
110401376|NCT04732000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110401377|NCT04732000|Antidotes|antidotes|mesh-ancestor
110401378|NCT01267266|Hydrocortisone|hydrocortisone|mesh-list
110401379|NCT01267266|Saracatinib|saracatinib|mesh-list
110401380|NCT01267266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110401381|NCT01267266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110401382|NCT01267266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110401383|NCT01267266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110401385|NCT01034176|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110401386|NCT01034176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110401387|NCT01034176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110401388|NCT01034176|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110401389|NCT01034176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110401390|NCT01034176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110401391|NCT01034176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110401392|NCT01034176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110401393|NCT01034176|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110401394|NCT01034176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110401395|NCT02889432|Melatonin|melatonin|mesh-list
110401396|NCT02889432|Antioxidants|antioxidants|mesh-ancestor
110401397|NCT02889432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110401398|NCT02889432|Protective Agents|protective agents|mesh-ancestor
110401399|NCT02889432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110401400|NCT02889432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110401401|NCT01033942|Tenofovir|tenofovir|mesh-list
110401402|NCT01033942|Emtricitabine|emtricitabine|mesh-list
110401403|NCT01033942|Antiviral Agents|antiviral agents|mesh-ancestor
110401404|NCT01033942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110401405|NCT01033942|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110401406|NCT01033942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110401407|NCT01033942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110401408|NCT01033942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110401409|NCT01033942|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110401410|NCT01033942|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110401411|NCT01062256|Phenylpropanolamine|phenylpropanolamine|mesh-list
110401412|NCT01062256|Guaifenesin|guaifenesin|mesh-list
110401413|NCT01062256|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
110401414|NCT01062256|Expectorants|expectorants|mesh-ancestor
110401415|NCT01062256|Respiratory System Agents|respiratory system agents|mesh-ancestor
110401416|NCT01062256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110401417|NCT01062256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110401418|NCT01062256|Adrenergic Agents|adrenergic agents|mesh-ancestor
110401419|NCT01062256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110401420|NCT01062256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110401421|NCT01062256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110401422|NCT01062256|Appetite Depressants|appetite depressants|mesh-ancestor
110401423|NCT01062256|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110401424|NCT01062256|Sympathomimetics|sympathomimetics|mesh-ancestor
110401425|NCT01062256|Autonomic Agents|autonomic agents|mesh-ancestor
110401426|NCT01062256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110401427|NCT01062256|Nasal Decongestants|nasal decongestants|mesh-ancestor
110401428|NCT01062256|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110401429|NCT01029886|Liraglutide|liraglutide|mesh-list
110401430|NCT01029886|Exenatide|exenatide|mesh-list
110401431|NCT01029886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110401432|NCT01029886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110401433|NCT01029886|Incretins|incretins|mesh-ancestor
110401434|NCT01029886|Hormones|hormones|mesh-ancestor
110401435|NCT01029886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110401436|NCT01029886|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110401439|NCT01244061|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110401440|NCT01244061|Cholinergic Agents|cholinergic agents|mesh-ancestor
110401441|NCT01244061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110401442|NCT01244061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110401443|NCT01244061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110401444|NCT01243671|Adalimumab|adalimumab|mesh-list
110401445|NCT01243671|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110401446|NCT01243671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110401447|NCT01243671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110401448|NCT01240785|Metformin|metformin|mesh-list
110401449|NCT01240785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110401450|NCT01240785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110401451|NCT01266876|Alirocumab|alirocumab|mesh-list
110401452|NCT01266876|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110401453|NCT01266876|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110401454|NCT01266876|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110401455|NCT01266876|Antimetabolites|antimetabolites|mesh-ancestor
110401456|NCT01266876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110401457|NCT01266876|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110401458|NCT01266876|Protease Inhibitors|protease inhibitors|mesh-ancestor
110401459|NCT01266876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110401460|NCT01266876|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110401461|NCT01033240|Sorafenib|sorafenib|mesh-list
110401462|NCT01033240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110401463|NCT01033240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110401464|NCT01033240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110401465|NCT01033240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110401466|NCT01032382|Gentamicins|gentamicins|mesh-list
110401467|NCT01032382|Paromomycin|paromomycin|mesh-list
110401468|NCT01032382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110401469|NCT01032382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110401470|NCT01032382|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110401471|NCT01032382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110401472|NCT01032382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110401473|NCT01032382|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110401474|NCT01032382|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110401475|NCT01029652|Triamcinolone|triamcinolone|mesh-list
110401476|NCT01029652|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110401477|NCT01029652|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110401478|NCT01029652|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110401479|NCT01029652|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110401480|NCT01029652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110401481|NCT01029652|Glucocorticoids|glucocorticoids|mesh-ancestor
110401482|NCT01029652|Hormones|hormones|mesh-ancestor
110401483|NCT01029652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110401484|NCT01029652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110401485|NCT01029652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110401486|NCT01029652|Immunologic Factors|immunologic factors|mesh-ancestor
110401487|NCT01029652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110401488|NCT01029652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110401489|NCT01029340|Factor VIII|factor viii|mesh-list
110401490|NCT01029340|Coagulants|coagulants|mesh-ancestor
110401491|NCT01265550|Baclofen|baclofen|mesh-list
110401492|NCT01265550|Desipramine|desipramine|mesh-list
110401493|NCT01265550|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110401494|NCT01265550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110401495|NCT01265550|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110401496|NCT01265550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110401497|NCT01265550|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110401498|NCT01265550|GABA Agonists|gaba agonists|mesh-ancestor
110401499|NCT01265550|GABA Agents|gaba agents|mesh-ancestor
110401500|NCT01265550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110401501|NCT01265550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110401502|NCT01265550|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110401503|NCT01265550|Antidepressive Agents|antidepressive agents|mesh-ancestor
110401504|NCT01265550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110401505|NCT01265550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110401506|NCT01265550|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110401507|NCT01265550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110401508|NCT01265550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110401509|NCT01265550|Adrenergic Agents|adrenergic agents|mesh-ancestor
110401510|NCT01265394|Flutemetamol|flutemetamol|mesh-list
110401511|NCT01265394|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110401512|NCT01265394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030527|NCT01386593|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110401513|NCT01029262|Lenalidomide|lenalidomide|mesh-list
110401514|NCT01029262|Immunologic Factors|immunologic factors|mesh-ancestor
110401515|NCT01029262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110401516|NCT01029262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110401517|NCT01029262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110401518|NCT01029262|Growth Substances|growth substances|mesh-ancestor
110401519|NCT01029262|Growth Inhibitors|growth inhibitors|mesh-ancestor
110401520|NCT01029262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110401521|NCT01061710|Varenicline|varenicline|mesh-list
110401522|NCT01061710|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110401523|NCT01061710|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110401524|NCT01061710|Cholinergic Agents|cholinergic agents|mesh-ancestor
110401525|NCT01061710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110401526|NCT01061710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110401527|NCT01061710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110401528|NCT01028014|Pseudoephedrine|pseudoephedrine|mesh-list
110401530|NCT01028014|Cyclobenzaprine|cyclobenzaprine|mesh-list
110401531|NCT01028014|Imipramine|imipramine|mesh-list
110401532|NCT01028014|Tamsulosin|tamsulosin|mesh-list
110401533|NCT01028014|Solifenacin Succinate|solifenacin succinate|mesh-list
110401534|NCT01028014|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110401535|NCT01028014|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110401536|NCT01028014|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110401537|NCT01028014|Adrenergic Agents|adrenergic agents|mesh-ancestor
110401538|NCT01028014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110401539|NCT01028014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110401540|NCT01028014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110401541|NCT01028014|Urological Agents|urological agents|mesh-ancestor
110401542|NCT01028014|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110401543|NCT01028014|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110401544|NCT01028014|Cholinergic Agents|cholinergic agents|mesh-ancestor
110401545|NCT01028014|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110401546|NCT01028014|Autonomic Agents|autonomic agents|mesh-ancestor
110401547|NCT01028014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110401548|NCT01028014|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110401549|NCT01028014|Respiratory System Agents|respiratory system agents|mesh-ancestor
110401550|NCT01028014|Nasal Decongestants|nasal decongestants|mesh-ancestor
110401551|NCT01028014|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110401552|NCT01028014|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110401553|NCT01028014|Sympathomimetics|sympathomimetics|mesh-ancestor
110401554|NCT01028014|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110401555|NCT01028014|Antidepressive Agents|antidepressive agents|mesh-ancestor
110401556|NCT01028014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110401557|NCT01028014|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110401558|NCT01028014|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110401559|NCT01028014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110401560|NCT01028014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110401561|NCT01028014|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110401562|NCT01028014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110030538|NCT01386593|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110401563|NCT01028014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110401565|NCT01264770|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110401566|NCT01264770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110401568|NCT02873650|Dabrafenib|dabrafenib|mesh-list
110401569|NCT02873650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110401570|NCT02873650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110401571|NCT02873650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110401572|NCT02873650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110401573|NCT01302080|Sertraline|sertraline|mesh-list
110401574|NCT01302080|Antidepressive Agents|antidepressive agents|mesh-ancestor
110401575|NCT01302080|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110401576|NCT01302080|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110401577|NCT01302080|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110401578|NCT01302080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110401579|NCT01302080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110401580|NCT01302080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110401581|NCT01302080|Serotonin Agents|serotonin agents|mesh-ancestor
110401582|NCT01302080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110401584|NCT01032070|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110055970|NCT01501136|Dexamethasone|dexamethasone|mesh-list
110401585|NCT01032070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110401586|NCT01032070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110401587|NCT01032070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110401588|NCT01032070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110401589|NCT01032070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110401590|NCT01032070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110401591|NCT01032070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110401592|NCT01237899|Eplerenone|eplerenone|mesh-list
110401593|NCT01237899|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110401594|NCT01237899|Hormone Antagonists|hormone antagonists|mesh-ancestor
110401595|NCT01237899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110401596|NCT01237899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110401597|NCT01237899|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110401598|NCT01237899|Diuretics|diuretics|mesh-ancestor
110401599|NCT01237899|Natriuretic Agents|natriuretic agents|mesh-ancestor
110401600|NCT01237899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110401601|NCT01263444|Timolol|timolol|mesh-list
110401602|NCT01263444|Bimatoprost|bimatoprost|mesh-list
110401603|NCT01263444|Travoprost|travoprost|mesh-list
110401604|NCT01263444|Latanoprost|latanoprost|mesh-list
110401605|NCT01263444|Brinzolamide|brinzolamide|mesh-list
110401606|NCT01263444|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110401607|NCT01263444|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110401608|NCT01263444|Adrenergic Agents|adrenergic agents|mesh-ancestor
110401609|NCT01263444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110401610|NCT01263444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110401611|NCT01263444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110401612|NCT01263444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110401613|NCT01263444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110401614|NCT01263444|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110401615|NCT01263444|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110401616|NCT01263444|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110401617|NCT01263444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110401618|NCT01031836|Sifalimumab|sifalimumab|mesh-list
110401619|NCT01031836|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110401620|NCT01031836|Immunologic Factors|immunologic factors|mesh-ancestor
110401621|NCT01031836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110401623|NCT01237587|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110401624|NCT01237587|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110401625|NCT01237587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110401626|NCT01237587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110401627|NCT01237587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110401628|NCT01237587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110401629|NCT01237587|Analgesics|analgesics|mesh-ancestor
110401630|NCT01237587|Sensory System Agents|sensory system agents|mesh-ancestor
110401631|NCT01237587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110401632|NCT01237587|Antidepressive Agents|antidepressive agents|mesh-ancestor
110401633|NCT01237587|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110401634|NCT01237587|Dopamine Agents|dopamine agents|mesh-ancestor
110401635|NCT01031680|Dapagliflozin|dapagliflozin|mesh-list
110401636|NCT01031680|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110401637|NCT01031680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110401638|NCT01031680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110401639|NCT01031680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110401641|NCT01031446|Everolimus|everolimus|mesh-list
110401642|NCT01031446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110401643|NCT01031446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110401644|NCT01031446|Tubulin Modulators|tubulin modulators|mesh-ancestor
110401645|NCT01031446|Antimitotic Agents|antimitotic agents|mesh-ancestor
110401646|NCT01031446|Mitosis Modulators|mitosis modulators|mesh-ancestor
110401647|NCT01031446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110401648|NCT01031446|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110401649|NCT01031446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110401650|NCT01031446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110401651|NCT01031446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110401652|NCT01031446|Immunologic Factors|immunologic factors|mesh-ancestor
110401653|NCT01031446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110401654|NCT01030900|Prednisone|prednisone|mesh-list
110401655|NCT01030900|Cyclophosphamide|cyclophosphamide|mesh-list
110401656|NCT01030900|Rituximab|rituximab|mesh-list
110401657|NCT01030900|Doxorubicin|doxorubicin|mesh-list
110401658|NCT01030900|Etoposide|etoposide|mesh-list
110401659|NCT01030900|Vincristine|vincristine|mesh-list
110401660|NCT01030900|Alemtuzumab|alemtuzumab|mesh-list
110401661|NCT01030900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110401662|NCT01030900|Immunologic Factors|immunologic factors|mesh-ancestor
110401663|NCT01030900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110401664|NCT01030900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110401665|NCT01030900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110401666|NCT01030900|Alkylating Agents|alkylating agents|mesh-ancestor
110401667|NCT01030900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110401668|NCT01030900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110401669|NCT01030900|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110401670|NCT01030900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110401671|NCT01030900|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110401672|NCT01030900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110401673|NCT01030900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110401674|NCT01030900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110401675|NCT01030900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110401676|NCT01030900|Glucocorticoids|glucocorticoids|mesh-ancestor
110401677|NCT01030900|Hormones|hormones|mesh-ancestor
110401678|NCT01030900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110401679|NCT01030900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110401680|NCT01030900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110401681|NCT01030900|Tubulin Modulators|tubulin modulators|mesh-ancestor
110401682|NCT01030900|Antimitotic Agents|antimitotic agents|mesh-ancestor
110401683|NCT01030900|Mitosis Modulators|mitosis modulators|mesh-ancestor
110401684|NCT01030822|Vaccines|vaccines|mesh-list
110401685|NCT01030822|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110401686|NCT01030822|Immunologic Factors|immunologic factors|mesh-ancestor
110401687|NCT01030822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110401688|NCT01026454|Valacyclovir|valacyclovir|mesh-list
110401689|NCT01026454|Acyclovir|acyclovir|mesh-list
110401690|NCT01026454|Antiviral Agents|antiviral agents|mesh-ancestor
110401691|NCT01026454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110401692|NCT01026220|Prednisone|prednisone|mesh-list
110401693|NCT01026220|Cyclophosphamide|cyclophosphamide|mesh-list
110401694|NCT01026220|Ifosfamide|ifosfamide|mesh-list
110401695|NCT01026220|Doxorubicin|doxorubicin|mesh-list
110401696|NCT01026220|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110401697|NCT01026220|Etoposide|etoposide|mesh-list
110401699|NCT01026220|Vinorelbine|vinorelbine|mesh-list
110401700|NCT01026220|Bleomycin|bleomycin|mesh-list
110401701|NCT01026220|Etoposide phosphate|etoposide phosphate|mesh-list
110401702|NCT01026220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110401703|NCT01026220|Immunologic Factors|immunologic factors|mesh-ancestor
110401704|NCT01026220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110401705|NCT01026220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110401706|NCT01026220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110401707|NCT01026220|Alkylating Agents|alkylating agents|mesh-ancestor
110401708|NCT01026220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110401709|NCT01026220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110401710|NCT01026220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110401711|NCT01026220|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110401712|NCT01026220|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110401713|NCT01026220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110401714|NCT01026220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110401715|NCT01026220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110401716|NCT01026220|Glucocorticoids|glucocorticoids|mesh-ancestor
110401717|NCT01026220|Hormones|hormones|mesh-ancestor
110401718|NCT01026220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110401719|NCT01026220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110401720|NCT01026220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110401721|NCT01026220|Tubulin Modulators|tubulin modulators|mesh-ancestor
110401722|NCT01026220|Antimitotic Agents|antimitotic agents|mesh-ancestor
110401723|NCT01026220|Mitosis Modulators|mitosis modulators|mesh-ancestor
110401724|NCT01026142|Capecitabine|capecitabine|mesh-list
110401725|NCT01026142|Trastuzumab|trastuzumab|mesh-list
110401726|NCT01026142|Pertuzumab|pertuzumab|mesh-list
110401727|NCT01026142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110401728|NCT01026142|Antimetabolites|antimetabolites|mesh-ancestor
110401729|NCT01026142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110401730|NCT01026142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110401731|NCT01026142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110401732|NCT06055491|Vitamin D|vitamin d|mesh-list
110401733|NCT06055491|Cholecalciferol|cholecalciferol|mesh-list
110401734|NCT06055491|Vitamins|vitamins|mesh-ancestor
110401735|NCT06055491|Micronutrients|micronutrients|mesh-ancestor
110401736|NCT06055491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110401737|NCT06055491|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110401738|NCT06055491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110030588|NCT01386866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110401740|NCT06055465|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
110401741|NCT06055465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110401742|NCT06055465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110401743|NCT06055465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110401744|NCT06055465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110401745|NCT06055465|Immunoconjugates|immunoconjugates|mesh-ancestor
110401746|NCT06055465|Immunologic Factors|immunologic factors|mesh-ancestor
110401747|NCT06055465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110401748|NCT06055452|Empagliflozin|empagliflozin|mesh-list
110401749|NCT06055452|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110401750|NCT06055452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110401751|NCT06055452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110401752|NCT06055452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110401753|NCT06055348|Paclitaxel|paclitaxel|mesh-list
110401754|NCT06055348|Gemcitabine|gemcitabine|mesh-list
110401755|NCT06055348|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110401756|NCT06055348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110401757|NCT06055348|Tubulin Modulators|tubulin modulators|mesh-ancestor
110401758|NCT06055348|Antimitotic Agents|antimitotic agents|mesh-ancestor
110401759|NCT06055348|Mitosis Modulators|mitosis modulators|mesh-ancestor
110401760|NCT06055348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110401761|NCT06055348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110401762|NCT06055348|Antimetabolites|antimetabolites|mesh-ancestor
110401763|NCT06055335|Anesthetics|anesthetics|mesh-list
110401764|NCT06055335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110401765|NCT06055335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110401766|NCT06055257|Clodronic Acid|clodronic acid|mesh-list
110401767|NCT06055257|Tocopherols|tocopherols|mesh-list
110401768|NCT06055257|Pentoxifylline|pentoxifylline|mesh-list
110401769|NCT06055257|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110401770|NCT06055257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110401771|NCT06055257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110401772|NCT06055257|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110401773|NCT06055257|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110401774|NCT06055257|Protective Agents|protective agents|mesh-ancestor
110401775|NCT06055257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110401777|NCT06055257|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110401778|NCT06055257|Antioxidants|antioxidants|mesh-ancestor
110401779|NCT06055257|Vitamins|vitamins|mesh-ancestor
110401780|NCT06055257|Micronutrients|micronutrients|mesh-ancestor
110401781|NCT06055257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110401782|NCT06055244|Amantadine|amantadine|mesh-list
110401783|NCT06055244|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110401784|NCT06055244|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110401785|NCT06055244|Antiviral Agents|antiviral agents|mesh-ancestor
110401786|NCT06055244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110401787|NCT06055244|Dopamine Agents|dopamine agents|mesh-ancestor
110401788|NCT06055244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110401789|NCT06055244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110401790|NCT06055244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110401791|NCT06055244|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110401792|NCT06055244|Analgesics|analgesics|mesh-ancestor
110401793|NCT06055244|Sensory System Agents|sensory system agents|mesh-ancestor
110401794|NCT06055244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110401795|NCT06055179|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
110401796|NCT06055179|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110401797|NCT06055179|Hormone Antagonists|hormone antagonists|mesh-ancestor
110401798|NCT06055179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110401799|NCT06055179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110401800|NCT06055179|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110401801|NCT06055179|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110401802|NCT06055179|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110401803|NCT06055166|Capecitabine|capecitabine|mesh-list
110401804|NCT06055166|Fluzoparib|fluzoparib|mesh-list
110401805|NCT06055166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110401806|NCT06055166|Antimetabolites|antimetabolites|mesh-ancestor
110401807|NCT06055166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110401808|NCT06055166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110056189|NCT01501708|Hormone Antagonists|hormone antagonists|mesh-ancestor
110401809|NCT06055166|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110401810|NCT06055166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110401812|NCT06055153|Immunoconjugates|immunoconjugates|mesh-ancestor
110401813|NCT06055153|Immunologic Factors|immunologic factors|mesh-ancestor
110401814|NCT06055153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110401815|NCT06055101|Dexmedetomidine|dexmedetomidine|mesh-list
110401816|NCT06055101|Bupivacaine|bupivacaine|mesh-list
110401817|NCT06055101|Neostigmine|neostigmine|mesh-list
110401818|NCT06055101|Anesthetics, Local|anesthetics, local|mesh-ancestor
110401819|NCT06055101|Anesthetics|anesthetics|mesh-ancestor
110401820|NCT06055101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110401821|NCT06055101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110401822|NCT06055101|Sensory System Agents|sensory system agents|mesh-ancestor
110401823|NCT06055101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110401824|NCT06055101|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110401825|NCT06055101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110401826|NCT06055101|Analgesics|analgesics|mesh-ancestor
110401827|NCT06055101|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110401828|NCT06055101|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110401829|NCT06055101|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110401830|NCT06055101|Adrenergic Agents|adrenergic agents|mesh-ancestor
110401831|NCT06055101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110401832|NCT06055101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110401833|NCT06055101|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110401834|NCT06055101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110401835|NCT06055101|Cholinergic Agents|cholinergic agents|mesh-ancestor
110401836|NCT06055101|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110401837|NCT06055101|Autonomic Agents|autonomic agents|mesh-ancestor
110401838|NCT06055075|Daratumumab|daratumumab|mesh-list
110401839|NCT06055075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110401841|NCT06054919|Cholecalciferol|cholecalciferol|mesh-list
110401842|NCT06054919|Vitamins|vitamins|mesh-ancestor
110401843|NCT06054919|Micronutrients|micronutrients|mesh-ancestor
110401844|NCT06054919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110401845|NCT06054919|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110401846|NCT06054919|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110401847|NCT06054815|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110401848|NCT06054815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110401849|NCT06054815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110401850|NCT06054815|Incretins|incretins|mesh-ancestor
110401852|NCT06054815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110030632|NCT01387191|Tezosentan|tezosentan|mesh-list
110401853|NCT06054815|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110401854|NCT06054815|Protease Inhibitors|protease inhibitors|mesh-ancestor
110401855|NCT06054815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110401856|NCT06054815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110401857|NCT06054789|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110401858|NCT06054789|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110401859|NCT06054789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110401860|NCT06054776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110401861|NCT06054776|Obinutuzumab|obinutuzumab|mesh-list
110401862|NCT06054776|Acalabrutinib|acalabrutinib|mesh-list
110401863|NCT06054776|Antibodies|antibodies|mesh-list
110401864|NCT06054776|Immunoglobulins|immunoglobulins|mesh-list
110401865|NCT06054776|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110401866|NCT06054776|Antibodies, Bispecific|antibodies, bispecific|mesh-list
110401867|NCT06054776|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
110401868|NCT06054776|Immunologic Factors|immunologic factors|mesh-ancestor
110401869|NCT06054776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110401870|NCT06054776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110401871|NCT06054776|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110401872|NCT06054776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110401873|NCT06054776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110401874|NCT06054750|Ropivacaine|ropivacaine|mesh-list
110401875|NCT06054750|Anesthetics, Local|anesthetics, local|mesh-ancestor
110401876|NCT06054750|Anesthetics|anesthetics|mesh-ancestor
110401877|NCT06054750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110401878|NCT06054750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110401879|NCT06054750|Sensory System Agents|sensory system agents|mesh-ancestor
110401880|NCT06054750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110401881|NCT06054555|Nivolumab|nivolumab|mesh-list
110401882|NCT06054555|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110401883|NCT06054555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110401884|NCT06054555|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110401885|NCT06054555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110401887|NCT06054529|Vitamin B Complex|vitamin b complex|mesh-ancestor
110401889|NCT06054529|Micronutrients|micronutrients|mesh-ancestor
110401890|NCT06054529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110401891|NCT06054477|Pembrolizumab|pembrolizumab|mesh-list
110401892|NCT06054477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110401893|NCT06054477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110401894|NCT06054477|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110401895|NCT06054477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110401896|NCT06054464|Rabeprazole|rabeprazole|mesh-list
110401897|NCT06054464|Famotidine|famotidine|mesh-list
110401898|NCT06054464|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110401899|NCT06054464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110401900|NCT06054464|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110401901|NCT06054464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110401902|NCT06054464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110401903|NCT06054464|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110401904|NCT06054464|Histamine Antagonists|histamine antagonists|mesh-ancestor
110401905|NCT06054464|Histamine Agents|histamine agents|mesh-ancestor
110401906|NCT06054464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110401908|NCT06054321|Dexetimide|dexetimide|mesh-list
110401909|NCT06054321|Aripiprazole|aripiprazole|mesh-list
110401910|NCT06054321|Mirtazapine|mirtazapine|mesh-list
110401911|NCT06054321|Citalopram|citalopram|mesh-list
110401912|NCT06054321|Antidepressive Agents|antidepressive agents|mesh-list
110401913|NCT06054321|Escitalopram|escitalopram|mesh-list
110401914|NCT06054321|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110401915|NCT06054321|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110401916|NCT06054321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110401917|NCT06054321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110401918|NCT06054321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110401919|NCT06054321|Serotonin Agents|serotonin agents|mesh-ancestor
110401920|NCT06054321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110401921|NCT06054321|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110401922|NCT06054321|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110401923|NCT06054321|Parasympatholytics|parasympatholytics|mesh-ancestor
110401924|NCT06054321|Autonomic Agents|autonomic agents|mesh-ancestor
110401925|NCT06054321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110401926|NCT06054321|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110401927|NCT06054321|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110401928|NCT06054321|Cholinergic Agents|cholinergic agents|mesh-ancestor
110401929|NCT06054321|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110401930|NCT06054321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110401931|NCT06054321|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110401932|NCT06054321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110401933|NCT06054321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110401934|NCT06054321|Dopamine Agonists|dopamine agonists|mesh-ancestor
110401935|NCT06054321|Dopamine Agents|dopamine agents|mesh-ancestor
110401936|NCT06054321|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110401937|NCT06054321|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110401938|NCT06054321|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110401939|NCT06054321|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110401940|NCT06054321|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110401941|NCT06054321|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110401942|NCT06054321|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110401943|NCT06054321|Histamine Antagonists|histamine antagonists|mesh-ancestor
110401944|NCT06054321|Histamine Agents|histamine agents|mesh-ancestor
110401945|NCT06054321|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110401946|NCT06054321|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110401947|NCT06054321|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110401948|NCT06054321|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110401949|NCT06054321|Adrenergic Agents|adrenergic agents|mesh-ancestor
110401950|NCT06054321|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110401951|NCT06054191|Trametinib|trametinib|mesh-list
110401952|NCT06054191|Dabrafenib|dabrafenib|mesh-list
110401953|NCT06054191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110401954|NCT06054191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110401955|NCT06054191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110401956|NCT06054191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110401957|NCT06054152|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110401958|NCT06054152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110401959|NCT06054152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110401960|NCT06054152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110401962|NCT06054113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110401964|NCT06054100|Gout Suppressants|gout suppressants|mesh-ancestor
110401965|NCT06054100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110401966|NCT06054100|Tubulin Modulators|tubulin modulators|mesh-ancestor
110401967|NCT06054100|Antimitotic Agents|antimitotic agents|mesh-ancestor
110401968|NCT06054100|Mitosis Modulators|mitosis modulators|mesh-ancestor
110401969|NCT06054100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110401970|NCT06054100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110401971|NCT06054035|Dapagliflozin|dapagliflozin|mesh-list
110401972|NCT06054035|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110401973|NCT06054035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110401974|NCT06054035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110401976|NCT06053983|Atorvastatin|atorvastatin|mesh-list
110401977|NCT06053983|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110401978|NCT06053983|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110401979|NCT06053983|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110401980|NCT06053983|Antimetabolites|antimetabolites|mesh-ancestor
110401981|NCT06053983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110401982|NCT06053983|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110401983|NCT06053983|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110401984|NCT06053983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110401985|NCT06053853|Antitoxins|antitoxins|mesh-list
110401986|NCT06053853|Diphtheria Antitoxin|diphtheria antitoxin|mesh-list
110401987|NCT06053853|Immunologic Factors|immunologic factors|mesh-ancestor
110401988|NCT06053853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110401990|NCT06053840|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110401991|NCT06053840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110401992|NCT06053840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110401993|NCT06053801|Omalizumab|omalizumab|mesh-list
110401994|NCT06053801|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110401995|NCT06053801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110401996|NCT06053801|Respiratory System Agents|respiratory system agents|mesh-ancestor
110401997|NCT06053749|Interferon-beta|interferon-beta|mesh-list
110401998|NCT06053749|Interferon beta-1b|interferon beta-1b|mesh-list
110401999|NCT06053749|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110402000|NCT06053749|Immunologic Factors|immunologic factors|mesh-ancestor
110402001|NCT06053749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110402002|NCT06053749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110402003|NCT06053749|Antiviral Agents|antiviral agents|mesh-ancestor
110402004|NCT06053749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110402005|NCT06053658|Nivolumab|nivolumab|mesh-list
110402006|NCT06053658|Tivozanib|tivozanib|mesh-list
110402007|NCT06053658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110402008|NCT06053658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110402009|NCT06053658|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110402010|NCT06053658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110402011|NCT06053658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110402012|NCT06053658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110402038|NCT06050824|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110402039|NCT06050824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110402040|NCT06050824|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110402041|NCT06050824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110402042|NCT06050824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110402043|NCT06050824|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110402056|NCT06036823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110402057|NCT06036823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110402058|NCT06036823|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110402059|NCT06036823|Autonomic Agents|autonomic agents|mesh-ancestor
110402060|NCT06036823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110402061|NCT06036823|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110402062|NCT06036823|Respiratory System Agents|respiratory system agents|mesh-ancestor
110402063|NCT06036823|Tocolytic Agents|tocolytic agents|mesh-ancestor
110402064|NCT06036823|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110402065|NCT06036823|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110402066|NCT06036823|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110402067|NCT06036823|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110402068|NCT06036823|Adrenergic Agents|adrenergic agents|mesh-ancestor
110402069|NCT06036823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110402070|NCT06036823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110402071|NCT06035874|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
110402072|NCT06035874|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110402073|NCT06035874|Antimetabolites|antimetabolites|mesh-ancestor
110402074|NCT06035874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110402075|NCT06035874|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110402076|NCT06035874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110402077|NCT06035874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110402095|NCT06026852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110402096|NCT06026852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110402097|NCT06026852|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110402098|NCT06026852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110402099|NCT06026852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110402100|NCT06024096|Atorvastatin|atorvastatin|mesh-list
110402101|NCT06024096|Vaccines|vaccines|mesh-list
110402102|NCT06024096|Immunologic Factors|immunologic factors|mesh-ancestor
110402103|NCT06024096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110056492|NCT01503398|Olanzapine|olanzapine|mesh-list
110402104|NCT06024096|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110402105|NCT06024096|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110402106|NCT06024096|Antimetabolites|antimetabolites|mesh-ancestor
110402107|NCT06024096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110402108|NCT06024096|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110402109|NCT06024096|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110402111|NCT06022146|Rifampin|rifampin|mesh-list
110402112|NCT06022146|Rifapentine|rifapentine|mesh-list
110402113|NCT06022146|Isoniazid|isoniazid|mesh-list
110402114|NCT06022146|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110402115|NCT06022146|Antitubercular Agents|antitubercular agents|mesh-ancestor
110402116|NCT06022146|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110402117|NCT06022146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110402118|NCT06022146|Leprostatic Agents|leprostatic agents|mesh-ancestor
110402119|NCT06022146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110402120|NCT06022146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110402121|NCT06022146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110402122|NCT06022146|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110402123|NCT06022146|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110402124|NCT06022146|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110402125|NCT06022146|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110402126|NCT06022146|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110402127|NCT06022146|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110402128|NCT06022146|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110402129|NCT06022146|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110402130|NCT06022146|Antimetabolites|antimetabolites|mesh-ancestor
110402131|NCT06022146|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110402133|NCT06021990|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110402139|NCT06021990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110402140|NCT06021990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110402147|NCT05983354|Ketorolac|ketorolac|mesh-list
110402148|NCT05983354|Metoclopramide|metoclopramide|mesh-list
110402149|NCT05983354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110402150|NCT05983354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110402151|NCT05983354|Analgesics|analgesics|mesh-ancestor
110402152|NCT05983354|Sensory System Agents|sensory system agents|mesh-ancestor
110402153|NCT05983354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110402154|NCT05983354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110402155|NCT05983354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110402156|NCT05983354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110402157|NCT05983354|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110402158|NCT05983354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110402159|NCT05983354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110402160|NCT05983354|Antiemetics|antiemetics|mesh-ancestor
110402161|NCT05983354|Autonomic Agents|autonomic agents|mesh-ancestor
110402162|NCT05983354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110402166|NCT05983354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110402178|NCT05959044|Vitamins|vitamins|mesh-ancestor
110402179|NCT05959044|Micronutrients|micronutrients|mesh-ancestor
110402180|NCT05959044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110402181|NCT05959044|Hematinics|hematinics|mesh-ancestor
110402182|NCT05959044|Vitamin B Complex|vitamin b complex|mesh-ancestor
110402184|NCT05955924|Niacin|niacin|mesh-list
110402185|NCT05955924|Nicotinic Acids|nicotinic acids|mesh-list
110402186|NCT05955924|Vitamin B Complex|vitamin b complex|mesh-ancestor
110402187|NCT05955924|Vitamins|vitamins|mesh-ancestor
110402188|NCT05955924|Micronutrients|micronutrients|mesh-ancestor
110402189|NCT05955924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110402190|NCT05955924|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110402191|NCT05955924|Antimetabolites|antimetabolites|mesh-ancestor
110402192|NCT05955924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110402193|NCT05955924|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110402194|NCT05955924|Vasodilator Agents|vasodilator agents|mesh-ancestor
110402195|NCT05954962|Progesterone|progesterone|mesh-list
110402196|NCT05954962|Ganirelix|ganirelix|mesh-list
110402197|NCT05954962|Progestins|progestins|mesh-ancestor
110402198|NCT05954962|Hormones|hormones|mesh-ancestor
110402199|NCT05954962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110402200|NCT05954962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110402201|NCT05954962|Hormone Antagonists|hormone antagonists|mesh-ancestor
110402202|NCT05943691|Dexamethasone|dexamethasone|mesh-list
110402203|NCT05943691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110402204|NCT05943691|Antiemetics|antiemetics|mesh-ancestor
110402205|NCT05943691|Autonomic Agents|autonomic agents|mesh-ancestor
110402206|NCT05943691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110402207|NCT05943691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110402208|NCT05943691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110402211|NCT05943691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110402212|NCT05943691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110402213|NCT05943691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110402214|NCT05941767|Lidocaine|lidocaine|mesh-list
110402215|NCT05941767|Dexmedetomidine|dexmedetomidine|mesh-list
110402216|NCT05941767|Anesthetics, Local|anesthetics, local|mesh-ancestor
110402217|NCT05941767|Anesthetics|anesthetics|mesh-ancestor
110402218|NCT05941767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110402219|NCT05941767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110402220|NCT05941767|Sensory System Agents|sensory system agents|mesh-ancestor
110402221|NCT05941767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110402222|NCT05941767|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110402223|NCT05941767|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110402224|NCT05941767|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110402225|NCT05941767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110402226|NCT05941767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110402227|NCT05941767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110402228|NCT05941767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110402229|NCT05941767|Analgesics|analgesics|mesh-ancestor
110402230|NCT05941767|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110402231|NCT05941767|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110402232|NCT05941767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110402233|NCT05941767|Adrenergic Agents|adrenergic agents|mesh-ancestor
110402234|NCT05941767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110402235|NCT05935930|Propofol|propofol|mesh-list
110402236|NCT05935930|Sevoflurane|sevoflurane|mesh-list
110402237|NCT05935930|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110402238|NCT05935930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110402239|NCT05935930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110402240|NCT05935930|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110402241|NCT05935930|Anesthetics, General|anesthetics, general|mesh-ancestor
110402242|NCT05935930|Anesthetics|anesthetics|mesh-ancestor
110402243|NCT05935930|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110402244|NCT05935930|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110402245|NCT05931575|Quinine|quinine|mesh-list
110402247|NCT05931575|1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine|1-(5-isoquinolinesulfonyl)-2-methylpiperazine|mesh-list
110402248|NCT05931575|Antimalarials|antimalarials|mesh-ancestor
110402249|NCT05931575|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110402250|NCT05931575|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110402251|NCT05931575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110402252|NCT05931575|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110402253|NCT05931575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110402254|NCT05931575|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110402255|NCT05931575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110402256|NCT05931575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110402257|NCT05931575|Analgesics|analgesics|mesh-ancestor
110402258|NCT05931575|Sensory System Agents|sensory system agents|mesh-ancestor
110402259|NCT05931575|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110402260|NCT05931575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110402261|NCT05931575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110402326|NCT05891119|Caffeine citrate|caffeine citrate|mesh-list
110402327|NCT05891119|Omeprazole|omeprazole|mesh-list
110402328|NCT05891119|Warfarin|warfarin|mesh-list
110402329|NCT05891119|Vitamins|vitamins|mesh-ancestor
110402330|NCT05891119|Micronutrients|micronutrients|mesh-ancestor
110402331|NCT05891119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110402332|NCT05891119|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110402333|NCT05891119|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110402334|NCT05891119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110402335|NCT05891119|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110402336|NCT05891119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110402337|NCT05891119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110402338|NCT05891119|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110402339|NCT05891119|Anesthetics, General|anesthetics, general|mesh-ancestor
110402340|NCT05891119|Anesthetics|anesthetics|mesh-ancestor
110402341|NCT05891119|GABA Modulators|gaba modulators|mesh-ancestor
110402342|NCT05891119|GABA Agents|gaba agents|mesh-ancestor
110402343|NCT05891119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110402344|NCT05891119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110402345|NCT05891119|Anticoagulants|anticoagulants|mesh-ancestor
110402346|NCT05891119|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110402347|NCT05891119|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110402348|NCT05891119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110402349|NCT05891119|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110402350|NCT05891119|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110402351|NCT05891119|Purinergic Agents|purinergic agents|mesh-ancestor
110402352|NCT05891119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110402353|NCT05891119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110402354|NCT05891119|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110402355|NCT05891119|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110402356|NCT05891119|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110402357|NCT05891119|Sympatholytics|sympatholytics|mesh-ancestor
110402358|NCT05891119|Autonomic Agents|autonomic agents|mesh-ancestor
110402359|NCT05891119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110402360|NCT05891119|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110402361|NCT05891119|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110402362|NCT05891119|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110402363|NCT05891119|Adrenergic Agents|adrenergic agents|mesh-ancestor
110402370|NCT05890586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110402371|NCT05890586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110402372|NCT05890586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110402373|NCT05890586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110402374|NCT05890586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110402375|NCT05890586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110402376|NCT05890586|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110402377|NCT05890586|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110402378|NCT05890586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110402379|NCT05890586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110402380|NCT05890586|Serotonin Agents|serotonin agents|mesh-ancestor
110402381|NCT05890586|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110402382|NCT05890586|Antidepressive Agents|antidepressive agents|mesh-ancestor
110402383|NCT05890586|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110402384|NCT05890586|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110402385|NCT05890586|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110402391|NCT05873881|Thiamine|thiamine|mesh-list
110402392|NCT05873881|Colchicine|colchicine|mesh-list
110402393|NCT05873881|Gout Suppressants|gout suppressants|mesh-ancestor
110402394|NCT05873881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110402395|NCT05873881|Tubulin Modulators|tubulin modulators|mesh-ancestor
110402396|NCT05873881|Antimitotic Agents|antimitotic agents|mesh-ancestor
110402397|NCT05873881|Mitosis Modulators|mitosis modulators|mesh-ancestor
110402398|NCT05873881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110402399|NCT05873881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110402400|NCT05873881|Vitamin B Complex|vitamin b complex|mesh-ancestor
110402401|NCT05873881|Vitamins|vitamins|mesh-ancestor
110402402|NCT05873881|Micronutrients|micronutrients|mesh-ancestor
110030745|NCT01388088|Natriuretic Agents|natriuretic agents|mesh-ancestor
110030751|NCT01388101|Antibodies|antibodies|mesh-list
110402403|NCT05873881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110402404|NCT05866055|Midazolam|midazolam|mesh-list
110402405|NCT05866055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110402406|NCT05866055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110402407|NCT05866055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110402408|NCT05866055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110402409|NCT05866055|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110402410|NCT05866055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110402411|NCT05866055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110402412|NCT05866055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110402413|NCT05866055|Anesthetics, General|anesthetics, general|mesh-ancestor
110402414|NCT05866055|Anesthetics|anesthetics|mesh-ancestor
110402415|NCT05866055|GABA Modulators|gaba modulators|mesh-ancestor
110402417|NCT05866055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110402418|NCT05866055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110402419|NCT05864625|Propofol|propofol|mesh-list
110402420|NCT05864625|Sevoflurane|sevoflurane|mesh-list
110402421|NCT05864625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110402422|NCT05864625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110402423|NCT05864625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110402424|NCT05864625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110402425|NCT05864625|Anesthetics, General|anesthetics, general|mesh-ancestor
110402427|NCT05864625|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110402428|NCT05864625|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110402429|NCT05852769|Flurbiprofen|flurbiprofen|mesh-list
110402430|NCT05852769|Digoxin|digoxin|mesh-list
110402431|NCT05852769|Midazolam|midazolam|mesh-list
110402432|NCT05852769|Caffeine|caffeine|mesh-list
110402433|NCT05852769|Omeprazole|omeprazole|mesh-list
110402434|NCT05852769|Pravastatin|pravastatin|mesh-list
110402435|NCT05852769|Montelukast|montelukast|mesh-list
110402436|NCT05852769|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110402437|NCT05852769|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110402438|NCT05852769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110402439|NCT05852769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110402440|NCT05852769|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110402441|NCT05852769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110402442|NCT05852769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110402443|NCT05852769|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110402444|NCT05852769|Anesthetics, General|anesthetics, general|mesh-ancestor
110402445|NCT05852769|Anesthetics|anesthetics|mesh-ancestor
110402446|NCT05852769|GABA Modulators|gaba modulators|mesh-ancestor
110402447|NCT05852769|GABA Agents|gaba agents|mesh-ancestor
110402448|NCT05852769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110402449|NCT05852769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110402450|NCT05852769|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110402451|NCT05852769|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110402453|NCT05852769|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110402454|NCT05852769|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110402455|NCT05852769|Purinergic Agents|purinergic agents|mesh-ancestor
110402456|NCT05852769|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110402457|NCT05852769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110402458|NCT05852769|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110402459|NCT05852769|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110402460|NCT05852769|Respiratory System Agents|respiratory system agents|mesh-ancestor
110402461|NCT05852769|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110030754|NCT01388114|Antibodies|antibodies|mesh-list
110402462|NCT05852769|Hormone Antagonists|hormone antagonists|mesh-ancestor
110402463|NCT05852769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110402464|NCT05852769|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110402465|NCT05852769|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110402466|NCT05852769|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110402467|NCT05852769|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110402468|NCT05852769|Protective Agents|protective agents|mesh-ancestor
110402471|NCT05852769|Antimetabolites|antimetabolites|mesh-ancestor
110402472|NCT05852769|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110402473|NCT05852769|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110402474|NCT05852769|Analgesics|analgesics|mesh-ancestor
110402475|NCT05852769|Sensory System Agents|sensory system agents|mesh-ancestor
110402476|NCT05852769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110402477|NCT05852769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110402478|NCT05852769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110402479|NCT05852769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110402480|NCT05852769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110402481|NCT05852769|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110402505|NCT05844501|Antiemetics|antiemetics|mesh-ancestor
110402506|NCT05844501|Autonomic Agents|autonomic agents|mesh-ancestor
110402507|NCT05844501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110402508|NCT05844501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110402509|NCT05844501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110402510|NCT05844501|Antipruritics|antipruritics|mesh-ancestor
110402511|NCT05844501|Dermatologic Agents|dermatologic agents|mesh-ancestor
110402512|NCT05844501|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110402513|NCT05844501|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110402514|NCT05844501|Serotonin Agents|serotonin agents|mesh-ancestor
110402515|NCT05844501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110402516|NCT05844501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110402517|NCT05843643|Upadacitinib|upadacitinib|mesh-list
110402518|NCT05843643|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110402519|NCT05843643|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110402520|NCT05843643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110402521|NCT05843643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110402523|NCT05822583|Abatacept|abatacept|mesh-list
110402524|NCT05822583|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110402525|NCT05822583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110402526|NCT05822583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110402527|NCT05822583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110402528|NCT05822583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110402529|NCT05822583|Immunologic Factors|immunologic factors|mesh-ancestor
110402531|NCT05822583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110402549|NCT05793060|Dexmedetomidine|dexmedetomidine|mesh-list
110402550|NCT05793060|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
110402551|NCT05793060|BB 1101|bb 1101|mesh-list
110402552|NCT05793060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110402553|NCT05793060|Antiemetics|antiemetics|mesh-ancestor
110402554|NCT05793060|Autonomic Agents|autonomic agents|mesh-ancestor
110402555|NCT05793060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110402556|NCT05793060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110402557|NCT05793060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110402558|NCT05793060|Glucocorticoids|glucocorticoids|mesh-ancestor
110056934|NCT01505127|Dexlansoprazole|dexlansoprazole|mesh-list
110402560|NCT05793060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110402561|NCT05793060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110402562|NCT05793060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110402563|NCT05793060|Protease Inhibitors|protease inhibitors|mesh-ancestor
110402564|NCT05793060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110402565|NCT05793060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110402566|NCT05793060|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110402567|NCT05793060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110402568|NCT05793060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110402569|NCT05793060|Analgesics|analgesics|mesh-ancestor
110402570|NCT05793060|Sensory System Agents|sensory system agents|mesh-ancestor
110402571|NCT05793060|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110402572|NCT05793060|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110402601|NCT05773092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110402602|NCT05773092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110402603|NCT05767034|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110402604|NCT05767034|Immunologic Factors|immunologic factors|mesh-ancestor
110402605|NCT05767034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110402606|NCT05759754|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110402607|NCT05759754|Protease Inhibitors|protease inhibitors|mesh-ancestor
110402608|NCT05759754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110402609|NCT05759754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110402610|NCT05755035|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110402611|NCT05755035|Immunoglobulins|immunoglobulins|mesh-list
110402613|NCT05755035|gamma-Globulins|gamma-globulins|mesh-list
110402614|NCT05755035|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110402615|NCT05755035|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110402616|NCT05755035|Immunoglobulin G|immunoglobulin g|mesh-list
110402617|NCT05755035|Immunologic Factors|immunologic factors|mesh-ancestor
110402618|NCT05755035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110402620|NCT05744739|Venetoclax|venetoclax|mesh-list
110402621|NCT05744739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110402622|NCT05744739|Antimetabolites|antimetabolites|mesh-ancestor
110402623|NCT05744739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110402624|NCT05744739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110402625|NCT05744739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110402627|NCT05734443|Luteolytic Agents|luteolytic agents|mesh-ancestor
110402628|NCT05734443|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110402629|NCT05734443|Contraceptive Agents|contraceptive agents|mesh-ancestor
110402630|NCT05734443|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110402631|NCT05734443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110402632|NCT05734443|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110402633|NCT05734443|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110402634|NCT05734443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110402635|NCT05715229|Paclitaxel|paclitaxel|mesh-list
110402636|NCT05715229|Carboplatin|carboplatin|mesh-list
110402637|NCT05715229|Nivolumab|nivolumab|mesh-list
110402638|NCT05715229|Pemetrexed|pemetrexed|mesh-list
110402639|NCT05715229|Ipilimumab|ipilimumab|mesh-list
110402640|NCT05715229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110402641|NCT05715229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110402642|NCT05715229|Tubulin Modulators|tubulin modulators|mesh-ancestor
110402643|NCT05715229|Antimitotic Agents|antimitotic agents|mesh-ancestor
110402644|NCT05715229|Mitosis Modulators|mitosis modulators|mesh-ancestor
110402645|NCT05715229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110402647|NCT05715229|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110402648|NCT05715229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110402649|NCT05715229|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110402650|NCT05715229|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110402668|NCT05707455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110402669|NCT05707455|Analgesics|analgesics|mesh-ancestor
110402670|NCT05707455|Sensory System Agents|sensory system agents|mesh-ancestor
110402671|NCT05707455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110402672|NCT05707455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110402673|NCT05707455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110402674|NCT05707455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110402675|NCT05705492|Olanzapine|olanzapine|mesh-list
110402676|NCT05705492|Antiemetics|antiemetics|mesh-ancestor
110402677|NCT05705492|Autonomic Agents|autonomic agents|mesh-ancestor
110402678|NCT05705492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110402679|NCT05705492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110402680|NCT05705492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110402681|NCT05705492|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110402682|NCT05705492|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110402683|NCT05705492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110402684|NCT05705492|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110402685|NCT05705492|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110402686|NCT05705492|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110402687|NCT05705492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110402688|NCT05705492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110402689|NCT05705492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110402690|NCT05705492|Serotonin Agents|serotonin agents|mesh-ancestor
110402691|NCT05704725|Aflibercept|aflibercept|mesh-list
110402692|NCT05704725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110402693|NCT05704725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110402694|NCT05704725|Growth Substances|growth substances|mesh-ancestor
110402695|NCT05704725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110402729|NCT05628038|Oxaliplatin|oxaliplatin|mesh-list
110402730|NCT05628038|Irinotecan|irinotecan|mesh-list
110402731|NCT05628038|Antibodies|antibodies|mesh-list
110402732|NCT05628038|Levoleucovorin|levoleucovorin|mesh-list
110402735|NCT05628038|Antimetabolites|antimetabolites|mesh-ancestor
110402736|NCT05628038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110402746|NCT05628038|Vitamins|vitamins|mesh-ancestor
110402747|NCT05628038|Micronutrients|micronutrients|mesh-ancestor
110402748|NCT05628038|Hematinics|hematinics|mesh-ancestor
110402749|NCT05628038|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110402756|NCT05625399|Relatlimab|relatlimab|mesh-list
110402757|NCT05625399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110402758|NCT05625399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110402759|NCT05625399|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110402760|NCT05625399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110402761|NCT05615051|Hydrogen Peroxide|hydrogen peroxide|mesh-list
110402762|NCT05615051|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110402763|NCT05615051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110402764|NCT05613842|Copper|copper|mesh-list
110402765|NCT05613842|Bombesin|bombesin|mesh-list
110402766|NCT05613842|Trace Elements|trace elements|mesh-ancestor
110402767|NCT05613842|Micronutrients|micronutrients|mesh-ancestor
110402768|NCT05613842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110402769|NCT05613842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110402770|NCT05613842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110402779|NCT05599984|Carboplatin|carboplatin|mesh-list
110402780|NCT05599984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110402781|NCT05592951|Methamphetamine|methamphetamine|mesh-list
110402782|NCT05592951|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110402783|NCT05592951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110402784|NCT05592951|Sympathomimetics|sympathomimetics|mesh-ancestor
110402786|NCT05592951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110402787|NCT05592951|Dopamine Agents|dopamine agents|mesh-ancestor
110402788|NCT05592951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110402789|NCT05592951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110402790|NCT05592951|Adrenergic Agents|adrenergic agents|mesh-ancestor
110402791|NCT05592951|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110402792|NCT05592951|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110402793|NCT05592951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110402794|NCT05592951|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110402795|NCT05585125|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110402796|NCT05585125|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110402797|NCT05585125|Adrenergic Agents|adrenergic agents|mesh-ancestor
110402798|NCT05585125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110402799|NCT05585125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110402800|NCT05585125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110402801|NCT05583474|Carteolol|carteolol|mesh-list
110402802|NCT05583474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110402803|NCT05583474|Latanoprost|latanoprost|mesh-list
110402804|NCT05583474|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110402805|NCT05583474|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110402806|NCT05583474|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110402807|NCT05583474|Adrenergic Agents|adrenergic agents|mesh-ancestor
110402808|NCT05583474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110402809|NCT05583474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110402810|NCT05583474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110402811|NCT05583474|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110402812|NCT05583474|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110402813|NCT05583474|Sympatholytics|sympatholytics|mesh-ancestor
110402814|NCT05583474|Autonomic Agents|autonomic agents|mesh-ancestor
110402815|NCT05583474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110402816|NCT05579119|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110402817|NCT05579119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110402818|NCT05579119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110402819|NCT05579119|Incretins|incretins|mesh-ancestor
110402820|NCT05579119|Hormones|hormones|mesh-ancestor
110402821|NCT05579119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110402822|NCT05579119|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110402823|NCT05579119|Protease Inhibitors|protease inhibitors|mesh-ancestor
110402824|NCT05579119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110402825|NCT05579119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110402826|NCT05575180|Acetazolamide|acetazolamide|mesh-list
110402827|NCT05575180|Methazolamide|methazolamide|mesh-list
110402828|NCT05575180|Anticonvulsants|anticonvulsants|mesh-ancestor
110402831|NCT05575180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110402832|NCT05575180|Diuretics|diuretics|mesh-ancestor
110402833|NCT05575180|Natriuretic Agents|natriuretic agents|mesh-ancestor
110402834|NCT05575180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110402899|NCT05487235|Omeprazole|omeprazole|mesh-list
110402900|NCT05487235|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110402901|NCT05487235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110402902|NCT05487235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110402903|NCT05487235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110402904|NCT05487235|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110402905|NCT05487235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110402906|NCT05487235|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110402907|NCT05487235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110402908|NCT05477004|Ketamine|ketamine|mesh-list
110402909|NCT05477004|Analgesics|analgesics|mesh-ancestor
110402910|NCT05477004|Sensory System Agents|sensory system agents|mesh-ancestor
110402911|NCT05477004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110402912|NCT05477004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110402913|NCT05477004|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110402914|NCT05477004|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110402915|NCT05477004|Anesthetics, General|anesthetics, general|mesh-ancestor
110402916|NCT05477004|Anesthetics|anesthetics|mesh-ancestor
110402917|NCT05477004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110402918|NCT05477004|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110402919|NCT05477004|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110402920|NCT05477004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110402921|NCT05477004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110402922|NCT05450029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110402923|NCT05450029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110402924|NCT05450029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110402925|NCT05450029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110402926|NCT05446870|Paclitaxel|paclitaxel|mesh-list
110402927|NCT05446870|Docetaxel|docetaxel|mesh-list
110402928|NCT05446870|Bevacizumab|bevacizumab|mesh-list
110402929|NCT05446870|Carboplatin|carboplatin|mesh-list
110402930|NCT05446870|Pembrolizumab|pembrolizumab|mesh-list
110402931|NCT05446870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110402932|NCT05446870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110402933|NCT05446870|Tubulin Modulators|tubulin modulators|mesh-ancestor
110402934|NCT05446870|Antimitotic Agents|antimitotic agents|mesh-ancestor
110402935|NCT05446870|Mitosis Modulators|mitosis modulators|mesh-ancestor
110402936|NCT05446870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110402937|NCT05446870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110402938|NCT05446870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110402939|NCT05446870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110402940|NCT05446870|Growth Substances|growth substances|mesh-ancestor
110402941|NCT05446870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110402942|NCT05446870|Growth Inhibitors|growth inhibitors|mesh-ancestor
110402943|NCT05446870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110402944|NCT05443555|Gabapentin|gabapentin|mesh-list
110402945|NCT05443555|Analgesics|analgesics|mesh-ancestor
110402946|NCT05443555|Sensory System Agents|sensory system agents|mesh-ancestor
110402947|NCT05443555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110402948|NCT05443555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110402949|NCT05443555|Anticonvulsants|anticonvulsants|mesh-ancestor
110402950|NCT05443555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110402951|NCT05443555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110402952|NCT05443555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110402953|NCT05443555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110402954|NCT05443555|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110402955|NCT05443555|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110402956|NCT05443555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110402957|NCT05443555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110402958|NCT05443555|Antimanic Agents|antimanic agents|mesh-ancestor
110402959|NCT05425420|Methadone|methadone|mesh-list
110402960|NCT05425420|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110402961|NCT05425420|Narcotics|narcotics|mesh-ancestor
110402962|NCT05425420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110402963|NCT05425420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110402964|NCT05425420|Analgesics|analgesics|mesh-ancestor
110402965|NCT05425420|Sensory System Agents|sensory system agents|mesh-ancestor
110402966|NCT05425420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110402967|NCT05425420|Antitussive Agents|antitussive agents|mesh-ancestor
110402968|NCT05425420|Respiratory System Agents|respiratory system agents|mesh-ancestor
110402969|NCT05425056|Sirolimus|sirolimus|mesh-list
110402970|NCT05425056|Temsirolimus|temsirolimus|mesh-list
110402971|NCT05425056|MTOR Inhibitors|mtor inhibitors|mesh-list
110402972|NCT05425056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110402973|NCT05425056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110402974|NCT05425056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110402975|NCT05425056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110402976|NCT05425056|Antifungal Agents|antifungal agents|mesh-ancestor
110402977|NCT05425056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110402978|NCT05425056|Immunologic Factors|immunologic factors|mesh-ancestor
110402979|NCT05425056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110402980|NCT05425056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110402981|NCT05425056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110030865|NCT01388842|Autonomic Agents|autonomic agents|mesh-ancestor
110030868|NCT01388842|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110402982|NCT05425056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110402983|NCT05422001|Ketamine|ketamine|mesh-list
110402984|NCT05422001|Analgesics|analgesics|mesh-ancestor
110402985|NCT05422001|Sensory System Agents|sensory system agents|mesh-ancestor
110402986|NCT05422001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110402987|NCT05422001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110402988|NCT05422001|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110402989|NCT05422001|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110402990|NCT05422001|Anesthetics, General|anesthetics, general|mesh-ancestor
110402991|NCT05422001|Anesthetics|anesthetics|mesh-ancestor
110402992|NCT05422001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110402993|NCT05422001|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110403002|NCT05363631|Pembrolizumab|pembrolizumab|mesh-list
110403003|NCT05363631|Axitinib|axitinib|mesh-list
110403004|NCT05363631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110403005|NCT05363631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110403006|NCT05363631|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110403007|NCT05363631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110403008|NCT05363631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110403009|NCT05363631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110403010|NCT05363631|Antioxidants|antioxidants|mesh-ancestor
110403011|NCT05363631|Protective Agents|protective agents|mesh-ancestor
110403012|NCT05363631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110403013|NCT05363631|Trace Elements|trace elements|mesh-ancestor
110403014|NCT05363631|Micronutrients|micronutrients|mesh-ancestor
110403015|NCT05359068|Valsartan|valsartan|mesh-list
110403016|NCT05359068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110403017|NCT05359068|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110403018|NCT05359068|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110403019|NCT05359068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110403020|NCT05357833|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
110403022|NCT05357833|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110403023|NCT05357833|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110403024|NCT05328908|Trifluridine|trifluridine|mesh-list
110403025|NCT05328908|Nivolumab|nivolumab|mesh-list
110403026|NCT05328908|Relatlimab|relatlimab|mesh-list
110403027|NCT05328908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110403028|NCT05328908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110403029|NCT05328908|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110403030|NCT05328908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110403031|NCT05328908|Antimetabolites|antimetabolites|mesh-ancestor
110403032|NCT05328908|Antiviral Agents|antiviral agents|mesh-ancestor
110403033|NCT05328908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110403034|NCT05327530|Avelumab|avelumab|mesh-list
110403035|NCT05327530|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
110403036|NCT05327530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110403037|NCT05327530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110403038|NCT05327530|Immunoconjugates|immunoconjugates|mesh-ancestor
110403039|NCT05327530|Immunologic Factors|immunologic factors|mesh-ancestor
110403040|NCT05327530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110403041|NCT05313620|Adalimumab|adalimumab|mesh-list
110403042|NCT05313620|Infliximab|infliximab|mesh-list
110403043|NCT05313620|Golimumab|golimumab|mesh-list
110403044|NCT05313620|Tofacitinib|tofacitinib|mesh-list
110403045|NCT05313620|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110403046|NCT05313620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110403047|NCT05313620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110403048|NCT05313620|Dermatologic Agents|dermatologic agents|mesh-ancestor
110403049|NCT05313620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110403050|NCT05313620|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110403051|NCT05313620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110403052|NCT05313620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110403053|NCT05313620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110403054|NCT05313620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110403055|NCT05313620|Immunologic Factors|immunologic factors|mesh-ancestor
110403056|NCT05313620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110403057|NCT05295589|Paclitaxel|paclitaxel|mesh-list
110403058|NCT05295589|Doxorubicin|doxorubicin|mesh-list
110403059|NCT05295589|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110403060|NCT05295589|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110403061|NCT05295589|Topotecan|topotecan|mesh-list
110403062|NCT05295589|Olaparib|olaparib|mesh-list
110403063|NCT05295589|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
110403064|NCT05295589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110403065|NCT05295589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110403066|NCT05295589|Tubulin Modulators|tubulin modulators|mesh-ancestor
110403067|NCT05295589|Antimitotic Agents|antimitotic agents|mesh-ancestor
110403068|NCT05295589|Mitosis Modulators|mitosis modulators|mesh-ancestor
110403069|NCT05295589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110403070|NCT05295589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110403071|NCT05295589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110403072|NCT05295589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110403073|NCT05295589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110403074|NCT05295589|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110403075|NCT05294965|Fenoterol|fenoterol|mesh-list
110403076|NCT05294965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110403077|NCT05294965|Autonomic Agents|autonomic agents|mesh-ancestor
110403078|NCT05294965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110403079|NCT05294965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110403080|NCT05294965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110403081|NCT05294965|Respiratory System Agents|respiratory system agents|mesh-ancestor
110403082|NCT05294965|Sympathomimetics|sympathomimetics|mesh-ancestor
110403083|NCT05294965|Tocolytic Agents|tocolytic agents|mesh-ancestor
110403084|NCT05294965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110403085|NCT05294965|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110403086|NCT05294965|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110403087|NCT05294965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110403099|NCT05280743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110403101|NCT05280743|Analgesics|analgesics|mesh-ancestor
110403102|NCT05280743|Sensory System Agents|sensory system agents|mesh-ancestor
110403103|NCT05280743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110403104|NCT05278975|Thiostrepton|thiostrepton|mesh-list
110403105|NCT05278975|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110403106|NCT05278975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110403107|NCT05259839|Dexamethasone|dexamethasone|mesh-list
110403108|NCT05259839|Lenalidomide|lenalidomide|mesh-list
110403109|NCT05259839|Daratumumab|daratumumab|mesh-list
110403110|NCT05259839|Pomalidomide|pomalidomide|mesh-list
110403111|NCT05259839|Nirogacestat|nirogacestat|mesh-list
110403112|NCT05259839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110403113|NCT05259839|Antiemetics|antiemetics|mesh-ancestor
110403114|NCT05259839|Autonomic Agents|autonomic agents|mesh-ancestor
110403115|NCT05259839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110403116|NCT05259839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110403117|NCT05259839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110403118|NCT05259839|Glucocorticoids|glucocorticoids|mesh-ancestor
110403119|NCT05259839|Hormones|hormones|mesh-ancestor
110403120|NCT05259839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110403121|NCT05259839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110403122|NCT05259839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110403123|NCT05259839|Immunologic Factors|immunologic factors|mesh-ancestor
110403124|NCT05259839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110403125|NCT05259839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110403126|NCT05259839|Growth Substances|growth substances|mesh-ancestor
110403127|NCT05259839|Growth Inhibitors|growth inhibitors|mesh-ancestor
110403128|NCT05259839|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
110403129|NCT05259839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110403130|NCT05259839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110403153|NCT05247320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110403154|NCT05247320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110403155|NCT05247320|Sympatholytics|sympatholytics|mesh-ancestor
110403156|NCT05247320|Autonomic Agents|autonomic agents|mesh-ancestor
110403157|NCT05247320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110403159|NCT05238714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110403160|NCT05238714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110403161|NCT05228496|Tislelizumab|tislelizumab|mesh-list
110403162|NCT05228496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110403163|NCT05228496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110403164|NCT05214599|Budesonide|budesonide|mesh-list
110403165|NCT05214599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110403166|NCT05214599|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110403167|NCT05214599|Autonomic Agents|autonomic agents|mesh-ancestor
110403168|NCT05214599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110403169|NCT05214599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110403170|NCT05214599|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110403171|NCT05214599|Respiratory System Agents|respiratory system agents|mesh-ancestor
110403172|NCT05214599|Glucocorticoids|glucocorticoids|mesh-ancestor
110403173|NCT05214599|Hormones|hormones|mesh-ancestor
110403174|NCT05214599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110403175|NCT05185947|Paclitaxel|paclitaxel|mesh-list
110403176|NCT05185947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110403177|NCT05185947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110403178|NCT05185947|Tubulin Modulators|tubulin modulators|mesh-ancestor
110403179|NCT05185947|Antimitotic Agents|antimitotic agents|mesh-ancestor
110403180|NCT05185947|Mitosis Modulators|mitosis modulators|mesh-ancestor
110403181|NCT05185947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110403182|NCT05183204|Metformin|metformin|mesh-list
110403183|NCT05183204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110403184|NCT05183204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110403185|NCT05179603|Pembrolizumab|pembrolizumab|mesh-list
110403186|NCT05179603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110403187|NCT05179603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110403188|NCT05179603|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110403189|NCT05179603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110403190|NCT05178173|Ethanol|ethanol|mesh-list
110403191|NCT05178173|Cetylpyridinium|cetylpyridinium|mesh-list
110403192|NCT05178173|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110403193|NCT05178173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110403194|NCT05178173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110403195|NCT05178173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110403196|NCT05163249|Osimertinib|osimertinib|mesh-list
110403197|NCT05163249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110403198|NCT05163249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110030918|NCT01389206|Bosentan|bosentan|mesh-list
110403199|NCT05163249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110403200|NCT05163249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110403201|NCT05155293|Aflibercept|aflibercept|mesh-list
110403202|NCT05155293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110403203|NCT05155293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110403204|NCT05155293|Growth Substances|growth substances|mesh-ancestor
110403205|NCT05155293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110403206|NCT05155293|Growth Inhibitors|growth inhibitors|mesh-ancestor
110403207|NCT05155293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110403208|NCT05151263|Salicylates|salicylates|mesh-list
110403209|NCT05151263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110403210|NCT05151263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110403211|NCT05151263|Analgesics|analgesics|mesh-ancestor
110403212|NCT05151263|Sensory System Agents|sensory system agents|mesh-ancestor
110403213|NCT05151263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110403214|NCT05151263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110403216|NCT05151263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110403217|NCT05151263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110403218|NCT05151263|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110403219|NCT05151263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110403220|NCT05132582|Trastuzumab|trastuzumab|mesh-list
110403221|NCT05132582|Pertuzumab|pertuzumab|mesh-list
110403222|NCT05132582|Tucatinib|tucatinib|mesh-list
110403223|NCT05132582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110403224|NCT05132582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110403225|NCT05132582|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110403226|NCT05132582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110403227|NCT05132582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110403228|NCT05130814|Hyaluronic Acid|hyaluronic acid|mesh-list
110403229|NCT05130814|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110403230|NCT05130814|Immunologic Factors|immunologic factors|mesh-ancestor
110403231|NCT05130814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110403232|NCT05130814|Viscosupplements|viscosupplements|mesh-ancestor
110403233|NCT05130814|Protective Agents|protective agents|mesh-ancestor
110403234|NCT05124457|Insulin|insulin|mesh-list
110403235|NCT05124457|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110403236|NCT05124457|Insulin Detemir|insulin detemir|mesh-list
110403237|NCT05124457|Isophane Insulin, Human|isophane insulin, human|mesh-list
110403238|NCT05124457|Insulin, Isophane|insulin, isophane|mesh-list
110403239|NCT05124457|Isophane insulin, beef|isophane insulin, beef|mesh-list
110403240|NCT05124457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110403241|NCT05124457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110403253|NCT05096195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110403254|NCT05096195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110403255|NCT05096195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110403256|NCT05093959|Metformin|metformin|mesh-list
110403257|NCT05093959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110403258|NCT05093959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110403259|NCT05064878|Fenfluramine|fenfluramine|mesh-list
110403260|NCT05064878|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110403261|NCT05064878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110403262|NCT05064878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110403263|NCT05064878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110403264|NCT05064878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110403265|NCT05064878|Serotonin Agents|serotonin agents|mesh-ancestor
110403266|NCT05064878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110403267|NCT05064280|Pembrolizumab|pembrolizumab|mesh-list
110403268|NCT05064280|Lenvatinib|lenvatinib|mesh-list
110403269|NCT05064280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110403270|NCT05064280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110403272|NCT05064280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030929|NCT01389271|Iloprost|iloprost|mesh-list
110403274|NCT05064280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110403275|NCT05044468|Lidocaine|lidocaine|mesh-list
110403276|NCT05044468|Bupivacaine|bupivacaine|mesh-list
110403277|NCT05044468|Anesthetics, Local|anesthetics, local|mesh-ancestor
110403278|NCT05044468|Anesthetics|anesthetics|mesh-ancestor
110403279|NCT05044468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110403280|NCT05044468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110403281|NCT05044468|Sensory System Agents|sensory system agents|mesh-ancestor
110403282|NCT05044468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110403283|NCT05044468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110403284|NCT05044468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110403285|NCT05044468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110403286|NCT05044468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110403287|NCT05044468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110403288|NCT04989283|Paclitaxel|paclitaxel|mesh-list
110403289|NCT04989283|Etoposide|etoposide|mesh-list
110403290|NCT04989283|Podophyllotoxin|podophyllotoxin|mesh-list
110403291|NCT04989283|Cisplatin|cisplatin|mesh-list
110403292|NCT04989283|Carboplatin|carboplatin|mesh-list
110403293|NCT04989283|Pemetrexed|pemetrexed|mesh-list
110403294|NCT04989283|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110403295|NCT04989283|Etoposide phosphate|etoposide phosphate|mesh-list
110403296|NCT04989283|Atezolizumab|atezolizumab|mesh-list
110403297|NCT04989283|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110403298|NCT04989283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110403299|NCT04989283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110403300|NCT04989283|Tubulin Modulators|tubulin modulators|mesh-ancestor
110403301|NCT04989283|Antimitotic Agents|antimitotic agents|mesh-ancestor
110403302|NCT04989283|Mitosis Modulators|mitosis modulators|mesh-ancestor
110403303|NCT04989283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110403304|NCT04989283|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110403305|NCT04989283|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110403306|NCT04989283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110403307|NCT04989283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110403308|NCT04989283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110403309|NCT04989283|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110403310|NCT04989283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110403321|NCT04988841|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110403322|NCT04988841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110403323|NCT04988841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110403324|NCT04987203|Nivolumab|nivolumab|mesh-list
110403325|NCT04987203|Tivozanib|tivozanib|mesh-list
110403326|NCT04987203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110403327|NCT04987203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110403328|NCT04987203|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110403329|NCT04987203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110403330|NCT04987203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110403331|NCT04987203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110403332|NCT04979910|Ixekizumab|ixekizumab|mesh-list
110403333|NCT04979910|Dermatologic Agents|dermatologic agents|mesh-ancestor
110403334|NCT04977778|Fluorides|fluorides|mesh-list
110403335|NCT04977778|Tin Fluorides|tin fluorides|mesh-list
110403336|NCT04977778|Cariostatic Agents|cariostatic agents|mesh-ancestor
110403337|NCT04977778|Protective Agents|protective agents|mesh-ancestor
110403338|NCT04977778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110403349|NCT04973254|Rilpivirine|rilpivirine|mesh-list
110403350|NCT04973254|Cabotegravir|cabotegravir|mesh-list
110403351|NCT04973254|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110403352|NCT04973254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110403353|NCT04973254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110403354|NCT04973254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110403359|NCT04973254|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110403360|NCT04973254|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110403362|NCT04964505|Venetoclax|venetoclax|mesh-list
110403363|NCT04964505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110403364|NCT04964505|Antimetabolites|antimetabolites|mesh-ancestor
110403365|NCT04964505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110403366|NCT04964505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110403398|NCT04889664|Analgesics|analgesics|mesh-ancestor
110403399|NCT04889664|Sensory System Agents|sensory system agents|mesh-ancestor
110403400|NCT04889664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110403415|NCT04873895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110403416|NCT04873895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110403417|NCT04873895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110403418|NCT04873895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110403420|NCT04873895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110403421|NCT04873895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110403422|NCT04869436|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110403423|NCT04869436|Immunologic Factors|immunologic factors|mesh-ancestor
110403424|NCT04869436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110403425|NCT04860154|Hematoporphyrins|hematoporphyrins|mesh-list
110403426|NCT04860154|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110403427|NCT04860154|Dermatologic Agents|dermatologic agents|mesh-ancestor
110403432|NCT04826003|Obinutuzumab|obinutuzumab|mesh-list
110403433|NCT04826003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110403434|NCT04826003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110403484|NCT04742673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110403485|NCT04742673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110403486|NCT04740918|Trastuzumab|trastuzumab|mesh-list
110403487|NCT04740918|Atezolizumab|atezolizumab|mesh-list
110403488|NCT04740918|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
110403490|NCT04740918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110403491|NCT04740918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110403492|NCT04740918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110403493|NCT04740918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110403494|NCT04740918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110403495|NCT04740918|Tubulin Modulators|tubulin modulators|mesh-ancestor
110403496|NCT04740918|Antimitotic Agents|antimitotic agents|mesh-ancestor
110403497|NCT04740918|Mitosis Modulators|mitosis modulators|mesh-ancestor
110403498|NCT04740918|Immunotoxins|immunotoxins|mesh-ancestor
110403499|NCT04740918|Immunoconjugates|immunoconjugates|mesh-ancestor
110403500|NCT04740918|Immunologic Factors|immunologic factors|mesh-ancestor
110403501|NCT04740918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110403502|NCT04703686|Obinutuzumab|obinutuzumab|mesh-list
110403503|NCT04703686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110403504|NCT04703686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110403505|NCT04657289|Ranibizumab|ranibizumab|mesh-list
110403506|NCT04657289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110403507|NCT04657289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110403508|NCT04657289|Growth Substances|growth substances|mesh-ancestor
110403509|NCT04657289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110403510|NCT04657289|Growth Inhibitors|growth inhibitors|mesh-ancestor
110403511|NCT04657289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110403512|NCT04624243|Risperidone|risperidone|mesh-list
110403513|NCT04624243|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110403514|NCT04624243|Serotonin Agents|serotonin agents|mesh-ancestor
110403515|NCT04624243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110403516|NCT04624243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110403517|NCT04624243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110403518|NCT04624243|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110403519|NCT04624243|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110403520|NCT04624243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110403521|NCT04624243|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110403522|NCT04624243|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110403523|NCT04624243|Dopamine Agents|dopamine agents|mesh-ancestor
110403524|NCT04622007|Pembrolizumab|pembrolizumab|mesh-list
110403525|NCT04622007|Pemetrexed|pemetrexed|mesh-list
110403526|NCT04622007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110403527|NCT04622007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110403528|NCT04622007|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110403529|NCT04622007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110403530|NCT04622007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110403531|NCT04622007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110403532|NCT04622007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110403533|NCT04616547|Edetic Acid|edetic acid|mesh-list
110403534|NCT04616547|Pentetic Acid|pentetic acid|mesh-list
110403535|NCT04616547|Antidotes|antidotes|mesh-ancestor
110403536|NCT04616547|Protective Agents|protective agents|mesh-ancestor
110403537|NCT04616547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110403538|NCT04616547|Chelating Agents|chelating agents|mesh-ancestor
110403539|NCT04616547|Sequestering Agents|sequestering agents|mesh-ancestor
110403540|NCT04616547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110403541|NCT04616547|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110403542|NCT04616547|Anticoagulants|anticoagulants|mesh-ancestor
110403543|NCT04616547|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110403545|NCT04615403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110403546|NCT04577755|Thalidomide|thalidomide|mesh-list
110403547|NCT04577755|Pomalidomide|pomalidomide|mesh-list
110403548|NCT04577755|Immunologic Factors|immunologic factors|mesh-ancestor
110403549|NCT04577755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110403550|NCT04577755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110403551|NCT04577755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110403552|NCT04577755|Growth Substances|growth substances|mesh-ancestor
110403554|NCT04577755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110403555|NCT04577755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110403556|NCT04577755|Leprostatic Agents|leprostatic agents|mesh-ancestor
110403557|NCT04577755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110403558|NCT04577755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110403559|NCT04577014|Gemcitabine|gemcitabine|mesh-list
110403560|NCT04577014|Docetaxel|docetaxel|mesh-list
110403561|NCT04577014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110403562|NCT04577014|Antimetabolites|antimetabolites|mesh-ancestor
110403563|NCT04577014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110403564|NCT04577014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110403565|NCT04577014|Tubulin Modulators|tubulin modulators|mesh-ancestor
110403566|NCT04577014|Antimitotic Agents|antimitotic agents|mesh-ancestor
110403567|NCT04577014|Mitosis Modulators|mitosis modulators|mesh-ancestor
110403568|NCT04573192|Lomustine|lomustine|mesh-list
110403569|NCT04573192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110403570|NCT04573192|Alkylating Agents|alkylating agents|mesh-ancestor
110403571|NCT04573192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110403572|NCT04573192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110403573|NCT04568902|Histamine Antagonists|histamine antagonists|mesh-list
110403574|NCT04568902|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
110403575|NCT04568902|Histamine Agents|histamine agents|mesh-ancestor
110403576|NCT04568902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110403577|NCT04568902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110403578|NCT04568902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110403579|NCT04567784|Cannabidiol|cannabidiol|mesh-list
110403580|NCT04567784|Anticonvulsants|anticonvulsants|mesh-ancestor
110403581|NCT04565483|Benralizumab|benralizumab|mesh-list
110403582|NCT04565483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110403583|NCT04565483|Respiratory System Agents|respiratory system agents|mesh-ancestor
110403584|NCT04535401|Calcium, Dietary|calcium, dietary|mesh-list
110403585|NCT04535401|Leucovorin|leucovorin|mesh-list
110403586|NCT04535401|Folic Acid|folic acid|mesh-list
110403587|NCT04535401|Fluorouracil|fluorouracil|mesh-list
110403588|NCT04535401|Irinotecan|irinotecan|mesh-list
110403589|NCT04535401|Camptothecin|camptothecin|mesh-list
110403590|NCT04535401|Calcium|calcium|mesh-list
110403591|NCT04535401|Levoleucovorin|levoleucovorin|mesh-list
110403592|NCT04535401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110403593|NCT04535401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110403594|NCT04535401|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110403595|NCT04535401|Antimetabolites|antimetabolites|mesh-ancestor
110403596|NCT04535401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110403597|NCT04535401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110403598|NCT04535401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110403599|NCT04535401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110403600|NCT04535401|Immunologic Factors|immunologic factors|mesh-ancestor
110403601|NCT04535401|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110403602|NCT04535401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110403603|NCT04535401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110403604|NCT04535401|Antidotes|antidotes|mesh-ancestor
110403605|NCT04535401|Protective Agents|protective agents|mesh-ancestor
110403606|NCT04535401|Vitamin B Complex|vitamin b complex|mesh-ancestor
110403607|NCT04535401|Vitamins|vitamins|mesh-ancestor
110403608|NCT04535401|Micronutrients|micronutrients|mesh-ancestor
110403609|NCT04535401|Hematinics|hematinics|mesh-ancestor
110403610|NCT04535401|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110403611|NCT04531046|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
110403612|NCT04531046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110403613|NCT04531046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110403614|NCT04527393|Morphine|morphine|mesh-list
110403615|NCT04527393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110403616|NCT04527393|Narcotics|narcotics|mesh-ancestor
110403617|NCT04527393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110403618|NCT04527393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110403619|NCT04527393|Analgesics|analgesics|mesh-ancestor
110403620|NCT04527393|Sensory System Agents|sensory system agents|mesh-ancestor
110403621|NCT04527393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110403623|NCT04494503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110403624|NCT04494503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110403625|NCT04494503|Immunologic Factors|immunologic factors|mesh-ancestor
110403626|NCT04494503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110403627|NCT04494503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110403628|NCT04477304|Analgesics, Opioid|analgesics, opioid|mesh-list
110403629|NCT04477304|Narcotics|narcotics|mesh-ancestor
110403630|NCT04477304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110403631|NCT04477304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110403632|NCT04477304|Analgesics|analgesics|mesh-ancestor
110030987|NCT01389427|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110403633|NCT04477304|Sensory System Agents|sensory system agents|mesh-ancestor
110403634|NCT04477304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110403635|NCT04460937|Adavosertib|adavosertib|mesh-list
110403636|NCT04460937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110403637|NCT04460937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110403639|NCT04448873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110403640|NCT04448873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110403641|NCT04448873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110403642|NCT04448873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110403643|NCT04448873|Antifungal Agents|antifungal agents|mesh-ancestor
110403644|NCT04448873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110403645|NCT04448873|Immunologic Factors|immunologic factors|mesh-ancestor
110403646|NCT04448873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110403647|NCT04430738|Leucovorin|leucovorin|mesh-list
110403648|NCT04430738|Pembrolizumab|pembrolizumab|mesh-list
110403649|NCT04430738|Trastuzumab|trastuzumab|mesh-list
110403650|NCT04430738|Fluorouracil|fluorouracil|mesh-list
110403651|NCT04430738|Capecitabine|capecitabine|mesh-list
110403652|NCT04430738|Oxaliplatin|oxaliplatin|mesh-list
110403653|NCT04430738|Tucatinib|tucatinib|mesh-list
110403654|NCT04430738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110403655|NCT04430738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110403656|NCT04430738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110403667|NCT04430738|Micronutrients|micronutrients|mesh-ancestor
110403668|NCT04430738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110403669|NCT04430738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110403670|NCT04396860|Nivolumab|nivolumab|mesh-list
110403671|NCT04396860|Ipilimumab|ipilimumab|mesh-list
110403672|NCT04396860|Temozolomide|temozolomide|mesh-list
110403673|NCT04396860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110403674|NCT04396860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110403675|NCT04396860|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110403676|NCT04396860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110403677|NCT04396860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110403678|NCT04396860|Alkylating Agents|alkylating agents|mesh-ancestor
110403679|NCT04394546|Anticoagulants|anticoagulants|mesh-list
110403710|NCT04356352|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110403711|NCT04356352|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110403712|NCT04356352|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110403713|NCT04356352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110403714|NCT04356352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110403715|NCT04356352|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110403716|NCT04356352|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110403717|NCT04356352|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110403718|NCT04356352|Adrenergic Agents|adrenergic agents|mesh-ancestor
110403719|NCT04356352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110403720|NCT04356326|Aspirin|aspirin|mesh-list
110403721|NCT04356326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110403722|NCT04356326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110403723|NCT04356326|Analgesics|analgesics|mesh-ancestor
110403724|NCT04356326|Sensory System Agents|sensory system agents|mesh-ancestor
110403725|NCT04356326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110403726|NCT04356326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110403727|NCT04356326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110403728|NCT04356326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110403729|NCT04356326|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110403730|NCT04356326|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110403731|NCT04356326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110403732|NCT04356326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110031005|NCT01389544|Ritonavir|ritonavir|mesh-list
110403745|NCT04339036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110403746|NCT04339036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110403747|NCT04339036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110403748|NCT04339036|Alkylating Agents|alkylating agents|mesh-ancestor
110403749|NCT04334941|Atezolizumab|atezolizumab|mesh-list
110403750|NCT04334941|Talazoparib|talazoparib|mesh-list
110403751|NCT04334941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110403752|NCT04334941|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110403753|NCT04334941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110403755|NCT04334941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110403756|NCT04334941|Immunologic Factors|immunologic factors|mesh-ancestor
110403757|NCT04334941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110403758|NCT04334941|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110403759|NCT04334941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110403760|NCT04334759|Cisplatin|cisplatin|mesh-list
110403761|NCT04334759|Carboplatin|carboplatin|mesh-list
110403762|NCT04334759|Nivolumab|nivolumab|mesh-list
110403763|NCT04334759|Pemetrexed|pemetrexed|mesh-list
110403764|NCT04334759|Ipilimumab|ipilimumab|mesh-list
110403765|NCT04334759|Durvalumab|durvalumab|mesh-list
110403766|NCT04334759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110403767|NCT04334759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110403768|NCT04334759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110403769|NCT04334759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110058129|NCT01511172|Hormones|hormones|mesh-ancestor
110403771|NCT04334759|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110403772|NCT04334759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110403773|NCT04329806|Amlodipine|amlodipine|mesh-list
110403774|NCT04329806|Moxonidine|moxonidine|mesh-list
110403775|NCT04329806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110403776|NCT04329806|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110403777|NCT04329806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110403778|NCT04329806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110403779|NCT04329806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110403780|NCT04329806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110403781|NCT04329806|Vasodilator Agents|vasodilator agents|mesh-ancestor
110403782|NCT04317105|Nivolumab|nivolumab|mesh-list
110403783|NCT04317105|Ipilimumab|ipilimumab|mesh-list
110403784|NCT04317105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110403785|NCT04317105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110403786|NCT04317105|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110403787|NCT04317105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110403788|NCT04300049|Glucagon|glucagon|mesh-list
110403789|NCT04300049|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110403790|NCT04300049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110403791|NCT04300049|Hormones|hormones|mesh-ancestor
110403792|NCT04300049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110403793|NCT04300049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110403794|NCT04300049|Incretins|incretins|mesh-ancestor
110403795|NCT04298567|Aspirin|aspirin|mesh-list
110403796|NCT04298567|Rivaroxaban|rivaroxaban|mesh-list
110031014|NCT01389544|Antiviral Agents|antiviral agents|mesh-ancestor
110403797|NCT04298567|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110403799|NCT04298567|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110403800|NCT04298567|Protease Inhibitors|protease inhibitors|mesh-ancestor
110403801|NCT04298567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110403802|NCT04298567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110403803|NCT04298567|Anticoagulants|anticoagulants|mesh-ancestor
110403804|NCT04298567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110403805|NCT04298567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110403806|NCT04298567|Analgesics|analgesics|mesh-ancestor
110403807|NCT04298567|Sensory System Agents|sensory system agents|mesh-ancestor
110403808|NCT04298567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110403809|NCT04298567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110403810|NCT04298567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110403811|NCT04298567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110403812|NCT04298567|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110403813|NCT04298567|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110403814|NCT04298567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110403815|NCT04298567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110403816|NCT04298567|Antipyretics|antipyretics|mesh-ancestor
110403817|NCT04284787|Pembrolizumab|pembrolizumab|mesh-list
110403818|NCT04284787|Azacitidine|azacitidine|mesh-list
110403819|NCT04284787|Venetoclax|venetoclax|mesh-list
110403820|NCT04284787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110403822|NCT04284787|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110403823|NCT04284787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110403824|NCT04284787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110403825|NCT04284787|Antimetabolites|antimetabolites|mesh-ancestor
110403826|NCT04284787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110403828|NCT04278729|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110403829|NCT04278729|Antithrombins|antithrombins|mesh-ancestor
110403830|NCT04278729|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110403831|NCT04278729|Protease Inhibitors|protease inhibitors|mesh-ancestor
110403832|NCT04278729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110403833|NCT04278729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110403834|NCT04278729|Anticoagulants|anticoagulants|mesh-ancestor
110403836|NCT04277442|Decitabine|decitabine|mesh-list
110403837|NCT04277442|Venetoclax|venetoclax|mesh-list
110403838|NCT04277442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110403839|NCT04277442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110403840|NCT04277442|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110403841|NCT04277442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110403842|NCT04277442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110403843|NCT04277442|Antimetabolites|antimetabolites|mesh-ancestor
110403844|NCT04277442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110403845|NCT04234568|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
110403846|NCT04234568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110403847|NCT04234568|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110403848|NCT04227847|Azacitidine|azacitidine|mesh-list
110403849|NCT04227847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110403850|NCT04227847|Antimetabolites|antimetabolites|mesh-ancestor
110403851|NCT04227847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110403852|NCT04227847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110403853|NCT04227847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110403854|NCT04225598|Buprenorphine|buprenorphine|mesh-list
110403855|NCT04225598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110403856|NCT04225598|Narcotics|narcotics|mesh-ancestor
110403857|NCT04225598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110403858|NCT04225598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110403859|NCT04225598|Analgesics|analgesics|mesh-ancestor
110031044|NCT01389713|Clomiphene|clomiphene|mesh-list
110403860|NCT04225598|Sensory System Agents|sensory system agents|mesh-ancestor
110403861|NCT04225598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110403862|NCT04225598|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110403863|NCT04221477|Acetaminophen|acetaminophen|mesh-list
110403864|NCT04221477|Diphenhydramine|diphenhydramine|mesh-list
110403865|NCT04221477|Promethazine|promethazine|mesh-list
110403867|NCT04221477|Methylprednisolone|methylprednisolone|mesh-list
110403868|NCT04221477|Obinutuzumab|obinutuzumab|mesh-list
110403869|NCT04221477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110403870|NCT04221477|Glucocorticoids|glucocorticoids|mesh-ancestor
110403871|NCT04221477|Hormones|hormones|mesh-ancestor
110403872|NCT04221477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110403873|NCT04221477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110403874|NCT04221477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110403875|NCT04221477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110403876|NCT04221477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110403877|NCT04221477|Analgesics|analgesics|mesh-ancestor
110403878|NCT04221477|Sensory System Agents|sensory system agents|mesh-ancestor
110403879|NCT04221477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110403880|NCT04221477|Antipyretics|antipyretics|mesh-ancestor
110403881|NCT04221477|Antiemetics|antiemetics|mesh-ancestor
110403882|NCT04221477|Autonomic Agents|autonomic agents|mesh-ancestor
110403883|NCT04221477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110403884|NCT04221477|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110403885|NCT04221477|Protective Agents|protective agents|mesh-ancestor
110403886|NCT04221477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110403887|NCT04221477|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110403888|NCT04221477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110403889|NCT04221477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110403890|NCT04221477|Anesthetics, Local|anesthetics, local|mesh-ancestor
110403892|NCT04221477|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110403893|NCT04221477|Histamine Antagonists|histamine antagonists|mesh-ancestor
110403894|NCT04221477|Histamine Agents|histamine agents|mesh-ancestor
110403895|NCT04221477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110403896|NCT04221477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110403897|NCT04221477|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110403898|NCT04221477|Antipruritics|antipruritics|mesh-ancestor
110403899|NCT04221477|Dermatologic Agents|dermatologic agents|mesh-ancestor
110403900|NCT04221451|Venglustat|venglustat|mesh-list
110403901|NCT04221451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110403902|NCT04221451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110403903|NCT04218851|Posaconazole|posaconazole|mesh-list
110403904|NCT04218851|Antifungal Agents|antifungal agents|mesh-ancestor
110403905|NCT04218851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110403906|NCT04218851|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110403907|NCT04218851|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110403908|NCT04218851|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110403909|NCT04218851|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110403910|NCT04218851|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110403911|NCT04218851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110403912|NCT04218851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110403913|NCT04218851|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110403914|NCT04218851|Hormone Antagonists|hormone antagonists|mesh-ancestor
110403915|NCT04218851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110403916|NCT04218851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110403917|NCT04216017|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110403918|NCT04216017|Lidocaine|lidocaine|mesh-list
110403919|NCT04216017|Anesthetics, Local|anesthetics, local|mesh-ancestor
110403920|NCT04216017|Anesthetics|anesthetics|mesh-ancestor
110403921|NCT04216017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110403922|NCT04216017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110403923|NCT04216017|Sensory System Agents|sensory system agents|mesh-ancestor
110403924|NCT04216017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110403925|NCT04216017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110403926|NCT04216017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110403927|NCT04216017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110403928|NCT04216017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110403929|NCT04216017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110403930|NCT04216017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110403931|NCT04216017|Glucocorticoids|glucocorticoids|mesh-ancestor
110403932|NCT04216017|Hormones|hormones|mesh-ancestor
110403933|NCT04216017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110403934|NCT04216017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110403935|NCT04216017|Immunologic Factors|immunologic factors|mesh-ancestor
110403936|NCT04214067|Pembrolizumab|pembrolizumab|mesh-list
110403945|NCT04197713|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
110403946|NCT04197713|Adavosertib|adavosertib|mesh-list
110403947|NCT04197713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110403948|NCT04197713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110403949|NCT04197713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110403950|NCT04191421|Spartalizumab|spartalizumab|mesh-list
110403951|NCT04191421|Siltuximab|siltuximab|mesh-list
110403952|NCT04191421|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110403953|NCT04191421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110403954|NCT04191421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110403955|NCT04191421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110403956|NCT04175912|Paclitaxel|paclitaxel|mesh-list
110403957|NCT04175912|Carboplatin|carboplatin|mesh-list
110403958|NCT04175912|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110403959|NCT04175912|Enzyme Inhibitors|enzyme inhibitors|mesh-list
110403960|NCT04175912|Pevonedistat|pevonedistat|mesh-list
110403961|NCT04175912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110403962|NCT04175912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110403963|NCT04175912|Tubulin Modulators|tubulin modulators|mesh-ancestor
110403964|NCT04175912|Antimitotic Agents|antimitotic agents|mesh-ancestor
110403965|NCT04175912|Mitosis Modulators|mitosis modulators|mesh-ancestor
110403966|NCT04175912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110403975|NCT04142125|Rivaroxaban|rivaroxaban|mesh-list
110403976|NCT04142125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110403977|NCT04142125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110403978|NCT04142125|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110403979|NCT04142125|Antithrombins|antithrombins|mesh-ancestor
110403980|NCT04142125|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110403981|NCT04142125|Protease Inhibitors|protease inhibitors|mesh-ancestor
110403982|NCT04142125|Anticoagulants|anticoagulants|mesh-ancestor
110403983|NCT04133194|Mesalamine|mesalamine|mesh-list
110404015|NCT04084769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110404016|NCT04079712|Nivolumab|nivolumab|mesh-list
110404017|NCT04079712|Ipilimumab|ipilimumab|mesh-list
110404018|NCT04079712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110404019|NCT04079712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110404020|NCT04079712|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110404021|NCT04079712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110404022|NCT04075266|Ocrelizumab|ocrelizumab|mesh-list
110404023|NCT04075266|Immunologic Factors|immunologic factors|mesh-ancestor
110404024|NCT04075266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110404026|NCT04059224|Dabrafenib|dabrafenib|mesh-list
110404027|NCT04059224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110404028|NCT04059224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110404029|NCT04059224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110404030|NCT04059224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110404032|NCT04029480|Ertugliflozin|ertugliflozin|mesh-list
110404033|NCT04029480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110404034|NCT04029480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110404035|NCT04029480|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110404036|NCT04029480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110404037|NCT04025554|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110404038|NCT04025554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110404040|NCT04022980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110404041|NCT04022980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110404042|NCT04022980|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110404043|NCT04022980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110404044|NCT04002518|Cimetidine|cimetidine|mesh-list
110404045|NCT04002518|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110404046|NCT04002518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110404047|NCT04002518|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110404048|NCT04002518|Histamine Antagonists|histamine antagonists|mesh-ancestor
110404049|NCT04002518|Histamine Agents|histamine agents|mesh-ancestor
110404050|NCT04002518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110404051|NCT04002518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110404052|NCT04002518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110404053|NCT04002518|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110404054|NCT04002518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110404055|NCT04002518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110404056|NCT03941860|Lenalidomide|lenalidomide|mesh-list
110404057|NCT03941860|Ixazomib|ixazomib|mesh-list
110404058|NCT03941860|Glycine|glycine|mesh-list
110404059|NCT03941860|Immunologic Factors|immunologic factors|mesh-ancestor
110404060|NCT03941860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110404061|NCT03941860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110404062|NCT03941860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110404063|NCT03941860|Growth Substances|growth substances|mesh-ancestor
110058427|NCT01512147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110404064|NCT03941860|Growth Inhibitors|growth inhibitors|mesh-ancestor
110404065|NCT03941860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110404066|NCT03941860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110404067|NCT03941860|Protease Inhibitors|protease inhibitors|mesh-ancestor
110404068|NCT03941860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110404069|NCT03941860|Glycine Agents|glycine agents|mesh-ancestor
110404070|NCT03941860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110404071|NCT03932201|Factor VIII|factor viii|mesh-list
110404072|NCT03932201|Coagulants|coagulants|mesh-ancestor
110404181|NCT03914300|Ipilimumab|ipilimumab|mesh-list
110404182|NCT03914300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110404183|NCT03914300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110404184|NCT03914300|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110404185|NCT03914300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110404186|NCT03914170|Cetuximab|cetuximab|mesh-list
110404187|NCT03914170|Folfirinox|folfirinox|mesh-list
110404188|NCT03914170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110404189|NCT03914170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110404192|NCT03911739|Narcotics|narcotics|mesh-ancestor
110404193|NCT03911739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110404194|NCT03911739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110404195|NCT03911739|Analgesics|analgesics|mesh-ancestor
110404196|NCT03911739|Sensory System Agents|sensory system agents|mesh-ancestor
110404197|NCT03911739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110404198|NCT03911739|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110404199|NCT03911466|Buprenorphine|buprenorphine|mesh-list
110404200|NCT03911466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110404201|NCT03911466|Narcotics|narcotics|mesh-ancestor
110404202|NCT03911466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110404203|NCT03911466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110404204|NCT03911466|Analgesics|analgesics|mesh-ancestor
110404205|NCT03911466|Sensory System Agents|sensory system agents|mesh-ancestor
110404206|NCT03911466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110404207|NCT03911466|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110404208|NCT03890367|Vaccines|vaccines|mesh-list
110404209|NCT03890367|Immunologic Factors|immunologic factors|mesh-ancestor
110404210|NCT03890367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110404211|NCT03885713|Adalimumab|adalimumab|mesh-list
110404212|NCT03885713|Infliximab|infliximab|mesh-list
110404213|NCT03885713|Golimumab|golimumab|mesh-list
110404214|NCT03885713|Ustekinumab|ustekinumab|mesh-list
110404215|NCT03885713|Vedolizumab|vedolizumab|mesh-list
110404216|NCT03885713|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110404217|NCT03885713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110404218|NCT03885713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110404219|NCT03885713|Dermatologic Agents|dermatologic agents|mesh-ancestor
110404220|NCT03885713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110404221|NCT03885713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110404222|NCT03885713|Immunologic Factors|immunologic factors|mesh-ancestor
110404223|NCT03885713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058570|NCT01513057|Mycophenolic Acid|mycophenolic acid|mesh-list
110404224|NCT03877549|Dexamethasone|dexamethasone|mesh-list
110404225|NCT03877549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110404226|NCT03877549|Antiemetics|antiemetics|mesh-ancestor
110404227|NCT03877549|Autonomic Agents|autonomic agents|mesh-ancestor
110404228|NCT03877549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110404229|NCT03877549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110404270|NCT03798678|Antiemetics|antiemetics|mesh-ancestor
110404271|NCT03798678|Autonomic Agents|autonomic agents|mesh-ancestor
110404272|NCT03798678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110404273|NCT03798678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110404274|NCT03798678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110404275|NCT03798678|Glucocorticoids|glucocorticoids|mesh-ancestor
110404276|NCT03798678|Hormones|hormones|mesh-ancestor
110404277|NCT03798678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110404278|NCT03798678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110404279|NCT03798678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110404290|NCT03772925|Belinostat|belinostat|mesh-list
110404291|NCT03772925|Enzyme Inhibitors|enzyme inhibitors|mesh-list
110404292|NCT03772925|Pevonedistat|pevonedistat|mesh-list
110404293|NCT03772925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110404294|NCT03772925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110404295|NCT03772925|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110404296|NCT03763162|Dexamethasone|dexamethasone|mesh-list
110404297|NCT03763162|Dexamethasone acetate|dexamethasone acetate|mesh-list
110404298|NCT03763162|Bortezomib|bortezomib|mesh-list
110404299|NCT03763162|Daratumumab|daratumumab|mesh-list
110404300|NCT03763162|Ixazomib|ixazomib|mesh-list
110404301|NCT03763162|Ichthammol|ichthammol|mesh-list
110404302|NCT03763162|BB 1101|bb 1101|mesh-list
110404303|NCT03763162|Glycine|glycine|mesh-list
110404304|NCT03763162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110404305|NCT03763162|Antiemetics|antiemetics|mesh-ancestor
110404306|NCT03763162|Autonomic Agents|autonomic agents|mesh-ancestor
110404307|NCT03763162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110404308|NCT03763162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110404309|NCT03763162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110404310|NCT03763162|Glucocorticoids|glucocorticoids|mesh-ancestor
110404311|NCT03763162|Hormones|hormones|mesh-ancestor
110404312|NCT03763162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110404313|NCT03763162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110404314|NCT03763162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110404315|NCT03763162|Protease Inhibitors|protease inhibitors|mesh-ancestor
110404316|NCT03763162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110404317|NCT03763162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110404318|NCT03763162|Dermatologic Agents|dermatologic agents|mesh-ancestor
110404320|NCT03763162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110404330|NCT03720717|Baclofen|baclofen|mesh-list
110404331|NCT03720717|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110404332|NCT03720717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110404333|NCT03720717|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110404334|NCT03720717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110404335|NCT03720717|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110404336|NCT03720717|GABA Agonists|gaba agonists|mesh-ancestor
110404337|NCT03720717|GABA Agents|gaba agents|mesh-ancestor
110404338|NCT03720717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110404339|NCT03720717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110404341|NCT03701321|Dexamethasone acetate|dexamethasone acetate|mesh-list
110404342|NCT03701321|Bortezomib|bortezomib|mesh-list
110404343|NCT03701321|Venetoclax|venetoclax|mesh-list
110404344|NCT03701321|Daratumumab|daratumumab|mesh-list
110404345|NCT03701321|Ichthammol|ichthammol|mesh-list
110404346|NCT03701321|BB 1101|bb 1101|mesh-list
110404347|NCT03701321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110404348|NCT03701321|Antiemetics|antiemetics|mesh-ancestor
110404349|NCT03701321|Autonomic Agents|autonomic agents|mesh-ancestor
110404350|NCT03701321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110404351|NCT03701321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110404352|NCT03701321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110404353|NCT03701321|Glucocorticoids|glucocorticoids|mesh-ancestor
110404354|NCT03701321|Hormones|hormones|mesh-ancestor
110404355|NCT03701321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110404356|NCT03701321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110404357|NCT03701321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110404358|NCT03701321|Protease Inhibitors|protease inhibitors|mesh-ancestor
110404359|NCT03701321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110404360|NCT03701321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110404361|NCT03701321|Dermatologic Agents|dermatologic agents|mesh-ancestor
110404362|NCT03701282|Venetoclax|venetoclax|mesh-list
110404363|NCT03701282|Obinutuzumab|obinutuzumab|mesh-list
110404364|NCT03701282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110404365|NCT03701282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110404366|NCT03678129|Clobazam|clobazam|mesh-list
110404367|NCT03678129|Anticonvulsants|anticonvulsants|mesh-ancestor
110404368|NCT03678129|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110404369|NCT03678129|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110404370|NCT03678129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110404371|NCT03678129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110404372|NCT03678129|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110404373|NCT03678129|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110031102|NCT01390012|BB 1101|bb 1101|mesh-list
110404389|NCT03660826|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
110404390|NCT03660826|Immunoglobulins|immunoglobulins|mesh-list
110404391|NCT03660826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110404392|NCT03660826|Immunoglobulin G|immunoglobulin g|mesh-list
110404393|NCT03660826|Maleic acid|maleic acid|mesh-list
110404394|NCT03660826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110404395|NCT03660826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110404396|NCT03660826|Immunologic Factors|immunologic factors|mesh-ancestor
110404397|NCT03660826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110404398|NCT03660826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110404399|NCT03660826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110404400|NCT03660826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110404401|NCT03641313|Irinotecan|irinotecan|mesh-list
110404402|NCT03641313|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110404403|NCT03641313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110404404|NCT03641313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110404405|NCT03641313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110404406|NCT03641313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110404421|NCT03587311|Paclitaxel|paclitaxel|mesh-list
110404422|NCT03587311|Maytansine|maytansine|mesh-list
110404423|NCT03587311|Bevacizumab|bevacizumab|mesh-list
110404424|NCT03587311|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110404425|NCT03587311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110404426|NCT03587311|Endothelial Growth Factors|endothelial growth factors|mesh-list
110404427|NCT03587311|Antibodies|antibodies|mesh-list
110404428|NCT03587311|Immunoglobulins|immunoglobulins|mesh-list
110404429|NCT03587311|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110404430|NCT03587311|Immunoglobulin G|immunoglobulin g|mesh-list
110404431|NCT03587311|Anetumab ravtansine|anetumab ravtansine|mesh-list
110404432|NCT03587311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110404433|NCT03587311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110404434|NCT03587311|Tubulin Modulators|tubulin modulators|mesh-ancestor
110404435|NCT03587311|Antimitotic Agents|antimitotic agents|mesh-ancestor
110404436|NCT03587311|Mitosis Modulators|mitosis modulators|mesh-ancestor
110404437|NCT03587311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110404438|NCT03587311|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110404439|NCT03587311|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110404440|NCT03587311|Growth Substances|growth substances|mesh-ancestor
110404441|NCT03587311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110404442|NCT03587311|Growth Inhibitors|growth inhibitors|mesh-ancestor
110404443|NCT03587311|Immunologic Factors|immunologic factors|mesh-ancestor
110404444|NCT03587311|Immunoconjugates|immunoconjugates|mesh-ancestor
110404446|NCT03583710|Etoposide|etoposide|mesh-list
110404447|NCT03583710|Etoposide phosphate|etoposide phosphate|mesh-list
110404448|NCT03583710|Podophyllotoxin|podophyllotoxin|mesh-list
110404449|NCT03583710|Mitotane|mitotane|mesh-list
110404450|NCT03583710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110404451|NCT03583710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110031117|NCT01390051|Tinzaparin|tinzaparin|mesh-list
110404452|NCT03583710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110404453|NCT03583710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110404454|NCT03583710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110404455|NCT03583710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110404456|NCT03583710|Keratolytic Agents|keratolytic agents|mesh-ancestor
110404457|NCT03583710|Dermatologic Agents|dermatologic agents|mesh-ancestor
110404458|NCT03583710|Tubulin Modulators|tubulin modulators|mesh-ancestor
110404459|NCT03583710|Antimitotic Agents|antimitotic agents|mesh-ancestor
110404460|NCT03583710|Mitosis Modulators|mitosis modulators|mesh-ancestor
110404461|NCT03583710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110404462|NCT03570892|Tisagenlecleucel|tisagenlecleucel|mesh-list
110404463|NCT03570892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110404464|NCT03570892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110404466|NCT03564691|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110404467|NCT03564691|Cisplatin|cisplatin|mesh-list
110404468|NCT03564691|Carboplatin|carboplatin|mesh-list
110404469|NCT03564691|Pembrolizumab|pembrolizumab|mesh-list
110404470|NCT03564691|Pemetrexed|pemetrexed|mesh-list
110404471|NCT03564691|Lenvatinib|lenvatinib|mesh-list
110404472|NCT03564691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110404473|NCT03564691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110404474|NCT03564691|Tubulin Modulators|tubulin modulators|mesh-ancestor
110404475|NCT03564691|Antimitotic Agents|antimitotic agents|mesh-ancestor
110404476|NCT03564691|Mitosis Modulators|mitosis modulators|mesh-ancestor
110404477|NCT03564691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110404478|NCT03564691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110404479|NCT03564691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110404480|NCT03564691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110404481|NCT03564691|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110404482|NCT03564691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110404483|NCT03564691|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110404484|NCT03561376|Petrolatum|petrolatum|mesh-list
110404485|NCT03561376|Zinc Oxide|zinc oxide|mesh-list
110404486|NCT03561376|Emollients|emollients|mesh-ancestor
110404487|NCT03561376|Dermatologic Agents|dermatologic agents|mesh-ancestor
110404488|NCT03561376|Sunscreening Agents|sunscreening agents|mesh-ancestor
110404489|NCT03561376|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110404490|NCT03561376|Protective Agents|protective agents|mesh-ancestor
110404491|NCT03561376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110404492|NCT03539744|Dexamethasone|dexamethasone|mesh-list
110404493|NCT03539744|Venetoclax|venetoclax|mesh-list
110404494|NCT03539744|Pomalidomide|pomalidomide|mesh-list
110404495|NCT03539744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110404496|NCT03539744|Antiemetics|antiemetics|mesh-ancestor
110404497|NCT03539744|Autonomic Agents|autonomic agents|mesh-ancestor
110404498|NCT03539744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110404499|NCT03539744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110404500|NCT03539744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110404501|NCT03539744|Glucocorticoids|glucocorticoids|mesh-ancestor
110404502|NCT03539744|Hormones|hormones|mesh-ancestor
110404503|NCT03539744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110404504|NCT03539744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110404505|NCT03539744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110404506|NCT03539744|Immunologic Factors|immunologic factors|mesh-ancestor
110031130|NCT01390324|Naproxen|naproxen|mesh-list
110404514|NCT03528642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110404516|NCT03517969|Carboplatin|carboplatin|mesh-list
110404517|NCT03517969|Docetaxel|docetaxel|mesh-list
110404518|NCT03517969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110404519|NCT03517969|Tubulin Modulators|tubulin modulators|mesh-ancestor
110404520|NCT03517969|Antimitotic Agents|antimitotic agents|mesh-ancestor
110404521|NCT03517969|Mitosis Modulators|mitosis modulators|mesh-ancestor
110404522|NCT03517969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110404523|NCT03485209|Carboplatin|carboplatin|mesh-list
110404524|NCT03485209|Pembrolizumab|pembrolizumab|mesh-list
110404525|NCT03485209|Tisotumab vedotin|tisotumab vedotin|mesh-list
110404526|NCT03485209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110404527|NCT03485209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110404528|NCT03485209|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110404529|NCT03485209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110404530|NCT03469271|Calcitriol|calcitriol|mesh-list
110404531|NCT03469271|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
110404532|NCT03469271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110404533|NCT03469271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110404534|NCT03469271|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110404535|NCT03469271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110404536|NCT03469271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110404537|NCT03469271|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110404539|NCT03469271|Micronutrients|micronutrients|mesh-ancestor
110404540|NCT03469271|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110404541|NCT03458260|Rituximab|rituximab|mesh-list
110404542|NCT03458260|Etoposide|etoposide|mesh-list
110404543|NCT03458260|Ifosfamide|ifosfamide|mesh-list
110404544|NCT03458260|Pixantrone|pixantrone|mesh-list
110404545|NCT03458260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110404546|NCT03458260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110404547|NCT03458260|Immunologic Factors|immunologic factors|mesh-ancestor
110404548|NCT03458260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110404549|NCT03458260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110404550|NCT03458260|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110404551|NCT03458260|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110404552|NCT03458260|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110404553|NCT03458260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110404554|NCT03458260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110404555|NCT03458260|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110404556|NCT03458260|Alkylating Agents|alkylating agents|mesh-ancestor
110404557|NCT03425279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110404558|NCT03425279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110404559|NCT03425279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110404560|NCT03425279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110404593|NCT03376672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110404594|NCT03376672|Immunologic Factors|immunologic factors|mesh-ancestor
110404595|NCT03376672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110404596|NCT03376672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110404597|NCT03376672|Growth Substances|growth substances|mesh-ancestor
110404598|NCT03376672|Growth Inhibitors|growth inhibitors|mesh-ancestor
110404599|NCT03376672|Protease Inhibitors|protease inhibitors|mesh-ancestor
110404600|NCT03376672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110404601|NCT03376672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110404603|NCT03367741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110404604|NCT03367741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110404605|NCT03367741|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110404606|NCT03367741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110404608|NCT03321643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110404609|NCT03321643|Atezolizumab|atezolizumab|mesh-list
110404610|NCT03321643|Gemcitabine|gemcitabine|mesh-list
110404611|NCT03321643|Oxaliplatin|oxaliplatin|mesh-list
110404612|NCT03321643|Antibodies|antibodies|mesh-list
110404613|NCT03321643|Immunoglobulins|immunoglobulins|mesh-list
110404614|NCT03321643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110404615|NCT03321643|Immunologic Factors|immunologic factors|mesh-ancestor
110404616|NCT03321643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110404617|NCT03321643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110404618|NCT03321643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110404619|NCT03321643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110404620|NCT03321643|Antimetabolites|antimetabolites|mesh-ancestor
110404621|NCT03321643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110404622|NCT03321643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110404623|NCT03302234|Pembrolizumab|pembrolizumab|mesh-list
110404624|NCT03302234|Ipilimumab|ipilimumab|mesh-list
110404625|NCT03302234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110404626|NCT03302234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110404627|NCT03302234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110404628|NCT03302234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110404629|NCT03290937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110404630|NCT03290937|Cetuximab|cetuximab|mesh-list
110404631|NCT03290937|Irinotecan|irinotecan|mesh-list
110404633|NCT03290937|Antibodies|antibodies|mesh-list
110404634|NCT03290937|Immunoglobulins|immunoglobulins|mesh-list
110404635|NCT03290937|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110404636|NCT03290937|Immunoglobulin G|immunoglobulin g|mesh-list
110404637|NCT03290937|Immunologic Factors|immunologic factors|mesh-ancestor
110404638|NCT03290937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110404639|NCT03290937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110404640|NCT03290937|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110404641|NCT03290937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110404642|NCT03290937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110404643|NCT03290937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110404644|NCT03290937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110404645|NCT03285321|Nivolumab|nivolumab|mesh-list
110404646|NCT03285321|Ipilimumab|ipilimumab|mesh-list
110404647|NCT03285321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110404648|NCT03285321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110404649|NCT03285321|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110404650|NCT03285321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110404651|NCT03245892|Paclitaxel|paclitaxel|mesh-list
110404652|NCT03245892|Carboplatin|carboplatin|mesh-list
110404653|NCT03245892|Nivolumab|nivolumab|mesh-list
110404654|NCT03245892|Ipilimumab|ipilimumab|mesh-list
110404655|NCT03245892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110404656|NCT03245892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110404657|NCT03245892|Tubulin Modulators|tubulin modulators|mesh-ancestor
110404658|NCT03245892|Antimitotic Agents|antimitotic agents|mesh-ancestor
110404659|NCT03245892|Mitosis Modulators|mitosis modulators|mesh-ancestor
110404660|NCT03245892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110404661|NCT03245892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110404662|NCT03245892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110404663|NCT03244384|Pembrolizumab|pembrolizumab|mesh-list
110404664|NCT03244384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110404665|NCT03244384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110404666|NCT03244384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110404667|NCT03244384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110404668|NCT03237780|Atezolizumab|atezolizumab|mesh-list
110404669|NCT03237780|Halichondrin B|halichondrin b|mesh-list
110404670|NCT03237780|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110404671|NCT03237780|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110404672|NCT03237780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110404673|NCT03237780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110404674|NCT03237780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110404675|NCT03237780|Immunologic Factors|immunologic factors|mesh-ancestor
110404676|NCT03237780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110404677|NCT03237780|Tubulin Modulators|tubulin modulators|mesh-ancestor
110404678|NCT03237780|Antimitotic Agents|antimitotic agents|mesh-ancestor
110404679|NCT03237780|Mitosis Modulators|mitosis modulators|mesh-ancestor
110404680|NCT03233711|Nivolumab|nivolumab|mesh-list
110404681|NCT03233711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110404682|NCT03233711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110404683|NCT03233711|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110404684|NCT03233711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110404686|NCT03228537|Pemetrexed|pemetrexed|mesh-list
110404687|NCT03228537|Atezolizumab|atezolizumab|mesh-list
110404688|NCT03228537|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110404689|NCT03228537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110404694|NCT03228537|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110404695|NCT03228537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110404696|NCT03228537|Immunologic Factors|immunologic factors|mesh-ancestor
110404697|NCT03228537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110404699|NCT03218137|Verapamil|verapamil|mesh-list
110404700|NCT03218137|Analgesics|analgesics|mesh-ancestor
110404701|NCT03218137|Sensory System Agents|sensory system agents|mesh-ancestor
110404702|NCT03218137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110404703|NCT03218137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110404704|NCT03218137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110404705|NCT03218137|Vasodilator Agents|vasodilator agents|mesh-ancestor
110404706|NCT03218137|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110404707|NCT03218137|Purinergic Agonists|purinergic agonists|mesh-ancestor
110404708|NCT03218137|Purinergic Agents|purinergic agents|mesh-ancestor
110404709|NCT03218137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110404710|NCT03218137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110404711|NCT03218137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110404712|NCT03218137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110404713|NCT03218137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110404720|NCT03206047|Atezolizumab|atezolizumab|mesh-list
110404721|NCT03206047|Guadecitabine|guadecitabine|mesh-list
110404722|NCT03206047|Azacitidine|azacitidine|mesh-list
110404723|NCT03206047|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110404724|NCT03206047|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110404726|NCT03206047|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110404727|NCT03206047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110404728|NCT03206047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110404729|NCT03206047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110404730|NCT03206047|Immunologic Factors|immunologic factors|mesh-ancestor
110404731|NCT03206047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110404732|NCT03206047|Interferon Inducers|interferon inducers|mesh-ancestor
110404733|NCT03206047|Laxatives|laxatives|mesh-ancestor
110404734|NCT03206047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110404735|NCT03206047|Antiviral Agents|antiviral agents|mesh-ancestor
110404736|NCT03206047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110404737|NCT03206047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110404738|NCT03206047|Antimetabolites|antimetabolites|mesh-ancestor
110404739|NCT03206047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110404740|NCT03199885|Paclitaxel|paclitaxel|mesh-list
110404741|NCT03199885|Docetaxel|docetaxel|mesh-list
110404742|NCT03199885|Trastuzumab|trastuzumab|mesh-list
110404743|NCT03199885|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110404744|NCT03199885|Atezolizumab|atezolizumab|mesh-list
110404745|NCT03199885|Pertuzumab|pertuzumab|mesh-list
110404746|NCT03199885|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
110404747|NCT03199885|Antibodies|antibodies|mesh-list
110404748|NCT03199885|Immunoglobulins|immunoglobulins|mesh-list
110404749|NCT03199885|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110404750|NCT03199885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110404751|NCT03199885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110404752|NCT03199885|Tubulin Modulators|tubulin modulators|mesh-ancestor
110404753|NCT03199885|Antimitotic Agents|antimitotic agents|mesh-ancestor
110404754|NCT03199885|Mitosis Modulators|mitosis modulators|mesh-ancestor
110404755|NCT03199885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110404756|NCT03199885|Immunologic Factors|immunologic factors|mesh-ancestor
110404757|NCT03199885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110404758|NCT03199885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110404759|NCT03199885|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110404760|NCT03161522|Fluorouracil|fluorouracil|mesh-list
110404761|NCT03161522|Capecitabine|capecitabine|mesh-list
110404762|NCT03161522|Antimetabolites|antimetabolites|mesh-ancestor
110404763|NCT03161522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110404764|NCT03161522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110404765|NCT03161522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110404766|NCT03161522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110404767|NCT03161522|Immunologic Factors|immunologic factors|mesh-ancestor
110404768|NCT03161522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110404788|NCT03155100|Glucocorticoids|glucocorticoids|mesh-ancestor
110404789|NCT03155100|Hormones|hormones|mesh-ancestor
110404790|NCT03155100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110404791|NCT03155100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110404792|NCT03155100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110404793|NCT03155100|Protease Inhibitors|protease inhibitors|mesh-ancestor
110404794|NCT03155100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110404795|NCT03155100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110404796|NCT03126630|Pembrolizumab|pembrolizumab|mesh-list
110404797|NCT03126630|Maytansine|maytansine|mesh-list
110404798|NCT03126630|Anetumab ravtansine|anetumab ravtansine|mesh-list
110404799|NCT03126630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110404800|NCT03126630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110404801|NCT03126630|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110404802|NCT03126630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110404803|NCT03126630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110404804|NCT03126630|Tubulin Modulators|tubulin modulators|mesh-ancestor
110404805|NCT03126630|Antimitotic Agents|antimitotic agents|mesh-ancestor
110404806|NCT03126630|Mitosis Modulators|mitosis modulators|mesh-ancestor
110404807|NCT03126630|Immunoconjugates|immunoconjugates|mesh-ancestor
110404808|NCT03126630|Immunologic Factors|immunologic factors|mesh-ancestor
110404809|NCT03126630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110404810|NCT03069131|Rifaximin|rifaximin|mesh-list
110404811|NCT03069131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110404812|NCT03069131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110404813|NCT03069131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110404814|NCT03060473|Amoxicillin|amoxicillin|mesh-list
110404815|NCT03060473|Azithromycin|azithromycin|mesh-list
110404816|NCT03060473|Erythromycin|erythromycin|mesh-list
110404817|NCT03060473|Erythromycin Estolate|erythromycin estolate|mesh-list
110404818|NCT03060473|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
110404819|NCT03060473|Erythromycin stearate|erythromycin stearate|mesh-list
110404820|NCT03060473|Ampicillin|ampicillin|mesh-list
110404821|NCT03060473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110404822|NCT03060473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110404823|NCT03060473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110404824|NCT03060473|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110404825|NCT03060473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110404835|NCT03038672|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110404836|NCT03038672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110404837|NCT03038672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110404839|NCT03038672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110404841|NCT03038672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110404852|NCT03008278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110404853|NCT03008278|Olaparib|olaparib|mesh-list
110404854|NCT03008278|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
110404856|NCT03008278|Antibodies|antibodies|mesh-list
110404857|NCT03008278|Immunoglobulins|immunoglobulins|mesh-list
110404858|NCT03008278|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110404859|NCT03008278|Lexatumumab|lexatumumab|mesh-list
110404860|NCT03008278|Immunologic Factors|immunologic factors|mesh-ancestor
110404861|NCT03008278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110404862|NCT03008278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110404863|NCT03008278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110404864|NCT03008278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110404865|NCT02983578|Durvalumab|durvalumab|mesh-list
110404866|NCT02983578|Immunoglobulins|immunoglobulins|mesh-list
110404867|NCT02983578|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110404868|NCT02983578|Immunoglobulin G|immunoglobulin g|mesh-list
110404869|NCT02983578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110404870|NCT02983578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110404871|NCT02983578|Immunologic Factors|immunologic factors|mesh-ancestor
110404872|NCT02983578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110404873|NCT02978625|Nivolumab|nivolumab|mesh-list
110404874|NCT02978625|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
110404875|NCT02978625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110404876|NCT02978625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110404877|NCT02978625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110404878|NCT02978625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110404879|NCT02971501|Bevacizumab|bevacizumab|mesh-list
110404880|NCT02971501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110404881|NCT02971501|Osimertinib|osimertinib|mesh-list
110404882|NCT02971501|Endothelial Growth Factors|endothelial growth factors|mesh-list
110404883|NCT02971501|Antibodies|antibodies|mesh-list
110404884|NCT02971501|Immunoglobulins|immunoglobulins|mesh-list
110404885|NCT02971501|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110404886|NCT02971501|Immunoglobulin G|immunoglobulin g|mesh-list
110404887|NCT02971501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110404888|NCT02971501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110404889|NCT02971501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110404890|NCT02971501|Growth Substances|growth substances|mesh-ancestor
110404891|NCT02971501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110404892|NCT02971501|Growth Inhibitors|growth inhibitors|mesh-ancestor
110404893|NCT02971501|Immunologic Factors|immunologic factors|mesh-ancestor
110404894|NCT02971501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110404895|NCT02971501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110404897|NCT02949284|Prednisone|prednisone|mesh-list
110404898|NCT02949284|Cortisone|cortisone|mesh-list
110404899|NCT02949284|Abiraterone Acetate|abiraterone acetate|mesh-list
110404901|NCT02949284|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
110404902|NCT02949284|Androgens|androgens|mesh-list
110404903|NCT02949284|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
110404904|NCT02949284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110404905|NCT02949284|Glucocorticoids|glucocorticoids|mesh-ancestor
110404906|NCT02949284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110404907|NCT02949284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110031228|NCT01390883|Anticoagulants|anticoagulants|mesh-ancestor
110404908|NCT02949284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110404909|NCT02949284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110404910|NCT02949284|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110404911|NCT02949284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110404912|NCT02949284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110404913|NCT02949284|Hormone Antagonists|hormone antagonists|mesh-ancestor
110404914|NCT02949284|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110404915|NCT02949284|Androgen Antagonists|androgen antagonists|mesh-ancestor
110404917|NCT02941783|Coagulants|coagulants|mesh-ancestor
110404918|NCT02933255|Nivolumab|nivolumab|mesh-list
110404919|NCT02933255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110404920|NCT02933255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110404921|NCT02933255|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110404922|NCT02933255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110404923|NCT02912559|Calcium, Dietary|calcium, dietary|mesh-list
110404924|NCT02912559|Leucovorin|leucovorin|mesh-list
110404925|NCT02912559|Folic Acid|folic acid|mesh-list
110404926|NCT02912559|Fluorouracil|fluorouracil|mesh-list
110404927|NCT02912559|Oxaliplatin|oxaliplatin|mesh-list
110404928|NCT02912559|Atezolizumab|atezolizumab|mesh-list
110404929|NCT02912559|Calcium|calcium|mesh-list
110404930|NCT02912559|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110404931|NCT02912559|Levoleucovorin|levoleucovorin|mesh-list
110404932|NCT02912559|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110404933|NCT02912559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110404934|NCT02912559|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110404935|NCT02912559|Antimetabolites|antimetabolites|mesh-ancestor
110404936|NCT02912559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110404937|NCT02912559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110404938|NCT02912559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110404939|NCT02912559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110404941|NCT02912559|Antidotes|antidotes|mesh-ancestor
110404942|NCT02912559|Protective Agents|protective agents|mesh-ancestor
110404943|NCT02912559|Vitamin B Complex|vitamin b complex|mesh-ancestor
110404944|NCT02912559|Vitamins|vitamins|mesh-ancestor
110404945|NCT02912559|Micronutrients|micronutrients|mesh-ancestor
110404946|NCT02912559|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110404947|NCT02912559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110404948|NCT02912559|Hematinics|hematinics|mesh-ancestor
110404949|NCT02891954|Canagliflozin|canagliflozin|mesh-list
110404950|NCT02891954|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110404951|NCT02891954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110404952|NCT02891954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110404953|NCT02891954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110404954|NCT02890329|Ipilimumab|ipilimumab|mesh-list
110404955|NCT02890329|Decitabine|decitabine|mesh-list
110404956|NCT02890329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110404957|NCT02890329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110404958|NCT02890329|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110404959|NCT02890329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110404960|NCT02890329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110404961|NCT02890329|Antimetabolites|antimetabolites|mesh-ancestor
110404962|NCT02890329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110404963|NCT02849496|Atezolizumab|atezolizumab|mesh-list
110404964|NCT02849496|Olaparib|olaparib|mesh-list
110404965|NCT02849496|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
110404966|NCT02849496|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110404967|NCT02849496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110404968|NCT02849496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110404969|NCT02849496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110404970|NCT02849496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110404971|NCT02849496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110404973|NCT02849496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110404975|NCT02839707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110404976|NCT02839707|Atezolizumab|atezolizumab|mesh-list
110404977|NCT02839707|Doxorubicin|doxorubicin|mesh-list
110404978|NCT02839707|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110404979|NCT02839707|Endothelial Growth Factors|endothelial growth factors|mesh-list
110404980|NCT02839707|Antibodies|antibodies|mesh-list
110404981|NCT02839707|Immunoglobulins|immunoglobulins|mesh-list
110404982|NCT02839707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110404983|NCT02839707|Immunoglobulin G|immunoglobulin g|mesh-list
110404984|NCT02839707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110404985|NCT02839707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110404986|NCT02839707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110404987|NCT02839707|Growth Substances|growth substances|mesh-ancestor
110404988|NCT02839707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110404989|NCT02839707|Growth Inhibitors|growth inhibitors|mesh-ancestor
110404990|NCT02839707|Immunologic Factors|immunologic factors|mesh-ancestor
110404991|NCT02839707|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110404992|NCT02839707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110404993|NCT02839707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110404994|NCT02839707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110404995|NCT02839707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110404996|NCT02839707|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110404997|NCT02775851|Pembrolizumab|pembrolizumab|mesh-list
110404998|NCT02775851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110404999|NCT02775851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110405000|NCT02775851|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110405056|NCT02685826|Durvalumab|durvalumab|mesh-list
110405057|NCT02685826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110405058|NCT02685826|Antiemetics|antiemetics|mesh-ancestor
110405059|NCT02685826|Autonomic Agents|autonomic agents|mesh-ancestor
110405060|NCT02685826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110059395|NCT01517399|Hemostatics|hemostatics|mesh-ancestor
110405061|NCT02685826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110405063|NCT02685826|Glucocorticoids|glucocorticoids|mesh-ancestor
110405064|NCT02685826|Hormones|hormones|mesh-ancestor
110405065|NCT02685826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110405066|NCT02685826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110405067|NCT02685826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110405068|NCT02685826|Immunologic Factors|immunologic factors|mesh-ancestor
110405069|NCT02685826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110405070|NCT02685826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110405071|NCT02685826|Growth Substances|growth substances|mesh-ancestor
110405072|NCT02685826|Growth Inhibitors|growth inhibitors|mesh-ancestor
110405073|NCT02685826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110405074|NCT02652195|Oxytocin|oxytocin|mesh-list
110405075|NCT02652195|Oxytocics|oxytocics|mesh-ancestor
110405076|NCT02652195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110405077|NCT02652195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110405078|NCT02631733|Irinotecan|irinotecan|mesh-list
110405079|NCT02631733|Veliparib|veliparib|mesh-list
110405080|NCT02631733|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
110405081|NCT02631733|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110405082|NCT02631733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110405084|NCT02631733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110405085|NCT02631733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110405086|NCT02631733|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110405087|NCT02631733|Hematinics|hematinics|mesh-ancestor
110405088|NCT02631733|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110405089|NCT02631733|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110405090|NCT02595931|Irinotecan|irinotecan|mesh-list
110405091|NCT02595931|Camptothecin|camptothecin|mesh-list
110405092|NCT02595931|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110405093|NCT02595931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110405094|NCT02595931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110405095|NCT02595931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110405096|NCT02595931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110405097|NCT02595931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110405098|NCT02595905|Cisplatin|cisplatin|mesh-list
110405099|NCT02595905|Veliparib|veliparib|mesh-list
110405100|NCT02595905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110405101|NCT02595905|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110405102|NCT02595905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110405103|NCT02595905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110405104|NCT02595879|Deoxyglucose|deoxyglucose|mesh-list
110405105|NCT02595879|Cisplatin|cisplatin|mesh-list
110405106|NCT02595879|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110405107|NCT02595879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110405108|NCT02595879|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110405109|NCT02595879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110405110|NCT02595879|Antimetabolites|antimetabolites|mesh-ancestor
110405111|NCT02595879|Antiviral Agents|antiviral agents|mesh-ancestor
110405112|NCT02595879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110405113|NCT02568553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110405114|NCT02568553|Lenalidomide|lenalidomide|mesh-list
110405115|NCT02568553|Blinatumomab|blinatumomab|mesh-list
110405116|NCT02568553|Antibodies|antibodies|mesh-list
110405117|NCT02568553|Immunoglobulins|immunoglobulins|mesh-list
110405118|NCT02568553|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110405119|NCT02568553|Muromonab-CD3|muromonab-cd3|mesh-list
110405120|NCT02568553|Antibodies, Bispecific|antibodies, bispecific|mesh-list
110405121|NCT02568553|Immunologic Factors|immunologic factors|mesh-ancestor
110405122|NCT02568553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110405123|NCT02568553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110405124|NCT02568553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110405125|NCT02568553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110405126|NCT02568553|Growth Substances|growth substances|mesh-ancestor
110405127|NCT02568553|Growth Inhibitors|growth inhibitors|mesh-ancestor
110405128|NCT02568553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110405129|NCT02502266|Paclitaxel|paclitaxel|mesh-list
110405130|NCT02502266|Doxorubicin|doxorubicin|mesh-list
110405131|NCT02502266|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110405132|NCT02502266|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110405133|NCT02502266|Topotecan|topotecan|mesh-list
110405134|NCT02502266|Olaparib|olaparib|mesh-list
110405135|NCT02502266|Cediranib|cediranib|mesh-list
110405136|NCT02502266|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
110405137|NCT02502266|Maleic acid|maleic acid|mesh-list
110405138|NCT02502266|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110405139|NCT02502266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110405140|NCT02502266|Tubulin Modulators|tubulin modulators|mesh-ancestor
110405141|NCT02502266|Antimitotic Agents|antimitotic agents|mesh-ancestor
110405142|NCT02502266|Mitosis Modulators|mitosis modulators|mesh-ancestor
110405143|NCT02502266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110405144|NCT02502266|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110405145|NCT02502266|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110405146|NCT02502266|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110405147|NCT02502266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110405148|NCT02502266|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110405149|NCT02502266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110405150|NCT02498613|Misonidazole|misonidazole|mesh-list
110405152|NCT02498613|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
110405153|NCT02498613|Cediranib|cediranib|mesh-list
110405154|NCT02498613|Maleic acid|maleic acid|mesh-list
110405155|NCT02498613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110405156|NCT02498613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110405157|NCT02498613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110405158|NCT02498613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110405159|NCT02498613|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110405160|NCT02498613|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110405161|NCT02498613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110405163|NCT02496663|Necitumumab|necitumumab|mesh-list
110405164|NCT02496663|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110405165|NCT02496663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110405166|NCT02496663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110405168|NCT02496663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110405169|NCT02496663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110405170|NCT02496663|Immunologic Factors|immunologic factors|mesh-ancestor
110405171|NCT02496663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110405172|NCT02496208|Nivolumab|nivolumab|mesh-list
110405173|NCT02496208|Ipilimumab|ipilimumab|mesh-list
110405174|NCT02496208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110405175|NCT02496208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110405176|NCT02496208|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110405177|NCT02496208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110405178|NCT02466971|Cisplatin|cisplatin|mesh-list
110405179|NCT02466971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110405180|NCT02446457|Rituximab|rituximab|mesh-list
110405181|NCT02446457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110405182|NCT02446457|Pembrolizumab|pembrolizumab|mesh-list
110405183|NCT02446457|Lenalidomide|lenalidomide|mesh-list
110405184|NCT02446457|Antibodies|antibodies|mesh-list
110405185|NCT02446457|Immunoglobulins|immunoglobulins|mesh-list
110405186|NCT02446457|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110405187|NCT02446457|Immunologic Factors|immunologic factors|mesh-ancestor
110405188|NCT02446457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110405189|NCT02446457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110405190|NCT02446457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110405191|NCT02446457|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110405192|NCT02446457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110405193|NCT02446457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110405194|NCT02446457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110405195|NCT02446457|Growth Substances|growth substances|mesh-ancestor
110405196|NCT02446457|Growth Inhibitors|growth inhibitors|mesh-ancestor
110405197|NCT02411656|Pembrolizumab|pembrolizumab|mesh-list
110405198|NCT02411656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110405199|NCT02411656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110405200|NCT02411656|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110405201|NCT02411656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110405202|NCT02400216|Cholic Acids|cholic acids|mesh-list
110031287|NCT01391104|Sildenafil Citrate|sildenafil citrate|mesh-list
110405204|NCT02398773|Estradiol|estradiol|mesh-list
110405205|NCT02398773|Estrogens|estrogens|mesh-ancestor
110405206|NCT02398773|Hormones|hormones|mesh-ancestor
110405207|NCT02398773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110405208|NCT02398773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110405209|NCT02350764|Nivolumab|nivolumab|mesh-list
110405210|NCT02350764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110405211|NCT02350764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110405212|NCT02350764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110405213|NCT02350764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110405214|NCT02314169|Nivolumab|nivolumab|mesh-list
110405215|NCT02314169|Ipilimumab|ipilimumab|mesh-list
110405216|NCT02314169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110405217|NCT02314169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110405218|NCT02314169|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110405219|NCT02314169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110405220|NCT02298959|Pembrolizumab|pembrolizumab|mesh-list
110405221|NCT02298959|Aflibercept|aflibercept|mesh-list
110405222|NCT02298959|Endothelial Growth Factors|endothelial growth factors|mesh-list
110405223|NCT02298959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110405224|NCT02298959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110405225|NCT02298959|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110405226|NCT02298959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110405227|NCT02298959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110405228|NCT02298959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110405229|NCT02298959|Growth Substances|growth substances|mesh-ancestor
110405230|NCT02298959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110405231|NCT02298959|Growth Inhibitors|growth inhibitors|mesh-ancestor
110405232|NCT02298257|Doxorubicin|doxorubicin|mesh-list
110405233|NCT02298257|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110405234|NCT02298257|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110405235|NCT02298257|Dacarbazine|dacarbazine|mesh-list
110405236|NCT02298257|Vinblastine|vinblastine|mesh-list
110405237|NCT02298257|Antibodies|antibodies|mesh-list
110405238|NCT02298257|Immunoglobulins|immunoglobulins|mesh-list
110405239|NCT02298257|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110405241|NCT02298257|Immunologic Factors|immunologic factors|mesh-ancestor
110405242|NCT02298257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110405243|NCT02298257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110405244|NCT02298257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110405245|NCT02298257|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110405246|NCT02298257|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110405247|NCT02298257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110405248|NCT02298257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110405249|NCT02298257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110405250|NCT02298257|Immunotoxins|immunotoxins|mesh-ancestor
110405251|NCT02298257|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110405252|NCT02298257|Alkylating Agents|alkylating agents|mesh-ancestor
110405253|NCT02298257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110405254|NCT02298257|Tubulin Modulators|tubulin modulators|mesh-ancestor
110405255|NCT02298257|Antimitotic Agents|antimitotic agents|mesh-ancestor
110405256|NCT02298257|Mitosis Modulators|mitosis modulators|mesh-ancestor
110405257|NCT02224781|Nivolumab|nivolumab|mesh-list
110405258|NCT02224781|Ipilimumab|ipilimumab|mesh-list
110405259|NCT02224781|Trametinib|trametinib|mesh-list
110405260|NCT02224781|Dabrafenib|dabrafenib|mesh-list
110405261|NCT02224781|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
110405262|NCT02224781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110405263|NCT02224781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110405264|NCT02224781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110405265|NCT02224781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110405266|NCT02224781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110405267|NCT02224781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110405268|NCT02224781|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110405269|NCT02224781|Protective Agents|protective agents|mesh-ancestor
110405316|NCT02095132|Adavosertib|adavosertib|mesh-list
110405317|NCT02095132|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110405318|NCT02095132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110405319|NCT02095132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110405320|NCT02095132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110405321|NCT02095132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110405322|NCT02095132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110405323|NCT02025010|Abiraterone Acetate|abiraterone acetate|mesh-list
110405324|NCT02025010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110405325|NCT02025010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110405326|NCT02025010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110405327|NCT02025010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110405328|NCT02025010|Hormone Antagonists|hormone antagonists|mesh-ancestor
110405329|NCT02025010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110405330|NCT02025010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110405331|NCT02025010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110405332|NCT02016924|Cobicistat|cobicistat|mesh-list
110405333|NCT02016924|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
110405334|NCT02016924|Emtricitabine|emtricitabine|mesh-list
110405335|NCT02016924|Tenofovir|tenofovir|mesh-list
110405336|NCT02016924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110405337|NCT02016924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110405338|NCT02016924|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110405339|NCT02016924|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110405340|NCT02016924|Antiviral Agents|antiviral agents|mesh-ancestor
110405341|NCT02016924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110405342|NCT02016924|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110405343|NCT02016924|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110405344|NCT02016924|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110405345|NCT02016924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110405346|NCT02003222|Cytarabine|cytarabine|mesh-list
110405347|NCT02003222|Dexamethasone|dexamethasone|mesh-list
110405348|NCT02003222|Dexamethasone acetate|dexamethasone acetate|mesh-list
110405349|NCT02003222|Prednisone|prednisone|mesh-list
110405350|NCT02003222|Cortisone|cortisone|mesh-list
110405351|NCT02003222|Cyclophosphamide|cyclophosphamide|mesh-list
110405352|NCT02003222|Rituximab|rituximab|mesh-list
110405353|NCT02003222|Methotrexate|methotrexate|mesh-list
110405354|NCT02003222|Etoposide|etoposide|mesh-list
110405355|NCT02003222|Vincristine|vincristine|mesh-list
110405356|NCT02003222|Etoposide phosphate|etoposide phosphate|mesh-list
110405357|NCT02003222|Daunorubicin|daunorubicin|mesh-list
110405358|NCT02003222|Asparaginase|asparaginase|mesh-list
110405359|NCT02003222|Mercaptopurine|mercaptopurine|mesh-list
110405360|NCT02003222|Podophyllotoxin|podophyllotoxin|mesh-list
110405361|NCT02003222|Pegaspargase|pegaspargase|mesh-list
110405362|NCT02003222|Blinatumomab|blinatumomab|mesh-list
110405363|NCT02003222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110405365|NCT02003222|Antibodies|antibodies|mesh-list
110405366|NCT02003222|Immunoglobulins|immunoglobulins|mesh-list
110405367|NCT02003222|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110405369|NCT02003222|BB 1101|bb 1101|mesh-list
110405370|NCT02003222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110405371|NCT02003222|Immunologic Factors|immunologic factors|mesh-ancestor
110405372|NCT02003222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110405373|NCT02003222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110405374|NCT02003222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110405375|NCT02003222|Alkylating Agents|alkylating agents|mesh-ancestor
110405376|NCT02003222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110405377|NCT02003222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110405378|NCT02003222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110405379|NCT02003222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110405380|NCT02003222|Antiemetics|antiemetics|mesh-ancestor
110405381|NCT02003222|Autonomic Agents|autonomic agents|mesh-ancestor
110405382|NCT02003222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110405383|NCT02003222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110405384|NCT02003222|Glucocorticoids|glucocorticoids|mesh-ancestor
110405385|NCT02003222|Hormones|hormones|mesh-ancestor
110405386|NCT02003222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110405387|NCT02003222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110405388|NCT02003222|Protease Inhibitors|protease inhibitors|mesh-ancestor
110405389|NCT02003222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110405390|NCT02003222|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110405391|NCT02003222|Abortifacient Agents|abortifacient agents|mesh-ancestor
110405392|NCT02003222|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110405393|NCT02003222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110405394|NCT02003222|Antimetabolites|antimetabolites|mesh-ancestor
110405395|NCT02003222|Dermatologic Agents|dermatologic agents|mesh-ancestor
110405396|NCT02003222|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110405397|NCT02003222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110405398|NCT02003222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110405399|NCT02003222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110405400|NCT02003222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110405401|NCT02003222|Antiviral Agents|antiviral agents|mesh-ancestor
110405402|NCT02003222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110405403|NCT02003222|Tubulin Modulators|tubulin modulators|mesh-ancestor
110405404|NCT02003222|Antimitotic Agents|antimitotic agents|mesh-ancestor
110405405|NCT02003222|Mitosis Modulators|mitosis modulators|mesh-ancestor
110405406|NCT02003222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110405407|NCT02003222|Keratolytic Agents|keratolytic agents|mesh-ancestor
110405408|NCT01989585|Trametinib|trametinib|mesh-list
110405409|NCT01989585|Dabrafenib|dabrafenib|mesh-list
110405410|NCT01989585|Navitoclax|navitoclax|mesh-list
110405411|NCT01989585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110405412|NCT01989585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110405413|NCT01989585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110405414|NCT01989585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110405415|NCT01919086|Dexamethasone|dexamethasone|mesh-list
110405416|NCT01919086|Lenalidomide|lenalidomide|mesh-list
110405417|NCT01919086|Bortezomib|bortezomib|mesh-list
110405418|NCT01919086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110405419|NCT01919086|Antiemetics|antiemetics|mesh-ancestor
110405420|NCT01919086|Autonomic Agents|autonomic agents|mesh-ancestor
110405421|NCT01919086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110405422|NCT01919086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110405423|NCT01919086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110405424|NCT01919086|Glucocorticoids|glucocorticoids|mesh-ancestor
110405425|NCT01919086|Hormones|hormones|mesh-ancestor
110405426|NCT01919086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110405427|NCT01919086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110405428|NCT01919086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110405429|NCT01919086|Immunologic Factors|immunologic factors|mesh-ancestor
110405430|NCT01919086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110405431|NCT01919086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110405432|NCT01919086|Growth Substances|growth substances|mesh-ancestor
110405433|NCT01919086|Growth Inhibitors|growth inhibitors|mesh-ancestor
110405434|NCT01913730|Dexamethasone|dexamethasone|mesh-list
110405435|NCT01913730|Bortezomib|bortezomib|mesh-list
110405436|NCT01913730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110405437|NCT01913730|Antiemetics|antiemetics|mesh-ancestor
110405438|NCT01913730|Autonomic Agents|autonomic agents|mesh-ancestor
110405439|NCT01913730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110405440|NCT01913730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110405442|NCT01913730|Glucocorticoids|glucocorticoids|mesh-ancestor
110405443|NCT01913730|Hormones|hormones|mesh-ancestor
110405444|NCT01913730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110405445|NCT01913730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110405446|NCT01913730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110405448|NCT01867333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110405449|NCT01867333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110405450|NCT01867333|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110405451|NCT01867333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110405452|NCT01865110|Prednisone|prednisone|mesh-list
110405453|NCT01865110|Rituximab|rituximab|mesh-list
110405454|NCT01865110|Lenalidomide|lenalidomide|mesh-list
110405455|NCT01865110|Cyclophosphamide|cyclophosphamide|mesh-list
110405456|NCT01865110|Vincristine|vincristine|mesh-list
110405457|NCT01865110|Doxorubicin|doxorubicin|mesh-list
110405458|NCT01865110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110405459|NCT01865110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110405460|NCT01865110|Immunologic Factors|immunologic factors|mesh-ancestor
110405461|NCT01865110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110405462|NCT01865110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110405463|NCT01865110|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110405464|NCT01865110|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110405465|NCT01865110|Growth Substances|growth substances|mesh-ancestor
110405466|NCT01865110|Growth Inhibitors|growth inhibitors|mesh-ancestor
110405467|NCT01865110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110405468|NCT01865110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110405469|NCT01865110|Alkylating Agents|alkylating agents|mesh-ancestor
110405470|NCT01865110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110405471|NCT01865110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110405472|NCT01865110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110405473|NCT01865110|Glucocorticoids|glucocorticoids|mesh-ancestor
110405474|NCT01865110|Hormones|hormones|mesh-ancestor
110405475|NCT01865110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110405476|NCT01865110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110405477|NCT01865110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110405478|NCT01865110|Tubulin Modulators|tubulin modulators|mesh-ancestor
110405479|NCT01865110|Antimitotic Agents|antimitotic agents|mesh-ancestor
110405480|NCT01865110|Mitosis Modulators|mitosis modulators|mesh-ancestor
110405481|NCT01865110|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110405482|NCT01865110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110405483|NCT01865110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110405484|NCT01865110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110405486|NCT01833715|Methadone|methadone|mesh-list
110405487|NCT01833715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110405488|NCT01833715|Narcotics|narcotics|mesh-ancestor
110405489|NCT01833715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110405490|NCT01833715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110405491|NCT01833715|Analgesics|analgesics|mesh-ancestor
110405492|NCT01833715|Sensory System Agents|sensory system agents|mesh-ancestor
110405493|NCT01833715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110405494|NCT01833715|Antitussive Agents|antitussive agents|mesh-ancestor
110405495|NCT01833715|Respiratory System Agents|respiratory system agents|mesh-ancestor
110405496|NCT01712620|Spironolactone|spironolactone|mesh-list
110405497|NCT01712620|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110405498|NCT01712620|Hormone Antagonists|hormone antagonists|mesh-ancestor
110405499|NCT01712620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110031337|NCT01391390|Protective Agents|protective agents|mesh-ancestor
110405500|NCT01712620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110405501|NCT01712620|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110405503|NCT01712620|Natriuretic Agents|natriuretic agents|mesh-ancestor
110405504|NCT01650701|Rituximab|rituximab|mesh-list
110405505|NCT01650701|Lenalidomide|lenalidomide|mesh-list
110405506|NCT01650701|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110405507|NCT01650701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110405508|NCT01650701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110405509|NCT01650701|Immunologic Factors|immunologic factors|mesh-ancestor
110405510|NCT01650701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110405511|NCT01650701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110405512|NCT01650701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110405513|NCT01650701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110405514|NCT01650701|Growth Substances|growth substances|mesh-ancestor
110405515|NCT01650701|Growth Inhibitors|growth inhibitors|mesh-ancestor
110059839|NCT01520012|Esomeprazole|esomeprazole|mesh-list
110405516|NCT01650701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110405517|NCT01650701|Alkylating Agents|alkylating agents|mesh-ancestor
110405518|NCT01650701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110405520|NCT01534494|Hallucinogens|hallucinogens|mesh-ancestor
110405521|NCT01534494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110405522|NCT01534494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110405523|NCT01306019|Busulfan|busulfan|mesh-list
110405524|NCT01306019|Alkylating Agents|alkylating agents|mesh-ancestor
110405525|NCT01306019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110405526|NCT01306019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110405527|NCT01306019|Immunologic Factors|immunologic factors|mesh-ancestor
110405528|NCT01306019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110405529|NCT01306019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110405530|NCT01306019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110405531|NCT01306019|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110405533|NCT01273441|Metronidazole|metronidazole|mesh-list
110405534|NCT01273441|Clarithromycin|clarithromycin|mesh-list
110405535|NCT01273441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110405536|NCT01273441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110405537|NCT01273441|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110405538|NCT01273441|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110405539|NCT01273441|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110405540|NCT01273441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110405541|NCT01273441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110405542|NCT01273441|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110405543|NCT01273441|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110405544|NCT01125228|Interferons|interferons|mesh-list
110405545|NCT01125228|Interferon-alpha|interferon-alpha|mesh-list
110405546|NCT01125228|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
110405547|NCT01125228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110405548|NCT01125228|Antiviral Agents|antiviral agents|mesh-ancestor
110405549|NCT01125228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110405550|NCT01125228|Immunologic Factors|immunologic factors|mesh-ancestor
110405551|NCT01125228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110405552|NCT00856037|Doxorubicin|doxorubicin|mesh-list
110405553|NCT00856037|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110405554|NCT00856037|Topotecan|topotecan|mesh-list
110405555|NCT00856037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110405556|NCT00856037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110405557|NCT00856037|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110405558|NCT00856037|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110405559|NCT00856037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110405560|NCT00856037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110405561|NCT00856037|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110405562|NCT00788671|Levonorgestrel|levonorgestrel|mesh-list
110405563|NCT00788671|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110405568|NCT00788671|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110405569|NCT00788671|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110405570|NCT00602797|Paclitaxel|paclitaxel|mesh-list
110405571|NCT00602797|Vinorelbine|vinorelbine|mesh-list
110405572|NCT00602797|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110405573|NCT00602797|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110405574|NCT00602797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110405575|NCT00602797|Tubulin Modulators|tubulin modulators|mesh-ancestor
110405576|NCT00602797|Antimitotic Agents|antimitotic agents|mesh-ancestor
110405577|NCT00602797|Mitosis Modulators|mitosis modulators|mesh-ancestor
110405578|NCT00602797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110405579|NCT00550615|Dasatinib|dasatinib|mesh-list
110405580|NCT00550615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110405581|NCT00550615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110405582|NCT00550615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110405583|NCT00550615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110405584|NCT00471848|Thymoglobulin|thymoglobulin|mesh-list
110405585|NCT00471848|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110405586|NCT00471848|Immunologic Factors|immunologic factors|mesh-ancestor
110405587|NCT00471848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110405588|NCT00471848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110059910|NCT01520350|Serotonin Agents|serotonin agents|mesh-ancestor
110405595|NCT00006721|Cyclophosphamide|cyclophosphamide|mesh-list
110405596|NCT00006721|Rituximab|rituximab|mesh-list
110405597|NCT00006721|Doxorubicin|doxorubicin|mesh-list
110405598|NCT00006721|Vincristine|vincristine|mesh-list
110405599|NCT00006721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110405600|NCT00006721|Immunologic Factors|immunologic factors|mesh-ancestor
110405601|NCT00006721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110405602|NCT00006721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110405603|NCT00006721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110405604|NCT00006721|Alkylating Agents|alkylating agents|mesh-ancestor
110405605|NCT00006721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110405606|NCT00006721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110405607|NCT00006721|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110405608|NCT00006721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110405609|NCT00006721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110405610|NCT00006721|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110405611|NCT00006721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110405612|NCT00006721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110405613|NCT00006721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110405614|NCT00006721|Glucocorticoids|glucocorticoids|mesh-ancestor
110405615|NCT00006721|Hormones|hormones|mesh-ancestor
110405616|NCT00006721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110405617|NCT00006721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110405618|NCT00006721|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110405652|NCT00001337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110061098|NCT06051370|Glucocorticoids|glucocorticoids|mesh-ancestor
110062062|NCT05255601|Nivolumab|nivolumab|mesh-list
110062207|NCT04947254|Prednisone|prednisone|mesh-list
110063262|NCT03214562|Cytarabine|cytarabine|mesh-list
110063845|NCT00336024|Alkylating Agents|alkylating agents|mesh-ancestor
110031433|NCT01392209|Growth Substances|growth substances|mesh-ancestor
110031439|NCT01392287|Dopamine Agents|dopamine agents|mesh-ancestor
110031445|NCT01392430|Azithromycin|azithromycin|mesh-list
110031538|NCT01392833|Prednisone|prednisone|mesh-list
110052789|NCT01482052|Vaccines|vaccines|mesh-list
110036194|NCT01409395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110031636|NCT01393288|Serotonin Agents|serotonin agents|mesh-ancestor
110031744|NCT01394094|Calcium|calcium|mesh-list
110052791|NCT01482052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110031917|NCT01394770|Vasodilator Agents|vasodilator agents|mesh-ancestor
110031943|NCT01394848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110032162|NCT01395862|Glucocorticoids|glucocorticoids|mesh-ancestor
110032337|NCT01397019|Vitamins|vitamins|mesh-ancestor
110032406|NCT05268627|Liraglutide|liraglutide|mesh-list
110032442|NCT05092698|Micronutrients|micronutrients|mesh-ancestor
110032443|NCT05092698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110052792|NCT01482104|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110032708|NCT05271539|Glucocorticoids|glucocorticoids|mesh-ancestor
110032745|NCT05271188|Anesthetics|anesthetics|mesh-list
110032812|NCT05270421|Furosemide|furosemide|mesh-list
110032890|NCT05248724|Autonomic Agents|autonomic agents|mesh-ancestor
110032929|NCT05162118|Nivolumab|nivolumab|mesh-list
110033035|NCT05052528|Cyclophosphamide|cyclophosphamide|mesh-list
110033048|NCT05052528|Alkylating Agents|alkylating agents|mesh-ancestor
110033064|NCT05051150|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110033099|NCT04961801|Antimetabolites|antimetabolites|mesh-ancestor
110033110|NCT04919564|Furosemide|furosemide|mesh-list
110033120|NCT04870333|Ciclesonide|ciclesonide|mesh-list
110033190|NCT04706767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110033237|NCT04399746|Vitamins|vitamins|mesh-ancestor
110033270|NCT04302168|Choline|choline|mesh-list
110033311|NCT04108026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110033330|NCT04044729|Cannabidiol|cannabidiol|mesh-list
110033331|NCT04044729|Anticonvulsants|anticonvulsants|mesh-ancestor
110033332|NCT04008082|Lenvatinib|lenvatinib|mesh-list
110033342|NCT03967925|Prednisone|prednisone|mesh-list
110033360|NCT03883412|Liraglutide|liraglutide|mesh-list
110094955|NCT01711827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110094957|NCT01711827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110094958|NCT01711827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110094959|NCT01711827|Antifungal Agents|antifungal agents|mesh-ancestor
110094960|NCT01711827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110094962|NCT01711905|Cholecalciferol|cholecalciferol|mesh-list
110094963|NCT01711905|Vitamins|vitamins|mesh-ancestor
110094964|NCT01711905|Micronutrients|micronutrients|mesh-ancestor
110094965|NCT01711905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094966|NCT01711905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110094967|NCT01711905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110094968|NCT01711931|Everolimus|everolimus|mesh-list
110094969|NCT01711931|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110094971|NCT01711931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110094972|NCT01711931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110094973|NCT01711931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110094974|NCT01711931|Immunologic Factors|immunologic factors|mesh-ancestor
110094975|NCT01711931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094976|NCT01711931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110094977|NCT01711957|Liver Extracts|liver extracts|mesh-list
110094978|NCT01711957|Hematinics|hematinics|mesh-ancestor
110094979|NCT01711970|Paclitaxel|paclitaxel|mesh-list
110094980|NCT01711970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110094981|NCT01711970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110094982|NCT01711970|Tubulin Modulators|tubulin modulators|mesh-ancestor
110094983|NCT01711970|Antimitotic Agents|antimitotic agents|mesh-ancestor
110094984|NCT01711970|Mitosis Modulators|mitosis modulators|mesh-ancestor
110094985|NCT01711970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110094986|NCT01712100|Irbesartan|irbesartan|mesh-list
110094987|NCT01712100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110094988|NCT01712100|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110094989|NCT01712100|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110094990|NCT01712100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110094991|NCT01712113|Irbesartan|irbesartan|mesh-list
110094992|NCT01712113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110094993|NCT01712113|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110094994|NCT01712113|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110094995|NCT01712113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110094996|NCT01712126|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110094997|NCT01712126|Irbesartan|irbesartan|mesh-list
110094998|NCT01712126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110094999|NCT01712126|Diuretics|diuretics|mesh-ancestor
110095000|NCT01712126|Natriuretic Agents|natriuretic agents|mesh-ancestor
110095001|NCT01712126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110095002|NCT01712126|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110095003|NCT01712126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110095004|NCT01712126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110095005|NCT01712126|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110095006|NCT01712126|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110095007|NCT01712139|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110095008|NCT01712139|Irbesartan|irbesartan|mesh-list
110095009|NCT01712139|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110095010|NCT01712139|Diuretics|diuretics|mesh-ancestor
110095011|NCT01712139|Natriuretic Agents|natriuretic agents|mesh-ancestor
110095012|NCT01712139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110095013|NCT01712139|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110095014|NCT01712139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110095015|NCT01712139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110095016|NCT01712139|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110095017|NCT01712139|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110095018|NCT01712295|Salicylic Acid|salicylic acid|mesh-list
110095019|NCT01712295|Salicylates|salicylates|mesh-list
110095020|NCT01712295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110095022|NCT01712295|Analgesics|analgesics|mesh-ancestor
110095023|NCT01712295|Sensory System Agents|sensory system agents|mesh-ancestor
110095024|NCT01712295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110095025|NCT01712295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110095026|NCT01712295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110095028|NCT01712295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110095029|NCT01712295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110095030|NCT01712295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110095032|NCT01712295|Antifungal Agents|antifungal agents|mesh-ancestor
110095033|NCT01712295|Keratolytic Agents|keratolytic agents|mesh-ancestor
110095034|NCT01712295|Dermatologic Agents|dermatologic agents|mesh-ancestor
110095035|NCT01712321|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
110095036|NCT01712321|Antidepressive Agents|antidepressive agents|mesh-ancestor
110095037|NCT01712321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110095038|NCT01712321|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110095039|NCT01712321|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110095040|NCT01712321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110095041|NCT01712321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110095042|NCT01712321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110095043|NCT01712321|Serotonin Agents|serotonin agents|mesh-ancestor
110095044|NCT01712321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110095045|NCT01712321|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110095046|NCT01712321|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110095047|NCT01712347|Bevacizumab|bevacizumab|mesh-list
110095048|NCT01712347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110095049|NCT01712347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110095050|NCT01712347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110095051|NCT01712347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110095052|NCT01712347|Growth Substances|growth substances|mesh-ancestor
110095053|NCT01712347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110095054|NCT01712347|Growth Inhibitors|growth inhibitors|mesh-ancestor
110095055|NCT01712464|Oxytocin|oxytocin|mesh-list
110095056|NCT01712464|Oxytocics|oxytocics|mesh-ancestor
110095057|NCT01712464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110095058|NCT01712464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110095059|NCT01712477|Midazolam|midazolam|mesh-list
110095060|NCT01712477|Propofol|propofol|mesh-list
110095061|NCT01712477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110095062|NCT01712477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110095063|NCT01712477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110095064|NCT01712477|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110095065|NCT01712477|Anesthetics, General|anesthetics, general|mesh-ancestor
110095066|NCT01712477|Anesthetics|anesthetics|mesh-ancestor
110095067|NCT01712477|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110095068|NCT01712477|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110095069|NCT01712477|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110095070|NCT01712477|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110095071|NCT01712477|GABA Modulators|gaba modulators|mesh-ancestor
110095072|NCT01712477|GABA Agents|gaba agents|mesh-ancestor
110095073|NCT01712477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110095074|NCT01712477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110095075|NCT01710761|Caffeine|caffeine|mesh-list
110095076|NCT01710761|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110095077|NCT01710761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110095078|NCT01710761|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110095079|NCT01710761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110095081|NCT01710761|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110095082|NCT01710761|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110095083|NCT01710761|Purinergic Agents|purinergic agents|mesh-ancestor
110095084|NCT01710761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110095085|NCT01712568|Ropinirole|ropinirole|mesh-list
110095086|NCT01712568|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110095087|NCT01712568|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110095088|NCT01712568|Dopamine Agonists|dopamine agonists|mesh-ancestor
110095089|NCT01712568|Dopamine Agents|dopamine agents|mesh-ancestor
110095090|NCT01712568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110095091|NCT01712568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110095092|NCT01712568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110095094|NCT01712646|Oxytocics|oxytocics|mesh-ancestor
110095095|NCT01712646|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110095096|NCT01712646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110095097|NCT01712828|Diphenhydramine|diphenhydramine|mesh-list
110095098|NCT01712828|Promethazine|promethazine|mesh-list
110095100|NCT01712828|Quinidine|quinidine|mesh-list
110095101|NCT01712828|Lenalidomide|lenalidomide|mesh-list
110095102|NCT01712828|Temsirolimus|temsirolimus|mesh-list
110095103|NCT01712828|MTOR Inhibitors|mtor inhibitors|mesh-list
110095104|NCT01712828|Immunologic Factors|immunologic factors|mesh-ancestor
110095105|NCT01712828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110095106|NCT01712828|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110095107|NCT01712828|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110095108|NCT01712828|Growth Substances|growth substances|mesh-ancestor
110095109|NCT01712828|Growth Inhibitors|growth inhibitors|mesh-ancestor
110095110|NCT01712828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110095111|NCT01712828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110095112|NCT01712828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110095113|NCT01712828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110095114|NCT01712828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110095115|NCT01712828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110095116|NCT01712828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110095117|NCT01712828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110095118|NCT01712828|Antifungal Agents|antifungal agents|mesh-ancestor
110095119|NCT01712828|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110095120|NCT01712828|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110095121|NCT01712828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110095122|NCT01712828|Anesthetics, Local|anesthetics, local|mesh-ancestor
110095123|NCT01712828|Anesthetics|anesthetics|mesh-ancestor
110095124|NCT01712828|Sensory System Agents|sensory system agents|mesh-ancestor
110095125|NCT01712828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110095126|NCT01712828|Antiemetics|antiemetics|mesh-ancestor
110095127|NCT01712828|Autonomic Agents|autonomic agents|mesh-ancestor
110095128|NCT01712828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110095129|NCT01712828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110095130|NCT01712828|Histamine Antagonists|histamine antagonists|mesh-ancestor
110095131|NCT01712828|Histamine Agents|histamine agents|mesh-ancestor
110095132|NCT01712828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110095133|NCT01712828|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110095134|NCT01712828|Antipruritics|antipruritics|mesh-ancestor
110095135|NCT01712828|Dermatologic Agents|dermatologic agents|mesh-ancestor
110095136|NCT01712828|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110095137|NCT01712828|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110095138|NCT01712828|Adrenergic Agents|adrenergic agents|mesh-ancestor
110095139|NCT01712828|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110095140|NCT01712828|Antimalarials|antimalarials|mesh-ancestor
110095141|NCT01712828|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110095142|NCT01712828|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110095143|NCT01712828|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110095144|NCT01712828|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110095145|NCT01712828|Cholinergic Agents|cholinergic agents|mesh-ancestor
110095146|NCT01712828|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110095147|NCT01712828|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110095148|NCT01712828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110095149|NCT01712828|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110095150|NCT01712828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110095151|NCT01712893|Goserelin|goserelin|mesh-list
110095152|NCT01712893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110095153|NCT01712893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110095154|NCT01712919|Paclitaxel|paclitaxel|mesh-list
110095155|NCT01712919|Cetuximab|cetuximab|mesh-list
110095156|NCT01712919|Nedaplatin|nedaplatin|mesh-list
110095157|NCT01712919|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110095158|NCT01712919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110095159|NCT01712919|Tubulin Modulators|tubulin modulators|mesh-ancestor
110095160|NCT01712919|Antimitotic Agents|antimitotic agents|mesh-ancestor
110095161|NCT01712919|Mitosis Modulators|mitosis modulators|mesh-ancestor
110095162|NCT01712919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110095163|NCT01712919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110095164|NCT01712945|Alemtuzumab|alemtuzumab|mesh-list
110095165|NCT01712945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110095166|NCT01712945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110095167|NCT01712997|Bosentan|bosentan|mesh-list
110095168|NCT01712997|Iloprost|iloprost|mesh-list
110095169|NCT01712997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110095170|NCT01712997|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110095171|NCT01712997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110095172|NCT01712997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110095173|NCT01712997|Vasodilator Agents|vasodilator agents|mesh-ancestor
110095175|NCT01713049|Antiviral Agents|antiviral agents|mesh-ancestor
110095176|NCT01713049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110095177|NCT01713101|Tranylcypromine|tranylcypromine|mesh-list
110095178|NCT01713101|Tranexamic Acid|tranexamic acid|mesh-list
110095179|NCT01713101|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
110095180|NCT01713101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110095181|NCT01713101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110095183|NCT01713101|Coagulants|coagulants|mesh-ancestor
110095184|NCT01713101|Antidepressive Agents|antidepressive agents|mesh-ancestor
110095185|NCT01713101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110095186|NCT01713101|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110095187|NCT01713101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110095188|NCT01713101|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110095189|NCT01713101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110095190|NCT01713101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110095191|NCT01713101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110095192|NCT01713127|Remifentanil|remifentanil|mesh-list
110095193|NCT01713127|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110095194|NCT01713127|Narcotics|narcotics|mesh-ancestor
110095195|NCT01713127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110095196|NCT01713127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110095197|NCT01713127|Analgesics|analgesics|mesh-ancestor
110095198|NCT01713127|Sensory System Agents|sensory system agents|mesh-ancestor
110095199|NCT01713127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110095200|NCT01713153|Misoprostol|misoprostol|mesh-list
110095201|NCT01713153|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110095202|NCT01713153|Abortifacient Agents|abortifacient agents|mesh-ancestor
110095203|NCT01713153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110095204|NCT01713153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110095205|NCT01713153|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110095206|NCT01713153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110095207|NCT01713153|Oxytocics|oxytocics|mesh-ancestor
110095208|NCT01713166|Plasma-lyte 148|plasma-lyte 148|mesh-list
110095209|NCT01713166|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110095210|NCT01713166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110095212|NCT01713179|Expectorants|expectorants|mesh-ancestor
110095213|NCT01713179|Respiratory System Agents|respiratory system agents|mesh-ancestor
110095214|NCT01713218|Gemcitabine|gemcitabine|mesh-list
110095215|NCT01713218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110095216|NCT01713218|Antimetabolites|antimetabolites|mesh-ancestor
110095217|NCT01713218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110095218|NCT01713218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110095219|NCT01713231|Vitamin D|vitamin d|mesh-list
110095220|NCT01713231|Ergocalciferols|ergocalciferols|mesh-list
110095221|NCT01713231|Cholecalciferol|cholecalciferol|mesh-list
110095222|NCT01713231|Vitamins|vitamins|mesh-list
110095223|NCT01713231|Micronutrients|micronutrients|mesh-ancestor
110095224|NCT01713231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110095225|NCT01713231|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110095226|NCT01713231|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110095227|NCT01713309|Lenograstim|lenograstim|mesh-list
110095228|NCT01713309|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110095229|NCT01713309|Immunologic Factors|immunologic factors|mesh-ancestor
110095230|NCT01713309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110095231|NCT01713361|Enoxaparin|enoxaparin|mesh-list
110095232|NCT01713361|Anticoagulants|anticoagulants|mesh-ancestor
110095233|NCT01713361|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110095234|NCT01713361|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110095235|NCT01713361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110095236|NCT01713387|Gemcitabine|gemcitabine|mesh-list
110095237|NCT01713387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110095238|NCT01713387|Antimetabolites|antimetabolites|mesh-ancestor
110095239|NCT01713387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110095240|NCT01713387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110095241|NCT01713426|Pregabalin|pregabalin|mesh-list
110095242|NCT01713426|Capsaicin|capsaicin|mesh-list
110095243|NCT01713426|Analgesics|analgesics|mesh-ancestor
110095244|NCT01713426|Sensory System Agents|sensory system agents|mesh-ancestor
110095245|NCT01713426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110186173|NCT00712881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110095248|NCT01713426|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110095249|NCT01713426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110095250|NCT01713426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110095251|NCT01713426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110095252|NCT01713426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110095253|NCT01713426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110095254|NCT01713426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110095255|NCT01713426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110095256|NCT01713426|Antipruritics|antipruritics|mesh-ancestor
110095257|NCT01713426|Dermatologic Agents|dermatologic agents|mesh-ancestor
110095258|NCT01713556|Propranolol|propranolol|mesh-list
110095259|NCT01713556|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110095260|NCT01713556|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110095261|NCT01713556|Adrenergic Agents|adrenergic agents|mesh-ancestor
110095262|NCT01713556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110095263|NCT01713556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110095264|NCT01713556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110095265|NCT01713556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110095266|NCT01713556|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110095267|NCT01713556|Vasodilator Agents|vasodilator agents|mesh-ancestor
110095268|NCT01713647|Losartan|losartan|mesh-list
110095269|NCT01713647|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110095270|NCT01713647|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110095271|NCT01713647|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110095272|NCT01713647|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110095273|NCT01713647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110095274|NCT01713725|Omalizumab|omalizumab|mesh-list
110095275|NCT01713725|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110095276|NCT01713725|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110095277|NCT01713725|Respiratory System Agents|respiratory system agents|mesh-ancestor
110095278|NCT01713738|Rituximab|rituximab|mesh-list
110095279|NCT01713738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110095280|NCT01713738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110095281|NCT01713738|Immunologic Factors|immunologic factors|mesh-ancestor
110095282|NCT01713738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110095283|NCT01713738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110095284|NCT01713777|Lamotrigine|lamotrigine|mesh-list
110095285|NCT01713777|Anticonvulsants|anticonvulsants|mesh-list
110095286|NCT01713777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110095287|NCT01713777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110095288|NCT01713777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110095289|NCT01713777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110095290|NCT01713777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110095291|NCT01713777|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110095292|NCT01713777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110095293|NCT01713777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110095294|NCT01713777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110095295|NCT01713777|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110095297|NCT01713803|Naloxone|naloxone|mesh-list
110095298|NCT01713803|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110095299|NCT01713803|Narcotics|narcotics|mesh-ancestor
110095300|NCT01713803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110095301|NCT01713803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110095302|NCT01713803|Analgesics|analgesics|mesh-ancestor
110095303|NCT01713803|Sensory System Agents|sensory system agents|mesh-ancestor
110095304|NCT01713803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110095305|NCT01713803|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110095306|NCT01713920|Amlodipine|amlodipine|mesh-list
110095307|NCT01713920|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110095308|NCT01713920|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110095309|NCT01713920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110095310|NCT01713920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110095311|NCT01713920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110095312|NCT01713920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110095313|NCT01713920|Vasodilator Agents|vasodilator agents|mesh-ancestor
110095314|NCT01713972|Dabrafenib|dabrafenib|mesh-list
110095315|NCT01713972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110186181|NCT00129038|Aspirin|aspirin|mesh-list
110095316|NCT01713972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110095317|NCT01713972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110095318|NCT01713972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110095320|NCT01714011|Ziprasidone|ziprasidone|mesh-list
110095321|NCT01714011|Antidepressive Agents|antidepressive agents|mesh-ancestor
110095322|NCT01714011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110095323|NCT01714011|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110095324|NCT01714011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110095325|NCT01714011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110095326|NCT01714011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110095327|NCT01714011|Dopamine Agonists|dopamine agonists|mesh-ancestor
110095328|NCT01714011|Dopamine Agents|dopamine agents|mesh-ancestor
110095329|NCT01714011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110095330|NCT01714011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110095331|NCT01714011|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110095332|NCT01714011|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110095333|NCT01714011|Serotonin Agents|serotonin agents|mesh-ancestor
110095334|NCT01714011|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110095335|NCT01714011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110095336|NCT01714011|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110095337|NCT01714011|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110095338|NCT01714037|Gemcitabine|gemcitabine|mesh-list
110095339|NCT01714037|Docetaxel|docetaxel|mesh-list
110095340|NCT01714037|Pemetrexed|pemetrexed|mesh-list
110095341|NCT01714037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110095342|NCT01714037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110095343|NCT01714037|Antimetabolites|antimetabolites|mesh-ancestor
110095344|NCT01714037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110095345|NCT01714037|Tubulin Modulators|tubulin modulators|mesh-ancestor
110095346|NCT01714037|Antimitotic Agents|antimitotic agents|mesh-ancestor
110095347|NCT01714037|Mitosis Modulators|mitosis modulators|mesh-ancestor
110095348|NCT01714037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110095349|NCT01714037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110095350|NCT01714037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110095351|NCT01714089|Interferons|interferons|mesh-list
110095352|NCT01714089|Interferon-beta|interferon-beta|mesh-list
110095353|NCT01714089|Interferon beta-1a|interferon beta-1a|mesh-list
110095354|NCT01714089|RNS60|rns60|mesh-list
110095355|NCT01714089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110095356|NCT01714089|Antiviral Agents|antiviral agents|mesh-ancestor
110095357|NCT01714089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110095359|NCT01714089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110095360|NCT01714089|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110095361|NCT01714089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110095362|NCT01714089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110095363|NCT01714089|Analgesics|analgesics|mesh-ancestor
110095364|NCT01714089|Sensory System Agents|sensory system agents|mesh-ancestor
110095365|NCT01714089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110095366|NCT01714089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110095367|NCT01714089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110095368|NCT01714089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110095369|NCT01714102|Resveratrol|resveratrol|mesh-list
110095370|NCT01714102|Antioxidants|antioxidants|mesh-ancestor
110095371|NCT01714102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110095372|NCT01714102|Protective Agents|protective agents|mesh-ancestor
110095373|NCT01714102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110095374|NCT01714102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110095375|NCT01714102|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110095376|NCT01714115|Aflibercept|aflibercept|mesh-list
110095377|NCT01714115|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110095378|NCT01714115|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110095379|NCT01714115|Growth Substances|growth substances|mesh-ancestor
110095380|NCT01714115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110095381|NCT01714115|Growth Inhibitors|growth inhibitors|mesh-ancestor
110095382|NCT01714115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110095383|NCT01714128|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110095384|NCT01714128|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110095385|NCT01714128|Estradiol|estradiol|mesh-list
110095386|NCT01714128|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110095387|NCT01714128|Estrogens|estrogens|mesh-ancestor
110095388|NCT01714128|Hormones|hormones|mesh-ancestor
110095389|NCT01714128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110095390|NCT01714128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110095391|NCT01714128|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110095392|NCT01714128|Contraceptive Agents|contraceptive agents|mesh-ancestor
110095394|NCT01714128|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110095395|NCT01714154|Ritonavir|ritonavir|mesh-list
110095396|NCT01714154|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110095397|NCT01714154|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110095398|NCT01714154|Protease Inhibitors|protease inhibitors|mesh-ancestor
110095399|NCT01714154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110095400|NCT01714154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110095401|NCT01714154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110095402|NCT01714154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110095403|NCT01714154|Antiviral Agents|antiviral agents|mesh-ancestor
110095404|NCT01714154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110095405|NCT01714154|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110095406|NCT01714154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110095407|NCT01714193|Canagliflozin|canagliflozin|mesh-list
110095408|NCT01714193|Contraceptive Agents|contraceptive agents|mesh-list
110095409|NCT01714193|Contraceptives, Oral|contraceptives, oral|mesh-list
110095410|NCT01714193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110095411|NCT01714193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110095412|NCT01714193|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110095413|NCT01714193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110095414|NCT01714193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110095415|NCT01714193|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110095416|NCT01714206|Canagliflozin|canagliflozin|mesh-list
110095418|NCT01714206|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110095419|NCT01714206|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110095420|NCT01714206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110095421|NCT01714206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110095422|NCT01714206|Protective Agents|protective agents|mesh-ancestor
110095423|NCT01714206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110095424|NCT01714206|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110095425|NCT01714206|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110095426|NCT01714297|Dalteparin|dalteparin|mesh-list
110095427|NCT01714297|Tinzaparin|tinzaparin|mesh-list
110095428|NCT01714297|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110095429|NCT01714297|Anticoagulants|anticoagulants|mesh-ancestor
110095430|NCT01714297|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110095431|NCT01714297|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110095432|NCT01714297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110095433|NCT01714388|Remifentanil|remifentanil|mesh-list
110095434|NCT01714388|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110095435|NCT01714388|Narcotics|narcotics|mesh-ancestor
110095436|NCT01714388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110095437|NCT01714388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110095438|NCT01714388|Analgesics|analgesics|mesh-ancestor
110095439|NCT01714388|Sensory System Agents|sensory system agents|mesh-ancestor
110095440|NCT01714388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110095441|NCT01714401|Albuterol|albuterol|mesh-list
110095442|NCT01714401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110095443|NCT01714401|Autonomic Agents|autonomic agents|mesh-ancestor
110095444|NCT01714401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110095445|NCT01714401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110095446|NCT01714401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110095447|NCT01714401|Respiratory System Agents|respiratory system agents|mesh-ancestor
110095448|NCT01714401|Tocolytic Agents|tocolytic agents|mesh-ancestor
110095449|NCT01714401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110095450|NCT01714401|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110095451|NCT01714401|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110095452|NCT01714401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110095453|NCT01714401|Adrenergic Agents|adrenergic agents|mesh-ancestor
110095454|NCT01714401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110095455|NCT01714401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110095456|NCT01714414|Lamivudine|lamivudine|mesh-list
110095457|NCT01714414|Zidovudine|zidovudine|mesh-list
110095458|NCT01714414|Efavirenz|efavirenz|mesh-list
110095459|NCT01714414|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110095460|NCT01714414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110095461|NCT01714414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110095462|NCT01714414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110095464|NCT01714414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110095465|NCT01714414|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110095466|NCT01714414|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110095467|NCT01714414|Antimetabolites|antimetabolites|mesh-ancestor
110095468|NCT01714414|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110095469|NCT01714414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110095470|NCT01714414|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110095471|NCT01714414|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110095472|NCT01714414|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110095473|NCT01714414|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110095474|NCT01714427|Dexamethasone|dexamethasone|mesh-list
110095475|NCT01714427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110095476|NCT01714427|Antiemetics|antiemetics|mesh-ancestor
110095477|NCT01714427|Autonomic Agents|autonomic agents|mesh-ancestor
110095478|NCT01714427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110095479|NCT01714427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110095480|NCT01714427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110095481|NCT01714427|Glucocorticoids|glucocorticoids|mesh-ancestor
110095483|NCT01714427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110095484|NCT01714427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110095485|NCT01714427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110095486|NCT01714557|Tazobactam|tazobactam|mesh-list
110095487|NCT01714557|Piperacillin|piperacillin|mesh-list
110095488|NCT01714557|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
110095489|NCT01714557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110095490|NCT01714557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110095491|NCT01714557|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110095492|NCT01714557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110095493|NCT01714557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110095494|NCT01714570|Tazobactam|tazobactam|mesh-list
110095495|NCT01714570|Piperacillin|piperacillin|mesh-list
110095496|NCT01714570|Imipenem|imipenem|mesh-list
110095497|NCT01714570|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
110095498|NCT01714570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110095499|NCT01714570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110095500|NCT01714570|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110095501|NCT01714570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110095502|NCT01714570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110095503|NCT01714596|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110095504|NCT01714596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110095505|NCT01714648|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110095506|NCT01714648|Luteolytic Agents|luteolytic agents|mesh-ancestor
110095507|NCT01714648|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110095508|NCT01714648|Contraceptive Agents|contraceptive agents|mesh-ancestor
110095509|NCT01714648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110095510|NCT01714648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110095511|NCT01714648|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110095512|NCT01714648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110095513|NCT01714648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110095514|NCT01714765|Everolimus|everolimus|mesh-list
110095515|NCT01714765|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110095516|NCT01714765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110095517|NCT01714765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110095518|NCT01714765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110095519|NCT01714765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110095520|NCT01714765|Immunologic Factors|immunologic factors|mesh-ancestor
110095521|NCT01714765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110095522|NCT01714765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110095523|NCT01714817|Mycophenolic Acid|mycophenolic acid|mesh-list
110095524|NCT01714817|Prednisone|prednisone|mesh-list
110095525|NCT01714817|Abatacept|abatacept|mesh-list
110095526|NCT01714817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110095527|NCT01714817|Glucocorticoids|glucocorticoids|mesh-ancestor
110095528|NCT01714817|Hormones|hormones|mesh-ancestor
110095529|NCT01714817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110095530|NCT01714817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110095531|NCT01714817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110095532|NCT01714817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110095533|NCT01714817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110095534|NCT01714817|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110095535|NCT01714817|Antitubercular Agents|antitubercular agents|mesh-ancestor
110095536|NCT01714817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110095537|NCT01714817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110095538|NCT01714817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110095539|NCT01714817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110095540|NCT01714817|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110095541|NCT01714817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110095542|NCT01714817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110095543|NCT01714817|Immunologic Factors|immunologic factors|mesh-ancestor
110095544|NCT01714817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110095545|NCT01714843|Linaclotide|linaclotide|mesh-list
110095546|NCT01714843|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
110095547|NCT01714843|Enzyme Activators|enzyme activators|mesh-ancestor
110095548|NCT01714843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110095549|NCT01714843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110095550|NCT01714856|Ropinirole|ropinirole|mesh-list
110095551|NCT01714856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110095552|NCT01714856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110095553|NCT01714856|Dopamine Agonists|dopamine agonists|mesh-ancestor
110095554|NCT01714856|Dopamine Agents|dopamine agents|mesh-ancestor
110095555|NCT01714856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110095556|NCT01714856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110095557|NCT01714856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110095558|NCT01714895|Insulin|insulin|mesh-list
110095559|NCT01714895|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110095560|NCT01714895|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110095561|NCT01714895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110095562|NCT01714908|Etoposide|etoposide|mesh-list
110095563|NCT01714908|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110095564|NCT01714908|Cisplatin|cisplatin|mesh-list
110095565|NCT01714908|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110095566|NCT01714908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110095567|NCT01714908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110095568|NCT01714908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110095569|NCT01714908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110095570|NCT01714908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110095571|NCT01714908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110095572|NCT01714960|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110095573|NCT01714960|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110095574|NCT01715077|Ipilimumab|ipilimumab|mesh-list
110095575|NCT01715077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110095576|NCT01715077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110095577|NCT01715077|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110095578|NCT01715077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110095579|NCT01715090|Insulin|insulin|mesh-list
110095580|NCT01715090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110095581|NCT01715090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110095582|NCT01715142|Paclitaxel|paclitaxel|mesh-list
110095583|NCT01715142|Gemcitabine|gemcitabine|mesh-list
110095584|NCT01715142|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110095585|NCT01715142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110095586|NCT01715142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110095587|NCT01715142|Tubulin Modulators|tubulin modulators|mesh-ancestor
110095588|NCT01715142|Antimitotic Agents|antimitotic agents|mesh-ancestor
110095589|NCT01715142|Mitosis Modulators|mitosis modulators|mesh-ancestor
110095590|NCT01715142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110095591|NCT01715142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110095592|NCT01715142|Antimetabolites|antimetabolites|mesh-ancestor
110095593|NCT01715168|Doxorubicin|doxorubicin|mesh-list
110095594|NCT01715168|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110095595|NCT01715168|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110095596|NCT01715168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110095597|NCT01715168|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110095598|NCT01715168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110095599|NCT01715168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110095600|NCT01715168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110095601|NCT01715220|Nitroglycerin|nitroglycerin|mesh-list
110095602|NCT01715220|Vasodilator Agents|vasodilator agents|mesh-ancestor
110095603|NCT01715259|Abiraterone Acetate|abiraterone acetate|mesh-list
110095604|NCT01715259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110095605|NCT01715259|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110095606|NCT01715259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110095607|NCT01715259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110095608|NCT01715259|Hormone Antagonists|hormone antagonists|mesh-ancestor
110095609|NCT01715259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110095610|NCT01715259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110095611|NCT01715259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110095612|NCT01715311|Tiotropium Bromide|tiotropium bromide|mesh-list
110095613|NCT01715311|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110095614|NCT01715311|Autonomic Agents|autonomic agents|mesh-ancestor
110095615|NCT01715311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110095616|NCT01715311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110095617|NCT01715311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110095618|NCT01715311|Respiratory System Agents|respiratory system agents|mesh-ancestor
110095620|NCT01715311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110095621|NCT01715311|Cholinergic Agents|cholinergic agents|mesh-ancestor
110095622|NCT01715311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110095623|NCT01715311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110095624|NCT01715363|Leucovorin|leucovorin|mesh-list
110095625|NCT01715363|Folic Acid|folic acid|mesh-list
110095626|NCT01715363|Oxaliplatin|oxaliplatin|mesh-list
110095627|NCT01715363|Levoleucovorin|levoleucovorin|mesh-list
110095628|NCT01715363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110095629|NCT01715363|Antidotes|antidotes|mesh-ancestor
110095630|NCT01715363|Protective Agents|protective agents|mesh-ancestor
110095631|NCT01715363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110095632|NCT01715363|Vitamin B Complex|vitamin b complex|mesh-ancestor
110095633|NCT01715363|Vitamins|vitamins|mesh-ancestor
110095634|NCT01715363|Micronutrients|micronutrients|mesh-ancestor
110095635|NCT01715363|Hematinics|hematinics|mesh-ancestor
110095636|NCT01715441|Irinotecan|irinotecan|mesh-list
110095637|NCT01715441|Sorafenib|sorafenib|mesh-list
110095638|NCT01715441|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110095639|NCT01715441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110095640|NCT01715441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110095641|NCT01715441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110095642|NCT01715441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110095643|NCT01715441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110095644|NCT01715493|Muramidase|muramidase|mesh-list
110095645|NCT01715493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110095646|NCT01715519|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
110095647|NCT01715519|Antidepressive Agents|antidepressive agents|mesh-ancestor
110095648|NCT01715519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110186222|NCT00470223|Immunologic Factors|immunologic factors|mesh-ancestor
110095649|NCT01715519|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110095650|NCT01715519|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110095651|NCT01715519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110095652|NCT01715519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110095653|NCT01715519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110095654|NCT01715519|Serotonin Agents|serotonin agents|mesh-ancestor
110095655|NCT01715519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110095656|NCT01715519|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110095657|NCT01715519|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110095658|NCT01715584|Nitrous Oxide|nitrous oxide|mesh-list
110095659|NCT01715584|Sevoflurane|sevoflurane|mesh-list
110095660|NCT01715584|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110095661|NCT01715584|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110095662|NCT01715584|Anesthetics, General|anesthetics, general|mesh-ancestor
110095663|NCT01715584|Anesthetics|anesthetics|mesh-ancestor
110095664|NCT01715584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110095665|NCT01715584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110095666|NCT01715584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110095667|NCT01715584|Analgesics|analgesics|mesh-ancestor
110095668|NCT01715584|Sensory System Agents|sensory system agents|mesh-ancestor
110095669|NCT01715584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110095670|NCT01715597|Ascorbic Acid|ascorbic acid|mesh-list
110095671|NCT01715597|Antioxidants|antioxidants|mesh-ancestor
110095672|NCT01715597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110095673|NCT01715597|Protective Agents|protective agents|mesh-ancestor
110095674|NCT01715597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110095676|NCT01715597|Micronutrients|micronutrients|mesh-ancestor
110095677|NCT01715610|Clindamycin|clindamycin|mesh-list
110095678|NCT01715610|Clindamycin palmitate|clindamycin palmitate|mesh-list
110095679|NCT01715610|Clindamycin phosphate|clindamycin phosphate|mesh-list
110095680|NCT01715610|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110095681|NCT01715610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110095682|NCT01715610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110095683|NCT01715610|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110095684|NCT01715610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110095685|NCT01715610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110095686|NCT01715610|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110095687|NCT01715636|Tenofovir|tenofovir|mesh-list
110095688|NCT01715636|Emtricitabine|emtricitabine|mesh-list
110095689|NCT01715636|Rilpivirine|rilpivirine|mesh-list
110095690|NCT01715636|Antiviral Agents|antiviral agents|mesh-ancestor
110095691|NCT01715636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110095692|NCT01715636|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110095693|NCT01715636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110095694|NCT01715636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110095695|NCT01715636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110095696|NCT01715636|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110095697|NCT01715636|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110095698|NCT01715688|Lidocaine|lidocaine|mesh-list
110095699|NCT01715688|Anesthetics, Local|anesthetics, local|mesh-ancestor
110095700|NCT01715688|Anesthetics|anesthetics|mesh-ancestor
110095701|NCT01715688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110095702|NCT01715688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110095703|NCT01715688|Sensory System Agents|sensory system agents|mesh-ancestor
110095704|NCT01715688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110095705|NCT01715688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110095706|NCT01715688|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110095707|NCT01715688|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110095708|NCT01715688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110095709|NCT01715688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110095710|NCT01715701|Iodine|iodine|mesh-list
110095711|NCT01715701|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110095712|NCT01715701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110095713|NCT01715701|Trace Elements|trace elements|mesh-ancestor
110095714|NCT01715701|Micronutrients|micronutrients|mesh-ancestor
110095715|NCT01715701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110095717|NCT01715909|Antiviral Agents|antiviral agents|mesh-ancestor
110095718|NCT01715909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110095719|NCT01715909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110095720|NCT01715909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110095721|NCT01715922|Fluconazole|fluconazole|mesh-list
110095722|NCT01715922|Flucytosine|flucytosine|mesh-list
110095723|NCT01715922|Antifungal Agents|antifungal agents|mesh-ancestor
110095724|NCT01715922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110095725|NCT01715922|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110095726|NCT01715922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110095727|NCT01715922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110095728|NCT01715922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110095729|NCT01715922|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110095730|NCT01715922|Hormone Antagonists|hormone antagonists|mesh-ancestor
110095731|NCT01715922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110095732|NCT01715922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110095733|NCT01715922|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110095734|NCT01715922|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110095735|NCT01715922|Antimetabolites|antimetabolites|mesh-ancestor
110095736|NCT01715935|Everolimus|everolimus|mesh-list
110095737|NCT01715935|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110095738|NCT01715935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110095739|NCT01715935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110095740|NCT01715935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110095741|NCT01715935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110095742|NCT01715935|Immunologic Factors|immunologic factors|mesh-ancestor
110095743|NCT01715935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110095744|NCT01715935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110095746|NCT01715987|Entecavir|entecavir|mesh-list
110095747|NCT01715987|Antiviral Agents|antiviral agents|mesh-ancestor
110095748|NCT01715987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110095749|NCT01715987|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110095750|NCT01715987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110095751|NCT01715987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110095752|NCT01715987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110095753|NCT01715987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110095754|NCT01715987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110095755|NCT01716273|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110095756|NCT01716273|Laxatives|laxatives|mesh-ancestor
110095757|NCT01716273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110095758|NCT01716338|Glyburide|glyburide|mesh-list
110095759|NCT01716338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110095760|NCT01716338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110095761|NCT01716377|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110095762|NCT01716377|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110095763|NCT01716377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110095764|NCT01716377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110095765|NCT01716377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110095766|NCT01716377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110095767|NCT01716377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110095768|NCT01716377|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110095769|NCT01716377|Antidepressive Agents|antidepressive agents|mesh-ancestor
110095770|NCT01716377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110095772|NCT01716416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110095773|NCT01716416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110095774|NCT01716442|Rituximab|rituximab|mesh-list
110095775|NCT01716442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110095776|NCT01716442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110095777|NCT01716442|Immunologic Factors|immunologic factors|mesh-ancestor
110095778|NCT01716442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110095779|NCT01716442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110095780|NCT01716572|Erythromycin|erythromycin|mesh-list
110095781|NCT01716572|Erythromycin Estolate|erythromycin estolate|mesh-list
110095782|NCT01716572|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
110095783|NCT01716572|Erythromycin stearate|erythromycin stearate|mesh-list
110095784|NCT01716572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110095785|NCT01716572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110095786|NCT01716572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110095787|NCT01716572|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110095788|NCT01716572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110095789|NCT01716572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110095790|NCT01716611|Tolvaptan|tolvaptan|mesh-list
110095791|NCT01716611|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110095792|NCT01716611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110095793|NCT01716611|Natriuretic Agents|natriuretic agents|mesh-ancestor
110095794|NCT01716611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110095795|NCT01716624|Oxybutynin|oxybutynin|mesh-list
110095796|NCT01716624|Botulinum Toxins|botulinum toxins|mesh-list
110095797|NCT01716624|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110095798|NCT01716624|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110095799|NCT01716624|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110095800|NCT01716624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110095801|NCT01716624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110095802|NCT01716624|Cholinergic Agents|cholinergic agents|mesh-ancestor
110095803|NCT01716624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110095804|NCT01716624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110095805|NCT01716624|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110095806|NCT01716624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110095807|NCT01716624|Parasympatholytics|parasympatholytics|mesh-ancestor
110095808|NCT01716624|Autonomic Agents|autonomic agents|mesh-ancestor
110095809|NCT01716624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110095810|NCT01716624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110095811|NCT01716624|Urological Agents|urological agents|mesh-ancestor
110095813|NCT01716637|Curcumin|curcumin|mesh-list
110095814|NCT01716637|Resveratrol|resveratrol|mesh-list
110095815|NCT01716637|Quercetin|quercetin|mesh-list
110095816|NCT01716637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110095817|NCT01716637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110095818|NCT01716637|Analgesics|analgesics|mesh-ancestor
110095819|NCT01716637|Sensory System Agents|sensory system agents|mesh-ancestor
110095820|NCT01716637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110095821|NCT01716637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110095822|NCT01716637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110095823|NCT01716637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110095824|NCT01716637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110095825|NCT01716637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110095826|NCT01716637|Immunologic Factors|immunologic factors|mesh-ancestor
110095827|NCT01716637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110095828|NCT01716637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110095829|NCT01716637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110095830|NCT01716637|Antioxidants|antioxidants|mesh-ancestor
110095831|NCT01716637|Protective Agents|protective agents|mesh-ancestor
110095832|NCT01716637|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110095833|NCT01716689|Cyclophosphamide|cyclophosphamide|mesh-list
110095834|NCT01716689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110095835|NCT01716689|Immunologic Factors|immunologic factors|mesh-ancestor
110095836|NCT01716689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110095837|NCT01716689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110095838|NCT01716689|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110095839|NCT01716689|Alkylating Agents|alkylating agents|mesh-ancestor
110095840|NCT01716689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110095841|NCT01716689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110095842|NCT01716689|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110095843|NCT01716767|Analgesics|analgesics|mesh-list
110095845|NCT01716767|Sensory System Agents|sensory system agents|mesh-ancestor
110095846|NCT01716767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110095847|NCT01716767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110095848|NCT01716767|Antipruritics|antipruritics|mesh-ancestor
110095849|NCT01716767|Dermatologic Agents|dermatologic agents|mesh-ancestor
110095850|NCT01716858|Sulforaphane|sulforaphane|mesh-list
110095851|NCT01716858|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110095852|NCT01716858|Protective Agents|protective agents|mesh-ancestor
110095853|NCT01716858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110095854|NCT01716858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110095855|NCT01716949|Fluorouracil|fluorouracil|mesh-list
110095856|NCT01716949|Capecitabine|capecitabine|mesh-list
110095857|NCT01716949|Oxaliplatin|oxaliplatin|mesh-list
110095858|NCT01716949|Antimetabolites|antimetabolites|mesh-ancestor
110095859|NCT01716949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110095860|NCT01716949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110095861|NCT01716949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110095862|NCT01716949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110095863|NCT01716949|Immunologic Factors|immunologic factors|mesh-ancestor
110095864|NCT01716949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110095865|NCT01717027|Oxycodone|oxycodone|mesh-list
110095866|NCT01717027|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110095867|NCT01717027|Narcotics|narcotics|mesh-ancestor
110095868|NCT01717027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110095869|NCT01717027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110095870|NCT01717027|Analgesics|analgesics|mesh-ancestor
110095871|NCT01717027|Sensory System Agents|sensory system agents|mesh-ancestor
110095872|NCT01717027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110095873|NCT01717066|Ginsenoside Rg3|ginsenoside rg3|mesh-list
110095874|NCT01717066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110095875|NCT01717066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110095876|NCT01717118|Vaccines|vaccines|mesh-list
110095877|NCT01717118|Immunologic Factors|immunologic factors|mesh-ancestor
110095878|NCT01717118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110095879|NCT01717157|Fentanyl|fentanyl|mesh-list
110095880|NCT01717157|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110095881|NCT01717157|Narcotics|narcotics|mesh-ancestor
110095882|NCT01717157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110095883|NCT01717157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110095884|NCT01717157|Analgesics|analgesics|mesh-ancestor
110095885|NCT01717157|Sensory System Agents|sensory system agents|mesh-ancestor
110095886|NCT01717157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110095887|NCT01717157|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110095888|NCT01717157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110095889|NCT01717157|Anesthetics, General|anesthetics, general|mesh-ancestor
110095890|NCT01717157|Anesthetics|anesthetics|mesh-ancestor
110095892|NCT01717222|Anesthetics, Local|anesthetics, local|mesh-ancestor
110095893|NCT01717222|Anesthetics|anesthetics|mesh-ancestor
110095894|NCT01717222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110095895|NCT01717222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110095896|NCT01717222|Sensory System Agents|sensory system agents|mesh-ancestor
110095897|NCT01717222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110095898|NCT01717222|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110095899|NCT01717222|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110095900|NCT01717222|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110095901|NCT01717222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110095902|NCT01717222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110095903|NCT01717235|Ropinirole|ropinirole|mesh-list
110095904|NCT01717235|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110095905|NCT01717235|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110095906|NCT01717235|Dopamine Agonists|dopamine agonists|mesh-ancestor
110095907|NCT01717235|Dopamine Agents|dopamine agents|mesh-ancestor
110095908|NCT01717235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110095909|NCT01717235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110095910|NCT01717235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110095911|NCT01717300|Oxazolidinones|oxazolidinones|mesh-list
110095912|NCT01717300|Anacetrapib|anacetrapib|mesh-list
110095913|NCT01717300|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110095914|NCT01717300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110095915|NCT01717300|Antimetabolites|antimetabolites|mesh-ancestor
110095916|NCT01717300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110095917|NCT01717300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110095918|NCT01717300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110095919|NCT01717300|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110095920|NCT01717300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110095921|NCT01717404|Mexiletine|mexiletine|mesh-list
110095922|NCT01717404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110095923|NCT01717404|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110095924|NCT01717404|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110095925|NCT01717404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110095926|NCT01717404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110095927|NCT01717599|Diclofenac|diclofenac|mesh-list
110095928|NCT01717599|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110095929|NCT01717599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110095930|NCT01717599|Analgesics|analgesics|mesh-ancestor
110095931|NCT01717599|Sensory System Agents|sensory system agents|mesh-ancestor
110095932|NCT01717599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110095933|NCT01717599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110095934|NCT01717599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110095935|NCT01717599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110095936|NCT01717599|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110095937|NCT01717599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110095938|NCT01717599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110095939|NCT01717612|Thrombin|thrombin|mesh-list
110095940|NCT01717612|Hemostatics|hemostatics|mesh-ancestor
110095941|NCT01717612|Coagulants|coagulants|mesh-ancestor
110095942|NCT01717625|Montelukast|montelukast|mesh-list
110095943|NCT01717625|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110095944|NCT01717625|Respiratory System Agents|respiratory system agents|mesh-ancestor
110095945|NCT01717625|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110095946|NCT01717625|Hormone Antagonists|hormone antagonists|mesh-ancestor
110095947|NCT01717625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110095948|NCT01717625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110095949|NCT01717625|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110095950|NCT01717625|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110095951|NCT01717625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110095953|NCT01717690|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110095954|NCT01717690|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
110095955|NCT01717690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110095956|NCT01717690|Disinfectants|disinfectants|mesh-ancestor
110095957|NCT01717690|Dermatologic Agents|dermatologic agents|mesh-ancestor
110095958|NCT01717729|Iodine|iodine|mesh-list
110095959|NCT01717729|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110095960|NCT01717729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110095961|NCT01717729|Trace Elements|trace elements|mesh-ancestor
110095962|NCT01717729|Micronutrients|micronutrients|mesh-ancestor
110095963|NCT01717729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110095964|NCT01716260|Chloroquine|chloroquine|mesh-list
110095965|NCT01716260|Primaquine|primaquine|mesh-list
110095966|NCT01716260|Amebicides|amebicides|mesh-ancestor
110095967|NCT01716260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110095968|NCT01716260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110095969|NCT01716260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110095970|NCT01716260|Antimalarials|antimalarials|mesh-ancestor
110095971|NCT01716260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110095972|NCT01717807|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110095973|NCT01717807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110095974|NCT01717807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110095975|NCT01717807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110095976|NCT01717807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110095977|NCT01717846|Abatacept|abatacept|mesh-list
110095978|NCT01717846|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110095979|NCT01717846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110095980|NCT01717846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110095981|NCT01717846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110095982|NCT01717846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110186262|NCT00128531|Leuprolide|leuprolide|mesh-list
110095983|NCT01717846|Immunologic Factors|immunologic factors|mesh-ancestor
110095985|NCT01717846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110095987|NCT01717911|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110095988|NCT01717911|Isophane Insulin, Human|isophane insulin, human|mesh-list
110095989|NCT01717911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110095990|NCT01717911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110095991|NCT01717911|Incretins|incretins|mesh-ancestor
110095992|NCT01717911|Hormones|hormones|mesh-ancestor
110095993|NCT01717911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110095994|NCT01717911|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110095995|NCT01717911|Protease Inhibitors|protease inhibitors|mesh-ancestor
110095996|NCT01717911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110095997|NCT01717911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110095998|NCT01717950|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110095999|NCT01717950|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110096000|NCT01717950|Immunologic Factors|immunologic factors|mesh-ancestor
110096001|NCT01717950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096002|NCT01717950|Antacids|antacids|mesh-ancestor
110096003|NCT01717950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110096004|NCT01717950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110096005|NCT01717963|Naltrexone|naltrexone|mesh-list
110096006|NCT01717963|Buprenorphine|buprenorphine|mesh-list
110096007|NCT01717963|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
110096008|NCT01717963|Naloxone|naloxone|mesh-list
110096009|NCT01717963|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110096010|NCT01717963|Narcotics|narcotics|mesh-ancestor
110096011|NCT01717963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110096012|NCT01717963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096013|NCT01717963|Analgesics|analgesics|mesh-ancestor
110096014|NCT01717963|Sensory System Agents|sensory system agents|mesh-ancestor
110096015|NCT01717963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110096016|NCT01717963|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110096017|NCT01717963|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110096018|NCT01718054|Chloroquine|chloroquine|mesh-list
110096019|NCT01718054|Amebicides|amebicides|mesh-ancestor
110096020|NCT01718054|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110096021|NCT01718054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110096022|NCT01718054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110096023|NCT01718054|Antimalarials|antimalarials|mesh-ancestor
110096024|NCT01718054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110096026|NCT01718093|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110096027|NCT01718093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110096028|NCT01718093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096029|NCT01718093|Incretins|incretins|mesh-ancestor
110096030|NCT01718093|Hormones|hormones|mesh-ancestor
110096031|NCT01718093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110096032|NCT01718093|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110096033|NCT01718093|Protease Inhibitors|protease inhibitors|mesh-ancestor
110096034|NCT01718093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110096035|NCT01718093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110096036|NCT01718223|Temoporfin|temoporfin|mesh-list
110096037|NCT01718223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110096038|NCT01718223|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110096039|NCT01718223|Dermatologic Agents|dermatologic agents|mesh-ancestor
110096040|NCT01718236|Rocuronium|rocuronium|mesh-list
110096041|NCT01718236|Succinylcholine|succinylcholine|mesh-list
110096042|NCT01718236|Neostigmine|neostigmine|mesh-list
110096043|NCT01718236|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110096044|NCT01718236|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110096045|NCT01718236|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110096046|NCT01718236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110096047|NCT01718236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096048|NCT01718236|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110096049|NCT01718236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110096050|NCT01718236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110096051|NCT01718236|Cholinergic Agents|cholinergic agents|mesh-ancestor
110096052|NCT01718236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110096053|NCT01718236|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110096054|NCT01718236|Autonomic Agents|autonomic agents|mesh-ancestor
110096055|NCT01718236|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
110096057|NCT01718288|Iloprost|iloprost|mesh-list
110096058|NCT01718288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110096059|NCT01718288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110096060|NCT01718288|Analgesics|analgesics|mesh-ancestor
110096061|NCT01718288|Sensory System Agents|sensory system agents|mesh-ancestor
110096062|NCT01718288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110096063|NCT01718288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096064|NCT01718288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110096065|NCT01718288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110096066|NCT01718288|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110096067|NCT01718288|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110096068|NCT01718288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110096069|NCT01718288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110096070|NCT01718288|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110096071|NCT01718288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110096072|NCT01718288|Antipyretics|antipyretics|mesh-ancestor
110096073|NCT01718288|Vasodilator Agents|vasodilator agents|mesh-ancestor
110096074|NCT01718301|Ribavirin|ribavirin|mesh-list
110096075|NCT01718301|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110096076|NCT01718301|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110096077|NCT01718301|Antimetabolites|antimetabolites|mesh-ancestor
110096078|NCT01718301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110096079|NCT01718301|Antiviral Agents|antiviral agents|mesh-ancestor
110096080|NCT01718301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110096081|NCT01718314|Lidocaine|lidocaine|mesh-list
110096082|NCT01718314|Misoprostol|misoprostol|mesh-list
110096083|NCT01718314|Anesthetics, Local|anesthetics, local|mesh-ancestor
110096084|NCT01718314|Anesthetics|anesthetics|mesh-ancestor
110096085|NCT01718314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110096086|NCT01718314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096087|NCT01718314|Sensory System Agents|sensory system agents|mesh-ancestor
110096088|NCT01718314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110096089|NCT01718314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110096090|NCT01718314|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110096091|NCT01718314|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110096092|NCT01718314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110096093|NCT01718314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110096094|NCT01718314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110096095|NCT01718314|Abortifacient Agents|abortifacient agents|mesh-ancestor
110096096|NCT01718314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110096097|NCT01718314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110096098|NCT01718314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110096099|NCT01718314|Oxytocics|oxytocics|mesh-ancestor
110096100|NCT01718327|Sunitinib|sunitinib|mesh-list
110096102|NCT01718327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110096103|NCT01718327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110096104|NCT01718327|Growth Substances|growth substances|mesh-ancestor
110096105|NCT01718327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096106|NCT01718327|Growth Inhibitors|growth inhibitors|mesh-ancestor
110096107|NCT01718327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110096108|NCT01718327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110096109|NCT01718327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110096110|NCT01718340|Metformin|metformin|mesh-list
110096111|NCT01718340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110096112|NCT01718340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096113|NCT01718366|Vitamin D|vitamin d|mesh-list
110096114|NCT01718366|Azacitidine|azacitidine|mesh-list
110096115|NCT01718366|Deferasirox|deferasirox|mesh-list
110096116|NCT01718366|Vitamins|vitamins|mesh-ancestor
110096117|NCT01718366|Micronutrients|micronutrients|mesh-ancestor
110096118|NCT01718366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096119|NCT01718366|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110096120|NCT01718366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110096121|NCT01718366|Antimetabolites|antimetabolites|mesh-ancestor
110096122|NCT01718366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110096123|NCT01718366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110096124|NCT01718366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110096125|NCT01718366|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110096126|NCT01718366|Chelating Agents|chelating agents|mesh-ancestor
110096127|NCT01718366|Sequestering Agents|sequestering agents|mesh-ancestor
110096128|NCT01718379|Lenalidomide|lenalidomide|mesh-list
110096129|NCT01718379|Immunologic Factors|immunologic factors|mesh-ancestor
110096130|NCT01718379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096131|NCT01718379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110096132|NCT01718379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110096133|NCT01718379|Growth Substances|growth substances|mesh-ancestor
110096134|NCT01718379|Growth Inhibitors|growth inhibitors|mesh-ancestor
110096135|NCT01718379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110096136|NCT01718496|Morphine|morphine|mesh-list
110096137|NCT01718496|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110096138|NCT01718496|Narcotics|narcotics|mesh-ancestor
110096139|NCT01718496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110096140|NCT01718496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096142|NCT01718496|Sensory System Agents|sensory system agents|mesh-ancestor
110096143|NCT01718496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110096144|NCT01718587|Lamivudine|lamivudine|mesh-list
110096145|NCT01718587|Antiviral Agents|antiviral agents|mesh-list
110096146|NCT01718587|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110096147|NCT01718587|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110096148|NCT01718587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110096149|NCT01718587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110096150|NCT01718587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110096151|NCT01718587|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110096152|NCT01718587|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110096153|NCT01718613|Vasopressins|vasopressins|mesh-list
110096154|NCT01718613|Arginine Vasopressin|arginine vasopressin|mesh-list
110096155|NCT01718613|Norepinephrine|norepinephrine|mesh-list
110096156|NCT01718613|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110096157|NCT01718613|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110096158|NCT01718613|Adrenergic Agents|adrenergic agents|mesh-ancestor
110096159|NCT01718613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110096160|NCT01718613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110096161|NCT01718613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096162|NCT01718613|Sympathomimetics|sympathomimetics|mesh-ancestor
110096163|NCT01718613|Autonomic Agents|autonomic agents|mesh-ancestor
110096164|NCT01718613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110096165|NCT01718613|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110096166|NCT01718613|Hemostatics|hemostatics|mesh-ancestor
110096167|NCT01718613|Coagulants|coagulants|mesh-ancestor
110096168|NCT01718613|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110096169|NCT01718613|Natriuretic Agents|natriuretic agents|mesh-ancestor
110096171|NCT01718626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110096173|NCT01718626|Antimitotic Agents|antimitotic agents|mesh-ancestor
110096174|NCT01718626|Mitosis Modulators|mitosis modulators|mesh-ancestor
110096175|NCT01718626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110096176|NCT01718652|Canagliflozin|canagliflozin|mesh-list
110096177|NCT01718652|Cyclosporine|cyclosporine|mesh-list
110096178|NCT01718652|Cyclosporins|cyclosporins|mesh-list
110096179|NCT01718652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110096180|NCT01718652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110096181|NCT01718652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110096182|NCT01718652|Immunologic Factors|immunologic factors|mesh-ancestor
110096183|NCT01718652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096184|NCT01718652|Antifungal Agents|antifungal agents|mesh-ancestor
110096185|NCT01718652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110096186|NCT01718652|Dermatologic Agents|dermatologic agents|mesh-ancestor
110096187|NCT01718652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110096188|NCT01718652|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110096189|NCT01718652|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110096190|NCT01718652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110096191|NCT01718678|Melatonin|melatonin|mesh-list
110096192|NCT01718678|Antioxidants|antioxidants|mesh-ancestor
110096193|NCT01718678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110096194|NCT01718678|Protective Agents|protective agents|mesh-ancestor
110096195|NCT01718678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096196|NCT01718678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110096197|NCT01718717|Morphine|morphine|mesh-list
110096198|NCT01718717|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110096199|NCT01718717|Narcotics|narcotics|mesh-ancestor
110096200|NCT01718717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110096201|NCT01718717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096202|NCT01718717|Analgesics|analgesics|mesh-ancestor
110096203|NCT01718717|Sensory System Agents|sensory system agents|mesh-ancestor
110096204|NCT01718717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110096205|NCT01718808|Capecitabine|capecitabine|mesh-list
110096206|NCT01718808|Cetuximab|cetuximab|mesh-list
110096207|NCT01718808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110096208|NCT01718808|Antimetabolites|antimetabolites|mesh-ancestor
110096209|NCT01718808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110096210|NCT01718808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110096211|NCT01718808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110096212|NCT01718834|Vaccines|vaccines|mesh-list
110096213|NCT01718834|Immunologic Factors|immunologic factors|mesh-ancestor
110096214|NCT01718834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096215|NCT01718899|Lenalidomide|lenalidomide|mesh-list
110096216|NCT01718899|Immunologic Factors|immunologic factors|mesh-ancestor
110096217|NCT01718899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096218|NCT01718899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110096219|NCT01718899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110096220|NCT01718899|Growth Substances|growth substances|mesh-ancestor
110096221|NCT01718899|Growth Inhibitors|growth inhibitors|mesh-ancestor
110096222|NCT01718899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110096224|NCT01718912|Nystatin|nystatin|mesh-list
110096225|NCT01718912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110096226|NCT01718912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110096227|NCT01718912|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110096228|NCT01718912|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110096229|NCT01718912|Antifungal Agents|antifungal agents|mesh-ancestor
110096230|NCT01718912|Ionophores|ionophores|mesh-ancestor
110096231|NCT01718912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110096232|NCT01718912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110096233|NCT01718951|Pamidronate|pamidronate|mesh-list
110096234|NCT01718951|Golimumab|golimumab|mesh-list
110096235|NCT01718951|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110096236|NCT01718951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110096237|NCT01718951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110096238|NCT01718951|Immunologic Factors|immunologic factors|mesh-ancestor
110096239|NCT01718951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096240|NCT01718951|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110096241|NCT01718964|Hydrocortisone|hydrocortisone|mesh-list
110096242|NCT01718964|Mannitol|mannitol|mesh-list
110096243|NCT01718964|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110096244|NCT01718964|Diuretics|diuretics|mesh-ancestor
110096245|NCT01718964|Natriuretic Agents|natriuretic agents|mesh-ancestor
110096246|NCT01718964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096247|NCT01718964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110096248|NCT01719042|Ondansetron|ondansetron|mesh-list
110096249|NCT01719042|Antiemetics|antiemetics|mesh-ancestor
110096250|NCT01719042|Autonomic Agents|autonomic agents|mesh-ancestor
110096251|NCT01719042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110096252|NCT01719042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096253|NCT01719042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110096254|NCT01719042|Antipruritics|antipruritics|mesh-ancestor
110096255|NCT01719042|Dermatologic Agents|dermatologic agents|mesh-ancestor
110096256|NCT01719042|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110096257|NCT01719042|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110096258|NCT01719042|Serotonin Agents|serotonin agents|mesh-ancestor
110096259|NCT01719042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110096260|NCT01719042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110096261|NCT01719133|Histamine|histamine|mesh-list
110096262|NCT01719133|Histamine phosphate|histamine phosphate|mesh-list
110096263|NCT01719133|Histamine Agonists|histamine agonists|mesh-ancestor
110096264|NCT01719133|Histamine Agents|histamine agents|mesh-ancestor
110096265|NCT01719133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110096266|NCT01719133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110096267|NCT01719133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096268|NCT01719159|Rituximab|rituximab|mesh-list
110096269|NCT01719159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110096270|NCT01719159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110096271|NCT01719159|Immunologic Factors|immunologic factors|mesh-ancestor
110096272|NCT01719159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096273|NCT01719159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110096274|NCT01719185|Vitamin B 12|vitamin b 12|mesh-list
110096275|NCT01719185|Phentermine|phentermine|mesh-list
110096276|NCT01719185|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110096277|NCT01719185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096278|NCT01719185|Appetite Depressants|appetite depressants|mesh-ancestor
110096279|NCT01719185|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110096280|NCT01719185|Sympathomimetics|sympathomimetics|mesh-ancestor
110096281|NCT01719185|Autonomic Agents|autonomic agents|mesh-ancestor
110096282|NCT01719185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110096283|NCT01719185|Adrenergic Agents|adrenergic agents|mesh-ancestor
110096284|NCT01719185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110096285|NCT01719185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110096286|NCT01719185|Vitamin B Complex|vitamin b complex|mesh-ancestor
110096287|NCT01719185|Vitamins|vitamins|mesh-ancestor
110096288|NCT01719185|Micronutrients|micronutrients|mesh-ancestor
110096289|NCT01719302|Gemcitabine|gemcitabine|mesh-list
110096290|NCT01719302|Docetaxel|docetaxel|mesh-list
110096291|NCT01719302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110096292|NCT01719302|Antimetabolites|antimetabolites|mesh-ancestor
110096293|NCT01719302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110096294|NCT01719302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110096295|NCT01719302|Tubulin Modulators|tubulin modulators|mesh-ancestor
110096296|NCT01719302|Antimitotic Agents|antimitotic agents|mesh-ancestor
110096297|NCT01719302|Mitosis Modulators|mitosis modulators|mesh-ancestor
110096298|NCT01719419|Orlistat|orlistat|mesh-list
110096299|NCT01719419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110096300|NCT01719419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110096301|NCT01719419|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110096302|NCT01719419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110096303|NCT01719588|Tapentadol|tapentadol|mesh-list
110096304|NCT01719588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110096305|NCT01719588|Narcotics|narcotics|mesh-ancestor
110096306|NCT01719588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110096307|NCT01719588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096308|NCT01719588|Analgesics|analgesics|mesh-ancestor
110096309|NCT01719588|Sensory System Agents|sensory system agents|mesh-ancestor
110096310|NCT01719588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110096311|NCT01719588|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110096312|NCT01719588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110096313|NCT01719588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110096314|NCT01719588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110096315|NCT01719588|Adrenergic Agents|adrenergic agents|mesh-ancestor
110096316|NCT01719588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110096317|NCT01719601|Tapentadol|tapentadol|mesh-list
110096318|NCT01719601|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110096319|NCT01719601|Narcotics|narcotics|mesh-ancestor
110096320|NCT01719601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110096321|NCT01719601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096322|NCT01719601|Analgesics|analgesics|mesh-ancestor
110096323|NCT01719601|Sensory System Agents|sensory system agents|mesh-ancestor
110096324|NCT01719601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110096325|NCT01719601|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110096326|NCT01719601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110096327|NCT01719601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110096328|NCT01719601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110096329|NCT01719601|Adrenergic Agents|adrenergic agents|mesh-ancestor
110096330|NCT01719601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110096332|NCT01719614|Rilpivirine|rilpivirine|mesh-list
110096333|NCT01719614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110096334|NCT01719614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096335|NCT01719614|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110096336|NCT01719614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110096337|NCT01719614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110096338|NCT01719614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110096339|NCT01719614|Antiviral Agents|antiviral agents|mesh-ancestor
110096340|NCT01719614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110096341|NCT01719614|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110096342|NCT01719614|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110096343|NCT01719627|Maraviroc|maraviroc|mesh-list
110096344|NCT01719627|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110096345|NCT01719627|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110096346|NCT01719627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110096347|NCT01719627|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110096348|NCT01719627|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110096349|NCT01719627|Antiviral Agents|antiviral agents|mesh-ancestor
110096350|NCT01719627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110096351|NCT01719627|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110096352|NCT01719692|Rituximab|rituximab|mesh-list
110096353|NCT01719692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110096354|NCT01719692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110096355|NCT01719692|Immunologic Factors|immunologic factors|mesh-ancestor
110096356|NCT01719692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096357|NCT01719692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110096358|NCT01719705|Pregabalin|pregabalin|mesh-list
110096359|NCT01719705|Analgesics|analgesics|mesh-ancestor
110096360|NCT01719705|Sensory System Agents|sensory system agents|mesh-ancestor
110096361|NCT01719705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110096362|NCT01719705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096363|NCT01719705|Anticonvulsants|anticonvulsants|mesh-ancestor
110096364|NCT01719705|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110096365|NCT01719705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110096366|NCT01719705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110096367|NCT01719705|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110096368|NCT01719705|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110096369|NCT01719705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110096370|NCT01719705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110096371|NCT01719705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110096372|NCT01719770|Rocuronium|rocuronium|mesh-list
110096373|NCT01719770|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110096374|NCT01719770|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110096375|NCT01719770|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110096376|NCT01719770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110096377|NCT01719770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096378|NCT01719835|Methylprednisolone|methylprednisolone|mesh-list
110096379|NCT01719835|Prednisolone|prednisolone|mesh-list
110096380|NCT01719835|Cyclophosphamide|cyclophosphamide|mesh-list
110096381|NCT01719835|Gemcitabine|gemcitabine|mesh-list
110096382|NCT01719835|Doxorubicin|doxorubicin|mesh-list
110096383|NCT01719835|Vincristine|vincristine|mesh-list
110096384|NCT01719835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110096385|NCT01719835|Immunologic Factors|immunologic factors|mesh-ancestor
110096386|NCT01719835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096387|NCT01719835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110096388|NCT01719835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110096389|NCT01719835|Alkylating Agents|alkylating agents|mesh-ancestor
110096390|NCT01719835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110096391|NCT01719835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110096392|NCT01719835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110096393|NCT01719835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110096394|NCT01719835|Antimetabolites|antimetabolites|mesh-ancestor
110096395|NCT01719835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110096396|NCT01719835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110096397|NCT01719835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110096398|NCT01719835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110096399|NCT01719835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110096400|NCT01719835|Tubulin Modulators|tubulin modulators|mesh-ancestor
110096401|NCT01719835|Antimitotic Agents|antimitotic agents|mesh-ancestor
110096402|NCT01719835|Mitosis Modulators|mitosis modulators|mesh-ancestor
110096403|NCT01719835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110096405|NCT01719835|Autonomic Agents|autonomic agents|mesh-ancestor
110096406|NCT01719835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110096407|NCT01719835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110096408|NCT01719835|Glucocorticoids|glucocorticoids|mesh-ancestor
110096410|NCT01719835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110096411|NCT01719835|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110096412|NCT01719835|Protective Agents|protective agents|mesh-ancestor
110096413|NCT01719835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110096414|NCT01719926|Indomethacin|indomethacin|mesh-list
110096415|NCT01719926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110096416|NCT01719926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110096417|NCT01719926|Analgesics|analgesics|mesh-ancestor
110096418|NCT01719926|Sensory System Agents|sensory system agents|mesh-ancestor
110096419|NCT01719926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110096420|NCT01719926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096421|NCT01719926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110096423|NCT01719926|Gout Suppressants|gout suppressants|mesh-ancestor
110096424|NCT01719926|Tocolytic Agents|tocolytic agents|mesh-ancestor
110096425|NCT01719926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110096426|NCT01719926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110096427|NCT01719926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110096428|NCT01719926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110096429|NCT01719952|Oxytocin|oxytocin|mesh-list
110096430|NCT01719952|Carbetocin|carbetocin|mesh-list
110096431|NCT01719952|Oxytocics|oxytocics|mesh-ancestor
110096432|NCT01719952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110096433|NCT01719952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096434|NCT01719978|Epinephrine|epinephrine|mesh-list
110096435|NCT01719978|Racepinephrine|racepinephrine|mesh-list
110096436|NCT01719978|Mepivacaine|mepivacaine|mesh-list
110096437|NCT01719978|Epinephryl borate|epinephryl borate|mesh-list
110096438|NCT01719978|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110096439|NCT01719978|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110096440|NCT01719978|Adrenergic Agents|adrenergic agents|mesh-ancestor
110096441|NCT01719978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110096442|NCT01719978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110096443|NCT01719978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096444|NCT01719978|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110096445|NCT01719978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110096446|NCT01719978|Autonomic Agents|autonomic agents|mesh-ancestor
110096447|NCT01719978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110096448|NCT01719978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110096449|NCT01719978|Respiratory System Agents|respiratory system agents|mesh-ancestor
110096450|NCT01719978|Mydriatics|mydriatics|mesh-ancestor
110096451|NCT01719978|Sympathomimetics|sympathomimetics|mesh-ancestor
110096452|NCT01719978|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110096453|NCT01719978|Anesthetics, Local|anesthetics, local|mesh-ancestor
110096454|NCT01719978|Anesthetics|anesthetics|mesh-ancestor
110096455|NCT01719978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110096456|NCT01719978|Sensory System Agents|sensory system agents|mesh-ancestor
110096457|NCT01720459|Resveratrol|resveratrol|mesh-list
110096458|NCT01720459|Antioxidants|antioxidants|mesh-ancestor
110096459|NCT01720459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110096460|NCT01720459|Protective Agents|protective agents|mesh-ancestor
110096461|NCT01720459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096462|NCT01720459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110096463|NCT01720459|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110096464|NCT01720537|Bococizumab|bococizumab|mesh-list
110096465|NCT01720537|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110096466|NCT01720537|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110096467|NCT01720537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110096468|NCT01720537|Antimetabolites|antimetabolites|mesh-ancestor
110096469|NCT01720537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110096470|NCT01720537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110096471|NCT01720537|Immunologic Factors|immunologic factors|mesh-ancestor
110096472|NCT01720537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096473|NCT01720719|Vitamin E|vitamin e|mesh-list
110096474|NCT01720719|Atorvastatin|atorvastatin|mesh-list
110096476|NCT01720719|Micronutrients|micronutrients|mesh-ancestor
110096477|NCT01720719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096478|NCT01720719|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110096479|NCT01720719|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110096480|NCT01720719|Antimetabolites|antimetabolites|mesh-ancestor
110096481|NCT01720719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110096482|NCT01720719|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110096483|NCT01720719|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110096484|NCT01720719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110096485|NCT01720719|Antioxidants|antioxidants|mesh-ancestor
110096486|NCT01720719|Protective Agents|protective agents|mesh-ancestor
110096487|NCT01722214|Adalimumab|adalimumab|mesh-list
110096488|NCT01722214|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110096489|NCT01722214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110096490|NCT01722214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110096491|NCT01722578|N-Methylaspartate|n-methylaspartate|mesh-list
110096492|NCT01722578|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
110096493|NCT01722578|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110096494|NCT01722578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110096495|NCT01722578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110096496|NCT01722578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096497|NCT01723852|Vitamin D|vitamin d|mesh-list
110096498|NCT01723852|Ergocalciferols|ergocalciferols|mesh-list
110096499|NCT01723852|Cholecalciferol|cholecalciferol|mesh-list
110096500|NCT01723852|Vitamins|vitamins|mesh-list
110096501|NCT01723852|Micronutrients|micronutrients|mesh-ancestor
110096502|NCT01723852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096503|NCT01723852|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110096504|NCT01723852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110096505|NCT01724229|Antifungal Agents|antifungal agents|mesh-list
110096506|NCT01724229|Clotrimazole|clotrimazole|mesh-list
110096507|NCT01724229|Miconazole|miconazole|mesh-list
110096508|NCT01724229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110096509|NCT01724229|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110096510|NCT01724229|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110096511|NCT01724229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110096512|NCT01724229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110096513|NCT01724229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110096514|NCT01724229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110096515|NCT01724229|Hormone Antagonists|hormone antagonists|mesh-ancestor
110096516|NCT01724229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110096517|NCT01724229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096518|NCT01724229|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110096519|NCT01724229|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110096520|NCT01724450|Carvedilol|carvedilol|mesh-list
110096521|NCT01724450|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110096522|NCT01724450|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110096523|NCT01724450|Adrenergic Agents|adrenergic agents|mesh-ancestor
110096524|NCT01724450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110096525|NCT01724450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110096526|NCT01724450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096527|NCT01724450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110096530|NCT01724450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110096531|NCT01724450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110096532|NCT01724450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110096533|NCT01724450|Vasodilator Agents|vasodilator agents|mesh-ancestor
110096534|NCT01724450|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110096535|NCT01724450|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110096536|NCT01724723|Entecavir|entecavir|mesh-list
110096537|NCT01724723|Antiviral Agents|antiviral agents|mesh-ancestor
110186310|NCT00038532|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110096538|NCT01724723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110096539|NCT01724892|Loteprednol Etabonate|loteprednol etabonate|mesh-list
110096540|NCT01724892|Dexamethasone|dexamethasone|mesh-list
110096541|NCT01724892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110096542|NCT01724892|Antiemetics|antiemetics|mesh-ancestor
110096543|NCT01724892|Autonomic Agents|autonomic agents|mesh-ancestor
110096544|NCT01724892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110096545|NCT01724892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096546|NCT01724892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110096547|NCT01724892|Glucocorticoids|glucocorticoids|mesh-ancestor
110096548|NCT01724892|Hormones|hormones|mesh-ancestor
110096549|NCT01724892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110096550|NCT01724892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110096551|NCT01724892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110096552|NCT01724892|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110096553|NCT01725256|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110096554|NCT01727427|Aspirin|aspirin|mesh-list
110096555|NCT01727427|Vitamin K|vitamin k|mesh-list
110096556|NCT01727427|Heparin|heparin|mesh-list
110096557|NCT01727427|Enoxaparin|enoxaparin|mesh-list
110096558|NCT01727427|Dalteparin|dalteparin|mesh-list
110096559|NCT01727427|Tinzaparin|tinzaparin|mesh-list
110096560|NCT01727427|PENTA|penta|mesh-list
110096561|NCT01727427|Nadroparin|nadroparin|mesh-list
110096562|NCT01727427|Warfarin|warfarin|mesh-list
110096563|NCT01727427|Rivaroxaban|rivaroxaban|mesh-list
110096564|NCT01727427|Dabigatran|dabigatran|mesh-list
110096565|NCT01727427|Apixaban|apixaban|mesh-list
110096566|NCT01727427|Fondaparinux|fondaparinux|mesh-list
110096567|NCT01727427|Acenocoumarol|acenocoumarol|mesh-list
110096568|NCT01727427|Phenprocoumon|phenprocoumon|mesh-list
110096569|NCT01727427|Bemiparin|bemiparin|mesh-list
110096570|NCT01727427|Vitamins|vitamins|mesh-ancestor
110096571|NCT01727427|Micronutrients|micronutrients|mesh-ancestor
110096572|NCT01727427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096573|NCT01727427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110096574|NCT01727427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110096575|NCT01727427|Analgesics|analgesics|mesh-ancestor
110096576|NCT01727427|Sensory System Agents|sensory system agents|mesh-ancestor
110096577|NCT01727427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110096578|NCT01727427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110096579|NCT01727427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110096580|NCT01727427|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110096581|NCT01727427|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110096582|NCT01727427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110096583|NCT01727427|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110096584|NCT01727427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110096585|NCT01727427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110096587|NCT01727427|Anticoagulants|anticoagulants|mesh-ancestor
110096588|NCT01727427|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110096589|NCT01727427|Antithrombins|antithrombins|mesh-ancestor
110096590|NCT01727427|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110096591|NCT01727427|Protease Inhibitors|protease inhibitors|mesh-ancestor
110096592|NCT01727427|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110096593|NCT01727427|Hemostatics|hemostatics|mesh-ancestor
110096594|NCT01727427|Coagulants|coagulants|mesh-ancestor
110096595|NCT01727778|Antibodies|antibodies|mesh-list
110096596|NCT01727778|Immunoglobulin M|immunoglobulin m|mesh-list
110096597|NCT01727778|Immunologic Factors|immunologic factors|mesh-ancestor
110096598|NCT01727778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096599|NCT01728025|Ranolazine|ranolazine|mesh-list
110096600|NCT01728025|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110096601|NCT01728025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110096602|NCT01728025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110096603|NCT01729195|Ciprofloxacin|ciprofloxacin|mesh-list
110096604|NCT01729195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110096605|NCT01729195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110096606|NCT01729195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110096607|NCT01729195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110096608|NCT01729195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110096609|NCT01729195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110096610|NCT01729195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110096611|NCT01729195|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110096612|NCT01729195|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110096613|NCT01730014|Insulin Glargine|insulin glargine|mesh-list
110096614|NCT01730014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110096615|NCT01730014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096616|NCT01730157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110096617|NCT01730157|Ipilimumab|ipilimumab|mesh-list
110096618|NCT01730157|Antibodies|antibodies|mesh-list
110096619|NCT01730157|Immunoglobulins|immunoglobulins|mesh-list
110096620|NCT01730157|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110096621|NCT01730157|Immunologic Factors|immunologic factors|mesh-ancestor
110096622|NCT01730157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096623|NCT01730157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110096624|NCT01730157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110096625|NCT01730157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110096626|NCT01730209|Everolimus|everolimus|mesh-list
110096627|NCT01730209|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110096628|NCT01730209|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110096629|NCT01730209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110096630|NCT01730209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110096631|NCT01730209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110096632|NCT01730209|Immunologic Factors|immunologic factors|mesh-ancestor
110096633|NCT01730209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096634|NCT01730209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110096636|NCT01730222|Gemcitabine|gemcitabine|mesh-list
110096637|NCT01730222|Capecitabine|capecitabine|mesh-list
110096638|NCT01730222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110096639|NCT01730222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110096640|NCT01730222|Tubulin Modulators|tubulin modulators|mesh-ancestor
110096641|NCT01730222|Antimitotic Agents|antimitotic agents|mesh-ancestor
110096642|NCT01730222|Mitosis Modulators|mitosis modulators|mesh-ancestor
110096643|NCT01730222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110096644|NCT01730222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110096645|NCT01730222|Antimetabolites|antimetabolites|mesh-ancestor
110096646|NCT01730287|Calcium, Dietary|calcium, dietary|mesh-list
110096647|NCT01730287|Calcium|calcium|mesh-list
110096648|NCT01730287|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110096649|NCT01730287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096650|NCT01730287|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110096651|NCT01730326|Acetaminophen|acetaminophen|mesh-list
110096652|NCT01730326|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
110096653|NCT01730326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110096654|NCT01730326|Analgesics|analgesics|mesh-ancestor
110096655|NCT01730326|Sensory System Agents|sensory system agents|mesh-ancestor
110096656|NCT01730326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110096657|NCT01730326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096658|NCT01730326|Antipyretics|antipyretics|mesh-ancestor
110096659|NCT01730326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110096660|NCT01730326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110096661|NCT01730326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110096662|NCT01730417|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
110096663|NCT01730417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110096664|NCT01730417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110096665|NCT01730417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110096666|NCT01730417|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110096667|NCT01730495|Etanercept|etanercept|mesh-list
110096668|NCT01730495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110096669|NCT01730495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110096670|NCT01730495|Analgesics|analgesics|mesh-ancestor
110096671|NCT01730495|Sensory System Agents|sensory system agents|mesh-ancestor
110096672|NCT01730495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110096673|NCT01730495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096674|NCT01730495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110096675|NCT01730495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110096676|NCT01730495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110096677|NCT01730495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110096678|NCT01730495|Immunologic Factors|immunologic factors|mesh-ancestor
110096679|NCT01730508|Interferons|interferons|mesh-list
110096680|NCT01730508|Interferon-alpha|interferon-alpha|mesh-list
110096681|NCT01730508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110096682|NCT01730508|Antiviral Agents|antiviral agents|mesh-ancestor
110096683|NCT01730508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110096684|NCT01730508|Immunologic Factors|immunologic factors|mesh-ancestor
110096685|NCT01730508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096686|NCT01726400|Interferons|interferons|mesh-list
110096687|NCT01726400|Ribavirin|ribavirin|mesh-list
110096688|NCT01726400|Interferon-alpha|interferon-alpha|mesh-list
110096689|NCT01726400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110096690|NCT01726400|Antiviral Agents|antiviral agents|mesh-ancestor
110096691|NCT01726400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110096692|NCT01726400|Antimetabolites|antimetabolites|mesh-ancestor
110096693|NCT01726400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110096694|NCT01726400|Immunologic Factors|immunologic factors|mesh-ancestor
110096695|NCT01726400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096696|NCT01730612|Histamine|histamine|mesh-list
110096697|NCT01730612|Glycine|glycine|mesh-list
110096698|NCT01730612|Histamine Agonists|histamine agonists|mesh-ancestor
110096699|NCT01730612|Histamine Agents|histamine agents|mesh-ancestor
110096700|NCT01730612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110096701|NCT01730612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110096702|NCT01730612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096703|NCT01730612|Glycine Agents|glycine agents|mesh-ancestor
110096704|NCT01730664|Ertapenem|ertapenem|mesh-list
110096705|NCT01730664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110096706|NCT01730664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110096707|NCT01730677|Vinorelbine|vinorelbine|mesh-list
110096708|NCT01730677|Lapatinib|lapatinib|mesh-list
110096709|NCT01730677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110096710|NCT01730677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110096711|NCT01730677|Tubulin Modulators|tubulin modulators|mesh-ancestor
110096712|NCT01730677|Antimitotic Agents|antimitotic agents|mesh-ancestor
110096713|NCT01730677|Mitosis Modulators|mitosis modulators|mesh-ancestor
110096714|NCT01730677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110096715|NCT01730677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110096716|NCT01730677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110096717|NCT01730976|Vitamin D|vitamin d|mesh-list
110096718|NCT01730976|Vitamins|vitamins|mesh-list
110096719|NCT01730976|Micronutrients|micronutrients|mesh-ancestor
110096720|NCT01730976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096721|NCT01730976|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110096722|NCT01731067|Fexofenadine|fexofenadine|mesh-list
110096723|NCT01731067|Flurbiprofen|flurbiprofen|mesh-list
110096724|NCT01731067|Midazolam|midazolam|mesh-list
110096725|NCT01731067|Dextromethorphan|dextromethorphan|mesh-list
110096726|NCT01731067|Caffeine|caffeine|mesh-list
110096727|NCT01731067|Bupropion|bupropion|mesh-list
110096728|NCT01731067|Omeprazole|omeprazole|mesh-list
110096729|NCT01731067|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110096730|NCT01731067|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110096731|NCT01731067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110096732|NCT01731067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096733|NCT01731067|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110096734|NCT01731067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110096735|NCT01731067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110096736|NCT01731067|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110096737|NCT01731067|Anesthetics, General|anesthetics, general|mesh-ancestor
110096738|NCT01731067|Anesthetics|anesthetics|mesh-ancestor
110096739|NCT01731067|GABA Modulators|gaba modulators|mesh-ancestor
110096740|NCT01731067|GABA Agents|gaba agents|mesh-ancestor
110096741|NCT01731067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110096742|NCT01731067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110096743|NCT01731067|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110096744|NCT01731067|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110096745|NCT01731067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110096746|NCT01731067|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110096747|NCT01731067|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110096748|NCT01731067|Purinergic Agents|purinergic agents|mesh-ancestor
110096749|NCT01731067|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110096750|NCT01731067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110096751|NCT01731067|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110096752|NCT01731067|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110096753|NCT01731067|Antidepressive Agents|antidepressive agents|mesh-ancestor
110096754|NCT01731067|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110096755|NCT01731067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110096756|NCT01731067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110096758|NCT01731067|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110096759|NCT01731067|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110096760|NCT01731067|Antitussive Agents|antitussive agents|mesh-ancestor
110096761|NCT01731067|Respiratory System Agents|respiratory system agents|mesh-ancestor
110096762|NCT01731067|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110096763|NCT01731067|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110096765|NCT01731067|Sensory System Agents|sensory system agents|mesh-ancestor
110096766|NCT01731067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110096767|NCT01731067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110096768|NCT01731067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110096769|NCT01731067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110096770|NCT01731067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110096771|NCT01731067|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110096772|NCT01731067|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110096773|NCT01731067|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110096774|NCT01731067|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110096775|NCT01731067|Histamine Antagonists|histamine antagonists|mesh-ancestor
110096776|NCT01731067|Histamine Agents|histamine agents|mesh-ancestor
110096778|NCT01731132|Levonorgestrel|levonorgestrel|mesh-list
110096779|NCT01731132|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110096780|NCT01731132|Contraceptive Agents|contraceptive agents|mesh-ancestor
110096781|NCT01731132|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110096782|NCT01731132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096783|NCT01731132|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110096784|NCT01731132|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110096785|NCT01731132|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110096786|NCT01731132|Trace Elements|trace elements|mesh-ancestor
110096787|NCT01731132|Micronutrients|micronutrients|mesh-ancestor
110096788|NCT01731158|Interferon alpha-2|interferon alpha-2|mesh-list
110096789|NCT01731158|Bevacizumab|bevacizumab|mesh-list
110096790|NCT01731158|Sunitinib|sunitinib|mesh-list
110096791|NCT01731158|Everolimus|everolimus|mesh-list
110096792|NCT01731158|Sorafenib|sorafenib|mesh-list
110096793|NCT01731158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110096794|NCT01731158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110096795|NCT01731158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110096796|NCT01731158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110096797|NCT01731158|Growth Substances|growth substances|mesh-ancestor
110096798|NCT01731158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096799|NCT01731158|Growth Inhibitors|growth inhibitors|mesh-ancestor
110096800|NCT01731158|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110096801|NCT01731158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110096802|NCT01731158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110096803|NCT01731158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110096804|NCT01731158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110096805|NCT01731158|Immunologic Factors|immunologic factors|mesh-ancestor
110096806|NCT01731158|Antiviral Agents|antiviral agents|mesh-ancestor
110096807|NCT01731158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110096808|NCT01731184|Midazolam|midazolam|mesh-list
110096809|NCT01731184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110096810|NCT01731184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110096811|NCT01731184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110096812|NCT01731184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096813|NCT01731184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110096814|NCT01731184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110096815|NCT01731184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110096816|NCT01731184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110096817|NCT01731184|Anesthetics, General|anesthetics, general|mesh-ancestor
110096818|NCT01731184|Anesthetics|anesthetics|mesh-ancestor
110096819|NCT01731184|GABA Modulators|gaba modulators|mesh-ancestor
110096820|NCT01731184|GABA Agents|gaba agents|mesh-ancestor
110096821|NCT01731184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110096822|NCT01731184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110096823|NCT01731275|Quetmolimab|quetmolimab|mesh-list
110096824|NCT01731275|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110096825|NCT01731275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110096826|NCT01731275|Immunologic Factors|immunologic factors|mesh-ancestor
110096827|NCT01731275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096828|NCT01731301|Ribavirin|ribavirin|mesh-list
110096829|NCT01731301|Antimetabolites|antimetabolites|mesh-ancestor
110096830|NCT01731301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110096831|NCT01731301|Antiviral Agents|antiviral agents|mesh-ancestor
110096832|NCT01731301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110096833|NCT01731327|Tofacitinib|tofacitinib|mesh-list
110096834|NCT01731327|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110096835|NCT01731327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110096836|NCT01731327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110096837|NCT01731327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110096838|NCT01731340|Calcium, Dietary|calcium, dietary|mesh-list
110096839|NCT01731340|Calcium|calcium|mesh-list
110096840|NCT01731340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110096841|NCT01731340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096842|NCT01731340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110096843|NCT01731431|Glyburide|glyburide|mesh-list
110096844|NCT01731431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110096845|NCT01731431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096846|NCT01731457|Etanercept|etanercept|mesh-list
110096847|NCT01731457|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110096848|NCT01731457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110096849|NCT01731457|Analgesics|analgesics|mesh-ancestor
110096850|NCT01731457|Sensory System Agents|sensory system agents|mesh-ancestor
110096851|NCT01731457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110096852|NCT01731457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096853|NCT01731457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110096854|NCT01731457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110096855|NCT01731457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110096856|NCT01731457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110096857|NCT01731457|Immunologic Factors|immunologic factors|mesh-ancestor
110096858|NCT01731561|Rituximab|rituximab|mesh-list
110096859|NCT01731561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110096860|NCT01731561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110096861|NCT01731561|Immunologic Factors|immunologic factors|mesh-ancestor
110096862|NCT01731561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096863|NCT01731561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110096864|NCT01731574|Dapivirine|dapivirine|mesh-list
110096865|NCT01731574|Miconazole|miconazole|mesh-list
110096866|NCT01731574|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110096867|NCT01731574|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110096868|NCT01731574|Antiviral Agents|antiviral agents|mesh-ancestor
110096869|NCT01731574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110096870|NCT01731574|Antifungal Agents|antifungal agents|mesh-ancestor
110096871|NCT01731574|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110096872|NCT01731574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110096873|NCT01731574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110096874|NCT01731574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110096875|NCT01731574|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110096876|NCT01731574|Hormone Antagonists|hormone antagonists|mesh-ancestor
110096877|NCT01731574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110096878|NCT01731574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096879|NCT01731574|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110096880|NCT01731574|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110096881|NCT01731587|Cyclophosphamide|cyclophosphamide|mesh-list
110096882|NCT01731587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110096883|NCT01731587|Immunologic Factors|immunologic factors|mesh-ancestor
110096884|NCT01731587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096885|NCT01731587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110096886|NCT01731587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110096887|NCT01731587|Alkylating Agents|alkylating agents|mesh-ancestor
110096888|NCT01731587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110096889|NCT01731587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110096890|NCT01731587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110096891|NCT01731652|Imiquimod|imiquimod|mesh-list
110096892|NCT01731652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110096893|NCT01731652|Immunologic Factors|immunologic factors|mesh-ancestor
110096894|NCT01731652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096895|NCT01731652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110096896|NCT01731652|Interferon Inducers|interferon inducers|mesh-ancestor
110096897|NCT01731756|Salicylic Acid|salicylic acid|mesh-list
110096898|NCT01731756|Salicylates|salicylates|mesh-list
110096899|NCT01731756|Petrolatum|petrolatum|mesh-list
110096900|NCT01731756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110096901|NCT01731756|Antifungal Agents|antifungal agents|mesh-ancestor
110096902|NCT01731756|Keratolytic Agents|keratolytic agents|mesh-ancestor
110096903|NCT01731756|Dermatologic Agents|dermatologic agents|mesh-ancestor
110096904|NCT01731756|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110096905|NCT01731756|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110096906|NCT01731756|Analgesics|analgesics|mesh-ancestor
110096907|NCT01731756|Sensory System Agents|sensory system agents|mesh-ancestor
110096908|NCT01731756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110096909|NCT01731756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096910|NCT01731756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110096911|NCT01731756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110096912|NCT01731756|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110096913|NCT01731756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110096914|NCT01731756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110096915|NCT01731756|Emollients|emollients|mesh-ancestor
110096916|NCT01731795|Dexamethasone|dexamethasone|mesh-list
110096917|NCT01731795|Dexamethasone acetate|dexamethasone acetate|mesh-list
110096918|NCT01731795|BB 1101|bb 1101|mesh-list
110096919|NCT01731795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110096920|NCT01731795|Antiemetics|antiemetics|mesh-ancestor
110096921|NCT01731795|Autonomic Agents|autonomic agents|mesh-ancestor
110096922|NCT01731795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110096923|NCT01731795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096924|NCT01731795|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110096925|NCT01731795|Glucocorticoids|glucocorticoids|mesh-ancestor
110096926|NCT01731795|Hormones|hormones|mesh-ancestor
110096927|NCT01731795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110096928|NCT01731795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110096929|NCT01731795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110096930|NCT01731795|Protease Inhibitors|protease inhibitors|mesh-ancestor
110096931|NCT01731795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110096932|NCT01731795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110096933|NCT01731899|Agomelatine|agomelatine|mesh-list
110096934|NCT01731899|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110096935|NCT01731899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110096936|NCT01731899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096937|NCT01731925|Sunitinib|sunitinib|mesh-list
110096938|NCT01731925|Lanreotide|lanreotide|mesh-list
110096939|NCT01731925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110096940|NCT01731925|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110096941|NCT01731925|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110096942|NCT01731925|Growth Substances|growth substances|mesh-ancestor
110096943|NCT01731925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096944|NCT01731925|Growth Inhibitors|growth inhibitors|mesh-ancestor
110096945|NCT01731925|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110096946|NCT01731925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110096947|NCT01731925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110096948|NCT01732055|Antidepressive Agents|antidepressive agents|mesh-list
110096949|NCT01732055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110096950|NCT01732068|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110096951|NCT01732068|Luteolytic Agents|luteolytic agents|mesh-ancestor
110096952|NCT01732068|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110096953|NCT01732068|Contraceptive Agents|contraceptive agents|mesh-ancestor
110096954|NCT01732068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110096955|NCT01732068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096956|NCT01732068|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110096957|NCT01732068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110096958|NCT01732068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110096959|NCT01732094|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110096960|NCT01732094|Luteolytic Agents|luteolytic agents|mesh-ancestor
110096961|NCT01732094|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110096962|NCT01732094|Contraceptive Agents|contraceptive agents|mesh-ancestor
110096963|NCT01732094|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110096964|NCT01732094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096965|NCT01732094|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110096966|NCT01732094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110096968|NCT01732146|Epoetin Alfa|epoetin alfa|mesh-list
110096969|NCT01732146|Hematinics|hematinics|mesh-ancestor
110096970|NCT01732198|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110096971|NCT01732198|Immunologic Factors|immunologic factors|mesh-ancestor
110096972|NCT01732198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096975|NCT01732224|Antiviral Agents|antiviral agents|mesh-ancestor
110096976|NCT01732224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110096977|NCT01732224|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110096978|NCT01732224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110096979|NCT01732224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110096980|NCT01732224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110096981|NCT01732224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110096982|NCT01732224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110096983|NCT01732250|Meropenem|meropenem|mesh-list
110096984|NCT01732250|Colistin|colistin|mesh-list
110096985|NCT01732250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110096986|NCT01732250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110096987|NCT01732276|Gefitinib|gefitinib|mesh-list
110096988|NCT01732276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110096989|NCT01732276|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110096990|NCT01732276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110096991|NCT01732276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110096992|NCT01732328|Vitamin D|vitamin d|mesh-list
110096993|NCT01732328|Calcium|calcium|mesh-list
110096994|NCT01732328|Vitamins|vitamins|mesh-ancestor
110096996|NCT01732328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110096997|NCT01732328|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110096998|NCT01732328|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110096999|NCT01732367|Tenofovir|tenofovir|mesh-list
110097000|NCT01732367|Lamivudine|lamivudine|mesh-list
110097001|NCT01732367|Adefovir|adefovir|mesh-list
110097002|NCT01732367|Antiviral Agents|antiviral agents|mesh-ancestor
110097003|NCT01732367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110097004|NCT01732367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110097005|NCT01732367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110097006|NCT01732367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110097007|NCT01732367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097008|NCT01732367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110097009|NCT01732367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110097010|NCT01732380|Oxaliplatin|oxaliplatin|mesh-list
110097011|NCT01732380|Raltitrexed|raltitrexed|mesh-list
110097012|NCT01732380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110097013|NCT01732380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110097014|NCT01732380|Antimetabolites|antimetabolites|mesh-ancestor
110097015|NCT01732380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097016|NCT01732380|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110097017|NCT01732380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110097018|NCT01732393|Quercetin|quercetin|mesh-list
110097019|NCT01732393|Antioxidants|antioxidants|mesh-ancestor
110097020|NCT01732393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097021|NCT01732393|Protective Agents|protective agents|mesh-ancestor
110097022|NCT01732393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097023|NCT01732666|Remifentanil|remifentanil|mesh-list
110097024|NCT01732666|Nefopam|nefopam|mesh-list
110097025|NCT01732666|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110097026|NCT01732666|Narcotics|narcotics|mesh-ancestor
110097027|NCT01732666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110097028|NCT01732666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097029|NCT01732666|Analgesics|analgesics|mesh-ancestor
110097030|NCT01732666|Sensory System Agents|sensory system agents|mesh-ancestor
110097031|NCT01732666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110097032|NCT01732666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110097033|NCT01732744|Sodium Hypochlorite|sodium hypochlorite|mesh-list
110097034|NCT01732744|Eusol|eusol|mesh-list
110097035|NCT01732744|Castor Oil|castor oil|mesh-list
110097036|NCT01732744|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110097037|NCT01732744|Disinfectants|disinfectants|mesh-ancestor
110097038|NCT01732744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110097039|NCT01732744|Cathartics|cathartics|mesh-ancestor
110097040|NCT01732744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110097041|NCT01732861|Lenalidomide|lenalidomide|mesh-list
110097042|NCT01732861|Immunologic Factors|immunologic factors|mesh-ancestor
110097043|NCT01732861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097044|NCT01732861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110097045|NCT01732861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110097046|NCT01732861|Growth Substances|growth substances|mesh-ancestor
110097047|NCT01732861|Growth Inhibitors|growth inhibitors|mesh-ancestor
110097048|NCT01732861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110097049|NCT01733017|Lycopene|lycopene|mesh-list
110097050|NCT01733017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110097051|NCT01733017|Antioxidants|antioxidants|mesh-ancestor
110097052|NCT01733017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097053|NCT01733017|Protective Agents|protective agents|mesh-ancestor
110097054|NCT01733017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097055|NCT01733017|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110097056|NCT01733017|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110097057|NCT01733017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110097058|NCT01733030|Cycloserine|cycloserine|mesh-list
110097059|NCT01733030|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110097060|NCT01733030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110097061|NCT01733030|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110097062|NCT01733030|Antitubercular Agents|antitubercular agents|mesh-ancestor
110097063|NCT01733030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110097064|NCT01733030|Antimetabolites|antimetabolites|mesh-ancestor
110097065|NCT01733030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097066|NCT01733043|Dexmedetomidine|dexmedetomidine|mesh-list
110097067|NCT01733043|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110097068|NCT01733043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110097069|NCT01733043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097070|NCT01733043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110097071|NCT01733043|Analgesics|analgesics|mesh-ancestor
110097072|NCT01733043|Sensory System Agents|sensory system agents|mesh-ancestor
110097073|NCT01733043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110097074|NCT01733043|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110097075|NCT01733043|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110097076|NCT01733043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110097077|NCT01733043|Adrenergic Agents|adrenergic agents|mesh-ancestor
110097078|NCT01733043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110097079|NCT01733043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097080|NCT01733095|Ambrisentan|ambrisentan|mesh-list
110097081|NCT01733095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110097082|NCT01733108|Canagliflozin|canagliflozin|mesh-list
110097083|NCT01733108|Glyburide|glyburide|mesh-list
110097084|NCT01733108|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110097085|NCT01733108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097086|NCT01733108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110097087|NCT01733108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097088|NCT01733134|Tolvaptan|tolvaptan|mesh-list
110097089|NCT01733134|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110097090|NCT01733134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097091|NCT01733134|Natriuretic Agents|natriuretic agents|mesh-ancestor
110097092|NCT01733134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097093|NCT01733290|Botulinum Toxins|botulinum toxins|mesh-list
110097094|NCT01733290|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110097095|NCT01733290|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110097096|NCT01733290|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110097097|NCT01733290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110097098|NCT01733290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097099|NCT01733290|Cholinergic Agents|cholinergic agents|mesh-ancestor
110097100|NCT01733290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110097101|NCT01733290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097102|NCT01733290|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110097103|NCT01733290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110097104|NCT01733342|Anesthetics|anesthetics|mesh-list
110097105|NCT01733342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110097106|NCT01733342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097107|NCT01733394|Lamotrigine|lamotrigine|mesh-list
110097108|NCT01733394|Anticonvulsants|anticonvulsants|mesh-list
110097109|NCT01733394|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110097110|NCT01733394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110097111|NCT01733394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097112|NCT01733394|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110097113|NCT01733394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097114|NCT01733394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110097115|NCT01733394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110097116|NCT01733394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110097117|NCT01733394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110097118|NCT01733394|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110097119|NCT01733459|Metformin|metformin|mesh-list
110097120|NCT01733459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110097121|NCT01733459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097122|NCT01733485|Aspirin|aspirin|mesh-list
110097123|NCT01733485|Indomethacin|indomethacin|mesh-list
110097124|NCT01733485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110097125|NCT01733485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110097126|NCT01733485|Analgesics|analgesics|mesh-ancestor
110097127|NCT01733485|Sensory System Agents|sensory system agents|mesh-ancestor
110097128|NCT01733485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110097129|NCT01733485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097130|NCT01733485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110097131|NCT01733485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110097132|NCT01733485|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110097133|NCT01733485|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110097134|NCT01733485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097135|NCT01733485|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110097136|NCT01733485|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110097137|NCT01733485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110097138|NCT01733485|Antipyretics|antipyretics|mesh-ancestor
110097139|NCT01733485|Gout Suppressants|gout suppressants|mesh-ancestor
110097140|NCT01733485|Tocolytic Agents|tocolytic agents|mesh-ancestor
110097141|NCT01733485|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110097143|NCT01733589|Cisplatin|cisplatin|mesh-list
110097144|NCT01733589|Endostatins|endostatins|mesh-list
110097145|NCT01733589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110097146|NCT01733589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110097147|NCT01733589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110097149|NCT01733589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110097150|NCT01733589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097151|NCT01733589|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110097152|NCT01733589|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110097153|NCT01733589|Growth Substances|growth substances|mesh-ancestor
110097154|NCT01733589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097155|NCT01733589|Growth Inhibitors|growth inhibitors|mesh-ancestor
110097156|NCT01733706|Nicotine|nicotine|mesh-list
110097157|NCT01733706|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110097158|NCT01733706|Autonomic Agents|autonomic agents|mesh-ancestor
110097159|NCT01733706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110097160|NCT01733706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097161|NCT01733706|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110097162|NCT01733706|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110097163|NCT01733706|Cholinergic Agents|cholinergic agents|mesh-ancestor
110097164|NCT01733706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110097165|NCT01733706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097166|NCT01733823|Nimorazole|nimorazole|mesh-list
110097167|NCT01733823|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
110097168|NCT01733823|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110097169|NCT01733823|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110097170|NCT01733823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110097171|NCT01733836|Metformin|metformin|mesh-list
110097172|NCT01733836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110097173|NCT01733836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097174|NCT01733966|Amoxicillin|amoxicillin|mesh-list
110097175|NCT01733966|Clavulanic Acids|clavulanic acids|mesh-list
110097176|NCT01733966|Clavulanic Acid|clavulanic acid|mesh-list
110097177|NCT01733966|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110097178|NCT01733966|Ciprofloxacin|ciprofloxacin|mesh-list
110097179|NCT01733966|Secnidazole|secnidazole|mesh-list
110097180|NCT01733966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110097181|NCT01733966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110097182|NCT01733966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110097183|NCT01733966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097184|NCT01733966|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110097185|NCT01733966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110097186|NCT01733966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110097187|NCT01733966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110097188|NCT01733966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110097189|NCT01733966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110097190|NCT01733966|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110097191|NCT01733966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110097192|NCT01733979|Iron|iron|mesh-list
110097193|NCT01733979|Trace Elements|trace elements|mesh-ancestor
110097194|NCT01733979|Micronutrients|micronutrients|mesh-ancestor
110097195|NCT01733979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097196|NCT01733992|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110097197|NCT01733992|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110097198|NCT01734044|Dexamethasone|dexamethasone|mesh-list
110097199|NCT01734044|Dexamethasone acetate|dexamethasone acetate|mesh-list
110097200|NCT01734044|BB 1101|bb 1101|mesh-list
110097201|NCT01734044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110097202|NCT01734044|Antiemetics|antiemetics|mesh-ancestor
110097203|NCT01734044|Autonomic Agents|autonomic agents|mesh-ancestor
110097204|NCT01734044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110097205|NCT01734044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097206|NCT01734044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110097207|NCT01734044|Glucocorticoids|glucocorticoids|mesh-ancestor
110097208|NCT01734044|Hormones|hormones|mesh-ancestor
110097209|NCT01734044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110097210|NCT01734044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110097211|NCT01734044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110097212|NCT01734044|Protease Inhibitors|protease inhibitors|mesh-ancestor
110097213|NCT01734044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110097214|NCT01734044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097215|NCT01734057|Dexamethasone|dexamethasone|mesh-list
110097216|NCT01734057|Rituximab|rituximab|mesh-list
110097217|NCT01734057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110097218|NCT01734057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110097219|NCT01734057|Immunologic Factors|immunologic factors|mesh-ancestor
110097220|NCT01734057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097221|NCT01734057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110097222|NCT01734057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110097223|NCT01734057|Antiemetics|antiemetics|mesh-ancestor
110097224|NCT01734057|Autonomic Agents|autonomic agents|mesh-ancestor
110097225|NCT01734057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110097226|NCT01734057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110097227|NCT01734057|Glucocorticoids|glucocorticoids|mesh-ancestor
110097228|NCT01734057|Hormones|hormones|mesh-ancestor
110097229|NCT01734057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110097230|NCT01734057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110097231|NCT01734096|Candesartan|candesartan|mesh-list
110097232|NCT01734096|Candesartan cilexetil|candesartan cilexetil|mesh-list
110097233|NCT01734096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110097234|NCT01734096|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110097235|NCT01734096|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110097236|NCT01734096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097237|NCT01734252|Argatroban|argatroban|mesh-list
110097238|NCT01734252|Antithrombins|antithrombins|mesh-ancestor
110097239|NCT01734252|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110097240|NCT01734252|Protease Inhibitors|protease inhibitors|mesh-ancestor
110097241|NCT01734252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110097242|NCT01734252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097243|NCT01734252|Anticoagulants|anticoagulants|mesh-ancestor
110097244|NCT01734252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110097245|NCT01734330|Nicotine|nicotine|mesh-list
110097246|NCT01734330|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110097247|NCT01734330|Autonomic Agents|autonomic agents|mesh-ancestor
110097248|NCT01734330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110097249|NCT01734330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097250|NCT01734330|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110097251|NCT01734330|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110097252|NCT01734330|Cholinergic Agents|cholinergic agents|mesh-ancestor
110097253|NCT01734330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110097254|NCT01734330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097255|NCT01734408|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110097256|NCT01734408|Aluminum sulfate|aluminum sulfate|mesh-list
110097257|NCT01734408|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110097258|NCT01734408|Immunologic Factors|immunologic factors|mesh-ancestor
110097259|NCT01734408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097260|NCT01734408|Antacids|antacids|mesh-ancestor
110097261|NCT01734408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097262|NCT01734408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110097263|NCT01734473|Caseins|caseins|mesh-list
110097264|NCT01734473|Chelating Agents|chelating agents|mesh-ancestor
110097265|NCT01734473|Sequestering Agents|sequestering agents|mesh-ancestor
110097266|NCT01734473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097267|NCT01734564|Poly I-C|poly i-c|mesh-list
110097268|NCT01734564|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110097269|NCT01734564|Poly ICLC|poly iclc|mesh-list
110097270|NCT01734564|Interferon Inducers|interferon inducers|mesh-ancestor
110097271|NCT01734564|Immunologic Factors|immunologic factors|mesh-ancestor
110097272|NCT01734564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097273|NCT01734564|Laxatives|laxatives|mesh-ancestor
110097274|NCT01734564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110097275|NCT01734564|Antiviral Agents|antiviral agents|mesh-ancestor
110097276|NCT01734564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110097277|NCT01734798|Gemcitabine|gemcitabine|mesh-list
110097278|NCT01734798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110097279|NCT01734798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110097280|NCT01734798|Antimetabolites|antimetabolites|mesh-ancestor
110097281|NCT01734798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097282|NCT01734824|Denosumab|denosumab|mesh-list
110097283|NCT01734824|Teriparatide|teriparatide|mesh-list
110097284|NCT01734824|Parathyroid Hormone|parathyroid hormone|mesh-list
110097285|NCT01734824|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110097286|NCT01734824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097287|NCT01734824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110097288|NCT01734915|Iproplatin|iproplatin|mesh-list
110097289|NCT01734915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110097290|NCT01734954|Midazolam|midazolam|mesh-list
110097291|NCT01734954|Analgesics|analgesics|mesh-list
110097292|NCT01734954|Anesthetics|anesthetics|mesh-list
110097293|NCT01734954|Levobupivacaine|levobupivacaine|mesh-list
110097294|NCT01734954|Anesthetics, Local|anesthetics, local|mesh-list
110097295|NCT01734954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110097296|NCT01734954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097297|NCT01734954|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110097298|NCT01734954|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110097299|NCT01734954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110097300|NCT01734954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110097301|NCT01734954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110097302|NCT01734954|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110097303|NCT01734954|Anesthetics, General|anesthetics, general|mesh-ancestor
110097304|NCT01734954|GABA Modulators|gaba modulators|mesh-ancestor
110097305|NCT01734954|GABA Agents|gaba agents|mesh-ancestor
110097306|NCT01734954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110186370|NCT05769049|Immunologic Factors|immunologic factors|mesh-ancestor
110097307|NCT01734954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097308|NCT01734954|Sensory System Agents|sensory system agents|mesh-ancestor
110097309|NCT01734954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110097311|NCT01735006|Immunologic Factors|immunologic factors|mesh-ancestor
110097312|NCT01735006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097313|NCT01735019|Remifentanil|remifentanil|mesh-list
110097314|NCT01735019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110097315|NCT01735019|Narcotics|narcotics|mesh-ancestor
110097316|NCT01735019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110097317|NCT01735019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097318|NCT01735019|Analgesics|analgesics|mesh-ancestor
110097319|NCT01735019|Sensory System Agents|sensory system agents|mesh-ancestor
110097320|NCT01735019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110097321|NCT01735058|Hyaluronic Acid|hyaluronic acid|mesh-list
110097322|NCT01735058|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110097323|NCT01735058|Immunologic Factors|immunologic factors|mesh-ancestor
110097324|NCT01735058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097325|NCT01735058|Viscosupplements|viscosupplements|mesh-ancestor
110097326|NCT01735058|Protective Agents|protective agents|mesh-ancestor
110097327|NCT01735071|Bevacizumab|bevacizumab|mesh-list
110097328|NCT01735071|Carboplatin|carboplatin|mesh-list
110097329|NCT01735071|Trabectedin|trabectedin|mesh-list
110097330|NCT01735071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110097331|NCT01735071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110097332|NCT01735071|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110097333|NCT01735071|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110097334|NCT01735071|Growth Substances|growth substances|mesh-ancestor
110097335|NCT01735071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097336|NCT01735071|Growth Inhibitors|growth inhibitors|mesh-ancestor
110097337|NCT01735071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110097338|NCT01735071|Alkylating Agents|alkylating agents|mesh-ancestor
110097339|NCT01735071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097340|NCT01735084|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110097341|NCT01735084|Immunologic Factors|immunologic factors|mesh-ancestor
110097342|NCT01735084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097343|NCT01735097|Vitamin E|vitamin e|mesh-list
110097344|NCT01735097|Vitamins|vitamins|mesh-ancestor
110097345|NCT01735097|Micronutrients|micronutrients|mesh-ancestor
110097346|NCT01735097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097347|NCT01735097|Antioxidants|antioxidants|mesh-ancestor
110097348|NCT01735097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097349|NCT01735097|Protective Agents|protective agents|mesh-ancestor
110097350|NCT01735123|Caseins|caseins|mesh-list
110097351|NCT01735123|Chelating Agents|chelating agents|mesh-ancestor
110097352|NCT01735123|Sequestering Agents|sequestering agents|mesh-ancestor
110097353|NCT01735123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097355|NCT01735227|Pantoprazole|pantoprazole|mesh-list
110097356|NCT01735227|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110097357|NCT01735227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110097358|NCT01735227|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110097359|NCT01735227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110097360|NCT01735227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097362|NCT01735240|Antifungal Agents|antifungal agents|mesh-ancestor
110097363|NCT01735240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110097364|NCT01735240|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110097365|NCT01735240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110097366|NCT01735240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110097367|NCT01735240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097368|NCT01735240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110097369|NCT01735240|Hormone Antagonists|hormone antagonists|mesh-ancestor
110097370|NCT01735240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110097371|NCT01735240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097372|NCT01735240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110097374|NCT01735318|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110097375|NCT01735318|Protease Inhibitors|protease inhibitors|mesh-ancestor
110097376|NCT01735318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110097377|NCT01735318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097378|NCT01735318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110097379|NCT01735318|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110097380|NCT01735318|Protective Agents|protective agents|mesh-ancestor
110097381|NCT01735318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097382|NCT01735344|Lisinopril|lisinopril|mesh-list
110097383|NCT01735344|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110097384|NCT01735344|Protease Inhibitors|protease inhibitors|mesh-ancestor
110097385|NCT01735344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110097386|NCT01735344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097387|NCT01735344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110097388|NCT01735344|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110097389|NCT01735344|Protective Agents|protective agents|mesh-ancestor
110097390|NCT01735344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097391|NCT01735370|Etodolac|etodolac|mesh-list
110097392|NCT01735370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110097393|NCT01735370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110097394|NCT01735370|Analgesics|analgesics|mesh-ancestor
110097395|NCT01735370|Sensory System Agents|sensory system agents|mesh-ancestor
110097396|NCT01735370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110097397|NCT01735370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097398|NCT01735370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110097399|NCT01735370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110097400|NCT01735370|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110097401|NCT01735370|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110097402|NCT01735370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110097403|NCT01735370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097404|NCT01735383|Etodolac|etodolac|mesh-list
110097405|NCT01735383|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110097406|NCT01735383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110097407|NCT01735383|Analgesics|analgesics|mesh-ancestor
110097408|NCT01735383|Sensory System Agents|sensory system agents|mesh-ancestor
110097409|NCT01735383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110097410|NCT01735383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097411|NCT01735383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110097412|NCT01735383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110097413|NCT01735383|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110097414|NCT01735383|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110097415|NCT01735383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110097416|NCT01735383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097417|NCT01735487|Nicotine|nicotine|mesh-list
110097418|NCT01735487|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110097419|NCT01735487|Autonomic Agents|autonomic agents|mesh-ancestor
110097420|NCT01735487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110097421|NCT01735487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097422|NCT01735487|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110097423|NCT01735487|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110097424|NCT01735487|Cholinergic Agents|cholinergic agents|mesh-ancestor
110097425|NCT01735487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110097426|NCT01735487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097427|NCT01735669|Remifentanil|remifentanil|mesh-list
110097428|NCT01735669|Nitrous Oxide|nitrous oxide|mesh-list
110097429|NCT01735669|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110097430|NCT01735669|Narcotics|narcotics|mesh-ancestor
110097431|NCT01735669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110097432|NCT01735669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097433|NCT01735669|Analgesics|analgesics|mesh-ancestor
110097434|NCT01735669|Sensory System Agents|sensory system agents|mesh-ancestor
110097435|NCT01735669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110097436|NCT01735669|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110097437|NCT01735669|Anesthetics, General|anesthetics, general|mesh-ancestor
110097438|NCT01735669|Anesthetics|anesthetics|mesh-ancestor
110097439|NCT01735669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110097440|NCT01735747|Vincristine|vincristine|mesh-list
110097441|NCT01735747|Temozolomide|temozolomide|mesh-list
110097442|NCT01735747|Nedaplatin|nedaplatin|mesh-list
110097443|NCT01735747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110097444|NCT01735747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110097446|NCT01735747|Antimitotic Agents|antimitotic agents|mesh-ancestor
110097447|NCT01735747|Mitosis Modulators|mitosis modulators|mesh-ancestor
110097448|NCT01735747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097449|NCT01735747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110097450|NCT01735747|Alkylating Agents|alkylating agents|mesh-ancestor
110097451|NCT01735864|Indirubin|indirubin|mesh-list
110097452|NCT01735864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110097453|NCT01735864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110097454|NCT01735890|Amlodipine|amlodipine|mesh-list
110097455|NCT01735890|Valsartan|valsartan|mesh-list
110097456|NCT01735890|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
110097457|NCT01735890|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110097458|NCT01735890|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110097459|NCT01735890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110097460|NCT01735890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097461|NCT01735890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110097462|NCT01735890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097463|NCT01735890|Vasodilator Agents|vasodilator agents|mesh-ancestor
110097464|NCT01735890|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110097465|NCT01735890|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110097466|NCT01736020|Dexmedetomidine|dexmedetomidine|mesh-list
110097467|NCT01736020|Nitrous Oxide|nitrous oxide|mesh-list
110097468|NCT01736020|Ketamine|ketamine|mesh-list
110097469|NCT01736020|Propofol|propofol|mesh-list
110097470|NCT01736020|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110097471|NCT01736020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110097472|NCT01736020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097473|NCT01736020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110097474|NCT01736020|Analgesics|analgesics|mesh-ancestor
110097475|NCT01736020|Sensory System Agents|sensory system agents|mesh-ancestor
110097476|NCT01736020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110097477|NCT01736020|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110097478|NCT01736020|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110097479|NCT01736020|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110097480|NCT01736020|Adrenergic Agents|adrenergic agents|mesh-ancestor
110097481|NCT01736020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110097482|NCT01736020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097483|NCT01736020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110097484|NCT01736020|Anesthetics, General|anesthetics, general|mesh-ancestor
110097485|NCT01736020|Anesthetics|anesthetics|mesh-ancestor
110097486|NCT01736020|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110097487|NCT01736020|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110097488|NCT01736020|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110097489|NCT01736020|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110097490|NCT01736033|Tamsulosin|tamsulosin|mesh-list
110097491|NCT01736033|Finasteride|finasteride|mesh-list
110097492|NCT01736033|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110097493|NCT01736033|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110097494|NCT01736033|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110097495|NCT01736033|Adrenergic Agents|adrenergic agents|mesh-ancestor
110097496|NCT01736033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110097497|NCT01736033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097498|NCT01736033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097499|NCT01736033|Urological Agents|urological agents|mesh-ancestor
110097500|NCT01736033|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110097501|NCT01736033|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110097502|NCT01736033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110097503|NCT01736033|Hormone Antagonists|hormone antagonists|mesh-ancestor
110097504|NCT01736033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110097506|NCT01736150|Chelating Agents|chelating agents|mesh-ancestor
110097507|NCT01736150|Sequestering Agents|sequestering agents|mesh-ancestor
110097508|NCT01736150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097509|NCT01736163|Hormones|hormones|mesh-list
110097510|NCT01736163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110097511|NCT01736163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097512|NCT01736371|Propofol|propofol|mesh-list
110097513|NCT01736371|Sevoflurane|sevoflurane|mesh-list
110097514|NCT01736371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110097515|NCT01736371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110097516|NCT01736371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097517|NCT01736371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110097518|NCT01736371|Anesthetics, General|anesthetics, general|mesh-ancestor
110097519|NCT01736371|Anesthetics|anesthetics|mesh-ancestor
110097520|NCT01736371|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110097521|NCT01736371|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110097522|NCT01736410|Trastuzumab|trastuzumab|mesh-list
110097523|NCT01736410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110097524|NCT01736410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110097525|NCT01736423|Ramosetron|ramosetron|mesh-list
110097526|NCT01736423|Antiemetics|antiemetics|mesh-ancestor
110097527|NCT01736423|Autonomic Agents|autonomic agents|mesh-ancestor
110097528|NCT01736423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110097529|NCT01736423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097530|NCT01736423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110097531|NCT01736423|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110097532|NCT01736423|Serotonin Agents|serotonin agents|mesh-ancestor
110097533|NCT01736423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110097534|NCT01736423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097535|NCT01736449|Bevacizumab|bevacizumab|mesh-list
110097536|NCT01736449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110097537|NCT01736449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110097538|NCT01736449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110097539|NCT01736449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110097540|NCT01736449|Growth Substances|growth substances|mesh-ancestor
110097541|NCT01736449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097542|NCT01736449|Growth Inhibitors|growth inhibitors|mesh-ancestor
110097543|NCT01736488|Atenolol|atenolol|mesh-list
110097544|NCT01736488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110097545|NCT01736488|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110097546|NCT01736488|Sympatholytics|sympatholytics|mesh-ancestor
110097547|NCT01736488|Autonomic Agents|autonomic agents|mesh-ancestor
110097548|NCT01736488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110097549|NCT01736488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097550|NCT01736488|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110097551|NCT01736488|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110097552|NCT01736488|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110097553|NCT01736488|Adrenergic Agents|adrenergic agents|mesh-ancestor
110097554|NCT01736488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110097555|NCT01736488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097556|NCT01736514|Allopurinol|allopurinol|mesh-list
110097557|NCT01736514|Febuxostat|febuxostat|mesh-list
110097558|NCT01736514|Antimetabolites|antimetabolites|mesh-ancestor
110097559|NCT01736514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097560|NCT01736514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110097561|NCT01736514|Gout Suppressants|gout suppressants|mesh-ancestor
110097562|NCT01736514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110097563|NCT01736514|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110097564|NCT01736514|Antioxidants|antioxidants|mesh-ancestor
110097565|NCT01736514|Protective Agents|protective agents|mesh-ancestor
110097566|NCT01736514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097567|NCT01736670|Triamcinolone|triamcinolone|mesh-list
110097568|NCT01736670|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110097569|NCT01736670|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110097570|NCT01736670|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110097571|NCT01736670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110097572|NCT01736670|Glucocorticoids|glucocorticoids|mesh-ancestor
110097573|NCT01736670|Hormones|hormones|mesh-ancestor
110097574|NCT01736670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110097575|NCT01736670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097576|NCT01736670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110097577|NCT01736670|Immunologic Factors|immunologic factors|mesh-ancestor
110097578|NCT01736670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110186402|NCT05762146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110097579|NCT01736670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097580|NCT01736761|Ritonavir|ritonavir|mesh-list
110097581|NCT01736761|Darunavir|darunavir|mesh-list
110097582|NCT01736761|Rilpivirine|rilpivirine|mesh-list
110097583|NCT01736761|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110097584|NCT01736761|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110097585|NCT01736761|Protease Inhibitors|protease inhibitors|mesh-ancestor
110097586|NCT01736761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110097587|NCT01736761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097588|NCT01736761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110097589|NCT01736761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110097590|NCT01736761|Antiviral Agents|antiviral agents|mesh-ancestor
110097591|NCT01736761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110097592|NCT01736761|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110097593|NCT01736761|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110097594|NCT01736761|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110097595|NCT01736761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110097596|NCT01736800|Temozolomide|temozolomide|mesh-list
110097597|NCT01736800|Topotecan|topotecan|mesh-list
110097598|NCT01736800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110097599|NCT01736800|Alkylating Agents|alkylating agents|mesh-ancestor
110097600|NCT01736800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097601|NCT01736800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110097602|NCT01736800|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110097603|NCT01736800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110097604|NCT01736800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110097605|NCT01736813|Maraviroc|maraviroc|mesh-list
110097606|NCT01736813|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110097607|NCT01736813|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110097608|NCT01736813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097609|NCT01736813|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110097610|NCT01736813|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110097611|NCT01736813|Antiviral Agents|antiviral agents|mesh-ancestor
110097612|NCT01736813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110097613|NCT01736813|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110097614|NCT01736878|Sorafenib|sorafenib|mesh-list
110097615|NCT01736878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110097617|NCT01736878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110097618|NCT01736878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097619|NCT01736891|Rasagiline|rasagiline|mesh-list
110097620|NCT01736891|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110097621|NCT01736891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110097622|NCT01736891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097623|NCT01736891|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110097624|NCT01736891|Protective Agents|protective agents|mesh-ancestor
110097625|NCT01736891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097626|NCT01737008|Cisplatin|cisplatin|mesh-list
110097627|NCT01737008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110097628|NCT01737073|Analgesics, Opioid|analgesics, opioid|mesh-list
110097629|NCT01737073|Narcotics|narcotics|mesh-ancestor
110097630|NCT01737073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110097631|NCT01737073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097632|NCT01737073|Analgesics|analgesics|mesh-ancestor
110097633|NCT01737073|Sensory System Agents|sensory system agents|mesh-ancestor
110097634|NCT01737073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110097636|NCT01737086|Astringents|astringents|mesh-ancestor
110097637|NCT01737086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097638|NCT01737086|Dermatologic Agents|dermatologic agents|mesh-ancestor
110097639|NCT01737112|HYNIC-3PRGD(2)|hynic-3prgd(2)|mesh-list
110097640|NCT01737112|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110097641|NCT01737112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097642|NCT01737177|Rituximab|rituximab|mesh-list
110097643|NCT01737177|Lenalidomide|lenalidomide|mesh-list
110097644|NCT01737177|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110097645|NCT01737177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110097646|NCT01737177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110097647|NCT01737177|Immunologic Factors|immunologic factors|mesh-ancestor
110097648|NCT01737177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097649|NCT01737177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110097650|NCT01737177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110097651|NCT01737177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110097652|NCT01737177|Growth Substances|growth substances|mesh-ancestor
110097653|NCT01737177|Growth Inhibitors|growth inhibitors|mesh-ancestor
110097654|NCT01737177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110097655|NCT01737177|Alkylating Agents|alkylating agents|mesh-ancestor
110097656|NCT01737177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097657|NCT01737203|Sildenafil Citrate|sildenafil citrate|mesh-list
110097658|NCT01737203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097659|NCT01737203|Vasodilator Agents|vasodilator agents|mesh-ancestor
110097660|NCT01737203|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110097661|NCT01737203|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110097662|NCT01737203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110097663|NCT01737203|Urological Agents|urological agents|mesh-ancestor
110097664|NCT01737216|Zoledronic Acid|zoledronic acid|mesh-list
110097665|NCT01737216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110097666|NCT01737216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097668|NCT01737294|Antipruritics|antipruritics|mesh-ancestor
110097669|NCT01737294|Dermatologic Agents|dermatologic agents|mesh-ancestor
110097670|NCT01737294|Sensory System Agents|sensory system agents|mesh-ancestor
110097671|NCT01737294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110097672|NCT01737294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097673|NCT01737307|Fluorides|fluorides|mesh-list
110097674|NCT01737307|Fluorides, Topical|fluorides, topical|mesh-list
110097675|NCT01737307|Cariostatic Agents|cariostatic agents|mesh-ancestor
110097676|NCT01737307|Protective Agents|protective agents|mesh-ancestor
110097677|NCT01737307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097678|NCT01737320|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110097679|NCT01737320|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110097680|NCT01737320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110097681|NCT01737320|Antitubercular Agents|antitubercular agents|mesh-ancestor
110097682|NCT01737346|Lomustine|lomustine|mesh-list
110097683|NCT01737346|Procarbazine|procarbazine|mesh-list
110097684|NCT01737346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110097685|NCT01737346|Alkylating Agents|alkylating agents|mesh-ancestor
110097686|NCT01737346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097687|NCT01737346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110097688|NCT01737359|Tenofovir|tenofovir|mesh-list
110097689|NCT01737359|Antiviral Agents|antiviral agents|mesh-ancestor
110097690|NCT01737359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110097691|NCT01737359|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110097692|NCT01737359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110097693|NCT01737359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110097694|NCT01737359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097695|NCT01737359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110097696|NCT01737359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110097697|NCT01737411|Solifenacin Succinate|solifenacin succinate|mesh-list
110097698|NCT01737411|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110097699|NCT01737411|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110097700|NCT01737411|Cholinergic Agents|cholinergic agents|mesh-ancestor
110097701|NCT01737411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110097702|NCT01737411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097703|NCT01737411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097704|NCT01737411|Urological Agents|urological agents|mesh-ancestor
110097705|NCT01737541|Fluoxetine|fluoxetine|mesh-list
110097706|NCT01737541|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110097707|NCT01737541|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110097708|NCT01737541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110097709|NCT01737541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097710|NCT01737541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110097711|NCT01737541|Serotonin Agents|serotonin agents|mesh-ancestor
110097712|NCT01737541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097713|NCT01737541|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110097714|NCT01737541|Antidepressive Agents|antidepressive agents|mesh-ancestor
110097715|NCT01737541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110097716|NCT01737541|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110097717|NCT01737541|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110097718|NCT01737541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110097719|NCT01737671|Leucovorin|leucovorin|mesh-list
110097720|NCT01737671|Methotrexate|methotrexate|mesh-list
110097721|NCT01737671|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110097722|NCT01737671|Abortifacient Agents|abortifacient agents|mesh-ancestor
110097723|NCT01737671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110097724|NCT01737671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097725|NCT01737671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110097726|NCT01737671|Antimetabolites|antimetabolites|mesh-ancestor
110097727|NCT01737671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097728|NCT01737671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110097729|NCT01737671|Dermatologic Agents|dermatologic agents|mesh-ancestor
110097730|NCT01737671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110097731|NCT01737671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110097732|NCT01737671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110097733|NCT01737671|Immunologic Factors|immunologic factors|mesh-ancestor
110097734|NCT01737671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110097735|NCT01737671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110097736|NCT01737671|Antidotes|antidotes|mesh-ancestor
110097737|NCT01737671|Protective Agents|protective agents|mesh-ancestor
110097738|NCT01737671|Vitamin B Complex|vitamin b complex|mesh-ancestor
110097739|NCT01737671|Vitamins|vitamins|mesh-ancestor
110097740|NCT01737671|Micronutrients|micronutrients|mesh-ancestor
110097741|NCT01737918|Solifenacin Succinate|solifenacin succinate|mesh-list
110097742|NCT01737918|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110097743|NCT01737918|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110097744|NCT01737918|Cholinergic Agents|cholinergic agents|mesh-ancestor
110097745|NCT01737918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110097746|NCT01737918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097747|NCT01737918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097748|NCT01737918|Urological Agents|urological agents|mesh-ancestor
110097749|NCT01738035|Budesonide|budesonide|mesh-list
110097750|NCT01738035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110097751|NCT01738035|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110097752|NCT01738035|Autonomic Agents|autonomic agents|mesh-ancestor
110097753|NCT01738035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110097754|NCT01738035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097755|NCT01738035|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110097756|NCT01738035|Respiratory System Agents|respiratory system agents|mesh-ancestor
110097757|NCT01738035|Glucocorticoids|glucocorticoids|mesh-ancestor
110097758|NCT01738035|Hormones|hormones|mesh-ancestor
110097759|NCT01738035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110097760|NCT01738087|Fluticasone|fluticasone|mesh-list
110097761|NCT01738087|Xhance|xhance|mesh-list
110097762|NCT01738087|Formoterol Fumarate|formoterol fumarate|mesh-list
110097763|NCT01738087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110097764|NCT01738087|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110097765|NCT01738087|Autonomic Agents|autonomic agents|mesh-ancestor
110097766|NCT01738087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110097767|NCT01738087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097768|NCT01738087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110097769|NCT01738087|Respiratory System Agents|respiratory system agents|mesh-ancestor
110097770|NCT01738087|Dermatologic Agents|dermatologic agents|mesh-ancestor
110097771|NCT01738087|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110097772|NCT01738087|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110097773|NCT01738087|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110097774|NCT01738087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110097775|NCT01738087|Adrenergic Agents|adrenergic agents|mesh-ancestor
110097776|NCT01738087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110097777|NCT01738087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097778|NCT01738100|Morphine|morphine|mesh-list
110097779|NCT01738100|Clopidogrel|clopidogrel|mesh-list
110097780|NCT01738100|Ticagrelor|ticagrelor|mesh-list
110097781|NCT01738100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110097782|NCT01738100|Narcotics|narcotics|mesh-ancestor
110097783|NCT01738100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110097784|NCT01738100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097786|NCT01738100|Sensory System Agents|sensory system agents|mesh-ancestor
110097787|NCT01738100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110097788|NCT01738100|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110097789|NCT01738100|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110097790|NCT01738100|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110097791|NCT01738100|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110097792|NCT01738100|Purinergic Agents|purinergic agents|mesh-ancestor
110097793|NCT01738100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110097794|NCT01738100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097795|NCT01738178|Caffeine|caffeine|mesh-list
110097796|NCT01738178|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110097797|NCT01738178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097798|NCT01738178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110097799|NCT01738178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110097800|NCT01738178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097801|NCT01738178|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110097802|NCT01738178|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110097803|NCT01738178|Purinergic Agents|purinergic agents|mesh-ancestor
110097804|NCT01738178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110097805|NCT01738243|Hyaluronic Acid|hyaluronic acid|mesh-list
110097806|NCT01738243|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110097807|NCT01738243|Immunologic Factors|immunologic factors|mesh-ancestor
110097808|NCT01738243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097809|NCT01738243|Viscosupplements|viscosupplements|mesh-ancestor
110097810|NCT01738243|Protective Agents|protective agents|mesh-ancestor
110097811|NCT01738282|Baclofen|baclofen|mesh-list
110097812|NCT01738282|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110097813|NCT01738282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097814|NCT01738282|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110097815|NCT01738282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110097816|NCT01738282|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110097817|NCT01738282|GABA Agonists|gaba agonists|mesh-ancestor
110097818|NCT01738282|GABA Agents|gaba agents|mesh-ancestor
110097819|NCT01738282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110097820|NCT01738282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097821|NCT01738295|Donepezil|donepezil|mesh-list
110097822|NCT01738295|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110097823|NCT01738295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110097824|NCT01738295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097825|NCT01738295|Cholinergic Agents|cholinergic agents|mesh-ancestor
110097826|NCT01738295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110097827|NCT01738295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097828|NCT01738295|Nootropic Agents|nootropic agents|mesh-ancestor
110097829|NCT01738360|Arsenic Trioxide|arsenic trioxide|mesh-list
110097830|NCT01738360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110097831|NCT01738373|Plerixafor|plerixafor|mesh-list
110097832|NCT01738373|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110097833|NCT01738373|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110097834|NCT01738373|Antiviral Agents|antiviral agents|mesh-ancestor
110097835|NCT01738373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110097836|NCT01738425|Hydrogen Sulfide|hydrogen sulfide|mesh-list
110097837|NCT01738425|Gasotransmitters|gasotransmitters|mesh-ancestor
110097838|NCT01738425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110097839|NCT01738425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097840|NCT01738425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097841|NCT01738451|Dabrafenib|dabrafenib|mesh-list
110097842|NCT01738451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110097843|NCT01738451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110097844|NCT01738451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110097845|NCT01738451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097846|NCT01738542|Antihypertensive Agents|antihypertensive agents|mesh-list
110097847|NCT01738542|Bosentan|bosentan|mesh-list
110097848|NCT01738542|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110186425|NCT05744674|Anesthetics|anesthetics|mesh-ancestor
110097849|NCT01738542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097850|NCT01738724|Goserelin|goserelin|mesh-list
110097851|NCT01738724|Dienogest|dienogest|mesh-list
110097852|NCT01738724|Desogestrel|desogestrel|mesh-list
110097853|NCT01738724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110097854|NCT01738724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110097855|NCT01738724|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110097856|NCT01738724|Contraceptive Agents|contraceptive agents|mesh-ancestor
110097857|NCT01738724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110097858|NCT01738724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097859|NCT01738724|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110097860|NCT01738724|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110097861|NCT01738724|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110097862|NCT01738724|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110097863|NCT01738724|Hormone Antagonists|hormone antagonists|mesh-ancestor
110097864|NCT01738724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110097866|NCT01738724|Progestins|progestins|mesh-ancestor
110097867|NCT01738724|Hormones|hormones|mesh-ancestor
110097868|NCT01738763|Inositol|inositol|mesh-list
110097869|NCT01738763|Vitamin B Complex|vitamin b complex|mesh-ancestor
110097870|NCT01738763|Vitamins|vitamins|mesh-ancestor
110097871|NCT01738763|Micronutrients|micronutrients|mesh-ancestor
110097872|NCT01738763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097873|NCT01738802|Micronutrients|micronutrients|mesh-list
110097874|NCT01738802|Trace Elements|trace elements|mesh-list
110097875|NCT01738802|Antioxidants|antioxidants|mesh-list
110097876|NCT01738802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097877|NCT01738802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097878|NCT01738802|Protective Agents|protective agents|mesh-ancestor
110097879|NCT01738815|Valproic Acid|valproic acid|mesh-list
110097880|NCT01738815|Anticonvulsants|anticonvulsants|mesh-ancestor
110097881|NCT01738815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110097882|NCT01738815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097883|NCT01738815|GABA Agents|gaba agents|mesh-ancestor
110097884|NCT01738815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110097885|NCT01738815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097886|NCT01738815|Antimanic Agents|antimanic agents|mesh-ancestor
110097887|NCT01738815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110097888|NCT01738815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110097889|NCT01738815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110097891|NCT01738867|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110097892|NCT01738867|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110097893|NCT01738867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097894|NCT01738867|Sensory System Agents|sensory system agents|mesh-ancestor
110097895|NCT01738867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110097896|NCT01738893|Gabapentin|gabapentin|mesh-list
110097897|NCT01738893|Analgesics|analgesics|mesh-ancestor
110097898|NCT01738893|Sensory System Agents|sensory system agents|mesh-ancestor
110097899|NCT01738893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110097900|NCT01738893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097901|NCT01738893|Anticonvulsants|anticonvulsants|mesh-ancestor
110097902|NCT01738893|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110097903|NCT01738893|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110097904|NCT01738893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110097905|NCT01738893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110097906|NCT01738893|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110097907|NCT01738893|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110097908|NCT01738893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110097909|NCT01738893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097910|NCT01738893|Antimanic Agents|antimanic agents|mesh-ancestor
110097911|NCT01738945|Amlodipine|amlodipine|mesh-list
110097912|NCT01738945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110097913|NCT01738945|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110097914|NCT01738945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110097915|NCT01738945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186433|NCT05736978|Antimetabolites|antimetabolites|mesh-ancestor
110097916|NCT01738945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110097917|NCT01738945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097918|NCT01738945|Vasodilator Agents|vasodilator agents|mesh-ancestor
110097919|NCT01739049|Liraglutide|liraglutide|mesh-list
110097920|NCT01739049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110097921|NCT01739049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097922|NCT01739049|Incretins|incretins|mesh-ancestor
110097923|NCT01739049|Hormones|hormones|mesh-ancestor
110097924|NCT01739049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110097926|NCT01739127|Aripiprazole|aripiprazole|mesh-list
110097927|NCT01739127|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110097928|NCT01739127|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110097929|NCT01739127|Serotonin Agents|serotonin agents|mesh-ancestor
110097930|NCT01739127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110097931|NCT01739127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097932|NCT01739127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097933|NCT01739127|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110097934|NCT01739127|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110097935|NCT01739127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110097936|NCT01739127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110097937|NCT01739127|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110097938|NCT01739127|Dopamine Agents|dopamine agents|mesh-ancestor
110097939|NCT01739127|Antidepressive Agents|antidepressive agents|mesh-ancestor
110097940|NCT01739127|Dopamine Agonists|dopamine agonists|mesh-ancestor
110097941|NCT01739127|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110097942|NCT01739127|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110097943|NCT01739127|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110097944|NCT01739127|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110097945|NCT01739192|Bupropion|bupropion|mesh-list
110097946|NCT01739192|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110097947|NCT01739192|Antidepressive Agents|antidepressive agents|mesh-ancestor
110097948|NCT01739192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110097949|NCT01739192|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110097950|NCT01739192|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110097951|NCT01739192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110097952|NCT01739192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097953|NCT01739192|Dopamine Agents|dopamine agents|mesh-ancestor
110097954|NCT01739192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110097955|NCT01739192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097956|NCT01739192|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110097957|NCT01739192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110097958|NCT01739192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110097960|NCT01739218|Bevacizumab|bevacizumab|mesh-list
110097961|NCT01739218|Carboplatin|carboplatin|mesh-list
110097962|NCT01739218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110097963|NCT01739218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110097964|NCT01739218|Tubulin Modulators|tubulin modulators|mesh-ancestor
110097965|NCT01739218|Antimitotic Agents|antimitotic agents|mesh-ancestor
110097966|NCT01739218|Mitosis Modulators|mitosis modulators|mesh-ancestor
110097967|NCT01739218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097968|NCT01739218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110097969|NCT01739218|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110097970|NCT01739218|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110097972|NCT01739218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097973|NCT01739218|Growth Inhibitors|growth inhibitors|mesh-ancestor
110097974|NCT01739413|Anesthetics|anesthetics|mesh-list
110097975|NCT01739413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110097976|NCT01739413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097977|NCT01739439|Gemcitabine|gemcitabine|mesh-list
110097978|NCT01739439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110097979|NCT01739439|Antimetabolites|antimetabolites|mesh-ancestor
110097980|NCT01739439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097981|NCT01739439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110097982|NCT01739504|Anesthetics|anesthetics|mesh-list
110097983|NCT01739504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110097984|NCT01739504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097986|NCT01739556|Ticagrelor|ticagrelor|mesh-list
110097987|NCT01739556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110097988|NCT01739556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110097989|NCT01739556|Analgesics|analgesics|mesh-ancestor
110097990|NCT01739556|Sensory System Agents|sensory system agents|mesh-ancestor
110097991|NCT01739556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110097992|NCT01739556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110097993|NCT01739556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110097994|NCT01739556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110097995|NCT01739556|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110097996|NCT01739556|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110097997|NCT01739556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097998|NCT01739556|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110097999|NCT01739556|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110098000|NCT01739556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110098001|NCT01739556|Antipyretics|antipyretics|mesh-ancestor
110098002|NCT01739556|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110098003|NCT01739556|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110098004|NCT01739556|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110098005|NCT01739556|Purinergic Agents|purinergic agents|mesh-ancestor
110098006|NCT01739556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110098007|NCT01739582|Enclomiphene|enclomiphene|mesh-list
110098008|NCT01739582|Clomiphene|clomiphene|mesh-list
110098009|NCT01739582|Zuclomiphene|zuclomiphene|mesh-list
110098010|NCT01739582|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110098011|NCT01739582|Hormone Antagonists|hormone antagonists|mesh-ancestor
110098012|NCT01739582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110098013|NCT01739582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098014|NCT01739582|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110098015|NCT01739582|Fertility Agents|fertility agents|mesh-ancestor
110098016|NCT01739582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110098017|NCT01739582|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110098018|NCT01739582|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110098019|NCT01739634|Antidiarrheals|antidiarrheals|mesh-list
110098020|NCT01739634|Calcium Aluminosilicate|calcium aluminosilicate|mesh-list
110098021|NCT01739634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110098023|NCT01739673|Vitamin B Complex|vitamin b complex|mesh-ancestor
110098024|NCT01739673|Vitamins|vitamins|mesh-ancestor
110098025|NCT01739673|Micronutrients|micronutrients|mesh-ancestor
110098026|NCT01739673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098027|NCT01739673|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110098028|NCT01739673|Dermatologic Agents|dermatologic agents|mesh-ancestor
110098029|NCT01739855|Ergocalciferols|ergocalciferols|mesh-list
110098030|NCT01739855|Calcium Carbonate|calcium carbonate|mesh-list
110098031|NCT01739855|Calcium|calcium|mesh-list
110098032|NCT01739855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110098033|NCT01739855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098034|NCT01739855|Antacids|antacids|mesh-ancestor
110098035|NCT01739855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110098036|NCT01739855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110098037|NCT01739855|Vitamins|vitamins|mesh-ancestor
110098038|NCT01739855|Micronutrients|micronutrients|mesh-ancestor
110098039|NCT01739855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110098040|NCT01739894|Paclitaxel|paclitaxel|mesh-list
110098041|NCT01739894|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110098042|NCT01739894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110098043|NCT01739894|Tubulin Modulators|tubulin modulators|mesh-ancestor
110098044|NCT01739894|Antimitotic Agents|antimitotic agents|mesh-ancestor
110098045|NCT01739894|Mitosis Modulators|mitosis modulators|mesh-ancestor
110098046|NCT01739894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110098047|NCT01739907|Vitamin D|vitamin d|mesh-list
110098048|NCT01739907|Vitamins|vitamins|mesh-ancestor
110098049|NCT01739907|Micronutrients|micronutrients|mesh-ancestor
110098050|NCT01739907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098051|NCT01739907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110098052|NCT01739920|Povidone-Iodine|povidone-iodine|mesh-list
110098053|NCT01739920|Povidone|povidone|mesh-list
110098054|NCT01739920|Plasma Substitutes|plasma substitutes|mesh-ancestor
110098055|NCT01739920|Blood Substitutes|blood substitutes|mesh-ancestor
110098056|NCT01739920|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110098057|NCT01739920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110098058|NCT01739985|Dexamethasone|dexamethasone|mesh-list
110098059|NCT01739985|Dexamethasone acetate|dexamethasone acetate|mesh-list
110098060|NCT01739985|Droperidol|droperidol|mesh-list
110098061|NCT01739985|Ondansetron|ondansetron|mesh-list
110098062|NCT01739985|BB 1101|bb 1101|mesh-list
110098063|NCT01739985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110098064|NCT01739985|Antiemetics|antiemetics|mesh-ancestor
110098065|NCT01739985|Autonomic Agents|autonomic agents|mesh-ancestor
110098066|NCT01739985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110098067|NCT01739985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098068|NCT01739985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110098069|NCT01739985|Glucocorticoids|glucocorticoids|mesh-ancestor
110098070|NCT01739985|Hormones|hormones|mesh-ancestor
110098071|NCT01739985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110098072|NCT01739985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110098073|NCT01739985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110098074|NCT01739985|Protease Inhibitors|protease inhibitors|mesh-ancestor
110098075|NCT01739985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110098076|NCT01739985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110098077|NCT01739985|Antipruritics|antipruritics|mesh-ancestor
110098078|NCT01739985|Dermatologic Agents|dermatologic agents|mesh-ancestor
110098079|NCT01739985|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110098080|NCT01739985|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110098081|NCT01739985|Serotonin Agents|serotonin agents|mesh-ancestor
110098082|NCT01739985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110098083|NCT01739985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110098084|NCT01739985|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110098085|NCT01739985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110098086|NCT01739985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110098087|NCT01739985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110098088|NCT01739985|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110098089|NCT01739985|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110098090|NCT01739985|Dopamine Agents|dopamine agents|mesh-ancestor
110098091|NCT01740245|Biguanides|biguanides|mesh-list
110098092|NCT01740245|Chlorhexidine|chlorhexidine|mesh-list
110098093|NCT01740245|Polihexanide|polihexanide|mesh-list
110098094|NCT01740245|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110098095|NCT01740245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110098096|NCT01740245|Disinfectants|disinfectants|mesh-ancestor
110098097|NCT01740245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110098098|NCT01740245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098099|NCT01740271|Epirubicin|epirubicin|mesh-list
110098100|NCT01740271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110098101|NCT01740271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110098102|NCT01740271|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110098103|NCT01740271|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110098104|NCT01740271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110098105|NCT01740271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110098106|NCT01740336|Paclitaxel|paclitaxel|mesh-list
110098107|NCT01740336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110098108|NCT01740336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110098109|NCT01740336|Tubulin Modulators|tubulin modulators|mesh-ancestor
110098110|NCT01740336|Antimitotic Agents|antimitotic agents|mesh-ancestor
110098111|NCT01740336|Mitosis Modulators|mitosis modulators|mesh-ancestor
110098112|NCT01740336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110098113|NCT01740453|Ropivacaine|ropivacaine|mesh-list
110098114|NCT01740453|Anesthetics, Local|anesthetics, local|mesh-ancestor
110098115|NCT01740453|Anesthetics|anesthetics|mesh-ancestor
110098116|NCT01740453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110098117|NCT01740453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098118|NCT01740453|Sensory System Agents|sensory system agents|mesh-ancestor
110098119|NCT01740453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110098120|NCT01740518|Ascorbic Acid|ascorbic acid|mesh-list
110098121|NCT01740518|Antioxidants|antioxidants|mesh-ancestor
110098122|NCT01740518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110098123|NCT01740518|Protective Agents|protective agents|mesh-ancestor
110098124|NCT01740518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098125|NCT01740518|Vitamins|vitamins|mesh-ancestor
110098126|NCT01740518|Micronutrients|micronutrients|mesh-ancestor
110098127|NCT01740921|Aspirin|aspirin|mesh-list
110098128|NCT01740921|Liraglutide|liraglutide|mesh-list
110098129|NCT01740921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110098130|NCT01740921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110098131|NCT01740921|Analgesics|analgesics|mesh-ancestor
110098132|NCT01740921|Sensory System Agents|sensory system agents|mesh-ancestor
110098133|NCT01740921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110098134|NCT01740921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098135|NCT01740921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110098136|NCT01740921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110098137|NCT01740921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110098138|NCT01740921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110098139|NCT01740921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110098140|NCT01740921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110098141|NCT01740921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110098142|NCT01740921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110098144|NCT01740921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110098145|NCT01740921|Incretins|incretins|mesh-ancestor
110098146|NCT01740921|Hormones|hormones|mesh-ancestor
110098147|NCT01740921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110098148|NCT01740947|Amphotericin B|amphotericin b|mesh-list
110098149|NCT01740947|Tobramycin|tobramycin|mesh-list
110098150|NCT01740947|Colistin|colistin|mesh-list
110098151|NCT01740947|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110098152|NCT01740947|Amebicides|amebicides|mesh-ancestor
110098153|NCT01740947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110098154|NCT01740947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110098155|NCT01740947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110098156|NCT01740947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110098157|NCT01740947|Antifungal Agents|antifungal agents|mesh-ancestor
110098158|NCT01740960|Dronabinol|dronabinol|mesh-list
110098159|NCT01740960|Hallucinogens|hallucinogens|mesh-ancestor
110098160|NCT01740960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098161|NCT01740960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110098162|NCT01740960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110098163|NCT01740960|Analgesics|analgesics|mesh-ancestor
110098164|NCT01740960|Sensory System Agents|sensory system agents|mesh-ancestor
110098165|NCT01740960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110098166|NCT01740960|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110098167|NCT01740960|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110098168|NCT01740960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110098169|NCT01740960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110098170|NCT01740960|Hormones|hormones|mesh-ancestor
110368556|NCT01165216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110098171|NCT01740960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110098173|NCT01741038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110098174|NCT01741038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110098176|NCT01741077|Hematinics|hematinics|mesh-ancestor
110098177|NCT01741077|Vitamin B Complex|vitamin b complex|mesh-ancestor
110098178|NCT01741077|Vitamins|vitamins|mesh-ancestor
110098179|NCT01741077|Micronutrients|micronutrients|mesh-ancestor
110098180|NCT01741077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098181|NCT01741142|Escitalopram|escitalopram|mesh-list
110098182|NCT01741142|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110098183|NCT01741142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110098184|NCT01741142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110098185|NCT01741142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110098186|NCT01741142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110098187|NCT01741142|Serotonin Agents|serotonin agents|mesh-ancestor
110098188|NCT01741142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098189|NCT01741181|Vitamin D|vitamin d|mesh-list
110098190|NCT01741181|Ergocalciferols|ergocalciferols|mesh-list
110098191|NCT01741181|Cholecalciferol|cholecalciferol|mesh-list
110098192|NCT01741181|Vitamins|vitamins|mesh-list
110098193|NCT01741181|Micronutrients|micronutrients|mesh-ancestor
110098194|NCT01741181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098195|NCT01741181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110098196|NCT01741181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110098197|NCT01741285|Fluticasone|fluticasone|mesh-list
110098198|NCT01741285|Beclomethasone|beclomethasone|mesh-list
110098199|NCT01741285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110098200|NCT01741285|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110098201|NCT01741285|Autonomic Agents|autonomic agents|mesh-ancestor
110098202|NCT01741285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110098203|NCT01741285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098204|NCT01741285|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110098205|NCT01741285|Respiratory System Agents|respiratory system agents|mesh-ancestor
110098206|NCT01741285|Dermatologic Agents|dermatologic agents|mesh-ancestor
110098207|NCT01741285|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110098208|NCT01741285|Glucocorticoids|glucocorticoids|mesh-ancestor
110098209|NCT01741285|Hormones|hormones|mesh-ancestor
110098210|NCT01741285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110098211|NCT01741324|Vitamin D|vitamin d|mesh-list
110098212|NCT01741324|Ergocalciferols|ergocalciferols|mesh-list
110098213|NCT01741324|Cholecalciferol|cholecalciferol|mesh-list
110098214|NCT01741324|Vitamins|vitamins|mesh-list
110098215|NCT01741324|Micronutrients|micronutrients|mesh-ancestor
110098216|NCT01741324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098217|NCT01741324|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110098218|NCT01741324|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110098219|NCT01741376|Progesterone|progesterone|mesh-list
110098220|NCT01741376|Progestins|progestins|mesh-ancestor
110098221|NCT01741376|Hormones|hormones|mesh-ancestor
110098222|NCT01741376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110098223|NCT01741376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098224|NCT01741389|Melatonin|melatonin|mesh-list
110098225|NCT01741389|Antioxidants|antioxidants|mesh-ancestor
110098226|NCT01741389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110098227|NCT01741389|Protective Agents|protective agents|mesh-ancestor
110098228|NCT01741389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098229|NCT01741389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110098230|NCT01741493|Upadacitinib|upadacitinib|mesh-list
110098231|NCT01741493|Tofacitinib|tofacitinib|mesh-list
110098232|NCT01741493|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110098233|NCT01741493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110098234|NCT01741493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110098235|NCT01741493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110098236|NCT01741493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110098237|NCT01741506|Dalteparin|dalteparin|mesh-list
110098238|NCT01741506|Tinzaparin|tinzaparin|mesh-list
110098239|NCT01741506|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110098240|NCT01741506|Anticoagulants|anticoagulants|mesh-ancestor
110098241|NCT01741506|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110098242|NCT01741506|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110098243|NCT01741506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110098244|NCT01741519|Landiolol|landiolol|mesh-list
110098245|NCT01741519|Esmolol|esmolol|mesh-list
110098246|NCT01741519|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110098247|NCT01741519|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110098248|NCT01741519|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110098249|NCT01741519|Adrenergic Agents|adrenergic agents|mesh-ancestor
110098250|NCT01741519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110098251|NCT01741519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110098252|NCT01741519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098253|NCT01741519|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110098254|NCT01741558|Riboflavin|riboflavin|mesh-list
110098255|NCT01741558|Methotrexate|methotrexate|mesh-list
110098256|NCT01741558|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110098257|NCT01741558|Abortifacient Agents|abortifacient agents|mesh-ancestor
110098258|NCT01741558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110098259|NCT01741558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098260|NCT01741558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110098261|NCT01741558|Antimetabolites|antimetabolites|mesh-ancestor
110098262|NCT01741558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110098263|NCT01741558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110098264|NCT01741558|Dermatologic Agents|dermatologic agents|mesh-ancestor
110098265|NCT01741558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110098266|NCT01741558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110098267|NCT01741558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110098268|NCT01741558|Immunologic Factors|immunologic factors|mesh-ancestor
110098269|NCT01741558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110098270|NCT01741558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110098271|NCT01741558|Vitamin B Complex|vitamin b complex|mesh-ancestor
110098272|NCT01741558|Vitamins|vitamins|mesh-ancestor
110098273|NCT01741558|Micronutrients|micronutrients|mesh-ancestor
110098274|NCT01741558|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110098276|NCT01741623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110098277|NCT01741623|Sympatholytics|sympatholytics|mesh-ancestor
110098278|NCT01741623|Autonomic Agents|autonomic agents|mesh-ancestor
110098279|NCT01741623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110098280|NCT01741623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098281|NCT01741623|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110098282|NCT01741623|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110098283|NCT01741623|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110098284|NCT01741623|Adrenergic Agents|adrenergic agents|mesh-ancestor
110098285|NCT01741623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110098286|NCT01741623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110098287|NCT01741649|Povidone|povidone|mesh-list
110098288|NCT01741649|Plasma Substitutes|plasma substitutes|mesh-ancestor
110098289|NCT01741649|Blood Substitutes|blood substitutes|mesh-ancestor
110098290|NCT01741727|ABT-414|abt-414|mesh-list
110098291|NCT01741727|Immunoconjugates|immunoconjugates|mesh-ancestor
110098292|NCT01741727|Immunologic Factors|immunologic factors|mesh-ancestor
110098293|NCT01741727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098294|NCT01741753|Prednisone|prednisone|mesh-list
110098295|NCT01741753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110098296|NCT01741753|Glucocorticoids|glucocorticoids|mesh-ancestor
110098297|NCT01741753|Hormones|hormones|mesh-ancestor
110098298|NCT01741753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110098299|NCT01741753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098300|NCT01741753|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110098301|NCT01741753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110098302|NCT01741831|Darunavir|darunavir|mesh-list
110098303|NCT01741831|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110098304|NCT01741831|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110098305|NCT01741831|Protease Inhibitors|protease inhibitors|mesh-ancestor
110098306|NCT01741831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110098307|NCT01741831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110098308|NCT01741831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110098309|NCT01741831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110098310|NCT01741831|Antiviral Agents|antiviral agents|mesh-ancestor
110098311|NCT01741831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110098312|NCT01741948|Contraceptive Agents|contraceptive agents|mesh-list
110098313|NCT01741948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110098314|NCT01741948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098315|NCT01742247|Palmidrol|palmidrol|mesh-list
110098316|NCT01742247|Analgesics|analgesics|mesh-ancestor
110098317|NCT01742247|Sensory System Agents|sensory system agents|mesh-ancestor
110098318|NCT01742247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110098319|NCT01742247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098320|NCT01742247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110098321|NCT01742247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110098322|NCT01742247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110098323|NCT01742247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110098324|NCT01742247|Antiviral Agents|antiviral agents|mesh-ancestor
110098325|NCT01742247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110098326|NCT01742247|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110098327|NCT01742247|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110098328|NCT01742247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110098329|NCT01742247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110098330|NCT01742247|Hormones|hormones|mesh-ancestor
110098331|NCT01742247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110098332|NCT01742273|Vitamin K|vitamin k|mesh-list
110098333|NCT01742273|Vitamin K 1|vitamin k 1|mesh-list
110098334|NCT01742273|Vitamins|vitamins|mesh-ancestor
110098335|NCT01742273|Micronutrients|micronutrients|mesh-ancestor
110098336|NCT01742273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098337|NCT01742273|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110098338|NCT01742273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110098339|NCT01742273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110098340|NCT01742273|Hemostatics|hemostatics|mesh-ancestor
110098341|NCT01742273|Coagulants|coagulants|mesh-ancestor
110098342|NCT01742338|Prednisone|prednisone|mesh-list
110098343|NCT01742338|Methylprednisolone|methylprednisolone|mesh-list
110098344|NCT01742338|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110098345|NCT01742338|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110098346|NCT01742338|Prednisolone|prednisolone|mesh-list
110098347|NCT01742338|Prednisolone acetate|prednisolone acetate|mesh-list
110098348|NCT01742338|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110098349|NCT01742338|Prednisolone phosphate|prednisolone phosphate|mesh-list
110098350|NCT01742338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110098351|NCT01742338|Glucocorticoids|glucocorticoids|mesh-ancestor
110098352|NCT01742338|Hormones|hormones|mesh-ancestor
110098353|NCT01742338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110098354|NCT01742338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098355|NCT01742338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110098356|NCT01742338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110098357|NCT01742338|Antiemetics|antiemetics|mesh-ancestor
110098358|NCT01742338|Autonomic Agents|autonomic agents|mesh-ancestor
110098359|NCT01742338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110098360|NCT01742338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110098361|NCT01742338|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110098362|NCT01742338|Protective Agents|protective agents|mesh-ancestor
110098363|NCT01742390|Risperidone|risperidone|mesh-list
110098364|NCT01742390|Aripiprazole|aripiprazole|mesh-list
110098365|NCT01742390|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110098366|NCT01742390|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110098367|NCT01742390|Serotonin Agents|serotonin agents|mesh-ancestor
110098368|NCT01742390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110098369|NCT01742390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110098370|NCT01742390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098371|NCT01742390|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110098372|NCT01742390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110098373|NCT01742390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110098374|NCT01742390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110098375|NCT01742390|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110098376|NCT01742390|Dopamine Agents|dopamine agents|mesh-ancestor
110098377|NCT01742390|Antidepressive Agents|antidepressive agents|mesh-ancestor
110098378|NCT01742390|Dopamine Agonists|dopamine agonists|mesh-ancestor
110098379|NCT01742390|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110098380|NCT01742390|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110098381|NCT01742390|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110098382|NCT01742390|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110098383|NCT01742429|Amoxicillin|amoxicillin|mesh-list
110098384|NCT01742429|Metronidazole|metronidazole|mesh-list
110098385|NCT01742429|Levofloxacin|levofloxacin|mesh-list
110098386|NCT01742429|Tetracycline|tetracycline|mesh-list
110098387|NCT01742429|Bismuth|bismuth|mesh-list
110098388|NCT01742429|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
110098389|NCT01742429|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
110098390|NCT01742429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110098391|NCT01742429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110098392|NCT01742429|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110098393|NCT01742429|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110098394|NCT01742429|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110098395|NCT01742429|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110098396|NCT01742429|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110098397|NCT01742429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110098398|NCT01742429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110098399|NCT01742429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110098400|NCT01742429|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110186478|NCT05672225|Dexmedetomidine|dexmedetomidine|mesh-list
110098401|NCT01742429|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110098402|NCT01742429|Antacids|antacids|mesh-ancestor
110098403|NCT01742429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110098404|NCT01742429|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110098405|NCT01742429|Antidiarrheals|antidiarrheals|mesh-ancestor
110098406|NCT01742533|Hormones|hormones|mesh-list
110098407|NCT01742533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110098408|NCT01742533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098409|NCT01742624|Mycophenolic Acid|mycophenolic acid|mesh-list
110098410|NCT01742624|Tacrolimus|tacrolimus|mesh-list
110098411|NCT01742624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110098412|NCT01742624|Immunologic Factors|immunologic factors|mesh-ancestor
110098413|NCT01742624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098414|NCT01742624|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110098415|NCT01742624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110098416|NCT01742624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110098417|NCT01742624|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110098418|NCT01742624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110098419|NCT01742624|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110098420|NCT01742624|Antitubercular Agents|antitubercular agents|mesh-ancestor
110098421|NCT01742624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110098422|NCT01742624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110098423|NCT01742637|Adapalene|adapalene|mesh-list
110098424|NCT01742637|Benzoyl Peroxide|benzoyl peroxide|mesh-list
110098425|NCT01742637|Dermatologic Agents|dermatologic agents|mesh-ancestor
110098426|NCT01742637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110098427|NCT01742637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110098428|NCT01742637|Analgesics|analgesics|mesh-ancestor
110098429|NCT01742637|Sensory System Agents|sensory system agents|mesh-ancestor
110098430|NCT01742637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110098431|NCT01742637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098432|NCT01742637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110098433|NCT01742637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110098434|NCT01742663|Diclofenac|diclofenac|mesh-list
110098435|NCT01742663|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110098436|NCT01742663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110098437|NCT01742663|Analgesics|analgesics|mesh-ancestor
110098438|NCT01742663|Sensory System Agents|sensory system agents|mesh-ancestor
110098439|NCT01742663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110098440|NCT01742663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098441|NCT01742663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110098442|NCT01742663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110098443|NCT01742663|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110098444|NCT01742663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110098445|NCT01742663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110098447|NCT01742676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110098448|NCT01742676|Immunologic Factors|immunologic factors|mesh-ancestor
110098449|NCT01742676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098450|NCT01742676|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110098451|NCT01742676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110098452|NCT01742676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110098453|NCT01742689|Indomethacin|indomethacin|mesh-list
110098454|NCT01742689|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
110098455|NCT01742689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110098456|NCT01742689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110098457|NCT01742689|Analgesics|analgesics|mesh-ancestor
110098458|NCT01742689|Sensory System Agents|sensory system agents|mesh-ancestor
110098459|NCT01742689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110098460|NCT01742689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098461|NCT01742689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110098462|NCT01742689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110098463|NCT01742689|Gout Suppressants|gout suppressants|mesh-ancestor
110098464|NCT01742689|Tocolytic Agents|tocolytic agents|mesh-ancestor
110098465|NCT01742689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110098466|NCT01742689|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110098467|NCT01742689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110098468|NCT01742689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110098469|NCT01742689|Hemostatics|hemostatics|mesh-ancestor
110098470|NCT01742689|Coagulants|coagulants|mesh-ancestor
110098471|NCT01742689|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110098473|NCT01742702|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
110098475|NCT01742702|Nitroglycerin|nitroglycerin|mesh-list
110098476|NCT01742702|Albuterol|albuterol|mesh-list
110098477|NCT01742702|Caseins|caseins|mesh-list
110098478|NCT01742702|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110098479|NCT01742702|Autonomic Agents|autonomic agents|mesh-ancestor
110098480|NCT01742702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110098481|NCT01742702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098482|NCT01742702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110098483|NCT01742702|Respiratory System Agents|respiratory system agents|mesh-ancestor
110098484|NCT01742702|Tocolytic Agents|tocolytic agents|mesh-ancestor
110098485|NCT01742702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110098486|NCT01742702|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110098487|NCT01742702|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110098488|NCT01742702|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110098489|NCT01742702|Adrenergic Agents|adrenergic agents|mesh-ancestor
110098490|NCT01742702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110098491|NCT01742702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110098492|NCT01742702|Vasodilator Agents|vasodilator agents|mesh-ancestor
110098493|NCT01742702|Chelating Agents|chelating agents|mesh-ancestor
110098494|NCT01742702|Sequestering Agents|sequestering agents|mesh-ancestor
110098495|NCT01742702|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110098496|NCT01742702|Sympatholytics|sympatholytics|mesh-ancestor
110098497|NCT01742702|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110098498|NCT01742702|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110098499|NCT01742702|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110098500|NCT01742702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110098502|NCT01742767|Cisplatin|cisplatin|mesh-list
110098503|NCT01742767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110098504|NCT01742767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110098505|NCT01742767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110098506|NCT01742767|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110098507|NCT01742767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110098508|NCT01742793|Lenalidomide|lenalidomide|mesh-list
110098509|NCT01742793|Romidepsin|romidepsin|mesh-list
110098510|NCT01742793|Immunologic Factors|immunologic factors|mesh-ancestor
110098511|NCT01742793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098512|NCT01742793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110098513|NCT01742793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110098514|NCT01742793|Growth Substances|growth substances|mesh-ancestor
110098515|NCT01742793|Growth Inhibitors|growth inhibitors|mesh-ancestor
110098516|NCT01742793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110098517|NCT01742793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110098518|NCT01742793|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110098519|NCT01742793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110098520|NCT01742793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110098521|NCT01742845|Ropivacaine|ropivacaine|mesh-list
110098522|NCT01742845|Anesthetics, Local|anesthetics, local|mesh-ancestor
110098523|NCT01742845|Anesthetics|anesthetics|mesh-ancestor
110098524|NCT01742845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110098525|NCT01742845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098526|NCT01742845|Sensory System Agents|sensory system agents|mesh-ancestor
110098527|NCT01742845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110098528|NCT01742988|Rituximab|rituximab|mesh-list
110098530|NCT01742988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110098531|NCT01742988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110098532|NCT01742988|Immunologic Factors|immunologic factors|mesh-ancestor
110098533|NCT01742988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098534|NCT01742988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110098535|NCT01743014|Ramipril|ramipril|mesh-list
110098536|NCT01743014|Clopidogrel|clopidogrel|mesh-list
110098537|NCT01743014|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110098538|NCT01743014|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110098539|NCT01743014|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110098540|NCT01743014|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110098542|NCT01743014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110098543|NCT01743014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110098544|NCT01743014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098545|NCT01743014|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110098546|NCT01743014|Protease Inhibitors|protease inhibitors|mesh-ancestor
110098547|NCT01743014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110098548|NCT01743014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110098549|NCT01743066|Vitamin E|vitamin e|mesh-list
110098550|NCT01743066|Vitamins|vitamins|mesh-ancestor
110098551|NCT01743066|Micronutrients|micronutrients|mesh-ancestor
110098552|NCT01743066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098553|NCT01743066|Antioxidants|antioxidants|mesh-ancestor
110098554|NCT01743066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110098555|NCT01743066|Protective Agents|protective agents|mesh-ancestor
110098556|NCT01743079|Lamivudine|lamivudine|mesh-list
110098557|NCT01743079|Telbivudine|telbivudine|mesh-list
110098558|NCT01743079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110098559|NCT01743079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110098560|NCT01743079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110098561|NCT01743079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110098562|NCT01743079|Antiviral Agents|antiviral agents|mesh-ancestor
110098563|NCT01743079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110098564|NCT01743079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110098565|NCT01743079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110098566|NCT01743118|Calcipotriene|calcipotriene|mesh-list
110098567|NCT01743118|Dermatologic Agents|dermatologic agents|mesh-ancestor
110098568|NCT01743144|Magnesium Sulfate|magnesium sulfate|mesh-list
110098569|NCT01743144|Analgesics|analgesics|mesh-ancestor
110098570|NCT01743144|Sensory System Agents|sensory system agents|mesh-ancestor
110098571|NCT01743144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110098572|NCT01743144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098573|NCT01743144|Anesthetics|anesthetics|mesh-ancestor
110098574|NCT01743144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110098575|NCT01743144|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110098576|NCT01743144|Anticonvulsants|anticonvulsants|mesh-ancestor
110098577|NCT01743144|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110098578|NCT01743144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110098579|NCT01743144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110098580|NCT01743144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110098581|NCT01743144|Tocolytic Agents|tocolytic agents|mesh-ancestor
110098582|NCT01743144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110098583|NCT01743157|Bevacizumab|bevacizumab|mesh-list
110098584|NCT01743157|Ipilimumab|ipilimumab|mesh-list
110098585|NCT01743157|Interleukin-2|interleukin-2|mesh-list
110098586|NCT01743157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110098587|NCT01743157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110098588|NCT01743157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110098589|NCT01743157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110098590|NCT01743157|Growth Substances|growth substances|mesh-ancestor
110098591|NCT01743157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098592|NCT01743157|Growth Inhibitors|growth inhibitors|mesh-ancestor
110098593|NCT01743157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110098594|NCT01743157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110098595|NCT01743157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110098596|NCT01743157|Analgesics|analgesics|mesh-ancestor
110098597|NCT01743157|Sensory System Agents|sensory system agents|mesh-ancestor
110098598|NCT01743157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110098600|NCT01743235|Testosterone|testosterone|mesh-list
110098601|NCT01743235|Androgens|androgens|mesh-ancestor
110098602|NCT01743235|Hormones|hormones|mesh-ancestor
110148394|NCT00006474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110148395|NCT00006474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110148396|NCT00006474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110148397|NCT04201834|Risperidone|risperidone|mesh-list
110148398|NCT04201834|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110148400|NCT04201834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110148401|NCT04201834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110148402|NCT04201834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110148403|NCT04201834|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110148404|NCT04201834|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110191416|NCT00027833|Immunologic Factors|immunologic factors|mesh-ancestor
110148405|NCT04201834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110148406|NCT04201834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110148407|NCT04201834|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110148408|NCT04201834|Dopamine Agents|dopamine agents|mesh-ancestor
110148409|NCT04192435|Tranexamic Acid|tranexamic acid|mesh-list
110148410|NCT04192435|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110148411|NCT04192435|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110148412|NCT04192435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110148413|NCT04192435|Hemostatics|hemostatics|mesh-ancestor
110148415|NCT03771157|Vaccines|vaccines|mesh-list
110148416|NCT03771157|Immunologic Factors|immunologic factors|mesh-ancestor
110148417|NCT03771157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110148418|NCT03624517|Octreotide|octreotide|mesh-list
110148419|NCT03624517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110148420|NCT03624517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110148421|NCT03624517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110148422|NCT00423397|Interferons|interferons|mesh-list
110148423|NCT00423397|Interferon-alpha|interferon-alpha|mesh-list
110148425|NCT00423397|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110148426|NCT00423397|Gefitinib|gefitinib|mesh-list
110148427|NCT00423397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110148428|NCT00423397|Antiviral Agents|antiviral agents|mesh-ancestor
110148429|NCT00423397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110148430|NCT00423397|Immunologic Factors|immunologic factors|mesh-ancestor
110148431|NCT00423397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110148432|NCT00423397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110148433|NCT00423397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110148434|NCT00423397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110148436|NCT03352765|Melphalan|melphalan|mesh-list
110148437|NCT03352765|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110148438|NCT03352765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110148439|NCT03352765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110148440|NCT03352765|Immunologic Factors|immunologic factors|mesh-ancestor
110148441|NCT03352765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110148442|NCT03352765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110148443|NCT03352765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110148444|NCT03352765|Alkylating Agents|alkylating agents|mesh-ancestor
110148445|NCT03352765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110148446|NCT03352765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110148447|NCT03352765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110148448|NCT03265405|Prednisolone|prednisolone|mesh-list
110148449|NCT03265405|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110148450|NCT03265405|Methylprednisolone|methylprednisolone|mesh-list
110148451|NCT03265405|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110148452|NCT03265405|Prednisolone acetate|prednisolone acetate|mesh-list
110148453|NCT03265405|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110148455|NCT03265405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110148456|NCT03265405|Glucocorticoids|glucocorticoids|mesh-ancestor
110148457|NCT03265405|Hormones|hormones|mesh-ancestor
110148458|NCT03265405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110148459|NCT03265405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110148460|NCT03265405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110148461|NCT03265405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110148462|NCT03265405|Antiemetics|antiemetics|mesh-ancestor
110148463|NCT03265405|Autonomic Agents|autonomic agents|mesh-ancestor
110148464|NCT03265405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110148465|NCT03265405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110148466|NCT03265405|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110148467|NCT03265405|Protective Agents|protective agents|mesh-ancestor
110148468|NCT03808480|Nivolumab|nivolumab|mesh-list
110148469|NCT03808480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110148470|NCT03808480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110148471|NCT03808480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110148472|NCT03808480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110148473|NCT02966548|Nivolumab|nivolumab|mesh-list
110148474|NCT02966548|Relatlimab|relatlimab|mesh-list
110148475|NCT02966548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110148476|NCT02966548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110148477|NCT02966548|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110148478|NCT02966548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110148479|NCT02890069|Everolimus|everolimus|mesh-list
110148480|NCT02890069|Panobinostat|panobinostat|mesh-list
110148481|NCT02890069|Spartalizumab|spartalizumab|mesh-list
110148482|NCT02890069|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110148484|NCT02890069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110148485|NCT02890069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110148486|NCT02890069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110148487|NCT02890069|Immunologic Factors|immunologic factors|mesh-ancestor
110148488|NCT02890069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110148489|NCT02890069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110148490|NCT02890069|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110148491|NCT02890069|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110148492|NCT02890069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110148493|NCT02425501|Aflibercept|aflibercept|mesh-list
110148494|NCT02425501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110148495|NCT02425501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110148496|NCT02425501|Growth Substances|growth substances|mesh-ancestor
110148497|NCT02425501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110148498|NCT02425501|Growth Inhibitors|growth inhibitors|mesh-ancestor
110148499|NCT02425501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110148500|NCT02409238|Metformin|metformin|mesh-list
110148501|NCT02409238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110148502|NCT02409238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110148504|NCT00006480|Ganciclovir|ganciclovir|mesh-list
110148505|NCT00006480|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
110148506|NCT00006480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110148507|NCT00006480|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110148508|NCT00006480|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110148509|NCT00006480|Antiviral Agents|antiviral agents|mesh-ancestor
110148510|NCT00006480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110148511|NCT00006480|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110148512|NCT00006480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110148513|NCT00006480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110148515|NCT00006483|Immunologic Factors|immunologic factors|mesh-ancestor
110148516|NCT00006483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110148517|NCT00006486|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
110148518|NCT00006486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110148519|NCT00006486|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110148520|NCT00006486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110148521|NCT00006486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110148522|NCT00006486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110148523|NCT00006486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110148524|NCT00006519|Capravirine|capravirine|mesh-list
110148525|NCT00006519|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110148526|NCT00006519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110148527|NCT00006519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110148528|NCT00006519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110148529|NCT00006519|Antiviral Agents|antiviral agents|mesh-ancestor
110148530|NCT00006519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110148531|NCT00006519|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110148532|NCT00006519|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110148533|NCT00006591|Ritonavir|ritonavir|mesh-list
110148534|NCT00006591|Amprenavir|amprenavir|mesh-list
110148535|NCT00006591|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110148536|NCT00006591|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110148537|NCT00006591|Protease Inhibitors|protease inhibitors|mesh-ancestor
110148538|NCT00006591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110148539|NCT00006591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110148540|NCT00006591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110148541|NCT00006591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110148542|NCT00006591|Antiviral Agents|antiviral agents|mesh-ancestor
110148543|NCT00006591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110148544|NCT00006591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110148545|NCT00006591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110148546|NCT00006591|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110148547|NCT00006591|Antitubercular Agents|antitubercular agents|mesh-ancestor
110148548|NCT00006591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110148549|NCT00006630|Immunoglobulins|immunoglobulins|mesh-list
110148550|NCT00006630|Antibodies|antibodies|mesh-list
110148551|NCT00006630|gamma-Globulins|gamma-globulins|mesh-list
110148552|NCT00006630|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110148553|NCT00006630|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110148554|NCT00006630|Immunologic Factors|immunologic factors|mesh-ancestor
110148555|NCT00006630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110148556|NCT00006669|Prednisone|prednisone|mesh-list
110148557|NCT00006669|Cyclophosphamide|cyclophosphamide|mesh-list
110148558|NCT00006669|Rituximab|rituximab|mesh-list
110148559|NCT00006669|Doxorubicin|doxorubicin|mesh-list
110148560|NCT00006669|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110148561|NCT00006669|Etoposide|etoposide|mesh-list
110148562|NCT00006669|Vincristine|vincristine|mesh-list
110148563|NCT00006669|Sargramostim|sargramostim|mesh-list
110148564|NCT00006669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110148565|NCT00006669|Immunologic Factors|immunologic factors|mesh-ancestor
110148566|NCT00006669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110148567|NCT00006669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110148568|NCT00006669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110148569|NCT00006669|Alkylating Agents|alkylating agents|mesh-ancestor
110148570|NCT00006669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110148571|NCT00006669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110148572|NCT00006669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110148573|NCT00006669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110148574|NCT00006669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110148575|NCT00006669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110148576|NCT00006669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110148577|NCT00006669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110148578|NCT00006669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110148579|NCT00006669|Glucocorticoids|glucocorticoids|mesh-ancestor
110148580|NCT00006669|Hormones|hormones|mesh-ancestor
110148581|NCT00006669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110148582|NCT00006669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110148583|NCT00006669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110148584|NCT00006669|Tubulin Modulators|tubulin modulators|mesh-ancestor
110148585|NCT00006669|Antimitotic Agents|antimitotic agents|mesh-ancestor
110148586|NCT00006669|Mitosis Modulators|mitosis modulators|mesh-ancestor
110148587|NCT00006708|Rituximab|rituximab|mesh-list
110148588|NCT00006708|Carboplatin|carboplatin|mesh-list
110148589|NCT00006708|Etoposide|etoposide|mesh-list
110148590|NCT00006708|Ifosfamide|ifosfamide|mesh-list
110148591|NCT00006708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110148592|NCT00006708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110148593|NCT00006708|Immunologic Factors|immunologic factors|mesh-ancestor
110148594|NCT00006708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110148595|NCT00006708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110148596|NCT00006708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110148597|NCT00006708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110148598|NCT00006708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110148599|NCT00006708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110148600|NCT00006708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110148601|NCT00006708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110148602|NCT00006708|Alkylating Agents|alkylating agents|mesh-ancestor
110148603|NCT00006747|Cytarabine|cytarabine|mesh-list
110148604|NCT00006747|Methotrexate|methotrexate|mesh-list
110148605|NCT00006747|Etoposide|etoposide|mesh-list
110148606|NCT00006747|Melphalan|melphalan|mesh-list
110148607|NCT00006747|Carmustine|carmustine|mesh-list
110148608|NCT00006747|Tacrolimus|tacrolimus|mesh-list
110148609|NCT00006747|Sargramostim|sargramostim|mesh-list
110148610|NCT00006747|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110148611|NCT00006747|Abortifacient Agents|abortifacient agents|mesh-ancestor
110148612|NCT00006747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110148613|NCT00006747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110148614|NCT00006747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110148615|NCT00006747|Antimetabolites|antimetabolites|mesh-ancestor
110148616|NCT00006747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110148617|NCT00006747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110148618|NCT00006747|Dermatologic Agents|dermatologic agents|mesh-ancestor
110148619|NCT00006747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110148620|NCT00006747|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110148621|NCT00006747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110148622|NCT00006747|Immunologic Factors|immunologic factors|mesh-ancestor
110148623|NCT00006747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110148624|NCT00006747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110148625|NCT00006747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110148626|NCT00006747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110148627|NCT00006747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110148628|NCT00006747|Antiviral Agents|antiviral agents|mesh-ancestor
110148629|NCT00006747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110148630|NCT00006747|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110148631|NCT00006747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110148632|NCT00006747|Alkylating Agents|alkylating agents|mesh-ancestor
110148633|NCT00006747|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110148634|NCT00006786|Leucovorin|leucovorin|mesh-list
110148635|NCT00006786|Bevacizumab|bevacizumab|mesh-list
110148636|NCT00006786|Fluorouracil|fluorouracil|mesh-list
110148637|NCT00006786|Irinotecan|irinotecan|mesh-list
110148638|NCT00006786|Calcium|calcium|mesh-list
110148639|NCT00006786|Levoleucovorin|levoleucovorin|mesh-list
110148640|NCT00006786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110148641|NCT00006786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110148642|NCT00006786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110148643|NCT00006786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110148645|NCT00006786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110148646|NCT00006786|Growth Inhibitors|growth inhibitors|mesh-ancestor
110148647|NCT00006786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110148648|NCT00006786|Antimetabolites|antimetabolites|mesh-ancestor
110148649|NCT00006786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110148650|NCT00006786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110148651|NCT00006786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110148652|NCT00006786|Immunologic Factors|immunologic factors|mesh-ancestor
110148653|NCT00006786|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110148654|NCT00006786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110148655|NCT00006786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110148656|NCT00006786|Antidotes|antidotes|mesh-ancestor
110148657|NCT00006786|Protective Agents|protective agents|mesh-ancestor
110148658|NCT00006786|Vitamin B Complex|vitamin b complex|mesh-ancestor
110148659|NCT00006786|Vitamins|vitamins|mesh-ancestor
110148660|NCT00006786|Micronutrients|micronutrients|mesh-ancestor
110148661|NCT00006825|Doxorubicin|doxorubicin|mesh-list
110148662|NCT00006825|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110148663|NCT00006825|Trastuzumab|trastuzumab|mesh-list
110148664|NCT00006825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110148665|NCT00006825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110148666|NCT00006825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110148667|NCT00006825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110148668|NCT00006825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110148669|NCT00006825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110148670|NCT00006825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110148672|NCT00006864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110148673|NCT00006864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110148674|NCT00006864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110148675|NCT00006864|Antiviral Agents|antiviral agents|mesh-ancestor
110148676|NCT00006864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110148677|NCT00006942|Bryostatin 1|bryostatin 1|mesh-list
110148678|NCT00006942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110148679|NCT00006942|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110148680|NCT00006942|Immunologic Factors|immunologic factors|mesh-ancestor
110148681|NCT00006942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110148682|NCT00006981|Immunotoxins|immunotoxins|mesh-list
110148683|NCT00006981|Immunoconjugates|immunoconjugates|mesh-ancestor
110148684|NCT00006981|Immunologic Factors|immunologic factors|mesh-ancestor
110148685|NCT00006981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110148687|NCT00007059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110148688|NCT00007059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110148689|NCT00007059|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110148690|NCT00007059|Antitubercular Agents|antitubercular agents|mesh-ancestor
110148691|NCT00007059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110148692|NCT00007059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110148693|NCT00007059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110148694|NCT00007059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110148695|NCT00387556|Ondansetron|ondansetron|mesh-list
110148696|NCT00387556|Antiemetics|antiemetics|mesh-ancestor
110148697|NCT00387556|Autonomic Agents|autonomic agents|mesh-ancestor
110148698|NCT00387556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110148699|NCT00387556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110148700|NCT00387556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110148701|NCT00387556|Antipruritics|antipruritics|mesh-ancestor
110148702|NCT00387556|Dermatologic Agents|dermatologic agents|mesh-ancestor
110148703|NCT00387556|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110148704|NCT00387556|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110148705|NCT00387556|Serotonin Agents|serotonin agents|mesh-ancestor
110148706|NCT00387556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110148707|NCT00387556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110148708|NCT03780790|Bupivacaine|bupivacaine|mesh-list
110148709|NCT03780790|Anesthetics, Local|anesthetics, local|mesh-ancestor
110148710|NCT03780790|Anesthetics|anesthetics|mesh-ancestor
110148711|NCT03780790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110148712|NCT03780790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110148713|NCT03780790|Sensory System Agents|sensory system agents|mesh-ancestor
110148714|NCT03780790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110148715|NCT00388167|Caspofungin|caspofungin|mesh-list
110148716|NCT00388167|Antifungal Agents|antifungal agents|mesh-ancestor
110148717|NCT00388167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110148718|NCT00388167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110148719|NCT00388167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110148720|NCT00006043|Temozolomide|temozolomide|mesh-list
110148721|NCT00006043|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110148722|NCT00006043|Alkylating Agents|alkylating agents|mesh-ancestor
110148723|NCT00006043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110148724|NCT00006043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110148725|NCT00006049|Paclitaxel|paclitaxel|mesh-list
110148726|NCT00006049|Carboplatin|carboplatin|mesh-list
110148727|NCT00006049|Gefitinib|gefitinib|mesh-list
110148728|NCT00006049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110148729|NCT00006049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110148730|NCT00006049|Tubulin Modulators|tubulin modulators|mesh-ancestor
110148731|NCT00006049|Antimitotic Agents|antimitotic agents|mesh-ancestor
110148732|NCT00006049|Mitosis Modulators|mitosis modulators|mesh-ancestor
110148733|NCT00006049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110148734|NCT00006049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110148735|NCT00006049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110148736|NCT00006052|Imatinib Mesylate|imatinib mesylate|mesh-list
110148737|NCT00006052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110148738|NCT00006052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110148739|NCT00006052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110148740|NCT00006052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110148741|NCT00006055|Cyclosporine|cyclosporine|mesh-list
110148742|NCT00006055|Prednisone|prednisone|mesh-list
110148743|NCT00006055|Methylprednisolone|methylprednisolone|mesh-list
110148744|NCT00006055|Cyclophosphamide|cyclophosphamide|mesh-list
110148745|NCT00006055|Cyclosporins|cyclosporins|mesh-list
110148746|NCT00006055|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110148747|NCT00006055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110148748|NCT00006055|Immunologic Factors|immunologic factors|mesh-ancestor
110148749|NCT00006055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110148750|NCT00006055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110148751|NCT00006055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110148752|NCT00006055|Alkylating Agents|alkylating agents|mesh-ancestor
110148753|NCT00006055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110148754|NCT00006055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110148755|NCT00006055|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110148756|NCT00006055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110148757|NCT00006055|Glucocorticoids|glucocorticoids|mesh-ancestor
110148758|NCT00006055|Hormones|hormones|mesh-ancestor
110148759|NCT00006055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110148760|NCT00006055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110148761|NCT00006055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110148762|NCT00006055|Antifungal Agents|antifungal agents|mesh-ancestor
110148763|NCT00006055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110148764|NCT00006055|Dermatologic Agents|dermatologic agents|mesh-ancestor
110148765|NCT00006055|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110148766|NCT00006055|Antiemetics|antiemetics|mesh-ancestor
110148767|NCT00006055|Autonomic Agents|autonomic agents|mesh-ancestor
110148768|NCT00006055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110148769|NCT00006055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110148770|NCT00006055|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110148771|NCT00006055|Protective Agents|protective agents|mesh-ancestor
110148773|NCT00006070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110148774|NCT00006070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110148775|NCT00006070|Analgesics|analgesics|mesh-ancestor
110148776|NCT00006070|Sensory System Agents|sensory system agents|mesh-ancestor
110148777|NCT00006070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110148778|NCT00006070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110148779|NCT00006070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110148780|NCT00006070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110148781|NCT00006070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110186549|NCT05453955|Anesthetics|anesthetics|mesh-ancestor
110148782|NCT00006070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110148783|NCT00006070|Immunologic Factors|immunologic factors|mesh-ancestor
110148784|NCT00006079|Eflornithine|eflornithine|mesh-list
110148785|NCT00006079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110148786|NCT00006079|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110148787|NCT00006079|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110148788|NCT00006079|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110148789|NCT00006079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110148790|NCT00006079|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
110148791|NCT00006079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110148792|NCT00006079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110148793|NCT00006082|Rubitecan|rubitecan|mesh-list
110148794|NCT00006082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110148795|NCT00006082|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110148796|NCT00006082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110148797|NCT00006082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110148798|NCT00006082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110148799|NCT00006088|Vinorelbine|vinorelbine|mesh-list
110148800|NCT00006088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110148802|NCT00006088|Tubulin Modulators|tubulin modulators|mesh-ancestor
110148803|NCT00006088|Antimitotic Agents|antimitotic agents|mesh-ancestor
110148804|NCT00006088|Mitosis Modulators|mitosis modulators|mesh-ancestor
110148805|NCT00006088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110148806|NCT00006091|Arsenic Trioxide|arsenic trioxide|mesh-list
110148807|NCT00006091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110148808|NCT00006094|Fluorouracil|fluorouracil|mesh-list
110148809|NCT00006094|Oxaliplatin|oxaliplatin|mesh-list
110148810|NCT00006094|Antimetabolites|antimetabolites|mesh-ancestor
110148811|NCT00006094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110148812|NCT00006094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110148813|NCT00006094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110148814|NCT00006094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110148815|NCT00006094|Immunologic Factors|immunologic factors|mesh-ancestor
110148816|NCT00006094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110148817|NCT00006100|Aldesleukin|aldesleukin|mesh-list
110148818|NCT00006100|Fludarabine|fludarabine|mesh-list
110148819|NCT00006100|Fludarabine phosphate|fludarabine phosphate|mesh-list
110148820|NCT00006100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110148821|NCT00006100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110148822|NCT00006100|Antimetabolites|antimetabolites|mesh-ancestor
110148823|NCT00006100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110148824|NCT00006100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110148825|NCT00006100|Immunologic Factors|immunologic factors|mesh-ancestor
110148826|NCT00006100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110148827|NCT00006100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110148828|NCT00006100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110148829|NCT00006100|Antiviral Agents|antiviral agents|mesh-ancestor
110148830|NCT00006100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110148831|NCT00006103|Leucovorin|leucovorin|mesh-list
110148832|NCT00006103|Fluorouracil|fluorouracil|mesh-list
110148833|NCT00006103|Irinotecan|irinotecan|mesh-list
110148834|NCT00006103|Calcium|calcium|mesh-list
110148835|NCT00006103|Levoleucovorin|levoleucovorin|mesh-list
110148836|NCT00006103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110148837|NCT00006103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110148838|NCT00006103|Antimetabolites|antimetabolites|mesh-ancestor
110148839|NCT00006103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110148840|NCT00006103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110148841|NCT00006103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110148842|NCT00006103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110148843|NCT00006103|Immunologic Factors|immunologic factors|mesh-ancestor
110148844|NCT00006103|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110148845|NCT00006103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110148846|NCT00006103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110148848|NCT00006103|Protective Agents|protective agents|mesh-ancestor
110148849|NCT00006103|Vitamin B Complex|vitamin b complex|mesh-ancestor
110148850|NCT00006103|Vitamins|vitamins|mesh-ancestor
110148851|NCT00006103|Micronutrients|micronutrients|mesh-ancestor
110148852|NCT00006106|Fluorouracil|fluorouracil|mesh-list
110148853|NCT00006106|Dl1520|dl1520|mesh-list
110148854|NCT00006106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110148855|NCT00006106|Antimetabolites|antimetabolites|mesh-ancestor
110148856|NCT00006106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110148857|NCT00006106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110148858|NCT00006106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110148859|NCT00006106|Immunologic Factors|immunologic factors|mesh-ancestor
110148860|NCT00006106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110148861|NCT00006112|Leucovorin|leucovorin|mesh-list
110148863|NCT00006112|Mitomycins|mitomycins|mesh-list
110148864|NCT00006112|Mitomycin|mitomycin|mesh-list
110148865|NCT00006112|Calcium|calcium|mesh-list
110148866|NCT00006112|Levoleucovorin|levoleucovorin|mesh-list
110148867|NCT00006112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110148868|NCT00006112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110148869|NCT00006112|Antimetabolites|antimetabolites|mesh-ancestor
110148870|NCT00006112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110148871|NCT00006112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110148872|NCT00006112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110148873|NCT00006112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110148874|NCT00006112|Immunologic Factors|immunologic factors|mesh-ancestor
110148875|NCT00006112|Antidotes|antidotes|mesh-ancestor
110148876|NCT00006112|Protective Agents|protective agents|mesh-ancestor
110148877|NCT00006112|Vitamin B Complex|vitamin b complex|mesh-ancestor
110148878|NCT00006112|Vitamins|vitamins|mesh-ancestor
110148879|NCT00006112|Micronutrients|micronutrients|mesh-ancestor
110148880|NCT00006112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110148881|NCT00006112|Alkylating Agents|alkylating agents|mesh-ancestor
110148882|NCT00006112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110148883|NCT00006112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110148885|NCT00006115|Fluorouracil|fluorouracil|mesh-list
110148886|NCT00006115|Oxaliplatin|oxaliplatin|mesh-list
110148887|NCT00006115|Irinotecan|irinotecan|mesh-list
110148889|NCT00006115|Levoleucovorin|levoleucovorin|mesh-list
110148890|NCT00006115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110148891|NCT00006115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110148892|NCT00006115|Antimetabolites|antimetabolites|mesh-ancestor
110148893|NCT00006115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110148894|NCT00006115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110148895|NCT00006115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110148896|NCT00006115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110148897|NCT00006115|Immunologic Factors|immunologic factors|mesh-ancestor
110148898|NCT00006115|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110148899|NCT00006115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110148900|NCT00006115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110148901|NCT00006115|Antidotes|antidotes|mesh-ancestor
110148902|NCT00006115|Protective Agents|protective agents|mesh-ancestor
110148903|NCT00006115|Vitamin B Complex|vitamin b complex|mesh-ancestor
110148905|NCT00006115|Micronutrients|micronutrients|mesh-ancestor
110148906|NCT00006118|Paclitaxel|paclitaxel|mesh-list
110148907|NCT00006118|Gemcitabine|gemcitabine|mesh-list
110148908|NCT00006118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110148909|NCT00006118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110148910|NCT00006118|Tubulin Modulators|tubulin modulators|mesh-ancestor
110148911|NCT00006118|Antimitotic Agents|antimitotic agents|mesh-ancestor
110148912|NCT00006118|Mitosis Modulators|mitosis modulators|mesh-ancestor
110148913|NCT00006118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110148914|NCT00006118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110148915|NCT00006118|Antimetabolites|antimetabolites|mesh-ancestor
110148916|NCT00006121|Oxaliplatin|oxaliplatin|mesh-list
110148917|NCT00006121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110148918|NCT00006124|Celecoxib|celecoxib|mesh-list
110148919|NCT00006124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110186559|NCT05417776|Chelating Agents|chelating agents|mesh-ancestor
110148920|NCT00006124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110148921|NCT00006124|Analgesics|analgesics|mesh-ancestor
110148922|NCT00006124|Sensory System Agents|sensory system agents|mesh-ancestor
110148923|NCT00006124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110148924|NCT00006124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110148925|NCT00006124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110148926|NCT00006124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110148927|NCT00006124|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110148928|NCT00006124|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110148929|NCT00006124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110225472|NCT05959356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110148930|NCT00006124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110148932|NCT00006127|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110148933|NCT00006127|Protective Agents|protective agents|mesh-ancestor
110148934|NCT00006127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110148935|NCT00006133|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110148936|NCT00006133|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110148938|NCT00006133|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110148939|NCT00006133|Medroxyprogesterone|medroxyprogesterone|mesh-list
110148940|NCT00006133|Norethindrone|norethindrone|mesh-list
110148941|NCT00006133|Norethindrone Acetate|norethindrone acetate|mesh-list
110148943|NCT00006133|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110148944|NCT00006133|Estrogens|estrogens|mesh-ancestor
110148945|NCT00006133|Hormones|hormones|mesh-ancestor
110148946|NCT00006133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110148947|NCT00006133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110148948|NCT00006133|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110148949|NCT00006133|Contraceptive Agents|contraceptive agents|mesh-ancestor
110148950|NCT00006133|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110148951|NCT00006133|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110148952|NCT00006133|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110148953|NCT00006133|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110148954|NCT00006133|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110148955|NCT00006133|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110148956|NCT00006133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110148957|NCT00006133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110148958|NCT00006136|Arginine butyrate|arginine butyrate|mesh-list
110148959|NCT00006136|Epoetin Alfa|epoetin alfa|mesh-list
110148960|NCT00006136|Hematinics|hematinics|mesh-ancestor
110148961|NCT00006136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110148962|NCT00006145|Valganciclovir|valganciclovir|mesh-list
110148963|NCT00006145|Antiviral Agents|antiviral agents|mesh-ancestor
110148964|NCT00006145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110148966|NCT00006154|Indinavir|indinavir|mesh-list
110148967|NCT00006154|Aldesleukin|aldesleukin|mesh-list
110148968|NCT00006154|Abacavir|abacavir|mesh-list
110148969|NCT00006154|Stavudine|stavudine|mesh-list
110148970|NCT00006154|Didanosine|didanosine|mesh-list
110148971|NCT00006154|Efavirenz|efavirenz|mesh-list
110148972|NCT00006154|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110148973|NCT00006154|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110148974|NCT00006154|Protease Inhibitors|protease inhibitors|mesh-ancestor
110148975|NCT00006154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110148976|NCT00006154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110148977|NCT00006154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110148978|NCT00006154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110148979|NCT00006154|Antiviral Agents|antiviral agents|mesh-ancestor
110148980|NCT00006154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110148981|NCT00006154|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110148982|NCT00006154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110148983|NCT00006154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110148984|NCT00006154|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110148985|NCT00006154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110148986|NCT00006154|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110148987|NCT00006154|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110148988|NCT00006154|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110148989|NCT00006154|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110148990|NCT00006154|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110148991|NCT00006154|Antimetabolites|antimetabolites|mesh-ancestor
110148992|NCT00006157|Desipramine|desipramine|mesh-list
110148993|NCT00006157|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110148994|NCT00006157|Antidepressive Agents|antidepressive agents|mesh-ancestor
110148995|NCT00006157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110148996|NCT00006157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110148997|NCT00006157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110148998|NCT00006157|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110148999|NCT00006157|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110149000|NCT00006157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110149001|NCT00006157|Adrenergic Agents|adrenergic agents|mesh-ancestor
110149002|NCT00006157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110149003|NCT00006157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110149004|NCT00006190|Lamivudine|lamivudine|mesh-list
110149005|NCT00006190|Efavirenz|efavirenz|mesh-list
110149007|NCT00006190|Nelfinavir|nelfinavir|mesh-list
110149008|NCT00006190|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110149009|NCT00006190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110149010|NCT00006190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110149011|NCT00006190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110149012|NCT00006190|Antiviral Agents|antiviral agents|mesh-ancestor
110149013|NCT00006190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110149014|NCT00006190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110149015|NCT00006190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110149016|NCT00006190|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110149017|NCT00006190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110149018|NCT00006190|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110149019|NCT00006190|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110149020|NCT00006190|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110149021|NCT00006190|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110149022|NCT00006190|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110149023|NCT00006190|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110149024|NCT00006190|Protease Inhibitors|protease inhibitors|mesh-ancestor
110149025|NCT00006190|Antimetabolites|antimetabolites|mesh-ancestor
110149026|NCT00006196|Vitamin D|vitamin d|mesh-list
110149027|NCT00006196|Vitamins|vitamins|mesh-ancestor
110149028|NCT00006196|Micronutrients|micronutrients|mesh-ancestor
110149029|NCT00006196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110149030|NCT00006196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110149031|NCT00006199|Topotecan|topotecan|mesh-list
110149032|NCT00006199|Tipifarnib|tipifarnib|mesh-list
110149033|NCT00006199|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110149034|NCT00006199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110149035|NCT00006199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110149036|NCT00006199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110149037|NCT00006199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110149038|NCT00006205|Topiramate|topiramate|mesh-list
110149039|NCT00006205|Ondansetron|ondansetron|mesh-list
110149040|NCT00006205|Antiemetics|antiemetics|mesh-ancestor
110149041|NCT00006205|Autonomic Agents|autonomic agents|mesh-ancestor
110149042|NCT00006205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110149043|NCT00006205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110149044|NCT00006205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110149045|NCT00006205|Antipruritics|antipruritics|mesh-ancestor
110149046|NCT00006205|Dermatologic Agents|dermatologic agents|mesh-ancestor
110149047|NCT00006205|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110149048|NCT00006205|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110149049|NCT00006205|Serotonin Agents|serotonin agents|mesh-ancestor
110149050|NCT00006205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110149051|NCT00006205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110149052|NCT00006205|Anticonvulsants|anticonvulsants|mesh-ancestor
110149053|NCT00006205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110149054|NCT00006208|Emtricitabine|emtricitabine|mesh-list
110149055|NCT00006208|Efavirenz|efavirenz|mesh-list
110149056|NCT00006208|Stavudine|stavudine|mesh-list
110149057|NCT00006208|Didanosine|didanosine|mesh-list
110149058|NCT00006208|Antiviral Agents|antiviral agents|mesh-ancestor
110149059|NCT00006208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110149060|NCT00006208|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110149061|NCT00006208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110149062|NCT00006208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110149063|NCT00006208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110149065|NCT00006208|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110149066|NCT00006208|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110149067|NCT00006208|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110149068|NCT00006208|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110149069|NCT00006208|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110149070|NCT00006208|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110149071|NCT00006208|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110149072|NCT00006208|Antimetabolites|antimetabolites|mesh-ancestor
110149073|NCT00006211|Nelfinavir|nelfinavir|mesh-list
110149074|NCT00006211|Capravirine|capravirine|mesh-list
110149075|NCT00006211|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110149076|NCT00006211|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110149077|NCT00006211|Protease Inhibitors|protease inhibitors|mesh-ancestor
110149079|NCT00006211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110149080|NCT00006211|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110149081|NCT00006211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110149082|NCT00006211|Antiviral Agents|antiviral agents|mesh-ancestor
110149083|NCT00006211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110149084|NCT00006211|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110149085|NCT00006211|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110149087|NCT00006214|Androgen Antagonists|androgen antagonists|mesh-ancestor
110149088|NCT00006214|Hormone Antagonists|hormone antagonists|mesh-ancestor
110149089|NCT00006214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110149090|NCT00006214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110149091|NCT00006214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110149092|NCT00006214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110149093|NCT00006220|Arsenic Trioxide|arsenic trioxide|mesh-list
110149094|NCT00006220|Tretinoin|tretinoin|mesh-list
110149095|NCT00006220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110149097|NCT00006220|Dermatologic Agents|dermatologic agents|mesh-ancestor
110149098|NCT00006223|Flt3 ligand protein|flt3 ligand protein|mesh-list
110149099|NCT00006223|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110149100|NCT00006223|Immunologic Factors|immunologic factors|mesh-ancestor
110149101|NCT00006223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110149102|NCT00006223|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110149103|NCT00006223|Protective Agents|protective agents|mesh-ancestor
110149104|NCT03761953|Oritavancin|oritavancin|mesh-list
110149105|NCT03761953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110149106|NCT03761953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110149107|NCT00006226|Thalidomide|thalidomide|mesh-list
110149108|NCT00006226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110149109|NCT00006226|Immunologic Factors|immunologic factors|mesh-ancestor
110149110|NCT00006226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110149111|NCT00006226|Leprostatic Agents|leprostatic agents|mesh-ancestor
110149112|NCT00006226|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110149113|NCT00006226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110149114|NCT00006226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110149115|NCT00006226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110149116|NCT00006226|Growth Substances|growth substances|mesh-ancestor
110149117|NCT00006226|Growth Inhibitors|growth inhibitors|mesh-ancestor
110149118|NCT00006226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110149119|NCT00006232|Dexamethasone|dexamethasone|mesh-list
110149120|NCT00006232|Doxorubicin|doxorubicin|mesh-list
110149121|NCT00006232|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110149122|NCT00006232|Vincristine|vincristine|mesh-list
110149123|NCT00006232|Idarubicin|idarubicin|mesh-list
110149124|NCT00006232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110149126|NCT00006232|Autonomic Agents|autonomic agents|mesh-ancestor
110149127|NCT00006232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110149128|NCT00006232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110149129|NCT00006232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110149130|NCT00006232|Glucocorticoids|glucocorticoids|mesh-ancestor
110149131|NCT00006232|Hormones|hormones|mesh-ancestor
110149132|NCT00006232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110149133|NCT00006232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110149134|NCT00006232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110149135|NCT00006232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110149136|NCT00006232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110149137|NCT00006232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110149138|NCT00006232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110149139|NCT00006232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110149140|NCT00006232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110149141|NCT00006232|Tubulin Modulators|tubulin modulators|mesh-ancestor
110149143|NCT00006232|Mitosis Modulators|mitosis modulators|mesh-ancestor
110149145|NCT00006235|Doxorubicin|doxorubicin|mesh-list
110149146|NCT00006235|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110149147|NCT00006235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110149148|NCT00006235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110149149|NCT00006235|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110149150|NCT00006235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110149151|NCT00006235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110149152|NCT00006235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110149153|NCT00006241|Lenograstim|lenograstim|mesh-list
110149154|NCT00006241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110149155|NCT00006241|Immunologic Factors|immunologic factors|mesh-ancestor
110149156|NCT00006241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110149158|NCT00006247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110149159|NCT00006247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110149160|NCT00006247|Growth Substances|growth substances|mesh-ancestor
110149161|NCT00006247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110149163|NCT00006247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110149164|NCT00006247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110149165|NCT00006247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110149166|NCT00006247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110149167|NCT00006250|Dexamethasone|dexamethasone|mesh-list
110149168|NCT00006250|Fludarabine|fludarabine|mesh-list
110149169|NCT00006250|Fludarabine phosphate|fludarabine phosphate|mesh-list
110149170|NCT00006250|Mitoxantrone|mitoxantrone|mesh-list
110149171|NCT00006250|Chlorambucil|chlorambucil|mesh-list
110149172|NCT00006250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110149173|NCT00006250|Antiemetics|antiemetics|mesh-ancestor
110149174|NCT00006250|Autonomic Agents|autonomic agents|mesh-ancestor
110149175|NCT00006250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110149176|NCT00006250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110149177|NCT00006250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110149178|NCT00006250|Glucocorticoids|glucocorticoids|mesh-ancestor
110186597|NCT05301023|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110149180|NCT00006250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110149182|NCT00006250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110149183|NCT00006250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110149184|NCT00006250|Antimetabolites|antimetabolites|mesh-ancestor
110149185|NCT00006250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110149186|NCT00006250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110149187|NCT00006250|Immunologic Factors|immunologic factors|mesh-ancestor
110149188|NCT00006250|Analgesics|analgesics|mesh-ancestor
110149189|NCT00006250|Sensory System Agents|sensory system agents|mesh-ancestor
110149190|NCT00006250|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110149191|NCT00006250|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110149192|NCT00006250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110149193|NCT00006250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110149194|NCT00006250|Alkylating Agents|alkylating agents|mesh-ancestor
110149195|NCT00006265|Cytarabine|cytarabine|mesh-list
110149196|NCT00006265|Gemtuzumab|gemtuzumab|mesh-list
110149197|NCT00006265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110149198|NCT00006265|Antimetabolites|antimetabolites|mesh-ancestor
110149199|NCT00006265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110149200|NCT00006265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110149201|NCT00006265|Antiviral Agents|antiviral agents|mesh-ancestor
110149202|NCT00006265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110149204|NCT00006265|Immunologic Factors|immunologic factors|mesh-ancestor
110149205|NCT00006265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110149206|NCT00006265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110149207|NCT00006265|Immunotoxins|immunotoxins|mesh-ancestor
110149208|NCT00006265|Immunoconjugates|immunoconjugates|mesh-ancestor
110149209|NCT00007527|Buprenorphine|buprenorphine|mesh-list
110149210|NCT00007527|Naloxone|naloxone|mesh-list
110149211|NCT00007527|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110149212|NCT00007527|Narcotics|narcotics|mesh-ancestor
110149213|NCT00007527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110149214|NCT00007527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110149215|NCT00007527|Analgesics|analgesics|mesh-ancestor
110149216|NCT00007527|Sensory System Agents|sensory system agents|mesh-ancestor
110149217|NCT00007527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110149218|NCT00007527|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110149219|NCT00006280|Tobramycin|tobramycin|mesh-list
110149220|NCT00006280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110149221|NCT00006280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110149222|NCT00006286|Fluoxetine|fluoxetine|mesh-list
110149223|NCT00006286|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110149224|NCT00006286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110149225|NCT00006286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110149226|NCT00006286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110149227|NCT00006286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110149228|NCT00006286|Serotonin Agents|serotonin agents|mesh-ancestor
110149229|NCT00006286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110149230|NCT00006286|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110149231|NCT00006286|Antidepressive Agents|antidepressive agents|mesh-ancestor
110149232|NCT00006286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110149233|NCT00006286|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110149234|NCT00006286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110149235|NCT00006286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110149236|NCT00007605|Amiodarone|amiodarone|mesh-list
110149237|NCT00007605|Sotalol|sotalol|mesh-list
110149238|NCT00007605|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110149239|NCT00007605|Vasodilator Agents|vasodilator agents|mesh-ancestor
110149240|NCT00007605|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110149241|NCT00007605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110149242|NCT00007605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110149243|NCT00007605|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110149244|NCT00007605|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110149245|NCT00007605|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110149246|NCT00007605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110186605|NCT05298696|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110149248|NCT00007605|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110149249|NCT00007605|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110149250|NCT00007605|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110149251|NCT00007605|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110149252|NCT00007605|Adrenergic Agents|adrenergic agents|mesh-ancestor
110149253|NCT00007605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110149254|NCT00007605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110149255|NCT00007605|Sympatholytics|sympatholytics|mesh-ancestor
110149256|NCT00007605|Autonomic Agents|autonomic agents|mesh-ancestor
110149257|NCT00007605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110149258|NCT00006292|Infliximab|infliximab|mesh-list
110149259|NCT00006292|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110149260|NCT00006292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110149261|NCT00006292|Dermatologic Agents|dermatologic agents|mesh-ancestor
110149262|NCT00006292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110149263|NCT00006292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110149264|NCT03709888|Pregabalin|pregabalin|mesh-list
110149265|NCT03709888|Memantine|memantine|mesh-list
110149266|NCT03709888|Analgesics|analgesics|mesh-ancestor
110149267|NCT03709888|Sensory System Agents|sensory system agents|mesh-ancestor
110149268|NCT03709888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110149269|NCT03709888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110149270|NCT03709888|Anticonvulsants|anticonvulsants|mesh-ancestor
110149271|NCT03709888|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110149272|NCT03709888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110149273|NCT03709888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110149274|NCT03709888|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110149275|NCT03709888|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110149276|NCT03709888|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110149277|NCT03709888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110149278|NCT03709888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110149279|NCT03709888|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110149280|NCT03709888|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110149281|NCT03709888|Dopamine Agents|dopamine agents|mesh-ancestor
110149282|NCT03709888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110149283|NCT03709888|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110149284|NCT03709888|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110149285|NCT00007683|Aspirin|aspirin|mesh-list
110149286|NCT00007683|Warfarin|warfarin|mesh-list
110149287|NCT00007683|Clopidogrel|clopidogrel|mesh-list
110149289|NCT00007683|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110149290|NCT00007683|Analgesics|analgesics|mesh-ancestor
110149291|NCT00007683|Sensory System Agents|sensory system agents|mesh-ancestor
110149292|NCT00007683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110149293|NCT00007683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110149294|NCT00007683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110149295|NCT00007683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110149296|NCT00007683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110149297|NCT00007683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110149298|NCT00007683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110149299|NCT00007683|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110149300|NCT00007683|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110149301|NCT00007683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110149303|NCT00007683|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110149304|NCT00007683|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110149305|NCT00007683|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110149306|NCT00007683|Purinergic Agents|purinergic agents|mesh-ancestor
110149307|NCT00007683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110149308|NCT00007683|Anticoagulants|anticoagulants|mesh-ancestor
110149309|NCT00006325|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110149310|NCT00006325|Antiviral Agents|antiviral agents|mesh-ancestor
110149311|NCT00006325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110149312|NCT00006337|Levodopa|levodopa|mesh-list
110149313|NCT00006337|Istradefylline|istradefylline|mesh-list
110149314|NCT00006337|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110149315|NCT00006337|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110149316|NCT00006337|Dopamine Agents|dopamine agents|mesh-ancestor
110149317|NCT00006337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110149318|NCT00006337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110149319|NCT00006337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110149320|NCT00006337|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
110149321|NCT00006337|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110149322|NCT00006337|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110149323|NCT00006337|Purinergic Agents|purinergic agents|mesh-ancestor
110149324|NCT00006340|Ganciclovir|ganciclovir|mesh-list
110149325|NCT00006340|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
110149326|NCT00006340|Arginine butyrate|arginine butyrate|mesh-list
110149327|NCT00006340|Antiviral Agents|antiviral agents|mesh-ancestor
110149328|NCT00006340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110149329|NCT00006340|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110149330|NCT00006340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110149331|NCT00006340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110149332|NCT00006340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110149334|NCT00006229|Carboplatin|carboplatin|mesh-list
110149335|NCT00006229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110149336|NCT00006229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110149337|NCT00006229|Tubulin Modulators|tubulin modulators|mesh-ancestor
110149338|NCT00006229|Antimitotic Agents|antimitotic agents|mesh-ancestor
110149339|NCT00006229|Mitosis Modulators|mitosis modulators|mesh-ancestor
110149340|NCT00006229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110149341|NCT00006343|Interferons|interferons|mesh-list
110149343|NCT00006343|Interferon-alpha|interferon-alpha|mesh-list
110149345|NCT00006343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110149346|NCT00006343|Antiviral Agents|antiviral agents|mesh-ancestor
110149347|NCT00006343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110149348|NCT00006343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110149349|NCT00006343|Antimetabolites|antimetabolites|mesh-ancestor
110149350|NCT00006343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110149351|NCT00006343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110149352|NCT00006343|Immunologic Factors|immunologic factors|mesh-ancestor
110149353|NCT00006343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110149354|NCT00006343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110149355|NCT00006343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110149356|NCT00387868|Etoposide|etoposide|mesh-list
110149357|NCT00387868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110149358|NCT00387868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110149359|NCT00387868|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110149360|NCT00387868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110149361|NCT00387868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110149362|NCT00387868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110149364|NCT03616717|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110149365|NCT03616717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110149366|NCT03616717|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110149367|NCT03616717|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110149368|NCT03616717|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110149369|NCT03616717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110149370|NCT00006349|Vitamin E|vitamin e|mesh-list
110149371|NCT00006349|Donepezil|donepezil|mesh-list
110149372|NCT00006349|Vitamins|vitamins|mesh-ancestor
110149373|NCT00006349|Micronutrients|micronutrients|mesh-ancestor
110149374|NCT00006349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110149375|NCT00006349|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110149376|NCT00006349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110149377|NCT00006349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110149378|NCT00006349|Cholinergic Agents|cholinergic agents|mesh-ancestor
110149379|NCT00006349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110149380|NCT00006349|Nootropic Agents|nootropic agents|mesh-ancestor
110149381|NCT00006349|Antioxidants|antioxidants|mesh-ancestor
110149382|NCT00006349|Protective Agents|protective agents|mesh-ancestor
110149383|NCT00006352|Antibodies|antibodies|mesh-list
110149384|NCT00006352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110149385|NCT00006352|BCG Vaccine|bcg vaccine|mesh-list
110149386|NCT00006352|Immunologic Factors|immunologic factors|mesh-ancestor
110149387|NCT00006352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110149388|NCT00006352|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110149389|NCT00007878|Leucovorin|leucovorin|mesh-list
110149390|NCT00007878|Fluorouracil|fluorouracil|mesh-list
110149391|NCT00007878|Bortezomib|bortezomib|mesh-list
110149392|NCT00007878|Calcium|calcium|mesh-list
110149393|NCT00007878|Levoleucovorin|levoleucovorin|mesh-list
110149394|NCT00007878|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110149395|NCT00007878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110149396|NCT00007878|Antimetabolites|antimetabolites|mesh-ancestor
110149397|NCT00007878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110149398|NCT00007878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110149399|NCT00007878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110149400|NCT00007878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110149401|NCT00007878|Immunologic Factors|immunologic factors|mesh-ancestor
110149402|NCT00007878|Antidotes|antidotes|mesh-ancestor
110149403|NCT00007878|Protective Agents|protective agents|mesh-ancestor
110149404|NCT00007878|Vitamin B Complex|vitamin b complex|mesh-ancestor
110149405|NCT00007878|Vitamins|vitamins|mesh-ancestor
110149406|NCT00007878|Micronutrients|micronutrients|mesh-ancestor
110149407|NCT00006355|NSC 366140|nsc 366140|mesh-list
110149408|NCT00006355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110149409|NCT00006358|Thalidomide|thalidomide|mesh-list
110149410|NCT00006358|Temozolomide|temozolomide|mesh-list
110149411|NCT00006358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110149412|NCT00006358|Alkylating Agents|alkylating agents|mesh-ancestor
110149413|NCT00006358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110149414|NCT00006358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110149415|NCT00006358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110149416|NCT00006358|Immunologic Factors|immunologic factors|mesh-ancestor
110149417|NCT00006358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110149418|NCT00006358|Leprostatic Agents|leprostatic agents|mesh-ancestor
110149419|NCT00006358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110149420|NCT00006358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110149421|NCT00006358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110149422|NCT00006358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110149423|NCT00006358|Growth Substances|growth substances|mesh-ancestor
110149424|NCT00006358|Growth Inhibitors|growth inhibitors|mesh-ancestor
110149425|NCT00006361|Semaxinib|semaxinib|mesh-list
110149426|NCT00006361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110149427|NCT00006361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110149428|NCT00006361|Growth Substances|growth substances|mesh-ancestor
110149429|NCT00006361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110149430|NCT00006361|Growth Inhibitors|growth inhibitors|mesh-ancestor
110149431|NCT00006361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110149432|NCT00006361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110149433|NCT00006361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110149434|NCT00006361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110149435|NCT00006364|Homoharringtonine|homoharringtonine|mesh-list
110149436|NCT00006364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110149437|NCT00006364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110149438|NCT00006364|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110149439|NCT00006364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110149440|NCT00006364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110149442|NCT00007917|Alvocidib|alvocidib|mesh-list
110149443|NCT00007917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110149444|NCT00007917|Antimetabolites|antimetabolites|mesh-ancestor
110149445|NCT00007917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110149446|NCT00007917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110149447|NCT00007917|Growth Inhibitors|growth inhibitors|mesh-ancestor
110149448|NCT00007917|Growth Substances|growth substances|mesh-ancestor
110149449|NCT00007917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110149450|NCT00007917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110149451|NCT00007917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110149452|NCT00006367|Cytarabine|cytarabine|mesh-list
110149453|NCT00006367|Busulfan|busulfan|mesh-list
110149454|NCT00006367|Idarubicin|idarubicin|mesh-list
110149455|NCT00006367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110149456|NCT00006367|Antimetabolites|antimetabolites|mesh-ancestor
110149457|NCT00006367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110149458|NCT00006367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110149459|NCT00006367|Antiviral Agents|antiviral agents|mesh-ancestor
110149460|NCT00006367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110149461|NCT00006367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110149462|NCT00006367|Immunologic Factors|immunologic factors|mesh-ancestor
110149463|NCT00006367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110149464|NCT00006367|Alkylating Agents|alkylating agents|mesh-ancestor
110149465|NCT00006367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110149466|NCT00006367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110149467|NCT00006367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110149468|NCT00006367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110149469|NCT00006367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110149470|NCT00006367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110149472|NCT00006370|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110149473|NCT00006370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110149474|NCT00007956|Antibodies|antibodies|mesh-list
110149475|NCT00007956|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110149476|NCT00007956|Immunologic Factors|immunologic factors|mesh-ancestor
110149477|NCT00007956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110149478|NCT00006373|Etoposide|etoposide|mesh-list
110149479|NCT00006373|Topotecan|topotecan|mesh-list
110149480|NCT00006373|Ifosfamide|ifosfamide|mesh-list
110149481|NCT00006373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110149482|NCT00006373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110149483|NCT00006373|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110149484|NCT00006373|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110149485|NCT00006373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110149486|NCT00006373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110149487|NCT00006373|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110149488|NCT00006373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110149489|NCT00006373|Alkylating Agents|alkylating agents|mesh-ancestor
110149490|NCT00006376|Tipifarnib|tipifarnib|mesh-list
110149491|NCT00006376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110149494|NCT00006379|Fludarabine phosphate|fludarabine phosphate|mesh-list
110149495|NCT00006379|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110149496|NCT00006379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110149497|NCT00006379|Immunologic Factors|immunologic factors|mesh-ancestor
110149498|NCT00006379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110149499|NCT00006379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110149500|NCT00006379|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110149501|NCT00006379|Alkylating Agents|alkylating agents|mesh-ancestor
110149502|NCT00006379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110149503|NCT00006379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110149504|NCT00006379|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110149505|NCT00006379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110149506|NCT00006379|Antimetabolites|antimetabolites|mesh-ancestor
110149507|NCT00006385|Interferons|interferons|mesh-list
110149508|NCT00006385|Interferon-alpha|interferon-alpha|mesh-list
110149509|NCT00006385|Sargramostim|sargramostim|mesh-list
110149510|NCT00006385|Freund's Adjuvant|freund's adjuvant|mesh-list
110186634|NCT05258721|Fluorides|fluorides|mesh-list
110149511|NCT00006385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110149512|NCT00006385|Antiviral Agents|antiviral agents|mesh-ancestor
110149513|NCT00006385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110149514|NCT00006385|Immunologic Factors|immunologic factors|mesh-ancestor
110149515|NCT00006385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110149516|NCT00006385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110149517|NCT00007995|Interferons|interferons|mesh-list
110149518|NCT00007995|Interferon-alpha|interferon-alpha|mesh-list
110149519|NCT00007995|Cyclophosphamide|cyclophosphamide|mesh-list
110149520|NCT00007995|Melphalan|melphalan|mesh-list
110149521|NCT00007995|Busulfan|busulfan|mesh-list
110149522|NCT00007995|Sargramostim|sargramostim|mesh-list
110149523|NCT00007995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110149524|NCT00007995|Immunologic Factors|immunologic factors|mesh-ancestor
110149525|NCT00007995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110149526|NCT00007995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110149527|NCT00007995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110149528|NCT00007995|Alkylating Agents|alkylating agents|mesh-ancestor
110149529|NCT00007995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110149530|NCT00007995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110149531|NCT00007995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110149532|NCT00007995|Antiviral Agents|antiviral agents|mesh-ancestor
110149533|NCT00007995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110149534|NCT00006388|Tamoxifen|tamoxifen|mesh-list
110149535|NCT00006388|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110149536|NCT00006388|Hormone Antagonists|hormone antagonists|mesh-ancestor
110149537|NCT00006388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110149538|NCT00006388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110149539|NCT00006388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110149540|NCT00006388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110149541|NCT00006388|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110149542|NCT00006388|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110149543|NCT00006388|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110149544|NCT00008034|Cyclophosphamide|cyclophosphamide|mesh-list
110149545|NCT00008034|Capecitabine|capecitabine|mesh-list
110149546|NCT00008034|Epirubicin|epirubicin|mesh-list
110149547|NCT00008034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110149548|NCT00008034|Immunologic Factors|immunologic factors|mesh-ancestor
110149549|NCT00008034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110149550|NCT00008034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110149551|NCT00008034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110149552|NCT00008034|Alkylating Agents|alkylating agents|mesh-ancestor
110149553|NCT00008034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110149554|NCT00008034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110149555|NCT00008034|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110149556|NCT00008034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110149557|NCT00008034|Antimetabolites|antimetabolites|mesh-ancestor
110149558|NCT00008034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110149559|NCT00008034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110149560|NCT00008034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110149562|NCT00006391|Oxaliplatin|oxaliplatin|mesh-list
110149563|NCT00006391|Topotecan|topotecan|mesh-list
110149564|NCT00006391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110149565|NCT00006391|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110149566|NCT00006391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110149567|NCT00006391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110149568|NCT00006391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110149569|NCT00006394|Hormones|hormones|mesh-list
110149570|NCT00006394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110149571|NCT00006394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110149572|NCT00008073|Doxorubicin|doxorubicin|mesh-list
110149573|NCT00008073|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110149574|NCT00008073|Octreotide|octreotide|mesh-list
110149575|NCT00008073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110186640|NCT05215730|Copper|copper|mesh-list
110149577|NCT00008073|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110149578|NCT00008073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110149579|NCT00008073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110149580|NCT00008073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110149581|NCT00008073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110149582|NCT00008073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110149584|NCT00006397|Indinavir|indinavir|mesh-list
110149585|NCT00006397|Stavudine|stavudine|mesh-list
110149587|NCT00006397|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110149588|NCT00006397|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110149589|NCT00006397|Protease Inhibitors|protease inhibitors|mesh-ancestor
110149590|NCT00006397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110149591|NCT00006397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110149593|NCT00006397|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110149594|NCT00006397|Antiviral Agents|antiviral agents|mesh-ancestor
110149595|NCT00006397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110149596|NCT00006397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110149597|NCT00006397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110149598|NCT00006397|Antimetabolites|antimetabolites|mesh-ancestor
110149599|NCT00006397|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110149600|NCT00006397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110149601|NCT00006412|Fenofibrate|fenofibrate|mesh-list
110149602|NCT00006412|Pravastatin|pravastatin|mesh-list
110149603|NCT00006412|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110149604|NCT00006412|Antimetabolites|antimetabolites|mesh-ancestor
110149605|NCT00006412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110149606|NCT00006412|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110149607|NCT00006412|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110149608|NCT00006412|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110149609|NCT00006412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110149610|NCT00008112|Cisplatin|cisplatin|mesh-list
110149611|NCT00008112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110149612|NCT00006427|Amitriptyline|amitriptyline|mesh-list
110149613|NCT00006427|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110149614|NCT00006427|Antidepressive Agents|antidepressive agents|mesh-ancestor
110149615|NCT00006427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110149616|NCT00006427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110149617|NCT00006427|Analgesics|analgesics|mesh-ancestor
110149618|NCT00006427|Sensory System Agents|sensory system agents|mesh-ancestor
110149619|NCT00006427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110149621|NCT00006427|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110149622|NCT00006427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110149623|NCT00006427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110149624|NCT00006427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110149625|NCT00006427|Adrenergic Agents|adrenergic agents|mesh-ancestor
110149627|NCT00008151|Cyclosporine|cyclosporine|mesh-list
110149628|NCT00008151|Mycophenolic Acid|mycophenolic acid|mesh-list
110149629|NCT00008151|Methotrexate|methotrexate|mesh-list
110149630|NCT00008151|Fludarabine phosphate|fludarabine phosphate|mesh-list
110149631|NCT00008151|Fludarabine|fludarabine|mesh-list
110149632|NCT00008151|Gemtuzumab|gemtuzumab|mesh-list
110149634|NCT00008151|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110149636|NCT00008151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110149637|NCT00008151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110149638|NCT00008151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110149640|NCT00008151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110149641|NCT00008151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110149642|NCT00008151|Dermatologic Agents|dermatologic agents|mesh-ancestor
110149643|NCT00008151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110149644|NCT00008151|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110149645|NCT00008151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110149646|NCT00008151|Immunologic Factors|immunologic factors|mesh-ancestor
110149647|NCT00008151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110149648|NCT00008151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110149649|NCT00008151|Antifungal Agents|antifungal agents|mesh-ancestor
110149650|NCT00008151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110149651|NCT00008151|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110149652|NCT00008151|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110149653|NCT00008151|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110149655|NCT00008151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110149656|NCT00008151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110149658|NCT00008151|Immunoconjugates|immunoconjugates|mesh-ancestor
110149660|NCT00006448|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110149661|NCT00006448|Narcotics|narcotics|mesh-ancestor
110149662|NCT00006448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110149663|NCT00006448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110149664|NCT00006448|Analgesics|analgesics|mesh-ancestor
110149665|NCT00006448|Sensory System Agents|sensory system agents|mesh-ancestor
110149666|NCT00006448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110149667|NCT00006448|Antitussive Agents|antitussive agents|mesh-ancestor
110149668|NCT00006448|Respiratory System Agents|respiratory system agents|mesh-ancestor
110149670|NCT00008190|Cyclophosphamide|cyclophosphamide|mesh-list
110149671|NCT00008190|Melphalan|melphalan|mesh-list
110149672|NCT00008190|Busulfan|busulfan|mesh-list
110149673|NCT00008190|Etoposide|etoposide|mesh-list
110149674|NCT00008190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110149675|NCT00008190|Immunologic Factors|immunologic factors|mesh-ancestor
110149676|NCT00008190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110149677|NCT00008190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110149678|NCT00008190|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110149679|NCT00008190|Alkylating Agents|alkylating agents|mesh-ancestor
110149680|NCT00008190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110149681|NCT00008190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110149682|NCT00008190|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110149683|NCT00008190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110149684|NCT00008190|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110149685|NCT00008190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110149688|NCT00008190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110149689|NCT00008190|Antiviral Agents|antiviral agents|mesh-ancestor
110149690|NCT00008190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110149692|NCT00006451|Methylprednisolone|methylprednisolone|mesh-list
110149693|NCT00006451|Cyclophosphamide|cyclophosphamide|mesh-list
110149694|NCT00006451|Methotrexate|methotrexate|mesh-list
110149695|NCT00006451|Cyclosporins|cyclosporins|mesh-list
110149696|NCT00006451|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110149697|NCT00006451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110149698|NCT00006451|Immunologic Factors|immunologic factors|mesh-ancestor
110149699|NCT00006451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110149700|NCT00006451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110149701|NCT00006451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110149702|NCT00006451|Alkylating Agents|alkylating agents|mesh-ancestor
110149703|NCT00006451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110149704|NCT00006451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110149705|NCT00006451|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110149706|NCT00006451|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110149707|NCT00006451|Abortifacient Agents|abortifacient agents|mesh-ancestor
110149708|NCT00006451|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110149709|NCT00006451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110149710|NCT00006451|Antimetabolites|antimetabolites|mesh-ancestor
110149711|NCT00006451|Dermatologic Agents|dermatologic agents|mesh-ancestor
110149713|NCT00006451|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110149714|NCT00006451|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110149715|NCT00006451|Antifungal Agents|antifungal agents|mesh-ancestor
110149716|NCT00006451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110149717|NCT00006451|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110149719|NCT00006451|Antiemetics|antiemetics|mesh-ancestor
110149720|NCT00006451|Autonomic Agents|autonomic agents|mesh-ancestor
110149721|NCT00006451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110149722|NCT00006451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110149723|NCT00006451|Glucocorticoids|glucocorticoids|mesh-ancestor
110149725|NCT00006451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110149726|NCT00006451|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110149727|NCT00006451|Protective Agents|protective agents|mesh-ancestor
110149728|NCT00006454|Paclitaxel|paclitaxel|mesh-list
110149729|NCT00006454|Carboplatin|carboplatin|mesh-list
110149730|NCT00006454|Topotecan|topotecan|mesh-list
110149731|NCT00006454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110149732|NCT00006454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110149733|NCT00006454|Tubulin Modulators|tubulin modulators|mesh-ancestor
110149734|NCT00006454|Antimitotic Agents|antimitotic agents|mesh-ancestor
110149735|NCT00006454|Mitosis Modulators|mitosis modulators|mesh-ancestor
110225473|NCT05952713|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110149736|NCT00006454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110149737|NCT00006454|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110149738|NCT00006454|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110149739|NCT00006454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110149740|NCT00008229|Melphalan|melphalan|mesh-list
110149741|NCT00008229|Immunologic Factors|immunologic factors|mesh-ancestor
110149742|NCT00008229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110149743|NCT00008229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110149744|NCT00008229|Alkylating Agents|alkylating agents|mesh-ancestor
110149745|NCT00008229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110149746|NCT00008229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110149747|NCT00008229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110149748|NCT00008229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110149750|NCT00006457|Antiviral Agents|antiviral agents|mesh-ancestor
110149751|NCT00006457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110149752|NCT00006457|Schistosomicides|schistosomicides|mesh-ancestor
110149753|NCT00006457|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110149754|NCT00006457|Anthelmintics|anthelmintics|mesh-ancestor
110149755|NCT00006457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110149756|NCT00006457|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110149757|NCT00006457|Protective Agents|protective agents|mesh-ancestor
110149758|NCT00006457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110149759|NCT00006457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110149760|NCT00006457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110149761|NCT00006457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110149762|NCT00006457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110149763|NCT00006457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110149765|NCT00008268|Immunologic Factors|immunologic factors|mesh-ancestor
110149766|NCT00008268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110149767|NCT00008268|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110149768|NCT00008268|Alkylating Agents|alkylating agents|mesh-ancestor
110191418|NCT00027833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110149769|NCT00008268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110149770|NCT00008268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110149771|NCT00008268|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110149772|NCT00008268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110149773|NCT00006463|Trabectedin|trabectedin|mesh-list
110149774|NCT00006463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110149775|NCT00006463|Alkylating Agents|alkylating agents|mesh-ancestor
110225474|NCT05952713|Amitriptyline|amitriptyline|mesh-list
110225475|NCT05952713|Vortioxetine|vortioxetine|mesh-list
110149776|NCT00006463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110149777|NCT00006463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110149778|NCT00008307|Cyclosporine|cyclosporine|mesh-list
110149779|NCT00008307|Mycophenolic Acid|mycophenolic acid|mesh-list
110149780|NCT00008307|Methylprednisolone|methylprednisolone|mesh-list
110149781|NCT00008307|Fludarabine|fludarabine|mesh-list
110149782|NCT00008307|Fludarabine phosphate|fludarabine phosphate|mesh-list
110149783|NCT00008307|Melphalan|melphalan|mesh-list
110149784|NCT00008307|Cyclosporins|cyclosporins|mesh-list
110186657|NCT05105919|Aspirin|aspirin|mesh-list
110149785|NCT00008307|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110149786|NCT00008307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110149787|NCT00008307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110149788|NCT00008307|Antimetabolites|antimetabolites|mesh-ancestor
110149789|NCT00008307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110149790|NCT00008307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110149791|NCT00008307|Immunologic Factors|immunologic factors|mesh-ancestor
110149792|NCT00008307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110149793|NCT00008307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110149794|NCT00008307|Antifungal Agents|antifungal agents|mesh-ancestor
110149795|NCT00008307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110149796|NCT00008307|Dermatologic Agents|dermatologic agents|mesh-ancestor
110149797|NCT00008307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110149798|NCT00008307|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110149799|NCT00008307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110149800|NCT00008307|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110149801|NCT00008307|Antitubercular Agents|antitubercular agents|mesh-ancestor
110149802|NCT00008307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110149803|NCT00008307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110149805|NCT00008307|Autonomic Agents|autonomic agents|mesh-ancestor
110149806|NCT00008307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110149807|NCT00008307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110149809|NCT00008307|Hormones|hormones|mesh-ancestor
110225476|NCT05952713|Mirtazapine|mirtazapine|mesh-list
110149810|NCT00008307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110149811|NCT00008307|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110149812|NCT00008307|Protective Agents|protective agents|mesh-ancestor
110149813|NCT00008307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110149814|NCT00008307|Alkylating Agents|alkylating agents|mesh-ancestor
110149815|NCT00008307|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110149817|NCT00006469|Carboplatin|carboplatin|mesh-list
110225477|NCT05952713|Agomelatine|agomelatine|mesh-list
110149818|NCT00006469|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110149819|NCT00006469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110149820|NCT00006469|Tubulin Modulators|tubulin modulators|mesh-ancestor
110149821|NCT00006469|Antimitotic Agents|antimitotic agents|mesh-ancestor
110149822|NCT00006469|Mitosis Modulators|mitosis modulators|mesh-ancestor
110149823|NCT00006469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110149824|NCT00006472|Paclitaxel|paclitaxel|mesh-list
110149825|NCT00006472|Carboplatin|carboplatin|mesh-list
110149826|NCT00006472|Fluorouracil|fluorouracil|mesh-list
110191419|NCT00027833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110149827|NCT00006472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110225478|NCT05952713|Citalopram|citalopram|mesh-list
110149828|NCT00006472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110149829|NCT00006472|Tubulin Modulators|tubulin modulators|mesh-ancestor
110149830|NCT00006472|Antimitotic Agents|antimitotic agents|mesh-ancestor
110149831|NCT00006472|Mitosis Modulators|mitosis modulators|mesh-ancestor
110149832|NCT00006472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110149833|NCT00006472|Antimetabolites|antimetabolites|mesh-ancestor
110149834|NCT00006472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110149835|NCT00006472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110149836|NCT00006472|Immunologic Factors|immunologic factors|mesh-ancestor
110149837|NCT00006472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110149839|NCT00006475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110149840|NCT00006475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110149842|NCT00006475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110149843|NCT00008424|Irinotecan|irinotecan|mesh-list
110149844|NCT00008424|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110149845|NCT00008424|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110149846|NCT00008424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110225479|NCT05952713|Fluoxetine|fluoxetine|mesh-list
110149847|NCT00008424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110149848|NCT00008424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110149849|NCT00006484|Paclitaxel|paclitaxel|mesh-list
110149850|NCT00006484|Carboplatin|carboplatin|mesh-list
110149851|NCT00006484|Tirapazamine|tirapazamine|mesh-list
110149852|NCT00006484|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110149853|NCT00006484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110149854|NCT00006484|Tubulin Modulators|tubulin modulators|mesh-ancestor
110149855|NCT00006484|Antimitotic Agents|antimitotic agents|mesh-ancestor
110149856|NCT00006484|Mitosis Modulators|mitosis modulators|mesh-ancestor
110149857|NCT00006484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110149858|NCT00006487|Etoposide|etoposide|mesh-list
110149859|NCT00006487|Tirapazamine|tirapazamine|mesh-list
110149860|NCT00006487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110149861|NCT00006487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110149862|NCT00006487|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110149863|NCT00006487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110149864|NCT00006487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110149865|NCT00006487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110149866|NCT00006493|Rosiglitazone|rosiglitazone|mesh-list
110149867|NCT00006493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110149868|NCT00006493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110149869|NCT00008463|Interferons|interferons|mesh-list
110149870|NCT00008463|Ribavirin|ribavirin|mesh-list
110149871|NCT00008463|Interferon-alpha|interferon-alpha|mesh-list
110149872|NCT00008463|Interferon alpha-2|interferon alpha-2|mesh-list
110149873|NCT00008463|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110149874|NCT00008463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110149875|NCT00008463|Antiviral Agents|antiviral agents|mesh-ancestor
110149876|NCT00008463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110149878|NCT00008463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110149879|NCT00008463|Immunologic Factors|immunologic factors|mesh-ancestor
110149880|NCT00008463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110149881|NCT00006508|Insulin|insulin|mesh-list
110149882|NCT00006508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110149883|NCT00006508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110149884|NCT00006682|Docetaxel|docetaxel|mesh-list
110149885|NCT00006682|Vinorelbine|vinorelbine|mesh-list
110149886|NCT00006682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110149887|NCT00006682|Tubulin Modulators|tubulin modulators|mesh-ancestor
110149888|NCT00006682|Antimitotic Agents|antimitotic agents|mesh-ancestor
110149889|NCT00006682|Mitosis Modulators|mitosis modulators|mesh-ancestor
110149890|NCT00006682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110149891|NCT00006682|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110149892|NCT00008697|Arsenic Trioxide|arsenic trioxide|mesh-list
110149893|NCT00008697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110149894|NCT00006760|Vinorelbine|vinorelbine|mesh-list
110149895|NCT00006760|Ifosfamide|ifosfamide|mesh-list
110225480|NCT05952713|Paroxetine|paroxetine|mesh-list
110149896|NCT00006760|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110149897|NCT00006760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110149898|NCT00006760|Tubulin Modulators|tubulin modulators|mesh-ancestor
110149899|NCT00006760|Antimitotic Agents|antimitotic agents|mesh-ancestor
110149900|NCT00006760|Mitosis Modulators|mitosis modulators|mesh-ancestor
110149901|NCT00006760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110149902|NCT00006760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110149903|NCT00006760|Alkylating Agents|alkylating agents|mesh-ancestor
110149904|NCT00008736|Metoclopramide|metoclopramide|mesh-list
110149905|NCT00008736|Antiemetics|antiemetics|mesh-ancestor
110149906|NCT00008736|Autonomic Agents|autonomic agents|mesh-ancestor
110149907|NCT00008736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110149908|NCT00008736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110149909|NCT00008736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110149910|NCT00008736|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110149911|NCT00008736|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110149912|NCT00008736|Dopamine Agents|dopamine agents|mesh-ancestor
110149913|NCT00008736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110225481|NCT05952713|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110149914|NCT00008736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110149916|NCT00006799|Megestrol Acetate|megestrol acetate|mesh-list
110149917|NCT00006799|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110149918|NCT00006799|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110149919|NCT00006799|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110149920|NCT00006799|Contraceptive Agents|contraceptive agents|mesh-ancestor
110149921|NCT00006799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110149922|NCT00006799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110149923|NCT00006799|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110149924|NCT00006799|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110225482|NCT05952713|Sertraline|sertraline|mesh-list
110149925|NCT00006799|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110149926|NCT00006799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110149927|NCT00006799|Appetite Stimulants|appetite stimulants|mesh-ancestor
110149928|NCT00006799|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110149930|NCT00006877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110149931|NCT00006877|Alkylating Agents|alkylating agents|mesh-ancestor
110149932|NCT00006877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110149933|NCT00006877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110149934|NCT00007033|Magnesium Sulfate|magnesium sulfate|mesh-list
110149935|NCT00007033|Analgesics|analgesics|mesh-ancestor
110191420|NCT00027833|Antidotes|antidotes|mesh-ancestor
110149937|NCT00007033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110149938|NCT00007033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110149939|NCT00007033|Anesthetics|anesthetics|mesh-ancestor
110149940|NCT00007033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110149941|NCT00007033|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110149942|NCT00007033|Anticonvulsants|anticonvulsants|mesh-ancestor
110149943|NCT00007033|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110149944|NCT00007033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110225483|NCT05952713|Antidepressive Agents|antidepressive agents|mesh-list
110225484|NCT05952713|Reboxetine|reboxetine|mesh-list
110225485|NCT05952713|Imipramine|imipramine|mesh-list
110225486|NCT05952713|Escitalopram|escitalopram|mesh-list
110149945|NCT00007033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110149946|NCT00007033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110149947|NCT00007033|Tocolytic Agents|tocolytic agents|mesh-ancestor
110149948|NCT00007033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110149949|NCT00388401|Alvimopan|alvimopan|mesh-list
110149950|NCT00388401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110149951|NCT00007189|Celecoxib|celecoxib|mesh-list
110149952|NCT00007189|Naproxen|naproxen|mesh-list
110149953|NCT00007189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110149954|NCT00007189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110149956|NCT00007189|Sensory System Agents|sensory system agents|mesh-ancestor
110149957|NCT00007189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110149958|NCT00007189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110149959|NCT00007189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110149960|NCT00007189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110149961|NCT00007189|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110149962|NCT00007189|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110149963|NCT00007189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110149964|NCT00007189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110149966|NCT00388219|Buprenorphine|buprenorphine|mesh-list
110149967|NCT00388219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110149968|NCT00388219|Narcotics|narcotics|mesh-ancestor
110149969|NCT00388219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110149970|NCT00388219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110149972|NCT00388219|Sensory System Agents|sensory system agents|mesh-ancestor
110149973|NCT00388219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110149974|NCT00388219|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110149975|NCT00388258|Alvimopan|alvimopan|mesh-list
110149976|NCT00388258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110149977|NCT00388336|Epoetin Alfa|epoetin alfa|mesh-list
110149978|NCT00388336|Hematinics|hematinics|mesh-ancestor
110149979|NCT00007306|Hormones|hormones|mesh-list
110149980|NCT00007306|Parathyroid Hormone|parathyroid hormone|mesh-list
110149981|NCT00007306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110149982|NCT00007306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110149983|NCT00007306|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110149984|NCT00007423|polysaccharide-K|polysaccharide-k|mesh-list
110149985|NCT00007423|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110149986|NCT00007423|Immunologic Factors|immunologic factors|mesh-ancestor
110149987|NCT00007423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110149988|NCT00007423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110149989|NCT00007423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110149990|NCT00007423|Antiviral Agents|antiviral agents|mesh-ancestor
110149991|NCT00007423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110149992|NCT00007423|Interferon Inducers|interferon inducers|mesh-ancestor
110149993|NCT00007423|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110149994|NCT00007423|Protective Agents|protective agents|mesh-ancestor
110149996|NCT00007735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110149997|NCT00007735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110149999|NCT00007735|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110150000|NCT00007735|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110150001|NCT00007774|Haloperidol|haloperidol|mesh-list
110150003|NCT00007774|Haloperidol decanoate|haloperidol decanoate|mesh-list
110150004|NCT00007774|Antiemetics|antiemetics|mesh-ancestor
110150006|NCT00007774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110150007|NCT00007774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110150008|NCT00007774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110150009|NCT00007774|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110150010|NCT00007774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110150011|NCT00007774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110150012|NCT00007774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110150013|NCT00007774|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110150014|NCT00007774|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110150015|NCT00007774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110191421|NCT00027833|Protective Agents|protective agents|mesh-ancestor
110150017|NCT00007774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110150018|NCT00007774|Serotonin Agents|serotonin agents|mesh-ancestor
110150019|NCT00007774|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110150020|NCT00007774|Dopamine Agents|dopamine agents|mesh-ancestor
110150021|NCT00007774|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110150022|NCT00007813|Cyclophosphamide|cyclophosphamide|mesh-list
110150025|NCT00007813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110150026|NCT00007813|Immunologic Factors|immunologic factors|mesh-ancestor
110150027|NCT00007813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110150028|NCT00007813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110150029|NCT00007813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110150030|NCT00007813|Alkylating Agents|alkylating agents|mesh-ancestor
110150031|NCT00007813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110150032|NCT00007813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110150033|NCT00007813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110150034|NCT00007813|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110150035|NCT00007813|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110150036|NCT00007813|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110150037|NCT00007813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110150039|NCT00007852|Rituximab|rituximab|mesh-list
110150040|NCT00007852|Etoposide|etoposide|mesh-list
110150041|NCT00007852|Melphalan|melphalan|mesh-list
110150042|NCT00007852|Carmustine|carmustine|mesh-list
110150043|NCT00007852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110150044|NCT00007852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110150045|NCT00007852|Immunologic Factors|immunologic factors|mesh-ancestor
110150046|NCT00007852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110150047|NCT00007852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110150048|NCT00007852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110150049|NCT00007852|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110150050|NCT00007852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110150051|NCT00007852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110150052|NCT00007852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110150054|NCT00007852|Antimetabolites|antimetabolites|mesh-ancestor
110150055|NCT00007852|Antiviral Agents|antiviral agents|mesh-ancestor
110150056|NCT00007852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110150057|NCT00007852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110186680|NCT05049603|Atorvastatin|atorvastatin|mesh-list
110150058|NCT00007852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110150059|NCT00007852|Alkylating Agents|alkylating agents|mesh-ancestor
110150060|NCT00007852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110150061|NCT00007891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110150063|NCT00007891|Immunoglobulins|immunoglobulins|mesh-list
110150064|NCT00007891|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110150065|NCT00007891|Immunologic Factors|immunologic factors|mesh-ancestor
110150066|NCT00007891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110150067|NCT00007891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110150068|NCT00007969|Verteporfin|verteporfin|mesh-list
110150069|NCT00007969|Detox adjuvant|detox adjuvant|mesh-list
110150070|NCT00007969|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110150071|NCT00007969|Dermatologic Agents|dermatologic agents|mesh-ancestor
110150072|NCT00007969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110150073|NCT00007969|Immunologic Factors|immunologic factors|mesh-ancestor
110150074|NCT00007969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110150076|NCT00008008|Thiotepa|thiotepa|mesh-list
110150077|NCT00008008|Sargramostim|sargramostim|mesh-list
110150078|NCT00008008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110150079|NCT00008008|Immunologic Factors|immunologic factors|mesh-ancestor
110150080|NCT00008008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110150081|NCT00008008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110150082|NCT00008008|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110150083|NCT00008008|Alkylating Agents|alkylating agents|mesh-ancestor
110150084|NCT00008008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110150085|NCT00008008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110150086|NCT00008008|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110150088|NCT00008047|Fluorouracil|fluorouracil|mesh-list
110150089|NCT00008047|Hydroxyurea|hydroxyurea|mesh-list
110150090|NCT00008047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110150092|NCT00008047|Tubulin Modulators|tubulin modulators|mesh-ancestor
110150093|NCT00008047|Antimitotic Agents|antimitotic agents|mesh-ancestor
110150094|NCT00008047|Mitosis Modulators|mitosis modulators|mesh-ancestor
110150095|NCT00008047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110150096|NCT00008047|Antimetabolites|antimetabolites|mesh-ancestor
110150097|NCT00008047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110150098|NCT00008047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110150099|NCT00008047|Immunologic Factors|immunologic factors|mesh-ancestor
110150100|NCT00008047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110150101|NCT00008047|Antisickling Agents|antisickling agents|mesh-ancestor
110150102|NCT00008047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110191422|NCT00027833|Vitamin B Complex|vitamin b complex|mesh-ancestor
110150103|NCT00008047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110150104|NCT00008086|Calcitriol|calcitriol|mesh-list
110150105|NCT00008086|Carboplatin|carboplatin|mesh-list
110150106|NCT00008086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110150107|NCT00008086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110150108|NCT00008086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110150109|NCT00008086|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110150110|NCT00008086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110150111|NCT00008086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110150113|NCT00008086|Vitamins|vitamins|mesh-ancestor
110150114|NCT00008086|Micronutrients|micronutrients|mesh-ancestor
110150115|NCT00008086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110150116|NCT00008125|Carboplatin|carboplatin|mesh-list
110150117|NCT00008125|Gemcitabine|gemcitabine|mesh-list
110150118|NCT00008125|Docetaxel|docetaxel|mesh-list
110150120|NCT00008125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110150121|NCT00008125|Antimetabolites|antimetabolites|mesh-ancestor
110150122|NCT00008125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110150123|NCT00008125|Tubulin Modulators|tubulin modulators|mesh-ancestor
110150124|NCT00008125|Antimitotic Agents|antimitotic agents|mesh-ancestor
110150125|NCT00008125|Mitosis Modulators|mitosis modulators|mesh-ancestor
110150126|NCT00008203|Interferons|interferons|mesh-list
110150127|NCT00008203|Aldesleukin|aldesleukin|mesh-list
110150128|NCT00008203|Interferon-gamma|interferon-gamma|mesh-list
110150129|NCT00008203|Cyclosporine|cyclosporine|mesh-list
110150130|NCT00008203|Cyclophosphamide|cyclophosphamide|mesh-list
110150131|NCT00008203|Thiotepa|thiotepa|mesh-list
110150132|NCT00008203|Carboplatin|carboplatin|mesh-list
110150133|NCT00008203|Cyclosporins|cyclosporins|mesh-list
110150134|NCT00008203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110150135|NCT00008203|Immunologic Factors|immunologic factors|mesh-ancestor
110150136|NCT00008203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110150137|NCT00008203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110150138|NCT00008203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110150139|NCT00008203|Alkylating Agents|alkylating agents|mesh-ancestor
110150140|NCT00008203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110150141|NCT00008203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110150142|NCT00008203|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110150143|NCT00008203|Antiviral Agents|antiviral agents|mesh-ancestor
110150144|NCT00008203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110150145|NCT00008203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110150146|NCT00008203|Antifungal Agents|antifungal agents|mesh-ancestor
110150147|NCT00008203|Dermatologic Agents|dermatologic agents|mesh-ancestor
110150148|NCT00008203|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110150149|NCT00008203|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110150150|NCT00008203|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110150151|NCT00008242|Thalidomide|thalidomide|mesh-list
110150152|NCT00008242|Dexamethasone|dexamethasone|mesh-list
110150153|NCT00008242|Doxorubicin|doxorubicin|mesh-list
110150154|NCT00008242|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110150155|NCT00008242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110150156|NCT00008242|Antiemetics|antiemetics|mesh-ancestor
110150157|NCT00008242|Autonomic Agents|autonomic agents|mesh-ancestor
110150158|NCT00008242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110150159|NCT00008242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110150160|NCT00008242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110150161|NCT00008242|Glucocorticoids|glucocorticoids|mesh-ancestor
110150163|NCT00008242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110150166|NCT00008242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110150167|NCT00008242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110150168|NCT00008242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110150169|NCT00008242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110150170|NCT00008242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110150171|NCT00008242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110150172|NCT00008242|Immunologic Factors|immunologic factors|mesh-ancestor
110150173|NCT00008242|Leprostatic Agents|leprostatic agents|mesh-ancestor
110150174|NCT00008242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110150175|NCT00008242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110150176|NCT00008242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110150177|NCT00008242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110150178|NCT00008242|Growth Substances|growth substances|mesh-ancestor
110150179|NCT00008242|Growth Inhibitors|growth inhibitors|mesh-ancestor
110150180|NCT00008281|Leucovorin|leucovorin|mesh-list
110150181|NCT00008281|Fluorouracil|fluorouracil|mesh-list
110150182|NCT00008281|Oxaliplatin|oxaliplatin|mesh-list
110150183|NCT00008281|Calcium|calcium|mesh-list
110150184|NCT00008281|Levoleucovorin|levoleucovorin|mesh-list
110150185|NCT00008281|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110150186|NCT00008281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110150187|NCT00008281|Antimetabolites|antimetabolites|mesh-ancestor
110150188|NCT00008281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110150189|NCT00008281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110150190|NCT00008281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110150191|NCT00008281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110150192|NCT00008281|Immunologic Factors|immunologic factors|mesh-ancestor
110150193|NCT00008281|Antidotes|antidotes|mesh-ancestor
110150194|NCT00008281|Protective Agents|protective agents|mesh-ancestor
110150195|NCT00008281|Vitamin B Complex|vitamin b complex|mesh-ancestor
110150197|NCT00008281|Micronutrients|micronutrients|mesh-ancestor
110150198|NCT00008359|Amphotericin B|amphotericin b|mesh-list
110191423|NCT00027833|Vitamins|vitamins|mesh-ancestor
110150199|NCT00008359|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110150200|NCT00008359|Caspofungin|caspofungin|mesh-list
110150201|NCT00008359|Amebicides|amebicides|mesh-ancestor
110150202|NCT00008359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110150203|NCT00008359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110150204|NCT00008359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110150205|NCT00008359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110150206|NCT00008359|Antifungal Agents|antifungal agents|mesh-ancestor
110150207|NCT00008359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110150208|NCT00008359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110150210|NCT00008398|Immunologic Factors|immunologic factors|mesh-ancestor
110150211|NCT00008398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110150212|NCT00008476|Capsaicin|capsaicin|mesh-list
110150213|NCT00008476|Antipruritics|antipruritics|mesh-ancestor
110150214|NCT00008476|Dermatologic Agents|dermatologic agents|mesh-ancestor
110150215|NCT00008476|Sensory System Agents|sensory system agents|mesh-ancestor
110150216|NCT00008476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110150217|NCT00008476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110150218|NCT00008515|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
110150219|NCT00008515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110150222|NCT00008515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110150223|NCT00008515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110150224|NCT00008554|Lamivudine|lamivudine|mesh-list
110150225|NCT00008554|Abacavir|abacavir|mesh-list
110150226|NCT00008554|Nelfinavir|nelfinavir|mesh-list
110150227|NCT00008554|Fosamprenavir|fosamprenavir|mesh-list
110150228|NCT00008554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110150229|NCT00008554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110150230|NCT00008554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110150231|NCT00008554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110150232|NCT00008554|Antiviral Agents|antiviral agents|mesh-ancestor
110150233|NCT00008554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110150235|NCT00008554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110150236|NCT00008554|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110186729|NCT05012189|Oseltamivir|oseltamivir|mesh-list
110150237|NCT00008554|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110150238|NCT00008554|Protease Inhibitors|protease inhibitors|mesh-ancestor
110150240|NCT05636566|Propofol|propofol|mesh-list
110150241|NCT05636566|Sevoflurane|sevoflurane|mesh-list
110150242|NCT05636566|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110150243|NCT05636566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110150244|NCT05636566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110150245|NCT05636566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110150246|NCT05636566|Analgesics|analgesics|mesh-ancestor
110150247|NCT05636566|Sensory System Agents|sensory system agents|mesh-ancestor
110150248|NCT05636566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110150249|NCT05636566|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110150250|NCT05636566|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110150251|NCT05636566|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110150252|NCT05636566|Adrenergic Agents|adrenergic agents|mesh-ancestor
110150254|NCT05636566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110150255|NCT05636566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110150256|NCT05636566|Anesthetics, General|anesthetics, general|mesh-ancestor
110150257|NCT05636566|Anesthetics|anesthetics|mesh-ancestor
110150258|NCT05636566|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110150259|NCT05636566|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110150260|NCT05637034|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110150261|NCT05637034|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110150262|NCT05637034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110150264|NCT05637073|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110150265|NCT05637073|Contraceptive Agents|contraceptive agents|mesh-ancestor
110150266|NCT05637073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110150267|NCT05637073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110150268|NCT05637073|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110150269|NCT05637073|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110150270|NCT05637073|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110150271|NCT05637073|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110150272|NCT05637073|Hormone Antagonists|hormone antagonists|mesh-ancestor
110150273|NCT05637073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110150274|NCT05637073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110150275|NCT05637073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110150277|NCT05637268|Cisplatin|cisplatin|mesh-list
110150278|NCT05637268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110150279|NCT05637268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110150280|NCT05637268|Tubulin Modulators|tubulin modulators|mesh-ancestor
110150281|NCT05637268|Antimitotic Agents|antimitotic agents|mesh-ancestor
110150282|NCT05637268|Mitosis Modulators|mitosis modulators|mesh-ancestor
110150283|NCT05637268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110150284|NCT05637216|Losartan|losartan|mesh-list
110150285|NCT05637216|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110150286|NCT05637216|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110150287|NCT05637216|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110150288|NCT05637216|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110150289|NCT05637216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110150290|NCT05638087|Dexamethasone|dexamethasone|mesh-list
110150291|NCT05638087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110150292|NCT05638087|Antiemetics|antiemetics|mesh-ancestor
110150294|NCT05638087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110150295|NCT05638087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110150296|NCT05638087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110150297|NCT05638087|Glucocorticoids|glucocorticoids|mesh-ancestor
110150298|NCT05638087|Hormones|hormones|mesh-ancestor
110150299|NCT05638087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110150300|NCT05638087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110150301|NCT05638087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110150302|NCT05638633|Vitamins|vitamins|mesh-list
110150303|NCT05638633|Vitamin B Complex|vitamin b complex|mesh-list
110150304|NCT05638633|Prednisolone|prednisolone|mesh-list
110150305|NCT05638633|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110150306|NCT05638633|Methylprednisolone|methylprednisolone|mesh-list
110150307|NCT05638633|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110150308|NCT05638633|Prednisolone acetate|prednisolone acetate|mesh-list
110150310|NCT05638633|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110150311|NCT05638633|Prednisolone phosphate|prednisolone phosphate|mesh-list
110150312|NCT05638633|Micronutrients|micronutrients|mesh-ancestor
110150313|NCT05638633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110150314|NCT05638633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110150315|NCT05638633|Glucocorticoids|glucocorticoids|mesh-ancestor
110150316|NCT05638633|Hormones|hormones|mesh-ancestor
110191424|NCT00027833|Micronutrients|micronutrients|mesh-ancestor
110191425|NCT00027872|Tipifarnib|tipifarnib|mesh-list
110150317|NCT05638633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110150318|NCT05638633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110150319|NCT05638633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110150320|NCT05638633|Antiemetics|antiemetics|mesh-ancestor
110150321|NCT05638633|Autonomic Agents|autonomic agents|mesh-ancestor
110150322|NCT05638633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110150323|NCT05638633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110150324|NCT05638633|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110150325|NCT05638633|Protective Agents|protective agents|mesh-ancestor
110150326|NCT05638984|Decitabine|decitabine|mesh-list
110150327|NCT05638984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110150328|NCT05638984|Antimetabolites|antimetabolites|mesh-ancestor
110150329|NCT05638984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110150330|NCT05638984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110150331|NCT05638984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110150332|NCT05639218|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
110150333|NCT05639218|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110150334|NCT05639218|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110150336|NCT05639218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110150337|NCT05639218|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110150338|NCT05639218|Protease Inhibitors|protease inhibitors|mesh-ancestor
110150339|NCT05639218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110150340|NCT05639218|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110150341|NCT05639257|Mexiletine|mexiletine|mesh-list
110150342|NCT05639257|Lamotrigine|lamotrigine|mesh-list
110150343|NCT05639257|Anticonvulsants|anticonvulsants|mesh-ancestor
110150344|NCT05639257|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110150345|NCT05639257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110150346|NCT05639257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110191426|NCT00027872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110150347|NCT05639257|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110150348|NCT05639257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110150349|NCT05639257|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110150350|NCT05639257|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110150351|NCT05639257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110150352|NCT05639257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110150353|NCT05639257|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110150354|NCT05639257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110150355|NCT05639257|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110150356|NCT00000115|Acetazolamide|acetazolamide|mesh-list
110150357|NCT00000115|Anticonvulsants|anticonvulsants|mesh-ancestor
110150358|NCT00000115|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110150359|NCT00000115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110150360|NCT00000115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110150361|NCT00000115|Diuretics|diuretics|mesh-ancestor
110150362|NCT00000115|Natriuretic Agents|natriuretic agents|mesh-ancestor
110150363|NCT00000115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110150364|NCT00000136|Ganciclovir|ganciclovir|mesh-list
110150365|NCT00000136|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
110150366|NCT00000136|Foscarnet|foscarnet|mesh-list
110150367|NCT00000136|Antiviral Agents|antiviral agents|mesh-ancestor
110150368|NCT00000136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110150369|NCT00000136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110150371|NCT00000136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110150372|NCT00000136|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110150373|NCT00000139|Acyclovir|acyclovir|mesh-list
110150374|NCT00000139|Antiviral Agents|antiviral agents|mesh-ancestor
110150375|NCT00000139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110150376|NCT00388687|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
110150377|NCT00388687|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110150378|NCT00388687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110150380|NCT00000142|Antiviral Agents|antiviral agents|mesh-ancestor
110150381|NCT00000142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110150382|NCT00000142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110150383|NCT00000142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110150385|NCT00000145|Antioxidants|antioxidants|mesh-list
110150386|NCT00000145|Trace Elements|trace elements|mesh-ancestor
110150387|NCT00000145|Micronutrients|micronutrients|mesh-ancestor
110150388|NCT00000145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110150389|NCT00000145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110150390|NCT00000145|Protective Agents|protective agents|mesh-ancestor
110150391|NCT00000151|Aspirin|aspirin|mesh-list
110150392|NCT00000151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110150393|NCT00000151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110150394|NCT00000151|Analgesics|analgesics|mesh-ancestor
110150395|NCT00000151|Sensory System Agents|sensory system agents|mesh-ancestor
110150396|NCT00000151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110150397|NCT00000151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110150398|NCT00000151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110150399|NCT00000151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110150400|NCT00000151|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110150401|NCT00000151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110150402|NCT00000151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110150403|NCT00000151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110150404|NCT00000151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110150405|NCT00000151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110150406|NCT00000151|Antipyretics|antipyretics|mesh-ancestor
110150407|NCT00000157|Aspirin|aspirin|mesh-list
110150408|NCT00000157|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110150409|NCT00000157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110150410|NCT00000157|Analgesics|analgesics|mesh-ancestor
110150411|NCT00000157|Sensory System Agents|sensory system agents|mesh-ancestor
110150412|NCT00000157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110150413|NCT00000157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110150414|NCT00000157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110150415|NCT00000157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110150416|NCT00000157|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110150417|NCT00000157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110191427|NCT00027911|Sargramostim|sargramostim|mesh-list
110150418|NCT00000157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110150419|NCT00000157|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110150420|NCT00000157|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110150421|NCT00000157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110150422|NCT00000157|Antipyretics|antipyretics|mesh-ancestor
110150423|NCT00000172|Galantamine|galantamine|mesh-list
110150424|NCT00000172|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110150425|NCT00000172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110150426|NCT00000172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110150427|NCT00000172|Cholinergic Agents|cholinergic agents|mesh-ancestor
110150428|NCT00000172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110150429|NCT00000172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110150430|NCT00000172|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110150431|NCT00000172|Autonomic Agents|autonomic agents|mesh-ancestor
110150432|NCT00000172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110150433|NCT00000172|Nootropic Agents|nootropic agents|mesh-ancestor
110150435|NCT00000175|Estrogens|estrogens|mesh-list
110150436|NCT00000175|Androgens|androgens|mesh-ancestor
110150437|NCT00000175|Hormones|hormones|mesh-ancestor
110150438|NCT00000175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110191428|NCT00027911|Immunologic Factors|immunologic factors|mesh-ancestor
110150439|NCT00000175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110150440|NCT00000187|Ritanserin|ritanserin|mesh-list
110150441|NCT00000187|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110150442|NCT00000187|Serotonin Agents|serotonin agents|mesh-ancestor
110150443|NCT00000187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110150444|NCT00000187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110150445|NCT00000187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110150447|NCT00000187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110150448|NCT00000187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110150451|NCT00000187|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110150452|NCT00000187|Antidepressive Agents|antidepressive agents|mesh-ancestor
110150453|NCT00000205|Buprenorphine|buprenorphine|mesh-list
110150454|NCT00000205|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110150455|NCT00000205|Narcotics|narcotics|mesh-ancestor
110150456|NCT00000205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110150457|NCT00000205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110150458|NCT00000205|Analgesics|analgesics|mesh-ancestor
110150459|NCT00000205|Sensory System Agents|sensory system agents|mesh-ancestor
110150460|NCT00000205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110150461|NCT00000205|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110150462|NCT00000214|Buprenorphine|buprenorphine|mesh-list
110150463|NCT00000214|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110150464|NCT00000214|Narcotics|narcotics|mesh-ancestor
110150465|NCT00000214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110150466|NCT00000214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110150467|NCT00000214|Analgesics|analgesics|mesh-ancestor
110150468|NCT00000214|Sensory System Agents|sensory system agents|mesh-ancestor
110150469|NCT00000214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110150470|NCT00000214|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110150471|NCT00000220|Buprenorphine|buprenorphine|mesh-list
110150472|NCT00000220|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110150473|NCT00000220|Narcotics|narcotics|mesh-ancestor
110150474|NCT00000220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110150475|NCT00000220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110150476|NCT00000220|Analgesics|analgesics|mesh-ancestor
110150477|NCT00000220|Sensory System Agents|sensory system agents|mesh-ancestor
110150478|NCT00000220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110150479|NCT00000220|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110150480|NCT00000256|Nitrous Oxide|nitrous oxide|mesh-list
110150481|NCT00000256|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110150482|NCT00000256|Anesthetics, General|anesthetics, general|mesh-ancestor
110150483|NCT00000256|Anesthetics|anesthetics|mesh-ancestor
110150484|NCT00000256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110150485|NCT00000256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110150486|NCT00000256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110150488|NCT00000256|Sensory System Agents|sensory system agents|mesh-ancestor
110150489|NCT00000256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110150490|NCT03582085|BCG Vaccine|bcg vaccine|mesh-list
110150491|NCT03582085|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110150492|NCT03582085|Immunologic Factors|immunologic factors|mesh-ancestor
110150493|NCT03582085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110150494|NCT00000421|Prednisone|prednisone|mesh-list
110150495|NCT00000421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110150496|NCT00000421|Glucocorticoids|glucocorticoids|mesh-ancestor
110150497|NCT00000421|Hormones|hormones|mesh-ancestor
110150498|NCT00000421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110150499|NCT00000421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110150500|NCT00000421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110150501|NCT00000421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110150503|NCT00000427|Hormones|hormones|mesh-list
110150504|NCT00000427|Parathyroid Hormone|parathyroid hormone|mesh-list
110150505|NCT00000427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110150506|NCT00000427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110150507|NCT00000427|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110150508|NCT00000427|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110150509|NCT00000457|Bupropion|bupropion|mesh-list
110150510|NCT00000457|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110150511|NCT00000457|Antidepressive Agents|antidepressive agents|mesh-ancestor
110150512|NCT00000457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110150513|NCT00000457|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110150514|NCT00000457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110150515|NCT00000457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110150516|NCT00000457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110150517|NCT00000457|Dopamine Agents|dopamine agents|mesh-ancestor
110150518|NCT00000457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110150519|NCT00000457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110150520|NCT00000457|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110150521|NCT00000457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110150522|NCT00000457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110150523|NCT00388479|Alvimopan|alvimopan|mesh-list
110150524|NCT00388479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110150525|NCT00000463|Warfarin|warfarin|mesh-list
110150526|NCT00000463|Lovastatin|lovastatin|mesh-list
110150527|NCT00000463|L 647318|l 647318|mesh-list
110150528|NCT00000463|Dihydromevinolin|dihydromevinolin|mesh-list
110150529|NCT00000463|Cholestyramine Resin|cholestyramine resin|mesh-list
110150530|NCT00000463|Anticoagulants|anticoagulants|mesh-ancestor
110150531|NCT00000463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110150532|NCT00000463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110150533|NCT00000463|Antimetabolites|antimetabolites|mesh-ancestor
110150534|NCT00000463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110150535|NCT00000463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110150536|NCT00000463|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110150537|NCT00000463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110150538|NCT00000466|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110150539|NCT00000466|Medroxyprogesterone|medroxyprogesterone|mesh-list
110150540|NCT00000466|Progesterone|progesterone|mesh-list
110150541|NCT00000466|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110150542|NCT00000466|Estrogens|estrogens|mesh-list
110150543|NCT00000466|Progestins|progestins|mesh-ancestor
110150544|NCT00000466|Hormones|hormones|mesh-ancestor
110150545|NCT00000466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110150546|NCT00000466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110150547|NCT00000466|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110150548|NCT00000466|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110150549|NCT00000466|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110150550|NCT00000466|Contraceptive Agents|contraceptive agents|mesh-ancestor
110150552|NCT00000466|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110150553|NCT00000466|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110150554|NCT00000466|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110150555|NCT00000466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110150556|NCT00000466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110150557|NCT00000472|Heparin|heparin|mesh-list
110150559|NCT00000472|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110150560|NCT00000472|Anticoagulants|anticoagulants|mesh-ancestor
110150561|NCT00000472|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110150562|NCT00000472|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110150563|NCT00000472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110150564|NCT00000478|Atenolol|atenolol|mesh-list
110150565|NCT00000478|Diltiazem|diltiazem|mesh-list
110150566|NCT00000478|Nifedipine|nifedipine|mesh-list
110150567|NCT00000478|Isosorbide|isosorbide|mesh-list
110150568|NCT00000478|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
110150569|NCT00000478|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
110150570|NCT00000478|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110150571|NCT00000478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110150572|NCT00000478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110150573|NCT00000478|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110150574|NCT00000478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110150576|NCT00000478|Tocolytic Agents|tocolytic agents|mesh-ancestor
110150577|NCT00000478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110150578|NCT00000478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110150579|NCT00000478|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110150580|NCT00000478|Sympatholytics|sympatholytics|mesh-ancestor
110150581|NCT00000478|Autonomic Agents|autonomic agents|mesh-ancestor
110150582|NCT00000478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110150583|NCT00000478|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110150584|NCT00000478|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110150585|NCT00000478|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110150586|NCT00000478|Adrenergic Agents|adrenergic agents|mesh-ancestor
110150587|NCT00000478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110150588|NCT00000478|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110150590|NCT00000478|Natriuretic Agents|natriuretic agents|mesh-ancestor
110150591|NCT00000478|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110150592|NCT00388882|Bromides|bromides|mesh-list
110150593|NCT00388882|Albuterol|albuterol|mesh-list
110150594|NCT00388882|Tiotropium Bromide|tiotropium bromide|mesh-list
110150595|NCT00388882|Ipratropium|ipratropium|mesh-list
110150596|NCT00388882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110150597|NCT00388882|Autonomic Agents|autonomic agents|mesh-ancestor
110150598|NCT00388882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110150599|NCT00388882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110150600|NCT00388882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110150601|NCT00388882|Respiratory System Agents|respiratory system agents|mesh-ancestor
110150602|NCT00388882|Parasympatholytics|parasympatholytics|mesh-ancestor
110150603|NCT00388882|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110150604|NCT00388882|Cholinergic Agents|cholinergic agents|mesh-ancestor
110150605|NCT00388882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110150606|NCT00388882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110150607|NCT00388882|Anticonvulsants|anticonvulsants|mesh-ancestor
110150608|NCT00388882|Tocolytic Agents|tocolytic agents|mesh-ancestor
110150609|NCT00388882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110150610|NCT00388882|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110150611|NCT00388882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110150612|NCT00388882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110150613|NCT00388882|Adrenergic Agents|adrenergic agents|mesh-ancestor
110150614|NCT00388999|Lectins|lectins|mesh-list
110150615|NCT00388999|Agglutinins|agglutinins|mesh-ancestor
110150616|NCT00388999|Immunologic Factors|immunologic factors|mesh-ancestor
110150617|NCT00388999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110150618|NCT00388999|Coagulants|coagulants|mesh-ancestor
110150619|NCT00000487|Antihypertensive Agents|antihypertensive agents|mesh-list
110150620|NCT00000487|Diuretics|diuretics|mesh-list
110150621|NCT00000487|Natriuretic Agents|natriuretic agents|mesh-ancestor
110150622|NCT00000487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110150623|NCT00000493|Propranolol|propranolol|mesh-list
110150624|NCT00000493|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110150625|NCT00000493|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110150626|NCT00000493|Adrenergic Agents|adrenergic agents|mesh-ancestor
110150627|NCT00000493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110150628|NCT00000493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110150629|NCT00000493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110150630|NCT00000493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110150631|NCT00000493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110150632|NCT00000493|Vasodilator Agents|vasodilator agents|mesh-ancestor
110150633|NCT00000499|Metoprolol|metoprolol|mesh-list
110150634|NCT00000499|Chlorthalidone|chlorthalidone|mesh-list
110150635|NCT00000499|Hydralazine|hydralazine|mesh-list
110150636|NCT00000499|Reserpine|reserpine|mesh-list
110150637|NCT00000499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110150638|NCT00000499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110150639|NCT00000499|Sympatholytics|sympatholytics|mesh-ancestor
110150640|NCT00000499|Autonomic Agents|autonomic agents|mesh-ancestor
110150641|NCT00000499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110150642|NCT00000499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110150643|NCT00000499|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110150644|NCT00000499|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110150645|NCT00000499|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110150646|NCT00000499|Adrenergic Agents|adrenergic agents|mesh-ancestor
110150647|NCT00000499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110150648|NCT00000499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110150649|NCT00000499|Diuretics|diuretics|mesh-ancestor
110150650|NCT00000499|Natriuretic Agents|natriuretic agents|mesh-ancestor
110150651|NCT00000499|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110150652|NCT00000499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110150653|NCT00000499|Vasodilator Agents|vasodilator agents|mesh-ancestor
110150654|NCT00000499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110150655|NCT00000499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110150656|NCT00000499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110150657|NCT00000499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110150658|NCT00000499|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110150659|NCT00000499|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110150660|NCT00000514|Atenolol|atenolol|mesh-list
110150661|NCT00000514|Chlorthalidone|chlorthalidone|mesh-list
110150662|NCT00000514|Reserpine|reserpine|mesh-list
110150663|NCT00000514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110150664|NCT00000514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110150665|NCT00000514|Sympatholytics|sympatholytics|mesh-ancestor
110150666|NCT00000514|Autonomic Agents|autonomic agents|mesh-ancestor
110150667|NCT00000514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110150668|NCT00000514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110150669|NCT00000514|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110150670|NCT00000514|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110150671|NCT00000514|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110150672|NCT00000514|Adrenergic Agents|adrenergic agents|mesh-ancestor
110150673|NCT00000514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110150674|NCT00000514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110150675|NCT00000514|Diuretics|diuretics|mesh-ancestor
110150676|NCT00000514|Natriuretic Agents|natriuretic agents|mesh-ancestor
110150677|NCT00000514|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110150678|NCT00000514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110150679|NCT00000514|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110150680|NCT00000514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110150681|NCT00000514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110150682|NCT00000514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110150683|NCT00000514|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110150684|NCT00000514|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110150685|NCT05638425|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110150686|NCT05638425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110150687|NCT05638425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110150688|NCT05638425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110150690|NCT00000517|Anticoagulants|anticoagulants|mesh-ancestor
110150691|NCT00000520|Aspirin|aspirin|mesh-list
110150692|NCT00000520|Immunoglobulins|immunoglobulins|mesh-list
110150693|NCT00000520|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110150694|NCT00000520|Antibodies|antibodies|mesh-list
110150695|NCT00000520|gamma-Globulins|gamma-globulins|mesh-list
110150696|NCT00000520|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110150697|NCT00000520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110150698|NCT00000520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110150699|NCT00000520|Analgesics|analgesics|mesh-ancestor
110150700|NCT00000520|Sensory System Agents|sensory system agents|mesh-ancestor
110150701|NCT00000520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110150702|NCT00000520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110150703|NCT00000520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110150704|NCT00000520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110150705|NCT00000520|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110150706|NCT00000520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110150707|NCT00000520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110150708|NCT00000520|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110150709|NCT00000520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110150710|NCT00000520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110150711|NCT00000520|Antipyretics|antipyretics|mesh-ancestor
110150712|NCT00000520|Immunologic Factors|immunologic factors|mesh-ancestor
110150713|NCT00000526|Flecainide|flecainide|mesh-list
110150714|NCT00000526|Moricizine|moricizine|mesh-list
110150715|NCT00000526|Encainide|encainide|mesh-list
110150716|NCT00000526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110150717|NCT00000526|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110150718|NCT00000526|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110150719|NCT00000526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110150720|NCT00000526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110150721|NCT00000529|Tamoxifen|tamoxifen|mesh-list
110150722|NCT00000529|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110150723|NCT00000529|Hormone Antagonists|hormone antagonists|mesh-ancestor
110150724|NCT00000529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110150725|NCT00000529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110150726|NCT00000529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110150727|NCT00000529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110150728|NCT00000529|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110150729|NCT00000529|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110150730|NCT00000529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110150732|NCT00000553|Simvastatin|simvastatin|mesh-list
110150733|NCT00000553|Antioxidants|antioxidants|mesh-list
110150734|NCT00000553|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110150735|NCT00000553|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110150736|NCT00000553|Antimetabolites|antimetabolites|mesh-ancestor
110150737|NCT00000553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110150738|NCT00000553|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110150739|NCT00000553|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110150740|NCT00000553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110150741|NCT00000553|Vasodilator Agents|vasodilator agents|mesh-ancestor
110150742|NCT00000553|Vitamin B Complex|vitamin b complex|mesh-ancestor
110150743|NCT00000553|Vitamins|vitamins|mesh-ancestor
110150744|NCT00000553|Micronutrients|micronutrients|mesh-ancestor
110150745|NCT00000553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110150746|NCT00000553|Protective Agents|protective agents|mesh-ancestor
110150747|NCT00000556|Quinidine|quinidine|mesh-list
110150748|NCT00000556|Digoxin|digoxin|mesh-list
110150749|NCT00000556|Amiodarone|amiodarone|mesh-list
110150750|NCT00000556|Verapamil|verapamil|mesh-list
110150751|NCT00000556|Sotalol|sotalol|mesh-list
110150752|NCT00000556|Flecainide|flecainide|mesh-list
110150753|NCT00000556|Propafenone|propafenone|mesh-list
110150754|NCT00000556|Procainamide|procainamide|mesh-list
110150755|NCT00000556|Moricizine|moricizine|mesh-list
110150756|NCT00000556|Disopyramide|disopyramide|mesh-list
110150757|NCT00000556|Diltiazem|diltiazem|mesh-list
110150758|NCT00000556|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110150759|NCT00000556|Adrenergic Agents|adrenergic agents|mesh-list
110150760|NCT00000556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110150761|NCT00000556|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110150762|NCT00000556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110150763|NCT00000556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110150764|NCT00000556|Protective Agents|protective agents|mesh-ancestor
110150765|NCT00000556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110150766|NCT00000556|Vasodilator Agents|vasodilator agents|mesh-ancestor
110150767|NCT00000556|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110150768|NCT00000556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110150769|NCT00000556|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110150770|NCT00000556|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110150771|NCT00000556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110150772|NCT00000556|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110186783|NCT04857684|Growth Inhibitors|growth inhibitors|mesh-ancestor
110150773|NCT00000556|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110150774|NCT00000556|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110150775|NCT00000556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110150776|NCT00000556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110150777|NCT00000556|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110150778|NCT00000556|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110150779|NCT00000556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110150780|NCT00000556|Sympatholytics|sympatholytics|mesh-ancestor
110150781|NCT00000556|Autonomic Agents|autonomic agents|mesh-ancestor
110150782|NCT00000556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110150783|NCT00000556|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110150784|NCT00000556|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110150785|NCT00000556|Antimalarials|antimalarials|mesh-ancestor
110150786|NCT00000556|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110150787|NCT00000556|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110150788|NCT00000556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110150789|NCT00000556|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110150790|NCT00000556|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110150791|NCT00000556|Cholinergic Agents|cholinergic agents|mesh-ancestor
110150792|NCT00000559|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110150793|NCT00000559|Medroxyprogesterone|medroxyprogesterone|mesh-list
110150795|NCT00000559|Estradiol|estradiol|mesh-list
110150796|NCT00000559|Estrogens|estrogens|mesh-list
110150797|NCT00000559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110150798|NCT00000559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110150799|NCT00000559|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110150800|NCT00000559|Contraceptive Agents|contraceptive agents|mesh-ancestor
110150801|NCT00000559|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110150802|NCT00000559|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110150803|NCT00000559|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110150804|NCT00000559|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110150805|NCT00000559|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110150806|NCT00000559|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110150807|NCT00000559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110150808|NCT00000559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110150809|NCT00000568|Ipratropium|ipratropium|mesh-list
110150810|NCT00000568|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110150811|NCT00000568|Autonomic Agents|autonomic agents|mesh-ancestor
110150812|NCT00000568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110150813|NCT00000568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110150814|NCT00000568|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110150815|NCT00000568|Respiratory System Agents|respiratory system agents|mesh-ancestor
110150816|NCT00000568|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110150817|NCT00000568|Cholinergic Agents|cholinergic agents|mesh-ancestor
110150818|NCT00000568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110150819|NCT00000568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110150820|NCT00000586|Hydroxyurea|hydroxyurea|mesh-list
110150821|NCT00000586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110150822|NCT00000586|Antisickling Agents|antisickling agents|mesh-ancestor
110150823|NCT00000586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110150824|NCT00000586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110150825|NCT00000586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110150826|NCT00000595|Deferoxamine|deferoxamine|mesh-list
110150827|NCT00000595|Siderophores|siderophores|mesh-ancestor
110150828|NCT00000595|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110150829|NCT00000595|Chelating Agents|chelating agents|mesh-ancestor
110150830|NCT00000595|Sequestering Agents|sequestering agents|mesh-ancestor
110150831|NCT00000595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110150832|NCT00000601|Hormones|hormones|mesh-list
110150833|NCT00000601|Progesterone|progesterone|mesh-list
110150834|NCT00000601|Estrogens|estrogens|mesh-list
110150835|NCT00000601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110150836|NCT00000601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110150837|NCT00000601|Progestins|progestins|mesh-ancestor
110150838|NCT00000625|Zidovudine|zidovudine|mesh-list
110150839|NCT00000625|Didanosine|didanosine|mesh-list
110150840|NCT00000625|Zalcitabine|zalcitabine|mesh-list
110150841|NCT00000625|Antimetabolites|antimetabolites|mesh-ancestor
110150842|NCT00000625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110150843|NCT00000625|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110150844|NCT00000625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110150845|NCT00000625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110150846|NCT00000625|Antiviral Agents|antiviral agents|mesh-ancestor
110150847|NCT00000625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110150848|NCT00000625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110150849|NCT00000625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110150850|NCT00000637|Zidovudine|zidovudine|mesh-list
110150851|NCT00000637|Didanosine|didanosine|mesh-list
110150853|NCT00000637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110150854|NCT00000637|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110150855|NCT00000637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110150856|NCT00000637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110150857|NCT00000637|Antiviral Agents|antiviral agents|mesh-ancestor
110150858|NCT00000637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110150860|NCT00000637|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110150861|NCT00000640|Clindamycin|clindamycin|mesh-list
110150862|NCT00000640|Clindamycin palmitate|clindamycin palmitate|mesh-list
110150863|NCT00000640|Clindamycin phosphate|clindamycin phosphate|mesh-list
110150864|NCT00000640|Dapsone|dapsone|mesh-list
110150865|NCT00000640|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110150866|NCT00000640|Primaquine|primaquine|mesh-list
110150867|NCT00000640|Trimethoprim|trimethoprim|mesh-list
110150868|NCT00000640|Sulfamethoxazole|sulfamethoxazole|mesh-list
110150869|NCT00000640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110150870|NCT00000640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110150871|NCT00000640|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110150872|NCT00000640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110150873|NCT00000640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110150874|NCT00000640|Antimalarials|antimalarials|mesh-ancestor
110150875|NCT00000640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110150876|NCT00000640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110150877|NCT00000640|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110150878|NCT00000640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110150879|NCT00000640|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110150880|NCT00000640|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110150881|NCT00000640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110150882|NCT00000640|Leprostatic Agents|leprostatic agents|mesh-ancestor
110150883|NCT00000646|Pentoxifylline|pentoxifylline|mesh-list
110150884|NCT00000646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110150885|NCT00000646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110150886|NCT00000646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110150887|NCT00000646|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110150888|NCT00000646|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110150890|NCT00000646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110150892|NCT00000646|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110150893|NCT00000646|Antioxidants|antioxidants|mesh-ancestor
110150894|NCT00389038|Amitriptyline|amitriptyline|mesh-list
110150895|NCT00389038|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110150897|NCT00389038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110150898|NCT00389038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110150899|NCT00389038|Analgesics|analgesics|mesh-ancestor
110150900|NCT00389038|Sensory System Agents|sensory system agents|mesh-ancestor
110150901|NCT00389038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110150902|NCT00389038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110150903|NCT00389038|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110150904|NCT00389038|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110150905|NCT00389038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110150906|NCT00389038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110150907|NCT00389038|Adrenergic Agents|adrenergic agents|mesh-ancestor
110150908|NCT00389038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110150909|NCT00000652|Zidovudine|zidovudine|mesh-list
110150910|NCT00000652|Didanosine|didanosine|mesh-list
110150911|NCT00000652|Antimetabolites|antimetabolites|mesh-ancestor
110150912|NCT00000652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110150913|NCT00000652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110150914|NCT00000652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110150915|NCT00000652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110150916|NCT00000652|Antiviral Agents|antiviral agents|mesh-ancestor
110150917|NCT00000652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110150918|NCT00000652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110150919|NCT00000652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110150920|NCT00000676|Fluconazole|fluconazole|mesh-list
110150922|NCT00000676|Miconazole|miconazole|mesh-list
110150923|NCT00000676|Antifungal Agents|antifungal agents|mesh-ancestor
110150924|NCT00000676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110150925|NCT00000676|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110150926|NCT00000676|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110150927|NCT00000676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110150928|NCT00000676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110150929|NCT00000676|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110150930|NCT00000676|Hormone Antagonists|hormone antagonists|mesh-ancestor
110191429|NCT00027911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110150931|NCT00000676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110150932|NCT00000676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110150933|NCT00000676|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110150934|NCT00000676|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110150935|NCT00000676|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110150936|NCT00000676|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110150937|NCT00000679|Zidovudine|zidovudine|mesh-list
110150938|NCT00000679|Zalcitabine|zalcitabine|mesh-list
110150939|NCT00000679|Antimetabolites|antimetabolites|mesh-ancestor
110150940|NCT00000679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110150941|NCT00000679|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110150942|NCT00000679|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110150944|NCT00000679|Antiviral Agents|antiviral agents|mesh-ancestor
110150945|NCT00000679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110150946|NCT00000679|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110150947|NCT00000679|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110150948|NCT00000682|Zidovudine|zidovudine|mesh-list
110150949|NCT00000682|Zalcitabine|zalcitabine|mesh-list
110150950|NCT00000682|Antimetabolites|antimetabolites|mesh-ancestor
110150951|NCT00000682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110150952|NCT00000682|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110150953|NCT00000682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110150954|NCT00000682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110150955|NCT00000682|Antiviral Agents|antiviral agents|mesh-ancestor
110150956|NCT00000682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110150957|NCT00000682|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110150958|NCT00000682|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110150959|NCT00000688|Ganciclovir|ganciclovir|mesh-list
110150960|NCT00000688|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
110150961|NCT00000688|Antiviral Agents|antiviral agents|mesh-ancestor
110150962|NCT00000688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110150963|NCT00000688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110150964|NCT00000688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110150965|NCT00000688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110150966|NCT00000712|Zidovudine|zidovudine|mesh-list
110150967|NCT00000712|Acyclovir|acyclovir|mesh-list
110150968|NCT00000712|Antimetabolites|antimetabolites|mesh-ancestor
110150969|NCT00000712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110150970|NCT00000712|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110150971|NCT00000712|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110150972|NCT00000712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110150973|NCT00000712|Antiviral Agents|antiviral agents|mesh-ancestor
110150974|NCT00000712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110150975|NCT00000712|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110150976|NCT00000712|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110150978|NCT00000715|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110150979|NCT00000715|Sulfamethoxazole|sulfamethoxazole|mesh-list
110150980|NCT00000715|Pentamidine|pentamidine|mesh-list
110150981|NCT00000715|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110150982|NCT00000715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110150983|NCT00000715|Antimalarials|antimalarials|mesh-ancestor
110150984|NCT00000715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110150985|NCT00000715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110150986|NCT00000715|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110150987|NCT00000715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110150988|NCT00000715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110150989|NCT00000715|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110150990|NCT00000715|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110150991|NCT00000715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110150992|NCT00000715|Antifungal Agents|antifungal agents|mesh-ancestor
110150993|NCT00000715|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110150994|NCT00000715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110150996|NCT00000718|Zalcitabine|zalcitabine|mesh-list
110150997|NCT00000718|Antimetabolites|antimetabolites|mesh-ancestor
110150998|NCT00000718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110150999|NCT00000718|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110151000|NCT00000718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110151001|NCT00000718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110151002|NCT00000718|Antiviral Agents|antiviral agents|mesh-ancestor
110151003|NCT00000718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110151004|NCT00000718|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110151005|NCT00000718|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110151006|NCT00000739|Dapsone|dapsone|mesh-list
110151007|NCT00000739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110151008|NCT00000739|Antimalarials|antimalarials|mesh-ancestor
110151009|NCT00000739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110151010|NCT00000739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110151011|NCT00000739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110151012|NCT00000739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110151013|NCT00000739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110151014|NCT00000739|Leprostatic Agents|leprostatic agents|mesh-ancestor
110151015|NCT00000739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110151016|NCT00000742|Zidovudine|zidovudine|mesh-list
110151017|NCT00000742|Didanosine|didanosine|mesh-list
110151018|NCT00000742|Atevirdine|atevirdine|mesh-list
110151019|NCT00000742|Antimetabolites|antimetabolites|mesh-ancestor
110151020|NCT00000742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110151021|NCT00000742|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110151022|NCT00000742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110151023|NCT00000742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110151024|NCT00000742|Antiviral Agents|antiviral agents|mesh-ancestor
110191430|NCT00027989|Gemcitabine|gemcitabine|mesh-list
110151025|NCT00000742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110151026|NCT00000742|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110151027|NCT00000742|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110151028|NCT00000745|Vaccines|vaccines|mesh-list
110151029|NCT00000745|Immunologic Factors|immunologic factors|mesh-ancestor
110151030|NCT00000745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110151031|NCT00000748|Trimethoprim|trimethoprim|mesh-list
110151032|NCT00000748|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110151033|NCT00000748|Sulfamethoxazole|sulfamethoxazole|mesh-list
110151034|NCT00000748|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110151035|NCT00000748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110151036|NCT00000748|Antimalarials|antimalarials|mesh-ancestor
110151037|NCT00000748|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110151038|NCT00000748|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110151039|NCT00000748|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110151040|NCT00000748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110186803|NCT04846348|Antiemetics|antiemetics|mesh-ancestor
110151041|NCT00000748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110151042|NCT00000748|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110151043|NCT00000748|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110151044|NCT00000748|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110151045|NCT00000748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110151046|NCT00000751|Zidovudine|zidovudine|mesh-list
110151047|NCT00000751|Immune Sera|immune sera|mesh-list
110151048|NCT00000751|Immunoglobulins|immunoglobulins|mesh-list
110151049|NCT00000751|Antibodies|antibodies|mesh-list
110151050|NCT00000751|Antimetabolites|antimetabolites|mesh-ancestor
110151051|NCT00000751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110151052|NCT00000751|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110151053|NCT00000751|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110151054|NCT00000751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110151055|NCT00000751|Antiviral Agents|antiviral agents|mesh-ancestor
110151056|NCT00000751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110151057|NCT00000751|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110151058|NCT00000751|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110151059|NCT00000751|Immunologic Factors|immunologic factors|mesh-ancestor
110151060|NCT00000751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110151061|NCT00000754|Interferons|interferons|mesh-list
110151062|NCT00000754|Interferon-alpha|interferon-alpha|mesh-list
110151063|NCT00000754|Interferon alpha-2|interferon alpha-2|mesh-list
110151064|NCT00000754|Zidovudine|zidovudine|mesh-list
110151065|NCT00000754|Zalcitabine|zalcitabine|mesh-list
110151066|NCT00000754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110151067|NCT00000754|Antiviral Agents|antiviral agents|mesh-ancestor
110151068|NCT00000754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110151069|NCT00000754|Immunologic Factors|immunologic factors|mesh-ancestor
110151070|NCT00000754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110151071|NCT00000754|Antimetabolites|antimetabolites|mesh-ancestor
110151072|NCT00000754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110151073|NCT00000754|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110151074|NCT00000754|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110151075|NCT00000754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110151076|NCT00000754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110151077|NCT00000754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110151078|NCT00000760|Zidovudine|zidovudine|mesh-list
110151079|NCT00000760|Didanosine|didanosine|mesh-list
110151080|NCT00000760|Antimetabolites|antimetabolites|mesh-ancestor
110151081|NCT00000760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110151082|NCT00000760|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110151083|NCT00000760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110151085|NCT00000760|Antiviral Agents|antiviral agents|mesh-ancestor
110151086|NCT00000760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110151087|NCT00000760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110151088|NCT00000760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110151089|NCT00000790|Thalidomide|thalidomide|mesh-list
110151090|NCT00000790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110151091|NCT00000790|Immunologic Factors|immunologic factors|mesh-ancestor
110151092|NCT00000790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110151093|NCT00000790|Leprostatic Agents|leprostatic agents|mesh-ancestor
110151094|NCT00000790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110151095|NCT00000790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110151096|NCT00000790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110151097|NCT00000790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110151098|NCT00000790|Growth Substances|growth substances|mesh-ancestor
110151099|NCT00000790|Growth Inhibitors|growth inhibitors|mesh-ancestor
110151100|NCT00000790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110151101|NCT00000793|Mexiletine|mexiletine|mesh-list
110151102|NCT00000793|Amitriptyline|amitriptyline|mesh-list
110151103|NCT00000793|Benztropine|benztropine|mesh-list
110151104|NCT00000793|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110151105|NCT00000793|Antidepressive Agents|antidepressive agents|mesh-ancestor
110151106|NCT00000793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110151107|NCT00000793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110151108|NCT00000793|Analgesics|analgesics|mesh-ancestor
110151109|NCT00000793|Sensory System Agents|sensory system agents|mesh-ancestor
110151110|NCT00000793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110151111|NCT00000793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110151112|NCT00000793|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110151113|NCT00000793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110151114|NCT00000793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110151115|NCT00000793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110151116|NCT00000793|Adrenergic Agents|adrenergic agents|mesh-ancestor
110151117|NCT00000793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110151118|NCT00000793|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110151119|NCT00000793|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110151120|NCT00000793|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110151121|NCT00000793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110151122|NCT00000793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110151123|NCT00000793|Parasympatholytics|parasympatholytics|mesh-ancestor
110151124|NCT00000793|Autonomic Agents|autonomic agents|mesh-ancestor
110151125|NCT00000793|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110151126|NCT00000793|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110151127|NCT00000793|Cholinergic Agents|cholinergic agents|mesh-ancestor
110151128|NCT00000793|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110151129|NCT00000793|Dopamine Agents|dopamine agents|mesh-ancestor
110151132|NCT00000799|Uricosuric Agents|uricosuric agents|mesh-ancestor
110151133|NCT00000799|Gout Suppressants|gout suppressants|mesh-ancestor
110151134|NCT00000799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110151135|NCT00000799|Antiviral Agents|antiviral agents|mesh-ancestor
110151136|NCT00000799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110151137|NCT00000799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110151138|NCT00000799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110151139|NCT00000817|Amitriptyline|amitriptyline|mesh-list
110151140|NCT00000817|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110151141|NCT00000817|Antidepressive Agents|antidepressive agents|mesh-ancestor
110151142|NCT00000817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110151143|NCT00000817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110151144|NCT00000817|Analgesics|analgesics|mesh-ancestor
110151145|NCT00000817|Sensory System Agents|sensory system agents|mesh-ancestor
110151146|NCT00000817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110151147|NCT00000817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110151148|NCT00000817|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110151149|NCT00000817|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110151150|NCT00000817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110151151|NCT00000817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110151152|NCT00000817|Adrenergic Agents|adrenergic agents|mesh-ancestor
110151153|NCT00000817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110151154|NCT00000820|Aldesleukin|aldesleukin|mesh-list
110151155|NCT00000820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110151156|NCT00000820|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110151157|NCT00000820|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110151158|NCT00000820|Antiviral Agents|antiviral agents|mesh-ancestor
110151159|NCT00000820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110151160|NCT00000826|Clarithromycin|clarithromycin|mesh-list
110151161|NCT00000826|Dapsone|dapsone|mesh-list
110151162|NCT00000826|Rifabutin|rifabutin|mesh-list
110151163|NCT00000826|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110151164|NCT00000826|Fluconazole|fluconazole|mesh-list
110151165|NCT00000826|Trimethoprim|trimethoprim|mesh-list
110151166|NCT00000826|Sulfamethoxazole|sulfamethoxazole|mesh-list
110151167|NCT00000826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110151168|NCT00000826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110151169|NCT00000826|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110151170|NCT00000826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110151171|NCT00000826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110151172|NCT00000826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110151173|NCT00000826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110151174|NCT00000826|Antifungal Agents|antifungal agents|mesh-ancestor
110151175|NCT00000826|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110151176|NCT00000826|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110151178|NCT00000826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110151179|NCT00000826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110151180|NCT00000826|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110186816|NCT04846348|Analgesics|analgesics|mesh-ancestor
110151181|NCT00000826|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110151182|NCT00000826|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110151183|NCT00000826|Antimalarials|antimalarials|mesh-ancestor
110151184|NCT00000826|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110151185|NCT00000826|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110151186|NCT00000826|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110151187|NCT00000826|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110151188|NCT00000826|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110151189|NCT00000826|Leprostatic Agents|leprostatic agents|mesh-ancestor
110151190|NCT00000826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110151191|NCT00000826|Antitubercular Agents|antitubercular agents|mesh-ancestor
110151192|NCT00000859|Ritonavir|ritonavir|mesh-list
110151193|NCT00000859|Nelfinavir|nelfinavir|mesh-list
110151194|NCT00000859|Indinavir|indinavir|mesh-list
110151195|NCT00000859|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110151196|NCT00000859|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110151197|NCT00000859|Protease Inhibitors|protease inhibitors|mesh-ancestor
110151198|NCT00000859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110151199|NCT00000859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110151200|NCT00000859|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110151201|NCT00000859|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110151202|NCT00000859|Antiviral Agents|antiviral agents|mesh-ancestor
110151203|NCT00000859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110151204|NCT00000859|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110151205|NCT00000859|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110151206|NCT00000877|Indinavir|indinavir|mesh-list
110151207|NCT00000877|Rifabutin|rifabutin|mesh-list
110151208|NCT00000877|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110151209|NCT00000877|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110151210|NCT00000877|Protease Inhibitors|protease inhibitors|mesh-ancestor
110151211|NCT00000877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110151212|NCT00000877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110151213|NCT00000877|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110151214|NCT00000877|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110151215|NCT00000877|Antiviral Agents|antiviral agents|mesh-ancestor
110151216|NCT00000877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110151217|NCT00000877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110151218|NCT00000877|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110151219|NCT00000877|Antitubercular Agents|antitubercular agents|mesh-ancestor
110151220|NCT00000883|Azithromycin|azithromycin|mesh-list
110151221|NCT00000883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110151222|NCT00000883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110151223|NCT00000892|Ritonavir|ritonavir|mesh-list
110151224|NCT00000892|Nelfinavir|nelfinavir|mesh-list
110151225|NCT00000892|Saquinavir|saquinavir|mesh-list
110151226|NCT00000892|Delavirdine|delavirdine|mesh-list
110151227|NCT00000892|Adefovir|adefovir|mesh-list
110151228|NCT00000892|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
110151229|NCT00000892|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110151230|NCT00000892|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110151231|NCT00000892|Protease Inhibitors|protease inhibitors|mesh-ancestor
110151232|NCT00000892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110151233|NCT00000892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110151234|NCT00000892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110151235|NCT00000892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110151236|NCT00000892|Antiviral Agents|antiviral agents|mesh-ancestor
110151237|NCT00000892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110191431|NCT00027989|Doxorubicin|doxorubicin|mesh-list
110151239|NCT00000892|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110191432|NCT00027989|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110151240|NCT00000892|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110151241|NCT00000892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110151243|NCT00000895|Nevirapine|nevirapine|mesh-list
110151244|NCT00000895|Nelfinavir|nelfinavir|mesh-list
110151245|NCT00000895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110151246|NCT00000895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110151247|NCT00000895|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110151248|NCT00000895|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110151249|NCT00000895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110151250|NCT00000895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110151251|NCT00000895|Antiviral Agents|antiviral agents|mesh-ancestor
110151252|NCT00000895|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110151253|NCT00000895|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110151254|NCT00000895|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110151255|NCT00000895|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110151256|NCT00000895|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110151257|NCT00000895|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110151258|NCT00000895|Protease Inhibitors|protease inhibitors|mesh-ancestor
110151259|NCT00000898|Ritonavir|ritonavir|mesh-list
110151260|NCT00000898|Nelfinavir|nelfinavir|mesh-list
110151261|NCT00000898|Saquinavir|saquinavir|mesh-list
110151262|NCT00000898|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110151263|NCT00000898|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110151264|NCT00000898|Protease Inhibitors|protease inhibitors|mesh-ancestor
110151265|NCT00000898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110151266|NCT00000898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110151267|NCT00000898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110151268|NCT00000898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110151269|NCT00000898|Antiviral Agents|antiviral agents|mesh-ancestor
110151270|NCT00000898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110151271|NCT00000898|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110151272|NCT00000898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110151273|NCT00389233|Ascorbic Acid|ascorbic acid|mesh-list
110151274|NCT00389233|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
110151275|NCT00389233|Antioxidants|antioxidants|mesh-ancestor
110151276|NCT00389233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110151277|NCT00389233|Protective Agents|protective agents|mesh-ancestor
110151278|NCT00389233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110151279|NCT00389233|Vitamins|vitamins|mesh-ancestor
110151280|NCT00389233|Micronutrients|micronutrients|mesh-ancestor
110151281|NCT00389233|Laxatives|laxatives|mesh-ancestor
110151282|NCT00389233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110151283|NCT00000904|polysaccharide-K|polysaccharide-k|mesh-list
110151284|NCT00000904|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110151285|NCT00000904|Immunologic Factors|immunologic factors|mesh-ancestor
110151286|NCT00000904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110151287|NCT00000904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110151288|NCT00000904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110151289|NCT00000904|Antiviral Agents|antiviral agents|mesh-ancestor
110151290|NCT00000904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110151291|NCT00000904|Interferon Inducers|interferon inducers|mesh-ancestor
110151292|NCT00000904|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110151293|NCT00000904|Protective Agents|protective agents|mesh-ancestor
110151295|NCT00000919|Nelfinavir|nelfinavir|mesh-list
110151296|NCT00000919|Indinavir|indinavir|mesh-list
110151297|NCT00000919|Amprenavir|amprenavir|mesh-list
110151298|NCT00000919|Lamivudine|lamivudine|mesh-list
110151299|NCT00000919|Zidovudine|zidovudine|mesh-list
110151300|NCT00000919|Abacavir|abacavir|mesh-list
110151301|NCT00000919|Stavudine|stavudine|mesh-list
110151302|NCT00000919|Didanosine|didanosine|mesh-list
110151303|NCT00000919|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
110151304|NCT00000919|Efavirenz|efavirenz|mesh-list
110151305|NCT00000919|Hydroxyurea|hydroxyurea|mesh-list
110151306|NCT00000919|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110151307|NCT00000919|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110151308|NCT00000919|Protease Inhibitors|protease inhibitors|mesh-ancestor
110151309|NCT00000919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110151310|NCT00000919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110151311|NCT00000919|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110151312|NCT00000919|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110151313|NCT00000919|Antiviral Agents|antiviral agents|mesh-ancestor
110151314|NCT00000919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110151315|NCT00000919|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110151316|NCT00000919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110151317|NCT00000919|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110151318|NCT00000919|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110151319|NCT00000919|Antimetabolites|antimetabolites|mesh-ancestor
110151320|NCT00000919|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110151321|NCT00000919|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110151322|NCT00000919|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110151323|NCT00000919|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110151324|NCT00000919|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110151325|NCT00000919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110151326|NCT00000919|Antisickling Agents|antisickling agents|mesh-ancestor
110151327|NCT00000919|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110151328|NCT00000919|Antitubercular Agents|antitubercular agents|mesh-ancestor
110151329|NCT00000919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110151331|NCT00000922|Efavirenz|efavirenz|mesh-list
110151332|NCT00000922|Nevirapine|nevirapine|mesh-list
110151333|NCT00000922|Abacavir|abacavir|mesh-list
110151334|NCT00000922|Stavudine|stavudine|mesh-list
110151335|NCT00000922|Didanosine|didanosine|mesh-list
110151336|NCT00000922|Nelfinavir|nelfinavir|mesh-list
110151337|NCT00000922|Indinavir|indinavir|mesh-list
110151338|NCT00000922|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110151339|NCT00000922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110151340|NCT00000922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110151341|NCT00000922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110151342|NCT00000922|Antiviral Agents|antiviral agents|mesh-ancestor
110151343|NCT00000922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110151344|NCT00000922|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110151345|NCT00000922|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110151346|NCT00000922|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110151347|NCT00000922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110151348|NCT00000922|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110151349|NCT00000922|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110151350|NCT00000922|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110151351|NCT00000922|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110151352|NCT00000922|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110151353|NCT00000922|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110151354|NCT00000922|Protease Inhibitors|protease inhibitors|mesh-ancestor
110151355|NCT00000922|Antimetabolites|antimetabolites|mesh-ancestor
110151356|NCT00000940|Ritonavir|ritonavir|mesh-list
110151357|NCT00000940|Amprenavir|amprenavir|mesh-list
110151360|NCT00000940|Stavudine|stavudine|mesh-list
110151361|NCT00000940|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110151362|NCT00000940|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110151363|NCT00000940|Protease Inhibitors|protease inhibitors|mesh-ancestor
110151364|NCT00000940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110151365|NCT00000940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110151366|NCT00000940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110151367|NCT00000940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110151368|NCT00000940|Antiviral Agents|antiviral agents|mesh-ancestor
110151369|NCT00000940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110151370|NCT00000940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110151371|NCT00000940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110151372|NCT00000940|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110151373|NCT00000940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110151374|NCT00000940|Antimetabolites|antimetabolites|mesh-ancestor
110151375|NCT00000940|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110151376|NCT00000940|Antitubercular Agents|antitubercular agents|mesh-ancestor
110151377|NCT00000940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110151379|NCT00000943|Immunologic Factors|immunologic factors|mesh-ancestor
110151380|NCT00000943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110151381|NCT00000952|Ritonavir|ritonavir|mesh-list
110151382|NCT00000952|Lamivudine|lamivudine|mesh-list
110151383|NCT00000952|Zidovudine|zidovudine|mesh-list
110151384|NCT00000952|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110151385|NCT00000952|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110151386|NCT00000952|Protease Inhibitors|protease inhibitors|mesh-ancestor
110151387|NCT00000952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110151388|NCT00000952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110151389|NCT00000952|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110151390|NCT00000952|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110151391|NCT00000952|Antiviral Agents|antiviral agents|mesh-ancestor
110151392|NCT00000952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110151393|NCT00000952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110151394|NCT00000952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110151395|NCT00000952|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110151396|NCT00000952|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110151397|NCT00000952|Antimetabolites|antimetabolites|mesh-ancestor
110151398|NCT00000643|Leucovorin|leucovorin|mesh-list
110151399|NCT00000643|Pyrimethamine|pyrimethamine|mesh-list
110151400|NCT00000643|Calcium|calcium|mesh-list
110151401|NCT00000643|Levoleucovorin|levoleucovorin|mesh-list
110151402|NCT00000643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110151403|NCT00000643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110151404|NCT00000643|Antidotes|antidotes|mesh-ancestor
110151405|NCT00000643|Protective Agents|protective agents|mesh-ancestor
110151406|NCT00000643|Vitamin B Complex|vitamin b complex|mesh-ancestor
110151407|NCT00000643|Vitamins|vitamins|mesh-ancestor
110151408|NCT00000643|Micronutrients|micronutrients|mesh-ancestor
110151409|NCT00000643|Antimalarials|antimalarials|mesh-ancestor
110151410|NCT00000643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110151411|NCT00000643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110151412|NCT00000643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110151413|NCT00000643|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110151414|NCT00000643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110151415|NCT00000643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110151416|NCT00000970|Ganciclovir|ganciclovir|mesh-list
110151417|NCT00000970|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
110151419|NCT00000970|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
110151420|NCT00000970|Antiviral Agents|antiviral agents|mesh-ancestor
110151421|NCT00000970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110151422|NCT00000970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110151423|NCT00000970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110151424|NCT00000970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110151425|NCT00000970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110151427|NCT00000973|Zidovudine|zidovudine|mesh-list
110151428|NCT00000973|Pyrimethamine|pyrimethamine|mesh-list
110151429|NCT00000973|Calcium|calcium|mesh-list
110151430|NCT00000973|Levoleucovorin|levoleucovorin|mesh-list
110151431|NCT00000973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110151432|NCT00000973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110151433|NCT00000973|Antidotes|antidotes|mesh-ancestor
110151434|NCT00000973|Protective Agents|protective agents|mesh-ancestor
110151435|NCT00000973|Vitamin B Complex|vitamin b complex|mesh-ancestor
110151436|NCT00000973|Vitamins|vitamins|mesh-ancestor
110151437|NCT00000973|Micronutrients|micronutrients|mesh-ancestor
110151438|NCT00000973|Antimetabolites|antimetabolites|mesh-ancestor
110151439|NCT00000973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110151440|NCT00000973|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110151441|NCT00000973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110151442|NCT00000973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110151443|NCT00000973|Antiviral Agents|antiviral agents|mesh-ancestor
110151444|NCT00000973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110151445|NCT00000973|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110151446|NCT00000973|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110151447|NCT00000973|Antimalarials|antimalarials|mesh-ancestor
110151448|NCT00000973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110151449|NCT00000973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110151450|NCT00000973|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110151452|NCT00000985|Foscarnet|foscarnet|mesh-list
110151453|NCT00000985|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
110151454|NCT00000985|Vidarabine|vidarabine|mesh-list
110151455|NCT00000985|Antiviral Agents|antiviral agents|mesh-ancestor
110151456|NCT00000985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110151457|NCT00000985|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110151458|NCT00000985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110151459|NCT00000985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110151460|NCT00000985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110151461|NCT00000985|Antimetabolites|antimetabolites|mesh-ancestor
110151462|NCT00001000|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
110151463|NCT00001000|Antiviral Agents|antiviral agents|mesh-ancestor
110151464|NCT00001000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110151465|NCT00001003|Zidovudine|zidovudine|mesh-list
110151466|NCT00001003|Pentamidine|pentamidine|mesh-list
110151467|NCT00001003|Antimetabolites|antimetabolites|mesh-ancestor
110151468|NCT00001003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110151469|NCT00001003|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110151470|NCT00001003|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110151471|NCT00001003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110151472|NCT00001003|Antiviral Agents|antiviral agents|mesh-ancestor
110151473|NCT00001003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110151474|NCT00001003|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110151475|NCT00001003|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110151476|NCT00001003|Antifungal Agents|antifungal agents|mesh-ancestor
110151477|NCT00001003|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110151478|NCT00001003|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110151479|NCT00001003|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110151480|NCT00001030|Clarithromycin|clarithromycin|mesh-list
110151481|NCT00001030|Rifabutin|rifabutin|mesh-list
110151482|NCT00001030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110151483|NCT00001030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110151484|NCT00001030|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110151485|NCT00001030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110151486|NCT00001030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110151487|NCT00001030|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110151488|NCT00001030|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110151489|NCT00001030|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110151490|NCT00001030|Antitubercular Agents|antitubercular agents|mesh-ancestor
110151491|NCT05639127|Prednisolone|prednisolone|mesh-list
110151493|NCT05639127|Glucocorticoids|glucocorticoids|mesh-ancestor
110151494|NCT05639127|Hormones|hormones|mesh-ancestor
110151495|NCT05639127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110151496|NCT05639127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110151497|NCT05639127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110151498|NCT05639127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110151499|NCT00001033|Pyridoxine|pyridoxine|mesh-list
110151500|NCT00001033|Vitamin B 6|vitamin b 6|mesh-list
110151501|NCT00001033|Levofloxacin|levofloxacin|mesh-list
110151502|NCT00001033|Rifampin|rifampin|mesh-list
110151503|NCT00001033|Isoniazid|isoniazid|mesh-list
110151504|NCT00001033|Pyrazinamide|pyrazinamide|mesh-list
110151505|NCT00001033|Ethambutol|ethambutol|mesh-list
110151506|NCT00001033|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110151507|NCT00001033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110151508|NCT00001033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110151509|NCT00001033|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110151510|NCT00001033|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110151511|NCT00001033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110151512|NCT00001033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110151513|NCT00001033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110151514|NCT00001033|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110151515|NCT00001033|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110151516|NCT00001033|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110151517|NCT00001033|Antitubercular Agents|antitubercular agents|mesh-ancestor
110151518|NCT00001033|Leprostatic Agents|leprostatic agents|mesh-ancestor
110151519|NCT00001033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110151520|NCT00001033|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110151522|NCT00001033|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110151523|NCT00001033|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110151524|NCT00001033|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110151525|NCT00001033|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110151526|NCT00001033|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110151527|NCT00001033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110151528|NCT00001033|Antimetabolites|antimetabolites|mesh-ancestor
110151529|NCT00001033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110151530|NCT00001033|Vitamin B Complex|vitamin b complex|mesh-ancestor
110151531|NCT00001033|Vitamins|vitamins|mesh-ancestor
110151532|NCT00001033|Micronutrients|micronutrients|mesh-ancestor
110186848|NCT04765709|Vinorelbine|vinorelbine|mesh-list
110151533|NCT00001033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110151534|NCT00001036|Zidovudine|zidovudine|mesh-list
110151535|NCT00001036|Interleukin-2|interleukin-2|mesh-list
110151536|NCT00001036|Thymalfasin|thymalfasin|mesh-list
110151537|NCT00001036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110151538|NCT00001036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110151539|NCT00001036|Analgesics|analgesics|mesh-ancestor
110151540|NCT00001036|Sensory System Agents|sensory system agents|mesh-ancestor
110151541|NCT00001036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110151542|NCT00001036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110151543|NCT00001036|Antimetabolites|antimetabolites|mesh-ancestor
110151544|NCT00001036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110151545|NCT00001036|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110151546|NCT00001036|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110151548|NCT00001036|Antiviral Agents|antiviral agents|mesh-ancestor
110151549|NCT00001036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110151550|NCT00001036|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110151551|NCT00001036|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110151552|NCT00001036|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110151553|NCT00001036|Immunologic Factors|immunologic factors|mesh-ancestor
110151554|NCT00001045|Zidovudine|zidovudine|mesh-list
110151555|NCT00001045|Nevirapine|nevirapine|mesh-list
110151556|NCT00001045|Didanosine|didanosine|mesh-list
110151557|NCT00001045|Antimetabolites|antimetabolites|mesh-ancestor
110151558|NCT00001045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110151559|NCT00001045|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110151560|NCT00001045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110151561|NCT00001045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110151562|NCT00001045|Antiviral Agents|antiviral agents|mesh-ancestor
110151563|NCT00001045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110151564|NCT00001045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110151565|NCT00001045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110151566|NCT00001045|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110151567|NCT00001045|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110151568|NCT00001048|Cytarabine|cytarabine|mesh-list
110151569|NCT00001048|Zidovudine|zidovudine|mesh-list
110151570|NCT00001048|Didanosine|didanosine|mesh-list
110151571|NCT00001048|Zalcitabine|zalcitabine|mesh-list
110151572|NCT00001048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110151573|NCT00001048|Antimetabolites|antimetabolites|mesh-ancestor
110151574|NCT00001048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110151575|NCT00001048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110151577|NCT00001048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110151578|NCT00001048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110151579|NCT00001048|Immunologic Factors|immunologic factors|mesh-ancestor
110151580|NCT00001048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110151581|NCT00001048|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110151582|NCT00001048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110151583|NCT00001048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110151584|NCT00001048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110151585|NCT00001048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110151586|NCT00001066|Lamivudine|lamivudine|mesh-list
110151587|NCT00001066|Zidovudine|zidovudine|mesh-list
110151588|NCT00001066|Didanosine|didanosine|mesh-list
110151589|NCT00001066|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110151590|NCT00001066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110151591|NCT00001066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110151592|NCT00001066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110151593|NCT00001066|Antiviral Agents|antiviral agents|mesh-ancestor
110151594|NCT00001066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110151595|NCT00001066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110151596|NCT00001066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110151597|NCT00001066|Antimetabolites|antimetabolites|mesh-ancestor
110151599|NCT00001075|Lamivudine|lamivudine|mesh-list
110151600|NCT00001075|Zidovudine|zidovudine|mesh-list
110151601|NCT00001075|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110151602|NCT00001075|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110151603|NCT00001075|Protease Inhibitors|protease inhibitors|mesh-ancestor
110151604|NCT00001075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110151605|NCT00001075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110151606|NCT00001075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110151607|NCT00001075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110151608|NCT00001075|Antiviral Agents|antiviral agents|mesh-ancestor
110151609|NCT00001075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110151610|NCT00001075|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110151611|NCT00001075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110151612|NCT00001075|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110151613|NCT00001075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110151614|NCT00001075|Antimetabolites|antimetabolites|mesh-ancestor
110151615|NCT00001084|Lamivudine|lamivudine|mesh-list
110151616|NCT00001084|Zidovudine|zidovudine|mesh-list
110151617|NCT00001084|Stavudine|stavudine|mesh-list
110151618|NCT00001084|Indinavir|indinavir|mesh-list
110151619|NCT00001084|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110151620|NCT00001084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110151621|NCT00001084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110191433|NCT00027989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110151622|NCT00001084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110151624|NCT00001084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110151625|NCT00001084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110151626|NCT00001084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110151627|NCT00001084|Antimetabolites|antimetabolites|mesh-ancestor
110151628|NCT00001084|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110151629|NCT00001084|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110151630|NCT00001084|Protease Inhibitors|protease inhibitors|mesh-ancestor
110151631|NCT00001087|Ritonavir|ritonavir|mesh-list
110151632|NCT00001087|Nelfinavir|nelfinavir|mesh-list
110151633|NCT00001087|Saquinavir|saquinavir|mesh-list
110151634|NCT00001087|Lamivudine|lamivudine|mesh-list
110151635|NCT00001087|Zidovudine|zidovudine|mesh-list
110151636|NCT00001087|Stavudine|stavudine|mesh-list
110151637|NCT00001087|Didanosine|didanosine|mesh-list
110151638|NCT00001087|Zalcitabine|zalcitabine|mesh-list
110151639|NCT00001087|Efavirenz|efavirenz|mesh-list
110151640|NCT00001087|Adefovir|adefovir|mesh-list
110151641|NCT00001087|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
110151642|NCT00001087|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110151643|NCT00001087|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110151644|NCT00001087|Protease Inhibitors|protease inhibitors|mesh-ancestor
110151645|NCT00001087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110151646|NCT00001087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110151647|NCT00001087|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110151648|NCT00001087|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110151649|NCT00001087|Antiviral Agents|antiviral agents|mesh-ancestor
110151650|NCT00001087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110151651|NCT00001087|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110186870|NCT04654689|Curcumin|curcumin|mesh-list
110151652|NCT00001087|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110151653|NCT00001087|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110151654|NCT00001087|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110151656|NCT00001087|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110151657|NCT00001087|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110151658|NCT00001087|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110151659|NCT00001087|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110151660|NCT00001087|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110151661|NCT00001105|Antibodies|antibodies|mesh-list
110151662|NCT00001105|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110151663|NCT00001105|Immunologic Factors|immunologic factors|mesh-ancestor
110151664|NCT00001105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110151665|NCT00001111|Zidovudine|zidovudine|mesh-list
110151666|NCT00001111|Nevirapine|nevirapine|mesh-list
110151667|NCT00001111|Antimetabolites|antimetabolites|mesh-ancestor
110191434|NCT00027989|Antimetabolites|antimetabolites|mesh-ancestor
110151668|NCT00001111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110151669|NCT00001111|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110151670|NCT00001111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110151671|NCT00001111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110151672|NCT00001111|Antiviral Agents|antiviral agents|mesh-ancestor
110151673|NCT00001111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110151674|NCT00001111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110151675|NCT00001111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110151676|NCT00001111|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110151677|NCT00001111|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110151678|NCT00001114|Interferons|interferons|mesh-list
110151679|NCT00001114|Interferon-alpha|interferon-alpha|mesh-list
110151680|NCT00001114|Interferon alpha-2|interferon alpha-2|mesh-list
110151681|NCT00001114|Didanosine|didanosine|mesh-list
110151682|NCT00001114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110151683|NCT00001114|Antiviral Agents|antiviral agents|mesh-ancestor
110151684|NCT00001114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110151685|NCT00001114|Immunologic Factors|immunologic factors|mesh-ancestor
110151686|NCT00001114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110151687|NCT00001114|Antimetabolites|antimetabolites|mesh-ancestor
110151688|NCT00001114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110151689|NCT00001114|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110151690|NCT00001114|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110151691|NCT00001114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110151692|NCT00001114|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110151693|NCT00001114|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110151694|NCT00001165|Doxorubicin|doxorubicin|mesh-list
110151695|NCT00001165|Streptozocin|streptozocin|mesh-list
110151696|NCT00001165|Fluorouracil|fluorouracil|mesh-list
110151697|NCT00001165|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110151698|NCT00001165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110151699|NCT00001165|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110151700|NCT00001165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110151701|NCT00001165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110151702|NCT00001165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110151703|NCT00001165|Antimetabolites|antimetabolites|mesh-ancestor
110151704|NCT00001165|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110151705|NCT00001165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110151706|NCT00001165|Immunologic Factors|immunologic factors|mesh-ancestor
110151707|NCT00001165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110151708|NCT00001180|Hormones|hormones|mesh-list
110151709|NCT00001180|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
110151710|NCT00001180|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
110151711|NCT00001180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110151712|NCT00001180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110151714|NCT00389272|Ibuprofen|ibuprofen|mesh-list
110151715|NCT00389272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110151716|NCT00389272|Analgesics|analgesics|mesh-ancestor
110151717|NCT00389272|Sensory System Agents|sensory system agents|mesh-ancestor
110151718|NCT00389272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110151719|NCT00389272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110151720|NCT00389272|Antipyretics|antipyretics|mesh-ancestor
110151721|NCT00389272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110151722|NCT00389272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110151723|NCT00389272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110151724|NCT00389272|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110151725|NCT00389272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110151726|NCT00389272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110151727|NCT00389311|Nonoxynol|nonoxynol|mesh-list
110151728|NCT00389311|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
110151729|NCT00389311|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
110151730|NCT00389311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110151731|NCT00389311|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110151732|NCT00389311|Contraceptive Agents|contraceptive agents|mesh-ancestor
110151733|NCT00389311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110151734|NCT00389311|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110151736|NCT00001213|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
110151737|NCT00001213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110151738|NCT00000114|Vitamins|vitamins|mesh-list
110151739|NCT00000114|Vitamin E|vitamin e|mesh-list
110151740|NCT00000114|Vitamin A|vitamin a|mesh-list
110151741|NCT00000114|Micronutrients|micronutrients|mesh-ancestor
110151742|NCT00000114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110151743|NCT00000114|Antioxidants|antioxidants|mesh-ancestor
110151744|NCT00000114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110151745|NCT00000114|Protective Agents|protective agents|mesh-ancestor
110151746|NCT00001261|gamma-Globulins|gamma-globulins|mesh-list
110151747|NCT00001261|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110151748|NCT00001261|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110151749|NCT00001261|Immunologic Factors|immunologic factors|mesh-ancestor
110151750|NCT00001261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110151751|NCT00001267|Zidovudine|zidovudine|mesh-list
110151752|NCT00001267|Didanosine|didanosine|mesh-list
110151753|NCT00001267|Antimetabolites|antimetabolites|mesh-ancestor
110151754|NCT00001267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110151755|NCT00001267|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110151756|NCT00001267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110151758|NCT00001267|Antiviral Agents|antiviral agents|mesh-ancestor
110151759|NCT00001267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110151760|NCT00001267|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110151761|NCT00001267|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110151762|NCT00001303|Nitric Oxide|nitric oxide|mesh-list
110151763|NCT00001303|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110151764|NCT00001303|Autonomic Agents|autonomic agents|mesh-ancestor
110151765|NCT00001303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110151766|NCT00001303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110151767|NCT00001303|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110151768|NCT00001303|Respiratory System Agents|respiratory system agents|mesh-ancestor
110151769|NCT00001303|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110191438|NCT00027989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110151771|NCT00001303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110151772|NCT00001303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110151773|NCT00001303|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110151774|NCT00001303|Vasodilator Agents|vasodilator agents|mesh-ancestor
110151775|NCT00001303|Gasotransmitters|gasotransmitters|mesh-ancestor
110151776|NCT00001303|Protective Agents|protective agents|mesh-ancestor
110151777|NCT00000120|Erythromycin|erythromycin|mesh-list
110151778|NCT00000120|Erythromycin Estolate|erythromycin estolate|mesh-list
110151779|NCT00000120|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
110151780|NCT00000120|Erythromycin stearate|erythromycin stearate|mesh-list
110151781|NCT00000120|Silver Nitrate|silver nitrate|mesh-list
110151782|NCT00000120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110151783|NCT00000120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110151784|NCT00000120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110151785|NCT00000120|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110151786|NCT00000120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110151787|NCT00000120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110151788|NCT00000120|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110151790|NCT00001333|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110151791|NCT00001333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110151792|NCT00001333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110151793|NCT00001333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110151794|NCT00001333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110151795|NCT00001378|Fenretinide|fenretinide|mesh-list
110151796|NCT00001378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110151797|NCT00001378|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110151798|NCT00001378|Protective Agents|protective agents|mesh-ancestor
110151799|NCT00001378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110151800|NCT00001387|Paclitaxel|paclitaxel|mesh-list
110151801|NCT00001387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110151802|NCT00001387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110151803|NCT00001387|Tubulin Modulators|tubulin modulators|mesh-ancestor
110151804|NCT00001387|Antimitotic Agents|antimitotic agents|mesh-ancestor
110151805|NCT00001387|Mitosis Modulators|mitosis modulators|mesh-ancestor
110151806|NCT00001387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110151807|NCT00388557|Ketoconazole|ketoconazole|mesh-list
110151808|NCT00388557|Antifungal Agents|antifungal agents|mesh-ancestor
110151809|NCT00388557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110151810|NCT00388557|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110151811|NCT00388557|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110151812|NCT00388557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110151813|NCT00388557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110151814|NCT00388557|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110151815|NCT00388557|Hormone Antagonists|hormone antagonists|mesh-ancestor
110151816|NCT00388557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110151817|NCT00388557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110151818|NCT00388557|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110151819|NCT00388635|Prednisone|prednisone|mesh-list
110151820|NCT00388635|Melphalan|melphalan|mesh-list
110151821|NCT00388635|Bortezomib|bortezomib|mesh-list
110151822|NCT00388635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110151823|NCT00388635|Glucocorticoids|glucocorticoids|mesh-ancestor
110151824|NCT00388635|Hormones|hormones|mesh-ancestor
110151825|NCT00388635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110151826|NCT00388635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110151828|NCT00388635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110151829|NCT00388635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110151830|NCT00388635|Alkylating Agents|alkylating agents|mesh-ancestor
110151831|NCT00388635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110151832|NCT00388635|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110151833|NCT00388635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110151834|NCT00388635|Immunologic Factors|immunologic factors|mesh-ancestor
110151836|NCT00001474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110151837|NCT00001474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110151838|NCT00001474|Analgesics|analgesics|mesh-ancestor
110151839|NCT00001474|Sensory System Agents|sensory system agents|mesh-ancestor
110151840|NCT00001474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110151841|NCT00001474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110151842|NCT00001483|Sertraline|sertraline|mesh-list
110151843|NCT00001483|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110151844|NCT00001483|Bupropion|bupropion|mesh-list
110151845|NCT00001483|Antidepressive Agents|antidepressive agents|mesh-ancestor
110151846|NCT00001483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110151847|NCT00001483|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110151848|NCT00001483|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110151849|NCT00001483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110151850|NCT00001483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110151851|NCT00001483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110151852|NCT00001483|Serotonin Agents|serotonin agents|mesh-ancestor
110151853|NCT00001483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110151854|NCT00001483|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110151855|NCT00001483|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110151856|NCT00001483|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110151857|NCT00001483|Dopamine Agents|dopamine agents|mesh-ancestor
110151858|NCT00001483|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110151859|NCT00001483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110151860|NCT00001483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110151861|NCT00001495|Irinotecan|irinotecan|mesh-list
110151862|NCT00001495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110151863|NCT00001495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110151864|NCT00001495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110151865|NCT00001495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110151866|NCT00001495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110151867|NCT00001507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110151868|NCT00001507|Antibodies|antibodies|mesh-list
110151869|NCT00001507|Immunoglobulins|immunoglobulins|mesh-list
110151870|NCT00001507|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110151871|NCT00001507|Immunologic Factors|immunologic factors|mesh-ancestor
110151872|NCT00001507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110151873|NCT00001507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110151874|NCT00001567|Interferon alpha-2|interferon alpha-2|mesh-list
110151875|NCT00001567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110151876|NCT00001567|Antiviral Agents|antiviral agents|mesh-ancestor
110151877|NCT00001567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110151878|NCT00001576|Leucovorin|leucovorin|mesh-list
110151879|NCT00001576|Melphalan|melphalan|mesh-list
110151880|NCT00001576|Floxuridine|floxuridine|mesh-list
110151881|NCT00001576|Antidotes|antidotes|mesh-ancestor
110151882|NCT00001576|Protective Agents|protective agents|mesh-ancestor
110151883|NCT00001576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110151884|NCT00001576|Vitamin B Complex|vitamin b complex|mesh-ancestor
110151885|NCT00001576|Vitamins|vitamins|mesh-ancestor
110151886|NCT00001576|Micronutrients|micronutrients|mesh-ancestor
110151887|NCT00001576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110151888|NCT00001576|Alkylating Agents|alkylating agents|mesh-ancestor
110151889|NCT00001576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110151890|NCT00001576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110151891|NCT00001576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110151892|NCT00001576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110151893|NCT00001576|Immunologic Factors|immunologic factors|mesh-ancestor
110151894|NCT00001576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110151895|NCT00001576|Antimetabolites|antimetabolites|mesh-ancestor
110151897|NCT00000147|Methylprednisolone|methylprednisolone|mesh-list
110151898|NCT00000147|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110151899|NCT00000147|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110151901|NCT00000147|Prednisolone acetate|prednisolone acetate|mesh-list
110151902|NCT00000147|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110151903|NCT00000147|Prednisolone phosphate|prednisolone phosphate|mesh-list
110151904|NCT00000147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110151905|NCT00000147|Glucocorticoids|glucocorticoids|mesh-ancestor
110151906|NCT00000147|Hormones|hormones|mesh-ancestor
110151907|NCT00000147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110151908|NCT00000147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110151909|NCT00000147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110151910|NCT00000147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110151911|NCT00000147|Antiemetics|antiemetics|mesh-ancestor
110151912|NCT00000147|Autonomic Agents|autonomic agents|mesh-ancestor
110151913|NCT00000147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110151914|NCT00000147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110151915|NCT00000147|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110151916|NCT00000147|Protective Agents|protective agents|mesh-ancestor
110151917|NCT00001624|Insulin|insulin|mesh-list
110151918|NCT00001624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110151919|NCT00001624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110151920|NCT00001666|Methamphetamine|methamphetamine|mesh-list
110151921|NCT00001666|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110151922|NCT00001666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110151923|NCT00001666|Sympathomimetics|sympathomimetics|mesh-ancestor
110151924|NCT00001666|Autonomic Agents|autonomic agents|mesh-ancestor
110151925|NCT00001666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110151926|NCT00001666|Dopamine Agents|dopamine agents|mesh-ancestor
110151927|NCT00001666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110151928|NCT00001666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110151929|NCT00001666|Adrenergic Agents|adrenergic agents|mesh-ancestor
110151930|NCT00001666|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110151931|NCT00001666|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110151932|NCT00001666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110151933|NCT00001666|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110151935|NCT00001669|Growth Substances|growth substances|mesh-ancestor
110151936|NCT00001669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110151937|NCT00001693|Celecoxib|celecoxib|mesh-list
110151938|NCT00001693|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110151939|NCT00001693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110151940|NCT00001693|Analgesics|analgesics|mesh-ancestor
110151941|NCT00001693|Sensory System Agents|sensory system agents|mesh-ancestor
110151942|NCT00001693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110151943|NCT00001693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110151944|NCT00001693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110151945|NCT00001693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110151946|NCT00001693|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110151947|NCT00001693|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110151948|NCT00001693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110151949|NCT00001693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110151950|NCT00001696|Genistein|genistein|mesh-list
110151951|NCT00001696|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110151952|NCT00001696|Protective Agents|protective agents|mesh-ancestor
110151953|NCT00001696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110151954|NCT00001696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110151955|NCT00001696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110151956|NCT00001696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110151957|NCT00001696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110151958|NCT00001696|Phytoestrogens|phytoestrogens|mesh-ancestor
110151959|NCT00001696|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110151960|NCT00001696|Estrogens|estrogens|mesh-ancestor
110151961|NCT00001696|Hormones|hormones|mesh-ancestor
110151962|NCT00001696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110151963|NCT00389428|Cytarabine|cytarabine|mesh-list
110151964|NCT00389428|Daunorubicin|daunorubicin|mesh-list
110151965|NCT00389428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110151966|NCT00389428|Antimetabolites|antimetabolites|mesh-ancestor
110151967|NCT00389428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110151969|NCT00389428|Antiviral Agents|antiviral agents|mesh-ancestor
110151970|NCT00389428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110151971|NCT00389428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110151972|NCT00389428|Immunologic Factors|immunologic factors|mesh-ancestor
110151973|NCT00389428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110151974|NCT00389428|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110151975|NCT00389428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110151976|NCT00389428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110151977|NCT00389428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110151978|NCT00001720|Alendronate|alendronate|mesh-list
110151979|NCT00001720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110151980|NCT00001720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110151981|NCT00001723|Orlistat|orlistat|mesh-list
110151982|NCT00001723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110151983|NCT00001723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110151984|NCT00001723|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110151985|NCT00001723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110151986|NCT00001729|Ribavirin|ribavirin|mesh-list
110151987|NCT00001729|Antimetabolites|antimetabolites|mesh-ancestor
110151988|NCT00001729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110151989|NCT00001729|Antiviral Agents|antiviral agents|mesh-ancestor
110151990|NCT00001729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110151991|NCT00001741|Losartan|losartan|mesh-list
110151992|NCT00001741|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110151993|NCT00001741|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110151994|NCT00001741|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110151995|NCT00001741|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110151996|NCT00001741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110151997|NCT00001777|Sertraline|sertraline|mesh-list
110151998|NCT00001777|Antidepressive Agents|antidepressive agents|mesh-ancestor
110151999|NCT00001777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110152000|NCT00001777|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110152001|NCT00001777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110152002|NCT00001777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110152003|NCT00001777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110152004|NCT00001777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110152005|NCT00001777|Serotonin Agents|serotonin agents|mesh-ancestor
110152006|NCT00001777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110152007|NCT00000171|Melatonin|melatonin|mesh-list
110152008|NCT00000171|Antioxidants|antioxidants|mesh-ancestor
110152009|NCT00000171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110152010|NCT00000171|Protective Agents|protective agents|mesh-ancestor
110152012|NCT00000171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110152013|NCT05641636|Hormones|hormones|mesh-list
110152014|NCT05641636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110152015|NCT05641636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110152016|NCT00000177|Estrogens|estrogens|mesh-list
110152017|NCT00000177|Hormones|hormones|mesh-ancestor
110152018|NCT00000177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110152019|NCT00000177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110152020|NCT03444376|Pembrolizumab|pembrolizumab|mesh-list
110152021|NCT03444376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110152022|NCT03444376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110152023|NCT03444376|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110152024|NCT03444376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110152025|NCT00000216|Buprenorphine|buprenorphine|mesh-list
110152026|NCT00000216|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110152027|NCT00000216|Narcotics|narcotics|mesh-ancestor
110152028|NCT00000216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110152029|NCT00000216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110152030|NCT00000216|Analgesics|analgesics|mesh-ancestor
110186942|NCT04573777|Evolocumab|evolocumab|mesh-list
110152031|NCT00000216|Sensory System Agents|sensory system agents|mesh-ancestor
110152032|NCT00000216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110152033|NCT00000216|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110152034|NCT00000252|Nitrous Oxide|nitrous oxide|mesh-list
110152035|NCT00000252|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110152036|NCT00000252|Anesthetics, General|anesthetics, general|mesh-ancestor
110152037|NCT00000252|Anesthetics|anesthetics|mesh-ancestor
110152038|NCT00000252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110152039|NCT00000252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110152040|NCT00000252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110152041|NCT00000252|Analgesics|analgesics|mesh-ancestor
110152042|NCT00000252|Sensory System Agents|sensory system agents|mesh-ancestor
110152043|NCT00000252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110152044|NCT05640817|Pentoxifylline|pentoxifylline|mesh-list
110152045|NCT05640817|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110152046|NCT05640817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110152047|NCT05640817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110152048|NCT05640817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110152049|NCT05640817|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110152050|NCT05640817|Protective Agents|protective agents|mesh-ancestor
110152051|NCT05640817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110152052|NCT05640817|Vasodilator Agents|vasodilator agents|mesh-ancestor
110152053|NCT05640817|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110152054|NCT05640817|Antioxidants|antioxidants|mesh-ancestor
110152055|NCT00000255|Nitrous Oxide|nitrous oxide|mesh-list
110152056|NCT00000255|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110152057|NCT00000255|Anesthetics, General|anesthetics, general|mesh-ancestor
110152058|NCT00000255|Anesthetics|anesthetics|mesh-ancestor
110152059|NCT00000255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110152060|NCT00000255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110152061|NCT00000255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110152062|NCT00000255|Analgesics|analgesics|mesh-ancestor
110152063|NCT00000255|Sensory System Agents|sensory system agents|mesh-ancestor
110152064|NCT00000255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110152065|NCT00000258|Nitrous Oxide|nitrous oxide|mesh-list
110152066|NCT00000258|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110152067|NCT00000258|Anesthetics, General|anesthetics, general|mesh-ancestor
110152068|NCT00000258|Anesthetics|anesthetics|mesh-ancestor
110152069|NCT00000258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110152070|NCT00000258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110152071|NCT00000258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110152072|NCT00000258|Analgesics|analgesics|mesh-ancestor
110152073|NCT00000258|Sensory System Agents|sensory system agents|mesh-ancestor
110152074|NCT00000258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110152075|NCT00389506|Cyclophosphamide|cyclophosphamide|mesh-list
110152076|NCT00389506|Fludarabine|fludarabine|mesh-list
110152077|NCT00389506|Fludarabine phosphate|fludarabine phosphate|mesh-list
110152078|NCT00389506|Immunotoxins|immunotoxins|mesh-list
110152079|NCT00389506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110152080|NCT00389506|Immunologic Factors|immunologic factors|mesh-ancestor
110152081|NCT00389506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110152082|NCT00389506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110152083|NCT00389506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110152084|NCT00389506|Alkylating Agents|alkylating agents|mesh-ancestor
110152085|NCT00389506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110152086|NCT00389506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110152087|NCT00389506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110152088|NCT00389506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110152089|NCT00389506|Antimetabolites|antimetabolites|mesh-ancestor
110152090|NCT00389506|Immunoconjugates|immunoconjugates|mesh-ancestor
110152091|NCT00389584|Irinotecan|irinotecan|mesh-list
110152092|NCT00389584|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110152093|NCT00389584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110152094|NCT00389584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110152095|NCT00389584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110152096|NCT00389584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110152097|NCT00000324|Tryptophan|tryptophan|mesh-list
110152098|NCT00000324|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110152099|NCT00000324|Antidepressive Agents|antidepressive agents|mesh-ancestor
110152100|NCT00000324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110152101|NCT05640427|Dexmedetomidine|dexmedetomidine|mesh-list
110152102|NCT05640427|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110152103|NCT05640427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110152104|NCT05640427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110152105|NCT05640427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110152106|NCT05640427|Analgesics|analgesics|mesh-ancestor
110152107|NCT05640427|Sensory System Agents|sensory system agents|mesh-ancestor
110152108|NCT05640427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110152109|NCT05640427|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110152110|NCT05640427|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110152111|NCT05640427|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110152112|NCT05640427|Adrenergic Agents|adrenergic agents|mesh-ancestor
110152113|NCT05640427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110152114|NCT05640427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110152115|NCT00000363|Histamine Antagonists|histamine antagonists|mesh-list
110152116|NCT00000363|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
110152117|NCT00000363|Histamine Agents|histamine agents|mesh-ancestor
110152118|NCT00000363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110152119|NCT00000363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110152120|NCT00000363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110152121|NCT00000369|Lithium Carbonate|lithium carbonate|mesh-list
110152122|NCT00000369|Antidepressive Agents|antidepressive agents|mesh-ancestor
110152123|NCT00000369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110152124|NCT00000369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110152125|NCT00000369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110152126|NCT00000369|Antimanic Agents|antimanic agents|mesh-ancestor
110152127|NCT00000369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110152128|NCT00000369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110152129|NCT00000369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110152131|NCT00000375|Antidepressive Agents|antidepressive agents|mesh-ancestor
110152132|NCT00000375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110152133|NCT00000375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110152134|NCT00000375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110152135|NCT00000375|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110152136|NCT00000375|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110152137|NCT00000375|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110152138|NCT00000375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110152139|NCT00000375|Adrenergic Agents|adrenergic agents|mesh-ancestor
110152140|NCT00000375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110152141|NCT03295747|Peppermint oil|peppermint oil|mesh-list
110152142|NCT03295747|Antiemetics|antiemetics|mesh-ancestor
110152143|NCT03295747|Autonomic Agents|autonomic agents|mesh-ancestor
110152144|NCT03295747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110152145|NCT03295747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110152146|NCT03295747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110152147|NCT03295747|Parasympatholytics|parasympatholytics|mesh-ancestor
110152148|NCT05639959|Mometasone Furoate|mometasone furoate|mesh-list
110152149|NCT05639959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110152150|NCT05639959|Dermatologic Agents|dermatologic agents|mesh-ancestor
110152151|NCT05639959|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110152152|NCT03575208|Interferons|interferons|mesh-list
110152154|NCT03575208|Immunoglobulins|immunoglobulins|mesh-list
110152155|NCT03575208|Antibodies|antibodies|mesh-list
110152156|NCT03575208|gamma-Globulins|gamma-globulins|mesh-list
110152157|NCT03575208|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110152158|NCT03575208|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110152159|NCT03575208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110152160|NCT03575208|Antiviral Agents|antiviral agents|mesh-ancestor
110152161|NCT03575208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110152162|NCT03575208|Immunologic Factors|immunologic factors|mesh-ancestor
110152163|NCT03575208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110152164|NCT03295552|Carboplatin|carboplatin|mesh-list
110152165|NCT03295552|Decitabine|decitabine|mesh-list
110152166|NCT03295552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110152167|NCT03295552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110152168|NCT03295552|Antimetabolites|antimetabolites|mesh-ancestor
110152169|NCT03295552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110152170|NCT03295552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110152171|NCT05629468|Azithromycin|azithromycin|mesh-list
110152172|NCT05629468|Benzoyl Peroxide|benzoyl peroxide|mesh-list
110152173|NCT05629468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110152174|NCT05629468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110152175|NCT05629468|Dermatologic Agents|dermatologic agents|mesh-ancestor
110152176|NCT00000378|Sertraline|sertraline|mesh-list
110152177|NCT00000378|Nortriptyline|nortriptyline|mesh-list
110152178|NCT00000378|Antidepressive Agents|antidepressive agents|mesh-ancestor
110152179|NCT00000378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110152180|NCT00000378|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110152181|NCT00000378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110152182|NCT00000378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110152183|NCT00000378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110152184|NCT00000378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110152185|NCT00000378|Serotonin Agents|serotonin agents|mesh-ancestor
110152186|NCT00000378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110152187|NCT00000378|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110152188|NCT00000378|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110152189|NCT00000378|Adrenergic Agents|adrenergic agents|mesh-ancestor
110152190|NCT00000381|Fluoxetine|fluoxetine|mesh-list
110152191|NCT00000381|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110152192|NCT00000381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110152193|NCT00000381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110152194|NCT00000381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110152195|NCT00000381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110152196|NCT00000381|Serotonin Agents|serotonin agents|mesh-ancestor
110152197|NCT00000381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110152198|NCT00000381|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110152199|NCT00000381|Antidepressive Agents|antidepressive agents|mesh-ancestor
110152200|NCT00000381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110152201|NCT00000381|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110152202|NCT00000381|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110152204|NCT05631925|Propofol|propofol|mesh-list
110152205|NCT05631925|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110152206|NCT05631925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110152207|NCT05631925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110152208|NCT05631925|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110152209|NCT05631925|Anesthetics, General|anesthetics, general|mesh-ancestor
110152210|NCT05631925|Anesthetics|anesthetics|mesh-ancestor
110152211|NCT00389701|Dexamethasone|dexamethasone|mesh-list
110152212|NCT00389701|Bortezomib|bortezomib|mesh-list
110152213|NCT00389701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110152214|NCT00389701|Antiemetics|antiemetics|mesh-ancestor
110152215|NCT00389701|Autonomic Agents|autonomic agents|mesh-ancestor
110152216|NCT00389701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110152217|NCT00389701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110152218|NCT00389701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110152220|NCT00389701|Hormones|hormones|mesh-ancestor
110152221|NCT00389701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110152222|NCT00389701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110152223|NCT00389701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110152224|NCT00000420|Norinyl|norinyl|mesh-list
110186959|NCT04507711|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110152225|NCT00000420|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110152226|NCT00000420|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110152227|NCT00000420|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110152228|NCT00000420|Contraceptive Agents|contraceptive agents|mesh-ancestor
110152229|NCT00000420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110152230|NCT00000420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110152231|NCT00000420|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110152232|NCT00000420|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110152233|NCT00000426|Calcium|calcium|mesh-list
110152234|NCT00000426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110152235|NCT00000426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110152236|NCT05551858|Proglumide|proglumide|mesh-list
110152237|NCT05551858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110152238|NCT05551858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110152239|NCT05530174|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110152240|NCT05530174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110152241|NCT00000456|Naltrexone|naltrexone|mesh-list
110152242|NCT00000456|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110152243|NCT00000456|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110152245|NCT00000456|Sensory System Agents|sensory system agents|mesh-ancestor
110152246|NCT00000456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110152247|NCT05519683|Escitalopram|escitalopram|mesh-list
110152248|NCT05519683|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110152249|NCT05519683|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110152250|NCT05519683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110152251|NCT05519683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110152252|NCT05519683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110152253|NCT05519683|Serotonin Agents|serotonin agents|mesh-ancestor
110152254|NCT05519683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110152256|NCT05442268|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110152257|NCT05442268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110152258|NCT05442268|Analgesics|analgesics|mesh-ancestor
110152259|NCT05442268|Sensory System Agents|sensory system agents|mesh-ancestor
110152260|NCT05442268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110152261|NCT05442268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110152262|NCT05442268|Antipyretics|antipyretics|mesh-ancestor
110152263|NCT05442268|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110152264|NCT05442268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110152265|NCT05442268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110191439|NCT00027989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110152266|NCT05442268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110152268|NCT05442268|Antidepressive Agents|antidepressive agents|mesh-ancestor
110152269|NCT05442268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110152270|NCT05442268|Dopamine Agents|dopamine agents|mesh-ancestor
110152272|NCT05448820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110152273|NCT05448820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110152274|NCT05448820|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110152275|NCT05448820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110152276|NCT05448820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110191440|NCT00027989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110152277|NCT05448820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110152278|NCT00000468|Plasminogen|plasminogen|mesh-list
110152279|NCT00000468|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110152280|NCT00000468|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110152281|NCT00000468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110152282|NCT00000468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110152283|NCT02972476|Fluticasone|fluticasone|mesh-list
110152286|NCT02972476|Bromides|bromides|mesh-list
110152287|NCT02972476|Formoterol Fumarate|formoterol fumarate|mesh-list
110152288|NCT02972476|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110191441|NCT00056004|Zileuton|zileuton|mesh-list
110152289|NCT02972476|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110152290|NCT02972476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110152291|NCT02972476|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110152293|NCT02972476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110152294|NCT02972476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110152295|NCT02972476|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110152296|NCT02972476|Respiratory System Agents|respiratory system agents|mesh-ancestor
110152297|NCT02972476|Dermatologic Agents|dermatologic agents|mesh-ancestor
110152298|NCT02972476|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110152299|NCT02972476|Glucocorticoids|glucocorticoids|mesh-ancestor
110152301|NCT02972476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110152302|NCT02972476|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110152303|NCT02972476|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110152304|NCT02972476|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110152305|NCT02972476|Adrenergic Agents|adrenergic agents|mesh-ancestor
110152306|NCT02972476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110152307|NCT02972476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110152308|NCT02972476|Anticonvulsants|anticonvulsants|mesh-ancestor
110152309|NCT02972476|Sympathomimetics|sympathomimetics|mesh-ancestor
110152310|NCT05418868|Cabotegravir|cabotegravir|mesh-list
110152311|NCT05418868|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110152312|NCT05418868|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110152313|NCT05418868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110152314|NCT05418868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110152315|NCT05418868|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110152316|NCT05418868|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110152317|NCT05418868|Antiviral Agents|antiviral agents|mesh-ancestor
110152318|NCT05418868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110152319|NCT02972320|Temozolomide|temozolomide|mesh-list
110152320|NCT02972320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110152321|NCT02972320|Alkylating Agents|alkylating agents|mesh-ancestor
110152322|NCT02972320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110152323|NCT02972320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110152324|NCT00000480|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
110152325|NCT05349838|Dolutegravir|dolutegravir|mesh-list
110152326|NCT05349838|Rilpivirine|rilpivirine|mesh-list
110152327|NCT05349838|Protease Inhibitors|protease inhibitors|mesh-list
110152328|NCT05349838|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110152329|NCT05349838|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110152330|NCT05349838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110152331|NCT05349838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110152332|NCT05349838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110152333|NCT05349838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110152334|NCT05349838|Antiviral Agents|antiviral agents|mesh-ancestor
110152335|NCT05349838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110152336|NCT05349838|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110152337|NCT05349838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110152339|NCT03164980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110152340|NCT03164980|Alkylating Agents|alkylating agents|mesh-ancestor
110152341|NCT03164980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110152342|NCT03164980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110152343|NCT05305456|Vitamins|vitamins|mesh-list
110152344|NCT05305456|Ascorbic Acid|ascorbic acid|mesh-list
110152345|NCT05305456|Micronutrients|micronutrients|mesh-ancestor
110152346|NCT05305456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110152347|NCT05305456|Antioxidants|antioxidants|mesh-ancestor
110152348|NCT05305456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110152349|NCT05305456|Protective Agents|protective agents|mesh-ancestor
110152350|NCT00388986|Glyburide|glyburide|mesh-list
110152351|NCT00388986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110152352|NCT00388986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110152353|NCT05233696|Paclitaxel|paclitaxel|mesh-list
110152354|NCT05233696|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110152355|NCT05233696|Pembrolizumab|pembrolizumab|mesh-list
110152356|NCT05233696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110152357|NCT05233696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110152358|NCT05233696|Tubulin Modulators|tubulin modulators|mesh-ancestor
110152359|NCT05233696|Antimitotic Agents|antimitotic agents|mesh-ancestor
110152360|NCT05233696|Mitosis Modulators|mitosis modulators|mesh-ancestor
110152361|NCT05233696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110152362|NCT05233696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110152363|NCT05233696|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110152364|NCT00000492|Propranolol|propranolol|mesh-list
110152365|NCT00000492|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110152366|NCT00000492|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110152367|NCT00000492|Adrenergic Agents|adrenergic agents|mesh-ancestor
110152368|NCT00000492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110152369|NCT00000492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110152370|NCT00000492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110152371|NCT00000492|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110152372|NCT00000492|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110152373|NCT00000492|Vasodilator Agents|vasodilator agents|mesh-ancestor
110152374|NCT00000498|Antihypertensive Agents|antihypertensive agents|mesh-list
110152376|NCT00000504|Moricizine|moricizine|mesh-list
110152377|NCT00000504|Encainide|encainide|mesh-list
110152378|NCT00000504|Imipramine|imipramine|mesh-list
110152379|NCT00000504|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110152380|NCT00000504|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110152381|NCT00000504|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110152382|NCT00000504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110152383|NCT00000504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110152384|NCT00000504|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110152385|NCT00000504|Antidepressive Agents|antidepressive agents|mesh-ancestor
110152387|NCT00000504|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110152388|NCT00000504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110152390|NCT00000504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110152391|NCT00000504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110152393|NCT00389935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110152394|NCT00389935|Immunologic Factors|immunologic factors|mesh-ancestor
110152395|NCT00389935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110152396|NCT00389935|Leprostatic Agents|leprostatic agents|mesh-ancestor
110152397|NCT00389935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110152398|NCT00389935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110152399|NCT00389935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110152400|NCT00389935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110152401|NCT00389935|Growth Substances|growth substances|mesh-ancestor
110152402|NCT00389935|Growth Inhibitors|growth inhibitors|mesh-ancestor
110152404|NCT05116930|Atropine|atropine|mesh-list
110152405|NCT05116930|Neostigmine|neostigmine|mesh-list
110152406|NCT05116930|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110152407|NCT05116930|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110152408|NCT05116930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110152409|NCT05116930|Autonomic Agents|autonomic agents|mesh-ancestor
110152410|NCT05116930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110152411|NCT05116930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110152412|NCT05116930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110152413|NCT05116930|Respiratory System Agents|respiratory system agents|mesh-ancestor
110152414|NCT05116930|Mydriatics|mydriatics|mesh-ancestor
110152415|NCT05116930|Parasympatholytics|parasympatholytics|mesh-ancestor
110152416|NCT05116930|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110152417|NCT05116930|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110152418|NCT05116930|Cholinergic Agents|cholinergic agents|mesh-ancestor
110152419|NCT05116930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110152420|NCT05116930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110152421|NCT05116930|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110152422|NCT05116930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110152423|NCT05116930|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110152424|NCT00423475|Goserelin|goserelin|mesh-list
110152425|NCT00423475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110152426|NCT00423475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110152427|NCT00000516|Enalapril|enalapril|mesh-list
110152428|NCT00000516|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110152429|NCT00000516|Protease Inhibitors|protease inhibitors|mesh-ancestor
110152430|NCT00000516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110152431|NCT00000516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110152432|NCT00000516|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110152433|NCT00000522|Acebutolol|acebutolol|mesh-list
110152434|NCT00000522|Amlodipine|amlodipine|mesh-list
110152435|NCT00000522|Enalapril|enalapril|mesh-list
110152436|NCT00000522|Chlorthalidone|chlorthalidone|mesh-list
110152437|NCT00000522|Doxazosin|doxazosin|mesh-list
110152438|NCT00000522|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110152439|NCT00000522|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110152440|NCT00000522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110152441|NCT00000522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110152442|NCT00000522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110152443|NCT00000522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110152444|NCT00000522|Vasodilator Agents|vasodilator agents|mesh-ancestor
110152445|NCT00000522|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110152446|NCT00000522|Protease Inhibitors|protease inhibitors|mesh-ancestor
110152447|NCT00000522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110152449|NCT00000522|Natriuretic Agents|natriuretic agents|mesh-ancestor
110152450|NCT00000522|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110152451|NCT00000522|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110152452|NCT00000522|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110152453|NCT00000522|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110152454|NCT00000522|Adrenergic Agents|adrenergic agents|mesh-ancestor
110152455|NCT00000522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110152456|NCT00000522|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110152458|NCT00000522|Autonomic Agents|autonomic agents|mesh-ancestor
110152459|NCT00000522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110152460|NCT00000522|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110152461|NCT00000522|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110152462|NCT03126799|Bevacizumab|bevacizumab|mesh-list
110152463|NCT03126799|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110152464|NCT03126799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110152465|NCT03126799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110152466|NCT03126799|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110152467|NCT03126799|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110152468|NCT03126799|Growth Substances|growth substances|mesh-ancestor
110152469|NCT03126799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110152470|NCT03126799|Growth Inhibitors|growth inhibitors|mesh-ancestor
110152471|NCT03126799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110152472|NCT03126799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110152473|NCT03126799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110152474|NCT00000525|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110152475|NCT00000525|Chlorthalidone|chlorthalidone|mesh-list
110152476|NCT00000525|Triamterene|triamterene|mesh-list
110152477|NCT00000525|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110152478|NCT00000525|Diuretics|diuretics|mesh-ancestor
110152479|NCT00000525|Natriuretic Agents|natriuretic agents|mesh-ancestor
110152480|NCT00000525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110152481|NCT00000525|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110152482|NCT00000525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110152483|NCT00000525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110152484|NCT00000525|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
110152485|NCT00000525|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110152486|NCT00000525|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110152487|NCT05020483|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
110152488|NCT05020483|Coagulants|coagulants|mesh-ancestor
110152491|NCT00000531|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110152492|NCT00000531|Vasodilator Agents|vasodilator agents|mesh-ancestor
110152493|NCT00000531|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110152494|NCT00000531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110152495|NCT00000531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110152496|NCT00000531|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110152497|NCT00000531|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110152498|NCT00000531|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110152499|NCT00000531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110152500|NCT00000531|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110152501|NCT00000531|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110152502|NCT00000531|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110152503|NCT00000531|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110152504|NCT00000531|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110152506|NCT00000531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110152507|NCT00000531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110152509|NCT00000531|Autonomic Agents|autonomic agents|mesh-ancestor
110152510|NCT00000531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110152511|NCT00000534|Calcium|calcium|mesh-list
110152512|NCT00000534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110152513|NCT00000534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110152515|NCT04935814|Arginine Vasopressin|arginine vasopressin|mesh-list
110152516|NCT04935814|Hemostatics|hemostatics|mesh-ancestor
110152517|NCT04935814|Coagulants|coagulants|mesh-ancestor
110152518|NCT04935814|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110152519|NCT04935814|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110152520|NCT04935814|Natriuretic Agents|natriuretic agents|mesh-ancestor
110152521|NCT04935814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110152522|NCT00000552|Fibrinolytic Agents|fibrinolytic agents|mesh-list
110152523|NCT00000552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110152524|NCT00000552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110152525|NCT00000555|Ascorbic Acid|ascorbic acid|mesh-list
110152527|NCT00000555|Hormones|hormones|mesh-list
110152529|NCT00000555|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110152530|NCT00000555|Estrogens|estrogens|mesh-list
110152531|NCT00000555|Vitamins|vitamins|mesh-ancestor
110152532|NCT00000555|Micronutrients|micronutrients|mesh-ancestor
110152533|NCT00000555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110152534|NCT00000555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110152535|NCT00000555|Progestins|progestins|mesh-ancestor
110152536|NCT00000555|Antioxidants|antioxidants|mesh-ancestor
110152537|NCT00000555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110152538|NCT00000555|Protective Agents|protective agents|mesh-ancestor
110152539|NCT04870957|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110152540|NCT04870957|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110152541|NCT04870957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110152542|NCT04870957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110152543|NCT04870957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110152544|NCT04870957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110152545|NCT04870957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110152546|NCT04870957|Analgesics|analgesics|mesh-ancestor
110152547|NCT04870957|Sensory System Agents|sensory system agents|mesh-ancestor
110152548|NCT04870957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110152549|NCT04870957|Antidepressive Agents|antidepressive agents|mesh-ancestor
110152550|NCT04870957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110152551|NCT04870957|Dopamine Agents|dopamine agents|mesh-ancestor
110152552|NCT00000558|Enzyme Inhibitors|enzyme inhibitors|mesh-list
110152553|NCT00000558|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110152554|NCT00000558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110152555|NCT00000558|Protease Inhibitors|protease inhibitors|mesh-ancestor
110152556|NCT04802746|Alprazolam|alprazolam|mesh-list
110152557|NCT04802746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110152558|NCT04802746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110152559|NCT04802746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110152560|NCT04802746|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110152561|NCT04802746|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110152562|NCT04802746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110152563|NCT04802746|GABA Modulators|gaba modulators|mesh-ancestor
110152564|NCT04802746|GABA Agents|gaba agents|mesh-ancestor
110152565|NCT04802746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110186991|NCT04488159|Micronutrients|micronutrients|mesh-ancestor
110152566|NCT04802746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110152567|NCT00000576|Beclomethasone|beclomethasone|mesh-list
110152568|NCT00000576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110152569|NCT00000576|Glucocorticoids|glucocorticoids|mesh-ancestor
110152570|NCT00000576|Hormones|hormones|mesh-ancestor
110152571|NCT00000576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110152572|NCT00000576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110152573|NCT00000576|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110152574|NCT00000576|Respiratory System Agents|respiratory system agents|mesh-ancestor
110152575|NCT00000579|Ketoconazole|ketoconazole|mesh-list
110152576|NCT00000579|Methylprednisolone|methylprednisolone|mesh-list
110152577|NCT00000579|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110152578|NCT00000579|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110152579|NCT00000579|Prednisolone|prednisolone|mesh-list
110152580|NCT00000579|Prednisolone acetate|prednisolone acetate|mesh-list
110152581|NCT00000579|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110152582|NCT00000579|Prednisolone phosphate|prednisolone phosphate|mesh-list
110152583|NCT00000579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110152584|NCT00000579|Antiemetics|antiemetics|mesh-ancestor
110152585|NCT00000579|Autonomic Agents|autonomic agents|mesh-ancestor
110152586|NCT00000579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110152587|NCT00000579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110152588|NCT00000579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110152589|NCT00000579|Glucocorticoids|glucocorticoids|mesh-ancestor
110152590|NCT00000579|Hormones|hormones|mesh-ancestor
110152591|NCT00000579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110152592|NCT00000579|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110152593|NCT00000579|Protective Agents|protective agents|mesh-ancestor
110152594|NCT00000579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110152595|NCT00000579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110152596|NCT00000579|Antifungal Agents|antifungal agents|mesh-ancestor
110152597|NCT00000579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110152598|NCT00000579|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110152599|NCT00000579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110152600|NCT00000579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110152601|NCT00000579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110152602|NCT00000579|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110152603|NCT00000579|Hormone Antagonists|hormone antagonists|mesh-ancestor
110152604|NCT00000579|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110152605|NCT00000588|Pyridoxal|pyridoxal|mesh-list
110152606|NCT00000588|Pyridoxal isonicotinoyl hydrazone|pyridoxal isonicotinoyl hydrazone|mesh-list
110152607|NCT00000588|Vitamin B Complex|vitamin b complex|mesh-ancestor
110152609|NCT00000588|Micronutrients|micronutrients|mesh-ancestor
110152610|NCT00000588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110152611|NCT00000588|Chelating Agents|chelating agents|mesh-ancestor
110152612|NCT00000588|Sequestering Agents|sequestering agents|mesh-ancestor
110152613|NCT00000588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110152614|NCT00000588|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110152615|NCT00000594|Cholestyramine Resin|cholestyramine resin|mesh-list
110152616|NCT00000594|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110152617|NCT00000594|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110152618|NCT00000594|Antimetabolites|antimetabolites|mesh-ancestor
110152619|NCT00000594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110152620|NCT00000594|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110152622|NCT00390091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110152623|NCT00390091|Immunologic Factors|immunologic factors|mesh-ancestor
110152624|NCT00390091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110152625|NCT00390130|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110152626|NCT00390130|Immunologic Factors|immunologic factors|mesh-ancestor
110152627|NCT00390130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110152628|NCT04650880|Vitamin D|vitamin d|mesh-list
110152629|NCT04650880|Vitamins|vitamins|mesh-ancestor
110152630|NCT04650880|Micronutrients|micronutrients|mesh-ancestor
110152631|NCT04650880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110152632|NCT04650880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110152634|NCT04601077|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110152635|NCT04601077|Autonomic Agents|autonomic agents|mesh-ancestor
110152636|NCT04601077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110152637|NCT04601077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110152639|NCT04601077|Respiratory System Agents|respiratory system agents|mesh-ancestor
110152640|NCT04601077|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110152641|NCT04601077|Antioxidants|antioxidants|mesh-ancestor
110152642|NCT04601077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110152643|NCT04601077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110152644|NCT04601077|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110152645|NCT04601077|Vasodilator Agents|vasodilator agents|mesh-ancestor
110152646|NCT04601077|Gasotransmitters|gasotransmitters|mesh-ancestor
110152647|NCT04601077|Protective Agents|protective agents|mesh-ancestor
110152648|NCT00000609|Amiodarone|amiodarone|mesh-list
110152649|NCT00000609|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110152650|NCT00000609|Vasodilator Agents|vasodilator agents|mesh-ancestor
110152651|NCT00000609|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110152652|NCT00000609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110152653|NCT00000609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110152654|NCT00000609|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110152655|NCT00000609|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110152656|NCT00000609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110152657|NCT00000609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110152658|NCT00000609|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110152659|NCT00000609|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110152660|NCT00000609|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110152661|NCT04547530|Vitamin D|vitamin d|mesh-list
110152662|NCT04547530|Vitamins|vitamins|mesh-ancestor
110152663|NCT04547530|Micronutrients|micronutrients|mesh-ancestor
110152664|NCT04547530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110152665|NCT04547530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110152666|NCT04544683|Dexamethasone|dexamethasone|mesh-list
110152667|NCT04544683|Dexamethasone acetate|dexamethasone acetate|mesh-list
110152668|NCT04544683|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
110152669|NCT04544683|BB 1101|bb 1101|mesh-list
110152670|NCT04544683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110152671|NCT04544683|Antiemetics|antiemetics|mesh-ancestor
110152672|NCT04544683|Autonomic Agents|autonomic agents|mesh-ancestor
110152673|NCT04544683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110152674|NCT04544683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110152675|NCT04544683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110152676|NCT04544683|Glucocorticoids|glucocorticoids|mesh-ancestor
110152677|NCT04544683|Hormones|hormones|mesh-ancestor
110152678|NCT04544683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110152679|NCT04544683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110152680|NCT04544683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110152681|NCT04544683|Protease Inhibitors|protease inhibitors|mesh-ancestor
110152682|NCT04544683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110152683|NCT04544683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110152684|NCT00000612|Estrogens|estrogens|mesh-list
110152685|NCT00000612|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110152686|NCT00000612|Hormones|hormones|mesh-ancestor
110152687|NCT00000612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110152688|NCT00000612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110152689|NCT00000639|Itraconazole|itraconazole|mesh-list
110152690|NCT00000639|Fluconazole|fluconazole|mesh-list
110152691|NCT00000639|Amphotericin B|amphotericin b|mesh-list
110152692|NCT00000639|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110152693|NCT00000639|Flucytosine|flucytosine|mesh-list
110152694|NCT00000639|Antifungal Agents|antifungal agents|mesh-ancestor
110152695|NCT00000639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110152696|NCT00000639|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110152697|NCT00000639|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110152698|NCT00000639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110152699|NCT00000639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110152701|NCT00000639|Hormone Antagonists|hormone antagonists|mesh-ancestor
110152702|NCT00000639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110152703|NCT00000639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110152704|NCT00000639|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110152705|NCT00000639|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110152706|NCT00000639|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110152707|NCT00000639|Amebicides|amebicides|mesh-ancestor
110152708|NCT00000639|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110152709|NCT00000639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110152710|NCT00000639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110152711|NCT00000639|Antimetabolites|antimetabolites|mesh-ancestor
110152712|NCT00000642|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
110152713|NCT00000642|Immunologic Factors|immunologic factors|mesh-ancestor
110152714|NCT00000642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110152715|NCT00000645|Hypericin|hypericin|mesh-list
110152716|NCT00000645|Antidepressive Agents|antidepressive agents|mesh-ancestor
110152717|NCT00000645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110152718|NCT00000645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110152719|NCT00000645|Antiviral Agents|antiviral agents|mesh-ancestor
110152720|NCT00000645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110152721|NCT00000645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110152722|NCT00000645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110152723|NCT00000645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110152724|NCT00000645|Immunologic Factors|immunologic factors|mesh-ancestor
110152725|NCT00000645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110152726|NCT04495504|Ropivacaine|ropivacaine|mesh-list
110152727|NCT04495504|Anesthetics, Local|anesthetics, local|mesh-ancestor
110152728|NCT04495504|Anesthetics|anesthetics|mesh-ancestor
110152729|NCT04495504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110152730|NCT04495504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110152731|NCT04495504|Sensory System Agents|sensory system agents|mesh-ancestor
110152732|NCT04495504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110152733|NCT00390208|Dexamethasone|dexamethasone|mesh-list
110152734|NCT00390208|Ranibizumab|ranibizumab|mesh-list
110152735|NCT00390208|Verteporfin|verteporfin|mesh-list
110152736|NCT00390208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110152737|NCT00390208|Antiemetics|antiemetics|mesh-ancestor
110152738|NCT00390208|Autonomic Agents|autonomic agents|mesh-ancestor
110152739|NCT00390208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110152740|NCT00390208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110152741|NCT00390208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110152742|NCT00390208|Glucocorticoids|glucocorticoids|mesh-ancestor
110152743|NCT00390208|Hormones|hormones|mesh-ancestor
110152744|NCT00390208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110152745|NCT00390208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110152746|NCT00390208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110152747|NCT00390208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110152748|NCT00390208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110152750|NCT00390208|Growth Inhibitors|growth inhibitors|mesh-ancestor
110152751|NCT00390208|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110152752|NCT00390208|Dermatologic Agents|dermatologic agents|mesh-ancestor
110152753|NCT00389025|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
110152754|NCT00389025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110152755|NCT00389025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110152756|NCT00389025|Analgesics|analgesics|mesh-ancestor
110152757|NCT00389025|Sensory System Agents|sensory system agents|mesh-ancestor
110152758|NCT00389025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110152759|NCT00389025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110152760|NCT00389025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110152761|NCT00389025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110152762|NCT00389025|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110152763|NCT00389025|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110152764|NCT00389025|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110187015|NCT04315948|Antimalarials|antimalarials|mesh-ancestor
110152766|NCT00389025|Histamine Agents|histamine agents|mesh-ancestor
110152767|NCT00389025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110152768|NCT00389025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110152769|NCT00390247|Thalidomide|thalidomide|mesh-list
110152770|NCT00390247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110152771|NCT00390247|Immunologic Factors|immunologic factors|mesh-ancestor
110152772|NCT00390247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110152773|NCT00390247|Leprostatic Agents|leprostatic agents|mesh-ancestor
110152774|NCT00390247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110152775|NCT00390247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110152776|NCT00390247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110152777|NCT00390247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110152778|NCT00390247|Growth Substances|growth substances|mesh-ancestor
110152779|NCT00390247|Growth Inhibitors|growth inhibitors|mesh-ancestor
110152780|NCT00390247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110152781|NCT00000651|Zidovudine|zidovudine|mesh-list
110152782|NCT00000651|Zalcitabine|zalcitabine|mesh-list
110152783|NCT00000651|Antimetabolites|antimetabolites|mesh-ancestor
110152784|NCT00000651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110152785|NCT00000651|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110152786|NCT00000651|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110152787|NCT00000651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110152789|NCT00000651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110152791|NCT00000651|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110152792|NCT00000666|Pyrimethamine|pyrimethamine|mesh-list
110152793|NCT00000666|Antimalarials|antimalarials|mesh-ancestor
110152794|NCT00000666|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110152795|NCT00000666|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110152796|NCT00000666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110152797|NCT00000666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110152798|NCT00000666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110152799|NCT00000666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110152800|NCT00000672|Didanosine|didanosine|mesh-list
110152801|NCT00000672|Antimetabolites|antimetabolites|mesh-ancestor
110152802|NCT00000672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110152803|NCT00000672|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110152804|NCT00000672|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110152805|NCT00000672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110152806|NCT00000672|Antiviral Agents|antiviral agents|mesh-ancestor
110152807|NCT00000672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110152808|NCT00000672|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110152809|NCT00000672|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110152810|NCT04321954|Lenvatinib|lenvatinib|mesh-list
110152811|NCT04321954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110152812|NCT04321954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110152813|NCT04321954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110152814|NCT04321954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110152815|NCT00000675|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
110152816|NCT00000675|Immunologic Factors|immunologic factors|mesh-ancestor
110152817|NCT00000675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110152819|NCT00000678|Zalcitabine|zalcitabine|mesh-list
110152820|NCT00000678|Antimetabolites|antimetabolites|mesh-ancestor
110152821|NCT00000678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110152822|NCT00000678|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110152823|NCT00000678|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110152824|NCT00000678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110152825|NCT00000678|Antiviral Agents|antiviral agents|mesh-ancestor
110152826|NCT00000678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110152827|NCT00000678|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110152828|NCT00000678|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110152829|NCT00390403|Acetic Acid|acetic acid|mesh-list
110152830|NCT00390403|Temozolomide|temozolomide|mesh-list
110152831|NCT00390403|Retinol acetate|retinol acetate|mesh-list
110152832|NCT00390403|Gossypol acetic acid|gossypol acetic acid|mesh-list
110152833|NCT00390403|Gossypol|gossypol|mesh-list
110152834|NCT00390403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110152835|NCT00390403|Alkylating Agents|alkylating agents|mesh-ancestor
110152836|NCT00390403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110152837|NCT00390403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110152838|NCT00390403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110152839|NCT00390403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110152840|NCT00390403|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110152841|NCT00390403|Immunologic Factors|immunologic factors|mesh-ancestor
110152842|NCT00390403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110152843|NCT00390403|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110152844|NCT00390403|Protective Agents|protective agents|mesh-ancestor
110152845|NCT00390403|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110152846|NCT00390403|Contraceptive Agents|contraceptive agents|mesh-ancestor
110152847|NCT00390403|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110152848|NCT00390403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110152849|NCT00390403|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110152850|NCT00390403|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
110152851|NCT00390403|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
110152852|NCT00000681|Zidovudine|zidovudine|mesh-list
110152853|NCT00000681|Doxorubicin|doxorubicin|mesh-list
110152854|NCT00000681|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110152855|NCT00000681|Bleomycin|bleomycin|mesh-list
110152856|NCT00000681|Vincristine|vincristine|mesh-list
110152858|NCT00000681|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110152859|NCT00000681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110152860|NCT00000681|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110152861|NCT00000681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110152862|NCT00000681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110152863|NCT00000681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110152864|NCT00000681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110152865|NCT00000681|Tubulin Modulators|tubulin modulators|mesh-ancestor
110152866|NCT00000681|Antimitotic Agents|antimitotic agents|mesh-ancestor
110152867|NCT00000681|Mitosis Modulators|mitosis modulators|mesh-ancestor
110152868|NCT00000681|Antimetabolites|antimetabolites|mesh-ancestor
110152869|NCT00000681|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110152870|NCT00000681|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110152871|NCT00000681|Antiviral Agents|antiviral agents|mesh-ancestor
110152872|NCT00000681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110152873|NCT00000681|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110152874|NCT00000681|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110152875|NCT00000681|Immunologic Factors|immunologic factors|mesh-ancestor
110152876|NCT00000681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110152877|NCT00000684|Dextrans|dextrans|mesh-list
110152878|NCT00000684|Anticoagulants|anticoagulants|mesh-ancestor
110152879|NCT00000684|Plasma Substitutes|plasma substitutes|mesh-ancestor
110152880|NCT00000684|Blood Substitutes|blood substitutes|mesh-ancestor
110152881|NCT00000687|Interferons|interferons|mesh-list
110152883|NCT00000687|Interferon alpha-2|interferon alpha-2|mesh-list
110152884|NCT00000687|Zidovudine|zidovudine|mesh-list
110152885|NCT00000687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110152886|NCT00000687|Antiviral Agents|antiviral agents|mesh-ancestor
110152887|NCT00000687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110152888|NCT00000687|Immunologic Factors|immunologic factors|mesh-ancestor
110152889|NCT00000687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110152890|NCT00000687|Antimetabolites|antimetabolites|mesh-ancestor
110152891|NCT00000687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110152892|NCT00000687|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110152893|NCT00000687|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110152895|NCT00000687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110152896|NCT00000687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110152897|NCT00000690|Dextrans|dextrans|mesh-list
110152898|NCT00000690|Anticoagulants|anticoagulants|mesh-ancestor
110152899|NCT00000690|Plasma Substitutes|plasma substitutes|mesh-ancestor
110152900|NCT00000690|Blood Substitutes|blood substitutes|mesh-ancestor
110152902|NCT00000696|Interferon-alpha|interferon-alpha|mesh-list
110152903|NCT00000696|Interferon alpha-2|interferon alpha-2|mesh-list
110152904|NCT00000696|Zidovudine|zidovudine|mesh-list
110152905|NCT00000696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110152906|NCT00000696|Antiviral Agents|antiviral agents|mesh-ancestor
110152907|NCT00000696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110152908|NCT00000696|Immunologic Factors|immunologic factors|mesh-ancestor
110152909|NCT00000696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110152910|NCT00000696|Antimetabolites|antimetabolites|mesh-ancestor
110152911|NCT00000696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110152912|NCT00000696|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110152913|NCT00000696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110152914|NCT00000696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110152916|NCT00000696|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110152917|NCT00000705|Zidovudine|zidovudine|mesh-list
110152918|NCT00000705|Antimetabolites|antimetabolites|mesh-ancestor
110152919|NCT00000705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110152920|NCT00000705|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110152921|NCT00000705|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110152922|NCT00000705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110152923|NCT00000705|Antiviral Agents|antiviral agents|mesh-ancestor
110152924|NCT00000705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110152925|NCT00000705|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110152926|NCT00000705|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110152927|NCT00000708|Fluconazole|fluconazole|mesh-list
110152928|NCT00000708|Amphotericin B|amphotericin b|mesh-list
110152929|NCT00000708|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110152930|NCT00000708|Flucytosine|flucytosine|mesh-list
110152931|NCT00000708|Antifungal Agents|antifungal agents|mesh-ancestor
110152932|NCT00000708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110152933|NCT00000708|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110152934|NCT00000708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110152936|NCT00000708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110152938|NCT00000708|Hormone Antagonists|hormone antagonists|mesh-ancestor
110152939|NCT00000708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110152940|NCT00000708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110152941|NCT00000708|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110152942|NCT00000708|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110152943|NCT00000708|Amebicides|amebicides|mesh-ancestor
110152944|NCT00000708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110152945|NCT00000708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110152946|NCT00000708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110152947|NCT00000708|Antimetabolites|antimetabolites|mesh-ancestor
110152948|NCT00000711|Zidovudine|zidovudine|mesh-list
110152949|NCT00000711|Sargramostim|sargramostim|mesh-list
110152950|NCT00000711|Antimetabolites|antimetabolites|mesh-ancestor
110152951|NCT00000711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110152952|NCT00000711|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110152953|NCT00000711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110152954|NCT00000711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110152955|NCT00000711|Antiviral Agents|antiviral agents|mesh-ancestor
110152956|NCT00000711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110152957|NCT00000711|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110152958|NCT00000711|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110152959|NCT00000711|Immunologic Factors|immunologic factors|mesh-ancestor
110152960|NCT00000711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110152962|NCT00000717|Clindamycin palmitate|clindamycin palmitate|mesh-list
110152963|NCT00000717|Clindamycin phosphate|clindamycin phosphate|mesh-list
110152964|NCT00000717|Primaquine|primaquine|mesh-list
110152965|NCT00000717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110152966|NCT00000717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110152967|NCT00000717|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110152968|NCT00000717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110152969|NCT00000717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110152970|NCT00000717|Antimalarials|antimalarials|mesh-ancestor
110152971|NCT00000717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110152972|NCT00000717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110152973|NCT00000720|Zidovudine|zidovudine|mesh-list
110152974|NCT00000720|Immunoglobulins|immunoglobulins|mesh-list
110152975|NCT00000720|Antibodies|antibodies|mesh-list
110152976|NCT00000720|Antimetabolites|antimetabolites|mesh-ancestor
110152977|NCT00000720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110152978|NCT00000720|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110152979|NCT00000720|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110152980|NCT00000720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110152981|NCT00000720|Antiviral Agents|antiviral agents|mesh-ancestor
110152982|NCT00000720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110152983|NCT00000720|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110152984|NCT00000720|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110152985|NCT00000720|Immunologic Factors|immunologic factors|mesh-ancestor
110152986|NCT00000720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110152988|NCT04142983|Immunologic Factors|immunologic factors|mesh-ancestor
110152989|NCT04142983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110152990|NCT00000726|Foscarnet|foscarnet|mesh-list
110152991|NCT00000726|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
110152992|NCT00000726|Antiviral Agents|antiviral agents|mesh-ancestor
110152993|NCT00000726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110152994|NCT00000726|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110152995|NCT00000726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110152996|NCT00000726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110152997|NCT00000726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110152999|NCT00000741|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110153000|NCT00000741|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110153001|NCT00000741|Prednisolone|prednisolone|mesh-list
110153002|NCT00000741|Prednisolone acetate|prednisolone acetate|mesh-list
110153003|NCT00000741|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110153004|NCT00000741|Prednisolone phosphate|prednisolone phosphate|mesh-list
110153005|NCT00000741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110153006|NCT00000741|Antiemetics|antiemetics|mesh-ancestor
110153007|NCT00000741|Autonomic Agents|autonomic agents|mesh-ancestor
110153008|NCT00000741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110153009|NCT00000741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110153010|NCT00000741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110153011|NCT00000741|Glucocorticoids|glucocorticoids|mesh-ancestor
110153013|NCT00000741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110153014|NCT00000741|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110153015|NCT00000741|Protective Agents|protective agents|mesh-ancestor
110153016|NCT00000741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110153017|NCT00000741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110153018|NCT04069897|Botulinum Toxins|botulinum toxins|mesh-list
110153019|NCT04069897|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110153020|NCT04069897|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110153021|NCT04069897|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110153022|NCT04069897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110153023|NCT04069897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110153024|NCT04069897|Cholinergic Agents|cholinergic agents|mesh-ancestor
110153025|NCT04069897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110153026|NCT04069897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110153027|NCT04069897|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110153028|NCT04069897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110153029|NCT00000744|Fluconazole|fluconazole|mesh-list
110153030|NCT00000744|Antifungal Agents|antifungal agents|mesh-ancestor
110153031|NCT00000744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110153032|NCT00000744|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110153033|NCT00000744|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110153034|NCT00000744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110153035|NCT00000744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110153036|NCT00000744|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110153037|NCT00000744|Hormone Antagonists|hormone antagonists|mesh-ancestor
110153038|NCT00000744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110153039|NCT00000744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110153040|NCT00000744|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110153041|NCT00000744|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110153042|NCT04038346|Acetaminophen|acetaminophen|mesh-list
110153043|NCT04038346|Naproxen|naproxen|mesh-list
110153044|NCT04038346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110153045|NCT04038346|Analgesics|analgesics|mesh-ancestor
110153046|NCT04038346|Sensory System Agents|sensory system agents|mesh-ancestor
110153047|NCT04038346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110187038|NCT04243629|Pramlintide|pramlintide|mesh-list
110153048|NCT04038346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110153050|NCT04038346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110153051|NCT04038346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110153052|NCT04038346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110153053|NCT04038346|Gout Suppressants|gout suppressants|mesh-ancestor
110153054|NCT04038346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110153055|NCT04038346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110153056|NCT04038346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110153057|NCT04020172|Dobutamine|dobutamine|mesh-list
110153058|NCT04020172|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110153059|NCT04020172|Sympathomimetics|sympathomimetics|mesh-ancestor
110153060|NCT04020172|Autonomic Agents|autonomic agents|mesh-ancestor
110153061|NCT04020172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110153062|NCT04020172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110153063|NCT04020172|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110153065|NCT04020172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110153066|NCT04020172|Adrenergic Agents|adrenergic agents|mesh-ancestor
110153067|NCT04020172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110153068|NCT04020172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110153069|NCT04020172|Protective Agents|protective agents|mesh-ancestor
110153071|NCT00000747|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110153072|NCT00000747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110153073|NCT00000747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110153074|NCT00000747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110153075|NCT00000747|Antiviral Agents|antiviral agents|mesh-ancestor
110153076|NCT00000747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110153077|NCT00000747|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110153078|NCT00000747|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110153079|NCT00000747|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110153080|NCT00000747|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110153081|NCT00000753|Zidovudine|zidovudine|mesh-list
110153082|NCT00000753|Didanosine|didanosine|mesh-list
110153083|NCT00000753|Zalcitabine|zalcitabine|mesh-list
110153084|NCT00000753|Atevirdine|atevirdine|mesh-list
110153085|NCT00000753|Antimetabolites|antimetabolites|mesh-ancestor
110153086|NCT00000753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110153087|NCT00000753|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110153088|NCT00000753|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110153089|NCT00000753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110153090|NCT00000753|Antiviral Agents|antiviral agents|mesh-ancestor
110153091|NCT00000753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110153092|NCT00000753|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110153093|NCT00000753|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110153094|NCT03991741|Interleukin-2|interleukin-2|mesh-list
110153095|NCT03991741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110153096|NCT03991741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110153097|NCT03991741|Analgesics|analgesics|mesh-ancestor
110153098|NCT03991741|Sensory System Agents|sensory system agents|mesh-ancestor
110153099|NCT03991741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110153100|NCT03991741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110153102|NCT00000768|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
110153103|NCT00000768|Antiviral Agents|antiviral agents|mesh-ancestor
110153104|NCT00000768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110153105|NCT00000768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110153106|NCT00000768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110153107|NCT00000768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110153108|NCT00000789|Zidovudine|zidovudine|mesh-list
110153109|NCT00000789|Stavudine|stavudine|mesh-list
110153110|NCT00000789|Antimetabolites|antimetabolites|mesh-ancestor
110153111|NCT00000789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110153112|NCT00000789|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110153113|NCT00000789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110153114|NCT00000789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110153116|NCT00000789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110153117|NCT00000789|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110153118|NCT00000789|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110153119|NCT00000792|Hypericin|hypericin|mesh-list
110153120|NCT00000792|Antidepressive Agents|antidepressive agents|mesh-ancestor
110153121|NCT00000792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110153122|NCT00000792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110153123|NCT00000792|Antiviral Agents|antiviral agents|mesh-ancestor
110153124|NCT00000792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110153125|NCT00000792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110153137|NCT00390520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110153138|NCT00390520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110153139|NCT00390520|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110153140|NCT00390520|Protease Inhibitors|protease inhibitors|mesh-ancestor
110153141|NCT00390520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110153142|NCT00390520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110153144|NCT00000813|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110153145|NCT00000813|Immunologic Factors|immunologic factors|mesh-ancestor
110153146|NCT00000813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110153147|NCT00000813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110153148|NCT00000813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110153149|NCT00000813|Antiviral Agents|antiviral agents|mesh-ancestor
110153150|NCT00000813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110153151|NCT00000813|Interferon Inducers|interferon inducers|mesh-ancestor
110153152|NCT00000813|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110153153|NCT00000813|Protective Agents|protective agents|mesh-ancestor
110153166|NCT00390598|Sennosides|sennosides|mesh-list
110153167|NCT00390598|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110153168|NCT00390598|Laxatives|laxatives|mesh-ancestor
110153169|NCT00390598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110153170|NCT00000816|Trimethoprim|trimethoprim|mesh-list
110153171|NCT00000816|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110153172|NCT00000816|Sulfamethoxazole|sulfamethoxazole|mesh-list
110153173|NCT00000816|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110153174|NCT00000816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110153175|NCT00000816|Antimalarials|antimalarials|mesh-ancestor
110153176|NCT00000816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110153177|NCT00000816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110153178|NCT00000816|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110153179|NCT00000816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110153180|NCT00000816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110153181|NCT00000816|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110153182|NCT00000816|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110153183|NCT00000816|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110153184|NCT00000816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110153185|NCT03801031|Lidocaine|lidocaine|mesh-list
110153186|NCT03801031|Anesthetics, Local|anesthetics, local|mesh-ancestor
110153187|NCT03801031|Anesthetics|anesthetics|mesh-ancestor
110153188|NCT03801031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110153189|NCT03801031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110153190|NCT03801031|Sensory System Agents|sensory system agents|mesh-ancestor
110153192|NCT03801031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110153193|NCT03801031|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110153194|NCT03801031|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110153195|NCT03801031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110153196|NCT03801031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110153197|NCT00000822|Ritonavir|ritonavir|mesh-list
110153198|NCT00000822|Stavudine|stavudine|mesh-list
110153199|NCT00000822|Didanosine|didanosine|mesh-list
110153200|NCT00000822|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110153201|NCT00000822|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110153202|NCT00000822|Protease Inhibitors|protease inhibitors|mesh-ancestor
110153203|NCT00000822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110153204|NCT00000822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110153205|NCT00000822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110153206|NCT00000822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110153207|NCT00000822|Antiviral Agents|antiviral agents|mesh-ancestor
110153208|NCT00000822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110153209|NCT00000822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110153210|NCT00000822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110153211|NCT00000822|Antimetabolites|antimetabolites|mesh-ancestor
110153212|NCT00000822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110153213|NCT00000822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110153214|NCT03797560|Pregabalin|pregabalin|mesh-list
110153215|NCT03797560|Analgesics|analgesics|mesh-ancestor
110153216|NCT03797560|Sensory System Agents|sensory system agents|mesh-ancestor
110153217|NCT03797560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110153218|NCT03797560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110153219|NCT03797560|Anticonvulsants|anticonvulsants|mesh-ancestor
110153220|NCT03797560|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110153221|NCT03797560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110153222|NCT03797560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110153223|NCT03797560|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110153225|NCT03797560|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110153226|NCT03797560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110153227|NCT03797560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110153228|NCT03729271|Rifaximin|rifaximin|mesh-list
110153229|NCT03729271|Lactulose|lactulose|mesh-list
110153230|NCT03729271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110153231|NCT03729271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110153232|NCT03729271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110153233|NCT03574402|Carboplatin|carboplatin|mesh-list
110153234|NCT03574402|Gemcitabine|gemcitabine|mesh-list
110153235|NCT03574402|Pemetrexed|pemetrexed|mesh-list
110153236|NCT03574402|Afatinib|afatinib|mesh-list
110153237|NCT03574402|Crizotinib|crizotinib|mesh-list
110153238|NCT03574402|Nimotuzumab|nimotuzumab|mesh-list
110153239|NCT03574402|Ensartinib|ensartinib|mesh-list
110153241|NCT03574402|Abivertinib|abivertinib|mesh-list
110153242|NCT03574402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110153243|NCT03574402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110153244|NCT03574402|Antimetabolites|antimetabolites|mesh-ancestor
110153245|NCT03574402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110153246|NCT03574402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110153247|NCT03574402|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110153248|NCT03574402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110153249|NCT03574402|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110153252|NCT03539302|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110153253|NCT03539302|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110153254|NCT03539302|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110153255|NCT03539302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110153256|NCT03539302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110153258|NCT00000831|Zidovudine|zidovudine|mesh-list
110153259|NCT00000831|Stavudine|stavudine|mesh-list
110153260|NCT00000831|Didanosine|didanosine|mesh-list
110153261|NCT00000831|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110153262|NCT00000831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110153263|NCT00000831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110153264|NCT00000831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110153265|NCT00000831|Antiviral Agents|antiviral agents|mesh-ancestor
110153266|NCT00000831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110153267|NCT00000831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110153268|NCT00000831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110153269|NCT00000831|Antimetabolites|antimetabolites|mesh-ancestor
110153270|NCT00000849|Aldesleukin|aldesleukin|mesh-list
110153271|NCT00000849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110153272|NCT00000849|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110153273|NCT00000849|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110153274|NCT00000849|Antiviral Agents|antiviral agents|mesh-ancestor
110153275|NCT00000849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110153276|NCT03357952|Daratumumab|daratumumab|mesh-list
110153278|NCT00000855|Zidovudine|zidovudine|mesh-list
110153279|NCT00000855|Antimetabolites|antimetabolites|mesh-ancestor
110153280|NCT00000855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110153281|NCT00000855|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110153282|NCT00000855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110153283|NCT00000855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110153284|NCT00000855|Antiviral Agents|antiviral agents|mesh-ancestor
110153285|NCT00000855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110153286|NCT00000855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110153287|NCT00000855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110153288|NCT00000867|Memantine|memantine|mesh-list
110153289|NCT00000867|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110153290|NCT00000867|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110153291|NCT00000867|Dopamine Agents|dopamine agents|mesh-ancestor
110153292|NCT00000867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110153293|NCT00000867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110153294|NCT00000867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110153295|NCT00000867|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110153296|NCT00000867|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110153297|NCT00390676|Carboplatin|carboplatin|mesh-list
110153298|NCT00390676|Docetaxel|docetaxel|mesh-list
110153299|NCT00390676|Capecitabine|capecitabine|mesh-list
110153300|NCT00390676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110153301|NCT00390676|Tubulin Modulators|tubulin modulators|mesh-ancestor
110153302|NCT00390676|Antimitotic Agents|antimitotic agents|mesh-ancestor
110153303|NCT00390676|Mitosis Modulators|mitosis modulators|mesh-ancestor
110153304|NCT00390676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110153305|NCT00390676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110153306|NCT00390676|Antimetabolites|antimetabolites|mesh-ancestor
110153307|NCT00000870|Lamivudine|lamivudine|mesh-list
110153308|NCT00000870|Zidovudine|zidovudine|mesh-list
110153309|NCT00000870|Stavudine|stavudine|mesh-list
110153310|NCT00000870|Didanosine|didanosine|mesh-list
110153311|NCT00000870|Aldesleukin|aldesleukin|mesh-list
110153312|NCT00000870|Indinavir|indinavir|mesh-list
110153313|NCT00000870|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110153314|NCT00000870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110153315|NCT00000870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110153316|NCT00000870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110153317|NCT00000870|Antiviral Agents|antiviral agents|mesh-ancestor
110153318|NCT00000870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110153319|NCT00000870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110153320|NCT00000870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110153321|NCT00000870|Antimetabolites|antimetabolites|mesh-ancestor
110153322|NCT00000870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110153323|NCT00000870|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110153324|NCT00000870|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110153325|NCT00000870|Protease Inhibitors|protease inhibitors|mesh-ancestor
110153327|NCT00390832|Hematinics|hematinics|mesh-ancestor
110153328|NCT00390871|Fentanyl|fentanyl|mesh-list
110153329|NCT00390871|Dexmedetomidine|dexmedetomidine|mesh-list
110153330|NCT00390871|Propofol|propofol|mesh-list
110153331|NCT00390871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110153332|NCT00390871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110153333|NCT00390871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110153334|NCT00390871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110153335|NCT00390871|Analgesics|analgesics|mesh-ancestor
110153336|NCT00390871|Sensory System Agents|sensory system agents|mesh-ancestor
110153337|NCT00390871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110153338|NCT00390871|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110153339|NCT00390871|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110153340|NCT00390871|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110153341|NCT00390871|Adrenergic Agents|adrenergic agents|mesh-ancestor
110153342|NCT00390871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110153343|NCT00390871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110153344|NCT00390871|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110153345|NCT00390871|Anesthetics, General|anesthetics, general|mesh-ancestor
110153346|NCT00390871|Anesthetics|anesthetics|mesh-ancestor
110153347|NCT00390871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110153348|NCT00390871|Narcotics|narcotics|mesh-ancestor
110153349|NCT00390871|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110153350|NCT03211741|Bevacizumab|bevacizumab|mesh-list
110153351|NCT03211741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110153352|NCT03211741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110153353|NCT03211741|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110153354|NCT03211741|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110153355|NCT03211741|Growth Substances|growth substances|mesh-ancestor
110153356|NCT03211741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110153357|NCT03211741|Growth Inhibitors|growth inhibitors|mesh-ancestor
110153359|NCT00000882|Zidovudine|zidovudine|mesh-list
110153360|NCT00000882|Stavudine|stavudine|mesh-list
110153361|NCT00000882|Delavirdine|delavirdine|mesh-list
110153362|NCT00000882|Indinavir|indinavir|mesh-list
110153363|NCT00000882|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110153364|NCT00000882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110153365|NCT00000882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110153366|NCT00000882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110153367|NCT00000882|Antiviral Agents|antiviral agents|mesh-ancestor
110153368|NCT00000882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110153369|NCT00000882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110153370|NCT00000882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110153371|NCT00000882|Antimetabolites|antimetabolites|mesh-ancestor
110153372|NCT00000882|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110153373|NCT00000882|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110153374|NCT00000882|Protease Inhibitors|protease inhibitors|mesh-ancestor
110153375|NCT00000888|Ritonavir|ritonavir|mesh-list
110153376|NCT00000888|Lamivudine|lamivudine|mesh-list
110153377|NCT00000888|Zidovudine|zidovudine|mesh-list
110153378|NCT00000888|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110153379|NCT00000888|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110153380|NCT00000888|Protease Inhibitors|protease inhibitors|mesh-ancestor
110153381|NCT00000888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110153382|NCT00000888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110153383|NCT00000888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110153384|NCT00000888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110153385|NCT00000888|Antiviral Agents|antiviral agents|mesh-ancestor
110153386|NCT00000888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110153387|NCT00000888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110153388|NCT00000888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110153389|NCT00000888|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110153390|NCT00000888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110153391|NCT00000888|Antimetabolites|antimetabolites|mesh-ancestor
110153392|NCT00000891|Ritonavir|ritonavir|mesh-list
110153393|NCT00000891|Saquinavir|saquinavir|mesh-list
110153394|NCT00000891|Lamivudine|lamivudine|mesh-list
110153395|NCT00000891|Zidovudine|zidovudine|mesh-list
110153396|NCT00000891|Stavudine|stavudine|mesh-list
110153398|NCT00000891|Delavirdine|delavirdine|mesh-list
110153399|NCT00000891|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110153400|NCT00000891|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110153402|NCT00000891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110153403|NCT00000891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110153404|NCT00000891|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110153405|NCT00000891|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110153406|NCT00000891|Antiviral Agents|antiviral agents|mesh-ancestor
110153407|NCT00000891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110153408|NCT00000891|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110153409|NCT00000891|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110153410|NCT00000891|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110153411|NCT00000891|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110153412|NCT00000891|Antimetabolites|antimetabolites|mesh-ancestor
110153413|NCT00000903|Lamivudine|lamivudine|mesh-list
110153414|NCT00000903|Zidovudine|zidovudine|mesh-list
110153415|NCT00000903|Efavirenz|efavirenz|mesh-list
110153416|NCT00000903|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
110153417|NCT00000903|Nelfinavir|nelfinavir|mesh-list
110153418|NCT00000903|Indinavir|indinavir|mesh-list
110153419|NCT00000903|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110153420|NCT00000903|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110153421|NCT00000903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110153422|NCT00000903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110153423|NCT00000903|Antiviral Agents|antiviral agents|mesh-ancestor
110153424|NCT00000903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110153425|NCT00000903|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110153426|NCT00000903|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110153427|NCT00000903|Antimetabolites|antimetabolites|mesh-ancestor
110153428|NCT00000903|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110153429|NCT00000903|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110153430|NCT00000903|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110153431|NCT00000903|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110153432|NCT00000903|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110153433|NCT00000903|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110153434|NCT00000903|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110153435|NCT00000903|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110153436|NCT00000903|Protease Inhibitors|protease inhibitors|mesh-ancestor
110153437|NCT02939365|Abatacept|abatacept|mesh-list
110153438|NCT02939365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110187100|NCT04182997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110153439|NCT02939365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110153440|NCT02939365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110153441|NCT02939365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110153442|NCT02939365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110153443|NCT02939365|Immunologic Factors|immunologic factors|mesh-ancestor
110153444|NCT02939365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110153445|NCT02939365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110153446|NCT00000906|Ritonavir|ritonavir|mesh-list
110153447|NCT00000906|Saquinavir|saquinavir|mesh-list
110153448|NCT00000906|Methadone|methadone|mesh-list
110153449|NCT00000906|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110153450|NCT00000906|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110153451|NCT00000906|Protease Inhibitors|protease inhibitors|mesh-ancestor
110153452|NCT00000906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110153453|NCT00000906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110153454|NCT00000906|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110153455|NCT00000906|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110153456|NCT00000906|Antiviral Agents|antiviral agents|mesh-ancestor
110153457|NCT00000906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110153458|NCT00000906|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110153459|NCT00000906|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110153460|NCT00000906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110153461|NCT00000906|Narcotics|narcotics|mesh-ancestor
110153462|NCT00000906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110153463|NCT00000906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110153464|NCT00000906|Analgesics|analgesics|mesh-ancestor
110153465|NCT00000906|Sensory System Agents|sensory system agents|mesh-ancestor
110153466|NCT00000906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110153467|NCT00000906|Antitussive Agents|antitussive agents|mesh-ancestor
110153468|NCT00000906|Respiratory System Agents|respiratory system agents|mesh-ancestor
110153469|NCT02681302|Nivolumab|nivolumab|mesh-list
110153470|NCT02681302|Ipilimumab|ipilimumab|mesh-list
110153471|NCT02681302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110153472|NCT02681302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110153473|NCT02681302|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110153474|NCT02681302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110153475|NCT00000951|Fluconazole|fluconazole|mesh-list
110153476|NCT00000951|Antifungal Agents|antifungal agents|mesh-ancestor
110153477|NCT00000951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110153478|NCT00000951|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110153479|NCT00000951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110153480|NCT00000951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110153481|NCT00000951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110153482|NCT00000951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110153483|NCT00000951|Hormone Antagonists|hormone antagonists|mesh-ancestor
110153484|NCT00000951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110153485|NCT00000951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110153486|NCT00000951|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110153487|NCT00000951|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110153489|NCT00000966|Azithromycin|azithromycin|mesh-list
110153490|NCT00000966|Pyrimethamine|pyrimethamine|mesh-list
110153491|NCT00000966|Calcium|calcium|mesh-list
110153492|NCT00000966|Levoleucovorin|levoleucovorin|mesh-list
110187112|NCT04115111|Durvalumab|durvalumab|mesh-list
110153493|NCT00000966|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110153494|NCT00000966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110153495|NCT00000966|Antidotes|antidotes|mesh-ancestor
110153496|NCT00000966|Protective Agents|protective agents|mesh-ancestor
110153497|NCT00000966|Vitamin B Complex|vitamin b complex|mesh-ancestor
110153498|NCT00000966|Vitamins|vitamins|mesh-ancestor
110153499|NCT00000966|Micronutrients|micronutrients|mesh-ancestor
110153500|NCT00000966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110153501|NCT00000966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110153502|NCT00000966|Antimalarials|antimalarials|mesh-ancestor
110153503|NCT00000966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110153504|NCT00000966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110153505|NCT00000966|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110153507|NCT00000966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110153508|NCT00000969|Didanosine|didanosine|mesh-list
110153509|NCT00000969|Zalcitabine|zalcitabine|mesh-list
110153510|NCT00000969|Antimetabolites|antimetabolites|mesh-ancestor
110153511|NCT00000969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110153512|NCT00000969|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110153513|NCT00000969|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110153514|NCT00000969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110153515|NCT00000969|Antiviral Agents|antiviral agents|mesh-ancestor
110153516|NCT00000969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110153517|NCT00000969|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110153518|NCT00000969|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110153519|NCT00000975|Itraconazole|itraconazole|mesh-list
110153520|NCT00000975|Antifungal Agents|antifungal agents|mesh-ancestor
110153521|NCT00000975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110153522|NCT00000975|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110153523|NCT00000975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110153524|NCT00000975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110153525|NCT00000975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110153526|NCT00000975|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110153527|NCT00000975|Hormone Antagonists|hormone antagonists|mesh-ancestor
110153528|NCT00000975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110153529|NCT00000975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110153530|NCT00000975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110153533|NCT00000978|Antimetabolites|antimetabolites|mesh-ancestor
110153534|NCT00000978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110153535|NCT00000978|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110153536|NCT00000978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110153538|NCT00000978|Antiviral Agents|antiviral agents|mesh-ancestor
110153539|NCT00000978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110153540|NCT00000978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110153541|NCT00000978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110153542|NCT00000999|Zidovudine|zidovudine|mesh-list
110153543|NCT00000999|Antimetabolites|antimetabolites|mesh-ancestor
110153544|NCT00000999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110153545|NCT00000999|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110153546|NCT00000999|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110153547|NCT00000999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110153548|NCT00000999|Antiviral Agents|antiviral agents|mesh-ancestor
110153549|NCT00000999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110153550|NCT00000999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110153551|NCT00000999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110153553|NCT00001002|Foscarnet|foscarnet|mesh-list
110153554|NCT00001002|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
110153555|NCT00001002|Antimetabolites|antimetabolites|mesh-ancestor
110153556|NCT00001002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110153557|NCT00001002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110153558|NCT00001002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110153560|NCT00001002|Antiviral Agents|antiviral agents|mesh-ancestor
110153561|NCT00001002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110153562|NCT00001002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110153563|NCT00001002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110153564|NCT00005819|Paclitaxel|paclitaxel|mesh-list
110153565|NCT00005819|Fenretinide|fenretinide|mesh-list
110153566|NCT00005819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110153567|NCT00005819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110153568|NCT00005819|Tubulin Modulators|tubulin modulators|mesh-ancestor
110153569|NCT00005819|Antimitotic Agents|antimitotic agents|mesh-ancestor
110153570|NCT00005819|Mitosis Modulators|mitosis modulators|mesh-ancestor
110153571|NCT00005819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110153572|NCT00005819|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110153573|NCT00005819|Protective Agents|protective agents|mesh-ancestor
110153574|NCT00005819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110153576|NCT00001005|Aldesleukin|aldesleukin|mesh-list
110153577|NCT00001005|Antimetabolites|antimetabolites|mesh-ancestor
110153578|NCT00001005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110153579|NCT00001005|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110153580|NCT00001005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110153581|NCT00001005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110153582|NCT00001005|Antiviral Agents|antiviral agents|mesh-ancestor
110153583|NCT00001005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110153584|NCT00001005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110153585|NCT00001005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110153586|NCT00001005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110153587|NCT00391105|Remifentanil|remifentanil|mesh-list
110153588|NCT00391105|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110153589|NCT00391105|Narcotics|narcotics|mesh-ancestor
110153590|NCT00391105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110153591|NCT00391105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110153592|NCT00391105|Analgesics|analgesics|mesh-ancestor
110153593|NCT00391105|Sensory System Agents|sensory system agents|mesh-ancestor
110153594|NCT00391105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110153595|NCT00391144|Triamcinolone|triamcinolone|mesh-list
110153596|NCT00391144|Bevacizumab|bevacizumab|mesh-list
110153597|NCT00391144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110153598|NCT00391144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110153599|NCT00391144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110153600|NCT00391144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110153601|NCT00391144|Growth Substances|growth substances|mesh-ancestor
110153602|NCT00391144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110153603|NCT00391144|Growth Inhibitors|growth inhibitors|mesh-ancestor
110153604|NCT00391144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110153605|NCT00391144|Glucocorticoids|glucocorticoids|mesh-ancestor
110153606|NCT00391144|Hormones|hormones|mesh-ancestor
110153607|NCT00391144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110153608|NCT00005822|Tamoxifen|tamoxifen|mesh-list
110153609|NCT00005822|Doxorubicin|doxorubicin|mesh-list
110153610|NCT00005822|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110153611|NCT00005822|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110153612|NCT00005822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110153613|NCT00005822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110153614|NCT00005822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110153615|NCT00005822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110153616|NCT00005822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110153617|NCT00005822|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110153618|NCT00005822|Hormone Antagonists|hormone antagonists|mesh-ancestor
110153619|NCT00005822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110153620|NCT00005822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110153621|NCT00005822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110153622|NCT00005822|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110153623|NCT00005822|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110153624|NCT00005822|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110153626|NCT00391261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110153627|NCT00391261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110153628|NCT00001008|Zidovudine|zidovudine|mesh-list
110153629|NCT00001008|Methadone|methadone|mesh-list
110153630|NCT00001008|Antimetabolites|antimetabolites|mesh-ancestor
110153631|NCT00001008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110153632|NCT00001008|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110153633|NCT00001008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110153634|NCT00001008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110153635|NCT00001008|Antiviral Agents|antiviral agents|mesh-ancestor
110153636|NCT00001008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110153637|NCT00001008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110153638|NCT00001008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110153639|NCT00001008|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110153640|NCT00001008|Narcotics|narcotics|mesh-ancestor
110153641|NCT00001008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110153642|NCT00001008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110153643|NCT00001008|Analgesics|analgesics|mesh-ancestor
110153644|NCT00001008|Sensory System Agents|sensory system agents|mesh-ancestor
110153645|NCT00001008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110153646|NCT00001008|Antitussive Agents|antitussive agents|mesh-ancestor
110153647|NCT00001008|Respiratory System Agents|respiratory system agents|mesh-ancestor
110153648|NCT00005825|Vinorelbine|vinorelbine|mesh-list
110153649|NCT00005825|Mitomycins|mitomycins|mesh-list
110153650|NCT00005825|Mitomycin|mitomycin|mesh-list
110153651|NCT00005825|Tretinoin|tretinoin|mesh-list
110153652|NCT00005825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110153653|NCT00005825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110153654|NCT00005825|Tubulin Modulators|tubulin modulators|mesh-ancestor
110153655|NCT00005825|Antimitotic Agents|antimitotic agents|mesh-ancestor
110153656|NCT00005825|Mitosis Modulators|mitosis modulators|mesh-ancestor
110153657|NCT00005825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110153658|NCT00005825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110153659|NCT00005825|Alkylating Agents|alkylating agents|mesh-ancestor
110153660|NCT00005825|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110153661|NCT00005825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110153662|NCT00005825|Keratolytic Agents|keratolytic agents|mesh-ancestor
110153663|NCT00005825|Dermatologic Agents|dermatologic agents|mesh-ancestor
110153665|NCT00001011|Antimetabolites|antimetabolites|mesh-ancestor
110153666|NCT00001011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110153667|NCT00001011|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110153668|NCT00001011|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110153669|NCT00001011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110153670|NCT00001011|Antiviral Agents|antiviral agents|mesh-ancestor
110153671|NCT00001011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110153672|NCT00001011|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110153673|NCT00001011|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110153675|NCT00001014|Trimethoprim|trimethoprim|mesh-list
110153676|NCT00001014|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110153677|NCT00001014|Sulfamethoxazole|sulfamethoxazole|mesh-list
110153678|NCT00001014|Trimetrexate|trimetrexate|mesh-list
110153680|NCT00001014|Levoleucovorin|levoleucovorin|mesh-list
110153681|NCT00001014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110153682|NCT00001014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110153683|NCT00001014|Antidotes|antidotes|mesh-ancestor
110153684|NCT00001014|Protective Agents|protective agents|mesh-ancestor
110153685|NCT00001014|Vitamin B Complex|vitamin b complex|mesh-ancestor
110153686|NCT00001014|Vitamins|vitamins|mesh-ancestor
110153687|NCT00001014|Micronutrients|micronutrients|mesh-ancestor
110153688|NCT00001014|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110153689|NCT00001014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110153690|NCT00001014|Antimalarials|antimalarials|mesh-ancestor
110153691|NCT00001014|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110153692|NCT00001014|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110153693|NCT00001014|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110153694|NCT00001014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110153695|NCT00001014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110153696|NCT00001014|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110153697|NCT00001014|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110153698|NCT00001014|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110153699|NCT00001014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110153700|NCT00001014|Antifungal Agents|antifungal agents|mesh-ancestor
110153701|NCT00001014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110153702|NCT00001014|Antimetabolites|antimetabolites|mesh-ancestor
110153703|NCT00001014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110153704|NCT00005831|Paclitaxel|paclitaxel|mesh-list
110153705|NCT00005831|Carboplatin|carboplatin|mesh-list
110153706|NCT00005831|Gemcitabine|gemcitabine|mesh-list
110153707|NCT00005831|Trastuzumab|trastuzumab|mesh-list
110153708|NCT00005831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110153709|NCT00005831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110153710|NCT00005831|Tubulin Modulators|tubulin modulators|mesh-ancestor
110153711|NCT00005831|Antimitotic Agents|antimitotic agents|mesh-ancestor
110153712|NCT00005831|Mitosis Modulators|mitosis modulators|mesh-ancestor
110153713|NCT00005831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110153714|NCT00005831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110153715|NCT00005831|Antimetabolites|antimetabolites|mesh-ancestor
110153716|NCT00005831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110153717|NCT00005834|Thalidomide|thalidomide|mesh-list
110153718|NCT00005834|Dexamethasone|dexamethasone|mesh-list
110153719|NCT00005834|Cyclophosphamide|cyclophosphamide|mesh-list
110153721|NCT00005834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110153722|NCT00005834|Immunologic Factors|immunologic factors|mesh-ancestor
110153723|NCT00005834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110153724|NCT00005834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110153725|NCT00005834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110153726|NCT00005834|Alkylating Agents|alkylating agents|mesh-ancestor
110187173|NCT03878082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110153727|NCT00005834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110153728|NCT00005834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110153729|NCT00005834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110153730|NCT00005834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110153731|NCT00005834|Antiemetics|antiemetics|mesh-ancestor
110153732|NCT00005834|Autonomic Agents|autonomic agents|mesh-ancestor
110153733|NCT00005834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110153734|NCT00005834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110153735|NCT00005834|Glucocorticoids|glucocorticoids|mesh-ancestor
110153736|NCT00005834|Hormones|hormones|mesh-ancestor
110153737|NCT00005834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110153738|NCT00005834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110153739|NCT00005834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110153740|NCT00005834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110153741|NCT00005834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110153742|NCT00005834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110153743|NCT00005834|Leprostatic Agents|leprostatic agents|mesh-ancestor
110153744|NCT00005834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110153745|NCT00005834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110153746|NCT00005834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110153747|NCT00005834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110153748|NCT00005834|Growth Substances|growth substances|mesh-ancestor
110153749|NCT00005834|Growth Inhibitors|growth inhibitors|mesh-ancestor
110153750|NCT00001029|Zidovudine|zidovudine|mesh-list
110153751|NCT00001029|Didanosine|didanosine|mesh-list
110153752|NCT00001029|Zalcitabine|zalcitabine|mesh-list
110153753|NCT00001029|Antimetabolites|antimetabolites|mesh-ancestor
110153754|NCT00001029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110153755|NCT00001029|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110153756|NCT00001029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110153757|NCT00001029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110153758|NCT00001029|Antiviral Agents|antiviral agents|mesh-ancestor
110153759|NCT00001029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110153760|NCT00001029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110153761|NCT00001029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110153762|NCT00001032|Zidovudine|zidovudine|mesh-list
110153763|NCT00001032|Zalcitabine|zalcitabine|mesh-list
110153764|NCT00001032|Antimetabolites|antimetabolites|mesh-ancestor
110153765|NCT00001032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110153766|NCT00001032|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110153767|NCT00001032|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110153768|NCT00001032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110153769|NCT00001032|Antiviral Agents|antiviral agents|mesh-ancestor
110153771|NCT00001032|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110153772|NCT00001032|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110153773|NCT00005837|Oxaliplatin|oxaliplatin|mesh-list
110153775|NCT00001038|Valacyclovir|valacyclovir|mesh-list
110153776|NCT00001038|Acyclovir|acyclovir|mesh-list
110153777|NCT00001038|Antiviral Agents|antiviral agents|mesh-ancestor
110153778|NCT00001038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110153779|NCT00005840|Paclitaxel|paclitaxel|mesh-list
110153781|NCT00005840|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110153782|NCT00005840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110153783|NCT00005840|Tubulin Modulators|tubulin modulators|mesh-ancestor
110153784|NCT00005840|Antimitotic Agents|antimitotic agents|mesh-ancestor
110153785|NCT00005840|Mitosis Modulators|mitosis modulators|mesh-ancestor
110153786|NCT00005840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110153788|NCT00005843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110153789|NCT00005849|Paclitaxel|paclitaxel|mesh-list
110153790|NCT00005849|Bryostatin 1|bryostatin 1|mesh-list
110153791|NCT00005849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110153792|NCT00005849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110153793|NCT00005849|Tubulin Modulators|tubulin modulators|mesh-ancestor
110153794|NCT00005849|Antimitotic Agents|antimitotic agents|mesh-ancestor
110153795|NCT00005849|Mitosis Modulators|mitosis modulators|mesh-ancestor
110153796|NCT00005849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110153797|NCT00005849|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110153798|NCT00005849|Immunologic Factors|immunologic factors|mesh-ancestor
110153799|NCT00005849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110153800|NCT00001047|Clarithromycin|clarithromycin|mesh-list
110153801|NCT00001047|Ethambutol|ethambutol|mesh-list
110153802|NCT00001047|Rifabutin|rifabutin|mesh-list
110153803|NCT00001047|Clofazimine|clofazimine|mesh-list
110153804|NCT00001047|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110153805|NCT00001047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110153806|NCT00001047|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110153807|NCT00001047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110153808|NCT00001047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110153809|NCT00001047|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110153810|NCT00001047|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110153811|NCT00001047|Antitubercular Agents|antitubercular agents|mesh-ancestor
110153812|NCT00001047|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110153813|NCT00001047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110153814|NCT00001047|Leprostatic Agents|leprostatic agents|mesh-ancestor
110153815|NCT00005852|Cyclosporine|cyclosporine|mesh-list
110153816|NCT00005852|Methylprednisolone|methylprednisolone|mesh-list
110153817|NCT00005852|Cyclophosphamide|cyclophosphamide|mesh-list
110153818|NCT00005852|Cyclosporins|cyclosporins|mesh-list
110153819|NCT00005852|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110153820|NCT00005852|Muromonab-CD3|muromonab-cd3|mesh-list
110153821|NCT00005852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110153822|NCT00005852|Immunologic Factors|immunologic factors|mesh-ancestor
110153823|NCT00005852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110153824|NCT00005852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110153825|NCT00005852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110153826|NCT00005852|Alkylating Agents|alkylating agents|mesh-ancestor
110153827|NCT00005852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110153828|NCT00005852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110153829|NCT00005852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110153830|NCT00005852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110153831|NCT00005852|Antifungal Agents|antifungal agents|mesh-ancestor
110153832|NCT00005852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110153833|NCT00005852|Dermatologic Agents|dermatologic agents|mesh-ancestor
110153834|NCT00005852|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110153835|NCT00005852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110153836|NCT00005852|Antiemetics|antiemetics|mesh-ancestor
110153837|NCT00005852|Autonomic Agents|autonomic agents|mesh-ancestor
110153838|NCT00005852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110153840|NCT00005852|Glucocorticoids|glucocorticoids|mesh-ancestor
110153841|NCT00005852|Hormones|hormones|mesh-ancestor
110187217|NCT03525873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110153842|NCT00005852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110153843|NCT00005852|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110153844|NCT00005852|Protective Agents|protective agents|mesh-ancestor
110153845|NCT00001071|Lenograstim|lenograstim|mesh-list
110153846|NCT00001071|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110153847|NCT00001071|Immunologic Factors|immunologic factors|mesh-ancestor
110153848|NCT00001071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110153849|NCT00005855|Carmustine|carmustine|mesh-list
110153850|NCT00005855|Efaproxiral|efaproxiral|mesh-list
110153851|NCT00005855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110153852|NCT00005855|Alkylating Agents|alkylating agents|mesh-ancestor
110153853|NCT00005855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110153854|NCT00005855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110153855|NCT00005855|Antisickling Agents|antisickling agents|mesh-ancestor
110153856|NCT00001074|Didanosine|didanosine|mesh-list
110153857|NCT00001074|Hydroxyurea|hydroxyurea|mesh-list
110153858|NCT00001074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110153859|NCT00001074|Antisickling Agents|antisickling agents|mesh-ancestor
110153860|NCT00001074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110153861|NCT00001074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110153862|NCT00001074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110153863|NCT00001074|Antimetabolites|antimetabolites|mesh-ancestor
110153864|NCT00001074|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110153865|NCT00001074|Antiviral Agents|antiviral agents|mesh-ancestor
110153866|NCT00001074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110153867|NCT00001074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110153868|NCT00001074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110153869|NCT00005858|Immunotoxins|immunotoxins|mesh-list
110153870|NCT00005858|Immunoconjugates|immunoconjugates|mesh-ancestor
110153871|NCT00005858|Immunologic Factors|immunologic factors|mesh-ancestor
110153872|NCT00005858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110153874|NCT00005861|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110153875|NCT00005861|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110153876|NCT00005861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110153877|NCT00005861|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110153878|NCT00005861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110153879|NCT00005861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110153880|NCT00005861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110153882|NCT00001083|Indinavir|indinavir|mesh-list
110153883|NCT00001083|Lamivudine|lamivudine|mesh-list
110153884|NCT00001083|Zidovudine|zidovudine|mesh-list
110153885|NCT00001083|Nevirapine|nevirapine|mesh-list
110153886|NCT00001083|Stavudine|stavudine|mesh-list
110153887|NCT00001083|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110153888|NCT00001083|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110153889|NCT00001083|Protease Inhibitors|protease inhibitors|mesh-ancestor
110153890|NCT00001083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110153891|NCT00001083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110153892|NCT00001083|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110153893|NCT00001083|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110153894|NCT00001083|Antiviral Agents|antiviral agents|mesh-ancestor
110153895|NCT00001083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110153896|NCT00001083|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110153897|NCT00001083|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110153898|NCT00001083|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110153899|NCT00001083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110153900|NCT00001083|Antimetabolites|antimetabolites|mesh-ancestor
110153901|NCT00001083|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110153902|NCT00001083|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110153903|NCT00005864|Sulfanilamides|sulfanilamides|mesh-list
110153904|NCT00005864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110153906|NCT00001086|Abacavir|abacavir|mesh-list
110153907|NCT00001086|Indinavir|indinavir|mesh-list
110153908|NCT00001086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110153909|NCT00001086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110153910|NCT00001086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110153911|NCT00001086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110153912|NCT00001086|Antiviral Agents|antiviral agents|mesh-ancestor
110153913|NCT00001086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110153914|NCT00001086|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110153915|NCT00001086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110153917|NCT00001086|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110153918|NCT00001086|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110153919|NCT00001086|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110153920|NCT00001086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110153921|NCT00001086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110153922|NCT00001086|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110153923|NCT00001086|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110153924|NCT00001086|Protease Inhibitors|protease inhibitors|mesh-ancestor
110153925|NCT00700258|Sirolimus|sirolimus|mesh-list
110153926|NCT00700258|Sunitinib|sunitinib|mesh-list
110153927|NCT00700258|Temsirolimus|temsirolimus|mesh-list
110153928|NCT00700258|Axitinib|axitinib|mesh-list
110153929|NCT00700258|MTOR Inhibitors|mtor inhibitors|mesh-list
110153930|NCT00700258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110153931|NCT00700258|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110153932|NCT00700258|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110153933|NCT00700258|Growth Substances|growth substances|mesh-ancestor
110153934|NCT00700258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110153935|NCT00700258|Growth Inhibitors|growth inhibitors|mesh-ancestor
110153936|NCT00700258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110153937|NCT00700258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110153938|NCT00700258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110153939|NCT00700258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110153940|NCT00700258|Immunologic Factors|immunologic factors|mesh-ancestor
110153941|NCT00700258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110153942|NCT00700258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110153943|NCT00700258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110153944|NCT00700258|Antifungal Agents|antifungal agents|mesh-ancestor
110153945|NCT00001113|Interferons|interferons|mesh-list
110153946|NCT00001113|Interferon-alpha|interferon-alpha|mesh-list
110153947|NCT00001113|Interferon alpha-2|interferon alpha-2|mesh-list
110153948|NCT00001113|Zidovudine|zidovudine|mesh-list
110153949|NCT00001113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110153950|NCT00001113|Antiviral Agents|antiviral agents|mesh-ancestor
110153951|NCT00001113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110153952|NCT00001113|Immunologic Factors|immunologic factors|mesh-ancestor
110153953|NCT00001113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110153954|NCT00001113|Antimetabolites|antimetabolites|mesh-ancestor
110153955|NCT00001113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110153956|NCT00001113|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110153957|NCT00001113|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110153958|NCT00001113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110153959|NCT00001113|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110153960|NCT00001113|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110153961|NCT00005867|Prednisolone|prednisolone|mesh-list
110153962|NCT00005867|Cyclophosphamide|cyclophosphamide|mesh-list
110153963|NCT00005867|Doxorubicin|doxorubicin|mesh-list
110153964|NCT00005867|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110153965|NCT00005867|Etoposide|etoposide|mesh-list
110153966|NCT00005867|Vincristine|vincristine|mesh-list
110153967|NCT00005867|Mitoxantrone|mitoxantrone|mesh-list
110153968|NCT00005867|Bleomycin|bleomycin|mesh-list
110153969|NCT00005867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110153970|NCT00005867|Immunologic Factors|immunologic factors|mesh-ancestor
110153971|NCT00005867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110153972|NCT00005867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110153973|NCT00005867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110153974|NCT00005867|Alkylating Agents|alkylating agents|mesh-ancestor
110153975|NCT00005867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110153976|NCT00005867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110153977|NCT00005867|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110153978|NCT00005867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110153979|NCT00005867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110153980|NCT00005867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110153981|NCT00005867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110153982|NCT00005867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110153983|NCT00005867|Tubulin Modulators|tubulin modulators|mesh-ancestor
110153984|NCT00005867|Antimitotic Agents|antimitotic agents|mesh-ancestor
110153985|NCT00005867|Mitosis Modulators|mitosis modulators|mesh-ancestor
110153986|NCT00005867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110153987|NCT00005867|Glucocorticoids|glucocorticoids|mesh-ancestor
110153988|NCT00005867|Hormones|hormones|mesh-ancestor
110153989|NCT00005867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110153990|NCT00005867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110153991|NCT00005867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110153992|NCT00005867|Analgesics|analgesics|mesh-ancestor
110153993|NCT00005867|Sensory System Agents|sensory system agents|mesh-ancestor
110153994|NCT00005870|Gemcitabine|gemcitabine|mesh-list
110153995|NCT00005870|Fluorouracil|fluorouracil|mesh-list
110153996|NCT00005870|Mitomycins|mitomycins|mesh-list
110153997|NCT00005870|Mitomycin|mitomycin|mesh-list
110153998|NCT00005870|Rubitecan|rubitecan|mesh-list
110153999|NCT00005870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110154000|NCT00005870|Antimetabolites|antimetabolites|mesh-ancestor
110154001|NCT00005870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110154002|NCT00005870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110154003|NCT00005870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110154004|NCT00005870|Immunologic Factors|immunologic factors|mesh-ancestor
110154005|NCT00005870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110154006|NCT00005870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110154007|NCT00005870|Alkylating Agents|alkylating agents|mesh-ancestor
110154008|NCT00005870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110154009|NCT00005870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110154010|NCT00005870|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110154011|NCT00005870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110154012|NCT00017407|Paclitaxel|paclitaxel|mesh-list
110154013|NCT00017407|Carboplatin|carboplatin|mesh-list
110154014|NCT00017407|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110154015|NCT00017407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110154016|NCT00017407|Tubulin Modulators|tubulin modulators|mesh-ancestor
110154017|NCT00017407|Antimitotic Agents|antimitotic agents|mesh-ancestor
110154018|NCT00017407|Mitosis Modulators|mitosis modulators|mesh-ancestor
110154019|NCT00017407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110154021|NCT00008866|Hydroxyurea|hydroxyurea|mesh-list
110154022|NCT00008866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110154023|NCT00008866|Antisickling Agents|antisickling agents|mesh-ancestor
110154024|NCT00008866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110154025|NCT00008866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110154026|NCT00008866|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110154028|NCT00008866|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110154029|NCT00008866|Antiviral Agents|antiviral agents|mesh-ancestor
110154030|NCT00008866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110154031|NCT00008866|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110154032|NCT00008866|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110154033|NCT00001119|Ritonavir|ritonavir|mesh-list
110154034|NCT00001119|Indinavir|indinavir|mesh-list
110154035|NCT00001119|Amprenavir|amprenavir|mesh-list
110154036|NCT00001119|Lamivudine|lamivudine|mesh-list
110154037|NCT00001119|Zidovudine|zidovudine|mesh-list
110154038|NCT00001119|Abacavir|abacavir|mesh-list
110154039|NCT00001119|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
110154042|NCT00001119|Immunologic Factors|immunologic factors|mesh-ancestor
110154043|NCT00001119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110154044|NCT00001119|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110154045|NCT00001119|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110154047|NCT00001119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110154048|NCT00001119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110154049|NCT00001119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110154050|NCT00001119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110154051|NCT00001119|Antiviral Agents|antiviral agents|mesh-ancestor
110154052|NCT00001119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110154053|NCT00001119|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110154054|NCT00001119|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110154055|NCT00001119|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110154056|NCT00001119|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110154057|NCT00001119|Antimetabolites|antimetabolites|mesh-ancestor
110154058|NCT00001119|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110154059|NCT00001119|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110154060|NCT00001119|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110154061|NCT00001119|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110154063|NCT00001119|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110154064|NCT00001119|Antitubercular Agents|antitubercular agents|mesh-ancestor
110154065|NCT00001119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110154066|NCT00009061|Ritonavir|ritonavir|mesh-list
110154067|NCT00009061|Nelfinavir|nelfinavir|mesh-list
110154068|NCT00009061|Fosamprenavir|fosamprenavir|mesh-list
110154069|NCT00009061|Lamivudine|lamivudine|mesh-list
110154070|NCT00009061|Abacavir|abacavir|mesh-list
110154071|NCT00009061|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110154072|NCT00009061|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110154073|NCT00009061|Protease Inhibitors|protease inhibitors|mesh-ancestor
110154074|NCT00009061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110154075|NCT00009061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110154076|NCT00009061|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110154077|NCT00009061|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110154078|NCT00009061|Antiviral Agents|antiviral agents|mesh-ancestor
110154079|NCT00009061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110154080|NCT00009061|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110154081|NCT00009061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110154082|NCT00009061|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110187257|NCT03255473|Dexamethasone acetate|dexamethasone acetate|mesh-list
110154083|NCT00009061|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110154084|NCT00005873|Rubitecan|rubitecan|mesh-list
110154085|NCT00005873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110154086|NCT00005873|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110154087|NCT00005873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110154088|NCT00005873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110154089|NCT00005873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110154091|NCT00009178|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110154092|NCT00009178|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110154093|NCT00009178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110154094|NCT00009178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110154095|NCT00009178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110154096|NCT00009178|Serotonin Agents|serotonin agents|mesh-ancestor
110154097|NCT00009178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110154098|NCT00009178|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110154099|NCT00009178|Antidepressive Agents|antidepressive agents|mesh-ancestor
110154100|NCT00009178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110154101|NCT00009178|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110154102|NCT00009178|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110154103|NCT00009178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110154104|NCT00009217|Haloperidol|haloperidol|mesh-list
110154105|NCT00009217|Haloperidol decanoate|haloperidol decanoate|mesh-list
110154106|NCT00009217|Antiemetics|antiemetics|mesh-ancestor
110154107|NCT00009217|Autonomic Agents|autonomic agents|mesh-ancestor
110154108|NCT00009217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110154109|NCT00009217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110154110|NCT00009217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110154111|NCT00009217|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110154112|NCT00009217|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110154113|NCT00009217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110154114|NCT00009217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110154115|NCT00009217|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110154116|NCT00009217|Dopamine Agents|dopamine agents|mesh-ancestor
110154117|NCT00009217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110154118|NCT00009217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110154119|NCT00009217|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110154120|NCT00005876|Rubitecan|rubitecan|mesh-list
110154121|NCT00005876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110154122|NCT00005876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110154123|NCT00005876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110154124|NCT00005876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110154125|NCT00005876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110154126|NCT00001146|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
110154127|NCT00001146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110154128|NCT00001146|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110154129|NCT00009646|Indomethacin|indomethacin|mesh-list
110154130|NCT00009646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110154131|NCT00009646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110154132|NCT00009646|Analgesics|analgesics|mesh-ancestor
110154133|NCT00009646|Sensory System Agents|sensory system agents|mesh-ancestor
110154134|NCT00009646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110154135|NCT00009646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110154136|NCT00009646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110154137|NCT00009646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110154138|NCT00009646|Gout Suppressants|gout suppressants|mesh-ancestor
110154140|NCT00009646|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110154141|NCT00009646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110187267|NCT03255473|Glucocorticoids|glucocorticoids|mesh-ancestor
110154142|NCT00009646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110154143|NCT00009646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110154144|NCT00009763|Cyclosporine|cyclosporine|mesh-list
110154145|NCT00009763|Paclitaxel|paclitaxel|mesh-list
110154146|NCT00009763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110154147|NCT00009763|Antibodies|antibodies|mesh-list
110154148|NCT00009763|Immunoglobulins|immunoglobulins|mesh-list
110154149|NCT00009763|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110154150|NCT00009763|Cyclosporins|cyclosporins|mesh-list
110154151|NCT00009763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110154152|NCT00009763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110154153|NCT00009763|Tubulin Modulators|tubulin modulators|mesh-ancestor
110154154|NCT00009763|Antimitotic Agents|antimitotic agents|mesh-ancestor
110154155|NCT00009763|Mitosis Modulators|mitosis modulators|mesh-ancestor
110154156|NCT00009763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110154157|NCT00009763|Immunologic Factors|immunologic factors|mesh-ancestor
110154158|NCT00009763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110154159|NCT00009763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110154160|NCT00009763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110154161|NCT00009763|Antifungal Agents|antifungal agents|mesh-ancestor
110154162|NCT00009763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110154163|NCT00009763|Dermatologic Agents|dermatologic agents|mesh-ancestor
110154164|NCT00009763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110154165|NCT00009763|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110154167|NCT00009802|Paclitaxel|paclitaxel|mesh-list
110154168|NCT00009802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110154169|NCT00009802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110154170|NCT00009802|Tubulin Modulators|tubulin modulators|mesh-ancestor
110154171|NCT00009802|Antimitotic Agents|antimitotic agents|mesh-ancestor
110154172|NCT00009802|Mitosis Modulators|mitosis modulators|mesh-ancestor
110154173|NCT00009802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110154174|NCT00009802|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110154175|NCT00009802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110154177|NCT00009802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110154178|NCT00009802|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110154180|NCT00009802|Micronutrients|micronutrients|mesh-ancestor
110154181|NCT00009802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110154182|NCT00009841|Mitogens|mitogens|mesh-list
110154183|NCT00009841|Mitosis Modulators|mitosis modulators|mesh-ancestor
110154184|NCT00009841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110154186|NCT00005891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110154187|NCT00005891|Immunologic Factors|immunologic factors|mesh-ancestor
110154188|NCT00005891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110154189|NCT00005891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110154190|NCT00005891|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110154191|NCT00005891|Alkylating Agents|alkylating agents|mesh-ancestor
110154192|NCT00005891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110154193|NCT00005891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110154194|NCT00005891|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110154196|NCT00009880|Fluorouracil|fluorouracil|mesh-list
110154197|NCT00009880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110154198|NCT00009880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110154199|NCT00009880|Tubulin Modulators|tubulin modulators|mesh-ancestor
110154200|NCT00009880|Antimitotic Agents|antimitotic agents|mesh-ancestor
110154201|NCT00009880|Mitosis Modulators|mitosis modulators|mesh-ancestor
110154202|NCT00009880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110154203|NCT00009880|Antimetabolites|antimetabolites|mesh-ancestor
110154204|NCT00009880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110154205|NCT00009880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110154206|NCT00009880|Immunologic Factors|immunologic factors|mesh-ancestor
110154207|NCT00009880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110154208|NCT00009919|Semaxinib|semaxinib|mesh-list
110154209|NCT00009919|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110154210|NCT00009919|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110154212|NCT00009919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110154213|NCT00009919|Growth Inhibitors|growth inhibitors|mesh-ancestor
110154214|NCT00009919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110154215|NCT00009919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110154216|NCT00009919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110154217|NCT00009919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110154218|NCT00009958|Metronidazole|metronidazole|mesh-list
110154219|NCT00009958|Vaccines|vaccines|mesh-list
110154220|NCT00009958|Sargramostim|sargramostim|mesh-list
110154221|NCT00009958|Immunologic Factors|immunologic factors|mesh-ancestor
110154222|NCT00009958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110154223|NCT00009958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110154224|NCT00009958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110154225|NCT00009958|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110154226|NCT00009958|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110154227|NCT00009997|Tamoxifen|tamoxifen|mesh-list
110154228|NCT00009997|Paclitaxel|paclitaxel|mesh-list
110154229|NCT00009997|Cyclophosphamide|cyclophosphamide|mesh-list
110154230|NCT00009997|Doxorubicin|doxorubicin|mesh-list
110154231|NCT00009997|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110154232|NCT00009997|Trastuzumab|trastuzumab|mesh-list
110154233|NCT00009997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110154234|NCT00009997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110154235|NCT00009997|Tubulin Modulators|tubulin modulators|mesh-ancestor
110154236|NCT00009997|Antimitotic Agents|antimitotic agents|mesh-ancestor
110154237|NCT00009997|Mitosis Modulators|mitosis modulators|mesh-ancestor
110154238|NCT00009997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110154239|NCT00009997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110154240|NCT00009997|Immunologic Factors|immunologic factors|mesh-ancestor
110154241|NCT00009997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110154242|NCT00009997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110154243|NCT00009997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110154244|NCT00009997|Alkylating Agents|alkylating agents|mesh-ancestor
110154245|NCT00009997|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110154246|NCT00009997|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110154247|NCT00009997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110154248|NCT00009997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110154249|NCT00009997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110154250|NCT00009997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110154251|NCT00009997|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110154252|NCT00009997|Hormone Antagonists|hormone antagonists|mesh-ancestor
110154253|NCT00009997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110187289|NCT03098225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110154254|NCT00009997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110154255|NCT00009997|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110154256|NCT00009997|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110154257|NCT00009997|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110154260|NCT00010036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110154261|NCT00010036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110154262|NCT00010036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110154263|NCT00010036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110154264|NCT00010036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110154265|NCT00010075|Leucovorin|leucovorin|mesh-list
110154266|NCT00010075|Fluorouracil|fluorouracil|mesh-list
110154269|NCT00010075|Levoleucovorin|levoleucovorin|mesh-list
110154270|NCT00010075|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110154271|NCT00010075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110154272|NCT00010075|Antimetabolites|antimetabolites|mesh-ancestor
110154273|NCT00010075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110154274|NCT00010075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110154275|NCT00010075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110154276|NCT00010075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110154277|NCT00010075|Immunologic Factors|immunologic factors|mesh-ancestor
110154278|NCT00010075|Antidotes|antidotes|mesh-ancestor
110154279|NCT00010075|Protective Agents|protective agents|mesh-ancestor
110154280|NCT00010075|Vitamin B Complex|vitamin b complex|mesh-ancestor
110154281|NCT00010075|Vitamins|vitamins|mesh-ancestor
110154282|NCT00010075|Micronutrients|micronutrients|mesh-ancestor
110154283|NCT00010075|Analgesics|analgesics|mesh-ancestor
110154284|NCT00010075|Sensory System Agents|sensory system agents|mesh-ancestor
110154285|NCT00010075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110154286|NCT00010075|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110154287|NCT00010075|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110154288|NCT00010075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110154289|NCT00010153|Fulvestrant|fulvestrant|mesh-list
110154290|NCT00010153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110154291|NCT00010153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110154292|NCT00010153|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110154293|NCT00010153|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110154294|NCT00010153|Hormone Antagonists|hormone antagonists|mesh-ancestor
110154295|NCT00010153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110154296|NCT00010153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110154297|NCT00010192|Aldesleukin|aldesleukin|mesh-list
110154298|NCT00010192|Rituximab|rituximab|mesh-list
110154299|NCT00010192|Interleukin-2|interleukin-2|mesh-list
110154300|NCT00010192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110154301|NCT00010192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110154302|NCT00010192|Immunologic Factors|immunologic factors|mesh-ancestor
110154303|NCT00010192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110154304|NCT00010192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110154305|NCT00010192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110154306|NCT00010192|Analgesics|analgesics|mesh-ancestor
110154307|NCT00010192|Sensory System Agents|sensory system agents|mesh-ancestor
110154308|NCT00010192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110154309|NCT00010192|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110154310|NCT00010192|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110154311|NCT00010192|Antiviral Agents|antiviral agents|mesh-ancestor
110154312|NCT00010192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110154313|NCT00005912|Voriconazole|voriconazole|mesh-list
110154314|NCT00005912|Antifungal Agents|antifungal agents|mesh-ancestor
110154315|NCT00005912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110154316|NCT00005912|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110154317|NCT00005912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110154318|NCT00005912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110154319|NCT00005912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110154320|NCT00005912|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110154321|NCT00005912|Hormone Antagonists|hormone antagonists|mesh-ancestor
110154322|NCT00005912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110154323|NCT00005912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110154324|NCT00005912|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110154325|NCT00010231|Calcitriol|calcitriol|mesh-list
110154326|NCT00010231|Dexamethasone|dexamethasone|mesh-list
110154327|NCT00010231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110154328|NCT00010231|Antiemetics|antiemetics|mesh-ancestor
110154329|NCT00010231|Autonomic Agents|autonomic agents|mesh-ancestor
110154330|NCT00010231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110154331|NCT00010231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110154332|NCT00010231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110154333|NCT00010231|Glucocorticoids|glucocorticoids|mesh-ancestor
110154335|NCT00010231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110154336|NCT00010231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110154337|NCT00010231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110154338|NCT00010231|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110154339|NCT00010231|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110154340|NCT00010231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110154341|NCT00010231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110154342|NCT00010231|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110154345|NCT00010231|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110154346|NCT00010270|Immunotoxins|immunotoxins|mesh-list
110154347|NCT00010270|Immunoconjugates|immunoconjugates|mesh-ancestor
110154348|NCT00010270|Immunologic Factors|immunologic factors|mesh-ancestor
110154349|NCT00010270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110154350|NCT00010387|Cyclophosphamide|cyclophosphamide|mesh-list
110154351|NCT00010387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110154352|NCT00010387|Immunologic Factors|immunologic factors|mesh-ancestor
110154353|NCT00010387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110154354|NCT00010387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110154355|NCT00010387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110154356|NCT00010387|Alkylating Agents|alkylating agents|mesh-ancestor
110154357|NCT00010387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110154358|NCT00010387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110154359|NCT00010387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110154360|NCT00010426|Cysteamine|cysteamine|mesh-list
110154361|NCT00010426|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
110154362|NCT00010426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110154363|NCT00386516|Fluorouracil|fluorouracil|mesh-list
110154364|NCT00386516|Antimetabolites|antimetabolites|mesh-ancestor
110154365|NCT00386516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110154366|NCT00386516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110154367|NCT00386516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110154368|NCT00386516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110154369|NCT00386516|Immunologic Factors|immunologic factors|mesh-ancestor
110154370|NCT00386516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110154371|NCT00010699|Vitamin E|vitamin e|mesh-list
110154372|NCT00010699|Vitamins|vitamins|mesh-ancestor
110154373|NCT00010699|Micronutrients|micronutrients|mesh-ancestor
110154374|NCT00010699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110154375|NCT00010699|Antioxidants|antioxidants|mesh-ancestor
110154376|NCT00010699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110154377|NCT00010699|Protective Agents|protective agents|mesh-ancestor
110154378|NCT00386555|Docetaxel|docetaxel|mesh-list
110154379|NCT00386555|Axitinib|axitinib|mesh-list
110154380|NCT00386555|Crenolanib|crenolanib|mesh-list
110154381|NCT00386555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110154382|NCT00386555|Tubulin Modulators|tubulin modulators|mesh-ancestor
110154383|NCT00386555|Antimitotic Agents|antimitotic agents|mesh-ancestor
110154384|NCT00386555|Mitosis Modulators|mitosis modulators|mesh-ancestor
110154385|NCT00386555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110154386|NCT00386555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110154387|NCT00386555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110154388|NCT00010855|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
110154389|NCT00010855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110187306|NCT03017131|Alkylating Agents|alkylating agents|mesh-ancestor
110154390|NCT00010855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110154391|NCT00001191|Omeprazole|omeprazole|mesh-list
110154392|NCT00001191|Pantoprazole|pantoprazole|mesh-list
110154393|NCT00001191|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110154394|NCT00001191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110154395|NCT00001191|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110154396|NCT00001191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110154397|NCT00001191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110154399|NCT00011089|Antiviral Agents|antiviral agents|mesh-ancestor
110154400|NCT00011089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110154401|NCT00011089|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110154402|NCT00011089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110154403|NCT00011089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110154404|NCT00011089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110154405|NCT00011089|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110154406|NCT00011089|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110154407|NCT00011128|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110154409|NCT00011128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110154410|NCT00005921|Caspofungin|caspofungin|mesh-list
110154411|NCT00005921|Antifungal Agents|antifungal agents|mesh-ancestor
110154412|NCT00005921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110154413|NCT00005921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110154414|NCT00005921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110154416|NCT00011362|Dexamethasone acetate|dexamethasone acetate|mesh-list
110154417|NCT00011362|BB 1101|bb 1101|mesh-list
110154418|NCT00011362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110154419|NCT00011362|Antiemetics|antiemetics|mesh-ancestor
110154420|NCT00011362|Autonomic Agents|autonomic agents|mesh-ancestor
110154421|NCT00011362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110154422|NCT00011362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110154423|NCT00011362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110154424|NCT00011362|Glucocorticoids|glucocorticoids|mesh-ancestor
110154425|NCT00011362|Hormones|hormones|mesh-ancestor
110154426|NCT00011362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110154427|NCT00011362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110154428|NCT00011362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110154429|NCT00011362|Protease Inhibitors|protease inhibitors|mesh-ancestor
110154430|NCT00011362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110154431|NCT00011362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110154432|NCT00001212|Cyclosporine|cyclosporine|mesh-list
110154433|NCT00001212|Prednisone|prednisone|mesh-list
110154434|NCT00001212|Cyclophosphamide|cyclophosphamide|mesh-list
110154435|NCT00001212|Cyclosporins|cyclosporins|mesh-list
110154436|NCT00001212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110154437|NCT00001212|Immunologic Factors|immunologic factors|mesh-ancestor
110154438|NCT00001212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110154439|NCT00001212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110154440|NCT00001212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110154441|NCT00001212|Alkylating Agents|alkylating agents|mesh-ancestor
110154442|NCT00001212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110154443|NCT00001212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110154444|NCT00001212|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110154445|NCT00001212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110154446|NCT00001212|Glucocorticoids|glucocorticoids|mesh-ancestor
110154447|NCT00001212|Hormones|hormones|mesh-ancestor
110154448|NCT00001212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110154449|NCT00001212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110154450|NCT00001212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110154451|NCT00001212|Antifungal Agents|antifungal agents|mesh-ancestor
110154452|NCT00001212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110154453|NCT00001212|Dermatologic Agents|dermatologic agents|mesh-ancestor
110154454|NCT00001212|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110154455|NCT00011479|Abacavir|abacavir|mesh-list
110154456|NCT00011479|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110154457|NCT00011479|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110154458|NCT00011479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110154459|NCT00011479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110154460|NCT00011479|Antiviral Agents|antiviral agents|mesh-ancestor
110154461|NCT00011479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110154462|NCT00011479|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110154463|NCT00011479|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110154465|NCT00011635|Antioxidants|antioxidants|mesh-ancestor
110154466|NCT00011635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110154467|NCT00011635|Protective Agents|protective agents|mesh-ancestor
110154468|NCT00011635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110154469|NCT00001221|Hormones|hormones|mesh-list
110154470|NCT00001221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110154471|NCT00001221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110154472|NCT00391417|Estradiol|estradiol|mesh-list
110154473|NCT00391417|Estrogens|estrogens|mesh-ancestor
110154474|NCT00391417|Hormones|hormones|mesh-ancestor
110154475|NCT00391417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110154476|NCT00391417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110154477|NCT00011908|Epratuzumab|epratuzumab|mesh-list
110154478|NCT00011908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110154479|NCT00011908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110154480|NCT00012025|Fulvestrant|fulvestrant|mesh-list
110154481|NCT00012025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110154482|NCT00012025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110154483|NCT00012025|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110154484|NCT00012025|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110154485|NCT00012025|Hormone Antagonists|hormone antagonists|mesh-ancestor
110154486|NCT00012025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110154487|NCT00012025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110154489|NCT00005942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110154490|NCT00005942|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110154491|NCT00005942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110154492|NCT00005942|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110154493|NCT00005942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110154494|NCT00005942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110154495|NCT00012103|Dimercaprol|dimercaprol|mesh-list
110154497|NCT00012103|Sequestering Agents|sequestering agents|mesh-ancestor
110154498|NCT00012103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110154499|NCT00001251|Mafosfamide|mafosfamide|mesh-list
110154500|NCT00001251|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110154501|NCT00001251|Immunologic Factors|immunologic factors|mesh-ancestor
110154502|NCT00001251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110154503|NCT00001251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110154504|NCT00012142|Sirolimus|sirolimus|mesh-list
110154505|NCT00012142|Temsirolimus|temsirolimus|mesh-list
110154506|NCT00012142|MTOR Inhibitors|mtor inhibitors|mesh-list
110154507|NCT00012142|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110154508|NCT00012142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110154509|NCT00012142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110154510|NCT00012142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110154511|NCT00012142|Immunologic Factors|immunologic factors|mesh-ancestor
110154512|NCT00012142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110154513|NCT00012142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110154514|NCT00012142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110154515|NCT00012142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110154516|NCT00012142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110154517|NCT00012142|Antifungal Agents|antifungal agents|mesh-ancestor
110154518|NCT00012181|Alvocidib|alvocidib|mesh-list
110154519|NCT00012181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110154520|NCT00012181|Growth Inhibitors|growth inhibitors|mesh-ancestor
110154521|NCT00012181|Growth Substances|growth substances|mesh-ancestor
110154522|NCT00012181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110154523|NCT00012181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110154525|NCT00012181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110154526|NCT00005945|Cytarabine|cytarabine|mesh-list
110154527|NCT00005945|Dexamethasone|dexamethasone|mesh-list
110154528|NCT00005945|Cyclophosphamide|cyclophosphamide|mesh-list
110154529|NCT00005945|Doxorubicin|doxorubicin|mesh-list
110154530|NCT00005945|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110154531|NCT00005945|Methotrexate|methotrexate|mesh-list
110154532|NCT00005945|Vincristine|vincristine|mesh-list
110154533|NCT00005945|Daunorubicin|daunorubicin|mesh-list
110154534|NCT00005945|Asparaginase|asparaginase|mesh-list
110154535|NCT00005945|Mercaptopurine|mercaptopurine|mesh-list
110154536|NCT00005945|Pegaspargase|pegaspargase|mesh-list
110154537|NCT00005945|Thioguanine|thioguanine|mesh-list
110154538|NCT00005945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110154539|NCT00005945|Immunologic Factors|immunologic factors|mesh-ancestor
110154540|NCT00005945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110154541|NCT00005945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110154542|NCT00005945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110154543|NCT00005945|Alkylating Agents|alkylating agents|mesh-ancestor
110154544|NCT00005945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110154545|NCT00005945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110154546|NCT00005945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110154547|NCT00005945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110154548|NCT00005945|Antiemetics|antiemetics|mesh-ancestor
110154549|NCT00005945|Autonomic Agents|autonomic agents|mesh-ancestor
110154550|NCT00005945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110154552|NCT00005945|Glucocorticoids|glucocorticoids|mesh-ancestor
110154553|NCT00005945|Hormones|hormones|mesh-ancestor
110154554|NCT00005945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110154555|NCT00005945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110154556|NCT00005945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110154557|NCT00005945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110154558|NCT00005945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110154559|NCT00005945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110154561|NCT00005945|Abortifacient Agents|abortifacient agents|mesh-ancestor
110154562|NCT00005945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110154563|NCT00005945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110154564|NCT00005945|Antimetabolites|antimetabolites|mesh-ancestor
110154565|NCT00005945|Dermatologic Agents|dermatologic agents|mesh-ancestor
110154566|NCT00005945|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110154567|NCT00005945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110154568|NCT00005945|Antiviral Agents|antiviral agents|mesh-ancestor
110154569|NCT00005945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110154570|NCT00005945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110154571|NCT00005945|Tubulin Modulators|tubulin modulators|mesh-ancestor
110154572|NCT00005945|Antimitotic Agents|antimitotic agents|mesh-ancestor
110154573|NCT00005945|Mitosis Modulators|mitosis modulators|mesh-ancestor
110154574|NCT01929811|Metformin|metformin|mesh-list
110154576|NCT01929811|Epirubicin|epirubicin|mesh-list
110154577|NCT01929811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110154578|NCT01929811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110154579|NCT01929811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110154580|NCT01929811|Tubulin Modulators|tubulin modulators|mesh-ancestor
110154581|NCT01929811|Antimitotic Agents|antimitotic agents|mesh-ancestor
110154583|NCT01929811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110154584|NCT01929811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110154585|NCT01929811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110154586|NCT01929811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110154587|NCT01929811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110154588|NCT00012220|Gemcitabine|gemcitabine|mesh-list
110154589|NCT00012220|Docetaxel|docetaxel|mesh-list
110154590|NCT00012220|Irinotecan|irinotecan|mesh-list
110154591|NCT00012220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110154592|NCT00012220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110154593|NCT00012220|Antimetabolites|antimetabolites|mesh-ancestor
110154594|NCT00012220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110154595|NCT00012220|Tubulin Modulators|tubulin modulators|mesh-ancestor
110154596|NCT00012220|Antimitotic Agents|antimitotic agents|mesh-ancestor
110154597|NCT00012220|Mitosis Modulators|mitosis modulators|mesh-ancestor
110154598|NCT00012220|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110154599|NCT00012220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110154600|NCT00012220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110154602|NCT00012259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110154603|NCT00012259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110154604|NCT00012259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110154606|NCT00012259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110154607|NCT00012337|Gefitinib|gefitinib|mesh-list
110154608|NCT00012337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110154609|NCT00012337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110154610|NCT00012337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110154611|NCT00012337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110154613|NCT00012376|Sargramostim|sargramostim|mesh-list
110154614|NCT00012376|Immunologic Factors|immunologic factors|mesh-ancestor
110154615|NCT00012376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110154616|NCT00012376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110154617|NCT00012376|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110154618|NCT00001266|Suramin|suramin|mesh-list
110154619|NCT00001266|Antinematodal Agents|antinematodal agents|mesh-ancestor
110154620|NCT00001266|Anthelmintics|anthelmintics|mesh-ancestor
110154621|NCT00001266|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110154622|NCT00001266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110154624|NCT00001266|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110154625|NCT00001266|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110154626|NCT00005948|Interferons|interferons|mesh-list
110154627|NCT00005948|Interferon-alpha|interferon-alpha|mesh-list
110154628|NCT00005948|Aldesleukin|aldesleukin|mesh-list
110154630|NCT00005948|Sargramostim|sargramostim|mesh-list
110154631|NCT00005948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110154632|NCT00005948|Antiviral Agents|antiviral agents|mesh-ancestor
110154633|NCT00005948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110154634|NCT00005948|Immunologic Factors|immunologic factors|mesh-ancestor
110154635|NCT00005948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110154636|NCT00005948|Alkylating Agents|alkylating agents|mesh-ancestor
110154637|NCT00005948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110154638|NCT00005948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110154639|NCT00005948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110154640|NCT00005948|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110154642|NCT00005948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110154643|NCT00012688|Chlorhexidine|chlorhexidine|mesh-list
110154644|NCT00012688|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110154645|NCT00012688|Doxycycline|doxycycline|mesh-list
110154647|NCT00012688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110154648|NCT00012688|Disinfectants|disinfectants|mesh-ancestor
110154650|NCT00012688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110154651|NCT00012688|Antimalarials|antimalarials|mesh-ancestor
110154652|NCT00012688|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110154653|NCT00012688|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110154654|NCT00005951|Irinotecan|irinotecan|mesh-list
110154655|NCT00005951|Temozolomide|temozolomide|mesh-list
110154656|NCT00005951|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110154657|NCT00005951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110154658|NCT00005951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110154659|NCT00005951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110154660|NCT00005951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110154661|NCT00005951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110154662|NCT00005951|Alkylating Agents|alkylating agents|mesh-ancestor
110154663|NCT00001287|Immunoglobulins|immunoglobulins|mesh-list
110154664|NCT00001287|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110154665|NCT00001287|Antibodies|antibodies|mesh-list
110154666|NCT00001287|gamma-Globulins|gamma-globulins|mesh-list
110154667|NCT00001287|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110154668|NCT00001287|Immunologic Factors|immunologic factors|mesh-ancestor
110154669|NCT00001287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110154671|NCT00005954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110154672|NCT00005954|Alkylating Agents|alkylating agents|mesh-ancestor
110154673|NCT00005954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110154674|NCT00005954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110154675|NCT00005960|Cyclophosphamide|cyclophosphamide|mesh-list
110154676|NCT00005960|Docetaxel|docetaxel|mesh-list
110154677|NCT00005960|Doxorubicin|doxorubicin|mesh-list
110154678|NCT00005960|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110154679|NCT00005960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110154680|NCT00005960|Immunologic Factors|immunologic factors|mesh-ancestor
110154681|NCT00005960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110154682|NCT00005960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110154683|NCT00005960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110154684|NCT00005960|Alkylating Agents|alkylating agents|mesh-ancestor
110154685|NCT00005960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110154686|NCT00005960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110154687|NCT00005960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110154688|NCT00005960|Tubulin Modulators|tubulin modulators|mesh-ancestor
110154689|NCT00005960|Antimitotic Agents|antimitotic agents|mesh-ancestor
110154690|NCT00005960|Mitosis Modulators|mitosis modulators|mesh-ancestor
110154691|NCT00005960|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110154692|NCT00005960|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110154693|NCT00005960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110154694|NCT00005960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110154695|NCT00005963|Carboplatin|carboplatin|mesh-list
110154696|NCT00005963|Docetaxel|docetaxel|mesh-list
110154697|NCT00005963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110154698|NCT00005963|Tubulin Modulators|tubulin modulators|mesh-ancestor
110154699|NCT00005963|Antimitotic Agents|antimitotic agents|mesh-ancestor
110154700|NCT00005963|Mitosis Modulators|mitosis modulators|mesh-ancestor
110154701|NCT00005963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110154702|NCT00013585|Selegiline|selegiline|mesh-list
110154703|NCT00013585|Antidepressive Agents|antidepressive agents|mesh-ancestor
110154704|NCT00013585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110154705|NCT00013585|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110154706|NCT00013585|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110154707|NCT00013585|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110154708|NCT00013585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110154709|NCT00013585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110154710|NCT00013585|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110154711|NCT00013585|Protective Agents|protective agents|mesh-ancestor
110154712|NCT00013585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110154714|NCT00013624|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110154715|NCT00013624|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110154716|NCT00013624|Dopamine Agents|dopamine agents|mesh-ancestor
110154717|NCT00013624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110154718|NCT00013624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110154719|NCT00013624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110154721|NCT00013663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110154722|NCT00013663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110154723|NCT00013663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110154724|NCT00013663|Antiviral Agents|antiviral agents|mesh-ancestor
110154725|NCT00013663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110154726|NCT00013702|Adefovir|adefovir|mesh-list
110154727|NCT00013702|Antiviral Agents|antiviral agents|mesh-ancestor
110154728|NCT00013702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110154729|NCT00013702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110154730|NCT00013702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110154731|NCT00013702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110154732|NCT00013702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110154733|NCT00005966|Interferons|interferons|mesh-list
110154734|NCT00005966|Interferon-alpha|interferon-alpha|mesh-list
110154735|NCT00005966|Thalidomide|thalidomide|mesh-list
110154736|NCT00005966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110154737|NCT00005966|Antiviral Agents|antiviral agents|mesh-ancestor
110154738|NCT00005966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110154739|NCT00005966|Immunologic Factors|immunologic factors|mesh-ancestor
110154740|NCT00005966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110154741|NCT00005966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110154742|NCT00005966|Leprostatic Agents|leprostatic agents|mesh-ancestor
110154743|NCT00005966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110154744|NCT00005966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110154745|NCT00005966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110154746|NCT00005966|Growth Substances|growth substances|mesh-ancestor
110154747|NCT00005966|Growth Inhibitors|growth inhibitors|mesh-ancestor
110154748|NCT00005969|Tretinoin|tretinoin|mesh-list
110154749|NCT00005969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110154750|NCT00005969|Keratolytic Agents|keratolytic agents|mesh-ancestor
110154751|NCT00005969|Dermatologic Agents|dermatologic agents|mesh-ancestor
110154752|NCT00014014|Lamivudine|lamivudine|mesh-list
110154753|NCT00014014|Zidovudine|zidovudine|mesh-list
110154754|NCT00014014|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
110154755|NCT00014014|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110154756|NCT00014014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110154757|NCT00014014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110154758|NCT00014014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110154759|NCT00014014|Antiviral Agents|antiviral agents|mesh-ancestor
110154760|NCT00014014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110154761|NCT00014014|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110154762|NCT00014014|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110154763|NCT00014014|Antimetabolites|antimetabolites|mesh-ancestor
110154764|NCT00014092|Interferons|interferons|mesh-list
110154765|NCT00014092|Interferon-alpha|interferon-alpha|mesh-list
110154766|NCT00014092|Aldesleukin|aldesleukin|mesh-list
110154767|NCT00014092|Temozolomide|temozolomide|mesh-list
110154768|NCT00014092|Sargramostim|sargramostim|mesh-list
110154769|NCT00014092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110154770|NCT00014092|Antiviral Agents|antiviral agents|mesh-ancestor
110154771|NCT00014092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110154772|NCT00014092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110154773|NCT00014092|Alkylating Agents|alkylating agents|mesh-ancestor
110154774|NCT00014092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110154775|NCT00014092|Immunologic Factors|immunologic factors|mesh-ancestor
110154776|NCT00014092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110154777|NCT00014092|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110154778|NCT00014092|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110154779|NCT00005972|Gemcitabine|gemcitabine|mesh-list
110154781|NCT00005972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110154782|NCT00005972|Antimetabolites|antimetabolites|mesh-ancestor
110154783|NCT00005972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110154784|NCT00005972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110154785|NCT00005972|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110154786|NCT00005972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110154787|NCT00005972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110154788|NCT00014170|Gefitinib|gefitinib|mesh-list
110154789|NCT00014170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110154790|NCT00014170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110154791|NCT00014170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110154792|NCT00014170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110154794|NCT00014209|Gemcitabine|gemcitabine|mesh-list
110154795|NCT00014209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110154796|NCT00014209|Antiemetics|antiemetics|mesh-ancestor
110154797|NCT00014209|Autonomic Agents|autonomic agents|mesh-ancestor
110154798|NCT00014209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110154799|NCT00014209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110154800|NCT00014209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110154801|NCT00014209|Glucocorticoids|glucocorticoids|mesh-ancestor
110154802|NCT00014209|Hormones|hormones|mesh-ancestor
110154803|NCT00014209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110154804|NCT00014209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110154805|NCT00014209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110154806|NCT00014209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110154808|NCT00014209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110154809|NCT00014248|Adenosine|adenosine|mesh-list
110154810|NCT00014248|Analgesics|analgesics|mesh-ancestor
110154811|NCT00014248|Sensory System Agents|sensory system agents|mesh-ancestor
110154812|NCT00014248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110154813|NCT00014248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110154814|NCT00014248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110154815|NCT00014248|Vasodilator Agents|vasodilator agents|mesh-ancestor
110154816|NCT00014248|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110154817|NCT00014248|Purinergic Agonists|purinergic agonists|mesh-ancestor
110154818|NCT00014248|Purinergic Agents|purinergic agents|mesh-ancestor
110154819|NCT00014248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110154820|NCT00014248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110154822|NCT00005975|Megestrol Acetate|megestrol acetate|mesh-list
110154823|NCT00005975|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110154824|NCT00005975|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110154825|NCT00005975|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110154826|NCT00005975|Contraceptive Agents|contraceptive agents|mesh-ancestor
110154827|NCT00005975|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110154828|NCT00005975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110154829|NCT00005975|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110154830|NCT00005975|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110154831|NCT00005975|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110154832|NCT00005975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110154833|NCT00005975|Appetite Stimulants|appetite stimulants|mesh-ancestor
110154834|NCT00005975|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110154835|NCT00014287|Gemcitabine|gemcitabine|mesh-list
110154836|NCT00014287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110154837|NCT00014287|Antimetabolites|antimetabolites|mesh-ancestor
110154838|NCT00014287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110154839|NCT00014287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110154840|NCT02971930|Factor VIII|factor viii|mesh-list
110154841|NCT02971930|Coagulants|coagulants|mesh-ancestor
110154842|NCT00005978|Carboplatin|carboplatin|mesh-list
110154843|NCT00005978|Etoposide|etoposide|mesh-list
110154844|NCT00005978|Melphalan|melphalan|mesh-list
110154845|NCT00005978|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
110154846|NCT00005978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110154847|NCT00005978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110154848|NCT00005978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110154849|NCT00005978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110154850|NCT00005978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110154851|NCT00005978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110154852|NCT00005978|Immunologic Factors|immunologic factors|mesh-ancestor
110154853|NCT00005978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110154854|NCT00005978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110154855|NCT00005978|Alkylating Agents|alkylating agents|mesh-ancestor
110154856|NCT00005978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110154857|NCT00005978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110154858|NCT00005978|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110154859|NCT00014404|Celecoxib|celecoxib|mesh-list
110154860|NCT00014404|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110154861|NCT00014404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110154862|NCT00014404|Analgesics|analgesics|mesh-ancestor
110154863|NCT00014404|Sensory System Agents|sensory system agents|mesh-ancestor
110154864|NCT00014404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110154865|NCT00014404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110154867|NCT00014404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110154868|NCT00014404|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110154869|NCT00014404|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110154870|NCT00014404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110154871|NCT00014404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110154873|NCT00001332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110154874|NCT00014599|Paclitaxel|paclitaxel|mesh-list
110154875|NCT00014599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110154876|NCT00014599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110154877|NCT00014599|Tubulin Modulators|tubulin modulators|mesh-ancestor
110154878|NCT00014599|Antimitotic Agents|antimitotic agents|mesh-ancestor
110154879|NCT00014599|Mitosis Modulators|mitosis modulators|mesh-ancestor
110154880|NCT00014599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110154881|NCT00005981|Carmustine|carmustine|mesh-list
110154882|NCT00005981|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
110154883|NCT00005981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110154884|NCT00005981|Alkylating Agents|alkylating agents|mesh-ancestor
110154885|NCT00005981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110154886|NCT00005981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110154887|NCT00005981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110154888|NCT00014638|Letrozole|letrozole|mesh-list
110154889|NCT00014638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110154890|NCT00014638|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110154891|NCT00014638|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110154892|NCT00014638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110154893|NCT00014638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110154894|NCT00014638|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110154895|NCT00014638|Hormone Antagonists|hormone antagonists|mesh-ancestor
110154896|NCT00014638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110154897|NCT00014638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110154898|NCT00001341|Raltitrexed|raltitrexed|mesh-list
110154899|NCT00001341|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110154901|NCT00001341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110154902|NCT00001341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110154903|NCT00001341|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110154904|NCT00001341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110154905|NCT00014677|Interleukin-4|interleukin-4|mesh-list
110154906|NCT00014677|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110154907|NCT00014677|Immunologic Factors|immunologic factors|mesh-ancestor
110154908|NCT00014677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110154909|NCT00014677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110154910|NCT00014677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110154911|NCT00391534|Oxcarbazepine|oxcarbazepine|mesh-list
110154912|NCT00391534|Anticonvulsants|anticonvulsants|mesh-ancestor
110154913|NCT00391534|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110154914|NCT00391534|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110154915|NCT00391534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110154916|NCT00391534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110154917|NCT00391534|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110154918|NCT00391534|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110154919|NCT00005984|Interferons|interferons|mesh-list
110154920|NCT00005984|Interferon-alpha|interferon-alpha|mesh-list
110154921|NCT00005984|Cyclophosphamide|cyclophosphamide|mesh-list
110154923|NCT00005984|Immunologic Factors|immunologic factors|mesh-ancestor
110154924|NCT00005984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110154925|NCT00005984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110187366|NCT02484261|Antimetabolites|antimetabolites|mesh-ancestor
110154926|NCT00005984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110154927|NCT00005984|Alkylating Agents|alkylating agents|mesh-ancestor
110154928|NCT00005984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110154929|NCT00005984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110154931|NCT00005984|Antiviral Agents|antiviral agents|mesh-ancestor
110154932|NCT00005984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110154933|NCT00391651|Nitrofurantoin|nitrofurantoin|mesh-list
110154934|NCT00391651|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110154935|NCT00391651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110154936|NCT00391651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110154937|NCT00391690|Zoledronic Acid|zoledronic acid|mesh-list
110154938|NCT00391690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110154939|NCT00391690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110154941|NCT00005987|Interferon-alpha|interferon-alpha|mesh-list
110154942|NCT00005987|Dexamethasone|dexamethasone|mesh-list
110154943|NCT00005987|Cyclophosphamide|cyclophosphamide|mesh-list
110154944|NCT00005987|Carmustine|carmustine|mesh-list
110154945|NCT00005987|Etoposide|etoposide|mesh-list
110154946|NCT00005987|Mitoxantrone|mitoxantrone|mesh-list
110154947|NCT00005987|Sargramostim|sargramostim|mesh-list
110154948|NCT00005987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110154949|NCT00005987|Immunologic Factors|immunologic factors|mesh-ancestor
110154950|NCT00005987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110154951|NCT00005987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110154952|NCT00005987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110154953|NCT00005987|Alkylating Agents|alkylating agents|mesh-ancestor
110154954|NCT00005987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110154955|NCT00005987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110154956|NCT00005987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110154957|NCT00005987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110154959|NCT00005987|Autonomic Agents|autonomic agents|mesh-ancestor
110154960|NCT00005987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110154961|NCT00005987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110154962|NCT00005987|Glucocorticoids|glucocorticoids|mesh-ancestor
110154963|NCT00005987|Hormones|hormones|mesh-ancestor
110154964|NCT00005987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110154965|NCT00005987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110154967|NCT00005987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110154968|NCT00005987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110154969|NCT00005987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110154970|NCT00005987|Antiviral Agents|antiviral agents|mesh-ancestor
110154971|NCT00005987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110154972|NCT00005987|Analgesics|analgesics|mesh-ancestor
110154973|NCT00005987|Sensory System Agents|sensory system agents|mesh-ancestor
110154974|NCT00014755|Prednisone|prednisone|mesh-list
110154975|NCT00014755|Cyclophosphamide|cyclophosphamide|mesh-list
110154976|NCT00014755|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110154977|NCT00014755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110154978|NCT00014755|Immunologic Factors|immunologic factors|mesh-ancestor
110154979|NCT00014755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110154980|NCT00014755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110154981|NCT00014755|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110154982|NCT00014755|Alkylating Agents|alkylating agents|mesh-ancestor
110154983|NCT00014755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110154984|NCT00014755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110154985|NCT00014755|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110154986|NCT00014755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110154987|NCT00014755|Glucocorticoids|glucocorticoids|mesh-ancestor
110154988|NCT00014755|Hormones|hormones|mesh-ancestor
110154989|NCT00014755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110154990|NCT00014755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110154991|NCT00005990|Topotecan|topotecan|mesh-list
110154992|NCT00005990|Tipifarnib|tipifarnib|mesh-list
110154993|NCT00005990|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110154994|NCT00005990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110187377|NCT02471430|Antiviral Agents|antiviral agents|mesh-ancestor
110154995|NCT00005990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110154996|NCT00005990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110154997|NCT00005990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110154998|NCT00001344|Dextromethorphan|dextromethorphan|mesh-list
110154999|NCT00001344|Antitussive Agents|antitussive agents|mesh-ancestor
110155000|NCT00001344|Respiratory System Agents|respiratory system agents|mesh-ancestor
110155001|NCT00001344|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110155002|NCT00001344|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110155003|NCT00001344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110155004|NCT00001344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110155005|NCT00001344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110155006|NCT00014989|Magnesium Sulfate|magnesium sulfate|mesh-list
110155007|NCT00014989|Analgesics|analgesics|mesh-ancestor
110155008|NCT00014989|Sensory System Agents|sensory system agents|mesh-ancestor
110155009|NCT00014989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110155010|NCT00014989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110155011|NCT00014989|Anesthetics|anesthetics|mesh-ancestor
110155012|NCT00014989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110155013|NCT00014989|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110155014|NCT00014989|Anticonvulsants|anticonvulsants|mesh-ancestor
110155015|NCT00014989|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110155016|NCT00014989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110155017|NCT00014989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110155018|NCT00014989|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110155019|NCT00014989|Tocolytic Agents|tocolytic agents|mesh-ancestor
110155020|NCT00014989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110155021|NCT00005993|Aldesleukin|aldesleukin|mesh-list
110155022|NCT00005993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110155023|NCT00005993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110155024|NCT00005993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110155025|NCT00005993|Antiviral Agents|antiviral agents|mesh-ancestor
110155026|NCT00005993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110155027|NCT00015028|Buprenorphine|buprenorphine|mesh-list
110155028|NCT00015028|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
110155029|NCT00015028|Naloxone|naloxone|mesh-list
110155030|NCT00015028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110155031|NCT00015028|Narcotics|narcotics|mesh-ancestor
110155032|NCT00015028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110155033|NCT00015028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110155034|NCT00015028|Analgesics|analgesics|mesh-ancestor
110155035|NCT00015028|Sensory System Agents|sensory system agents|mesh-ancestor
110155036|NCT00015028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110155037|NCT00015028|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110155038|NCT00015067|Methylphenidate|methylphenidate|mesh-list
110155039|NCT00015067|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110155040|NCT00015067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110155041|NCT00015067|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110155042|NCT00015067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110155043|NCT00015067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110155044|NCT00015067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110155045|NCT00015067|Dopamine Agents|dopamine agents|mesh-ancestor
110155046|NCT00015067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110155047|NCT00015106|Lamotrigine|lamotrigine|mesh-list
110155048|NCT00015106|Anticonvulsants|anticonvulsants|mesh-ancestor
110155050|NCT00015106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110155051|NCT00015106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110155052|NCT00015106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110155053|NCT00015106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110155054|NCT00015106|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110155055|NCT00015106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110187385|NCT02438007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110155056|NCT00015106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110155057|NCT00015106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110155058|NCT00015106|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110155060|NCT00005996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110155061|NCT00005996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110155062|NCT00005996|Antimetabolites|antimetabolites|mesh-ancestor
110155063|NCT00005996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110155064|NCT00001359|Penicillins|penicillins|mesh-list
110155065|NCT00001359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110155066|NCT00001359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110155067|NCT00015223|Methylphenidate|methylphenidate|mesh-list
110155068|NCT00015223|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110155069|NCT00015223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110155070|NCT00015223|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110155071|NCT00015223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110155072|NCT00015223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110155073|NCT00015223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110155074|NCT00015223|Dopamine Agents|dopamine agents|mesh-ancestor
110155075|NCT00015223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110155076|NCT00015301|Methylphenidate|methylphenidate|mesh-list
110155077|NCT00015301|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110155078|NCT00015301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110155079|NCT00015301|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110155080|NCT00015301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110155081|NCT00015301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110155082|NCT00015301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110155083|NCT00015301|Dopamine Agents|dopamine agents|mesh-ancestor
110155084|NCT00015301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110155085|NCT00015340|Buprenorphine|buprenorphine|mesh-list
110155086|NCT00015340|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
110155088|NCT00015340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110155089|NCT00015340|Narcotics|narcotics|mesh-ancestor
110155090|NCT00015340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110155091|NCT00015340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110155092|NCT00015340|Analgesics|analgesics|mesh-ancestor
110155093|NCT00015340|Sensory System Agents|sensory system agents|mesh-ancestor
110155094|NCT00015340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110155095|NCT00015340|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110155096|NCT00015652|Ribavirin|ribavirin|mesh-list
110155097|NCT00015652|Aldesleukin|aldesleukin|mesh-list
110155098|NCT00015652|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110155099|NCT00015652|Antimetabolites|antimetabolites|mesh-ancestor
110155100|NCT00015652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110155101|NCT00015652|Antiviral Agents|antiviral agents|mesh-ancestor
110155102|NCT00015652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110155103|NCT00015652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110155104|NCT00015652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110155105|NCT00015652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110155106|NCT00005999|Arsenic Trioxide|arsenic trioxide|mesh-list
110155107|NCT00005999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110155108|NCT00015691|Metformin|metformin|mesh-list
110155109|NCT00015691|Rosiglitazone|rosiglitazone|mesh-list
110155110|NCT00015691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110155111|NCT00015691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110155112|NCT00015769|Levetiracetam|levetiracetam|mesh-list
110155113|NCT00015769|Anticonvulsants|anticonvulsants|mesh-ancestor
110155114|NCT00015769|Nootropic Agents|nootropic agents|mesh-ancestor
110155115|NCT00015808|Idebenone|idebenone|mesh-list
110155116|NCT00015808|Antioxidants|antioxidants|mesh-ancestor
110155117|NCT00015808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110155118|NCT00015808|Protective Agents|protective agents|mesh-ancestor
110155119|NCT00015808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110155121|NCT00015886|Fluorouracil|fluorouracil|mesh-list
110155122|NCT00015886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110155123|NCT00015886|Tubulin Modulators|tubulin modulators|mesh-ancestor
110155124|NCT00015886|Antimitotic Agents|antimitotic agents|mesh-ancestor
110155125|NCT00015886|Mitosis Modulators|mitosis modulators|mesh-ancestor
110155126|NCT00015886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110155127|NCT00015886|Antimetabolites|antimetabolites|mesh-ancestor
110155128|NCT00015886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110155129|NCT00015886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110155130|NCT00015886|Immunologic Factors|immunologic factors|mesh-ancestor
110155131|NCT00015886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110155132|NCT00006002|Dexamethasone|dexamethasone|mesh-list
110155133|NCT00006002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110155134|NCT00006002|Antiemetics|antiemetics|mesh-ancestor
110155135|NCT00006002|Autonomic Agents|autonomic agents|mesh-ancestor
110155136|NCT00006002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110155137|NCT00006002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110155138|NCT00006002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110155139|NCT00006002|Glucocorticoids|glucocorticoids|mesh-ancestor
110155140|NCT00006002|Hormones|hormones|mesh-ancestor
110155141|NCT00006002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110155142|NCT00006002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110155143|NCT00006002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110155144|NCT00001365|Dextromethorphan|dextromethorphan|mesh-list
110155145|NCT00001365|Antitussive Agents|antitussive agents|mesh-ancestor
110155146|NCT00001365|Respiratory System Agents|respiratory system agents|mesh-ancestor
110155147|NCT00001365|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110155148|NCT00001365|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110155149|NCT00001365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110155150|NCT00001365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110155151|NCT00001365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110155152|NCT00015925|Entinostat|entinostat|mesh-list
110155153|NCT00015925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110155154|NCT00015925|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110155155|NCT00015925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110155156|NCT00015925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110155157|NCT00006005|Thalidomide|thalidomide|mesh-list
110155158|NCT00006005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110155159|NCT00006005|Immunologic Factors|immunologic factors|mesh-ancestor
110155160|NCT00006005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110155161|NCT00006005|Leprostatic Agents|leprostatic agents|mesh-ancestor
110155162|NCT00006005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110155163|NCT00006005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110155164|NCT00006005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110155165|NCT00006005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110155166|NCT00006005|Growth Substances|growth substances|mesh-ancestor
110155167|NCT00006005|Growth Inhibitors|growth inhibitors|mesh-ancestor
110155168|NCT00006005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110155169|NCT00015964|Gefitinib|gefitinib|mesh-list
110155170|NCT00015964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110155171|NCT00015964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110155172|NCT00015964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110155173|NCT00015964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110155174|NCT01630213|Vitamin D|vitamin d|mesh-list
110155175|NCT01630213|Ergocalciferols|ergocalciferols|mesh-list
110155176|NCT01630213|Cholecalciferol|cholecalciferol|mesh-list
110155177|NCT01630213|Vitamins|vitamins|mesh-list
110155178|NCT01630213|Micronutrients|micronutrients|mesh-ancestor
110155179|NCT01630213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110155180|NCT01630213|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110155181|NCT01630213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110155182|NCT00006008|Arsenic Trioxide|arsenic trioxide|mesh-list
110155183|NCT00006008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110155184|NCT00016042|Interferons|interferons|mesh-list
110155185|NCT00016042|Interferon-alpha|interferon-alpha|mesh-list
110155186|NCT00016042|Fluorouracil|fluorouracil|mesh-list
110155187|NCT00016042|Sargramostim|sargramostim|mesh-list
110155188|NCT00016042|Antimetabolites|antimetabolites|mesh-ancestor
110155189|NCT00016042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110155190|NCT00016042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110155191|NCT00016042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110155192|NCT00016042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110155193|NCT00016042|Immunologic Factors|immunologic factors|mesh-ancestor
110155194|NCT00016042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110155195|NCT00016042|Antiviral Agents|antiviral agents|mesh-ancestor
110155196|NCT00016042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110155198|NCT00016081|Antimetabolites|antimetabolites|mesh-ancestor
110155199|NCT00016081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110155200|NCT00016081|Antiviral Agents|antiviral agents|mesh-ancestor
110155201|NCT00016081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110155202|NCT00016159|Idarubicin|idarubicin|mesh-list
110155203|NCT00016159|Arsenic Trioxide|arsenic trioxide|mesh-list
110155204|NCT00016159|Tretinoin|tretinoin|mesh-list
110155205|NCT00016159|Lintuzumab|lintuzumab|mesh-list
110155206|NCT00016159|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110155207|NCT00016159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110155208|NCT00016159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110155209|NCT00016159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110155210|NCT00016159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110155211|NCT00016159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110155212|NCT00016159|Keratolytic Agents|keratolytic agents|mesh-ancestor
110155213|NCT00016159|Dermatologic Agents|dermatologic agents|mesh-ancestor
110155214|NCT00016159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110155215|NCT00016198|Leucovorin|leucovorin|mesh-list
110155216|NCT00016198|Fluorouracil|fluorouracil|mesh-list
110155217|NCT00016198|Oxaliplatin|oxaliplatin|mesh-list
110155218|NCT00016198|Calcium|calcium|mesh-list
110155219|NCT00016198|Levoleucovorin|levoleucovorin|mesh-list
110155220|NCT00016198|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110155221|NCT00016198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110155222|NCT00016198|Antimetabolites|antimetabolites|mesh-ancestor
110155223|NCT00016198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110155224|NCT00016198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110155225|NCT00016198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110155226|NCT00016198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110155227|NCT00016198|Immunologic Factors|immunologic factors|mesh-ancestor
110155228|NCT00016198|Antidotes|antidotes|mesh-ancestor
110155229|NCT00016198|Protective Agents|protective agents|mesh-ancestor
110155230|NCT00016198|Vitamin B Complex|vitamin b complex|mesh-ancestor
110155231|NCT00016198|Vitamins|vitamins|mesh-ancestor
110155232|NCT00016198|Micronutrients|micronutrients|mesh-ancestor
110155233|NCT00016276|Tamoxifen|tamoxifen|mesh-list
110155234|NCT00016276|Paclitaxel|paclitaxel|mesh-list
110155235|NCT00016276|Razoxane|razoxane|mesh-list
110155236|NCT00016276|Cyclophosphamide|cyclophosphamide|mesh-list
110155237|NCT00016276|Doxorubicin|doxorubicin|mesh-list
110155238|NCT00016276|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110155239|NCT00016276|Trastuzumab|trastuzumab|mesh-list
110155240|NCT00016276|Dexrazoxane|dexrazoxane|mesh-list
110155241|NCT00016276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110155242|NCT00016276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110155243|NCT00016276|Tubulin Modulators|tubulin modulators|mesh-ancestor
110155244|NCT00016276|Antimitotic Agents|antimitotic agents|mesh-ancestor
110155245|NCT00016276|Mitosis Modulators|mitosis modulators|mesh-ancestor
110155246|NCT00016276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110155247|NCT00016276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110155248|NCT00016276|Immunologic Factors|immunologic factors|mesh-ancestor
110155249|NCT00016276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110155250|NCT00016276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110155251|NCT00016276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110155252|NCT00016276|Alkylating Agents|alkylating agents|mesh-ancestor
110155253|NCT00016276|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110155254|NCT00016276|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110155255|NCT00016276|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110155256|NCT00016276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110155257|NCT00016276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110155258|NCT00016276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110155259|NCT00016276|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110155260|NCT00016276|Hormone Antagonists|hormone antagonists|mesh-ancestor
110155261|NCT00016276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110155262|NCT00016276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110155263|NCT00016276|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110155264|NCT00016276|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110155265|NCT00016276|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110155266|NCT00016276|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110155267|NCT00016276|Protective Agents|protective agents|mesh-ancestor
110155268|NCT00016315|Paclitaxel|paclitaxel|mesh-list
110155269|NCT00016315|Carboplatin|carboplatin|mesh-list
110155270|NCT00016315|Gemcitabine|gemcitabine|mesh-list
110155271|NCT00016315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110155272|NCT00016315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110155273|NCT00016315|Tubulin Modulators|tubulin modulators|mesh-ancestor
110155274|NCT00016315|Antimitotic Agents|antimitotic agents|mesh-ancestor
110155275|NCT00016315|Mitosis Modulators|mitosis modulators|mesh-ancestor
110155276|NCT00016315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110155277|NCT00016315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110155278|NCT00016315|Antimetabolites|antimetabolites|mesh-ancestor
110155280|NCT00006014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110155281|NCT00006014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110155282|NCT00006014|Growth Substances|growth substances|mesh-ancestor
110155283|NCT00006014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110155284|NCT00006014|Growth Inhibitors|growth inhibitors|mesh-ancestor
110155285|NCT00006014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110155286|NCT00006014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110155287|NCT00006014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110155288|NCT00006014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110155289|NCT00016432|Exemestane|exemestane|mesh-list
110155290|NCT00016432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110155291|NCT00016432|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110155292|NCT00016432|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110155293|NCT00016432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110155294|NCT00016432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110155295|NCT00016432|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110155296|NCT00016432|Hormone Antagonists|hormone antagonists|mesh-ancestor
110187438|NCT01885949|Tivozanib|tivozanib|mesh-list
110155297|NCT00016432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110155298|NCT00016432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110155299|NCT00389376|Silymarin|silymarin|mesh-list
110155300|NCT00389376|Antioxidants|antioxidants|mesh-ancestor
110155301|NCT00389376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110155302|NCT00389376|Protective Agents|protective agents|mesh-ancestor
110155303|NCT00389376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110155304|NCT00016549|Bevacizumab|bevacizumab|mesh-list
110155305|NCT00016549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110155306|NCT00016549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110155307|NCT00016549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110155308|NCT00016549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110155309|NCT00016549|Growth Substances|growth substances|mesh-ancestor
110155310|NCT00016549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110155311|NCT00016549|Growth Inhibitors|growth inhibitors|mesh-ancestor
110155312|NCT00006023|Capecitabine|capecitabine|mesh-list
110155313|NCT00006023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110155315|NCT00006023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110155316|NCT00006023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110155317|NCT00016588|Tenofovir|tenofovir|mesh-list
110155318|NCT00016588|Antiviral Agents|antiviral agents|mesh-ancestor
110155319|NCT00016588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110155320|NCT00016588|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110155321|NCT00016588|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110155322|NCT00016588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110155323|NCT00016588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110155324|NCT00016588|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110155325|NCT00016588|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110155326|NCT00006026|Rubitecan|rubitecan|mesh-list
110155327|NCT00006026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110155328|NCT00006026|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110155329|NCT00006026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110155330|NCT00006026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110155331|NCT00006026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110155332|NCT00016666|Propranolol|propranolol|mesh-list
110155333|NCT00016666|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110155334|NCT00016666|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110155335|NCT00016666|Adrenergic Agents|adrenergic agents|mesh-ancestor
110155336|NCT00016666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110155337|NCT00016666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110155338|NCT00016666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110155339|NCT00016666|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110155340|NCT00016666|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110155341|NCT00016666|Vasodilator Agents|vasodilator agents|mesh-ancestor
110155342|NCT00016744|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
110155344|NCT00016744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110155345|NCT00016744|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110155346|NCT00016744|Protective Agents|protective agents|mesh-ancestor
110155347|NCT00016744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110155348|NCT00016744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110155349|NCT00016744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110155350|NCT00016744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110155351|NCT00016744|Phytoestrogens|phytoestrogens|mesh-ancestor
110155352|NCT00016744|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110155354|NCT00016744|Hormones|hormones|mesh-ancestor
110155355|NCT00016744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110155356|NCT00016861|Irinotecan|irinotecan|mesh-list
110155357|NCT00016861|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110155358|NCT00016861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110155359|NCT00016861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110155360|NCT00016861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110155361|NCT00016861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110155362|NCT00016900|Paclitaxel|paclitaxel|mesh-list
110155363|NCT00016900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110155364|NCT00016900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110155365|NCT00016900|Tubulin Modulators|tubulin modulators|mesh-ancestor
110155366|NCT00016900|Antimitotic Agents|antimitotic agents|mesh-ancestor
110155367|NCT00016900|Mitosis Modulators|mitosis modulators|mesh-ancestor
110155368|NCT00016900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110155369|NCT00016939|Alvocidib|alvocidib|mesh-list
110155370|NCT00016939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110155371|NCT00016939|Growth Inhibitors|growth inhibitors|mesh-ancestor
110155372|NCT00016939|Growth Substances|growth substances|mesh-ancestor
110155373|NCT00016939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110155374|NCT00016939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110155375|NCT00016939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110155376|NCT00016939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110155377|NCT00386672|Calcium, Dietary|calcium, dietary|mesh-list
110155378|NCT00386672|Vitamin D|vitamin d|mesh-list
110155379|NCT00386672|Ergocalciferols|ergocalciferols|mesh-list
110155380|NCT00386672|Cholecalciferol|cholecalciferol|mesh-list
110155381|NCT00386672|Vitamins|vitamins|mesh-list
110155382|NCT00386672|Calcium|calcium|mesh-list
110155383|NCT00386672|Micronutrients|micronutrients|mesh-ancestor
110155384|NCT00386672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110155385|NCT00386672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110155386|NCT00386672|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110155388|NCT00016978|Fluorouracil|fluorouracil|mesh-list
110155389|NCT00016978|Oxaliplatin|oxaliplatin|mesh-list
110155390|NCT00016978|Calcium|calcium|mesh-list
110155391|NCT00016978|Levoleucovorin|levoleucovorin|mesh-list
110155392|NCT00016978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110155393|NCT00016978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110155394|NCT00016978|Antimetabolites|antimetabolites|mesh-ancestor
110155395|NCT00016978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110155396|NCT00016978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110155397|NCT00016978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110155398|NCT00016978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110155399|NCT00016978|Immunologic Factors|immunologic factors|mesh-ancestor
110155401|NCT00016978|Protective Agents|protective agents|mesh-ancestor
110155402|NCT00016978|Vitamin B Complex|vitamin b complex|mesh-ancestor
110155403|NCT00016978|Vitamins|vitamins|mesh-ancestor
110155404|NCT00016978|Micronutrients|micronutrients|mesh-ancestor
110155405|NCT00017017|Paclitaxel|paclitaxel|mesh-list
110155406|NCT00017017|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
110155407|NCT00017017|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110155408|NCT00017017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110155409|NCT00017017|Tubulin Modulators|tubulin modulators|mesh-ancestor
110155410|NCT00017017|Antimitotic Agents|antimitotic agents|mesh-ancestor
110155411|NCT00017017|Mitosis Modulators|mitosis modulators|mesh-ancestor
110155412|NCT00017017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110155413|NCT00017095|Cyclophosphamide|cyclophosphamide|mesh-list
110155414|NCT00017095|Docetaxel|docetaxel|mesh-list
110155415|NCT00017095|Fluorouracil|fluorouracil|mesh-list
110155416|NCT00017095|Epirubicin|epirubicin|mesh-list
110155417|NCT00017095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110155418|NCT00017095|Immunologic Factors|immunologic factors|mesh-ancestor
110155419|NCT00017095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110155420|NCT00017095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110155421|NCT00017095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110155422|NCT00017095|Alkylating Agents|alkylating agents|mesh-ancestor
110155423|NCT00017095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110155424|NCT00017095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110155425|NCT00017095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110155426|NCT00017095|Tubulin Modulators|tubulin modulators|mesh-ancestor
110155427|NCT00017095|Antimitotic Agents|antimitotic agents|mesh-ancestor
110155428|NCT00017095|Mitosis Modulators|mitosis modulators|mesh-ancestor
110155429|NCT00017095|Antimetabolites|antimetabolites|mesh-ancestor
110155430|NCT00017095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110155431|NCT00017095|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110155432|NCT00017095|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110155433|NCT00017095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110155434|NCT00017095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110155437|NCT00006029|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110155438|NCT00006029|Vinorelbine|vinorelbine|mesh-list
110155439|NCT00006029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110155440|NCT00006029|Antimetabolites|antimetabolites|mesh-ancestor
110155441|NCT00006029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110155442|NCT00006029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110155443|NCT00006029|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110155444|NCT00006029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110155445|NCT00006029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110155446|NCT00006029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110155447|NCT00006029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110155448|NCT00006029|Tubulin Modulators|tubulin modulators|mesh-ancestor
110155449|NCT00006029|Antimitotic Agents|antimitotic agents|mesh-ancestor
110155450|NCT00006029|Mitosis Modulators|mitosis modulators|mesh-ancestor
110155451|NCT00371059|Memantine|memantine|mesh-list
110155452|NCT00371059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110155453|NCT00371059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110155454|NCT00371059|Dopamine Agents|dopamine agents|mesh-ancestor
110155455|NCT00371059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110155456|NCT00371059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110155457|NCT00371059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110155458|NCT00371059|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110155459|NCT00371059|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110155460|NCT00001482|Lamotrigine|lamotrigine|mesh-list
110155462|NCT00001482|Analgesics|analgesics|mesh-ancestor
110155463|NCT00001482|Sensory System Agents|sensory system agents|mesh-ancestor
110155464|NCT00001482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110155465|NCT00001482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110155467|NCT00001482|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110155468|NCT00001482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110155469|NCT00001482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110155470|NCT00001482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110155471|NCT00001482|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110155472|NCT00001482|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110155473|NCT00001482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110155474|NCT00001482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110155475|NCT00001482|Antimanic Agents|antimanic agents|mesh-ancestor
110155476|NCT00001482|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110155477|NCT00001482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110155478|NCT00001482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110155479|NCT00001482|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110155480|NCT00001482|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110155481|NCT00017134|Fenretinide|fenretinide|mesh-list
110155482|NCT00017134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110155483|NCT00017134|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110155484|NCT00017134|Protective Agents|protective agents|mesh-ancestor
110155485|NCT00017134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110155486|NCT04734418|Dexmedetomidine|dexmedetomidine|mesh-list
110155487|NCT04734418|Remifentanil|remifentanil|mesh-list
110155488|NCT04734418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110155489|NCT04734418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110155490|NCT04734418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110155491|NCT04734418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110155492|NCT04734418|Analgesics|analgesics|mesh-ancestor
110155493|NCT04734418|Sensory System Agents|sensory system agents|mesh-ancestor
110155494|NCT04734418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110155495|NCT04734418|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110155496|NCT04734418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110155497|NCT04734418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110155498|NCT04734418|Adrenergic Agents|adrenergic agents|mesh-ancestor
110155499|NCT04734418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110155500|NCT04734418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110155501|NCT04734418|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110155502|NCT04734418|Narcotics|narcotics|mesh-ancestor
110155503|NCT00006032|Etoposide|etoposide|mesh-list
110155504|NCT00006032|Topotecan|topotecan|mesh-list
110155505|NCT00006032|Ifosfamide|ifosfamide|mesh-list
110155506|NCT00006032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110155507|NCT00006032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110155508|NCT00006032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110155509|NCT00006032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110155510|NCT00006032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110155511|NCT00006032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110155512|NCT00006032|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110155513|NCT00006032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110155514|NCT00006032|Alkylating Agents|alkylating agents|mesh-ancestor
110155515|NCT00017173|Cisplatin|cisplatin|mesh-list
110155516|NCT00017173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110155517|NCT00001509|Tretinoin|tretinoin|mesh-list
110155518|NCT00001509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110155519|NCT00001509|Keratolytic Agents|keratolytic agents|mesh-ancestor
110155520|NCT00001509|Dermatologic Agents|dermatologic agents|mesh-ancestor
110155521|NCT00006035|Bleomycin|bleomycin|mesh-list
110155522|NCT00006035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110155523|NCT00006035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110155524|NCT00017212|Exatecan|exatecan|mesh-list
110155525|NCT00017212|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110155526|NCT00017212|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110155527|NCT00017212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110155528|NCT00017212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110155529|NCT00017212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110155530|NCT00017251|Carboplatin|carboplatin|mesh-list
110155531|NCT00017251|Etoposide|etoposide|mesh-list
110155532|NCT00017251|Etoposide phosphate|etoposide phosphate|mesh-list
110155533|NCT00017251|Oblimersen|oblimersen|mesh-list
110155534|NCT00017251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110155535|NCT00017251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110155536|NCT00017251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110155537|NCT00017251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110155538|NCT00017251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110155539|NCT00017251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110155540|NCT00006038|Leucovorin|leucovorin|mesh-list
110155541|NCT00006038|Docetaxel|docetaxel|mesh-list
110155542|NCT00006038|Fluorouracil|fluorouracil|mesh-list
110155543|NCT00006038|Floxuridine|floxuridine|mesh-list
110155544|NCT00006038|Calcium|calcium|mesh-list
110155545|NCT00006038|Levoleucovorin|levoleucovorin|mesh-list
110155546|NCT00006038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110155547|NCT00006038|Tubulin Modulators|tubulin modulators|mesh-ancestor
110155548|NCT00006038|Antimitotic Agents|antimitotic agents|mesh-ancestor
110155549|NCT00006038|Mitosis Modulators|mitosis modulators|mesh-ancestor
110155550|NCT00006038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110155551|NCT00006038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110155552|NCT00006038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110155553|NCT00006038|Antimetabolites|antimetabolites|mesh-ancestor
110155554|NCT00006038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110155555|NCT00006038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110155556|NCT00006038|Immunologic Factors|immunologic factors|mesh-ancestor
110155557|NCT00006038|Antidotes|antidotes|mesh-ancestor
110155558|NCT00006038|Protective Agents|protective agents|mesh-ancestor
110155559|NCT00006038|Vitamin B Complex|vitamin b complex|mesh-ancestor
110155560|NCT00006038|Vitamins|vitamins|mesh-ancestor
110155561|NCT00006038|Micronutrients|micronutrients|mesh-ancestor
110155563|NCT00017290|Cyclophosphamide|cyclophosphamide|mesh-list
110155564|NCT00017290|Vincristine|vincristine|mesh-list
110155565|NCT00017290|Immunoglobulins|immunoglobulins|mesh-list
110155566|NCT00017290|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110155567|NCT00017290|Antibodies|antibodies|mesh-list
110155568|NCT00017290|Sargramostim|sargramostim|mesh-list
110155569|NCT00017290|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
110155570|NCT00017290|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
110155571|NCT00017290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110155572|NCT00017290|Immunologic Factors|immunologic factors|mesh-ancestor
110155573|NCT00017290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110155574|NCT00017290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110155575|NCT00017290|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110155576|NCT00017290|Alkylating Agents|alkylating agents|mesh-ancestor
110155577|NCT00017290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110155578|NCT00017290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110155579|NCT00017290|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110155580|NCT00017290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110155581|NCT00017290|Glucocorticoids|glucocorticoids|mesh-ancestor
110155582|NCT00017290|Hormones|hormones|mesh-ancestor
110155583|NCT00017290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110155584|NCT00017290|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110155585|NCT00017290|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110155586|NCT00017290|Tubulin Modulators|tubulin modulators|mesh-ancestor
110155587|NCT00017290|Antimitotic Agents|antimitotic agents|mesh-ancestor
110155588|NCT00017290|Mitosis Modulators|mitosis modulators|mesh-ancestor
110155589|NCT00017290|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110155590|NCT00017329|Bortezomib|bortezomib|mesh-list
110155591|NCT00017329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110155592|NCT00017368|Cyclophosphamide|cyclophosphamide|mesh-list
110155593|NCT00017368|Melphalan|melphalan|mesh-list
110155594|NCT00017368|Ifosfamide|ifosfamide|mesh-list
110155595|NCT00017368|Thiotepa|thiotepa|mesh-list
110155596|NCT00017368|Carboplatin|carboplatin|mesh-list
110155597|NCT00017368|Doxorubicin|doxorubicin|mesh-list
110155598|NCT00017368|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110155599|NCT00017368|Etoposide|etoposide|mesh-list
110155600|NCT00017368|Etoposide phosphate|etoposide phosphate|mesh-list
110155601|NCT00017368|Vincristine|vincristine|mesh-list
110155602|NCT00017368|Isotretinoin|isotretinoin|mesh-list
110155603|NCT00017368|Sargramostim|sargramostim|mesh-list
110155604|NCT00017368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110155605|NCT00017368|Immunologic Factors|immunologic factors|mesh-ancestor
110155606|NCT00017368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110155607|NCT00017368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110155608|NCT00017368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110155609|NCT00017368|Alkylating Agents|alkylating agents|mesh-ancestor
110155610|NCT00017368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110155611|NCT00017368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110155612|NCT00017368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110155613|NCT00017368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110155614|NCT00017368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110155615|NCT00017368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110155616|NCT00017368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110155617|NCT00017368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110155618|NCT00017368|Tubulin Modulators|tubulin modulators|mesh-ancestor
110155619|NCT00017368|Antimitotic Agents|antimitotic agents|mesh-ancestor
110155620|NCT00017368|Mitosis Modulators|mitosis modulators|mesh-ancestor
110155621|NCT00017368|Dermatologic Agents|dermatologic agents|mesh-ancestor
110155623|NCT00001524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110155624|NCT00001524|Immunologic Factors|immunologic factors|mesh-ancestor
110155625|NCT00001524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110155626|NCT00001524|Leprostatic Agents|leprostatic agents|mesh-ancestor
110155627|NCT00001524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110155628|NCT00001524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110155629|NCT00001524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110155630|NCT00001524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110155631|NCT00001524|Growth Substances|growth substances|mesh-ancestor
110155632|NCT00001524|Growth Inhibitors|growth inhibitors|mesh-ancestor
110155633|NCT00001524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110155635|NCT00006041|Saponin QA-21V1|saponin qa-21v1|mesh-list
110155636|NCT00006041|Immunologic Factors|immunologic factors|mesh-ancestor
110155637|NCT00006041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110155638|NCT00006041|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110155639|NCT00017602|Dexamethasone|dexamethasone|mesh-list
110155640|NCT00017602|Oblimersen|oblimersen|mesh-list
110155641|NCT00017602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110155642|NCT00017602|Antiemetics|antiemetics|mesh-ancestor
110155643|NCT00017602|Autonomic Agents|autonomic agents|mesh-ancestor
110155644|NCT00017602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110155645|NCT00017602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110155646|NCT00017602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110155647|NCT00017602|Glucocorticoids|glucocorticoids|mesh-ancestor
110155648|NCT00017602|Hormones|hormones|mesh-ancestor
110155649|NCT00017602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110155650|NCT00017602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110155651|NCT00017602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110155652|NCT00001533|Cyclosporine|cyclosporine|mesh-list
110155653|NCT00001533|Cyclosporins|cyclosporins|mesh-list
110155654|NCT00001533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110155655|NCT00001533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110155656|NCT00001533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110155657|NCT00001533|Immunologic Factors|immunologic factors|mesh-ancestor
110155658|NCT00001533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110155659|NCT00001533|Antifungal Agents|antifungal agents|mesh-ancestor
110155660|NCT00001533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110155661|NCT00001533|Dermatologic Agents|dermatologic agents|mesh-ancestor
110155662|NCT00001533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110155663|NCT00001533|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110155664|NCT00017641|Cyclophosphamide|cyclophosphamide|mesh-list
110155665|NCT00017641|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110155666|NCT00017641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110155667|NCT00017641|Immunologic Factors|immunologic factors|mesh-ancestor
110155668|NCT00017641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110155670|NCT00017641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110155671|NCT00017641|Alkylating Agents|alkylating agents|mesh-ancestor
110155672|NCT00017641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110155673|NCT00017641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110155674|NCT00017641|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110155675|NCT00017680|Melphalan|melphalan|mesh-list
110155676|NCT00017680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110155677|NCT00017680|Alkylating Agents|alkylating agents|mesh-ancestor
110155678|NCT00017680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110155679|NCT00017680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110155680|NCT00017680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110155681|NCT00017680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110155682|NCT00017680|Immunologic Factors|immunologic factors|mesh-ancestor
110155683|NCT00017680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110155684|NCT00017719|Lamivudine|lamivudine|mesh-list
110155685|NCT00017719|Zidovudine|zidovudine|mesh-list
110155686|NCT00017719|Nevirapine|nevirapine|mesh-list
110155687|NCT00017719|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
110155688|NCT00017719|Nelfinavir|nelfinavir|mesh-list
110155689|NCT00017719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110155690|NCT00017719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110155691|NCT00017719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110155692|NCT00017719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110155693|NCT00017719|Antiviral Agents|antiviral agents|mesh-ancestor
110155694|NCT00017719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110155695|NCT00017719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110155696|NCT00017719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110155697|NCT00017719|Antimetabolites|antimetabolites|mesh-ancestor
110155698|NCT00017719|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110155699|NCT00017719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110155700|NCT00017719|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110155701|NCT00017719|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110155702|NCT00017719|Protease Inhibitors|protease inhibitors|mesh-ancestor
110155703|NCT00001542|Fluconazole|fluconazole|mesh-list
110155704|NCT00001542|Antifungal Agents|antifungal agents|mesh-ancestor
110155705|NCT00001542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110155706|NCT00001542|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110155707|NCT00001542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110155708|NCT00001542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110155709|NCT00001542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110155710|NCT00001542|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110155711|NCT00001542|Hormone Antagonists|hormone antagonists|mesh-ancestor
110155712|NCT00001542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110155713|NCT00001542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110155714|NCT00001542|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110155715|NCT00001542|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110155718|NCT00017758|Atorvastatin|atorvastatin|mesh-list
110155719|NCT00017758|Simvastatin|simvastatin|mesh-list
110155720|NCT00017758|Pravastatin|pravastatin|mesh-list
110155721|NCT00017758|Calcium|calcium|mesh-list
110155722|NCT00017758|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110155723|NCT00017758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110155724|NCT00017758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110155725|NCT00017758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110155726|NCT00017758|Antimetabolites|antimetabolites|mesh-ancestor
110155727|NCT00017758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110155728|NCT00017758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110155729|NCT00017758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110155730|NCT00017758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110155731|NCT00017758|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110155732|NCT00017758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110155733|NCT00017758|Antiviral Agents|antiviral agents|mesh-ancestor
110155734|NCT00017758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110155735|NCT00017758|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110155736|NCT00017758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110155737|NCT00017758|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110155738|NCT00017758|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110155739|NCT00017758|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110155740|NCT00017758|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110155741|NCT00017758|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110155742|NCT00017758|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110155743|NCT00017758|Protease Inhibitors|protease inhibitors|mesh-ancestor
110155744|NCT00017758|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110155745|NCT00017758|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110155747|NCT00017992|Lopinavir|lopinavir|mesh-list
110155748|NCT00017992|Emtricitabine|emtricitabine|mesh-list
110155749|NCT00017992|Stavudine|stavudine|mesh-list
110155750|NCT00017992|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110155751|NCT00017992|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110155752|NCT00017992|Protease Inhibitors|protease inhibitors|mesh-ancestor
110155753|NCT00017992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110155754|NCT00017992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110155756|NCT00017992|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110155757|NCT00017992|Antiviral Agents|antiviral agents|mesh-ancestor
110155758|NCT00017992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110155759|NCT00017992|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110155760|NCT00017992|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110155761|NCT00017992|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110155762|NCT00017992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110155763|NCT00017992|Antimetabolites|antimetabolites|mesh-ancestor
110155764|NCT04734067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110155765|NCT04734067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110155766|NCT04734067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110155768|NCT00018148|Nortriptyline|nortriptyline|mesh-list
110155769|NCT00018148|Nicotine|nicotine|mesh-list
110155770|NCT00018148|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110155771|NCT00018148|Autonomic Agents|autonomic agents|mesh-ancestor
110155772|NCT00018148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110155773|NCT00018148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110155774|NCT00018148|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110155775|NCT00018148|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110155776|NCT00018148|Cholinergic Agents|cholinergic agents|mesh-ancestor
110155777|NCT00018148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110155778|NCT00018148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110155779|NCT00018148|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110155780|NCT00018148|Antidepressive Agents|antidepressive agents|mesh-ancestor
110155781|NCT00018148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110155782|NCT00018148|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110155783|NCT00018148|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110155784|NCT00018148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110155785|NCT00018148|Adrenergic Agents|adrenergic agents|mesh-ancestor
110155786|NCT00001563|Rituximab|rituximab|mesh-list
110155787|NCT00001563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110155788|NCT00001563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110155789|NCT00001563|Immunologic Factors|immunologic factors|mesh-ancestor
110155790|NCT00001563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110155791|NCT00001563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110155792|NCT00018187|Mecamylamine|mecamylamine|mesh-list
110155793|NCT00018187|Bupropion|bupropion|mesh-list
110155794|NCT00018187|Nicotine|nicotine|mesh-list
110155795|NCT00018187|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110155796|NCT00018187|Autonomic Agents|autonomic agents|mesh-ancestor
110155797|NCT00018187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110155798|NCT00018187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110155799|NCT00018187|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110155800|NCT00018187|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110155801|NCT00018187|Cholinergic Agents|cholinergic agents|mesh-ancestor
110155802|NCT00018187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110155803|NCT00018187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110155804|NCT00018187|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110155805|NCT00018187|Antidepressive Agents|antidepressive agents|mesh-ancestor
110155806|NCT00018187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110155807|NCT00018187|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110155808|NCT00018187|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110155809|NCT00018187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110155810|NCT00018187|Dopamine Agents|dopamine agents|mesh-ancestor
110155811|NCT00018187|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110155812|NCT00018187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110155813|NCT00018187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110155814|NCT00018187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110155815|NCT00018187|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
110155816|NCT00018187|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
110155817|NCT00018187|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110155819|NCT00018343|Hormones|hormones|mesh-ancestor
110155820|NCT00018343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110155821|NCT00018343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110155822|NCT00001566|Indinavir|indinavir|mesh-list
110155823|NCT00001566|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110155824|NCT00001566|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110155825|NCT00001566|Protease Inhibitors|protease inhibitors|mesh-ancestor
110155826|NCT00001566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110155827|NCT00001566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110155828|NCT00001566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110155829|NCT00001566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110155830|NCT00001566|Antiviral Agents|antiviral agents|mesh-ancestor
110155831|NCT00001566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110155833|NCT00018382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110155834|NCT00018382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110155835|NCT00018460|Vitamins|vitamins|mesh-list
110155836|NCT00018460|Vitamin B Complex|vitamin b complex|mesh-list
110155837|NCT00018460|Micronutrients|micronutrients|mesh-ancestor
110155838|NCT00018460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110155839|NCT00386750|Lumefantrine|lumefantrine|mesh-list
110155840|NCT00386750|Artemether|artemether|mesh-list
110155841|NCT00386750|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110155842|NCT00386750|Antimalarials|antimalarials|mesh-ancestor
110155843|NCT00386750|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110155844|NCT00386750|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110155845|NCT00386750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110155846|NCT00001575|Edetic Acid|edetic acid|mesh-list
110155847|NCT00001575|Calcium|calcium|mesh-list
110155848|NCT00001575|Pentetic Acid|pentetic acid|mesh-list
110155849|NCT00001575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110155850|NCT00001575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110155851|NCT00001575|Antidotes|antidotes|mesh-ancestor
110155852|NCT00001575|Protective Agents|protective agents|mesh-ancestor
110155853|NCT00001575|Chelating Agents|chelating agents|mesh-ancestor
110155854|NCT00001575|Sequestering Agents|sequestering agents|mesh-ancestor
110155855|NCT00001575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110155856|NCT00001575|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110155857|NCT00001575|Anticoagulants|anticoagulants|mesh-ancestor
110155858|NCT00001575|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110155859|NCT00001596|Pirfenidone|pirfenidone|mesh-list
110155860|NCT00001596|Analgesics|analgesics|mesh-ancestor
110155861|NCT00001596|Sensory System Agents|sensory system agents|mesh-ancestor
110155862|NCT00001596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110155863|NCT00001596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110155864|NCT00001596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110155865|NCT00001596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110155866|NCT00001596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110155867|NCT00001596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110155868|NCT00001596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110155870|NCT05576194|Taurolidine|taurolidine|mesh-list
110155871|NCT05576194|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110155872|NCT05576194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110155873|NCT05576194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110155874|NCT00391885|Anesthetics|anesthetics|mesh-list
110155875|NCT00391885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110155876|NCT00391885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110155877|NCT00391924|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
110155878|NCT00391924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110155879|NCT00391924|Immunologic Factors|immunologic factors|mesh-ancestor
110155880|NCT00391924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110155881|NCT00392002|Esomeprazole|esomeprazole|mesh-list
110155882|NCT00392002|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110155883|NCT00392002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110155884|NCT00392002|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110155885|NCT00392002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110155886|NCT00392002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110155887|NCT00392080|Naproxen|naproxen|mesh-list
110155888|NCT00392080|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110155889|NCT00392080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110155890|NCT00392080|Analgesics|analgesics|mesh-ancestor
110155891|NCT00392080|Sensory System Agents|sensory system agents|mesh-ancestor
110155892|NCT00392080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110155893|NCT00392080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110155894|NCT00392080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110155895|NCT00392080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110155896|NCT00392080|Gout Suppressants|gout suppressants|mesh-ancestor
110155897|NCT00392080|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110155898|NCT00392080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110155899|NCT00392080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110155900|NCT00001644|Lamivudine|lamivudine|mesh-list
110155901|NCT00001644|Zidovudine|zidovudine|mesh-list
110155902|NCT00001644|Nevirapine|nevirapine|mesh-list
110155903|NCT00001644|Indinavir|indinavir|mesh-list
110155904|NCT00001644|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110187572|NCT05771675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110155905|NCT00001644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110155906|NCT00001644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110155907|NCT00001644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110155908|NCT00001644|Antiviral Agents|antiviral agents|mesh-ancestor
110155909|NCT00001644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110155910|NCT00001644|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110155911|NCT00001644|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110155912|NCT00001644|Antimetabolites|antimetabolites|mesh-ancestor
110155913|NCT00001644|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110155914|NCT00001644|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110155915|NCT00001644|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110155916|NCT00001644|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110155917|NCT00001644|Protease Inhibitors|protease inhibitors|mesh-ancestor
110155918|NCT05573386|Lenograstim|lenograstim|mesh-list
110155919|NCT05573386|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110155920|NCT05573386|Immunologic Factors|immunologic factors|mesh-ancestor
110155921|NCT05573386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110155923|NCT00001656|Clozapine|clozapine|mesh-list
110155924|NCT00001656|Antiemetics|antiemetics|mesh-ancestor
110155926|NCT00001656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110155927|NCT00001656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110155928|NCT00001656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110155929|NCT00001656|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110155930|NCT00001656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110155932|NCT00001656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110155933|NCT00001656|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110155934|NCT00001656|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110155935|NCT00001656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110155936|NCT00001656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110155937|NCT00001656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110155938|NCT00001656|Serotonin Agents|serotonin agents|mesh-ancestor
110155939|NCT00001656|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110155940|NCT00001656|GABA Antagonists|gaba antagonists|mesh-ancestor
110155941|NCT00001656|GABA Agents|gaba agents|mesh-ancestor
110155942|NCT05573191|Lidocaine|lidocaine|mesh-list
110155943|NCT05573191|Anesthetics, Local|anesthetics, local|mesh-ancestor
110155944|NCT05573191|Anesthetics|anesthetics|mesh-ancestor
110155945|NCT05573191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110155946|NCT05573191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110155947|NCT05573191|Sensory System Agents|sensory system agents|mesh-ancestor
110155948|NCT05573191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110155949|NCT05573191|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110155950|NCT05573191|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110155951|NCT05573191|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110155952|NCT05573191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110155953|NCT05573191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110155954|NCT05679830|Cannabidiol|cannabidiol|mesh-list
110155955|NCT05679830|Anticonvulsants|anticonvulsants|mesh-ancestor
110155956|NCT05572996|Treprostinil|treprostinil|mesh-list
110155957|NCT05572996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110155958|NCT05572723|Dexmedetomidine|dexmedetomidine|mesh-list
110155959|NCT05572723|Remifentanil|remifentanil|mesh-list
110155960|NCT05572723|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110155961|NCT05572723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110155962|NCT05572723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110155963|NCT05572723|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110155964|NCT05572723|Analgesics|analgesics|mesh-ancestor
110155965|NCT05572723|Sensory System Agents|sensory system agents|mesh-ancestor
110155966|NCT05572723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110155967|NCT05572723|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110155968|NCT05572723|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110155969|NCT05572723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110155970|NCT05572723|Adrenergic Agents|adrenergic agents|mesh-ancestor
110155971|NCT05572723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110155972|NCT05572723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110155973|NCT05572723|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110155974|NCT05572723|Narcotics|narcotics|mesh-ancestor
110155975|NCT05563753|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110155976|NCT05563753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110155977|NCT00389415|Vildagliptin|vildagliptin|mesh-list
110155978|NCT00389415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110155979|NCT00389415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110155980|NCT00389415|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110155981|NCT00389415|Protease Inhibitors|protease inhibitors|mesh-ancestor
110155982|NCT00389415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110155983|NCT00389415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110155984|NCT05419921|Lidocaine|lidocaine|mesh-list
110155985|NCT05419921|Anesthetics, Local|anesthetics, local|mesh-ancestor
110155986|NCT05419921|Anesthetics|anesthetics|mesh-ancestor
110155987|NCT05419921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110155988|NCT05419921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110155989|NCT05419921|Sensory System Agents|sensory system agents|mesh-ancestor
110155990|NCT05419921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110155991|NCT05419921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110155992|NCT05419921|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110155993|NCT05419921|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110155994|NCT05419921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110155995|NCT05419921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110155997|NCT00386828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110155998|NCT00386828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110155999|NCT00386828|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110156000|NCT00386828|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110156001|NCT00386828|Growth Substances|growth substances|mesh-ancestor
110156002|NCT00386828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110156003|NCT00386828|Growth Inhibitors|growth inhibitors|mesh-ancestor
110156004|NCT05367271|Dexamethasone|dexamethasone|mesh-list
110156005|NCT05367271|Cortisone|cortisone|mesh-list
110156006|NCT05367271|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110156007|NCT05367271|Botulinum Toxins|botulinum toxins|mesh-list
110156008|NCT05367271|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110156009|NCT05367271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110156010|NCT05367271|Antiemetics|antiemetics|mesh-ancestor
110156011|NCT05367271|Autonomic Agents|autonomic agents|mesh-ancestor
110156012|NCT05367271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110156013|NCT05367271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110156014|NCT05367271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110156015|NCT05367271|Glucocorticoids|glucocorticoids|mesh-ancestor
110156016|NCT05367271|Hormones|hormones|mesh-ancestor
110156017|NCT05367271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110156018|NCT05367271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110156019|NCT05367271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110156020|NCT05367271|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110156021|NCT05367271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110156022|NCT05367271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110156023|NCT05367271|Cholinergic Agents|cholinergic agents|mesh-ancestor
110156024|NCT05367271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110156025|NCT05367271|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110156026|NCT00001725|Dextromethorphan|dextromethorphan|mesh-list
110156027|NCT00001725|Antitussive Agents|antitussive agents|mesh-ancestor
110156028|NCT00001725|Respiratory System Agents|respiratory system agents|mesh-ancestor
110156029|NCT00001725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110156030|NCT00001725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110156031|NCT00001725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110156032|NCT00001725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110156033|NCT00001725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110156034|NCT05311618|Pembrolizumab|pembrolizumab|mesh-list
110156035|NCT05311618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110156036|NCT05311618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110156037|NCT05311618|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110156038|NCT05311618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110156039|NCT00001728|Alendronate|alendronate|mesh-list
110156040|NCT00001728|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110156041|NCT00001728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110156042|NCT05673629|Docetaxel|docetaxel|mesh-list
110156043|NCT05673629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110156044|NCT05673629|Tubulin Modulators|tubulin modulators|mesh-ancestor
110156045|NCT05673629|Antimitotic Agents|antimitotic agents|mesh-ancestor
110156046|NCT05673629|Mitosis Modulators|mitosis modulators|mesh-ancestor
110156047|NCT05673629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110156048|NCT00001731|Cyclosporine|cyclosporine|mesh-list
110156049|NCT00001731|Cyclosporins|cyclosporins|mesh-list
110156050|NCT00001731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110156051|NCT00001731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110156052|NCT00001731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110156053|NCT00001731|Immunologic Factors|immunologic factors|mesh-ancestor
110156054|NCT00001731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110156055|NCT00001731|Antifungal Agents|antifungal agents|mesh-ancestor
110156056|NCT00001731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110156057|NCT00001731|Dermatologic Agents|dermatologic agents|mesh-ancestor
110156058|NCT00001731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110156059|NCT00001731|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110156060|NCT00392158|Anesthetics|anesthetics|mesh-list
110156061|NCT00392158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110156062|NCT00392158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110156063|NCT00392275|Ciprofloxacin|ciprofloxacin|mesh-list
110156064|NCT00392275|Levofloxacin|levofloxacin|mesh-list
110156065|NCT00392275|Ofloxacin|ofloxacin|mesh-list
110156066|NCT00392275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110156067|NCT00392275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110156068|NCT00392275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110156069|NCT00392275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110156070|NCT00392275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110156071|NCT00392275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110156072|NCT00392275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110156073|NCT00392275|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110156074|NCT00392275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110156075|NCT00392275|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110156076|NCT00001749|Cyclosporine|cyclosporine|mesh-list
110156077|NCT00001749|Cyclosporins|cyclosporins|mesh-list
110156078|NCT00001749|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110156079|NCT00001749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110156080|NCT00001749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110156081|NCT00001749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110156082|NCT00001749|Immunologic Factors|immunologic factors|mesh-ancestor
110156083|NCT00001749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110156084|NCT00001749|Antifungal Agents|antifungal agents|mesh-ancestor
110156085|NCT00001749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110156086|NCT00001749|Dermatologic Agents|dermatologic agents|mesh-ancestor
110156087|NCT00001749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110156088|NCT00001749|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110156089|NCT00001752|Estrogens|estrogens|mesh-list
110156090|NCT00001752|Hormones|hormones|mesh-ancestor
110156091|NCT00001752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110156092|NCT00001752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110156093|NCT05171179|Lidocaine|lidocaine|mesh-list
110156094|NCT05171179|Bupivacaine|bupivacaine|mesh-list
110156095|NCT05171179|Anesthetics, Local|anesthetics, local|mesh-ancestor
110156096|NCT05171179|Anesthetics|anesthetics|mesh-ancestor
110156097|NCT05171179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110156098|NCT05171179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110156099|NCT05171179|Sensory System Agents|sensory system agents|mesh-ancestor
110156100|NCT05171179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110156101|NCT05171179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110156102|NCT05171179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110156103|NCT05171179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110156104|NCT05171179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110156105|NCT05171179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110156107|NCT05156905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110156108|NCT05156905|Tubulin Modulators|tubulin modulators|mesh-ancestor
110156109|NCT05156905|Antimitotic Agents|antimitotic agents|mesh-ancestor
110156110|NCT05156905|Mitosis Modulators|mitosis modulators|mesh-ancestor
110156111|NCT05156905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110156112|NCT00001758|Efavirenz|efavirenz|mesh-list
110156113|NCT00001758|Abacavir|abacavir|mesh-list
110156114|NCT00001758|Amprenavir|amprenavir|mesh-list
110156115|NCT00001758|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110156116|NCT00001758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110156117|NCT00001758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110156118|NCT00001758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110156119|NCT00001758|Antiviral Agents|antiviral agents|mesh-ancestor
110156120|NCT00001758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110156121|NCT00001758|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110156122|NCT00001758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110156123|NCT00001758|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110156124|NCT00001758|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110156125|NCT00001758|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110156126|NCT00001758|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110156127|NCT00001758|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110156128|NCT00001758|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110156129|NCT00001758|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110156130|NCT00001758|Antitubercular Agents|antitubercular agents|mesh-ancestor
110156131|NCT00001758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110156132|NCT00001758|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110156133|NCT00001758|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110156134|NCT00001758|Protease Inhibitors|protease inhibitors|mesh-ancestor
110156135|NCT00001764|Mycophenolic Acid|mycophenolic acid|mesh-list
110156136|NCT00001764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110156137|NCT00001764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110156138|NCT00001764|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110156139|NCT00001764|Antitubercular Agents|antitubercular agents|mesh-ancestor
110156140|NCT00001764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110156141|NCT00001764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110156142|NCT00001764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110156143|NCT00001764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110156145|NCT04971343|Immunoglobulins|immunoglobulins|mesh-list
110156146|NCT04971343|Immunologic Factors|immunologic factors|mesh-ancestor
110156147|NCT04971343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110156148|NCT04951804|Bupivacaine|bupivacaine|mesh-list
110156149|NCT04951804|Anesthetics, Local|anesthetics, local|mesh-ancestor
110156150|NCT04951804|Anesthetics|anesthetics|mesh-ancestor
110156151|NCT04951804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110156152|NCT04951804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110156153|NCT04951804|Sensory System Agents|sensory system agents|mesh-ancestor
110156154|NCT04951804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110156155|NCT05620628|Durvalumab|durvalumab|mesh-list
110156156|NCT05620628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110156157|NCT05620628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110156158|NCT04905121|Psilocybin|psilocybin|mesh-list
110156159|NCT04905121|Hallucinogens|hallucinogens|mesh-ancestor
110156160|NCT04905121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110156161|NCT04905121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110156162|NCT00001818|Hydroxyurea|hydroxyurea|mesh-list
110156163|NCT00001818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110156164|NCT00001818|Antisickling Agents|antisickling agents|mesh-ancestor
110156165|NCT00001818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110156166|NCT00001818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110156167|NCT00001818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110156168|NCT04887805|Pembrolizumab|pembrolizumab|mesh-list
110156169|NCT04887805|Lenvatinib|lenvatinib|mesh-list
110156170|NCT04887805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110156171|NCT04887805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110156172|NCT04887805|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110156173|NCT04887805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110156174|NCT04887805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110156175|NCT04887805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110156176|NCT00392314|Deoxyglucose|deoxyglucose|mesh-list
110156177|NCT00392314|Antimetabolites|antimetabolites|mesh-ancestor
110156178|NCT00392314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110156179|NCT00392314|Antiviral Agents|antiviral agents|mesh-ancestor
110156180|NCT00392314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110156181|NCT00000102|Nifedipine|nifedipine|mesh-list
110156182|NCT00000102|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110156183|NCT00000102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110156184|NCT00000102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110156185|NCT00000102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110156186|NCT00000102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110156187|NCT00000102|Vasodilator Agents|vasodilator agents|mesh-ancestor
110156188|NCT00000102|Tocolytic Agents|tocolytic agents|mesh-ancestor
110156189|NCT00000102|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110156190|NCT05641623|3-(3-(methylsulfonyl)phenyl)-1-propylpiperidine|3-(3-(methylsulfonyl)phenyl)-1-propylpiperidine|mesh-list
110156191|NCT05641623|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110156192|NCT05641623|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110156193|NCT05641623|Dopamine Agents|dopamine agents|mesh-ancestor
110156194|NCT05641623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110156195|NCT05641623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110156196|NCT05641623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110156197|NCT05641506|Niraparib|niraparib|mesh-list
110156198|NCT05641506|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110156199|NCT05641506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110156200|NCT05641506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110156201|NCT05641506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110156202|NCT00386867|Misoprostol|misoprostol|mesh-list
110156203|NCT00386867|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110156204|NCT00386867|Abortifacient Agents|abortifacient agents|mesh-ancestor
110156205|NCT00386867|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110156206|NCT00386867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110156207|NCT00386867|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110156208|NCT00386867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110156209|NCT00386867|Oxytocics|oxytocics|mesh-ancestor
110156211|NCT04526119|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110156212|NCT04526119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110156213|NCT04526119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110156214|NCT04526119|Cholinergic Agents|cholinergic agents|mesh-ancestor
110156215|NCT04526119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110156216|NCT04526119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110156217|NCT04526119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110156219|NCT00392431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110156220|NCT00392431|Vasodilator Agents|vasodilator agents|mesh-ancestor
110156221|NCT00392431|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110156222|NCT00392431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110156223|NCT00392431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110156224|NCT00392431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110156225|NCT00392431|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110156226|NCT00392431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110156227|NCT00392431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110156228|NCT00392431|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110156229|NCT00392431|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110156230|NCT00392431|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110156231|NCT00392470|Irinotecan|irinotecan|mesh-list
110156232|NCT00392470|Cetuximab|cetuximab|mesh-list
110156233|NCT00392470|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110156234|NCT00392470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110156235|NCT00392470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110156236|NCT00392470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110156237|NCT00392470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110156238|NCT00392470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110156239|NCT03960151|Dexamethasone|dexamethasone|mesh-list
110156240|NCT03960151|Olanzapine|olanzapine|mesh-list
110156241|NCT03960151|Palonosetron|palonosetron|mesh-list
110156242|NCT03960151|Rolapitant|rolapitant|mesh-list
110156243|NCT03960151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110156244|NCT03960151|Antiemetics|antiemetics|mesh-ancestor
110156245|NCT03960151|Autonomic Agents|autonomic agents|mesh-ancestor
110156246|NCT03960151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110156247|NCT03960151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110156248|NCT03960151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110156249|NCT03960151|Glucocorticoids|glucocorticoids|mesh-ancestor
110156250|NCT03960151|Hormones|hormones|mesh-ancestor
110156251|NCT03960151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110156252|NCT03960151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110156253|NCT03960151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110156254|NCT03960151|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110156255|NCT03960151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110156256|NCT03960151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110156257|NCT03960151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110156258|NCT03960151|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110156259|NCT03960151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110156260|NCT03960151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110156261|NCT03960151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110156262|NCT03960151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110156263|NCT03960151|Serotonin Agents|serotonin agents|mesh-ancestor
110156264|NCT03960151|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110156265|NCT03960151|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110156266|NCT03960151|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110156268|NCT04733326|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110156269|NCT04733326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110156270|NCT04733326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110156271|NCT04733326|Analgesics|analgesics|mesh-ancestor
110156272|NCT04733326|Sensory System Agents|sensory system agents|mesh-ancestor
110156273|NCT04733326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110156274|NCT04733326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110156275|NCT04733326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110156276|NCT04733326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110156277|NCT04733326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110156278|NCT04733326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110156279|NCT04733326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110156281|NCT00386984|Somatostatin|somatostatin|mesh-list
110156282|NCT00386984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110156283|NCT00386984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110156284|NCT00386984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110156285|NCT00386984|Hormones|hormones|mesh-ancestor
110156286|NCT00386984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110156287|NCT00386984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110156288|NCT03959761|Nivolumab|nivolumab|mesh-list
110156289|NCT03959761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110156290|NCT03959761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110156291|NCT03959761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110156292|NCT03959761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110156293|NCT00387179|Melatonin|melatonin|mesh-list
110156294|NCT00387179|Antioxidants|antioxidants|mesh-ancestor
110156295|NCT00387179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110156296|NCT00387179|Protective Agents|protective agents|mesh-ancestor
110156297|NCT00387179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110156298|NCT00387179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110156299|NCT03959332|Baloxavir|baloxavir|mesh-list
110156300|NCT03959332|Antiviral Agents|antiviral agents|mesh-ancestor
110156301|NCT03959332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110156302|NCT03959332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110156303|NCT03959332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110156304|NCT04733521|Cisplatin|cisplatin|mesh-list
110156305|NCT04733521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110156306|NCT05640726|Leucovorin|leucovorin|mesh-list
110156307|NCT05640726|Bevacizumab|bevacizumab|mesh-list
110156308|NCT05640726|Fluorouracil|fluorouracil|mesh-list
110156309|NCT05640726|Oxaliplatin|oxaliplatin|mesh-list
110156310|NCT05640726|Calcium|calcium|mesh-list
110156311|NCT05640726|Levoleucovorin|levoleucovorin|mesh-list
110156312|NCT05640726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110156313|NCT05640726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110156314|NCT05640726|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110156315|NCT05640726|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110156316|NCT05640726|Growth Substances|growth substances|mesh-ancestor
110156317|NCT05640726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110156318|NCT05640726|Growth Inhibitors|growth inhibitors|mesh-ancestor
110156319|NCT05640726|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110156320|NCT05640726|Antimetabolites|antimetabolites|mesh-ancestor
110156321|NCT05640726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110156322|NCT05640726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110156323|NCT05640726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110156324|NCT05640726|Immunologic Factors|immunologic factors|mesh-ancestor
110156325|NCT05640726|Antidotes|antidotes|mesh-ancestor
110156326|NCT05640726|Protective Agents|protective agents|mesh-ancestor
110156327|NCT05640726|Vitamin B Complex|vitamin b complex|mesh-ancestor
110156328|NCT05640726|Vitamins|vitamins|mesh-ancestor
110156329|NCT05640726|Micronutrients|micronutrients|mesh-ancestor
110156330|NCT03959176|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110156331|NCT03959176|Phenylephrine|phenylephrine|mesh-list
110156332|NCT03959176|Oxymetazoline|oxymetazoline|mesh-list
110156333|NCT03959176|Tropicamide|tropicamide|mesh-list
110156334|NCT03959176|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110156335|NCT03959176|Mydriatics|mydriatics|mesh-ancestor
110156336|NCT03959176|Autonomic Agents|autonomic agents|mesh-ancestor
110156337|NCT03959176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110156338|NCT03959176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110156339|NCT03959176|Sympathomimetics|sympathomimetics|mesh-ancestor
110156340|NCT03959176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110156341|NCT03959176|Nasal Decongestants|nasal decongestants|mesh-ancestor
110156342|NCT03959176|Respiratory System Agents|respiratory system agents|mesh-ancestor
110156343|NCT03959176|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110156344|NCT03959176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110156345|NCT03959176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110156346|NCT03959176|Adrenergic Agents|adrenergic agents|mesh-ancestor
110156347|NCT03959176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110156348|NCT03959176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110156349|NCT03959176|Protective Agents|protective agents|mesh-ancestor
110156350|NCT03959176|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110156351|NCT03959176|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110156352|NCT03959176|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110156353|NCT03959176|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110156354|NCT03959176|Cholinergic Agents|cholinergic agents|mesh-ancestor
110156355|NCT03958981|Castor Oil|castor oil|mesh-list
110156356|NCT03958981|Cathartics|cathartics|mesh-ancestor
110156357|NCT03958981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110156358|NCT03958942|Bupivacaine|bupivacaine|mesh-list
110156359|NCT03958942|Anesthetics, Local|anesthetics, local|mesh-ancestor
110156360|NCT03958942|Anesthetics|anesthetics|mesh-ancestor
110156361|NCT03958942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110187651|NCT05757011|Bupivacaine|bupivacaine|mesh-list
110156362|NCT03958942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110156364|NCT03958942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110156366|NCT03958708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110156367|NCT03958708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110156368|NCT03958708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110156369|NCT05640609|Bevacizumab|bevacizumab|mesh-list
110156370|NCT05640609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110156371|NCT05640609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110156372|NCT05640609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110156373|NCT05640609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110156374|NCT05640609|Growth Substances|growth substances|mesh-ancestor
110156375|NCT05640609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110156376|NCT05640609|Growth Inhibitors|growth inhibitors|mesh-ancestor
110156377|NCT05411861|Analgesics|analgesics|mesh-list
110156378|NCT05411861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
110156379|NCT05411861|Sensory System Agents|sensory system agents|mesh-ancestor
110156380|NCT05411861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110156381|NCT05411861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110156382|NCT03958513|Bupivacaine|bupivacaine|mesh-list
110156383|NCT03958513|Anesthetics, Local|anesthetics, local|mesh-ancestor
110156384|NCT03958513|Anesthetics|anesthetics|mesh-ancestor
110156385|NCT03958513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110156386|NCT03958513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110156387|NCT03958513|Sensory System Agents|sensory system agents|mesh-ancestor
110156388|NCT03958513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110156389|NCT03958396|Remifentanil|remifentanil|mesh-list
110156390|NCT03958396|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110156391|NCT03958396|Narcotics|narcotics|mesh-ancestor
110156392|NCT03958396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110156393|NCT03958396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110156394|NCT03958396|Analgesics|analgesics|mesh-ancestor
110156395|NCT03958396|Sensory System Agents|sensory system agents|mesh-ancestor
110156396|NCT03958396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110156398|NCT03958123|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110156399|NCT03958123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110156400|NCT03958123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110156401|NCT03958123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110156402|NCT03958123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110156403|NCT03958123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110156404|NCT03958123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110156405|NCT03958123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110156406|NCT03958123|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110156407|NCT03958123|Contraceptive Agents|contraceptive agents|mesh-ancestor
110156408|NCT03958123|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110156409|NCT03958123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110156410|NCT03958123|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110156411|NCT03958123|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110156412|NCT03958123|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110156413|NCT03933865|Ketamine|ketamine|mesh-list
110156414|NCT03933865|Hydromorphone|hydromorphone|mesh-list
110156415|NCT03933865|Analgesics|analgesics|mesh-ancestor
110156416|NCT03933865|Sensory System Agents|sensory system agents|mesh-ancestor
110156417|NCT03933865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110156418|NCT03933865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110156419|NCT03933865|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110156420|NCT03933865|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110156421|NCT03933865|Anesthetics, General|anesthetics, general|mesh-ancestor
110156422|NCT03933865|Anesthetics|anesthetics|mesh-ancestor
110156423|NCT03933865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110156424|NCT03933865|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110156425|NCT03933865|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110156426|NCT03933865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110156427|NCT03933865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110156428|NCT03933865|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110156429|NCT03933865|Narcotics|narcotics|mesh-ancestor
110156430|NCT03819322|Sofosbuvir|sofosbuvir|mesh-list
110156431|NCT03819322|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
110156432|NCT03819322|Velpatasvir|velpatasvir|mesh-list
110156433|NCT03819322|Antiviral Agents|antiviral agents|mesh-ancestor
110156434|NCT03819322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110156435|NCT05206175|Methamphetamine|methamphetamine|mesh-list
110156436|NCT05206175|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110156437|NCT05206175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110156438|NCT05206175|Sympathomimetics|sympathomimetics|mesh-ancestor
110156439|NCT05206175|Autonomic Agents|autonomic agents|mesh-ancestor
110156440|NCT05206175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110156441|NCT05206175|Dopamine Agents|dopamine agents|mesh-ancestor
110156442|NCT05206175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110156443|NCT05206175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110156444|NCT05206175|Adrenergic Agents|adrenergic agents|mesh-ancestor
110156445|NCT05206175|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110156446|NCT05206175|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110156447|NCT05206175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110156448|NCT05206175|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110156450|NCT00392899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110156451|NCT00392899|Antimetabolites|antimetabolites|mesh-ancestor
110156452|NCT00392899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110156453|NCT00392899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110156454|NCT05638893|Metformin|metformin|mesh-list
110156455|NCT05638893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110156456|NCT05638893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110156457|NCT00392938|Docetaxel|docetaxel|mesh-list
110156458|NCT00392938|Androgen Antagonists|androgen antagonists|mesh-list
110156459|NCT00392938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110156460|NCT00392938|Tubulin Modulators|tubulin modulators|mesh-ancestor
110156461|NCT00392938|Antimitotic Agents|antimitotic agents|mesh-ancestor
110156462|NCT00392938|Mitosis Modulators|mitosis modulators|mesh-ancestor
110156463|NCT00392938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110156464|NCT00392938|Hormone Antagonists|hormone antagonists|mesh-ancestor
110156465|NCT00392938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110156466|NCT00392938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110156467|NCT05637567|Aspirin|aspirin|mesh-list
110156468|NCT05637567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110156469|NCT05637567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110156470|NCT05637567|Analgesics|analgesics|mesh-ancestor
110156471|NCT05637567|Sensory System Agents|sensory system agents|mesh-ancestor
110156472|NCT05637567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110156473|NCT05637567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110156474|NCT05637567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110156475|NCT05637567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110156476|NCT05637567|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110156477|NCT05637567|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110156478|NCT05637567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110156479|NCT05637567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110156480|NCT05637567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110156481|NCT05637567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110156482|NCT05637567|Antipyretics|antipyretics|mesh-ancestor
110156483|NCT03432091|Melatonin|melatonin|mesh-list
110156484|NCT03432091|Antioxidants|antioxidants|mesh-ancestor
110156485|NCT03432091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110156486|NCT03432091|Protective Agents|protective agents|mesh-ancestor
110156487|NCT03432091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110156488|NCT03432091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110156489|NCT05634564|Paclitaxel|paclitaxel|mesh-list
110156490|NCT05634564|Gemcitabine|gemcitabine|mesh-list
110156491|NCT05634564|Tislelizumab|tislelizumab|mesh-list
110156492|NCT05634564|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110156493|NCT05634564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110156495|NCT05634564|Antimitotic Agents|antimitotic agents|mesh-ancestor
110156496|NCT05634564|Mitosis Modulators|mitosis modulators|mesh-ancestor
110156497|NCT05634564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110156498|NCT05634564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110156499|NCT05634564|Antimetabolites|antimetabolites|mesh-ancestor
110156500|NCT05634564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110156501|NCT03152149|Fluticasone|fluticasone|mesh-list
110156502|NCT03152149|Xhance|xhance|mesh-list
110156503|NCT03152149|Tiotropium Bromide|tiotropium bromide|mesh-list
110156504|NCT03152149|Olodaterol|olodaterol|mesh-list
110156505|NCT03152149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110156506|NCT03152149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110156507|NCT03152149|Autonomic Agents|autonomic agents|mesh-ancestor
110156508|NCT03152149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110156509|NCT03152149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110156510|NCT03152149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110156511|NCT03152149|Respiratory System Agents|respiratory system agents|mesh-ancestor
110156512|NCT03152149|Dermatologic Agents|dermatologic agents|mesh-ancestor
110156513|NCT03152149|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110156514|NCT03152149|Parasympatholytics|parasympatholytics|mesh-ancestor
110156515|NCT03152149|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110156516|NCT03152149|Cholinergic Agents|cholinergic agents|mesh-ancestor
110156517|NCT03152149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110156518|NCT03152149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110156519|NCT03151993|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110156521|NCT03151993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110156522|NCT03151993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110156525|NCT05633472|Micronutrients|micronutrients|mesh-ancestor
110156526|NCT05633472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110156527|NCT05633472|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110156528|NCT03151876|Gemcitabine|gemcitabine|mesh-list
110156529|NCT03151876|Busulfan|busulfan|mesh-list
110156530|NCT03151876|Cladribine|cladribine|mesh-list
110156531|NCT03151876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110156532|NCT03151876|Antimetabolites|antimetabolites|mesh-ancestor
110156533|NCT03151876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110156534|NCT03151876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110156535|NCT03151876|Alkylating Agents|alkylating agents|mesh-ancestor
110156536|NCT03151876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110156537|NCT03151876|Immunologic Factors|immunologic factors|mesh-ancestor
110156538|NCT03151876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110156539|NCT03151876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110156540|NCT03151876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110156541|NCT03151720|Loratadine|loratadine|mesh-list
110156542|NCT03151720|Antipruritics|antipruritics|mesh-ancestor
110156543|NCT03151720|Dermatologic Agents|dermatologic agents|mesh-ancestor
110156544|NCT03151720|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110156545|NCT03151720|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110156546|NCT03151720|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110156547|NCT03151720|Histamine Antagonists|histamine antagonists|mesh-ancestor
110156548|NCT03151720|Histamine Agents|histamine agents|mesh-ancestor
110156549|NCT03151720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110156550|NCT03151720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110156551|NCT03151720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110156553|NCT03151603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110156554|NCT03151603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110156555|NCT03151525|Infliximab|infliximab|mesh-list
110156556|NCT03151525|Azathioprine|azathioprine|mesh-list
110156557|NCT03151525|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110156558|NCT03151525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110156559|NCT03151525|Dermatologic Agents|dermatologic agents|mesh-ancestor
110156561|NCT03151525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110156562|NCT03151525|Antimetabolites|antimetabolites|mesh-ancestor
110156563|NCT03151525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110156564|NCT03151525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110156565|NCT03151525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110156566|NCT03151525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110156567|NCT03151525|Immunologic Factors|immunologic factors|mesh-ancestor
110156568|NCT03151525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110156570|NCT03151486|Purinergic P2X Receptor Antagonists|purinergic p2x receptor antagonists|mesh-ancestor
110156571|NCT03151486|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110156572|NCT03151486|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110156573|NCT03151486|Purinergic Agents|purinergic agents|mesh-ancestor
110156574|NCT03151486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110156575|NCT03151486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110156576|NCT03151486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110156577|NCT00387374|Paclitaxel|paclitaxel|mesh-list
110156578|NCT00387374|Bevacizumab|bevacizumab|mesh-list
110156579|NCT00387374|Carboplatin|carboplatin|mesh-list
110156580|NCT00387374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110156581|NCT00387374|Antibodies|antibodies|mesh-list
110156582|NCT00387374|Immunoglobulins|immunoglobulins|mesh-list
110156583|NCT00387374|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110156584|NCT00387374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110156585|NCT00387374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110156586|NCT00387374|Tubulin Modulators|tubulin modulators|mesh-ancestor
110156587|NCT00387374|Antimitotic Agents|antimitotic agents|mesh-ancestor
110156588|NCT00387374|Mitosis Modulators|mitosis modulators|mesh-ancestor
110156589|NCT00387374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110156590|NCT00387374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110156591|NCT00387374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110156592|NCT00387374|Growth Substances|growth substances|mesh-ancestor
110156593|NCT00387374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110156594|NCT00387374|Growth Inhibitors|growth inhibitors|mesh-ancestor
110156595|NCT00387374|Immunologic Factors|immunologic factors|mesh-ancestor
110156597|NCT03151369|Analgesics|analgesics|mesh-list
110156598|NCT03151369|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110156599|NCT03151369|Narcotics|narcotics|mesh-ancestor
110156600|NCT03151369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110156601|NCT03151369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110156602|NCT03151369|Sensory System Agents|sensory system agents|mesh-ancestor
110156603|NCT03151369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110156604|NCT04712266|Insulin|insulin|mesh-list
110156605|NCT04712266|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110156606|NCT04712266|Glucagon|glucagon|mesh-list
110156607|NCT04712266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110156608|NCT04712266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110156609|NCT04712266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110156610|NCT04712266|Hormones|hormones|mesh-ancestor
110156611|NCT04712266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110156612|NCT03151213|Pregabalin|pregabalin|mesh-list
110156613|NCT03151213|Analgesics|analgesics|mesh-ancestor
110156614|NCT03151213|Sensory System Agents|sensory system agents|mesh-ancestor
110156615|NCT03151213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110156616|NCT03151213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110156617|NCT03151213|Anticonvulsants|anticonvulsants|mesh-ancestor
110156618|NCT03151213|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110156619|NCT03151213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110156620|NCT03151213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110156621|NCT03151213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110156622|NCT03151213|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110156623|NCT03151213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110156624|NCT03151213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110156625|NCT03151213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110156626|NCT03151174|Vitamin D|vitamin d|mesh-list
110156627|NCT03151174|Ergocalciferols|ergocalciferols|mesh-list
110156628|NCT03151174|Cholecalciferol|cholecalciferol|mesh-list
110156629|NCT03151174|Vitamins|vitamins|mesh-list
110156630|NCT03151174|Micronutrients|micronutrients|mesh-ancestor
110156631|NCT03151174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110156632|NCT03151174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110156633|NCT03151174|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110156634|NCT03151096|Riboflavin|riboflavin|mesh-list
110156635|NCT03151096|Vitamin B Complex|vitamin b complex|mesh-ancestor
110156636|NCT03151096|Vitamins|vitamins|mesh-ancestor
110156637|NCT03151096|Micronutrients|micronutrients|mesh-ancestor
110156638|NCT03151096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110156639|NCT03151096|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110156640|NCT03151096|Dermatologic Agents|dermatologic agents|mesh-ancestor
110156641|NCT03906539|Atorvastatin|atorvastatin|mesh-list
110156642|NCT03906539|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110156643|NCT03906539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110156644|NCT03906539|Antimetabolites|antimetabolites|mesh-ancestor
110156645|NCT03906539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110156646|NCT03906539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110156647|NCT03906539|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110156648|NCT03906539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110156649|NCT00389688|Pemetrexed|pemetrexed|mesh-list
110156650|NCT00389688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110156651|NCT00389688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110156652|NCT00389688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110156653|NCT00389688|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110156654|NCT00389688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110156655|NCT05605665|Sirolimus|sirolimus|mesh-list
110156656|NCT05605665|Aldesleukin|aldesleukin|mesh-list
110156657|NCT05605665|Interleukin-2|interleukin-2|mesh-list
110156658|NCT05605665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110156659|NCT05605665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110156660|NCT05605665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110156661|NCT05605665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110156662|NCT05605665|Antifungal Agents|antifungal agents|mesh-ancestor
110156663|NCT05605665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110156664|NCT05605665|Immunologic Factors|immunologic factors|mesh-ancestor
110156665|NCT05605665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110156666|NCT05605665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110156667|NCT05605665|Analgesics|analgesics|mesh-ancestor
110156668|NCT05605665|Sensory System Agents|sensory system agents|mesh-ancestor
110156669|NCT05605665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110156670|NCT05605665|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110156671|NCT05605665|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110156672|NCT05605665|Antiviral Agents|antiviral agents|mesh-ancestor
110156673|NCT03150706|Avelumab|avelumab|mesh-list
110156674|NCT03150706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110156675|NCT03150706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110156676|NCT03150667|Clopidogrel|clopidogrel|mesh-list
110156677|NCT03150667|Ticagrelor|ticagrelor|mesh-list
110156678|NCT03150667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110156679|NCT03150667|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110156680|NCT03150667|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110156681|NCT03150667|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110156682|NCT03150667|Purinergic Agents|purinergic agents|mesh-ancestor
110156683|NCT03150667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110156684|NCT03150667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110156685|NCT03150667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110156686|NCT03150316|Dexamethasone|dexamethasone|mesh-list
110156687|NCT03150316|Lenalidomide|lenalidomide|mesh-list
110156688|NCT03150316|CKD-581|ckd-581|mesh-list
110156689|NCT03150316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110156690|NCT03150316|Antiemetics|antiemetics|mesh-ancestor
110156691|NCT03150316|Autonomic Agents|autonomic agents|mesh-ancestor
110156692|NCT03150316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110156693|NCT03150316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110156694|NCT03150316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110156695|NCT03150316|Glucocorticoids|glucocorticoids|mesh-ancestor
110156696|NCT03150316|Hormones|hormones|mesh-ancestor
110156697|NCT03150316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110156698|NCT03150316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110156699|NCT03150316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110156701|NCT03150316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110156702|NCT03150316|Immunologic Factors|immunologic factors|mesh-ancestor
110156703|NCT03150316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110156704|NCT03150316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110156705|NCT03150316|Growth Substances|growth substances|mesh-ancestor
110156706|NCT03150316|Growth Inhibitors|growth inhibitors|mesh-ancestor
110156707|NCT03150316|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110156708|NCT02972125|Lacosamide|lacosamide|mesh-list
110156709|NCT02972125|Anticonvulsants|anticonvulsants|mesh-ancestor
110156710|NCT02972125|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110156711|NCT02972125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110156712|NCT02972125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110156713|NCT02972125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110156714|NCT05597553|Pemetrexed|pemetrexed|mesh-list
110156715|NCT05597553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110156716|NCT05597553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110156717|NCT05597553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110156718|NCT05597553|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110156719|NCT05597553|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110156720|NCT03086044|Sofosbuvir|sofosbuvir|mesh-list
110156721|NCT03086044|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
110156722|NCT03086044|Velpatasvir|velpatasvir|mesh-list
110156723|NCT03086044|Antiviral Agents|antiviral agents|mesh-ancestor
110156724|NCT03086044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110156725|NCT03083665|Brivaracetam|brivaracetam|mesh-list
110156726|NCT03083665|Anticonvulsants|anticonvulsants|mesh-ancestor
110156727|NCT02866006|Topotecan|topotecan|mesh-list
110156728|NCT02866006|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110156729|NCT02866006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110156730|NCT02866006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110156731|NCT02866006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110156732|NCT02866006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110156733|NCT02719327|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
110156734|NCT02719327|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110156735|NCT02719327|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110156736|NCT02633098|Artesunate|artesunate|mesh-list
110156737|NCT02633098|Antimalarials|antimalarials|mesh-ancestor
110156738|NCT02633098|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110156739|NCT02633098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110156740|NCT02633098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110156741|NCT02633098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110156742|NCT02633098|Antiviral Agents|antiviral agents|mesh-ancestor
110156743|NCT02633098|Schistosomicides|schistosomicides|mesh-ancestor
110156744|NCT02633098|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110156745|NCT02633098|Anthelmintics|anthelmintics|mesh-ancestor
110156746|NCT00393289|Calcium|calcium|mesh-list
110156747|NCT00393289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110156748|NCT00393289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110156749|NCT02285179|Tamoxifen|tamoxifen|mesh-list
110156750|NCT02285179|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110156752|NCT02285179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110156753|NCT02285179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110156754|NCT02285179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110156755|NCT02285179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110156756|NCT02285179|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110156757|NCT02285179|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110156758|NCT02285179|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110156759|NCT02122081|Cyclophosphamide|cyclophosphamide|mesh-list
110156760|NCT02122081|Methotrexate|methotrexate|mesh-list
110156761|NCT02122081|Tacrolimus|tacrolimus|mesh-list
110156762|NCT02122081|Thymoglobulin|thymoglobulin|mesh-list
110156763|NCT02122081|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110156764|NCT02122081|Immunoglobulins|immunoglobulins|mesh-list
110156765|NCT02122081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110156766|NCT02122081|Immunologic Factors|immunologic factors|mesh-ancestor
110156767|NCT02122081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110156768|NCT02122081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110156769|NCT02122081|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110156770|NCT02122081|Alkylating Agents|alkylating agents|mesh-ancestor
110156771|NCT02122081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110156772|NCT02122081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110156773|NCT02122081|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110156774|NCT02122081|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110156775|NCT02122081|Abortifacient Agents|abortifacient agents|mesh-ancestor
110156776|NCT02122081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110156777|NCT02122081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110156778|NCT02122081|Antimetabolites|antimetabolites|mesh-ancestor
110156779|NCT02122081|Dermatologic Agents|dermatologic agents|mesh-ancestor
110156780|NCT02122081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110156781|NCT02122081|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110156782|NCT02122081|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110156783|NCT02122081|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110156784|NCT04708886|Alendronate|alendronate|mesh-list
110156785|NCT04708886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110156786|NCT04708886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110156787|NCT00393328|Ritonavir|ritonavir|mesh-list
110156788|NCT00393328|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110156789|NCT00393328|Aripiprazole|aripiprazole|mesh-list
110156790|NCT00393328|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110156791|NCT00393328|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110156792|NCT00393328|Protease Inhibitors|protease inhibitors|mesh-ancestor
110156793|NCT00393328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110156794|NCT00393328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110156795|NCT00393328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110156796|NCT00393328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110156797|NCT00393328|Antiviral Agents|antiviral agents|mesh-ancestor
110156798|NCT00393328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110156799|NCT00393328|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110156800|NCT00393328|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110156801|NCT00393328|Antidepressive Agents|antidepressive agents|mesh-ancestor
110156802|NCT00393328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110156803|NCT00393328|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110156804|NCT00393328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110156805|NCT00393328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110156806|NCT00393328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110156808|NCT00393328|Dopamine Agents|dopamine agents|mesh-ancestor
110156809|NCT00393328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110156810|NCT00393328|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110156811|NCT00393328|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110156812|NCT00393328|Serotonin Agents|serotonin agents|mesh-ancestor
110156813|NCT00393328|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110156814|NCT00393328|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110156815|NCT00393328|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110156817|NCT05530551|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110156818|NCT05530551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110156820|NCT01807429|Ketamine|ketamine|mesh-list
110156821|NCT01807429|Morphine|morphine|mesh-list
110156822|NCT01807429|Analgesics|analgesics|mesh-ancestor
110156823|NCT01807429|Sensory System Agents|sensory system agents|mesh-ancestor
110156824|NCT01807429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110156825|NCT01807429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110156826|NCT01807429|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110156827|NCT01807429|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110156828|NCT01807429|Anesthetics, General|anesthetics, general|mesh-ancestor
110156829|NCT01807429|Anesthetics|anesthetics|mesh-ancestor
110156830|NCT01807429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110156831|NCT01807429|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110156832|NCT01807429|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110156833|NCT01807429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110156834|NCT01807429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110156835|NCT01807429|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110156836|NCT01807429|Narcotics|narcotics|mesh-ancestor
110156837|NCT01807429|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110156838|NCT01807429|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110156839|NCT01807429|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110156840|NCT01807429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110156841|NCT01807429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110156842|NCT01807429|GABA Modulators|gaba modulators|mesh-ancestor
110156843|NCT01807429|GABA Agents|gaba agents|mesh-ancestor
110156844|NCT01807078|Ezetimibe|ezetimibe|mesh-list
110156845|NCT01807078|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110156846|NCT01807078|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110156847|NCT01807078|Antimetabolites|antimetabolites|mesh-ancestor
110156848|NCT01807078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110156849|NCT01807078|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110156850|NCT01349803|Formoterol Fumarate|formoterol fumarate|mesh-list
110156851|NCT01349803|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110156852|NCT01349803|Autonomic Agents|autonomic agents|mesh-ancestor
110156853|NCT01349803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110156854|NCT01349803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110156855|NCT01349803|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110156856|NCT01349803|Respiratory System Agents|respiratory system agents|mesh-ancestor
110156857|NCT01349803|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110156858|NCT01349803|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110156859|NCT01349803|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110156860|NCT01349803|Adrenergic Agents|adrenergic agents|mesh-ancestor
110156861|NCT01349803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110156862|NCT01349803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110156864|NCT01807000|Laxatives|laxatives|mesh-ancestor
110156865|NCT01807000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110156866|NCT01807000|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
110156867|NCT01807000|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110156868|NCT01807000|Serotonin Agents|serotonin agents|mesh-ancestor
110156869|NCT01807000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110156870|NCT01807000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110156871|NCT01807000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110156873|NCT01806805|Anticonvulsants|anticonvulsants|mesh-ancestor
110156874|NCT01806805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110156875|NCT01806805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110156876|NCT01806805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110156877|NCT01806805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110156878|NCT01806805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110156879|NCT00387413|Niacinamide|niacinamide|mesh-list
110156880|NCT00387413|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110187725|NCT05646992|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110156881|NCT00387413|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110156882|NCT00387413|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110156883|NCT00387413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110156884|NCT00387413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110156885|NCT00387413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110156886|NCT00387413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110156888|NCT00387413|Sensory System Agents|sensory system agents|mesh-ancestor
110156889|NCT00387413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110156890|NCT00387413|Antidepressive Agents|antidepressive agents|mesh-ancestor
110156891|NCT00387413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110156892|NCT00387413|Dopamine Agents|dopamine agents|mesh-ancestor
110156893|NCT00387413|Vitamin B Complex|vitamin b complex|mesh-ancestor
110156895|NCT00387413|Micronutrients|micronutrients|mesh-ancestor
110156896|NCT01806610|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110156897|NCT01806610|Immunologic Factors|immunologic factors|mesh-ancestor
110156898|NCT01806610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110156899|NCT05517291|Paclitaxel|paclitaxel|mesh-list
110156900|NCT05517291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110156901|NCT05517291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110156902|NCT05517291|Tubulin Modulators|tubulin modulators|mesh-ancestor
110156903|NCT05517291|Antimitotic Agents|antimitotic agents|mesh-ancestor
110156904|NCT05517291|Mitosis Modulators|mitosis modulators|mesh-ancestor
110156905|NCT05517291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110156906|NCT01806454|Calcium|calcium|mesh-list
110156907|NCT01806454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110156908|NCT01806454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110156909|NCT01806415|Imidazole|imidazole|mesh-list
110156910|NCT01806415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110156911|NCT01806415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110156912|NCT01806376|Maleic acid|maleic acid|mesh-list
110156913|NCT01806376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110156914|NCT01806376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110156915|NCT01806337|Alemtuzumab|alemtuzumab|mesh-list
110156916|NCT01806337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110156917|NCT01806337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110156918|NCT01806259|Ketorolac|ketorolac|mesh-list
110156919|NCT01806259|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110156920|NCT01806259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110156921|NCT01806259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110156922|NCT01806259|Analgesics|analgesics|mesh-ancestor
110156923|NCT01806259|Sensory System Agents|sensory system agents|mesh-ancestor
110156924|NCT01806259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110156925|NCT01806259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110156926|NCT01806259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110156927|NCT01806259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110156928|NCT01806259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110156929|NCT01806259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110156930|NCT01806259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110156932|NCT05482542|Rituximab|rituximab|mesh-list
110156933|NCT05482542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110156934|NCT05482542|Immunologic Factors|immunologic factors|mesh-ancestor
110156935|NCT05482542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110156936|NCT05482542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110156937|NCT05482542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110156938|NCT05482542|Alkylating Agents|alkylating agents|mesh-ancestor
110156939|NCT05482542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110156940|NCT05482542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110156941|NCT05482542|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110156942|NCT05482542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110156944|NCT04579757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110156945|NCT04579757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110156946|NCT00393445|Glucagon|glucagon|mesh-list
110156947|NCT00393445|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110156948|NCT00393445|Incretins|incretins|mesh-ancestor
110156949|NCT00393445|Hormones|hormones|mesh-ancestor
110156950|NCT00393445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110156951|NCT00393445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110156952|NCT00393445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110156953|NCT00393562|Methylphenidate|methylphenidate|mesh-list
110156954|NCT00393562|Modafinil|modafinil|mesh-list
110156955|NCT00393562|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110156956|NCT00393562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110156957|NCT00393562|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110156958|NCT00393562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110156959|NCT00393562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110156960|NCT00393562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110156961|NCT00393562|Dopamine Agents|dopamine agents|mesh-ancestor
110156962|NCT00393562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110156963|NCT00393562|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110156964|NCT00393562|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110156965|NCT00393562|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110156966|NCT01806103|Anti-Infective Agents|anti-infective agents|mesh-list
110156967|NCT01806103|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110156968|NCT01805908|Pertuzumab|pertuzumab|mesh-list
110156969|NCT01805908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110156970|NCT01805908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110156971|NCT04527107|Aflibercept|aflibercept|mesh-list
110156972|NCT04527107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110156973|NCT04527107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110156974|NCT04527107|Growth Substances|growth substances|mesh-ancestor
110156975|NCT04527107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110156976|NCT04527107|Growth Inhibitors|growth inhibitors|mesh-ancestor
110156977|NCT04527107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110156978|NCT05437887|Fucoidan|fucoidan|mesh-list
110156979|NCT05437887|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110156980|NCT05437887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110156981|NCT05437887|Anticoagulants|anticoagulants|mesh-ancestor
110156982|NCT05437887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110156983|NCT01805596|Clopidogrel|clopidogrel|mesh-list
110156984|NCT01805596|Ticagrelor|ticagrelor|mesh-list
110156985|NCT01805596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110156986|NCT01805596|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110156987|NCT01805596|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110156988|NCT01805596|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110156989|NCT01805596|Purinergic Agents|purinergic agents|mesh-ancestor
110156990|NCT01805596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110156991|NCT01805596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110156992|NCT01805596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110156993|NCT04474223|Dexamethasone|dexamethasone|mesh-list
110156994|NCT04474223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110156995|NCT04474223|Antiemetics|antiemetics|mesh-ancestor
110156996|NCT04474223|Autonomic Agents|autonomic agents|mesh-ancestor
110156997|NCT04474223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110156998|NCT04474223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110156999|NCT04474223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110157000|NCT04474223|Glucocorticoids|glucocorticoids|mesh-ancestor
110157001|NCT04474223|Hormones|hormones|mesh-ancestor
110157002|NCT04474223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110157003|NCT04474223|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110157004|NCT04474223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110157005|NCT01466530|Misoprostol|misoprostol|mesh-list
110157006|NCT01466530|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110157007|NCT01466530|Abortifacient Agents|abortifacient agents|mesh-ancestor
110157008|NCT01466530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110157009|NCT01466530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110157010|NCT01466530|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110157011|NCT01466530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110157012|NCT01466530|Oxytocics|oxytocics|mesh-ancestor
110157013|NCT01466452|Aspirin|aspirin|mesh-list
110157014|NCT01466452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110157015|NCT01466452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110157016|NCT01466452|Analgesics|analgesics|mesh-ancestor
110157017|NCT01466452|Sensory System Agents|sensory system agents|mesh-ancestor
110157018|NCT01466452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110157019|NCT01466452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110157020|NCT01466452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110157021|NCT01466452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110157022|NCT01466452|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110157023|NCT01466452|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110157024|NCT01466452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110157025|NCT01466452|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110157026|NCT01466452|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110157027|NCT01466452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110157030|NCT01466374|Immunoglobulins|immunoglobulins|mesh-list
110157031|NCT01466374|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110157032|NCT01466374|Immunologic Factors|immunologic factors|mesh-ancestor
110157033|NCT01466374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110157034|NCT01466257|Cetuximab|cetuximab|mesh-list
110157035|NCT01466257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110157036|NCT01466257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110157037|NCT01466101|Pregabalin|pregabalin|mesh-list
110157038|NCT01466101|Analgesics|analgesics|mesh-ancestor
110157039|NCT01466101|Sensory System Agents|sensory system agents|mesh-ancestor
110157040|NCT01466101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110157041|NCT01466101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110157042|NCT01466101|Anticonvulsants|anticonvulsants|mesh-ancestor
110157043|NCT01466101|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110157044|NCT01466101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110157045|NCT01466101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110157046|NCT01466101|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110157047|NCT01466101|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110157048|NCT01466101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110157049|NCT01466101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110157050|NCT01466101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110157051|NCT01465984|Acetaminophen|acetaminophen|mesh-list
110157052|NCT01465984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110157053|NCT01465984|Analgesics|analgesics|mesh-ancestor
110157054|NCT01465984|Sensory System Agents|sensory system agents|mesh-ancestor
110157055|NCT01465984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110157056|NCT01465984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110157057|NCT01465984|Antipyretics|antipyretics|mesh-ancestor
110157058|NCT01465906|Bromides|bromides|mesh-list
110157059|NCT01465906|Tiotropium Bromide|tiotropium bromide|mesh-list
110157060|NCT01465906|Tulobuterol|tulobuterol|mesh-list
110157061|NCT01465906|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110157062|NCT01465906|Autonomic Agents|autonomic agents|mesh-ancestor
110157063|NCT01465906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110157064|NCT01465906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110157065|NCT01465906|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110157066|NCT01465906|Respiratory System Agents|respiratory system agents|mesh-ancestor
110157067|NCT01465906|Parasympatholytics|parasympatholytics|mesh-ancestor
110157068|NCT01465906|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110157069|NCT01465906|Cholinergic Agents|cholinergic agents|mesh-ancestor
110157070|NCT01465906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110157071|NCT01465906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110157072|NCT01465906|Anticonvulsants|anticonvulsants|mesh-ancestor
110157073|NCT01465906|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110157074|NCT01465906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110157075|NCT01465906|Adrenergic Agents|adrenergic agents|mesh-ancestor
110157077|NCT01465867|Antioxidants|antioxidants|mesh-ancestor
110157078|NCT01465867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110157079|NCT01465867|Protective Agents|protective agents|mesh-ancestor
110157080|NCT01465867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110157081|NCT01465867|Trace Elements|trace elements|mesh-ancestor
110157082|NCT01465867|Micronutrients|micronutrients|mesh-ancestor
110157083|NCT01465828|Clopidogrel|clopidogrel|mesh-list
110157084|NCT01465828|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110157085|NCT01465828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110157086|NCT01465828|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110157087|NCT01465828|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110157088|NCT01465828|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110157089|NCT01465828|Purinergic Agents|purinergic agents|mesh-ancestor
110157090|NCT01465828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110157091|NCT01465828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110157092|NCT01465828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110157094|NCT01465438|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110157095|NCT01465438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110157096|NCT01465438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110157097|NCT01465399|Mitogens|mitogens|mesh-list
110157098|NCT01465399|Mitosis Modulators|mitosis modulators|mesh-ancestor
110157099|NCT01465399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110157100|NCT05393505|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110157101|NCT05393505|Amoxicillin|amoxicillin|mesh-list
110157102|NCT05393505|Levofloxacin|levofloxacin|mesh-list
110157103|NCT05393505|Meropenem|meropenem|mesh-list
110157104|NCT05393505|Clavulanic Acid|clavulanic acid|mesh-list
110157105|NCT05393505|Clavulanic Acids|clavulanic acids|mesh-list
110157106|NCT05393505|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110157107|NCT05393505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110157108|NCT05393505|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110157109|NCT05393505|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110157110|NCT05393505|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110157112|NCT05393505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110157113|NCT05393505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110157114|NCT05393505|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110157115|NCT05393505|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110157116|NCT05393505|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110157117|NCT04201457|Hydroxychloroquine|hydroxychloroquine|mesh-list
110157118|NCT04201457|Trametinib|trametinib|mesh-list
110157119|NCT04201457|Dabrafenib|dabrafenib|mesh-list
110157120|NCT04201457|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
110157121|NCT04201457|Antimalarials|antimalarials|mesh-ancestor
110157122|NCT04201457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110157123|NCT04201457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110157124|NCT04201457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110157125|NCT04201457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110157126|NCT04201457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110157127|NCT04201457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110157128|NCT04201457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110157129|NCT04201457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110157130|NCT04201457|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110157131|NCT04201457|Protective Agents|protective agents|mesh-ancestor
110157132|NCT04201457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110157133|NCT04201457|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110157135|NCT01465009|Aspirin|aspirin|mesh-list
110157136|NCT01465009|Acetaminophen|acetaminophen|mesh-list
110157137|NCT01465009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110157138|NCT01465009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110157139|NCT01465009|Analgesics|analgesics|mesh-ancestor
110157140|NCT01465009|Sensory System Agents|sensory system agents|mesh-ancestor
110157141|NCT01465009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110157142|NCT01465009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110157143|NCT01465009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110157144|NCT01465009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110157145|NCT01465009|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110157146|NCT01465009|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110157147|NCT01465009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110157148|NCT01465009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110157149|NCT01465009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110157150|NCT01465009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110157151|NCT01465009|Antipyretics|antipyretics|mesh-ancestor
110157152|NCT00389766|Topotecan|topotecan|mesh-list
110157154|NCT00389766|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110157155|NCT00389766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110157156|NCT00389766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110157157|NCT00389766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110157158|NCT00389766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110157159|NCT00389766|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110157161|NCT01464697|Progestins|progestins|mesh-ancestor
110157162|NCT01464697|Hormones|hormones|mesh-ancestor
110157163|NCT01464697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110157164|NCT01464697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110157165|NCT04083950|Aspirin|aspirin|mesh-list
110157166|NCT04083950|Vaccines|vaccines|mesh-list
110157167|NCT04083950|Immunologic Factors|immunologic factors|mesh-ancestor
110157168|NCT04083950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110157169|NCT04083950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110157170|NCT04083950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110157172|NCT04083950|Sensory System Agents|sensory system agents|mesh-ancestor
110157173|NCT04083950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110157174|NCT04083950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110157175|NCT04083950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110157176|NCT04083950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110157177|NCT04083950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110157178|NCT04083950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110157179|NCT04083950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110157180|NCT04083950|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110157181|NCT04083950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110157182|NCT04083950|Antipyretics|antipyretics|mesh-ancestor
110157183|NCT00393679|Artesunate|artesunate|mesh-list
110157184|NCT00393679|Lumefantrine|lumefantrine|mesh-list
110157185|NCT00393679|Artemether|artemether|mesh-list
110157186|NCT00393679|Piperaquine|piperaquine|mesh-list
110157187|NCT00393679|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110157188|NCT00393679|Amodiaquine|amodiaquine|mesh-list
110157189|NCT00393679|Artenimol|artenimol|mesh-list
110157190|NCT00393679|Dapsone|dapsone|mesh-list
110157191|NCT00393679|Chlorproguanil|chlorproguanil|mesh-list
110157192|NCT00393679|Antimalarials|antimalarials|mesh-ancestor
110157193|NCT00393679|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110157194|NCT00393679|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110157195|NCT00393679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110157196|NCT00393679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110157197|NCT00393679|Antiviral Agents|antiviral agents|mesh-ancestor
110157198|NCT00393679|Schistosomicides|schistosomicides|mesh-ancestor
110157199|NCT00393679|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110157200|NCT00393679|Anthelmintics|anthelmintics|mesh-ancestor
110157201|NCT00393679|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110157202|NCT00393679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110157203|NCT00393679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110157204|NCT00393679|Leprostatic Agents|leprostatic agents|mesh-ancestor
110157205|NCT00393679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110157206|NCT00393835|Azithromycin|azithromycin|mesh-list
110157207|NCT00393835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110157208|NCT00393835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110157209|NCT01057069|Paclitaxel|paclitaxel|mesh-list
110157210|NCT01057069|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110157211|NCT01057069|Cyclophosphamide|cyclophosphamide|mesh-list
110157212|NCT01057069|Carboplatin|carboplatin|mesh-list
110157213|NCT01057069|Doxorubicin|doxorubicin|mesh-list
110157214|NCT01057069|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110157215|NCT01057069|Thiotepa|thiotepa|mesh-list
110157216|NCT01057069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110157217|NCT01057069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110157218|NCT01057069|Tubulin Modulators|tubulin modulators|mesh-ancestor
110157219|NCT01057069|Antimitotic Agents|antimitotic agents|mesh-ancestor
110157220|NCT01057069|Mitosis Modulators|mitosis modulators|mesh-ancestor
110157221|NCT01057069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110157222|NCT01057069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110157223|NCT01057069|Immunologic Factors|immunologic factors|mesh-ancestor
110157224|NCT01057069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110157225|NCT01057069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110157226|NCT01057069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110157227|NCT01057069|Alkylating Agents|alkylating agents|mesh-ancestor
110157228|NCT01057069|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110157229|NCT01057069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110157230|NCT01057069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110157231|NCT01057069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110157232|NCT01057069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110157233|NCT00847834|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110157234|NCT00847834|Irbesartan|irbesartan|mesh-list
110157235|NCT00847834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110157236|NCT00847834|Diuretics|diuretics|mesh-ancestor
110157237|NCT00847834|Natriuretic Agents|natriuretic agents|mesh-ancestor
110157238|NCT00847834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110157239|NCT00847834|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110157240|NCT00847834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110157241|NCT00847834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110157242|NCT00847834|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110157243|NCT00847834|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110157244|NCT00847678|Amphotericin B|amphotericin b|mesh-list
110157245|NCT00847678|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110157246|NCT00847678|Flucytosine|flucytosine|mesh-list
110157247|NCT00847678|Efungumab|efungumab|mesh-list
110157248|NCT00847678|Amebicides|amebicides|mesh-ancestor
110157249|NCT00847678|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110157250|NCT00847678|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110157251|NCT00847678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110157252|NCT00847678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110157253|NCT00847678|Antifungal Agents|antifungal agents|mesh-ancestor
110157254|NCT00847678|Antimetabolites|antimetabolites|mesh-ancestor
110157255|NCT00847678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110157256|NCT00847639|Lenalidomide|lenalidomide|mesh-list
110157257|NCT00847639|Immunologic Factors|immunologic factors|mesh-ancestor
110157258|NCT00847639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110157259|NCT00847639|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110157260|NCT00847639|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110157261|NCT00847639|Growth Substances|growth substances|mesh-ancestor
110157262|NCT00847639|Growth Inhibitors|growth inhibitors|mesh-ancestor
110157263|NCT00847639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110157264|NCT00847483|Bimatoprost|bimatoprost|mesh-list
110157265|NCT00847483|Travoprost|travoprost|mesh-list
110157266|NCT00847483|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110157267|NCT00847483|Latanoprost|latanoprost|mesh-list
110157268|NCT00847483|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110157269|NCT00847483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110157270|NCT04034927|Olaparib|olaparib|mesh-list
110157271|NCT04034927|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
110157272|NCT04034927|Tremelimumab|tremelimumab|mesh-list
110157273|NCT04034927|Ipilimumab|ipilimumab|mesh-list
110157274|NCT04034927|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110157275|NCT04034927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110157276|NCT04034927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110157277|NCT04034927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110157278|NCT04034927|Immunologic Factors|immunologic factors|mesh-ancestor
110157279|NCT04034927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110157280|NCT04034927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110157281|NCT04034927|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110157283|NCT00847366|Trastuzumab|trastuzumab|mesh-list
110157284|NCT00847366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110157285|NCT00847366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110157286|NCT00847366|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110157287|NCT00847366|Hormone Antagonists|hormone antagonists|mesh-ancestor
110157288|NCT00847366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110157289|NCT00847366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110157290|NCT00847366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110157291|NCT00847366|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110157292|NCT00847366|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110157293|NCT00847366|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110157294|NCT05321160|Ketamine|ketamine|mesh-list
110157295|NCT05321160|Sevoflurane|sevoflurane|mesh-list
110157296|NCT05321160|Esketamine|esketamine|mesh-list
110157297|NCT05321160|Analgesics|analgesics|mesh-ancestor
110157298|NCT05321160|Sensory System Agents|sensory system agents|mesh-ancestor
110157299|NCT05321160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110157300|NCT05321160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110157301|NCT05321160|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110157302|NCT05321160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110157303|NCT05321160|Anesthetics, General|anesthetics, general|mesh-ancestor
110157304|NCT05321160|Anesthetics|anesthetics|mesh-ancestor
110157305|NCT05321160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110157306|NCT05321160|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110157307|NCT05321160|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110157308|NCT05321160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110157309|NCT05321160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110157310|NCT05321160|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110157311|NCT05321160|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110157312|NCT05321160|Antidepressive Agents|antidepressive agents|mesh-ancestor
110157313|NCT05321160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110157314|NCT04009343|Lumefantrine|lumefantrine|mesh-list
110157315|NCT04009343|Artemether|artemether|mesh-list
110157316|NCT04009343|Piperaquine|piperaquine|mesh-list
110157317|NCT04009343|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110157318|NCT04009343|Artenimol|artenimol|mesh-list
110157319|NCT04009343|Antimalarials|antimalarials|mesh-ancestor
110157320|NCT04009343|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110157321|NCT04009343|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110157322|NCT04009343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110157323|NCT03969641|Vaccines|vaccines|mesh-list
110157324|NCT03969641|Immunologic Factors|immunologic factors|mesh-ancestor
110157325|NCT03969641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110157326|NCT00847210|Dexlansoprazole|dexlansoprazole|mesh-list
110157327|NCT00847210|Lansoprazole|lansoprazole|mesh-list
110157328|NCT00847210|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110157329|NCT00847210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110157330|NCT00847210|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110157331|NCT00847210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110157332|NCT00847210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110157333|NCT00847171|Cyclophosphamide|cyclophosphamide|mesh-list
110157334|NCT00847171|Trastuzumab|trastuzumab|mesh-list
110157335|NCT00847171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110157336|NCT00847171|Immunologic Factors|immunologic factors|mesh-ancestor
110157337|NCT00847171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110157338|NCT00847171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110157339|NCT00847171|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110157340|NCT00847171|Alkylating Agents|alkylating agents|mesh-ancestor
110157341|NCT00847171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110157342|NCT00847171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110157343|NCT00847171|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110157344|NCT00847171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110157346|NCT00847093|Anesthetics, Local|anesthetics, local|mesh-ancestor
110157348|NCT00847093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110157349|NCT00847093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110157350|NCT00847093|Sensory System Agents|sensory system agents|mesh-ancestor
110157351|NCT00847093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110157352|NCT00847093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110157353|NCT00847093|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110157354|NCT00847093|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110157355|NCT00847093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110157356|NCT00847093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110157357|NCT00847054|Antibodies|antibodies|mesh-list
110157358|NCT00847054|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110157359|NCT00847054|Immunologic Factors|immunologic factors|mesh-ancestor
110157360|NCT00847054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110157361|NCT00846976|Bicalutamide|bicalutamide|mesh-list
110157362|NCT00846976|Androgen Antagonists|androgen antagonists|mesh-ancestor
110157363|NCT00846976|Hormone Antagonists|hormone antagonists|mesh-ancestor
110157364|NCT00846976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110157365|NCT00846976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110157366|NCT00846976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110157367|NCT00846859|Varenicline|varenicline|mesh-list
110157368|NCT00846859|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110157369|NCT00846859|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110157370|NCT00846859|Cholinergic Agents|cholinergic agents|mesh-ancestor
110157371|NCT00846859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110157372|NCT00846859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110157373|NCT00846859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110157374|NCT03885830|Imatinib Mesylate|imatinib mesylate|mesh-list
110157375|NCT03885830|Dasatinib|dasatinib|mesh-list
110157376|NCT03885830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110157377|NCT03885830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110157378|NCT03885830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110157379|NCT03885830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110157380|NCT00846703|Dexamethasone|dexamethasone|mesh-list
110157381|NCT00846703|Methotrexate|methotrexate|mesh-list
110157382|NCT00846703|Vincristine|vincristine|mesh-list
110157383|NCT00846703|Mercaptopurine|mercaptopurine|mesh-list
110157384|NCT00846703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110157385|NCT00846703|Antiemetics|antiemetics|mesh-ancestor
110157386|NCT00846703|Autonomic Agents|autonomic agents|mesh-ancestor
110157387|NCT00846703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110157388|NCT00846703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110157389|NCT00846703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110157390|NCT00846703|Glucocorticoids|glucocorticoids|mesh-ancestor
110157391|NCT00846703|Hormones|hormones|mesh-ancestor
110157392|NCT00846703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110157393|NCT00846703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110157394|NCT00846703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110157395|NCT00846703|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110157396|NCT00846703|Abortifacient Agents|abortifacient agents|mesh-ancestor
110157397|NCT00846703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110157398|NCT00846703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110157400|NCT00846703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110157401|NCT00846703|Dermatologic Agents|dermatologic agents|mesh-ancestor
110157402|NCT00846703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110157403|NCT00846703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110157404|NCT00846703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110157406|NCT00846703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110157407|NCT00846703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110157408|NCT00846703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110157409|NCT00846703|Tubulin Modulators|tubulin modulators|mesh-ancestor
110157410|NCT00846703|Antimitotic Agents|antimitotic agents|mesh-ancestor
110157411|NCT00846703|Mitosis Modulators|mitosis modulators|mesh-ancestor
110157413|NCT03772964|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110157414|NCT03772964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110157415|NCT00846625|Triamcinolone|triamcinolone|mesh-list
110157416|NCT00846625|Ranibizumab|ranibizumab|mesh-list
110157417|NCT00846625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110157418|NCT00846625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110157419|NCT00846625|Growth Substances|growth substances|mesh-ancestor
110157420|NCT00846625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110157421|NCT00846625|Growth Inhibitors|growth inhibitors|mesh-ancestor
110157422|NCT00846625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110157423|NCT00846625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110157424|NCT00846625|Glucocorticoids|glucocorticoids|mesh-ancestor
110157425|NCT00846625|Hormones|hormones|mesh-ancestor
110157426|NCT00846625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110157427|NCT00846508|Cisplatin|cisplatin|mesh-list
110187779|NCT05458479|Serotonin Agents|serotonin agents|mesh-ancestor
110157428|NCT00846508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110157429|NCT03721172|Apremilast|apremilast|mesh-list
110157430|NCT03721172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110157431|NCT03721172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110157432|NCT03721172|Analgesics|analgesics|mesh-ancestor
110157433|NCT03721172|Sensory System Agents|sensory system agents|mesh-ancestor
110157434|NCT03721172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110157435|NCT03721172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110157436|NCT03721172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110157437|NCT03721172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110157438|NCT03721172|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110157439|NCT03721172|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110157440|NCT03721172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110157441|NCT03721172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110157442|NCT00846274|Antithrombins|antithrombins|mesh-list
110157443|NCT00846274|Antithrombin III|antithrombin iii|mesh-list
110157444|NCT00846274|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110157445|NCT00846274|Protease Inhibitors|protease inhibitors|mesh-ancestor
110157446|NCT00846274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110157447|NCT00846274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110157448|NCT00846274|Anticoagulants|anticoagulants|mesh-ancestor
110157450|NCT00846235|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110157451|NCT00846235|Protective Agents|protective agents|mesh-ancestor
110157452|NCT00846235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110157453|NCT00846196|Risedronic Acid|risedronic acid|mesh-list
110157454|NCT00846196|Etidronic Acid|etidronic acid|mesh-list
110157455|NCT00846196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110157456|NCT00846196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110157457|NCT00846196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110157458|NCT00846196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110157459|NCT00846196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110157460|NCT00846196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110157461|NCT00846118|Pitavastatin|pitavastatin|mesh-list
110157462|NCT00846118|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110157463|NCT00846118|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110157464|NCT00846118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110157465|NCT00846118|Antimetabolites|antimetabolites|mesh-ancestor
110157466|NCT00846118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110157467|NCT00846118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110157468|NCT00846118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110157469|NCT00846079|Regadenoson|regadenoson|mesh-list
110157470|NCT00846079|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
110157471|NCT00846079|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110157472|NCT00846079|Purinergic Agonists|purinergic agonists|mesh-ancestor
110157473|NCT00846079|Purinergic Agents|purinergic agents|mesh-ancestor
110157474|NCT00846079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110157475|NCT00846079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110157476|NCT00846079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110157477|NCT00845962|Bupivacaine|bupivacaine|mesh-list
110157478|NCT00845962|Chloroprocaine|chloroprocaine|mesh-list
110157479|NCT00845962|Anesthetics, Local|anesthetics, local|mesh-ancestor
110157480|NCT00845962|Anesthetics|anesthetics|mesh-ancestor
110157481|NCT00845962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110157482|NCT00845962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110157484|NCT00845962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110157485|NCT03620942|Phenylephrine|phenylephrine|mesh-list
110157486|NCT03620942|Oxymetazoline|oxymetazoline|mesh-list
110157487|NCT03620942|Ephedrine|ephedrine|mesh-list
110157488|NCT03620942|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
110157489|NCT03620942|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110157490|NCT03620942|Mydriatics|mydriatics|mesh-ancestor
110157491|NCT03620942|Autonomic Agents|autonomic agents|mesh-ancestor
110157492|NCT03620942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110157493|NCT03620942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110157494|NCT03620942|Sympathomimetics|sympathomimetics|mesh-ancestor
110157495|NCT03620942|Nasal Decongestants|nasal decongestants|mesh-ancestor
110157496|NCT03620942|Respiratory System Agents|respiratory system agents|mesh-ancestor
110157497|NCT03620942|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110157499|NCT03620942|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110157500|NCT03620942|Adrenergic Agents|adrenergic agents|mesh-ancestor
110157501|NCT03620942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110157502|NCT03620942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110157503|NCT03620942|Protective Agents|protective agents|mesh-ancestor
110157504|NCT03620942|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110157505|NCT00277108|Escitalopram|escitalopram|mesh-list
110157506|NCT00277108|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110157507|NCT00277108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110157508|NCT00277108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110157509|NCT00277108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110157510|NCT00277108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110157511|NCT00277108|Serotonin Agents|serotonin agents|mesh-ancestor
110157512|NCT00277108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110157513|NCT00277069|Carboplatin|carboplatin|mesh-list
110157514|NCT00277069|Capecitabine|capecitabine|mesh-list
110157515|NCT00277069|Vinorelbine|vinorelbine|mesh-list
110157516|NCT00277069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110157517|NCT00277069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110157518|NCT00277069|Antimetabolites|antimetabolites|mesh-ancestor
110157519|NCT00277069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110157520|NCT00277069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110157521|NCT00277069|Tubulin Modulators|tubulin modulators|mesh-ancestor
110157522|NCT00277069|Antimitotic Agents|antimitotic agents|mesh-ancestor
110157523|NCT00277069|Mitosis Modulators|mitosis modulators|mesh-ancestor
110157524|NCT00277030|Pulmonary Surfactants|pulmonary surfactants|mesh-list
110157525|NCT00277030|Respiratory System Agents|respiratory system agents|mesh-ancestor
110157526|NCT00276991|Immunomodulating Agents|immunomodulating agents|mesh-list
110157527|NCT00276991|Immunologic Factors|immunologic factors|mesh-ancestor
110157528|NCT00276991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110157529|NCT00276874|Aripiprazole|aripiprazole|mesh-list
110157530|NCT00276874|Antidepressive Agents|antidepressive agents|mesh-ancestor
110157531|NCT00276874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110157532|NCT00276874|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110157533|NCT00276874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110157534|NCT00276874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110157535|NCT00276874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110157536|NCT00276874|Dopamine Agonists|dopamine agonists|mesh-ancestor
110157537|NCT00276874|Dopamine Agents|dopamine agents|mesh-ancestor
110157538|NCT00276874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110157539|NCT00276874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110157540|NCT00276874|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110157541|NCT00276874|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110157542|NCT00276874|Serotonin Agents|serotonin agents|mesh-ancestor
110157543|NCT00276874|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110157544|NCT00276874|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110157545|NCT00276874|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110157546|NCT00276874|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110157547|NCT00276835|Aldesleukin|aldesleukin|mesh-list
110157548|NCT00276835|Interleukin-2|interleukin-2|mesh-list
110157549|NCT00276835|Genistein|genistein|mesh-list
110157550|NCT00276835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110157551|NCT00276835|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110157552|NCT00276835|Analgesics|analgesics|mesh-ancestor
110157553|NCT00276835|Sensory System Agents|sensory system agents|mesh-ancestor
110157554|NCT00276835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110157555|NCT00276835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110157556|NCT00276835|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110157557|NCT00276835|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110157558|NCT00276835|Antiviral Agents|antiviral agents|mesh-ancestor
110157559|NCT00276835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110157560|NCT00276835|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110157561|NCT00276835|Protective Agents|protective agents|mesh-ancestor
110157562|NCT00276835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110157563|NCT00276835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110157564|NCT00276835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110157565|NCT00276835|Phytoestrogens|phytoestrogens|mesh-ancestor
110157566|NCT00276835|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110157567|NCT00276835|Estrogens|estrogens|mesh-ancestor
110157568|NCT00276835|Hormones|hormones|mesh-ancestor
110157569|NCT00276835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110157570|NCT00276796|Paclitaxel|paclitaxel|mesh-list
110157571|NCT00276796|Topotecan|topotecan|mesh-list
110157572|NCT00276796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110157574|NCT00276796|Tubulin Modulators|tubulin modulators|mesh-ancestor
110157575|NCT00276796|Antimitotic Agents|antimitotic agents|mesh-ancestor
110157576|NCT00276796|Mitosis Modulators|mitosis modulators|mesh-ancestor
110157577|NCT00276796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110157578|NCT00276796|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110157579|NCT00276796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110157580|NCT00276796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110157581|NCT00276757|Leucovorin|leucovorin|mesh-list
110157582|NCT00276757|Prednisolone|prednisolone|mesh-list
110157583|NCT00276757|Methotrexate|methotrexate|mesh-list
110157584|NCT00276757|Vinblastine|vinblastine|mesh-list
110157585|NCT00276757|Calcium|calcium|mesh-list
110157586|NCT00276757|Levoleucovorin|levoleucovorin|mesh-list
110157587|NCT00276757|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110157588|NCT00276757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110157589|NCT00276757|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110157590|NCT00276757|Abortifacient Agents|abortifacient agents|mesh-ancestor
110157591|NCT00276757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110157592|NCT00276757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110157593|NCT00276757|Antimetabolites|antimetabolites|mesh-ancestor
110157594|NCT00276757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110157595|NCT00276757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110157596|NCT00276757|Dermatologic Agents|dermatologic agents|mesh-ancestor
110157597|NCT00276757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110157598|NCT00276757|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110157599|NCT00276757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110157600|NCT00276757|Immunologic Factors|immunologic factors|mesh-ancestor
110157601|NCT00276757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110157602|NCT00276757|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110157603|NCT00276757|Antidotes|antidotes|mesh-ancestor
110157604|NCT00276757|Protective Agents|protective agents|mesh-ancestor
110157605|NCT00276757|Vitamin B Complex|vitamin b complex|mesh-ancestor
110157606|NCT00276757|Vitamins|vitamins|mesh-ancestor
110157607|NCT00276757|Micronutrients|micronutrients|mesh-ancestor
110157608|NCT00276757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110157609|NCT00276757|Glucocorticoids|glucocorticoids|mesh-ancestor
110157610|NCT00276757|Hormones|hormones|mesh-ancestor
110157611|NCT00276757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110157612|NCT00276757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110157613|NCT00276757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110157614|NCT00276757|Tubulin Modulators|tubulin modulators|mesh-ancestor
110157615|NCT00276757|Antimitotic Agents|antimitotic agents|mesh-ancestor
110157616|NCT00276757|Mitosis Modulators|mitosis modulators|mesh-ancestor
110157617|NCT00276718|Carboplatin|carboplatin|mesh-list
110157618|NCT00276718|Etoposide|etoposide|mesh-list
110157619|NCT00276718|Bleomycin|bleomycin|mesh-list
110157620|NCT00276718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110157621|NCT00276718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110157622|NCT00276718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110157623|NCT00276718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110157624|NCT00276718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110157625|NCT00276718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110157626|NCT00276718|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110157627|NCT00276679|Temozolomide|temozolomide|mesh-list
110157628|NCT00276679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110157629|NCT00276679|Alkylating Agents|alkylating agents|mesh-ancestor
110157630|NCT00276679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110157631|NCT00276679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110157634|NCT00276601|Mercaptopurine|mercaptopurine|mesh-list
110157635|NCT00276601|Daunorubicin|daunorubicin|mesh-list
110157636|NCT00276601|Arsenic Trioxide|arsenic trioxide|mesh-list
110157637|NCT00276601|Tretinoin|tretinoin|mesh-list
110157638|NCT00276601|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110157639|NCT00276601|Abortifacient Agents|abortifacient agents|mesh-ancestor
110157640|NCT00276601|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110157641|NCT00276601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110157642|NCT00276601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110157643|NCT00276601|Antimetabolites|antimetabolites|mesh-ancestor
110157644|NCT00276601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110157645|NCT00276601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110157646|NCT00276601|Dermatologic Agents|dermatologic agents|mesh-ancestor
110157647|NCT00276601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110157648|NCT00276601|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110157649|NCT00276601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110157650|NCT00276601|Immunologic Factors|immunologic factors|mesh-ancestor
110157651|NCT00276601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110157652|NCT00276601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110157653|NCT00276601|Antiviral Agents|antiviral agents|mesh-ancestor
110157654|NCT00276601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110157655|NCT00276601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110157656|NCT00276601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110157657|NCT00276601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110157658|NCT00276601|Keratolytic Agents|keratolytic agents|mesh-ancestor
110157660|NCT00276523|Interferon-alpha|interferon-alpha|mesh-list
110157661|NCT00276523|Interferon alpha-2|interferon alpha-2|mesh-list
110157662|NCT00276523|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110157663|NCT00276523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110157664|NCT00276523|Antiviral Agents|antiviral agents|mesh-ancestor
110157665|NCT00276523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110157666|NCT00276523|Immunologic Factors|immunologic factors|mesh-ancestor
110157667|NCT00276523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110157668|NCT00276445|Beta-1,3-glucan|beta-1,3-glucan|mesh-list
110157669|NCT00276445|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110157670|NCT00276445|Immunologic Factors|immunologic factors|mesh-ancestor
110157671|NCT00276445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110157672|NCT00276406|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
110157673|NCT00276406|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110157674|NCT00276406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110157675|NCT00276406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110157676|NCT00276406|Cholinergic Agents|cholinergic agents|mesh-ancestor
110157677|NCT00276406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110157678|NCT00276406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110157679|NCT00389883|Anesthetics|anesthetics|mesh-list
110157680|NCT00389883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110157681|NCT00389883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110157682|NCT00389922|Vinorelbine|vinorelbine|mesh-list
110157683|NCT00389922|Lapatinib|lapatinib|mesh-list
110157684|NCT00389922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110157685|NCT00389922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110157686|NCT00389922|Tubulin Modulators|tubulin modulators|mesh-ancestor
110157687|NCT00389922|Antimitotic Agents|antimitotic agents|mesh-ancestor
110157688|NCT00389922|Mitosis Modulators|mitosis modulators|mesh-ancestor
110157689|NCT00389922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110157690|NCT00389922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110157691|NCT00389922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110187811|NCT05209308|Rituximab|rituximab|mesh-list
110157692|NCT00276289|Spironolactone|spironolactone|mesh-list
110157693|NCT00276289|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110157694|NCT00276289|Hormone Antagonists|hormone antagonists|mesh-ancestor
110157695|NCT00276289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110157696|NCT00276289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110157697|NCT00276289|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110157698|NCT00276289|Diuretics|diuretics|mesh-ancestor
110157699|NCT00276289|Natriuretic Agents|natriuretic agents|mesh-ancestor
110157701|NCT00276250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110157702|NCT00276250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110157703|NCT00276250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110157704|NCT00276250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110157705|NCT00276250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110157706|NCT00276250|Immunologic Factors|immunologic factors|mesh-ancestor
110157707|NCT00276250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110157708|NCT00276250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110157710|NCT00394186|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110157711|NCT00394186|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110157712|NCT00394186|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110157713|NCT00394186|Adrenergic Agents|adrenergic agents|mesh-ancestor
110157714|NCT00394186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110157715|NCT00394186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110157716|NCT00394186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110157718|NCT00276172|Immunologic Factors|immunologic factors|mesh-ancestor
110157719|NCT00276172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110157720|NCT00276133|Atorvastatin|atorvastatin|mesh-list
110157721|NCT00276133|Probucol|probucol|mesh-list
110157722|NCT00276133|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110157723|NCT00276133|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110157724|NCT00276133|Antimetabolites|antimetabolites|mesh-ancestor
110157725|NCT00276133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110157726|NCT00276133|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110157727|NCT00276133|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110157729|NCT00276133|Antioxidants|antioxidants|mesh-ancestor
110157730|NCT00276133|Protective Agents|protective agents|mesh-ancestor
110157731|NCT00276133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110157732|NCT00276055|Bevacizumab|bevacizumab|mesh-list
110157733|NCT00276055|Gemcitabine|gemcitabine|mesh-list
110157734|NCT00276055|Docetaxel|docetaxel|mesh-list
110157735|NCT00276055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110157736|NCT00276055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110157737|NCT00276055|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110157738|NCT00276055|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110157739|NCT00276055|Growth Substances|growth substances|mesh-ancestor
110157741|NCT00276055|Growth Inhibitors|growth inhibitors|mesh-ancestor
110157742|NCT00276055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110157743|NCT00276055|Antimetabolites|antimetabolites|mesh-ancestor
110157744|NCT00276055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110157745|NCT00276055|Tubulin Modulators|tubulin modulators|mesh-ancestor
110157746|NCT00276055|Antimitotic Agents|antimitotic agents|mesh-ancestor
110157747|NCT00276055|Mitosis Modulators|mitosis modulators|mesh-ancestor
110157748|NCT00275938|Interferons|interferons|mesh-list
110157749|NCT00275938|Ribavirin|ribavirin|mesh-list
110157750|NCT00275938|Interferon-alpha|interferon-alpha|mesh-list
110157751|NCT00275938|Interferon alpha-2|interferon alpha-2|mesh-list
110157752|NCT00275938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110157753|NCT00275938|Antiviral Agents|antiviral agents|mesh-ancestor
110157754|NCT00275938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110157755|NCT00275938|Antimetabolites|antimetabolites|mesh-ancestor
110157756|NCT00275938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110157757|NCT00275938|Immunologic Factors|immunologic factors|mesh-ancestor
110157758|NCT00275938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110157759|NCT00275665|Valganciclovir|valganciclovir|mesh-list
110157760|NCT00275665|Antiviral Agents|antiviral agents|mesh-ancestor
110157761|NCT00275665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110157763|NCT00276640|Etoposide|etoposide|mesh-list
110157764|NCT00276640|Vincristine|vincristine|mesh-list
110157765|NCT00276640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110157766|NCT00276640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110157767|NCT00276640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110157768|NCT00276640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110157769|NCT00276640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110157770|NCT00276640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110157771|NCT00276640|Tubulin Modulators|tubulin modulators|mesh-ancestor
110157772|NCT00276640|Antimitotic Agents|antimitotic agents|mesh-ancestor
110157773|NCT00276640|Mitosis Modulators|mitosis modulators|mesh-ancestor
110157775|NCT00275548|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110157776|NCT00275548|Antimetabolites|antimetabolites|mesh-ancestor
110157777|NCT00275548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110157778|NCT00275548|Antiviral Agents|antiviral agents|mesh-ancestor
110157779|NCT00275548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110157780|NCT00275431|Gossypol acetic acid|gossypol acetic acid|mesh-list
110157781|NCT00275431|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110157782|NCT00275431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110157783|NCT00275431|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110157784|NCT00275431|Contraceptive Agents|contraceptive agents|mesh-ancestor
110157785|NCT00275431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110157786|NCT00275431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110157787|NCT00275431|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
110157788|NCT00275431|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
110157789|NCT00275431|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110157790|NCT05566054|Azacitidine|azacitidine|mesh-list
110157791|NCT05566054|Venetoclax|venetoclax|mesh-list
110157792|NCT05566054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110157793|NCT05566054|Antimetabolites|antimetabolites|mesh-ancestor
110157794|NCT05566054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110157795|NCT05566054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110157796|NCT05566054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110157797|NCT05565430|Cholinergic Antagonists|cholinergic antagonists|mesh-list
110157798|NCT05565430|Cholinergic Agents|cholinergic agents|mesh-ancestor
110157799|NCT05565430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110157800|NCT05565430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110157801|NCT05565430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110157802|NCT05140746|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110157803|NCT05140746|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110157804|NCT05140746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110157805|NCT02979977|Cetuximab|cetuximab|mesh-list
110157806|NCT02979977|Afatinib|afatinib|mesh-list
110157807|NCT02979977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110157808|NCT02979977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110157809|NCT02979977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110157810|NCT02979977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110157811|NCT02979977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110157812|NCT05424757|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
110157813|NCT05424757|Laxatives|laxatives|mesh-ancestor
110157814|NCT05424757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110157815|NCT02921555|Prednisone|prednisone|mesh-list
110157816|NCT02921555|Methylprednisolone|methylprednisolone|mesh-list
110157817|NCT02921555|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110157818|NCT02921555|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110157819|NCT02921555|Prednisolone|prednisolone|mesh-list
110157820|NCT02921555|Prednisolone acetate|prednisolone acetate|mesh-list
110157821|NCT02921555|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110157822|NCT02921555|Prednisolone phosphate|prednisolone phosphate|mesh-list
110157823|NCT02921555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110157824|NCT02921555|Glucocorticoids|glucocorticoids|mesh-ancestor
110157825|NCT02921555|Hormones|hormones|mesh-ancestor
110157826|NCT02921555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110157827|NCT02921555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110157828|NCT02921555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110187825|NCT05112848|Vaccines|vaccines|mesh-list
110157829|NCT02921555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110157830|NCT02921555|Antiemetics|antiemetics|mesh-ancestor
110157831|NCT02921555|Autonomic Agents|autonomic agents|mesh-ancestor
110157832|NCT02921555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110157833|NCT02921555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110157834|NCT02921555|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110157835|NCT02921555|Protective Agents|protective agents|mesh-ancestor
110157836|NCT05070585|Phenethyl isothiocyanate|phenethyl isothiocyanate|mesh-list
110157837|NCT05070585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110157838|NCT05070585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110157839|NCT05070585|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110157840|NCT05070585|Protective Agents|protective agents|mesh-ancestor
110157841|NCT05070585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110157842|NCT05070585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110157843|NCT00387530|Valganciclovir|valganciclovir|mesh-list
110157844|NCT00387530|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
110157845|NCT00387530|Antiviral Agents|antiviral agents|mesh-ancestor
110157846|NCT00387530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110157847|NCT00387530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110157855|NCT02680184|Pembrolizumab|pembrolizumab|mesh-list
110157856|NCT02680184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110157857|NCT02680184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110157858|NCT02680184|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110157859|NCT02680184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110157861|NCT00390000|Vatalanib|vatalanib|mesh-list
110157862|NCT00390000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110157863|NCT00390000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110157864|NCT00390000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110157865|NCT00390000|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110157866|NCT00390000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110157867|NCT00390000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110157868|NCT04856176|Paclitaxel|paclitaxel|mesh-list
110157869|NCT04856176|Carboplatin|carboplatin|mesh-list
110157870|NCT04856176|Pembrolizumab|pembrolizumab|mesh-list
110157871|NCT04856176|Pemetrexed|pemetrexed|mesh-list
110157872|NCT04856176|Molgramostim|molgramostim|mesh-list
110157873|NCT04856176|Sargramostim|sargramostim|mesh-list
110157874|NCT04856176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110157875|NCT04856176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110157876|NCT04856176|Tubulin Modulators|tubulin modulators|mesh-ancestor
110157877|NCT04856176|Antimitotic Agents|antimitotic agents|mesh-ancestor
110157878|NCT04856176|Mitosis Modulators|mitosis modulators|mesh-ancestor
110157879|NCT04856176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110157880|NCT04856176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110157881|NCT04856176|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110157882|NCT04856176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110157883|NCT04856176|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110157884|NCT04856176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110157885|NCT04856176|Immunologic Factors|immunologic factors|mesh-ancestor
110157886|NCT04856176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110157887|NCT02632760|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
110157888|NCT02632760|Hematinics|hematinics|mesh-ancestor
110157889|NCT04732507|Lidocaine|lidocaine|mesh-list
110157890|NCT04732507|Bupivacaine|bupivacaine|mesh-list
110157891|NCT04732507|Anesthetics, Local|anesthetics, local|mesh-ancestor
110157892|NCT04732507|Anesthetics|anesthetics|mesh-ancestor
110157893|NCT04732507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110157894|NCT04732507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110157895|NCT04732507|Sensory System Agents|sensory system agents|mesh-ancestor
110157896|NCT04732507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110157897|NCT04732507|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110157898|NCT04732507|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110157899|NCT04732507|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110157900|NCT04732507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110157901|NCT04732507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110157903|NCT05047770|Immunologic Factors|immunologic factors|mesh-ancestor
110157904|NCT05047770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110157905|NCT02453984|Atezolizumab|atezolizumab|mesh-list
110157906|NCT02453984|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110157907|NCT02453984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110157908|NCT02453984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110157909|NCT02453984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110157910|NCT04574245|Immunomodulating Agents|immunomodulating agents|mesh-list
110157911|NCT04574245|Immunologic Factors|immunologic factors|mesh-ancestor
110157912|NCT04574245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110157913|NCT04556617|Prednisone|prednisone|mesh-list
110157914|NCT04556617|Olaparib|olaparib|mesh-list
110157915|NCT04556617|Abiraterone Acetate|abiraterone acetate|mesh-list
110157916|NCT04556617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110157917|NCT04556617|Glucocorticoids|glucocorticoids|mesh-ancestor
110157918|NCT04556617|Hormones|hormones|mesh-ancestor
110157919|NCT04556617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110157920|NCT04556617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110157921|NCT04556617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110157922|NCT04556617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110157923|NCT04556617|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110157924|NCT04556617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110157925|NCT04556617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110157926|NCT04556617|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110157927|NCT04556617|Hormone Antagonists|hormone antagonists|mesh-ancestor
110157928|NCT04556617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110157929|NCT04554862|Ketorolac|ketorolac|mesh-list
110157930|NCT04554862|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110157931|NCT04554862|Magnesium Sulfate|magnesium sulfate|mesh-list
110157932|NCT04554862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110157933|NCT04554862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110157934|NCT04554862|Analgesics|analgesics|mesh-ancestor
110157935|NCT04554862|Sensory System Agents|sensory system agents|mesh-ancestor
110157936|NCT04554862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110157937|NCT04554862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110157938|NCT04554862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110157939|NCT04554862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110157940|NCT04554862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110157941|NCT04554862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110157942|NCT04554862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110157943|NCT04554862|Anesthetics|anesthetics|mesh-ancestor
110157944|NCT04554862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110157945|NCT04554862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110157946|NCT04554862|Anticonvulsants|anticonvulsants|mesh-ancestor
110157947|NCT04554862|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110157948|NCT04554862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110157949|NCT04554862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110157950|NCT04554862|Tocolytic Agents|tocolytic agents|mesh-ancestor
110157951|NCT04554862|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110157952|NCT03802097|Anti-Infective Agents|anti-infective agents|mesh-list
110157953|NCT03802097|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110157954|NCT04230499|Sirolimus|sirolimus|mesh-list
110157955|NCT04230499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110157956|NCT04230499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110157957|NCT04230499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110157958|NCT04230499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110157959|NCT04230499|Antifungal Agents|antifungal agents|mesh-ancestor
110157960|NCT04230499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110157961|NCT04230499|Immunologic Factors|immunologic factors|mesh-ancestor
110157962|NCT04230499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110157964|NCT04712435|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110157965|NCT04712435|Antiviral Agents|antiviral agents|mesh-ancestor
110157966|NCT04712435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110157967|NCT04712435|Expectorants|expectorants|mesh-ancestor
110157968|NCT04712435|Respiratory System Agents|respiratory system agents|mesh-ancestor
110157969|NCT04712435|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110157970|NCT04712435|Antioxidants|antioxidants|mesh-ancestor
110157971|NCT04712435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110157972|NCT04712435|Protective Agents|protective agents|mesh-ancestor
110157973|NCT04712435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110157974|NCT04712435|Antidotes|antidotes|mesh-ancestor
110157976|NCT03977194|Carboplatin|carboplatin|mesh-list
110157977|NCT03977194|Atezolizumab|atezolizumab|mesh-list
110157978|NCT03977194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110157979|NCT03977194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110157980|NCT03977194|Tubulin Modulators|tubulin modulators|mesh-ancestor
110157981|NCT03977194|Antimitotic Agents|antimitotic agents|mesh-ancestor
110157982|NCT03977194|Mitosis Modulators|mitosis modulators|mesh-ancestor
110157983|NCT03977194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110157984|NCT03977194|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110157985|NCT03977194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110157987|NCT04729465|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110157988|NCT04729465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110157989|NCT04729465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110157990|NCT04729465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110157991|NCT04729465|Anesthetics, General|anesthetics, general|mesh-ancestor
110157992|NCT04729465|Anesthetics|anesthetics|mesh-ancestor
110157993|NCT04712357|Tenofovir|tenofovir|mesh-list
110157994|NCT04712357|Emtricitabine|emtricitabine|mesh-list
110157995|NCT04712357|Antiviral Agents|antiviral agents|mesh-ancestor
110157996|NCT04712357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110157997|NCT04712357|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110157998|NCT04712357|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110157999|NCT04712357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110158000|NCT04712357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110158001|NCT04712357|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110158002|NCT04712357|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110158003|NCT00390039|Morphine|morphine|mesh-list
110158004|NCT00390039|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110158005|NCT00390039|Narcotics|narcotics|mesh-ancestor
110158006|NCT00390039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110158007|NCT00390039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110158008|NCT00390039|Analgesics|analgesics|mesh-ancestor
110158009|NCT00390039|Sensory System Agents|sensory system agents|mesh-ancestor
110158010|NCT00390039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110158011|NCT02966665|Vitamins|vitamins|mesh-list
110158012|NCT02966665|Vitamin E|vitamin e|mesh-list
110158013|NCT02966665|Thioctic Acid|thioctic acid|mesh-list
110158014|NCT02966665|Fexofenadine|fexofenadine|mesh-list
110158015|NCT02966665|Valsartan|valsartan|mesh-list
110158016|NCT02966665|Nitroprusside|nitroprusside|mesh-list
110158017|NCT02966665|Phentolamine|phentolamine|mesh-list
110158018|NCT02966665|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
110158019|NCT02966665|Norepinephrine|norepinephrine|mesh-list
110158020|NCT02966665|Angiotensin II|angiotensin ii|mesh-list
110158021|NCT02966665|Giapreza|giapreza|mesh-list
110158022|NCT02966665|Acetylcholine|acetylcholine|mesh-list
110158023|NCT02966665|Ranitidine|ranitidine|mesh-list
110158024|NCT02966665|Angiotensinogen|angiotensinogen|mesh-list
110158025|NCT02966665|Micronutrients|micronutrients|mesh-ancestor
110158026|NCT02966665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110158027|NCT02966665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110158028|NCT02966665|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110158029|NCT02966665|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110158030|NCT02966665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110158031|NCT02966665|Antioxidants|antioxidants|mesh-ancestor
110158032|NCT02966665|Protective Agents|protective agents|mesh-ancestor
110158033|NCT02966665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110158034|NCT02966665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110158035|NCT02966665|Adrenergic Agents|adrenergic agents|mesh-ancestor
110158036|NCT02966665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110158037|NCT02966665|Sympathomimetics|sympathomimetics|mesh-ancestor
110158038|NCT02966665|Autonomic Agents|autonomic agents|mesh-ancestor
110158039|NCT02966665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110158040|NCT02966665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110158041|NCT02966665|Vitamin B Complex|vitamin b complex|mesh-ancestor
110158042|NCT02966665|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110158043|NCT02966665|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110158044|NCT02966665|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110158045|NCT02966665|Histamine Antagonists|histamine antagonists|mesh-ancestor
110158046|NCT02966665|Histamine Agents|histamine agents|mesh-ancestor
110158047|NCT02966665|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110158048|NCT02966665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110158049|NCT02966665|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110158050|NCT02966665|Vasodilator Agents|vasodilator agents|mesh-ancestor
110158052|NCT02966665|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110158053|NCT02966665|Protease Inhibitors|protease inhibitors|mesh-ancestor
110158054|NCT02966665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110158055|NCT02966665|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110158056|NCT02966665|Cholinergic Agents|cholinergic agents|mesh-ancestor
110158057|NCT02966665|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110158058|NCT02966665|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110158059|NCT02966665|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110158060|NCT02832544|Vitamin K|vitamin k|mesh-list
110158061|NCT02832544|Warfarin|warfarin|mesh-list
110158062|NCT02832544|Rivaroxaban|rivaroxaban|mesh-list
110158063|NCT02832544|Vitamins|vitamins|mesh-ancestor
110158064|NCT02832544|Micronutrients|micronutrients|mesh-ancestor
110158065|NCT02832544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110158066|NCT02832544|Anticoagulants|anticoagulants|mesh-ancestor
110158067|NCT02832544|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110158068|NCT02832544|Antithrombins|antithrombins|mesh-ancestor
110158069|NCT02832544|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110158070|NCT02832544|Protease Inhibitors|protease inhibitors|mesh-ancestor
110158071|NCT02832544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110158072|NCT02832544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110158073|NCT02832544|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110158074|NCT02832544|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110158075|NCT02832544|Hemostatics|hemostatics|mesh-ancestor
110158076|NCT02832544|Coagulants|coagulants|mesh-ancestor
110158077|NCT00006044|Testosterone|testosterone|mesh-list
110158078|NCT00006044|Androgens|androgens|mesh-ancestor
110158079|NCT00006044|Hormones|hormones|mesh-ancestor
110158080|NCT00006044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110158081|NCT00006044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110158082|NCT02490241|Lithium Carbonate|lithium carbonate|mesh-list
110158083|NCT02490241|Antidepressive Agents|antidepressive agents|mesh-ancestor
110158084|NCT02490241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110158085|NCT02490241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110158086|NCT02490241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110158087|NCT02490241|Antimanic Agents|antimanic agents|mesh-ancestor
110158088|NCT02490241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110158089|NCT02490241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110158090|NCT02490241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110158091|NCT02395705|Paclitaxel|paclitaxel|mesh-list
110158093|NCT02395705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110158094|NCT02395705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110158095|NCT02395705|Tubulin Modulators|tubulin modulators|mesh-ancestor
110158097|NCT02395705|Mitosis Modulators|mitosis modulators|mesh-ancestor
110158098|NCT02395705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110158099|NCT00006047|Etoposide|etoposide|mesh-list
110158100|NCT00006047|Rubitecan|rubitecan|mesh-list
110158101|NCT00006047|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-list
110158102|NCT00006047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110158103|NCT00006047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110158104|NCT00006047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110158105|NCT00006047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110158106|NCT00006047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110158107|NCT00006047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110158108|NCT00083824|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110158109|NCT00083824|Medroxyprogesterone|medroxyprogesterone|mesh-list
110158110|NCT00083824|Estrogens|estrogens|mesh-list
110158111|NCT00083824|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110158112|NCT00083824|Hormones|hormones|mesh-ancestor
110158113|NCT00083824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110187850|NCT04892511|Nitroprusside|nitroprusside|mesh-list
110158114|NCT00083824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110158115|NCT00083824|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110158117|NCT00083824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110158118|NCT00083824|Contraceptive Agents|contraceptive agents|mesh-ancestor
110158119|NCT00083824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110158120|NCT00083824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110158121|NCT00083824|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110158122|NCT00083824|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110158123|NCT00083824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110158124|NCT00083824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110158125|NCT00083902|Thalidomide|thalidomide|mesh-list
110158126|NCT00083902|Dexamethasone|dexamethasone|mesh-list
110158127|NCT00083902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110158128|NCT00083902|Antiemetics|antiemetics|mesh-ancestor
110158129|NCT00083902|Autonomic Agents|autonomic agents|mesh-ancestor
110158130|NCT00083902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110158131|NCT00083902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110158132|NCT00083902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110158133|NCT00083902|Glucocorticoids|glucocorticoids|mesh-ancestor
110158134|NCT00083902|Hormones|hormones|mesh-ancestor
110158135|NCT00083902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110158136|NCT00083902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110158137|NCT00083902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110158138|NCT00083902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110158139|NCT00083902|Immunologic Factors|immunologic factors|mesh-ancestor
110158140|NCT00083902|Leprostatic Agents|leprostatic agents|mesh-ancestor
110158141|NCT00083902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110158142|NCT00083902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110158143|NCT00083902|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110158144|NCT00083902|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110158145|NCT00083902|Growth Substances|growth substances|mesh-ancestor
110158146|NCT00083902|Growth Inhibitors|growth inhibitors|mesh-ancestor
110158147|NCT00006050|Leucovorin|leucovorin|mesh-list
110158148|NCT00006050|Fluorouracil|fluorouracil|mesh-list
110158149|NCT00006050|Oxaliplatin|oxaliplatin|mesh-list
110158150|NCT00006050|Calcium|calcium|mesh-list
110158151|NCT00006050|Levoleucovorin|levoleucovorin|mesh-list
110158152|NCT00006050|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110158153|NCT00006050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110158154|NCT00006050|Antimetabolites|antimetabolites|mesh-ancestor
110158155|NCT00006050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110158156|NCT00006050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110158157|NCT00006050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110158158|NCT00006050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110158159|NCT00006050|Immunologic Factors|immunologic factors|mesh-ancestor
110158160|NCT00006050|Antidotes|antidotes|mesh-ancestor
110158161|NCT00006050|Protective Agents|protective agents|mesh-ancestor
110158162|NCT00006050|Vitamin B Complex|vitamin b complex|mesh-ancestor
110158163|NCT00006050|Vitamins|vitamins|mesh-ancestor
110158164|NCT00006050|Micronutrients|micronutrients|mesh-ancestor
110158165|NCT00083980|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110158166|NCT00083980|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110158167|NCT00083980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110158168|NCT00083980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110158169|NCT00083980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110158170|NCT00083980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110158171|NCT00083980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110158172|NCT00083980|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110158173|NCT00083980|Antidepressive Agents|antidepressive agents|mesh-ancestor
110158174|NCT00083980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110158175|NCT04893174|Hyaluronic Acid|hyaluronic acid|mesh-list
110158176|NCT04893174|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110158177|NCT04893174|Immunologic Factors|immunologic factors|mesh-ancestor
110158178|NCT04893174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110158179|NCT04893174|Viscosupplements|viscosupplements|mesh-ancestor
110158180|NCT04893174|Protective Agents|protective agents|mesh-ancestor
110158181|NCT00084019|Ritonavir|ritonavir|mesh-list
110158182|NCT00084019|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110158183|NCT00084019|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110158184|NCT00084019|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110158185|NCT00084019|Protease Inhibitors|protease inhibitors|mesh-ancestor
110158186|NCT00084019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110158187|NCT00084019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110158188|NCT00084019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110158189|NCT00084019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110158190|NCT00084019|Antiviral Agents|antiviral agents|mesh-ancestor
110158191|NCT00084019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110158192|NCT00084019|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110158193|NCT00084019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110158194|NCT00084058|Ritonavir|ritonavir|mesh-list
110158195|NCT00084058|Lopinavir|lopinavir|mesh-list
110158196|NCT00084058|Saquinavir|saquinavir|mesh-list
110158197|NCT00084058|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110158198|NCT00084058|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110158199|NCT00084058|Protease Inhibitors|protease inhibitors|mesh-ancestor
110158200|NCT00084058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110158201|NCT00084058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110158202|NCT00084058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110158203|NCT00084058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110158204|NCT00084058|Antiviral Agents|antiviral agents|mesh-ancestor
110158205|NCT00084058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110158206|NCT00084058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110158207|NCT00084058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110158208|NCT00006053|Imatinib Mesylate|imatinib mesylate|mesh-list
110158209|NCT00006053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110158210|NCT00006053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110158211|NCT00006053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110158212|NCT00006053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110158214|NCT00084097|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110158215|NCT00084097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110158216|NCT00084097|Respiratory System Agents|respiratory system agents|mesh-ancestor
110158217|NCT00084214|Paclitaxel|paclitaxel|mesh-list
110158218|NCT00084214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110158219|NCT00084214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110158220|NCT00084214|Tubulin Modulators|tubulin modulators|mesh-ancestor
110158221|NCT00084214|Antimitotic Agents|antimitotic agents|mesh-ancestor
110158222|NCT00084214|Mitosis Modulators|mitosis modulators|mesh-ancestor
110158223|NCT00084214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110158224|NCT00006056|Cyclosporine|cyclosporine|mesh-list
110158225|NCT00006056|Cyclophosphamide|cyclophosphamide|mesh-list
110158226|NCT00006056|Busulfan|busulfan|mesh-list
110158227|NCT00006056|Methotrexate|methotrexate|mesh-list
110158228|NCT00006056|Etoposide|etoposide|mesh-list
110158229|NCT00006056|Cyclosporins|cyclosporins|mesh-list
110158230|NCT00006056|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110158231|NCT00006056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110158232|NCT00006056|Immunologic Factors|immunologic factors|mesh-ancestor
110158233|NCT00006056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110158234|NCT00006056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110158235|NCT00006056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110158236|NCT00006056|Alkylating Agents|alkylating agents|mesh-ancestor
110158237|NCT00006056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110158238|NCT00006056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110158239|NCT00006056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110158240|NCT00006056|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110158241|NCT00006056|Abortifacient Agents|abortifacient agents|mesh-ancestor
110158242|NCT00006056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110158243|NCT00006056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110158244|NCT00006056|Antimetabolites|antimetabolites|mesh-ancestor
110158245|NCT00006056|Dermatologic Agents|dermatologic agents|mesh-ancestor
110158246|NCT00006056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110158247|NCT00006056|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110158248|NCT00006056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110158249|NCT00006056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110158250|NCT00006056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110158251|NCT00006056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110158252|NCT00006056|Antifungal Agents|antifungal agents|mesh-ancestor
110158253|NCT00006056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110158254|NCT00006056|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110158255|NCT00084370|Celecoxib|celecoxib|mesh-list
110158256|NCT00084370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110158257|NCT00084370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110158258|NCT00084370|Analgesics|analgesics|mesh-ancestor
110158259|NCT00084370|Sensory System Agents|sensory system agents|mesh-ancestor
110158260|NCT00084370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110158261|NCT00084370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110158262|NCT00084370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110158263|NCT00084370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110158264|NCT00084370|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110158265|NCT00084370|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110158266|NCT00084370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110158267|NCT00084370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110158268|NCT00084448|Celecoxib|celecoxib|mesh-list
110158269|NCT00084448|Paclitaxel|paclitaxel|mesh-list
110158270|NCT00084448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110158271|NCT00084448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110158272|NCT00084448|Tubulin Modulators|tubulin modulators|mesh-ancestor
110158273|NCT00084448|Antimitotic Agents|antimitotic agents|mesh-ancestor
110158274|NCT00084448|Mitosis Modulators|mitosis modulators|mesh-ancestor
110158275|NCT00084448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110158276|NCT00084448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110158277|NCT00084448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110158278|NCT00084448|Analgesics|analgesics|mesh-ancestor
110158279|NCT00084448|Sensory System Agents|sensory system agents|mesh-ancestor
110158280|NCT00084448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110158281|NCT00084448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110158282|NCT00084448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110158283|NCT00084448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110158284|NCT00084448|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110158285|NCT00084448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110158286|NCT00084448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110158287|NCT00084565|Paclitaxel|paclitaxel|mesh-list
110158288|NCT00084565|Topotecan|topotecan|mesh-list
110158289|NCT00084565|Estramustine|estramustine|mesh-list
110158290|NCT00084565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110158291|NCT00084565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110158292|NCT00084565|Tubulin Modulators|tubulin modulators|mesh-ancestor
110158293|NCT00084565|Antimitotic Agents|antimitotic agents|mesh-ancestor
110158294|NCT00084565|Mitosis Modulators|mitosis modulators|mesh-ancestor
110158295|NCT00084565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110158296|NCT00084565|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110158297|NCT00084565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110158298|NCT00084565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110158299|NCT00084565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110158300|NCT00084565|Alkylating Agents|alkylating agents|mesh-ancestor
110158301|NCT00084565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110158302|NCT00084604|Bevacizumab|bevacizumab|mesh-list
110158303|NCT00084604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110158304|NCT00084604|Irinotecan|irinotecan|mesh-list
110158305|NCT00084604|Antibodies|antibodies|mesh-list
110158307|NCT00084604|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110158308|NCT00084604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110158309|NCT00084604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110158310|NCT00084604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110158311|NCT00084604|Growth Substances|growth substances|mesh-ancestor
110158312|NCT00084604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110158313|NCT00084604|Growth Inhibitors|growth inhibitors|mesh-ancestor
110158314|NCT00084604|Immunologic Factors|immunologic factors|mesh-ancestor
110158315|NCT00084604|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110158316|NCT00084604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110158317|NCT00084604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110158318|NCT00084604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110158319|NCT00084643|Capecitabine|capecitabine|mesh-list
110158320|NCT00084643|Oxaliplatin|oxaliplatin|mesh-list
110158321|NCT00084643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110158322|NCT00084643|Antimetabolites|antimetabolites|mesh-ancestor
110158323|NCT00084643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110158324|NCT00084643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110158326|NCT00006062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110158328|NCT00084721|Irinotecan|irinotecan|mesh-list
110158329|NCT00084721|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110158331|NCT00084721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110158332|NCT00084721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110158333|NCT00084721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110158334|NCT00084721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110158335|NCT00084721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110158336|NCT00084721|Analgesics|analgesics|mesh-ancestor
110158337|NCT00084721|Sensory System Agents|sensory system agents|mesh-ancestor
110158338|NCT00084721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110158339|NCT00084721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110158340|NCT00084721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110158341|NCT00084721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110158342|NCT00084721|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110158343|NCT00084721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110158344|NCT00084877|Irinotecan|irinotecan|mesh-list
110158345|NCT00084877|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110158346|NCT00084877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110158347|NCT00084877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110158348|NCT00084877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110158349|NCT00084877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110158350|NCT00084916|Sirolimus|sirolimus|mesh-list
110158351|NCT00084916|Temsirolimus|temsirolimus|mesh-list
110158352|NCT00084916|MTOR Inhibitors|mtor inhibitors|mesh-list
110158353|NCT00084916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110158354|NCT00084916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110158355|NCT00084916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110158356|NCT00084916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110158357|NCT00084916|Immunologic Factors|immunologic factors|mesh-ancestor
110158358|NCT00084916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110158359|NCT00084916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110158360|NCT00084916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110158361|NCT00084916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110158362|NCT00084916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110158363|NCT00084916|Antifungal Agents|antifungal agents|mesh-ancestor
110158364|NCT00085111|Bevacizumab|bevacizumab|mesh-list
110158365|NCT00085111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110158367|NCT00085111|Immunoglobulins|immunoglobulins|mesh-list
110158368|NCT00085111|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110158369|NCT00085111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110158370|NCT00085111|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110158371|NCT00085111|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110158372|NCT00085111|Growth Substances|growth substances|mesh-ancestor
110158373|NCT00085111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110158374|NCT00085111|Growth Inhibitors|growth inhibitors|mesh-ancestor
110158375|NCT00085111|Immunologic Factors|immunologic factors|mesh-ancestor
110158376|NCT00085150|Immunotoxins|immunotoxins|mesh-list
110158377|NCT00085150|Immunoconjugates|immunoconjugates|mesh-ancestor
110158378|NCT00085150|Immunologic Factors|immunologic factors|mesh-ancestor
110158379|NCT00085150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110158380|NCT00400075|Cyclophosphamide|cyclophosphamide|mesh-list
110158381|NCT00400075|Azathioprine|azathioprine|mesh-list
110158382|NCT00400075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110158383|NCT00400075|Immunologic Factors|immunologic factors|mesh-ancestor
110158384|NCT00400075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110158385|NCT00400075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110158386|NCT00400075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110158387|NCT00400075|Alkylating Agents|alkylating agents|mesh-ancestor
110158388|NCT00400075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110158389|NCT00400075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110158390|NCT00400075|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110158391|NCT00400075|Antimetabolites|antimetabolites|mesh-ancestor
110158392|NCT00400075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110158394|NCT00400114|Sunitinib|sunitinib|mesh-list
110158395|NCT00400114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110158396|NCT00400114|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110158397|NCT00400114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110158398|NCT00400114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110158399|NCT00400114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110158400|NCT00400114|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110158401|NCT00400114|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110158402|NCT00400114|Growth Substances|growth substances|mesh-ancestor
110158403|NCT00400114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110158404|NCT00400114|Growth Inhibitors|growth inhibitors|mesh-ancestor
110158405|NCT00400114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110158406|NCT00085189|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
110158407|NCT00085189|Freund's Adjuvant|freund's adjuvant|mesh-list
110158408|NCT00085189|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110158409|NCT00085189|Immunologic Factors|immunologic factors|mesh-ancestor
110158410|NCT00085189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110158411|NCT00085228|Docetaxel|docetaxel|mesh-list
110158412|NCT00085228|Oblimersen|oblimersen|mesh-list
110158413|NCT00085228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110158414|NCT00085228|Tubulin Modulators|tubulin modulators|mesh-ancestor
110158415|NCT00085228|Antimitotic Agents|antimitotic agents|mesh-ancestor
110158416|NCT00085228|Mitosis Modulators|mitosis modulators|mesh-ancestor
110158417|NCT00085228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110158418|NCT00085306|Interferons|interferons|mesh-list
110158419|NCT00085306|Interferon-beta|interferon-beta|mesh-list
110158420|NCT00085306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110158421|NCT00085306|Antiviral Agents|antiviral agents|mesh-ancestor
110158422|NCT00085306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110158423|NCT00085306|Immunologic Factors|immunologic factors|mesh-ancestor
110158424|NCT00085306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110158425|NCT00006077|Levodopa|levodopa|mesh-list
110158426|NCT00006077|Domperidone|domperidone|mesh-list
110158427|NCT00006077|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110158428|NCT00006077|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110158429|NCT00006077|Dopamine Agents|dopamine agents|mesh-ancestor
110158430|NCT00006077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110158431|NCT00006077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110158432|NCT00006077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110158433|NCT00006077|Antiemetics|antiemetics|mesh-ancestor
110158434|NCT00006077|Autonomic Agents|autonomic agents|mesh-ancestor
110158435|NCT00006077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110158436|NCT00006077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110158437|NCT00006077|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110158438|NCT04729348|Pembrolizumab|pembrolizumab|mesh-list
110158439|NCT04729348|Lenvatinib|lenvatinib|mesh-list
110158440|NCT04729348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110158441|NCT04729348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110158442|NCT04729348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110158443|NCT04729348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110158444|NCT04729348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110158445|NCT04729348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110158447|NCT00085345|Melphalan|melphalan|mesh-list
110158448|NCT00085345|Arsenic Trioxide|arsenic trioxide|mesh-list
110158449|NCT00085345|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110158450|NCT00085345|Alkylating Agents|alkylating agents|mesh-ancestor
110158451|NCT00085345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110158452|NCT00085345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110158453|NCT00085345|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110187881|NCT04855695|Venetoclax|venetoclax|mesh-list
110158454|NCT00085345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110158455|NCT00085345|Immunologic Factors|immunologic factors|mesh-ancestor
110158456|NCT00085345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110158457|NCT00085345|Antioxidants|antioxidants|mesh-ancestor
110158458|NCT00085345|Protective Agents|protective agents|mesh-ancestor
110158459|NCT00085345|Vitamins|vitamins|mesh-ancestor
110158460|NCT00085345|Micronutrients|micronutrients|mesh-ancestor
110158461|NCT00085384|Interferons|interferons|mesh-list
110158462|NCT00085384|Interferon-alpha|interferon-alpha|mesh-list
110158463|NCT00085384|Interferon alpha-2|interferon alpha-2|mesh-list
110158464|NCT00085384|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110158465|NCT00085384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110158466|NCT00085384|Antiviral Agents|antiviral agents|mesh-ancestor
110158467|NCT00085384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110158468|NCT00085384|Immunologic Factors|immunologic factors|mesh-ancestor
110158469|NCT00085384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110158471|NCT00006080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110158472|NCT00006080|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110158473|NCT00006080|Protective Agents|protective agents|mesh-ancestor
110158474|NCT00006080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110158475|NCT00085462|Aldesleukin|aldesleukin|mesh-list
110158476|NCT00085462|Cyclophosphamide|cyclophosphamide|mesh-list
110158477|NCT00085462|Fludarabine|fludarabine|mesh-list
110158478|NCT00085462|Fludarabine phosphate|fludarabine phosphate|mesh-list
110158479|NCT00085462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110158480|NCT00085462|Immunologic Factors|immunologic factors|mesh-ancestor
110158481|NCT00085462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110158482|NCT00085462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110158483|NCT00085462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110158484|NCT00085462|Alkylating Agents|alkylating agents|mesh-ancestor
110158485|NCT00085462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110158486|NCT00085462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110158487|NCT00085462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110158488|NCT00085462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110158489|NCT00085462|Antimetabolites|antimetabolites|mesh-ancestor
110158490|NCT00085462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110158491|NCT00085462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110158492|NCT00085462|Antiviral Agents|antiviral agents|mesh-ancestor
110158493|NCT00085462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110158494|NCT00085501|Paclitaxel|paclitaxel|mesh-list
110158495|NCT00085501|Carboplatin|carboplatin|mesh-list
110158496|NCT00085501|Cetuximab|cetuximab|mesh-list
110158497|NCT00085501|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110158498|NCT00085501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110158499|NCT00085501|Tubulin Modulators|tubulin modulators|mesh-ancestor
110158500|NCT00085501|Antimitotic Agents|antimitotic agents|mesh-ancestor
110158501|NCT00085501|Mitosis Modulators|mitosis modulators|mesh-ancestor
110158502|NCT00085501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110158503|NCT00085501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110158504|NCT00006083|Dalteparin|dalteparin|mesh-list
110158505|NCT00006083|Anticoagulants|anticoagulants|mesh-ancestor
110158506|NCT00006083|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110158507|NCT00006083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110158508|NCT00006083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110158509|NCT00085579|Aldesleukin|aldesleukin|mesh-list
110158510|NCT00085579|Sargramostim|sargramostim|mesh-list
110158511|NCT00085579|Immunologic Factors|immunologic factors|mesh-ancestor
110158512|NCT00085579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110158513|NCT00085579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110158514|NCT00085579|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110158515|NCT00085579|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110158516|NCT00085579|Antiviral Agents|antiviral agents|mesh-ancestor
110158517|NCT00085579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110158518|NCT00085696|Rituximab|rituximab|mesh-list
110158519|NCT00085696|Bortezomib|bortezomib|mesh-list
110158520|NCT00085696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110158521|NCT00085696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110158522|NCT00085696|Immunologic Factors|immunologic factors|mesh-ancestor
110158523|NCT00085696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110158524|NCT00085696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110158526|NCT00006086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110158527|NCT04798638|Osimertinib|osimertinib|mesh-list
110158528|NCT04798638|Complement Factor H|complement factor h|mesh-list
110158529|NCT04798638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110158530|NCT04798638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110158531|NCT04798638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110158532|NCT04798638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110158533|NCT04798638|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110158534|NCT04798638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110158535|NCT04798638|Immunologic Factors|immunologic factors|mesh-ancestor
110158536|NCT04798638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110158537|NCT00006089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110158538|NCT00006089|Trastuzumab|trastuzumab|mesh-list
110158539|NCT00006089|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
110158540|NCT00006089|Antibodies|antibodies|mesh-list
110158541|NCT00006089|Immunoglobulins|immunoglobulins|mesh-list
110158542|NCT00006089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110158544|NCT00006089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110158545|NCT00006089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110158546|NCT00085891|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110158547|NCT00085891|Antidepressive Agents|antidepressive agents|mesh-ancestor
110158548|NCT00085891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110158549|NCT00085891|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110158550|NCT00085891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110158551|NCT00085891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110158552|NCT00085891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110158553|NCT00085969|Exenatide|exenatide|mesh-list
110158554|NCT00085969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110158555|NCT00085969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110158556|NCT00085969|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110158557|NCT00085969|Incretins|incretins|mesh-ancestor
110158558|NCT00085969|Hormones|hormones|mesh-ancestor
110158559|NCT00085969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110158560|NCT00086086|Darbepoetin alfa|darbepoetin alfa|mesh-list
110158561|NCT00086086|Hematinics|hematinics|mesh-ancestor
110158562|NCT00006092|Arsenic Trioxide|arsenic trioxide|mesh-list
110158563|NCT00006092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110158564|NCT00086125|Sirolimus|sirolimus|mesh-list
110158565|NCT00086125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110158566|NCT00086125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110158567|NCT00086125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110158568|NCT00086125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110158569|NCT00086125|Antifungal Agents|antifungal agents|mesh-ancestor
110158571|NCT00086125|Immunologic Factors|immunologic factors|mesh-ancestor
110158572|NCT00086125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110158573|NCT00086203|Rituximab|rituximab|mesh-list
110158574|NCT00086203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110158575|NCT00086203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110158576|NCT00086203|Immunologic Factors|immunologic factors|mesh-ancestor
110158577|NCT00086203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110158578|NCT00086203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110158579|NCT00006095|Irinotecan|irinotecan|mesh-list
110158580|NCT00006095|Vincristine|vincristine|mesh-list
110158581|NCT00006095|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110158582|NCT00006095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110158583|NCT00006095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110158584|NCT00006095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110158585|NCT00006095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110158586|NCT00006095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110158587|NCT00006095|Tubulin Modulators|tubulin modulators|mesh-ancestor
110158588|NCT00006095|Antimitotic Agents|antimitotic agents|mesh-ancestor
110158589|NCT00006095|Mitosis Modulators|mitosis modulators|mesh-ancestor
110158590|NCT00086320|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110158591|NCT00086320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110158592|NCT00086320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110158593|NCT00086320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110158594|NCT00086320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110158595|NCT00086320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110158596|NCT00086320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110158597|NCT00086320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110158598|NCT00086320|Serotonin Agents|serotonin agents|mesh-ancestor
110158599|NCT00086320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110158600|NCT00086320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110158601|NCT00086320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110158602|NCT00086320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110158603|NCT00086320|Dopamine Agents|dopamine agents|mesh-ancestor
110158606|NCT00086359|Lamivudine|lamivudine|mesh-list
110158607|NCT00086359|Zidovudine|zidovudine|mesh-list
110158608|NCT00086359|Abacavir|abacavir|mesh-list
110158609|NCT00086359|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
110158610|NCT00086359|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110158611|NCT00086359|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110158612|NCT00086359|Protease Inhibitors|protease inhibitors|mesh-ancestor
110158613|NCT00086359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110158614|NCT00086359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110158615|NCT00086359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110158616|NCT00086359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110158617|NCT00086359|Antiviral Agents|antiviral agents|mesh-ancestor
110158618|NCT00086359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110158619|NCT00086359|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110158620|NCT00086359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110158621|NCT00086359|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110158622|NCT00086359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110158624|NCT00006098|Bortezomib|bortezomib|mesh-list
110158625|NCT00006098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110158626|NCT00086593|Lamotrigine|lamotrigine|mesh-list
110158627|NCT00086593|Anticonvulsants|anticonvulsants|mesh-ancestor
110158628|NCT00086593|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110158629|NCT00086593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110158630|NCT00086593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110158631|NCT00086593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110158632|NCT00086593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110158633|NCT00086593|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110158634|NCT00086593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110158635|NCT00086593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110158636|NCT00086593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110158637|NCT00086593|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110158639|NCT00387569|Immunologic Factors|immunologic factors|mesh-ancestor
110158640|NCT00387569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110158642|NCT04784637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110158643|NCT04784637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110158644|NCT00086632|Oregovomab|oregovomab|mesh-list
110158645|NCT00086632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110158646|NCT00086632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110158647|NCT00086710|Enfuvirtide|enfuvirtide|mesh-list
110158648|NCT00086710|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110187914|NCT04752163|Cortisone|cortisone|mesh-list
110158649|NCT00086710|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110158650|NCT00086710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110158651|NCT00086710|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110158652|NCT00086710|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110158653|NCT00086710|Antiviral Agents|antiviral agents|mesh-ancestor
110158654|NCT00086710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110158656|NCT00006104|Trastuzumab|trastuzumab|mesh-list
110158657|NCT00006104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110158658|NCT00006104|Tubulin Modulators|tubulin modulators|mesh-ancestor
110158659|NCT00006104|Antimitotic Agents|antimitotic agents|mesh-ancestor
110158660|NCT00006104|Mitosis Modulators|mitosis modulators|mesh-ancestor
110158661|NCT00006104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110158662|NCT00006104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110158663|NCT00086827|Romidepsin|romidepsin|mesh-list
110158664|NCT00086827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110158665|NCT00086827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110158666|NCT00086827|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110158667|NCT00086827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110158668|NCT00086827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110158669|NCT00086944|Rituximab|rituximab|mesh-list
110158670|NCT00086944|Carboplatin|carboplatin|mesh-list
110158671|NCT00086944|Etoposide|etoposide|mesh-list
110158672|NCT00086944|Etoposide phosphate|etoposide phosphate|mesh-list
110158673|NCT00086944|Ifosfamide|ifosfamide|mesh-list
110158674|NCT00086944|Oblimersen|oblimersen|mesh-list
110158675|NCT00086944|Lenograstim|lenograstim|mesh-list
110158676|NCT00086944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110158677|NCT00086944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110158678|NCT00086944|Immunologic Factors|immunologic factors|mesh-ancestor
110158679|NCT00086944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110158680|NCT00086944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110158681|NCT00086944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110158682|NCT00086944|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110158683|NCT00086944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110158684|NCT00086944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110158685|NCT00086944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110158686|NCT00086944|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110158687|NCT00086944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110158688|NCT00086944|Alkylating Agents|alkylating agents|mesh-ancestor
110158689|NCT00006107|Docetaxel|docetaxel|mesh-list
110158690|NCT00006107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110158691|NCT00006107|Tubulin Modulators|tubulin modulators|mesh-ancestor
110158692|NCT00006107|Antimitotic Agents|antimitotic agents|mesh-ancestor
110158693|NCT00006107|Mitosis Modulators|mitosis modulators|mesh-ancestor
110158694|NCT00006107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110158695|NCT00086983|Oxaliplatin|oxaliplatin|mesh-list
110158696|NCT00086983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110158697|NCT00087100|Pemetrexed|pemetrexed|mesh-list
110158698|NCT00087100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110158699|NCT00087100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110158700|NCT00087100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110158701|NCT00087100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110158702|NCT00087100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110158703|NCT00006113|Interferons|interferons|mesh-list
110158704|NCT00006113|Aldesleukin|aldesleukin|mesh-list
110158705|NCT00006113|Interferon-gamma|interferon-gamma|mesh-list
110158706|NCT00006113|Interleukin-4|interleukin-4|mesh-list
110158708|NCT00006113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110158709|NCT00006113|Antiviral Agents|antiviral agents|mesh-ancestor
110158710|NCT00006113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110158711|NCT00006113|Immunologic Factors|immunologic factors|mesh-ancestor
110158712|NCT00006113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110158713|NCT00006113|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110158714|NCT00006113|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110158715|NCT00006113|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110158716|NCT00006113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110158717|NCT00087217|Paclitaxel|paclitaxel|mesh-list
110158718|NCT00087217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110158719|NCT00087217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110158720|NCT00087217|Tubulin Modulators|tubulin modulators|mesh-ancestor
110158721|NCT00087217|Antimitotic Agents|antimitotic agents|mesh-ancestor
110158722|NCT00087217|Mitosis Modulators|mitosis modulators|mesh-ancestor
110158723|NCT00087217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110158725|NCT00087256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110158726|NCT00087256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110158727|NCT00087256|Analgesics|analgesics|mesh-ancestor
110158728|NCT00087256|Sensory System Agents|sensory system agents|mesh-ancestor
110158729|NCT00087256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110158730|NCT00087256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110158731|NCT00087256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110158732|NCT00087256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110158733|NCT00087256|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110158734|NCT00087256|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110158735|NCT00087256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110158736|NCT00087256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110158737|NCT00006116|Gemcitabine|gemcitabine|mesh-list
110158738|NCT00006116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110158739|NCT00006116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110158740|NCT00006116|Antimetabolites|antimetabolites|mesh-ancestor
110158741|NCT00006116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110158742|NCT00087295|Romidepsin|romidepsin|mesh-list
110158743|NCT00087295|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110158744|NCT00087295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110158745|NCT00087295|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110158746|NCT00087295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110158747|NCT00087295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110158748|NCT04762953|Leucovorin|leucovorin|mesh-list
110158749|NCT04762953|Paclitaxel|paclitaxel|mesh-list
110158750|NCT04762953|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110158751|NCT04762953|Fluorouracil|fluorouracil|mesh-list
110158753|NCT04762953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110158754|NCT04762953|Tubulin Modulators|tubulin modulators|mesh-ancestor
110158755|NCT04762953|Antimitotic Agents|antimitotic agents|mesh-ancestor
110158756|NCT04762953|Mitosis Modulators|mitosis modulators|mesh-ancestor
110158757|NCT04762953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110158758|NCT04762953|Antimetabolites|antimetabolites|mesh-ancestor
110158759|NCT04762953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110158760|NCT04762953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110187952|NCT04752163|Antimetabolites|antimetabolites|mesh-ancestor
110158762|NCT04762953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110158763|NCT04762953|Antidotes|antidotes|mesh-ancestor
110158764|NCT04762953|Protective Agents|protective agents|mesh-ancestor
110158765|NCT04762953|Vitamin B Complex|vitamin b complex|mesh-ancestor
110158766|NCT04762953|Vitamins|vitamins|mesh-ancestor
110158767|NCT04762953|Micronutrients|micronutrients|mesh-ancestor
110158768|NCT00087334|Capecitabine|capecitabine|mesh-list
110158769|NCT00087334|Oxaliplatin|oxaliplatin|mesh-list
110158771|NCT00087334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110158772|NCT00087334|Antimetabolites|antimetabolites|mesh-ancestor
110158773|NCT00087334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110158774|NCT00087334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110158775|NCT00087334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110158776|NCT00087334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110158777|NCT00087373|Metronidazole|metronidazole|mesh-list
110158778|NCT00087373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110158779|NCT00087373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110158780|NCT00087373|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110158781|NCT00087373|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110158782|NCT00006119|Hydroxyurea|hydroxyurea|mesh-list
110158783|NCT00006119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110158784|NCT00006119|Antisickling Agents|antisickling agents|mesh-ancestor
110158785|NCT00006119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110158786|NCT00006119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110158787|NCT00006119|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110158788|NCT00087412|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110158789|NCT00087412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110158791|NCT00087412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110158792|NCT00087412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110158793|NCT00390078|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
110158794|NCT00390078|Antiviral Agents|antiviral agents|mesh-ancestor
110158795|NCT00390078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110158796|NCT00006122|Cytarabine|cytarabine|mesh-list
110158797|NCT00006122|Etoposide|etoposide|mesh-list
110158798|NCT00006122|Mitoxantrone|mitoxantrone|mesh-list
110158799|NCT00006122|Idarubicin|idarubicin|mesh-list
110158800|NCT00006122|Gemtuzumab|gemtuzumab|mesh-list
110158801|NCT00006122|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110158802|NCT00006122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110158803|NCT00006122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110158804|NCT00006122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110158805|NCT00006122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110158806|NCT00006122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110158807|NCT00006122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110158808|NCT00006122|Antimetabolites|antimetabolites|mesh-ancestor
110158809|NCT00006122|Antiviral Agents|antiviral agents|mesh-ancestor
110158810|NCT00006122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110158811|NCT00006122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110158812|NCT00006122|Immunologic Factors|immunologic factors|mesh-ancestor
110158813|NCT00006122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110158814|NCT00006122|Analgesics|analgesics|mesh-ancestor
110158816|NCT00006122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110158817|NCT00006122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110158818|NCT00006122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110158819|NCT00006122|Immunotoxins|immunotoxins|mesh-ancestor
110158820|NCT00006122|Immunoconjugates|immunoconjugates|mesh-ancestor
110158821|NCT00087802|Paclitaxel|paclitaxel|mesh-list
110158822|NCT00087802|Carboplatin|carboplatin|mesh-list
110158823|NCT00087802|Gemcitabine|gemcitabine|mesh-list
110158824|NCT00087802|Oxaliplatin|oxaliplatin|mesh-list
110187967|NCT04752163|Mitosis Modulators|mitosis modulators|mesh-ancestor
110158825|NCT00087802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110158826|NCT00087802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110158827|NCT00087802|Tubulin Modulators|tubulin modulators|mesh-ancestor
110158828|NCT00087802|Antimitotic Agents|antimitotic agents|mesh-ancestor
110158829|NCT00087802|Mitosis Modulators|mitosis modulators|mesh-ancestor
110158830|NCT00087802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110158831|NCT00087802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110158832|NCT00087802|Antimetabolites|antimetabolites|mesh-ancestor
110158833|NCT00006125|Doxorubicin|doxorubicin|mesh-list
110158834|NCT00006125|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110158835|NCT00006125|Topotecan|topotecan|mesh-list
110158836|NCT00006125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110158837|NCT00006125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110158838|NCT00006125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110158839|NCT00006125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110158840|NCT00006125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110158841|NCT00006125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110158842|NCT00006125|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110158843|NCT00087841|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
110158844|NCT00087841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110158845|NCT00087841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110158846|NCT00087880|Bupropion|bupropion|mesh-list
110158847|NCT00087880|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110158848|NCT00087880|Antidepressive Agents|antidepressive agents|mesh-ancestor
110158849|NCT00087880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110158850|NCT00087880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110158851|NCT00087880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110158852|NCT00087880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110158853|NCT00087880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110158854|NCT00087880|Dopamine Agents|dopamine agents|mesh-ancestor
110158855|NCT00087880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110158856|NCT00087880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110158857|NCT00087880|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110158858|NCT00087880|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110158859|NCT00087880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110158860|NCT00088036|Olanzapine|olanzapine|mesh-list
110158861|NCT00088036|Antiemetics|antiemetics|mesh-ancestor
110158862|NCT00088036|Autonomic Agents|autonomic agents|mesh-ancestor
110158863|NCT00088036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110158864|NCT00088036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110158865|NCT00088036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110158866|NCT00088036|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110158867|NCT00088036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110158868|NCT00088036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110158869|NCT00088036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110158870|NCT00088036|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110158871|NCT00088036|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110158872|NCT00088036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110158873|NCT00088036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110158874|NCT00088036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110158876|NCT00088075|Risperidone|risperidone|mesh-list
110158877|NCT00088075|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110158878|NCT00088075|Serotonin Agents|serotonin agents|mesh-ancestor
110158879|NCT00088075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110158880|NCT00088075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110158881|NCT00088075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110158882|NCT00088075|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110158883|NCT00088075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110158884|NCT00088075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110158885|NCT00088075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110158886|NCT00088075|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110158887|NCT00088075|Dopamine Agents|dopamine agents|mesh-ancestor
110158888|NCT00088114|Paclitaxel|paclitaxel|mesh-list
110158889|NCT00088114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110158890|NCT00088114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110158891|NCT00088114|Tubulin Modulators|tubulin modulators|mesh-ancestor
110158892|NCT00088114|Antimitotic Agents|antimitotic agents|mesh-ancestor
110158893|NCT00088114|Mitosis Modulators|mitosis modulators|mesh-ancestor
110158894|NCT00088114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110158895|NCT00006131|Valacyclovir|valacyclovir|mesh-list
110158896|NCT00006131|Antiviral Agents|antiviral agents|mesh-ancestor
110158897|NCT00006131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110158898|NCT00088231|Imatinib Mesylate|imatinib mesylate|mesh-list
110158899|NCT00088231|Vatalanib|vatalanib|mesh-list
110158900|NCT00088231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110158901|NCT00088231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110158902|NCT00088231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110158903|NCT00088231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110158904|NCT00088270|Leucovorin|leucovorin|mesh-list
110158905|NCT00088270|Fluorouracil|fluorouracil|mesh-list
110158906|NCT00088270|Antimetabolites|antimetabolites|mesh-ancestor
110158907|NCT00088270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110158908|NCT00088270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110158909|NCT00088270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110158910|NCT00088270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110158911|NCT00088270|Immunologic Factors|immunologic factors|mesh-ancestor
110158912|NCT00088270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110158913|NCT00088270|Antidotes|antidotes|mesh-ancestor
110158914|NCT00088270|Protective Agents|protective agents|mesh-ancestor
110158915|NCT00088270|Vitamin B Complex|vitamin b complex|mesh-ancestor
110158917|NCT00088270|Micronutrients|micronutrients|mesh-ancestor
110158919|NCT00088387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110158920|NCT00088387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110158921|NCT00088387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110158922|NCT00088387|Antimanic Agents|antimanic agents|mesh-ancestor
110158923|NCT00088387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110158924|NCT00088387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110158925|NCT00088387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110158926|NCT00088387|Anticonvulsants|anticonvulsants|mesh-ancestor
110158927|NCT00088387|GABA Agents|gaba agents|mesh-ancestor
110158928|NCT00088387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110158929|NCT00088504|Interferons|interferons|mesh-list
110158930|NCT00088504|Ribavirin|ribavirin|mesh-list
110158931|NCT00088504|Interferon-alpha|interferon-alpha|mesh-list
110158932|NCT00088504|Interferon alpha-2|interferon alpha-2|mesh-list
110158933|NCT00088504|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110158934|NCT00088504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110158935|NCT00088504|Antiviral Agents|antiviral agents|mesh-ancestor
110158936|NCT00088504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110158938|NCT00088504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110158939|NCT00088504|Immunologic Factors|immunologic factors|mesh-ancestor
110158940|NCT00088504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110158941|NCT00006137|Enalapril|enalapril|mesh-list
110158942|NCT00006137|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110158943|NCT00006137|Protease Inhibitors|protease inhibitors|mesh-ancestor
110158944|NCT00006137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110158945|NCT00006137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110158946|NCT00006137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110158947|NCT00088543|Thymoglobulin|thymoglobulin|mesh-list
110158948|NCT00088543|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110158949|NCT00088543|Immunologic Factors|immunologic factors|mesh-ancestor
110158950|NCT00088543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110158951|NCT00088543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110158952|NCT00088582|Octreotide|octreotide|mesh-list
110158953|NCT00088582|Pasireotide|pasireotide|mesh-list
110158954|NCT00088582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110158955|NCT00088582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110158956|NCT00088582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110158958|NCT00088582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110158959|NCT00088582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110158960|NCT00088816|Tegafur|tegafur|mesh-list
110158961|NCT00088816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110158962|NCT00088816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110158963|NCT00088816|Antimetabolites|antimetabolites|mesh-ancestor
110158964|NCT00088816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110158965|NCT04688736|Chlorpheniramine|chlorpheniramine|mesh-list
110158966|NCT04688736|Antipruritics|antipruritics|mesh-ancestor
110158967|NCT04688736|Dermatologic Agents|dermatologic agents|mesh-ancestor
110158968|NCT04688736|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110158969|NCT04688736|Histamine Antagonists|histamine antagonists|mesh-ancestor
110158970|NCT04688736|Histamine Agents|histamine agents|mesh-ancestor
110158971|NCT04688736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110158972|NCT04688736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110158973|NCT04688736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110158974|NCT04688736|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110158975|NCT00088855|Doxorubicin|doxorubicin|mesh-list
110158976|NCT00088855|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110158977|NCT00088855|Bortezomib|bortezomib|mesh-list
110158978|NCT00088855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110158979|NCT00088855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110158980|NCT00088855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110158981|NCT00088855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110158982|NCT00088855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110158983|NCT00088855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110158985|NCT00088894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110158986|NCT00088894|Gemcitabine|gemcitabine|mesh-list
110158987|NCT00088894|Antibodies|antibodies|mesh-list
110158988|NCT00088894|Immunoglobulins|immunoglobulins|mesh-list
110158989|NCT00088894|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110158990|NCT00088894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110158991|NCT00088894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110158992|NCT00088894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110158993|NCT00088894|Growth Substances|growth substances|mesh-ancestor
110158994|NCT00088894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110158995|NCT00088894|Growth Inhibitors|growth inhibitors|mesh-ancestor
110158996|NCT00088894|Immunologic Factors|immunologic factors|mesh-ancestor
110158997|NCT00088894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110158998|NCT00088894|Antimetabolites|antimetabolites|mesh-ancestor
110158999|NCT00088894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159000|NCT00006152|Ritonavir|ritonavir|mesh-list
110159001|NCT00006152|Amprenavir|amprenavir|mesh-list
110159002|NCT00006152|Abacavir|abacavir|mesh-list
110159003|NCT00006152|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110159004|NCT00006152|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110159005|NCT00006152|Protease Inhibitors|protease inhibitors|mesh-ancestor
110159006|NCT00006152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110159007|NCT00006152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159008|NCT00006152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110159009|NCT00006152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110159010|NCT00006152|Antiviral Agents|antiviral agents|mesh-ancestor
110159011|NCT00006152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110159012|NCT00006152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110159013|NCT00006152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110159014|NCT00006152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110159015|NCT00006152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110159016|NCT00006152|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110159017|NCT00006152|Antitubercular Agents|antitubercular agents|mesh-ancestor
110159018|NCT00006152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110159019|NCT00088933|Metronidazole|metronidazole|mesh-list
110159021|NCT00088933|Vaccines|vaccines|mesh-list
110159022|NCT00088933|Sargramostim|sargramostim|mesh-list
110159023|NCT00088933|Immunologic Factors|immunologic factors|mesh-ancestor
110159024|NCT00088933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110159025|NCT00088933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110159026|NCT00088933|Tubulin Modulators|tubulin modulators|mesh-ancestor
110159027|NCT00088933|Antimitotic Agents|antimitotic agents|mesh-ancestor
110159028|NCT00088933|Mitosis Modulators|mitosis modulators|mesh-ancestor
110159029|NCT00088933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159030|NCT00088933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110159031|NCT00088933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110159033|NCT00088933|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110159034|NCT00089050|Cyclosporine|cyclosporine|mesh-list
110159035|NCT00089050|Gemtuzumab|gemtuzumab|mesh-list
110159036|NCT00089050|Cyclosporins|cyclosporins|mesh-list
110159037|NCT00089050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110159038|NCT00089050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159039|NCT00089050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110159040|NCT00089050|Immunologic Factors|immunologic factors|mesh-ancestor
110159041|NCT00089050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110159042|NCT00089050|Antifungal Agents|antifungal agents|mesh-ancestor
110159043|NCT00089050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110159044|NCT00089050|Dermatologic Agents|dermatologic agents|mesh-ancestor
110159045|NCT00089050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110159046|NCT00089050|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110159047|NCT00089050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110159050|NCT00089050|Immunoconjugates|immunoconjugates|mesh-ancestor
110159051|NCT00006155|Carboplatin|carboplatin|mesh-list
110159052|NCT00006155|Semaxinib|semaxinib|mesh-list
110159053|NCT00006155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110159054|NCT00006155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110159055|NCT00006155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110159056|NCT00006155|Growth Substances|growth substances|mesh-ancestor
110159057|NCT00006155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110159058|NCT00006155|Growth Inhibitors|growth inhibitors|mesh-ancestor
110159059|NCT00006155|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110159060|NCT00006155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110159061|NCT00006155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159062|NCT00089089|Decitabine|decitabine|mesh-list
110159063|NCT00089089|Azacitidine|azacitidine|mesh-list
110159064|NCT00089089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110159065|NCT00089089|Antimetabolites|antimetabolites|mesh-ancestor
110159066|NCT00089089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159067|NCT00089089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110159068|NCT00089089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110159069|NCT00089167|Thalidomide|thalidomide|mesh-list
110159071|NCT00089167|Melphalan|melphalan|mesh-list
110159072|NCT00089167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110159073|NCT00089167|Antiemetics|antiemetics|mesh-ancestor
110159074|NCT00089167|Autonomic Agents|autonomic agents|mesh-ancestor
110159075|NCT00089167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110159076|NCT00089167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110159077|NCT00089167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110159078|NCT00089167|Glucocorticoids|glucocorticoids|mesh-ancestor
110159079|NCT00089167|Hormones|hormones|mesh-ancestor
110159080|NCT00089167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110159081|NCT00089167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110159082|NCT00089167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110159083|NCT00089167|Immunologic Factors|immunologic factors|mesh-ancestor
110159084|NCT00089167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110159085|NCT00089167|Alkylating Agents|alkylating agents|mesh-ancestor
110159086|NCT00089167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159088|NCT00089167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110159089|NCT00089167|Leprostatic Agents|leprostatic agents|mesh-ancestor
110159090|NCT00089167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110159091|NCT00089167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110159092|NCT00089167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110188005|NCT04702256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110159093|NCT00089167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110159094|NCT00089167|Growth Substances|growth substances|mesh-ancestor
110159095|NCT00089167|Growth Inhibitors|growth inhibitors|mesh-ancestor
110159097|NCT00089206|Freund's Adjuvant|freund's adjuvant|mesh-list
110159098|NCT00089206|Immunologic Factors|immunologic factors|mesh-ancestor
110159099|NCT00089206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110159100|NCT00089206|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110159101|NCT00400231|Metformin|metformin|mesh-list
110159102|NCT00400231|Fenofibrate|fenofibrate|mesh-list
110159103|NCT00400231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110159104|NCT00400231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110159105|NCT00400231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110159106|NCT00400231|Antimetabolites|antimetabolites|mesh-ancestor
110159107|NCT00400231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159108|NCT00400231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110159109|NCT00006158|Testosterone|testosterone|mesh-list
110159110|NCT00006158|Androgens|androgens|mesh-ancestor
110159111|NCT00006158|Hormones|hormones|mesh-ancestor
110159112|NCT00006158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110159113|NCT00006158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110159114|NCT00423826|Cytarabine|cytarabine|mesh-list
110159115|NCT00423826|Mycophenolic Acid|mycophenolic acid|mesh-list
110159116|NCT00423826|Fludarabine|fludarabine|mesh-list
110159117|NCT00423826|Fludarabine phosphate|fludarabine phosphate|mesh-list
110159118|NCT00423826|Busulfan|busulfan|mesh-list
110159119|NCT00423826|Tacrolimus|tacrolimus|mesh-list
110159120|NCT00423826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110159121|NCT00423826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110159123|NCT00423826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159124|NCT00423826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110159125|NCT00423826|Immunologic Factors|immunologic factors|mesh-ancestor
110159126|NCT00423826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110159127|NCT00423826|Antiviral Agents|antiviral agents|mesh-ancestor
110159128|NCT00423826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110159129|NCT00423826|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110159130|NCT00423826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110159131|NCT00423826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110159132|NCT00423826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110159133|NCT00423826|Antitubercular Agents|antitubercular agents|mesh-ancestor
110159134|NCT00423826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110159135|NCT00423826|Alkylating Agents|alkylating agents|mesh-ancestor
110159136|NCT00423826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110159137|NCT00423826|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110159138|NCT00423865|Everolimus|everolimus|mesh-list
110159139|NCT00423865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110159140|NCT00423865|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110159141|NCT00423865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110159142|NCT00423865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110159143|NCT00423865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159144|NCT00423865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110159145|NCT00423865|Immunologic Factors|immunologic factors|mesh-ancestor
110159146|NCT00423865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110159148|NCT00423982|Rifampin|rifampin|mesh-list
110159149|NCT00423982|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110159150|NCT00423982|Cloxacillin|cloxacillin|mesh-list
110159151|NCT00423982|Anti-Infective Agents|anti-infective agents|mesh-list
110159152|NCT00423982|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110159153|NCT00423982|Antitubercular Agents|antitubercular agents|mesh-ancestor
110159154|NCT00423982|Leprostatic Agents|leprostatic agents|mesh-ancestor
110159155|NCT00423982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110159156|NCT00423982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110159157|NCT00423982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159158|NCT00423982|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110159159|NCT00423982|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110159160|NCT00423982|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110159161|NCT00423982|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110159162|NCT00423982|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110159163|NCT00423982|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110159164|NCT02965261|Fluoxetine|fluoxetine|mesh-list
110159165|NCT02965261|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110159166|NCT02965261|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110159167|NCT02965261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110159168|NCT02965261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159169|NCT02965261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110159170|NCT02965261|Serotonin Agents|serotonin agents|mesh-ancestor
110159171|NCT02965261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110159172|NCT02965261|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110159173|NCT02965261|Antidepressive Agents|antidepressive agents|mesh-ancestor
110159174|NCT02965261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110159175|NCT02965261|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110159176|NCT02965261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110159177|NCT02965261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110159178|NCT00390156|Cyclophosphamide|cyclophosphamide|mesh-list
110159179|NCT00390156|Bevacizumab|bevacizumab|mesh-list
110159180|NCT00390156|Imatinib Mesylate|imatinib mesylate|mesh-list
110159181|NCT00390156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110159182|NCT00390156|Immunologic Factors|immunologic factors|mesh-ancestor
110159183|NCT00390156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110159184|NCT00390156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110159185|NCT00390156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110159186|NCT00390156|Alkylating Agents|alkylating agents|mesh-ancestor
110159187|NCT00390156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159189|NCT00390156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110159190|NCT00390156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110159191|NCT00390156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110159192|NCT00390156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110159193|NCT00390156|Growth Substances|growth substances|mesh-ancestor
110159194|NCT00390156|Growth Inhibitors|growth inhibitors|mesh-ancestor
110159195|NCT00390156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110159196|NCT00390156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110159198|NCT00089401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110159199|NCT00089401|Alkylating Agents|alkylating agents|mesh-ancestor
110159200|NCT00089401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159201|NCT00089401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110159203|NCT00089401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110159204|NCT00089401|Immunologic Factors|immunologic factors|mesh-ancestor
110159205|NCT00089401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110159206|NCT00089440|Aripiprazole|aripiprazole|mesh-list
110159207|NCT00089440|Antidepressive Agents|antidepressive agents|mesh-ancestor
110159208|NCT00089440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110159209|NCT00089440|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110159211|NCT00089440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110159212|NCT00089440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110159213|NCT00089440|Dopamine Agonists|dopamine agonists|mesh-ancestor
110159214|NCT00089440|Dopamine Agents|dopamine agents|mesh-ancestor
110159215|NCT00089440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110159216|NCT00089440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159217|NCT00089440|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110159218|NCT00089440|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110159219|NCT00089440|Serotonin Agents|serotonin agents|mesh-ancestor
110159220|NCT00089440|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110159221|NCT00089440|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110159222|NCT00089440|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110159223|NCT00089440|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110159225|NCT00089518|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110159226|NCT00089518|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110159227|NCT00089518|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110159228|NCT00089518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159229|NCT00089557|Capsaicin|capsaicin|mesh-list
110159231|NCT00089557|Dermatologic Agents|dermatologic agents|mesh-ancestor
110159232|NCT00089557|Sensory System Agents|sensory system agents|mesh-ancestor
110159233|NCT00089557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110159234|NCT00089557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110159235|NCT00087451|Sirolimus|sirolimus|mesh-list
110159236|NCT00087451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110159237|NCT00087451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110159238|NCT00087451|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110159239|NCT00087451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110159240|NCT00087451|Antifungal Agents|antifungal agents|mesh-ancestor
110159241|NCT00087451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110159242|NCT00087451|Immunologic Factors|immunologic factors|mesh-ancestor
110159243|NCT00087451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110159244|NCT00089830|Squalamine|squalamine|mesh-list
110159245|NCT00089830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110159247|NCT00089830|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110159248|NCT00089830|Protective Agents|protective agents|mesh-ancestor
110159249|NCT00089830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110159250|NCT00089830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110159251|NCT00089830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110159252|NCT00089830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110159254|NCT00089830|Growth Inhibitors|growth inhibitors|mesh-ancestor
110159255|NCT00089869|Olanzapine|olanzapine|mesh-list
110159256|NCT00089869|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110159257|NCT00089869|Antiemetics|antiemetics|mesh-ancestor
110159258|NCT00089869|Autonomic Agents|autonomic agents|mesh-ancestor
110159259|NCT00089869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110159260|NCT00089869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110159261|NCT00089869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110159262|NCT00089869|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110159263|NCT00089869|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110159264|NCT00089869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110159265|NCT00089869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110159266|NCT00089869|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110159267|NCT00089869|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110159268|NCT00089869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110159269|NCT00089869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159270|NCT00089869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110159272|NCT00089869|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110159273|NCT00089869|Adrenergic Agents|adrenergic agents|mesh-ancestor
110159274|NCT00006167|Oxandrolone|oxandrolone|mesh-list
110159275|NCT00006167|Androgens|androgens|mesh-ancestor
110159276|NCT00006167|Hormones|hormones|mesh-ancestor
110159277|NCT00006167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110159278|NCT00006167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110159279|NCT00006167|Anabolic Agents|anabolic agents|mesh-ancestor
110159280|NCT00089947|Thymoglobulin|thymoglobulin|mesh-list
110159281|NCT00089947|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110159282|NCT00089947|Immunologic Factors|immunologic factors|mesh-ancestor
110159283|NCT00089947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110159284|NCT00089947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110159285|NCT00090025|Leucovorin|leucovorin|mesh-list
110159286|NCT00090025|Fluorouracil|fluorouracil|mesh-list
110159287|NCT00090025|Antimetabolites|antimetabolites|mesh-ancestor
110159288|NCT00090025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159289|NCT00090025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110159290|NCT00090025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110159291|NCT00090025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110159292|NCT00090025|Immunologic Factors|immunologic factors|mesh-ancestor
110159293|NCT00090025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110159295|NCT00090025|Protective Agents|protective agents|mesh-ancestor
110159296|NCT00090025|Vitamin B Complex|vitamin b complex|mesh-ancestor
110159297|NCT00090025|Vitamins|vitamins|mesh-ancestor
110159298|NCT00090025|Micronutrients|micronutrients|mesh-ancestor
110159299|NCT04633902|Pembrolizumab|pembrolizumab|mesh-list
110159300|NCT04633902|Olaparib|olaparib|mesh-list
110159301|NCT04633902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110159302|NCT04633902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110159303|NCT04633902|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110159304|NCT04633902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159305|NCT04633902|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110159306|NCT04633902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110159307|NCT00090727|AQ4N|aq4n|mesh-list
110159308|NCT00090727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110159309|NCT00006185|Rosiglitazone|rosiglitazone|mesh-list
110159310|NCT00006185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110159311|NCT00006185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110159312|NCT00091039|Metronidazole|metronidazole|mesh-list
110159314|NCT00091039|Carboplatin|carboplatin|mesh-list
110159315|NCT00091039|Vaccines|vaccines|mesh-list
110159316|NCT00091039|Adjuvants, Vaccine|adjuvants, vaccine|mesh-list
110159317|NCT00091039|Immunologic Factors|immunologic factors|mesh-ancestor
110159318|NCT00091039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110159319|NCT00091039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110159320|NCT00091039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110159321|NCT00091039|Tubulin Modulators|tubulin modulators|mesh-ancestor
110159322|NCT00091039|Antimitotic Agents|antimitotic agents|mesh-ancestor
110159323|NCT00091039|Mitosis Modulators|mitosis modulators|mesh-ancestor
110159324|NCT00091039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159325|NCT00091039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110159326|NCT00091039|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110159327|NCT00091039|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110159328|NCT00091039|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110159329|NCT00091039|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110159330|NCT00091078|Imatinib Mesylate|imatinib mesylate|mesh-list
110159331|NCT00091078|Oblimersen|oblimersen|mesh-list
110159332|NCT00091078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110159333|NCT00091078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110159334|NCT00091078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110159335|NCT00091078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159337|NCT00091117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110159338|NCT00091156|Gefitinib|gefitinib|mesh-list
110159339|NCT00091156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110159340|NCT00091156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110159341|NCT00091156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110159342|NCT00091156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159343|NCT00091195|Romidepsin|romidepsin|mesh-list
110159344|NCT00091195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110159345|NCT00091195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110159346|NCT00091195|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110159347|NCT00091195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110159348|NCT00091195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159350|NCT00091234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110159351|NCT00091234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110159352|NCT00091234|Immunotoxins|immunotoxins|mesh-ancestor
110159353|NCT00091234|Immunoconjugates|immunoconjugates|mesh-ancestor
110159354|NCT00091234|Immunologic Factors|immunologic factors|mesh-ancestor
110159355|NCT00091234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110159356|NCT00091312|Leucovorin|leucovorin|mesh-list
110159357|NCT00091312|Fluorouracil|fluorouracil|mesh-list
110159358|NCT00091312|Irinotecan|irinotecan|mesh-list
110159359|NCT00091312|Calcium|calcium|mesh-list
110159360|NCT00091312|Levoleucovorin|levoleucovorin|mesh-list
110159361|NCT00091312|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110159362|NCT00091312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110159363|NCT00091312|Antimetabolites|antimetabolites|mesh-ancestor
110159364|NCT00091312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159365|NCT00091312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110159366|NCT00091312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110159367|NCT00091312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110159368|NCT00091312|Immunologic Factors|immunologic factors|mesh-ancestor
110159369|NCT00091312|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110159370|NCT00091312|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110159371|NCT00091312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110159372|NCT00091312|Antidotes|antidotes|mesh-ancestor
110159373|NCT00091312|Protective Agents|protective agents|mesh-ancestor
110159374|NCT00091312|Vitamin B Complex|vitamin b complex|mesh-ancestor
110159375|NCT00091312|Vitamins|vitamins|mesh-ancestor
110159376|NCT00091312|Micronutrients|micronutrients|mesh-ancestor
110159377|NCT04619706|Palmidrol|palmidrol|mesh-list
110159378|NCT04619706|Analgesics|analgesics|mesh-ancestor
110159379|NCT04619706|Sensory System Agents|sensory system agents|mesh-ancestor
110159380|NCT04619706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110159381|NCT04619706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110159382|NCT04619706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110159383|NCT04619706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110159384|NCT04619706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110159385|NCT04619706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110159386|NCT04619706|Antiviral Agents|antiviral agents|mesh-ancestor
110159387|NCT04619706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110159388|NCT04619706|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110159389|NCT04619706|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110159390|NCT04619706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110159391|NCT04619706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159392|NCT04619706|Hormones|hormones|mesh-ancestor
110159393|NCT04619706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110159394|NCT00091429|Ranolazine|ranolazine|mesh-list
110159395|NCT00091429|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110159396|NCT00091429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110159397|NCT00091429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159398|NCT00091468|Nicotine|nicotine|mesh-list
110159399|NCT00091468|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110159400|NCT00091468|Autonomic Agents|autonomic agents|mesh-ancestor
110159401|NCT00091468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110159402|NCT00091468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110159403|NCT00091468|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110159404|NCT00091468|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110159405|NCT00091468|Cholinergic Agents|cholinergic agents|mesh-ancestor
110159406|NCT00091468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110159407|NCT00091468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159408|NCT00006200|Thalidomide|thalidomide|mesh-list
110159409|NCT00006200|Dacarbazine|dacarbazine|mesh-list
110159410|NCT00006200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110159411|NCT00006200|Immunologic Factors|immunologic factors|mesh-ancestor
110159412|NCT00006200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110159415|NCT00006200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110159416|NCT00006200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110159417|NCT00006200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110159418|NCT00006200|Growth Substances|growth substances|mesh-ancestor
110159419|NCT00006200|Growth Inhibitors|growth inhibitors|mesh-ancestor
110159420|NCT00006200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110159421|NCT00006200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110159423|NCT00006200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159424|NCT00006203|Naltrexone|naltrexone|mesh-list
110159425|NCT00006203|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110159426|NCT00006203|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110159427|NCT00006203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110159428|NCT00006203|Sensory System Agents|sensory system agents|mesh-ancestor
110159429|NCT00006203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110159430|NCT00091624|Lenalidomide|lenalidomide|mesh-list
110159431|NCT00091624|Immunologic Factors|immunologic factors|mesh-ancestor
110159432|NCT00091624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110159433|NCT00091624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110159434|NCT00091624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110159435|NCT00091624|Growth Substances|growth substances|mesh-ancestor
110159436|NCT00091624|Growth Inhibitors|growth inhibitors|mesh-ancestor
110159437|NCT00091624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110159438|NCT00091663|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110159439|NCT00091663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110159440|NCT00091663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110159441|NCT00091663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110159442|NCT00091663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159443|NCT00006206|Naltrexone|naltrexone|mesh-list
110159444|NCT00006206|Acamprosate|acamprosate|mesh-list
110159445|NCT00006206|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110159446|NCT00006206|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110159447|NCT00006206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110159448|NCT00006206|Sensory System Agents|sensory system agents|mesh-ancestor
110159449|NCT00006206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110159450|NCT00091702|Vaccines|vaccines|mesh-list
110159451|NCT00091702|Immunologic Factors|immunologic factors|mesh-ancestor
110159452|NCT00091702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110159453|NCT00091741|Etanercept|etanercept|mesh-list
110159454|NCT00091741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110159455|NCT00091741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110159456|NCT00091741|Analgesics|analgesics|mesh-ancestor
110159457|NCT00091741|Sensory System Agents|sensory system agents|mesh-ancestor
110159458|NCT00091741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110159459|NCT00091741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110159460|NCT00091741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110159461|NCT00091741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110159462|NCT00091741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110159463|NCT00091741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110159464|NCT00091741|Immunologic Factors|immunologic factors|mesh-ancestor
110159466|NCT00091858|Hematinics|hematinics|mesh-ancestor
110159467|NCT00390195|Everolimus|everolimus|mesh-list
110159468|NCT00390195|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110159469|NCT00390195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110159470|NCT00390195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110159471|NCT00390195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159472|NCT00390195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110159473|NCT00390195|Immunologic Factors|immunologic factors|mesh-ancestor
110159474|NCT00390195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110159475|NCT00390195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110159476|NCT00091897|Rituximab|rituximab|mesh-list
110159477|NCT00091897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110159478|NCT00091897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110159479|NCT00091897|Immunologic Factors|immunologic factors|mesh-ancestor
110159480|NCT00091897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110159481|NCT00091897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110159482|NCT00006212|Vinblastine|vinblastine|mesh-list
110159483|NCT00006212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110159484|NCT00006212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110159485|NCT00006212|Tubulin Modulators|tubulin modulators|mesh-ancestor
110159486|NCT00006212|Antimitotic Agents|antimitotic agents|mesh-ancestor
110159487|NCT00006212|Mitosis Modulators|mitosis modulators|mesh-ancestor
110159488|NCT00006212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159490|NCT00091936|Efavirenz|efavirenz|mesh-list
110159491|NCT00091936|Didanosine|didanosine|mesh-list
110159492|NCT00091936|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110159493|NCT00091936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110159494|NCT00091936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110159495|NCT00091936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159496|NCT00091936|Antiviral Agents|antiviral agents|mesh-ancestor
110159497|NCT00091936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110159498|NCT00091936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110159499|NCT00091936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110159500|NCT00091936|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110159501|NCT00091936|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110159502|NCT00091936|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110159503|NCT00091936|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110159504|NCT00091936|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110159505|NCT00091936|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110159506|NCT00091936|Antimetabolites|antimetabolites|mesh-ancestor
110159507|NCT02972346|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
110159508|NCT02972346|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
110159509|NCT02972346|beta-Endorphin|beta-endorphin|mesh-list
110159510|NCT02972346|Hormones|hormones|mesh-ancestor
110159511|NCT02972346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110159512|NCT02972346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110159513|NCT02972346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110159514|NCT02972346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159515|NCT00092170|Clavulanic Acid|clavulanic acid|mesh-list
110159516|NCT00092170|Clavulanic Acids|clavulanic acids|mesh-list
110159517|NCT00092170|Ertapenem|ertapenem|mesh-list
110159518|NCT00092170|Ticarcillin|ticarcillin|mesh-list
110159519|NCT00092170|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110159520|NCT00092170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110159521|NCT00092170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159522|NCT00092170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110159523|NCT00092170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110159524|NCT00006215|Docetaxel|docetaxel|mesh-list
110159525|NCT00006215|Vinorelbine|vinorelbine|mesh-list
110159526|NCT00006215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110159527|NCT00006215|Tubulin Modulators|tubulin modulators|mesh-ancestor
110159528|NCT00006215|Antimitotic Agents|antimitotic agents|mesh-ancestor
110159529|NCT00006215|Mitosis Modulators|mitosis modulators|mesh-ancestor
110159530|NCT00006215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159531|NCT00006215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110159532|NCT00092287|Lanreotide|lanreotide|mesh-list
110159533|NCT00092287|Octreotide|octreotide|mesh-list
110159534|NCT00092287|Somatostatin|somatostatin|mesh-list
110159535|NCT00092287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110159536|NCT00092287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110159537|NCT00092287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110159538|NCT00092287|Hormones|hormones|mesh-ancestor
110159539|NCT00092287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110159541|NCT00092326|Acetaminophen|acetaminophen|mesh-list
110159542|NCT00092326|Rofecoxib|rofecoxib|mesh-list
110159543|NCT00092326|Oxycodone|oxycodone|mesh-list
110159544|NCT00092326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110159545|NCT00092326|Analgesics|analgesics|mesh-ancestor
110159546|NCT00092326|Sensory System Agents|sensory system agents|mesh-ancestor
110159547|NCT00092326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110159548|NCT00092326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110159549|NCT00092326|Antipyretics|antipyretics|mesh-ancestor
110159550|NCT00092326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110159551|NCT00092326|Narcotics|narcotics|mesh-ancestor
110159552|NCT00092326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110159553|NCT00092326|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110159554|NCT00092326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110159555|NCT00092326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110159556|NCT00092326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159557|NCT00092326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110159558|NCT00092326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110159559|NCT00092326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110159560|NCT00092365|Celecoxib|celecoxib|mesh-list
110159561|NCT00092365|Rofecoxib|rofecoxib|mesh-list
110159562|NCT00092365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110159563|NCT00092365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110159564|NCT00092365|Analgesics|analgesics|mesh-ancestor
110159565|NCT00092365|Sensory System Agents|sensory system agents|mesh-ancestor
110159566|NCT00092365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110159567|NCT00092365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110159568|NCT00092365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110159569|NCT00092365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110159570|NCT00092365|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110159571|NCT00092365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110159572|NCT00092365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110159573|NCT00092365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159575|NCT00092404|Immunologic Factors|immunologic factors|mesh-ancestor
110159576|NCT00092404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110159577|NCT04728880|Remdesivir|remdesivir|mesh-list
110159578|NCT04728880|Antimetabolites|antimetabolites|mesh-ancestor
110159579|NCT04728880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159580|NCT04728880|Antiviral Agents|antiviral agents|mesh-ancestor
110159581|NCT04728880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110159582|NCT00093028|Bortezomib|bortezomib|mesh-list
110159583|NCT00093028|Lenalidomide|lenalidomide|mesh-list
110159584|NCT00093028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110159585|NCT00093028|Immunologic Factors|immunologic factors|mesh-ancestor
110159586|NCT00093028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110159587|NCT00093028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110159588|NCT00093028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110159589|NCT00093028|Growth Substances|growth substances|mesh-ancestor
110159590|NCT00093028|Growth Inhibitors|growth inhibitors|mesh-ancestor
110159591|NCT00093067|Daptomycin|daptomycin|mesh-list
110159592|NCT00093067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110159593|NCT00093067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110159594|NCT00093184|Anticoagulants|anticoagulants|mesh-list
110159596|NCT00093184|Antithrombins|antithrombins|mesh-ancestor
110159597|NCT00093184|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110159599|NCT00093184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110159600|NCT00093184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159602|NCT00006224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110159603|NCT00006224|Antimetabolites|antimetabolites|mesh-ancestor
110159604|NCT00006224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159605|NCT00006224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110159606|NCT00093223|Paclitaxel|paclitaxel|mesh-list
110159607|NCT00093223|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110159608|NCT00093223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110159609|NCT00093223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110159610|NCT00093223|Tubulin Modulators|tubulin modulators|mesh-ancestor
110159612|NCT00093223|Mitosis Modulators|mitosis modulators|mesh-ancestor
110159613|NCT00093223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159614|NCT00093262|Clevidipine|clevidipine|mesh-list
110159615|NCT00093262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110159616|NCT00093262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110159617|NCT00093262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159618|NCT00093262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110159619|NCT00093262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110159621|NCT00093301|Dobutamine|dobutamine|mesh-list
110159622|NCT00093301|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110159623|NCT00093301|Vasodilator Agents|vasodilator agents|mesh-ancestor
110159624|NCT00093301|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110159625|NCT00093301|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110159626|NCT00093301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110159627|NCT00093301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159628|NCT00093301|Protective Agents|protective agents|mesh-ancestor
110159629|NCT00093301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110159630|NCT00093301|Sympathomimetics|sympathomimetics|mesh-ancestor
110159631|NCT00093301|Autonomic Agents|autonomic agents|mesh-ancestor
110159632|NCT00093301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110159633|NCT00093301|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110159634|NCT00093301|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110159635|NCT00093301|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110159636|NCT00093301|Adrenergic Agents|adrenergic agents|mesh-ancestor
110159637|NCT00093301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110159639|NCT00093418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110159640|NCT00387608|Veliparib|veliparib|mesh-list
110159641|NCT00387608|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110159642|NCT00387608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110159643|NCT00387608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159644|NCT00387608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110159645|NCT00093613|Sorafenib|sorafenib|mesh-list
110159646|NCT00093613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110159647|NCT00093613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110159648|NCT00093613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110159649|NCT00093613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159651|NCT00093652|Gefitinib|gefitinib|mesh-list
110159652|NCT00093652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110159653|NCT00093652|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110159654|NCT00093652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110159655|NCT00093652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159656|NCT00006230|Rubitecan|rubitecan|mesh-list
110159657|NCT00006230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110159658|NCT00006230|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110159659|NCT00006230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110159660|NCT00006230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110159661|NCT00006230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159663|NCT00093769|Bortezomib|bortezomib|mesh-list
110159664|NCT00093769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110159665|NCT00093769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110159666|NCT00093769|Immunologic Factors|immunologic factors|mesh-ancestor
110159667|NCT00093769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110159668|NCT00093769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110159669|NCT00400348|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
110159670|NCT00400348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110159671|NCT00400348|Tubulin Modulators|tubulin modulators|mesh-ancestor
110159672|NCT00400348|Antimitotic Agents|antimitotic agents|mesh-ancestor
110159673|NCT00400348|Mitosis Modulators|mitosis modulators|mesh-ancestor
110159674|NCT00400348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159675|NCT00006233|Cyclosporine|cyclosporine|mesh-list
110159676|NCT00006233|Mycophenolic Acid|mycophenolic acid|mesh-list
110159677|NCT00006233|Fludarabine|fludarabine|mesh-list
110159678|NCT00006233|Fludarabine phosphate|fludarabine phosphate|mesh-list
110159679|NCT00006233|Cyclosporins|cyclosporins|mesh-list
110159680|NCT00006233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110159681|NCT00006233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110159682|NCT00006233|Antimetabolites|antimetabolites|mesh-ancestor
110159683|NCT00006233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159684|NCT00006233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110159685|NCT00006233|Immunologic Factors|immunologic factors|mesh-ancestor
110159686|NCT00006233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110159687|NCT00006233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110159688|NCT00006233|Antifungal Agents|antifungal agents|mesh-ancestor
110159689|NCT00006233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110159690|NCT00006233|Dermatologic Agents|dermatologic agents|mesh-ancestor
110159691|NCT00006233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110159692|NCT00006233|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110159693|NCT00006233|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110159694|NCT00006233|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110159695|NCT00006233|Antitubercular Agents|antitubercular agents|mesh-ancestor
110188133|NCT04512079|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110159696|NCT00006233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110159697|NCT02964715|Empagliflozin|empagliflozin|mesh-list
110159698|NCT02964715|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110159699|NCT02964715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159700|NCT02964715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110159701|NCT02964715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110159702|NCT00093886|Clevidipine|clevidipine|mesh-list
110159703|NCT00093886|Nitroglycerin|nitroglycerin|mesh-list
110159704|NCT00093886|Vasodilator Agents|vasodilator agents|mesh-ancestor
110159705|NCT00093886|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110159706|NCT00093886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110159707|NCT00093886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159708|NCT00093886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110159709|NCT00093886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110159712|NCT00093925|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110159713|NCT00093925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110159714|NCT00093925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159715|NCT00093925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110159716|NCT00093925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110159717|NCT00093925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110159718|NCT00093925|Vasodilator Agents|vasodilator agents|mesh-ancestor
110159720|NCT00006239|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
110159721|NCT00006239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110159722|NCT00006239|Keratolytic Agents|keratolytic agents|mesh-ancestor
110159723|NCT00006239|Dermatologic Agents|dermatologic agents|mesh-ancestor
110159724|NCT00094003|Poly I-C|poly i-c|mesh-list
110159725|NCT00094003|Antiviral Agents|antiviral agents|mesh-ancestor
110159726|NCT00094003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110159727|NCT00094003|Interferon Inducers|interferon inducers|mesh-ancestor
110159728|NCT00094003|Immunologic Factors|immunologic factors|mesh-ancestor
110159729|NCT00094003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110159730|NCT00094081|Tirapazamine|tirapazamine|mesh-list
110159731|NCT00094081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110159732|NCT00094120|Squalamine|squalamine|mesh-list
110159733|NCT00094120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110159734|NCT00094120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110159735|NCT00094120|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110159736|NCT00094120|Protective Agents|protective agents|mesh-ancestor
110159737|NCT00094120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110159738|NCT00094120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110159739|NCT00094120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110159740|NCT00094120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110159742|NCT00094120|Growth Inhibitors|growth inhibitors|mesh-ancestor
110159743|NCT00006245|Paclitaxel|paclitaxel|mesh-list
110159744|NCT00006245|Alvocidib|alvocidib|mesh-list
110159745|NCT00006245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110159746|NCT00006245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110159747|NCT00006245|Tubulin Modulators|tubulin modulators|mesh-ancestor
110159748|NCT00006245|Antimitotic Agents|antimitotic agents|mesh-ancestor
110159749|NCT00006245|Mitosis Modulators|mitosis modulators|mesh-ancestor
110159750|NCT00006245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159752|NCT00006245|Growth Substances|growth substances|mesh-ancestor
110159753|NCT00006245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110159754|NCT00006245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110159755|NCT00006245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110159756|NCT00094315|Cocaine|cocaine|mesh-list
110159757|NCT00094315|Anesthetics, Local|anesthetics, local|mesh-ancestor
110159758|NCT00094315|Anesthetics|anesthetics|mesh-ancestor
110159759|NCT00094315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110159760|NCT00094315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110159761|NCT00094315|Sensory System Agents|sensory system agents|mesh-ancestor
110159762|NCT00094315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110159763|NCT00094315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110159764|NCT00094315|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110159765|NCT00094315|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110159766|NCT00094315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110159767|NCT00094315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159768|NCT00094315|Dopamine Agents|dopamine agents|mesh-ancestor
110159769|NCT00094315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110159770|NCT00094432|Aripiprazole|aripiprazole|mesh-list
110159771|NCT00094432|Antidepressive Agents|antidepressive agents|mesh-ancestor
110159772|NCT00094432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110159773|NCT00094432|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110159774|NCT00094432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110159775|NCT00094432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110159776|NCT00094432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110159777|NCT00094432|Dopamine Agonists|dopamine agonists|mesh-ancestor
110159778|NCT00094432|Dopamine Agents|dopamine agents|mesh-ancestor
110159779|NCT00094432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110159780|NCT00094432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159781|NCT00094432|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110159782|NCT00094432|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110159783|NCT00094432|Serotonin Agents|serotonin agents|mesh-ancestor
110159785|NCT00094432|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110159786|NCT00094432|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110159787|NCT00094432|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110159788|NCT00006248|Paclitaxel|paclitaxel|mesh-list
110159789|NCT00006248|Fluorouracil|fluorouracil|mesh-list
110159790|NCT00006248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110159791|NCT00006248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110159792|NCT00006248|Tubulin Modulators|tubulin modulators|mesh-ancestor
110159793|NCT00006248|Antimitotic Agents|antimitotic agents|mesh-ancestor
110159794|NCT00006248|Mitosis Modulators|mitosis modulators|mesh-ancestor
110159795|NCT00006248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159796|NCT00006248|Antimetabolites|antimetabolites|mesh-ancestor
110159797|NCT00006248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110159798|NCT00006248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110159799|NCT00006248|Immunologic Factors|immunologic factors|mesh-ancestor
110159800|NCT00006248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110159801|NCT00094549|Valproic Acid|valproic acid|mesh-list
110159802|NCT00094549|Olanzapine|olanzapine|mesh-list
110159803|NCT00094549|Antiemetics|antiemetics|mesh-ancestor
110159804|NCT00094549|Autonomic Agents|autonomic agents|mesh-ancestor
110159805|NCT00094549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110159806|NCT00094549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110159807|NCT00094549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110159808|NCT00094549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110159809|NCT00094549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110159810|NCT00094549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110159811|NCT00094549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110159812|NCT00094549|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110188163|NCT04437485|Serotonin Agents|serotonin agents|mesh-ancestor
110159813|NCT00094549|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110159814|NCT00094549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110159815|NCT00094549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159816|NCT00094549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110159817|NCT00094549|Serotonin Agents|serotonin agents|mesh-ancestor
110159818|NCT00094549|Anticonvulsants|anticonvulsants|mesh-ancestor
110159819|NCT00094549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110159821|NCT00094549|Antimanic Agents|antimanic agents|mesh-ancestor
110159822|NCT00094627|Gaboxadol|gaboxadol|mesh-list
110159823|NCT00094627|Analgesics|analgesics|mesh-ancestor
110159824|NCT00094627|Sensory System Agents|sensory system agents|mesh-ancestor
110159825|NCT00094627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110159826|NCT00094627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110159827|NCT00094627|Anticonvulsants|anticonvulsants|mesh-ancestor
110159828|NCT00094627|GABA Agonists|gaba agonists|mesh-ancestor
110159829|NCT00094627|GABA Agents|gaba agents|mesh-ancestor
110159830|NCT00094627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110159831|NCT00094627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159832|NCT00094666|Gaboxadol|gaboxadol|mesh-list
110159833|NCT00094666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110159834|NCT00094666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159835|NCT00094666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110159836|NCT00094666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110159838|NCT00094666|Sensory System Agents|sensory system agents|mesh-ancestor
110159839|NCT00094666|Anticonvulsants|anticonvulsants|mesh-ancestor
110159840|NCT00094666|GABA Agonists|gaba agonists|mesh-ancestor
110159841|NCT00094666|GABA Agents|gaba agents|mesh-ancestor
110159842|NCT00006251|Cyclosporine|cyclosporine|mesh-list
110159843|NCT00006251|Mycophenolic Acid|mycophenolic acid|mesh-list
110159844|NCT00006251|Fludarabine|fludarabine|mesh-list
110159845|NCT00006251|Fludarabine phosphate|fludarabine phosphate|mesh-list
110159846|NCT00006251|Cyclosporins|cyclosporins|mesh-list
110159847|NCT00006251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110159848|NCT00006251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110159849|NCT00006251|Antimetabolites|antimetabolites|mesh-ancestor
110159850|NCT00006251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159851|NCT00006251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110159852|NCT00006251|Immunologic Factors|immunologic factors|mesh-ancestor
110159853|NCT00006251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110159854|NCT00006251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110159855|NCT00006251|Antifungal Agents|antifungal agents|mesh-ancestor
110159856|NCT00006251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110159857|NCT00006251|Dermatologic Agents|dermatologic agents|mesh-ancestor
110159858|NCT00006251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110159859|NCT00006251|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110159860|NCT00006251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110159861|NCT00006251|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110159862|NCT00006251|Antitubercular Agents|antitubercular agents|mesh-ancestor
110159863|NCT00006251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110159864|NCT00094978|Alvocidib|alvocidib|mesh-list
110159865|NCT00094978|Romidepsin|romidepsin|mesh-list
110159866|NCT00094978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110159867|NCT00094978|Growth Inhibitors|growth inhibitors|mesh-ancestor
110159868|NCT00094978|Growth Substances|growth substances|mesh-ancestor
110159869|NCT00094978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110159870|NCT00094978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110159871|NCT00094978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110159872|NCT00094978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159873|NCT00094978|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110159874|NCT00094978|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110159876|NCT00095134|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110159877|NCT00095134|Serotonin Agents|serotonin agents|mesh-ancestor
110159878|NCT00095134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110159879|NCT00095134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159880|NCT00095134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110159881|NCT00095134|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110159882|NCT00095134|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110159883|NCT00095134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110159884|NCT00095134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110159885|NCT00095134|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110159886|NCT00095134|Dopamine Agents|dopamine agents|mesh-ancestor
110159887|NCT00006257|Paclitaxel|paclitaxel|mesh-list
110159888|NCT00006257|Semaxinib|semaxinib|mesh-list
110159889|NCT00006257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110159890|NCT00006257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110159891|NCT00006257|Tubulin Modulators|tubulin modulators|mesh-ancestor
110159892|NCT00006257|Antimitotic Agents|antimitotic agents|mesh-ancestor
110159893|NCT00006257|Mitosis Modulators|mitosis modulators|mesh-ancestor
110159894|NCT00006257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159895|NCT00006257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110159896|NCT00006257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110159897|NCT00006257|Growth Substances|growth substances|mesh-ancestor
110159898|NCT00006257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110159899|NCT00006257|Growth Inhibitors|growth inhibitors|mesh-ancestor
110159900|NCT00006257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110159901|NCT00006257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110159902|NCT00095251|Dexmedetomidine|dexmedetomidine|mesh-list
110159903|NCT00095251|Lorazepam|lorazepam|mesh-list
110159904|NCT00095251|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110159905|NCT00095251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110159906|NCT00095251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110159907|NCT00095251|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110159908|NCT00095251|Analgesics|analgesics|mesh-ancestor
110159909|NCT00095251|Sensory System Agents|sensory system agents|mesh-ancestor
110159910|NCT00095251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110159911|NCT00095251|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110159912|NCT00095251|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110159913|NCT00095251|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110159914|NCT00095251|Adrenergic Agents|adrenergic agents|mesh-ancestor
110159915|NCT00095251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110159916|NCT00095251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159918|NCT00095251|Antiemetics|antiemetics|mesh-ancestor
110159919|NCT00095251|Autonomic Agents|autonomic agents|mesh-ancestor
110159920|NCT00095251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110159921|NCT00095251|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110159922|NCT00095251|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110159923|NCT00095251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110159924|NCT00095251|GABA Modulators|gaba modulators|mesh-ancestor
110159925|NCT00095251|GABA Agents|gaba agents|mesh-ancestor
110159926|NCT00006260|Etoposide|etoposide|mesh-list
110159927|NCT00006260|Ifosfamide|ifosfamide|mesh-list
110159928|NCT00006260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110159929|NCT00006260|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110159930|NCT00006260|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110159931|NCT00006260|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110159932|NCT00006260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110159933|NCT00006260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159934|NCT00006260|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110159935|NCT00006260|Alkylating Agents|alkylating agents|mesh-ancestor
110159937|NCT00095329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110159938|NCT00095329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110159939|NCT00095329|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110159940|NCT00095329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110159941|NCT00095329|Antifungal Agents|antifungal agents|mesh-ancestor
110159942|NCT00095329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110159943|NCT00095329|Immunologic Factors|immunologic factors|mesh-ancestor
110159944|NCT00095329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110159945|NCT00095368|Amoxicillin|amoxicillin|mesh-list
110159946|NCT00095368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110159947|NCT00095368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110159948|NCT00095446|Insulin Aspart|insulin aspart|mesh-list
110159949|NCT00095446|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110159950|NCT00095446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110159951|NCT00006263|Carboplatin|carboplatin|mesh-list
110159952|NCT00006263|Temozolomide|temozolomide|mesh-list
110159953|NCT00006263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110159954|NCT00006263|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110159955|NCT00006263|Alkylating Agents|alkylating agents|mesh-ancestor
110159956|NCT00006263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159957|NCT00095524|Aripiprazole|aripiprazole|mesh-list
110159958|NCT00095524|Antidepressive Agents|antidepressive agents|mesh-ancestor
110159959|NCT00095524|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110159960|NCT00095524|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110159961|NCT00095524|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110159962|NCT00095524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110159963|NCT00095524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110159964|NCT00095524|Dopamine Agonists|dopamine agonists|mesh-ancestor
110159965|NCT00095524|Dopamine Agents|dopamine agents|mesh-ancestor
110159966|NCT00095524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110159967|NCT00095524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159968|NCT00095524|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110159969|NCT00095524|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110159970|NCT00095524|Serotonin Agents|serotonin agents|mesh-ancestor
110159971|NCT00095524|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110159972|NCT00095524|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110159973|NCT00095524|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110159974|NCT00095524|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110159975|NCT00095641|Capecitabine|capecitabine|mesh-list
110159976|NCT00095641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110159977|NCT00095641|Antimetabolites|antimetabolites|mesh-ancestor
110159978|NCT00095641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159981|NCT00006269|Octreotide|octreotide|mesh-list
110159982|NCT00006269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110159983|NCT00006269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110159984|NCT00006269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110159985|NCT00006269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159986|NCT00006269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110159987|NCT00006269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110159988|NCT00006269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110159989|NCT04476030|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110159990|NCT04476030|Citalopram|citalopram|mesh-list
110159991|NCT04476030|Sertraline|sertraline|mesh-list
110159992|NCT04476030|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
110159993|NCT04476030|Escitalopram|escitalopram|mesh-list
110159994|NCT04476030|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110159995|NCT04476030|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110159996|NCT04476030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110159997|NCT04476030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159998|NCT04476030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110160000|NCT04476030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110160001|NCT04476030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110160002|NCT04476030|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110160003|NCT04476030|Antidepressive Agents|antidepressive agents|mesh-ancestor
110160004|NCT04476030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110160005|NCT04476030|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110160006|NCT04476030|Analgesics|analgesics|mesh-ancestor
110160007|NCT04476030|Sensory System Agents|sensory system agents|mesh-ancestor
110160008|NCT04476030|Dopamine Agents|dopamine agents|mesh-ancestor
110160009|NCT00095680|Bortezomib|bortezomib|mesh-list
110160010|NCT00095680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110160011|NCT00095719|Aripiprazole|aripiprazole|mesh-list
110160012|NCT00095719|Antidepressive Agents|antidepressive agents|mesh-ancestor
110160013|NCT00095719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110160014|NCT00095719|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110160015|NCT00095719|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110160016|NCT00095719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110160017|NCT00095719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110160018|NCT00095719|Dopamine Agonists|dopamine agonists|mesh-ancestor
110160019|NCT00095719|Dopamine Agents|dopamine agents|mesh-ancestor
110160020|NCT00095719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110160021|NCT00095719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160022|NCT00095719|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110160023|NCT00095719|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110160024|NCT00095719|Serotonin Agents|serotonin agents|mesh-ancestor
110160025|NCT00095719|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110160026|NCT00095719|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110160027|NCT00095719|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110160028|NCT00095719|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110160029|NCT00095758|Aripiprazole|aripiprazole|mesh-list
110160030|NCT00095758|Antidepressive Agents|antidepressive agents|mesh-list
110160031|NCT00095758|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110160032|NCT00095758|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110160033|NCT00095758|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110160034|NCT00095758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110160035|NCT00095758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110160036|NCT00095758|Dopamine Agonists|dopamine agonists|mesh-ancestor
110160037|NCT00095758|Dopamine Agents|dopamine agents|mesh-ancestor
110160038|NCT00095758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110160039|NCT00095758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160040|NCT00095758|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110160041|NCT00095758|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110160042|NCT00095758|Serotonin Agents|serotonin agents|mesh-ancestor
110160043|NCT00095758|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110160044|NCT00095758|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110160045|NCT00095758|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110160046|NCT00095758|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110160048|NCT00095914|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110160049|NCT00095914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110160050|NCT00095914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110160051|NCT00095914|Tubulin Modulators|tubulin modulators|mesh-ancestor
110160052|NCT00095914|Antimitotic Agents|antimitotic agents|mesh-ancestor
110160053|NCT00095914|Mitosis Modulators|mitosis modulators|mesh-ancestor
110160054|NCT00095914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160056|NCT04432428|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110160057|NCT04432428|Narcotics|narcotics|mesh-ancestor
110160058|NCT04432428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110160059|NCT04432428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110160061|NCT04432428|Sensory System Agents|sensory system agents|mesh-ancestor
110160062|NCT04432428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110160063|NCT04432428|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110160064|NCT04432428|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110160065|NCT04432428|Anesthetics, General|anesthetics, general|mesh-ancestor
110160066|NCT04432428|Anesthetics|anesthetics|mesh-ancestor
110160067|NCT00096070|Gemcitabine|gemcitabine|mesh-list
110160068|NCT00096070|Fluorouracil|fluorouracil|mesh-list
110160069|NCT00096070|Oxaliplatin|oxaliplatin|mesh-list
110160070|NCT00096070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110160071|NCT00096070|Antimetabolites|antimetabolites|mesh-ancestor
110160072|NCT00096070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160073|NCT00096070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110160074|NCT00096070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110160075|NCT00096070|Immunologic Factors|immunologic factors|mesh-ancestor
110160076|NCT00096070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110160078|NCT00006275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110160079|NCT00006275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110160080|NCT00006275|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110160081|NCT00006275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110160082|NCT00006275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160083|NCT00006275|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110160084|NCT00006275|Vitamins|vitamins|mesh-ancestor
110160085|NCT00006275|Micronutrients|micronutrients|mesh-ancestor
110160086|NCT00006275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110160087|NCT00096148|Cytarabine|cytarabine|mesh-list
110160088|NCT00096148|Bevacizumab|bevacizumab|mesh-list
110160089|NCT00096148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110160090|NCT00096148|Idarubicin|idarubicin|mesh-list
110160091|NCT00096148|Antibodies|antibodies|mesh-list
110160092|NCT00096148|Immunoglobulins|immunoglobulins|mesh-list
110160093|NCT00096148|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110160094|NCT00096148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110160095|NCT00096148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110160096|NCT00096148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110160097|NCT00096148|Growth Substances|growth substances|mesh-ancestor
110160098|NCT00096148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110160099|NCT00096148|Growth Inhibitors|growth inhibitors|mesh-ancestor
110160100|NCT00096148|Immunologic Factors|immunologic factors|mesh-ancestor
110160101|NCT00096148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110160102|NCT00096148|Antimetabolites|antimetabolites|mesh-ancestor
110160103|NCT00096148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160104|NCT00096148|Antiviral Agents|antiviral agents|mesh-ancestor
110160105|NCT00096148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110160106|NCT00096148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110160107|NCT00096148|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110160108|NCT00096148|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110160109|NCT00096148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110160110|NCT00096148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110160111|NCT00096187|Pemetrexed|pemetrexed|mesh-list
110160112|NCT00096187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110160113|NCT00096187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110160114|NCT00096187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160115|NCT00096187|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110160116|NCT00096187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110160118|NCT00096304|Epirubicin|epirubicin|mesh-list
110160119|NCT00096304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110160120|NCT00096304|Tubulin Modulators|tubulin modulators|mesh-ancestor
110160121|NCT00096304|Antimitotic Agents|antimitotic agents|mesh-ancestor
110160122|NCT00096304|Mitosis Modulators|mitosis modulators|mesh-ancestor
110160123|NCT00096304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160124|NCT00096304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110160125|NCT00096304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110160126|NCT00096304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110160127|NCT00096304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110160129|NCT00096343|Carboplatin|carboplatin|mesh-list
110160130|NCT00096343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110160131|NCT00096343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110160132|NCT00096343|Tubulin Modulators|tubulin modulators|mesh-ancestor
110160133|NCT00096343|Antimitotic Agents|antimitotic agents|mesh-ancestor
110160134|NCT00096343|Mitosis Modulators|mitosis modulators|mesh-ancestor
110160135|NCT00096343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160136|NCT00096616|Albuterol|albuterol|mesh-list
110160137|NCT00096616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110160138|NCT00096616|Autonomic Agents|autonomic agents|mesh-ancestor
110160139|NCT00096616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110160140|NCT00096616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110160141|NCT00096616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110160142|NCT00096616|Respiratory System Agents|respiratory system agents|mesh-ancestor
110160143|NCT00096616|Tocolytic Agents|tocolytic agents|mesh-ancestor
110160144|NCT00096616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110160145|NCT00096616|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110160146|NCT00096616|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110160147|NCT00096616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110160148|NCT00096616|Adrenergic Agents|adrenergic agents|mesh-ancestor
110160149|NCT00096616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110160150|NCT00096616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160151|NCT00096655|Infliximab|infliximab|mesh-list
110160152|NCT00096655|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110160153|NCT00096655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110160154|NCT00096655|Dermatologic Agents|dermatologic agents|mesh-ancestor
110160155|NCT00096655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110160156|NCT00096655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110160157|NCT00096694|Levonorgestrel|levonorgestrel|mesh-list
110160158|NCT00096694|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110160159|NCT00096694|Contraceptive Agents|contraceptive agents|mesh-ancestor
110160160|NCT00096694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110160161|NCT00096694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110160162|NCT00096694|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110160163|NCT00096694|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110160164|NCT00096694|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110160165|NCT00006299|Celecoxib|celecoxib|mesh-list
110160166|NCT00006299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110160167|NCT00006299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110160168|NCT00006299|Analgesics|analgesics|mesh-ancestor
110160169|NCT00006299|Sensory System Agents|sensory system agents|mesh-ancestor
110160170|NCT00006299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110160171|NCT00006299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110160172|NCT00006299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110160173|NCT00006299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110160174|NCT00006299|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110160175|NCT00006299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110160176|NCT00006299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110160177|NCT00006299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160178|NCT00096811|Entecavir|entecavir|mesh-list
110160179|NCT00096811|Antiviral Agents|antiviral agents|mesh-ancestor
110160180|NCT00096811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110160181|NCT00096850|Ritonavir|ritonavir|mesh-list
110160182|NCT00096850|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110160183|NCT00096850|Rifampin|rifampin|mesh-list
110160184|NCT00096850|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110160185|NCT00096850|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110160186|NCT00096850|Protease Inhibitors|protease inhibitors|mesh-ancestor
110160187|NCT00096850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110160188|NCT00096850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160189|NCT00096850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110160190|NCT00096850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110160191|NCT00096850|Antiviral Agents|antiviral agents|mesh-ancestor
110160192|NCT00096850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110160193|NCT00096850|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110160194|NCT00096850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110160195|NCT00096850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110160196|NCT00096850|Antitubercular Agents|antitubercular agents|mesh-ancestor
110160197|NCT00096850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110160198|NCT00096850|Leprostatic Agents|leprostatic agents|mesh-ancestor
110160199|NCT00096850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110160200|NCT00096850|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110160201|NCT00096850|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110160202|NCT00096850|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110160203|NCT00096850|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110160204|NCT00096850|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110160205|NCT00096850|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110160207|NCT00096967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110160208|NCT00096967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110160209|NCT00096967|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110160210|NCT00096967|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110160211|NCT00096967|Growth Substances|growth substances|mesh-ancestor
110160212|NCT00096967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110160213|NCT00096967|Growth Inhibitors|growth inhibitors|mesh-ancestor
110160214|NCT04340076|Ixekizumab|ixekizumab|mesh-list
110160215|NCT04340076|Brodalumab|brodalumab|mesh-list
110160216|NCT04340076|Dermatologic Agents|dermatologic agents|mesh-ancestor
110160217|NCT00097045|Interferons|interferons|mesh-list
110160218|NCT00097045|Ribavirin|ribavirin|mesh-list
110160219|NCT00097045|Interferon omega 1|interferon omega 1|mesh-list
110160220|NCT00097045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110160221|NCT00097045|Antiviral Agents|antiviral agents|mesh-ancestor
110160222|NCT00097045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110160223|NCT00097045|Antimetabolites|antimetabolites|mesh-ancestor
110160224|NCT00097045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160225|NCT00097084|Insulin|insulin|mesh-list
110160226|NCT00097084|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110160227|NCT00097084|Insulin Glargine|insulin glargine|mesh-list
110160228|NCT00097084|Insulin Aspart|insulin aspart|mesh-list
110160229|NCT00097084|Insulin Detemir|insulin detemir|mesh-list
110160230|NCT00097084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110160231|NCT00097084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110160232|NCT04310709|Nivolumab|nivolumab|mesh-list
110160233|NCT04310709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110160234|NCT04310709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110160235|NCT04310709|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110160236|NCT04310709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160237|NCT00006320|Anti-HIV Agents|anti-hiv agents|mesh-list
110160238|NCT00006320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110160239|NCT00006320|Antiviral Agents|antiviral agents|mesh-ancestor
110160240|NCT00006320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110160241|NCT00097123|Misoprostol|misoprostol|mesh-list
110160242|NCT00097123|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110160243|NCT00097123|Abortifacient Agents|abortifacient agents|mesh-ancestor
110160244|NCT00097123|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110160245|NCT00097123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110160246|NCT00097123|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110160247|NCT00097123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110160249|NCT00097279|Metformin|metformin|mesh-list
110160250|NCT00097279|Pioglitazone|pioglitazone|mesh-list
110160251|NCT00097279|Insulin Aspart|insulin aspart|mesh-list
110160252|NCT00097279|Biphasic Insulins|biphasic insulins|mesh-list
110160253|NCT00097279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110160254|NCT00097279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110160255|NCT00390273|Metformin|metformin|mesh-list
110160256|NCT00390273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110160257|NCT00390273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110160258|NCT00097318|Interferons|interferons|mesh-list
110160259|NCT00097318|Interferon-beta|interferon-beta|mesh-list
110160260|NCT00097318|Interferon beta-1a|interferon beta-1a|mesh-list
110160261|NCT00097318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110160262|NCT00097318|Antiviral Agents|antiviral agents|mesh-ancestor
110160263|NCT00097318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110160264|NCT00097318|Immunologic Factors|immunologic factors|mesh-ancestor
110160265|NCT00097318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110160266|NCT00097318|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110160267|NCT00097435|Ribavirin|ribavirin|mesh-list
110160268|NCT00097435|Antimetabolites|antimetabolites|mesh-ancestor
110160269|NCT00097435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160270|NCT00097435|Antiviral Agents|antiviral agents|mesh-ancestor
110160271|NCT00097435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110160272|NCT00006326|Ritonavir|ritonavir|mesh-list
110160273|NCT00006326|Indinavir|indinavir|mesh-list
110160274|NCT00006326|Delavirdine|delavirdine|mesh-list
110160275|NCT00006326|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110160276|NCT00006326|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110160277|NCT00006326|Protease Inhibitors|protease inhibitors|mesh-ancestor
110160278|NCT00006326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110160279|NCT00006326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160280|NCT00006326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110160281|NCT00006326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110160282|NCT00006326|Antiviral Agents|antiviral agents|mesh-ancestor
110160283|NCT00006326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110160284|NCT00006326|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110160285|NCT00006326|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110160286|NCT00006326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110160287|NCT00006326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110160289|NCT00390312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110160290|NCT00390312|Narcotics|narcotics|mesh-ancestor
110160291|NCT00390312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110160292|NCT00390312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110160293|NCT00390312|Analgesics|analgesics|mesh-ancestor
110160294|NCT00390312|Sensory System Agents|sensory system agents|mesh-ancestor
110160295|NCT00390312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110160297|NCT00400387|Thiamine|thiamine|mesh-list
110160298|NCT00400387|Pyridoxine|pyridoxine|mesh-list
110160299|NCT00400387|Vitamin B 12|vitamin b 12|mesh-list
110160300|NCT00400387|Folic Acid|folic acid|mesh-list
110160301|NCT00400387|Vitamin B Complex|vitamin b complex|mesh-list
110160302|NCT00400387|Tocopherols|tocopherols|mesh-list
110160303|NCT00400387|Vitamin E|vitamin e|mesh-list
110160304|NCT00400387|Tocotrienols|tocotrienols|mesh-list
110160305|NCT00400387|alpha-Tocopherol|alpha-tocopherol|mesh-list
110160306|NCT00400387|Heparin|heparin|mesh-list
110160307|NCT00400387|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110160308|NCT00400387|Tinzaparin|tinzaparin|mesh-list
110160309|NCT00400387|Dalteparin|dalteparin|mesh-list
110160310|NCT00400387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110160311|NCT00400387|Anticoagulants|anticoagulants|mesh-ancestor
110160312|NCT00400387|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110160313|NCT00400387|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110160314|NCT00400387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160315|NCT00400387|Vitamins|vitamins|mesh-ancestor
110160316|NCT00400387|Micronutrients|micronutrients|mesh-ancestor
110160317|NCT00400387|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110160318|NCT00400387|Dermatologic Agents|dermatologic agents|mesh-ancestor
110160319|NCT00400387|Antioxidants|antioxidants|mesh-ancestor
110160320|NCT00400387|Protective Agents|protective agents|mesh-ancestor
110160321|NCT00400387|Hematinics|hematinics|mesh-ancestor
110160322|NCT00006332|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
110160323|NCT00006332|Chelating Agents|chelating agents|mesh-ancestor
110160324|NCT00006332|Sequestering Agents|sequestering agents|mesh-ancestor
110160325|NCT00006332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160326|NCT00006332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110160327|NCT00006332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110188315|NCT03589729|Razoxane|razoxane|mesh-list
110160328|NCT00006332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110160329|NCT00006332|Growth Substances|growth substances|mesh-ancestor
110160330|NCT00006332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110160331|NCT00006332|Growth Inhibitors|growth inhibitors|mesh-ancestor
110160332|NCT00006332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110160333|NCT00390390|Lansoprazole|lansoprazole|mesh-list
110160334|NCT00390390|Dexlansoprazole|dexlansoprazole|mesh-list
110160335|NCT00390390|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110160336|NCT00390390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110160337|NCT00390390|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110160338|NCT00390390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110160339|NCT00390390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160341|NCT00097825|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110160342|NCT00097825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110160343|NCT00097903|Camptothecin|camptothecin|mesh-list
110160344|NCT00097903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110160345|NCT00097903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110160346|NCT00097903|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110160347|NCT00097903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110160348|NCT00097903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110160349|NCT00097903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160350|NCT00097942|Memantine|memantine|mesh-list
110160352|NCT00097942|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110160353|NCT00097942|Dopamine Agents|dopamine agents|mesh-ancestor
110160354|NCT00097942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110160355|NCT00097942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160356|NCT00097942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110160357|NCT00097942|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110160358|NCT00097942|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110160359|NCT04294836|Curcumin|curcumin|mesh-list
110160360|NCT04294836|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110160361|NCT04294836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110160362|NCT04294836|Analgesics|analgesics|mesh-ancestor
110160363|NCT04294836|Sensory System Agents|sensory system agents|mesh-ancestor
110160364|NCT04294836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110160365|NCT04294836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110160366|NCT04294836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110160367|NCT04294836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110160368|NCT04294836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110160369|NCT04294836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110160370|NCT04294836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160372|NCT00098137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110160373|NCT00098137|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110160374|NCT00098137|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110160375|NCT00098137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160376|NCT00098488|Rituximab|rituximab|mesh-list
110160377|NCT00098488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110160378|NCT00098488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110160379|NCT00098488|Immunologic Factors|immunologic factors|mesh-ancestor
110160380|NCT00098488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110160381|NCT00098488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110160383|NCT00098527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110160384|NCT00098527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110160385|NCT00098527|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110160386|NCT00098527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110160387|NCT00098527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160388|NCT00006347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110160390|NCT00006347|Immunoglobulins|immunoglobulins|mesh-list
110160391|NCT00006347|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110160392|NCT00006347|Immunologic Factors|immunologic factors|mesh-ancestor
110160393|NCT00006347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110160394|NCT00006347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110160395|NCT00098605|Lapatinib|lapatinib|mesh-list
110160396|NCT00098605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110160397|NCT00098605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110160398|NCT00098605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110160399|NCT00098605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160400|NCT00098683|Amifostine|amifostine|mesh-list
110160401|NCT00098683|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110160402|NCT00098683|Protective Agents|protective agents|mesh-ancestor
110160403|NCT00098683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110160404|NCT00098800|Fenretinide|fenretinide|mesh-list
110160405|NCT00098800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110160406|NCT00098800|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110160407|NCT00098800|Protective Agents|protective agents|mesh-ancestor
110160408|NCT00098800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110160409|NCT00098878|Carboplatin|carboplatin|mesh-list
110160410|NCT00098878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110160411|NCT03633305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
110160412|NCT03633305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110160413|NCT03633305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110160414|NCT00098917|Vaccines|vaccines|mesh-list
110160415|NCT00098917|Immunologic Factors|immunologic factors|mesh-ancestor
110160416|NCT00098917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110160417|NCT00098995|Tirapazamine|tirapazamine|mesh-list
110160418|NCT00098995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110160419|NCT00099190|Beta-lapachone|beta-lapachone|mesh-list
110160420|NCT00099190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110160421|NCT00099190|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110160422|NCT00099190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110160423|NCT00099190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110160424|NCT00099190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160425|NCT00099190|Antiviral Agents|antiviral agents|mesh-ancestor
110160426|NCT00099502|Interferons|interferons|mesh-list
110160427|NCT00099502|Interferon-beta|interferon-beta|mesh-list
110160428|NCT00099502|Glatiramer Acetate|glatiramer acetate|mesh-list
110160429|NCT00099502|Interferon beta-1b|interferon beta-1b|mesh-list
110160430|NCT00099502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110160431|NCT00099502|Antiviral Agents|antiviral agents|mesh-ancestor
110160432|NCT00099502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110160433|NCT00099502|Immunologic Factors|immunologic factors|mesh-ancestor
110160434|NCT00099502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110160435|NCT00099502|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110160436|NCT00099502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110160437|NCT00099502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110160439|NCT00387920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110160440|NCT00387920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110188351|NCT03479307|Ketotifen|ketotifen|mesh-list
110160441|NCT00387920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110160442|NCT00387920|Growth Substances|growth substances|mesh-ancestor
110160443|NCT00387920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110160444|NCT00387920|Growth Inhibitors|growth inhibitors|mesh-ancestor
110160445|NCT00387920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110160446|NCT00387920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110160447|NCT00387920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160449|NCT00099541|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110160450|NCT00099541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110160452|NCT02888067|Rocuronium|rocuronium|mesh-list
110160453|NCT02888067|Anticonvulsants|anticonvulsants|mesh-ancestor
110160454|NCT02888067|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110160455|NCT02888067|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110160456|NCT02888067|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110160457|NCT02888067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110160458|NCT02888067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110160459|NCT00006350|Mycophenolic Acid|mycophenolic acid|mesh-list
110160461|NCT00006350|Daclizumab|daclizumab|mesh-list
110160462|NCT00006350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110160463|NCT00006350|Immunologic Factors|immunologic factors|mesh-ancestor
110160464|NCT00006350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110160465|NCT00006350|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110160466|NCT00006350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110160467|NCT00006350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160468|NCT00006350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110160469|NCT00006350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110160470|NCT00006350|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110160471|NCT00006350|Antitubercular Agents|antitubercular agents|mesh-ancestor
110160472|NCT00006350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110160473|NCT00006350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110160475|NCT00400582|Candesartan cilexetil|candesartan cilexetil|mesh-list
110160476|NCT00400582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110160477|NCT00400582|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110160478|NCT00400582|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110160479|NCT00400582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160480|NCT00400621|Acetaminophen|acetaminophen|mesh-list
110160481|NCT00400621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110160482|NCT00400621|Analgesics|analgesics|mesh-ancestor
110160483|NCT00400621|Sensory System Agents|sensory system agents|mesh-ancestor
110160484|NCT00400621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110160485|NCT00400621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110160486|NCT00400621|Antipyretics|antipyretics|mesh-ancestor
110160487|NCT00006353|Temozolomide|temozolomide|mesh-list
110160488|NCT00006353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110160489|NCT00006353|Alkylating Agents|alkylating agents|mesh-ancestor
110160490|NCT00006353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160491|NCT00006353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110160492|NCT00400738|Ritonavir|ritonavir|mesh-list
110160493|NCT00400738|Lopinavir|lopinavir|mesh-list
110160494|NCT00400738|Saquinavir|saquinavir|mesh-list
110160495|NCT00400738|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110160496|NCT00400738|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110160497|NCT00400738|Protease Inhibitors|protease inhibitors|mesh-ancestor
110160498|NCT00400738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110160499|NCT00400738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160500|NCT00400738|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110160501|NCT00400738|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110160502|NCT00400738|Antiviral Agents|antiviral agents|mesh-ancestor
110160503|NCT00400738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110160504|NCT00400738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110160505|NCT00400738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110160507|NCT00006356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110160508|NCT00099619|Insulin|insulin|mesh-list
110160509|NCT00099619|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110160510|NCT00099619|Insulin Glargine|insulin glargine|mesh-list
110160511|NCT00099619|Exenatide|exenatide|mesh-list
110160512|NCT00099619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110160513|NCT00099619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110160514|NCT00099619|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110160515|NCT00099619|Incretins|incretins|mesh-ancestor
110160516|NCT00099619|Hormones|hormones|mesh-ancestor
110160517|NCT00099619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110160518|NCT00006359|Androgen Antagonists|androgen antagonists|mesh-list
110160519|NCT00006359|Hormone Antagonists|hormone antagonists|mesh-ancestor
110160520|NCT00006359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110160521|NCT00006359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110160522|NCT00099736|Cyclosporine|cyclosporine|mesh-list
110160523|NCT00099736|Cyclosporins|cyclosporins|mesh-list
110160524|NCT00099736|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
110160525|NCT00099736|Antifungal Agents|antifungal agents|mesh-ancestor
110160526|NCT00099736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110160527|NCT00099736|Dermatologic Agents|dermatologic agents|mesh-ancestor
110160528|NCT00099736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110160529|NCT00099736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160530|NCT00099736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110160531|NCT00099736|Immunologic Factors|immunologic factors|mesh-ancestor
110160532|NCT00099736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110160533|NCT00099736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110160534|NCT00099736|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110160535|NCT00099736|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110160537|NCT04143711|Nivolumab|nivolumab|mesh-list
110160538|NCT04143711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110160539|NCT04143711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110160540|NCT04143711|Tubulin Modulators|tubulin modulators|mesh-ancestor
110160541|NCT04143711|Antimitotic Agents|antimitotic agents|mesh-ancestor
110160542|NCT04143711|Mitosis Modulators|mitosis modulators|mesh-ancestor
110160543|NCT04143711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160544|NCT04143711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110160545|NCT04143711|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110160546|NCT00099775|Caspofungin|caspofungin|mesh-list
110160547|NCT00099775|Antifungal Agents|antifungal agents|mesh-ancestor
110160548|NCT00099775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110160549|NCT00099775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110160550|NCT00099775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160552|NCT00006362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110160553|NCT00099892|Vildagliptin|vildagliptin|mesh-list
110160554|NCT00099892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110160555|NCT00099892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110160556|NCT00099892|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110160557|NCT00099892|Protease Inhibitors|protease inhibitors|mesh-ancestor
110160559|NCT00099892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160560|NCT00099931|Vildagliptin|vildagliptin|mesh-list
110160561|NCT00099931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110160562|NCT00099931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110160563|NCT00099931|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110160564|NCT00099931|Protease Inhibitors|protease inhibitors|mesh-ancestor
110160565|NCT00099931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110160566|NCT00099931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160567|NCT00099970|Dacarbazine|dacarbazine|mesh-list
110160568|NCT00099970|Volociximab|volociximab|mesh-list
110160569|NCT00099970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110160570|NCT00099970|Alkylating Agents|alkylating agents|mesh-ancestor
110160571|NCT00099970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160572|NCT00099970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110160573|NCT00099970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110160574|NCT00099970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110160575|NCT00099970|Growth Substances|growth substances|mesh-ancestor
110160576|NCT00099970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110160579|NCT00100009|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110160580|NCT00100009|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110160581|NCT00100009|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110160582|NCT00100009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110160583|NCT00100009|Glucocorticoids|glucocorticoids|mesh-ancestor
110160584|NCT00100009|Hormones|hormones|mesh-ancestor
110160585|NCT00100009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110160586|NCT00100009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110160587|NCT00100009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110160588|NCT00100009|Immunologic Factors|immunologic factors|mesh-ancestor
110160589|NCT00100009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110160590|NCT00100009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160591|NCT00100126|Amoxicillin|amoxicillin|mesh-list
110160592|NCT00100126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110160593|NCT00100126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110160594|NCT00100243|Abarelix|abarelix|mesh-list
110160595|NCT00100243|Hormone Antagonists|hormone antagonists|mesh-ancestor
110160596|NCT00100243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110160597|NCT00100243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110160598|NCT04071756|Tazarotene|tazarotene|mesh-list
110160599|NCT04071756|Dermatologic Agents|dermatologic agents|mesh-ancestor
110160600|NCT04071756|Keratolytic Agents|keratolytic agents|mesh-ancestor
110160601|NCT00006368|Edotreotide|edotreotide|mesh-list
110160602|NCT00006368|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110160603|NCT00006368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160604|NCT00100477|Etoposide|etoposide|mesh-list
110160605|NCT00100477|Mitoxantrone|mitoxantrone|mesh-list
110160606|NCT00100477|Topotecan|topotecan|mesh-list
110160607|NCT00100477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110160608|NCT00100477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110160609|NCT00100477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110160610|NCT00100477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110160611|NCT00100477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110160612|NCT00100477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160613|NCT00100477|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110160614|NCT00100477|Analgesics|analgesics|mesh-ancestor
110160615|NCT00100477|Sensory System Agents|sensory system agents|mesh-ancestor
110160616|NCT00100477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110160617|NCT00100477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110160618|NCT00100555|Zoledronic Acid|zoledronic acid|mesh-list
110160619|NCT00100555|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110160620|NCT00100555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110160621|NCT00006371|Ketoconazole|ketoconazole|mesh-list
110160622|NCT00006371|Hydrocortisone|hydrocortisone|mesh-list
110160623|NCT00006371|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110160624|NCT00006371|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110160625|NCT00006371|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110160626|NCT00006371|Aminoglutethimide|aminoglutethimide|mesh-list
110160627|NCT00006371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110160628|NCT00006371|Antifungal Agents|antifungal agents|mesh-ancestor
110160629|NCT00006371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110160630|NCT00006371|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110160631|NCT00006371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110160632|NCT00006371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110160633|NCT00006371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160634|NCT00006371|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110160635|NCT00006371|Hormone Antagonists|hormone antagonists|mesh-ancestor
110160636|NCT00006371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110160637|NCT00006371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110160638|NCT00006371|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110160639|NCT00006371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110160647|NCT00100594|Zidovudine|zidovudine|mesh-list
110160648|NCT00100594|Efavirenz|efavirenz|mesh-list
110160649|NCT00100594|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
110160650|NCT00100594|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110160651|NCT00100594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110160652|NCT00100594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110160653|NCT00100594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160655|NCT00100594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110160656|NCT00100594|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110160657|NCT00100594|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110160658|NCT00100594|Antimetabolites|antimetabolites|mesh-ancestor
110160659|NCT00100594|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110160660|NCT00100594|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110160661|NCT00100594|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110160662|NCT00100594|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110160663|NCT00100594|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110160664|NCT00100594|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110160665|NCT00006374|Paclitaxel|paclitaxel|mesh-list
110160666|NCT00006374|Etoposide|etoposide|mesh-list
110160667|NCT00006374|Topotecan|topotecan|mesh-list
110160668|NCT00006374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110160669|NCT00006374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110160670|NCT00006374|Tubulin Modulators|tubulin modulators|mesh-ancestor
110160671|NCT00006374|Antimitotic Agents|antimitotic agents|mesh-ancestor
110160672|NCT00006374|Mitosis Modulators|mitosis modulators|mesh-ancestor
110160673|NCT00006374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160674|NCT00006374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110160675|NCT00006374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110160676|NCT00006374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110160677|NCT00006374|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110160679|NCT00100750|Tipifarnib|tipifarnib|mesh-list
110160680|NCT00100750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110160681|NCT00100750|Antimetabolites|antimetabolites|mesh-ancestor
110160682|NCT00100750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160683|NCT00100750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110160684|NCT00006377|Paclitaxel|paclitaxel|mesh-list
110160685|NCT00006377|Carboplatin|carboplatin|mesh-list
110160686|NCT00006377|Doxorubicin|doxorubicin|mesh-list
110160687|NCT00006377|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110160688|NCT00006377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110160689|NCT00006377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110160690|NCT00006377|Tubulin Modulators|tubulin modulators|mesh-ancestor
110160691|NCT00006377|Antimitotic Agents|antimitotic agents|mesh-ancestor
110160692|NCT00006377|Mitosis Modulators|mitosis modulators|mesh-ancestor
110160693|NCT00006377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160694|NCT00006377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110160695|NCT00006377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110160696|NCT00006377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110160697|NCT00006377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110160698|NCT01350102|Ascorbic Acid|ascorbic acid|mesh-list
110160699|NCT01350102|Bacitracin|bacitracin|mesh-list
110160700|NCT01350102|Vitamins|vitamins|mesh-ancestor
110160701|NCT01350102|Micronutrients|micronutrients|mesh-ancestor
110160702|NCT01350102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110160703|NCT01350102|Antioxidants|antioxidants|mesh-ancestor
110160704|NCT01350102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160705|NCT01350102|Protective Agents|protective agents|mesh-ancestor
110160706|NCT01350102|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110160707|NCT01350102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110160708|NCT01350102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110160710|NCT00424060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110160711|NCT00006380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110160712|NCT00006380|Antibodies|antibodies|mesh-list
110160713|NCT00006380|Immunoglobulins|immunoglobulins|mesh-list
110160714|NCT00006380|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110160715|NCT00006380|Immunologic Factors|immunologic factors|mesh-ancestor
110160716|NCT00006380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110160717|NCT00006380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110160718|NCT00100906|Aldesleukin|aldesleukin|mesh-list
110160719|NCT00100906|Interleukin-2|interleukin-2|mesh-list
110160720|NCT00100906|Tretinoin|tretinoin|mesh-list
110160721|NCT00100906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110160722|NCT00100906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110160723|NCT00100906|Analgesics|analgesics|mesh-ancestor
110160724|NCT00100906|Sensory System Agents|sensory system agents|mesh-ancestor
110160725|NCT00100906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110160726|NCT00100906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110160727|NCT00100906|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110160728|NCT00100906|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110160729|NCT00100906|Antiviral Agents|antiviral agents|mesh-ancestor
110160730|NCT00100906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110160731|NCT00100906|Keratolytic Agents|keratolytic agents|mesh-ancestor
110160732|NCT00100906|Dermatologic Agents|dermatologic agents|mesh-ancestor
110160734|NCT00100945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110160735|NCT00100945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110160736|NCT00100945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110160737|NCT00100945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160738|NCT00006383|Vincristine|vincristine|mesh-list
110160739|NCT00006383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110160740|NCT00006383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110160741|NCT00006383|Tubulin Modulators|tubulin modulators|mesh-ancestor
110160742|NCT00006383|Antimitotic Agents|antimitotic agents|mesh-ancestor
110160743|NCT00006383|Mitosis Modulators|mitosis modulators|mesh-ancestor
110160744|NCT00006383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160745|NCT00100984|Enfuvirtide|enfuvirtide|mesh-list
110160746|NCT00100984|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110160747|NCT00100984|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110160748|NCT00100984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160749|NCT00100984|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110160750|NCT00100984|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110160751|NCT00100984|Antiviral Agents|antiviral agents|mesh-ancestor
110160752|NCT00100984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110160754|NCT00101062|Letrozole|letrozole|mesh-list
110160755|NCT00101062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110160756|NCT00101062|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110160757|NCT00101062|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110160758|NCT00101062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110160759|NCT00101062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160760|NCT00101062|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110160761|NCT00101062|Hormone Antagonists|hormone antagonists|mesh-ancestor
110188536|NCT02511418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110160762|NCT00101062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110160763|NCT00101062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110160764|NCT00101062|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110160765|NCT00101062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110160766|NCT00101062|Analgesics|analgesics|mesh-ancestor
110160767|NCT00101062|Sensory System Agents|sensory system agents|mesh-ancestor
110160768|NCT00101062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110160769|NCT00101062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110160770|NCT00101062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110160771|NCT00101062|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110160772|NCT00101062|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110160774|NCT00006386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110160775|NCT00006386|Alkylating Agents|alkylating agents|mesh-ancestor
110160776|NCT00006386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160777|NCT00006386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110160778|NCT00101140|Fludarabine|fludarabine|mesh-list
110160779|NCT00101140|Fludarabine phosphate|fludarabine phosphate|mesh-list
110160780|NCT00101140|Thiotepa|thiotepa|mesh-list
110160781|NCT00101140|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110160782|NCT00101140|Immunomodulating Agents|immunomodulating agents|mesh-list
110160783|NCT00101140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110160784|NCT00101140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110160785|NCT00101140|Antimetabolites|antimetabolites|mesh-ancestor
110160786|NCT00101140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160787|NCT00101140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110160788|NCT00101140|Immunologic Factors|immunologic factors|mesh-ancestor
110160789|NCT00101140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110160790|NCT00101140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110160791|NCT00101140|Alkylating Agents|alkylating agents|mesh-ancestor
110160792|NCT00101140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110160793|NCT00101179|Azacitidine|azacitidine|mesh-list
110160794|NCT00101179|Entinostat|entinostat|mesh-list
110160795|NCT00101179|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
110160796|NCT00101179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110160798|NCT00101179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160799|NCT00101179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110160800|NCT00101179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110160801|NCT00400777|Amlodipine|amlodipine|mesh-list
110160802|NCT00400777|Valsartan|valsartan|mesh-list
110160803|NCT00400777|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110160804|NCT00400777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110160805|NCT00400777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110160806|NCT00400777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110160807|NCT00400777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160808|NCT00400777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110160809|NCT00400777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110160810|NCT00400777|Vasodilator Agents|vasodilator agents|mesh-ancestor
110160811|NCT00400777|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110160812|NCT00400777|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110160813|NCT00400777|Diuretics|diuretics|mesh-ancestor
110160814|NCT00400777|Natriuretic Agents|natriuretic agents|mesh-ancestor
110160815|NCT00400777|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110160816|NCT00400816|Temozolomide|temozolomide|mesh-list
110160817|NCT00400816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110160818|NCT00400816|Alkylating Agents|alkylating agents|mesh-ancestor
110160819|NCT00400816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160820|NCT00400816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110160822|NCT00400855|Xhance|xhance|mesh-list
110160823|NCT00400855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110160824|NCT00400855|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110160825|NCT00400855|Autonomic Agents|autonomic agents|mesh-ancestor
110160826|NCT00400855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110160827|NCT00400855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110160828|NCT00400855|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110160829|NCT00400855|Respiratory System Agents|respiratory system agents|mesh-ancestor
110160830|NCT00400855|Dermatologic Agents|dermatologic agents|mesh-ancestor
110160831|NCT00400855|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110160832|NCT00101296|Tipifarnib|tipifarnib|mesh-list
110160833|NCT00101296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110160834|NCT00006398|Timolol|timolol|mesh-list
110160835|NCT00006398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160836|NCT00006398|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110160840|NCT00006398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110160841|NCT00006398|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110160842|NCT00006398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110160844|NCT00101335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110160845|NCT00101335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110160847|NCT00101335|Sensory System Agents|sensory system agents|mesh-ancestor
110160848|NCT00101335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110160849|NCT00101335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110160850|NCT00101335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110160851|NCT00101335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110160852|NCT00101335|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110160853|NCT00101335|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110160854|NCT00101335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110160855|NCT00101335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160856|NCT00101374|Leflunomide|leflunomide|mesh-list
110160857|NCT00101374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110160858|NCT00101374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160859|NCT00101374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110160860|NCT00101374|Immunologic Factors|immunologic factors|mesh-ancestor
110160861|NCT00101374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110160863|NCT00006401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110160864|NCT00006401|Autonomic Agents|autonomic agents|mesh-ancestor
110160865|NCT00006401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110160866|NCT00006401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110160867|NCT00006401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110160868|NCT00006401|Respiratory System Agents|respiratory system agents|mesh-ancestor
110160869|NCT00006401|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110160870|NCT00006401|Antioxidants|antioxidants|mesh-ancestor
110160871|NCT00006401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160872|NCT00006401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110160873|NCT00006401|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110160874|NCT00006401|Vasodilator Agents|vasodilator agents|mesh-ancestor
110160876|NCT00006401|Protective Agents|protective agents|mesh-ancestor
110160877|NCT00101569|Aripiprazole|aripiprazole|mesh-list
110160878|NCT00101569|Antidepressive Agents|antidepressive agents|mesh-ancestor
110160879|NCT00101569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110160880|NCT00101569|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110160881|NCT00101569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110160882|NCT00101569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110160883|NCT00101569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110160884|NCT00101569|Dopamine Agonists|dopamine agonists|mesh-ancestor
110160885|NCT00101569|Dopamine Agents|dopamine agents|mesh-ancestor
110160886|NCT00101569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110160887|NCT00101569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160888|NCT00101569|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110160889|NCT00101569|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110160890|NCT00101569|Serotonin Agents|serotonin agents|mesh-ancestor
110160891|NCT00101569|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110160892|NCT00101569|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110160893|NCT00101569|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110160894|NCT00101569|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110160895|NCT00101764|Triamcinolone|triamcinolone|mesh-list
110160896|NCT00101764|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110160897|NCT00101764|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110160898|NCT00101764|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110160899|NCT00101764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110160900|NCT00101764|Glucocorticoids|glucocorticoids|mesh-ancestor
110160901|NCT00101764|Hormones|hormones|mesh-ancestor
110160902|NCT00101764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110160903|NCT00101764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110160905|NCT00101764|Immunologic Factors|immunologic factors|mesh-ancestor
110160906|NCT00101764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110160907|NCT00101764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160909|NCT00101803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110160910|NCT00101803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110160911|NCT00101803|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110160912|NCT00101803|Protease Inhibitors|protease inhibitors|mesh-ancestor
110160913|NCT00101803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110160914|NCT00101803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160917|NCT00101842|Cisplatin|cisplatin|mesh-list
110160918|NCT00101842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110160919|NCT00101842|Antimetabolites|antimetabolites|mesh-ancestor
110160920|NCT00101842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160921|NCT00101842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110160922|NCT00101842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110160923|NCT00101842|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110160924|NCT00101842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110160925|NCT00102115|Talaporfin|talaporfin|mesh-list
110160926|NCT00102115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110160927|NCT00102115|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110160928|NCT00102115|Dermatologic Agents|dermatologic agents|mesh-ancestor
110160929|NCT00102154|Gaboxadol|gaboxadol|mesh-list
110160930|NCT00102154|Analgesics|analgesics|mesh-ancestor
110160931|NCT00102154|Sensory System Agents|sensory system agents|mesh-ancestor
110160932|NCT00102154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110160933|NCT00102154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110160934|NCT00102154|Anticonvulsants|anticonvulsants|mesh-ancestor
110160935|NCT00102154|GABA Agonists|gaba agonists|mesh-ancestor
110160936|NCT00102154|GABA Agents|gaba agents|mesh-ancestor
110160937|NCT00102154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110160938|NCT00102154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160939|NCT00102271|Oxypurinol|oxypurinol|mesh-list
110160940|NCT00102271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110160941|NCT00102271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160942|NCT00102310|Z 338|z 338|mesh-list
110160944|NCT00102310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110160945|NCT00102310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160946|NCT00102310|Cholinergic Agents|cholinergic agents|mesh-ancestor
110160947|NCT00102310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110160948|NCT00102310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110160949|NCT00102310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110160951|NCT00102388|Gliclazide|gliclazide|mesh-list
110160952|NCT00102388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110160953|NCT00102388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110160954|NCT00102388|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110160955|NCT00102388|Protease Inhibitors|protease inhibitors|mesh-ancestor
110160956|NCT00102388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110160957|NCT00102388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160958|NCT00102505|Motexafin gadolinium|motexafin gadolinium|mesh-list
110160959|NCT00102505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110160960|NCT00102505|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110160961|NCT00102505|Dermatologic Agents|dermatologic agents|mesh-ancestor
110160962|NCT00102583|Cyclosporine|cyclosporine|mesh-list
110160963|NCT00102583|Cyclosporins|cyclosporins|mesh-list
110160964|NCT00102583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110160965|NCT00102583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160966|NCT00102583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110160967|NCT00102583|Immunologic Factors|immunologic factors|mesh-ancestor
110160969|NCT00102583|Antifungal Agents|antifungal agents|mesh-ancestor
110160970|NCT00102583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110160971|NCT00102583|Dermatologic Agents|dermatologic agents|mesh-ancestor
110160972|NCT00102583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110160973|NCT00102583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110160975|NCT00102622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110160976|NCT00102622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110160977|NCT00102622|Tubulin Modulators|tubulin modulators|mesh-ancestor
110160978|NCT00102622|Antimitotic Agents|antimitotic agents|mesh-ancestor
110160979|NCT00102622|Mitosis Modulators|mitosis modulators|mesh-ancestor
110160980|NCT00102622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160982|NCT00006428|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110160983|NCT00006428|Antidepressive Agents|antidepressive agents|mesh-ancestor
110160984|NCT00006428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110160985|NCT00006428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110160986|NCT00006428|Analgesics|analgesics|mesh-ancestor
110160987|NCT00006428|Sensory System Agents|sensory system agents|mesh-ancestor
110160988|NCT00006428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110160989|NCT00006428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110160990|NCT00006428|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110160991|NCT00006428|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110160992|NCT00006428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110160993|NCT00006428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160994|NCT00006428|Adrenergic Agents|adrenergic agents|mesh-ancestor
110160995|NCT00006428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110160996|NCT00102661|Alemtuzumab|alemtuzumab|mesh-list
110160997|NCT00102661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110160998|NCT00102661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110160999|NCT00102700|Beta-lapachone|beta-lapachone|mesh-list
110161000|NCT00102700|Gemcitabine|gemcitabine|mesh-list
110161001|NCT00102700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110161002|NCT00102700|Antimetabolites|antimetabolites|mesh-ancestor
110161003|NCT00102700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110161004|NCT00102700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110161005|NCT00102700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110161006|NCT00102700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110161007|NCT00102700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110161008|NCT00102700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110161009|NCT00102700|Antiviral Agents|antiviral agents|mesh-ancestor
110161011|NCT00102778|Lopinavir|lopinavir|mesh-list
110161012|NCT00102778|Aplaviroc|aplaviroc|mesh-list
110161013|NCT00102778|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110161014|NCT00102778|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110161015|NCT00102778|Protease Inhibitors|protease inhibitors|mesh-ancestor
110161016|NCT00102778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110161017|NCT00102778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110161018|NCT00102778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110161019|NCT00102778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110161020|NCT00102778|Antiviral Agents|antiviral agents|mesh-ancestor
110161021|NCT00102778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110161022|NCT00102778|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110161023|NCT00102778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110161024|NCT00102778|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110161026|NCT00101998|Alvimopan|alvimopan|mesh-list
110161028|NCT00102856|Pramipexole|pramipexole|mesh-list
110161029|NCT00102856|Rivastigmine|rivastigmine|mesh-list
110161030|NCT00102856|Antioxidants|antioxidants|mesh-ancestor
110161031|NCT00102856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110161032|NCT00102856|Protective Agents|protective agents|mesh-ancestor
110161033|NCT00102856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110161034|NCT00102856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110161035|NCT00102856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110161036|NCT00102856|Dopamine Agonists|dopamine agonists|mesh-ancestor
110161037|NCT00102856|Dopamine Agents|dopamine agents|mesh-ancestor
110161038|NCT00102856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110161039|NCT00102856|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110161040|NCT00102856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110161041|NCT00102856|Cholinergic Agents|cholinergic agents|mesh-ancestor
110161042|NCT00102856|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110161043|NCT00102934|Enfuvirtide|enfuvirtide|mesh-list
110161044|NCT00102934|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110161045|NCT00102934|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110161046|NCT00102934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110161047|NCT00102934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110161048|NCT00102934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110161049|NCT00102934|Antiviral Agents|antiviral agents|mesh-ancestor
110161050|NCT00102934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110161051|NCT00006443|Lamivudine|lamivudine|mesh-list
110161052|NCT00006443|Stavudine|stavudine|mesh-list
110161053|NCT00006443|Nelfinavir|nelfinavir|mesh-list
110161054|NCT00006443|Indinavir|indinavir|mesh-list
110161055|NCT00006443|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110161056|NCT00006443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110161057|NCT00006443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110161058|NCT00006443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110161059|NCT00006443|Antiviral Agents|antiviral agents|mesh-ancestor
110161060|NCT00006443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110161061|NCT00006443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110161062|NCT00006443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110161063|NCT00006443|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110161064|NCT00006443|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110161065|NCT00006443|Protease Inhibitors|protease inhibitors|mesh-ancestor
110161066|NCT00006443|Antimetabolites|antimetabolites|mesh-ancestor
110161067|NCT00102973|Carboplatin|carboplatin|mesh-list
110161069|NCT00102973|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110161070|NCT00102973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110161071|NCT00102973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110161072|NCT00102973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110161073|NCT00102973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110161074|NCT00102973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110161075|NCT00102973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110161076|NCT00103051|Gemcitabine|gemcitabine|mesh-list
110161077|NCT00103051|Gefitinib|gefitinib|mesh-list
110161078|NCT00103051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110161079|NCT00103051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110161080|NCT00103051|Antimetabolites|antimetabolites|mesh-ancestor
110161081|NCT00103051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110161082|NCT00103051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110188680|NCT00018824|Naltrexone|naltrexone|mesh-list
110161083|NCT00103051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110161084|NCT00103168|Imatinib Mesylate|imatinib mesylate|mesh-list
110161085|NCT00103168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110161086|NCT00103168|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110161087|NCT00103168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110161088|NCT00103168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110161090|NCT02697474|Immunologic Factors|immunologic factors|mesh-ancestor
110161091|NCT02697474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110161094|NCT00103246|Trace Elements|trace elements|mesh-ancestor
110161095|NCT00103246|Micronutrients|micronutrients|mesh-ancestor
110161096|NCT00103246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110161097|NCT00103246|Antimalarials|antimalarials|mesh-ancestor
110161098|NCT00103246|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110161099|NCT00103246|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110161100|NCT00103246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110161101|NCT00103246|Antiviral Agents|antiviral agents|mesh-ancestor
110161102|NCT00103246|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110161103|NCT00103246|Dermatologic Agents|dermatologic agents|mesh-ancestor
110161104|NCT00103324|Lapatinib|lapatinib|mesh-list
110161105|NCT00103324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110161106|NCT00103324|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110161107|NCT00103324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110161108|NCT00103324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110161109|NCT00103519|3,5-diiodothyropropionic acid|3,5-diiodothyropropionic acid|mesh-list
110161110|NCT00103519|Hormones|hormones|mesh-ancestor
110161111|NCT00103519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110161112|NCT00103519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110161113|NCT00103597|Fludrocortisone|fludrocortisone|mesh-list
110161114|NCT00103597|Domperidone|domperidone|mesh-list
110161115|NCT00103597|Antiemetics|antiemetics|mesh-ancestor
110161116|NCT00103597|Autonomic Agents|autonomic agents|mesh-ancestor
110161117|NCT00103597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110161118|NCT00103597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110161119|NCT00103597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110161120|NCT00103597|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110161121|NCT00103597|Dopamine Agents|dopamine agents|mesh-ancestor
110161122|NCT00103597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110161123|NCT00103597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110161124|NCT00103597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110161125|NCT00006449|Naltrexone|naltrexone|mesh-list
110161126|NCT00006449|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110161127|NCT00006449|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110161128|NCT00006449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110161129|NCT00006449|Sensory System Agents|sensory system agents|mesh-ancestor
110161130|NCT00006449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110161131|NCT00103753|Deferiprone|deferiprone|mesh-list
110161132|NCT00103753|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110161133|NCT00103753|Chelating Agents|chelating agents|mesh-ancestor
110161134|NCT00103753|Sequestering Agents|sequestering agents|mesh-ancestor
110161135|NCT00103753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110161136|NCT00006452|Motexafin gadolinium|motexafin gadolinium|mesh-list
110161137|NCT00006452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110161138|NCT00006452|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110161139|NCT00006452|Dermatologic Agents|dermatologic agents|mesh-ancestor
110161140|NCT00103792|Mycophenolic Acid|mycophenolic acid|mesh-list
110161141|NCT00103792|Cyclophosphamide|cyclophosphamide|mesh-list
110161142|NCT00103792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110161143|NCT00103792|Immunologic Factors|immunologic factors|mesh-ancestor
110161144|NCT00103792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110161145|NCT00103792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110161146|NCT00103792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110161147|NCT00103792|Alkylating Agents|alkylating agents|mesh-ancestor
110161148|NCT00103792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110161149|NCT00103792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110161150|NCT00103792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110161151|NCT00103792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110161152|NCT00103792|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110161153|NCT00103792|Antitubercular Agents|antitubercular agents|mesh-ancestor
110161154|NCT00103792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110161155|NCT00103792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110161156|NCT00103792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110161158|NCT00103948|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110161159|NCT00103948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110161160|NCT00103948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110161161|NCT00103948|Cholinergic Agents|cholinergic agents|mesh-ancestor
110161162|NCT00103948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110161163|NCT00103948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110161165|NCT00006458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110161167|NCT00006458|Immunoglobulins|immunoglobulins|mesh-list
110161168|NCT00006458|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110161169|NCT00006458|Immunologic Factors|immunologic factors|mesh-ancestor
110161170|NCT00006458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110161171|NCT00006458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110161174|NCT03879408|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
110161175|NCT03879408|Hydrocodone|hydrocodone|mesh-list
110161176|NCT03879408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110161177|NCT03879408|Analgesics|analgesics|mesh-ancestor
110161178|NCT03879408|Sensory System Agents|sensory system agents|mesh-ancestor
110161179|NCT03879408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110161180|NCT03879408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110161181|NCT03879408|Antipyretics|antipyretics|mesh-ancestor
110161182|NCT03879408|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110161183|NCT03879408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110161184|NCT03879408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110161186|NCT03879408|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110161187|NCT03879408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110161188|NCT03879408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110161190|NCT03879408|Narcotics|narcotics|mesh-ancestor
110161191|NCT03879408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110161192|NCT03879408|Antitussive Agents|antitussive agents|mesh-ancestor
110161193|NCT03879408|Respiratory System Agents|respiratory system agents|mesh-ancestor
110161194|NCT00104182|Insulin|insulin|mesh-list
110161195|NCT00104182|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110161196|NCT00104182|Insulin Detemir|insulin detemir|mesh-list
110161197|NCT00104182|Isophane Insulin, Human|isophane insulin, human|mesh-list
110161198|NCT00104182|Insulin, Isophane|insulin, isophane|mesh-list
110161199|NCT00104182|Isophane insulin, beef|isophane insulin, beef|mesh-list
110161200|NCT00104182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110161201|NCT00104182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110161202|NCT00104260|Verapamil|verapamil|mesh-list
110161203|NCT00104260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110161204|NCT00104260|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110161205|NCT00104260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110161206|NCT00104260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110161207|NCT00104260|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110161208|NCT00104260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110161209|NCT00104260|Vasodilator Agents|vasodilator agents|mesh-ancestor
110161211|NCT00388076|Carboplatin|carboplatin|mesh-list
110161212|NCT00388076|Lapatinib|lapatinib|mesh-list
110161213|NCT00388076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110161214|NCT00388076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110161215|NCT00388076|Tubulin Modulators|tubulin modulators|mesh-ancestor
110161216|NCT00388076|Antimitotic Agents|antimitotic agents|mesh-ancestor
110161217|NCT00388076|Mitosis Modulators|mitosis modulators|mesh-ancestor
110161218|NCT00388076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110161219|NCT00388076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110161221|NCT00104689|Capecitabine|capecitabine|mesh-list
110161222|NCT00104689|Oxaliplatin|oxaliplatin|mesh-list
110161223|NCT00104689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110161224|NCT00104689|Antimetabolites|antimetabolites|mesh-ancestor
110161225|NCT00104689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110161226|NCT00104689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110161227|NCT00006461|Cyclophosphamide|cyclophosphamide|mesh-list
110161228|NCT00006461|Etoposide|etoposide|mesh-list
110161229|NCT00006461|Vincristine|vincristine|mesh-list
110161230|NCT00006461|Etoposide phosphate|etoposide phosphate|mesh-list
110161234|NCT00006461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110161235|NCT00006461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110161236|NCT00006461|Alkylating Agents|alkylating agents|mesh-ancestor
110161237|NCT00006461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110161238|NCT00006461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110161239|NCT00006461|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110161240|NCT00006461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110161241|NCT00006461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110161242|NCT00006461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110161243|NCT00006461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110161244|NCT00006461|Tubulin Modulators|tubulin modulators|mesh-ancestor
110161245|NCT00006461|Antimitotic Agents|antimitotic agents|mesh-ancestor
110161246|NCT00006461|Mitosis Modulators|mitosis modulators|mesh-ancestor
110161247|NCT00104767|Celecoxib|celecoxib|mesh-list
110161248|NCT00104767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110161249|NCT00104767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110161250|NCT00104767|Analgesics|analgesics|mesh-ancestor
110161251|NCT00104767|Sensory System Agents|sensory system agents|mesh-ancestor
110161252|NCT00104767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110161253|NCT00104767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110161254|NCT00104767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110161255|NCT00104767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110161256|NCT00104767|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110161257|NCT00104767|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110161258|NCT00104767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110161259|NCT00104767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110161260|NCT02972268|Tamsulosin|tamsulosin|mesh-list
110161261|NCT02972268|Solifenacin Succinate|solifenacin succinate|mesh-list
110161262|NCT02972268|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110161263|NCT02972268|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110161264|NCT02972268|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110161265|NCT02972268|Adrenergic Agents|adrenergic agents|mesh-ancestor
110161266|NCT02972268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110161267|NCT02972268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110161268|NCT02972268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110161269|NCT02972268|Urological Agents|urological agents|mesh-ancestor
110161270|NCT02972268|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110161271|NCT02972268|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110161272|NCT02972268|Cholinergic Agents|cholinergic agents|mesh-ancestor
110161273|NCT00104806|Cholecalciferol|cholecalciferol|mesh-list
110161274|NCT00104806|Vitamin D|vitamin d|mesh-list
110161275|NCT00104806|Arsenic Trioxide|arsenic trioxide|mesh-list
110161276|NCT00104806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110161277|NCT00104806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110161278|NCT00104806|Vitamins|vitamins|mesh-ancestor
110161279|NCT00104806|Micronutrients|micronutrients|mesh-ancestor
110161280|NCT00104806|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110161281|NCT00104806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110161282|NCT00401128|Gemcitabine|gemcitabine|mesh-list
110161283|NCT00401128|Irinotecan|irinotecan|mesh-list
110161284|NCT00401128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110161285|NCT00401128|Antimetabolites|antimetabolites|mesh-ancestor
110161286|NCT00401128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110161287|NCT00401128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110161288|NCT00401128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110161289|NCT00401128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110161290|NCT00401128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110161292|NCT00401167|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110161293|NCT00401167|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110161294|NCT00401167|Dopamine Agents|dopamine agents|mesh-ancestor
110161295|NCT00401167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110161296|NCT00401167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110161297|NCT00401167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110161298|NCT00401167|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110161299|NCT00401167|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110161300|NCT00006464|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
110161301|NCT00006464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110161302|NCT00006464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110161303|NCT00006464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110161304|NCT00006464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110161306|NCT00104845|Immunologic Factors|immunologic factors|mesh-ancestor
110161307|NCT00104845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110161308|NCT00104923|Fenretinide|fenretinide|mesh-list
110161309|NCT00104923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110161310|NCT00104923|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110161311|NCT00104923|Protective Agents|protective agents|mesh-ancestor
110161312|NCT00104923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110161313|NCT00104962|Lenalidomide|lenalidomide|mesh-list
110161314|NCT00104962|Immunologic Factors|immunologic factors|mesh-ancestor
110161315|NCT00104962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110161316|NCT00104962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110161317|NCT00104962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110161318|NCT00104962|Growth Substances|growth substances|mesh-ancestor
110161319|NCT00104962|Growth Inhibitors|growth inhibitors|mesh-ancestor
110161320|NCT00104962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110161322|NCT00006467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110161323|NCT00006467|Antimetabolites|antimetabolites|mesh-ancestor
110161324|NCT00006467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110161325|NCT00006467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110161326|NCT00105040|Levetiracetam|levetiracetam|mesh-list
110161327|NCT00105040|Anticonvulsants|anticonvulsants|mesh-ancestor
110161328|NCT00105040|Nootropic Agents|nootropic agents|mesh-ancestor
110161329|NCT00006470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110161330|NCT00006470|Vaccines|vaccines|mesh-list
110161331|NCT00006470|Antibodies|antibodies|mesh-list
110161332|NCT00006470|Immunoglobulins|immunoglobulins|mesh-list
110161333|NCT00006470|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110161334|NCT00006470|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
110161335|NCT00006470|Immunologic Factors|immunologic factors|mesh-ancestor
110161336|NCT00006470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110161337|NCT00006470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110161339|NCT00105352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110161340|NCT00105352|Hormones|hormones|mesh-ancestor
110161341|NCT00105352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110161342|NCT00105352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110161344|NCT03862950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110161345|NCT03862950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110161346|NCT00105547|Flurbiprofen|flurbiprofen|mesh-list
110161347|NCT00105547|Tarenflurbil|tarenflurbil|mesh-list
110161348|NCT00105547|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
110161349|NCT00105547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110161350|NCT00105547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110161352|NCT00105547|Sensory System Agents|sensory system agents|mesh-ancestor
110161353|NCT00105547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110161354|NCT00105547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110161356|NCT00105547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110161357|NCT00105547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110161358|NCT00105547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110161359|NCT00105547|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110161360|NCT00390624|Mannitol|mannitol|mesh-list
110161361|NCT00390624|Ularitide|ularitide|mesh-list
110161362|NCT00390624|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110161363|NCT00390624|Diuretics|diuretics|mesh-ancestor
110161364|NCT00390624|Natriuretic Agents|natriuretic agents|mesh-ancestor
110161365|NCT00390624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110161366|NCT00390624|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110161367|NCT00390624|Autonomic Agents|autonomic agents|mesh-ancestor
110161368|NCT00390624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110161369|NCT00390624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110161370|NCT00390624|Respiratory System Agents|respiratory system agents|mesh-ancestor
110161371|NCT00006473|Oxaliplatin|oxaliplatin|mesh-list
110161372|NCT00006473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110161373|NCT00006476|Suramin|suramin|mesh-list
110161375|NCT00006476|Anthelmintics|anthelmintics|mesh-ancestor
110161376|NCT00006476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110161377|NCT00006476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110161378|NCT00006476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110161379|NCT00006476|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110161380|NCT00006476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110161382|NCT00105937|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110161383|NCT00105937|Narcotics|narcotics|mesh-ancestor
110161384|NCT00105937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110161385|NCT00105937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110161386|NCT00105937|Analgesics|analgesics|mesh-ancestor
110161387|NCT00105937|Sensory System Agents|sensory system agents|mesh-ancestor
110161388|NCT00105937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110161389|NCT00105937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110161390|NCT00105937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110161391|NCT00105937|Anesthetics, General|anesthetics, general|mesh-ancestor
110161392|NCT00105937|Anesthetics|anesthetics|mesh-ancestor
110161393|NCT00006479|Leucovorin|leucovorin|mesh-list
110161394|NCT00006479|Fluorouracil|fluorouracil|mesh-list
110161395|NCT00006479|Oxaliplatin|oxaliplatin|mesh-list
110161396|NCT00006479|Calcium|calcium|mesh-list
110161398|NCT00006479|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110161399|NCT00006479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110161400|NCT00006479|Antimetabolites|antimetabolites|mesh-ancestor
110161401|NCT00006479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110161402|NCT00006479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110161403|NCT00006479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110161404|NCT00006479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110161405|NCT00006479|Immunologic Factors|immunologic factors|mesh-ancestor
110161406|NCT00006479|Antidotes|antidotes|mesh-ancestor
110161407|NCT00006479|Protective Agents|protective agents|mesh-ancestor
110161408|NCT00006479|Vitamin B Complex|vitamin b complex|mesh-ancestor
110161409|NCT00006479|Vitamins|vitamins|mesh-ancestor
110161410|NCT00006479|Micronutrients|micronutrients|mesh-ancestor
110161411|NCT00106054|Leucovorin|leucovorin|mesh-list
110161412|NCT00106054|Bevacizumab|bevacizumab|mesh-list
110161413|NCT00106054|Irinotecan|irinotecan|mesh-list
110161414|NCT00106054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110161415|NCT00106054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110161416|NCT00106054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110161417|NCT00106054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110161418|NCT00106054|Growth Substances|growth substances|mesh-ancestor
110161419|NCT00106054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110161420|NCT00106054|Growth Inhibitors|growth inhibitors|mesh-ancestor
110161422|NCT00106054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110161423|NCT00106054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110161424|NCT00106054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110161425|NCT00106054|Antidotes|antidotes|mesh-ancestor
110161426|NCT00106054|Protective Agents|protective agents|mesh-ancestor
110161427|NCT00106054|Vitamin B Complex|vitamin b complex|mesh-ancestor
110161428|NCT00106054|Vitamins|vitamins|mesh-ancestor
110161429|NCT00106054|Micronutrients|micronutrients|mesh-ancestor
110161430|NCT00106132|Triamcinolone|triamcinolone|mesh-list
110161431|NCT00106132|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110161432|NCT00106132|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110161433|NCT00106132|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110161434|NCT00106132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110161437|NCT00106132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110161438|NCT00106132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110161439|NCT00106132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110161440|NCT00106132|Immunologic Factors|immunologic factors|mesh-ancestor
110161441|NCT00106132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110161442|NCT00106132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110161443|NCT03815682|Pembrolizumab|pembrolizumab|mesh-list
110161444|NCT03815682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110161445|NCT03815682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110161446|NCT03815682|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110161447|NCT03815682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110161448|NCT00106288|Amphotericin B|amphotericin b|mesh-list
110161449|NCT00106288|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110161450|NCT00106288|Micafungin|micafungin|mesh-list
110161451|NCT00106288|Amebicides|amebicides|mesh-ancestor
110161452|NCT00106288|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110161453|NCT00106288|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110161454|NCT00106288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110161455|NCT00106288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110161456|NCT00106288|Antifungal Agents|antifungal agents|mesh-ancestor
110161457|NCT00006482|Gemcitabine|gemcitabine|mesh-list
110161458|NCT00006482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110161459|NCT00006482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110161460|NCT00006482|Antimetabolites|antimetabolites|mesh-ancestor
110161461|NCT00006482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110161462|NCT00106366|Insulin|insulin|mesh-list
110161463|NCT00106366|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110161464|NCT00106366|Insulin Glargine|insulin glargine|mesh-list
110161465|NCT00106366|Insulin Aspart|insulin aspart|mesh-list
110161466|NCT00106366|Insulin Detemir|insulin detemir|mesh-list
110161467|NCT00106366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110161468|NCT00106366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110161469|NCT00106405|Memantine|memantine|mesh-list
110161470|NCT00106405|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110161471|NCT00106405|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110161472|NCT00106405|Dopamine Agents|dopamine agents|mesh-ancestor
110161473|NCT00106405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110161474|NCT00106405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110161475|NCT00106405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110161476|NCT00106405|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110161477|NCT00106405|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110161478|NCT00006485|Irinotecan|irinotecan|mesh-list
110161479|NCT00006485|Alvocidib|alvocidib|mesh-list
110161480|NCT00006485|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110161481|NCT00006485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110161482|NCT00006485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110161483|NCT00006485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110161484|NCT00006485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110161485|NCT00006485|Growth Inhibitors|growth inhibitors|mesh-ancestor
110161486|NCT00006485|Growth Substances|growth substances|mesh-ancestor
110161487|NCT00006485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110161488|NCT00006485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110161492|NCT00106522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110161493|NCT00106522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110161494|NCT00106522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110161495|NCT00106522|Antimetabolites|antimetabolites|mesh-ancestor
110161496|NCT00106522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110161497|NCT00106522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110161498|NCT00106522|Dermatologic Agents|dermatologic agents|mesh-ancestor
110161499|NCT00106522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110161500|NCT00106522|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110161501|NCT00106522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110161502|NCT00106522|Immunologic Factors|immunologic factors|mesh-ancestor
110161503|NCT00106522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110161504|NCT00106522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110161506|NCT00106561|Spironolactone|spironolactone|mesh-list
110161507|NCT00106561|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110161508|NCT00106561|Hormone Antagonists|hormone antagonists|mesh-ancestor
110161509|NCT00106561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110161510|NCT00106561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110161511|NCT00106561|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110161512|NCT00106561|Diuretics|diuretics|mesh-ancestor
110161513|NCT00106561|Natriuretic Agents|natriuretic agents|mesh-ancestor
110161514|NCT00106561|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110161515|NCT00106561|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110161516|NCT00106561|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110161517|NCT00106561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110161518|NCT00401206|Dexmedetomidine|dexmedetomidine|mesh-list
110161519|NCT00401206|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110161520|NCT00401206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110161521|NCT00401206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110161522|NCT00401206|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110161523|NCT00401206|Analgesics|analgesics|mesh-ancestor
110161524|NCT00401206|Sensory System Agents|sensory system agents|mesh-ancestor
110161525|NCT00401206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110161526|NCT00401206|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110161527|NCT00401206|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110161528|NCT00401206|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110161529|NCT00401206|Adrenergic Agents|adrenergic agents|mesh-ancestor
110161530|NCT00401206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110161531|NCT00401206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110161532|NCT00401323|Docetaxel|docetaxel|mesh-list
110161533|NCT00401323|Fluorouracil|fluorouracil|mesh-list
110161534|NCT00401323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110161535|NCT00401323|Tubulin Modulators|tubulin modulators|mesh-ancestor
110161536|NCT00401323|Antimitotic Agents|antimitotic agents|mesh-ancestor
110161537|NCT00401323|Mitosis Modulators|mitosis modulators|mesh-ancestor
110161538|NCT00401323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110161540|NCT00401323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110161541|NCT00401323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110161542|NCT00401323|Immunologic Factors|immunologic factors|mesh-ancestor
110161543|NCT00401323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110161545|NCT00401362|Methylnaltrexone|methylnaltrexone|mesh-list
110161546|NCT00401362|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110161547|NCT00401362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110161548|NCT00401362|Sensory System Agents|sensory system agents|mesh-ancestor
110161549|NCT00401362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110161550|NCT00401362|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110161552|NCT00106834|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110161553|NCT00106834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110161554|NCT00106834|Dermatologic Agents|dermatologic agents|mesh-ancestor
110161555|NCT00106834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110161556|NCT00106834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110161557|NCT00107107|Pramlintide|pramlintide|mesh-list
110161558|NCT00107107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110161559|NCT00107107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110161560|NCT00107263|Zoledronic Acid|zoledronic acid|mesh-list
110161561|NCT00107263|Letrozole|letrozole|mesh-list
110161562|NCT00107263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110161563|NCT00107263|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110161564|NCT00107263|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110161565|NCT00107263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110161566|NCT00107263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110161567|NCT00107263|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110161568|NCT00107263|Hormone Antagonists|hormone antagonists|mesh-ancestor
110161569|NCT00107263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110161570|NCT00107263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110161571|NCT00107263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110161572|NCT02964949|Edoxaban|edoxaban|mesh-list
110161573|NCT02964949|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110161574|NCT02964949|Antithrombins|antithrombins|mesh-ancestor
110161575|NCT02964949|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110161576|NCT02964949|Protease Inhibitors|protease inhibitors|mesh-ancestor
110161577|NCT02964949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110161578|NCT02964949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110161579|NCT02964949|Anticoagulants|anticoagulants|mesh-ancestor
110161580|NCT00107341|Paclitaxel|paclitaxel|mesh-list
110161581|NCT00107341|Carboplatin|carboplatin|mesh-list
110161582|NCT00107341|Bortezomib|bortezomib|mesh-list
110161583|NCT00107341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110161584|NCT00107341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110161585|NCT00107341|Tubulin Modulators|tubulin modulators|mesh-ancestor
110161587|NCT00107341|Mitosis Modulators|mitosis modulators|mesh-ancestor
110161588|NCT00107341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110161589|NCT00107419|Pemetrexed|pemetrexed|mesh-list
110161590|NCT00107419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110161591|NCT00107419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110161592|NCT00107419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110161593|NCT00107419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110161594|NCT00107419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110161595|NCT03683667|Azithromycin|azithromycin|mesh-list
110161596|NCT03683667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110161597|NCT03683667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110161598|NCT00006578|Ritonavir|ritonavir|mesh-list
110161599|NCT00006578|Amprenavir|amprenavir|mesh-list
110161600|NCT00006578|Lamivudine|lamivudine|mesh-list
110161601|NCT00006578|Abacavir|abacavir|mesh-list
110161602|NCT00006578|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110161603|NCT00006578|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110161605|NCT00006578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110161606|NCT00006578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110161607|NCT00006578|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110161608|NCT00006578|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110161609|NCT00006578|Antiviral Agents|antiviral agents|mesh-ancestor
110161610|NCT00006578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110161611|NCT00006578|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110161612|NCT00006578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110161613|NCT00006578|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110161614|NCT00006578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110161615|NCT00006578|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110161616|NCT00006578|Antitubercular Agents|antitubercular agents|mesh-ancestor
110161617|NCT00006578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110161618|NCT00107458|Valproic Acid|valproic acid|mesh-list
110161619|NCT00107458|Anticonvulsants|anticonvulsants|mesh-ancestor
110161620|NCT00107458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110161621|NCT00107458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110161622|NCT00107458|GABA Agents|gaba agents|mesh-ancestor
110161623|NCT00107458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110161624|NCT00107458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110161625|NCT00107458|Antimanic Agents|antimanic agents|mesh-ancestor
110161626|NCT00107458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110161627|NCT00107458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110161628|NCT00107458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110161629|NCT00006617|Lamivudine|lamivudine|mesh-list
110161630|NCT00006617|Zidovudine|zidovudine|mesh-list
110161631|NCT00006617|Abacavir|abacavir|mesh-list
110161632|NCT00006617|Amprenavir|amprenavir|mesh-list
110161633|NCT00006617|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110161634|NCT00006617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110161635|NCT00006617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110161636|NCT00006617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110161637|NCT00006617|Antiviral Agents|antiviral agents|mesh-ancestor
110161638|NCT00006617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110161639|NCT00006617|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110161640|NCT00006617|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110161641|NCT00006617|Antimetabolites|antimetabolites|mesh-ancestor
110161642|NCT00006617|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110161643|NCT00006617|Antitubercular Agents|antitubercular agents|mesh-ancestor
110161644|NCT00006617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110161645|NCT00006617|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110161646|NCT00006617|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110161647|NCT00006617|Protease Inhibitors|protease inhibitors|mesh-ancestor
110161648|NCT00107731|Valproic Acid|valproic acid|mesh-list
110161649|NCT00107731|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110161650|NCT00107731|Antidepressive Agents|antidepressive agents|mesh-ancestor
110161651|NCT00107731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110161652|NCT00107731|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110161653|NCT00107731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110161654|NCT00107731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110161655|NCT00107731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110161656|NCT00107731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110161657|NCT00107731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110161658|NCT00107731|Antimanic Agents|antimanic agents|mesh-ancestor
110161659|NCT00107731|Anticonvulsants|anticonvulsants|mesh-ancestor
110161660|NCT00107731|GABA Agents|gaba agents|mesh-ancestor
110161661|NCT00107731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110161662|NCT04712396|Itraconazole|itraconazole|mesh-list
110161663|NCT04712396|Antifungal Agents|antifungal agents|mesh-ancestor
110161665|NCT04712396|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110161666|NCT04712396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110161668|NCT04712396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110161669|NCT04712396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110161670|NCT04712396|Hormone Antagonists|hormone antagonists|mesh-ancestor
110161671|NCT04712396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110161672|NCT04712396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110161673|NCT04712396|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110161674|NCT00107770|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
110161675|NCT00107770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110161676|NCT00107809|Modafinil|modafinil|mesh-list
110161677|NCT00107809|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110161678|NCT00107809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110161679|NCT00107809|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110161680|NCT00107809|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110161681|NCT00107809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110161682|NCT00107809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110161683|NCT00006656|Ethanol|ethanol|mesh-list
110161684|NCT00006656|Carmustine|carmustine|mesh-list
110161685|NCT00006656|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110161686|NCT00006656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110161687|NCT00006656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110161688|NCT00006656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110161689|NCT00006656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110161690|NCT00006656|Alkylating Agents|alkylating agents|mesh-ancestor
110161691|NCT00006656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110161692|NCT00006656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110161693|NCT03667482|Cetuximab|cetuximab|mesh-list
110161694|NCT03667482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110161695|NCT03667482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110161697|NCT00107848|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110161698|NCT00107848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110161699|NCT00107848|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110161700|NCT00107848|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110161701|NCT00107848|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110161702|NCT00107848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110161703|NCT00006695|Iodine|iodine|mesh-list
110161704|NCT00006695|Cytarabine|cytarabine|mesh-list
110161705|NCT00006695|Etoposide|etoposide|mesh-list
110161706|NCT00006695|Melphalan|melphalan|mesh-list
110161707|NCT00006695|Carmustine|carmustine|mesh-list
110161708|NCT00006695|Tositumomab I-131|tositumomab i-131|mesh-list
110161709|NCT00006695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110161710|NCT00006695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110161711|NCT00006695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110161712|NCT00006695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110161713|NCT00006695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110161714|NCT00006695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110161715|NCT00006695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110161716|NCT00006695|Antimetabolites|antimetabolites|mesh-ancestor
110161717|NCT00006695|Antiviral Agents|antiviral agents|mesh-ancestor
110161718|NCT00006695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110161719|NCT00006695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110161720|NCT00006695|Immunologic Factors|immunologic factors|mesh-ancestor
110161721|NCT00006695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110161722|NCT00006695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110161723|NCT00006695|Alkylating Agents|alkylating agents|mesh-ancestor
110161724|NCT00006695|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110161725|NCT00006695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110161726|NCT00006695|Trace Elements|trace elements|mesh-ancestor
110161734|NCT00108238|Estrogens|estrogens|mesh-ancestor
110161735|NCT00108238|Hormones|hormones|mesh-ancestor
110161736|NCT00108238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110161737|NCT00108238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110161738|NCT00108238|Progestins|progestins|mesh-ancestor
110161739|NCT00108238|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110161740|NCT00108238|Hormone Antagonists|hormone antagonists|mesh-ancestor
110161741|NCT00108238|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110161742|NCT00108238|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110161743|NCT00108238|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110161744|NCT03625323|Pembrolizumab|pembrolizumab|mesh-list
110161745|NCT03625323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110161746|NCT03625323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110161747|NCT03625323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110161748|NCT03625323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110161749|NCT00108316|Fluoxetine|fluoxetine|mesh-list
110161750|NCT00108316|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110161751|NCT00108316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110161752|NCT00108316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110161753|NCT00108316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110161754|NCT00108316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110161755|NCT00108316|Serotonin Agents|serotonin agents|mesh-ancestor
110161756|NCT00108316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110161757|NCT00108316|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110161758|NCT00108316|Antidepressive Agents|antidepressive agents|mesh-ancestor
110161759|NCT00108316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110161760|NCT00108316|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110161761|NCT00108316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110161762|NCT00108316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110161763|NCT00108394|Pamidronate|pamidronate|mesh-list
110161764|NCT00108394|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110161765|NCT00108394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110161766|NCT00108511|Gemfibrozil|gemfibrozil|mesh-list
110161767|NCT00108511|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110161768|NCT00108511|Antimetabolites|antimetabolites|mesh-ancestor
110188806|NCT00039117|Oblimersen|oblimersen|mesh-list
110161769|NCT00108511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110161770|NCT00108511|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110161771|NCT00108511|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110161772|NCT00108511|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110161774|NCT00401440|Misoprostol|misoprostol|mesh-list
110161775|NCT00401440|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110161776|NCT00401440|Abortifacient Agents|abortifacient agents|mesh-ancestor
110161777|NCT00401440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110161778|NCT00401440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110161781|NCT00401440|Oxytocics|oxytocics|mesh-ancestor
110161782|NCT00108667|Levodopa|levodopa|mesh-list
110161783|NCT00108667|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110161784|NCT00108667|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110161785|NCT00108667|Dopamine Agents|dopamine agents|mesh-ancestor
110161786|NCT00108667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110161787|NCT00108667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110161788|NCT00108667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110161789|NCT00006773|Bortezomib|bortezomib|mesh-list
110161790|NCT00006773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110161791|NCT00108706|Candesartan|candesartan|mesh-list
110161792|NCT00108706|Candesartan cilexetil|candesartan cilexetil|mesh-list
110161793|NCT00108706|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110161794|NCT00108706|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110161795|NCT00108706|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110161796|NCT00108706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110161797|NCT00006812|Capecitabine|capecitabine|mesh-list
110161798|NCT00006812|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110161799|NCT00006812|Antimetabolites|antimetabolites|mesh-ancestor
110161800|NCT00006812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110161801|NCT00006812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110161802|NCT00006890|Thalidomide|thalidomide|mesh-list
110161803|NCT00006890|Prednisone|prednisone|mesh-list
110161804|NCT00006890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110161805|NCT00006890|Glucocorticoids|glucocorticoids|mesh-ancestor
110161806|NCT00006890|Hormones|hormones|mesh-ancestor
110161807|NCT00006890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110161808|NCT00006890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110161809|NCT00006890|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110161810|NCT00006890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110161811|NCT00006890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110161812|NCT00006890|Immunologic Factors|immunologic factors|mesh-ancestor
110161813|NCT00006890|Leprostatic Agents|leprostatic agents|mesh-ancestor
110161814|NCT00006890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110161815|NCT00006890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110161816|NCT00006890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110161817|NCT00006890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110161818|NCT00006890|Growth Substances|growth substances|mesh-ancestor
110161819|NCT00006890|Growth Inhibitors|growth inhibitors|mesh-ancestor
110161820|NCT00108979|Escitalopram|escitalopram|mesh-list
110161821|NCT00108979|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110161822|NCT00108979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110161823|NCT00108979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110161824|NCT00108979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110161825|NCT00108979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110161826|NCT00108979|Serotonin Agents|serotonin agents|mesh-ancestor
110161827|NCT00108979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110161828|NCT03608397|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110161829|NCT03608397|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110161830|NCT03608397|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110161831|NCT03608397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110161832|NCT03608397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110161833|NCT03608397|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110161834|NCT03608397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110161835|NCT03608397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110161836|NCT03608397|Cholinergic Agents|cholinergic agents|mesh-ancestor
110161837|NCT03608397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110161838|NCT00109057|Bevacizumab|bevacizumab|mesh-list
110161839|NCT00109057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110161840|NCT00109057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110161842|NCT00109057|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110161844|NCT00109057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110161845|NCT00109057|Growth Inhibitors|growth inhibitors|mesh-ancestor
110161846|NCT00109096|Pemetrexed|pemetrexed|mesh-list
110161847|NCT00109096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110161848|NCT00109096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110161849|NCT00109096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110161850|NCT00109096|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110161851|NCT00109096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110161852|NCT00109135|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
110161853|NCT00109135|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110161854|NCT00109135|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110161855|NCT00109135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110161856|NCT00109135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110161857|NCT00109135|Hormones|hormones|mesh-ancestor
110161858|NCT00109135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110161859|NCT00109135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110161860|NCT00006929|Suramin|suramin|mesh-list
110161861|NCT00006929|Paclitaxel|paclitaxel|mesh-list
110161862|NCT00006929|Carboplatin|carboplatin|mesh-list
110161863|NCT00006929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110161864|NCT00006929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110161865|NCT00006929|Tubulin Modulators|tubulin modulators|mesh-ancestor
110161866|NCT00006929|Antimitotic Agents|antimitotic agents|mesh-ancestor
110161867|NCT00006929|Mitosis Modulators|mitosis modulators|mesh-ancestor
110161868|NCT00006929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110161869|NCT00006929|Antinematodal Agents|antinematodal agents|mesh-ancestor
110161870|NCT00006929|Anthelmintics|anthelmintics|mesh-ancestor
110161871|NCT00006929|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110161872|NCT00006929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110161873|NCT00006929|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110161874|NCT00006929|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110161875|NCT00006968|Cyclosporine|cyclosporine|mesh-list
110161876|NCT00006968|Pentostatin|pentostatin|mesh-list
110161877|NCT00006968|Cyclosporins|cyclosporins|mesh-list
110161878|NCT00006968|Immunologic Factors|immunologic factors|mesh-ancestor
110161879|NCT00006968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110161880|NCT00006968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110161881|NCT00006968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110161882|NCT00006968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110161883|NCT00006968|Antifungal Agents|antifungal agents|mesh-ancestor
110161884|NCT00006968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110161885|NCT00006968|Dermatologic Agents|dermatologic agents|mesh-ancestor
110161886|NCT00006968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110161887|NCT00006968|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110161888|NCT00006968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110161889|NCT00006968|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
110161890|NCT00109408|Methotrexate|methotrexate|mesh-list
110161891|NCT00109408|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110161892|NCT00109408|Abortifacient Agents|abortifacient agents|mesh-ancestor
110161893|NCT00109408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110161894|NCT00109408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110161895|NCT00109408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110161896|NCT00109408|Antimetabolites|antimetabolites|mesh-ancestor
110161897|NCT00109408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110161898|NCT00109408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110161899|NCT00109408|Dermatologic Agents|dermatologic agents|mesh-ancestor
110161900|NCT00109408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110161901|NCT00109408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110161902|NCT00109408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110161903|NCT00109408|Immunologic Factors|immunologic factors|mesh-ancestor
110161904|NCT00109408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110161905|NCT00109408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110161906|NCT00109564|Acetylcholine|acetylcholine|mesh-list
110161907|NCT00109564|Nicotinic Agonists|nicotinic agonists|mesh-list
110161908|NCT00109564|Vasodilator Agents|vasodilator agents|mesh-ancestor
110161909|NCT00109564|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110161910|NCT00109564|Cholinergic Agents|cholinergic agents|mesh-ancestor
110161911|NCT00109564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110161912|NCT00109564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110161913|NCT00109564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110161914|NCT00109603|Tenofovir|tenofovir|mesh-list
110161915|NCT00109603|Antiviral Agents|antiviral agents|mesh-ancestor
110161916|NCT00109603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110161917|NCT00109603|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110161918|NCT00109603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110161919|NCT00109603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110161920|NCT00109603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110161921|NCT00109603|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110161922|NCT00109603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110161923|NCT00109798|Temozolomide|temozolomide|mesh-list
110161924|NCT00109798|Topotecan|topotecan|mesh-list
110161925|NCT00109798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110161926|NCT00109798|Alkylating Agents|alkylating agents|mesh-ancestor
110161927|NCT00109798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110188882|NCT00019409|Hormones|hormones|mesh-ancestor
110161928|NCT00109798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110161929|NCT00109798|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110161930|NCT00109798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110161931|NCT00109798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110161932|NCT00109954|Cisplatin|cisplatin|mesh-list
110161933|NCT00109954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110161934|NCT00109993|Methylprednisolone|methylprednisolone|mesh-list
110161935|NCT00109993|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110161936|NCT00109993|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110161937|NCT00109993|Prednisolone|prednisolone|mesh-list
110161938|NCT00109993|Prednisolone acetate|prednisolone acetate|mesh-list
110161939|NCT00109993|Alemtuzumab|alemtuzumab|mesh-list
110161940|NCT00109993|Tacrolimus|tacrolimus|mesh-list
110161941|NCT00109993|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110161942|NCT00109993|Prednisolone phosphate|prednisolone phosphate|mesh-list
110161943|NCT00109993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110161944|NCT00109993|Immunologic Factors|immunologic factors|mesh-ancestor
110161945|NCT00109993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110161946|NCT00109993|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110161947|NCT00109993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110161948|NCT00109993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110161949|NCT00109993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110161950|NCT00109993|Antiemetics|antiemetics|mesh-ancestor
110161951|NCT00109993|Autonomic Agents|autonomic agents|mesh-ancestor
110161952|NCT00109993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110161953|NCT00109993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110161954|NCT00109993|Glucocorticoids|glucocorticoids|mesh-ancestor
110161955|NCT00109993|Hormones|hormones|mesh-ancestor
110161956|NCT00109993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110161957|NCT00109993|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110161958|NCT00109993|Protective Agents|protective agents|mesh-ancestor
110161959|NCT00109993|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110161960|NCT00109993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110161961|NCT00109993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110161963|NCT00110032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110161964|NCT00110071|Iodine|iodine|mesh-list
110161965|NCT00110071|Cadexomer iodine|cadexomer iodine|mesh-list
110161966|NCT00110071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110161967|NCT00110071|Fludarabine|fludarabine|mesh-list
110161968|NCT00110071|Fludarabine phosphate|fludarabine phosphate|mesh-list
110161969|NCT00110071|Tositumomab I-131|tositumomab i-131|mesh-list
110161971|NCT00110071|Immunoglobulins|immunoglobulins|mesh-list
110161972|NCT00110071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110161973|NCT00110071|Immunologic Factors|immunologic factors|mesh-ancestor
110161974|NCT00110071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110161975|NCT00110071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110161976|NCT00110071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110161977|NCT00110071|Antimetabolites|antimetabolites|mesh-ancestor
110161978|NCT00110071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110161979|NCT00110071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110161980|NCT00110071|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110161981|NCT00110071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110161982|NCT00110071|Trace Elements|trace elements|mesh-ancestor
110161983|NCT00110071|Micronutrients|micronutrients|mesh-ancestor
110161985|NCT00110188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110161986|NCT00110188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110161987|NCT00110188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110161988|NCT00110188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110161989|NCT00110188|Antifungal Agents|antifungal agents|mesh-ancestor
110161990|NCT00110188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110161991|NCT00110188|Immunologic Factors|immunologic factors|mesh-ancestor
110161992|NCT00110188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110161993|NCT00007202|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110161995|NCT00007202|Didanosine|didanosine|mesh-list
110161996|NCT00007202|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110188886|NCT00019409|Abortifacient Agents|abortifacient agents|mesh-ancestor
110161997|NCT00007202|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110161998|NCT00007202|Protease Inhibitors|protease inhibitors|mesh-ancestor
110161999|NCT00007202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110162000|NCT00007202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110162002|NCT00007202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110162003|NCT00007202|Antiviral Agents|antiviral agents|mesh-ancestor
110162004|NCT00007202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110162005|NCT00007202|Antimetabolites|antimetabolites|mesh-ancestor
110162006|NCT00007202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110162007|NCT00007202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110162008|NCT00110344|Sorafenib|sorafenib|mesh-list
110162009|NCT00110344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110162010|NCT00110344|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110162011|NCT00110344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110162012|NCT00110344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110162013|NCT00401479|Solabegron|solabegron|mesh-list
110162014|NCT00401479|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110162015|NCT00401479|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110162016|NCT00401479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110162017|NCT00401479|Adrenergic Agents|adrenergic agents|mesh-ancestor
110162018|NCT00401479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110162019|NCT00401479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110162020|NCT00401479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110162022|NCT00110578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110162023|NCT00110578|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110162024|NCT00110578|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110162025|NCT00110578|Antiviral Agents|antiviral agents|mesh-ancestor
110162026|NCT00110578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110162027|NCT00388193|Rituximab|rituximab|mesh-list
110162028|NCT00388193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110162029|NCT00388193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110162030|NCT00388193|Immunologic Factors|immunologic factors|mesh-ancestor
110162031|NCT00388193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110162032|NCT00388193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110162034|NCT00110695|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110162035|NCT00110695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110162036|NCT00110695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110162037|NCT00110695|Tubulin Modulators|tubulin modulators|mesh-ancestor
110162038|NCT00110695|Antimitotic Agents|antimitotic agents|mesh-ancestor
110162039|NCT00110695|Mitosis Modulators|mitosis modulators|mesh-ancestor
110162040|NCT00110695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110162041|NCT00110734|Lidocaine|lidocaine|mesh-list
110162042|NCT00110734|Tetracaine|tetracaine|mesh-list
110162043|NCT00110734|Anesthetics, Local|anesthetics, local|mesh-ancestor
110162044|NCT00110734|Anesthetics|anesthetics|mesh-ancestor
110162045|NCT00110734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110162046|NCT00110734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110162047|NCT00110734|Sensory System Agents|sensory system agents|mesh-ancestor
110162049|NCT00110734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110162050|NCT00110734|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110162051|NCT00110734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110162052|NCT00110734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110162053|NCT00110734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110162054|NCT00110773|Lidocaine|lidocaine|mesh-list
110162055|NCT00110773|Tetracaine|tetracaine|mesh-list
110162056|NCT00110773|Anesthetics, Local|anesthetics, local|mesh-ancestor
110162057|NCT00110773|Anesthetics|anesthetics|mesh-ancestor
110162058|NCT00110773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110162059|NCT00110773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110162060|NCT00110773|Sensory System Agents|sensory system agents|mesh-ancestor
110162061|NCT00110773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110162062|NCT00110773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110162063|NCT00110773|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110162065|NCT00110773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110162066|NCT00110773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110162068|NCT00110851|Rosiglitazone|rosiglitazone|mesh-list
110162069|NCT00110851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110162070|NCT00110851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110162071|NCT00110929|Cinacalcet|cinacalcet|mesh-list
110162072|NCT00110929|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110162073|NCT00110929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110162074|NCT00110929|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
110162075|NCT00110929|Hormone Antagonists|hormone antagonists|mesh-ancestor
110162076|NCT00110929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110162077|NCT00111046|Ibuprofen|ibuprofen|mesh-list
110162078|NCT00111046|Tramadol|tramadol|mesh-list
110162079|NCT00111046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110162081|NCT00111046|Analgesics|analgesics|mesh-ancestor
110162082|NCT00111046|Sensory System Agents|sensory system agents|mesh-ancestor
110162083|NCT00111046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110162084|NCT00111046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110162085|NCT00111046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110162086|NCT00111046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110162087|NCT00111046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110162088|NCT00111046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110162089|NCT00111046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110162090|NCT00111046|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110162091|NCT00111046|Narcotics|narcotics|mesh-ancestor
110162092|NCT00111046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110162093|NCT00388271|Alfuzosin|alfuzosin|mesh-list
110162094|NCT00388271|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110162095|NCT00388271|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110162096|NCT00388271|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110162097|NCT00388271|Adrenergic Agents|adrenergic agents|mesh-ancestor
110162098|NCT00388271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110162099|NCT00388271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110162100|NCT00388271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110162101|NCT00388271|Urological Agents|urological agents|mesh-ancestor
110162102|NCT00111124|Etanercept|etanercept|mesh-list
110162103|NCT00111124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110162104|NCT00111124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110162105|NCT00111124|Analgesics|analgesics|mesh-ancestor
110162106|NCT00111124|Sensory System Agents|sensory system agents|mesh-ancestor
110162107|NCT00111124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110162108|NCT00111124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110162109|NCT00111124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110162110|NCT00111124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110162111|NCT00111124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110162115|NCT00111163|Pyrimethamine|pyrimethamine|mesh-list
110162116|NCT00111163|Sulfadoxine|sulfadoxine|mesh-list
110162117|NCT00111163|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110162118|NCT00111163|Amodiaquine|amodiaquine|mesh-list
110162119|NCT00111163|Dapsone|dapsone|mesh-list
110162120|NCT00111163|Chlorproguanil|chlorproguanil|mesh-list
110162121|NCT00111163|Antimalarials|antimalarials|mesh-ancestor
110162122|NCT00111163|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110162123|NCT00111163|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110162124|NCT00111163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110162125|NCT00111163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110162126|NCT00111163|Antiviral Agents|antiviral agents|mesh-ancestor
110162127|NCT00111163|Schistosomicides|schistosomicides|mesh-ancestor
110162128|NCT00111163|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110162129|NCT00111163|Anthelmintics|anthelmintics|mesh-ancestor
110188903|NCT00019448|Interleukin-2|interleukin-2|mesh-list
110162130|NCT00111163|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110162131|NCT00111163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110162132|NCT00111163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110162133|NCT00111163|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110162134|NCT00111163|Leprostatic Agents|leprostatic agents|mesh-ancestor
110162135|NCT00111163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110162136|NCT00111280|Etravirine|etravirine|mesh-list
110162137|NCT00111280|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110162138|NCT00111280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110162139|NCT00111280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110162140|NCT00111280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110162141|NCT00111280|Antiviral Agents|antiviral agents|mesh-ancestor
110162142|NCT00111280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110162144|NCT00111319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110162145|NCT00111397|Interferons|interferons|mesh-list
110162146|NCT00111397|Interferon-gamma|interferon-gamma|mesh-list
110162147|NCT00111397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110162148|NCT00111397|Antiviral Agents|antiviral agents|mesh-ancestor
110162149|NCT00111397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110162150|NCT00111436|Etanercept|etanercept|mesh-list
110162151|NCT00111436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110162152|NCT00111436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110162154|NCT00111436|Sensory System Agents|sensory system agents|mesh-ancestor
110162155|NCT00111436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110162156|NCT00111436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110162157|NCT00111436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110162158|NCT00111436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110162159|NCT00111436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110162160|NCT00111436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110162161|NCT00111436|Immunologic Factors|immunologic factors|mesh-ancestor
110162162|NCT00111631|Metformin|metformin|mesh-list
110162163|NCT00111631|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
110162164|NCT00111631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110162165|NCT00111631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110162166|NCT00111631|Protease Inhibitors|protease inhibitors|mesh-ancestor
110162167|NCT00111631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110162168|NCT00111631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110162169|NCT00111670|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
110162170|NCT00111670|Protease Inhibitors|protease inhibitors|mesh-ancestor
110162171|NCT00111670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110162172|NCT00111670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110162173|NCT00111670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110162174|NCT00111670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110162176|NCT00111748|Dexamethasone|dexamethasone|mesh-list
110162178|NCT00111748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110162181|NCT00111748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110162182|NCT00111748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110162184|NCT00111748|Glucocorticoids|glucocorticoids|mesh-ancestor
110162185|NCT00111748|Hormones|hormones|mesh-ancestor
110162186|NCT00111748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110162187|NCT00111748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110162189|NCT00111748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110162190|NCT00111748|Immunologic Factors|immunologic factors|mesh-ancestor
110162191|NCT00111748|Leprostatic Agents|leprostatic agents|mesh-ancestor
110162192|NCT00111748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110162193|NCT00111748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110162194|NCT00111748|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110162195|NCT00111748|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110162196|NCT00111748|Growth Substances|growth substances|mesh-ancestor
110162197|NCT00111748|Growth Inhibitors|growth inhibitors|mesh-ancestor
110162199|NCT00111787|Lapatinib|lapatinib|mesh-list
110162200|NCT00111787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110162201|NCT00111787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110162202|NCT00111787|Tubulin Modulators|tubulin modulators|mesh-ancestor
110162203|NCT00111787|Antimitotic Agents|antimitotic agents|mesh-ancestor
110162204|NCT00111787|Mitosis Modulators|mitosis modulators|mesh-ancestor
110162205|NCT00111787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110162206|NCT00111787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110162207|NCT00111787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110162209|NCT00111904|genexol-PM|genexol-pm|mesh-list
110162210|NCT00111904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110162211|NCT00111904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110162212|NCT00111904|Tubulin Modulators|tubulin modulators|mesh-ancestor
110162213|NCT00111904|Antimitotic Agents|antimitotic agents|mesh-ancestor
110162214|NCT00111904|Mitosis Modulators|mitosis modulators|mesh-ancestor
110162215|NCT00111904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110162216|NCT00111943|Tenofovir|tenofovir|mesh-list
110162217|NCT00111943|Antiviral Agents|antiviral agents|mesh-ancestor
110162218|NCT00111943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110162219|NCT00111943|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110162220|NCT00111943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110162222|NCT00111943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110162223|NCT00111943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110162224|NCT00111943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110162225|NCT00401596|Omalizumab|omalizumab|mesh-list
110162226|NCT00401596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110162227|NCT00401596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110162228|NCT00401596|Respiratory System Agents|respiratory system agents|mesh-ancestor
110162229|NCT00401635|Carboplatin|carboplatin|mesh-list
110162230|NCT00401635|Doxorubicin|doxorubicin|mesh-list
110162231|NCT00401635|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110162232|NCT00401635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110162233|NCT00401635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110162234|NCT00401635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110162235|NCT00401635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110162236|NCT00401635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110162237|NCT00401635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110162239|NCT00401674|Carboplatin|carboplatin|mesh-list
110162240|NCT00401674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110162241|NCT00401674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110162244|NCT00401674|Mitosis Modulators|mitosis modulators|mesh-ancestor
110162245|NCT00401674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110162247|NCT00112021|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
110162248|NCT00112021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110162249|NCT00112021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110162250|NCT00112021|Appetite Depressants|appetite depressants|mesh-ancestor
110162251|NCT00112021|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110162252|NCT00112021|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
110162253|NCT00112021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110162254|NCT00007358|Dexamethasone|dexamethasone|mesh-list
110162255|NCT00007358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110162256|NCT00007358|Antiemetics|antiemetics|mesh-ancestor
110162257|NCT00007358|Autonomic Agents|autonomic agents|mesh-ancestor
110162258|NCT00007358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110162259|NCT00007358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110162260|NCT00007358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110162262|NCT00007358|Hormones|hormones|mesh-ancestor
110162263|NCT00007358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110162264|NCT00007358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110162265|NCT00007358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110162266|NCT00112138|Gabapentin|gabapentin|mesh-list
110162267|NCT00112138|Analgesics|analgesics|mesh-ancestor
110162268|NCT00112138|Sensory System Agents|sensory system agents|mesh-ancestor
110162269|NCT00112138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110162270|NCT00112138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110162271|NCT00112138|Anticonvulsants|anticonvulsants|mesh-ancestor
110162272|NCT00112138|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110162273|NCT00112138|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110162274|NCT00112138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110162275|NCT00112138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110162276|NCT00112138|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110162277|NCT00112138|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110162278|NCT00112138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110162279|NCT00112138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110162280|NCT00112138|Antimanic Agents|antimanic agents|mesh-ancestor
110162281|NCT03330639|Capsaicin|capsaicin|mesh-list
110162282|NCT03330639|Antipruritics|antipruritics|mesh-ancestor
110162283|NCT03330639|Dermatologic Agents|dermatologic agents|mesh-ancestor
110162284|NCT03330639|Sensory System Agents|sensory system agents|mesh-ancestor
110162285|NCT03330639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110162286|NCT03330639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110162287|NCT00007436|Tenofovir|tenofovir|mesh-list
110162291|NCT00007436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110162293|NCT00007436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110162295|NCT00007436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110162296|NCT00112216|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
110162297|NCT00112216|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110162298|NCT00112216|Immunologic Factors|immunologic factors|mesh-ancestor
110162299|NCT00112216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110162300|NCT00112372|Sirolimus|sirolimus|mesh-list
110162301|NCT00112372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110162302|NCT00112372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110162303|NCT00112372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110162304|NCT00112372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110162305|NCT00112372|Antifungal Agents|antifungal agents|mesh-ancestor
110162306|NCT00112372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110162307|NCT00112372|Immunologic Factors|immunologic factors|mesh-ancestor
110162308|NCT00112372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110162309|NCT00112528|Bevacizumab|bevacizumab|mesh-list
110162310|NCT00112528|Gemcitabine|gemcitabine|mesh-list
110162311|NCT00112528|Oxaliplatin|oxaliplatin|mesh-list
110162312|NCT00112528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110162313|NCT00112528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110162314|NCT00112528|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110162315|NCT00112528|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110162316|NCT00112528|Growth Substances|growth substances|mesh-ancestor
110162317|NCT00112528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110162318|NCT00112528|Growth Inhibitors|growth inhibitors|mesh-ancestor
110162319|NCT00112528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110162320|NCT00112528|Antimetabolites|antimetabolites|mesh-ancestor
110162321|NCT00112528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110162322|NCT00007592|Chlorthalidone|chlorthalidone|mesh-list
110162324|NCT00007592|Diuretics|diuretics|mesh-ancestor
110162325|NCT00007592|Natriuretic Agents|natriuretic agents|mesh-ancestor
110162326|NCT00007592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110162327|NCT00007592|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110162328|NCT00007592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110162329|NCT00007592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110162330|NCT00007592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110162331|NCT00007592|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110162333|NCT00007631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110162334|NCT00007631|Keratolytic Agents|keratolytic agents|mesh-ancestor
110162335|NCT00007631|Dermatologic Agents|dermatologic agents|mesh-ancestor
110162336|NCT00112567|Fludarabine|fludarabine|mesh-list
110162337|NCT00112567|Fludarabine phosphate|fludarabine phosphate|mesh-list
110162338|NCT00112567|Thiotepa|thiotepa|mesh-list
110162339|NCT00112567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110162340|NCT00112567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110162341|NCT00112567|Antimetabolites|antimetabolites|mesh-ancestor
110162342|NCT00112567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110162343|NCT00112567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110162344|NCT00112567|Immunologic Factors|immunologic factors|mesh-ancestor
110162345|NCT00112567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110162346|NCT00112567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110162347|NCT00112567|Alkylating Agents|alkylating agents|mesh-ancestor
110162350|NCT00112645|Methylprednisolone|methylprednisolone|mesh-list
110162351|NCT00112645|Methotrexate|methotrexate|mesh-list
110162352|NCT00112645|Melphalan|melphalan|mesh-list
110162353|NCT00112645|Busulfan|busulfan|mesh-list
110162354|NCT00112645|Cyclosporins|cyclosporins|mesh-list
110162355|NCT00112645|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110162356|NCT00112645|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110162357|NCT00112645|Abortifacient Agents|abortifacient agents|mesh-ancestor
110162358|NCT00112645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110162359|NCT00112645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110162360|NCT00112645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110162361|NCT00112645|Antimetabolites|antimetabolites|mesh-ancestor
110162362|NCT00112645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110162363|NCT00112645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110162365|NCT00112645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110162366|NCT00112645|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110162367|NCT00112645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110162368|NCT00112645|Immunologic Factors|immunologic factors|mesh-ancestor
110162369|NCT00112645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110162370|NCT00112645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110162371|NCT00112645|Antifungal Agents|antifungal agents|mesh-ancestor
110162372|NCT00112645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110162373|NCT00112645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110162374|NCT00112645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110162376|NCT00112645|Autonomic Agents|autonomic agents|mesh-ancestor
110162377|NCT00112645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110162378|NCT00112645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110162379|NCT00112645|Glucocorticoids|glucocorticoids|mesh-ancestor
110162381|NCT00112645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110162382|NCT00112645|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110162383|NCT00112645|Protective Agents|protective agents|mesh-ancestor
110162384|NCT00112645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110162385|NCT00112645|Alkylating Agents|alkylating agents|mesh-ancestor
110162386|NCT00112645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110162387|NCT00112684|Alvocidib|alvocidib|mesh-list
110162388|NCT00112684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110162389|NCT00112684|Growth Inhibitors|growth inhibitors|mesh-ancestor
110162390|NCT00112684|Growth Substances|growth substances|mesh-ancestor
110162391|NCT00112684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110162392|NCT00112684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110162393|NCT00112684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110162394|NCT00112684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110162395|NCT00007670|Lamotrigine|lamotrigine|mesh-list
110162396|NCT00007670|Carbamazepine|carbamazepine|mesh-list
110162398|NCT00007670|Analgesics|analgesics|mesh-ancestor
110162399|NCT00007670|Sensory System Agents|sensory system agents|mesh-ancestor
110188934|NCT00039351|Hormones|hormones|mesh-ancestor
110162400|NCT00007670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110162402|NCT00007670|Anticonvulsants|anticonvulsants|mesh-ancestor
110162403|NCT00007670|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110162404|NCT00007670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110162405|NCT00007670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110162406|NCT00007670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110162407|NCT00007670|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110162408|NCT00007670|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110162409|NCT00007670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110162410|NCT00007670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110162411|NCT00007670|Antimanic Agents|antimanic agents|mesh-ancestor
110162412|NCT00007670|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110162413|NCT00007670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110162417|NCT00007670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110162418|NCT00007670|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110162419|NCT00007670|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110162421|NCT00112879|Thalidomide|thalidomide|mesh-list
110162422|NCT00112879|Dexamethasone|dexamethasone|mesh-list
110162423|NCT00112879|Arsenic Trioxide|arsenic trioxide|mesh-list
110162424|NCT00112879|Mitogens|mitogens|mesh-list
110162425|NCT00112879|Immunomodulating Agents|immunomodulating agents|mesh-list
110162426|NCT00112879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110162427|NCT00112879|Antiemetics|antiemetics|mesh-ancestor
110162428|NCT00112879|Autonomic Agents|autonomic agents|mesh-ancestor
110162429|NCT00112879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110162430|NCT00112879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110162431|NCT00112879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110162432|NCT00112879|Glucocorticoids|glucocorticoids|mesh-ancestor
110162434|NCT00112879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110162435|NCT00112879|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110162436|NCT00112879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110162437|NCT00112879|Mitosis Modulators|mitosis modulators|mesh-ancestor
110162438|NCT00112879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110162439|NCT00112879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110162440|NCT00112879|Immunologic Factors|immunologic factors|mesh-ancestor
110162441|NCT00112879|Leprostatic Agents|leprostatic agents|mesh-ancestor
110162442|NCT00112879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110162443|NCT00112879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110162444|NCT00112879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110162445|NCT00112879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110162446|NCT00112879|Growth Substances|growth substances|mesh-ancestor
110162447|NCT00112879|Growth Inhibitors|growth inhibitors|mesh-ancestor
110162448|NCT00112879|Antioxidants|antioxidants|mesh-ancestor
110162449|NCT00112879|Protective Agents|protective agents|mesh-ancestor
110162450|NCT00112879|Vitamins|vitamins|mesh-ancestor
110162451|NCT00112879|Micronutrients|micronutrients|mesh-ancestor
110162452|NCT00112996|Thioctic Acid|thioctic acid|mesh-list
110162453|NCT00112996|Antioxidants|antioxidants|mesh-ancestor
110162454|NCT00112996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110162455|NCT00112996|Protective Agents|protective agents|mesh-ancestor
110162456|NCT00112996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110162457|NCT00112996|Vitamin B Complex|vitamin b complex|mesh-ancestor
110162458|NCT00112996|Vitamins|vitamins|mesh-ancestor
110162459|NCT00112996|Micronutrients|micronutrients|mesh-ancestor
110162460|NCT00113074|Nicotine|nicotine|mesh-list
110162461|NCT00113074|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110162462|NCT00113074|Autonomic Agents|autonomic agents|mesh-ancestor
110162463|NCT00113074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110162464|NCT00113074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110162465|NCT00113074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110162466|NCT00113074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110162467|NCT00113074|Cholinergic Agents|cholinergic agents|mesh-ancestor
110162468|NCT00113074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110162469|NCT00113074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110162471|NCT00113113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110162472|NCT00113113|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110162473|NCT00113113|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110162477|NCT00007787|Tacrolimus|tacrolimus|mesh-list
110162478|NCT00007787|Cyclosporins|cyclosporins|mesh-list
110162479|NCT00007787|Thymoglobulin|thymoglobulin|mesh-list
110162480|NCT00007787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110162481|NCT00007787|Immunologic Factors|immunologic factors|mesh-ancestor
110162482|NCT00007787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110162483|NCT00007787|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110162484|NCT00007787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110162485|NCT00007787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110162487|NCT00007787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110162488|NCT00007787|Dermatologic Agents|dermatologic agents|mesh-ancestor
110162489|NCT00007787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110162490|NCT00390897|Interferons|interferons|mesh-list
110162491|NCT00390897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110162492|NCT00390897|Antiviral Agents|antiviral agents|mesh-ancestor
110162493|NCT00390897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110162494|NCT00113347|Docetaxel|docetaxel|mesh-list
110162495|NCT00113347|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110162496|NCT00113347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110162497|NCT00113347|Tubulin Modulators|tubulin modulators|mesh-ancestor
110162498|NCT00113347|Antimitotic Agents|antimitotic agents|mesh-ancestor
110162499|NCT00113347|Mitosis Modulators|mitosis modulators|mesh-ancestor
110162500|NCT00113347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110162501|NCT00113347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110162502|NCT00113347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110162504|NCT00113503|Antimetabolites|antimetabolites|mesh-ancestor
110162505|NCT00113503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110162506|NCT00113503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110162507|NCT00113503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110162508|NCT00113503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110162509|NCT00113503|Immunologic Factors|immunologic factors|mesh-ancestor
110162510|NCT00113503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110162511|NCT00113503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110162512|NCT00113542|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
110162513|NCT00113542|Chelating Agents|chelating agents|mesh-ancestor
110162514|NCT00113542|Sequestering Agents|sequestering agents|mesh-ancestor
110162515|NCT00113542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110162516|NCT00113542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110162517|NCT00113542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110162518|NCT00113542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110162519|NCT00113542|Growth Substances|growth substances|mesh-ancestor
110162520|NCT00113542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110162521|NCT00113542|Growth Inhibitors|growth inhibitors|mesh-ancestor
110162522|NCT00113542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110162524|NCT00007826|Vaccines|vaccines|mesh-list
110162525|NCT00007826|Antibodies|antibodies|mesh-list
110162526|NCT00007826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110162527|NCT00007826|BCG Vaccine|bcg vaccine|mesh-list
110162528|NCT00007826|Aluminum sulfate|aluminum sulfate|mesh-list
110162529|NCT00007826|Immunologic Factors|immunologic factors|mesh-ancestor
110162530|NCT00007826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110162531|NCT00007826|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110162532|NCT00007826|Antacids|antacids|mesh-ancestor
110188952|NCT00019721|Aldesleukin|aldesleukin|mesh-list
110162536|NCT00007865|Carboplatin|carboplatin|mesh-list
110162538|NCT00007865|Ifosfamide|ifosfamide|mesh-list
110162539|NCT00007865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110162540|NCT00007865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110162541|NCT00007865|Immunologic Factors|immunologic factors|mesh-ancestor
110162542|NCT00007865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110162543|NCT00007865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110162544|NCT00007865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110162546|NCT00007865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110162547|NCT00007865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110162548|NCT00007865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110162550|NCT00007865|Alkylating Agents|alkylating agents|mesh-ancestor
110162551|NCT00113698|Enalapril|enalapril|mesh-list
110162552|NCT00113698|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110162553|NCT00113698|Protease Inhibitors|protease inhibitors|mesh-ancestor
110162554|NCT00113698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110162555|NCT00113698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110162556|NCT00113698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110162557|NCT00113737|Fluoxetine|fluoxetine|mesh-list
110162558|NCT00113737|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110162559|NCT00113737|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110162560|NCT00113737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110162561|NCT00113737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110162562|NCT00113737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110162564|NCT00113737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110162565|NCT00113737|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110162566|NCT00113737|Antidepressive Agents|antidepressive agents|mesh-ancestor
110162567|NCT00113737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110162568|NCT00113737|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110162569|NCT00113737|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110162570|NCT00113737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110162571|NCT03272295|Fenugreek seed meal|fenugreek seed meal|mesh-list
110162572|NCT03272295|Menthol|menthol|mesh-list
110162573|NCT03272295|Sorbitol|sorbitol|mesh-list
110162574|NCT03272295|Glycerol|glycerol|mesh-list
110162575|NCT03272295|Antipruritics|antipruritics|mesh-ancestor
110162577|NCT03272295|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110162578|NCT03272295|Protective Agents|protective agents|mesh-ancestor
110162579|NCT03272295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110162580|NCT03272295|Cathartics|cathartics|mesh-ancestor
110162581|NCT03272295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110162582|NCT03272295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110162583|NCT00007904|Tamoxifen|tamoxifen|mesh-list
110162584|NCT00007904|Paclitaxel|paclitaxel|mesh-list
110162585|NCT00007904|Cyclophosphamide|cyclophosphamide|mesh-list
110162586|NCT00007904|Doxorubicin|doxorubicin|mesh-list
110162587|NCT00007904|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110162588|NCT00007904|Lenograstim|lenograstim|mesh-list
110162589|NCT00007904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110162590|NCT00007904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110162592|NCT00007904|Antimitotic Agents|antimitotic agents|mesh-ancestor
110162593|NCT00007904|Mitosis Modulators|mitosis modulators|mesh-ancestor
110162594|NCT00007904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110162595|NCT00007904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110162599|NCT00007904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110162600|NCT00007904|Alkylating Agents|alkylating agents|mesh-ancestor
110162601|NCT00007904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110162602|NCT00007904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110162603|NCT00007904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110162604|NCT00007904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110162605|NCT00007904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110162606|NCT00007904|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110162607|NCT00007904|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110162608|NCT00007904|Hormone Antagonists|hormone antagonists|mesh-ancestor
110162609|NCT00007904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110162610|NCT00007904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110162611|NCT00007904|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110162612|NCT00007904|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110162613|NCT00007904|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110162614|NCT00113815|Topiramate|topiramate|mesh-list
110162616|NCT00113815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110162617|NCT00113815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110162618|NCT00113854|Mannitol|mannitol|mesh-list
110162619|NCT00113854|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110162620|NCT00113854|Diuretics|diuretics|mesh-ancestor
110162621|NCT00113854|Natriuretic Agents|natriuretic agents|mesh-ancestor
110162622|NCT00113854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110162623|NCT00007943|Gemcitabine|gemcitabine|mesh-list
110162624|NCT00007943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110162625|NCT00007943|Antimetabolites|antimetabolites|mesh-ancestor
110162626|NCT00007943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110162627|NCT00007943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110162628|NCT00113971|Epratuzumab|epratuzumab|mesh-list
110162629|NCT00113971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110162630|NCT00113971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110162631|NCT00114010|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110162632|NCT00114010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110162633|NCT00114010|Immunologic Factors|immunologic factors|mesh-ancestor
110162634|NCT00114010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110162635|NCT00114010|Antacids|antacids|mesh-ancestor
110162636|NCT00114010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110162637|NCT00114010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110162638|NCT00007982|Cyclophosphamide|cyclophosphamide|mesh-list
110162639|NCT00007982|Thiotepa|thiotepa|mesh-list
110162640|NCT00007982|Carmustine|carmustine|mesh-list
110162641|NCT00007982|Etoposide|etoposide|mesh-list
110162642|NCT00007982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110162643|NCT00007982|Immunologic Factors|immunologic factors|mesh-ancestor
110162644|NCT00007982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110162645|NCT00007982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110162646|NCT00007982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110162647|NCT00007982|Alkylating Agents|alkylating agents|mesh-ancestor
110162648|NCT00007982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110162649|NCT00007982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110162650|NCT00007982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110162651|NCT00007982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110162652|NCT00007982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110162653|NCT00007982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110162654|NCT00007982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110162655|NCT00114205|Docetaxel|docetaxel|mesh-list
110162656|NCT00114205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110162657|NCT00114205|Tubulin Modulators|tubulin modulators|mesh-ancestor
110162658|NCT00114205|Antimitotic Agents|antimitotic agents|mesh-ancestor
110162659|NCT00114205|Mitosis Modulators|mitosis modulators|mesh-ancestor
110162660|NCT00114205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110162662|NCT00114283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110188972|NCT00019760|Vitamins|vitamins|mesh-ancestor
110162663|NCT00114283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110162664|NCT00114283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110162665|NCT00114283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110162667|NCT00114361|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110162668|NCT00114361|Antimetabolites|antimetabolites|mesh-ancestor
110162669|NCT00114361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110162670|NCT00114361|Antiviral Agents|antiviral agents|mesh-ancestor
110162671|NCT00114361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110162672|NCT00114400|Vitamins|vitamins|mesh-list
110162673|NCT00114400|Folic Acid|folic acid|mesh-list
110162674|NCT00114400|Vitamin B 12|vitamin b 12|mesh-list
110162675|NCT00114400|Vitamin B 6|vitamin b 6|mesh-list
110162677|NCT00114400|Pyridoxine|pyridoxine|mesh-list
110162678|NCT00114400|Vitamin B Complex|vitamin b complex|mesh-list
110162679|NCT00114400|Micronutrients|micronutrients|mesh-ancestor
110162680|NCT00114400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110162681|NCT00114400|Hematinics|hematinics|mesh-ancestor
110162682|NCT00114439|Lithium Carbonate|lithium carbonate|mesh-list
110162683|NCT00114439|Antidepressive Agents|antidepressive agents|mesh-ancestor
110162684|NCT00114439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110162685|NCT00114439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110162686|NCT00114439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110162687|NCT00114439|Antimanic Agents|antimanic agents|mesh-ancestor
110162688|NCT00114439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110162689|NCT00114439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110162690|NCT00114439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110162691|NCT00114478|Epinephrine|epinephrine|mesh-list
110162692|NCT00114478|Albuterol|albuterol|mesh-list
110162693|NCT00114478|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110162695|NCT00114478|Adrenergic Agents|adrenergic agents|mesh-ancestor
110162696|NCT00114478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110162697|NCT00114478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110162698|NCT00114478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110162699|NCT00114478|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110162700|NCT00114478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110162701|NCT00114478|Autonomic Agents|autonomic agents|mesh-ancestor
110162702|NCT00114478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110162703|NCT00114478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110162704|NCT00114478|Respiratory System Agents|respiratory system agents|mesh-ancestor
110162705|NCT00114478|Mydriatics|mydriatics|mesh-ancestor
110162707|NCT00114478|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110162709|NCT00114478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110162710|NCT00114478|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110162712|NCT00114556|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110162713|NCT00114556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110162714|NCT00008021|Cyclosporine|cyclosporine|mesh-list
110162715|NCT00008021|Paclitaxel|paclitaxel|mesh-list
110162716|NCT00008021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110162717|NCT00008021|Antibodies|antibodies|mesh-list
110162718|NCT00008021|Immunoglobulins|immunoglobulins|mesh-list
110162719|NCT00008021|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110162720|NCT00008021|Cyclosporins|cyclosporins|mesh-list
110162721|NCT00008021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110162722|NCT00008021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110162723|NCT00008021|Tubulin Modulators|tubulin modulators|mesh-ancestor
110162724|NCT00008021|Antimitotic Agents|antimitotic agents|mesh-ancestor
110162725|NCT00008021|Mitosis Modulators|mitosis modulators|mesh-ancestor
110162726|NCT00008021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110162727|NCT00008021|Immunologic Factors|immunologic factors|mesh-ancestor
110162728|NCT00008021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110162729|NCT00008021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110162730|NCT00008021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110162731|NCT00008021|Antifungal Agents|antifungal agents|mesh-ancestor
110162732|NCT00008021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110162735|NCT00008021|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110162736|NCT03079440|Capecitabine|capecitabine|mesh-list
110162737|NCT03079440|Temozolomide|temozolomide|mesh-list
110162738|NCT03079440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110162739|NCT03079440|Antimetabolites|antimetabolites|mesh-ancestor
110162740|NCT03079440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110162741|NCT03079440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110162742|NCT03079440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110162743|NCT03079440|Alkylating Agents|alkylating agents|mesh-ancestor
110162744|NCT04728178|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110162746|NCT00008060|Fluorouracil|fluorouracil|mesh-list
110162747|NCT00008060|Oxaliplatin|oxaliplatin|mesh-list
110162748|NCT00008060|Irinotecan|irinotecan|mesh-list
110162749|NCT00008060|Calcium|calcium|mesh-list
110162750|NCT00008060|Levoleucovorin|levoleucovorin|mesh-list
110162751|NCT00008060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110162752|NCT00008060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110162753|NCT00008060|Antimetabolites|antimetabolites|mesh-ancestor
110162754|NCT00008060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110162755|NCT00008060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110162756|NCT00008060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110162757|NCT00008060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110162758|NCT00008060|Immunologic Factors|immunologic factors|mesh-ancestor
110162759|NCT00008060|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110162760|NCT00008060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110162761|NCT00008060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110162762|NCT00008060|Antidotes|antidotes|mesh-ancestor
110162763|NCT00008060|Protective Agents|protective agents|mesh-ancestor
110162764|NCT00008060|Vitamin B Complex|vitamin b complex|mesh-ancestor
110162766|NCT00008060|Micronutrients|micronutrients|mesh-ancestor
110162767|NCT00114868|Vitamins|vitamins|mesh-list
110162768|NCT00114868|Vitamin A|vitamin a|mesh-list
110162770|NCT00114868|Micronutrients|micronutrients|mesh-ancestor
110162771|NCT00114868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110162772|NCT00114868|Antioxidants|antioxidants|mesh-ancestor
110162773|NCT00114868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110162775|NCT00114868|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110162776|NCT00114868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110162777|NCT03034200|TIC10 compound|tic10 compound|mesh-list
110162778|NCT03034200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110162779|NCT00114946|Bevacizumab|bevacizumab|mesh-list
110162780|NCT00114946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110162781|NCT00114946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110162782|NCT00114946|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110162783|NCT00114946|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110162784|NCT00114946|Growth Substances|growth substances|mesh-ancestor
110162785|NCT00114946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110162786|NCT00114946|Growth Inhibitors|growth inhibitors|mesh-ancestor
110162788|NCT00115024|Estrogens|estrogens|mesh-ancestor
110162789|NCT00115024|Hormones|hormones|mesh-ancestor
110162790|NCT00115024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110162791|NCT00115024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110162793|NCT00008177|Cyclosporine|cyclosporine|mesh-list
110162794|NCT00008177|Mycophenolic Acid|mycophenolic acid|mesh-list
110162795|NCT00008177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110162796|NCT00008177|Fludarabine|fludarabine|mesh-list
110162797|NCT00008177|Fludarabine phosphate|fludarabine phosphate|mesh-list
110162799|NCT00008177|Immunoglobulins|immunoglobulins|mesh-list
110162800|NCT00008177|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110162801|NCT00008177|Cyclosporins|cyclosporins|mesh-list
110162802|NCT00008177|Immunologic Factors|immunologic factors|mesh-ancestor
110162803|NCT00008177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110162805|NCT00008177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110162806|NCT00008177|Antimetabolites|antimetabolites|mesh-ancestor
110162807|NCT00008177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110162808|NCT00008177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110162809|NCT00008177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110162810|NCT00008177|Antifungal Agents|antifungal agents|mesh-ancestor
110162811|NCT00008177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110162812|NCT00008177|Dermatologic Agents|dermatologic agents|mesh-ancestor
110162814|NCT00008177|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110162815|NCT00008177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110162816|NCT00008177|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110162817|NCT00008177|Antitubercular Agents|antitubercular agents|mesh-ancestor
110162818|NCT00008177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110162819|NCT00008177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110162820|NCT00008177|Trace Elements|trace elements|mesh-ancestor
110162821|NCT00008177|Micronutrients|micronutrients|mesh-ancestor
110162822|NCT03007407|Durvalumab|durvalumab|mesh-list
110162823|NCT03007407|Tremelimumab|tremelimumab|mesh-list
110162824|NCT03007407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110162825|NCT03007407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110162827|NCT00115102|Ketamine|ketamine|mesh-list
110162828|NCT00115102|Esketamine|esketamine|mesh-list
110162829|NCT00115102|Analgesics|analgesics|mesh-ancestor
110162830|NCT00115102|Sensory System Agents|sensory system agents|mesh-ancestor
110162831|NCT00115102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110162832|NCT00115102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110162833|NCT00115102|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110162834|NCT00115102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110162835|NCT00115102|Anesthetics, General|anesthetics, general|mesh-ancestor
110162836|NCT00115102|Anesthetics|anesthetics|mesh-ancestor
110162837|NCT00115102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110162838|NCT00115102|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110162839|NCT00115102|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110162840|NCT00115102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110162841|NCT00115102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110162842|NCT00115102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110162843|NCT00115102|Narcotics|narcotics|mesh-ancestor
110162844|NCT00115102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110162845|NCT00115102|Antidepressive Agents|antidepressive agents|mesh-ancestor
110162846|NCT00115102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110162847|NCT00115219|Etanercept|etanercept|mesh-list
110162848|NCT00115219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110162849|NCT00115219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110162850|NCT00115219|Analgesics|analgesics|mesh-ancestor
110162851|NCT00115219|Sensory System Agents|sensory system agents|mesh-ancestor
110162852|NCT00115219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110162854|NCT00115219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110162855|NCT00115219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110162856|NCT00115219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110162857|NCT00115219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110162858|NCT00115219|Immunologic Factors|immunologic factors|mesh-ancestor
110162859|NCT00115375|Clopidogrel|clopidogrel|mesh-list
110162860|NCT00115375|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110162861|NCT00115375|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110162862|NCT00115375|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110162863|NCT00115375|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110162864|NCT00115375|Purinergic Agents|purinergic agents|mesh-ancestor
110162865|NCT00115375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110162866|NCT00115375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110162867|NCT00115375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110162868|NCT00115414|Cyclophosphamide|cyclophosphamide|mesh-list
110162869|NCT00115414|Docetaxel|docetaxel|mesh-list
110162870|NCT00115414|Doxorubicin|doxorubicin|mesh-list
110162871|NCT00115414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110162872|NCT00115414|Immunologic Factors|immunologic factors|mesh-ancestor
110162873|NCT00115414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110162876|NCT00115414|Alkylating Agents|alkylating agents|mesh-ancestor
110162877|NCT00115414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110162878|NCT00115414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110162879|NCT00115414|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110162880|NCT00115414|Tubulin Modulators|tubulin modulators|mesh-ancestor
110162881|NCT00115414|Antimitotic Agents|antimitotic agents|mesh-ancestor
110162882|NCT00115414|Mitosis Modulators|mitosis modulators|mesh-ancestor
110162883|NCT00115414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110162884|NCT00115414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110162885|NCT00115414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110162886|NCT00115414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110162888|NCT00115492|Xhance|xhance|mesh-list
110162889|NCT00115492|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110162890|NCT00115492|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110162891|NCT00115492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110162892|NCT00115492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110162893|NCT00115492|Autonomic Agents|autonomic agents|mesh-ancestor
110162894|NCT00115492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110162895|NCT00115492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110162896|NCT00115492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110162897|NCT00115492|Respiratory System Agents|respiratory system agents|mesh-ancestor
110162898|NCT00115492|Dermatologic Agents|dermatologic agents|mesh-ancestor
110162899|NCT00115492|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110162900|NCT00115492|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110162902|NCT00115492|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110162903|NCT00115492|Adrenergic Agents|adrenergic agents|mesh-ancestor
110162904|NCT00115492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110162905|NCT00115492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110162906|NCT00115492|Glucocorticoids|glucocorticoids|mesh-ancestor
110162908|NCT00115492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110162909|NCT00115492|Sympathomimetics|sympathomimetics|mesh-ancestor
110162910|NCT02993406|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
110162911|NCT02993406|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110162912|NCT02993406|Antimetabolites|antimetabolites|mesh-ancestor
110162913|NCT02993406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110162914|NCT02993406|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110162915|NCT02993406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110162916|NCT02993406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110162917|NCT02993406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110162918|NCT00115531|Vaccines|vaccines|mesh-list
110162919|NCT00115531|Immunologic Factors|immunologic factors|mesh-ancestor
110162920|NCT00115531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110162921|NCT00115570|Insulin|insulin|mesh-list
110162922|NCT00115570|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110162923|NCT00115570|Insulin Glargine|insulin glargine|mesh-list
110162924|NCT00115570|Insulin Lispro|insulin lispro|mesh-list
110162925|NCT00115570|Insulin glulisine|insulin glulisine|mesh-list
110162926|NCT00115570|Insulin, Isophane|insulin, isophane|mesh-list
110162927|NCT00115570|Isophane Insulin, Human|isophane insulin, human|mesh-list
110162928|NCT00115570|Isophane insulin, beef|isophane insulin, beef|mesh-list
110162929|NCT00115570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110162930|NCT00115570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110162931|NCT00115609|Tenofovir|tenofovir|mesh-list
110162932|NCT00115609|Emtricitabine|emtricitabine|mesh-list
110162933|NCT00115609|Efavirenz|efavirenz|mesh-list
110162934|NCT00115609|Antiviral Agents|antiviral agents|mesh-ancestor
110162935|NCT00115609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110162936|NCT00115609|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110162937|NCT00115609|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110162938|NCT00115609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110162940|NCT00115609|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110162941|NCT00115609|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110162942|NCT00115609|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110162943|NCT00115609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110162944|NCT00115609|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110162945|NCT00115609|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110162946|NCT00115609|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110162947|NCT00115609|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110162950|NCT00115648|Antimetabolites|antimetabolites|mesh-ancestor
110162951|NCT00115648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110162953|NCT00115648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110162955|NCT00115648|Antiviral Agents|antiviral agents|mesh-ancestor
110162956|NCT00115648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110162957|NCT00115648|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110162958|NCT00115648|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110162959|NCT00115648|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110162960|NCT00115648|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110162961|NCT00008294|Leucovorin|leucovorin|mesh-list
110162962|NCT00008294|Dexamethasone|dexamethasone|mesh-list
110162963|NCT00008294|Fluorouracil|fluorouracil|mesh-list
110162964|NCT00008294|Oxaliplatin|oxaliplatin|mesh-list
110162965|NCT00008294|Floxuridine|floxuridine|mesh-list
110162966|NCT00008294|Calcium|calcium|mesh-list
110162967|NCT00008294|Levoleucovorin|levoleucovorin|mesh-list
110162968|NCT00008294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110162970|NCT00008294|Autonomic Agents|autonomic agents|mesh-ancestor
110162971|NCT00008294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110162972|NCT00008294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110162974|NCT00008294|Glucocorticoids|glucocorticoids|mesh-ancestor
110162975|NCT00008294|Hormones|hormones|mesh-ancestor
110162976|NCT00008294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110162977|NCT00008294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110162978|NCT00008294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110162979|NCT00008294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110162980|NCT00008294|Antimetabolites|antimetabolites|mesh-ancestor
110162981|NCT00008294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110162982|NCT00008294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110162983|NCT00008294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110162984|NCT00008294|Immunologic Factors|immunologic factors|mesh-ancestor
110162985|NCT00008294|Antidotes|antidotes|mesh-ancestor
110162986|NCT00008294|Protective Agents|protective agents|mesh-ancestor
110162987|NCT00008294|Vitamin B Complex|vitamin b complex|mesh-ancestor
110162988|NCT00008294|Vitamins|vitamins|mesh-ancestor
110162989|NCT00008294|Micronutrients|micronutrients|mesh-ancestor
110162990|NCT00115687|Nicotine|nicotine|mesh-list
110162991|NCT00115687|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110162992|NCT00115687|Autonomic Agents|autonomic agents|mesh-ancestor
110162993|NCT00115687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110162994|NCT00115687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110162995|NCT00115687|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110162996|NCT00115687|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110162997|NCT00115687|Cholinergic Agents|cholinergic agents|mesh-ancestor
110162998|NCT00115687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110162999|NCT00115687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110163000|NCT00115726|Furosemide|furosemide|mesh-list
110163001|NCT00115726|Diuretics|diuretics|mesh-ancestor
110163002|NCT00115726|Natriuretic Agents|natriuretic agents|mesh-ancestor
110163003|NCT00115726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110163004|NCT00115726|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110163005|NCT00115726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110163006|NCT00115726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110163007|NCT00401869|Epoetin Alfa|epoetin alfa|mesh-list
110163008|NCT00401869|Hematinics|hematinics|mesh-ancestor
110163009|NCT00008333|Vinorelbine|vinorelbine|mesh-list
110163010|NCT00008333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110163011|NCT00008333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110163012|NCT00008333|Tubulin Modulators|tubulin modulators|mesh-ancestor
110163013|NCT00008333|Antimitotic Agents|antimitotic agents|mesh-ancestor
110163014|NCT00008333|Mitosis Modulators|mitosis modulators|mesh-ancestor
110163015|NCT00008333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110163016|NCT00008372|Sulfanilamides|sulfanilamides|mesh-list
110163017|NCT00008372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110163018|NCT00115921|Antimalarials|antimalarials|mesh-list
110163019|NCT00115921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110163020|NCT00115921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110163021|NCT00115921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110163022|NCT00008411|Docetaxel|docetaxel|mesh-list
110163023|NCT00008411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110163024|NCT00008411|Tubulin Modulators|tubulin modulators|mesh-ancestor
110163025|NCT00008411|Antimitotic Agents|antimitotic agents|mesh-ancestor
110163026|NCT00008411|Mitosis Modulators|mitosis modulators|mesh-ancestor
110163027|NCT00008411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110163028|NCT04727671|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110163029|NCT04727671|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110163030|NCT04727671|Cetrorelix|cetrorelix|mesh-list
110163032|NCT04727671|Luteolytic Agents|luteolytic agents|mesh-ancestor
110163033|NCT04727671|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110163034|NCT04727671|Contraceptive Agents|contraceptive agents|mesh-ancestor
110163035|NCT04727671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110163036|NCT04727671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110163037|NCT04727671|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110163038|NCT04727671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110163039|NCT04727671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110163040|NCT04727671|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110163041|NCT04727671|Fertility Agents|fertility agents|mesh-ancestor
110163042|NCT04727671|Hormone Antagonists|hormone antagonists|mesh-ancestor
110163043|NCT04727671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110163044|NCT00008450|Cyclosporine|cyclosporine|mesh-list
110163045|NCT00008450|Mycophenolic Acid|mycophenolic acid|mesh-list
110163046|NCT00008450|Cyclosporins|cyclosporins|mesh-list
110163047|NCT00008450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110163048|NCT00008450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110163049|NCT00008450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110163050|NCT00008450|Immunologic Factors|immunologic factors|mesh-ancestor
110163051|NCT00008450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110163052|NCT00008450|Antifungal Agents|antifungal agents|mesh-ancestor
110163053|NCT00008450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110163054|NCT00008450|Dermatologic Agents|dermatologic agents|mesh-ancestor
110163055|NCT00008450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110163056|NCT00008450|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110163057|NCT00008450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110163058|NCT00008450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110163059|NCT00008450|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110163060|NCT00008450|Antitubercular Agents|antitubercular agents|mesh-ancestor
110163061|NCT00008450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110163062|NCT00008489|Didanosine|didanosine|mesh-list
110163063|NCT00008489|Antimetabolites|antimetabolites|mesh-ancestor
110163064|NCT00008489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110163065|NCT00008489|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110163066|NCT00008489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110163067|NCT00008489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110163068|NCT00008489|Antiviral Agents|antiviral agents|mesh-ancestor
110163069|NCT00008489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110163070|NCT00008489|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110189036|NCT00039546|Antimetabolites|antimetabolites|mesh-ancestor
110163071|NCT00008489|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110163074|NCT00116350|Oxytocics|oxytocics|mesh-ancestor
110163075|NCT00116350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110163076|NCT00116350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110163077|NCT00116350|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110163078|NCT00116350|Abortifacient Agents|abortifacient agents|mesh-ancestor
110163079|NCT00116350|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110163080|NCT00116350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110163081|NCT00116389|Gemcitabine|gemcitabine|mesh-list
110163082|NCT00116389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110163083|NCT00116389|Antimetabolites|antimetabolites|mesh-ancestor
110163084|NCT00116389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110163085|NCT00116389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110163086|NCT00116467|Vaccines|vaccines|mesh-list
110163087|NCT00116467|Immunologic Factors|immunologic factors|mesh-ancestor
110163088|NCT00116467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110163089|NCT00008528|Enfuvirtide|enfuvirtide|mesh-list
110163090|NCT00008528|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110163091|NCT00008528|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110163092|NCT00008528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110163093|NCT00008528|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110163094|NCT00008528|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110163095|NCT00008528|Antiviral Agents|antiviral agents|mesh-ancestor
110163096|NCT00008528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110163097|NCT00116506|Bevacizumab|bevacizumab|mesh-list
110163098|NCT00116506|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110163099|NCT00116506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110163100|NCT00116506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110163101|NCT00116506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110163102|NCT00116506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110163103|NCT00116506|Growth Substances|growth substances|mesh-ancestor
110163104|NCT00116506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110163105|NCT00116506|Growth Inhibitors|growth inhibitors|mesh-ancestor
110163106|NCT00116506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110163107|NCT00116506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110163108|NCT00116506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110163110|NCT00116545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110163111|NCT00116545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110163112|NCT00116623|Indomethacin|indomethacin|mesh-list
110163113|NCT00116623|Magnesium Sulfate|magnesium sulfate|mesh-list
110163114|NCT00116623|Analgesics|analgesics|mesh-ancestor
110163115|NCT00116623|Sensory System Agents|sensory system agents|mesh-ancestor
110163116|NCT00116623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110163117|NCT00116623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110163118|NCT00116623|Anesthetics|anesthetics|mesh-ancestor
110163119|NCT00116623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110163120|NCT00116623|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110163121|NCT00116623|Anticonvulsants|anticonvulsants|mesh-ancestor
110163122|NCT00116623|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110163123|NCT00116623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110163124|NCT00116623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110163125|NCT00116623|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110163126|NCT00116623|Tocolytic Agents|tocolytic agents|mesh-ancestor
110163127|NCT00116623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110163128|NCT00116623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110163129|NCT00116623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110163130|NCT00116623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110163131|NCT00116623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110163132|NCT00116623|Gout Suppressants|gout suppressants|mesh-ancestor
110163133|NCT00116623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110163134|NCT00116623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110163135|NCT02909322|Hydromorphone|hydromorphone|mesh-list
110163136|NCT02909322|Bupivacaine|bupivacaine|mesh-list
110163138|NCT02909322|Anesthetics, Local|anesthetics, local|mesh-ancestor
110163140|NCT02909322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110163141|NCT02909322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110163142|NCT02909322|Sensory System Agents|sensory system agents|mesh-ancestor
110163143|NCT02909322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110163144|NCT02909322|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110163145|NCT02909322|Narcotics|narcotics|mesh-ancestor
110163146|NCT02909322|Analgesics|analgesics|mesh-ancestor
110163147|NCT00116701|Darbepoetin alfa|darbepoetin alfa|mesh-list
110163148|NCT00116701|Hematinics|hematinics|mesh-ancestor
110163149|NCT00116896|Cisplatin|cisplatin|mesh-list
110163150|NCT00116896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110163151|NCT02752815|Prednisone|prednisone|mesh-list
110163152|NCT02752815|Cyclophosphamide|cyclophosphamide|mesh-list
110163153|NCT02752815|Rituximab|rituximab|mesh-list
110163154|NCT02752815|Vincristine|vincristine|mesh-list
110163155|NCT02752815|Epirubicin|epirubicin|mesh-list
110163156|NCT02752815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110163157|NCT02752815|Immunologic Factors|immunologic factors|mesh-ancestor
110163158|NCT02752815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110163159|NCT02752815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110163160|NCT02752815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110163161|NCT02752815|Alkylating Agents|alkylating agents|mesh-ancestor
110163162|NCT02752815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110163163|NCT02752815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110163164|NCT02752815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110163165|NCT02752815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110163166|NCT02752815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110163169|NCT02752815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110163170|NCT02752815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110163171|NCT02752815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110163172|NCT02752815|Tubulin Modulators|tubulin modulators|mesh-ancestor
110163173|NCT02752815|Antimitotic Agents|antimitotic agents|mesh-ancestor
110163174|NCT02752815|Mitosis Modulators|mitosis modulators|mesh-ancestor
110163175|NCT02752815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110163176|NCT02752815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110163177|NCT02752815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110163178|NCT02752815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110163179|NCT00116935|Imatinib Mesylate|imatinib mesylate|mesh-list
110163180|NCT00116935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110163181|NCT00116935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110163182|NCT00116935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110163183|NCT00116935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110163184|NCT00388388|Losartan|losartan|mesh-list
110163185|NCT00388388|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110163186|NCT00388388|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110163187|NCT00388388|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110163188|NCT00388388|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110163189|NCT00388388|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110163190|NCT00388388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110163191|NCT00388388|Diuretics|diuretics|mesh-ancestor
110163192|NCT00388388|Natriuretic Agents|natriuretic agents|mesh-ancestor
110163193|NCT00388388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110163194|NCT00388388|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110163195|NCT00388388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110163197|NCT00117013|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110163198|NCT00117013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110163199|NCT00117013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110163200|NCT00117013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110163201|NCT00117013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110163202|NCT02743455|Vaccines|vaccines|mesh-list
110163203|NCT02743455|Immunologic Factors|immunologic factors|mesh-ancestor
110163204|NCT02743455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110163205|NCT00117052|Cinacalcet|cinacalcet|mesh-list
110189046|NCT00019994|Aldesleukin|aldesleukin|mesh-list
110163206|NCT00117052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110163207|NCT00117052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110163208|NCT00117052|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
110163209|NCT00117052|Hormone Antagonists|hormone antagonists|mesh-ancestor
110163210|NCT00117052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110163211|NCT00117091|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110163212|NCT00117091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110163213|NCT02972450|Vedolizumab|vedolizumab|mesh-list
110163214|NCT02972450|Vaccines|vaccines|mesh-list
110163215|NCT02972450|Immunologic Factors|immunologic factors|mesh-ancestor
110163216|NCT02972450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110163217|NCT02972450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110163218|NCT00117130|Darbepoetin alfa|darbepoetin alfa|mesh-list
110163219|NCT00117130|Hematinics|hematinics|mesh-ancestor
110163220|NCT00117208|Mannitol|mannitol|mesh-list
110163221|NCT00117208|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110163223|NCT00117208|Natriuretic Agents|natriuretic agents|mesh-ancestor
110163224|NCT00117208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110163225|NCT00117247|Darbepoetin alfa|darbepoetin alfa|mesh-list
110163226|NCT00117247|Hematinics|hematinics|mesh-ancestor
110163228|NCT00388427|Dasatinib|dasatinib|mesh-list
110163229|NCT00388427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110163230|NCT00388427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110163231|NCT00388427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110163233|NCT00388427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110163234|NCT00117364|Sacchachitin|sacchachitin|mesh-list
110163235|NCT00117364|Antioxidants|antioxidants|mesh-ancestor
110163236|NCT00117364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110163237|NCT00117364|Protective Agents|protective agents|mesh-ancestor
110163238|NCT00117364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110163239|NCT00117403|Vitamins|vitamins|mesh-list
110163240|NCT00117403|Vitamin E|vitamin e|mesh-list
110163241|NCT00117403|Thioctic Acid|thioctic acid|mesh-list
110163242|NCT00117403|Coenzyme Q10|coenzyme q10|mesh-list
110163243|NCT00117403|Ubiquinone|ubiquinone|mesh-list
110163244|NCT00117403|Micronutrients|micronutrients|mesh-ancestor
110163245|NCT00117403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110163246|NCT00117403|Antioxidants|antioxidants|mesh-ancestor
110163247|NCT00117403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110163248|NCT00117403|Protective Agents|protective agents|mesh-ancestor
110163249|NCT00117403|Vitamin B Complex|vitamin b complex|mesh-ancestor
110163250|NCT00117442|Paclitaxel|paclitaxel|mesh-list
110163251|NCT00117442|Carboplatin|carboplatin|mesh-list
110163252|NCT00117442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110163253|NCT00117442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110163254|NCT00117442|Tubulin Modulators|tubulin modulators|mesh-ancestor
110163255|NCT00117442|Antimitotic Agents|antimitotic agents|mesh-ancestor
110163256|NCT00117442|Mitosis Modulators|mitosis modulators|mesh-ancestor
110163257|NCT00117442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110163258|NCT00117520|Caffeine|caffeine|mesh-list
110163259|NCT00117520|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110163260|NCT00117520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110163261|NCT00117520|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110163262|NCT00117520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110163263|NCT00117520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110163264|NCT00117520|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110163265|NCT00117520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110163266|NCT00117520|Purinergic Agents|purinergic agents|mesh-ancestor
110163267|NCT00117520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110163268|NCT04727515|Fentanyl|fentanyl|mesh-list
110163269|NCT04727515|Isoflurane|isoflurane|mesh-list
110163271|NCT04727515|Narcotics|narcotics|mesh-ancestor
110189056|NCT00039663|Rosiglitazone|rosiglitazone|mesh-list
110163272|NCT04727515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110163273|NCT04727515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110163275|NCT04727515|Sensory System Agents|sensory system agents|mesh-ancestor
110163276|NCT04727515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110163277|NCT04727515|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110163278|NCT04727515|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110163279|NCT04727515|Anesthetics, General|anesthetics, general|mesh-ancestor
110163280|NCT04727515|Anesthetics|anesthetics|mesh-ancestor
110163281|NCT04727515|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110163282|NCT00117754|Terbinafine|terbinafine|mesh-list
110163283|NCT00117754|Antifungal Agents|antifungal agents|mesh-ancestor
110163284|NCT00117754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110163285|NCT00117754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110163286|NCT00117754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110163287|NCT00117832|Azelastine|azelastine|mesh-list
110163288|NCT00117832|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110163289|NCT00117832|Autonomic Agents|autonomic agents|mesh-ancestor
110163290|NCT00117832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110163291|NCT00117832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110163293|NCT00117832|Respiratory System Agents|respiratory system agents|mesh-ancestor
110163294|NCT00117832|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110163295|NCT00117832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110163296|NCT00117832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110163297|NCT00117832|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110163298|NCT00117832|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110163299|NCT00117832|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110163300|NCT00117832|Histamine Antagonists|histamine antagonists|mesh-ancestor
110163302|NCT00117832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110163303|NCT00118027|Pyrimethamine|pyrimethamine|mesh-list
110163304|NCT00118027|Sulfadoxine|sulfadoxine|mesh-list
110163305|NCT00118027|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110163306|NCT00118027|Antimalarials|antimalarials|mesh-ancestor
110163307|NCT00118027|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110163308|NCT00118027|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110163309|NCT00118027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110163310|NCT00118027|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110163311|NCT00118027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110163312|NCT00118027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110163313|NCT00118027|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110163315|NCT00118066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110163316|NCT00118066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110163317|NCT00118066|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110163318|NCT00118066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110163319|NCT00118066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110163320|NCT00118066|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110163321|NCT00118066|Vitamins|vitamins|mesh-ancestor
110163322|NCT00118066|Micronutrients|micronutrients|mesh-ancestor
110163323|NCT00118066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110163324|NCT00118105|Bevacizumab|bevacizumab|mesh-list
110163325|NCT00118105|Capecitabine|capecitabine|mesh-list
110163326|NCT00118105|Oxaliplatin|oxaliplatin|mesh-list
110163327|NCT00118105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110163328|NCT00118105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110163329|NCT00118105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110163330|NCT00118105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110163331|NCT00118105|Growth Substances|growth substances|mesh-ancestor
110163332|NCT00118105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110163333|NCT00118105|Growth Inhibitors|growth inhibitors|mesh-ancestor
110163334|NCT00118105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110163335|NCT00118105|Antimetabolites|antimetabolites|mesh-ancestor
110163337|NCT00118183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110163339|NCT00118183|Docetaxel|docetaxel|mesh-list
110163340|NCT00118183|Bortezomib|bortezomib|mesh-list
110163341|NCT00118183|Antibodies|antibodies|mesh-list
110163342|NCT00118183|Immunoglobulins|immunoglobulins|mesh-list
110163343|NCT00118183|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110163344|NCT00118183|Immunologic Factors|immunologic factors|mesh-ancestor
110163345|NCT00118183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110163346|NCT00118183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110163347|NCT00118183|Tubulin Modulators|tubulin modulators|mesh-ancestor
110163348|NCT00118183|Antimitotic Agents|antimitotic agents|mesh-ancestor
110163349|NCT00118183|Mitosis Modulators|mitosis modulators|mesh-ancestor
110163350|NCT00118183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110163352|NCT00390975|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110163353|NCT00390975|Serotonin Agents|serotonin agents|mesh-ancestor
110163354|NCT00390975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110163355|NCT00390975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110163356|NCT00390975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110163357|NCT00118222|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
110163358|NCT00118222|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
110163360|NCT00118222|Trioxsalen|trioxsalen|mesh-list
110163361|NCT00118222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110163362|NCT00118222|Dermatologic Agents|dermatologic agents|mesh-ancestor
110163363|NCT00118222|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110163364|NCT00118222|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110163365|NCT00118222|Anesthetics, General|anesthetics, general|mesh-ancestor
110163367|NCT00118222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110163368|NCT00118222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110163369|NCT00118261|Leucovorin|leucovorin|mesh-list
110163370|NCT00118261|Bevacizumab|bevacizumab|mesh-list
110163371|NCT00118261|Fluorouracil|fluorouracil|mesh-list
110163372|NCT00118261|Oxaliplatin|oxaliplatin|mesh-list
110163373|NCT00118261|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110163374|NCT00118261|Calcium|calcium|mesh-list
110163375|NCT00118261|Levoleucovorin|levoleucovorin|mesh-list
110163376|NCT00118261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110163377|NCT00118261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110163378|NCT00118261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110163379|NCT00118261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110163380|NCT00118261|Growth Substances|growth substances|mesh-ancestor
110163381|NCT00118261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110163382|NCT00118261|Growth Inhibitors|growth inhibitors|mesh-ancestor
110163383|NCT00118261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110163384|NCT00118261|Antimetabolites|antimetabolites|mesh-ancestor
110163385|NCT00118261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110163386|NCT00118261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110163387|NCT00118261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110163388|NCT00118261|Immunologic Factors|immunologic factors|mesh-ancestor
110163389|NCT00118261|Antidotes|antidotes|mesh-ancestor
110163390|NCT00118261|Protective Agents|protective agents|mesh-ancestor
110163391|NCT00118261|Vitamin B Complex|vitamin b complex|mesh-ancestor
110163392|NCT00118261|Vitamins|vitamins|mesh-ancestor
110163393|NCT00118261|Micronutrients|micronutrients|mesh-ancestor
110163394|NCT00118261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110163395|NCT00118261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110163396|NCT00118300|Capecitabine|capecitabine|mesh-list
110163397|NCT00118300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110163398|NCT00118300|Antimetabolites|antimetabolites|mesh-ancestor
110163399|NCT00118300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110163400|NCT00118300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110163401|NCT02710734|Doxorubicin|doxorubicin|mesh-list
110163402|NCT02710734|Methotrexate|methotrexate|mesh-list
110163404|NCT02710734|Mitomycin|mitomycin|mesh-list
110163405|NCT02710734|Vinblastine|vinblastine|mesh-list
110163406|NCT02710734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110163407|NCT02710734|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110163408|NCT02710734|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110163409|NCT02710734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110163410|NCT02710734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110163411|NCT02710734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110163412|NCT02710734|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110163413|NCT02710734|Abortifacient Agents|abortifacient agents|mesh-ancestor
110163414|NCT02710734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110163415|NCT02710734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110163416|NCT02710734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110163417|NCT02710734|Antimetabolites|antimetabolites|mesh-ancestor
110163418|NCT02710734|Dermatologic Agents|dermatologic agents|mesh-ancestor
110163419|NCT02710734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110163420|NCT02710734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110163421|NCT02710734|Immunologic Factors|immunologic factors|mesh-ancestor
110163422|NCT02710734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110163423|NCT02710734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110163424|NCT02710734|Alkylating Agents|alkylating agents|mesh-ancestor
110163425|NCT02710734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110163426|NCT02710734|Tubulin Modulators|tubulin modulators|mesh-ancestor
110163427|NCT02710734|Antimitotic Agents|antimitotic agents|mesh-ancestor
110163428|NCT02710734|Mitosis Modulators|mitosis modulators|mesh-ancestor
110163431|NCT00118690|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110163432|NCT00118690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110163433|NCT00118690|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110163434|NCT00118690|Autonomic Agents|autonomic agents|mesh-ancestor
110163435|NCT00118690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110163436|NCT00118690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110163437|NCT00118690|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110163438|NCT00118690|Respiratory System Agents|respiratory system agents|mesh-ancestor
110163439|NCT00118690|Dermatologic Agents|dermatologic agents|mesh-ancestor
110163440|NCT00118690|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110163441|NCT00118690|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110163442|NCT00118690|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110163443|NCT00118690|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110163444|NCT00118690|Adrenergic Agents|adrenergic agents|mesh-ancestor
110163445|NCT00118690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110163446|NCT00118690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110163447|NCT00402142|Vaccines|vaccines|mesh-list
110189114|NCT00039975|Ritonavir|ritonavir|mesh-list
110163448|NCT00402142|Immunologic Factors|immunologic factors|mesh-ancestor
110163449|NCT00402142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110163451|NCT00118768|Interferon-alpha|interferon-alpha|mesh-list
110163452|NCT00118768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110163453|NCT00118768|Antiviral Agents|antiviral agents|mesh-ancestor
110163454|NCT00118768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110163455|NCT00118768|Immunologic Factors|immunologic factors|mesh-ancestor
110163456|NCT00118768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110163457|NCT00118807|Artesunate|artesunate|mesh-list
110163458|NCT00118807|Chloroquine|chloroquine|mesh-list
110163459|NCT00118807|Pyrimethamine|pyrimethamine|mesh-list
110163460|NCT00118807|Sulfadoxine|sulfadoxine|mesh-list
110163461|NCT00118807|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110163462|NCT00118807|Amodiaquine|amodiaquine|mesh-list
110163463|NCT00118807|Antimalarials|antimalarials|mesh-ancestor
110163464|NCT00118807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110163465|NCT00118807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110163466|NCT00118807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110163467|NCT00118807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110163469|NCT00118807|Schistosomicides|schistosomicides|mesh-ancestor
110163470|NCT00118807|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110163471|NCT00118807|Anthelmintics|anthelmintics|mesh-ancestor
110163472|NCT00118807|Amebicides|amebicides|mesh-ancestor
110163473|NCT00118807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110163474|NCT00118807|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110163475|NCT00118807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110163476|NCT00118807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110163477|NCT00118807|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110163479|NCT00118963|Insulin Aspart|insulin aspart|mesh-list
110163480|NCT00118963|Repaglinide|repaglinide|mesh-list
110163481|NCT00118963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110163482|NCT00118963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110163483|NCT00119002|Dexamethasone|dexamethasone|mesh-list
110163484|NCT00119002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110163485|NCT00119002|Antiemetics|antiemetics|mesh-ancestor
110163486|NCT00119002|Autonomic Agents|autonomic agents|mesh-ancestor
110163487|NCT00119002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110163488|NCT00119002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110163489|NCT00119002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110163490|NCT00119002|Glucocorticoids|glucocorticoids|mesh-ancestor
110163491|NCT00119002|Hormones|hormones|mesh-ancestor
110163492|NCT00119002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110163493|NCT00119002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110163494|NCT00119002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110163495|NCT00119119|Tocopherols|tocopherols|mesh-list
110163496|NCT00119119|Vitamin E|vitamin e|mesh-list
110163497|NCT00119119|Tocotrienols|tocotrienols|mesh-list
110163498|NCT00119119|alpha-Tocopherol|alpha-tocopherol|mesh-list
110163499|NCT00119119|Antioxidants|antioxidants|mesh-ancestor
110163500|NCT00119119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110163501|NCT00119119|Protective Agents|protective agents|mesh-ancestor
110163502|NCT00119119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110163503|NCT00119119|Vitamins|vitamins|mesh-ancestor
110163504|NCT00119119|Micronutrients|micronutrients|mesh-ancestor
110163505|NCT00119236|Irinotecan|irinotecan|mesh-list
110163506|NCT00119236|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110163507|NCT00119236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110163508|NCT00119236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110163509|NCT00119236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110163510|NCT00119236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110163511|NCT00119314|Gemcitabine|gemcitabine|mesh-list
110163512|NCT00119314|Capecitabine|capecitabine|mesh-list
110163513|NCT00119314|Docetaxel|docetaxel|mesh-list
110163514|NCT00119314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110163515|NCT00119314|Antimetabolites|antimetabolites|mesh-ancestor
110163516|NCT00119314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042183|NCT01440790|Antioxidants|antioxidants|mesh-ancestor
110163517|NCT00119314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110163518|NCT00119314|Tubulin Modulators|tubulin modulators|mesh-ancestor
110163519|NCT00119314|Antimitotic Agents|antimitotic agents|mesh-ancestor
110163520|NCT00119314|Mitosis Modulators|mitosis modulators|mesh-ancestor
110163521|NCT00119431|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
110163522|NCT00119431|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110163523|NCT00119431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110163524|NCT00119431|Immunologic Factors|immunologic factors|mesh-ancestor
110163525|NCT00119431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110163526|NCT00119587|Darbepoetin alfa|darbepoetin alfa|mesh-list
110163527|NCT00119587|Hematinics|hematinics|mesh-ancestor
110163528|NCT00119626|Disufenton sodium|disufenton sodium|mesh-list
110163529|NCT00119626|Antioxidants|antioxidants|mesh-ancestor
110163530|NCT00119626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110163531|NCT00119626|Protective Agents|protective agents|mesh-ancestor
110163532|NCT00119626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110163533|NCT00119704|Botulinum Toxins|botulinum toxins|mesh-list
110163534|NCT00119704|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110163535|NCT00119704|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110163536|NCT00119704|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110163537|NCT00119704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110163538|NCT00119704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110163539|NCT00119704|Cholinergic Agents|cholinergic agents|mesh-ancestor
110163540|NCT00119704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110163541|NCT00119704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110163542|NCT00119704|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110163543|NCT00119704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110163544|NCT02621151|Gemcitabine|gemcitabine|mesh-list
110163545|NCT02621151|Pembrolizumab|pembrolizumab|mesh-list
110163546|NCT02621151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110163547|NCT02621151|Antimetabolites|antimetabolites|mesh-ancestor
110163548|NCT02621151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110163549|NCT02621151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110163550|NCT02621151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110163551|NCT02621151|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110163553|NCT00120055|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110163554|NCT00120055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110163555|NCT00120055|Antimetabolites|antimetabolites|mesh-ancestor
110163556|NCT00120055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110163557|NCT00120055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110163558|NCT00120055|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110163559|NCT00120055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110163560|NCT00120133|Atorvastatin|atorvastatin|mesh-list
110163561|NCT00120133|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110163562|NCT00120133|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110163563|NCT00120133|Antimetabolites|antimetabolites|mesh-ancestor
110163564|NCT00120133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110163565|NCT00120133|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110163566|NCT00120133|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110163567|NCT00120133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110163569|NCT00120172|Capecitabine|capecitabine|mesh-list
110163570|NCT00120172|Oxaliplatin|oxaliplatin|mesh-list
110163571|NCT00120172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110163573|NCT00120172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110163574|NCT00120172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110163575|NCT00120172|Growth Substances|growth substances|mesh-ancestor
110163576|NCT00120172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110163577|NCT00120172|Growth Inhibitors|growth inhibitors|mesh-ancestor
110163578|NCT00120172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110163579|NCT00120172|Antimetabolites|antimetabolites|mesh-ancestor
110163580|NCT00120172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110163581|NCT00402181|Dexamethasone|dexamethasone|mesh-list
110163583|NCT00402181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110163584|NCT00402181|Antiemetics|antiemetics|mesh-ancestor
110163585|NCT00402181|Autonomic Agents|autonomic agents|mesh-ancestor
110163586|NCT00402181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110163587|NCT00402181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110163588|NCT00402181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110163589|NCT00402181|Glucocorticoids|glucocorticoids|mesh-ancestor
110163590|NCT00402181|Hormones|hormones|mesh-ancestor
110163591|NCT00402181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110163592|NCT00402181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110163593|NCT00402181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110163594|NCT04727437|Heparin|heparin|mesh-list
110163595|NCT04727437|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110163596|NCT04727437|Tinzaparin|tinzaparin|mesh-list
110163597|NCT04727437|Dalteparin|dalteparin|mesh-list
110163598|NCT04727437|Warfarin|warfarin|mesh-list
110163599|NCT04727437|Anticoagulants|anticoagulants|mesh-list
110163600|NCT04727437|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110163601|NCT04727437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110163602|NCT04727437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110163603|NCT00120367|Tenofovir|tenofovir|mesh-list
110163604|NCT00120367|Emtricitabine|emtricitabine|mesh-list
110163605|NCT00120367|Enfuvirtide|enfuvirtide|mesh-list
110163607|NCT00120367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110163608|NCT00120367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110163609|NCT00120367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110163610|NCT00120367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110163611|NCT00120367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110163612|NCT00120367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110163613|NCT00120367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110163614|NCT00120367|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110163615|NCT00120367|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110163617|NCT04727320|Antiviral Agents|antiviral agents|mesh-ancestor
110163618|NCT04727320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110163619|NCT04727320|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110163620|NCT04727320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110163621|NCT00120484|Vitamin B 12|vitamin b 12|mesh-list
110163623|NCT00120484|Vitamins|vitamins|mesh-ancestor
110163624|NCT00120484|Micronutrients|micronutrients|mesh-ancestor
110163625|NCT00120484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110163626|NCT00120484|Vitamin B Complex|vitamin b complex|mesh-ancestor
110163627|NCT00120484|Hematinics|hematinics|mesh-ancestor
110163628|NCT00391014|Amphotericin B|amphotericin b|mesh-list
110163629|NCT00391014|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110163630|NCT00391014|Amebicides|amebicides|mesh-ancestor
110163632|NCT00391014|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110163633|NCT00391014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110163634|NCT00391014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110163635|NCT00391014|Antifungal Agents|antifungal agents|mesh-ancestor
110163636|NCT00120601|Naltrexone|naltrexone|mesh-list
110163637|NCT00120601|Acamprosate|acamprosate|mesh-list
110163638|NCT00120601|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110163639|NCT00120601|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110163640|NCT00120601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110163641|NCT00120601|Sensory System Agents|sensory system agents|mesh-ancestor
110163642|NCT00120601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110163643|NCT00120640|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
110163644|NCT00120640|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
110163645|NCT00120640|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110163646|NCT00120640|Hormone Antagonists|hormone antagonists|mesh-ancestor
110163647|NCT00120640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110163648|NCT00120640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110163649|NCT00120640|Progestins|progestins|mesh-ancestor
110163650|NCT00120640|Hormones|hormones|mesh-ancestor
110163651|NCT00120679|Epoetin Alfa|epoetin alfa|mesh-list
110163652|NCT00120679|Darbepoetin alfa|darbepoetin alfa|mesh-list
110163653|NCT00120679|Hematinics|hematinics|mesh-ancestor
110163654|NCT00120718|Fasudil|fasudil|mesh-list
110163655|NCT00120718|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110163656|NCT00120718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110163657|NCT00120718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110163658|NCT00120718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110163659|NCT00120718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110163660|NCT00120718|Vasodilator Agents|vasodilator agents|mesh-ancestor
110163661|NCT00120718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110163662|NCT00120718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110163664|NCT00120757|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110163665|NCT00120757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110163666|NCT00120796|Lamivudine|lamivudine|mesh-list
110163667|NCT00120796|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110163668|NCT00120796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110163669|NCT00120796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110163670|NCT00120796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110163672|NCT00120796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110163674|NCT00120796|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110163676|NCT00120835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110163677|NCT00120835|Antiviral Agents|antiviral agents|mesh-ancestor
110163678|NCT00120835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110163680|NCT00120913|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
110163681|NCT00120913|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110163682|NCT00120913|Contraceptive Agents|contraceptive agents|mesh-ancestor
110163683|NCT00120913|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110163684|NCT00120913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110163685|NCT00121030|Epoetin Alfa|epoetin alfa|mesh-list
110163686|NCT00121030|Darbepoetin alfa|darbepoetin alfa|mesh-list
110163687|NCT00121030|Hematinics|hematinics|mesh-ancestor
110163688|NCT00121069|Escitalopram|escitalopram|mesh-list
110163689|NCT00121069|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110163690|NCT00121069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110163691|NCT00121069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110163692|NCT00121069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110163693|NCT00121069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110163695|NCT00121069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110163696|NCT00121147|Travoprost|travoprost|mesh-list
110163697|NCT00121147|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110163698|NCT00121147|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110163699|NCT00121147|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110163700|NCT00121147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110163701|NCT00121147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110163702|NCT00121147|Adrenergic Agents|adrenergic agents|mesh-ancestor
110163703|NCT00121147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110163704|NCT00121147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110163705|NCT00121147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110163706|NCT00121264|Sorafenib|sorafenib|mesh-list
110163707|NCT00121264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110163708|NCT00121264|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110163709|NCT00121264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110163710|NCT00121264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110163711|NCT00121303|Cytarabine|cytarabine|mesh-list
110163712|NCT00121303|Daunorubicin|daunorubicin|mesh-list
110163713|NCT00121303|Gemtuzumab|gemtuzumab|mesh-list
110163714|NCT00121303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110163715|NCT00121303|Antimetabolites|antimetabolites|mesh-ancestor
110163716|NCT00121303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110163717|NCT00121303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110163718|NCT00121303|Antiviral Agents|antiviral agents|mesh-ancestor
110163719|NCT00121303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110163720|NCT00121303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110163721|NCT00121303|Immunologic Factors|immunologic factors|mesh-ancestor
110163722|NCT00121303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110163723|NCT00121303|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110163724|NCT00121303|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110163725|NCT00121303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110163726|NCT00121303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110163727|NCT00121303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110163728|NCT00121303|Immunotoxins|immunotoxins|mesh-ancestor
110163729|NCT00121303|Immunoconjugates|immunoconjugates|mesh-ancestor
110163730|NCT00121381|Pimecrolimus|pimecrolimus|mesh-list
110163733|NCT00121381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110163735|NCT00121381|Sensory System Agents|sensory system agents|mesh-ancestor
110163736|NCT00121381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110163737|NCT00121381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110163738|NCT00121381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110163739|NCT00121381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110163740|NCT00121381|Dermatologic Agents|dermatologic agents|mesh-ancestor
110163741|NCT00121381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110163742|NCT00121381|Immunologic Factors|immunologic factors|mesh-ancestor
110163743|NCT00121381|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110163744|NCT00121381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110163745|NCT00121381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110163746|NCT00121420|Motexafin gadolinium|motexafin gadolinium|mesh-list
110163747|NCT00121420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110163748|NCT00121420|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110163750|NCT00121459|Psyllium|psyllium|mesh-list
110163751|NCT00121459|Calcium polycarbophil|calcium polycarbophil|mesh-list
110163752|NCT00121459|Cathartics|cathartics|mesh-ancestor
110163754|NCT00121459|Antidiarrheals|antidiarrheals|mesh-ancestor
110163755|NCT00121498|Lidocaine|lidocaine|mesh-list
110163756|NCT00121498|Anesthetics, Local|anesthetics, local|mesh-list
110163757|NCT00121498|Anesthetics|anesthetics|mesh-list
110163758|NCT00121498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110163759|NCT00121498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110163760|NCT00121498|Sensory System Agents|sensory system agents|mesh-ancestor
110163761|NCT00121498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110163762|NCT00121498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110163763|NCT00121498|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110163764|NCT00121498|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110163765|NCT00121498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110163766|NCT00121498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110163767|NCT00121615|Etanercept|etanercept|mesh-list
110163768|NCT00121615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110163769|NCT00121615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110163770|NCT00121615|Analgesics|analgesics|mesh-ancestor
110163771|NCT00121615|Sensory System Agents|sensory system agents|mesh-ancestor
110163772|NCT00121615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110163773|NCT00121615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110163774|NCT00121615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110163775|NCT00121615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110163776|NCT00121615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110163777|NCT00121615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110163778|NCT00121615|Immunologic Factors|immunologic factors|mesh-ancestor
110163779|NCT00391248|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110163780|NCT00391248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110163781|NCT00391248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110163782|NCT00391248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110163783|NCT00391248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110163785|NCT04711096|Anesthetics, Local|anesthetics, local|mesh-ancestor
110163786|NCT04711096|Anesthetics|anesthetics|mesh-ancestor
110163787|NCT04711096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110163788|NCT04711096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110163789|NCT04711096|Sensory System Agents|sensory system agents|mesh-ancestor
110163790|NCT04711096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110163791|NCT04705948|Magnesium Sulfate|magnesium sulfate|mesh-list
110163792|NCT04705948|Ketamine|ketamine|mesh-list
110163793|NCT04705948|Analgesics|analgesics|mesh-ancestor
110163794|NCT04705948|Sensory System Agents|sensory system agents|mesh-ancestor
110163795|NCT04705948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110163796|NCT04705948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110163802|NCT04705948|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110163803|NCT04705948|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110163804|NCT04705948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110163805|NCT04705948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110163807|NCT04705948|Anticonvulsants|anticonvulsants|mesh-ancestor
110163808|NCT04705948|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110163809|NCT04705948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110163810|NCT04705948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110163811|NCT04705948|Tocolytic Agents|tocolytic agents|mesh-ancestor
110163812|NCT04705948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110163813|NCT00121888|Paroxetine|paroxetine|mesh-list
110163814|NCT00121888|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110163815|NCT00121888|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110163816|NCT00121888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110163817|NCT00121888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110163818|NCT00121888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110163820|NCT00121888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110163821|NCT00121888|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110163822|NCT00121888|Antidepressive Agents|antidepressive agents|mesh-ancestor
110163823|NCT00121888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110189187|NCT00020501|Melphalan|melphalan|mesh-list
110163824|NCT00121888|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110163825|NCT00121888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110163826|NCT00121888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110163828|NCT00121966|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110163829|NCT00121966|Metformin|metformin|mesh-list
110163830|NCT00121966|Insulin Aspart|insulin aspart|mesh-list
110163831|NCT00121966|Rosiglitazone|rosiglitazone|mesh-list
110163832|NCT00121966|Isophane Insulin, Human|isophane insulin, human|mesh-list
110163833|NCT00121966|Insulin, Isophane|insulin, isophane|mesh-list
110163834|NCT00121966|Isophane insulin, beef|isophane insulin, beef|mesh-list
110163835|NCT00121966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110163836|NCT00121966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110163837|NCT00122044|Trihexyphenidyl|trihexyphenidyl|mesh-list
110163838|NCT00122044|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110163839|NCT00122044|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110163840|NCT00122044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110163841|NCT00122044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110163842|NCT00122044|Cholinergic Agents|cholinergic agents|mesh-ancestor
110163843|NCT00122044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110163844|NCT00122044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110163845|NCT00122044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110163847|NCT02013492|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110163848|NCT02013492|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110163849|NCT02013492|Adrenergic Agents|adrenergic agents|mesh-ancestor
110163850|NCT02013492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110163851|NCT02013492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110163852|NCT02013492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110163853|NCT02013492|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110163854|NCT02013492|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110163855|NCT02013492|Vasodilator Agents|vasodilator agents|mesh-ancestor
110163858|NCT00122356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110163859|NCT01931709|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110163860|NCT01931709|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110163861|NCT01931709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110163862|NCT00122434|Tiotropium Bromide|tiotropium bromide|mesh-list
110163863|NCT00122434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110163864|NCT00122434|Autonomic Agents|autonomic agents|mesh-ancestor
110163865|NCT00122434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110163866|NCT00122434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110163867|NCT00122434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110163868|NCT00122434|Respiratory System Agents|respiratory system agents|mesh-ancestor
110163869|NCT00122434|Parasympatholytics|parasympatholytics|mesh-ancestor
110163870|NCT00122434|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110163871|NCT00122434|Cholinergic Agents|cholinergic agents|mesh-ancestor
110163872|NCT00122434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110163873|NCT00122434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110163874|NCT00122473|Imatinib Mesylate|imatinib mesylate|mesh-list
110163875|NCT00122473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110163876|NCT00122473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110163877|NCT00122473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110163878|NCT00122473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110163879|NCT00122512|Tenofovir|tenofovir|mesh-list
110163880|NCT00122512|Antiviral Agents|antiviral agents|mesh-ancestor
110163881|NCT00122512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110163882|NCT00122512|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110163883|NCT00122512|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110163884|NCT00122512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110163885|NCT00122512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110163887|NCT00122512|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110163888|NCT01720407|Imiquimod|imiquimod|mesh-list
110163889|NCT01720407|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110163890|NCT01720407|Immunologic Factors|immunologic factors|mesh-ancestor
110163891|NCT01720407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110163892|NCT01720407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110163893|NCT01720407|Interferon Inducers|interferon inducers|mesh-ancestor
110163894|NCT00122551|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110163895|NCT00122551|Antiviral Agents|antiviral agents|mesh-ancestor
110163896|NCT00122551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110163897|NCT00122590|Ritonavir|ritonavir|mesh-list
110163898|NCT00122590|Lopinavir|lopinavir|mesh-list
110163899|NCT00122590|Nelfinavir|nelfinavir|mesh-list
110163900|NCT00122590|Indinavir|indinavir|mesh-list
110163901|NCT00122590|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110163902|NCT00122590|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110163903|NCT00122590|Protease Inhibitors|protease inhibitors|mesh-ancestor
110163904|NCT00122590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110163905|NCT00122590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110163906|NCT00122590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110163907|NCT00122590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110163908|NCT00122590|Antiviral Agents|antiviral agents|mesh-ancestor
110163909|NCT00122590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110163910|NCT00122590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110163911|NCT00122590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110163912|NCT00122629|Interferons|interferons|mesh-list
110163913|NCT00122629|Ribavirin|ribavirin|mesh-list
110163914|NCT00122629|Interferon-alpha|interferon-alpha|mesh-list
110163915|NCT00122629|Interferon alpha-2|interferon alpha-2|mesh-list
110163916|NCT00122629|Amantadine|amantadine|mesh-list
110163917|NCT00122629|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110163918|NCT00122629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110163919|NCT00122629|Antiviral Agents|antiviral agents|mesh-ancestor
110163920|NCT00122629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110163921|NCT00122629|Antimetabolites|antimetabolites|mesh-ancestor
110163923|NCT00122629|Immunologic Factors|immunologic factors|mesh-ancestor
110163924|NCT00122629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110163925|NCT00122629|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110163926|NCT00122629|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110163927|NCT00122629|Dopamine Agents|dopamine agents|mesh-ancestor
110163928|NCT00122629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110163929|NCT00122629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110163930|NCT00122629|Analgesics|analgesics|mesh-ancestor
110163931|NCT00122629|Sensory System Agents|sensory system agents|mesh-ancestor
110163932|NCT00122629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110163933|NCT00122668|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
110163934|NCT00122668|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
110163935|NCT00122668|Protease Inhibitors|protease inhibitors|mesh-list
110163936|NCT00122668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110163937|NCT00122668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110163938|NCT00122668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110163939|NCT00122668|Antiviral Agents|antiviral agents|mesh-ancestor
110163940|NCT00122668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110163941|NCT00122668|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110163942|NCT00122668|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110163943|NCT00122668|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110163944|NCT05637164|Norepinephrine|norepinephrine|mesh-list
110163945|NCT05637164|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110163946|NCT05637164|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110163947|NCT05637164|Adrenergic Agents|adrenergic agents|mesh-ancestor
110163948|NCT05637164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110163949|NCT05637164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110163950|NCT05637164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110163952|NCT05637164|Autonomic Agents|autonomic agents|mesh-ancestor
110163953|NCT05637164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110163954|NCT05637164|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110163955|NCT00129337|Bavituximab|bavituximab|mesh-list
110163956|NCT00129337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110163957|NCT00129337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110163959|NCT00129298|Anticonvulsants|anticonvulsants|mesh-ancestor
110163960|NCT00129298|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
110163961|NCT00129298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110163962|NCT00129298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110163963|NCT00129298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110163964|NCT00129298|GABA Agents|gaba agents|mesh-ancestor
110163965|NCT00129298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110163966|NCT00129298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110163967|NCT00129181|Levodopa|levodopa|mesh-list
110163968|NCT00129181|Carbidopa|carbidopa|mesh-list
110163969|NCT00129181|Cabergoline|cabergoline|mesh-list
110163970|NCT00129181|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110163971|NCT00129181|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110163972|NCT00129181|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110163973|NCT00129181|Dopamine Agents|dopamine agents|mesh-ancestor
110163974|NCT00129181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110163975|NCT00129181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110163976|NCT00129181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110163977|NCT00129181|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110163979|NCT00129181|Dopamine Agonists|dopamine agonists|mesh-ancestor
110163980|NCT00129181|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110163981|NCT00129181|Immunologic Factors|immunologic factors|mesh-ancestor
110163983|NCT00129142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110163984|NCT00129142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110163985|NCT00129142|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110163986|NCT00129142|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110163987|NCT00129142|Hormone Antagonists|hormone antagonists|mesh-ancestor
110225487|NCT05952713|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110163989|NCT00129142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110163990|NCT00129142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110163992|NCT00128947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110163993|NCT00128947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110163994|NCT00128947|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110163995|NCT00128947|Antitubercular Agents|antitubercular agents|mesh-ancestor
110163996|NCT00128947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110163997|NCT00128947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110163998|NCT00128947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110163999|NCT00128947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110164000|NCT00819780|Bevacizumab|bevacizumab|mesh-list
110164001|NCT00819780|Panitumumab|panitumumab|mesh-list
110164003|NCT00819780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110164004|NCT00819780|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110164005|NCT00819780|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110164006|NCT00819780|Growth Substances|growth substances|mesh-ancestor
110164007|NCT00819780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110164008|NCT00819780|Growth Inhibitors|growth inhibitors|mesh-ancestor
110164009|NCT00128908|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110164010|NCT00128908|Antiviral Agents|antiviral agents|mesh-ancestor
110164011|NCT00128908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110164012|NCT00128791|Nitroprusside|nitroprusside|mesh-list
110164013|NCT00128791|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110164014|NCT00128791|Vasodilator Agents|vasodilator agents|mesh-ancestor
110164015|NCT00128791|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110164016|NCT00128791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110164017|NCT00128752|Beta Carotene|beta carotene|mesh-list
110164018|NCT00128752|Carotenoids|carotenoids|mesh-list
110164019|NCT00128752|Antioxidants|antioxidants|mesh-ancestor
110164020|NCT00128752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110164021|NCT00128752|Protective Agents|protective agents|mesh-ancestor
110164022|NCT00128752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110164024|NCT00128752|Vitamins|vitamins|mesh-ancestor
110189215|NCT00020579|Entinostat|entinostat|mesh-list
110164025|NCT00128752|Micronutrients|micronutrients|mesh-ancestor
110164026|NCT05638295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110164028|NCT05638295|Sotorasib|sotorasib|mesh-list
110164029|NCT05638295|Antibodies|antibodies|mesh-list
110164030|NCT05638295|Immunoglobulins|immunoglobulins|mesh-list
110164031|NCT05638295|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110164032|NCT05638295|Immunologic Factors|immunologic factors|mesh-ancestor
110164033|NCT05638295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110164034|NCT05638295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110164035|NCT05638295|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110164036|NCT05638295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110164038|NCT00063414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110164039|NCT00063414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110164040|NCT00063414|Immunologic Factors|immunologic factors|mesh-ancestor
110164043|NCT05638451|Temozolomide|temozolomide|mesh-list
110164044|NCT05638451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110164045|NCT05638451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110164046|NCT05638451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110164047|NCT05638451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110164048|NCT05638451|Growth Substances|growth substances|mesh-ancestor
110164049|NCT05638451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110164050|NCT05638451|Growth Inhibitors|growth inhibitors|mesh-ancestor
110164051|NCT05638451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110164052|NCT05638451|Alkylating Agents|alkylating agents|mesh-ancestor
110164053|NCT05638451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110164055|NCT00009009|Complement System Proteins|complement system proteins|mesh-list
110164056|NCT00009009|Immunologic Factors|immunologic factors|mesh-ancestor
110164057|NCT00009009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110164058|NCT05638763|Ketoconazole|ketoconazole|mesh-list
110164059|NCT05638763|Dasatinib|dasatinib|mesh-list
110164060|NCT05638763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110164061|NCT05638763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110164062|NCT05638763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110164063|NCT05638763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110164064|NCT05638763|Antifungal Agents|antifungal agents|mesh-ancestor
110164065|NCT05638763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110164066|NCT05638763|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110164067|NCT05638763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110164068|NCT05638763|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110164069|NCT05638763|Hormone Antagonists|hormone antagonists|mesh-ancestor
110164070|NCT05638763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110164071|NCT05638763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110164072|NCT05638763|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110164073|NCT00128635|Antibodies|antibodies|mesh-list
110164074|NCT00128635|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110164075|NCT00128635|Immunologic Factors|immunologic factors|mesh-ancestor
110164076|NCT00128635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110164077|NCT00009048|Levodopa|levodopa|mesh-list
110164078|NCT00009048|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110164080|NCT00009048|Dopamine Agents|dopamine agents|mesh-ancestor
110164081|NCT00009048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110164082|NCT00009048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110164083|NCT00009048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110164084|NCT00128596|Arsenic Trioxide|arsenic trioxide|mesh-list
110164085|NCT00128596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110164086|NCT00128557|Vitamin A|vitamin a|mesh-list
110164091|NCT00128518|Indapamide|indapamide|mesh-list
110164092|NCT00128518|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110164093|NCT00128518|Protease Inhibitors|protease inhibitors|mesh-ancestor
110164094|NCT00128518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110164095|NCT00128518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110164096|NCT00128518|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110164097|NCT00128518|Diuretics|diuretics|mesh-ancestor
110164098|NCT00128518|Natriuretic Agents|natriuretic agents|mesh-ancestor
110164099|NCT00128518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110164100|NCT00128518|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110164101|NCT00128518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110164102|NCT00009204|Perphenazine|perphenazine|mesh-list
110164103|NCT00009204|Citalopram|citalopram|mesh-list
110164104|NCT00009204|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110164105|NCT00009204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110164106|NCT00009204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110164107|NCT00009204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110164108|NCT00009204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110164109|NCT00009204|Serotonin Agents|serotonin agents|mesh-ancestor
110164110|NCT00009204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110164111|NCT00009204|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110164112|NCT00009204|Antidepressive Agents|antidepressive agents|mesh-ancestor
110164113|NCT00009204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110164114|NCT00009204|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110164115|NCT00009204|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110164116|NCT00009204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110164117|NCT00009204|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110164118|NCT00009204|Dopamine Agents|dopamine agents|mesh-ancestor
110164120|NCT00394459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110164121|NCT00394459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110164122|NCT00394498|Lenograstim|lenograstim|mesh-list
110164123|NCT00394498|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110164124|NCT00394498|Immunologic Factors|immunologic factors|mesh-ancestor
110164125|NCT00394498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110164126|NCT00394537|Labetalol|labetalol|mesh-list
110164127|NCT00394537|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110164129|NCT00394537|Adrenergic Agents|adrenergic agents|mesh-ancestor
110164130|NCT00394537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110164131|NCT00394537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110164132|NCT00394537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110164133|NCT00394537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110164134|NCT00394537|Sympathomimetics|sympathomimetics|mesh-ancestor
110164135|NCT00394537|Autonomic Agents|autonomic agents|mesh-ancestor
110164136|NCT00394537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110164137|NCT00394537|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110164138|NCT00394537|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110164139|NCT00009555|Testosterone|testosterone|mesh-list
110164140|NCT00009555|Androgens|androgens|mesh-ancestor
110164141|NCT00009555|Hormones|hormones|mesh-ancestor
110164142|NCT00009555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110164143|NCT00009555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110164144|NCT00128479|Mifepristone|mifepristone|mesh-list
110164145|NCT00128479|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110164146|NCT00128479|Abortifacient Agents|abortifacient agents|mesh-ancestor
110164147|NCT00128479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110164148|NCT00128479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110164151|NCT00128479|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110164152|NCT00128479|Contraceptive Agents|contraceptive agents|mesh-ancestor
110164153|NCT00128479|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110164154|NCT00128479|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110164155|NCT00128479|Hormone Antagonists|hormone antagonists|mesh-ancestor
110164156|NCT00128479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110164157|NCT00128479|Luteolytic Agents|luteolytic agents|mesh-ancestor
110164158|NCT00128479|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110164159|NCT00128479|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110164160|NCT00128440|Tiotropium Bromide|tiotropium bromide|mesh-list
110164161|NCT00128440|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110164162|NCT00128440|Autonomic Agents|autonomic agents|mesh-ancestor
110164163|NCT00128440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110164164|NCT00128440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110164165|NCT00128440|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110164166|NCT00128440|Respiratory System Agents|respiratory system agents|mesh-ancestor
110164168|NCT00128440|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110164170|NCT00128440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110164171|NCT00128440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110164172|NCT00128401|Cycloserine|cycloserine|mesh-list
110164173|NCT00128401|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110164174|NCT00128401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110164175|NCT00128401|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110164176|NCT00128401|Antitubercular Agents|antitubercular agents|mesh-ancestor
110164177|NCT00128401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110164179|NCT00128401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110164181|NCT00128323|Gentian Violet|gentian violet|mesh-list
110164182|NCT00128323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110164183|NCT00128323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110164184|NCT00128323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110164186|NCT00128323|Ionophores|ionophores|mesh-ancestor
110164187|NCT00128323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110164188|NCT00128323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110164189|NCT00128323|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110164190|NCT00009672|Morphine|morphine|mesh-list
110164191|NCT00009672|Nortriptyline|nortriptyline|mesh-list
110164192|NCT00009672|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110164193|NCT00009672|Narcotics|narcotics|mesh-ancestor
110164194|NCT00009672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110164195|NCT00009672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110164196|NCT00009672|Analgesics|analgesics|mesh-ancestor
110164197|NCT00009672|Sensory System Agents|sensory system agents|mesh-ancestor
110164198|NCT00009672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110164199|NCT00009672|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110164200|NCT00009672|Antidepressive Agents|antidepressive agents|mesh-ancestor
110164201|NCT00009672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110164202|NCT00009672|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110164203|NCT00009672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110164204|NCT00009672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110164205|NCT00009672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110164206|NCT00009672|Adrenergic Agents|adrenergic agents|mesh-ancestor
110164207|NCT00009672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110164208|NCT00018694|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
110164209|NCT00018694|Cathartics|cathartics|mesh-ancestor
110164210|NCT00018694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110164211|NCT00018733|Paroxetine|paroxetine|mesh-list
110164213|NCT00018733|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110164214|NCT00018733|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110164218|NCT00018733|Serotonin Agents|serotonin agents|mesh-ancestor
110164219|NCT00018733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110164220|NCT00018733|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110164221|NCT00018733|Antidepressive Agents|antidepressive agents|mesh-ancestor
110164222|NCT00018733|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110164223|NCT00018733|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110164224|NCT00018733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110164225|NCT00018733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110164226|NCT00018733|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110164227|NCT00018733|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110164228|NCT00018733|Adrenergic Agents|adrenergic agents|mesh-ancestor
110164229|NCT00018850|Haloperidol|haloperidol|mesh-list
110164230|NCT00018850|Ondansetron|ondansetron|mesh-list
110164231|NCT00018850|Haloperidol decanoate|haloperidol decanoate|mesh-list
110164233|NCT00018850|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110164234|NCT00018850|Autonomic Agents|autonomic agents|mesh-ancestor
110164235|NCT00018850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110164236|NCT00018850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110164237|NCT00018850|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110164238|NCT00018850|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110164239|NCT00018850|Cholinergic Agents|cholinergic agents|mesh-ancestor
110164240|NCT00018850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110164241|NCT00018850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110164242|NCT00018850|Antiemetics|antiemetics|mesh-ancestor
110164243|NCT00018850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110164244|NCT00018850|Antipruritics|antipruritics|mesh-ancestor
110164245|NCT00018850|Dermatologic Agents|dermatologic agents|mesh-ancestor
110164246|NCT00018850|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110164247|NCT00018850|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110164248|NCT00018850|Serotonin Agents|serotonin agents|mesh-ancestor
110164249|NCT00018850|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110164250|NCT00018850|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110164251|NCT00018850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110164252|NCT00018850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110164254|NCT00018850|Dopamine Agents|dopamine agents|mesh-ancestor
110164255|NCT00018850|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110164256|NCT00009750|Cyclosporine|cyclosporine|mesh-list
110164257|NCT00009750|Paclitaxel|paclitaxel|mesh-list
110164258|NCT00009750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110164260|NCT00009750|Immunoglobulins|immunoglobulins|mesh-list
110164261|NCT00009750|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110164262|NCT00009750|Cyclosporins|cyclosporins|mesh-list
110164263|NCT00009750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110164264|NCT00009750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110164265|NCT00009750|Tubulin Modulators|tubulin modulators|mesh-ancestor
110164266|NCT00009750|Antimitotic Agents|antimitotic agents|mesh-ancestor
110164267|NCT00009750|Mitosis Modulators|mitosis modulators|mesh-ancestor
110164268|NCT00009750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110164269|NCT00009750|Immunologic Factors|immunologic factors|mesh-ancestor
110164270|NCT00009750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110164271|NCT00009750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110164272|NCT00009750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110164273|NCT00009750|Antifungal Agents|antifungal agents|mesh-ancestor
110164274|NCT00009750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110164275|NCT00009750|Dermatologic Agents|dermatologic agents|mesh-ancestor
110164276|NCT00009750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110164277|NCT00009750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110164278|NCT00019006|Detox adjuvant|detox adjuvant|mesh-list
110164279|NCT00019006|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110164280|NCT00019006|Immunologic Factors|immunologic factors|mesh-ancestor
110164281|NCT00019006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110164282|NCT00019084|Aldesleukin|aldesleukin|mesh-list
110164283|NCT00019084|Vaccines|vaccines|mesh-list
110164284|NCT00019084|Sargramostim|sargramostim|mesh-list
110164285|NCT00019084|Immunologic Factors|immunologic factors|mesh-ancestor
110164286|NCT00019084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110164287|NCT00019084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110164288|NCT00019084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110164289|NCT00019084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110164290|NCT00019084|Antiviral Agents|antiviral agents|mesh-ancestor
110164291|NCT00019084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110164292|NCT00019123|Thalidomide|thalidomide|mesh-list
110164293|NCT00019123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110164294|NCT00019123|Immunologic Factors|immunologic factors|mesh-ancestor
110164295|NCT00019123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110164296|NCT00019123|Leprostatic Agents|leprostatic agents|mesh-ancestor
110164297|NCT00019123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110164298|NCT00019123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110164299|NCT00019123|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110164300|NCT00019123|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110164301|NCT00019123|Growth Substances|growth substances|mesh-ancestor
110189228|NCT00040209|Emetics|emetics|mesh-ancestor
110164302|NCT00019123|Growth Inhibitors|growth inhibitors|mesh-ancestor
110164303|NCT00019123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110164304|NCT00019240|Cidofovir|cidofovir|mesh-list
110164305|NCT00019240|Antiviral Agents|antiviral agents|mesh-ancestor
110164306|NCT00019240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110164307|NCT00019240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110164308|NCT00019240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110164309|NCT00019357|Aldesleukin|aldesleukin|mesh-list
110164310|NCT00019357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110164311|NCT00019357|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110164312|NCT00019357|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110164313|NCT00019357|Antiviral Agents|antiviral agents|mesh-ancestor
110164314|NCT00019357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110164315|NCT00019396|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
110164316|NCT00019396|Flt3 ligand protein|flt3 ligand protein|mesh-list
110164317|NCT00019396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110164318|NCT00019396|Immunologic Factors|immunologic factors|mesh-ancestor
110164319|NCT00019396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110164320|NCT00019396|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110164321|NCT00019396|Protective Agents|protective agents|mesh-ancestor
110164322|NCT00009828|Leucovorin|leucovorin|mesh-list
110164323|NCT00009828|Paclitaxel|paclitaxel|mesh-list
110164324|NCT00009828|Tegafur|tegafur|mesh-list
110164326|NCT00009828|Levoleucovorin|levoleucovorin|mesh-list
110164327|NCT00009828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110164328|NCT00009828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110164329|NCT00009828|Tubulin Modulators|tubulin modulators|mesh-ancestor
110164330|NCT00009828|Antimitotic Agents|antimitotic agents|mesh-ancestor
110164332|NCT00009828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110164333|NCT00009828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110164334|NCT00009828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110164335|NCT00009828|Antidotes|antidotes|mesh-ancestor
110164336|NCT00009828|Protective Agents|protective agents|mesh-ancestor
110164337|NCT00009828|Vitamin B Complex|vitamin b complex|mesh-ancestor
110164338|NCT00009828|Vitamins|vitamins|mesh-ancestor
110164339|NCT00009828|Micronutrients|micronutrients|mesh-ancestor
110164340|NCT00009828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110164341|NCT00009828|Antimetabolites|antimetabolites|mesh-ancestor
110164342|NCT00019435|Immunotoxins|immunotoxins|mesh-list
110164343|NCT00019435|Immunoconjugates|immunoconjugates|mesh-ancestor
110164344|NCT00019435|Immunologic Factors|immunologic factors|mesh-ancestor
110164345|NCT00019435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110164346|NCT00019474|Interferons|interferons|mesh-list
110164347|NCT00019474|Interferon-alpha|interferon-alpha|mesh-list
110164348|NCT00019474|Fluorouracil|fluorouracil|mesh-list
110164349|NCT00019474|Hydroxyurea|hydroxyurea|mesh-list
110164350|NCT00019474|Antimetabolites|antimetabolites|mesh-ancestor
110164351|NCT00019474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110164352|NCT00019474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110164353|NCT00019474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110164354|NCT00019474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110164355|NCT00019474|Immunologic Factors|immunologic factors|mesh-ancestor
110164356|NCT00019474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110164357|NCT00019474|Antiviral Agents|antiviral agents|mesh-ancestor
110164358|NCT00019474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110164359|NCT00019474|Antisickling Agents|antisickling agents|mesh-ancestor
110189237|NCT00020618|Morphine|morphine|mesh-list
110164360|NCT00019474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110164361|NCT00019474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110164362|NCT00019513|Leucovorin|leucovorin|mesh-list
110164363|NCT00019513|Gemcitabine|gemcitabine|mesh-list
110164364|NCT00019513|Fluorouracil|fluorouracil|mesh-list
110164365|NCT00019513|Calcium|calcium|mesh-list
110164366|NCT00019513|Levoleucovorin|levoleucovorin|mesh-list
110164367|NCT00019513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110164368|NCT00019513|Antimetabolites|antimetabolites|mesh-ancestor
110164369|NCT00019513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110164370|NCT00019513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110164371|NCT00019513|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110164372|NCT00019513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110164373|NCT00019513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110164374|NCT00019513|Immunologic Factors|immunologic factors|mesh-ancestor
110164375|NCT00019513|Antidotes|antidotes|mesh-ancestor
110164376|NCT00019513|Protective Agents|protective agents|mesh-ancestor
110164377|NCT00019513|Vitamin B Complex|vitamin b complex|mesh-ancestor
110164378|NCT00019513|Vitamins|vitamins|mesh-ancestor
110164379|NCT00019513|Micronutrients|micronutrients|mesh-ancestor
110164380|NCT00019552|Irofulven|irofulven|mesh-list
110164381|NCT00019552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110164382|NCT00019552|Alkylating Agents|alkylating agents|mesh-ancestor
110164383|NCT00019552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110164384|NCT00019552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110164385|NCT00009867|Arsenic Trioxide|arsenic trioxide|mesh-list
110164386|NCT00009867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110164387|NCT00019591|Aldesleukin|aldesleukin|mesh-list
110164388|NCT00019591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110164389|NCT00019591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110164390|NCT00019591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110164391|NCT00019591|Antiviral Agents|antiviral agents|mesh-ancestor
110164392|NCT00019591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110164393|NCT00019630|Doxorubicin|doxorubicin|mesh-list
110164394|NCT00019630|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110164395|NCT00019630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110164396|NCT00019630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110164397|NCT00019630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110164398|NCT00019630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110164399|NCT00019630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110164400|NCT00019630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110164402|NCT00019669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110164403|NCT00019669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110164404|NCT00019669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110164405|NCT00019669|Antiviral Agents|antiviral agents|mesh-ancestor
110164406|NCT00019669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110164407|NCT00009906|Imatinib Mesylate|imatinib mesylate|mesh-list
110164408|NCT00009906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110164409|NCT00009906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110164410|NCT00009906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110164411|NCT00009906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110164412|NCT00019786|Melphalan|melphalan|mesh-list
110164413|NCT00019786|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110164414|NCT00019786|Alkylating Agents|alkylating agents|mesh-ancestor
110164415|NCT00019786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110164416|NCT00019786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110164417|NCT00019786|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110164418|NCT00019786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110164419|NCT00019786|Immunologic Factors|immunologic factors|mesh-ancestor
110164420|NCT00019786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110164422|NCT00019825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110164423|NCT00019825|Antimetabolites|antimetabolites|mesh-ancestor
110164424|NCT00019825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110164425|NCT00019825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110164426|NCT00019825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110164427|NCT00019864|Leucovorin|leucovorin|mesh-list
110164428|NCT00019864|Doxorubicin|doxorubicin|mesh-list
110164429|NCT00019864|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110164430|NCT00019864|Methotrexate|methotrexate|mesh-list
110164431|NCT00019864|Dexrazoxane|dexrazoxane|mesh-list
110164432|NCT00019864|Razoxane|razoxane|mesh-list
110164433|NCT00019864|Calcium|calcium|mesh-list
110164434|NCT00019864|Levoleucovorin|levoleucovorin|mesh-list
110164435|NCT00019864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110164436|NCT00019864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110164437|NCT00019864|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110164438|NCT00019864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110164439|NCT00019864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110164440|NCT00019864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110164441|NCT00019864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110164442|NCT00019864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110164443|NCT00019864|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110164444|NCT00019864|Abortifacient Agents|abortifacient agents|mesh-ancestor
110164445|NCT00019864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110164446|NCT00019864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110164447|NCT00019864|Antimetabolites|antimetabolites|mesh-ancestor
110164448|NCT00019864|Dermatologic Agents|dermatologic agents|mesh-ancestor
110164449|NCT00019864|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110164450|NCT00019864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110164451|NCT00019864|Immunologic Factors|immunologic factors|mesh-ancestor
110164452|NCT00019864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110164453|NCT00019864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110164454|NCT00019864|Antidotes|antidotes|mesh-ancestor
110164455|NCT00019864|Protective Agents|protective agents|mesh-ancestor
110164456|NCT00019864|Vitamin B Complex|vitamin b complex|mesh-ancestor
110164458|NCT00019864|Micronutrients|micronutrients|mesh-ancestor
110164459|NCT00019864|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110164460|NCT00019864|Antimitotic Agents|antimitotic agents|mesh-ancestor
110164461|NCT00019864|Mitosis Modulators|mitosis modulators|mesh-ancestor
110164462|NCT00020176|Cyclosporine|cyclosporine|mesh-list
110164463|NCT00020176|Cyclophosphamide|cyclophosphamide|mesh-list
110164464|NCT00020176|Fludarabine|fludarabine|mesh-list
110164465|NCT00020176|Fludarabine phosphate|fludarabine phosphate|mesh-list
110164466|NCT00020176|Cyclosporins|cyclosporins|mesh-list
110164467|NCT00020176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110164468|NCT00020176|Immunologic Factors|immunologic factors|mesh-ancestor
110164469|NCT00020176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110164470|NCT00020176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110164471|NCT00020176|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110164472|NCT00020176|Alkylating Agents|alkylating agents|mesh-ancestor
110164473|NCT00020176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110164474|NCT00020176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110164475|NCT00020176|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110164476|NCT00020176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110164477|NCT00020176|Antimetabolites|antimetabolites|mesh-ancestor
110164478|NCT00020176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110164479|NCT00020176|Antifungal Agents|antifungal agents|mesh-ancestor
110164480|NCT00020176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110164481|NCT00020176|Dermatologic Agents|dermatologic agents|mesh-ancestor
110164482|NCT00020176|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110164483|NCT00020254|Aldesleukin|aldesleukin|mesh-list
110164484|NCT00020254|Nilutamide|nilutamide|mesh-list
110164485|NCT00020254|Vaccines|vaccines|mesh-list
110164486|NCT00020254|Sargramostim|sargramostim|mesh-list
110164487|NCT00020254|Immunologic Factors|immunologic factors|mesh-ancestor
110164488|NCT00020254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110164489|NCT00020254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110164490|NCT00020254|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110164491|NCT00020254|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110164492|NCT00020254|Antiviral Agents|antiviral agents|mesh-ancestor
110164493|NCT00020254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110164494|NCT00020254|Androgen Antagonists|androgen antagonists|mesh-ancestor
110164495|NCT00020254|Hormone Antagonists|hormone antagonists|mesh-ancestor
110164496|NCT00020254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110164497|NCT00009984|Thalidomide|thalidomide|mesh-list
110164498|NCT00009984|Fludarabine|fludarabine|mesh-list
110164499|NCT00009984|Fludarabine phosphate|fludarabine phosphate|mesh-list
110164500|NCT00009984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110164501|NCT00009984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110164502|NCT00009984|Antimetabolites|antimetabolites|mesh-ancestor
110164503|NCT00009984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110164504|NCT00009984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110164505|NCT00009984|Immunologic Factors|immunologic factors|mesh-ancestor
110164506|NCT00009984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110164507|NCT00009984|Leprostatic Agents|leprostatic agents|mesh-ancestor
110164508|NCT00009984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110164509|NCT00009984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110164510|NCT00009984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110164511|NCT00009984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110164512|NCT00009984|Growth Substances|growth substances|mesh-ancestor
110164513|NCT00009984|Growth Inhibitors|growth inhibitors|mesh-ancestor
110164514|NCT00020332|Docetaxel|docetaxel|mesh-list
110164515|NCT00020332|Alvocidib|alvocidib|mesh-list
110164516|NCT00020332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110164518|NCT00020332|Antimitotic Agents|antimitotic agents|mesh-ancestor
110164519|NCT00020332|Mitosis Modulators|mitosis modulators|mesh-ancestor
110164520|NCT00020332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110164521|NCT00020332|Growth Inhibitors|growth inhibitors|mesh-ancestor
110164522|NCT00020332|Growth Substances|growth substances|mesh-ancestor
110164523|NCT00020332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110164524|NCT00020332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110164525|NCT00020332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110164526|NCT00020371|Lenograstim|lenograstim|mesh-list
110164527|NCT00020371|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110164528|NCT00020371|Immunologic Factors|immunologic factors|mesh-ancestor
110164529|NCT00020371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110164530|NCT00020410|Antibodies|antibodies|mesh-list
110164531|NCT00020410|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110164532|NCT00020410|Immunologic Factors|immunologic factors|mesh-ancestor
110164533|NCT00020410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110164534|NCT00020449|Paclitaxel|paclitaxel|mesh-list
110164535|NCT00020449|Doxorubicin|doxorubicin|mesh-list
110164536|NCT00020449|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110164537|NCT00020449|Interleukin-12|interleukin-12|mesh-list
110164538|NCT00020449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110164539|NCT00020449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110164540|NCT00020449|Tubulin Modulators|tubulin modulators|mesh-ancestor
110164541|NCT00020449|Antimitotic Agents|antimitotic agents|mesh-ancestor
110164542|NCT00020449|Mitosis Modulators|mitosis modulators|mesh-ancestor
110164543|NCT00020449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110164544|NCT00020449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110164545|NCT00020449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110164546|NCT00020449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110164547|NCT00020449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110164548|NCT00020449|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110164550|NCT00020449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110164551|NCT00020449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110164552|NCT00020449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110164553|NCT00020449|Growth Substances|growth substances|mesh-ancestor
110164554|NCT00020449|Growth Inhibitors|growth inhibitors|mesh-ancestor
110164555|NCT00010023|Capecitabine|capecitabine|mesh-list
110164556|NCT00010023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110164557|NCT00010023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110164558|NCT00010023|Antimetabolites|antimetabolites|mesh-ancestor
110164559|NCT00010023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110164560|NCT00020488|Leucovorin|leucovorin|mesh-list
110164561|NCT00020488|Fluorouracil|fluorouracil|mesh-list
110164562|NCT00020488|Irinotecan|irinotecan|mesh-list
110164563|NCT00020488|Calcium|calcium|mesh-list
110164564|NCT00020488|Levoleucovorin|levoleucovorin|mesh-list
110164565|NCT00020488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110164566|NCT00020488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110164568|NCT00020488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110164569|NCT00020488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110164570|NCT00020488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110164571|NCT00020488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110164572|NCT00020488|Immunologic Factors|immunologic factors|mesh-ancestor
110164573|NCT00020488|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110164574|NCT00020488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110164575|NCT00020488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110164576|NCT00020488|Antidotes|antidotes|mesh-ancestor
110164577|NCT00020488|Protective Agents|protective agents|mesh-ancestor
110164578|NCT00020488|Vitamin B Complex|vitamin b complex|mesh-ancestor
110164580|NCT00020488|Micronutrients|micronutrients|mesh-ancestor
110164581|NCT00020527|Caspofungin|caspofungin|mesh-list
110164582|NCT00020527|Antifungal Agents|antifungal agents|mesh-ancestor
110164583|NCT00020527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110164584|NCT00020527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110164585|NCT00020527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110164586|NCT00020566|Dactinomycin|dactinomycin|mesh-list
110164587|NCT00020566|Doxorubicin|doxorubicin|mesh-list
110164588|NCT00020566|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110164589|NCT00020566|Etoposide|etoposide|mesh-list
110164590|NCT00020566|Vincristine|vincristine|mesh-list
110164591|NCT00020566|Melphalan|melphalan|mesh-list
110164592|NCT00020566|Busulfan|busulfan|mesh-list
110164593|NCT00020566|Ifosfamide|ifosfamide|mesh-list
110164594|NCT00020566|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110164595|NCT00020566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110164596|NCT00020566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110164597|NCT00020566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110164598|NCT00020566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110164599|NCT00020566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110164600|NCT00020566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110164601|NCT00020566|Tubulin Modulators|tubulin modulators|mesh-ancestor
110164602|NCT00020566|Antimitotic Agents|antimitotic agents|mesh-ancestor
110164603|NCT00020566|Mitosis Modulators|mitosis modulators|mesh-ancestor
110164604|NCT00020566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110164605|NCT00020566|Alkylating Agents|alkylating agents|mesh-ancestor
110164606|NCT00020566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110164607|NCT00020566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110164608|NCT00020566|Immunologic Factors|immunologic factors|mesh-ancestor
110164609|NCT00020566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110164610|NCT00020566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110164611|NCT00020566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110164612|NCT00020566|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110164613|NCT00020566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110164614|NCT00010062|Fluorouracil|fluorouracil|mesh-list
110164615|NCT00010062|Antimetabolites|antimetabolites|mesh-ancestor
110164616|NCT00010062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110164617|NCT00010062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110164618|NCT00010062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110164619|NCT00010062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110164620|NCT00010062|Immunologic Factors|immunologic factors|mesh-ancestor
110164621|NCT00010062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110164622|NCT00020605|Naloxone|naloxone|mesh-list
110164623|NCT00020605|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110164624|NCT00020605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110164625|NCT00020605|Sensory System Agents|sensory system agents|mesh-ancestor
110164626|NCT00020605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110164627|NCT00020644|Gemcitabine|gemcitabine|mesh-list
110164628|NCT00020644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110164629|NCT00020644|Antimetabolites|antimetabolites|mesh-ancestor
110164630|NCT00020644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110164631|NCT00020644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110164632|NCT00020761|Paclitaxel|paclitaxel|mesh-list
110164633|NCT00020761|Irinotecan|irinotecan|mesh-list
110164634|NCT00020761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110164635|NCT00020761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110164636|NCT00020761|Tubulin Modulators|tubulin modulators|mesh-ancestor
110164637|NCT00020761|Antimitotic Agents|antimitotic agents|mesh-ancestor
110164638|NCT00020761|Mitosis Modulators|mitosis modulators|mesh-ancestor
110164639|NCT00020761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110164640|NCT00020761|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110164643|NCT00020800|Rituximab|rituximab|mesh-list
110164644|NCT00020800|Fludarabine|fludarabine|mesh-list
110164645|NCT00020800|Fludarabine phosphate|fludarabine phosphate|mesh-list
110164646|NCT00020800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110164647|NCT00020800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110164648|NCT00020800|Immunologic Factors|immunologic factors|mesh-ancestor
110164649|NCT00020800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110164650|NCT00020800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110164651|NCT00020800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110164652|NCT00020800|Antimetabolites|antimetabolites|mesh-ancestor
110164653|NCT00020800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110164654|NCT00020800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110164655|NCT00020839|Temozolomide|temozolomide|mesh-list
110164656|NCT00020839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110164657|NCT00020839|Alkylating Agents|alkylating agents|mesh-ancestor
110164658|NCT00020839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110164659|NCT00020839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110164660|NCT00010140|Tamoxifen|tamoxifen|mesh-list
110164661|NCT00010140|Docetaxel|docetaxel|mesh-list
110164662|NCT00010140|Epirubicin|epirubicin|mesh-list
110164663|NCT00010140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110164664|NCT00010140|Tubulin Modulators|tubulin modulators|mesh-ancestor
110164665|NCT00010140|Antimitotic Agents|antimitotic agents|mesh-ancestor
110164666|NCT00010140|Mitosis Modulators|mitosis modulators|mesh-ancestor
110164667|NCT00010140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110164668|NCT00010140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110164669|NCT00010140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110164670|NCT00010140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110164672|NCT00010140|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110164673|NCT00010140|Hormone Antagonists|hormone antagonists|mesh-ancestor
110164674|NCT00010140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110164675|NCT00010140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110164676|NCT00010140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110164677|NCT00010140|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110164678|NCT00010140|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110164679|NCT00010140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110164681|NCT00020878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110164682|NCT00020878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110164683|NCT00020878|Analgesics|analgesics|mesh-ancestor
110164684|NCT00020878|Sensory System Agents|sensory system agents|mesh-ancestor
110164685|NCT00020878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110164686|NCT00020878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110164687|NCT00020878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110164688|NCT00020878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110164689|NCT00020878|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110164690|NCT00020878|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110164691|NCT00020878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110164692|NCT00020878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110164694|NCT00020917|Fluorouracil|fluorouracil|mesh-list
110164695|NCT00020917|Irinotecan|irinotecan|mesh-list
110164696|NCT00020917|Cetuximab|cetuximab|mesh-list
110164697|NCT00020917|Calcium|calcium|mesh-list
110164698|NCT00020917|Levoleucovorin|levoleucovorin|mesh-list
110164699|NCT00020917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110164700|NCT00020917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110164701|NCT00020917|Antimetabolites|antimetabolites|mesh-ancestor
110189285|NCT00020735|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110164702|NCT00020917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110164703|NCT00020917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110164704|NCT00020917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110164705|NCT00020917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110164707|NCT00020917|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110164708|NCT00020917|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110164709|NCT00020917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110164710|NCT00020917|Antidotes|antidotes|mesh-ancestor
110164711|NCT00020917|Protective Agents|protective agents|mesh-ancestor
110164712|NCT00020917|Vitamin B Complex|vitamin b complex|mesh-ancestor
110164713|NCT00020917|Vitamins|vitamins|mesh-ancestor
110164714|NCT00020917|Micronutrients|micronutrients|mesh-ancestor
110164715|NCT00020917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110164716|NCT00021034|Taurolidine|taurolidine|mesh-list
110164717|NCT00021034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110164718|NCT00021034|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110164719|NCT00021034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110164721|NCT00010179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110164722|NCT00021073|Leucovorin|leucovorin|mesh-list
110164723|NCT00021073|Fluorouracil|fluorouracil|mesh-list
110164724|NCT00021073|Irinotecan|irinotecan|mesh-list
110164725|NCT00021073|Alvocidib|alvocidib|mesh-list
110164726|NCT00021073|Calcium|calcium|mesh-list
110164727|NCT00021073|Levoleucovorin|levoleucovorin|mesh-list
110164728|NCT00021073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110164729|NCT00021073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110164731|NCT00021073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110164732|NCT00021073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110164733|NCT00021073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110164734|NCT00021073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110164735|NCT00021073|Immunologic Factors|immunologic factors|mesh-ancestor
110164736|NCT00021073|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110164737|NCT00021073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110164738|NCT00021073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110164739|NCT00021073|Antidotes|antidotes|mesh-ancestor
110164740|NCT00021073|Protective Agents|protective agents|mesh-ancestor
110164741|NCT00021073|Vitamin B Complex|vitamin b complex|mesh-ancestor
110164742|NCT00021073|Vitamins|vitamins|mesh-ancestor
110164743|NCT00021073|Micronutrients|micronutrients|mesh-ancestor
110164744|NCT00021073|Growth Inhibitors|growth inhibitors|mesh-ancestor
110164745|NCT00021073|Growth Substances|growth substances|mesh-ancestor
110164746|NCT00021073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110164747|NCT00021112|Etoposide|etoposide|mesh-list
110164748|NCT00021112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110164749|NCT00021112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110164750|NCT00021112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110164751|NCT00021112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110164752|NCT00021112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110164753|NCT00021112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110164754|NCT00000122|Fluorouracil|fluorouracil|mesh-list
110164755|NCT00000122|Antimetabolites|antimetabolites|mesh-ancestor
110164756|NCT00000122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110164757|NCT00000122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110164758|NCT00000122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110164759|NCT00000122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110164760|NCT00000122|Immunologic Factors|immunologic factors|mesh-ancestor
110164761|NCT00000122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110164762|NCT00021151|Alemtuzumab|alemtuzumab|mesh-list
110164763|NCT00021151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110164764|NCT00021151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110164765|NCT00021268|8-chloro-cyclic adenosine monophosphate|8-chloro-cyclic adenosine monophosphate|mesh-list
110164766|NCT00021268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110164767|NCT00021268|Immunologic Factors|immunologic factors|mesh-ancestor
110164768|NCT00021268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110164769|NCT00021307|Carboplatin|carboplatin|mesh-list
110164770|NCT00021307|Temozolomide|temozolomide|mesh-list
110560341|NCT00638729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110560343|NCT00638729|Sensory System Agents|sensory system agents|mesh-ancestor
110560344|NCT00638729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110560345|NCT00638729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110560346|NCT00638729|Sympatholytics|sympatholytics|mesh-ancestor
110560347|NCT00638729|Autonomic Agents|autonomic agents|mesh-ancestor
110560348|NCT00638729|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110560349|NCT00638729|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110560350|NCT00638729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110560351|NCT00638729|Adrenergic Agents|adrenergic agents|mesh-ancestor
110560352|NCT00697892|Ritonavir|ritonavir|mesh-list
110560353|NCT00697892|Lopinavir|lopinavir|mesh-list
110560354|NCT00697892|Efavirenz|efavirenz|mesh-list
110560356|NCT00697892|Artemether|artemether|mesh-list
110560357|NCT00697892|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110560358|NCT00697892|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110560359|NCT00697892|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110560360|NCT00697892|Protease Inhibitors|protease inhibitors|mesh-ancestor
110560361|NCT00697892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110560362|NCT00697892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110560363|NCT00697892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110560364|NCT00697892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110560365|NCT00697892|Antiviral Agents|antiviral agents|mesh-ancestor
110560366|NCT00697892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110560367|NCT00697892|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110560368|NCT00697892|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110560369|NCT00697892|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110560370|NCT00697892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110560371|NCT00697892|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110560372|NCT00697892|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110560373|NCT00697892|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110560374|NCT00697892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110560375|NCT00697892|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110560376|NCT00697892|Antimalarials|antimalarials|mesh-ancestor
110560377|NCT00697892|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110560378|NCT00697892|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110560379|NCT00699452|Candesartan|candesartan|mesh-list
110560380|NCT00699452|Candesartan cilexetil|candesartan cilexetil|mesh-list
110560381|NCT00699452|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110560382|NCT00699452|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110560383|NCT00699452|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110560384|NCT00699452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110560385|NCT02683733|Aminosalicylic Acid|aminosalicylic acid|mesh-list
110560386|NCT02683733|Curcumin|curcumin|mesh-list
110560387|NCT02683733|Mesalamine|mesalamine|mesh-list
110560388|NCT02683733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110560389|NCT02683733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110560390|NCT02683733|Analgesics|analgesics|mesh-ancestor
110560391|NCT02683733|Sensory System Agents|sensory system agents|mesh-ancestor
110560392|NCT02683733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110560393|NCT02683733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110560394|NCT02683733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110560395|NCT02683733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110560396|NCT02683733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110560397|NCT02683733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110560398|NCT02683733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110560399|NCT02683733|Antitubercular Agents|antitubercular agents|mesh-ancestor
110560400|NCT02683733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110560401|NCT02683733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110560403|NCT02683655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110560404|NCT02683655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110560405|NCT02683655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110560406|NCT02683655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110560407|NCT00494221|Leucovorin|leucovorin|mesh-list
110560408|NCT00494221|Fluorouracil|fluorouracil|mesh-list
110560409|NCT00494221|Oxaliplatin|oxaliplatin|mesh-list
110560410|NCT00494221|Cediranib|cediranib|mesh-list
110560411|NCT00494221|Levoleucovorin|levoleucovorin|mesh-list
110560412|NCT00494221|Antimetabolites|antimetabolites|mesh-ancestor
110560413|NCT00494221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110560414|NCT00494221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110560415|NCT00494221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110560416|NCT00494221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110560417|NCT00494221|Immunologic Factors|immunologic factors|mesh-ancestor
110560418|NCT00494221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110560419|NCT00494221|Antidotes|antidotes|mesh-ancestor
110560420|NCT00494221|Protective Agents|protective agents|mesh-ancestor
110560421|NCT00494221|Vitamin B Complex|vitamin b complex|mesh-ancestor
110560422|NCT00494221|Vitamins|vitamins|mesh-ancestor
110560423|NCT00494221|Micronutrients|micronutrients|mesh-ancestor
110560424|NCT00494221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110560425|NCT00494221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110560426|NCT00909935|Dexmedetomidine|dexmedetomidine|mesh-list
110560427|NCT00909935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110560428|NCT00909935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110560429|NCT00909935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110560430|NCT00909935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110560431|NCT00909935|Analgesics|analgesics|mesh-ancestor
110560432|NCT00909935|Sensory System Agents|sensory system agents|mesh-ancestor
110560433|NCT00909935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110560434|NCT00909935|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110560435|NCT00909935|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110560436|NCT00909935|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110560437|NCT00909935|Adrenergic Agents|adrenergic agents|mesh-ancestor
110560438|NCT00909935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110560439|NCT00909935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110560440|NCT00857948|Ivermectin|ivermectin|mesh-list
110560441|NCT00857948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110560442|NCT00857948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110560443|NCT02688491|Sunitinib|sunitinib|mesh-list
110560444|NCT02688491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110560445|NCT02688491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110560446|NCT02688491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110560447|NCT02688491|Growth Substances|growth substances|mesh-ancestor
110560448|NCT02688491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110560449|NCT02688491|Growth Inhibitors|growth inhibitors|mesh-ancestor
110560450|NCT02688491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110560451|NCT02688491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110560452|NCT02688491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110560453|NCT00857792|Regadenoson|regadenoson|mesh-list
110560454|NCT00857792|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
110560455|NCT00857792|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110560456|NCT00857792|Purinergic Agonists|purinergic agonists|mesh-ancestor
110560457|NCT00857792|Purinergic Agents|purinergic agents|mesh-ancestor
110560458|NCT00857792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110560459|NCT00857792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110560460|NCT00857792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110560461|NCT02613494|Glycopyrrolate|glycopyrrolate|mesh-list
110560462|NCT02613494|Scopolamine|scopolamine|mesh-list
110560463|NCT02613494|Bromides|bromides|mesh-list
110560464|NCT02613494|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
110560465|NCT02613494|Anticonvulsants|anticonvulsants|mesh-ancestor
110560466|NCT02613494|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110560467|NCT02613494|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110560468|NCT02613494|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110560469|NCT02613494|Cholinergic Agents|cholinergic agents|mesh-ancestor
110560470|NCT02613494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110560471|NCT02613494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110560472|NCT02613494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110560474|NCT02613494|Autonomic Agents|autonomic agents|mesh-ancestor
110560475|NCT02613494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110560476|NCT02613494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110560477|NCT02613494|Mydriatics|mydriatics|mesh-ancestor
110560478|NCT02613494|Parasympatholytics|parasympatholytics|mesh-ancestor
110560479|NCT00699530|Cabergoline|cabergoline|mesh-list
110560480|NCT00699530|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110560481|NCT00699530|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110560482|NCT00699530|Dopamine Agonists|dopamine agonists|mesh-ancestor
110560483|NCT00699530|Dopamine Agents|dopamine agents|mesh-ancestor
110560484|NCT00699530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110560485|NCT00699530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110560486|NCT00699530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110560487|NCT02617862|Anesthetics|anesthetics|mesh-list
110560488|NCT02617862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110560489|NCT02617862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110560490|NCT00601835|Vaccines|vaccines|mesh-list
110560491|NCT00601835|Immunologic Factors|immunologic factors|mesh-ancestor
110560492|NCT00601835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110560493|NCT00640367|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110560494|NCT00640367|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110560495|NCT00640367|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110560496|NCT00640367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110560497|NCT00697502|Capecitabine|capecitabine|mesh-list
110560498|NCT00697502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110560499|NCT00697502|Antimetabolites|antimetabolites|mesh-ancestor
110560500|NCT00697502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110560501|NCT00697502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110560502|NCT00857246|Irinotecan|irinotecan|mesh-list
110560503|NCT00857246|Cetuximab|cetuximab|mesh-list
110189338|NCT00021047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110560504|NCT00857246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110560505|NCT00857246|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110560506|NCT00857246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110560507|NCT00857246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110560508|NCT00857246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110560509|NCT00857246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110560510|NCT00699686|Insulin Glargine|insulin glargine|mesh-list
110560511|NCT00699686|Insulin Detemir|insulin detemir|mesh-list
110560512|NCT00699686|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110560513|NCT00699686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110560514|NCT00640679|Clopidogrel|clopidogrel|mesh-list
110560515|NCT00640679|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110560516|NCT00640679|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110560517|NCT00640679|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110560518|NCT00640679|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110560519|NCT00640679|Purinergic Agents|purinergic agents|mesh-ancestor
110560520|NCT00640679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110560521|NCT00640679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110560522|NCT00640679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110560523|NCT02682953|Plerixafor|plerixafor|mesh-list
110560524|NCT02682953|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110560525|NCT02682953|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110560526|NCT02682953|Antiviral Agents|antiviral agents|mesh-ancestor
110560527|NCT02682953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110560528|NCT02683031|Ionophores|ionophores|mesh-list
110560529|NCT02683031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110560530|NCT02683031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110560531|NCT04184141|Alprazolam|alprazolam|mesh-list
110560532|NCT04184141|Hydroxyzine|hydroxyzine|mesh-list
110560533|NCT04184141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110560534|NCT04184141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110560535|NCT04184141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110560536|NCT04184141|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110560537|NCT04184141|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110560538|NCT04184141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110560539|NCT04184141|GABA Modulators|gaba modulators|mesh-ancestor
110560540|NCT04184141|GABA Agents|gaba agents|mesh-ancestor
110560541|NCT04184141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110560542|NCT04184141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110560543|NCT04184141|Antipruritics|antipruritics|mesh-ancestor
110560544|NCT04184141|Dermatologic Agents|dermatologic agents|mesh-ancestor
110560545|NCT04184141|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110560546|NCT04184141|Histamine Antagonists|histamine antagonists|mesh-ancestor
110560547|NCT04184141|Histamine Agents|histamine agents|mesh-ancestor
110560548|NCT02682329|Hydrogen Peroxide|hydrogen peroxide|mesh-list
110560549|NCT02682329|Carbamide Peroxide|carbamide peroxide|mesh-list
110560550|NCT02682329|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110560551|NCT02682329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110560552|NCT00640991|Insulin|insulin|mesh-list
110560553|NCT00640991|Insulin Glargine|insulin glargine|mesh-list
110560554|NCT00640991|Insulin glulisine|insulin glulisine|mesh-list
110560555|NCT00640991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110560556|NCT00640991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110560557|NCT00638807|Celecoxib|celecoxib|mesh-list
110560558|NCT00638807|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110560559|NCT00638807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110560560|NCT00638807|Analgesics|analgesics|mesh-ancestor
110560562|NCT00638807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110560563|NCT00638807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110560564|NCT00638807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110560565|NCT00638807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110560566|NCT00638807|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110560567|NCT00638807|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110560568|NCT00638807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110560569|NCT00638807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110560571|NCT00856856|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110560572|NCT00856856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110560573|NCT00856856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110560574|NCT00856856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110560575|NCT00856856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110560576|NCT00856856|Immunologic Factors|immunologic factors|mesh-ancestor
110560577|NCT00856856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110560578|NCT00856856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110560580|NCT00782327|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110560581|NCT00782327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110560582|NCT00782327|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110560583|NCT00782327|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110560584|NCT00782327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110560585|NCT00559091|Ribavirin|ribavirin|mesh-list
110560586|NCT00559091|Antimetabolites|antimetabolites|mesh-ancestor
110560587|NCT00559091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110560588|NCT00559091|Antiviral Agents|antiviral agents|mesh-ancestor
110560589|NCT00559091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110560590|NCT02682017|Fucoidan|fucoidan|mesh-list
110560591|NCT02682017|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110560592|NCT02682017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110560593|NCT02682017|Anticoagulants|anticoagulants|mesh-ancestor
110560594|NCT02682017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110560595|NCT00603473|Gabapentin|gabapentin|mesh-list
110560596|NCT00603473|Analgesics|analgesics|mesh-ancestor
110560597|NCT00603473|Sensory System Agents|sensory system agents|mesh-ancestor
110560598|NCT00603473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110560599|NCT00603473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110560600|NCT00603473|Anticonvulsants|anticonvulsants|mesh-ancestor
110560601|NCT00603473|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110560602|NCT00603473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110560603|NCT00603473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110560604|NCT00603473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110560605|NCT00603473|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110560606|NCT00603473|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110560607|NCT00603473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110560608|NCT00603473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110560609|NCT00603473|Antimanic Agents|antimanic agents|mesh-ancestor
110560610|NCT02688023|Leucovorin|leucovorin|mesh-list
110560611|NCT02688023|Fluorouracil|fluorouracil|mesh-list
110560612|NCT02688023|Capecitabine|capecitabine|mesh-list
110560613|NCT02688023|Oxaliplatin|oxaliplatin|mesh-list
110560614|NCT02688023|Irinotecan|irinotecan|mesh-list
110560615|NCT02688023|Antimetabolites|antimetabolites|mesh-ancestor
110560616|NCT02688023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110560617|NCT02688023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110560618|NCT02688023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110560619|NCT02688023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110560620|NCT02688023|Immunologic Factors|immunologic factors|mesh-ancestor
110560621|NCT02688023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110189373|NCT00040872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110560622|NCT02688023|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110560623|NCT02688023|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110560624|NCT02688023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110560625|NCT02688023|Antidotes|antidotes|mesh-ancestor
110560626|NCT02688023|Protective Agents|protective agents|mesh-ancestor
110560627|NCT02688023|Vitamin B Complex|vitamin b complex|mesh-ancestor
110560628|NCT02688023|Vitamins|vitamins|mesh-ancestor
110560629|NCT02688023|Micronutrients|micronutrients|mesh-ancestor
110560630|NCT00910013|Ropivacaine|ropivacaine|mesh-list
110560631|NCT00910013|Anesthetics, Local|anesthetics, local|mesh-ancestor
110560632|NCT00910013|Anesthetics|anesthetics|mesh-ancestor
110560633|NCT00910013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110560634|NCT00910013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110560635|NCT00910013|Sensory System Agents|sensory system agents|mesh-ancestor
110560636|NCT00910013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110560637|NCT04182191|Tenoxicam|tenoxicam|mesh-list
110560638|NCT04182191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110560639|NCT04182191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110560640|NCT04182191|Analgesics|analgesics|mesh-ancestor
110560641|NCT04182191|Sensory System Agents|sensory system agents|mesh-ancestor
110560642|NCT04182191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110560643|NCT04182191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110560644|NCT04182191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110560645|NCT04182191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110560646|NCT04182191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110560647|NCT04182191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110560648|NCT04182191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110560649|NCT02680379|Minocycline|minocycline|mesh-list
110560650|NCT02680379|Lovastatin|lovastatin|mesh-list
110560651|NCT02680379|L 647318|l 647318|mesh-list
110560652|NCT02680379|Dihydromevinolin|dihydromevinolin|mesh-list
110560653|NCT02680379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110560654|NCT02680379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110560655|NCT02680379|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110560656|NCT02680379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110560657|NCT02680379|Antimetabolites|antimetabolites|mesh-ancestor
110560658|NCT02680379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110560659|NCT02680379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110560660|NCT02680379|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110560661|NCT02680379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110560663|NCT03996421|Trace Elements|trace elements|mesh-ancestor
110560664|NCT03996421|Micronutrients|micronutrients|mesh-ancestor
110560665|NCT03996421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110560666|NCT00641693|Budesonide|budesonide|mesh-list
110560667|NCT00641693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110560668|NCT00641693|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110560669|NCT00641693|Autonomic Agents|autonomic agents|mesh-ancestor
110560670|NCT00641693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110560671|NCT00641693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110560672|NCT00641693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110560673|NCT00641693|Respiratory System Agents|respiratory system agents|mesh-ancestor
110560674|NCT00641693|Glucocorticoids|glucocorticoids|mesh-ancestor
110560675|NCT00641693|Hormones|hormones|mesh-ancestor
110560676|NCT00641693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110560677|NCT04183361|Cortisone|cortisone|mesh-list
110560678|NCT04183361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110560679|NCT02687867|Vitamin K|vitamin k|mesh-list
110560680|NCT02687867|Dabigatran|dabigatran|mesh-list
110560681|NCT02687867|Vitamins|vitamins|mesh-ancestor
110560682|NCT02687867|Micronutrients|micronutrients|mesh-ancestor
110560683|NCT02687867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110560684|NCT02687867|Antithrombins|antithrombins|mesh-ancestor
110560685|NCT02687867|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110560686|NCT02687867|Protease Inhibitors|protease inhibitors|mesh-ancestor
110560687|NCT02687867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110560688|NCT02687867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110560689|NCT02687867|Anticoagulants|anticoagulants|mesh-ancestor
110560690|NCT02687867|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110560691|NCT02687867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110560692|NCT02687867|Hemostatics|hemostatics|mesh-ancestor
110560693|NCT02687867|Coagulants|coagulants|mesh-ancestor
110560694|NCT02681783|Aflibercept|aflibercept|mesh-list
110560695|NCT02681783|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110560696|NCT02681783|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110560697|NCT02681783|Growth Substances|growth substances|mesh-ancestor
110560698|NCT02681783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110560699|NCT02681783|Growth Inhibitors|growth inhibitors|mesh-ancestor
110560701|NCT00486811|Oxycodone|oxycodone|mesh-list
110560702|NCT00486811|Tapentadol|tapentadol|mesh-list
110560703|NCT00486811|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110560704|NCT00486811|Narcotics|narcotics|mesh-ancestor
110560705|NCT00486811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110560706|NCT00486811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110560707|NCT00486811|Analgesics|analgesics|mesh-ancestor
110560708|NCT00486811|Sensory System Agents|sensory system agents|mesh-ancestor
110560709|NCT00486811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110560710|NCT00486811|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110560711|NCT00486811|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110560712|NCT00486811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110560713|NCT00486811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110560714|NCT00486811|Adrenergic Agents|adrenergic agents|mesh-ancestor
110560715|NCT00486811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110560716|NCT00921700|Acetaminophen|acetaminophen|mesh-list
110560717|NCT00921700|Ibuprofen|ibuprofen|mesh-list
110560718|NCT00921700|Codeine|codeine|mesh-list
110560719|NCT00921700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110560720|NCT00921700|Analgesics|analgesics|mesh-ancestor
110560721|NCT00921700|Sensory System Agents|sensory system agents|mesh-ancestor
110560722|NCT00921700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110560723|NCT00921700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110560724|NCT00921700|Antipyretics|antipyretics|mesh-ancestor
110560725|NCT00921700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110560726|NCT00921700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110560727|NCT00921700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110560728|NCT00921700|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110560729|NCT00921700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110560730|NCT00921700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110560731|NCT00921700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110560732|NCT00921700|Narcotics|narcotics|mesh-ancestor
110560733|NCT00921700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110560734|NCT00921700|Antitussive Agents|antitussive agents|mesh-ancestor
110560735|NCT00921700|Respiratory System Agents|respiratory system agents|mesh-ancestor
110560737|NCT02678195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110560738|NCT02678195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110560739|NCT03996577|Lidocaine|lidocaine|mesh-list
110560740|NCT03996577|Anesthetics, Local|anesthetics, local|mesh-ancestor
110560741|NCT03996577|Anesthetics|anesthetics|mesh-ancestor
110560742|NCT03996577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110560743|NCT03996577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110560744|NCT03996577|Sensory System Agents|sensory system agents|mesh-ancestor
110560745|NCT03996577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110560746|NCT03996577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110560747|NCT03996577|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110560748|NCT03996577|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110560749|NCT03996577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110560750|NCT03996577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110560751|NCT02681705|Temozolomide|temozolomide|mesh-list
110560752|NCT02681705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110560753|NCT02681705|Alkylating Agents|alkylating agents|mesh-ancestor
110560754|NCT02681705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110560755|NCT02681705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110560756|NCT00921622|Vitamin D|vitamin d|mesh-list
110560757|NCT00921622|Vitamins|vitamins|mesh-list
110560758|NCT00921622|Micronutrients|micronutrients|mesh-ancestor
110560759|NCT00921622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110560760|NCT00921622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110560761|NCT02681471|Mannitol|mannitol|mesh-list
110560762|NCT02681471|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110560763|NCT02681471|Diuretics|diuretics|mesh-ancestor
110560764|NCT02681471|Natriuretic Agents|natriuretic agents|mesh-ancestor
110560765|NCT02681471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110560766|NCT00642395|Bortezomib|bortezomib|mesh-list
110560767|NCT00642395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110560768|NCT01018615|Silymarin|silymarin|mesh-list
110560769|NCT01018615|Antioxidants|antioxidants|mesh-ancestor
110560770|NCT01018615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110560771|NCT01018615|Protective Agents|protective agents|mesh-ancestor
110560772|NCT01018615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110560773|NCT00743782|Hormones|hormones|mesh-list
110560774|NCT00743782|Parathyroid Hormone|parathyroid hormone|mesh-list
110560775|NCT00743782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110560776|NCT00743782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110560777|NCT00743782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110560778|NCT02678117|Magnesium Sulfate|magnesium sulfate|mesh-list
110560780|NCT02678117|Analgesics|analgesics|mesh-ancestor
110560781|NCT02678117|Sensory System Agents|sensory system agents|mesh-ancestor
110560782|NCT02678117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110560783|NCT02678117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110560784|NCT02678117|Anticonvulsants|anticonvulsants|mesh-ancestor
110560785|NCT02678117|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110560786|NCT02678117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110560787|NCT02678117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110560788|NCT02678117|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110560789|NCT02678117|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110560790|NCT02678117|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110560791|NCT02678117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110560792|NCT02678117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110560793|NCT02678117|Anesthetics|anesthetics|mesh-ancestor
110560794|NCT02678117|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110560795|NCT02678117|Tocolytic Agents|tocolytic agents|mesh-ancestor
110560796|NCT02678117|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110560797|NCT01018849|Vitamin D|vitamin d|mesh-list
110560798|NCT01018849|Cholecalciferol|cholecalciferol|mesh-list
110560799|NCT01018849|Vitamins|vitamins|mesh-ancestor
110560800|NCT01018849|Micronutrients|micronutrients|mesh-ancestor
110560801|NCT01018849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110560802|NCT01018849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110560803|NCT01018849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110560805|NCT04102319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110560806|NCT00743860|Darapladib|darapladib|mesh-list
110560807|NCT00743860|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
110560808|NCT00743860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110560809|NCT00743860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110560810|NCT00747526|Rabeprazole|rabeprazole|mesh-list
110560811|NCT00747526|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110560812|NCT00747526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110560813|NCT00747526|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110560814|NCT00747526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110560815|NCT00747526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110560816|NCT00747604|Mecasermin|mecasermin|mesh-list
110560817|NCT00747604|Growth Substances|growth substances|mesh-ancestor
110560818|NCT00747604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110560819|NCT02151604|Xenon|xenon|mesh-list
110560820|NCT02151604|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110560821|NCT02151604|Anesthetics, General|anesthetics, general|mesh-ancestor
110560822|NCT02151604|Anesthetics|anesthetics|mesh-ancestor
110560823|NCT02151604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110560824|NCT02151604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110560825|NCT00466921|Lenalidomide|lenalidomide|mesh-list
110560826|NCT00466921|Immunologic Factors|immunologic factors|mesh-ancestor
110560827|NCT00466921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110560828|NCT00466921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110560829|NCT00466921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110560830|NCT00466921|Growth Substances|growth substances|mesh-ancestor
110560831|NCT00466921|Growth Inhibitors|growth inhibitors|mesh-ancestor
110560832|NCT00466921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110560834|NCT00601523|Antioxidants|antioxidants|mesh-ancestor
110560835|NCT00601523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110560836|NCT00601523|Protective Agents|protective agents|mesh-ancestor
110560837|NCT00601523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110560838|NCT00601523|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110560839|NCT00601523|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110560840|NCT00601523|Dopamine Agonists|dopamine agonists|mesh-ancestor
110560841|NCT00601523|Dopamine Agents|dopamine agents|mesh-ancestor
110560842|NCT00601523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110560843|NCT00466687|Bevacizumab|bevacizumab|mesh-list
110560844|NCT00466687|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110560845|NCT00466687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110560846|NCT00466687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110560847|NCT00466687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110560848|NCT00466687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110560849|NCT00466687|Growth Substances|growth substances|mesh-ancestor
110560850|NCT00466687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110560851|NCT00466687|Growth Inhibitors|growth inhibitors|mesh-ancestor
110560852|NCT00466687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110560853|NCT00466687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110560854|NCT00466687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110560855|NCT01522768|Paclitaxel|paclitaxel|mesh-list
110560856|NCT01522768|Afatinib|afatinib|mesh-list
110560857|NCT01522768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110560858|NCT01522768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110560859|NCT01522768|Tubulin Modulators|tubulin modulators|mesh-ancestor
110560860|NCT01522768|Antimitotic Agents|antimitotic agents|mesh-ancestor
110560861|NCT01522768|Mitosis Modulators|mitosis modulators|mesh-ancestor
110560862|NCT01522768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110560863|NCT01522768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110560864|NCT01522768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110560865|NCT01759459|Lidocaine|lidocaine|mesh-list
110560866|NCT01759459|Anesthetics, Local|anesthetics, local|mesh-ancestor
110560867|NCT01759459|Anesthetics|anesthetics|mesh-ancestor
110560868|NCT01759459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110560869|NCT01759459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110560870|NCT01759459|Sensory System Agents|sensory system agents|mesh-ancestor
110560871|NCT01759459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110560872|NCT01759459|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110560873|NCT01759459|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110560874|NCT01759459|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110560875|NCT01759459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110560876|NCT01759459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110560877|NCT02562742|Ribavirin|ribavirin|mesh-list
110560878|NCT02562742|Antimetabolites|antimetabolites|mesh-ancestor
110560879|NCT02562742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110560880|NCT02562742|Antiviral Agents|antiviral agents|mesh-ancestor
110560881|NCT02562742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110560882|NCT00744016|Mesalamine|mesalamine|mesh-list
110560883|NCT00744016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110560884|NCT00744016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110560885|NCT00744016|Analgesics|analgesics|mesh-ancestor
110560886|NCT00744016|Sensory System Agents|sensory system agents|mesh-ancestor
110560887|NCT00744016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110560888|NCT00744016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110560889|NCT00744016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110560890|NCT00744016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110560891|NCT04182737|Immunoglobulins|immunoglobulins|mesh-list
110560892|NCT04182737|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110560893|NCT04182737|Antibodies|antibodies|mesh-list
110560894|NCT04182737|Immunoglobulin M|immunoglobulin m|mesh-list
110560895|NCT04182737|Immunoglobulin A|immunoglobulin a|mesh-list
110560896|NCT04182737|Immunologic Factors|immunologic factors|mesh-ancestor
110560897|NCT04182737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110560898|NCT04181645|Paclitaxel|paclitaxel|mesh-list
110560899|NCT04181645|Gemcitabine|gemcitabine|mesh-list
110560900|NCT04181645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110560901|NCT04181645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110560902|NCT04181645|Tubulin Modulators|tubulin modulators|mesh-ancestor
110560903|NCT04181645|Antimitotic Agents|antimitotic agents|mesh-ancestor
110560904|NCT04181645|Mitosis Modulators|mitosis modulators|mesh-ancestor
110560905|NCT04181645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110560906|NCT04181645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110560907|NCT04181645|Antimetabolites|antimetabolites|mesh-ancestor
110560908|NCT02679833|Vitamin B 12|vitamin b 12|mesh-list
110560909|NCT02679833|Hydroxocobalamin|hydroxocobalamin|mesh-list
110560910|NCT02679833|Vitamin B Complex|vitamin b complex|mesh-ancestor
110560911|NCT02679833|Vitamins|vitamins|mesh-ancestor
110560912|NCT02679833|Micronutrients|micronutrients|mesh-ancestor
110560913|NCT02679833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110560914|NCT02679833|Hematinics|hematinics|mesh-ancestor
110560915|NCT00641927|Lithium Carbonate|lithium carbonate|mesh-list
110560916|NCT00641927|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110560917|NCT00641927|Antidepressive Agents|antidepressive agents|mesh-ancestor
110560918|NCT00641927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110560919|NCT00641927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110560920|NCT00641927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110560921|NCT00641927|Antimanic Agents|antimanic agents|mesh-ancestor
110560922|NCT00641927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110560923|NCT00641927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110560924|NCT00641927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110560925|NCT00641927|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110560926|NCT00641927|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110560927|NCT00641927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110560928|NCT00641927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110560929|NCT00641927|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110560930|NCT02677571|Morphine|morphine|mesh-list
110560931|NCT02677571|Levobupivacaine|levobupivacaine|mesh-list
110560932|NCT02677571|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110560933|NCT02677571|Narcotics|narcotics|mesh-ancestor
110560934|NCT02677571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110560935|NCT02677571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110560936|NCT02677571|Analgesics|analgesics|mesh-ancestor
110560937|NCT02677571|Sensory System Agents|sensory system agents|mesh-ancestor
110560938|NCT02677571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110560939|NCT02677571|Anesthetics, Local|anesthetics, local|mesh-ancestor
110560940|NCT02677571|Anesthetics|anesthetics|mesh-ancestor
110560941|NCT04181567|Agomelatine|agomelatine|mesh-list
110560942|NCT04181567|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110560943|NCT04181567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110560944|NCT04181567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110560945|NCT05664191|Simendan|simendan|mesh-list
110560946|NCT05664191|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110560947|NCT05664191|Vasodilator Agents|vasodilator agents|mesh-ancestor
110560948|NCT05664191|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110560949|NCT05664191|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110560950|NCT05664191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110560951|NCT05664191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110560952|NCT05664191|Protective Agents|protective agents|mesh-ancestor
110560953|NCT05664191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110560955|NCT02676011|Succinylcholine|succinylcholine|mesh-list
110560956|NCT02676011|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110560957|NCT02676011|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110560958|NCT02676011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110560960|NCT02676011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110560961|NCT02676011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110560962|NCT02676011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110560963|NCT02676011|Respiratory System Agents|respiratory system agents|mesh-ancestor
110560964|NCT02676011|Mydriatics|mydriatics|mesh-ancestor
110560965|NCT02676011|Parasympatholytics|parasympatholytics|mesh-ancestor
110560966|NCT02676011|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110560967|NCT02676011|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110560969|NCT02676011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110560970|NCT02676011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110560971|NCT02676011|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
110560972|NCT02676011|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110560973|NCT02676011|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110560974|NCT05662943|Aflibercept|aflibercept|mesh-list
110560975|NCT05662943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110560976|NCT05662943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110560977|NCT05662943|Growth Substances|growth substances|mesh-ancestor
110560978|NCT05662943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110560979|NCT05662943|Growth Inhibitors|growth inhibitors|mesh-ancestor
110560980|NCT05662943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110560981|NCT05663255|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110560982|NCT05663255|Azithromycin|azithromycin|mesh-list
110560983|NCT05663255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110560985|NCT02678975|Temozolomide|temozolomide|mesh-list
110560986|NCT02678975|Lomustine|lomustine|mesh-list
110560987|NCT02678975|Disulfiram|disulfiram|mesh-list
110560988|NCT02678975|Alkylating Agents|alkylating agents|mesh-list
110560989|NCT02678975|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110560990|NCT02678975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110560991|NCT02678975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110560992|NCT02678975|Trace Elements|trace elements|mesh-ancestor
110560993|NCT02678975|Micronutrients|micronutrients|mesh-ancestor
110560994|NCT02678975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110560995|NCT02678975|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110560996|NCT02678975|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
110560997|NCT02678975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110560998|NCT02677415|Anesthetics|anesthetics|mesh-list
110560999|NCT02677415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
110561000|NCT02677415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110561001|NCT02677415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110561002|NCT02677415|Anesthetics, General|anesthetics, general|mesh-ancestor
110561003|NCT00454051|Omalizumab|omalizumab|mesh-list
110561004|NCT00454051|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110561005|NCT00454051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110561006|NCT00454051|Respiratory System Agents|respiratory system agents|mesh-ancestor
110561007|NCT04181489|Prednisolone|prednisolone|mesh-list
110561008|NCT04181489|Cyclophosphamide|cyclophosphamide|mesh-list
110561009|NCT04181489|Rituximab|rituximab|mesh-list
110561010|NCT04181489|Doxorubicin|doxorubicin|mesh-list
110561011|NCT04181489|Vincristine|vincristine|mesh-list
110561012|NCT04181489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110561013|NCT04181489|Immunologic Factors|immunologic factors|mesh-ancestor
110561014|NCT04181489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110561015|NCT04181489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110561016|NCT04181489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110561017|NCT04181489|Alkylating Agents|alkylating agents|mesh-ancestor
110561018|NCT04181489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110561019|NCT04181489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110561020|NCT04181489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110561021|NCT04181489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110561022|NCT04181489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110561023|NCT04181489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110561024|NCT04181489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110561025|NCT04181489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110561026|NCT04181489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110561027|NCT04181489|Tubulin Modulators|tubulin modulators|mesh-ancestor
110561028|NCT04181489|Antimitotic Agents|antimitotic agents|mesh-ancestor
110561029|NCT04181489|Mitosis Modulators|mitosis modulators|mesh-ancestor
110561030|NCT04181489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110561031|NCT04181489|Glucocorticoids|glucocorticoids|mesh-ancestor
110561032|NCT04181489|Hormones|hormones|mesh-ancestor
110561033|NCT04181489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110561034|NCT04181489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110561035|NCT02537561|Cisplatin|cisplatin|mesh-list
110561036|NCT02537561|Gemcitabine|gemcitabine|mesh-list
110561037|NCT02537561|Talazoparib|talazoparib|mesh-list
110561038|NCT02537561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110561039|NCT02537561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110561040|NCT02537561|Antimetabolites|antimetabolites|mesh-ancestor
110561041|NCT02537561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110561042|NCT02537561|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110561043|NCT02537561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110561044|NCT02676089|Tiotropium Bromide|tiotropium bromide|mesh-list
110561045|NCT02676089|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110561046|NCT02676089|Autonomic Agents|autonomic agents|mesh-ancestor
110561047|NCT02676089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110561048|NCT02676089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110561049|NCT02676089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110561050|NCT02676089|Respiratory System Agents|respiratory system agents|mesh-ancestor
110561051|NCT02676089|Parasympatholytics|parasympatholytics|mesh-ancestor
110561052|NCT02676089|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110561053|NCT02676089|Cholinergic Agents|cholinergic agents|mesh-ancestor
110561054|NCT02676089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110561055|NCT02676089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110561056|NCT02679131|Belinostat|belinostat|mesh-list
110561057|NCT02679131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110561058|NCT02679131|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110561059|NCT02679131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110561060|NCT02679131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110561061|NCT00484939|Bevacizumab|bevacizumab|mesh-list
110561062|NCT00484939|Capecitabine|capecitabine|mesh-list
110561063|NCT00484939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110561064|NCT00484939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110561065|NCT00484939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110561066|NCT00484939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110561067|NCT00484939|Growth Substances|growth substances|mesh-ancestor
110561068|NCT00484939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110561069|NCT00484939|Growth Inhibitors|growth inhibitors|mesh-ancestor
110561070|NCT00484939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110561071|NCT00484939|Antimetabolites|antimetabolites|mesh-ancestor
110561072|NCT00484939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110561073|NCT00642161|Budesonide|budesonide|mesh-list
110561074|NCT00642161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110561075|NCT00642161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110561076|NCT00642161|Autonomic Agents|autonomic agents|mesh-ancestor
110561077|NCT00642161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110561078|NCT00642161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110561079|NCT00642161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110561080|NCT00642161|Respiratory System Agents|respiratory system agents|mesh-ancestor
110561081|NCT00642161|Glucocorticoids|glucocorticoids|mesh-ancestor
110561082|NCT00642161|Hormones|hormones|mesh-ancestor
110561083|NCT00642161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110561084|NCT05663177|Vinorelbine|vinorelbine|mesh-list
110561085|NCT05663177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110561086|NCT05663177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110561087|NCT05663177|Tubulin Modulators|tubulin modulators|mesh-ancestor
110561088|NCT05663177|Antimitotic Agents|antimitotic agents|mesh-ancestor
110561089|NCT05663177|Mitosis Modulators|mitosis modulators|mesh-ancestor
110561090|NCT05663177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110561091|NCT00642551|Vitamin K 2|vitamin k 2|mesh-list
110561092|NCT00642551|Vitamin K|vitamin k|mesh-list
110561093|NCT00642551|Menaquinone 7|menaquinone 7|mesh-list
110561094|NCT00642551|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110561095|NCT00642551|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110561096|NCT00642551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110561097|NCT00642551|Hemostatics|hemostatics|mesh-ancestor
110561098|NCT00642551|Coagulants|coagulants|mesh-ancestor
110561099|NCT00642551|Vitamins|vitamins|mesh-ancestor
110561100|NCT00642551|Micronutrients|micronutrients|mesh-ancestor
110561101|NCT00642551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110561102|NCT04181957|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
110561103|NCT04181957|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110561104|NCT04181957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110561105|NCT04181957|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110561106|NCT04181957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110561107|NCT04181957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110561108|NCT04181957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110561110|NCT04181957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110561111|NCT00643409|Azithromycin|azithromycin|mesh-list
110561112|NCT00643409|Levofloxacin|levofloxacin|mesh-list
110561113|NCT00643409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110561114|NCT00643409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110561115|NCT00643409|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110561116|NCT00643409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110561117|NCT00643409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110561118|NCT00643409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110561119|NCT00643409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110561120|NCT00643409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110561121|NCT00643409|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110561122|NCT00643409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110561123|NCT04180007|Apatinib|apatinib|mesh-list
110561124|NCT04180007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110561125|NCT04180007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110561126|NCT04180007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110225488|NCT05952713|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110561127|NCT04180007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110561129|NCT02675309|Simvastatin|simvastatin|mesh-list
110561130|NCT02675309|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110561131|NCT02675309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110561132|NCT02675309|Antimetabolites|antimetabolites|mesh-ancestor
110561133|NCT02675309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110561134|NCT02675309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110561135|NCT02675309|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110561136|NCT02675309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110561137|NCT01025245|Remifentanil|remifentanil|mesh-list
110561138|NCT01025245|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110561139|NCT01025245|Narcotics|narcotics|mesh-ancestor
110561140|NCT01025245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110561141|NCT01025245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110561142|NCT01025245|Analgesics|analgesics|mesh-ancestor
110561143|NCT01025245|Sensory System Agents|sensory system agents|mesh-ancestor
110561144|NCT01025245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110561145|NCT02677259|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110561146|NCT02677259|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110561147|NCT02677259|Estradiol|estradiol|mesh-list
110561149|NCT02677259|Progesterone|progesterone|mesh-list
110561150|NCT02677259|Estrogens|estrogens|mesh-ancestor
110561151|NCT02677259|Hormones|hormones|mesh-ancestor
110561152|NCT02677259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110561153|NCT02677259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110561154|NCT02677259|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110561155|NCT02677259|Contraceptive Agents|contraceptive agents|mesh-ancestor
110561156|NCT02677259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110561157|NCT02677259|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110561158|NCT02677259|Progestins|progestins|mesh-ancestor
110561159|NCT02675387|Lidocaine|lidocaine|mesh-list
110561160|NCT02675387|Anesthetics, Local|anesthetics, local|mesh-ancestor
110561161|NCT02675387|Anesthetics|anesthetics|mesh-ancestor
110561162|NCT02675387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110561163|NCT02675387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110561164|NCT02675387|Sensory System Agents|sensory system agents|mesh-ancestor
110561165|NCT02675387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110561167|NCT02675387|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110561168|NCT02675387|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110561169|NCT02675387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110561170|NCT02675387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110561171|NCT02678507|Analgesics, Opioid|analgesics, opioid|mesh-list
110561172|NCT02678507|Narcotics|narcotics|mesh-ancestor
110561173|NCT02678507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110561174|NCT02678507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110561175|NCT02678507|Analgesics|analgesics|mesh-ancestor
110561176|NCT02678507|Sensory System Agents|sensory system agents|mesh-ancestor
110561177|NCT02678507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110561178|NCT00464737|Rotigotine|rotigotine|mesh-list
110561179|NCT00464737|Dopamine Agonists|dopamine agonists|mesh-ancestor
110561180|NCT00464737|Dopamine Agents|dopamine agents|mesh-ancestor
110561181|NCT00464737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110208748|NCT00195637|Antibodies|antibodies|mesh-list
110561182|NCT00464737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110561183|NCT00464737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110561184|NCT02678585|Lidocaine|lidocaine|mesh-list
110561185|NCT02678585|Nalbuphine|nalbuphine|mesh-list
110561186|NCT02678585|Anesthetics, Local|anesthetics, local|mesh-ancestor
110561187|NCT02678585|Anesthetics|anesthetics|mesh-ancestor
110561188|NCT02678585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110561189|NCT02678585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110561190|NCT02678585|Sensory System Agents|sensory system agents|mesh-ancestor
110561191|NCT02678585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110561192|NCT02678585|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110561193|NCT02678585|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110561194|NCT02678585|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110561195|NCT02678585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110561196|NCT02678585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110561197|NCT02678585|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110561198|NCT02678585|Narcotics|narcotics|mesh-ancestor
110561199|NCT02678585|Analgesics|analgesics|mesh-ancestor
110561200|NCT00453349|Moxifloxacin|moxifloxacin|mesh-list
110561201|NCT00453349|Metronidazole|metronidazole|mesh-list
110561202|NCT00453349|Levofloxacin|levofloxacin|mesh-list
110561203|NCT00453349|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110561204|NCT00453349|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110561205|NCT00453349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110561206|NCT00453349|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110561207|NCT00453349|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110561208|NCT00453349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110561209|NCT00453349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110561210|NCT00453349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110561211|NCT00453349|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110561212|NCT00453349|Contraceptive Agents|contraceptive agents|mesh-ancestor
110561213|NCT00453349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110561214|NCT00453349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110561215|NCT00453349|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110561216|NCT00453349|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110561217|NCT00453349|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110561218|NCT00453349|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110561219|NCT00453349|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110561220|NCT00453349|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110561221|NCT00453349|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110561222|NCT00453349|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110561223|NCT02675153|Sirolimus|sirolimus|mesh-list
110561224|NCT02675153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110561225|NCT02675153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110561226|NCT02675153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110561227|NCT02675153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110561228|NCT02675153|Antifungal Agents|antifungal agents|mesh-ancestor
110561229|NCT02675153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110561230|NCT02675153|Immunologic Factors|immunologic factors|mesh-ancestor
110561231|NCT02675153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110561232|NCT04179617|Nicotine|nicotine|mesh-list
110561233|NCT04179617|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110561234|NCT04179617|Autonomic Agents|autonomic agents|mesh-ancestor
110561235|NCT04179617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110561236|NCT04179617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110561237|NCT04179617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110561238|NCT04179617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110561239|NCT04179617|Cholinergic Agents|cholinergic agents|mesh-ancestor
110561240|NCT04179617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110561241|NCT04179617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110561242|NCT00464269|Brivaracetam|brivaracetam|mesh-list
110561243|NCT00464269|Anticonvulsants|anticonvulsants|mesh-ancestor
110561244|NCT00642863|Vitamin D|vitamin d|mesh-list
110561245|NCT00642863|Vitamins|vitamins|mesh-list
110561246|NCT00642863|Vitamin A|vitamin a|mesh-list
110561247|NCT00642863|Retinol palmitate|retinol palmitate|mesh-list
110561248|NCT00642863|Micronutrients|micronutrients|mesh-ancestor
110561249|NCT00642863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110561250|NCT00642863|Antioxidants|antioxidants|mesh-ancestor
110561251|NCT00642863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110561252|NCT00642863|Protective Agents|protective agents|mesh-ancestor
110561253|NCT00642863|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110561254|NCT00642863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110561255|NCT00642863|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110561256|NCT02674997|Factor VIII|factor viii|mesh-list
110561258|NCT04178291|Erythritol|erythritol|mesh-list
110561259|NCT04178291|Vasodilator Agents|vasodilator agents|mesh-ancestor
110561260|NCT00643643|Maraviroc|maraviroc|mesh-list
110189507|NCT00021671|Metronidazole|metronidazole|mesh-list
110561261|NCT00643643|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110561262|NCT00643643|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110561263|NCT00643643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110561264|NCT00643643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110561265|NCT00643643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110561266|NCT00643643|Antiviral Agents|antiviral agents|mesh-ancestor
110561267|NCT00643643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110561268|NCT00643643|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110561269|NCT02676869|Pembrolizumab|pembrolizumab|mesh-list
110561270|NCT02676869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110561271|NCT02676869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110561272|NCT02676869|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110561273|NCT02676869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110561274|NCT02673047|Botulinum Toxins|botulinum toxins|mesh-list
110561275|NCT02673047|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110561277|NCT02673047|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110561278|NCT02673047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110561279|NCT02673047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110561280|NCT02673047|Cholinergic Agents|cholinergic agents|mesh-ancestor
110561281|NCT02673047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110561282|NCT02673047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110561283|NCT02673047|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110561284|NCT02673047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110561285|NCT05584319|Empagliflozin|empagliflozin|mesh-list
110561286|NCT05584319|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110561287|NCT05584319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110561288|NCT05584319|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110561289|NCT05584319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110561291|NCT02676323|Cytarabine|cytarabine|mesh-list
110561292|NCT02676323|Hydrocortisone|hydrocortisone|mesh-list
110561293|NCT02676323|Methotrexate|methotrexate|mesh-list
110561294|NCT02676323|Fludarabine phosphate|fludarabine phosphate|mesh-list
110561295|NCT02676323|Fludarabine|fludarabine|mesh-list
110561296|NCT02676323|Panobinostat|panobinostat|mesh-list
110561297|NCT02676323|Levoleucovorin|levoleucovorin|mesh-list
110561298|NCT02676323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110561299|NCT02676323|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110561300|NCT02676323|Abortifacient Agents|abortifacient agents|mesh-ancestor
110561301|NCT02676323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110561302|NCT02676323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110561303|NCT02676323|Antimetabolites|antimetabolites|mesh-ancestor
110561304|NCT02676323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110561305|NCT02676323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110561306|NCT02676323|Dermatologic Agents|dermatologic agents|mesh-ancestor
110561307|NCT02676323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110561308|NCT02676323|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110561309|NCT02676323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110561310|NCT02676323|Immunologic Factors|immunologic factors|mesh-ancestor
110561311|NCT02676323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110561312|NCT02676323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110561313|NCT02676323|Antiviral Agents|antiviral agents|mesh-ancestor
110561314|NCT02676323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110561315|NCT02676323|Antidotes|antidotes|mesh-ancestor
110561316|NCT02676323|Protective Agents|protective agents|mesh-ancestor
110561317|NCT02676323|Vitamin B Complex|vitamin b complex|mesh-ancestor
110561318|NCT02676323|Vitamins|vitamins|mesh-ancestor
110561319|NCT02676323|Micronutrients|micronutrients|mesh-ancestor
110561320|NCT02676323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110561321|NCT02676323|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110561322|NCT00643799|Celecoxib|celecoxib|mesh-list
110561323|NCT00643799|Naproxen|naproxen|mesh-list
110561324|NCT00643799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110561325|NCT00643799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110561326|NCT00643799|Analgesics|analgesics|mesh-ancestor
110561327|NCT00643799|Sensory System Agents|sensory system agents|mesh-ancestor
110561328|NCT00643799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110561329|NCT00643799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110561330|NCT00643799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110208910|NCT00196612|Efavirenz|efavirenz|mesh-list
110561331|NCT00643799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110561332|NCT00643799|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110561333|NCT00643799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110561335|NCT00643799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110561336|NCT00643799|Gout Suppressants|gout suppressants|mesh-ancestor
110561337|NCT05348213|Decitabine|decitabine|mesh-list
110561338|NCT05348213|Pomalidomide|pomalidomide|mesh-list
110561339|NCT05348213|Zanubrutinib|zanubrutinib|mesh-list
110561340|NCT05348213|Tofacitinib|tofacitinib|mesh-list
110561341|NCT05348213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110561342|NCT05348213|Antimetabolites|antimetabolites|mesh-ancestor
110561343|NCT05348213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110561344|NCT05348213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110561345|NCT05348213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110561346|NCT05348213|Immunologic Factors|immunologic factors|mesh-ancestor
110561347|NCT05348213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110561348|NCT05348213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110561349|NCT05348213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110561350|NCT05348213|Growth Substances|growth substances|mesh-ancestor
110561351|NCT05348213|Growth Inhibitors|growth inhibitors|mesh-ancestor
110561352|NCT05348213|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110561353|NCT05348213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110561354|NCT00643877|Oxaliplatin|oxaliplatin|mesh-list
110561355|NCT00643877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110561357|NCT02674295|Antidepressive Agents|antidepressive agents|mesh-ancestor
110561358|NCT02674295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110561359|NCT04179071|Famotidine|famotidine|mesh-list
110561360|NCT04179071|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110561361|NCT04179071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110561362|NCT04179071|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110561363|NCT04179071|Histamine Antagonists|histamine antagonists|mesh-ancestor
110561364|NCT04179071|Histamine Agents|histamine agents|mesh-ancestor
110561365|NCT04179071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110561366|NCT04179071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110561367|NCT04179071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110561369|NCT02674139|Trace Elements|trace elements|mesh-ancestor
110561370|NCT02674139|Micronutrients|micronutrients|mesh-ancestor
110561371|NCT02674139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110561372|NCT00644033|Frovatriptan|frovatriptan|mesh-list
110561373|NCT00644033|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110561374|NCT00644033|Serotonin Agents|serotonin agents|mesh-ancestor
110561375|NCT00644033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110561376|NCT00644033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110561377|NCT00644033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110561378|NCT00484315|Paclitaxel|paclitaxel|mesh-list
110561379|NCT00484315|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110561380|NCT00484315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110561381|NCT00484315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110561382|NCT00484315|Tubulin Modulators|tubulin modulators|mesh-ancestor
110561383|NCT00484315|Antimitotic Agents|antimitotic agents|mesh-ancestor
110561384|NCT00484315|Mitosis Modulators|mitosis modulators|mesh-ancestor
110561385|NCT00484315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110561386|NCT01019083|Zinc|zinc|mesh-list
110561387|NCT01019083|Albendazole|albendazole|mesh-list
110561388|NCT01019083|Secnidazole|secnidazole|mesh-list
110561389|NCT01019083|Zinc Sulfate|zinc sulfate|mesh-list
110561390|NCT01019083|Trace Elements|trace elements|mesh-ancestor
110561391|NCT01019083|Micronutrients|micronutrients|mesh-ancestor
110561392|NCT01019083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110561393|NCT01019083|Anthelmintics|anthelmintics|mesh-ancestor
110561394|NCT01019083|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110561395|NCT01019083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110561396|NCT01019083|Anticestodal Agents|anticestodal agents|mesh-ancestor
110189523|NCT00021671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110561398|NCT01019083|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110561399|NCT01019083|Tubulin Modulators|tubulin modulators|mesh-ancestor
110561400|NCT01019083|Antimitotic Agents|antimitotic agents|mesh-ancestor
110561401|NCT01019083|Mitosis Modulators|mitosis modulators|mesh-ancestor
110561402|NCT01019083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110561403|NCT01019083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110561404|NCT01019083|Astringents|astringents|mesh-ancestor
110561405|NCT01019083|Dermatologic Agents|dermatologic agents|mesh-ancestor
110561406|NCT00463801|Daptomycin|daptomycin|mesh-list
110561407|NCT00463801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110561408|NCT00463801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110561409|NCT02672345|Sevoflurane|sevoflurane|mesh-list
110561410|NCT02672345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110561411|NCT02672345|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110561412|NCT02672345|Anesthetics, General|anesthetics, general|mesh-ancestor
110561413|NCT02672345|Anesthetics|anesthetics|mesh-ancestor
110561414|NCT02672345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110561415|NCT02672345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110561416|NCT02537249|Dexmedetomidine|dexmedetomidine|mesh-list
110561417|NCT02537249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110561418|NCT02537249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110561419|NCT02537249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110561420|NCT02537249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110561421|NCT02537249|Analgesics|analgesics|mesh-ancestor
110561422|NCT02537249|Sensory System Agents|sensory system agents|mesh-ancestor
110561423|NCT02537249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110561424|NCT02537249|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110561425|NCT02537249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110561426|NCT02537249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110561427|NCT02537249|Adrenergic Agents|adrenergic agents|mesh-ancestor
110561428|NCT02537249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110561429|NCT02537249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110561431|NCT00644111|Bupivacaine|bupivacaine|mesh-list
110561432|NCT00644111|Anesthetics, Local|anesthetics, local|mesh-ancestor
110561433|NCT00644111|Anesthetics|anesthetics|mesh-ancestor
110561434|NCT00644111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110561435|NCT00644111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110561436|NCT00644111|Sensory System Agents|sensory system agents|mesh-ancestor
110561437|NCT00644111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110561438|NCT00644111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110561439|NCT00644111|Narcotics|narcotics|mesh-ancestor
110561440|NCT00644111|Analgesics|analgesics|mesh-ancestor
110561441|NCT00644891|Amoxicillin|amoxicillin|mesh-list
110561442|NCT00644891|Cefdinir|cefdinir|mesh-list
110561443|NCT00644891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110561444|NCT00644891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110561445|NCT05203445|Pembrolizumab|pembrolizumab|mesh-list
110561446|NCT05203445|Olaparib|olaparib|mesh-list
110561447|NCT05203445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110561448|NCT05203445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110561449|NCT05203445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110561450|NCT05203445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110561451|NCT05203445|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110561452|NCT05203445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110561453|NCT04178057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110561454|NCT04178057|Antibodies|antibodies|mesh-list
110561455|NCT04178057|Immunoglobulins|immunoglobulins|mesh-list
110561456|NCT04178057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110561457|NCT04178057|Mitogens|mitogens|mesh-list
110561458|NCT04178057|Endothelial Growth Factors|endothelial growth factors|mesh-list
110561459|NCT04178057|Immunologic Factors|immunologic factors|mesh-ancestor
110561460|NCT04178057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110561461|NCT04178057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110561462|NCT04178057|Mitosis Modulators|mitosis modulators|mesh-ancestor
110561463|NCT04178057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110561465|NCT04177043|Antibodies|antibodies|mesh-list
110561466|NCT04177043|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
110561467|NCT04177043|Immunologic Factors|immunologic factors|mesh-ancestor
110561468|NCT04177043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110561469|NCT02670785|Estradiol|estradiol|mesh-list
110561470|NCT02670785|Estrogens|estrogens|mesh-ancestor
110561471|NCT02670785|Hormones|hormones|mesh-ancestor
110561472|NCT02670785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110561473|NCT02670785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110561475|NCT02670317|Cyclophosphamide|cyclophosphamide|mesh-list
110561476|NCT02670317|Doxorubicin|doxorubicin|mesh-list
110561477|NCT02670317|Vincristine|vincristine|mesh-list
110561478|NCT02670317|Obinutuzumab|obinutuzumab|mesh-list
110561479|NCT02670317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110561480|NCT02670317|Immunologic Factors|immunologic factors|mesh-ancestor
110561481|NCT02670317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110561482|NCT02670317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110561483|NCT02670317|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110561484|NCT02670317|Alkylating Agents|alkylating agents|mesh-ancestor
110561485|NCT02670317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110561486|NCT02670317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110561487|NCT02670317|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110561488|NCT02670317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110561489|NCT02670317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110561490|NCT02670317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110561491|NCT02670317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110561492|NCT02670317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110561493|NCT02670317|Glucocorticoids|glucocorticoids|mesh-ancestor
110561494|NCT02670317|Hormones|hormones|mesh-ancestor
110561495|NCT02670317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110561496|NCT02670317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110561497|NCT02670317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110561498|NCT02670317|Tubulin Modulators|tubulin modulators|mesh-ancestor
110561499|NCT02670317|Antimitotic Agents|antimitotic agents|mesh-ancestor
110561500|NCT02670317|Mitosis Modulators|mitosis modulators|mesh-ancestor
110561501|NCT02670317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110561502|NCT02671565|Hyaluronic Acid|hyaluronic acid|mesh-list
110561503|NCT02671565|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110561504|NCT02671565|Immunologic Factors|immunologic factors|mesh-ancestor
110561505|NCT02671565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110561506|NCT02671565|Viscosupplements|viscosupplements|mesh-ancestor
110561507|NCT02671565|Protective Agents|protective agents|mesh-ancestor
110561508|NCT02537405|Rivaroxaban|rivaroxaban|mesh-list
110561509|NCT02537405|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110561510|NCT02537405|Antithrombins|antithrombins|mesh-ancestor
110561511|NCT02537405|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110561512|NCT02537405|Protease Inhibitors|protease inhibitors|mesh-ancestor
110561513|NCT02537405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110561514|NCT02537405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110561515|NCT02537405|Anticoagulants|anticoagulants|mesh-ancestor
110561516|NCT04175171|Trastuzumab|trastuzumab|mesh-list
110561517|NCT04175171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110561518|NCT04175171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110561519|NCT04175093|N,N-dimethylarginine|n,n-dimethylarginine|mesh-list
110561520|NCT04175093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110561521|NCT04175093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110561522|NCT00645125|Amoxicillin|amoxicillin|mesh-list
110561523|NCT00645125|Cefdinir|cefdinir|mesh-list
110561524|NCT00645125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110561525|NCT00645125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110561526|NCT02669459|Imiquimod|imiquimod|mesh-list
110561527|NCT02669459|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110561528|NCT02669459|Immunologic Factors|immunologic factors|mesh-ancestor
110561529|NCT02669459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110561530|NCT02669459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110561531|NCT02669459|Interferon Inducers|interferon inducers|mesh-ancestor
110561533|NCT04176887|Levetiracetam|levetiracetam|mesh-list
110561534|NCT04176887|Anticonvulsants|anticonvulsants|mesh-ancestor
110561535|NCT04176887|Nootropic Agents|nootropic agents|mesh-ancestor
110561536|NCT04176887|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110561537|NCT04176887|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110561538|NCT04176887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110561539|NCT04176887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110561540|NCT04176887|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110561541|NCT04176887|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110561542|NCT04174937|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110561543|NCT04174937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110561544|NCT00645203|Cefdinir|cefdinir|mesh-list
110561545|NCT00645203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110561546|NCT00645203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110561547|NCT02669303|Methylprednisolone|methylprednisolone|mesh-list
110561548|NCT02669303|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110561549|NCT02669303|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110561550|NCT02669303|Prednisolone|prednisolone|mesh-list
110561551|NCT02669303|Prednisolone acetate|prednisolone acetate|mesh-list
110561552|NCT02669303|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110561553|NCT02669303|Prednisolone phosphate|prednisolone phosphate|mesh-list
110561554|NCT02669303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110561555|NCT02669303|Antiemetics|antiemetics|mesh-ancestor
110561556|NCT02669303|Autonomic Agents|autonomic agents|mesh-ancestor
110561557|NCT02669303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110209152|NCT00198094|Alprazolam|alprazolam|mesh-list
110561558|NCT02669303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110561559|NCT02669303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110561560|NCT02669303|Glucocorticoids|glucocorticoids|mesh-ancestor
110561561|NCT02669303|Hormones|hormones|mesh-ancestor
110561562|NCT02669303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110561563|NCT02669303|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110561564|NCT02669303|Protective Agents|protective agents|mesh-ancestor
110561565|NCT02669303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110561567|NCT00645281|Tolterodine Tartrate|tolterodine tartrate|mesh-list
110561568|NCT00645281|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110561569|NCT00645281|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110561570|NCT00645281|Cholinergic Agents|cholinergic agents|mesh-ancestor
110561571|NCT00645281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110561572|NCT00645281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110561573|NCT00645281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110561574|NCT00645281|Urological Agents|urological agents|mesh-ancestor
110561575|NCT02668679|Hormones|hormones|mesh-list
110561576|NCT02668679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110561577|NCT02668679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110561578|NCT00645437|Levofloxacin|levofloxacin|mesh-list
110561579|NCT00645437|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110561580|NCT00645437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110561581|NCT00645437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110561582|NCT00645437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110561583|NCT00645437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110561584|NCT00645437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110561585|NCT00645437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110561586|NCT00645437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110561587|NCT00645437|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110561588|NCT00645437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110561589|NCT02537171|Apatinib|apatinib|mesh-list
110561590|NCT02537171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110561591|NCT02537171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110561592|NCT02537171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110561593|NCT02537171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110561594|NCT00645515|Risperidone|risperidone|mesh-list
110561595|NCT00645515|Ziprasidone|ziprasidone|mesh-list
110561596|NCT00645515|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110561597|NCT00645515|Serotonin Agents|serotonin agents|mesh-ancestor
110561598|NCT00645515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110561599|NCT00645515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110561600|NCT00645515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110561601|NCT00645515|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110561602|NCT00645515|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110561603|NCT00645515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110561604|NCT00645515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110561605|NCT00645515|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110561606|NCT00645515|Dopamine Agents|dopamine agents|mesh-ancestor
110561607|NCT00644735|Esomeprazole|esomeprazole|mesh-list
110561608|NCT00644735|Lansoprazole|lansoprazole|mesh-list
110561609|NCT00644735|Dexlansoprazole|dexlansoprazole|mesh-list
110561610|NCT00644735|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110561611|NCT00644735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110561612|NCT00644735|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110561613|NCT00644735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110561614|NCT00644735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110561615|NCT02667743|Paclitaxel|paclitaxel|mesh-list
110561616|NCT02667743|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110561617|NCT02667743|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110561618|NCT02667743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110561619|NCT02667743|Tubulin Modulators|tubulin modulators|mesh-ancestor
110561620|NCT02667743|Antimitotic Agents|antimitotic agents|mesh-ancestor
110561621|NCT02667743|Mitosis Modulators|mitosis modulators|mesh-ancestor
110561622|NCT02667743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110561623|NCT02666651|Tolvaptan|tolvaptan|mesh-list
110561624|NCT02666651|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110561625|NCT02666651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110561626|NCT02666651|Natriuretic Agents|natriuretic agents|mesh-ancestor
110561627|NCT02666651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110561628|NCT02671175|Piperaquine|piperaquine|mesh-list
110561629|NCT02671175|Artenimol|artenimol|mesh-list
110561630|NCT02671175|Artemisinins|artemisinins|mesh-list
110561631|NCT02671175|Antimalarials|antimalarials|mesh-ancestor
110561632|NCT02671175|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110561633|NCT02671175|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110561634|NCT02671175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110561635|NCT02671097|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110561636|NCT02671097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110561637|NCT02671097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110561638|NCT02671097|Antimetabolites|antimetabolites|mesh-ancestor
110561639|NCT02671097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110561640|NCT02671097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110561641|NCT02671097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110561642|NCT02671097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110561643|NCT02667197|Analgesics, Opioid|analgesics, opioid|mesh-list
110561644|NCT02667197|Narcotics|narcotics|mesh-ancestor
110561645|NCT02667197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110561646|NCT02667197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110561647|NCT02667197|Analgesics|analgesics|mesh-ancestor
110561648|NCT02667197|Sensory System Agents|sensory system agents|mesh-ancestor
110561649|NCT02667197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110561650|NCT00463567|Formoterol Fumarate|formoterol fumarate|mesh-list
110561651|NCT00463567|Tiotropium Bromide|tiotropium bromide|mesh-list
110561652|NCT00463567|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110561653|NCT00463567|Autonomic Agents|autonomic agents|mesh-ancestor
110561654|NCT00463567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110561655|NCT00463567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110561656|NCT00463567|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110561657|NCT00463567|Respiratory System Agents|respiratory system agents|mesh-ancestor
110561658|NCT00463567|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110561659|NCT00463567|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110561660|NCT00463567|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110561661|NCT00463567|Adrenergic Agents|adrenergic agents|mesh-ancestor
110561662|NCT00463567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110561663|NCT00463567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110561664|NCT00463567|Parasympatholytics|parasympatholytics|mesh-ancestor
110561665|NCT00463567|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110561666|NCT00463567|Cholinergic Agents|cholinergic agents|mesh-ancestor
110561667|NCT00646061|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
110561668|NCT00646061|Parasympatholytics|parasympatholytics|mesh-ancestor
110561669|NCT00646061|Autonomic Agents|autonomic agents|mesh-ancestor
110561670|NCT00646061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110561671|NCT00646061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110561672|NCT00646061|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110561673|NCT00646061|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110561674|NCT00646061|Cholinergic Agents|cholinergic agents|mesh-ancestor
110561675|NCT00646061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110561676|NCT00646061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110561678|NCT00646841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110561679|NCT00646841|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110561680|NCT00646841|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110561681|NCT00646841|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110561682|NCT00646841|Adrenergic Agents|adrenergic agents|mesh-ancestor
110561683|NCT00646841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110561684|NCT00646841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110561685|NCT00646841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110561686|NCT04786067|Abatacept|abatacept|mesh-list
110561687|NCT04786067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110561688|NCT04786067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110561689|NCT04786067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110561690|NCT04786067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110561691|NCT04786067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110561692|NCT04786067|Immunologic Factors|immunologic factors|mesh-ancestor
110561693|NCT04786067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110561694|NCT04786067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110561695|NCT00646139|Tirbanibulin|tirbanibulin|mesh-list
110561696|NCT00646139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110561697|NCT00646139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110561698|NCT00484159|Lidocaine|lidocaine|mesh-list
110561699|NCT00484159|Bupivacaine|bupivacaine|mesh-list
110561700|NCT00484159|Anesthetics, Local|anesthetics, local|mesh-ancestor
110561701|NCT00484159|Anesthetics|anesthetics|mesh-ancestor
110561702|NCT00484159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110561703|NCT00484159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110561704|NCT00484159|Sensory System Agents|sensory system agents|mesh-ancestor
110561705|NCT00484159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110561706|NCT00484159|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110561707|NCT00484159|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110209278|NCT00409942|Torsemide|torsemide|mesh-list
110561708|NCT00484159|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110561709|NCT00484159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110561710|NCT00484159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110561712|NCT02666417|Trace Elements|trace elements|mesh-ancestor
110561713|NCT02666417|Micronutrients|micronutrients|mesh-ancestor
110561714|NCT02666417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110561715|NCT00910637|Gestodene|gestodene|mesh-list
110561716|NCT00910637|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110561717|NCT00910637|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110561718|NCT00910637|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110561719|NCT00910637|Contraceptive Agents|contraceptive agents|mesh-ancestor
110561720|NCT00910637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110561721|NCT00910637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110561722|NCT00910637|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110561723|NCT00910637|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110561724|NCT00910637|Progestins|progestins|mesh-ancestor
110561726|NCT00910637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110561727|NCT00462865|Bevacizumab|bevacizumab|mesh-list
110561728|NCT00462865|Gemcitabine|gemcitabine|mesh-list
110561729|NCT00462865|Capecitabine|capecitabine|mesh-list
110561730|NCT00462865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110561731|NCT00462865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110561732|NCT00462865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110561733|NCT00462865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110561734|NCT00462865|Growth Substances|growth substances|mesh-ancestor
110561735|NCT00462865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110561736|NCT00462865|Growth Inhibitors|growth inhibitors|mesh-ancestor
110561737|NCT00462865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110561738|NCT00462865|Antimetabolites|antimetabolites|mesh-ancestor
110561739|NCT00462865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110561740|NCT02667353|Anesthetics|anesthetics|mesh-list
110561741|NCT02667353|Etomidate|etomidate|mesh-list
110561742|NCT02667353|Succinylcholine|succinylcholine|mesh-list
110561743|NCT02667353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110561744|NCT02667353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110561745|NCT02667353|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110561746|NCT02667353|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110561747|NCT02667353|Anesthetics, General|anesthetics, general|mesh-ancestor
110561748|NCT02667353|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
110561749|NCT02667353|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110561750|NCT02667353|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110561751|NCT02667353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110561752|NCT00462709|Complement C1s|complement c1s|mesh-list
110561753|NCT00462709|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
110561754|NCT00462709|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
110561755|NCT00462709|Immunologic Factors|immunologic factors|mesh-ancestor
110561756|NCT00462709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110561757|NCT00462709|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110561758|NCT00462709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110561759|NCT02664857|Vitamin D|vitamin d|mesh-list
110561760|NCT02664857|Ergocalciferols|ergocalciferols|mesh-list
110561761|NCT02664857|Cholecalciferol|cholecalciferol|mesh-list
110561762|NCT02664857|Vitamins|vitamins|mesh-list
110561763|NCT02664857|Micronutrients|micronutrients|mesh-ancestor
110561764|NCT02664857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110561765|NCT02664857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110561766|NCT02664857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110561767|NCT02665871|Vaccines|vaccines|mesh-list
110561768|NCT02665871|Immunologic Factors|immunologic factors|mesh-ancestor
110561769|NCT02665871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110561770|NCT00647543|Atorvastatin|atorvastatin|mesh-list
110561771|NCT00647543|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110561772|NCT00647543|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110561773|NCT00647543|Antimetabolites|antimetabolites|mesh-ancestor
110561774|NCT00647543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110561775|NCT00647543|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110561776|NCT00647543|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110561777|NCT00647543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110561778|NCT00647621|Phenytoin|phenytoin|mesh-list
110561779|NCT00647621|Anticonvulsants|anticonvulsants|mesh-ancestor
110561780|NCT00647621|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110209344|NCT00199147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110561781|NCT00647621|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110561782|NCT00647621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110561783|NCT00647621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110561784|NCT00647621|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110561785|NCT00647621|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110561786|NCT00461305|Drospirenone|drospirenone|mesh-list
110561787|NCT00461305|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110561788|NCT00461305|Hormone Antagonists|hormone antagonists|mesh-ancestor
110561789|NCT00461305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110561790|NCT00461305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110561791|NCT00461305|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110561793|NCT00461305|Natriuretic Agents|natriuretic agents|mesh-ancestor
110561794|NCT01022671|Belotecan|belotecan|mesh-list
110561795|NCT01022671|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110561796|NCT01022671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110561797|NCT01022671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110561798|NCT01022671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110561799|NCT01022671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110561800|NCT01022749|Vaccines|vaccines|mesh-list
110561801|NCT01022749|Immunologic Factors|immunologic factors|mesh-ancestor
110561802|NCT01022749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110561803|NCT00645905|Adalimumab|adalimumab|mesh-list
110561804|NCT00645905|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110561805|NCT00645905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110561806|NCT00645905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110561807|NCT00647777|Olanzapine|olanzapine|mesh-list
110561808|NCT00647777|Antiemetics|antiemetics|mesh-ancestor
110561809|NCT00647777|Autonomic Agents|autonomic agents|mesh-ancestor
110561810|NCT00647777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110561811|NCT00647777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110561812|NCT00647777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110561813|NCT00647777|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110561814|NCT00647777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110561815|NCT00647777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110561816|NCT00647777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110561817|NCT00647777|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110561818|NCT00647777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110561819|NCT00647777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110561820|NCT00647777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110561821|NCT00647777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110561822|NCT00647777|Serotonin Agents|serotonin agents|mesh-ancestor
110561823|NCT04173611|Bupivacaine|bupivacaine|mesh-list
110561824|NCT04173611|Anesthetics, Local|anesthetics, local|mesh-ancestor
110561825|NCT04173611|Anesthetics|anesthetics|mesh-ancestor
110561826|NCT04173611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110561827|NCT04173611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110561828|NCT04173611|Sensory System Agents|sensory system agents|mesh-ancestor
110561829|NCT04173611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110561830|NCT02665637|Trastuzumab|trastuzumab|mesh-list
110561831|NCT02665637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110561832|NCT02665637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110561833|NCT04733183|Dacarbazine|dacarbazine|mesh-list
110561834|NCT04733183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110561835|NCT04733183|Alkylating Agents|alkylating agents|mesh-ancestor
110189603|NCT00049296|Immunologic Factors|immunologic factors|mesh-ancestor
110561836|NCT04733183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110561837|NCT04733183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110561838|NCT00648011|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110561839|NCT00648011|Quinapril|quinapril|mesh-list
110561840|NCT00648011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110561841|NCT00648011|Diuretics|diuretics|mesh-ancestor
110561842|NCT00648011|Natriuretic Agents|natriuretic agents|mesh-ancestor
110561843|NCT00648011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110561844|NCT00648011|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110561845|NCT00648011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110561846|NCT00648011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110561847|NCT00648011|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110561848|NCT00648011|Protease Inhibitors|protease inhibitors|mesh-ancestor
110561849|NCT00648011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110561850|NCT00646529|Budesonide|budesonide|mesh-list
110561851|NCT00646529|Formoterol Fumarate|formoterol fumarate|mesh-list
110209419|NCT00199576|Methylprednisolone|methylprednisolone|mesh-list
110561852|NCT00646529|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110561853|NCT00646529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110561854|NCT00646529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110561856|NCT00646529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110561857|NCT00646529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110561858|NCT00646529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110561859|NCT00646529|Respiratory System Agents|respiratory system agents|mesh-ancestor
110561860|NCT00646529|Glucocorticoids|glucocorticoids|mesh-ancestor
110561862|NCT00646529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110561863|NCT00646529|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110561864|NCT00646529|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110561865|NCT00646529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110561866|NCT00646529|Adrenergic Agents|adrenergic agents|mesh-ancestor
110561867|NCT00646529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110561868|NCT00646529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110561869|NCT00646607|Leucovorin|leucovorin|mesh-list
110561870|NCT00646607|Fluorouracil|fluorouracil|mesh-list
110561871|NCT00646607|Oxaliplatin|oxaliplatin|mesh-list
110561872|NCT00646607|Levoleucovorin|levoleucovorin|mesh-list
110561873|NCT00646607|Antimetabolites|antimetabolites|mesh-ancestor
110561874|NCT00646607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110561875|NCT00646607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110561876|NCT00646607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110561877|NCT00646607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110561878|NCT00646607|Immunologic Factors|immunologic factors|mesh-ancestor
110561879|NCT00646607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110561880|NCT00646607|Antidotes|antidotes|mesh-ancestor
110561881|NCT00646607|Protective Agents|protective agents|mesh-ancestor
110561882|NCT00646607|Vitamin B Complex|vitamin b complex|mesh-ancestor
110561883|NCT00646607|Vitamins|vitamins|mesh-ancestor
110561884|NCT00646607|Micronutrients|micronutrients|mesh-ancestor
110561885|NCT00856544|Tofacitinib|tofacitinib|mesh-list
110561886|NCT00856544|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110561887|NCT00856544|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110561888|NCT00856544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110561889|NCT00856544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110561890|NCT00648245|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110561891|NCT00648323|Doxazosin|doxazosin|mesh-list
110561892|NCT00648323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110561893|NCT00648323|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110561894|NCT00648323|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110561895|NCT00648323|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110561896|NCT00648323|Adrenergic Agents|adrenergic agents|mesh-ancestor
110561897|NCT00648323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110561898|NCT00648323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110561899|NCT00648323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110561900|NCT00856388|Fludarabine|fludarabine|mesh-list
110561901|NCT00856388|Fludarabine phosphate|fludarabine phosphate|mesh-list
110561902|NCT00856388|Melphalan|melphalan|mesh-list
110561903|NCT00856388|Thymoglobulin|thymoglobulin|mesh-list
110561904|NCT00856388|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110561905|NCT00856388|Immunoglobulins|immunoglobulins|mesh-list
110561906|NCT00856388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110561907|NCT00856388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110561908|NCT00856388|Antimetabolites|antimetabolites|mesh-ancestor
110561909|NCT00856388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110561910|NCT00856388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110561911|NCT00856388|Immunologic Factors|immunologic factors|mesh-ancestor
110561912|NCT00856388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110561913|NCT00856388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110561914|NCT00856388|Alkylating Agents|alkylating agents|mesh-ancestor
110561915|NCT00856388|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110561917|NCT00648401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110561918|NCT00648401|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110561919|NCT00648401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110561920|NCT00648401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110561921|NCT00648401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110561922|NCT00648401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110561923|NCT00648401|Vasodilator Agents|vasodilator agents|mesh-ancestor
110561924|NCT02663999|Diazepam|diazepam|mesh-list
110209501|NCT00410254|Anesthetics|anesthetics|mesh-ancestor
110561926|NCT02663999|Anticonvulsants|anticonvulsants|mesh-ancestor
110561927|NCT02663999|Antiemetics|antiemetics|mesh-ancestor
110561928|NCT02663999|Autonomic Agents|autonomic agents|mesh-ancestor
110561929|NCT02663999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110561930|NCT02663999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110561931|NCT02663999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110561932|NCT02663999|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110561933|NCT02663999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110561934|NCT02663999|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110561935|NCT02663999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110561936|NCT02663999|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110561937|NCT02663999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110561938|NCT02663999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110561939|NCT02663999|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110561940|NCT02663999|Anesthetics, General|anesthetics, general|mesh-ancestor
110561941|NCT02663999|Anesthetics|anesthetics|mesh-ancestor
110561942|NCT02663999|GABA Modulators|gaba modulators|mesh-ancestor
110561943|NCT02663999|GABA Agents|gaba agents|mesh-ancestor
110561944|NCT02663999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110561945|NCT02663999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110561946|NCT04171427|Lithium Carbonate|lithium carbonate|mesh-list
110561947|NCT04171427|Antidepressive Agents|antidepressive agents|mesh-ancestor
110561948|NCT04171427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110561949|NCT04171427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110561950|NCT04171427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110561951|NCT04171427|Antimanic Agents|antimanic agents|mesh-ancestor
110561952|NCT04171427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110561953|NCT04171427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110561954|NCT04171427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110561955|NCT04171739|Itraconazole|itraconazole|mesh-list
110561956|NCT04171739|Olorofim|olorofim|mesh-list
110561957|NCT04171739|Rifampin|rifampin|mesh-list
110561958|NCT04171739|Antifungal Agents|antifungal agents|mesh-ancestor
110561959|NCT04171739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110561960|NCT04171739|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110561961|NCT04171739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110561962|NCT04171739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110561963|NCT04171739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110561964|NCT04171739|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110561965|NCT04171739|Hormone Antagonists|hormone antagonists|mesh-ancestor
110561966|NCT04171739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110561967|NCT04171739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110561968|NCT04171739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110561969|NCT04171739|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110561970|NCT04171739|Antitubercular Agents|antitubercular agents|mesh-ancestor
110561971|NCT04171739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110561972|NCT04171739|Leprostatic Agents|leprostatic agents|mesh-ancestor
110561973|NCT04171739|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110561974|NCT04171739|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110561975|NCT04171739|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110561976|NCT04171739|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110561977|NCT04171739|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110561978|NCT04171739|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110561979|NCT04171739|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110561982|NCT02656121|Vitamins|vitamins|mesh-ancestor
110561983|NCT02656121|Micronutrients|micronutrients|mesh-ancestor
110561984|NCT02656121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110561985|NCT02656121|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110561986|NCT02656121|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110561987|NCT02656121|Hormone Antagonists|hormone antagonists|mesh-ancestor
110561988|NCT02656121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110561989|NCT02656121|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110561990|NCT02656121|Fertility Agents|fertility agents|mesh-ancestor
110561991|NCT02656121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110561992|NCT02656121|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110561993|NCT02656121|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110561994|NCT00648713|Terbinafine|terbinafine|mesh-list
110561995|NCT00648713|Antifungal Agents|antifungal agents|mesh-ancestor
110561996|NCT00648713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110561997|NCT00648713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110561998|NCT00648713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110561999|NCT00649883|Vaccines|vaccines|mesh-list
110562000|NCT00649883|Immunologic Factors|immunologic factors|mesh-ancestor
110562001|NCT00649883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562002|NCT00648791|Finasteride|finasteride|mesh-list
110562003|NCT00648791|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110562004|NCT00648791|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110562005|NCT00648791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110562006|NCT00648791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110562007|NCT00648791|Hormone Antagonists|hormone antagonists|mesh-ancestor
110562008|NCT00648791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110562009|NCT00648791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562010|NCT00648791|Urological Agents|urological agents|mesh-ancestor
110562011|NCT00649181|Metolazone|metolazone|mesh-list
110562012|NCT00649181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110562013|NCT00649181|Diuretics|diuretics|mesh-ancestor
110562014|NCT00649181|Natriuretic Agents|natriuretic agents|mesh-ancestor
110562015|NCT00649181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562016|NCT00649181|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110562017|NCT00649181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110562018|NCT00649181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110562019|NCT02655965|Clonidine|clonidine|mesh-list
110562020|NCT02655965|Ropivacaine|ropivacaine|mesh-list
110562021|NCT02655965|Anesthetics, Local|anesthetics, local|mesh-ancestor
110562022|NCT02655965|Anesthetics|anesthetics|mesh-ancestor
110562023|NCT02655965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110562024|NCT02655965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562025|NCT02655965|Sensory System Agents|sensory system agents|mesh-ancestor
110562026|NCT02655965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110562028|NCT02655965|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110562030|NCT02655965|Autonomic Agents|autonomic agents|mesh-ancestor
110562031|NCT02655965|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110562032|NCT02655965|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110562033|NCT02655965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110562034|NCT02655965|Adrenergic Agents|adrenergic agents|mesh-ancestor
110562035|NCT02655965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110562036|NCT02655965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110562037|NCT04170179|Lenvatinib|lenvatinib|mesh-list
110562038|NCT04170179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110562039|NCT04170179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110562040|NCT04170179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110562041|NCT04170179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110562042|NCT02659085|Ketamine|ketamine|mesh-list
110562043|NCT02659085|Analgesics|analgesics|mesh-ancestor
110562044|NCT02659085|Sensory System Agents|sensory system agents|mesh-ancestor
110562045|NCT02659085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110562046|NCT02659085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562047|NCT02659085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110562048|NCT02659085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110562049|NCT02659085|Anesthetics, General|anesthetics, general|mesh-ancestor
110562050|NCT02659085|Anesthetics|anesthetics|mesh-ancestor
110562051|NCT02659085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110562052|NCT02659085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110562053|NCT02659085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110562054|NCT02659085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110562055|NCT02659085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110562057|NCT04171193|Sertraline|sertraline|mesh-list
110562058|NCT04171193|Antidepressive Agents|antidepressive agents|mesh-ancestor
110562059|NCT04171193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110562060|NCT04171193|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110562061|NCT04171193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110562062|NCT04171193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110562063|NCT04171193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110562064|NCT04171193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110562065|NCT04171193|Serotonin Agents|serotonin agents|mesh-ancestor
110562066|NCT04171193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562067|NCT04171193|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110562068|NCT04171193|Anesthetics, General|anesthetics, general|mesh-ancestor
110562069|NCT04171193|Anesthetics|anesthetics|mesh-ancestor
110562070|NCT04171193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110562071|NCT02663141|Bevacizumab|bevacizumab|mesh-list
110562072|NCT02663141|Losartan|losartan|mesh-list
110562073|NCT02663141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110562074|NCT02663141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110562075|NCT02663141|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110562076|NCT02663141|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110562077|NCT02663141|Growth Substances|growth substances|mesh-ancestor
110562078|NCT02663141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562079|NCT02663141|Growth Inhibitors|growth inhibitors|mesh-ancestor
110562080|NCT02663141|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110562081|NCT02663141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110562082|NCT02663141|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110562083|NCT02663141|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110562084|NCT02663141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110562085|NCT04171349|Dexmedetomidine|dexmedetomidine|mesh-list
110562086|NCT04171349|Carticaine|carticaine|mesh-list
110562087|NCT04171349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110562088|NCT04171349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110562089|NCT04171349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562090|NCT04171349|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110562091|NCT04171349|Analgesics|analgesics|mesh-ancestor
110562092|NCT04171349|Sensory System Agents|sensory system agents|mesh-ancestor
110562093|NCT04171349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110562094|NCT04171349|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110562095|NCT04171349|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110562096|NCT04171349|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110562098|NCT04171349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110562099|NCT04171349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110562100|NCT04171349|Anesthetics, Local|anesthetics, local|mesh-ancestor
110562102|NCT00650039|Valdecoxib|valdecoxib|mesh-list
110562103|NCT00650039|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110562104|NCT00650039|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110562105|NCT00650039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110562106|NCT00650039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110562107|NCT00650039|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110562108|NCT00650039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110562109|NCT00650039|Analgesics|analgesics|mesh-ancestor
110562110|NCT00650039|Sensory System Agents|sensory system agents|mesh-ancestor
110562111|NCT00650039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110562112|NCT00650039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562113|NCT00650039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110562114|NCT00650039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110562115|NCT00649259|Oxybutynin|oxybutynin|mesh-list
110562116|NCT00649259|Parasympatholytics|parasympatholytics|mesh-ancestor
110562117|NCT00649259|Autonomic Agents|autonomic agents|mesh-ancestor
110562118|NCT00649259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110562119|NCT00649259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562120|NCT00649259|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110562121|NCT00649259|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110562122|NCT00649259|Cholinergic Agents|cholinergic agents|mesh-ancestor
110562123|NCT00649259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110562124|NCT00649259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110562125|NCT00649259|Urological Agents|urological agents|mesh-ancestor
110562126|NCT04401059|Gefitinib|gefitinib|mesh-list
110562127|NCT04401059|Osimertinib|osimertinib|mesh-list
110562128|NCT04401059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110562129|NCT04401059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110562130|NCT04401059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110562131|NCT04401059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110562132|NCT02658773|Lidocaine|lidocaine|mesh-list
110562133|NCT02658773|Prilocaine|prilocaine|mesh-list
110562134|NCT02658773|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
110562135|NCT02658773|Anesthetics, Local|anesthetics, local|mesh-ancestor
110562136|NCT02658773|Anesthetics|anesthetics|mesh-ancestor
110562137|NCT02658773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110562138|NCT02658773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562139|NCT02658773|Sensory System Agents|sensory system agents|mesh-ancestor
110562140|NCT02658773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110562141|NCT02658773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110562142|NCT02658773|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110562143|NCT02658773|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110209721|NCT00221494|Serotonin Agents|serotonin agents|mesh-ancestor
110562144|NCT02658773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110562145|NCT02658773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110562146|NCT02658773|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
110562147|NCT00648869|Metformin|metformin|mesh-list
110562148|NCT00648869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110562149|NCT00648869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562150|NCT04169945|Erythritol|erythritol|mesh-list
110562151|NCT04169945|Vasodilator Agents|vasodilator agents|mesh-ancestor
110562152|NCT04169867|Nivolumab|nivolumab|mesh-list
110562153|NCT04169867|Ipilimumab|ipilimumab|mesh-list
110562155|NCT04169867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110562156|NCT04169867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110562157|NCT04169867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110562158|NCT04169867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110562159|NCT02655029|Amlodipine|amlodipine|mesh-list
110562160|NCT02655029|Perindopril|perindopril|mesh-list
110562161|NCT02655029|Indapamide|indapamide|mesh-list
110562162|NCT02655029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110562164|NCT02655029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110562165|NCT02655029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110562166|NCT02655029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110562167|NCT02655029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562168|NCT02655029|Vasodilator Agents|vasodilator agents|mesh-ancestor
110562169|NCT02655029|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110562170|NCT02655029|Protease Inhibitors|protease inhibitors|mesh-ancestor
110562171|NCT02655029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110562172|NCT02655029|Diuretics|diuretics|mesh-ancestor
110562173|NCT02655029|Natriuretic Agents|natriuretic agents|mesh-ancestor
110562174|NCT02655029|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110562175|NCT02536859|Insulin|insulin|mesh-list
110562176|NCT02536859|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110562177|NCT02536859|Insulin Glargine|insulin glargine|mesh-list
110562178|NCT02536859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110562179|NCT02536859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562180|NCT02536937|Eliglustat|eliglustat|mesh-list
110562181|NCT02536937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110562182|NCT02536937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110562183|NCT02654561|Heparin|heparin|mesh-list
110562184|NCT02654561|Calcium heparin|calcium heparin|mesh-list
110562185|NCT02654561|Anticoagulants|anticoagulants|mesh-ancestor
110562186|NCT02654561|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110562187|NCT02654561|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110562188|NCT02654561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110562189|NCT02654405|Butyric Acid|butyric acid|mesh-list
110562190|NCT02654405|Histamine Antagonists|histamine antagonists|mesh-ancestor
110562191|NCT02654405|Histamine Agents|histamine agents|mesh-ancestor
110562192|NCT02654405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110562193|NCT02654405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110562194|NCT02654405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562196|NCT00649415|Piroxicam|piroxicam|mesh-list
110562197|NCT00649415|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110562198|NCT00649415|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110562199|NCT00649415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110562200|NCT00649415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110562201|NCT00649415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110562202|NCT00649415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110562203|NCT00649415|Analgesics|analgesics|mesh-ancestor
110562204|NCT00649415|Sensory System Agents|sensory system agents|mesh-ancestor
110562205|NCT00649415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110562206|NCT00649415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562207|NCT00649415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110562208|NCT00649415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110562209|NCT00650117|Fentanyl|fentanyl|mesh-list
110562210|NCT00650117|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110562211|NCT00650117|Narcotics|narcotics|mesh-ancestor
110562212|NCT00650117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110562213|NCT00650117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562214|NCT00650117|Analgesics|analgesics|mesh-ancestor
110562215|NCT00650117|Sensory System Agents|sensory system agents|mesh-ancestor
110562216|NCT00650117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110209807|NCT00085761|Capsaicin|capsaicin|mesh-list
110562217|NCT00650117|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110562218|NCT00650117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110562219|NCT00650117|Anesthetics, General|anesthetics, general|mesh-ancestor
110562220|NCT00650117|Anesthetics|anesthetics|mesh-ancestor
110562221|NCT00648947|Clopidogrel|clopidogrel|mesh-list
110562222|NCT00648947|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110562223|NCT00648947|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110562224|NCT00648947|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110562225|NCT00648947|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110562226|NCT00648947|Purinergic Agents|purinergic agents|mesh-ancestor
110562227|NCT00648947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110562228|NCT00648947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110189650|NCT00049413|Cyclophosphamide|cyclophosphamide|mesh-list
110562229|NCT00648947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562230|NCT00649493|Rabeprazole|rabeprazole|mesh-list
110562231|NCT00649493|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110562232|NCT00649493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110562233|NCT00649493|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110562234|NCT00649493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110562235|NCT00649493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110562236|NCT02654093|Cholecalciferol|cholecalciferol|mesh-list
110562238|NCT02654093|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
110562239|NCT02654093|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110562240|NCT02654093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562241|NCT02654093|Vitamins|vitamins|mesh-ancestor
110562242|NCT02654093|Micronutrients|micronutrients|mesh-ancestor
110562243|NCT02654093|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110562244|NCT02654093|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110562245|NCT02654093|Hormone Antagonists|hormone antagonists|mesh-ancestor
110562246|NCT02654093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110562247|NCT02654093|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110562248|NCT02654093|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110562249|NCT04168619|Methotrexate|methotrexate|mesh-list
110562250|NCT04168619|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110562251|NCT04168619|Abortifacient Agents|abortifacient agents|mesh-ancestor
110562252|NCT04168619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110562253|NCT04168619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562254|NCT04168619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110562255|NCT04168619|Antimetabolites|antimetabolites|mesh-ancestor
110562256|NCT04168619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110562257|NCT04168619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110562258|NCT04168619|Dermatologic Agents|dermatologic agents|mesh-ancestor
110562259|NCT04168619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110562260|NCT04168619|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110562261|NCT04168619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110562262|NCT04168619|Immunologic Factors|immunologic factors|mesh-ancestor
110562263|NCT04168619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110562264|NCT04168619|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110562266|NCT02654171|Antiviral Agents|antiviral agents|mesh-ancestor
110562267|NCT02654171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110562268|NCT00650195|Metolazone|metolazone|mesh-list
110562269|NCT00650195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110562270|NCT00650195|Diuretics|diuretics|mesh-ancestor
110562271|NCT00650195|Natriuretic Agents|natriuretic agents|mesh-ancestor
110562272|NCT00650195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562273|NCT00650195|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110562274|NCT00650195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110562275|NCT00650195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110562276|NCT04170959|Metformin|metformin|mesh-list
110562277|NCT04170959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110562278|NCT04170959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562279|NCT00848354|Etanercept|etanercept|mesh-list
110562280|NCT00848354|Methotrexate|methotrexate|mesh-list
110562281|NCT00848354|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110562282|NCT00848354|Abortifacient Agents|abortifacient agents|mesh-ancestor
110562283|NCT00848354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110562284|NCT00848354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562285|NCT00848354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110562286|NCT00848354|Antimetabolites|antimetabolites|mesh-ancestor
110562287|NCT00848354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110562288|NCT00848354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110562289|NCT00848354|Dermatologic Agents|dermatologic agents|mesh-ancestor
110562290|NCT00848354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110562291|NCT00848354|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110562292|NCT00848354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110562293|NCT00848354|Immunologic Factors|immunologic factors|mesh-ancestor
110562294|NCT00848354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110189656|NCT00049413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110562295|NCT00848354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110562296|NCT00848354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110562297|NCT00848354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110562298|NCT00848354|Analgesics|analgesics|mesh-ancestor
110562299|NCT00848354|Sensory System Agents|sensory system agents|mesh-ancestor
110562300|NCT00848354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110562301|NCT00848354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110562302|NCT00848354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110562303|NCT00600821|Paclitaxel|paclitaxel|mesh-list
110562304|NCT00600821|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110562305|NCT00600821|Bevacizumab|bevacizumab|mesh-list
110562306|NCT00600821|Carboplatin|carboplatin|mesh-list
110562307|NCT00600821|Axitinib|axitinib|mesh-list
110562308|NCT00600821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110562309|NCT00600821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110562310|NCT00600821|Tubulin Modulators|tubulin modulators|mesh-ancestor
110562311|NCT00600821|Antimitotic Agents|antimitotic agents|mesh-ancestor
110562312|NCT00600821|Mitosis Modulators|mitosis modulators|mesh-ancestor
110562313|NCT00600821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110562314|NCT00600821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110562315|NCT00600821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110562316|NCT00600821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110562317|NCT00600821|Growth Substances|growth substances|mesh-ancestor
110562318|NCT00600821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562319|NCT00600821|Growth Inhibitors|growth inhibitors|mesh-ancestor
110562320|NCT00600821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110562321|NCT00600821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110562323|NCT00699764|Immunologic Factors|immunologic factors|mesh-ancestor
110562324|NCT00699764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562326|NCT02653703|Menthol|menthol|mesh-list
110562327|NCT02653703|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110562328|NCT02653703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110562329|NCT02653703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110562330|NCT02653703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562331|NCT02653703|Antipruritics|antipruritics|mesh-ancestor
110562332|NCT02653703|Dermatologic Agents|dermatologic agents|mesh-ancestor
110562333|NCT00649571|Doxycycline|doxycycline|mesh-list
110562334|NCT00649571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110562335|NCT00649571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110562336|NCT00649571|Antimalarials|antimalarials|mesh-ancestor
110562337|NCT00649571|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110562338|NCT00649571|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110562339|NCT02662283|Acteoside|acteoside|mesh-list
110562340|NCT02662283|Prednisolone|prednisolone|mesh-list
110562341|NCT02662283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110562342|NCT02662283|Glucocorticoids|glucocorticoids|mesh-ancestor
110562343|NCT02662283|Hormones|hormones|mesh-ancestor
110562344|NCT02662283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110562345|NCT02662283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562346|NCT02662283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110562347|NCT02662283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110562348|NCT02662283|Protective Agents|protective agents|mesh-ancestor
110562349|NCT02662283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110562350|NCT02662283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110562351|NCT02662283|Antioxidants|antioxidants|mesh-ancestor
110562352|NCT02662283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110562353|NCT02662283|Chelating Agents|chelating agents|mesh-ancestor
110562354|NCT02662283|Sequestering Agents|sequestering agents|mesh-ancestor
110562355|NCT02662283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110562356|NCT02662283|Immunologic Factors|immunologic factors|mesh-ancestor
110562357|NCT02657603|Lidocaine|lidocaine|mesh-list
110562358|NCT02657603|Anesthetics, Local|anesthetics, local|mesh-ancestor
110562359|NCT02657603|Anesthetics|anesthetics|mesh-ancestor
110562360|NCT02657603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110562361|NCT02657603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562362|NCT02657603|Sensory System Agents|sensory system agents|mesh-ancestor
110562363|NCT02657603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110562364|NCT02657603|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110562365|NCT02657603|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110562366|NCT02657603|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110562367|NCT02657603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110562368|NCT02657603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110562369|NCT02657447|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
110562370|NCT02657447|Chelating Agents|chelating agents|mesh-ancestor
110562371|NCT02657447|Sequestering Agents|sequestering agents|mesh-ancestor
110562372|NCT02657447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110562373|NCT00649649|Quinapril|quinapril|mesh-list
110562374|NCT00649649|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110562375|NCT00649649|Protease Inhibitors|protease inhibitors|mesh-ancestor
110562376|NCT00649649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110562377|NCT00649649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110562378|NCT00649649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110562379|NCT02657291|Ropivacaine|ropivacaine|mesh-list
110562380|NCT02657291|Anesthetics, Local|anesthetics, local|mesh-ancestor
110562381|NCT02657291|Anesthetics|anesthetics|mesh-ancestor
110562382|NCT02657291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110562383|NCT02657291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562384|NCT02657291|Sensory System Agents|sensory system agents|mesh-ancestor
110562385|NCT02657291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110562386|NCT00699920|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110562388|NCT00699920|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110562389|NCT00699920|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110562390|NCT00699920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110562392|NCT02661893|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110562393|NCT02661893|Antitubercular Agents|antitubercular agents|mesh-ancestor
110562394|NCT02661893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110562395|NCT02661893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110562396|NCT02661893|Leprostatic Agents|leprostatic agents|mesh-ancestor
110562397|NCT02661893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110562398|NCT02661893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110562399|NCT02661893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110562400|NCT02661893|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110562401|NCT02661893|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110562402|NCT02661893|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110562403|NCT02661893|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110562404|NCT02661893|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110562405|NCT02661893|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110562407|NCT00855920|Rilonacept|rilonacept|mesh-list
110562408|NCT00855920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110562409|NCT00855920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110562410|NCT00855920|Analgesics|analgesics|mesh-ancestor
110562411|NCT00855920|Sensory System Agents|sensory system agents|mesh-ancestor
110562412|NCT00855920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110562413|NCT00855920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562414|NCT00855920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110562415|NCT00855920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110562416|NCT00855920|Gout Suppressants|gout suppressants|mesh-ancestor
110562417|NCT00855920|Tocolytic Agents|tocolytic agents|mesh-ancestor
110562418|NCT00855920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110562419|NCT00855920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110562420|NCT00855920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110562421|NCT00855920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110562423|NCT02657213|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110562424|NCT02657213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110562425|NCT02657213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562426|NCT00649727|Oxybutynin|oxybutynin|mesh-list
110562427|NCT00649727|Parasympatholytics|parasympatholytics|mesh-ancestor
110562428|NCT00649727|Autonomic Agents|autonomic agents|mesh-ancestor
110562429|NCT00649727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110562430|NCT00649727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562431|NCT00649727|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110562432|NCT00649727|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110562433|NCT00649727|Cholinergic Agents|cholinergic agents|mesh-ancestor
110562434|NCT00649727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110562435|NCT00649727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110562436|NCT00649727|Urological Agents|urological agents|mesh-ancestor
110562438|NCT00650273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110562439|NCT00650273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110562440|NCT00698126|Insulin|insulin|mesh-list
110562441|NCT00698126|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110562442|NCT00698126|Insulin Aspart|insulin aspart|mesh-list
110562443|NCT00698126|Biphasic Insulins|biphasic insulins|mesh-list
110562444|NCT00698126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110562445|NCT00698126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562446|NCT02661425|Immunoglobulins|immunoglobulins|mesh-list
110562447|NCT02661425|Immunologic Factors|immunologic factors|mesh-ancestor
110562448|NCT02661425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562449|NCT02656901|Anesthetics|anesthetics|mesh-list
110562450|NCT02656901|Sevoflurane|sevoflurane|mesh-list
110562451|NCT02656901|Desflurane|desflurane|mesh-list
110562452|NCT02656901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110562453|NCT02656901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562454|NCT02656901|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110562455|NCT02656901|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110562456|NCT02656901|Anesthetics, General|anesthetics, general|mesh-ancestor
110562457|NCT00847886|Methotrexate|methotrexate|mesh-list
110562458|NCT00847886|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110562459|NCT00847886|Abortifacient Agents|abortifacient agents|mesh-ancestor
110562460|NCT00847886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110562461|NCT00847886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562462|NCT00847886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110562463|NCT00847886|Antimetabolites|antimetabolites|mesh-ancestor
110562464|NCT00847886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110562465|NCT00847886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110562466|NCT00847886|Dermatologic Agents|dermatologic agents|mesh-ancestor
110562467|NCT00847886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110562468|NCT00847886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110562469|NCT00847886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110562470|NCT00847886|Immunologic Factors|immunologic factors|mesh-ancestor
110562471|NCT00847886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110562472|NCT00847886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110562473|NCT00847808|Dexlansoprazole|dexlansoprazole|mesh-list
110562474|NCT00847808|Lansoprazole|lansoprazole|mesh-list
110562475|NCT00847808|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110562476|NCT00847808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110562477|NCT00847808|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110562478|NCT00847808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110562479|NCT00847808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110562480|NCT02656979|Latanoprost|latanoprost|mesh-list
110562481|NCT02656979|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110562482|NCT02656979|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110562483|NCT04017455|Bevacizumab|bevacizumab|mesh-list
110562484|NCT04017455|Atezolizumab|atezolizumab|mesh-list
110562485|NCT04017455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110562486|NCT04017455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110562487|NCT04017455|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110562488|NCT04017455|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110562489|NCT04017455|Growth Substances|growth substances|mesh-ancestor
110562490|NCT04017455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562491|NCT04017455|Growth Inhibitors|growth inhibitors|mesh-ancestor
110562492|NCT04017455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110562493|NCT04017455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110562494|NCT05298020|Paclitaxel|paclitaxel|mesh-list
110562495|NCT05298020|Gemcitabine|gemcitabine|mesh-list
110562496|NCT05298020|Endostar protein|endostar protein|mesh-list
110562497|NCT05298020|Endostatins|endostatins|mesh-list
110562498|NCT05298020|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110562499|NCT05298020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110562500|NCT05298020|Tubulin Modulators|tubulin modulators|mesh-ancestor
110562501|NCT05298020|Antimitotic Agents|antimitotic agents|mesh-ancestor
110562502|NCT05298020|Mitosis Modulators|mitosis modulators|mesh-ancestor
110562503|NCT05298020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110562504|NCT05298020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110562505|NCT05298020|Antimetabolites|antimetabolites|mesh-ancestor
110562506|NCT05298020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562507|NCT05298020|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110562508|NCT05298020|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110562509|NCT05298020|Growth Substances|growth substances|mesh-ancestor
110562510|NCT05298020|Growth Inhibitors|growth inhibitors|mesh-ancestor
110562511|NCT04170647|Plasminogen|plasminogen|mesh-list
110562512|NCT04170647|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110562513|NCT04170647|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110210109|NCT00223717|Dopamine Agents|dopamine agents|mesh-ancestor
110562514|NCT04170647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110562515|NCT02661347|Risperidone|risperidone|mesh-list
110562516|NCT02661347|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110562517|NCT02661347|Serotonin Agents|serotonin agents|mesh-ancestor
110562518|NCT02661347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110562519|NCT02661347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110562520|NCT02661347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562521|NCT02661347|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110562522|NCT02661347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110562523|NCT02661347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110562524|NCT02661347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110562525|NCT02661347|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110562526|NCT02661347|Dopamine Agents|dopamine agents|mesh-ancestor
110562527|NCT00649805|Verapamil|verapamil|mesh-list
110562528|NCT00649805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110562529|NCT00649805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110562530|NCT00649805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110562531|NCT00649805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110562532|NCT00649805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110562533|NCT00649805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562534|NCT00649805|Vasodilator Agents|vasodilator agents|mesh-ancestor
110562535|NCT02656589|Capecitabine|capecitabine|mesh-list
110562536|NCT02656589|Trastuzumab|trastuzumab|mesh-list
110562537|NCT02656589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110562538|NCT02656589|Antimetabolites|antimetabolites|mesh-ancestor
110562539|NCT02656589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110562540|NCT02656589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110562541|NCT02656589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110562542|NCT00600353|Dexamethasone|dexamethasone|mesh-list
110562543|NCT00600353|Aprepitant|aprepitant|mesh-list
110562544|NCT00600353|Palonosetron|palonosetron|mesh-list
110562545|NCT00600353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110562546|NCT00600353|Antiemetics|antiemetics|mesh-ancestor
110562547|NCT00600353|Autonomic Agents|autonomic agents|mesh-ancestor
110562548|NCT00600353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110562549|NCT00600353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562550|NCT00600353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110189691|NCT00049569|Hydrocortisone|hydrocortisone|mesh-list
110562552|NCT00600353|Hormones|hormones|mesh-ancestor
110562553|NCT00600353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110562554|NCT00600353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110562555|NCT00600353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110562556|NCT00600353|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110562557|NCT00600353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110562558|NCT00600353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110562559|NCT00600353|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110562560|NCT00600353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110562561|NCT00600353|Serotonin Agents|serotonin agents|mesh-ancestor
110562562|NCT02661191|Cholecalciferol|cholecalciferol|mesh-list
110562563|NCT02661191|Vitamin D|vitamin d|mesh-list
110562564|NCT02661191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110562565|NCT02661191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562567|NCT02661191|Micronutrients|micronutrients|mesh-ancestor
110562568|NCT02661191|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110562569|NCT00691210|Niacinamide|niacinamide|mesh-list
110562570|NCT00691210|Niacin|niacin|mesh-list
110562571|NCT00691210|Nicotinic Acids|nicotinic acids|mesh-list
110562572|NCT00691210|Etoposide|etoposide|mesh-list
110562573|NCT00691210|Vorinostat|vorinostat|mesh-list
110562574|NCT00691210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110562575|NCT00691210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110562576|NCT00691210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110562577|NCT00691210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110562578|NCT00691210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110562579|NCT00691210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110562580|NCT00691210|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110562581|NCT00691210|Vitamin B Complex|vitamin b complex|mesh-ancestor
110562582|NCT00691210|Vitamins|vitamins|mesh-ancestor
110562583|NCT00691210|Micronutrients|micronutrients|mesh-ancestor
110562584|NCT00691210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562585|NCT00691210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110562586|NCT00691210|Antimetabolites|antimetabolites|mesh-ancestor
110562587|NCT00691210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110210169|NCT00061997|Vitamin B Complex|vitamin b complex|mesh-ancestor
110562588|NCT00691210|Vasodilator Agents|vasodilator agents|mesh-ancestor
110562589|NCT02652065|Acetylcholine|acetylcholine|mesh-list
110562590|NCT02652065|Vasodilator Agents|vasodilator agents|mesh-ancestor
110562591|NCT02652065|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110562592|NCT02652065|Cholinergic Agents|cholinergic agents|mesh-ancestor
110562593|NCT02652065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110562594|NCT02652065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110562595|NCT02652065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562596|NCT00650429|Ziprasidone|ziprasidone|mesh-list
110562597|NCT00650429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110562598|NCT00650429|Serotonin Agents|serotonin agents|mesh-ancestor
110562599|NCT00650429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110562600|NCT00650429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110562601|NCT00650429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562602|NCT00650429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110562603|NCT00650429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110562604|NCT00650429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110562605|NCT00650429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110562606|NCT00650429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110562607|NCT00650429|Dopamine Agents|dopamine agents|mesh-ancestor
110562608|NCT00691132|Phenethyl isothiocyanate|phenethyl isothiocyanate|mesh-list
110562609|NCT00691132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110562610|NCT00691132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110562611|NCT00691132|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110562612|NCT00691132|Protective Agents|protective agents|mesh-ancestor
110562613|NCT00691132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562614|NCT00691132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110562615|NCT02651753|Calcium, Dietary|calcium, dietary|mesh-list
110562616|NCT02651753|Atorvastatin|atorvastatin|mesh-list
110562617|NCT02651753|Fenofibrate|fenofibrate|mesh-list
110562618|NCT02651753|Calcium|calcium|mesh-list
110562619|NCT02651753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110562620|NCT02651753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562621|NCT02651753|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110562622|NCT02651753|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110562623|NCT02651753|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110562624|NCT02651753|Antimetabolites|antimetabolites|mesh-ancestor
110562625|NCT02651753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110562626|NCT02651753|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110562627|NCT02651753|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110562628|NCT02651753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110562629|NCT00855218|Sorafenib|sorafenib|mesh-list
110562630|NCT00855218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110562631|NCT00855218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110562632|NCT00855218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110562633|NCT00855218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110562634|NCT00748150|Vaccines|vaccines|mesh-list
110562635|NCT00748150|Immunologic Factors|immunologic factors|mesh-ancestor
110562636|NCT00748150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562637|NCT02651519|Ropivacaine|ropivacaine|mesh-list
110562638|NCT02651519|Anesthetics, Local|anesthetics, local|mesh-ancestor
110562639|NCT02651519|Anesthetics|anesthetics|mesh-ancestor
110562640|NCT02651519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110562641|NCT02651519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562642|NCT02651519|Sensory System Agents|sensory system agents|mesh-ancestor
110562643|NCT02651519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110562644|NCT02651441|Gemcitabine|gemcitabine|mesh-list
110562645|NCT02651441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110562646|NCT02651441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110562647|NCT02651441|Antimetabolites|antimetabolites|mesh-ancestor
110562648|NCT02651441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110562649|NCT01063348|Acetylcysteine|acetylcysteine|mesh-list
110562650|NCT01063348|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110562651|NCT01063348|Antiviral Agents|antiviral agents|mesh-ancestor
110562652|NCT01063348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110562653|NCT01063348|Expectorants|expectorants|mesh-ancestor
110562654|NCT01063348|Respiratory System Agents|respiratory system agents|mesh-ancestor
110562655|NCT01063348|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110562656|NCT01063348|Antioxidants|antioxidants|mesh-ancestor
110562657|NCT01063348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110562658|NCT01063348|Protective Agents|protective agents|mesh-ancestor
110562659|NCT01063348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562660|NCT01063348|Antidotes|antidotes|mesh-ancestor
110562661|NCT00855062|Minocycline|minocycline|mesh-list
110562662|NCT00855062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110562663|NCT00855062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110562664|NCT00744250|Pancrelipase|pancrelipase|mesh-list
110562665|NCT00744250|Pancreatin|pancreatin|mesh-list
110562666|NCT00744250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110562667|NCT02651207|Lidocaine|lidocaine|mesh-list
110562668|NCT02651207|Ethyl Chloride|ethyl chloride|mesh-list
110562669|NCT02651207|Contraceptive Agents|contraceptive agents|mesh-list
110562670|NCT02651207|Anesthetics, Local|anesthetics, local|mesh-ancestor
110562671|NCT02651207|Anesthetics|anesthetics|mesh-ancestor
110562672|NCT02651207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110562673|NCT02651207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562674|NCT02651207|Sensory System Agents|sensory system agents|mesh-ancestor
110562675|NCT02651207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110562676|NCT02651207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110562677|NCT02651207|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110562678|NCT02651207|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110562679|NCT02651207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110562680|NCT02651207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110562681|NCT02651207|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110562683|NCT02564536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110562684|NCT02564536|Antimetabolites|antimetabolites|mesh-ancestor
110562685|NCT02564536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110562686|NCT02564536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110562687|NCT02564536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110562688|NCT00600119|Naloxegol|naloxegol|mesh-list
110562689|NCT00600119|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110562690|NCT00600119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562691|NCT00600119|Sensory System Agents|sensory system agents|mesh-ancestor
110562692|NCT00600119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110562693|NCT00866294|Paroxetine|paroxetine|mesh-list
110562694|NCT00866294|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110562695|NCT00866294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110562696|NCT00866294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110562697|NCT00866294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110562698|NCT00866294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110562699|NCT00866294|Serotonin Agents|serotonin agents|mesh-ancestor
110562700|NCT00866294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562701|NCT00866294|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110562702|NCT00866294|Antidepressive Agents|antidepressive agents|mesh-ancestor
110562703|NCT00866294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110562704|NCT00866294|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110562705|NCT00866294|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110562706|NCT00866294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110562707|NCT02660255|Cannabidiol|cannabidiol|mesh-list
110562708|NCT02660255|Anticonvulsants|anticonvulsants|mesh-ancestor
110562710|NCT00649103|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110562711|NCT00649103|Protease Inhibitors|protease inhibitors|mesh-ancestor
110562712|NCT00649103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110562713|NCT00649103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110562714|NCT00649103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110562715|NCT02660177|Dipyrone|dipyrone|mesh-list
110562716|NCT02660177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110562717|NCT02660177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110562718|NCT02660177|Analgesics|analgesics|mesh-ancestor
110562719|NCT02660177|Sensory System Agents|sensory system agents|mesh-ancestor
110562720|NCT02660177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110562721|NCT02660177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562722|NCT02660177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110562723|NCT02660177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110562724|NCT02660177|Antipyretics|antipyretics|mesh-ancestor
110562725|NCT00701246|Folic Acid|folic acid|mesh-list
110562726|NCT00701246|Vitamin B Complex|vitamin b complex|mesh-list
110562727|NCT00701246|Hematinics|hematinics|mesh-ancestor
110562728|NCT00701246|Vitamins|vitamins|mesh-ancestor
110562729|NCT00701246|Micronutrients|micronutrients|mesh-ancestor
110562730|NCT00701246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562731|NCT02648711|Leucovorin|leucovorin|mesh-list
110562732|NCT02648711|Bevacizumab|bevacizumab|mesh-list
110562733|NCT02648711|Oxaliplatin|oxaliplatin|mesh-list
110562734|NCT02648711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110562736|NCT02648711|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110562737|NCT02648711|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110562738|NCT02648711|Growth Substances|growth substances|mesh-ancestor
110562739|NCT02648711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562740|NCT02648711|Growth Inhibitors|growth inhibitors|mesh-ancestor
110562741|NCT02648711|Antidotes|antidotes|mesh-ancestor
110562742|NCT02648711|Protective Agents|protective agents|mesh-ancestor
110562743|NCT02648711|Vitamin B Complex|vitamin b complex|mesh-ancestor
110562744|NCT02648711|Vitamins|vitamins|mesh-ancestor
110562745|NCT02648711|Micronutrients|micronutrients|mesh-ancestor
110562746|NCT00854360|Beclomethasone|beclomethasone|mesh-list
110562747|NCT00854360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110562748|NCT00854360|Glucocorticoids|glucocorticoids|mesh-ancestor
110562749|NCT00854360|Hormones|hormones|mesh-ancestor
110562750|NCT00854360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110562751|NCT00854360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562752|NCT00854360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110562753|NCT00854360|Respiratory System Agents|respiratory system agents|mesh-ancestor
110562754|NCT00650351|Ciprofloxacin|ciprofloxacin|mesh-list
110562755|NCT00650351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110562756|NCT00650351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110562757|NCT00650351|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110562758|NCT00650351|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110562759|NCT00650351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110562760|NCT00650351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110562761|NCT00650351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110562762|NCT00650351|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110562763|NCT00650351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110562764|NCT02648633|Nivolumab|nivolumab|mesh-list
110562765|NCT02648633|Valproic Acid|valproic acid|mesh-list
110562766|NCT02648633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110562767|NCT02648633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110562768|NCT02648633|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110562769|NCT02648633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110562771|NCT02648633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110562772|NCT02648633|GABA Agents|gaba agents|mesh-ancestor
110562773|NCT02648633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110562774|NCT02648633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562775|NCT02648633|Antimanic Agents|antimanic agents|mesh-ancestor
110562776|NCT02648633|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110562777|NCT02648633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110562778|NCT02648633|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110562779|NCT00853970|Bromfenac|bromfenac|mesh-list
110562780|NCT00853970|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110562781|NCT00853970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110562782|NCT00853970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110562783|NCT00853970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110562784|NCT00853970|Analgesics|analgesics|mesh-ancestor
110562785|NCT00853970|Sensory System Agents|sensory system agents|mesh-ancestor
110562786|NCT00853970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110562787|NCT00853970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562788|NCT00853970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110562789|NCT00853970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110562790|NCT00651287|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110562791|NCT00651287|Quinapril|quinapril|mesh-list
110562792|NCT00651287|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110562793|NCT00651287|Diuretics|diuretics|mesh-ancestor
110562794|NCT00651287|Natriuretic Agents|natriuretic agents|mesh-ancestor
110562795|NCT00651287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562796|NCT00651287|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110562797|NCT00651287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110562798|NCT00651287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110562799|NCT00651287|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110562800|NCT00651287|Protease Inhibitors|protease inhibitors|mesh-ancestor
110562801|NCT00651287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110562802|NCT02650427|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110562803|NCT02650427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110562804|NCT02650427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562805|NCT02650427|Incretins|incretins|mesh-ancestor
110562806|NCT02650427|Hormones|hormones|mesh-ancestor
110562807|NCT02650427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110562808|NCT02650427|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110562809|NCT02650427|Protease Inhibitors|protease inhibitors|mesh-ancestor
110562810|NCT02650427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110562811|NCT02650427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110562812|NCT02644811|Anesthetics|anesthetics|mesh-list
110562813|NCT02644811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110562814|NCT02644811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562816|NCT00651443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110562817|NCT00651443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110562818|NCT00650897|Escitalopram|escitalopram|mesh-list
110562819|NCT00650897|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110562820|NCT00650897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110562821|NCT00650897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110562822|NCT00650897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110562823|NCT00650897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110562825|NCT00650897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562826|NCT02644499|Folic Acid|folic acid|mesh-list
110562827|NCT02644499|Hydroxychloroquine|hydroxychloroquine|mesh-list
110562828|NCT02644499|Prednisolone|prednisolone|mesh-list
110562829|NCT02644499|Methotrexate|methotrexate|mesh-list
110562830|NCT02644499|Leflunomide|leflunomide|mesh-list
110562831|NCT02644499|Glucocorticoids|glucocorticoids|mesh-list
110562832|NCT02644499|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110562833|NCT02644499|Abortifacient Agents|abortifacient agents|mesh-ancestor
110562834|NCT02644499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110562835|NCT02644499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562836|NCT02644499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110562837|NCT02644499|Antimetabolites|antimetabolites|mesh-ancestor
110562838|NCT02644499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110562839|NCT02644499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110562840|NCT02644499|Dermatologic Agents|dermatologic agents|mesh-ancestor
110562841|NCT02644499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110562842|NCT02644499|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110562843|NCT02644499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110562844|NCT02644499|Immunologic Factors|immunologic factors|mesh-ancestor
110562845|NCT02644499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110562846|NCT02644499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110562847|NCT02644499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110562848|NCT02644499|Hormones|hormones|mesh-ancestor
110562849|NCT02644499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110562850|NCT02644499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110562851|NCT02644499|Antimalarials|antimalarials|mesh-ancestor
110562852|NCT02644499|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110562853|NCT02644499|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110562854|NCT02644499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110562855|NCT02644499|Hematinics|hematinics|mesh-ancestor
110562856|NCT02644499|Vitamin B Complex|vitamin b complex|mesh-ancestor
110562857|NCT02644499|Vitamins|vitamins|mesh-ancestor
110562858|NCT02644499|Micronutrients|micronutrients|mesh-ancestor
110562859|NCT00652691|Cyclophosphamide|cyclophosphamide|mesh-list
110562860|NCT00652691|Carboplatin|carboplatin|mesh-list
110562861|NCT00652691|Topotecan|topotecan|mesh-list
110562862|NCT00652691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110562863|NCT00652691|Immunologic Factors|immunologic factors|mesh-ancestor
110562864|NCT00652691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562865|NCT00652691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110562866|NCT00652691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110562867|NCT00652691|Alkylating Agents|alkylating agents|mesh-ancestor
110562868|NCT00652691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110562869|NCT00652691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110562870|NCT00652691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110562871|NCT00652691|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110562872|NCT00652691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110562873|NCT00652691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110562874|NCT02649179|Ropivacaine|ropivacaine|mesh-list
110562875|NCT02649179|Anesthetics, Local|anesthetics, local|mesh-ancestor
110562876|NCT02649179|Anesthetics|anesthetics|mesh-ancestor
110562877|NCT02649179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110562878|NCT02649179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562879|NCT02649179|Sensory System Agents|sensory system agents|mesh-ancestor
110562880|NCT02649179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110562881|NCT02644577|Metformin|metformin|mesh-list
110562882|NCT02644577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110562883|NCT02644577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562884|NCT02644421|Lidocaine|lidocaine|mesh-list
110562885|NCT02644421|Anesthetics, Local|anesthetics, local|mesh-ancestor
110210472|NCT00225433|Ganirelix|ganirelix|mesh-list
110562886|NCT02644421|Anesthetics|anesthetics|mesh-ancestor
110562887|NCT02644421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110562888|NCT02644421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562889|NCT02644421|Sensory System Agents|sensory system agents|mesh-ancestor
110562890|NCT02644421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110562891|NCT02644421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110562892|NCT02644421|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110562893|NCT02644421|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110562894|NCT02644421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110562895|NCT02644421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110562897|NCT00651599|Estradiol|estradiol|mesh-list
110562898|NCT00651599|Estrogens|estrogens|mesh-ancestor
110562899|NCT00651599|Hormones|hormones|mesh-ancestor
110562900|NCT00651599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110562901|NCT00651599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562902|NCT00651599|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110562903|NCT00651599|Hormone Antagonists|hormone antagonists|mesh-ancestor
110562904|NCT00651599|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110562905|NCT00651599|Diuretics|diuretics|mesh-ancestor
110562906|NCT00651599|Natriuretic Agents|natriuretic agents|mesh-ancestor
110562907|NCT02647151|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110562908|NCT02647151|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
110562909|NCT02647151|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110562910|NCT02647151|Dermatologic Agents|dermatologic agents|mesh-ancestor
110562911|NCT02536391|Ipatasertib|ipatasertib|mesh-list
110562912|NCT02536391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110562913|NCT02536391|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110562914|NCT02536391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110562915|NCT02536391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110562916|NCT02644187|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110562917|NCT02644187|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110562918|NCT02644187|Dermatologic Agents|dermatologic agents|mesh-ancestor
110562919|NCT00651131|Daptomycin|daptomycin|mesh-list
110562920|NCT00651131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110562921|NCT00651131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110562922|NCT04167137|Atezolizumab|atezolizumab|mesh-list
110562923|NCT04167137|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110562924|NCT04167137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110562925|NCT04167137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110562926|NCT04167137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110562927|NCT02649413|Prednisone|prednisone|mesh-list
110562928|NCT02649413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110562929|NCT02649413|Glucocorticoids|glucocorticoids|mesh-ancestor
110562930|NCT02649413|Hormones|hormones|mesh-ancestor
110562931|NCT02649413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110562932|NCT02649413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562933|NCT02649413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110562934|NCT02649413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110562935|NCT02643563|Epinephrine|epinephrine|mesh-list
110562937|NCT02643563|Ropivacaine|ropivacaine|mesh-list
110562938|NCT02643563|Anesthetics, Local|anesthetics, local|mesh-ancestor
110562939|NCT02643563|Anesthetics|anesthetics|mesh-ancestor
110562940|NCT02643563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110562941|NCT02643563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562942|NCT02643563|Sensory System Agents|sensory system agents|mesh-ancestor
110562943|NCT02643563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110562944|NCT02643563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110562946|NCT02643563|Adrenergic Agents|adrenergic agents|mesh-ancestor
110562947|NCT02643563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110562948|NCT02643563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110562949|NCT02643563|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110562950|NCT02643563|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110562951|NCT02643563|Autonomic Agents|autonomic agents|mesh-ancestor
110562952|NCT02643563|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110562953|NCT02643563|Respiratory System Agents|respiratory system agents|mesh-ancestor
110562954|NCT02643563|Mydriatics|mydriatics|mesh-ancestor
110562955|NCT02643563|Sympathomimetics|sympathomimetics|mesh-ancestor
110562956|NCT02643563|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110562957|NCT00651209|Tenofovir|tenofovir|mesh-list
110562958|NCT00651209|Antiviral Agents|antiviral agents|mesh-ancestor
110562959|NCT00651209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110562960|NCT00651209|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110562961|NCT00651209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110562962|NCT00651209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110562963|NCT00651209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110562964|NCT00651209|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110562965|NCT00651209|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110562966|NCT00652925|Celecoxib|celecoxib|mesh-list
110562967|NCT00652925|Naproxen|naproxen|mesh-list
110562968|NCT00652925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110562969|NCT00652925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110562970|NCT00652925|Analgesics|analgesics|mesh-ancestor
110562971|NCT00652925|Sensory System Agents|sensory system agents|mesh-ancestor
110562972|NCT00652925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110562973|NCT00652925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562974|NCT00652925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110562975|NCT00652925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110562976|NCT00652925|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110562977|NCT00652925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110562978|NCT00652925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110562979|NCT00652925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110562980|NCT00652925|Gout Suppressants|gout suppressants|mesh-ancestor
110562981|NCT00653003|Leflunomide|leflunomide|mesh-list
110562982|NCT00653003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110562983|NCT00653003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110562984|NCT00653003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110562985|NCT00653003|Immunologic Factors|immunologic factors|mesh-ancestor
110562986|NCT00653003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562987|NCT02643719|Topiramate|topiramate|mesh-list
110562988|NCT02643719|Naproxen|naproxen|mesh-list
110562989|NCT02643719|Sumatriptan|sumatriptan|mesh-list
110562990|NCT02643719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110189814|NCT00397800|Cyclophosphamide|cyclophosphamide|mesh-list
110562991|NCT02643719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110562992|NCT02643719|Analgesics|analgesics|mesh-ancestor
110562993|NCT02643719|Sensory System Agents|sensory system agents|mesh-ancestor
110562994|NCT02643719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110562995|NCT02643719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562996|NCT02643719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110562997|NCT02643719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110562998|NCT02643719|Gout Suppressants|gout suppressants|mesh-ancestor
110562999|NCT02643719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110563000|NCT02643719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110563001|NCT02643719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110563002|NCT02643719|Anticonvulsants|anticonvulsants|mesh-ancestor
110563003|NCT02643719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110563004|NCT02643719|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110563005|NCT02643719|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110563006|NCT02643719|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110563007|NCT02643719|Serotonin Agents|serotonin agents|mesh-ancestor
110563010|NCT02649101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110563011|NCT02649101|Immunologic Factors|immunologic factors|mesh-ancestor
110563012|NCT02649101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110563013|NCT02649101|Leprostatic Agents|leprostatic agents|mesh-ancestor
110563014|NCT02649101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110563015|NCT02649101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110563016|NCT02649101|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110563017|NCT02649101|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110563018|NCT02649101|Growth Substances|growth substances|mesh-ancestor
110563019|NCT02649101|Growth Inhibitors|growth inhibitors|mesh-ancestor
110563020|NCT02649101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110563021|NCT00700154|Insulin|insulin|mesh-list
110563022|NCT00700154|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110563023|NCT00700154|Insulin Aspart|insulin aspart|mesh-list
110563024|NCT00700154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110563025|NCT00700154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110563026|NCT00651911|Rasburicase|rasburicase|mesh-list
110563027|NCT00651911|Gout Suppressants|gout suppressants|mesh-ancestor
110563028|NCT00651911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110563029|NCT02643407|Docetaxel|docetaxel|mesh-list
110563030|NCT02643407|Nedaplatin|nedaplatin|mesh-list
110563031|NCT02643407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110563032|NCT02643407|Tubulin Modulators|tubulin modulators|mesh-ancestor
110563033|NCT02643407|Antimitotic Agents|antimitotic agents|mesh-ancestor
110563034|NCT02643407|Mitosis Modulators|mitosis modulators|mesh-ancestor
110563035|NCT02643407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110563036|NCT02643329|Gliclazide|gliclazide|mesh-list
110563037|NCT02643329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110563038|NCT02643329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110563039|NCT02643017|Dexmedetomidine|dexmedetomidine|mesh-list
110563040|NCT02643017|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110563041|NCT02643017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110563042|NCT02643017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110563043|NCT02643017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110563044|NCT02643017|Analgesics|analgesics|mesh-ancestor
110563045|NCT02643017|Sensory System Agents|sensory system agents|mesh-ancestor
110563046|NCT02643017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110563047|NCT02643017|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110563048|NCT02643017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110563049|NCT02643017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110563050|NCT02643017|Adrenergic Agents|adrenergic agents|mesh-ancestor
110563051|NCT02643017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110563052|NCT02643017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110563053|NCT02643173|Anesthetics|anesthetics|mesh-list
110563054|NCT02643173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
110563055|NCT02643173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110563056|NCT02643173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110563057|NCT02643173|Anesthetics, General|anesthetics, general|mesh-ancestor
110563058|NCT02646137|Chlorotrianisene|chlorotrianisene|mesh-list
110563059|NCT02646137|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110563060|NCT02646137|Estrogens|estrogens|mesh-ancestor
110563061|NCT02646137|Hormones|hormones|mesh-ancestor
110563062|NCT02646137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110563063|NCT02646137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110563064|NCT02646137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110563065|NCT02646137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110563066|NCT00653549|Torsemide|torsemide|mesh-list
110563067|NCT00653549|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110563068|NCT00653549|Diuretics|diuretics|mesh-ancestor
110563069|NCT00653549|Natriuretic Agents|natriuretic agents|mesh-ancestor
110563070|NCT00653549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110563071|NCT00653549|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110563072|NCT00653549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110563073|NCT00653549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110563074|NCT02642861|Cyclobenzaprine|cyclobenzaprine|mesh-list
110563075|NCT02642861|Calcium Carbonate|calcium carbonate|mesh-list
110563076|NCT02642861|Calcium|calcium|mesh-list
110563077|NCT02642861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110563078|NCT02642861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110563079|NCT02642861|Antacids|antacids|mesh-ancestor
110563080|NCT02642861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110563081|NCT02642861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110563082|NCT02642861|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110563083|NCT02642861|Antidepressive Agents|antidepressive agents|mesh-ancestor
110563084|NCT02642861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110563085|NCT02642861|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110563086|NCT02642861|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110563087|NCT02642861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110563088|NCT02642861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110563089|NCT02642861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110563090|NCT02641457|Ranibizumab|ranibizumab|mesh-list
110563091|NCT02641457|Aflibercept|aflibercept|mesh-list
110563092|NCT02641457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110563093|NCT02641457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110563094|NCT02641457|Growth Substances|growth substances|mesh-ancestor
110563095|NCT02641457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110563096|NCT02641457|Growth Inhibitors|growth inhibitors|mesh-ancestor
110563097|NCT02641457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110563099|NCT02642939|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110563100|NCT02642939|Abortifacient Agents|abortifacient agents|mesh-ancestor
110563101|NCT02642939|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110563102|NCT02642939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110563103|NCT02642939|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110563104|NCT02642939|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110563105|NCT02642939|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110563106|NCT02642939|Contraceptive Agents|contraceptive agents|mesh-ancestor
110563107|NCT02642939|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110563108|NCT02642939|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110563109|NCT02642939|Hormone Antagonists|hormone antagonists|mesh-ancestor
110563110|NCT02642939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110563111|NCT02642939|Luteolytic Agents|luteolytic agents|mesh-ancestor
110563112|NCT02642939|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110563114|NCT02641301|Morphine|morphine|mesh-list
110563115|NCT02641301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110563116|NCT02641301|Narcotics|narcotics|mesh-ancestor
110563117|NCT02641301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110563118|NCT02641301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110563120|NCT02641301|Sensory System Agents|sensory system agents|mesh-ancestor
110563121|NCT02641301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110563123|NCT02640989|Immunologic Factors|immunologic factors|mesh-ancestor
110563124|NCT02640989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110563125|NCT02645747|Aflibercept|aflibercept|mesh-list
110563126|NCT02645747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110563127|NCT02645747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110563128|NCT02645747|Growth Substances|growth substances|mesh-ancestor
110563129|NCT02645747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110563130|NCT02645747|Growth Inhibitors|growth inhibitors|mesh-ancestor
110563131|NCT02645747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110563132|NCT00653237|Chlorhexidine|chlorhexidine|mesh-list
110563133|NCT00653237|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110563134|NCT00653237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110563135|NCT00653237|Disinfectants|disinfectants|mesh-ancestor
110563137|NCT00653315|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110563138|NCT00653315|Narcotics|narcotics|mesh-ancestor
110563139|NCT00653315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110563140|NCT00653315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110563141|NCT00653315|Analgesics|analgesics|mesh-ancestor
110563142|NCT00653315|Sensory System Agents|sensory system agents|mesh-ancestor
110563143|NCT00653315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110563145|NCT02640833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110563146|NCT00653393|Tranylcypromine|tranylcypromine|mesh-list
110563147|NCT00653393|Antidepressive Agents|antidepressive agents|mesh-ancestor
110563148|NCT00653393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110563149|NCT00653393|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110563150|NCT00653393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110563151|NCT00653393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110563152|NCT00653393|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110563153|NCT00653393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110563154|NCT00653393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110563155|NCT00653393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110563156|NCT02645903|Morphine|morphine|mesh-list
110563157|NCT02645903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110563158|NCT02645903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110563159|NCT02645903|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110563160|NCT02645903|Narcotics|narcotics|mesh-ancestor
110563161|NCT02645903|Analgesics|analgesics|mesh-ancestor
110563162|NCT02645903|Sensory System Agents|sensory system agents|mesh-ancestor
110563163|NCT02645903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110563164|NCT02645981|Sorafenib|sorafenib|mesh-list
110563165|NCT02645981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110563166|NCT02645981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110563167|NCT02645981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110563168|NCT02645981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110563169|NCT02535767|Primaquine|primaquine|mesh-list
110563170|NCT02535767|Antimalarials|antimalarials|mesh-ancestor
110563171|NCT02535767|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110563172|NCT02535767|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110563173|NCT02535767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110563174|NCT02640443|Sulfamethoxazole|sulfamethoxazole|mesh-list
110563175|NCT02640443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110563176|NCT02640365|Leucovorin|leucovorin|mesh-list
110563177|NCT02640365|Bevacizumab|bevacizumab|mesh-list
110563178|NCT02640365|Irinotecan|irinotecan|mesh-list
110563179|NCT02640365|Camptothecin|camptothecin|mesh-list
110563180|NCT02640365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110563181|NCT02640365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110563182|NCT02640365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110563183|NCT02640365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110563184|NCT02640365|Growth Substances|growth substances|mesh-ancestor
110563185|NCT02640365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110563186|NCT02640365|Growth Inhibitors|growth inhibitors|mesh-ancestor
110563187|NCT02640365|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110563188|NCT02640365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110563189|NCT02640365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110563190|NCT02640365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110563191|NCT02640365|Antidotes|antidotes|mesh-ancestor
110563192|NCT02640365|Protective Agents|protective agents|mesh-ancestor
110563193|NCT02640365|Vitamin B Complex|vitamin b complex|mesh-ancestor
110563194|NCT02640365|Vitamins|vitamins|mesh-ancestor
110563195|NCT02640365|Micronutrients|micronutrients|mesh-ancestor
110563196|NCT02640365|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110563197|NCT02642003|Lenograstim|lenograstim|mesh-list
110563198|NCT02642003|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110563199|NCT02642003|Immunologic Factors|immunologic factors|mesh-ancestor
110563200|NCT02642003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110563201|NCT02641847|Cyclophosphamide|cyclophosphamide|mesh-list
110563202|NCT02641847|Gemcitabine|gemcitabine|mesh-list
110563203|NCT02641847|Docetaxel|docetaxel|mesh-list
110563204|NCT02641847|Doxorubicin|doxorubicin|mesh-list
110563205|NCT02641847|Epirubicin|epirubicin|mesh-list
110563206|NCT02641847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110563207|NCT02641847|Immunologic Factors|immunologic factors|mesh-ancestor
110563208|NCT02641847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110563209|NCT02641847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110563210|NCT02641847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110563211|NCT02641847|Alkylating Agents|alkylating agents|mesh-ancestor
110563212|NCT02641847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110563213|NCT02641847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110563214|NCT02641847|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110563215|NCT02641847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110563216|NCT02641847|Antimetabolites|antimetabolites|mesh-ancestor
110563217|NCT02641847|Tubulin Modulators|tubulin modulators|mesh-ancestor
110563218|NCT02641847|Antimitotic Agents|antimitotic agents|mesh-ancestor
110563219|NCT02641847|Mitosis Modulators|mitosis modulators|mesh-ancestor
110563220|NCT02641847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110563221|NCT02641847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110563222|NCT02641847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110563223|NCT02641847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110563224|NCT00599027|Mometasone Furoate|mometasone furoate|mesh-list
110563225|NCT00599027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110563226|NCT00599027|Dermatologic Agents|dermatologic agents|mesh-ancestor
110563227|NCT00599027|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110563228|NCT00652379|Octreotide|octreotide|mesh-list
110563229|NCT00652379|Lanreotide|lanreotide|mesh-list
110563230|NCT00652379|Somatostatin|somatostatin|mesh-list
110563231|NCT00652379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110563232|NCT00652379|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110563233|NCT00652379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110563234|NCT00652379|Hormones|hormones|mesh-ancestor
110563235|NCT00652379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110563236|NCT00652379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110563237|NCT04164797|Endostar protein|endostar protein|mesh-list
110563238|NCT04164797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110563239|NCT04164797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110563240|NCT04164797|Growth Substances|growth substances|mesh-ancestor
110563241|NCT04164797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110563242|NCT04164797|Growth Inhibitors|growth inhibitors|mesh-ancestor
110563243|NCT04164797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110563244|NCT00654017|Sildenafil Citrate|sildenafil citrate|mesh-list
110563245|NCT00654017|Vasodilator Agents|vasodilator agents|mesh-ancestor
110563246|NCT00654017|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110563247|NCT00654017|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110563248|NCT00654017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110563249|NCT00654017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110563250|NCT00654017|Urological Agents|urological agents|mesh-ancestor
110563251|NCT02639819|Aminocaproic Acid|aminocaproic acid|mesh-list
110563252|NCT02639819|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110563253|NCT02639819|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110563254|NCT02639819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110563255|NCT02639819|Hemostatics|hemostatics|mesh-ancestor
110563256|NCT02639819|Coagulants|coagulants|mesh-ancestor
110563257|NCT02639741|Vitamins|vitamins|mesh-list
110563258|NCT02639741|Ascorbic Acid|ascorbic acid|mesh-list
110563259|NCT02639741|Melatonin|melatonin|mesh-list
110563260|NCT02639741|Micronutrients|micronutrients|mesh-ancestor
110563261|NCT02639741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110563262|NCT02639741|Antioxidants|antioxidants|mesh-ancestor
110563263|NCT02639741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110563264|NCT02639741|Protective Agents|protective agents|mesh-ancestor
110563265|NCT02639741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110563266|NCT04164719|Cyclobenzaprine|cyclobenzaprine|mesh-list
110563267|NCT04164719|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110563268|NCT04164719|Antidepressive Agents|antidepressive agents|mesh-ancestor
110563269|NCT04164719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110563270|NCT04164719|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110563271|NCT04164719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110563272|NCT04164719|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110563273|NCT04164719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110563274|NCT04164719|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110563275|NCT04164719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110563277|NCT00654173|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110563278|NCT00654173|Simvastatin|simvastatin|mesh-list
110563279|NCT00654173|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110563280|NCT00654173|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110563281|NCT00654173|Antimetabolites|antimetabolites|mesh-ancestor
110563282|NCT00654173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110563283|NCT00654173|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110563284|NCT00654173|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110563285|NCT00654173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110563286|NCT02645279|Midazolam|midazolam|mesh-list
110563287|NCT02645279|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110563288|NCT02645279|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110563289|NCT02645279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110563290|NCT02645279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110563291|NCT02645279|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110563292|NCT02645279|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110563293|NCT02645279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110563294|NCT02645279|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110563295|NCT02645279|Anesthetics, General|anesthetics, general|mesh-ancestor
110563296|NCT02645279|Anesthetics|anesthetics|mesh-ancestor
110563298|NCT02645279|GABA Agents|gaba agents|mesh-ancestor
110563299|NCT02645279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110563300|NCT02645279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110563301|NCT04164329|Anesthetics|anesthetics|mesh-list
110563302|NCT04164329|Anesthetics, General|anesthetics, general|mesh-list
110563303|NCT04164329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110563304|NCT04164329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110563305|NCT02639039|Cortisone|cortisone|mesh-list
110563306|NCT02639039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110563307|NCT00655265|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
110563308|NCT00655265|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110563310|NCT00655265|Antimetabolites|antimetabolites|mesh-ancestor
110563311|NCT00655265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110563312|NCT00655265|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110563314|NCT02562664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110563315|NCT02562664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110563316|NCT00654407|Atorvastatin|atorvastatin|mesh-list
110563317|NCT00654407|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110563318|NCT00654407|Simvastatin|simvastatin|mesh-list
110563319|NCT00654407|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110563320|NCT00654407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110563321|NCT00654407|Antimetabolites|antimetabolites|mesh-ancestor
110563322|NCT00654407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110563323|NCT00654407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110563324|NCT00654407|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110563325|NCT00654407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110563326|NCT00691054|Paclitaxel|paclitaxel|mesh-list
110563327|NCT00691054|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110563328|NCT00691054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110563329|NCT00691054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110563330|NCT00691054|Tubulin Modulators|tubulin modulators|mesh-ancestor
110563331|NCT00691054|Antimitotic Agents|antimitotic agents|mesh-ancestor
110563332|NCT00691054|Mitosis Modulators|mitosis modulators|mesh-ancestor
110563333|NCT00691054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110563334|NCT00598871|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110563335|NCT00598871|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110563336|NCT00744406|Sertraline|sertraline|mesh-list
110563337|NCT00744406|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110563338|NCT00744406|Antidepressive Agents|antidepressive agents|mesh-list
110563339|NCT00744406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110563340|NCT00744406|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110563341|NCT00744406|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110563342|NCT00744406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110563343|NCT00744406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110563344|NCT00744406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110563345|NCT00744406|Serotonin Agents|serotonin agents|mesh-ancestor
110563346|NCT00744406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110563347|NCT00744406|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110563348|NCT00744406|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110563349|NCT00690820|Pancrelipase|pancrelipase|mesh-list
110563350|NCT00690820|Pancreatin|pancreatin|mesh-list
110563351|NCT00690820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110563352|NCT02562508|Vaccines|vaccines|mesh-list
110563353|NCT02562508|Immunologic Factors|immunologic factors|mesh-ancestor
110563354|NCT02562508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110563355|NCT00689338|Fluconazole|fluconazole|mesh-list
110563356|NCT00689338|Voriconazole|voriconazole|mesh-list
110563357|NCT00689338|Anidulafungin|anidulafungin|mesh-list
110563358|NCT00689338|Antifungal Agents|antifungal agents|mesh-ancestor
110563359|NCT00689338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110563360|NCT00689338|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110563361|NCT00689338|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110563362|NCT00689338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110563363|NCT00689338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110563365|NCT00689338|Hormone Antagonists|hormone antagonists|mesh-ancestor
110563366|NCT00689338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110563367|NCT00689338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110563368|NCT00689338|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110563369|NCT00689338|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110563370|NCT00689338|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110563371|NCT00686998|Olanzapine|olanzapine|mesh-list
110563372|NCT00686998|Antiemetics|antiemetics|mesh-ancestor
110563373|NCT00686998|Autonomic Agents|autonomic agents|mesh-ancestor
110563374|NCT00686998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110563375|NCT00686998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110563376|NCT00686998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110563377|NCT00686998|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110563378|NCT00686998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110563379|NCT00686998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110563380|NCT00686998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110563381|NCT00686998|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110563382|NCT00686998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110563383|NCT00686998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110563384|NCT00686998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110563385|NCT00686998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110563386|NCT00686998|Serotonin Agents|serotonin agents|mesh-ancestor
110563387|NCT00744640|Gemcitabine|gemcitabine|mesh-list
110563388|NCT00744640|Capecitabine|capecitabine|mesh-list
110563389|NCT00744640|Oxaliplatin|oxaliplatin|mesh-list
110563390|NCT00744640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110563391|NCT00744640|Antimetabolites|antimetabolites|mesh-ancestor
110563392|NCT00744640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110563393|NCT00744640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110563395|NCT00848718|Docetaxel|docetaxel|mesh-list
110563396|NCT00848718|Carboplatin|carboplatin|mesh-list
110563397|NCT00848718|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110563398|NCT00848718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110563399|NCT00848718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110563400|NCT00848718|Tubulin Modulators|tubulin modulators|mesh-ancestor
110563401|NCT00848718|Antimitotic Agents|antimitotic agents|mesh-ancestor
110563402|NCT00848718|Mitosis Modulators|mitosis modulators|mesh-ancestor
110563403|NCT00848718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110563404|NCT00848718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110563405|NCT00848718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110563406|NCT02612844|Insulin Aspart|insulin aspart|mesh-list
110563407|NCT02612844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110563408|NCT02612844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110563409|NCT00883337|Interferons|interferons|mesh-list
110563410|NCT00883337|Interferon-beta|interferon-beta|mesh-list
110563411|NCT00883337|Interferon beta-1a|interferon beta-1a|mesh-list
110563412|NCT00883337|Teriflunomide|teriflunomide|mesh-list
110563413|NCT00883337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110563414|NCT00883337|Antiviral Agents|antiviral agents|mesh-ancestor
110563415|NCT00883337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110563416|NCT00883337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110563417|NCT00883337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110563419|NCT00883337|Sensory System Agents|sensory system agents|mesh-ancestor
110563420|NCT00883337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110563421|NCT00883337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110563422|NCT00883337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110563423|NCT00883337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110563424|NCT00883337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110563425|NCT00883337|Immunologic Factors|immunologic factors|mesh-ancestor
110563426|NCT00883337|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110563427|NCT04163783|Zanubrutinib|zanubrutinib|mesh-list
110563428|NCT04163783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110563429|NCT04163783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110563430|NCT04163783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110563431|NCT04163783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110563432|NCT00654485|Atorvastatin|atorvastatin|mesh-list
110563433|NCT00654485|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110563434|NCT00654485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110563435|NCT00654485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110563436|NCT00654485|Antimetabolites|antimetabolites|mesh-ancestor
110563437|NCT00654485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110563438|NCT00654485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110563439|NCT00654485|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110563440|NCT00654485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110563442|NCT00837876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110563443|NCT00837876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110563444|NCT00837876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110563445|NCT00837876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110563446|NCT00655421|Tolonium Chloride|tolonium chloride|mesh-list
110563447|NCT00655421|Hemostatics|hemostatics|mesh-ancestor
110563448|NCT00655421|Coagulants|coagulants|mesh-ancestor
110563449|NCT00655421|Heparin Antagonists|heparin antagonists|mesh-ancestor
110563450|NCT00655421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110563451|NCT00707070|Acitretin|acitretin|mesh-list
110563452|NCT00707070|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110563453|NCT00707070|Immunologic Factors|immunologic factors|mesh-ancestor
110563454|NCT00707070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110563455|NCT00707070|Keratolytic Agents|keratolytic agents|mesh-ancestor
110563456|NCT00707070|Dermatologic Agents|dermatologic agents|mesh-ancestor
110563457|NCT00686920|Rifaximin|rifaximin|mesh-list
110563458|NCT00686920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110563459|NCT00686920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110563460|NCT00686920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110563462|NCT02562118|Lenvatinib|lenvatinib|mesh-list
110563463|NCT02562118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110563464|NCT02562118|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110563465|NCT02562118|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110563466|NCT02562118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110563467|NCT02562118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110563468|NCT02562118|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110563469|NCT02562118|Hormone Antagonists|hormone antagonists|mesh-ancestor
110563470|NCT02562118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110563471|NCT02562118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110563472|NCT02562118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110563473|NCT00744718|Bevacizumab|bevacizumab|mesh-list
110563474|NCT00744718|Carboplatin|carboplatin|mesh-list
110563475|NCT00744718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110563476|NCT00744718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110563477|NCT00744718|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110563478|NCT00744718|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110563479|NCT00744718|Growth Substances|growth substances|mesh-ancestor
110563480|NCT00744718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110563481|NCT00744718|Growth Inhibitors|growth inhibitors|mesh-ancestor
110563482|NCT00741910|Semapimod|semapimod|mesh-list
110563484|NCT00741910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110563485|NCT00741910|Analgesics|analgesics|mesh-ancestor
110563486|NCT00741910|Sensory System Agents|sensory system agents|mesh-ancestor
110563487|NCT00741910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110563488|NCT00741910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110563489|NCT00741910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110563490|NCT00741910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110563491|NCT00741910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110563492|NCT00741910|Immunologic Factors|immunologic factors|mesh-ancestor
110563493|NCT00845832|Rituximab|rituximab|mesh-list
110563494|NCT00845832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110563495|NCT00845832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110563496|NCT00845832|Immunologic Factors|immunologic factors|mesh-ancestor
110563497|NCT00845832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110563498|NCT00845832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110563499|NCT00703482|Coenzyme Q10|coenzyme q10|mesh-list
110563500|NCT00703482|Ubiquinone|ubiquinone|mesh-list
110563501|NCT00703482|Fenofibrate|fenofibrate|mesh-list
110563502|NCT00703482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110563503|NCT00703482|Antimetabolites|antimetabolites|mesh-ancestor
110563504|NCT00703482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110563505|NCT00703482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110563506|NCT00703482|Vitamins|vitamins|mesh-ancestor
110563507|NCT00703482|Micronutrients|micronutrients|mesh-ancestor
110563508|NCT00703482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110563509|NCT00885755|Capecitabine|capecitabine|mesh-list
110563510|NCT00885755|Trastuzumab|trastuzumab|mesh-list
110563511|NCT00885755|Taxane|taxane|mesh-list
110563512|NCT00885755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110563513|NCT00885755|Antimetabolites|antimetabolites|mesh-ancestor
110563514|NCT00885755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110563515|NCT00885755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110563516|NCT00885755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110563517|NCT00749710|Clopidogrel|clopidogrel|mesh-list
110563518|NCT00749710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110563519|NCT00749710|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110563520|NCT00749710|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110563521|NCT00749710|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110563522|NCT00749710|Purinergic Agents|purinergic agents|mesh-ancestor
110563523|NCT00749710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110563524|NCT00749710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110563525|NCT00749710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110563526|NCT00749866|Gentamicins|gentamicins|mesh-list
110563527|NCT00749866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110563528|NCT00749866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110563529|NCT00749866|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110563530|NCT00749866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110563531|NCT00749866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110563532|NCT04058236|Polygeline|polygeline|mesh-list
110563533|NCT04058236|Plasma Substitutes|plasma substitutes|mesh-ancestor
110563534|NCT04058236|Blood Substitutes|blood substitutes|mesh-ancestor
110563535|NCT00742066|Felodipine|felodipine|mesh-list
110563536|NCT00742066|Irbesartan|irbesartan|mesh-list
110563537|NCT00742066|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110563538|NCT00742066|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110563539|NCT00742066|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110563540|NCT00742066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110563541|NCT00742066|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110563542|NCT00742066|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110563543|NCT00742066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110563544|NCT00742066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110563545|NCT00742066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110563546|NCT00742066|Vasodilator Agents|vasodilator agents|mesh-ancestor
110563547|NCT00742144|Ofatumumab|ofatumumab|mesh-list
110563548|NCT00742144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110563549|NCT00845676|Interferons|interferons|mesh-list
110563550|NCT00845676|Ribavirin|ribavirin|mesh-list
110563551|NCT00845676|Interferon-alpha|interferon-alpha|mesh-list
110563552|NCT00845676|Interferon alpha-2|interferon alpha-2|mesh-list
110563553|NCT00845676|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110563554|NCT00845676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110563555|NCT00845676|Antiviral Agents|antiviral agents|mesh-ancestor
110563556|NCT00845676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110563557|NCT00845676|Antimetabolites|antimetabolites|mesh-ancestor
110563558|NCT00845676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110563559|NCT00845676|Immunologic Factors|immunologic factors|mesh-ancestor
110563560|NCT00845676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110563562|NCT00742300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110563563|NCT00742300|Immunologic Factors|immunologic factors|mesh-ancestor
110563564|NCT00742300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110563565|NCT00742300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110563566|NCT00742300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110563567|NCT00742300|Alkylating Agents|alkylating agents|mesh-ancestor
110563568|NCT00742300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110563569|NCT00742300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110563570|NCT00742300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110563571|NCT02611908|Obinutuzumab|obinutuzumab|mesh-list
110563572|NCT02611908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110563573|NCT02611908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110563574|NCT02561884|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110563575|NCT02561884|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110563576|NCT02561884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110563577|NCT02561884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110563578|NCT02561884|Antimetabolites|antimetabolites|mesh-ancestor
110563579|NCT02561884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110563580|NCT02561884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110563581|NCT02561884|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110563582|NCT02561884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110563583|NCT02561884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110563584|NCT02561884|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110563585|NCT02561884|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110563586|NCT00655655|Everolimus|everolimus|mesh-list
110563587|NCT00655655|Vatalanib|vatalanib|mesh-list
110563588|NCT00655655|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110563589|NCT00655655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110563590|NCT00655655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110563591|NCT00655655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110563592|NCT00655655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110563593|NCT00655655|Immunologic Factors|immunologic factors|mesh-ancestor
110563594|NCT00655655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110563595|NCT00655655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110563596|NCT00844896|Butyl phosphorotrithioate|butyl phosphorotrithioate|mesh-list
110563597|NCT00844896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110563598|NCT00844896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110563599|NCT05483400|Atezolizumab|atezolizumab|mesh-list
110563600|NCT05483400|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110563601|NCT05483400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110563602|NCT05483400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110563603|NCT05483400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110563604|NCT00837330|Ranibizumab|ranibizumab|mesh-list
110563605|NCT00837330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110563606|NCT00837330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110563607|NCT00837330|Growth Substances|growth substances|mesh-ancestor
110563608|NCT00837330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110563609|NCT00837330|Growth Inhibitors|growth inhibitors|mesh-ancestor
110563610|NCT00837330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110563611|NCT00703638|Pemetrexed|pemetrexed|mesh-list
110563612|NCT00703638|Sorafenib|sorafenib|mesh-list
110563613|NCT00703638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110563614|NCT00703638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110563615|NCT00703638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110563616|NCT00703638|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110563617|NCT00703638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110563618|NCT00703638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110563619|NCT02637479|Deoxyglucose|deoxyglucose|mesh-list
110563620|NCT02637479|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110563621|NCT02637479|Antimetabolites|antimetabolites|mesh-ancestor
110563622|NCT02637479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110563623|NCT02637479|Antiviral Agents|antiviral agents|mesh-ancestor
110563624|NCT02637479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110563625|NCT02637479|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110563626|NCT00885365|Tobramycin|tobramycin|mesh-list
110563627|NCT00885365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110563628|NCT00885365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110563629|NCT00827112|Ritonavir|ritonavir|mesh-list
110563630|NCT00827112|Lopinavir|lopinavir|mesh-list
110563631|NCT00827112|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110563632|NCT00827112|Darunavir|darunavir|mesh-list
110563633|NCT00827112|Tenofovir|tenofovir|mesh-list
110563634|NCT00827112|Emtricitabine|emtricitabine|mesh-list
110563635|NCT00827112|Maraviroc|maraviroc|mesh-list
110563636|NCT00827112|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110563637|NCT00827112|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110563638|NCT00827112|Protease Inhibitors|protease inhibitors|mesh-ancestor
110563639|NCT00827112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110563640|NCT00827112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110211221|NCT00075699|Mitomycins|mitomycins|mesh-list
110563641|NCT00827112|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110563642|NCT00827112|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110563643|NCT00827112|Antiviral Agents|antiviral agents|mesh-ancestor
110563644|NCT00827112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110563645|NCT00827112|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110563646|NCT00827112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110563647|NCT00827112|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110563648|NCT00827112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110563649|NCT00827112|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110563650|NCT00827112|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110563651|NCT00827112|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110563653|NCT00689104|Tolterodine Tartrate|tolterodine tartrate|mesh-list
110563654|NCT00689104|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110563655|NCT00689104|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110563656|NCT00689104|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110563657|NCT00689104|Adrenergic Agents|adrenergic agents|mesh-ancestor
110563658|NCT00689104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110563659|NCT00689104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110563660|NCT00689104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110563661|NCT00689104|Urological Agents|urological agents|mesh-ancestor
110563662|NCT00689104|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110563663|NCT00689104|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110563664|NCT00689104|Cholinergic Agents|cholinergic agents|mesh-ancestor
110563665|NCT02118467|Phenylephrine|phenylephrine|mesh-list
110563666|NCT02118467|Vasopressins|vasopressins|mesh-list
110563667|NCT02118467|Arginine Vasopressin|arginine vasopressin|mesh-list
110563668|NCT02118467|Epinephrine|epinephrine|mesh-list
110563669|NCT02118467|Oxymetazoline|oxymetazoline|mesh-list
110563670|NCT02118467|Norepinephrine|norepinephrine|mesh-list
110563671|NCT02118467|Synephrine|synephrine|mesh-list
110563672|NCT02118467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110563673|NCT02118467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110563674|NCT02118467|Adrenergic Agents|adrenergic agents|mesh-ancestor
110563675|NCT02118467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110563676|NCT02118467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110563677|NCT02118467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110563678|NCT02118467|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110563679|NCT02118467|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110563680|NCT02118467|Autonomic Agents|autonomic agents|mesh-ancestor
110563681|NCT02118467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110563682|NCT02118467|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110563683|NCT02118467|Respiratory System Agents|respiratory system agents|mesh-ancestor
110563685|NCT02118467|Sympathomimetics|sympathomimetics|mesh-ancestor
110563686|NCT02118467|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110563687|NCT02118467|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110563688|NCT02118467|Nasal Decongestants|nasal decongestants|mesh-ancestor
110563689|NCT02118467|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110563690|NCT02118467|Protective Agents|protective agents|mesh-ancestor
110563691|NCT02118467|Hemostatics|hemostatics|mesh-ancestor
110563692|NCT02118467|Coagulants|coagulants|mesh-ancestor
110563693|NCT02118467|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110563694|NCT02118467|Natriuretic Agents|natriuretic agents|mesh-ancestor
110563695|NCT00702156|Bisoprolol|bisoprolol|mesh-list
110563696|NCT00702156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110563697|NCT00702156|Sympatholytics|sympatholytics|mesh-ancestor
110563698|NCT00702156|Autonomic Agents|autonomic agents|mesh-ancestor
110563699|NCT00702156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110563700|NCT00702156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110563701|NCT00702156|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110563702|NCT00702156|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110563703|NCT00702156|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110563704|NCT00702156|Adrenergic Agents|adrenergic agents|mesh-ancestor
110563705|NCT00702156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110563706|NCT00702156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110563707|NCT02638415|Carvedilol|carvedilol|mesh-list
110563708|NCT02638415|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110563709|NCT02638415|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110563710|NCT02638415|Adrenergic Agents|adrenergic agents|mesh-ancestor
110563711|NCT02638415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110563712|NCT02638415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110563713|NCT02638415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110563714|NCT02638415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110563715|NCT02638415|Antioxidants|antioxidants|mesh-ancestor
110563716|NCT02638415|Protective Agents|protective agents|mesh-ancestor
110368630|NCT05419583|Antimetabolites|antimetabolites|mesh-ancestor
110563717|NCT02638415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110563718|NCT02638415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110563719|NCT02638415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110563720|NCT02638415|Vasodilator Agents|vasodilator agents|mesh-ancestor
110563721|NCT02638415|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110563722|NCT02638415|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110563723|NCT00703872|Interferons|interferons|mesh-list
110563724|NCT00703872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110563725|NCT00703872|Antiviral Agents|antiviral agents|mesh-ancestor
110563726|NCT00703872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110563727|NCT00689026|Lubiprostone|lubiprostone|mesh-list
110563728|NCT00689026|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110563729|NCT00689026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110563730|NCT00689026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110563731|NCT00598559|Acetaminophen|acetaminophen|mesh-list
110563732|NCT00598559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110563733|NCT00598559|Analgesics|analgesics|mesh-ancestor
110563734|NCT00598559|Sensory System Agents|sensory system agents|mesh-ancestor
110563735|NCT00598559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110563736|NCT00598559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110563737|NCT00598559|Antipyretics|antipyretics|mesh-ancestor
110563739|NCT00686686|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110563740|NCT00686686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110563741|NCT00686686|Dermatologic Agents|dermatologic agents|mesh-ancestor
110563742|NCT00686686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110563743|NCT00686686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110563745|NCT02637167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110563746|NCT02637167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110563747|NCT02637167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110563748|NCT04057300|Aspirin|aspirin|mesh-list
110563749|NCT04057300|Clopidogrel|clopidogrel|mesh-list
110563750|NCT04057300|Ticagrelor|ticagrelor|mesh-list
110563751|NCT04057300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110563752|NCT04057300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110563753|NCT04057300|Analgesics|analgesics|mesh-ancestor
110563754|NCT04057300|Sensory System Agents|sensory system agents|mesh-ancestor
110563755|NCT04057300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110563756|NCT04057300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110563757|NCT04057300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110563758|NCT04057300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110563759|NCT04057300|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110563760|NCT04057300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110563761|NCT04057300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110563762|NCT04057300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110563763|NCT04057300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110563764|NCT04057300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110563765|NCT04057300|Antipyretics|antipyretics|mesh-ancestor
110563766|NCT04057300|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110563767|NCT04057300|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110563768|NCT04057300|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110563769|NCT04057300|Purinergic Agents|purinergic agents|mesh-ancestor
110563770|NCT04057300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110563771|NCT00750100|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110563772|NCT00750100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110563773|NCT00750100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110563774|NCT00655109|Fluticasone|fluticasone|mesh-list
110563775|NCT00655109|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
110563776|NCT00655109|Lubricant Eye Drops|lubricant eye drops|mesh-list
110563777|NCT00655109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110563778|NCT00655109|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110563779|NCT00655109|Autonomic Agents|autonomic agents|mesh-ancestor
110563780|NCT00655109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110563781|NCT00655109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110563782|NCT00655109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110563783|NCT00655109|Respiratory System Agents|respiratory system agents|mesh-ancestor
110563784|NCT00655109|Dermatologic Agents|dermatologic agents|mesh-ancestor
110563785|NCT00655109|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110563786|NCT00655109|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110563787|NCT00655109|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110563788|NCT00655109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110563789|NCT00655109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110563791|NCT00655109|Sensory System Agents|sensory system agents|mesh-ancestor
110563792|NCT00655109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110563793|NCT00655109|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110563794|NCT00655109|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110563795|NCT00655109|Histamine Antagonists|histamine antagonists|mesh-ancestor
110563796|NCT00655109|Histamine Agents|histamine agents|mesh-ancestor
110563797|NCT00655109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110563798|NCT00655109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110563799|NCT02632877|Pirfenidone|pirfenidone|mesh-list
110563800|NCT02632877|Ketanserin|ketanserin|mesh-list
110563801|NCT02632877|Analgesics|analgesics|mesh-ancestor
110563802|NCT02632877|Sensory System Agents|sensory system agents|mesh-ancestor
110563803|NCT02632877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110563804|NCT02632877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110563805|NCT02632877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110563806|NCT02632877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110563807|NCT02632877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110563808|NCT02632877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110563809|NCT02632877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110046910|NCT04819906|Moxifloxacin|moxifloxacin|mesh-list
110563810|NCT02632877|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110563811|NCT02632877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110563812|NCT02632877|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110563813|NCT02632877|Serotonin Agents|serotonin agents|mesh-ancestor
110563814|NCT02632877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110563815|NCT02632877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110563816|NCT00656123|Cyclophosphamide|cyclophosphamide|mesh-list
110563817|NCT00656123|Molgramostim|molgramostim|mesh-list
110563818|NCT00656123|Sargramostim|sargramostim|mesh-list
110563819|NCT00656123|Immunologic Factors|immunologic factors|mesh-ancestor
110563820|NCT00656123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110563821|NCT00656123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110563822|NCT00656123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110563823|NCT00656123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110563824|NCT00656123|Alkylating Agents|alkylating agents|mesh-ancestor
110563825|NCT00656123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110563826|NCT00656123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110563827|NCT00656123|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110563828|NCT04163471|Hemostatics|hemostatics|mesh-list
110563829|NCT04163471|Coagulants|coagulants|mesh-ancestor
110563830|NCT00657449|Valdecoxib|valdecoxib|mesh-list
110563831|NCT00657449|Rofecoxib|rofecoxib|mesh-list
110563832|NCT00657449|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110563833|NCT00657449|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110563834|NCT00657449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110563835|NCT00657449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110563836|NCT00657449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110563837|NCT00657449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110563838|NCT00657449|Analgesics|analgesics|mesh-ancestor
110563839|NCT00657449|Sensory System Agents|sensory system agents|mesh-ancestor
110563840|NCT00657449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110563841|NCT00657449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110563842|NCT00657449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110563843|NCT00657449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110563844|NCT04160195|Cyclophosphamide|cyclophosphamide|mesh-list
110563846|NCT04160195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110563847|NCT04160195|Immunologic Factors|immunologic factors|mesh-ancestor
110563848|NCT04160195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110563849|NCT04160195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110563850|NCT04160195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110563851|NCT04160195|Alkylating Agents|alkylating agents|mesh-ancestor
110563852|NCT04160195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110563853|NCT04160195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110563854|NCT04160195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110563855|NCT00911261|Oxymorphone|oxymorphone|mesh-list
110563856|NCT00911261|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110563857|NCT00911261|Narcotics|narcotics|mesh-ancestor
110563858|NCT00911261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110563859|NCT00911261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110563860|NCT00911261|Analgesics|analgesics|mesh-ancestor
110563861|NCT00911261|Sensory System Agents|sensory system agents|mesh-ancestor
110563862|NCT00911261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110563863|NCT00911261|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110563865|NCT00686374|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110563866|NCT00686374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110563867|NCT00686374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110563868|NCT00750178|Vorinostat|vorinostat|mesh-list
110563869|NCT00750178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110563870|NCT00750178|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110563871|NCT00750178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110563872|NCT00750178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110563873|NCT00750334|Clofarabine|clofarabine|mesh-list
110563874|NCT00750334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110563875|NCT00750334|Antimetabolites|antimetabolites|mesh-ancestor
110563876|NCT00750334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110563877|NCT00750334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110563878|NCT00745186|Glucagon|glucagon|mesh-list
110563879|NCT00745186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110563880|NCT00745186|Hormones|hormones|mesh-ancestor
110563881|NCT00745186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110563882|NCT00745186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110563883|NCT00750724|Hyaluronic Acid|hyaluronic acid|mesh-list
110563884|NCT00750724|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110563885|NCT00750724|Immunologic Factors|immunologic factors|mesh-ancestor
110563886|NCT00750724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110563887|NCT00750724|Viscosupplements|viscosupplements|mesh-ancestor
110563888|NCT00750724|Protective Agents|protective agents|mesh-ancestor
110563889|NCT00752518|Bortezomib|bortezomib|mesh-list
110563890|NCT00752518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110563891|NCT00752596|Azimilide|azimilide|mesh-list
110563892|NCT00752596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110563893|NCT00752596|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110563894|NCT00752596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110563895|NCT00752596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110563896|NCT00752596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110563897|NCT00752596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110563898|NCT00750802|Lorazepam|lorazepam|mesh-list
110563899|NCT00750802|Anticonvulsants|anticonvulsants|mesh-ancestor
110563900|NCT00750802|Antiemetics|antiemetics|mesh-ancestor
110563901|NCT00750802|Autonomic Agents|autonomic agents|mesh-ancestor
110563902|NCT00750802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110563903|NCT00750802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110563904|NCT00750802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110563905|NCT00750802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110563906|NCT00750802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110563907|NCT00750802|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110563908|NCT00750802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110563909|NCT00750802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110563911|NCT00750802|GABA Agents|gaba agents|mesh-ancestor
110563912|NCT00750802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110563913|NCT00750802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110563914|NCT00751504|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110563915|NCT00751504|Antidepressive Agents|antidepressive agents|mesh-ancestor
110563916|NCT00751504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110563917|NCT00751504|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110563918|NCT00751504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110563919|NCT00751504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110563920|NCT00751504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110563921|NCT00576628|Epoetin Alfa|epoetin alfa|mesh-list
110563922|NCT00576628|Hematinics|hematinics|mesh-ancestor
110563923|NCT00683878|Pioglitazone|pioglitazone|mesh-list
110563924|NCT00683878|Dapagliflozin|dapagliflozin|mesh-list
110563925|NCT00683878|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
110563926|NCT00683878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110563927|NCT00683878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110563928|NCT00683878|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110563929|NCT00683878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110563930|NCT00884741|Bevacizumab|bevacizumab|mesh-list
110563931|NCT00884741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110563932|NCT00884741|Temozolomide|temozolomide|mesh-list
110563933|NCT00884741|Endothelial Growth Factors|endothelial growth factors|mesh-list
110563934|NCT00884741|Antibodies|antibodies|mesh-list
110563935|NCT00884741|Immunoglobulins|immunoglobulins|mesh-list
110563936|NCT00884741|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110563937|NCT00884741|Immunoglobulin G|immunoglobulin g|mesh-list
110563938|NCT00884741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110563939|NCT00884741|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110563940|NCT00884741|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110563941|NCT00884741|Growth Substances|growth substances|mesh-ancestor
110563942|NCT00884741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110563943|NCT00884741|Growth Inhibitors|growth inhibitors|mesh-ancestor
110563944|NCT00884741|Immunologic Factors|immunologic factors|mesh-ancestor
110563945|NCT00884741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110563946|NCT00884741|Alkylating Agents|alkylating agents|mesh-ancestor
110563947|NCT00884741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110563948|NCT00657527|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110563949|NCT00657527|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110563950|NCT00657527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110563951|NCT00657527|Antimetabolites|antimetabolites|mesh-ancestor
110563952|NCT00657527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110563953|NCT00657527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110563954|NCT00657527|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110563955|NCT00657527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110563956|NCT00598481|Busulfan|busulfan|mesh-list
110563957|NCT00598481|Alkylating Agents|alkylating agents|mesh-ancestor
110563958|NCT00598481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110563959|NCT00598481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110563960|NCT00598481|Immunologic Factors|immunologic factors|mesh-ancestor
110563961|NCT00598481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110563962|NCT00598481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110563963|NCT00598481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110563964|NCT00598481|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110563965|NCT04159649|Letrozole|letrozole|mesh-list
110563966|NCT04159649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110563967|NCT04159649|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110563968|NCT04159649|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110563969|NCT04159649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110563970|NCT04159649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110563971|NCT04159649|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110563972|NCT04159649|Hormone Antagonists|hormone antagonists|mesh-ancestor
110563973|NCT04159649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110563974|NCT04159649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110563975|NCT00880763|Interferons|interferons|mesh-list
110563977|NCT00880763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110563978|NCT00880763|Antiviral Agents|antiviral agents|mesh-ancestor
110563979|NCT00880763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110563980|NCT00880763|Antimetabolites|antimetabolites|mesh-ancestor
110563981|NCT00880763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110563982|NCT00884273|Goserelin|goserelin|mesh-list
110563983|NCT00884273|Bicalutamide|bicalutamide|mesh-list
110563984|NCT00884273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110563985|NCT00884273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110563986|NCT00884273|Androgen Antagonists|androgen antagonists|mesh-ancestor
110563987|NCT00884273|Hormone Antagonists|hormone antagonists|mesh-ancestor
110563988|NCT00884273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110189993|NCT00023348|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110563989|NCT00884273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110563991|NCT00657761|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110563992|NCT00657761|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110563993|NCT00657761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110563994|NCT00657761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110563995|NCT00657761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110563996|NCT00657761|Antiviral Agents|antiviral agents|mesh-ancestor
110563997|NCT00657761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110563998|NCT00657839|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110563999|NCT00657839|Vasodilator Agents|vasodilator agents|mesh-ancestor
110564000|NCT00657839|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110564001|NCT00657839|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110564002|NCT00657839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110564003|NCT00657839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110564004|NCT00657839|Urological Agents|urological agents|mesh-ancestor
110564005|NCT00884117|Oseltamivir|oseltamivir|mesh-list
110564006|NCT00884117|Antiviral Agents|antiviral agents|mesh-ancestor
110564007|NCT00884117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110564008|NCT00884117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110564009|NCT00884117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110564010|NCT04159181|Lactulose|lactulose|mesh-list
110564011|NCT04159181|Picosulfate sodium|picosulfate sodium|mesh-list
110564012|NCT04159181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110564013|NCT04159181|Cathartics|cathartics|mesh-ancestor
110564014|NCT00884039|Hydrocortisone|hydrocortisone|mesh-list
110564015|NCT00884039|Anecortave|anecortave|mesh-list
110564016|NCT00884039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110564017|NCT00884039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110564018|NCT00884039|Growth Substances|growth substances|mesh-ancestor
110564019|NCT00884039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110564020|NCT00884039|Growth Inhibitors|growth inhibitors|mesh-ancestor
110564021|NCT00884039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110564022|NCT00884039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110564023|NCT00657995|Pancrelipase|pancrelipase|mesh-list
110564024|NCT00657995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110564025|NCT02632565|Lidocaine|lidocaine|mesh-list
110564026|NCT02632565|Anesthetics, Local|anesthetics, local|mesh-ancestor
110564027|NCT02632565|Anesthetics|anesthetics|mesh-ancestor
110564028|NCT02632565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110564029|NCT02632565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110564030|NCT02632565|Sensory System Agents|sensory system agents|mesh-ancestor
110564031|NCT02632565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110564032|NCT02632565|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110564033|NCT02632565|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110564034|NCT02632565|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110564035|NCT02632565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110564036|NCT02632565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110564037|NCT04158947|Trastuzumab|trastuzumab|mesh-list
110564038|NCT04158947|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
110564039|NCT04158947|Afatinib|afatinib|mesh-list
110564040|NCT04158947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110564041|NCT04158947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110564042|NCT04158947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110564043|NCT04158947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110564044|NCT04158947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110564045|NCT04158947|Tubulin Modulators|tubulin modulators|mesh-ancestor
110564046|NCT04158947|Antimitotic Agents|antimitotic agents|mesh-ancestor
110564047|NCT04158947|Mitosis Modulators|mitosis modulators|mesh-ancestor
110564048|NCT04158947|Immunotoxins|immunotoxins|mesh-ancestor
110564049|NCT04158947|Immunoconjugates|immunoconjugates|mesh-ancestor
110564050|NCT04158947|Immunologic Factors|immunologic factors|mesh-ancestor
110564051|NCT04158947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110564052|NCT00835770|Dimethyl Fumarate|dimethyl fumarate|mesh-list
110564053|NCT00835770|Dermatologic Agents|dermatologic agents|mesh-ancestor
110564054|NCT00835770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110564055|NCT00835770|Immunologic Factors|immunologic factors|mesh-ancestor
110564056|NCT00835770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110564057|NCT04163237|Sorafenib|sorafenib|mesh-list
110564058|NCT04163237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110564059|NCT04163237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110564060|NCT04163237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110564061|NCT04163237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110564062|NCT00880685|Memantine|memantine|mesh-list
110564063|NCT00880685|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110564064|NCT00880685|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110564065|NCT00880685|Dopamine Agents|dopamine agents|mesh-ancestor
110564066|NCT00880685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110564067|NCT00880685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110564068|NCT00880685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110564069|NCT00880685|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110564070|NCT00880685|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110564071|NCT02612298|Metoprolol|metoprolol|mesh-list
110564072|NCT02612298|Arotinolol|arotinolol|mesh-list
110564073|NCT02612298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110564074|NCT02612298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110564075|NCT02612298|Sympatholytics|sympatholytics|mesh-ancestor
110564076|NCT02612298|Autonomic Agents|autonomic agents|mesh-ancestor
110564077|NCT02612298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110564078|NCT02612298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110564079|NCT02612298|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110564080|NCT02612298|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110564081|NCT02612298|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110564082|NCT02612298|Adrenergic Agents|adrenergic agents|mesh-ancestor
110564083|NCT02612298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110564084|NCT02612298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110564086|NCT00880607|Morphine|morphine|mesh-list
110564087|NCT00880607|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110564088|NCT00880607|Narcotics|narcotics|mesh-ancestor
110564089|NCT00880607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110564090|NCT00880607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211609|NCT00063713|Bortezomib|bortezomib|mesh-list
110564092|NCT00880607|Sensory System Agents|sensory system agents|mesh-ancestor
110564093|NCT00880607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110564094|NCT00656435|Bevacizumab|bevacizumab|mesh-list
110564095|NCT00656435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110564096|NCT00656435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110564097|NCT00656435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110564098|NCT00656435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110564099|NCT00656435|Growth Substances|growth substances|mesh-ancestor
110564100|NCT00656435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110564101|NCT00656435|Growth Inhibitors|growth inhibitors|mesh-ancestor
110564102|NCT02636231|Endostatins|endostatins|mesh-list
110564103|NCT02636231|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110564104|NCT02636231|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110564105|NCT02636231|Growth Substances|growth substances|mesh-ancestor
110564106|NCT02636231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110564107|NCT02636231|Growth Inhibitors|growth inhibitors|mesh-ancestor
110564108|NCT02636231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110564109|NCT00658463|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110564110|NCT00658463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110564111|NCT00658463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110564112|NCT00658463|Antimetabolites|antimetabolites|mesh-ancestor
110564113|NCT00658463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110564114|NCT00658463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110564115|NCT00658463|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110564116|NCT00658463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110564117|NCT00656591|Methotrexate|methotrexate|mesh-list
110564118|NCT00656591|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110564119|NCT00656591|Abortifacient Agents|abortifacient agents|mesh-ancestor
110564120|NCT00656591|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110564121|NCT00656591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110564122|NCT00656591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110564123|NCT00656591|Antimetabolites|antimetabolites|mesh-ancestor
110564124|NCT00656591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110564125|NCT00656591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110564126|NCT00656591|Dermatologic Agents|dermatologic agents|mesh-ancestor
110564127|NCT00656591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110564128|NCT00656591|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110564129|NCT00656591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110564130|NCT00656591|Immunologic Factors|immunologic factors|mesh-ancestor
110564131|NCT00656591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110564132|NCT00656591|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110564133|NCT00658931|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110564134|NCT00658931|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110564135|NCT00658931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110564136|NCT00658931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110564137|NCT00658931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110564138|NCT00658931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110564139|NCT00658931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110564140|NCT00658931|Analgesics|analgesics|mesh-ancestor
110564141|NCT00658931|Sensory System Agents|sensory system agents|mesh-ancestor
110564142|NCT00658931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110564143|NCT00658931|Antidepressive Agents|antidepressive agents|mesh-ancestor
110564144|NCT00658931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110564145|NCT00658931|Dopamine Agents|dopamine agents|mesh-ancestor
110564147|NCT00834912|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110564148|NCT00834912|Narcotics|narcotics|mesh-ancestor
110564149|NCT00834912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110564150|NCT00834912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110564151|NCT00834912|Analgesics|analgesics|mesh-ancestor
110564152|NCT00834912|Sensory System Agents|sensory system agents|mesh-ancestor
110564153|NCT00834912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110564154|NCT02535689|Tofacitinib|tofacitinib|mesh-list
110564155|NCT02535689|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110564156|NCT02535689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110564157|NCT02535689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110564158|NCT02535689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110564160|NCT02632331|Analgesics|analgesics|mesh-ancestor
110564161|NCT02632331|Sensory System Agents|sensory system agents|mesh-ancestor
110564162|NCT02632331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110211672|NCT00232492|Anesthetics|anesthetics|mesh-ancestor
110564163|NCT02632331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110564164|NCT02632331|Anticonvulsants|anticonvulsants|mesh-ancestor
110564165|NCT02632331|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110564166|NCT02632331|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110564167|NCT02632331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110564168|NCT02632331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110564169|NCT02632331|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110564170|NCT02632331|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110564171|NCT02632331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110564172|NCT02632331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110564173|NCT02632331|Antimanic Agents|antimanic agents|mesh-ancestor
110564174|NCT04162535|Lidocaine|lidocaine|mesh-list
110564175|NCT04162535|Propofol|propofol|mesh-list
110564176|NCT04162535|Anesthetics|anesthetics|mesh-list
110564177|NCT04162535|Sevoflurane|sevoflurane|mesh-list
110564178|NCT04162535|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
110564179|NCT04162535|Anesthetics, Local|anesthetics, local|mesh-ancestor
110564180|NCT04162535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110564181|NCT04162535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110564182|NCT04162535|Sensory System Agents|sensory system agents|mesh-ancestor
110564183|NCT04162535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110564184|NCT04162535|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110564185|NCT04162535|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110564186|NCT04162535|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110564187|NCT04162535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110564188|NCT04162535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110564189|NCT04162535|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110564190|NCT04162535|Anesthetics, General|anesthetics, general|mesh-ancestor
110564191|NCT04162535|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110564192|NCT04162535|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110564194|NCT02632019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110564195|NCT02632019|Antimetabolites|antimetabolites|mesh-ancestor
110564196|NCT02632019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110564197|NCT02632019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110564198|NCT00883493|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110564199|NCT00883493|Lithium Carbonate|lithium carbonate|mesh-list
110564200|NCT00883493|Antidepressive Agents|antidepressive agents|mesh-ancestor
110564201|NCT00883493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110564202|NCT00883493|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110564203|NCT00883493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110564204|NCT00883493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110564205|NCT00883493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110564206|NCT00883493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110564207|NCT00883493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110564208|NCT00883493|Antimanic Agents|antimanic agents|mesh-ancestor
110564210|NCT00659321|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110564211|NCT00659321|Autonomic Agents|autonomic agents|mesh-ancestor
110564212|NCT00659321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110564213|NCT00659321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110564214|NCT00659321|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110564215|NCT00659321|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110564216|NCT00659321|Cholinergic Agents|cholinergic agents|mesh-ancestor
110564217|NCT00659321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110564218|NCT00659321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110564219|NCT00659399|PENTA|penta|mesh-list
110564220|NCT00659399|Fondaparinux|fondaparinux|mesh-list
110564221|NCT00659399|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110564222|NCT00659399|Antithrombins|antithrombins|mesh-ancestor
110564223|NCT00659399|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110564224|NCT00659399|Protease Inhibitors|protease inhibitors|mesh-ancestor
110564225|NCT00659399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110564226|NCT00659399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110564227|NCT00659399|Anticoagulants|anticoagulants|mesh-ancestor
110564228|NCT00659399|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110564229|NCT00659399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110564230|NCT00659477|Insulin Glargine|insulin glargine|mesh-list
110564232|NCT00659477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110564233|NCT00911339|Atorvastatin|atorvastatin|mesh-list
110564234|NCT00911339|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110564235|NCT00911339|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110564236|NCT00911339|Antimetabolites|antimetabolites|mesh-ancestor
110564237|NCT00911339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110564238|NCT00911339|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110564239|NCT00911339|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110564240|NCT00911339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110564241|NCT05863195|Leucovorin|leucovorin|mesh-list
110564242|NCT05863195|Bevacizumab|bevacizumab|mesh-list
110190045|NCT00050934|Oxcarbazepine|oxcarbazepine|mesh-list
110564243|NCT05863195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110564246|NCT05863195|Fluorouracil|fluorouracil|mesh-list
110564248|NCT05863195|Irinotecan|irinotecan|mesh-list
110564249|NCT05863195|Floxuridine|floxuridine|mesh-list
110564250|NCT05863195|Endothelial Growth Factors|endothelial growth factors|mesh-list
110564251|NCT05863195|Antibodies|antibodies|mesh-list
110564252|NCT05863195|Immunoglobulins|immunoglobulins|mesh-list
110564253|NCT05863195|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110564254|NCT05863195|Immunoglobulin G|immunoglobulin g|mesh-list
110564255|NCT05863195|Deoxyuridine|deoxyuridine|mesh-list
110564256|NCT05863195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110564257|NCT05863195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110564258|NCT05863195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110564259|NCT05863195|Growth Substances|growth substances|mesh-ancestor
110564260|NCT05863195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110564261|NCT05863195|Growth Inhibitors|growth inhibitors|mesh-ancestor
110564262|NCT05863195|Immunologic Factors|immunologic factors|mesh-ancestor
110564263|NCT05863195|Antimetabolites|antimetabolites|mesh-ancestor
110564264|NCT05863195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110564265|NCT05863195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110564266|NCT05863195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110564267|NCT05863195|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110564268|NCT05863195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110564269|NCT05863195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110564270|NCT05863195|Antidotes|antidotes|mesh-ancestor
110564271|NCT05863195|Protective Agents|protective agents|mesh-ancestor
110564272|NCT05863195|Vitamin B Complex|vitamin b complex|mesh-ancestor
110564273|NCT05863195|Vitamins|vitamins|mesh-ancestor
110564274|NCT05863195|Micronutrients|micronutrients|mesh-ancestor
110564275|NCT05863104|Glycopyrrolate|glycopyrrolate|mesh-list
110564276|NCT05863104|Bromides|bromides|mesh-list
110564277|NCT05863104|Anticonvulsants|anticonvulsants|mesh-ancestor
110564278|NCT05863104|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110564279|NCT05863104|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110564280|NCT05863104|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110564281|NCT05863104|Cholinergic Agents|cholinergic agents|mesh-ancestor
110564282|NCT05863104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110564283|NCT05863104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110564284|NCT05863104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110564285|NCT05863052|Immunomodulating Agents|immunomodulating agents|mesh-list
110564286|NCT05863052|Immunologic Factors|immunologic factors|mesh-ancestor
110564287|NCT05863052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110564288|NCT05862792|Bupivacaine|bupivacaine|mesh-list
110564289|NCT05862792|Anesthetics, Local|anesthetics, local|mesh-ancestor
110564290|NCT05862792|Anesthetics|anesthetics|mesh-ancestor
110564291|NCT05862792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110564292|NCT05862792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110564293|NCT05862792|Sensory System Agents|sensory system agents|mesh-ancestor
110564294|NCT05862792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110564295|NCT05862753|Etomidate|etomidate|mesh-list
110564296|NCT05862753|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110564297|NCT05862753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110564298|NCT05862753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110564300|NCT05862753|Anesthetics, General|anesthetics, general|mesh-ancestor
110564301|NCT05862753|Anesthetics|anesthetics|mesh-ancestor
110564302|NCT05862714|Itraconazole|itraconazole|mesh-list
110564303|NCT05862714|Fluconazole|fluconazole|mesh-list
110564304|NCT05862714|Antifungal Agents|antifungal agents|mesh-ancestor
110564305|NCT05862714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110564306|NCT05862714|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110564307|NCT05862714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110564308|NCT05862714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110564309|NCT05862714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110564310|NCT05862714|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110564311|NCT05862714|Hormone Antagonists|hormone antagonists|mesh-ancestor
110211822|NCT02958566|Narcotics|narcotics|mesh-ancestor
110564312|NCT05862714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110564313|NCT05862714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110564314|NCT05862714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110564315|NCT05862714|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110564316|NCT05862714|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110564318|NCT05862701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110564319|NCT05862701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110564320|NCT05862688|Anti-Infective Agents|anti-infective agents|mesh-list
110564321|NCT05862688|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110564322|NCT05862519|Testosterone|testosterone|mesh-list
110564323|NCT05862519|Androgens|androgens|mesh-ancestor
110564324|NCT05862519|Hormones|hormones|mesh-ancestor
110564325|NCT05862519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110564326|NCT05862519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110564327|NCT05862428|Misoprostol|misoprostol|mesh-list
110564328|NCT05862428|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110564329|NCT05862428|Abortifacient Agents|abortifacient agents|mesh-ancestor
110564330|NCT05862428|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110564331|NCT05862428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110564332|NCT05862428|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110564333|NCT05862428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110564334|NCT05862428|Oxytocics|oxytocics|mesh-ancestor
110564335|NCT05862402|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110564336|NCT05862402|Gentamicins|gentamicins|mesh-list
110564337|NCT05862402|Meropenem|meropenem|mesh-list
110564338|NCT05862402|Imipenem|imipenem|mesh-list
110564339|NCT05862402|Amikacin|amikacin|mesh-list
110564340|NCT05862402|Ceftazidime|ceftazidime|mesh-list
110564341|NCT05862402|Colistin|colistin|mesh-list
110564342|NCT05862402|Tigecycline|tigecycline|mesh-list
110564343|NCT05862402|Avibactam|avibactam|mesh-list
110564344|NCT05862402|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110564345|NCT05862402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110564346|NCT05862402|Antitubercular Agents|antitubercular agents|mesh-ancestor
110564347|NCT05862402|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110564348|NCT05862402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110564349|NCT05862402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110564350|NCT05862402|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110564351|NCT05862220|Fibrin fragment D|fibrin fragment d|mesh-list
110564352|NCT05862220|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110564353|NCT05862220|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110564354|NCT05862220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110564355|NCT05862220|Hemostatics|hemostatics|mesh-ancestor
110190074|NCT00051090|Lamivudine|lamivudine|mesh-list
110564356|NCT05862220|Coagulants|coagulants|mesh-ancestor
110564357|NCT05862064|Paclitaxel|paclitaxel|mesh-list
110564358|NCT05862064|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110564359|NCT05862064|Cyclophosphamide|cyclophosphamide|mesh-list
110564360|NCT05862064|Epirubicin|epirubicin|mesh-list
110564361|NCT05862064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110564362|NCT05862064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110564363|NCT05862064|Tubulin Modulators|tubulin modulators|mesh-ancestor
110564364|NCT05862064|Antimitotic Agents|antimitotic agents|mesh-ancestor
110564365|NCT05862064|Mitosis Modulators|mitosis modulators|mesh-ancestor
110564366|NCT05862064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110564367|NCT05862064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110564368|NCT05862064|Immunologic Factors|immunologic factors|mesh-ancestor
110564369|NCT05862064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110564370|NCT05862064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110564371|NCT05862064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110564372|NCT05862064|Alkylating Agents|alkylating agents|mesh-ancestor
110564373|NCT05862064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110564374|NCT05862064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110564375|NCT05862064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110564376|NCT05862064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110564377|NCT05862064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110564378|NCT05861791|Ketorolac|ketorolac|mesh-list
110564379|NCT05861791|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110564380|NCT05861791|Fentanyl|fentanyl|mesh-list
110564382|NCT05861791|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110564383|NCT05861791|Narcotics|narcotics|mesh-ancestor
110564384|NCT05861791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110564385|NCT05861791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110564386|NCT05861791|Analgesics|analgesics|mesh-ancestor
110564387|NCT05861791|Sensory System Agents|sensory system agents|mesh-ancestor
110564388|NCT05861791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110564389|NCT05861791|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110564390|NCT05861791|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110564391|NCT05861791|Anesthetics, General|anesthetics, general|mesh-ancestor
110564393|NCT05861791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110564394|NCT05861791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110564395|NCT05861791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110564396|NCT05861791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110564397|NCT05861791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110564398|NCT05861791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110564399|NCT05861791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110564400|NCT05861713|Dimenhydrinate|dimenhydrinate|mesh-list
110564402|NCT05861713|Autonomic Agents|autonomic agents|mesh-ancestor
110564403|NCT05861713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110564404|NCT05861713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110564405|NCT05861713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110564406|NCT05861713|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110564407|NCT05861713|Histamine Antagonists|histamine antagonists|mesh-ancestor
110564408|NCT05861713|Histamine Agents|histamine agents|mesh-ancestor
110564409|NCT05861713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110564410|NCT05861713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110564411|NCT05861687|Amoxicillin|amoxicillin|mesh-list
110564412|NCT05861687|Clarithromycin|clarithromycin|mesh-list
110564413|NCT05861687|Esomeprazole|esomeprazole|mesh-list
110564414|NCT05861687|Lansoprazole|lansoprazole|mesh-list
110564415|NCT05861687|Dexlansoprazole|dexlansoprazole|mesh-list
110564416|NCT05861687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110564417|NCT05861687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110564418|NCT05861687|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110564419|NCT05861687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110564420|NCT05861687|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110564421|NCT05861687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110564422|NCT05861687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110564423|NCT05861687|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110564424|NCT05861687|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110564425|NCT05861687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110564426|NCT05861648|Folic Acid|folic acid|mesh-list
110564427|NCT05861648|Hematinics|hematinics|mesh-ancestor
110564428|NCT05861648|Vitamin B Complex|vitamin b complex|mesh-ancestor
110564429|NCT05861648|Vitamins|vitamins|mesh-ancestor
110564430|NCT05861648|Micronutrients|micronutrients|mesh-ancestor
110564431|NCT05861648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110564432|NCT05861635|Tislelizumab|tislelizumab|mesh-list
110564433|NCT05861635|Disitamab vedotin|disitamab vedotin|mesh-list
110564434|NCT05861635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110564435|NCT05861635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110564436|NCT05861635|Immunoconjugates|immunoconjugates|mesh-ancestor
110564437|NCT05861635|Immunologic Factors|immunologic factors|mesh-ancestor
110564438|NCT05861635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110564439|NCT05861609|Analgesics|analgesics|mesh-list
110564440|NCT05861609|Sensory System Agents|sensory system agents|mesh-ancestor
110564441|NCT05861609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110564442|NCT05861609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110564443|NCT05857384|Acetazolamide|acetazolamide|mesh-list
110564445|NCT05857384|Anticonvulsants|anticonvulsants|mesh-ancestor
110564446|NCT05857384|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110564447|NCT05857384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110564448|NCT05857384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110564449|NCT05857384|Diuretics|diuretics|mesh-ancestor
110564450|NCT05857384|Natriuretic Agents|natriuretic agents|mesh-ancestor
110564451|NCT05857384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110564452|NCT05857384|Hallucinogens|hallucinogens|mesh-ancestor
110564453|NCT05857384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110564454|NCT05857384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110564455|NCT05857384|Analgesics|analgesics|mesh-ancestor
110564456|NCT05857384|Sensory System Agents|sensory system agents|mesh-ancestor
110564457|NCT05857384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110564458|NCT05857384|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110564459|NCT05857384|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110564460|NCT05857384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110564461|NCT05857384|Hormones|hormones|mesh-ancestor
110564462|NCT05857384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110564463|NCT05773326|Sirolimus|sirolimus|mesh-list
110564464|NCT05773326|Temsirolimus|temsirolimus|mesh-list
110564465|NCT05773326|MTOR Inhibitors|mtor inhibitors|mesh-list
110564466|NCT05773326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110564467|NCT05773326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110564468|NCT05773326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110564469|NCT05773326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110564470|NCT05773326|Immunologic Factors|immunologic factors|mesh-ancestor
110564471|NCT05773326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110564472|NCT05773326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110564473|NCT05773326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110564474|NCT05773326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110564475|NCT05773326|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110564476|NCT05773326|Antifungal Agents|antifungal agents|mesh-ancestor
110564477|NCT05765071|Botulinum Toxins|botulinum toxins|mesh-list
110564478|NCT05765071|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110564479|NCT05765071|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110564480|NCT05765071|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110564481|NCT05765071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110564482|NCT05765071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110564483|NCT05765071|Cholinergic Agents|cholinergic agents|mesh-ancestor
110564484|NCT05765071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110564485|NCT05765071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110564487|NCT05765071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110564488|NCT05750745|Fluorides|fluorides|mesh-list
110564489|NCT05750745|Cariostatic Agents|cariostatic agents|mesh-ancestor
110564490|NCT05750745|Protective Agents|protective agents|mesh-ancestor
110564491|NCT05750745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110564493|NCT05746897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110564495|NCT05746897|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110564496|NCT05746897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110564498|NCT05686564|Lipotropic Agents|lipotropic agents|mesh-ancestor
110564499|NCT05686564|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110564500|NCT05686564|Antimetabolites|antimetabolites|mesh-ancestor
110564501|NCT05686564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110564502|NCT05686564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110564503|NCT05686564|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110564504|NCT05686564|Nootropic Agents|nootropic agents|mesh-ancestor
110564505|NCT05671900|Gemcitabine|gemcitabine|mesh-list
110564506|NCT05671900|Docetaxel|docetaxel|mesh-list
110564507|NCT05671900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110564508|NCT05671900|Antimetabolites|antimetabolites|mesh-ancestor
110564509|NCT05671900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110564510|NCT05671900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110564511|NCT05671900|Tubulin Modulators|tubulin modulators|mesh-ancestor
110564512|NCT05671900|Antimitotic Agents|antimitotic agents|mesh-ancestor
110564513|NCT05671900|Mitosis Modulators|mitosis modulators|mesh-ancestor
110564514|NCT05594147|Sorafenib|sorafenib|mesh-list
110564515|NCT05594147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110564516|NCT05594147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110564517|NCT05594147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110564518|NCT05594147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110564519|NCT05533242|Immunoglobulin Fab Fragments|immunoglobulin fab fragments|mesh-list
110564520|NCT05533242|Immunologic Factors|immunologic factors|mesh-ancestor
110564521|NCT05533242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110564522|NCT05489185|Tranexamic Acid|tranexamic acid|mesh-list
110564523|NCT05489185|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110564524|NCT05489185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110564525|NCT05489185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110564527|NCT05489185|Coagulants|coagulants|mesh-ancestor
110564528|NCT05465304|Azithromycin|azithromycin|mesh-list
110564529|NCT05465304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110564530|NCT05465304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110564531|NCT05458024|Vitamin D|vitamin d|mesh-list
110564533|NCT05458024|Cholecalciferol|cholecalciferol|mesh-list
110564535|NCT05458024|Micronutrients|micronutrients|mesh-ancestor
110564536|NCT05458024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110564537|NCT05458024|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110564538|NCT05458024|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110564539|NCT05456685|Carboplatin|carboplatin|mesh-list
110564541|NCT05456685|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
110564542|NCT05456685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110564543|NCT05456685|Immunoconjugates|immunoconjugates|mesh-ancestor
110564544|NCT05456685|Immunologic Factors|immunologic factors|mesh-ancestor
110564545|NCT05456685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110564546|NCT05456685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110564547|NCT05456685|Tubulin Modulators|tubulin modulators|mesh-ancestor
110564549|NCT05456685|Mitosis Modulators|mitosis modulators|mesh-ancestor
110564550|NCT05456685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110564553|NCT05370313|Autonomic Agents|autonomic agents|mesh-ancestor
110564554|NCT05370313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110564555|NCT05370313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110564556|NCT05370313|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110564557|NCT05370313|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110564558|NCT05370313|Cholinergic Agents|cholinergic agents|mesh-ancestor
110564559|NCT05370313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110564560|NCT05370313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110564562|NCT05368623|Autonomic Agents|autonomic agents|mesh-ancestor
110564563|NCT05368623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110564564|NCT05368623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110564565|NCT05357768|Formaldehyde|formaldehyde|mesh-list
110564566|NCT05357768|Disinfectants|disinfectants|mesh-ancestor
110564567|NCT05357768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110564568|NCT05324449|Cannabidiol|cannabidiol|mesh-list
110564569|NCT05324449|Anticonvulsants|anticonvulsants|mesh-ancestor
110564570|NCT05304871|Cefazolin|cefazolin|mesh-list
110564571|NCT05304871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110564572|NCT05304871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110564573|NCT05281406|Carboplatin|carboplatin|mesh-list
110564574|NCT05281406|Pemetrexed|pemetrexed|mesh-list
110564575|NCT05281406|Osimertinib|osimertinib|mesh-list
110564576|NCT05281406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110564577|NCT05281406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110564578|NCT05281406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110564579|NCT05281406|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110564580|NCT05281406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110564581|NCT05281406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110564582|NCT05265299|Aspirin|aspirin|mesh-list
110564583|NCT05265299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110564584|NCT05265299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110564585|NCT05265299|Analgesics|analgesics|mesh-ancestor
110564586|NCT05265299|Sensory System Agents|sensory system agents|mesh-ancestor
110564587|NCT05265299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110564588|NCT05265299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110564589|NCT05265299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110564590|NCT05265299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110564591|NCT05265299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110564592|NCT05265299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110564593|NCT05265299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110564594|NCT05265299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110564595|NCT05265299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110564596|NCT05265299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110564597|NCT05265299|Antipyretics|antipyretics|mesh-ancestor
110564598|NCT05233722|Sirolimus|sirolimus|mesh-list
110564599|NCT05233722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110564600|NCT05233722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110564601|NCT05233722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110564602|NCT05233722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110564603|NCT05233722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110564604|NCT05233722|Antifungal Agents|antifungal agents|mesh-ancestor
110564605|NCT05233722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110564606|NCT05233722|Immunologic Factors|immunologic factors|mesh-ancestor
110564608|NCT05221892|Pyridoxine|pyridoxine|mesh-list
110564609|NCT05221892|Vitamin B 12|vitamin b 12|mesh-list
110564610|NCT05221892|Hydroxocobalamin|hydroxocobalamin|mesh-list
110564611|NCT05221892|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
110564612|NCT05221892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110564613|NCT05221892|Vitamin B Complex|vitamin b complex|mesh-ancestor
110564614|NCT05221892|Vitamins|vitamins|mesh-ancestor
110564615|NCT05221892|Micronutrients|micronutrients|mesh-ancestor
110564616|NCT05221892|Hematinics|hematinics|mesh-ancestor
110564617|NCT05221892|GABA Agents|gaba agents|mesh-ancestor
110564618|NCT05221892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110564619|NCT05221892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110564620|NCT05161338|Estradiol|estradiol|mesh-list
110564621|NCT05161338|Progesterone|progesterone|mesh-list
110564622|NCT05161338|Estrogens|estrogens|mesh-ancestor
110564623|NCT05161338|Hormones|hormones|mesh-ancestor
110564624|NCT05161338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110564625|NCT05161338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110564626|NCT05161338|Progestins|progestins|mesh-ancestor
110564627|NCT05045794|Liver Extracts|liver extracts|mesh-list
110564628|NCT05045794|Hematinics|hematinics|mesh-ancestor
110564629|NCT05044936|Cannabidiol|cannabidiol|mesh-list
110564630|NCT05044936|Anticonvulsants|anticonvulsants|mesh-ancestor
110564631|NCT05036408|Coal Tar|coal tar|mesh-list
110564632|NCT05036408|Keratolytic Agents|keratolytic agents|mesh-ancestor
110564633|NCT05036408|Dermatologic Agents|dermatologic agents|mesh-ancestor
110564634|NCT05033743|Secnidazole|secnidazole|mesh-list
110564635|NCT05033743|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110564636|NCT05033743|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110564637|NCT05033743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110564638|NCT05021900|Tenalisib|tenalisib|mesh-list
110564639|NCT05021900|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
110564640|NCT05021900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110564641|NCT05021900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110564642|NCT05014646|Cholestyramine Resin|cholestyramine resin|mesh-list
110564643|NCT05014646|Leflunomide|leflunomide|mesh-list
110564644|NCT05014646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110564645|NCT05014646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110564646|NCT05014646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110564647|NCT05014646|Immunologic Factors|immunologic factors|mesh-ancestor
110564648|NCT05014646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110564649|NCT05014646|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110564650|NCT05014646|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110564651|NCT05014646|Antimetabolites|antimetabolites|mesh-ancestor
110564652|NCT05014646|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110564653|NCT04979806|Meropenem|meropenem|mesh-list
110564654|NCT04979806|Cefepime|cefepime|mesh-list
110564655|NCT04979806|Cefepime-zidebactam|cefepime-zidebactam|mesh-list
110564656|NCT04979806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110564657|NCT04979806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110564660|NCT04971954|Autonomic Agents|autonomic agents|mesh-ancestor
110564661|NCT04971954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110564662|NCT04971954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110564664|NCT04971954|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110564665|NCT04971954|Cholinergic Agents|cholinergic agents|mesh-ancestor
110564666|NCT04971954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110564667|NCT04971954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110564668|NCT04942340|Dexmedetomidine|dexmedetomidine|mesh-list
110564670|NCT04942340|Atipamezole|atipamezole|mesh-list
110564671|NCT04942340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110564672|NCT04942340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110564673|NCT04942340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110564674|NCT04942340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110564675|NCT04942340|Analgesics|analgesics|mesh-ancestor
110564676|NCT04942340|Sensory System Agents|sensory system agents|mesh-ancestor
110564677|NCT04942340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110564678|NCT04942340|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110564679|NCT04942340|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110564680|NCT04942340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110564681|NCT04942340|Adrenergic Agents|adrenergic agents|mesh-ancestor
110564682|NCT04942340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110564683|NCT04942340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110564684|NCT04942340|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110564685|NCT04942340|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110564686|NCT04942340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110564687|NCT04942340|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110564688|NCT04942340|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110564689|NCT04942340|Purinergic Agents|purinergic agents|mesh-ancestor
110564690|NCT04942340|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110564691|NCT04942340|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110564692|NCT04942340|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110564693|NCT04905654|Cromakalim|cromakalim|mesh-list
110564694|NCT04905654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110564695|NCT04905654|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110564696|NCT04905654|Autonomic Agents|autonomic agents|mesh-ancestor
110564697|NCT04905654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110564698|NCT04905654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110564699|NCT04905654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110564700|NCT04905654|Respiratory System Agents|respiratory system agents|mesh-ancestor
110564701|NCT04905654|Parasympatholytics|parasympatholytics|mesh-ancestor
110564702|NCT04905654|Vasodilator Agents|vasodilator agents|mesh-ancestor
110564704|NCT04857398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110564705|NCT04857398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110564706|NCT04826432|Pasireotide|pasireotide|mesh-list
110564707|NCT04826432|Hormones|hormones|mesh-ancestor
110564708|NCT04826432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110564709|NCT04826432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110564711|NCT04812548|Venetoclax|venetoclax|mesh-list
110564712|NCT04812548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110564713|NCT04812548|Antimetabolites|antimetabolites|mesh-ancestor
110564714|NCT04812548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110564715|NCT04812548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110564716|NCT04812548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110564717|NCT04702022|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110564718|NCT04702022|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110564719|NCT04702022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110564720|NCT04698525|Valproic Acid|valproic acid|mesh-list
110564721|NCT04698525|Memantine|memantine|mesh-list
110564722|NCT04698525|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110564723|NCT04698525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110564724|NCT04698525|Dopamine Agents|dopamine agents|mesh-ancestor
110564725|NCT04698525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110564726|NCT04698525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110564727|NCT04698525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110564728|NCT04698525|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110564729|NCT04698525|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110564730|NCT04698525|Anticonvulsants|anticonvulsants|mesh-ancestor
110190140|NCT00051441|Benzydamine|benzydamine|mesh-list
110564731|NCT04698525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110564733|NCT04698525|Antimanic Agents|antimanic agents|mesh-ancestor
110564734|NCT04698525|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110564735|NCT04698525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110564736|NCT04698525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110564737|NCT04667104|Tenofovir|tenofovir|mesh-list
110564738|NCT04667104|Entecavir|entecavir|mesh-list
110564739|NCT04667104|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110564740|NCT04667104|Antiviral Agents|antiviral agents|mesh-ancestor
110564741|NCT04667104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110564742|NCT04667104|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110564743|NCT04667104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110564744|NCT04667104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110564745|NCT04667104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110564746|NCT04667104|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110564747|NCT04667104|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110564748|NCT04659369|Nivolumab|nivolumab|mesh-list
110564749|NCT04659369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110564750|NCT04659369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110564751|NCT04659369|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110564752|NCT04659369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110564755|NCT04651439|Immunologic Factors|immunologic factors|mesh-ancestor
110564756|NCT04651439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110564757|NCT04635774|Insulin|insulin|mesh-list
110564758|NCT04635774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110564759|NCT04635774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110564760|NCT04634799|Plasminogen|plasminogen|mesh-list
110564761|NCT04634799|Plasminogen Activator Inhibitor 1|plasminogen activator inhibitor 1|mesh-list
110564762|NCT04634799|Plasminogen Inactivators|plasminogen inactivators|mesh-list
110564763|NCT04634799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110564764|NCT04634799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110564765|NCT04634799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110564766|NCT04634799|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110564767|NCT04634799|Protease Inhibitors|protease inhibitors|mesh-ancestor
110564768|NCT04634799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110564769|NCT04603365|Temozolomide|temozolomide|mesh-list
110564770|NCT04603365|Pamiparib|pamiparib|mesh-list
110564771|NCT04603365|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
110564772|NCT04603365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110564773|NCT04603365|Alkylating Agents|alkylating agents|mesh-ancestor
110564774|NCT04603365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110564775|NCT04603365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110564776|NCT04603365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110564777|NCT04565015|Immunoglobulins|immunoglobulins|mesh-list
110564778|NCT04565015|gamma-Globulins|gamma-globulins|mesh-list
110564779|NCT04565015|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110564780|NCT04565015|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110564781|NCT04565015|Immunologic Factors|immunologic factors|mesh-ancestor
110564782|NCT04565015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110564784|NCT04560660|Ketamine|ketamine|mesh-list
110564785|NCT04560660|Analgesics|analgesics|mesh-ancestor
110564786|NCT04560660|Sensory System Agents|sensory system agents|mesh-ancestor
110564787|NCT04560660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110564788|NCT04560660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110564789|NCT04560660|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110564790|NCT04560660|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110564791|NCT04560660|Anesthetics, General|anesthetics, general|mesh-ancestor
110564792|NCT04560660|Anesthetics|anesthetics|mesh-ancestor
110564793|NCT04560660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110564794|NCT04560660|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110564795|NCT04560660|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110564796|NCT04560660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110564797|NCT04560660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110564798|NCT04560660|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110564804|NCT04560660|GABA Agents|gaba agents|mesh-ancestor
110564805|NCT04556526|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
110564807|NCT04556526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110564808|NCT04517435|Prednisone|prednisone|mesh-list
110564809|NCT04517435|Cyclophosphamide|cyclophosphamide|mesh-list
110564810|NCT04517435|Rituximab|rituximab|mesh-list
110564811|NCT04517435|Doxorubicin|doxorubicin|mesh-list
110564812|NCT04517435|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110564813|NCT04517435|Vincristine|vincristine|mesh-list
110564814|NCT04517435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110051195|NCT01471808|Metformin|metformin|mesh-list
110564816|NCT04517435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110564817|NCT04517435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110564818|NCT04517435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110564819|NCT04517435|Alkylating Agents|alkylating agents|mesh-ancestor
110564820|NCT04517435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110564821|NCT04517435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110564822|NCT04517435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110564823|NCT04517435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110564824|NCT04517435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110564825|NCT04517435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110564826|NCT04517435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110564827|NCT04517435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110564828|NCT04517435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110564829|NCT04517435|Glucocorticoids|glucocorticoids|mesh-ancestor
110564830|NCT04517435|Hormones|hormones|mesh-ancestor
110564831|NCT04517435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110564832|NCT04517435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110564833|NCT04517435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110564834|NCT04517435|Tubulin Modulators|tubulin modulators|mesh-ancestor
110564835|NCT04517435|Antimitotic Agents|antimitotic agents|mesh-ancestor
110564836|NCT04517435|Mitosis Modulators|mitosis modulators|mesh-ancestor
110564837|NCT04478617|Metronidazole|metronidazole|mesh-list
110564838|NCT04478617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110564839|NCT04478617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110564840|NCT04478617|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110564841|NCT04478617|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110564847|NCT04424966|Infigratinib|infigratinib|mesh-list
110564848|NCT04424966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110564849|NCT04340258|Pembrolizumab|pembrolizumab|mesh-list
110564850|NCT04340258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110564851|NCT04340258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110564852|NCT04340258|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110564853|NCT04340258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110564854|NCT04301271|Simvastatin|simvastatin|mesh-list
110564855|NCT04301271|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110564856|NCT04301271|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110564857|NCT04301271|Antimetabolites|antimetabolites|mesh-ancestor
110564858|NCT04301271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110564859|NCT04301271|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110564860|NCT04301271|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110564861|NCT04301271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110564862|NCT04228783|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
110564863|NCT04228783|Antiviral Agents|antiviral agents|mesh-ancestor
110564864|NCT04228783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110564865|NCT04188119|Aspirin|aspirin|mesh-list
110564866|NCT04188119|Avelumab|avelumab|mesh-list
110564867|NCT04188119|Lansoprazole|lansoprazole|mesh-list
110564868|NCT04188119|Dexlansoprazole|dexlansoprazole|mesh-list
110564869|NCT04188119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110564870|NCT04188119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110564871|NCT04188119|Analgesics|analgesics|mesh-ancestor
110564872|NCT04188119|Sensory System Agents|sensory system agents|mesh-ancestor
110564873|NCT04188119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110564874|NCT04188119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110564875|NCT04188119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110564876|NCT04188119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110564877|NCT04188119|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110564878|NCT04188119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110564879|NCT04188119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110564880|NCT04188119|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110564881|NCT04188119|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110564882|NCT04188119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110564883|NCT04188119|Antipyretics|antipyretics|mesh-ancestor
110564884|NCT04188119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110564885|NCT04188119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110564886|NCT04188119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110564887|NCT04188119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110564888|NCT04188119|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110564889|NCT04142658|Warfarin|warfarin|mesh-list
110564890|NCT04142658|Apixaban|apixaban|mesh-list
110564891|NCT04142658|Anticoagulants|anticoagulants|mesh-ancestor
110564892|NCT04142658|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110564893|NCT04142658|Antithrombins|antithrombins|mesh-ancestor
110564894|NCT04142658|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110564895|NCT04142658|Protease Inhibitors|protease inhibitors|mesh-ancestor
110564896|NCT04142658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110564897|NCT04142658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110564898|NCT04138394|Ascorbic Acid|ascorbic acid|mesh-list
110564900|NCT04138394|Micronutrients|micronutrients|mesh-ancestor
110564901|NCT04138394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110564902|NCT04138394|Antioxidants|antioxidants|mesh-ancestor
110564903|NCT04138394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110564904|NCT04138394|Protective Agents|protective agents|mesh-ancestor
110564905|NCT04129931|Imatinib Mesylate|imatinib mesylate|mesh-list
110564906|NCT04129931|Broncho-Vaxom|broncho-vaxom|mesh-list
110564907|NCT04129931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110564908|NCT04129931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110564909|NCT04129931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110564910|NCT04129931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110564911|NCT04129931|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110564912|NCT04129931|Immunologic Factors|immunologic factors|mesh-ancestor
110564913|NCT04129931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110564915|NCT04095442|Anesthetics, Local|anesthetics, local|mesh-ancestor
110564916|NCT04095442|Anesthetics|anesthetics|mesh-ancestor
110564917|NCT04095442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110564918|NCT04095442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110564919|NCT04095442|Sensory System Agents|sensory system agents|mesh-ancestor
110564920|NCT04095442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110564921|NCT03977363|Anticoagulants|anticoagulants|mesh-list
110564922|NCT03950674|Folic Acid|folic acid|mesh-list
110564923|NCT03950674|Vitamin B 12|vitamin b 12|mesh-list
110564924|NCT03950674|Dexamethasone|dexamethasone|mesh-list
110564925|NCT03950674|Carboplatin|carboplatin|mesh-list
110564926|NCT03950674|Pembrolizumab|pembrolizumab|mesh-list
110564927|NCT03950674|Pemetrexed|pemetrexed|mesh-list
110564928|NCT03950674|Vitamins|vitamins|mesh-ancestor
110564929|NCT03950674|Micronutrients|micronutrients|mesh-ancestor
110564930|NCT03950674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110564931|NCT03950674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110564932|NCT03950674|Antiemetics|antiemetics|mesh-ancestor
110564933|NCT03950674|Autonomic Agents|autonomic agents|mesh-ancestor
110564934|NCT03950674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110564935|NCT03950674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110564936|NCT03950674|Glucocorticoids|glucocorticoids|mesh-ancestor
110564937|NCT03950674|Hormones|hormones|mesh-ancestor
110564938|NCT03950674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110564939|NCT03950674|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110564940|NCT03950674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110564941|NCT03950674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110564942|NCT03950674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110564943|NCT03950674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110564944|NCT03950674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110564947|NCT03950674|Hematinics|hematinics|mesh-ancestor
110564948|NCT03950674|Vitamin B Complex|vitamin b complex|mesh-ancestor
110564949|NCT03911661|Warfarin|warfarin|mesh-list
110564950|NCT03911661|Anticoagulants|anticoagulants|mesh-ancestor
110564952|NCT03909477|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110564953|NCT03909477|Anesthetics, General|anesthetics, general|mesh-ancestor
110564954|NCT03909477|Anesthetics|anesthetics|mesh-ancestor
110564955|NCT03909477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110564956|NCT03909477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110564957|NCT03874052|Venetoclax|venetoclax|mesh-list
110564958|NCT03874052|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
110564959|NCT03874052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110564960|NCT03874052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110564961|NCT03874052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110564962|NCT03874052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110564963|NCT03851159|Mannitol|mannitol|mesh-list
110564964|NCT03851159|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110564965|NCT03851159|Diuretics|diuretics|mesh-ancestor
110564966|NCT03851159|Natriuretic Agents|natriuretic agents|mesh-ancestor
110564967|NCT03851159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110564971|NCT03829410|Bevacizumab|bevacizumab|mesh-list
110564972|NCT03829410|Onvansertib|onvansertib|mesh-list
110564973|NCT03829410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110564974|NCT03829410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110564975|NCT03829410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110564976|NCT03829410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110564977|NCT03829410|Growth Substances|growth substances|mesh-ancestor
110564978|NCT03829410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110564979|NCT03829410|Growth Inhibitors|growth inhibitors|mesh-ancestor
110564980|NCT03829410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110564981|NCT03829410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110564982|NCT03829410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110564983|NCT03711604|Tenalisib|tenalisib|mesh-list
110564984|NCT03711604|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
110564985|NCT03711604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110564986|NCT03711604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110564987|NCT03708627|Bimatoprost|bimatoprost|mesh-list
110564988|NCT03708627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110564989|NCT03702621|Bupivacaine|bupivacaine|mesh-list
110564990|NCT03702621|Anesthetics, Local|anesthetics, local|mesh-ancestor
110564991|NCT03702621|Anesthetics|anesthetics|mesh-ancestor
110564992|NCT03702621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110564993|NCT03702621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110564994|NCT03702621|Sensory System Agents|sensory system agents|mesh-ancestor
110564995|NCT03702621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110564996|NCT03688295|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110564997|NCT03688295|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110564998|NCT03688295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110564999|NCT03688295|Antitubercular Agents|antitubercular agents|mesh-ancestor
110565000|NCT03684876|Diuretics|diuretics|mesh-list
110565001|NCT03684876|Natriuretic Agents|natriuretic agents|mesh-ancestor
110565002|NCT03684876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110565003|NCT03655665|Ofloxacin|ofloxacin|mesh-list
110565004|NCT03655665|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110565005|NCT03655665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110565006|NCT03655665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110565007|NCT03655665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110565008|NCT03655665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110565009|NCT03655665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110565010|NCT03655665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565011|NCT03655665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110565012|NCT03655665|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110565013|NCT03655665|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110565014|NCT03641690|Anti-Infective Agents|anti-infective agents|mesh-list
110565015|NCT03641690|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110565016|NCT03604627|Calcium|calcium|mesh-list
110565017|NCT03604627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110565018|NCT03604627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110565019|NCT03516656|Heparin|heparin|mesh-list
110565020|NCT03516656|Calcium heparin|calcium heparin|mesh-list
110565021|NCT03516656|Anticoagulants|anticoagulants|mesh-ancestor
110565023|NCT03516656|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110565024|NCT03516656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565025|NCT03479268|Enzyme Inhibitors|enzyme inhibitors|mesh-list
110565026|NCT03479268|Pevonedistat|pevonedistat|mesh-list
110565027|NCT03479268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565028|NCT03459092|Botulinum Toxins|botulinum toxins|mesh-list
110565029|NCT03459092|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110565030|NCT03459092|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110565031|NCT03459092|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110565032|NCT03459092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110565033|NCT03459092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565034|NCT03459092|Cholinergic Agents|cholinergic agents|mesh-ancestor
110565035|NCT03459092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110565036|NCT03459092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110565037|NCT03459092|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110565038|NCT03459092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110565039|NCT03437421|Vitamin D|vitamin d|mesh-list
110565040|NCT03437421|Cholecalciferol|cholecalciferol|mesh-list
110565041|NCT03437421|Vitamins|vitamins|mesh-ancestor
110565042|NCT03437421|Micronutrients|micronutrients|mesh-ancestor
110565043|NCT03437421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110565044|NCT03437421|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110565045|NCT03437421|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110565046|NCT03416270|Ertugliflozin|ertugliflozin|mesh-list
110565047|NCT03416270|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110565048|NCT03416270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565049|NCT03416270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110565050|NCT03416270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110565051|NCT03414034|Prednisone|prednisone|mesh-list
110565052|NCT03414034|Onvansertib|onvansertib|mesh-list
110565053|NCT03414034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110565054|NCT03414034|Glucocorticoids|glucocorticoids|mesh-ancestor
110565055|NCT03414034|Hormones|hormones|mesh-ancestor
110565056|NCT03414034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110565057|NCT03414034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110565058|NCT03414034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110565059|NCT03414034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110565060|NCT03414034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110565061|NCT03414034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110565062|NCT03414034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565063|NCT03284866|Vaccines|vaccines|mesh-list
110565064|NCT03284866|Immunologic Factors|immunologic factors|mesh-ancestor
110565065|NCT03284866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110565066|NCT03260894|Pembrolizumab|pembrolizumab|mesh-list
110565067|NCT03260894|Sunitinib|sunitinib|mesh-list
110565068|NCT03260894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110565069|NCT03260894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110565070|NCT03260894|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110565071|NCT03260894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565072|NCT03260894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110212580|NCT00065273|Olanzapine|olanzapine|mesh-list
110565074|NCT03260894|Growth Substances|growth substances|mesh-ancestor
110565075|NCT03260894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110565076|NCT03260894|Growth Inhibitors|growth inhibitors|mesh-ancestor
110565077|NCT03260894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110565078|NCT03260894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110565079|NCT03245008|Fasinumab|fasinumab|mesh-list
110565080|NCT03245008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110565081|NCT03245008|Analgesics|analgesics|mesh-ancestor
110565082|NCT03245008|Sensory System Agents|sensory system agents|mesh-ancestor
110565083|NCT03245008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110565084|NCT03245008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110565085|NCT03203473|Nivolumab|nivolumab|mesh-list
110565086|NCT03203473|Ipilimumab|ipilimumab|mesh-list
110565087|NCT03203473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110565088|NCT03203473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110565089|NCT03203473|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110565090|NCT03203473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565091|NCT03185208|Lithium Carbonate|lithium carbonate|mesh-list
110565092|NCT03185208|Antidepressive Agents|antidepressive agents|mesh-ancestor
110565093|NCT03185208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110565094|NCT03185208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110565095|NCT03185208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565096|NCT03185208|Antimanic Agents|antimanic agents|mesh-ancestor
110565097|NCT03185208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110565098|NCT03185208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110565099|NCT03185208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110565100|NCT03142568|Sildenafil Citrate|sildenafil citrate|mesh-list
110565101|NCT03142568|Vasodilator Agents|vasodilator agents|mesh-ancestor
110565102|NCT03142568|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110565103|NCT03142568|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110565104|NCT03142568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110565105|NCT03142568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565107|NCT03115567|Triamcinolone|triamcinolone|mesh-list
110565108|NCT03115567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110565109|NCT03115567|Glucocorticoids|glucocorticoids|mesh-ancestor
110565110|NCT03115567|Hormones|hormones|mesh-ancestor
110565111|NCT03115567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110565112|NCT03115567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110565113|NCT03051659|Pembrolizumab|pembrolizumab|mesh-list
110565114|NCT03051659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110565115|NCT03051659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110565116|NCT03051659|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110565117|NCT03051659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565118|NCT02982902|Immunomodulating Agents|immunomodulating agents|mesh-list
110565119|NCT02982902|Immunologic Factors|immunologic factors|mesh-ancestor
110565120|NCT02982902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110565121|NCT02971761|Pembrolizumab|pembrolizumab|mesh-list
110565122|NCT02971761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110565123|NCT02971761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110565124|NCT02971761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110565125|NCT02971761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565126|NCT02964559|Pembrolizumab|pembrolizumab|mesh-list
110565127|NCT02964559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110565128|NCT02964559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110565129|NCT02964559|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110565130|NCT02964559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565131|NCT02893293|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
110565132|NCT02893293|Hematinics|hematinics|mesh-ancestor
110565133|NCT02893293|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110565134|NCT02893293|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110565135|NCT02860000|Fulvestrant|fulvestrant|mesh-list
110565136|NCT02860000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110565137|NCT02860000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110565138|NCT02860000|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110565139|NCT02860000|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110565140|NCT02860000|Hormone Antagonists|hormone antagonists|mesh-ancestor
110565141|NCT02860000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110565142|NCT02860000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110565143|NCT02724878|Bevacizumab|bevacizumab|mesh-list
110565144|NCT02724878|Atezolizumab|atezolizumab|mesh-list
110565145|NCT02724878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110565146|NCT02724878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110565147|NCT02724878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110565148|NCT02724878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110565149|NCT02724878|Growth Substances|growth substances|mesh-ancestor
110565150|NCT02724878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110565151|NCT02724878|Growth Inhibitors|growth inhibitors|mesh-ancestor
110565152|NCT02724878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110565153|NCT02724878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565155|NCT02691923|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110565156|NCT02691923|Dermatologic Agents|dermatologic agents|mesh-ancestor
110565157|NCT02672475|Paclitaxel|paclitaxel|mesh-list
110565158|NCT02672475|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110565159|NCT02672475|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110565160|NCT02672475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110565161|NCT02672475|Tubulin Modulators|tubulin modulators|mesh-ancestor
110565162|NCT02672475|Antimitotic Agents|antimitotic agents|mesh-ancestor
110565163|NCT02672475|Mitosis Modulators|mitosis modulators|mesh-ancestor
110565164|NCT02672475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565165|NCT02578680|Folic Acid|folic acid|mesh-list
110565166|NCT02578680|Vitamin B 12|vitamin b 12|mesh-list
110565167|NCT02578680|Dexamethasone|dexamethasone|mesh-list
110565168|NCT02578680|Carboplatin|carboplatin|mesh-list
110565169|NCT02578680|Pembrolizumab|pembrolizumab|mesh-list
110565170|NCT02578680|Pemetrexed|pemetrexed|mesh-list
110565171|NCT02578680|Vitamins|vitamins|mesh-ancestor
110565172|NCT02578680|Micronutrients|micronutrients|mesh-ancestor
110565173|NCT02578680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110565174|NCT02578680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110565175|NCT02578680|Antiemetics|antiemetics|mesh-ancestor
110565176|NCT02578680|Autonomic Agents|autonomic agents|mesh-ancestor
110565177|NCT02578680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110565178|NCT02578680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110565179|NCT02578680|Glucocorticoids|glucocorticoids|mesh-ancestor
110565180|NCT02578680|Hormones|hormones|mesh-ancestor
110565181|NCT02578680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110565182|NCT02578680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110565183|NCT02578680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110565184|NCT02578680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110565185|NCT02578680|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110565186|NCT02578680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565187|NCT02578680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110565188|NCT02578680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110565189|NCT02578680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110565191|NCT02578680|Vitamin B Complex|vitamin b complex|mesh-ancestor
110565192|NCT02385266|Cycloserine|cycloserine|mesh-list
110565193|NCT02385266|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110565194|NCT02385266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110565195|NCT02385266|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110565197|NCT02385266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110565198|NCT02385266|Antimetabolites|antimetabolites|mesh-ancestor
110565199|NCT02385266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565200|NCT02351765|Cisplatin|cisplatin|mesh-list
110565201|NCT02351765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110565202|NCT02251431|Exenatide|exenatide|mesh-list
110565203|NCT02251431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110565204|NCT02251431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051583|NCT01474499|Sorbitol|sorbitol|mesh-list
110565205|NCT02251431|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110565206|NCT02251431|Incretins|incretins|mesh-ancestor
110565208|NCT02251431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110565209|NCT02191488|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110565210|NCT02191488|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110565211|NCT02191488|Dermatologic Agents|dermatologic agents|mesh-ancestor
110565212|NCT02000089|Secretin|secretin|mesh-list
110565213|NCT02000089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110565214|NCT02000089|Hormones|hormones|mesh-ancestor
110565215|NCT02000089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110565216|NCT02000089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110565217|NCT01494441|Calcium, Dietary|calcium, dietary|mesh-list
110565218|NCT01494441|Calcium|calcium|mesh-list
110565219|NCT01494441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110565220|NCT01494441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110565221|NCT01494441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110565222|NCT01367002|Paclitaxel|paclitaxel|mesh-list
110565223|NCT01367002|Carboplatin|carboplatin|mesh-list
110565224|NCT01367002|Trastuzumab|trastuzumab|mesh-list
110565225|NCT01367002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110565226|NCT01367002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110565227|NCT01367002|Tubulin Modulators|tubulin modulators|mesh-ancestor
110565228|NCT01367002|Antimitotic Agents|antimitotic agents|mesh-ancestor
110565229|NCT01367002|Mitosis Modulators|mitosis modulators|mesh-ancestor
110565230|NCT01367002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565231|NCT01367002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110565232|NCT00858273|Insulin|insulin|mesh-list
110565233|NCT00858273|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110565234|NCT00858273|Antioxidants|antioxidants|mesh-list
110565235|NCT00858273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110565236|NCT00858273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110565237|NCT00858273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565238|NCT00858273|Protective Agents|protective agents|mesh-ancestor
110565239|NCT04158167|Oxytocin|oxytocin|mesh-list
110565240|NCT04158167|Oxytocics|oxytocics|mesh-ancestor
110565241|NCT04158167|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110565242|NCT04158167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110565243|NCT00659555|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110565244|NCT00659555|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110565245|NCT02635607|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110565246|NCT02635607|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110565247|NCT02635607|Ganirelix|ganirelix|mesh-list
110565248|NCT02635607|Luteolytic Agents|luteolytic agents|mesh-ancestor
110565249|NCT02635607|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110565250|NCT02635607|Contraceptive Agents|contraceptive agents|mesh-ancestor
110565251|NCT02635607|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110565252|NCT02635607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110565253|NCT02635607|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110565254|NCT02635607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110565255|NCT02635607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110565256|NCT02635607|Hormones|hormones|mesh-ancestor
110565257|NCT02635607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110565258|NCT02635607|Hormone Antagonists|hormone antagonists|mesh-ancestor
110565259|NCT00660257|Vaccines|vaccines|mesh-list
110565260|NCT00660257|Immunologic Factors|immunologic factors|mesh-ancestor
110565261|NCT00660257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110565262|NCT00844428|Eculizumab|eculizumab|mesh-list
110565263|NCT00844428|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110565264|NCT00844428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110565265|NCT00844428|Immunologic Factors|immunologic factors|mesh-ancestor
110565266|NCT00844428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110565268|NCT00660335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110565269|NCT00660335|Hormones|hormones|mesh-ancestor
110565270|NCT00660335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110565271|NCT00660335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110565272|NCT00707772|Ribavirin|ribavirin|mesh-list
110565273|NCT00707772|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110565274|NCT00707772|Interferon-alpha|interferon-alpha|mesh-list
110565275|NCT00707772|Antimetabolites|antimetabolites|mesh-ancestor
110565276|NCT00707772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565277|NCT00707772|Antiviral Agents|antiviral agents|mesh-ancestor
110565278|NCT00707772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110565279|NCT00707772|Immunologic Factors|immunologic factors|mesh-ancestor
110565280|NCT00707772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110565281|NCT00834834|Fluoxetine|fluoxetine|mesh-list
110565282|NCT00834834|Citalopram|citalopram|mesh-list
110565283|NCT00834834|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110565284|NCT00834834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110565285|NCT00834834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110565286|NCT00834834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565287|NCT00834834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110565288|NCT00834834|Serotonin Agents|serotonin agents|mesh-ancestor
110565289|NCT00834834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110565290|NCT00834834|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110565291|NCT00834834|Antidepressive Agents|antidepressive agents|mesh-ancestor
110565292|NCT00834834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110565293|NCT00834834|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110565294|NCT00834834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110565295|NCT00834834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110565296|NCT00834366|Tramadol|tramadol|mesh-list
110565297|NCT00834366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110565298|NCT00834366|Narcotics|narcotics|mesh-ancestor
110565299|NCT00834366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110565300|NCT00834366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110565302|NCT00834366|Sensory System Agents|sensory system agents|mesh-ancestor
110565303|NCT00834366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110565304|NCT00704574|Insulin Detemir|insulin detemir|mesh-list
110565305|NCT00704574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110565306|NCT00704574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110565307|NCT00660647|Adalimumab|adalimumab|mesh-list
110565308|NCT00660647|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110565309|NCT00660647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110565310|NCT00660647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110565311|NCT04156451|Furosemide|furosemide|mesh-list
110565312|NCT04156451|Diuretics|diuretics|mesh-ancestor
110565313|NCT04156451|Natriuretic Agents|natriuretic agents|mesh-ancestor
110565314|NCT04156451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110565315|NCT04156451|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110565316|NCT04156451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110565317|NCT04156451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565319|NCT00660725|Oxaliplatin|oxaliplatin|mesh-list
110565320|NCT00660725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110565321|NCT00660725|Antimetabolites|antimetabolites|mesh-ancestor
110565322|NCT00660725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565323|NCT00660725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110565324|NCT00844194|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110565325|NCT00844194|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110565326|NCT00844194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110565327|NCT00844194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110565328|NCT00844194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565329|NCT00844194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110565330|NCT00844194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110565332|NCT00844194|Sensory System Agents|sensory system agents|mesh-ancestor
110565333|NCT00844194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110565334|NCT00844194|Antidepressive Agents|antidepressive agents|mesh-ancestor
110565335|NCT00844194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110565336|NCT00844194|Dopamine Agents|dopamine agents|mesh-ancestor
110565337|NCT00660803|Fulvestrant|fulvestrant|mesh-list
110565338|NCT00660803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110565339|NCT00660803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110565340|NCT00660803|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110565341|NCT00660803|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110565342|NCT00660803|Hormone Antagonists|hormone antagonists|mesh-ancestor
110565343|NCT00660803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110565344|NCT00660803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110565345|NCT00661115|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110565346|NCT00661115|Vasodilator Agents|vasodilator agents|mesh-ancestor
110565347|NCT00661115|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110565348|NCT00661115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110565349|NCT00661115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110565350|NCT00661115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565351|NCT00661115|Urological Agents|urological agents|mesh-ancestor
110565352|NCT04157699|Tenofovir|tenofovir|mesh-list
110565353|NCT04157699|Antiviral Agents|antiviral agents|mesh-ancestor
110565354|NCT04157699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110565355|NCT04157699|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110565356|NCT04157699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110565357|NCT04157699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110565358|NCT04157699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565359|NCT04157699|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110565360|NCT04157699|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110565361|NCT00665717|Raltegravir Potassium|raltegravir potassium|mesh-list
110565362|NCT00665717|Pravastatin|pravastatin|mesh-list
110565363|NCT00665717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110565364|NCT00665717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110565365|NCT00665717|Antiviral Agents|antiviral agents|mesh-ancestor
110190335|NCT00052026|Antioxidants|antioxidants|mesh-ancestor
110565367|NCT00665717|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110565368|NCT00665717|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110565369|NCT00665717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110565370|NCT00665717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565371|NCT00665717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110565372|NCT00665717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110565373|NCT00665717|Antimetabolites|antimetabolites|mesh-ancestor
110565374|NCT00665717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110565375|NCT00665717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110565377|NCT02611596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110565378|NCT02611596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110565379|NCT02611596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565380|NCT00661349|Ritonavir|ritonavir|mesh-list
110565381|NCT00661349|Lopinavir|lopinavir|mesh-list
110565382|NCT00661349|Nevirapine|nevirapine|mesh-list
110565383|NCT00661349|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110565384|NCT00661349|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110565385|NCT00661349|Protease Inhibitors|protease inhibitors|mesh-ancestor
110565386|NCT00661349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110565387|NCT00661349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565388|NCT00661349|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110565389|NCT00661349|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110565390|NCT00661349|Antiviral Agents|antiviral agents|mesh-ancestor
110565391|NCT00661349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110565392|NCT00661349|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110565393|NCT00661349|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110565394|NCT00661349|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110565395|NCT00661349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110565396|NCT00661349|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110565397|NCT00661349|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110565398|NCT00665873|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110565399|NCT00665873|Amoxicillin|amoxicillin|mesh-list
110565400|NCT00665873|Clavulanic Acids|clavulanic acids|mesh-list
110565401|NCT00665873|Clavulanic Acid|clavulanic acid|mesh-list
110565402|NCT00665873|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110565403|NCT00665873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110565404|NCT00665873|Antitubercular Agents|antitubercular agents|mesh-ancestor
110565405|NCT00665873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110565406|NCT00665873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565407|NCT00665873|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110565408|NCT00707850|Ribavirin|ribavirin|mesh-list
110565409|NCT00707850|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110565410|NCT00707850|Interferon-alpha|interferon-alpha|mesh-list
110565411|NCT00707850|Antimetabolites|antimetabolites|mesh-ancestor
110565412|NCT00707850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565413|NCT00707850|Antiviral Agents|antiviral agents|mesh-ancestor
110565414|NCT00707850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110565415|NCT00707850|Immunologic Factors|immunologic factors|mesh-ancestor
110565416|NCT00707850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110565417|NCT00665951|Ritonavir|ritonavir|mesh-list
110565418|NCT00665951|Lopinavir|lopinavir|mesh-list
110565419|NCT00665951|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110565420|NCT00665951|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110565421|NCT00665951|Protease Inhibitors|protease inhibitors|mesh-ancestor
110565422|NCT00665951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110565423|NCT00665951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565424|NCT00665951|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110565425|NCT00665951|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110565426|NCT00665951|Antiviral Agents|antiviral agents|mesh-ancestor
110565427|NCT00665951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110565428|NCT00665951|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110565429|NCT00665951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110565430|NCT00661739|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110565431|NCT00661739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110565432|NCT00661739|Alkylating Agents|alkylating agents|mesh-ancestor
110565433|NCT00661739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565434|NCT00661739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110565435|NCT00878969|Valsartan|valsartan|mesh-list
110565436|NCT00878969|Ramipril|ramipril|mesh-list
110565437|NCT00878969|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110565438|NCT00878969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110565439|NCT00878969|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110565440|NCT00878969|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110565441|NCT00878969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565442|NCT00878969|Protease Inhibitors|protease inhibitors|mesh-ancestor
110565443|NCT00878969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110565445|NCT00843492|Nadroparin|nadroparin|mesh-list
110565446|NCT00843492|Fondaparinux|fondaparinux|mesh-list
110565447|NCT00843492|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110565448|NCT00843492|Antithrombins|antithrombins|mesh-ancestor
110565449|NCT00843492|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110565450|NCT00843492|Protease Inhibitors|protease inhibitors|mesh-ancestor
110565451|NCT00843492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110565452|NCT00843492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565453|NCT00843492|Anticoagulants|anticoagulants|mesh-ancestor
110565454|NCT00843492|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110565455|NCT00843492|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110565456|NCT00666107|Vaccines|vaccines|mesh-list
110565457|NCT00666107|Immunologic Factors|immunologic factors|mesh-ancestor
110565458|NCT00666107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110565459|NCT00666185|Fluconazole|fluconazole|mesh-list
110565460|NCT00666185|Micafungin|micafungin|mesh-list
110565461|NCT00666185|Antifungal Agents|antifungal agents|mesh-ancestor
110565462|NCT00666185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110565463|NCT00666185|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110565464|NCT00666185|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110565465|NCT00666185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110565466|NCT00666185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565467|NCT00666185|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110565468|NCT00666185|Hormone Antagonists|hormone antagonists|mesh-ancestor
110565469|NCT00666185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110565470|NCT00666185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110565471|NCT00666185|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110565472|NCT00666185|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110565473|NCT00913224|Diclofenac|diclofenac|mesh-list
110565474|NCT00913224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110565475|NCT00913224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110565476|NCT00913224|Analgesics|analgesics|mesh-ancestor
110565477|NCT00913224|Sensory System Agents|sensory system agents|mesh-ancestor
110565478|NCT00913224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110565479|NCT00913224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110565480|NCT00913224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110565482|NCT00913224|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110565483|NCT00913224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110565484|NCT00913224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565485|NCT00666341|Immunomodulating Agents|immunomodulating agents|mesh-list
110565486|NCT00666341|Immunologic Factors|immunologic factors|mesh-list
110565487|NCT00666341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110565488|NCT00661973|Budesonide|budesonide|mesh-list
110565489|NCT00661973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110565490|NCT00661973|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110565491|NCT00661973|Autonomic Agents|autonomic agents|mesh-ancestor
110565492|NCT00661973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110565493|NCT00661973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110190355|NCT00024440|Fludarabine|fludarabine|mesh-list
110565494|NCT00661973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110565495|NCT00661973|Respiratory System Agents|respiratory system agents|mesh-ancestor
110565496|NCT00661973|Glucocorticoids|glucocorticoids|mesh-ancestor
110565498|NCT00661973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110565499|NCT00666575|Gabapentin|gabapentin|mesh-list
110565500|NCT00666575|Analgesics|analgesics|mesh-ancestor
110565501|NCT00666575|Sensory System Agents|sensory system agents|mesh-ancestor
110565502|NCT00666575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110565503|NCT00666575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110565504|NCT00666575|Anticonvulsants|anticonvulsants|mesh-ancestor
110565505|NCT00666575|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110565506|NCT00666575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110565507|NCT00666575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110565508|NCT00666575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110565509|NCT00666575|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110565510|NCT00666575|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110565511|NCT00666575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110565512|NCT00666575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565513|NCT00666575|Antimanic Agents|antimanic agents|mesh-ancestor
110565514|NCT00666653|Pramipexole|pramipexole|mesh-list
110565515|NCT00666653|Antioxidants|antioxidants|mesh-ancestor
110565516|NCT00666653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565517|NCT00666653|Protective Agents|protective agents|mesh-ancestor
110565518|NCT00666653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110565519|NCT00666653|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110565520|NCT00666653|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110565521|NCT00666653|Dopamine Agonists|dopamine agonists|mesh-ancestor
110565522|NCT00666653|Dopamine Agents|dopamine agents|mesh-ancestor
110565523|NCT00666653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110565524|NCT00707928|Nitroglycerin|nitroglycerin|mesh-list
110565525|NCT00707928|Vasodilator Agents|vasodilator agents|mesh-ancestor
110565526|NCT00666809|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110565527|NCT00666809|Vasodilator Agents|vasodilator agents|mesh-ancestor
110565528|NCT00666809|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110565529|NCT00666809|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110565530|NCT00666809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110565531|NCT00666809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565532|NCT00666809|Urological Agents|urological agents|mesh-ancestor
110565533|NCT00666887|Minocycline|minocycline|mesh-list
110565534|NCT00666887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110565535|NCT00666887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110565536|NCT00667043|Fentanyl|fentanyl|mesh-list
110565537|NCT00667043|Midazolam|midazolam|mesh-list
110565538|NCT00667043|Remifentanil|remifentanil|mesh-list
110565539|NCT00667043|Propofol|propofol|mesh-list
110565540|NCT00667043|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110565541|NCT00667043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110565542|NCT00667043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110565543|NCT00667043|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110565544|NCT00667043|Anesthetics, General|anesthetics, general|mesh-ancestor
110565545|NCT00667043|Anesthetics|anesthetics|mesh-ancestor
110565546|NCT00667043|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110565547|NCT00667043|Narcotics|narcotics|mesh-ancestor
110565548|NCT00667043|Analgesics|analgesics|mesh-ancestor
110565549|NCT00667043|Sensory System Agents|sensory system agents|mesh-ancestor
110565550|NCT00667043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110565551|NCT00667043|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110565552|NCT00667043|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110565553|NCT00667043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110565554|NCT00667043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110565555|NCT00667043|GABA Modulators|gaba modulators|mesh-ancestor
110565556|NCT00667043|GABA Agents|gaba agents|mesh-ancestor
110565557|NCT00667043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110565558|NCT00667043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565560|NCT02631473|Lopinavir|lopinavir|mesh-list
110565561|NCT02631473|Efavirenz|efavirenz|mesh-list
110565562|NCT02631473|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110565563|NCT02631473|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110565564|NCT02631473|Protease Inhibitors|protease inhibitors|mesh-ancestor
110565565|NCT02631473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110565566|NCT02631473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565568|NCT02631473|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110565569|NCT02631473|Antiviral Agents|antiviral agents|mesh-ancestor
110565570|NCT02631473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110565571|NCT02631473|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110565572|NCT02631473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110565573|NCT02631473|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110565574|NCT02631473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110565575|NCT02631473|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110565576|NCT02631473|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110565577|NCT02631473|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110565578|NCT02631473|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110565579|NCT02631473|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110565580|NCT00825162|Vaccines|vaccines|mesh-list
110565581|NCT00825162|Immunologic Factors|immunologic factors|mesh-ancestor
110565582|NCT00825162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110565583|NCT00662441|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110565584|NCT00662441|Vasodilator Agents|vasodilator agents|mesh-ancestor
110565585|NCT00662441|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110565586|NCT00662441|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110565587|NCT00662441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110565588|NCT00662441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565589|NCT00662441|Urological Agents|urological agents|mesh-ancestor
110565590|NCT00911573|Vancomycin|vancomycin|mesh-list
110565591|NCT00911573|Clindamycin|clindamycin|mesh-list
110565592|NCT00911573|Clindamycin palmitate|clindamycin palmitate|mesh-list
110565593|NCT00911573|Clindamycin phosphate|clindamycin phosphate|mesh-list
110565595|NCT00911573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110565596|NCT00911573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110565597|NCT00911573|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110565598|NCT00911573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110565599|NCT00911573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565600|NCT00667433|Tenofovir|tenofovir|mesh-list
110565601|NCT00667433|Emtricitabine|emtricitabine|mesh-list
110565602|NCT00667433|Raltegravir Potassium|raltegravir potassium|mesh-list
110565603|NCT00667433|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110565604|NCT00667433|Antiviral Agents|antiviral agents|mesh-ancestor
110565605|NCT00667433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110565606|NCT00667433|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110565607|NCT00667433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110565608|NCT00667433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110565609|NCT00667433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565610|NCT00667433|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110565611|NCT00667433|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110565612|NCT00667433|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110565613|NCT00667433|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110565614|NCT00662519|Lenograstim|lenograstim|mesh-list
110565615|NCT00662519|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110565616|NCT00662519|Immunologic Factors|immunologic factors|mesh-ancestor
110565617|NCT00662519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110565618|NCT00667901|Riluzole|riluzole|mesh-list
110565619|NCT00667901|Anticonvulsants|anticonvulsants|mesh-ancestor
110565620|NCT00667901|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110565621|NCT00667901|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110565622|NCT00667901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110565623|NCT00667901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565624|NCT00667901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110565625|NCT00667901|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110565626|NCT00667901|Protective Agents|protective agents|mesh-ancestor
110565627|NCT00667979|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110565628|NCT00667979|Vasodilator Agents|vasodilator agents|mesh-ancestor
110565629|NCT00667979|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110565630|NCT00667979|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110565631|NCT00667979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110565632|NCT00667979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565634|NCT00668057|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110565635|NCT00668057|Vasodilator Agents|vasodilator agents|mesh-ancestor
110565636|NCT00668057|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110565637|NCT00668057|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110565638|NCT00668057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110565639|NCT00668057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565640|NCT00668057|Urological Agents|urological agents|mesh-ancestor
110565641|NCT00668135|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110565642|NCT00668135|Vasodilator Agents|vasodilator agents|mesh-ancestor
110565643|NCT00668135|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110565644|NCT00668135|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110565645|NCT00668135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110565646|NCT00668135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565647|NCT00668135|Urological Agents|urological agents|mesh-ancestor
110565648|NCT02630303|Coal Tar|coal tar|mesh-list
110565649|NCT02630303|Keratolytic Agents|keratolytic agents|mesh-ancestor
110565650|NCT02630303|Dermatologic Agents|dermatologic agents|mesh-ancestor
110565651|NCT04155983|Ropivacaine|ropivacaine|mesh-list
110565652|NCT04155983|Anesthetics, Local|anesthetics, local|mesh-ancestor
110565653|NCT04155983|Anesthetics|anesthetics|mesh-ancestor
110565654|NCT04155983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110565655|NCT04155983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110565656|NCT04155983|Sensory System Agents|sensory system agents|mesh-ancestor
110565657|NCT04155983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110565658|NCT00668603|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110565659|NCT00668603|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110565660|NCT00668603|Estradiol|estradiol|mesh-list
110565661|NCT00668603|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110565662|NCT00668603|Estrogens|estrogens|mesh-ancestor
110565663|NCT00668603|Hormones|hormones|mesh-ancestor
110565664|NCT00668603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110565665|NCT00668603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110565666|NCT00668603|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110565667|NCT00668603|Contraceptive Agents|contraceptive agents|mesh-ancestor
110565668|NCT00668603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110565669|NCT00668603|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110565670|NCT00662987|Amoxicillin|amoxicillin|mesh-list
110565671|NCT00662987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110565672|NCT00662987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110565673|NCT00668759|Amiodarone|amiodarone|mesh-list
110565674|NCT00668759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110565675|NCT00668759|Vasodilator Agents|vasodilator agents|mesh-ancestor
110565676|NCT00668759|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110565677|NCT00668759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110565678|NCT00668759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565679|NCT00668759|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110565680|NCT00668759|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110565681|NCT00668759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110565682|NCT00668759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110565683|NCT00668759|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110565684|NCT00668759|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110565685|NCT00668759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110565686|NCT00668837|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110565687|NCT00668837|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110565688|NCT00668837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110565689|NCT00668837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110565690|NCT00668837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110565691|NCT00668837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110565692|NCT00668837|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110565693|NCT00668837|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110565694|NCT00668837|Serotonin Agents|serotonin agents|mesh-ancestor
110565695|NCT00668837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110565696|NCT00668837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565697|NCT00668837|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110565698|NCT00668837|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110565699|NCT00668837|Dopamine Agents|dopamine agents|mesh-ancestor
110565700|NCT00663221|Vitamin D|vitamin d|mesh-list
110565701|NCT00663221|Calcium|calcium|mesh-list
110565702|NCT00663221|Vitamins|vitamins|mesh-ancestor
110565703|NCT00663221|Micronutrients|micronutrients|mesh-ancestor
110565704|NCT00663221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110565705|NCT00663221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110565706|NCT00663221|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110565707|NCT00824850|Vaccines|vaccines|mesh-list
110565708|NCT00824850|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110565709|NCT00824850|Immunologic Factors|immunologic factors|mesh-ancestor
110565710|NCT00824850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110565711|NCT00596687|Insulin|insulin|mesh-list
110565712|NCT00596687|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110565713|NCT00596687|Insulin Glargine|insulin glargine|mesh-list
110565714|NCT00596687|Insulin glulisine|insulin glulisine|mesh-list
110565715|NCT00596687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110565716|NCT00596687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110565717|NCT02631239|Dexamethasone|dexamethasone|mesh-list
110565718|NCT02631239|Methotrexate|methotrexate|mesh-list
110565719|NCT02631239|Etoposide|etoposide|mesh-list
110565720|NCT02631239|Pegaspargase|pegaspargase|mesh-list
110565721|NCT02631239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110565722|NCT02631239|Antiemetics|antiemetics|mesh-ancestor
110565723|NCT02631239|Autonomic Agents|autonomic agents|mesh-ancestor
110565724|NCT02631239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110565725|NCT02631239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110565726|NCT02631239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110565727|NCT02631239|Glucocorticoids|glucocorticoids|mesh-ancestor
110565728|NCT02631239|Hormones|hormones|mesh-ancestor
110565729|NCT02631239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110565730|NCT02631239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110565731|NCT02631239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110565732|NCT02631239|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110565733|NCT02631239|Abortifacient Agents|abortifacient agents|mesh-ancestor
110565734|NCT02631239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110565735|NCT02631239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110565736|NCT02631239|Antimetabolites|antimetabolites|mesh-ancestor
110565737|NCT02631239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565738|NCT02631239|Dermatologic Agents|dermatologic agents|mesh-ancestor
110565739|NCT02631239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110565740|NCT02631239|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110565741|NCT02631239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110565742|NCT02631239|Immunologic Factors|immunologic factors|mesh-ancestor
110565743|NCT02631239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110565744|NCT02631239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110565745|NCT02631239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110565746|NCT02631239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110565747|NCT02631239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110565748|NCT00663377|Losartan|losartan|mesh-list
110565749|NCT00663377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110565750|NCT00663377|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110565751|NCT00663377|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110565752|NCT00663377|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110565753|NCT00663377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565754|NCT00669149|Aspirin|aspirin|mesh-list
110565755|NCT00669149|Heparin|heparin|mesh-list
110565756|NCT00669149|Enoxaparin|enoxaparin|mesh-list
110565757|NCT00669149|Bivalirudin|bivalirudin|mesh-list
110565758|NCT00669149|Clopidogrel|clopidogrel|mesh-list
110565759|NCT00669149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110565760|NCT00669149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110565761|NCT00669149|Analgesics|analgesics|mesh-ancestor
110565762|NCT00669149|Sensory System Agents|sensory system agents|mesh-ancestor
110565763|NCT00669149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110565764|NCT00669149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110565765|NCT00669149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110565766|NCT00669149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110565767|NCT00669149|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110565768|NCT00669149|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110565769|NCT00669149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565770|NCT00669149|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110565771|NCT00669149|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110565772|NCT00669149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110565773|NCT00669149|Antipyretics|antipyretics|mesh-ancestor
110565774|NCT00669149|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110565775|NCT00669149|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110565776|NCT00669149|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110565777|NCT00669149|Purinergic Agents|purinergic agents|mesh-ancestor
110565778|NCT00669149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110565779|NCT00669149|Anticoagulants|anticoagulants|mesh-ancestor
110565780|NCT00669149|Antithrombins|antithrombins|mesh-ancestor
110565781|NCT00669149|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110565782|NCT00669149|Protease Inhibitors|protease inhibitors|mesh-ancestor
110565783|NCT00663455|Cyclosporine|cyclosporine|mesh-list
110565784|NCT00663455|Cyclosporins|cyclosporins|mesh-list
110565785|NCT00663455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110565786|NCT00663455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565787|NCT00663455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110565788|NCT00663455|Immunologic Factors|immunologic factors|mesh-ancestor
110565789|NCT00663455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110565790|NCT00663455|Antifungal Agents|antifungal agents|mesh-ancestor
110565791|NCT00663455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110565792|NCT00663455|Dermatologic Agents|dermatologic agents|mesh-ancestor
110565793|NCT00663455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110565794|NCT00663455|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110565795|NCT00669695|Atorvastatin|atorvastatin|mesh-list
110565796|NCT00669695|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110565797|NCT00669695|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110565798|NCT00669695|Antimetabolites|antimetabolites|mesh-ancestor
110565799|NCT00669695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110190407|NCT00052338|Bortezomib|bortezomib|mesh-list
110565800|NCT00669695|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110565801|NCT00669695|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110565802|NCT00669695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110565803|NCT00663689|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110565804|NCT00663689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110565805|NCT00663689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110565806|NCT00663689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110565807|NCT00663689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565808|NCT00669773|Docetaxel|docetaxel|mesh-list
110565809|NCT00669773|Doxorubicin|doxorubicin|mesh-list
110565810|NCT00669773|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110565812|NCT00669773|Tubulin Modulators|tubulin modulators|mesh-ancestor
110565813|NCT00669773|Antimitotic Agents|antimitotic agents|mesh-ancestor
110565814|NCT00669773|Mitosis Modulators|mitosis modulators|mesh-ancestor
110565815|NCT00669773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565816|NCT00669773|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110565817|NCT00669773|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110565818|NCT00669773|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110565819|NCT00669773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110565820|NCT00824616|Insulin|insulin|mesh-list
110565821|NCT00824616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110565822|NCT00824616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110565823|NCT00663845|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110565824|NCT00663845|Vasodilator Agents|vasodilator agents|mesh-ancestor
110565825|NCT00663845|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110565826|NCT00663845|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110565827|NCT00663845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110565828|NCT00663845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565829|NCT00663845|Urological Agents|urological agents|mesh-ancestor
110565830|NCT00708240|Escitalopram|escitalopram|mesh-list
110565831|NCT00708240|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110565832|NCT00708240|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110565833|NCT00708240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110565834|NCT00708240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565835|NCT00708240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110565836|NCT00708240|Serotonin Agents|serotonin agents|mesh-ancestor
110565837|NCT00708240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110565838|NCT04155515|Ribavirin|ribavirin|mesh-list
110565839|NCT04155515|Yimitasvir|yimitasvir|mesh-list
110565840|NCT04155515|Antimetabolites|antimetabolites|mesh-ancestor
110565841|NCT04155515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565842|NCT04155515|Antiviral Agents|antiviral agents|mesh-ancestor
110565843|NCT04155515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110565844|NCT00664001|Antioxidants|antioxidants|mesh-list
110565845|NCT00664001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565846|NCT00664001|Protective Agents|protective agents|mesh-ancestor
110565847|NCT00664001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110565848|NCT00824382|Olodaterol|olodaterol|mesh-list
110565849|NCT00824382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110565850|NCT00824382|Autonomic Agents|autonomic agents|mesh-ancestor
110565851|NCT00824382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110565852|NCT00824382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110565853|NCT00824382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110565854|NCT00824382|Respiratory System Agents|respiratory system agents|mesh-ancestor
110565855|NCT00670319|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
110565856|NCT00670319|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110565857|NCT00670319|Hormone Antagonists|hormone antagonists|mesh-ancestor
110565858|NCT00670319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110565859|NCT00670319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110565860|NCT00670319|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110565861|NCT00670319|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110565862|NCT00670319|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110565863|NCT00708318|Fentanyl|fentanyl|mesh-list
110565864|NCT00708318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110565865|NCT00708318|Narcotics|narcotics|mesh-ancestor
110565866|NCT00708318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110565867|NCT00708318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110565868|NCT00708318|Analgesics|analgesics|mesh-ancestor
110565869|NCT00708318|Sensory System Agents|sensory system agents|mesh-ancestor
110565870|NCT00708318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110565871|NCT00708318|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110565872|NCT00708318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110565873|NCT00708318|Anesthetics, General|anesthetics, general|mesh-ancestor
110565874|NCT00708318|Anesthetics|anesthetics|mesh-ancestor
110565875|NCT00670475|Piroxicam|piroxicam|mesh-list
110565876|NCT00670475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110565877|NCT00670475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110565878|NCT00670475|Analgesics|analgesics|mesh-ancestor
110565879|NCT00670475|Sensory System Agents|sensory system agents|mesh-ancestor
110565880|NCT00670475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110565881|NCT00670475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110565882|NCT00670475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110565883|NCT00670475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110565884|NCT00670475|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110565885|NCT00670475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110565886|NCT00670475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565888|NCT04154033|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110565889|NCT04154033|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110565890|NCT04154033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110565891|NCT04154033|Sensory System Agents|sensory system agents|mesh-ancestor
110565892|NCT04154033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110565893|NCT05530356|Dextrans|dextrans|mesh-list
110565894|NCT05530356|Anticoagulants|anticoagulants|mesh-ancestor
110565895|NCT05530356|Plasma Substitutes|plasma substitutes|mesh-ancestor
110565896|NCT05530356|Blood Substitutes|blood substitutes|mesh-ancestor
110565897|NCT00664313|Linezolid|linezolid|mesh-list
110565898|NCT00664313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110565899|NCT00664313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110565900|NCT00664313|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110565901|NCT00664313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110565902|NCT00664313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565903|NCT00670553|Panobinostat|panobinostat|mesh-list
110565904|NCT00670553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110565905|NCT00670553|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110565906|NCT00670553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110565907|NCT00670553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565908|NCT00833040|Sufentanil|sufentanil|mesh-list
110565909|NCT00833040|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110565910|NCT00833040|Narcotics|narcotics|mesh-ancestor
110565911|NCT00833040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110565912|NCT00833040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110565913|NCT00833040|Analgesics|analgesics|mesh-ancestor
110565914|NCT00833040|Sensory System Agents|sensory system agents|mesh-ancestor
110565915|NCT00833040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110565916|NCT00833040|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110565917|NCT00833040|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110565918|NCT00833040|Anesthetics, General|anesthetics, general|mesh-ancestor
110565919|NCT00833040|Anesthetics|anesthetics|mesh-ancestor
110565920|NCT02629835|Dexamethasone|dexamethasone|mesh-list
110565921|NCT02629835|Dexamethasone acetate|dexamethasone acetate|mesh-list
110565922|NCT02629835|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110565923|NCT02629835|BB 1101|bb 1101|mesh-list
110565924|NCT02629835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110565925|NCT02629835|Antiemetics|antiemetics|mesh-ancestor
110565926|NCT02629835|Autonomic Agents|autonomic agents|mesh-ancestor
110565927|NCT02629835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110565928|NCT02629835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110565929|NCT02629835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110565930|NCT02629835|Glucocorticoids|glucocorticoids|mesh-ancestor
110565931|NCT02629835|Hormones|hormones|mesh-ancestor
110565932|NCT02629835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110565933|NCT02629835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110565934|NCT02629835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110565935|NCT02629835|Protease Inhibitors|protease inhibitors|mesh-ancestor
110565936|NCT02629835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110565937|NCT02629835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565938|NCT00664469|Atorvastatin|atorvastatin|mesh-list
110565939|NCT00664469|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110565940|NCT00664469|Simvastatin|simvastatin|mesh-list
110565941|NCT00664469|Ezetimibe|ezetimibe|mesh-list
110565942|NCT00664469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110565944|NCT00664469|Antimetabolites|antimetabolites|mesh-ancestor
110565945|NCT00664469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565946|NCT00664469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110565947|NCT00664469|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110565948|NCT00664469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110565949|NCT00843024|Naproxen|naproxen|mesh-list
110565950|NCT00843024|Sumatriptan|sumatriptan|mesh-list
110565951|NCT00843024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110565952|NCT00843024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110565953|NCT00843024|Analgesics|analgesics|mesh-ancestor
110565954|NCT00843024|Sensory System Agents|sensory system agents|mesh-ancestor
110565955|NCT00843024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110565956|NCT00843024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110565957|NCT00843024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110565958|NCT00843024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110565959|NCT00843024|Gout Suppressants|gout suppressants|mesh-ancestor
110565960|NCT00843024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110565961|NCT00843024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110565962|NCT00843024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565963|NCT00843024|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110565964|NCT00843024|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110213474|NCT02962024|Morphine|morphine|mesh-list
110565965|NCT00843024|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110565966|NCT00843024|Serotonin Agents|serotonin agents|mesh-ancestor
110565967|NCT00843024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110565968|NCT04154813|Topiramate|topiramate|mesh-list
110565969|NCT04154813|Fluoxetine|fluoxetine|mesh-list
110565970|NCT04154813|Anticonvulsants|anticonvulsants|mesh-ancestor
110565971|NCT04154813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110565972|NCT04154813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110565973|NCT04154813|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110565974|NCT04154813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110565975|NCT04154813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110565976|NCT04154813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565977|NCT04154813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110565978|NCT04154813|Serotonin Agents|serotonin agents|mesh-ancestor
110565979|NCT04154813|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110565980|NCT04154813|Antidepressive Agents|antidepressive agents|mesh-ancestor
110565981|NCT04154813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110565982|NCT04154813|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110565983|NCT04154813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110565984|NCT04154813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110565985|NCT00664703|Methylphenidate|methylphenidate|mesh-list
110565986|NCT00664703|Lobeline|lobeline|mesh-list
110565987|NCT00664703|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110565988|NCT00664703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110565989|NCT00664703|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110565990|NCT00664703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110565991|NCT00664703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110565992|NCT00664703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565993|NCT00664703|Dopamine Agents|dopamine agents|mesh-ancestor
110565994|NCT00664703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110565995|NCT00664703|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110565996|NCT00664703|Autonomic Agents|autonomic agents|mesh-ancestor
110565998|NCT00664703|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110565999|NCT00664703|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110566000|NCT00664703|Cholinergic Agents|cholinergic agents|mesh-ancestor
110566001|NCT00664703|Respiratory System Agents|respiratory system agents|mesh-ancestor
110566002|NCT00670787|Losartan|losartan|mesh-list
110566003|NCT00670787|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110566004|NCT00670787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110566005|NCT00670787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110566006|NCT00670787|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110566007|NCT00670787|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110566008|NCT00670787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110566009|NCT00670787|Diuretics|diuretics|mesh-ancestor
110566010|NCT00670787|Natriuretic Agents|natriuretic agents|mesh-ancestor
110566011|NCT00670787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110566012|NCT00670787|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110566013|NCT00670787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110566014|NCT00664781|Rucaparib|rucaparib|mesh-list
110566015|NCT00664781|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110566016|NCT00664781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110566017|NCT00664781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110566018|NCT00664781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110566019|NCT00832650|Solifenacin Succinate|solifenacin succinate|mesh-list
110566020|NCT00832650|Fesoterodine|fesoterodine|mesh-list
110566021|NCT00832650|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110566022|NCT00832650|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110566023|NCT00832650|Cholinergic Agents|cholinergic agents|mesh-ancestor
110566024|NCT00832650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110566025|NCT00832650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110566026|NCT00832650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110566027|NCT00832650|Urological Agents|urological agents|mesh-ancestor
110566028|NCT00708396|Escitalopram|escitalopram|mesh-list
110566029|NCT00708396|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110566030|NCT00708396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110566031|NCT00708396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110566032|NCT00708396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110566033|NCT00708396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110566034|NCT00708396|Serotonin Agents|serotonin agents|mesh-ancestor
110566035|NCT00708396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110566036|NCT00665093|Insulin|insulin|mesh-list
110566037|NCT00665093|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110566039|NCT00665093|Insulin Detemir|insulin detemir|mesh-list
110566040|NCT00665093|Biphasic Insulins|biphasic insulins|mesh-list
110566041|NCT00665093|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110566042|NCT00665093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110566043|NCT00665093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110566044|NCT00595517|Esomeprazole|esomeprazole|mesh-list
110566045|NCT00595517|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110566046|NCT00595517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110566047|NCT00595517|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110566048|NCT00595517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110566049|NCT00595517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110566050|NCT00911651|Bromides|bromides|mesh-list
110566051|NCT00911651|Albuterol|albuterol|mesh-list
110566052|NCT00911651|Ipratropium|ipratropium|mesh-list
110566053|NCT00911651|Anticonvulsants|anticonvulsants|mesh-ancestor
110566054|NCT00911651|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110190468|NCT00395174|Hemagglutinins|hemagglutinins|mesh-list
110566056|NCT00911651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110566057|NCT00911651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110566058|NCT00911651|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110566059|NCT00911651|Respiratory System Agents|respiratory system agents|mesh-ancestor
110566060|NCT00911651|Tocolytic Agents|tocolytic agents|mesh-ancestor
110566061|NCT00911651|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110566062|NCT00911651|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110566065|NCT00911651|Adrenergic Agents|adrenergic agents|mesh-ancestor
110566066|NCT00911651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110566067|NCT00911651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110566068|NCT00911651|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110566069|NCT00911651|Cholinergic Agents|cholinergic agents|mesh-ancestor
110566070|NCT00665327|Moxifloxacin|moxifloxacin|mesh-list
110566071|NCT00665327|Levofloxacin|levofloxacin|mesh-list
110566072|NCT00665327|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110566073|NCT00665327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110566074|NCT00665327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110566075|NCT00665327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110566076|NCT00665327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110566077|NCT00665327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110566078|NCT00665327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110566079|NCT00665327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110566080|NCT00665327|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110566081|NCT00665327|Contraceptive Agents|contraceptive agents|mesh-ancestor
110566082|NCT00665327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110566083|NCT00665327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110566084|NCT00665327|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110566085|NCT00665327|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110566086|NCT00665327|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110566087|NCT00665327|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110566088|NCT00665327|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110566089|NCT00665327|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110566090|NCT00823836|Ropinirole|ropinirole|mesh-list
110566091|NCT00823836|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110566092|NCT00823836|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110566093|NCT00823836|Dopamine Agonists|dopamine agonists|mesh-ancestor
110566094|NCT00823836|Dopamine Agents|dopamine agents|mesh-ancestor
110566095|NCT00823836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110566096|NCT00823836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110566097|NCT00823836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110566098|NCT04154735|Rifaximin|rifaximin|mesh-list
110566099|NCT04154735|Cyclophosphamide|cyclophosphamide|mesh-list
110566100|NCT04154735|Fludarabine|fludarabine|mesh-list
110566101|NCT04154735|Alemtuzumab|alemtuzumab|mesh-list
110566102|NCT04154735|Tacrolimus|tacrolimus|mesh-list
110566103|NCT04154735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110566104|NCT04154735|Immunologic Factors|immunologic factors|mesh-ancestor
110566105|NCT04154735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110566106|NCT04154735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110566107|NCT04154735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110566108|NCT04154735|Alkylating Agents|alkylating agents|mesh-ancestor
110566109|NCT04154735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110566110|NCT04154735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110213625|NCT00099216|Rivastigmine|rivastigmine|mesh-list
110566111|NCT04154735|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110566112|NCT04154735|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110566113|NCT04154735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110566114|NCT04154735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110566115|NCT04154735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110566116|NCT04154735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110566117|NCT04154735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110566118|NCT00705042|Etanercept|etanercept|mesh-list
110566119|NCT00705042|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110566120|NCT00705042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110566121|NCT00705042|Analgesics|analgesics|mesh-ancestor
110566122|NCT00705042|Sensory System Agents|sensory system agents|mesh-ancestor
110566123|NCT00705042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110566124|NCT00705042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110566125|NCT00705042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110566126|NCT00705042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110566127|NCT00705042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110566128|NCT00705042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110566129|NCT00705042|Immunologic Factors|immunologic factors|mesh-ancestor
110566130|NCT00879437|Bevacizumab|bevacizumab|mesh-list
110566131|NCT00879437|Valproic Acid|valproic acid|mesh-list
110566132|NCT00879437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110566133|NCT00879437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110566134|NCT00879437|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110566135|NCT00879437|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110566136|NCT00879437|Growth Substances|growth substances|mesh-ancestor
110566137|NCT00879437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110566138|NCT00879437|Growth Inhibitors|growth inhibitors|mesh-ancestor
110566139|NCT00879437|Anticonvulsants|anticonvulsants|mesh-ancestor
110566140|NCT00879437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110566141|NCT00879437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110566142|NCT00879437|GABA Agents|gaba agents|mesh-ancestor
110566143|NCT00879437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110566144|NCT00879437|Antimanic Agents|antimanic agents|mesh-ancestor
110566145|NCT00879437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110566146|NCT00879437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110566147|NCT00879437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110566148|NCT00665639|Caspofungin|caspofungin|mesh-list
110566149|NCT00665639|Micafungin|micafungin|mesh-list
110566150|NCT00665639|Antifungal Agents|antifungal agents|mesh-ancestor
110566151|NCT00665639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110566152|NCT00665639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110566153|NCT00665639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110566154|NCT04153253|Aflibercept|aflibercept|mesh-list
110566155|NCT04153253|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110566156|NCT04153253|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110566157|NCT04153253|Growth Substances|growth substances|mesh-ancestor
110566158|NCT04153253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110566159|NCT04153253|Growth Inhibitors|growth inhibitors|mesh-ancestor
110566160|NCT04153253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110566161|NCT00671645|Bevacizumab|bevacizumab|mesh-list
110566162|NCT00671645|Capecitabine|capecitabine|mesh-list
110566163|NCT00671645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110566164|NCT00671645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110566165|NCT00671645|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110566166|NCT00671645|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110566167|NCT00671645|Growth Substances|growth substances|mesh-ancestor
110566168|NCT00671645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110566169|NCT00671645|Growth Inhibitors|growth inhibitors|mesh-ancestor
110566170|NCT00671645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110566171|NCT00671645|Antimetabolites|antimetabolites|mesh-ancestor
110566172|NCT00671645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110566173|NCT02629523|Afatinib|afatinib|mesh-list
110566174|NCT02629523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110566175|NCT02629523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110566176|NCT02629523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110566177|NCT02629523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110566178|NCT00671801|Irinotecan|irinotecan|mesh-list
110566179|NCT00671801|Lenalidomide|lenalidomide|mesh-list
110566180|NCT00671801|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110566181|NCT00671801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110566182|NCT00671801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110566183|NCT00671801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110566184|NCT00671801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110213700|NCT00244153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110566185|NCT00671801|Immunologic Factors|immunologic factors|mesh-ancestor
110566186|NCT00671801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110566187|NCT00671801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110566188|NCT00671801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110566189|NCT00671801|Growth Substances|growth substances|mesh-ancestor
110566190|NCT00671801|Growth Inhibitors|growth inhibitors|mesh-ancestor
110566191|NCT00676559|Ranibizumab|ranibizumab|mesh-list
110566192|NCT00676559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110566193|NCT00676559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110566194|NCT00676559|Growth Substances|growth substances|mesh-ancestor
110566195|NCT00676559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110566196|NCT00676559|Growth Inhibitors|growth inhibitors|mesh-ancestor
110566197|NCT00676559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110566199|NCT00672113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110566200|NCT00672113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110566201|NCT00672113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110566202|NCT00672113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110566203|NCT00672113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110566204|NCT00672113|Vasodilator Agents|vasodilator agents|mesh-ancestor
110566205|NCT00672113|Tocolytic Agents|tocolytic agents|mesh-ancestor
110566206|NCT00672113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110566207|NCT00676637|Timolol|timolol|mesh-list
110566208|NCT00676637|Travoprost|travoprost|mesh-list
110566209|NCT00676637|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110566210|NCT00676637|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110566211|NCT00676637|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110566212|NCT00676637|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110566213|NCT00676637|Adrenergic Agents|adrenergic agents|mesh-ancestor
110566214|NCT00676637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110566215|NCT00676637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110566216|NCT00676637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110566217|NCT00676637|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110566218|NCT00676637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110566219|NCT00672347|Clonidine|clonidine|mesh-list
110566220|NCT00672347|Morphine|morphine|mesh-list
110566221|NCT00672347|Bupivacaine|bupivacaine|mesh-list
110566222|NCT00672347|Anesthetics, Local|anesthetics, local|mesh-ancestor
110566223|NCT00672347|Anesthetics|anesthetics|mesh-ancestor
110566224|NCT00672347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110566225|NCT00672347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110566226|NCT00672347|Sensory System Agents|sensory system agents|mesh-ancestor
110566227|NCT00672347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110566228|NCT00672347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110566229|NCT00672347|Narcotics|narcotics|mesh-ancestor
110566230|NCT00672347|Analgesics|analgesics|mesh-ancestor
110566231|NCT00672347|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110566232|NCT00672347|Sympatholytics|sympatholytics|mesh-ancestor
110566233|NCT00672347|Autonomic Agents|autonomic agents|mesh-ancestor
110566234|NCT00672347|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110566235|NCT00672347|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110566236|NCT00672347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110566237|NCT00672347|Adrenergic Agents|adrenergic agents|mesh-ancestor
110566238|NCT00672347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110566239|NCT00672347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110566240|NCT00676871|Blinatumomab|blinatumomab|mesh-list
110566241|NCT00676871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110566242|NCT00677027|Lentinan|lentinan|mesh-list
110566243|NCT00677027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110566244|NCT00677027|Immunologic Factors|immunologic factors|mesh-ancestor
110566245|NCT00677027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110566246|NCT00677027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110566248|NCT00595127|Fludarabine|fludarabine|mesh-list
110566249|NCT00595127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110566250|NCT00595127|Immunologic Factors|immunologic factors|mesh-ancestor
110566251|NCT00595127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110566252|NCT00595127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110566253|NCT00595127|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110566255|NCT00595127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110566256|NCT00595127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110566257|NCT00595127|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110566258|NCT00672659|Dexetimide|dexetimide|mesh-list
110566259|NCT00672659|Pipamperone|pipamperone|mesh-list
110213774|NCT00244426|Analgesics|analgesics|mesh-ancestor
110566260|NCT00672659|Citalopram|citalopram|mesh-list
110566261|NCT00672659|Escitalopram|escitalopram|mesh-list
110566262|NCT00672659|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110566263|NCT00672659|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110566264|NCT00672659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110566265|NCT00672659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110566266|NCT00672659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110566267|NCT00672659|Serotonin Agents|serotonin agents|mesh-ancestor
110566268|NCT00672659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110566269|NCT00672659|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110566270|NCT00672659|Antidepressive Agents|antidepressive agents|mesh-ancestor
110566271|NCT00672659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110566272|NCT00672659|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110566273|NCT00672659|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110566274|NCT00672659|Parasympatholytics|parasympatholytics|mesh-ancestor
110566275|NCT00672659|Autonomic Agents|autonomic agents|mesh-ancestor
110566276|NCT00672659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110566277|NCT00672659|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110566278|NCT00672659|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110566279|NCT00672659|Cholinergic Agents|cholinergic agents|mesh-ancestor
110566280|NCT00672659|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110566281|NCT00672659|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110566282|NCT00672659|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110566283|NCT00672659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110566284|NCT00877487|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
110566285|NCT00877487|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110566286|NCT00877487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110566287|NCT00877487|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110566288|NCT00877487|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110566289|NCT00877487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110566290|NCT00877487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110566291|NCT00877487|Dopamine Agents|dopamine agents|mesh-ancestor
110566292|NCT00877487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110566293|NCT00677261|Anesthetics|anesthetics|mesh-list
110566294|NCT00677261|Anesthetics, Local|anesthetics, local|mesh-list
110566295|NCT00677261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110566296|NCT00677261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110566297|NCT00677261|Sensory System Agents|sensory system agents|mesh-ancestor
110566298|NCT00677261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110566299|NCT00912119|Aminocaproic Acid|aminocaproic acid|mesh-list
110566300|NCT00912119|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110566301|NCT00912119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110566302|NCT00912119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110566304|NCT00912119|Coagulants|coagulants|mesh-ancestor
110566306|NCT00677339|Ergocalciferols|ergocalciferols|mesh-list
110566307|NCT00677339|Cholecalciferol|cholecalciferol|mesh-list
110566308|NCT00677339|Vitamins|vitamins|mesh-list
110566309|NCT00677339|Micronutrients|micronutrients|mesh-ancestor
110566310|NCT00677339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110566311|NCT00677339|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110566312|NCT00677339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110566313|NCT00672971|Permethrin|permethrin|mesh-list
110566314|NCT00672971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110566315|NCT00672971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110566316|NCT00673205|Bicalutamide|bicalutamide|mesh-list
110566317|NCT00673205|Androgen Antagonists|androgen antagonists|mesh-ancestor
110566318|NCT00673205|Hormone Antagonists|hormone antagonists|mesh-ancestor
110566319|NCT00673205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110190503|NCT00395252|Gemcitabine|gemcitabine|mesh-list
110566320|NCT00673205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110566321|NCT00673205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110566322|NCT00677729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110566323|NCT00677729|Albuterol|albuterol|mesh-list
110566324|NCT00677729|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110566325|NCT00677729|Autonomic Agents|autonomic agents|mesh-ancestor
110566326|NCT00677729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110566327|NCT00677729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110566328|NCT00677729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110566329|NCT00677729|Respiratory System Agents|respiratory system agents|mesh-ancestor
110566330|NCT00677729|Tocolytic Agents|tocolytic agents|mesh-ancestor
110566331|NCT00677729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110566332|NCT00677729|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110213848|NCT00244972|Sorafenib|sorafenib|mesh-list
110566333|NCT00677729|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110566334|NCT00677729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110566335|NCT00677729|Adrenergic Agents|adrenergic agents|mesh-ancestor
110566336|NCT00677729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110566337|NCT00677729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110566338|NCT02628197|Vitamin D|vitamin d|mesh-list
110566339|NCT02628197|Calcium|calcium|mesh-list
110566340|NCT02628197|Vitamins|vitamins|mesh-ancestor
110566341|NCT02628197|Micronutrients|micronutrients|mesh-ancestor
110566342|NCT02628197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110566343|NCT02628197|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110566344|NCT02628197|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110566345|NCT00673829|Interleukin-2|interleukin-2|mesh-list
110566346|NCT00673829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110566347|NCT00673829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110566348|NCT00673829|Analgesics|analgesics|mesh-ancestor
110566349|NCT00673829|Sensory System Agents|sensory system agents|mesh-ancestor
110566350|NCT00673829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110566351|NCT00673829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110566352|NCT04152629|Methylphenidate|methylphenidate|mesh-list
110566353|NCT04152629|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
110566354|NCT04152629|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110566355|NCT04152629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110566356|NCT04152629|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110566357|NCT04152629|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110566358|NCT04152629|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110566359|NCT04152629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110566360|NCT04152629|Dopamine Agents|dopamine agents|mesh-ancestor
110566361|NCT04152629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110566362|NCT02535299|Metformin|metformin|mesh-list
110566363|NCT02535299|Liraglutide|liraglutide|mesh-list
110566364|NCT02535299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110566365|NCT02535299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110566366|NCT02535299|Incretins|incretins|mesh-ancestor
110566367|NCT02535299|Hormones|hormones|mesh-ancestor
110566368|NCT02535299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110566369|NCT00674063|Alefacept|alefacept|mesh-list
110566370|NCT00674063|Dermatologic Agents|dermatologic agents|mesh-ancestor
110566371|NCT00674063|Immunologic Factors|immunologic factors|mesh-ancestor
110566372|NCT00674063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110566373|NCT04151459|Metformin|metformin|mesh-list
110566374|NCT04151459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110566375|NCT04151459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110566376|NCT00674141|Dexamethasone|dexamethasone|mesh-list
110566377|NCT00674141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110566378|NCT00674141|Antiemetics|antiemetics|mesh-ancestor
110566379|NCT00674141|Autonomic Agents|autonomic agents|mesh-ancestor
110566380|NCT00674141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110566381|NCT00674141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110566382|NCT00674141|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110566383|NCT00674141|Glucocorticoids|glucocorticoids|mesh-ancestor
110566384|NCT00674141|Hormones|hormones|mesh-ancestor
110190508|NCT00395252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110566385|NCT00674141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110566386|NCT00674141|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110566387|NCT00674141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110566388|NCT00678275|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110566389|NCT00678275|Immunologic Factors|immunologic factors|mesh-ancestor
110566390|NCT00678275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110566391|NCT00678275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110566392|NCT02627807|Cisplatin|cisplatin|mesh-list
110566393|NCT02627807|Gemcitabine|gemcitabine|mesh-list
110566394|NCT02627807|Docetaxel|docetaxel|mesh-list
110566395|NCT02627807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110566396|NCT02627807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110566397|NCT02627807|Antimetabolites|antimetabolites|mesh-ancestor
110566398|NCT02627807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110566399|NCT02627807|Tubulin Modulators|tubulin modulators|mesh-ancestor
110566400|NCT02627807|Antimitotic Agents|antimitotic agents|mesh-ancestor
110566401|NCT02627807|Mitosis Modulators|mitosis modulators|mesh-ancestor
110566402|NCT00678431|Resveratrol|resveratrol|mesh-list
110566403|NCT00678431|Antioxidants|antioxidants|mesh-ancestor
110566404|NCT00678431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110566405|NCT00678431|Protective Agents|protective agents|mesh-ancestor
110566406|NCT00678431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110566407|NCT00678431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110566408|NCT00678431|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110566409|NCT00678509|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
110566410|NCT00678509|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110566411|NCT00678509|Immunologic Factors|immunologic factors|mesh-ancestor
110566412|NCT00678509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110566413|NCT00674687|Gabapentin|gabapentin|mesh-list
110566414|NCT00674687|Analgesics|analgesics|mesh-ancestor
110566415|NCT00674687|Sensory System Agents|sensory system agents|mesh-ancestor
110566416|NCT00674687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110566417|NCT00674687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110566418|NCT00674687|Anticonvulsants|anticonvulsants|mesh-ancestor
110566419|NCT00674687|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110566420|NCT00674687|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110566421|NCT00674687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110566422|NCT00674687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110566423|NCT00674687|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110566424|NCT00674687|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110566425|NCT00674687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110566426|NCT00674687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110566427|NCT00674687|Antimanic Agents|antimanic agents|mesh-ancestor
110566428|NCT00656747|Amoxicillin|amoxicillin|mesh-list
110566429|NCT00656747|Moxifloxacin|moxifloxacin|mesh-list
110566430|NCT00656747|Clavulanic Acids|clavulanic acids|mesh-list
110566431|NCT00656747|Clavulanic Acid|clavulanic acid|mesh-list
110566432|NCT00656747|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110566433|NCT00656747|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110566434|NCT00656747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110566435|NCT00656747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110566436|NCT00656747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110566437|NCT00656747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110566438|NCT00656747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110566439|NCT00656747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110566440|NCT00656747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110566441|NCT00656747|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110566442|NCT00656747|Contraceptive Agents|contraceptive agents|mesh-ancestor
110566443|NCT00656747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110566444|NCT00656747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110566445|NCT00656747|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110566446|NCT00656747|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110566447|NCT00656747|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110566448|NCT00656747|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110566449|NCT00678743|Simvastatin|simvastatin|mesh-list
110566450|NCT00678743|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110566451|NCT00678743|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110566452|NCT00678743|Antimetabolites|antimetabolites|mesh-ancestor
110566453|NCT00678743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110566454|NCT00678743|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110566455|NCT00678743|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110566456|NCT00678743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110566457|NCT04152317|Misoprostol|misoprostol|mesh-list
110566458|NCT04152317|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110566459|NCT04152317|Abortifacient Agents|abortifacient agents|mesh-ancestor
110566460|NCT04152317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110566461|NCT04152317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110566462|NCT04152317|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110566463|NCT04152317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110566464|NCT04152317|Oxytocics|oxytocics|mesh-ancestor
110566465|NCT02628665|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
110566466|NCT02628665|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
110566467|NCT02628665|Trioxsalen|trioxsalen|mesh-list
110566468|NCT02628665|Photosensitizing Agents|photosensitizing agents|mesh-list
110566469|NCT02628665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110566470|NCT02628665|Dermatologic Agents|dermatologic agents|mesh-ancestor
110566471|NCT00678977|Gemcitabine|gemcitabine|mesh-list
110566472|NCT00678977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110566473|NCT00678977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110566474|NCT00678977|Antimetabolites|antimetabolites|mesh-ancestor
110566475|NCT00678977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110566476|NCT00674921|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110566477|NCT00674921|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110566478|NCT00674921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110566479|NCT00674921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110566480|NCT00674921|Antimalarials|antimalarials|mesh-ancestor
110566481|NCT00674921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110566482|NCT00674921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110566483|NCT00674999|Bacitracin|bacitracin|mesh-list
110566484|NCT00674999|Nystatin|nystatin|mesh-list
110566485|NCT00674999|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110566486|NCT00674999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110566487|NCT00674999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110566488|NCT00674999|Antifungal Agents|antifungal agents|mesh-ancestor
110566489|NCT00674999|Ionophores|ionophores|mesh-ancestor
110566490|NCT00674999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110566491|NCT00674999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110566492|NCT00882713|Epoetin Alfa|epoetin alfa|mesh-list
110566493|NCT00882713|Hematinics|hematinics|mesh-ancestor
110566494|NCT04151381|Aminophylline|aminophylline|mesh-list
110566495|NCT04151381|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110566496|NCT04151381|Autonomic Agents|autonomic agents|mesh-ancestor
110566497|NCT04151381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110566498|NCT04151381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110566499|NCT04151381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110566500|NCT04151381|Respiratory System Agents|respiratory system agents|mesh-ancestor
110566501|NCT04151381|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110566502|NCT04151381|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110566503|NCT04151381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110566504|NCT04151381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110566505|NCT04151381|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110566506|NCT04151381|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110566507|NCT04151381|Purinergic Agents|purinergic agents|mesh-ancestor
110566508|NCT04151381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110566509|NCT04151381|Protective Agents|protective agents|mesh-ancestor
110566510|NCT00809133|Paclitaxel|paclitaxel|mesh-list
110566511|NCT00809133|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110566512|NCT00809133|Bevacizumab|bevacizumab|mesh-list
110566513|NCT00809133|Carboplatin|carboplatin|mesh-list
110566514|NCT00809133|Afatinib|afatinib|mesh-list
110566515|NCT00809133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110566516|NCT00809133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110566517|NCT00809133|Tubulin Modulators|tubulin modulators|mesh-ancestor
110566518|NCT00809133|Antimitotic Agents|antimitotic agents|mesh-ancestor
110566519|NCT00809133|Mitosis Modulators|mitosis modulators|mesh-ancestor
110566520|NCT00809133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110566521|NCT00809133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110566522|NCT00809133|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110566523|NCT00809133|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110566524|NCT00809133|Growth Substances|growth substances|mesh-ancestor
110566525|NCT00809133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110566526|NCT00809133|Growth Inhibitors|growth inhibitors|mesh-ancestor
110566527|NCT00809133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110566528|NCT00809133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110566529|NCT00912275|Vinorelbine|vinorelbine|mesh-list
110566530|NCT00912275|Lapatinib|lapatinib|mesh-list
110566531|NCT00912275|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110566532|NCT00912275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110566533|NCT00912275|Tubulin Modulators|tubulin modulators|mesh-ancestor
110566534|NCT00912275|Antimitotic Agents|antimitotic agents|mesh-ancestor
110566535|NCT00912275|Mitosis Modulators|mitosis modulators|mesh-ancestor
110566536|NCT00912275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110566537|NCT00912275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110566538|NCT00912275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110566540|NCT00882557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110566541|NCT00882557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110566542|NCT02627573|Mycophenolic Acid|mycophenolic acid|mesh-list
110566543|NCT02627573|Cyclophosphamide|cyclophosphamide|mesh-list
110566544|NCT02627573|Busulfan|busulfan|mesh-list
110566545|NCT02627573|Fludarabine|fludarabine|mesh-list
110566546|NCT02627573|Fludarabine phosphate|fludarabine phosphate|mesh-list
110566547|NCT02627573|Tacrolimus|tacrolimus|mesh-list
110566548|NCT02627573|Thymoglobulin|thymoglobulin|mesh-list
110566549|NCT02627573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110566550|NCT02627573|Immunologic Factors|immunologic factors|mesh-ancestor
110566551|NCT02627573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110566552|NCT02627573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110566553|NCT02627573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110566554|NCT02627573|Alkylating Agents|alkylating agents|mesh-ancestor
110566555|NCT02627573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110566556|NCT02627573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110566557|NCT02627573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110566558|NCT02627573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110566559|NCT02627573|Antimetabolites|antimetabolites|mesh-ancestor
110566560|NCT02627573|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110566561|NCT02627573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110566562|NCT02627573|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110566563|NCT02627573|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110566564|NCT02627573|Antitubercular Agents|antitubercular agents|mesh-ancestor
110566565|NCT02627573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110566566|NCT02627573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110566568|NCT00675545|Docetaxel|docetaxel|mesh-list
110566569|NCT00675545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110566570|NCT00675545|Tubulin Modulators|tubulin modulators|mesh-ancestor
110566571|NCT00675545|Antimitotic Agents|antimitotic agents|mesh-ancestor
110566572|NCT00675545|Mitosis Modulators|mitosis modulators|mesh-ancestor
110566573|NCT00675545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110566574|NCT00679523|Tavaborole|tavaborole|mesh-list
110566575|NCT00679523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110566576|NCT00679523|Antifungal Agents|antifungal agents|mesh-ancestor
110566577|NCT00679523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110566578|NCT00675701|Moxifloxacin|moxifloxacin|mesh-list
110566579|NCT00675701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110566580|NCT00675701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110566581|NCT00675701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110566582|NCT00675701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110566583|NCT00675701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110164771|NCT00021307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110566584|NCT00675701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110566585|NCT00675701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110566586|NCT00808899|Cyclophosphamide|cyclophosphamide|mesh-list
110566587|NCT00808899|Doxorubicin|doxorubicin|mesh-list
110566588|NCT00808899|Irinotecan|irinotecan|mesh-list
110566589|NCT00808899|Etoposide|etoposide|mesh-list
110566590|NCT00808899|Topotecan|topotecan|mesh-list
110566591|NCT00808899|Temsirolimus|temsirolimus|mesh-list
110566592|NCT00808899|Tretinoin|tretinoin|mesh-list
110566593|NCT00808899|Isotretinoin|isotretinoin|mesh-list
110566594|NCT00808899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110566595|NCT00808899|Immunologic Factors|immunologic factors|mesh-ancestor
110566596|NCT00808899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110566597|NCT00808899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110566598|NCT00808899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110566599|NCT00808899|Alkylating Agents|alkylating agents|mesh-ancestor
110566600|NCT00808899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110566601|NCT00808899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110566602|NCT00808899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110566603|NCT00808899|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110566604|NCT00808899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110566605|NCT00808899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110566606|NCT00808899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110566607|NCT00808899|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110566608|NCT00808899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110566609|NCT00808899|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110566610|NCT00808899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110566611|NCT00808899|Keratolytic Agents|keratolytic agents|mesh-ancestor
110566612|NCT00808899|Dermatologic Agents|dermatologic agents|mesh-ancestor
110566613|NCT00808665|Dexmedetomidine|dexmedetomidine|mesh-list
110566614|NCT00808665|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110566615|NCT00808665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110566616|NCT00808665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110566617|NCT00808665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110566618|NCT00808665|Analgesics|analgesics|mesh-ancestor
110566619|NCT00808665|Sensory System Agents|sensory system agents|mesh-ancestor
110566620|NCT00808665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110566621|NCT00808665|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110566622|NCT00808665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110566623|NCT00808665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110053295|NCT01485744|Folfirinox|folfirinox|mesh-list
110566624|NCT00808665|Adrenergic Agents|adrenergic agents|mesh-ancestor
110566625|NCT00808665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110566626|NCT00808665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110566628|NCT00808509|Methotrexate|methotrexate|mesh-list
110566629|NCT00808509|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110566630|NCT00808509|Abortifacient Agents|abortifacient agents|mesh-ancestor
110566631|NCT00808509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110566632|NCT00808509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110566633|NCT00808509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110566634|NCT00808509|Antimetabolites|antimetabolites|mesh-ancestor
110566635|NCT00808509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110566636|NCT00808509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110566637|NCT00808509|Dermatologic Agents|dermatologic agents|mesh-ancestor
110566638|NCT00808509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110566639|NCT00808509|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110566640|NCT00808509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110566641|NCT00808509|Immunologic Factors|immunologic factors|mesh-ancestor
110566642|NCT00808509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110566643|NCT00808509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110566644|NCT00808509|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110566645|NCT00808509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110566646|NCT04444869|Cisplatin|cisplatin|mesh-list
110566647|NCT04444869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110566648|NCT04276857|Leucovorin|leucovorin|mesh-list
110566649|NCT04276857|Paclitaxel|paclitaxel|mesh-list
110566650|NCT04276857|Gemcitabine|gemcitabine|mesh-list
110566651|NCT04276857|Oxaliplatin|oxaliplatin|mesh-list
110566653|NCT04276857|Folfirinox|folfirinox|mesh-list
110566654|NCT04276857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110566655|NCT04276857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110566656|NCT04276857|Tubulin Modulators|tubulin modulators|mesh-ancestor
110566657|NCT04276857|Antimitotic Agents|antimitotic agents|mesh-ancestor
110566658|NCT04276857|Mitosis Modulators|mitosis modulators|mesh-ancestor
110566659|NCT04276857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110566660|NCT04276857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110566661|NCT04276857|Antimetabolites|antimetabolites|mesh-ancestor
110566662|NCT04276857|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110566663|NCT04276857|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110566664|NCT04276857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110566665|NCT04276857|Antidotes|antidotes|mesh-ancestor
110566666|NCT04276857|Protective Agents|protective agents|mesh-ancestor
110566667|NCT04276857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110566668|NCT04276857|Vitamin B Complex|vitamin b complex|mesh-ancestor
110566669|NCT04276857|Vitamins|vitamins|mesh-ancestor
110566670|NCT04276857|Micronutrients|micronutrients|mesh-ancestor
110566671|NCT00807573|Paclitaxel|paclitaxel|mesh-list
110566672|NCT00807573|Bevacizumab|bevacizumab|mesh-list
110566673|NCT00807573|Pemetrexed|pemetrexed|mesh-list
110566674|NCT00807573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110566675|NCT00807573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110566676|NCT00807573|Tubulin Modulators|tubulin modulators|mesh-ancestor
110566677|NCT00807573|Antimitotic Agents|antimitotic agents|mesh-ancestor
110566678|NCT00807573|Mitosis Modulators|mitosis modulators|mesh-ancestor
110566679|NCT00807573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110566680|NCT00807573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110566681|NCT00807573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110566682|NCT00807573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110566683|NCT00807573|Growth Substances|growth substances|mesh-ancestor
110566684|NCT00807573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110566685|NCT00807573|Growth Inhibitors|growth inhibitors|mesh-ancestor
110566686|NCT00807573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110566687|NCT00807573|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110566688|NCT00807573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110566689|NCT00842712|Cisplatin|cisplatin|mesh-list
110566690|NCT00842712|Gemcitabine|gemcitabine|mesh-list
110566691|NCT00842712|Cetuximab|cetuximab|mesh-list
110566692|NCT00842712|Vinorelbine|vinorelbine|mesh-list
110566693|NCT00842712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110566694|NCT00842712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110566695|NCT00842712|Antimetabolites|antimetabolites|mesh-ancestor
110566696|NCT00842712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110566697|NCT00842712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110566698|NCT00842712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110566699|NCT00842712|Tubulin Modulators|tubulin modulators|mesh-ancestor
110566700|NCT00842712|Antimitotic Agents|antimitotic agents|mesh-ancestor
110566701|NCT00842712|Mitosis Modulators|mitosis modulators|mesh-ancestor
110566702|NCT00705120|Cyclosporine|cyclosporine|mesh-list
110566703|NCT00705120|Cyclophosphamide|cyclophosphamide|mesh-list
110566704|NCT00705120|Busulfan|busulfan|mesh-list
110566705|NCT00705120|Cyclosporins|cyclosporins|mesh-list
110566706|NCT00705120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110566707|NCT00705120|Immunologic Factors|immunologic factors|mesh-ancestor
110566708|NCT00705120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110566709|NCT00705120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110566710|NCT00705120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110566711|NCT00705120|Alkylating Agents|alkylating agents|mesh-ancestor
110566712|NCT00705120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110566713|NCT00705120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110566714|NCT00705120|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110566715|NCT00705120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110566716|NCT00705120|Antifungal Agents|antifungal agents|mesh-ancestor
110566717|NCT00705120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110566718|NCT00705120|Dermatologic Agents|dermatologic agents|mesh-ancestor
110566719|NCT00705120|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110566720|NCT00842244|Capecitabine|capecitabine|mesh-list
110566721|NCT00842244|Axitinib|axitinib|mesh-list
110566722|NCT00842244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110566723|NCT00842244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110566724|NCT00842244|Antimetabolites|antimetabolites|mesh-ancestor
110566725|NCT00842244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110566726|NCT00842244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110566727|NCT00842244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110566728|NCT00832416|Tramadol|tramadol|mesh-list
110566729|NCT00832416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110566730|NCT00832416|Narcotics|narcotics|mesh-ancestor
110566731|NCT00832416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110566732|NCT00832416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110566733|NCT00832416|Analgesics|analgesics|mesh-ancestor
110566734|NCT00832416|Sensory System Agents|sensory system agents|mesh-ancestor
110566735|NCT00832416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110566736|NCT00705198|Temozolomide|temozolomide|mesh-list
110566737|NCT00705198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110566738|NCT00705198|Alkylating Agents|alkylating agents|mesh-ancestor
110566739|NCT00705198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110566740|NCT00705198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110566741|NCT00702936|Telmisartan|telmisartan|mesh-list
110566742|NCT00702936|Ramipril|ramipril|mesh-list
110566743|NCT00702936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110566744|NCT00702936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110566745|NCT00702936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110566746|NCT00702936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110566747|NCT00702936|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110566748|NCT00702936|Protease Inhibitors|protease inhibitors|mesh-ancestor
110566749|NCT00702936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110566750|NCT00683800|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
110566751|NCT00683800|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110566752|NCT00683800|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110566753|NCT00683800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110566754|NCT00683800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110566755|NCT00683800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110566756|NCT00683800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110566757|NCT00683800|Antidepressive Agents|antidepressive agents|mesh-ancestor
110566758|NCT00683800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110566759|NCT00683644|Zinc|zinc|mesh-list
110566760|NCT00683644|Zinc Sulfate|zinc sulfate|mesh-list
110566761|NCT00683644|Trace Elements|trace elements|mesh-ancestor
110566762|NCT00683644|Micronutrients|micronutrients|mesh-ancestor
110566763|NCT00683644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110566764|NCT00683644|Astringents|astringents|mesh-ancestor
110566765|NCT00683644|Dermatologic Agents|dermatologic agents|mesh-ancestor
110566766|NCT00753064|Prazosin|prazosin|mesh-list
110566767|NCT00753064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110566768|NCT00753064|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110566769|NCT00753064|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110566770|NCT00753064|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110566771|NCT00753064|Adrenergic Agents|adrenergic agents|mesh-ancestor
110566772|NCT00753064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110566773|NCT00753064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110566774|NCT00753064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110566775|NCT00751738|Azimilide|azimilide|mesh-list
110566776|NCT00751738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110566777|NCT00751738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110566778|NCT00751738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110566779|NCT00751738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110566780|NCT00751738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110566781|NCT00751738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110566782|NCT04060264|Eculizumab|eculizumab|mesh-list
110566783|NCT04060264|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110566784|NCT04060264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110566785|NCT04060264|Immunologic Factors|immunologic factors|mesh-ancestor
110566786|NCT04060264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214305|NCT00248131|Octreotide|octreotide|mesh-list
110566787|NCT00684814|Zolpidem|zolpidem|mesh-list
110566788|NCT00684814|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110566789|NCT00684814|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110566790|NCT00684814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110566791|NCT00684814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110566792|NCT00684814|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110566793|NCT00684814|GABA Agonists|gaba agonists|mesh-ancestor
110566794|NCT00684814|GABA Agents|gaba agents|mesh-ancestor
110566795|NCT00684814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110566796|NCT00684814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110566797|NCT00576472|Methylphenidate|methylphenidate|mesh-list
110566798|NCT00576472|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110566799|NCT00576472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110566800|NCT00576472|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110566801|NCT00576472|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110566802|NCT00576472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110566803|NCT00576472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110566804|NCT00576472|Dopamine Agents|dopamine agents|mesh-ancestor
110566805|NCT00576472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110566806|NCT00823212|Aspirin|aspirin|mesh-list
110566807|NCT00823212|Ticlopidine|ticlopidine|mesh-list
110566808|NCT00823212|Clopidogrel|clopidogrel|mesh-list
110566809|NCT00823212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110566810|NCT00823212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110566811|NCT00823212|Analgesics|analgesics|mesh-ancestor
110566812|NCT00823212|Sensory System Agents|sensory system agents|mesh-ancestor
110566813|NCT00823212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110566814|NCT00823212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110566815|NCT00823212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110566816|NCT00823212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110566817|NCT00823212|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110566818|NCT00823212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110566819|NCT00823212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110566820|NCT00823212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110566821|NCT00823212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110566822|NCT00823212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110566823|NCT00823212|Antipyretics|antipyretics|mesh-ancestor
110566824|NCT00823212|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110566825|NCT00823212|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110566826|NCT00823212|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110566827|NCT00823212|Purinergic Agents|purinergic agents|mesh-ancestor
110566828|NCT00823212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110566829|NCT00823212|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110566830|NCT00823212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110566831|NCT02561494|Nefopam|nefopam|mesh-list
110566832|NCT02561494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110566833|NCT02561494|Analgesics|analgesics|mesh-ancestor
110566834|NCT02561494|Sensory System Agents|sensory system agents|mesh-ancestor
110566835|NCT02561494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110566836|NCT02561494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110566837|NCT05958693|Lumefantrine|lumefantrine|mesh-list
110566838|NCT05958693|Artemether|artemether|mesh-list
110566839|NCT05958693|Primaquine|primaquine|mesh-list
110566840|NCT05958693|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110566841|NCT05958693|Antimalarials|antimalarials|mesh-ancestor
110566842|NCT05958693|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110566843|NCT05958693|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110566844|NCT05958693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110566845|NCT05958589|Levobupivacaine|levobupivacaine|mesh-list
110566846|NCT05958589|Anesthetics|anesthetics|mesh-ancestor
110566847|NCT05958589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110566848|NCT05958589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110566849|NCT05958589|Anesthetics, Local|anesthetics, local|mesh-ancestor
110566850|NCT05958589|Sensory System Agents|sensory system agents|mesh-ancestor
110566851|NCT05958589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110566852|NCT05958342|Vasopressins|vasopressins|mesh-list
110566853|NCT05958342|Arginine Vasopressin|arginine vasopressin|mesh-list
110566854|NCT05958342|Calcium|calcium|mesh-list
110566855|NCT05958342|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110566856|NCT05958342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110566857|NCT05958342|Hemostatics|hemostatics|mesh-ancestor
110566858|NCT05958342|Coagulants|coagulants|mesh-ancestor
110566859|NCT05958342|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110566860|NCT05958342|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110566861|NCT05958342|Natriuretic Agents|natriuretic agents|mesh-ancestor
110566862|NCT05958277|Vitamins|vitamins|mesh-list
110566863|NCT05958277|Vitamin B 12|vitamin b 12|mesh-list
110566864|NCT05958277|Niacinamide|niacinamide|mesh-list
110566865|NCT05958277|Vitamin B Complex|vitamin b complex|mesh-list
110566866|NCT05958277|Micronutrients|micronutrients|mesh-ancestor
110566867|NCT05958277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110566868|NCT05958173|Capsaicin|capsaicin|mesh-list
110566869|NCT05958173|Piperine|piperine|mesh-list
110566870|NCT05958173|Antipruritics|antipruritics|mesh-ancestor
110566871|NCT05958173|Dermatologic Agents|dermatologic agents|mesh-ancestor
110566872|NCT05958173|Sensory System Agents|sensory system agents|mesh-ancestor
110566873|NCT05958173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110566874|NCT05958173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110566875|NCT05958173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110566876|NCT05958173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110566877|NCT05958173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110566878|NCT05958160|Topiramate|topiramate|mesh-list
110566879|NCT05958160|Anticonvulsants|anticonvulsants|mesh-ancestor
110566880|NCT05958160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110566881|NCT05958160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110566882|NCT05958069|Minocycline|minocycline|mesh-list
110566883|NCT05958069|Anticonvulsants|anticonvulsants|mesh-list
110566884|NCT05958069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110566885|NCT05958069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110566886|NCT05957991|Metformin|metformin|mesh-list
110566887|NCT05957991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110566888|NCT05957991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110566889|NCT05957978|Paromomycin|paromomycin|mesh-list
110566890|NCT05957978|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
110566891|NCT05957978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110566892|NCT05957978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110566893|NCT05957978|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110566894|NCT05957978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110566895|NCT05957978|Schistosomicides|schistosomicides|mesh-ancestor
110566896|NCT05957978|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110566897|NCT05957978|Anthelmintics|anthelmintics|mesh-ancestor
110566898|NCT05957913|Tenofovir|tenofovir|mesh-list
110566899|NCT05957913|Emtricitabine|emtricitabine|mesh-list
110566900|NCT05957913|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110566901|NCT05957913|Antiviral Agents|antiviral agents|mesh-ancestor
110566902|NCT05957913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110566903|NCT05957913|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110566904|NCT05957913|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110566905|NCT05957913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110566906|NCT05957913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110566907|NCT05957913|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110566908|NCT05957913|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110566909|NCT05957887|Dapagliflozin|dapagliflozin|mesh-list
110566910|NCT05957887|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110566911|NCT05957887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110566912|NCT05957887|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110566913|NCT05957887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110190585|NCT00025064|Prednisolone|prednisolone|mesh-list
110566914|NCT05957822|Tranexamic Acid|tranexamic acid|mesh-list
110566915|NCT05957822|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110566916|NCT05957822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110566917|NCT05957822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110566918|NCT05957822|Hemostatics|hemostatics|mesh-ancestor
110566919|NCT05957822|Coagulants|coagulants|mesh-ancestor
110566920|NCT05957666|Misoprostol|misoprostol|mesh-list
110566921|NCT05957666|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110566922|NCT05957666|Abortifacient Agents|abortifacient agents|mesh-ancestor
110566923|NCT05957666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110566924|NCT05957666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110566925|NCT05957666|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110566926|NCT05957666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110566927|NCT05957666|Oxytocics|oxytocics|mesh-ancestor
110566928|NCT05957653|Lidocaine|lidocaine|mesh-list
110566929|NCT05957653|Sufentanil|sufentanil|mesh-list
110566930|NCT05957653|Anesthetics, Local|anesthetics, local|mesh-ancestor
110566931|NCT05957653|Anesthetics|anesthetics|mesh-ancestor
110566932|NCT05957653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110566933|NCT05957653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110566934|NCT05957653|Sensory System Agents|sensory system agents|mesh-ancestor
110566935|NCT05957653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110566936|NCT05957653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110566937|NCT05957653|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110566938|NCT05957653|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110566939|NCT05957653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110053602|NCT01487382|Insulin Aspart|insulin aspart|mesh-list
110566940|NCT05957653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110566942|NCT05957653|Narcotics|narcotics|mesh-ancestor
110566943|NCT05957653|Analgesics|analgesics|mesh-ancestor
110566944|NCT05957653|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110566945|NCT05957653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110566946|NCT05957653|Anesthetics, General|anesthetics, general|mesh-ancestor
110566947|NCT05957510|Carboplatin|carboplatin|mesh-list
110566948|NCT05957510|Etoposide|etoposide|mesh-list
110566949|NCT05957510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110566950|NCT05957510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110566951|NCT05957510|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110566952|NCT05957510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110566953|NCT05957510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110566954|NCT05957510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110566955|NCT05957432|Amoxicillin|amoxicillin|mesh-list
110566956|NCT05957432|Clarithromycin|clarithromycin|mesh-list
110566957|NCT05957432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110566958|NCT05957432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110566959|NCT05957432|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110566960|NCT05957432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110566961|NCT05957432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110566962|NCT05957432|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110566963|NCT05957432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110566964|NCT05957328|Ascorbic Acid|ascorbic acid|mesh-list
110566965|NCT05957328|Antioxidants|antioxidants|mesh-ancestor
110566966|NCT05957328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110566967|NCT05957328|Protective Agents|protective agents|mesh-ancestor
110566968|NCT05957328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110566969|NCT05957328|Vitamins|vitamins|mesh-ancestor
110566970|NCT05957328|Micronutrients|micronutrients|mesh-ancestor
110566971|NCT05957302|Fentanyl|fentanyl|mesh-list
110566972|NCT05957302|Ketamine|ketamine|mesh-list
110566973|NCT05957302|Analgesics|analgesics|mesh-ancestor
110566974|NCT05957302|Sensory System Agents|sensory system agents|mesh-ancestor
110566975|NCT05957302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110566976|NCT05957302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110566977|NCT05957302|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110566978|NCT05957302|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110566979|NCT05957302|Anesthetics, General|anesthetics, general|mesh-ancestor
110566980|NCT05957302|Anesthetics|anesthetics|mesh-ancestor
110566981|NCT05957302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110566982|NCT05957302|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110566983|NCT05957302|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110190590|NCT00025064|Melphalan|melphalan|mesh-list
110566984|NCT05957302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110566985|NCT05957302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110566986|NCT05957302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110566987|NCT05957302|Narcotics|narcotics|mesh-ancestor
110566988|NCT05957302|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110566989|NCT05957250|FAPI-46|fapi-46|mesh-list
110566990|NCT05957250|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110566991|NCT05957250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110566992|NCT05957211|Cyclosporine|cyclosporine|mesh-list
110566993|NCT05957211|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110566994|NCT05957211|Cyclosporins|cyclosporins|mesh-list
110566995|NCT05957211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110566996|NCT05957211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110566997|NCT05957211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110566998|NCT05957211|Immunologic Factors|immunologic factors|mesh-ancestor
110566999|NCT05957211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110567000|NCT05957211|Antifungal Agents|antifungal agents|mesh-ancestor
110567001|NCT05957211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110567002|NCT05957211|Dermatologic Agents|dermatologic agents|mesh-ancestor
110567003|NCT05957211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110567004|NCT05957211|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110567005|NCT05957211|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110567006|NCT05957094|Citalopram|citalopram|mesh-list
110567007|NCT05957094|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110567008|NCT05957094|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110567009|NCT05957094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110567010|NCT05957094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110567011|NCT05957094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110567012|NCT05957094|Serotonin Agents|serotonin agents|mesh-ancestor
110567013|NCT05957094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110567014|NCT05957094|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110567015|NCT05957094|Antidepressive Agents|antidepressive agents|mesh-ancestor
110567016|NCT05957094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110567017|NCT05957055|Methylphenidate|methylphenidate|mesh-list
110567018|NCT05957055|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
110567019|NCT05957055|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110567020|NCT05957055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110567021|NCT05957055|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110567022|NCT05957055|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110567023|NCT05957055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110567024|NCT05957055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110567025|NCT05957055|Dopamine Agents|dopamine agents|mesh-ancestor
110567026|NCT05957055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110567027|NCT05956899|Ondansetron|ondansetron|mesh-list
110567028|NCT05956899|Palonosetron|palonosetron|mesh-list
110567029|NCT05956899|Antiemetics|antiemetics|mesh-ancestor
110567030|NCT05956899|Autonomic Agents|autonomic agents|mesh-ancestor
110567031|NCT05956899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110567032|NCT05956899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110567033|NCT05956899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110567034|NCT05956899|Antipruritics|antipruritics|mesh-ancestor
110567035|NCT05956899|Dermatologic Agents|dermatologic agents|mesh-ancestor
110567036|NCT05956899|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110567037|NCT05956899|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110567038|NCT05956899|Serotonin Agents|serotonin agents|mesh-ancestor
110567039|NCT05956899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110567040|NCT05956899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110567041|NCT05954104|Calcipotriene|calcipotriene|mesh-list
110567042|NCT05954104|Dermatologic Agents|dermatologic agents|mesh-ancestor
110567043|NCT05951712|Acetylcysteine|acetylcysteine|mesh-list
110567044|NCT05951712|Simethicone|simethicone|mesh-list
110567045|NCT05951712|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110567046|NCT05951712|Antiviral Agents|antiviral agents|mesh-ancestor
110190601|NCT00025064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110567047|NCT05951712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110567048|NCT05951712|Expectorants|expectorants|mesh-ancestor
110567049|NCT05951712|Respiratory System Agents|respiratory system agents|mesh-ancestor
110567050|NCT05951712|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110567051|NCT05951712|Antioxidants|antioxidants|mesh-ancestor
110567052|NCT05951712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110567053|NCT05951712|Protective Agents|protective agents|mesh-ancestor
110567054|NCT05951712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110567055|NCT05951712|Antidotes|antidotes|mesh-ancestor
110567056|NCT05951712|Antifoaming Agents|antifoaming agents|mesh-ancestor
110567057|NCT05951712|Emollients|emollients|mesh-ancestor
110567058|NCT05951712|Dermatologic Agents|dermatologic agents|mesh-ancestor
110567059|NCT05951595|Artesunate|artesunate|mesh-list
110567060|NCT05951595|Lumefantrine|lumefantrine|mesh-list
110567061|NCT05951595|Artemether|artemether|mesh-list
110567062|NCT05951595|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110567063|NCT05951595|Amodiaquine|amodiaquine|mesh-list
110567064|NCT05951595|Antimalarials|antimalarials|mesh-ancestor
110567065|NCT05951595|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110567066|NCT05951595|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110567067|NCT05951595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110567068|NCT05951595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110567069|NCT05951595|Antiviral Agents|antiviral agents|mesh-ancestor
110567070|NCT05951595|Schistosomicides|schistosomicides|mesh-ancestor
110567071|NCT05951595|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110567073|NCT05947448|Nifedipine|nifedipine|mesh-list
110567074|NCT05947448|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
110567075|NCT05947448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110567076|NCT05947448|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110567077|NCT05947448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110567078|NCT05947448|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110567079|NCT05947448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110567080|NCT05947448|Vasodilator Agents|vasodilator agents|mesh-ancestor
110567081|NCT05947448|Tocolytic Agents|tocolytic agents|mesh-ancestor
110567082|NCT05947448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110567083|NCT05947448|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110567084|NCT05947448|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110567086|NCT05941715|Faricimab|faricimab|mesh-list
110567087|NCT05941715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110567088|NCT05941715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110567089|NCT05941715|Growth Substances|growth substances|mesh-ancestor
110567090|NCT05941715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110567091|NCT05941715|Growth Inhibitors|growth inhibitors|mesh-ancestor
110567092|NCT05941715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110567094|NCT05936203|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110567095|NCT05936203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110567096|NCT05929157|Artesunate|artesunate|mesh-list
110567097|NCT05929157|Pyronaridine|pyronaridine|mesh-list
110567098|NCT05929157|Antimalarials|antimalarials|mesh-ancestor
110567099|NCT05929157|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110567100|NCT05929157|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110567101|NCT05929157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110567102|NCT05929157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110567103|NCT05929157|Antiviral Agents|antiviral agents|mesh-ancestor
110567104|NCT05929157|Schistosomicides|schistosomicides|mesh-ancestor
110567105|NCT05929157|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110567106|NCT05929157|Anthelmintics|anthelmintics|mesh-ancestor
110567107|NCT05861167|Ustekinumab|ustekinumab|mesh-list
110567108|NCT05861167|Dermatologic Agents|dermatologic agents|mesh-ancestor
110567109|NCT05828459|Paclitaxel|paclitaxel|mesh-list
110567110|NCT05828459|Bevacizumab|bevacizumab|mesh-list
110567111|NCT05828459|Lenalidomide|lenalidomide|mesh-list
110567112|NCT05828459|Pomalidomide|pomalidomide|mesh-list
110567113|NCT05828459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110567114|NCT05828459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110567115|NCT05828459|Tubulin Modulators|tubulin modulators|mesh-ancestor
110567116|NCT05828459|Antimitotic Agents|antimitotic agents|mesh-ancestor
110567117|NCT05828459|Mitosis Modulators|mitosis modulators|mesh-ancestor
110567118|NCT05828459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110567119|NCT05828459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110567120|NCT05828459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110567121|NCT05828459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110567122|NCT05828459|Growth Substances|growth substances|mesh-ancestor
110567123|NCT05828459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110567124|NCT05828459|Growth Inhibitors|growth inhibitors|mesh-ancestor
110567125|NCT05828459|Immunologic Factors|immunologic factors|mesh-ancestor
110567126|NCT05819619|Ibuprofen|ibuprofen|mesh-list
110567127|NCT05819619|Ondansetron|ondansetron|mesh-list
110567128|NCT05819619|Misoprostol|misoprostol|mesh-list
110567129|NCT05819619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110567130|NCT05819619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110567131|NCT05819619|Analgesics|analgesics|mesh-ancestor
110567132|NCT05819619|Sensory System Agents|sensory system agents|mesh-ancestor
110567133|NCT05819619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110567134|NCT05819619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110567135|NCT05819619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110567136|NCT05819619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110567137|NCT05819619|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110567138|NCT05819619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110567139|NCT05819619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110567140|NCT05819619|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110567141|NCT05819619|Abortifacient Agents|abortifacient agents|mesh-ancestor
110567142|NCT05819619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110567143|NCT05819619|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110567144|NCT05819619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110567145|NCT05819619|Oxytocics|oxytocics|mesh-ancestor
110567146|NCT05819619|Antiemetics|antiemetics|mesh-ancestor
110567147|NCT05819619|Autonomic Agents|autonomic agents|mesh-ancestor
110567148|NCT05819619|Antipruritics|antipruritics|mesh-ancestor
110567149|NCT05819619|Dermatologic Agents|dermatologic agents|mesh-ancestor
110567150|NCT05819619|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110567151|NCT05819619|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110567152|NCT05819619|Serotonin Agents|serotonin agents|mesh-ancestor
110567153|NCT05819619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110567154|NCT05809895|Paclitaxel|paclitaxel|mesh-list
110567155|NCT05809895|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110567156|NCT05809895|Carboplatin|carboplatin|mesh-list
110567157|NCT05809895|Gemcitabine|gemcitabine|mesh-list
110567158|NCT05809895|Pembrolizumab|pembrolizumab|mesh-list
110567159|NCT05809895|Tislelizumab|tislelizumab|mesh-list
110567160|NCT05809895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110567161|NCT05809895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110567162|NCT05809895|Tubulin Modulators|tubulin modulators|mesh-ancestor
110567163|NCT05809895|Antimitotic Agents|antimitotic agents|mesh-ancestor
110567164|NCT05809895|Mitosis Modulators|mitosis modulators|mesh-ancestor
110567165|NCT05809895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110567166|NCT05809895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110567167|NCT05809895|Antimetabolites|antimetabolites|mesh-ancestor
110567168|NCT05809895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110567169|NCT05809895|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110567170|NCT05791097|Paclitaxel|paclitaxel|mesh-list
110567171|NCT05791097|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110567172|NCT05791097|Carboplatin|carboplatin|mesh-list
110567173|NCT05791097|Pembrolizumab|pembrolizumab|mesh-list
110567174|NCT05791097|Pemetrexed|pemetrexed|mesh-list
110567175|NCT05791097|Tislelizumab|tislelizumab|mesh-list
110567176|NCT05791097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110567177|NCT05791097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110567178|NCT05791097|Tubulin Modulators|tubulin modulators|mesh-ancestor
110567179|NCT05791097|Antimitotic Agents|antimitotic agents|mesh-ancestor
110567180|NCT05791097|Mitosis Modulators|mitosis modulators|mesh-ancestor
110567181|NCT05791097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110567182|NCT05791097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110567183|NCT05791097|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110567184|NCT05791097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110567185|NCT05791097|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110567186|NCT05791097|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110567187|NCT05715281|Atezolizumab|atezolizumab|mesh-list
110567188|NCT05715281|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110567189|NCT05715281|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110567190|NCT05715281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110567191|NCT05715281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110567192|NCT05715281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110567193|NCT05715281|Immunologic Factors|immunologic factors|mesh-ancestor
110567194|NCT05715281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110567195|NCT05689021|Prednisone|prednisone|mesh-list
110567196|NCT05689021|Cortisone|cortisone|mesh-list
110567197|NCT05689021|Abiraterone Acetate|abiraterone acetate|mesh-list
110567198|NCT05689021|Niraparib|niraparib|mesh-list
110567199|NCT05689021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110567200|NCT05689021|Glucocorticoids|glucocorticoids|mesh-ancestor
110567201|NCT05689021|Hormones|hormones|mesh-ancestor
110567202|NCT05689021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110567203|NCT05689021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110567204|NCT05689021|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110567205|NCT05689021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110567206|NCT05689021|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110567207|NCT05689021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110567208|NCT05689021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110567209|NCT05689021|Hormone Antagonists|hormone antagonists|mesh-ancestor
110567210|NCT05689021|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110567211|NCT05689021|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110567212|NCT05671081|Magnesium Sulfate|magnesium sulfate|mesh-list
110567213|NCT05671081|Dexmedetomidine|dexmedetomidine|mesh-list
110567214|NCT05671081|Analgesics|analgesics|mesh-list
110567215|NCT05671081|Narcotics|narcotics|mesh-list
110567216|NCT05671081|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110567217|NCT05671081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110567218|NCT05671081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110567219|NCT05671081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110567220|NCT05671081|Sensory System Agents|sensory system agents|mesh-ancestor
110567221|NCT05671081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110567222|NCT05671081|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110567223|NCT05671081|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110567224|NCT05671081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110567225|NCT05671081|Adrenergic Agents|adrenergic agents|mesh-ancestor
110567226|NCT05671081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110567227|NCT05671081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110567228|NCT05671081|Anesthetics|anesthetics|mesh-ancestor
110567229|NCT05671081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110567230|NCT05671081|Anticonvulsants|anticonvulsants|mesh-ancestor
110567231|NCT05671081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110567232|NCT05671081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110567233|NCT05671081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110567234|NCT05671081|Tocolytic Agents|tocolytic agents|mesh-ancestor
110567235|NCT05671081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110567236|NCT05664659|Misoprostol|misoprostol|mesh-list
110567237|NCT05664659|Oxytocin|oxytocin|mesh-list
110567238|NCT05664659|Carbetocin|carbetocin|mesh-list
110567239|NCT05664659|Oxytocics|oxytocics|mesh-ancestor
110567240|NCT05664659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110567241|NCT05664659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110567242|NCT05664659|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110567243|NCT05664659|Abortifacient Agents|abortifacient agents|mesh-ancestor
110567244|NCT05664659|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110567245|NCT05664659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110567247|NCT05647551|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110567248|NCT05647551|Anesthetics, Local|anesthetics, local|mesh-ancestor
110567249|NCT05647551|Anesthetics|anesthetics|mesh-ancestor
110567250|NCT05647551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110567251|NCT05647551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110567252|NCT05647551|Sensory System Agents|sensory system agents|mesh-ancestor
110567253|NCT05647551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110567254|NCT05647551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110567255|NCT05647551|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110567270|NCT05626478|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110567271|NCT05626478|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110567272|NCT05626478|Prednisolone phosphate|prednisolone phosphate|mesh-list
110567273|NCT05626478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110567274|NCT05626478|Antiemetics|antiemetics|mesh-ancestor
110567275|NCT05626478|Autonomic Agents|autonomic agents|mesh-ancestor
110567276|NCT05626478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110567277|NCT05626478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110567278|NCT05626478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110567279|NCT05626478|Glucocorticoids|glucocorticoids|mesh-ancestor
110567280|NCT05626478|Hormones|hormones|mesh-ancestor
110567281|NCT05626478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110567282|NCT05626478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110567283|NCT05626478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110567284|NCT05626478|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110567285|NCT05626478|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110567286|NCT05626478|Protective Agents|protective agents|mesh-ancestor
110567287|NCT05600309|Pembrolizumab|pembrolizumab|mesh-list
110567288|NCT05600309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110567289|NCT05600309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110567290|NCT05600309|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110567291|NCT05600309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110567292|NCT05589597|Nivolumab|nivolumab|mesh-list
110567293|NCT05589597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110567294|NCT05589597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110567295|NCT05589597|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110567296|NCT05589597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110567311|NCT05481645|Paclitaxel|paclitaxel|mesh-list
110567312|NCT05481645|Docetaxel|docetaxel|mesh-list
110567313|NCT05481645|Carboplatin|carboplatin|mesh-list
110567314|NCT05481645|Gemcitabine|gemcitabine|mesh-list
110567315|NCT05481645|Doxorubicin|doxorubicin|mesh-list
110214815|NCT00068861|Metformin|metformin|mesh-list
110567316|NCT05481645|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110567317|NCT05481645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110567318|NCT05481645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110567319|NCT05481645|Tubulin Modulators|tubulin modulators|mesh-ancestor
110567320|NCT05481645|Antimitotic Agents|antimitotic agents|mesh-ancestor
110567321|NCT05481645|Mitosis Modulators|mitosis modulators|mesh-ancestor
110567322|NCT05481645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110567323|NCT05481645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110567324|NCT05481645|Antimetabolites|antimetabolites|mesh-ancestor
110567325|NCT05481645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110567326|NCT05481645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110567327|NCT05481645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110567328|NCT05481645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110567329|NCT05397652|Tranexamic Acid|tranexamic acid|mesh-list
110567330|NCT05397652|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110567331|NCT05397652|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110567332|NCT05397652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110567333|NCT05397652|Hemostatics|hemostatics|mesh-ancestor
110567334|NCT05397652|Coagulants|coagulants|mesh-ancestor
110567335|NCT05397405|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
110567336|NCT05397405|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110567337|NCT05397405|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110567338|NCT05397405|Antimetabolites|antimetabolites|mesh-ancestor
110567339|NCT05397405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110567340|NCT05397405|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110567341|NCT05397405|Protease Inhibitors|protease inhibitors|mesh-ancestor
110567342|NCT05397405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110567343|NCT05397405|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110567344|NCT05371600|Midazolam|midazolam|mesh-list
110567345|NCT05371600|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110567346|NCT05371600|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110567347|NCT05371600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110567348|NCT05371600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110567349|NCT05371600|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110567350|NCT05371600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110567351|NCT05371600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110567352|NCT05371600|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110567353|NCT05371600|Anesthetics, General|anesthetics, general|mesh-ancestor
110567354|NCT05371600|Anesthetics|anesthetics|mesh-ancestor
110567355|NCT05371600|GABA Modulators|gaba modulators|mesh-ancestor
110567356|NCT05371600|GABA Agents|gaba agents|mesh-ancestor
110567357|NCT05371600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110567358|NCT05371600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110567359|NCT05370911|Psilocybin|psilocybin|mesh-list
110567360|NCT05370911|Hallucinogens|hallucinogens|mesh-ancestor
110567361|NCT05370911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110567362|NCT05370911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110567363|NCT05345522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110567364|NCT05345522|Antibodies|antibodies|mesh-list
110567365|NCT05345522|Immunoglobulins|immunoglobulins|mesh-list
110567366|NCT05345522|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110567367|NCT05345522|Immunologic Factors|immunologic factors|mesh-ancestor
110567368|NCT05345522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110567369|NCT05345522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110567370|NCT05342584|Cytarabine|cytarabine|mesh-list
110567371|NCT05342584|Daunorubicin|daunorubicin|mesh-list
110567372|NCT05342584|Venetoclax|venetoclax|mesh-list
110567373|NCT05342584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110567374|NCT05342584|Antimetabolites|antimetabolites|mesh-ancestor
110567375|NCT05342584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110567376|NCT05342584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110567377|NCT05342584|Antiviral Agents|antiviral agents|mesh-ancestor
110567378|NCT05342584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110567379|NCT05342584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110567380|NCT05342584|Immunologic Factors|immunologic factors|mesh-ancestor
110567381|NCT05342584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110567382|NCT05342584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110567383|NCT05342584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110567384|NCT05342584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110567385|NCT05342584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110567386|NCT05340504|Acetylcysteine|acetylcysteine|mesh-list
110190638|NCT00025103|Etoposide|etoposide|mesh-list
110567387|NCT05340504|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110567388|NCT05340504|Antiviral Agents|antiviral agents|mesh-ancestor
110567389|NCT05340504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110567390|NCT05340504|Expectorants|expectorants|mesh-ancestor
110567391|NCT05340504|Respiratory System Agents|respiratory system agents|mesh-ancestor
110567392|NCT05340504|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110567393|NCT05340504|Antioxidants|antioxidants|mesh-ancestor
110567394|NCT05340504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110567395|NCT05340504|Protective Agents|protective agents|mesh-ancestor
110567396|NCT05340504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110567397|NCT05340504|Antidotes|antidotes|mesh-ancestor
110567398|NCT05338658|Pembrolizumab|pembrolizumab|mesh-list
110567399|NCT05338658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110567400|NCT05338658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110567401|NCT05338658|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110567402|NCT05338658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110567403|NCT05333549|Istradefylline|istradefylline|mesh-list
110567404|NCT05333549|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
110567405|NCT05333549|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110567406|NCT05333549|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110567407|NCT05333549|Purinergic Agents|purinergic agents|mesh-ancestor
110567408|NCT05333549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110567409|NCT05333549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110567410|NCT05333549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110567411|NCT05278715|Carboplatin|carboplatin|mesh-list
110567412|NCT05278715|Vincristine|vincristine|mesh-list
110567413|NCT05278715|Endostatins|endostatins|mesh-list
110567414|NCT05278715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110567415|NCT05278715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110567416|NCT05278715|Tubulin Modulators|tubulin modulators|mesh-ancestor
110567417|NCT05278715|Antimitotic Agents|antimitotic agents|mesh-ancestor
110567418|NCT05278715|Mitosis Modulators|mitosis modulators|mesh-ancestor
110567419|NCT05278715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110567420|NCT05278715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110567421|NCT05278715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110567422|NCT05278715|Growth Substances|growth substances|mesh-ancestor
110567423|NCT05278715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110567424|NCT05278715|Growth Inhibitors|growth inhibitors|mesh-ancestor
110567425|NCT05262738|Misoprostol|misoprostol|mesh-list
110567426|NCT05262738|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110567427|NCT05262738|Abortifacient Agents|abortifacient agents|mesh-ancestor
110567428|NCT05262738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110567429|NCT05262738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110567430|NCT05262738|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110567431|NCT05262738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110567432|NCT05262738|Oxytocics|oxytocics|mesh-ancestor
110567434|NCT05256719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110567435|NCT05256719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110567436|NCT05256719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110567437|NCT05256719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110567438|NCT05256719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110567439|NCT05256719|Immunologic Factors|immunologic factors|mesh-ancestor
110567440|NCT05256719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110567441|NCT05256719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110567442|NCT05244226|Fentanyl|fentanyl|mesh-list
110567443|NCT05244226|Methadone|methadone|mesh-list
110567444|NCT05244226|Hydromorphone|hydromorphone|mesh-list
110567445|NCT05244226|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110567446|NCT05244226|Narcotics|narcotics|mesh-ancestor
110567447|NCT05244226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110567448|NCT05244226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110567449|NCT05244226|Analgesics|analgesics|mesh-ancestor
110567450|NCT05244226|Sensory System Agents|sensory system agents|mesh-ancestor
110567451|NCT05244226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110567452|NCT05244226|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110567453|NCT05244226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110567454|NCT05244226|Anesthetics, General|anesthetics, general|mesh-ancestor
110567455|NCT05244226|Anesthetics|anesthetics|mesh-ancestor
110567456|NCT05244226|Antitussive Agents|antitussive agents|mesh-ancestor
110567457|NCT05244226|Respiratory System Agents|respiratory system agents|mesh-ancestor
110567458|NCT05232851|Pembrolizumab|pembrolizumab|mesh-list
110567459|NCT05232851|Vaccines|vaccines|mesh-list
110567460|NCT05232851|Immunologic Factors|immunologic factors|mesh-ancestor
110567461|NCT05232851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110567462|NCT05232851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110567463|NCT05232851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110567464|NCT05232851|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110567465|NCT05232851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110033537|NCT03203876|Nivolumab|nivolumab|mesh-list
110033565|NCT03071601|Lidocaine|lidocaine|mesh-list
110033688|NCT03011775|Diuretics|diuretics|mesh-ancestor
110033728|NCT02879942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110033789|NCT02666794|Narcotics|narcotics|mesh-ancestor
110033852|NCT02539225|Paclitaxel|paclitaxel|mesh-list
110033874|NCT02427581|Poly I-C|poly i-c|mesh-list
110033897|NCT02293109|Leucovorin|leucovorin|mesh-list
110033945|NCT02293109|Antiviral Agents|antiviral agents|mesh-ancestor
110033986|NCT01940809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110034010|NCT01729754|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110034022|NCT01622998|Nicotine|nicotine|mesh-list
110034032|NCT01595620|Dronabinol|dronabinol|mesh-list
110034131|NCT00768820|Risperidone|risperidone|mesh-list
110034213|NCT00066963|Fluorides|fluorides|mesh-list
110034226|NCT01397513|Analgesics|analgesics|mesh-ancestor
110034258|NCT01397994|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110034283|NCT01398046|Lipotropic Agents|lipotropic agents|mesh-ancestor
110034352|NCT01398293|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110034461|NCT01399151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034488|NCT01399450|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110034502|NCT01399463|Paclitaxel|paclitaxel|mesh-list
110034581|NCT01400191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110034591|NCT01400256|Valsartan|valsartan|mesh-list
110034603|NCT01400464|Prednisone|prednisone|mesh-list
110034690|NCT01400789|Insulin Lispro|insulin lispro|mesh-list
110034707|NCT01400867|Vancomycin|vancomycin|mesh-list
110052793|NCT01482104|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
110034748|NCT01401179|Cefazolin|cefazolin|mesh-list
110034893|NCT01402297|Acetovanillone|acetovanillone|mesh-list
110034894|NCT01402297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110035025|NCT01403363|Fentanyl|fentanyl|mesh-list
110035580|NCT01405482|Botulinum Toxins|botulinum toxins|mesh-list
110035685|NCT01406158|Solifenacin Succinate|solifenacin succinate|mesh-list
110035943|NCT01408160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110036125|NCT01409122|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110036181|NCT01409369|Charcoal|charcoal|mesh-list
110042751|NCT01443741|Insulin|insulin|mesh-list
110047774|NCT03222492|Immunotoxins|immunotoxins|mesh-ancestor
110056263|NCT01501890|Progestins|progestins|mesh-ancestor
110057684|NCT01508468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110052898|NCT01482624|Viscosupplements|viscosupplements|mesh-ancestor
110052794|NCT01482104|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110052985|NCT01483638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110052986|NCT01483729|Ritonavir|ritonavir|mesh-list
110052987|NCT01483729|Lactams|lactams|mesh-list
110054806|NCT01494363|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110052988|NCT01483729|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110052989|NCT01483729|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110052990|NCT01483729|Protease Inhibitors|protease inhibitors|mesh-ancestor
110052991|NCT01483729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110052992|NCT01483729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110052994|NCT01483729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110052995|NCT01483729|Antiviral Agents|antiviral agents|mesh-ancestor
110052996|NCT01483729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110052997|NCT01483729|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110052998|NCT01483729|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110052999|NCT01483729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110053000|NCT01483781|Canagliflozin|canagliflozin|mesh-list
110036333|NCT01410630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110053006|NCT01483859|Hematinics|hematinics|mesh-ancestor
110369330|NCT01998035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110369332|NCT01998035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110369333|NCT01998035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110369334|NCT01998035|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110369336|NCT04611243|Immunologic Factors|immunologic factors|mesh-ancestor
110369337|NCT04611243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369338|NCT00564057|Candesartan|candesartan|mesh-list
110369339|NCT00564057|Candesartan cilexetil|candesartan cilexetil|mesh-list
110369340|NCT00564057|Lercanidipine|lercanidipine|mesh-list
110369341|NCT00564057|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110369342|NCT00564057|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110369343|NCT00564057|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110369344|NCT00564057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110369345|NCT00564057|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110369346|NCT00564057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110369347|NCT00564057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110369348|NCT00564057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369349|NCT04610541|Remdesivir|remdesivir|mesh-list
110369350|NCT04610541|Antimetabolites|antimetabolites|mesh-ancestor
110369351|NCT04610541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110369352|NCT04610541|Antiviral Agents|antiviral agents|mesh-ancestor
110369353|NCT04610541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110369354|NCT04677335|Lovastatin|lovastatin|mesh-list
110369355|NCT04677335|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110369356|NCT04677335|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110369357|NCT04677335|Antimetabolites|antimetabolites|mesh-ancestor
110369358|NCT04677335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110369359|NCT04677335|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110369360|NCT04677335|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110369361|NCT04677335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110369363|NCT04630548|Trace Elements|trace elements|mesh-ancestor
110369364|NCT04630548|Micronutrients|micronutrients|mesh-ancestor
110369365|NCT04630548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369366|NCT01975610|Spebrutinib|spebrutinib|mesh-list
110369367|NCT01975610|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110369368|NCT01975610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110369369|NCT01975610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110369370|NCT01969838|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
110369371|NCT01969838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110369372|NCT01969838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110369373|NCT01969838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110369375|NCT01967810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110369376|NCT01967810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110369377|NCT01967810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110369378|NCT01967810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110369379|NCT01967810|Growth Substances|growth substances|mesh-ancestor
110369380|NCT01967810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369381|NCT01967810|Growth Inhibitors|growth inhibitors|mesh-ancestor
110369382|NCT01165138|Fluticasone|fluticasone|mesh-list
110369383|NCT01165138|Xhance|xhance|mesh-list
110369384|NCT01165138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110369386|NCT01165138|Autonomic Agents|autonomic agents|mesh-ancestor
110369387|NCT01165138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110369388|NCT01165138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369389|NCT01165138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110369390|NCT01165138|Respiratory System Agents|respiratory system agents|mesh-ancestor
110369391|NCT01165138|Dermatologic Agents|dermatologic agents|mesh-ancestor
110369392|NCT01165138|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110369394|NCT00561054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110369395|NCT00561054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110369396|NCT04206358|Molgramostim|molgramostim|mesh-list
110369397|NCT04206358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110369398|NCT00561093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110369399|NCT00561093|Pentoxifylline|pentoxifylline|mesh-list
110369400|NCT00561093|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110369401|NCT00561093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110369402|NCT00561093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110369403|NCT00561093|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110369404|NCT00561093|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110369405|NCT00561093|Protective Agents|protective agents|mesh-ancestor
110369406|NCT00561093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369407|NCT00561093|Vasodilator Agents|vasodilator agents|mesh-ancestor
110369408|NCT00561093|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110369409|NCT00561093|Antioxidants|antioxidants|mesh-ancestor
110369410|NCT01960010|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110369411|NCT01960010|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110369412|NCT01165021|Folic Acid|folic acid|mesh-list
110369413|NCT01165021|Vitamin B 12|vitamin b 12|mesh-list
110369414|NCT01165021|Dexamethasone|dexamethasone|mesh-list
110369415|NCT01165021|Pemetrexed|pemetrexed|mesh-list
110369416|NCT01165021|Vitamins|vitamins|mesh-ancestor
110369417|NCT01165021|Micronutrients|micronutrients|mesh-ancestor
110369418|NCT01165021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369420|NCT01165021|Antiemetics|antiemetics|mesh-ancestor
110369421|NCT01165021|Autonomic Agents|autonomic agents|mesh-ancestor
110369422|NCT01165021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110369423|NCT01165021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110369424|NCT01165021|Glucocorticoids|glucocorticoids|mesh-ancestor
110369425|NCT01165021|Hormones|hormones|mesh-ancestor
110369426|NCT01165021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110369427|NCT01165021|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110369428|NCT01165021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110369430|NCT01165021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110369432|NCT01165021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110369433|NCT01165021|Hematinics|hematinics|mesh-ancestor
110369434|NCT01165021|Vitamin B Complex|vitamin b complex|mesh-ancestor
110369435|NCT00561132|Vanadyl sulfate|vanadyl sulfate|mesh-list
110369436|NCT00561132|Magnesium Oxide|magnesium oxide|mesh-list
110369437|NCT00561132|Antacids|antacids|mesh-ancestor
110369438|NCT00561132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110369439|NCT00561132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110369440|NCT00561132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110369441|NCT00561132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369442|NCT01956812|Gemcitabine|gemcitabine|mesh-list
110369443|NCT01956812|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110369444|NCT01956812|Antimetabolites|antimetabolites|mesh-ancestor
110369445|NCT01956812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110369446|NCT01956812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110369447|NCT01952990|Phenylephrine|phenylephrine|mesh-list
110369448|NCT01952990|Oxymetazoline|oxymetazoline|mesh-list
110369449|NCT01952990|Tetracaine|tetracaine|mesh-list
110369450|NCT01952990|Anesthetics, Local|anesthetics, local|mesh-ancestor
110369451|NCT01952990|Anesthetics|anesthetics|mesh-ancestor
110369452|NCT01952990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110369453|NCT01952990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369454|NCT01952990|Sensory System Agents|sensory system agents|mesh-ancestor
110369455|NCT01952990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110369456|NCT01952990|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110369457|NCT01952990|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110369458|NCT01952990|Adrenergic Agents|adrenergic agents|mesh-ancestor
110369459|NCT01952990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110369460|NCT01952990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110369461|NCT01952990|Sympathomimetics|sympathomimetics|mesh-ancestor
110369462|NCT01952990|Autonomic Agents|autonomic agents|mesh-ancestor
110369463|NCT01952990|Nasal Decongestants|nasal decongestants|mesh-ancestor
110369464|NCT01952990|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110369465|NCT01952990|Respiratory System Agents|respiratory system agents|mesh-ancestor
110369466|NCT01952990|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110369467|NCT01952990|Mydriatics|mydriatics|mesh-ancestor
110369468|NCT01952990|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110369469|NCT01952990|Protective Agents|protective agents|mesh-ancestor
110369470|NCT04314310|Tenoxicam|tenoxicam|mesh-list
110369471|NCT04314310|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110369472|NCT04314310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110369473|NCT04314310|Analgesics|analgesics|mesh-ancestor
110369474|NCT04314310|Sensory System Agents|sensory system agents|mesh-ancestor
110369475|NCT04314310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110369476|NCT04314310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369477|NCT04314310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110369478|NCT04314310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110369479|NCT04314310|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110369480|NCT04314310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110369481|NCT04314310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110369482|NCT04610307|Anesthetics|anesthetics|mesh-list
110369483|NCT04610307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110369484|NCT04610307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369485|NCT04610502|Immunoglobulins|immunoglobulins|mesh-list
110369486|NCT04610502|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110369487|NCT04610502|Antibodies|antibodies|mesh-list
110369488|NCT04610502|Immunologic Factors|immunologic factors|mesh-ancestor
110369489|NCT04610502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369490|NCT01164475|Plerixafor|plerixafor|mesh-list
110369491|NCT01164475|Lenograstim|lenograstim|mesh-list
110369492|NCT01164475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110369493|NCT01164475|Immunologic Factors|immunologic factors|mesh-ancestor
110369494|NCT01164475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369495|NCT01164475|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110369496|NCT01164475|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110369497|NCT01164475|Antiviral Agents|antiviral agents|mesh-ancestor
110369498|NCT01164475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110369499|NCT01164007|Bevacizumab|bevacizumab|mesh-list
110369500|NCT01164007|Dacarbazine|dacarbazine|mesh-list
110369501|NCT01164007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110369502|NCT01164007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110369503|NCT01164007|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110369504|NCT01164007|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110369505|NCT01164007|Growth Substances|growth substances|mesh-ancestor
110369506|NCT01164007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369507|NCT01164007|Growth Inhibitors|growth inhibitors|mesh-ancestor
110369508|NCT01164007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110369509|NCT01164007|Alkylating Agents|alkylating agents|mesh-ancestor
110369510|NCT01164007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110369511|NCT01941836|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
110369513|NCT01941836|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110369514|NCT01941836|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110369516|NCT01941836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110369517|NCT01941836|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110369518|NCT01941836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110369519|NCT01941836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110369520|NCT01941836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369521|NCT04629885|Oxytocin|oxytocin|mesh-list
110369522|NCT04629885|Oxytocics|oxytocics|mesh-ancestor
110369523|NCT04629885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110369524|NCT04629885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369525|NCT01163851|Bococizumab|bococizumab|mesh-list
110369526|NCT01163851|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110369527|NCT01163851|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110369528|NCT01163851|Antimetabolites|antimetabolites|mesh-ancestor
110369529|NCT01163851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110369530|NCT01163851|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110369531|NCT01917383|Timolol|timolol|mesh-list
110369532|NCT01917383|Latanoprost|latanoprost|mesh-list
110369533|NCT01917383|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110369534|NCT01917383|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110369535|NCT01917383|Adrenergic Agents|adrenergic agents|mesh-ancestor
110369536|NCT01917383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110369537|NCT01917383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110369538|NCT01917383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369539|NCT01917383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110369540|NCT01917383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110369541|NCT01917383|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110369542|NCT01917383|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110369543|NCT01163617|Adalimumab|adalimumab|mesh-list
110369544|NCT01163617|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110369545|NCT01163617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110369546|NCT01163617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110369547|NCT01911767|Dimethyl Fumarate|dimethyl fumarate|mesh-list
110369548|NCT01911767|Dermatologic Agents|dermatologic agents|mesh-ancestor
110369549|NCT01911767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110369550|NCT01911767|Immunologic Factors|immunologic factors|mesh-ancestor
110369551|NCT01911767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369552|NCT04629846|Docetaxel|docetaxel|mesh-list
110369553|NCT04629846|Trastuzumab|trastuzumab|mesh-list
110369554|NCT04629846|Pertuzumab|pertuzumab|mesh-list
110369555|NCT04629846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110369556|NCT04629846|Tubulin Modulators|tubulin modulators|mesh-ancestor
110369557|NCT04629846|Antimitotic Agents|antimitotic agents|mesh-ancestor
110369558|NCT04629846|Mitosis Modulators|mitosis modulators|mesh-ancestor
110369560|NCT04629846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110369562|NCT01909427|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110369563|NCT01909427|Abortifacient Agents|abortifacient agents|mesh-ancestor
110369564|NCT01909427|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110369565|NCT01909427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369566|NCT01909427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110369567|NCT01909427|Antimetabolites|antimetabolites|mesh-ancestor
110369568|NCT01909427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110369569|NCT01909427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110369570|NCT01909427|Dermatologic Agents|dermatologic agents|mesh-ancestor
110369571|NCT01909427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110369572|NCT01909427|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110369573|NCT01909427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110369574|NCT01909427|Immunologic Factors|immunologic factors|mesh-ancestor
110369575|NCT01909427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110369576|NCT01909427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110369577|NCT04629573|Anesthetics|anesthetics|mesh-list
110369578|NCT04629573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110369579|NCT04629573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369580|NCT00564174|Aspirin|aspirin|mesh-list
110369581|NCT00564174|Heparin|heparin|mesh-list
110369582|NCT00564174|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110369583|NCT00564174|Tinzaparin|tinzaparin|mesh-list
110369584|NCT00564174|Dalteparin|dalteparin|mesh-list
110369585|NCT00564174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110369586|NCT00564174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110369587|NCT00564174|Analgesics|analgesics|mesh-ancestor
110369588|NCT00564174|Sensory System Agents|sensory system agents|mesh-ancestor
110369589|NCT00564174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110369590|NCT00564174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369591|NCT00564174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110369592|NCT00564174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110369593|NCT00564174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110369594|NCT00564174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110369595|NCT00564174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110369596|NCT00564174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110369597|NCT00564174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110369598|NCT00564174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110369599|NCT00564174|Antipyretics|antipyretics|mesh-ancestor
110369600|NCT00564174|Anticoagulants|anticoagulants|mesh-ancestor
110369601|NCT01163266|Vortioxetine|vortioxetine|mesh-list
110369602|NCT01163266|Antidepressive Agents|antidepressive agents|mesh-ancestor
110369603|NCT01163266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110369604|NCT01163266|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110369605|NCT01163266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110369606|NCT01163266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110369607|NCT01163266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369608|NCT01163266|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110369609|NCT01163266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110369610|NCT01163266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110369611|NCT01163266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110369612|NCT01163266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110369613|NCT01163266|Serotonin Agents|serotonin agents|mesh-ancestor
110369614|NCT01163266|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110369615|NCT01163266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110369616|NCT01163266|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110369617|NCT01163266|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110369621|NCT01873703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110369622|NCT01873703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110369623|NCT01873703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110369624|NCT01870505|Letrozole|letrozole|mesh-list
110369625|NCT01870505|Exemestane|exemestane|mesh-list
110369626|NCT01870505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110369627|NCT01870505|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110369628|NCT01870505|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110369629|NCT01870505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110369630|NCT01870505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110369631|NCT01870505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110369632|NCT01870505|Hormone Antagonists|hormone antagonists|mesh-ancestor
110369633|NCT01870505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110369634|NCT01870505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369635|NCT04629612|Anesthetics|anesthetics|mesh-list
110369636|NCT04629612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110369637|NCT04629612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369638|NCT00564213|Mitomycins|mitomycins|mesh-list
110369639|NCT00564213|Mitomycin|mitomycin|mesh-list
110369640|NCT00564213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110369641|NCT00564213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110369642|NCT00564213|Alkylating Agents|alkylating agents|mesh-ancestor
110369643|NCT00564213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110369644|NCT00564213|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110369645|NCT00564213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110369646|NCT01861847|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
110369647|NCT01861847|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110369648|NCT01861847|Immunologic Factors|immunologic factors|mesh-ancestor
110369649|NCT01861847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369650|NCT00564252|Finasteride|finasteride|mesh-list
110369651|NCT00564252|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110369652|NCT00564252|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110369653|NCT00564252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110369654|NCT00564252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110369655|NCT00564252|Hormone Antagonists|hormone antagonists|mesh-ancestor
110369656|NCT00564252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110369657|NCT00564252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369658|NCT00564252|Urological Agents|urological agents|mesh-ancestor
110369659|NCT04629144|Belimumab|belimumab|mesh-list
110369660|NCT04629144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110369661|NCT04629144|Immunologic Factors|immunologic factors|mesh-ancestor
110369662|NCT04629144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369663|NCT04609488|Pulmonary Surfactants|pulmonary surfactants|mesh-list
110369664|NCT04609488|Respiratory System Agents|respiratory system agents|mesh-ancestor
110369666|NCT01847573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110369667|NCT01847573|Coccidiostats|coccidiostats|mesh-ancestor
110369668|NCT01847573|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110369669|NCT01847573|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110369670|NCT01847573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110369671|NCT01847573|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110369674|NCT01847573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110369675|NCT01847573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110369676|NCT01847573|Growth Substances|growth substances|mesh-ancestor
110369677|NCT01847573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369678|NCT01847573|Growth Inhibitors|growth inhibitors|mesh-ancestor
110369679|NCT04609254|Acetaminophen|acetaminophen|mesh-list
110369680|NCT04609254|Ibuprofen|ibuprofen|mesh-list
110369681|NCT04609254|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
110369682|NCT04609254|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110369683|NCT04609254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110369684|NCT04609254|Analgesics|analgesics|mesh-ancestor
110369685|NCT04609254|Sensory System Agents|sensory system agents|mesh-ancestor
110369686|NCT04609254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110369687|NCT04609254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369688|NCT04609254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110369689|NCT04609254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110369690|NCT04609254|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110369691|NCT04609254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110369692|NCT04609254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110369694|NCT01846481|Cocaine|cocaine|mesh-list
110369695|NCT01846481|Anesthetics, Local|anesthetics, local|mesh-ancestor
110369696|NCT01846481|Anesthetics|anesthetics|mesh-ancestor
110369697|NCT01846481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110369698|NCT01846481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369699|NCT01846481|Sensory System Agents|sensory system agents|mesh-ancestor
110369700|NCT01846481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110369701|NCT01846481|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110369702|NCT01846481|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110369703|NCT01846481|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110369704|NCT01846481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110369705|NCT01846481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110369706|NCT01846481|Dopamine Agents|dopamine agents|mesh-ancestor
110369707|NCT01846481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110369709|NCT04609293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110369710|NCT04609293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110369711|NCT04609293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110369712|NCT04609293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110369715|NCT04676789|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110369716|NCT04676789|Immunologic Factors|immunologic factors|mesh-ancestor
110369717|NCT04676789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369719|NCT01811576|Hormones|hormones|mesh-list
110369720|NCT01811576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110369721|NCT01811576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369722|NCT01811498|Bevacizumab|bevacizumab|mesh-list
110369723|NCT01811498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110369724|NCT01811498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110369725|NCT01811498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110369726|NCT01811498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110369727|NCT01811498|Growth Substances|growth substances|mesh-ancestor
110369728|NCT01811498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369729|NCT01811498|Growth Inhibitors|growth inhibitors|mesh-ancestor
110369730|NCT01804829|Immunoglobulins|immunoglobulins|mesh-list
110369731|NCT01804829|Antibodies|antibodies|mesh-list
110369732|NCT01804829|gamma-Globulins|gamma-globulins|mesh-list
110369734|NCT01804829|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110369736|NCT01804829|Immunologic Factors|immunologic factors|mesh-ancestor
110369737|NCT01804829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369738|NCT00565422|Escitalopram|escitalopram|mesh-list
110369739|NCT00565422|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110369740|NCT00565422|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110369741|NCT00565422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110369742|NCT00565422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110369743|NCT00565422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110369744|NCT00565422|Serotonin Agents|serotonin agents|mesh-ancestor
110369745|NCT00565422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369746|NCT01802723|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110369747|NCT01802723|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110369748|NCT01802723|Autonomic Agents|autonomic agents|mesh-ancestor
110369749|NCT01802723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110369750|NCT01802723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369751|NCT01802723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110369752|NCT01802723|Respiratory System Agents|respiratory system agents|mesh-ancestor
110369753|NCT01802723|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110369754|NCT01802723|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110369755|NCT01802723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110369756|NCT01802723|Adrenergic Agents|adrenergic agents|mesh-ancestor
110369757|NCT01802723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110369758|NCT01802723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110369759|NCT01789736|Travoprost|travoprost|mesh-list
110369760|NCT01789736|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110369761|NCT01789736|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110369762|NCT01789736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110369763|NCT00564330|Esomeprazole|esomeprazole|mesh-list
110369764|NCT00564330|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110369765|NCT00564330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110369766|NCT00564330|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110369768|NCT00564330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110369769|NCT01780844|Mycophenolic Acid|mycophenolic acid|mesh-list
110369770|NCT01780844|Prednisone|prednisone|mesh-list
110369771|NCT01780844|Tacrolimus|tacrolimus|mesh-list
110369772|NCT01780844|Basiliximab|basiliximab|mesh-list
110369773|NCT01780844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110369774|NCT01780844|Glucocorticoids|glucocorticoids|mesh-ancestor
110369775|NCT01780844|Hormones|hormones|mesh-ancestor
110369776|NCT01780844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110369777|NCT01780844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369778|NCT01780844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110369779|NCT01780844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110369780|NCT01780844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110369781|NCT01780844|Immunologic Factors|immunologic factors|mesh-ancestor
110369782|NCT01780844|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110369783|NCT01780844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110369784|NCT01780844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110369785|NCT01780844|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110369786|NCT01780844|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110369787|NCT01780844|Antitubercular Agents|antitubercular agents|mesh-ancestor
110369788|NCT01780844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110369789|NCT01780844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110369790|NCT01779947|Estradiol|estradiol|mesh-list
110369791|NCT01779947|Estrogens|estrogens|mesh-ancestor
110369792|NCT01779947|Hormones|hormones|mesh-ancestor
110369793|NCT01779947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110369794|NCT01779947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369795|NCT00564408|Carbachol|carbachol|mesh-list
110369796|NCT00564408|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110369797|NCT00564408|Miotics|miotics|mesh-ancestor
110369798|NCT00564408|Autonomic Agents|autonomic agents|mesh-ancestor
110369799|NCT00564408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110369800|NCT00564408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369801|NCT00564408|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110369802|NCT00564408|Cholinergic Agents|cholinergic agents|mesh-ancestor
110369803|NCT00564408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110369804|NCT00564408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110369805|NCT00564408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110369807|NCT00564408|Sensory System Agents|sensory system agents|mesh-ancestor
110369808|NCT00564408|Protective Agents|protective agents|mesh-ancestor
110369810|NCT01773785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110369811|NCT01773785|Tubulin Modulators|tubulin modulators|mesh-ancestor
110369812|NCT01773785|Antimitotic Agents|antimitotic agents|mesh-ancestor
110369813|NCT01773785|Mitosis Modulators|mitosis modulators|mesh-ancestor
110369814|NCT01773785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110369815|NCT01758458|Interferons|interferons|mesh-list
110369816|NCT01758458|Aldesleukin|aldesleukin|mesh-list
110369817|NCT01758458|Interferon-beta|interferon-beta|mesh-list
110369818|NCT01758458|Interleukin-2|interleukin-2|mesh-list
110369819|NCT01758458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110369820|NCT01758458|Antiviral Agents|antiviral agents|mesh-ancestor
110369821|NCT01758458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110369822|NCT01758458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110369823|NCT01758458|Analgesics|analgesics|mesh-ancestor
110369824|NCT01758458|Sensory System Agents|sensory system agents|mesh-ancestor
110369825|NCT01758458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110369826|NCT01758458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369827|NCT01758458|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110369828|NCT01758458|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110369829|NCT01758458|Immunologic Factors|immunologic factors|mesh-ancestor
110369830|NCT04608981|Prednisolone|prednisolone|mesh-list
110369832|NCT04608981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110369834|NCT04608981|Hormones|hormones|mesh-ancestor
110369835|NCT04608981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110369836|NCT04608981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369837|NCT04608981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110369838|NCT04608981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110369839|NCT04608981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110369840|NCT04608981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110369841|NCT04608981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110369842|NCT04608981|Analgesics|analgesics|mesh-ancestor
110369843|NCT04608981|Sensory System Agents|sensory system agents|mesh-ancestor
110369844|NCT04608981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110369845|NCT04608981|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110369846|NCT04608981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110369847|NCT04608981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110369849|NCT01737905|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110369850|NCT01737905|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110369851|NCT01737905|Adrenergic Agents|adrenergic agents|mesh-ancestor
110369852|NCT01737905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110369853|NCT01737905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110369854|NCT01737905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369855|NCT01737905|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110369856|NCT01737905|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110369857|NCT01737905|Autonomic Agents|autonomic agents|mesh-ancestor
110369858|NCT01737905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110369859|NCT01737905|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110369860|NCT01737905|Respiratory System Agents|respiratory system agents|mesh-ancestor
110369861|NCT01737905|Mydriatics|mydriatics|mesh-ancestor
110369862|NCT01737905|Sympathomimetics|sympathomimetics|mesh-ancestor
110369863|NCT01737905|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110369864|NCT01730027|Montelukast|montelukast|mesh-list
110369865|NCT01730027|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110369866|NCT01730027|Respiratory System Agents|respiratory system agents|mesh-ancestor
110369867|NCT01730027|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110369868|NCT01730027|Hormone Antagonists|hormone antagonists|mesh-ancestor
110369869|NCT01730027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110369870|NCT01730027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369871|NCT01730027|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110369872|NCT01730027|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110369873|NCT01730027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110369875|NCT04608669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110369876|NCT04608669|Analgesics|analgesics|mesh-ancestor
110369877|NCT04608669|Sensory System Agents|sensory system agents|mesh-ancestor
110369878|NCT04608669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110369879|NCT04608669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369880|NCT04608669|Antipyretics|antipyretics|mesh-ancestor
110369881|NCT00555230|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110369882|NCT00555230|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110369883|NCT00555230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110369884|NCT00555230|Antimetabolites|antimetabolites|mesh-ancestor
110369885|NCT00555230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110369886|NCT00555230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110369887|NCT00555230|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110369888|NCT00555230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110369890|NCT04600089|Analgesics|analgesics|mesh-ancestor
110369891|NCT04600089|Sensory System Agents|sensory system agents|mesh-ancestor
110369892|NCT04600089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110369893|NCT04600089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369894|NCT04600089|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110369895|NCT04600089|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110369896|NCT04600089|Anesthetics, General|anesthetics, general|mesh-ancestor
110369897|NCT04600089|Anesthetics|anesthetics|mesh-ancestor
110369898|NCT04600089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110369899|NCT04600089|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110369900|NCT04600089|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110369901|NCT04600089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110369902|NCT04600089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110369903|NCT01704365|Vaccines|vaccines|mesh-list
110369904|NCT01704365|Immunologic Factors|immunologic factors|mesh-ancestor
110369905|NCT01704365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369906|NCT01698281|Dexamethasone|dexamethasone|mesh-list
110369907|NCT01698281|Doxorubicin|doxorubicin|mesh-list
110369908|NCT01698281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110369909|NCT01698281|Antiemetics|antiemetics|mesh-ancestor
110369910|NCT01698281|Autonomic Agents|autonomic agents|mesh-ancestor
110369911|NCT01698281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110369912|NCT01698281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369913|NCT01698281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110369914|NCT01698281|Glucocorticoids|glucocorticoids|mesh-ancestor
110369915|NCT01698281|Hormones|hormones|mesh-ancestor
110369916|NCT01698281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110369917|NCT01698281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110369918|NCT01698281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110369919|NCT01698281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110369920|NCT01698281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110369921|NCT01698281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110369922|NCT01698281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110369923|NCT01698281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110369925|NCT00565461|Immunologic Factors|immunologic factors|mesh-ancestor
110369926|NCT00565461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369928|NCT01858883|Gemcitabine|gemcitabine|mesh-list
110369929|NCT01858883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110369930|NCT01858883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110369931|NCT01858883|Tubulin Modulators|tubulin modulators|mesh-ancestor
110369932|NCT01858883|Antimitotic Agents|antimitotic agents|mesh-ancestor
110369933|NCT01858883|Mitosis Modulators|mitosis modulators|mesh-ancestor
110369934|NCT01858883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110369935|NCT01858883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110369937|NCT01697072|Cisplatin|cisplatin|mesh-list
110369938|NCT01697072|Capecitabine|capecitabine|mesh-list
110369939|NCT01697072|Epirubicin|epirubicin|mesh-list
110369940|NCT01697072|Rilotumumab|rilotumumab|mesh-list
110369941|NCT01697072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110369942|NCT01697072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110369943|NCT01697072|Antimetabolites|antimetabolites|mesh-ancestor
110369944|NCT01697072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110369945|NCT01697072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110369946|NCT01697072|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110369947|NCT01697072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110369948|NCT01697072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110369949|NCT01697072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110369950|NCT00565500|Ibuprofen|ibuprofen|mesh-list
110369951|NCT00565500|Celecoxib|celecoxib|mesh-list
110369952|NCT00565500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110369953|NCT00565500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110369954|NCT00565500|Analgesics|analgesics|mesh-ancestor
110369955|NCT00565500|Sensory System Agents|sensory system agents|mesh-ancestor
110369956|NCT00565500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110369957|NCT00565500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369958|NCT00565500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110369959|NCT00565500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110369960|NCT00565500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110369961|NCT00565500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110369962|NCT00565500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110369963|NCT00565500|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110369964|NCT04608084|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110369965|NCT04608084|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110369966|NCT01691846|Metformin|metformin|mesh-list
110369967|NCT01691846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110369968|NCT01691846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369969|NCT01658501|Metformin|metformin|mesh-list
110369970|NCT01658501|Liraglutide|liraglutide|mesh-list
110369971|NCT01658501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110369972|NCT01658501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369973|NCT01658501|Incretins|incretins|mesh-ancestor
110369974|NCT01658501|Hormones|hormones|mesh-ancestor
110369975|NCT01658501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110369976|NCT01651871|Cetirizine|cetirizine|mesh-list
110369977|NCT01651871|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110369978|NCT01651871|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110369979|NCT01651871|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110369980|NCT01651871|Histamine Antagonists|histamine antagonists|mesh-ancestor
110369981|NCT01651871|Histamine Agents|histamine agents|mesh-ancestor
110369982|NCT01651871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110369983|NCT01651871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110369984|NCT01651871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369985|NCT04608006|Fentanyl|fentanyl|mesh-list
110369986|NCT04608006|Bupivacaine|bupivacaine|mesh-list
110369987|NCT04608006|Anesthetics, Local|anesthetics, local|mesh-ancestor
110369988|NCT04608006|Anesthetics|anesthetics|mesh-ancestor
110369989|NCT04608006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110369990|NCT04608006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369991|NCT04608006|Sensory System Agents|sensory system agents|mesh-ancestor
110369992|NCT04608006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110369993|NCT04608006|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110369994|NCT04608006|Narcotics|narcotics|mesh-ancestor
110369995|NCT04608006|Analgesics|analgesics|mesh-ancestor
110369996|NCT04608006|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110369997|NCT04608006|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110369998|NCT04608006|Anesthetics, General|anesthetics, general|mesh-ancestor
110369999|NCT04599621|Uric Acid|uric acid|mesh-list
110370000|NCT04599621|Antioxidants|antioxidants|mesh-ancestor
110370001|NCT04599621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110370002|NCT04599621|Protective Agents|protective agents|mesh-ancestor
110370003|NCT04599621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370004|NCT00564525|Amitriptyline|amitriptyline|mesh-list
110370005|NCT00564525|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110370006|NCT00564525|Antidepressive Agents|antidepressive agents|mesh-ancestor
110370007|NCT00564525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110370008|NCT00564525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110370009|NCT00564525|Analgesics|analgesics|mesh-ancestor
110370010|NCT00564525|Sensory System Agents|sensory system agents|mesh-ancestor
110370011|NCT00564525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110370012|NCT00564525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370013|NCT00564525|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110370014|NCT00564525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110370015|NCT00564525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110370016|NCT00564525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110370017|NCT00564525|Adrenergic Agents|adrenergic agents|mesh-ancestor
110370018|NCT00564525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110370019|NCT04607733|Mirikizumab|mirikizumab|mesh-list
110370020|NCT04607733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110370021|NCT04607733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110370022|NCT04607733|Analgesics|analgesics|mesh-ancestor
110370023|NCT04607733|Sensory System Agents|sensory system agents|mesh-ancestor
110370024|NCT04607733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110370025|NCT04607733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370026|NCT04607733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110370027|NCT04607733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110370028|NCT04607733|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110370029|NCT04607733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110370030|NCT01632137|Rebamipide|rebamipide|mesh-list
110370031|NCT01632137|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110370032|NCT01632137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110370033|NCT01632137|Antioxidants|antioxidants|mesh-ancestor
110370034|NCT01632137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110370035|NCT01632137|Protective Agents|protective agents|mesh-ancestor
110370036|NCT01632137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370037|NCT01632137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110370038|NCT00565539|Interferons|interferons|mesh-list
110370039|NCT00565539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110370041|NCT00565539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110370042|NCT04599699|Androgens|androgens|mesh-list
110370043|NCT04599699|Hormones|hormones|mesh-ancestor
110370044|NCT04599699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110370045|NCT04599699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370046|NCT01563731|Antihypertensive Agents|antihypertensive agents|mesh-list
110370047|NCT01563731|Calcium Channel Blockers|calcium channel blockers|mesh-list
110370048|NCT01563731|Atorvastatin|atorvastatin|mesh-list
110370049|NCT01563731|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110370050|NCT01563731|Simvastatin|simvastatin|mesh-list
110370051|NCT01563731|Pravastatin|pravastatin|mesh-list
110370052|NCT01563731|Enzyme Inhibitors|enzyme inhibitors|mesh-list
110370053|NCT01563731|Diuretics|diuretics|mesh-list
110370054|NCT01563731|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110370055|NCT01563731|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
110370056|NCT01563731|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
110370057|NCT01563731|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
110370058|NCT01563731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110370059|NCT01563731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370060|NCT01563731|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110370061|NCT01563731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110370062|NCT01563731|Antimetabolites|antimetabolites|mesh-ancestor
110370063|NCT01563731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110370064|NCT01563731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110370065|NCT01563731|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110370066|NCT01563731|Natriuretic Agents|natriuretic agents|mesh-ancestor
110370067|NCT01563731|Protease Inhibitors|protease inhibitors|mesh-ancestor
110370068|NCT01563731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110370069|NCT01563731|Hormone Antagonists|hormone antagonists|mesh-ancestor
110370070|NCT01563731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110370071|NCT01563731|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110370072|NCT01516346|Hydralazine|hydralazine|mesh-list
110370073|NCT01516346|Isosorbide|isosorbide|mesh-list
110370074|NCT01516346|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
110370075|NCT01516346|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
110370076|NCT01516346|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110370077|NCT01516346|Diuretics|diuretics|mesh-ancestor
110370078|NCT01516346|Natriuretic Agents|natriuretic agents|mesh-ancestor
110370079|NCT01516346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370081|NCT01516346|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110370082|NCT01516346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110370083|NCT01516346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110370084|NCT01303796|Decitabine|decitabine|mesh-list
110370085|NCT01303796|Sapacitabine|sapacitabine|mesh-list
110370086|NCT01303796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110370087|NCT01303796|Antimetabolites|antimetabolites|mesh-ancestor
110370088|NCT01303796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110370089|NCT01303796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110370090|NCT01303796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110370091|NCT04598880|Magnesium citrate|magnesium citrate|mesh-list
110370092|NCT04598880|Picosulfate sodium|picosulfate sodium|mesh-list
110370093|NCT04598880|Cathartics|cathartics|mesh-ancestor
110370094|NCT04598880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110370095|NCT00564564|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110370096|NCT00564564|Clomipramine|clomipramine|mesh-list
110370097|NCT00564564|Antidepressive Agents|antidepressive agents|mesh-ancestor
110370098|NCT00564564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110370099|NCT00564564|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110370100|NCT00564564|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110370101|NCT00564564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110370102|NCT00564564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370103|NCT00564564|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110370104|NCT00564564|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110370105|NCT00564564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110370106|NCT00564564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110370107|NCT00564564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110370108|NCT00564564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110370109|NCT00564564|Serotonin Agents|serotonin agents|mesh-ancestor
110370110|NCT02894138|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110370111|NCT02894138|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110370112|NCT02894138|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110370113|NCT02894138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110370114|NCT00565656|Bevacizumab|bevacizumab|mesh-list
110370115|NCT00565656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110370116|NCT00565656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110370117|NCT00565656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110370118|NCT00565656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110370119|NCT00565656|Growth Substances|growth substances|mesh-ancestor
110370120|NCT00565656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370121|NCT00565656|Growth Inhibitors|growth inhibitors|mesh-ancestor
110370123|NCT00564603|Dexamethasone acetate|dexamethasone acetate|mesh-list
110370124|NCT00564603|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
110370125|NCT00564603|BB 1101|bb 1101|mesh-list
110370126|NCT00564603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110370127|NCT00564603|Antiemetics|antiemetics|mesh-ancestor
110370128|NCT00564603|Autonomic Agents|autonomic agents|mesh-ancestor
110370129|NCT00564603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110370130|NCT00564603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370131|NCT00564603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110370132|NCT00564603|Glucocorticoids|glucocorticoids|mesh-ancestor
110370133|NCT00564603|Hormones|hormones|mesh-ancestor
110370134|NCT00564603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110370135|NCT00564603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110370136|NCT00564603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110370137|NCT00564603|Protease Inhibitors|protease inhibitors|mesh-ancestor
110370138|NCT00564603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110370139|NCT00564603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110370140|NCT00555347|Modafinil|modafinil|mesh-list
110370141|NCT00555347|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110370143|NCT00555347|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110370144|NCT00555347|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110370145|NCT00555347|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110370146|NCT00555347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110370148|NCT00564642|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110370149|NCT00564642|Antiviral Agents|antiviral agents|mesh-ancestor
110370150|NCT00564642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110370151|NCT00564642|Expectorants|expectorants|mesh-ancestor
110370152|NCT00564642|Respiratory System Agents|respiratory system agents|mesh-ancestor
110370153|NCT00564642|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110370154|NCT00564642|Antioxidants|antioxidants|mesh-ancestor
110370155|NCT00564642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110370156|NCT00564642|Protective Agents|protective agents|mesh-ancestor
110370157|NCT00564642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370158|NCT00564642|Antidotes|antidotes|mesh-ancestor
110370160|NCT00555386|Antioxidants|antioxidants|mesh-ancestor
110370161|NCT00555386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110370162|NCT00555386|Protective Agents|protective agents|mesh-ancestor
110370163|NCT00555386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370164|NCT00555386|Trace Elements|trace elements|mesh-ancestor
110370166|NCT00565929|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
110370167|NCT00565929|Antiviral Agents|antiviral agents|mesh-ancestor
110370168|NCT00565929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110370169|NCT04676516|GSK-3326595|gsk-3326595|mesh-list
110370170|NCT04676516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110370171|NCT04676516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110370172|NCT04675697|Etoposide|etoposide|mesh-list
110370173|NCT04675697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110370174|NCT04675697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110370175|NCT04675697|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110370176|NCT04675697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110370177|NCT04675697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110370178|NCT04675697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110370180|NCT04606836|Anesthetics, Local|anesthetics, local|mesh-ancestor
110370181|NCT04606836|Anesthetics|anesthetics|mesh-ancestor
110370182|NCT04606836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110370183|NCT04606836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370184|NCT04606836|Sensory System Agents|sensory system agents|mesh-ancestor
110370185|NCT04606836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110370186|NCT01163149|Immunoglobulin G|immunoglobulin g|mesh-list
110370187|NCT01163149|Immunologic Factors|immunologic factors|mesh-ancestor
110370188|NCT01163149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370189|NCT04676126|Dorzolamide|dorzolamide|mesh-list
110370190|NCT04676126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110370191|NCT04676126|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110370192|NCT04676126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110370193|NCT04676126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110370195|NCT04675619|Analgesics|analgesics|mesh-ancestor
110370196|NCT04675619|Sensory System Agents|sensory system agents|mesh-ancestor
110370197|NCT04675619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110370198|NCT04675619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370199|NCT04675619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110370200|NCT04675619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110370201|NCT04675619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110370202|NCT04675619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110370203|NCT04675619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110370204|NCT05305300|Vaccines|vaccines|mesh-list
110370207|NCT05305300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370208|NCT05305300|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110370209|NCT05305300|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110370210|NCT05305300|Protease Inhibitors|protease inhibitors|mesh-ancestor
110370211|NCT05305300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110370212|NCT05305300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110370214|NCT04187755|Cefepime|cefepime|mesh-list
110370215|NCT04187755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110370216|NCT04187755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110370217|NCT00555542|Rituximab|rituximab|mesh-list
110370218|NCT00555542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110370219|NCT00555542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110370220|NCT00555542|Immunologic Factors|immunologic factors|mesh-ancestor
110370221|NCT00555542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370222|NCT00555542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110370223|NCT04606563|Losartan|losartan|mesh-list
110370224|NCT04606563|Valsartan|valsartan|mesh-list
110370225|NCT04606563|Telmisartan|telmisartan|mesh-list
110370226|NCT04606563|Candesartan|candesartan|mesh-list
110370227|NCT04606563|Candesartan cilexetil|candesartan cilexetil|mesh-list
110370228|NCT04606563|Olmesartan|olmesartan|mesh-list
110370230|NCT04606563|Eprosartan|eprosartan|mesh-list
110370231|NCT04606563|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
110370232|NCT04606563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110370233|NCT04606563|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110370234|NCT04606563|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110370235|NCT04606563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110370236|NCT04606563|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110370237|NCT04606563|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
110370239|NCT00565968|Melphalan|melphalan|mesh-list
110370240|NCT00565968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110370241|NCT00565968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110370242|NCT00565968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110370243|NCT00565968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110370244|NCT00565968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110370245|NCT00565968|Alkylating Agents|alkylating agents|mesh-ancestor
110370246|NCT00565968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110370247|NCT00565968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110370248|NCT00565968|Immunologic Factors|immunologic factors|mesh-ancestor
110370249|NCT00565968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370250|NCT01162486|Rifampin|rifampin|mesh-list
110370251|NCT01162486|Rifapentine|rifapentine|mesh-list
110370252|NCT01162486|Midazolam|midazolam|mesh-list
110370253|NCT01162486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110370254|NCT01162486|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110370255|NCT01162486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110370256|NCT01162486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370257|NCT01162486|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110370258|NCT01162486|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110370259|NCT01162486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110370260|NCT01162486|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110370261|NCT01162486|Anesthetics, General|anesthetics, general|mesh-ancestor
110370262|NCT01162486|Anesthetics|anesthetics|mesh-ancestor
110370263|NCT01162486|GABA Modulators|gaba modulators|mesh-ancestor
110370264|NCT01162486|GABA Agents|gaba agents|mesh-ancestor
110370265|NCT01162486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110370266|NCT01162486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110370267|NCT01162486|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110370268|NCT01162486|Antitubercular Agents|antitubercular agents|mesh-ancestor
110370269|NCT01162486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110370270|NCT01162486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110370271|NCT01162486|Leprostatic Agents|leprostatic agents|mesh-ancestor
110370272|NCT01162486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110370273|NCT01162486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110370274|NCT01162486|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110370275|NCT01162486|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110370276|NCT01162486|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110370277|NCT01162486|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110370278|NCT01162486|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110370279|NCT01162486|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110370280|NCT01162135|Digoxin|digoxin|mesh-list
110370281|NCT01162135|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110370282|NCT01162135|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110370283|NCT01162135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110370284|NCT01162135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110370285|NCT01162135|Protective Agents|protective agents|mesh-ancestor
110370286|NCT01162135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370287|NCT00555776|Gabapentin|gabapentin|mesh-list
110370288|NCT00555776|Analgesics|analgesics|mesh-ancestor
110370289|NCT00555776|Sensory System Agents|sensory system agents|mesh-ancestor
110370290|NCT00555776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110370291|NCT00555776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370292|NCT00555776|Anticonvulsants|anticonvulsants|mesh-ancestor
110370293|NCT00555776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110370294|NCT00555776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110370295|NCT00555776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110370296|NCT00555776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110370297|NCT00555776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110370298|NCT00555776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110370299|NCT00555776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110370300|NCT00555776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110370301|NCT00555776|Antimanic Agents|antimanic agents|mesh-ancestor
110370303|NCT01161628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110370304|NCT01161628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110370305|NCT01161628|Immunologic Factors|immunologic factors|mesh-ancestor
110370306|NCT01161628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370307|NCT01161628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110370308|NCT04314505|Analgesics, Opioid|analgesics, opioid|mesh-list
110370309|NCT04314505|Narcotics|narcotics|mesh-ancestor
110370310|NCT04314505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110370311|NCT04314505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370312|NCT04314505|Analgesics|analgesics|mesh-ancestor
110370313|NCT04314505|Sensory System Agents|sensory system agents|mesh-ancestor
110370314|NCT04314505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110370315|NCT02885545|Anticoagulants|anticoagulants|mesh-list
110370317|NCT01161472|Fesoterodine|fesoterodine|mesh-list
110370318|NCT01161472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110370319|NCT01161472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110370320|NCT01161472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370322|NCT01161472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110370323|NCT01161472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110370324|NCT01161472|GABA Modulators|gaba modulators|mesh-ancestor
110370325|NCT01161472|GABA Agents|gaba agents|mesh-ancestor
110370326|NCT01161472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110370327|NCT01161472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110370328|NCT01161472|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110370329|NCT01161472|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110370330|NCT01161472|Cholinergic Agents|cholinergic agents|mesh-ancestor
110370331|NCT01161472|Urological Agents|urological agents|mesh-ancestor
110370332|NCT04675385|Hyaluronic Acid|hyaluronic acid|mesh-list
110370333|NCT04675385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110370334|NCT04675385|Immunologic Factors|immunologic factors|mesh-ancestor
110370335|NCT04675385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370336|NCT04675385|Viscosupplements|viscosupplements|mesh-ancestor
110370337|NCT04675385|Protective Agents|protective agents|mesh-ancestor
110370338|NCT04598061|Dexmedetomidine|dexmedetomidine|mesh-list
110370339|NCT04598061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110370340|NCT04598061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110370341|NCT04598061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370342|NCT04598061|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110370343|NCT04598061|Analgesics|analgesics|mesh-ancestor
110370344|NCT04598061|Sensory System Agents|sensory system agents|mesh-ancestor
110370345|NCT04598061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110370346|NCT04598061|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110370347|NCT04598061|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110370348|NCT04598061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110370349|NCT04598061|Adrenergic Agents|adrenergic agents|mesh-ancestor
110370350|NCT04598061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110370351|NCT04598061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110370352|NCT04674956|Paclitaxel|paclitaxel|mesh-list
110370353|NCT04674956|Gemcitabine|gemcitabine|mesh-list
110370354|NCT04674956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110370355|NCT04674956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110370356|NCT04674956|Tubulin Modulators|tubulin modulators|mesh-ancestor
110370357|NCT04674956|Antimitotic Agents|antimitotic agents|mesh-ancestor
110370358|NCT04674956|Mitosis Modulators|mitosis modulators|mesh-ancestor
110370359|NCT04674956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110370360|NCT04674956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110370361|NCT04674956|Antimetabolites|antimetabolites|mesh-ancestor
110370362|NCT00564720|Gemcitabine|gemcitabine|mesh-list
110370363|NCT00564720|Oxaliplatin|oxaliplatin|mesh-list
110370364|NCT00564720|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110370365|NCT00564720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110370366|NCT00564720|Antimetabolites|antimetabolites|mesh-ancestor
110370367|NCT00564720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110370368|NCT00564720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110370369|NCT00564720|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110370370|NCT00564720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110370371|NCT01160770|Clobazam|clobazam|mesh-list
110370372|NCT01160770|Anticonvulsants|anticonvulsants|mesh-ancestor
110370373|NCT01160770|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110370374|NCT01160770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110370375|NCT01160770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110370376|NCT01160770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370377|NCT01160770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110370378|NCT01160770|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110370380|NCT01160770|GABA Agents|gaba agents|mesh-ancestor
110370381|NCT01160770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110370382|NCT01160770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110370383|NCT04632758|Crizotinib|crizotinib|mesh-list
110370384|NCT04632758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110370385|NCT04632758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110370386|NCT04632758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110370387|NCT04632758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110370388|NCT00566046|Levetiracetam|levetiracetam|mesh-list
110370389|NCT00566046|Anticonvulsants|anticonvulsants|mesh-ancestor
110370390|NCT00566046|Nootropic Agents|nootropic agents|mesh-ancestor
110370392|NCT01160614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110370393|NCT01160614|Narcotics|narcotics|mesh-ancestor
110370394|NCT01160614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110370395|NCT01160614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370396|NCT01160614|Analgesics|analgesics|mesh-ancestor
110370397|NCT01160614|Sensory System Agents|sensory system agents|mesh-ancestor
110370398|NCT01160614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110370399|NCT00566124|Insulin|insulin|mesh-list
110370400|NCT00566124|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110370401|NCT00566124|Insulin Glargine|insulin glargine|mesh-list
110370402|NCT00566124|Insulin Detemir|insulin detemir|mesh-list
110370403|NCT00566124|Isophane Insulin, Human|isophane insulin, human|mesh-list
110370404|NCT00566124|Insulin, Isophane|insulin, isophane|mesh-list
110370405|NCT00566124|Isophane insulin, beef|isophane insulin, beef|mesh-list
110370406|NCT00566124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110370407|NCT00566124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370408|NCT01159912|Fluticasone|fluticasone|mesh-list
110370409|NCT01159912|Xhance|xhance|mesh-list
110370410|NCT01159912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110370411|NCT01159912|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110370412|NCT01159912|Autonomic Agents|autonomic agents|mesh-ancestor
110370413|NCT01159912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110370414|NCT01159912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370415|NCT01159912|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110370416|NCT01159912|Respiratory System Agents|respiratory system agents|mesh-ancestor
110370417|NCT01159912|Dermatologic Agents|dermatologic agents|mesh-ancestor
110370418|NCT01159912|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110370419|NCT04606212|Losartan|losartan|mesh-list
110370420|NCT04606212|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110370421|NCT04606212|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110370422|NCT04606212|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110370423|NCT04606212|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110370424|NCT04606212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110370425|NCT04606017|Calcium Carbonate|calcium carbonate|mesh-list
110370426|NCT04606017|Antacids|antacids|mesh-ancestor
110370427|NCT04606017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110370428|NCT04606017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110370430|NCT04631822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110370431|NCT04631822|Antiemetics|antiemetics|mesh-ancestor
110370432|NCT04631822|Autonomic Agents|autonomic agents|mesh-ancestor
110370433|NCT04631822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110370434|NCT04631822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370435|NCT04631822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110370436|NCT04631822|Glucocorticoids|glucocorticoids|mesh-ancestor
110370438|NCT04631822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110370439|NCT04631822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110370440|NCT04631822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110370441|NCT04605705|Chrysarobin|chrysarobin|mesh-list
110370442|NCT04605705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110370443|NCT04605705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110370444|NCT04605705|Analgesics|analgesics|mesh-ancestor
110370445|NCT04605705|Sensory System Agents|sensory system agents|mesh-ancestor
110370446|NCT04605705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110370447|NCT04605705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370448|NCT04605705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110370449|NCT04605705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110370450|NCT00560924|Estradiol|estradiol|mesh-list
110370451|NCT00560924|Estrogens|estrogens|mesh-ancestor
110370452|NCT00560924|Hormones|hormones|mesh-ancestor
110370453|NCT00560924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110370454|NCT00560924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370455|NCT00560963|Everolimus|everolimus|mesh-list
110370456|NCT00560963|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110370457|NCT00560963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110370458|NCT00560963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110370459|NCT00560963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110370460|NCT00560963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110370462|NCT00560963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370463|NCT00560963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110370464|NCT01159600|Empagliflozin|empagliflozin|mesh-list
110370465|NCT01159600|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110370466|NCT01159600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110370467|NCT01159600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110370468|NCT01159600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370470|NCT04631627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110370471|NCT04631627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110370472|NCT04631627|Analgesics|analgesics|mesh-ancestor
110370473|NCT04631627|Sensory System Agents|sensory system agents|mesh-ancestor
110370474|NCT04631627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110370475|NCT04631627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370476|NCT04631627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110370477|NCT04631627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110370478|NCT04631627|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110370479|NCT04631627|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110370480|NCT04631627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110370481|NCT04631627|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110370482|NCT04631627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110370483|NCT04631627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110370484|NCT04631627|Antipyretics|antipyretics|mesh-ancestor
110370485|NCT04314193|Prednisolone|prednisolone|mesh-list
110370486|NCT04314193|Methotrexate|methotrexate|mesh-list
110370487|NCT04314193|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110370488|NCT04314193|Abortifacient Agents|abortifacient agents|mesh-ancestor
110370489|NCT04314193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110370490|NCT04314193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370491|NCT04314193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110370492|NCT04314193|Antimetabolites|antimetabolites|mesh-ancestor
110370493|NCT04314193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110370494|NCT04314193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110370495|NCT04314193|Dermatologic Agents|dermatologic agents|mesh-ancestor
110370496|NCT04314193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110370497|NCT04314193|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110370498|NCT04314193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110370499|NCT04314193|Immunologic Factors|immunologic factors|mesh-ancestor
110370500|NCT04314193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110370501|NCT04314193|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110370502|NCT04314193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110370503|NCT04314193|Glucocorticoids|glucocorticoids|mesh-ancestor
110370504|NCT04314193|Hormones|hormones|mesh-ancestor
110370505|NCT04314193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110370506|NCT04314193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110370507|NCT01159171|Bevacizumab|bevacizumab|mesh-list
110370508|NCT01159171|Capecitabine|capecitabine|mesh-list
110370509|NCT01159171|Oxaliplatin|oxaliplatin|mesh-list
110370510|NCT01159171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110370511|NCT01159171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110370512|NCT01159171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110370513|NCT01159171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110370514|NCT01159171|Growth Substances|growth substances|mesh-ancestor
110370515|NCT01159171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370516|NCT01159171|Growth Inhibitors|growth inhibitors|mesh-ancestor
110370517|NCT01159171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110370518|NCT01159171|Antimetabolites|antimetabolites|mesh-ancestor
110370519|NCT01159171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110370520|NCT04631315|Prednisolone|prednisolone|mesh-list
110370521|NCT04631315|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110370522|NCT04631315|Methylprednisolone|methylprednisolone|mesh-list
110370523|NCT04631315|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110370524|NCT04631315|Prednisolone acetate|prednisolone acetate|mesh-list
110370525|NCT04631315|Phenylephrine|phenylephrine|mesh-list
110370526|NCT04631315|Oxymetazoline|oxymetazoline|mesh-list
110370527|NCT04631315|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110370528|NCT04631315|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110370529|NCT04631315|Prednisolone phosphate|prednisolone phosphate|mesh-list
110370530|NCT04631315|Difluprednate|difluprednate|mesh-list
110370531|NCT04631315|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110370532|NCT04631315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110370535|NCT04631315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110370537|NCT04631315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110370538|NCT04631315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110370539|NCT04631315|Antiemetics|antiemetics|mesh-ancestor
110370540|NCT04631315|Autonomic Agents|autonomic agents|mesh-ancestor
110370541|NCT04631315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110370542|NCT04631315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110370543|NCT04631315|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110370544|NCT04631315|Protective Agents|protective agents|mesh-ancestor
110370545|NCT04631315|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110370546|NCT04631315|Mydriatics|mydriatics|mesh-ancestor
110370547|NCT04631315|Sympathomimetics|sympathomimetics|mesh-ancestor
110370548|NCT04631315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110370549|NCT04631315|Nasal Decongestants|nasal decongestants|mesh-ancestor
110370550|NCT04631315|Respiratory System Agents|respiratory system agents|mesh-ancestor
110370551|NCT04631315|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110370552|NCT04631315|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110370553|NCT04631315|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110370554|NCT04631315|Adrenergic Agents|adrenergic agents|mesh-ancestor
110370555|NCT04631315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110370556|NCT04631315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110370557|NCT04597203|Hydroquinone|hydroquinone|mesh-list
110370558|NCT04597203|Antioxidants|antioxidants|mesh-ancestor
110370559|NCT04597203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110370560|NCT04597203|Protective Agents|protective agents|mesh-ancestor
110370561|NCT04597203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370562|NCT04597203|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110370563|NCT01158118|Plerixafor|plerixafor|mesh-list
110370564|NCT01158118|Sargramostim|sargramostim|mesh-list
110370565|NCT01158118|Immunologic Factors|immunologic factors|mesh-ancestor
110370566|NCT01158118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370567|NCT01158118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110370569|NCT01158118|Antiviral Agents|antiviral agents|mesh-ancestor
110370570|NCT01158118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110370571|NCT02885311|Naltrexone|naltrexone|mesh-list
110370572|NCT02885311|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110370573|NCT02885311|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110370574|NCT02885311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370575|NCT02885311|Sensory System Agents|sensory system agents|mesh-ancestor
110370576|NCT02885311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110370577|NCT00566241|Mecasermin|mecasermin|mesh-list
110370578|NCT00566241|Growth Substances|growth substances|mesh-ancestor
110370579|NCT00566241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370580|NCT00561119|Paclitaxel|paclitaxel|mesh-list
110370581|NCT00561119|Gemcitabine|gemcitabine|mesh-list
110370582|NCT00561119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110370583|NCT00561119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110370584|NCT00561119|Tubulin Modulators|tubulin modulators|mesh-ancestor
110370585|NCT00561119|Antimitotic Agents|antimitotic agents|mesh-ancestor
110370586|NCT00561119|Mitosis Modulators|mitosis modulators|mesh-ancestor
110370587|NCT00561119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110370588|NCT00561119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110370589|NCT00561119|Antimetabolites|antimetabolites|mesh-ancestor
110370590|NCT00561197|Gossypol acetic acid|gossypol acetic acid|mesh-list
110370591|NCT00561197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110370592|NCT00561197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110370593|NCT00561197|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110370594|NCT00561197|Contraceptive Agents|contraceptive agents|mesh-ancestor
110370595|NCT00561197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110370596|NCT00561197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370597|NCT00561197|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
110370598|NCT00561197|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
110370599|NCT00561197|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110370600|NCT00564993|Dobutamine|dobutamine|mesh-list
110370601|NCT00564993|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110370602|NCT00564993|Sympathomimetics|sympathomimetics|mesh-ancestor
110370603|NCT00564993|Autonomic Agents|autonomic agents|mesh-ancestor
110370604|NCT00564993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110370605|NCT00564993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370606|NCT00564993|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110370607|NCT00564993|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110370608|NCT00564993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110370609|NCT00564993|Adrenergic Agents|adrenergic agents|mesh-ancestor
110370610|NCT00564993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110370611|NCT00564993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110370612|NCT00564993|Protective Agents|protective agents|mesh-ancestor
110370613|NCT04595916|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
110370614|NCT04595916|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110370615|NCT04595916|Antimetabolites|antimetabolites|mesh-ancestor
110370616|NCT04595916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110370617|NCT04595916|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110370618|NCT04604886|Dobutamine|dobutamine|mesh-list
110370619|NCT04604886|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110370620|NCT04604886|Sympathomimetics|sympathomimetics|mesh-ancestor
110370621|NCT04604886|Autonomic Agents|autonomic agents|mesh-ancestor
110370622|NCT04604886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110370623|NCT04604886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370624|NCT04604886|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110370625|NCT04604886|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110370626|NCT04604886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110370627|NCT04604886|Adrenergic Agents|adrenergic agents|mesh-ancestor
110370628|NCT04604886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110370629|NCT04604886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110370630|NCT04604886|Protective Agents|protective agents|mesh-ancestor
110370632|NCT04595877|Endorphins|endorphins|mesh-list
110370633|NCT04595877|beta-Endorphin|beta-endorphin|mesh-list
110370634|NCT04595877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110370635|NCT04595877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110370636|NCT04595877|Analgesics|analgesics|mesh-ancestor
110370637|NCT04595877|Sensory System Agents|sensory system agents|mesh-ancestor
110370638|NCT04595877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110370639|NCT04595877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370640|NCT04595877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110370641|NCT04595877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110370642|NCT04595877|Antipyretics|antipyretics|mesh-ancestor
110370643|NCT04595877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110370644|NCT04595877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110370645|NCT00561509|Antidepressive Agents|antidepressive agents|mesh-list
110370646|NCT00561509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110370647|NCT03454646|Rivastigmine|rivastigmine|mesh-list
110370648|NCT03454646|Donepezil|donepezil|mesh-list
110370649|NCT03454646|Galantamine|galantamine|mesh-list
110370650|NCT03454646|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
110370651|NCT03454646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110370652|NCT03454646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110370653|NCT03454646|Cholinergic Agents|cholinergic agents|mesh-ancestor
110370654|NCT03454646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110370655|NCT03454646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370656|NCT03454646|Nootropic Agents|nootropic agents|mesh-ancestor
110370657|NCT03454646|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110370658|NCT03454646|Autonomic Agents|autonomic agents|mesh-ancestor
110370659|NCT03454646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110370660|NCT03454646|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110370661|NCT03454646|Protective Agents|protective agents|mesh-ancestor
110370662|NCT00566553|Grape Seed Extract|grape seed extract|mesh-list
110370663|NCT00566553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110370664|NCT00566553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110370665|NCT00566553|Antioxidants|antioxidants|mesh-ancestor
110370666|NCT00566553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110370667|NCT00566553|Protective Agents|protective agents|mesh-ancestor
110370668|NCT00566553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370669|NCT01157182|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110370670|NCT01157182|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110370671|NCT01157182|Norethindrone|norethindrone|mesh-list
110370672|NCT01157182|Norethindrone Acetate|norethindrone acetate|mesh-list
110370673|NCT01157182|Estradiol|estradiol|mesh-list
110370674|NCT01157182|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110370675|NCT01157182|Estrogens|estrogens|mesh-ancestor
110370676|NCT01157182|Hormones|hormones|mesh-ancestor
110370677|NCT01157182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110370678|NCT01157182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370679|NCT01157182|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110370680|NCT01157182|Contraceptive Agents|contraceptive agents|mesh-ancestor
110370681|NCT01157182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110370682|NCT01157182|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110370683|NCT01157182|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110370684|NCT01157182|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110370685|NCT01157182|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110370686|NCT01157065|Ranibizumab|ranibizumab|mesh-list
110370687|NCT01157065|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110370688|NCT01157065|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110370689|NCT01157065|Growth Substances|growth substances|mesh-ancestor
110370690|NCT01157065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370691|NCT01157065|Growth Inhibitors|growth inhibitors|mesh-ancestor
110370692|NCT01157065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110370693|NCT00566592|Ethanol|ethanol|mesh-list
110370694|NCT00566592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110370695|NCT00566592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110370696|NCT00566592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110370697|NCT00566592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370699|NCT01156792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110370700|NCT01156792|Respiratory System Agents|respiratory system agents|mesh-ancestor
110370701|NCT01156792|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110370702|NCT01156792|Hormone Antagonists|hormone antagonists|mesh-ancestor
110370703|NCT01156792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110370704|NCT01156792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370705|NCT01156792|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110370706|NCT01156792|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110370707|NCT01156792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110370708|NCT04604223|Pioglitazone|pioglitazone|mesh-list
110370709|NCT04604223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110370710|NCT04604223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370711|NCT04628624|Antioxidants|antioxidants|mesh-list
110370712|NCT04628624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110370713|NCT04628624|Protective Agents|protective agents|mesh-ancestor
110370714|NCT04628624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370715|NCT04604028|Cyclophosphamide|cyclophosphamide|mesh-list
110370716|NCT04604028|Lenalidomide|lenalidomide|mesh-list
110370717|NCT04604028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110370718|NCT04604028|Immunologic Factors|immunologic factors|mesh-ancestor
110370719|NCT04604028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370720|NCT04604028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110370721|NCT04604028|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110370722|NCT04604028|Alkylating Agents|alkylating agents|mesh-ancestor
110370723|NCT04604028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110370724|NCT04604028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110370725|NCT04604028|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110370726|NCT04604028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110370727|NCT04604028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110370728|NCT04604028|Growth Substances|growth substances|mesh-ancestor
110370729|NCT04604028|Growth Inhibitors|growth inhibitors|mesh-ancestor
110370730|NCT01156480|Hydrocortisone|hydrocortisone|mesh-list
110370731|NCT01156480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110370732|NCT00561587|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110370733|NCT00561587|Antidepressive Agents|antidepressive agents|mesh-ancestor
110370734|NCT00561587|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110370735|NCT00561587|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110370736|NCT00561587|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110370737|NCT00561587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110370738|NCT00561587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370739|NCT01156363|Epoetin Alfa|epoetin alfa|mesh-list
110370740|NCT01156363|Hematinics|hematinics|mesh-ancestor
110370741|NCT02884921|Acetaminophen|acetaminophen|mesh-list
110370742|NCT02884921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110370743|NCT02884921|Analgesics|analgesics|mesh-ancestor
110370744|NCT02884921|Sensory System Agents|sensory system agents|mesh-ancestor
110370745|NCT02884921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110370746|NCT02884921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370747|NCT02884921|Antipyretics|antipyretics|mesh-ancestor
110370748|NCT00561704|Losartan|losartan|mesh-list
110370749|NCT00561704|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110370750|NCT00561704|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110370751|NCT00561704|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110370752|NCT00561704|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110370753|NCT00561704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110370754|NCT01156051|Guanfacine|guanfacine|mesh-list
110370755|NCT01156051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110370756|NCT01156051|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110370757|NCT01156051|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110370758|NCT01156051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110370759|NCT01156051|Adrenergic Agents|adrenergic agents|mesh-ancestor
110370760|NCT01156051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110370761|NCT01156051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110370762|NCT01156051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370763|NCT04595409|Ustekinumab|ustekinumab|mesh-list
110370764|NCT04595409|Dermatologic Agents|dermatologic agents|mesh-ancestor
110370766|NCT04628000|Ergocalciferols|ergocalciferols|mesh-list
110370767|NCT04628000|Cholecalciferol|cholecalciferol|mesh-list
110370768|NCT04628000|Vitamins|vitamins|mesh-list
110370769|NCT04628000|Micronutrients|micronutrients|mesh-ancestor
110370770|NCT04628000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370771|NCT04628000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110370772|NCT04628000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110370773|NCT01155661|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
110370774|NCT01155661|Serotonin|serotonin|mesh-list
110370775|NCT01155661|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
110370776|NCT01155661|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110370777|NCT01155661|Serotonin Agents|serotonin agents|mesh-ancestor
110370778|NCT01155661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110370779|NCT01155661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110370780|NCT01155661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370781|NCT01155661|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110370782|NCT01155661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110370783|NCT01155661|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110370784|NCT01155661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110370785|NCT01155661|Disinfectants|disinfectants|mesh-ancestor
110370786|NCT00565188|Adenosine|adenosine|mesh-list
110370787|NCT00565188|Analgesics|analgesics|mesh-ancestor
110370788|NCT00565188|Sensory System Agents|sensory system agents|mesh-ancestor
110370789|NCT00565188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110370790|NCT00565188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370791|NCT00565188|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110370792|NCT00565188|Vasodilator Agents|vasodilator agents|mesh-ancestor
110370793|NCT00565188|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110370794|NCT00565188|Purinergic Agonists|purinergic agonists|mesh-ancestor
110370795|NCT00565188|Purinergic Agents|purinergic agents|mesh-ancestor
110370796|NCT00565188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110370797|NCT00565188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110370798|NCT04603833|Docetaxel|docetaxel|mesh-list
110370799|NCT04603833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110370800|NCT04603833|Tubulin Modulators|tubulin modulators|mesh-ancestor
110370801|NCT04603833|Antimitotic Agents|antimitotic agents|mesh-ancestor
110370802|NCT04603833|Mitosis Modulators|mitosis modulators|mesh-ancestor
110370803|NCT04603833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110370804|NCT04603872|Dasatinib|dasatinib|mesh-list
110370805|NCT04603872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110370806|NCT04603872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110370807|NCT04603872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110370808|NCT04603872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110370809|NCT04603794|Chlorhexidine|chlorhexidine|mesh-list
110370810|NCT04603794|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110370811|NCT04603794|Povidone-Iodine|povidone-iodine|mesh-list
110370812|NCT04603794|Hydrogen Peroxide|hydrogen peroxide|mesh-list
110370813|NCT04603794|Povidone|povidone|mesh-list
110370814|NCT04603794|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110370815|NCT04603794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110370816|NCT04603794|Disinfectants|disinfectants|mesh-ancestor
110370817|NCT04603794|Dermatologic Agents|dermatologic agents|mesh-ancestor
110370818|NCT04603794|Plasma Substitutes|plasma substitutes|mesh-ancestor
110370819|NCT04603794|Blood Substitutes|blood substitutes|mesh-ancestor
110370820|NCT01155583|Dexamethasone|dexamethasone|mesh-list
110370821|NCT01155583|Lenalidomide|lenalidomide|mesh-list
110370822|NCT01155583|Azacitidine|azacitidine|mesh-list
110370823|NCT01155583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110370824|NCT01155583|Antiemetics|antiemetics|mesh-ancestor
110370825|NCT01155583|Autonomic Agents|autonomic agents|mesh-ancestor
110370826|NCT01155583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110370827|NCT01155583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370829|NCT01155583|Glucocorticoids|glucocorticoids|mesh-ancestor
110370830|NCT01155583|Hormones|hormones|mesh-ancestor
110370831|NCT01155583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110370832|NCT01155583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110370834|NCT01155583|Immunologic Factors|immunologic factors|mesh-ancestor
110370835|NCT01155583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110370836|NCT01155583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110370837|NCT01155583|Growth Substances|growth substances|mesh-ancestor
110370838|NCT01155583|Growth Inhibitors|growth inhibitors|mesh-ancestor
110370839|NCT01155583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110370840|NCT01155583|Antimetabolites|antimetabolites|mesh-ancestor
110370841|NCT01155583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110370842|NCT01155583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110370843|NCT04603131|Vaccines|vaccines|mesh-list
110370844|NCT04603131|Immunologic Factors|immunologic factors|mesh-ancestor
110370845|NCT04603131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370846|NCT04627181|Hydroxocobalamin|hydroxocobalamin|mesh-list
110370847|NCT04627181|Vitamin B 12|vitamin b 12|mesh-list
110370848|NCT04627181|Hematinics|hematinics|mesh-ancestor
110370849|NCT04627181|Vitamin B Complex|vitamin b complex|mesh-ancestor
110370850|NCT04627181|Vitamins|vitamins|mesh-ancestor
110370851|NCT04627181|Micronutrients|micronutrients|mesh-ancestor
110370852|NCT04627181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370853|NCT04626752|Cyclophosphamide|cyclophosphamide|mesh-list
110370854|NCT04626752|Fludarabine|fludarabine|mesh-list
110370855|NCT04626752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110370857|NCT04626752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370858|NCT04626752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110370859|NCT04626752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110370860|NCT04626752|Alkylating Agents|alkylating agents|mesh-ancestor
110370861|NCT04626752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110370862|NCT04626752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110370863|NCT04626752|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110370864|NCT01155466|Rasagiline|rasagiline|mesh-list
110370865|NCT01155466|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110370866|NCT01155466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110370867|NCT01155466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110370868|NCT01155466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110370869|NCT01155466|Protective Agents|protective agents|mesh-ancestor
110370870|NCT01155466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370872|NCT00561899|Amodiaquine|amodiaquine|mesh-list
110370873|NCT00561899|Artenimol|artenimol|mesh-list
110370874|NCT00561899|Antimalarials|antimalarials|mesh-ancestor
110370875|NCT00561899|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110370876|NCT00561899|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110370877|NCT00561899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110370878|NCT01155388|Ferrous fumarate|ferrous fumarate|mesh-list
110370879|NCT01155388|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
110370880|NCT01155388|Hematinics|hematinics|mesh-ancestor
110370881|NCT01155388|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110370882|NCT01155388|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110370883|NCT01155388|Trace Elements|trace elements|mesh-ancestor
110370884|NCT01155388|Micronutrients|micronutrients|mesh-ancestor
110370885|NCT01155388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370886|NCT00565227|Docetaxel|docetaxel|mesh-list
110370887|NCT00565227|Vorinostat|vorinostat|mesh-list
110370888|NCT00565227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110370889|NCT00565227|Tubulin Modulators|tubulin modulators|mesh-ancestor
110370890|NCT00565227|Antimitotic Agents|antimitotic agents|mesh-ancestor
110370891|NCT00565227|Mitosis Modulators|mitosis modulators|mesh-ancestor
110370892|NCT00565227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110370893|NCT00565227|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110370894|NCT00565227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110370895|NCT04602273|Azacitidine|azacitidine|mesh-list
110370896|NCT04602273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110370897|NCT04602273|Antimetabolites|antimetabolites|mesh-ancestor
110370898|NCT04602273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110370899|NCT04602273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110370900|NCT04602273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110370901|NCT04313764|Bupivacaine|bupivacaine|mesh-list
110370902|NCT04313764|Anesthetics, Local|anesthetics, local|mesh-ancestor
110370903|NCT04313764|Anesthetics|anesthetics|mesh-ancestor
110370904|NCT04313764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110370905|NCT04313764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370906|NCT04313764|Sensory System Agents|sensory system agents|mesh-ancestor
110370907|NCT04313764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110370908|NCT04626089|Metformin|metformin|mesh-list
110370909|NCT04626089|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110370910|NCT04626089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370911|NCT04601688|Dexamethasone|dexamethasone|mesh-list
110370912|NCT04601688|Bevacizumab|bevacizumab|mesh-list
110370913|NCT04601688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110370914|NCT04601688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110370915|NCT04601688|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110370916|NCT04601688|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110370917|NCT04601688|Growth Substances|growth substances|mesh-ancestor
110370918|NCT04601688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370919|NCT04601688|Growth Inhibitors|growth inhibitors|mesh-ancestor
110370920|NCT04601688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110370921|NCT04601688|Antiemetics|antiemetics|mesh-ancestor
110370922|NCT04601688|Autonomic Agents|autonomic agents|mesh-ancestor
110370923|NCT04601688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110370924|NCT04601688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110370925|NCT04601688|Glucocorticoids|glucocorticoids|mesh-ancestor
110370926|NCT04601688|Hormones|hormones|mesh-ancestor
110370927|NCT04601688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110370929|NCT01154452|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
110370932|NCT01154452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110370933|NCT04313452|Insulin|insulin|mesh-list
110370934|NCT04313452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110370935|NCT04313452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370936|NCT01154218|Crizotinib|crizotinib|mesh-list
110370938|NCT01154218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110370939|NCT01154218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110370940|NCT01154218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110370941|NCT04601142|Methylprednisolone|methylprednisolone|mesh-list
110370942|NCT04601142|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110370943|NCT04601142|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110370944|NCT04601142|Prednisolone|prednisolone|mesh-list
110370945|NCT04601142|Prednisolone acetate|prednisolone acetate|mesh-list
110370946|NCT04601142|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110370947|NCT04601142|Prednisolone phosphate|prednisolone phosphate|mesh-list
110370948|NCT04601142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110370949|NCT04601142|Antiemetics|antiemetics|mesh-ancestor
110370950|NCT04601142|Autonomic Agents|autonomic agents|mesh-ancestor
110370951|NCT04601142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110370952|NCT04601142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370953|NCT04601142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110370954|NCT04601142|Glucocorticoids|glucocorticoids|mesh-ancestor
110370955|NCT04601142|Hormones|hormones|mesh-ancestor
110370956|NCT04601142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110370957|NCT04601142|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110370958|NCT04601142|Protective Agents|protective agents|mesh-ancestor
110370959|NCT04601142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110370960|NCT04601142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110370961|NCT04625543|Paclitaxel|paclitaxel|mesh-list
110370962|NCT04625543|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110370963|NCT04625543|Cisplatin|cisplatin|mesh-list
110370964|NCT04625543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110370965|NCT04625543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110370966|NCT04625543|Tubulin Modulators|tubulin modulators|mesh-ancestor
110370967|NCT04625543|Antimitotic Agents|antimitotic agents|mesh-ancestor
110370968|NCT04625543|Mitosis Modulators|mitosis modulators|mesh-ancestor
110370969|NCT04625543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110370970|NCT04601259|Salicylic Acid|salicylic acid|mesh-list
110370971|NCT04601259|Salicylates|salicylates|mesh-list
110370972|NCT04601259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110370973|NCT04601259|Antifungal Agents|antifungal agents|mesh-ancestor
110370974|NCT04601259|Keratolytic Agents|keratolytic agents|mesh-ancestor
110370975|NCT04601259|Dermatologic Agents|dermatologic agents|mesh-ancestor
110370976|NCT04601259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110370977|NCT04601259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110370978|NCT04601259|Analgesics|analgesics|mesh-ancestor
110370979|NCT04601259|Sensory System Agents|sensory system agents|mesh-ancestor
110370980|NCT04601259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110370981|NCT04601259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370982|NCT04601259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110370983|NCT04601259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110370984|NCT04601259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110370985|NCT04601259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110370986|NCT04601259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110370987|NCT00565383|Fentanyl|fentanyl|mesh-list
110370988|NCT00565383|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110370989|NCT00565383|Narcotics|narcotics|mesh-ancestor
110370990|NCT00565383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110370991|NCT00565383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110370992|NCT00565383|Analgesics|analgesics|mesh-ancestor
110370993|NCT00565383|Sensory System Agents|sensory system agents|mesh-ancestor
110370994|NCT00565383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110370995|NCT00565383|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110370997|NCT00565383|Anesthetics, General|anesthetics, general|mesh-ancestor
110370998|NCT00565383|Anesthetics|anesthetics|mesh-ancestor
110370999|NCT04625426|Protective Agents|protective agents|mesh-list
110371000|NCT04625426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110371001|NCT04625114|Gabexate|gabexate|mesh-list
110371002|NCT04625114|Camostat|camostat|mesh-list
110371003|NCT04625114|Protease Inhibitors|protease inhibitors|mesh-ancestor
110371004|NCT04625114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110371005|NCT04625114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110371006|NCT04625114|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110371007|NCT04625114|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110371008|NCT04625114|Anticoagulants|anticoagulants|mesh-ancestor
110371009|NCT00567099|Aripiprazole|aripiprazole|mesh-list
110371010|NCT00567099|Antidepressive Agents|antidepressive agents|mesh-ancestor
110371011|NCT00567099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110371012|NCT00567099|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110371013|NCT00567099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110371014|NCT00567099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110371015|NCT00567099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110371016|NCT00567099|Dopamine Agonists|dopamine agonists|mesh-ancestor
110371017|NCT00567099|Dopamine Agents|dopamine agents|mesh-ancestor
110371018|NCT00567099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110371019|NCT00567099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110371020|NCT00567099|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110371021|NCT00567099|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110371023|NCT00567099|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110371024|NCT00567099|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110371025|NCT00567099|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110371026|NCT00567099|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110371027|NCT00567177|Cyclosporine|cyclosporine|mesh-list
110371028|NCT00567177|Cyclosporins|cyclosporins|mesh-list
110371029|NCT00567177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110371030|NCT00567177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110371031|NCT00567177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110371032|NCT00567177|Immunologic Factors|immunologic factors|mesh-ancestor
110371033|NCT00567177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110371034|NCT00567177|Antifungal Agents|antifungal agents|mesh-ancestor
110371035|NCT00567177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110371036|NCT00567177|Dermatologic Agents|dermatologic agents|mesh-ancestor
110371037|NCT00567177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110371038|NCT00567177|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110371040|NCT00567216|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110371041|NCT00567216|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110371042|NCT00567216|Adrenergic Agents|adrenergic agents|mesh-ancestor
110371043|NCT00567216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110371044|NCT00567216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110371045|NCT00567216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110371046|NCT00567216|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110371047|NCT00567216|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110371048|NCT00567216|Sympatholytics|sympatholytics|mesh-ancestor
110371049|NCT00567216|Autonomic Agents|autonomic agents|mesh-ancestor
110371050|NCT00567216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110371051|NCT00562055|Reboxetine|reboxetine|mesh-list
110371052|NCT00562055|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110371053|NCT00562055|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110371054|NCT00562055|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110371055|NCT00562055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110371056|NCT00562055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110371057|NCT00562055|Adrenergic Agents|adrenergic agents|mesh-ancestor
110371058|NCT00562055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110371059|NCT00562055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110371060|NCT00562055|Antidepressive Agents|antidepressive agents|mesh-ancestor
110371061|NCT00562055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110371062|NCT04624217|Paclitaxel|paclitaxel|mesh-list
110371063|NCT04624217|Gemcitabine|gemcitabine|mesh-list
110371064|NCT04624217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110371065|NCT04624217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110371066|NCT04624217|Tubulin Modulators|tubulin modulators|mesh-ancestor
110371067|NCT04624217|Antimitotic Agents|antimitotic agents|mesh-ancestor
110371068|NCT04624217|Mitosis Modulators|mitosis modulators|mesh-ancestor
110371069|NCT04624217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110371070|NCT04624217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110371071|NCT04624217|Antimetabolites|antimetabolites|mesh-ancestor
110371072|NCT04623866|Valsartan|valsartan|mesh-list
110371073|NCT04623866|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110371074|NCT04623866|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110371075|NCT04623866|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110371076|NCT04623866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110371077|NCT00567372|Bevacizumab|bevacizumab|mesh-list
110371078|NCT00567372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110371079|NCT00567372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110371080|NCT00567372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110371081|NCT00567372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110371082|NCT00567372|Growth Substances|growth substances|mesh-ancestor
110371083|NCT00567372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110371084|NCT00567372|Growth Inhibitors|growth inhibitors|mesh-ancestor
110371085|NCT00562133|Insulin|insulin|mesh-list
110371086|NCT00562133|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110371087|NCT00562133|Insulin glulisine|insulin glulisine|mesh-list
110371088|NCT00562133|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110371089|NCT00562133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110371090|NCT00567411|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110371091|NCT00567411|Apraclonidine|apraclonidine|mesh-list
110371092|NCT00567411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110371093|NCT00567411|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110371094|NCT00567411|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110371095|NCT00567411|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110371096|NCT00567411|Adrenergic Agents|adrenergic agents|mesh-ancestor
110371097|NCT00567411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110371098|NCT00567411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110371099|NCT00567411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110371100|NCT00562172|Metformin|metformin|mesh-list
110371101|NCT00562172|Insulin Glargine|insulin glargine|mesh-list
110371102|NCT00562172|Glimepiride|glimepiride|mesh-list
110371103|NCT00562172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110371104|NCT00562172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110371105|NCT00562172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110371106|NCT00562172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110371107|NCT00562172|Immunologic Factors|immunologic factors|mesh-ancestor
110371108|NCT00567450|Ropivacaine|ropivacaine|mesh-list
110371109|NCT00567450|Mepivacaine|mepivacaine|mesh-list
110371110|NCT00567450|Anesthetics, Local|anesthetics, local|mesh-ancestor
110371111|NCT00567450|Anesthetics|anesthetics|mesh-ancestor
110371112|NCT00567450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110371113|NCT00567450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110371114|NCT00567450|Sensory System Agents|sensory system agents|mesh-ancestor
110371115|NCT00567450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110371116|NCT00567528|Ibuprofen|ibuprofen|mesh-list
110371117|NCT00567528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110371118|NCT00567528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110371119|NCT00567528|Analgesics|analgesics|mesh-ancestor
110371120|NCT00567528|Sensory System Agents|sensory system agents|mesh-ancestor
110371121|NCT00567528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110371122|NCT00567528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110371123|NCT00567528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110371124|NCT00567528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110371125|NCT00567528|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110371126|NCT00567528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110371127|NCT00567528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110371128|NCT04590612|Levodopa|levodopa|mesh-list
110371129|NCT04590612|Carbidopa|carbidopa|mesh-list
110371130|NCT04590612|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110371131|NCT04590612|Citalopram|citalopram|mesh-list
110371132|NCT04590612|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
110371133|NCT04590612|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110371134|NCT04590612|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110371135|NCT04590612|Dopamine Agents|dopamine agents|mesh-ancestor
110371136|NCT04590612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110371137|NCT04590612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110371138|NCT04590612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110371139|NCT04590612|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110371140|NCT04590612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110371141|NCT04590612|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110371142|NCT04590612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110371143|NCT04590612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110371144|NCT04590612|Serotonin Agents|serotonin agents|mesh-ancestor
110371145|NCT04590612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110371146|NCT04590612|Antidepressive Agents|antidepressive agents|mesh-ancestor
110371147|NCT04590612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110371148|NCT04590612|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110371149|NCT04590612|Immunologic Factors|immunologic factors|mesh-ancestor
110371150|NCT04590612|Dopamine Agonists|dopamine agonists|mesh-ancestor
110371151|NCT00562250|Dapagliflozin|dapagliflozin|mesh-list
110371152|NCT00562250|Glimepiride|glimepiride|mesh-list
110371153|NCT00562250|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110371154|NCT00562250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110371155|NCT00562250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110371156|NCT00562250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110371157|NCT00562250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110371158|NCT00562250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110371159|NCT00562250|Immunologic Factors|immunologic factors|mesh-ancestor
110371160|NCT00562289|Aspirin|aspirin|mesh-list
110371161|NCT00562289|Dipyridamole|dipyridamole|mesh-list
110371162|NCT00562289|Rivaroxaban|rivaroxaban|mesh-list
110371163|NCT00562289|Apixaban|apixaban|mesh-list
110371164|NCT00562289|Dabigatran|dabigatran|mesh-list
110371165|NCT00562289|Antivitamins K|antivitamins k|mesh-list
110371166|NCT00562289|Clopidogrel|clopidogrel|mesh-list
110371167|NCT00562289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110371169|NCT00562289|Analgesics|analgesics|mesh-ancestor
110371170|NCT00562289|Sensory System Agents|sensory system agents|mesh-ancestor
110371171|NCT00562289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110371172|NCT00562289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110371173|NCT00562289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110371174|NCT00562289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110371175|NCT00562289|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110371176|NCT00562289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110371177|NCT00562289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110371178|NCT00562289|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110371179|NCT00562289|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110371180|NCT00562289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110371181|NCT00562289|Antipyretics|antipyretics|mesh-ancestor
110371182|NCT00562289|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110371183|NCT00562289|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110371184|NCT00562289|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110371185|NCT00562289|Purinergic Agents|purinergic agents|mesh-ancestor
110371186|NCT00562289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110371187|NCT00562289|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110371188|NCT00562289|Antithrombins|antithrombins|mesh-ancestor
110371189|NCT00562289|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110371190|NCT00562289|Protease Inhibitors|protease inhibitors|mesh-ancestor
110371191|NCT00562289|Anticoagulants|anticoagulants|mesh-ancestor
110371192|NCT00562289|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110371193|NCT00562289|Vasodilator Agents|vasodilator agents|mesh-ancestor
110371194|NCT04313218|Misoprostol|misoprostol|mesh-list
110371196|NCT04313218|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110371197|NCT04313218|Abortifacient Agents|abortifacient agents|mesh-ancestor
110371198|NCT04313218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110371200|NCT04313218|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110371201|NCT04313218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110371202|NCT04313218|Oxytocics|oxytocics|mesh-ancestor
110371203|NCT00624871|Ascorbic Acid|ascorbic acid|mesh-list
110371204|NCT00624871|Ibuprofen|ibuprofen|mesh-list
110371205|NCT00624871|Vitamins|vitamins|mesh-ancestor
110371206|NCT00624871|Micronutrients|micronutrients|mesh-ancestor
110371207|NCT00624871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110371208|NCT00624871|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110371209|NCT00624871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110371210|NCT00624871|Analgesics|analgesics|mesh-ancestor
110371211|NCT00624871|Sensory System Agents|sensory system agents|mesh-ancestor
110371212|NCT00624871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110371213|NCT00624871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110371214|NCT00624871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110371215|NCT00624871|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110371216|NCT00624871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110371217|NCT00624871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110371218|NCT00624871|Antioxidants|antioxidants|mesh-ancestor
110371219|NCT00624871|Protective Agents|protective agents|mesh-ancestor
110371220|NCT01153984|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110371221|NCT01153984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110371222|NCT01153984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110371223|NCT01153984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110371224|NCT01153984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110371225|NCT04590183|Prednisolone|prednisolone|mesh-list
110371227|NCT04590183|Methylprednisolone|methylprednisolone|mesh-list
110371228|NCT04590183|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110371229|NCT04590183|Prednisolone acetate|prednisolone acetate|mesh-list
110371230|NCT04590183|Tacrolimus|tacrolimus|mesh-list
110371231|NCT04590183|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110371232|NCT04590183|Prednisolone phosphate|prednisolone phosphate|mesh-list
110371233|NCT04590183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110371234|NCT04590183|Immunologic Factors|immunologic factors|mesh-ancestor
110371235|NCT04590183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110371237|NCT04590183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110371238|NCT04590183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110371239|NCT04590183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110371240|NCT04590183|Glucocorticoids|glucocorticoids|mesh-ancestor
110371241|NCT04590183|Hormones|hormones|mesh-ancestor
110371242|NCT04590183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110371243|NCT04590183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110371244|NCT04590183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110371245|NCT04590183|Antiemetics|antiemetics|mesh-ancestor
110371246|NCT04590183|Autonomic Agents|autonomic agents|mesh-ancestor
110371247|NCT04590183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110371248|NCT04590183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110371249|NCT04590183|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110371250|NCT04590183|Protective Agents|protective agents|mesh-ancestor
110371251|NCT04622618|Gabapentin|gabapentin|mesh-list
110371252|NCT04622618|Analgesics|analgesics|mesh-ancestor
110371253|NCT04622618|Sensory System Agents|sensory system agents|mesh-ancestor
110371254|NCT04622618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110371255|NCT04622618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110371256|NCT04622618|Anticonvulsants|anticonvulsants|mesh-ancestor
110371257|NCT04622618|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110371258|NCT04622618|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110371259|NCT04622618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110371260|NCT04622618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110371261|NCT04622618|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110371262|NCT04622618|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110371263|NCT04622618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110371264|NCT04622618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110371265|NCT04622618|Antimanic Agents|antimanic agents|mesh-ancestor
110371268|NCT04622891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110371269|NCT04622891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110371270|NCT04622891|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110371271|NCT04622891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110371272|NCT04622891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110371273|NCT04622891|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110371274|NCT04622891|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110371276|NCT04622579|Lenalidomide|lenalidomide|mesh-list
110371277|NCT04622579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110371278|NCT04622579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110371279|NCT04622579|Immunologic Factors|immunologic factors|mesh-ancestor
110371280|NCT04622579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110371281|NCT04622579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110371282|NCT04622579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110371283|NCT04622579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110371284|NCT04622579|Growth Substances|growth substances|mesh-ancestor
110371285|NCT04622579|Growth Inhibitors|growth inhibitors|mesh-ancestor
110371286|NCT01153009|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110371287|NCT01153009|Vortioxetine|vortioxetine|mesh-list
110371288|NCT01153009|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110371289|NCT01153009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110371290|NCT01153009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110371291|NCT01153009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110371292|NCT01153009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110371293|NCT01153009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110371295|NCT01153009|Sensory System Agents|sensory system agents|mesh-ancestor
110371296|NCT01153009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110371297|NCT01153009|Antidepressive Agents|antidepressive agents|mesh-ancestor
110371298|NCT01153009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110371299|NCT01153009|Dopamine Agents|dopamine agents|mesh-ancestor
110371300|NCT01153009|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110371301|NCT01153009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110371302|NCT01153009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110371303|NCT01153009|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110371304|NCT01153009|Serotonin Agents|serotonin agents|mesh-ancestor
110371305|NCT01153009|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110371306|NCT01153009|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110371307|NCT01153009|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110371308|NCT01153009|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110371309|NCT04622111|Metformin|metformin|mesh-list
110371310|NCT04622111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110371311|NCT04622111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110371312|NCT04622033|Brodalumab|brodalumab|mesh-list
110371313|NCT04622033|Dermatologic Agents|dermatologic agents|mesh-ancestor
110371314|NCT01152580|Melatonin|melatonin|mesh-list
110371315|NCT01152580|Antioxidants|antioxidants|mesh-ancestor
110371316|NCT01152580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110371317|NCT01152580|Protective Agents|protective agents|mesh-ancestor
110371318|NCT01152580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110371319|NCT01152580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110371321|NCT04621799|Hemostatics|hemostatics|mesh-ancestor
110371322|NCT04621799|Coagulants|coagulants|mesh-ancestor
110371323|NCT04621370|Capecitabine|capecitabine|mesh-list
110371324|NCT04621370|Durvalumab|durvalumab|mesh-list
110371325|NCT04621370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110371326|NCT04621370|Antimetabolites|antimetabolites|mesh-ancestor
110371327|NCT04621370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110371328|NCT04621370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110371330|NCT04621487|Amoxicillin|amoxicillin|mesh-list
110371331|NCT04621487|Metronidazole|metronidazole|mesh-list
110371332|NCT04621487|Clarithromycin|clarithromycin|mesh-list
110371333|NCT04621487|Pantoprazole|pantoprazole|mesh-list
110371334|NCT04621487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110371335|NCT04621487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110371336|NCT04621487|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110371337|NCT04621487|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110371338|NCT04621487|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110371339|NCT04621487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110371340|NCT04621487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110371341|NCT04621487|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110371342|NCT04621487|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110371343|NCT04621487|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110371344|NCT04621487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110371345|NCT04621487|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110371347|NCT01152190|Vasodilator Agents|vasodilator agents|mesh-ancestor
110371348|NCT01152190|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110371349|NCT01152190|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110371350|NCT01152190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110371351|NCT01152190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110371352|NCT01152190|Urological Agents|urological agents|mesh-ancestor
110371354|NCT04621565|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110371355|NCT04621565|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110371356|NCT04621565|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110371357|NCT04621565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110371358|NCT01151410|Enalapril|enalapril|mesh-list
110371359|NCT01151410|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110371361|NCT01151410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110371362|NCT01151410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110371363|NCT01151410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110371364|NCT00562406|Ranibizumab|ranibizumab|mesh-list
110371365|NCT00562406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110371366|NCT00562406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110371367|NCT00562406|Growth Substances|growth substances|mesh-ancestor
110371368|NCT00562406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110371369|NCT00562406|Growth Inhibitors|growth inhibitors|mesh-ancestor
110371370|NCT00562406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110371371|NCT04621409|Anti-Infective Agents|anti-infective agents|mesh-list
110371372|NCT04621409|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110371374|NCT04588935|Perindopril|perindopril|mesh-list
110371375|NCT04588935|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110371376|NCT04588935|Sympatholytics|sympatholytics|mesh-ancestor
110371377|NCT04588935|Autonomic Agents|autonomic agents|mesh-ancestor
110371378|NCT04588935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110371379|NCT04588935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110371380|NCT04588935|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110371381|NCT04588935|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110371382|NCT04588935|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110371383|NCT04588935|Adrenergic Agents|adrenergic agents|mesh-ancestor
110371384|NCT04588935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110371385|NCT04588935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110371386|NCT04588935|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110371387|NCT04588935|Protease Inhibitors|protease inhibitors|mesh-ancestor
110371388|NCT04588935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110371389|NCT00562523|Sorafenib|sorafenib|mesh-list
110371390|NCT00562523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110371391|NCT00562523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110371392|NCT00562523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110371393|NCT00562523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110371395|NCT04649697|Rebamipide|rebamipide|mesh-list
110371396|NCT04649697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110371397|NCT04649697|Glucocorticoids|glucocorticoids|mesh-ancestor
110371398|NCT04649697|Hormones|hormones|mesh-ancestor
110371399|NCT04649697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110371400|NCT04649697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110371401|NCT04649697|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110371402|NCT04649697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110371403|NCT04649697|Antioxidants|antioxidants|mesh-ancestor
110371404|NCT04649697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110371405|NCT04649697|Protective Agents|protective agents|mesh-ancestor
110371406|NCT04649697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110371408|NCT04649502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110371409|NCT04649502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110371410|NCT04621253|Dipyrone|dipyrone|mesh-list
110371411|NCT04621253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110371412|NCT04621253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110371413|NCT04621253|Analgesics|analgesics|mesh-ancestor
110371414|NCT04621253|Sensory System Agents|sensory system agents|mesh-ancestor
110371415|NCT04621253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110371416|NCT04621253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110371417|NCT04621253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110371418|NCT04621253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110371419|NCT04621253|Antipyretics|antipyretics|mesh-ancestor
110371420|NCT00567762|Tacrolimus|tacrolimus|mesh-list
110371421|NCT00567762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110371423|NCT00567762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110371424|NCT00567762|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110371425|NCT00567762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110371426|NCT00567762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110371427|NCT04620785|Methylene Blue|methylene blue|mesh-list
110371428|NCT04620785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110371429|NCT04620785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110371430|NCT04620590|Dapagliflozin|dapagliflozin|mesh-list
110371431|NCT04620590|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110371432|NCT04620590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110371433|NCT04620590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110371434|NCT04620590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110371435|NCT04691063|Carboplatin|carboplatin|mesh-list
110371437|NCT04691063|Etoposide phosphate|etoposide phosphate|mesh-list
110371438|NCT04691063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110371439|NCT04691063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110371440|NCT04691063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110371441|NCT04691063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110371442|NCT04691063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110371443|NCT04691063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110371444|NCT01151215|Anastrozole|anastrozole|mesh-list
110371445|NCT01151215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110371446|NCT01151215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110371447|NCT01151215|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110371448|NCT01151215|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110371450|NCT01151215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110371451|NCT01151215|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110371452|NCT01151215|Hormone Antagonists|hormone antagonists|mesh-ancestor
110371453|NCT01151215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110371454|NCT01151215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110371455|NCT04588389|Lidocaine|lidocaine|mesh-list
110371456|NCT04588389|Ropivacaine|ropivacaine|mesh-list
110371457|NCT04588389|Anesthetics, Local|anesthetics, local|mesh-ancestor
110371458|NCT04588389|Anesthetics|anesthetics|mesh-ancestor
110371459|NCT04588389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110371460|NCT04588389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110371461|NCT04588389|Sensory System Agents|sensory system agents|mesh-ancestor
110371462|NCT04588389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110371463|NCT04588389|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110371464|NCT04588389|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110371465|NCT04588389|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110371466|NCT04588389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110371467|NCT04588389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110371468|NCT00637234|Oxcarbazepine|oxcarbazepine|mesh-list
110371469|NCT00637234|Anticonvulsants|anticonvulsants|mesh-ancestor
110371470|NCT00637234|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110371471|NCT00637234|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110371472|NCT00637234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110371473|NCT00637234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110371474|NCT00637234|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110371475|NCT00637234|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110371476|NCT04588194|Dexamethasone|dexamethasone|mesh-list
110371477|NCT04588194|Rituximab|rituximab|mesh-list
110371478|NCT04588194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110371479|NCT04588194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110371480|NCT04588194|Immunologic Factors|immunologic factors|mesh-ancestor
110371481|NCT04588194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110371482|NCT04588194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110371483|NCT04588194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110371484|NCT04588194|Antiemetics|antiemetics|mesh-ancestor
110371485|NCT04588194|Autonomic Agents|autonomic agents|mesh-ancestor
110371486|NCT04588194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110371487|NCT04588194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110371488|NCT04588194|Glucocorticoids|glucocorticoids|mesh-ancestor
110371489|NCT04588194|Hormones|hormones|mesh-ancestor
110371490|NCT04588194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110371491|NCT04588194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110371492|NCT02940314|Solifenacin Succinate|solifenacin succinate|mesh-list
110371493|NCT02940314|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110371494|NCT02940314|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110371495|NCT02940314|Cholinergic Agents|cholinergic agents|mesh-ancestor
110371496|NCT02940314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110371497|NCT02940314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110371498|NCT02940314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110371499|NCT02940314|Urological Agents|urological agents|mesh-ancestor
110371500|NCT04581213|Anesthetics|anesthetics|mesh-list
110371501|NCT04581213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110371502|NCT04581213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110371503|NCT01151137|Dronedarone|dronedarone|mesh-list
110371504|NCT01151137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110371505|NCT01151098|Buprenorphine|buprenorphine|mesh-list
110371506|NCT01151098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110371507|NCT01151098|Narcotics|narcotics|mesh-ancestor
110371508|NCT01151098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110371509|NCT01151098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110371510|NCT01151098|Analgesics|analgesics|mesh-ancestor
110371511|NCT01151098|Sensory System Agents|sensory system agents|mesh-ancestor
110371512|NCT01151098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110371513|NCT01151098|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110371514|NCT04619303|Dexamethasone|dexamethasone|mesh-list
110371515|NCT04619303|Bevacizumab|bevacizumab|mesh-list
110371516|NCT04619303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110371524|NCT04619303|Antiemetics|antiemetics|mesh-ancestor
110371525|NCT04619303|Autonomic Agents|autonomic agents|mesh-ancestor
110371526|NCT04619303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110371527|NCT04619303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110371528|NCT04619303|Glucocorticoids|glucocorticoids|mesh-ancestor
110371530|NCT04619303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110371531|NCT04619303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110371532|NCT04619537|Docetaxel|docetaxel|mesh-list
110371533|NCT04619537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110371534|NCT04619537|Tubulin Modulators|tubulin modulators|mesh-ancestor
110371535|NCT04619537|Antimitotic Agents|antimitotic agents|mesh-ancestor
110371536|NCT04619537|Mitosis Modulators|mitosis modulators|mesh-ancestor
110371537|NCT04619537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110371538|NCT04619381|Clopidogrel|clopidogrel|mesh-list
110371539|NCT04619381|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110371540|NCT04619381|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110371541|NCT04619381|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110371542|NCT04619381|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110371543|NCT04619381|Purinergic Agents|purinergic agents|mesh-ancestor
110371544|NCT04619381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110371545|NCT04619381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110371546|NCT04619381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110371548|NCT00568503|Tiotropium Bromide|tiotropium bromide|mesh-list
110371549|NCT00568503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110371550|NCT00568503|Autonomic Agents|autonomic agents|mesh-ancestor
110371551|NCT00568503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110371552|NCT00568503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110371553|NCT00568503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110371554|NCT00568503|Respiratory System Agents|respiratory system agents|mesh-ancestor
110371555|NCT00568503|Parasympatholytics|parasympatholytics|mesh-ancestor
110371556|NCT00568503|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110371558|NCT00568503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110371559|NCT00568503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110371560|NCT00568503|Anticonvulsants|anticonvulsants|mesh-ancestor
110371561|NCT00568542|Epoetin Alfa|epoetin alfa|mesh-list
110371562|NCT00568542|Hematinics|hematinics|mesh-ancestor
110371563|NCT00562835|Thiamine|thiamine|mesh-list
110371564|NCT00562835|Methylprednisolone|methylprednisolone|mesh-list
110371565|NCT00562835|Vitamins|vitamins|mesh-ancestor
110371566|NCT00562835|Micronutrients|micronutrients|mesh-ancestor
110371567|NCT00562835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110371568|NCT00562835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110371569|NCT00562835|Antiemetics|antiemetics|mesh-ancestor
110371570|NCT00562835|Autonomic Agents|autonomic agents|mesh-ancestor
110371571|NCT00562835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110371572|NCT00562835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110371573|NCT00562835|Glucocorticoids|glucocorticoids|mesh-ancestor
110371574|NCT00562835|Hormones|hormones|mesh-ancestor
110371575|NCT00562835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110371576|NCT00562835|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110371577|NCT00562835|Protective Agents|protective agents|mesh-ancestor
110371578|NCT00562835|Vitamin B Complex|vitamin b complex|mesh-ancestor
110371579|NCT00568737|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
110371580|NCT00568737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110371581|NCT04587141|Ferric gluconate|ferric gluconate|mesh-list
110371582|NCT04587141|Hematinics|hematinics|mesh-ancestor
110371583|NCT04586790|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
110371584|NCT04586790|Epinephrine|epinephrine|mesh-list
110371585|NCT04586790|Racepinephrine|racepinephrine|mesh-list
110371586|NCT04586790|Midodrine|midodrine|mesh-list
110371587|NCT04586790|Norepinephrine|norepinephrine|mesh-list
110371588|NCT04586790|Epinephryl borate|epinephryl borate|mesh-list
110371589|NCT04586790|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110371590|NCT04586790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110371591|NCT04586790|Adrenergic Agents|adrenergic agents|mesh-ancestor
110371592|NCT04586790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110371593|NCT04586790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110371594|NCT04586790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110371595|NCT04586790|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110371596|NCT04586790|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110371597|NCT04586790|Autonomic Agents|autonomic agents|mesh-ancestor
110371598|NCT04586790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110371599|NCT04586790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110371600|NCT04586790|Respiratory System Agents|respiratory system agents|mesh-ancestor
110371601|NCT04586790|Mydriatics|mydriatics|mesh-ancestor
110371602|NCT04586790|Sympathomimetics|sympathomimetics|mesh-ancestor
110371603|NCT04586790|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110371604|NCT04586790|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110371605|NCT04586790|Hemostatics|hemostatics|mesh-ancestor
110371606|NCT04586790|Coagulants|coagulants|mesh-ancestor
110371607|NCT04586790|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110371608|NCT04586790|Natriuretic Agents|natriuretic agents|mesh-ancestor
110371609|NCT00568815|Rituximab|rituximab|mesh-list
110371610|NCT00568815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110371611|NCT00568815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110371612|NCT00568815|Immunologic Factors|immunologic factors|mesh-ancestor
110371613|NCT00568815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110371614|NCT00568815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110371615|NCT00568893|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
110371616|NCT00568893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110371617|NCT00568971|Docetaxel|docetaxel|mesh-list
110371618|NCT00568971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110371619|NCT00568971|Tubulin Modulators|tubulin modulators|mesh-ancestor
110371620|NCT00568971|Antimitotic Agents|antimitotic agents|mesh-ancestor
110371621|NCT00568971|Mitosis Modulators|mitosis modulators|mesh-ancestor
110371622|NCT00568971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110371623|NCT00562913|Sorafenib|sorafenib|mesh-list
110371624|NCT00562913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110371625|NCT00562913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110371626|NCT00562913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110371627|NCT00562913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110371628|NCT00569088|Mannitol|mannitol|mesh-list
110371629|NCT00569088|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110371630|NCT00569088|Diuretics|diuretics|mesh-ancestor
110371631|NCT00569088|Natriuretic Agents|natriuretic agents|mesh-ancestor
110371632|NCT00569088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110371633|NCT00569244|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
110371634|NCT00569244|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110371635|NCT00569244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110371636|NCT04586361|Hyaluronic Acid|hyaluronic acid|mesh-list
110371637|NCT04586361|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110371638|NCT04586361|Immunologic Factors|immunologic factors|mesh-ancestor
110371639|NCT04586361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110371640|NCT04586361|Viscosupplements|viscosupplements|mesh-ancestor
110371641|NCT04586361|Protective Agents|protective agents|mesh-ancestor
110371642|NCT04618952|Calcium|calcium|mesh-list
110371643|NCT04618952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110371644|NCT04618952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110371646|NCT04619069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110371648|NCT04585932|Leuprolide|leuprolide|mesh-list
110371649|NCT04585932|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110371650|NCT04585932|Fertility Agents|fertility agents|mesh-ancestor
110371651|NCT04585932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110371652|NCT04585932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110371653|NCT04585932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110371654|NCT04585932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110371655|NCT00569400|Insulin|insulin|mesh-list
110371656|NCT00569400|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110371657|NCT00569400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110371658|NCT00569400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110371659|NCT04618367|Lenvatinib|lenvatinib|mesh-list
110371660|NCT04618367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110371661|NCT04618367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110371662|NCT04618367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110371663|NCT04618367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110371664|NCT00562952|Telmisartan|telmisartan|mesh-list
110371665|NCT00562952|Bisoprolol|bisoprolol|mesh-list
110371666|NCT00562952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110371667|NCT00562952|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110371668|NCT00562952|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110371669|NCT00562952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110371670|NCT00562952|Sympatholytics|sympatholytics|mesh-ancestor
110371671|NCT00562952|Autonomic Agents|autonomic agents|mesh-ancestor
110371672|NCT00562952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110371673|NCT00562952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110371674|NCT00562952|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110371675|NCT00562952|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110371676|NCT00562952|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110371677|NCT00562952|Adrenergic Agents|adrenergic agents|mesh-ancestor
110371678|NCT00562952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110371679|NCT05035316|Aspirin|aspirin|mesh-list
110371680|NCT05035316|Calcium|calcium|mesh-list
110371681|NCT05035316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110371682|NCT05035316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110371683|NCT05035316|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110371684|NCT05035316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110371685|NCT05035316|Analgesics|analgesics|mesh-ancestor
110371686|NCT05035316|Sensory System Agents|sensory system agents|mesh-ancestor
110371687|NCT05035316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110371688|NCT05035316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110371689|NCT05035316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110371690|NCT05035316|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110371691|NCT05035316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110371692|NCT05035316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110371693|NCT05035316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110371694|NCT05035316|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110371695|NCT05035316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110371699|NCT04618601|Hormone Antagonists|hormone antagonists|mesh-ancestor
110371700|NCT04618601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110371701|NCT04618601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110371702|NCT04618601|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110371703|NCT04618601|Diuretics|diuretics|mesh-ancestor
110371704|NCT04618601|Natriuretic Agents|natriuretic agents|mesh-ancestor
110371705|NCT00567918|Tacrolimus|tacrolimus|mesh-list
110371706|NCT00567918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110371707|NCT00567918|Immunologic Factors|immunologic factors|mesh-ancestor
110371708|NCT00567918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110371709|NCT00567918|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110371710|NCT00567918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110371711|NCT00567918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110371713|NCT00569712|Formoterol Fumarate|formoterol fumarate|mesh-list
110371714|NCT00569712|Dimercaprol|dimercaprol|mesh-list
110371715|NCT00569712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110371716|NCT00569712|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110371717|NCT00569712|Autonomic Agents|autonomic agents|mesh-ancestor
110371718|NCT00569712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110371719|NCT00569712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110371720|NCT00569712|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110371721|NCT00569712|Respiratory System Agents|respiratory system agents|mesh-ancestor
110371722|NCT00569712|Glucocorticoids|glucocorticoids|mesh-ancestor
110371723|NCT00569712|Hormones|hormones|mesh-ancestor
110371724|NCT00569712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110371725|NCT00569712|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110371726|NCT00569712|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110371727|NCT00569712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110371728|NCT00569712|Adrenergic Agents|adrenergic agents|mesh-ancestor
110371729|NCT00569712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110371730|NCT00569712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110371731|NCT00569712|Chelating Agents|chelating agents|mesh-ancestor
110371732|NCT00569712|Sequestering Agents|sequestering agents|mesh-ancestor
110371733|NCT00569751|Paclitaxel|paclitaxel|mesh-list
110371734|NCT00569751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110371735|NCT00569751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110371736|NCT00569751|Tubulin Modulators|tubulin modulators|mesh-ancestor
110371737|NCT00569751|Antimitotic Agents|antimitotic agents|mesh-ancestor
110371738|NCT00569751|Mitosis Modulators|mitosis modulators|mesh-ancestor
110371739|NCT00569751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110371740|NCT00569790|Bevacizumab|bevacizumab|mesh-list
110371741|NCT00569790|Irinotecan|irinotecan|mesh-list
110371742|NCT00569790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110371743|NCT00569790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110371744|NCT00569790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110371745|NCT00569790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110371746|NCT00569790|Growth Substances|growth substances|mesh-ancestor
110371747|NCT00569790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110371748|NCT00569790|Growth Inhibitors|growth inhibitors|mesh-ancestor
110371749|NCT00569790|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110371750|NCT00569790|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110371751|NCT00569790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110371752|NCT00569790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110371753|NCT00567957|Remifentanil|remifentanil|mesh-list
110371756|NCT00567957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110371757|NCT00567957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110371758|NCT00567957|Analgesics|analgesics|mesh-ancestor
110371759|NCT00567957|Sensory System Agents|sensory system agents|mesh-ancestor
110371760|NCT00567957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110371761|NCT02940002|Betamethasone|betamethasone|mesh-list
110371762|NCT02940002|Clobetasol|clobetasol|mesh-list
110371763|NCT02940002|Calcipotriene|calcipotriene|mesh-list
110371764|NCT02940002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110371765|NCT02940002|Glucocorticoids|glucocorticoids|mesh-ancestor
110371766|NCT02940002|Hormones|hormones|mesh-ancestor
110371767|NCT02940002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110371768|NCT02940002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110371769|NCT02940002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110371770|NCT02940002|Respiratory System Agents|respiratory system agents|mesh-ancestor
110371771|NCT02940002|Dermatologic Agents|dermatologic agents|mesh-ancestor
110371772|NCT04618328|Tretinoin|tretinoin|mesh-list
110371773|NCT04618328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110371774|NCT04618328|Keratolytic Agents|keratolytic agents|mesh-ancestor
110371775|NCT04618328|Dermatologic Agents|dermatologic agents|mesh-ancestor
110371776|NCT04617782|Donepezil|donepezil|mesh-list
110371777|NCT04617782|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110371778|NCT04617782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110371779|NCT04617782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110371780|NCT04617782|Cholinergic Agents|cholinergic agents|mesh-ancestor
110371781|NCT04617782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110371782|NCT04617782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110371783|NCT04617782|Nootropic Agents|nootropic agents|mesh-ancestor
110371784|NCT00569985|Cyclophosphamide|cyclophosphamide|mesh-list
110371785|NCT00569985|Carmustine|carmustine|mesh-list
110371786|NCT00569985|Etoposide|etoposide|mesh-list
110371787|NCT00569985|Etoposide phosphate|etoposide phosphate|mesh-list
110371788|NCT00569985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110371789|NCT00569985|Immunologic Factors|immunologic factors|mesh-ancestor
110371790|NCT00569985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110371791|NCT00569985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110371792|NCT00569985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110371793|NCT00569985|Alkylating Agents|alkylating agents|mesh-ancestor
110371794|NCT00569985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110371795|NCT00569985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110371796|NCT00569985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110371797|NCT00569985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110371798|NCT00569985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110371799|NCT00569985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110371800|NCT00569985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110371801|NCT04617626|Azithromycin|azithromycin|mesh-list
110371802|NCT04617626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110371804|NCT04585230|Mineral Oil|mineral oil|mesh-list
110371805|NCT04585230|Emollients|emollients|mesh-ancestor
110371806|NCT04585230|Dermatologic Agents|dermatologic agents|mesh-ancestor
110371807|NCT00570180|Bortezomib|bortezomib|mesh-list
110371808|NCT00570180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110371809|NCT02939846|Trametinib|trametinib|mesh-list
110371810|NCT02939846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110371811|NCT02939846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110371812|NCT02939846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110371813|NCT02939846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110371814|NCT02939495|Sildenafil Citrate|sildenafil citrate|mesh-list
110371815|NCT02939495|Vasodilator Agents|vasodilator agents|mesh-ancestor
110371816|NCT02939495|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110371817|NCT02939495|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110371818|NCT02939495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110371820|NCT02939495|Urological Agents|urological agents|mesh-ancestor
110371821|NCT00570219|Valproic Acid|valproic acid|mesh-list
110371822|NCT00570219|Anticonvulsants|anticonvulsants|mesh-ancestor
110371823|NCT00570219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110371824|NCT00570219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110371825|NCT00570219|GABA Agents|gaba agents|mesh-ancestor
110371826|NCT00570219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110371827|NCT00570219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110371828|NCT00570219|Antimanic Agents|antimanic agents|mesh-ancestor
110371829|NCT00570219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110371830|NCT00570219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110371831|NCT00570219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110371832|NCT00570375|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110371833|NCT00570375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110371834|NCT00570375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110371835|NCT00570375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110371836|NCT00570375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110371837|NCT00568074|Repaglinide|repaglinide|mesh-list
110371838|NCT00568074|Acarbose|acarbose|mesh-list
110371839|NCT00568074|Gliquidone|gliquidone|mesh-list
110371840|NCT00568074|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110371841|NCT00568074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110371842|NCT00568074|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110371843|NCT00568074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110371844|NCT00568074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110371845|NCT00568113|Acetylcysteine|acetylcysteine|mesh-list
110371846|NCT00568113|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110371847|NCT00568113|Antiviral Agents|antiviral agents|mesh-ancestor
110371848|NCT00568113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110371849|NCT00568113|Expectorants|expectorants|mesh-ancestor
110371850|NCT00568113|Respiratory System Agents|respiratory system agents|mesh-ancestor
110371851|NCT00568113|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110371852|NCT00568113|Antioxidants|antioxidants|mesh-ancestor
110371853|NCT00568113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110371854|NCT00568113|Protective Agents|protective agents|mesh-ancestor
110371855|NCT00568113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110371856|NCT00568113|Antidotes|antidotes|mesh-ancestor
110371857|NCT00568152|Aspirin|aspirin|mesh-list
110371858|NCT00568152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110371859|NCT00568152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110371860|NCT00568152|Analgesics|analgesics|mesh-ancestor
110371861|NCT00568152|Sensory System Agents|sensory system agents|mesh-ancestor
110371862|NCT00568152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110371863|NCT00568152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110371864|NCT00568152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110371865|NCT00568152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110371866|NCT00568152|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110371867|NCT00568152|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110371868|NCT00568152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110371869|NCT00568152|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110371870|NCT00568152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110371871|NCT00568152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110371872|NCT00568152|Antipyretics|antipyretics|mesh-ancestor
110371873|NCT04610879|Carbamazepine|carbamazepine|mesh-list
110371874|NCT04610879|Levetiracetam|levetiracetam|mesh-list
110371875|NCT04610879|Anticonvulsants|anticonvulsants|mesh-ancestor
110371876|NCT04610879|Nootropic Agents|nootropic agents|mesh-ancestor
110371877|NCT04610879|Antimanic Agents|antimanic agents|mesh-ancestor
110371878|NCT04610879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110371879|NCT04610879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110371880|NCT04610879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110371881|NCT04610879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110371882|NCT04610879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110371883|NCT04610879|Analgesics|analgesics|mesh-ancestor
110371885|NCT04610879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110371886|NCT04610879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110371887|NCT04610879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110371888|NCT04610879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110371889|NCT04610879|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110371890|NCT04610879|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110371891|NCT00570648|Hyaluronic Acid|hyaluronic acid|mesh-list
110371892|NCT00570648|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110371893|NCT00570648|Immunologic Factors|immunologic factors|mesh-ancestor
110371894|NCT00570648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110371895|NCT00570648|Viscosupplements|viscosupplements|mesh-ancestor
110371896|NCT00570648|Protective Agents|protective agents|mesh-ancestor
110371897|NCT00570726|Ranibizumab|ranibizumab|mesh-list
110371898|NCT00570726|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110371899|NCT00570726|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110371900|NCT00570726|Growth Substances|growth substances|mesh-ancestor
110371901|NCT00570726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110371902|NCT00570726|Growth Inhibitors|growth inhibitors|mesh-ancestor
110371903|NCT00570726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110371904|NCT00570843|Lubricant Eye Drops|lubricant eye drops|mesh-list
110371905|NCT00570843|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110371906|NCT00570843|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110371907|NCT00563069|Midazolam|midazolam|mesh-list
110371909|NCT00563069|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110371910|NCT00563069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110371911|NCT00563069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110371912|NCT00563069|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110371913|NCT00563069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110371914|NCT00563069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110371915|NCT00563069|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110371916|NCT00563069|Anesthetics, General|anesthetics, general|mesh-ancestor
110371917|NCT00563069|Anesthetics|anesthetics|mesh-ancestor
110371918|NCT00563069|GABA Modulators|gaba modulators|mesh-ancestor
110371919|NCT00563069|GABA Agents|gaba agents|mesh-ancestor
110371920|NCT00563069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110371921|NCT00563069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110371922|NCT04580355|Amoxicillin|amoxicillin|mesh-list
110371923|NCT04580355|Metronidazole|metronidazole|mesh-list
110371924|NCT04580355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110371925|NCT04580355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110371926|NCT04580355|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110371927|NCT04580355|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110371928|NCT00563108|Basiliximab|basiliximab|mesh-list
110371929|NCT00563108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110371930|NCT00563108|Immunologic Factors|immunologic factors|mesh-ancestor
110371931|NCT00563108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110371932|NCT00570882|Sunitinib|sunitinib|mesh-list
110371933|NCT00570882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110371934|NCT00570882|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110371935|NCT00570882|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110371936|NCT00570882|Growth Substances|growth substances|mesh-ancestor
110371937|NCT00570882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110371938|NCT00570882|Growth Inhibitors|growth inhibitors|mesh-ancestor
110371939|NCT00570882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110371940|NCT00570882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110371941|NCT00570882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110371942|NCT00563147|Sirolimus|sirolimus|mesh-list
110371943|NCT00563147|Temsirolimus|temsirolimus|mesh-list
110371944|NCT00563147|MTOR Inhibitors|mtor inhibitors|mesh-list
110371945|NCT00563147|Tivozanib|tivozanib|mesh-list
110371946|NCT00563147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110371947|NCT00563147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110371948|NCT00563147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110371950|NCT00563147|Immunologic Factors|immunologic factors|mesh-ancestor
110371951|NCT00563147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110371952|NCT00563147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110371953|NCT00563147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110371954|NCT00563147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110371955|NCT00563147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110371956|NCT00563147|Antifungal Agents|antifungal agents|mesh-ancestor
110371959|NCT00570999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110371960|NCT04616261|Formoterol Fumarate|formoterol fumarate|mesh-list
110371961|NCT04616261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110371962|NCT04616261|Autonomic Agents|autonomic agents|mesh-ancestor
110371963|NCT04616261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110371964|NCT04616261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110371965|NCT04616261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110371966|NCT04616261|Respiratory System Agents|respiratory system agents|mesh-ancestor
110371967|NCT04616261|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110371968|NCT04616261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110371969|NCT04616261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110371970|NCT04616261|Adrenergic Agents|adrenergic agents|mesh-ancestor
110371971|NCT04616261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110371972|NCT04616261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110371974|NCT00563225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110371975|NCT00563225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110371976|NCT00571116|Arsenic Trioxide|arsenic trioxide|mesh-list
110371977|NCT00571116|Disulfiram|disulfiram|mesh-list
110371978|NCT00571116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110371979|NCT00571116|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110371980|NCT00571116|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
110371981|NCT00571116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110371982|NCT00571116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110371983|NCT00571155|Levetiracetam|levetiracetam|mesh-list
110371984|NCT00571155|Anticonvulsants|anticonvulsants|mesh-ancestor
110371985|NCT00571155|Nootropic Agents|nootropic agents|mesh-ancestor
110371986|NCT04615481|Metronidazole|metronidazole|mesh-list
110371987|NCT04615481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110371988|NCT04615481|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110371989|NCT04615481|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110371990|NCT04615481|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110371991|NCT04614584|Mirtazapine|mirtazapine|mesh-list
110371992|NCT04614584|Methamphetamine|methamphetamine|mesh-list
110371993|NCT04614584|Antidepressive Agents|antidepressive agents|mesh-ancestor
110371994|NCT04614584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110371995|NCT04614584|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110371996|NCT04614584|Histamine Antagonists|histamine antagonists|mesh-ancestor
110371997|NCT04614584|Histamine Agents|histamine agents|mesh-ancestor
110371998|NCT04614584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110371999|NCT04614584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110372000|NCT04614584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372001|NCT04614584|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110372002|NCT04614584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110372003|NCT04614584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110372004|NCT04614584|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110372006|NCT04614584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110372007|NCT04614584|Adrenergic Agents|adrenergic agents|mesh-ancestor
110372008|NCT04614584|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110372009|NCT04614584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110372010|NCT04614584|Serotonin Agents|serotonin agents|mesh-ancestor
110372011|NCT04614584|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110372012|NCT04614584|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110372013|NCT04614584|Sympathomimetics|sympathomimetics|mesh-ancestor
110372014|NCT04614584|Autonomic Agents|autonomic agents|mesh-ancestor
110372015|NCT04614584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110372016|NCT04614584|Dopamine Agents|dopamine agents|mesh-ancestor
110372017|NCT04614584|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110372018|NCT04614584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110372019|NCT04614584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110372020|NCT04614584|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110372021|NCT00563303|Hydrocortisone|hydrocortisone|mesh-list
110372022|NCT00563303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110372023|NCT00571506|Pioglitazone|pioglitazone|mesh-list
110372024|NCT00571506|Rosiglitazone|rosiglitazone|mesh-list
110372025|NCT00571506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110372026|NCT00571506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372027|NCT04613609|Nicotine|nicotine|mesh-list
110372028|NCT04613609|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110372029|NCT04613609|Autonomic Agents|autonomic agents|mesh-ancestor
110372030|NCT04613609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110372031|NCT04613609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372032|NCT04613609|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110372033|NCT04613609|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110372034|NCT04613609|Cholinergic Agents|cholinergic agents|mesh-ancestor
110372035|NCT04613609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110372036|NCT04613609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110372038|NCT00571740|Bevacizumab|bevacizumab|mesh-list
110372039|NCT00571740|Cetuximab|cetuximab|mesh-list
110372041|NCT00571740|Oxaliplatin|oxaliplatin|mesh-list
110372042|NCT00571740|Calcium|calcium|mesh-list
110372043|NCT00571740|Levoleucovorin|levoleucovorin|mesh-list
110372044|NCT00571740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110372045|NCT00571740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110372046|NCT00571740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110372047|NCT00571740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110372048|NCT00571740|Growth Substances|growth substances|mesh-ancestor
110372049|NCT00571740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372050|NCT00571740|Growth Inhibitors|growth inhibitors|mesh-ancestor
110372051|NCT00571740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110372053|NCT00571740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110372054|NCT00571740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110372055|NCT00571740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110372056|NCT00571740|Immunologic Factors|immunologic factors|mesh-ancestor
110372057|NCT00571740|Antidotes|antidotes|mesh-ancestor
110372058|NCT00571740|Protective Agents|protective agents|mesh-ancestor
110372059|NCT00571740|Vitamin B Complex|vitamin b complex|mesh-ancestor
110372060|NCT00571740|Vitamins|vitamins|mesh-ancestor
110372061|NCT00571740|Micronutrients|micronutrients|mesh-ancestor
110372062|NCT00563342|Ethanol|ethanol|mesh-list
110372063|NCT00563342|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110372064|NCT00563342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110372066|NCT00563342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372067|NCT04583046|Iloprost|iloprost|mesh-list
110372068|NCT04583046|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110372069|NCT04583046|Vasodilator Agents|vasodilator agents|mesh-ancestor
110372070|NCT04582929|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110372071|NCT04582929|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110372072|NCT04582929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110372073|NCT04582929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372074|NCT04582929|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110372075|NCT04582929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110372076|NCT04582929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110372077|NCT04582929|Cholinergic Agents|cholinergic agents|mesh-ancestor
110372078|NCT04582929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110372079|NCT04613726|Ondansetron|ondansetron|mesh-list
110372080|NCT04613726|Granisetron|granisetron|mesh-list
110372081|NCT04613726|Antiemetics|antiemetics|mesh-ancestor
110372082|NCT04613726|Autonomic Agents|autonomic agents|mesh-ancestor
110372083|NCT04613726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110372084|NCT04613726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372085|NCT04613726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110372086|NCT04613726|Antipruritics|antipruritics|mesh-ancestor
110372087|NCT04613726|Dermatologic Agents|dermatologic agents|mesh-ancestor
110372088|NCT04613726|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110372090|NCT04613726|Serotonin Agents|serotonin agents|mesh-ancestor
110372091|NCT04613726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110372092|NCT04613726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110372093|NCT04613804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110372094|NCT04613804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110372095|NCT04613804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110372096|NCT04613804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110372097|NCT04613102|Cannabidiol|cannabidiol|mesh-list
110372098|NCT04613102|Anticonvulsants|anticonvulsants|mesh-ancestor
110372099|NCT04613219|Tofacitinib|tofacitinib|mesh-list
110372100|NCT04613219|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110372101|NCT04613219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110372102|NCT04613219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110372103|NCT04613219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110372104|NCT00563615|Tegaserod|tegaserod|mesh-list
110372105|NCT00563615|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110372106|NCT00563615|Serotonin Agents|serotonin agents|mesh-ancestor
110372107|NCT00563615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110372108|NCT00563615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110372109|NCT00563615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372111|NCT00563654|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110372112|NCT00563654|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110372113|NCT00563654|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110372114|NCT00563654|Adrenergic Agents|adrenergic agents|mesh-ancestor
110372115|NCT00563654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110372116|NCT00563654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110372117|NCT00563654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372118|NCT00563654|Urological Agents|urological agents|mesh-ancestor
110372120|NCT04613180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110372121|NCT04613180|Respiratory System Agents|respiratory system agents|mesh-ancestor
110372122|NCT04613180|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110372124|NCT04613180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110372126|NCT04613180|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110372127|NCT04613180|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110372128|NCT04613180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110372129|NCT00571935|Insulin|insulin|mesh-list
110372130|NCT00571935|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110372131|NCT00571935|Insulin Aspart|insulin aspart|mesh-list
110372132|NCT00571935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110372134|NCT04612634|Vaccines|vaccines|mesh-list
110372135|NCT04612634|Immunologic Factors|immunologic factors|mesh-ancestor
110372136|NCT04612634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372137|NCT04612556|Vaccines|vaccines|mesh-list
110372138|NCT04612556|Immunologic Factors|immunologic factors|mesh-ancestor
110372139|NCT04612556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372140|NCT04580199|Ethanol|ethanol|mesh-list
110372141|NCT04580199|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110372142|NCT04580199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110372143|NCT04580199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110372144|NCT04580199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372145|NCT00568347|Fluticasone|fluticasone|mesh-list
110372147|NCT00568347|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110372148|NCT00568347|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110372149|NCT00568347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110372150|NCT00568347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110372151|NCT00568347|Autonomic Agents|autonomic agents|mesh-ancestor
110372152|NCT00568347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110372153|NCT00568347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372154|NCT00568347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110372155|NCT00568347|Respiratory System Agents|respiratory system agents|mesh-ancestor
110372156|NCT00568347|Dermatologic Agents|dermatologic agents|mesh-ancestor
110372158|NCT00568347|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110372159|NCT00568347|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110372160|NCT00568347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110372161|NCT00568347|Adrenergic Agents|adrenergic agents|mesh-ancestor
110372162|NCT00568347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110372163|NCT00568347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110372165|NCT00568347|Hormones|hormones|mesh-ancestor
110372166|NCT00568347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110372167|NCT00568347|Sympathomimetics|sympathomimetics|mesh-ancestor
110372168|NCT04611971|Belimumab|belimumab|mesh-list
110372169|NCT04611971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110372170|NCT04611971|Immunologic Factors|immunologic factors|mesh-ancestor
110372171|NCT04611971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372172|NCT00572208|Gabapentin|gabapentin|mesh-list
110372173|NCT00572208|Analgesics|analgesics|mesh-ancestor
110372174|NCT00572208|Sensory System Agents|sensory system agents|mesh-ancestor
110372175|NCT00572208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110372176|NCT00572208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372177|NCT00572208|Anticonvulsants|anticonvulsants|mesh-ancestor
110372178|NCT00572208|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110372179|NCT00572208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110372180|NCT00572208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110372181|NCT00572208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110372182|NCT00572208|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110372183|NCT00572208|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110372184|NCT00572208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110372185|NCT00572208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110372188|NCT00572364|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
110372189|NCT00572364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110372190|NCT00572364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110372191|NCT00572364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110372192|NCT00563771|Rasburicase|rasburicase|mesh-list
110372193|NCT00563771|Gout Suppressants|gout suppressants|mesh-ancestor
110372194|NCT00563771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110372195|NCT04582032|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
110372196|NCT04582032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110372197|NCT04582032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110372198|NCT04582032|Analgesics|analgesics|mesh-ancestor
110372199|NCT04582032|Sensory System Agents|sensory system agents|mesh-ancestor
110372200|NCT04582032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110372201|NCT04582032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372202|NCT04582032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110372203|NCT04582032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110372204|NCT00563849|Leflunomide|leflunomide|mesh-list
110372205|NCT00563849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110372206|NCT00563849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110372207|NCT00563849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110372208|NCT00563849|Immunologic Factors|immunologic factors|mesh-ancestor
110372209|NCT00563849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372210|NCT04581876|Paclitaxel|paclitaxel|mesh-list
110372211|NCT04581876|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110372212|NCT04581876|Raltitrexed|raltitrexed|mesh-list
110372213|NCT04581876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110372214|NCT04581876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110372215|NCT04581876|Tubulin Modulators|tubulin modulators|mesh-ancestor
110372216|NCT04581876|Antimitotic Agents|antimitotic agents|mesh-ancestor
110372217|NCT04581876|Mitosis Modulators|mitosis modulators|mesh-ancestor
110372218|NCT04581876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110372219|NCT04581876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110372220|NCT04581876|Antimetabolites|antimetabolites|mesh-ancestor
110372221|NCT04581876|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110372222|NCT04581876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110372223|NCT00563927|Fluorouracil|fluorouracil|mesh-list
110372224|NCT00563927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110372225|NCT00563927|Antimetabolites|antimetabolites|mesh-ancestor
110372226|NCT00563927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110372227|NCT00563927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110372228|NCT00563927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110372229|NCT00563927|Immunologic Factors|immunologic factors|mesh-ancestor
110372230|NCT00563927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372231|NCT01150123|Vaccines|vaccines|mesh-list
110372232|NCT01150123|Immunologic Factors|immunologic factors|mesh-ancestor
110372233|NCT01150123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372234|NCT00572559|Vancomycin|vancomycin|mesh-list
110372235|NCT00572559|Linezolid|linezolid|mesh-list
110372236|NCT00572559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110372237|NCT00572559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110372238|NCT00572559|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110372239|NCT00572559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110372240|NCT00572559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110372241|NCT04611464|Misoprostol|misoprostol|mesh-list
110372242|NCT04611464|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110372243|NCT04611464|Abortifacient Agents|abortifacient agents|mesh-ancestor
110372244|NCT04611464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110372247|NCT04611464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110372248|NCT04611464|Oxytocics|oxytocics|mesh-ancestor
110372250|NCT04611776|Carboplatin|carboplatin|mesh-list
110372251|NCT04611776|Gemcitabine|gemcitabine|mesh-list
110372254|NCT04611776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110372255|NCT04611776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110372256|NCT04611776|Tubulin Modulators|tubulin modulators|mesh-ancestor
110372257|NCT04611776|Antimitotic Agents|antimitotic agents|mesh-ancestor
110372258|NCT04611776|Mitosis Modulators|mitosis modulators|mesh-ancestor
110372259|NCT04611776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110372260|NCT04611776|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110372261|NCT04611776|Antimetabolites|antimetabolites|mesh-ancestor
110372262|NCT04611776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110372263|NCT04611776|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110372264|NCT04611776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110372265|NCT04611776|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110372266|NCT04611776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110372267|NCT00572637|Delanzomib|delanzomib|mesh-list
110372268|NCT00572637|Proteasome Inhibitors|proteasome inhibitors|mesh-ancestor
110372269|NCT00572637|Protease Inhibitors|protease inhibitors|mesh-ancestor
110372270|NCT00572637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110372271|NCT00572637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110372272|NCT01149655|Aripiprazole|aripiprazole|mesh-list
110372273|NCT01149655|Antidepressive Agents|antidepressive agents|mesh-ancestor
110372274|NCT01149655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110372275|NCT01149655|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110372276|NCT01149655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110372277|NCT01149655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110372278|NCT01149655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372279|NCT01149655|Dopamine Agonists|dopamine agonists|mesh-ancestor
110372280|NCT01149655|Dopamine Agents|dopamine agents|mesh-ancestor
110372281|NCT01149655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110372282|NCT01149655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110372283|NCT01149655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110372284|NCT01149655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110372285|NCT01149655|Serotonin Agents|serotonin agents|mesh-ancestor
110372286|NCT01149655|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110372287|NCT01149655|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110372288|NCT01149655|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110372289|NCT01149655|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110372291|NCT00575406|Cyclophosphamide|cyclophosphamide|mesh-list
110372292|NCT00575406|Rituximab|rituximab|mesh-list
110372293|NCT00575406|Doxorubicin|doxorubicin|mesh-list
110372294|NCT00575406|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110372295|NCT00575406|Vincristine|vincristine|mesh-list
110372296|NCT00575406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110372297|NCT00575406|Immunologic Factors|immunologic factors|mesh-ancestor
110372298|NCT00575406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372299|NCT00575406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110372300|NCT00575406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110372301|NCT00575406|Alkylating Agents|alkylating agents|mesh-ancestor
110372302|NCT00575406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110372303|NCT00575406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110372304|NCT00575406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110372305|NCT00575406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110372306|NCT00575406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110372307|NCT00575406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110372308|NCT00575406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110372309|NCT00575406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110372310|NCT00575406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110372314|NCT00575406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110372315|NCT00575406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110372316|NCT00575406|Tubulin Modulators|tubulin modulators|mesh-ancestor
110372317|NCT00575406|Antimitotic Agents|antimitotic agents|mesh-ancestor
110372318|NCT00575406|Mitosis Modulators|mitosis modulators|mesh-ancestor
110372319|NCT01149538|Choline|choline|mesh-list
110372320|NCT01149538|Lipotropic Agents|lipotropic agents|mesh-ancestor
110372321|NCT01149538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110372322|NCT01149538|Antimetabolites|antimetabolites|mesh-ancestor
110372323|NCT01149538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110372324|NCT01149538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110372325|NCT01149538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110372326|NCT01149538|Nootropic Agents|nootropic agents|mesh-ancestor
110372328|NCT01149460|Antiviral Agents|antiviral agents|mesh-ancestor
110372329|NCT01149460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110372330|NCT00575523|Atropine|atropine|mesh-list
110372331|NCT00575523|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110372332|NCT00575523|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110372333|NCT00575523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110372334|NCT00575523|Autonomic Agents|autonomic agents|mesh-ancestor
110372335|NCT00575523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110372336|NCT00575523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372337|NCT00575523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110372338|NCT00575523|Respiratory System Agents|respiratory system agents|mesh-ancestor
110372339|NCT00575523|Mydriatics|mydriatics|mesh-ancestor
110372340|NCT00575523|Parasympatholytics|parasympatholytics|mesh-ancestor
110372341|NCT00575523|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110372342|NCT00575523|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110372343|NCT00575523|Cholinergic Agents|cholinergic agents|mesh-ancestor
110372344|NCT00575523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110372345|NCT00575523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110372346|NCT01149421|Dulaglutide|dulaglutide|mesh-list
110372347|NCT01149421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110372348|NCT01149421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372349|NCT00575601|Simvastatin|simvastatin|mesh-list
110372350|NCT00575601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110372351|NCT00575601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110372352|NCT00575601|Antimetabolites|antimetabolites|mesh-ancestor
110372353|NCT00575601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110372354|NCT00575601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110372355|NCT00575601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110372356|NCT00575601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110372357|NCT04600271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110372358|NCT04600271|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
110372359|NCT04600271|Norepinephrine|norepinephrine|mesh-list
110372360|NCT04600271|Analgesics|analgesics|mesh-list
110372361|NCT04600271|Diuretics|diuretics|mesh-list
110372362|NCT04600271|Sensory System Agents|sensory system agents|mesh-ancestor
110372363|NCT04600271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110372364|NCT04600271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372365|NCT04600271|Natriuretic Agents|natriuretic agents|mesh-ancestor
110372366|NCT04600271|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110372367|NCT04600271|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110372368|NCT04600271|Adrenergic Agents|adrenergic agents|mesh-ancestor
110372369|NCT04600271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110372370|NCT04600271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110372372|NCT04600271|Autonomic Agents|autonomic agents|mesh-ancestor
110372373|NCT04600271|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110372374|NCT04600271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110372375|NCT04600271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110372376|NCT00575640|Hydralazine|hydralazine|mesh-list
110372377|NCT00575640|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110372378|NCT00575640|Vasodilator Agents|vasodilator agents|mesh-ancestor
110372379|NCT04599959|Hydrocortisone|hydrocortisone|mesh-list
110372380|NCT04599959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110372381|NCT04579731|Lactitol|lactitol|mesh-list
110372382|NCT04579731|Cathartics|cathartics|mesh-ancestor
110372383|NCT04579731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110372384|NCT00565487|Capecitabine|capecitabine|mesh-list
110372385|NCT00565487|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110372386|NCT00565487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110372387|NCT00565487|Antimetabolites|antimetabolites|mesh-ancestor
110372388|NCT00565487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110372389|NCT00565487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110372390|NCT00565487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110372391|NCT00565487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110372392|NCT04600115|Adenosine|adenosine|mesh-list
110372393|NCT04600115|Regadenoson|regadenoson|mesh-list
110372394|NCT04600115|Analgesics|analgesics|mesh-ancestor
110372395|NCT04600115|Sensory System Agents|sensory system agents|mesh-ancestor
110372396|NCT04600115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110372397|NCT04600115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372398|NCT04600115|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110372400|NCT04600115|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110372401|NCT04600115|Purinergic Agonists|purinergic agonists|mesh-ancestor
110372402|NCT04600115|Purinergic Agents|purinergic agents|mesh-ancestor
110372403|NCT04600115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110372404|NCT04600115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110372405|NCT04600115|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
110372407|NCT04600037|Analgesics|analgesics|mesh-ancestor
110372408|NCT04600037|Sensory System Agents|sensory system agents|mesh-ancestor
110372409|NCT04600037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110372410|NCT04600037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372411|NCT04600037|Anticonvulsants|anticonvulsants|mesh-ancestor
110372412|NCT04600037|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110372413|NCT04600037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110372414|NCT04600037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110372415|NCT04600037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110372416|NCT04600037|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110372417|NCT04600037|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110372418|NCT04600037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110372419|NCT04600037|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110372420|NCT00575796|Vinblastine|vinblastine|mesh-list
110372421|NCT00575796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110372422|NCT00575796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110372423|NCT00575796|Tubulin Modulators|tubulin modulators|mesh-ancestor
110372424|NCT00575796|Antimitotic Agents|antimitotic agents|mesh-ancestor
110372425|NCT00575796|Mitosis Modulators|mitosis modulators|mesh-ancestor
110372426|NCT00575796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110372427|NCT00575835|Vitamin D|vitamin d|mesh-list
110372428|NCT00575835|Ergocalciferols|ergocalciferols|mesh-list
110372429|NCT00575835|Cholecalciferol|cholecalciferol|mesh-list
110372430|NCT00575835|Vitamins|vitamins|mesh-list
110372431|NCT00575835|Micronutrients|micronutrients|mesh-ancestor
110372432|NCT00575835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372433|NCT00575835|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110372434|NCT00575835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110372435|NCT00573222|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110372436|NCT00573222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110372437|NCT00573222|Respiratory System Agents|respiratory system agents|mesh-ancestor
110372438|NCT00575874|Pioglitazone|pioglitazone|mesh-list
110372439|NCT00575874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110372440|NCT00575874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372442|NCT03454217|Tramadol|tramadol|mesh-list
110372443|NCT03454217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110372444|NCT03454217|Narcotics|narcotics|mesh-ancestor
110372445|NCT03454217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110372446|NCT03454217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372447|NCT03454217|Analgesics|analgesics|mesh-ancestor
110372448|NCT03454217|Sensory System Agents|sensory system agents|mesh-ancestor
110372449|NCT03454217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110372450|NCT00575913|Alfuzosin|alfuzosin|mesh-list
110372451|NCT00575913|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110372452|NCT00575913|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110372453|NCT00575913|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110372454|NCT00575913|Adrenergic Agents|adrenergic agents|mesh-ancestor
110372455|NCT00575913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110372456|NCT00575913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110372457|NCT00575913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372458|NCT00575913|Urological Agents|urological agents|mesh-ancestor
110372459|NCT04579302|Bupivacaine|bupivacaine|mesh-list
110372460|NCT04579302|Anesthetics, Local|anesthetics, local|mesh-ancestor
110372461|NCT04579302|Anesthetics|anesthetics|mesh-ancestor
110372462|NCT04579302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110372463|NCT04579302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372464|NCT04579302|Sensory System Agents|sensory system agents|mesh-ancestor
110372465|NCT04579302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110372466|NCT00565682|Etoricoxib|etoricoxib|mesh-list
110372467|NCT00565682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110372468|NCT00565682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110372469|NCT00565682|Analgesics|analgesics|mesh-ancestor
110372470|NCT00565682|Sensory System Agents|sensory system agents|mesh-ancestor
110372471|NCT00565682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110372472|NCT00565682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372473|NCT00565682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110372474|NCT00565682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110372475|NCT00565682|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110372476|NCT00565682|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110372477|NCT00565682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110372478|NCT00565682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110372479|NCT00575952|Paclitaxel|paclitaxel|mesh-list
110372480|NCT00575952|Doxorubicin|doxorubicin|mesh-list
110372481|NCT00575952|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110372482|NCT00575952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110372483|NCT00575952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110372484|NCT00575952|Tubulin Modulators|tubulin modulators|mesh-ancestor
110372485|NCT00575952|Antimitotic Agents|antimitotic agents|mesh-ancestor
110372486|NCT00575952|Mitosis Modulators|mitosis modulators|mesh-ancestor
110372487|NCT00575952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110372488|NCT00575952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110372489|NCT00575952|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110372490|NCT00575952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110372491|NCT00575952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110372492|NCT00573417|Modafinil|modafinil|mesh-list
110372493|NCT00573417|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110372494|NCT00573417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372495|NCT00573417|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110372496|NCT00573417|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110372497|NCT00573417|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110372498|NCT00573417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110372499|NCT00573495|BIRC5 protein, human|birc5 protein, human|mesh-list
110372500|NCT00573495|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
110372501|NCT00573495|Protease Inhibitors|protease inhibitors|mesh-ancestor
110372502|NCT00573495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110372503|NCT00573495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110372504|NCT00565955|Montelukast|montelukast|mesh-list
110372505|NCT00565955|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110372506|NCT00565955|Respiratory System Agents|respiratory system agents|mesh-ancestor
110372507|NCT00565955|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110372508|NCT00565955|Hormone Antagonists|hormone antagonists|mesh-ancestor
110372509|NCT00565955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110372510|NCT00565955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372511|NCT00565955|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110372512|NCT00565955|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110372513|NCT00565955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110372515|NCT04598594|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110372516|NCT04598594|Autonomic Agents|autonomic agents|mesh-ancestor
110372517|NCT04598594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110372518|NCT04598594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372519|NCT04598594|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110372520|NCT04598594|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110372521|NCT04598594|Cholinergic Agents|cholinergic agents|mesh-ancestor
110372522|NCT04598594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110372523|NCT04598594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110372524|NCT00576069|Fluticasone|fluticasone|mesh-list
110372525|NCT00576069|Mometasone Furoate|mometasone furoate|mesh-list
110372527|NCT00576069|Budesonide|budesonide|mesh-list
110372528|NCT00576069|Formoterol Fumarate|formoterol fumarate|mesh-list
110372529|NCT00576069|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110372530|NCT00576069|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110372531|NCT00576069|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110372532|NCT00576069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110372533|NCT00576069|Glucocorticoids|glucocorticoids|mesh-ancestor
110372534|NCT00576069|Hormones|hormones|mesh-ancestor
110372535|NCT00576069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110372536|NCT00576069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372537|NCT00576069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110372538|NCT00576069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110372540|NCT00576069|Autonomic Agents|autonomic agents|mesh-ancestor
110372541|NCT00576069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110372542|NCT00576069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110372543|NCT00576069|Respiratory System Agents|respiratory system agents|mesh-ancestor
110372544|NCT00576069|Dermatologic Agents|dermatologic agents|mesh-ancestor
110372545|NCT00576069|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110372546|NCT00576069|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110372547|NCT00576069|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110372548|NCT00576069|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110372549|NCT00576069|Adrenergic Agents|adrenergic agents|mesh-ancestor
110372550|NCT00576069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110372551|NCT00576069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110372552|NCT00576069|Sympathomimetics|sympathomimetics|mesh-ancestor
110372553|NCT00573690|Carboplatin|carboplatin|mesh-list
110372554|NCT00573690|Etoposide|etoposide|mesh-list
110372555|NCT00573690|Pemetrexed|pemetrexed|mesh-list
110372556|NCT00573690|Sorafenib|sorafenib|mesh-list
110372557|NCT00573690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110372558|NCT00573690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110372559|NCT00573690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110372560|NCT00573690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110372561|NCT00573690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110372562|NCT00573690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110372563|NCT00573690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110372564|NCT00573690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110372565|NCT00573690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110372566|NCT00576225|Paclitaxel|paclitaxel|mesh-list
110372567|NCT00576225|Carboplatin|carboplatin|mesh-list
110372568|NCT00576225|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
110372569|NCT00576225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110372570|NCT00576225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110372571|NCT00576225|Tubulin Modulators|tubulin modulators|mesh-ancestor
110372572|NCT00576225|Antimitotic Agents|antimitotic agents|mesh-ancestor
110372573|NCT00576225|Mitosis Modulators|mitosis modulators|mesh-ancestor
110372574|NCT00576225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110372575|NCT04597931|Zoledronic Acid|zoledronic acid|mesh-list
110372576|NCT04597931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110372577|NCT04597931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372578|NCT00576459|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
110372579|NCT00576459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110372580|NCT00576459|Glucocorticoids|glucocorticoids|mesh-ancestor
110372581|NCT00576459|Hormones|hormones|mesh-ancestor
110372582|NCT00576459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110372583|NCT00576459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372584|NCT04597775|Hydroxychloroquine|hydroxychloroquine|mesh-list
110372585|NCT04597775|Antimalarials|antimalarials|mesh-ancestor
110372586|NCT04597775|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110372587|NCT04597775|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110372588|NCT04597775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110372589|NCT04597775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110372590|NCT04597775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110372591|NCT04597775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110372592|NCT00573885|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
110372593|NCT00573885|Antioxidants|antioxidants|mesh-ancestor
110372594|NCT00573885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110372595|NCT00573885|Protective Agents|protective agents|mesh-ancestor
110372596|NCT00573885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372597|NCT00573885|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110372598|NCT00573885|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110372599|NCT00573885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110372600|NCT00573885|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110372602|NCT00573924|Dexlansoprazole|dexlansoprazole|mesh-list
110372603|NCT00573924|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
110372604|NCT00573924|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110372605|NCT00573924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110372606|NCT00573924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110372607|NCT00573924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110372608|NCT00573963|Ropivacaine|ropivacaine|mesh-list
110372609|NCT00573963|Anesthetics, Local|anesthetics, local|mesh-ancestor
110372610|NCT00573963|Anesthetics|anesthetics|mesh-ancestor
110372611|NCT00573963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110372612|NCT00573963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372613|NCT00573963|Sensory System Agents|sensory system agents|mesh-ancestor
110372614|NCT00573963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110372616|NCT00576615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110372617|NCT00576615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110372618|NCT00576615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372619|NCT00576615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110372620|NCT00576615|Anesthetics, General|anesthetics, general|mesh-ancestor
110372621|NCT00576615|Anesthetics|anesthetics|mesh-ancestor
110372622|NCT00574041|Interferons|interferons|mesh-list
110372623|NCT00574041|Interferon-beta|interferon-beta|mesh-list
110372624|NCT00574041|Interferon beta-1a|interferon beta-1a|mesh-list
110372625|NCT00574041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110372626|NCT00574041|Antiviral Agents|antiviral agents|mesh-ancestor
110372627|NCT00574041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110372628|NCT00574041|Immunologic Factors|immunologic factors|mesh-ancestor
110372629|NCT00574041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372630|NCT00574041|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110372631|NCT00566267|Simvastatin|simvastatin|mesh-list
110372632|NCT00566267|Ezetimibe|ezetimibe|mesh-list
110372633|NCT00566267|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110372634|NCT00566267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110372635|NCT00566267|Antimetabolites|antimetabolites|mesh-ancestor
110372636|NCT00566267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110372637|NCT00566267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110372638|NCT00566267|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110372639|NCT00566267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110372640|NCT00574353|Misonidazole|misonidazole|mesh-list
110372641|NCT00574353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110372642|NCT00574353|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110372643|NCT00574353|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110372644|NCT00574353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110372646|NCT04596839|Antimetabolites|antimetabolites|mesh-ancestor
110372647|NCT04596839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110372648|NCT04596839|Antiviral Agents|antiviral agents|mesh-ancestor
110372649|NCT04596839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110372650|NCT00574470|Infliximab|infliximab|mesh-list
110372651|NCT00574470|Daclizumab|daclizumab|mesh-list
110372652|NCT00574470|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110372653|NCT00574470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110372654|NCT00574470|Dermatologic Agents|dermatologic agents|mesh-ancestor
110372655|NCT00574470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110372656|NCT00574470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110372657|NCT00574470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110372658|NCT00574470|Immunologic Factors|immunologic factors|mesh-ancestor
110372659|NCT00574470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372661|NCT00577161|Rituximab|rituximab|mesh-list
110372662|NCT00577161|Fludarabine|fludarabine|mesh-list
110372663|NCT00577161|Fludarabine phosphate|fludarabine phosphate|mesh-list
110372664|NCT00577161|Pixantrone|pixantrone|mesh-list
110372665|NCT00577161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110372666|NCT00577161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110372667|NCT00577161|Immunologic Factors|immunologic factors|mesh-ancestor
110372668|NCT00577161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372669|NCT00577161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110372670|NCT00577161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110372672|NCT00577161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110372673|NCT00577161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110372674|NCT00577161|Antiviral Agents|antiviral agents|mesh-ancestor
110372675|NCT00577161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110372676|NCT00577161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110372677|NCT00577161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110372678|NCT00577161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110372679|NCT00574509|Tositumomab I-131|tositumomab i-131|mesh-list
110372680|NCT00574509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110372681|NCT04596488|Efavirenz|efavirenz|mesh-list
110372682|NCT04596488|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110372683|NCT04596488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110372684|NCT04596488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110372685|NCT04596488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110372686|NCT04596488|Antiviral Agents|antiviral agents|mesh-ancestor
110372687|NCT04596488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110372688|NCT04596488|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110372689|NCT04596488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110372690|NCT04596488|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110372691|NCT04596488|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110372692|NCT04596488|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110372693|NCT04596488|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110372694|NCT04595942|Fludrocortisone|fludrocortisone|mesh-list
110372695|NCT04595942|Midodrine|midodrine|mesh-list
110372696|NCT04595942|Sympathomimetics|sympathomimetics|mesh-ancestor
110372697|NCT04595942|Autonomic Agents|autonomic agents|mesh-ancestor
110372698|NCT04595942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110372699|NCT04595942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372700|NCT04595942|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110372701|NCT04595942|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110372702|NCT04595942|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110372703|NCT04595942|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110372704|NCT04595942|Adrenergic Agents|adrenergic agents|mesh-ancestor
110372705|NCT04595942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110372706|NCT04595942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110372707|NCT04595942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110372708|NCT00566384|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
110372709|NCT00566384|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110372710|NCT00566384|Immunologic Factors|immunologic factors|mesh-ancestor
110372711|NCT00566384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372712|NCT00574743|Mycophenolic Acid|mycophenolic acid|mesh-list
110372713|NCT00574743|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110372714|NCT00574743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110372715|NCT00574743|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110372716|NCT00574743|Antitubercular Agents|antitubercular agents|mesh-ancestor
110372717|NCT00574743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110372718|NCT00574743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110372719|NCT00574743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110372720|NCT00574743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110372721|NCT04595318|Varenicline|varenicline|mesh-list
110372722|NCT04595318|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110372723|NCT04595318|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110372724|NCT04595318|Cholinergic Agents|cholinergic agents|mesh-ancestor
110372725|NCT04595318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110372726|NCT04595318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110372727|NCT04595318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372728|NCT00577668|Thalidomide|thalidomide|mesh-list
110372729|NCT00577668|Dexamethasone|dexamethasone|mesh-list
110372731|NCT00577668|Bortezomib|bortezomib|mesh-list
110372732|NCT00577668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110372733|NCT00577668|Antiemetics|antiemetics|mesh-ancestor
110372734|NCT00577668|Autonomic Agents|autonomic agents|mesh-ancestor
110372735|NCT00577668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110372736|NCT00577668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372737|NCT00577668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110372738|NCT00577668|Glucocorticoids|glucocorticoids|mesh-ancestor
110372739|NCT00577668|Hormones|hormones|mesh-ancestor
110372740|NCT00577668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110372741|NCT00577668|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110372742|NCT00577668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110372743|NCT00577668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110372744|NCT00577668|Alkylating Agents|alkylating agents|mesh-ancestor
110372745|NCT00577668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110372746|NCT00577668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110372747|NCT00577668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110372748|NCT00577668|Immunologic Factors|immunologic factors|mesh-ancestor
110372749|NCT00577668|Leprostatic Agents|leprostatic agents|mesh-ancestor
110372750|NCT00577668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110372751|NCT00577668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110372752|NCT00577668|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110372753|NCT00577668|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110372754|NCT00577668|Growth Substances|growth substances|mesh-ancestor
110372755|NCT00577668|Growth Inhibitors|growth inhibitors|mesh-ancestor
110372757|NCT01147744|Xhance|xhance|mesh-list
110372758|NCT01147744|Montelukast|montelukast|mesh-list
110372759|NCT01147744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110372760|NCT01147744|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110372761|NCT01147744|Autonomic Agents|autonomic agents|mesh-ancestor
110372762|NCT01147744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110372763|NCT01147744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372764|NCT01147744|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110372765|NCT01147744|Respiratory System Agents|respiratory system agents|mesh-ancestor
110372766|NCT01147744|Dermatologic Agents|dermatologic agents|mesh-ancestor
110372767|NCT01147744|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110372768|NCT01147744|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110372769|NCT01147744|Hormone Antagonists|hormone antagonists|mesh-ancestor
110372771|NCT01147744|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110372772|NCT01147744|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110372773|NCT01147744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110372774|NCT04313374|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
110372775|NCT04313374|Morphine|morphine|mesh-list
110372776|NCT04313374|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110372777|NCT04313374|Narcotics|narcotics|mesh-ancestor
110372778|NCT04313374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110372779|NCT04313374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372780|NCT04313374|Analgesics|analgesics|mesh-ancestor
110372781|NCT04313374|Sensory System Agents|sensory system agents|mesh-ancestor
110372782|NCT04313374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110372783|NCT04313374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110372784|NCT04313374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110372785|NCT04313374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110372787|NCT04313335|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110372788|NCT04313335|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110372789|NCT04313335|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110372790|NCT04313335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110372791|NCT04313335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110372792|NCT04313335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110372793|NCT04313335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372794|NCT04313335|Analgesics|analgesics|mesh-ancestor
110372795|NCT04313335|Sensory System Agents|sensory system agents|mesh-ancestor
110372796|NCT04313335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110372797|NCT04313335|Antidepressive Agents|antidepressive agents|mesh-ancestor
110372798|NCT04313335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110372799|NCT04313335|Dopamine Agents|dopamine agents|mesh-ancestor
110372800|NCT00577980|Testosterone|testosterone|mesh-list
110372801|NCT00577980|Androgens|androgens|mesh-ancestor
110372802|NCT00577980|Hormones|hormones|mesh-ancestor
110372803|NCT00577980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110372804|NCT00577980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372805|NCT04594343|Disulfiram|disulfiram|mesh-list
110372806|NCT04594343|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110372807|NCT04594343|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
110372808|NCT04594343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110372809|NCT04594343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110372811|NCT01147393|Veltuzumab|veltuzumab|mesh-list
110372812|NCT01147393|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
110372813|NCT01147393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110372814|NCT01147393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110372815|NCT01147393|Chelating Agents|chelating agents|mesh-ancestor
110372816|NCT01147393|Sequestering Agents|sequestering agents|mesh-ancestor
110372817|NCT01147393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110372818|NCT00578097|Botulinum Toxins|botulinum toxins|mesh-list
110372819|NCT00578097|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110372820|NCT00578097|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110372821|NCT00578097|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110372822|NCT00578097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110372823|NCT00578097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110372824|NCT00578097|Cholinergic Agents|cholinergic agents|mesh-ancestor
110372825|NCT00578097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110372826|NCT00578097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372827|NCT00578097|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110372828|NCT00578097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110372829|NCT00578370|Cyclosporine|cyclosporine|mesh-list
110372830|NCT00578370|Betamethasone|betamethasone|mesh-list
110372831|NCT00578370|Calcipotriene|calcipotriene|mesh-list
110372832|NCT00578370|Cyclosporins|cyclosporins|mesh-list
110372833|NCT00578370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110372834|NCT00578370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110372835|NCT00578370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110372836|NCT00578370|Immunologic Factors|immunologic factors|mesh-ancestor
110372837|NCT00578370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372838|NCT00578370|Antifungal Agents|antifungal agents|mesh-ancestor
110372839|NCT00578370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110372840|NCT00578370|Dermatologic Agents|dermatologic agents|mesh-ancestor
110372841|NCT00578370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110372842|NCT00578370|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110372843|NCT00578370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110372844|NCT00578370|Glucocorticoids|glucocorticoids|mesh-ancestor
110372845|NCT00578370|Hormones|hormones|mesh-ancestor
110372846|NCT00578370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110372847|NCT00578370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110372848|NCT00578370|Respiratory System Agents|respiratory system agents|mesh-ancestor
110372849|NCT04593836|Peppermint oil|peppermint oil|mesh-list
110372850|NCT04593836|Menthol|menthol|mesh-list
110372851|NCT04593836|Antipruritics|antipruritics|mesh-ancestor
110372852|NCT04593836|Dermatologic Agents|dermatologic agents|mesh-ancestor
110372853|NCT04593836|Antiemetics|antiemetics|mesh-ancestor
110372854|NCT04593836|Autonomic Agents|autonomic agents|mesh-ancestor
110372855|NCT04593836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110372856|NCT04593836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372857|NCT04593836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110372858|NCT04593836|Parasympatholytics|parasympatholytics|mesh-ancestor
110372859|NCT04593524|Vitamin D|vitamin d|mesh-list
110372860|NCT04593524|Vitamins|vitamins|mesh-ancestor
110372861|NCT04593524|Micronutrients|micronutrients|mesh-ancestor
110372862|NCT04593524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372863|NCT04593524|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110372865|NCT00578526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110372866|NCT00578526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110372867|NCT00578526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110372868|NCT00578526|Growth Substances|growth substances|mesh-ancestor
110372869|NCT00578526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372870|NCT00578526|Growth Inhibitors|growth inhibitors|mesh-ancestor
110372871|NCT00578526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110372872|NCT00578526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110372873|NCT00578526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110372874|NCT04593446|Picosulfate sodium|picosulfate sodium|mesh-list
110372875|NCT04593446|Cathartics|cathartics|mesh-ancestor
110372876|NCT04593446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110372877|NCT00566891|Tirofiban|tirofiban|mesh-list
110372878|NCT00566891|Clopidogrel|clopidogrel|mesh-list
110372879|NCT00566891|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110372880|NCT00566891|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110372881|NCT00566891|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110372882|NCT00566891|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110372883|NCT00566891|Purinergic Agents|purinergic agents|mesh-ancestor
110372884|NCT00566891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110372885|NCT00566891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110372886|NCT00566891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372888|NCT00566891|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110372889|NCT00578760|Aspirin|aspirin|mesh-list
110372890|NCT00578760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110372891|NCT00578760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110372892|NCT00578760|Analgesics|analgesics|mesh-ancestor
110372893|NCT00578760|Sensory System Agents|sensory system agents|mesh-ancestor
110372894|NCT00578760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110372895|NCT00578760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372896|NCT00578760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110372897|NCT00578760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110372898|NCT00578760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110372899|NCT00578760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110372900|NCT00578760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110372901|NCT00578760|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110372902|NCT00578760|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110372903|NCT00578760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110372904|NCT00578760|Antipyretics|antipyretics|mesh-ancestor
110372905|NCT04592822|Dabigatran|dabigatran|mesh-list
110372906|NCT04592822|Antithrombins|antithrombins|mesh-ancestor
110372907|NCT04592822|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110372908|NCT04592822|Protease Inhibitors|protease inhibitors|mesh-ancestor
110372909|NCT04592822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110372910|NCT04592822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110372911|NCT04592822|Anticoagulants|anticoagulants|mesh-ancestor
110372913|NCT00567047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110372914|NCT00567047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372915|NCT00567047|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110372916|NCT00567047|Protease Inhibitors|protease inhibitors|mesh-ancestor
110372917|NCT00567047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110372918|NCT00567047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110372920|NCT04592666|Pemetrexed|pemetrexed|mesh-list
110372921|NCT04592666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110372922|NCT04592666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110372923|NCT04592666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110372924|NCT04592666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110372925|NCT04592666|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110372926|NCT04592198|Palonosetron|palonosetron|mesh-list
110372927|NCT04592198|Antiemetics|antiemetics|mesh-ancestor
110372928|NCT04592198|Autonomic Agents|autonomic agents|mesh-ancestor
110372929|NCT04592198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110372930|NCT04592198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372931|NCT04592198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110372932|NCT04592198|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110372933|NCT04592198|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110372934|NCT04592198|Serotonin Agents|serotonin agents|mesh-ancestor
110372935|NCT04592198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110372936|NCT04592198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110372937|NCT04592081|Dexamethasone|dexamethasone|mesh-list
110372938|NCT04592081|Dexamethasone acetate|dexamethasone acetate|mesh-list
110372939|NCT04592081|BB 1101|bb 1101|mesh-list
110372940|NCT04592081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110372941|NCT04592081|Antiemetics|antiemetics|mesh-ancestor
110372942|NCT04592081|Autonomic Agents|autonomic agents|mesh-ancestor
110372943|NCT04592081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110372944|NCT04592081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372948|NCT04592081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110372949|NCT04592081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110372950|NCT04592081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110372951|NCT04592081|Protease Inhibitors|protease inhibitors|mesh-ancestor
110372952|NCT04592081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110372953|NCT04592081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110372954|NCT04591847|Vitamin D|vitamin d|mesh-list
110372955|NCT04591847|Ergocalciferols|ergocalciferols|mesh-list
110372956|NCT04591847|Vitamins|vitamins|mesh-ancestor
110372957|NCT04591847|Micronutrients|micronutrients|mesh-ancestor
110372958|NCT04591847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372959|NCT04591847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110372960|NCT04591847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110372962|NCT04591535|Carbidopa|carbidopa|mesh-list
110372963|NCT04591535|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110372964|NCT04591535|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110372965|NCT04591535|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110372966|NCT04591535|Dopamine Agents|dopamine agents|mesh-ancestor
110372967|NCT04591535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110372968|NCT04591535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110372969|NCT04591535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372970|NCT04591535|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110372971|NCT04591535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110372972|NCT04591535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110372973|NCT04591535|Immunologic Factors|immunologic factors|mesh-ancestor
110372974|NCT04591535|Dopamine Agonists|dopamine agonists|mesh-ancestor
110372975|NCT00580242|Lenalidomide|lenalidomide|mesh-list
110372976|NCT00580242|Bortezomib|bortezomib|mesh-list
110372977|NCT00580242|Immunologic Factors|immunologic factors|mesh-ancestor
110372978|NCT00580242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372979|NCT00580242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110372980|NCT00580242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110372981|NCT00580242|Growth Substances|growth substances|mesh-ancestor
110372982|NCT00580242|Growth Inhibitors|growth inhibitors|mesh-ancestor
110372983|NCT00580242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110372984|NCT04591457|Insulin|insulin|mesh-list
110372985|NCT04591457|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110372986|NCT04591457|Insulin Glargine|insulin glargine|mesh-list
110372987|NCT04591457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110372988|NCT04591457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372989|NCT00580320|Bortezomib|bortezomib|mesh-list
110372990|NCT00580320|Dacarbazine|dacarbazine|mesh-list
110372991|NCT00580320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110372992|NCT00580320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110372993|NCT00580320|Alkylating Agents|alkylating agents|mesh-ancestor
110372994|NCT00580320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110372996|NCT00580359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110372997|NCT00580359|Antimetabolites|antimetabolites|mesh-ancestor
110372998|NCT00580359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110372999|NCT00580359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110373000|NCT00580437|Dobutamine|dobutamine|mesh-list
110373001|NCT00580437|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110373002|NCT00580437|Sympathomimetics|sympathomimetics|mesh-ancestor
110373003|NCT00580437|Autonomic Agents|autonomic agents|mesh-ancestor
110373004|NCT00580437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110373005|NCT00580437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110373006|NCT00580437|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110373007|NCT00580437|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110373008|NCT00580437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110373009|NCT00580437|Adrenergic Agents|adrenergic agents|mesh-ancestor
110373010|NCT00580437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110373011|NCT00580437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110373012|NCT00580437|Protective Agents|protective agents|mesh-ancestor
110373013|NCT00580827|Disulfiram|disulfiram|mesh-list
110373014|NCT00580827|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110373015|NCT00580827|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
110373016|NCT00580827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110373017|NCT00580827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110373018|NCT00580905|Adenosine|adenosine|mesh-list
110373019|NCT00580905|Nitroprusside|nitroprusside|mesh-list
110373020|NCT00580905|Analgesics|analgesics|mesh-ancestor
110373021|NCT00580905|Sensory System Agents|sensory system agents|mesh-ancestor
110373022|NCT00580905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110373023|NCT00580905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110373024|NCT00580905|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110373025|NCT00580905|Vasodilator Agents|vasodilator agents|mesh-ancestor
110373026|NCT00580905|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110373027|NCT00580905|Purinergic Agonists|purinergic agonists|mesh-ancestor
110373028|NCT00580905|Purinergic Agents|purinergic agents|mesh-ancestor
110373029|NCT00580905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110373030|NCT00580905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110373031|NCT00580905|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110373032|NCT00580905|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110373033|NCT04590638|Epinephrine|epinephrine|mesh-list
110373034|NCT04590638|Racepinephrine|racepinephrine|mesh-list
110373035|NCT04590638|Epinephryl borate|epinephryl borate|mesh-list
110373036|NCT04590638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110373037|NCT04590638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110373038|NCT04590638|Adrenergic Agents|adrenergic agents|mesh-ancestor
110373039|NCT04590638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110373040|NCT04590638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110373041|NCT04590638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110373042|NCT04590638|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110373043|NCT04590638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110373044|NCT04590638|Autonomic Agents|autonomic agents|mesh-ancestor
110373045|NCT04590638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110373046|NCT04590638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110373047|NCT04590638|Respiratory System Agents|respiratory system agents|mesh-ancestor
110373048|NCT04590638|Mydriatics|mydriatics|mesh-ancestor
110373049|NCT04590638|Sympathomimetics|sympathomimetics|mesh-ancestor
110373050|NCT04590638|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110373053|NCT00567554|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110373054|NCT00567554|Cyclophosphamide|cyclophosphamide|mesh-list
110373055|NCT00567554|Bevacizumab|bevacizumab|mesh-list
110373056|NCT00567554|Trastuzumab|trastuzumab|mesh-list
110373057|NCT00567554|Everolimus|everolimus|mesh-list
110373058|NCT00567554|Epirubicin|epirubicin|mesh-list
110373059|NCT00567554|Lapatinib|lapatinib|mesh-list
110373060|NCT00567554|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110373061|NCT00567554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110373062|NCT00567554|Tubulin Modulators|tubulin modulators|mesh-ancestor
110373063|NCT00567554|Antimitotic Agents|antimitotic agents|mesh-ancestor
110373064|NCT00567554|Mitosis Modulators|mitosis modulators|mesh-ancestor
110373065|NCT00567554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110373066|NCT00567554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110373067|NCT00567554|Immunologic Factors|immunologic factors|mesh-ancestor
110373068|NCT00567554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110373069|NCT00567554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110373070|NCT00567554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110373071|NCT00567554|Alkylating Agents|alkylating agents|mesh-ancestor
110373072|NCT00567554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110373074|NCT00567554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110373075|NCT00567554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110373076|NCT00567554|Growth Substances|growth substances|mesh-ancestor
110373077|NCT00567554|Growth Inhibitors|growth inhibitors|mesh-ancestor
110373078|NCT00567554|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110373080|NCT00567554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110373081|NCT00567554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110373082|NCT00567554|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110373083|NCT00567554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110373085|NCT04590482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110373086|NCT04590482|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110373087|NCT04590482|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110373088|NCT04590482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110373089|NCT04590482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110373090|NCT04590482|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110373091|NCT04590482|Hormone Antagonists|hormone antagonists|mesh-ancestor
110373092|NCT04590482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110373093|NCT04590482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110373094|NCT00581217|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110373095|NCT00581217|Laxatives|laxatives|mesh-ancestor
110373096|NCT00581217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110373097|NCT00567710|Risperidone|risperidone|mesh-list
110373098|NCT00567710|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110373099|NCT00567710|Serotonin Agents|serotonin agents|mesh-ancestor
110373100|NCT00567710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110373101|NCT00567710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110373102|NCT00567710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110373103|NCT00567710|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110373104|NCT00567710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110373105|NCT00567710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110373106|NCT00567710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110373107|NCT00567710|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110373108|NCT00567710|Dopamine Agents|dopamine agents|mesh-ancestor
110373109|NCT04589429|Morphine|morphine|mesh-list
110373110|NCT04589429|Nalbuphine|nalbuphine|mesh-list
110373111|NCT04589429|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110373112|NCT04589429|Narcotics|narcotics|mesh-ancestor
110373113|NCT04589429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110373114|NCT04589429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110373115|NCT04589429|Analgesics|analgesics|mesh-ancestor
110373116|NCT04589429|Sensory System Agents|sensory system agents|mesh-ancestor
110373117|NCT04589429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110373118|NCT04589390|Selexipag|selexipag|mesh-list
110373119|NCT04589390|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110373120|NCT04577040|Tadalafil|tadalafil|mesh-list
110373121|NCT04577040|Vasodilator Agents|vasodilator agents|mesh-ancestor
110373122|NCT04577040|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110373123|NCT04577040|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110373124|NCT04577040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110373125|NCT04577040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110373126|NCT04577040|Urological Agents|urological agents|mesh-ancestor
110373127|NCT04589234|Gemcitabine|gemcitabine|mesh-list
110373128|NCT04589234|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110373129|NCT04589234|Folfirinox|folfirinox|mesh-list
110373130|NCT04589234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110373131|NCT04589234|Antimetabolites|antimetabolites|mesh-ancestor
110373132|NCT04589234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110373133|NCT04589234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110373134|NCT03453177|Fosfomycin|fosfomycin|mesh-list
110373135|NCT03453177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110373136|NCT03453177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110373137|NCT04594629|Nitroglycerin|nitroglycerin|mesh-list
110373138|NCT04594629|Vasodilator Agents|vasodilator agents|mesh-ancestor
110373139|NCT04588532|Doxepin|doxepin|mesh-list
110373140|NCT04588532|Histamine|histamine|mesh-list
110373141|NCT04588532|Histamine Agonists|histamine agonists|mesh-ancestor
110373142|NCT04588532|Histamine Agents|histamine agents|mesh-ancestor
110373143|NCT04588532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110373144|NCT04588532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110373145|NCT04588532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110373146|NCT04588532|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110373147|NCT04588532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110373148|NCT04588532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110373149|NCT04588532|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110373150|NCT04588532|Antidepressive Agents|antidepressive agents|mesh-ancestor
110373151|NCT04588532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110373152|NCT04588532|Histamine Antagonists|histamine antagonists|mesh-ancestor
110373153|NCT04577430|Dexmedetomidine|dexmedetomidine|mesh-list
110373154|NCT04577430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110373155|NCT04577430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110373156|NCT04577430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110373157|NCT04577430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110373158|NCT04577430|Analgesics|analgesics|mesh-ancestor
110373159|NCT04577430|Sensory System Agents|sensory system agents|mesh-ancestor
110373160|NCT04577430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110373161|NCT04577430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110373162|NCT04577430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110373163|NCT04577430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110373164|NCT04577430|Adrenergic Agents|adrenergic agents|mesh-ancestor
110373165|NCT04577430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110373166|NCT04577430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110373167|NCT00567788|Bimatoprost|bimatoprost|mesh-list
110373168|NCT00567788|Latanoprost|latanoprost|mesh-list
110373169|NCT00567788|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110373170|NCT00567788|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110373171|NCT00567788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110373172|NCT00581607|Bosentan|bosentan|mesh-list
110373173|NCT00581607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110373174|NCT00581607|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110373175|NCT00581607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110373176|NCT00581685|Celecoxib|celecoxib|mesh-list
110373178|NCT00581685|Analgesics|analgesics|mesh-ancestor
110373179|NCT00581685|Sensory System Agents|sensory system agents|mesh-ancestor
110373180|NCT00581685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110373181|NCT00581685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110373182|NCT00581685|Anticonvulsants|anticonvulsants|mesh-ancestor
110373183|NCT00581685|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110373184|NCT00581685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110373185|NCT00581685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110373186|NCT00581685|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110373187|NCT00581685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110373188|NCT00581685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110373189|NCT00581685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110373190|NCT00581685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110373191|NCT00581685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110373192|NCT00581685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110373193|NCT00581685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110373194|NCT00581685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110373195|NCT00581685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110373196|NCT00581685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110373197|NCT00581685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110373198|NCT04588220|Plasminogen|plasminogen|mesh-list
110373200|NCT04588220|Antioxidants|antioxidants|mesh-ancestor
110373201|NCT04588220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110373202|NCT04588220|Protective Agents|protective agents|mesh-ancestor
110373203|NCT04588220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110373204|NCT04588220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110373205|NCT04588220|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110373206|NCT04588220|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110373208|NCT04586543|Selegiline|selegiline|mesh-list
110373209|NCT04586543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110373210|NCT04586543|Tubulin Modulators|tubulin modulators|mesh-ancestor
110373212|NCT04586543|Mitosis Modulators|mitosis modulators|mesh-ancestor
110373213|NCT04586543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110373214|NCT04586543|Antidepressive Agents|antidepressive agents|mesh-ancestor
110373215|NCT04586543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110373216|NCT04586543|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110373217|NCT04586543|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110373218|NCT04586543|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110373219|NCT04586543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110373221|NCT04586543|Protective Agents|protective agents|mesh-ancestor
110373222|NCT04586543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110373223|NCT04586465|Carboplatin|carboplatin|mesh-list
110373224|NCT04586465|Gemcitabine|gemcitabine|mesh-list
110373225|NCT04586465|Pembrolizumab|pembrolizumab|mesh-list
110373226|NCT04586465|Pemetrexed|pemetrexed|mesh-list
110373227|NCT04586465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110373228|NCT04586465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110373229|NCT04586465|Antimetabolites|antimetabolites|mesh-ancestor
110373230|NCT04586465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110373231|NCT04586465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110373232|NCT04586465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110373233|NCT04586465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110373234|NCT04586465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110373235|NCT04586465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110373236|NCT00566865|Gemfibrozil|gemfibrozil|mesh-list
110373237|NCT00566865|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110373238|NCT00566865|Antimetabolites|antimetabolites|mesh-ancestor
110373239|NCT00566865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110373240|NCT00566865|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110373241|NCT00566865|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110373242|NCT00566865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110373243|NCT00566865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110373244|NCT04585997|Omalizumab|omalizumab|mesh-list
110373245|NCT04585997|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110373246|NCT04585997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110373247|NCT04585997|Respiratory System Agents|respiratory system agents|mesh-ancestor
110373248|NCT04593108|Letrozole|letrozole|mesh-list
110373249|NCT04593108|Misoprostol|misoprostol|mesh-list
110373250|NCT04593108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110373251|NCT04593108|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110373252|NCT04593108|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110373253|NCT04593108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110373254|NCT04593108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110373255|NCT04593108|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110373256|NCT04593108|Hormone Antagonists|hormone antagonists|mesh-ancestor
110373257|NCT04593108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110373258|NCT04593108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110373259|NCT04593108|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110373261|NCT04593108|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110373262|NCT04593108|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110373263|NCT04593108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110373264|NCT04593108|Oxytocics|oxytocics|mesh-ancestor
110373265|NCT04585334|Diclofenac|diclofenac|mesh-list
110373266|NCT04585334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110373267|NCT04585334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110373268|NCT04585334|Analgesics|analgesics|mesh-ancestor
110373269|NCT04585334|Sensory System Agents|sensory system agents|mesh-ancestor
110373270|NCT04585334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110373272|NCT04585334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110373273|NCT04585334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110373274|NCT04585334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110373275|NCT04585334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110373276|NCT04585334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110373277|NCT04585412|Palonosetron|palonosetron|mesh-list
110373278|NCT04585412|Antiemetics|antiemetics|mesh-ancestor
110373279|NCT04585412|Autonomic Agents|autonomic agents|mesh-ancestor
110373280|NCT04585412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110373281|NCT04585412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110373282|NCT04585412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110373283|NCT04585412|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110373284|NCT04585412|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110373285|NCT04585412|Serotonin Agents|serotonin agents|mesh-ancestor
110373286|NCT04585412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110373287|NCT04585412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110373288|NCT00567866|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110373289|NCT00567866|Antidepressive Agents|antidepressive agents|mesh-ancestor
110373291|NCT00567866|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110373292|NCT00567866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110373293|NCT00567866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110373294|NCT00567866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110373295|NCT00567983|Cyclosporine|cyclosporine|mesh-list
110373296|NCT00567983|Cyclosporins|cyclosporins|mesh-list
110373297|NCT00567983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110373298|NCT00567983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110373299|NCT00567983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110373300|NCT00567983|Immunologic Factors|immunologic factors|mesh-ancestor
110373301|NCT00567983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110373302|NCT00567983|Antifungal Agents|antifungal agents|mesh-ancestor
110373303|NCT00567983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110373304|NCT00567983|Dermatologic Agents|dermatologic agents|mesh-ancestor
110373305|NCT00567983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110373306|NCT00567983|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110373307|NCT00582582|Vitamin D|vitamin d|mesh-list
110373308|NCT00582582|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
110373309|NCT00582582|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
110373310|NCT00582582|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
110373311|NCT00582582|Docetaxel|docetaxel|mesh-list
110373312|NCT00582582|Vitamins|vitamins|mesh-ancestor
110373314|NCT00582582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110373315|NCT00582582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110373316|NCT00582582|Tubulin Modulators|tubulin modulators|mesh-ancestor
110373317|NCT00582582|Antimitotic Agents|antimitotic agents|mesh-ancestor
110373318|NCT00582582|Mitosis Modulators|mitosis modulators|mesh-ancestor
110373319|NCT00582582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110373320|NCT00582582|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110373321|NCT00566904|Aspirin|aspirin|mesh-list
110373322|NCT00566904|Lidocaine|lidocaine|mesh-list
110373323|NCT00566904|Anesthetics, Local|anesthetics, local|mesh-list
110373324|NCT00566904|Anesthetics|anesthetics|mesh-list
110373325|NCT00566904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110373326|NCT00566904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110373327|NCT00566904|Sensory System Agents|sensory system agents|mesh-ancestor
110373328|NCT00566904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110373329|NCT00566904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110373330|NCT00566904|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110373331|NCT00566904|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110373332|NCT00566904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110373333|NCT00566904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110373334|NCT00566904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110373335|NCT00566904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110373336|NCT00566904|Analgesics|analgesics|mesh-ancestor
110373337|NCT00566904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110373338|NCT00566904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110373339|NCT00566904|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110373340|NCT00566904|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110373341|NCT00566904|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110373342|NCT00566904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110373343|NCT00566904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110373344|NCT00566904|Antipyretics|antipyretics|mesh-ancestor
110373345|NCT04584983|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
110373346|NCT04584983|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
110373347|NCT04584983|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110373349|NCT04584515|Itraconazole|itraconazole|mesh-list
110373350|NCT04584515|Rifampin|rifampin|mesh-list
110373351|NCT04584515|Antifungal Agents|antifungal agents|mesh-ancestor
110373352|NCT04584515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110373353|NCT04584515|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110373354|NCT04584515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110373355|NCT04584515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110373356|NCT04584515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110373357|NCT04584515|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110373358|NCT04584515|Hormone Antagonists|hormone antagonists|mesh-ancestor
110373359|NCT04584515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110373360|NCT04584515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110373361|NCT04584515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110373362|NCT04584515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110373363|NCT04584515|Antitubercular Agents|antitubercular agents|mesh-ancestor
110373364|NCT04584515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110373365|NCT04584515|Leprostatic Agents|leprostatic agents|mesh-ancestor
110373366|NCT04584515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110373367|NCT04584515|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110373368|NCT04584515|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110373369|NCT04584515|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110373370|NCT04584515|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110373371|NCT04584515|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110373372|NCT04584515|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110373373|NCT04584710|Dactolisib|dactolisib|mesh-list
110373374|NCT04584710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110373375|NCT04584671|Xenon|xenon|mesh-list
110373376|NCT04584671|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110373377|NCT04584671|Anesthetics, General|anesthetics, general|mesh-ancestor
110373378|NCT04584671|Anesthetics|anesthetics|mesh-ancestor
110373379|NCT04584671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110373380|NCT04584671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110373381|NCT04584008|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
110373382|NCT04584008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110373384|NCT04584008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110373385|NCT04592211|Paclitaxel|paclitaxel|mesh-list
110373386|NCT04592211|Pembrolizumab|pembrolizumab|mesh-list
110373387|NCT04592211|Olaparib|olaparib|mesh-list
110373388|NCT04592211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110373389|NCT04592211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110373390|NCT04592211|Tubulin Modulators|tubulin modulators|mesh-ancestor
110373391|NCT04592211|Antimitotic Agents|antimitotic agents|mesh-ancestor
110373392|NCT04592211|Mitosis Modulators|mitosis modulators|mesh-ancestor
110373393|NCT04592211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110373394|NCT04592211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110373395|NCT04592211|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110373396|NCT04592211|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110373397|NCT04592211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110373398|NCT04583813|Empagliflozin|empagliflozin|mesh-list
110373399|NCT04583813|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110373400|NCT04583813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110373401|NCT04583813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110373402|NCT04583813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110373403|NCT04576143|Paclitaxel|paclitaxel|mesh-list
110373404|NCT04576143|Docetaxel|docetaxel|mesh-list
110373405|NCT04576143|Cyclophosphamide|cyclophosphamide|mesh-list
110373406|NCT04576143|Epirubicin|epirubicin|mesh-list
110373407|NCT04576143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110373408|NCT04576143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110373409|NCT04576143|Tubulin Modulators|tubulin modulators|mesh-ancestor
110373410|NCT04576143|Antimitotic Agents|antimitotic agents|mesh-ancestor
110373411|NCT04576143|Mitosis Modulators|mitosis modulators|mesh-ancestor
110373412|NCT04576143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110373413|NCT04576143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110373414|NCT04576143|Immunologic Factors|immunologic factors|mesh-ancestor
110373415|NCT04576143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110373416|NCT04576143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110373417|NCT04576143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110373418|NCT04576143|Alkylating Agents|alkylating agents|mesh-ancestor
110373419|NCT04576143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110373420|NCT04576143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110373421|NCT04576143|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110373422|NCT04576143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110373423|NCT04576143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110373424|NCT04583267|Tenofovir|tenofovir|mesh-list
110373425|NCT04583267|Emtricitabine|emtricitabine|mesh-list
110373426|NCT04583267|Antiviral Agents|antiviral agents|mesh-ancestor
110373427|NCT04583267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110373428|NCT04583267|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110373429|NCT04583267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110373430|NCT04583267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110373431|NCT04583267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110373432|NCT04583267|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110373433|NCT04583267|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110373434|NCT04583111|Domperidone|domperidone|mesh-list
110373435|NCT04583111|Sulpiride|sulpiride|mesh-list
110373436|NCT04583111|Antiemetics|antiemetics|mesh-ancestor
110373437|NCT04583111|Autonomic Agents|autonomic agents|mesh-ancestor
110373438|NCT04583111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110373439|NCT04583111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110373440|NCT04583111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110373441|NCT04583111|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110373442|NCT04583111|Dopamine Agents|dopamine agents|mesh-ancestor
110373443|NCT04583111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110373444|NCT04583111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110373445|NCT04583111|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110373446|NCT04583111|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110373447|NCT04583111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110373448|NCT04583111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110373449|NCT04583111|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110373450|NCT04583111|Antidepressive Agents|antidepressive agents|mesh-ancestor
110373451|NCT01146613|Varenicline|varenicline|mesh-list
110373452|NCT01146613|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110373453|NCT01146613|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110373454|NCT01146613|Cholinergic Agents|cholinergic agents|mesh-ancestor
110373455|NCT01146613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110373456|NCT01146613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110373457|NCT01146613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110373458|NCT01145755|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110373459|NCT01145755|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110373460|NCT01145755|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110373461|NCT01145755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110373462|NCT01145755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110373463|NCT01145755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110373464|NCT01145755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110373466|NCT01145755|Sensory System Agents|sensory system agents|mesh-ancestor
110373467|NCT01145755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110373468|NCT01145755|Antidepressive Agents|antidepressive agents|mesh-ancestor
110373469|NCT01145755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110373470|NCT01145755|Dopamine Agents|dopamine agents|mesh-ancestor
110373471|NCT04591743|Nicotine|nicotine|mesh-list
110373472|NCT04591743|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110373473|NCT04591743|Autonomic Agents|autonomic agents|mesh-ancestor
110373474|NCT04591743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110373475|NCT04591743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110373476|NCT04591743|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110373477|NCT04591743|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110373478|NCT04591743|Cholinergic Agents|cholinergic agents|mesh-ancestor
110373479|NCT04591743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110373480|NCT04591743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110373481|NCT00567060|Piracetam|piracetam|mesh-list
110373482|NCT00567060|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110373483|NCT00567060|Protective Agents|protective agents|mesh-ancestor
110373484|NCT00567060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110373486|NCT00568217|Acetaminophen|acetaminophen|mesh-list
110373487|NCT00568217|Ibuprofen|ibuprofen|mesh-list
110373488|NCT00568217|Diclofenac|diclofenac|mesh-list
110373489|NCT00568217|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110373490|NCT00568217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110373491|NCT00568217|Analgesics|analgesics|mesh-ancestor
110373492|NCT00568217|Sensory System Agents|sensory system agents|mesh-ancestor
110373493|NCT00568217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110373494|NCT00568217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110373495|NCT00568217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110373496|NCT00568217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110373497|NCT00568217|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110373498|NCT00568217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110373499|NCT00568217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110373500|NCT00568217|Antipyretics|antipyretics|mesh-ancestor
110373501|NCT00583323|Atropine sulfate-diphenoxylate hydrochloride drug combination|atropine sulfate-diphenoxylate hydrochloride drug combination|mesh-list
110373502|NCT00583323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110373503|NCT04582604|Decitabine|decitabine|mesh-list
110373504|NCT04582604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110373505|NCT04582604|Antimetabolites|antimetabolites|mesh-ancestor
110373506|NCT04582604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110373507|NCT04582604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110373508|NCT04582604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110373509|NCT00590928|Esomeprazole|esomeprazole|mesh-list
110373510|NCT00590928|Ranitidine|ranitidine|mesh-list
110373511|NCT00590928|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
110373512|NCT00590928|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110373513|NCT00590928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110373514|NCT00590928|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110373515|NCT00590928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110373516|NCT00590928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110373517|NCT00590928|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110373518|NCT00590928|Histamine Antagonists|histamine antagonists|mesh-ancestor
110373520|NCT00590928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110373521|NCT00590928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110373522|NCT01145482|Insulin|insulin|mesh-list
110373523|NCT01145482|Insulin Aspart|insulin aspart|mesh-list
110373525|NCT01145482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110373526|NCT00568295|Acetaminophen|acetaminophen|mesh-list
110373527|NCT00568295|Rofecoxib|rofecoxib|mesh-list
110373528|NCT00568295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110373529|NCT00568295|Analgesics|analgesics|mesh-ancestor
110373530|NCT00568295|Sensory System Agents|sensory system agents|mesh-ancestor
110373531|NCT00568295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110373532|NCT00568295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110373533|NCT00568295|Antipyretics|antipyretics|mesh-ancestor
110373534|NCT00568295|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110373535|NCT00568295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110373536|NCT00568295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110373537|NCT00568295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110373538|NCT00568295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110373539|NCT00568295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110373540|NCT00568295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110373541|NCT00591162|Tetracycline|tetracycline|mesh-list
110373542|NCT00591162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110373543|NCT00591162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110373544|NCT00591162|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110373545|NCT00591162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110373546|NCT00591162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110373548|NCT00583518|Parathyroid Hormone|parathyroid hormone|mesh-list
110373549|NCT00583518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110373550|NCT00583518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110373551|NCT00583518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110373553|NCT04582136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110373554|NCT04582136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110373555|NCT04582136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110373556|NCT04582136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110373557|NCT04582136|Antifungal Agents|antifungal agents|mesh-ancestor
110373558|NCT04582136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110373559|NCT04582136|Immunologic Factors|immunologic factors|mesh-ancestor
110373560|NCT04582136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110373562|NCT00591201|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110373563|NCT00591201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110373564|NCT00591201|Dermatologic Agents|dermatologic agents|mesh-ancestor
110373565|NCT00591201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110373566|NCT00591201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110373568|NCT04582097|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110373569|NCT04582097|Protease Inhibitors|protease inhibitors|mesh-ancestor
110373570|NCT04582097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110373571|NCT04582097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110373572|NCT04582097|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110373573|NCT00591357|Loperamide|loperamide|mesh-list
110373574|NCT00591357|Antidiarrheals|antidiarrheals|mesh-list
110373575|NCT00591357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110373576|NCT04575675|Dapagliflozin|dapagliflozin|mesh-list
110373577|NCT04575675|Valsartan|valsartan|mesh-list
110373578|NCT04575675|Carvedilol|carvedilol|mesh-list
110373579|NCT04575675|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110373580|NCT04575675|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110373581|NCT04575675|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
110373582|NCT04575675|Mineralocorticoids|mineralocorticoids|mesh-list
110373583|NCT04575675|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110373584|NCT04575675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110373585|NCT04575675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110373586|NCT04575675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110373587|NCT04575675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110373588|NCT04575675|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110373589|NCT04575675|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110373590|NCT04575675|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110373591|NCT04575675|Adrenergic Agents|adrenergic agents|mesh-ancestor
110373592|NCT04575675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110373594|NCT04575675|Protective Agents|protective agents|mesh-ancestor
110373595|NCT04575675|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110373596|NCT04575675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110373597|NCT04575675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110373598|NCT04575675|Vasodilator Agents|vasodilator agents|mesh-ancestor
110373599|NCT04575675|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110373600|NCT04575675|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110373601|NCT04575675|Hormone Antagonists|hormone antagonists|mesh-ancestor
110373602|NCT04575675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110373603|NCT04575675|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110373605|NCT04575675|Natriuretic Agents|natriuretic agents|mesh-ancestor
110373606|NCT04575675|Hormones|hormones|mesh-ancestor
110373607|NCT00568412|Pimecrolimus|pimecrolimus|mesh-list
110373608|NCT00568412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110373609|NCT00568412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110373610|NCT00568412|Analgesics|analgesics|mesh-ancestor
110373611|NCT00568412|Sensory System Agents|sensory system agents|mesh-ancestor
110373612|NCT00568412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110373613|NCT00568412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110373614|NCT00568412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110373615|NCT00568412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110373616|NCT00568412|Dermatologic Agents|dermatologic agents|mesh-ancestor
110373617|NCT00568412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110373618|NCT00568412|Immunologic Factors|immunologic factors|mesh-ancestor
110373619|NCT00568412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110373620|NCT00568412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110373621|NCT00568412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110373622|NCT00568529|Capecitabine|capecitabine|mesh-list
110373623|NCT00568529|Oxaliplatin|oxaliplatin|mesh-list
110373624|NCT00568529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110373625|NCT00568529|Antimetabolites|antimetabolites|mesh-ancestor
110373626|NCT00568529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110373627|NCT00568529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110373629|NCT00568568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110373630|NCT00568568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110373631|NCT04575558|Azithromycin|azithromycin|mesh-list
110373632|NCT04575558|Hydroxychloroquine|hydroxychloroquine|mesh-list
110373633|NCT04575558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110373634|NCT04575558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110373635|NCT04575558|Antimalarials|antimalarials|mesh-ancestor
110373636|NCT04575558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110373637|NCT04575558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110373638|NCT04575558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110373639|NCT04575558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110373640|NCT04575558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110373641|NCT00568763|Sargramostim|sargramostim|mesh-list
110373642|NCT00568763|Immunologic Factors|immunologic factors|mesh-ancestor
110373643|NCT00568763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110373644|NCT00568841|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110373645|NCT00568841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110373646|NCT00568841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110373647|NCT00568841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110373648|NCT00568841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110373650|NCT00583869|Analgesics|analgesics|mesh-ancestor
110373651|NCT00583869|Sensory System Agents|sensory system agents|mesh-ancestor
110373652|NCT00583869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110373653|NCT00583869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110373654|NCT00583869|Anticonvulsants|anticonvulsants|mesh-ancestor
110373655|NCT00583869|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110373656|NCT00583869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110373657|NCT00583869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110373658|NCT00583869|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110373660|NCT00583869|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110373661|NCT00583869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110373662|NCT00583869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110373663|NCT00568880|Hydroxychloroquine|hydroxychloroquine|mesh-list
110373665|NCT00568880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110373666|NCT00568880|Antimalarials|antimalarials|mesh-ancestor
110373667|NCT00568880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110373668|NCT00568880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110373669|NCT00568880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110373670|NCT00568880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110373671|NCT00568880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110373672|NCT00568880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110373674|NCT03451695|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110373675|NCT03451695|Narcotics|narcotics|mesh-ancestor
110373676|NCT03451695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110373677|NCT03451695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110373678|NCT03451695|Analgesics|analgesics|mesh-ancestor
110373679|NCT03451695|Sensory System Agents|sensory system agents|mesh-ancestor
110373680|NCT03451695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110373681|NCT00569465|Acetylcysteine|acetylcysteine|mesh-list
110373682|NCT00569465|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110373683|NCT00569465|Antiviral Agents|antiviral agents|mesh-ancestor
110373684|NCT00569465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110373685|NCT00569465|Expectorants|expectorants|mesh-ancestor
110373686|NCT00569465|Respiratory System Agents|respiratory system agents|mesh-ancestor
110373687|NCT00569465|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110373688|NCT00569465|Antioxidants|antioxidants|mesh-ancestor
110373689|NCT00569465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110373690|NCT00569465|Protective Agents|protective agents|mesh-ancestor
110373691|NCT00569465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110373692|NCT00569465|Antidotes|antidotes|mesh-ancestor
110373693|NCT00583986|Albuterol|albuterol|mesh-list
110373694|NCT00583986|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110373696|NCT00583986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110373697|NCT00583986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110373698|NCT00583986|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110373699|NCT00583986|Respiratory System Agents|respiratory system agents|mesh-ancestor
110373700|NCT00583986|Tocolytic Agents|tocolytic agents|mesh-ancestor
110373701|NCT00583986|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110373702|NCT00583986|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110373703|NCT00583986|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110373704|NCT00583986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110373705|NCT00583986|Adrenergic Agents|adrenergic agents|mesh-ancestor
110373706|NCT00583986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110373707|NCT00583986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110373709|NCT00569621|Parasympatholytics|parasympatholytics|mesh-ancestor
110373710|NCT00569621|Autonomic Agents|autonomic agents|mesh-ancestor
110373711|NCT00569621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110373712|NCT00569621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110373714|NCT00569699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110373715|NCT00569699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110373716|NCT00569699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110373717|NCT00569699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110373718|NCT00569699|Growth Substances|growth substances|mesh-ancestor
110373719|NCT00569699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110373720|NCT00569699|Growth Inhibitors|growth inhibitors|mesh-ancestor
110373721|NCT00569816|Sevoflurane|sevoflurane|mesh-list
110373722|NCT00569816|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110373723|NCT00569816|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110373724|NCT00569816|Anesthetics, General|anesthetics, general|mesh-ancestor
110373725|NCT00569816|Anesthetics|anesthetics|mesh-ancestor
110373726|NCT00569816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110373727|NCT00569816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110373728|NCT00570050|Insulin|insulin|mesh-list
110373729|NCT00570050|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110373730|NCT00570050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110373731|NCT00570050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110373732|NCT00570245|Nitric Oxide|nitric oxide|mesh-list
110373733|NCT00570245|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110373734|NCT00570245|Autonomic Agents|autonomic agents|mesh-ancestor
110373735|NCT00570245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110373736|NCT00570245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110373737|NCT00570245|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110373738|NCT00570245|Respiratory System Agents|respiratory system agents|mesh-ancestor
110373739|NCT00570245|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110373741|NCT00570245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110373742|NCT00570245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110373743|NCT00570245|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110373744|NCT00570245|Vasodilator Agents|vasodilator agents|mesh-ancestor
110373745|NCT00570245|Gasotransmitters|gasotransmitters|mesh-ancestor
110373746|NCT00570245|Protective Agents|protective agents|mesh-ancestor
110373747|NCT00570284|Panobinostat|panobinostat|mesh-list
110373748|NCT00570284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110373749|NCT00570284|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110373751|NCT00570284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110373752|NCT00570440|Levonorgestrel|levonorgestrel|mesh-list
110373753|NCT00570440|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110373754|NCT00570440|Contraceptive Agents|contraceptive agents|mesh-list
110373755|NCT00570440|Contraceptives, Oral|contraceptives, oral|mesh-list
110373756|NCT00570440|Estradiol|estradiol|mesh-list
110373757|NCT00570440|Estrogens|estrogens|mesh-ancestor
110373758|NCT00570440|Hormones|hormones|mesh-ancestor
110373759|NCT00570440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110373760|NCT00570440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110373761|NCT00570440|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110373762|NCT00570440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110373763|NCT00570440|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110373764|NCT00570440|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110373765|NCT00570440|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110373767|NCT00570479|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110373768|NCT00570479|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110373769|NCT00570479|Growth Substances|growth substances|mesh-ancestor
110373770|NCT00570479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110373771|NCT00570479|Growth Inhibitors|growth inhibitors|mesh-ancestor
110373772|NCT00570479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110373773|NCT00584298|Octreotide|octreotide|mesh-list
110373774|NCT00584298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110373775|NCT00584298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110373776|NCT00584298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110373777|NCT00584376|Pregabalin|pregabalin|mesh-list
110373778|NCT00584376|Analgesics|analgesics|mesh-ancestor
110373779|NCT00584376|Sensory System Agents|sensory system agents|mesh-ancestor
110373780|NCT00584376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110373781|NCT00584376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110373782|NCT00584376|Anticonvulsants|anticonvulsants|mesh-ancestor
110373783|NCT00584376|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110373784|NCT00584376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110373785|NCT00584376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110373786|NCT00584376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110373787|NCT00584376|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110373788|NCT00584376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110373789|NCT00584376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110373790|NCT00584376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110373791|NCT00570830|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
110373792|NCT00570830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110373793|NCT00570830|Glucocorticoids|glucocorticoids|mesh-ancestor
110373794|NCT00570830|Hormones|hormones|mesh-ancestor
110373795|NCT00570830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110373796|NCT00570830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110373797|NCT00584493|Tremelimumab|tremelimumab|mesh-list
110373798|NCT00584493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110373800|NCT04580342|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110373801|NCT04580342|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110373802|NCT04580342|Adrenergic Agents|adrenergic agents|mesh-ancestor
110373803|NCT04580342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110373804|NCT04580342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110373805|NCT04580342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110373806|NCT04580342|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110373807|NCT04580342|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110373808|NCT04580342|Vasodilator Agents|vasodilator agents|mesh-ancestor
110373809|NCT00571142|Bevacizumab|bevacizumab|mesh-list
110373811|NCT00571142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110373812|NCT00571142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110373814|NCT00571142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110373815|NCT00571142|Growth Substances|growth substances|mesh-ancestor
110373816|NCT00571142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110373817|NCT00571142|Growth Inhibitors|growth inhibitors|mesh-ancestor
110373818|NCT00571142|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110373819|NCT00571142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110373820|NCT00571142|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110373821|NCT00571142|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110373822|NCT00571142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110373823|NCT00571142|GABA Modulators|gaba modulators|mesh-ancestor
110373825|NCT00571142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110373826|NCT00571142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110373827|NCT00584532|Genistein|genistein|mesh-list
110373828|NCT00584532|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110373829|NCT00584532|Protective Agents|protective agents|mesh-ancestor
110373830|NCT00584532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110373831|NCT00584532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110021689|NCT00002682|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
110373832|NCT00584532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110373833|NCT00584532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110373834|NCT00584532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110373835|NCT00584532|Phytoestrogens|phytoestrogens|mesh-ancestor
110373836|NCT00584532|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110373837|NCT00584532|Estrogens|estrogens|mesh-ancestor
110373838|NCT00584532|Hormones|hormones|mesh-ancestor
110373839|NCT00584532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110373840|NCT00584571|Dexetimide|dexetimide|mesh-list
110373841|NCT00584571|Citalopram|citalopram|mesh-list
110373842|NCT00584571|Escitalopram|escitalopram|mesh-list
110373843|NCT00584571|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110373844|NCT00584571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110373845|NCT00584571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110373846|NCT00584571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110373847|NCT00584571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110373848|NCT00584571|Serotonin Agents|serotonin agents|mesh-ancestor
110373849|NCT00584571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110373850|NCT00584571|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110373851|NCT00584571|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110373852|NCT00584571|Parasympatholytics|parasympatholytics|mesh-ancestor
110373853|NCT00584571|Autonomic Agents|autonomic agents|mesh-ancestor
110373854|NCT00584571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110373855|NCT00584571|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110373856|NCT00584571|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110373857|NCT00584571|Cholinergic Agents|cholinergic agents|mesh-ancestor
110373858|NCT00584571|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110373859|NCT00584571|Antidepressive Agents|antidepressive agents|mesh-ancestor
110373860|NCT00584571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110373861|NCT03451500|Levodopa|levodopa|mesh-list
110373862|NCT03451500|Carbidopa|carbidopa|mesh-list
110373863|NCT03451500|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110373864|NCT03451500|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110373865|NCT03451500|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110373866|NCT03451500|Dopamine Agents|dopamine agents|mesh-ancestor
110373867|NCT03451500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110373868|NCT03451500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110373869|NCT03451500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110373870|NCT03451500|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110373871|NCT03451500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110373872|NCT03451500|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110373873|NCT03451500|Immunologic Factors|immunologic factors|mesh-ancestor
110373874|NCT03451500|Dopamine Agonists|dopamine agonists|mesh-ancestor
110373876|NCT00584610|Levonorgestrel|levonorgestrel|mesh-list
110373877|NCT00584610|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110373878|NCT00584610|Contraceptive Agents|contraceptive agents|mesh-ancestor
110373879|NCT00584610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110373880|NCT00584610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110373881|NCT00584610|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110373882|NCT00584610|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110373883|NCT00584610|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110373884|NCT00584610|Trace Elements|trace elements|mesh-ancestor
110373885|NCT00584610|Micronutrients|micronutrients|mesh-ancestor
110373886|NCT00571298|Sodium thiosulfate|sodium thiosulfate|mesh-list
110373887|NCT00571298|Gemcitabine|gemcitabine|mesh-list
110373888|NCT00571298|Amifostine|amifostine|mesh-list
110373889|NCT00571298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110373890|NCT00571298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110373891|NCT00571298|Antimetabolites|antimetabolites|mesh-ancestor
110373892|NCT00571298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110373894|NCT00571298|Protective Agents|protective agents|mesh-ancestor
110373895|NCT00571298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110373898|NCT00571298|Antitubercular Agents|antitubercular agents|mesh-ancestor
110373899|NCT00571298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110373900|NCT00571298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110373901|NCT00571298|Chelating Agents|chelating agents|mesh-ancestor
110373902|NCT00571298|Sequestering Agents|sequestering agents|mesh-ancestor
110373904|NCT00571337|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110373905|NCT00571337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110373906|NCT00571337|Dermatologic Agents|dermatologic agents|mesh-ancestor
110373907|NCT00571337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110373908|NCT00571337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110373909|NCT04575519|Aspirin|aspirin|mesh-list
110373910|NCT04575519|Ibuprofen|ibuprofen|mesh-list
110373911|NCT04575519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110373912|NCT04575519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110373913|NCT04575519|Analgesics|analgesics|mesh-ancestor
110373914|NCT04575519|Sensory System Agents|sensory system agents|mesh-ancestor
110373915|NCT04575519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110373916|NCT04575519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110373917|NCT04575519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110373918|NCT04575519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110373920|NCT04575519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110373921|NCT04575519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110373922|NCT04575519|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110373923|NCT04575519|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110373924|NCT04575519|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110373925|NCT04575519|Antipyretics|antipyretics|mesh-ancestor
110373926|NCT04573803|Phenytoin|phenytoin|mesh-list
110373927|NCT04573803|Levetiracetam|levetiracetam|mesh-list
110373928|NCT04573803|Anticonvulsants|anticonvulsants|mesh-ancestor
110373929|NCT04573803|Nootropic Agents|nootropic agents|mesh-ancestor
110373930|NCT04573803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110373931|NCT04573803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110373932|NCT04573803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110373933|NCT04573803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110373934|NCT04573803|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110373935|NCT04573803|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110373936|NCT00584688|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110373937|NCT00584688|Antidepressive Agents|antidepressive agents|mesh-ancestor
110373938|NCT00584688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110373939|NCT00584688|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110373940|NCT00584688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110373941|NCT00584688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110373942|NCT00584688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110373943|NCT04573686|Epoetin Alfa|epoetin alfa|mesh-list
110373944|NCT04573686|Hematinics|hematinics|mesh-ancestor
110373945|NCT01143337|Methotrexate|methotrexate|mesh-list
110373946|NCT01143337|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110373947|NCT01143337|Abortifacient Agents|abortifacient agents|mesh-ancestor
110373948|NCT01143337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110373949|NCT01143337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110373950|NCT01143337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110373952|NCT01143337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110373953|NCT01143337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110373955|NCT01143337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110373956|NCT01143337|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110373957|NCT01143337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110373958|NCT01143337|Immunologic Factors|immunologic factors|mesh-ancestor
110373959|NCT01143337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110373960|NCT01143337|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110373961|NCT04313023|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
110373962|NCT04313023|Respiratory System Agents|respiratory system agents|mesh-ancestor
110373963|NCT02883595|Thymalfasin|thymalfasin|mesh-list
110373964|NCT02883595|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110373965|NCT02883595|Immunologic Factors|immunologic factors|mesh-ancestor
110373966|NCT02883595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110373968|NCT01143259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110373969|NCT00571805|Varenicline|varenicline|mesh-list
110373970|NCT00571805|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110373971|NCT00571805|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110373972|NCT00571805|Cholinergic Agents|cholinergic agents|mesh-ancestor
110373973|NCT00571805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110373974|NCT00571805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110373975|NCT00571805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110373977|NCT02883556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110373978|NCT02883556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110373979|NCT02883556|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110373980|NCT02883556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110373981|NCT00585000|Tremelimumab|tremelimumab|mesh-list
110373982|NCT00585000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110373983|NCT00572078|Sorafenib|sorafenib|mesh-list
110373984|NCT00572078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110373985|NCT00572078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110373986|NCT00572078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110373987|NCT00572078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110373988|NCT00572312|Atorvastatin|atorvastatin|mesh-list
110373990|NCT00572312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110373991|NCT00572312|Antimetabolites|antimetabolites|mesh-ancestor
110373992|NCT00572312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110373993|NCT00572312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110373994|NCT00572312|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110373995|NCT00572312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110373997|NCT00585156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110373998|NCT00585156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110373999|NCT00585156|Analgesics|analgesics|mesh-ancestor
110374000|NCT00585156|Sensory System Agents|sensory system agents|mesh-ancestor
110374001|NCT00585156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110374002|NCT00585156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110374003|NCT00585156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110374004|NCT00585156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110374005|NCT00585156|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110374006|NCT00585156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110374007|NCT00585156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110374008|NCT00585156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374009|NCT01142596|Asenapine|asenapine|mesh-list
110374010|NCT01142596|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110374011|NCT01142596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110374012|NCT01142596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110374013|NCT01142596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110374014|NCT01142596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110374015|NCT00572390|Estrogens|estrogens|mesh-list
110374016|NCT00572390|Hormones|hormones|mesh-ancestor
110374017|NCT00572390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110374018|NCT00572390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110374019|NCT01142128|Esomeprazole|esomeprazole|mesh-list
110374020|NCT01142128|Pancrelipase|pancrelipase|mesh-list
110374022|NCT01142128|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110374023|NCT01142128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110374024|NCT01142128|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110374025|NCT01142128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110374026|NCT01142128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374027|NCT04572867|Diuretics|diuretics|mesh-list
110374028|NCT04572867|Natriuretic Agents|natriuretic agents|mesh-ancestor
110374029|NCT04572867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110374030|NCT01142089|Rifamycins|rifamycins|mesh-list
110374031|NCT01142089|Rifamycin SV|rifamycin sv|mesh-list
110374032|NCT01142089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110374033|NCT01142089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110374034|NCT01142089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110374036|NCT00572663|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110374037|NCT00572663|Antiviral Agents|antiviral agents|mesh-ancestor
110374039|NCT00572663|Expectorants|expectorants|mesh-ancestor
110374040|NCT00572663|Respiratory System Agents|respiratory system agents|mesh-ancestor
110374041|NCT00572663|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110374042|NCT00572663|Antioxidants|antioxidants|mesh-ancestor
110374043|NCT00572663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374044|NCT00572663|Protective Agents|protective agents|mesh-ancestor
110374045|NCT00572663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110374046|NCT00572663|Antidotes|antidotes|mesh-ancestor
110374047|NCT01140880|Tenofovir|tenofovir|mesh-list
110374048|NCT01140880|Emtricitabine|emtricitabine|mesh-list
110374049|NCT01140880|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110374050|NCT01140880|Antiviral Agents|antiviral agents|mesh-ancestor
110374051|NCT01140880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110374052|NCT01140880|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110374053|NCT01140880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110374054|NCT01140880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110374055|NCT01140880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374056|NCT01140880|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110374057|NCT01140880|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110374059|NCT00572741|Vitamins|vitamins|mesh-ancestor
110374060|NCT00572741|Micronutrients|micronutrients|mesh-ancestor
110374061|NCT00572741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110374062|NCT00572819|Misoprostol|misoprostol|mesh-list
110374063|NCT00572819|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110374064|NCT00572819|Abortifacient Agents|abortifacient agents|mesh-ancestor
110374065|NCT00572819|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110374066|NCT00572819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110374067|NCT00572819|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110374068|NCT00572819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110374070|NCT03451110|Fluconazole|fluconazole|mesh-list
110374071|NCT03451110|Lemborexant|lemborexant|mesh-list
110374072|NCT03451110|Famotidine|famotidine|mesh-list
110374073|NCT03451110|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
110374074|NCT03451110|Antifungal Agents|antifungal agents|mesh-ancestor
110374075|NCT03451110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110374076|NCT03451110|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110374077|NCT03451110|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110374078|NCT03451110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110374079|NCT03451110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374080|NCT03451110|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110374081|NCT03451110|Hormone Antagonists|hormone antagonists|mesh-ancestor
110374082|NCT03451110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110374083|NCT03451110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110374084|NCT03451110|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110374085|NCT03451110|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110374086|NCT03451110|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110374087|NCT03451110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110374088|NCT03451110|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110374089|NCT03451110|Histamine Antagonists|histamine antagonists|mesh-ancestor
110374091|NCT03451110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110374092|NCT03451110|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
110374093|NCT03451110|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110374094|NCT03451110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110374095|NCT03451110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110374096|NCT03451110|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110374097|NCT03451110|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110374098|NCT03451110|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110374099|NCT03451110|Contraceptive Agents|contraceptive agents|mesh-ancestor
110374100|NCT03451110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110374101|NCT03451110|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110374102|NCT03451110|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110374103|NCT03451110|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
110374104|NCT03451110|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110374106|NCT00585741|Antiviral Agents|antiviral agents|mesh-ancestor
110374107|NCT00585741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110374108|NCT03450798|Anesthetics|anesthetics|mesh-list
110374109|NCT03450798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110374110|NCT03450798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110374111|NCT00573326|Imatinib Mesylate|imatinib mesylate|mesh-list
110374112|NCT00573326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110374113|NCT00573326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110374114|NCT00573326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110374115|NCT00573326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374117|NCT01140061|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110374118|NCT01140061|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110374119|NCT01140061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110374120|NCT01140061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374122|NCT04312750|Anesthetics, Local|anesthetics, local|mesh-ancestor
110374123|NCT04312750|Anesthetics|anesthetics|mesh-ancestor
110374124|NCT04312750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110374125|NCT04312750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110374126|NCT04312750|Sensory System Agents|sensory system agents|mesh-ancestor
110374127|NCT04312750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110374128|NCT04312750|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110374129|NCT04312750|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110374130|NCT04312750|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110374131|NCT04312750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110374132|NCT04312750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374133|NCT00573404|Sunitinib|sunitinib|mesh-list
110374134|NCT00573404|Imatinib Mesylate|imatinib mesylate|mesh-list
110374135|NCT00573404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110374136|NCT00573404|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110374138|NCT00573404|Growth Substances|growth substances|mesh-ancestor
110374139|NCT00573404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110374140|NCT00573404|Growth Inhibitors|growth inhibitors|mesh-ancestor
110374141|NCT00573404|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110374142|NCT00573404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110374143|NCT00573404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374144|NCT01139125|Cysteamine|cysteamine|mesh-list
110374145|NCT01139125|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
110374146|NCT01139125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374147|NCT01139047|Metronidazole|metronidazole|mesh-list
110374148|NCT01139047|Azelaic acid|azelaic acid|mesh-list
110374149|NCT01139047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110374150|NCT01139047|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110374151|NCT01139047|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110374152|NCT01139047|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110374153|NCT01139047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110374154|NCT01139047|Dermatologic Agents|dermatologic agents|mesh-ancestor
110374155|NCT01139008|Metronidazole|metronidazole|mesh-list
110374156|NCT01139008|Azelaic acid|azelaic acid|mesh-list
110374157|NCT01139008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110374158|NCT01139008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110374159|NCT01139008|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110374160|NCT01139008|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110374161|NCT01139008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110374162|NCT01139008|Dermatologic Agents|dermatologic agents|mesh-ancestor
110374163|NCT00573599|Diphenhydramine|diphenhydramine|mesh-list
110374164|NCT00573599|Prochlorperazine|prochlorperazine|mesh-list
110374165|NCT00573599|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110374166|NCT00573599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110374167|NCT00573599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110374168|NCT00573599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110374169|NCT00573599|Anesthetics, Local|anesthetics, local|mesh-ancestor
110374170|NCT00573599|Anesthetics|anesthetics|mesh-ancestor
110374171|NCT00573599|Sensory System Agents|sensory system agents|mesh-ancestor
110374172|NCT00573599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110374173|NCT00573599|Antiemetics|antiemetics|mesh-ancestor
110374174|NCT00573599|Autonomic Agents|autonomic agents|mesh-ancestor
110374175|NCT00573599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110374176|NCT00573599|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110374177|NCT00573599|Histamine Antagonists|histamine antagonists|mesh-ancestor
110374178|NCT00573599|Histamine Agents|histamine agents|mesh-ancestor
110374179|NCT00573599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110374180|NCT00573599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374181|NCT00573599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110374182|NCT00573599|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110374183|NCT00573599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110374184|NCT00573599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110374185|NCT00573599|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110374186|NCT00573599|Dopamine Agents|dopamine agents|mesh-ancestor
110374187|NCT04572516|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110374188|NCT04572516|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110374189|NCT04572516|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110374190|NCT04572516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110374191|NCT04572516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110374192|NCT04572516|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110374193|NCT04572516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110374194|NCT04572516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374195|NCT04572516|Cholinergic Agents|cholinergic agents|mesh-ancestor
110374196|NCT04572516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110374197|NCT00573638|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110374198|NCT00573638|Latanoprost|latanoprost|mesh-list
110374199|NCT00573638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110374200|NCT01138657|Prednisone|prednisone|mesh-list
110374201|NCT01138657|Adalimumab|adalimumab|mesh-list
110374203|NCT01138657|Glucocorticoids|glucocorticoids|mesh-ancestor
110374204|NCT01138657|Hormones|hormones|mesh-ancestor
110374205|NCT01138657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110374206|NCT01138657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110374207|NCT01138657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110374208|NCT01138657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110374209|NCT01138657|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110374210|NCT01138657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110374211|NCT01138501|Factor VIII|factor viii|mesh-list
110374212|NCT01138501|Coagulants|coagulants|mesh-ancestor
110374213|NCT01138150|Naproxen|naproxen|mesh-list
110374214|NCT01138150|Sumatriptan|sumatriptan|mesh-list
110374215|NCT01138150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110374216|NCT01138150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110374217|NCT01138150|Analgesics|analgesics|mesh-ancestor
110374218|NCT01138150|Sensory System Agents|sensory system agents|mesh-ancestor
110374219|NCT01138150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110374220|NCT01138150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110374221|NCT01138150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110374222|NCT01138150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110374224|NCT01138150|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110374225|NCT01138150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110374226|NCT01138150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374227|NCT01138150|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110374228|NCT01138150|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110374229|NCT01138150|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110374230|NCT01138150|Serotonin Agents|serotonin agents|mesh-ancestor
110374231|NCT01138150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110374232|NCT00586092|Bevacizumab|bevacizumab|mesh-list
110374233|NCT00586092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110374234|NCT00586092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110374235|NCT00586092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110374236|NCT00586092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110374237|NCT00586092|Growth Substances|growth substances|mesh-ancestor
110374238|NCT00586092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110374239|NCT00586092|Growth Inhibitors|growth inhibitors|mesh-ancestor
110374241|NCT01137955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110374242|NCT01137955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110374243|NCT01137955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110374244|NCT00573950|Cilostazol|cilostazol|mesh-list
110374245|NCT00573950|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110374246|NCT00573950|Autonomic Agents|autonomic agents|mesh-ancestor
110374247|NCT00573950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110374248|NCT00573950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110374249|NCT00573950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110374250|NCT00573950|Respiratory System Agents|respiratory system agents|mesh-ancestor
110374251|NCT00573950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110374252|NCT00573950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110374253|NCT00573950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374254|NCT00573950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110374255|NCT00573950|Vasodilator Agents|vasodilator agents|mesh-ancestor
110374256|NCT00573950|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110374257|NCT00573950|Protective Agents|protective agents|mesh-ancestor
110374258|NCT00573950|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110374259|NCT00573950|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110374261|NCT00586131|Citric Acid|citric acid|mesh-list
110374262|NCT00586131|Sodium Citrate|sodium citrate|mesh-list
110374263|NCT00586131|Anticoagulants|anticoagulants|mesh-ancestor
110374264|NCT00586131|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110374265|NCT00586131|Chelating Agents|chelating agents|mesh-ancestor
110374266|NCT00586131|Sequestering Agents|sequestering agents|mesh-ancestor
110374267|NCT00586131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374268|NCT00586287|Phenprocoumon|phenprocoumon|mesh-list
110374269|NCT00586287|Anticoagulants|anticoagulants|mesh-ancestor
110374270|NCT00586365|Naproxen|naproxen|mesh-list
110374271|NCT00586365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110374272|NCT00586365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110374273|NCT00586365|Analgesics|analgesics|mesh-ancestor
110374274|NCT00586365|Sensory System Agents|sensory system agents|mesh-ancestor
110374275|NCT00586365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110374276|NCT00586365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110374277|NCT00586365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110374278|NCT00586365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110374279|NCT00586365|Gout Suppressants|gout suppressants|mesh-ancestor
110374280|NCT00586365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110374282|NCT00586365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374283|NCT00574652|Aldesleukin|aldesleukin|mesh-list
110374284|NCT00574652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110374285|NCT00574652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110374286|NCT00574652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110374287|NCT00574652|Antiviral Agents|antiviral agents|mesh-ancestor
110374288|NCT00574652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110374289|NCT00574769|Bevacizumab|bevacizumab|mesh-list
110374290|NCT00574769|Docetaxel|docetaxel|mesh-list
110374291|NCT00574769|Everolimus|everolimus|mesh-list
110374292|NCT00574769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110374293|NCT00574769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110374294|NCT00574769|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110374295|NCT00574769|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110374296|NCT00574769|Growth Substances|growth substances|mesh-ancestor
110374297|NCT00574769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110374298|NCT00574769|Growth Inhibitors|growth inhibitors|mesh-ancestor
110374300|NCT00574769|Antimitotic Agents|antimitotic agents|mesh-ancestor
110374301|NCT00574769|Mitosis Modulators|mitosis modulators|mesh-ancestor
110374302|NCT00574769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374303|NCT00574769|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110374304|NCT00574769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110374305|NCT00574769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110374306|NCT00574769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110374307|NCT00574769|Immunologic Factors|immunologic factors|mesh-ancestor
110374308|NCT00586443|Bevacizumab|bevacizumab|mesh-list
110374309|NCT00586443|Panitumumab|panitumumab|mesh-list
110374310|NCT00586443|Everolimus|everolimus|mesh-list
110374311|NCT00586443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110374312|NCT00586443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110374313|NCT00586443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110374314|NCT00586443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110374315|NCT00586443|Growth Substances|growth substances|mesh-ancestor
110374316|NCT00586443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110374317|NCT00586443|Growth Inhibitors|growth inhibitors|mesh-ancestor
110374318|NCT00586443|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110374319|NCT00586443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110374320|NCT00586443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110374321|NCT00586443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374322|NCT00586443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110374323|NCT00586443|Immunologic Factors|immunologic factors|mesh-ancestor
110374325|NCT00574925|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110374326|NCT00574925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110374327|NCT00574925|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110374328|NCT00574925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110374329|NCT00574925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374330|NCT00586560|Cyclophosphamide|cyclophosphamide|mesh-list
110374331|NCT00586560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110374332|NCT00586560|Immunologic Factors|immunologic factors|mesh-ancestor
110374333|NCT00586560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110374334|NCT00586560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110374335|NCT00586560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110374336|NCT00586560|Alkylating Agents|alkylating agents|mesh-ancestor
110374337|NCT00586560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374338|NCT00586560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110374339|NCT00586560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110374340|NCT00574964|Temozolomide|temozolomide|mesh-list
110374341|NCT00574964|Carmustine|carmustine|mesh-list
110374342|NCT00574964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110374343|NCT00574964|Alkylating Agents|alkylating agents|mesh-ancestor
110374344|NCT00574964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374345|NCT00574964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110374346|NCT01137682|Octreotide|octreotide|mesh-list
110374347|NCT01137682|Lanreotide|lanreotide|mesh-list
110374348|NCT01137682|Pasireotide|pasireotide|mesh-list
110374349|NCT01137682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110374350|NCT01137682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110374351|NCT01137682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110374353|NCT01137682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110374354|NCT01137682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110374356|NCT00586794|Vasodilator Agents|vasodilator agents|mesh-ancestor
110374357|NCT00586794|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110374358|NCT00586794|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110374359|NCT00586794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110374360|NCT00586794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374361|NCT00586794|Urological Agents|urological agents|mesh-ancestor
110374362|NCT00586833|Neurotransmitter Agents|neurotransmitter agents|mesh-list
110374363|NCT00586833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374364|NCT00586833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110374365|NCT00575354|Sevoflurane|sevoflurane|mesh-list
110374366|NCT00575354|Isoflurane|isoflurane|mesh-list
110374367|NCT00575354|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110374368|NCT00575354|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110374369|NCT00575354|Anesthetics, General|anesthetics, general|mesh-ancestor
110374370|NCT00575354|Anesthetics|anesthetics|mesh-ancestor
110374371|NCT00575354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110374372|NCT00575354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110374374|NCT00586911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110374375|NCT00586911|Lipotropic Agents|lipotropic agents|mesh-ancestor
110374376|NCT00586911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110374378|NCT00586911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374379|NCT00586911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110374380|NCT00575393|Gold Sodium Thiomalate|gold sodium thiomalate|mesh-list
110374381|NCT00575393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110374382|NCT00575549|Dobutamine|dobutamine|mesh-list
110374383|NCT00575549|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110374384|NCT00575549|Sympathomimetics|sympathomimetics|mesh-ancestor
110374385|NCT00575549|Autonomic Agents|autonomic agents|mesh-ancestor
110374386|NCT00575549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110374387|NCT00575549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110374388|NCT00575549|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110374390|NCT00575549|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110374391|NCT00575549|Adrenergic Agents|adrenergic agents|mesh-ancestor
110374392|NCT00575549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110374393|NCT00575549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374394|NCT00575549|Protective Agents|protective agents|mesh-ancestor
110374395|NCT03453684|Vancomycin|vancomycin|mesh-list
110374396|NCT03453684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110374397|NCT03453684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110374398|NCT00575627|Interferons|interferons|mesh-list
110374399|NCT00575627|Ribavirin|ribavirin|mesh-list
110374400|NCT00575627|Interferon-alpha|interferon-alpha|mesh-list
110374401|NCT00575627|Interferon alpha-2|interferon alpha-2|mesh-list
110374402|NCT00575627|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110374403|NCT00575627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110374404|NCT00575627|Antiviral Agents|antiviral agents|mesh-ancestor
110374405|NCT00575627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110374406|NCT00575627|Antimetabolites|antimetabolites|mesh-ancestor
110374407|NCT00575627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374408|NCT00575627|Immunologic Factors|immunologic factors|mesh-ancestor
110374409|NCT00575627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110374411|NCT00555854|Anesthetics, Local|anesthetics, local|mesh-ancestor
110374412|NCT00555854|Anesthetics|anesthetics|mesh-ancestor
110374413|NCT00555854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110374414|NCT00555854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110374415|NCT00555854|Sensory System Agents|sensory system agents|mesh-ancestor
110374416|NCT00555854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110374417|NCT04674332|Insulin, Long-Acting|insulin, long-acting|mesh-list
110374418|NCT04674332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110374419|NCT04674332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110374421|NCT00587145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110374422|NCT00587145|Tubulin Modulators|tubulin modulators|mesh-ancestor
110374423|NCT00587145|Antimitotic Agents|antimitotic agents|mesh-ancestor
110374425|NCT00587145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374427|NCT04674176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110374428|NCT04674176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110374429|NCT04674176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110374430|NCT04674527|Temozolomide|temozolomide|mesh-list
110374431|NCT04674527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110374432|NCT04674527|Alkylating Agents|alkylating agents|mesh-ancestor
110374433|NCT04674527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374434|NCT04674527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110374435|NCT00199836|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
110374436|NCT00199836|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110374437|NCT00199836|Immunologic Factors|immunologic factors|mesh-ancestor
110374438|NCT00199836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110374440|NCT00199797|Fluorouracil|fluorouracil|mesh-list
110374441|NCT00199797|Oxaliplatin|oxaliplatin|mesh-list
110374442|NCT00199797|Antimetabolites|antimetabolites|mesh-ancestor
110374443|NCT00199797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374444|NCT00199797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110374445|NCT00199797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110374446|NCT00199797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110374447|NCT00199797|Immunologic Factors|immunologic factors|mesh-ancestor
110374448|NCT00199797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110374449|NCT00199797|Antidotes|antidotes|mesh-ancestor
110374450|NCT00199797|Protective Agents|protective agents|mesh-ancestor
110374452|NCT00199797|Vitamins|vitamins|mesh-ancestor
110374453|NCT00199797|Micronutrients|micronutrients|mesh-ancestor
110374454|NCT01137604|Bevacizumab|bevacizumab|mesh-list
110374455|NCT01137604|Lenvatinib|lenvatinib|mesh-list
110374456|NCT01137604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110374457|NCT01137604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110374459|NCT01137604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110374460|NCT01137604|Growth Substances|growth substances|mesh-ancestor
110374461|NCT01137604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110374462|NCT01137604|Growth Inhibitors|growth inhibitors|mesh-ancestor
110374463|NCT01137604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110374464|NCT01137604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110374465|NCT01137604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374466|NCT03454919|Palbociclib|palbociclib|mesh-list
110374467|NCT03454919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110374468|NCT03454919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110374469|NCT03454919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110374470|NCT03454919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374472|NCT00198822|Beta Carotene|beta carotene|mesh-list
110374473|NCT00198822|Carotenoids|carotenoids|mesh-list
110374474|NCT00198822|Vitamins|vitamins|mesh-ancestor
110374475|NCT00198822|Micronutrients|micronutrients|mesh-ancestor
110374476|NCT00198822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110374477|NCT00198822|Antioxidants|antioxidants|mesh-ancestor
110374478|NCT00198822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374479|NCT00198822|Protective Agents|protective agents|mesh-ancestor
110374480|NCT00198822|Provitamins|provitamins|mesh-ancestor
110374481|NCT05214976|Paclitaxel|paclitaxel|mesh-list
110374482|NCT05214976|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110374483|NCT05214976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110374484|NCT05214976|Tubulin Modulators|tubulin modulators|mesh-ancestor
110374485|NCT05214976|Antimitotic Agents|antimitotic agents|mesh-ancestor
110374486|NCT05214976|Mitosis Modulators|mitosis modulators|mesh-ancestor
110374487|NCT05214976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374488|NCT05204134|Insulin|insulin|mesh-list
110374489|NCT05204134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110374490|NCT05204134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110374491|NCT05181436|Chrysarobin|chrysarobin|mesh-list
110374492|NCT05181436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110374493|NCT05181436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110374494|NCT05181436|Analgesics|analgesics|mesh-ancestor
110374495|NCT05181436|Sensory System Agents|sensory system agents|mesh-ancestor
110374496|NCT05181436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110374497|NCT05181436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110374498|NCT05181436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110374499|NCT05181436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110374500|NCT01137292|Voriconazole|voriconazole|mesh-list
110374501|NCT01137292|Antifungal Agents|antifungal agents|mesh-ancestor
110374502|NCT01137292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110374503|NCT01137292|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110374504|NCT01137292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110374506|NCT01137292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374507|NCT01137292|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110374508|NCT01137292|Hormone Antagonists|hormone antagonists|mesh-ancestor
110374509|NCT01137292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110374510|NCT01137292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110374511|NCT01137292|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110374512|NCT02883478|Riboflavin|riboflavin|mesh-list
110374513|NCT02883478|Vitamin B Complex|vitamin b complex|mesh-ancestor
110374514|NCT02883478|Vitamins|vitamins|mesh-ancestor
110374515|NCT02883478|Micronutrients|micronutrients|mesh-ancestor
110374516|NCT02883478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110374517|NCT02883478|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110374518|NCT02883478|Dermatologic Agents|dermatologic agents|mesh-ancestor
110374519|NCT00197145|Aplaviroc|aplaviroc|mesh-list
110374520|NCT00197145|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110374522|NCT00197145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374523|NCT00197145|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110374524|NCT00197145|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110374525|NCT00197145|Antiviral Agents|antiviral agents|mesh-ancestor
110374526|NCT00197145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110374527|NCT04674137|Histamine|histamine|mesh-list
110374529|NCT04674137|Histamine Agonists|histamine agonists|mesh-ancestor
110374530|NCT04674137|Histamine Agents|histamine agents|mesh-ancestor
110374531|NCT04674137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110374532|NCT04674137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374533|NCT04674137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110374535|NCT04674137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110374536|NCT04312438|Caseins|caseins|mesh-list
110374537|NCT04312438|Chelating Agents|chelating agents|mesh-ancestor
110374538|NCT04312438|Sequestering Agents|sequestering agents|mesh-ancestor
110374539|NCT04312438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374541|NCT00197106|Xhance|xhance|mesh-list
110374542|NCT00197106|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110374543|NCT00197106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110374544|NCT00197106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110374545|NCT00197106|Autonomic Agents|autonomic agents|mesh-ancestor
110374546|NCT00197106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110374547|NCT00197106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110374548|NCT00197106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110374549|NCT00197106|Respiratory System Agents|respiratory system agents|mesh-ancestor
110374550|NCT00197106|Dermatologic Agents|dermatologic agents|mesh-ancestor
110374551|NCT00197106|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110374552|NCT00197106|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110374553|NCT00197106|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110374554|NCT00197106|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110374555|NCT00197106|Adrenergic Agents|adrenergic agents|mesh-ancestor
110374556|NCT00197106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110374557|NCT00197106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374558|NCT01136746|Insulin|insulin|mesh-list
110374559|NCT01136746|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110374560|NCT01136746|Insulin Glargine|insulin glargine|mesh-list
110374561|NCT01136746|Insulin Lispro|insulin lispro|mesh-list
110374562|NCT01136746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110374563|NCT01136746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110374564|NCT01136356|Morphine|morphine|mesh-list
110374565|NCT01136356|Buprenorphine|buprenorphine|mesh-list
110374566|NCT01136356|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110374567|NCT01136356|Narcotics|narcotics|mesh-ancestor
110374568|NCT01136356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110374569|NCT01136356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110374570|NCT01136356|Analgesics|analgesics|mesh-ancestor
110374571|NCT01136356|Sensory System Agents|sensory system agents|mesh-ancestor
110374572|NCT01136356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110374573|NCT01136356|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110374574|NCT00587379|Atorvastatin|atorvastatin|mesh-list
110374575|NCT00587379|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110374576|NCT00587379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110374577|NCT00587379|Antimetabolites|antimetabolites|mesh-ancestor
110374578|NCT00587379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374579|NCT00587379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110374580|NCT00587379|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110374581|NCT00587379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110374583|NCT04673396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110374584|NCT04673396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110374585|NCT04673396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374586|NCT00637390|Alemtuzumab|alemtuzumab|mesh-list
110374587|NCT00637390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110374588|NCT00637390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110374589|NCT00196326|Levonorgestrel|levonorgestrel|mesh-list
110374590|NCT00196326|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110374592|NCT00196326|Estrogens|estrogens|mesh-ancestor
110374593|NCT00196326|Hormones|hormones|mesh-ancestor
110374594|NCT00196326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110374595|NCT00196326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110374596|NCT00196326|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110374597|NCT00196326|Contraceptive Agents|contraceptive agents|mesh-ancestor
110374598|NCT00196326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110374599|NCT00196326|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110374600|NCT00196326|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110374601|NCT00196326|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110374602|NCT00196326|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110374603|NCT00587496|Aspirin|aspirin|mesh-list
110374604|NCT00587496|Valacyclovir|valacyclovir|mesh-list
110374605|NCT00587496|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110374606|NCT00587496|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110374607|NCT00587496|Analgesics|analgesics|mesh-ancestor
110374608|NCT00587496|Sensory System Agents|sensory system agents|mesh-ancestor
110374609|NCT00587496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110374610|NCT00587496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110374611|NCT00587496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110374612|NCT00587496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110374613|NCT00587496|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110374614|NCT00587496|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110374615|NCT00587496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374616|NCT00587496|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110374617|NCT00587496|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110374618|NCT00587496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110374619|NCT00587496|Antipyretics|antipyretics|mesh-ancestor
110374620|NCT00587496|Antiviral Agents|antiviral agents|mesh-ancestor
110374621|NCT00587496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110374622|NCT00195663|Adalimumab|adalimumab|mesh-list
110374624|NCT00195663|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110374625|NCT00195663|Abortifacient Agents|abortifacient agents|mesh-ancestor
110374626|NCT00195663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110374627|NCT00195663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110374628|NCT00195663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110374629|NCT00195663|Antimetabolites|antimetabolites|mesh-ancestor
110374630|NCT00195663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374631|NCT00195663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110374632|NCT00195663|Dermatologic Agents|dermatologic agents|mesh-ancestor
110374634|NCT00195663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110374635|NCT00195663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110374636|NCT00195663|Immunologic Factors|immunologic factors|mesh-ancestor
110374637|NCT00195663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110374638|NCT00195663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110374639|NCT00195663|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110374640|NCT00195663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110374642|NCT01135498|Capecitabine|capecitabine|mesh-list
110374643|NCT01135498|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110374644|NCT01135498|Oxaliplatin|oxaliplatin|mesh-list
110374645|NCT01135498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110374646|NCT01135498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110374647|NCT01135498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110374648|NCT01135498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110374649|NCT01135498|Growth Substances|growth substances|mesh-ancestor
110374650|NCT01135498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110374651|NCT01135498|Growth Inhibitors|growth inhibitors|mesh-ancestor
110374652|NCT01135498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110374654|NCT01135498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374655|NCT01135498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110374658|NCT04610567|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110374659|NCT04610567|Abortifacient Agents|abortifacient agents|mesh-ancestor
110374660|NCT04610567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110374661|NCT04610567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110374662|NCT04610567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110374663|NCT04610567|Antimetabolites|antimetabolites|mesh-ancestor
110374664|NCT04610567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374665|NCT04610567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110374666|NCT04610567|Dermatologic Agents|dermatologic agents|mesh-ancestor
110374667|NCT04610567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110374668|NCT04610567|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110374669|NCT04610567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110374670|NCT04610567|Immunologic Factors|immunologic factors|mesh-ancestor
110374671|NCT04610567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110374672|NCT04610567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110374673|NCT02883439|Fluticasone|fluticasone|mesh-list
110374675|NCT02883439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110374676|NCT02883439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110374677|NCT02883439|Autonomic Agents|autonomic agents|mesh-ancestor
110374678|NCT02883439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110374679|NCT02883439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110374680|NCT02883439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110374681|NCT02883439|Respiratory System Agents|respiratory system agents|mesh-ancestor
110374682|NCT02883439|Dermatologic Agents|dermatologic agents|mesh-ancestor
110374683|NCT02883439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110374684|NCT00195507|Etanercept|etanercept|mesh-list
110374685|NCT00195507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110374686|NCT00195507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110374687|NCT00195507|Analgesics|analgesics|mesh-ancestor
110374688|NCT00195507|Sensory System Agents|sensory system agents|mesh-ancestor
110374689|NCT00195507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110374690|NCT00195507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110374691|NCT00195507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110374692|NCT00195507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110374693|NCT00195507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110374694|NCT00195507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110374695|NCT00195507|Immunologic Factors|immunologic factors|mesh-ancestor
110374696|NCT00195429|Sirolimus|sirolimus|mesh-list
110374697|NCT00195429|Prednisone|prednisone|mesh-list
110374698|NCT00195429|Tacrolimus|tacrolimus|mesh-list
110374699|NCT00195429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110374700|NCT00195429|Glucocorticoids|glucocorticoids|mesh-ancestor
110374701|NCT00195429|Hormones|hormones|mesh-ancestor
110374702|NCT00195429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110374703|NCT00195429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110374704|NCT00195429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110374705|NCT00195429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110374706|NCT00195429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110374707|NCT00195429|Immunologic Factors|immunologic factors|mesh-ancestor
110374708|NCT00195429|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110374709|NCT00195429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110374710|NCT00195429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374711|NCT00195429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110374712|NCT00195429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110374713|NCT00195429|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110374714|NCT00195429|Antifungal Agents|antifungal agents|mesh-ancestor
110374716|NCT00195351|Ceftriaxone|ceftriaxone|mesh-list
110374717|NCT00195351|Tigecycline|tigecycline|mesh-list
110374718|NCT00195351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110374719|NCT00195351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110374720|NCT00195351|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110374721|NCT00195351|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110374722|NCT00195351|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110374723|NCT00195351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110374724|NCT00195351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374725|NCT04609748|Nimesulide|nimesulide|mesh-list
110374726|NCT04609748|Cannabidiol|cannabidiol|mesh-list
110374727|NCT04609748|Anticonvulsants|anticonvulsants|mesh-ancestor
110374728|NCT04609748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110374729|NCT04609748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110374730|NCT04609748|Analgesics|analgesics|mesh-ancestor
110374731|NCT04609748|Sensory System Agents|sensory system agents|mesh-ancestor
110374732|NCT04609748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110374733|NCT04609748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110374734|NCT04609748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110374735|NCT04609748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110374736|NCT04609748|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110374737|NCT04609748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110374738|NCT04609748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374740|NCT00195273|Sirolimus|sirolimus|mesh-list
110374741|NCT00195273|Mycophenolic Acid|mycophenolic acid|mesh-list
110374742|NCT00195273|Cyclosporins|cyclosporins|mesh-list
110374743|NCT00195273|Daclizumab|daclizumab|mesh-list
110374744|NCT00195273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110374745|NCT00195273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374746|NCT00195273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110374747|NCT00195273|Immunologic Factors|immunologic factors|mesh-ancestor
110374748|NCT00195273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110374749|NCT00195273|Antifungal Agents|antifungal agents|mesh-ancestor
110374750|NCT00195273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110374751|NCT00195273|Dermatologic Agents|dermatologic agents|mesh-ancestor
110374752|NCT00195273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110374753|NCT00195273|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110374754|NCT00195273|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110374755|NCT00195273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110374756|NCT00195273|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110374757|NCT00195273|Antitubercular Agents|antitubercular agents|mesh-ancestor
110374758|NCT00195273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110374759|NCT00564200|Dexamethasone|dexamethasone|mesh-list
110374760|NCT00564200|Fludarabine|fludarabine|mesh-list
110374761|NCT00564200|Bortezomib|bortezomib|mesh-list
110374763|NCT00564200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110374764|NCT00564200|Antiemetics|antiemetics|mesh-ancestor
110374765|NCT00564200|Autonomic Agents|autonomic agents|mesh-ancestor
110374766|NCT00564200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110374767|NCT00564200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110374768|NCT00564200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110374769|NCT00564200|Glucocorticoids|glucocorticoids|mesh-ancestor
110374771|NCT00564200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110374773|NCT00564200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110374774|NCT00564200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374776|NCT00564200|Immunologic Factors|immunologic factors|mesh-ancestor
110374777|NCT00564200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110374778|NCT00564200|Alkylating Agents|alkylating agents|mesh-ancestor
110374779|NCT00564200|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110374780|NCT00193479|Prednisone|prednisone|mesh-list
110374781|NCT00193479|Cyclophosphamide|cyclophosphamide|mesh-list
110374782|NCT00193479|Rituximab|rituximab|mesh-list
110374783|NCT00193479|Vincristine|vincristine|mesh-list
110374784|NCT00193479|Mitoxantrone|mitoxantrone|mesh-list
110374785|NCT00193479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110374787|NCT00193479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110374788|NCT00193479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110374789|NCT00193479|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110374790|NCT00193479|Alkylating Agents|alkylating agents|mesh-ancestor
110374791|NCT00193479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374792|NCT00193479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110374793|NCT00193479|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110374794|NCT00193479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110374795|NCT00193479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110374796|NCT00193479|Glucocorticoids|glucocorticoids|mesh-ancestor
110374797|NCT00193479|Hormones|hormones|mesh-ancestor
110374798|NCT00193479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110374799|NCT00193479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110374800|NCT00193479|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110374801|NCT00193479|Tubulin Modulators|tubulin modulators|mesh-ancestor
110374802|NCT00193479|Antimitotic Agents|antimitotic agents|mesh-ancestor
110374803|NCT00193479|Mitosis Modulators|mitosis modulators|mesh-ancestor
110374804|NCT00193479|Analgesics|analgesics|mesh-ancestor
110374805|NCT00193479|Sensory System Agents|sensory system agents|mesh-ancestor
110374806|NCT00193479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110374807|NCT00193479|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110374808|NCT00193479|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110374809|NCT00193479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110374810|NCT00193206|Paclitaxel|paclitaxel|mesh-list
110374811|NCT00193206|Gemcitabine|gemcitabine|mesh-list
110374812|NCT00193206|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110374813|NCT00193206|Epirubicin|epirubicin|mesh-list
110374814|NCT00193206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110374815|NCT00193206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110374816|NCT00193206|Tubulin Modulators|tubulin modulators|mesh-ancestor
110374817|NCT00193206|Antimitotic Agents|antimitotic agents|mesh-ancestor
110374818|NCT00193206|Mitosis Modulators|mitosis modulators|mesh-ancestor
110374819|NCT00193206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374820|NCT00193206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110374821|NCT00193206|Antimetabolites|antimetabolites|mesh-ancestor
110374822|NCT00193206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110374823|NCT00193206|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110374825|NCT00193206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110374826|NCT00193050|Gemcitabine|gemcitabine|mesh-list
110374827|NCT00193050|Docetaxel|docetaxel|mesh-list
110374828|NCT00193050|Epirubicin|epirubicin|mesh-list
110374829|NCT00193050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110374830|NCT00193050|Antimetabolites|antimetabolites|mesh-ancestor
110374831|NCT00193050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374832|NCT00193050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110374833|NCT00193050|Tubulin Modulators|tubulin modulators|mesh-ancestor
110374834|NCT00193050|Antimitotic Agents|antimitotic agents|mesh-ancestor
110374835|NCT00193050|Mitosis Modulators|mitosis modulators|mesh-ancestor
110374836|NCT00193050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110374837|NCT00193050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110374838|NCT00193050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110374840|NCT04608734|Midazolam|midazolam|mesh-list
110374841|NCT04608734|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110374842|NCT04608734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110374843|NCT04608734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110374844|NCT04608734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110374845|NCT04608734|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110374846|NCT04608734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110374848|NCT04608734|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110374849|NCT04608734|Anesthetics, General|anesthetics, general|mesh-ancestor
110374851|NCT04608734|GABA Modulators|gaba modulators|mesh-ancestor
110374852|NCT04608734|GABA Agents|gaba agents|mesh-ancestor
110374853|NCT04608734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110374854|NCT04608734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374855|NCT00192075|Leucovorin|leucovorin|mesh-list
110374856|NCT00192075|Folic Acid|folic acid|mesh-list
110374857|NCT00192075|Gemcitabine|gemcitabine|mesh-list
110374858|NCT00192075|Oxaliplatin|oxaliplatin|mesh-list
110374859|NCT00192075|Levoleucovorin|levoleucovorin|mesh-list
110374860|NCT00192075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110374861|NCT00192075|Antimetabolites|antimetabolites|mesh-ancestor
110374862|NCT00192075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374863|NCT00192075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110374864|NCT00192075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110374865|NCT00192075|Antidotes|antidotes|mesh-ancestor
110374866|NCT00192075|Protective Agents|protective agents|mesh-ancestor
110374867|NCT00192075|Vitamin B Complex|vitamin b complex|mesh-ancestor
110374868|NCT00192075|Vitamins|vitamins|mesh-ancestor
110374869|NCT00192075|Micronutrients|micronutrients|mesh-ancestor
110374870|NCT00192075|Hematinics|hematinics|mesh-ancestor
110374871|NCT00192036|Gemcitabine|gemcitabine|mesh-list
110374872|NCT00192036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110374873|NCT00192036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110374874|NCT00192036|Antimetabolites|antimetabolites|mesh-ancestor
110374875|NCT00192036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374876|NCT00191724|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
110374877|NCT00191724|Enoxaparin|enoxaparin|mesh-list
110374878|NCT00191724|Protein C|protein c|mesh-list
110374879|NCT00191724|Anticoagulants|anticoagulants|mesh-ancestor
110374880|NCT00191724|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110374881|NCT00191724|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110374882|NCT00191724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374883|NCT00191724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110374884|NCT00191646|Paclitaxel|paclitaxel|mesh-list
110374885|NCT00191646|Carboplatin|carboplatin|mesh-list
110374886|NCT00191646|Gemcitabine|gemcitabine|mesh-list
110374887|NCT00191646|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110374888|NCT00191646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110374889|NCT00191646|Tubulin Modulators|tubulin modulators|mesh-ancestor
110374890|NCT00191646|Antimitotic Agents|antimitotic agents|mesh-ancestor
110374891|NCT00191646|Mitosis Modulators|mitosis modulators|mesh-ancestor
110374892|NCT00191646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374893|NCT00191646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110374894|NCT00191646|Antimetabolites|antimetabolites|mesh-ancestor
110374895|NCT00191451|Carboplatin|carboplatin|mesh-list
110374896|NCT00191451|Gemcitabine|gemcitabine|mesh-list
110374897|NCT00191451|Trastuzumab|trastuzumab|mesh-list
110374898|NCT00191451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110374899|NCT00191451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110374900|NCT00191451|Antimetabolites|antimetabolites|mesh-ancestor
110374901|NCT00191451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374902|NCT00191451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110374903|NCT00191334|Gemcitabine|gemcitabine|mesh-list
110374904|NCT00191334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110374905|NCT00191334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110374906|NCT00191334|Antimetabolites|antimetabolites|mesh-ancestor
110374907|NCT00191334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374908|NCT00191139|Cisplatin|cisplatin|mesh-list
110374909|NCT00191139|Gemcitabine|gemcitabine|mesh-list
110374911|NCT00191139|Etoposide|etoposide|mesh-list
110374912|NCT00191139|Etoposide phosphate|etoposide phosphate|mesh-list
110374913|NCT00191139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110374914|NCT00191139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110374915|NCT00191139|Antimetabolites|antimetabolites|mesh-ancestor
110374916|NCT00191139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374917|NCT00191139|Tubulin Modulators|tubulin modulators|mesh-ancestor
110374918|NCT00191139|Antimitotic Agents|antimitotic agents|mesh-ancestor
110374919|NCT00191139|Mitosis Modulators|mitosis modulators|mesh-ancestor
110374920|NCT00191139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110374921|NCT00191139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110374922|NCT00191139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110374923|NCT00191139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110374924|NCT00564512|Cyclophosphamide|cyclophosphamide|mesh-list
110374926|NCT00564512|Fludarabine|fludarabine|mesh-list
110374927|NCT00564512|Alemtuzumab|alemtuzumab|mesh-list
110374928|NCT00564512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110374929|NCT00564512|Immunologic Factors|immunologic factors|mesh-ancestor
110374930|NCT00564512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110374931|NCT00564512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110374932|NCT00564512|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110374933|NCT00564512|Alkylating Agents|alkylating agents|mesh-ancestor
110374934|NCT00564512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374935|NCT00564512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110374936|NCT00564512|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110374937|NCT00564512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110374938|NCT00564551|Calcium, Dietary|calcium, dietary|mesh-list
110374939|NCT00564551|Calcium|calcium|mesh-list
110374940|NCT00564551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110374941|NCT00564551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110374942|NCT00564551|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110374943|NCT00190983|Pemetrexed|pemetrexed|mesh-list
110374944|NCT00190983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110374945|NCT00190983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110374946|NCT00190983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374947|NCT00190983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110374948|NCT00190983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110374949|NCT00190749|Olanzapine|olanzapine|mesh-list
110374950|NCT00190749|Risperidone|risperidone|mesh-list
110374951|NCT00190749|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110374952|NCT00190749|Serotonin Agents|serotonin agents|mesh-ancestor
110374953|NCT00190749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110374954|NCT00190749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374955|NCT00190749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110374956|NCT00190749|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110374957|NCT00190749|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110374958|NCT00190749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110374959|NCT00190749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110374960|NCT00190749|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110374961|NCT00190749|Dopamine Agents|dopamine agents|mesh-ancestor
110374962|NCT00190749|Antiemetics|antiemetics|mesh-ancestor
110374963|NCT00190749|Autonomic Agents|autonomic agents|mesh-ancestor
110374964|NCT00190749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110374965|NCT00190749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110374966|NCT00190749|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110374967|NCT00190749|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110374968|NCT00190749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110374969|NCT04607447|Dexamethasone|dexamethasone|mesh-list
110374970|NCT04607447|Atorvastatin|atorvastatin|mesh-list
110374971|NCT04607447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110374972|NCT04607447|Antiemetics|antiemetics|mesh-ancestor
110374973|NCT04607447|Autonomic Agents|autonomic agents|mesh-ancestor
110374974|NCT04607447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110374975|NCT04607447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110374976|NCT04607447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110374977|NCT04607447|Glucocorticoids|glucocorticoids|mesh-ancestor
110374979|NCT04607447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110374980|NCT04607447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110374981|NCT04607447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110374982|NCT04607447|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110374983|NCT04607447|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110374984|NCT04607447|Antimetabolites|antimetabolites|mesh-ancestor
110374985|NCT04607447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374986|NCT04607447|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110374987|NCT04607447|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110374988|NCT04607447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110374989|NCT00190671|Cyclophosphamide|cyclophosphamide|mesh-list
110374990|NCT00190671|Pemetrexed|pemetrexed|mesh-list
110374991|NCT00190671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110374992|NCT00190671|Immunologic Factors|immunologic factors|mesh-ancestor
110374993|NCT00190671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110374994|NCT00190671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110374995|NCT00190671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110374996|NCT00190671|Alkylating Agents|alkylating agents|mesh-ancestor
110374997|NCT00190671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374998|NCT00190671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110374999|NCT00190671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110375000|NCT00190671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110375001|NCT00190671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110375002|NCT00190671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110375003|NCT04607525|Dexmedetomidine|dexmedetomidine|mesh-list
110375004|NCT04607525|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110375005|NCT04607525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110375006|NCT04607525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375007|NCT04607525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110375009|NCT04607525|Sensory System Agents|sensory system agents|mesh-ancestor
110375010|NCT04607525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110375011|NCT04607525|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110375012|NCT04607525|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110375013|NCT04607525|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110375014|NCT04607525|Adrenergic Agents|adrenergic agents|mesh-ancestor
110375015|NCT04607525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110375016|NCT04607525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110375017|NCT00198276|Bleomycin|bleomycin|mesh-list
110375018|NCT00198276|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110375019|NCT00198276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110375020|NCT04607642|Manganese|manganese|mesh-list
110375021|NCT04607642|Trace Elements|trace elements|mesh-ancestor
110375022|NCT04607642|Micronutrients|micronutrients|mesh-ancestor
110375023|NCT04607642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375024|NCT00588003|Anastrozole|anastrozole|mesh-list
110375025|NCT00588003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110375026|NCT00588003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110375027|NCT00588003|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110375028|NCT00588003|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110375029|NCT00588003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110375030|NCT00588003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110375031|NCT00588003|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110375032|NCT00588003|Hormone Antagonists|hormone antagonists|mesh-ancestor
110375033|NCT00588003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110375034|NCT00588003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375035|NCT04607057|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-list
110375036|NCT04607057|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110375037|NCT00564590|Melatonin|melatonin|mesh-list
110375040|NCT00564590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110375042|NCT00564590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375043|NCT00564590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110375044|NCT00564590|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110375045|NCT00564590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110375046|NCT00564590|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110375047|NCT00564590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110375048|NCT00564668|Insulin Aspart|insulin aspart|mesh-list
110375049|NCT00564668|Biphasic Insulins|biphasic insulins|mesh-list
110375050|NCT00564668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110375051|NCT00564668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375052|NCT00564707|Botulinum Toxins|botulinum toxins|mesh-list
110375053|NCT00564707|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110375054|NCT00564707|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110375055|NCT00564707|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110375056|NCT00564707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110375057|NCT00564707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110375058|NCT00564707|Cholinergic Agents|cholinergic agents|mesh-ancestor
110375059|NCT00564707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110375060|NCT00564707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375061|NCT00564707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110375062|NCT00564707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110375063|NCT04606082|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110375064|NCT04606082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110375065|NCT04606082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375066|NCT04605770|Pemetrexed|pemetrexed|mesh-list
110375067|NCT04605770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110375068|NCT04605770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110375069|NCT04605770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110375070|NCT04605770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110375071|NCT04605770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110375072|NCT04605887|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
110375073|NCT04605887|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110375074|NCT04605887|Vasodilator Agents|vasodilator agents|mesh-ancestor
110375075|NCT04605419|Calcium|calcium|mesh-list
110375076|NCT04605419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110375077|NCT04605419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375078|NCT04605575|Vinorelbine|vinorelbine|mesh-list
110375079|NCT04605575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110375080|NCT04605575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110375081|NCT04605575|Tubulin Modulators|tubulin modulators|mesh-ancestor
110375082|NCT04605575|Antimitotic Agents|antimitotic agents|mesh-ancestor
110375083|NCT04605575|Mitosis Modulators|mitosis modulators|mesh-ancestor
110375084|NCT04605575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110375085|NCT00589134|Ganirelix|ganirelix|mesh-list
110375086|NCT00589134|Hormone Antagonists|hormone antagonists|mesh-ancestor
110375087|NCT00589134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110375088|NCT00589134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375089|NCT00589251|Penicillins|penicillins|mesh-list
110375090|NCT00589251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110375091|NCT00589251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110375092|NCT00564824|Caffeine|caffeine|mesh-list
110375093|NCT00564824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110375095|NCT00564824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110375096|NCT00564824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110375097|NCT00564824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110375098|NCT00564824|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110375099|NCT00564824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110375100|NCT00564824|Purinergic Agents|purinergic agents|mesh-ancestor
110375101|NCT00564824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110375102|NCT00589485|Cobalt|cobalt|mesh-list
110375103|NCT00589485|Trace Elements|trace elements|mesh-ancestor
110375104|NCT00589485|Micronutrients|micronutrients|mesh-ancestor
110375105|NCT00589485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375106|NCT00564941|Deferasirox|deferasirox|mesh-list
110375107|NCT00564941|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110375108|NCT00564941|Chelating Agents|chelating agents|mesh-ancestor
110375109|NCT00564941|Sequestering Agents|sequestering agents|mesh-ancestor
110375110|NCT00564941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110375111|NCT04605107|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110375112|NCT04605107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110375113|NCT04605107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375115|NCT00589953|Hematinics|hematinics|mesh-ancestor
110375116|NCT00589992|Ibutilide|ibutilide|mesh-list
110375117|NCT00589992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110375118|NCT00590070|Adenosine|adenosine|mesh-list
110375119|NCT00590070|Nitroprusside|nitroprusside|mesh-list
110375120|NCT00590070|Analgesics|analgesics|mesh-ancestor
110375121|NCT00590070|Sensory System Agents|sensory system agents|mesh-ancestor
110375122|NCT00590070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110375123|NCT00590070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375124|NCT00590070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110375125|NCT00590070|Vasodilator Agents|vasodilator agents|mesh-ancestor
110375126|NCT00590070|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110375127|NCT00590070|Purinergic Agonists|purinergic agonists|mesh-ancestor
110375128|NCT00590070|Purinergic Agents|purinergic agents|mesh-ancestor
110375129|NCT00590070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110375130|NCT00590070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110375131|NCT00590070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110375132|NCT00590070|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110375133|NCT00565019|Triamcinolone|triamcinolone|mesh-list
110375134|NCT00565019|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110375135|NCT00565019|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110375136|NCT00565019|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110375137|NCT00565019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110375138|NCT00565019|Glucocorticoids|glucocorticoids|mesh-ancestor
110375139|NCT00565019|Hormones|hormones|mesh-ancestor
110375140|NCT00565019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110375141|NCT00565019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375142|NCT00565019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110375143|NCT00565019|Immunologic Factors|immunologic factors|mesh-ancestor
110375144|NCT00565019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110375145|NCT00565019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110375157|NCT00590343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110375158|NCT04604678|Metformin|metformin|mesh-list
110375159|NCT04604678|Naltrexone|naltrexone|mesh-list
110375160|NCT04604678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110375161|NCT04604678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375162|NCT04604678|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110375163|NCT04604678|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110375164|NCT04604678|Sensory System Agents|sensory system agents|mesh-ancestor
110375165|NCT04604678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110375166|NCT04604327|Bemiparin|bemiparin|mesh-list
110375167|NCT04604327|Anticoagulants|anticoagulants|mesh-ancestor
110375168|NCT00590694|Ranibizumab|ranibizumab|mesh-list
110375169|NCT00590694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110375170|NCT00590694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110375171|NCT00590694|Growth Substances|growth substances|mesh-ancestor
110375172|NCT00590694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375173|NCT00590694|Growth Inhibitors|growth inhibitors|mesh-ancestor
110375174|NCT00590694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110375175|NCT00565175|Famotidine|famotidine|mesh-list
110375176|NCT00565175|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110375177|NCT00565175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110375178|NCT00565175|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110375179|NCT00565175|Histamine Antagonists|histamine antagonists|mesh-ancestor
110375180|NCT00565175|Histamine Agents|histamine agents|mesh-ancestor
110375181|NCT00565175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110375182|NCT00565175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110375183|NCT00565175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375184|NCT00477165|Citalopram|citalopram|mesh-list
110375185|NCT00477165|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110375186|NCT00477165|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110375187|NCT00477165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110375188|NCT00477165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110375189|NCT00477165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110375194|NCT00477165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110375195|NCT04604054|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110375196|NCT04604054|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110375197|NCT04604054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375198|NCT00476229|Rituximab|rituximab|mesh-list
110375199|NCT00476229|Thymoglobulin|thymoglobulin|mesh-list
110375200|NCT00476229|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110375201|NCT00476229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110375202|NCT00476229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110375204|NCT00476229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375205|NCT00476229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110375206|NCT00476229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110375207|NCT04603976|Erenumab|erenumab|mesh-list
110375208|NCT04603976|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
110375209|NCT04603976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110375210|NCT04603976|Analgesics|analgesics|mesh-ancestor
110375211|NCT04603976|Sensory System Agents|sensory system agents|mesh-ancestor
110375212|NCT04603976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110375213|NCT04603976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375214|NCT00476151|Ketamine|ketamine|mesh-list
110375215|NCT00476151|Amitriptyline|amitriptyline|mesh-list
110375216|NCT00476151|Analgesics|analgesics|mesh-ancestor
110375217|NCT00476151|Sensory System Agents|sensory system agents|mesh-ancestor
110375218|NCT00476151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110375219|NCT00476151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375220|NCT00476151|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110375221|NCT00476151|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110375222|NCT00476151|Anesthetics, General|anesthetics, general|mesh-ancestor
110375223|NCT00476151|Anesthetics|anesthetics|mesh-ancestor
110375224|NCT00476151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110375225|NCT00476151|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110375226|NCT00476151|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110375227|NCT00476151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110375228|NCT00476151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110375229|NCT00476151|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110375230|NCT00476151|Antidepressive Agents|antidepressive agents|mesh-ancestor
110375231|NCT00476151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110375232|NCT00476151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110375233|NCT00476151|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110375234|NCT00476151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110375235|NCT00476151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110375236|NCT00476151|Adrenergic Agents|adrenergic agents|mesh-ancestor
110375238|NCT04603664|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
110375239|NCT04603664|Protease Inhibitors|protease inhibitors|mesh-ancestor
110375240|NCT04603664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110375241|NCT04603664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110375242|NCT00474903|Aspirin|aspirin|mesh-list
110375243|NCT00474903|Esomeprazole|esomeprazole|mesh-list
110375244|NCT00474903|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110375245|NCT00474903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110375246|NCT00474903|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110375247|NCT00474903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110375248|NCT00474903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110375249|NCT00474903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110375250|NCT00474903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110375251|NCT00474903|Analgesics|analgesics|mesh-ancestor
110375252|NCT00474903|Sensory System Agents|sensory system agents|mesh-ancestor
110375253|NCT00474903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110375254|NCT00474903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375255|NCT00474903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110375256|NCT00474903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110375257|NCT00474903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110375258|NCT00474903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110375259|NCT00474903|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110375260|NCT00474903|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110375261|NCT00474903|Antipyretics|antipyretics|mesh-ancestor
110375262|NCT01134055|Ranibizumab|ranibizumab|mesh-list
110375263|NCT01134055|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110375264|NCT01134055|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110375265|NCT01134055|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110375266|NCT01134055|Growth Substances|growth substances|mesh-ancestor
110375267|NCT01134055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375268|NCT01134055|Growth Inhibitors|growth inhibitors|mesh-ancestor
110375269|NCT01134055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110375270|NCT01134055|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110375271|NCT00474708|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110375272|NCT00474708|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110375273|NCT00474708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110375274|NCT00474708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110375275|NCT00474708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110375276|NCT00474708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110375277|NCT00474708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375278|NCT00474708|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110375279|NCT00474708|Antidepressive Agents|antidepressive agents|mesh-ancestor
110375281|NCT00474240|Atorvastatin|atorvastatin|mesh-list
110375282|NCT00474240|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110375283|NCT00474240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110375284|NCT00474240|Antimetabolites|antimetabolites|mesh-ancestor
110375285|NCT00474240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110375286|NCT00474240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110375287|NCT00474240|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110375289|NCT00473889|Paclitaxel|paclitaxel|mesh-list
110375290|NCT00473889|Carboplatin|carboplatin|mesh-list
110375291|NCT00473889|Vorinostat|vorinostat|mesh-list
110375292|NCT00473889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110375293|NCT00473889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110375294|NCT00473889|Tubulin Modulators|tubulin modulators|mesh-ancestor
110375295|NCT00473889|Antimitotic Agents|antimitotic agents|mesh-ancestor
110375296|NCT00473889|Mitosis Modulators|mitosis modulators|mesh-ancestor
110375297|NCT00473889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110375298|NCT00473889|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110375299|NCT00473889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110375300|NCT00565214|Vitamins|vitamins|mesh-list
110375301|NCT00565214|Vitamin E|vitamin e|mesh-list
110375302|NCT00565214|Selenium|selenium|mesh-list
110375303|NCT00565214|Micronutrients|micronutrients|mesh-ancestor
110375304|NCT00565214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375305|NCT00565214|Antioxidants|antioxidants|mesh-ancestor
110375306|NCT00565214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110375307|NCT00565214|Protective Agents|protective agents|mesh-ancestor
110375308|NCT00565214|Trace Elements|trace elements|mesh-ancestor
110375309|NCT00565253|Nitric Oxide|nitric oxide|mesh-list
110375310|NCT00565253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110375311|NCT00565253|Autonomic Agents|autonomic agents|mesh-ancestor
110375312|NCT00565253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110375313|NCT00565253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375315|NCT00565253|Respiratory System Agents|respiratory system agents|mesh-ancestor
110375316|NCT00565253|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110375317|NCT00565253|Antioxidants|antioxidants|mesh-ancestor
110375318|NCT00565253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110375319|NCT00565253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110375320|NCT00565253|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110375321|NCT00565253|Vasodilator Agents|vasodilator agents|mesh-ancestor
110375322|NCT00565253|Gasotransmitters|gasotransmitters|mesh-ancestor
110375323|NCT00565253|Protective Agents|protective agents|mesh-ancestor
110375324|NCT02277600|Darunavir|darunavir|mesh-list
110375325|NCT02277600|Cobicistat|cobicistat|mesh-list
110375326|NCT02277600|Fostemsavir|fostemsavir|mesh-list
110375327|NCT02277600|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110375328|NCT02277600|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110375329|NCT02277600|Protease Inhibitors|protease inhibitors|mesh-ancestor
110375330|NCT02277600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110375331|NCT02277600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110375332|NCT02277600|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110375333|NCT02277600|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110375334|NCT02277600|Antiviral Agents|antiviral agents|mesh-ancestor
110375335|NCT02277600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110375336|NCT02277600|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110375337|NCT02277600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110375338|NCT02277600|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110375339|NCT02277600|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110375340|NCT04602143|Testosterone|testosterone|mesh-list
110375341|NCT04602143|Androgens|androgens|mesh-ancestor
110375342|NCT04602143|Hormones|hormones|mesh-ancestor
110375343|NCT04602143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110375344|NCT04602143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375345|NCT02277678|Morphine|morphine|mesh-list
110375346|NCT02277678|Oxycodone|oxycodone|mesh-list
110375347|NCT02277678|Analgesics, Opioid|analgesics, opioid|mesh-list
110375348|NCT02277678|Narcotics|narcotics|mesh-ancestor
110375349|NCT02277678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110375350|NCT02277678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375351|NCT02277678|Analgesics|analgesics|mesh-ancestor
110375353|NCT02277678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110375354|NCT04601675|Dexamethasone|dexamethasone|mesh-list
110375355|NCT04601675|Ranibizumab|ranibizumab|mesh-list
110375356|NCT04601675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110375357|NCT04601675|Antiemetics|antiemetics|mesh-ancestor
110375358|NCT04601675|Autonomic Agents|autonomic agents|mesh-ancestor
110375359|NCT04601675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110375360|NCT04601675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375361|NCT04601675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110375362|NCT04601675|Glucocorticoids|glucocorticoids|mesh-ancestor
110375363|NCT04601675|Hormones|hormones|mesh-ancestor
110375364|NCT04601675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110375365|NCT04601675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110375366|NCT04601675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110375367|NCT04601675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110375368|NCT04601675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110375369|NCT04601675|Growth Substances|growth substances|mesh-ancestor
110375370|NCT04601675|Growth Inhibitors|growth inhibitors|mesh-ancestor
110375371|NCT00565292|Anacetrapib|anacetrapib|mesh-list
110375372|NCT00565292|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110375373|NCT00565292|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110375374|NCT00565292|Antimetabolites|antimetabolites|mesh-ancestor
110375375|NCT00565292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110375376|NCT00565292|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110375377|NCT01580865|Mycophenolic Acid|mycophenolic acid|mesh-list
110375378|NCT01580865|Tacrolimus|tacrolimus|mesh-list
110375379|NCT01580865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110375380|NCT01580865|Immunologic Factors|immunologic factors|mesh-ancestor
110375381|NCT01580865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375382|NCT01580865|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110375384|NCT01580865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110375385|NCT01580865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110375386|NCT01580865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110375387|NCT01580865|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110375388|NCT01580865|Antitubercular Agents|antitubercular agents|mesh-ancestor
110375389|NCT01580865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110375390|NCT01580865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110375392|NCT00473694|Rocuronium|rocuronium|mesh-list
110375393|NCT00473694|Vecuronium Bromide|vecuronium bromide|mesh-list
110375395|NCT00473694|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110375396|NCT00473694|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110375397|NCT00473694|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110375398|NCT00473694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110375399|NCT00473694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375400|NCT00473694|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110375401|NCT00473694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110375402|NCT00473694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110375403|NCT00473694|Cholinergic Agents|cholinergic agents|mesh-ancestor
110375404|NCT00473694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110375405|NCT00473694|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110375406|NCT00473694|Autonomic Agents|autonomic agents|mesh-ancestor
110375407|NCT00473694|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110375408|NCT00473694|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110375409|NCT00473694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110375410|NCT00473694|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
110375412|NCT04601324|Xhance|xhance|mesh-list
110375413|NCT04601324|Azelastine|azelastine|mesh-list
110375414|NCT04601324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110375415|NCT04601324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110375417|NCT04601324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110375418|NCT04601324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375419|NCT04601324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110375420|NCT04601324|Respiratory System Agents|respiratory system agents|mesh-ancestor
110375421|NCT04601324|Dermatologic Agents|dermatologic agents|mesh-ancestor
110375422|NCT04601324|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110375423|NCT04601324|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110375424|NCT04601324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110375425|NCT04601324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110375426|NCT04601324|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110375427|NCT04601324|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110375428|NCT04601324|Histamine Antagonists|histamine antagonists|mesh-ancestor
110375429|NCT04601324|Histamine Agents|histamine agents|mesh-ancestor
110375430|NCT04601324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110375432|NCT00565331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110375433|NCT00565331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110375434|NCT00565331|Immunologic Factors|immunologic factors|mesh-ancestor
110375435|NCT00565331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375436|NCT00565331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110375437|NCT00473655|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110375438|NCT00473655|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110375439|NCT00473655|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110375440|NCT00473655|Antimetabolites|antimetabolites|mesh-ancestor
110375441|NCT00473655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110375442|NCT00473655|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110375443|NCT00473655|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110375444|NCT00473655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110375445|NCT00582920|Zoledronic Acid|zoledronic acid|mesh-list
110375446|NCT00582920|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110375453|NCT00473382|Growth Inhibitors|growth inhibitors|mesh-ancestor
110375454|NCT00473382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110375455|NCT02210325|Azithromycin|azithromycin|mesh-list
110375456|NCT02210325|Ceftriaxone|ceftriaxone|mesh-list
110375457|NCT02210325|Solithromycin|solithromycin|mesh-list
110375458|NCT02210325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110375459|NCT02210325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110375460|NCT00473265|Teriparatide|teriparatide|mesh-list
110375461|NCT00473265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110375462|NCT00473265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375463|NCT00473265|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110375464|NCT00472641|Ziprasidone|ziprasidone|mesh-list
110375465|NCT00472641|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110375467|NCT00472641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110375468|NCT00472641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110375469|NCT00472641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375471|NCT00472641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110375472|NCT00472641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110375473|NCT00472641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110375474|NCT00472641|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110375475|NCT00472641|Dopamine Agents|dopamine agents|mesh-ancestor
110375476|NCT04576208|Antidiarrheals|antidiarrheals|mesh-list
110375477|NCT04576208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110375478|NCT04571151|Halobetasol|halobetasol|mesh-list
110375479|NCT04571151|Calcipotriene|calcipotriene|mesh-list
110375480|NCT04571151|Dermatologic Agents|dermatologic agents|mesh-ancestor
110375481|NCT04571151|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110375482|NCT01133977|Lenvatinib|lenvatinib|mesh-list
110375483|NCT01133977|Dacarbazine|dacarbazine|mesh-list
110375484|NCT01133977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110375485|NCT01133977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110375486|NCT01133977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110375487|NCT01133977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110375488|NCT01133977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110375489|NCT01133977|Alkylating Agents|alkylating agents|mesh-ancestor
110375490|NCT00583193|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110375491|NCT00583193|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110375492|NCT00583193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110375493|NCT00583193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110375494|NCT00583193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110375495|NCT00583193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110375496|NCT00583193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375498|NCT00583193|Sensory System Agents|sensory system agents|mesh-ancestor
110375499|NCT00583193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110375500|NCT00583193|Antidepressive Agents|antidepressive agents|mesh-ancestor
110375501|NCT00583193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110036239|NCT01409616|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110036380|NCT01411111|Antimetabolites|antimetabolites|mesh-ancestor
110036555|NCT01412307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110036621|NCT01412658|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110036746|NCT01413854|Diclofenac|diclofenac|mesh-list
110036938|NCT01415596|Autonomic Agents|autonomic agents|mesh-ancestor
110037151|NCT01416909|Laxatives|laxatives|mesh-list
110037413|NCT01418274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110037478|NCT01418599|Urological Agents|urological agents|mesh-ancestor
110037667|NCT01420094|Aspirin|aspirin|mesh-list
110037728|NCT01420471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110037733|NCT01420523|Maraviroc|maraviroc|mesh-list
110037791|NCT01420900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110038031|NCT01422291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110038098|NCT01422616|Analgesics|analgesics|mesh-ancestor
110038162|NCT01423019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110038218|NCT01423305|Budesonide|budesonide|mesh-list
110038324|NCT01423838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110038450|NCT01424449|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110038451|NCT01424449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110038708|NCT01425697|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110038773|NCT05386160|Growth Substances|growth substances|mesh-ancestor
110038846|NCT05385029|Antithyroid Agents|antithyroid agents|mesh-ancestor
110038914|NCT04850378|Protease Inhibitors|protease inhibitors|mesh-ancestor
110039040|NCT04421677|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
110039188|NCT01949714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110039321|NCT01426490|Vitamin B Complex|vitamin b complex|mesh-list
110039451|NCT01427192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110039521|NCT01427686|Dobutamine|dobutamine|mesh-list
110039588|NCT01428037|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110039659|NCT01428414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110040314|NCT01432522|Mydriatics|mydriatics|mesh-ancestor
110040364|NCT01432821|Autonomic Agents|autonomic agents|mesh-ancestor
110040464|NCT01433952|Vitamin B Complex|vitamin b complex|mesh-ancestor
110040709|NCT01435213|Ketamine|ketamine|mesh-list
110040773|NCT01435395|Alkylating Agents|alkylating agents|mesh-ancestor
110040834|NCT01435941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110040996|NCT01437228|Povidone|povidone|mesh-list
110041117|NCT01437813|Metformin|metformin|mesh-list
110041414|NCT04850222|Antidepressive Agents|antidepressive agents|mesh-ancestor
110041542|NCT04322552|Apatinib|apatinib|mesh-list
110041797|NCT00523341|Denosumab|denosumab|mesh-list
110041995|NCT01439243|Nootropic Agents|nootropic agents|mesh-ancestor
110042065|NCT01440114|Analgesics|analgesics|mesh-ancestor
110042127|NCT01440582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110042191|NCT01440829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042258|NCT01441232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110042644|NCT01443117|Vaccines|vaccines|mesh-list
110042703|NCT01443416|Immunologic Factors|immunologic factors|mesh-ancestor
110042841|NCT01444547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110043251|NCT01446731|Docetaxel|docetaxel|mesh-list
110043319|NCT01447212|Heroin|heroin|mesh-list
110043516|NCT01448395|Avibactam|avibactam|mesh-list
110044005|NCT05963334|Paclitaxel|paclitaxel|mesh-list
110044075|NCT05962619|Viscosupplements|viscosupplements|mesh-ancestor
110044213|NCT05960942|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110044282|NCT05955365|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110044346|NCT05887726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110044481|NCT05739942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110044504|NCT05734625|Hormones|hormones|mesh-ancestor
110044553|NCT05653193|Interferons|interferons|mesh-list
110045660|NCT06039280|Acetylcysteine|acetylcysteine|mesh-list
110045661|NCT06039280|Dexamethasone|dexamethasone|mesh-list
110045663|NCT06039280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110045664|NCT06039280|Antiemetics|antiemetics|mesh-ancestor
110045665|NCT06039280|Autonomic Agents|autonomic agents|mesh-ancestor
110045666|NCT06039280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110045667|NCT06039280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110045668|NCT06039280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110045669|NCT06039280|Glucocorticoids|glucocorticoids|mesh-ancestor
110045671|NCT06039280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110045672|NCT06039280|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110045673|NCT06039280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110045674|NCT06039280|Antiviral Agents|antiviral agents|mesh-ancestor
110045675|NCT06039280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110045676|NCT06039280|Expectorants|expectorants|mesh-ancestor
110045678|NCT06039280|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110045721|NCT06039020|Antibodies|antibodies|mesh-list
110046498|NCT05192889|Cytarabine|cytarabine|mesh-list
110046714|NCT05039619|Autonomic Agents|autonomic agents|mesh-ancestor
110046804|NCT04964934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110047134|NCT04561206|Immunotoxins|immunotoxins|mesh-ancestor
110047199|NCT04458610|Immunoglobulins|immunoglobulins|mesh-list
110047292|NCT04294264|Trifluridine|trifluridine|mesh-list
110047344|NCT04191499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110047345|NCT04191499|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110047346|NCT04191499|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110047347|NCT04191499|Hormone Antagonists|hormone antagonists|mesh-ancestor
110047348|NCT04191499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110047349|NCT04191499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110047350|NCT04191499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110047351|NCT04191499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110047352|NCT04191499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110047353|NCT04191499|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
110047354|NCT04181333|Trastuzumab|trastuzumab|mesh-list
110047355|NCT04181333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110047356|NCT04181333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110047357|NCT04180215|Pembrolizumab|pembrolizumab|mesh-list
110047358|NCT04180215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110047359|NCT04180215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110047360|NCT04180215|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110047361|NCT04180215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110047362|NCT04161066|Psilocybin|psilocybin|mesh-list
110047363|NCT04161066|Hallucinogens|hallucinogens|mesh-ancestor
110047364|NCT04161066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110047365|NCT04161066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110047366|NCT04100135|Clopidogrel|clopidogrel|mesh-list
110047367|NCT04100135|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110047557|NCT03692052|Mitapivat|mitapivat|mesh-list
110047874|NCT02988297|RNS60|rns60|mesh-list
110047962|NCT02719613|Dexamethasone|dexamethasone|mesh-list
110048108|NCT02265770|Antimetabolites|antimetabolites|mesh-ancestor
110048603|NCT04279054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110048611|NCT04263051|Nivolumab|nivolumab|mesh-list
110048612|NCT04263051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110048613|NCT04263051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110048614|NCT04263051|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110048615|NCT04263051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110048616|NCT04237935|Clopidogrel|clopidogrel|mesh-list
110048666|NCT04215536|Protease Inhibitors|protease inhibitors|mesh-ancestor
110048667|NCT04215536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110048668|NCT04215523|Dapagliflozin|dapagliflozin|mesh-list
110048669|NCT04215523|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
110048670|NCT04215523|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110048671|NCT04215523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110048803|NCT03937830|Growth Substances|growth substances|mesh-ancestor
110048931|NCT03762473|Tacrolimus|tacrolimus|mesh-list
110048996|NCT03613792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110049064|NCT03584516|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110049065|NCT03584516|Prednisolone phosphate|prednisolone phosphate|mesh-list
110049066|NCT03584516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110049067|NCT03584516|Glucocorticoids|glucocorticoids|mesh-ancestor
110049068|NCT03584516|Hormones|hormones|mesh-ancestor
110049069|NCT03584516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110049194|NCT03323437|Serotonin Agents|serotonin agents|mesh-ancestor
110049987|NCT01460979|Sirolimus|sirolimus|mesh-list
110050267|NCT01464008|Interferons|interferons|mesh-list
110050408|NCT01466855|Topotecan|topotecan|mesh-list
110050613|NCT01468025|Naproxen|naproxen|mesh-list
110050964|NCT01470092|Tibolone|tibolone|mesh-list
110051096|NCT01471067|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110052273|NCT01478737|Autonomic Agents|autonomic agents|mesh-ancestor
110052550|NCT01480765|Ketamine|ketamine|mesh-list
110053301|NCT01485744|Immunologic Factors|immunologic factors|mesh-ancestor
110053612|NCT01487395|Nootropic Agents|nootropic agents|mesh-ancestor
110053680|NCT01488253|Sirolimus|sirolimus|mesh-list
110054217|NCT01490437|Hormones|hormones|mesh-ancestor
110054420|NCT01491438|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110054560|NCT01492894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110054861|NCT01494636|Sensory System Agents|sensory system agents|mesh-ancestor
110054927|NCT01495104|Anticonvulsants|anticonvulsants|mesh-ancestor
110055000|NCT01495260|Protective Agents|protective agents|mesh-ancestor
110055071|NCT01495845|Clopidogrel|clopidogrel|mesh-list
110055132|NCT01496196|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110055387|NCT01497561|Insulin|insulin|mesh-list
110055527|NCT01498796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110055528|NCT01498796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110055589|NCT01498939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055724|NCT01500005|Vitamin D|vitamin d|mesh-list
110055803|NCT01500538|Vorinostat|vorinostat|mesh-list
110055804|NCT01500538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110055805|NCT01500538|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110055806|NCT01500538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110055807|NCT01500538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110056027|NCT01501214|Hormone Antagonists|hormone antagonists|mesh-ancestor
110056089|NCT01501396|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110056258|NCT01501890|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
110056259|NCT01501890|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110056381|NCT01502800|Antiviral Agents|antiviral agents|mesh-ancestor
110056382|NCT01502878|Cefpodoxime|cefpodoxime|mesh-list
110056563|NCT01503580|Tolterodine Tartrate|tolterodine tartrate|mesh-list
110056630|NCT01503801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110056834|NCT01504646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110056961|NCT01505231|Sympathomimetics|sympathomimetics|mesh-ancestor
110057032|NCT01505777|Mosapride|mosapride|mesh-list
110057171|NCT01506167|Antidotes|antidotes|mesh-ancestor
110057236|NCT01506544|Antisickling Agents|antisickling agents|mesh-ancestor
110057363|NCT01506921|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110057429|NCT01507363|Anticonvulsants|anticonvulsants|mesh-ancestor
110057572|NCT01507857|Vaccines|vaccines|mesh-list
110057706|NCT01508494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110057982|NCT01510288|Ipilimumab|ipilimumab|mesh-list
110058127|NCT01511172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058194|NCT01511289|Imatinib Mesylate|imatinib mesylate|mesh-list
110058332|NCT01511770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058396|NCT01511991|Anesthetics, General|anesthetics, general|mesh-ancestor
110058528|NCT01512901|Betamethasone|betamethasone|mesh-list
110058751|NCT01514110|Paclitaxel|paclitaxel|mesh-list
110059098|NCT01515852|Anesthetics|anesthetics|mesh-list
110059239|NCT01516710|Liver Extracts|liver extracts|mesh-list
110059358|NCT01517399|Vitamin K|vitamin k|mesh-list
110059493|NCT01518101|Metformin|metformin|mesh-list
110059494|NCT01518101|Liraglutide|liraglutide|mesh-list
110059562|NCT01518231|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110059699|NCT01519076|Keratolytic Agents|keratolytic agents|mesh-ancestor
110059768|NCT01519401|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110059978|NCT01520766|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110059982|NCT01520792|Acetaminophen|acetaminophen|mesh-list
110060044|NCT01521377|Moxifloxacin|moxifloxacin|mesh-list
110060190|NCT01522326|Antiemetics|antiemetics|mesh-ancestor
110060331|NCT01523002|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110060470|NCT01523431|Antidotes|antidotes|mesh-ancestor
110060533|NCT01523860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110060598|NCT01524237|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110060599|NCT01524237|Anesthetics, General|anesthetics, general|mesh-ancestor
110060875|NCT06052995|Sensory System Agents|sensory system agents|mesh-ancestor
110060876|NCT06052995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110060893|NCT06052852|Pembrolizumab|pembrolizumab|mesh-list
110061048|NCT06051630|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110061049|NCT06051630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110061050|NCT06051630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110061056|NCT06051513|Colistin|colistin|mesh-list
110061057|NCT06051513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110061058|NCT06051513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110061066|NCT06051474|Nicotine|nicotine|mesh-list
110061067|NCT06051474|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110061068|NCT06051474|Autonomic Agents|autonomic agents|mesh-ancestor
110061069|NCT06051474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110061070|NCT06051474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110061071|NCT06051474|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110061072|NCT06051474|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110061076|NCT06051409|Imatinib Mesylate|imatinib mesylate|mesh-list
110061413|NCT05891262|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110061414|NCT05891262|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110061584|NCT05733598|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110061585|NCT05733598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110061587|NCT05715216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110061588|NCT05715216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110061855|NCT05547542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110061860|NCT05494593|Rituximab|rituximab|mesh-list
110061924|NCT05415397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110061925|NCT05415397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110062025|NCT05269355|Dacarbazine|dacarbazine|mesh-list
110062388|NCT04766723|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110062389|NCT04766723|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110062390|NCT04766723|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
110062391|NCT04766723|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110062392|NCT04766723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110062393|NCT04766723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110062394|NCT04766723|Cholinergic Agents|cholinergic agents|mesh-ancestor
110062395|NCT04766723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110062396|NCT04766723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110062399|NCT04765059|Cisplatin|cisplatin|mesh-list
110062488|NCT04626141|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110062489|NCT04626141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110062490|NCT04609904|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110062491|NCT04609904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110062492|NCT04609904|Respiratory System Agents|respiratory system agents|mesh-ancestor
110062493|NCT04597619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
110062494|NCT04597619|Analgesics|analgesics|mesh-ancestor
110062495|NCT04597619|Sensory System Agents|sensory system agents|mesh-ancestor
110062496|NCT04597619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110062497|NCT04597619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110062498|NCT04593940|Remdesivir|remdesivir|mesh-list
110062499|NCT04593940|Cenicriviroc|cenicriviroc|mesh-list
110062500|NCT04593940|Infliximab|infliximab|mesh-list
110062501|NCT04593940|Abatacept|abatacept|mesh-list
110062502|NCT04593940|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110062503|NCT04593940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110062504|NCT04593940|Dermatologic Agents|dermatologic agents|mesh-ancestor
110062505|NCT04593940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110062506|NCT04593940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110062507|NCT04593940|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110062508|NCT04593940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110062509|NCT04593940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110062510|NCT04593940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110062511|NCT04593940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110062512|NCT04593940|Immunologic Factors|immunologic factors|mesh-ancestor
110062513|NCT04593940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110062514|NCT04593940|Antimetabolites|antimetabolites|mesh-ancestor
110062515|NCT04593940|Antiviral Agents|antiviral agents|mesh-ancestor
110062518|NCT04593940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110062528|NCT04576091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110062592|NCT04522336|Pembrolizumab|pembrolizumab|mesh-list
110062593|NCT04522336|Fluorouracil|fluorouracil|mesh-list
110062594|NCT04522336|Oxaliplatin|oxaliplatin|mesh-list
110062595|NCT04522336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110062596|NCT04522336|Tubulin Modulators|tubulin modulators|mesh-ancestor
110062597|NCT04522336|Antimitotic Agents|antimitotic agents|mesh-ancestor
110062599|NCT04522336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110062600|NCT04522336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110062602|NCT04522336|Antimetabolites|antimetabolites|mesh-ancestor
110062663|NCT04397484|Adrenergic Agents|adrenergic agents|mesh-ancestor
110062664|NCT04397484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110062665|NCT04397484|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110062666|NCT04397484|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110062667|NCT04397484|Autonomic Agents|autonomic agents|mesh-ancestor
110062668|NCT04397484|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110062669|NCT04397484|Respiratory System Agents|respiratory system agents|mesh-ancestor
110062670|NCT04397484|Mydriatics|mydriatics|mesh-ancestor
110062671|NCT04397484|Sympathomimetics|sympathomimetics|mesh-ancestor
110062672|NCT04397484|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110062673|NCT04393298|Leucovorin|leucovorin|mesh-list
110062674|NCT04393298|Trifluridine|trifluridine|mesh-list
110062675|NCT04393298|Fluorouracil|fluorouracil|mesh-list
110062676|NCT04393298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110062677|NCT04393298|Antimetabolites|antimetabolites|mesh-ancestor
110062678|NCT04393298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110062768|NCT04262843|Vidarabine|vidarabine|mesh-list
110062769|NCT04262843|Mycophenolic Acid|mycophenolic acid|mesh-list
110062770|NCT04262843|Cyclophosphamide|cyclophosphamide|mesh-list
110062771|NCT04262843|Fludarabine|fludarabine|mesh-list
110062772|NCT04262843|Fludarabine phosphate|fludarabine phosphate|mesh-list
110062773|NCT04262843|Tacrolimus|tacrolimus|mesh-list
110062774|NCT04262843|Lenograstim|lenograstim|mesh-list
110062775|NCT04262843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110062776|NCT04262843|Immunologic Factors|immunologic factors|mesh-ancestor
110062777|NCT04262843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110062778|NCT04262843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110062779|NCT04262843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110062780|NCT04262843|Alkylating Agents|alkylating agents|mesh-ancestor
110062781|NCT04262843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110062782|NCT04262843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110062783|NCT04262843|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110062784|NCT04262843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110062785|NCT04262843|Antimetabolites|antimetabolites|mesh-ancestor
110062786|NCT04262843|Antiviral Agents|antiviral agents|mesh-ancestor
110062787|NCT04262843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110062788|NCT04262843|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110062789|NCT04262843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110062790|NCT04262843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110062791|NCT04262843|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110062862|NCT04074746|Alkylating Agents|alkylating agents|mesh-ancestor
110062863|NCT04074746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110062866|NCT04074746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110062867|NCT04074746|Antimetabolites|antimetabolites|mesh-ancestor
110062868|NCT04074746|Antiviral Agents|antiviral agents|mesh-ancestor
110062870|NCT04038619|Loperamide|loperamide|mesh-list
110063060|NCT03803761|Fulvestrant|fulvestrant|mesh-list
110063130|NCT03726879|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110063132|NCT03726879|Immunoconjugates|immunoconjugates|mesh-ancestor
110063133|NCT03723187|Heparin|heparin|mesh-list
110063134|NCT03723187|Anticoagulants|anticoagulants|mesh-ancestor
110063135|NCT03723187|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110063136|NCT03723187|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110063138|NCT03691051|Capecitabine|capecitabine|mesh-list
110063304|NCT03186638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110063305|NCT03165292|Topotecan|topotecan|mesh-list
110063306|NCT03165292|Thiotepa|thiotepa|mesh-list
110063335|NCT03077542|Cyclophosphamide|cyclophosphamide|mesh-list
110063428|NCT02975934|Docetaxel|docetaxel|mesh-list
110063430|NCT02975934|Rucaparib|rucaparib|mesh-list
110063431|NCT02975934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110063432|NCT02975934|Tubulin Modulators|tubulin modulators|mesh-ancestor
110063433|NCT02975934|Antimitotic Agents|antimitotic agents|mesh-ancestor
110063434|NCT02975934|Mitosis Modulators|mitosis modulators|mesh-ancestor
110063435|NCT02975934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110063436|NCT02975934|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110063437|NCT02975934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110063438|NCT02975934|Hormone Antagonists|hormone antagonists|mesh-ancestor
110063439|NCT02975934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110063440|NCT02975934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110063441|NCT02975934|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110063442|NCT02975934|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110063443|NCT02927301|Atezolizumab|atezolizumab|mesh-list
110063444|NCT02927301|Antibodies|antibodies|mesh-list
110063445|NCT02927301|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110063446|NCT02927301|Immunologic Factors|immunologic factors|mesh-ancestor
110063447|NCT02927301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110063448|NCT02927301|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110063449|NCT02927301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110063450|NCT02927301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110063451|NCT02927301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110063452|NCT02923778|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
110063453|NCT02923778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110063454|NCT02923778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110063456|NCT02876302|Cyclophosphamide|cyclophosphamide|mesh-list
110063457|NCT02876302|Doxorubicin|doxorubicin|mesh-list
110063458|NCT02876302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110063459|NCT02876302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110063460|NCT02876302|Tubulin Modulators|tubulin modulators|mesh-ancestor
110063461|NCT02876302|Antimitotic Agents|antimitotic agents|mesh-ancestor
110063475|NCT02846623|Atezolizumab|atezolizumab|mesh-list
110063577|NCT02379377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110063583|NCT02357797|Vortioxetine|vortioxetine|mesh-list
110063584|NCT02357797|Antidepressive Agents|antidepressive agents|mesh-ancestor
110063585|NCT02357797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110063586|NCT02357797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110063587|NCT02357797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110063588|NCT02357797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110063589|NCT02357797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110063590|NCT02357797|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110063591|NCT02357797|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110063681|NCT01842386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110063804|NCT00591851|Paclitaxel|paclitaxel|mesh-list
110063912|NCT00092222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110063913|NCT00092222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110063914|NCT00092222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110063915|NCT00092222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110063916|NCT00092222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110063917|NCT00092222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110063918|NCT00092222|Glucocorticoids|glucocorticoids|mesh-ancestor
110063919|NCT00092222|Hormones|hormones|mesh-ancestor
110063920|NCT00092222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110035938|NCT01408160|Antimetabolites|antimetabolites|mesh-ancestor
110017382|NCT02970162|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110017425|NCT03009396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110017428|NCT03009396|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110017483|NCT03035760|Oxfendazole|oxfendazole|mesh-list
110017516|NCT03044418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110017517|NCT03044418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110017554|NCT03061812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110017591|NCT03070470|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110017592|NCT03070470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110017594|NCT03070470|Vasodilator Agents|vasodilator agents|mesh-ancestor
110017648|NCT03096444|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110017699|NCT05093790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110017730|NCT04890366|Dermatologic Agents|dermatologic agents|mesh-ancestor
110017731|NCT04890366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110017761|NCT04473924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110017773|NCT04426500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110017774|NCT04426500|Sensory System Agents|sensory system agents|mesh-ancestor
110017775|NCT04426500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110017812|NCT03409614|Cemiplimab|cemiplimab|mesh-list
110017873|NCT03218592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110017874|NCT03218592|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110017876|NCT03218592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110017918|NCT03239106|Sensory System Agents|sensory system agents|mesh-ancestor
110017941|NCT03278886|Nalmefene|nalmefene|mesh-list
110017968|NCT03287310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110017969|NCT03287310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018013|NCT03341910|Dermatologic Agents|dermatologic agents|mesh-ancestor
110018014|NCT03341910|Keratolytic Agents|keratolytic agents|mesh-ancestor
110018052|NCT03395886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110018053|NCT03395886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018106|NCT03459612|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110018108|NCT03459612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018126|NCT03463512|Racecadotril|racecadotril|mesh-list
110018142|NCT03496974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110018143|NCT03503292|Ondansetron|ondansetron|mesh-list
110018144|NCT03503292|Granisetron|granisetron|mesh-list
110018156|NCT03503292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018158|NCT03506724|Nifedipine|nifedipine|mesh-list
110018159|NCT03506724|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110018170|NCT03506724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110018192|NCT03533244|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110018193|NCT03533244|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110018201|NCT03541356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018213|NCT03572478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018231|NCT03610464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110018261|NCT03630198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110018283|NCT03674970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018292|NCT03704376|Analgesics|analgesics|mesh-ancestor
110018309|NCT03889158|Ascorbic Acid|ascorbic acid|mesh-list
110018313|NCT03889158|Antioxidants|antioxidants|mesh-ancestor
110018314|NCT03889158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110017334|NCT02956122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018328|NCT04138758|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110018329|NCT04138758|Cholinergic Agents|cholinergic agents|mesh-ancestor
110018342|NCT04420572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110018359|NCT04335552|Azithromycin|azithromycin|mesh-list
110018360|NCT04335552|Hydroxychloroquine|hydroxychloroquine|mesh-list
110018363|NCT04335552|Antimalarials|antimalarials|mesh-ancestor
110018367|NCT04335552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018368|NCT04335552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110017404|NCT02988882|Hormones|hormones|mesh-ancestor
110018379|NCT04267770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018380|NCT04204200|Vitamins|vitamins|mesh-list
110018381|NCT04204200|Ascorbic Acid|ascorbic acid|mesh-list
110018387|NCT04179474|Erenumab|erenumab|mesh-list
110018388|NCT04179474|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
110018405|NCT04112160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110017442|NCT03017508|Protective Agents|protective agents|mesh-ancestor
110018417|NCT04053270|Dermatologic Agents|dermatologic agents|mesh-ancestor
110018419|NCT03976752|Emtricitabine|emtricitabine|mesh-list
110018431|NCT03976752|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110018432|NCT03976752|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110018433|NCT03976752|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110018434|NCT03976752|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110018437|NCT03962634|Carticaine|carticaine|mesh-list
110018438|NCT03962634|Anesthetics, Local|anesthetics, local|mesh-ancestor
110018439|NCT03962634|Anesthetics|anesthetics|mesh-ancestor
110018441|NCT03962634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018444|NCT03962634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110018445|NCT03962634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110018446|NCT03962634|Adrenergic Agents|adrenergic agents|mesh-ancestor
110018472|NCT03933618|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110018477|NCT03930264|Azathioprine|azathioprine|mesh-list
110018481|NCT03930264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110018482|NCT03930264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110018483|NCT03930264|Immunologic Factors|immunologic factors|mesh-ancestor
110017559|NCT03061812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110017569|NCT03070470|Verapamil|verapamil|mesh-list
110018517|NCT03812328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110018519|NCT03805386|Analgesics, Opioid|analgesics, opioid|mesh-list
110018528|NCT03796260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110017632|NCT03096444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110018537|NCT03730116|Bisoprolol|bisoprolol|mesh-list
110018548|NCT03730116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110018549|NCT03730116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018550|NCT03730116|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110018560|NCT03161964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018570|NCT03078270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018591|NCT02985840|Hormones|hormones|mesh-ancestor
110018692|NCT02345460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018693|NCT02345460|Antimetabolites|antimetabolites|mesh-ancestor
110019299|NCT03301038|Rifampin|rifampin|mesh-list
110019583|NCT00000240|Narcotics|narcotics|mesh-ancestor
110019584|NCT00000240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110020017|NCT00000912|Adefovir|adefovir|mesh-list
110020109|NCT00000942|Nevirapine|nevirapine|mesh-list
110020310|NCT00001626|Cyclosporine|cyclosporine|mesh-list
110020460|NCT00002028|Didanosine|didanosine|mesh-list
110020902|NCT00002322|Atevirdine|atevirdine|mesh-list
110021124|NCT00002436|Antiviral Agents|antiviral agents|mesh-ancestor
110022099|NCT05312112|Venetoclax|venetoclax|mesh-list
110022258|NCT03701490|Progesterone|progesterone|mesh-list
110022638|NCT00003000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110022922|NCT00003204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110023214|NCT00003552|Alkylating Agents|alkylating agents|mesh-ancestor
110023583|NCT00003870|Antimetabolites|antimetabolites|mesh-ancestor
110024101|NCT00004242|Gemcitabine|gemcitabine|mesh-list
110024243|NCT00004422|Immunoglobulins|immunoglobulins|mesh-list
110024828|NCT00005634|Vorinostat|vorinostat|mesh-list
110025060|NCT00357240|Ritonavir|ritonavir|mesh-list
110025631|NCT00370500|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110025632|NCT00370500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110025637|NCT00370656|Amitriptyline|amitriptyline|mesh-list
110026060|NCT00382980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110026432|NCT02993640|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110026433|NCT02993640|Natriuretic Agents|natriuretic agents|mesh-ancestor
110026590|NCT01271166|Leucovorin|leucovorin|mesh-list
110026835|NCT01271790|Ribavirin|ribavirin|mesh-list
110027067|NCT03467256|Cytarabine|cytarabine|mesh-list
110027863|NCT01729260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110028069|NCT03402204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110028086|NCT03402048|Carboplatin|carboplatin|mesh-list
110022328|NCT01096368|Podophyllotoxin|podophyllotoxin|mesh-list
110029544|NCT04477317|Autonomic Agents|autonomic agents|mesh-ancestor
110029865|NCT02932826|Insulin|insulin|mesh-list
110030129|NCT00309192|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110030134|NCT00309192|Hormones|hormones|mesh-ancestor
110030197|NCT01384448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110030275|NCT01384994|Micronutrients|micronutrients|mesh-ancestor
110030347|NCT01385891|Clofarabine|clofarabine|mesh-list
110030490|NCT01386567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030492|NCT01386567|Hormones|hormones|mesh-ancestor
110030493|NCT01386567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110030494|NCT01386567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110030552|NCT01386593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110030553|NCT01386593|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110030687|NCT01387620|Viscosupplements|viscosupplements|mesh-ancestor
110030769|NCT01388322|Enoxaparin|enoxaparin|mesh-list
110030904|NCT01389167|Sensory System Agents|sensory system agents|mesh-ancestor
110030905|NCT01389167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110030906|NCT01389193|Ibudilast|ibudilast|mesh-list
110030907|NCT01389193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110031054|NCT01389713|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110031055|NCT01389713|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110031056|NCT01389713|Luteolytic Agents|luteolytic agents|mesh-ancestor
110031057|NCT01389713|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110031114|NCT01390012|Protease Inhibitors|protease inhibitors|mesh-ancestor
110031115|NCT01390012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110031118|NCT01390051|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110031331|NCT01391377|Vitamins|vitamins|mesh-ancestor
110031417|NCT01392157|Copper|copper|mesh-list
110031418|NCT01392157|Levonorgestrel|levonorgestrel|mesh-list
110031436|NCT01392287|Memantine|memantine|mesh-list
110031489|NCT01392638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110031490|NCT01392638|Urological Agents|urological agents|mesh-ancestor
110031491|NCT01392716|Rituximab|rituximab|mesh-list
110031492|NCT01392716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110031493|NCT01392716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110031494|NCT01392716|Immunologic Factors|immunologic factors|mesh-ancestor
110031495|NCT01392716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110031555|NCT01392833|Autonomic Agents|autonomic agents|mesh-ancestor
110031556|NCT01392833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110031557|NCT01392833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110031558|NCT01392833|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110031559|NCT01392833|Protective Agents|protective agents|mesh-ancestor
110031560|NCT01392833|Antimetabolites|antimetabolites|mesh-ancestor
110031561|NCT01392833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110031773|NCT01394341|Incretins|incretins|mesh-ancestor
110031918|NCT01394796|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
110031919|NCT01394796|Antioxidants|antioxidants|mesh-ancestor
110031920|NCT01394796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110031922|NCT01394796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110031992|NCT01395147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110031993|NCT01395147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032004|NCT01395199|Amlodipine|amlodipine|mesh-list
110032285|NCT01396720|Fluvoxamine|fluvoxamine|mesh-list
110032657|NCT05274100|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110032658|NCT05274100|Immunologic Factors|immunologic factors|mesh-ancestor
110032659|NCT05274100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032668|NCT05273528|Vaccines|vaccines|mesh-list
110032813|NCT05270421|Diuretics|diuretics|mesh-ancestor
110032958|NCT05138029|Hormones|hormones|mesh-ancestor
110033111|NCT04919564|Diuretics|diuretics|mesh-ancestor
110033183|NCT04706767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110033406|NCT03705338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110033407|NCT03705338|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110033409|NCT03704285|Anesthetics|anesthetics|mesh-list
110033410|NCT03704285|Anesthetics, General|anesthetics, general|mesh-list
110033411|NCT03704285|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110033412|NCT03704285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110033487|NCT03315039|Annamycin|annamycin|mesh-list
110033626|NCT03012672|Cytarabine|cytarabine|mesh-list
110033755|NCT02810457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110033757|NCT02745535|Sofosbuvir|sofosbuvir|mesh-list
110017913|NCT03223272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110033825|NCT02619552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110033826|NCT02619552|Dermatologic Agents|dermatologic agents|mesh-ancestor
110034031|NCT01622998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034317|NCT01398111|Cholinergic Agents|cholinergic agents|mesh-ancestor
110034320|NCT01398189|Serotonin Agents|serotonin agents|mesh-ancestor
110035037|NCT01403389|Eculizumab|eculizumab|mesh-list
110035169|NCT01404013|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110035172|NCT01404104|Sirolimus|sirolimus|mesh-list
110035399|NCT01404767|Metoprolol|metoprolol|mesh-list
110017940|NCT03278886|Naltrexone|naltrexone|mesh-list
110054794|NCT01494311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110052804|NCT01482117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110054795|NCT01494363|Leucovorin|leucovorin|mesh-list
110052805|NCT01482117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110052806|NCT01482117|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110052807|NCT01482117|Autonomic Agents|autonomic agents|mesh-ancestor
110052808|NCT01482117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110052809|NCT01482117|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110052810|NCT01482117|Respiratory System Agents|respiratory system agents|mesh-ancestor
110052811|NCT01482117|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110052813|NCT01482117|Vasodilator Agents|vasodilator agents|mesh-ancestor
110052814|NCT01482117|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110052815|NCT01482117|Protective Agents|protective agents|mesh-ancestor
110054796|NCT01494363|Fluorouracil|fluorouracil|mesh-list
110054798|NCT01494363|Irinotecan|irinotecan|mesh-list
110052816|NCT01482117|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110052817|NCT01482117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110052818|NCT01482117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110054799|NCT01494363|Antimetabolites|antimetabolites|mesh-ancestor
110052820|NCT01482156|Dactolisib|dactolisib|mesh-list
110022329|NCT01096368|Lenograstim|lenograstim|mesh-list
110052821|NCT01482156|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110022330|NCT01096368|Mesna|mesna|mesh-list
110052822|NCT01482156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110052823|NCT01482156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110052824|NCT01482156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018117|NCT03459612|Histamine Antagonists|histamine antagonists|mesh-ancestor
110052825|NCT01482156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110052826|NCT01482156|Immunologic Factors|immunologic factors|mesh-ancestor
110052827|NCT01482156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110052828|NCT01482156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110052829|NCT01482299|Everolimus|everolimus|mesh-list
110052830|NCT01482299|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110052831|NCT01482299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110052832|NCT01482299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110052833|NCT01482299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110052834|NCT01482299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110018177|NCT03509766|Histamine|histamine|mesh-list
110052835|NCT01482299|Immunologic Factors|immunologic factors|mesh-ancestor
110052836|NCT01482299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110052838|NCT01482338|Drospirenone|drospirenone|mesh-list
110052840|NCT01482338|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110052841|NCT01482338|Hormone Antagonists|hormone antagonists|mesh-ancestor
110018226|NCT03610464|Amphetamine|amphetamine|mesh-list
110018240|NCT03615534|Niacin|niacin|mesh-list
110052842|NCT01482338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110052843|NCT01482338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110052844|NCT01482338|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110052845|NCT01482338|Diuretics|diuretics|mesh-ancestor
110052846|NCT01482338|Natriuretic Agents|natriuretic agents|mesh-ancestor
110052847|NCT01482338|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110052848|NCT01482338|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110052851|NCT01482338|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110018274|NCT03674970|Nicotine|nicotine|mesh-list
110052852|NCT01482338|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110052853|NCT01482338|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110052855|NCT01482338|Hormones|hormones|mesh-ancestor
110052856|NCT01482377|Cetuximab|cetuximab|mesh-list
110018290|NCT03704376|Sensory System Agents|sensory system agents|mesh-ancestor
110052857|NCT01482377|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110052859|NCT01482377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110052860|NCT01482377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110052861|NCT01482377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110052862|NCT01482377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110052863|NCT01482416|Estrogens|estrogens|mesh-list
110052864|NCT01482416|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110052865|NCT01482416|Hormones|hormones|mesh-ancestor
110052866|NCT01482416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110052867|NCT01482416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110052868|NCT01482442|Sorafenib|sorafenib|mesh-list
110052869|NCT01482442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110018332|NCT04138758|Anticonvulsants|anticonvulsants|mesh-ancestor
110052870|NCT01482442|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110018353|NCT04511520|Trimetazidine|trimetazidine|mesh-list
110052872|NCT01482442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110052874|NCT01482468|Antiemetics|antiemetics|mesh-ancestor
110052875|NCT01482468|Autonomic Agents|autonomic agents|mesh-ancestor
110052876|NCT01482468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110052877|NCT01482468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110052878|NCT01482468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110052879|NCT01482468|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110052880|NCT01482468|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110052881|NCT01482468|Serotonin Agents|serotonin agents|mesh-ancestor
110052882|NCT01482468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110052883|NCT01482468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110052884|NCT01482559|Dopamine|dopamine|mesh-list
110052885|NCT01482559|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110052886|NCT01482559|Sympathomimetics|sympathomimetics|mesh-ancestor
110052887|NCT01482559|Autonomic Agents|autonomic agents|mesh-ancestor
110052888|NCT01482559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110052889|NCT01482559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110052890|NCT01482559|Dopamine Agents|dopamine agents|mesh-ancestor
110052891|NCT01482559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110052892|NCT01482559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110052893|NCT01482559|Protective Agents|protective agents|mesh-ancestor
110052894|NCT01482624|Hyaluronic Acid|hyaluronic acid|mesh-list
110052895|NCT01482624|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110052896|NCT01482624|Immunologic Factors|immunologic factors|mesh-ancestor
110052897|NCT01482624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110052899|NCT01482624|Protective Agents|protective agents|mesh-ancestor
110052900|NCT01482728|Dasatinib|dasatinib|mesh-list
110052901|NCT01482728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110052903|NCT01482728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110052904|NCT01482728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110052906|NCT01482754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110052907|NCT01482754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110052908|NCT01482754|Immunologic Factors|immunologic factors|mesh-ancestor
110052909|NCT01482754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110052910|NCT01482754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110052911|NCT01482897|Prednisolone|prednisolone|mesh-list
110052912|NCT01482897|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110052914|NCT01482897|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110052916|NCT01482897|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110052917|NCT01482897|Prednisolone phosphate|prednisolone phosphate|mesh-list
110052918|NCT01482897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110052919|NCT01482897|Glucocorticoids|glucocorticoids|mesh-ancestor
110052920|NCT01482897|Hormones|hormones|mesh-ancestor
110052921|NCT01482897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110052922|NCT01482897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110052923|NCT01482897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110052924|NCT01482897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110052925|NCT01482897|Antiemetics|antiemetics|mesh-ancestor
110052926|NCT01482897|Autonomic Agents|autonomic agents|mesh-ancestor
110018418|NCT03976752|Tenofovir|tenofovir|mesh-list
110052927|NCT01482897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110052928|NCT01482897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110052929|NCT01482897|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110052930|NCT01482897|Protective Agents|protective agents|mesh-ancestor
110052931|NCT01482936|Oxycodone|oxycodone|mesh-list
110052932|NCT01482936|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110052933|NCT01482936|Narcotics|narcotics|mesh-ancestor
110052934|NCT01482936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110018435|NCT03962634|Oxymetazoline|oxymetazoline|mesh-list
110052936|NCT01482936|Analgesics|analgesics|mesh-ancestor
110052937|NCT01482936|Sensory System Agents|sensory system agents|mesh-ancestor
110052938|NCT01482936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110052939|NCT01483014|Imatinib Mesylate|imatinib mesylate|mesh-list
110052940|NCT01483014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110052941|NCT01483014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110052942|NCT01483014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110052943|NCT01483014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110052944|NCT01483053|Agomelatine|agomelatine|mesh-list
110052946|NCT01483053|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110052947|NCT01483053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110052948|NCT01483053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110018512|NCT03806556|Hemostatics|hemostatics|mesh-ancestor
110052949|NCT01483053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110052950|NCT01483053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110052951|NCT01483053|Serotonin Agents|serotonin agents|mesh-ancestor
110052952|NCT01483053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110052953|NCT01483053|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110018583|NCT02985840|Ondansetron|ondansetron|mesh-list
110052954|NCT01483053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110018585|NCT02985840|Antiemetics|antiemetics|mesh-ancestor
110052955|NCT01483248|Interferons|interferons|mesh-list
110052956|NCT01483248|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
110054800|NCT01494363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110052957|NCT01483248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110052958|NCT01483248|Antiviral Agents|antiviral agents|mesh-ancestor
110052959|NCT01483248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110052960|NCT01483248|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110052961|NCT01483248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110052962|NCT01483274|Vaccines|vaccines|mesh-list
110052963|NCT01483274|Immunologic Factors|immunologic factors|mesh-ancestor
110054801|NCT01494363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110018698|NCT02345460|Immunologic Factors|immunologic factors|mesh-ancestor
110052964|NCT01483274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110052966|NCT01483300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110052968|NCT01483365|Progestins|progestins|mesh-ancestor
110052970|NCT01483365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110052971|NCT01483365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054802|NCT01494363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110052972|NCT01483508|Proanthocyanidin|proanthocyanidin|mesh-list
110052973|NCT01483508|Procyanidin|procyanidin|mesh-list
110018745|NCT02015910|Hormones|hormones|mesh-ancestor
110052975|NCT01483508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110052976|NCT01483508|Protective Agents|protective agents|mesh-ancestor
110054804|NCT01494363|Immunologic Factors|immunologic factors|mesh-ancestor
110054805|NCT01494363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018775|NCT01878786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110018795|NCT01846182|Pregabalin|pregabalin|mesh-list
110052977|NCT01483508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110052978|NCT01483508|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110052979|NCT01483508|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110052980|NCT01483508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110052981|NCT01483638|Axitinib|axitinib|mesh-list
110052982|NCT01483638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110052983|NCT01483638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110052984|NCT01483638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110018859|NCT01608906|Heparin|heparin|mesh-list
110053001|NCT01483781|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110053002|NCT01483781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110053004|NCT01483781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053005|NCT01483859|Liver Extracts|liver extracts|mesh-list
110053007|NCT01483911|Gontivimab|gontivimab|mesh-list
110053008|NCT01483911|Antiviral Agents|antiviral agents|mesh-ancestor
110053009|NCT01483911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110053010|NCT01484015|Cefepime|cefepime|mesh-list
110019148|NCT00676026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110019256|NCT04954638|Eusol|eusol|mesh-list
110054807|NCT01494363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110053011|NCT01484015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110053012|NCT01484015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110019519|NCT00000192|Lamotrigine|lamotrigine|mesh-list
110054808|NCT01494363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110054809|NCT01494363|Antidotes|antidotes|mesh-ancestor
110022411|NCT00002802|Doxorubicin|doxorubicin|mesh-list
110053013|NCT01484080|Paclitaxel|paclitaxel|mesh-list
110019559|NCT00000222|Analgesics|analgesics|mesh-ancestor
110020264|NCT00001296|Interferons|interferons|mesh-list
110054810|NCT01494363|Protective Agents|protective agents|mesh-ancestor
110020837|NCT00002274|Didanosine|didanosine|mesh-list
110021200|NCT00002472|Etoposide|etoposide|mesh-list
110053014|NCT01484080|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110054811|NCT01494363|Vitamin B Complex|vitamin b complex|mesh-ancestor
110021722|NCT00002688|Analgesics|analgesics|mesh-ancestor
110021787|NCT00002718|Cytarabine|cytarabine|mesh-list
110021861|NCT00002760|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110053015|NCT01484080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110022365|NCT00577200|Anesthetics|anesthetics|mesh-ancestor
110022441|NCT00002814|Mitosis Modulators|mitosis modulators|mesh-ancestor
110022811|NCT00003126|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110023038|NCT00003336|Antiemetics|antiemetics|mesh-ancestor
110023350|NCT00003666|Irofulven|irofulven|mesh-list
110035961|NCT01408186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110053016|NCT01484080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023546|NCT00003852|Immunologic Factors|immunologic factors|mesh-ancestor
110023927|NCT00004158|Melphalan|melphalan|mesh-list
110053017|NCT01484080|Tubulin Modulators|tubulin modulators|mesh-ancestor
110053018|NCT01484080|Antimitotic Agents|antimitotic agents|mesh-ancestor
110053019|NCT01484080|Mitosis Modulators|mitosis modulators|mesh-ancestor
110054812|NCT01494363|Vitamins|vitamins|mesh-ancestor
110035981|NCT01408342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110025190|NCT00359190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110025412|NCT00365040|Mitomycins|mitomycins|mesh-list
110025547|NCT00368238|Hematinics|hematinics|mesh-ancestor
110025690|NCT00371124|Cholinergic Agents|cholinergic agents|mesh-ancestor
110025749|NCT00372762|Furosemide|furosemide|mesh-list
110054813|NCT01494363|Micronutrients|micronutrients|mesh-ancestor
110053020|NCT01484080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110053022|NCT01484145|Antifungal Agents|antifungal agents|mesh-ancestor
110053023|NCT01484145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110053024|NCT01484145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110053025|NCT01484145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110053027|NCT01484171|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110053028|NCT01484171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110053029|NCT01484171|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110053030|NCT01484171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110053031|NCT01484171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110053032|NCT01484171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110054815|NCT01494402|Esomeprazole|esomeprazole|mesh-list
110054816|NCT01494402|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110053033|NCT01484184|Levodopa|levodopa|mesh-list
110053034|NCT01484184|Buspirone|buspirone|mesh-list
110053035|NCT01484184|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110053036|NCT01484184|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110053037|NCT01484184|Dopamine Agents|dopamine agents|mesh-ancestor
110053038|NCT01484184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110026463|NCT02992392|Blood Substitutes|blood substitutes|mesh-ancestor
110053039|NCT01484184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110053040|NCT01484184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053042|NCT01484184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110053043|NCT01484184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110053044|NCT01484184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110053045|NCT01484184|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110053046|NCT01484184|Serotonin Agents|serotonin agents|mesh-ancestor
110026499|NCT02999958|Protective Agents|protective agents|mesh-ancestor
110053047|NCT01484262|Liraglutide|liraglutide|mesh-list
110053048|NCT01484262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110053049|NCT01484262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053050|NCT01484262|Incretins|incretins|mesh-ancestor
110053051|NCT01484262|Hormones|hormones|mesh-ancestor
110022412|NCT00002802|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110053052|NCT01484262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110026647|NCT01273506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110026797|NCT01272180|Vaccines|vaccines|mesh-list
110026918|NCT00247962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110027027|NCT03801252|Cefazolin|cefazolin|mesh-list
110027087|NCT03467256|Hormones|hormones|mesh-ancestor
110027385|NCT01831674|Metformin|metformin|mesh-list
110027428|NCT01834014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110027504|NCT01838928|Bupivacaine|bupivacaine|mesh-list
110053053|NCT01484327|Carvedilol|carvedilol|mesh-list
110027625|NCT01720212|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110027692|NCT01724190|Vitamins|vitamins|mesh-ancestor
110027716|NCT01724268|Glucocorticoids|glucocorticoids|mesh-ancestor
110027731|NCT01724424|Melatonin|melatonin|mesh-list
110027747|NCT01725048|Serotonin Agents|serotonin agents|mesh-ancestor
110027803|NCT01726686|Ropivacaine|ropivacaine|mesh-list
110027897|NCT01049334|Sensory System Agents|sensory system agents|mesh-ancestor
110027999|NCT03408054|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110028088|NCT03402048|Docetaxel|docetaxel|mesh-list
110028288|NCT02243436|Glucocorticoids|glucocorticoids|mesh-ancestor
110028331|NCT02244528|Sildenafil Citrate|sildenafil citrate|mesh-list
110028349|NCT02246244|Serotonin Agents|serotonin agents|mesh-ancestor
110053054|NCT01484327|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110053055|NCT01484327|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110028392|NCT02247414|Anticoagulants|anticoagulants|mesh-ancestor
110028437|NCT02248506|Miconazole|miconazole|mesh-list
110028454|NCT02248896|Enzyme Inhibitors|enzyme inhibitors|mesh-list
110028528|NCT02244606|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110028557|NCT02243358|Antimetabolites|antimetabolites|mesh-ancestor
110028561|NCT00559962|Ezetimibe|ezetimibe|mesh-list
110028571|NCT00559104|Carmustine|carmustine|mesh-list
110028575|NCT00559104|Immunologic Factors|immunologic factors|mesh-ancestor
110028742|NCT03029676|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110028770|NCT04278846|Bupivacaine|bupivacaine|mesh-list
110028918|NCT05768334|Lubiprostone|lubiprostone|mesh-list
110028946|NCT05768204|Hormones|hormones|mesh-ancestor
110028966|NCT05767827|Lidocaine|lidocaine|mesh-list
110029012|NCT05767723|Analgesics|analgesics|mesh-ancestor
110029027|NCT05767632|Mirabegron|mirabegron|mesh-list
110029039|NCT05767515|Inositol|inositol|mesh-list
110029197|NCT05468099|Chlorhexidine|chlorhexidine|mesh-list
110029256|NCT05193370|Arginine Vasopressin|arginine vasopressin|mesh-list
110029257|NCT05193370|Angiotensin II|angiotensin ii|mesh-list
110029270|NCT05172947|Resveratrol|resveratrol|mesh-list
110029280|NCT05147220|Teriflunomide|teriflunomide|mesh-list
110029347|NCT05019638|Ketorolac|ketorolac|mesh-list
110053056|NCT01484327|Adrenergic Agents|adrenergic agents|mesh-ancestor
110029467|NCT04612920|Acetaminophen|acetaminophen|mesh-list
110029575|NCT04344262|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110029589|NCT04291521|Etomidate|etomidate|mesh-list
110029602|NCT04291521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110029617|NCT04280601|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110053057|NCT01484327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110029737|NCT03786783|Tubulin Modulators|tubulin modulators|mesh-ancestor
110029756|NCT03670056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110029775|NCT03654833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110029978|NCT02588872|Viscosupplements|viscosupplements|mesh-ancestor
110030141|NCT00110591|Leronlimab|leronlimab|mesh-list
110030346|NCT01385891|Etoposide|etoposide|mesh-list
110030362|NCT01385956|Hormones|hormones|mesh-ancestor
110030386|NCT01386164|Vaccines|vaccines|mesh-list
110030446|NCT01386333|Oxytocin|oxytocin|mesh-list
110030654|NCT01387373|Capecitabine|capecitabine|mesh-list
110030763|NCT01388270|Heparin|heparin|mesh-list
110030897|NCT01389063|Antiviral Agents|antiviral agents|mesh-ancestor
110030923|NCT01389206|Vasodilator Agents|vasodilator agents|mesh-ancestor
110053058|NCT01484327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030997|NCT01389505|Bevacizumab|bevacizumab|mesh-list
110031124|NCT01390311|Azacitidine|azacitidine|mesh-list
110031144|NCT01390324|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110031173|NCT01390506|Trace Elements|trace elements|mesh-ancestor
110031207|NCT01390766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110031215|NCT01390792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110031236|NCT01390896|Protease Inhibitors|protease inhibitors|mesh-ancestor
110031346|NCT01391520|Deferiprone|deferiprone|mesh-list
110031347|NCT01391520|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110031348|NCT01391520|Chelating Agents|chelating agents|mesh-ancestor
110031349|NCT01391520|Sequestering Agents|sequestering agents|mesh-ancestor
110031350|NCT01391520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110031351|NCT01391572|Fluorouracil|fluorouracil|mesh-list
110031352|NCT01391572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110031353|NCT01391572|Antimetabolites|antimetabolites|mesh-ancestor
110031354|NCT01391572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110031355|NCT01391572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110031356|NCT01391572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110031357|NCT01391572|Immunologic Factors|immunologic factors|mesh-ancestor
110031358|NCT01391572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110031359|NCT01391598|Lidocaine|lidocaine|mesh-list
110031360|NCT01391598|Anesthetics, Local|anesthetics, local|mesh-ancestor
110031361|NCT01391598|Anesthetics|anesthetics|mesh-ancestor
110031366|NCT01391598|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110031367|NCT01391598|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110031387|NCT01391845|Contraceptive Agents|contraceptive agents|mesh-ancestor
110031456|NCT01392430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110031457|NCT01392430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110054789|NCT01494311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110031588|NCT01393080|Cisplatin|cisplatin|mesh-list
110053059|NCT01484327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110031685|NCT01393574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110031715|NCT01393782|Protease Inhibitors|protease inhibitors|mesh-ancestor
110031743|NCT01394029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110031768|NCT01394263|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110031769|NCT01394263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110031770|NCT01394341|Liraglutide|liraglutide|mesh-list
110053060|NCT01484327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110031821|NCT01394419|Protective Agents|protective agents|mesh-ancestor
110031831|NCT01394445|Miotics|miotics|mesh-ancestor
110031897|NCT01394757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110031911|NCT01394770|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110031956|NCT01394887|Metformin|metformin|mesh-list
110032005|NCT01395199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110032046|NCT01395433|Dexetimide|dexetimide|mesh-list
110053061|NCT01484327|Antioxidants|antioxidants|mesh-ancestor
110053062|NCT01484327|Protective Agents|protective agents|mesh-ancestor
110032309|NCT01396733|Vitamins|vitamins|mesh-ancestor
110032329|NCT01397019|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110032384|NCT05269290|Antiviral Agents|antiviral agents|mesh-ancestor
110032398|NCT05268718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110032483|NCT04453449|Anesthetics|anesthetics|mesh-ancestor
110032488|NCT04415333|Butyric Acid|butyric acid|mesh-list
110032522|NCT03129321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110032549|NCT03040726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110054790|NCT01494311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110032746|NCT05271188|Anesthetics, Local|anesthetics, local|mesh-list
110032937|NCT05142267|Oxycodone|oxycodone|mesh-list
110032972|NCT05135039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110033008|NCT05067439|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110033093|NCT04961801|Tacrolimus|tacrolimus|mesh-list
110033095|NCT04961801|Abortifacient Agents|abortifacient agents|mesh-ancestor
110033187|NCT04706767|Analgesics|analgesics|mesh-ancestor
110033229|NCT04433390|Sensory System Agents|sensory system agents|mesh-ancestor
110033269|NCT04324021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110033320|NCT04095104|Sympathomimetics|sympathomimetics|mesh-ancestor
110033366|NCT03858621|Fentanyl|fentanyl|mesh-list
110033424|NCT03661996|Sensory System Agents|sensory system agents|mesh-ancestor
110033494|NCT03289325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110033519|NCT03276533|Analgesics|analgesics|mesh-ancestor
110033543|NCT03191240|Vasopressins|vasopressins|mesh-list
110017297|NCT02953860|Fulvestrant|fulvestrant|mesh-list
110033562|NCT03180294|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110033586|NCT03071601|Autonomic Agents|autonomic agents|mesh-ancestor
110033589|NCT03071601|Mydriatics|mydriatics|mesh-ancestor
110033615|NCT03055390|Autonomic Agents|autonomic agents|mesh-ancestor
110017379|NCT02970162|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110017464|NCT03020082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110033691|NCT02960997|Sirolimus|sirolimus|mesh-list
110017546|NCT03061812|Dexamethasone|dexamethasone|mesh-list
110033786|NCT02666794|Sensory System Agents|sensory system agents|mesh-ancestor
110033819|NCT02619552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110033830|NCT02578368|Leucovorin|leucovorin|mesh-list
110033913|NCT02293109|Levoleucovorin|levoleucovorin|mesh-list
110017886|NCT03219294|Vecuronium Bromide|vecuronium bromide|mesh-list
110033990|NCT01940809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110033995|NCT01879228|Hormones|hormones|mesh-ancestor
110034070|NCT01515306|Antimitotic Agents|antimitotic agents|mesh-ancestor
110034106|NCT01226732|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110034123|NCT00962988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110034142|NCT00768820|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110017887|NCT03219294|Anticonvulsants|anticonvulsants|mesh-ancestor
110034204|NCT00430040|Protease Inhibitors|protease inhibitors|mesh-ancestor
110034212|NCT00290251|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110017972|NCT03301272|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110034237|NCT01397513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110018140|NCT03496974|Immunologic Factors|immunologic factors|mesh-ancestor
110034318|NCT01398189|Clozapine|clozapine|mesh-list
110018423|NCT03976752|Elvitegravir|elvitegravir|mesh-list
110034345|NCT01398267|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110034348|NCT01398293|Ritonavir|ritonavir|mesh-list
110034412|NCT01398618|Rifampin|rifampin|mesh-list
110034456|NCT01399151|Vitamin D|vitamin d|mesh-list
110034467|NCT01399216|Anticoagulants|anticoagulants|mesh-ancestor
110034481|NCT01399346|Insulin|insulin|mesh-list
110034489|NCT01399450|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110034528|NCT01399645|Hormones|hormones|mesh-ancestor
110034535|NCT01399853|Vaccines|vaccines|mesh-list
110034572|NCT01400165|Serotonin Agents|serotonin agents|mesh-ancestor
110034612|NCT01400568|Xhance|xhance|mesh-list
110034624|NCT01400633|Antimetabolites|antimetabolites|mesh-ancestor
110034628|NCT01400646|Vitamins|vitamins|mesh-list
110034643|NCT01400646|Hemostatics|hemostatics|mesh-ancestor
110034648|NCT01400672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034649|NCT01400672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110034650|NCT01400672|Interferon Inducers|interferon inducers|mesh-ancestor
110034651|NCT01400685|Rituximab|rituximab|mesh-list
110034652|NCT01400685|Lenalidomide|lenalidomide|mesh-list
110034653|NCT01400685|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110034654|NCT01400685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110034655|NCT01400685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110034656|NCT01400685|Immunologic Factors|immunologic factors|mesh-ancestor
110034669|NCT01400737|Analgesics|analgesics|mesh-ancestor
110018424|NCT03976752|Antiviral Agents|antiviral agents|mesh-ancestor
110018425|NCT03976752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110018708|NCT02345772|Trastuzumab|trastuzumab|mesh-list
110018709|NCT02345772|Fulvestrant|fulvestrant|mesh-list
110034732|NCT01401075|Viscum album peptide|viscum album peptide|mesh-list
110034745|NCT01401075|Appetite Stimulants|appetite stimulants|mesh-ancestor
110034761|NCT01401192|Cisplatin|cisplatin|mesh-list
110019096|NCT00749658|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110019097|NCT00749658|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110019098|NCT00749658|Cholinergic Agents|cholinergic agents|mesh-ancestor
110034804|NCT01401933|Rifampin|rifampin|mesh-list
110034819|NCT01402024|Aprepitant|aprepitant|mesh-list
110019100|NCT00738972|Simvastatin|simvastatin|mesh-list
110019101|NCT00738972|Ezetimibe|ezetimibe|mesh-list
110034957|NCT01402674|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110034971|NCT01402843|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110035008|NCT01403259|Oxaliplatin|oxaliplatin|mesh-list
110035049|NCT01403415|Mitoxantrone|mitoxantrone|mesh-list
110035084|NCT01403415|Antifungal Agents|antifungal agents|mesh-ancestor
110019257|NCT04954638|Disinfectants|disinfectants|mesh-ancestor
110035124|NCT01403740|Immunologic Factors|immunologic factors|mesh-ancestor
110019333|NCT00558870|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110035143|NCT01403818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110019334|NCT00558870|Narcotics|narcotics|mesh-ancestor
110036376|NCT01411098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110036377|NCT01411111|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110036378|NCT01411111|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110036379|NCT01411111|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110036381|NCT01411111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110036382|NCT01411111|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110036383|NCT01411111|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110036384|NCT01411111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110036385|NCT01411124|Diphenhydramine|diphenhydramine|mesh-list
110036386|NCT01411124|Promethazine|promethazine|mesh-list
110036387|NCT01411124|Gabapentin|gabapentin|mesh-list
110036388|NCT01411124|Analgesics|analgesics|mesh-ancestor
110036415|NCT01411176|Menthol|menthol|mesh-list
110036438|NCT01411254|Respiratory System Agents|respiratory system agents|mesh-ancestor
110036439|NCT01411280|Methylphenidate|methylphenidate|mesh-list
110036440|NCT01411280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110036572|NCT01412411|Trace Elements|trace elements|mesh-list
110036701|NCT01413477|Hormones|hormones|mesh-ancestor
110036706|NCT01413477|Dermatologic Agents|dermatologic agents|mesh-ancestor
110035186|NCT01404117|Interferons|interferons|mesh-list
110036830|NCT01414868|Leukotriene Antagonists|leukotriene antagonists|mesh-list
110036915|NCT01415505|Valsartan|valsartan|mesh-list
110036960|NCT01415687|Cathartics|cathartics|mesh-ancestor
110037037|NCT01416038|Immunologic Factors|immunologic factors|mesh-ancestor
110035200|NCT01404156|Leucovorin|leucovorin|mesh-list
110037102|NCT01416415|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110037171|NCT01416961|Cisplatin|cisplatin|mesh-list
110037213|NCT01417351|Vitamin D|vitamin d|mesh-list
110037216|NCT01417351|Vitamins|vitamins|mesh-list
110035216|NCT01404156|Immunologic Factors|immunologic factors|mesh-ancestor
110037403|NCT01418274|Ritonavir|ritonavir|mesh-list
110037467|NCT01418586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110037527|NCT01418794|Sirolimus|sirolimus|mesh-list
110037596|NCT01419366|Nootropic Agents|nootropic agents|mesh-ancestor
110037775|NCT01420692|Insulin Detemir|insulin detemir|mesh-list
110037899|NCT01421693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110037900|NCT01421693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110035242|NCT01404312|Rifapentine|rifapentine|mesh-list
110035243|NCT01404312|Vitamins|vitamins|mesh-ancestor
110038088|NCT01422616|Sympatholytics|sympatholytics|mesh-ancestor
110035257|NCT01404338|Halobetasol|halobetasol|mesh-list
110038185|NCT01423123|Mitosis Modulators|mitosis modulators|mesh-ancestor
110038250|NCT01423500|Fludarabine|fludarabine|mesh-list
110038251|NCT01423500|Etoposide|etoposide|mesh-list
110038383|NCT01424137|Hormones|hormones|mesh-ancestor
110038672|NCT01425619|Lidocaine|lidocaine|mesh-list
110035317|NCT01404468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110019411|NCT00090870|Antiviral Agents|antiviral agents|mesh-ancestor
110038735|NCT05386446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110038794|NCT05386056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110038861|NCT05379374|Morphine|morphine|mesh-list
110038984|NCT04425902|Omeprazole|omeprazole|mesh-list
110039038|NCT04425902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110039111|NCT03559426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039113|NCT03444753|Nivolumab|nivolumab|mesh-list
110019954|NCT00000810|Zidovudine|zidovudine|mesh-list
110019955|NCT00000810|Didanosine|didanosine|mesh-list
110039696|NCT01428531|Fondaparinux|fondaparinux|mesh-list
110039769|NCT01429129|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110039831|NCT01429571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110039982|NCT01430260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110040048|NCT01431053|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110040122|NCT01431456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110040198|NCT01431924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110040200|NCT01432028|Drospirenone|drospirenone|mesh-list
110040271|NCT01432223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110040362|NCT01432821|Emetics|emetics|mesh-ancestor
110040424|NCT01433614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110040502|NCT01434069|Fluorouracil|fluorouracil|mesh-list
110040503|NCT01434069|Pasireotide|pasireotide|mesh-list
110040504|NCT01434069|Antimetabolites|antimetabolites|mesh-ancestor
110040630|NCT01434381|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110040631|NCT01434381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110040936|NCT01436825|Factor VIII|factor viii|mesh-list
110041079|NCT01437644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041307|NCT05164159|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110041382|NCT04922567|Alkylating Agents|alkylating agents|mesh-ancestor
110041383|NCT04922567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110041456|NCT04660799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110041530|NCT04332393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110041606|NCT03512496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110041970|NCT01439191|Vinorelbine|vinorelbine|mesh-list
110041971|NCT01439191|Antibodies|antibodies|mesh-list
110041980|NCT01439230|Donepezil|donepezil|mesh-list
110042123|NCT01440582|Glucocorticoids|glucocorticoids|mesh-ancestor
110042201|NCT01440933|Anesthetics|anesthetics|mesh-ancestor
110042211|NCT01440985|Nicotine|nicotine|mesh-list
110042273|NCT01441284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110042274|NCT01441284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110042347|NCT01441700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110042421|NCT01442311|Ribavirin|ribavirin|mesh-list
110042496|NCT01442571|Immunologic Factors|immunologic factors|mesh-ancestor
110042497|NCT01442571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042572|NCT01442935|Growth Inhibitors|growth inhibitors|mesh-ancestor
110042573|NCT01442935|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110042574|NCT01442935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110042575|NCT01442935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110042576|NCT01442935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042578|NCT01442935|Protective Agents|protective agents|mesh-ancestor
110042579|NCT01442935|Vitamin B Complex|vitamin b complex|mesh-ancestor
110042580|NCT01442935|Vitamins|vitamins|mesh-ancestor
110042581|NCT01442935|Micronutrients|micronutrients|mesh-ancestor
110042647|NCT01443169|Pregabalin|pregabalin|mesh-list
110042712|NCT01443520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110042854|NCT01444586|Anticoagulants|anticoagulants|mesh-ancestor
110042926|NCT01444976|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110042999|NCT01445340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110043000|NCT01445379|Ipilimumab|ipilimumab|mesh-list
110043073|NCT01445756|Sensory System Agents|sensory system agents|mesh-ancestor
110043074|NCT01445756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110043126|NCT01446211|Gusperimus|gusperimus|mesh-list
110043127|NCT01446211|Cyclophosphamide|cyclophosphamide|mesh-list
110043128|NCT01446211|Methotrexate|methotrexate|mesh-list
110043129|NCT01446211|Azathioprine|azathioprine|mesh-list
110043149|NCT01446211|Hormones|hormones|mesh-ancestor
110043197|NCT01446445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110043198|NCT01446458|Folfirinox|folfirinox|mesh-list
110043199|NCT01446458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110043200|NCT01446484|Cyclosporine|cyclosporine|mesh-list
110043272|NCT01446952|Vitamin E|vitamin e|mesh-list
110043351|NCT01447394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110043426|NCT01448096|Rituximab|rituximab|mesh-list
110043443|NCT01448239|Alirocumab|alirocumab|mesh-list
110043523|NCT01448434|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110043677|NCT01449344|Dexamethasone acetate|dexamethasone acetate|mesh-list
110043678|NCT01449344|Rituximab|rituximab|mesh-list
110043975|NCT05964257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110044052|NCT05962775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110044127|NCT05961761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110044271|NCT05960617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110044272|NCT05955365|Aspirin|aspirin|mesh-list
110044273|NCT05955365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110044274|NCT05955365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110044276|NCT05955365|Sensory System Agents|sensory system agents|mesh-ancestor
110044287|NCT05955365|Antipyretics|antipyretics|mesh-ancestor
110044343|NCT05887726|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110044419|NCT05818852|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110044420|NCT05818852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110044421|NCT05818852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110044422|NCT05818852|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110044423|NCT05818852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110044489|NCT05734625|Prednisolone acetate|prednisolone acetate|mesh-list
110044563|NCT05653193|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110044564|NCT05653193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110044709|NCT05523934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110044710|NCT05508100|Pembrolizumab|pembrolizumab|mesh-list
110044711|NCT05508100|Tislelizumab|tislelizumab|mesh-list
110044860|NCT05275738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110044861|NCT05275738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110044868|NCT05271552|Analgesics|analgesics|mesh-ancestor
110044940|NCT05179512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110019958|NCT00000810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110045215|NCT04927390|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110045216|NCT04927390|Antitubercular Agents|antitubercular agents|mesh-ancestor
110045217|NCT04927390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110045288|NCT04892732|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110045363|NCT04808323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110045364|NCT04808323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110045365|NCT04793529|Cholecalciferol|cholecalciferol|mesh-list
110045515|NCT06039826|Drospirenone|drospirenone|mesh-list
110021039|NCT00002400|Antimetabolites|antimetabolites|mesh-ancestor
110046054|NCT05776875|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110046055|NCT05776875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110046056|NCT05775731|Hemostatics|hemostatics|mesh-list
110046057|NCT05775731|Coagulants|coagulants|mesh-ancestor
110046059|NCT05774639|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110046060|NCT05774639|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110046061|NCT05774639|Respiratory System Agents|respiratory system agents|mesh-ancestor
110046062|NCT05740982|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
110046064|NCT05740982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110046083|NCT05729568|Antiviral Agents|antiviral agents|mesh-ancestor
110046084|NCT05729568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110046085|NCT05710783|Vaccines|vaccines|mesh-list
110046086|NCT05710783|Immunologic Factors|immunologic factors|mesh-ancestor
110046087|NCT05710783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110046088|NCT05706506|Tirzepatide|tirzepatide|mesh-list
110046091|NCT05706506|Incretins|incretins|mesh-ancestor
110046135|NCT05646862|Inavolisib|inavolisib|mesh-list
110046341|NCT05353361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110046342|NCT05353361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110046343|NCT05353361|Tubulin Modulators|tubulin modulators|mesh-ancestor
110046344|NCT05353361|Antimitotic Agents|antimitotic agents|mesh-ancestor
110046348|NCT05330429|Leucovorin|leucovorin|mesh-list
110046431|NCT05288166|Prednisone|prednisone|mesh-list
110046432|NCT05288166|Prednisolone|prednisolone|mesh-list
110046433|NCT05288166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110046434|NCT05288166|Glucocorticoids|glucocorticoids|mesh-ancestor
110046435|NCT05288166|Hormones|hormones|mesh-ancestor
110046436|NCT05288166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110046437|NCT05288166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110046438|NCT05288166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110046439|NCT05288166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110046440|NCT05284214|Ipilimumab|ipilimumab|mesh-list
110046441|NCT05284214|Sargramostim|sargramostim|mesh-list
110046442|NCT05284214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110046443|NCT05284214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110046444|NCT05284214|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110046557|NCT05176639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110046558|NCT05176639|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110046559|NCT05176639|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110046560|NCT05176639|Cholinergic Agents|cholinergic agents|mesh-ancestor
110046561|NCT05176639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110046562|NCT05176639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110046761|NCT04975997|Bortezomib|bortezomib|mesh-list
110046798|NCT04964934|Palbociclib|palbociclib|mesh-list
110046799|NCT04964934|Anastrozole|anastrozole|mesh-list
110035398|NCT01404741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110047033|NCT04684368|Mesna|mesna|mesh-list
110047139|NCT04539366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110047216|NCT04449874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110047217|NCT04449874|Growth Substances|growth substances|mesh-ancestor
110047290|NCT04294771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110047415|NCT04023253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110047416|NCT04023253|Adrenergic Agents|adrenergic agents|mesh-ancestor
110047679|NCT03390686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110047830|NCT03110107|Ipilimumab|ipilimumab|mesh-list
110047907|NCT02828761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110048056|NCT02456857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110048057|NCT02456857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110048210|NCT01371630|Alkylating Agents|alkylating agents|mesh-ancestor
110048211|NCT01371630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110048212|NCT01371630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110048375|NCT04742777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110048376|NCT04742777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110048377|NCT04742777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110048378|NCT04742777|Antifungal Agents|antifungal agents|mesh-ancestor
110048379|NCT04742777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110048525|NCT04518410|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
110048598|NCT04279054|Narcotics|narcotics|mesh-ancestor
110048776|NCT03978598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110048777|NCT03978598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110048779|NCT03975231|Trametinib|trametinib|mesh-list
110048921|NCT03770416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110048924|NCT03769025|Narcotics|narcotics|mesh-ancestor
110048982|NCT03613792|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110048983|NCT03613792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110049059|NCT03584516|Methylprednisolone|methylprednisolone|mesh-list
110049060|NCT03584516|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110049061|NCT03584516|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110049145|NCT03406897|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110049146|NCT03406897|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110049220|NCT03215277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110049221|NCT03214510|Fentanyl|fentanyl|mesh-list
110049296|NCT02899052|Glucocorticoids|glucocorticoids|mesh-ancestor
110049297|NCT02899052|Hormones|hormones|mesh-ancestor
110049298|NCT02899052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110049299|NCT02899052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110049300|NCT02899052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110049301|NCT02874742|Dexamethasone|dexamethasone|mesh-list
110049373|NCT02586831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110049527|NCT01959698|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110049737|NCT00544115|Cyclophosphamide|cyclophosphamide|mesh-list
110049813|NCT01456650|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110049815|NCT01457040|Etoposide|etoposide|mesh-list
110049888|NCT01460212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110049962|NCT01460667|Sensory System Agents|sensory system agents|mesh-ancestor
110049965|NCT01460667|Antipyretics|antipyretics|mesh-ancestor
110050038|NCT01461460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110050115|NCT01462617|Nemiralisib|nemiralisib|mesh-list
110050116|NCT01462617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110050188|NCT01463280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110050189|NCT01463332|Dexmedetomidine|dexmedetomidine|mesh-list
110050190|NCT01463332|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110050193|NCT01463332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110050261|NCT01463956|Ribavirin|ribavirin|mesh-list
110050331|NCT01464242|Protective Agents|protective agents|mesh-ancestor
110050390|NCT01466712|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110050466|NCT01467141|Insulin Aspart|insulin aspart|mesh-list
110050467|NCT01467141|Isophane Insulin, Human|isophane insulin, human|mesh-list
110050468|NCT01467141|Insulin, Isophane|insulin, isophane|mesh-list
110050541|NCT01467518|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110050680|NCT01468285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110050681|NCT01468285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110050751|NCT01468714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110050825|NCT01469416|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110050899|NCT01469884|Cyclosporins|cyclosporins|mesh-list
110050900|NCT01469884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110051106|NCT01471145|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110051157|NCT01471535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110051169|NCT01471678|Tamsulosin|tamsulosin|mesh-list
110051307|NCT01472146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110051611|NCT01475019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110051613|NCT01475019|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110051685|NCT01475552|Anticoagulants|anticoagulants|mesh-ancestor
110051686|NCT01475578|Ergoloid Mesylates|ergoloid mesylates|mesh-list
110051687|NCT01475578|Dihydroergotoxine|dihydroergotoxine|mesh-list
110051688|NCT01475578|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110051689|NCT01475578|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110051690|NCT01475578|Adrenergic Agents|adrenergic agents|mesh-ancestor
110051691|NCT01475578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110051692|NCT01475578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110051693|NCT01475578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051694|NCT01475578|Vasodilator Agents|vasodilator agents|mesh-ancestor
110051695|NCT01475578|Nootropic Agents|nootropic agents|mesh-ancestor
110051696|NCT01475578|Dopamine Agonists|dopamine agonists|mesh-ancestor
110051697|NCT01475578|Dopamine Agents|dopamine agents|mesh-ancestor
110051698|NCT01475617|Calcium, Dietary|calcium, dietary|mesh-list
110051701|NCT01475617|Calcium|calcium|mesh-list
110051888|NCT01476813|Glycopyrrolate|glycopyrrolate|mesh-list
110051889|NCT01476813|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110051890|NCT01476813|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110051891|NCT01476813|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110051896|NCT01477021|Cyclophosphamide|cyclophosphamide|mesh-list
110051958|NCT01477242|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110052032|NCT01477632|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110052033|NCT01477632|Estrogens|estrogens|mesh-ancestor
110052180|NCT01478490|Metoprolol|metoprolol|mesh-list
110052181|NCT01478490|Mirabegron|mirabegron|mesh-list
110052254|NCT01478685|Cc-486|cc-486|mesh-list
110052255|NCT01478685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110021118|NCT00002436|Zidovudine|zidovudine|mesh-list
110021119|NCT00002436|Zalcitabine|zalcitabine|mesh-list
110052477|NCT01480141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110052551|NCT01480765|Analgesics|analgesics|mesh-ancestor
110052552|NCT01480765|Sensory System Agents|sensory system agents|mesh-ancestor
110021197|NCT00002466|Tubulin Modulators|tubulin modulators|mesh-ancestor
110021198|NCT00002466|Antimitotic Agents|antimitotic agents|mesh-ancestor
110021199|NCT00002466|Mitosis Modulators|mitosis modulators|mesh-ancestor
110052777|NCT01481870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110053138|NCT01485146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110053139|NCT01485146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053140|NCT01485185|Gabapentin|gabapentin|mesh-list
110053214|NCT01485445|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110053292|NCT01485744|Fluorouracil|fluorouracil|mesh-list
110053293|NCT01485744|Oxaliplatin|oxaliplatin|mesh-list
110053512|NCT01486901|Isophane Insulin, Human|isophane insulin, human|mesh-list
110053588|NCT01487304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110053589|NCT01487304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053663|NCT01487811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053667|NCT01488136|Diazoxide|diazoxide|mesh-list
110053738|NCT01488266|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110053739|NCT01488266|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110053812|NCT01488734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110053813|NCT01488773|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110053886|NCT01489202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110053961|NCT01489592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053963|NCT01489631|Gabapentin|gabapentin|mesh-list
110053964|NCT01489631|Bupivacaine|bupivacaine|mesh-list
110054110|NCT01489995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110054112|NCT01490047|Doxorubicin|doxorubicin|mesh-list
110054183|NCT01490268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110054184|NCT01490268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110054259|NCT01490749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110054335|NCT01491048|Cholinergic Agents|cholinergic agents|mesh-ancestor
110054336|NCT01491048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110054487|NCT01492387|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110021279|NCT00002532|Asparaginase|asparaginase|mesh-list
110021280|NCT00002532|Ifosfamide|ifosfamide|mesh-list
110021281|NCT00002532|Idarubicin|idarubicin|mesh-list
110054639|NCT01493310|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110054712|NCT01493843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054892|NCT01494740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055121|NCT01496105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110055180|NCT01496443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110055254|NCT01496989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110055256|NCT01496989|Growth Substances|growth substances|mesh-ancestor
110055332|NCT01497431|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110055333|NCT01497431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110055408|NCT01497600|Insulin, Isophane|insulin, isophane|mesh-list
110055484|NCT01498380|Analgesics|analgesics|mesh-ancestor
110055560|NCT01498861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110055561|NCT01498861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110055636|NCT01499251|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
110055637|NCT01499251|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110021283|NCT00002532|Levoleucovorin|levoleucovorin|mesh-list
110021284|NCT00002532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110021285|NCT00002532|Antiemetics|antiemetics|mesh-ancestor
110021286|NCT00002532|Autonomic Agents|autonomic agents|mesh-ancestor
110021287|NCT00002532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110056110|NCT01501435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110056183|NCT01501708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110056184|NCT01501708|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110056193|NCT01501708|Amebicides|amebicides|mesh-ancestor
110056260|NCT01501890|Hormone Antagonists|hormone antagonists|mesh-ancestor
110056261|NCT01501890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110056335|NCT01502267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110056336|NCT01502267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110056412|NCT01503008|Metformin|metformin|mesh-list
110056487|NCT01503385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110056488|NCT01503385|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110056489|NCT01503385|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110021442|NCT00002586|Antioxidants|antioxidants|mesh-ancestor
110021443|NCT00002586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110056633|NCT01503801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110056634|NCT01503801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110056635|NCT01503801|Respiratory System Agents|respiratory system agents|mesh-ancestor
110056705|NCT01504074|Sympatholytics|sympatholytics|mesh-ancestor
110056721|NCT01504139|Hormones|hormones|mesh-ancestor
110056785|NCT01504334|Sensory System Agents|sensory system agents|mesh-ancestor
110056791|NCT01504334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110056862|NCT01504776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110056863|NCT01504776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110056864|NCT01504828|Ramipril|ramipril|mesh-list
110057014|NCT01505504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110057015|NCT01505504|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110057016|NCT01505504|Histamine Antagonists|histamine antagonists|mesh-ancestor
110057086|NCT01506011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110057160|NCT01506167|Growth Substances|growth substances|mesh-ancestor
110057162|NCT01506167|Growth Inhibitors|growth inhibitors|mesh-ancestor
110057238|NCT01506544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110057312|NCT01506791|Desloratadine|desloratadine|mesh-list
110057321|NCT01506791|Histamine Agents|histamine agents|mesh-ancestor
110057377|NCT01507064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110057378|NCT01507077|CKD732|ckd732|mesh-list
110057379|NCT01507077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110021602|NCT00002658|Thioguanine|thioguanine|mesh-list
110057531|NCT01507701|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110057760|NCT01508845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110057761|NCT01508858|Liraglutide|liraglutide|mesh-list
110057762|NCT01508858|Levonorgestrel|levonorgestrel|mesh-list
110021680|NCT00002676|Mitosis Modulators|mitosis modulators|mesh-ancestor
110057910|NCT01509560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110057987|NCT01510366|Vaccines|vaccines|mesh-list
110058060|NCT01510795|Diuretics|diuretics|mesh-ancestor
110058140|NCT01511198|Metformin|metformin|mesh-list
110058200|NCT01511302|RNS60|rns60|mesh-list
110058294|NCT01511718|Dermatologic Agents|dermatologic agents|mesh-ancestor
110058355|NCT01511822|Micronutrients|micronutrients|mesh-ancestor
110021681|NCT00002676|Trace Elements|trace elements|mesh-ancestor
110021682|NCT00002676|Micronutrients|micronutrients|mesh-ancestor
110021683|NCT00002682|Amoxicillin|amoxicillin|mesh-list
110058507|NCT01512537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110035442|NCT01404871|Antidepressive Agents|antidepressive agents|mesh-ancestor
110058508|NCT01512537|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110058650|NCT01513603|Cladribine|cladribine|mesh-list
110058707|NCT01513772|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110058708|NCT01513772|Adrenergic Agents|adrenergic agents|mesh-ancestor
110058783|NCT01514175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110058784|NCT01514175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110058935|NCT01514968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110058936|NCT01514968|Antiviral Agents|antiviral agents|mesh-ancestor
110059012|NCT01515774|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110059013|NCT01515774|Dopamine Agonists|dopamine agonists|mesh-ancestor
110021685|NCT00002682|Clarithromycin|clarithromycin|mesh-list
110021686|NCT00002682|Tetracycline|tetracycline|mesh-list
110021687|NCT00002682|Omeprazole|omeprazole|mesh-list
110059154|NCT01516372|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110059155|NCT01516372|Contraceptive Agents|contraceptive agents|mesh-ancestor
110059156|NCT01516372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110059308|NCT01517009|Antimetabolites|antimetabolites|mesh-ancestor
110059309|NCT01517022|Nicotine|nicotine|mesh-list
110059386|NCT01517399|Purinergic Agents|purinergic agents|mesh-ancestor
110059397|NCT01517490|Insulin|insulin|mesh-list
110059464|NCT01517854|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110059465|NCT01517854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110059468|NCT01517932|Dexmedetomidine|dexmedetomidine|mesh-list
110059543|NCT01518231|Analgesics|analgesics|mesh-ancestor
110059690|NCT01519011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110059763|NCT01519336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110059994|NCT01520818|Biphasic Insulins|biphasic insulins|mesh-list
110060143|NCT01521975|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
110060219|NCT01522547|Growth Inhibitors|growth inhibitors|mesh-ancestor
110060220|NCT01522547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110060296|NCT01522872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110060519|NCT01523678|Antimitotic Agents|antimitotic agents|mesh-ancestor
110060520|NCT01523678|Mitosis Modulators|mitosis modulators|mesh-ancestor
110060595|NCT01524237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110060668|NCT01524601|Antimetabolites|antimetabolites|mesh-ancestor
110060676|NCT01524653|Antimetabolites|antimetabolites|mesh-ancestor
110060733|NCT01524809|Insulin Aspart|insulin aspart|mesh-list
110060734|NCT01524809|Insulin, Long-Acting|insulin, long-acting|mesh-list
110060834|NCT06053281|Micronutrients|micronutrients|mesh-ancestor
110061017|NCT06051851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110061281|NCT05973851|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110061470|NCT05869955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110061471|NCT05869955|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110061472|NCT05851924|Capecitabine|capecitabine|mesh-list
110061473|NCT05851924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110061700|NCT05605899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110061701|NCT05605899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110061702|NCT05605899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110061703|NCT05605899|Glucocorticoids|glucocorticoids|mesh-ancestor
110061705|NCT05605899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110061706|NCT05605899|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110061846|NCT05548296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110061853|NCT05547542|Analgesics|analgesics|mesh-ancestor
110061936|NCT05386810|Immunologic Factors|immunologic factors|mesh-ancestor
110061937|NCT05386810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110062027|NCT05269355|Alkylating Agents|alkylating agents|mesh-ancestor
110062224|NCT04947254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110062225|NCT04947254|Hormone Antagonists|hormone antagonists|mesh-ancestor
110062226|NCT04947254|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110062227|NCT04947254|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110062229|NCT04947254|Protective Agents|protective agents|mesh-ancestor
110062591|NCT04522336|Docetaxel|docetaxel|mesh-list
110062719|NCT04313881|Antimetabolites|antimetabolites|mesh-ancestor
110062720|NCT04313881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110062721|NCT04313881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110062722|NCT04313881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110062723|NCT04313881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110062737|NCT04294576|Pembrolizumab|pembrolizumab|mesh-list
110062738|NCT04294576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110062739|NCT04294576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110062740|NCT04294576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110062741|NCT04294576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110062792|NCT04262843|Antitubercular Agents|antitubercular agents|mesh-ancestor
110062794|NCT04262843|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110063017|NCT03819517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110063119|NCT03726879|Immunologic Factors|immunologic factors|mesh-ancestor
110063120|NCT03726879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110063121|NCT03726879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110063122|NCT03726879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110063123|NCT03726879|Alkylating Agents|alkylating agents|mesh-ancestor
110063124|NCT03726879|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110063233|NCT03340675|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110063530|NCT02532257|Immunologic Factors|immunologic factors|mesh-ancestor
110063538|NCT02530034|Antibodies|antibodies|mesh-list
110063680|NCT01842386|Immunologic Factors|immunologic factors|mesh-ancestor
110063682|NCT01842386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110063691|NCT01415882|Dexamethasone|dexamethasone|mesh-list
110063692|NCT01415882|Dexamethasone acetate|dexamethasone acetate|mesh-list
110063693|NCT01415882|Cyclophosphamide|cyclophosphamide|mesh-list
110063694|NCT01415882|Daratumumab|daratumumab|mesh-list
110063695|NCT01415882|Ixazomib|ixazomib|mesh-list
110063696|NCT01415882|Ichthammol|ichthammol|mesh-list
110063697|NCT01415882|BB 1101|bb 1101|mesh-list
110063698|NCT01415882|Glycine|glycine|mesh-list
110063699|NCT01415882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110063700|NCT01415882|Immunologic Factors|immunologic factors|mesh-ancestor
110063853|NCT00336024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110063854|NCT00336024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110063855|NCT00336024|Antimetabolites|antimetabolites|mesh-ancestor
110063856|NCT00336024|Dermatologic Agents|dermatologic agents|mesh-ancestor
110035508|NCT01405157|Glucocorticoids|glucocorticoids|mesh-ancestor
110035568|NCT01405365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110035596|NCT01405612|Midazolam|midazolam|mesh-list
110035783|NCT01406522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110021688|NCT00002682|Bismuth|bismuth|mesh-list
110035813|NCT01406704|Vitamins|vitamins|mesh-ancestor
110035815|NCT01406782|Rituximab|rituximab|mesh-list
110035882|NCT01407848|Furosemide|furosemide|mesh-list
110035884|NCT01407848|Natriuretic Agents|natriuretic agents|mesh-ancestor
110035993|NCT01408394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110036936|NCT01415596|Albuterol|albuterol|mesh-list
110036975|NCT01415713|Micronutrients|micronutrients|mesh-ancestor
110037045|NCT01416116|Lidocaine|lidocaine|mesh-list
110037090|NCT01416220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110037391|NCT01418157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110038146|NCT01422785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110038206|NCT01423240|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110040784|NCT01435486|Purinergic Agents|purinergic agents|mesh-ancestor
110047185|NCT04458831|Glucocorticoids|glucocorticoids|mesh-ancestor
110043895|NCT01452256|Anesthetics|anesthetics|mesh-ancestor
110044333|NCT05887726|Prednisone|prednisone|mesh-list
110045536|NCT06039774|Antimetabolites|antimetabolites|mesh-ancestor
110045662|NCT06039280|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110047505|NCT03783949|Paclitaxel|paclitaxel|mesh-list
110049281|NCT02903368|Fertility Agents|fertility agents|mesh-ancestor
110036137|NCT01409174|Interleukin-2|interleukin-2|mesh-list
110049289|NCT02899052|Venetoclax|venetoclax|mesh-list
110049988|NCT01460979|Temsirolimus|temsirolimus|mesh-list
110050937|NCT01470040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110057625|NCT01507610|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110058201|NCT01511302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110058644|NCT01513564|Narcotics|narcotics|mesh-ancestor
110060016|NCT01520896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110060065|NCT01521455|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110060187|NCT01522326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110060275|NCT01522872|Dexamethasone|dexamethasone|mesh-list
110062598|NCT04522336|Mitosis Modulators|mitosis modulators|mesh-ancestor
110036271|NCT01409694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110036272|NCT01409694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110036273|NCT01409694|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110036274|NCT01409694|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110036275|NCT01409733|Doxorubicin|doxorubicin|mesh-list
110036276|NCT01409733|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110036277|NCT01409733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110036278|NCT01409733|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110036279|NCT01409733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110036280|NCT01409733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110036281|NCT01409733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110036282|NCT01409499|Sorafenib|sorafenib|mesh-list
110036283|NCT01409499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110036284|NCT01409499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110036285|NCT01409499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110036286|NCT01409499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110036287|NCT01410162|Tacrolimus|tacrolimus|mesh-list
110017298|NCT02953860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110017299|NCT02953860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110017300|NCT02953860|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110017301|NCT02953860|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110017302|NCT02953860|Hormone Antagonists|hormone antagonists|mesh-ancestor
110017303|NCT02953860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110017304|NCT02953860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110017306|NCT02956044|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110017307|NCT02956044|Glimepiride|glimepiride|mesh-list
110017309|NCT02956044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110017310|NCT02956044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110017311|NCT02956044|Incretins|incretins|mesh-ancestor
110017312|NCT02956044|Hormones|hormones|mesh-ancestor
110017313|NCT02956044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110017314|NCT02956044|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110017315|NCT02956044|Protease Inhibitors|protease inhibitors|mesh-ancestor
110017316|NCT02956044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110017317|NCT02956044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110017318|NCT02956044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110017319|NCT02956044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110017320|NCT02956044|Immunologic Factors|immunologic factors|mesh-ancestor
110017321|NCT02956122|Methylprednisolone|methylprednisolone|mesh-list
110017322|NCT02956122|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110017323|NCT02956122|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110017324|NCT02956122|Prednisolone|prednisolone|mesh-list
110017325|NCT02956122|Prednisolone acetate|prednisolone acetate|mesh-list
110017326|NCT02956122|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110017327|NCT02956122|Prednisolone phosphate|prednisolone phosphate|mesh-list
110017328|NCT02956122|Protease Inhibitors|protease inhibitors|mesh-list
110017329|NCT02956122|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
110017330|NCT02956122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110017331|NCT02956122|Antiemetics|antiemetics|mesh-ancestor
110017332|NCT02956122|Autonomic Agents|autonomic agents|mesh-ancestor
110017333|NCT02956122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110017335|NCT02956122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110017336|NCT02956122|Glucocorticoids|glucocorticoids|mesh-ancestor
110017337|NCT02956122|Hormones|hormones|mesh-ancestor
110017338|NCT02956122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110017339|NCT02956122|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110017340|NCT02956122|Protective Agents|protective agents|mesh-ancestor
110017341|NCT02956122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110017342|NCT02956122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110017344|NCT02956122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110017345|NCT02956122|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110017346|NCT02956122|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110017347|NCT02956746|Immunoglobulins|immunoglobulins|mesh-list
110017348|NCT02956746|Antibodies|antibodies|mesh-list
110017350|NCT02956746|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110017351|NCT02956746|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110017352|NCT02956746|Immunologic Factors|immunologic factors|mesh-ancestor
110017353|NCT02956746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110017354|NCT02967354|Tryptophan|tryptophan|mesh-list
110017355|NCT02967354|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
110017356|NCT02967354|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110017357|NCT02967354|Antidepressive Agents|antidepressive agents|mesh-ancestor
110017358|NCT02967354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110017359|NCT02968134|Posaconazole|posaconazole|mesh-list
110017360|NCT02968134|Antifungal Agents|antifungal agents|mesh-ancestor
110017361|NCT02968134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110017362|NCT02968134|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110017363|NCT02968134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110017364|NCT02968134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110017365|NCT02968134|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110017366|NCT02968134|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110017367|NCT02968134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110017368|NCT02968134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110017369|NCT02968134|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110017370|NCT02968134|Hormone Antagonists|hormone antagonists|mesh-ancestor
110017371|NCT02968134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110017372|NCT02968134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110017374|NCT02968368|Hematinics|hematinics|mesh-ancestor
110017375|NCT02968914|Benralizumab|benralizumab|mesh-list
110017376|NCT02968914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110017377|NCT02968914|Respiratory System Agents|respiratory system agents|mesh-ancestor
110017380|NCT02970162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110017381|NCT02970162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110017383|NCT02970162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110017384|NCT02970162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110017386|NCT02970552|Progestins|progestins|mesh-ancestor
110017387|NCT02970552|Hormones|hormones|mesh-ancestor
110017388|NCT02970552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110017389|NCT02970552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110017390|NCT02978508|Permethrin|permethrin|mesh-list
110017391|NCT02978508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110017392|NCT02978508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110017393|NCT02881008|Entecavir|entecavir|mesh-list
110017394|NCT02881008|Antiviral Agents|antiviral agents|mesh-ancestor
110017395|NCT02881008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110017396|NCT02988882|Dexamethasone|dexamethasone|mesh-list
110017397|NCT02988882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110017398|NCT02988882|Antiemetics|antiemetics|mesh-ancestor
110017399|NCT02988882|Autonomic Agents|autonomic agents|mesh-ancestor
110017400|NCT02988882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110017401|NCT02988882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110017402|NCT02988882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110017403|NCT02988882|Glucocorticoids|glucocorticoids|mesh-ancestor
110017405|NCT02988882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110017406|NCT02988882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110017407|NCT02988882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110017408|NCT03002454|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
110017409|NCT03002454|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
110017410|NCT03002454|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110017411|NCT03002454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110017412|NCT03009162|Lasmiditan|lasmiditan|mesh-list
110017414|NCT03009162|Serotonin Agents|serotonin agents|mesh-ancestor
110017415|NCT03009162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110017416|NCT03009162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110017417|NCT03009162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110017419|NCT03009396|Rifabutin|rifabutin|mesh-list
110017420|NCT03009396|Clofazimine|clofazimine|mesh-list
110017421|NCT03009396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110017422|NCT03009396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110017423|NCT03009396|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110017424|NCT03009396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110017426|NCT03009396|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110017427|NCT03009396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110017429|NCT03009396|Antitubercular Agents|antitubercular agents|mesh-ancestor
110017430|NCT03009396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110017431|NCT03009396|Leprostatic Agents|leprostatic agents|mesh-ancestor
110017432|NCT03012594|Lanreotide|lanreotide|mesh-list
110017433|NCT03012594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110017434|NCT03017508|Riluzole|riluzole|mesh-list
110017435|NCT03017508|Anticonvulsants|anticonvulsants|mesh-ancestor
110017436|NCT03017508|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110017437|NCT03017508|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110017438|NCT03017508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110017439|NCT03017508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110017440|NCT03017508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110017441|NCT03017508|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110017444|NCT03020004|Ribavirin|ribavirin|mesh-list
110017445|NCT03020004|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110017446|NCT03020004|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110017448|NCT03020004|Protease Inhibitors|protease inhibitors|mesh-ancestor
110017449|NCT03020004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110017450|NCT03020004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110017451|NCT03020004|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110017452|NCT03020004|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110017453|NCT03020004|Antiviral Agents|antiviral agents|mesh-ancestor
110017454|NCT03020004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110017455|NCT03020004|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110017456|NCT03020004|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110017457|NCT03020004|Antimetabolites|antimetabolites|mesh-ancestor
110017458|NCT03020082|Ritonavir|ritonavir|mesh-list
110017459|NCT03020082|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110017460|NCT03020082|Ribavirin|ribavirin|mesh-list
110017462|NCT03020082|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110017463|NCT03020082|Protease Inhibitors|protease inhibitors|mesh-ancestor
110017465|NCT03020082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110017467|NCT03020082|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110017468|NCT03020082|Antiviral Agents|antiviral agents|mesh-ancestor
110017469|NCT03020082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110017470|NCT03020082|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110017471|NCT03020082|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110017472|NCT03020082|Antimetabolites|antimetabolites|mesh-ancestor
110017473|NCT03026556|Rivaroxaban|rivaroxaban|mesh-list
110017474|NCT03026556|Apixaban|apixaban|mesh-list
110017475|NCT03026556|Dabigatran|dabigatran|mesh-list
110017476|NCT03026556|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110017477|NCT03026556|Antithrombins|antithrombins|mesh-ancestor
110017478|NCT03026556|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110017480|NCT03026556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110017481|NCT03026556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110017482|NCT03026556|Anticoagulants|anticoagulants|mesh-ancestor
110017484|NCT03035760|Anthelmintics|anthelmintics|mesh-ancestor
110017485|NCT03035760|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110017486|NCT03035760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110017487|NCT03035760|Antinematodal Agents|antinematodal agents|mesh-ancestor
110017488|NCT03036384|Sufentanil|sufentanil|mesh-list
110017489|NCT03036384|Morphine|morphine|mesh-list
110017490|NCT03036384|Prilocaine|prilocaine|mesh-list
110017491|NCT03036384|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110017492|NCT03036384|Narcotics|narcotics|mesh-ancestor
110017493|NCT03036384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110017494|NCT03036384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110017495|NCT03036384|Analgesics|analgesics|mesh-ancestor
110017496|NCT03036384|Sensory System Agents|sensory system agents|mesh-ancestor
110017497|NCT03036384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110017498|NCT03036384|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110017499|NCT03036384|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110017500|NCT03036384|Anesthetics, General|anesthetics, general|mesh-ancestor
110017501|NCT03036384|Anesthetics|anesthetics|mesh-ancestor
110017502|NCT03036384|Anesthetics, Local|anesthetics, local|mesh-ancestor
110017503|NCT03040362|Lasmiditan|lasmiditan|mesh-list
110017504|NCT03040362|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110017505|NCT03040362|Serotonin Agents|serotonin agents|mesh-ancestor
110017506|NCT03040362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110017508|NCT03040362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110017509|NCT03041298|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
110017510|NCT03041298|Chelating Agents|chelating agents|mesh-ancestor
110017511|NCT03041298|Sequestering Agents|sequestering agents|mesh-ancestor
110017512|NCT03041298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110017514|NCT03044418|Anesthetics|anesthetics|mesh-ancestor
110017515|NCT03044418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110017518|NCT03044418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110017519|NCT03044418|Anesthetics, General|anesthetics, general|mesh-ancestor
110017520|NCT03048006|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
110017521|NCT03048006|Chelating Agents|chelating agents|mesh-ancestor
110017522|NCT03048006|Sequestering Agents|sequestering agents|mesh-ancestor
110017523|NCT03048006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110017524|NCT03051672|Pembrolizumab|pembrolizumab|mesh-list
110017525|NCT03051672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110017526|NCT03051672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110017527|NCT03051672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110017528|NCT03051672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110017529|NCT03057132|Protective Agents|protective agents|mesh-list
110017530|NCT03057132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110017531|NCT03057366|Paclitaxel|paclitaxel|mesh-list
110017532|NCT03057366|Docetaxel|docetaxel|mesh-list
110017533|NCT03057366|Carboplatin|carboplatin|mesh-list
110017534|NCT03057366|Pevonedistat|pevonedistat|mesh-list
110017535|NCT03057366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110017536|NCT03057366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110017537|NCT03057366|Tubulin Modulators|tubulin modulators|mesh-ancestor
110017538|NCT03057366|Antimitotic Agents|antimitotic agents|mesh-ancestor
110017539|NCT03057366|Mitosis Modulators|mitosis modulators|mesh-ancestor
110017540|NCT03057366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110017541|NCT03057366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110017542|NCT03060486|Hybenx|hybenx|mesh-list
110017543|NCT03060486|Dental Disinfectants|dental disinfectants|mesh-ancestor
110017544|NCT03060486|Disinfectants|disinfectants|mesh-ancestor
110017545|NCT03060486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110017551|NCT03061812|Autonomic Agents|autonomic agents|mesh-ancestor
110017552|NCT03061812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110017553|NCT03061812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110017555|NCT03061812|Glucocorticoids|glucocorticoids|mesh-ancestor
110017556|NCT03061812|Hormones|hormones|mesh-ancestor
110017557|NCT03061812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110017567|NCT03070470|Lopinavir|lopinavir|mesh-list
110017568|NCT03070470|Chloroquine|chloroquine|mesh-list
110017570|NCT03070470|Dofetilide|dofetilide|mesh-list
110017571|NCT03070470|Diltiazem|diltiazem|mesh-list
110017572|NCT03070470|Ranolazine|ranolazine|mesh-list
110017573|NCT03070470|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110017574|NCT03070470|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110017575|NCT03070470|Protease Inhibitors|protease inhibitors|mesh-ancestor
110017576|NCT03070470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110017577|NCT03070470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110017578|NCT03070470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110017579|NCT03070470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110017580|NCT03070470|Antiviral Agents|antiviral agents|mesh-ancestor
110017581|NCT03070470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110017582|NCT03070470|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110017583|NCT03070470|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110017584|NCT03070470|Amebicides|amebicides|mesh-ancestor
110017585|NCT03070470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110017586|NCT03070470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110017587|NCT03070470|Antimalarials|antimalarials|mesh-ancestor
110017588|NCT03070470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110017589|NCT03070470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110017590|NCT03070470|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110017593|NCT03070470|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110017595|NCT03070470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110017596|NCT03070470|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110017597|NCT03070470|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110017598|NCT03070548|Talazoparib|talazoparib|mesh-list
110017599|NCT03070548|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110017600|NCT03070548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110017601|NCT03070548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110017602|NCT03070548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110017604|NCT03080142|Ropivacaine|ropivacaine|mesh-list
110017605|NCT03080142|Anesthetics, Local|anesthetics, local|mesh-ancestor
110017606|NCT03080142|Anesthetics|anesthetics|mesh-ancestor
110017607|NCT03080142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110017608|NCT03080142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110017609|NCT03080142|Sensory System Agents|sensory system agents|mesh-ancestor
110017610|NCT03080142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110017611|NCT03088800|Ibuprofen|ibuprofen|mesh-list
110017612|NCT03088800|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110017613|NCT03088800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110017614|NCT03088800|Analgesics|analgesics|mesh-ancestor
110017615|NCT03088800|Sensory System Agents|sensory system agents|mesh-ancestor
110017616|NCT03088800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110017617|NCT03088800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110017618|NCT03088800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110017619|NCT03088800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110017620|NCT03088800|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110017621|NCT03088800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110017622|NCT03088800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110017623|NCT03096444|Lidocaine|lidocaine|mesh-list
110017624|NCT03096444|Ketamine|ketamine|mesh-list
110017625|NCT03096444|Amitriptyline|amitriptyline|mesh-list
110017626|NCT03096444|Anesthetics, Local|anesthetics, local|mesh-ancestor
110017627|NCT03096444|Anesthetics|anesthetics|mesh-ancestor
110017628|NCT03096444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110017629|NCT03096444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110017630|NCT03096444|Sensory System Agents|sensory system agents|mesh-ancestor
110017631|NCT03096444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110017633|NCT03096444|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110017634|NCT03096444|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110017635|NCT03096444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110017636|NCT03096444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110017639|NCT03096444|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110017640|NCT03096444|Anesthetics, General|anesthetics, general|mesh-ancestor
110017723|NCT05406180|Immunologic Factors|immunologic factors|mesh-ancestor
110017641|NCT03096444|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110017642|NCT03096444|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110017643|NCT03096444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110017644|NCT03096444|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110017645|NCT03096444|Antidepressive Agents|antidepressive agents|mesh-ancestor
110017646|NCT03096444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110017647|NCT03096444|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110017649|NCT03096444|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110017650|NCT03096444|Adrenergic Agents|adrenergic agents|mesh-ancestor
110017653|NCT03107754|Anesthetics, Local|anesthetics, local|mesh-ancestor
110017654|NCT03107754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110017655|NCT03107754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110017656|NCT03107754|Sensory System Agents|sensory system agents|mesh-ancestor
110017657|NCT03107754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110017658|NCT03107754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110017659|NCT03107754|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110017660|NCT03107754|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110017662|NCT03107754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110017663|NCT03124758|Chrysarobin|chrysarobin|mesh-list
110017664|NCT03124758|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110017665|NCT03124758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110017666|NCT03124758|Analgesics|analgesics|mesh-ancestor
110017667|NCT03124758|Sensory System Agents|sensory system agents|mesh-ancestor
110017668|NCT03124758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110017669|NCT03124758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110017670|NCT03124758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110017671|NCT03124758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110017672|NCT03148236|Ascorbic Acid|ascorbic acid|mesh-list
110017673|NCT03148236|Vitamins|vitamins|mesh-ancestor
110017674|NCT03148236|Micronutrients|micronutrients|mesh-ancestor
110017675|NCT03148236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110017676|NCT03148236|Antioxidants|antioxidants|mesh-ancestor
110017677|NCT03148236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110017678|NCT03148236|Protective Agents|protective agents|mesh-ancestor
110017679|NCT03174366|Denosumab|denosumab|mesh-list
110017680|NCT03174366|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110017681|NCT03174366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110017682|NCT03177798|Icatibant|icatibant|mesh-list
110017683|NCT03177798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110017684|NCT03177798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110017685|NCT03177798|Analgesics|analgesics|mesh-ancestor
110017686|NCT03177798|Sensory System Agents|sensory system agents|mesh-ancestor
110017687|NCT03177798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110017688|NCT03177798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110017689|NCT03177798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110017691|NCT03177798|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
110017692|NCT03177798|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
110017693|NCT03177798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110017694|NCT03177798|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110017695|NCT03177798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110017696|NCT03177798|Immunologic Factors|immunologic factors|mesh-ancestor
110017700|NCT05093790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110017701|NCT05093790|Analgesics|analgesics|mesh-ancestor
110017702|NCT05093790|Sensory System Agents|sensory system agents|mesh-ancestor
110017703|NCT05093790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110017704|NCT05093790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110017705|NCT05093790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110017706|NCT05093790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110017707|NCT05093790|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110017708|NCT05093790|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110017709|NCT05093790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110017710|NCT05093790|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110017711|NCT05093790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110017712|NCT05093790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110017714|NCT05093790|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110017715|NCT05093790|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110017716|NCT05093790|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110017717|NCT05093790|Purinergic Agents|purinergic agents|mesh-ancestor
110017720|NCT04933344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110017721|NCT04933344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110017722|NCT05406180|Vaccines|vaccines|mesh-list
110017724|NCT05406180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110017726|NCT05405478|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110017727|NCT05405478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110017728|NCT05405478|Respiratory System Agents|respiratory system agents|mesh-ancestor
110017729|NCT04890366|Dimethyl Fumarate|dimethyl fumarate|mesh-list
110017732|NCT04890366|Immunologic Factors|immunologic factors|mesh-ancestor
110017733|NCT04890366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110017734|NCT04601532|Sulfadiazine|sulfadiazine|mesh-list
110017735|NCT04601532|Silver Sulfadiazine|silver sulfadiazine|mesh-list
110017736|NCT04601532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110017737|NCT04601532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110017738|NCT04601532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110017739|NCT04601532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110017740|NCT04601532|Coccidiostats|coccidiostats|mesh-ancestor
110017741|NCT04601532|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110017742|NCT03137160|Ixekizumab|ixekizumab|mesh-list
110017743|NCT03137160|Dermatologic Agents|dermatologic agents|mesh-ancestor
110017744|NCT02856126|Sorafenib|sorafenib|mesh-list
110017745|NCT02856126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110017746|NCT02856126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110017747|NCT02856126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110017748|NCT02856126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110017749|NCT04589364|Botulinum Toxins|botulinum toxins|mesh-list
110017750|NCT04589364|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110017751|NCT04589364|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110017752|NCT04589364|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110017753|NCT04589364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110017754|NCT04589364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110017755|NCT04589364|Cholinergic Agents|cholinergic agents|mesh-ancestor
110017756|NCT04589364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110017757|NCT04589364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110017758|NCT04589364|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110017759|NCT04589364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110017760|NCT04473924|Mycophenolic Acid|mycophenolic acid|mesh-list
110017762|NCT04473924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110017763|NCT04473924|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110017764|NCT04473924|Antitubercular Agents|antitubercular agents|mesh-ancestor
110017765|NCT04473924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110017766|NCT04473924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110017767|NCT04473924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110017768|NCT04473924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110017769|NCT04426500|Bupivacaine|bupivacaine|mesh-list
110017770|NCT04426500|Anesthetics, Local|anesthetics, local|mesh-ancestor
110017771|NCT04426500|Anesthetics|anesthetics|mesh-ancestor
110017776|NCT04131192|Gemcitabine|gemcitabine|mesh-list
110017777|NCT04131192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110017778|NCT04131192|Antimetabolites|antimetabolites|mesh-ancestor
110017779|NCT04131192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110017780|NCT04131192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110017781|NCT03925116|Contraceptive Agents|contraceptive agents|mesh-list
110017782|NCT03925116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110017783|NCT03925116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110017784|NCT03883074|Magnesium trisilicate|magnesium trisilicate|mesh-list
110017786|NCT03883074|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110017787|NCT03883074|Immunologic Factors|immunologic factors|mesh-ancestor
110017788|NCT03883074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110017790|NCT03883074|Protective Agents|protective agents|mesh-ancestor
110017791|NCT03883074|Antacids|antacids|mesh-ancestor
110017792|NCT03883074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110017793|NCT03883074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110017794|NCT03670836|Misoprostol|misoprostol|mesh-list
110017795|NCT03670836|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110017796|NCT03670836|Abortifacient Agents|abortifacient agents|mesh-ancestor
110017797|NCT03670836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110017798|NCT03670836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110017799|NCT03670836|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110017800|NCT03670836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110017801|NCT03670836|Oxytocics|oxytocics|mesh-ancestor
110017802|NCT03607656|Docetaxel|docetaxel|mesh-list
110017803|NCT03607656|Capecitabine|capecitabine|mesh-list
110017804|NCT03607656|Oxaliplatin|oxaliplatin|mesh-list
110017805|NCT03607656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110017806|NCT03607656|Tubulin Modulators|tubulin modulators|mesh-ancestor
110017807|NCT03607656|Antimitotic Agents|antimitotic agents|mesh-ancestor
110017808|NCT03607656|Mitosis Modulators|mitosis modulators|mesh-ancestor
110017810|NCT03607656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110017811|NCT03607656|Antimetabolites|antimetabolites|mesh-ancestor
110017813|NCT03409614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110017814|NCT03409614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110017815|NCT02651844|Mifepristone|mifepristone|mesh-list
110017816|NCT02651844|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110017817|NCT02651844|Abortifacient Agents|abortifacient agents|mesh-ancestor
110017818|NCT02651844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110017819|NCT02651844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110017820|NCT02651844|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110017821|NCT02651844|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110017822|NCT02651844|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110017823|NCT02651844|Contraceptive Agents|contraceptive agents|mesh-ancestor
110017824|NCT02651844|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110017825|NCT02651844|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110017826|NCT02651844|Hormone Antagonists|hormone antagonists|mesh-ancestor
110017827|NCT02651844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110017828|NCT02651844|Luteolytic Agents|luteolytic agents|mesh-ancestor
110017829|NCT02651844|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110017830|NCT02651844|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110017831|NCT01463670|Lenalidomide|lenalidomide|mesh-list
110017832|NCT01463670|Immunologic Factors|immunologic factors|mesh-ancestor
110017833|NCT01463670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110017834|NCT01463670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110017835|NCT01463670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110017836|NCT01463670|Growth Substances|growth substances|mesh-ancestor
110017837|NCT01463670|Growth Inhibitors|growth inhibitors|mesh-ancestor
110017838|NCT01463670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110017839|NCT00151398|Donepezil|donepezil|mesh-list
110017840|NCT00151398|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110017841|NCT00151398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110017842|NCT00151398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110017843|NCT00151398|Cholinergic Agents|cholinergic agents|mesh-ancestor
110017844|NCT00151398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110017845|NCT00151398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110017846|NCT00151398|Nootropic Agents|nootropic agents|mesh-ancestor
110017847|NCT03181308|Nivolumab|nivolumab|mesh-list
110017848|NCT03181308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110017849|NCT03181308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110017850|NCT03181308|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110017851|NCT03181308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110017852|NCT03202134|Analgesics, Opioid|analgesics, opioid|mesh-list
110017853|NCT03202134|Anesthetics|anesthetics|mesh-list
110017854|NCT03202134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110017855|NCT03202134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110017856|NCT03202134|Narcotics|narcotics|mesh-ancestor
110017857|NCT03202134|Analgesics|analgesics|mesh-ancestor
110017858|NCT03202134|Sensory System Agents|sensory system agents|mesh-ancestor
110017859|NCT03202134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110017860|NCT03207438|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110017861|NCT03207438|Antidepressive Agents|antidepressive agents|mesh-ancestor
110017862|NCT03207438|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110017863|NCT03207438|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110017864|NCT03207438|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110017865|NCT03207438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110017866|NCT03207438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110017867|NCT03218592|Tenofovir|tenofovir|mesh-list
110017868|NCT03218592|Emtricitabine|emtricitabine|mesh-list
110017869|NCT03218592|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110017870|NCT03218592|Dolutegravir|dolutegravir|mesh-list
110017871|NCT03218592|Maraviroc|maraviroc|mesh-list
110017872|NCT03218592|Antiviral Agents|antiviral agents|mesh-ancestor
110017875|NCT03218592|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110017877|NCT03218592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110017878|NCT03218592|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110017879|NCT03218592|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110017880|NCT03218592|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110017881|NCT03218592|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110017882|NCT03218592|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110017883|NCT03218592|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110017884|NCT03218592|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110017888|NCT03219294|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110017889|NCT03219294|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110017890|NCT03219294|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110017891|NCT03219294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110017892|NCT03219294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110017893|NCT03219294|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
110017894|NCT03219294|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110017895|NCT03219294|Cholinergic Agents|cholinergic agents|mesh-ancestor
110017896|NCT03219294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110017897|NCT03219294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110017898|NCT03219840|Cetylpyridinium|cetylpyridinium|mesh-list
110017899|NCT03219840|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110017900|NCT03219840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110017901|NCT03223272|Reserpine|reserpine|mesh-list
110017902|NCT03223272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110017903|NCT03223272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110017905|NCT03223272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110017906|NCT03223272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110017907|NCT03223272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110017908|NCT03223272|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110017909|NCT03223272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110017910|NCT03223272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110017911|NCT03223272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110017912|NCT03223272|Adrenergic Agents|adrenergic agents|mesh-ancestor
110017914|NCT03239106|Apremilast|apremilast|mesh-list
110017915|NCT03239106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110017916|NCT03239106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110017917|NCT03239106|Analgesics|analgesics|mesh-ancestor
110017919|NCT03239106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110017920|NCT03239106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110017921|NCT03239106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110017922|NCT03239106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110017923|NCT03239106|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110017924|NCT03239106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110017925|NCT03239106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110017926|NCT03239106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110017927|NCT03257202|Clindamycin|clindamycin|mesh-list
110017928|NCT03257202|Clindamycin palmitate|clindamycin palmitate|mesh-list
110017929|NCT03257202|Clindamycin phosphate|clindamycin phosphate|mesh-list
110017930|NCT03257202|Benzoyl Peroxide|benzoyl peroxide|mesh-list
110017931|NCT03257202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110017932|NCT03257202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110017933|NCT03257202|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110017934|NCT03257202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110017935|NCT03257202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110017936|NCT03257202|Dermatologic Agents|dermatologic agents|mesh-ancestor
110017937|NCT03260790|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110017938|NCT03260790|Immunologic Factors|immunologic factors|mesh-ancestor
110017939|NCT03260790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110017942|NCT03278886|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110017943|NCT03278886|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110017944|NCT03278886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110017945|NCT03278886|Sensory System Agents|sensory system agents|mesh-ancestor
110017946|NCT03278886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110017950|NCT03285984|Cariostatic Agents|cariostatic agents|mesh-ancestor
110017951|NCT03285984|Protective Agents|protective agents|mesh-ancestor
110017952|NCT03285984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110017953|NCT03285984|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110017954|NCT03285984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110017955|NCT03287310|Albuterol|albuterol|mesh-list
110017956|NCT03287310|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110017957|NCT03287310|Autonomic Agents|autonomic agents|mesh-ancestor
110017958|NCT03287310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110017959|NCT03287310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110017960|NCT03287310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110017961|NCT03287310|Respiratory System Agents|respiratory system agents|mesh-ancestor
110017962|NCT03287310|Tocolytic Agents|tocolytic agents|mesh-ancestor
110017963|NCT03287310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110017964|NCT03287310|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110017966|NCT03287310|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110017967|NCT03287310|Adrenergic Agents|adrenergic agents|mesh-ancestor
110017970|NCT03301272|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110017971|NCT03301272|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110017973|NCT03301272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110017974|NCT03301272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110017975|NCT03301272|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110017976|NCT03301272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110017977|NCT03301272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110017978|NCT03301272|Cholinergic Agents|cholinergic agents|mesh-ancestor
110017979|NCT03301272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110017980|NCT03315780|Dulaglutide|dulaglutide|mesh-list
110017981|NCT03315780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110017982|NCT03315780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110017983|NCT03334734|Isoniazid|isoniazid|mesh-list
110017984|NCT03334734|Macozinone|macozinone|mesh-list
110017985|NCT03334734|Antitubercular Agents|antitubercular agents|mesh-ancestor
110017986|NCT03334734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110017987|NCT03334734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110017988|NCT03334734|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110017989|NCT03334734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110017990|NCT03334734|Antimetabolites|antimetabolites|mesh-ancestor
110017991|NCT03334734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110017992|NCT03334734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110017993|NCT03336450|Midazolam|midazolam|mesh-list
110017994|NCT03336450|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110017995|NCT03336450|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110017996|NCT03336450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110017997|NCT03336450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110017999|NCT03336450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110018000|NCT03336450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110018001|NCT03336450|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110018002|NCT03336450|Anesthetics, General|anesthetics, general|mesh-ancestor
110018003|NCT03336450|Anesthetics|anesthetics|mesh-ancestor
110018004|NCT03336450|GABA Modulators|gaba modulators|mesh-ancestor
110018005|NCT03336450|GABA Agents|gaba agents|mesh-ancestor
110018006|NCT03336450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110018007|NCT03336450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018008|NCT03340350|Minocycline|minocycline|mesh-list
110018009|NCT03340350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110018010|NCT03340350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110018011|NCT03341910|Nicotinic Acids|nicotinic acids|mesh-list
110018015|NCT03341910|Vitamin B Complex|vitamin b complex|mesh-ancestor
110018017|NCT03341910|Micronutrients|micronutrients|mesh-ancestor
110018018|NCT03341910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018019|NCT03343080|Lidocaine|lidocaine|mesh-list
110018020|NCT03343080|Anesthetics, Local|anesthetics, local|mesh-ancestor
110018021|NCT03343080|Anesthetics|anesthetics|mesh-ancestor
110018022|NCT03343080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110018023|NCT03343080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018024|NCT03343080|Sensory System Agents|sensory system agents|mesh-ancestor
110018025|NCT03343080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110018026|NCT03343080|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110018027|NCT03343080|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110018028|NCT03343080|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110018029|NCT03343080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110018030|NCT03343080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018031|NCT03375294|Nitrous Oxide|nitrous oxide|mesh-list
110018032|NCT03375294|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110018033|NCT03375294|Anesthetics, General|anesthetics, general|mesh-ancestor
110018034|NCT03375294|Anesthetics|anesthetics|mesh-ancestor
110018035|NCT03375294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110018036|NCT03375294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018037|NCT03375294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110018038|NCT03375294|Analgesics|analgesics|mesh-ancestor
110018039|NCT03375294|Sensory System Agents|sensory system agents|mesh-ancestor
110018040|NCT03375294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110018042|NCT03395808|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110018044|NCT03395808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110018045|NCT03395808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018046|NCT03395808|Analgesics|analgesics|mesh-ancestor
110018047|NCT03395808|Sensory System Agents|sensory system agents|mesh-ancestor
110018048|NCT03395808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110018049|NCT03395886|Dexmedetomidine|dexmedetomidine|mesh-list
110018050|NCT03395886|Remifentanil|remifentanil|mesh-list
110018051|NCT03395886|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110018054|NCT03395886|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110018055|NCT03395886|Analgesics|analgesics|mesh-ancestor
110018056|NCT03395886|Sensory System Agents|sensory system agents|mesh-ancestor
110018057|NCT03395886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110018058|NCT03395886|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110018059|NCT03395886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110018060|NCT03395886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110018061|NCT03395886|Adrenergic Agents|adrenergic agents|mesh-ancestor
110018062|NCT03395886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110018063|NCT03395886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018064|NCT03395886|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110018065|NCT03395886|Narcotics|narcotics|mesh-ancestor
110018066|NCT03426228|Progesterone|progesterone|mesh-list
110018067|NCT03426228|Estrogens|estrogens|mesh-list
110018068|NCT03426228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018069|NCT03426228|Hormones|hormones|mesh-ancestor
110018070|NCT03426228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110018071|NCT03426228|Progestins|progestins|mesh-ancestor
110018072|NCT03430050|Progesterone|progesterone|mesh-list
110018073|NCT03430050|Progestins|progestins|mesh-ancestor
110018074|NCT03430050|Hormones|hormones|mesh-ancestor
110018075|NCT03430050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110018076|NCT03430050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018077|NCT03440424|Lemborexant|lemborexant|mesh-list
110018078|NCT03440424|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
110018079|NCT03440424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110018080|NCT03440424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018081|NCT03440424|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110018082|NCT03440424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110018083|NCT03440424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110018084|NCT03440424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018086|NCT03448068|Analgesics|analgesics|mesh-ancestor
110018087|NCT03448068|Sensory System Agents|sensory system agents|mesh-ancestor
110018088|NCT03448068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110018089|NCT03448068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018090|NCT03448068|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110018091|NCT03448068|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110018092|NCT03448068|Anesthetics, General|anesthetics, general|mesh-ancestor
110018093|NCT03448068|Anesthetics|anesthetics|mesh-ancestor
110018094|NCT03448068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110018095|NCT03448068|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110018096|NCT03448068|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110018097|NCT03448068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110018098|NCT03448068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018100|NCT03453060|Hemostatics|hemostatics|mesh-ancestor
110018101|NCT03453060|Coagulants|coagulants|mesh-ancestor
110018102|NCT03459612|Diphenhydramine|diphenhydramine|mesh-list
110018104|NCT03459612|Lasmiditan|lasmiditan|mesh-list
110018105|NCT03459612|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110018107|NCT03459612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110018109|NCT03459612|Anesthetics, Local|anesthetics, local|mesh-ancestor
110018110|NCT03459612|Anesthetics|anesthetics|mesh-ancestor
110018111|NCT03459612|Sensory System Agents|sensory system agents|mesh-ancestor
110018112|NCT03459612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110018113|NCT03459612|Antiemetics|antiemetics|mesh-ancestor
110018114|NCT03459612|Autonomic Agents|autonomic agents|mesh-ancestor
110018115|NCT03459612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110018116|NCT03459612|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110018118|NCT03459612|Histamine Agents|histamine agents|mesh-ancestor
110018119|NCT03459612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110018120|NCT03459612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018121|NCT03459612|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110018122|NCT03459612|Antipruritics|antipruritics|mesh-ancestor
110018123|NCT03459612|Dermatologic Agents|dermatologic agents|mesh-ancestor
110018124|NCT03459612|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110018125|NCT03459612|Serotonin Agents|serotonin agents|mesh-ancestor
110018127|NCT03463512|Antidiarrheals|antidiarrheals|mesh-ancestor
110018128|NCT03463512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110018129|NCT03463512|Protease Inhibitors|protease inhibitors|mesh-ancestor
110018130|NCT03463512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110018131|NCT03463512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018132|NCT03473184|Diacerein|diacerein|mesh-list
110018133|NCT03473184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110018134|NCT03485976|Ixekizumab|ixekizumab|mesh-list
110018135|NCT03485976|Dermatologic Agents|dermatologic agents|mesh-ancestor
110018136|NCT03496974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110018138|NCT03496974|Immunoglobulins|immunoglobulins|mesh-list
110018139|NCT03496974|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110018141|NCT03496974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018145|NCT03503292|Antiemetics|antiemetics|mesh-ancestor
110018146|NCT03503292|Autonomic Agents|autonomic agents|mesh-ancestor
110018147|NCT03503292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110018148|NCT03503292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018149|NCT03503292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110018150|NCT03503292|Antipruritics|antipruritics|mesh-ancestor
110018152|NCT03503292|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110018153|NCT03503292|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110018154|NCT03503292|Serotonin Agents|serotonin agents|mesh-ancestor
110018155|NCT03503292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110018160|NCT03506724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110018161|NCT03506724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018162|NCT03506724|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110018163|NCT03506724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018164|NCT03506724|Vasodilator Agents|vasodilator agents|mesh-ancestor
110018165|NCT03506724|Tocolytic Agents|tocolytic agents|mesh-ancestor
110018166|NCT03506724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110018167|NCT03506724|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110018168|NCT03506724|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110018169|NCT03506724|Adrenergic Agents|adrenergic agents|mesh-ancestor
110018171|NCT03506724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110018172|NCT03506724|Sympathomimetics|sympathomimetics|mesh-ancestor
110018173|NCT03506724|Autonomic Agents|autonomic agents|mesh-ancestor
110018174|NCT03506724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110018175|NCT03506724|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110018178|NCT03509766|Histamine Agonists|histamine agonists|mesh-ancestor
110018179|NCT03509766|Histamine Agents|histamine agents|mesh-ancestor
110018180|NCT03509766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110018181|NCT03509766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018182|NCT03509766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018183|NCT03532776|Podophyllotoxin|podophyllotoxin|mesh-list
110018184|NCT03532776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110018185|NCT03532776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110018186|NCT03532776|Keratolytic Agents|keratolytic agents|mesh-ancestor
110018187|NCT03532776|Dermatologic Agents|dermatologic agents|mesh-ancestor
110018188|NCT03532776|Tubulin Modulators|tubulin modulators|mesh-ancestor
110018189|NCT03532776|Antimitotic Agents|antimitotic agents|mesh-ancestor
110018190|NCT03532776|Mitosis Modulators|mitosis modulators|mesh-ancestor
110018191|NCT03532776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018194|NCT03541356|Carbidopa|carbidopa|mesh-list
110018195|NCT03541356|Levodopa|levodopa|mesh-list
110018196|NCT03541356|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
110018197|NCT03541356|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110018198|NCT03541356|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110018199|NCT03541356|Dopamine Agents|dopamine agents|mesh-ancestor
110018200|NCT03541356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110018202|NCT03541356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018203|NCT03541356|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110018204|NCT03541356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110018205|NCT03557658|Bexagliflozin|bexagliflozin|mesh-list
110018206|NCT03557658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110018207|NCT03557658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018208|NCT03572478|Nivolumab|nivolumab|mesh-list
110018209|NCT03572478|Rucaparib|rucaparib|mesh-list
110018210|NCT03572478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110018211|NCT03572478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110018212|NCT03572478|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110018214|NCT03572478|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110018215|NCT03572478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110018216|NCT03574818|Gemcitabine|gemcitabine|mesh-list
110018217|NCT03574818|Necitumumab|necitumumab|mesh-list
110018219|NCT03574818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110018220|NCT03574818|Antimetabolites|antimetabolites|mesh-ancestor
110018221|NCT03574818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018222|NCT03574818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110018223|NCT03593538|Metformin|metformin|mesh-list
110018224|NCT03593538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110018225|NCT03593538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018227|NCT03610464|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110018228|NCT03610464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018230|NCT03610464|Autonomic Agents|autonomic agents|mesh-ancestor
110018232|NCT03610464|Dopamine Agents|dopamine agents|mesh-ancestor
110018233|NCT03610464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110018234|NCT03610464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018235|NCT03610464|Adrenergic Agents|adrenergic agents|mesh-ancestor
110018236|NCT03610464|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110018237|NCT03610464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110018238|NCT03610464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110018239|NCT03610464|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110018242|NCT03615534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110018243|NCT03615534|Antimetabolites|antimetabolites|mesh-ancestor
110018244|NCT03615534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018245|NCT03615534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110018246|NCT03615534|Vasodilator Agents|vasodilator agents|mesh-ancestor
110018247|NCT03615534|Vitamin B Complex|vitamin b complex|mesh-ancestor
110018248|NCT03615534|Vitamins|vitamins|mesh-ancestor
110018249|NCT03615534|Micronutrients|micronutrients|mesh-ancestor
110018250|NCT03615534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018251|NCT03630198|Lidocaine|lidocaine|mesh-list
110018252|NCT03630198|Anesthetics, Local|anesthetics, local|mesh-ancestor
110018253|NCT03630198|Anesthetics|anesthetics|mesh-ancestor
110018256|NCT03630198|Sensory System Agents|sensory system agents|mesh-ancestor
110018257|NCT03630198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110018258|NCT03630198|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110018259|NCT03630198|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110018260|NCT03630198|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110018262|NCT03630198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018263|NCT03638622|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110018264|NCT03638622|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110018265|NCT03638622|Dermatologic Agents|dermatologic agents|mesh-ancestor
110018267|NCT03655080|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110018268|NCT03655080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110018269|NCT03655080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110018270|NCT03655080|Tubulin Modulators|tubulin modulators|mesh-ancestor
110018271|NCT03655080|Antimitotic Agents|antimitotic agents|mesh-ancestor
110018272|NCT03655080|Mitosis Modulators|mitosis modulators|mesh-ancestor
110018273|NCT03655080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018275|NCT03674970|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110018276|NCT03674970|Autonomic Agents|autonomic agents|mesh-ancestor
110018277|NCT03674970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110018278|NCT03674970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018279|NCT03674970|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110018280|NCT03674970|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110018281|NCT03674970|Cholinergic Agents|cholinergic agents|mesh-ancestor
110018282|NCT03674970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110018284|NCT03704376|Clonidine|clonidine|mesh-list
110018285|NCT03704376|Ropivacaine|ropivacaine|mesh-list
110018286|NCT03704376|Anesthetics, Local|anesthetics, local|mesh-ancestor
110018287|NCT03704376|Anesthetics|anesthetics|mesh-ancestor
110018288|NCT03704376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110018289|NCT03704376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018291|NCT03704376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110018293|NCT03704376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110018294|NCT03704376|Sympatholytics|sympatholytics|mesh-ancestor
110018295|NCT03704376|Autonomic Agents|autonomic agents|mesh-ancestor
110018296|NCT03704376|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110018297|NCT03704376|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110018298|NCT03704376|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110018299|NCT03704376|Adrenergic Agents|adrenergic agents|mesh-ancestor
110018300|NCT03704376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110018301|NCT03704376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018302|NCT03716076|Carbetocin|carbetocin|mesh-list
110018303|NCT03716076|Oxytocics|oxytocics|mesh-ancestor
110018305|NCT03716076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018306|NCT03835728|Ocrelizumab|ocrelizumab|mesh-list
110018307|NCT03835728|Immunologic Factors|immunologic factors|mesh-ancestor
110018308|NCT03835728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018310|NCT03889158|Vaccines|vaccines|mesh-list
110018311|NCT03889158|Immunologic Factors|immunologic factors|mesh-ancestor
110018312|NCT03889158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018315|NCT03889158|Protective Agents|protective agents|mesh-ancestor
110018316|NCT03889158|Vitamins|vitamins|mesh-ancestor
110018317|NCT03889158|Micronutrients|micronutrients|mesh-ancestor
110018318|NCT04138758|Bromides|bromides|mesh-list
110018319|NCT04138758|Tiotropium Bromide|tiotropium bromide|mesh-list
110018320|NCT04138758|Olodaterol|olodaterol|mesh-list
110018321|NCT04138758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110018322|NCT04138758|Autonomic Agents|autonomic agents|mesh-ancestor
110018323|NCT04138758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110018325|NCT04138758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110018326|NCT04138758|Respiratory System Agents|respiratory system agents|mesh-ancestor
110018327|NCT04138758|Parasympatholytics|parasympatholytics|mesh-ancestor
110018330|NCT04138758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110018331|NCT04138758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018333|NCT04323852|Vitamin D|vitamin d|mesh-list
110018334|NCT04323852|Vitamins|vitamins|mesh-ancestor
110018335|NCT04323852|Micronutrients|micronutrients|mesh-ancestor
110018336|NCT04323852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018337|NCT04323852|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110018338|NCT04420572|Betamethasone|betamethasone|mesh-list
110018339|NCT04420572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110018340|NCT04420572|Glucocorticoids|glucocorticoids|mesh-ancestor
110018343|NCT04420572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018344|NCT04420572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110018345|NCT04420572|Respiratory System Agents|respiratory system agents|mesh-ancestor
110018346|NCT03541980|Acetaminophen|acetaminophen|mesh-list
110018347|NCT03541980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110018348|NCT03541980|Analgesics|analgesics|mesh-ancestor
110018349|NCT03541980|Sensory System Agents|sensory system agents|mesh-ancestor
110018350|NCT03541980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110018351|NCT03541980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018352|NCT03541980|Antipyretics|antipyretics|mesh-ancestor
110018354|NCT04511520|Vasodilator Agents|vasodilator agents|mesh-ancestor
110018355|NCT04463004|Mavrilimumab|mavrilimumab|mesh-list
110018356|NCT04463004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110018357|NCT04399980|Mavrilimumab|mavrilimumab|mesh-list
110018361|NCT04335552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110018362|NCT04335552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110018364|NCT04335552|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110018365|NCT04335552|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110018366|NCT04335552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110018370|NCT04284930|Anesthetics, Local|anesthetics, local|mesh-ancestor
110018371|NCT04284930|Anesthetics|anesthetics|mesh-ancestor
110018372|NCT04284930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110018373|NCT04284930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018374|NCT04284930|Sensory System Agents|sensory system agents|mesh-ancestor
110018375|NCT04284930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110018376|NCT04267770|Insulin|insulin|mesh-list
110018378|NCT04267770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110018382|NCT04204200|Micronutrients|micronutrients|mesh-ancestor
110018383|NCT04204200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018384|NCT04204200|Antioxidants|antioxidants|mesh-ancestor
110018385|NCT04204200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018386|NCT04204200|Protective Agents|protective agents|mesh-ancestor
110018389|NCT04179474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018390|NCT04179474|Analgesics|analgesics|mesh-ancestor
110018391|NCT04179474|Sensory System Agents|sensory system agents|mesh-ancestor
110018392|NCT04179474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110018393|NCT04179474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018395|NCT04150224|Antitubercular Agents|antitubercular agents|mesh-ancestor
110018396|NCT04150224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110018397|NCT04150224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110018398|NCT04112160|Ketorolac|ketorolac|mesh-list
110018399|NCT04112160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110018400|NCT04112160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110018401|NCT04112160|Analgesics|analgesics|mesh-ancestor
110018402|NCT04112160|Sensory System Agents|sensory system agents|mesh-ancestor
110018403|NCT04112160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110018404|NCT04112160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018406|NCT04112160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110018407|NCT04112160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110018408|NCT04112160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110018409|NCT04112160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018410|NCT04102956|Kallikreins|kallikreins|mesh-list
110018411|NCT04102956|Coagulants|coagulants|mesh-ancestor
110018412|NCT04102956|Fertility Agents, Male|fertility agents, male|mesh-ancestor
110018414|NCT04102956|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110018415|NCT04102956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018416|NCT04053270|Afamelanotide|afamelanotide|mesh-list
110018420|NCT03976752|Cobicistat|cobicistat|mesh-list
110018421|NCT03976752|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
110018422|NCT03976752|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110018426|NCT03976752|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110018427|NCT03976752|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110018428|NCT03976752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110018429|NCT03976752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018430|NCT03976752|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110018440|NCT03962634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110018442|NCT03962634|Sensory System Agents|sensory system agents|mesh-ancestor
110018443|NCT03962634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110018447|NCT03962634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110018448|NCT03962634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018449|NCT03962634|Sympathomimetics|sympathomimetics|mesh-ancestor
110018450|NCT03962634|Autonomic Agents|autonomic agents|mesh-ancestor
110018451|NCT03962634|Nasal Decongestants|nasal decongestants|mesh-ancestor
110018452|NCT03962634|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110018453|NCT03962634|Respiratory System Agents|respiratory system agents|mesh-ancestor
110018454|NCT03933774|Tretinoin|tretinoin|mesh-list
110018455|NCT03933774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110018456|NCT03933774|Keratolytic Agents|keratolytic agents|mesh-ancestor
110018457|NCT03933774|Dermatologic Agents|dermatologic agents|mesh-ancestor
110018458|NCT03933618|Anastrozole|anastrozole|mesh-list
110018459|NCT03933618|Clomiphene|clomiphene|mesh-list
110018460|NCT03933618|Enclomiphene|enclomiphene|mesh-list
110018461|NCT03933618|Zuclomiphene|zuclomiphene|mesh-list
110018462|NCT03933618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018463|NCT03933618|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110018464|NCT03933618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110018465|NCT03933618|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110018466|NCT03933618|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110018467|NCT03933618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110018468|NCT03933618|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110018469|NCT03933618|Hormone Antagonists|hormone antagonists|mesh-ancestor
110018470|NCT03933618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110018471|NCT03933618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018474|NCT03933618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110018475|NCT03933618|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110018476|NCT03933618|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110018478|NCT03930264|Antimetabolites|antimetabolites|mesh-ancestor
110018479|NCT03930264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018480|NCT03930264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110018484|NCT03930264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018485|NCT03930264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110018486|NCT03861000|BPN14770|bpn14770|mesh-list
110018487|NCT03861000|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110018488|NCT03861000|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110018489|NCT03861000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110018490|NCT03861000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018491|NCT03858894|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110018492|NCT03858894|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110018493|NCT03856164|Tranexamic Acid|tranexamic acid|mesh-list
110018494|NCT03856164|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110018495|NCT03856164|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110018496|NCT03856164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018497|NCT03856164|Hemostatics|hemostatics|mesh-ancestor
110018498|NCT03856164|Coagulants|coagulants|mesh-ancestor
110018499|NCT03849690|Esomeprazole|esomeprazole|mesh-list
110018500|NCT03849690|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110018501|NCT03849690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110018502|NCT03849690|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110018503|NCT03849690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110018504|NCT03849690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018505|NCT03822078|Denosumab|denosumab|mesh-list
110018506|NCT03822078|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110018507|NCT03822078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018508|NCT03806556|Tranexamic Acid|tranexamic acid|mesh-list
110018509|NCT03806556|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110018510|NCT03806556|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110018511|NCT03806556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018513|NCT03806556|Coagulants|coagulants|mesh-ancestor
110018514|NCT03812328|Enoxaparin|enoxaparin|mesh-list
110018515|NCT03812328|Anticoagulants|anticoagulants|mesh-ancestor
110018516|NCT03812328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110018518|NCT03812328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018520|NCT03805386|Narcotics|narcotics|mesh-ancestor
110018707|NCT02345772|Docetaxel|docetaxel|mesh-list
110018521|NCT03805386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110018522|NCT03805386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018524|NCT03805386|Sensory System Agents|sensory system agents|mesh-ancestor
110018525|NCT03805386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110018529|NCT03796260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018530|NCT03796182|Metformin|metformin|mesh-list
110018531|NCT03796182|Abrocitinib|abrocitinib|mesh-list
110018532|NCT03796182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110018533|NCT03796182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018534|NCT03796182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110018535|NCT03796182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110018536|NCT03796182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018538|NCT03730116|Perindopril|perindopril|mesh-list
110018539|NCT03730116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110018540|NCT03730116|Sympatholytics|sympatholytics|mesh-ancestor
110018541|NCT03730116|Autonomic Agents|autonomic agents|mesh-ancestor
110018542|NCT03730116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110018543|NCT03730116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018544|NCT03730116|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110018545|NCT03730116|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110018546|NCT03730116|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110018547|NCT03730116|Adrenergic Agents|adrenergic agents|mesh-ancestor
110018551|NCT03730116|Protease Inhibitors|protease inhibitors|mesh-ancestor
110018552|NCT03730116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110018553|NCT03370536|Ibutilide|ibutilide|mesh-list
110018554|NCT03370536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110018555|NCT03161964|Propranolol|propranolol|mesh-list
110018556|NCT03161964|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110018557|NCT03161964|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110018558|NCT03161964|Adrenergic Agents|adrenergic agents|mesh-ancestor
110018559|NCT03161964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110018561|NCT03161964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018562|NCT03161964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110018563|NCT03161964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110018564|NCT03161964|Vasodilator Agents|vasodilator agents|mesh-ancestor
110018565|NCT03078270|Botulinum Toxins|botulinum toxins|mesh-list
110018566|NCT03078270|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110018567|NCT03078270|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110018568|NCT03078270|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110018569|NCT03078270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110018571|NCT03078270|Cholinergic Agents|cholinergic agents|mesh-ancestor
110018572|NCT03078270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110018573|NCT03078270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018574|NCT03078270|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110018575|NCT03078270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110018576|NCT03042780|Folfirinox|folfirinox|mesh-list
110018577|NCT03042780|Lenograstim|lenograstim|mesh-list
110018578|NCT03042780|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110018579|NCT03042780|Immunologic Factors|immunologic factors|mesh-ancestor
110018580|NCT03042780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018581|NCT03042780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110018582|NCT02985840|Dexamethasone|dexamethasone|mesh-list
110018584|NCT02985840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110018586|NCT02985840|Autonomic Agents|autonomic agents|mesh-ancestor
110018587|NCT02985840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110018588|NCT02985840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018589|NCT02985840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110018592|NCT02985840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110018593|NCT02985840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110018594|NCT02985840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110018595|NCT02985840|Antipruritics|antipruritics|mesh-ancestor
110018596|NCT02985840|Dermatologic Agents|dermatologic agents|mesh-ancestor
110018597|NCT02985840|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110018598|NCT02985840|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110018599|NCT02985840|Serotonin Agents|serotonin agents|mesh-ancestor
110018600|NCT02985840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110018601|NCT02985840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018602|NCT02974686|Mycophenolic Acid|mycophenolic acid|mesh-list
110018603|NCT02974686|Everolimus|everolimus|mesh-list
110018604|NCT02974686|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110018605|NCT02974686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110018606|NCT02974686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110018607|NCT02974686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018608|NCT02974686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110018616|NCT02974686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110018618|NCT02966184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110018619|NCT02966184|Autonomic Agents|autonomic agents|mesh-ancestor
110018620|NCT02966184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110018621|NCT02966184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018622|NCT02966184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110018623|NCT02966184|Respiratory System Agents|respiratory system agents|mesh-ancestor
110018624|NCT02966184|Tocolytic Agents|tocolytic agents|mesh-ancestor
110018625|NCT02966184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110018626|NCT02966184|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110018627|NCT02966184|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110018628|NCT02966184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110018629|NCT02966184|Adrenergic Agents|adrenergic agents|mesh-ancestor
110018630|NCT02966184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110018631|NCT02966184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018639|NCT02744352|Ropivacaine|ropivacaine|mesh-list
110018640|NCT02744352|Anesthetics, Local|anesthetics, local|mesh-ancestor
110018641|NCT02744352|Anesthetics|anesthetics|mesh-ancestor
110018642|NCT02744352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110018643|NCT02744352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018644|NCT02744352|Sensory System Agents|sensory system agents|mesh-ancestor
110018645|NCT02744352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110018646|NCT02587650|Ceritinib|ceritinib|mesh-list
110018647|NCT02587650|Entrectinib|entrectinib|mesh-list
110018648|NCT02587650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110018649|NCT02587650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110018650|NCT02587650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110018651|NCT02587650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018652|NCT02514252|Fentanyl|fentanyl|mesh-list
110018653|NCT02514252|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110018654|NCT02514252|Narcotics|narcotics|mesh-ancestor
110018655|NCT02514252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110018656|NCT02514252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018657|NCT02514252|Analgesics|analgesics|mesh-ancestor
110018658|NCT02514252|Sensory System Agents|sensory system agents|mesh-ancestor
110018659|NCT02514252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110018660|NCT02514252|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110018662|NCT02514252|Anesthetics, General|anesthetics, general|mesh-ancestor
110018663|NCT02514252|Anesthetics|anesthetics|mesh-ancestor
110018664|NCT02434146|Phenylephrine|phenylephrine|mesh-list
110018665|NCT02434146|Oxymetazoline|oxymetazoline|mesh-list
110018666|NCT02434146|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110018667|NCT02434146|Mydriatics|mydriatics|mesh-ancestor
110018668|NCT02434146|Autonomic Agents|autonomic agents|mesh-ancestor
110018669|NCT02434146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110018670|NCT02434146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018671|NCT02434146|Sympathomimetics|sympathomimetics|mesh-ancestor
110018672|NCT02434146|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110018673|NCT02434146|Nasal Decongestants|nasal decongestants|mesh-ancestor
110018674|NCT02434146|Respiratory System Agents|respiratory system agents|mesh-ancestor
110018675|NCT02434146|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110018676|NCT02434146|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110018677|NCT02434146|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110018679|NCT02434146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110018680|NCT02434146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018681|NCT02434146|Protective Agents|protective agents|mesh-ancestor
110018683|NCT02382588|Antiviral Agents|antiviral agents|mesh-ancestor
110018684|NCT02382588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110018685|NCT02345460|Leucovorin|leucovorin|mesh-list
110018686|NCT02345460|Fluorouracil|fluorouracil|mesh-list
110018687|NCT02345460|Oxaliplatin|oxaliplatin|mesh-list
110018688|NCT02345460|Irinotecan|irinotecan|mesh-list
110018689|NCT02345460|Calcium|calcium|mesh-list
110018690|NCT02345460|Levoleucovorin|levoleucovorin|mesh-list
110018691|NCT02345460|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110018694|NCT02345460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018696|NCT02345460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110018697|NCT02345460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110018699|NCT02345460|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110018700|NCT02345460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110018701|NCT02345460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110018702|NCT02345460|Antidotes|antidotes|mesh-ancestor
110018703|NCT02345460|Protective Agents|protective agents|mesh-ancestor
110018704|NCT02345460|Vitamin B Complex|vitamin b complex|mesh-ancestor
110018705|NCT02345460|Vitamins|vitamins|mesh-ancestor
110018706|NCT02345460|Micronutrients|micronutrients|mesh-ancestor
110018712|NCT02345772|Tubulin Modulators|tubulin modulators|mesh-ancestor
110018713|NCT02345772|Antimitotic Agents|antimitotic agents|mesh-ancestor
110018714|NCT02345772|Mitosis Modulators|mitosis modulators|mesh-ancestor
110018715|NCT02345772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018716|NCT02345772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110018717|NCT02345772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110018718|NCT02345772|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110018719|NCT02345772|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110018720|NCT02345772|Hormone Antagonists|hormone antagonists|mesh-ancestor
110018721|NCT02345772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110018722|NCT02345772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018723|NCT02280252|Paclitaxel|paclitaxel|mesh-list
110018724|NCT02280252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110018725|NCT02280252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110018726|NCT02280252|Tubulin Modulators|tubulin modulators|mesh-ancestor
110018728|NCT02280252|Mitosis Modulators|mitosis modulators|mesh-ancestor
110018729|NCT02280252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018730|NCT02140788|Metformin|metformin|mesh-list
110018731|NCT02140788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110018732|NCT02140788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018733|NCT02133534|Atorvastatin|atorvastatin|mesh-list
110018734|NCT02133534|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110018735|NCT02133534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110018736|NCT02133534|Antimetabolites|antimetabolites|mesh-ancestor
110018737|NCT02133534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018738|NCT02133534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110018739|NCT02133534|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110018740|NCT02133534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110018741|NCT02015910|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110018742|NCT02015910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110018743|NCT02015910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018744|NCT02015910|Incretins|incretins|mesh-ancestor
110018746|NCT02015910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110018747|NCT02015910|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110018748|NCT02015910|Protease Inhibitors|protease inhibitors|mesh-ancestor
110018749|NCT02015910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110018750|NCT02015910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018751|NCT01980342|Efavirenz|efavirenz|mesh-list
110018752|NCT01980342|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110018753|NCT01980342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110018754|NCT01980342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110018755|NCT01980342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018756|NCT01980342|Antiviral Agents|antiviral agents|mesh-ancestor
110018757|NCT01980342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110018758|NCT01980342|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110018759|NCT01980342|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110018760|NCT01980342|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110018762|NCT01980342|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110018763|NCT01980342|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110018764|NCT01881984|Glycerol|glycerol|mesh-list
110018765|NCT01881984|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110018766|NCT01881984|Protective Agents|protective agents|mesh-ancestor
110018767|NCT01881984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018768|NCT01878786|Mycophenolic Acid|mycophenolic acid|mesh-list
110018769|NCT01878786|Everolimus|everolimus|mesh-list
110018770|NCT01878786|Tacrolimus|tacrolimus|mesh-list
110018771|NCT01878786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110018772|NCT01878786|Immunologic Factors|immunologic factors|mesh-ancestor
110018773|NCT01878786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018774|NCT01878786|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110018776|NCT01878786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018777|NCT01878786|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110018778|NCT01878786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110018779|NCT01878786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110018780|NCT01878786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110018781|NCT01878786|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110018782|NCT01878786|Antitubercular Agents|antitubercular agents|mesh-ancestor
110018783|NCT01878786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110018784|NCT01878786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110018786|NCT01851174|Gemcitabine|gemcitabine|mesh-list
110018787|NCT01851174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110018788|NCT01851174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110018789|NCT01851174|Tubulin Modulators|tubulin modulators|mesh-ancestor
110018790|NCT01851174|Antimitotic Agents|antimitotic agents|mesh-ancestor
110018791|NCT01851174|Mitosis Modulators|mitosis modulators|mesh-ancestor
110018792|NCT01851174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018793|NCT01851174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110018794|NCT01851174|Antimetabolites|antimetabolites|mesh-ancestor
110018798|NCT01846182|Sensory System Agents|sensory system agents|mesh-ancestor
110018799|NCT01846182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110018800|NCT01846182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018801|NCT01846182|Anticonvulsants|anticonvulsants|mesh-ancestor
110018802|NCT01846182|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110018803|NCT01846182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110018804|NCT01846182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018805|NCT01846182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110018806|NCT01846182|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110018807|NCT01846182|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110018808|NCT01846182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110018809|NCT01846182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110018810|NCT01846182|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110018811|NCT01846182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110018812|NCT01846182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110018813|NCT01846182|Antidepressive Agents|antidepressive agents|mesh-ancestor
110018814|NCT01846182|Dopamine Agents|dopamine agents|mesh-ancestor
110018815|NCT01800162|Methotrexate|methotrexate|mesh-list
110018816|NCT01800162|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110018817|NCT01800162|Abortifacient Agents|abortifacient agents|mesh-ancestor
110018818|NCT01800162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110018819|NCT01800162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018820|NCT01800162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110018822|NCT01800162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018823|NCT01800162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110018824|NCT01800162|Dermatologic Agents|dermatologic agents|mesh-ancestor
110018825|NCT01800162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110018826|NCT01800162|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110018827|NCT01800162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110018828|NCT01800162|Immunologic Factors|immunologic factors|mesh-ancestor
110018829|NCT01800162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110018830|NCT01800162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110018831|NCT01756560|Bupivacaine|bupivacaine|mesh-list
110018832|NCT01756560|Anesthetics, Local|anesthetics, local|mesh-ancestor
110018833|NCT01756560|Anesthetics|anesthetics|mesh-ancestor
110018834|NCT01756560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110018835|NCT01756560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018836|NCT01756560|Sensory System Agents|sensory system agents|mesh-ancestor
110018837|NCT01756560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110018838|NCT01738698|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
110018839|NCT01738698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110018840|NCT01738698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018841|NCT01738698|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110018842|NCT01738698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110018843|NCT01738698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110018844|NCT01738698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018846|NCT01738698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110018847|NCT01717482|Metformin|metformin|mesh-list
110018848|NCT01717482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110018849|NCT01717482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018850|NCT01702896|Interleukin-2|interleukin-2|mesh-list
110018851|NCT01702896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110018852|NCT01702896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110018853|NCT01702896|Analgesics|analgesics|mesh-ancestor
110018854|NCT01702896|Sensory System Agents|sensory system agents|mesh-ancestor
110018855|NCT01702896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110018856|NCT01702896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018857|NCT01683864|Cisplatin|cisplatin|mesh-list
110018858|NCT01683864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110018860|NCT01608906|Calcium heparin|calcium heparin|mesh-list
110018861|NCT01608906|Anticoagulants|anticoagulants|mesh-ancestor
110018862|NCT01608906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110018863|NCT01608906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110018864|NCT01608906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018866|NCT01602198|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110018867|NCT01602198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110018868|NCT01602198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018869|NCT01602198|Cholinergic Agents|cholinergic agents|mesh-ancestor
110018870|NCT01602198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110018871|NCT01602198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018872|NCT01602198|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110018873|NCT01602198|Protective Agents|protective agents|mesh-ancestor
110018878|NCT01527942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110018879|NCT01527942|Analgesics|analgesics|mesh-ancestor
110018880|NCT01527942|Sensory System Agents|sensory system agents|mesh-ancestor
110018881|NCT01527942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110018882|NCT01527942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018883|NCT01527942|Antipyretics|antipyretics|mesh-ancestor
110018884|NCT01507584|Bimatoprost|bimatoprost|mesh-list
110018885|NCT01507584|Brinzolamide|brinzolamide|mesh-list
110018886|NCT01507584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110018887|NCT01507584|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110018888|NCT01507584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110018889|NCT01507584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018890|NCT01483872|Tigecycline|tigecycline|mesh-list
110018891|NCT01483872|Heparin|heparin|mesh-list
110018892|NCT01483872|Calcium heparin|calcium heparin|mesh-list
110018894|NCT01483872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018895|NCT01483872|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110018896|NCT01483872|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110018897|NCT01483872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110018898|NCT01483872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110018899|NCT01483872|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110018900|NCT01483872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110018901|NCT01385280|Exemestane|exemestane|mesh-list
110018902|NCT01385280|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110018903|NCT01385280|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110018904|NCT01385280|Estradiol|estradiol|mesh-list
110018905|NCT01385280|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110018906|NCT01385280|Estrogens|estrogens|mesh-ancestor
110018907|NCT01385280|Hormones|hormones|mesh-ancestor
110018908|NCT01385280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110018909|NCT01385280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018910|NCT01385280|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110018911|NCT01385280|Contraceptive Agents|contraceptive agents|mesh-ancestor
110018912|NCT01385280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110018913|NCT01385280|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110018914|NCT01385280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110018915|NCT01385280|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110018916|NCT01385280|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110018917|NCT01385280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110018918|NCT01385280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018919|NCT01385280|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110018920|NCT01385280|Hormone Antagonists|hormone antagonists|mesh-ancestor
110018922|NCT01350258|Fludarabine phosphate|fludarabine phosphate|mesh-list
110018923|NCT01350258|Melphalan|melphalan|mesh-list
110018924|NCT01350258|Thiotepa|thiotepa|mesh-list
110018925|NCT01350258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110018926|NCT01350258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110018927|NCT01350258|Antimetabolites|antimetabolites|mesh-ancestor
110018928|NCT01350258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018929|NCT01350258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110018930|NCT01350258|Immunologic Factors|immunologic factors|mesh-ancestor
110018931|NCT01350258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018932|NCT01350258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110018933|NCT01350258|Alkylating Agents|alkylating agents|mesh-ancestor
110018934|NCT01350258|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110018935|NCT01302444|Tadalafil|tadalafil|mesh-list
110018936|NCT01302444|Vasodilator Agents|vasodilator agents|mesh-ancestor
110018937|NCT01302444|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110018938|NCT01302444|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110018939|NCT01302444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110018940|NCT01302444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018941|NCT01302444|Urological Agents|urological agents|mesh-ancestor
110018942|NCT01292070|Histamine|histamine|mesh-list
110018943|NCT01292070|Histamine Agonists|histamine agonists|mesh-ancestor
110018944|NCT01292070|Histamine Agents|histamine agents|mesh-ancestor
110018945|NCT01292070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110018946|NCT01292070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018947|NCT01292070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018948|NCT01284504|Celecoxib|celecoxib|mesh-list
110018949|NCT01284504|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110018950|NCT01284504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110018951|NCT01284504|Analgesics|analgesics|mesh-ancestor
110018952|NCT01284504|Sensory System Agents|sensory system agents|mesh-ancestor
110018953|NCT01284504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110018954|NCT01284504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018955|NCT01284504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110018956|NCT01284504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110018957|NCT01284504|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110018958|NCT01284504|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110018959|NCT01284504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110018960|NCT01284504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018961|NCT01183416|Tretinoin|tretinoin|mesh-list
110018962|NCT01183416|Isotretinoin|isotretinoin|mesh-list
110018963|NCT01183416|Antibodies|antibodies|mesh-list
110018964|NCT01183416|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110018965|NCT01183416|Immunologic Factors|immunologic factors|mesh-ancestor
110018966|NCT01183416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018967|NCT01183416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110018968|NCT01183416|Keratolytic Agents|keratolytic agents|mesh-ancestor
110018969|NCT01183416|Dermatologic Agents|dermatologic agents|mesh-ancestor
110018970|NCT01169610|Varenicline|varenicline|mesh-list
110018971|NCT01169610|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110018972|NCT01169610|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110018973|NCT01169610|Cholinergic Agents|cholinergic agents|mesh-ancestor
110018974|NCT01169610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110018975|NCT01169610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018976|NCT01169610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018977|NCT01166724|Sirolimus|sirolimus|mesh-list
110018978|NCT01166724|Tacrolimus|tacrolimus|mesh-list
110018979|NCT01166724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110018980|NCT01166724|Immunologic Factors|immunologic factors|mesh-ancestor
110018981|NCT01166724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018982|NCT01166724|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110018983|NCT01166724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110018984|NCT01166724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018985|NCT01166724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110018986|NCT01166724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110018987|NCT01166724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110018988|NCT01166724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110018989|NCT01166724|Antifungal Agents|antifungal agents|mesh-ancestor
110018990|NCT01151904|Timolol|timolol|mesh-list
110018991|NCT01151904|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110018992|NCT01151904|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110018993|NCT01151904|Latanoprost|latanoprost|mesh-list
110018994|NCT01151904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110018995|NCT01151904|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110018996|NCT01151904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110018997|NCT01151904|Adrenergic Agents|adrenergic agents|mesh-ancestor
110018998|NCT01151904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110018999|NCT01151904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110019000|NCT01151904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110019001|NCT01151904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110019002|NCT01151904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110019003|NCT01151904|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110019004|NCT01151904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110019005|NCT01151904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110019006|NCT01115244|Dapsone|dapsone|mesh-list
110019007|NCT01115244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110019008|NCT01115244|Antimalarials|antimalarials|mesh-ancestor
110019009|NCT01115244|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110019010|NCT01115244|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110019011|NCT01115244|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110019012|NCT01115244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110019013|NCT01115244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110019014|NCT01115244|Leprostatic Agents|leprostatic agents|mesh-ancestor
110019015|NCT01115244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110019017|NCT01031550|Isoflurane|isoflurane|mesh-list
110019018|NCT01031550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110019019|NCT01031550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110019020|NCT01031550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110019021|NCT01031550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110019022|NCT01031550|Anesthetics, General|anesthetics, general|mesh-ancestor
110019023|NCT01031550|Anesthetics|anesthetics|mesh-ancestor
110019024|NCT01031550|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110019025|NCT00986310|Fluoxetine|fluoxetine|mesh-list
110019026|NCT00986310|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110019027|NCT00986310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110019028|NCT00986310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110019029|NCT00986310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110019030|NCT00986310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110019031|NCT00986310|Serotonin Agents|serotonin agents|mesh-ancestor
110019032|NCT00986310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110019033|NCT00986310|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110019034|NCT00986310|Antidepressive Agents|antidepressive agents|mesh-ancestor
110019035|NCT00986310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110019036|NCT00986310|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110019037|NCT00986310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110019038|NCT00986310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110019039|NCT00907218|Varenicline|varenicline|mesh-list
110019040|NCT00907218|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110019041|NCT00907218|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110019042|NCT00907218|Cholinergic Agents|cholinergic agents|mesh-ancestor
110019043|NCT00907218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110019044|NCT00907218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110019045|NCT00907218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110019046|NCT00903396|Palonosetron|palonosetron|mesh-list
110019047|NCT00903396|Antiemetics|antiemetics|mesh-ancestor
110019048|NCT00903396|Autonomic Agents|autonomic agents|mesh-ancestor
110019049|NCT00903396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110019050|NCT00903396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110019051|NCT00903396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110019052|NCT00903396|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110019053|NCT00903396|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110019054|NCT00903396|Serotonin Agents|serotonin agents|mesh-ancestor
110019055|NCT00903396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110019056|NCT00903396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110019057|NCT00875394|Metformin|metformin|mesh-list
110019058|NCT00875394|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110019059|NCT00875394|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110019060|NCT00875394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110019061|NCT00875394|Incretins|incretins|mesh-ancestor
110019062|NCT00875394|Hormones|hormones|mesh-ancestor
110019063|NCT00875394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110019064|NCT00875394|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110019065|NCT00875394|Protease Inhibitors|protease inhibitors|mesh-ancestor
110019066|NCT00875394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110019067|NCT00875394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110019068|NCT00832572|Ranolazine|ranolazine|mesh-list
110019069|NCT00832572|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110019070|NCT00832572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110019071|NCT00832572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110019072|NCT00811590|Everolimus|everolimus|mesh-list
110019073|NCT00811590|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110019074|NCT00811590|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110019075|NCT00811590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110019076|NCT00811590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110019077|NCT00811590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110019078|NCT00811590|Immunologic Factors|immunologic factors|mesh-ancestor
110019079|NCT00811590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110019080|NCT00811590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110019081|NCT00749658|Bupropion|bupropion|mesh-list
110019082|NCT00749658|Varenicline|varenicline|mesh-list
110019083|NCT00749658|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110019084|NCT00749658|Antidepressive Agents|antidepressive agents|mesh-ancestor
110019085|NCT00749658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110019086|NCT00749658|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110019087|NCT00749658|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110019088|NCT00749658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110019089|NCT00749658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110019090|NCT00749658|Dopamine Agents|dopamine agents|mesh-ancestor
110019091|NCT00749658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110019092|NCT00749658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110019093|NCT00749658|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110019094|NCT00749658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110019095|NCT00749658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110019104|NCT00738972|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110019105|NCT00738972|Antimetabolites|antimetabolites|mesh-ancestor
110019106|NCT00738972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110019107|NCT00738972|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110019108|NCT00738972|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110019109|NCT00738972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110019110|NCT00738972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110019111|NCT00738972|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110019112|NCT00738972|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110019113|NCT00726180|Trastuzumab|trastuzumab|mesh-list
110019114|NCT00726180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110019115|NCT00726180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110019117|NCT00704496|Ephedrine|ephedrine|mesh-list
110019118|NCT00704496|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110019119|NCT00704496|Autonomic Agents|autonomic agents|mesh-ancestor
110019120|NCT00704496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110019121|NCT00704496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110019122|NCT00704496|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110019123|NCT00704496|Respiratory System Agents|respiratory system agents|mesh-ancestor
110019124|NCT00704496|Nasal Decongestants|nasal decongestants|mesh-ancestor
110019125|NCT00704496|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110019126|NCT00704496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110019127|NCT00704496|Sympathomimetics|sympathomimetics|mesh-ancestor
110019128|NCT00704496|Adrenergic Agents|adrenergic agents|mesh-ancestor
110019129|NCT00704496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110019130|NCT00704496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110019132|NCT00692094|Antioxidants|antioxidants|mesh-ancestor
110019133|NCT00692094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110019134|NCT00692094|Protective Agents|protective agents|mesh-ancestor
110019135|NCT00692094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110019136|NCT00692094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110019137|NCT00676026|Zolpidem|zolpidem|mesh-list
110019138|NCT00676026|Fluoxetine|fluoxetine|mesh-list
110019139|NCT00676026|Progesterone|progesterone|mesh-list
110019140|NCT00676026|Progestins|progestins|mesh-ancestor
110019141|NCT00676026|Hormones|hormones|mesh-ancestor
110019142|NCT00676026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110019143|NCT00676026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110019144|NCT00676026|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110019145|NCT00676026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110019146|NCT00676026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110019147|NCT00676026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110019149|NCT00676026|Serotonin Agents|serotonin agents|mesh-ancestor
110019150|NCT00676026|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110019151|NCT00676026|Antidepressive Agents|antidepressive agents|mesh-ancestor
110019152|NCT00676026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110019153|NCT00676026|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110019154|NCT00676026|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110019155|NCT00676026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110019156|NCT00676026|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110019157|NCT00676026|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110019158|NCT00676026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110019159|NCT00676026|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110019160|NCT00676026|GABA Agonists|gaba agonists|mesh-ancestor
110019161|NCT00676026|GABA Agents|gaba agents|mesh-ancestor
110019162|NCT00656916|Fluticasone|fluticasone|mesh-list
110019163|NCT00656916|Xhance|xhance|mesh-list
110019164|NCT00656916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110019165|NCT00656916|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110019166|NCT00656916|Autonomic Agents|autonomic agents|mesh-ancestor
110019167|NCT00656916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110019168|NCT00656916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110019169|NCT00656916|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110019170|NCT00656916|Respiratory System Agents|respiratory system agents|mesh-ancestor
110019171|NCT00656916|Dermatologic Agents|dermatologic agents|mesh-ancestor
110019172|NCT00656916|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110019173|NCT00619242|Sorafenib|sorafenib|mesh-list
110019174|NCT00619242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110019175|NCT00619242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110019176|NCT00619242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110019177|NCT00619242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110019178|NCT00601848|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
110019179|NCT00601848|Trioxsalen|trioxsalen|mesh-list
110019180|NCT00601848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110019181|NCT00601848|Dermatologic Agents|dermatologic agents|mesh-ancestor
110019182|NCT00601848|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110019183|NCT00586716|Immunoglobulins|immunoglobulins|mesh-list
110019185|NCT00586716|gamma-Globulins|gamma-globulins|mesh-list
110019186|NCT00586716|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110019187|NCT00586716|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110019188|NCT00586716|Immunologic Factors|immunologic factors|mesh-ancestor
110019189|NCT00586716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110019190|NCT00571194|Pravastatin|pravastatin|mesh-list
110019191|NCT00571194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110019192|NCT00571194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110019193|NCT00571194|Antimetabolites|antimetabolites|mesh-ancestor
110019194|NCT00571194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110019195|NCT00571194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110019196|NCT00571194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110019197|NCT00571194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110019198|NCT00570258|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110019199|NCT00570258|Fulvestrant|fulvestrant|mesh-list
110019200|NCT00570258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110019201|NCT00570258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110019203|NCT00570258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110019204|NCT00570258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110019205|NCT00570258|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110019206|NCT00570258|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110019207|NCT00570258|Hormone Antagonists|hormone antagonists|mesh-ancestor
110019208|NCT00570258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110019209|NCT00570258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110019210|NCT00568698|Hydroxyurea|hydroxyurea|mesh-list
110019211|NCT00568698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110019212|NCT00568698|Antisickling Agents|antisickling agents|mesh-ancestor
110019213|NCT00568698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110019214|NCT00568698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110019215|NCT00568698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110019216|NCT00577356|Docetaxel|docetaxel|mesh-list
110019217|NCT00577356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110019218|NCT00577356|Tubulin Modulators|tubulin modulators|mesh-ancestor
110019219|NCT00577356|Antimitotic Agents|antimitotic agents|mesh-ancestor
110019220|NCT00577356|Mitosis Modulators|mitosis modulators|mesh-ancestor
110019221|NCT00577356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110019222|NCT00569868|Bortezomib|bortezomib|mesh-list
110019223|NCT00569868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110019225|NCT05599230|Elexacaftor|elexacaftor|mesh-list
110019226|NCT05599230|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110019227|NCT05599230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110019228|NCT05599230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110019229|NCT05403762|Protective Agents|protective agents|mesh-list
110019230|NCT05403762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110019231|NCT05164614|Teriparatide|teriparatide|mesh-list
110019232|NCT05164614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110019233|NCT05164614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110019234|NCT05164614|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110019235|NCT05001048|Phenylephrine|phenylephrine|mesh-list
110019236|NCT05001048|Oxymetazoline|oxymetazoline|mesh-list
110019238|NCT05001048|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110019239|NCT05001048|Mydriatics|mydriatics|mesh-ancestor
110019240|NCT05001048|Autonomic Agents|autonomic agents|mesh-ancestor
110019241|NCT05001048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110019242|NCT05001048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110019243|NCT05001048|Sympathomimetics|sympathomimetics|mesh-ancestor
110019244|NCT05001048|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110019245|NCT05001048|Nasal Decongestants|nasal decongestants|mesh-ancestor
110019246|NCT05001048|Respiratory System Agents|respiratory system agents|mesh-ancestor
110019247|NCT05001048|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110019248|NCT05001048|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110019249|NCT05001048|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110019250|NCT05001048|Adrenergic Agents|adrenergic agents|mesh-ancestor
110019251|NCT05001048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110019252|NCT05001048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110019253|NCT05001048|Protective Agents|protective agents|mesh-ancestor
110019254|NCT04954638|Sodium Hypochlorite|sodium hypochlorite|mesh-list
110019255|NCT04954638|Chlorine dioxide|chlorine dioxide|mesh-list
110019258|NCT04954638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110019259|NCT04954638|Dental Disinfectants|dental disinfectants|mesh-ancestor
110019260|NCT04810572|Silymarin|silymarin|mesh-list
110019261|NCT04810572|Antioxidants|antioxidants|mesh-ancestor
110019262|NCT04810572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110019263|NCT04810572|Protective Agents|protective agents|mesh-ancestor
110019264|NCT04810572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110019265|NCT04575090|Simvastatin|simvastatin|mesh-list
110019266|NCT04575090|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110019267|NCT04575090|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110019268|NCT04575090|Antimetabolites|antimetabolites|mesh-ancestor
110019269|NCT04575090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110019270|NCT04575090|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110019271|NCT04575090|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110019272|NCT04575090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110019273|NCT04100772|Vaccines|vaccines|mesh-list
110019274|NCT04100772|Immunologic Factors|immunologic factors|mesh-ancestor
110019275|NCT04100772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110019276|NCT04043520|Estradiol|estradiol|mesh-list
110019277|NCT04043520|Estrogens|estrogens|mesh-list
110019278|NCT04043520|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
110019279|NCT04043520|Hormones|hormones|mesh-ancestor
110019280|NCT04043520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110019281|NCT04043520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110019282|NCT03582930|Calfactant|calfactant|mesh-list
110019283|NCT03582930|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
110019284|NCT03582930|Respiratory System Agents|respiratory system agents|mesh-ancestor
110019285|NCT03472872|Acetaminophen|acetaminophen|mesh-list
110019286|NCT03472872|Ketorolac|ketorolac|mesh-list
110019287|NCT03472872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110019288|NCT03472872|Analgesics|analgesics|mesh-ancestor
110019289|NCT03472872|Sensory System Agents|sensory system agents|mesh-ancestor
110019290|NCT03472872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110019291|NCT03472872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110019292|NCT03472872|Antipyretics|antipyretics|mesh-ancestor
110019293|NCT03472872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110019294|NCT03472872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110019295|NCT03472872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110019296|NCT03472872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110019297|NCT03472872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110019298|NCT03472872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110019300|NCT03301038|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110019301|NCT03301038|Antitubercular Agents|antitubercular agents|mesh-ancestor
110019302|NCT03301038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110019303|NCT03301038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110019304|NCT03301038|Leprostatic Agents|leprostatic agents|mesh-ancestor
110019305|NCT03301038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110019306|NCT03301038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110019307|NCT03301038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110019308|NCT03301038|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110019309|NCT03301038|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110019310|NCT03301038|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110019311|NCT03301038|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110019312|NCT03301038|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110019313|NCT03301038|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110019314|NCT02411526|Risperidone|risperidone|mesh-list
110019315|NCT02411526|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110019316|NCT02411526|Serotonin Agents|serotonin agents|mesh-ancestor
110019317|NCT02411526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110019318|NCT02411526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110019319|NCT02411526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110019320|NCT02411526|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110019321|NCT02411526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110019322|NCT02411526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110019323|NCT02411526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110019324|NCT02411526|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110019325|NCT02411526|Dopamine Agents|dopamine agents|mesh-ancestor
110019326|NCT00564876|Dasatinib|dasatinib|mesh-list
110019327|NCT00564876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110019328|NCT00564876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110019329|NCT00564876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110019330|NCT00564876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110019331|NCT00558870|Morphine|morphine|mesh-list
110019332|NCT00558870|Methadone|methadone|mesh-list
110019335|NCT00558870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110019336|NCT00558870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110019337|NCT00558870|Analgesics|analgesics|mesh-ancestor
110019338|NCT00558870|Sensory System Agents|sensory system agents|mesh-ancestor
110019339|NCT00558870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110019340|NCT00558870|Antitussive Agents|antitussive agents|mesh-ancestor
110019341|NCT00558870|Respiratory System Agents|respiratory system agents|mesh-ancestor
110019342|NCT00548886|Epinephrine|epinephrine|mesh-list
110019343|NCT00548886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110019344|NCT00548886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110019345|NCT00548886|Adrenergic Agents|adrenergic agents|mesh-ancestor
110019346|NCT00548886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110019347|NCT00548886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110019348|NCT00548886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110019349|NCT00548886|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110019350|NCT00548886|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110019351|NCT00548886|Autonomic Agents|autonomic agents|mesh-ancestor
110019352|NCT00548886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110019353|NCT00548886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110019354|NCT00548886|Respiratory System Agents|respiratory system agents|mesh-ancestor
110019355|NCT00548886|Mydriatics|mydriatics|mesh-ancestor
110019356|NCT00548886|Sympathomimetics|sympathomimetics|mesh-ancestor
110019357|NCT00548886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110019359|NCT00538980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110019360|NCT00538980|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110019361|NCT00538980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110019362|NCT00538980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110019363|NCT00519090|Imatinib Mesylate|imatinib mesylate|mesh-list
110019364|NCT00519090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110019365|NCT00519090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110019366|NCT00519090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110019367|NCT00519090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110019368|NCT00506064|Melatonin|melatonin|mesh-list
110019369|NCT00506064|Antioxidants|antioxidants|mesh-ancestor
110019370|NCT00506064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110019371|NCT00506064|Protective Agents|protective agents|mesh-ancestor
110019372|NCT00506064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110019373|NCT00506064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110019374|NCT00475332|Tositumomab I-131|tositumomab i-131|mesh-list
110019376|NCT00470574|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
110019377|NCT00470574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110019378|NCT00470574|Immunologic Factors|immunologic factors|mesh-ancestor
110019379|NCT00470574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110019380|NCT00442260|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110019381|NCT00442260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110019382|NCT00145704|Vitamin D|vitamin d|mesh-list
110019383|NCT00145704|Ergocalciferols|ergocalciferols|mesh-list
110019384|NCT00145704|Cholecalciferol|cholecalciferol|mesh-list
110019385|NCT00145704|Risedronic Acid|risedronic acid|mesh-list
110019386|NCT00145704|Diphosphonates|diphosphonates|mesh-list
110019387|NCT00145704|Vitamins|vitamins|mesh-list
110019388|NCT00145704|Micronutrients|micronutrients|mesh-ancestor
110019389|NCT00145704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110019390|NCT00145704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110019391|NCT00145704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110019392|NCT00145704|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110019393|NCT00145704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110019394|NCT00145704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110019395|NCT00108342|Nicotine|nicotine|mesh-list
110019396|NCT00108342|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110019397|NCT00108342|Autonomic Agents|autonomic agents|mesh-ancestor
110019398|NCT00108342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110019399|NCT00108342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110019400|NCT00108342|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110019401|NCT00108342|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110019402|NCT00108342|Cholinergic Agents|cholinergic agents|mesh-ancestor
110019403|NCT00108342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110019404|NCT00108342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110019405|NCT00090870|Interferons|interferons|mesh-list
110019406|NCT00090870|Interferon-alpha|interferon-alpha|mesh-list
110019407|NCT00090870|Interferon alpha-2|interferon alpha-2|mesh-list
110019408|NCT00090870|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110019409|NCT00090870|Thalidomide|thalidomide|mesh-list
110019410|NCT00090870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110019412|NCT00090870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110019413|NCT00090870|Immunologic Factors|immunologic factors|mesh-ancestor
110019414|NCT00090870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110019415|NCT00090870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110019416|NCT00090870|Leprostatic Agents|leprostatic agents|mesh-ancestor
110019417|NCT00090870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110019418|NCT00090870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110019419|NCT00090870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110019420|NCT00090870|Growth Substances|growth substances|mesh-ancestor
110019421|NCT00090870|Growth Inhibitors|growth inhibitors|mesh-ancestor
110019422|NCT00074724|Dobutamine|dobutamine|mesh-list
110019423|NCT00074724|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110019424|NCT00074724|Sympathomimetics|sympathomimetics|mesh-ancestor
110019425|NCT00074724|Autonomic Agents|autonomic agents|mesh-ancestor
110019426|NCT00074724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110019427|NCT00074724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110019428|NCT00074724|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110019429|NCT00074724|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110019430|NCT00074724|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110019431|NCT00074724|Adrenergic Agents|adrenergic agents|mesh-ancestor
110019432|NCT00074724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110019433|NCT00074724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110019434|NCT00074724|Protective Agents|protective agents|mesh-ancestor
110019435|NCT00058188|Cholecalciferol|cholecalciferol|mesh-list
110019436|NCT00058188|Vitamin D|vitamin d|mesh-list
110019437|NCT00058188|Zoledronic Acid|zoledronic acid|mesh-list
110019438|NCT00058188|Calcium|calcium|mesh-list
110019439|NCT00058188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110019440|NCT00058188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110019441|NCT00058188|Vitamins|vitamins|mesh-ancestor
110019442|NCT00058188|Micronutrients|micronutrients|mesh-ancestor
110019443|NCT00058188|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110019444|NCT00003726|Lepirudin|lepirudin|mesh-list
110019445|NCT00003726|Antithrombins|antithrombins|mesh-ancestor
110019446|NCT00003726|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110019447|NCT00003726|Protease Inhibitors|protease inhibitors|mesh-ancestor
110019448|NCT00003726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110019449|NCT00003726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110019450|NCT00003726|Anticoagulants|anticoagulants|mesh-ancestor
110019451|NCT00003726|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110019452|NCT00003726|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110019453|NCT02595996|Propranolol|propranolol|mesh-list
110019454|NCT02595996|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110019455|NCT02595996|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110019456|NCT02595996|Adrenergic Agents|adrenergic agents|mesh-ancestor
110019457|NCT02595996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110019458|NCT02595996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110019459|NCT02595996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110019460|NCT02595996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110019461|NCT02595996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110019462|NCT02595996|Vasodilator Agents|vasodilator agents|mesh-ancestor
110019463|NCT04422210|Carboplatin|carboplatin|mesh-list
110019464|NCT04422210|Etoposide|etoposide|mesh-list
110019465|NCT04422210|Atezolizumab|atezolizumab|mesh-list
110019466|NCT04422210|Venetoclax|venetoclax|mesh-list
110019467|NCT04422210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110019468|NCT04422210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110019469|NCT04422210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110019470|NCT04422210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110019471|NCT04422210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110019472|NCT04422210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110019474|NCT04422210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110019475|NCT00000132|Betaxolol|betaxolol|mesh-list
110019476|NCT00000132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110019477|NCT00000132|Sympatholytics|sympatholytics|mesh-ancestor
110019478|NCT00000132|Autonomic Agents|autonomic agents|mesh-ancestor
110019479|NCT00000132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110019480|NCT00000132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110019481|NCT00000132|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110019482|NCT00000132|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110019483|NCT00000132|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110019484|NCT00000132|Adrenergic Agents|adrenergic agents|mesh-ancestor
110019485|NCT00000132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110019486|NCT00000132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110019487|NCT00000138|Acyclovir|acyclovir|mesh-list
110019488|NCT00000138|Prednisolone|prednisolone|mesh-list
110019489|NCT00000138|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110019490|NCT00000138|Methylprednisolone|methylprednisolone|mesh-list
110019491|NCT00000138|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110019492|NCT00000138|Prednisolone acetate|prednisolone acetate|mesh-list
110019493|NCT00000138|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110019494|NCT00000138|Prednisolone phosphate|prednisolone phosphate|mesh-list
110019495|NCT00000138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110019496|NCT00000138|Glucocorticoids|glucocorticoids|mesh-ancestor
110019498|NCT00000138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110019499|NCT00000138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110019500|NCT00000138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110019501|NCT00000138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110019502|NCT00000138|Antiemetics|antiemetics|mesh-ancestor
110019503|NCT00000138|Autonomic Agents|autonomic agents|mesh-ancestor
110019504|NCT00000138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110019505|NCT00000138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110019506|NCT00000138|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110019507|NCT00000138|Protective Agents|protective agents|mesh-ancestor
110019508|NCT00000138|Antiviral Agents|antiviral agents|mesh-ancestor
110019509|NCT00000138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110019510|NCT00000174|Rivastigmine|rivastigmine|mesh-list
110019511|NCT00000174|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110019512|NCT00000174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110019513|NCT00000174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110019514|NCT00000174|Cholinergic Agents|cholinergic agents|mesh-ancestor
110019515|NCT00000174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110019516|NCT00000174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110019517|NCT00000174|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110019520|NCT00000192|Anticonvulsants|anticonvulsants|mesh-ancestor
110019521|NCT00000192|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110019522|NCT00000192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110019523|NCT00000192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110019524|NCT00000192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110019525|NCT00000192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110019526|NCT00000192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110019527|NCT00000192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110019528|NCT00000192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110019529|NCT00000192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110019530|NCT00000192|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110019531|NCT00000198|Piracetam|piracetam|mesh-list
110019532|NCT00000198|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110019533|NCT00000198|Protective Agents|protective agents|mesh-ancestor
110019534|NCT00000198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110019535|NCT00000198|Nootropic Agents|nootropic agents|mesh-ancestor
110019536|NCT00000204|Buprenorphine|buprenorphine|mesh-list
110019537|NCT00000204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110019538|NCT00000204|Narcotics|narcotics|mesh-ancestor
110019539|NCT00000204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110019540|NCT00000204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110019542|NCT00000204|Sensory System Agents|sensory system agents|mesh-ancestor
110019543|NCT00000204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110019544|NCT00000204|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110019545|NCT00000210|Buprenorphine|buprenorphine|mesh-list
110019546|NCT00000210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110019547|NCT00000210|Narcotics|narcotics|mesh-ancestor
110019548|NCT00000210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110019549|NCT00000210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110019550|NCT00000210|Analgesics|analgesics|mesh-ancestor
110019551|NCT00000210|Sensory System Agents|sensory system agents|mesh-ancestor
110019552|NCT00000210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110019553|NCT00000210|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110019554|NCT00000222|Buprenorphine|buprenorphine|mesh-list
110019555|NCT00000222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110019556|NCT00000222|Narcotics|narcotics|mesh-ancestor
110019557|NCT00000222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110019558|NCT00000222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110019560|NCT00000222|Sensory System Agents|sensory system agents|mesh-ancestor
110019561|NCT00000222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110019562|NCT00000222|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110019563|NCT00000228|Buprenorphine|buprenorphine|mesh-list
110019564|NCT00000228|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110019565|NCT00000228|Narcotics|narcotics|mesh-ancestor
110019566|NCT00000228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110019567|NCT00000228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110019568|NCT00000228|Analgesics|analgesics|mesh-ancestor
110019570|NCT00000228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110019571|NCT00000228|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110019572|NCT00000234|Buprenorphine|buprenorphine|mesh-list
110019573|NCT00000234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110019574|NCT00000234|Narcotics|narcotics|mesh-ancestor
110019575|NCT00000234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110019576|NCT00000234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110019577|NCT00000234|Analgesics|analgesics|mesh-ancestor
110019578|NCT00000234|Sensory System Agents|sensory system agents|mesh-ancestor
110019579|NCT00000234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110019580|NCT00000234|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110019581|NCT00000240|Buprenorphine|buprenorphine|mesh-list
110019582|NCT00000240|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110019585|NCT00000240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110019586|NCT00000240|Analgesics|analgesics|mesh-ancestor
110019587|NCT00000240|Sensory System Agents|sensory system agents|mesh-ancestor
110019588|NCT00000240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110019589|NCT00000240|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110019590|NCT00000246|Flumazenil|flumazenil|mesh-list
110019591|NCT00000246|Antidotes|antidotes|mesh-ancestor
110019592|NCT00000246|Protective Agents|protective agents|mesh-ancestor
110019593|NCT00000246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110019594|NCT00000246|GABA Modulators|gaba modulators|mesh-ancestor
110019595|NCT00000246|GABA Agents|gaba agents|mesh-ancestor
110019596|NCT00000246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110019597|NCT00000246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110019598|NCT00000264|Ethanol|ethanol|mesh-list
110019599|NCT00000264|Nitrous Oxide|nitrous oxide|mesh-list
110019600|NCT00000264|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110019601|NCT00000264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110019602|NCT00000264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110019603|NCT00000264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110019604|NCT00000264|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110019605|NCT00000264|Anesthetics, General|anesthetics, general|mesh-ancestor
110019606|NCT00000264|Anesthetics|anesthetics|mesh-ancestor
110019607|NCT00000264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110019608|NCT00000264|Analgesics|analgesics|mesh-ancestor
110019609|NCT00000264|Sensory System Agents|sensory system agents|mesh-ancestor
110019610|NCT00000264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110019611|NCT00000270|Cocaine|cocaine|mesh-list
110019612|NCT00000270|Anesthetics, Local|anesthetics, local|mesh-ancestor
110019613|NCT00000270|Anesthetics|anesthetics|mesh-ancestor
110019614|NCT00000270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110019615|NCT00000270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110019616|NCT00000270|Sensory System Agents|sensory system agents|mesh-ancestor
110019617|NCT00000270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110019618|NCT00000270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110019619|NCT00000270|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110019620|NCT00000270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110019621|NCT00000270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110019622|NCT00000270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110019623|NCT00000270|Dopamine Agents|dopamine agents|mesh-ancestor
110019624|NCT00000270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110019625|NCT00000276|Bupropion|bupropion|mesh-list
110019626|NCT00000276|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110019627|NCT00000276|Antidepressive Agents|antidepressive agents|mesh-ancestor
110019628|NCT00000276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110019629|NCT00000276|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110019630|NCT00000276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110019631|NCT00000276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110019632|NCT00000276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110019633|NCT00000276|Dopamine Agents|dopamine agents|mesh-ancestor
110019634|NCT00000276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110019635|NCT00000276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110019636|NCT00000276|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110019637|NCT00000276|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110019638|NCT00000276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110019639|NCT00000282|Pemoline|pemoline|mesh-list
110019640|NCT00000282|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110019641|NCT00000282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110019642|NCT00000294|Carvedilol|carvedilol|mesh-list
110019643|NCT00000294|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110019644|NCT00000294|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110019646|NCT00000294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110019647|NCT00000294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110019648|NCT00000294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110019649|NCT00000294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110019650|NCT00000294|Antioxidants|antioxidants|mesh-ancestor
110019651|NCT00000294|Protective Agents|protective agents|mesh-ancestor
110019652|NCT00000294|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110019653|NCT00000294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110019654|NCT00000294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110019655|NCT00000294|Vasodilator Agents|vasodilator agents|mesh-ancestor
110019656|NCT00000294|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110019657|NCT00000294|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110019658|NCT00000306|Dextroamphetamine|dextroamphetamine|mesh-list
110019659|NCT00000306|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110019660|NCT00000306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110019661|NCT00000306|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110019662|NCT00000306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110019663|NCT00000306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110019664|NCT00000306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110019666|NCT00000306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110019667|NCT00000318|Buprenorphine|buprenorphine|mesh-list
110019668|NCT00000318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110019669|NCT00000318|Narcotics|narcotics|mesh-ancestor
110019670|NCT00000318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110019671|NCT00000318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110019672|NCT00000318|Analgesics|analgesics|mesh-ancestor
110019673|NCT00000318|Sensory System Agents|sensory system agents|mesh-ancestor
110019674|NCT00000318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110019676|NCT00000330|Analgesics, Opioid|analgesics, opioid|mesh-list
110019677|NCT00000330|Narcotics|narcotics|mesh-ancestor
110019678|NCT00000330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110019679|NCT00000330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110019680|NCT00000330|Analgesics|analgesics|mesh-ancestor
110019681|NCT00000330|Sensory System Agents|sensory system agents|mesh-ancestor
110019682|NCT00000330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110019683|NCT00000336|Selegiline|selegiline|mesh-list
110019684|NCT00000336|Antidepressive Agents|antidepressive agents|mesh-ancestor
110019685|NCT00000336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110019686|NCT00000336|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110019687|NCT00000336|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110019688|NCT00000336|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110019689|NCT00000336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110019690|NCT00000336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110019691|NCT00000336|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110019692|NCT00000336|Protective Agents|protective agents|mesh-ancestor
110019693|NCT00000336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110019694|NCT00000342|Risperidone|risperidone|mesh-list
110019695|NCT00000342|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110019696|NCT00000342|Serotonin Agents|serotonin agents|mesh-ancestor
110019697|NCT00000342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110019698|NCT00000342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110019699|NCT00000342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110019700|NCT00000342|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110019701|NCT00000342|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110019702|NCT00000342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110019703|NCT00000342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110019704|NCT00000342|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110019705|NCT00000342|Dopamine Agents|dopamine agents|mesh-ancestor
110019706|NCT00000348|Dihydrexidine|dihydrexidine|mesh-list
110019707|NCT00000348|Dopamine Agonists|dopamine agonists|mesh-ancestor
110019708|NCT00000348|Dopamine Agents|dopamine agents|mesh-ancestor
110019709|NCT00000348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110019710|NCT00000348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110019711|NCT00000348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110019712|NCT00000354|Lofexidine|lofexidine|mesh-list
110019713|NCT00000354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110019714|NCT00000354|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110019715|NCT00000354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110019717|NCT00000354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110019718|NCT00000354|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110019719|NCT00000354|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110019720|NCT00000354|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110019721|NCT00000354|Adrenergic Agents|adrenergic agents|mesh-ancestor
110019722|NCT00000354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110019723|NCT00000354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110019724|NCT00000372|Cycloserine|cycloserine|mesh-list
110019726|NCT00000372|Glycine|glycine|mesh-list
110019727|NCT00000372|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110019728|NCT00000372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110019729|NCT00000372|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110019730|NCT00000372|Antitubercular Agents|antitubercular agents|mesh-ancestor
110019731|NCT00000372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110019732|NCT00000372|Antimetabolites|antimetabolites|mesh-ancestor
110019733|NCT00000372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110019734|NCT00000372|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110019735|NCT00000372|Serotonin Agents|serotonin agents|mesh-ancestor
110019736|NCT00000372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110019737|NCT00000372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110019738|NCT00000372|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110019739|NCT00000372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110019740|NCT00000372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110019741|NCT00000372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110019742|NCT00000372|GABA Antagonists|gaba antagonists|mesh-ancestor
110019743|NCT00000372|GABA Agents|gaba agents|mesh-ancestor
110019744|NCT00000372|Glycine Agents|glycine agents|mesh-ancestor
110019746|NCT00000384|Antidepressive Agents|antidepressive agents|mesh-ancestor
110019747|NCT00000384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110019748|NCT00000384|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110019749|NCT00000384|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110019750|NCT00000384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110019751|NCT00000384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110019752|NCT00000384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110019753|NCT00000384|Serotonin Agents|serotonin agents|mesh-ancestor
110019754|NCT00000384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110019755|NCT00000390|Imipramine|imipramine|mesh-list
110019756|NCT00000390|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110019757|NCT00000390|Antidepressive Agents|antidepressive agents|mesh-ancestor
110019758|NCT00000390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110019759|NCT00000390|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110019760|NCT00000390|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110019761|NCT00000390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110019762|NCT00000390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110019763|NCT00000390|Adrenergic Agents|adrenergic agents|mesh-ancestor
110019764|NCT00000390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110019765|NCT00000390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110019766|NCT00000402|Calcium|calcium|mesh-list
110019767|NCT00000402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110019768|NCT00000402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110019769|NCT00000438|Naltrexone|naltrexone|mesh-list
110019770|NCT00000438|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110019771|NCT00000438|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110019772|NCT00000438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110019773|NCT00000438|Sensory System Agents|sensory system agents|mesh-ancestor
110019774|NCT00000438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110019775|NCT00000444|Nicotine|nicotine|mesh-list
110019776|NCT00000444|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110019777|NCT00000444|Autonomic Agents|autonomic agents|mesh-ancestor
110019778|NCT00000444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110019779|NCT00000444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110019780|NCT00000444|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110019781|NCT00000444|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110019782|NCT00000444|Cholinergic Agents|cholinergic agents|mesh-ancestor
110019783|NCT00000444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110019784|NCT00000444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110019785|NCT00000450|Naltrexone|naltrexone|mesh-list
110019786|NCT00000450|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110019787|NCT00000450|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110019788|NCT00000450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110019789|NCT00000450|Sensory System Agents|sensory system agents|mesh-ancestor
110019790|NCT00000450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110019791|NCT00000510|Aspirin|aspirin|mesh-list
110019792|NCT00000510|Dipyridamole|dipyridamole|mesh-list
110019793|NCT00000510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110019794|NCT00000510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110019795|NCT00000510|Analgesics|analgesics|mesh-ancestor
110019796|NCT00000510|Sensory System Agents|sensory system agents|mesh-ancestor
110019797|NCT00000510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110019798|NCT00000510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110019799|NCT00000510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110019800|NCT00000510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110019801|NCT00000510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110019802|NCT00000510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110019803|NCT00000510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110019804|NCT00000510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110019805|NCT00000510|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110019806|NCT00000510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110019807|NCT00000510|Antipyretics|antipyretics|mesh-ancestor
110019808|NCT00000510|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110019809|NCT00000510|Vasodilator Agents|vasodilator agents|mesh-ancestor
110019810|NCT00000570|Pulmonary Surfactants|pulmonary surfactants|mesh-list
110019811|NCT00000570|Respiratory System Agents|respiratory system agents|mesh-ancestor
110019812|NCT00000600|Vitamins|vitamins|mesh-list
110019813|NCT00000600|Vitamin E|vitamin e|mesh-list
110019814|NCT00000600|Micronutrients|micronutrients|mesh-ancestor
110019815|NCT00000600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110019816|NCT00000600|Antioxidants|antioxidants|mesh-ancestor
110019817|NCT00000600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110019818|NCT00000600|Protective Agents|protective agents|mesh-ancestor
110019819|NCT00000636|Pyridoxine|pyridoxine|mesh-list
110019820|NCT00000636|Vitamin B 6|vitamin b 6|mesh-list
110019821|NCT00000636|Rifampin|rifampin|mesh-list
110019822|NCT00000636|Isoniazid|isoniazid|mesh-list
110019823|NCT00000636|Pyrazinamide|pyrazinamide|mesh-list
110019824|NCT00000636|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110019825|NCT00000636|Antitubercular Agents|antitubercular agents|mesh-ancestor
110019826|NCT00000636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110019827|NCT00000636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110019828|NCT00000636|Leprostatic Agents|leprostatic agents|mesh-ancestor
110019829|NCT00000636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110019830|NCT00000636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110019831|NCT00000636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110019832|NCT00000636|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110019833|NCT00000636|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110019834|NCT00000636|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110019835|NCT00000636|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110019836|NCT00000636|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110019837|NCT00000636|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110019838|NCT00000636|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110019839|NCT00000636|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110019840|NCT00000636|Antimetabolites|antimetabolites|mesh-ancestor
110019841|NCT00000636|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110019842|NCT00000636|Vitamin B Complex|vitamin b complex|mesh-ancestor
110019843|NCT00000636|Vitamins|vitamins|mesh-ancestor
110019844|NCT00000636|Micronutrients|micronutrients|mesh-ancestor
110019845|NCT00000636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110019846|NCT00000648|Ceftriaxone|ceftriaxone|mesh-list
110019847|NCT00000648|Penicillins|penicillins|mesh-list
110019848|NCT00000648|Penicillin G|penicillin g|mesh-list
110019849|NCT00000648|Penicillin G Benzathine|penicillin g benzathine|mesh-list
110019850|NCT00000648|Penicillin G Procaine|penicillin g procaine|mesh-list
110019851|NCT00000648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110019852|NCT00000648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110019853|NCT00000654|Fialuridine|fialuridine|mesh-list
110019854|NCT00000654|Antiviral Agents|antiviral agents|mesh-ancestor
110019855|NCT00000654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110019856|NCT00000654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110019857|NCT00000654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110019858|NCT00000654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110019860|NCT00000660|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110019861|NCT00000660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110019862|NCT00000660|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110019863|NCT00000660|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110019864|NCT00000660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110019865|NCT00000660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110019867|NCT00000702|Antimetabolites|antimetabolites|mesh-ancestor
110019868|NCT00000702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110019869|NCT00000702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110019870|NCT00000702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110019871|NCT00000702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110019872|NCT00000702|Antiviral Agents|antiviral agents|mesh-ancestor
110019873|NCT00000702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110019874|NCT00000702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110019875|NCT00000702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110019877|NCT00000714|Trimetrexate|trimetrexate|mesh-list
110019878|NCT00000714|Calcium|calcium|mesh-list
110019879|NCT00000714|Levoleucovorin|levoleucovorin|mesh-list
110019880|NCT00000714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110019881|NCT00000714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110019882|NCT00000714|Antidotes|antidotes|mesh-ancestor
110019883|NCT00000714|Protective Agents|protective agents|mesh-ancestor
110019884|NCT00000714|Vitamin B Complex|vitamin b complex|mesh-ancestor
110019885|NCT00000714|Vitamins|vitamins|mesh-ancestor
110019886|NCT00000714|Micronutrients|micronutrients|mesh-ancestor
110019888|NCT00000714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110019889|NCT00000714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110019890|NCT00000714|Antimetabolites|antimetabolites|mesh-ancestor
110019891|NCT00000714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110019892|NCT00000714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110019893|NCT00000714|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110019894|NCT00000714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110019895|NCT00000732|Zidovudine|zidovudine|mesh-list
110019896|NCT00000732|Trimethoprim|trimethoprim|mesh-list
110019897|NCT00000732|Sulfamethoxazole|sulfamethoxazole|mesh-list
110019898|NCT00000732|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110019899|NCT00000732|Antimetabolites|antimetabolites|mesh-ancestor
110019900|NCT00000732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110019901|NCT00000732|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110019902|NCT00000732|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110019903|NCT00000732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110019904|NCT00000732|Antiviral Agents|antiviral agents|mesh-ancestor
110019905|NCT00000732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110019906|NCT00000732|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110019907|NCT00000732|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110019908|NCT00000732|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110019909|NCT00000732|Antimalarials|antimalarials|mesh-ancestor
110019910|NCT00000732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110019911|NCT00000732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110019912|NCT00000732|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110019913|NCT00000732|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110019914|NCT00000732|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110019915|NCT00000732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110019916|NCT00000732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110019917|NCT00000738|Zidovudine|zidovudine|mesh-list
110019918|NCT00000738|Nimodipine|nimodipine|mesh-list
110019919|NCT00000738|Antimetabolites|antimetabolites|mesh-ancestor
110019920|NCT00000738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110019921|NCT00000738|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110019922|NCT00000738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110019923|NCT00000738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110019924|NCT00000738|Antiviral Agents|antiviral agents|mesh-ancestor
110019925|NCT00000738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110019926|NCT00000738|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110019927|NCT00000738|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110019928|NCT00000738|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110019929|NCT00000738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110019930|NCT00000738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110019931|NCT00000738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110019932|NCT00000738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110019933|NCT00000738|Vasodilator Agents|vasodilator agents|mesh-ancestor
110019934|NCT00000750|Zidovudine|zidovudine|mesh-list
110019935|NCT00000750|Antimetabolites|antimetabolites|mesh-ancestor
110019936|NCT00000750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110019937|NCT00000750|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110019938|NCT00000750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110019939|NCT00000750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110019941|NCT00000750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110019942|NCT00000750|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110019943|NCT00000750|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110019945|NCT00000804|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110019946|NCT00000804|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110019947|NCT00000804|Protease Inhibitors|protease inhibitors|mesh-ancestor
110019948|NCT00000804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110019949|NCT00000804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110019950|NCT00000804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110019951|NCT00000804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110019952|NCT00000804|Antiviral Agents|antiviral agents|mesh-ancestor
110019953|NCT00000804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110019959|NCT00000810|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110019960|NCT00000810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110019961|NCT00000810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110019962|NCT00000810|Antiviral Agents|antiviral agents|mesh-ancestor
110019963|NCT00000810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110019964|NCT00000810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110019965|NCT00000810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110019966|NCT00000834|Lamivudine|lamivudine|mesh-list
110019967|NCT00000834|Zidovudine|zidovudine|mesh-list
110019968|NCT00000834|Methotrexate|methotrexate|mesh-list
110019969|NCT00000834|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110019970|NCT00000834|Abortifacient Agents|abortifacient agents|mesh-ancestor
110019971|NCT00000834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110019972|NCT00000834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110019973|NCT00000834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110019974|NCT00000834|Antimetabolites|antimetabolites|mesh-ancestor
110019975|NCT00000834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110019976|NCT00000834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110019977|NCT00000834|Dermatologic Agents|dermatologic agents|mesh-ancestor
110019978|NCT00000834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110019979|NCT00000834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110019980|NCT00000834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110019981|NCT00000834|Immunologic Factors|immunologic factors|mesh-ancestor
110019982|NCT00000834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110019983|NCT00000834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110019984|NCT00000834|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110019985|NCT00000834|Antiviral Agents|antiviral agents|mesh-ancestor
110019986|NCT00000834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110019987|NCT00000834|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110019988|NCT00000834|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110019989|NCT00000864|Zidovudine|zidovudine|mesh-list
110019990|NCT00000864|Abacavir|abacavir|mesh-list
110019991|NCT00000864|Antimetabolites|antimetabolites|mesh-ancestor
110019992|NCT00000864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110019993|NCT00000864|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110019994|NCT00000864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110019995|NCT00000864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110019996|NCT00000864|Antiviral Agents|antiviral agents|mesh-ancestor
110019997|NCT00000864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110019998|NCT00000864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110019999|NCT00000864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110020000|NCT00000876|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
110020001|NCT00000876|Immunologic Factors|immunologic factors|mesh-ancestor
110020002|NCT00000876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110020003|NCT00000894|Ganciclovir|ganciclovir|mesh-list
110020004|NCT00000894|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
110020005|NCT00000894|Cidofovir|cidofovir|mesh-list
110020006|NCT00000894|Probenecid|probenecid|mesh-list
110020007|NCT00000894|Antiviral Agents|antiviral agents|mesh-ancestor
110020008|NCT00000894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110020009|NCT00000894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110020010|NCT00000894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110020011|NCT00000894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020012|NCT00000894|Uricosuric Agents|uricosuric agents|mesh-ancestor
110020013|NCT00000894|Gout Suppressants|gout suppressants|mesh-ancestor
110020015|NCT00000912|Efavirenz|efavirenz|mesh-list
110020016|NCT00000912|Abacavir|abacavir|mesh-list
110020018|NCT00000912|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
110020019|NCT00000912|Nelfinavir|nelfinavir|mesh-list
110020020|NCT00000912|Indinavir|indinavir|mesh-list
110020021|NCT00000912|Saquinavir|saquinavir|mesh-list
110020022|NCT00000912|Amprenavir|amprenavir|mesh-list
110020023|NCT00000912|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110020024|NCT00000912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110020025|NCT00000912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110020026|NCT00000912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020027|NCT00000912|Antiviral Agents|antiviral agents|mesh-ancestor
110020028|NCT00000912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110020029|NCT00000912|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110020030|NCT00000912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110020031|NCT00000912|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110020032|NCT00000912|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110020033|NCT00000912|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110020034|NCT00000912|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110020035|NCT00000912|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110020036|NCT00000912|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110020037|NCT00000912|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110020038|NCT00000912|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110020039|NCT00000912|Protease Inhibitors|protease inhibitors|mesh-ancestor
110020040|NCT00000912|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110020041|NCT00000912|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110020042|NCT00000912|Antitubercular Agents|antitubercular agents|mesh-ancestor
110020043|NCT00000912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110020045|NCT00000918|Indinavir|indinavir|mesh-list
110020046|NCT00000918|Saquinavir|saquinavir|mesh-list
110020047|NCT00000918|Amprenavir|amprenavir|mesh-list
110020048|NCT00000918|Lamivudine|lamivudine|mesh-list
110020049|NCT00000918|Zidovudine|zidovudine|mesh-list
110020050|NCT00000918|Stavudine|stavudine|mesh-list
110020051|NCT00000918|Didanosine|didanosine|mesh-list
110020052|NCT00000918|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
110020054|NCT00000918|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110020055|NCT00000918|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110020056|NCT00000918|Protease Inhibitors|protease inhibitors|mesh-ancestor
110020057|NCT00000918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110020058|NCT00000918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020059|NCT00000918|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110020060|NCT00000918|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110020061|NCT00000918|Antiviral Agents|antiviral agents|mesh-ancestor
110020062|NCT00000918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110020063|NCT00000918|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110020064|NCT00000918|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110020065|NCT00000918|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110020066|NCT00000918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110020067|NCT00000918|Antimetabolites|antimetabolites|mesh-ancestor
110020068|NCT00000918|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110020069|NCT00000918|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110020070|NCT00000918|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110020071|NCT00000918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110020072|NCT00000918|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110020073|NCT00000918|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110020074|NCT00000918|Antitubercular Agents|antitubercular agents|mesh-ancestor
110020075|NCT00000918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110020076|NCT00000924|Ritonavir|ritonavir|mesh-list
110020077|NCT00000924|Nelfinavir|nelfinavir|mesh-list
110020078|NCT00000924|Nevirapine|nevirapine|mesh-list
110020079|NCT00000924|Stavudine|stavudine|mesh-list
110020080|NCT00000924|Didanosine|didanosine|mesh-list
110020081|NCT00000924|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110020082|NCT00000924|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110020083|NCT00000924|Protease Inhibitors|protease inhibitors|mesh-ancestor
110020084|NCT00000924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110020085|NCT00000924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020086|NCT00000924|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110020087|NCT00000924|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110020088|NCT00000924|Antiviral Agents|antiviral agents|mesh-ancestor
110020089|NCT00000924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110020090|NCT00000924|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110020091|NCT00000924|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110020092|NCT00000924|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110020093|NCT00000924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110020094|NCT00000924|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110020095|NCT00000924|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110020097|NCT00000936|Cyclosporine|cyclosporine|mesh-list
110020098|NCT00000936|Cyclosporins|cyclosporins|mesh-list
110020099|NCT00000936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110020100|NCT00000936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020101|NCT00000936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110020102|NCT00000936|Immunologic Factors|immunologic factors|mesh-ancestor
110020103|NCT00000936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110020104|NCT00000936|Antifungal Agents|antifungal agents|mesh-ancestor
110020105|NCT00000936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110020106|NCT00000936|Dermatologic Agents|dermatologic agents|mesh-ancestor
110020107|NCT00000936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110020108|NCT00000936|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110020110|NCT00000942|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110020111|NCT00000942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110020112|NCT00000942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110020113|NCT00000942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020114|NCT00000942|Antiviral Agents|antiviral agents|mesh-ancestor
110020115|NCT00000942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110020116|NCT00000942|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110020117|NCT00000942|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110020119|NCT00000942|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110020120|NCT00000948|Aldesleukin|aldesleukin|mesh-list
110020121|NCT00000948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110020122|NCT00000948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110020123|NCT00000948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110020124|NCT00000948|Antiviral Agents|antiviral agents|mesh-ancestor
110020125|NCT00000948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110020126|NCT00000954|Didanosine|didanosine|mesh-list
110020127|NCT00000954|Zalcitabine|zalcitabine|mesh-list
110020128|NCT00000954|Doxorubicin|doxorubicin|mesh-list
110020129|NCT00000954|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110020130|NCT00000954|Bleomycin|bleomycin|mesh-list
110020131|NCT00000954|Vincristine|vincristine|mesh-list
110020132|NCT00000954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110020133|NCT00000954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110020134|NCT00000954|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110020135|NCT00000954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110020136|NCT00000954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110020137|NCT00000954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020138|NCT00000954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110020139|NCT00000954|Tubulin Modulators|tubulin modulators|mesh-ancestor
110020140|NCT00000954|Antimitotic Agents|antimitotic agents|mesh-ancestor
110020141|NCT00000954|Mitosis Modulators|mitosis modulators|mesh-ancestor
110020142|NCT00000954|Antimetabolites|antimetabolites|mesh-ancestor
110020143|NCT00000954|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110020144|NCT00000954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110020145|NCT00000954|Antiviral Agents|antiviral agents|mesh-ancestor
110020146|NCT00000954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110020147|NCT00000954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110020148|NCT00000954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110020149|NCT00000960|Zidovudine|zidovudine|mesh-list
110020150|NCT00000960|Antimetabolites|antimetabolites|mesh-ancestor
110020151|NCT00000960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020152|NCT00000960|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110020153|NCT00000960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110020154|NCT00000960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110020155|NCT00000960|Antiviral Agents|antiviral agents|mesh-ancestor
110020156|NCT00000960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110020157|NCT00000960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110020158|NCT00000960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110020159|NCT00000990|Zidovudine|zidovudine|mesh-list
110020160|NCT00000990|Antimetabolites|antimetabolites|mesh-ancestor
110020161|NCT00000990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020162|NCT00000990|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110020163|NCT00000990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110020165|NCT00000990|Antiviral Agents|antiviral agents|mesh-ancestor
110020166|NCT00000990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110020167|NCT00000990|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110020168|NCT00000990|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110020170|NCT00000996|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110020171|NCT00000996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110020172|NCT00000996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110020173|NCT00000996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110020174|NCT00000996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110020175|NCT00000996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110020176|NCT00000996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020177|NCT00001044|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110020178|NCT00001044|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110020179|NCT00001044|Immunologic Factors|immunologic factors|mesh-ancestor
110020180|NCT00001044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110020181|NCT00001044|Antacids|antacids|mesh-ancestor
110020182|NCT00001044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020183|NCT00001044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110020184|NCT00001062|Ganciclovir|ganciclovir|mesh-list
110020185|NCT00001062|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
110020186|NCT00001062|Antiviral Agents|antiviral agents|mesh-ancestor
110020187|NCT00001062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110020188|NCT00001062|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110020189|NCT00001062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110020190|NCT00001062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020191|NCT00001068|Lamivudine|lamivudine|mesh-list
110020192|NCT00001068|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110020193|NCT00001068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110020194|NCT00001068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110020501|NCT00002046|Antiviral Agents|antiviral agents|mesh-ancestor
110020195|NCT00001068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020196|NCT00001068|Antiviral Agents|antiviral agents|mesh-ancestor
110020197|NCT00001068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110020198|NCT00001068|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110020199|NCT00001068|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110020200|NCT00001080|Lamivudine|lamivudine|mesh-list
110020201|NCT00001080|Vaccines|vaccines|mesh-list
110020202|NCT00001080|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110020203|NCT00001080|Immunologic Factors|immunologic factors|mesh-ancestor
110020204|NCT00001080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110020205|NCT00001080|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110020206|NCT00001080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110020207|NCT00001080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110020208|NCT00001080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020209|NCT00001080|Antiviral Agents|antiviral agents|mesh-ancestor
110020210|NCT00001080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110020211|NCT00001080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110020212|NCT00001080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110020213|NCT00001104|Zidovudine|zidovudine|mesh-list
110020214|NCT00001104|Antimetabolites|antimetabolites|mesh-ancestor
110020215|NCT00001104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020216|NCT00001104|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110020217|NCT00001104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110020218|NCT00001104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110020219|NCT00001104|Antiviral Agents|antiviral agents|mesh-ancestor
110020220|NCT00001104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110020221|NCT00001104|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110020222|NCT00001104|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110020223|NCT00001110|Dimercaprol|dimercaprol|mesh-list
110020224|NCT00001110|Chelating Agents|chelating agents|mesh-ancestor
110020225|NCT00001110|Sequestering Agents|sequestering agents|mesh-ancestor
110020226|NCT00001110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020227|NCT00001122|Efavirenz|efavirenz|mesh-list
110020228|NCT00001122|Stavudine|stavudine|mesh-list
110020229|NCT00001122|Didanosine|didanosine|mesh-list
110020230|NCT00001122|Nelfinavir|nelfinavir|mesh-list
110020231|NCT00001122|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110020232|NCT00001122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110020233|NCT00001122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110020234|NCT00001122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020235|NCT00001122|Antiviral Agents|antiviral agents|mesh-ancestor
110020236|NCT00001122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110020237|NCT00001122|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110020238|NCT00001122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110020239|NCT00001122|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110020240|NCT00001122|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110020241|NCT00001122|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110020242|NCT00001122|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110020243|NCT00001122|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110020244|NCT00001122|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110020245|NCT00001122|Protease Inhibitors|protease inhibitors|mesh-ancestor
110020246|NCT00001122|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110020247|NCT00001122|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110020248|NCT00001122|Antimetabolites|antimetabolites|mesh-ancestor
110020249|NCT00001128|Azithromycin|azithromycin|mesh-list
110020251|NCT00001128|Interleukin-12|interleukin-12|mesh-list
110020252|NCT00001128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110020253|NCT00001128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110020254|NCT00001128|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110020255|NCT00001128|Immunologic Factors|immunologic factors|mesh-ancestor
110020256|NCT00001128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110020257|NCT00001128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110020258|NCT00001128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110020259|NCT00001128|Growth Substances|growth substances|mesh-ancestor
110020260|NCT00001128|Growth Inhibitors|growth inhibitors|mesh-ancestor
110020261|NCT00001128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110020262|NCT00001128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110020263|NCT00001128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110020265|NCT00001296|Interferon-gamma|interferon-gamma|mesh-list
110020267|NCT00001296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110020268|NCT00001296|Antiviral Agents|antiviral agents|mesh-ancestor
110020269|NCT00001296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110020270|NCT00001296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110020271|NCT00001296|Alkylating Agents|alkylating agents|mesh-ancestor
110020272|NCT00001296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020273|NCT00001296|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110020274|NCT00001296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110020275|NCT00001296|Immunologic Factors|immunologic factors|mesh-ancestor
110020276|NCT00001296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110020277|NCT00001422|Fludarabine|fludarabine|mesh-list
110020278|NCT00001422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110020279|NCT00001428|Fluorouracil|fluorouracil|mesh-list
110020280|NCT00001428|Antimetabolites|antimetabolites|mesh-ancestor
110020281|NCT00001428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020282|NCT00001428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110020283|NCT00001428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110020284|NCT00001428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110020285|NCT00001428|Immunologic Factors|immunologic factors|mesh-ancestor
110020286|NCT00001428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110020287|NCT00001440|Interleukin-2|interleukin-2|mesh-list
110020288|NCT00001440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110020289|NCT00001440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110020290|NCT00001440|Analgesics|analgesics|mesh-ancestor
110020291|NCT00001440|Sensory System Agents|sensory system agents|mesh-ancestor
110020292|NCT00001440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110020293|NCT00001440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110020294|NCT00001446|Thalidomide|thalidomide|mesh-list
110020295|NCT00001446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110020296|NCT00001446|Immunologic Factors|immunologic factors|mesh-ancestor
110020297|NCT00001446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110020298|NCT00001446|Leprostatic Agents|leprostatic agents|mesh-ancestor
110020299|NCT00001446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110020300|NCT00001446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110020301|NCT00001446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110020302|NCT00001446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110020303|NCT00001446|Growth Substances|growth substances|mesh-ancestor
110020304|NCT00001446|Growth Inhibitors|growth inhibitors|mesh-ancestor
110020305|NCT00001446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110020306|NCT00001572|Saponin QA-21V1|saponin qa-21v1|mesh-list
110020307|NCT00001572|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110020308|NCT00001572|Immunologic Factors|immunologic factors|mesh-ancestor
110020309|NCT00001572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110020311|NCT00001626|Cyclophosphamide|cyclophosphamide|mesh-list
110020312|NCT00001626|Cyclosporins|cyclosporins|mesh-list
110020314|NCT00001626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110020315|NCT00001626|Immunologic Factors|immunologic factors|mesh-ancestor
110020316|NCT00001626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110020317|NCT00001626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110020318|NCT00001626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110020319|NCT00001626|Alkylating Agents|alkylating agents|mesh-ancestor
110020320|NCT00001626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020321|NCT00001626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110020322|NCT00001626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110020323|NCT00001626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110020324|NCT00001626|Antifungal Agents|antifungal agents|mesh-ancestor
110020325|NCT00001626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110020326|NCT00001626|Dermatologic Agents|dermatologic agents|mesh-ancestor
110020327|NCT00001626|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110020329|NCT00001680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110020330|NCT00001680|Immunologic Factors|immunologic factors|mesh-ancestor
110020331|NCT00001680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110020332|NCT00001680|Leprostatic Agents|leprostatic agents|mesh-ancestor
110020333|NCT00001680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110020334|NCT00001680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110020335|NCT00001680|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110020336|NCT00001680|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110020337|NCT00001680|Growth Substances|growth substances|mesh-ancestor
110020338|NCT00001680|Growth Inhibitors|growth inhibitors|mesh-ancestor
110020339|NCT00001680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110020340|NCT00001698|Ketorolac|ketorolac|mesh-list
110020341|NCT00001698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110020342|NCT00001698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110020343|NCT00001698|Analgesics|analgesics|mesh-ancestor
110020344|NCT00001698|Sensory System Agents|sensory system agents|mesh-ancestor
110020345|NCT00001698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110020346|NCT00001698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110020347|NCT00001698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110020348|NCT00001698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110020349|NCT00001698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110020350|NCT00001698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110020503|NCT00002046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110020351|NCT00001698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020353|NCT00001716|Nitroglycerin|nitroglycerin|mesh-list
110020354|NCT00001716|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110020355|NCT00001716|Autonomic Agents|autonomic agents|mesh-ancestor
110020356|NCT00001716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110020357|NCT00001716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110020358|NCT00001716|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110020359|NCT00001716|Respiratory System Agents|respiratory system agents|mesh-ancestor
110020360|NCT00001716|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110020361|NCT00001716|Antioxidants|antioxidants|mesh-ancestor
110020362|NCT00001716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020363|NCT00001716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110020364|NCT00001716|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110020365|NCT00001716|Vasodilator Agents|vasodilator agents|mesh-ancestor
110020366|NCT00001716|Gasotransmitters|gasotransmitters|mesh-ancestor
110020367|NCT00001716|Protective Agents|protective agents|mesh-ancestor
110020368|NCT00001812|Nystatin|nystatin|mesh-list
110020369|NCT00001812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110020370|NCT00001812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110020371|NCT00001812|Antifungal Agents|antifungal agents|mesh-ancestor
110020372|NCT00001812|Ionophores|ionophores|mesh-ancestor
110020373|NCT00001812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110020374|NCT00001812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020375|NCT00001842|Dexamethasone|dexamethasone|mesh-list
110020376|NCT00001842|Lenograstim|lenograstim|mesh-list
110020377|NCT00001842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110020378|NCT00001842|Antiemetics|antiemetics|mesh-ancestor
110020379|NCT00001842|Autonomic Agents|autonomic agents|mesh-ancestor
110020380|NCT00001842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110020381|NCT00001842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110020382|NCT00001842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110020383|NCT00001842|Glucocorticoids|glucocorticoids|mesh-ancestor
110020384|NCT00001842|Hormones|hormones|mesh-ancestor
110020385|NCT00001842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110020386|NCT00001842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110020387|NCT00001842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110020388|NCT00001842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110020389|NCT00001842|Immunologic Factors|immunologic factors|mesh-ancestor
110020390|NCT00001848|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
110020391|NCT00001848|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110020392|NCT00001848|Hormone Antagonists|hormone antagonists|mesh-ancestor
110020393|NCT00001848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110020394|NCT00001848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110020395|NCT00001848|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110020396|NCT00001848|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110020397|NCT00001848|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110020398|NCT00001854|Ribavirin|ribavirin|mesh-list
110020399|NCT00001854|Antimetabolites|antimetabolites|mesh-ancestor
110020400|NCT00001854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020401|NCT00001854|Antiviral Agents|antiviral agents|mesh-ancestor
110020402|NCT00001854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110020403|NCT00001860|Octreotide|octreotide|mesh-list
110020404|NCT00001860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110020405|NCT00001860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110020406|NCT00001860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110020407|NCT00001890|Estrogens|estrogens|mesh-list
110020408|NCT00001890|Hormones|hormones|mesh-ancestor
110020409|NCT00001890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110020410|NCT00001890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110020411|NCT00001944|Vinorelbine|vinorelbine|mesh-list
110020412|NCT00001944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110020413|NCT00001944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110020414|NCT00001944|Tubulin Modulators|tubulin modulators|mesh-ancestor
110020415|NCT00001944|Antimitotic Agents|antimitotic agents|mesh-ancestor
110020416|NCT00001944|Mitosis Modulators|mitosis modulators|mesh-ancestor
110020417|NCT00001944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020418|NCT00001968|Ritonavir|ritonavir|mesh-list
110020419|NCT00001968|Amprenavir|amprenavir|mesh-list
110020420|NCT00001968|Lamivudine|lamivudine|mesh-list
110020421|NCT00001968|Abacavir|abacavir|mesh-list
110020422|NCT00001968|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110020423|NCT00001968|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110020424|NCT00001968|Protease Inhibitors|protease inhibitors|mesh-ancestor
110020425|NCT00001968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110020502|NCT00002046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110020426|NCT00001968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020427|NCT00001968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110020428|NCT00001968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110020429|NCT00001968|Antiviral Agents|antiviral agents|mesh-ancestor
110020431|NCT00001968|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110020432|NCT00001968|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110020433|NCT00001968|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110020434|NCT00001968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110020435|NCT00001968|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110020436|NCT00001968|Antitubercular Agents|antitubercular agents|mesh-ancestor
110020437|NCT00001968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110020439|NCT00001998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110020440|NCT00001998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110020441|NCT00001998|Antifungal Agents|antifungal agents|mesh-ancestor
110020442|NCT00001998|Ionophores|ionophores|mesh-ancestor
110020443|NCT00001998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110020444|NCT00001998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020445|NCT00002010|Fluconazole|fluconazole|mesh-list
110020446|NCT00002010|Antifungal Agents|antifungal agents|mesh-ancestor
110020447|NCT00002010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110020448|NCT00002010|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110020449|NCT00002010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110020450|NCT00002010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110020451|NCT00002010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020452|NCT00002010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110020453|NCT00002010|Hormone Antagonists|hormone antagonists|mesh-ancestor
110020454|NCT00002010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110020455|NCT00002010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110020456|NCT00002010|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110020457|NCT00002010|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110020461|NCT00002028|Antimetabolites|antimetabolites|mesh-ancestor
110020462|NCT00002028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020463|NCT00002028|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110020464|NCT00002028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110020465|NCT00002028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110020466|NCT00002028|Antiviral Agents|antiviral agents|mesh-ancestor
110020467|NCT00002028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110020468|NCT00002028|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110020469|NCT00002028|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110020470|NCT00002034|Zidovudine|zidovudine|mesh-list
110020471|NCT00002034|Ganciclovir|ganciclovir|mesh-list
110020472|NCT00002034|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
110020473|NCT00002034|Antimetabolites|antimetabolites|mesh-ancestor
110020474|NCT00002034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020475|NCT00002034|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110020476|NCT00002034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110020477|NCT00002034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110020478|NCT00002034|Antiviral Agents|antiviral agents|mesh-ancestor
110020479|NCT00002034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110020480|NCT00002034|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110020481|NCT00002034|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110020483|NCT00002040|Antifungal Agents|antifungal agents|mesh-ancestor
110020484|NCT00002040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110020485|NCT00002040|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110020486|NCT00002040|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110020487|NCT00002040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110020488|NCT00002040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020489|NCT00002040|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110020490|NCT00002040|Hormone Antagonists|hormone antagonists|mesh-ancestor
110020491|NCT00002040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110020492|NCT00002040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110020493|NCT00002040|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110020494|NCT00002040|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110020495|NCT00002046|Zidovudine|zidovudine|mesh-list
110020496|NCT00002046|Antimetabolites|antimetabolites|mesh-ancestor
110020497|NCT00002046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020498|NCT00002046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110020499|NCT00002046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110020500|NCT00002046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110020504|NCT00002046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110020505|NCT00002052|Amoxicillin|amoxicillin|mesh-list
110020506|NCT00002052|Ceftriaxone|ceftriaxone|mesh-list
110020507|NCT00002052|Ampicillin|ampicillin|mesh-list
110020508|NCT00002052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110020509|NCT00002052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110020510|NCT00002058|Clofazimine|clofazimine|mesh-list
110020511|NCT00002058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110020512|NCT00002058|Leprostatic Agents|leprostatic agents|mesh-ancestor
110020513|NCT00002058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110020514|NCT00002058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110020516|NCT00002064|Clindamycin palmitate|clindamycin palmitate|mesh-list
110020517|NCT00002064|Clindamycin phosphate|clindamycin phosphate|mesh-list
110020518|NCT00002064|Pyrimethamine|pyrimethamine|mesh-list
110020519|NCT00002064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110020520|NCT00002064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110020521|NCT00002064|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110020522|NCT00002064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110020523|NCT00002064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020524|NCT00002064|Antimalarials|antimalarials|mesh-ancestor
110020525|NCT00002064|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110020526|NCT00002064|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110020527|NCT00002064|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110020528|NCT00002070|Ganciclovir|ganciclovir|mesh-list
110020529|NCT00002070|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
110020530|NCT00002070|Sargramostim|sargramostim|mesh-list
110020531|NCT00002070|Immunologic Factors|immunologic factors|mesh-ancestor
110020532|NCT00002070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110020533|NCT00002070|Antiviral Agents|antiviral agents|mesh-ancestor
110020534|NCT00002070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110020535|NCT00002070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110020536|NCT00002070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110020537|NCT00002070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020538|NCT00002076|Fluconazole|fluconazole|mesh-list
110020539|NCT00002076|Antifungal Agents|antifungal agents|mesh-ancestor
110020540|NCT00002076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110020541|NCT00002076|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110020542|NCT00002076|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110020543|NCT00002076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110020544|NCT00002076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020545|NCT00002076|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110020546|NCT00002076|Hormone Antagonists|hormone antagonists|mesh-ancestor
110020547|NCT00002076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110020548|NCT00002076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110020549|NCT00002076|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110020550|NCT00002076|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110020551|NCT00002082|Azithromycin|azithromycin|mesh-list
110020552|NCT00002082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110020553|NCT00002082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110020554|NCT00002094|Atevirdine|atevirdine|mesh-list
110020555|NCT00002094|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110020556|NCT00002094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110020557|NCT00002094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110020558|NCT00002094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020559|NCT00002094|Antiviral Agents|antiviral agents|mesh-ancestor
110020560|NCT00002094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110020561|NCT00002100|Curdlan sulfate|curdlan sulfate|mesh-list
110020562|NCT00002100|Antimalarials|antimalarials|mesh-ancestor
110020563|NCT00002100|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110020564|NCT00002100|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110020565|NCT00002100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110020567|NCT00002106|Ranitidine|ranitidine|mesh-list
110020568|NCT00002106|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
110020569|NCT00002106|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110020570|NCT00002106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110020571|NCT00002106|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110020572|NCT00002106|Histamine Antagonists|histamine antagonists|mesh-ancestor
110020573|NCT00002106|Histamine Agents|histamine agents|mesh-ancestor
110020574|NCT00002106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110020575|NCT00002106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020576|NCT00002106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110020577|NCT00002112|Fluconazole|fluconazole|mesh-list
110020578|NCT00002112|Nystatin|nystatin|mesh-list
110020579|NCT00002112|Antifungal Agents|antifungal agents|mesh-ancestor
110020580|NCT00002112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110020659|NCT00002160|Ziconotide|ziconotide|mesh-list
110020581|NCT00002112|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110020582|NCT00002112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110020583|NCT00002112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110020584|NCT00002112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020585|NCT00002112|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110020586|NCT00002112|Hormone Antagonists|hormone antagonists|mesh-ancestor
110020587|NCT00002112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110020588|NCT00002112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110020589|NCT00002112|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110020590|NCT00002112|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110020591|NCT00002112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110020593|NCT00002112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110020594|NCT00002118|Zalcitabine|zalcitabine|mesh-list
110020595|NCT00002118|Antimetabolites|antimetabolites|mesh-ancestor
110020596|NCT00002118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020597|NCT00002118|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110020598|NCT00002118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110020599|NCT00002118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110020600|NCT00002118|Antiviral Agents|antiviral agents|mesh-ancestor
110020601|NCT00002118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110020602|NCT00002118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110020604|NCT00002124|Lamivudine|lamivudine|mesh-list
110020605|NCT00002124|Zidovudine|zidovudine|mesh-list
110020606|NCT00002124|Delavirdine|delavirdine|mesh-list
110020607|NCT00002124|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110020608|NCT00002124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110020609|NCT00002124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110020610|NCT00002124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020611|NCT00002124|Antiviral Agents|antiviral agents|mesh-ancestor
110020612|NCT00002124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110020613|NCT00002124|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110020614|NCT00002124|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110020615|NCT00002124|Antimetabolites|antimetabolites|mesh-ancestor
110020616|NCT00002130|Vesnarinone|vesnarinone|mesh-list
110020617|NCT00002130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110020618|NCT00002130|Immunologic Factors|immunologic factors|mesh-ancestor
110020619|NCT00002130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110020620|NCT00002130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110020621|NCT00002130|Antiviral Agents|antiviral agents|mesh-ancestor
110020622|NCT00002130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110020623|NCT00002130|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110020624|NCT00002130|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110020625|NCT00002130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110020626|NCT00002130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020627|NCT00002130|Protective Agents|protective agents|mesh-ancestor
110020628|NCT00002142|Cidofovir|cidofovir|mesh-list
110020629|NCT00002142|Probenecid|probenecid|mesh-list
110020630|NCT00002142|Uricosuric Agents|uricosuric agents|mesh-ancestor
110020631|NCT00002142|Gout Suppressants|gout suppressants|mesh-ancestor
110020632|NCT00002142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110020633|NCT00002142|Antiviral Agents|antiviral agents|mesh-ancestor
110020634|NCT00002142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110020635|NCT00002142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110020636|NCT00002142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020638|NCT00002148|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110020639|NCT00002148|Antioxidants|antioxidants|mesh-ancestor
110020640|NCT00002148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020641|NCT00002148|Protective Agents|protective agents|mesh-ancestor
110020642|NCT00002148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110020643|NCT00002154|Thioctic Acid|thioctic acid|mesh-list
110020644|NCT00002154|Selegiline|selegiline|mesh-list
110020645|NCT00002154|Antidepressive Agents|antidepressive agents|mesh-ancestor
110020646|NCT00002154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110020647|NCT00002154|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110020648|NCT00002154|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110020649|NCT00002154|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110020650|NCT00002154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110020651|NCT00002154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020652|NCT00002154|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110020653|NCT00002154|Protective Agents|protective agents|mesh-ancestor
110020654|NCT00002154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110020655|NCT00002154|Antioxidants|antioxidants|mesh-ancestor
110020656|NCT00002154|Vitamin B Complex|vitamin b complex|mesh-ancestor
110020657|NCT00002154|Vitamins|vitamins|mesh-ancestor
110020658|NCT00002154|Micronutrients|micronutrients|mesh-ancestor
110020661|NCT00002160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110020662|NCT00002160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020663|NCT00002160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110020664|NCT00002160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110020665|NCT00002160|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110020666|NCT00002160|Protective Agents|protective agents|mesh-ancestor
110020667|NCT00002160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110020668|NCT00002160|Analgesics|analgesics|mesh-ancestor
110020669|NCT00002160|Sensory System Agents|sensory system agents|mesh-ancestor
110020670|NCT00002160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110020671|NCT00002166|Nevirapine|nevirapine|mesh-list
110020672|NCT00002166|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110020673|NCT00002166|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110020674|NCT00002166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110020675|NCT00002166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020676|NCT00002166|Antiviral Agents|antiviral agents|mesh-ancestor
110020677|NCT00002166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110020678|NCT00002166|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110020679|NCT00002166|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110020680|NCT00002166|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110020681|NCT00002166|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110020682|NCT00002178|Ritonavir|ritonavir|mesh-list
110020683|NCT00002178|Nelfinavir|nelfinavir|mesh-list
110020684|NCT00002178|Saquinavir|saquinavir|mesh-list
110020685|NCT00002178|Delavirdine|delavirdine|mesh-list
110020686|NCT00002178|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110020687|NCT00002178|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110020688|NCT00002178|Protease Inhibitors|protease inhibitors|mesh-ancestor
110020689|NCT00002178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110020690|NCT00002178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020691|NCT00002178|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110020692|NCT00002178|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110020693|NCT00002178|Antiviral Agents|antiviral agents|mesh-ancestor
110020694|NCT00002178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110020695|NCT00002178|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110020696|NCT00002178|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110020697|NCT00002178|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110020698|NCT00002178|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110020699|NCT00002184|Lamivudine|lamivudine|mesh-list
110020700|NCT00002184|Zidovudine|zidovudine|mesh-list
110020701|NCT00002184|Stavudine|stavudine|mesh-list
110020702|NCT00002184|Adefovir|adefovir|mesh-list
110020703|NCT00002184|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
110020704|NCT00002184|Nelfinavir|nelfinavir|mesh-list
110020705|NCT00002184|Saquinavir|saquinavir|mesh-list
110020706|NCT00002184|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110020707|NCT00002184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110020708|NCT00002184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110020709|NCT00002184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020710|NCT00002184|Antiviral Agents|antiviral agents|mesh-ancestor
110020711|NCT00002184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110020712|NCT00002184|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110020713|NCT00002184|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110020714|NCT00002184|Antimetabolites|antimetabolites|mesh-ancestor
110020715|NCT00002184|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110020716|NCT00002184|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110020717|NCT00002184|Protease Inhibitors|protease inhibitors|mesh-ancestor
110020718|NCT00002184|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110020719|NCT00002184|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110020720|NCT00002190|Lamivudine|lamivudine|mesh-list
110020721|NCT00002190|Zidovudine|zidovudine|mesh-list
110020722|NCT00002190|Saquinavir|saquinavir|mesh-list
110020723|NCT00002190|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110020724|NCT00002190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110020725|NCT00002190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110020726|NCT00002190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020727|NCT00002190|Antiviral Agents|antiviral agents|mesh-ancestor
110020728|NCT00002190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110020729|NCT00002190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110020730|NCT00002190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110020731|NCT00002190|Antimetabolites|antimetabolites|mesh-ancestor
110020732|NCT00002190|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110020733|NCT00002190|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110020734|NCT00002190|Protease Inhibitors|protease inhibitors|mesh-ancestor
110020736|NCT00002190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110020738|NCT00002202|Amprenavir|amprenavir|mesh-list
110020739|NCT00002202|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110020740|NCT00002202|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110020741|NCT00002202|Protease Inhibitors|protease inhibitors|mesh-ancestor
110020742|NCT00002202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110020743|NCT00002202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020745|NCT00002202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110020746|NCT00002202|Antiviral Agents|antiviral agents|mesh-ancestor
110020747|NCT00002202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110020748|NCT00002202|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110020749|NCT00002202|Antitubercular Agents|antitubercular agents|mesh-ancestor
110020750|NCT00002202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110020751|NCT00002208|Lamivudine|lamivudine|mesh-list
110020752|NCT00002208|Zidovudine|zidovudine|mesh-list
110020753|NCT00002208|Stavudine|stavudine|mesh-list
110020754|NCT00002208|Indinavir|indinavir|mesh-list
110020755|NCT00002208|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110020756|NCT00002208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110020757|NCT00002208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110020758|NCT00002208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020759|NCT00002208|Antiviral Agents|antiviral agents|mesh-ancestor
110020760|NCT00002208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110020761|NCT00002208|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110020762|NCT00002208|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110020763|NCT00002208|Antimetabolites|antimetabolites|mesh-ancestor
110020764|NCT00002208|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110020765|NCT00002208|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110020766|NCT00002208|Protease Inhibitors|protease inhibitors|mesh-ancestor
110020767|NCT00002214|Capravirine|capravirine|mesh-list
110020768|NCT00002214|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110020769|NCT00002214|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110020770|NCT00002214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110020771|NCT00002214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020772|NCT00002214|Antiviral Agents|antiviral agents|mesh-ancestor
110020773|NCT00002214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110020774|NCT00002214|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110020775|NCT00002214|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110020776|NCT00002220|Efavirenz|efavirenz|mesh-list
110020777|NCT00002220|Adefovir|adefovir|mesh-list
110020778|NCT00002220|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
110020779|NCT00002220|Indinavir|indinavir|mesh-list
110020780|NCT00002220|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110020781|NCT00002220|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110020782|NCT00002220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110020783|NCT00002220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020784|NCT00002220|Antiviral Agents|antiviral agents|mesh-ancestor
110020785|NCT00002220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110020786|NCT00002220|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110020787|NCT00002220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110020788|NCT00002220|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110020789|NCT00002220|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110020790|NCT00002220|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110020791|NCT00002220|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110020792|NCT00002220|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110020793|NCT00002220|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110020794|NCT00002220|Protease Inhibitors|protease inhibitors|mesh-ancestor
110020795|NCT00002220|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110020797|NCT00002226|Semaxinib|semaxinib|mesh-list
110020798|NCT00002226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110020799|NCT00002226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110020800|NCT00002226|Growth Substances|growth substances|mesh-ancestor
110020801|NCT00002226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110020802|NCT00002226|Growth Inhibitors|growth inhibitors|mesh-ancestor
110020803|NCT00002226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110020804|NCT00002226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110020805|NCT00002226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110020806|NCT00002226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020807|NCT00002238|Interferons|interferons|mesh-list
110020808|NCT00002238|Zidovudine|zidovudine|mesh-list
110020809|NCT00002238|Interferon-beta|interferon-beta|mesh-list
110020810|NCT00002238|Interferon beta-1b|interferon beta-1b|mesh-list
110020814|NCT00002238|Antimetabolites|antimetabolites|mesh-ancestor
110020815|NCT00002238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020816|NCT00002238|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110020817|NCT00002238|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110020818|NCT00002238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110020819|NCT00002238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110020820|NCT00002238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110020821|NCT00002238|Immunologic Factors|immunologic factors|mesh-ancestor
110020822|NCT00002238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110020823|NCT00002238|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110020824|NCT00002250|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
110020825|NCT00002250|Immunologic Factors|immunologic factors|mesh-ancestor
110020826|NCT00002250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110020827|NCT00002256|Zalcitabine|zalcitabine|mesh-list
110020828|NCT00002256|Antimetabolites|antimetabolites|mesh-ancestor
110020829|NCT00002256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020830|NCT00002256|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110020831|NCT00002256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110020832|NCT00002256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110020833|NCT00002256|Antiviral Agents|antiviral agents|mesh-ancestor
110020834|NCT00002256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110020835|NCT00002256|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110020836|NCT00002256|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110020838|NCT00002274|Antimetabolites|antimetabolites|mesh-ancestor
110020839|NCT00002274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020840|NCT00002274|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110020841|NCT00002274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110020842|NCT00002274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110020844|NCT00002274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110020845|NCT00002274|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110020846|NCT00002274|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110020847|NCT00002280|Didanosine|didanosine|mesh-list
110020848|NCT00002280|Antimetabolites|antimetabolites|mesh-ancestor
110020849|NCT00002280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020850|NCT00002280|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110020851|NCT00002280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110020852|NCT00002280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110020853|NCT00002280|Antiviral Agents|antiviral agents|mesh-ancestor
110020854|NCT00002280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110020855|NCT00002280|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110020856|NCT00002280|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110020857|NCT00002286|Zidovudine|zidovudine|mesh-list
110020858|NCT00002286|Antimetabolites|antimetabolites|mesh-ancestor
110020859|NCT00002286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020860|NCT00002286|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110020861|NCT00002286|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110020863|NCT00002286|Antiviral Agents|antiviral agents|mesh-ancestor
110020864|NCT00002286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110020865|NCT00002286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110020866|NCT00002286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110020867|NCT00002292|Pentamidine|pentamidine|mesh-list
110020868|NCT00002292|Antifungal Agents|antifungal agents|mesh-ancestor
110020869|NCT00002292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110020870|NCT00002292|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110020871|NCT00002292|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110020872|NCT00002292|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110020873|NCT00002298|Ribavirin|ribavirin|mesh-list
110020874|NCT00002298|Antimetabolites|antimetabolites|mesh-ancestor
110020875|NCT00002298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020876|NCT00002298|Antiviral Agents|antiviral agents|mesh-ancestor
110020877|NCT00002298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110020878|NCT00002304|Fluconazole|fluconazole|mesh-list
110020879|NCT00002304|Ketoconazole|ketoconazole|mesh-list
110020880|NCT00002304|Antifungal Agents|antifungal agents|mesh-ancestor
110020881|NCT00002304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110020882|NCT00002304|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110020883|NCT00002304|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110020884|NCT00002304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110020885|NCT00002304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020887|NCT00002304|Hormone Antagonists|hormone antagonists|mesh-ancestor
110020888|NCT00002304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110020889|NCT00002304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110020890|NCT00002304|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110020891|NCT00002304|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110020892|NCT00002304|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110020893|NCT00002316|Amphotericin B|amphotericin b|mesh-list
110020894|NCT00002316|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110020895|NCT00002316|Amebicides|amebicides|mesh-ancestor
110020896|NCT00002316|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110020897|NCT00002316|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110020898|NCT00002316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110020899|NCT00002316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110020900|NCT00002316|Antifungal Agents|antifungal agents|mesh-ancestor
110020901|NCT00002322|Zidovudine|zidovudine|mesh-list
110020904|NCT00002322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020905|NCT00002322|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110020906|NCT00002322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110020907|NCT00002322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110020908|NCT00002322|Antiviral Agents|antiviral agents|mesh-ancestor
110020909|NCT00002322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110020910|NCT00002322|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110020911|NCT00002322|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110020912|NCT00002328|Azithromycin|azithromycin|mesh-list
110020913|NCT00002328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110020914|NCT00002328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110020915|NCT00002334|Zidovudine|zidovudine|mesh-list
110020916|NCT00002334|Zalcitabine|zalcitabine|mesh-list
110020917|NCT00002334|Saquinavir|saquinavir|mesh-list
110020919|NCT00002334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020920|NCT00002334|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110020921|NCT00002334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110020922|NCT00002334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110020923|NCT00002334|Antiviral Agents|antiviral agents|mesh-ancestor
110020924|NCT00002334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110020925|NCT00002334|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110020926|NCT00002334|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110020927|NCT00002334|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110020928|NCT00002334|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110020929|NCT00002334|Protease Inhibitors|protease inhibitors|mesh-ancestor
110020930|NCT00002334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110020931|NCT00002334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110020933|NCT00002340|Pentamidine|pentamidine|mesh-list
110020934|NCT00002340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110020935|NCT00002340|Antimalarials|antimalarials|mesh-ancestor
110020936|NCT00002340|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110020937|NCT00002340|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110020938|NCT00002340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110020939|NCT00002340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020940|NCT00002340|Antifungal Agents|antifungal agents|mesh-ancestor
110020941|NCT00002340|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110020942|NCT00002346|Adefovir|adefovir|mesh-list
110020943|NCT00002346|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
110020944|NCT00002346|Antiviral Agents|antiviral agents|mesh-ancestor
110020945|NCT00002346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110020946|NCT00002346|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110020947|NCT00002346|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110020948|NCT00002346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110020949|NCT00002346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020950|NCT00002352|Lobucavir|lobucavir|mesh-list
110020951|NCT00002352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110020952|NCT00002352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020953|NCT00002352|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110020954|NCT00002352|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110020955|NCT00002352|Antiviral Agents|antiviral agents|mesh-ancestor
110020956|NCT00002352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110020957|NCT00002352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110020958|NCT00002358|Sorivudine|sorivudine|mesh-list
110020959|NCT00002358|Antiviral Agents|antiviral agents|mesh-ancestor
110020960|NCT00002358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110020961|NCT00002358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110020962|NCT00002358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020963|NCT00002364|Abacavir|abacavir|mesh-list
110020965|NCT00002364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110020966|NCT00002364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110020967|NCT00002364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020968|NCT00002364|Antiviral Agents|antiviral agents|mesh-ancestor
110020969|NCT00002364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110020970|NCT00002364|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110020971|NCT00002364|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110020972|NCT00002370|Itraconazole|itraconazole|mesh-list
110020973|NCT00002370|Antifungal Agents|antifungal agents|mesh-ancestor
110020974|NCT00002370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110020975|NCT00002370|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110020976|NCT00002370|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110020977|NCT00002370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110020978|NCT00002370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020979|NCT00002370|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110020980|NCT00002370|Hormone Antagonists|hormone antagonists|mesh-ancestor
110020981|NCT00002370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110020982|NCT00002370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110020983|NCT00002370|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110020984|NCT00002376|Lamivudine|lamivudine|mesh-list
110020985|NCT00002376|Zidovudine|zidovudine|mesh-list
110020986|NCT00002376|Stavudine|stavudine|mesh-list
110020987|NCT00002376|Didanosine|didanosine|mesh-list
110020988|NCT00002376|Indinavir|indinavir|mesh-list
110020989|NCT00002376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110020990|NCT00002376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110020991|NCT00002376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110020992|NCT00002376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110020993|NCT00002376|Antiviral Agents|antiviral agents|mesh-ancestor
110020994|NCT00002376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110020995|NCT00002376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110020996|NCT00002376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110020997|NCT00002376|Antimetabolites|antimetabolites|mesh-ancestor
110020998|NCT00002376|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110020999|NCT00002376|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110021000|NCT00002376|Protease Inhibitors|protease inhibitors|mesh-ancestor
110021002|NCT00002382|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110021003|NCT00002382|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110021004|NCT00002382|Protease Inhibitors|protease inhibitors|mesh-ancestor
110021005|NCT00002382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110021006|NCT00002382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110021007|NCT00002382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110021008|NCT00002382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110021009|NCT00002382|Antiviral Agents|antiviral agents|mesh-ancestor
110021010|NCT00002382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110021011|NCT00002382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110021012|NCT00002382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110021013|NCT00002388|Abacavir|abacavir|mesh-list
110021014|NCT00002388|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110021015|NCT00002388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110021016|NCT00002388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110021017|NCT00002388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110021018|NCT00002388|Antiviral Agents|antiviral agents|mesh-ancestor
110021019|NCT00002388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110021020|NCT00002388|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110021021|NCT00002388|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110021023|NCT00002394|Antifungal Agents|antifungal agents|mesh-ancestor
110021024|NCT00002394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110021025|NCT00002394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110021026|NCT00002394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110021027|NCT00002400|Lamivudine|lamivudine|mesh-list
110021028|NCT00002400|Zidovudine|zidovudine|mesh-list
110021029|NCT00002400|Delavirdine|delavirdine|mesh-list
110021030|NCT00002400|Indinavir|indinavir|mesh-list
110021031|NCT00002400|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110021032|NCT00002400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110021033|NCT00002400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110021034|NCT00002400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110021035|NCT00002400|Antiviral Agents|antiviral agents|mesh-ancestor
110021036|NCT00002400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110021037|NCT00002400|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110021038|NCT00002400|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110021040|NCT00002400|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110021041|NCT00002400|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110021043|NCT00002406|Indinavir|indinavir|mesh-list
110021044|NCT00002406|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110021045|NCT00002406|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110021046|NCT00002406|Protease Inhibitors|protease inhibitors|mesh-ancestor
110021047|NCT00002406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110054793|NCT01494311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110021048|NCT00002406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110021049|NCT00002406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110021050|NCT00002406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110021051|NCT00002406|Antiviral Agents|antiviral agents|mesh-ancestor
110021052|NCT00002406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110021053|NCT00002412|Stavudine|stavudine|mesh-list
110021054|NCT00002412|Didanosine|didanosine|mesh-list
110021055|NCT00002412|Emivirine|emivirine|mesh-list
110021056|NCT00002412|Hydroxyurea|hydroxyurea|mesh-list
110021057|NCT00002412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110021058|NCT00002412|Antisickling Agents|antisickling agents|mesh-ancestor
110021059|NCT00002412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110021060|NCT00002412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110021061|NCT00002412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110021062|NCT00002412|Antimetabolites|antimetabolites|mesh-ancestor
110021063|NCT00002412|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110021064|NCT00002412|Antiviral Agents|antiviral agents|mesh-ancestor
110021065|NCT00002412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110021066|NCT00002412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110021067|NCT00002412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110021068|NCT00002418|Nevirapine|nevirapine|mesh-list
110021069|NCT00002418|Stavudine|stavudine|mesh-list
110021070|NCT00002418|Didanosine|didanosine|mesh-list
110021071|NCT00002418|Emivirine|emivirine|mesh-list
110021072|NCT00002418|Hydroxyurea|hydroxyurea|mesh-list
110021073|NCT00002418|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110021074|NCT00002418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110021075|NCT00002418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110021076|NCT00002418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110021077|NCT00002418|Antiviral Agents|antiviral agents|mesh-ancestor
110021078|NCT00002418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110021079|NCT00002418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110021080|NCT00002418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110021081|NCT00002418|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110021082|NCT00002418|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110021083|NCT00002418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110021084|NCT00002418|Antisickling Agents|antisickling agents|mesh-ancestor
110021085|NCT00002418|Antimetabolites|antimetabolites|mesh-ancestor
110021087|NCT00002424|Stavudine|stavudine|mesh-list
110021088|NCT00002424|Indinavir|indinavir|mesh-list
110021089|NCT00002424|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110021090|NCT00002424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110021091|NCT00002424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110021092|NCT00002424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110021093|NCT00002424|Antiviral Agents|antiviral agents|mesh-ancestor
110021094|NCT00002424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110021095|NCT00002424|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110021096|NCT00002424|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110021097|NCT00002424|Antimetabolites|antimetabolites|mesh-ancestor
110021098|NCT00002424|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110021099|NCT00002424|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110021100|NCT00002424|Protease Inhibitors|protease inhibitors|mesh-ancestor
110021101|NCT00002430|Lamivudine|lamivudine|mesh-list
110021102|NCT00002430|Stavudine|stavudine|mesh-list
110021103|NCT00002430|Nelfinavir|nelfinavir|mesh-list
110021104|NCT00002430|Indinavir|indinavir|mesh-list
110021105|NCT00002430|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110021106|NCT00002430|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110021107|NCT00002430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110021108|NCT00002430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110021109|NCT00002430|Antiviral Agents|antiviral agents|mesh-ancestor
110021110|NCT00002430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110021111|NCT00002430|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110021112|NCT00002430|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110021113|NCT00002430|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110021114|NCT00002430|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110021115|NCT00002430|Protease Inhibitors|protease inhibitors|mesh-ancestor
110021116|NCT00002430|Antimetabolites|antimetabolites|mesh-ancestor
110021117|NCT00002436|Lamivudine|lamivudine|mesh-list
110021120|NCT00002436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110021121|NCT00002436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110021123|NCT00002436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110021125|NCT00002436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110021126|NCT00002436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110021127|NCT00002436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110021128|NCT00002436|Antimetabolites|antimetabolites|mesh-ancestor
110021129|NCT00002442|Lamivudine|lamivudine|mesh-list
110021130|NCT00002442|Stavudine|stavudine|mesh-list
110021131|NCT00002442|Nelfinavir|nelfinavir|mesh-list
110021132|NCT00002442|Indinavir|indinavir|mesh-list
110021133|NCT00002442|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110021135|NCT00002442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110021136|NCT00002442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110021137|NCT00002442|Antiviral Agents|antiviral agents|mesh-ancestor
110021138|NCT00002442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110021139|NCT00002442|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110021140|NCT00002442|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110021141|NCT00002442|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110021142|NCT00002442|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110021143|NCT00002442|Protease Inhibitors|protease inhibitors|mesh-ancestor
110021144|NCT00002442|Antimetabolites|antimetabolites|mesh-ancestor
110021145|NCT00002448|Ritonavir|ritonavir|mesh-list
110021146|NCT00002448|Saquinavir|saquinavir|mesh-list
110021147|NCT00002448|Efavirenz|efavirenz|mesh-list
110021148|NCT00002448|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110021149|NCT00002448|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110021150|NCT00002448|Protease Inhibitors|protease inhibitors|mesh-ancestor
110021151|NCT00002448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110021152|NCT00002448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110021153|NCT00002448|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110021154|NCT00002448|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110021155|NCT00002448|Antiviral Agents|antiviral agents|mesh-ancestor
110021156|NCT00002448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110021157|NCT00002448|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110021158|NCT00002448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110021159|NCT00002448|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110021160|NCT00002448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110021161|NCT00002448|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110021162|NCT00002448|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110021163|NCT00002448|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110021164|NCT00002448|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110021165|NCT00002448|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110021166|NCT00002460|Tamoxifen|tamoxifen|mesh-list
110021167|NCT00002460|Goserelin|goserelin|mesh-list
110021168|NCT00002460|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110021169|NCT00002460|Hormone Antagonists|hormone antagonists|mesh-ancestor
110021170|NCT00002460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110021171|NCT00002460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110021172|NCT00002460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110021173|NCT00002460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110021174|NCT00002460|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110021175|NCT00002460|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110021176|NCT00002460|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110021178|NCT00002466|Ifosfamide|ifosfamide|mesh-list
110021179|NCT00002466|Doxorubicin|doxorubicin|mesh-list
110021180|NCT00002466|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110021181|NCT00002466|Etoposide|etoposide|mesh-list
110021182|NCT00002466|Vincristine|vincristine|mesh-list
110021183|NCT00002466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110021184|NCT00002466|Immunologic Factors|immunologic factors|mesh-ancestor
110021185|NCT00002466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110021186|NCT00002466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110021187|NCT00002466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110021188|NCT00002466|Alkylating Agents|alkylating agents|mesh-ancestor
110021189|NCT00002466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110021190|NCT00002466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110021191|NCT00002466|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110021192|NCT00002466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110021193|NCT00002466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110021194|NCT00002466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110021195|NCT00002466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110021196|NCT00002466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110021202|NCT00002472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110021203|NCT00002472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110021204|NCT00002472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110021205|NCT00002472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110021206|NCT00002472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110021208|NCT00002478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110021209|NCT00002478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110021210|NCT00002478|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110021211|NCT00002478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110021212|NCT00002478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110021213|NCT00002478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110021214|NCT00002490|Mitomycins|mitomycins|mesh-list
110021215|NCT00002490|Mitomycin|mitomycin|mesh-list
110021216|NCT00002490|BCG Vaccine|bcg vaccine|mesh-list
110021217|NCT00002490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110021218|NCT00002490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110021219|NCT00002490|Alkylating Agents|alkylating agents|mesh-ancestor
110021220|NCT00002490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110021221|NCT00002490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110021222|NCT00002490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110021223|NCT00002490|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110021224|NCT00002490|Immunologic Factors|immunologic factors|mesh-ancestor
110021225|NCT00002490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110021226|NCT00002496|Cobalt|cobalt|mesh-list
110021227|NCT00002496|Fluorouracil|fluorouracil|mesh-list
110021228|NCT00002496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110021229|NCT00002496|Antimetabolites|antimetabolites|mesh-ancestor
110021230|NCT00002496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110021231|NCT00002496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110021232|NCT00002496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110021233|NCT00002496|Immunologic Factors|immunologic factors|mesh-ancestor
110021234|NCT00002496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110021235|NCT00002496|Trace Elements|trace elements|mesh-ancestor
110021236|NCT00002496|Micronutrients|micronutrients|mesh-ancestor
110021237|NCT00002502|Cytarabine|cytarabine|mesh-list
110021238|NCT00002502|Cyclophosphamide|cyclophosphamide|mesh-list
110021239|NCT00002502|Busulfan|busulfan|mesh-list
110021240|NCT00002502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110021241|NCT00002502|Immunologic Factors|immunologic factors|mesh-ancestor
110021242|NCT00002502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110021243|NCT00002502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110021244|NCT00002502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110021245|NCT00002502|Alkylating Agents|alkylating agents|mesh-ancestor
110021246|NCT00002502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110021248|NCT00002502|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110021249|NCT00002502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110021250|NCT00002502|Antimetabolites|antimetabolites|mesh-ancestor
110021251|NCT00002502|Antiviral Agents|antiviral agents|mesh-ancestor
110021252|NCT00002502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110021253|NCT00002508|Carboplatin|carboplatin|mesh-list
110021254|NCT00002508|Etoposide|etoposide|mesh-list
110021255|NCT00002508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110021256|NCT00002508|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110021257|NCT00002508|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110021258|NCT00002508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110021259|NCT00002508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110021260|NCT00002508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110021261|NCT00002526|Doxorubicin|doxorubicin|mesh-list
110021262|NCT00002526|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110021263|NCT00002526|Ifosfamide|ifosfamide|mesh-list
110021264|NCT00002526|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110021265|NCT00002526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110021266|NCT00002526|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110021267|NCT00002526|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110021268|NCT00002526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110021269|NCT00002526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110021270|NCT00002526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110021271|NCT00002526|Alkylating Agents|alkylating agents|mesh-ancestor
110021273|NCT00002532|Cytarabine|cytarabine|mesh-list
110021274|NCT00002532|Dexamethasone|dexamethasone|mesh-list
110021275|NCT00002532|Prednisolone|prednisolone|mesh-list
110021276|NCT00002532|Methotrexate|methotrexate|mesh-list
110021277|NCT00002532|Etoposide|etoposide|mesh-list
110021278|NCT00002532|Daunorubicin|daunorubicin|mesh-list
110021289|NCT00002532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110021290|NCT00002532|Glucocorticoids|glucocorticoids|mesh-ancestor
110021292|NCT00002532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110021293|NCT00002532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110021294|NCT00002532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110021295|NCT00002532|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110021296|NCT00002532|Abortifacient Agents|abortifacient agents|mesh-ancestor
110021297|NCT00002532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110021298|NCT00002532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110021299|NCT00002532|Antimetabolites|antimetabolites|mesh-ancestor
110021300|NCT00002532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110021301|NCT00002532|Dermatologic Agents|dermatologic agents|mesh-ancestor
110021302|NCT00002532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110021303|NCT00002532|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110021304|NCT00002532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110021305|NCT00002532|Immunologic Factors|immunologic factors|mesh-ancestor
110021306|NCT00002532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110021307|NCT00002532|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110021308|NCT00002532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110021309|NCT00002532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110021310|NCT00002532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110021311|NCT00002532|Antiviral Agents|antiviral agents|mesh-ancestor
110021312|NCT00002532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110021313|NCT00002532|Antidotes|antidotes|mesh-ancestor
110021314|NCT00002532|Protective Agents|protective agents|mesh-ancestor
110021315|NCT00002532|Vitamin B Complex|vitamin b complex|mesh-ancestor
110021316|NCT00002532|Vitamins|vitamins|mesh-ancestor
110021317|NCT00002532|Micronutrients|micronutrients|mesh-ancestor
110021318|NCT00002532|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110021319|NCT00002532|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110021320|NCT00002532|Alkylating Agents|alkylating agents|mesh-ancestor
110021321|NCT00002532|Tubulin Modulators|tubulin modulators|mesh-ancestor
110021322|NCT00002532|Antimitotic Agents|antimitotic agents|mesh-ancestor
110021323|NCT00002532|Mitosis Modulators|mitosis modulators|mesh-ancestor
110021324|NCT00002544|Docetaxel|docetaxel|mesh-list
110021325|NCT00002544|Mitoxantrone|mitoxantrone|mesh-list
110021326|NCT00002544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110021327|NCT00002544|Tubulin Modulators|tubulin modulators|mesh-ancestor
110021328|NCT00002544|Antimitotic Agents|antimitotic agents|mesh-ancestor
110021329|NCT00002544|Mitosis Modulators|mitosis modulators|mesh-ancestor
110021330|NCT00002544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110021332|NCT00002544|Sensory System Agents|sensory system agents|mesh-ancestor
110021333|NCT00002544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110021334|NCT00002544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110021335|NCT00002544|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110021336|NCT00002544|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110021337|NCT00002544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110021339|NCT00002550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110021340|NCT00002550|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110021341|NCT00002550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110021342|NCT00002550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110021343|NCT00002550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110021344|NCT00002550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110021345|NCT00002556|Interferons|interferons|mesh-list
110021346|NCT00002556|Interferon-alpha|interferon-alpha|mesh-list
110021347|NCT00002556|Interferon alpha-2|interferon alpha-2|mesh-list
110021349|NCT00002556|Cyclophosphamide|cyclophosphamide|mesh-list
110021350|NCT00002556|Melphalan|melphalan|mesh-list
110021351|NCT00002556|Carmustine|carmustine|mesh-list
110021352|NCT00002556|Vincristine|vincristine|mesh-list
110021353|NCT00002556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110021354|NCT00002556|Immunologic Factors|immunologic factors|mesh-ancestor
110021355|NCT00002556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110021356|NCT00002556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110021357|NCT00002556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110021358|NCT00002556|Alkylating Agents|alkylating agents|mesh-ancestor
110021359|NCT00002556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110021360|NCT00002556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110021361|NCT00002556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110021362|NCT00002556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110021363|NCT00002556|Glucocorticoids|glucocorticoids|mesh-ancestor
110021364|NCT00002556|Hormones|hormones|mesh-ancestor
110021365|NCT00002556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110021366|NCT00002556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110021367|NCT00002556|Antiviral Agents|antiviral agents|mesh-ancestor
110021368|NCT00002556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110021369|NCT00002556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110021370|NCT00002556|Tubulin Modulators|tubulin modulators|mesh-ancestor
110021371|NCT00002556|Antimitotic Agents|antimitotic agents|mesh-ancestor
110021372|NCT00002556|Mitosis Modulators|mitosis modulators|mesh-ancestor
110021374|NCT00002562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110021375|NCT00002562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110021376|NCT00002562|Tubulin Modulators|tubulin modulators|mesh-ancestor
110021377|NCT00002562|Antimitotic Agents|antimitotic agents|mesh-ancestor
110021378|NCT00002562|Mitosis Modulators|mitosis modulators|mesh-ancestor
110021379|NCT00002562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110021380|NCT00002568|Paclitaxel|paclitaxel|mesh-list
110021381|NCT00002568|Cisplatin|cisplatin|mesh-list
110021382|NCT00002568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110021383|NCT00002568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110021384|NCT00002568|Tubulin Modulators|tubulin modulators|mesh-ancestor
110021385|NCT00002568|Antimitotic Agents|antimitotic agents|mesh-ancestor
110021386|NCT00002568|Mitosis Modulators|mitosis modulators|mesh-ancestor
110021387|NCT00002568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110021388|NCT00002574|Interferons|interferons|mesh-list
110021389|NCT00002574|Interferon-alpha|interferon-alpha|mesh-list
110021390|NCT00002574|Homoharringtonine|homoharringtonine|mesh-list
110021391|NCT00002574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110021392|NCT00002574|Antiviral Agents|antiviral agents|mesh-ancestor
110021393|NCT00002574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110021394|NCT00002574|Immunologic Factors|immunologic factors|mesh-ancestor
110021395|NCT00002574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110021396|NCT00002574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110021397|NCT00002574|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110021398|NCT00002574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110021399|NCT00002574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110021400|NCT00002580|Tamoxifen|tamoxifen|mesh-list
110021401|NCT00002580|Cyclophosphamide|cyclophosphamide|mesh-list
110021402|NCT00002580|Fluorouracil|fluorouracil|mesh-list
110021403|NCT00002580|Methotrexate|methotrexate|mesh-list
110021404|NCT00002580|Leuprolide|leuprolide|mesh-list
110021405|NCT00002580|Goserelin|goserelin|mesh-list
110021406|NCT00002580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110021407|NCT00002580|Immunologic Factors|immunologic factors|mesh-ancestor
110021408|NCT00002580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110021409|NCT00002580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110021410|NCT00002580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110021411|NCT00002580|Alkylating Agents|alkylating agents|mesh-ancestor
110021412|NCT00002580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110021413|NCT00002580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110021414|NCT00002580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110021415|NCT00002580|Antimetabolites|antimetabolites|mesh-ancestor
110021416|NCT00002580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110021417|NCT00002580|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110021418|NCT00002580|Abortifacient Agents|abortifacient agents|mesh-ancestor
110021419|NCT00002580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110021420|NCT00002580|Dermatologic Agents|dermatologic agents|mesh-ancestor
110021421|NCT00002580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110021422|NCT00002580|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110021423|NCT00002580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110021424|NCT00002580|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110021425|NCT00002580|Hormone Antagonists|hormone antagonists|mesh-ancestor
110021426|NCT00002580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110021427|NCT00002580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110021428|NCT00002580|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110021429|NCT00002580|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110021430|NCT00002580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110021431|NCT00002580|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110021432|NCT00002580|Fertility Agents|fertility agents|mesh-ancestor
110021433|NCT00002586|Vitamin E|vitamin e|mesh-list
110021434|NCT00002586|Tocopherols|tocopherols|mesh-list
110021435|NCT00002586|Tocotrienols|tocotrienols|mesh-list
110021436|NCT00002586|alpha-Tocopherol|alpha-tocopherol|mesh-list
110021437|NCT00002586|Tretinoin|tretinoin|mesh-list
110021438|NCT00002586|Isotretinoin|isotretinoin|mesh-list
110021439|NCT00002586|Vitamins|vitamins|mesh-ancestor
110021440|NCT00002586|Micronutrients|micronutrients|mesh-ancestor
110021441|NCT00002586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110021445|NCT00002586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110021446|NCT00002586|Keratolytic Agents|keratolytic agents|mesh-ancestor
110021447|NCT00002586|Dermatologic Agents|dermatologic agents|mesh-ancestor
110021448|NCT00002592|Cyclophosphamide|cyclophosphamide|mesh-list
110021450|NCT00002592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110021451|NCT00002592|Immunologic Factors|immunologic factors|mesh-ancestor
110021452|NCT00002592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110021453|NCT00002592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110021454|NCT00002592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110021455|NCT00002592|Alkylating Agents|alkylating agents|mesh-ancestor
110021456|NCT00002592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110021457|NCT00002592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110021458|NCT00002592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110021459|NCT00002598|Interferons|interferons|mesh-list
110021461|NCT00002598|Interferon-alpha|interferon-alpha|mesh-list
110021462|NCT00002598|Cyclophosphamide|cyclophosphamide|mesh-list
110021463|NCT00002598|Methotrexate|methotrexate|mesh-list
110021464|NCT00002598|Etoposide|etoposide|mesh-list
110021465|NCT00002598|Mitoxantrone|mitoxantrone|mesh-list
110021466|NCT00002598|Sargramostim|sargramostim|mesh-list
110021467|NCT00002598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110021468|NCT00002598|Immunologic Factors|immunologic factors|mesh-ancestor
110021469|NCT00002598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110021470|NCT00002598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110021471|NCT00002598|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110021472|NCT00002598|Alkylating Agents|alkylating agents|mesh-ancestor
110021473|NCT00002598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110021474|NCT00002598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110021475|NCT00002598|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110021476|NCT00002598|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110021477|NCT00002598|Abortifacient Agents|abortifacient agents|mesh-ancestor
110021478|NCT00002598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110021479|NCT00002598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110021480|NCT00002598|Antimetabolites|antimetabolites|mesh-ancestor
110021481|NCT00002598|Dermatologic Agents|dermatologic agents|mesh-ancestor
110021482|NCT00002598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110021483|NCT00002598|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110021484|NCT00002598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110021485|NCT00002598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110021486|NCT00002598|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110021487|NCT00002598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110021488|NCT00002598|Antiviral Agents|antiviral agents|mesh-ancestor
110021489|NCT00002598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110021490|NCT00002598|Analgesics|analgesics|mesh-ancestor
110021491|NCT00002598|Sensory System Agents|sensory system agents|mesh-ancestor
110021492|NCT00002598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110021493|NCT00002604|Carmustine|carmustine|mesh-list
110021494|NCT00002604|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
110021495|NCT00002604|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110021496|NCT00002604|Alkylating Agents|alkylating agents|mesh-ancestor
110021497|NCT00002604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110021498|NCT00002604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110021499|NCT00002604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110021500|NCT00002610|Dactinomycin|dactinomycin|mesh-list
110021501|NCT00002610|Cyclophosphamide|cyclophosphamide|mesh-list
110021502|NCT00002610|Carboplatin|carboplatin|mesh-list
110021503|NCT00002610|Doxorubicin|doxorubicin|mesh-list
110021504|NCT00002610|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110021505|NCT00002610|Etoposide|etoposide|mesh-list
110021506|NCT00002610|Vincristine|vincristine|mesh-list
110021507|NCT00002610|Lenograstim|lenograstim|mesh-list
110021508|NCT00002610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110021509|NCT00002610|Immunologic Factors|immunologic factors|mesh-ancestor
110021510|NCT00002610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110021511|NCT00002610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110021512|NCT00002610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110021513|NCT00002610|Alkylating Agents|alkylating agents|mesh-ancestor
110021514|NCT00002610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110021515|NCT00002610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110021516|NCT00002610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110021517|NCT00002610|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110021518|NCT00002610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110021519|NCT00002610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110021520|NCT00002610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110021521|NCT00002610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110021522|NCT00002610|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110021523|NCT00002610|Tubulin Modulators|tubulin modulators|mesh-ancestor
110021524|NCT00002610|Antimitotic Agents|antimitotic agents|mesh-ancestor
110021525|NCT00002610|Mitosis Modulators|mitosis modulators|mesh-ancestor
110021526|NCT00002610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110021527|NCT00002610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110021528|NCT00002610|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110021529|NCT00002610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110021530|NCT00002616|Aldesleukin|aldesleukin|mesh-list
110021531|NCT00002616|Cyclophosphamide|cyclophosphamide|mesh-list
110021533|NCT00002616|Carboplatin|carboplatin|mesh-list
110021534|NCT00002616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110021535|NCT00002616|Immunologic Factors|immunologic factors|mesh-ancestor
110021536|NCT00002616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110021537|NCT00002616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110021538|NCT00002616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110021539|NCT00002616|Alkylating Agents|alkylating agents|mesh-ancestor
110021540|NCT00002616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110021541|NCT00002616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110021542|NCT00002616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110021543|NCT00002616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110021544|NCT00002616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110021545|NCT00002616|Antiviral Agents|antiviral agents|mesh-ancestor
110021546|NCT00002616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110021547|NCT00002634|Cobalt|cobalt|mesh-list
110021548|NCT00002634|Cyclophosphamide|cyclophosphamide|mesh-list
110021549|NCT00002634|Doxorubicin|doxorubicin|mesh-list
110021550|NCT00002634|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110021551|NCT00002634|Etoposide|etoposide|mesh-list
110021552|NCT00002634|Vincristine|vincristine|mesh-list
110021553|NCT00002634|Antibodies|antibodies|mesh-list
110021554|NCT00002634|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110021555|NCT00002634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110021556|NCT00002634|Immunologic Factors|immunologic factors|mesh-ancestor
110021557|NCT00002634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110021558|NCT00002634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110021559|NCT00002634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110021560|NCT00002634|Alkylating Agents|alkylating agents|mesh-ancestor
110021561|NCT00002634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110021562|NCT00002634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110021563|NCT00002634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110021564|NCT00002634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110021565|NCT00002634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110021566|NCT00002634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110021567|NCT00002634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110021568|NCT00002634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110021569|NCT00002634|Tubulin Modulators|tubulin modulators|mesh-ancestor
110021570|NCT00002634|Antimitotic Agents|antimitotic agents|mesh-ancestor
110021571|NCT00002634|Mitosis Modulators|mitosis modulators|mesh-ancestor
110021572|NCT00002634|Trace Elements|trace elements|mesh-ancestor
110021573|NCT00002634|Micronutrients|micronutrients|mesh-ancestor
110021574|NCT00002646|Tamoxifen|tamoxifen|mesh-list
110021575|NCT00002646|Fenretinide|fenretinide|mesh-list
110021576|NCT00002646|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110021577|NCT00002646|Hormone Antagonists|hormone antagonists|mesh-ancestor
110021578|NCT00002646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110021579|NCT00002646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110021580|NCT00002646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110021581|NCT00002646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110021582|NCT00002646|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110021583|NCT00002646|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110021584|NCT00002646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110021585|NCT00002646|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110021586|NCT00002646|Protective Agents|protective agents|mesh-ancestor
110021587|NCT00002652|Suramin|suramin|mesh-list
110021588|NCT00002652|Antinematodal Agents|antinematodal agents|mesh-ancestor
110021589|NCT00002652|Anthelmintics|anthelmintics|mesh-ancestor
110021590|NCT00002652|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110021591|NCT00002652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110021592|NCT00002652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110021593|NCT00002652|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110021594|NCT00002652|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110021595|NCT00002658|Cytarabine|cytarabine|mesh-list
110021596|NCT00002658|Cyclophosphamide|cyclophosphamide|mesh-list
110021597|NCT00002658|Etoposide|etoposide|mesh-list
110021598|NCT00002658|Daunorubicin|daunorubicin|mesh-list
110021599|NCT00002658|Mitoxantrone|mitoxantrone|mesh-list
110021600|NCT00002658|Idarubicin|idarubicin|mesh-list
110021601|NCT00002658|Tretinoin|tretinoin|mesh-list
110021606|NCT00002658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110021607|NCT00002658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110021608|NCT00002658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110021609|NCT00002658|Alkylating Agents|alkylating agents|mesh-ancestor
110021610|NCT00002658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110021611|NCT00002658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110021612|NCT00002658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110021613|NCT00002658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110021614|NCT00002658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110021615|NCT00002658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110021616|NCT00002658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110021617|NCT00002658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110021618|NCT00002658|Antimetabolites|antimetabolites|mesh-ancestor
110021619|NCT00002658|Antiviral Agents|antiviral agents|mesh-ancestor
110021620|NCT00002658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110021621|NCT00002658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110021622|NCT00002658|Analgesics|analgesics|mesh-ancestor
110021623|NCT00002658|Sensory System Agents|sensory system agents|mesh-ancestor
110021624|NCT00002658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110021625|NCT00002658|Keratolytic Agents|keratolytic agents|mesh-ancestor
110021626|NCT00002658|Dermatologic Agents|dermatologic agents|mesh-ancestor
110021627|NCT00002664|Sargramostim|sargramostim|mesh-list
110021628|NCT00002664|Edrecolomab|edrecolomab|mesh-list
110021629|NCT00002664|Immunologic Factors|immunologic factors|mesh-ancestor
110021630|NCT00002664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110021631|NCT00002664|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110021633|NCT00002670|Trace Elements|trace elements|mesh-ancestor
110021634|NCT00002670|Micronutrients|micronutrients|mesh-ancestor
110021635|NCT00002670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110021637|NCT00002676|Cytarabine|cytarabine|mesh-list
110021638|NCT00002676|Dexamethasone|dexamethasone|mesh-list
110021639|NCT00002676|Cyclophosphamide|cyclophosphamide|mesh-list
110021640|NCT00002676|Carmustine|carmustine|mesh-list
110021641|NCT00002676|Doxorubicin|doxorubicin|mesh-list
110021642|NCT00002676|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110021643|NCT00002676|Methotrexate|methotrexate|mesh-list
110021644|NCT00002676|Vincristine|vincristine|mesh-list
110021645|NCT00002676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110021646|NCT00002676|Immunologic Factors|immunologic factors|mesh-ancestor
110021647|NCT00002676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110021648|NCT00002676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110021649|NCT00002676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110021650|NCT00002676|Alkylating Agents|alkylating agents|mesh-ancestor
110021651|NCT00002676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110021652|NCT00002676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110021653|NCT00002676|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110021654|NCT00002676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110021655|NCT00002676|Antiemetics|antiemetics|mesh-ancestor
110021656|NCT00002676|Autonomic Agents|autonomic agents|mesh-ancestor
110021657|NCT00002676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110021658|NCT00002676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110021659|NCT00002676|Glucocorticoids|glucocorticoids|mesh-ancestor
110021660|NCT00002676|Hormones|hormones|mesh-ancestor
110021661|NCT00002676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110021662|NCT00002676|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110021663|NCT00002676|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110021664|NCT00002676|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110021665|NCT00002676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110021666|NCT00002676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110021667|NCT00002676|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110021668|NCT00002676|Abortifacient Agents|abortifacient agents|mesh-ancestor
110021669|NCT00002676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110021670|NCT00002676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110021671|NCT00002676|Antimetabolites|antimetabolites|mesh-ancestor
110021672|NCT00002676|Dermatologic Agents|dermatologic agents|mesh-ancestor
110021673|NCT00002676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110021674|NCT00002676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110021675|NCT00002676|Antiviral Agents|antiviral agents|mesh-ancestor
110021676|NCT00002676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110021677|NCT00002676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110021678|NCT00002676|Tubulin Modulators|tubulin modulators|mesh-ancestor
110021679|NCT00002676|Antimitotic Agents|antimitotic agents|mesh-ancestor
110021690|NCT00002682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110021691|NCT00002682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110021692|NCT00002682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110021693|NCT00002682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110021694|NCT00002682|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110021695|NCT00002682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110021696|NCT00002682|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110021697|NCT00002682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110021698|NCT00002682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110021699|NCT00002682|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110021700|NCT00002682|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110021701|NCT00002682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110021702|NCT00002682|Antacids|antacids|mesh-ancestor
110021703|NCT00002682|Antidiarrheals|antidiarrheals|mesh-ancestor
110021704|NCT00002688|Cyclosporine|cyclosporine|mesh-list
110021705|NCT00002688|Etoposide|etoposide|mesh-list
110021706|NCT00002688|Mitoxantrone|mitoxantrone|mesh-list
110021707|NCT00002688|Cyclosporins|cyclosporins|mesh-list
110021708|NCT00002688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110021709|NCT00002688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110021710|NCT00002688|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110021711|NCT00002688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110021712|NCT00002688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110021713|NCT00002688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110021714|NCT00002688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110021715|NCT00002688|Immunologic Factors|immunologic factors|mesh-ancestor
110021716|NCT00002688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110021717|NCT00002688|Antifungal Agents|antifungal agents|mesh-ancestor
110021718|NCT00002688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110021719|NCT00002688|Dermatologic Agents|dermatologic agents|mesh-ancestor
110021720|NCT00002688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110021721|NCT00002688|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110021723|NCT00002688|Sensory System Agents|sensory system agents|mesh-ancestor
110021724|NCT00002688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110021725|NCT00002700|Leucovorin|leucovorin|mesh-list
110021726|NCT00002700|Cytarabine|cytarabine|mesh-list
110021727|NCT00002700|Dexamethasone|dexamethasone|mesh-list
110021728|NCT00002700|Prednisone|prednisone|mesh-list
110021729|NCT00002700|Prednisolone|prednisolone|mesh-list
110021730|NCT00002700|Hydrocortisone|hydrocortisone|mesh-list
110021731|NCT00002700|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110021732|NCT00002700|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110021733|NCT00002700|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110021734|NCT00002700|Cyclophosphamide|cyclophosphamide|mesh-list
110021735|NCT00002700|Doxorubicin|doxorubicin|mesh-list
110021736|NCT00002700|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110021737|NCT00002700|Methotrexate|methotrexate|mesh-list
110021738|NCT00002700|Vincristine|vincristine|mesh-list
110021739|NCT00002700|Daunorubicin|daunorubicin|mesh-list
110021740|NCT00002700|Asparaginase|asparaginase|mesh-list
110021741|NCT00002700|Mitoxantrone|mitoxantrone|mesh-list
110021742|NCT00002700|Mercaptopurine|mercaptopurine|mesh-list
110021743|NCT00002700|Levoleucovorin|levoleucovorin|mesh-list
110021744|NCT00002700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110021745|NCT00002700|Immunologic Factors|immunologic factors|mesh-ancestor
110021746|NCT00002700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110021747|NCT00002700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110021748|NCT00002700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110021749|NCT00002700|Alkylating Agents|alkylating agents|mesh-ancestor
110021750|NCT00002700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110021751|NCT00002700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110021752|NCT00002700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110021753|NCT00002700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110021754|NCT00002700|Antiemetics|antiemetics|mesh-ancestor
110021755|NCT00002700|Autonomic Agents|autonomic agents|mesh-ancestor
110021756|NCT00002700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110021757|NCT00002700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110021758|NCT00002700|Glucocorticoids|glucocorticoids|mesh-ancestor
110021759|NCT00002700|Hormones|hormones|mesh-ancestor
110021760|NCT00002700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110021761|NCT00002700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110021762|NCT00002700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110021763|NCT00002700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110021764|NCT00002700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110021765|NCT00002700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110021766|NCT00002700|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110021767|NCT00002700|Abortifacient Agents|abortifacient agents|mesh-ancestor
110021768|NCT00002700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110021771|NCT00002700|Dermatologic Agents|dermatologic agents|mesh-ancestor
110021772|NCT00002700|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110021773|NCT00002700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110021774|NCT00002700|Antiviral Agents|antiviral agents|mesh-ancestor
110021775|NCT00002700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110021776|NCT00002700|Antidotes|antidotes|mesh-ancestor
110021777|NCT00002700|Protective Agents|protective agents|mesh-ancestor
110021778|NCT00002700|Vitamin B Complex|vitamin b complex|mesh-ancestor
110021779|NCT00002700|Vitamins|vitamins|mesh-ancestor
110021780|NCT00002700|Micronutrients|micronutrients|mesh-ancestor
110021781|NCT00002700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110021782|NCT00002700|Tubulin Modulators|tubulin modulators|mesh-ancestor
110021783|NCT00002700|Antimitotic Agents|antimitotic agents|mesh-ancestor
110021784|NCT00002700|Mitosis Modulators|mitosis modulators|mesh-ancestor
110021785|NCT00002700|Analgesics|analgesics|mesh-ancestor
110021788|NCT00002718|Methylprednisolone|methylprednisolone|mesh-list
110021789|NCT00002718|Cyclophosphamide|cyclophosphamide|mesh-list
110021790|NCT00002718|Thiotepa|thiotepa|mesh-list
110021791|NCT00002718|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110021792|NCT00002718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110021793|NCT00002718|Immunologic Factors|immunologic factors|mesh-ancestor
110021794|NCT00002718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110021795|NCT00002718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110021796|NCT00002718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110021797|NCT00002718|Alkylating Agents|alkylating agents|mesh-ancestor
110021798|NCT00002718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110021799|NCT00002718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110021800|NCT00002718|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110021801|NCT00002718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110021802|NCT00002718|Antimetabolites|antimetabolites|mesh-ancestor
110021803|NCT00002718|Antiviral Agents|antiviral agents|mesh-ancestor
110021804|NCT00002718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110021805|NCT00002718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110021806|NCT00002718|Antiemetics|antiemetics|mesh-ancestor
110021807|NCT00002718|Autonomic Agents|autonomic agents|mesh-ancestor
110021808|NCT00002718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110021809|NCT00002718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110021810|NCT00002718|Glucocorticoids|glucocorticoids|mesh-ancestor
110021811|NCT00002718|Hormones|hormones|mesh-ancestor
110021812|NCT00002718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110021813|NCT00002718|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110021814|NCT00002718|Protective Agents|protective agents|mesh-ancestor
110021815|NCT00002730|Melphalan|melphalan|mesh-list
110021816|NCT00002730|Buthionine Sulfoximine|buthionine sulfoximine|mesh-list
110021817|NCT00002730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110021818|NCT00002730|Alkylating Agents|alkylating agents|mesh-ancestor
110021819|NCT00002730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110021820|NCT00002730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110021821|NCT00002730|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110021822|NCT00002730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110021823|NCT00002730|Immunologic Factors|immunologic factors|mesh-ancestor
110021824|NCT00002730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110021825|NCT00002730|Antimetabolites|antimetabolites|mesh-ancestor
110021826|NCT00002730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110021827|NCT00002730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110021828|NCT00002730|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110021829|NCT00002730|Protective Agents|protective agents|mesh-ancestor
110021830|NCT00002742|Amphotericin B|amphotericin b|mesh-list
110021831|NCT00002742|Nystatin|nystatin|mesh-list
110021832|NCT00002742|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110021833|NCT00002742|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
110021834|NCT00002742|Deoxycholic Acid|deoxycholic acid|mesh-list
110021835|NCT00002742|Amebicides|amebicides|mesh-ancestor
110021836|NCT00002742|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110021837|NCT00002742|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110021838|NCT00002742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110021839|NCT00002742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110021840|NCT00002742|Antifungal Agents|antifungal agents|mesh-ancestor
110021842|NCT00002742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110021843|NCT00002742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110021844|NCT00002742|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110021845|NCT00002742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110021846|NCT00002748|Interleukin-2|interleukin-2|mesh-list
110021849|NCT00002748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110021850|NCT00002748|Analgesics|analgesics|mesh-ancestor
110021851|NCT00002748|Sensory System Agents|sensory system agents|mesh-ancestor
110021852|NCT00002748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110021853|NCT00002748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110021854|NCT00002748|Immunologic Factors|immunologic factors|mesh-ancestor
110021855|NCT00002754|Antibodies|antibodies|mesh-list
110021856|NCT00002754|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110021857|NCT00002754|Immunologic Factors|immunologic factors|mesh-ancestor
110021858|NCT00002754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110021859|NCT00002760|Ketoconazole|ketoconazole|mesh-list
110021860|NCT00002760|Hydrocortisone|hydrocortisone|mesh-list
110021862|NCT00002760|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110021863|NCT00002760|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110021864|NCT00002760|Androgen Antagonists|androgen antagonists|mesh-list
110021865|NCT00002760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110021866|NCT00002760|Antifungal Agents|antifungal agents|mesh-ancestor
110021867|NCT00002760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110021868|NCT00002760|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110021869|NCT00002760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110021870|NCT00002760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110021871|NCT00002760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110021872|NCT00002760|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110021873|NCT00002760|Hormone Antagonists|hormone antagonists|mesh-ancestor
110021874|NCT00002760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110021875|NCT00002760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110021876|NCT00002760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110021877|NCT00002772|Tamoxifen|tamoxifen|mesh-list
110021878|NCT00002772|Paclitaxel|paclitaxel|mesh-list
110021879|NCT00002772|Cyclophosphamide|cyclophosphamide|mesh-list
110021880|NCT00002772|Carboplatin|carboplatin|mesh-list
110021881|NCT00002772|Doxorubicin|doxorubicin|mesh-list
110021882|NCT00002772|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110021883|NCT00002772|Thiotepa|thiotepa|mesh-list
110021885|NCT00002772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110021886|NCT00002772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110021887|NCT00002772|Tubulin Modulators|tubulin modulators|mesh-ancestor
110021888|NCT00002772|Antimitotic Agents|antimitotic agents|mesh-ancestor
110021889|NCT00002772|Mitosis Modulators|mitosis modulators|mesh-ancestor
110021890|NCT00002772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110021891|NCT00002772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110021892|NCT00002772|Immunologic Factors|immunologic factors|mesh-ancestor
110021893|NCT00002772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110021894|NCT00002772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110021895|NCT00002772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110021896|NCT00002772|Alkylating Agents|alkylating agents|mesh-ancestor
110021897|NCT00002772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110021898|NCT00002772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110021899|NCT00002772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110021900|NCT00002772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110021901|NCT00002772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110021902|NCT00002772|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110021903|NCT00002772|Hormone Antagonists|hormone antagonists|mesh-ancestor
110021904|NCT00002772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110021905|NCT00002772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110021906|NCT00002772|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110021907|NCT00002772|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110021908|NCT00002772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110021909|NCT00002778|Sargramostim|sargramostim|mesh-list
110021910|NCT00002778|Immunologic Factors|immunologic factors|mesh-ancestor
110021911|NCT00002778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110021912|NCT00002784|Tamoxifen|tamoxifen|mesh-list
110021913|NCT00002784|Cyclophosphamide|cyclophosphamide|mesh-list
110021915|NCT00002784|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110021916|NCT00002784|Fluorouracil|fluorouracil|mesh-list
110021917|NCT00002784|Methotrexate|methotrexate|mesh-list
110021918|NCT00002784|Epirubicin|epirubicin|mesh-list
110021919|NCT00002784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110021920|NCT00002784|Immunologic Factors|immunologic factors|mesh-ancestor
110021921|NCT00002784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110021922|NCT00002784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110021923|NCT00002784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110021924|NCT00002784|Alkylating Agents|alkylating agents|mesh-ancestor
110022157|NCT04521114|HIV Antibodies|hiv antibodies|mesh-list
110021926|NCT00002784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110021927|NCT00002784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110021928|NCT00002784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110021929|NCT00002784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110021930|NCT00002784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110021931|NCT00002784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110021932|NCT00002784|Antimetabolites|antimetabolites|mesh-ancestor
110021933|NCT00002784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110021934|NCT00002784|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110021935|NCT00002784|Abortifacient Agents|abortifacient agents|mesh-ancestor
110021936|NCT00002784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110021937|NCT00002784|Dermatologic Agents|dermatologic agents|mesh-ancestor
110021938|NCT00002784|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110021939|NCT00002784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110021940|NCT00002784|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110021941|NCT00002784|Hormone Antagonists|hormone antagonists|mesh-ancestor
110021942|NCT00002784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110021943|NCT00002784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110021944|NCT00002784|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110021945|NCT00002784|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110021946|NCT00002784|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110021947|NCT00002790|Cyclosporine|cyclosporine|mesh-list
110021949|NCT00002790|Methotrexate|methotrexate|mesh-list
110021950|NCT00002790|Cyclosporins|cyclosporins|mesh-list
110021951|NCT00002790|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110021952|NCT00002790|Abortifacient Agents|abortifacient agents|mesh-ancestor
110021953|NCT00002790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110021954|NCT00002790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110021955|NCT00002790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110021956|NCT00002790|Antimetabolites|antimetabolites|mesh-ancestor
110021957|NCT00002790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110021958|NCT00002790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110021959|NCT00002790|Dermatologic Agents|dermatologic agents|mesh-ancestor
110021960|NCT00002790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110021961|NCT00002790|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110021962|NCT00002790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110021963|NCT00002790|Immunologic Factors|immunologic factors|mesh-ancestor
110021964|NCT00002790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110021965|NCT00002790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110021966|NCT00002790|Antifungal Agents|antifungal agents|mesh-ancestor
110021967|NCT00002790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110021968|NCT00002790|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110021969|NCT00002790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110021970|NCT00002790|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110021971|NCT05752110|Ketamine|ketamine|mesh-list
110021972|NCT05752110|Analgesics|analgesics|mesh-ancestor
110021973|NCT05752110|Sensory System Agents|sensory system agents|mesh-ancestor
110021974|NCT05752110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110021975|NCT05752110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110021976|NCT05752110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110021977|NCT05752110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110021978|NCT05752110|Anesthetics, General|anesthetics, general|mesh-ancestor
110021979|NCT05752110|Anesthetics|anesthetics|mesh-ancestor
110021980|NCT05752110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110021981|NCT05752110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110021982|NCT05752110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110021983|NCT05752110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110021984|NCT05752110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110021985|NCT05751876|Dienogest|dienogest|mesh-list
110021986|NCT05751876|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110021987|NCT05751876|Contraceptive Agents|contraceptive agents|mesh-ancestor
110021988|NCT05751876|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110021989|NCT05751876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110021990|NCT05751876|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110021991|NCT05751876|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110021992|NCT05751876|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110021993|NCT05751876|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110021994|NCT05751876|Hormone Antagonists|hormone antagonists|mesh-ancestor
110022070|NCT05497674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110021995|NCT05751876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110021996|NCT05751876|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110021997|NCT05751876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110021999|NCT05751252|Hormone Antagonists|hormone antagonists|mesh-ancestor
110022000|NCT05751252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110022001|NCT05751252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110022002|NCT00002628|Paclitaxel|paclitaxel|mesh-list
110022003|NCT00002628|Cyclophosphamide|cyclophosphamide|mesh-list
110022004|NCT00002628|Carboplatin|carboplatin|mesh-list
110022005|NCT00002628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110022006|NCT00002628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110022007|NCT00002628|Tubulin Modulators|tubulin modulators|mesh-ancestor
110022008|NCT00002628|Antimitotic Agents|antimitotic agents|mesh-ancestor
110022009|NCT00002628|Mitosis Modulators|mitosis modulators|mesh-ancestor
110022010|NCT00002628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110022011|NCT00002628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110022012|NCT00002628|Immunologic Factors|immunologic factors|mesh-ancestor
110022013|NCT00002628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110022014|NCT00002628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110022015|NCT00002628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110022016|NCT00002628|Alkylating Agents|alkylating agents|mesh-ancestor
110022017|NCT00002628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110022018|NCT05749614|Lidocaine|lidocaine|mesh-list
110022019|NCT05749614|Anesthetics, Local|anesthetics, local|mesh-ancestor
110022020|NCT05749614|Anesthetics|anesthetics|mesh-ancestor
110022021|NCT05749614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110022022|NCT05749614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110022023|NCT05749614|Sensory System Agents|sensory system agents|mesh-ancestor
110022024|NCT05749614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110022025|NCT05749614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110022026|NCT05749614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110022027|NCT05749614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110022028|NCT05749614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110022029|NCT05749614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110022030|NCT05749380|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110022031|NCT05749380|Antifungal Agents|antifungal agents|mesh-ancestor
110022032|NCT05749380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110022033|NCT05749380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110022034|NCT05749380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110022035|NCT05748990|Insulin|insulin|mesh-list
110022036|NCT05748990|Insulin Lispro|insulin lispro|mesh-list
110022037|NCT05748990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110022038|NCT05748990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110022039|NCT05677698|Peppermint oil|peppermint oil|mesh-list
110022040|NCT05677698|Antiemetics|antiemetics|mesh-ancestor
110022041|NCT05677698|Autonomic Agents|autonomic agents|mesh-ancestor
110022042|NCT05677698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110022043|NCT05677698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110022044|NCT05677698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110022045|NCT05677698|Parasympatholytics|parasympatholytics|mesh-ancestor
110022046|NCT05588388|Bevacizumab|bevacizumab|mesh-list
110022047|NCT05588388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110022049|NCT05588388|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110022050|NCT05588388|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110022051|NCT05588388|Growth Substances|growth substances|mesh-ancestor
110022052|NCT05588388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110022053|NCT05588388|Growth Inhibitors|growth inhibitors|mesh-ancestor
110022054|NCT05516628|Bevacizumab|bevacizumab|mesh-list
110022055|NCT05516628|Atezolizumab|atezolizumab|mesh-list
110022056|NCT05516628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110022057|NCT05516628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110022058|NCT05516628|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110022059|NCT05516628|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110022060|NCT05516628|Growth Substances|growth substances|mesh-ancestor
110022061|NCT05516628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110022062|NCT05516628|Growth Inhibitors|growth inhibitors|mesh-ancestor
110022063|NCT05516628|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110022064|NCT05516628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110022065|NCT05497674|Rifampin|rifampin|mesh-list
110022066|NCT05497674|Probenecid|probenecid|mesh-list
110022067|NCT05497674|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110022068|NCT05497674|Antitubercular Agents|antitubercular agents|mesh-ancestor
110022069|NCT05497674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110022075|NCT05497674|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110022076|NCT05497674|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110022077|NCT05497674|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110022078|NCT05497674|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110022079|NCT05497674|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110022080|NCT05497674|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110022082|NCT05497674|Gout Suppressants|gout suppressants|mesh-ancestor
110022083|NCT05497674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110022084|NCT05360628|Allopurinol|allopurinol|mesh-list
110022085|NCT05360628|Antimetabolites|antimetabolites|mesh-ancestor
110022086|NCT05360628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110022087|NCT05360628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110022088|NCT05360628|Gout Suppressants|gout suppressants|mesh-ancestor
110022089|NCT05360628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110022090|NCT05360628|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110022091|NCT05360628|Antioxidants|antioxidants|mesh-ancestor
110022092|NCT05360628|Protective Agents|protective agents|mesh-ancestor
110022093|NCT05360628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110022094|NCT05326308|Zanubrutinib|zanubrutinib|mesh-list
110022095|NCT05326308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110022096|NCT05326308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110022097|NCT05326308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110022098|NCT05326308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110022100|NCT05312112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110022101|NCT05218668|Fasudil|fasudil|mesh-list
110022102|NCT05218668|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110022103|NCT05218668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110022104|NCT05218668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110022105|NCT05218668|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110022106|NCT05218668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110022107|NCT05218668|Vasodilator Agents|vasodilator agents|mesh-ancestor
110022108|NCT05218668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110022109|NCT05218668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110022115|NCT05048940|Vaccines|vaccines|mesh-list
110022116|NCT05048940|Immunologic Factors|immunologic factors|mesh-ancestor
110022117|NCT05048940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110022118|NCT04836780|Dexamethasone|dexamethasone|mesh-list
110022119|NCT04836780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110022120|NCT04836780|Antiemetics|antiemetics|mesh-ancestor
110022121|NCT04836780|Autonomic Agents|autonomic agents|mesh-ancestor
110022122|NCT04836780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110022123|NCT04836780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110022124|NCT04836780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110022125|NCT04836780|Glucocorticoids|glucocorticoids|mesh-ancestor
110022126|NCT04836780|Hormones|hormones|mesh-ancestor
110022127|NCT04836780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110022128|NCT04836780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110022129|NCT04836780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110022130|NCT04740294|Magnesium Sulfate|magnesium sulfate|mesh-list
110022131|NCT04740294|Analgesics|analgesics|mesh-ancestor
110022132|NCT04740294|Sensory System Agents|sensory system agents|mesh-ancestor
110022133|NCT04740294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110022134|NCT04740294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110022135|NCT04740294|Anesthetics|anesthetics|mesh-ancestor
110022136|NCT04740294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110022137|NCT04740294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110022138|NCT04740294|Anticonvulsants|anticonvulsants|mesh-ancestor
110022139|NCT04740294|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110022140|NCT04740294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110022141|NCT04740294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110022143|NCT04740294|Tocolytic Agents|tocolytic agents|mesh-ancestor
110022144|NCT04740294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110022145|NCT04705818|Durvalumab|durvalumab|mesh-list
110022146|NCT04705818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110022147|NCT04705818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110022148|NCT04610736|Temozolomide|temozolomide|mesh-list
110022149|NCT04610736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110022150|NCT04610736|Alkylating Agents|alkylating agents|mesh-ancestor
110022151|NCT04610736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110022152|NCT04610736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110022153|NCT04529538|Vaccines|vaccines|mesh-list
110022154|NCT04529538|Immunologic Factors|immunologic factors|mesh-ancestor
110022155|NCT04529538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110022156|NCT04521114|Leronlimab|leronlimab|mesh-list
110022158|NCT04521114|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110022159|NCT04521114|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110022160|NCT04521114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110022161|NCT04521114|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110022162|NCT04521114|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110022163|NCT04521114|Antiviral Agents|antiviral agents|mesh-ancestor
110022164|NCT04521114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110022165|NCT04521114|Immunologic Factors|immunologic factors|mesh-ancestor
110022166|NCT04521114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110022167|NCT04519164|Eplerenone|eplerenone|mesh-list
110022168|NCT04519164|Chlorthalidone|chlorthalidone|mesh-list
110022169|NCT04519164|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110022170|NCT04519164|Hormone Antagonists|hormone antagonists|mesh-ancestor
110022171|NCT04519164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110022172|NCT04519164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110022173|NCT04519164|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110022175|NCT04519164|Natriuretic Agents|natriuretic agents|mesh-ancestor
110022176|NCT04519164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110022177|NCT04519164|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110022178|NCT04519164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110022179|NCT04519164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110022180|NCT04471974|Pembrolizumab|pembrolizumab|mesh-list
110022181|NCT04471974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110022182|NCT04471974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110022183|NCT04471974|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110022184|NCT04471974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110022185|NCT04360824|Enoxaparin|enoxaparin|mesh-list
110022186|NCT04360824|Anticoagulants|anticoagulants|mesh-ancestor
110022187|NCT04360824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110022188|NCT04360824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110022189|NCT04360824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110022207|NCT03874338|Gout Suppressants|gout suppressants|mesh-ancestor
110022208|NCT03874338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110022209|NCT03874338|Tubulin Modulators|tubulin modulators|mesh-ancestor
110022210|NCT03874338|Antimitotic Agents|antimitotic agents|mesh-ancestor
110022211|NCT03874338|Mitosis Modulators|mitosis modulators|mesh-ancestor
110022212|NCT03874338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110022213|NCT03874338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110022214|NCT03846570|Beclomethasone|beclomethasone|mesh-list
110022215|NCT03846570|Formoterol Fumarate|formoterol fumarate|mesh-list
110022216|NCT03846570|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110022217|NCT03846570|Autonomic Agents|autonomic agents|mesh-ancestor
110022218|NCT03846570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110022219|NCT03846570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110022221|NCT03846570|Respiratory System Agents|respiratory system agents|mesh-ancestor
110022222|NCT03846570|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110022223|NCT03846570|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110022224|NCT03846570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110022225|NCT03846570|Adrenergic Agents|adrenergic agents|mesh-ancestor
110022226|NCT03846570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110022227|NCT03846570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110022228|NCT03846570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110022229|NCT03846570|Glucocorticoids|glucocorticoids|mesh-ancestor
110022230|NCT03846570|Hormones|hormones|mesh-ancestor
110022231|NCT03846570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110022232|NCT03838848|Carboplatin|carboplatin|mesh-list
110022233|NCT03838848|Pemetrexed|pemetrexed|mesh-list
110022234|NCT03838848|Antibodies|antibodies|mesh-list
110022235|NCT03838848|Immunoglobulins|immunoglobulins|mesh-list
110022236|NCT03838848|Immunologic Factors|immunologic factors|mesh-ancestor
110022237|NCT03838848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110022238|NCT03838848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110022239|NCT03838848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110022240|NCT03838848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110022241|NCT03838848|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110022242|NCT03838848|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110022243|NCT03787602|Avelumab|avelumab|mesh-list
110022244|NCT03787602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110022245|NCT03787602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110022247|NCT03745170|Oxaliplatin|oxaliplatin|mesh-list
110022248|NCT03745170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110022249|NCT03745170|Antimetabolites|antimetabolites|mesh-ancestor
110022250|NCT03745170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110022253|NCT03737370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110022254|NCT03737370|Tubulin Modulators|tubulin modulators|mesh-ancestor
110022255|NCT03737370|Antimitotic Agents|antimitotic agents|mesh-ancestor
110022256|NCT03737370|Mitosis Modulators|mitosis modulators|mesh-ancestor
110022257|NCT03737370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110022259|NCT03701490|Progestins|progestins|mesh-ancestor
110022261|NCT03701490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110022262|NCT03701490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110022263|NCT03691974|Fasinumab|fasinumab|mesh-list
110022264|NCT03691974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110022265|NCT03691974|Analgesics|analgesics|mesh-ancestor
110022266|NCT03691974|Sensory System Agents|sensory system agents|mesh-ancestor
110022267|NCT03691974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110022268|NCT03691974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110022269|NCT03652428|Paclitaxel|paclitaxel|mesh-list
110022270|NCT03652428|Gemcitabine|gemcitabine|mesh-list
110022271|NCT03652428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110022272|NCT03652428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110022273|NCT03652428|Tubulin Modulators|tubulin modulators|mesh-ancestor
110022274|NCT03652428|Antimitotic Agents|antimitotic agents|mesh-ancestor
110022275|NCT03652428|Mitosis Modulators|mitosis modulators|mesh-ancestor
110022276|NCT03652428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110022277|NCT03652428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110022278|NCT03652428|Antimetabolites|antimetabolites|mesh-ancestor
110022279|NCT03580044|Aztreonam|aztreonam|mesh-list
110022280|NCT03580044|Avibactam|avibactam|mesh-list
110022281|NCT03580044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110022282|NCT03580044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110022283|NCT03580044|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110022284|NCT03580044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110022285|NCT03580044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110022286|NCT02972034|Pembrolizumab|pembrolizumab|mesh-list
110022288|NCT02972034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110022289|NCT02972034|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110022290|NCT02972034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110022291|NCT02795988|Fluorouracil|fluorouracil|mesh-list
110022292|NCT02795988|Capecitabine|capecitabine|mesh-list
110022293|NCT02795988|Oxaliplatin|oxaliplatin|mesh-list
110022294|NCT02795988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110022295|NCT02795988|Antimetabolites|antimetabolites|mesh-ancestor
110022296|NCT02795988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110022297|NCT02795988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110022298|NCT02795988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110022299|NCT02795988|Immunologic Factors|immunologic factors|mesh-ancestor
110022300|NCT02795988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110022301|NCT02782104|Esketamine|esketamine|mesh-list
110022302|NCT02782104|Antidepressive Agents|antidepressive agents|mesh-ancestor
110022303|NCT02782104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110022304|NCT01821690|Buspirone|buspirone|mesh-list
110022305|NCT01821690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110022306|NCT01821690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110022307|NCT01821690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110022308|NCT01821690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110022310|NCT01821690|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110022311|NCT01821690|Serotonin Agents|serotonin agents|mesh-ancestor
110022312|NCT01821690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110022313|NCT01821690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110022314|NCT01394016|Fulvestrant|fulvestrant|mesh-list
110022315|NCT01394016|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110022316|NCT01394016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110022317|NCT01394016|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110022318|NCT01394016|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110022319|NCT01394016|Hormone Antagonists|hormone antagonists|mesh-ancestor
110022320|NCT01394016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110022321|NCT01394016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110022322|NCT01096368|Cyclophosphamide|cyclophosphamide|mesh-list
110022323|NCT01096368|Cisplatin|cisplatin|mesh-list
110022324|NCT01096368|Carboplatin|carboplatin|mesh-list
110022325|NCT01096368|Etoposide|etoposide|mesh-list
110022326|NCT01096368|Vincristine|vincristine|mesh-list
110022327|NCT01096368|Etoposide phosphate|etoposide phosphate|mesh-list
110022331|NCT01096368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110022332|NCT01096368|Immunologic Factors|immunologic factors|mesh-ancestor
110022333|NCT01096368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110022334|NCT01096368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110022335|NCT01096368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110022336|NCT01096368|Alkylating Agents|alkylating agents|mesh-ancestor
110022337|NCT01096368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110022338|NCT01096368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110022339|NCT01096368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110022340|NCT01096368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110022341|NCT01096368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110022342|NCT01096368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110022343|NCT01096368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110022344|NCT01096368|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110022345|NCT01096368|Tubulin Modulators|tubulin modulators|mesh-ancestor
110022346|NCT01096368|Antimitotic Agents|antimitotic agents|mesh-ancestor
110022347|NCT01096368|Mitosis Modulators|mitosis modulators|mesh-ancestor
110022348|NCT01096368|Protective Agents|protective agents|mesh-ancestor
110022349|NCT01096368|Keratolytic Agents|keratolytic agents|mesh-ancestor
110022350|NCT01096368|Dermatologic Agents|dermatologic agents|mesh-ancestor
110022352|NCT00978822|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110022353|NCT00978822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110022354|NCT00978822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110022355|NCT00978822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110022356|NCT00978822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110022357|NCT00577200|Midazolam|midazolam|mesh-list
110022358|NCT00577200|Sufentanil|sufentanil|mesh-list
110022359|NCT00577200|Propofol|propofol|mesh-list
110022360|NCT00577200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110022361|NCT00577200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110022362|NCT00577200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110022363|NCT00577200|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110022364|NCT00577200|Anesthetics, General|anesthetics, general|mesh-ancestor
110022366|NCT00577200|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110022367|NCT00577200|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110022368|NCT00577200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110022369|NCT00577200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110022370|NCT00577200|GABA Modulators|gaba modulators|mesh-ancestor
110022372|NCT00577200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110022373|NCT00577200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110022374|NCT00577200|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110022375|NCT00577200|Narcotics|narcotics|mesh-ancestor
110022376|NCT00577200|Analgesics|analgesics|mesh-ancestor
110022377|NCT00577200|Sensory System Agents|sensory system agents|mesh-ancestor
110022378|NCT00577200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110022379|NCT00002796|Interferons|interferons|mesh-list
110022380|NCT00002796|Interferon-gamma|interferon-gamma|mesh-list
110022381|NCT00002796|Indomethacin|indomethacin|mesh-list
110022382|NCT00002796|Fluorouracil|fluorouracil|mesh-list
110022383|NCT00002796|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
110022384|NCT00002796|Antimetabolites|antimetabolites|mesh-ancestor
110022385|NCT00002796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110022386|NCT00002796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110022387|NCT00002796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110022388|NCT00002796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110022389|NCT00002796|Immunologic Factors|immunologic factors|mesh-ancestor
110022390|NCT00002796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110022391|NCT00002796|Antiviral Agents|antiviral agents|mesh-ancestor
110022392|NCT00002796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110022393|NCT00002796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110022394|NCT00002796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110022395|NCT00002796|Analgesics|analgesics|mesh-ancestor
110022396|NCT00002796|Sensory System Agents|sensory system agents|mesh-ancestor
110022397|NCT00002796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110022398|NCT00002796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110022399|NCT00002796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110022400|NCT00002796|Gout Suppressants|gout suppressants|mesh-ancestor
110022401|NCT00002796|Tocolytic Agents|tocolytic agents|mesh-ancestor
110022402|NCT00002796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110022403|NCT00002796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110022404|NCT00002796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110022406|NCT00002802|Cyclophosphamide|cyclophosphamide|mesh-list
110022407|NCT00002802|Melphalan|melphalan|mesh-list
110022408|NCT00002802|Ifosfamide|ifosfamide|mesh-list
110022409|NCT00002802|Dacarbazine|dacarbazine|mesh-list
110022416|NCT00002802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110022417|NCT00002802|Immunologic Factors|immunologic factors|mesh-ancestor
110022418|NCT00002802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110022419|NCT00002802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110022420|NCT00002802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110022421|NCT00002802|Alkylating Agents|alkylating agents|mesh-ancestor
110022422|NCT00002802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110022423|NCT00002802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110022424|NCT00002802|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110022425|NCT00002802|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110022426|NCT00002802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110022427|NCT00002802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110022428|NCT00002802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110022429|NCT00002802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110022430|NCT00002802|Tubulin Modulators|tubulin modulators|mesh-ancestor
110022431|NCT00002802|Antimitotic Agents|antimitotic agents|mesh-ancestor
110022432|NCT00002802|Mitosis Modulators|mitosis modulators|mesh-ancestor
110022433|NCT00002802|Trace Elements|trace elements|mesh-ancestor
110022434|NCT00002802|Micronutrients|micronutrients|mesh-ancestor
110022435|NCT00002814|Paclitaxel|paclitaxel|mesh-list
110022436|NCT00002814|Topotecan|topotecan|mesh-list
110022437|NCT00002814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110022438|NCT00002814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110022439|NCT00002814|Tubulin Modulators|tubulin modulators|mesh-ancestor
110022440|NCT00002814|Antimitotic Agents|antimitotic agents|mesh-ancestor
110022442|NCT00002814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110022443|NCT00002814|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110022444|NCT00002814|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110022445|NCT00002814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110022446|NCT00002832|Cyclosporine|cyclosporine|mesh-list
110022448|NCT00002832|Cyclosporins|cyclosporins|mesh-list
110022449|NCT00002832|Immunologic Factors|immunologic factors|mesh-ancestor
110022450|NCT00002832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110022451|NCT00002832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110022452|NCT00002832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110022453|NCT00002832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110022454|NCT00002832|Antifungal Agents|antifungal agents|mesh-ancestor
110022455|NCT00002832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110022456|NCT00002832|Dermatologic Agents|dermatologic agents|mesh-ancestor
110022457|NCT00002832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110022458|NCT00002832|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110022459|NCT00002832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110022460|NCT00002832|Antimetabolites|antimetabolites|mesh-ancestor
110022461|NCT00002832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110022462|NCT00002838|Cyclophosphamide|cyclophosphamide|mesh-list
110022463|NCT00002838|Fludarabine|fludarabine|mesh-list
110022464|NCT00002838|Fludarabine phosphate|fludarabine phosphate|mesh-list
110022465|NCT00002838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110022466|NCT00002838|Immunologic Factors|immunologic factors|mesh-ancestor
110022467|NCT00002838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110022468|NCT00002838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110022469|NCT00002838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110022470|NCT00002838|Alkylating Agents|alkylating agents|mesh-ancestor
110022471|NCT00002838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110022472|NCT00002838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110022473|NCT00002838|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110022474|NCT00002838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110022475|NCT00002838|Antimetabolites|antimetabolites|mesh-ancestor
110022476|NCT00002844|Cyclophosphamide|cyclophosphamide|mesh-list
110022477|NCT00002844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110022478|NCT00002844|Immunologic Factors|immunologic factors|mesh-ancestor
110022479|NCT00002844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110022480|NCT00002844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110022481|NCT00002844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110022482|NCT00002844|Alkylating Agents|alkylating agents|mesh-ancestor
110022483|NCT00002844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110022484|NCT00002844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110022485|NCT00002844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110022486|NCT00002862|Perillyl alcohol|perillyl alcohol|mesh-list
110022487|NCT00002862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110022488|NCT00002862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110022489|NCT00002862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110022491|NCT00002880|Etoposide phosphate|etoposide phosphate|mesh-list
110022492|NCT00002880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110022493|NCT00002880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110022494|NCT00002880|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110022495|NCT00002880|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110022496|NCT00002880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110022497|NCT00002880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110022499|NCT00002892|Interferon-alpha|interferon-alpha|mesh-list
110022500|NCT00002892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110022501|NCT00002892|Antiviral Agents|antiviral agents|mesh-ancestor
110022502|NCT00002892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110022503|NCT00002892|Immunologic Factors|immunologic factors|mesh-ancestor
110022504|NCT00002892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110022506|NCT00002898|Cyclophosphamide|cyclophosphamide|mesh-list
110022507|NCT00002898|Ifosfamide|ifosfamide|mesh-list
110022508|NCT00002898|Carboplatin|carboplatin|mesh-list
110022509|NCT00002898|Etoposide|etoposide|mesh-list
110022510|NCT00002898|Vincristine|vincristine|mesh-list
110022511|NCT00002898|Epirubicin|epirubicin|mesh-list
110022512|NCT00002898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110022513|NCT00002898|Immunologic Factors|immunologic factors|mesh-ancestor
110022514|NCT00002898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110022515|NCT00002898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110022516|NCT00002898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110022517|NCT00002898|Alkylating Agents|alkylating agents|mesh-ancestor
110022518|NCT00002898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110022519|NCT00002898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110022520|NCT00002898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110022521|NCT00002898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110022522|NCT00002898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110022523|NCT00002898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110022524|NCT00002898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110022525|NCT00002898|Tubulin Modulators|tubulin modulators|mesh-ancestor
110022526|NCT00002898|Antimitotic Agents|antimitotic agents|mesh-ancestor
110022527|NCT00002898|Mitosis Modulators|mitosis modulators|mesh-ancestor
110022528|NCT00002898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110022529|NCT00002898|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110022530|NCT00002898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110022531|NCT00002898|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110022532|NCT00002898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110022534|NCT00002904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110022535|NCT00002904|Alkylating Agents|alkylating agents|mesh-ancestor
110022536|NCT00002904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110022537|NCT00002904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110022539|NCT00002928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110022540|NCT00002928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110022541|NCT00002928|Tubulin Modulators|tubulin modulators|mesh-ancestor
110022542|NCT00002928|Antimitotic Agents|antimitotic agents|mesh-ancestor
110022543|NCT00002928|Mitosis Modulators|mitosis modulators|mesh-ancestor
110022544|NCT00002928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110022545|NCT00002940|Hydroxyurea|hydroxyurea|mesh-list
110022546|NCT00002940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110022547|NCT00002940|Antisickling Agents|antisickling agents|mesh-ancestor
110022548|NCT00002940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110022549|NCT00002940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110022550|NCT00002940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110022551|NCT00002946|Penclomedine|penclomedine|mesh-list
110022552|NCT00002946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110022553|NCT00002952|Interleukin-12|interleukin-12|mesh-list
110022554|NCT00002952|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110022555|NCT00002952|Immunologic Factors|immunologic factors|mesh-ancestor
110022556|NCT00002952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110022557|NCT00002952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110022558|NCT00002952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110022559|NCT00002952|Growth Substances|growth substances|mesh-ancestor
110022560|NCT00002952|Growth Inhibitors|growth inhibitors|mesh-ancestor
110022561|NCT00002952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110022562|NCT00002964|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
110022563|NCT00002964|Trioxsalen|trioxsalen|mesh-list
110022564|NCT00002964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110022565|NCT00002964|Dermatologic Agents|dermatologic agents|mesh-ancestor
110022566|NCT00002964|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110022567|NCT00002970|Cytarabine|cytarabine|mesh-list
110022568|NCT00002970|Hydrocortisone|hydrocortisone|mesh-list
110022569|NCT00002970|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110022570|NCT00002970|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110022571|NCT00002970|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110022574|NCT00002970|Abortifacient Agents|abortifacient agents|mesh-ancestor
110022575|NCT00002970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110022576|NCT00002970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110022577|NCT00002970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110022578|NCT00002970|Antimetabolites|antimetabolites|mesh-ancestor
110022579|NCT00002970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110022580|NCT00002970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110022581|NCT00002970|Dermatologic Agents|dermatologic agents|mesh-ancestor
110022582|NCT00002970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110022583|NCT00002970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110022584|NCT00002970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110022585|NCT00002970|Immunologic Factors|immunologic factors|mesh-ancestor
110022586|NCT00002970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110022587|NCT00002970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110022588|NCT00002970|Antiviral Agents|antiviral agents|mesh-ancestor
110022589|NCT00002970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110022590|NCT00002970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110022592|NCT00002976|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110022593|NCT00002976|Hormones|hormones|mesh-ancestor
110022594|NCT00002976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110022595|NCT00002976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110022596|NCT00002982|Cytarabine|cytarabine|mesh-list
110022597|NCT00002982|Carboplatin|carboplatin|mesh-list
110022598|NCT00002982|Etoposide|etoposide|mesh-list
110022599|NCT00002982|Melphalan|melphalan|mesh-list
110022600|NCT00002982|Ifosfamide|ifosfamide|mesh-list
110022601|NCT00002982|Carmustine|carmustine|mesh-list
110022602|NCT00002982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110022603|NCT00002982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110022604|NCT00002982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110022605|NCT00002982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110022606|NCT00002982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110022607|NCT00002982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110022608|NCT00002982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110022609|NCT00002982|Antimetabolites|antimetabolites|mesh-ancestor
110022610|NCT00002982|Antiviral Agents|antiviral agents|mesh-ancestor
110022611|NCT00002982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110022612|NCT00002982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110022613|NCT00002982|Immunologic Factors|immunologic factors|mesh-ancestor
110022614|NCT00002982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110022615|NCT00002982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110022616|NCT00002982|Alkylating Agents|alkylating agents|mesh-ancestor
110022617|NCT00002982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110022618|NCT00002988|Irinotecan|irinotecan|mesh-list
110022619|NCT00002988|Carmustine|carmustine|mesh-list
110022620|NCT00002988|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110022621|NCT00002988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110022622|NCT00002988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110022623|NCT00002988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110022624|NCT00002988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110022625|NCT00002988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110022626|NCT00002988|Alkylating Agents|alkylating agents|mesh-ancestor
110022627|NCT00002994|Interleukin-2|interleukin-2|mesh-list
110022628|NCT00002994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110022629|NCT00002994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110022630|NCT00002994|Analgesics|analgesics|mesh-ancestor
110022631|NCT00002994|Sensory System Agents|sensory system agents|mesh-ancestor
110022632|NCT00002994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110022633|NCT00002994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110022634|NCT00003000|Fentanyl|fentanyl|mesh-list
110022635|NCT00003000|Morphine|morphine|mesh-list
110022636|NCT00003000|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110022637|NCT00003000|Narcotics|narcotics|mesh-ancestor
110022639|NCT00003000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110022640|NCT00003000|Analgesics|analgesics|mesh-ancestor
110022641|NCT00003000|Sensory System Agents|sensory system agents|mesh-ancestor
110022642|NCT00003000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110022643|NCT00003000|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110022644|NCT00003000|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110022645|NCT00003000|Anesthetics, General|anesthetics, general|mesh-ancestor
110022646|NCT00003000|Anesthetics|anesthetics|mesh-ancestor
110022647|NCT00003012|Cyclophosphamide|cyclophosphamide|mesh-list
110022648|NCT00003012|Fluorouracil|fluorouracil|mesh-list
110022649|NCT00003012|Methotrexate|methotrexate|mesh-list
110022650|NCT00003012|Epirubicin|epirubicin|mesh-list
110022652|NCT00003012|Immunologic Factors|immunologic factors|mesh-ancestor
110022653|NCT00003012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110022654|NCT00003012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110022655|NCT00003012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110022656|NCT00003012|Alkylating Agents|alkylating agents|mesh-ancestor
110022657|NCT00003012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110022658|NCT00003012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110022659|NCT00003012|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110022660|NCT00003012|Antimetabolites|antimetabolites|mesh-ancestor
110022661|NCT00003012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110022662|NCT00003012|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110022663|NCT00003012|Abortifacient Agents|abortifacient agents|mesh-ancestor
110022664|NCT00003012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110022666|NCT00003012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110022667|NCT00003012|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110022668|NCT00003012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110022669|NCT00003012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110022670|NCT00003012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110022671|NCT00003012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110022672|NCT00003048|Amifostine|amifostine|mesh-list
110022673|NCT00003048|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110022674|NCT00003048|Protective Agents|protective agents|mesh-ancestor
110022675|NCT00003048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110022676|NCT00003054|Paclitaxel|paclitaxel|mesh-list
110022677|NCT00003054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110022678|NCT00003054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110022679|NCT00003054|Tubulin Modulators|tubulin modulators|mesh-ancestor
110022680|NCT00003054|Antimitotic Agents|antimitotic agents|mesh-ancestor
110022681|NCT00003054|Mitosis Modulators|mitosis modulators|mesh-ancestor
110022682|NCT00003054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110022683|NCT00003060|Cyclosporine|cyclosporine|mesh-list
110022684|NCT00003060|Cyclophosphamide|cyclophosphamide|mesh-list
110022685|NCT00003060|Busulfan|busulfan|mesh-list
110022686|NCT00003060|Methotrexate|methotrexate|mesh-list
110022687|NCT00003060|Cyclosporins|cyclosporins|mesh-list
110022688|NCT00003060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110022689|NCT00003060|Immunologic Factors|immunologic factors|mesh-ancestor
110022690|NCT00003060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110022691|NCT00003060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110022692|NCT00003060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110022693|NCT00003060|Alkylating Agents|alkylating agents|mesh-ancestor
110022694|NCT00003060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110022695|NCT00003060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110022696|NCT00003060|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110022697|NCT00003060|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110022698|NCT00003060|Abortifacient Agents|abortifacient agents|mesh-ancestor
110022699|NCT00003060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110022700|NCT00003060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110022701|NCT00003060|Antimetabolites|antimetabolites|mesh-ancestor
110022702|NCT00003060|Dermatologic Agents|dermatologic agents|mesh-ancestor
110022703|NCT00003060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110022704|NCT00003060|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110022705|NCT00003060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110022706|NCT00003060|Antifungal Agents|antifungal agents|mesh-ancestor
110022708|NCT00003060|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110022709|NCT00003066|Docetaxel|docetaxel|mesh-list
110022710|NCT00003066|Estramustine|estramustine|mesh-list
110022711|NCT00003066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110022712|NCT00003066|Tubulin Modulators|tubulin modulators|mesh-ancestor
110022713|NCT00003066|Antimitotic Agents|antimitotic agents|mesh-ancestor
110022714|NCT00003066|Mitosis Modulators|mitosis modulators|mesh-ancestor
110022715|NCT00003066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110022716|NCT00003066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110022717|NCT00003066|Alkylating Agents|alkylating agents|mesh-ancestor
110022718|NCT00003066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110022719|NCT00003072|Paclitaxel|paclitaxel|mesh-list
110022720|NCT00003072|Carboplatin|carboplatin|mesh-list
110022721|NCT00003072|Amifostine|amifostine|mesh-list
110022722|NCT00003072|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110022723|NCT00003072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110022724|NCT00003072|Tubulin Modulators|tubulin modulators|mesh-ancestor
110022725|NCT00003072|Antimitotic Agents|antimitotic agents|mesh-ancestor
110022726|NCT00003072|Mitosis Modulators|mitosis modulators|mesh-ancestor
110022728|NCT00003072|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110022729|NCT00003072|Protective Agents|protective agents|mesh-ancestor
110022730|NCT00003072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110022732|NCT00003078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110022733|NCT00003078|Antimetabolites|antimetabolites|mesh-ancestor
110022734|NCT00003078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110022735|NCT00003078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110022736|NCT00003078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110022737|NCT00003078|Immunologic Factors|immunologic factors|mesh-ancestor
110022738|NCT00003078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110022739|NCT00003084|Ketoconazole|ketoconazole|mesh-list
110022740|NCT00003084|Paclitaxel|paclitaxel|mesh-list
110022741|NCT00003084|Etoposide|etoposide|mesh-list
110022742|NCT00003084|Vinblastine|vinblastine|mesh-list
110022743|NCT00003084|Doxorubicin|doxorubicin|mesh-list
110022744|NCT00003084|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110022745|NCT00003084|Estramustine|estramustine|mesh-list
110022746|NCT00003084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110022747|NCT00003084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110022748|NCT00003084|Tubulin Modulators|tubulin modulators|mesh-ancestor
110022749|NCT00003084|Antimitotic Agents|antimitotic agents|mesh-ancestor
110022750|NCT00003084|Mitosis Modulators|mitosis modulators|mesh-ancestor
110022751|NCT00003084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110022752|NCT00003084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110022753|NCT00003084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110022754|NCT00003084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110022755|NCT00003084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110022756|NCT00003084|Antifungal Agents|antifungal agents|mesh-ancestor
110022757|NCT00003084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110022758|NCT00003084|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110022759|NCT00003084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110022760|NCT00003084|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110022761|NCT00003084|Hormone Antagonists|hormone antagonists|mesh-ancestor
110022762|NCT00003084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110022763|NCT00003084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110022764|NCT00003084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110022765|NCT00003084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110022766|NCT00003084|Alkylating Agents|alkylating agents|mesh-ancestor
110022767|NCT00003084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110022768|NCT00003090|Aldesleukin|aldesleukin|mesh-list
110022769|NCT00003090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110022770|NCT00003090|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110022771|NCT00003090|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110022772|NCT00003090|Antiviral Agents|antiviral agents|mesh-ancestor
110022773|NCT00003090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110022774|NCT00003108|Bryostatin 1|bryostatin 1|mesh-list
110022775|NCT00003108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110022776|NCT00003108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110022777|NCT00003108|Immunologic Factors|immunologic factors|mesh-ancestor
110022778|NCT00003108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110022779|NCT00003114|Cyclophosphamide|cyclophosphamide|mesh-list
110022780|NCT00003114|Lomustine|lomustine|mesh-list
110022781|NCT00003114|Etoposide|etoposide|mesh-list
110022782|NCT00003114|Procarbazine|procarbazine|mesh-list
110022783|NCT00003114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110022784|NCT00003114|Immunologic Factors|immunologic factors|mesh-ancestor
110022785|NCT00003114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110022786|NCT00003114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110022787|NCT00003114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110022788|NCT00003114|Alkylating Agents|alkylating agents|mesh-ancestor
110022789|NCT00003114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110022790|NCT00003114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110022791|NCT00003114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110022792|NCT00003114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110022793|NCT00003114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110022794|NCT00003114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110022795|NCT00003114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110022796|NCT00003120|Paclitaxel|paclitaxel|mesh-list
110022797|NCT00003120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110022798|NCT00003120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110022799|NCT00003120|Tubulin Modulators|tubulin modulators|mesh-ancestor
110022800|NCT00003120|Antimitotic Agents|antimitotic agents|mesh-ancestor
110022803|NCT00003126|Aldesleukin|aldesleukin|mesh-list
110022804|NCT00003126|Interleukin-2|interleukin-2|mesh-list
110022805|NCT00003126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110022806|NCT00003126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110022807|NCT00003126|Analgesics|analgesics|mesh-ancestor
110022808|NCT00003126|Sensory System Agents|sensory system agents|mesh-ancestor
110022809|NCT00003126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110022810|NCT00003126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110022812|NCT00003126|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110022813|NCT00003126|Antiviral Agents|antiviral agents|mesh-ancestor
110022814|NCT00003126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110022815|NCT00003132|Bryostatin 1|bryostatin 1|mesh-list
110022816|NCT00003132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110022817|NCT00003132|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110022818|NCT00003132|Immunologic Factors|immunologic factors|mesh-ancestor
110022819|NCT00003132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110022820|NCT00003144|Gemcitabine|gemcitabine|mesh-list
110022821|NCT00003144|Amifostine|amifostine|mesh-list
110022822|NCT00003144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110022823|NCT00003144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110022824|NCT00003144|Antimetabolites|antimetabolites|mesh-ancestor
110022825|NCT00003144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110022827|NCT00003144|Protective Agents|protective agents|mesh-ancestor
110022828|NCT00003144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110022829|NCT00003150|Prednisone|prednisone|mesh-list
110022830|NCT00003150|Cyclophosphamide|cyclophosphamide|mesh-list
110022831|NCT00003150|Rituximab|rituximab|mesh-list
110022832|NCT00003150|Doxorubicin|doxorubicin|mesh-list
110022833|NCT00003150|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110022834|NCT00003150|Vincristine|vincristine|mesh-list
110022835|NCT00003150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110022836|NCT00003150|Immunologic Factors|immunologic factors|mesh-ancestor
110022837|NCT00003150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110022838|NCT00003150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110022839|NCT00003150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110022840|NCT00003150|Alkylating Agents|alkylating agents|mesh-ancestor
110022841|NCT00003150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110022842|NCT00003150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110022843|NCT00003150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110022844|NCT00003150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110022845|NCT00003150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110022846|NCT00003150|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110022847|NCT00003150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110022848|NCT00003150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110022849|NCT00003150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110022850|NCT00003150|Glucocorticoids|glucocorticoids|mesh-ancestor
110022851|NCT00003150|Hormones|hormones|mesh-ancestor
110022852|NCT00003150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110022853|NCT00003150|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110022854|NCT00003150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110022855|NCT00003150|Tubulin Modulators|tubulin modulators|mesh-ancestor
110022856|NCT00003150|Antimitotic Agents|antimitotic agents|mesh-ancestor
110022857|NCT00003150|Mitosis Modulators|mitosis modulators|mesh-ancestor
110022858|NCT00003156|Topotecan|topotecan|mesh-list
110022859|NCT00003156|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110022860|NCT00003156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110022861|NCT00003156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110022862|NCT00003156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110022863|NCT00003156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110022864|NCT00003174|Cladribine|cladribine|mesh-list
110022865|NCT00003174|Bryostatin 1|bryostatin 1|mesh-list
110022866|NCT00003174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110022868|NCT00003174|Immunologic Factors|immunologic factors|mesh-ancestor
110022869|NCT00003174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110022870|NCT00003174|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110022871|NCT00003018|Leucovorin|leucovorin|mesh-list
110022872|NCT00003018|Fluorouracil|fluorouracil|mesh-list
110022873|NCT00003018|Mitomycins|mitomycins|mesh-list
110022874|NCT00003018|Mitomycin|mitomycin|mesh-list
110022875|NCT00003018|Dipyridamole|dipyridamole|mesh-list
110022876|NCT00003018|Calcium|calcium|mesh-list
110022877|NCT00003018|Levoleucovorin|levoleucovorin|mesh-list
110022878|NCT00003018|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110022879|NCT00003018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110022880|NCT00003018|Antimetabolites|antimetabolites|mesh-ancestor
110022881|NCT00003018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110022882|NCT00003018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110022883|NCT00003018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110022884|NCT00003018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110022885|NCT00003018|Immunologic Factors|immunologic factors|mesh-ancestor
110022886|NCT00003018|Antidotes|antidotes|mesh-ancestor
110022887|NCT00003018|Protective Agents|protective agents|mesh-ancestor
110022888|NCT00003018|Vitamin B Complex|vitamin b complex|mesh-ancestor
110022889|NCT00003018|Vitamins|vitamins|mesh-ancestor
110022890|NCT00003018|Micronutrients|micronutrients|mesh-ancestor
110022891|NCT00003018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110022893|NCT00003018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110022894|NCT00003018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110022895|NCT00003018|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110022896|NCT00003018|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110022897|NCT00003018|Vasodilator Agents|vasodilator agents|mesh-ancestor
110022898|NCT00003198|Topotecan|topotecan|mesh-list
110022899|NCT00003198|Ifosfamide|ifosfamide|mesh-list
110022900|NCT00003198|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110022901|NCT00003198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110022902|NCT00003198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110022903|NCT00003198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110022904|NCT00003198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110022905|NCT00003198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110022906|NCT00003198|Alkylating Agents|alkylating agents|mesh-ancestor
110022907|NCT00003204|Prednisone|prednisone|mesh-list
110022908|NCT00003204|Cyclophosphamide|cyclophosphamide|mesh-list
110022909|NCT00003204|Rituximab|rituximab|mesh-list
110022910|NCT00003204|Fludarabine|fludarabine|mesh-list
110022911|NCT00003204|Fludarabine phosphate|fludarabine phosphate|mesh-list
110022912|NCT00003204|Vincristine|vincristine|mesh-list
110022913|NCT00003204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110022914|NCT00003204|Immunologic Factors|immunologic factors|mesh-ancestor
110022915|NCT00003204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110022916|NCT00003204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110022917|NCT00003204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110022918|NCT00003204|Alkylating Agents|alkylating agents|mesh-ancestor
110022919|NCT00003204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110022920|NCT00003204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110022921|NCT00003204|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110022923|NCT00003204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110022924|NCT00003204|Glucocorticoids|glucocorticoids|mesh-ancestor
110022925|NCT00003204|Hormones|hormones|mesh-ancestor
110022926|NCT00003204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110022927|NCT00003204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110022928|NCT00003204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110022929|NCT00003204|Antimetabolites|antimetabolites|mesh-ancestor
110022930|NCT00003204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110022931|NCT00003204|Tubulin Modulators|tubulin modulators|mesh-ancestor
110022932|NCT00003204|Antimitotic Agents|antimitotic agents|mesh-ancestor
110022933|NCT00003204|Mitosis Modulators|mitosis modulators|mesh-ancestor
110022934|NCT00003210|Interleukin-12|interleukin-12|mesh-list
110022935|NCT00003210|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110022936|NCT00003210|Immunologic Factors|immunologic factors|mesh-ancestor
110022937|NCT00003210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110022938|NCT00003210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110022939|NCT00003210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110022940|NCT00003210|Growth Substances|growth substances|mesh-ancestor
110022941|NCT00003210|Growth Inhibitors|growth inhibitors|mesh-ancestor
110022942|NCT00003210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110022943|NCT00003216|Gemcitabine|gemcitabine|mesh-list
110022945|NCT00003216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110022946|NCT00003216|Antimetabolites|antimetabolites|mesh-ancestor
110022947|NCT00003216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110022948|NCT00003216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110022949|NCT00003216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110022950|NCT00003216|Immunologic Factors|immunologic factors|mesh-ancestor
110022951|NCT00003216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110022952|NCT00003234|Vinorelbine|vinorelbine|mesh-list
110022953|NCT00003234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110022954|NCT00003234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110022955|NCT00003234|Tubulin Modulators|tubulin modulators|mesh-ancestor
110022956|NCT00003234|Antimitotic Agents|antimitotic agents|mesh-ancestor
110022957|NCT00003234|Mitosis Modulators|mitosis modulators|mesh-ancestor
110022958|NCT00003234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110022970|NCT00003240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110022971|NCT00003240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110022972|NCT00003240|Alkylating Agents|alkylating agents|mesh-ancestor
110022973|NCT00003240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110022974|NCT00003240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110022975|NCT00003240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110022977|NCT00003252|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110022978|NCT00003252|Protective Agents|protective agents|mesh-ancestor
110022979|NCT00003252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110022981|NCT00003264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110022982|NCT00003264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110022983|NCT00003264|Antimetabolites|antimetabolites|mesh-ancestor
110022984|NCT00003264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110022985|NCT00003276|Irinotecan|irinotecan|mesh-list
110022986|NCT00003276|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110022987|NCT00003276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110022988|NCT00003276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110022989|NCT00003276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110022990|NCT00003276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110022992|NCT00003288|Tirapazamine|tirapazamine|mesh-list
110022993|NCT00003288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110022994|NCT00003288|Immunologic Factors|immunologic factors|mesh-ancestor
110022995|NCT00003288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110022996|NCT00003288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110022997|NCT00003288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110022998|NCT00003288|Alkylating Agents|alkylating agents|mesh-ancestor
110022999|NCT00003288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110023000|NCT00003288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023001|NCT00003288|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110023002|NCT00003294|Paclitaxel|paclitaxel|mesh-list
110023003|NCT00003294|Carboplatin|carboplatin|mesh-list
110023004|NCT00003294|Amifostine|amifostine|mesh-list
110023005|NCT00003294|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110023006|NCT00003294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023007|NCT00003294|Tubulin Modulators|tubulin modulators|mesh-ancestor
110023008|NCT00003294|Antimitotic Agents|antimitotic agents|mesh-ancestor
110023009|NCT00003294|Mitosis Modulators|mitosis modulators|mesh-ancestor
110023010|NCT00003294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110023011|NCT00003294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110023012|NCT00003294|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110023013|NCT00003294|Protective Agents|protective agents|mesh-ancestor
110023015|NCT00003330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110023016|NCT00003330|Immunologic Factors|immunologic factors|mesh-ancestor
110023017|NCT00003330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110023018|NCT00003330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110023019|NCT00003330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110023020|NCT00003330|Growth Substances|growth substances|mesh-ancestor
110023021|NCT00003330|Growth Inhibitors|growth inhibitors|mesh-ancestor
110023022|NCT00003330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023023|NCT00003336|Methylprednisolone|methylprednisolone|mesh-list
110023024|NCT00003336|Cyclophosphamide|cyclophosphamide|mesh-list
110023025|NCT00003336|Melphalan|melphalan|mesh-list
110023026|NCT00003336|Busulfan|busulfan|mesh-list
110023027|NCT00003336|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110023028|NCT00003336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110023030|NCT00003336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110023031|NCT00003336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110023032|NCT00003336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110023033|NCT00003336|Alkylating Agents|alkylating agents|mesh-ancestor
110023034|NCT00003336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110023035|NCT00003336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023036|NCT00003336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110023037|NCT00003336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110023039|NCT00003336|Autonomic Agents|autonomic agents|mesh-ancestor
110023040|NCT00003336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110023041|NCT00003336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110023042|NCT00003336|Glucocorticoids|glucocorticoids|mesh-ancestor
110023043|NCT00003336|Hormones|hormones|mesh-ancestor
110023044|NCT00003336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110023045|NCT00003336|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110023046|NCT00003336|Protective Agents|protective agents|mesh-ancestor
110023047|NCT00003342|Paclitaxel|paclitaxel|mesh-list
110023048|NCT00003342|Carboplatin|carboplatin|mesh-list
110023177|NCT00003426|Antimetabolites|antimetabolites|mesh-ancestor
110023178|NCT00003426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110023180|NCT00003462|Busulfan|busulfan|mesh-list
110023181|NCT00003462|Alkylating Agents|alkylating agents|mesh-ancestor
110023182|NCT00003462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110023183|NCT00003462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110023184|NCT00003462|Immunologic Factors|immunologic factors|mesh-ancestor
110023185|NCT00003462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110023186|NCT00003462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110023187|NCT00003462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023188|NCT00003462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110023189|NCT00003528|Raltitrexed|raltitrexed|mesh-list
110023190|NCT00003528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110023191|NCT00003528|Antimetabolites|antimetabolites|mesh-ancestor
110023192|NCT00003528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110023193|NCT00003528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023195|NCT00003528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110023196|NCT00003540|Gemcitabine|gemcitabine|mesh-list
110023197|NCT00003540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110023198|NCT00003540|Antimetabolites|antimetabolites|mesh-ancestor
110023199|NCT00003540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110023200|NCT00003540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023201|NCT00003546|Gemcitabine|gemcitabine|mesh-list
110023202|NCT00003546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110023203|NCT00003546|Antimetabolites|antimetabolites|mesh-ancestor
110023204|NCT00003546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110023205|NCT00003546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023206|NCT00003552|Cyclophosphamide|cyclophosphamide|mesh-list
110023207|NCT00003552|Fludarabine|fludarabine|mesh-list
110023209|NCT00003552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110023210|NCT00003552|Immunologic Factors|immunologic factors|mesh-ancestor
110023211|NCT00003552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110023212|NCT00003552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110023213|NCT00003552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110023215|NCT00003552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110023216|NCT00003552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023217|NCT00003552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110023218|NCT00003558|Leucovorin|leucovorin|mesh-list
110023219|NCT00003558|Paclitaxel|paclitaxel|mesh-list
110023220|NCT00003558|Etoposide|etoposide|mesh-list
110023221|NCT00003558|Carboplatin|carboplatin|mesh-list
110023222|NCT00003558|Fluorouracil|fluorouracil|mesh-list
110023223|NCT00003558|Calcium|calcium|mesh-list
110023224|NCT00003558|Levoleucovorin|levoleucovorin|mesh-list
110023225|NCT00003558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110023226|NCT00003558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023227|NCT00003558|Tubulin Modulators|tubulin modulators|mesh-ancestor
110023228|NCT00003558|Antimitotic Agents|antimitotic agents|mesh-ancestor
110023229|NCT00003558|Mitosis Modulators|mitosis modulators|mesh-ancestor
110023230|NCT00003558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110023231|NCT00003558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110023232|NCT00003558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110023233|NCT00003558|Antimetabolites|antimetabolites|mesh-ancestor
110023234|NCT00003558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110023235|NCT00003558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110023236|NCT00003558|Immunologic Factors|immunologic factors|mesh-ancestor
110023237|NCT00003558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110023238|NCT00003558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110023239|NCT00003558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110023240|NCT00003558|Antidotes|antidotes|mesh-ancestor
110023241|NCT00003558|Protective Agents|protective agents|mesh-ancestor
110023242|NCT00003558|Vitamin B Complex|vitamin b complex|mesh-ancestor
110023244|NCT00003558|Micronutrients|micronutrients|mesh-ancestor
110023245|NCT00003564|Procarbazine|procarbazine|mesh-list
110023246|NCT00003564|Isotretinoin|isotretinoin|mesh-list
110023247|NCT00003564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023248|NCT00003564|Dermatologic Agents|dermatologic agents|mesh-ancestor
110023249|NCT00003576|Fluorouracil|fluorouracil|mesh-list
110023250|NCT00003576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023251|NCT00003576|Antimetabolites|antimetabolites|mesh-ancestor
110023252|NCT00003576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110023253|NCT00003576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110023254|NCT00003576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110023256|NCT00003576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110023258|NCT00003582|Fluorouracil|fluorouracil|mesh-list
110023259|NCT00003582|Amifostine|amifostine|mesh-list
110023260|NCT00003582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110023261|NCT00003582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023262|NCT00003582|Tubulin Modulators|tubulin modulators|mesh-ancestor
110023263|NCT00003582|Antimitotic Agents|antimitotic agents|mesh-ancestor
110023264|NCT00003582|Mitosis Modulators|mitosis modulators|mesh-ancestor
110023265|NCT00003582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110023266|NCT00003582|Antimetabolites|antimetabolites|mesh-ancestor
110023267|NCT00003582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110023268|NCT00003582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110023269|NCT00003582|Immunologic Factors|immunologic factors|mesh-ancestor
110023270|NCT00003582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110023271|NCT00003582|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110023272|NCT00003582|Protective Agents|protective agents|mesh-ancestor
110023273|NCT00003594|Leucovorin|leucovorin|mesh-list
110023274|NCT00003594|Fluorouracil|fluorouracil|mesh-list
110023275|NCT00003594|Oxaliplatin|oxaliplatin|mesh-list
110023276|NCT00003594|Irinotecan|irinotecan|mesh-list
110023277|NCT00003594|Calcium|calcium|mesh-list
110023278|NCT00003594|Levoleucovorin|levoleucovorin|mesh-list
110023279|NCT00003594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110023280|NCT00003594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110023281|NCT00003594|Antimetabolites|antimetabolites|mesh-ancestor
110023282|NCT00003594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110023283|NCT00003594|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110023284|NCT00003594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023285|NCT00003594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110023286|NCT00003594|Immunologic Factors|immunologic factors|mesh-ancestor
110023287|NCT00003594|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110023288|NCT00003594|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110023289|NCT00003594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110023290|NCT00003594|Antidotes|antidotes|mesh-ancestor
110023291|NCT00003594|Protective Agents|protective agents|mesh-ancestor
110023292|NCT00003594|Vitamin B Complex|vitamin b complex|mesh-ancestor
110023293|NCT00003594|Vitamins|vitamins|mesh-ancestor
110023294|NCT00003594|Micronutrients|micronutrients|mesh-ancestor
110023295|NCT00003600|Epoetin Alfa|epoetin alfa|mesh-list
110023296|NCT00003600|Hematinics|hematinics|mesh-ancestor
110023297|NCT00003606|Cyclophosphamide|cyclophosphamide|mesh-list
110023298|NCT00003606|Etoposide|etoposide|mesh-list
110023299|NCT00003606|Epirubicin|epirubicin|mesh-list
110023300|NCT00003606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110023301|NCT00003606|Immunologic Factors|immunologic factors|mesh-ancestor
110023302|NCT00003606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110023303|NCT00003606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110023304|NCT00003606|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110023305|NCT00003606|Alkylating Agents|alkylating agents|mesh-ancestor
110023306|NCT00003606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110023307|NCT00003606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023308|NCT00003606|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110023309|NCT00003606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110023310|NCT00003606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110023311|NCT00003606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110023312|NCT00003606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110023313|NCT00003606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110023314|NCT00003612|Paclitaxel|paclitaxel|mesh-list
110023315|NCT00003612|Carboplatin|carboplatin|mesh-list
110023316|NCT00003612|Trastuzumab|trastuzumab|mesh-list
110023317|NCT00003612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110023318|NCT00003612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023319|NCT00003612|Tubulin Modulators|tubulin modulators|mesh-ancestor
110023320|NCT00003612|Antimitotic Agents|antimitotic agents|mesh-ancestor
110023321|NCT00003612|Mitosis Modulators|mitosis modulators|mesh-ancestor
110023322|NCT00003612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110023323|NCT00003612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110023324|NCT00003624|Paclitaxel|paclitaxel|mesh-list
110023325|NCT00003624|Amifostine|amifostine|mesh-list
110023326|NCT00003624|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110023327|NCT00003624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023328|NCT00003624|Tubulin Modulators|tubulin modulators|mesh-ancestor
110023329|NCT00003624|Antimitotic Agents|antimitotic agents|mesh-ancestor
110023330|NCT00003624|Mitosis Modulators|mitosis modulators|mesh-ancestor
110023331|NCT00003624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110023332|NCT00003624|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110023334|NCT00003624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110023335|NCT00003630|Arsenic Trioxide|arsenic trioxide|mesh-list
110023336|NCT00003630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023337|NCT00003636|Carboplatin|carboplatin|mesh-list
110023338|NCT00003636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023339|NCT00003642|Fluorouracil|fluorouracil|mesh-list
110023340|NCT00003642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023341|NCT00003642|Antimetabolites|antimetabolites|mesh-ancestor
110023342|NCT00003642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110023343|NCT00003642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110023344|NCT00003642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110023345|NCT00003642|Immunologic Factors|immunologic factors|mesh-ancestor
110023346|NCT00003642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110023347|NCT00003654|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
110023348|NCT00003654|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110023349|NCT00003654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110023351|NCT00003666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110023352|NCT00003666|Alkylating Agents|alkylating agents|mesh-ancestor
110023353|NCT00003666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110023354|NCT00003666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023356|NCT00003678|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110023357|NCT00003678|Hormone Antagonists|hormone antagonists|mesh-ancestor
110023358|NCT00003678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110023359|NCT00003678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110023360|NCT00003678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110023361|NCT00003678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023362|NCT00003678|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110023363|NCT00003678|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110023364|NCT00003678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110023365|NCT00003684|Theophylline|theophylline|mesh-list
110023366|NCT00003684|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110023367|NCT00003684|Autonomic Agents|autonomic agents|mesh-ancestor
110023368|NCT00003684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110023369|NCT00003684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110023370|NCT00003684|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110023371|NCT00003684|Respiratory System Agents|respiratory system agents|mesh-ancestor
110023372|NCT00003684|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110023373|NCT00003684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110023374|NCT00003684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110023375|NCT00003684|Vasodilator Agents|vasodilator agents|mesh-ancestor
110023376|NCT00003684|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110023377|NCT00003684|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110023378|NCT00003684|Purinergic Agents|purinergic agents|mesh-ancestor
110023379|NCT00003684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110023380|NCT00003690|Carboplatin|carboplatin|mesh-list
110023381|NCT00003690|Alvocidib|alvocidib|mesh-list
110023382|NCT00003690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023383|NCT00003690|Growth Inhibitors|growth inhibitors|mesh-ancestor
110023384|NCT00003690|Growth Substances|growth substances|mesh-ancestor
110023385|NCT00003690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110023386|NCT00003690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110023387|NCT00003690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110023388|NCT00003690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110023389|NCT00003696|Paclitaxel|paclitaxel|mesh-list
110023390|NCT00003696|Etoposide|etoposide|mesh-list
110023391|NCT00003696|Cyclophosphamide|cyclophosphamide|mesh-list
110023392|NCT00003696|Carboplatin|carboplatin|mesh-list
110023393|NCT00003696|Doxorubicin|doxorubicin|mesh-list
110023394|NCT00003696|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110023395|NCT00003696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110023396|NCT00003696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023397|NCT00003696|Tubulin Modulators|tubulin modulators|mesh-ancestor
110023398|NCT00003696|Antimitotic Agents|antimitotic agents|mesh-ancestor
110023399|NCT00003696|Mitosis Modulators|mitosis modulators|mesh-ancestor
110023400|NCT00003696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110023401|NCT00003696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110023402|NCT00003696|Immunologic Factors|immunologic factors|mesh-ancestor
110023403|NCT00003696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110023404|NCT00003696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110023405|NCT00003696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110023406|NCT00003696|Alkylating Agents|alkylating agents|mesh-ancestor
110023407|NCT00003696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110023409|NCT00003696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110023410|NCT00003696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110023411|NCT00003696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110023412|NCT00003708|Temozolomide|temozolomide|mesh-list
110023413|NCT00003708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110023414|NCT00003708|Alkylating Agents|alkylating agents|mesh-ancestor
110023415|NCT00003708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110023416|NCT00003708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023418|NCT00003714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023419|NCT00003720|Semaxinib|semaxinib|mesh-list
110023420|NCT00003720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110023421|NCT00003720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110023422|NCT00003720|Growth Substances|growth substances|mesh-ancestor
110023423|NCT00003720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110023424|NCT00003720|Growth Inhibitors|growth inhibitors|mesh-ancestor
110023425|NCT00003720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023426|NCT00003720|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110023427|NCT00003720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110023428|NCT00003720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110023429|NCT00003732|Paclitaxel|paclitaxel|mesh-list
110023430|NCT00003732|Carboplatin|carboplatin|mesh-list
110023431|NCT00003732|Topotecan|topotecan|mesh-list
110023432|NCT00003732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110023433|NCT00003732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023434|NCT00003732|Tubulin Modulators|tubulin modulators|mesh-ancestor
110023435|NCT00003732|Antimitotic Agents|antimitotic agents|mesh-ancestor
110023436|NCT00003732|Mitosis Modulators|mitosis modulators|mesh-ancestor
110023437|NCT00003732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110023438|NCT00003732|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110023439|NCT00003732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110023440|NCT00003732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110023442|NCT00003744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110023443|NCT00003744|Antimetabolites|antimetabolites|mesh-ancestor
110023444|NCT00003744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110023445|NCT00003744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023446|NCT00003762|Gemcitabine|gemcitabine|mesh-list
110023447|NCT00003762|Docetaxel|docetaxel|mesh-list
110023448|NCT00003762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110023449|NCT00003762|Antimetabolites|antimetabolites|mesh-ancestor
110023450|NCT00003762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110023451|NCT00003762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023452|NCT00003762|Tubulin Modulators|tubulin modulators|mesh-ancestor
110023453|NCT00003762|Antimitotic Agents|antimitotic agents|mesh-ancestor
110023454|NCT00003762|Mitosis Modulators|mitosis modulators|mesh-ancestor
110023455|NCT00003768|Fosbretabulin|fosbretabulin|mesh-list
110023456|NCT00003768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110023457|NCT00003768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023458|NCT00003780|Gemcitabine|gemcitabine|mesh-list
110023459|NCT00003780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110023460|NCT00003780|Antimetabolites|antimetabolites|mesh-ancestor
110023461|NCT00003780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110023462|NCT00003780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023463|NCT00003786|Irofulven|irofulven|mesh-list
110023464|NCT00003786|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110023465|NCT00003786|Alkylating Agents|alkylating agents|mesh-ancestor
110023466|NCT00003786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110023467|NCT00003786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023468|NCT00003792|Lenograstim|lenograstim|mesh-list
110023469|NCT00003792|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110023470|NCT00003792|Immunologic Factors|immunologic factors|mesh-ancestor
110023471|NCT00003792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110023472|NCT00003798|Motexafin gadolinium|motexafin gadolinium|mesh-list
110023473|NCT00003798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023474|NCT00003798|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110023475|NCT00003798|Dermatologic Agents|dermatologic agents|mesh-ancestor
110023476|NCT00003804|Dactinomycin|dactinomycin|mesh-list
110023477|NCT00003804|Vincristine|vincristine|mesh-list
110023478|NCT00003804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110023479|NCT00003804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023480|NCT00003804|Tubulin Modulators|tubulin modulators|mesh-ancestor
110023481|NCT00003804|Antimitotic Agents|antimitotic agents|mesh-ancestor
110023482|NCT00003804|Mitosis Modulators|mitosis modulators|mesh-ancestor
110023714|NCT00003960|Glucocorticoids|glucocorticoids|mesh-ancestor
110023484|NCT00003804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110023485|NCT00003804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110023486|NCT00003804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110023487|NCT00003804|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110023488|NCT00003804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110023489|NCT00003804|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110023490|NCT00003828|Vinorelbine|vinorelbine|mesh-list
110023491|NCT00003828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110023492|NCT00003828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023493|NCT00003828|Tubulin Modulators|tubulin modulators|mesh-ancestor
110023494|NCT00003828|Antimitotic Agents|antimitotic agents|mesh-ancestor
110023495|NCT00003828|Mitosis Modulators|mitosis modulators|mesh-ancestor
110023496|NCT00003828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110023497|NCT00003834|Leucovorin|leucovorin|mesh-list
110023498|NCT00003834|Fluorouracil|fluorouracil|mesh-list
110023499|NCT00003834|Oxaliplatin|oxaliplatin|mesh-list
110023500|NCT00003834|Calcium|calcium|mesh-list
110023501|NCT00003834|Levoleucovorin|levoleucovorin|mesh-list
110023502|NCT00003834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110023503|NCT00003834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110023504|NCT00003834|Antimetabolites|antimetabolites|mesh-ancestor
110023505|NCT00003834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110023506|NCT00003834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110023507|NCT00003834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023508|NCT00003834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110023509|NCT00003834|Immunologic Factors|immunologic factors|mesh-ancestor
110023510|NCT00003834|Antidotes|antidotes|mesh-ancestor
110023511|NCT00003834|Protective Agents|protective agents|mesh-ancestor
110023512|NCT00003834|Vitamin B Complex|vitamin b complex|mesh-ancestor
110023513|NCT00003834|Vitamins|vitamins|mesh-ancestor
110023514|NCT00003834|Micronutrients|micronutrients|mesh-ancestor
110023515|NCT00003846|Cyclophosphamide|cyclophosphamide|mesh-list
110023516|NCT00003846|Thiotepa|thiotepa|mesh-list
110023517|NCT00003846|Carboplatin|carboplatin|mesh-list
110023518|NCT00003846|Vincristine|vincristine|mesh-list
110023519|NCT00003846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110023520|NCT00003846|Immunologic Factors|immunologic factors|mesh-ancestor
110023521|NCT00003846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110023522|NCT00003846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110023523|NCT00003846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110023524|NCT00003846|Alkylating Agents|alkylating agents|mesh-ancestor
110023525|NCT00003846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110023526|NCT00003846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023527|NCT00003846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110023528|NCT00003846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110023529|NCT00003846|Tubulin Modulators|tubulin modulators|mesh-ancestor
110023530|NCT00003846|Antimitotic Agents|antimitotic agents|mesh-ancestor
110023531|NCT00003846|Mitosis Modulators|mitosis modulators|mesh-ancestor
110023532|NCT00003852|Paclitaxel|paclitaxel|mesh-list
110023533|NCT00003852|Etoposide|etoposide|mesh-list
110023534|NCT00003852|Cyclophosphamide|cyclophosphamide|mesh-list
110023535|NCT00003852|Carboplatin|carboplatin|mesh-list
110023536|NCT00003852|Epirubicin|epirubicin|mesh-list
110023537|NCT00003852|Ifosfamide|ifosfamide|mesh-list
110023538|NCT00003852|Thiotepa|thiotepa|mesh-list
110023539|NCT00003852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110023540|NCT00003852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023541|NCT00003852|Tubulin Modulators|tubulin modulators|mesh-ancestor
110023542|NCT00003852|Antimitotic Agents|antimitotic agents|mesh-ancestor
110023543|NCT00003852|Mitosis Modulators|mitosis modulators|mesh-ancestor
110023544|NCT00003852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110023545|NCT00003852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110023547|NCT00003852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110023548|NCT00003852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110023549|NCT00003852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110023550|NCT00003852|Alkylating Agents|alkylating agents|mesh-ancestor
110023551|NCT00003852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110023552|NCT00003852|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110023553|NCT00003852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110023554|NCT00003852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110023555|NCT00003852|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110023556|NCT00003858|Mitoxantrone|mitoxantrone|mesh-list
110023557|NCT00003858|Analgesics|analgesics|mesh-ancestor
110023559|NCT00003858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110023560|NCT00003858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110023562|NCT00003858|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110023563|NCT00003858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110023564|NCT00003858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110023565|NCT00003858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110023566|NCT00003870|Cyclophosphamide|cyclophosphamide|mesh-list
110023567|NCT00003870|Methotrexate|methotrexate|mesh-list
110023568|NCT00003870|Antibodies|antibodies|mesh-list
110023569|NCT00003870|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110023570|NCT00003870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110023571|NCT00003870|Immunologic Factors|immunologic factors|mesh-ancestor
110023572|NCT00003870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110023573|NCT00003870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110023574|NCT00003870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110023575|NCT00003870|Alkylating Agents|alkylating agents|mesh-ancestor
110023576|NCT00003870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110023577|NCT00003870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023578|NCT00003870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110023579|NCT00003870|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110023580|NCT00003870|Abortifacient Agents|abortifacient agents|mesh-ancestor
110023581|NCT00003870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110023582|NCT00003870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110023584|NCT00003870|Dermatologic Agents|dermatologic agents|mesh-ancestor
110023585|NCT00003870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110023586|NCT00003870|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110023587|NCT00003870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110023589|NCT00003876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110023590|NCT00003876|Alkylating Agents|alkylating agents|mesh-ancestor
110023591|NCT00003876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110023592|NCT00003876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023593|NCT00003888|Docetaxel|docetaxel|mesh-list
110023594|NCT00003888|Fluorouracil|fluorouracil|mesh-list
110023595|NCT00003888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023596|NCT00003888|Tubulin Modulators|tubulin modulators|mesh-ancestor
110023597|NCT00003888|Antimitotic Agents|antimitotic agents|mesh-ancestor
110023598|NCT00003888|Mitosis Modulators|mitosis modulators|mesh-ancestor
110023599|NCT00003888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110023600|NCT00003888|Antimetabolites|antimetabolites|mesh-ancestor
110023601|NCT00003888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110023602|NCT00003888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110023603|NCT00003888|Immunologic Factors|immunologic factors|mesh-ancestor
110023604|NCT00003888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110023605|NCT00003894|Thalidomide|thalidomide|mesh-list
110023606|NCT00003894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110023607|NCT00003894|Immunologic Factors|immunologic factors|mesh-ancestor
110023608|NCT00003894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110023609|NCT00003894|Leprostatic Agents|leprostatic agents|mesh-ancestor
110023610|NCT00003894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110023611|NCT00003894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110023612|NCT00003894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110023613|NCT00003894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110023614|NCT00003894|Growth Substances|growth substances|mesh-ancestor
110023615|NCT00003894|Growth Inhibitors|growth inhibitors|mesh-ancestor
110023616|NCT00003894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023617|NCT00003900|Docetaxel|docetaxel|mesh-list
110023618|NCT00003900|Irinotecan|irinotecan|mesh-list
110023619|NCT00003900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023620|NCT00003900|Tubulin Modulators|tubulin modulators|mesh-ancestor
110023621|NCT00003900|Antimitotic Agents|antimitotic agents|mesh-ancestor
110023622|NCT00003900|Mitosis Modulators|mitosis modulators|mesh-ancestor
110023623|NCT00003900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110023624|NCT00003900|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110023625|NCT00003900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110023626|NCT00003900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110023627|NCT00003906|Tamoxifen|tamoxifen|mesh-list
110023628|NCT00003906|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
110023629|NCT00003906|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110023630|NCT00003906|Hormone Antagonists|hormone antagonists|mesh-ancestor
110023631|NCT00003906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110036240|NCT01409616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110036241|NCT01409616|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110036242|NCT01409616|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110036243|NCT01409616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110036244|NCT01409616|Antipyretics|antipyretics|mesh-ancestor
110036245|NCT01409616|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110036246|NCT01409616|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110036247|NCT01409616|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110036248|NCT01409616|Purinergic Agents|purinergic agents|mesh-ancestor
110036249|NCT01409616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110036250|NCT01409616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110036251|NCT01409616|Antifungal Agents|antifungal agents|mesh-ancestor
110036252|NCT01409616|Keratolytic Agents|keratolytic agents|mesh-ancestor
110036253|NCT01409616|Dermatologic Agents|dermatologic agents|mesh-ancestor
110036254|NCT01409616|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110036255|NCT01409616|Antithrombins|antithrombins|mesh-ancestor
110036256|NCT01409616|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110036258|NCT01409616|Anticoagulants|anticoagulants|mesh-ancestor
110036260|NCT01409694|Ergocalciferols|ergocalciferols|mesh-list
110036261|NCT01409694|Cholecalciferol|cholecalciferol|mesh-list
110036262|NCT01409694|Vitamins|vitamins|mesh-list
110036263|NCT01409694|Memantine|memantine|mesh-list
110036264|NCT01409694|Micronutrients|micronutrients|mesh-ancestor
110036265|NCT01409694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036266|NCT01409694|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110036267|NCT01409694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110036268|NCT01409694|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110036269|NCT01409694|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110036270|NCT01409694|Dopamine Agents|dopamine agents|mesh-ancestor
110036288|NCT01410162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110036289|NCT01410162|Immunologic Factors|immunologic factors|mesh-ancestor
110036291|NCT01410162|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110036292|NCT01410162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110036293|NCT01410162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110036294|NCT01410201|Dexamethasone|dexamethasone|mesh-list
110036295|NCT01410201|Dexamethasone acetate|dexamethasone acetate|mesh-list
110036296|NCT01410201|BB 1101|bb 1101|mesh-list
110036297|NCT01410201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110036298|NCT01410201|Antiemetics|antiemetics|mesh-ancestor
110036299|NCT01410201|Autonomic Agents|autonomic agents|mesh-ancestor
110036300|NCT01410201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110036301|NCT01410201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036302|NCT01410201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110036303|NCT01410201|Glucocorticoids|glucocorticoids|mesh-ancestor
110036304|NCT01410201|Hormones|hormones|mesh-ancestor
110036305|NCT01410201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110036306|NCT01410201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110036307|NCT01410201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110036308|NCT01410201|Protease Inhibitors|protease inhibitors|mesh-ancestor
110036309|NCT01410201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110036310|NCT01410201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110036311|NCT01410214|Cisplatin|cisplatin|mesh-list
110023632|NCT00003906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110023633|NCT00003906|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110023634|NCT00003906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023635|NCT00003906|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110023636|NCT00003906|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110023637|NCT00003906|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110023639|NCT00003912|Doxorubicin|doxorubicin|mesh-list
110023640|NCT00003912|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110023641|NCT00003912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023642|NCT00003912|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110023643|NCT00003912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110023644|NCT00003912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110023645|NCT00003912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110023646|NCT00003912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110023647|NCT00003924|Interferons|interferons|mesh-list
110023648|NCT00003924|Interferon-alpha|interferon-alpha|mesh-list
110023649|NCT00003924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023650|NCT00003924|Antiviral Agents|antiviral agents|mesh-ancestor
110023651|NCT00003924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110023652|NCT00003924|Immunologic Factors|immunologic factors|mesh-ancestor
110023653|NCT00003924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110023654|NCT00003930|Paclitaxel|paclitaxel|mesh-list
110023655|NCT00003930|Gemcitabine|gemcitabine|mesh-list
110023656|NCT00003930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110023657|NCT00003930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023658|NCT00003930|Tubulin Modulators|tubulin modulators|mesh-ancestor
110023659|NCT00003930|Antimitotic Agents|antimitotic agents|mesh-ancestor
110023660|NCT00003930|Mitosis Modulators|mitosis modulators|mesh-ancestor
110023661|NCT00003930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110023662|NCT00003930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110023663|NCT00003930|Antimetabolites|antimetabolites|mesh-ancestor
110023664|NCT00003936|Bryostatin 1|bryostatin 1|mesh-list
110023665|NCT00003936|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110023666|NCT00003936|Immunologic Factors|immunologic factors|mesh-ancestor
110023667|NCT00003936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110023668|NCT00003936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023669|NCT00003954|Cyclosporine|cyclosporine|mesh-list
110023670|NCT00003954|Mycophenolic Acid|mycophenolic acid|mesh-list
110023671|NCT00003954|Melphalan|melphalan|mesh-list
110023672|NCT00003954|Cyclosporins|cyclosporins|mesh-list
110023673|NCT00003954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110023674|NCT00003954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110023675|NCT00003954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110023676|NCT00003954|Immunologic Factors|immunologic factors|mesh-ancestor
110023677|NCT00003954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110023678|NCT00003954|Antifungal Agents|antifungal agents|mesh-ancestor
110023679|NCT00003954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110023680|NCT00003954|Dermatologic Agents|dermatologic agents|mesh-ancestor
110023681|NCT00003954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110023682|NCT00003954|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110023683|NCT00003954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110023684|NCT00003954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023685|NCT00003954|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110023686|NCT00003954|Antitubercular Agents|antitubercular agents|mesh-ancestor
110023687|NCT00003954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110023688|NCT00003954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110023689|NCT00003954|Alkylating Agents|alkylating agents|mesh-ancestor
110023690|NCT00003954|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110023692|NCT00003960|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110023693|NCT00003960|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110023694|NCT00003960|Prednisolone|prednisolone|mesh-list
110023695|NCT00003960|Prednisolone acetate|prednisolone acetate|mesh-list
110023696|NCT00003960|Cyclophosphamide|cyclophosphamide|mesh-list
110023697|NCT00003960|Busulfan|busulfan|mesh-list
110023698|NCT00003960|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110023699|NCT00003960|Prednisolone phosphate|prednisolone phosphate|mesh-list
110023700|NCT00003960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110023701|NCT00003960|Immunologic Factors|immunologic factors|mesh-ancestor
110023702|NCT00003960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110023703|NCT00003960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110023704|NCT00003960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110023705|NCT00003960|Alkylating Agents|alkylating agents|mesh-ancestor
110023706|NCT00003960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110023707|NCT00003960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023708|NCT00003960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110023709|NCT00003960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110023710|NCT00003960|Antiemetics|antiemetics|mesh-ancestor
110023711|NCT00003960|Autonomic Agents|autonomic agents|mesh-ancestor
110023712|NCT00003960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110023713|NCT00003960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110023716|NCT00003960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110023717|NCT00003960|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110023718|NCT00003960|Protective Agents|protective agents|mesh-ancestor
110023719|NCT00003960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110023720|NCT00003966|Defibrotide|defibrotide|mesh-list
110023721|NCT00003966|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110023722|NCT00003966|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110023723|NCT00003966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110023724|NCT00003966|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110023725|NCT00003972|Tamoxifen|tamoxifen|mesh-list
110023726|NCT00003972|Paclitaxel|paclitaxel|mesh-list
110023727|NCT00003972|Cyclophosphamide|cyclophosphamide|mesh-list
110023728|NCT00003972|Carboplatin|carboplatin|mesh-list
110023729|NCT00003972|Melphalan|melphalan|mesh-list
110023730|NCT00003972|Busulfan|busulfan|mesh-list
110023731|NCT00003972|Thiotepa|thiotepa|mesh-list
110023732|NCT00003972|Sargramostim|sargramostim|mesh-list
110023733|NCT00003972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110023734|NCT00003972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023735|NCT00003972|Tubulin Modulators|tubulin modulators|mesh-ancestor
110023736|NCT00003972|Antimitotic Agents|antimitotic agents|mesh-ancestor
110023737|NCT00003972|Mitosis Modulators|mitosis modulators|mesh-ancestor
110023738|NCT00003972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110023739|NCT00003972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110023740|NCT00003972|Immunologic Factors|immunologic factors|mesh-ancestor
110023742|NCT00003972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110023743|NCT00003972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110023744|NCT00003972|Alkylating Agents|alkylating agents|mesh-ancestor
110023745|NCT00003972|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110023746|NCT00003972|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110023747|NCT00003972|Hormone Antagonists|hormone antagonists|mesh-ancestor
110023748|NCT00003972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110023749|NCT00003972|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110023750|NCT00003972|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110023751|NCT00003972|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110023752|NCT00003972|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110023754|NCT00003984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110023755|NCT00003984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023757|NCT00003996|Carmustine|carmustine|mesh-list
110023758|NCT00003996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023759|NCT00003996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110023760|NCT00003996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110023761|NCT00003996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110023762|NCT00003996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110023763|NCT00003996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110023764|NCT00003996|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110023765|NCT00003996|Alkylating Agents|alkylating agents|mesh-ancestor
110023767|NCT00004002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023768|NCT00004008|Bryostatin 1|bryostatin 1|mesh-list
110023769|NCT00004008|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110023770|NCT00004008|Immunologic Factors|immunologic factors|mesh-ancestor
110023771|NCT00004008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110023772|NCT00004008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023773|NCT00004014|Doxorubicin|doxorubicin|mesh-list
110023774|NCT00004014|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110023775|NCT00004014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110023776|NCT00004014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023777|NCT00004014|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110023778|NCT00004014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110023779|NCT00004014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110023780|NCT00004014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110023781|NCT00004032|Interferons|interferons|mesh-list
110023782|NCT00004032|Interferon-gamma|interferon-gamma|mesh-list
110023783|NCT00004032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023784|NCT00004032|Antiviral Agents|antiviral agents|mesh-ancestor
110023785|NCT00004032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110023786|NCT00004050|Interleukin-2|interleukin-2|mesh-list
110023787|NCT00004050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023788|NCT00004050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110023789|NCT00004050|Analgesics|analgesics|mesh-ancestor
110023790|NCT00004050|Sensory System Agents|sensory system agents|mesh-ancestor
110023791|NCT00004050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110023792|NCT00004050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110023793|NCT00004056|Cytarabine|cytarabine|mesh-list
110023794|NCT00004056|Thioguanine|thioguanine|mesh-list
110023799|NCT00004056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110023800|NCT00004056|Antimetabolites|antimetabolites|mesh-ancestor
110023801|NCT00004056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110023802|NCT00004056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023803|NCT00004056|Antiviral Agents|antiviral agents|mesh-ancestor
110023804|NCT00004056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110023805|NCT00004056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110023806|NCT00004056|Immunologic Factors|immunologic factors|mesh-ancestor
110023807|NCT00004056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110023808|NCT00004056|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110023809|NCT00004056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110023810|NCT00004056|Alkylating Agents|alkylating agents|mesh-ancestor
110023811|NCT00004056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110023812|NCT00004056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110023813|NCT00004056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110023814|NCT00004056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110023815|NCT00004056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110023816|NCT00004062|Azacitidine|azacitidine|mesh-list
110023817|NCT00004062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110023819|NCT00004062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110023820|NCT00004062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023821|NCT00004062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110023822|NCT00004068|Irinotecan|irinotecan|mesh-list
110023823|NCT00004068|Temozolomide|temozolomide|mesh-list
110023824|NCT00004068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110023825|NCT00004068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110023826|NCT00004068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110023827|NCT00004068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110023828|NCT00004068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023829|NCT00004068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110023830|NCT00004068|Alkylating Agents|alkylating agents|mesh-ancestor
110023831|NCT00004074|Carboplatin|carboplatin|mesh-list
110023832|NCT00004074|Trastuzumab|trastuzumab|mesh-list
110023833|NCT00004074|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110023834|NCT00004074|Interleukin-12|interleukin-12|mesh-list
110023835|NCT00004074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023836|NCT00004074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110023837|NCT00004074|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110023838|NCT00004074|Immunologic Factors|immunologic factors|mesh-ancestor
110023839|NCT00004074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110023840|NCT00004074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110023841|NCT00004074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110023842|NCT00004074|Growth Substances|growth substances|mesh-ancestor
110023843|NCT00004074|Growth Inhibitors|growth inhibitors|mesh-ancestor
110023844|NCT00004086|Cytarabine|cytarabine|mesh-list
110023845|NCT00004086|Etoposide|etoposide|mesh-list
110023846|NCT00004086|Ifosfamide|ifosfamide|mesh-list
110023847|NCT00004086|Epratuzumab|epratuzumab|mesh-list
110023848|NCT00004086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023849|NCT00004086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110023850|NCT00004086|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110023851|NCT00004086|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110023852|NCT00004086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110023853|NCT00004086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110023854|NCT00004086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110023855|NCT00004086|Antimetabolites|antimetabolites|mesh-ancestor
110023857|NCT00004086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110023858|NCT00004086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110023859|NCT00004086|Immunologic Factors|immunologic factors|mesh-ancestor
110023860|NCT00004086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110023861|NCT00004086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110023862|NCT00004086|Alkylating Agents|alkylating agents|mesh-ancestor
110023863|NCT00004086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110023864|NCT00004104|Interferons|interferons|mesh-list
110023865|NCT00004104|Interferon-alpha|interferon-alpha|mesh-list
110023866|NCT00004104|Interleukin-2|interleukin-2|mesh-list
110023867|NCT00004104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023868|NCT00004104|Antiviral Agents|antiviral agents|mesh-ancestor
110023869|NCT00004104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110023870|NCT00004104|Immunologic Factors|immunologic factors|mesh-ancestor
110023871|NCT00004104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110023872|NCT00004104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110023873|NCT00004104|Analgesics|analgesics|mesh-ancestor
110023874|NCT00004104|Sensory System Agents|sensory system agents|mesh-ancestor
110023875|NCT00004104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110023876|NCT00004110|Etoposide|etoposide|mesh-list
110023882|NCT00004110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110023883|NCT00004110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023884|NCT00004110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110023885|NCT00004110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110023887|NCT00004110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110023888|NCT00004110|Dermatologic Agents|dermatologic agents|mesh-ancestor
110023889|NCT00004122|Interferons|interferons|mesh-list
110023890|NCT00004122|Interferon-alpha|interferon-alpha|mesh-list
110023891|NCT00004122|BCG Vaccine|bcg vaccine|mesh-list
110023892|NCT00004122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023893|NCT00004122|Antiviral Agents|antiviral agents|mesh-ancestor
110023894|NCT00004122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110023895|NCT00004122|Immunologic Factors|immunologic factors|mesh-ancestor
110023896|NCT00004122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110023897|NCT00004122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110023898|NCT00004128|Cytarabine|cytarabine|mesh-list
110023899|NCT00004128|Aldesleukin|aldesleukin|mesh-list
110023900|NCT00004128|Cyclophosphamide|cyclophosphamide|mesh-list
110023901|NCT00004128|Busulfan|busulfan|mesh-list
110023902|NCT00004128|Etoposide|etoposide|mesh-list
110023903|NCT00004128|Daunorubicin|daunorubicin|mesh-list
110023904|NCT00004128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110023905|NCT00004128|Immunologic Factors|immunologic factors|mesh-ancestor
110023906|NCT00004128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110023907|NCT00004128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110023908|NCT00004128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110052819|NCT01482156|Everolimus|everolimus|mesh-list
110023909|NCT00004128|Alkylating Agents|alkylating agents|mesh-ancestor
110023910|NCT00004128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110023911|NCT00004128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023912|NCT00004128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110023913|NCT00004128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110023914|NCT00004128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110023915|NCT00004128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110023916|NCT00004128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110023917|NCT00004128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110023918|NCT00004128|Antimetabolites|antimetabolites|mesh-ancestor
110023919|NCT00004128|Antiviral Agents|antiviral agents|mesh-ancestor
110023920|NCT00004128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110023921|NCT00004128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110023922|NCT00004128|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110023923|NCT00004128|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110023924|NCT00004152|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110023925|NCT00004152|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110023926|NCT00004152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110023928|NCT00004158|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110023929|NCT00004158|Alkylating Agents|alkylating agents|mesh-ancestor
110023930|NCT00004158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110023931|NCT00004158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023932|NCT00004158|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110023933|NCT00004158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110023934|NCT00004158|Immunologic Factors|immunologic factors|mesh-ancestor
110023935|NCT00004158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110023937|NCT00004164|Docetaxel|docetaxel|mesh-list
110023938|NCT00004164|Fluorouracil|fluorouracil|mesh-list
110023939|NCT00004164|Calcium|calcium|mesh-list
110023940|NCT00004164|Levoleucovorin|levoleucovorin|mesh-list
110023941|NCT00004164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023942|NCT00004164|Tubulin Modulators|tubulin modulators|mesh-ancestor
110023943|NCT00004164|Antimitotic Agents|antimitotic agents|mesh-ancestor
110023944|NCT00004164|Mitosis Modulators|mitosis modulators|mesh-ancestor
110023945|NCT00004164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110023946|NCT00004164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110023947|NCT00004164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110023948|NCT00004164|Antimetabolites|antimetabolites|mesh-ancestor
110023949|NCT00004164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110023950|NCT00004164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110023951|NCT00004164|Immunologic Factors|immunologic factors|mesh-ancestor
110023952|NCT00004164|Antidotes|antidotes|mesh-ancestor
110023953|NCT00004164|Protective Agents|protective agents|mesh-ancestor
110023954|NCT00004164|Vitamin B Complex|vitamin b complex|mesh-ancestor
110023956|NCT00004164|Micronutrients|micronutrients|mesh-ancestor
110023958|NCT00004176|Amifostine|amifostine|mesh-list
110023959|NCT00004176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023960|NCT00004176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110023963|NCT00004176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110023964|NCT00004176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110023965|NCT00004176|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110023966|NCT00004176|Protective Agents|protective agents|mesh-ancestor
110023967|NCT00004176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110023968|NCT00004188|Cyclophosphamide|cyclophosphamide|mesh-list
110023969|NCT00004188|Melphalan|melphalan|mesh-list
110023970|NCT00004188|Mechlorethamine|mechlorethamine|mesh-list
110023971|NCT00004188|Cisplatin|cisplatin|mesh-list
110023972|NCT00004188|Carboplatin|carboplatin|mesh-list
110023973|NCT00004188|Doxorubicin|doxorubicin|mesh-list
110023974|NCT00004188|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110023975|NCT00004188|Etoposide|etoposide|mesh-list
110023976|NCT00004188|Vincristine|vincristine|mesh-list
110023977|NCT00004188|Topotecan|topotecan|mesh-list
110023978|NCT00004188|Isotretinoin|isotretinoin|mesh-list
110023979|NCT00004188|Lenograstim|lenograstim|mesh-list
110023980|NCT00004188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110023981|NCT00004188|Immunologic Factors|immunologic factors|mesh-ancestor
110023982|NCT00004188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110023983|NCT00004188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110023984|NCT00004188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110023985|NCT00004188|Alkylating Agents|alkylating agents|mesh-ancestor
110023986|NCT00004188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110023987|NCT00004188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023988|NCT00004188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110023989|NCT00004188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110023990|NCT00004188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110023991|NCT00004188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110023992|NCT00004188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110023993|NCT00004188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110023994|NCT00004188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110023995|NCT00004188|Tubulin Modulators|tubulin modulators|mesh-ancestor
110023996|NCT00004188|Antimitotic Agents|antimitotic agents|mesh-ancestor
110023997|NCT00004188|Mitosis Modulators|mitosis modulators|mesh-ancestor
110023998|NCT00004188|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110023999|NCT00004188|Dermatologic Agents|dermatologic agents|mesh-ancestor
110024001|NCT00004194|Fludarabine phosphate|fludarabine phosphate|mesh-list
110024002|NCT00004194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110024003|NCT00004194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110024004|NCT00004194|Antimetabolites|antimetabolites|mesh-ancestor
110024005|NCT00004194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110024006|NCT00004194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110024007|NCT00004194|Immunologic Factors|immunologic factors|mesh-ancestor
110024008|NCT00004194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110024009|NCT00004200|Temozolomide|temozolomide|mesh-list
110024010|NCT00004200|Prinomastat|prinomastat|mesh-list
110024011|NCT00004200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110024012|NCT00004200|Alkylating Agents|alkylating agents|mesh-ancestor
110024013|NCT00004200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110024014|NCT00004200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110024015|NCT00004200|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
110024016|NCT00004200|Protease Inhibitors|protease inhibitors|mesh-ancestor
110024017|NCT00004200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110024019|NCT00004206|Fluorouracil|fluorouracil|mesh-list
110024020|NCT00004206|Oxaliplatin|oxaliplatin|mesh-list
110024021|NCT00004206|Calcium|calcium|mesh-list
110024022|NCT00004206|Levoleucovorin|levoleucovorin|mesh-list
110024023|NCT00004206|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110024024|NCT00004206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110024025|NCT00004206|Antimetabolites|antimetabolites|mesh-ancestor
110024026|NCT00004206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110024027|NCT00004206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110024028|NCT00004206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110024029|NCT00004206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110024030|NCT00004206|Immunologic Factors|immunologic factors|mesh-ancestor
110024031|NCT00004206|Antidotes|antidotes|mesh-ancestor
110024032|NCT00004206|Protective Agents|protective agents|mesh-ancestor
110024033|NCT00004206|Vitamin B Complex|vitamin b complex|mesh-ancestor
110024034|NCT00004206|Vitamins|vitamins|mesh-ancestor
110024035|NCT00004206|Micronutrients|micronutrients|mesh-ancestor
110024036|NCT00004212|Exatecan|exatecan|mesh-list
110024037|NCT00004212|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110024040|NCT00004212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110024041|NCT00004212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110024042|NCT00004218|Prednisolone|prednisolone|mesh-list
110024043|NCT00004218|Cyclophosphamide|cyclophosphamide|mesh-list
110024044|NCT00004218|Chlorambucil|chlorambucil|mesh-list
110024045|NCT00004218|Doxorubicin|doxorubicin|mesh-list
110024046|NCT00004218|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110024047|NCT00004218|Fludarabine|fludarabine|mesh-list
110024048|NCT00004218|Fludarabine phosphate|fludarabine phosphate|mesh-list
110024049|NCT00004218|Vincristine|vincristine|mesh-list
110024050|NCT00004218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110024051|NCT00004218|Immunologic Factors|immunologic factors|mesh-ancestor
110024052|NCT00004218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110024053|NCT00004218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110024054|NCT00004218|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110024055|NCT00004218|Alkylating Agents|alkylating agents|mesh-ancestor
110024056|NCT00004218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110024057|NCT00004218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110024058|NCT00004218|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110024059|NCT00004218|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110024060|NCT00004218|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110024061|NCT00004218|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110024062|NCT00004218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110024063|NCT00004218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110024065|NCT00004218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110024066|NCT00004218|Tubulin Modulators|tubulin modulators|mesh-ancestor
110024067|NCT00004218|Antimitotic Agents|antimitotic agents|mesh-ancestor
110024068|NCT00004218|Mitosis Modulators|mitosis modulators|mesh-ancestor
110024069|NCT00004218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110024070|NCT00004218|Glucocorticoids|glucocorticoids|mesh-ancestor
110024071|NCT00004218|Hormones|hormones|mesh-ancestor
110024072|NCT00004218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110024073|NCT00004218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110024074|NCT00004224|Cyclophosphamide|cyclophosphamide|mesh-list
110024075|NCT00004224|Etoposide|etoposide|mesh-list
110024076|NCT00004224|Vincristine|vincristine|mesh-list
110024077|NCT00004224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110024078|NCT00004224|Immunologic Factors|immunologic factors|mesh-ancestor
110024079|NCT00004224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110024080|NCT00004224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110024081|NCT00004224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110024082|NCT00004224|Alkylating Agents|alkylating agents|mesh-ancestor
110024083|NCT00004224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110024084|NCT00004224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110024085|NCT00004224|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110024086|NCT00004224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110024087|NCT00004224|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110024088|NCT00004224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110024089|NCT00004224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110024090|NCT00004224|Tubulin Modulators|tubulin modulators|mesh-ancestor
110024091|NCT00004224|Antimitotic Agents|antimitotic agents|mesh-ancestor
110024092|NCT00004224|Mitosis Modulators|mitosis modulators|mesh-ancestor
110024094|NCT00004236|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110024095|NCT00004236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110024096|NCT00004236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110024097|NCT00004236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110024098|NCT00004236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110024099|NCT00004236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110024100|NCT00004236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110024102|NCT00004242|Fluorouracil|fluorouracil|mesh-list
110024103|NCT00004242|Oxaliplatin|oxaliplatin|mesh-list
110024104|NCT00004242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110024105|NCT00004242|Antimetabolites|antimetabolites|mesh-ancestor
110024106|NCT00004242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110024108|NCT00004242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110024109|NCT00004242|Immunologic Factors|immunologic factors|mesh-ancestor
110024110|NCT00004242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110024111|NCT00004248|Aldesleukin|aldesleukin|mesh-list
110024112|NCT00004248|Doxorubicin|doxorubicin|mesh-list
110024113|NCT00004248|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110024114|NCT00004248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110024115|NCT00004248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110024116|NCT00004248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110024117|NCT00004248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110024118|NCT00004248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110024119|NCT00004248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110024120|NCT00004248|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110024121|NCT00004248|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110024122|NCT00004248|Antiviral Agents|antiviral agents|mesh-ancestor
110024123|NCT00004248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110024124|NCT00004254|Raltitrexed|raltitrexed|mesh-list
110024125|NCT00004254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110024126|NCT00004254|Antimetabolites|antimetabolites|mesh-ancestor
110024127|NCT00004254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110024128|NCT00004254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110024129|NCT00004254|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110024130|NCT00004254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110024131|NCT00004260|Rituximab|rituximab|mesh-list
110024132|NCT00004260|Interleukin-12|interleukin-12|mesh-list
110024133|NCT00004260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110024134|NCT00004260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110024135|NCT00004260|Immunologic Factors|immunologic factors|mesh-ancestor
110024136|NCT00004260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110024137|NCT00004260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110024138|NCT00004260|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110024139|NCT00004260|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110024140|NCT00004260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110024141|NCT00004260|Growth Substances|growth substances|mesh-ancestor
110024142|NCT00004260|Growth Inhibitors|growth inhibitors|mesh-ancestor
110024143|NCT00004266|Lisinopril|lisinopril|mesh-list
110024145|NCT00004266|Simvastatin|simvastatin|mesh-list
110024146|NCT00004266|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110024147|NCT00004266|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110024148|NCT00004266|Antimetabolites|antimetabolites|mesh-ancestor
110024149|NCT00004266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110024150|NCT00004266|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110024151|NCT00004266|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110024152|NCT00004266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110024153|NCT00004266|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110024154|NCT00004266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110024155|NCT00004266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110024156|NCT00004266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110024157|NCT00004266|Vasodilator Agents|vasodilator agents|mesh-ancestor
110024158|NCT00004266|Tocolytic Agents|tocolytic agents|mesh-ancestor
110024159|NCT00004266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110024160|NCT00004266|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110024161|NCT00004266|Protease Inhibitors|protease inhibitors|mesh-ancestor
110024162|NCT00004266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110024163|NCT00004266|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110024164|NCT00004266|Protective Agents|protective agents|mesh-ancestor
110024165|NCT00004278|Ganciclovir|ganciclovir|mesh-list
110024166|NCT00004278|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
110024167|NCT00004278|Antiviral Agents|antiviral agents|mesh-ancestor
110024168|NCT00004278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110024169|NCT00004278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110024170|NCT00004278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110024171|NCT00004278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110024172|NCT00004284|Potassium Citrate|potassium citrate|mesh-list
110024173|NCT00004284|Potassium phosphate|potassium phosphate|mesh-list
110024174|NCT00004284|Diuretics|diuretics|mesh-ancestor
110024175|NCT00004284|Natriuretic Agents|natriuretic agents|mesh-ancestor
110024176|NCT00004284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110024177|NCT00004284|Expectorants|expectorants|mesh-ancestor
110024178|NCT00004284|Respiratory System Agents|respiratory system agents|mesh-ancestor
110024179|NCT00004284|Cariostatic Agents|cariostatic agents|mesh-ancestor
110024180|NCT00004284|Protective Agents|protective agents|mesh-ancestor
110024182|NCT00004344|Testosterone|testosterone|mesh-list
110024183|NCT00004344|Androgens|androgens|mesh-ancestor
110024184|NCT00004344|Hormones|hormones|mesh-ancestor
110024185|NCT00004344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110024186|NCT00004344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110024187|NCT00004344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110024188|NCT00004344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110024189|NCT00004344|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110024190|NCT00004344|Fertility Agents|fertility agents|mesh-ancestor
110024191|NCT00004344|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110024199|NCT00004368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110024201|NCT00004380|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110024202|NCT00004380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110024203|NCT00004380|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110024204|NCT00004380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110024205|NCT00004398|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
110024206|NCT00004398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110024207|NCT00004398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110024208|NCT00004404|Clotrimazole|clotrimazole|mesh-list
110024209|NCT00004404|Miconazole|miconazole|mesh-list
110024210|NCT00004404|Hydroxyurea|hydroxyurea|mesh-list
110024211|NCT00004404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110024212|NCT00004404|Antisickling Agents|antisickling agents|mesh-ancestor
110024213|NCT00004404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110024214|NCT00004404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110024215|NCT00004404|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110024216|NCT00004404|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110024217|NCT00004404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110024218|NCT00004404|Antifungal Agents|antifungal agents|mesh-ancestor
110024219|NCT00004404|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110024220|NCT00004404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110024221|NCT00004404|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110024222|NCT00004404|Hormone Antagonists|hormone antagonists|mesh-ancestor
110024223|NCT00004404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110024224|NCT00004404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110024225|NCT00004404|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110024226|NCT00004404|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110024227|NCT00004410|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
110024228|NCT00004410|Antiviral Agents|antiviral agents|mesh-ancestor
110024229|NCT00004410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110024230|NCT00004410|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110024231|NCT00004410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110024232|NCT00004416|Botulinum Toxins|botulinum toxins|mesh-list
110024233|NCT00004416|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110024234|NCT00004416|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110024235|NCT00004416|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110024236|NCT00004416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110024237|NCT00004416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110024238|NCT00004416|Cholinergic Agents|cholinergic agents|mesh-ancestor
110024239|NCT00004416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110024240|NCT00004416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110024241|NCT00004416|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110024242|NCT00004416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110024245|NCT00004422|gamma-Globulins|gamma-globulins|mesh-list
110024246|NCT00004422|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110024247|NCT00004422|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110024248|NCT00004422|Immunologic Factors|immunologic factors|mesh-ancestor
110024249|NCT00004422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110024250|NCT00004440|Ibuprofen|ibuprofen|mesh-list
110024251|NCT00004440|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110024252|NCT00004440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110024253|NCT00004440|Analgesics|analgesics|mesh-ancestor
110024254|NCT00004440|Sensory System Agents|sensory system agents|mesh-ancestor
110024255|NCT00004440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110024256|NCT00004440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110024257|NCT00004440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110024258|NCT00004440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110024259|NCT00004440|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110024260|NCT00004440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110024261|NCT00004440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110024262|NCT00004446|Fluoxetine|fluoxetine|mesh-list
110024263|NCT00004446|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110024264|NCT00004446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110024265|NCT00004446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110024266|NCT00004446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110024267|NCT00004446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110024268|NCT00004446|Serotonin Agents|serotonin agents|mesh-ancestor
110024269|NCT00004446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110024270|NCT00004446|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110024271|NCT00004446|Antidepressive Agents|antidepressive agents|mesh-ancestor
110024272|NCT00004446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110024273|NCT00004446|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110024274|NCT00004446|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110024275|NCT00004446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110024276|NCT00004464|Cyclophosphamide|cyclophosphamide|mesh-list
110024277|NCT00004464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110024278|NCT00004464|Immunologic Factors|immunologic factors|mesh-ancestor
110024279|NCT00004464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110024280|NCT00004464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110024281|NCT00004464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110024282|NCT00004464|Alkylating Agents|alkylating agents|mesh-ancestor
110024283|NCT00004464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110024284|NCT00004464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110024285|NCT00004464|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110024286|NCT00004482|Cyclosporine|cyclosporine|mesh-list
110024287|NCT00004482|Prednisone|prednisone|mesh-list
110024288|NCT00004482|Methylprednisolone|methylprednisolone|mesh-list
110024289|NCT00004482|Cyclosporins|cyclosporins|mesh-list
110024290|NCT00004482|Muromonab-CD3|muromonab-cd3|mesh-list
110024291|NCT00004482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110024292|NCT00004482|Glucocorticoids|glucocorticoids|mesh-ancestor
110024293|NCT00004482|Hormones|hormones|mesh-ancestor
110024294|NCT00004482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110024295|NCT00004482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110024296|NCT00004482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110024297|NCT00004482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110024298|NCT00004482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110024299|NCT00004482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110024300|NCT00004482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110024301|NCT00004482|Immunologic Factors|immunologic factors|mesh-ancestor
110024302|NCT00004482|Antifungal Agents|antifungal agents|mesh-ancestor
110024303|NCT00004482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110024304|NCT00004482|Dermatologic Agents|dermatologic agents|mesh-ancestor
110024305|NCT00004482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110024306|NCT00004482|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110024307|NCT00004482|Antiemetics|antiemetics|mesh-ancestor
110024308|NCT00004482|Autonomic Agents|autonomic agents|mesh-ancestor
110024309|NCT00004482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110024310|NCT00004482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110024311|NCT00004482|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110024312|NCT00004482|Protective Agents|protective agents|mesh-ancestor
110024313|NCT00004488|Cholecalciferol|cholecalciferol|mesh-list
110024315|NCT00004488|Alendronate|alendronate|mesh-list
110024316|NCT00004488|Calcium Carbonate|calcium carbonate|mesh-list
110024317|NCT00004488|Calcium|calcium|mesh-list
110024318|NCT00004488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110024319|NCT00004488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110024320|NCT00004488|Vitamins|vitamins|mesh-ancestor
110024321|NCT00004488|Micronutrients|micronutrients|mesh-ancestor
110024322|NCT00004488|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110024323|NCT00004488|Antacids|antacids|mesh-ancestor
110024324|NCT00004488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110024325|NCT00004488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110024326|NCT00004554|Naltrexone|naltrexone|mesh-list
110024327|NCT00004554|Sertraline|sertraline|mesh-list
110024328|NCT00004554|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110024329|NCT00004554|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110024330|NCT00004554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110024331|NCT00004554|Sensory System Agents|sensory system agents|mesh-ancestor
110024332|NCT00004554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110024333|NCT00004554|Antidepressive Agents|antidepressive agents|mesh-ancestor
110024334|NCT00004554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110024335|NCT00004554|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110024336|NCT00004554|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110024337|NCT00004554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110024338|NCT00004554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110024339|NCT00004554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110024340|NCT00004554|Serotonin Agents|serotonin agents|mesh-ancestor
110024341|NCT00004578|Ritonavir|ritonavir|mesh-list
110024342|NCT00004578|Lopinavir|lopinavir|mesh-list
110024343|NCT00004578|Lamivudine|lamivudine|mesh-list
110024344|NCT00004578|Stavudine|stavudine|mesh-list
110024345|NCT00004578|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110024346|NCT00004578|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110024347|NCT00004578|Protease Inhibitors|protease inhibitors|mesh-ancestor
110024348|NCT00004578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110024349|NCT00004578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110024350|NCT00004578|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110024351|NCT00004578|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110024352|NCT00004578|Antiviral Agents|antiviral agents|mesh-ancestor
110024353|NCT00004578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110024354|NCT00004578|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110024355|NCT00004578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110024356|NCT00004578|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110024357|NCT00004578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110024358|NCT00004578|Antimetabolites|antimetabolites|mesh-ancestor
110024360|NCT00004644|Antiviral Agents|antiviral agents|mesh-ancestor
110024361|NCT00004644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110024362|NCT00004650|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110024363|NCT00004650|Medroxyprogesterone|medroxyprogesterone|mesh-list
110024364|NCT00004650|Estrogens|estrogens|mesh-list
110024365|NCT00004650|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110024366|NCT00004650|Hormones|hormones|mesh-ancestor
110024367|NCT00004650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110024368|NCT00004650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110024369|NCT00004650|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110024370|NCT00004650|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110024371|NCT00004650|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110024372|NCT00004650|Contraceptive Agents|contraceptive agents|mesh-ancestor
110024373|NCT00004650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110024374|NCT00004650|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110024375|NCT00004650|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110024376|NCT00004650|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110024377|NCT00004650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110024378|NCT00004650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110024379|NCT00004662|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
110024380|NCT00004662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110024381|NCT00004662|Immunologic Factors|immunologic factors|mesh-ancestor
110024382|NCT00004662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110024383|NCT00004686|Prednisone|prednisone|mesh-list
110024384|NCT00004686|Methotrexate|methotrexate|mesh-list
110024385|NCT00004686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110024386|NCT00004686|Glucocorticoids|glucocorticoids|mesh-ancestor
110024387|NCT00004686|Hormones|hormones|mesh-ancestor
110024388|NCT00004686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110024389|NCT00004686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110024390|NCT00004686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110024391|NCT00004686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110024392|NCT00004686|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110024393|NCT00004686|Abortifacient Agents|abortifacient agents|mesh-ancestor
110024394|NCT00004686|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110024395|NCT00004686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110024396|NCT00004686|Antimetabolites|antimetabolites|mesh-ancestor
110024397|NCT00004686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110024398|NCT00004686|Dermatologic Agents|dermatologic agents|mesh-ancestor
110024399|NCT00004686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110024400|NCT00004686|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110024401|NCT00004686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110024402|NCT00004686|Immunologic Factors|immunologic factors|mesh-ancestor
110024403|NCT00004686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110024404|NCT00004686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110024405|NCT00004728|Aspirin|aspirin|mesh-list
110024406|NCT00004728|Warfarin|warfarin|mesh-list
110024407|NCT00004728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110024408|NCT00004728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110024409|NCT00004728|Analgesics|analgesics|mesh-ancestor
110024410|NCT00004728|Sensory System Agents|sensory system agents|mesh-ancestor
110024411|NCT00004728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110024412|NCT00004728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110024413|NCT00004728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110024414|NCT00004728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110024415|NCT00004728|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110024416|NCT00004728|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110024417|NCT00004728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110024418|NCT00004728|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110024419|NCT00004728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110024420|NCT00004728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110024422|NCT00004728|Anticoagulants|anticoagulants|mesh-ancestor
110024431|NCT00004734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110024432|NCT00004740|Isoniazid|isoniazid|mesh-list
110024433|NCT00004740|Antitubercular Agents|antitubercular agents|mesh-ancestor
110024434|NCT00004740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110024435|NCT00004740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110024436|NCT00004740|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110024437|NCT00004740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110024438|NCT00004740|Antimetabolites|antimetabolites|mesh-ancestor
110024439|NCT00004740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110024440|NCT00004740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110024441|NCT00004758|Pyridoxine|pyridoxine|mesh-list
110024442|NCT00004758|Carbamazepine|carbamazepine|mesh-list
110024443|NCT00004758|Valproic Acid|valproic acid|mesh-list
110024444|NCT00004758|Nitrazepam|nitrazepam|mesh-list
110024445|NCT00004758|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
110024446|NCT00004758|Anticonvulsants|anticonvulsants|mesh-ancestor
110024447|NCT00004758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110024448|NCT00004758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110024449|NCT00004758|GABA Agents|gaba agents|mesh-ancestor
110024450|NCT00004758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110024451|NCT00004758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110024452|NCT00004758|Antimanic Agents|antimanic agents|mesh-ancestor
110024453|NCT00004758|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110024454|NCT00004758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110024455|NCT00004758|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110024456|NCT00004758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110024457|NCT00004758|Analgesics|analgesics|mesh-ancestor
110024458|NCT00004758|Sensory System Agents|sensory system agents|mesh-ancestor
110024459|NCT00004758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110024460|NCT00004758|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110024461|NCT00004758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110024462|NCT00004758|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110024463|NCT00004758|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110024464|NCT00004758|Vitamin B Complex|vitamin b complex|mesh-ancestor
110024465|NCT00004758|Vitamins|vitamins|mesh-ancestor
110024466|NCT00004758|Micronutrients|micronutrients|mesh-ancestor
110024467|NCT00004758|Hormones|hormones|mesh-ancestor
110024468|NCT00004758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110024469|NCT00004758|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110024470|NCT00004758|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110024471|NCT00004758|GABA Modulators|gaba modulators|mesh-ancestor
110024472|NCT00004770|Thioctic Acid|thioctic acid|mesh-list
110024473|NCT00004770|Antioxidants|antioxidants|mesh-ancestor
110024474|NCT00004770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110024475|NCT00004770|Protective Agents|protective agents|mesh-ancestor
110024476|NCT00004770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110024477|NCT00004770|Vitamin B Complex|vitamin b complex|mesh-ancestor
110024478|NCT00004770|Vitamins|vitamins|mesh-ancestor
110024479|NCT00004770|Micronutrients|micronutrients|mesh-ancestor
110024480|NCT00004776|Topiramate|topiramate|mesh-list
110024481|NCT00004776|Anticonvulsants|anticonvulsants|mesh-ancestor
110024482|NCT00004776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110024483|NCT00004776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110024484|NCT00004794|Cidofovir|cidofovir|mesh-list
110024485|NCT00004794|Antiviral Agents|antiviral agents|mesh-ancestor
110024486|NCT00004794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110024487|NCT00004794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110024488|NCT00004794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110024489|NCT00004800|Vaccines|vaccines|mesh-list
110024490|NCT00004800|Immunologic Factors|immunologic factors|mesh-ancestor
110024491|NCT00004800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110024493|NCT00004842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110024494|NCT00004842|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110024495|NCT00004842|Autonomic Agents|autonomic agents|mesh-ancestor
110024496|NCT00004842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110024497|NCT00004842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110024498|NCT00004842|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110024499|NCT00004842|Respiratory System Agents|respiratory system agents|mesh-ancestor
110024500|NCT00004842|Glucocorticoids|glucocorticoids|mesh-ancestor
110024501|NCT00004842|Hormones|hormones|mesh-ancestor
110024502|NCT00004842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110024503|NCT00004854|Carvedilol|carvedilol|mesh-list
110024504|NCT00004854|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110024505|NCT00004854|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110024506|NCT00004854|Adrenergic Agents|adrenergic agents|mesh-ancestor
110024507|NCT00004854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110024583|NCT00004926|Ro 23-7553|ro 23-7553|mesh-list
110024584|NCT00004926|Vitamins|vitamins|mesh-ancestor
110024509|NCT00004854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110024510|NCT00004854|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110024511|NCT00004854|Antioxidants|antioxidants|mesh-ancestor
110024512|NCT00004854|Protective Agents|protective agents|mesh-ancestor
110024513|NCT00004854|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110024514|NCT00004854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110024515|NCT00004854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110024516|NCT00004854|Vasodilator Agents|vasodilator agents|mesh-ancestor
110024517|NCT00004854|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110024518|NCT00004854|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110024519|NCT00004866|Exatecan|exatecan|mesh-list
110024520|NCT00004866|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110024521|NCT00004866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110024522|NCT00004866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110024523|NCT00004866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110024524|NCT00004866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110024525|NCT00004872|Endostatins|endostatins|mesh-list
110024526|NCT00004872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110024527|NCT00004872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110024528|NCT00004872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110024529|NCT00004872|Growth Substances|growth substances|mesh-ancestor
110024530|NCT00004872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110024531|NCT00004872|Growth Inhibitors|growth inhibitors|mesh-ancestor
110024532|NCT00004878|Cytarabine|cytarabine|mesh-list
110024533|NCT00004878|Methotrexate|methotrexate|mesh-list
110024534|NCT00004878|Fludarabine phosphate|fludarabine phosphate|mesh-list
110024535|NCT00004878|Fludarabine|fludarabine|mesh-list
110024536|NCT00004878|Idarubicin|idarubicin|mesh-list
110024537|NCT00004878|Tacrolimus|tacrolimus|mesh-list
110024538|NCT00004878|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110024539|NCT00004878|Abortifacient Agents|abortifacient agents|mesh-ancestor
110024540|NCT00004878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110024541|NCT00004878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110024542|NCT00004878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110024543|NCT00004878|Antimetabolites|antimetabolites|mesh-ancestor
110024544|NCT00004878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110024545|NCT00004878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110024546|NCT00004878|Dermatologic Agents|dermatologic agents|mesh-ancestor
110024547|NCT00004878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110024548|NCT00004878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110024549|NCT00004878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110024550|NCT00004878|Immunologic Factors|immunologic factors|mesh-ancestor
110024551|NCT00004878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110024552|NCT00004878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110024553|NCT00004878|Antiviral Agents|antiviral agents|mesh-ancestor
110024554|NCT00004878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110024555|NCT00004878|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110024556|NCT00004878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110024557|NCT00004878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110024558|NCT00004878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110024559|NCT00004884|Gemcitabine|gemcitabine|mesh-list
110024560|NCT00004884|Docetaxel|docetaxel|mesh-list
110024561|NCT00004884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110024562|NCT00004884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110024563|NCT00004884|Antimetabolites|antimetabolites|mesh-ancestor
110024564|NCT00004884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110024565|NCT00004884|Tubulin Modulators|tubulin modulators|mesh-ancestor
110024566|NCT00004884|Antimitotic Agents|antimitotic agents|mesh-ancestor
110024567|NCT00004884|Mitosis Modulators|mitosis modulators|mesh-ancestor
110024568|NCT00004890|Aldesleukin|aldesleukin|mesh-list
110024569|NCT00004890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110024570|NCT00004890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110024571|NCT00004890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110024572|NCT00004890|Antiviral Agents|antiviral agents|mesh-ancestor
110024573|NCT00004890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110024574|NCT00004920|Raltitrexed|raltitrexed|mesh-list
110024575|NCT00004920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110024576|NCT00004920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110024577|NCT00004920|Antimetabolites|antimetabolites|mesh-ancestor
110024578|NCT00004920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110024579|NCT00004920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110024580|NCT00004920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110024582|NCT00004926|Cholecalciferol|cholecalciferol|mesh-list
110024586|NCT00004926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110024587|NCT00004926|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110024588|NCT00004926|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110024589|NCT00004926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110024590|NCT00004932|Imatinib Mesylate|imatinib mesylate|mesh-list
110024591|NCT00004932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110024592|NCT00004932|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110024593|NCT00004932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110024594|NCT00004932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110024595|NCT00004938|Fluconazole|fluconazole|mesh-list
110024596|NCT00004938|Antifungal Agents|antifungal agents|mesh-ancestor
110024597|NCT00004938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110024598|NCT00004938|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110024599|NCT00004938|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110024600|NCT00004938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110024601|NCT00004938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110024602|NCT00004938|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110024603|NCT00004938|Hormone Antagonists|hormone antagonists|mesh-ancestor
110024604|NCT00004938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110024605|NCT00004938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110024606|NCT00004938|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110024607|NCT00004938|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110024608|NCT00004986|Nitazoxanide|nitazoxanide|mesh-list
110024609|NCT00004986|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110024610|NCT00004986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110024611|NCT00004992|Metformin|metformin|mesh-list
110024612|NCT00004992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110024613|NCT00004992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110024614|NCT00004998|Lamivudine|lamivudine|mesh-list
110024615|NCT00004998|Zidovudine|zidovudine|mesh-list
110024616|NCT00004998|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
110024617|NCT00004998|Capravirine|capravirine|mesh-list
110024618|NCT00004998|Nelfinavir|nelfinavir|mesh-list
110024619|NCT00004998|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110024620|NCT00004998|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110024621|NCT00004998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110024622|NCT00004998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110024623|NCT00004998|Antiviral Agents|antiviral agents|mesh-ancestor
110024624|NCT00004998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110024625|NCT00004998|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110024626|NCT00004998|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110024627|NCT00004998|Antimetabolites|antimetabolites|mesh-ancestor
110024628|NCT00004998|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110024629|NCT00004998|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110024630|NCT00004998|Protease Inhibitors|protease inhibitors|mesh-ancestor
110024631|NCT00005010|Irbesartan|irbesartan|mesh-list
110024632|NCT00005010|Pravastatin|pravastatin|mesh-list
110024633|NCT00005010|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110024634|NCT00005010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110024635|NCT00005010|Antimetabolites|antimetabolites|mesh-ancestor
110024636|NCT00005010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110024637|NCT00005010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110024638|NCT00005010|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110024639|NCT00005010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110024640|NCT00005010|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110024641|NCT00005010|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110024642|NCT00005010|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110024643|NCT00005022|Etoposide|etoposide|mesh-list
110024644|NCT00005022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110024645|NCT00005022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110024646|NCT00005022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110024647|NCT00005022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110024648|NCT00005022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110024649|NCT00005022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110024650|NCT00005028|Paclitaxel|paclitaxel|mesh-list
110024651|NCT00005028|Bryostatin 1|bryostatin 1|mesh-list
110024652|NCT00005028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110024653|NCT00005028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110024654|NCT00005028|Tubulin Modulators|tubulin modulators|mesh-ancestor
110024655|NCT00005028|Antimitotic Agents|antimitotic agents|mesh-ancestor
110024656|NCT00005028|Mitosis Modulators|mitosis modulators|mesh-ancestor
110024657|NCT00005028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110024658|NCT00005028|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110024660|NCT00005028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110024661|NCT00005040|Arsenic Trioxide|arsenic trioxide|mesh-list
110024662|NCT00005040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110024663|NCT00005046|Paclitaxel|paclitaxel|mesh-list
110024664|NCT00005046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110024665|NCT00005046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110024666|NCT00005046|Tubulin Modulators|tubulin modulators|mesh-ancestor
110024667|NCT00005046|Antimitotic Agents|antimitotic agents|mesh-ancestor
110024668|NCT00005046|Mitosis Modulators|mitosis modulators|mesh-ancestor
110024669|NCT00005046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110024670|NCT00005064|Bortezomib|bortezomib|mesh-list
110024671|NCT00005064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110024672|NCT00005070|Irofulven|irofulven|mesh-list
110024673|NCT00005070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110024674|NCT00005070|Alkylating Agents|alkylating agents|mesh-ancestor
110024675|NCT00005070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110024676|NCT00005070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110024677|NCT00005076|Irinotecan|irinotecan|mesh-list
110024679|NCT00005076|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110024680|NCT00005076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110024681|NCT00005076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110024682|NCT00005076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110024684|NCT00005076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110024685|NCT00005088|Cisplatin|cisplatin|mesh-list
110024686|NCT00005088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110024687|NCT00005094|Celecoxib|celecoxib|mesh-list
110024688|NCT00005094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110024689|NCT00005094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110024690|NCT00005094|Analgesics|analgesics|mesh-ancestor
110024691|NCT00005094|Sensory System Agents|sensory system agents|mesh-ancestor
110024692|NCT00005094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110024693|NCT00005094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110024694|NCT00005094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110024695|NCT00005094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110024696|NCT00005094|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110024697|NCT00005094|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110024698|NCT00005094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110024699|NCT00005094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110024700|NCT00005106|Lamivudine|lamivudine|mesh-list
110024701|NCT00005106|Zidovudine|zidovudine|mesh-list
110024702|NCT00005106|Abacavir|abacavir|mesh-list
110024703|NCT00005106|Stavudine|stavudine|mesh-list
110024704|NCT00005106|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
110024705|NCT00005106|Nelfinavir|nelfinavir|mesh-list
110024706|NCT00005106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110024707|NCT00005106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110024708|NCT00005106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110024709|NCT00005106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110024710|NCT00005106|Antiviral Agents|antiviral agents|mesh-ancestor
110024711|NCT00005106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110024712|NCT00005106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110024713|NCT00005106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110024714|NCT00005106|Antimetabolites|antimetabolites|mesh-ancestor
110024715|NCT00005106|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110024716|NCT00005106|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110024717|NCT00005106|Protease Inhibitors|protease inhibitors|mesh-ancestor
110024718|NCT00005118|Ritonavir|ritonavir|mesh-list
110024719|NCT00005118|Indinavir|indinavir|mesh-list
110024720|NCT00005118|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110024721|NCT00005118|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110024722|NCT00005118|Protease Inhibitors|protease inhibitors|mesh-ancestor
110024723|NCT00005118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110024724|NCT00005118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110024726|NCT00005118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110024727|NCT00005118|Antiviral Agents|antiviral agents|mesh-ancestor
110024728|NCT00005118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110024729|NCT00005118|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110024730|NCT00005118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110024731|NCT00005520|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110024732|NCT00005520|Candesartan|candesartan|mesh-list
110024733|NCT00005520|Candesartan cilexetil|candesartan cilexetil|mesh-list
110024734|NCT00005520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110024735|NCT00005520|Diuretics|diuretics|mesh-ancestor
110024736|NCT00005520|Natriuretic Agents|natriuretic agents|mesh-ancestor
110024737|NCT00005520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110024738|NCT00005520|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110024739|NCT00005520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110024740|NCT00005520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110024741|NCT00005520|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110024742|NCT00005520|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110024744|NCT00005574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110024745|NCT00005574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110024746|NCT00005574|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110024747|NCT00005574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110024748|NCT00005574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110024749|NCT00005580|Fludarabine|fludarabine|mesh-list
110024750|NCT00005580|Fludarabine phosphate|fludarabine phosphate|mesh-list
110024751|NCT00005580|Bryostatin 1|bryostatin 1|mesh-list
110024752|NCT00005580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110024753|NCT00005580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110024754|NCT00005580|Antimetabolites|antimetabolites|mesh-ancestor
110024755|NCT00005580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110024756|NCT00005580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110024757|NCT00005580|Immunologic Factors|immunologic factors|mesh-ancestor
110024758|NCT00005580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110024759|NCT00005580|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110024760|NCT00005586|Leucovorin|leucovorin|mesh-list
110024761|NCT00005586|Fluorouracil|fluorouracil|mesh-list
110024762|NCT00005586|Levoleucovorin|levoleucovorin|mesh-list
110024763|NCT00005586|Antimetabolites|antimetabolites|mesh-ancestor
110024764|NCT00005586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110024765|NCT00005586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110024766|NCT00005586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110024767|NCT00005586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110024768|NCT00005586|Immunologic Factors|immunologic factors|mesh-ancestor
110024769|NCT00005586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110024770|NCT00005586|Antidotes|antidotes|mesh-ancestor
110024771|NCT00005586|Protective Agents|protective agents|mesh-ancestor
110024772|NCT00005586|Vitamin B Complex|vitamin b complex|mesh-ancestor
110024773|NCT00005586|Vitamins|vitamins|mesh-ancestor
110024774|NCT00005586|Micronutrients|micronutrients|mesh-ancestor
110024775|NCT00005592|Rituximab|rituximab|mesh-list
110024776|NCT00005592|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110024777|NCT00005592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110024778|NCT00005592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110024779|NCT00005592|Immunologic Factors|immunologic factors|mesh-ancestor
110024780|NCT00005592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110024781|NCT00005592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110024782|NCT00005598|Azacitidine|azacitidine|mesh-list
110024783|NCT00005598|Amifostine|amifostine|mesh-list
110024784|NCT00005598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110024785|NCT00005598|Antimetabolites|antimetabolites|mesh-ancestor
110024786|NCT00005598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110024787|NCT00005598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110024788|NCT00005598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110024789|NCT00005598|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110024790|NCT00005598|Protective Agents|protective agents|mesh-ancestor
110024791|NCT00005598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110024792|NCT00005604|Aldesleukin|aldesleukin|mesh-list
110024793|NCT00005604|Interleukin-2|interleukin-2|mesh-list
110024794|NCT00005604|Interleukin-12|interleukin-12|mesh-list
110024795|NCT00005604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110024796|NCT00005604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110024797|NCT00005604|Analgesics|analgesics|mesh-ancestor
110024798|NCT00005604|Sensory System Agents|sensory system agents|mesh-ancestor
110024799|NCT00005604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110024800|NCT00005604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110024801|NCT00005604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110024802|NCT00005604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110024803|NCT00005604|Antiviral Agents|antiviral agents|mesh-ancestor
110024804|NCT00005604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110024805|NCT00005604|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110024806|NCT00005604|Immunologic Factors|immunologic factors|mesh-ancestor
110024807|NCT00005604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110024808|NCT00005604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110024809|NCT00005604|Growth Substances|growth substances|mesh-ancestor
110024810|NCT00005604|Growth Inhibitors|growth inhibitors|mesh-ancestor
110024811|NCT00005610|Sargramostim|sargramostim|mesh-list
110024812|NCT00005610|Immunologic Factors|immunologic factors|mesh-ancestor
110024813|NCT00005610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110024814|NCT00005616|Antibodies|antibodies|mesh-list
110024817|NCT00005616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110024818|NCT00005622|Cyclophosphamide|cyclophosphamide|mesh-list
110024819|NCT00005622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110024820|NCT00005622|Immunologic Factors|immunologic factors|mesh-ancestor
110024821|NCT00005622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110024822|NCT00005622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110024823|NCT00005622|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110024824|NCT00005622|Alkylating Agents|alkylating agents|mesh-ancestor
110024825|NCT00005622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110024826|NCT00005622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110024827|NCT00005622|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110024829|NCT00005634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110024830|NCT00005634|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110024831|NCT00005634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110024832|NCT00005634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110024833|NCT00005640|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
110024834|NCT00005640|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110024835|NCT00005640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110024837|NCT00005646|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110024838|NCT00005646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110024839|NCT00005646|Tubulin Modulators|tubulin modulators|mesh-ancestor
110024840|NCT00005646|Antimitotic Agents|antimitotic agents|mesh-ancestor
110024841|NCT00005646|Mitosis Modulators|mitosis modulators|mesh-ancestor
110024842|NCT00005646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110024843|NCT00005652|Rituximab|rituximab|mesh-list
110024844|NCT00005652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110024845|NCT00005652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110024846|NCT00005652|Immunologic Factors|immunologic factors|mesh-ancestor
110024847|NCT00005652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110024848|NCT00005652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110024849|NCT00005658|Glycine|glycine|mesh-list
110024850|NCT00005658|Glycine Agents|glycine agents|mesh-ancestor
110024851|NCT00005658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110024852|NCT00005658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110024853|NCT00005658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110024854|NCT00005796|Vincristine|vincristine|mesh-list
110024855|NCT00005796|Lomustine|lomustine|mesh-list
110024856|NCT00005796|Procarbazine|procarbazine|mesh-list
110024857|NCT00005796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110024858|NCT00005796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110024859|NCT00005796|Tubulin Modulators|tubulin modulators|mesh-ancestor
110024860|NCT00005796|Antimitotic Agents|antimitotic agents|mesh-ancestor
110024861|NCT00005796|Mitosis Modulators|mitosis modulators|mesh-ancestor
110024862|NCT00005796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110024863|NCT00005796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110024864|NCT00005796|Alkylating Agents|alkylating agents|mesh-ancestor
110024865|NCT00005802|Cytarabine|cytarabine|mesh-list
110024867|NCT00005802|Hydrocortisone|hydrocortisone|mesh-list
110024868|NCT00005802|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110024869|NCT00005802|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110024870|NCT00005802|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110024871|NCT00005802|Methotrexate|methotrexate|mesh-list
110024872|NCT00005802|Fludarabine phosphate|fludarabine phosphate|mesh-list
110024873|NCT00005802|Fludarabine|fludarabine|mesh-list
110024874|NCT00005802|Etoposide|etoposide|mesh-list
110024875|NCT00005802|Mitoxantrone|mitoxantrone|mesh-list
110024876|NCT00005802|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110024877|NCT00005802|Abortifacient Agents|abortifacient agents|mesh-ancestor
110024878|NCT00005802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110024879|NCT00005802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110024880|NCT00005802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110024881|NCT00005802|Antimetabolites|antimetabolites|mesh-ancestor
110024882|NCT00005802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110024883|NCT00005802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110024884|NCT00005802|Dermatologic Agents|dermatologic agents|mesh-ancestor
110024885|NCT00005802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110024886|NCT00005802|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110024887|NCT00005802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110024888|NCT00005802|Immunologic Factors|immunologic factors|mesh-ancestor
110024889|NCT00005802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110024890|NCT00005802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110024891|NCT00005802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110024893|NCT00005802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110024894|NCT00005802|Antiviral Agents|antiviral agents|mesh-ancestor
110024896|NCT00005802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110024897|NCT00005802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110024898|NCT00005802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110024899|NCT00005802|Analgesics|analgesics|mesh-ancestor
110024900|NCT00005802|Sensory System Agents|sensory system agents|mesh-ancestor
110024901|NCT00005802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110024902|NCT00005808|Motexafin lutetium|motexafin lutetium|mesh-list
110024903|NCT00005808|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110024904|NCT00005808|Dermatologic Agents|dermatologic agents|mesh-ancestor
110024906|NCT00005814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110024907|NCT00005814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110024908|NCT00354900|Aprotinin|aprotinin|mesh-list
110024909|NCT00354900|Hemostatics|hemostatics|mesh-ancestor
110024910|NCT00354900|Coagulants|coagulants|mesh-ancestor
110024911|NCT00354900|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110024912|NCT00354900|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110024913|NCT00354900|Protease Inhibitors|protease inhibitors|mesh-ancestor
110024914|NCT00354900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110024915|NCT00354900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110024917|NCT00355290|Vitamins|vitamins|mesh-ancestor
110024918|NCT00355290|Micronutrients|micronutrients|mesh-ancestor
110024919|NCT00355290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110024920|NCT00355290|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110024921|NCT00355290|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110024922|NCT00355290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110024923|NCT00355290|Hemostatics|hemostatics|mesh-ancestor
110024924|NCT00355290|Coagulants|coagulants|mesh-ancestor
110024925|NCT00355446|Bimatoprost|bimatoprost|mesh-list
110024926|NCT00355446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110024927|NCT00355524|Ritonavir|ritonavir|mesh-list
110024928|NCT00355524|Darunavir|darunavir|mesh-list
110024929|NCT00355524|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110024930|NCT00355524|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110024931|NCT00355524|Protease Inhibitors|protease inhibitors|mesh-ancestor
110024932|NCT00355524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110024933|NCT00355524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110024935|NCT00355524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110024936|NCT00355524|Antiviral Agents|antiviral agents|mesh-ancestor
110024937|NCT00355524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110024938|NCT00355524|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110024939|NCT00355524|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110024940|NCT00355602|Metronidazole|metronidazole|mesh-list
110024941|NCT00355602|Vancomycin|vancomycin|mesh-list
110024942|NCT00355602|Clarithromycin|clarithromycin|mesh-list
110024943|NCT00355602|Doxycycline|doxycycline|mesh-list
110024944|NCT00355602|Ciprofloxacin|ciprofloxacin|mesh-list
110024945|NCT00355602|Rifaximin|rifaximin|mesh-list
110024946|NCT00355602|Cefuroxime|cefuroxime|mesh-list
110024947|NCT00355602|Neomycin|neomycin|mesh-list
110024948|NCT00355602|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110024949|NCT00355602|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110024950|NCT00355602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110024951|NCT00355602|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110024952|NCT00355602|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110024953|NCT00355602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110024954|NCT00355602|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110024955|NCT00355602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110024956|NCT00355602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110024957|NCT00355602|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110024958|NCT00355602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110024959|NCT00355602|Antimalarials|antimalarials|mesh-ancestor
110024960|NCT00355602|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110024961|NCT00355602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110024962|NCT00355602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110024963|NCT00355602|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110024964|NCT00355602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110024965|NCT00355602|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110024966|NCT00355602|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110024967|NCT00356070|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110024968|NCT00356070|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110024969|NCT00356070|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110024970|NCT00356070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110024971|NCT00356070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110024972|NCT00356070|Adrenergic Agents|adrenergic agents|mesh-ancestor
110024974|NCT00356070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110024975|NCT00356226|Clonidine|clonidine|mesh-list
110024976|NCT00356226|Analgesics|analgesics|mesh-ancestor
110024977|NCT00356226|Sensory System Agents|sensory system agents|mesh-ancestor
110024978|NCT00356226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110024979|NCT00356226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110024980|NCT00356226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110024981|NCT00356226|Sympatholytics|sympatholytics|mesh-ancestor
110024982|NCT00356226|Autonomic Agents|autonomic agents|mesh-ancestor
110024983|NCT00356226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110024984|NCT00356226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110024985|NCT00356226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110024986|NCT00356226|Adrenergic Agents|adrenergic agents|mesh-ancestor
110024987|NCT00356226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110024988|NCT00356226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110024989|NCT00356460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110024990|NCT00356460|Antibodies|antibodies|mesh-list
110024991|NCT00356460|Immunoglobulins|immunoglobulins|mesh-list
110024992|NCT00356460|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110024993|NCT00356460|Mitogens|mitogens|mesh-list
110024994|NCT00356460|Immunologic Factors|immunologic factors|mesh-ancestor
110024995|NCT00356460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110024996|NCT00356460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110024997|NCT00356460|Mitosis Modulators|mitosis modulators|mesh-ancestor
110024998|NCT00356460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110024999|NCT00356616|Tenofovir|tenofovir|mesh-list
110025000|NCT00356616|Abacavir|abacavir|mesh-list
110025001|NCT00356616|Antiviral Agents|antiviral agents|mesh-ancestor
110025002|NCT00356616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110025003|NCT00356616|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110025004|NCT00356616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110025005|NCT00356616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110025006|NCT00356616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110025007|NCT00356616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110025008|NCT00356616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110025009|NCT00356772|Azithromycin|azithromycin|mesh-list
110025010|NCT00356772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110025011|NCT00356772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110025012|NCT00356850|Azithromycin|azithromycin|mesh-list
110025013|NCT00356850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110025014|NCT00356850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110025015|NCT00356928|Cyclophosphamide|cyclophosphamide|mesh-list
110025016|NCT00356928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110025017|NCT00356928|Immunologic Factors|immunologic factors|mesh-ancestor
110025018|NCT00356928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025019|NCT00356928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110025020|NCT00356928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110025021|NCT00356928|Alkylating Agents|alkylating agents|mesh-ancestor
110025022|NCT00356928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110025023|NCT00356928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110025024|NCT00356928|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110025025|NCT00357084|Prednisone|prednisone|mesh-list
110025026|NCT00357084|Methylprednisolone|methylprednisolone|mesh-list
110025027|NCT00357084|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110025028|NCT00357084|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110025029|NCT00357084|Prednisolone|prednisolone|mesh-list
110025030|NCT00357084|Prednisolone acetate|prednisolone acetate|mesh-list
110025031|NCT00357084|Methotrexate|methotrexate|mesh-list
110025032|NCT00357084|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110025033|NCT00357084|Prednisolone phosphate|prednisolone phosphate|mesh-list
110025034|NCT00357084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110025035|NCT00357084|Glucocorticoids|glucocorticoids|mesh-ancestor
110025036|NCT00357084|Hormones|hormones|mesh-ancestor
110025037|NCT00357084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110025038|NCT00357084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025039|NCT00357084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110025040|NCT00357084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110025041|NCT00357084|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110025042|NCT00357084|Abortifacient Agents|abortifacient agents|mesh-ancestor
110025043|NCT00357084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110025044|NCT00357084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110025045|NCT00357084|Antimetabolites|antimetabolites|mesh-ancestor
110025046|NCT00357084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110025050|NCT00357084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110025051|NCT00357084|Immunologic Factors|immunologic factors|mesh-ancestor
110025052|NCT00357084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110025053|NCT00357084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110025054|NCT00357084|Antiemetics|antiemetics|mesh-ancestor
110025055|NCT00357084|Autonomic Agents|autonomic agents|mesh-ancestor
110025056|NCT00357084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110025057|NCT00357084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110025058|NCT00357084|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110025059|NCT00357084|Protective Agents|protective agents|mesh-ancestor
110025061|NCT00357240|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110025062|NCT00357240|Omeprazole|omeprazole|mesh-list
110025063|NCT00357240|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110025064|NCT00357240|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110025065|NCT00357240|Protease Inhibitors|protease inhibitors|mesh-ancestor
110025066|NCT00357240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110025067|NCT00357240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110025068|NCT00357240|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110025069|NCT00357240|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110025070|NCT00357240|Antiviral Agents|antiviral agents|mesh-ancestor
110025071|NCT00357240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110025072|NCT00357240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110025073|NCT00357240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110025074|NCT00357240|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110025075|NCT00357240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110025076|NCT00357240|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110025077|NCT00357318|Bevacizumab|bevacizumab|mesh-list
110025078|NCT00357318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110025079|NCT00357318|Sunitinib|sunitinib|mesh-list
110025080|NCT00357318|Antibodies|antibodies|mesh-list
110025081|NCT00357318|Immunoglobulins|immunoglobulins|mesh-list
110025082|NCT00357318|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110025083|NCT00357318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110025084|NCT00357318|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110025085|NCT00357318|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110025086|NCT00357318|Growth Substances|growth substances|mesh-ancestor
110025087|NCT00357318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025088|NCT00357318|Growth Inhibitors|growth inhibitors|mesh-ancestor
110025089|NCT00357318|Immunologic Factors|immunologic factors|mesh-ancestor
110025090|NCT00357318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110025091|NCT00357318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110025092|NCT00357318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110025094|NCT00357474|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110025095|NCT00357474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110025096|NCT00357474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110025097|NCT00357474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025098|NCT00357630|Gemcitabine|gemcitabine|mesh-list
110025099|NCT00357630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110025100|NCT00357630|Antimetabolites|antimetabolites|mesh-ancestor
110025101|NCT00357630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110025102|NCT00357630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110025103|NCT00357708|Decitabine|decitabine|mesh-list
110025104|NCT00357708|Azacitidine|azacitidine|mesh-list
110025105|NCT00357708|Vorinostat|vorinostat|mesh-list
110025106|NCT00357708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110025107|NCT00357708|Antimetabolites|antimetabolites|mesh-ancestor
110025108|NCT00357708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110025109|NCT00357708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110025110|NCT00357708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110025111|NCT00357708|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110025112|NCT00357864|Carbachol|carbachol|mesh-list
110025113|NCT00357864|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110025114|NCT00357864|Miotics|miotics|mesh-ancestor
110025115|NCT00357864|Autonomic Agents|autonomic agents|mesh-ancestor
110025116|NCT00357864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110025117|NCT00357864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025118|NCT00357864|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110025119|NCT00357864|Cholinergic Agents|cholinergic agents|mesh-ancestor
110025120|NCT00357864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110025121|NCT00357864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110025122|NCT00357864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110025124|NCT00357864|Sensory System Agents|sensory system agents|mesh-ancestor
110025125|NCT00357864|Protective Agents|protective agents|mesh-ancestor
110025126|NCT00357942|Morphine|morphine|mesh-list
110025130|NCT00357942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025131|NCT00357942|Analgesics|analgesics|mesh-ancestor
110025132|NCT00357942|Sensory System Agents|sensory system agents|mesh-ancestor
110025133|NCT00357942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110025134|NCT00358020|Thalidomide|thalidomide|mesh-list
110025135|NCT00358020|Bortezomib|bortezomib|mesh-list
110025136|NCT00358020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110025137|NCT00358020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110025138|NCT00358020|Immunologic Factors|immunologic factors|mesh-ancestor
110025139|NCT00358020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025140|NCT00358020|Leprostatic Agents|leprostatic agents|mesh-ancestor
110025141|NCT00358020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110025142|NCT00358020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110025143|NCT00358020|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110025144|NCT00358020|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110025145|NCT00358020|Growth Substances|growth substances|mesh-ancestor
110025146|NCT00358020|Growth Inhibitors|growth inhibitors|mesh-ancestor
110025147|NCT00358176|Risedronic Acid|risedronic acid|mesh-list
110025148|NCT00358176|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110025149|NCT00358176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110025150|NCT00358176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110025151|NCT00358176|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110025152|NCT00358176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025153|NCT00358176|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110025154|NCT00358410|Casopitant|casopitant|mesh-list
110025155|NCT00358410|Antiemetics|antiemetics|mesh-ancestor
110025156|NCT00358410|Autonomic Agents|autonomic agents|mesh-ancestor
110025157|NCT00358410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110025158|NCT00358410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025159|NCT00358410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110025160|NCT00358410|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110025161|NCT00358410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110025162|NCT00358410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110025163|NCT00358488|Albuterol|albuterol|mesh-list
110025164|NCT00358488|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110025165|NCT00358488|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110025166|NCT00358488|Autonomic Agents|autonomic agents|mesh-ancestor
110025167|NCT00358488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110025168|NCT00358488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025169|NCT00358488|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110025170|NCT00358488|Respiratory System Agents|respiratory system agents|mesh-ancestor
110025171|NCT00358488|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110025174|NCT00358488|Adrenergic Agents|adrenergic agents|mesh-ancestor
110025175|NCT00358488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110025176|NCT00358488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110025177|NCT00358488|Tocolytic Agents|tocolytic agents|mesh-ancestor
110025178|NCT00358488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110025179|NCT00358566|Gemcitabine|gemcitabine|mesh-list
110025180|NCT00358566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110025181|NCT00358566|Antimetabolites|antimetabolites|mesh-ancestor
110025182|NCT00358566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110025183|NCT00358566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110025184|NCT00359112|Metformin|metformin|mesh-list
110025185|NCT00359112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110025186|NCT00359112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025187|NCT00359190|Lapatinib|lapatinib|mesh-list
110025188|NCT00359190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110025189|NCT00359190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110025191|NCT00359190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110025192|NCT00359658|Cyclosporine|cyclosporine|mesh-list
110025193|NCT00359658|Prednisolone|prednisolone|mesh-list
110025194|NCT00359658|Cyclosporins|cyclosporins|mesh-list
110025195|NCT00359658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110025196|NCT00359658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110025197|NCT00359658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110025198|NCT00359658|Immunologic Factors|immunologic factors|mesh-ancestor
110025199|NCT00359658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025200|NCT00359658|Antifungal Agents|antifungal agents|mesh-ancestor
110025201|NCT00359658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110025202|NCT00359658|Dermatologic Agents|dermatologic agents|mesh-ancestor
110025203|NCT00359658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110025204|NCT00359658|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110025205|NCT00359658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110025207|NCT00359658|Hormones|hormones|mesh-ancestor
110025208|NCT00359658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110025209|NCT00359658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110025210|NCT00359658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110025211|NCT00359814|Cyclosporine|cyclosporine|mesh-list
110025212|NCT00359814|Cyclosporins|cyclosporins|mesh-list
110025213|NCT00359814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110025214|NCT00359814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110025215|NCT00359814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110025216|NCT00359814|Immunologic Factors|immunologic factors|mesh-ancestor
110025217|NCT00359814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025218|NCT00359814|Antifungal Agents|antifungal agents|mesh-ancestor
110025219|NCT00359814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110025220|NCT00359814|Dermatologic Agents|dermatologic agents|mesh-ancestor
110025221|NCT00359814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110025222|NCT00359814|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110025223|NCT00359892|Obatoclax|obatoclax|mesh-list
110025224|NCT00359892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110025225|NCT00359892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110025226|NCT00359970|Azithromycin|azithromycin|mesh-list
110025227|NCT00359970|Loperamide|loperamide|mesh-list
110025228|NCT00359970|Antidiarrheals|antidiarrheals|mesh-list
110025229|NCT00359970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110025230|NCT00359970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110025231|NCT00359970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110025232|NCT00360048|Oxytocin|oxytocin|mesh-list
110025233|NCT00360048|Oxytocics|oxytocics|mesh-ancestor
110025234|NCT00360048|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110025236|NCT00360438|Rasburicase|rasburicase|mesh-list
110025237|NCT00360438|Gout Suppressants|gout suppressants|mesh-ancestor
110025238|NCT00360438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110025239|NCT00360594|Acamprosate|acamprosate|mesh-list
110025240|NCT00360594|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110025241|NCT00360750|Cytarabine|cytarabine|mesh-list
110025242|NCT00360750|Carboplatin|carboplatin|mesh-list
110025243|NCT00360750|Etoposide|etoposide|mesh-list
110025244|NCT00360750|Vincristine|vincristine|mesh-list
110025245|NCT00360750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110025246|NCT00360750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110025247|NCT00360750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110025248|NCT00360750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110025250|NCT00360750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110025251|NCT00360750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110025252|NCT00360750|Antimetabolites|antimetabolites|mesh-ancestor
110025253|NCT00360750|Antiviral Agents|antiviral agents|mesh-ancestor
110025254|NCT00360750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110025255|NCT00360750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110025256|NCT00360750|Immunologic Factors|immunologic factors|mesh-ancestor
110025257|NCT00360750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025258|NCT00360750|Tubulin Modulators|tubulin modulators|mesh-ancestor
110025259|NCT00360750|Antimitotic Agents|antimitotic agents|mesh-ancestor
110025260|NCT00360750|Mitosis Modulators|mitosis modulators|mesh-ancestor
110025262|NCT00360984|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110025263|NCT00360984|Insulin Glargine|insulin glargine|mesh-list
110025264|NCT00360984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110025265|NCT00360984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025267|NCT00361452|Albuterol|albuterol|mesh-list
110025268|NCT00361452|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110025269|NCT00361452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110025270|NCT00361452|Adrenergic Agents|adrenergic agents|mesh-ancestor
110025271|NCT00361452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110025272|NCT00361452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110025273|NCT00361452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025274|NCT00361452|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110025275|NCT00361452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110025276|NCT00361452|Autonomic Agents|autonomic agents|mesh-ancestor
110025277|NCT00361452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110025278|NCT00361452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110025279|NCT00361452|Respiratory System Agents|respiratory system agents|mesh-ancestor
110025280|NCT00361452|Mydriatics|mydriatics|mesh-ancestor
110025281|NCT00361452|Sympathomimetics|sympathomimetics|mesh-ancestor
110025282|NCT00361452|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110025283|NCT00361452|Tocolytic Agents|tocolytic agents|mesh-ancestor
110025284|NCT00361452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110025285|NCT00361452|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110025290|NCT00361686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110025292|NCT00361686|Analgesics|analgesics|mesh-ancestor
110025293|NCT00361686|Sensory System Agents|sensory system agents|mesh-ancestor
110025294|NCT00361686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110025295|NCT00361920|Prednisone|prednisone|mesh-list
110025296|NCT00361920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110025297|NCT00361920|Glucocorticoids|glucocorticoids|mesh-ancestor
110025298|NCT00361920|Hormones|hormones|mesh-ancestor
110025299|NCT00361920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110025300|NCT00361920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025301|NCT00361920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110025302|NCT00361920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110025303|NCT00361998|Nitrofurantoin|nitrofurantoin|mesh-list
110025304|NCT00361998|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110025305|NCT00361998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110025306|NCT00361998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110025307|NCT00362310|Indinavir|indinavir|mesh-list
110025308|NCT00362310|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110025309|NCT00362310|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110025310|NCT00362310|Protease Inhibitors|protease inhibitors|mesh-ancestor
110025311|NCT00362310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110025312|NCT00362310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110025313|NCT00362310|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110025314|NCT00362310|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110025315|NCT00362310|Antiviral Agents|antiviral agents|mesh-ancestor
110025316|NCT00362310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110025317|NCT00362544|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110025318|NCT00362544|Antifungal Agents|antifungal agents|mesh-ancestor
110025319|NCT00362544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110025320|NCT00362544|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110025321|NCT00362544|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110025322|NCT00362700|Clevudine|clevudine|mesh-list
110025324|NCT00362700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110025325|NCT00362778|Insulin|insulin|mesh-list
110025326|NCT00362778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110025327|NCT00362778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025328|NCT00362934|Atorvastatin|atorvastatin|mesh-list
110025329|NCT00362934|Simvastatin|simvastatin|mesh-list
110025330|NCT00362934|Fenofibrate|fenofibrate|mesh-list
110025331|NCT00362934|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110025332|NCT00362934|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110025333|NCT00362934|Antimetabolites|antimetabolites|mesh-ancestor
110025334|NCT00362934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110025335|NCT00362934|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110025336|NCT00362934|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110025337|NCT00362934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110025339|NCT00363090|Cyclophosphamide|cyclophosphamide|mesh-list
110025340|NCT00363090|Doxorubicin|doxorubicin|mesh-list
110025341|NCT00363090|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110025342|NCT00363090|Vincristine|vincristine|mesh-list
110025343|NCT00363090|Alemtuzumab|alemtuzumab|mesh-list
110025344|NCT00363090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110025345|NCT00363090|Immunologic Factors|immunologic factors|mesh-ancestor
110025346|NCT00363090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025347|NCT00363090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110025348|NCT00363090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110025350|NCT00363090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110025352|NCT00363090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110025353|NCT00363090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110025354|NCT00363090|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110025355|NCT00363090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110025356|NCT00363090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110025357|NCT00363090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110025358|NCT00363090|Glucocorticoids|glucocorticoids|mesh-ancestor
110025359|NCT00363090|Hormones|hormones|mesh-ancestor
110025360|NCT00363090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110025361|NCT00363090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110025362|NCT00363090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110025363|NCT00363090|Tubulin Modulators|tubulin modulators|mesh-ancestor
110025364|NCT00363090|Antimitotic Agents|antimitotic agents|mesh-ancestor
110025365|NCT00363090|Mitosis Modulators|mitosis modulators|mesh-ancestor
110025366|NCT00363090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110025367|NCT00363792|Nitroglycerin|nitroglycerin|mesh-list
110025368|NCT00363792|Vasodilator Agents|vasodilator agents|mesh-ancestor
110025371|NCT00363948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025372|NCT00363948|Incretins|incretins|mesh-ancestor
110025374|NCT00363948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110025375|NCT00363948|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110025376|NCT00363948|Protease Inhibitors|protease inhibitors|mesh-ancestor
110025377|NCT00363948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110025378|NCT00363948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110025379|NCT00364026|Darusentan|darusentan|mesh-list
110025380|NCT00364026|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110025381|NCT00364026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110025382|NCT00364260|Epoetin Alfa|epoetin alfa|mesh-list
110025383|NCT00364260|Hematinics|hematinics|mesh-ancestor
110025384|NCT00364572|Etanercept|etanercept|mesh-list
110025385|NCT00364572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110025386|NCT00364572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110025387|NCT00364572|Analgesics|analgesics|mesh-ancestor
110025388|NCT00364572|Sensory System Agents|sensory system agents|mesh-ancestor
110025389|NCT00364572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110025390|NCT00364572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025391|NCT00364572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110025392|NCT00364572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110025393|NCT00364572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110025394|NCT00364572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110025395|NCT00364572|Immunologic Factors|immunologic factors|mesh-ancestor
110025396|NCT00364806|Metoclopramide|metoclopramide|mesh-list
110025397|NCT00364806|Prochlorperazine|prochlorperazine|mesh-list
110025398|NCT00364806|Antiemetics|antiemetics|mesh-ancestor
110025399|NCT00364806|Autonomic Agents|autonomic agents|mesh-ancestor
110025400|NCT00364806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110025401|NCT00364806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025402|NCT00364806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110025403|NCT00364806|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110025404|NCT00364806|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110025405|NCT00364806|Dopamine Agents|dopamine agents|mesh-ancestor
110025406|NCT00364806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110025407|NCT00364806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110025408|NCT00364806|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110025409|NCT00364806|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110025410|NCT00364806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110025411|NCT00364806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110025413|NCT00365040|Mitomycin|mitomycin|mesh-list
110025414|NCT00365040|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110025415|NCT00365040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110025416|NCT00365040|Alkylating Agents|alkylating agents|mesh-ancestor
110025417|NCT00365040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110025418|NCT00365040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110025421|NCT00365586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110025422|NCT00365586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110025423|NCT00365586|Analgesics|analgesics|mesh-ancestor
110025424|NCT00365586|Sensory System Agents|sensory system agents|mesh-ancestor
110025425|NCT00365586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110025426|NCT00365586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025427|NCT00365586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110025428|NCT00365586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110025429|NCT00365586|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110025430|NCT00365586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110025431|NCT00365586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110025432|NCT00365742|Simvastatin|simvastatin|mesh-list
110025433|NCT00365742|Red yeast rice|red yeast rice|mesh-list
110025434|NCT00365742|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110025435|NCT00365742|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110025436|NCT00365742|Antimetabolites|antimetabolites|mesh-ancestor
110025437|NCT00365742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110025438|NCT00365742|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110025439|NCT00365742|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110025440|NCT00365742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110025441|NCT00365820|Tegaserod|tegaserod|mesh-list
110025442|NCT00365820|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110025443|NCT00365820|Serotonin Agents|serotonin agents|mesh-ancestor
110025444|NCT00365820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110025445|NCT00365820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110025446|NCT00365820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025450|NCT00365898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110025451|NCT00365898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025452|NCT00365898|Analgesics|analgesics|mesh-ancestor
110025453|NCT00365898|Sensory System Agents|sensory system agents|mesh-ancestor
110025454|NCT00365898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110025455|NCT00366834|Dexamethasone|dexamethasone|mesh-list
110025456|NCT00366834|Dexamethasone acetate|dexamethasone acetate|mesh-list
110025457|NCT00366834|Ondansetron|ondansetron|mesh-list
110025458|NCT00366834|Casopitant|casopitant|mesh-list
110025459|NCT00366834|BB 1101|bb 1101|mesh-list
110025460|NCT00366834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110025461|NCT00366834|Antiemetics|antiemetics|mesh-ancestor
110025462|NCT00366834|Autonomic Agents|autonomic agents|mesh-ancestor
110025463|NCT00366834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110025464|NCT00366834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025466|NCT00366834|Glucocorticoids|glucocorticoids|mesh-ancestor
110025467|NCT00366834|Hormones|hormones|mesh-ancestor
110025468|NCT00366834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110025469|NCT00366834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110025470|NCT00366834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110025471|NCT00366834|Protease Inhibitors|protease inhibitors|mesh-ancestor
110025473|NCT00366834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110025474|NCT00366834|Antipruritics|antipruritics|mesh-ancestor
110025475|NCT00366834|Dermatologic Agents|dermatologic agents|mesh-ancestor
110025476|NCT00366834|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110025477|NCT00366834|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110025478|NCT00366834|Serotonin Agents|serotonin agents|mesh-ancestor
110025479|NCT00366834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110025480|NCT00366834|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110025481|NCT00367068|Baclofen|baclofen|mesh-list
110025482|NCT00367068|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110025483|NCT00367068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025484|NCT00367068|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110025486|NCT00367068|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110025487|NCT00367068|GABA Agonists|gaba agonists|mesh-ancestor
110025488|NCT00367068|GABA Agents|gaba agents|mesh-ancestor
110025489|NCT00367068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110025490|NCT00367068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110025491|NCT00367302|Buprenorphine|buprenorphine|mesh-list
110025492|NCT00367302|Methadone|methadone|mesh-list
110025493|NCT00367302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110025495|NCT00367302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110025496|NCT00367302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025497|NCT00367302|Analgesics|analgesics|mesh-ancestor
110025498|NCT00367302|Sensory System Agents|sensory system agents|mesh-ancestor
110025499|NCT00367302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110025500|NCT00367302|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110025501|NCT00367302|Antitussive Agents|antitussive agents|mesh-ancestor
110025502|NCT00367302|Respiratory System Agents|respiratory system agents|mesh-ancestor
110025503|NCT00367536|Bazedoxifene|bazedoxifene|mesh-list
110025504|NCT00367536|Estrogens|estrogens|mesh-list
110025505|NCT00367536|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110025506|NCT00367536|Hormones|hormones|mesh-ancestor
110025507|NCT00367536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110025508|NCT00367536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025509|NCT00367536|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110025510|NCT00367536|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110025511|NCT00367536|Hormone Antagonists|hormone antagonists|mesh-ancestor
110025512|NCT00367536|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110025513|NCT00367614|Pantoprazole|pantoprazole|mesh-list
110025514|NCT00367614|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110025515|NCT00367614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110025516|NCT00367614|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110025517|NCT00367614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110025518|NCT00367614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110025519|NCT00368160|Eszopiclone|eszopiclone|mesh-list
110025520|NCT00368160|Zopiclone|zopiclone|mesh-list
110025521|NCT00368160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110025522|NCT00368160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110025523|NCT00368160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025524|NCT00368238|Aspirin|aspirin|mesh-list
110025525|NCT00368238|Epoetin Alfa|epoetin alfa|mesh-list
110025526|NCT00368238|Clopidogrel|clopidogrel|mesh-list
110025527|NCT00368238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110025528|NCT00368238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110025529|NCT00368238|Analgesics|analgesics|mesh-ancestor
110025532|NCT00368238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025533|NCT00368238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110025534|NCT00368238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110025535|NCT00368238|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110025536|NCT00368238|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110025537|NCT00368238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110025538|NCT00368238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110025539|NCT00368238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110025540|NCT00368238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110025541|NCT00368238|Antipyretics|antipyretics|mesh-ancestor
110025542|NCT00368238|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110025543|NCT00368238|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110025544|NCT00368238|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110025545|NCT00368238|Purinergic Agents|purinergic agents|mesh-ancestor
110025546|NCT00368238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110025548|NCT00368394|Insulin glulisine|insulin glulisine|mesh-list
110025549|NCT00368394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110025550|NCT00368394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025551|NCT00368706|Solifenacin Succinate|solifenacin succinate|mesh-list
110025552|NCT00368706|Tolterodine Tartrate|tolterodine tartrate|mesh-list
110025553|NCT00368706|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110025554|NCT00368706|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110025555|NCT00368706|Cholinergic Agents|cholinergic agents|mesh-ancestor
110025556|NCT00368706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110025557|NCT00368706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110025558|NCT00368706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025559|NCT00368706|Urological Agents|urological agents|mesh-ancestor
110025560|NCT00368862|Memantine|memantine|mesh-list
110025561|NCT00368862|Escitalopram|escitalopram|mesh-list
110025562|NCT00368862|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110025563|NCT00368862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110025564|NCT00368862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110025565|NCT00368862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110025566|NCT00368862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110025567|NCT00368862|Serotonin Agents|serotonin agents|mesh-ancestor
110025568|NCT00368862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025569|NCT00368862|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110025570|NCT00368862|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110025571|NCT00368862|Dopamine Agents|dopamine agents|mesh-ancestor
110025572|NCT00368862|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110025573|NCT00368862|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110025574|NCT00369018|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110025575|NCT00369018|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
110025576|NCT00369018|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110025577|NCT00369018|Dermatologic Agents|dermatologic agents|mesh-ancestor
110025578|NCT00369096|Bemiparin|bemiparin|mesh-list
110025579|NCT00369096|Anticoagulants|anticoagulants|mesh-ancestor
110025580|NCT00369174|Rosiglitazone|rosiglitazone|mesh-list
110025581|NCT00369174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110025582|NCT00369174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025583|NCT00369252|Nimotuzumab|nimotuzumab|mesh-list
110036313|NCT01410214|Vinorelbine|vinorelbine|mesh-list
110025584|NCT00369252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110025585|NCT00369252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110025586|NCT00369408|Naltrexone|naltrexone|mesh-list
110025587|NCT00369408|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110025588|NCT00369408|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110025589|NCT00369408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025590|NCT00369408|Sensory System Agents|sensory system agents|mesh-ancestor
110025591|NCT00369408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110025592|NCT00369798|Rolipram|rolipram|mesh-list
110025593|NCT00369798|Antidepressive Agents|antidepressive agents|mesh-ancestor
110025594|NCT00369798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110025595|NCT00369798|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110025596|NCT00369798|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110025597|NCT00369798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110025598|NCT00369798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110025600|NCT00369954|Gemcitabine|gemcitabine|mesh-list
110025601|NCT00369954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110025602|NCT00369954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110025603|NCT00369954|Antimetabolites|antimetabolites|mesh-ancestor
110025604|NCT00369954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110025606|NCT00370188|Anticonvulsants|anticonvulsants|mesh-ancestor
110025607|NCT00370188|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110025608|NCT00370188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025609|NCT00370266|Triamcinolone|triamcinolone|mesh-list
110025610|NCT00370266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110025611|NCT00370266|Glucocorticoids|glucocorticoids|mesh-ancestor
110025612|NCT00370266|Hormones|hormones|mesh-ancestor
110025613|NCT00370266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110025614|NCT00370266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025615|NCT00370422|Triamcinolone|triamcinolone|mesh-list
110025616|NCT00370422|Bevacizumab|bevacizumab|mesh-list
110025617|NCT00370422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110025618|NCT00370422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110025619|NCT00370422|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110025620|NCT00370422|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110025621|NCT00370422|Growth Substances|growth substances|mesh-ancestor
110025622|NCT00370422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025623|NCT00370422|Growth Inhibitors|growth inhibitors|mesh-ancestor
110025624|NCT00370422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110025625|NCT00370422|Glucocorticoids|glucocorticoids|mesh-ancestor
110025627|NCT00370422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110025628|NCT00370500|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110025629|NCT00370500|Antidepressive Agents|antidepressive agents|mesh-ancestor
110025630|NCT00370500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110025633|NCT00370500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110025634|NCT00370500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025636|NCT00370656|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110025638|NCT00370656|Analgesics|analgesics|mesh-ancestor
110025639|NCT00370656|Sensory System Agents|sensory system agents|mesh-ancestor
110025640|NCT00370656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110025641|NCT00370656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025642|NCT00370656|Anticonvulsants|anticonvulsants|mesh-ancestor
110025643|NCT00370656|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110025644|NCT00370656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110025645|NCT00370656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110025646|NCT00370656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110025647|NCT00370656|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110025648|NCT00370656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110025649|NCT00370656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110025650|NCT00370656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110025651|NCT00370656|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110025652|NCT00370656|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110025653|NCT00370656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110025654|NCT00370656|Antidepressive Agents|antidepressive agents|mesh-ancestor
110025655|NCT00370656|Dopamine Agents|dopamine agents|mesh-ancestor
110025656|NCT00370656|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110025657|NCT00370656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110025658|NCT00370656|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110025659|NCT00370656|Adrenergic Agents|adrenergic agents|mesh-ancestor
110025660|NCT00370734|Botulinum Toxins|botulinum toxins|mesh-list
110025661|NCT00370734|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110025662|NCT00370734|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110025663|NCT00370734|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110025664|NCT00370734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110025665|NCT00370734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110025666|NCT00370734|Cholinergic Agents|cholinergic agents|mesh-ancestor
110025667|NCT00370734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110025668|NCT00370734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025669|NCT00370734|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110025670|NCT00370734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110025671|NCT00370968|Zinc Sulfate|zinc sulfate|mesh-list
110025672|NCT00370968|Astringents|astringents|mesh-ancestor
110025673|NCT00370968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025674|NCT00370968|Dermatologic Agents|dermatologic agents|mesh-ancestor
110025675|NCT00371124|Atropine|atropine|mesh-list
110025676|NCT00371124|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110025677|NCT00371124|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110025678|NCT00371124|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110025679|NCT00371124|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110025680|NCT00371124|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110025681|NCT00371124|Autonomic Agents|autonomic agents|mesh-ancestor
110025683|NCT00371124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025684|NCT00371124|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110025685|NCT00371124|Respiratory System Agents|respiratory system agents|mesh-ancestor
110025687|NCT00371124|Parasympatholytics|parasympatholytics|mesh-ancestor
110025688|NCT00371124|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110025689|NCT00371124|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110025691|NCT00371124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110025692|NCT00371124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110025694|NCT00371592|Antiviral Agents|antiviral agents|mesh-ancestor
110025695|NCT00371592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110025697|NCT00371904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110025698|NCT00371904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110025699|NCT00371904|Immunologic Factors|immunologic factors|mesh-ancestor
110025700|NCT00371904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025701|NCT00371904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110025702|NCT00372138|Thrombin|thrombin|mesh-list
110025703|NCT00372138|Hemostatics|hemostatics|mesh-ancestor
110025704|NCT00372138|Coagulants|coagulants|mesh-ancestor
110025705|NCT00372216|Clopidogrel|clopidogrel|mesh-list
110025706|NCT00372216|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110025707|NCT00372216|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110025708|NCT00372216|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110025709|NCT00372216|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110025710|NCT00372216|Purinergic Agents|purinergic agents|mesh-ancestor
110025711|NCT00372216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110025712|NCT00372216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110025713|NCT00372216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025714|NCT00372294|Clindamycin|clindamycin|mesh-list
110025715|NCT00372294|Clindamycin palmitate|clindamycin palmitate|mesh-list
110025716|NCT00372294|Clindamycin phosphate|clindamycin phosphate|mesh-list
110025717|NCT00372294|Sulfadiazine|sulfadiazine|mesh-list
110025718|NCT00372294|Pyrimethamine|pyrimethamine|mesh-list
110025719|NCT00372294|Dexamethasone|dexamethasone|mesh-list
110025720|NCT00372294|Prednisolone|prednisolone|mesh-list
110025721|NCT00372294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110025722|NCT00372294|Antiemetics|antiemetics|mesh-ancestor
110025723|NCT00372294|Autonomic Agents|autonomic agents|mesh-ancestor
110025724|NCT00372294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110025725|NCT00372294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025726|NCT00372294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110025728|NCT00372294|Hormones|hormones|mesh-ancestor
110025729|NCT00372294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110025730|NCT00372294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110025731|NCT00372294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110025732|NCT00372294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110025733|NCT00372294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110025734|NCT00372294|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110025735|NCT00372294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110025736|NCT00372294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110025737|NCT00372294|Antimalarials|antimalarials|mesh-ancestor
110025738|NCT00372294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110025739|NCT00372294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110025740|NCT00372294|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110025741|NCT00372294|Coccidiostats|coccidiostats|mesh-ancestor
110025742|NCT00372372|Risedronic Acid|risedronic acid|mesh-list
110025743|NCT00372372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110025744|NCT00372372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110025745|NCT00372372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110025746|NCT00372372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110025747|NCT00372372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025748|NCT00372372|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110025751|NCT00372762|Diuretics|diuretics|mesh-ancestor
110025752|NCT00372762|Natriuretic Agents|natriuretic agents|mesh-ancestor
110025753|NCT00372762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025754|NCT00372762|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110025755|NCT00372762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110025756|NCT00372762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110025757|NCT00373464|Etoricoxib|etoricoxib|mesh-list
110025758|NCT00373464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110025759|NCT00373464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110025761|NCT00373464|Sensory System Agents|sensory system agents|mesh-ancestor
110025762|NCT00373464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110025763|NCT00373464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025764|NCT00373464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110025765|NCT00373464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110025766|NCT00373464|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110025767|NCT00373464|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110025768|NCT00373464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110025769|NCT00373464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110025771|NCT00373620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110025772|NCT00373620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110025773|NCT00373620|Tubulin Modulators|tubulin modulators|mesh-ancestor
110025774|NCT00373620|Antimitotic Agents|antimitotic agents|mesh-ancestor
110025775|NCT00373620|Mitosis Modulators|mitosis modulators|mesh-ancestor
110025776|NCT00373620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110025777|NCT00373776|Miltefosine|miltefosine|mesh-list
110025778|NCT00373776|Antifungal Agents|antifungal agents|mesh-ancestor
110025779|NCT00373776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110025780|NCT00373776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110025781|NCT00373776|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110025782|NCT00373776|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110025783|NCT00374478|Scopolamine|scopolamine|mesh-list
110025784|NCT00374478|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
110025785|NCT00374478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110025786|NCT00374478|Antiemetics|antiemetics|mesh-ancestor
110025787|NCT00374478|Autonomic Agents|autonomic agents|mesh-ancestor
110025788|NCT00374478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110025789|NCT00374478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025790|NCT00374478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110025791|NCT00374478|Mydriatics|mydriatics|mesh-ancestor
110025792|NCT00374478|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110025794|NCT00374478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110025795|NCT00374478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110025796|NCT00374478|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110025797|NCT00374478|Parasympatholytics|parasympatholytics|mesh-ancestor
110025799|NCT00373542|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110025800|NCT00373542|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110025801|NCT00373542|Dopamine Agonists|dopamine agonists|mesh-ancestor
110025802|NCT00373542|Dopamine Agents|dopamine agents|mesh-ancestor
110025803|NCT00373542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110025804|NCT00373542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110025805|NCT00373542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025806|NCT00375258|Tranexamic Acid|tranexamic acid|mesh-list
110025807|NCT00375258|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110025808|NCT00375258|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110025809|NCT00375258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110025810|NCT00375258|Hemostatics|hemostatics|mesh-ancestor
110025811|NCT00375258|Coagulants|coagulants|mesh-ancestor
110025812|NCT00375648|Zoledronic Acid|zoledronic acid|mesh-list
110025813|NCT00375648|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110025814|NCT00375648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025815|NCT00376038|Metformin|metformin|mesh-list
110025816|NCT00376038|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110025817|NCT00376038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025818|NCT00376272|Valsartan|valsartan|mesh-list
110025819|NCT00376272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110025820|NCT00376272|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110025821|NCT00376272|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110025822|NCT00376272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110025823|NCT00376428|Gentamicins|gentamicins|mesh-list
110025824|NCT00376428|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110025825|NCT00376428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110025826|NCT00376428|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110025827|NCT00376428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110025828|NCT00376428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110025830|NCT00376584|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110025831|NCT00376584|Antimetabolites|antimetabolites|mesh-ancestor
110025832|NCT00376584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110025833|NCT00376584|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110025834|NCT00376584|Vasodilator Agents|vasodilator agents|mesh-ancestor
110025835|NCT00376584|Vitamin B Complex|vitamin b complex|mesh-ancestor
110025836|NCT00376584|Vitamins|vitamins|mesh-ancestor
110025837|NCT00376584|Micronutrients|micronutrients|mesh-ancestor
110025839|NCT00376662|Etidronic Acid|etidronic acid|mesh-list
110025840|NCT00376662|Hormones|hormones|mesh-list
110025841|NCT00376662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110025842|NCT00376662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025843|NCT00376662|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110025844|NCT00376740|Zoledronic Acid|zoledronic acid|mesh-list
110025845|NCT00376740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110025846|NCT00376740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025847|NCT00376818|Hormones|hormones|mesh-list
110025848|NCT00376818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110025849|NCT00376818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025850|NCT00377442|Simvastatin|simvastatin|mesh-list
110025851|NCT00377442|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110025852|NCT00377442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110025853|NCT00377442|Antimetabolites|antimetabolites|mesh-ancestor
110025854|NCT00377442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110025855|NCT00377442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110025856|NCT00377442|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110025857|NCT00377442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110025859|NCT00377910|Polidocanol|polidocanol|mesh-list
110025860|NCT00377910|Anesthetics, Local|anesthetics, local|mesh-ancestor
110025861|NCT00377910|Anesthetics|anesthetics|mesh-ancestor
110025862|NCT00377910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110025863|NCT00377910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025864|NCT00377910|Sensory System Agents|sensory system agents|mesh-ancestor
110025865|NCT00377910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110025866|NCT00377910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110025867|NCT00377910|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110025868|NCT00377910|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110025869|NCT00377910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110025870|NCT00377910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110025871|NCT00377910|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
110025872|NCT00377910|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110025873|NCT00377988|Contraceptive Agents|contraceptive agents|mesh-list
110025874|NCT00377988|Norgestimate|norgestimate|mesh-list
110025875|NCT00377988|Contraceptives, Oral|contraceptives, oral|mesh-list
110025876|NCT00377988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110025877|NCT00377988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025878|NCT00377988|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110025879|NCT00377988|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110025880|NCT00377988|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110025881|NCT00378066|Bevacizumab|bevacizumab|mesh-list
110025882|NCT00378066|Capecitabine|capecitabine|mesh-list
110025883|NCT00378066|Oxaliplatin|oxaliplatin|mesh-list
110025884|NCT00378066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110025885|NCT00378066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110025886|NCT00378066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110025887|NCT00378066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110025888|NCT00378066|Growth Substances|growth substances|mesh-ancestor
110025889|NCT00378066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025890|NCT00378066|Growth Inhibitors|growth inhibitors|mesh-ancestor
110025891|NCT00378066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110025892|NCT00378066|Antimetabolites|antimetabolites|mesh-ancestor
110025893|NCT00378066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110025894|NCT00378144|Acetaminophen|acetaminophen|mesh-list
110025895|NCT00378144|Pseudoephedrine|pseudoephedrine|mesh-list
110025896|NCT00378144|Ephedrine|ephedrine|mesh-list
110025897|NCT00378144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110025898|NCT00378144|Analgesics|analgesics|mesh-ancestor
110025899|NCT00378144|Sensory System Agents|sensory system agents|mesh-ancestor
110025900|NCT00378144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110025901|NCT00378144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025902|NCT00378144|Antipyretics|antipyretics|mesh-ancestor
110025903|NCT00378144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110025904|NCT00378144|Autonomic Agents|autonomic agents|mesh-ancestor
110025905|NCT00378144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110025906|NCT00378144|Respiratory System Agents|respiratory system agents|mesh-ancestor
110025907|NCT00378144|Nasal Decongestants|nasal decongestants|mesh-ancestor
110025908|NCT00378144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110025909|NCT00378144|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110025910|NCT00378144|Sympathomimetics|sympathomimetics|mesh-ancestor
110025912|NCT00378144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110025913|NCT00378144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110025915|NCT00378456|Leucovorin|leucovorin|mesh-list
110025916|NCT00378456|Folic Acid|folic acid|mesh-list
110025917|NCT00378456|Vitamin A|vitamin a|mesh-list
110025918|NCT00378456|Zinc|zinc|mesh-list
110025919|NCT00378456|Selenium|selenium|mesh-list
110025920|NCT00378456|Retinol palmitate|retinol palmitate|mesh-list
110025921|NCT00378456|Levoleucovorin|levoleucovorin|mesh-list
110025922|NCT00378456|Antioxidants|antioxidants|mesh-list
110025923|NCT00378456|Micronutrients|micronutrients|mesh-ancestor
110025924|NCT00378456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025925|NCT00378456|Trace Elements|trace elements|mesh-ancestor
110025926|NCT00378456|Antidotes|antidotes|mesh-ancestor
110025927|NCT00378456|Protective Agents|protective agents|mesh-ancestor
110025928|NCT00378456|Vitamin B Complex|vitamin b complex|mesh-ancestor
110025929|NCT00378456|Hematinics|hematinics|mesh-ancestor
110025930|NCT00378456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110025931|NCT00378456|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110025932|NCT00378456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110025933|NCT00378612|Sirolimus|sirolimus|mesh-list
110025934|NCT00378612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110025935|NCT00378612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110025936|NCT00378612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110025937|NCT00378612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110025938|NCT00378612|Antifungal Agents|antifungal agents|mesh-ancestor
110025939|NCT00378612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110025940|NCT00378612|Immunologic Factors|immunologic factors|mesh-ancestor
110025941|NCT00378612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025942|NCT00378690|Leuprolide|leuprolide|mesh-list
110025943|NCT00378690|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110025944|NCT00378690|Fertility Agents|fertility agents|mesh-ancestor
110025945|NCT00378690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110025946|NCT00378690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025947|NCT00378690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110025948|NCT00378690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110025949|NCT00378768|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110025950|NCT00378768|Immunologic Factors|immunologic factors|mesh-ancestor
110025951|NCT00378768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025952|NCT00378768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110025953|NCT00379158|Micronutrients|micronutrients|mesh-list
110025954|NCT00379158|Trace Elements|trace elements|mesh-list
110025955|NCT00379158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025956|NCT00379626|Hormones|hormones|mesh-list
110025957|NCT00379626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110025958|NCT00379626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025959|NCT00380406|Leuprolide|leuprolide|mesh-list
110025960|NCT00380406|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110025961|NCT00380406|Fertility Agents|fertility agents|mesh-ancestor
110025962|NCT00380406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110025963|NCT00380406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025964|NCT00380406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110025965|NCT00380406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110025967|NCT00380484|Montelukast|montelukast|mesh-list
110025968|NCT00380484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110025969|NCT00380484|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110025970|NCT00380484|Autonomic Agents|autonomic agents|mesh-ancestor
110025971|NCT00380484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110025972|NCT00380484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025973|NCT00380484|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110025974|NCT00380484|Respiratory System Agents|respiratory system agents|mesh-ancestor
110025975|NCT00380484|Glucocorticoids|glucocorticoids|mesh-ancestor
110025976|NCT00380484|Hormones|hormones|mesh-ancestor
110025977|NCT00380484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110025978|NCT00380484|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110025979|NCT00380484|Hormone Antagonists|hormone antagonists|mesh-ancestor
110025980|NCT00380484|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110025981|NCT00380484|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110025982|NCT00380484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110025983|NCT00380640|Trimethoprim|trimethoprim|mesh-list
110025984|NCT00380640|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110025985|NCT00380640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110025986|NCT00380640|Antimalarials|antimalarials|mesh-ancestor
110025987|NCT00380640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110025988|NCT00380640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110025989|NCT00380640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110025991|NCT00380640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110025992|NCT00380640|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110025993|NCT00380640|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110025994|NCT00380640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110025996|NCT00381030|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110025997|NCT00381030|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110025998|NCT00381030|Adrenergic Agents|adrenergic agents|mesh-ancestor
110025999|NCT00381030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110026000|NCT00381030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110026001|NCT00381030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026002|NCT00381030|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110026003|NCT00381030|Antioxidants|antioxidants|mesh-ancestor
110026004|NCT00381030|Protective Agents|protective agents|mesh-ancestor
110026005|NCT00381030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110026006|NCT00381030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110026007|NCT00381030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110026008|NCT00381030|Vasodilator Agents|vasodilator agents|mesh-ancestor
110026009|NCT00381030|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110026010|NCT00381030|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110026011|NCT00381264|Nabilone|nabilone|mesh-list
110026012|NCT00381264|Antiemetics|antiemetics|mesh-ancestor
110026013|NCT00381264|Autonomic Agents|autonomic agents|mesh-ancestor
110026014|NCT00381264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110026015|NCT00381264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026016|NCT00381264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110026017|NCT00381264|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110026018|NCT00381264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110026019|NCT00381264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110026020|NCT00381264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110026021|NCT00381342|Exenatide|exenatide|mesh-list
110026022|NCT00381342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110026023|NCT00381342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026024|NCT00381342|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110026025|NCT00381342|Incretins|incretins|mesh-ancestor
110026026|NCT00381342|Hormones|hormones|mesh-ancestor
110026027|NCT00381342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110026029|NCT00381654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110026030|NCT00381654|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110026031|NCT00381654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110026032|NCT00381654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110026034|NCT00381732|Vasodilator Agents|vasodilator agents|mesh-ancestor
110026035|NCT00381732|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110026036|NCT00381732|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110026037|NCT00381732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110026038|NCT00381732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110026039|NCT00381732|Urological Agents|urological agents|mesh-ancestor
110026040|NCT00382044|Darbepoetin alfa|darbepoetin alfa|mesh-list
110026041|NCT00382044|Hematinics|hematinics|mesh-ancestor
110026042|NCT00382356|Dutasteride|dutasteride|mesh-list
110026043|NCT00382356|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110026044|NCT00382356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110026045|NCT00382356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110026046|NCT00382356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110026047|NCT00382356|Hormone Antagonists|hormone antagonists|mesh-ancestor
110026048|NCT00382356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110026049|NCT00382356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026050|NCT00382668|Dasatinib|dasatinib|mesh-list
110026051|NCT00382668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110026052|NCT00382668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110026053|NCT00382668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110026054|NCT00382668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110026055|NCT00382980|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110026056|NCT00382980|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110026057|NCT00382980|Immunologic Factors|immunologic factors|mesh-ancestor
110026058|NCT00382980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026059|NCT00382980|Antacids|antacids|mesh-ancestor
110026061|NCT00382980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110026062|NCT00383136|Tirofiban|tirofiban|mesh-list
110026063|NCT00383136|Abciximab|abciximab|mesh-list
110026064|NCT00383136|Anticoagulants|anticoagulants|mesh-ancestor
110026065|NCT00383136|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110026066|NCT00383136|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110026067|NCT00383136|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110026068|NCT00383136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110026069|NCT00383214|Epratuzumab|epratuzumab|mesh-list
110026070|NCT00383214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110026071|NCT00383214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110026072|NCT00383370|Aflibercept|aflibercept|mesh-list
110026073|NCT00383370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110026074|NCT00383370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110026075|NCT00383370|Growth Substances|growth substances|mesh-ancestor
110026076|NCT00383370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026077|NCT00383370|Growth Inhibitors|growth inhibitors|mesh-ancestor
110026078|NCT00383370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110026080|NCT00383526|Immunologic Factors|immunologic factors|mesh-ancestor
110026081|NCT00383526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026083|NCT00383682|Morphine|morphine|mesh-list
110026084|NCT00383682|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110026085|NCT00383682|Narcotics|narcotics|mesh-ancestor
110026086|NCT00383682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110026087|NCT00383682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026088|NCT00383682|Analgesics|analgesics|mesh-ancestor
110026089|NCT00383682|Sensory System Agents|sensory system agents|mesh-ancestor
110026090|NCT00383682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110026091|NCT00383682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110026092|NCT00383682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110026093|NCT00383682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110026094|NCT00383682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110026095|NCT00383682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110026096|NCT00383916|Pantoprazole|pantoprazole|mesh-list
110026097|NCT00383916|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110026098|NCT00383916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110026099|NCT00383916|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110026100|NCT00383916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110026101|NCT00383916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110026102|NCT00383994|Rituximab|rituximab|mesh-list
110026103|NCT00383994|Sargramostim|sargramostim|mesh-list
110026104|NCT00383994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110026105|NCT00383994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110026106|NCT00383994|Immunologic Factors|immunologic factors|mesh-ancestor
110026107|NCT00383994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026108|NCT00383994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110026109|NCT00384072|Bazedoxifene|bazedoxifene|mesh-list
110026110|NCT00384072|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110026111|NCT00384072|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110026112|NCT00384072|Hormone Antagonists|hormone antagonists|mesh-ancestor
110026113|NCT00384072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110026114|NCT00384072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026115|NCT00384072|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110026116|NCT00384306|Prednisolone|prednisolone|mesh-list
110026117|NCT00384306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110026118|NCT00384306|Glucocorticoids|glucocorticoids|mesh-ancestor
110026119|NCT00384306|Hormones|hormones|mesh-ancestor
110026120|NCT00384306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110026121|NCT00384306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026122|NCT00384306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110026124|NCT00384384|Glycyrrhetinic Acid|glycyrrhetinic acid|mesh-list
110026125|NCT00384384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110026126|NCT00384540|Dobutamine|dobutamine|mesh-list
110026127|NCT00384540|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110026128|NCT00384540|Sympathomimetics|sympathomimetics|mesh-ancestor
110026129|NCT00384540|Autonomic Agents|autonomic agents|mesh-ancestor
110026130|NCT00384540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110026131|NCT00384540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026132|NCT00384540|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110026134|NCT00384540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110026135|NCT00384540|Adrenergic Agents|adrenergic agents|mesh-ancestor
110026136|NCT00384540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110026137|NCT00384540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110026138|NCT00384540|Protective Agents|protective agents|mesh-ancestor
110026139|NCT00384618|Vitamin E|vitamin e|mesh-list
110026140|NCT00384618|Pravastatin|pravastatin|mesh-list
110026141|NCT00384618|Vitamins|vitamins|mesh-ancestor
110026142|NCT00384618|Micronutrients|micronutrients|mesh-ancestor
110026143|NCT00384618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026145|NCT00384618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110026146|NCT00384618|Protective Agents|protective agents|mesh-ancestor
110026148|NCT00384618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110026149|NCT00384618|Antimetabolites|antimetabolites|mesh-ancestor
110026150|NCT00384618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110026151|NCT00384618|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110026152|NCT00384618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110026153|NCT00384696|Nicotine|nicotine|mesh-list
110026154|NCT00384696|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110026155|NCT00384696|Autonomic Agents|autonomic agents|mesh-ancestor
110026156|NCT00384696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110026157|NCT00384696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026158|NCT00384696|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110026159|NCT00384696|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110026160|NCT00384696|Cholinergic Agents|cholinergic agents|mesh-ancestor
110026161|NCT00384696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110026162|NCT00384696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110026163|NCT00385086|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
110026164|NCT00385086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110026165|NCT00385398|Temozolomide|temozolomide|mesh-list
110026166|NCT00385398|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110026167|NCT00385398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110026168|NCT00385398|Alkylating Agents|alkylating agents|mesh-ancestor
110026169|NCT00385398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110026170|NCT00385398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110026171|NCT00385398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110026172|NCT00385398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110026174|NCT00385554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110026175|NCT00385554|Antiviral Agents|antiviral agents|mesh-ancestor
110026176|NCT00385554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110026177|NCT00385632|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110026178|NCT00385632|Antiviral Agents|antiviral agents|mesh-ancestor
110026179|NCT00385632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110026180|NCT00385710|Valproic Acid|valproic acid|mesh-list
110026181|NCT00385710|Anticonvulsants|anticonvulsants|mesh-ancestor
110026182|NCT00385710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110026183|NCT00385710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110026184|NCT00385710|GABA Agents|gaba agents|mesh-ancestor
110026185|NCT00385710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110026186|NCT00385710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026187|NCT00385710|Antimanic Agents|antimanic agents|mesh-ancestor
110026188|NCT00385710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110026189|NCT00385710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110026190|NCT00385710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110026191|NCT00386178|Vitamin E|vitamin e|mesh-list
110026192|NCT00386178|Tocopherols|tocopherols|mesh-list
110026193|NCT00386178|Tocotrienols|tocotrienols|mesh-list
110026194|NCT00386178|alpha-Tocopherol|alpha-tocopherol|mesh-list
110026195|NCT00386178|gamma-Tocopherol|gamma-tocopherol|mesh-list
110026196|NCT00386178|Vitamins|vitamins|mesh-ancestor
110026197|NCT00386178|Micronutrients|micronutrients|mesh-ancestor
110026198|NCT00386178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026199|NCT00386178|Antioxidants|antioxidants|mesh-ancestor
110026200|NCT00386178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110026201|NCT00386178|Protective Agents|protective agents|mesh-ancestor
110026202|NCT00421824|Capecitabine|capecitabine|mesh-list
110026203|NCT00421824|Oxaliplatin|oxaliplatin|mesh-list
110026204|NCT00421824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110026205|NCT00421824|Antimetabolites|antimetabolites|mesh-ancestor
110026206|NCT00421824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110026207|NCT00421824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110026208|NCT00421980|Etanercept|etanercept|mesh-list
110026209|NCT00421980|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110026210|NCT00421980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110026211|NCT00421980|Analgesics|analgesics|mesh-ancestor
110026212|NCT00421980|Sensory System Agents|sensory system agents|mesh-ancestor
110026213|NCT00421980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110026214|NCT00421980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026215|NCT00421980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110026216|NCT00421980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110026217|NCT00421980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110026218|NCT00421980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110026219|NCT00421980|Immunologic Factors|immunologic factors|mesh-ancestor
110026220|NCT00422214|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110026221|NCT00422214|Antidepressive Agents|antidepressive agents|mesh-ancestor
110026222|NCT00422214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110026225|NCT00422214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110026226|NCT00422214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026228|NCT00422526|Progestins|progestins|mesh-ancestor
110026229|NCT00422526|Hormones|hormones|mesh-ancestor
110026230|NCT00422526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110026231|NCT00422526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026232|NCT00422604|Tiotropium Bromide|tiotropium bromide|mesh-list
110026233|NCT00422604|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110026234|NCT00422604|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110026235|NCT00422604|Autonomic Agents|autonomic agents|mesh-ancestor
110026236|NCT00422604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110026237|NCT00422604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026238|NCT00422604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110026239|NCT00422604|Respiratory System Agents|respiratory system agents|mesh-ancestor
110026240|NCT00422604|Parasympatholytics|parasympatholytics|mesh-ancestor
110026241|NCT00422604|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110026242|NCT00422604|Cholinergic Agents|cholinergic agents|mesh-ancestor
110026243|NCT00422604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110026244|NCT00422604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110026245|NCT00422604|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110026246|NCT00422604|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110026247|NCT00422604|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110026248|NCT00422604|Adrenergic Agents|adrenergic agents|mesh-ancestor
110026249|NCT00422682|Paclitaxel|paclitaxel|mesh-list
110026250|NCT00422682|Carboplatin|carboplatin|mesh-list
110026251|NCT00422682|Gemcitabine|gemcitabine|mesh-list
110026252|NCT00422682|Temozolomide|temozolomide|mesh-list
110026253|NCT00422682|Topotecan|topotecan|mesh-list
110026254|NCT00422682|Iniparib|iniparib|mesh-list
110026255|NCT00422682|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110026256|NCT00422682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110026257|NCT00422682|Tubulin Modulators|tubulin modulators|mesh-ancestor
110026258|NCT00422682|Antimitotic Agents|antimitotic agents|mesh-ancestor
110026259|NCT00422682|Mitosis Modulators|mitosis modulators|mesh-ancestor
110026260|NCT00422682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110026261|NCT00422682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110026262|NCT00422682|Antimetabolites|antimetabolites|mesh-ancestor
110026263|NCT00422682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110026264|NCT00422682|Alkylating Agents|alkylating agents|mesh-ancestor
110026265|NCT00422682|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110026266|NCT00422682|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110026267|NCT00422682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110026268|NCT00422682|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110026269|NCT00422994|Ropinirole|ropinirole|mesh-list
110026270|NCT00422994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110026271|NCT00422994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110026272|NCT00422994|Dopamine Agonists|dopamine agonists|mesh-ancestor
110026273|NCT00422994|Dopamine Agents|dopamine agents|mesh-ancestor
110026274|NCT00422994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110026275|NCT00422994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110026276|NCT00422994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026277|NCT00423228|Donepezil|donepezil|mesh-list
110026278|NCT00423228|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110026279|NCT00423228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110026280|NCT00423228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110026281|NCT00423228|Cholinergic Agents|cholinergic agents|mesh-ancestor
110026282|NCT00423228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110026283|NCT00423228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026285|NCT01799616|Pamidronate|pamidronate|mesh-list
110026286|NCT01799616|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110026287|NCT01799616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026288|NCT01799850|Pioglitazone|pioglitazone|mesh-list
110026289|NCT01799850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110026290|NCT01799850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026291|NCT01792050|Paclitaxel|paclitaxel|mesh-list
110026292|NCT01792050|Docetaxel|docetaxel|mesh-list
110026293|NCT01792050|Tryptophan|tryptophan|mesh-list
110026294|NCT01792050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110026295|NCT01792050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110026296|NCT01792050|Tubulin Modulators|tubulin modulators|mesh-ancestor
110026297|NCT01792050|Antimitotic Agents|antimitotic agents|mesh-ancestor
110026298|NCT01792050|Mitosis Modulators|mitosis modulators|mesh-ancestor
110026299|NCT01792050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110026782|NCT01275144|Anticonvulsants|anticonvulsants|mesh-ancestor
110026300|NCT01792050|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110026301|NCT01792050|Antidepressive Agents|antidepressive agents|mesh-ancestor
110026302|NCT01792050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110026303|NCT01790100|Ribavirin|ribavirin|mesh-list
110026304|NCT01790100|Antimetabolites|antimetabolites|mesh-ancestor
110026305|NCT01790100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110026306|NCT01790100|Antiviral Agents|antiviral agents|mesh-ancestor
110026307|NCT01790100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110026309|NCT01799460|Cyclophosphamide|cyclophosphamide|mesh-list
110026310|NCT01799460|Tacrolimus|tacrolimus|mesh-list
110026311|NCT01799460|Cyclosporins|cyclosporins|mesh-list
110026312|NCT01799460|Immunosuppressive Agents|immunosuppressive agents|mesh-list
110026313|NCT01799460|Glucocorticoids|glucocorticoids|mesh-list
110026314|NCT01799460|Immunologic Factors|immunologic factors|mesh-ancestor
110026315|NCT01799460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026316|NCT01799460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110026317|NCT01799460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110026318|NCT01799460|Alkylating Agents|alkylating agents|mesh-ancestor
110026319|NCT01799460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110026320|NCT01799460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110026321|NCT01799460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110026322|NCT01799460|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110026323|NCT01799460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110026324|NCT01799460|Antifungal Agents|antifungal agents|mesh-ancestor
110026325|NCT01799460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110026326|NCT01799460|Dermatologic Agents|dermatologic agents|mesh-ancestor
110026328|NCT01799460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110026329|NCT02999724|Gabapentin|gabapentin|mesh-list
110026330|NCT02999724|Analgesics|analgesics|mesh-ancestor
110026331|NCT02999724|Sensory System Agents|sensory system agents|mesh-ancestor
110026332|NCT02999724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110026333|NCT02999724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026334|NCT02999724|Anticonvulsants|anticonvulsants|mesh-ancestor
110026335|NCT02999724|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110026336|NCT02999724|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110026337|NCT02999724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110026338|NCT02999724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110026339|NCT02999724|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110026340|NCT02999724|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110026341|NCT02999724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110026342|NCT02999724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110026343|NCT02999724|Antimanic Agents|antimanic agents|mesh-ancestor
110026344|NCT02999490|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110026345|NCT02999490|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110026346|NCT02999490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110026347|NCT02998242|Apatinib|apatinib|mesh-list
110026348|NCT02998242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110026349|NCT02998242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110026350|NCT02998242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110026351|NCT02998242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110026352|NCT02998398|Infliximab|infliximab|mesh-list
110026353|NCT02998398|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110026354|NCT02998398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110026355|NCT02998398|Dermatologic Agents|dermatologic agents|mesh-ancestor
110026356|NCT02998398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110026357|NCT02998398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110026358|NCT02998320|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110026360|NCT02998320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110026361|NCT02998320|Antiviral Agents|antiviral agents|mesh-ancestor
110026362|NCT02998320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110026364|NCT02996916|Olmesartan|olmesartan|mesh-list
110026365|NCT02996916|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110026366|NCT02996916|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110026367|NCT02996916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110026368|NCT02996916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110026369|NCT02996916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110026370|NCT02996916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026371|NCT02996916|Vasodilator Agents|vasodilator agents|mesh-ancestor
110026372|NCT02996916|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110026373|NCT02996916|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110026374|NCT02996214|Paclitaxel|paclitaxel|mesh-list
110026375|NCT02996214|Gemcitabine|gemcitabine|mesh-list
110026376|NCT02996214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110026378|NCT02996214|Tubulin Modulators|tubulin modulators|mesh-ancestor
110026379|NCT02996214|Antimitotic Agents|antimitotic agents|mesh-ancestor
110026380|NCT02996214|Mitosis Modulators|mitosis modulators|mesh-ancestor
110026381|NCT02996214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110026382|NCT02996214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110026383|NCT02996214|Antimetabolites|antimetabolites|mesh-ancestor
110026384|NCT02996058|Dexmedetomidine|dexmedetomidine|mesh-list
110026385|NCT02996058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110026386|NCT02996058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110026387|NCT02996058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026388|NCT02996058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110026389|NCT02996058|Analgesics|analgesics|mesh-ancestor
110026390|NCT02996058|Sensory System Agents|sensory system agents|mesh-ancestor
110026391|NCT02996058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110026392|NCT02996058|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110026393|NCT02996058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110026394|NCT02996058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110026395|NCT02996058|Adrenergic Agents|adrenergic agents|mesh-ancestor
110026396|NCT02996058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110026397|NCT02996058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110026398|NCT02995512|Colchicine|colchicine|mesh-list
110026399|NCT02995512|Gout Suppressants|gout suppressants|mesh-ancestor
110026400|NCT02995512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110026401|NCT02995512|Tubulin Modulators|tubulin modulators|mesh-ancestor
110026402|NCT02995512|Antimitotic Agents|antimitotic agents|mesh-ancestor
110026403|NCT02995512|Mitosis Modulators|mitosis modulators|mesh-ancestor
110026404|NCT02995512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110026405|NCT02995512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110026407|NCT02994888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110026408|NCT02994888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110026409|NCT02993718|Dexmedetomidine|dexmedetomidine|mesh-list
110026410|NCT02993718|Propofol|propofol|mesh-list
110026411|NCT02993718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110026412|NCT02993718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110026413|NCT02993718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026414|NCT02993718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110026415|NCT02993718|Analgesics|analgesics|mesh-ancestor
110026416|NCT02993718|Sensory System Agents|sensory system agents|mesh-ancestor
110026417|NCT02993718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110026418|NCT02993718|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110026419|NCT02993718|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110026420|NCT02993718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110026421|NCT02993718|Adrenergic Agents|adrenergic agents|mesh-ancestor
110026422|NCT02993718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110026423|NCT02993718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110026424|NCT02993718|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110026426|NCT02993718|Anesthetics|anesthetics|mesh-ancestor
110026427|NCT02993640|Vasopressins|vasopressins|mesh-list
110026428|NCT02993640|Arginine Vasopressin|arginine vasopressin|mesh-list
110026429|NCT02993640|Hemostatics|hemostatics|mesh-ancestor
110026430|NCT02993640|Coagulants|coagulants|mesh-ancestor
110026431|NCT02993640|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110026434|NCT02993640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026436|NCT02993094|Ixazomib|ixazomib|mesh-list
110026437|NCT02993094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110026438|NCT02993094|Protease Inhibitors|protease inhibitors|mesh-ancestor
110026439|NCT02993094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110026440|NCT02993094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110026441|NCT02992938|Acetazolamide|acetazolamide|mesh-list
110026442|NCT02992938|Anticonvulsants|anticonvulsants|mesh-ancestor
110026443|NCT02992938|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110026444|NCT02992938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110026445|NCT02992938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110026447|NCT02992938|Natriuretic Agents|natriuretic agents|mesh-ancestor
110026448|NCT02992938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026449|NCT02992704|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110026450|NCT02992704|Antiviral Agents|antiviral agents|mesh-ancestor
110026451|NCT02992704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110026452|NCT02992548|Pravastatin|pravastatin|mesh-list
110026453|NCT02992548|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110026454|NCT02992548|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110026455|NCT02992548|Antimetabolites|antimetabolites|mesh-ancestor
110026538|NCT01270074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110026456|NCT02992548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110026457|NCT02992548|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110026458|NCT02992548|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110026459|NCT02992548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110026460|NCT02992392|Dextrans|dextrans|mesh-list
110026461|NCT02992392|Anticoagulants|anticoagulants|mesh-ancestor
110026462|NCT02992392|Plasma Substitutes|plasma substitutes|mesh-ancestor
110026464|NCT02991768|Budesonide|budesonide|mesh-list
110026465|NCT02991768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110026466|NCT02991768|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110026467|NCT02991768|Autonomic Agents|autonomic agents|mesh-ancestor
110026468|NCT02991768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110026469|NCT02991768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026470|NCT02991768|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110026471|NCT02991768|Respiratory System Agents|respiratory system agents|mesh-ancestor
110026472|NCT02991768|Glucocorticoids|glucocorticoids|mesh-ancestor
110026473|NCT02991768|Hormones|hormones|mesh-ancestor
110026474|NCT02991768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110026475|NCT02991612|Rifaximin|rifaximin|mesh-list
110026476|NCT02991612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110026477|NCT02991612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110026478|NCT02991612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110026479|NCT02990286|Mycophenolic Acid|mycophenolic acid|mesh-list
110026480|NCT02990286|Rituximab|rituximab|mesh-list
110026481|NCT02990286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110026482|NCT02990286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110026483|NCT02990286|Immunologic Factors|immunologic factors|mesh-ancestor
110026484|NCT02990286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026487|NCT02990286|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110026488|NCT02990286|Antitubercular Agents|antitubercular agents|mesh-ancestor
110026489|NCT02990286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110026490|NCT02990286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110026491|NCT02990286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110026492|NCT02990286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110026493|NCT02999958|Thioctic Acid|thioctic acid|mesh-list
110026494|NCT02999958|Acetylcarnitine|acetylcarnitine|mesh-list
110026495|NCT02999958|Acetylcysteine|acetylcysteine|mesh-list
110026496|NCT02999958|Antioxidants|antioxidants|mesh-list
110026497|NCT02999958|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110026498|NCT02999958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110026500|NCT02999958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026501|NCT02999958|Vitamin B Complex|vitamin b complex|mesh-ancestor
110026502|NCT02999958|Vitamins|vitamins|mesh-ancestor
110026503|NCT02999958|Micronutrients|micronutrients|mesh-ancestor
110026504|NCT02999958|Nootropic Agents|nootropic agents|mesh-ancestor
110026506|NCT02999958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110026507|NCT02999958|Expectorants|expectorants|mesh-ancestor
110026508|NCT02999958|Respiratory System Agents|respiratory system agents|mesh-ancestor
110026509|NCT02999958|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110026511|NCT02995746|Dexamethasone|dexamethasone|mesh-list
110026512|NCT02995746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110026513|NCT02995746|Antiemetics|antiemetics|mesh-ancestor
110026514|NCT02995746|Autonomic Agents|autonomic agents|mesh-ancestor
110026515|NCT02995746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110026516|NCT02995746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026517|NCT02995746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110026518|NCT02995746|Glucocorticoids|glucocorticoids|mesh-ancestor
110026520|NCT02995746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110026521|NCT02995746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110026522|NCT02995746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110026523|NCT02990364|Lidocaine|lidocaine|mesh-list
110026524|NCT02990364|Anesthetics, Local|anesthetics, local|mesh-list
110026525|NCT02990364|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
110026526|NCT02990364|Anesthetics|anesthetics|mesh-list
110026527|NCT02990364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110026528|NCT02990364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026529|NCT02990364|Sensory System Agents|sensory system agents|mesh-ancestor
110026530|NCT02990364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110026531|NCT02990364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110026532|NCT02990364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110026533|NCT02990364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110026534|NCT02990364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110026535|NCT02990364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110026536|NCT02990364|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
110026537|NCT01270074|Azithromycin|azithromycin|mesh-list
110026540|NCT01270308|Lansoprazole|lansoprazole|mesh-list
110026541|NCT01270308|Dexlansoprazole|dexlansoprazole|mesh-list
110026542|NCT01270308|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110026543|NCT01270308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110026544|NCT01270308|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110026545|NCT01270308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110026546|NCT01270308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110026547|NCT01270386|Apatinib|apatinib|mesh-list
110026548|NCT01270386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110026549|NCT01270386|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110026550|NCT01270386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110026551|NCT01270386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110026552|NCT01270854|Plasma-lyte 148|plasma-lyte 148|mesh-list
110026553|NCT01270854|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110026554|NCT01270854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110026555|NCT01270932|Dexamethasone|dexamethasone|mesh-list
110026556|NCT01270932|Dexamethasone acetate|dexamethasone acetate|mesh-list
110026557|NCT01270932|Lenalidomide|lenalidomide|mesh-list
110026559|NCT01270932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110026560|NCT01270932|Antiemetics|antiemetics|mesh-ancestor
110026561|NCT01270932|Autonomic Agents|autonomic agents|mesh-ancestor
110026562|NCT01270932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110026563|NCT01270932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026564|NCT01270932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110026565|NCT01270932|Glucocorticoids|glucocorticoids|mesh-ancestor
110026567|NCT01270932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110026568|NCT01270932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110026569|NCT01270932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110026570|NCT01270932|Protease Inhibitors|protease inhibitors|mesh-ancestor
110026572|NCT01270932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110026573|NCT01270932|Immunologic Factors|immunologic factors|mesh-ancestor
110026574|NCT01270932|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110026575|NCT01270932|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110026576|NCT01270932|Growth Substances|growth substances|mesh-ancestor
110026577|NCT01270932|Growth Inhibitors|growth inhibitors|mesh-ancestor
110026578|NCT01271088|Acetylcysteine|acetylcysteine|mesh-list
110026579|NCT01271088|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110026580|NCT01271088|Antiviral Agents|antiviral agents|mesh-ancestor
110026581|NCT01271088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110026582|NCT01271088|Expectorants|expectorants|mesh-ancestor
110026583|NCT01271088|Respiratory System Agents|respiratory system agents|mesh-ancestor
110026584|NCT01271088|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110026585|NCT01271088|Antioxidants|antioxidants|mesh-ancestor
110026586|NCT01271088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110026587|NCT01271088|Protective Agents|protective agents|mesh-ancestor
110026588|NCT01271088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026589|NCT01271088|Antidotes|antidotes|mesh-ancestor
110026591|NCT01271166|Bevacizumab|bevacizumab|mesh-list
110026592|NCT01271166|Fluorouracil|fluorouracil|mesh-list
110026593|NCT01271166|Oxaliplatin|oxaliplatin|mesh-list
110026594|NCT01271166|Imatinib Mesylate|imatinib mesylate|mesh-list
110026595|NCT01271166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110026596|NCT01271166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110026597|NCT01271166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110026598|NCT01271166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110026599|NCT01271166|Growth Substances|growth substances|mesh-ancestor
110026600|NCT01271166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026601|NCT01271166|Growth Inhibitors|growth inhibitors|mesh-ancestor
110026602|NCT01271166|Antimetabolites|antimetabolites|mesh-ancestor
110026604|NCT01271166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110026605|NCT01271166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110026606|NCT01271166|Immunologic Factors|immunologic factors|mesh-ancestor
110026607|NCT01271166|Antidotes|antidotes|mesh-ancestor
110026608|NCT01271166|Protective Agents|protective agents|mesh-ancestor
110026609|NCT01271166|Vitamin B Complex|vitamin b complex|mesh-ancestor
110026610|NCT01271166|Vitamins|vitamins|mesh-ancestor
110026611|NCT01271166|Micronutrients|micronutrients|mesh-ancestor
110026612|NCT01271166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110026613|NCT01271166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110026614|NCT01271556|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110026615|NCT01271556|Bronchodilator Agents|bronchodilator agents|mesh-list
110026616|NCT01271556|Autonomic Agents|autonomic agents|mesh-ancestor
110026617|NCT01271556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110026618|NCT01271556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026619|NCT01271556|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110026621|NCT01271556|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110026622|NCT01271556|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110026623|NCT01271556|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110026624|NCT01271556|Adrenergic Agents|adrenergic agents|mesh-ancestor
110026625|NCT01271556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110026626|NCT01271556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110026628|NCT01272258|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110026629|NCT01272258|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110026630|NCT01272258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110026631|NCT01272258|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110026632|NCT01272258|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110026633|NCT01272258|Antiviral Agents|antiviral agents|mesh-ancestor
110026634|NCT01272258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110026635|NCT01272414|Botulinum Toxins|botulinum toxins|mesh-list
110026636|NCT01272414|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110026637|NCT01272414|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110026638|NCT01272414|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110026639|NCT01272414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110026641|NCT01272414|Cholinergic Agents|cholinergic agents|mesh-ancestor
110026642|NCT01272414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110026643|NCT01272414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026644|NCT01272414|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110026645|NCT01272414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110026648|NCT01273506|Narcotics|narcotics|mesh-ancestor
110026649|NCT01273506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110026650|NCT01273506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026651|NCT01273506|Analgesics|analgesics|mesh-ancestor
110026652|NCT01273506|Sensory System Agents|sensory system agents|mesh-ancestor
110026653|NCT01273506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110026654|NCT01273506|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110026655|NCT01273506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110026656|NCT01273506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110026657|NCT01273506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110026658|NCT01273506|Adrenergic Agents|adrenergic agents|mesh-ancestor
110026660|NCT01273662|Axitinib|axitinib|mesh-list
110026661|NCT01273662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110026662|NCT01273662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110026663|NCT01273662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110026664|NCT01273662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110026666|NCT01273974|Immunologic Factors|immunologic factors|mesh-ancestor
110026667|NCT01273974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026668|NCT01274130|Metformin|metformin|mesh-list
110026670|NCT01274130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026671|NCT01276080|Donepezil|donepezil|mesh-list
110026672|NCT01276080|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110026673|NCT01276080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110026674|NCT01276080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110026675|NCT01276080|Cholinergic Agents|cholinergic agents|mesh-ancestor
110026676|NCT01276080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110026677|NCT01276080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026678|NCT01276080|Nootropic Agents|nootropic agents|mesh-ancestor
110026679|NCT01276548|Carboplatin|carboplatin|mesh-list
110026681|NCT01276548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110026682|NCT01276548|Tubulin Modulators|tubulin modulators|mesh-ancestor
110026683|NCT01276548|Antimitotic Agents|antimitotic agents|mesh-ancestor
110026684|NCT01276548|Mitosis Modulators|mitosis modulators|mesh-ancestor
110026685|NCT01276548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110026686|NCT01277172|Rituximab|rituximab|mesh-list
110026688|NCT01277172|Antibodies|antibodies|mesh-list
110026689|NCT01277172|Immunoglobulins|immunoglobulins|mesh-list
110026690|NCT01277172|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110026691|NCT01277172|Immunologic Factors|immunologic factors|mesh-ancestor
110026692|NCT01277172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026693|NCT01277172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110026694|NCT01277172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110026695|NCT01277640|Dapivirine|dapivirine|mesh-list
110026696|NCT01277640|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110026697|NCT01277640|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110026698|NCT01277640|Antiviral Agents|antiviral agents|mesh-ancestor
110026699|NCT01277640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110026700|NCT01278576|Botulinum Toxins|botulinum toxins|mesh-list
110026701|NCT01278576|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110026702|NCT01278576|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110026704|NCT01278576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110026705|NCT01278576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110026706|NCT01278576|Cholinergic Agents|cholinergic agents|mesh-ancestor
110026707|NCT01278576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110026708|NCT01278576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026709|NCT01278576|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110026710|NCT01278576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110026711|NCT01279434|Vitamins|vitamins|mesh-list
110026712|NCT01279434|Vitamin E|vitamin e|mesh-list
110026713|NCT01279434|Tocopherols|tocopherols|mesh-list
110026714|NCT01279434|Tocotrienols|tocotrienols|mesh-list
110026715|NCT01279434|alpha-Tocopherol|alpha-tocopherol|mesh-list
110026716|NCT01279434|Micronutrients|micronutrients|mesh-ancestor
110026717|NCT01279434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026718|NCT01279434|Antioxidants|antioxidants|mesh-ancestor
110026719|NCT01279434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110026720|NCT01279434|Protective Agents|protective agents|mesh-ancestor
110026721|NCT01279512|Metformin|metformin|mesh-list
110026722|NCT01279512|Acarbose|acarbose|mesh-list
110026723|NCT01279512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110026724|NCT01279512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026725|NCT01279512|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110026726|NCT01279512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110026727|NCT01279512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110026728|NCT01279668|Montelukast|montelukast|mesh-list
110026730|NCT01279668|Respiratory System Agents|respiratory system agents|mesh-ancestor
110026731|NCT01279668|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110026732|NCT01279668|Hormone Antagonists|hormone antagonists|mesh-ancestor
110026733|NCT01279668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110026734|NCT01279668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026735|NCT01279668|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110026736|NCT01279668|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110026737|NCT01279668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110026739|NCT01279902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110026740|NCT01279902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110026741|NCT01279902|Immunologic Factors|immunologic factors|mesh-ancestor
110026742|NCT01279902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026743|NCT01279902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110026745|NCT01278342|Cabergoline|cabergoline|mesh-list
110026746|NCT01278342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110026747|NCT01278342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110026748|NCT01278342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110026749|NCT01278342|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110026750|NCT01278342|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110026751|NCT01278342|Dopamine Agonists|dopamine agonists|mesh-ancestor
110026752|NCT01278342|Dopamine Agents|dopamine agents|mesh-ancestor
110026753|NCT01278342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110026754|NCT01278342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110026755|NCT01278342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026756|NCT01277718|Rabeprazole|rabeprazole|mesh-list
110026759|NCT01277718|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110026760|NCT01277718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110026761|NCT01277718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110026763|NCT01276236|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110026764|NCT01276236|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110026765|NCT01276236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110026766|NCT01276236|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110026767|NCT01276236|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110026768|NCT01276236|Antiviral Agents|antiviral agents|mesh-ancestor
110026769|NCT01276236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110026770|NCT01276236|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110026771|NCT01275222|Everolimus|everolimus|mesh-list
110026772|NCT01275222|Imatinib Mesylate|imatinib mesylate|mesh-list
110026773|NCT01275222|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110026774|NCT01275222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110026775|NCT01275222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110026776|NCT01275222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110026777|NCT01275222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110026778|NCT01275222|Immunologic Factors|immunologic factors|mesh-ancestor
110026779|NCT01275222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026780|NCT01275222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110026785|NCT01275144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110026786|NCT01275144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026787|NCT01275144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110026788|NCT01275144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110026789|NCT01275144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110026790|NCT01275144|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110026791|NCT01275144|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110026792|NCT01275144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110026793|NCT01275144|GABA Modulators|gaba modulators|mesh-ancestor
110026795|NCT01275144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110026796|NCT01275144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110026798|NCT01272180|Immunologic Factors|immunologic factors|mesh-ancestor
110026799|NCT01272180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026800|NCT01271010|Cyclophosphamide|cyclophosphamide|mesh-list
110026801|NCT01271010|Rituximab|rituximab|mesh-list
110026802|NCT01271010|Fludarabine|fludarabine|mesh-list
110026803|NCT01271010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110026804|NCT01271010|Immunologic Factors|immunologic factors|mesh-ancestor
110026805|NCT01271010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026806|NCT01271010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110026807|NCT01271010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110026816|NCT01270620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110026817|NCT01270620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026818|NCT01270620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110026819|NCT01270620|Anesthetics, General|anesthetics, general|mesh-ancestor
110026820|NCT01270620|Anesthetics|anesthetics|mesh-ancestor
110026821|NCT01270620|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110026822|NCT01270464|Reslizumab|reslizumab|mesh-list
110026823|NCT01270464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110026824|NCT01270464|Respiratory System Agents|respiratory system agents|mesh-ancestor
110026825|NCT01279590|Atorvastatin|atorvastatin|mesh-list
110026826|NCT01279590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110026827|NCT01279590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110026829|NCT01279590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110026830|NCT01279590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110026831|NCT01279590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110026832|NCT01279590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110026833|NCT01271790|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110026834|NCT01271790|Interferon-alpha|interferon-alpha|mesh-list
110026836|NCT01271790|Antiviral Agents|antiviral agents|mesh-ancestor
110026837|NCT01271790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110026838|NCT01271790|Immunologic Factors|immunologic factors|mesh-ancestor
110026839|NCT01271790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026840|NCT01271790|Antimetabolites|antimetabolites|mesh-ancestor
110026841|NCT01271790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110026843|NCT01270152|Antioxidants|antioxidants|mesh-ancestor
110026844|NCT01270152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110026845|NCT01270152|Protective Agents|protective agents|mesh-ancestor
110026846|NCT01270152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026848|NCT01270152|Micronutrients|micronutrients|mesh-ancestor
110026849|NCT01274988|Methadone|methadone|mesh-list
110026850|NCT01274988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110026851|NCT01274988|Narcotics|narcotics|mesh-ancestor
110026852|NCT01274988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110026853|NCT01274988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026854|NCT01274988|Analgesics|analgesics|mesh-ancestor
110026855|NCT01274988|Sensory System Agents|sensory system agents|mesh-ancestor
110026856|NCT01274988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110026857|NCT01274988|Antitussive Agents|antitussive agents|mesh-ancestor
110026858|NCT01274988|Respiratory System Agents|respiratory system agents|mesh-ancestor
110026860|NCT01278498|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110026861|NCT01278498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110026862|NCT01278498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110026863|NCT01278498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110026864|NCT01278498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110026865|NCT01278498|Serotonin Agents|serotonin agents|mesh-ancestor
110026866|NCT01278498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026867|NCT01279980|Anesthetics|anesthetics|mesh-list
110026868|NCT01279980|Anesthetics, Local|anesthetics, local|mesh-list
110026869|NCT01279980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110026870|NCT01279980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026871|NCT01279980|Sensory System Agents|sensory system agents|mesh-ancestor
110026872|NCT01279980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110026873|NCT00249834|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110026874|NCT00249834|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110026876|NCT00249834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110026877|NCT00249834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026878|NCT00249834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110026879|NCT00249444|Mirtazapine|mirtazapine|mesh-list
110026880|NCT00249444|Antidepressive Agents|antidepressive agents|mesh-ancestor
110026881|NCT00249444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110026882|NCT00249444|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110026883|NCT00249444|Histamine Antagonists|histamine antagonists|mesh-ancestor
110026884|NCT00249444|Histamine Agents|histamine agents|mesh-ancestor
110026885|NCT00249444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110026886|NCT00249444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110026887|NCT00249444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026888|NCT00249444|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110026889|NCT00249444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110026890|NCT00249444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110026891|NCT00249444|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110026892|NCT00249444|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110026893|NCT00249444|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110026894|NCT00249444|Adrenergic Agents|adrenergic agents|mesh-ancestor
110026895|NCT00249444|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110026896|NCT00249444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110026897|NCT00249444|Serotonin Agents|serotonin agents|mesh-ancestor
110026898|NCT00249444|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110026899|NCT00249288|Folic Acid|folic acid|mesh-list
110026900|NCT00249288|Vitamin B Complex|vitamin b complex|mesh-list
110026901|NCT00249288|Hematinics|hematinics|mesh-ancestor
110026902|NCT00249288|Vitamins|vitamins|mesh-ancestor
110026903|NCT00249288|Micronutrients|micronutrients|mesh-ancestor
110026904|NCT00249288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026906|NCT00247962|Etanercept|etanercept|mesh-list
110026907|NCT00247962|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110026908|NCT00247962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110026909|NCT00247962|Analgesics|analgesics|mesh-ancestor
110026910|NCT00247962|Sensory System Agents|sensory system agents|mesh-ancestor
110026911|NCT00247962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110026912|NCT00247962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026913|NCT00247962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110026914|NCT00247962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110026915|NCT00247962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110026916|NCT00247962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110026917|NCT00247962|Immunologic Factors|immunologic factors|mesh-ancestor
110026922|NCT00247416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110026923|NCT00247416|Antiemetics|antiemetics|mesh-ancestor
110026924|NCT00247416|Autonomic Agents|autonomic agents|mesh-ancestor
110026925|NCT00247416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110026926|NCT00247416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026927|NCT00247416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110026928|NCT00247416|Glucocorticoids|glucocorticoids|mesh-ancestor
110026929|NCT00247416|Hormones|hormones|mesh-ancestor
110026930|NCT00247416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110026931|NCT00247416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110026932|NCT00247416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110026933|NCT00247416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110026934|NCT00247416|Antimetabolites|antimetabolites|mesh-ancestor
110026935|NCT00247416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110026936|NCT00246012|Dacarbazine|dacarbazine|mesh-list
110026937|NCT00246012|Intetumumab|intetumumab|mesh-list
110026938|NCT00246012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110026940|NCT00246012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110026941|NCT00246012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110026942|NCT00246012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110026943|NCT00245856|Dalteparin|dalteparin|mesh-list
110026944|NCT00245856|Tinzaparin|tinzaparin|mesh-list
110026945|NCT00245856|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110026946|NCT00245856|Warfarin|warfarin|mesh-list
110026947|NCT00245856|Anticoagulants|anticoagulants|mesh-ancestor
110026948|NCT00245856|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110026949|NCT00245856|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110026950|NCT00245856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110026951|NCT00242580|Triamcinolone|triamcinolone|mesh-list
110026952|NCT00242580|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110026953|NCT00242580|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110026956|NCT00242580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110026957|NCT00242580|Glucocorticoids|glucocorticoids|mesh-ancestor
110026958|NCT00242580|Hormones|hormones|mesh-ancestor
110026959|NCT00242580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110026961|NCT00242580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110026962|NCT00242580|Immunologic Factors|immunologic factors|mesh-ancestor
110026963|NCT00242580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110026964|NCT00242580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110026966|NCT00242580|Dermatologic Agents|dermatologic agents|mesh-ancestor
110026968|NCT00241644|Immunologic Factors|immunologic factors|mesh-ancestor
110026969|NCT00241644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026970|NCT03805152|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110026971|NCT03805152|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110026972|NCT03805152|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110026973|NCT03805152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110026974|NCT03805152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110026975|NCT03805152|Cholinergic Agents|cholinergic agents|mesh-ancestor
110026976|NCT03805152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110026977|NCT03805152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026978|NCT03805152|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110026979|NCT03805152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110026981|NCT03804840|Hallucinogens|hallucinogens|mesh-ancestor
110026982|NCT03804840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110026983|NCT03804840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110026984|NCT03804840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110026985|NCT03804840|Analgesics|analgesics|mesh-ancestor
110026986|NCT03804840|Sensory System Agents|sensory system agents|mesh-ancestor
110026987|NCT03804840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110026988|NCT03804840|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110026989|NCT03804840|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110026990|NCT03804840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110026991|NCT03804840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110026993|NCT03804840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110026994|NCT03804372|Tenofovir|tenofovir|mesh-list
110026995|NCT03804372|Rituximab|rituximab|mesh-list
110026998|NCT03804372|Immunologic Factors|immunologic factors|mesh-ancestor
110026999|NCT03804372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027000|NCT03804372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110027001|NCT03804372|Antiviral Agents|antiviral agents|mesh-ancestor
110027002|NCT03804372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110027003|NCT03804372|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110027004|NCT03804372|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110027005|NCT03804372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110027006|NCT03804372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110027007|NCT03804372|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110027008|NCT03804372|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110027010|NCT03803124|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110027011|NCT03803124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110027012|NCT03803124|Natriuretic Agents|natriuretic agents|mesh-ancestor
110027013|NCT03803124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027014|NCT03802032|Lidocaine|lidocaine|mesh-list
110027015|NCT03802032|Anesthetics, Local|anesthetics, local|mesh-ancestor
110027016|NCT03802032|Anesthetics|anesthetics|mesh-ancestor
110027017|NCT03802032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110027018|NCT03802032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027019|NCT03802032|Sensory System Agents|sensory system agents|mesh-ancestor
110027020|NCT03802032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110027021|NCT03802032|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110027022|NCT03802032|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110027023|NCT03802032|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110027024|NCT03802032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110027025|NCT03802032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110027026|NCT03801252|Azithromycin|azithromycin|mesh-list
110027028|NCT03801252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110027029|NCT03801252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110027030|NCT03800550|Clarithromycin|clarithromycin|mesh-list
110027031|NCT03800550|Bedaquiline|bedaquiline|mesh-list
110027032|NCT03800550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110027033|NCT03800550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110027034|NCT03800550|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110027036|NCT03800550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110027038|NCT03800550|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110027039|NCT03800550|Antitubercular Agents|antitubercular agents|mesh-ancestor
110027040|NCT03803202|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110027041|NCT03803202|Immunologic Factors|immunologic factors|mesh-ancestor
110027042|NCT03803202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027043|NCT05742750|Apatinib|apatinib|mesh-list
110027044|NCT05742750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110027045|NCT05742750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110027046|NCT05742750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110027047|NCT05742750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110027048|NCT05740332|Hand Sanitizers|hand sanitizers|mesh-list
110027049|NCT05740332|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110027050|NCT05740332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110027051|NCT05740332|Disinfectants|disinfectants|mesh-ancestor
110027052|NCT04741074|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110027054|NCT04581408|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110027055|NCT04581408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110027056|NCT04581408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110027057|NCT04295772|Islatravir|islatravir|mesh-list
110027058|NCT04295772|Antiviral Agents|antiviral agents|mesh-ancestor
110027059|NCT04295772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110027060|NCT04295772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110027061|NCT04295772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110027062|NCT04295772|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110027063|NCT04295772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110027064|NCT04295772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110027065|NCT04148430|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110027066|NCT04148430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110027068|NCT03467256|Dexamethasone|dexamethasone|mesh-list
110027069|NCT03467256|Cyclophosphamide|cyclophosphamide|mesh-list
110027070|NCT03467256|Fludarabine|fludarabine|mesh-list
110027071|NCT03467256|Etoposide|etoposide|mesh-list
110027072|NCT03467256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110027073|NCT03467256|Immunologic Factors|immunologic factors|mesh-ancestor
110027075|NCT03467256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110027076|NCT03467256|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110027077|NCT03467256|Alkylating Agents|alkylating agents|mesh-ancestor
110027078|NCT03467256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110027079|NCT03467256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110027080|NCT03467256|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110027081|NCT03467256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110027082|NCT03467256|Antiemetics|antiemetics|mesh-ancestor
110027083|NCT03467256|Autonomic Agents|autonomic agents|mesh-ancestor
110027084|NCT03467256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110027085|NCT03467256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110027086|NCT03467256|Glucocorticoids|glucocorticoids|mesh-ancestor
110027088|NCT03467256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110027089|NCT03467256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110027090|NCT03467256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110027091|NCT03467256|Antimetabolites|antimetabolites|mesh-ancestor
110027092|NCT03467256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110027093|NCT03467256|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110027094|NCT03467256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110027095|NCT03467256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110027096|NCT03467256|Antiviral Agents|antiviral agents|mesh-ancestor
110027097|NCT03467256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110027098|NCT03265080|Pembrolizumab|pembrolizumab|mesh-list
110027099|NCT03265080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110027100|NCT03265080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110027101|NCT03265080|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110027102|NCT03265080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110027103|NCT02017704|Leucovorin|leucovorin|mesh-list
110027104|NCT02017704|Fluorouracil|fluorouracil|mesh-list
110027105|NCT02017704|Capecitabine|capecitabine|mesh-list
110027106|NCT02017704|Oxaliplatin|oxaliplatin|mesh-list
110027107|NCT02017704|Antimetabolites|antimetabolites|mesh-ancestor
110027108|NCT02017704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110027109|NCT02017704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110027110|NCT02017704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110027111|NCT02017704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110027113|NCT02017704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027115|NCT02017704|Protective Agents|protective agents|mesh-ancestor
110027116|NCT02017704|Vitamin B Complex|vitamin b complex|mesh-ancestor
110027118|NCT02017704|Micronutrients|micronutrients|mesh-ancestor
110027119|NCT01622322|Nitrous Oxide|nitrous oxide|mesh-list
110027120|NCT01622322|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110027122|NCT01622322|Anesthetics|anesthetics|mesh-ancestor
110027123|NCT01622322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110027124|NCT01622322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027125|NCT01622322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110027126|NCT01622322|Analgesics|analgesics|mesh-ancestor
110027127|NCT01622322|Sensory System Agents|sensory system agents|mesh-ancestor
110027128|NCT01622322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110027129|NCT05313282|Apatinib|apatinib|mesh-list
110027130|NCT05313282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110027131|NCT05313282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110027132|NCT05313282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110027133|NCT05313282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110027134|NCT05312034|Anti-Infective Agents|anti-infective agents|mesh-list
110027135|NCT05312034|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110027136|NCT05311722|Dexmedetomidine|dexmedetomidine|mesh-list
110027138|NCT05311722|Tramadol|tramadol|mesh-list
110027139|NCT05311722|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110027140|NCT05311722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110027141|NCT05311722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027142|NCT05311722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110027143|NCT05311722|Analgesics|analgesics|mesh-ancestor
110027144|NCT05311722|Sensory System Agents|sensory system agents|mesh-ancestor
110027145|NCT05311722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110027146|NCT05311722|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110027147|NCT05311722|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110027148|NCT05311722|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110027149|NCT05311722|Adrenergic Agents|adrenergic agents|mesh-ancestor
110027150|NCT05311722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110027151|NCT05311722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110027152|NCT05311722|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110027153|NCT05311722|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110027154|NCT05311722|Anesthetics, General|anesthetics, general|mesh-ancestor
110027155|NCT05311722|Anesthetics|anesthetics|mesh-ancestor
110027156|NCT05311722|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110027157|NCT05311722|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110027158|NCT05311722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110027159|NCT05311722|Narcotics|narcotics|mesh-ancestor
110027161|NCT03215940|Cannabidiol|cannabidiol|mesh-list
110027162|NCT03215940|Anticonvulsants|anticonvulsants|mesh-ancestor
110027163|NCT03215940|Hallucinogens|hallucinogens|mesh-ancestor
110027164|NCT03215940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027165|NCT03215940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110027166|NCT03215940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110027167|NCT03215940|Analgesics|analgesics|mesh-ancestor
110027168|NCT03215940|Sensory System Agents|sensory system agents|mesh-ancestor
110027169|NCT03215940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110027170|NCT03215940|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110027171|NCT03215940|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110027172|NCT03215940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110027173|NCT03215940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110027174|NCT03215940|Hormones|hormones|mesh-ancestor
110027175|NCT03215940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110027176|NCT03219528|Rifaximin|rifaximin|mesh-list
110027177|NCT03219528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110027178|NCT03219528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110027179|NCT03219528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110027180|NCT03219762|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110027181|NCT03219762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110027182|NCT03218514|Dalteparin|dalteparin|mesh-list
110027183|NCT03218514|Tinzaparin|tinzaparin|mesh-list
110027184|NCT03218514|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110027186|NCT03218514|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110027187|NCT03218514|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110027188|NCT03218514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110027189|NCT03218124|Remifentanil|remifentanil|mesh-list
110027190|NCT03218124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110027191|NCT03218124|Narcotics|narcotics|mesh-ancestor
110027192|NCT03218124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110027194|NCT03218124|Analgesics|analgesics|mesh-ancestor
110027195|NCT03218124|Sensory System Agents|sensory system agents|mesh-ancestor
110027196|NCT03218124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110027197|NCT03217734|Adalimumab|adalimumab|mesh-list
110027198|NCT03217734|Methotrexate|methotrexate|mesh-list
110027199|NCT03217734|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110027200|NCT03217734|Abortifacient Agents|abortifacient agents|mesh-ancestor
110027201|NCT03217734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110027202|NCT03217734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027203|NCT03217734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110027204|NCT03217734|Antimetabolites|antimetabolites|mesh-ancestor
110027206|NCT03217734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110027207|NCT03217734|Dermatologic Agents|dermatologic agents|mesh-ancestor
110027208|NCT03217734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110027209|NCT03217734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110027210|NCT03217734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110027211|NCT03217734|Immunologic Factors|immunologic factors|mesh-ancestor
110027212|NCT03217734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110027213|NCT03217734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110027214|NCT03217734|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110027215|NCT03217734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110027216|NCT03216876|Ursolic acid|ursolic acid|mesh-list
110027217|NCT03216876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110027218|NCT03216876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110027219|NCT03216876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110027220|NCT03216876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110027221|NCT03216876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110027222|NCT03216876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110027223|NCT03216876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110027224|NCT03216876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110027225|NCT03216876|Analgesics|analgesics|mesh-ancestor
110027226|NCT03216876|Sensory System Agents|sensory system agents|mesh-ancestor
110027227|NCT03216876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110027228|NCT03216876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027229|NCT03216876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110027230|NCT03216876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110027231|NCT03216642|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110027232|NCT03216642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110027233|NCT03216408|Botulinum Toxins|botulinum toxins|mesh-list
110027234|NCT03216408|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110027235|NCT03216408|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110027236|NCT03216408|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110027237|NCT03216408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110027238|NCT03216408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110027239|NCT03216408|Cholinergic Agents|cholinergic agents|mesh-ancestor
110027240|NCT03216408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110027241|NCT03216408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027242|NCT03216408|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110027243|NCT03216408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110027244|NCT03216564|Vitamin D|vitamin d|mesh-list
110027245|NCT03216564|Calcitriol|calcitriol|mesh-list
110027246|NCT03216564|Vitamins|vitamins|mesh-ancestor
110027247|NCT03216564|Micronutrients|micronutrients|mesh-ancestor
110027248|NCT03216564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027249|NCT03216564|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110027250|NCT03216564|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110027251|NCT03216564|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110027252|NCT03216564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110027253|NCT03216564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110027255|NCT03216096|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110027256|NCT03216096|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110027257|NCT03214848|Contraceptive Agents|contraceptive agents|mesh-list
110027258|NCT03214848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110027259|NCT03214848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027260|NCT03214536|Ropivacaine|ropivacaine|mesh-list
110027261|NCT03214536|Anesthetics|anesthetics|mesh-ancestor
110027262|NCT03214536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110027263|NCT03214536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027264|NCT03214536|Anesthetics, Local|anesthetics, local|mesh-ancestor
110027265|NCT03214536|Sensory System Agents|sensory system agents|mesh-ancestor
110027266|NCT03214536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110027267|NCT03214770|Calcium, Dietary|calcium, dietary|mesh-list
110027269|NCT03214770|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110027270|NCT03214770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027271|NCT03214770|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110027273|NCT03213834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110027274|NCT03213834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110027275|NCT03213834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110027276|NCT03213444|Oxaliplatin|oxaliplatin|mesh-list
110027277|NCT03213444|Fluorouracil|fluorouracil|mesh-list
110027278|NCT03213444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110027279|NCT03213444|Antimetabolites|antimetabolites|mesh-ancestor
110027280|NCT03213444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110027281|NCT03213444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110027282|NCT03213444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110027283|NCT03213444|Immunologic Factors|immunologic factors|mesh-ancestor
110027284|NCT03213444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027285|NCT03212820|Methamphetamine|methamphetamine|mesh-list
110027286|NCT03212820|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110027287|NCT03212820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027289|NCT03212820|Autonomic Agents|autonomic agents|mesh-ancestor
110027290|NCT03212820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110027291|NCT03212820|Dopamine Agents|dopamine agents|mesh-ancestor
110027292|NCT03212820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110027293|NCT03212820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110027294|NCT03212820|Adrenergic Agents|adrenergic agents|mesh-ancestor
110027295|NCT03212820|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110027296|NCT03212820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110027297|NCT03212820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110027298|NCT03212820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110027299|NCT03211728|Pregabalin|pregabalin|mesh-list
110027300|NCT03211728|Analgesics|analgesics|mesh-ancestor
110027301|NCT03211728|Sensory System Agents|sensory system agents|mesh-ancestor
110027302|NCT03211728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110027303|NCT03211728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027304|NCT03211728|Anticonvulsants|anticonvulsants|mesh-ancestor
110027305|NCT03211728|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110027306|NCT03211728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110027307|NCT03211728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110027308|NCT03211728|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110027309|NCT03211728|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110027310|NCT03211728|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110027311|NCT03211728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110027312|NCT03211728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110027313|NCT03211572|Tamoxifen|tamoxifen|mesh-list
110027314|NCT03211572|Anastrozole|anastrozole|mesh-list
110027315|NCT03211572|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110027316|NCT03211572|Hormone Antagonists|hormone antagonists|mesh-ancestor
110027317|NCT03211572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110027318|NCT03211572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027319|NCT03211572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110027320|NCT03211572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110027321|NCT03211572|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110027322|NCT03211572|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110027323|NCT03211572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110027324|NCT03211572|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110027325|NCT03211572|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110027326|NCT03211572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110027327|NCT03211572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110027328|NCT03211650|Hyaluronic Acid|hyaluronic acid|mesh-list
110027329|NCT03211650|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110027330|NCT03211650|Immunologic Factors|immunologic factors|mesh-ancestor
110027331|NCT03211650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027332|NCT03211650|Viscosupplements|viscosupplements|mesh-ancestor
110027333|NCT03211650|Protective Agents|protective agents|mesh-ancestor
110027334|NCT03211104|Curcumin|curcumin|mesh-list
110027335|NCT03211104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110027336|NCT03211104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110027337|NCT03211104|Analgesics|analgesics|mesh-ancestor
110027338|NCT03211104|Sensory System Agents|sensory system agents|mesh-ancestor
110027339|NCT03211104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110027340|NCT03211104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027343|NCT03211104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110027344|NCT03211104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110027345|NCT03211104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110027346|NCT03210246|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
110027347|NCT03210246|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
110027348|NCT03210246|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110027349|NCT03210246|Contraceptive Agents|contraceptive agents|mesh-ancestor
110027350|NCT03210246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110027351|NCT03210246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027352|NCT03210246|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110027353|NCT03210246|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110027354|NCT03210246|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110027355|NCT03210246|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110027356|NCT03210246|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110027357|NCT03210246|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
110027358|NCT03210246|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110027359|NCT03210246|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110027360|NCT03210324|Mifepristone|mifepristone|mesh-list
110027361|NCT03210324|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110027362|NCT03210324|Abortifacient Agents|abortifacient agents|mesh-ancestor
110027363|NCT03210324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110027364|NCT03210324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027365|NCT03210324|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110027366|NCT03210324|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110027367|NCT03210324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110027368|NCT03210324|Contraceptive Agents|contraceptive agents|mesh-ancestor
110027369|NCT03210324|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110027370|NCT03210324|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110027371|NCT03210324|Hormone Antagonists|hormone antagonists|mesh-ancestor
110027372|NCT03210324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110027373|NCT03210324|Luteolytic Agents|luteolytic agents|mesh-ancestor
110027374|NCT03210324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110027375|NCT03210324|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110027376|NCT03210480|Lithium Carbonate|lithium carbonate|mesh-list
110027377|NCT03210480|Antidepressive Agents|antidepressive agents|mesh-ancestor
110027378|NCT03210480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110027379|NCT03210480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110027380|NCT03210480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110027381|NCT03210480|Antimanic Agents|antimanic agents|mesh-ancestor
110027382|NCT03210480|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110027383|NCT03210480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110027384|NCT03210480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027386|NCT01831674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110027387|NCT01831674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027389|NCT01832922|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110027390|NCT01832922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110027391|NCT01832922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110027392|NCT01832922|Immunologic Factors|immunologic factors|mesh-ancestor
110027393|NCT01832922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027394|NCT01832922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110027395|NCT01832922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110027396|NCT01832922|Alkylating Agents|alkylating agents|mesh-ancestor
110027397|NCT01832922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110027398|NCT01833312|Meperidine|meperidine|mesh-list
110027399|NCT01833312|Buspirone|buspirone|mesh-list
110027400|NCT01833312|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110027401|NCT01833312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110027402|NCT01833312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110027403|NCT01833312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027404|NCT01833312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110027405|NCT01833312|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110027406|NCT01833312|Serotonin Agents|serotonin agents|mesh-ancestor
110027407|NCT01833312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110027408|NCT01833312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110027409|NCT01833312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110027410|NCT01833312|Narcotics|narcotics|mesh-ancestor
110027411|NCT01833312|Analgesics|analgesics|mesh-ancestor
110027412|NCT01833312|Sensory System Agents|sensory system agents|mesh-ancestor
110027413|NCT01833312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110027414|NCT01833312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110027415|NCT01834014|Bevacizumab|bevacizumab|mesh-list
110027417|NCT01834014|Fluorouracil|fluorouracil|mesh-list
110027418|NCT01834014|Oxaliplatin|oxaliplatin|mesh-list
110027419|NCT01834014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110027420|NCT01834014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110027421|NCT01834014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110027422|NCT01834014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110027423|NCT01834014|Growth Substances|growth substances|mesh-ancestor
110027424|NCT01834014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027425|NCT01834014|Growth Inhibitors|growth inhibitors|mesh-ancestor
110027426|NCT01834014|Antimetabolites|antimetabolites|mesh-ancestor
110027427|NCT01834014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110027429|NCT01834014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110027430|NCT01834014|Immunologic Factors|immunologic factors|mesh-ancestor
110027432|NCT01834170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110027433|NCT01834170|Antimetabolites|antimetabolites|mesh-ancestor
110027434|NCT01834170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110027435|NCT01834170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110027436|NCT01835184|Vemurafenib|vemurafenib|mesh-list
110027437|NCT01835184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110027438|NCT01835184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110027439|NCT01835184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110027440|NCT01835184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110027441|NCT01835340|Anesthetics|anesthetics|mesh-list
110027443|NCT01835340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110027444|NCT01835340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027445|NCT01835340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110027446|NCT01835340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110027447|NCT01835340|Anesthetics, General|anesthetics, general|mesh-ancestor
110027448|NCT01836120|Docetaxel|docetaxel|mesh-list
110027449|NCT01836120|Raltitrexed|raltitrexed|mesh-list
110027450|NCT01836120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110027451|NCT01836120|Tubulin Modulators|tubulin modulators|mesh-ancestor
110027452|NCT01836120|Antimitotic Agents|antimitotic agents|mesh-ancestor
110027453|NCT01836120|Mitosis Modulators|mitosis modulators|mesh-ancestor
110027454|NCT01836120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110027455|NCT01836120|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110027456|NCT01836120|Antimetabolites|antimetabolites|mesh-ancestor
110027457|NCT01836120|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110027458|NCT01836120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110027459|NCT01836822|Dimercaprol|dimercaprol|mesh-list
110027460|NCT01836822|Chelating Agents|chelating agents|mesh-ancestor
110027461|NCT01836822|Sequestering Agents|sequestering agents|mesh-ancestor
110027462|NCT01836822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110027463|NCT01836900|Hemostatics|hemostatics|mesh-list
110027464|NCT01836900|Coagulants|coagulants|mesh-ancestor
110027465|NCT01837992|Primaquine|primaquine|mesh-list
110027466|NCT01837992|Antimalarials|antimalarials|mesh-ancestor
110027467|NCT01837992|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110027468|NCT01837992|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110027469|NCT01837992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110027470|NCT01838460|Lobeline|lobeline|mesh-list
110027471|NCT01838460|Nicotine|nicotine|mesh-list
110027472|NCT01838460|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110027473|NCT01838460|Autonomic Agents|autonomic agents|mesh-ancestor
110027474|NCT01838460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110027475|NCT01838460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027476|NCT01838460|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110027477|NCT01838460|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110027478|NCT01838460|Cholinergic Agents|cholinergic agents|mesh-ancestor
110027479|NCT01838460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110027480|NCT01838460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110027481|NCT01838460|Respiratory System Agents|respiratory system agents|mesh-ancestor
110027482|NCT01838538|Paclitaxel|paclitaxel|mesh-list
110027483|NCT01838538|Bevacizumab|bevacizumab|mesh-list
110027484|NCT01838538|Carboplatin|carboplatin|mesh-list
110027485|NCT01838538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110027486|NCT01838538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110027487|NCT01838538|Tubulin Modulators|tubulin modulators|mesh-ancestor
110027488|NCT01838538|Antimitotic Agents|antimitotic agents|mesh-ancestor
110027489|NCT01838538|Mitosis Modulators|mitosis modulators|mesh-ancestor
110027490|NCT01838538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110027491|NCT01838538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110027494|NCT01838538|Growth Substances|growth substances|mesh-ancestor
110027495|NCT01838538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027496|NCT01838538|Growth Inhibitors|growth inhibitors|mesh-ancestor
110027497|NCT01838772|Interferons|interferons|mesh-list
110027499|NCT01838772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110027500|NCT01838772|Antiviral Agents|antiviral agents|mesh-ancestor
110027501|NCT01838772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110027502|NCT01838772|Antimetabolites|antimetabolites|mesh-ancestor
110027506|NCT01838928|Anesthetics|anesthetics|mesh-ancestor
110027507|NCT01838928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110027508|NCT01838928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027509|NCT01838928|Sensory System Agents|sensory system agents|mesh-ancestor
110027510|NCT01838928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110027511|NCT01839084|Isoflurane|isoflurane|mesh-list
110027512|NCT01839084|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110027513|NCT01839084|Anesthetics, General|anesthetics, general|mesh-ancestor
110027514|NCT01839084|Anesthetics|anesthetics|mesh-ancestor
110027515|NCT01839084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110027516|NCT01839084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027517|NCT01839240|Cytarabine|cytarabine|mesh-list
110027518|NCT01839240|Azacitidine|azacitidine|mesh-list
110027519|NCT01839240|Mitoxantrone|mitoxantrone|mesh-list
110027520|NCT01839240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110027521|NCT01839240|Antimetabolites|antimetabolites|mesh-ancestor
110027522|NCT01839240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110027523|NCT01839240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110027524|NCT01839240|Antiviral Agents|antiviral agents|mesh-ancestor
110027525|NCT01839240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110027526|NCT01839240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110027527|NCT01839240|Immunologic Factors|immunologic factors|mesh-ancestor
110027528|NCT01839240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027529|NCT01839240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110027530|NCT01839240|Analgesics|analgesics|mesh-ancestor
110027531|NCT01839240|Sensory System Agents|sensory system agents|mesh-ancestor
110027532|NCT01839240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110027533|NCT01839240|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110027534|NCT01839240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110027535|NCT01839552|Fentanyl|fentanyl|mesh-list
110027536|NCT01839552|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110027537|NCT01839552|Narcotics|narcotics|mesh-ancestor
110027538|NCT01839552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110027539|NCT01839552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027540|NCT01839552|Analgesics|analgesics|mesh-ancestor
110027541|NCT01839552|Sensory System Agents|sensory system agents|mesh-ancestor
110027542|NCT01839552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110027543|NCT01839552|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110027544|NCT01839552|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110027545|NCT01839552|Anesthetics, General|anesthetics, general|mesh-ancestor
110027546|NCT01839552|Anesthetics|anesthetics|mesh-ancestor
110027547|NCT01839630|Sorafenib|sorafenib|mesh-list
110027548|NCT01839630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110027549|NCT01839630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110027550|NCT01839630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110027551|NCT01839630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110027552|NCT01839864|Chrysarobin|chrysarobin|mesh-list
110027553|NCT01839864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110027554|NCT01839864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110027555|NCT01839864|Analgesics|analgesics|mesh-ancestor
110027556|NCT01839864|Sensory System Agents|sensory system agents|mesh-ancestor
110027557|NCT01839864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110027558|NCT01839864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027559|NCT01839864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110027560|NCT01839864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110027561|NCT01834248|Poly I-C|poly i-c|mesh-list
110027562|NCT01834248|Decitabine|decitabine|mesh-list
110027563|NCT01834248|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110027564|NCT01834248|Poly ICLC|poly iclc|mesh-list
110027565|NCT01834248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110027566|NCT01834248|Antimetabolites|antimetabolites|mesh-ancestor
110027567|NCT01834248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110027568|NCT01834248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110027569|NCT01834248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110027570|NCT01834248|Interferon Inducers|interferon inducers|mesh-ancestor
110027575|NCT01834248|Antiviral Agents|antiviral agents|mesh-ancestor
110027576|NCT01834248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110027577|NCT01833858|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110027578|NCT01833858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110027579|NCT01833858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027580|NCT01836432|Leucovorin|leucovorin|mesh-list
110027581|NCT01836432|Paclitaxel|paclitaxel|mesh-list
110027582|NCT01836432|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110027583|NCT01836432|Gemcitabine|gemcitabine|mesh-list
110027584|NCT01836432|Fluorouracil|fluorouracil|mesh-list
110027585|NCT01836432|Capecitabine|capecitabine|mesh-list
110027586|NCT01836432|Oxaliplatin|oxaliplatin|mesh-list
110027587|NCT01836432|Irinotecan|irinotecan|mesh-list
110027588|NCT01836432|Folfirinox|folfirinox|mesh-list
110027589|NCT01836432|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110027590|NCT01836432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110027591|NCT01836432|Tubulin Modulators|tubulin modulators|mesh-ancestor
110027592|NCT01836432|Antimitotic Agents|antimitotic agents|mesh-ancestor
110027593|NCT01836432|Mitosis Modulators|mitosis modulators|mesh-ancestor
110027594|NCT01836432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110027595|NCT01836432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110027596|NCT01836432|Antimetabolites|antimetabolites|mesh-ancestor
110027597|NCT01836432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110027598|NCT01836432|Immunologic Factors|immunologic factors|mesh-ancestor
110027599|NCT01836432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027600|NCT01836432|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110027601|NCT01836432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110027602|NCT01836432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110027603|NCT01836432|Antidotes|antidotes|mesh-ancestor
110027604|NCT01836432|Protective Agents|protective agents|mesh-ancestor
110027605|NCT01836432|Vitamin B Complex|vitamin b complex|mesh-ancestor
110027606|NCT01836432|Vitamins|vitamins|mesh-ancestor
110027607|NCT01836432|Micronutrients|micronutrients|mesh-ancestor
110027608|NCT01720056|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110027609|NCT01720056|Verapamil|verapamil|mesh-list
110027610|NCT01720056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110027611|NCT01720056|Glucocorticoids|glucocorticoids|mesh-ancestor
110027612|NCT01720056|Hormones|hormones|mesh-ancestor
110027613|NCT01720056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110027614|NCT01720056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027615|NCT01720056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110027616|NCT01720056|Immunologic Factors|immunologic factors|mesh-ancestor
110027617|NCT01720056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110027618|NCT01720056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110027619|NCT01720056|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110027620|NCT01720056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110027621|NCT01720056|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110027622|NCT01720056|Vasodilator Agents|vasodilator agents|mesh-ancestor
110027623|NCT01720212|Mirabegron|mirabegron|mesh-list
110027624|NCT01720212|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110027626|NCT01720212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110027627|NCT01720212|Adrenergic Agents|adrenergic agents|mesh-ancestor
110027628|NCT01720212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110027629|NCT01720212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110027630|NCT01720212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027632|NCT01720290|Metformin|metformin|mesh-list
110027633|NCT01720290|Repaglinide|repaglinide|mesh-list
110027634|NCT01720290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110027635|NCT01720290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027636|NCT01721382|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110027637|NCT01721382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110027638|NCT01721382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027639|NCT01721382|Incretins|incretins|mesh-ancestor
110027640|NCT01721382|Hormones|hormones|mesh-ancestor
110027641|NCT01721382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110027642|NCT01721382|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110027643|NCT01721382|Protease Inhibitors|protease inhibitors|mesh-ancestor
110027644|NCT01721382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110027645|NCT01721382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110027647|NCT01721616|Cefazolin|cefazolin|mesh-list
110027648|NCT01721616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110027656|NCT01722396|Vitamins|vitamins|mesh-ancestor
110027657|NCT01722396|Micronutrients|micronutrients|mesh-ancestor
110027658|NCT01722396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027659|NCT01722396|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110027660|NCT01722630|Dopamine|dopamine|mesh-list
110027661|NCT01722630|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110027662|NCT01722630|Sympathomimetics|sympathomimetics|mesh-ancestor
110027663|NCT01722630|Autonomic Agents|autonomic agents|mesh-ancestor
110027664|NCT01722630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110027665|NCT01722630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027666|NCT01722630|Dopamine Agents|dopamine agents|mesh-ancestor
110027667|NCT01722630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110027668|NCT01722630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110027669|NCT01722630|Protective Agents|protective agents|mesh-ancestor
110027671|NCT01722942|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110027672|NCT01722942|Vasodilator Agents|vasodilator agents|mesh-ancestor
110027673|NCT01722942|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110027674|NCT01722942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110027675|NCT01722942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110027676|NCT01722942|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110027677|NCT01722942|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110027678|NCT01722942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110027679|NCT01722942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110027680|NCT01722942|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110027681|NCT01722942|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110027682|NCT01722942|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110027684|NCT01723800|Pemetrexed|pemetrexed|mesh-list
110027685|NCT01723800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110027686|NCT01723800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110027687|NCT01723800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110027688|NCT01723800|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110027689|NCT01723800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110027690|NCT01724190|Vitamin D|vitamin d|mesh-list
110027691|NCT01724190|Cholecalciferol|cholecalciferol|mesh-list
110027693|NCT01724190|Micronutrients|micronutrients|mesh-ancestor
110027694|NCT01724190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027695|NCT01724190|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110027696|NCT01724190|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110027697|NCT01724268|Prednisolone|prednisolone|mesh-list
110027698|NCT01724268|Methotrexate|methotrexate|mesh-list
110027700|NCT01724268|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110027701|NCT01724268|Abortifacient Agents|abortifacient agents|mesh-ancestor
110027702|NCT01724268|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110027703|NCT01724268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027704|NCT01724268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110027705|NCT01724268|Antimetabolites|antimetabolites|mesh-ancestor
110027706|NCT01724268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110027707|NCT01724268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110027708|NCT01724268|Dermatologic Agents|dermatologic agents|mesh-ancestor
110027709|NCT01724268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110027710|NCT01724268|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110027711|NCT01724268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110027712|NCT01724268|Immunologic Factors|immunologic factors|mesh-ancestor
110027713|NCT01724268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110027714|NCT01724268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110027715|NCT01724268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110027718|NCT01724268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110027719|NCT01724268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110027720|NCT01724268|Autonomic Agents|autonomic agents|mesh-ancestor
110027721|NCT01724268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110027726|NCT01724268|Adrenergic Agents|adrenergic agents|mesh-ancestor
110027727|NCT01724268|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110027728|NCT01724268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110027729|NCT01724268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110027730|NCT01724268|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110027732|NCT01724424|Antioxidants|antioxidants|mesh-ancestor
110027733|NCT01724424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110027734|NCT01724424|Protective Agents|protective agents|mesh-ancestor
110027735|NCT01724424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027736|NCT01724424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110027737|NCT01724814|Insulin|insulin|mesh-list
110027738|NCT01724814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110027739|NCT01724814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027740|NCT01725048|Mirtazapine|mirtazapine|mesh-list
110027741|NCT01725048|Citalopram|citalopram|mesh-list
110027742|NCT01725048|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110027743|NCT01725048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110027744|NCT01725048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110027745|NCT01725048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110027746|NCT01725048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110027748|NCT01725048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027749|NCT01725048|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110027750|NCT01725048|Antidepressive Agents|antidepressive agents|mesh-ancestor
110027751|NCT01725048|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110027752|NCT01725048|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110027753|NCT01725048|Histamine Antagonists|histamine antagonists|mesh-ancestor
110027754|NCT01725048|Histamine Agents|histamine agents|mesh-ancestor
110027755|NCT01725048|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110027756|NCT01725048|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110027757|NCT01725048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110027758|NCT01725048|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110027759|NCT01725048|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110027760|NCT01725048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110027761|NCT01725048|Adrenergic Agents|adrenergic agents|mesh-ancestor
110027762|NCT01725048|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110027763|NCT01725048|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110027764|NCT01725048|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110027765|NCT01725204|Dasatinib|dasatinib|mesh-list
110027766|NCT01725204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110027767|NCT01725204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110027768|NCT01725204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110027769|NCT01725204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110027770|NCT01725360|Montelukast|montelukast|mesh-list
110027771|NCT01725360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110027772|NCT01725360|Respiratory System Agents|respiratory system agents|mesh-ancestor
110027773|NCT01725360|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110027774|NCT01725360|Hormone Antagonists|hormone antagonists|mesh-ancestor
110027775|NCT01725360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110027776|NCT01725360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027777|NCT01725360|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110027778|NCT01725360|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110027779|NCT01725360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110027781|NCT01725672|Glimepiride|glimepiride|mesh-list
110027782|NCT01725672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110027783|NCT01725672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027784|NCT01725672|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110027785|NCT01725672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110027786|NCT01725672|Immunologic Factors|immunologic factors|mesh-ancestor
110027787|NCT01725906|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110027788|NCT01725906|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110027789|NCT01725906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110027790|NCT01725906|Antitubercular Agents|antitubercular agents|mesh-ancestor
110027792|NCT01726530|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110027793|NCT01726530|Narcotics|narcotics|mesh-ancestor
110027798|NCT01726530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110027799|NCT01726530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110027800|NCT01726530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110027801|NCT01726530|Anesthetics, General|anesthetics, general|mesh-ancestor
110027802|NCT01726530|Anesthetics|anesthetics|mesh-ancestor
110027804|NCT01726686|Anesthetics, Local|anesthetics, local|mesh-ancestor
110027805|NCT01726686|Anesthetics|anesthetics|mesh-ancestor
110027806|NCT01726686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110027807|NCT01726686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027808|NCT01726686|Sensory System Agents|sensory system agents|mesh-ancestor
110027809|NCT01726686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110027810|NCT01726764|Metformin|metformin|mesh-list
110027811|NCT01726764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110027812|NCT01726764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027813|NCT01726920|Naproxen|naproxen|mesh-list
110027814|NCT01726920|Naratriptan|naratriptan|mesh-list
110027815|NCT01726920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110027816|NCT01726920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110027817|NCT01726920|Analgesics|analgesics|mesh-ancestor
110027818|NCT01726920|Sensory System Agents|sensory system agents|mesh-ancestor
110027819|NCT01726920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110027820|NCT01726920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027821|NCT01726920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110027822|NCT01726920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110027823|NCT01726920|Gout Suppressants|gout suppressants|mesh-ancestor
110027824|NCT01726920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110027825|NCT01726920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110027826|NCT01726920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110027827|NCT01726920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110027828|NCT01726920|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110027829|NCT01726920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110027830|NCT01726920|Serotonin Agents|serotonin agents|mesh-ancestor
110027831|NCT01726920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110027832|NCT01727622|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110027833|NCT01727622|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110027834|NCT01727622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110027835|NCT01728090|Hand Sanitizers|hand sanitizers|mesh-list
110027836|NCT01728090|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110027837|NCT01728090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110027838|NCT01728090|Disinfectants|disinfectants|mesh-ancestor
110027839|NCT01728480|Cisplatin|cisplatin|mesh-list
110027840|NCT01728480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110027841|NCT01728948|Sorafenib|sorafenib|mesh-list
110027842|NCT01728948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110027843|NCT01728948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110027844|NCT01728948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110027845|NCT01728948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110027846|NCT01729104|Rituximab|rituximab|mesh-list
110027847|NCT01729104|Lenalidomide|lenalidomide|mesh-list
110027848|NCT01729104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110027849|NCT01729104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110027850|NCT01729104|Immunologic Factors|immunologic factors|mesh-ancestor
110027851|NCT01729104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027852|NCT01729104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110027853|NCT01729104|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110027854|NCT01729104|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110027855|NCT01729104|Growth Substances|growth substances|mesh-ancestor
110027856|NCT01729104|Growth Inhibitors|growth inhibitors|mesh-ancestor
110027857|NCT01729260|Mebendazole|mebendazole|mesh-list
110027858|NCT01729260|Piperazine|piperazine|mesh-list
110027859|NCT01729260|Piperazine citrate|piperazine citrate|mesh-list
110027860|NCT01729260|DMP 777|dmp 777|mesh-list
110027861|NCT01729260|Antinematodal Agents|antinematodal agents|mesh-ancestor
110027862|NCT01729260|Anthelmintics|anthelmintics|mesh-ancestor
110027864|NCT01729260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110027866|NCT01729260|Antimitotic Agents|antimitotic agents|mesh-ancestor
110027867|NCT01729260|Mitosis Modulators|mitosis modulators|mesh-ancestor
110027868|NCT01729260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110027876|NCT01729806|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110027877|NCT01729806|Immunologic Factors|immunologic factors|mesh-ancestor
110027878|NCT01729806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027879|NCT01729806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110027880|NCT01729806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110027881|NCT01729806|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110027882|NCT01729806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110027883|NCT01724658|Methyltestosterone|methyltestosterone|mesh-list
110027884|NCT01724658|Testosterone|testosterone|mesh-list
110027885|NCT01724658|Testosterone undecanoate|testosterone undecanoate|mesh-list
110027886|NCT01724658|Testosterone enanthate|testosterone enanthate|mesh-list
110027887|NCT01724658|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110027888|NCT01724658|Androgens|androgens|mesh-ancestor
110027889|NCT01724658|Hormones|hormones|mesh-ancestor
110027890|NCT01724658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110027891|NCT01724658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027892|NCT01724658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110027893|NCT01724658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110027894|NCT01724658|Anabolic Agents|anabolic agents|mesh-ancestor
110027895|NCT01049334|Flurbiprofen|flurbiprofen|mesh-list
110027896|NCT01049334|Analgesics|analgesics|mesh-ancestor
110027898|NCT01049334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110027899|NCT01049334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027900|NCT01049334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110027901|NCT01049334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110027902|NCT01049334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110027903|NCT01049334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110027904|NCT01049334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110027905|NCT01049334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110027906|NCT01049334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110027907|NCT01048944|Bupropion|bupropion|mesh-list
110027908|NCT01048944|Nicotine|nicotine|mesh-list
110027909|NCT01048944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110027910|NCT01048944|Autonomic Agents|autonomic agents|mesh-ancestor
110027911|NCT01048944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110027912|NCT01048944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027913|NCT01048944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110027914|NCT01048944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110027915|NCT01048944|Cholinergic Agents|cholinergic agents|mesh-ancestor
110027916|NCT01048944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110027917|NCT01048944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110027918|NCT01048944|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110027919|NCT01048944|Antidepressive Agents|antidepressive agents|mesh-ancestor
110027920|NCT01048944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110027921|NCT01048944|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110027922|NCT01048944|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110027923|NCT01048944|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110027924|NCT01048944|Dopamine Agents|dopamine agents|mesh-ancestor
110027925|NCT01048944|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110027926|NCT01048944|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110027927|NCT01048944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110027928|NCT01048866|Acetaminophen|acetaminophen|mesh-list
110027929|NCT01048866|Flurbiprofen|flurbiprofen|mesh-list
110027930|NCT01048866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110027932|NCT01048866|Sensory System Agents|sensory system agents|mesh-ancestor
110027933|NCT01048866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110027934|NCT01048866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027935|NCT01048866|Antipyretics|antipyretics|mesh-ancestor
110027936|NCT01048866|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110027937|NCT01048866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110027938|NCT01048866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110027939|NCT01048866|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110027940|NCT01048866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110027945|NCT01048788|Natriuretic Agents|natriuretic agents|mesh-ancestor
110027946|NCT01048788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027947|NCT01046682|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
110027948|NCT01046682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110027949|NCT01046682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110027950|NCT01046682|Analgesics|analgesics|mesh-ancestor
110027951|NCT01046682|Sensory System Agents|sensory system agents|mesh-ancestor
110027952|NCT01046682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110027953|NCT01046682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027954|NCT01046682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110027955|NCT01046682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110027956|NCT01044498|Norinyl|norinyl|mesh-list
110027957|NCT01044498|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110027958|NCT01044498|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110027959|NCT01044498|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110027960|NCT01044498|Contraceptive Agents|contraceptive agents|mesh-ancestor
110027961|NCT01044498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110027962|NCT01044498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027963|NCT01044498|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110027964|NCT01044498|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110027965|NCT01042938|Curcumin|curcumin|mesh-list
110027966|NCT01042938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110027967|NCT01042938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110027968|NCT01042938|Analgesics|analgesics|mesh-ancestor
110027969|NCT01042938|Sensory System Agents|sensory system agents|mesh-ancestor
110027970|NCT01042938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110027971|NCT01042938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027972|NCT01042938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110027973|NCT01042938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110027974|NCT01042938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110027975|NCT01042938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110027976|NCT01042938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110027977|NCT01042158|Ambrisentan|ambrisentan|mesh-list
110027979|NCT01042158|Vasodilator Agents|vasodilator agents|mesh-ancestor
110027980|NCT01042158|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110027981|NCT01042158|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110027982|NCT01042158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110027983|NCT01042158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110027984|NCT01042158|Urological Agents|urological agents|mesh-ancestor
110027985|NCT01042158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110027986|NCT03405870|SMOFlipid|smoflipid|mesh-list
110027987|NCT03405870|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
110027988|NCT03405870|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110027989|NCT03405870|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110027990|NCT03409458|Avelumab|avelumab|mesh-list
110027991|NCT03409458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110027992|NCT03409458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110027993|NCT03409068|Anesthetics|anesthetics|mesh-list
110027994|NCT03409068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110027995|NCT03409068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027996|NCT03408054|Nitroglycerin|nitroglycerin|mesh-list
110027997|NCT03408054|Oxytocin|oxytocin|mesh-list
110027998|NCT03408054|Oxytocics|oxytocics|mesh-ancestor
110028000|NCT03408054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110028001|NCT03408054|Vasodilator Agents|vasodilator agents|mesh-ancestor
110028002|NCT03407976|Pembrolizumab|pembrolizumab|mesh-list
110028003|NCT03407976|Apatinib|apatinib|mesh-list
110028004|NCT03407976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110028005|NCT03407976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110028006|NCT03407976|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110028007|NCT03407976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110028008|NCT03407976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110028009|NCT03407976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110028011|NCT03407196|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110028012|NCT03407196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110028014|NCT03407196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110028015|NCT03405948|Botulinum Toxins|botulinum toxins|mesh-list
110028016|NCT03405948|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110028017|NCT03405948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110028018|NCT03405948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110028019|NCT03405948|Cholinergic Agents|cholinergic agents|mesh-ancestor
110028020|NCT03405948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110028021|NCT03405948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110028022|NCT03405168|Moxifloxacin|moxifloxacin|mesh-list
110028023|NCT03405168|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110028024|NCT03405168|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110028025|NCT03405168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110028026|NCT03405168|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110028027|NCT03405168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110028028|NCT03405168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110028029|NCT03405168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110028030|NCT03405168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110028031|NCT03405168|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110028032|NCT03405168|Contraceptive Agents|contraceptive agents|mesh-ancestor
110028033|NCT03405168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110028034|NCT03405168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110028035|NCT03405168|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110028036|NCT03405168|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110028037|NCT03405168|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110028038|NCT03403452|Apatinib|apatinib|mesh-list
110028039|NCT03403452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110028040|NCT03403452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110028041|NCT03403452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110028042|NCT03403452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110028043|NCT03403140|Etanercept|etanercept|mesh-list
110028044|NCT03403140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110028045|NCT03403140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110028046|NCT03403140|Analgesics|analgesics|mesh-ancestor
110028047|NCT03403140|Sensory System Agents|sensory system agents|mesh-ancestor
110028048|NCT03403140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110028049|NCT03403140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110028050|NCT03403140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110028051|NCT03403140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110028052|NCT03403140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110028053|NCT03403140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110028054|NCT03403140|Immunologic Factors|immunologic factors|mesh-ancestor
110028055|NCT03402984|Z 338|z 338|mesh-list
110028056|NCT03402984|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110028057|NCT03402984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110028058|NCT03402984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110028059|NCT03402984|Cholinergic Agents|cholinergic agents|mesh-ancestor
110028060|NCT03402984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110028061|NCT03402984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110028062|NCT03402984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110028063|NCT03402438|Fulacimstat|fulacimstat|mesh-list
110028064|NCT03402438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110028066|NCT03402204|Ubenimex|ubenimex|mesh-list
110028067|NCT03402204|Simvastatin|simvastatin|mesh-list
110028068|NCT03402204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110028070|NCT03402204|Antimetabolites|antimetabolites|mesh-ancestor
110028071|NCT03402204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110028072|NCT03402204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110028073|NCT03402204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110028074|NCT03402204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110028075|NCT03402204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110028076|NCT03402204|Immunologic Factors|immunologic factors|mesh-ancestor
110028077|NCT03402204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110028078|NCT03402204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110028079|NCT03402204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110028080|NCT03402204|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110028081|NCT03402204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110028082|NCT03402204|Protease Inhibitors|protease inhibitors|mesh-ancestor
110028083|NCT03402204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110028084|NCT03402204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110028085|NCT03402204|Antiviral Agents|antiviral agents|mesh-ancestor
110028092|NCT03402048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110028093|NCT03402048|Antimetabolites|antimetabolites|mesh-ancestor
110028094|NCT03402048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110028095|NCT03402048|Tubulin Modulators|tubulin modulators|mesh-ancestor
110028096|NCT03402048|Antimitotic Agents|antimitotic agents|mesh-ancestor
110028097|NCT03402048|Mitosis Modulators|mitosis modulators|mesh-ancestor
110028098|NCT03402048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110028099|NCT03402048|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110028100|NCT03402048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110028101|NCT03402048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110028103|NCT03401502|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110028104|NCT03401502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110028105|NCT03401502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110028106|NCT03401346|Dihydroergotamine|dihydroergotamine|mesh-list
110028107|NCT03401346|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110028108|NCT03401346|Dopamine Agonists|dopamine agonists|mesh-ancestor
110028109|NCT03401346|Dopamine Agents|dopamine agents|mesh-ancestor
110028110|NCT03401346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110028111|NCT03401346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110028112|NCT03401346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110028113|NCT03401346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110028114|NCT03401346|Analgesics|analgesics|mesh-ancestor
110028115|NCT03401346|Sensory System Agents|sensory system agents|mesh-ancestor
110028116|NCT03401346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110028117|NCT03401268|Immunoglobulins|immunoglobulins|mesh-list
110028118|NCT03401268|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110028119|NCT03401268|Antibodies|antibodies|mesh-list
110028120|NCT03401268|Immunologic Factors|immunologic factors|mesh-ancestor
110028121|NCT03401268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110028122|NCT03400722|Clomiphene|clomiphene|mesh-list
110028123|NCT03400722|Hormones|hormones|mesh-list
110028124|NCT03400722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110028125|NCT03400722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110028126|NCT03400722|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110028127|NCT03400722|Hormone Antagonists|hormone antagonists|mesh-ancestor
110028128|NCT03400722|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110028129|NCT03400722|Fertility Agents|fertility agents|mesh-ancestor
110028130|NCT03400722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110028131|NCT03400722|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110028132|NCT03400722|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110028133|NCT03400254|Hydroxychloroquine|hydroxychloroquine|mesh-list
110028134|NCT03400254|Gedatolisib|gedatolisib|mesh-list
110028135|NCT03400254|Antimalarials|antimalarials|mesh-ancestor
110028136|NCT03400254|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110028137|NCT03400254|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110028138|NCT03400254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110028139|NCT03400254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110028140|NCT03400254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110028141|NCT03400254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110028142|NCT03400254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110028143|NCT03400020|Ascorbic Acid|ascorbic acid|mesh-list
110028144|NCT03400020|Vitamins|vitamins|mesh-ancestor
110028145|NCT03400020|Micronutrients|micronutrients|mesh-ancestor
110028146|NCT03400020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110028147|NCT03400020|Antioxidants|antioxidants|mesh-ancestor
110028148|NCT03400020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110028149|NCT03400020|Protective Agents|protective agents|mesh-ancestor
110028150|NCT00012012|Amifostine|amifostine|mesh-list
110028151|NCT00012012|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110028152|NCT00012012|Protective Agents|protective agents|mesh-ancestor
110028153|NCT00012012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110028154|NCT02240160|Nabiximols|nabiximols|mesh-list
110028155|NCT02240160|Analgesics|analgesics|mesh-ancestor
110028156|NCT02240160|Sensory System Agents|sensory system agents|mesh-ancestor
110028157|NCT02240160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110028158|NCT02240160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110028159|NCT02240238|Gemcitabine|gemcitabine|mesh-list
110028160|NCT02240238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110028161|NCT02240238|Antimetabolites|antimetabolites|mesh-ancestor
110028162|NCT02240238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110028163|NCT02240238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110028164|NCT02241096|Lidocaine|lidocaine|mesh-list
110028165|NCT02241096|Anesthetics, Local|anesthetics, local|mesh-ancestor
110028169|NCT02241096|Sensory System Agents|sensory system agents|mesh-ancestor
110028170|NCT02241096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110028171|NCT02241096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110028172|NCT02241096|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110028173|NCT02241096|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110028174|NCT02241096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110028175|NCT02241096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110028177|NCT02241174|Eusol|eusol|mesh-list
110028178|NCT02241174|Disinfectants|disinfectants|mesh-ancestor
110028179|NCT02241174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110028181|NCT02241564|MTOR Inhibitors|mtor inhibitors|mesh-list
110028182|NCT02241564|Temsirolimus|temsirolimus|mesh-list
110028183|NCT02241564|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
110028184|NCT02241564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110028185|NCT02241564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110028186|NCT02241564|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110028187|NCT02241564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110028188|NCT02241564|Immunologic Factors|immunologic factors|mesh-ancestor
110028189|NCT02241564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110028190|NCT02241564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110028191|NCT02241564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110028192|NCT02241564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110028193|NCT02241564|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110028194|NCT02241564|Antifungal Agents|antifungal agents|mesh-ancestor
110028195|NCT02241876|Acetylcysteine|acetylcysteine|mesh-list
110028196|NCT02241876|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110028197|NCT02241876|Antiviral Agents|antiviral agents|mesh-ancestor
110028198|NCT02241876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110028199|NCT02241876|Expectorants|expectorants|mesh-ancestor
110028200|NCT02241876|Respiratory System Agents|respiratory system agents|mesh-ancestor
110028201|NCT02241876|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110028202|NCT02241876|Antioxidants|antioxidants|mesh-ancestor
110028203|NCT02241876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110028204|NCT02241876|Protective Agents|protective agents|mesh-ancestor
110028205|NCT02241876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110028206|NCT02241876|Antidotes|antidotes|mesh-ancestor
110028207|NCT02242032|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110028208|NCT02242032|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110028209|NCT02242266|Tiotropium Bromide|tiotropium bromide|mesh-list
110028210|NCT02242266|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110028211|NCT02242266|Autonomic Agents|autonomic agents|mesh-ancestor
110028212|NCT02242266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110028213|NCT02242266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110028214|NCT02242266|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110028215|NCT02242266|Respiratory System Agents|respiratory system agents|mesh-ancestor
110028216|NCT02242266|Parasympatholytics|parasympatholytics|mesh-ancestor
110028217|NCT02242266|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110028218|NCT02242266|Cholinergic Agents|cholinergic agents|mesh-ancestor
110028219|NCT02242266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110028220|NCT02242266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110028221|NCT02242344|Telmisartan|telmisartan|mesh-list
110028222|NCT02242344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110028223|NCT02242344|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110028224|NCT02242344|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110028225|NCT02242344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110028226|NCT02242656|Opium|opium|mesh-list
110028227|NCT02242656|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110028228|NCT02242656|Narcotics|narcotics|mesh-ancestor
110028229|NCT02242656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110028230|NCT02242656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110028232|NCT02242656|Sensory System Agents|sensory system agents|mesh-ancestor
110028233|NCT02242656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110028234|NCT02242656|Antidiarrheals|antidiarrheals|mesh-ancestor
110028235|NCT02242656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110028236|NCT02242656|Antitussive Agents|antitussive agents|mesh-ancestor
110028237|NCT02242656|Respiratory System Agents|respiratory system agents|mesh-ancestor
110028239|NCT02242812|Telmisartan|telmisartan|mesh-list
110028240|NCT02242812|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110028241|NCT02242812|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110028470|NCT02249130|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110028246|NCT02242812|Autonomic Agents|autonomic agents|mesh-ancestor
110028247|NCT02242812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110028248|NCT02242812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110028250|NCT02242812|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110028251|NCT02242812|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110028252|NCT02242812|Adrenergic Agents|adrenergic agents|mesh-ancestor
110028253|NCT02242812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110028254|NCT02243124|Dexamethasone|dexamethasone|mesh-list
110028255|NCT02243124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110028256|NCT02243124|Antiemetics|antiemetics|mesh-ancestor
110028257|NCT02243124|Autonomic Agents|autonomic agents|mesh-ancestor
110028258|NCT02243124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110028259|NCT02243124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110028260|NCT02243124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110028261|NCT02243124|Glucocorticoids|glucocorticoids|mesh-ancestor
110028262|NCT02243124|Hormones|hormones|mesh-ancestor
110028263|NCT02243124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110028264|NCT02243124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110028265|NCT02243124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110028266|NCT02243436|Cytarabine|cytarabine|mesh-list
110028267|NCT02243436|Methylprednisolone|methylprednisolone|mesh-list
110028268|NCT02243436|Etoposide|etoposide|mesh-list
110028269|NCT02243436|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110028270|NCT02243436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110028271|NCT02243436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110028272|NCT02243436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110028273|NCT02243436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110028274|NCT02243436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110028275|NCT02243436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110028276|NCT02243436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110028277|NCT02243436|Antimetabolites|antimetabolites|mesh-ancestor
110028278|NCT02243436|Antiviral Agents|antiviral agents|mesh-ancestor
110028279|NCT02243436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110028280|NCT02243436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110028281|NCT02243436|Immunologic Factors|immunologic factors|mesh-ancestor
110028282|NCT02243436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110028283|NCT02243436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110028284|NCT02243436|Antiemetics|antiemetics|mesh-ancestor
110028285|NCT02243436|Autonomic Agents|autonomic agents|mesh-ancestor
110028286|NCT02243436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110028287|NCT02243436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110028289|NCT02243436|Hormones|hormones|mesh-ancestor
110028290|NCT02243436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110028291|NCT02243436|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110028292|NCT02243436|Protective Agents|protective agents|mesh-ancestor
110028293|NCT02243436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110028294|NCT02243436|Immunotoxins|immunotoxins|mesh-ancestor
110028295|NCT02243436|Immunoconjugates|immunoconjugates|mesh-ancestor
110028296|NCT02243826|Nitrous Oxide|nitrous oxide|mesh-list
110028297|NCT02243826|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110028298|NCT02243826|Anesthetics, General|anesthetics, general|mesh-ancestor
110028299|NCT02243826|Anesthetics|anesthetics|mesh-ancestor
110028300|NCT02243826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110028301|NCT02243826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110028302|NCT02243826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110028304|NCT02243826|Sensory System Agents|sensory system agents|mesh-ancestor
110028305|NCT02243826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110028306|NCT02244216|Fenoterol|fenoterol|mesh-list
110028307|NCT02244216|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110028308|NCT02244216|Autonomic Agents|autonomic agents|mesh-ancestor
110028309|NCT02244216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110028310|NCT02244216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110028311|NCT02244216|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110028312|NCT02244216|Respiratory System Agents|respiratory system agents|mesh-ancestor
110028313|NCT02244216|Sympathomimetics|sympathomimetics|mesh-ancestor
110028314|NCT02244216|Tocolytic Agents|tocolytic agents|mesh-ancestor
110028315|NCT02244216|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110028317|NCT02244216|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110028318|NCT02244216|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110028319|NCT02244216|Adrenergic Agents|adrenergic agents|mesh-ancestor
110028320|NCT02244216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110028321|NCT02244216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110028322|NCT02244294|Tamsulosin|tamsulosin|mesh-list
110028323|NCT02244294|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110028324|NCT02244294|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110028325|NCT02244294|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110028326|NCT02244294|Adrenergic Agents|adrenergic agents|mesh-ancestor
110028327|NCT02244294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110028328|NCT02244294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110028329|NCT02244294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110028330|NCT02244294|Urological Agents|urological agents|mesh-ancestor
110028332|NCT02244528|Vasodilator Agents|vasodilator agents|mesh-ancestor
110028333|NCT02244528|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110028334|NCT02244528|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110028335|NCT02244528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110028336|NCT02244528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110028337|NCT02244528|Urological Agents|urological agents|mesh-ancestor
110028338|NCT02245464|Telmisartan|telmisartan|mesh-list
110028339|NCT02245464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110028340|NCT02245464|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110028341|NCT02245464|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110028342|NCT02245464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110028343|NCT02246244|Escitalopram|escitalopram|mesh-list
110028344|NCT02246244|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110028345|NCT02246244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110028346|NCT02246244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110028347|NCT02246244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110028348|NCT02246244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110028350|NCT02246244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110028351|NCT02246712|Tramadol|tramadol|mesh-list
110028352|NCT02246712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110028353|NCT02246712|Narcotics|narcotics|mesh-ancestor
110028354|NCT02246712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110028355|NCT02246712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110028356|NCT02246712|Analgesics|analgesics|mesh-ancestor
110028357|NCT02246712|Sensory System Agents|sensory system agents|mesh-ancestor
110028358|NCT02246712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110028359|NCT02246868|Factor VIII|factor viii|mesh-list
110028360|NCT02246868|Coagulants|coagulants|mesh-ancestor
110028361|NCT02247258|Azathioprine|azathioprine|mesh-list
110028362|NCT02247258|Antimetabolites|antimetabolites|mesh-ancestor
110028363|NCT02247258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110028364|NCT02247258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110028365|NCT02247258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110028366|NCT02247258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110028367|NCT02247258|Immunologic Factors|immunologic factors|mesh-ancestor
110028368|NCT02247258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110028369|NCT02247258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110028370|NCT02247414|Aspirin|aspirin|mesh-list
110028371|NCT02247414|Heparin|heparin|mesh-list
110028372|NCT02247414|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110028373|NCT02247414|Tinzaparin|tinzaparin|mesh-list
110028374|NCT02247414|Dalteparin|dalteparin|mesh-list
110028375|NCT02247414|Dipyridamole|dipyridamole|mesh-list
110028376|NCT02247414|Warfarin|warfarin|mesh-list
110028377|NCT02247414|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110028379|NCT02247414|Analgesics|analgesics|mesh-ancestor
110028380|NCT02247414|Sensory System Agents|sensory system agents|mesh-ancestor
110028381|NCT02247414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110028382|NCT02247414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110028383|NCT02247414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110028384|NCT02247414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110028385|NCT02247414|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110028386|NCT02247414|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110028387|NCT02247414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110028388|NCT02247414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110028389|NCT02247414|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110028390|NCT02247414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110028395|NCT02247648|Tramadol|tramadol|mesh-list
110028396|NCT02247648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110028397|NCT02247648|Narcotics|narcotics|mesh-ancestor
110028398|NCT02247648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110028399|NCT02247648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110028400|NCT02247648|Analgesics|analgesics|mesh-ancestor
110028401|NCT02247648|Sensory System Agents|sensory system agents|mesh-ancestor
110028402|NCT02247648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110028403|NCT02248428|Clarithromycin|clarithromycin|mesh-list
110028404|NCT02248428|Thalidomide|thalidomide|mesh-list
110028405|NCT02248428|Dexamethasone|dexamethasone|mesh-list
110028406|NCT02248428|Cyclophosphamide|cyclophosphamide|mesh-list
110028407|NCT02248428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110028408|NCT02248428|Immunologic Factors|immunologic factors|mesh-ancestor
110028409|NCT02248428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110028410|NCT02248428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110028411|NCT02248428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110028412|NCT02248428|Alkylating Agents|alkylating agents|mesh-ancestor
110028413|NCT02248428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110028414|NCT02248428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110028415|NCT02248428|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110028416|NCT02248428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110028417|NCT02248428|Antiemetics|antiemetics|mesh-ancestor
110028418|NCT02248428|Autonomic Agents|autonomic agents|mesh-ancestor
110028419|NCT02248428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110028420|NCT02248428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110028421|NCT02248428|Glucocorticoids|glucocorticoids|mesh-ancestor
110028422|NCT02248428|Hormones|hormones|mesh-ancestor
110028423|NCT02248428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110028424|NCT02248428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110028425|NCT02248428|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110028426|NCT02248428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110028427|NCT02248428|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110028428|NCT02248428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110028429|NCT02248428|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110028430|NCT02248428|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110028431|NCT02248428|Leprostatic Agents|leprostatic agents|mesh-ancestor
110028432|NCT02248428|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110028433|NCT02248428|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110028434|NCT02248428|Growth Substances|growth substances|mesh-ancestor
110028435|NCT02248428|Growth Inhibitors|growth inhibitors|mesh-ancestor
110028436|NCT02248506|Clotrimazole|clotrimazole|mesh-list
110028438|NCT02248506|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110028439|NCT02248506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110028440|NCT02248506|Antifungal Agents|antifungal agents|mesh-ancestor
110028442|NCT02248506|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110028443|NCT02248506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110028444|NCT02248506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110028445|NCT02248506|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110028446|NCT02248506|Hormone Antagonists|hormone antagonists|mesh-ancestor
110028447|NCT02248506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110028448|NCT02248506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110028449|NCT02248506|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110028450|NCT02248506|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110028453|NCT02248896|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
110028455|NCT02248896|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110028456|NCT02248896|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110028457|NCT02248896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110028458|NCT02248896|Protease Inhibitors|protease inhibitors|mesh-ancestor
110028459|NCT02249130|Ritonavir|ritonavir|mesh-list
110028460|NCT02249130|Lamivudine|lamivudine|mesh-list
110028461|NCT02249130|Zidovudine|zidovudine|mesh-list
110028462|NCT02249130|Stavudine|stavudine|mesh-list
110028463|NCT02249130|Tipranavir|tipranavir|mesh-list
110028464|NCT02249130|Delavirdine|delavirdine|mesh-list
110028465|NCT02249130|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110028466|NCT02249130|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110028467|NCT02249130|Protease Inhibitors|protease inhibitors|mesh-ancestor
110028468|NCT02249130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110028469|NCT02249130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110028477|NCT02249130|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110028479|NCT02249364|Propofol|propofol|mesh-list
110028480|NCT02249364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110028481|NCT02249364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110028482|NCT02249364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110028483|NCT02249364|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110028484|NCT02249364|Anesthetics, General|anesthetics, general|mesh-ancestor
110028485|NCT02249364|Anesthetics|anesthetics|mesh-ancestor
110028486|NCT02249442|Ritonavir|ritonavir|mesh-list
110028487|NCT02249442|Tipranavir|tipranavir|mesh-list
110028488|NCT02249442|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110028489|NCT02249442|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110028490|NCT02249442|Protease Inhibitors|protease inhibitors|mesh-ancestor
110028491|NCT02249442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110028492|NCT02249442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110028493|NCT02249442|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110028494|NCT02249442|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110028495|NCT02249442|Antiviral Agents|antiviral agents|mesh-ancestor
110028496|NCT02249442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110028497|NCT02249442|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110028498|NCT02249442|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110028499|NCT02244762|Hydrocodone|hydrocodone|mesh-list
110028500|NCT02244762|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110028501|NCT02244762|Narcotics|narcotics|mesh-ancestor
110028502|NCT02244762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110028503|NCT02244762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110028504|NCT02244762|Analgesics|analgesics|mesh-ancestor
110028505|NCT02244762|Sensory System Agents|sensory system agents|mesh-ancestor
110028506|NCT02244762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110028507|NCT02244762|Antitussive Agents|antitussive agents|mesh-ancestor
110028508|NCT02244762|Respiratory System Agents|respiratory system agents|mesh-ancestor
110028509|NCT02242734|Hydrocodone|hydrocodone|mesh-list
110028510|NCT02242734|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110028511|NCT02242734|Narcotics|narcotics|mesh-ancestor
110028512|NCT02242734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110028513|NCT02242734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110028514|NCT02242734|Analgesics|analgesics|mesh-ancestor
110028515|NCT02242734|Sensory System Agents|sensory system agents|mesh-ancestor
110028516|NCT02242734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110028518|NCT02242734|Respiratory System Agents|respiratory system agents|mesh-ancestor
110028519|NCT02244606|Fluconazole|fluconazole|mesh-list
110028520|NCT02244606|Micafungin|micafungin|mesh-list
110028521|NCT02244606|Ibrexafungerp|ibrexafungerp|mesh-list
110028522|NCT02244606|Antifungal Agents|antifungal agents|mesh-ancestor
110028523|NCT02244606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110028524|NCT02244606|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110028525|NCT02244606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110028526|NCT02244606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110028529|NCT02244606|Hormone Antagonists|hormone antagonists|mesh-ancestor
110028530|NCT02244606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110028531|NCT02244606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110028532|NCT02244606|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110028533|NCT02244606|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110028534|NCT02245308|Bupropion|bupropion|mesh-list
110028535|NCT02245308|Nicotine|nicotine|mesh-list
110028536|NCT02245308|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110028537|NCT02245308|Autonomic Agents|autonomic agents|mesh-ancestor
110028538|NCT02245308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110028539|NCT02245308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110028540|NCT02245308|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110028541|NCT02245308|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110028542|NCT02245308|Cholinergic Agents|cholinergic agents|mesh-ancestor
110028543|NCT02245308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110028548|NCT02245308|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110028549|NCT02245308|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110028550|NCT02245308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110028552|NCT02245308|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110028553|NCT02245308|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110028554|NCT02245308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110028555|NCT02243358|Gemcitabine|gemcitabine|mesh-list
110028556|NCT02243358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110028558|NCT02243358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110028559|NCT02243358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110028560|NCT00559962|Atorvastatin|atorvastatin|mesh-list
110028562|NCT00559962|Fenofibrate|fenofibrate|mesh-list
110028563|NCT00559962|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110028565|NCT00559962|Antimetabolites|antimetabolites|mesh-ancestor
110028566|NCT00559962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110028567|NCT00559962|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110028568|NCT00559962|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110028569|NCT00559962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110028570|NCT00559104|Cyclophosphamide|cyclophosphamide|mesh-list
110028572|NCT00559104|Etoposide|etoposide|mesh-list
110028573|NCT00559104|Lenograstim|lenograstim|mesh-list
110028574|NCT00559104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110028576|NCT00559104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110028577|NCT00559104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110028578|NCT00559104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110028579|NCT00559104|Alkylating Agents|alkylating agents|mesh-ancestor
110028580|NCT00559104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110028581|NCT00559104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110028582|NCT00559104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110028583|NCT00559104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110028584|NCT00559104|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110028585|NCT00559104|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110028587|NCT00559104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110028588|NCT00558636|Paclitaxel|paclitaxel|mesh-list
110028589|NCT00558636|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110028590|NCT00558636|Carboplatin|carboplatin|mesh-list
110028591|NCT00558636|Sorafenib|sorafenib|mesh-list
110028592|NCT00558636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110028593|NCT00558636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110028594|NCT00558636|Tubulin Modulators|tubulin modulators|mesh-ancestor
110028595|NCT00558636|Antimitotic Agents|antimitotic agents|mesh-ancestor
110028596|NCT00558636|Mitosis Modulators|mitosis modulators|mesh-ancestor
110028597|NCT00558636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110028599|NCT00558636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110028600|NCT00558558|Flurandrenolone|flurandrenolone|mesh-list
110028601|NCT00558558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110028602|NCT00558558|Glucocorticoids|glucocorticoids|mesh-ancestor
110028603|NCT00558558|Hormones|hormones|mesh-ancestor
110028604|NCT00558558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110028605|NCT00558558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110028606|NCT00557622|Paroxetine|paroxetine|mesh-list
110028607|NCT00557622|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110028609|NCT00557622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110028610|NCT00557622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110028611|NCT00557622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110028612|NCT00557622|Serotonin Agents|serotonin agents|mesh-ancestor
110028613|NCT00557622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110028614|NCT00557622|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110028615|NCT00557622|Antidepressive Agents|antidepressive agents|mesh-ancestor
110028616|NCT00557622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110028617|NCT00557622|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110028618|NCT00557622|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110028619|NCT00557622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110028626|NCT00557466|Respiratory System Agents|respiratory system agents|mesh-ancestor
110028627|NCT00557466|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110028628|NCT00557466|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110028630|NCT00557466|Adrenergic Agents|adrenergic agents|mesh-ancestor
110028631|NCT00557466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110028632|NCT00557466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110028633|NCT00557310|Teriparatide|teriparatide|mesh-list
110028634|NCT00557310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110028635|NCT00557310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110028636|NCT00557310|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110028637|NCT00555438|PENTA|penta|mesh-list
110028638|NCT00555438|Fondaparinux|fondaparinux|mesh-list
110028639|NCT00555438|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110028640|NCT00555438|Antithrombins|antithrombins|mesh-ancestor
110028641|NCT00555438|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110028642|NCT00555438|Protease Inhibitors|protease inhibitors|mesh-ancestor
110028643|NCT00555438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110028644|NCT00555438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110028645|NCT00555438|Anticoagulants|anticoagulants|mesh-ancestor
110028646|NCT00555438|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110028647|NCT00555438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110028648|NCT00553644|Lenalidomide|lenalidomide|mesh-list
110028649|NCT00553644|Bortezomib|bortezomib|mesh-list
110028650|NCT00553644|Immunologic Factors|immunologic factors|mesh-ancestor
110028651|NCT00553644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110028652|NCT00553644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110028653|NCT00553644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110028654|NCT00553644|Growth Substances|growth substances|mesh-ancestor
110028655|NCT00553644|Growth Inhibitors|growth inhibitors|mesh-ancestor
110028656|NCT00553644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110028657|NCT00552240|Ritonavir|ritonavir|mesh-list
110028658|NCT00552240|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110028659|NCT00552240|Tenofovir|tenofovir|mesh-list
110028660|NCT00552240|Emtricitabine|emtricitabine|mesh-list
110028661|NCT00552240|Nevirapine|nevirapine|mesh-list
110028663|NCT00552240|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110028664|NCT00552240|Protease Inhibitors|protease inhibitors|mesh-ancestor
110028665|NCT00552240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110028666|NCT00552240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110028667|NCT00552240|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110028668|NCT00552240|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110028669|NCT00552240|Antiviral Agents|antiviral agents|mesh-ancestor
110028670|NCT00552240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110028671|NCT00552240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110028672|NCT00552240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110028673|NCT00552240|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110028674|NCT00552240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110028675|NCT00552240|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110028676|NCT00552240|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110028677|NCT00550836|Gemcitabine|gemcitabine|mesh-list
110028678|NCT00550836|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110028679|NCT00550836|Panitumumab|panitumumab|mesh-list
110028680|NCT00550836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110028681|NCT00550836|Antimetabolites|antimetabolites|mesh-ancestor
110028682|NCT00550836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110028683|NCT00550836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110028684|NCT00550836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110028685|NCT00550836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110028686|NCT00550836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110028687|NCT00550680|Epoetin Alfa|epoetin alfa|mesh-list
110028688|NCT00550680|Hematinics|hematinics|mesh-ancestor
110028689|NCT00556920|Carvedilol|carvedilol|mesh-list
110028690|NCT00556920|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110028691|NCT00556920|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110028697|NCT00556920|Antioxidants|antioxidants|mesh-ancestor
110028698|NCT00556920|Protective Agents|protective agents|mesh-ancestor
110028699|NCT00556920|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110028700|NCT00556920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110028701|NCT00556920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110028702|NCT00556920|Vasodilator Agents|vasodilator agents|mesh-ancestor
110028703|NCT00556920|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110028704|NCT00556920|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110028706|NCT00552708|Carvedilol|carvedilol|mesh-list
110028707|NCT00552708|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110028708|NCT00552708|Protease Inhibitors|protease inhibitors|mesh-ancestor
110028709|NCT00552708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110028710|NCT00552708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110028712|NCT00552708|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110028713|NCT00552708|Protective Agents|protective agents|mesh-ancestor
110028714|NCT00552708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110028715|NCT00552708|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110028716|NCT00552708|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110028717|NCT00552708|Adrenergic Agents|adrenergic agents|mesh-ancestor
110028718|NCT00552708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110028719|NCT00552708|Antioxidants|antioxidants|mesh-ancestor
110028720|NCT00552708|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110028721|NCT00552708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110028722|NCT00552708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110028723|NCT00552708|Vasodilator Agents|vasodilator agents|mesh-ancestor
110028724|NCT00552708|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110028725|NCT00552708|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110028726|NCT00556374|Zoledronic Acid|zoledronic acid|mesh-list
110028728|NCT00556374|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110028729|NCT00556374|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110028730|NCT00556374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110028731|NCT00556374|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110028732|NCT00556374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110028733|NCT00556374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110028734|NCT00556374|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110028735|NCT00556374|Hormone Antagonists|hormone antagonists|mesh-ancestor
110028736|NCT00556374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110028737|NCT03029676|Fentanyl|fentanyl|mesh-list
110028738|NCT03029676|Midazolam|midazolam|mesh-list
110028739|NCT03029676|Anesthetics|anesthetics|mesh-ancestor
110028740|NCT03029676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110028741|NCT03029676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110028744|NCT03029676|Analgesics|analgesics|mesh-ancestor
110028745|NCT03029676|Sensory System Agents|sensory system agents|mesh-ancestor
110028746|NCT03029676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110028747|NCT03029676|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110028748|NCT03029676|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110028749|NCT03029676|Anesthetics, General|anesthetics, general|mesh-ancestor
110028750|NCT03029676|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110028751|NCT03029676|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110028752|NCT03029676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110028753|NCT03029676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110028754|NCT03029676|GABA Modulators|gaba modulators|mesh-ancestor
110028755|NCT03029676|GABA Agents|gaba agents|mesh-ancestor
110028756|NCT03029676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110028757|NCT03029676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110028758|NCT04270344|Valsartan|valsartan|mesh-list
110028759|NCT04270344|Pitavastatin|pitavastatin|mesh-list
110028760|NCT04270344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110028761|NCT04270344|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110028762|NCT04270344|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110028763|NCT04270344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110028764|NCT04270344|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110028765|NCT04270344|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110028772|NCT04278846|Anesthetics|anesthetics|mesh-ancestor
110028773|NCT04278846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110028774|NCT04278846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110028775|NCT04278846|Sensory System Agents|sensory system agents|mesh-ancestor
110028776|NCT04278846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110028777|NCT03839550|Apatinib|apatinib|mesh-list
110028778|NCT03839550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110028779|NCT03839550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110028780|NCT03839550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110028781|NCT03839550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110028782|NCT03839160|Morphine|morphine|mesh-list
110028783|NCT03839160|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110028784|NCT03839160|Narcotics|narcotics|mesh-ancestor
110028785|NCT03839160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110028786|NCT03839160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110028788|NCT03839160|Sensory System Agents|sensory system agents|mesh-ancestor
110028789|NCT03839160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110028790|NCT03838926|Trichostatin A|trichostatin a|mesh-list
110028791|NCT03838926|Antifungal Agents|antifungal agents|mesh-ancestor
110028792|NCT03838926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110028793|NCT03838926|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110028794|NCT03838926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110028795|NCT03838926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110028796|NCT03838926|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110028797|NCT03834012|Beclomethasone|beclomethasone|mesh-list
110028798|NCT03834012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110028799|NCT03834012|Glucocorticoids|glucocorticoids|mesh-ancestor
110028800|NCT03834012|Hormones|hormones|mesh-ancestor
110028801|NCT03834012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110028802|NCT03834012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110028803|NCT03834012|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110028804|NCT03834012|Respiratory System Agents|respiratory system agents|mesh-ancestor
110028806|NCT03833466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110028807|NCT03833466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110028808|NCT03833388|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110028809|NCT03833388|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110028810|NCT03830034|Iron|iron|mesh-list
110028812|NCT03830034|Iron Chelating Agents|iron chelating agents|mesh-list
110028813|NCT03830034|Trace Elements|trace elements|mesh-ancestor
110028814|NCT03830034|Micronutrients|micronutrients|mesh-ancestor
110028815|NCT03830034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110028816|NCT03830034|Chelating Agents|chelating agents|mesh-ancestor
110028817|NCT03830034|Sequestering Agents|sequestering agents|mesh-ancestor
110028818|NCT03830034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110028819|NCT03838068|Anesthetics|anesthetics|mesh-list
110028822|NCT03838068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110028823|NCT03838068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110028824|NCT03838068|Sensory System Agents|sensory system agents|mesh-ancestor
110028825|NCT03838068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110028826|NCT05440734|Melatonin|melatonin|mesh-list
110028827|NCT05440734|Antioxidants|antioxidants|mesh-ancestor
110028828|NCT05440734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110028829|NCT05440734|Protective Agents|protective agents|mesh-ancestor
110028830|NCT05440734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110028831|NCT05440734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110028832|NCT05447208|Hormones|hormones|mesh-list
110028833|NCT05447208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110028834|NCT05447208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110028835|NCT05444556|Repaglinide|repaglinide|mesh-list
110028836|NCT05444556|Quinidine|quinidine|mesh-list
110028837|NCT05444556|Digoxin|digoxin|mesh-list
110028838|NCT05444556|Dextromethorphan|dextromethorphan|mesh-list
110028839|NCT05444556|Omeprazole|omeprazole|mesh-list
110028840|NCT05444556|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110028841|NCT05444556|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110028842|NCT05444556|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110028843|NCT05444556|Antimetabolites|antimetabolites|mesh-ancestor
110028911|NCT05768542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110028849|NCT05444556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110028850|NCT05444556|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110028851|NCT05444556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110028852|NCT05444556|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110028853|NCT05444556|Protective Agents|protective agents|mesh-ancestor
110028854|NCT05444556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110028855|NCT05444556|Antitussive Agents|antitussive agents|mesh-ancestor
110028856|NCT05444556|Respiratory System Agents|respiratory system agents|mesh-ancestor
110028857|NCT05444556|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110028858|NCT05444556|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110028859|NCT05444556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110028860|NCT05444556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110028861|NCT05444556|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110028862|NCT05444556|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110028863|NCT05444556|Adrenergic Agents|adrenergic agents|mesh-ancestor
110028864|NCT05444556|Antimalarials|antimalarials|mesh-ancestor
110028865|NCT05444556|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110028866|NCT05444556|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110028867|NCT05444556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110028868|NCT05444556|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110028869|NCT05444556|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110028870|NCT05444556|Cholinergic Agents|cholinergic agents|mesh-ancestor
110028871|NCT05444556|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110028872|NCT05444556|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110028873|NCT05444556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110028874|NCT05444556|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110028875|NCT05444556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110028877|NCT05440578|Olaparib|olaparib|mesh-list
110028878|NCT05440578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110028879|NCT05440578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110028880|NCT05440578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110028881|NCT05440578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110028882|NCT05440578|Growth Substances|growth substances|mesh-ancestor
110028883|NCT05440578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110028884|NCT05440578|Growth Inhibitors|growth inhibitors|mesh-ancestor
110028885|NCT05440578|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110028886|NCT05440578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110028887|NCT05440578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110028888|NCT01689558|Endostatins|endostatins|mesh-list
110028889|NCT01689558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110028890|NCT01689558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110028891|NCT01689558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110028892|NCT01689558|Growth Substances|growth substances|mesh-ancestor
110028893|NCT01689558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110028894|NCT01689558|Growth Inhibitors|growth inhibitors|mesh-ancestor
110028895|NCT01689870|Ipilimumab|ipilimumab|mesh-list
110028896|NCT01689870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110028897|NCT01689870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110028898|NCT01689870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110028899|NCT01689870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110028900|NCT05768542|Metoprolol|metoprolol|mesh-list
110028901|NCT05768542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110028902|NCT05768542|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110028903|NCT05768542|Sympatholytics|sympatholytics|mesh-ancestor
110028904|NCT05768542|Autonomic Agents|autonomic agents|mesh-ancestor
110028905|NCT05768542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110028906|NCT05768542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110028907|NCT05768542|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110028908|NCT05768542|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110028909|NCT05768542|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110028910|NCT05768542|Adrenergic Agents|adrenergic agents|mesh-ancestor
110029210|NCT05411107|Vasodilator Agents|vasodilator agents|mesh-ancestor
110028920|NCT05768334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110028921|NCT05768334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110028922|NCT05768243|Hyaluronic Acid|hyaluronic acid|mesh-list
110028923|NCT05768243|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110028924|NCT05768243|Immunologic Factors|immunologic factors|mesh-ancestor
110028925|NCT05768243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110028926|NCT05768243|Viscosupplements|viscosupplements|mesh-ancestor
110028927|NCT05768243|Protective Agents|protective agents|mesh-ancestor
110028928|NCT05768230|Simendan|simendan|mesh-list
110028929|NCT05768230|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110028930|NCT05768230|Vasodilator Agents|vasodilator agents|mesh-ancestor
110028931|NCT05768230|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110028932|NCT05768230|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110028933|NCT05768230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110028934|NCT05768230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110028935|NCT05768230|Protective Agents|protective agents|mesh-ancestor
110028936|NCT05768230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110028937|NCT05768204|Prednisolone|prednisolone|mesh-list
110028938|NCT05768204|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110028939|NCT05768204|Methylprednisolone|methylprednisolone|mesh-list
110028940|NCT05768204|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110028941|NCT05768204|Prednisolone acetate|prednisolone acetate|mesh-list
110028942|NCT05768204|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110028943|NCT05768204|Prednisolone phosphate|prednisolone phosphate|mesh-list
110028944|NCT05768204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110028945|NCT05768204|Glucocorticoids|glucocorticoids|mesh-ancestor
110028947|NCT05768204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110028948|NCT05768204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110028949|NCT05768204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110028950|NCT05768204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110028951|NCT05768204|Antiemetics|antiemetics|mesh-ancestor
110028952|NCT05768204|Autonomic Agents|autonomic agents|mesh-ancestor
110028953|NCT05768204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110028954|NCT05768204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110028955|NCT05768204|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110028956|NCT05768204|Protective Agents|protective agents|mesh-ancestor
110028957|NCT05768126|Rivastigmine|rivastigmine|mesh-list
110028959|NCT05768126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110028960|NCT05768126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110028961|NCT05768126|Cholinergic Agents|cholinergic agents|mesh-ancestor
110028962|NCT05768126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110028963|NCT05768126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110028964|NCT05768126|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110028965|NCT05768126|Protective Agents|protective agents|mesh-ancestor
110028967|NCT05767827|Epinephrine|epinephrine|mesh-list
110028968|NCT05767827|Racepinephrine|racepinephrine|mesh-list
110028969|NCT05767827|Dexmedetomidine|dexmedetomidine|mesh-list
110028970|NCT05767827|Ropivacaine|ropivacaine|mesh-list
110028971|NCT05767827|Epinephryl borate|epinephryl borate|mesh-list
110028972|NCT05767827|Anesthetics, Local|anesthetics, local|mesh-ancestor
110028973|NCT05767827|Anesthetics|anesthetics|mesh-ancestor
110028974|NCT05767827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110028975|NCT05767827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110028976|NCT05767827|Sensory System Agents|sensory system agents|mesh-ancestor
110028977|NCT05767827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110028978|NCT05767827|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110028979|NCT05767827|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110028980|NCT05767827|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110028981|NCT05767827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110029211|NCT05379686|Glucagon|glucagon|mesh-list
110028989|NCT05767827|Adrenergic Agents|adrenergic agents|mesh-ancestor
110028990|NCT05767827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110028991|NCT05767827|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110028992|NCT05767827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110028993|NCT05767827|Autonomic Agents|autonomic agents|mesh-ancestor
110028994|NCT05767827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110028995|NCT05767827|Respiratory System Agents|respiratory system agents|mesh-ancestor
110028996|NCT05767827|Mydriatics|mydriatics|mesh-ancestor
110028997|NCT05767827|Sympathomimetics|sympathomimetics|mesh-ancestor
110029000|NCT05767723|Ticagrelor|ticagrelor|mesh-list
110029001|NCT05767723|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110029002|NCT05767723|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110029003|NCT05767723|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110029004|NCT05767723|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110029005|NCT05767723|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110029006|NCT05767723|Purinergic Agents|purinergic agents|mesh-ancestor
110029007|NCT05767723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110029008|NCT05767723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110029009|NCT05767723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029010|NCT05767723|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110029011|NCT05767723|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110029013|NCT05767723|Sensory System Agents|sensory system agents|mesh-ancestor
110029014|NCT05767723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110029015|NCT05767723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110029017|NCT05767723|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110029018|NCT05767723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110029019|NCT05767723|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110029020|NCT05767723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110029021|NCT05767723|Antipyretics|antipyretics|mesh-ancestor
110029022|NCT05767671|Dimercaprol|dimercaprol|mesh-list
110029023|NCT05767671|Chelating Agents|chelating agents|mesh-ancestor
110029024|NCT05767671|Sequestering Agents|sequestering agents|mesh-ancestor
110029025|NCT05767671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110029026|NCT05767632|Solifenacin Succinate|solifenacin succinate|mesh-list
110029028|NCT05767632|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110029029|NCT05767632|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110029030|NCT05767632|Cholinergic Agents|cholinergic agents|mesh-ancestor
110029031|NCT05767632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110029032|NCT05767632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110029033|NCT05767632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029034|NCT05767632|Urological Agents|urological agents|mesh-ancestor
110029035|NCT05767632|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110029036|NCT05767632|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110029037|NCT05767632|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110029038|NCT05767632|Adrenergic Agents|adrenergic agents|mesh-ancestor
110029040|NCT05767515|Acetylcarnitine|acetylcarnitine|mesh-list
110029041|NCT05767515|Metformin|metformin|mesh-list
110029042|NCT05767515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110029043|NCT05767515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029044|NCT05767515|Vitamin B Complex|vitamin b complex|mesh-ancestor
110029046|NCT05767515|Micronutrients|micronutrients|mesh-ancestor
110029047|NCT05767515|Nootropic Agents|nootropic agents|mesh-ancestor
110029048|NCT05767255|Insulin|insulin|mesh-list
110029049|NCT05767255|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110029050|NCT05767255|Insulin Glargine|insulin glargine|mesh-list
110029051|NCT05767255|Insulin Aspart|insulin aspart|mesh-list
110029052|NCT05767255|Liraglutide|liraglutide|mesh-list
110029053|NCT05767255|Xultophy|xultophy|mesh-list
110029054|NCT05767255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110029055|NCT05767255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029057|NCT05767255|Hormones|hormones|mesh-ancestor
110029131|NCT05631028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029062|NCT05767229|Adrenergic Agents|adrenergic agents|mesh-ancestor
110029063|NCT05767229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110029064|NCT05767229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110029065|NCT05767229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029066|NCT05767229|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110029067|NCT05767229|Antioxidants|antioxidants|mesh-ancestor
110029068|NCT05767229|Protective Agents|protective agents|mesh-ancestor
110029069|NCT05767229|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110029070|NCT05767229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110029071|NCT05767229|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110029073|NCT05767229|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110029074|NCT05767229|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110029075|NCT05767060|Antibodies, Bispecific|antibodies, bispecific|mesh-list
110029076|NCT05767060|Immunologic Factors|immunologic factors|mesh-ancestor
110029077|NCT05767060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029078|NCT05761431|Octreotide|octreotide|mesh-list
110029079|NCT05761431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110029080|NCT05761431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110029081|NCT05761431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110029082|NCT05755789|Cefoxitin|cefoxitin|mesh-list
110029083|NCT05755789|Cefotaxime|cefotaxime|mesh-list
110029084|NCT05755789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110029085|NCT05755789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110029086|NCT05753267|Mesalamine|mesalamine|mesh-list
110029088|NCT05753267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110029089|NCT05753267|Antimetabolites|antimetabolites|mesh-ancestor
110029090|NCT05753267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110029091|NCT05753267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110029092|NCT05753267|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110029093|NCT05753267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110029094|NCT05753267|Analgesics|analgesics|mesh-ancestor
110029095|NCT05753267|Sensory System Agents|sensory system agents|mesh-ancestor
110029096|NCT05753267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110029097|NCT05753267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029098|NCT05753267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110029099|NCT05753267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110029100|NCT05751343|Bevacizumab|bevacizumab|mesh-list
110029101|NCT05751343|Atezolizumab|atezolizumab|mesh-list
110029102|NCT05751343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110029103|NCT05751343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110029104|NCT05751343|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110029106|NCT05751343|Growth Substances|growth substances|mesh-ancestor
110029107|NCT05751343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029108|NCT05751343|Growth Inhibitors|growth inhibitors|mesh-ancestor
110029109|NCT05751343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110029110|NCT05751343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110029111|NCT05647681|Acetaminophen|acetaminophen|mesh-list
110029112|NCT05647681|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110029113|NCT05647681|Analgesics|analgesics|mesh-ancestor
110029114|NCT05647681|Sensory System Agents|sensory system agents|mesh-ancestor
110029115|NCT05647681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110029116|NCT05647681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029117|NCT05647681|Antipyretics|antipyretics|mesh-ancestor
110029118|NCT05644145|Vaccines|vaccines|mesh-list
110029119|NCT05644145|Immunologic Factors|immunologic factors|mesh-ancestor
110029120|NCT05644145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029121|NCT05642416|Ropivacaine|ropivacaine|mesh-list
110029122|NCT05642416|Anesthetics, Local|anesthetics, local|mesh-ancestor
110029123|NCT05642416|Anesthetics|anesthetics|mesh-ancestor
110029124|NCT05642416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110029125|NCT05642416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029126|NCT05642416|Sensory System Agents|sensory system agents|mesh-ancestor
110029127|NCT05642416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110029128|NCT05631028|Dexmedetomidine|dexmedetomidine|mesh-list
110029129|NCT05631028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110029130|NCT05631028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110029133|NCT05631028|Analgesics|analgesics|mesh-ancestor
110029134|NCT05631028|Sensory System Agents|sensory system agents|mesh-ancestor
110029135|NCT05631028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110029136|NCT05631028|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110029137|NCT05631028|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110029138|NCT05631028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110029139|NCT05631028|Adrenergic Agents|adrenergic agents|mesh-ancestor
110029140|NCT05631028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110029141|NCT05631028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110029142|NCT05604599|Fentanyl|fentanyl|mesh-list
110029143|NCT05604599|Dexmedetomidine|dexmedetomidine|mesh-list
110029144|NCT05604599|Propofol|propofol|mesh-list
110029145|NCT05604599|Isoflurane|isoflurane|mesh-list
110029146|NCT05604599|Atracurium|atracurium|mesh-list
110029147|NCT05604599|Cisatracurium|cisatracurium|mesh-list
110029148|NCT05604599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110029149|NCT05604599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110029150|NCT05604599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029151|NCT05604599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110029152|NCT05604599|Analgesics|analgesics|mesh-ancestor
110029153|NCT05604599|Sensory System Agents|sensory system agents|mesh-ancestor
110029154|NCT05604599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110029155|NCT05604599|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110029156|NCT05604599|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110029157|NCT05604599|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110029158|NCT05604599|Adrenergic Agents|adrenergic agents|mesh-ancestor
110029159|NCT05604599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110029160|NCT05604599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110029161|NCT05604599|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110029162|NCT05604599|Anesthetics, General|anesthetics, general|mesh-ancestor
110029164|NCT05604599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110029165|NCT05604599|Narcotics|narcotics|mesh-ancestor
110029166|NCT05604599|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110029167|NCT05604599|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110029168|NCT05604599|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110029169|NCT05604599|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110029170|NCT05604599|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110029171|NCT05604599|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
110029172|NCT05604599|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110029173|NCT05604599|Cholinergic Agents|cholinergic agents|mesh-ancestor
110029174|NCT05543837|Capsaicin|capsaicin|mesh-list
110029175|NCT05543837|Antipruritics|antipruritics|mesh-ancestor
110029177|NCT05543837|Sensory System Agents|sensory system agents|mesh-ancestor
110029178|NCT05543837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110029179|NCT05543837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029180|NCT05486026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110029181|NCT05486026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
110029182|NCT05486026|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110029183|NCT05486026|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110029184|NCT05486026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110029185|NCT05486026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110029186|NCT05486026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110029187|NCT05486026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110029188|NCT05486026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029190|NCT05486026|Sensory System Agents|sensory system agents|mesh-ancestor
110029191|NCT05486026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110029192|NCT05486026|Antidepressive Agents|antidepressive agents|mesh-ancestor
110029193|NCT05486026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110029194|NCT05486026|Dopamine Agents|dopamine agents|mesh-ancestor
110029195|NCT05486026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110029196|NCT05486026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110029198|NCT05468099|Povidone-Iodine|povidone-iodine|mesh-list
110029199|NCT05468099|Povidone|povidone|mesh-list
110029200|NCT05468099|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110029201|NCT05468099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110029202|NCT05468099|Disinfectants|disinfectants|mesh-ancestor
110029203|NCT05468099|Plasma Substitutes|plasma substitutes|mesh-ancestor
110029204|NCT05468099|Blood Substitutes|blood substitutes|mesh-ancestor
110029205|NCT05419427|Denosumab|denosumab|mesh-list
110029206|NCT05419427|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110029207|NCT05419427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029208|NCT05411107|Iloprost|iloprost|mesh-list
110029209|NCT05411107|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110029214|NCT05379686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110029216|NCT05334472|Ofatumumab|ofatumumab|mesh-list
110029217|NCT05334472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110029218|NCT05332067|Omalizumab|omalizumab|mesh-list
110029219|NCT05332067|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110029220|NCT05332067|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110029221|NCT05332067|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110029222|NCT05332067|Respiratory System Agents|respiratory system agents|mesh-ancestor
110029223|NCT05332067|Immunologic Factors|immunologic factors|mesh-ancestor
110029224|NCT05332067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029225|NCT05323890|Tislelizumab|tislelizumab|mesh-list
110029226|NCT05323890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110029227|NCT05323890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110029228|NCT05284019|Erenumab|erenumab|mesh-list
110029229|NCT05284019|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110029230|NCT05284019|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110029231|NCT05284019|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
110029232|NCT05284019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110029234|NCT05284019|Sensory System Agents|sensory system agents|mesh-ancestor
110029235|NCT05284019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110029236|NCT05284019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029237|NCT05284019|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110029238|NCT05284019|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110029239|NCT05284019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110029240|NCT05284019|Cholinergic Agents|cholinergic agents|mesh-ancestor
110029241|NCT05284019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110029242|NCT05249634|Testosterone|testosterone|mesh-list
110029243|NCT05249634|Androgens|androgens|mesh-ancestor
110029245|NCT05249634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110029246|NCT05249634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029247|NCT05217342|Diuretics|diuretics|mesh-list
110029248|NCT05217342|Natriuretic Agents|natriuretic agents|mesh-ancestor
110029249|NCT05217342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029250|NCT05199714|Pramlintide|pramlintide|mesh-list
110029251|NCT05199714|Pancrelipase|pancrelipase|mesh-list
110029254|NCT05199714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029255|NCT05193370|Vasopressins|vasopressins|mesh-list
110029258|NCT05193370|Giapreza|giapreza|mesh-list
110029259|NCT05193370|Angiotensinogen|angiotensinogen|mesh-list
110029260|NCT05193370|Hemostatics|hemostatics|mesh-ancestor
110029261|NCT05193370|Coagulants|coagulants|mesh-ancestor
110029262|NCT05193370|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110029263|NCT05193370|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110029264|NCT05193370|Natriuretic Agents|natriuretic agents|mesh-ancestor
110029265|NCT05193370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029266|NCT05193370|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110029267|NCT05193370|Protease Inhibitors|protease inhibitors|mesh-ancestor
110029268|NCT05193370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110029269|NCT05193370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110029276|NCT05172947|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110029277|NCT05170607|Antibodies|antibodies|mesh-list
110029278|NCT05170607|Immunologic Factors|immunologic factors|mesh-ancestor
110029279|NCT05170607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029281|NCT05147220|Remibrutinib|remibrutinib|mesh-list
110029282|NCT05147220|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110029283|NCT05147220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110029284|NCT05147220|Analgesics|analgesics|mesh-ancestor
110029285|NCT05147220|Sensory System Agents|sensory system agents|mesh-ancestor
110029286|NCT05147220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110029287|NCT05147220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029288|NCT05147220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110029289|NCT05147220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110029290|NCT05147220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110029291|NCT05147220|Immunologic Factors|immunologic factors|mesh-ancestor
110029292|NCT05147220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110029293|NCT05147220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110029294|NCT05147220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110029296|NCT05078827|Antimetabolites|antimetabolites|mesh-ancestor
110029297|NCT05078827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110029303|NCT05076981|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110029304|NCT05076981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110029305|NCT05076981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029306|NCT05065164|Denosumab|denosumab|mesh-list
110029307|NCT05065164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110029308|NCT05065164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029309|NCT05057819|Empagliflozin|empagliflozin|mesh-list
110029310|NCT05057819|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110029311|NCT05057819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110029312|NCT05057819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110029313|NCT05057819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029314|NCT05037812|Ketorolac|ketorolac|mesh-list
110029315|NCT05037812|Clonidine|clonidine|mesh-list
110029316|NCT05037812|Epinephrine|epinephrine|mesh-list
110029317|NCT05037812|Morphine|morphine|mesh-list
110029318|NCT05037812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110029319|NCT05037812|Narcotics|narcotics|mesh-ancestor
110029320|NCT05037812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110029321|NCT05037812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029322|NCT05037812|Analgesics|analgesics|mesh-ancestor
110029323|NCT05037812|Sensory System Agents|sensory system agents|mesh-ancestor
110029324|NCT05037812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110029325|NCT05037812|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110029326|NCT05037812|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110029327|NCT05037812|Adrenergic Agents|adrenergic agents|mesh-ancestor
110029328|NCT05037812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110029329|NCT05037812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110029330|NCT05037812|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110029331|NCT05037812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110029332|NCT05037812|Autonomic Agents|autonomic agents|mesh-ancestor
110029333|NCT05037812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110029334|NCT05037812|Respiratory System Agents|respiratory system agents|mesh-ancestor
110029335|NCT05037812|Mydriatics|mydriatics|mesh-ancestor
110029336|NCT05037812|Sympathomimetics|sympathomimetics|mesh-ancestor
110029337|NCT05037812|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110029338|NCT05037812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110029339|NCT05037812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110029340|NCT05037812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110029341|NCT05037812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110029342|NCT05037812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110029343|NCT05037812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110029344|NCT05037812|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110029345|NCT05037812|Sympatholytics|sympatholytics|mesh-ancestor
110029346|NCT05037812|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110029348|NCT05019638|Epinephrine|epinephrine|mesh-list
110029349|NCT05019638|Racepinephrine|racepinephrine|mesh-list
110029351|NCT05019638|Bupivacaine|bupivacaine|mesh-list
110029352|NCT05019638|Epinephryl borate|epinephryl borate|mesh-list
110029353|NCT05019638|Anesthetics, Local|anesthetics, local|mesh-ancestor
110029354|NCT05019638|Anesthetics|anesthetics|mesh-ancestor
110029355|NCT05019638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110029356|NCT05019638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029357|NCT05019638|Sensory System Agents|sensory system agents|mesh-ancestor
110029358|NCT05019638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110029359|NCT05019638|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110029360|NCT05019638|Narcotics|narcotics|mesh-ancestor
110029361|NCT05019638|Analgesics|analgesics|mesh-ancestor
110029362|NCT05019638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110029363|NCT05019638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110029364|NCT05019638|Adrenergic Agents|adrenergic agents|mesh-ancestor
110029365|NCT05019638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110029366|NCT05019638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110029368|NCT05019638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110029369|NCT05019638|Autonomic Agents|autonomic agents|mesh-ancestor
110029370|NCT05019638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110029371|NCT05019638|Respiratory System Agents|respiratory system agents|mesh-ancestor
110029380|NCT05019638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110029381|NCT04905979|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110029382|NCT04905979|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110029383|NCT04905979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110029384|NCT04905979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110029385|NCT04905979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110029386|NCT04905979|Adrenergic Agents|adrenergic agents|mesh-ancestor
110029387|NCT04905979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110029388|NCT04905979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029389|NCT04854512|Metformin|metformin|mesh-list
110029390|NCT04854512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110029391|NCT04854512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029392|NCT04806386|Psyllium|psyllium|mesh-list
110029393|NCT04806386|Cathartics|cathartics|mesh-ancestor
110029394|NCT04806386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110029395|NCT04804072|Analgesics, Opioid|analgesics, opioid|mesh-list
110029396|NCT04804072|Narcotics|narcotics|mesh-ancestor
110029397|NCT04804072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110029399|NCT04804072|Analgesics|analgesics|mesh-ancestor
110029400|NCT04804072|Sensory System Agents|sensory system agents|mesh-ancestor
110029401|NCT04804072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110029402|NCT04797156|Tranexamic Acid|tranexamic acid|mesh-list
110029403|NCT04797156|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110029404|NCT04797156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110029405|NCT04797156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110029406|NCT04797156|Hemostatics|hemostatics|mesh-ancestor
110029407|NCT04797156|Coagulants|coagulants|mesh-ancestor
110029408|NCT04772300|Sirolimus|sirolimus|mesh-list
110029409|NCT04772300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110029410|NCT04772300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110029411|NCT04772300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110029412|NCT04772300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110029413|NCT04772300|Antifungal Agents|antifungal agents|mesh-ancestor
110029414|NCT04772300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110029415|NCT04772300|Immunologic Factors|immunologic factors|mesh-ancestor
110029416|NCT04772300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029417|NCT04759144|Insulin|insulin|mesh-list
110029418|NCT04759144|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110029419|NCT04759144|Insulin Aspart|insulin aspart|mesh-list
110029420|NCT04759144|Insulin, Long-Acting|insulin, long-acting|mesh-list
110029421|NCT04759144|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110029422|NCT04759144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110029423|NCT04759144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029426|NCT04724031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110029427|NCT04724031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110029429|NCT04679376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110029430|NCT04679376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110029431|NCT04679376|Antimetabolites|antimetabolites|mesh-ancestor
110029432|NCT04679376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110029433|NCT04679376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110029438|NCT04677959|Albuterol|albuterol|mesh-list
110029439|NCT04677959|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110029440|NCT04677959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110029441|NCT04677959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110029442|NCT04677959|Autonomic Agents|autonomic agents|mesh-ancestor
110029443|NCT04677959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110029444|NCT04677959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029445|NCT04677959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110029446|NCT04677959|Respiratory System Agents|respiratory system agents|mesh-ancestor
110029447|NCT04677959|Dermatologic Agents|dermatologic agents|mesh-ancestor
110029448|NCT04677959|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110029449|NCT04677959|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110029450|NCT04677959|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110029455|NCT04677959|Tocolytic Agents|tocolytic agents|mesh-ancestor
110029456|NCT04677959|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110029458|NCT04671043|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110029459|NCT04671043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029460|NCT04671043|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110029461|NCT04671043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110029462|NCT04671043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110029463|NCT04671043|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110029464|NCT04671043|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110029465|NCT04671043|Purinergic Agents|purinergic agents|mesh-ancestor
110029466|NCT04671043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110029468|NCT04612920|Ibuprofen|ibuprofen|mesh-list
110029469|NCT04612920|Oxycodone|oxycodone|mesh-list
110029470|NCT04612920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110029471|NCT04612920|Analgesics|analgesics|mesh-ancestor
110029472|NCT04612920|Sensory System Agents|sensory system agents|mesh-ancestor
110029473|NCT04612920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110029474|NCT04612920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029476|NCT04612920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110029477|NCT04612920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110029478|NCT04612920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110029479|NCT04612920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110029480|NCT04612920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110029481|NCT04612920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110029482|NCT04612920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110029483|NCT04612920|Narcotics|narcotics|mesh-ancestor
110029484|NCT04612920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110029486|NCT04570293|Anesthetics, Local|anesthetics, local|mesh-ancestor
110029488|NCT04570293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110029489|NCT04570293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029490|NCT04570293|Sensory System Agents|sensory system agents|mesh-ancestor
110029491|NCT04570293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110029492|NCT04570293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110029493|NCT04570293|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110029494|NCT04570293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110029495|NCT04570293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110029496|NCT04570293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110029497|NCT04531462|Empagliflozin|empagliflozin|mesh-list
110029498|NCT04531462|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110029499|NCT04531462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110029500|NCT04531462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110029501|NCT04531462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029502|NCT04520139|Acetylcysteine|acetylcysteine|mesh-list
110029503|NCT04520139|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110029504|NCT04520139|Antiviral Agents|antiviral agents|mesh-ancestor
110029505|NCT04520139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110029506|NCT04520139|Expectorants|expectorants|mesh-ancestor
110029507|NCT04520139|Respiratory System Agents|respiratory system agents|mesh-ancestor
110029508|NCT04520139|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110029509|NCT04520139|Antioxidants|antioxidants|mesh-ancestor
110029510|NCT04520139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110029511|NCT04520139|Protective Agents|protective agents|mesh-ancestor
110029512|NCT04520139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029513|NCT04520139|Antidotes|antidotes|mesh-ancestor
110029514|NCT04512105|Venetoclax|venetoclax|mesh-list
110029515|NCT04512105|Pitavastatin|pitavastatin|mesh-list
110029516|NCT04512105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110029517|NCT04512105|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110029518|NCT04512105|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110029519|NCT04512105|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110029520|NCT04512105|Antimetabolites|antimetabolites|mesh-ancestor
110029521|NCT04512105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110029522|NCT04512105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110029523|NCT04512105|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110029524|NCT04501120|Azacitidine|azacitidine|mesh-list
110029525|NCT04501120|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110029526|NCT04501120|Antimetabolites|antimetabolites|mesh-ancestor
110029527|NCT04501120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110029529|NCT04501120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110029530|NCT04477317|Epinephrine|epinephrine|mesh-list
110029531|NCT04477317|Racepinephrine|racepinephrine|mesh-list
110029533|NCT04477317|Carticaine|carticaine|mesh-list
110029534|NCT04477317|Mepivacaine|mepivacaine|mesh-list
110029535|NCT04477317|Epinephryl borate|epinephryl borate|mesh-list
110029536|NCT04477317|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110029537|NCT04477317|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110029538|NCT04477317|Adrenergic Agents|adrenergic agents|mesh-ancestor
110029539|NCT04477317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110029540|NCT04477317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110029541|NCT04477317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029542|NCT04477317|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110029543|NCT04477317|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110029545|NCT04477317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110029546|NCT04477317|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110029547|NCT04477317|Respiratory System Agents|respiratory system agents|mesh-ancestor
110029548|NCT04477317|Mydriatics|mydriatics|mesh-ancestor
110029549|NCT04477317|Sympathomimetics|sympathomimetics|mesh-ancestor
110029550|NCT04477317|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110029551|NCT04477317|Anesthetics, Local|anesthetics, local|mesh-ancestor
110029552|NCT04477317|Anesthetics|anesthetics|mesh-ancestor
110029553|NCT04477317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110029555|NCT04469959|Levodopa|levodopa|mesh-list
110029556|NCT04469959|Carbidopa|carbidopa|mesh-list
110029557|NCT04469959|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110029558|NCT04469959|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110029559|NCT04469959|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110029560|NCT04469959|Dopamine Agents|dopamine agents|mesh-ancestor
110029561|NCT04469959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110029562|NCT04469959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110029563|NCT04469959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029564|NCT04469959|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110029565|NCT04469959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110029566|NCT04469959|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110029567|NCT04469959|Immunologic Factors|immunologic factors|mesh-ancestor
110029568|NCT04469959|Dopamine Agonists|dopamine agonists|mesh-ancestor
110029570|NCT04434196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110029571|NCT04434196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110029572|NCT04344262|Atracurium|atracurium|mesh-list
110029573|NCT04344262|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110029576|NCT04344262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110029577|NCT04344262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029578|NCT04344262|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
110029579|NCT04344262|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110029580|NCT04344262|Cholinergic Agents|cholinergic agents|mesh-ancestor
110029581|NCT04344262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110029582|NCT04344262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110029583|NCT04330638|Siltuximab|siltuximab|mesh-list
110029584|NCT04330638|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110029585|NCT04330638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110029586|NCT04330638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110029587|NCT04291521|Ketamine|ketamine|mesh-list
110029588|NCT04291521|Propofol|propofol|mesh-list
110029590|NCT04291521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110029591|NCT04291521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110029592|NCT04291521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029593|NCT04291521|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110029594|NCT04291521|Anesthetics, General|anesthetics, general|mesh-ancestor
110029595|NCT04291521|Anesthetics|anesthetics|mesh-ancestor
110029596|NCT04291521|Analgesics|analgesics|mesh-ancestor
110029597|NCT04291521|Sensory System Agents|sensory system agents|mesh-ancestor
110029598|NCT04291521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110029599|NCT04291521|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110029600|NCT04291521|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110029601|NCT04291521|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110029603|NCT04291521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110029604|NCT04288427|Finasteride|finasteride|mesh-list
110029605|NCT04288427|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110029606|NCT04288427|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110029607|NCT04288427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110029685|NCT03965689|Mitosis Modulators|mitosis modulators|mesh-ancestor
110029614|NCT04280601|Vitamins|vitamins|mesh-ancestor
110029615|NCT04280601|Micronutrients|micronutrients|mesh-ancestor
110029616|NCT04280601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029618|NCT04263064|Clonidine|clonidine|mesh-list
110029619|NCT04263064|Analgesics|analgesics|mesh-ancestor
110029620|NCT04263064|Sensory System Agents|sensory system agents|mesh-ancestor
110029621|NCT04263064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110029622|NCT04263064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029623|NCT04263064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110029624|NCT04263064|Sympatholytics|sympatholytics|mesh-ancestor
110029625|NCT04263064|Autonomic Agents|autonomic agents|mesh-ancestor
110029626|NCT04263064|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110029627|NCT04263064|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110029629|NCT04263064|Adrenergic Agents|adrenergic agents|mesh-ancestor
110029630|NCT04263064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110029631|NCT04263064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110029632|NCT04131309|Dexamethasone|dexamethasone|mesh-list
110029633|NCT04131309|Bortezomib|bortezomib|mesh-list
110029634|NCT04131309|Daratumumab|daratumumab|mesh-list
110029635|NCT04131309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110029636|NCT04131309|Antiemetics|antiemetics|mesh-ancestor
110029637|NCT04131309|Autonomic Agents|autonomic agents|mesh-ancestor
110029638|NCT04131309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110029639|NCT04131309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029640|NCT04131309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110029641|NCT04131309|Glucocorticoids|glucocorticoids|mesh-ancestor
110029642|NCT04131309|Hormones|hormones|mesh-ancestor
110029643|NCT04131309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110029644|NCT04131309|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110029645|NCT04131309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110029646|NCT04125134|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110029647|NCT04125134|Lubricant Eye Drops|lubricant eye drops|mesh-list
110029648|NCT04125134|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110029650|NCT04090567|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
110029652|NCT04090567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110029653|NCT04090567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110029654|NCT04090567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110029655|NCT04090567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110029657|NCT04061746|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110029658|NCT04061746|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110029659|NCT04040959|Niacinamide|niacinamide|mesh-list
110029661|NCT04040959|Nicotinic Acids|nicotinic acids|mesh-list
110029662|NCT04040959|Vitamin B Complex|vitamin b complex|mesh-ancestor
110029663|NCT04040959|Vitamins|vitamins|mesh-ancestor
110029664|NCT04040959|Micronutrients|micronutrients|mesh-ancestor
110029665|NCT04040959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029666|NCT04040959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110029667|NCT04040959|Antimetabolites|antimetabolites|mesh-ancestor
110029668|NCT04040959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110029669|NCT04040959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110029670|NCT04040959|Vasodilator Agents|vasodilator agents|mesh-ancestor
110029671|NCT04035031|Dapagliflozin|dapagliflozin|mesh-list
110029672|NCT04035031|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110029673|NCT04035031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110029674|NCT04035031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110029675|NCT04035031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029676|NCT03965689|Paclitaxel|paclitaxel|mesh-list
110029677|NCT03965689|Carboplatin|carboplatin|mesh-list
110029678|NCT03965689|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110029679|NCT03965689|Enzyme Inhibitors|enzyme inhibitors|mesh-list
110029681|NCT03965689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110029682|NCT03965689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110029683|NCT03965689|Tubulin Modulators|tubulin modulators|mesh-ancestor
110029684|NCT03965689|Antimitotic Agents|antimitotic agents|mesh-ancestor
110029699|NCT03786783|Cyclophosphamide|cyclophosphamide|mesh-list
110029700|NCT03786783|Melphalan|melphalan|mesh-list
110029701|NCT03786783|Mechlorethamine|mechlorethamine|mesh-list
110029702|NCT03786783|Thiotepa|thiotepa|mesh-list
110029703|NCT03786783|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
110029704|NCT03786783|Cisplatin|cisplatin|mesh-list
110029705|NCT03786783|Carboplatin|carboplatin|mesh-list
110029706|NCT03786783|Doxorubicin|doxorubicin|mesh-list
110029707|NCT03786783|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110029708|NCT03786783|Etoposide|etoposide|mesh-list
110029709|NCT03786783|Vincristine|vincristine|mesh-list
110029710|NCT03786783|Etoposide phosphate|etoposide phosphate|mesh-list
110029711|NCT03786783|Daunorubicin|daunorubicin|mesh-list
110029712|NCT03786783|Topotecan|topotecan|mesh-list
110029713|NCT03786783|Tretinoin|tretinoin|mesh-list
110029714|NCT03786783|Podophyllotoxin|podophyllotoxin|mesh-list
110029715|NCT03786783|Dinutuximab|dinutuximab|mesh-list
110029717|NCT03786783|Razoxane|razoxane|mesh-list
110029718|NCT03786783|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|mesh-list
110029719|NCT03786783|Isotretinoin|isotretinoin|mesh-list
110029720|NCT03786783|Sargramostim|sargramostim|mesh-list
110029721|NCT03786783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110029722|NCT03786783|Immunologic Factors|immunologic factors|mesh-ancestor
110029723|NCT03786783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029724|NCT03786783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110029725|NCT03786783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110029726|NCT03786783|Alkylating Agents|alkylating agents|mesh-ancestor
110029727|NCT03786783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110029728|NCT03786783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110029729|NCT03786783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110029730|NCT03786783|Vitamins|vitamins|mesh-ancestor
110029731|NCT03786783|Micronutrients|micronutrients|mesh-ancestor
110029732|NCT03786783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110029733|NCT03786783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110029734|NCT03786783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110029735|NCT03786783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110029736|NCT03786783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110029738|NCT03786783|Antimitotic Agents|antimitotic agents|mesh-ancestor
110029740|NCT03786783|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110029742|NCT03786783|Dermatologic Agents|dermatologic agents|mesh-ancestor
110029743|NCT03786783|Protective Agents|protective agents|mesh-ancestor
110029744|NCT03786783|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110029745|NCT03785587|Bromides|bromides|mesh-list
110029746|NCT03785587|Anticonvulsants|anticonvulsants|mesh-ancestor
110029747|NCT03769181|Cemiplimab|cemiplimab|mesh-list
110029748|NCT03769181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110029749|NCT03769181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110029757|NCT03670056|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110029758|NCT03670056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110029759|NCT03654833|Bevacizumab|bevacizumab|mesh-list
110029760|NCT03654833|Pembrolizumab|pembrolizumab|mesh-list
110029761|NCT03654833|Atezolizumab|atezolizumab|mesh-list
110029762|NCT03654833|Niraparib|niraparib|mesh-list
110029763|NCT03654833|Rucaparib|rucaparib|mesh-list
110029764|NCT03654833|Dostarlimab|dostarlimab|mesh-list
110029765|NCT03654833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110029772|NCT03654833|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110029773|NCT03654833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110029774|NCT03654833|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110029777|NCT03635333|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110029778|NCT03635333|Autonomic Agents|autonomic agents|mesh-ancestor
110029779|NCT03635333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110029780|NCT03635333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029781|NCT03635333|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110029782|NCT03635333|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110029783|NCT03635333|Cholinergic Agents|cholinergic agents|mesh-ancestor
110029784|NCT03635333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110029785|NCT03635333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110029786|NCT03634839|Nicotine|nicotine|mesh-list
110029787|NCT03634839|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110029788|NCT03634839|Autonomic Agents|autonomic agents|mesh-ancestor
110029789|NCT03634839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110029790|NCT03634839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029791|NCT03634839|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110029792|NCT03634839|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110029793|NCT03634839|Cholinergic Agents|cholinergic agents|mesh-ancestor
110029794|NCT03634839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110029795|NCT03634839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110029796|NCT03426904|Leucovorin|leucovorin|mesh-list
110029797|NCT03426904|Fluorouracil|fluorouracil|mesh-list
110029798|NCT03426904|Oxaliplatin|oxaliplatin|mesh-list
110029799|NCT03426904|Antimetabolites|antimetabolites|mesh-ancestor
110029800|NCT03426904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110029801|NCT03426904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110029802|NCT03426904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110029803|NCT03426904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110029804|NCT03426904|Immunologic Factors|immunologic factors|mesh-ancestor
110029805|NCT03426904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029806|NCT03426904|Antidotes|antidotes|mesh-ancestor
110029807|NCT03426904|Protective Agents|protective agents|mesh-ancestor
110029808|NCT03426904|Vitamin B Complex|vitamin b complex|mesh-ancestor
110029809|NCT03426904|Vitamins|vitamins|mesh-ancestor
110029810|NCT03426904|Micronutrients|micronutrients|mesh-ancestor
110029811|NCT03361072|Immunomodulating Agents|immunomodulating agents|mesh-list
110029812|NCT03361072|Immunologic Factors|immunologic factors|mesh-ancestor
110029813|NCT03361072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029815|NCT03287778|Vitamin B 6|vitamin b 6|mesh-list
110029816|NCT03287778|Vitamins|vitamins|mesh-ancestor
110029817|NCT03287778|Micronutrients|micronutrients|mesh-ancestor
110029818|NCT03287778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029819|NCT03287778|Vitamin B Complex|vitamin b complex|mesh-ancestor
110029820|NCT03273413|Pravastatin|pravastatin|mesh-list
110029821|NCT03273413|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110029822|NCT03273413|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110029823|NCT03273413|Antimetabolites|antimetabolites|mesh-ancestor
110029824|NCT03273413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110029825|NCT03273413|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110029826|NCT03273413|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110029827|NCT03273413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110029835|NCT03074539|Enzyme Activators|enzyme activators|mesh-ancestor
110029836|NCT03074539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110029838|NCT03030131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110029839|NCT03030131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110029841|NCT03011021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110029842|NCT03011021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029843|NCT03011021|Incretins|incretins|mesh-ancestor
110029844|NCT03011021|Hormones|hormones|mesh-ancestor
110029845|NCT03011021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110029869|NCT02834637|Immunologic Factors|immunologic factors|mesh-ancestor
110029870|NCT02834637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029873|NCT02817360|Carvedilol|carvedilol|mesh-list
110029874|NCT02817360|Candesartan|candesartan|mesh-list
110029875|NCT02817360|Ramipril|ramipril|mesh-list
110029876|NCT02817360|Enalapril|enalapril|mesh-list
110029877|NCT02817360|Lisinopril|lisinopril|mesh-list
110029878|NCT02817360|Irbesartan|irbesartan|mesh-list
110029879|NCT02817360|Nebivolol|nebivolol|mesh-list
110029880|NCT02817360|Bisoprolol|bisoprolol|mesh-list
110029881|NCT02817360|Perindopril|perindopril|mesh-list
110029882|NCT02817360|Captopril|captopril|mesh-list
110029883|NCT02817360|Quinapril|quinapril|mesh-list
110029884|NCT02817360|Trandolapril|trandolapril|mesh-list
110029885|NCT02817360|Fosinopril|fosinopril|mesh-list
110029886|NCT02817360|Eprosartan|eprosartan|mesh-list
110029887|NCT02817360|Zofenopril|zofenopril|mesh-list
110029888|NCT02817360|Spirapril|spirapril|mesh-list
110029889|NCT02817360|Cilazapril|cilazapril|mesh-list
110029890|NCT02817360|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110029891|NCT02817360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110029892|NCT02817360|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110029893|NCT02817360|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110029894|NCT02817360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110029895|NCT02817360|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110029896|NCT02817360|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110029897|NCT02817360|Adrenergic Agents|adrenergic agents|mesh-ancestor
110029898|NCT02817360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110029899|NCT02817360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029901|NCT02817360|Protective Agents|protective agents|mesh-ancestor
110029902|NCT02817360|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110029903|NCT02817360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110029904|NCT02817360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110029905|NCT02817360|Vasodilator Agents|vasodilator agents|mesh-ancestor
110029907|NCT02817360|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110029908|NCT02817360|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110029909|NCT02817360|Protease Inhibitors|protease inhibitors|mesh-ancestor
110029910|NCT02817360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110029911|NCT02817360|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110029912|NCT02817360|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110029913|NCT02817360|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110029914|NCT02817360|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110029915|NCT02817360|Sympatholytics|sympatholytics|mesh-ancestor
110029916|NCT02817360|Autonomic Agents|autonomic agents|mesh-ancestor
110029917|NCT02817360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110029918|NCT02817360|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110029919|NCT02817360|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
110029921|NCT02743806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110029922|NCT02689778|Pirfenidone|pirfenidone|mesh-list
110029923|NCT02689778|Analgesics|analgesics|mesh-ancestor
110029924|NCT02689778|Sensory System Agents|sensory system agents|mesh-ancestor
110029925|NCT02689778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110029926|NCT02689778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029927|NCT02689778|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110029928|NCT02689778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110029929|NCT02689778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110029939|NCT02678377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110029941|NCT02678377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110029942|NCT02659384|Aspirin|aspirin|mesh-list
110029943|NCT02659384|Bevacizumab|bevacizumab|mesh-list
110029944|NCT02659384|Atezolizumab|atezolizumab|mesh-list
110029945|NCT02659384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110029946|NCT02659384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110029947|NCT02659384|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110029948|NCT02659384|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110029949|NCT02659384|Growth Substances|growth substances|mesh-ancestor
110029950|NCT02659384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029951|NCT02659384|Growth Inhibitors|growth inhibitors|mesh-ancestor
110029952|NCT02659384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110029953|NCT02659384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110029954|NCT02659384|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110029955|NCT02659384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110029956|NCT02659384|Analgesics|analgesics|mesh-ancestor
110029957|NCT02659384|Sensory System Agents|sensory system agents|mesh-ancestor
110029958|NCT02659384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110029959|NCT02659384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110029960|NCT02659384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110029961|NCT02659384|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110029962|NCT02659384|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110029963|NCT02659384|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110029964|NCT02659384|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110029965|NCT02659384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110029966|NCT02659384|Antipyretics|antipyretics|mesh-ancestor
110029967|NCT02659306|Metformin|metformin|mesh-list
110029968|NCT02659306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110029969|NCT02659306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029970|NCT02591147|Fluorides|fluorides|mesh-list
110029971|NCT02591147|Cariostatic Agents|cariostatic agents|mesh-ancestor
110029972|NCT02591147|Protective Agents|protective agents|mesh-ancestor
110029973|NCT02591147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029974|NCT02588872|Hyaluronic Acid|hyaluronic acid|mesh-list
110029975|NCT02588872|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110029976|NCT02588872|Immunologic Factors|immunologic factors|mesh-ancestor
110029977|NCT02588872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029979|NCT02588872|Protective Agents|protective agents|mesh-ancestor
110029980|NCT02538510|Pembrolizumab|pembrolizumab|mesh-list
110029981|NCT02538510|Vorinostat|vorinostat|mesh-list
110029982|NCT02538510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110029983|NCT02538510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110029984|NCT02538510|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110029985|NCT02538510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110029986|NCT02538510|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110029987|NCT02538510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110029988|NCT02419040|Lidocaine|lidocaine|mesh-list
110029989|NCT02419040|Anesthetics, Local|anesthetics, local|mesh-ancestor
110029990|NCT02419040|Anesthetics|anesthetics|mesh-ancestor
110029991|NCT02419040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110029992|NCT02419040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029993|NCT02419040|Sensory System Agents|sensory system agents|mesh-ancestor
110029994|NCT02419040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110029995|NCT02419040|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110029996|NCT02419040|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110029997|NCT02419040|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110029998|NCT02419040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110030008|NCT02387203|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110030009|NCT02387203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110030011|NCT02387203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110030012|NCT02387203|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110030013|NCT02381353|Bupivacaine|bupivacaine|mesh-list
110030014|NCT02381353|Anesthetics, Local|anesthetics, local|mesh-ancestor
110030015|NCT02381353|Anesthetics|anesthetics|mesh-ancestor
110030016|NCT02381353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110030017|NCT02381353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110030018|NCT02381353|Sensory System Agents|sensory system agents|mesh-ancestor
110030019|NCT02381353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110030020|NCT02296229|Androgens|androgens|mesh-list
110030021|NCT02296229|Hormones|hormones|mesh-ancestor
110030022|NCT02296229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110030023|NCT02296229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110030024|NCT02192398|Guanfacine|guanfacine|mesh-list
110030025|NCT02192398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110030026|NCT02192398|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110030027|NCT02192398|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110030028|NCT02192398|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110030029|NCT02192398|Adrenergic Agents|adrenergic agents|mesh-ancestor
110030030|NCT02192398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110030031|NCT02192398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030032|NCT02192398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110030033|NCT01992653|Prednisone|prednisone|mesh-list
110030034|NCT01992653|Prednisolone|prednisolone|mesh-list
110030035|NCT01992653|Cyclophosphamide|cyclophosphamide|mesh-list
110030036|NCT01992653|Rituximab|rituximab|mesh-list
110030038|NCT01992653|Obinutuzumab|obinutuzumab|mesh-list
110030039|NCT01992653|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
110030040|NCT01992653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110030041|NCT01992653|Immunologic Factors|immunologic factors|mesh-ancestor
110030042|NCT01992653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110030043|NCT01992653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110030044|NCT01992653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110030045|NCT01992653|Alkylating Agents|alkylating agents|mesh-ancestor
110030046|NCT01992653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030047|NCT01992653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110030048|NCT01992653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110030049|NCT01992653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110030050|NCT01992653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110030051|NCT01992653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110030052|NCT01992653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110030053|NCT01992653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110030054|NCT01992653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110030055|NCT01992653|Glucocorticoids|glucocorticoids|mesh-ancestor
110030057|NCT01992653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110030058|NCT01992653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110030059|NCT01992653|Immunoconjugates|immunoconjugates|mesh-ancestor
110030060|NCT01850303|Gemcitabine|gemcitabine|mesh-list
110030062|NCT01850303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110030063|NCT01850303|Antimetabolites|antimetabolites|mesh-ancestor
110030064|NCT01850303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030065|NCT01850303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110030073|NCT01763671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110030074|NCT01763671|Tubulin Modulators|tubulin modulators|mesh-ancestor
110030075|NCT01763671|Antimitotic Agents|antimitotic agents|mesh-ancestor
110030076|NCT01763671|Mitosis Modulators|mitosis modulators|mesh-ancestor
110030077|NCT01763671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030078|NCT01763671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110030079|NCT01763671|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110030080|NCT01763671|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110030081|NCT01763671|Growth Substances|growth substances|mesh-ancestor
110030082|NCT01763671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110030083|NCT01763671|Growth Inhibitors|growth inhibitors|mesh-ancestor
110030084|NCT01696435|Vitamin D|vitamin d|mesh-list
110030085|NCT01696435|Ergocalciferols|ergocalciferols|mesh-list
110030086|NCT01696435|Cholecalciferol|cholecalciferol|mesh-list
110030087|NCT01696435|Vitamins|vitamins|mesh-list
110030088|NCT01696435|Micronutrients|micronutrients|mesh-ancestor
110030089|NCT01696435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110030090|NCT01696435|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110030091|NCT01696435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110030093|NCT01681264|Morphine|morphine|mesh-list
110030094|NCT01681264|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110030095|NCT01681264|Narcotics|narcotics|mesh-ancestor
110030096|NCT01681264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110030097|NCT01681264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110030098|NCT01681264|Analgesics|analgesics|mesh-ancestor
110030099|NCT01681264|Sensory System Agents|sensory system agents|mesh-ancestor
110030100|NCT01681264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110030101|NCT01681264|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110030102|NCT01681264|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110030103|NCT01681264|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110030104|NCT01681264|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110030105|NCT01681264|Adrenergic Agents|adrenergic agents|mesh-ancestor
110030106|NCT01681264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110030107|NCT01681264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030108|NCT01654276|Febuxostat|febuxostat|mesh-list
110030109|NCT01654276|Gout Suppressants|gout suppressants|mesh-ancestor
110030110|NCT01654276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110030111|NCT01527591|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110030112|NCT01527591|Immunologic Factors|immunologic factors|mesh-ancestor
110030113|NCT01527591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110030114|NCT00590122|Levodopa|levodopa|mesh-list
110030115|NCT00590122|Carbidopa|carbidopa|mesh-list
110030116|NCT00590122|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110030117|NCT00590122|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110030118|NCT00590122|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110030119|NCT00590122|Dopamine Agents|dopamine agents|mesh-ancestor
110030120|NCT00590122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110030121|NCT00590122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030122|NCT00590122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110030123|NCT00590122|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110030124|NCT00590122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110030125|NCT00590122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110030126|NCT00590122|Immunologic Factors|immunologic factors|mesh-ancestor
110030127|NCT00590122|Dopamine Agonists|dopamine agonists|mesh-ancestor
110030128|NCT00309192|Triamcinolone|triamcinolone|mesh-list
110030130|NCT00309192|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110030131|NCT00309192|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110030132|NCT00309192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110030133|NCT00309192|Glucocorticoids|glucocorticoids|mesh-ancestor
110030135|NCT00309192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110030136|NCT00309192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110030137|NCT00309192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110030138|NCT00309192|Immunologic Factors|immunologic factors|mesh-ancestor
110030139|NCT00309192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110030140|NCT00309192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030148|NCT00110591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110030149|NCT01689246|Methylene Blue|methylene blue|mesh-list
110030150|NCT01689246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110030151|NCT01689246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030152|NCT01685268|Prednisone|prednisone|mesh-list
110030153|NCT01685268|Prednisolone|prednisolone|mesh-list
110030154|NCT01685268|Abiraterone Acetate|abiraterone acetate|mesh-list
110030155|NCT01685268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110030156|NCT01685268|Glucocorticoids|glucocorticoids|mesh-ancestor
110030157|NCT01685268|Hormones|hormones|mesh-ancestor
110030158|NCT01685268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110030159|NCT01685268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110030160|NCT01685268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110030161|NCT01685268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110030162|NCT01685268|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110030163|NCT01685268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110030164|NCT01685268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030165|NCT01685268|Hormone Antagonists|hormone antagonists|mesh-ancestor
110030166|NCT01685268|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110030167|NCT01683786|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110030168|NCT01683786|Antiviral Agents|antiviral agents|mesh-ancestor
110030169|NCT01683786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110030171|NCT01683084|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110030172|NCT01683084|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110030173|NCT01683084|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110030174|NCT01683084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030175|NCT04823442|Bisoprolol|bisoprolol|mesh-list
110030176|NCT04823442|Mirabegron|mirabegron|mesh-list
110030177|NCT04823442|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110030178|NCT04823442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110030179|NCT04823442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110030180|NCT04823442|Adrenergic Agents|adrenergic agents|mesh-ancestor
110030181|NCT04823442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110030182|NCT04823442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030183|NCT04823442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110030184|NCT04823442|Urological Agents|urological agents|mesh-ancestor
110030185|NCT04823442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110030186|NCT04823442|Sympatholytics|sympatholytics|mesh-ancestor
110030187|NCT04823442|Autonomic Agents|autonomic agents|mesh-ancestor
110030188|NCT04823442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110030189|NCT04823442|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110030190|NCT04823442|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110030191|NCT04823442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110030192|NCT01384448|Dobutamine|dobutamine|mesh-list
110030193|NCT01384448|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110030194|NCT01384448|Sympathomimetics|sympathomimetics|mesh-ancestor
110030195|NCT01384448|Autonomic Agents|autonomic agents|mesh-ancestor
110030196|NCT01384448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110030198|NCT01384448|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110030199|NCT01384448|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110030200|NCT01384448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110030201|NCT01384448|Adrenergic Agents|adrenergic agents|mesh-ancestor
110030202|NCT01384448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110030203|NCT01384448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030204|NCT01384448|Protective Agents|protective agents|mesh-ancestor
110030205|NCT01384578|Vitamins|vitamins|mesh-list
110030206|NCT01384578|Vitamin E|vitamin e|mesh-list
110030207|NCT01384578|Tocopherols|tocopherols|mesh-list
110030209|NCT01384578|alpha-Tocopherol|alpha-tocopherol|mesh-list
110030210|NCT01384578|Pentoxifylline|pentoxifylline|mesh-list
110030211|NCT01384578|Micronutrients|micronutrients|mesh-ancestor
110030212|NCT01384578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110030213|NCT01384578|Antioxidants|antioxidants|mesh-ancestor
110030217|NCT01384578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110030218|NCT01384578|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110030219|NCT01384578|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110030220|NCT01384578|Vasodilator Agents|vasodilator agents|mesh-ancestor
110030221|NCT01384578|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110030223|NCT01384643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110030224|NCT01384643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110030225|NCT01384643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110030226|NCT01384643|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110030227|NCT01384643|Anesthetics, General|anesthetics, general|mesh-ancestor
110030229|NCT01384656|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110030231|NCT01384682|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110030232|NCT01384682|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110030233|NCT01384682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030234|NCT01384682|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110030235|NCT01384682|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110030236|NCT01384682|Antiviral Agents|antiviral agents|mesh-ancestor
110030237|NCT01384682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110030238|NCT01384682|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110030239|NCT01384695|Proflavine|proflavine|mesh-list
110030240|NCT01384695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110030241|NCT01384695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110030242|NCT01384708|Proflavine|proflavine|mesh-list
110030244|NCT01384708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110030245|NCT01384799|Cisplatin|cisplatin|mesh-list
110030246|NCT01384799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110030247|NCT01384812|Dinoprostone|dinoprostone|mesh-list
110030248|NCT01384812|Oxytocics|oxytocics|mesh-ancestor
110030249|NCT01384812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110030250|NCT01384812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110030251|NCT01384864|Proflavine|proflavine|mesh-list
110030252|NCT01384864|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110030253|NCT01384864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110030254|NCT01384903|Antithrombins|antithrombins|mesh-list
110030255|NCT01384903|Antithrombin III|antithrombin iii|mesh-list
110030257|NCT01384903|Protease Inhibitors|protease inhibitors|mesh-ancestor
110030258|NCT01384903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110030259|NCT01384903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030260|NCT01384903|Anticoagulants|anticoagulants|mesh-ancestor
110030261|NCT01384994|Folic Acid|folic acid|mesh-list
110030262|NCT01384994|Vitamin B Complex|vitamin b complex|mesh-list
110030263|NCT01384994|Oxaliplatin|oxaliplatin|mesh-list
110030264|NCT01384994|Fluorouracil|fluorouracil|mesh-list
110030265|NCT01384994|Panitumumab|panitumumab|mesh-list
110030266|NCT01384994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110030267|NCT01384994|Antimetabolites|antimetabolites|mesh-ancestor
110030268|NCT01384994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030269|NCT01384994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110030271|NCT01384994|Immunologic Factors|immunologic factors|mesh-ancestor
110030272|NCT01384994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110030273|NCT01384994|Hematinics|hematinics|mesh-ancestor
110030274|NCT01384994|Vitamins|vitamins|mesh-ancestor
110030276|NCT01384994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110030277|NCT01385020|Gemfibrozil|gemfibrozil|mesh-list
110030278|NCT01385020|Red yeast rice|red yeast rice|mesh-list
110030279|NCT01385020|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110030280|NCT01385020|Antimetabolites|antimetabolites|mesh-ancestor
110030281|NCT01385020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030282|NCT01385020|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110030283|NCT01385020|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110030284|NCT01385020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110030285|NCT01385020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110030286|NCT01385020|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110030287|NCT01385020|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110030288|NCT01385124|Cannabidiol|cannabidiol|mesh-list
110030291|NCT01385228|Docetaxel|docetaxel|mesh-list
110030292|NCT01385228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110030293|NCT01385228|Tubulin Modulators|tubulin modulators|mesh-ancestor
110030294|NCT01385228|Antimitotic Agents|antimitotic agents|mesh-ancestor
110030296|NCT01385228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030297|NCT01385228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110030298|NCT01385228|Glucocorticoids|glucocorticoids|mesh-ancestor
110030300|NCT01385228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110030301|NCT01385228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110030302|NCT01385228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110030304|NCT01385345|Cholecalciferol|cholecalciferol|mesh-list
110030305|NCT01385345|Vitamins|vitamins|mesh-ancestor
110030306|NCT01385345|Micronutrients|micronutrients|mesh-ancestor
110030307|NCT01385345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110030308|NCT01385345|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110030309|NCT01385345|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110030310|NCT01385527|Triamcinolone|triamcinolone|mesh-list
110030311|NCT01385527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110030312|NCT01385527|Glucocorticoids|glucocorticoids|mesh-ancestor
110030313|NCT01385527|Hormones|hormones|mesh-ancestor
110030314|NCT01385527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110030315|NCT01385527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110030316|NCT01385631|Ezetimibe|ezetimibe|mesh-list
110030317|NCT01385631|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110030318|NCT01385631|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110030320|NCT01385631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030321|NCT01385631|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110030322|NCT01385683|Clarithromycin|clarithromycin|mesh-list
110030324|NCT01385683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110030325|NCT01385683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110030326|NCT01385683|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110030327|NCT01385683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110030328|NCT01385683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030329|NCT01385683|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110030330|NCT01385683|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110030331|NCT01385683|Antithrombins|antithrombins|mesh-ancestor
110030333|NCT01385683|Protease Inhibitors|protease inhibitors|mesh-ancestor
110030334|NCT01385683|Anticoagulants|anticoagulants|mesh-ancestor
110030335|NCT01385735|Rasagiline|rasagiline|mesh-list
110030336|NCT01385735|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110030337|NCT01385735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110030338|NCT01385735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030339|NCT01385735|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110030340|NCT01385735|Protective Agents|protective agents|mesh-ancestor
110030341|NCT01385735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110030342|NCT01385826|Antibodies|antibodies|mesh-list
110030343|NCT01385826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110030344|NCT01385826|Immunologic Factors|immunologic factors|mesh-ancestor
110030345|NCT01385826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110030348|NCT01385891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110030349|NCT01385891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110030350|NCT01385891|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110030351|NCT01385891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110030352|NCT01385891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110030353|NCT01385891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030354|NCT01385891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110030355|NCT01385891|Antimetabolites|antimetabolites|mesh-ancestor
110030356|NCT01385956|Gemcitabine|gemcitabine|mesh-list
110030357|NCT01385956|Pasireotide|pasireotide|mesh-list
110030358|NCT01385956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110030359|NCT01385956|Antimetabolites|antimetabolites|mesh-ancestor
110030360|NCT01385956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030361|NCT01385956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110030363|NCT01385956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110030364|NCT01385956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110030365|NCT01386086|Aripiprazole|aripiprazole|mesh-list
110030366|NCT01386086|Antidepressive Agents|antidepressive agents|mesh-ancestor
110030367|NCT01386086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110030369|NCT01386086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110030370|NCT01386086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110030371|NCT01386086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110030372|NCT01386086|Dopamine Agonists|dopamine agonists|mesh-ancestor
110030373|NCT01386086|Dopamine Agents|dopamine agents|mesh-ancestor
110030374|NCT01386086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110030375|NCT01386086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030376|NCT01386086|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110030377|NCT01386086|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110030378|NCT01386086|Serotonin Agents|serotonin agents|mesh-ancestor
110030379|NCT01386086|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110030380|NCT01386086|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110030381|NCT01386086|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110030382|NCT01386086|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110030384|NCT01386151|Mitosis Modulators|mitosis modulators|mesh-ancestor
110030385|NCT01386151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030387|NCT01386164|Immunologic Factors|immunologic factors|mesh-ancestor
110030388|NCT01386164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110030389|NCT01386177|Doxazosin|doxazosin|mesh-list
110030390|NCT01386177|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
110030391|NCT01386177|Hallucinogens|hallucinogens|mesh-ancestor
110030392|NCT01386177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110030393|NCT01386177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110030394|NCT01386177|Serotonin Agents|serotonin agents|mesh-ancestor
110030395|NCT01386177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110030396|NCT01386177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030397|NCT01386177|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110030398|NCT01386177|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110030399|NCT01386177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110030400|NCT01386177|Adrenergic Agents|adrenergic agents|mesh-ancestor
110030401|NCT01386177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110030402|NCT01386177|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110030403|NCT01386177|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110030404|NCT01386177|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110030406|NCT01386229|Etomidate|etomidate|mesh-list
110030407|NCT01386229|Analgesics|analgesics|mesh-ancestor
110030408|NCT01386229|Sensory System Agents|sensory system agents|mesh-ancestor
110030409|NCT01386229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110030410|NCT01386229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110030411|NCT01386229|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110030412|NCT01386229|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110030413|NCT01386229|Anesthetics, General|anesthetics, general|mesh-ancestor
110030414|NCT01386229|Anesthetics|anesthetics|mesh-ancestor
110030415|NCT01386229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110030416|NCT01386229|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110030417|NCT01386229|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110030418|NCT01386229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110030419|NCT01386229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030420|NCT01386229|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110030421|NCT01386242|Interferons|interferons|mesh-list
110030422|NCT01386242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110030423|NCT01386242|Antiviral Agents|antiviral agents|mesh-ancestor
110030424|NCT01386242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110030426|NCT01386255|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110030427|NCT01386255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110030429|NCT01386255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110030430|NCT01386255|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110030431|NCT01386255|GABA Agonists|gaba agonists|mesh-ancestor
110030432|NCT01386255|GABA Agents|gaba agents|mesh-ancestor
110030433|NCT01386255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110030434|NCT01386255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030436|NCT01386268|Coagulants|coagulants|mesh-ancestor
110030437|NCT01386294|Tenofovir|tenofovir|mesh-list
110030438|NCT01386294|Antiviral Agents|antiviral agents|mesh-ancestor
110030439|NCT01386294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110030440|NCT01386294|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110030441|NCT01386294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110030442|NCT01386294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110030443|NCT01386294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030444|NCT01386294|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110030445|NCT01386294|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110030447|NCT01386333|Oxytocics|oxytocics|mesh-ancestor
110030448|NCT01386333|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110030449|NCT01386333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110030450|NCT01386346|Capecitabine|capecitabine|mesh-list
110030451|NCT01386346|Azacitidine|azacitidine|mesh-list
110030452|NCT01386346|Oxaliplatin|oxaliplatin|mesh-list
110030453|NCT01386346|Epirubicin|epirubicin|mesh-list
110030454|NCT01386346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110030455|NCT01386346|Antimetabolites|antimetabolites|mesh-ancestor
110030540|NCT01386593|Leprostatic Agents|leprostatic agents|mesh-ancestor
110030456|NCT01386346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030458|NCT01386346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110030459|NCT01386346|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110030460|NCT01386346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110030461|NCT01386346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110030462|NCT01386372|Tolvaptan|tolvaptan|mesh-list
110030463|NCT01386372|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110030464|NCT01386372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030465|NCT01386372|Natriuretic Agents|natriuretic agents|mesh-ancestor
110030466|NCT01386372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110030468|NCT01386398|Vorinostat|vorinostat|mesh-list
110030469|NCT01386398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110030470|NCT01386398|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110030471|NCT01386398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110030472|NCT01386398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030473|NCT01386502|Pidilizumab|pidilizumab|mesh-list
110030474|NCT01386502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110030475|NCT01386502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110030476|NCT01386567|Methyltestosterone|methyltestosterone|mesh-list
110030477|NCT01386567|Citric Acid|citric acid|mesh-list
110030478|NCT01386567|Sodium Citrate|sodium citrate|mesh-list
110030479|NCT01386567|Enclomiphene|enclomiphene|mesh-list
110030480|NCT01386567|Clomiphene|clomiphene|mesh-list
110030481|NCT01386567|Zuclomiphene|zuclomiphene|mesh-list
110030482|NCT01386567|Testosterone|testosterone|mesh-list
110030483|NCT01386567|Testosterone undecanoate|testosterone undecanoate|mesh-list
110030484|NCT01386567|Testosterone enanthate|testosterone enanthate|mesh-list
110030485|NCT01386567|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110030486|NCT01386567|Anticoagulants|anticoagulants|mesh-ancestor
110030487|NCT01386567|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110030488|NCT01386567|Chelating Agents|chelating agents|mesh-ancestor
110030489|NCT01386567|Sequestering Agents|sequestering agents|mesh-ancestor
110030495|NCT01386567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110030496|NCT01386567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110030497|NCT01386567|Anabolic Agents|anabolic agents|mesh-ancestor
110030498|NCT01386567|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110030499|NCT01386567|Hormone Antagonists|hormone antagonists|mesh-ancestor
110030500|NCT01386567|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110030501|NCT01386567|Fertility Agents|fertility agents|mesh-ancestor
110030502|NCT01386567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110030503|NCT01386567|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110030504|NCT01386567|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110030505|NCT01386580|Doxorubicin|doxorubicin|mesh-list
110030506|NCT01386580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110030507|NCT01386580|Trastuzumab|trastuzumab|mesh-list
110030508|NCT01386580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110030509|NCT01386580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110030510|NCT01386580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110030511|NCT01386580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110030512|NCT01386580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110030513|NCT01386580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030514|NCT01386580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110030515|NCT01386593|Ciprofloxacin|ciprofloxacin|mesh-list
110030516|NCT01386593|Rifampin|rifampin|mesh-list
110030517|NCT01386593|Fluconazole|fluconazole|mesh-list
110030518|NCT01386593|Paroxetine|paroxetine|mesh-list
110030519|NCT01386593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110030520|NCT01386593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110030521|NCT01386593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110030522|NCT01386593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110030523|NCT01386593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110030524|NCT01386593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030525|NCT01386593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110030526|NCT01386593|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110030528|NCT01386593|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110030529|NCT01386593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110030530|NCT01386593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110030531|NCT01386593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110030532|NCT01386593|Serotonin Agents|serotonin agents|mesh-ancestor
110030533|NCT01386593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110030534|NCT01386593|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110030535|NCT01386593|Antidepressive Agents|antidepressive agents|mesh-ancestor
110030536|NCT01386593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110030537|NCT01386593|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110030539|NCT01386593|Antitubercular Agents|antitubercular agents|mesh-ancestor
110030541|NCT01386593|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110030542|NCT01386593|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110030543|NCT01386593|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110030544|NCT01386593|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110030545|NCT01386593|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110030546|NCT01386593|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110030547|NCT01386593|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110030548|NCT01386593|Antifungal Agents|antifungal agents|mesh-ancestor
110030549|NCT01386593|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110030550|NCT01386593|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110030551|NCT01386593|Hormone Antagonists|hormone antagonists|mesh-ancestor
110030554|NCT01386593|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110030555|NCT01386658|Icatibant|icatibant|mesh-list
110030556|NCT01386658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110030557|NCT01386658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110030558|NCT01386658|Analgesics|analgesics|mesh-ancestor
110030559|NCT01386658|Sensory System Agents|sensory system agents|mesh-ancestor
110030560|NCT01386658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110030561|NCT01386658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110030562|NCT01386658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110030563|NCT01386658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110030564|NCT01386658|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
110030565|NCT01386658|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
110030566|NCT01386658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030567|NCT01386658|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110030568|NCT01386658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110030569|NCT01386658|Immunologic Factors|immunologic factors|mesh-ancestor
110030570|NCT01386671|Metformin|metformin|mesh-list
110030571|NCT01386671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110030572|NCT01386671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110030573|NCT01386736|Vitamin D|vitamin d|mesh-list
110030574|NCT01386736|Vitamins|vitamins|mesh-ancestor
110030575|NCT01386736|Micronutrients|micronutrients|mesh-ancestor
110030576|NCT01386736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110030577|NCT01386736|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110030578|NCT01386853|Atorvastatin|atorvastatin|mesh-list
110030579|NCT01386853|Pitavastatin|pitavastatin|mesh-list
110030580|NCT01386853|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110030581|NCT01386853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110030582|NCT01386853|Antimetabolites|antimetabolites|mesh-ancestor
110030583|NCT01386853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030584|NCT01386853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110030585|NCT01386853|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110030586|NCT01386853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110030587|NCT01386866|Motesanib diphosphate|motesanib diphosphate|mesh-list
110030589|NCT01386866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110030590|NCT01386866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030592|NCT01386879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110030593|NCT01386879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030594|NCT01386996|Budesonide|budesonide|mesh-list
110030595|NCT01386996|Formoterol Fumarate|formoterol fumarate|mesh-list
110030596|NCT01386996|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110030597|NCT01386996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110030598|NCT01386996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110030599|NCT01386996|Autonomic Agents|autonomic agents|mesh-ancestor
110030600|NCT01386996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110030601|NCT01386996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110030602|NCT01386996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110030603|NCT01386996|Respiratory System Agents|respiratory system agents|mesh-ancestor
110030604|NCT01386996|Glucocorticoids|glucocorticoids|mesh-ancestor
110030605|NCT01386996|Hormones|hormones|mesh-ancestor
110030606|NCT01386996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110030607|NCT01386996|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110030608|NCT01386996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110030609|NCT01386996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110030610|NCT01386996|Adrenergic Agents|adrenergic agents|mesh-ancestor
110030611|NCT01386996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110030612|NCT01386996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030613|NCT01387048|Adapalene|adapalene|mesh-list
110030614|NCT01387048|Azelaic acid|azelaic acid|mesh-list
110030615|NCT01387048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110030616|NCT01387048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110030618|NCT01387048|Sensory System Agents|sensory system agents|mesh-ancestor
110030619|NCT01387048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110030620|NCT01387048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110030621|NCT01387048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110030622|NCT01387048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110030623|NCT01387048|Dermatologic Agents|dermatologic agents|mesh-ancestor
110030624|NCT01387048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110030625|NCT01387087|Peficitinib|peficitinib|mesh-list
110030626|NCT01387087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110030627|NCT01387087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030628|NCT01387087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110030629|NCT01387087|Immunologic Factors|immunologic factors|mesh-ancestor
110030630|NCT01387087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110030631|NCT01387191|Epoprostenol|epoprostenol|mesh-list
110030633|NCT01387191|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110030634|NCT01387191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110030635|NCT01387191|Vasodilator Agents|vasodilator agents|mesh-ancestor
110030637|NCT01387204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110030638|NCT01387204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110030639|NCT01387204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110030640|NCT01387204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030642|NCT01387243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110030643|NCT01387243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030644|NCT01387243|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110030645|NCT01387243|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110030646|NCT01387295|Capecitabine|capecitabine|mesh-list
110030647|NCT01387295|Oxaliplatin|oxaliplatin|mesh-list
110030648|NCT01387295|Trastuzumab|trastuzumab|mesh-list
110030649|NCT01387295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110030650|NCT01387295|Antimetabolites|antimetabolites|mesh-ancestor
110030651|NCT01387295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030652|NCT01387295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110030653|NCT01387295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110030655|NCT01387373|Oxaliplatin|oxaliplatin|mesh-list
110030656|NCT01387373|Trastuzumab|trastuzumab|mesh-list
110030657|NCT01387373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110030658|NCT01387373|Antimetabolites|antimetabolites|mesh-ancestor
110030659|NCT01387373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030660|NCT01387373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110030661|NCT01387373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110030662|NCT01387399|Cisplatin|cisplatin|mesh-list
110030663|NCT01387399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110030664|NCT01387425|Varenicline|varenicline|mesh-list
110030665|NCT01387425|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110030666|NCT01387425|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110030667|NCT01387425|Cholinergic Agents|cholinergic agents|mesh-ancestor
110030668|NCT01387425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110030669|NCT01387425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030670|NCT01387425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110030671|NCT01387568|Lidocaine|lidocaine|mesh-list
110030672|NCT01387568|Anesthetics, Local|anesthetics, local|mesh-ancestor
110030673|NCT01387568|Anesthetics|anesthetics|mesh-ancestor
110030674|NCT01387568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110030675|NCT01387568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110030676|NCT01387568|Sensory System Agents|sensory system agents|mesh-ancestor
110030677|NCT01387568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110030678|NCT01387568|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110030679|NCT01387568|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110030680|NCT01387568|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110030681|NCT01387568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110030682|NCT01387568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030683|NCT01387620|Hyaluronic Acid|hyaluronic acid|mesh-list
110030684|NCT01387620|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110030685|NCT01387620|Immunologic Factors|immunologic factors|mesh-ancestor
110030686|NCT01387620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110030688|NCT01387620|Protective Agents|protective agents|mesh-ancestor
110030690|NCT01387880|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110030691|NCT01387880|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110030692|NCT01387880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110030693|NCT01387880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030694|NCT01387880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110030695|NCT01387880|Immunologic Factors|immunologic factors|mesh-ancestor
110030696|NCT01387880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110030697|NCT01387880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110030698|NCT01387906|Bimatoprost|bimatoprost|mesh-list
110030699|NCT01387906|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110030700|NCT01387997|Antibodies|antibodies|mesh-list
110030701|NCT01387997|Immunologic Factors|immunologic factors|mesh-ancestor
110030702|NCT01387997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110030703|NCT01388023|Chlorhexidine|chlorhexidine|mesh-list
110030704|NCT01388023|Listerine|listerine|mesh-list
110030705|NCT01388023|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110030706|NCT01388023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110030707|NCT01388023|Disinfectants|disinfectants|mesh-ancestor
110030708|NCT01388036|Esmolol|esmolol|mesh-list
110030709|NCT01388036|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110030710|NCT01388036|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110030711|NCT01388036|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110030712|NCT01388036|Adrenergic Agents|adrenergic agents|mesh-ancestor
110030713|NCT01388036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110030714|NCT01388036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030715|NCT01388036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110030716|NCT01388049|Antibodies|antibodies|mesh-list
110030717|NCT01388049|Immunologic Factors|immunologic factors|mesh-ancestor
110030718|NCT01388049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110030719|NCT01388062|Antibodies|antibodies|mesh-list
110030720|NCT01388062|Immunologic Factors|immunologic factors|mesh-ancestor
110030721|NCT01388062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110030723|NCT01388075|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110030724|NCT01388075|Antitubercular Agents|antitubercular agents|mesh-ancestor
110030725|NCT01388075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110030726|NCT01388075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110030727|NCT01388075|Leprostatic Agents|leprostatic agents|mesh-ancestor
110030728|NCT01388075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110030729|NCT01388075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110030730|NCT01388075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030731|NCT01388075|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110030732|NCT01388075|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110030733|NCT01388075|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110030734|NCT01388075|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110030735|NCT01388075|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110030736|NCT01388075|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110030737|NCT01388088|Amiloride|amiloride|mesh-list
110030738|NCT01388088|Spironolactone|spironolactone|mesh-list
110030739|NCT01388088|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110030740|NCT01388088|Hormone Antagonists|hormone antagonists|mesh-ancestor
110030741|NCT01388088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110030742|NCT01388088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110030743|NCT01388088|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110030744|NCT01388088|Diuretics|diuretics|mesh-ancestor
110030746|NCT01388088|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
110030747|NCT01388088|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110030748|NCT01388088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110030749|NCT01388088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030750|NCT01388088|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
110030752|NCT01388101|Immunologic Factors|immunologic factors|mesh-ancestor
110030753|NCT01388101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110030755|NCT01388114|Immunologic Factors|immunologic factors|mesh-ancestor
110030756|NCT01388114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110030757|NCT01388153|Acarbose|acarbose|mesh-list
110030758|NCT01388153|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110030759|NCT01388153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110030760|NCT01388153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030761|NCT01388153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110030762|NCT01388153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110030764|NCT01388270|Calcium heparin|calcium heparin|mesh-list
110030765|NCT01388270|Anticoagulants|anticoagulants|mesh-ancestor
110030766|NCT01388270|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110030767|NCT01388270|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110030768|NCT01388270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030770|NCT01388322|Anticoagulants|anticoagulants|mesh-ancestor
110030771|NCT01388322|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110030772|NCT01388322|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110030773|NCT01388322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030774|NCT01388413|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110031260|NCT01390961|Pheniramine|pheniramine|mesh-list
110030775|NCT01388413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110030776|NCT01388439|Oseltamivir|oseltamivir|mesh-list
110030777|NCT01388439|Antiviral Agents|antiviral agents|mesh-ancestor
110030778|NCT01388439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110030779|NCT01388439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110030780|NCT01388439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030781|NCT01388517|Vitamin D|vitamin d|mesh-list
110030782|NCT01388517|Calcitriol|calcitriol|mesh-list
110030783|NCT01388517|Petrolatum|petrolatum|mesh-list
110030784|NCT01388517|Tacrolimus|tacrolimus|mesh-list
110030785|NCT01388517|Vitamins|vitamins|mesh-ancestor
110030787|NCT01388517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110030788|NCT01388517|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110030789|NCT01388517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110030790|NCT01388517|Immunologic Factors|immunologic factors|mesh-ancestor
110030791|NCT01388517|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110030792|NCT01388517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110030793|NCT01388517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030794|NCT01388517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110030795|NCT01388517|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110030796|NCT01388517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110030797|NCT01388517|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110030798|NCT01388517|Emollients|emollients|mesh-ancestor
110030799|NCT01388517|Dermatologic Agents|dermatologic agents|mesh-ancestor
110030800|NCT01388582|Copper|copper|mesh-list
110030801|NCT01388582|Contraceptive Agents|contraceptive agents|mesh-list
110030802|NCT01388582|Levonorgestrel|levonorgestrel|mesh-list
110030803|NCT01388582|Etonogestrel|etonogestrel|mesh-list
110030804|NCT01388582|Desogestrel|desogestrel|mesh-list
110030805|NCT01388582|Contraceptives, Oral|contraceptives, oral|mesh-list
110030806|NCT01388582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110030807|NCT01388582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110030808|NCT01388582|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110030809|NCT01388582|Trace Elements|trace elements|mesh-ancestor
110030810|NCT01388582|Micronutrients|micronutrients|mesh-ancestor
110030811|NCT01388582|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110030812|NCT01388582|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110030813|NCT01388582|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110030814|NCT01388582|Progestins|progestins|mesh-ancestor
110030815|NCT01388582|Hormones|hormones|mesh-ancestor
110030816|NCT01388582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110030817|NCT01388595|Fluticasone|fluticasone|mesh-list
110030818|NCT01388595|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110030819|NCT01388595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110030820|NCT01388595|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110030821|NCT01388595|Autonomic Agents|autonomic agents|mesh-ancestor
110030822|NCT01388595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110030823|NCT01388595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110030824|NCT01388595|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110030825|NCT01388595|Respiratory System Agents|respiratory system agents|mesh-ancestor
110030826|NCT01388595|Dermatologic Agents|dermatologic agents|mesh-ancestor
110030827|NCT01388595|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110030828|NCT01388595|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110030829|NCT01388595|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110030830|NCT01388595|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110030831|NCT01388595|Adrenergic Agents|adrenergic agents|mesh-ancestor
110030832|NCT01388595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110030833|NCT01388595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030834|NCT01388621|Carboplatin|carboplatin|mesh-list
110030835|NCT01388621|Gemcitabine|gemcitabine|mesh-list
110030836|NCT01388621|Doxorubicin|doxorubicin|mesh-list
110030837|NCT01388621|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110030838|NCT01388621|Panitumumab|panitumumab|mesh-list
110030839|NCT01388621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110030840|NCT01388621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110030841|NCT01388621|Antimetabolites|antimetabolites|mesh-ancestor
110030842|NCT01388621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030843|NCT01388621|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110030844|NCT01388621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110030845|NCT01388621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110030846|NCT01388621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110030847|NCT01388621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110030848|NCT01388660|Clopidogrel|clopidogrel|mesh-list
110030849|NCT01388660|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110030850|NCT01388660|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110030851|NCT01388660|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110030852|NCT01388660|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110030853|NCT01388660|Purinergic Agents|purinergic agents|mesh-ancestor
110030854|NCT01388660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110030855|NCT01388660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030856|NCT01388660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110030857|NCT01388738|Cerebrolysin|cerebrolysin|mesh-list
110030858|NCT01388738|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
110030859|NCT01388738|Nootropic Agents|nootropic agents|mesh-ancestor
110030860|NCT01388738|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110030861|NCT01388738|Protective Agents|protective agents|mesh-ancestor
110030862|NCT01388738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110030863|NCT01388842|Nitric Oxide|nitric oxide|mesh-list
110030864|NCT01388842|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110030866|NCT01388842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110030867|NCT01388842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110030869|NCT01388842|Respiratory System Agents|respiratory system agents|mesh-ancestor
110030870|NCT01388842|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110030871|NCT01388842|Antioxidants|antioxidants|mesh-ancestor
110030872|NCT01388842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030873|NCT01388842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110030874|NCT01388842|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110030875|NCT01388842|Vasodilator Agents|vasodilator agents|mesh-ancestor
110030876|NCT01388842|Gasotransmitters|gasotransmitters|mesh-ancestor
110030877|NCT01388842|Protective Agents|protective agents|mesh-ancestor
110030878|NCT01388855|Vitamin D|vitamin d|mesh-list
110030879|NCT01388855|Cholecalciferol|cholecalciferol|mesh-list
110030880|NCT01388855|Vitamins|vitamins|mesh-ancestor
110030881|NCT01388855|Micronutrients|micronutrients|mesh-ancestor
110030882|NCT01388855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110030883|NCT01388855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110030884|NCT01388855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110030885|NCT01388959|Rituximab|rituximab|mesh-list
110030886|NCT01388959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110030887|NCT01388959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110030888|NCT01388959|Immunologic Factors|immunologic factors|mesh-ancestor
110030889|NCT01388959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110030890|NCT01388959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110030891|NCT01389063|Maraviroc|maraviroc|mesh-list
110030892|NCT01389063|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110030893|NCT01389063|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110030894|NCT01389063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030895|NCT01389063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110030896|NCT01389063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110030898|NCT01389063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110030899|NCT01389063|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110030900|NCT01389167|Naltrexone|naltrexone|mesh-list
110030901|NCT01389167|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110030902|NCT01389167|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110030903|NCT01389167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110030908|NCT01389193|Autonomic Agents|autonomic agents|mesh-ancestor
110030909|NCT01389193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110030910|NCT01389193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110030911|NCT01389193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110030912|NCT01389193|Respiratory System Agents|respiratory system agents|mesh-ancestor
110030913|NCT01389193|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110030914|NCT01389193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110030915|NCT01389193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030916|NCT01389193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110030917|NCT01389193|Vasodilator Agents|vasodilator agents|mesh-ancestor
110030919|NCT01389206|Selexipag|selexipag|mesh-list
110030920|NCT01389206|Iloprost|iloprost|mesh-list
110030921|NCT01389206|Macitentan|macitentan|mesh-list
110030922|NCT01389206|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110030924|NCT01389206|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110030925|NCT01389206|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110030926|NCT01389206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030927|NCT01389206|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
110030928|NCT01389206|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
110030930|NCT01389271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110030931|NCT01389271|Vasodilator Agents|vasodilator agents|mesh-ancestor
110030932|NCT01389388|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110030933|NCT01389388|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110030935|NCT01389388|Antimetabolites|antimetabolites|mesh-ancestor
110030936|NCT01389388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030937|NCT01389388|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110030938|NCT01389388|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110030939|NCT01389388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110030940|NCT01389401|Omeprazole|omeprazole|mesh-list
110030941|NCT01389401|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110030942|NCT01389401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110030943|NCT01389401|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110030944|NCT01389401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110030945|NCT01389401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030946|NCT01389414|Gemcitabine|gemcitabine|mesh-list
110030947|NCT01389414|Oxaliplatin|oxaliplatin|mesh-list
110030948|NCT01389414|Panitumumab|panitumumab|mesh-list
110030949|NCT01389414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110030950|NCT01389414|Antimetabolites|antimetabolites|mesh-ancestor
110030951|NCT01389414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030952|NCT01389414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110030953|NCT01389414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110030954|NCT01389427|Sirolimus|sirolimus|mesh-list
110030955|NCT01389427|Prednisone|prednisone|mesh-list
110030956|NCT01389427|Temsirolimus|temsirolimus|mesh-list
110030957|NCT01389427|MTOR Inhibitors|mtor inhibitors|mesh-list
110030958|NCT01389427|Cyclophosphamide|cyclophosphamide|mesh-list
110030959|NCT01389427|Vincristine|vincristine|mesh-list
110030960|NCT01389427|Rituximab|rituximab|mesh-list
110030961|NCT01389427|Doxorubicin|doxorubicin|mesh-list
110030962|NCT01389427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110030963|NCT01389427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110030964|NCT01389427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030965|NCT01389427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110030966|NCT01389427|Immunologic Factors|immunologic factors|mesh-ancestor
110030967|NCT01389427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110030968|NCT01389427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110030969|NCT01389427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110030970|NCT01389427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110030971|NCT01389427|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110030972|NCT01389427|Antifungal Agents|antifungal agents|mesh-ancestor
110030973|NCT01389427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110030974|NCT01389427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110030975|NCT01389427|Alkylating Agents|alkylating agents|mesh-ancestor
110030976|NCT01389427|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110030977|NCT01389427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110030978|NCT01389427|Glucocorticoids|glucocorticoids|mesh-ancestor
110030979|NCT01389427|Hormones|hormones|mesh-ancestor
110030980|NCT01389427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110030981|NCT01389427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110030982|NCT01389427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110030983|NCT01389427|Tubulin Modulators|tubulin modulators|mesh-ancestor
110030984|NCT01389427|Antimitotic Agents|antimitotic agents|mesh-ancestor
110030985|NCT01389427|Mitosis Modulators|mitosis modulators|mesh-ancestor
110030986|NCT01389427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110030988|NCT01389427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110030989|NCT01389440|Gemcitabine|gemcitabine|mesh-list
110030990|NCT01389440|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110030991|NCT01389440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110030992|NCT01389440|Antimetabolites|antimetabolites|mesh-ancestor
110030993|NCT01389440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030994|NCT01389440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110030995|NCT01389440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110030996|NCT01389440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110030998|NCT01389505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110030999|NCT01389505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110031000|NCT01389505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110031001|NCT01389505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110031002|NCT01389505|Growth Substances|growth substances|mesh-ancestor
110031003|NCT01389505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110031004|NCT01389505|Growth Inhibitors|growth inhibitors|mesh-ancestor
110031006|NCT01389544|Methadone|methadone|mesh-list
110031007|NCT01389544|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110031008|NCT01389544|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110031010|NCT01389544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110031011|NCT01389544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110031012|NCT01389544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110031013|NCT01389544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110031015|NCT01389544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110031016|NCT01389544|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110031017|NCT01389544|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110031018|NCT01389544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110031019|NCT01389544|Narcotics|narcotics|mesh-ancestor
110031020|NCT01389544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110031021|NCT01389544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110031022|NCT01389544|Analgesics|analgesics|mesh-ancestor
110031023|NCT01389544|Sensory System Agents|sensory system agents|mesh-ancestor
110031024|NCT01389544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110031025|NCT01389544|Antitussive Agents|antitussive agents|mesh-ancestor
110031026|NCT01389544|Respiratory System Agents|respiratory system agents|mesh-ancestor
110031027|NCT01389557|Primaquine|primaquine|mesh-list
110031028|NCT01389557|Piperaquine|piperaquine|mesh-list
110031029|NCT01389557|Artenimol|artenimol|mesh-list
110031030|NCT01389557|Antimalarials|antimalarials|mesh-ancestor
110031031|NCT01389557|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110031032|NCT01389557|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110031033|NCT01389557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110031034|NCT01389609|Doxazosin|doxazosin|mesh-list
110031035|NCT01389609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110031036|NCT01389609|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110031037|NCT01389609|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110031038|NCT01389609|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110031039|NCT01389609|Adrenergic Agents|adrenergic agents|mesh-ancestor
110031040|NCT01389609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110031041|NCT01389609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110031042|NCT01389609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110031043|NCT01389713|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110031045|NCT01389713|Enclomiphene|enclomiphene|mesh-list
110031046|NCT01389713|Zuclomiphene|zuclomiphene|mesh-list
110031047|NCT01389713|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110031048|NCT01389713|Hormone Antagonists|hormone antagonists|mesh-ancestor
110031049|NCT01389713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110031050|NCT01389713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110031051|NCT01389713|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110031052|NCT01389713|Fertility Agents|fertility agents|mesh-ancestor
110031053|NCT01389713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110031058|NCT01389713|Contraceptive Agents|contraceptive agents|mesh-ancestor
110031059|NCT01389713|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110031060|NCT01389713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110031061|NCT01389713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110031062|NCT01389778|Metformin|metformin|mesh-list
110031063|NCT01389778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110031064|NCT01389778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110031065|NCT01389791|Magnesium Sulfate|magnesium sulfate|mesh-list
110031066|NCT01389791|Rocuronium|rocuronium|mesh-list
110031067|NCT01389791|Analgesics|analgesics|mesh-ancestor
110031068|NCT01389791|Sensory System Agents|sensory system agents|mesh-ancestor
110031069|NCT01389791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110031070|NCT01389791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110031071|NCT01389791|Anesthetics|anesthetics|mesh-ancestor
110031072|NCT01389791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110031073|NCT01389791|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110031074|NCT01389791|Anticonvulsants|anticonvulsants|mesh-ancestor
110031075|NCT01389791|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110031076|NCT01389791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110031077|NCT01389791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110031078|NCT01389791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110031079|NCT01389791|Tocolytic Agents|tocolytic agents|mesh-ancestor
110031080|NCT01389791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110031081|NCT01389791|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110031082|NCT01389791|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110031083|NCT01389791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110031084|NCT01389908|Olanzapine|olanzapine|mesh-list
110031085|NCT01389908|Antiemetics|antiemetics|mesh-ancestor
110031086|NCT01389908|Autonomic Agents|autonomic agents|mesh-ancestor
110031087|NCT01389908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110031088|NCT01389908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110031089|NCT01389908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110031090|NCT01389908|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110031091|NCT01389908|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110031092|NCT01389908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110031093|NCT01389908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110031094|NCT01389908|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110031095|NCT01389908|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110031096|NCT01389908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110031097|NCT01389908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110031098|NCT01389908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110031099|NCT01389908|Serotonin Agents|serotonin agents|mesh-ancestor
110031100|NCT01390012|Dexamethasone|dexamethasone|mesh-list
110031101|NCT01390012|Dexamethasone acetate|dexamethasone acetate|mesh-list
110031103|NCT01390012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110031104|NCT01390012|Antiemetics|antiemetics|mesh-ancestor
110031105|NCT01390012|Autonomic Agents|autonomic agents|mesh-ancestor
110031106|NCT01390012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110031107|NCT01390012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110031108|NCT01390012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110031109|NCT01390012|Glucocorticoids|glucocorticoids|mesh-ancestor
110031110|NCT01390012|Hormones|hormones|mesh-ancestor
110031111|NCT01390012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110031112|NCT01390012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110031113|NCT01390012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110031116|NCT01390012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110031119|NCT01390051|Dalteparin|dalteparin|mesh-list
110031120|NCT01390051|Anticoagulants|anticoagulants|mesh-ancestor
110031121|NCT01390051|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110031122|NCT01390051|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110031123|NCT01390051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110031125|NCT01390311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110031126|NCT01390311|Antimetabolites|antimetabolites|mesh-ancestor
110031127|NCT01390311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110031128|NCT01390311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110031129|NCT01390311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110031131|NCT01390324|Naratriptan|naratriptan|mesh-list
110031132|NCT01390324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110031133|NCT01390324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110031134|NCT01390324|Analgesics|analgesics|mesh-ancestor
110031135|NCT01390324|Sensory System Agents|sensory system agents|mesh-ancestor
110031136|NCT01390324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110031137|NCT01390324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110031138|NCT01390324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110031139|NCT01390324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110031140|NCT01390324|Gout Suppressants|gout suppressants|mesh-ancestor
110031141|NCT01390324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110031142|NCT01390324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110031143|NCT01390324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110031145|NCT01390324|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110031146|NCT01390324|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110031147|NCT01390324|Serotonin Agents|serotonin agents|mesh-ancestor
110031148|NCT01390324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110031149|NCT01390337|Cytarabine|cytarabine|mesh-list
110031150|NCT01390337|Daunorubicin|daunorubicin|mesh-list
110031151|NCT01390337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110031152|NCT01390337|Antimetabolites|antimetabolites|mesh-ancestor
110031153|NCT01390337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110031154|NCT01390337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110031155|NCT01390337|Antiviral Agents|antiviral agents|mesh-ancestor
110031156|NCT01390337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110031157|NCT01390337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110031158|NCT01390337|Immunologic Factors|immunologic factors|mesh-ancestor
110031159|NCT01390337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110031160|NCT01390337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110031161|NCT01390337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110031162|NCT01390337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110031163|NCT01390337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110031164|NCT01390480|Cholecalciferol|cholecalciferol|mesh-list
110031165|NCT01390480|Vitamin D|vitamin d|mesh-list
110031166|NCT01390480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110031167|NCT01390480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110031168|NCT01390480|Vitamins|vitamins|mesh-ancestor
110031169|NCT01390480|Micronutrients|micronutrients|mesh-ancestor
110031170|NCT01390480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110031171|NCT01390506|Selenious Acid|selenious acid|mesh-list
110031172|NCT01390506|Sodium Selenite|sodium selenite|mesh-list
110031174|NCT01390506|Micronutrients|micronutrients|mesh-ancestor
110031175|NCT01390506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110031176|NCT01390519|Everolimus|everolimus|mesh-list
110031177|NCT01390519|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110031178|NCT01390519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110031179|NCT01390519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110031261|NCT01390961|Naphazoline|naphazoline|mesh-list
110031180|NCT01390519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110031181|NCT01390519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110031182|NCT01390519|Immunologic Factors|immunologic factors|mesh-ancestor
110031183|NCT01390519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110031184|NCT01390519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110031185|NCT01390571|Temozolomide|temozolomide|mesh-list
110031186|NCT01390571|Olaparib|olaparib|mesh-list
110031187|NCT01390571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110031188|NCT01390571|Alkylating Agents|alkylating agents|mesh-ancestor
110031189|NCT01390571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110031190|NCT01390571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110031191|NCT01390571|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110031192|NCT01390571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110031193|NCT01390623|Ceftriaxone|ceftriaxone|mesh-list
110031194|NCT01390623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110031195|NCT01390623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110031196|NCT01390662|Vitamin D|vitamin d|mesh-list
110031197|NCT01390662|Cholecalciferol|cholecalciferol|mesh-list
110031198|NCT01390662|Vitamins|vitamins|mesh-ancestor
110031199|NCT01390662|Micronutrients|micronutrients|mesh-ancestor
110031200|NCT01390662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110031201|NCT01390662|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110031202|NCT01390662|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110031203|NCT01390766|Azathioprine|azathioprine|mesh-list
110031204|NCT01390766|Antimetabolites|antimetabolites|mesh-ancestor
110031205|NCT01390766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110031206|NCT01390766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110031208|NCT01390766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110031209|NCT01390766|Immunologic Factors|immunologic factors|mesh-ancestor
110031210|NCT01390766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110031211|NCT01390766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110031212|NCT01390792|Zanamivir|zanamivir|mesh-list
110031213|NCT01390792|Antiviral Agents|antiviral agents|mesh-ancestor
110031214|NCT01390792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110031216|NCT01390792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110031218|NCT01390805|Antiviral Agents|antiviral agents|mesh-ancestor
110031219|NCT01390805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110031220|NCT01390883|PENTA|penta|mesh-list
110031221|NCT01390883|Fondaparinux|fondaparinux|mesh-list
110031222|NCT01390883|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110031223|NCT01390883|Antithrombins|antithrombins|mesh-ancestor
110031224|NCT01390883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110031225|NCT01390883|Protease Inhibitors|protease inhibitors|mesh-ancestor
110031226|NCT01390883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110031227|NCT01390883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110031229|NCT01390883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110031230|NCT01390883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110031231|NCT01390896|PENTA|penta|mesh-list
110031232|NCT01390896|Fondaparinux|fondaparinux|mesh-list
110031233|NCT01390896|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110031234|NCT01390896|Antithrombins|antithrombins|mesh-ancestor
110031235|NCT01390896|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110031237|NCT01390896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110031238|NCT01390896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110031239|NCT01390896|Anticoagulants|anticoagulants|mesh-ancestor
110031240|NCT01390896|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110031241|NCT01390896|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110031242|NCT01390922|Botulinum Toxins|botulinum toxins|mesh-list
110031243|NCT01390922|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110031244|NCT01390922|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110031245|NCT01390922|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110031246|NCT01390922|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110031247|NCT01390922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110031248|NCT01390922|Cholinergic Agents|cholinergic agents|mesh-ancestor
110031249|NCT01390922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110031250|NCT01390922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110031251|NCT01390922|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110031252|NCT01390922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110031253|NCT01390935|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
110031254|NCT01390935|Hormone Antagonists|hormone antagonists|mesh-ancestor
110031255|NCT01390935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110031256|NCT01390935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110031257|NCT01390935|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110031258|NCT01390935|Diuretics|diuretics|mesh-ancestor
110031259|NCT01390935|Natriuretic Agents|natriuretic agents|mesh-ancestor
110031262|NCT01390961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110031263|NCT01390961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110031264|NCT01390961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110031265|NCT01390961|Adrenergic Agents|adrenergic agents|mesh-ancestor
110031266|NCT01390961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110031267|NCT01390961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110031268|NCT01390961|Nasal Decongestants|nasal decongestants|mesh-ancestor
110031269|NCT01390961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110031270|NCT01390961|Respiratory System Agents|respiratory system agents|mesh-ancestor
110031271|NCT01390961|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110031272|NCT01390961|Histamine Antagonists|histamine antagonists|mesh-ancestor
110031273|NCT01390961|Histamine Agents|histamine agents|mesh-ancestor
110031274|NCT01390961|Antipruritics|antipruritics|mesh-ancestor
110031275|NCT01390961|Dermatologic Agents|dermatologic agents|mesh-ancestor
110031276|NCT01390961|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110031277|NCT01391052|Norethindrone|norethindrone|mesh-list
110031278|NCT01391052|Norethindrone Acetate|norethindrone acetate|mesh-list
110031279|NCT01391052|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110031280|NCT01391052|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110031281|NCT01391052|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110031282|NCT01391052|Contraceptive Agents|contraceptive agents|mesh-ancestor
110031283|NCT01391052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110031284|NCT01391052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110031285|NCT01391052|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110031286|NCT01391052|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110031288|NCT01391104|Vasodilator Agents|vasodilator agents|mesh-ancestor
110031289|NCT01391104|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110031290|NCT01391104|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110031291|NCT01391104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110031292|NCT01391104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110031293|NCT01391104|Urological Agents|urological agents|mesh-ancestor
110031294|NCT01391156|Minoxidil|minoxidil|mesh-list
110031295|NCT01391156|Finasteride|finasteride|mesh-list
110031296|NCT01391156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110031297|NCT01391156|Vasodilator Agents|vasodilator agents|mesh-ancestor
110031298|NCT01391156|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110031299|NCT01391156|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110031300|NCT01391156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110031301|NCT01391156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110031302|NCT01391156|Hormone Antagonists|hormone antagonists|mesh-ancestor
110031303|NCT01391156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110031304|NCT01391156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110031305|NCT01391156|Urological Agents|urological agents|mesh-ancestor
110031306|NCT01391221|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110031307|NCT01391221|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110031308|NCT01391221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110031309|NCT01391221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110031310|NCT01391221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110031311|NCT01391221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110031312|NCT01391221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110031313|NCT01391221|Analgesics|analgesics|mesh-ancestor
110031314|NCT01391221|Sensory System Agents|sensory system agents|mesh-ancestor
110031315|NCT01391221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110031316|NCT01391221|Antidepressive Agents|antidepressive agents|mesh-ancestor
110031317|NCT01391221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110031318|NCT01391221|Dopamine Agents|dopamine agents|mesh-ancestor
110031319|NCT01391260|Gefitinib|gefitinib|mesh-list
110031320|NCT01391260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110031321|NCT01391260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110031322|NCT01391260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110031323|NCT01391260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110031325|NCT01391377|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110031326|NCT01391377|Antimetabolites|antimetabolites|mesh-ancestor
110031327|NCT01391377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110031328|NCT01391377|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110031329|NCT01391377|Vasodilator Agents|vasodilator agents|mesh-ancestor
110031330|NCT01391377|Vitamin B Complex|vitamin b complex|mesh-ancestor
110031332|NCT01391377|Micronutrients|micronutrients|mesh-ancestor
110031333|NCT01391377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110031334|NCT01391390|Melatonin|melatonin|mesh-list
110031335|NCT01391390|Antioxidants|antioxidants|mesh-ancestor
110031336|NCT01391390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110031437|NCT01392287|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110031338|NCT01391390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110031339|NCT01391390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110031340|NCT01391403|Artemisinins|artemisinins|mesh-list
110031341|NCT01391403|Artemisinin|artemisinin|mesh-list
110031342|NCT01391403|Antimalarials|antimalarials|mesh-ancestor
110031343|NCT01391403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110031344|NCT01391403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110031345|NCT01391403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110031362|NCT01391598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110031363|NCT01391598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110031364|NCT01391598|Sensory System Agents|sensory system agents|mesh-ancestor
110031365|NCT01391598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110031368|NCT01391598|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110031369|NCT01391598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110031370|NCT01391598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110031371|NCT01391624|Mineral Oil|mineral oil|mesh-list
110031372|NCT01391624|Emollients|emollients|mesh-ancestor
110031373|NCT01391624|Dermatologic Agents|dermatologic agents|mesh-ancestor
110031374|NCT01391689|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
110031375|NCT01391689|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110031376|NCT01391689|Protective Agents|protective agents|mesh-ancestor
110031377|NCT01391689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110031378|NCT01391689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110031379|NCT01391715|Rabeprazole|rabeprazole|mesh-list
110031380|NCT01391715|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110031381|NCT01391715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110031382|NCT01391715|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110031383|NCT01391715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110031384|NCT01391715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110031386|NCT01391845|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110031388|NCT01391845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110031389|NCT01391845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110031390|NCT01391845|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110031391|NCT01392014|Primaquine|primaquine|mesh-list
110031392|NCT01392014|Piperaquine|piperaquine|mesh-list
110031393|NCT01392014|Artenimol|artenimol|mesh-list
110031394|NCT01392014|Artemisinins|artemisinins|mesh-list
110031395|NCT01392014|Antimalarials|antimalarials|mesh-ancestor
110031396|NCT01392014|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110031397|NCT01392014|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110031398|NCT01392014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110031399|NCT01392079|Alemtuzumab|alemtuzumab|mesh-list
110031400|NCT01392079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110031401|NCT01392079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110031402|NCT01392144|Nitric Oxide|nitric oxide|mesh-list
110031403|NCT01392144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110031404|NCT01392144|Autonomic Agents|autonomic agents|mesh-ancestor
110031405|NCT01392144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110031406|NCT01392144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110031407|NCT01392144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110031408|NCT01392144|Respiratory System Agents|respiratory system agents|mesh-ancestor
110031409|NCT01392144|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110031410|NCT01392144|Antioxidants|antioxidants|mesh-ancestor
110031411|NCT01392144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110031412|NCT01392144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110031413|NCT01392144|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110031414|NCT01392144|Vasodilator Agents|vasodilator agents|mesh-ancestor
110031415|NCT01392144|Gasotransmitters|gasotransmitters|mesh-ancestor
110031416|NCT01392144|Protective Agents|protective agents|mesh-ancestor
110031419|NCT01392157|Trace Elements|trace elements|mesh-ancestor
110031420|NCT01392157|Micronutrients|micronutrients|mesh-ancestor
110031421|NCT01392157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110031422|NCT01392157|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110031423|NCT01392157|Contraceptive Agents|contraceptive agents|mesh-ancestor
110031424|NCT01392157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110031425|NCT01392157|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110031426|NCT01392157|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110031427|NCT01392157|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110031428|NCT01392209|Bevacizumab|bevacizumab|mesh-list
110031429|NCT01392209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110031430|NCT01392209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110031431|NCT01392209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110031432|NCT01392209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110031434|NCT01392209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110031435|NCT01392209|Growth Inhibitors|growth inhibitors|mesh-ancestor
110031438|NCT01392287|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110031440|NCT01392287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110031441|NCT01392287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110031442|NCT01392287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110031443|NCT01392287|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110031444|NCT01392287|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110031446|NCT01392430|Dapsone|dapsone|mesh-list
110031447|NCT01392430|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110031448|NCT01392430|Itraconazole|itraconazole|mesh-list
110031449|NCT01392430|Fluconazole|fluconazole|mesh-list
110031450|NCT01392430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110031451|NCT01392430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110031452|NCT01392430|Antifungal Agents|antifungal agents|mesh-ancestor
110031453|NCT01392430|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110031454|NCT01392430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110031459|NCT01392430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110031460|NCT01392430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110031461|NCT01392430|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110031462|NCT01392430|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110031463|NCT01392430|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110031465|NCT01392430|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110031466|NCT01392430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110031467|NCT01392430|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110031468|NCT01392430|Leprostatic Agents|leprostatic agents|mesh-ancestor
110031469|NCT01392430|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110031470|NCT01392534|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110031471|NCT01392534|Telmisartan|telmisartan|mesh-list
110031472|NCT01392534|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
110031473|NCT01392534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110031475|NCT01392534|Natriuretic Agents|natriuretic agents|mesh-ancestor
110031476|NCT01392534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110031477|NCT01392534|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110031478|NCT01392534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110031479|NCT01392534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110031480|NCT01392534|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110031481|NCT01392534|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110031482|NCT01392612|Epoetin Alfa|epoetin alfa|mesh-list
110031483|NCT01392612|Hematinics|hematinics|mesh-ancestor
110031484|NCT01392638|Sildenafil Citrate|sildenafil citrate|mesh-list
110031485|NCT01392638|Vasodilator Agents|vasodilator agents|mesh-ancestor
110031486|NCT01392638|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110031487|NCT01392638|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110031488|NCT01392638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110031496|NCT01392716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110031497|NCT01392755|Ritonavir|ritonavir|mesh-list
110031498|NCT01392755|Omeprazole|omeprazole|mesh-list
110031499|NCT01392755|Ranitidine|ranitidine|mesh-list
110031500|NCT01392755|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
110031501|NCT01392755|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110031502|NCT01392755|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110031503|NCT01392755|Protease Inhibitors|protease inhibitors|mesh-ancestor
110031504|NCT01392755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110031505|NCT01392755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110031506|NCT01392755|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110031507|NCT01392755|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110031508|NCT01392755|Antiviral Agents|antiviral agents|mesh-ancestor
110031509|NCT01392755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110031510|NCT01392755|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110031511|NCT01392755|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110031512|NCT01392755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110031513|NCT01392755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110031514|NCT01392755|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110031515|NCT01392755|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110031516|NCT01392755|Histamine Antagonists|histamine antagonists|mesh-ancestor
110031517|NCT01392755|Histamine Agents|histamine agents|mesh-ancestor
110031518|NCT01392755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110031519|NCT01392755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110031520|NCT01392768|Levetiracetam|levetiracetam|mesh-list
110031521|NCT01392768|Anticonvulsants|anticonvulsants|mesh-ancestor
110031522|NCT01392768|Nootropic Agents|nootropic agents|mesh-ancestor
110031523|NCT01392794|Ramosetron|ramosetron|mesh-list
110031524|NCT01392794|Antiemetics|antiemetics|mesh-ancestor
110031525|NCT01392794|Autonomic Agents|autonomic agents|mesh-ancestor
110031526|NCT01392794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110031527|NCT01392794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110031528|NCT01392794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110031529|NCT01392794|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110031530|NCT01392794|Serotonin Agents|serotonin agents|mesh-ancestor
110031531|NCT01392794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110031532|NCT01392794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110031534|NCT01392807|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110031535|NCT01392807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110031536|NCT01392807|Sensory System Agents|sensory system agents|mesh-ancestor
110031537|NCT01392807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110031539|NCT01392833|Methylprednisolone|methylprednisolone|mesh-list
110031540|NCT01392833|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110031541|NCT01392833|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110031542|NCT01392833|Prednisolone|prednisolone|mesh-list
110031543|NCT01392833|Prednisolone acetate|prednisolone acetate|mesh-list
110031544|NCT01392833|Azathioprine|azathioprine|mesh-list
110031545|NCT01392833|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110031546|NCT01392833|Prednisolone phosphate|prednisolone phosphate|mesh-list
110031547|NCT01392833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110031548|NCT01392833|Glucocorticoids|glucocorticoids|mesh-ancestor
110031550|NCT01392833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110031551|NCT01392833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110031552|NCT01392833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110031553|NCT01392833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110031554|NCT01392833|Antiemetics|antiemetics|mesh-ancestor
110031562|NCT01392833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110031563|NCT01392833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110031564|NCT01392833|Immunologic Factors|immunologic factors|mesh-ancestor
110031565|NCT01392833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110031566|NCT01392898|Liraglutide|liraglutide|mesh-list
110031567|NCT01392898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110031568|NCT01392898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110031569|NCT01392898|Incretins|incretins|mesh-ancestor
110031570|NCT01392898|Hormones|hormones|mesh-ancestor
110031571|NCT01392898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110031572|NCT01392911|Rifampin|rifampin|mesh-list
110031573|NCT01392911|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110031574|NCT01392911|Antitubercular Agents|antitubercular agents|mesh-ancestor
110031575|NCT01392911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110031576|NCT01392911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110031577|NCT01392911|Leprostatic Agents|leprostatic agents|mesh-ancestor
110031578|NCT01392911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110031579|NCT01392911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110031580|NCT01392911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110031581|NCT01392911|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110031582|NCT01392911|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110031583|NCT01392911|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110031584|NCT01392911|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110031585|NCT01392911|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110031586|NCT01392911|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110031587|NCT01393080|Nimotuzumab|nimotuzumab|mesh-list
110031589|NCT01393080|Paclitaxel|paclitaxel|mesh-list
110031590|NCT01393080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110031591|NCT01393080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110031592|NCT01393080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110031593|NCT01393080|Tubulin Modulators|tubulin modulators|mesh-ancestor
110031594|NCT01393080|Antimitotic Agents|antimitotic agents|mesh-ancestor
110031595|NCT01393080|Mitosis Modulators|mitosis modulators|mesh-ancestor
110031596|NCT01393080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110031597|NCT01393145|Fluticasone|fluticasone|mesh-list
110031598|NCT01393145|Xhance|xhance|mesh-list
110031599|NCT01393145|Formoterol Fumarate|formoterol fumarate|mesh-list
110031600|NCT01393145|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110031601|NCT01393145|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110031602|NCT01393145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110031603|NCT01393145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110031604|NCT01393145|Autonomic Agents|autonomic agents|mesh-ancestor
110031605|NCT01393145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110031606|NCT01393145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110031607|NCT01393145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110031608|NCT01393145|Respiratory System Agents|respiratory system agents|mesh-ancestor
110031609|NCT01393145|Dermatologic Agents|dermatologic agents|mesh-ancestor
110031610|NCT01393145|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110032324|NCT01397006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110031611|NCT01393145|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110031612|NCT01393145|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110031613|NCT01393145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110031614|NCT01393145|Adrenergic Agents|adrenergic agents|mesh-ancestor
110031615|NCT01393145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110031616|NCT01393145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110031617|NCT01393145|Glucocorticoids|glucocorticoids|mesh-ancestor
110031619|NCT01393145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110031620|NCT01393145|Sympathomimetics|sympathomimetics|mesh-ancestor
110031621|NCT01393184|Nimotuzumab|nimotuzumab|mesh-list
110031622|NCT01393184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110031623|NCT01393184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110031625|NCT01393288|Ondansetron|ondansetron|mesh-list
110031626|NCT01393288|Aprepitant|aprepitant|mesh-list
110031627|NCT01393288|Antiemetics|antiemetics|mesh-ancestor
110031628|NCT01393288|Autonomic Agents|autonomic agents|mesh-ancestor
110031629|NCT01393288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110031630|NCT01393288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110031631|NCT01393288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110031632|NCT01393288|Antipruritics|antipruritics|mesh-ancestor
110031633|NCT01393288|Dermatologic Agents|dermatologic agents|mesh-ancestor
110031634|NCT01393288|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110031635|NCT01393288|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110031637|NCT01393288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110031638|NCT01393288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110031639|NCT01393288|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110031640|NCT01393288|Anticonvulsants|anticonvulsants|mesh-ancestor
110031641|NCT01393288|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110031642|NCT01393288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110031643|NCT01393288|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110031644|NCT01393288|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110031645|NCT01393288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110031646|NCT01393288|GABA Modulators|gaba modulators|mesh-ancestor
110031647|NCT01393288|GABA Agents|gaba agents|mesh-ancestor
110031648|NCT01393340|Omalizumab|omalizumab|mesh-list
110031649|NCT01393340|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110031650|NCT01393340|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110031651|NCT01393340|Respiratory System Agents|respiratory system agents|mesh-ancestor
110031652|NCT01393548|Brompheniramine|brompheniramine|mesh-list
110031653|NCT01393548|Phenylephrine|phenylephrine|mesh-list
110031654|NCT01393548|Oxymetazoline|oxymetazoline|mesh-list
110031655|NCT01393548|Pseudoephedrine|pseudoephedrine|mesh-list
110031657|NCT01393548|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110031658|NCT01393548|Mydriatics|mydriatics|mesh-ancestor
110031659|NCT01393548|Autonomic Agents|autonomic agents|mesh-ancestor
110031660|NCT01393548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110031661|NCT01393548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110031662|NCT01393548|Sympathomimetics|sympathomimetics|mesh-ancestor
110031663|NCT01393548|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110031664|NCT01393548|Nasal Decongestants|nasal decongestants|mesh-ancestor
110031665|NCT01393548|Respiratory System Agents|respiratory system agents|mesh-ancestor
110031666|NCT01393548|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110031667|NCT01393548|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110031668|NCT01393548|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110031669|NCT01393548|Adrenergic Agents|adrenergic agents|mesh-ancestor
110031670|NCT01393548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110031671|NCT01393548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110031672|NCT01393548|Protective Agents|protective agents|mesh-ancestor
110031673|NCT01393548|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110031674|NCT01393548|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110031675|NCT01393548|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110031676|NCT01393548|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110031677|NCT01393548|Histamine Antagonists|histamine antagonists|mesh-ancestor
110031678|NCT01393548|Histamine Agents|histamine agents|mesh-ancestor
110031679|NCT01393548|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110031680|NCT01393574|Melatonin|melatonin|mesh-list
110031681|NCT01393574|Methylphenidate|methylphenidate|mesh-list
110031682|NCT01393574|Antioxidants|antioxidants|mesh-ancestor
110031683|NCT01393574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110031684|NCT01393574|Protective Agents|protective agents|mesh-ancestor
110031686|NCT01393574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110031687|NCT01393574|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110031688|NCT01393574|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110031689|NCT01393574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110031690|NCT01393574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110031692|NCT01393574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110031693|NCT01393756|Lenalidomide|lenalidomide|mesh-list
110031694|NCT01393756|Immunologic Factors|immunologic factors|mesh-ancestor
110031695|NCT01393756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110031696|NCT01393756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110031697|NCT01393756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110031698|NCT01393756|Growth Substances|growth substances|mesh-ancestor
110031699|NCT01393756|Growth Inhibitors|growth inhibitors|mesh-ancestor
110031700|NCT01393756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110031702|NCT01393769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110031703|NCT01393769|Alkylating Agents|alkylating agents|mesh-ancestor
110031704|NCT01393769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110031705|NCT01393769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110031706|NCT01393769|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110031707|NCT01393769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110031708|NCT01393769|Immunologic Factors|immunologic factors|mesh-ancestor
110031709|NCT01393769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110031710|NCT01393782|Angiotensin II|angiotensin ii|mesh-list
110031711|NCT01393782|Giapreza|giapreza|mesh-list
110031712|NCT01393782|Angiotensinogen|angiotensinogen|mesh-list
110031713|NCT01393782|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110031714|NCT01393782|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110031716|NCT01393782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110031717|NCT01393782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110031718|NCT01393795|Capsaicin|capsaicin|mesh-list
110031719|NCT01393795|Antipruritics|antipruritics|mesh-ancestor
110031720|NCT01393795|Dermatologic Agents|dermatologic agents|mesh-ancestor
110031721|NCT01393795|Sensory System Agents|sensory system agents|mesh-ancestor
110031722|NCT01393795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110031723|NCT01393795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110031724|NCT01393912|Crenolanib|crenolanib|mesh-list
110031725|NCT01393912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110031726|NCT01393925|Parecoxib|parecoxib|mesh-list
110031727|NCT01393925|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110031728|NCT01393925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110031729|NCT01393925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110031730|NCT01393925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110031731|NCT01393925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110031732|NCT01393925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110031733|NCT01393925|Analgesics|analgesics|mesh-ancestor
110031734|NCT01393925|Sensory System Agents|sensory system agents|mesh-ancestor
110031735|NCT01393925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110031736|NCT01393925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110031737|NCT01393925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110031738|NCT01393925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110031739|NCT01394029|Deferasirox|deferasirox|mesh-list
110031740|NCT01394029|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110031741|NCT01394029|Chelating Agents|chelating agents|mesh-ancestor
110031742|NCT01394029|Sequestering Agents|sequestering agents|mesh-ancestor
110031745|NCT01394094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110031746|NCT01394094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110031747|NCT01394133|Ritonavir|ritonavir|mesh-list
110031748|NCT01394133|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110031749|NCT01394133|Tenofovir|tenofovir|mesh-list
110031750|NCT01394133|Emtricitabine|emtricitabine|mesh-list
110031751|NCT01394133|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110031752|NCT01394133|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110031753|NCT01394133|Protease Inhibitors|protease inhibitors|mesh-ancestor
110031754|NCT01394133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110031755|NCT01394133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110031756|NCT01394133|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110031757|NCT01394133|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110031758|NCT01394133|Antiviral Agents|antiviral agents|mesh-ancestor
110031759|NCT01394133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110031760|NCT01394133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110031761|NCT01394133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110031762|NCT01394133|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110031763|NCT01394133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110031764|NCT01394224|Levetiracetam|levetiracetam|mesh-list
110031765|NCT01394224|Anticonvulsants|anticonvulsants|mesh-ancestor
110031766|NCT01394224|Nootropic Agents|nootropic agents|mesh-ancestor
110031767|NCT01394263|Goserelin|goserelin|mesh-list
110031771|NCT01394341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110031772|NCT01394341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110031774|NCT01394341|Hormones|hormones|mesh-ancestor
110031775|NCT01394341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110031776|NCT01394354|Dexamethasone|dexamethasone|mesh-list
110031777|NCT01394354|Dexamethasone acetate|dexamethasone acetate|mesh-list
110031778|NCT01394354|Doxorubicin|doxorubicin|mesh-list
110031779|NCT01394354|Bortezomib|bortezomib|mesh-list
110031780|NCT01394354|Vorinostat|vorinostat|mesh-list
110031781|NCT01394354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110031782|NCT01394354|Antiemetics|antiemetics|mesh-ancestor
110031783|NCT01394354|Autonomic Agents|autonomic agents|mesh-ancestor
110031784|NCT01394354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110031785|NCT01394354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110031786|NCT01394354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110031787|NCT01394354|Glucocorticoids|glucocorticoids|mesh-ancestor
110031788|NCT01394354|Hormones|hormones|mesh-ancestor
110031789|NCT01394354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110031790|NCT01394354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110031791|NCT01394354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110031792|NCT01394354|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110031793|NCT01394354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110031794|NCT01394354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110031795|NCT01394354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110031796|NCT01394354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110031797|NCT01394354|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110031798|NCT01394406|Ketamine|ketamine|mesh-list
110031799|NCT01394406|Analgesics|analgesics|mesh-ancestor
110031800|NCT01394406|Sensory System Agents|sensory system agents|mesh-ancestor
110031801|NCT01394406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110031802|NCT01394406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110031803|NCT01394406|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110031804|NCT01394406|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110031805|NCT01394406|Anesthetics, General|anesthetics, general|mesh-ancestor
110031806|NCT01394406|Anesthetics|anesthetics|mesh-ancestor
110031807|NCT01394406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110031808|NCT01394406|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110031809|NCT01394406|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110031810|NCT01394406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110031811|NCT01394406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110031812|NCT01394419|Acetylcysteine|acetylcysteine|mesh-list
110031813|NCT01394419|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110031814|NCT01394419|Antiviral Agents|antiviral agents|mesh-ancestor
110031815|NCT01394419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110031816|NCT01394419|Expectorants|expectorants|mesh-ancestor
110031817|NCT01394419|Respiratory System Agents|respiratory system agents|mesh-ancestor
110031818|NCT01394419|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110031819|NCT01394419|Antioxidants|antioxidants|mesh-ancestor
110031820|NCT01394419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110031822|NCT01394419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110031823|NCT01394419|Antidotes|antidotes|mesh-ancestor
110031824|NCT01394445|Physostigmine|physostigmine|mesh-list
110031825|NCT01394445|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110031826|NCT01394445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110031827|NCT01394445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110031828|NCT01394445|Cholinergic Agents|cholinergic agents|mesh-ancestor
110031829|NCT01394445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110031830|NCT01394445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110031832|NCT01394445|Autonomic Agents|autonomic agents|mesh-ancestor
110031833|NCT01394445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110031834|NCT01394458|Ethanol|ethanol|mesh-list
110031835|NCT01394458|Heparin|heparin|mesh-list
110031836|NCT01394458|Citric Acid|citric acid|mesh-list
110031837|NCT01394458|Sodium Citrate|sodium citrate|mesh-list
110031838|NCT01394458|Anticoagulants|anticoagulants|mesh-ancestor
110031839|NCT01394458|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110031840|NCT01394458|Chelating Agents|chelating agents|mesh-ancestor
110031841|NCT01394458|Sequestering Agents|sequestering agents|mesh-ancestor
110031842|NCT01394458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110031843|NCT01394458|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110031844|NCT01394458|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110031845|NCT01394458|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110031846|NCT01394458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110031847|NCT01394458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110031848|NCT01394458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110031849|NCT01394471|Oxytocin|oxytocin|mesh-list
110031850|NCT01394471|Oxytocics|oxytocics|mesh-ancestor
110031851|NCT01394471|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110032325|NCT01397019|Leucovorin|leucovorin|mesh-list
110031852|NCT01394471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110031854|NCT01394497|Antiviral Agents|antiviral agents|mesh-ancestor
110031855|NCT01394497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110031856|NCT01394497|Expectorants|expectorants|mesh-ancestor
110031857|NCT01394497|Respiratory System Agents|respiratory system agents|mesh-ancestor
110031858|NCT01394497|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110031859|NCT01394497|Antioxidants|antioxidants|mesh-ancestor
110031860|NCT01394497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110031861|NCT01394497|Protective Agents|protective agents|mesh-ancestor
110031862|NCT01394497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110031863|NCT01394640|Vaccines|vaccines|mesh-list
110031864|NCT01394640|Immunologic Factors|immunologic factors|mesh-ancestor
110031865|NCT01394640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110031866|NCT01394653|Ramosetron|ramosetron|mesh-list
110031867|NCT01394653|Antiemetics|antiemetics|mesh-ancestor
110031868|NCT01394653|Autonomic Agents|autonomic agents|mesh-ancestor
110031869|NCT01394653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110031870|NCT01394653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110031871|NCT01394653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110031872|NCT01394653|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110031873|NCT01394653|Serotonin Agents|serotonin agents|mesh-ancestor
110031874|NCT01394653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110031875|NCT01394653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110031876|NCT01394679|Deoxyglucose|deoxyglucose|mesh-list
110031877|NCT01394679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110031878|NCT01394679|Antimetabolites|antimetabolites|mesh-ancestor
110031879|NCT01394679|Antiviral Agents|antiviral agents|mesh-ancestor
110031880|NCT01394679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110031881|NCT01394731|Acetaminophen|acetaminophen|mesh-list
110031882|NCT01394731|Meperidine|meperidine|mesh-list
110031883|NCT01394731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110031884|NCT01394731|Analgesics|analgesics|mesh-ancestor
110031885|NCT01394731|Sensory System Agents|sensory system agents|mesh-ancestor
110031886|NCT01394731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110031887|NCT01394731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110031888|NCT01394731|Antipyretics|antipyretics|mesh-ancestor
110031889|NCT01394731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110031890|NCT01394731|Narcotics|narcotics|mesh-ancestor
110031891|NCT01394731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110031892|NCT01394731|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110031893|NCT01394757|Ketamine|ketamine|mesh-list
110031894|NCT01394757|Esketamine|esketamine|mesh-list
110031895|NCT01394757|Analgesics|analgesics|mesh-ancestor
110031896|NCT01394757|Sensory System Agents|sensory system agents|mesh-ancestor
110031898|NCT01394757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110031899|NCT01394757|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110031900|NCT01394757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110031901|NCT01394757|Anesthetics, General|anesthetics, general|mesh-ancestor
110031902|NCT01394757|Anesthetics|anesthetics|mesh-ancestor
110031903|NCT01394757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110031904|NCT01394757|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110031905|NCT01394757|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110031906|NCT01394757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110031907|NCT01394757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110031908|NCT01394757|Antidepressive Agents|antidepressive agents|mesh-ancestor
110031909|NCT01394757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110031910|NCT01394770|Amlodipine|amlodipine|mesh-list
110031912|NCT01394770|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110031913|NCT01394770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110031914|NCT01394770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110031915|NCT01394770|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110031916|NCT01394770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110031923|NCT01394796|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110031924|NCT01394796|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110031925|NCT01394796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110031926|NCT01394796|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110031927|NCT01394835|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
110031928|NCT01394835|Protein C Inhibitor|protein c inhibitor|mesh-list
110031929|NCT01394835|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110031930|NCT01394835|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110031931|NCT01394835|Protease Inhibitors|protease inhibitors|mesh-ancestor
110031932|NCT01394835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110031933|NCT01394835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110031934|NCT01394848|Everolimus|everolimus|mesh-list
110031935|NCT01394848|Clopidogrel|clopidogrel|mesh-list
110031936|NCT01394848|Atorvastatin|atorvastatin|mesh-list
110031937|NCT01394848|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110031938|NCT01394848|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110031939|NCT01394848|Antimetabolites|antimetabolites|mesh-ancestor
110031940|NCT01394848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110031941|NCT01394848|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110031942|NCT01394848|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110031944|NCT01394848|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110031945|NCT01394848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110031946|NCT01394848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110031947|NCT01394848|Immunologic Factors|immunologic factors|mesh-ancestor
110031948|NCT01394848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110031949|NCT01394848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110031950|NCT01394848|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110031951|NCT01394848|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110031952|NCT01394848|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110031953|NCT01394848|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110031954|NCT01394848|Purinergic Agents|purinergic agents|mesh-ancestor
110031955|NCT01394848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110031957|NCT01394887|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110031958|NCT01394887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110031959|NCT01394913|Etanercept|etanercept|mesh-list
110031960|NCT01394913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110031961|NCT01394913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110031962|NCT01394913|Analgesics|analgesics|mesh-ancestor
110031963|NCT01394913|Sensory System Agents|sensory system agents|mesh-ancestor
110031964|NCT01394913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110031965|NCT01394913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110031966|NCT01394913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110031967|NCT01394913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110031968|NCT01394913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110031969|NCT01394913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110031970|NCT01394913|Immunologic Factors|immunologic factors|mesh-ancestor
110031971|NCT01395069|Ketorolac|ketorolac|mesh-list
110031972|NCT01395069|Nepafenac|nepafenac|mesh-list
110031973|NCT01395069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110031974|NCT01395069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110031975|NCT01395069|Analgesics|analgesics|mesh-ancestor
110031976|NCT01395069|Sensory System Agents|sensory system agents|mesh-ancestor
110031977|NCT01395069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110031978|NCT01395069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110031979|NCT01395069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110031980|NCT01395069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110031981|NCT01395069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110031982|NCT01395069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110031983|NCT01395069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110031985|NCT01395108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110031986|NCT01395108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110031987|NCT01395147|Vortioxetine|vortioxetine|mesh-list
110031988|NCT01395147|Antidepressive Agents|antidepressive agents|mesh-ancestor
110031989|NCT01395147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110031990|NCT01395147|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110031991|NCT01395147|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110031994|NCT01395147|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110031995|NCT01395147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110031996|NCT01395147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110031997|NCT01395147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110031998|NCT01395147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110031999|NCT01395147|Serotonin Agents|serotonin agents|mesh-ancestor
110032000|NCT01395147|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110032001|NCT01395147|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110032002|NCT01395147|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110032003|NCT01395147|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110032006|NCT01395199|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110032007|NCT01395199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110032008|NCT01395199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110032009|NCT01395199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110032010|NCT01395199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032011|NCT01395199|Vasodilator Agents|vasodilator agents|mesh-ancestor
110032012|NCT01395251|Prednisolone|prednisolone|mesh-list
110032013|NCT01395251|Glucocorticoids|glucocorticoids|mesh-list
110032014|NCT01395251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110032015|NCT01395251|Hormones|hormones|mesh-ancestor
110032326|NCT01397019|Oxaliplatin|oxaliplatin|mesh-list
110032016|NCT01395251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110032017|NCT01395251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032018|NCT01395251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110032019|NCT01395251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110032020|NCT01395290|Cholecalciferol|cholecalciferol|mesh-list
110032021|NCT01395290|Vitamin D|vitamin d|mesh-list
110032022|NCT01395290|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110032023|NCT01395290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032024|NCT01395290|Vitamins|vitamins|mesh-ancestor
110032025|NCT01395290|Micronutrients|micronutrients|mesh-ancestor
110032026|NCT01395290|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110032027|NCT01395381|Albendazole|albendazole|mesh-list
110032028|NCT01395381|Anthelmintics|anthelmintics|mesh-ancestor
110032029|NCT01395381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110032030|NCT01395381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110032031|NCT01395381|Anticestodal Agents|anticestodal agents|mesh-ancestor
110032032|NCT01395381|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110032033|NCT01395381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110032034|NCT01395381|Tubulin Modulators|tubulin modulators|mesh-ancestor
110032035|NCT01395381|Antimitotic Agents|antimitotic agents|mesh-ancestor
110032036|NCT01395381|Mitosis Modulators|mitosis modulators|mesh-ancestor
110032037|NCT01395381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110032038|NCT01395381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110032039|NCT01395420|Ceftazidime|ceftazidime|mesh-list
110032040|NCT01395420|Avibactam|avibactam|mesh-list
110032041|NCT01395420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110032042|NCT01395420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110032043|NCT01395420|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110032044|NCT01395420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110032045|NCT01395420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110032047|NCT01395433|Citalopram|citalopram|mesh-list
110032048|NCT01395433|Escitalopram|escitalopram|mesh-list
110032049|NCT01395433|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110032050|NCT01395433|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110032051|NCT01395433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110032052|NCT01395433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110032053|NCT01395433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110032054|NCT01395433|Serotonin Agents|serotonin agents|mesh-ancestor
110032055|NCT01395433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032056|NCT01395433|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110032057|NCT01395433|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110032058|NCT01395433|Parasympatholytics|parasympatholytics|mesh-ancestor
110032059|NCT01395433|Autonomic Agents|autonomic agents|mesh-ancestor
110032060|NCT01395433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110032061|NCT01395433|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110032062|NCT01395433|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110032063|NCT01395433|Cholinergic Agents|cholinergic agents|mesh-ancestor
110032064|NCT01395433|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110032065|NCT01395433|Antidepressive Agents|antidepressive agents|mesh-ancestor
110032066|NCT01395433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110032067|NCT01395485|Brodalumab|brodalumab|mesh-list
110032068|NCT01395485|Dermatologic Agents|dermatologic agents|mesh-ancestor
110032069|NCT01395589|Vitamin D|vitamin d|mesh-list
110032070|NCT01395589|Vitamins|vitamins|mesh-ancestor
110032071|NCT01395589|Micronutrients|micronutrients|mesh-ancestor
110032072|NCT01395589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032073|NCT01395589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110032074|NCT01395602|Cabergoline|cabergoline|mesh-list
110032075|NCT01395602|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110032076|NCT01395602|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110032077|NCT01395602|Dopamine Agonists|dopamine agonists|mesh-ancestor
110032079|NCT01395602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110032080|NCT01395602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110032081|NCT01395602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032082|NCT01395654|Rifampin|rifampin|mesh-list
110032084|NCT01395654|Pyrazinamide|pyrazinamide|mesh-list
110032085|NCT01395654|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110032086|NCT01395654|Antitubercular Agents|antitubercular agents|mesh-ancestor
110032087|NCT01395654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110032088|NCT01395654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110032089|NCT01395654|Leprostatic Agents|leprostatic agents|mesh-ancestor
110032090|NCT01395654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110032091|NCT01395654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110032092|NCT01395654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110032093|NCT01395654|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110032094|NCT01395654|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110032095|NCT01395654|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110032096|NCT01395654|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110032097|NCT01395654|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110032098|NCT01395654|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110032099|NCT01395654|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110032100|NCT01395654|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110032101|NCT01395654|Antimetabolites|antimetabolites|mesh-ancestor
110032102|NCT01395654|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110032103|NCT01395667|Leucovorin|leucovorin|mesh-list
110032104|NCT01395667|Fluorouracil|fluorouracil|mesh-list
110032105|NCT01395667|Oxaliplatin|oxaliplatin|mesh-list
110032106|NCT01395667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110032107|NCT01395667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032109|NCT01395667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110032110|NCT01395667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110032111|NCT01395667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110032112|NCT01395667|Immunologic Factors|immunologic factors|mesh-ancestor
110032113|NCT01395667|Antidotes|antidotes|mesh-ancestor
110032114|NCT01395667|Protective Agents|protective agents|mesh-ancestor
110032115|NCT01395667|Vitamin B Complex|vitamin b complex|mesh-ancestor
110032116|NCT01395667|Vitamins|vitamins|mesh-ancestor
110032117|NCT01395667|Micronutrients|micronutrients|mesh-ancestor
110032118|NCT01395732|Bosentan|bosentan|mesh-list
110032119|NCT01395732|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110032120|NCT01395732|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110032121|NCT01395732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110032122|NCT01395849|Fluticasone|fluticasone|mesh-list
110032123|NCT01395849|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110032124|NCT01395849|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110032125|NCT01395849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110032126|NCT01395849|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110032127|NCT01395849|Autonomic Agents|autonomic agents|mesh-ancestor
110032128|NCT01395849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110032129|NCT01395849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032130|NCT01395849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110032131|NCT01395849|Respiratory System Agents|respiratory system agents|mesh-ancestor
110032132|NCT01395849|Dermatologic Agents|dermatologic agents|mesh-ancestor
110032133|NCT01395849|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110032134|NCT01395849|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110032135|NCT01395849|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110032136|NCT01395849|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110032137|NCT01395849|Adrenergic Agents|adrenergic agents|mesh-ancestor
110032138|NCT01395849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110032139|NCT01395849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110032140|NCT01395849|Glucocorticoids|glucocorticoids|mesh-ancestor
110032141|NCT01395849|Hormones|hormones|mesh-ancestor
110032142|NCT01395849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110032143|NCT01395849|Sympathomimetics|sympathomimetics|mesh-ancestor
110032144|NCT01395862|Fluticasone|fluticasone|mesh-list
110032145|NCT01395862|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110032146|NCT01395862|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110032147|NCT01395862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110032148|NCT01395862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110032150|NCT01395862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110032151|NCT01395862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032153|NCT01395862|Respiratory System Agents|respiratory system agents|mesh-ancestor
110032154|NCT01395862|Dermatologic Agents|dermatologic agents|mesh-ancestor
110032155|NCT01395862|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110032156|NCT01395862|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110032157|NCT01395862|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110032158|NCT01395862|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110032159|NCT01395862|Adrenergic Agents|adrenergic agents|mesh-ancestor
110032160|NCT01395862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110032161|NCT01395862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110032163|NCT01395862|Hormones|hormones|mesh-ancestor
110032164|NCT01395862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110032165|NCT01395862|Sympathomimetics|sympathomimetics|mesh-ancestor
110032166|NCT01395875|Fluticasone|fluticasone|mesh-list
110032168|NCT01395875|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110032169|NCT01395875|Cholinergic Antagonists|cholinergic antagonists|mesh-list
110032170|NCT01395875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110032171|NCT01395875|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110032172|NCT01395875|Autonomic Agents|autonomic agents|mesh-ancestor
110032173|NCT01395875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110032174|NCT01395875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032175|NCT01395875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110032176|NCT01395875|Respiratory System Agents|respiratory system agents|mesh-ancestor
110032177|NCT01395875|Dermatologic Agents|dermatologic agents|mesh-ancestor
110032178|NCT01395875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110032179|NCT01395875|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110032180|NCT01395875|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110032181|NCT01395875|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110032182|NCT01395875|Adrenergic Agents|adrenergic agents|mesh-ancestor
110032183|NCT01395875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110032184|NCT01395875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110032185|NCT01395875|Cholinergic Agents|cholinergic agents|mesh-ancestor
110032186|NCT01395927|Canagliflozin|canagliflozin|mesh-list
110032187|NCT01395927|Rifampin|rifampin|mesh-list
110032188|NCT01395927|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110032189|NCT01395927|Antitubercular Agents|antitubercular agents|mesh-ancestor
110032190|NCT01395927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110032191|NCT01395927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110032192|NCT01395927|Leprostatic Agents|leprostatic agents|mesh-ancestor
110032193|NCT01395927|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110032194|NCT01395927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110032195|NCT01395927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110032196|NCT01395927|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110032197|NCT01395927|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110032198|NCT01395927|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110032199|NCT01395927|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110032200|NCT01395927|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110032201|NCT01395927|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110032202|NCT01395927|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110032203|NCT01395927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110032204|NCT01395927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032205|NCT01395953|Buspirone|buspirone|mesh-list
110032207|NCT01395953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110032208|NCT01395953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110032209|NCT01395953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032210|NCT01395953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110032211|NCT01395953|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110032212|NCT01395953|Serotonin Agents|serotonin agents|mesh-ancestor
110032213|NCT01395953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110032214|NCT01395953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110032215|NCT01395992|Asenapine|asenapine|mesh-list
110032216|NCT01395992|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110032217|NCT01395992|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110032218|NCT01395992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110032219|NCT01395992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032220|NCT01395992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110032221|NCT01396200|Hydroxychloroquine|hydroxychloroquine|mesh-list
110032223|NCT01396200|Antimalarials|antimalarials|mesh-ancestor
110032224|NCT01396200|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110032225|NCT01396200|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110032226|NCT01396200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110032227|NCT01396200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110032228|NCT01396200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110032229|NCT01396200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110032230|NCT01396200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110032231|NCT01396200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110032232|NCT01396200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110032233|NCT01396200|Antifungal Agents|antifungal agents|mesh-ancestor
110032234|NCT01396200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110032235|NCT01396200|Immunologic Factors|immunologic factors|mesh-ancestor
110032236|NCT01396200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032237|NCT01396291|Asenapine|asenapine|mesh-list
110032238|NCT01396291|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110032239|NCT01396291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110032240|NCT01396291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110032241|NCT01396291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032242|NCT01396291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110032243|NCT01396304|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110032244|NCT01396304|Calcium|calcium|mesh-list
110032245|NCT01396304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110032246|NCT01396304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032247|NCT01396304|Laxatives|laxatives|mesh-ancestor
110032248|NCT01396304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110032251|NCT01396564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110032252|NCT01396564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032253|NCT01396642|Emollients|emollients|mesh-list
110032254|NCT01396642|Dermatologic Agents|dermatologic agents|mesh-ancestor
110032255|NCT01396655|Docetaxel|docetaxel|mesh-list
110032256|NCT01396655|Doxorubicin|doxorubicin|mesh-list
110032257|NCT01396655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110032258|NCT01396655|Tubulin Modulators|tubulin modulators|mesh-ancestor
110032259|NCT01396655|Antimitotic Agents|antimitotic agents|mesh-ancestor
110032260|NCT01396655|Mitosis Modulators|mitosis modulators|mesh-ancestor
110032261|NCT01396655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110032262|NCT01396655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110032263|NCT01396655|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110032264|NCT01396655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110032265|NCT01396655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110032266|NCT01396668|Gemcitabine|gemcitabine|mesh-list
110032267|NCT01396668|Capecitabine|capecitabine|mesh-list
110032268|NCT01396668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110032269|NCT01396668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110032270|NCT01396668|Antimetabolites|antimetabolites|mesh-ancestor
110032271|NCT01396668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110032272|NCT01396681|Gemcitabine|gemcitabine|mesh-list
110032273|NCT01396681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110032274|NCT01396681|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110032275|NCT01396681|Antimetabolites|antimetabolites|mesh-ancestor
110032276|NCT01396681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110032277|NCT01396707|Capecitabine|capecitabine|mesh-list
110032278|NCT01396707|Oxaliplatin|oxaliplatin|mesh-list
110032279|NCT01396707|Trastuzumab|trastuzumab|mesh-list
110032280|NCT01396707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110032281|NCT01396707|Antimetabolites|antimetabolites|mesh-ancestor
110032282|NCT01396707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110032283|NCT01396707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110032284|NCT01396707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110032286|NCT01396720|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110032287|NCT01396720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110032288|NCT01396720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110032289|NCT01396720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032290|NCT01396720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110032291|NCT01396720|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110032292|NCT01396720|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110032293|NCT01396720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110032294|NCT01396720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110032295|NCT01396720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110032296|NCT01396720|Serotonin Agents|serotonin agents|mesh-ancestor
110032297|NCT01396720|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110032298|NCT01396720|Antidepressive Agents|antidepressive agents|mesh-ancestor
110032299|NCT01396720|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110032300|NCT01396720|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110032301|NCT01396720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110032302|NCT01396720|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110032303|NCT01396733|Thioctic Acid|thioctic acid|mesh-list
110032304|NCT01396733|Antioxidants|antioxidants|mesh-ancestor
110032305|NCT01396733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110032306|NCT01396733|Protective Agents|protective agents|mesh-ancestor
110032307|NCT01396733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032308|NCT01396733|Vitamin B Complex|vitamin b complex|mesh-ancestor
110032310|NCT01396733|Micronutrients|micronutrients|mesh-ancestor
110032311|NCT01397006|Pregabalin|pregabalin|mesh-list
110032312|NCT01397006|Analgesics|analgesics|mesh-ancestor
110032313|NCT01397006|Sensory System Agents|sensory system agents|mesh-ancestor
110032314|NCT01397006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110032315|NCT01397006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032316|NCT01397006|Anticonvulsants|anticonvulsants|mesh-ancestor
110032317|NCT01397006|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110032318|NCT01397006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110032319|NCT01397006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110032320|NCT01397006|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110032321|NCT01397006|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110032322|NCT01397006|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110032323|NCT01397006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110032328|NCT01397019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110032330|NCT01397019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110032331|NCT01397019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110032332|NCT01397019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110032333|NCT01397019|Antidotes|antidotes|mesh-ancestor
110032334|NCT01397019|Protective Agents|protective agents|mesh-ancestor
110032335|NCT01397019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032336|NCT01397019|Vitamin B Complex|vitamin b complex|mesh-ancestor
110032338|NCT01397019|Micronutrients|micronutrients|mesh-ancestor
110032339|NCT01397097|Etonogestrel|etonogestrel|mesh-list
110032340|NCT01397097|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110032341|NCT01397097|Contraceptive Agents|contraceptive agents|mesh-ancestor
110032342|NCT01397097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110032343|NCT01397097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032344|NCT01397097|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110032345|NCT01397175|Everolimus|everolimus|mesh-list
110032346|NCT01397175|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110032347|NCT01397175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110032348|NCT01397175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110032349|NCT01397175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110032350|NCT01397175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110032351|NCT01397175|Immunologic Factors|immunologic factors|mesh-ancestor
110032352|NCT01397175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032353|NCT01397175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110032354|NCT01397214|Megestrol Acetate|megestrol acetate|mesh-list
110032355|NCT01397214|Megestrol|megestrol|mesh-list
110032356|NCT01397214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110032357|NCT01397214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110032358|NCT01397214|Appetite Stimulants|appetite stimulants|mesh-ancestor
110032359|NCT01397214|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110032360|NCT01397214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032361|NCT01397214|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110032362|NCT01397214|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110032363|NCT01397214|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110032364|NCT01397214|Contraceptive Agents|contraceptive agents|mesh-ancestor
110032365|NCT01397214|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110032366|NCT01397214|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110032367|NCT01397214|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110032369|NCT01397305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110032370|NCT01397305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110032371|NCT01397305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110032372|NCT01397305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110032373|NCT01397305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110032374|NCT01397331|Propofol|propofol|mesh-list
110032375|NCT01397331|Isoflurane|isoflurane|mesh-list
110032376|NCT01397331|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110032377|NCT01397331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110032378|NCT01397331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032379|NCT01397331|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110032380|NCT01397331|Anesthetics, General|anesthetics, general|mesh-ancestor
110032381|NCT01397331|Anesthetics|anesthetics|mesh-ancestor
110032382|NCT01397331|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110032383|NCT05269290|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
110032385|NCT05269290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110032386|NCT05268835|Clindamycin|clindamycin|mesh-list
110032387|NCT05268835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110032388|NCT05268835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110032389|NCT05268835|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110032390|NCT05268835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110032391|NCT05268835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110032392|NCT05268718|Voriconazole|voriconazole|mesh-list
110032393|NCT05268718|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110032394|NCT05268718|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110032395|NCT05268718|Antifungal Agents|antifungal agents|mesh-ancestor
110032396|NCT05268718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110032397|NCT05268718|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110032399|NCT05268718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110032400|NCT05268718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110032401|NCT05268718|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110032402|NCT05268718|Hormone Antagonists|hormone antagonists|mesh-ancestor
110032403|NCT05268718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110032404|NCT05268718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032405|NCT05268718|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110032411|NCT05268627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110032412|NCT05268601|Sotrovimab|sotrovimab|mesh-list
110032413|NCT05268601|Bamlanivimab|bamlanivimab|mesh-list
110032414|NCT05268601|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
110032415|NCT05268601|Antiviral Agents|antiviral agents|mesh-ancestor
110032416|NCT05268601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110032417|NCT05268068|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110032418|NCT05268068|Immunologic Factors|immunologic factors|mesh-ancestor
110032419|NCT05268068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032420|NCT05267977|Cephalosporins|cephalosporins|mesh-list
110032421|NCT05267977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110032422|NCT05267977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110032423|NCT05186558|Rituximab|rituximab|mesh-list
110032424|NCT05186558|Gemcitabine|gemcitabine|mesh-list
110032425|NCT05186558|Oxaliplatin|oxaliplatin|mesh-list
110032426|NCT05186558|Lenalidomide|lenalidomide|mesh-list
110032427|NCT05186558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110032428|NCT05186558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110032429|NCT05186558|Immunologic Factors|immunologic factors|mesh-ancestor
110032430|NCT05186558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032431|NCT05186558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110032432|NCT05186558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110032433|NCT05186558|Antimetabolites|antimetabolites|mesh-ancestor
110032434|NCT05186558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110032435|NCT05186558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110032436|NCT05186558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110032437|NCT05186558|Growth Substances|growth substances|mesh-ancestor
110032438|NCT05186558|Growth Inhibitors|growth inhibitors|mesh-ancestor
110032439|NCT05092698|Vitamin D|vitamin d|mesh-list
110032440|NCT05092698|Cholecalciferol|cholecalciferol|mesh-list
110032441|NCT05092698|Vitamins|vitamins|mesh-ancestor
110032444|NCT05092698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110032445|NCT05092698|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110032446|NCT04975269|Acetazolamide|acetazolamide|mesh-list
110032448|NCT04975269|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110032449|NCT04975269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110032450|NCT04975269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110032451|NCT04975269|Diuretics|diuretics|mesh-ancestor
110032452|NCT04975269|Natriuretic Agents|natriuretic agents|mesh-ancestor
110032453|NCT04975269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032454|NCT04965870|Trifluridine|trifluridine|mesh-list
110032455|NCT04965870|Antimetabolites|antimetabolites|mesh-ancestor
110032456|NCT04965870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110032457|NCT04965870|Antiviral Agents|antiviral agents|mesh-ancestor
110032458|NCT04965870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110032462|NCT04500756|Metformin|metformin|mesh-list
110032463|NCT04500756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110032464|NCT04500756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032465|NCT04466540|Hydroxychloroquine|hydroxychloroquine|mesh-list
110032466|NCT04466540|Antimalarials|antimalarials|mesh-ancestor
110032467|NCT04466540|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110032468|NCT04466540|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110032469|NCT04466540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110032470|NCT04466540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110032471|NCT04466540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110032472|NCT04466540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110032473|NCT04453449|Midazolam|midazolam|mesh-list
110032474|NCT04453449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110032475|NCT04453449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110032476|NCT04453449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110032477|NCT04453449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032478|NCT04453449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110032479|NCT04453449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110032480|NCT04453449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110032481|NCT04453449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110032482|NCT04453449|Anesthetics, General|anesthetics, general|mesh-ancestor
110032484|NCT04453449|GABA Modulators|gaba modulators|mesh-ancestor
110032485|NCT04453449|GABA Agents|gaba agents|mesh-ancestor
110032486|NCT04453449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110032487|NCT04453449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110032489|NCT04415333|Histamine Antagonists|histamine antagonists|mesh-ancestor
110032490|NCT04415333|Histamine Agents|histamine agents|mesh-ancestor
110032491|NCT04415333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110032492|NCT04415333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110032493|NCT04415333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032494|NCT03524170|Atezolizumab|atezolizumab|mesh-list
110032495|NCT03524170|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110032496|NCT03524170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110032497|NCT03524170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110032498|NCT03524170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110032499|NCT03336983|Zoledronic Acid|zoledronic acid|mesh-list
110032500|NCT03336983|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110032501|NCT03336983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032502|NCT03283813|Inositol|inositol|mesh-list
110032503|NCT03283813|Vitamin B Complex|vitamin b complex|mesh-ancestor
110032504|NCT03283813|Vitamins|vitamins|mesh-ancestor
110032505|NCT03283813|Micronutrients|micronutrients|mesh-ancestor
110032506|NCT03283813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032507|NCT03245827|Clomiphene|clomiphene|mesh-list
110032508|NCT03245827|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110032509|NCT03245827|Hormone Antagonists|hormone antagonists|mesh-ancestor
110032510|NCT03245827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110032511|NCT03245827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032512|NCT03245827|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110032513|NCT03245827|Fertility Agents|fertility agents|mesh-ancestor
110032514|NCT03245827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110032515|NCT03245827|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110032516|NCT03245827|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110032517|NCT03129321|Econazole|econazole|mesh-list
110032518|NCT03129321|Antifungal Agents|antifungal agents|mesh-ancestor
110032519|NCT03129321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110032520|NCT03129321|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110032521|NCT03129321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110032523|NCT03129321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110032524|NCT03129321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110032525|NCT03129321|Hormone Antagonists|hormone antagonists|mesh-ancestor
110032526|NCT03129321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110032527|NCT03129321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032528|NCT03107611|Pimecrolimus|pimecrolimus|mesh-list
110032529|NCT03107611|Tacrolimus|tacrolimus|mesh-list
110032530|NCT03107611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110032531|NCT03107611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110032532|NCT03107611|Analgesics|analgesics|mesh-ancestor
110032533|NCT03107611|Sensory System Agents|sensory system agents|mesh-ancestor
110032534|NCT03107611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110032535|NCT03107611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032536|NCT03107611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110032537|NCT03107611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110032538|NCT03107611|Dermatologic Agents|dermatologic agents|mesh-ancestor
110032539|NCT03107611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110032540|NCT03107611|Immunologic Factors|immunologic factors|mesh-ancestor
110032541|NCT03107611|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110032542|NCT03107611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110032543|NCT03107611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110032544|NCT03040726|Palonosetron|palonosetron|mesh-list
110032545|NCT03040726|Antiemetics|antiemetics|mesh-ancestor
110032546|NCT03040726|Autonomic Agents|autonomic agents|mesh-ancestor
110032547|NCT03040726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110032548|NCT03040726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032550|NCT03040726|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110032551|NCT03040726|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110032552|NCT03040726|Serotonin Agents|serotonin agents|mesh-ancestor
110032553|NCT03040726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110032554|NCT03040726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110032555|NCT02607956|Dolutegravir|dolutegravir|mesh-list
110032556|NCT02607956|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
110032557|NCT02607956|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110032558|NCT02607956|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110032559|NCT02607956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110032560|NCT02607956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110032561|NCT02607956|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110032562|NCT02607956|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110032563|NCT02607956|Antiviral Agents|antiviral agents|mesh-ancestor
110032564|NCT02607956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110032565|NCT02607956|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110032566|NCT02607956|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110032567|NCT02564523|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
110032568|NCT02564523|Antiviral Agents|antiviral agents|mesh-ancestor
110032569|NCT02564523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110032570|NCT02499666|Clopidogrel|clopidogrel|mesh-list
110032571|NCT02499666|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110032572|NCT02499666|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110032573|NCT02499666|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110032574|NCT02499666|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110032575|NCT02499666|Purinergic Agents|purinergic agents|mesh-ancestor
110032576|NCT02499666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110032577|NCT02499666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110032578|NCT02499666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032580|NCT02420912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110032581|NCT02420912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110032582|NCT02420912|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110032583|NCT02420912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110032585|NCT02094716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110032586|NCT02094716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110032587|NCT01460810|Silicon|silicon|mesh-list
110032588|NCT01460810|Trace Elements|trace elements|mesh-ancestor
110032589|NCT01460810|Micronutrients|micronutrients|mesh-ancestor
110032590|NCT01460810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032591|NCT00667329|Cyclophosphamide|cyclophosphamide|mesh-list
110032592|NCT00667329|Rituximab|rituximab|mesh-list
110032593|NCT00667329|Cladribine|cladribine|mesh-list
110032594|NCT00667329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110032595|NCT00667329|Immunologic Factors|immunologic factors|mesh-ancestor
110032596|NCT00667329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032597|NCT00667329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110032598|NCT00667329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110032599|NCT00667329|Alkylating Agents|alkylating agents|mesh-ancestor
110032600|NCT00667329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110032601|NCT00667329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110032602|NCT00667329|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110032603|NCT00667329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110032604|NCT00492167|Antibodies|antibodies|mesh-list
110032605|NCT00492167|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110032606|NCT00492167|Immunologic Factors|immunologic factors|mesh-ancestor
110032607|NCT00492167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032608|NCT05274438|Imatinib Mesylate|imatinib mesylate|mesh-list
110032609|NCT05274438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110032610|NCT05274438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110032611|NCT05274438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110032612|NCT05274438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110032613|NCT05274191|Maleic acid|maleic acid|mesh-list
110032614|NCT05274191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110032615|NCT05274191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110032616|NCT05274139|Cytarabine|cytarabine|mesh-list
110032617|NCT05274139|Dexamethasone|dexamethasone|mesh-list
110032618|NCT05274139|Temozolomide|temozolomide|mesh-list
110032619|NCT05274139|Fotemustine|fotemustine|mesh-list
110032620|NCT05274139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110032621|NCT05274139|Antiemetics|antiemetics|mesh-ancestor
110032622|NCT05274139|Autonomic Agents|autonomic agents|mesh-ancestor
110032623|NCT05274139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110032624|NCT05274139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032625|NCT05274139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110032626|NCT05274139|Glucocorticoids|glucocorticoids|mesh-ancestor
110032627|NCT05274139|Hormones|hormones|mesh-ancestor
110032628|NCT05274139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110032629|NCT05274139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110032630|NCT05274139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110032631|NCT05274139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110032632|NCT05274139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110032633|NCT05274139|Antimetabolites|antimetabolites|mesh-ancestor
110032634|NCT05274139|Antiviral Agents|antiviral agents|mesh-ancestor
110032635|NCT05274139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110032636|NCT05274139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110032637|NCT05274139|Immunologic Factors|immunologic factors|mesh-ancestor
110032638|NCT05274139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110032639|NCT05274139|Alkylating Agents|alkylating agents|mesh-ancestor
110032640|NCT05274113|Dexamethasone|dexamethasone|mesh-list
110032641|NCT05274113|Ropivacaine|ropivacaine|mesh-list
110032642|NCT05274113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110032643|NCT05274113|Antiemetics|antiemetics|mesh-ancestor
110032644|NCT05274113|Autonomic Agents|autonomic agents|mesh-ancestor
110032728|NCT05271253|Dexmedetomidine|dexmedetomidine|mesh-list
110032645|NCT05274113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110032646|NCT05274113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032647|NCT05274113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110032648|NCT05274113|Glucocorticoids|glucocorticoids|mesh-ancestor
110032649|NCT05274113|Hormones|hormones|mesh-ancestor
110032650|NCT05274113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110032651|NCT05274113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110032652|NCT05274113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110032653|NCT05274113|Anesthetics, Local|anesthetics, local|mesh-ancestor
110032654|NCT05274113|Anesthetics|anesthetics|mesh-ancestor
110032655|NCT05274113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110032656|NCT05274113|Sensory System Agents|sensory system agents|mesh-ancestor
110032661|NCT05273944|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110032662|NCT05273944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110032663|NCT05273944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110032664|NCT05273944|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110032665|NCT05273944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110032666|NCT05273944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110032667|NCT05273944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110032669|NCT05273528|Immunologic Factors|immunologic factors|mesh-ancestor
110032670|NCT05273528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032671|NCT05273398|Diazepam|diazepam|mesh-list
110032672|NCT05273398|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110032673|NCT05273398|Anticonvulsants|anticonvulsants|mesh-ancestor
110032674|NCT05273398|Antiemetics|antiemetics|mesh-ancestor
110032675|NCT05273398|Autonomic Agents|autonomic agents|mesh-ancestor
110032676|NCT05273398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110032677|NCT05273398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032678|NCT05273398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110032679|NCT05273398|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110032680|NCT05273398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110032681|NCT05273398|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110032683|NCT05273398|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110032684|NCT05273398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110032685|NCT05273398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110032686|NCT05273398|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110032687|NCT05273398|Anesthetics, General|anesthetics, general|mesh-ancestor
110032688|NCT05273398|Anesthetics|anesthetics|mesh-ancestor
110032689|NCT05273398|GABA Modulators|gaba modulators|mesh-ancestor
110032690|NCT05273398|GABA Agents|gaba agents|mesh-ancestor
110032691|NCT05273398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110032692|NCT05273398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110032693|NCT05272839|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110032694|NCT05272839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032695|NCT05272462|Minoxidil|minoxidil|mesh-list
110032696|NCT05272462|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110032697|NCT05272462|Vasodilator Agents|vasodilator agents|mesh-ancestor
110032698|NCT05272371|Dinutuximab|dinutuximab|mesh-list
110032699|NCT05272371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110032700|NCT05271539|Dexamethasone|dexamethasone|mesh-list
110032701|NCT05271539|Ranibizumab|ranibizumab|mesh-list
110032702|NCT05271539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110032703|NCT05271539|Antiemetics|antiemetics|mesh-ancestor
110032704|NCT05271539|Autonomic Agents|autonomic agents|mesh-ancestor
110032705|NCT05271539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110032706|NCT05271539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032707|NCT05271539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110032709|NCT05271539|Hormones|hormones|mesh-ancestor
110032710|NCT05271539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110032711|NCT05271539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110032712|NCT05271539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110032713|NCT05271539|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110032714|NCT05271539|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110032715|NCT05271539|Growth Substances|growth substances|mesh-ancestor
110032716|NCT05271539|Growth Inhibitors|growth inhibitors|mesh-ancestor
110032717|NCT05271370|Leronlimab|leronlimab|mesh-list
110032718|NCT05271370|HIV Antibodies|hiv antibodies|mesh-list
110032719|NCT05271370|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110032720|NCT05271370|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110032721|NCT05271370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110032722|NCT05271370|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110032723|NCT05271370|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110032724|NCT05271370|Antiviral Agents|antiviral agents|mesh-ancestor
110032725|NCT05271370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110032726|NCT05271370|Immunologic Factors|immunologic factors|mesh-ancestor
110032727|NCT05271370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032732|NCT05271253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110032733|NCT05271253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032734|NCT05271253|Sensory System Agents|sensory system agents|mesh-ancestor
110032735|NCT05271253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110032736|NCT05271253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110032737|NCT05271253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110032738|NCT05271253|Analgesics|analgesics|mesh-ancestor
110032739|NCT05271253|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110032740|NCT05271253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110032741|NCT05271253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110032742|NCT05271253|Adrenergic Agents|adrenergic agents|mesh-ancestor
110032743|NCT05271253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110032744|NCT05271253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110032747|NCT05271188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110032748|NCT05271188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032749|NCT05271188|Sensory System Agents|sensory system agents|mesh-ancestor
110032750|NCT05271188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110032751|NCT05271136|Sunscreening Agents|sunscreening agents|mesh-list
110032752|NCT05271136|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110032753|NCT05271136|Protective Agents|protective agents|mesh-ancestor
110032754|NCT05271136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032755|NCT05271136|Dermatologic Agents|dermatologic agents|mesh-ancestor
110032756|NCT05271058|Dexamethasone|dexamethasone|mesh-list
110032757|NCT05271058|Dexamethasone acetate|dexamethasone acetate|mesh-list
110032758|NCT05271058|Triamcinolone|triamcinolone|mesh-list
110032759|NCT05271058|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110032760|NCT05271058|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110032761|NCT05271058|BB 1101|bb 1101|mesh-list
110032762|NCT05271058|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110032763|NCT05271058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110032764|NCT05271058|Antiemetics|antiemetics|mesh-ancestor
110032765|NCT05271058|Autonomic Agents|autonomic agents|mesh-ancestor
110032766|NCT05271058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110032767|NCT05271058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032768|NCT05271058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110032769|NCT05271058|Glucocorticoids|glucocorticoids|mesh-ancestor
110032771|NCT05271058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110032772|NCT05271058|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110032773|NCT05271058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110032774|NCT05271058|Protease Inhibitors|protease inhibitors|mesh-ancestor
110032775|NCT05271058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110032776|NCT05271058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110032777|NCT05271058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110032778|NCT05271058|Immunologic Factors|immunologic factors|mesh-ancestor
110032779|NCT05271045|Vitamin D|vitamin d|mesh-list
110032780|NCT05271045|Vitamin A|vitamin a|mesh-list
110032781|NCT05271045|Vitamins|vitamins|mesh-ancestor
110032782|NCT05271045|Micronutrients|micronutrients|mesh-ancestor
110032783|NCT05271045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032784|NCT05271045|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110032785|NCT05270967|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110032786|NCT05270967|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110032787|NCT05270967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110032788|NCT05270889|Tislelizumab|tislelizumab|mesh-list
110032789|NCT05270889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110032790|NCT05270889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110032791|NCT05270824|Immunomodulating Agents|immunomodulating agents|mesh-list
110032792|NCT05270824|Immunologic Factors|immunologic factors|mesh-ancestor
110032793|NCT05270824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032794|NCT05270434|Dipyrone|dipyrone|mesh-list
110032795|NCT05270434|Meperidine|meperidine|mesh-list
110032796|NCT05270434|Morphine|morphine|mesh-list
110032797|NCT05270434|Buprenorphine|buprenorphine|mesh-list
110032798|NCT05270434|Analgesics|analgesics|mesh-list
110032799|NCT05270434|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110032800|NCT05270434|Narcotics|narcotics|mesh-ancestor
110032801|NCT05270434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110032802|NCT05270434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032803|NCT05270434|Sensory System Agents|sensory system agents|mesh-ancestor
110032804|NCT05270434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110032805|NCT05270434|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110032806|NCT05270434|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110032807|NCT05270434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110032808|NCT05270434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110032809|NCT05270434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110032815|NCT05270421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032816|NCT05270421|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110032817|NCT05270421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110032818|NCT05270421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110032819|NCT05270382|Cetylpyridinium|cetylpyridinium|mesh-list
110032820|NCT05270382|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110032821|NCT05270382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110032822|NCT05270343|Cholecalciferol|cholecalciferol|mesh-list
110032824|NCT05270343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110032825|NCT05270343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032826|NCT05270343|Vitamins|vitamins|mesh-ancestor
110032827|NCT05270343|Micronutrients|micronutrients|mesh-ancestor
110032828|NCT05270343|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110032829|NCT05270018|Broncho-Vaxom|broncho-vaxom|mesh-list
110032830|NCT05270018|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110032831|NCT05270018|Immunologic Factors|immunologic factors|mesh-ancestor
110032832|NCT05270018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032833|NCT05269654|Mannitol|mannitol|mesh-list
110032834|NCT05269654|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110032835|NCT05269654|Diuretics|diuretics|mesh-ancestor
110032836|NCT05269654|Natriuretic Agents|natriuretic agents|mesh-ancestor
110032837|NCT05269654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032838|NCT05253846|Fluorouracil|fluorouracil|mesh-list
110032839|NCT05253846|Oxaliplatin|oxaliplatin|mesh-list
110032840|NCT05253846|Irinotecan|irinotecan|mesh-list
110032841|NCT05253846|Antimetabolites|antimetabolites|mesh-ancestor
110032842|NCT05253846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110032843|NCT05253846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110032844|NCT05253846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110032845|NCT05253846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110032846|NCT05253846|Immunologic Factors|immunologic factors|mesh-ancestor
110032847|NCT05253846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032848|NCT05253846|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110032849|NCT05253846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110032850|NCT05253846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110032851|NCT05250141|Levodopa|levodopa|mesh-list
110032852|NCT05250141|Carbidopa|carbidopa|mesh-list
110032853|NCT05250141|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110032854|NCT05250141|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110032855|NCT05250141|Dopamine Agents|dopamine agents|mesh-ancestor
110032856|NCT05250141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110032857|NCT05250141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110032858|NCT05250141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032859|NCT05250141|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110032860|NCT05250141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110032861|NCT05248724|Ketorolac|ketorolac|mesh-list
110032862|NCT05248724|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110032863|NCT05248724|Epinephrine|epinephrine|mesh-list
110032864|NCT05248724|Racepinephrine|racepinephrine|mesh-list
110032865|NCT05248724|Morphine|morphine|mesh-list
110032866|NCT05248724|Ropivacaine|ropivacaine|mesh-list
110032867|NCT05248724|Epinephryl borate|epinephryl borate|mesh-list
110032868|NCT05248724|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110032869|NCT05248724|Narcotics|narcotics|mesh-ancestor
110032870|NCT05248724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110032871|NCT05248724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032872|NCT05248724|Analgesics|analgesics|mesh-ancestor
110032873|NCT05248724|Sensory System Agents|sensory system agents|mesh-ancestor
110032874|NCT05248724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110032875|NCT05248724|Anesthetics, Local|anesthetics, local|mesh-ancestor
110032876|NCT05248724|Anesthetics|anesthetics|mesh-ancestor
110032877|NCT05248724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110032878|NCT05248724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110032879|NCT05248724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110032880|NCT05248724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110032881|NCT05248724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110032882|NCT05248724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110032883|NCT05248724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110032884|NCT05248724|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110032885|NCT05248724|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110032886|NCT05248724|Adrenergic Agents|adrenergic agents|mesh-ancestor
110032887|NCT05248724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110032888|NCT05248724|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110032889|NCT05248724|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110032891|NCT05248724|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110032892|NCT05248724|Respiratory System Agents|respiratory system agents|mesh-ancestor
110032893|NCT05248724|Mydriatics|mydriatics|mesh-ancestor
110032894|NCT05248724|Sympathomimetics|sympathomimetics|mesh-ancestor
110032895|NCT05248724|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110032896|NCT05232006|Niraparib|niraparib|mesh-list
110032897|NCT05232006|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110032898|NCT05232006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110032899|NCT05232006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110032900|NCT05232006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110032901|NCT05209841|Heparin|heparin|mesh-list
110032902|NCT05209841|Anticoagulants|anticoagulants|mesh-ancestor
110032903|NCT05209841|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110032904|NCT05209841|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110032905|NCT05209841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110032906|NCT05173142|Gemcitabine|gemcitabine|mesh-list
110032907|NCT05173142|Docetaxel|docetaxel|mesh-list
110032908|NCT05173142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110032909|NCT05173142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110032910|NCT05173142|Antimetabolites|antimetabolites|mesh-ancestor
110032911|NCT05173142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110032912|NCT05173142|Tubulin Modulators|tubulin modulators|mesh-ancestor
110032913|NCT05173142|Antimitotic Agents|antimitotic agents|mesh-ancestor
110032914|NCT05173142|Mitosis Modulators|mitosis modulators|mesh-ancestor
110032915|NCT05165875|Hydrocortisone|hydrocortisone|mesh-list
110032916|NCT05165875|Lidocaine|lidocaine|mesh-list
110032917|NCT05165875|Anesthetics, Local|anesthetics, local|mesh-ancestor
110032918|NCT05165875|Anesthetics|anesthetics|mesh-ancestor
110032919|NCT05165875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110032920|NCT05165875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032921|NCT05165875|Sensory System Agents|sensory system agents|mesh-ancestor
110032922|NCT05165875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110032923|NCT05165875|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110032924|NCT05165875|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110032925|NCT05165875|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110032926|NCT05165875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110032927|NCT05165875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110032928|NCT05165875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110032930|NCT05162118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110032931|NCT05162118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110032932|NCT05162118|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110032933|NCT05162118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110032934|NCT05155917|Insulin Glargine|insulin glargine|mesh-list
110032935|NCT05155917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110032936|NCT05155917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032938|NCT05142267|Naloxone|naloxone|mesh-list
110032939|NCT05142267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110032940|NCT05142267|Narcotics|narcotics|mesh-ancestor
110032941|NCT05142267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110032942|NCT05142267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032943|NCT05142267|Analgesics|analgesics|mesh-ancestor
110032944|NCT05142267|Sensory System Agents|sensory system agents|mesh-ancestor
110032945|NCT05142267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110032946|NCT05142267|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110032947|NCT05138029|Dexamethasone|dexamethasone|mesh-list
110032948|NCT05138029|Dexamethasone acetate|dexamethasone acetate|mesh-list
110032949|NCT05138029|Ranibizumab|ranibizumab|mesh-list
110032950|NCT05138029|BB 1101|bb 1101|mesh-list
110032951|NCT05138029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110032952|NCT05138029|Antiemetics|antiemetics|mesh-ancestor
110032953|NCT05138029|Autonomic Agents|autonomic agents|mesh-ancestor
110032954|NCT05138029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110032955|NCT05138029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032956|NCT05138029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110032957|NCT05138029|Glucocorticoids|glucocorticoids|mesh-ancestor
110032959|NCT05138029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110032960|NCT05138029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110032961|NCT05138029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110032962|NCT05138029|Protease Inhibitors|protease inhibitors|mesh-ancestor
110032963|NCT05138029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110032964|NCT05138029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110032965|NCT05138029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110032966|NCT05138029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110032967|NCT05138029|Growth Substances|growth substances|mesh-ancestor
110032968|NCT05138029|Growth Inhibitors|growth inhibitors|mesh-ancestor
110032969|NCT05135039|Canagliflozin|canagliflozin|mesh-list
110032970|NCT05135039|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110032971|NCT05135039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110032973|NCT05135039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032974|NCT05128591|Rivaroxaban|rivaroxaban|mesh-list
110032975|NCT05128591|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110032976|NCT05128591|Antithrombins|antithrombins|mesh-ancestor
110032977|NCT05128591|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110032978|NCT05128591|Protease Inhibitors|protease inhibitors|mesh-ancestor
110032979|NCT05128591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110032980|NCT05128591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110032981|NCT05128591|Anticoagulants|anticoagulants|mesh-ancestor
110032982|NCT05088928|Rivaroxaban|rivaroxaban|mesh-list
110032984|NCT05088928|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110032985|NCT05088928|Antithrombins|antithrombins|mesh-ancestor
110032986|NCT05088928|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110032987|NCT05088928|Protease Inhibitors|protease inhibitors|mesh-ancestor
110032988|NCT05088928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110032989|NCT05088928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110032990|NCT05088928|Anticoagulants|anticoagulants|mesh-ancestor
110032991|NCT05075122|Pembrolizumab|pembrolizumab|mesh-list
110032992|NCT05075122|Sargramostim|sargramostim|mesh-list
110032993|NCT05075122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110032994|NCT05075122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110032995|NCT05075122|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110032996|NCT05075122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110032997|NCT05075122|Immunologic Factors|immunologic factors|mesh-ancestor
110032998|NCT05075122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032999|NCT05067439|Efavirenz|efavirenz|mesh-list
110033000|NCT05067439|Caffeine|caffeine|mesh-list
110033001|NCT05067439|Omeprazole|omeprazole|mesh-list
110033002|NCT05067439|Abrocitinib|abrocitinib|mesh-list
110033003|NCT05067439|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110033004|NCT05067439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110033005|NCT05067439|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110033006|NCT05067439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110033007|NCT05067439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110033009|NCT05067439|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110033010|NCT05067439|Purinergic Agents|purinergic agents|mesh-ancestor
110033011|NCT05067439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110033012|NCT05067439|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110033013|NCT05067439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110033014|NCT05067439|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110033015|NCT05067439|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110033016|NCT05067439|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110033017|NCT05067439|Antiviral Agents|antiviral agents|mesh-ancestor
110033018|NCT05067439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110033019|NCT05067439|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110033020|NCT05067439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110033021|NCT05067439|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110033022|NCT05067439|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110033023|NCT05067439|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110033024|NCT05067439|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110033025|NCT05067439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110033026|NCT05064137|Listerine|listerine|mesh-list
110033027|NCT05064137|Fluorides|fluorides|mesh-list
110033028|NCT05064137|Sodium Fluoride|sodium fluoride|mesh-list
110033029|NCT05064137|Fluorides, Topical|fluorides, topical|mesh-list
110033030|NCT05064137|Cariostatic Agents|cariostatic agents|mesh-ancestor
110033031|NCT05064137|Protective Agents|protective agents|mesh-ancestor
110033032|NCT05064137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110033033|NCT05064137|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110033034|NCT05064137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110033036|NCT05052528|Rituximab|rituximab|mesh-list
110033037|NCT05052528|Fludarabine|fludarabine|mesh-list
110033038|NCT05052528|Fludarabine phosphate|fludarabine phosphate|mesh-list
110033039|NCT05052528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110033040|NCT05052528|Antibodies|antibodies|mesh-list
110033041|NCT05052528|Immunoglobulins|immunoglobulins|mesh-list
110033042|NCT05052528|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110033043|NCT05052528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110033044|NCT05052528|Immunologic Factors|immunologic factors|mesh-ancestor
110033045|NCT05052528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110033046|NCT05052528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110033047|NCT05052528|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110033131|NCT04870333|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110033049|NCT05052528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110033050|NCT05052528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110033051|NCT05052528|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110033052|NCT05052528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110033053|NCT05052528|Antimetabolites|antimetabolites|mesh-ancestor
110033055|NCT05051150|Racepinephrine|racepinephrine|mesh-list
110033056|NCT05051150|Epinephryl borate|epinephryl borate|mesh-list
110033057|NCT05051150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110033058|NCT05051150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110033059|NCT05051150|Adrenergic Agents|adrenergic agents|mesh-ancestor
110033060|NCT05051150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110033061|NCT05051150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110033062|NCT05051150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110033063|NCT05051150|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110033065|NCT05051150|Autonomic Agents|autonomic agents|mesh-ancestor
110033066|NCT05051150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110033067|NCT05051150|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110033068|NCT05051150|Respiratory System Agents|respiratory system agents|mesh-ancestor
110033069|NCT05051150|Mydriatics|mydriatics|mesh-ancestor
110033070|NCT05051150|Sympathomimetics|sympathomimetics|mesh-ancestor
110033071|NCT05051150|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110033072|NCT05045313|Probenecid|probenecid|mesh-list
110033073|NCT05045313|Digoxin|digoxin|mesh-list
110033074|NCT05045313|Warfarin|warfarin|mesh-list
110033075|NCT05045313|Anticoagulants|anticoagulants|mesh-ancestor
110033076|NCT05045313|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110033077|NCT05045313|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110033078|NCT05045313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110033079|NCT05045313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110033080|NCT05045313|Protective Agents|protective agents|mesh-ancestor
110033081|NCT05045313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110033082|NCT05045313|Uricosuric Agents|uricosuric agents|mesh-ancestor
110033083|NCT05045313|Gout Suppressants|gout suppressants|mesh-ancestor
110033084|NCT05045313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110033085|NCT05007561|Naltrexone|naltrexone|mesh-list
110033086|NCT05007561|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110033087|NCT05007561|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110033088|NCT05007561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110033089|NCT05007561|Sensory System Agents|sensory system agents|mesh-ancestor
110033090|NCT05007561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110033091|NCT04961801|Methotrexate|methotrexate|mesh-list
110033092|NCT04961801|Acalabrutinib|acalabrutinib|mesh-list
110033094|NCT04961801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110033096|NCT04961801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110033097|NCT04961801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110033098|NCT04961801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110033100|NCT04961801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110033101|NCT04961801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110033102|NCT04961801|Dermatologic Agents|dermatologic agents|mesh-ancestor
110033103|NCT04961801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110033104|NCT04961801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110033105|NCT04961801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110033106|NCT04961801|Immunologic Factors|immunologic factors|mesh-ancestor
110033107|NCT04961801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110033108|NCT04961801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110033109|NCT04961801|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110033112|NCT04919564|Natriuretic Agents|natriuretic agents|mesh-ancestor
110033113|NCT04919564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110033114|NCT04919564|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110033115|NCT04919564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110033116|NCT04919564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110033117|NCT04886284|Ertapenem|ertapenem|mesh-list
110033118|NCT04886284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110033119|NCT04886284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110033121|NCT04870333|Sotrovimab|sotrovimab|mesh-list
110033122|NCT04870333|Niclosamide|niclosamide|mesh-list
110033123|NCT04870333|Glucocorticoids|glucocorticoids|mesh-ancestor
110033124|NCT04870333|Hormones|hormones|mesh-ancestor
110033125|NCT04870333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110033126|NCT04870333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110033127|NCT04870333|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110033128|NCT04870333|Antiviral Agents|antiviral agents|mesh-ancestor
110033129|NCT04870333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110033130|NCT04870333|Anticestodal Agents|anticestodal agents|mesh-ancestor
110033136|NCT04835402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110033137|NCT04835402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110033138|NCT04835402|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110033139|NCT04835402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110033141|NCT04801641|Antiemetics|antiemetics|mesh-ancestor
110033142|NCT04801641|Autonomic Agents|autonomic agents|mesh-ancestor
110033143|NCT04801641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110033144|NCT04801641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110033145|NCT04801641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110033146|NCT04801641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110033147|NCT04801641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110033148|NCT04801641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110033149|NCT04801641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110033151|NCT04783376|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110033152|NCT04783376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110033153|NCT04783376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110033154|NCT04768829|Carbamide Peroxide|carbamide peroxide|mesh-list
110033155|NCT04768829|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110033156|NCT04768829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110033158|NCT04760912|Anesthetics|anesthetics|mesh-list
110033159|NCT04760912|Rocuronium|rocuronium|mesh-list
110033160|NCT04760912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110033161|NCT04760912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110033162|NCT04760912|Anticonvulsants|anticonvulsants|mesh-ancestor
110033163|NCT04760912|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110033164|NCT04760912|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110033165|NCT04760912|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110033166|NCT04760912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110033167|NCT04710641|Sorafenib|sorafenib|mesh-list
110033168|NCT04710641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110033169|NCT04710641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110033170|NCT04710641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110033171|NCT04710641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110033172|NCT04706767|Lidocaine|lidocaine|mesh-list
110033173|NCT04706767|Dexmedetomidine|dexmedetomidine|mesh-list
110033174|NCT04706767|Anesthetics, Local|anesthetics, local|mesh-ancestor
110033175|NCT04706767|Anesthetics|anesthetics|mesh-ancestor
110033176|NCT04706767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110033177|NCT04706767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110033178|NCT04706767|Sensory System Agents|sensory system agents|mesh-ancestor
110033179|NCT04706767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110033180|NCT04706767|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110033181|NCT04706767|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110033182|NCT04706767|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110033184|NCT04706767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110033185|NCT04706767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110033186|NCT04706767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110033188|NCT04706767|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110033189|NCT04706767|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110033191|NCT04706767|Adrenergic Agents|adrenergic agents|mesh-ancestor
110033192|NCT04706767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110033193|NCT04690686|Paclitaxel|paclitaxel|mesh-list
110033194|NCT04690686|Atezolizumab|atezolizumab|mesh-list
110033195|NCT04690686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110033196|NCT04690686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110033197|NCT04690686|Tubulin Modulators|tubulin modulators|mesh-ancestor
110033198|NCT04690686|Antimitotic Agents|antimitotic agents|mesh-ancestor
110033199|NCT04690686|Mitosis Modulators|mitosis modulators|mesh-ancestor
110033200|NCT04690686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110033201|NCT04690686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110033202|NCT04690686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110033203|NCT04682626|Cholecalciferol|cholecalciferol|mesh-list
110033204|NCT04682626|Vitamin D|vitamin d|mesh-list
110033205|NCT04682626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110033206|NCT04682626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110033207|NCT04682626|Vitamins|vitamins|mesh-ancestor
110033208|NCT04682626|Micronutrients|micronutrients|mesh-ancestor
110033209|NCT04682626|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110033211|NCT04604691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110033212|NCT04580381|Natalizumab|natalizumab|mesh-list
110033213|NCT04580381|Immunologic Factors|immunologic factors|mesh-ancestor
110033214|NCT04580381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110033215|NCT04496245|Broncho-Vaxom|broncho-vaxom|mesh-list
110033216|NCT04496245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110033217|NCT04496245|Immunologic Factors|immunologic factors|mesh-ancestor
110033218|NCT04496245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110033219|NCT04476745|Vitamin D|vitamin d|mesh-list
110033220|NCT04476745|Cholecalciferol|cholecalciferol|mesh-list
110033221|NCT04476745|Vitamins|vitamins|mesh-ancestor
110033222|NCT04476745|Micronutrients|micronutrients|mesh-ancestor
110033223|NCT04476745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110033224|NCT04476745|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110033225|NCT04476745|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110033226|NCT04433390|Naloxegol|naloxegol|mesh-list
110033227|NCT04433390|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110033228|NCT04433390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110033230|NCT04433390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110033231|NCT04399746|Cholecalciferol|cholecalciferol|mesh-list
110033232|NCT04399746|Vitamin D|vitamin d|mesh-list
110033233|NCT04399746|Azithromycin|azithromycin|mesh-list
110033234|NCT04399746|Ivermectin|ivermectin|mesh-list
110033235|NCT04399746|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110033236|NCT04399746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110033238|NCT04399746|Micronutrients|micronutrients|mesh-ancestor
110033239|NCT04399746|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110033240|NCT04399746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110033241|NCT04399746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110033242|NCT04399746|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110033243|NCT04391608|Tenofovir|tenofovir|mesh-list
110033244|NCT04391608|Antiviral Agents|antiviral agents|mesh-ancestor
110033245|NCT04391608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110033246|NCT04391608|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110033247|NCT04391608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110033248|NCT04391608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110033249|NCT04391608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110033250|NCT04391608|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110033251|NCT04391608|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110033252|NCT04368091|Sirolimus|sirolimus|mesh-list
110033253|NCT04368091|Temsirolimus|temsirolimus|mesh-list
110033254|NCT04368091|MTOR Inhibitors|mtor inhibitors|mesh-list
110033255|NCT04368091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110033256|NCT04368091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110033257|NCT04368091|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110033258|NCT04368091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110033260|NCT04368091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110033261|NCT04368091|Immunologic Factors|immunologic factors|mesh-ancestor
110033262|NCT04368091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110033263|NCT04368091|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110033264|NCT04368091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110033265|NCT04368091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110033266|NCT04328090|Anti-Infective Agents|anti-infective agents|mesh-list
110033267|NCT04328090|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110033268|NCT04324021|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110033271|NCT04302168|Lipotropic Agents|lipotropic agents|mesh-ancestor
110033272|NCT04302168|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110033273|NCT04302168|Antimetabolites|antimetabolites|mesh-ancestor
110033274|NCT04302168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110033275|NCT04302168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110033276|NCT04302168|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110033277|NCT04302168|Nootropic Agents|nootropic agents|mesh-ancestor
110033278|NCT04245644|Aspirin|aspirin|mesh-list
110033279|NCT04245644|Metformin|metformin|mesh-list
110033280|NCT04245644|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110033281|NCT04245644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110033282|NCT04245644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110033283|NCT04245644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110033284|NCT04245644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110033285|NCT04245644|Analgesics|analgesics|mesh-ancestor
110033286|NCT04245644|Sensory System Agents|sensory system agents|mesh-ancestor
110033287|NCT04245644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110033288|NCT04245644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110033289|NCT04245644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110033290|NCT04245644|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110033291|NCT04245644|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110033292|NCT04245644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110033293|NCT04245644|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110033294|NCT04245644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110033295|NCT04245644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110033296|NCT04245644|Antipyretics|antipyretics|mesh-ancestor
110033301|NCT04238845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110033302|NCT04223037|Vaccines|vaccines|mesh-list
110033303|NCT04223037|Immunologic Factors|immunologic factors|mesh-ancestor
110033304|NCT04223037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110033305|NCT04186663|Fluorides|fluorides|mesh-list
110033306|NCT04186663|Cariostatic Agents|cariostatic agents|mesh-ancestor
110033307|NCT04186663|Protective Agents|protective agents|mesh-ancestor
110033308|NCT04186663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110033309|NCT04108026|Durvalumab|durvalumab|mesh-list
110033310|NCT04108026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110033312|NCT04095104|Topiramate|topiramate|mesh-list
110033313|NCT04095104|Phentermine|phentermine|mesh-list
110033314|NCT04095104|Anticonvulsants|anticonvulsants|mesh-ancestor
110033315|NCT04095104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110033316|NCT04095104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110033317|NCT04095104|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110033318|NCT04095104|Appetite Depressants|appetite depressants|mesh-ancestor
110033319|NCT04095104|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110033321|NCT04095104|Autonomic Agents|autonomic agents|mesh-ancestor
110033322|NCT04095104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110033323|NCT04095104|Adrenergic Agents|adrenergic agents|mesh-ancestor
110033324|NCT04095104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110033325|NCT04095104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110033333|NCT04008082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110033334|NCT04008082|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110033335|NCT04008082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110033336|NCT04008082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110033338|NCT03974243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110033339|NCT03974243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110033340|NCT03974243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110033341|NCT03974243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110033343|NCT03967925|Prednisolone|prednisolone|mesh-list
110033344|NCT03967925|Rituximab|rituximab|mesh-list
110033345|NCT03967925|Belimumab|belimumab|mesh-list
110033346|NCT03967925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110033347|NCT03967925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110033348|NCT03967925|Immunologic Factors|immunologic factors|mesh-ancestor
110033349|NCT03967925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110033350|NCT03967925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110033351|NCT03967925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110033352|NCT03967925|Glucocorticoids|glucocorticoids|mesh-ancestor
110033353|NCT03967925|Hormones|hormones|mesh-ancestor
110033354|NCT03967925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110033355|NCT03967925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110033356|NCT03967925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110033357|NCT03954743|Vaccines|vaccines|mesh-list
110033358|NCT03954743|Immunologic Factors|immunologic factors|mesh-ancestor
110033359|NCT03954743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110033361|NCT03883412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110033362|NCT03883412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110033363|NCT03883412|Incretins|incretins|mesh-ancestor
110033364|NCT03883412|Hormones|hormones|mesh-ancestor
110033365|NCT03883412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110033367|NCT03858621|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110033368|NCT03858621|Narcotics|narcotics|mesh-ancestor
110033369|NCT03858621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110033370|NCT03858621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110033371|NCT03858621|Analgesics|analgesics|mesh-ancestor
110033372|NCT03858621|Sensory System Agents|sensory system agents|mesh-ancestor
110033373|NCT03858621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110033374|NCT03858621|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110033375|NCT03858621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110033376|NCT03858621|Anesthetics, General|anesthetics, general|mesh-ancestor
110033377|NCT03858621|Anesthetics|anesthetics|mesh-ancestor
110033387|NCT03758170|Dexamethasone|dexamethasone|mesh-list
110033388|NCT03758170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110033389|NCT03758170|Antiemetics|antiemetics|mesh-ancestor
110033390|NCT03758170|Autonomic Agents|autonomic agents|mesh-ancestor
110033391|NCT03758170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110033392|NCT03758170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110033393|NCT03758170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110033394|NCT03758170|Glucocorticoids|glucocorticoids|mesh-ancestor
110033395|NCT03758170|Hormones|hormones|mesh-ancestor
110033396|NCT03758170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110033397|NCT03758170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110033398|NCT03758170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110033400|NCT03733119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110033401|NCT03705338|Propofol|propofol|mesh-list
110033402|NCT03705338|Anesthetics|anesthetics|mesh-list
110033403|NCT03705338|Anesthetics, General|anesthetics, general|mesh-list
110033404|NCT03705338|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110033405|NCT03705338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110033413|NCT03704285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110033414|NCT03704285|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110033415|NCT03696537|Fludarabine|fludarabine|mesh-list
110033416|NCT03696537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110033417|NCT03661996|Lidocaine|lidocaine|mesh-list
110033418|NCT03661996|Epinephrine|epinephrine|mesh-list
110033419|NCT03661996|Capsaicin|capsaicin|mesh-list
110033420|NCT03661996|Anesthetics, Local|anesthetics, local|mesh-ancestor
110033422|NCT03661996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110033423|NCT03661996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110033425|NCT03661996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110033426|NCT03661996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110033427|NCT03661996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110033428|NCT03661996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110033429|NCT03661996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110033430|NCT03661996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110033431|NCT03661996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110033432|NCT03661996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110033433|NCT03661996|Adrenergic Agents|adrenergic agents|mesh-ancestor
110033434|NCT03661996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110033435|NCT03661996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110033436|NCT03661996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110033437|NCT03661996|Autonomic Agents|autonomic agents|mesh-ancestor
110033438|NCT03661996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110033439|NCT03661996|Respiratory System Agents|respiratory system agents|mesh-ancestor
110033440|NCT03661996|Mydriatics|mydriatics|mesh-ancestor
110033441|NCT03661996|Sympathomimetics|sympathomimetics|mesh-ancestor
110033442|NCT03661996|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110033443|NCT03661996|Antipruritics|antipruritics|mesh-ancestor
110033444|NCT03661996|Dermatologic Agents|dermatologic agents|mesh-ancestor
110033445|NCT03410355|Cortisone|cortisone|mesh-list
110033446|NCT03410355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110033447|NCT03399617|Micronutrients|micronutrients|mesh-list
110033448|NCT03399617|Trace Elements|trace elements|mesh-list
110033449|NCT03399617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110033450|NCT03386162|Fulvestrant|fulvestrant|mesh-list
110033451|NCT03386162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110033452|NCT03386162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110033453|NCT03386162|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110033454|NCT03386162|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110033455|NCT03386162|Hormone Antagonists|hormone antagonists|mesh-ancestor
110033456|NCT03386162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110033457|NCT03386162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110033458|NCT03360214|Bupivacaine|bupivacaine|mesh-list
110033459|NCT03360214|Ropivacaine|ropivacaine|mesh-list
110033460|NCT03360214|Anesthetics, Local|anesthetics, local|mesh-ancestor
110033461|NCT03360214|Anesthetics|anesthetics|mesh-ancestor
110033462|NCT03360214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110033463|NCT03360214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110033464|NCT03360214|Sensory System Agents|sensory system agents|mesh-ancestor
110033465|NCT03360214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110033466|NCT03359239|Atezolizumab|atezolizumab|mesh-list
110033467|NCT03359239|Poly ICLC|poly iclc|mesh-list
110033468|NCT03359239|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110033469|NCT03359239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110033470|NCT03359239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110033471|NCT03359239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110033472|NCT03359239|Interferon Inducers|interferon inducers|mesh-ancestor
110033473|NCT03359239|Immunologic Factors|immunologic factors|mesh-ancestor
110033474|NCT03359239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110033475|NCT03332173|Zanubrutinib|zanubrutinib|mesh-list
110033476|NCT03332173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110033477|NCT03332173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110033478|NCT03332173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110033479|NCT03332173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110033480|NCT03328676|Chlorophyllin|chlorophyllin|mesh-list
110033481|NCT03328676|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110033482|NCT03328676|Protective Agents|protective agents|mesh-ancestor
110033483|NCT03328676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110033484|NCT03322293|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110033485|NCT03322293|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110033486|NCT03322293|Dermatologic Agents|dermatologic agents|mesh-ancestor
110033488|NCT03315039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110033489|NCT03315039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110033490|NCT03289325|Dexmedetomidine|dexmedetomidine|mesh-list
110033491|NCT03289325|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110033492|NCT03289325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110033493|NCT03289325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110033495|NCT03289325|Analgesics|analgesics|mesh-ancestor
110033496|NCT03289325|Sensory System Agents|sensory system agents|mesh-ancestor
110033497|NCT03289325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110033498|NCT03289325|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110033499|NCT03289325|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110033500|NCT03289325|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110033501|NCT03289325|Adrenergic Agents|adrenergic agents|mesh-ancestor
110033502|NCT03289325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110033503|NCT03289325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110033504|NCT03276533|Lidocaine|lidocaine|mesh-list
110033505|NCT03276533|Dexmedetomidine|dexmedetomidine|mesh-list
110033506|NCT03276533|Anesthetics, Local|anesthetics, local|mesh-ancestor
110033507|NCT03276533|Anesthetics|anesthetics|mesh-ancestor
110033508|NCT03276533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110033509|NCT03276533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110033510|NCT03276533|Sensory System Agents|sensory system agents|mesh-ancestor
110033511|NCT03276533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110033512|NCT03276533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110033513|NCT03276533|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110033514|NCT03276533|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110033515|NCT03276533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110033516|NCT03276533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110033517|NCT03276533|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110033518|NCT03276533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110033520|NCT03276533|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110033521|NCT03276533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110033522|NCT03276533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110033523|NCT03276533|Adrenergic Agents|adrenergic agents|mesh-ancestor
110033524|NCT03276533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110033525|NCT03254394|Lidocaine|lidocaine|mesh-list
110033526|NCT03254394|Anesthetics, Local|anesthetics, local|mesh-ancestor
110033527|NCT03254394|Anesthetics|anesthetics|mesh-ancestor
110033528|NCT03254394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110033529|NCT03254394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110033530|NCT03254394|Sensory System Agents|sensory system agents|mesh-ancestor
110033531|NCT03254394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110033532|NCT03254394|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110033533|NCT03254394|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110033534|NCT03254394|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110033535|NCT03254394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110033536|NCT03254394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110033538|NCT03203876|Ipilimumab|ipilimumab|mesh-list
110033539|NCT03203876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110033540|NCT03203876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110033541|NCT03203876|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110033542|NCT03203876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110033544|NCT03191240|Arginine Vasopressin|arginine vasopressin|mesh-list
110033545|NCT03191240|Hemostatics|hemostatics|mesh-ancestor
110033546|NCT03191240|Coagulants|coagulants|mesh-ancestor
110033547|NCT03191240|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110033548|NCT03191240|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110033549|NCT03191240|Natriuretic Agents|natriuretic agents|mesh-ancestor
110033550|NCT03191240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110033551|NCT03180294|Bupropion|bupropion|mesh-list
110033552|NCT03180294|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110033553|NCT03180294|Antidepressive Agents|antidepressive agents|mesh-ancestor
110033554|NCT03180294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110033555|NCT03180294|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110033556|NCT03180294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110033557|NCT03180294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110033558|NCT03180294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110033560|NCT03180294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110033561|NCT03180294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110033563|NCT03180294|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110033568|NCT03071601|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
110033569|NCT03071601|Anesthetics, Local|anesthetics, local|mesh-ancestor
110033570|NCT03071601|Anesthetics|anesthetics|mesh-ancestor
110033571|NCT03071601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110033572|NCT03071601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110033573|NCT03071601|Sensory System Agents|sensory system agents|mesh-ancestor
110033574|NCT03071601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110033575|NCT03071601|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110033576|NCT03071601|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110033577|NCT03071601|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110033578|NCT03071601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110033579|NCT03071601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110033580|NCT03071601|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110033581|NCT03071601|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110033582|NCT03071601|Adrenergic Agents|adrenergic agents|mesh-ancestor
110033583|NCT03071601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110033584|NCT03071601|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110033585|NCT03071601|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110033587|NCT03071601|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110033588|NCT03071601|Respiratory System Agents|respiratory system agents|mesh-ancestor
110033590|NCT03071601|Sympathomimetics|sympathomimetics|mesh-ancestor
110033591|NCT03071601|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110033592|NCT03071601|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
110033593|NCT03061903|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110033594|NCT03061903|Laxatives|laxatives|mesh-ancestor
110033595|NCT03061903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110033596|NCT03061643|Docetaxel|docetaxel|mesh-list
110033597|NCT03061643|Androgens|androgens|mesh-list
110033598|NCT03061643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110033599|NCT03061643|Tubulin Modulators|tubulin modulators|mesh-ancestor
110033600|NCT03061643|Antimitotic Agents|antimitotic agents|mesh-ancestor
110033601|NCT03061643|Mitosis Modulators|mitosis modulators|mesh-ancestor
110033602|NCT03061643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110033603|NCT03061643|Hormones|hormones|mesh-ancestor
110033604|NCT03061643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110033605|NCT03061643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110033606|NCT03061630|Gemcitabine|gemcitabine|mesh-list
110033607|NCT03061630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110033608|NCT03061630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110033609|NCT03061630|Antimetabolites|antimetabolites|mesh-ancestor
110033610|NCT03061630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110033612|NCT03055390|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
110033613|NCT03055390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110033614|NCT03055390|Antiemetics|antiemetics|mesh-ancestor
110033616|NCT03055390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110033617|NCT03055390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110033618|NCT03055390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110033619|NCT03055390|Mydriatics|mydriatics|mesh-ancestor
110033620|NCT03055390|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110033621|NCT03055390|Cholinergic Agents|cholinergic agents|mesh-ancestor
110033622|NCT03055390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110033623|NCT03055390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110033624|NCT03055390|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110033625|NCT03055390|Parasympatholytics|parasympatholytics|mesh-ancestor
110033627|NCT03012672|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
110033628|NCT03012672|Mitoxantrone|mitoxantrone|mesh-list
110033629|NCT03012672|Cladribine|cladribine|mesh-list
110033630|NCT03012672|Lenograstim|lenograstim|mesh-list
110033631|NCT03012672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110033632|NCT03012672|Antimetabolites|antimetabolites|mesh-ancestor
110033633|NCT03012672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110033634|NCT03012672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110033636|NCT03012672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110033637|NCT03012672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110033638|NCT03012672|Immunologic Factors|immunologic factors|mesh-ancestor
110033639|NCT03012672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110033640|NCT03012672|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110033641|NCT03012672|Analgesics|analgesics|mesh-ancestor
110033642|NCT03012672|Sensory System Agents|sensory system agents|mesh-ancestor
110033643|NCT03012672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110033644|NCT03012672|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110033645|NCT03012672|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110033646|NCT03012672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110033647|NCT03011775|Aspirin|aspirin|mesh-list
110033654|NCT03011775|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
110033655|NCT03011775|Vasodilator Agents|vasodilator agents|mesh-list
110033656|NCT03011775|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
110033657|NCT03011775|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110033658|NCT03011775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110033659|NCT03011775|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110033660|NCT03011775|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110033661|NCT03011775|Antimetabolites|antimetabolites|mesh-ancestor
110033662|NCT03011775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110033663|NCT03011775|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110033664|NCT03011775|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110033665|NCT03011775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110033666|NCT03011775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110033667|NCT03011775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110033668|NCT03011775|Analgesics|analgesics|mesh-ancestor
110033669|NCT03011775|Sensory System Agents|sensory system agents|mesh-ancestor
110033670|NCT03011775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110033671|NCT03011775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110033672|NCT03011775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110033673|NCT03011775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110033674|NCT03011775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110033675|NCT03011775|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110033676|NCT03011775|Antipyretics|antipyretics|mesh-ancestor
110033677|NCT03011775|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110033678|NCT03011775|Protease Inhibitors|protease inhibitors|mesh-ancestor
110033679|NCT03011775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110033680|NCT03011775|Sympatholytics|sympatholytics|mesh-ancestor
110033681|NCT03011775|Autonomic Agents|autonomic agents|mesh-ancestor
110033682|NCT03011775|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110033683|NCT03011775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110033684|NCT03011775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110033685|NCT03011775|Adrenergic Agents|adrenergic agents|mesh-ancestor
110033686|NCT03011775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110033687|NCT03011775|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110033689|NCT03011775|Natriuretic Agents|natriuretic agents|mesh-ancestor
110033690|NCT03011775|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110033692|NCT02960997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110033693|NCT02960997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110033694|NCT02960997|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110033695|NCT02960997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110033696|NCT02960997|Antifungal Agents|antifungal agents|mesh-ancestor
110033697|NCT02960997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110033698|NCT02960997|Immunologic Factors|immunologic factors|mesh-ancestor
110033699|NCT02960997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110033700|NCT02924480|Lidocaine|lidocaine|mesh-list
110033701|NCT02924480|Anesthetics, Local|anesthetics, local|mesh-ancestor
110033702|NCT02924480|Anesthetics|anesthetics|mesh-ancestor
110033703|NCT02924480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110033704|NCT02924480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110033705|NCT02924480|Sensory System Agents|sensory system agents|mesh-ancestor
110033706|NCT02924480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110033707|NCT02924480|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110033708|NCT02924480|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110033709|NCT02924480|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110033710|NCT02924480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110033711|NCT02924480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110033713|NCT02924064|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110033714|NCT02924064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110033715|NCT02889900|Olaparib|olaparib|mesh-list
110033716|NCT02889900|Cediranib|cediranib|mesh-list
110033717|NCT02889900|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110033718|NCT02889900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110033719|NCT02889900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110033720|NCT02889900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110033721|NCT02889900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110033722|NCT02879942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
110033723|NCT02879942|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-list
110033724|NCT02879942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110033725|NCT02879942|Growth Substances|growth substances|mesh-ancestor
110033726|NCT02879942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110033727|NCT02879942|Growth Inhibitors|growth inhibitors|mesh-ancestor
110033729|NCT02873819|Cyclophosphamide|cyclophosphamide|mesh-list
110033730|NCT02873819|Sargramostim|sargramostim|mesh-list
110033731|NCT02873819|Poly ICLC|poly iclc|mesh-list
110033732|NCT02873819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110033733|NCT02873819|Immunologic Factors|immunologic factors|mesh-ancestor
110033734|NCT02873819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110033735|NCT02873819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110033736|NCT02873819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110033737|NCT02873819|Alkylating Agents|alkylating agents|mesh-ancestor
110033738|NCT02873819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110033739|NCT02873819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110033740|NCT02873819|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110033741|NCT02873819|Interferon Inducers|interferon inducers|mesh-ancestor
110033742|NCT02810457|Paclitaxel|paclitaxel|mesh-list
110033743|NCT02810457|Bevacizumab|bevacizumab|mesh-list
110033744|NCT02810457|Carboplatin|carboplatin|mesh-list
110033745|NCT02810457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110033746|NCT02810457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110033747|NCT02810457|Tubulin Modulators|tubulin modulators|mesh-ancestor
110033748|NCT02810457|Antimitotic Agents|antimitotic agents|mesh-ancestor
110033749|NCT02810457|Mitosis Modulators|mitosis modulators|mesh-ancestor
110033750|NCT02810457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110033751|NCT02810457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110033752|NCT02810457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110033753|NCT02810457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110033754|NCT02810457|Growth Substances|growth substances|mesh-ancestor
110033758|NCT02745535|Velpatasvir|velpatasvir|mesh-list
110033759|NCT02745535|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
110033760|NCT02745535|Antiviral Agents|antiviral agents|mesh-ancestor
110033761|NCT02745535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110033762|NCT02729701|Bazedoxifene|bazedoxifene|mesh-list
110033763|NCT02729701|Estrogens|estrogens|mesh-list
110033764|NCT02729701|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110033765|NCT02729701|Hormones|hormones|mesh-ancestor
110033766|NCT02729701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110033767|NCT02729701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110033768|NCT02729701|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110033769|NCT02729701|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110033770|NCT02729701|Hormone Antagonists|hormone antagonists|mesh-ancestor
110033771|NCT02729701|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110033772|NCT02684253|Nivolumab|nivolumab|mesh-list
110033773|NCT02684253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110033774|NCT02684253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110033775|NCT02684253|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110033776|NCT02684253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110033777|NCT02666794|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
110033779|NCT02666794|Morphine|morphine|mesh-list
110033780|NCT02666794|Dsuvia|dsuvia|mesh-list
110033781|NCT02666794|Bupivacaine|bupivacaine|mesh-list
110033782|NCT02666794|Anesthetics, Local|anesthetics, local|mesh-ancestor
110033783|NCT02666794|Anesthetics|anesthetics|mesh-ancestor
110033784|NCT02666794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110033785|NCT02666794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110033787|NCT02666794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110033788|NCT02666794|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110033790|NCT02666794|Analgesics|analgesics|mesh-ancestor
110033791|NCT02666794|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110033792|NCT02666794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110033793|NCT02666794|Anesthetics, General|anesthetics, general|mesh-ancestor
110033794|NCT02656550|Thymoglobulin|thymoglobulin|mesh-list
110033795|NCT02656550|Immunologic Factors|immunologic factors|mesh-ancestor
110033796|NCT02656550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110033797|NCT02656550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110033798|NCT02642094|Sirolimus|sirolimus|mesh-list
110033799|NCT02642094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110033800|NCT02642094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110033801|NCT02642094|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110033802|NCT02642094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110033803|NCT02642094|Antifungal Agents|antifungal agents|mesh-ancestor
110033804|NCT02642094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110033805|NCT02642094|Immunologic Factors|immunologic factors|mesh-ancestor
110033806|NCT02642094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110033807|NCT02619552|Prednisone|prednisone|mesh-list
110033808|NCT02619552|Budesonide|budesonide|mesh-list
110033809|NCT02619552|Adalimumab|adalimumab|mesh-list
110033810|NCT02619552|Infliximab|infliximab|mesh-list
110033811|NCT02619552|Certolizumab Pegol|certolizumab pegol|mesh-list
110033812|NCT02619552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110033813|NCT02619552|Glucocorticoids|glucocorticoids|mesh-ancestor
110033814|NCT02619552|Hormones|hormones|mesh-ancestor
110033815|NCT02619552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110033816|NCT02619552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110033817|NCT02619552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110033818|NCT02619552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110033820|NCT02619552|Autonomic Agents|autonomic agents|mesh-ancestor
110033821|NCT02619552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110033822|NCT02619552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110033823|NCT02619552|Respiratory System Agents|respiratory system agents|mesh-ancestor
110033824|NCT02619552|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110033827|NCT02619552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110033828|NCT02619552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110033829|NCT02619552|Immunologic Factors|immunologic factors|mesh-ancestor
110033832|NCT02578368|Fluorouracil|fluorouracil|mesh-list
110033833|NCT02578368|Oxaliplatin|oxaliplatin|mesh-list
110033834|NCT02578368|Trastuzumab|trastuzumab|mesh-list
110033835|NCT02578368|Levoleucovorin|levoleucovorin|mesh-list
110033836|NCT02578368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110033837|NCT02578368|Tubulin Modulators|tubulin modulators|mesh-ancestor
110033838|NCT02578368|Antimitotic Agents|antimitotic agents|mesh-ancestor
110033839|NCT02578368|Mitosis Modulators|mitosis modulators|mesh-ancestor
110033840|NCT02578368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110033841|NCT02578368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110033842|NCT02578368|Antimetabolites|antimetabolites|mesh-ancestor
110033843|NCT02578368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110033844|NCT02578368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110033845|NCT02578368|Immunologic Factors|immunologic factors|mesh-ancestor
110033846|NCT02578368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110033848|NCT02578368|Protective Agents|protective agents|mesh-ancestor
110033849|NCT02578368|Vitamin B Complex|vitamin b complex|mesh-ancestor
110033851|NCT02578368|Micronutrients|micronutrients|mesh-ancestor
110033853|NCT02539225|Oxaliplatin|oxaliplatin|mesh-list
110033854|NCT02539225|Ramucirumab|ramucirumab|mesh-list
110033855|NCT02539225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110033856|NCT02539225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110033857|NCT02539225|Tubulin Modulators|tubulin modulators|mesh-ancestor
110033858|NCT02539225|Antimitotic Agents|antimitotic agents|mesh-ancestor
110033859|NCT02539225|Mitosis Modulators|mitosis modulators|mesh-ancestor
110033860|NCT02539225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110033861|NCT02535650|Tipifarnib|tipifarnib|mesh-list
110033862|NCT02535650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110033863|NCT02526017|Nivolumab|nivolumab|mesh-list
110033864|NCT02526017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110033865|NCT02526017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110033866|NCT02526017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110033867|NCT02526017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110033868|NCT02516657|Liraglutide|liraglutide|mesh-list
110033869|NCT02516657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110033870|NCT02516657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110033871|NCT02516657|Incretins|incretins|mesh-ancestor
110033873|NCT02516657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110033875|NCT02427581|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110033876|NCT02427581|Poly ICLC|poly iclc|mesh-list
110033877|NCT02427581|Interferon Inducers|interferon inducers|mesh-ancestor
110033878|NCT02427581|Immunologic Factors|immunologic factors|mesh-ancestor
110033879|NCT02427581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110033880|NCT02427581|Laxatives|laxatives|mesh-ancestor
110033881|NCT02427581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110033882|NCT02427581|Antiviral Agents|antiviral agents|mesh-ancestor
110033883|NCT02427581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110033884|NCT02423525|Afatinib|afatinib|mesh-list
110033885|NCT02423525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110033886|NCT02423525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110033887|NCT02423525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110033888|NCT02423525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110033889|NCT02369653|Apixaban|apixaban|mesh-list
110033890|NCT02369653|Anticoagulants|anticoagulants|mesh-list
110033891|NCT02369653|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110033892|NCT02369653|Antithrombins|antithrombins|mesh-ancestor
110033893|NCT02369653|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110033894|NCT02369653|Protease Inhibitors|protease inhibitors|mesh-ancestor
110033895|NCT02369653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110033896|NCT02369653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110033898|NCT02293109|Cytarabine|cytarabine|mesh-list
110033899|NCT02293109|Dexamethasone|dexamethasone|mesh-list
110033900|NCT02293109|Methylprednisolone|methylprednisolone|mesh-list
110033901|NCT02293109|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110033908|NCT02293109|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110033909|NCT02293109|Methotrexate|methotrexate|mesh-list
110033910|NCT02293109|Vincristine|vincristine|mesh-list
110033911|NCT02293109|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110033912|NCT02293109|Prednisolone phosphate|prednisolone phosphate|mesh-list
110033914|NCT02293109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110033915|NCT02293109|Immunologic Factors|immunologic factors|mesh-ancestor
110033916|NCT02293109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110033917|NCT02293109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110033918|NCT02293109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110033919|NCT02293109|Alkylating Agents|alkylating agents|mesh-ancestor
110033920|NCT02293109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110033921|NCT02293109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110033922|NCT02293109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110033923|NCT02293109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110033924|NCT02293109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110033925|NCT02293109|Antiemetics|antiemetics|mesh-ancestor
110033926|NCT02293109|Autonomic Agents|autonomic agents|mesh-ancestor
110033927|NCT02293109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110033928|NCT02293109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110033929|NCT02293109|Glucocorticoids|glucocorticoids|mesh-ancestor
110033931|NCT02293109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110033932|NCT02293109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110033933|NCT02293109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110033934|NCT02293109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110033935|NCT02293109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110033936|NCT02293109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110033937|NCT02293109|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110033938|NCT02293109|Abortifacient Agents|abortifacient agents|mesh-ancestor
110033939|NCT02293109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110033940|NCT02293109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110033941|NCT02293109|Antimetabolites|antimetabolites|mesh-ancestor
110033942|NCT02293109|Dermatologic Agents|dermatologic agents|mesh-ancestor
110033943|NCT02293109|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110033944|NCT02293109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110033946|NCT02293109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110033947|NCT02293109|Antidotes|antidotes|mesh-ancestor
110033948|NCT02293109|Protective Agents|protective agents|mesh-ancestor
110033949|NCT02293109|Vitamin B Complex|vitamin b complex|mesh-ancestor
110033950|NCT02293109|Vitamins|vitamins|mesh-ancestor
110033951|NCT02293109|Micronutrients|micronutrients|mesh-ancestor
110033952|NCT02293109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110033953|NCT02293109|Tubulin Modulators|tubulin modulators|mesh-ancestor
110033954|NCT02293109|Antimitotic Agents|antimitotic agents|mesh-ancestor
110033955|NCT02293109|Mitosis Modulators|mitosis modulators|mesh-ancestor
110033956|NCT02293109|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110033958|NCT02195986|Estrogens|estrogens|mesh-ancestor
110033959|NCT02195986|Hormones|hormones|mesh-ancestor
110033960|NCT02195986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110033961|NCT02195986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110033962|NCT02183883|Afatinib|afatinib|mesh-list
110033963|NCT02183883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110033964|NCT02183883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110033965|NCT02183883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110033966|NCT02183883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110033967|NCT01982630|Liraglutide|liraglutide|mesh-list
110033968|NCT01982630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110033969|NCT01982630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110033970|NCT01982630|Incretins|incretins|mesh-ancestor
110033971|NCT01982630|Hormones|hormones|mesh-ancestor
110033972|NCT01982630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110033973|NCT01951469|Pemetrexed|pemetrexed|mesh-list
110033974|NCT01951469|Gefitinib|gefitinib|mesh-list
110033975|NCT01951469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110033976|NCT01951469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110033993|NCT01879228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110033996|NCT01879228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110033997|NCT01879228|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110033998|NCT01879228|Protease Inhibitors|protease inhibitors|mesh-ancestor
110033999|NCT01879228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110034000|NCT01879228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034001|NCT01779557|Dialysis Solutions|dialysis solutions|mesh-list
110034002|NCT01779557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110034003|NCT01740297|Ipilimumab|ipilimumab|mesh-list
110034004|NCT01740297|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
110034005|NCT01740297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110034006|NCT01740297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110034007|NCT01740297|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110034008|NCT01740297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034011|NCT01729754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110034012|NCT01729754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110034013|NCT01729754|Analgesics|analgesics|mesh-ancestor
110034014|NCT01729754|Sensory System Agents|sensory system agents|mesh-ancestor
110034015|NCT01729754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110034016|NCT01729754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034017|NCT01729754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110034018|NCT01729754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110034019|NCT01729754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110034020|NCT01729754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110034023|NCT01622998|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110034024|NCT01622998|Autonomic Agents|autonomic agents|mesh-ancestor
110034025|NCT01622998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110034026|NCT01622998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034027|NCT01622998|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110034028|NCT01622998|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110034029|NCT01622998|Cholinergic Agents|cholinergic agents|mesh-ancestor
110034030|NCT01622998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110034034|NCT01595620|Hallucinogens|hallucinogens|mesh-ancestor
110034035|NCT01595620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034036|NCT01595620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110034037|NCT01595620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110034038|NCT01595620|Analgesics|analgesics|mesh-ancestor
110034039|NCT01595620|Sensory System Agents|sensory system agents|mesh-ancestor
110034040|NCT01595620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110034041|NCT01595620|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110034042|NCT01595620|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110034043|NCT01595620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110034044|NCT01595620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034046|NCT01595620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110034061|NCT01591629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110034062|NCT01591629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034063|NCT01591629|Hormones|hormones|mesh-ancestor
110034064|NCT01591629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110034065|NCT01515306|Paclitaxel|paclitaxel|mesh-list
110034066|NCT01515306|Ramucirumab|ramucirumab|mesh-list
110034067|NCT01515306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110034068|NCT01515306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110034069|NCT01515306|Tubulin Modulators|tubulin modulators|mesh-ancestor
110034071|NCT01515306|Mitosis Modulators|mitosis modulators|mesh-ancestor
110034072|NCT01515306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034073|NCT01513187|Interferons|interferons|mesh-list
110034074|NCT01513187|Interferon-alpha|interferon-alpha|mesh-list
110034075|NCT01513187|Interferon alpha-2|interferon alpha-2|mesh-list
110034076|NCT01513187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110034077|NCT01513187|Antiviral Agents|antiviral agents|mesh-ancestor
110034078|NCT01513187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110034079|NCT01513187|Immunologic Factors|immunologic factors|mesh-ancestor
110034080|NCT01513187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034081|NCT01433965|Lenalidomide|lenalidomide|mesh-list
110034082|NCT01433965|Immunologic Factors|immunologic factors|mesh-ancestor
110034083|NCT01433965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034084|NCT01433965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110034085|NCT01433965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110034086|NCT01433965|Growth Substances|growth substances|mesh-ancestor
110034087|NCT01433965|Growth Inhibitors|growth inhibitors|mesh-ancestor
110034088|NCT01433965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110034089|NCT01360593|Gemcitabine|gemcitabine|mesh-list
110034090|NCT01360593|Capecitabine|capecitabine|mesh-list
110034091|NCT01360593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110034092|NCT01360593|Antimetabolites|antimetabolites|mesh-ancestor
110034093|NCT01360593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034094|NCT01360593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110034095|NCT01354977|Resveratrol|resveratrol|mesh-list
110034096|NCT01354977|Antioxidants|antioxidants|mesh-ancestor
110034097|NCT01354977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034098|NCT01354977|Protective Agents|protective agents|mesh-ancestor
110034099|NCT01354977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034100|NCT01354977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110034101|NCT01354977|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110034103|NCT01334606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110034104|NCT01334606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034105|NCT01226732|Capecitabine|capecitabine|mesh-list
110034107|NCT01226732|Antimetabolites|antimetabolites|mesh-ancestor
110034108|NCT01226732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034109|NCT01226732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110034110|NCT00962988|Bupropion|bupropion|mesh-list
110034111|NCT00962988|Nicotine|nicotine|mesh-list
110034112|NCT00962988|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110034113|NCT00962988|Autonomic Agents|autonomic agents|mesh-ancestor
110034114|NCT00962988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110034115|NCT00962988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034116|NCT00962988|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110034117|NCT00962988|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110034118|NCT00962988|Cholinergic Agents|cholinergic agents|mesh-ancestor
110034119|NCT00962988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110034120|NCT00962988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034126|NCT00962988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110034128|NCT00962988|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110034129|NCT00962988|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110034130|NCT00962988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110034132|NCT00768820|Methylphenidate|methylphenidate|mesh-list
110034133|NCT00768820|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110034134|NCT00768820|Serotonin Agents|serotonin agents|mesh-ancestor
110034135|NCT00768820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110034136|NCT00768820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034137|NCT00768820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034138|NCT00768820|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110034139|NCT00768820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110034140|NCT00768820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110034141|NCT00768820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110034143|NCT00768820|Dopamine Agents|dopamine agents|mesh-ancestor
110034144|NCT00768820|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110034145|NCT00768820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110034146|NCT00768820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110034147|NCT00768820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110034148|NCT00678730|Dronabinol|dronabinol|mesh-list
110034149|NCT00678730|Hallucinogens|hallucinogens|mesh-ancestor
110034150|NCT00678730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034151|NCT00678730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110034152|NCT00678730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110034153|NCT00678730|Analgesics|analgesics|mesh-ancestor
110034154|NCT00678730|Sensory System Agents|sensory system agents|mesh-ancestor
110034155|NCT00678730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110034156|NCT00678730|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110034157|NCT00678730|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110034158|NCT00678730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110034159|NCT00678730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034160|NCT00678730|Hormones|hormones|mesh-ancestor
110034161|NCT00678730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110034162|NCT00600015|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110034163|NCT00600015|Sorafenib|sorafenib|mesh-list
110034164|NCT00600015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110034165|NCT00600015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110034166|NCT00600015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110034167|NCT00600015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034168|NCT00500071|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
110034169|NCT00500071|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110034170|NCT00500071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034171|NCT00500071|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110034172|NCT00500071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110034173|NCT00500071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110034174|NCT00500071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034175|NCT00500071|Dopamine Agents|dopamine agents|mesh-ancestor
110034176|NCT00500071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110034177|NCT00447122|Gemcitabine|gemcitabine|mesh-list
110034178|NCT00447122|Oxaliplatin|oxaliplatin|mesh-list
110034179|NCT00447122|Lapatinib|lapatinib|mesh-list
110034180|NCT00447122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110034181|NCT00447122|Antimetabolites|antimetabolites|mesh-ancestor
110034182|NCT00447122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034183|NCT00447122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110034184|NCT00447122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110034185|NCT00447122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110034187|NCT00430040|Lisinopril|lisinopril|mesh-list
110034188|NCT00430040|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110034189|NCT00430040|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110034190|NCT00430040|Adrenergic Agents|adrenergic agents|mesh-ancestor
110034191|NCT00430040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110034194|NCT00430040|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110034195|NCT00430040|Antioxidants|antioxidants|mesh-ancestor
110034196|NCT00430040|Protective Agents|protective agents|mesh-ancestor
110034197|NCT00430040|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110034198|NCT00430040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110034199|NCT00430040|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110034200|NCT00430040|Vasodilator Agents|vasodilator agents|mesh-ancestor
110034201|NCT00430040|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110034202|NCT00430040|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110034203|NCT00430040|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110034205|NCT00430040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110034206|NCT00430040|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110034207|NCT00290251|Ulipristal acetate|ulipristal acetate|mesh-list
110034208|NCT00290251|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110034209|NCT00290251|Contraceptive Agents|contraceptive agents|mesh-ancestor
110034210|NCT00290251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110034211|NCT00290251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034214|NCT00066963|Fluorides, Topical|fluorides, topical|mesh-list
110034215|NCT00066963|Cariostatic Agents|cariostatic agents|mesh-ancestor
110034216|NCT00066963|Protective Agents|protective agents|mesh-ancestor
110034217|NCT00066963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034218|NCT01397500|Testosterone|testosterone|mesh-list
110034219|NCT01397500|Androgens|androgens|mesh-ancestor
110034220|NCT01397500|Hormones|hormones|mesh-ancestor
110034221|NCT01397500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110034222|NCT01397500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034223|NCT01397513|Aspirin|aspirin|mesh-list
110034224|NCT01397513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110034225|NCT01397513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110034227|NCT01397513|Sensory System Agents|sensory system agents|mesh-ancestor
110034228|NCT01397513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110034229|NCT01397513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034230|NCT01397513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110034231|NCT01397513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110034232|NCT01397513|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110034233|NCT01397513|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110034234|NCT01397513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034235|NCT01397513|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110034236|NCT01397513|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110034239|NCT01397630|Oxytocin|oxytocin|mesh-list
110034240|NCT01397630|Oxytocics|oxytocics|mesh-ancestor
110034241|NCT01397630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110034242|NCT01397630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034243|NCT01397734|Arsenic Trioxide|arsenic trioxide|mesh-list
110034244|NCT01397734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110034245|NCT01397799|Tirbanibulin|tirbanibulin|mesh-list
110034246|NCT01397799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110034247|NCT01397799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034248|NCT01397994|Nicorandil|nicorandil|mesh-list
110034249|NCT01397994|Atenolol|atenolol|mesh-list
110034250|NCT01397994|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110034251|NCT01397994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110034252|NCT01397994|Sympatholytics|sympatholytics|mesh-ancestor
110034253|NCT01397994|Autonomic Agents|autonomic agents|mesh-ancestor
110034254|NCT01397994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110034255|NCT01397994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034256|NCT01397994|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110034257|NCT01397994|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110034259|NCT01397994|Adrenergic Agents|adrenergic agents|mesh-ancestor
110034260|NCT01397994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110034261|NCT01397994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034262|NCT01397994|Vasodilator Agents|vasodilator agents|mesh-ancestor
110034263|NCT01397994|Vitamin B Complex|vitamin b complex|mesh-ancestor
110034265|NCT01397994|Micronutrients|micronutrients|mesh-ancestor
110034267|NCT01398033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110034268|NCT01398033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110034269|NCT01398033|Tubulin Modulators|tubulin modulators|mesh-ancestor
110034270|NCT01398033|Antimitotic Agents|antimitotic agents|mesh-ancestor
110034271|NCT01398033|Mitosis Modulators|mitosis modulators|mesh-ancestor
110034276|NCT01398046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110034277|NCT01398046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110034278|NCT01398046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110034279|NCT01398046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034280|NCT01398046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110034281|NCT01398046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110034282|NCT01398046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110034284|NCT01398046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110034285|NCT01398046|Antimetabolites|antimetabolites|mesh-ancestor
110034286|NCT01398046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110034287|NCT01398072|Moxifloxacin|moxifloxacin|mesh-list
110034288|NCT01398072|Azithromycin|azithromycin|mesh-list
110034289|NCT01398072|Doxycycline|doxycycline|mesh-list
110034290|NCT01398072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110034291|NCT01398072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110034292|NCT01398072|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110034293|NCT01398072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110034294|NCT01398072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110034295|NCT01398072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034296|NCT01398072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110034297|NCT01398072|Antimalarials|antimalarials|mesh-ancestor
110034298|NCT01398072|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110034299|NCT01398072|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110034300|NCT01398111|Glycopyrrolate|glycopyrrolate|mesh-list
110034301|NCT01398111|Formoterol Fumarate|formoterol fumarate|mesh-list
110034302|NCT01398111|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110034303|NCT01398111|Autonomic Agents|autonomic agents|mesh-ancestor
110034304|NCT01398111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110034305|NCT01398111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034306|NCT01398111|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110034307|NCT01398111|Respiratory System Agents|respiratory system agents|mesh-ancestor
110034308|NCT01398111|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110034309|NCT01398111|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110034310|NCT01398111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110034311|NCT01398111|Adrenergic Agents|adrenergic agents|mesh-ancestor
110034312|NCT01398111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110034313|NCT01398111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034314|NCT01398111|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110034315|NCT01398111|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110034316|NCT01398111|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110034319|NCT01398189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110034321|NCT01398189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110034322|NCT01398189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034323|NCT01398189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034325|NCT01398189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110034326|NCT01398189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110034327|NCT01398189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110034328|NCT01398189|GABA Antagonists|gaba antagonists|mesh-ancestor
110034329|NCT01398189|GABA Agents|gaba agents|mesh-ancestor
110034330|NCT01398202|Vitamin D|vitamin d|mesh-list
110034331|NCT01398202|Cholecalciferol|cholecalciferol|mesh-list
110034332|NCT01398202|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
110034333|NCT01398202|Calcifediol|calcifediol|mesh-list
110034334|NCT01398202|Vitamins|vitamins|mesh-ancestor
110034335|NCT01398202|Micronutrients|micronutrients|mesh-ancestor
110034336|NCT01398202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034337|NCT01398202|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110034338|NCT01398202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110034339|NCT01398267|Lisinopril|lisinopril|mesh-list
110034340|NCT01398267|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110034341|NCT01398267|Protease Inhibitors|protease inhibitors|mesh-ancestor
110034342|NCT01398267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110034343|NCT01398267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034344|NCT01398267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110034346|NCT01398267|Protective Agents|protective agents|mesh-ancestor
110034347|NCT01398267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034349|NCT01398293|Moxifloxacin|moxifloxacin|mesh-list
110034350|NCT01398293|Lactams|lactams|mesh-list
110034353|NCT01398293|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110034354|NCT01398293|Protease Inhibitors|protease inhibitors|mesh-ancestor
110034355|NCT01398293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110034356|NCT01398293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034357|NCT01398293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110034358|NCT01398293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110034359|NCT01398293|Antiviral Agents|antiviral agents|mesh-ancestor
110034360|NCT01398293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110034361|NCT01398293|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110034362|NCT01398293|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110034363|NCT01398293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110034364|NCT01398293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110034365|NCT01398293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110034366|NCT01398293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110034367|NCT01398293|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110034368|NCT01398293|Contraceptive Agents|contraceptive agents|mesh-ancestor
110034369|NCT01398293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110034370|NCT01398293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034371|NCT01398293|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110034372|NCT01398293|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110034373|NCT01398293|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110034375|NCT01398371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110034376|NCT01398371|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110034377|NCT01398371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110034378|NCT01398371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034379|NCT01398371|Protective Agents|protective agents|mesh-ancestor
110034380|NCT01398371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034382|NCT01398384|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110034383|NCT01398384|Autonomic Agents|autonomic agents|mesh-ancestor
110034384|NCT01398384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110034385|NCT01398384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034386|NCT01398384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110034387|NCT01398384|Respiratory System Agents|respiratory system agents|mesh-ancestor
110034388|NCT01398384|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110034389|NCT01398384|Antioxidants|antioxidants|mesh-ancestor
110034390|NCT01398384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034391|NCT01398384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110034392|NCT01398384|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110034393|NCT01398384|Vasodilator Agents|vasodilator agents|mesh-ancestor
110034394|NCT01398384|Gasotransmitters|gasotransmitters|mesh-ancestor
110034395|NCT01398384|Protective Agents|protective agents|mesh-ancestor
110034397|NCT01398501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110034398|NCT01398501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110034399|NCT01398501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110034400|NCT01398501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034401|NCT01398592|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110034402|NCT01398592|Vildagliptin|vildagliptin|mesh-list
110034403|NCT01398592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110034404|NCT01398592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034405|NCT01398592|Incretins|incretins|mesh-ancestor
110034406|NCT01398592|Hormones|hormones|mesh-ancestor
110034407|NCT01398592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110034408|NCT01398592|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110034409|NCT01398592|Protease Inhibitors|protease inhibitors|mesh-ancestor
110034410|NCT01398592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110034411|NCT01398592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034413|NCT01398618|Isoniazid|isoniazid|mesh-list
110034414|NCT01398618|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110034415|NCT01398618|Antitubercular Agents|antitubercular agents|mesh-ancestor
110034416|NCT01398618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110034417|NCT01398618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110034418|NCT01398618|Leprostatic Agents|leprostatic agents|mesh-ancestor
110034419|NCT01398618|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110034420|NCT01398618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110034421|NCT01398618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034422|NCT01398618|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110034423|NCT01398618|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110034424|NCT01398618|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110034425|NCT01398618|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110034428|NCT01398618|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110034430|NCT01398618|Antimetabolites|antimetabolites|mesh-ancestor
110034431|NCT01398618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110034432|NCT01398657|Androgens|androgens|mesh-list
110034433|NCT01398657|Hormones|hormones|mesh-ancestor
110034434|NCT01398657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110034435|NCT01398657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034436|NCT01398670|Insulin|insulin|mesh-list
110034437|NCT01398670|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110034438|NCT01398670|Insulin Lispro|insulin lispro|mesh-list
110034439|NCT01398670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110034440|NCT01398670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034441|NCT01398722|Insulin|insulin|mesh-list
110034442|NCT01398722|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110034443|NCT01398722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110034444|NCT01398722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034445|NCT01398995|Insulin|insulin|mesh-list
110034446|NCT01398995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110034447|NCT01398995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034448|NCT01399086|Fulvestrant|fulvestrant|mesh-list
110034449|NCT01399086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110034450|NCT01399086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110034451|NCT01399086|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110034452|NCT01399086|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110034453|NCT01399086|Hormone Antagonists|hormone antagonists|mesh-ancestor
110034454|NCT01399086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110034455|NCT01399086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034457|NCT01399151|Ergocalciferols|ergocalciferols|mesh-list
110034458|NCT01399151|Cholecalciferol|cholecalciferol|mesh-list
110034459|NCT01399151|Vitamins|vitamins|mesh-list
110034460|NCT01399151|Micronutrients|micronutrients|mesh-ancestor
110034462|NCT01399151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110034463|NCT01399151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110034464|NCT01399216|Fucoidan|fucoidan|mesh-list
110034465|NCT01399216|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110034466|NCT01399216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110034468|NCT01399216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110034469|NCT01399242|Everolimus|everolimus|mesh-list
110034470|NCT01399242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110034471|NCT01399242|Immunologic Factors|immunologic factors|mesh-ancestor
110034472|NCT01399242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034473|NCT01399242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110034474|NCT01399242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034475|NCT01399242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110034476|NCT01399242|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110034477|NCT01399242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110034478|NCT01399255|Insulin Lispro|insulin lispro|mesh-list
110034479|NCT01399255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110034480|NCT01399255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034482|NCT01399346|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110034483|NCT01399346|Insulin Aspart|insulin aspart|mesh-list
110034484|NCT01399346|Insulin, Long-Acting|insulin, long-acting|mesh-list
110034485|NCT01399346|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110034486|NCT01399346|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110034487|NCT01399346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034490|NCT01399450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110034491|NCT01399450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110034492|NCT01399450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034493|NCT01399450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110034494|NCT01399450|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110034495|NCT01399450|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110034496|NCT01399450|Serotonin Agents|serotonin agents|mesh-ancestor
110034497|NCT01399450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110034498|NCT01399450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034499|NCT01399450|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110034500|NCT01399450|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110034501|NCT01399450|Dopamine Agents|dopamine agents|mesh-ancestor
110034503|NCT01399463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110034504|NCT01399463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110034508|NCT01399463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034509|NCT01399515|Valproic Acid|valproic acid|mesh-list
110034510|NCT01399515|Anticonvulsants|anticonvulsants|mesh-ancestor
110034511|NCT01399515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110034512|NCT01399515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034513|NCT01399515|GABA Agents|gaba agents|mesh-ancestor
110034514|NCT01399515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110034515|NCT01399515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034516|NCT01399515|Antimanic Agents|antimanic agents|mesh-ancestor
110034517|NCT01399515|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110034518|NCT01399515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110034519|NCT01399515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110034520|NCT01399645|Insulin|insulin|mesh-list
110034521|NCT01399645|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110034522|NCT01399645|Metformin|metformin|mesh-list
110034523|NCT01399645|Insulin Glargine|insulin glargine|mesh-list
110034524|NCT01399645|Liraglutide|liraglutide|mesh-list
110034525|NCT01399645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110034526|NCT01399645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034529|NCT01399645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110034530|NCT01399840|Talazoparib|talazoparib|mesh-list
110034531|NCT01399840|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110034532|NCT01399840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110034533|NCT01399840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034534|NCT01399840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110034536|NCT01399853|Immunologic Factors|immunologic factors|mesh-ancestor
110034537|NCT01399853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034538|NCT01400009|Vitamin D|vitamin d|mesh-list
110034539|NCT01400009|Cholecalciferol|cholecalciferol|mesh-list
110034540|NCT01400009|Vitamins|vitamins|mesh-ancestor
110034541|NCT01400009|Micronutrients|micronutrients|mesh-ancestor
110034542|NCT01400009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034543|NCT01400009|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110034544|NCT01400009|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110034545|NCT01400022|Cortisone|cortisone|mesh-list
110034546|NCT01400022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110034547|NCT01400074|Imatinib Mesylate|imatinib mesylate|mesh-list
110034548|NCT01400074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110034549|NCT01400074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110034550|NCT01400074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110034551|NCT01400074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034552|NCT01400100|Octreotide|octreotide|mesh-list
110034553|NCT01400100|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110034554|NCT01400100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110034555|NCT01400100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110034556|NCT01400100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110034557|NCT01400165|Pindolol|pindolol|mesh-list
110034558|NCT01400165|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110034559|NCT01400165|Trazodone|trazodone|mesh-list
110034561|NCT01400165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110034562|NCT01400165|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110034563|NCT01400165|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110034564|NCT01400165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110034565|NCT01400165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034566|NCT01400165|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110034567|NCT01400165|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110034568|NCT01400165|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110034569|NCT01400165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110034570|NCT01400165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034571|NCT01400165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110034573|NCT01400165|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110034574|NCT01400165|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110034575|NCT01400165|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110034576|NCT01400165|Adrenergic Agents|adrenergic agents|mesh-ancestor
110034577|NCT01400165|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110034578|NCT01400165|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110034579|NCT01400165|Vasodilator Agents|vasodilator agents|mesh-ancestor
110034580|NCT01400191|Metformin|metformin|mesh-list
110034582|NCT01400191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034583|NCT01400217|Beclomethasone|beclomethasone|mesh-list
110034584|NCT01400217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110034585|NCT01400217|Glucocorticoids|glucocorticoids|mesh-ancestor
110034586|NCT01400217|Hormones|hormones|mesh-ancestor
110034587|NCT01400217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110034679|NCT01400750|Tobramycin|tobramycin|mesh-list
110034588|NCT01400217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034589|NCT01400217|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110034590|NCT01400217|Respiratory System Agents|respiratory system agents|mesh-ancestor
110034592|NCT01400256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110034593|NCT01400256|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110034594|NCT01400256|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110034595|NCT01400256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034597|NCT01400308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110034598|NCT01400308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110034599|NCT01400308|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110034600|NCT01400308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110034601|NCT01400308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034602|NCT01400360|Vasodilator Agents|vasodilator agents|mesh-list
110034604|NCT01400464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110034605|NCT01400464|Glucocorticoids|glucocorticoids|mesh-ancestor
110034606|NCT01400464|Hormones|hormones|mesh-ancestor
110034607|NCT01400464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110034608|NCT01400464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034609|NCT01400464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110034610|NCT01400464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110034613|NCT01400568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110034614|NCT01400568|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110034615|NCT01400568|Autonomic Agents|autonomic agents|mesh-ancestor
110034616|NCT01400568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110034617|NCT01400568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034618|NCT01400568|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110034619|NCT01400568|Respiratory System Agents|respiratory system agents|mesh-ancestor
110034620|NCT01400568|Dermatologic Agents|dermatologic agents|mesh-ancestor
110034621|NCT01400568|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110034622|NCT01400633|Decitabine|decitabine|mesh-list
110034623|NCT01400633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110034625|NCT01400633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034626|NCT01400633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110034627|NCT01400633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110034630|NCT01400646|Warfarin|warfarin|mesh-list
110034631|NCT01400646|Rivaroxaban|rivaroxaban|mesh-list
110034632|NCT01400646|Micronutrients|micronutrients|mesh-ancestor
110034633|NCT01400646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034634|NCT01400646|Anticoagulants|anticoagulants|mesh-ancestor
110034635|NCT01400646|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110034636|NCT01400646|Antithrombins|antithrombins|mesh-ancestor
110034637|NCT01400646|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110034638|NCT01400646|Protease Inhibitors|protease inhibitors|mesh-ancestor
110034639|NCT01400646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110034640|NCT01400646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034641|NCT01400646|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110034642|NCT01400646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110034644|NCT01400646|Coagulants|coagulants|mesh-ancestor
110034645|NCT01400672|Imiquimod|imiquimod|mesh-list
110034646|NCT01400672|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110034647|NCT01400672|Immunologic Factors|immunologic factors|mesh-ancestor
110034657|NCT01400685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034658|NCT01400685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110034659|NCT01400685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110034660|NCT01400685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110034661|NCT01400685|Growth Substances|growth substances|mesh-ancestor
110034662|NCT01400685|Growth Inhibitors|growth inhibitors|mesh-ancestor
110034663|NCT01400685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110034664|NCT01400685|Alkylating Agents|alkylating agents|mesh-ancestor
110034665|NCT01400685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034666|NCT01400737|Ibuprofen|ibuprofen|mesh-list
110034667|NCT01400737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110034668|NCT01400737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110034670|NCT01400737|Sensory System Agents|sensory system agents|mesh-ancestor
110034671|NCT01400737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110034672|NCT01400737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034673|NCT01400737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110034674|NCT01400737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110034675|NCT01400737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110034676|NCT01400737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110034677|NCT01400737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034678|NCT01400750|Ciprofloxacin|ciprofloxacin|mesh-list
110034681|NCT01400750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110034682|NCT01400750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110034683|NCT01400750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110034684|NCT01400750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110034685|NCT01400750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110034686|NCT01400750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034687|NCT01400750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110034688|NCT01400750|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110034689|NCT01400750|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110034691|NCT01400789|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
110034692|NCT01400789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110034693|NCT01400789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034694|NCT01400802|Insulin Lispro|insulin lispro|mesh-list
110034695|NCT01400802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110034696|NCT01400802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034697|NCT01400828|Desloratadine|desloratadine|mesh-list
110034698|NCT01400828|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110034699|NCT01400828|Cholinergic Agents|cholinergic agents|mesh-ancestor
110034700|NCT01400828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110034701|NCT01400828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034702|NCT01400828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034703|NCT01400828|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110034704|NCT01400828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110034705|NCT01400828|Histamine Antagonists|histamine antagonists|mesh-ancestor
110034706|NCT01400828|Histamine Agents|histamine agents|mesh-ancestor
110034708|NCT01400867|Clindamycin|clindamycin|mesh-list
110034709|NCT01400867|Clindamycin palmitate|clindamycin palmitate|mesh-list
110034710|NCT01400867|Clindamycin phosphate|clindamycin phosphate|mesh-list
110034711|NCT01400867|Cefazolin|cefazolin|mesh-list
110034712|NCT01400867|Linezolid|linezolid|mesh-list
110034713|NCT01400867|Cephalexin|cephalexin|mesh-list
110034714|NCT01400867|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
110034715|NCT01400867|Aztreonam|aztreonam|mesh-list
110034716|NCT01400867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110034717|NCT01400867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110034718|NCT01400867|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110034719|NCT01400867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110034720|NCT01400867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034721|NCT01400945|Pantoprazole|pantoprazole|mesh-list
110034722|NCT01400945|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110034723|NCT01400945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110034724|NCT01400945|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110034725|NCT01400945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110034726|NCT01400945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034727|NCT01401036|Umirolimus|umirolimus|mesh-list
110034728|NCT01401036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110034729|NCT01401036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110034731|NCT01401036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034733|NCT01401075|Doxifluridine|doxifluridine|mesh-list
110034734|NCT01401075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110034735|NCT01401075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110034736|NCT01401075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110034737|NCT01401075|Antiviral Agents|antiviral agents|mesh-ancestor
110034738|NCT01401075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110034739|NCT01401075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110034740|NCT01401075|Antimetabolites|antimetabolites|mesh-ancestor
110034741|NCT01401075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034742|NCT01401075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110034743|NCT01401075|Immunologic Factors|immunologic factors|mesh-ancestor
110034744|NCT01401075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034746|NCT01401075|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110034747|NCT01401179|Clarithromycin|clarithromycin|mesh-list
110034749|NCT01401179|Erythromycin|erythromycin|mesh-list
110034750|NCT01401179|Erythromycin Estolate|erythromycin estolate|mesh-list
110034751|NCT01401179|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
110034752|NCT01401179|Erythromycin stearate|erythromycin stearate|mesh-list
110034753|NCT01401179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110034754|NCT01401179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110034755|NCT01401179|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110034756|NCT01401179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110034757|NCT01401179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034758|NCT01401179|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110034759|NCT01401179|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110034760|NCT01401179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110034771|NCT01401387|Pancreatin|pancreatin|mesh-list
110034772|NCT01401387|Pancrelipase|pancrelipase|mesh-list
110034773|NCT01401387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110034774|NCT01401491|Clozapine|clozapine|mesh-list
110034775|NCT01401491|Fluvoxamine|fluvoxamine|mesh-list
110034776|NCT01401491|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110034777|NCT01401491|Serotonin Agents|serotonin agents|mesh-ancestor
110034778|NCT01401491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110034779|NCT01401491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034780|NCT01401491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034781|NCT01401491|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110034782|NCT01401491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110034783|NCT01401491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110034784|NCT01401491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110034785|NCT01401491|GABA Antagonists|gaba antagonists|mesh-ancestor
110034786|NCT01401491|GABA Agents|gaba agents|mesh-ancestor
110034787|NCT01401491|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110034788|NCT01401491|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110034789|NCT01401491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110034790|NCT01401491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110034791|NCT01401491|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110034792|NCT01401491|Antidepressive Agents|antidepressive agents|mesh-ancestor
110034793|NCT01401491|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110034794|NCT01401491|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110034795|NCT01401491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110034796|NCT01401491|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110034798|NCT01401803|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110034799|NCT01401803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110034800|NCT01401803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034801|NCT01401803|Cholinergic Agents|cholinergic agents|mesh-ancestor
110034802|NCT01401803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110034803|NCT01401803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034805|NCT01401933|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110034806|NCT01401933|Antitubercular Agents|antitubercular agents|mesh-ancestor
110034807|NCT01401933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110034808|NCT01401933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110034809|NCT01401933|Leprostatic Agents|leprostatic agents|mesh-ancestor
110034810|NCT01401933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110034811|NCT01401933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110034812|NCT01401933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034813|NCT01401933|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110034814|NCT01401933|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110034815|NCT01401933|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110034816|NCT01401933|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110034817|NCT01401933|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110034818|NCT01401933|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110034820|NCT01402024|Antiemetics|antiemetics|mesh-ancestor
110034821|NCT01402024|Autonomic Agents|autonomic agents|mesh-ancestor
110034822|NCT01402024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110034823|NCT01402024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034824|NCT01402024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110034825|NCT01402024|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110034826|NCT01402024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110034827|NCT01402024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034828|NCT01402076|Rosiglitazone|rosiglitazone|mesh-list
110034829|NCT01402076|Midazolam|midazolam|mesh-list
110034830|NCT01402076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110034831|NCT01402076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110034832|NCT01402076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110034833|NCT01402076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034834|NCT01402076|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110034836|NCT01402076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110034837|NCT01402076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110034838|NCT01402076|Anesthetics, General|anesthetics, general|mesh-ancestor
110034839|NCT01402076|Anesthetics|anesthetics|mesh-ancestor
110034840|NCT01402076|GABA Modulators|gaba modulators|mesh-ancestor
110034841|NCT01402076|GABA Agents|gaba agents|mesh-ancestor
110034842|NCT01402076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110034843|NCT01402076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034844|NCT01402076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110034846|NCT01402089|Sunitinib|sunitinib|mesh-list
110034847|NCT01402089|Midazolam|midazolam|mesh-list
110034848|NCT01402089|Caffeine|caffeine|mesh-list
110034849|NCT01402089|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110034850|NCT01402089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110034851|NCT01402089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110034852|NCT01402089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034853|NCT01402089|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110034854|NCT01402089|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110034855|NCT01402089|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110034856|NCT01402089|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110034857|NCT01402089|Anesthetics, General|anesthetics, general|mesh-ancestor
110034858|NCT01402089|Anesthetics|anesthetics|mesh-ancestor
110034859|NCT01402089|GABA Modulators|gaba modulators|mesh-ancestor
110034860|NCT01402089|GABA Agents|gaba agents|mesh-ancestor
110034861|NCT01402089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110034862|NCT01402089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034863|NCT01402089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110034865|NCT01402089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110034866|NCT01402089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110034867|NCT01402089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110034868|NCT01402089|Growth Substances|growth substances|mesh-ancestor
110034869|NCT01402089|Growth Inhibitors|growth inhibitors|mesh-ancestor
110034870|NCT01402089|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110034871|NCT01402089|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110034872|NCT01402089|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110034873|NCT01402089|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110034874|NCT01402089|Purinergic Agents|purinergic agents|mesh-ancestor
110034875|NCT01402180|Nimotuzumab|nimotuzumab|mesh-list
110034876|NCT01402180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110034877|NCT01402180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110034878|NCT01402193|Anastrozole|anastrozole|mesh-list
110034879|NCT01402193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110034880|NCT01402193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110034881|NCT01402193|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110034882|NCT01402193|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110034883|NCT01402193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110034884|NCT01402193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034885|NCT01402193|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110034886|NCT01402193|Hormone Antagonists|hormone antagonists|mesh-ancestor
110034887|NCT01402193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110034888|NCT01402193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034890|NCT01402245|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110034891|NCT01402245|Immunologic Factors|immunologic factors|mesh-ancestor
110034892|NCT01402245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034895|NCT01402297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110034896|NCT01402297|Analgesics|analgesics|mesh-ancestor
110034897|NCT01402297|Sensory System Agents|sensory system agents|mesh-ancestor
110034898|NCT01402297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110034899|NCT01402297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034900|NCT01402297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110034901|NCT01402297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110034902|NCT01402297|Antioxidants|antioxidants|mesh-ancestor
110034903|NCT01402297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034904|NCT01402297|Protective Agents|protective agents|mesh-ancestor
110034905|NCT01402297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110034906|NCT01402336|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110034907|NCT01402336|Cetrorelix|cetrorelix|mesh-list
110034908|NCT01402336|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
110034909|NCT01402336|Hormones|hormones|mesh-ancestor
110034910|NCT01402336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110034911|NCT01402336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034912|NCT01402336|Luteolytic Agents|luteolytic agents|mesh-ancestor
110034913|NCT01402336|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110034914|NCT01402336|Contraceptive Agents|contraceptive agents|mesh-ancestor
110034915|NCT01402336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110034916|NCT01402336|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110034917|NCT01402336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110034918|NCT01402336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110034919|NCT01402336|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110034920|NCT01402336|Fertility Agents|fertility agents|mesh-ancestor
110034921|NCT01402336|Hormone Antagonists|hormone antagonists|mesh-ancestor
110034923|NCT01402479|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110034925|NCT01402479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110034926|NCT01402479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034927|NCT01402479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110034928|NCT01402583|Ribavirin|ribavirin|mesh-list
110034929|NCT01402583|Antimetabolites|antimetabolites|mesh-ancestor
110034930|NCT01402583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034931|NCT01402583|Antiviral Agents|antiviral agents|mesh-ancestor
110034932|NCT01402583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110034933|NCT01402596|Midazolam|midazolam|mesh-list
110034934|NCT01402596|Chloral Hydrate|chloral hydrate|mesh-list
110034935|NCT01402596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110034936|NCT01402596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110034937|NCT01402596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110034938|NCT01402596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034940|NCT01402596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110034941|NCT01402596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110034942|NCT01402596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110034943|NCT01402596|Anesthetics, General|anesthetics, general|mesh-ancestor
110034944|NCT01402596|Anesthetics|anesthetics|mesh-ancestor
110034945|NCT01402596|GABA Modulators|gaba modulators|mesh-ancestor
110034946|NCT01402596|GABA Agents|gaba agents|mesh-ancestor
110034947|NCT01402596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110034948|NCT01402596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034949|NCT01402622|Propofol|propofol|mesh-list
110034950|NCT01402622|Anesthetics|anesthetics|mesh-ancestor
110034951|NCT01402622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110034952|NCT01402622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034953|NCT01402622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110034954|NCT01402622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110034955|NCT01402622|Anesthetics, General|anesthetics, general|mesh-ancestor
110034956|NCT01402674|Phentermine|phentermine|mesh-list
110034958|NCT01402674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034959|NCT01402674|Appetite Depressants|appetite depressants|mesh-ancestor
110034960|NCT01402674|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110034961|NCT01402674|Sympathomimetics|sympathomimetics|mesh-ancestor
110034962|NCT01402674|Autonomic Agents|autonomic agents|mesh-ancestor
110034963|NCT01402674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110034964|NCT01402674|Adrenergic Agents|adrenergic agents|mesh-ancestor
110034965|NCT01402674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110034966|NCT01402674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034967|NCT01402843|Valsartan|valsartan|mesh-list
110034968|NCT01402843|Pitavastatin|pitavastatin|mesh-list
110034969|NCT01402843|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110034970|NCT01402843|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110034972|NCT01402843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034973|NCT01402843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110034974|NCT01402843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110034975|NCT01402843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110034976|NCT01402843|Antimetabolites|antimetabolites|mesh-ancestor
110034977|NCT01402843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110034978|NCT01402843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110034979|NCT01402882|Tranexamic Acid|tranexamic acid|mesh-list
110034980|NCT01402882|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110034981|NCT01402882|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110034982|NCT01402882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034983|NCT01402882|Hemostatics|hemostatics|mesh-ancestor
110034984|NCT01402882|Coagulants|coagulants|mesh-ancestor
110034985|NCT01403025|Liraglutide|liraglutide|mesh-list
110034986|NCT01403025|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110034987|NCT01403025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034988|NCT01403025|Incretins|incretins|mesh-ancestor
110034989|NCT01403025|Hormones|hormones|mesh-ancestor
110034990|NCT01403025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110034991|NCT01403103|Vitamin D|vitamin d|mesh-list
110034992|NCT01403103|Cholecalciferol|cholecalciferol|mesh-list
110034993|NCT01403103|Vitamins|vitamins|mesh-ancestor
110034994|NCT01403103|Micronutrients|micronutrients|mesh-ancestor
110034995|NCT01403103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034996|NCT01403103|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110034997|NCT01403103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110034998|NCT01403168|Analgesics|analgesics|mesh-list
110034999|NCT01403168|Sensory System Agents|sensory system agents|mesh-ancestor
110035000|NCT01403168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110035001|NCT01403168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035003|NCT01403181|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110035004|NCT01403181|Antimetabolites|antimetabolites|mesh-ancestor
110035005|NCT01403181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110035006|NCT01403181|Antiviral Agents|antiviral agents|mesh-ancestor
110035007|NCT01403181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110035009|NCT01403259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110035010|NCT01403285|Cyclophosphamide|cyclophosphamide|mesh-list
110035011|NCT01403285|Molgramostim|molgramostim|mesh-list
110035012|NCT01403285|Imiquimod|imiquimod|mesh-list
110035013|NCT01403285|Sargramostim|sargramostim|mesh-list
110035014|NCT01403285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110035015|NCT01403285|Immunologic Factors|immunologic factors|mesh-ancestor
110035016|NCT01403285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035017|NCT01403285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110035018|NCT01403285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110035020|NCT01403285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110035021|NCT01403285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110035022|NCT01403285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110035023|NCT01403285|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110035024|NCT01403285|Interferon Inducers|interferon inducers|mesh-ancestor
110035026|NCT01403363|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110035027|NCT01403363|Narcotics|narcotics|mesh-ancestor
110035028|NCT01403363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110035029|NCT01403363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035030|NCT01403363|Analgesics|analgesics|mesh-ancestor
110035031|NCT01403363|Sensory System Agents|sensory system agents|mesh-ancestor
110035032|NCT01403363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110035033|NCT01403363|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110035034|NCT01403363|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110035035|NCT01403363|Anesthetics, General|anesthetics, general|mesh-ancestor
110035036|NCT01403363|Anesthetics|anesthetics|mesh-ancestor
110035038|NCT01403389|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110035039|NCT01403389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110035040|NCT01403389|Immunologic Factors|immunologic factors|mesh-ancestor
110035041|NCT01403389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035042|NCT01403415|Sirolimus|sirolimus|mesh-list
110035043|NCT01403415|Dexamethasone|dexamethasone|mesh-list
110035044|NCT01403415|Dexamethasone acetate|dexamethasone acetate|mesh-list
110035045|NCT01403415|Methotrexate|methotrexate|mesh-list
110035046|NCT01403415|Vincristine|vincristine|mesh-list
110035047|NCT01403415|Temsirolimus|temsirolimus|mesh-list
110035048|NCT01403415|Asparaginase|asparaginase|mesh-list
110035050|NCT01403415|Pegaspargase|pegaspargase|mesh-list
110035051|NCT01403415|MTOR Inhibitors|mtor inhibitors|mesh-list
110035053|NCT01403415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110035054|NCT01403415|Antiemetics|antiemetics|mesh-ancestor
110035055|NCT01403415|Autonomic Agents|autonomic agents|mesh-ancestor
110035056|NCT01403415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110035057|NCT01403415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035058|NCT01403415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110035059|NCT01403415|Glucocorticoids|glucocorticoids|mesh-ancestor
110035060|NCT01403415|Hormones|hormones|mesh-ancestor
110035061|NCT01403415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110035062|NCT01403415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110035063|NCT01403415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110035064|NCT01403415|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110035065|NCT01403415|Abortifacient Agents|abortifacient agents|mesh-ancestor
110035066|NCT01403415|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110035067|NCT01403415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110035069|NCT01403415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110035070|NCT01403415|Dermatologic Agents|dermatologic agents|mesh-ancestor
110035071|NCT01403415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110035072|NCT01403415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110035073|NCT01403415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110035074|NCT01403415|Immunologic Factors|immunologic factors|mesh-ancestor
110035075|NCT01403415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110035076|NCT01403415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110035077|NCT01403415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110035078|NCT01403415|Tubulin Modulators|tubulin modulators|mesh-ancestor
110035079|NCT01403415|Antimitotic Agents|antimitotic agents|mesh-ancestor
110035080|NCT01403415|Mitosis Modulators|mitosis modulators|mesh-ancestor
110035081|NCT01403415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110035082|NCT01403415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110035083|NCT01403415|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110035085|NCT01403415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110035086|NCT01403415|Protease Inhibitors|protease inhibitors|mesh-ancestor
110035088|NCT01403415|Sensory System Agents|sensory system agents|mesh-ancestor
110035089|NCT01403415|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110035090|NCT01403415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110035091|NCT01403506|Acetylcysteine|acetylcysteine|mesh-list
110035092|NCT01403506|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110035093|NCT01403506|Antiviral Agents|antiviral agents|mesh-ancestor
110035094|NCT01403506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110035095|NCT01403506|Expectorants|expectorants|mesh-ancestor
110035096|NCT01403506|Respiratory System Agents|respiratory system agents|mesh-ancestor
110035097|NCT01403506|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110035098|NCT01403506|Antioxidants|antioxidants|mesh-ancestor
110035099|NCT01403506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110035100|NCT01403506|Protective Agents|protective agents|mesh-ancestor
110035101|NCT01403506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035102|NCT01403506|Antidotes|antidotes|mesh-ancestor
110035103|NCT01403545|Curcumin|curcumin|mesh-list
110035104|NCT01403545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110035105|NCT01403545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110035106|NCT01403545|Analgesics|analgesics|mesh-ancestor
110035107|NCT01403545|Sensory System Agents|sensory system agents|mesh-ancestor
110035108|NCT01403545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110035109|NCT01403545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035110|NCT01403545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110035111|NCT01403545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110035112|NCT01403545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110035113|NCT01403545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110035114|NCT01403545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110035115|NCT01403662|Minocycline|minocycline|mesh-list
110035116|NCT01403662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110035117|NCT01403662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110035118|NCT01403740|Cyclosporine|cyclosporine|mesh-list
110035119|NCT01403740|Rituximab|rituximab|mesh-list
110035120|NCT01403740|Azathioprine|azathioprine|mesh-list
110035121|NCT01403740|Cyclosporins|cyclosporins|mesh-list
110035122|NCT01403740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110035123|NCT01403740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110035125|NCT01403740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035126|NCT01403740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110035127|NCT01403740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110035128|NCT01403740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110035129|NCT01403740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110035130|NCT01403740|Antifungal Agents|antifungal agents|mesh-ancestor
110035131|NCT01403740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110035132|NCT01403740|Dermatologic Agents|dermatologic agents|mesh-ancestor
110035133|NCT01403740|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110035134|NCT01403740|Antimetabolites|antimetabolites|mesh-ancestor
110035135|NCT01403740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110035136|NCT01403818|Ipragliflozin|ipragliflozin|mesh-list
110035137|NCT01403818|Mitiglinide|mitiglinide|mesh-list
110035139|NCT01403818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110035140|NCT01403818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035141|NCT01403818|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110035142|NCT01403818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110035144|NCT01403844|Carotenoids|carotenoids|mesh-list
110035145|NCT01403844|Antioxidants|antioxidants|mesh-ancestor
110035146|NCT01403844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110035147|NCT01403844|Protective Agents|protective agents|mesh-ancestor
110035148|NCT01403844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035149|NCT01403896|Plerixafor|plerixafor|mesh-list
110035150|NCT01403896|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110035151|NCT01403896|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110035152|NCT01403896|Antiviral Agents|antiviral agents|mesh-ancestor
110035153|NCT01403896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110035154|NCT01403948|BI 836826|bi 836826|mesh-list
110035155|NCT01403948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110035156|NCT01403948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110035157|NCT01404000|Charcoal|charcoal|mesh-list
110035158|NCT01404000|Antidotes|antidotes|mesh-ancestor
110035159|NCT01404000|Protective Agents|protective agents|mesh-ancestor
110035160|NCT01404000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035161|NCT01404013|Montelukast|montelukast|mesh-list
110035162|NCT01404013|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110035326|NCT01404598|Analgesics|analgesics|mesh-ancestor
110035163|NCT01404013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110035164|NCT01404013|Respiratory System Agents|respiratory system agents|mesh-ancestor
110035165|NCT01404013|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110035166|NCT01404013|Hormone Antagonists|hormone antagonists|mesh-ancestor
110035167|NCT01404013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110035168|NCT01404013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035170|NCT01404013|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110035171|NCT01404013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110035173|NCT01404104|Temsirolimus|temsirolimus|mesh-list
110035174|NCT01404104|MTOR Inhibitors|mtor inhibitors|mesh-list
110035175|NCT01404104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110035176|NCT01404104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110035177|NCT01404104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110035178|NCT01404104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110035179|NCT01404104|Immunologic Factors|immunologic factors|mesh-ancestor
110035180|NCT01404104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035181|NCT01404104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110035182|NCT01404104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110035183|NCT01404104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110035184|NCT01404104|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110035185|NCT01404104|Antifungal Agents|antifungal agents|mesh-ancestor
110035187|NCT01404117|Interferon-beta|interferon-beta|mesh-list
110035188|NCT01404117|Glatiramer Acetate|glatiramer acetate|mesh-list
110035189|NCT01404117|(T,G)-A-L|(t,g)-a-l|mesh-list
110035190|NCT01404117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110035191|NCT01404117|Antiviral Agents|antiviral agents|mesh-ancestor
110035192|NCT01404117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110035193|NCT01404117|Immunologic Factors|immunologic factors|mesh-ancestor
110035194|NCT01404117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035195|NCT01404117|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110035196|NCT01404117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110035197|NCT01404117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110035198|NCT01404130|Isotretinoin|isotretinoin|mesh-list
110035199|NCT01404130|Dermatologic Agents|dermatologic agents|mesh-ancestor
110035201|NCT01404156|Paclitaxel|paclitaxel|mesh-list
110035202|NCT01404156|Docetaxel|docetaxel|mesh-list
110035203|NCT01404156|Carboplatin|carboplatin|mesh-list
110035204|NCT01404156|Fluorouracil|fluorouracil|mesh-list
110035205|NCT01404156|Oxaliplatin|oxaliplatin|mesh-list
110035206|NCT01404156|Epirubicin|epirubicin|mesh-list
110035207|NCT01404156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110035208|NCT01404156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110035209|NCT01404156|Tubulin Modulators|tubulin modulators|mesh-ancestor
110035210|NCT01404156|Antimitotic Agents|antimitotic agents|mesh-ancestor
110035211|NCT01404156|Mitosis Modulators|mitosis modulators|mesh-ancestor
110035212|NCT01404156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110035213|NCT01404156|Antimetabolites|antimetabolites|mesh-ancestor
110035214|NCT01404156|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110035215|NCT01404156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110035217|NCT01404156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035218|NCT01404156|Antidotes|antidotes|mesh-ancestor
110035219|NCT01404156|Protective Agents|protective agents|mesh-ancestor
110035220|NCT01404156|Vitamin B Complex|vitamin b complex|mesh-ancestor
110035221|NCT01404156|Vitamins|vitamins|mesh-ancestor
110035222|NCT01404156|Micronutrients|micronutrients|mesh-ancestor
110035223|NCT01404156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110035224|NCT01404156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110035225|NCT01404156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110035227|NCT01404169|Donepezil|donepezil|mesh-list
110035228|NCT01404169|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110035229|NCT01404169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110035230|NCT01404169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110035231|NCT01404169|Cholinergic Agents|cholinergic agents|mesh-ancestor
110035232|NCT01404169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110035233|NCT01404169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035234|NCT01404169|Nootropic Agents|nootropic agents|mesh-ancestor
110035235|NCT01404182|Vaccines|vaccines|mesh-list
110035236|NCT01404182|Immunologic Factors|immunologic factors|mesh-ancestor
110035237|NCT01404182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035238|NCT01404312|Pyridoxine|pyridoxine|mesh-list
110035239|NCT01404312|Pyridoxal|pyridoxal|mesh-list
110035240|NCT01404312|Vitamin B 6|vitamin b 6|mesh-list
110035241|NCT01404312|Isoniazid|isoniazid|mesh-list
110035244|NCT01404312|Micronutrients|micronutrients|mesh-ancestor
110035245|NCT01404312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035246|NCT01404312|Vitamin B Complex|vitamin b complex|mesh-ancestor
110035247|NCT01404312|Antitubercular Agents|antitubercular agents|mesh-ancestor
110035248|NCT01404312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110035249|NCT01404312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110035250|NCT01404312|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110035251|NCT01404312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110035252|NCT01404312|Antimetabolites|antimetabolites|mesh-ancestor
110035253|NCT01404312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110035254|NCT01404312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110035255|NCT01404312|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110035256|NCT01404312|Leprostatic Agents|leprostatic agents|mesh-ancestor
110035258|NCT01404338|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110035259|NCT01404364|Triamcinolone|triamcinolone|mesh-list
110035260|NCT01404364|Chlorpromazine|chlorpromazine|mesh-list
110035261|NCT01404364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110035262|NCT01404364|Glucocorticoids|glucocorticoids|mesh-ancestor
110035263|NCT01404364|Hormones|hormones|mesh-ancestor
110035264|NCT01404364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110035265|NCT01404364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035266|NCT01404364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110035267|NCT01404364|Antiemetics|antiemetics|mesh-ancestor
110035268|NCT01404364|Autonomic Agents|autonomic agents|mesh-ancestor
110035269|NCT01404364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110035270|NCT01404364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110035271|NCT01404364|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110035272|NCT01404364|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110035273|NCT01404364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110035274|NCT01404364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110035275|NCT01404364|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110035276|NCT01404364|Dopamine Agents|dopamine agents|mesh-ancestor
110035277|NCT01404364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110035278|NCT01404377|Ropivacaine|ropivacaine|mesh-list
110035279|NCT01404377|Anesthetics, Local|anesthetics, local|mesh-ancestor
110035280|NCT01404377|Anesthetics|anesthetics|mesh-ancestor
110035281|NCT01404377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110035282|NCT01404377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035283|NCT01404377|Sensory System Agents|sensory system agents|mesh-ancestor
110035284|NCT01404377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110035285|NCT01404442|Midazolam|midazolam|mesh-list
110035286|NCT01404442|Ketamine|ketamine|mesh-list
110035287|NCT01404442|Analgesics|analgesics|mesh-ancestor
110035288|NCT01404442|Sensory System Agents|sensory system agents|mesh-ancestor
110035289|NCT01404442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110035290|NCT01404442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035291|NCT01404442|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110035292|NCT01404442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110035293|NCT01404442|Anesthetics, General|anesthetics, general|mesh-ancestor
110035294|NCT01404442|Anesthetics|anesthetics|mesh-ancestor
110035295|NCT01404442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110035296|NCT01404442|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110035297|NCT01404442|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110035298|NCT01404442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110035299|NCT01404442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110035300|NCT01404442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110035301|NCT01404442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110035302|NCT01404442|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110035303|NCT01404442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110035304|NCT01404442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110035305|NCT01404442|GABA Modulators|gaba modulators|mesh-ancestor
110035306|NCT01404442|GABA Agents|gaba agents|mesh-ancestor
110035307|NCT01404468|Lidocaine|lidocaine|mesh-list
110035308|NCT01404468|Anesthetics, Local|anesthetics, local|mesh-ancestor
110035309|NCT01404468|Anesthetics|anesthetics|mesh-ancestor
110035310|NCT01404468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110035311|NCT01404468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035312|NCT01404468|Sensory System Agents|sensory system agents|mesh-ancestor
110035313|NCT01404468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110035314|NCT01404468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110035315|NCT01404468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110035316|NCT01404468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110035318|NCT01404468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110035319|NCT01404507|Abciximab|abciximab|mesh-list
110035320|NCT01404507|Anticoagulants|anticoagulants|mesh-ancestor
110035321|NCT01404507|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110035322|NCT01404598|Naproxen|naproxen|mesh-list
110035323|NCT01404598|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
110035324|NCT01404598|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110035325|NCT01404598|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110035328|NCT01404598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110035329|NCT01404598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035330|NCT01404598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110035331|NCT01404598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110035332|NCT01404598|Gout Suppressants|gout suppressants|mesh-ancestor
110035333|NCT01404598|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110035334|NCT01404598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110035335|NCT01404598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110035336|NCT01404598|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110035337|NCT01404637|Tamsulosin|tamsulosin|mesh-list
110035338|NCT01404637|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110035339|NCT01404637|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110035340|NCT01404637|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110035341|NCT01404637|Adrenergic Agents|adrenergic agents|mesh-ancestor
110035342|NCT01404637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110035343|NCT01404637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110035344|NCT01404637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035345|NCT01404637|Urological Agents|urological agents|mesh-ancestor
110035346|NCT01404676|Glimepiride|glimepiride|mesh-list
110035347|NCT01404676|Vildagliptin|vildagliptin|mesh-list
110035348|NCT01404676|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110035349|NCT01404676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110035350|NCT01404676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035351|NCT01404676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110035352|NCT01404676|Immunologic Factors|immunologic factors|mesh-ancestor
110035353|NCT01404676|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110035354|NCT01404676|Protease Inhibitors|protease inhibitors|mesh-ancestor
110035355|NCT01404676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110035356|NCT01404676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110035357|NCT01404689|Dexmedetomidine|dexmedetomidine|mesh-list
110035358|NCT01404689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110035359|NCT01404689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110035360|NCT01404689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035361|NCT01404689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110035362|NCT01404689|Analgesics|analgesics|mesh-ancestor
110035363|NCT01404689|Sensory System Agents|sensory system agents|mesh-ancestor
110035364|NCT01404689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110035365|NCT01404689|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110035366|NCT01404689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110035367|NCT01404689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110035368|NCT01404689|Adrenergic Agents|adrenergic agents|mesh-ancestor
110035369|NCT01404689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110035370|NCT01404689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110035371|NCT01404702|Zoledronic Acid|zoledronic acid|mesh-list
110035372|NCT01404702|Aldesleukin|aldesleukin|mesh-list
110035373|NCT01404702|Interleukin-2|interleukin-2|mesh-list
110035374|NCT01404702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110035375|NCT01404702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110035376|NCT01404702|Analgesics|analgesics|mesh-ancestor
110035377|NCT01404702|Sensory System Agents|sensory system agents|mesh-ancestor
110035378|NCT01404702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110035379|NCT01404702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035380|NCT01404702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110035381|NCT01404702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110035382|NCT01404702|Antiviral Agents|antiviral agents|mesh-ancestor
110035383|NCT01404702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110035384|NCT01404702|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110035386|NCT01404715|Imatinib Mesylate|imatinib mesylate|mesh-list
110035387|NCT01404715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110035388|NCT01404715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035389|NCT01404715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110035390|NCT01404715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110035391|NCT01404715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110035392|NCT01404715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110035393|NCT01404741|Azacitidine|azacitidine|mesh-list
110035394|NCT01404741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110035395|NCT01404741|Antimetabolites|antimetabolites|mesh-ancestor
110035396|NCT01404741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110035400|NCT01404767|Esmolol|esmolol|mesh-list
110035401|NCT01404767|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110035402|NCT01404767|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110035403|NCT01404767|Sympatholytics|sympatholytics|mesh-ancestor
110035405|NCT01404767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110035406|NCT01404767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035407|NCT01404767|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110035408|NCT01404767|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110035409|NCT01404767|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110035410|NCT01404767|Adrenergic Agents|adrenergic agents|mesh-ancestor
110035411|NCT01404767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110035412|NCT01404767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110035413|NCT01404793|Rocuronium|rocuronium|mesh-list
110035414|NCT01404793|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110035415|NCT01404793|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110035416|NCT01404793|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110035417|NCT01404793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110035418|NCT01404793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035419|NCT01404806|Dolutegravir|dolutegravir|mesh-list
110035420|NCT01404806|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110035421|NCT01404806|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110035422|NCT01404806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110035423|NCT01404806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110035424|NCT01404806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110035425|NCT01404806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110035426|NCT01404806|Antiviral Agents|antiviral agents|mesh-ancestor
110035427|NCT01404806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110035428|NCT01404819|Anesthetics|anesthetics|mesh-list
110035429|NCT01404819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110035430|NCT01404819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035431|NCT01404871|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110035432|NCT01404871|Clomipramine|clomipramine|mesh-list
110035433|NCT01404871|Escitalopram|escitalopram|mesh-list
110035434|NCT01404871|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110035435|NCT01404871|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110035436|NCT01404871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110035437|NCT01404871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110035438|NCT01404871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110035439|NCT01404871|Serotonin Agents|serotonin agents|mesh-ancestor
110035440|NCT01404871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035441|NCT01404871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110035443|NCT01404871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110035444|NCT01404871|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110035445|NCT01404871|Analgesics|analgesics|mesh-ancestor
110035446|NCT01404871|Sensory System Agents|sensory system agents|mesh-ancestor
110035447|NCT01404871|Dopamine Agents|dopamine agents|mesh-ancestor
110035448|NCT01404871|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110035449|NCT01405079|Vinorelbine|vinorelbine|mesh-list
110035451|NCT01405079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110035452|NCT01405079|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110035453|NCT01405079|Tubulin Modulators|tubulin modulators|mesh-ancestor
110035454|NCT01405079|Antimitotic Agents|antimitotic agents|mesh-ancestor
110035455|NCT01405079|Mitosis Modulators|mitosis modulators|mesh-ancestor
110035456|NCT01405079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110035457|NCT01405079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110035458|NCT01405079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110035459|NCT01405118|Metformin|metformin|mesh-list
110035460|NCT01405118|Tofacitinib|tofacitinib|mesh-list
110035461|NCT01405118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110035462|NCT01405118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035463|NCT01405118|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110035464|NCT01405118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110035465|NCT01405118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110035466|NCT01405118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110035467|NCT01405131|Methylprednisolone|methylprednisolone|mesh-list
110035468|NCT01405131|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110035469|NCT01405131|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110035470|NCT01405131|Prednisolone|prednisolone|mesh-list
110035471|NCT01405131|Prednisolone acetate|prednisolone acetate|mesh-list
110035472|NCT01405131|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110035473|NCT01405131|Prednisolone phosphate|prednisolone phosphate|mesh-list
110035474|NCT01405131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110035475|NCT01405131|Antiemetics|antiemetics|mesh-ancestor
110035476|NCT01405131|Autonomic Agents|autonomic agents|mesh-ancestor
110035477|NCT01405131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110035478|NCT01405131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035479|NCT01405131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110035483|NCT01405131|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110035484|NCT01405131|Protective Agents|protective agents|mesh-ancestor
110035485|NCT01405131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110035486|NCT01405131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110035487|NCT01405144|Fluorouracil|fluorouracil|mesh-list
110035488|NCT01405144|Antimetabolites|antimetabolites|mesh-ancestor
110035489|NCT01405144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110035490|NCT01405144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110035491|NCT01405144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110035492|NCT01405144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110035493|NCT01405144|Immunologic Factors|immunologic factors|mesh-ancestor
110035494|NCT01405144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035495|NCT01405157|Methylprednisolone|methylprednisolone|mesh-list
110035496|NCT01405157|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110035497|NCT01405157|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110035498|NCT01405157|Prednisolone|prednisolone|mesh-list
110035499|NCT01405157|Prednisolone acetate|prednisolone acetate|mesh-list
110035500|NCT01405157|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110035501|NCT01405157|Prednisolone phosphate|prednisolone phosphate|mesh-list
110035502|NCT01405157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110035503|NCT01405157|Antiemetics|antiemetics|mesh-ancestor
110035504|NCT01405157|Autonomic Agents|autonomic agents|mesh-ancestor
110035505|NCT01405157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110035506|NCT01405157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035507|NCT01405157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110035509|NCT01405157|Hormones|hormones|mesh-ancestor
110035510|NCT01405157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110035511|NCT01405157|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110035512|NCT01405157|Protective Agents|protective agents|mesh-ancestor
110035513|NCT01405157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110035515|NCT01405170|Methylprednisolone|methylprednisolone|mesh-list
110035516|NCT01405170|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110035517|NCT01405170|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110035518|NCT01405170|Prednisolone|prednisolone|mesh-list
110035519|NCT01405170|Prednisolone acetate|prednisolone acetate|mesh-list
110035520|NCT01405170|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110035521|NCT01405170|Prednisolone phosphate|prednisolone phosphate|mesh-list
110035522|NCT01405170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110035523|NCT01405170|Antiemetics|antiemetics|mesh-ancestor
110035524|NCT01405170|Autonomic Agents|autonomic agents|mesh-ancestor
110035525|NCT01405170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110035526|NCT01405170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035527|NCT01405170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110035528|NCT01405170|Glucocorticoids|glucocorticoids|mesh-ancestor
110035529|NCT01405170|Hormones|hormones|mesh-ancestor
110035530|NCT01405170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110035531|NCT01405170|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110035532|NCT01405170|Protective Agents|protective agents|mesh-ancestor
110035533|NCT01405170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110035534|NCT01405170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110035535|NCT01405235|Paclitaxel|paclitaxel|mesh-list
110035536|NCT01405235|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110035537|NCT01405235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110035538|NCT01405235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110035539|NCT01405235|Tubulin Modulators|tubulin modulators|mesh-ancestor
110035540|NCT01405235|Antimitotic Agents|antimitotic agents|mesh-ancestor
110035541|NCT01405235|Mitosis Modulators|mitosis modulators|mesh-ancestor
110035542|NCT01405235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110035543|NCT01405248|3-n-butylphthalide|3-n-butylphthalide|mesh-list
110035544|NCT01405248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110035545|NCT01405248|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110035546|NCT01405248|Protective Agents|protective agents|mesh-ancestor
110035547|NCT01405248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035549|NCT01405326|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110035550|NCT01405326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110035551|NCT01405326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110035552|NCT01405339|Budesonide|budesonide|mesh-list
110035553|NCT01405339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110035554|NCT01405339|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110035555|NCT01405339|Autonomic Agents|autonomic agents|mesh-ancestor
110035556|NCT01405339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110035557|NCT01405339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035558|NCT01405339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110035559|NCT01405339|Respiratory System Agents|respiratory system agents|mesh-ancestor
110035560|NCT01405339|Glucocorticoids|glucocorticoids|mesh-ancestor
110035561|NCT01405339|Hormones|hormones|mesh-ancestor
110035562|NCT01405339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110035563|NCT01405352|Vitamin A|vitamin a|mesh-list
110035564|NCT01405352|Vitamins|vitamins|mesh-ancestor
110035565|NCT01405352|Micronutrients|micronutrients|mesh-ancestor
110035566|NCT01405352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035567|NCT01405365|Metronidazole|metronidazole|mesh-list
110035569|NCT01405365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110035570|NCT01405365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110035571|NCT01405365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110035572|NCT01405430|Bevacizumab|bevacizumab|mesh-list
110035573|NCT01405430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110035574|NCT01405430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110035575|NCT01405430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110035576|NCT01405430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110035577|NCT01405430|Growth Substances|growth substances|mesh-ancestor
110035578|NCT01405430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035579|NCT01405430|Growth Inhibitors|growth inhibitors|mesh-ancestor
110035581|NCT01405482|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110035582|NCT01405482|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110035583|NCT01405482|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110035584|NCT01405482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110035585|NCT01405482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110035586|NCT01405482|Cholinergic Agents|cholinergic agents|mesh-ancestor
110035587|NCT01405482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110035588|NCT01405482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035589|NCT01405482|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110035590|NCT01405482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110035592|NCT01405573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110035593|NCT01405573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110035594|NCT01405573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110035595|NCT01405573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110035597|NCT01405612|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110035598|NCT01405612|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110035599|NCT01405612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110035600|NCT01405612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035601|NCT01405612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110035602|NCT01405612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110035603|NCT01405612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110035604|NCT01405612|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110035605|NCT01405612|Anesthetics, General|anesthetics, general|mesh-ancestor
110035606|NCT01405612|Anesthetics|anesthetics|mesh-ancestor
110035607|NCT01405612|GABA Modulators|gaba modulators|mesh-ancestor
110035608|NCT01405612|GABA Agents|gaba agents|mesh-ancestor
110035609|NCT01405612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110035610|NCT01405612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110035611|NCT01405807|Alemtuzumab|alemtuzumab|mesh-list
110035612|NCT01405807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110035613|NCT01405807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110035614|NCT01405846|Gefitinib|gefitinib|mesh-list
110035615|NCT01405846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110035616|NCT01405846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110035617|NCT01405846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110035618|NCT01405846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110035619|NCT01405872|Interferon beta-1a|interferon beta-1a|mesh-list
110035620|NCT01405872|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110035621|NCT01405872|Immunologic Factors|immunologic factors|mesh-ancestor
110035622|NCT01405872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035623|NCT01405872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110035624|NCT01405872|Antiviral Agents|antiviral agents|mesh-ancestor
110035625|NCT01405872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110035626|NCT01405989|Ketoconazole|ketoconazole|mesh-list
110035627|NCT01405989|Darexaban|darexaban|mesh-list
110035628|NCT01405989|Antifungal Agents|antifungal agents|mesh-ancestor
110035629|NCT01405989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110035630|NCT01405989|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110035631|NCT01405989|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110035632|NCT01405989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110035633|NCT01405989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110035634|NCT01405989|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110035635|NCT01405989|Hormone Antagonists|hormone antagonists|mesh-ancestor
110035873|NCT01407822|Cisplatin|cisplatin|mesh-list
110035636|NCT01405989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110035637|NCT01405989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035638|NCT01405989|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110035639|NCT01405989|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110035640|NCT01405989|Antithrombins|antithrombins|mesh-ancestor
110035641|NCT01405989|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110035642|NCT01405989|Protease Inhibitors|protease inhibitors|mesh-ancestor
110035643|NCT01405989|Anticoagulants|anticoagulants|mesh-ancestor
110035644|NCT01406002|Rifampin|rifampin|mesh-list
110035645|NCT01406002|Darexaban|darexaban|mesh-list
110035646|NCT01406002|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110035647|NCT01406002|Antitubercular Agents|antitubercular agents|mesh-ancestor
110035648|NCT01406002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110035649|NCT01406002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110035650|NCT01406002|Leprostatic Agents|leprostatic agents|mesh-ancestor
110035651|NCT01406002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110035652|NCT01406002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110035653|NCT01406002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110035654|NCT01406002|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110035655|NCT01406002|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110035656|NCT01406002|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110035657|NCT01406002|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110035658|NCT01406002|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110035659|NCT01406002|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110035660|NCT01406002|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110035661|NCT01406002|Antithrombins|antithrombins|mesh-ancestor
110035662|NCT01406002|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110035663|NCT01406002|Protease Inhibitors|protease inhibitors|mesh-ancestor
110035664|NCT01406002|Anticoagulants|anticoagulants|mesh-ancestor
110035666|NCT01406080|Tretinoin|tretinoin|mesh-list
110035667|NCT01406080|Emollients|emollients|mesh-list
110035668|NCT01406080|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110035669|NCT01406080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110035670|NCT01406080|Analgesics|analgesics|mesh-ancestor
110035671|NCT01406080|Sensory System Agents|sensory system agents|mesh-ancestor
110035672|NCT01406080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110035673|NCT01406080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035674|NCT01406080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110035675|NCT01406080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110035676|NCT01406080|Dermatologic Agents|dermatologic agents|mesh-ancestor
110035677|NCT01406080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110035678|NCT01406080|Keratolytic Agents|keratolytic agents|mesh-ancestor
110035679|NCT01406132|Peficitinib|peficitinib|mesh-list
110035680|NCT01406132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110035681|NCT01406132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110035682|NCT01406132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110035683|NCT01406132|Immunologic Factors|immunologic factors|mesh-ancestor
110035684|NCT01406132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035686|NCT01406158|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110035687|NCT01406158|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110035688|NCT01406158|Cholinergic Agents|cholinergic agents|mesh-ancestor
110035689|NCT01406158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110035690|NCT01406158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110035691|NCT01406158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035692|NCT01406158|Urological Agents|urological agents|mesh-ancestor
110035693|NCT01406171|Isavuconazole|isavuconazole|mesh-list
110035694|NCT01406171|Midazolam|midazolam|mesh-list
110035695|NCT01406171|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110035696|NCT01406171|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110035697|NCT01406171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110035698|NCT01406171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035699|NCT01406171|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110035700|NCT01406171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110035701|NCT01406171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110035702|NCT01406171|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110035703|NCT01406171|Anesthetics, General|anesthetics, general|mesh-ancestor
110035704|NCT01406171|Anesthetics|anesthetics|mesh-ancestor
110035705|NCT01406171|GABA Modulators|gaba modulators|mesh-ancestor
110035706|NCT01406171|GABA Agents|gaba agents|mesh-ancestor
110035707|NCT01406171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110035708|NCT01406171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110035709|NCT01406171|Antifungal Agents|antifungal agents|mesh-ancestor
110035710|NCT01406171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110035711|NCT01406262|Moxifloxacin|moxifloxacin|mesh-list
110035712|NCT01406262|rGLP-1 protein|rglp-1 protein|mesh-list
110035713|NCT01406262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110035714|NCT01406262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110035715|NCT01406262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110035716|NCT01406262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110035717|NCT01406262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110035718|NCT01406262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110035719|NCT01406262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110035720|NCT01406262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035721|NCT01406262|Incretins|incretins|mesh-ancestor
110035722|NCT01406262|Hormones|hormones|mesh-ancestor
110035723|NCT01406262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110035724|NCT01406275|Amoxicillin|amoxicillin|mesh-list
110035725|NCT01406275|Clavulanic Acid|clavulanic acid|mesh-list
110035726|NCT01406275|Clavulanic Acids|clavulanic acids|mesh-list
110035727|NCT01406275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110035728|NCT01406275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110035729|NCT01406275|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110035730|NCT01406275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110035731|NCT01406275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110035733|NCT01406301|Fondaparinux|fondaparinux|mesh-list
110035734|NCT01406301|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110035735|NCT01406301|Antithrombins|antithrombins|mesh-ancestor
110035736|NCT01406301|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110035737|NCT01406301|Protease Inhibitors|protease inhibitors|mesh-ancestor
110035738|NCT01406301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110035739|NCT01406301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110035740|NCT01406301|Anticoagulants|anticoagulants|mesh-ancestor
110035741|NCT01406301|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110035742|NCT01406301|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110035743|NCT01406327|Ambrisentan|ambrisentan|mesh-list
110035744|NCT01406327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110035745|NCT01406392|Misoprostol|misoprostol|mesh-list
110035746|NCT01406392|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110035747|NCT01406392|Abortifacient Agents|abortifacient agents|mesh-ancestor
110035748|NCT01406392|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110035749|NCT01406392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035750|NCT01406392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110035751|NCT01406392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110035752|NCT01406392|Oxytocics|oxytocics|mesh-ancestor
110035753|NCT01406431|Valsartan|valsartan|mesh-list
110035754|NCT01406431|Pitavastatin|pitavastatin|mesh-list
110035755|NCT01406431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110035756|NCT01406431|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110035757|NCT01406431|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110035758|NCT01406431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110035759|NCT01406431|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110035760|NCT01406431|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110035761|NCT01406431|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110035762|NCT01406431|Antimetabolites|antimetabolites|mesh-ancestor
110035763|NCT01406431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110035764|NCT01406431|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110035765|NCT01406470|Immunoglobulins|immunoglobulins|mesh-list
110035766|NCT01406470|Antibodies|antibodies|mesh-list
110035767|NCT01406470|gamma-Globulins|gamma-globulins|mesh-list
110035768|NCT01406470|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110035769|NCT01406470|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110035770|NCT01406470|Immunoglobulin G|immunoglobulin g|mesh-list
110035771|NCT01406470|Immunologic Factors|immunologic factors|mesh-ancestor
110035772|NCT01406470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035773|NCT01406496|Insulin|insulin|mesh-list
110035774|NCT01406496|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110035775|NCT01406496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110035776|NCT01406496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035777|NCT01406522|Tacrine|tacrine|mesh-list
110035778|NCT01406522|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110035779|NCT01406522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110035780|NCT01406522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110035781|NCT01406522|Cholinergic Agents|cholinergic agents|mesh-ancestor
110035782|NCT01406522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110035784|NCT01406522|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110035785|NCT01406522|Autonomic Agents|autonomic agents|mesh-ancestor
110035786|NCT01406522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110035787|NCT01406522|Nootropic Agents|nootropic agents|mesh-ancestor
110035788|NCT01406535|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110035789|NCT01406535|Vasodilator Agents|vasodilator agents|mesh-ancestor
110035790|NCT01406535|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110035791|NCT01406535|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110035792|NCT01406535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110035793|NCT01406535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110035794|NCT01406535|Urological Agents|urological agents|mesh-ancestor
110035795|NCT01406600|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110035796|NCT01406600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110035797|NCT01406600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035798|NCT01406639|Ranibizumab|ranibizumab|mesh-list
110035799|NCT01406639|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110035800|NCT01406639|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110035801|NCT01406639|Growth Substances|growth substances|mesh-ancestor
110035802|NCT01406639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035803|NCT01406639|Growth Inhibitors|growth inhibitors|mesh-ancestor
110035804|NCT01406639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110035805|NCT01406704|Thioctic Acid|thioctic acid|mesh-list
110035806|NCT01406704|Rosiglitazone|rosiglitazone|mesh-list
110035807|NCT01406704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110035808|NCT01406704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035809|NCT01406704|Antioxidants|antioxidants|mesh-ancestor
110035810|NCT01406704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110035811|NCT01406704|Protective Agents|protective agents|mesh-ancestor
110035812|NCT01406704|Vitamin B Complex|vitamin b complex|mesh-ancestor
110035814|NCT01406704|Micronutrients|micronutrients|mesh-ancestor
110035816|NCT01406782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110035817|NCT01406782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110035818|NCT01406782|Immunologic Factors|immunologic factors|mesh-ancestor
110035819|NCT01406782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035820|NCT01406782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110035821|NCT01407016|Metronidazole|metronidazole|mesh-list
110035822|NCT01407016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110035823|NCT01407016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110035824|NCT01407016|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110035825|NCT01407016|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110035826|NCT01407211|Vitamin A|vitamin a|mesh-list
110035827|NCT01407211|Vitamins|vitamins|mesh-ancestor
110035828|NCT01407211|Micronutrients|micronutrients|mesh-ancestor
110035829|NCT01407211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035831|NCT01407237|Giapreza|giapreza|mesh-list
110035832|NCT01407237|Angiotensinogen|angiotensinogen|mesh-list
110035833|NCT01407237|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110035834|NCT01407237|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110035835|NCT01407237|Protease Inhibitors|protease inhibitors|mesh-ancestor
110035836|NCT01407237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110035837|NCT01407237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110035838|NCT01407289|Insulin|insulin|mesh-list
110035839|NCT01407289|Insulin Glargine|insulin glargine|mesh-list
110035840|NCT01407289|Insulin Aspart|insulin aspart|mesh-list
110035841|NCT01407289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110035842|NCT01407289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035843|NCT01407432|Folic Acid|folic acid|mesh-list
110035844|NCT01407432|Vitamin B Complex|vitamin b complex|mesh-list
110035845|NCT01407432|Hematinics|hematinics|mesh-ancestor
110035846|NCT01407432|Vitamins|vitamins|mesh-ancestor
110035847|NCT01407432|Micronutrients|micronutrients|mesh-ancestor
110035848|NCT01407432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035850|NCT01407471|Spironolactone|spironolactone|mesh-list
110035851|NCT01407471|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110035852|NCT01407471|Hormone Antagonists|hormone antagonists|mesh-ancestor
110035853|NCT01407471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110035854|NCT01407471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035855|NCT01407471|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110035856|NCT01407471|Diuretics|diuretics|mesh-ancestor
110035857|NCT01407471|Natriuretic Agents|natriuretic agents|mesh-ancestor
110035858|NCT01407471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110035859|NCT01407471|Glucocorticoids|glucocorticoids|mesh-ancestor
110035860|NCT01407471|Hormones|hormones|mesh-ancestor
110035861|NCT01407484|Prednisone|prednisone|mesh-list
110035862|NCT01407484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110035863|NCT01407484|Glucocorticoids|glucocorticoids|mesh-ancestor
110035864|NCT01407484|Hormones|hormones|mesh-ancestor
110035865|NCT01407484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110035866|NCT01407484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035867|NCT01407484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110035868|NCT01407484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110035869|NCT01407497|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110035870|NCT01407679|Alitretinoin|alitretinoin|mesh-list
110035871|NCT01407679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110035872|NCT01407679|Dermatologic Agents|dermatologic agents|mesh-ancestor
110035875|NCT01407822|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110035876|NCT01407822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110035877|NCT01407822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110035878|NCT01407822|Antimetabolites|antimetabolites|mesh-ancestor
110035879|NCT01407822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110035880|NCT01407822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110035881|NCT01407822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110035883|NCT01407848|Diuretics|diuretics|mesh-ancestor
110035885|NCT01407848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035886|NCT01407848|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110035887|NCT01407848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110035888|NCT01407848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110035890|NCT01407887|Amodiaquine|amodiaquine|mesh-list
110035891|NCT01407887|Methylene Blue|methylene blue|mesh-list
110035892|NCT01407887|Antimalarials|antimalarials|mesh-ancestor
110035893|NCT01407887|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110035894|NCT01407887|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110035895|NCT01407887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110035896|NCT01407887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110035897|NCT01407887|Antiviral Agents|antiviral agents|mesh-ancestor
110035898|NCT01407887|Schistosomicides|schistosomicides|mesh-ancestor
110035899|NCT01407887|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110035900|NCT01407887|Anthelmintics|anthelmintics|mesh-ancestor
110035901|NCT01407887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110035902|NCT01407887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110035903|NCT01408004|Everolimus|everolimus|mesh-list
110035904|NCT01408004|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110035905|NCT01408004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110035906|NCT01408004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110035907|NCT01408004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110035908|NCT01408004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110035909|NCT01408004|Immunologic Factors|immunologic factors|mesh-ancestor
110035910|NCT01408004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035911|NCT01408004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110035912|NCT01408056|Mupirocin|mupirocin|mesh-list
110035913|NCT01408056|Timolol|timolol|mesh-list
110035914|NCT01408056|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110035915|NCT01408056|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110035916|NCT01408056|Adrenergic Agents|adrenergic agents|mesh-ancestor
110035917|NCT01408056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110035918|NCT01408056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110035919|NCT01408056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035920|NCT01408056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110035921|NCT01408056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110035922|NCT01408056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110035923|NCT01408056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110035924|NCT01408056|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110035925|NCT01408056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110035926|NCT01408095|Glimepiride|glimepiride|mesh-list
110035927|NCT01408095|Globalagliatin|globalagliatin|mesh-list
110035928|NCT01408095|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110035929|NCT01408095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110035930|NCT01408095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035931|NCT01408095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110035932|NCT01408095|Immunologic Factors|immunologic factors|mesh-ancestor
110035933|NCT01408095|Enzyme Activators|enzyme activators|mesh-ancestor
110035934|NCT01408095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110035936|NCT01408160|Immunotoxins|immunotoxins|mesh-list
110035937|NCT01408160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110035939|NCT01408160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110035940|NCT01408160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110035941|NCT01408160|Antiviral Agents|antiviral agents|mesh-ancestor
110035942|NCT01408160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110035944|NCT01408160|Immunologic Factors|immunologic factors|mesh-ancestor
110035945|NCT01408160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035946|NCT01408160|Immunoconjugates|immunoconjugates|mesh-ancestor
110035947|NCT01408173|Caffeine|caffeine|mesh-list
110035948|NCT01408173|Caffeine citrate|caffeine citrate|mesh-list
110035949|NCT01408173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110035950|NCT01408173|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110035951|NCT01408173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035952|NCT01408173|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110035953|NCT01408173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110035954|NCT01408173|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110035955|NCT01408173|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110035956|NCT01408173|Purinergic Agents|purinergic agents|mesh-ancestor
110035957|NCT01408173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110035958|NCT01408186|Rabeprazole|rabeprazole|mesh-list
110035959|NCT01408186|Famotidine|famotidine|mesh-list
110035960|NCT01408186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110035962|NCT01408186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110035963|NCT01408186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110035964|NCT01408186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110035965|NCT01408186|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110035966|NCT01408186|Histamine Antagonists|histamine antagonists|mesh-ancestor
110035967|NCT01408186|Histamine Agents|histamine agents|mesh-ancestor
110035968|NCT01408186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110035969|NCT01408186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035970|NCT01408199|Lenalidomide|lenalidomide|mesh-list
110035971|NCT01408199|Immunologic Factors|immunologic factors|mesh-ancestor
110035972|NCT01408199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035973|NCT01408199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110035974|NCT01408199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110035975|NCT01408199|Growth Substances|growth substances|mesh-ancestor
110035976|NCT01408199|Growth Inhibitors|growth inhibitors|mesh-ancestor
110035977|NCT01408199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110035978|NCT01408342|Rituximab|rituximab|mesh-list
110035979|NCT01408342|Alemtuzumab|alemtuzumab|mesh-list
110035980|NCT01408342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110035982|NCT01408342|Immunologic Factors|immunologic factors|mesh-ancestor
110035983|NCT01408342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035984|NCT01408342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110035985|NCT01408394|Ecopipam|ecopipam|mesh-list
110035986|NCT01408394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110035987|NCT01408394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110035988|NCT01408394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110035989|NCT01408394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035990|NCT01408394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110035991|NCT01408394|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110035992|NCT01408394|Dopamine Agents|dopamine agents|mesh-ancestor
110035994|NCT01408394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110035996|NCT01408446|Antipruritics|antipruritics|mesh-ancestor
110035997|NCT01408446|Dermatologic Agents|dermatologic agents|mesh-ancestor
110035998|NCT01408498|Testosterone|testosterone|mesh-list
110035999|NCT01408498|Androgens|androgens|mesh-ancestor
110036000|NCT01408498|Hormones|hormones|mesh-ancestor
110036001|NCT01408498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110036002|NCT01408498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036003|NCT01408524|Diltiazem|diltiazem|mesh-list
110036004|NCT01408524|Labetalol|labetalol|mesh-list
110036005|NCT01408524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110036006|NCT01408524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110036007|NCT01408524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110036008|NCT01408524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110036009|NCT01408524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110036010|NCT01408524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036011|NCT01408524|Vasodilator Agents|vasodilator agents|mesh-ancestor
110036012|NCT01408524|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110036013|NCT01408524|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110036014|NCT01408524|Adrenergic Agents|adrenergic agents|mesh-ancestor
110036016|NCT01408524|Sympathomimetics|sympathomimetics|mesh-ancestor
110036017|NCT01408524|Autonomic Agents|autonomic agents|mesh-ancestor
110036018|NCT01408524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110036019|NCT01408524|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110036020|NCT01408524|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110036021|NCT01408589|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110036022|NCT01408589|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110036023|NCT01408589|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110036024|NCT01408589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110036025|NCT01408589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110036026|NCT01408589|Adrenergic Agents|adrenergic agents|mesh-ancestor
110036027|NCT01408589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110036028|NCT01408589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036029|NCT01408680|Ubiquinone|ubiquinone|mesh-list
110036030|NCT01408680|Coenzyme Q10|coenzyme q10|mesh-list
110036031|NCT01408680|Micronutrients|micronutrients|mesh-ancestor
110036032|NCT01408680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036033|NCT01408680|Vitamins|vitamins|mesh-ancestor
110036035|NCT01408797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110036036|NCT01408810|Infliximab|infliximab|mesh-list
110036037|NCT01408810|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110036038|NCT01408810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110036039|NCT01408810|Dermatologic Agents|dermatologic agents|mesh-ancestor
110036040|NCT01408810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110036041|NCT01408810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110036043|NCT01408836|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110036044|NCT01408836|Methylprednisolone|methylprednisolone|mesh-list
110036045|NCT01408836|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110036046|NCT01408836|Prednisolone acetate|prednisolone acetate|mesh-list
110036047|NCT01408836|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110036048|NCT01408836|Prednisolone phosphate|prednisolone phosphate|mesh-list
110036049|NCT01408836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110036050|NCT01408836|Glucocorticoids|glucocorticoids|mesh-ancestor
110036051|NCT01408836|Hormones|hormones|mesh-ancestor
110036052|NCT01408836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110036053|NCT01408836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036054|NCT01408836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110036055|NCT01408836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110036056|NCT01408836|Antiemetics|antiemetics|mesh-ancestor
110036057|NCT01408836|Autonomic Agents|autonomic agents|mesh-ancestor
110036058|NCT01408836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110036059|NCT01408836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110036060|NCT01408836|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110036061|NCT01408836|Protective Agents|protective agents|mesh-ancestor
110036063|NCT01408849|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110036064|NCT01408849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110036065|NCT01408849|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110036066|NCT01408849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110036067|NCT01408849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110036068|NCT01408927|Aspirin|aspirin|mesh-list
110036069|NCT01408927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110036070|NCT01408927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110036071|NCT01408927|Analgesics|analgesics|mesh-ancestor
110036072|NCT01408927|Sensory System Agents|sensory system agents|mesh-ancestor
110036073|NCT01408927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110036074|NCT01408927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036075|NCT01408927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110036076|NCT01408927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110036077|NCT01408927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110036078|NCT01408927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110036079|NCT01408927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110036080|NCT01408927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110036081|NCT01408927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110036082|NCT01408927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110036083|NCT01408927|Antipyretics|antipyretics|mesh-ancestor
110036084|NCT01408953|Bevacizumab|bevacizumab|mesh-list
110036085|NCT01408953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110036086|NCT01408953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110036087|NCT01408953|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110036088|NCT01408953|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110036089|NCT01408953|Growth Substances|growth substances|mesh-ancestor
110036090|NCT01408953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036091|NCT01408953|Growth Inhibitors|growth inhibitors|mesh-ancestor
110036092|NCT01408979|Magnesium Sulfate|magnesium sulfate|mesh-list
110036093|NCT01408979|Analgesics|analgesics|mesh-ancestor
110036094|NCT01408979|Sensory System Agents|sensory system agents|mesh-ancestor
110036095|NCT01408979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110036096|NCT01408979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036097|NCT01408979|Anesthetics|anesthetics|mesh-ancestor
110036098|NCT01408979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110036099|NCT01408979|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110036100|NCT01408979|Anticonvulsants|anticonvulsants|mesh-ancestor
110036101|NCT01408979|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110036102|NCT01408979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110036103|NCT01408979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110036104|NCT01408979|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110036105|NCT01408979|Tocolytic Agents|tocolytic agents|mesh-ancestor
110036106|NCT01408979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110036107|NCT01409005|Gemcitabine|gemcitabine|mesh-list
110036108|NCT01409005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110036109|NCT01409005|Antimetabolites|antimetabolites|mesh-ancestor
110036110|NCT01409005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110036111|NCT01409005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110036113|NCT01409018|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
110036114|NCT01409018|Antifungal Agents|antifungal agents|mesh-ancestor
110036115|NCT01409018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110036116|NCT01409018|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110036117|NCT01409018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110036118|NCT01409018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110036119|NCT01409018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110036120|NCT01409018|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110036121|NCT01409018|Hormone Antagonists|hormone antagonists|mesh-ancestor
110036122|NCT01409018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110036123|NCT01409018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036124|NCT01409018|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110036126|NCT01409148|Antibodies|antibodies|mesh-list
110036127|NCT01409148|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110036128|NCT01409148|Immunologic Factors|immunologic factors|mesh-ancestor
110036129|NCT01409148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036130|NCT01409174|Interferons|interferons|mesh-list
110036131|NCT01409174|Interferon-alpha|interferon-alpha|mesh-list
110036132|NCT01409174|Interferon alpha-2|interferon alpha-2|mesh-list
110036133|NCT01409174|Aldesleukin|aldesleukin|mesh-list
110036134|NCT01409174|Cisplatin|cisplatin|mesh-list
110036135|NCT01409174|Temozolomide|temozolomide|mesh-list
110036138|NCT01409174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110036139|NCT01409174|Antiviral Agents|antiviral agents|mesh-ancestor
110036140|NCT01409174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110036141|NCT01409174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110036142|NCT01409174|Alkylating Agents|alkylating agents|mesh-ancestor
110036143|NCT01409174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110036144|NCT01409174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110036145|NCT01409174|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110036146|NCT01409174|Immunologic Factors|immunologic factors|mesh-ancestor
110036147|NCT01409174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036148|NCT01409174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110036149|NCT01409174|Analgesics|analgesics|mesh-ancestor
110036150|NCT01409174|Sensory System Agents|sensory system agents|mesh-ancestor
110036151|NCT01409174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110036152|NCT01409174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110036153|NCT01409174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110036154|NCT01409187|Interferons|interferons|mesh-list
110036155|NCT01409187|Interferon-alpha|interferon-alpha|mesh-list
110036156|NCT01409187|Interferon alpha-2|interferon alpha-2|mesh-list
110036157|NCT01409187|Aldesleukin|aldesleukin|mesh-list
110036158|NCT01409187|Ipilimumab|ipilimumab|mesh-list
110036159|NCT01409187|Interleukin-2|interleukin-2|mesh-list
110036160|NCT01409187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110036161|NCT01409187|Antiviral Agents|antiviral agents|mesh-ancestor
110036162|NCT01409187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110036163|NCT01409187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110036164|NCT01409187|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110036165|NCT01409187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110036166|NCT01409187|Immunologic Factors|immunologic factors|mesh-ancestor
110036167|NCT01409187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036168|NCT01409187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110036169|NCT01409187|Analgesics|analgesics|mesh-ancestor
110036170|NCT01409187|Sensory System Agents|sensory system agents|mesh-ancestor
110036171|NCT01409187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110036172|NCT01409187|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110036173|NCT01409187|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110036174|NCT01409278|Ropivacaine|ropivacaine|mesh-list
110036175|NCT01409278|Anesthetics, Local|anesthetics, local|mesh-ancestor
110036176|NCT01409278|Anesthetics|anesthetics|mesh-ancestor
110036177|NCT01409278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110036178|NCT01409278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036179|NCT01409278|Sensory System Agents|sensory system agents|mesh-ancestor
110036180|NCT01409278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110036182|NCT01409369|Antidotes|antidotes|mesh-ancestor
110036183|NCT01409369|Protective Agents|protective agents|mesh-ancestor
110036184|NCT01409369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036185|NCT01409395|Metformin|metformin|mesh-list
110036186|NCT01409395|Nizatidine|nizatidine|mesh-list
110036187|NCT01409395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110036188|NCT01409395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036189|NCT01409395|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110036190|NCT01409395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110036412|NCT01411124|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110036413|NCT01411124|Antipruritics|antipruritics|mesh-ancestor
110036414|NCT01411124|Dermatologic Agents|dermatologic agents|mesh-ancestor
110036416|NCT01411176|Antipruritics|antipruritics|mesh-ancestor
110036417|NCT01411176|Dermatologic Agents|dermatologic agents|mesh-ancestor
110036418|NCT01411189|Menthol|menthol|mesh-list
110036419|NCT01411189|Antipruritics|antipruritics|mesh-ancestor
110036420|NCT01411189|Dermatologic Agents|dermatologic agents|mesh-ancestor
110036421|NCT01411202|Doxycycline|doxycycline|mesh-list
110036422|NCT01411202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110036423|NCT01411202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110036424|NCT01411202|Antimalarials|antimalarials|mesh-ancestor
110036425|NCT01411202|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110036426|NCT01411202|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110036428|NCT01411254|Betamethasone Valerate|betamethasone valerate|mesh-list
110036429|NCT01411254|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
110036430|NCT01411254|Betamethasone benzoate|betamethasone benzoate|mesh-list
110036431|NCT01411254|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
110036432|NCT01411254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110036433|NCT01411254|Glucocorticoids|glucocorticoids|mesh-ancestor
110036434|NCT01411254|Hormones|hormones|mesh-ancestor
110036435|NCT01411254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110036441|NCT01411280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036442|NCT01411280|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110036443|NCT01411280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110036444|NCT01411280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110036445|NCT01411280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110036446|NCT01411280|Dopamine Agents|dopamine agents|mesh-ancestor
110036447|NCT01411280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110036448|NCT01411410|Paclitaxel|paclitaxel|mesh-list
110036449|NCT01411410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110036450|NCT01411410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110036451|NCT01411410|Tubulin Modulators|tubulin modulators|mesh-ancestor
110036452|NCT01411410|Antimitotic Agents|antimitotic agents|mesh-ancestor
110036453|NCT01411410|Mitosis Modulators|mitosis modulators|mesh-ancestor
110036454|NCT01411410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110036455|NCT01411423|Sorafenib|sorafenib|mesh-list
110036456|NCT01411423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110036457|NCT01411423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110036458|NCT01411423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110036459|NCT01411423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110036460|NCT01411436|Sorafenib|sorafenib|mesh-list
110036461|NCT01411436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110036462|NCT01411436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110036463|NCT01411436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110036464|NCT01411436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110036465|NCT01411514|Prednisone|prednisone|mesh-list
110036466|NCT01411514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110036467|NCT01411514|Glucocorticoids|glucocorticoids|mesh-ancestor
110036468|NCT01411514|Hormones|hormones|mesh-ancestor
110036469|NCT01411514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110036470|NCT01411514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036471|NCT01411514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110036472|NCT01411514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110036473|NCT01411670|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
110036474|NCT01411670|Protein C|protein c|mesh-list
110036475|NCT01411670|Anticoagulants|anticoagulants|mesh-ancestor
110036476|NCT01411670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110036477|NCT01411670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110036478|NCT01411670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110036479|NCT01411670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110036480|NCT01411735|Enalapril|enalapril|mesh-list
110036481|NCT01411735|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110036482|NCT01411735|Protease Inhibitors|protease inhibitors|mesh-ancestor
110036483|NCT01411735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110036484|NCT01411735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110036485|NCT01411735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110036487|NCT01411930|Aripiprazole|aripiprazole|mesh-list
110036488|NCT01411930|Antiemetics|antiemetics|mesh-ancestor
110036489|NCT01411930|Autonomic Agents|autonomic agents|mesh-ancestor
110036490|NCT01411930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110036491|NCT01411930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036492|NCT01411930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110036493|NCT01411930|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110036494|NCT01411930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110036495|NCT01411930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110036496|NCT01411930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110036497|NCT01411930|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110036498|NCT01411930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110036499|NCT01411930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110036500|NCT01411930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110036501|NCT01411930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110036502|NCT01411930|Serotonin Agents|serotonin agents|mesh-ancestor
110036503|NCT01411930|Antidepressive Agents|antidepressive agents|mesh-ancestor
110036504|NCT01411930|Dopamine Agonists|dopamine agonists|mesh-ancestor
110036505|NCT01411930|Dopamine Agents|dopamine agents|mesh-ancestor
110036506|NCT01411930|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110036507|NCT01411930|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110036508|NCT01411930|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110036509|NCT01411930|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110036511|NCT01411930|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110036512|NCT01411969|Phenylephrine|phenylephrine|mesh-list
110036513|NCT01411969|Oxymetazoline|oxymetazoline|mesh-list
110036514|NCT01411969|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110036515|NCT01411969|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110036516|NCT01411969|Adrenergic Agents|adrenergic agents|mesh-ancestor
110036517|NCT01411969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110036518|NCT01411969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110036519|NCT01411969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036520|NCT01411969|Sympathomimetics|sympathomimetics|mesh-ancestor
110036521|NCT01411969|Autonomic Agents|autonomic agents|mesh-ancestor
110036522|NCT01411969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110036523|NCT01411969|Nasal Decongestants|nasal decongestants|mesh-ancestor
110036524|NCT01411969|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110036525|NCT01411969|Respiratory System Agents|respiratory system agents|mesh-ancestor
110036526|NCT01411969|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110036527|NCT01411969|Mydriatics|mydriatics|mesh-ancestor
110036528|NCT01411969|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110036529|NCT01411969|Protective Agents|protective agents|mesh-ancestor
110036530|NCT01412008|Botulinum Toxins|botulinum toxins|mesh-list
110036531|NCT01412008|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110036532|NCT01412008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110036533|NCT01412008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110036534|NCT01412008|Cholinergic Agents|cholinergic agents|mesh-ancestor
110036535|NCT01412008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110036536|NCT01412008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036537|NCT01412073|Misoprostol|misoprostol|mesh-list
110036539|NCT01412073|Oxytocics|oxytocics|mesh-ancestor
110036540|NCT01412073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110036541|NCT01412073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036542|NCT01412073|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110036543|NCT01412073|Abortifacient Agents|abortifacient agents|mesh-ancestor
110036544|NCT01412073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110036545|NCT01412073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110036546|NCT01412294|Capecitabine|capecitabine|mesh-list
110036547|NCT01412294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110036548|NCT01412294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110036549|NCT01412294|Antimetabolites|antimetabolites|mesh-ancestor
110036550|NCT01412294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110036551|NCT01412307|Lenalidomide|lenalidomide|mesh-list
110036552|NCT01412307|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110036553|NCT01412307|Immunologic Factors|immunologic factors|mesh-ancestor
110036554|NCT01412307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036556|NCT01412307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110036557|NCT01412307|Growth Substances|growth substances|mesh-ancestor
110036558|NCT01412307|Growth Inhibitors|growth inhibitors|mesh-ancestor
110036559|NCT01412307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110036560|NCT01412307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110036561|NCT01412307|Alkylating Agents|alkylating agents|mesh-ancestor
110036562|NCT01412307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110036563|NCT01412385|Immunoglobulins|immunoglobulins|mesh-list
110036564|NCT01412385|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110036565|NCT01412385|Antibodies|antibodies|mesh-list
110036566|NCT01412385|gamma-Globulins|gamma-globulins|mesh-list
110036567|NCT01412385|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110036568|NCT01412385|Immunoglobulin G|immunoglobulin g|mesh-list
110036569|NCT01412385|Immunologic Factors|immunologic factors|mesh-ancestor
110036570|NCT01412385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036571|NCT01412411|Micronutrients|micronutrients|mesh-list
110036573|NCT01412411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036574|NCT01412437|Verapamil|verapamil|mesh-list
110036575|NCT01412437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110036576|NCT01412437|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110036577|NCT01412437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110036578|NCT01412437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110036579|NCT01412437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110036580|NCT01412437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036581|NCT01412437|Vasodilator Agents|vasodilator agents|mesh-ancestor
110036582|NCT01412515|Everolimus|everolimus|mesh-list
110036583|NCT01412515|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110036584|NCT01412515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110036585|NCT01412515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110036663|NCT01413022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110036586|NCT01412515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110036588|NCT01412515|Immunologic Factors|immunologic factors|mesh-ancestor
110036589|NCT01412515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036590|NCT01412515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110036591|NCT01412567|Vaccines|vaccines|mesh-list
110036592|NCT01412567|Immunologic Factors|immunologic factors|mesh-ancestor
110036593|NCT01412567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036594|NCT01412632|Remifentanil|remifentanil|mesh-list
110036595|NCT01412632|Propofol|propofol|mesh-list
110036596|NCT01412632|Prilocaine|prilocaine|mesh-list
110036597|NCT01412632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110036598|NCT01412632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110036599|NCT01412632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036600|NCT01412632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110036601|NCT01412632|Anesthetics, General|anesthetics, general|mesh-ancestor
110036602|NCT01412632|Anesthetics|anesthetics|mesh-ancestor
110036603|NCT01412632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110036604|NCT01412632|Narcotics|narcotics|mesh-ancestor
110036605|NCT01412632|Analgesics|analgesics|mesh-ancestor
110036606|NCT01412632|Sensory System Agents|sensory system agents|mesh-ancestor
110036607|NCT01412632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110036608|NCT01412632|Anesthetics, Local|anesthetics, local|mesh-ancestor
110036609|NCT01412645|Resveratrol|resveratrol|mesh-list
110036610|NCT01412645|Antioxidants|antioxidants|mesh-ancestor
110036611|NCT01412645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110036612|NCT01412645|Protective Agents|protective agents|mesh-ancestor
110036613|NCT01412645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036614|NCT01412645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110036615|NCT01412645|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110036616|NCT01412658|Caseins|caseins|mesh-list
110036617|NCT01412658|Glycerol|glycerol|mesh-list
110036618|NCT01412658|Chelating Agents|chelating agents|mesh-ancestor
110036619|NCT01412658|Sequestering Agents|sequestering agents|mesh-ancestor
110036620|NCT01412658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110036622|NCT01412658|Protective Agents|protective agents|mesh-ancestor
110036623|NCT01412658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036624|NCT01412671|Sorafenib|sorafenib|mesh-list
110036625|NCT01412671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110036626|NCT01412671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110036627|NCT01412671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110036628|NCT01412671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110036629|NCT01412840|Diclofenac|diclofenac|mesh-list
110036630|NCT01412840|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110036631|NCT01412840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110036632|NCT01412840|Analgesics|analgesics|mesh-ancestor
110036633|NCT01412840|Sensory System Agents|sensory system agents|mesh-ancestor
110036634|NCT01412840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110036635|NCT01412840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036636|NCT01412840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110036637|NCT01412840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110036638|NCT01412840|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110036639|NCT01412840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110036640|NCT01412840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110036641|NCT01412892|Everolimus|everolimus|mesh-list
110036642|NCT01412892|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110036643|NCT01412892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110036644|NCT01412892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110036645|NCT01412892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110036646|NCT01412892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110036647|NCT01412892|Immunologic Factors|immunologic factors|mesh-ancestor
110036648|NCT01412892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036649|NCT01412892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110036651|NCT01413022|Fluorouracil|fluorouracil|mesh-list
110036652|NCT01413022|Oxaliplatin|oxaliplatin|mesh-list
110036653|NCT01413022|Irinotecan|irinotecan|mesh-list
110036654|NCT01413022|Antimetabolites|antimetabolites|mesh-ancestor
110036655|NCT01413022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110036656|NCT01413022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110036657|NCT01413022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110036658|NCT01413022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110036659|NCT01413022|Immunologic Factors|immunologic factors|mesh-ancestor
110036660|NCT01413022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036661|NCT01413022|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110036662|NCT01413022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110036664|NCT01413022|Antidotes|antidotes|mesh-ancestor
110036665|NCT01413022|Protective Agents|protective agents|mesh-ancestor
110036666|NCT01413022|Vitamin B Complex|vitamin b complex|mesh-ancestor
110036667|NCT01413022|Vitamins|vitamins|mesh-ancestor
110036668|NCT01413022|Micronutrients|micronutrients|mesh-ancestor
110036669|NCT01413048|Carvedilol|carvedilol|mesh-list
110036670|NCT01413048|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110036671|NCT01413048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110036672|NCT01413048|Adrenergic Agents|adrenergic agents|mesh-ancestor
110036673|NCT01413048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110036674|NCT01413048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110036675|NCT01413048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036676|NCT01413048|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110036677|NCT01413048|Antioxidants|antioxidants|mesh-ancestor
110036678|NCT01413048|Protective Agents|protective agents|mesh-ancestor
110036679|NCT01413048|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110036680|NCT01413048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110036681|NCT01413048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110036682|NCT01413048|Vasodilator Agents|vasodilator agents|mesh-ancestor
110036683|NCT01413048|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110036684|NCT01413048|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110036685|NCT01413230|Cholecalciferol|cholecalciferol|mesh-list
110036686|NCT01413230|Vitamin D|vitamin d|mesh-list
110036687|NCT01413230|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110036688|NCT01413230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036689|NCT01413230|Vitamins|vitamins|mesh-ancestor
110036690|NCT01413230|Micronutrients|micronutrients|mesh-ancestor
110036691|NCT01413230|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110036692|NCT01413477|Calcitriol|calcitriol|mesh-list
110036693|NCT01413477|Betamethasone|betamethasone|mesh-list
110036694|NCT01413477|Betamethasone Valerate|betamethasone valerate|mesh-list
110036695|NCT01413477|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
110036697|NCT01413477|Calcipotriene|calcipotriene|mesh-list
110036698|NCT01413477|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
110036699|NCT01413477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110036700|NCT01413477|Glucocorticoids|glucocorticoids|mesh-ancestor
110036702|NCT01413477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110036703|NCT01413477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036704|NCT01413477|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110036705|NCT01413477|Respiratory System Agents|respiratory system agents|mesh-ancestor
110036707|NCT01413477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110036708|NCT01413477|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110036709|NCT01413477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110036710|NCT01413477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110036711|NCT01413477|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110036712|NCT01413477|Vitamins|vitamins|mesh-ancestor
110036713|NCT01413477|Micronutrients|micronutrients|mesh-ancestor
110036714|NCT01413477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110036715|NCT01413490|Rimantadine|rimantadine|mesh-list
110036716|NCT01413490|Antiviral Agents|antiviral agents|mesh-ancestor
110036717|NCT01413490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110036718|NCT01413490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110036720|NCT01413490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110036721|NCT01413581|Bile Acids and Salts|bile acids and salts|mesh-list
110036722|NCT01413581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110036723|NCT01413620|Vitamins|vitamins|mesh-list
110036724|NCT01413620|Vitamin E|vitamin e|mesh-list
110036725|NCT01413620|Tocopherols|tocopherols|mesh-list
110036726|NCT01413620|Tocotrienols|tocotrienols|mesh-list
110036727|NCT01413620|alpha-Tocopherol|alpha-tocopherol|mesh-list
110036728|NCT01413620|Micronutrients|micronutrients|mesh-ancestor
110036729|NCT01413620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036730|NCT01413620|Antioxidants|antioxidants|mesh-ancestor
110036731|NCT01413620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110036732|NCT01413620|Protective Agents|protective agents|mesh-ancestor
110036733|NCT01413711|Vigabatrin|vigabatrin|mesh-list
110036734|NCT01413711|Anticonvulsants|anticonvulsants|mesh-ancestor
110036735|NCT01413711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110036736|NCT01413711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110036737|NCT01413711|GABA Agents|gaba agents|mesh-ancestor
110036738|NCT01413711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110036739|NCT01413711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036740|NCT01413763|Imiquimod|imiquimod|mesh-list
110036741|NCT01413763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110036742|NCT01413763|Immunologic Factors|immunologic factors|mesh-ancestor
110036743|NCT01413763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036745|NCT01413763|Interferon Inducers|interferon inducers|mesh-ancestor
110036747|NCT01413854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110036748|NCT01413854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110036749|NCT01413854|Analgesics|analgesics|mesh-ancestor
110036750|NCT01413854|Sensory System Agents|sensory system agents|mesh-ancestor
110036751|NCT01413854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110036752|NCT01413854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036753|NCT01413854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110036754|NCT01413854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110036755|NCT01413854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110036756|NCT01413854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110036757|NCT01413854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110036759|NCT01414140|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110036760|NCT01414140|Contraceptive Agents|contraceptive agents|mesh-ancestor
110036761|NCT01414140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110036762|NCT01414140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036763|NCT01414140|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110036764|NCT01414140|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110036765|NCT01414140|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110036767|NCT01414231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110036768|NCT01414231|Antimetabolites|antimetabolites|mesh-ancestor
110036769|NCT01414231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110036770|NCT01414231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110036771|NCT01414231|Antiviral Agents|antiviral agents|mesh-ancestor
110036772|NCT01414231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110036773|NCT01414231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110036774|NCT01414231|Immunologic Factors|immunologic factors|mesh-ancestor
110036775|NCT01414231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036776|NCT01414465|Orlistat|orlistat|mesh-list
110036777|NCT01414465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110036778|NCT01414465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110036779|NCT01414465|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110036780|NCT01414465|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110036781|NCT01414504|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110036782|NCT01414504|Immunologic Factors|immunologic factors|mesh-ancestor
110036783|NCT01414504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036784|NCT01414530|Contraceptive Agents|contraceptive agents|mesh-list
110036785|NCT01414530|Contraceptives, Oral|contraceptives, oral|mesh-list
110036786|NCT01414530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110036787|NCT01414530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036788|NCT01414530|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110036789|NCT01414556|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
110036790|NCT01414556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110036791|NCT01414556|Incretins|incretins|mesh-ancestor
110036792|NCT01414556|Hormones|hormones|mesh-ancestor
110036793|NCT01414556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110036794|NCT01414556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036795|NCT01414569|Dexamethasone|dexamethasone|mesh-list
110036796|NCT01414569|Dexamethasone acetate|dexamethasone acetate|mesh-list
110036797|NCT01414569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110036798|NCT01414569|Antiemetics|antiemetics|mesh-ancestor
110036799|NCT01414569|Autonomic Agents|autonomic agents|mesh-ancestor
110036800|NCT01414569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110036801|NCT01414569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036802|NCT01414569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110036803|NCT01414569|Glucocorticoids|glucocorticoids|mesh-ancestor
110036804|NCT01414569|Hormones|hormones|mesh-ancestor
110036805|NCT01414569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110036806|NCT01414569|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110036807|NCT01414569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110036808|NCT01414608|Paclitaxel|paclitaxel|mesh-list
110036809|NCT01414608|Cisplatin|cisplatin|mesh-list
110036810|NCT01414608|Carboplatin|carboplatin|mesh-list
110036811|NCT01414608|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110036812|NCT01414608|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110036813|NCT01414608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110036814|NCT01414608|Tubulin Modulators|tubulin modulators|mesh-ancestor
110036815|NCT01414608|Antimitotic Agents|antimitotic agents|mesh-ancestor
110036817|NCT01414608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110036818|NCT01414816|Interferons|interferons|mesh-list
110036819|NCT01414816|Interferon-beta|interferon-beta|mesh-list
110036820|NCT01414816|Interferon beta-1b|interferon beta-1b|mesh-list
110036823|NCT01414816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110036824|NCT01414816|Immunologic Factors|immunologic factors|mesh-ancestor
110036825|NCT01414816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036826|NCT01414816|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110036827|NCT01414842|Dialysis Solutions|dialysis solutions|mesh-list
110036828|NCT01414842|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110036829|NCT01414868|Montelukast|montelukast|mesh-list
110036831|NCT01414868|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110036832|NCT01414868|Respiratory System Agents|respiratory system agents|mesh-ancestor
110036833|NCT01414868|Hormone Antagonists|hormone antagonists|mesh-ancestor
110036834|NCT01414868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110036835|NCT01414868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036836|NCT01414868|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110036837|NCT01414868|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110036838|NCT01414868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110036839|NCT01414881|Mipomersen|mipomersen|mesh-list
110036840|NCT01414881|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110036841|NCT01414881|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110036842|NCT01414881|Antimetabolites|antimetabolites|mesh-ancestor
110036843|NCT01414881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110036844|NCT01414881|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110036845|NCT01414972|Vitamin A|vitamin a|mesh-list
110036846|NCT01414972|Vitamins|vitamins|mesh-ancestor
110036847|NCT01414972|Micronutrients|micronutrients|mesh-ancestor
110036848|NCT01414972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036849|NCT01414998|Nicotine|nicotine|mesh-list
110036850|NCT01414998|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110036851|NCT01414998|Autonomic Agents|autonomic agents|mesh-ancestor
110036852|NCT01414998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110036853|NCT01414998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036854|NCT01414998|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110036855|NCT01414998|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110036856|NCT01414998|Cholinergic Agents|cholinergic agents|mesh-ancestor
110036857|NCT01414998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110036858|NCT01414998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110036859|NCT01415011|Afatinib|afatinib|mesh-list
110036860|NCT01415011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110036861|NCT01415011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110036862|NCT01415011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110036863|NCT01415011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110036864|NCT01415128|Rosiglitazone|rosiglitazone|mesh-list
110036865|NCT01415128|Desipramine|desipramine|mesh-list
110036866|NCT01415128|Omeprazole|omeprazole|mesh-list
110036867|NCT01415128|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110036869|NCT01415128|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110036870|NCT01415128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110036871|NCT01415128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110036872|NCT01415128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110036873|NCT01415128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036874|NCT01415128|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110036875|NCT01415128|Antidepressive Agents|antidepressive agents|mesh-ancestor
110036876|NCT01415128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110036877|NCT01415128|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110036878|NCT01415128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110036879|NCT01415128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110036880|NCT01415128|Adrenergic Agents|adrenergic agents|mesh-ancestor
110036881|NCT01415128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110036882|NCT01415141|Ribavirin|ribavirin|mesh-list
110036883|NCT01415141|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110036884|NCT01415141|Antimetabolites|antimetabolites|mesh-ancestor
110036885|NCT01415141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110036886|NCT01415141|Antiviral Agents|antiviral agents|mesh-ancestor
110036887|NCT01415141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110036888|NCT01415284|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
110036889|NCT01415284|Plasma Substitutes|plasma substitutes|mesh-ancestor
110036890|NCT01415284|Blood Substitutes|blood substitutes|mesh-ancestor
110036891|NCT01415336|Cyclophosphamide|cyclophosphamide|mesh-list
110036892|NCT01415336|Doxorubicin|doxorubicin|mesh-list
110036893|NCT01415336|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110036894|NCT01415336|Capecitabine|capecitabine|mesh-list
110036895|NCT01415336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110036896|NCT01415336|Immunologic Factors|immunologic factors|mesh-ancestor
110036897|NCT01415336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036898|NCT01415336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110036899|NCT01415336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110036900|NCT01415336|Alkylating Agents|alkylating agents|mesh-ancestor
110036901|NCT01415336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110036902|NCT01415336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110036903|NCT01415336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110036904|NCT01415336|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110036905|NCT01415336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110036906|NCT01415336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110036907|NCT01415336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110036908|NCT01415336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110036909|NCT01415336|Antimetabolites|antimetabolites|mesh-ancestor
110036910|NCT01415466|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110036911|NCT01415466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110036912|NCT01415466|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110036913|NCT01415466|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110036914|NCT01415466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110036916|NCT01415505|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110036917|NCT01415505|Nebivolol|nebivolol|mesh-list
110036918|NCT01415505|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110036919|NCT01415505|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110036920|NCT01415505|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110036921|NCT01415505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110036922|NCT01415505|Diuretics|diuretics|mesh-ancestor
110036923|NCT01415505|Natriuretic Agents|natriuretic agents|mesh-ancestor
110036924|NCT01415505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036925|NCT01415505|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110036926|NCT01415505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110036927|NCT01415505|Vasodilator Agents|vasodilator agents|mesh-ancestor
110036928|NCT01415505|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110036929|NCT01415505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110036930|NCT01415505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110036931|NCT01415505|Adrenergic Agents|adrenergic agents|mesh-ancestor
110036932|NCT01415505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110036933|NCT01415557|Micronutrients|micronutrients|mesh-list
110036934|NCT01415557|Trace Elements|trace elements|mesh-list
110036935|NCT01415557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036937|NCT01415596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110036939|NCT01415596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110036940|NCT01415596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036942|NCT01415596|Respiratory System Agents|respiratory system agents|mesh-ancestor
110036943|NCT01415596|Tocolytic Agents|tocolytic agents|mesh-ancestor
110036944|NCT01415596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110036945|NCT01415596|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110036946|NCT01415596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110036947|NCT01415596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110036948|NCT01415596|Adrenergic Agents|adrenergic agents|mesh-ancestor
110036949|NCT01415596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110036950|NCT01415596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110036951|NCT01415687|Bisacodyl|bisacodyl|mesh-list
110036952|NCT01415687|Magnesium citrate|magnesium citrate|mesh-list
110036953|NCT01415687|Citric Acid|citric acid|mesh-list
110036954|NCT01415687|Sodium Citrate|sodium citrate|mesh-list
110036955|NCT01415687|Anticoagulants|anticoagulants|mesh-ancestor
110036956|NCT01415687|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110036957|NCT01415687|Chelating Agents|chelating agents|mesh-ancestor
110036958|NCT01415687|Sequestering Agents|sequestering agents|mesh-ancestor
110036959|NCT01415687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110036961|NCT01415687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110036962|NCT01415687|Laxatives|laxatives|mesh-ancestor
110036963|NCT01415713|Leucovorin|leucovorin|mesh-list
110036964|NCT01415713|Gemcitabine|gemcitabine|mesh-list
110036965|NCT01415713|Oxaliplatin|oxaliplatin|mesh-list
110036966|NCT01415713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110036967|NCT01415713|Antimetabolites|antimetabolites|mesh-ancestor
110036968|NCT01415713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110036969|NCT01415713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110036970|NCT01415713|Antidotes|antidotes|mesh-ancestor
110036971|NCT01415713|Protective Agents|protective agents|mesh-ancestor
110036972|NCT01415713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036973|NCT01415713|Vitamin B Complex|vitamin b complex|mesh-ancestor
110036974|NCT01415713|Vitamins|vitamins|mesh-ancestor
110036976|NCT01415765|Prednisone|prednisone|mesh-list
110036977|NCT01415765|Cyclophosphamide|cyclophosphamide|mesh-list
110036979|NCT01415765|Doxorubicin|doxorubicin|mesh-list
110036980|NCT01415765|Etoposide|etoposide|mesh-list
110036981|NCT01415765|Vincristine|vincristine|mesh-list
110036982|NCT01415765|Pevonedistat|pevonedistat|mesh-list
110036983|NCT01415765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110036984|NCT01415765|Immunologic Factors|immunologic factors|mesh-ancestor
110036985|NCT01415765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036986|NCT01415765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110036987|NCT01415765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110036988|NCT01415765|Alkylating Agents|alkylating agents|mesh-ancestor
110036989|NCT01415765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110036990|NCT01415765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110036991|NCT01415765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110036992|NCT01415765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110036993|NCT01415765|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110036994|NCT01415765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110036995|NCT01415765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110036996|NCT01415765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110036997|NCT01415765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110036998|NCT01415765|Glucocorticoids|glucocorticoids|mesh-ancestor
110036999|NCT01415765|Hormones|hormones|mesh-ancestor
110037000|NCT01415765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110037001|NCT01415765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110037002|NCT01415765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110037003|NCT01415765|Tubulin Modulators|tubulin modulators|mesh-ancestor
110037004|NCT01415765|Antimitotic Agents|antimitotic agents|mesh-ancestor
110037005|NCT01415765|Mitosis Modulators|mitosis modulators|mesh-ancestor
110037006|NCT01415778|Bicalutamide|bicalutamide|mesh-list
110037007|NCT01415778|Androgen Antagonists|androgen antagonists|mesh-ancestor
110037008|NCT01415778|Hormone Antagonists|hormone antagonists|mesh-ancestor
110037009|NCT01415778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110037010|NCT01415778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037011|NCT01415778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110037012|NCT01415791|Bicalutamide|bicalutamide|mesh-list
110037013|NCT01415791|Androgen Antagonists|androgen antagonists|mesh-ancestor
110037014|NCT01415791|Hormone Antagonists|hormone antagonists|mesh-ancestor
110037015|NCT01415791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110037016|NCT01415791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037017|NCT01415791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110037018|NCT01415895|Clonidine|clonidine|mesh-list
110037019|NCT01415895|Naltrexone|naltrexone|mesh-list
110037020|NCT01415895|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110037021|NCT01415895|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110037022|NCT01415895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037023|NCT01415895|Sensory System Agents|sensory system agents|mesh-ancestor
110037024|NCT01415895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110037025|NCT01415895|Analgesics|analgesics|mesh-ancestor
110037026|NCT01415895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110037027|NCT01415895|Sympatholytics|sympatholytics|mesh-ancestor
110037028|NCT01415895|Autonomic Agents|autonomic agents|mesh-ancestor
110037029|NCT01415895|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110037030|NCT01415895|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110037031|NCT01415895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110037032|NCT01415895|Adrenergic Agents|adrenergic agents|mesh-ancestor
110037033|NCT01415895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110037034|NCT01415895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110037035|NCT01416038|Cyclophosphamide|cyclophosphamide|mesh-list
110037036|NCT01416038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110037038|NCT01416038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037039|NCT01416038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110037040|NCT01416038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110037041|NCT01416038|Alkylating Agents|alkylating agents|mesh-ancestor
110037042|NCT01416038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110037043|NCT01416038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110037044|NCT01416038|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110037046|NCT01416116|Tramadol|tramadol|mesh-list
110037047|NCT01416116|Capsaicin|capsaicin|mesh-list
110037048|NCT01416116|Anesthetics, Local|anesthetics, local|mesh-ancestor
110037049|NCT01416116|Anesthetics|anesthetics|mesh-ancestor
110037050|NCT01416116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110037051|NCT01416116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037052|NCT01416116|Sensory System Agents|sensory system agents|mesh-ancestor
110037053|NCT01416116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110037054|NCT01416116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110037055|NCT01416116|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110037056|NCT01416116|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110037057|NCT01416116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110037058|NCT01416116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110037059|NCT01416116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110037060|NCT01416116|Narcotics|narcotics|mesh-ancestor
110037061|NCT01416116|Analgesics|analgesics|mesh-ancestor
110037062|NCT01416116|Antipruritics|antipruritics|mesh-ancestor
110037063|NCT01416116|Dermatologic Agents|dermatologic agents|mesh-ancestor
110037064|NCT01416207|Interferons|interferons|mesh-list
110037065|NCT01416207|Interferon beta-1a|interferon beta-1a|mesh-list
110037066|NCT01416207|Interferon-beta|interferon-beta|mesh-list
110037067|NCT01416207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110037068|NCT01416207|Antiviral Agents|antiviral agents|mesh-ancestor
110037069|NCT01416207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110037070|NCT01416207|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110037071|NCT01416207|Immunologic Factors|immunologic factors|mesh-ancestor
110037072|NCT01416207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037073|NCT01416220|Lithium Carbonate|lithium carbonate|mesh-list
110037074|NCT01416220|Paroxetine|paroxetine|mesh-list
110037075|NCT01416220|Antidepressive Agents|antidepressive agents|mesh-ancestor
110037076|NCT01416220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110037077|NCT01416220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110037078|NCT01416220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110037079|NCT01416220|Antimanic Agents|antimanic agents|mesh-ancestor
110037080|NCT01416220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110037081|NCT01416220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110037082|NCT01416220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037083|NCT01416220|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110037084|NCT01416220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110037085|NCT01416220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110037086|NCT01416220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110037087|NCT01416220|Serotonin Agents|serotonin agents|mesh-ancestor
110037088|NCT01416220|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110037089|NCT01416220|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110037091|NCT01416246|Anti-Infective Agents|anti-infective agents|mesh-list
110037092|NCT01416246|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110037093|NCT01416337|Trametinib|trametinib|mesh-list
110037094|NCT01416337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110037095|NCT01416337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110037096|NCT01416337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110037097|NCT01416337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110037098|NCT01416350|Azithromycin|azithromycin|mesh-list
110037099|NCT01416350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110037100|NCT01416350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110037101|NCT01416415|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110037103|NCT01416480|Theobromine|theobromine|mesh-list
110037104|NCT01416480|Dipropizine|dipropizine|mesh-list
110037105|NCT01416480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110037106|NCT01416480|Autonomic Agents|autonomic agents|mesh-ancestor
110037107|NCT01416480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110037108|NCT01416480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037109|NCT01416480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110037110|NCT01416480|Respiratory System Agents|respiratory system agents|mesh-ancestor
110037111|NCT01416480|Vasodilator Agents|vasodilator agents|mesh-ancestor
110037112|NCT01416480|Antitussive Agents|antitussive agents|mesh-ancestor
110037113|NCT01416558|Paclitaxel|paclitaxel|mesh-list
110037114|NCT01416558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110037115|NCT01416558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110037116|NCT01416558|Tubulin Modulators|tubulin modulators|mesh-ancestor
110037117|NCT01416558|Antimitotic Agents|antimitotic agents|mesh-ancestor
110037118|NCT01416558|Mitosis Modulators|mitosis modulators|mesh-ancestor
110037119|NCT01416558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110037120|NCT01416649|Exenatide|exenatide|mesh-list
110037121|NCT01416649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110037122|NCT01416649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037123|NCT01416649|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110037124|NCT01416649|Incretins|incretins|mesh-ancestor
110037125|NCT01416649|Hormones|hormones|mesh-ancestor
110037126|NCT01416649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110037127|NCT01416662|Gemcitabine|gemcitabine|mesh-list
110037128|NCT01416662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110037129|NCT01416662|Antimetabolites|antimetabolites|mesh-ancestor
110037130|NCT01416662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110037131|NCT01416662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110037132|NCT01416701|Vitamin D|vitamin d|mesh-list
110037133|NCT01416701|Cholecalciferol|cholecalciferol|mesh-list
110037134|NCT01416701|Vitamins|vitamins|mesh-list
110037135|NCT01416701|Micronutrients|micronutrients|mesh-ancestor
110037136|NCT01416701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037137|NCT01416701|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110037138|NCT01416701|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110037139|NCT01416870|Bicalutamide|bicalutamide|mesh-list
110037140|NCT01416870|Androgen Antagonists|androgen antagonists|mesh-ancestor
110037141|NCT01416870|Hormone Antagonists|hormone antagonists|mesh-ancestor
110037142|NCT01416870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110037143|NCT01416870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037144|NCT01416870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110037145|NCT01416883|Bicalutamide|bicalutamide|mesh-list
110037146|NCT01416883|Androgen Antagonists|androgen antagonists|mesh-ancestor
110037147|NCT01416883|Hormone Antagonists|hormone antagonists|mesh-ancestor
110037148|NCT01416883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110037149|NCT01416883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037150|NCT01416883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110037152|NCT01416909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110037153|NCT01416948|Methylphenidate|methylphenidate|mesh-list
110037154|NCT01416948|Galantamine|galantamine|mesh-list
110037155|NCT01416948|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110037156|NCT01416948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037157|NCT01416948|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110037158|NCT01416948|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110037159|NCT01416948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110037160|NCT01416948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110037161|NCT01416948|Dopamine Agents|dopamine agents|mesh-ancestor
110037162|NCT01416948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110037163|NCT01416948|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110037164|NCT01416948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110037165|NCT01416948|Cholinergic Agents|cholinergic agents|mesh-ancestor
110037166|NCT01416948|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110037167|NCT01416948|Autonomic Agents|autonomic agents|mesh-ancestor
110037168|NCT01416948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110037169|NCT01416948|Nootropic Agents|nootropic agents|mesh-ancestor
110037172|NCT01416961|Etoposide phosphate|etoposide phosphate|mesh-list
110037173|NCT01416961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110037174|NCT01416961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110037175|NCT01416961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110037176|NCT01416961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110037177|NCT01416961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110037178|NCT01416961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110037179|NCT01416974|Cyclophosphamide|cyclophosphamide|mesh-list
110037180|NCT01416974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110037181|NCT01416974|Immunologic Factors|immunologic factors|mesh-ancestor
110037182|NCT01416974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037183|NCT01416974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110037184|NCT01416974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110037185|NCT01416974|Alkylating Agents|alkylating agents|mesh-ancestor
110037186|NCT01416974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110037187|NCT01416974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110037188|NCT01416974|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110037189|NCT01417013|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110037190|NCT01417013|Lubricant Eye Drops|lubricant eye drops|mesh-list
110037191|NCT01417013|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110037192|NCT01417065|Sirolimus|sirolimus|mesh-list
110037193|NCT01417065|Temsirolimus|temsirolimus|mesh-list
110037194|NCT01417065|MTOR Inhibitors|mtor inhibitors|mesh-list
110037195|NCT01417065|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110037196|NCT01417065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110037197|NCT01417065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110037198|NCT01417065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110037199|NCT01417065|Immunologic Factors|immunologic factors|mesh-ancestor
110037200|NCT01417065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037201|NCT01417065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110037202|NCT01417065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110037203|NCT01417065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110037204|NCT01417065|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110037205|NCT01417065|Antifungal Agents|antifungal agents|mesh-ancestor
110037206|NCT01417169|Micafungin|micafungin|mesh-list
110037207|NCT01417169|Antifungal Agents|antifungal agents|mesh-ancestor
110037208|NCT01417169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110037209|NCT01417273|Vitamin A|vitamin a|mesh-list
110037210|NCT01417273|Vitamins|vitamins|mesh-ancestor
110037211|NCT01417273|Micronutrients|micronutrients|mesh-ancestor
110037212|NCT01417273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037214|NCT01417351|Ergocalciferols|ergocalciferols|mesh-list
110037215|NCT01417351|Cholecalciferol|cholecalciferol|mesh-list
110037217|NCT01417351|Micronutrients|micronutrients|mesh-ancestor
110037218|NCT01417351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037219|NCT01417351|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110037220|NCT01417351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110037221|NCT01417364|Methyltestosterone|methyltestosterone|mesh-list
110037222|NCT01417364|Testosterone|testosterone|mesh-list
110037223|NCT01417364|Testosterone undecanoate|testosterone undecanoate|mesh-list
110037224|NCT01417364|Testosterone enanthate|testosterone enanthate|mesh-list
110037225|NCT01417364|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110037226|NCT01417364|Androgens|androgens|mesh-ancestor
110037227|NCT01417364|Hormones|hormones|mesh-ancestor
110037228|NCT01417364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110037229|NCT01417364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037230|NCT01417364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110037231|NCT01417364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110037232|NCT01417364|Anabolic Agents|anabolic agents|mesh-ancestor
110037233|NCT01417390|Cisplatin|cisplatin|mesh-list
110037234|NCT01417390|Gemcitabine|gemcitabine|mesh-list
110037235|NCT01417390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110037236|NCT01417390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110037237|NCT01417390|Antimetabolites|antimetabolites|mesh-ancestor
110037238|NCT01417390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110037239|NCT01417403|Hydroxychloroquine|hydroxychloroquine|mesh-list
110037240|NCT01417403|Antimalarials|antimalarials|mesh-ancestor
110037241|NCT01417403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110037242|NCT01417403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110037243|NCT01417403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110037244|NCT01417403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110037245|NCT01417403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110037246|NCT01417403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110037247|NCT01417429|Galantamine|galantamine|mesh-list
110037248|NCT01417429|Nicotine|nicotine|mesh-list
110037249|NCT01417429|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110037250|NCT01417429|Autonomic Agents|autonomic agents|mesh-ancestor
110037251|NCT01417429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110037252|NCT01417429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037253|NCT01417429|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110037254|NCT01417429|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110037255|NCT01417429|Cholinergic Agents|cholinergic agents|mesh-ancestor
110037256|NCT01417429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110037257|NCT01417429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110037258|NCT01417429|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110037259|NCT01417429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110037260|NCT01417429|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110037261|NCT01417429|Nootropic Agents|nootropic agents|mesh-ancestor
110037262|NCT01417494|Leucovorin|leucovorin|mesh-list
110037263|NCT01417494|Bevacizumab|bevacizumab|mesh-list
110037264|NCT01417494|Fluorouracil|fluorouracil|mesh-list
110037265|NCT01417494|Oxaliplatin|oxaliplatin|mesh-list
110037266|NCT01417494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110037267|NCT01417494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110037268|NCT01417494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110037269|NCT01417494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110037270|NCT01417494|Growth Substances|growth substances|mesh-ancestor
110037271|NCT01417494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037272|NCT01417494|Growth Inhibitors|growth inhibitors|mesh-ancestor
110037273|NCT01417494|Antimetabolites|antimetabolites|mesh-ancestor
110037274|NCT01417494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110037275|NCT01417494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110037276|NCT01417494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110037277|NCT01417494|Immunologic Factors|immunologic factors|mesh-ancestor
110037278|NCT01417494|Antidotes|antidotes|mesh-ancestor
110037279|NCT01417494|Protective Agents|protective agents|mesh-ancestor
110037280|NCT01417494|Vitamin B Complex|vitamin b complex|mesh-ancestor
110037281|NCT01417494|Vitamins|vitamins|mesh-ancestor
110037282|NCT01417494|Micronutrients|micronutrients|mesh-ancestor
110037283|NCT01417572|Lidocaine|lidocaine|mesh-list
110037284|NCT01417572|Anesthetics, Local|anesthetics, local|mesh-ancestor
110037285|NCT01417572|Anesthetics|anesthetics|mesh-ancestor
110037286|NCT01417572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110037287|NCT01417572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037289|NCT01417572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110037290|NCT01417572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110037291|NCT01417572|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110037292|NCT01417572|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110037293|NCT01417572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110037294|NCT01417572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110037296|NCT01417689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110037298|NCT01417754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110037299|NCT01417754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110037300|NCT01417754|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110037301|NCT01417754|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110037302|NCT01417754|Hormone Antagonists|hormone antagonists|mesh-ancestor
110037303|NCT01417754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110037304|NCT01417754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037305|NCT01417754|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110037306|NCT01417767|Decitabine|decitabine|mesh-list
110037307|NCT01417767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110037308|NCT01417767|Antimetabolites|antimetabolites|mesh-ancestor
110037309|NCT01417767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110037310|NCT01417767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110037311|NCT01417767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110037312|NCT01417806|Topotecan|topotecan|mesh-list
110037313|NCT01417806|Pasireotide|pasireotide|mesh-list
110037314|NCT01417806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110037315|NCT01417806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110037316|NCT01417806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110037317|NCT01417806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110037318|NCT01417806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110037319|NCT01417806|Hormones|hormones|mesh-ancestor
110037320|NCT01417806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110037321|NCT01417806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037322|NCT01417858|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110037323|NCT01417858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110037324|NCT01417858|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110037325|NCT01417858|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110037326|NCT01417858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110037327|NCT01417858|Adrenergic Agents|adrenergic agents|mesh-ancestor
110037328|NCT01417858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110037329|NCT01417858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110037330|NCT01417858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037331|NCT01417897|Insulin|insulin|mesh-list
110037332|NCT01417897|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110037333|NCT01417897|Insulin Aspart|insulin aspart|mesh-list
110037334|NCT01417897|Insulin glulisine|insulin glulisine|mesh-list
110037335|NCT01417897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110037336|NCT01417897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037338|NCT01417923|Vitamins|vitamins|mesh-ancestor
110037339|NCT01417923|Micronutrients|micronutrients|mesh-ancestor
110037340|NCT01417923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037341|NCT01417923|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110037342|NCT01417949|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110037343|NCT01417949|Antiviral Agents|antiviral agents|mesh-ancestor
110037344|NCT01417949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110037345|NCT01418118|Dobutamine|dobutamine|mesh-list
110037346|NCT01418118|Epinephrine|epinephrine|mesh-list
110037347|NCT01418118|Norepinephrine|norepinephrine|mesh-list
110037348|NCT01418118|Dopexamine|dopexamine|mesh-list
110037349|NCT01418118|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110037350|NCT01418118|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110037351|NCT01418118|Adrenergic Agents|adrenergic agents|mesh-ancestor
110037352|NCT01418118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110037353|NCT01418118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110037354|NCT01418118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037355|NCT01418118|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110037356|NCT01418118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110037357|NCT01418118|Autonomic Agents|autonomic agents|mesh-ancestor
110037358|NCT01418118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110037359|NCT01418118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110037360|NCT01418118|Respiratory System Agents|respiratory system agents|mesh-ancestor
110037361|NCT01418118|Mydriatics|mydriatics|mesh-ancestor
110037364|NCT01418118|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110037365|NCT01418118|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110037366|NCT01418118|Protective Agents|protective agents|mesh-ancestor
110037367|NCT01418118|Vasodilator Agents|vasodilator agents|mesh-ancestor
110037368|NCT01418118|Dopamine Agonists|dopamine agonists|mesh-ancestor
110037369|NCT01418118|Dopamine Agents|dopamine agents|mesh-ancestor
110037370|NCT01418131|Tacrolimus|tacrolimus|mesh-list
110037371|NCT01418131|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
110037372|NCT01418131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110037373|NCT01418131|Immunologic Factors|immunologic factors|mesh-ancestor
110037374|NCT01418131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037375|NCT01418131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110037376|NCT01418131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110037377|NCT01418144|Ropivacaine|ropivacaine|mesh-list
110037378|NCT01418144|Anesthetics, Local|anesthetics, local|mesh-ancestor
110037379|NCT01418144|Anesthetics|anesthetics|mesh-ancestor
110037380|NCT01418144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110037381|NCT01418144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037382|NCT01418144|Sensory System Agents|sensory system agents|mesh-ancestor
110037383|NCT01418144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110037384|NCT01418157|Acetazolamide|acetazolamide|mesh-list
110037385|NCT01418157|Anticonvulsants|anticonvulsants|mesh-ancestor
110037386|NCT01418157|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110037387|NCT01418157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110037388|NCT01418157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110037389|NCT01418157|Diuretics|diuretics|mesh-ancestor
110037390|NCT01418157|Natriuretic Agents|natriuretic agents|mesh-ancestor
110037392|NCT01418183|Levobupivacaine|levobupivacaine|mesh-list
110037393|NCT01418183|Anesthetics, Local|anesthetics, local|mesh-ancestor
110037394|NCT01418183|Anesthetics|anesthetics|mesh-ancestor
110037395|NCT01418183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110037396|NCT01418183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037397|NCT01418183|Sensory System Agents|sensory system agents|mesh-ancestor
110037398|NCT01418183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110037399|NCT01418235|MF59 oil emulsion|mf59 oil emulsion|mesh-list
110037400|NCT01418235|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110037401|NCT01418235|Immunologic Factors|immunologic factors|mesh-ancestor
110037402|NCT01418235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037404|NCT01418274|Escitalopram|escitalopram|mesh-list
110037405|NCT01418274|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110037406|NCT01418274|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110037407|NCT01418274|Protease Inhibitors|protease inhibitors|mesh-ancestor
110037408|NCT01418274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110037409|NCT01418274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110037410|NCT01418274|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110037411|NCT01418274|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110037412|NCT01418274|Antiviral Agents|antiviral agents|mesh-ancestor
110037414|NCT01418274|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110037415|NCT01418274|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110037416|NCT01418274|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110037417|NCT01418274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110037418|NCT01418274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110037419|NCT01418274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110037420|NCT01418274|Serotonin Agents|serotonin agents|mesh-ancestor
110037421|NCT01418274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037422|NCT01418417|Pantoprazole|pantoprazole|mesh-list
110037423|NCT01418417|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110037424|NCT01418417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110037425|NCT01418417|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110037426|NCT01418417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110037427|NCT01418417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110037428|NCT01418430|Daclizumab|daclizumab|mesh-list
110037429|NCT01418430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110037430|NCT01418430|Immunologic Factors|immunologic factors|mesh-ancestor
110037431|NCT01418430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037432|NCT01418443|Pantoprazole|pantoprazole|mesh-list
110037433|NCT01418443|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110037434|NCT01418443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110037435|NCT01418443|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110037436|NCT01418443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110037437|NCT01418443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110037438|NCT01418456|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110037439|NCT01418456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110037440|NCT01418521|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110037441|NCT01418534|Isosorbide|isosorbide|mesh-list
110037442|NCT01418534|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
110037443|NCT01418534|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
110037444|NCT01418534|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110037445|NCT01418534|Diuretics|diuretics|mesh-ancestor
110037446|NCT01418534|Natriuretic Agents|natriuretic agents|mesh-ancestor
110037447|NCT01418534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037448|NCT01418534|Vasodilator Agents|vasodilator agents|mesh-ancestor
110037449|NCT01418534|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110037450|NCT01418534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110037451|NCT01418547|Isosorbide|isosorbide|mesh-list
110037452|NCT01418547|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
110037453|NCT01418547|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
110037454|NCT01418547|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110037455|NCT01418547|Diuretics|diuretics|mesh-ancestor
110037456|NCT01418547|Natriuretic Agents|natriuretic agents|mesh-ancestor
110037457|NCT01418547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037458|NCT01418547|Vasodilator Agents|vasodilator agents|mesh-ancestor
110037459|NCT01418547|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110037460|NCT01418547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110037461|NCT01418586|Alfuzosin|alfuzosin|mesh-list
110037462|NCT01418586|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110037463|NCT01418586|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110037464|NCT01418586|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110037465|NCT01418586|Adrenergic Agents|adrenergic agents|mesh-ancestor
110037466|NCT01418586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110037468|NCT01418586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037469|NCT01418586|Urological Agents|urological agents|mesh-ancestor
110037471|NCT01418599|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110037472|NCT01418599|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110037473|NCT01418599|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110037474|NCT01418599|Adrenergic Agents|adrenergic agents|mesh-ancestor
110037475|NCT01418599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110037476|NCT01418599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110037477|NCT01418599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037479|NCT01418612|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110037480|NCT01418612|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110037481|NCT01418612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110037482|NCT01418612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110037483|NCT01418612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110037484|NCT01418612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110037485|NCT01418612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037486|NCT01418612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110037487|NCT01418612|Antidepressive Agents|antidepressive agents|mesh-ancestor
110037488|NCT01418612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110037489|NCT01418625|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110037490|NCT01418625|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110037491|NCT01418625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110037492|NCT01418625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110037493|NCT01418625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110037494|NCT01418625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110037495|NCT01418625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037496|NCT01418625|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110037497|NCT01418625|Antidepressive Agents|antidepressive agents|mesh-ancestor
110037498|NCT01418625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110037499|NCT01418651|Milnacipran|milnacipran|mesh-list
110037500|NCT01418651|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110037501|NCT01418651|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110037502|NCT01418651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110037503|NCT01418651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110037504|NCT01418651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110037505|NCT01418651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037506|NCT01418651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110037507|NCT01418651|Analgesics|analgesics|mesh-ancestor
110037508|NCT01418651|Sensory System Agents|sensory system agents|mesh-ancestor
110037509|NCT01418651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110037510|NCT01418729|Pravastatin|pravastatin|mesh-list
110037511|NCT01418729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110037514|NCT01418729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110037516|NCT01418729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110037517|NCT01418729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110037518|NCT01418742|Doxycycline|doxycycline|mesh-list
110037519|NCT01418742|Panitumumab|panitumumab|mesh-list
110037520|NCT01418742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110037521|NCT01418742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110037522|NCT01418742|Antimalarials|antimalarials|mesh-ancestor
110037523|NCT01418742|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110037524|NCT01418742|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110037525|NCT01418742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110037526|NCT01418742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110037528|NCT01418794|Temsirolimus|temsirolimus|mesh-list
110037529|NCT01418794|MTOR Inhibitors|mtor inhibitors|mesh-list
110037530|NCT01418794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110037531|NCT01418794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110037532|NCT01418794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110037533|NCT01418794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110037534|NCT01418794|Antifungal Agents|antifungal agents|mesh-ancestor
110037535|NCT01418794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110037536|NCT01418794|Immunologic Factors|immunologic factors|mesh-ancestor
110037537|NCT01418794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037538|NCT01418794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110037539|NCT01418794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110037540|NCT01418794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110037542|NCT01419041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110037543|NCT01419041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110037544|NCT01419041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110037545|NCT01419041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110037546|NCT01419119|Cholecalciferol|cholecalciferol|mesh-list
110037548|NCT01419119|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110037549|NCT01419119|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110037550|NCT01419119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037551|NCT01419119|Vitamins|vitamins|mesh-ancestor
110037552|NCT01419119|Micronutrients|micronutrients|mesh-ancestor
110037553|NCT01419119|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110037554|NCT01419132|Furosemide|furosemide|mesh-list
110037555|NCT01419132|Diuretics|diuretics|mesh-list
110037556|NCT01419132|Natriuretic Agents|natriuretic agents|mesh-ancestor
110037557|NCT01419132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037558|NCT01419132|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110037559|NCT01419132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110037560|NCT01419132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110037561|NCT01419262|Vitamin D|vitamin d|mesh-list
110037562|NCT01419262|Ergocalciferols|ergocalciferols|mesh-list
110037563|NCT01419262|Cholecalciferol|cholecalciferol|mesh-list
110037564|NCT01419262|Vitamins|vitamins|mesh-list
110037565|NCT01419262|Micronutrients|micronutrients|mesh-ancestor
110037566|NCT01419262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037567|NCT01419262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110037568|NCT01419262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110037569|NCT01419340|Donepezil|donepezil|mesh-list
110037570|NCT01419340|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110037571|NCT01419340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110037572|NCT01419340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110037573|NCT01419340|Cholinergic Agents|cholinergic agents|mesh-ancestor
110037574|NCT01419340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110037575|NCT01419340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037576|NCT01419340|Nootropic Agents|nootropic agents|mesh-ancestor
110037577|NCT01419353|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110037578|NCT01419353|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110037579|NCT01419353|Estradiol|estradiol|mesh-list
110037580|NCT01419353|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110037581|NCT01419353|Estrogens|estrogens|mesh-ancestor
110037582|NCT01419353|Hormones|hormones|mesh-ancestor
110037583|NCT01419353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110037584|NCT01419353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037585|NCT01419353|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110037586|NCT01419353|Contraceptive Agents|contraceptive agents|mesh-ancestor
110037587|NCT01419353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110037588|NCT01419353|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110037589|NCT01419366|Donepezil|donepezil|mesh-list
110037590|NCT01419366|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110037591|NCT01419366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110037592|NCT01419366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110037593|NCT01419366|Cholinergic Agents|cholinergic agents|mesh-ancestor
110037594|NCT01419366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110037595|NCT01419366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037597|NCT01419392|Sildenafil Citrate|sildenafil citrate|mesh-list
110037598|NCT01419392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110037599|NCT01419392|Vasodilator Agents|vasodilator agents|mesh-ancestor
110037600|NCT01419392|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110037601|NCT01419392|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110037602|NCT01419392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110037603|NCT01419392|Urological Agents|urological agents|mesh-ancestor
110037604|NCT01419405|Pregabalin|pregabalin|mesh-list
110037605|NCT01419405|Remifentanil|remifentanil|mesh-list
110037606|NCT01419405|Analgesics|analgesics|mesh-ancestor
110037607|NCT01419405|Sensory System Agents|sensory system agents|mesh-ancestor
110037608|NCT01419405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110037609|NCT01419405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037610|NCT01419405|Anticonvulsants|anticonvulsants|mesh-ancestor
110037611|NCT01419405|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110037612|NCT01419405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110037613|NCT01419405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110037614|NCT01419405|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110037615|NCT01419405|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110037616|NCT01419405|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110037617|NCT01419405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110037618|NCT01419405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110037619|NCT01419405|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110037620|NCT01419405|Narcotics|narcotics|mesh-ancestor
110037621|NCT01419457|Favipiravir|favipiravir|mesh-list
110037622|NCT01419457|Antiviral Agents|antiviral agents|mesh-ancestor
110037623|NCT01419457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110037624|NCT01419548|Paclitaxel|paclitaxel|mesh-list
110037625|NCT01419548|Carboplatin|carboplatin|mesh-list
110037626|NCT01419548|Veliparib|veliparib|mesh-list
110037627|NCT01419548|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110037628|NCT01419548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110037629|NCT01419548|Tubulin Modulators|tubulin modulators|mesh-ancestor
110037630|NCT01419548|Antimitotic Agents|antimitotic agents|mesh-ancestor
110037631|NCT01419548|Mitosis Modulators|mitosis modulators|mesh-ancestor
110037632|NCT01419548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110037633|NCT01419548|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110037634|NCT01419548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110037635|NCT01419652|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110037636|NCT01419652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037637|NCT01419691|Auranofin|auranofin|mesh-list
110037638|NCT01419691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110037639|NCT01419730|Vitamin D|vitamin d|mesh-list
110037640|NCT01419730|Cholecalciferol|cholecalciferol|mesh-list
110037641|NCT01419730|Vitamins|vitamins|mesh-ancestor
110037642|NCT01419730|Micronutrients|micronutrients|mesh-ancestor
110037643|NCT01419730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037644|NCT01419730|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110037645|NCT01419730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110037646|NCT01419821|Vitamin D|vitamin d|mesh-list
110037647|NCT01419821|Ergocalciferols|ergocalciferols|mesh-list
110037648|NCT01419821|Cholecalciferol|cholecalciferol|mesh-list
110037649|NCT01419821|Vitamins|vitamins|mesh-list
110037650|NCT01419821|Micronutrients|micronutrients|mesh-ancestor
110037651|NCT01419821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037652|NCT01419821|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110037653|NCT01419821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110037656|NCT01419847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110037657|NCT01419873|Insulin|insulin|mesh-list
110037658|NCT01419873|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110037659|NCT01419873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110037660|NCT01419873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037661|NCT01420055|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
110037662|NCT01420055|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110037663|NCT01420055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110037664|NCT01420055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110037665|NCT01420055|Immunologic Factors|immunologic factors|mesh-ancestor
110037670|NCT01420094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110037671|NCT01420094|Analgesics|analgesics|mesh-ancestor
110037672|NCT01420094|Sensory System Agents|sensory system agents|mesh-ancestor
110037673|NCT01420094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110037674|NCT01420094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037675|NCT01420094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110037676|NCT01420094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110037677|NCT01420094|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110037678|NCT01420094|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110037679|NCT01420094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110037680|NCT01420094|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110037681|NCT01420094|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110037682|NCT01420094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110037683|NCT01420094|Antipyretics|antipyretics|mesh-ancestor
110037684|NCT01420159|Methoxyflurane|methoxyflurane|mesh-list
110037685|NCT01420159|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110037686|NCT01420159|Anesthetics, General|anesthetics, general|mesh-ancestor
110037687|NCT01420159|Anesthetics|anesthetics|mesh-ancestor
110037688|NCT01420159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110037689|NCT01420159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037690|NCT01420302|Insulin|insulin|mesh-list
110037691|NCT01420302|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110037692|NCT01420302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110037693|NCT01420302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037694|NCT01420328|Simvastatin|simvastatin|mesh-list
110037695|NCT01420328|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
110037696|NCT01420328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110037697|NCT01420328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110037698|NCT01420328|Antimetabolites|antimetabolites|mesh-ancestor
110037699|NCT01420328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110037700|NCT01420328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110037701|NCT01420328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110037702|NCT01420328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110037703|NCT01420341|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110037704|NCT01420341|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110037705|NCT01420341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110037706|NCT01420341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110037707|NCT01420341|Antimalarials|antimalarials|mesh-ancestor
110037708|NCT01420341|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110037709|NCT01420341|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110037710|NCT01420367|Metronidazole|metronidazole|mesh-list
110037711|NCT01420367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110037712|NCT01420367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110037713|NCT01420367|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110037714|NCT01420367|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110037715|NCT01420406|Vitamin A|vitamin a|mesh-list
110037716|NCT01420406|Vitamins|vitamins|mesh-ancestor
110037717|NCT01420406|Micronutrients|micronutrients|mesh-ancestor
110037718|NCT01420406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037719|NCT01420471|Triamcinolone|triamcinolone|mesh-list
110037720|NCT01420471|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110037721|NCT01420471|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110037722|NCT01420471|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110037723|NCT01420471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110037724|NCT01420471|Glucocorticoids|glucocorticoids|mesh-ancestor
110037725|NCT01420471|Hormones|hormones|mesh-ancestor
110037726|NCT01420471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110037727|NCT01420471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037729|NCT01420471|Immunologic Factors|immunologic factors|mesh-ancestor
110037730|NCT01420471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110037731|NCT01420471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110037732|NCT01420523|Raltegravir Potassium|raltegravir potassium|mesh-list
110037734|NCT01420523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110037735|NCT01420523|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110037736|NCT01420523|Antiviral Agents|antiviral agents|mesh-ancestor
110037737|NCT01420523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110037738|NCT01420523|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110037739|NCT01420523|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110037740|NCT01420523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110037741|NCT01420523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110037743|NCT01420523|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110037744|NCT01420523|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110037745|NCT01420575|Olanzapine|olanzapine|mesh-list
110037746|NCT01420575|Antiemetics|antiemetics|mesh-ancestor
110037747|NCT01420575|Autonomic Agents|autonomic agents|mesh-ancestor
110037748|NCT01420575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110037749|NCT01420575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037750|NCT01420575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110037751|NCT01420575|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110037752|NCT01420575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110037753|NCT01420575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110037754|NCT01420575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110037755|NCT01420575|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110037756|NCT01420575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110037757|NCT01420575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110037758|NCT01420575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110037759|NCT01420575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110037760|NCT01420575|Serotonin Agents|serotonin agents|mesh-ancestor
110037761|NCT01420666|Acetaminophen|acetaminophen|mesh-list
110037762|NCT01420666|Ibuprofen|ibuprofen|mesh-list
110037763|NCT01420666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110037764|NCT01420666|Analgesics|analgesics|mesh-ancestor
110037765|NCT01420666|Sensory System Agents|sensory system agents|mesh-ancestor
110037766|NCT01420666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110037767|NCT01420666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037768|NCT01420666|Antipyretics|antipyretics|mesh-ancestor
110037769|NCT01420666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110037770|NCT01420666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110037771|NCT01420666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110037772|NCT01420666|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110037773|NCT01420666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110037774|NCT01420666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110037776|NCT01420692|Gliclazide|gliclazide|mesh-list
110037777|NCT01420692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110037778|NCT01420692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037780|NCT01420822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110037781|NCT01420822|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110037782|NCT01420822|Autonomic Agents|autonomic agents|mesh-ancestor
110037783|NCT01420822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110037784|NCT01420822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037785|NCT01420822|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110037786|NCT01420822|Respiratory System Agents|respiratory system agents|mesh-ancestor
110037787|NCT01420822|Dermatologic Agents|dermatologic agents|mesh-ancestor
110037788|NCT01420822|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110037789|NCT01420900|Tacrine|tacrine|mesh-list
110037790|NCT01420900|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110037792|NCT01420900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110037793|NCT01420900|Cholinergic Agents|cholinergic agents|mesh-ancestor
110037794|NCT01420900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110037795|NCT01420900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037796|NCT01420900|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110037797|NCT01420900|Autonomic Agents|autonomic agents|mesh-ancestor
110037798|NCT01420900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110037799|NCT01420900|Nootropic Agents|nootropic agents|mesh-ancestor
110037800|NCT01420913|Pregabalin|pregabalin|mesh-list
110037801|NCT01420913|Analgesics|analgesics|mesh-ancestor
110037802|NCT01420913|Sensory System Agents|sensory system agents|mesh-ancestor
110037803|NCT01420913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110037804|NCT01420913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037805|NCT01420913|Anticonvulsants|anticonvulsants|mesh-ancestor
110037806|NCT01420913|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110037807|NCT01420913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110037808|NCT01420913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110037809|NCT01420913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110037810|NCT01420913|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110037811|NCT01420913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110037812|NCT01420913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110037813|NCT01420913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110037814|NCT01421043|Triazolam|triazolam|mesh-list
110037815|NCT01421043|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110037816|NCT01421043|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110037823|NCT01421043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110037824|NCT01421043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110037825|NCT01421121|Vaccines|vaccines|mesh-list
110037826|NCT01421121|Immunologic Factors|immunologic factors|mesh-ancestor
110037827|NCT01421121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037828|NCT01421160|Citric Acid|citric acid|mesh-list
110037829|NCT01421160|Sodium Citrate|sodium citrate|mesh-list
110037830|NCT01421160|Anticoagulants|anticoagulants|mesh-ancestor
110037831|NCT01421160|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110037832|NCT01421160|Chelating Agents|chelating agents|mesh-ancestor
110037833|NCT01421160|Sequestering Agents|sequestering agents|mesh-ancestor
110037834|NCT01421160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110037835|NCT01421173|Dexamethasone|dexamethasone|mesh-list
110037836|NCT01421173|Dexamethasone acetate|dexamethasone acetate|mesh-list
110037837|NCT01421173|Rituximab|rituximab|mesh-list
110037838|NCT01421173|Gemcitabine|gemcitabine|mesh-list
110037839|NCT01421173|Melphalan|melphalan|mesh-list
110037840|NCT01421173|Busulfan|busulfan|mesh-list
110037841|NCT01421173|Vorinostat|vorinostat|mesh-list
110037842|NCT01421173|BB 1101|bb 1101|mesh-list
110037843|NCT01421173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110037844|NCT01421173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110037845|NCT01421173|Immunologic Factors|immunologic factors|mesh-ancestor
110037846|NCT01421173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037847|NCT01421173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110037848|NCT01421173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110037849|NCT01421173|Antiemetics|antiemetics|mesh-ancestor
110037850|NCT01421173|Autonomic Agents|autonomic agents|mesh-ancestor
110037851|NCT01421173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110037852|NCT01421173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110037854|NCT01421173|Hormones|hormones|mesh-ancestor
110037855|NCT01421173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110037856|NCT01421173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110037857|NCT01421173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110037858|NCT01421173|Antimetabolites|antimetabolites|mesh-ancestor
110037859|NCT01421173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110037860|NCT01421173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110037861|NCT01421173|Alkylating Agents|alkylating agents|mesh-ancestor
110037862|NCT01421173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110037863|NCT01421173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110037864|NCT01421173|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110037865|NCT01421173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110037866|NCT01421173|Protease Inhibitors|protease inhibitors|mesh-ancestor
110037867|NCT01421212|Immunoglobulins|immunoglobulins|mesh-list
110037868|NCT01421212|Antibodies|antibodies|mesh-list
110037869|NCT01421212|gamma-Globulins|gamma-globulins|mesh-list
110037870|NCT01421212|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110037871|NCT01421212|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110037872|NCT01421212|Immunoglobulin G|immunoglobulin g|mesh-list
110037873|NCT01421212|Immunologic Factors|immunologic factors|mesh-ancestor
110037874|NCT01421212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037875|NCT01421368|Tenofovir|tenofovir|mesh-list
110037876|NCT01421368|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110037877|NCT01421368|Contraceptive Agents|contraceptive agents|mesh-list
110037878|NCT01421368|Medroxyprogesterone|medroxyprogesterone|mesh-list
110037879|NCT01421368|Contraceptives, Oral|contraceptives, oral|mesh-list
110037880|NCT01421368|Antiviral Agents|antiviral agents|mesh-ancestor
110037881|NCT01421368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110037882|NCT01421368|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110037883|NCT01421368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110037884|NCT01421368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110037885|NCT01421368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110037886|NCT01421368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110037887|NCT01421368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110037888|NCT01421368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110037889|NCT01421368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037890|NCT01421368|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110037891|NCT01421368|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110037892|NCT01421368|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110037893|NCT01421368|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110037894|NCT01421368|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110037895|NCT01421368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110037896|NCT01421368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110037898|NCT01421693|Gatifloxacin|gatifloxacin|mesh-list
110037901|NCT01421693|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110037902|NCT01421693|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110037903|NCT01421693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110037904|NCT01421693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110037905|NCT01421693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110037906|NCT01421693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110037907|NCT01421693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110037908|NCT01421706|Clarithromycin|clarithromycin|mesh-list
110037909|NCT01421706|Sibutramine|sibutramine|mesh-list
110037910|NCT01421706|Clopidogrel|clopidogrel|mesh-list
110037911|NCT01421706|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110037912|NCT01421706|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110037913|NCT01421706|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110037914|NCT01421706|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110037915|NCT01421706|Purinergic Agents|purinergic agents|mesh-ancestor
110037916|NCT01421706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110037917|NCT01421706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110037918|NCT01421706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037919|NCT01421706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110037920|NCT01421706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110037921|NCT01421706|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110037922|NCT01421706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110037923|NCT01421706|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110037924|NCT01421706|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110037925|NCT01421706|Antidepressive Agents|antidepressive agents|mesh-ancestor
110037926|NCT01421706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110037927|NCT01421706|Appetite Depressants|appetite depressants|mesh-ancestor
110037928|NCT01421706|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110037929|NCT01421771|Antihypertensive Agents|antihypertensive agents|mesh-list
110037930|NCT01421901|Ertapenem|ertapenem|mesh-list
110037931|NCT01421901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110037932|NCT01421901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110037933|NCT01421914|Bupivacaine|bupivacaine|mesh-list
110037934|NCT01421914|Anesthetics, Local|anesthetics, local|mesh-ancestor
110037935|NCT01421914|Anesthetics|anesthetics|mesh-ancestor
110037936|NCT01421914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110037937|NCT01421914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037938|NCT01421914|Sensory System Agents|sensory system agents|mesh-ancestor
110037939|NCT01421914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110037940|NCT01421927|Lenalidomide|lenalidomide|mesh-list
110037941|NCT01421927|Immunologic Factors|immunologic factors|mesh-ancestor
110037942|NCT01421927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037943|NCT01421927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110037944|NCT01421927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110037945|NCT01421927|Growth Substances|growth substances|mesh-ancestor
110037946|NCT01421927|Growth Inhibitors|growth inhibitors|mesh-ancestor
110037947|NCT01421927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110037948|NCT01421940|Udenafil|udenafil|mesh-list
110037949|NCT01421940|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110037950|NCT01421940|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110037951|NCT01421940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110037952|NCT01421940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110037953|NCT01421979|Caffeine|caffeine|mesh-list
110037954|NCT01421979|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110037955|NCT01421979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037956|NCT01421979|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110037957|NCT01421979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110037958|NCT01421979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110037959|NCT01421979|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110037960|NCT01421979|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110037961|NCT01421979|Purinergic Agents|purinergic agents|mesh-ancestor
110037962|NCT01421979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110037963|NCT01421992|Methylphenidate|methylphenidate|mesh-list
110037965|NCT01421992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037966|NCT01421992|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110037967|NCT01421992|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110037968|NCT01421992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110037969|NCT01421992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110037970|NCT01421992|Dopamine Agents|dopamine agents|mesh-ancestor
110037971|NCT01421992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110037972|NCT01422018|Bevacizumab|bevacizumab|mesh-list
110037973|NCT01422018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110037974|NCT01422018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110037975|NCT01422018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110037976|NCT01422018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110037977|NCT01422018|Growth Substances|growth substances|mesh-ancestor
110037978|NCT01422018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037979|NCT01422018|Growth Inhibitors|growth inhibitors|mesh-ancestor
110037980|NCT01422096|Leuprolide|leuprolide|mesh-list
110037981|NCT01422096|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110037982|NCT01422096|Fertility Agents|fertility agents|mesh-ancestor
110037983|NCT01422096|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110037984|NCT01422096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037985|NCT01422096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110037986|NCT01422096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110037987|NCT01422109|Aspirin|aspirin|mesh-list
110037988|NCT01422109|Clopidogrel|clopidogrel|mesh-list
110037989|NCT01422109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110037990|NCT01422109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110037991|NCT01422109|Analgesics|analgesics|mesh-ancestor
110037992|NCT01422109|Sensory System Agents|sensory system agents|mesh-ancestor
110037993|NCT01422109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110037994|NCT01422109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037995|NCT01422109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110037996|NCT01422109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110037997|NCT01422109|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110037998|NCT01422109|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110037999|NCT01422109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110038000|NCT01422109|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110038001|NCT01422109|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110038002|NCT01422109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110038003|NCT01422109|Antipyretics|antipyretics|mesh-ancestor
110038004|NCT01422109|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110038005|NCT01422109|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110038006|NCT01422109|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110038007|NCT01422109|Purinergic Agents|purinergic agents|mesh-ancestor
110038008|NCT01422109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110038009|NCT01422122|Vitamin D|vitamin d|mesh-list
110038010|NCT01422122|Ergocalciferols|ergocalciferols|mesh-list
110038011|NCT01422122|Cholecalciferol|cholecalciferol|mesh-list
110038012|NCT01422122|Vitamins|vitamins|mesh-list
110038013|NCT01422122|Micronutrients|micronutrients|mesh-ancestor
110038014|NCT01422122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110038015|NCT01422122|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110038016|NCT01422122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110038017|NCT01422291|Acetaminophen|acetaminophen|mesh-list
110038018|NCT01422291|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
110038019|NCT01422291|Morphine|morphine|mesh-list
110038020|NCT01422291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110038021|NCT01422291|Narcotics|narcotics|mesh-ancestor
110038022|NCT01422291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110038023|NCT01422291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110038024|NCT01422291|Analgesics|analgesics|mesh-ancestor
110038025|NCT01422291|Sensory System Agents|sensory system agents|mesh-ancestor
110038026|NCT01422291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110038027|NCT01422291|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110038028|NCT01422291|Antipyretics|antipyretics|mesh-ancestor
110038029|NCT01422291|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110038030|NCT01422291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110038033|NCT01422317|Vitamin E|vitamin e|mesh-list
110038034|NCT01422317|Tocotrienols|tocotrienols|mesh-list
110038035|NCT01422317|alpha-Tocopherol|alpha-tocopherol|mesh-list
110038036|NCT01422317|Antioxidants|antioxidants|mesh-ancestor
110038037|NCT01422317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110038038|NCT01422317|Protective Agents|protective agents|mesh-ancestor
110038039|NCT01422317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110038042|NCT01422330|Etravirine|etravirine|mesh-list
110038043|NCT01422330|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110038044|NCT01422330|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110038045|NCT01422330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110038046|NCT01422330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110038047|NCT01422330|Antiviral Agents|antiviral agents|mesh-ancestor
110038050|NCT01422460|Mitosis Modulators|mitosis modulators|mesh-ancestor
110038051|NCT01422460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110038052|NCT01422499|Vorinostat|vorinostat|mesh-list
110038053|NCT01422499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110038054|NCT01422499|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110038055|NCT01422499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110038056|NCT01422499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110038057|NCT01422590|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110038058|NCT01422590|Mitiglinide|mitiglinide|mesh-list
110038059|NCT01422590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110038060|NCT01422590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110038061|NCT01422590|Incretins|incretins|mesh-ancestor
110038062|NCT01422590|Hormones|hormones|mesh-ancestor
110038063|NCT01422590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110038064|NCT01422590|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110038065|NCT01422590|Protease Inhibitors|protease inhibitors|mesh-ancestor
110038066|NCT01422590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110038067|NCT01422590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110038068|NCT01422603|Clofarabine|clofarabine|mesh-list
110038069|NCT01422603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110038070|NCT01422603|Antimetabolites|antimetabolites|mesh-ancestor
110038071|NCT01422603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110038072|NCT01422603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110038073|NCT01422616|Metoprolol|metoprolol|mesh-list
110038074|NCT01422616|Clonidine|clonidine|mesh-list
110038075|NCT01422616|Labetalol|labetalol|mesh-list
110038076|NCT01422616|Hydralazine|hydralazine|mesh-list
110038077|NCT01422616|Nicardipine|nicardipine|mesh-list
110038078|NCT01422616|Phentolamine|phentolamine|mesh-list
110038079|NCT01422616|Urapidil|urapidil|mesh-list
110038080|NCT01422616|Enalaprilat|enalaprilat|mesh-list
110038081|NCT01422616|Enalapril|enalapril|mesh-list
110038082|NCT01422616|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110038083|NCT01422616|Nitroglycerin|nitroglycerin|mesh-list
110038084|NCT01422616|Esmolol|esmolol|mesh-list
110038085|NCT01422616|Glycerol|glycerol|mesh-list
110038086|NCT01422616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110038087|NCT01422616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110038089|NCT01422616|Autonomic Agents|autonomic agents|mesh-ancestor
110038090|NCT01422616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110038091|NCT01422616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110038092|NCT01422616|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110038093|NCT01422616|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110038094|NCT01422616|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110038095|NCT01422616|Adrenergic Agents|adrenergic agents|mesh-ancestor
110038096|NCT01422616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110038097|NCT01422616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110038099|NCT01422616|Sensory System Agents|sensory system agents|mesh-ancestor
110038100|NCT01422616|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110038101|NCT01422616|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110038102|NCT01422616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110038103|NCT01422616|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110038104|NCT01422616|Protective Agents|protective agents|mesh-ancestor
110038105|NCT01422616|Sympathomimetics|sympathomimetics|mesh-ancestor
110038106|NCT01422616|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110038107|NCT01422616|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110038108|NCT01422616|Vasodilator Agents|vasodilator agents|mesh-ancestor
110038109|NCT01422616|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110038110|NCT01422616|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110038111|NCT01422616|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110038112|NCT01422616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110038113|NCT01422616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110038114|NCT01422616|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110038115|NCT01422616|Serotonin Agents|serotonin agents|mesh-ancestor
110038116|NCT01422616|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110038117|NCT01422616|Protease Inhibitors|protease inhibitors|mesh-ancestor
110038118|NCT01422616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110038119|NCT01422707|Hydrocortisone|hydrocortisone|mesh-list
110038120|NCT01422707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110038121|NCT01422733|Dexamethasone|dexamethasone|mesh-list
110038122|NCT01422733|Hydrocortisone|hydrocortisone|mesh-list
110038123|NCT01422733|Cosyntropin|cosyntropin|mesh-list
110038124|NCT01422733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110038125|NCT01422733|Antiemetics|antiemetics|mesh-ancestor
110038126|NCT01422733|Autonomic Agents|autonomic agents|mesh-ancestor
110038127|NCT01422733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110038128|NCT01422733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110038129|NCT01422733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110038130|NCT01422733|Glucocorticoids|glucocorticoids|mesh-ancestor
110038132|NCT01422733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110038133|NCT01422733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110038134|NCT01422733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110038135|NCT01422785|Clindamycin|clindamycin|mesh-list
110038136|NCT01422785|Clindamycin palmitate|clindamycin palmitate|mesh-list
110038137|NCT01422785|Clindamycin phosphate|clindamycin phosphate|mesh-list
110038138|NCT01422785|Tretinoin|tretinoin|mesh-list
110038139|NCT01422785|Benzoyl Peroxide|benzoyl peroxide|mesh-list
110038140|NCT01422785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110038141|NCT01422785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110038142|NCT01422785|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110038143|NCT01422785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110038144|NCT01422785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110038145|NCT01422785|Dermatologic Agents|dermatologic agents|mesh-ancestor
110038147|NCT01422785|Keratolytic Agents|keratolytic agents|mesh-ancestor
110038148|NCT01422954|Chloroquine|chloroquine|mesh-list
110038149|NCT01422954|Mefloquine|mefloquine|mesh-list
110038150|NCT01422954|Proguanil|proguanil|mesh-list
110038151|NCT01422954|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
110038152|NCT01422954|Amebicides|amebicides|mesh-ancestor
110038153|NCT01422954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110038154|NCT01422954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110038155|NCT01422954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110038156|NCT01422954|Antimalarials|antimalarials|mesh-ancestor
110038157|NCT01422954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110038158|NCT01422954|Antimetabolites|antimetabolites|mesh-ancestor
110038159|NCT01422954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110038160|NCT01423019|Synephrine|synephrine|mesh-list
110038161|NCT01423019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110038163|NCT01423019|Adrenergic Agents|adrenergic agents|mesh-ancestor
110038164|NCT01423019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110038165|NCT01423019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110038166|NCT01423019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110038167|NCT01423019|Sympathomimetics|sympathomimetics|mesh-ancestor
110038168|NCT01423019|Autonomic Agents|autonomic agents|mesh-ancestor
110038169|NCT01423019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110038170|NCT01423019|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110038171|NCT01423019|Nasal Decongestants|nasal decongestants|mesh-ancestor
110038172|NCT01423019|Respiratory System Agents|respiratory system agents|mesh-ancestor
110038173|NCT01423032|Fludarabine|fludarabine|mesh-list
110038174|NCT01423032|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110038175|NCT01423032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110038176|NCT01423032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110038177|NCT01423032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110038178|NCT01423032|Alkylating Agents|alkylating agents|mesh-ancestor
110038179|NCT01423123|Paclitaxel|paclitaxel|mesh-list
110038180|NCT01423123|Trastuzumab|trastuzumab|mesh-list
110038181|NCT01423123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110038182|NCT01423123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110038183|NCT01423123|Tubulin Modulators|tubulin modulators|mesh-ancestor
110038184|NCT01423123|Antimitotic Agents|antimitotic agents|mesh-ancestor
110038186|NCT01423123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110038187|NCT01423123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110038188|NCT01423175|Clofarabine|clofarabine|mesh-list
110038189|NCT01423175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110038190|NCT01423175|Antimetabolites|antimetabolites|mesh-ancestor
110038191|NCT01423175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110038192|NCT01423175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110038193|NCT01423240|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
110038194|NCT01423240|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110038195|NCT01423240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110038196|NCT01423240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110038197|NCT01423240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110038198|NCT01423240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110038199|NCT01423240|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110038200|NCT01423240|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110038201|NCT01423240|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110038202|NCT01423240|Adrenergic Agents|adrenergic agents|mesh-ancestor
110038203|NCT01423240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110038204|NCT01423240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110038205|NCT01423240|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110038207|NCT01423240|Serotonin Agents|serotonin agents|mesh-ancestor
110038208|NCT01423240|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110038209|NCT01423240|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110038210|NCT01423240|Dopamine Agents|dopamine agents|mesh-ancestor
110038212|NCT01423292|Anesthetics, Local|anesthetics, local|mesh-ancestor
110038214|NCT01423292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110038215|NCT01423292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110038216|NCT01423292|Sensory System Agents|sensory system agents|mesh-ancestor
110038217|NCT01423292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110038219|NCT01423305|Formoterol Fumarate|formoterol fumarate|mesh-list
110038220|NCT01423305|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110038221|NCT01423305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110038222|NCT01423305|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110038223|NCT01423305|Autonomic Agents|autonomic agents|mesh-ancestor
110038224|NCT01423305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110038225|NCT01423305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110038226|NCT01423305|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110038227|NCT01423305|Respiratory System Agents|respiratory system agents|mesh-ancestor
110038228|NCT01423305|Glucocorticoids|glucocorticoids|mesh-ancestor
110038229|NCT01423305|Hormones|hormones|mesh-ancestor
110038230|NCT01423305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110038231|NCT01423305|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110038232|NCT01423305|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110038233|NCT01423305|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110038234|NCT01423305|Adrenergic Agents|adrenergic agents|mesh-ancestor
110038235|NCT01423305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110038236|NCT01423305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110038237|NCT01423370|Tadalafil|tadalafil|mesh-list
110038238|NCT01423370|Vasodilator Agents|vasodilator agents|mesh-ancestor
110038239|NCT01423370|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110038240|NCT01423370|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110038241|NCT01423370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110038242|NCT01423370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110038243|NCT01423370|Urological Agents|urological agents|mesh-ancestor
110038244|NCT01423435|Beraprost|beraprost|mesh-list
110038245|NCT01423435|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110038246|NCT01423435|Vasodilator Agents|vasodilator agents|mesh-ancestor
110038247|NCT01423487|Metformin|metformin|mesh-list
110038248|NCT01423487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110038249|NCT01423487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110038252|NCT01423500|Etoposide phosphate|etoposide phosphate|mesh-list
110038253|NCT01423500|Thiotepa|thiotepa|mesh-list
110038254|NCT01423500|Treosulfan|treosulfan|mesh-list
110038255|NCT01423500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110038256|NCT01423500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110038257|NCT01423500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110038258|NCT01423500|Immunologic Factors|immunologic factors|mesh-ancestor
110038259|NCT01423500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110038260|NCT01423500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110038261|NCT01423500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110038262|NCT01423500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110038263|NCT01423500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110038264|NCT01423500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110038265|NCT01423500|Alkylating Agents|alkylating agents|mesh-ancestor
110038266|NCT01423500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110038267|NCT01423539|Rituximab|rituximab|mesh-list
110038268|NCT01423539|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110038269|NCT01423539|Navitoclax|navitoclax|mesh-list
110038270|NCT01423539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110038271|NCT01423539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110038272|NCT01423539|Immunologic Factors|immunologic factors|mesh-ancestor
110038273|NCT01423539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110038274|NCT01423539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110038275|NCT01423539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110038276|NCT01423539|Alkylating Agents|alkylating agents|mesh-ancestor
110038277|NCT01423539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110038279|NCT01423591|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110038280|NCT01423591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110038281|NCT01423591|Dermatologic Agents|dermatologic agents|mesh-ancestor
110038282|NCT01423591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110038283|NCT01423591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110038284|NCT01423695|Paclitaxel|paclitaxel|mesh-list
110038285|NCT01423695|Trastuzumab|trastuzumab|mesh-list
110038286|NCT01423695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110038287|NCT01423695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110038288|NCT01423695|Tubulin Modulators|tubulin modulators|mesh-ancestor
110038289|NCT01423695|Antimitotic Agents|antimitotic agents|mesh-ancestor
110038290|NCT01423695|Mitosis Modulators|mitosis modulators|mesh-ancestor
110038291|NCT01423695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110038292|NCT01423695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110038293|NCT01423708|Everolimus|everolimus|mesh-list
110038294|NCT01423708|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110038295|NCT01423708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110038296|NCT01423708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110038297|NCT01423708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110038298|NCT01423708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110038299|NCT01423708|Immunologic Factors|immunologic factors|mesh-ancestor
110038300|NCT01423708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110038301|NCT01423708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110038304|NCT01423747|Etoposide phosphate|etoposide phosphate|mesh-list
110038305|NCT01423747|Thiotepa|thiotepa|mesh-list
110038306|NCT01423747|Treosulfan|treosulfan|mesh-list
110038307|NCT01423747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110038308|NCT01423747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110038309|NCT01423747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110038310|NCT01423747|Immunologic Factors|immunologic factors|mesh-ancestor
110038311|NCT01423747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110038312|NCT01423747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110038313|NCT01423747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110038314|NCT01423747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110038315|NCT01423747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110038316|NCT01423747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110038317|NCT01423747|Alkylating Agents|alkylating agents|mesh-ancestor
110038318|NCT01423747|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110038319|NCT01423838|Solifenacin Succinate|solifenacin succinate|mesh-list
110038320|NCT01423838|Oxybutynin|oxybutynin|mesh-list
110038321|NCT01423838|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110038322|NCT01423838|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110038323|NCT01423838|Cholinergic Agents|cholinergic agents|mesh-ancestor
110038325|NCT01423838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110038326|NCT01423838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110038327|NCT01423838|Urological Agents|urological agents|mesh-ancestor
110038328|NCT01423838|Parasympatholytics|parasympatholytics|mesh-ancestor
110038329|NCT01423838|Autonomic Agents|autonomic agents|mesh-ancestor
110038330|NCT01423838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110038331|NCT01423864|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110038332|NCT01423864|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110038333|NCT01423864|Methylprednisolone|methylprednisolone|mesh-list
110038334|NCT01423864|Prednisolone|prednisolone|mesh-list
110038335|NCT01423864|Prednisolone acetate|prednisolone acetate|mesh-list
110038336|NCT01423864|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110038337|NCT01423864|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110038338|NCT01423864|Prednisolone phosphate|prednisolone phosphate|mesh-list
110038339|NCT01423864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110038340|NCT01423864|Glucocorticoids|glucocorticoids|mesh-ancestor
110053074|NCT01484613|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
110038342|NCT01423864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110038343|NCT01423864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110038344|NCT01423864|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110038345|NCT01423864|Protective Agents|protective agents|mesh-ancestor
110038346|NCT01423864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110038347|NCT01423864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110038348|NCT01423864|Antiemetics|antiemetics|mesh-ancestor
110038349|NCT01423864|Autonomic Agents|autonomic agents|mesh-ancestor
110038350|NCT01423864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110038351|NCT01423864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110038352|NCT01423955|Epoetin Alfa|epoetin alfa|mesh-list
110038353|NCT01423955|Hematinics|hematinics|mesh-ancestor
110038354|NCT01424046|Insulin Glargine|insulin glargine|mesh-list
110038355|NCT01424046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110038356|NCT01424046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110038357|NCT01424111|Escitalopram|escitalopram|mesh-list
110038358|NCT01424111|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110038359|NCT01424111|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110038360|NCT01424111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110038361|NCT01424111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110038362|NCT01424111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110038363|NCT01424111|Serotonin Agents|serotonin agents|mesh-ancestor
110038364|NCT01424111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110038365|NCT01424124|Montelukast|montelukast|mesh-list
110038366|NCT01424124|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110038367|NCT01424124|Respiratory System Agents|respiratory system agents|mesh-ancestor
110038368|NCT01424124|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110038369|NCT01424124|Hormone Antagonists|hormone antagonists|mesh-ancestor
110038370|NCT01424124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110038371|NCT01424124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110038372|NCT01424124|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110038373|NCT01424124|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110038374|NCT01424124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110038375|NCT01424137|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110038376|NCT01424137|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110038377|NCT01424137|Autonomic Agents|autonomic agents|mesh-ancestor
110038378|NCT01424137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110038379|NCT01424137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110038380|NCT01424137|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110038381|NCT01424137|Respiratory System Agents|respiratory system agents|mesh-ancestor
110038382|NCT01424137|Glucocorticoids|glucocorticoids|mesh-ancestor
110038384|NCT01424137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110038385|NCT01424137|Sympathomimetics|sympathomimetics|mesh-ancestor
110038386|NCT01424176|Pramipexole|pramipexole|mesh-list
110038387|NCT01424176|Antioxidants|antioxidants|mesh-ancestor
110038388|NCT01424176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110038389|NCT01424176|Protective Agents|protective agents|mesh-ancestor
110038390|NCT01424176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110038392|NCT01424176|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110038393|NCT01424176|Dopamine Agonists|dopamine agonists|mesh-ancestor
110038394|NCT01424176|Dopamine Agents|dopamine agents|mesh-ancestor
110038395|NCT01424176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110038396|NCT01424241|Octreotide|octreotide|mesh-list
110038397|NCT01424241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110038398|NCT01424241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110038399|NCT01424241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110038400|NCT01424319|Atrasentan|atrasentan|mesh-list
110038401|NCT01424319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110038402|NCT01424319|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
110038403|NCT01424319|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110038404|NCT01424319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110038405|NCT01424332|Aspirin|aspirin|mesh-list
110038406|NCT01424332|Salicylic Acid|salicylic acid|mesh-list
110038407|NCT01424332|Salicylates|salicylates|mesh-list
110038408|NCT01424332|Darexaban|darexaban|mesh-list
110038409|NCT01424332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110038410|NCT01424332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110038411|NCT01424332|Analgesics|analgesics|mesh-ancestor
110038412|NCT01424332|Sensory System Agents|sensory system agents|mesh-ancestor
110038413|NCT01424332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110038414|NCT01424332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110038415|NCT01424332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110038416|NCT01424332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110038417|NCT01424332|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110038418|NCT01424332|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110038419|NCT01424332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110038420|NCT01424332|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110038421|NCT01424332|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110038422|NCT01424332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110038424|NCT01424332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110038425|NCT01424332|Antifungal Agents|antifungal agents|mesh-ancestor
110038426|NCT01424332|Keratolytic Agents|keratolytic agents|mesh-ancestor
110038427|NCT01424332|Dermatologic Agents|dermatologic agents|mesh-ancestor
110038428|NCT01424332|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110038429|NCT01424332|Antithrombins|antithrombins|mesh-ancestor
110038430|NCT01424332|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110038431|NCT01424332|Protease Inhibitors|protease inhibitors|mesh-ancestor
110038432|NCT01424332|Anticoagulants|anticoagulants|mesh-ancestor
110038433|NCT01424345|Immunosuppressive Agents|immunosuppressive agents|mesh-list
110038434|NCT01424345|Immunologic Factors|immunologic factors|mesh-ancestor
110038435|NCT01424345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110038437|NCT01424384|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110038438|NCT01424384|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110038439|NCT01424384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110038440|NCT01424384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110038441|NCT01424384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110038442|NCT01424384|Serotonin Agents|serotonin agents|mesh-ancestor
110038443|NCT01424384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110038444|NCT01424384|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110038445|NCT01424384|Antidepressive Agents|antidepressive agents|mesh-ancestor
110038446|NCT01424384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110038447|NCT01424449|Aripiprazole|aripiprazole|mesh-list
110038448|NCT01424449|Antidepressive Agents|antidepressive agents|mesh-ancestor
110038449|NCT01424449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110038452|NCT01424449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110038453|NCT01424449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110038454|NCT01424449|Dopamine Agonists|dopamine agonists|mesh-ancestor
110038455|NCT01424449|Dopamine Agents|dopamine agents|mesh-ancestor
110038456|NCT01424449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110038457|NCT01424449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110038458|NCT01424449|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110038459|NCT01424449|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110038461|NCT01424449|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110038462|NCT01424449|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110038463|NCT01424449|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110038464|NCT01424449|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110038465|NCT01424618|Leuprolide|leuprolide|mesh-list
110038466|NCT01424618|Ganirelix|ganirelix|mesh-list
110038467|NCT01424618|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110038468|NCT01424618|Fertility Agents|fertility agents|mesh-ancestor
110038469|NCT01424618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110038470|NCT01424618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110038471|NCT01424618|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110038472|NCT01424618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110038473|NCT01424618|Hormone Antagonists|hormone antagonists|mesh-ancestor
110038474|NCT01424618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110038475|NCT01424709|Cisplatin|cisplatin|mesh-list
110038476|NCT01424709|Gemcitabine|gemcitabine|mesh-list
110038477|NCT01424709|Docetaxel|docetaxel|mesh-list
110038478|NCT01424709|Irinotecan|irinotecan|mesh-list
110038479|NCT01424709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110038480|NCT01424709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110038481|NCT01424709|Antimetabolites|antimetabolites|mesh-ancestor
110038482|NCT01424709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110038483|NCT01424709|Tubulin Modulators|tubulin modulators|mesh-ancestor
110038484|NCT01424709|Antimitotic Agents|antimitotic agents|mesh-ancestor
110038485|NCT01424709|Mitosis Modulators|mitosis modulators|mesh-ancestor
110038486|NCT01424709|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110038487|NCT01424709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110038488|NCT01424709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110038489|NCT01424761|Ubiquinone|ubiquinone|mesh-list
110038490|NCT01424761|Coenzyme Q10|coenzyme q10|mesh-list
110038491|NCT01424761|Micronutrients|micronutrients|mesh-ancestor
110038492|NCT01424761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110038493|NCT01424761|Vitamins|vitamins|mesh-ancestor
110038494|NCT01424826|Raltegravir Potassium|raltegravir potassium|mesh-list
110038495|NCT01424826|Rifampin|rifampin|mesh-list
110038496|NCT01424826|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110038497|NCT01424826|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110038498|NCT01424826|Antiviral Agents|antiviral agents|mesh-ancestor
110038499|NCT01424826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110038500|NCT01424826|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110038501|NCT01424826|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110038502|NCT01424826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110038503|NCT01424826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110038504|NCT01424826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110038505|NCT01424826|Antitubercular Agents|antitubercular agents|mesh-ancestor
110038506|NCT01424826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110038509|NCT01424826|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110038510|NCT01424826|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110038511|NCT01424826|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110038512|NCT01424826|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110038513|NCT01424826|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110038514|NCT01424826|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110038515|NCT01424839|Cisplatin|cisplatin|mesh-list
110038516|NCT01424839|Carboplatin|carboplatin|mesh-list
110038517|NCT01424839|Etoposide|etoposide|mesh-list
110038518|NCT01424839|Etoposide phosphate|etoposide phosphate|mesh-list
110038519|NCT01424839|Ifosfamide|ifosfamide|mesh-list
110038520|NCT01424839|Isophosphamide mustard|isophosphamide mustard|mesh-list
110038521|NCT01424839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110038522|NCT01424839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110038523|NCT01424839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110038524|NCT01424839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110038525|NCT01424839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110038526|NCT01424839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110038527|NCT01424839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110038528|NCT01424839|Alkylating Agents|alkylating agents|mesh-ancestor
110038529|NCT01424891|Simvastatin|simvastatin|mesh-list
110038530|NCT01424891|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110038531|NCT01424891|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110038532|NCT01424891|Antimetabolites|antimetabolites|mesh-ancestor
110038533|NCT01424891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110038534|NCT01424891|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110038535|NCT01424891|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110038536|NCT01424891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110038537|NCT01425060|Contraceptive Agents|contraceptive agents|mesh-list
110038538|NCT01425060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110038539|NCT01425060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110038540|NCT01425073|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110038541|NCT01425073|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110038542|NCT01425073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110038543|NCT01425073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110038544|NCT01425073|Antimalarials|antimalarials|mesh-ancestor
110038545|NCT01425073|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110038546|NCT01425073|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110038547|NCT01425099|Dolutegravir|dolutegravir|mesh-list
110038548|NCT01425099|Prednisone|prednisone|mesh-list
110038549|NCT01425099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110038550|NCT01425099|Glucocorticoids|glucocorticoids|mesh-ancestor
110038551|NCT01425099|Hormones|hormones|mesh-ancestor
110038552|NCT01425099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110038553|NCT01425099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110038554|NCT01425099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110038555|NCT01425099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110038556|NCT01425099|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110038557|NCT01425099|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110038558|NCT01425099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110038559|NCT01425099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110038560|NCT01425099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110038561|NCT01425099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110038562|NCT01425099|Antiviral Agents|antiviral agents|mesh-ancestor
110038563|NCT01425099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110038564|NCT01425125|Tolvaptan|tolvaptan|mesh-list
110038565|NCT01425125|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110038566|NCT01425125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110038567|NCT01425125|Natriuretic Agents|natriuretic agents|mesh-ancestor
110038568|NCT01425125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110038569|NCT01425164|Carvedilol|carvedilol|mesh-list
110038570|NCT01425164|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110038571|NCT01425164|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110038572|NCT01425164|Adrenergic Agents|adrenergic agents|mesh-ancestor
110038573|NCT01425164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110038574|NCT01425164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110038575|NCT01425164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110038576|NCT01425164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110038577|NCT01425164|Antioxidants|antioxidants|mesh-ancestor
110038578|NCT01425164|Protective Agents|protective agents|mesh-ancestor
110038579|NCT01425164|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110038580|NCT01425164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110038581|NCT01425164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110038582|NCT01425164|Vasodilator Agents|vasodilator agents|mesh-ancestor
110038583|NCT01425164|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110038584|NCT01425164|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110038586|NCT01425216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110038587|NCT01425216|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110038588|NCT01425216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110038589|NCT01425216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110038592|NCT01425242|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110038593|NCT01425242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110038594|NCT01425242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110038595|NCT01425242|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110038596|NCT01425242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110038597|NCT01425242|Vasodilator Agents|vasodilator agents|mesh-ancestor
110038599|NCT01425320|Adapalene|adapalene|mesh-list
110038600|NCT01425320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110038601|NCT01425320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110038602|NCT01425320|Analgesics|analgesics|mesh-ancestor
110038603|NCT01425320|Sensory System Agents|sensory system agents|mesh-ancestor
110038604|NCT01425320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110038605|NCT01425320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110038606|NCT01425320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110038607|NCT01425320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110038608|NCT01425320|Dermatologic Agents|dermatologic agents|mesh-ancestor
110038609|NCT01425320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110038610|NCT01425320|Antimalarials|antimalarials|mesh-ancestor
110038611|NCT01425320|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110038612|NCT01425320|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110038613|NCT01425320|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110038614|NCT01425320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110038615|NCT01425320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110038616|NCT01425320|Leprostatic Agents|leprostatic agents|mesh-ancestor
110038617|NCT01425320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110038618|NCT01425398|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110038619|NCT01425398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110038620|NCT01425398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110038621|NCT01425398|Antimetabolites|antimetabolites|mesh-ancestor
110038622|NCT01425398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110038623|NCT01425398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110038624|NCT01425398|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110038625|NCT01425398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110038626|NCT01425411|Valsartan|valsartan|mesh-list
110038628|NCT01425411|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110038629|NCT01425411|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110038630|NCT01425411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110038631|NCT01425424|Vitamin D|vitamin d|mesh-list
110038632|NCT01425424|Ergocalciferols|ergocalciferols|mesh-list
110038633|NCT01425424|Cholecalciferol|cholecalciferol|mesh-list
110038634|NCT01425424|Vitamins|vitamins|mesh-list
110038635|NCT01425424|Micronutrients|micronutrients|mesh-ancestor
110038636|NCT01425424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110038637|NCT01425424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110038638|NCT01425424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110038639|NCT01425476|Vitamin D|vitamin d|mesh-list
110038640|NCT01425476|Cholecalciferol|cholecalciferol|mesh-list
110038641|NCT01425476|Celecoxib|celecoxib|mesh-list
110038642|NCT01425476|Vitamins|vitamins|mesh-ancestor
110038643|NCT01425476|Micronutrients|micronutrients|mesh-ancestor
110038644|NCT01425476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110038645|NCT01425476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110038646|NCT01425476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110038647|NCT01425476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110038648|NCT01425476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110038649|NCT01425476|Analgesics|analgesics|mesh-ancestor
110038650|NCT01425476|Sensory System Agents|sensory system agents|mesh-ancestor
110038651|NCT01425476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110038652|NCT01425476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110038653|NCT01425476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110038733|NCT05386446|Interferons|interferons|mesh-list
110038654|NCT01425476|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110038655|NCT01425476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110038656|NCT01425476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110038657|NCT01425476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110038658|NCT01425567|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
110038659|NCT01425567|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110038660|NCT01425567|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110038661|NCT01425580|Metformin|metformin|mesh-list
110038662|NCT01425580|Liraglutide|liraglutide|mesh-list
110038663|NCT01425580|Glimepiride|glimepiride|mesh-list
110038664|NCT01425580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110038665|NCT01425580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110038666|NCT01425580|Incretins|incretins|mesh-ancestor
110038667|NCT01425580|Hormones|hormones|mesh-ancestor
110038668|NCT01425580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110038669|NCT01425580|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110038670|NCT01425580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110038671|NCT01425580|Immunologic Factors|immunologic factors|mesh-ancestor
110038673|NCT01425619|Prilocaine|prilocaine|mesh-list
110038674|NCT01425619|Anesthetics, Local|anesthetics, local|mesh-ancestor
110038675|NCT01425619|Anesthetics|anesthetics|mesh-ancestor
110038676|NCT01425619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110038677|NCT01425619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110038678|NCT01425619|Sensory System Agents|sensory system agents|mesh-ancestor
110038679|NCT01425619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110038680|NCT01425619|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110038681|NCT01425619|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110038682|NCT01425619|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110038683|NCT01425619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110038684|NCT01425619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110038685|NCT01425658|Clonidine|clonidine|mesh-list
110038686|NCT01425658|Fentanyl|fentanyl|mesh-list
110038687|NCT01425658|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110038688|NCT01425658|Narcotics|narcotics|mesh-ancestor
110038689|NCT01425658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110038690|NCT01425658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110038691|NCT01425658|Analgesics|analgesics|mesh-ancestor
110038692|NCT01425658|Sensory System Agents|sensory system agents|mesh-ancestor
110038693|NCT01425658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110038694|NCT01425658|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110038695|NCT01425658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110038696|NCT01425658|Anesthetics, General|anesthetics, general|mesh-ancestor
110038697|NCT01425658|Anesthetics|anesthetics|mesh-ancestor
110038698|NCT01425658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110038699|NCT01425658|Sympatholytics|sympatholytics|mesh-ancestor
110038700|NCT01425658|Autonomic Agents|autonomic agents|mesh-ancestor
110038701|NCT01425658|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110038702|NCT01425658|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110038703|NCT01425658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110038704|NCT01425658|Adrenergic Agents|adrenergic agents|mesh-ancestor
110038705|NCT01425658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110038706|NCT01425658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110038707|NCT01425697|Chlorhexidine|chlorhexidine|mesh-list
110038709|NCT01425697|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110038710|NCT01425697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110038711|NCT01425697|Disinfectants|disinfectants|mesh-ancestor
110038712|NCT01425697|Dermatologic Agents|dermatologic agents|mesh-ancestor
110038713|NCT01425736|Cisplatin|cisplatin|mesh-list
110038714|NCT01425736|Docetaxel|docetaxel|mesh-list
110038715|NCT01425736|Fluorouracil|fluorouracil|mesh-list
110038716|NCT01425736|Nimotuzumab|nimotuzumab|mesh-list
110038717|NCT01425736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110038718|NCT01425736|Tubulin Modulators|tubulin modulators|mesh-ancestor
110038719|NCT01425736|Antimitotic Agents|antimitotic agents|mesh-ancestor
110038720|NCT01425736|Mitosis Modulators|mitosis modulators|mesh-ancestor
110038721|NCT01425736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110038723|NCT01425736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110038724|NCT01425736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110038725|NCT01425736|Immunologic Factors|immunologic factors|mesh-ancestor
110038726|NCT01425736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110038727|NCT01425736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110038728|NCT01425775|Vitamin D|vitamin d|mesh-list
110038729|NCT01425775|Vitamins|vitamins|mesh-ancestor
110038730|NCT01425775|Micronutrients|micronutrients|mesh-ancestor
110038731|NCT01425775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110038732|NCT01425775|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110038738|NCT05386433|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
110038739|NCT05386433|Antiviral Agents|antiviral agents|mesh-ancestor
110038740|NCT05386433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110038741|NCT05386290|Infliximab|infliximab|mesh-list
110038742|NCT05386290|Mesalamine|mesalamine|mesh-list
110038743|NCT05386290|Ustekinumab|ustekinumab|mesh-list
110038744|NCT05386290|Vedolizumab|vedolizumab|mesh-list
110038745|NCT05386290|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110038746|NCT05386290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110038747|NCT05386290|Dermatologic Agents|dermatologic agents|mesh-ancestor
110038748|NCT05386290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110038749|NCT05386290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110038750|NCT05386290|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110038751|NCT05386290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110038752|NCT05386290|Analgesics|analgesics|mesh-ancestor
110038753|NCT05386290|Sensory System Agents|sensory system agents|mesh-ancestor
110038754|NCT05386290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110038755|NCT05386290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110038756|NCT05386186|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110038757|NCT05386186|Glimepiride|glimepiride|mesh-list
110038758|NCT05386186|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
110038759|NCT05386186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110038760|NCT05386186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110038761|NCT05386186|Incretins|incretins|mesh-ancestor
110038762|NCT05386186|Hormones|hormones|mesh-ancestor
110038763|NCT05386186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110038764|NCT05386186|Protease Inhibitors|protease inhibitors|mesh-ancestor
110038765|NCT05386186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110038766|NCT05386186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110038767|NCT05386186|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110038768|NCT05386186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110038769|NCT05386186|Immunologic Factors|immunologic factors|mesh-ancestor
110038770|NCT05386160|Ranibizumab|ranibizumab|mesh-list
110038771|NCT05386160|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110038772|NCT05386160|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110038774|NCT05386160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110038775|NCT05386160|Growth Inhibitors|growth inhibitors|mesh-ancestor
110038776|NCT05386160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110038777|NCT05386121|Fentanyl|fentanyl|mesh-list
110038778|NCT05386121|Meperidine|meperidine|mesh-list
110038779|NCT05386121|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110038780|NCT05386121|Narcotics|narcotics|mesh-ancestor
110038781|NCT05386121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110038782|NCT05386121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110038783|NCT05386121|Analgesics|analgesics|mesh-ancestor
110038784|NCT05386121|Sensory System Agents|sensory system agents|mesh-ancestor
110038785|NCT05386121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110038786|NCT05386121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110038787|NCT05386121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110038788|NCT05386121|Anesthetics, General|anesthetics, general|mesh-ancestor
110038789|NCT05386121|Anesthetics|anesthetics|mesh-ancestor
110038790|NCT05386056|Pembrolizumab|pembrolizumab|mesh-list
110038791|NCT05386056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110038792|NCT05386056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110038793|NCT05386056|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110054818|NCT01494402|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110038796|NCT05385900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110038797|NCT05385887|Metronidazole|metronidazole|mesh-list
110038798|NCT05385887|Ciprofloxacin|ciprofloxacin|mesh-list
110038799|NCT05385887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110038800|NCT05385887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110038801|NCT05385887|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110038802|NCT05385887|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110038803|NCT05385887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110038804|NCT05385887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110038805|NCT05385887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110038806|NCT05385887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110038807|NCT05385887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110038808|NCT05385887|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110038809|NCT05385887|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110038810|NCT05385861|Carboplatin|carboplatin|mesh-list
110038813|NCT05385861|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110038814|NCT05385861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110038815|NCT05385861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110038816|NCT05385861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110038817|NCT05385744|Teriflunomide|teriflunomide|mesh-list
110038818|NCT05385744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110038819|NCT05385744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110038820|NCT05385744|Analgesics|analgesics|mesh-ancestor
110038821|NCT05385744|Sensory System Agents|sensory system agents|mesh-ancestor
110038822|NCT05385744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110038823|NCT05385744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110038824|NCT05385744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110038825|NCT05385744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110038826|NCT05385744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110038827|NCT05385744|Immunologic Factors|immunologic factors|mesh-ancestor
110038828|NCT05385185|Endostatins|endostatins|mesh-list
110038829|NCT05385185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110038830|NCT05385185|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110038831|NCT05385185|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110038832|NCT05385185|Growth Substances|growth substances|mesh-ancestor
110038833|NCT05385185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110038834|NCT05385185|Growth Inhibitors|growth inhibitors|mesh-ancestor
110038835|NCT05385094|Cystatins|cystatins|mesh-list
110038836|NCT05385094|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
110038837|NCT05385094|Protease Inhibitors|protease inhibitors|mesh-ancestor
110038838|NCT05385094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110038839|NCT05385094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110038841|NCT05385068|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110038842|NCT05385068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110038843|NCT05385068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110038844|NCT05385068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110038847|NCT05385029|Hormone Antagonists|hormone antagonists|mesh-ancestor
110038848|NCT05385029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110038849|NCT05385029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110038850|NCT05379413|Botulinum Toxins|botulinum toxins|mesh-list
110038851|NCT05379413|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110038852|NCT05379413|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110038853|NCT05379413|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110038854|NCT05379413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110038855|NCT05379413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110038856|NCT05379413|Cholinergic Agents|cholinergic agents|mesh-ancestor
110038857|NCT05379413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110038858|NCT05379413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110038859|NCT05379413|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110038860|NCT05379413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110038862|NCT05379374|Bupivacaine|bupivacaine|mesh-list
110038863|NCT05379374|Anesthetics, Local|anesthetics, local|mesh-ancestor
110038864|NCT05379374|Anesthetics|anesthetics|mesh-ancestor
110038865|NCT05379374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110038866|NCT05379374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110038867|NCT05379374|Sensory System Agents|sensory system agents|mesh-ancestor
110038868|NCT05379374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110038869|NCT05379374|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110038870|NCT05379374|Narcotics|narcotics|mesh-ancestor
110038871|NCT05379374|Analgesics|analgesics|mesh-ancestor
110038872|NCT05375708|Bevacizumab|bevacizumab|mesh-list
110038873|NCT05375708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110038874|NCT05375708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110038875|NCT05375708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110038876|NCT05375708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110038877|NCT05375708|Growth Substances|growth substances|mesh-ancestor
110038878|NCT05375708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110038879|NCT05375708|Growth Inhibitors|growth inhibitors|mesh-ancestor
110038880|NCT05176379|Fluconazole|fluconazole|mesh-list
110038881|NCT05176379|Antifungal Agents|antifungal agents|mesh-ancestor
110038882|NCT05176379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110038883|NCT05176379|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110038884|NCT05176379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110038885|NCT05176379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110039121|NCT03142035|Contraceptive Agents|contraceptive agents|mesh-ancestor
110038886|NCT05176379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110038887|NCT05176379|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110038888|NCT05176379|Hormone Antagonists|hormone antagonists|mesh-ancestor
110038889|NCT05176379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110038890|NCT05176379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110038891|NCT05176379|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110038892|NCT05176379|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110038893|NCT05113615|Bromides|bromides|mesh-list
110038894|NCT05113615|Tiotropium Bromide|tiotropium bromide|mesh-list
110038895|NCT05113615|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110038896|NCT05113615|Autonomic Agents|autonomic agents|mesh-ancestor
110038897|NCT05113615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110038898|NCT05113615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110038899|NCT05113615|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110038900|NCT05113615|Respiratory System Agents|respiratory system agents|mesh-ancestor
110038901|NCT05113615|Parasympatholytics|parasympatholytics|mesh-ancestor
110038902|NCT05113615|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110038903|NCT05113615|Cholinergic Agents|cholinergic agents|mesh-ancestor
110038904|NCT05113615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110038905|NCT05113615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110038906|NCT05113615|Anticonvulsants|anticonvulsants|mesh-ancestor
110038907|NCT04850378|Dalteparin|dalteparin|mesh-list
110038908|NCT04850378|Tinzaparin|tinzaparin|mesh-list
110038909|NCT04850378|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110038910|NCT04850378|Apixaban|apixaban|mesh-list
110038911|NCT04850378|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110038912|NCT04850378|Antithrombins|antithrombins|mesh-ancestor
110038913|NCT04850378|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110038915|NCT04850378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110038916|NCT04850378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110038917|NCT04850378|Anticoagulants|anticoagulants|mesh-ancestor
110038918|NCT04850378|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110038919|NCT04850378|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110038920|NCT04809103|Cisplatin|cisplatin|mesh-list
110038921|NCT04809103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110038922|NCT04804371|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110038923|NCT04804371|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110038924|NCT04804371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110038925|NCT04765371|Dexamethasone|dexamethasone|mesh-list
110038926|NCT04765371|Dexamethasone acetate|dexamethasone acetate|mesh-list
110038927|NCT04765371|Prednisolone|prednisolone|mesh-list
110038928|NCT04765371|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110038929|NCT04765371|Methylprednisolone|methylprednisolone|mesh-list
110038930|NCT04765371|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110038931|NCT04765371|Prednisolone acetate|prednisolone acetate|mesh-list
110038932|NCT04765371|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110038933|NCT04765371|Prednisolone phosphate|prednisolone phosphate|mesh-list
110038934|NCT04765371|BB 1101|bb 1101|mesh-list
110038935|NCT04765371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110038936|NCT04765371|Antiemetics|antiemetics|mesh-ancestor
110038937|NCT04765371|Autonomic Agents|autonomic agents|mesh-ancestor
110038938|NCT04765371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110038939|NCT04765371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110038940|NCT04765371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110038941|NCT04765371|Glucocorticoids|glucocorticoids|mesh-ancestor
110038942|NCT04765371|Hormones|hormones|mesh-ancestor
110038943|NCT04765371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110038944|NCT04765371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110038945|NCT04765371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110038946|NCT04765371|Protease Inhibitors|protease inhibitors|mesh-ancestor
110038947|NCT04765371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110038948|NCT04765371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110038949|NCT04765371|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110038950|NCT04765371|Protective Agents|protective agents|mesh-ancestor
110038951|NCT04744363|Ustekinumab|ustekinumab|mesh-list
110038952|NCT04744363|Dermatologic Agents|dermatologic agents|mesh-ancestor
110038953|NCT04673162|Methylprednisolone|methylprednisolone|mesh-list
110038954|NCT04673162|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110038955|NCT04673162|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110038956|NCT04673162|Prednisolone|prednisolone|mesh-list
110038957|NCT04673162|Prednisolone acetate|prednisolone acetate|mesh-list
110038958|NCT04673162|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110038959|NCT04673162|Prednisolone phosphate|prednisolone phosphate|mesh-list
110038960|NCT04673162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110038961|NCT04673162|Antiemetics|antiemetics|mesh-ancestor
110038962|NCT04673162|Autonomic Agents|autonomic agents|mesh-ancestor
110038963|NCT04673162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110038964|NCT04673162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110038965|NCT04673162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110038966|NCT04673162|Glucocorticoids|glucocorticoids|mesh-ancestor
110038967|NCT04673162|Hormones|hormones|mesh-ancestor
110038968|NCT04673162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110038969|NCT04673162|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110038970|NCT04673162|Protective Agents|protective agents|mesh-ancestor
110038971|NCT04673162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110038972|NCT04673162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110038973|NCT04622020|Anesthetics|anesthetics|mesh-list
110038974|NCT04622020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110038975|NCT04622020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110038976|NCT04560556|Antibodies|antibodies|mesh-list
110038977|NCT04560556|Immunologic Factors|immunologic factors|mesh-ancestor
110038978|NCT04560556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110038979|NCT04425902|Flurbiprofen|flurbiprofen|mesh-list
110038980|NCT04425902|Metoprolol|metoprolol|mesh-list
110038981|NCT04425902|Digoxin|digoxin|mesh-list
110038982|NCT04425902|Midazolam|midazolam|mesh-list
110038983|NCT04425902|Caffeine|caffeine|mesh-list
110038985|NCT04425902|Pravastatin|pravastatin|mesh-list
110038986|NCT04425902|Montelukast|montelukast|mesh-list
110038987|NCT04425902|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110038988|NCT04425902|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110038989|NCT04425902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110038990|NCT04425902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110038991|NCT04425902|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110038992|NCT04425902|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110038993|NCT04425902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110038994|NCT04425902|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110038995|NCT04425902|Anesthetics, General|anesthetics, general|mesh-ancestor
110038996|NCT04425902|Anesthetics|anesthetics|mesh-ancestor
110038997|NCT04425902|GABA Modulators|gaba modulators|mesh-ancestor
110038998|NCT04425902|GABA Agents|gaba agents|mesh-ancestor
110038999|NCT04425902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110039000|NCT04425902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110039001|NCT04425902|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110039002|NCT04425902|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110039003|NCT04425902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110039004|NCT04425902|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110039005|NCT04425902|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110039006|NCT04425902|Purinergic Agents|purinergic agents|mesh-ancestor
110039007|NCT04425902|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110039008|NCT04425902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110039009|NCT04425902|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110039010|NCT04425902|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110039011|NCT04425902|Respiratory System Agents|respiratory system agents|mesh-ancestor
110039012|NCT04425902|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110039013|NCT04425902|Hormone Antagonists|hormone antagonists|mesh-ancestor
110039014|NCT04425902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110039015|NCT04425902|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110039016|NCT04425902|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110039017|NCT04425902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110039018|NCT04425902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110039019|NCT04425902|Sympatholytics|sympatholytics|mesh-ancestor
110039020|NCT04425902|Autonomic Agents|autonomic agents|mesh-ancestor
110039021|NCT04425902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110039022|NCT04425902|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110039023|NCT04425902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110039024|NCT04425902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110039025|NCT04425902|Adrenergic Agents|adrenergic agents|mesh-ancestor
110039026|NCT04425902|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110039028|NCT04425902|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110039029|NCT04425902|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110039030|NCT04425902|Antimetabolites|antimetabolites|mesh-ancestor
110039031|NCT04425902|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110039032|NCT04425902|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110039034|NCT04425902|Sensory System Agents|sensory system agents|mesh-ancestor
110039035|NCT04425902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110039036|NCT04425902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110039039|NCT04425902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110039041|NCT04421677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110039043|NCT04311762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110039044|NCT04203472|Budesonide|budesonide|mesh-list
110039046|NCT04203472|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110039047|NCT04203472|Autonomic Agents|autonomic agents|mesh-ancestor
110039048|NCT04203472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110039049|NCT04203472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039050|NCT04203472|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110039051|NCT04203472|Respiratory System Agents|respiratory system agents|mesh-ancestor
110039052|NCT04203472|Glucocorticoids|glucocorticoids|mesh-ancestor
110039053|NCT04203472|Hormones|hormones|mesh-ancestor
110039054|NCT04203472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110039055|NCT04072146|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110039056|NCT04072146|Varenicline|varenicline|mesh-list
110039057|NCT04072146|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110039058|NCT04072146|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110039059|NCT04072146|Cholinergic Agents|cholinergic agents|mesh-ancestor
110039060|NCT04072146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110039061|NCT04072146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110039062|NCT04072146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039063|NCT03945084|Niraparib|niraparib|mesh-list
110039064|NCT03945084|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110039065|NCT03945084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110039066|NCT03945084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110039067|NCT03945084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110039068|NCT03882463|Insulin|insulin|mesh-list
110039069|NCT03882463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110039070|NCT03882463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039071|NCT03861481|Rozanolixizumab|rozanolixizumab|mesh-list
110039072|NCT03861481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110039073|NCT03861481|Immunologic Factors|immunologic factors|mesh-ancestor
110039074|NCT03861481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039075|NCT03821649|Naloxone|naloxone|mesh-list
110039076|NCT03821649|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110039077|NCT03821649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039078|NCT03821649|Sensory System Agents|sensory system agents|mesh-ancestor
110039079|NCT03821649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110039080|NCT03811262|Levobupivacaine|levobupivacaine|mesh-list
110039081|NCT03811262|Anesthetics, Local|anesthetics, local|mesh-ancestor
110039082|NCT03811262|Anesthetics|anesthetics|mesh-ancestor
110039083|NCT03811262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110039084|NCT03811262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039085|NCT03811262|Sensory System Agents|sensory system agents|mesh-ancestor
110039086|NCT03811262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110039088|NCT03734211|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110039089|NCT03734211|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110039090|NCT03734211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110039091|NCT03734211|Antimetabolites|antimetabolites|mesh-ancestor
110039092|NCT03734211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110039093|NCT03734211|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110039094|NCT03734211|Protease Inhibitors|protease inhibitors|mesh-ancestor
110039095|NCT03734211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110039096|NCT03734211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110039097|NCT03730974|Snake venom protein C activator|snake venom protein c activator|mesh-list
110039098|NCT03730974|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110039099|NCT03730974|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110039100|NCT03730974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110039101|NCT03708198|Bupivacaine|bupivacaine|mesh-list
110039102|NCT03708198|Anesthetics, Local|anesthetics, local|mesh-ancestor
110039103|NCT03708198|Anesthetics|anesthetics|mesh-ancestor
110039104|NCT03708198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110039105|NCT03708198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039106|NCT03708198|Sensory System Agents|sensory system agents|mesh-ancestor
110039107|NCT03708198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110039108|NCT03559426|Antipsychotic Agents|antipsychotic agents|mesh-list
110039109|NCT03559426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110039110|NCT03559426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110039112|NCT03559426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110039114|NCT03444753|Ipilimumab|ipilimumab|mesh-list
110039115|NCT03444753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110039116|NCT03444753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110039117|NCT03444753|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110039118|NCT03444753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110039119|NCT03142035|Dienogest|dienogest|mesh-list
110039120|NCT03142035|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110039122|NCT03142035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110039123|NCT03142035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039124|NCT03142035|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110039125|NCT03142035|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110039126|NCT03142035|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110039127|NCT03142035|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110039128|NCT03142035|Hormone Antagonists|hormone antagonists|mesh-ancestor
110039129|NCT03142035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110039130|NCT03142035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110039131|NCT03142035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110039132|NCT02786875|Vitamin D|vitamin d|mesh-list
110039133|NCT02786875|Ergocalciferols|ergocalciferols|mesh-list
110039134|NCT02786875|Cholecalciferol|cholecalciferol|mesh-list
110039135|NCT02786875|Vitamins|vitamins|mesh-list
110039136|NCT02786875|Micronutrients|micronutrients|mesh-ancestor
110039137|NCT02786875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039138|NCT02786875|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110039139|NCT02786875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110039140|NCT02767882|Dexamethasone|dexamethasone|mesh-list
110039141|NCT02767882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110039142|NCT02767882|Antiemetics|antiemetics|mesh-ancestor
110039143|NCT02767882|Autonomic Agents|autonomic agents|mesh-ancestor
110039144|NCT02767882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110039145|NCT02767882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039146|NCT02767882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110039147|NCT02767882|Glucocorticoids|glucocorticoids|mesh-ancestor
110039149|NCT02767882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110039150|NCT02767882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110039151|NCT02767882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110039152|NCT02246257|Metformin|metformin|mesh-list
110039153|NCT02246257|Losartan|losartan|mesh-list
110039154|NCT02246257|Simvastatin|simvastatin|mesh-list
110039155|NCT02246257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110039156|NCT02246257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039157|NCT02246257|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110039158|NCT02246257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110039159|NCT02246257|Antimetabolites|antimetabolites|mesh-ancestor
110039160|NCT02246257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110039161|NCT02246257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110039162|NCT02246257|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110039163|NCT02246257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110039164|NCT02246257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110039165|NCT02246257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110039166|NCT02246257|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110039167|NCT02246257|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110039168|NCT02197221|Bortezomib|bortezomib|mesh-list
110039169|NCT02197221|Melphalan|melphalan|mesh-list
110039170|NCT02197221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110039171|NCT02197221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110039172|NCT02197221|Alkylating Agents|alkylating agents|mesh-ancestor
110039173|NCT02197221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110039174|NCT02197221|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110039175|NCT02197221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110039176|NCT02197221|Immunologic Factors|immunologic factors|mesh-ancestor
110039177|NCT02197221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039178|NCT02010385|Octreotide|octreotide|mesh-list
110039179|NCT02010385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110039180|NCT02010385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110039181|NCT02010385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110039182|NCT01949714|Epinephrine|epinephrine|mesh-list
110039183|NCT01949714|Racepinephrine|racepinephrine|mesh-list
110039184|NCT01949714|Epinephryl borate|epinephryl borate|mesh-list
110039185|NCT01949714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110039186|NCT01949714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110039187|NCT01949714|Adrenergic Agents|adrenergic agents|mesh-ancestor
110039189|NCT01949714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110039190|NCT01949714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039191|NCT01949714|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110039192|NCT01949714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110039193|NCT01949714|Autonomic Agents|autonomic agents|mesh-ancestor
110039194|NCT01949714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110039195|NCT01949714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110039196|NCT01949714|Respiratory System Agents|respiratory system agents|mesh-ancestor
110039197|NCT01949714|Mydriatics|mydriatics|mesh-ancestor
110039198|NCT01949714|Sympathomimetics|sympathomimetics|mesh-ancestor
110039199|NCT01949714|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110039200|NCT00223145|Goserelin|goserelin|mesh-list
110039201|NCT00223145|Bicalutamide|bicalutamide|mesh-list
110039202|NCT00223145|Androgens|androgens|mesh-list
110039203|NCT00223145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110039204|NCT00223145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110039205|NCT00223145|Hormones|hormones|mesh-ancestor
110039206|NCT00223145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110039207|NCT00223145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039208|NCT00223145|Androgen Antagonists|androgen antagonists|mesh-ancestor
110039209|NCT00223145|Hormone Antagonists|hormone antagonists|mesh-ancestor
110039211|NCT01425827|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110039212|NCT01425827|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110039213|NCT01425827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110039214|NCT01425827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110039216|NCT01425827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039217|NCT01425827|Analgesics|analgesics|mesh-ancestor
110039218|NCT01425827|Sensory System Agents|sensory system agents|mesh-ancestor
110039219|NCT01425827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110039220|NCT01425827|Antidepressive Agents|antidepressive agents|mesh-ancestor
110039221|NCT01425827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110039222|NCT01425827|Dopamine Agents|dopamine agents|mesh-ancestor
110039223|NCT01425840|Lidocaine|lidocaine|mesh-list
110039224|NCT01425840|Anesthetics, Local|anesthetics, local|mesh-ancestor
110039225|NCT01425840|Anesthetics|anesthetics|mesh-ancestor
110039226|NCT01425840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110039227|NCT01425840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039228|NCT01425840|Sensory System Agents|sensory system agents|mesh-ancestor
110039229|NCT01425840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110039230|NCT01425840|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110039231|NCT01425840|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110039232|NCT01425840|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110039233|NCT01425840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110039234|NCT01425840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110039235|NCT01425996|Camptothecin|camptothecin|mesh-list
110039236|NCT01425996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110039237|NCT01425996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110039238|NCT01425996|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110039239|NCT01425996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110039240|NCT01425996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110039241|NCT01425996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110039242|NCT01426022|Ethanol|ethanol|mesh-list
110039243|NCT01426022|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110039244|NCT01426022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110039245|NCT01426022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110039246|NCT01426022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039247|NCT01426074|Bevacizumab|bevacizumab|mesh-list
110039248|NCT01426074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110039249|NCT01426074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110039250|NCT01426074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110039251|NCT01426074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110039252|NCT01426074|Growth Substances|growth substances|mesh-ancestor
110039253|NCT01426074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039254|NCT01426074|Growth Inhibitors|growth inhibitors|mesh-ancestor
110039255|NCT01426087|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110039256|NCT01426087|Somatostatin|somatostatin|mesh-list
110039257|NCT01426087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110039258|NCT01426087|Hormones|hormones|mesh-ancestor
110039259|NCT01426087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110039260|NCT01426087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039261|NCT01426100|Telmisartan|telmisartan|mesh-list
110039262|NCT01426100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110039263|NCT01426100|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110039264|NCT01426100|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110039265|NCT01426100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110039266|NCT01426126|genexol-PM|genexol-pm|mesh-list
110039267|NCT01426126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110039268|NCT01426126|Tubulin Modulators|tubulin modulators|mesh-ancestor
110039269|NCT01426126|Antimitotic Agents|antimitotic agents|mesh-ancestor
110039272|NCT01426165|Magnesium Sulfate|magnesium sulfate|mesh-list
110039273|NCT01426165|Analgesics|analgesics|mesh-ancestor
110039274|NCT01426165|Sensory System Agents|sensory system agents|mesh-ancestor
110039275|NCT01426165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110039276|NCT01426165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039277|NCT01426165|Anesthetics|anesthetics|mesh-ancestor
110039278|NCT01426165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110039279|NCT01426165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110039280|NCT01426165|Anticonvulsants|anticonvulsants|mesh-ancestor
110039281|NCT01426165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110039282|NCT01426165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110039283|NCT01426165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110039284|NCT01426165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110039285|NCT01426165|Tocolytic Agents|tocolytic agents|mesh-ancestor
110039286|NCT01426165|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110039287|NCT01426256|Vitamin D|vitamin d|mesh-list
110039288|NCT01426256|Cholecalciferol|cholecalciferol|mesh-list
110039289|NCT01426256|Vitamins|vitamins|mesh-ancestor
110039290|NCT01426256|Micronutrients|micronutrients|mesh-ancestor
110039291|NCT01426256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039292|NCT01426256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110039293|NCT01426256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110039294|NCT01426334|Cyclosporine|cyclosporine|mesh-list
110039295|NCT01426334|Dasatinib|dasatinib|mesh-list
110039296|NCT01426334|Cyclosporins|cyclosporins|mesh-list
110039297|NCT01426334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110039298|NCT01426334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110039299|NCT01426334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110039300|NCT01426334|Immunologic Factors|immunologic factors|mesh-ancestor
110039301|NCT01426334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039302|NCT01426334|Antifungal Agents|antifungal agents|mesh-ancestor
110039303|NCT01426334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110039304|NCT01426334|Dermatologic Agents|dermatologic agents|mesh-ancestor
110039305|NCT01426334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110039306|NCT01426334|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110039307|NCT01426334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110039308|NCT01426334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110039310|NCT01426399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110039311|NCT01426399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039312|NCT01426464|Latanoprost|latanoprost|mesh-list
110039313|NCT01426464|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110039314|NCT01426464|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110039315|NCT01426490|Vitamins|vitamins|mesh-list
110039316|NCT01426490|Ascorbic Acid|ascorbic acid|mesh-list
110039317|NCT01426490|Folic Acid|folic acid|mesh-list
110039318|NCT01426490|Pyridoxine|pyridoxine|mesh-list
110039319|NCT01426490|Pyridoxal|pyridoxal|mesh-list
110039320|NCT01426490|Vitamin B 6|vitamin b 6|mesh-list
110039322|NCT01426490|Micronutrients|micronutrients|mesh-ancestor
110039323|NCT01426490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039324|NCT01426490|Antioxidants|antioxidants|mesh-ancestor
110039325|NCT01426490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110039326|NCT01426490|Protective Agents|protective agents|mesh-ancestor
110039327|NCT01426490|Hematinics|hematinics|mesh-ancestor
110039328|NCT01426542|Topiramate|topiramate|mesh-list
110039329|NCT01426542|Anticonvulsants|anticonvulsants|mesh-ancestor
110039330|NCT01426542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110039331|NCT01426542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039332|NCT01426633|Gemcitabine|gemcitabine|mesh-list
110039333|NCT01426633|Trabectedin|trabectedin|mesh-list
110039334|NCT01426633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110039335|NCT01426633|Antimetabolites|antimetabolites|mesh-ancestor
110039336|NCT01426633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110039337|NCT01426633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110039338|NCT01426633|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110039340|NCT01426646|Cisplatin|cisplatin|mesh-list
110039341|NCT01426646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110039342|NCT01426737|Vildagliptin|vildagliptin|mesh-list
110039344|NCT01426737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039345|NCT01426737|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110039346|NCT01426737|Protease Inhibitors|protease inhibitors|mesh-ancestor
110039347|NCT01426737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110039348|NCT01426737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110039349|NCT01426802|Vildagliptin|vildagliptin|mesh-list
110039350|NCT01426802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110039351|NCT01426802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039352|NCT01426802|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110039353|NCT01426802|Protease Inhibitors|protease inhibitors|mesh-ancestor
110039354|NCT01426802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110039424|NCT01426984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110039357|NCT01426815|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110039358|NCT01426815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110039359|NCT01426815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110039360|NCT01426815|Immunologic Factors|immunologic factors|mesh-ancestor
110039361|NCT01426815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039363|NCT01426880|Carboplatin|carboplatin|mesh-list
110039364|NCT01426880|Lapatinib|lapatinib|mesh-list
110039365|NCT01426880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110039366|NCT01426880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110039367|NCT01426880|Tubulin Modulators|tubulin modulators|mesh-ancestor
110039368|NCT01426880|Antimitotic Agents|antimitotic agents|mesh-ancestor
110039369|NCT01426880|Mitosis Modulators|mitosis modulators|mesh-ancestor
110039370|NCT01426880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110039371|NCT01426880|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110039372|NCT01426880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110039373|NCT01426906|Rifampin|rifampin|mesh-list
110039374|NCT01426906|Ketoconazole|ketoconazole|mesh-list
110039375|NCT01426906|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110039376|NCT01426906|Antitubercular Agents|antitubercular agents|mesh-ancestor
110039377|NCT01426906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110039378|NCT01426906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110039379|NCT01426906|Leprostatic Agents|leprostatic agents|mesh-ancestor
110039380|NCT01426906|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110039381|NCT01426906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110039382|NCT01426906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110039383|NCT01426906|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110039384|NCT01426906|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110039385|NCT01426906|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110039386|NCT01426906|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110039387|NCT01426906|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110039388|NCT01426906|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110039389|NCT01426906|Antifungal Agents|antifungal agents|mesh-ancestor
110039390|NCT01426906|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110039391|NCT01426906|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110039392|NCT01426906|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110039393|NCT01426906|Hormone Antagonists|hormone antagonists|mesh-ancestor
110039394|NCT01426906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110039395|NCT01426906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039396|NCT01426906|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110039397|NCT01426971|Ibuprofen|ibuprofen|mesh-list
110039398|NCT01426971|Caffeine|caffeine|mesh-list
110039399|NCT01426971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110039400|NCT01426971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110039401|NCT01426971|Analgesics|analgesics|mesh-ancestor
110039402|NCT01426971|Sensory System Agents|sensory system agents|mesh-ancestor
110039403|NCT01426971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110039404|NCT01426971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039405|NCT01426971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110039406|NCT01426971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110039407|NCT01426971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110039408|NCT01426971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110039409|NCT01426971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110039410|NCT01426971|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110039411|NCT01426971|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110039412|NCT01426971|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110039413|NCT01426971|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110039414|NCT01426971|Purinergic Agents|purinergic agents|mesh-ancestor
110039415|NCT01426971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110039416|NCT01426984|Methylphenidate|methylphenidate|mesh-list
110039417|NCT01426984|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110054819|NCT01494402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110039419|NCT01426984|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110039420|NCT01426984|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110039421|NCT01426984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110039422|NCT01426984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110039423|NCT01426984|Dopamine Agents|dopamine agents|mesh-ancestor
110039427|NCT01427114|Rituximab|rituximab|mesh-list
110039428|NCT01427114|Vincristine|vincristine|mesh-list
110039429|NCT01427114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110039430|NCT01427114|Immunologic Factors|immunologic factors|mesh-ancestor
110039431|NCT01427114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039432|NCT01427114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110039433|NCT01427114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110039434|NCT01427114|Alkylating Agents|alkylating agents|mesh-ancestor
110039435|NCT01427114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110039436|NCT01427114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110039437|NCT01427114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110039438|NCT01427114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110039439|NCT01427114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110039440|NCT01427114|Tubulin Modulators|tubulin modulators|mesh-ancestor
110039441|NCT01427114|Antimitotic Agents|antimitotic agents|mesh-ancestor
110039442|NCT01427114|Mitosis Modulators|mitosis modulators|mesh-ancestor
110039443|NCT01427114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110039444|NCT01427114|Glucocorticoids|glucocorticoids|mesh-ancestor
110039445|NCT01427114|Hormones|hormones|mesh-ancestor
110039446|NCT01427114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110039447|NCT01427114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110039448|NCT01427192|Acetazolamide|acetazolamide|mesh-list
110039449|NCT01427192|Anticonvulsants|anticonvulsants|mesh-ancestor
110039450|NCT01427192|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110039452|NCT01427192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110039453|NCT01427192|Diuretics|diuretics|mesh-ancestor
110039454|NCT01427192|Natriuretic Agents|natriuretic agents|mesh-ancestor
110039455|NCT01427192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039456|NCT01427205|Cetuximab|cetuximab|mesh-list
110039457|NCT01427205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110039458|NCT01427205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110039460|NCT01427244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110039461|NCT01427244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110039462|NCT01427270|Oxycodone|oxycodone|mesh-list
110039463|NCT01427270|Naloxone|naloxone|mesh-list
110039464|NCT01427270|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110039465|NCT01427270|Narcotics|narcotics|mesh-ancestor
110039466|NCT01427270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110039467|NCT01427270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039468|NCT01427270|Analgesics|analgesics|mesh-ancestor
110039469|NCT01427270|Sensory System Agents|sensory system agents|mesh-ancestor
110039470|NCT01427270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110039471|NCT01427270|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110039472|NCT01427283|Oxycodone|oxycodone|mesh-list
110039473|NCT01427283|Naloxone|naloxone|mesh-list
110039474|NCT01427283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110039475|NCT01427283|Narcotics|narcotics|mesh-ancestor
110039476|NCT01427283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110039477|NCT01427283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039478|NCT01427283|Analgesics|analgesics|mesh-ancestor
110039479|NCT01427283|Sensory System Agents|sensory system agents|mesh-ancestor
110039480|NCT01427283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110039481|NCT01427283|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110039482|NCT01427322|Lapatinib|lapatinib|mesh-list
110039483|NCT01427322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110039484|NCT01427322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110039485|NCT01427322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110039486|NCT01427322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110039487|NCT01427335|Calcium, Dietary|calcium, dietary|mesh-list
110039488|NCT01427335|Calcium|calcium|mesh-list
110039489|NCT01427335|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110039490|NCT01427335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039491|NCT01427335|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110039492|NCT01427387|Linaclotide|linaclotide|mesh-list
110039493|NCT01427387|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
110039494|NCT01427387|Enzyme Activators|enzyme activators|mesh-ancestor
110039495|NCT01427387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110039496|NCT01427387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110039497|NCT01427400|Botulinum Toxins|botulinum toxins|mesh-list
110039498|NCT01427400|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110039499|NCT01427400|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110039500|NCT01427400|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110039501|NCT01427400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110039502|NCT01427400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110039503|NCT01427400|Cholinergic Agents|cholinergic agents|mesh-ancestor
110039504|NCT01427400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110039505|NCT01427400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039506|NCT01427400|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110039507|NCT01427400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110039508|NCT01427478|Afatinib|afatinib|mesh-list
110039509|NCT01427478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110039510|NCT01427478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110039511|NCT01427478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110039512|NCT01427478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110039513|NCT01427491|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110039514|NCT01427491|Laxatives|laxatives|mesh-ancestor
110039515|NCT01427491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110039516|NCT01427582|Trabectedin|trabectedin|mesh-list
110039517|NCT01427582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110039518|NCT01427582|Alkylating Agents|alkylating agents|mesh-ancestor
110039519|NCT01427582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110039522|NCT01427686|Dopamine|dopamine|mesh-list
110039523|NCT01427686|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110039524|NCT01427686|Sympathomimetics|sympathomimetics|mesh-ancestor
110039525|NCT01427686|Autonomic Agents|autonomic agents|mesh-ancestor
110039526|NCT01427686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110039527|NCT01427686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039528|NCT01427686|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110039529|NCT01427686|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110039530|NCT01427686|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110039531|NCT01427686|Adrenergic Agents|adrenergic agents|mesh-ancestor
110039532|NCT01427686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110039533|NCT01427686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110039534|NCT01427686|Protective Agents|protective agents|mesh-ancestor
110039535|NCT01427686|Dopamine Agents|dopamine agents|mesh-ancestor
110039536|NCT01427699|Antibodies|antibodies|mesh-list
110039537|NCT01427699|Immunologic Factors|immunologic factors|mesh-ancestor
110039538|NCT01427699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039539|NCT01427842|Vancomycin|vancomycin|mesh-list
110039540|NCT01427842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110039541|NCT01427842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110039542|NCT01427868|Maleic acid|maleic acid|mesh-list
110039543|NCT01427868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110039544|NCT01427868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110039545|NCT01427946|Everolimus|everolimus|mesh-list
110039546|NCT01427946|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110039547|NCT01427946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110039548|NCT01427946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110039549|NCT01427946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110039550|NCT01427946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110039551|NCT01427946|Immunologic Factors|immunologic factors|mesh-ancestor
110039552|NCT01427946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039553|NCT01427946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110039554|NCT01427985|Atropine|atropine|mesh-list
110039555|NCT01427985|Fentanyl|fentanyl|mesh-list
110039556|NCT01427985|Mivacurium|mivacurium|mesh-list
110039557|NCT01427985|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110039558|NCT01427985|Narcotics|narcotics|mesh-ancestor
110039559|NCT01427985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110039560|NCT01427985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039561|NCT01427985|Analgesics|analgesics|mesh-ancestor
110039562|NCT01427985|Sensory System Agents|sensory system agents|mesh-ancestor
110039563|NCT01427985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110039564|NCT01427985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110039565|NCT01427985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110039566|NCT01427985|Anesthetics, General|anesthetics, general|mesh-ancestor
110039567|NCT01427985|Anesthetics|anesthetics|mesh-ancestor
110039568|NCT01427985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110039569|NCT01427985|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110039570|NCT01427985|Autonomic Agents|autonomic agents|mesh-ancestor
110039571|NCT01427985|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110039572|NCT01427985|Respiratory System Agents|respiratory system agents|mesh-ancestor
110039574|NCT01427985|Parasympatholytics|parasympatholytics|mesh-ancestor
110039575|NCT01427985|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110039576|NCT01427985|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110039577|NCT01427985|Cholinergic Agents|cholinergic agents|mesh-ancestor
110039578|NCT01427985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110039657|NCT01428414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110039579|NCT01427985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110039580|NCT01427985|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110039581|NCT01427985|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110039582|NCT01427985|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110039583|NCT01428037|Misoprostol|misoprostol|mesh-list
110039584|NCT01428037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110039585|NCT01428037|Abortifacient Agents|abortifacient agents|mesh-ancestor
110039586|NCT01428037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110039587|NCT01428037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039589|NCT01428037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110039590|NCT01428037|Oxytocics|oxytocics|mesh-ancestor
110039591|NCT01427127|Ramosetron|ramosetron|mesh-list
110039592|NCT01427127|Antiemetics|antiemetics|mesh-ancestor
110039593|NCT01427127|Autonomic Agents|autonomic agents|mesh-ancestor
110039594|NCT01427127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110039595|NCT01427127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039596|NCT01427127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110039597|NCT01427127|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110039598|NCT01427127|Serotonin Agents|serotonin agents|mesh-ancestor
110039599|NCT01427127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110039600|NCT01427127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110039601|NCT01428050|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110039602|NCT01428154|Darbepoetin alfa|darbepoetin alfa|mesh-list
110039603|NCT01428154|Hematinics|hematinics|mesh-ancestor
110039604|NCT01428180|Ibuprofen|ibuprofen|mesh-list
110039605|NCT01428180|Indomethacin|indomethacin|mesh-list
110039606|NCT01428180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110039607|NCT01428180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110039608|NCT01428180|Analgesics|analgesics|mesh-ancestor
110039609|NCT01428180|Sensory System Agents|sensory system agents|mesh-ancestor
110039610|NCT01428180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110039612|NCT01428180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110039613|NCT01428180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110039614|NCT01428180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110039615|NCT01428180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110039616|NCT01428180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110039617|NCT01428180|Gout Suppressants|gout suppressants|mesh-ancestor
110039618|NCT01428180|Tocolytic Agents|tocolytic agents|mesh-ancestor
110039619|NCT01428180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110039620|NCT01428284|Canagliflozin|canagliflozin|mesh-list
110039621|NCT01428284|Probenecid|probenecid|mesh-list
110039622|NCT01428284|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110039623|NCT01428284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110039624|NCT01428284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110039625|NCT01428284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039626|NCT01428284|Uricosuric Agents|uricosuric agents|mesh-ancestor
110039627|NCT01428284|Gout Suppressants|gout suppressants|mesh-ancestor
110039628|NCT01428284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110039629|NCT01428375|Acetaminophen|acetaminophen|mesh-list
110039630|NCT01428375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110039631|NCT01428375|Analgesics|analgesics|mesh-ancestor
110039632|NCT01428375|Sensory System Agents|sensory system agents|mesh-ancestor
110039633|NCT01428375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110039634|NCT01428375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039635|NCT01428375|Antipyretics|antipyretics|mesh-ancestor
110039636|NCT01428388|Bevacizumab|bevacizumab|mesh-list
110039637|NCT01428388|Ranibizumab|ranibizumab|mesh-list
110039638|NCT01428388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110039639|NCT01428388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110039640|NCT01428388|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110039641|NCT01428388|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110039642|NCT01428388|Growth Substances|growth substances|mesh-ancestor
110039643|NCT01428388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039644|NCT01428388|Growth Inhibitors|growth inhibitors|mesh-ancestor
110039645|NCT01428414|Paclitaxel|paclitaxel|mesh-list
110039646|NCT01428414|Carboplatin|carboplatin|mesh-list
110039647|NCT01428414|Trastuzumab|trastuzumab|mesh-list
110039648|NCT01428414|Epirubicin|epirubicin|mesh-list
110039649|NCT01428414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110039650|NCT01428414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110039651|NCT01428414|Tubulin Modulators|tubulin modulators|mesh-ancestor
110039652|NCT01428414|Antimitotic Agents|antimitotic agents|mesh-ancestor
110039653|NCT01428414|Mitosis Modulators|mitosis modulators|mesh-ancestor
110039654|NCT01428414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110039655|NCT01428414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110039656|NCT01428414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110039660|NCT01428427|Gemcitabine|gemcitabine|mesh-list
110039662|NCT01428427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110039663|NCT01428427|Antimetabolites|antimetabolites|mesh-ancestor
110039664|NCT01428427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110039665|NCT01428427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110039666|NCT01428427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110039667|NCT01428427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110039668|NCT01428466|Benzoyl Peroxide|benzoyl peroxide|mesh-list
110039669|NCT01428466|Dermatologic Agents|dermatologic agents|mesh-ancestor
110039671|NCT01428492|Bortezomib|bortezomib|mesh-list
110039672|NCT01428492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110039673|NCT01428492|Antiemetics|antiemetics|mesh-ancestor
110039674|NCT01428492|Autonomic Agents|autonomic agents|mesh-ancestor
110039675|NCT01428492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110039676|NCT01428492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039677|NCT01428492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110039678|NCT01428492|Glucocorticoids|glucocorticoids|mesh-ancestor
110039679|NCT01428492|Hormones|hormones|mesh-ancestor
110039680|NCT01428492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110039681|NCT01428492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110039682|NCT01428492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110039683|NCT01428518|Lamotrigine|lamotrigine|mesh-list
110039684|NCT01428518|Anticonvulsants|anticonvulsants|mesh-ancestor
110039685|NCT01428518|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110039686|NCT01428518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110039687|NCT01428518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110039688|NCT01428518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110039689|NCT01428518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039690|NCT01428518|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110039691|NCT01428518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110039692|NCT01428518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110039694|NCT01428518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110039697|NCT01428531|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110039698|NCT01428531|Antithrombins|antithrombins|mesh-ancestor
110039699|NCT01428531|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110039700|NCT01428531|Protease Inhibitors|protease inhibitors|mesh-ancestor
110039701|NCT01428531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110039702|NCT01428531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110039703|NCT01428531|Anticoagulants|anticoagulants|mesh-ancestor
110039704|NCT01428531|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110039705|NCT01428531|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110039706|NCT01428544|PENTA|penta|mesh-list
110039707|NCT01428544|Fondaparinux|fondaparinux|mesh-list
110039708|NCT01428544|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110039709|NCT01428544|Antithrombins|antithrombins|mesh-ancestor
110039710|NCT01428544|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110039711|NCT01428544|Protease Inhibitors|protease inhibitors|mesh-ancestor
110039712|NCT01428544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110039713|NCT01428544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110039714|NCT01428544|Anticoagulants|anticoagulants|mesh-ancestor
110039715|NCT01428544|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110039716|NCT01428544|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110039717|NCT01428622|Olodaterol|olodaterol|mesh-list
110039718|NCT01428622|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110039719|NCT01428622|Autonomic Agents|autonomic agents|mesh-ancestor
110039720|NCT01428622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110039721|NCT01428622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039722|NCT01428622|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110039723|NCT01428622|Respiratory System Agents|respiratory system agents|mesh-ancestor
110039724|NCT01428817|Carbetocin|carbetocin|mesh-list
110039725|NCT01428817|Oxytocin|oxytocin|mesh-list
110039726|NCT01428817|Oxytocics|oxytocics|mesh-ancestor
110039727|NCT01428817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110039728|NCT01428817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039729|NCT01428908|Vaccines|vaccines|mesh-list
110039730|NCT01428908|Immunologic Factors|immunologic factors|mesh-ancestor
110039731|NCT01428908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039732|NCT01428986|Maraviroc|maraviroc|mesh-list
110039733|NCT01428986|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110039734|NCT01428986|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110039735|NCT01428986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110039736|NCT01428986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110039737|NCT01428986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110039738|NCT01428986|Antiviral Agents|antiviral agents|mesh-ancestor
110039739|NCT01428986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110039740|NCT01428986|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110039741|NCT01429025|Rituximab|rituximab|mesh-list
110039742|NCT01429025|Lenalidomide|lenalidomide|mesh-list
110039743|NCT01429025|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110039744|NCT01429025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110039745|NCT01429025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110039746|NCT01429025|Immunologic Factors|immunologic factors|mesh-ancestor
110039747|NCT01429025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039748|NCT01429025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110039749|NCT01429025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110039750|NCT01429025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110039751|NCT01429025|Growth Substances|growth substances|mesh-ancestor
110039752|NCT01429025|Growth Inhibitors|growth inhibitors|mesh-ancestor
110039753|NCT01429025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110039754|NCT01429025|Alkylating Agents|alkylating agents|mesh-ancestor
110039755|NCT01429025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110039756|NCT01429090|Methantheline|methantheline|mesh-list
110039757|NCT01429090|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110039758|NCT01429090|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110039759|NCT01429090|Cholinergic Agents|cholinergic agents|mesh-ancestor
110039760|NCT01429090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110039761|NCT01429090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110039762|NCT01429090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039763|NCT01429129|Nicotine|nicotine|mesh-list
110039764|NCT01429129|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110039765|NCT01429129|Autonomic Agents|autonomic agents|mesh-ancestor
110039766|NCT01429129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110039767|NCT01429129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039768|NCT01429129|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110039770|NCT01429129|Cholinergic Agents|cholinergic agents|mesh-ancestor
110039771|NCT01429129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110039772|NCT01429129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110039773|NCT01429181|Methadone|methadone|mesh-list
110039774|NCT01429181|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110039775|NCT01429181|Narcotics|narcotics|mesh-ancestor
110039776|NCT01429181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110039777|NCT01429181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039778|NCT01429181|Analgesics|analgesics|mesh-ancestor
110039779|NCT01429181|Sensory System Agents|sensory system agents|mesh-ancestor
110039780|NCT01429181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110039781|NCT01429181|Antitussive Agents|antitussive agents|mesh-ancestor
110039782|NCT01429181|Respiratory System Agents|respiratory system agents|mesh-ancestor
110039783|NCT01429337|Midostaurin|midostaurin|mesh-list
110039784|NCT01429337|Staurosporine|staurosporine|mesh-list
110039785|NCT01429337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110039786|NCT01429337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110039788|NCT01429337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110039789|NCT01429402|Botulinum Toxins|botulinum toxins|mesh-list
110039790|NCT01429402|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110039791|NCT01429402|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110039792|NCT01429402|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110039793|NCT01429402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110039794|NCT01429402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110039795|NCT01429402|Cholinergic Agents|cholinergic agents|mesh-ancestor
110039796|NCT01429402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110039797|NCT01429402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039798|NCT01429402|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110039799|NCT01429402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110039800|NCT01429415|Magnesium Sulfate|magnesium sulfate|mesh-list
110039801|NCT01429415|Analgesics|analgesics|mesh-ancestor
110039802|NCT01429415|Sensory System Agents|sensory system agents|mesh-ancestor
110039803|NCT01429415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110039804|NCT01429415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039805|NCT01429415|Anesthetics|anesthetics|mesh-ancestor
110039806|NCT01429415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110039807|NCT01429415|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110039808|NCT01429415|Anticonvulsants|anticonvulsants|mesh-ancestor
110039809|NCT01429415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110039810|NCT01429415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110039811|NCT01429415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110039812|NCT01429415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110039813|NCT01429415|Tocolytic Agents|tocolytic agents|mesh-ancestor
110039814|NCT01429415|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110039816|NCT01429545|Vasotocin|vasotocin|mesh-list
110039817|NCT01429545|Atosiban|atosiban|mesh-list
110039818|NCT01429545|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110039819|NCT01429545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110039820|NCT01429545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110039821|NCT01429545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110039822|NCT01429545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039823|NCT01429545|Vasodilator Agents|vasodilator agents|mesh-ancestor
110039824|NCT01429545|Tocolytic Agents|tocolytic agents|mesh-ancestor
110039825|NCT01429545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110039826|NCT01429545|Hormone Antagonists|hormone antagonists|mesh-ancestor
110039827|NCT01429545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110039828|NCT01429545|Oxytocics|oxytocics|mesh-ancestor
110039829|NCT01429545|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110039830|NCT01429571|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110039832|NCT01429610|Cytarabine|cytarabine|mesh-list
110039833|NCT01429610|Rituximab|rituximab|mesh-list
110039834|NCT01429610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110039835|NCT01429610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110039836|NCT01429610|Immunologic Factors|immunologic factors|mesh-ancestor
110039837|NCT01429610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039838|NCT01429610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110039839|NCT01429610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110039840|NCT01429610|Antimetabolites|antimetabolites|mesh-ancestor
110039841|NCT01429610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110039842|NCT01429610|Antiviral Agents|antiviral agents|mesh-ancestor
110039843|NCT01429610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110039844|NCT01429610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110039845|NCT01429675|Ibandronic Acid|ibandronic acid|mesh-list
110039846|NCT01429675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110039847|NCT01429675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039848|NCT01429701|Gentamicins|gentamicins|mesh-list
110039849|NCT01429701|Polymyxins|polymyxins|mesh-list
110039850|NCT01429701|Polymyxin B|polymyxin b|mesh-list
110039851|NCT01429701|Prednisolone|prednisolone|mesh-list
110039852|NCT01429701|Betamethasone|betamethasone|mesh-list
110039853|NCT01429701|Benzocaine|benzocaine|mesh-list
110039854|NCT01429701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110039855|NCT01429701|Glucocorticoids|glucocorticoids|mesh-ancestor
110039856|NCT01429701|Hormones|hormones|mesh-ancestor
110039857|NCT01429701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110039858|NCT01429701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039859|NCT01429701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110039860|NCT01429701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110039861|NCT01429701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110039862|NCT01429701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110039863|NCT01429701|Respiratory System Agents|respiratory system agents|mesh-ancestor
110039864|NCT01429701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110039865|NCT01429701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110039866|NCT01429701|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110039867|NCT01429701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110039868|NCT01429701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110039869|NCT01429701|Anesthetics, Local|anesthetics, local|mesh-ancestor
110039870|NCT01429701|Anesthetics|anesthetics|mesh-ancestor
110039871|NCT01429701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110039872|NCT01429701|Sensory System Agents|sensory system agents|mesh-ancestor
110039873|NCT01429714|Oxymetazoline|oxymetazoline|mesh-list
110039874|NCT01429714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110039875|NCT01429714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110039876|NCT01429714|Adrenergic Agents|adrenergic agents|mesh-ancestor
110039877|NCT01429714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110039878|NCT01429714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110039879|NCT01429714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039880|NCT01429714|Sympathomimetics|sympathomimetics|mesh-ancestor
110039881|NCT01429714|Autonomic Agents|autonomic agents|mesh-ancestor
110039882|NCT01429714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110039883|NCT01429714|Nasal Decongestants|nasal decongestants|mesh-ancestor
110039884|NCT01429714|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110039885|NCT01429714|Respiratory System Agents|respiratory system agents|mesh-ancestor
110039886|NCT01429818|Metformin|metformin|mesh-list
110039887|NCT01429818|Glimepiride|glimepiride|mesh-list
110039889|NCT01429818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039890|NCT01429818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110039893|NCT01429831|Aripiprazole|aripiprazole|mesh-list
110039894|NCT01429831|Antidepressive Agents|antidepressive agents|mesh-ancestor
110039896|NCT01429831|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110039897|NCT01429831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110039898|NCT01429831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110039899|NCT01429831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039900|NCT01429831|Dopamine Agonists|dopamine agonists|mesh-ancestor
110039901|NCT01429831|Dopamine Agents|dopamine agents|mesh-ancestor
110039902|NCT01429831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110039903|NCT01429831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110039904|NCT01429831|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110039905|NCT01429831|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110039906|NCT01429831|Serotonin Agents|serotonin agents|mesh-ancestor
110039907|NCT01429831|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110039908|NCT01429831|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110039909|NCT01429831|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110039910|NCT01429831|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110039911|NCT01429844|Cyclosporine|cyclosporine|mesh-list
110039912|NCT01429844|Tacrolimus|tacrolimus|mesh-list
110039913|NCT01429844|Cyclosporins|cyclosporins|mesh-list
110039914|NCT01429844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110039915|NCT01429844|Immunologic Factors|immunologic factors|mesh-ancestor
110039916|NCT01429844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039917|NCT01429844|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110039918|NCT01429844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110039919|NCT01429844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110039920|NCT01429844|Antifungal Agents|antifungal agents|mesh-ancestor
110039921|NCT01429844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110039922|NCT01429844|Dermatologic Agents|dermatologic agents|mesh-ancestor
110039923|NCT01429844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110039924|NCT01429870|Triamcinolone|triamcinolone|mesh-list
110039925|NCT01429870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110039926|NCT01429870|Glucocorticoids|glucocorticoids|mesh-ancestor
110039927|NCT01429870|Hormones|hormones|mesh-ancestor
110039928|NCT01429870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110039929|NCT01429870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039930|NCT01429935|Ibuprofen|ibuprofen|mesh-list
110039931|NCT01429935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110039932|NCT01429935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110039933|NCT01429935|Analgesics|analgesics|mesh-ancestor
110039934|NCT01429935|Sensory System Agents|sensory system agents|mesh-ancestor
110039935|NCT01429935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110039936|NCT01429935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039937|NCT01429935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110039938|NCT01429935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110039939|NCT01429935|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110039940|NCT01429935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110039941|NCT01429935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110039942|NCT01430013|Endostar protein|endostar protein|mesh-list
110039943|NCT01430013|Endostatins|endostatins|mesh-list
110039944|NCT01430013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110039945|NCT01430013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110039947|NCT01430013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039948|NCT01430013|Growth Inhibitors|growth inhibitors|mesh-ancestor
110039949|NCT01430013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110039950|NCT01430052|Gemcitabine|gemcitabine|mesh-list
110039951|NCT01430052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110039952|NCT01430052|Antimetabolites|antimetabolites|mesh-ancestor
110039953|NCT01430052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110039954|NCT01430052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110039955|NCT01430065|Tacrolimus|tacrolimus|mesh-list
110039956|NCT01430065|Peficitinib|peficitinib|mesh-list
110039957|NCT01430065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110039958|NCT01430065|Immunologic Factors|immunologic factors|mesh-ancestor
110039959|NCT01430065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039960|NCT01430065|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110039961|NCT01430065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110039962|NCT01430065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110039963|NCT01430078|Niacinamide|niacinamide|mesh-list
110039964|NCT01430078|Peficitinib|peficitinib|mesh-list
110039965|NCT01430078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110039967|NCT01430078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110039968|NCT01430078|Immunologic Factors|immunologic factors|mesh-ancestor
110039969|NCT01430078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039970|NCT01430078|Vitamin B Complex|vitamin b complex|mesh-ancestor
110039972|NCT01430078|Micronutrients|micronutrients|mesh-ancestor
110039973|NCT01430195|Afamelanotide|afamelanotide|mesh-list
110039974|NCT01430195|Dermatologic Agents|dermatologic agents|mesh-ancestor
110039975|NCT01430234|Pancreatin|pancreatin|mesh-list
110039976|NCT01430234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110039977|NCT01430260|Ciclesonide|ciclesonide|mesh-list
110039978|NCT01430260|Cetirizine|cetirizine|mesh-list
110039979|NCT01430260|Levocetirizine|levocetirizine|mesh-list
110039980|NCT01430260|Glucocorticoids|glucocorticoids|mesh-ancestor
110039981|NCT01430260|Hormones|hormones|mesh-ancestor
110039983|NCT01430260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110039984|NCT01430260|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110039985|NCT01430260|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110039986|NCT01430260|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110039987|NCT01430260|Histamine Antagonists|histamine antagonists|mesh-ancestor
110039988|NCT01430260|Histamine Agents|histamine agents|mesh-ancestor
110039989|NCT01430260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110039990|NCT01430260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110039991|NCT01430312|Azelaic acid|azelaic acid|mesh-list
110039992|NCT01430312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110039993|NCT01430312|Dermatologic Agents|dermatologic agents|mesh-ancestor
110039994|NCT01430520|Escitalopram|escitalopram|mesh-list
110039995|NCT01430520|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110039996|NCT01430520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110039997|NCT01430520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110039998|NCT01430520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110039999|NCT01430520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110040000|NCT01430520|Serotonin Agents|serotonin agents|mesh-ancestor
110040001|NCT01430520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040002|NCT01430533|Azelaic acid|azelaic acid|mesh-list
110040003|NCT01430533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110040004|NCT01430533|Dermatologic Agents|dermatologic agents|mesh-ancestor
110040005|NCT01430650|Saw palmetto extract|saw palmetto extract|mesh-list
110040006|NCT01430650|Urological Agents|urological agents|mesh-ancestor
110040008|NCT01430689|Immunologic Factors|immunologic factors|mesh-ancestor
110040009|NCT01430689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040010|NCT01430793|Vitamin D|vitamin d|mesh-list
110040011|NCT01430793|Ergocalciferols|ergocalciferols|mesh-list
110040012|NCT01430793|Cholecalciferol|cholecalciferol|mesh-list
110040013|NCT01430793|Vitamins|vitamins|mesh-list
110040014|NCT01430793|Micronutrients|micronutrients|mesh-ancestor
110040015|NCT01430793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040016|NCT01430793|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110040017|NCT01430793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110040019|NCT01430806|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110040020|NCT01430910|Ceftazidime|ceftazidime|mesh-list
110040021|NCT01430910|Avibactam|avibactam|mesh-list
110040022|NCT01430910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110040023|NCT01430910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110040024|NCT01430910|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110040025|NCT01430910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110040026|NCT01430910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110040027|NCT01430923|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110040028|NCT01430923|Latanoprost|latanoprost|mesh-list
110040029|NCT01430923|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110040030|NCT01431053|Aspirin|aspirin|mesh-list
110040031|NCT01431053|Exemestane|exemestane|mesh-list
110040032|NCT01431053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110040033|NCT01431053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110040034|NCT01431053|Analgesics|analgesics|mesh-ancestor
110040035|NCT01431053|Sensory System Agents|sensory system agents|mesh-ancestor
110040036|NCT01431053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110040037|NCT01431053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040038|NCT01431053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110040039|NCT01431053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110040040|NCT01431053|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110040041|NCT01431053|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110040042|NCT01431053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110040043|NCT01431053|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110040044|NCT01431053|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110040046|NCT01431053|Antipyretics|antipyretics|mesh-ancestor
110040047|NCT01431053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110040049|NCT01431053|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110040050|NCT01431053|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110040051|NCT01431053|Hormone Antagonists|hormone antagonists|mesh-ancestor
110040052|NCT01431053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110040053|NCT01431092|Melatonin|melatonin|mesh-list
110040054|NCT01431092|Antioxidants|antioxidants|mesh-ancestor
110040055|NCT01431092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110040056|NCT01431092|Protective Agents|protective agents|mesh-ancestor
110040057|NCT01431092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040058|NCT01431092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110040059|NCT01431118|Camphor|camphor|mesh-list
110040060|NCT01431118|Salicylates|salicylates|mesh-list
110040061|NCT01431118|Methyl salicylate|methyl salicylate|mesh-list
110040062|NCT01431118|Menthol|menthol|mesh-list
110040063|NCT01431118|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110040064|NCT01431118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110040065|NCT01431118|Antipruritics|antipruritics|mesh-ancestor
110040066|NCT01431118|Dermatologic Agents|dermatologic agents|mesh-ancestor
110040067|NCT01431118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110040068|NCT01431118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110040069|NCT01431118|Analgesics|analgesics|mesh-ancestor
110040070|NCT01431118|Sensory System Agents|sensory system agents|mesh-ancestor
110040071|NCT01431118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110040072|NCT01431118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040073|NCT01431118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110040074|NCT01431118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110040075|NCT01431118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110040076|NCT01431118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110040077|NCT01431118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110040078|NCT01431352|Letrozole|letrozole|mesh-list
110040079|NCT01431352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110040080|NCT01431352|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110040081|NCT01431352|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110040082|NCT01431352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110040083|NCT01431352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110040084|NCT01431352|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110040085|NCT01431352|Hormone Antagonists|hormone antagonists|mesh-ancestor
110040086|NCT01431352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110040087|NCT01431352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040088|NCT01431404|Etanercept|etanercept|mesh-list
110040089|NCT01431404|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110040090|NCT01431404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110040091|NCT01431404|Analgesics|analgesics|mesh-ancestor
110040092|NCT01431404|Sensory System Agents|sensory system agents|mesh-ancestor
110040093|NCT01431404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110040094|NCT01431404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040095|NCT01431404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110040096|NCT01431404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110040097|NCT01431404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110040098|NCT01431404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110040099|NCT01431404|Immunologic Factors|immunologic factors|mesh-ancestor
110040100|NCT01431430|Cholecalciferol|cholecalciferol|mesh-list
110040101|NCT01431430|Vitamin D|vitamin d|mesh-list
110040102|NCT01431430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110040103|NCT01431430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040104|NCT01431430|Vitamins|vitamins|mesh-ancestor
110040105|NCT01431430|Micronutrients|micronutrients|mesh-ancestor
110040106|NCT01431430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110040107|NCT01431443|Theobromine|theobromine|mesh-list
110040108|NCT01431443|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110040109|NCT01431443|Autonomic Agents|autonomic agents|mesh-ancestor
110040110|NCT01431443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110040111|NCT01431443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040112|NCT01431443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110040113|NCT01431443|Respiratory System Agents|respiratory system agents|mesh-ancestor
110040114|NCT01431443|Vasodilator Agents|vasodilator agents|mesh-ancestor
110040115|NCT01431456|Nadroparin|nadroparin|mesh-list
110040116|NCT01431456|Rivaroxaban|rivaroxaban|mesh-list
110040117|NCT01431456|Dabigatran|dabigatran|mesh-list
110040118|NCT01431456|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110040119|NCT01431456|Antithrombins|antithrombins|mesh-ancestor
110040120|NCT01431456|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110040123|NCT01431456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110040125|NCT01431456|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110040126|NCT01431456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110040127|NCT01431495|Clopidogrel|clopidogrel|mesh-list
110040128|NCT01431495|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110040129|NCT01431495|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110040130|NCT01431495|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110040131|NCT01431495|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110040132|NCT01431495|Purinergic Agents|purinergic agents|mesh-ancestor
110040133|NCT01431495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110040134|NCT01431495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110040136|NCT01431547|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110040137|NCT01431547|Immunologic Factors|immunologic factors|mesh-ancestor
110040138|NCT01431547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040139|NCT01431612|Phenylephrine|phenylephrine|mesh-list
110040140|NCT01431612|Oxymetazoline|oxymetazoline|mesh-list
110040141|NCT01431612|Esmolol|esmolol|mesh-list
110040142|NCT01431612|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110040143|NCT01431612|Mydriatics|mydriatics|mesh-ancestor
110040144|NCT01431612|Autonomic Agents|autonomic agents|mesh-ancestor
110040145|NCT01431612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110040146|NCT01431612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040147|NCT01431612|Sympathomimetics|sympathomimetics|mesh-ancestor
110040148|NCT01431612|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110040149|NCT01431612|Nasal Decongestants|nasal decongestants|mesh-ancestor
110040150|NCT01431612|Respiratory System Agents|respiratory system agents|mesh-ancestor
110040151|NCT01431612|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110040152|NCT01431612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110040153|NCT01431612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110040154|NCT01431612|Adrenergic Agents|adrenergic agents|mesh-ancestor
110040155|NCT01431612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110040156|NCT01431612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110040157|NCT01431612|Protective Agents|protective agents|mesh-ancestor
110040158|NCT01431612|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110040159|NCT01431612|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110040160|NCT01431612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110040161|NCT01431690|Warfarin|warfarin|mesh-list
110040162|NCT01431690|Anticoagulants|anticoagulants|mesh-list
110040164|NCT01431729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110040165|NCT01431742|Buprenorphine|buprenorphine|mesh-list
110040166|NCT01431742|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110040167|NCT01431742|Narcotics|narcotics|mesh-ancestor
110040168|NCT01431742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110040169|NCT01431742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040170|NCT01431742|Analgesics|analgesics|mesh-ancestor
110040171|NCT01431742|Sensory System Agents|sensory system agents|mesh-ancestor
110040172|NCT01431742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110040173|NCT01431742|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110040174|NCT01431781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110040175|NCT01431781|Somatostatin|somatostatin|mesh-list
110040176|NCT01431781|Hormones|hormones|mesh-ancestor
110040177|NCT01431781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110040178|NCT01431781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040179|NCT01431833|Tedizolid phosphate|tedizolid phosphate|mesh-list
110040180|NCT01431833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110040181|NCT01431833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110040182|NCT01431924|Fluticasone|fluticasone|mesh-list
110040183|NCT01431924|Xhance|xhance|mesh-list
110040184|NCT01431924|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110040185|NCT01431924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110040186|NCT01431924|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110040187|NCT01431924|Autonomic Agents|autonomic agents|mesh-ancestor
110040188|NCT01431924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110040189|NCT01431924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040190|NCT01431924|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110040191|NCT01431924|Respiratory System Agents|respiratory system agents|mesh-ancestor
110040192|NCT01431924|Dermatologic Agents|dermatologic agents|mesh-ancestor
110040193|NCT01431924|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110040194|NCT01431924|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110040196|NCT01431924|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110040197|NCT01431924|Adrenergic Agents|adrenergic agents|mesh-ancestor
110040351|NCT01432782|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110040201|NCT01432028|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110040202|NCT01432028|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110040204|NCT01432028|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110040205|NCT01432028|Progesterone|progesterone|mesh-list
110040206|NCT01432028|Estrogens|estrogens|mesh-ancestor
110040207|NCT01432028|Hormones|hormones|mesh-ancestor
110040208|NCT01432028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110040209|NCT01432028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040210|NCT01432028|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110040211|NCT01432028|Contraceptive Agents|contraceptive agents|mesh-ancestor
110040212|NCT01432028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110040213|NCT01432028|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110040214|NCT01432028|Progestins|progestins|mesh-ancestor
110040215|NCT01432028|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110040216|NCT01432028|Hormone Antagonists|hormone antagonists|mesh-ancestor
110040217|NCT01432028|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110040218|NCT01432028|Diuretics|diuretics|mesh-ancestor
110040219|NCT01432028|Natriuretic Agents|natriuretic agents|mesh-ancestor
110040220|NCT01432080|Azithromycin|azithromycin|mesh-list
110040221|NCT01432080|Prednisone|prednisone|mesh-list
110040222|NCT01432080|Budesonide|budesonide|mesh-list
110040223|NCT01432080|Formoterol Fumarate|formoterol fumarate|mesh-list
110040224|NCT01432080|Montelukast|montelukast|mesh-list
110040225|NCT01432080|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110040226|NCT01432080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110040227|NCT01432080|Glucocorticoids|glucocorticoids|mesh-ancestor
110040228|NCT01432080|Hormones|hormones|mesh-ancestor
110040229|NCT01432080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110040230|NCT01432080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040231|NCT01432080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110040232|NCT01432080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110040233|NCT01432080|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110040234|NCT01432080|Autonomic Agents|autonomic agents|mesh-ancestor
110040235|NCT01432080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110040236|NCT01432080|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110040237|NCT01432080|Respiratory System Agents|respiratory system agents|mesh-ancestor
110040238|NCT01432080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110040239|NCT01432080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110040240|NCT01432080|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110040241|NCT01432080|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110040242|NCT01432080|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110040243|NCT01432080|Adrenergic Agents|adrenergic agents|mesh-ancestor
110040244|NCT01432080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110040245|NCT01432080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110040246|NCT01432080|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110040247|NCT01432080|Hormone Antagonists|hormone antagonists|mesh-ancestor
110040248|NCT01432080|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110040249|NCT01432080|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110040250|NCT01432106|Valsartan|valsartan|mesh-list
110040251|NCT01432106|Ramipril|ramipril|mesh-list
110040252|NCT01432106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110040253|NCT01432106|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110040254|NCT01432106|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110040255|NCT01432106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110040256|NCT01432106|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110040257|NCT01432106|Protease Inhibitors|protease inhibitors|mesh-ancestor
110040259|NCT01432119|Cetuximab|cetuximab|mesh-list
110040260|NCT01432119|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110040261|NCT01432119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110040262|NCT01432119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110040263|NCT01432119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110040264|NCT01432119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110040265|NCT01432119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110040266|NCT01432158|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110040267|NCT01432158|Immunologic Factors|immunologic factors|mesh-ancestor
110040268|NCT01432158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040270|NCT01432223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110040272|NCT01432223|Tubulin Modulators|tubulin modulators|mesh-ancestor
110040273|NCT01432223|Antimitotic Agents|antimitotic agents|mesh-ancestor
110040274|NCT01432223|Mitosis Modulators|mitosis modulators|mesh-ancestor
110040352|NCT01432782|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110040275|NCT01432223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110040277|NCT01432249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110040279|NCT01432249|Analgesics|analgesics|mesh-ancestor
110040280|NCT01432249|Sensory System Agents|sensory system agents|mesh-ancestor
110040281|NCT01432249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110040282|NCT01432249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040283|NCT01432249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110040284|NCT01432249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110040285|NCT01432249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110040286|NCT01432249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110040287|NCT01432249|Immunologic Factors|immunologic factors|mesh-ancestor
110040288|NCT01432470|Oxytocin|oxytocin|mesh-list
110040289|NCT01432470|Oxytocics|oxytocics|mesh-ancestor
110040290|NCT01432470|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110040291|NCT01432470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040292|NCT01432483|Denileukin diftitox|denileukin diftitox|mesh-list
110040293|NCT01432483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110040294|NCT01432496|Ropivacaine|ropivacaine|mesh-list
110040295|NCT01432496|Anesthetics, Local|anesthetics, local|mesh-ancestor
110040296|NCT01432496|Anesthetics|anesthetics|mesh-ancestor
110040297|NCT01432496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110040298|NCT01432496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040299|NCT01432496|Sensory System Agents|sensory system agents|mesh-ancestor
110040300|NCT01432496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110040301|NCT01432522|Epinephrine|epinephrine|mesh-list
110040302|NCT01432522|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110040303|NCT01432522|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110040304|NCT01432522|Adrenergic Agents|adrenergic agents|mesh-ancestor
110040305|NCT01432522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110040306|NCT01432522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110040307|NCT01432522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040308|NCT01432522|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110040309|NCT01432522|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110040310|NCT01432522|Autonomic Agents|autonomic agents|mesh-ancestor
110040311|NCT01432522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110040312|NCT01432522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110040313|NCT01432522|Respiratory System Agents|respiratory system agents|mesh-ancestor
110040315|NCT01432522|Sympathomimetics|sympathomimetics|mesh-ancestor
110040316|NCT01432522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110040317|NCT01432587|Diflunisal|diflunisal|mesh-list
110040318|NCT01432587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110040319|NCT01432587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110040320|NCT01432587|Analgesics|analgesics|mesh-ancestor
110040321|NCT01432587|Sensory System Agents|sensory system agents|mesh-ancestor
110040322|NCT01432587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110040323|NCT01432587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040324|NCT01432587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110040325|NCT01432587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110040326|NCT01432587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110040327|NCT01432587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110040328|NCT01432587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110040329|NCT01432665|Sildenafil Citrate|sildenafil citrate|mesh-list
110040330|NCT01432665|Testosterone|testosterone|mesh-list
110040331|NCT01432665|Androgens|androgens|mesh-ancestor
110040332|NCT01432665|Hormones|hormones|mesh-ancestor
110040333|NCT01432665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110040334|NCT01432665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040335|NCT01432665|Vasodilator Agents|vasodilator agents|mesh-ancestor
110040336|NCT01432665|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110040337|NCT01432665|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110040338|NCT01432665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110040339|NCT01432665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110040340|NCT01432665|Urological Agents|urological agents|mesh-ancestor
110040341|NCT01432704|Cholecalciferol|cholecalciferol|mesh-list
110040342|NCT01432704|Vitamin D|vitamin d|mesh-list
110040343|NCT01432704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110040344|NCT01432704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040345|NCT01432704|Vitamins|vitamins|mesh-ancestor
110040346|NCT01432704|Micronutrients|micronutrients|mesh-ancestor
110040347|NCT01432704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110040348|NCT01432717|Luspatercept|luspatercept|mesh-list
110040349|NCT01432717|Hematinics|hematinics|mesh-ancestor
110040350|NCT01432782|Botulinum Toxins|botulinum toxins|mesh-list
110040355|NCT01432782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110040356|NCT01432782|Cholinergic Agents|cholinergic agents|mesh-ancestor
110040357|NCT01432782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110040358|NCT01432782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040359|NCT01432782|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110040360|NCT01432782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110040361|NCT01432821|Apomorphine|apomorphine|mesh-list
110040363|NCT01432821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040365|NCT01432821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110040366|NCT01432821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110040367|NCT01432821|Dopamine Agonists|dopamine agonists|mesh-ancestor
110040368|NCT01432821|Dopamine Agents|dopamine agents|mesh-ancestor
110040369|NCT01432821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110040370|NCT01432821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110040371|NCT01432873|Selenium|selenium|mesh-list
110040372|NCT01432873|Antioxidants|antioxidants|mesh-ancestor
110040373|NCT01432873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110040374|NCT01432873|Protective Agents|protective agents|mesh-ancestor
110040375|NCT01432873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040376|NCT01432873|Trace Elements|trace elements|mesh-ancestor
110040377|NCT01432873|Micronutrients|micronutrients|mesh-ancestor
110040378|NCT01432977|Acetaminophen|acetaminophen|mesh-list
110040379|NCT01432977|Droperidol|droperidol|mesh-list
110040380|NCT01432977|Ondansetron|ondansetron|mesh-list
110040382|NCT01432977|Analgesics|analgesics|mesh-ancestor
110040383|NCT01432977|Sensory System Agents|sensory system agents|mesh-ancestor
110040384|NCT01432977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110040385|NCT01432977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040386|NCT01432977|Antipyretics|antipyretics|mesh-ancestor
110040387|NCT01432977|Antiemetics|antiemetics|mesh-ancestor
110040388|NCT01432977|Autonomic Agents|autonomic agents|mesh-ancestor
110040389|NCT01432977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110040390|NCT01432977|Antipruritics|antipruritics|mesh-ancestor
110040391|NCT01432977|Dermatologic Agents|dermatologic agents|mesh-ancestor
110040392|NCT01432977|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110040393|NCT01432977|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110040394|NCT01432977|Serotonin Agents|serotonin agents|mesh-ancestor
110040395|NCT01432977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110040396|NCT01432977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110040397|NCT01432977|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110040398|NCT01432977|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110040399|NCT01432977|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110040400|NCT01432977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110040401|NCT01432977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110040402|NCT01432977|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110040403|NCT01432977|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110040404|NCT01432977|Dopamine Agents|dopamine agents|mesh-ancestor
110040405|NCT01433445|Panobinostat|panobinostat|mesh-list
110040406|NCT01433445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110040407|NCT01433445|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110040408|NCT01433445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110040409|NCT01433445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110040410|NCT01433614|Paclitaxel|paclitaxel|mesh-list
110040411|NCT01433614|Capecitabine|capecitabine|mesh-list
110040412|NCT01433614|Epirubicin|epirubicin|mesh-list
110040413|NCT01433614|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110040414|NCT01433614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110040415|NCT01433614|Tubulin Modulators|tubulin modulators|mesh-ancestor
110040416|NCT01433614|Antimitotic Agents|antimitotic agents|mesh-ancestor
110040417|NCT01433614|Mitosis Modulators|mitosis modulators|mesh-ancestor
110040418|NCT01433614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110040419|NCT01433614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110040420|NCT01433614|Antimetabolites|antimetabolites|mesh-ancestor
110040421|NCT01433614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110040422|NCT01433614|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110040423|NCT01433614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110040425|NCT01433627|Hirudins|hirudins|mesh-list
110040426|NCT01433627|Bivalirudin|bivalirudin|mesh-list
110040427|NCT01433627|Antithrombins|antithrombins|mesh-ancestor
110040428|NCT01433627|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110040429|NCT01433627|Protease Inhibitors|protease inhibitors|mesh-ancestor
110040430|NCT01433627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110040431|NCT01433627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110040432|NCT01433627|Anticoagulants|anticoagulants|mesh-ancestor
110040433|NCT01433627|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110040434|NCT01433627|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110040435|NCT01433666|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-list
110040436|NCT01433666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110040437|NCT01433666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110040438|NCT01433666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110040439|NCT01433705|Regadenoson|regadenoson|mesh-list
110040440|NCT01433705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110040441|NCT01433705|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
110040442|NCT01433705|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110040443|NCT01433705|Purinergic Agonists|purinergic agonists|mesh-ancestor
110040444|NCT01433705|Purinergic Agents|purinergic agents|mesh-ancestor
110040445|NCT01433705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110040446|NCT01433705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040447|NCT01433757|Ampicillin|ampicillin|mesh-list
110040448|NCT01433757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110040449|NCT01433757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110040450|NCT01433770|Alefacept|alefacept|mesh-list
110040451|NCT01433770|Dermatologic Agents|dermatologic agents|mesh-ancestor
110040452|NCT01433770|Immunologic Factors|immunologic factors|mesh-ancestor
110040453|NCT01433770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040454|NCT01433887|Ribavirin|ribavirin|mesh-list
110040455|NCT01433887|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110040456|NCT01433887|Antimetabolites|antimetabolites|mesh-ancestor
110040457|NCT01433887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110040458|NCT01433887|Antiviral Agents|antiviral agents|mesh-ancestor
110040459|NCT01433887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110040460|NCT01433900|Latanoprost|latanoprost|mesh-list
110040461|NCT01433900|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110040462|NCT01433900|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110040463|NCT01433952|Thiamine|thiamine|mesh-list
110040465|NCT01433952|Vitamins|vitamins|mesh-ancestor
110040466|NCT01433952|Micronutrients|micronutrients|mesh-ancestor
110040467|NCT01433952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040468|NCT01434017|Dexamethasone|dexamethasone|mesh-list
110040469|NCT01434017|Dexamethasone acetate|dexamethasone acetate|mesh-list
110040470|NCT01434017|Droperidol|droperidol|mesh-list
110040471|NCT01434017|Ondansetron|ondansetron|mesh-list
110040472|NCT01434017|BB 1101|bb 1101|mesh-list
110040473|NCT01434017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110040474|NCT01434017|Antiemetics|antiemetics|mesh-ancestor
110040475|NCT01434017|Autonomic Agents|autonomic agents|mesh-ancestor
110040476|NCT01434017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110040477|NCT01434017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040478|NCT01434017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110040479|NCT01434017|Glucocorticoids|glucocorticoids|mesh-ancestor
110040480|NCT01434017|Hormones|hormones|mesh-ancestor
110040481|NCT01434017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110040482|NCT01434017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110040483|NCT01434017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110040484|NCT01434017|Protease Inhibitors|protease inhibitors|mesh-ancestor
110040485|NCT01434017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110040486|NCT01434017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110040487|NCT01434017|Antipruritics|antipruritics|mesh-ancestor
110040488|NCT01434017|Dermatologic Agents|dermatologic agents|mesh-ancestor
110040489|NCT01434017|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110040490|NCT01434017|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110040491|NCT01434017|Serotonin Agents|serotonin agents|mesh-ancestor
110040492|NCT01434017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110040493|NCT01434017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110040494|NCT01434017|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110040495|NCT01434017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110040496|NCT01434017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110040497|NCT01434017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110040498|NCT01434017|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110040499|NCT01434017|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110040500|NCT01434017|Dopamine Agents|dopamine agents|mesh-ancestor
110040501|NCT01434069|Leucovorin|leucovorin|mesh-list
110040505|NCT01434069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110040506|NCT01434069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110040507|NCT01434069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110040508|NCT01434069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110040509|NCT01434069|Immunologic Factors|immunologic factors|mesh-ancestor
110040510|NCT01434069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040511|NCT01434069|Antidotes|antidotes|mesh-ancestor
110040512|NCT01434069|Protective Agents|protective agents|mesh-ancestor
110040513|NCT01434069|Vitamin B Complex|vitamin b complex|mesh-ancestor
110040517|NCT01434069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110040518|NCT01434108|Phenylacetic acid|phenylacetic acid|mesh-list
110040519|NCT01434108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110040520|NCT01434108|Antimetabolites|antimetabolites|mesh-ancestor
110040521|NCT01434108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110040522|NCT01434108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110040523|NCT01434134|Metoprolol|metoprolol|mesh-list
110040524|NCT01434134|Candesartan|candesartan|mesh-list
110040525|NCT01434134|Candesartan cilexetil|candesartan cilexetil|mesh-list
110040526|NCT01434134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110040527|NCT01434134|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110040528|NCT01434134|Sympatholytics|sympatholytics|mesh-ancestor
110040529|NCT01434134|Autonomic Agents|autonomic agents|mesh-ancestor
110040530|NCT01434134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110040531|NCT01434134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040532|NCT01434134|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110040533|NCT01434134|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110040534|NCT01434134|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110040535|NCT01434134|Adrenergic Agents|adrenergic agents|mesh-ancestor
110040536|NCT01434134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110040537|NCT01434134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110040538|NCT01434134|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110040539|NCT01434134|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110040541|NCT01434147|Capecitabine|capecitabine|mesh-list
110040542|NCT01434147|Oxaliplatin|oxaliplatin|mesh-list
110040543|NCT01434147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110040544|NCT01434147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110040545|NCT01434147|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110040546|NCT01434147|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110040547|NCT01434147|Growth Substances|growth substances|mesh-ancestor
110040548|NCT01434147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040549|NCT01434147|Growth Inhibitors|growth inhibitors|mesh-ancestor
110040550|NCT01434147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110040551|NCT01434147|Antimetabolites|antimetabolites|mesh-ancestor
110040552|NCT01434147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110040553|NCT01434160|Levonorgestrel|levonorgestrel|mesh-list
110040554|NCT01434160|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110040555|NCT01434160|Contraceptive Agents|contraceptive agents|mesh-ancestor
110040556|NCT01434160|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110040557|NCT01434160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040558|NCT01434160|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110040559|NCT01434160|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110040560|NCT01434160|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110040561|NCT01434173|Amoxicillin|amoxicillin|mesh-list
110040562|NCT01434173|Moxifloxacin|moxifloxacin|mesh-list
110040563|NCT01434173|Clarithromycin|clarithromycin|mesh-list
110040564|NCT01434173|Doxycycline|doxycycline|mesh-list
110040565|NCT01434173|Levofloxacin|levofloxacin|mesh-list
110040566|NCT01434173|Clavulanic Acids|clavulanic acids|mesh-list
110040567|NCT01434173|Clavulanic Acid|clavulanic acid|mesh-list
110040568|NCT01434173|Cefuroxime|cefuroxime|mesh-list
110040569|NCT01434173|Telithromycin|telithromycin|mesh-list
110040570|NCT01434173|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110040571|NCT01434173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110040572|NCT01434173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110040573|NCT01434173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110040574|NCT01434173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110040575|NCT01434173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110040576|NCT01434173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110040577|NCT01434173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110040578|NCT01434173|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110040579|NCT01434173|Contraceptive Agents|contraceptive agents|mesh-ancestor
110040580|NCT01434173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110040581|NCT01434173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040582|NCT01434173|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110040583|NCT01434173|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110040584|NCT01434173|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110040585|NCT01434173|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110040586|NCT01434173|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110040587|NCT01434173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110040589|NCT01434173|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110040590|NCT01434173|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110040591|NCT01434173|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110040592|NCT01434173|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110040593|NCT01434173|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110040594|NCT01434212|Interferons|interferons|mesh-list
110040595|NCT01434212|Ribavirin|ribavirin|mesh-list
110040596|NCT01434212|Interferon-alpha|interferon-alpha|mesh-list
110040597|NCT01434212|Interferon alpha-2|interferon alpha-2|mesh-list
110040599|NCT01434212|Antiviral Agents|antiviral agents|mesh-ancestor
110040600|NCT01434212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110040601|NCT01434212|Antimetabolites|antimetabolites|mesh-ancestor
110040602|NCT01434212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110040603|NCT01434212|Immunologic Factors|immunologic factors|mesh-ancestor
110040604|NCT01434212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040606|NCT01434225|Diuretics|diuretics|mesh-ancestor
110040607|NCT01434225|Natriuretic Agents|natriuretic agents|mesh-ancestor
110040608|NCT01434225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040609|NCT01434225|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110040610|NCT01434225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110040611|NCT01434225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110040612|NCT01434251|Antihypertensive Agents|antihypertensive agents|mesh-list
110040613|NCT01434277|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110040614|NCT01434277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110040615|NCT01434303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110040616|NCT01434303|Trastuzumab|trastuzumab|mesh-list
110040617|NCT01434303|Lapatinib|lapatinib|mesh-list
110040618|NCT01434303|Entinostat|entinostat|mesh-list
110040619|NCT01434303|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
110040620|NCT01434303|Antibodies|antibodies|mesh-list
110040621|NCT01434303|Immunoglobulins|immunoglobulins|mesh-list
110040622|NCT01434303|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110040623|NCT01434303|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
110040624|NCT01434303|Immunologic Factors|immunologic factors|mesh-ancestor
110040625|NCT01434303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040626|NCT01434303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110040627|NCT01434303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110040628|NCT01434303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110040629|NCT01434303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110040632|NCT01434381|Immunologic Factors|immunologic factors|mesh-ancestor
110040633|NCT01434381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040634|NCT01434381|Antacids|antacids|mesh-ancestor
110040635|NCT01434381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110040636|NCT01434381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110040637|NCT01434394|Cetuximab|cetuximab|mesh-list
110040638|NCT01434394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110040639|NCT01434394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110040640|NCT01434459|Gemcitabine|gemcitabine|mesh-list
110040641|NCT01434459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110040642|NCT01434459|Antimetabolites|antimetabolites|mesh-ancestor
110040643|NCT01434459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110040644|NCT01434459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110040645|NCT01434849|Timolol|timolol|mesh-list
110040646|NCT01434849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110040647|NCT01434849|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110040648|NCT01434849|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110040649|NCT01434849|Adrenergic Agents|adrenergic agents|mesh-ancestor
110040650|NCT01434849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110040651|NCT01434849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040652|NCT01434849|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110040653|NCT01434849|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110040654|NCT01434862|Pramlintide|pramlintide|mesh-list
110040655|NCT01434862|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
110040656|NCT01434862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110040657|NCT01434862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040658|NCT01434862|Appetite Depressants|appetite depressants|mesh-ancestor
110040659|NCT01434862|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110040660|NCT01434862|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
110040661|NCT01434862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110040662|NCT01434888|Timolol|timolol|mesh-list
110040663|NCT01434888|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110040664|NCT01434888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110040665|NCT01434888|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110040666|NCT01434888|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110040667|NCT01434888|Adrenergic Agents|adrenergic agents|mesh-ancestor
110040668|NCT01434888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110040669|NCT01434888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110040670|NCT01434888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040671|NCT01434888|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110040672|NCT01434888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110040674|NCT01434901|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110040675|NCT01434901|Autonomic Agents|autonomic agents|mesh-ancestor
110040676|NCT01434901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110040677|NCT01434901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040678|NCT01434901|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110040679|NCT01434901|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110040680|NCT01434901|Cholinergic Agents|cholinergic agents|mesh-ancestor
110040681|NCT01434901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110040682|NCT01434901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110040683|NCT01434914|Octenidine|octenidine|mesh-list
110040684|NCT01434914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110040685|NCT01434914|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110040686|NCT01435083|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
110040687|NCT01435083|Hemostatics|hemostatics|mesh-ancestor
110040688|NCT01435083|Coagulants|coagulants|mesh-ancestor
110040689|NCT01435083|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110040690|NCT01435083|Natriuretic Agents|natriuretic agents|mesh-ancestor
110040691|NCT01435083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040692|NCT01435161|Telmisartan|telmisartan|mesh-list
110040693|NCT01435161|Antihypertensive Agents|antihypertensive agents|mesh-list
110040694|NCT01435161|Nifedipine|nifedipine|mesh-list
110040695|NCT01435161|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110040696|NCT01435161|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110040697|NCT01435161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110040698|NCT01435161|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110040699|NCT01435161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110040700|NCT01435161|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110040701|NCT01435161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040703|NCT01435161|Tocolytic Agents|tocolytic agents|mesh-ancestor
110040704|NCT01435161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110040705|NCT01435200|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
110040706|NCT01435200|Hematinics|hematinics|mesh-ancestor
110040707|NCT01435213|Insulin|insulin|mesh-list
110040708|NCT01435213|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110040710|NCT01435213|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110040711|NCT01435213|Atipamezole|atipamezole|mesh-list
110040712|NCT01435213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110040713|NCT01435213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040714|NCT01435213|Analgesics|analgesics|mesh-ancestor
110040715|NCT01435213|Sensory System Agents|sensory system agents|mesh-ancestor
110040716|NCT01435213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110040717|NCT01435213|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110040718|NCT01435213|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110040719|NCT01435213|Anesthetics, General|anesthetics, general|mesh-ancestor
110040720|NCT01435213|Anesthetics|anesthetics|mesh-ancestor
110040721|NCT01435213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110040722|NCT01435213|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110040723|NCT01435213|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110040724|NCT01435213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110040725|NCT01435213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110040726|NCT01435213|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110040727|NCT01435213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110040728|NCT01435213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110040729|NCT01435213|Adrenergic Agents|adrenergic agents|mesh-ancestor
110040730|NCT01435213|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110040731|NCT01435213|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110040732|NCT01435213|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110040733|NCT01435252|Cetuximab|cetuximab|mesh-list
110040734|NCT01435252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110040735|NCT01435252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110040736|NCT01435291|Tacrolimus|tacrolimus|mesh-list
110040737|NCT01435291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110040738|NCT01435291|Immunologic Factors|immunologic factors|mesh-ancestor
110040739|NCT01435291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040740|NCT01435291|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110040741|NCT01435291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110040742|NCT01435291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110040743|NCT01435343|Cytarabine|cytarabine|mesh-list
110040744|NCT01435343|Plerixafor|plerixafor|mesh-list
110040745|NCT01435343|Fludarabine|fludarabine|mesh-list
110040746|NCT01435343|Idarubicin|idarubicin|mesh-list
110040747|NCT01435343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110040748|NCT01435343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110040749|NCT01435343|Antimetabolites|antimetabolites|mesh-ancestor
110040750|NCT01435343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110040751|NCT01435343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110040752|NCT01435343|Immunologic Factors|immunologic factors|mesh-ancestor
110040753|NCT01435343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040754|NCT01435343|Antiviral Agents|antiviral agents|mesh-ancestor
110040755|NCT01435343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110040756|NCT01435343|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110040757|NCT01435343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110040758|NCT01435343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110040759|NCT01435343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110040760|NCT01435343|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110040761|NCT01435343|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110040762|NCT01435395|Bevacizumab|bevacizumab|mesh-list
110040763|NCT01435395|Temozolomide|temozolomide|mesh-list
110040764|NCT01435395|Bortezomib|bortezomib|mesh-list
110040765|NCT01435395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110040766|NCT01435395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110040767|NCT01435395|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110040768|NCT01435395|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110040769|NCT01435395|Growth Substances|growth substances|mesh-ancestor
110040770|NCT01435395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040771|NCT01435395|Growth Inhibitors|growth inhibitors|mesh-ancestor
110040772|NCT01435395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110040774|NCT01435395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110040776|NCT01435486|Caffeine citrate|caffeine citrate|mesh-list
110040777|NCT01435486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110040778|NCT01435486|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110040779|NCT01435486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040780|NCT01435486|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110040781|NCT01435486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110040782|NCT01435486|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110040783|NCT01435486|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110040785|NCT01435486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110040786|NCT01435499|Cyclophosphamide|cyclophosphamide|mesh-list
110040787|NCT01435499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110040788|NCT01435499|Immunologic Factors|immunologic factors|mesh-ancestor
110040789|NCT01435499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040790|NCT01435499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110040791|NCT01435499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110040792|NCT01435499|Alkylating Agents|alkylating agents|mesh-ancestor
110040793|NCT01435499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110040794|NCT01435499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110040795|NCT01435499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110040796|NCT01435707|Triamcinolone|triamcinolone|mesh-list
110040797|NCT01435707|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110040798|NCT01435707|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110040799|NCT01435707|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110040800|NCT01435707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110040801|NCT01435707|Glucocorticoids|glucocorticoids|mesh-ancestor
110040802|NCT01435707|Hormones|hormones|mesh-ancestor
110040803|NCT01435707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110040804|NCT01435707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040805|NCT01435707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110040806|NCT01435707|Immunologic Factors|immunologic factors|mesh-ancestor
110040807|NCT01435707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110040808|NCT01435707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110040809|NCT01435837|Caffeine|caffeine|mesh-list
110040810|NCT01435837|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110040811|NCT01435837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040812|NCT01435837|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110040813|NCT01435837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110040814|NCT01435837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110040815|NCT01435837|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110040816|NCT01435837|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110040817|NCT01435837|Purinergic Agents|purinergic agents|mesh-ancestor
110040818|NCT01435837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110040819|NCT01435915|Ropinirole|ropinirole|mesh-list
110040820|NCT01435915|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110040821|NCT01435915|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110040822|NCT01435915|Dopamine Agonists|dopamine agonists|mesh-ancestor
110040823|NCT01435915|Dopamine Agents|dopamine agents|mesh-ancestor
110040824|NCT01435915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110040825|NCT01435915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110040826|NCT01435915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040827|NCT01435941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110040828|NCT01435941|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
110040829|NCT01435941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110040830|NCT01435941|Analgesics|analgesics|mesh-ancestor
110040831|NCT01435941|Sensory System Agents|sensory system agents|mesh-ancestor
110040832|NCT01435941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110040833|NCT01435941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040835|NCT01435954|Doxazosin|doxazosin|mesh-list
110040836|NCT01435954|Tamsulosin|tamsulosin|mesh-list
110040837|NCT01435954|Finasteride|finasteride|mesh-list
110040838|NCT01435954|Silodosin|silodosin|mesh-list
110040839|NCT01435954|Terazosin|terazosin|mesh-list
110040840|NCT01435954|Alfuzosin|alfuzosin|mesh-list
110040841|NCT01435954|Dutasteride|dutasteride|mesh-list
110040842|NCT01435954|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110040843|NCT01435954|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110040844|NCT01435954|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110040845|NCT01435954|Adrenergic Agents|adrenergic agents|mesh-ancestor
110040846|NCT01435954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110040847|NCT01435954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110040848|NCT01435954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040849|NCT01435954|Urological Agents|urological agents|mesh-ancestor
110040850|NCT01435954|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110040851|NCT01435954|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110040852|NCT01435954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110040853|NCT01435954|Hormone Antagonists|hormone antagonists|mesh-ancestor
110040854|NCT01435954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110040855|NCT01435954|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110040856|NCT01435980|Exenatide|exenatide|mesh-list
110040857|NCT01435980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110040858|NCT01435980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040859|NCT01435980|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110040860|NCT01435980|Incretins|incretins|mesh-ancestor
110040861|NCT01435980|Hormones|hormones|mesh-ancestor
110040862|NCT01435980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110040863|NCT01436123|Everolimus|everolimus|mesh-list
110040864|NCT01436123|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110040865|NCT01436123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110040866|NCT01436123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110040867|NCT01436123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110040868|NCT01436123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110040869|NCT01436123|Immunologic Factors|immunologic factors|mesh-ancestor
110040870|NCT01436123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040871|NCT01436123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110040872|NCT01436188|Ibuprofen|ibuprofen|mesh-list
110040873|NCT01436188|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110040874|NCT01436188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110040875|NCT01436188|Analgesics|analgesics|mesh-ancestor
110040876|NCT01436188|Sensory System Agents|sensory system agents|mesh-ancestor
110040877|NCT01436188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110040878|NCT01436188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040879|NCT01436188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110040880|NCT01436188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110040881|NCT01436188|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110040882|NCT01436188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110040883|NCT01436188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110040884|NCT01436422|Vaccines|vaccines|mesh-list
110040885|NCT01436422|Immunologic Factors|immunologic factors|mesh-ancestor
110040886|NCT01436422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040887|NCT01435902|Fluticasone|fluticasone|mesh-list
110040888|NCT01435902|Xhance|xhance|mesh-list
110040889|NCT01435902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110040890|NCT01435902|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110040891|NCT01435902|Autonomic Agents|autonomic agents|mesh-ancestor
110040892|NCT01435902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110040893|NCT01435902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040894|NCT01435902|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110040896|NCT01435902|Dermatologic Agents|dermatologic agents|mesh-ancestor
110040897|NCT01435902|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110040898|NCT01436474|Varenicline|varenicline|mesh-list
110040899|NCT01436474|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110040900|NCT01436474|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110040901|NCT01436474|Cholinergic Agents|cholinergic agents|mesh-ancestor
110040902|NCT01436474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110040903|NCT01436474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110040904|NCT01436474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040905|NCT01436513|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110040906|NCT01436513|Estrogens|estrogens|mesh-ancestor
110040907|NCT01436513|Hormones|hormones|mesh-ancestor
110040908|NCT01436513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110040909|NCT01436513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040910|NCT01436539|Adefovir|adefovir|mesh-list
110040911|NCT01436539|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
110040912|NCT01436539|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
110040913|NCT01436539|Antiviral Agents|antiviral agents|mesh-ancestor
110040914|NCT01436539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110040915|NCT01436539|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110040916|NCT01436539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110040917|NCT01436539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110040918|NCT01436539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110040919|NCT01436539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110040920|NCT01436539|Antimetabolites|antimetabolites|mesh-ancestor
110040921|NCT01436539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110040922|NCT01436578|Posaconazole|posaconazole|mesh-list
110040923|NCT01436578|Antifungal Agents|antifungal agents|mesh-ancestor
110040924|NCT01436578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110040925|NCT01436578|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110040926|NCT01436578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110040927|NCT01436578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110040928|NCT01436578|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110040929|NCT01436578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110040930|NCT01436578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110040931|NCT01436578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110040932|NCT01436578|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110040933|NCT01436578|Hormone Antagonists|hormone antagonists|mesh-ancestor
110040934|NCT01436578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110040935|NCT01436578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040937|NCT01436825|Coagulants|coagulants|mesh-ancestor
110040938|NCT01436838|Interferons|interferons|mesh-list
110040939|NCT01436838|Interferon-beta|interferon-beta|mesh-list
110040940|NCT01436838|Interferon beta-1b|interferon beta-1b|mesh-list
110040941|NCT01436838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110040942|NCT01436838|Antiviral Agents|antiviral agents|mesh-ancestor
110040943|NCT01436838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110040944|NCT01436838|Immunologic Factors|immunologic factors|mesh-ancestor
110040945|NCT01436838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040946|NCT01436838|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110040947|NCT01436916|Cholecalciferol|cholecalciferol|mesh-list
110040949|NCT01436916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110040950|NCT01436916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040951|NCT01436916|Vitamins|vitamins|mesh-ancestor
110040952|NCT01436916|Micronutrients|micronutrients|mesh-ancestor
110040953|NCT01436916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110040954|NCT01436929|Silymarin|silymarin|mesh-list
110040955|NCT01436929|Antioxidants|antioxidants|mesh-ancestor
110040956|NCT01436929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110040957|NCT01436929|Protective Agents|protective agents|mesh-ancestor
110040958|NCT01436929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040959|NCT01436994|Propylthiouracil|propylthiouracil|mesh-list
110040960|NCT01436994|Carbimazole|carbimazole|mesh-list
110040961|NCT01436994|Antimetabolites|antimetabolites|mesh-ancestor
110040962|NCT01436994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110040963|NCT01436994|Antithyroid Agents|antithyroid agents|mesh-ancestor
110040964|NCT01436994|Hormone Antagonists|hormone antagonists|mesh-ancestor
110040965|NCT01436994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110040966|NCT01436994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040968|NCT01437007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110040969|NCT01437007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110041046|NCT01437462|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110040970|NCT01437007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110040971|NCT01437020|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110040972|NCT01437020|Antifungal Agents|antifungal agents|mesh-ancestor
110040973|NCT01437020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110040974|NCT01437020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110040975|NCT01437020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110040977|NCT01437046|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110040978|NCT01437046|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110040979|NCT01437046|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110040980|NCT01437046|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110040981|NCT01437046|Adrenergic Agents|adrenergic agents|mesh-ancestor
110040982|NCT01437046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110040983|NCT01437046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110040984|NCT01437046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040985|NCT01437189|Sertraline|sertraline|mesh-list
110040986|NCT01437189|Antidepressive Agents|antidepressive agents|mesh-ancestor
110040987|NCT01437189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110040988|NCT01437189|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110040989|NCT01437189|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110040990|NCT01437189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110040991|NCT01437189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110040992|NCT01437189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110040993|NCT01437189|Serotonin Agents|serotonin agents|mesh-ancestor
110040994|NCT01437189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040995|NCT01437228|Povidone-Iodine|povidone-iodine|mesh-list
110040997|NCT01437228|Plasma Substitutes|plasma substitutes|mesh-ancestor
110040998|NCT01437228|Blood Substitutes|blood substitutes|mesh-ancestor
110040999|NCT01437228|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110041000|NCT01437228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110041001|NCT01437293|Carbidopa|carbidopa|mesh-list
110041002|NCT01437293|Entacapone|entacapone|mesh-list
110041003|NCT01437293|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110041004|NCT01437293|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110041005|NCT01437293|Dopamine Agents|dopamine agents|mesh-ancestor
110041006|NCT01437293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110041007|NCT01437293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110041008|NCT01437293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041009|NCT01437293|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110041010|NCT01437293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110041011|NCT01437293|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
110041012|NCT01437306|Lofexidine|lofexidine|mesh-list
110041013|NCT01437306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110041014|NCT01437306|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110041015|NCT01437306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041016|NCT01437306|Sensory System Agents|sensory system agents|mesh-ancestor
110041017|NCT01437306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110041018|NCT01437306|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110041019|NCT01437306|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110041020|NCT01437306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110041021|NCT01437306|Adrenergic Agents|adrenergic agents|mesh-ancestor
110041022|NCT01437306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110041023|NCT01437306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110041024|NCT01437371|Ramipril|ramipril|mesh-list
110041025|NCT01437371|Enalapril|enalapril|mesh-list
110041026|NCT01437371|Lisinopril|lisinopril|mesh-list
110041027|NCT01437371|Captopril|captopril|mesh-list
110041028|NCT01437371|Trandolapril|trandolapril|mesh-list
110041029|NCT01437371|Enzyme Inhibitors|enzyme inhibitors|mesh-list
110041030|NCT01437371|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110041031|NCT01437371|Protease Inhibitors|protease inhibitors|mesh-ancestor
110041032|NCT01437371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110041033|NCT01437371|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110041034|NCT01437371|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110041035|NCT01437371|Protective Agents|protective agents|mesh-ancestor
110041036|NCT01437371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041037|NCT01437462|Propofol|propofol|mesh-list
110041038|NCT01437462|Sevoflurane|sevoflurane|mesh-list
110041039|NCT01437462|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110041041|NCT01437462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041042|NCT01437462|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110041043|NCT01437462|Anesthetics, General|anesthetics, general|mesh-ancestor
110041044|NCT01437462|Anesthetics|anesthetics|mesh-ancestor
110041045|NCT01437462|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110041047|NCT01437566|Fulvestrant|fulvestrant|mesh-list
110041048|NCT01437566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110041049|NCT01437566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110041050|NCT01437566|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110041051|NCT01437566|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110041052|NCT01437566|Hormone Antagonists|hormone antagonists|mesh-ancestor
110041053|NCT01437566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110041054|NCT01437566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041055|NCT01437579|Botulinum Toxins|botulinum toxins|mesh-list
110041056|NCT01437579|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110041057|NCT01437579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110041058|NCT01437579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110041059|NCT01437579|Cholinergic Agents|cholinergic agents|mesh-ancestor
110041060|NCT01437579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110041061|NCT01437579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041063|NCT01437592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110041064|NCT01437592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041065|NCT01437618|Bevacizumab|bevacizumab|mesh-list
110041066|NCT01437618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110041067|NCT01437618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110041068|NCT01437618|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110041069|NCT01437618|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110041070|NCT01437618|Growth Substances|growth substances|mesh-ancestor
110041071|NCT01437618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041072|NCT01437618|Growth Inhibitors|growth inhibitors|mesh-ancestor
110041073|NCT01437644|Botulinum Toxins|botulinum toxins|mesh-list
110041074|NCT01437644|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110041075|NCT01437644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110041076|NCT01437644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110041077|NCT01437644|Cholinergic Agents|cholinergic agents|mesh-ancestor
110041078|NCT01437644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110041080|NCT01437670|Solifenacin Succinate|solifenacin succinate|mesh-list
110041081|NCT01437670|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110041082|NCT01437670|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110041083|NCT01437670|Cholinergic Agents|cholinergic agents|mesh-ancestor
110041084|NCT01437670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110041085|NCT01437670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110041086|NCT01437670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041087|NCT01437670|Urological Agents|urological agents|mesh-ancestor
110041089|NCT01437696|Ergocalciferols|ergocalciferols|mesh-list
110041090|NCT01437696|Cholecalciferol|cholecalciferol|mesh-list
110041091|NCT01437696|Vitamins|vitamins|mesh-list
110041092|NCT01437696|Micronutrients|micronutrients|mesh-ancestor
110041093|NCT01437696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041094|NCT01437696|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110041095|NCT01437696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110041097|NCT01437748|Tiotropium Bromide|tiotropium bromide|mesh-list
110041098|NCT01437748|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110041099|NCT01437748|Autonomic Agents|autonomic agents|mesh-ancestor
110041100|NCT01437748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110041101|NCT01437748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041102|NCT01437748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110041103|NCT01437748|Respiratory System Agents|respiratory system agents|mesh-ancestor
110041104|NCT01437748|Parasympatholytics|parasympatholytics|mesh-ancestor
110041105|NCT01437748|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110041106|NCT01437748|Cholinergic Agents|cholinergic agents|mesh-ancestor
110041107|NCT01437748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110041108|NCT01437748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110041109|NCT01437748|Anticonvulsants|anticonvulsants|mesh-ancestor
110041110|NCT01437800|Metformin|metformin|mesh-list
110041111|NCT01437800|Glimepiride|glimepiride|mesh-list
110041112|NCT01437800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110041113|NCT01437800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041114|NCT01437800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110041115|NCT01437800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110041116|NCT01437800|Immunologic Factors|immunologic factors|mesh-ancestor
110041118|NCT01437813|Glimepiride|glimepiride|mesh-list
110041119|NCT01437813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110041120|NCT01437813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041121|NCT01437813|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110041122|NCT01437813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110041123|NCT01437813|Immunologic Factors|immunologic factors|mesh-ancestor
110041124|NCT01437826|Selenium|selenium|mesh-list
110041125|NCT01437826|Antioxidants|antioxidants|mesh-list
110041129|NCT01437826|Trace Elements|trace elements|mesh-ancestor
110041130|NCT01437826|Micronutrients|micronutrients|mesh-ancestor
110041131|NCT01437839|Apixaban|apixaban|mesh-list
110041132|NCT01437839|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110041133|NCT01437839|Antithrombins|antithrombins|mesh-ancestor
110041134|NCT01437839|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110041135|NCT01437839|Protease Inhibitors|protease inhibitors|mesh-ancestor
110041136|NCT01437839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110041137|NCT01437839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110041138|NCT01437839|Anticoagulants|anticoagulants|mesh-ancestor
110041139|NCT01437982|Loteprednol Etabonate|loteprednol etabonate|mesh-list
110041140|NCT01437982|Prednisolone|prednisolone|mesh-list
110041141|NCT01437982|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110041142|NCT01437982|Methylprednisolone|methylprednisolone|mesh-list
110041143|NCT01437982|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110041144|NCT01437982|Prednisolone acetate|prednisolone acetate|mesh-list
110041145|NCT01437982|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110041146|NCT01437982|Prednisolone phosphate|prednisolone phosphate|mesh-list
110041147|NCT01437982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110041148|NCT01437982|Glucocorticoids|glucocorticoids|mesh-ancestor
110041149|NCT01437982|Hormones|hormones|mesh-ancestor
110041150|NCT01437982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110041151|NCT01437982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041152|NCT01437982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110041153|NCT01437982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110041154|NCT01437982|Antiemetics|antiemetics|mesh-ancestor
110041155|NCT01437982|Autonomic Agents|autonomic agents|mesh-ancestor
110041156|NCT01437982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110041157|NCT01437982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110041158|NCT01437982|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110041159|NCT01437982|Protective Agents|protective agents|mesh-ancestor
110041161|NCT01438021|Methotrexate|methotrexate|mesh-list
110041162|NCT01438021|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110041163|NCT01438021|Abortifacient Agents|abortifacient agents|mesh-ancestor
110041164|NCT01438021|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110041165|NCT01438021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041166|NCT01438021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110041167|NCT01438021|Antimetabolites|antimetabolites|mesh-ancestor
110041168|NCT01438021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110041169|NCT01438021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110041170|NCT01438021|Dermatologic Agents|dermatologic agents|mesh-ancestor
110041171|NCT01438021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110041172|NCT01438021|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110041173|NCT01438021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110041174|NCT01438021|Immunologic Factors|immunologic factors|mesh-ancestor
110041175|NCT01438021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110041176|NCT01438021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110041177|NCT01438086|Mecasermin|mecasermin|mesh-list
110041178|NCT01438086|Growth Substances|growth substances|mesh-ancestor
110041179|NCT01438086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041180|NCT01438112|Interferons|interferons|mesh-list
110041181|NCT01438112|Gemcitabine|gemcitabine|mesh-list
110041182|NCT01438112|Mitomycins|mitomycins|mesh-list
110041183|NCT01438112|Mitomycin|mitomycin|mesh-list
110041184|NCT01438112|Valrubicin|valrubicin|mesh-list
110041185|NCT01438112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110041186|NCT01438112|Antimetabolites|antimetabolites|mesh-ancestor
110041187|NCT01438112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110041188|NCT01438112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110041189|NCT01438112|Antiviral Agents|antiviral agents|mesh-ancestor
110041190|NCT01438112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110041191|NCT01438112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110041192|NCT01438112|Alkylating Agents|alkylating agents|mesh-ancestor
110041193|NCT01438112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110041194|NCT01438112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110041195|NCT01438112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110041196|NCT01438112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110041197|NCT01438190|Metformin|metformin|mesh-list
110041198|NCT01438190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110041199|NCT01438190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041200|NCT01438320|Quercetin|quercetin|mesh-list
110041201|NCT01438320|Antioxidants|antioxidants|mesh-ancestor
110041202|NCT01438320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110041203|NCT01438320|Protective Agents|protective agents|mesh-ancestor
110041204|NCT01438320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041205|NCT05578859|Sotorasib|sotorasib|mesh-list
110041206|NCT05578859|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110041207|NCT05578859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110041208|NCT05578859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110041209|NCT05578859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110041210|NCT05554393|Cytarabine|cytarabine|mesh-list
110041211|NCT05554393|Azacitidine|azacitidine|mesh-list
110041212|NCT05554393|Daunorubicin|daunorubicin|mesh-list
110041213|NCT05554393|Venetoclax|venetoclax|mesh-list
110041214|NCT05554393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110041215|NCT05554393|Antimetabolites|antimetabolites|mesh-ancestor
110041216|NCT05554393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110041217|NCT05554393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110041218|NCT05554393|Antiviral Agents|antiviral agents|mesh-ancestor
110041219|NCT05554393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110041220|NCT05554393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110041221|NCT05554393|Immunologic Factors|immunologic factors|mesh-ancestor
110041222|NCT05554393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041223|NCT05554393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110041224|NCT05554393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110041225|NCT05554393|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110041226|NCT05554393|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110041227|NCT05525013|Simvastatin|simvastatin|mesh-list
110041228|NCT05525013|Calcium|calcium|mesh-list
110041229|NCT05525013|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110041230|NCT05525013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041231|NCT05525013|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110041232|NCT05525013|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110041233|NCT05525013|Antimetabolites|antimetabolites|mesh-ancestor
110041234|NCT05525013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110041235|NCT05525013|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110041236|NCT05525013|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110041237|NCT05525013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110041238|NCT05465174|Nivolumab|nivolumab|mesh-list
110041239|NCT05465174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110041240|NCT05465174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110041241|NCT05465174|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110041242|NCT05465174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110041243|NCT05418088|Cyclophosphamide|cyclophosphamide|mesh-list
110041244|NCT05418088|Fludarabine|fludarabine|mesh-list
110041245|NCT05418088|Fludarabine phosphate|fludarabine phosphate|mesh-list
110041246|NCT05418088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110041247|NCT05418088|Immunologic Factors|immunologic factors|mesh-ancestor
110041248|NCT05418088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041249|NCT05418088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110041250|NCT05418088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110041251|NCT05418088|Alkylating Agents|alkylating agents|mesh-ancestor
110041252|NCT05418088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110041253|NCT05418088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110041254|NCT05418088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110041255|NCT05418088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110041256|NCT05418088|Antimetabolites|antimetabolites|mesh-ancestor
110041257|NCT05387525|Diclofenac|diclofenac|mesh-list
110041258|NCT05387525|Tirbanibulin|tirbanibulin|mesh-list
110041259|NCT05387525|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110041260|NCT05387525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110041261|NCT05387525|Analgesics|analgesics|mesh-ancestor
110041262|NCT05387525|Sensory System Agents|sensory system agents|mesh-ancestor
110041263|NCT05387525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110041264|NCT05387525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041265|NCT05387525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110041266|NCT05387525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110041267|NCT05387525|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110041268|NCT05387525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110041269|NCT05387525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110041270|NCT05382312|Bedaquiline|bedaquiline|mesh-list
110041272|NCT05382312|Antitubercular Agents|antitubercular agents|mesh-ancestor
110041273|NCT05382312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110041274|NCT05382312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110041277|NCT05371275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110041278|NCT05371275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110041279|NCT05371275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110041280|NCT05370794|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110041281|NCT05370794|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110041282|NCT05370794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041284|NCT05343507|Analgesics|analgesics|mesh-ancestor
110041285|NCT05343507|Sensory System Agents|sensory system agents|mesh-ancestor
110041286|NCT05343507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110041287|NCT05343507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041288|NCT05343507|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110041290|NCT05343507|Anesthetics, General|anesthetics, general|mesh-ancestor
110041291|NCT05343507|Anesthetics|anesthetics|mesh-ancestor
110041292|NCT05343507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110041293|NCT05343507|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110041294|NCT05343507|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110041295|NCT05343507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110041296|NCT05343507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110041297|NCT05213832|Isoflurane|isoflurane|mesh-list
110041298|NCT05213832|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110041299|NCT05213832|Anesthetics, General|anesthetics, general|mesh-ancestor
110041300|NCT05213832|Anesthetics|anesthetics|mesh-ancestor
110041301|NCT05213832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110041302|NCT05213832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041303|NCT05164159|Propofol|propofol|mesh-list
110041304|NCT05164159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110041305|NCT05164159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110041306|NCT05164159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041309|NCT05164159|Anesthetics|anesthetics|mesh-ancestor
110041310|NCT05164146|Propofol|propofol|mesh-list
110041311|NCT05164146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110041312|NCT05164146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110041313|NCT05164146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041314|NCT05164146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110041315|NCT05164146|Anesthetics, General|anesthetics, general|mesh-ancestor
110041316|NCT05164146|Anesthetics|anesthetics|mesh-ancestor
110041317|NCT05111431|Dexmedetomidine|dexmedetomidine|mesh-list
110041318|NCT05111431|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110041319|NCT05111431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110041320|NCT05111431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041321|NCT05111431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110041322|NCT05111431|Analgesics|analgesics|mesh-ancestor
110041323|NCT05111431|Sensory System Agents|sensory system agents|mesh-ancestor
110041324|NCT05111431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110041325|NCT05111431|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110041326|NCT05111431|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110041327|NCT05111431|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110041328|NCT05111431|Adrenergic Agents|adrenergic agents|mesh-ancestor
110041329|NCT05111431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110041330|NCT05111431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110041331|NCT04965298|Lansoprazole|lansoprazole|mesh-list
110041332|NCT04965298|Dexlansoprazole|dexlansoprazole|mesh-list
110041333|NCT04965298|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110041334|NCT04965298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110041335|NCT04965298|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110041336|NCT04965298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110041337|NCT04965298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110041338|NCT04956939|Levodopa|levodopa|mesh-list
110041339|NCT04956939|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110041340|NCT04956939|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110041341|NCT04956939|Dopamine Agents|dopamine agents|mesh-ancestor
110041342|NCT04956939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110041343|NCT04956939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110041344|NCT04956939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041345|NCT04955470|Midazolam|midazolam|mesh-list
110041346|NCT04955470|Ketamine|ketamine|mesh-list
110041347|NCT04955470|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110041348|NCT04955470|Analgesics|analgesics|mesh-ancestor
110041349|NCT04955470|Sensory System Agents|sensory system agents|mesh-ancestor
110041350|NCT04955470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110041351|NCT04955470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041353|NCT04955470|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110041354|NCT04955470|Anesthetics, General|anesthetics, general|mesh-ancestor
110041355|NCT04955470|Anesthetics|anesthetics|mesh-ancestor
110041356|NCT04955470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110041357|NCT04955470|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110041358|NCT04955470|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110041359|NCT04955470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110041360|NCT04955470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110041361|NCT04955470|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110041362|NCT04955470|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110041363|NCT04955470|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110041364|NCT04955470|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110041365|NCT04955470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110041366|NCT04955470|GABA Modulators|gaba modulators|mesh-ancestor
110041367|NCT04955470|GABA Agents|gaba agents|mesh-ancestor
110041368|NCT04938557|Insulin|insulin|mesh-list
110041369|NCT04938557|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110041370|NCT04938557|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110041371|NCT04938557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041372|NCT04922567|Prednisone|prednisone|mesh-list
110041373|NCT04922567|Cyclophosphamide|cyclophosphamide|mesh-list
110041374|NCT04922567|Doxorubicin|doxorubicin|mesh-list
110041375|NCT04922567|Vincristine|vincristine|mesh-list
110041376|NCT04922567|Lenalidomide|lenalidomide|mesh-list
110041377|NCT04922567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110041378|NCT04922567|Immunologic Factors|immunologic factors|mesh-ancestor
110041379|NCT04922567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041380|NCT04922567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110041381|NCT04922567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110041384|NCT04922567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110041385|NCT04922567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110041386|NCT04922567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110041387|NCT04922567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110041388|NCT04922567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110041389|NCT04922567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110041390|NCT04922567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110041391|NCT04922567|Glucocorticoids|glucocorticoids|mesh-ancestor
110041392|NCT04922567|Hormones|hormones|mesh-ancestor
110041393|NCT04922567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110041394|NCT04922567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110041395|NCT04922567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110041396|NCT04922567|Tubulin Modulators|tubulin modulators|mesh-ancestor
110041397|NCT04922567|Antimitotic Agents|antimitotic agents|mesh-ancestor
110041398|NCT04922567|Mitosis Modulators|mitosis modulators|mesh-ancestor
110041399|NCT04922567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110041400|NCT04922567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110041401|NCT04922567|Growth Substances|growth substances|mesh-ancestor
110041402|NCT04922567|Growth Inhibitors|growth inhibitors|mesh-ancestor
110041403|NCT04850222|Fluoxetine|fluoxetine|mesh-list
110041404|NCT04850222|Calcium|calcium|mesh-list
110041405|NCT04850222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110041406|NCT04850222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041407|NCT04850222|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110041408|NCT04850222|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110041409|NCT04850222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110041410|NCT04850222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110041412|NCT04850222|Serotonin Agents|serotonin agents|mesh-ancestor
110041413|NCT04850222|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110041415|NCT04850222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110041416|NCT04850222|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110041417|NCT04850222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110041418|NCT04850222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110041419|NCT04800692|Verapamil|verapamil|mesh-list
110041420|NCT04800692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110041421|NCT04800692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110041422|NCT04800692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110041423|NCT04800692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110041424|NCT04800692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110041425|NCT04800692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041426|NCT04800692|Vasodilator Agents|vasodilator agents|mesh-ancestor
110041427|NCT04787848|Bromides|bromides|mesh-list
110041428|NCT04787848|Methylnaltrexone|methylnaltrexone|mesh-list
110041429|NCT04787848|Anticonvulsants|anticonvulsants|mesh-ancestor
110041430|NCT04787848|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110041431|NCT04787848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041432|NCT04787848|Sensory System Agents|sensory system agents|mesh-ancestor
110041433|NCT04787848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110041434|NCT04660799|Diphenhydramine|diphenhydramine|mesh-list
110041435|NCT04660799|Promethazine|promethazine|mesh-list
110041436|NCT04660799|Prednisone|prednisone|mesh-list
110041437|NCT04660799|Cyclophosphamide|cyclophosphamide|mesh-list
110041438|NCT04660799|Rituximab|rituximab|mesh-list
110041439|NCT04660799|Doxorubicin|doxorubicin|mesh-list
110041440|NCT04660799|Vincristine|vincristine|mesh-list
110041441|NCT04660799|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
110041442|NCT04660799|Histamine Antagonists|histamine antagonists|mesh-list
110041443|NCT04660799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110041444|NCT04660799|Immunologic Factors|immunologic factors|mesh-ancestor
110041445|NCT04660799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041446|NCT04660799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110041447|NCT04660799|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110041448|NCT04660799|Alkylating Agents|alkylating agents|mesh-ancestor
110041449|NCT04660799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110041450|NCT04660799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110041451|NCT04660799|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110041452|NCT04660799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110041453|NCT04660799|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110041454|NCT04660799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110041457|NCT04660799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110041458|NCT04660799|Glucocorticoids|glucocorticoids|mesh-ancestor
110041459|NCT04660799|Hormones|hormones|mesh-ancestor
110041460|NCT04660799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110041461|NCT04660799|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110041462|NCT04660799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110041463|NCT04660799|Tubulin Modulators|tubulin modulators|mesh-ancestor
110041464|NCT04660799|Antimitotic Agents|antimitotic agents|mesh-ancestor
110041465|NCT04660799|Mitosis Modulators|mitosis modulators|mesh-ancestor
110041466|NCT04660799|Sensory System Agents|sensory system agents|mesh-ancestor
110041467|NCT04660799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110041468|NCT04660799|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110041469|NCT04660799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110041470|NCT04660799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110041471|NCT04660799|Anesthetics, Local|anesthetics, local|mesh-ancestor
110041472|NCT04660799|Anesthetics|anesthetics|mesh-ancestor
110041473|NCT04660799|Antiemetics|antiemetics|mesh-ancestor
110041474|NCT04660799|Autonomic Agents|autonomic agents|mesh-ancestor
110041475|NCT04660799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110041476|NCT04660799|Histamine Agents|histamine agents|mesh-ancestor
110041477|NCT04660799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110041478|NCT04660799|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110041479|NCT04660799|Antipruritics|antipruritics|mesh-ancestor
110041480|NCT04660799|Dermatologic Agents|dermatologic agents|mesh-ancestor
110041481|NCT04636632|Fosaprepitant|fosaprepitant|mesh-list
110041482|NCT04636632|Aprepitant|aprepitant|mesh-list
110041483|NCT04636632|Antiemetics|antiemetics|mesh-ancestor
110041484|NCT04636632|Autonomic Agents|autonomic agents|mesh-ancestor
110041485|NCT04636632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110041486|NCT04636632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041487|NCT04636632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110041488|NCT04636632|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110041489|NCT04636632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110041490|NCT04636632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110041492|NCT04597372|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110041493|NCT04597372|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110041494|NCT04597372|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110041495|NCT04597372|Adrenergic Agents|adrenergic agents|mesh-ancestor
110041496|NCT04597372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110041497|NCT04597372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110041498|NCT04597372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041499|NCT04597372|Urological Agents|urological agents|mesh-ancestor
110041500|NCT04585542|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
110041501|NCT04585542|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
110041502|NCT04585542|Laxatives|laxatives|mesh-ancestor
110041503|NCT04585542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110041504|NCT04585542|Chelating Agents|chelating agents|mesh-ancestor
110041505|NCT04585542|Sequestering Agents|sequestering agents|mesh-ancestor
110041506|NCT04585542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110041507|NCT04545060|Sotrovimab|sotrovimab|mesh-list
110041508|NCT04545060|Antiviral Agents|antiviral agents|mesh-ancestor
110041509|NCT04545060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110041511|NCT04502602|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110041512|NCT04502602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110041513|NCT04502602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110041514|NCT04502602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110041515|NCT04375202|Colchicine|colchicine|mesh-list
110041516|NCT04375202|Gout Suppressants|gout suppressants|mesh-ancestor
110041517|NCT04375202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110041518|NCT04375202|Tubulin Modulators|tubulin modulators|mesh-ancestor
110041519|NCT04375202|Antimitotic Agents|antimitotic agents|mesh-ancestor
110041520|NCT04375202|Mitosis Modulators|mitosis modulators|mesh-ancestor
110041521|NCT04375202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110041522|NCT04375202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110041523|NCT04345744|Chlorhexidine|chlorhexidine|mesh-list
110041524|NCT04345744|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110041525|NCT04345744|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110041526|NCT04345744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110041527|NCT04345744|Disinfectants|disinfectants|mesh-ancestor
110041528|NCT04345744|Dermatologic Agents|dermatologic agents|mesh-ancestor
110041529|NCT04332393|Metformin|metformin|mesh-list
110041531|NCT04332393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041533|NCT04329572|Hydroxychloroquine|hydroxychloroquine|mesh-list
110041534|NCT04329572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110041535|NCT04329572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110041536|NCT04329572|Antimalarials|antimalarials|mesh-ancestor
110041537|NCT04329572|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110041538|NCT04329572|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110041539|NCT04329572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110041540|NCT04329572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110041541|NCT04329572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110041543|NCT04322552|Digoxin|digoxin|mesh-list
110041544|NCT04322552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110041545|NCT04322552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110041546|NCT04322552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110041547|NCT04322552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110041548|NCT04322552|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110041549|NCT04322552|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110041550|NCT04322552|Protective Agents|protective agents|mesh-ancestor
110041551|NCT04322552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041552|NCT04234061|Tisagenlecleucel|tisagenlecleucel|mesh-list
110041553|NCT04234061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110041554|NCT04234061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110041555|NCT04189848|Dulaglutide|dulaglutide|mesh-list
110041556|NCT04189848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110041557|NCT04189848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041558|NCT04156334|Anesthetics|anesthetics|mesh-list
110041559|NCT04156334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110041560|NCT04156334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041561|NCT04078906|SMOFlipid|smoflipid|mesh-list
110041562|NCT04078906|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
110041563|NCT04078906|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110041564|NCT04078906|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110041565|NCT03980171|Lenalidomide|lenalidomide|mesh-list
110041566|NCT03980171|Venetoclax|venetoclax|mesh-list
110041567|NCT03980171|Obinutuzumab|obinutuzumab|mesh-list
110041568|NCT03980171|Immunologic Factors|immunologic factors|mesh-ancestor
110041569|NCT03980171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041570|NCT03980171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110041571|NCT03980171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110041572|NCT03980171|Growth Substances|growth substances|mesh-ancestor
110041573|NCT03980171|Growth Inhibitors|growth inhibitors|mesh-ancestor
110041574|NCT03980171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110041575|NCT03980171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110041576|NCT03979365|Tacrolimus|tacrolimus|mesh-list
110041577|NCT03979365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110041578|NCT03979365|Immunologic Factors|immunologic factors|mesh-ancestor
110041579|NCT03979365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041580|NCT03979365|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110041581|NCT03979365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110041582|NCT03979365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110041583|NCT03860077|Nicotine|nicotine|mesh-list
110041584|NCT03860077|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110041585|NCT03860077|Autonomic Agents|autonomic agents|mesh-ancestor
110041586|NCT03860077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110041587|NCT03860077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041588|NCT03860077|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110041589|NCT03860077|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110041590|NCT03860077|Cholinergic Agents|cholinergic agents|mesh-ancestor
110041591|NCT03860077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110041592|NCT03860077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110041593|NCT03558724|Bevacizumab|bevacizumab|mesh-list
110041594|NCT03558724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110041595|NCT03558724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110041596|NCT03558724|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110041597|NCT03558724|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110041598|NCT03558724|Growth Substances|growth substances|mesh-ancestor
110041599|NCT03558724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041600|NCT03558724|Growth Inhibitors|growth inhibitors|mesh-ancestor
110041601|NCT03512496|Caffeine|caffeine|mesh-list
110041602|NCT03512496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110041603|NCT03512496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041604|NCT03512496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110041605|NCT03512496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110041607|NCT03512496|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110041608|NCT03512496|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110041609|NCT03512496|Purinergic Agents|purinergic agents|mesh-ancestor
110041610|NCT03512496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110041611|NCT03416127|Metformin|metformin|mesh-list
110041612|NCT03416127|Propolis|propolis|mesh-list
110041613|NCT03416127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110041614|NCT03416127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041615|NCT03416127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110041616|NCT03293069|Deferiprone|deferiprone|mesh-list
110041617|NCT03293069|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110041618|NCT03293069|Chelating Agents|chelating agents|mesh-ancestor
110041619|NCT03293069|Sequestering Agents|sequestering agents|mesh-ancestor
110041620|NCT03293069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110041621|NCT03255018|Pembrolizumab|pembrolizumab|mesh-list
110041622|NCT03255018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110041623|NCT03255018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110041624|NCT03255018|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110041625|NCT03255018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110041626|NCT03232346|Buprenorphine|buprenorphine|mesh-list
110041627|NCT03232346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110041628|NCT03232346|Narcotics|narcotics|mesh-ancestor
110041629|NCT03232346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110041630|NCT03232346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041631|NCT03232346|Analgesics|analgesics|mesh-ancestor
110041632|NCT03232346|Sensory System Agents|sensory system agents|mesh-ancestor
110041633|NCT03232346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110041634|NCT03232346|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110041635|NCT03227731|Tenofovir|tenofovir|mesh-list
110041636|NCT03227731|Emtricitabine|emtricitabine|mesh-list
110041637|NCT03227731|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110041638|NCT03227731|Antiviral Agents|antiviral agents|mesh-ancestor
110041639|NCT03227731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110041640|NCT03227731|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110041641|NCT03227731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110041642|NCT03227731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110041643|NCT03227731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110041644|NCT03227731|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110041645|NCT03227731|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110041646|NCT03200015|Metformin|metformin|mesh-list
110041647|NCT03200015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110041648|NCT03200015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041649|NCT03193281|Imatinib Mesylate|imatinib mesylate|mesh-list
110041650|NCT03193281|Dasatinib|dasatinib|mesh-list
110041651|NCT03193281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110041652|NCT03193281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110041653|NCT03193281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110041654|NCT03193281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110041655|NCT03149640|Amikacin|amikacin|mesh-list
110041656|NCT03149640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110041657|NCT03149640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110041658|NCT03098355|Interleukin-2|interleukin-2|mesh-list
110041659|NCT03098355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110041660|NCT03098355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110041661|NCT03098355|Analgesics|analgesics|mesh-ancestor
110041662|NCT03098355|Sensory System Agents|sensory system agents|mesh-ancestor
110041664|NCT03098355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041666|NCT02986334|Omeprazole|omeprazole|mesh-list
110041667|NCT02986334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110041668|NCT02986334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110041669|NCT02986334|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110041670|NCT02986334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110041671|NCT02986334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110041672|NCT02986334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110041673|NCT02986334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110041675|NCT02986334|Sensory System Agents|sensory system agents|mesh-ancestor
110041676|NCT02986334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110041677|NCT02986334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041678|NCT02986334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110041679|NCT02986334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110041680|NCT02986334|Gout Suppressants|gout suppressants|mesh-ancestor
110041681|NCT02986334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110041682|NCT02668289|Anesthetics|anesthetics|mesh-list
110041683|NCT02668289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110041684|NCT02668289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041685|NCT02655315|Deferiprone|deferiprone|mesh-list
110041686|NCT02655315|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110041687|NCT02655315|Chelating Agents|chelating agents|mesh-ancestor
110041688|NCT02655315|Sequestering Agents|sequestering agents|mesh-ancestor
110041689|NCT02655315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110041690|NCT02572843|Durvalumab|durvalumab|mesh-list
110041691|NCT02572843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110041692|NCT02572843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110041693|NCT02436733|Pemetrexed|pemetrexed|mesh-list
110041694|NCT02436733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110041695|NCT02436733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110041696|NCT02436733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110041697|NCT02436733|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110041698|NCT02436733|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110041699|NCT02426502|Cyclosporine|cyclosporine|mesh-list
110041700|NCT02426502|Mycophenolic Acid|mycophenolic acid|mesh-list
110041701|NCT02426502|Prednisone|prednisone|mesh-list
110041702|NCT02426502|Azathioprine|azathioprine|mesh-list
110041703|NCT02426502|Antihypertensive Agents|antihypertensive agents|mesh-list
110041704|NCT02426502|Cyclosporins|cyclosporins|mesh-list
110041705|NCT02426502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110041706|NCT02426502|Glucocorticoids|glucocorticoids|mesh-ancestor
110041707|NCT02426502|Hormones|hormones|mesh-ancestor
110041708|NCT02426502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110041709|NCT02426502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041710|NCT02426502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110041711|NCT02426502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110041712|NCT02426502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110041713|NCT02426502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110041714|NCT02426502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110041715|NCT02426502|Immunologic Factors|immunologic factors|mesh-ancestor
110041716|NCT02426502|Antifungal Agents|antifungal agents|mesh-ancestor
110041717|NCT02426502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110041718|NCT02426502|Dermatologic Agents|dermatologic agents|mesh-ancestor
110041719|NCT02426502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110041720|NCT02426502|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110041721|NCT02426502|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110041722|NCT02426502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110041723|NCT02426502|Antitubercular Agents|antitubercular agents|mesh-ancestor
110041724|NCT02426502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110041725|NCT02426502|Antimetabolites|antimetabolites|mesh-ancestor
110041726|NCT02426502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110041727|NCT02275156|Evolocumab|evolocumab|mesh-list
110041728|NCT02275156|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110041729|NCT02275156|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110041730|NCT02275156|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110041731|NCT02275156|Antimetabolites|antimetabolites|mesh-ancestor
110041732|NCT02275156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110041733|NCT02275156|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110041734|NCT02275156|Protease Inhibitors|protease inhibitors|mesh-ancestor
110041735|NCT02275156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110041736|NCT02275156|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110041737|NCT02124902|Carboplatin|carboplatin|mesh-list
110041738|NCT02124902|Docetaxel|docetaxel|mesh-list
110041740|NCT02124902|Tubulin Modulators|tubulin modulators|mesh-ancestor
110041741|NCT02124902|Antimitotic Agents|antimitotic agents|mesh-ancestor
110041742|NCT02124902|Mitosis Modulators|mitosis modulators|mesh-ancestor
110041743|NCT02124902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110041745|NCT02067182|Antithrombins|antithrombins|mesh-ancestor
110041746|NCT02067182|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110041747|NCT02067182|Protease Inhibitors|protease inhibitors|mesh-ancestor
110041748|NCT02067182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110041749|NCT02067182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110041750|NCT02067182|Anticoagulants|anticoagulants|mesh-ancestor
110041751|NCT01877837|Fludarabine|fludarabine|mesh-list
110041752|NCT01877837|Fludarabine phosphate|fludarabine phosphate|mesh-list
110041753|NCT01877837|Melphalan|melphalan|mesh-list
110041754|NCT01877837|Alemtuzumab|alemtuzumab|mesh-list
110041755|NCT01877837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110041756|NCT01877837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110041757|NCT01877837|Antimetabolites|antimetabolites|mesh-ancestor
110041758|NCT01877837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110041759|NCT01877837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110041760|NCT01877837|Immunologic Factors|immunologic factors|mesh-ancestor
110041761|NCT01877837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041762|NCT01877837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110041763|NCT01877837|Alkylating Agents|alkylating agents|mesh-ancestor
110041764|NCT01877837|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110041765|NCT01877837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110041766|NCT01781468|Modafinil|modafinil|mesh-list
110041767|NCT01781468|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110041768|NCT01781468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041769|NCT01781468|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110041770|NCT01781468|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110041771|NCT01781468|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110041772|NCT01781468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110041773|NCT01624142|Evolocumab|evolocumab|mesh-list
110041774|NCT01624142|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110041775|NCT01624142|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110041776|NCT01624142|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110041777|NCT01624142|Antimetabolites|antimetabolites|mesh-ancestor
110041778|NCT01624142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110041779|NCT01624142|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110041780|NCT01624142|Protease Inhibitors|protease inhibitors|mesh-ancestor
110041781|NCT01624142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110041782|NCT01624142|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110041783|NCT01375764|Ezetimibe|ezetimibe|mesh-list
110041784|NCT01375764|Evolocumab|evolocumab|mesh-list
110041785|NCT01375764|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110041786|NCT01375764|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110041787|NCT01375764|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110041788|NCT01375764|Antimetabolites|antimetabolites|mesh-ancestor
110041789|NCT01375764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110041790|NCT01375764|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110041791|NCT01375764|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110041792|NCT01375764|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110041793|NCT01375764|Protease Inhibitors|protease inhibitors|mesh-ancestor
110041794|NCT01375764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110041795|NCT01375764|Immunologic Factors|immunologic factors|mesh-ancestor
110041796|NCT01375764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041798|NCT00523341|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110041799|NCT00523341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041800|NCT00364013|Panitumumab|panitumumab|mesh-list
110041801|NCT00364013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110041802|NCT00364013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110041803|NCT00345839|Cinacalcet|cinacalcet|mesh-list
110041804|NCT00345839|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110041805|NCT00345839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041806|NCT00345839|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
110041807|NCT00345839|Hormone Antagonists|hormone antagonists|mesh-ancestor
110041808|NCT00345839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110041810|NCT00330759|Denosumab|denosumab|mesh-list
110041811|NCT00330759|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110041812|NCT00330759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041813|NCT00113763|Panitumumab|panitumumab|mesh-list
110041814|NCT00113763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110041815|NCT00113763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110041816|NCT01438359|Furosemide|furosemide|mesh-list
110041817|NCT01438359|Diuretics|diuretics|mesh-ancestor
110041818|NCT01438359|Natriuretic Agents|natriuretic agents|mesh-ancestor
110041819|NCT01438359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041820|NCT01438359|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110041821|NCT01438359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110041822|NCT01438359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110041823|NCT01438372|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
110041824|NCT01438372|Hematinics|hematinics|mesh-ancestor
110041825|NCT01438515|Chlorhexidine|chlorhexidine|mesh-list
110041826|NCT01438515|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110041827|NCT01438515|Doxycycline|doxycycline|mesh-list
110041828|NCT01438515|Rifampin|rifampin|mesh-list
110041829|NCT01438515|Mupirocin|mupirocin|mesh-list
110041830|NCT01438515|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110041831|NCT01438515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110041832|NCT01438515|Disinfectants|disinfectants|mesh-ancestor
110041833|NCT01438515|Dermatologic Agents|dermatologic agents|mesh-ancestor
110041834|NCT01438515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110041835|NCT01438515|Antimalarials|antimalarials|mesh-ancestor
110041836|NCT01438515|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110041837|NCT01438515|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110041838|NCT01438515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110041839|NCT01438515|Antitubercular Agents|antitubercular agents|mesh-ancestor
110041840|NCT01438515|Leprostatic Agents|leprostatic agents|mesh-ancestor
110041841|NCT01438515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110041842|NCT01438515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110041843|NCT01438515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110041844|NCT01438515|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110041845|NCT01438515|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110041846|NCT01438515|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110041847|NCT01438515|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110041848|NCT01438515|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110041849|NCT01438515|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110041850|NCT01438515|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110041851|NCT01438554|Trametinib|trametinib|mesh-list
110041852|NCT01438554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110041853|NCT01438554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110041854|NCT01438554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110041855|NCT01438554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110041856|NCT01438567|Oxycodone|oxycodone|mesh-list
110041857|NCT01438567|Naloxone|naloxone|mesh-list
110041858|NCT01438567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110041859|NCT01438567|Narcotics|narcotics|mesh-ancestor
110041860|NCT01438567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110041861|NCT01438567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041862|NCT01438567|Analgesics|analgesics|mesh-ancestor
110041863|NCT01438567|Sensory System Agents|sensory system agents|mesh-ancestor
110041864|NCT01438567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110041865|NCT01438567|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110041866|NCT01438580|Aspirin|aspirin|mesh-list
110041867|NCT01438580|Warfarin|warfarin|mesh-list
110041868|NCT01438580|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110041869|NCT01438580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110041870|NCT01438580|Analgesics|analgesics|mesh-ancestor
110041871|NCT01438580|Sensory System Agents|sensory system agents|mesh-ancestor
110041872|NCT01438580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110041873|NCT01438580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041874|NCT01438580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110041875|NCT01438580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110041876|NCT01438580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110041877|NCT01438580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110041878|NCT01438580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110041879|NCT01438580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110041880|NCT01438580|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110041882|NCT01438580|Antipyretics|antipyretics|mesh-ancestor
110041883|NCT01438580|Anticoagulants|anticoagulants|mesh-ancestor
110041884|NCT01438632|Insulin|insulin|mesh-list
110041885|NCT01438632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110041886|NCT01438632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041887|NCT01438723|Metformin|metformin|mesh-list
110041888|NCT01438723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110041889|NCT01438723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041890|NCT01438736|Etonogestrel|etonogestrel|mesh-list
110041891|NCT01438736|Desogestrel|desogestrel|mesh-list
110041893|NCT01438736|Contraceptive Agents|contraceptive agents|mesh-ancestor
110041894|NCT01438736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110041895|NCT01438736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041896|NCT01438736|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110041897|NCT01438736|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110041898|NCT01438736|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110041899|NCT01438736|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110041902|NCT01438736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110041903|NCT01438749|Diazepam|diazepam|mesh-list
110041904|NCT01438749|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110041905|NCT01438749|Anticonvulsants|anticonvulsants|mesh-ancestor
110041906|NCT01438749|Antiemetics|antiemetics|mesh-ancestor
110041907|NCT01438749|Autonomic Agents|autonomic agents|mesh-ancestor
110041908|NCT01438749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110041909|NCT01438749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041910|NCT01438749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110041911|NCT01438749|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110041912|NCT01438749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110041913|NCT01438749|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110041914|NCT01438749|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110041915|NCT01438749|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110041916|NCT01438749|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110041917|NCT01438749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110041918|NCT01438749|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110041919|NCT01438749|Anesthetics, General|anesthetics, general|mesh-ancestor
110041920|NCT01438749|Anesthetics|anesthetics|mesh-ancestor
110041921|NCT01438749|GABA Modulators|gaba modulators|mesh-ancestor
110041922|NCT01438749|GABA Agents|gaba agents|mesh-ancestor
110041923|NCT01438749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110041924|NCT01438749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110041926|NCT01438866|Sodium Fluoride|sodium fluoride|mesh-list
110041928|NCT01438866|Cariostatic Agents|cariostatic agents|mesh-ancestor
110041929|NCT01438866|Protective Agents|protective agents|mesh-ancestor
110041930|NCT01438866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041931|NCT01438944|Nicotine|nicotine|mesh-list
110041932|NCT01438944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110041933|NCT01438944|Autonomic Agents|autonomic agents|mesh-ancestor
110041934|NCT01438944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110041935|NCT01438944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041936|NCT01438944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110041937|NCT01438944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110041938|NCT01438944|Cholinergic Agents|cholinergic agents|mesh-ancestor
110041939|NCT01438944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110041940|NCT01438944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110041941|NCT01439100|Oxycodone|oxycodone|mesh-list
110041942|NCT01439100|Naloxone|naloxone|mesh-list
110041943|NCT01439100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110041944|NCT01439100|Narcotics|narcotics|mesh-ancestor
110041945|NCT01439100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110041946|NCT01439100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041947|NCT01439100|Analgesics|analgesics|mesh-ancestor
110041948|NCT01439100|Sensory System Agents|sensory system agents|mesh-ancestor
110041949|NCT01439100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110041950|NCT01439100|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110041951|NCT01439152|Maytansine|maytansine|mesh-list
110041952|NCT01439152|Anetumab ravtansine|anetumab ravtansine|mesh-list
110041953|NCT01439152|Immunoconjugates|immunoconjugates|mesh-list
110041954|NCT01439152|Immunologic Factors|immunologic factors|mesh-ancestor
110041955|NCT01439152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041956|NCT01439152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110041957|NCT01439152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110041958|NCT01439152|Tubulin Modulators|tubulin modulators|mesh-ancestor
110041959|NCT01439152|Antimitotic Agents|antimitotic agents|mesh-ancestor
110041960|NCT01439152|Mitosis Modulators|mitosis modulators|mesh-ancestor
110041961|NCT01439152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110041962|NCT01439178|Bevacizumab|bevacizumab|mesh-list
110041963|NCT01439178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110041964|NCT01439178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110041965|NCT01439178|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110041966|NCT01439178|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110041967|NCT01439178|Growth Substances|growth substances|mesh-ancestor
110041968|NCT01439178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041969|NCT01439178|Growth Inhibitors|growth inhibitors|mesh-ancestor
110041972|NCT01439191|Immunologic Factors|immunologic factors|mesh-ancestor
110041973|NCT01439191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041974|NCT01439191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110041975|NCT01439191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110041976|NCT01439191|Tubulin Modulators|tubulin modulators|mesh-ancestor
110041977|NCT01439191|Antimitotic Agents|antimitotic agents|mesh-ancestor
110041978|NCT01439191|Mitosis Modulators|mitosis modulators|mesh-ancestor
110041979|NCT01439191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110041981|NCT01439230|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110041982|NCT01439230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110041983|NCT01439230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110041984|NCT01439230|Cholinergic Agents|cholinergic agents|mesh-ancestor
110041985|NCT01439230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110041986|NCT01439230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041987|NCT01439230|Nootropic Agents|nootropic agents|mesh-ancestor
110041988|NCT01439243|Donepezil|donepezil|mesh-list
110041989|NCT01439243|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110041990|NCT01439243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110041991|NCT01439243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110041992|NCT01439243|Cholinergic Agents|cholinergic agents|mesh-ancestor
110041993|NCT01439243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110041994|NCT01439243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041996|NCT01439399|Lidocaine|lidocaine|mesh-list
110041997|NCT01439399|Ketamine|ketamine|mesh-list
110041998|NCT01439399|Anesthetics, Local|anesthetics, local|mesh-ancestor
110041999|NCT01439399|Anesthetics|anesthetics|mesh-ancestor
110042000|NCT01439399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110042001|NCT01439399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042002|NCT01439399|Sensory System Agents|sensory system agents|mesh-ancestor
110042003|NCT01439399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110042004|NCT01439399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110042005|NCT01439399|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110042006|NCT01439399|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110042007|NCT01439399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110042008|NCT01439399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042009|NCT01439399|Analgesics|analgesics|mesh-ancestor
110042010|NCT01439399|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110042011|NCT01439399|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110042012|NCT01439399|Anesthetics, General|anesthetics, general|mesh-ancestor
110042013|NCT01439399|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110042014|NCT01439399|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110042015|NCT01439399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110042016|NCT01439438|Topiramate|topiramate|mesh-list
110042017|NCT01439438|Anticonvulsants|anticonvulsants|mesh-ancestor
110042018|NCT01439438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110042019|NCT01439438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042020|NCT01439542|Hormones|hormones|mesh-list
110042021|NCT01439542|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
110042022|NCT01439542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110042023|NCT01439542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042024|NCT01439750|Rituximab|rituximab|mesh-list
110042025|NCT01439750|Bortezomib|bortezomib|mesh-list
110042026|NCT01439750|Cladribine|cladribine|mesh-list
110042027|NCT01439750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110042028|NCT01439750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110042029|NCT01439750|Immunologic Factors|immunologic factors|mesh-ancestor
110042030|NCT01439750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042031|NCT01439750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110042032|NCT01439750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110042033|NCT01439984|Clomipramine|clomipramine|mesh-list
110042034|NCT01439984|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110042035|NCT01439984|Antidepressive Agents|antidepressive agents|mesh-ancestor
110042036|NCT01439984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110042037|NCT01439984|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110042038|NCT01439984|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110042039|NCT01439984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110042040|NCT01439984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042041|NCT01439984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110042042|NCT01439984|Serotonin Agents|serotonin agents|mesh-ancestor
110042043|NCT01439984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042044|NCT01440062|Vitamin D|vitamin d|mesh-list
110042045|NCT01440062|Ergocalciferols|ergocalciferols|mesh-list
110042046|NCT01440062|Cholecalciferol|cholecalciferol|mesh-list
110042048|NCT01440062|Micronutrients|micronutrients|mesh-ancestor
110042049|NCT01440062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042050|NCT01440062|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110042051|NCT01440062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110042052|NCT01440088|Doxorubicin|doxorubicin|mesh-list
110042053|NCT01440088|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110042054|NCT01440088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110042055|NCT01440088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110042056|NCT01440088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110042057|NCT01440088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110042058|NCT01440088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110042059|NCT01440088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042061|NCT01440114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110042063|NCT01440114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110042064|NCT01440114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042066|NCT01440114|Sensory System Agents|sensory system agents|mesh-ancestor
110042067|NCT01440114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110042068|NCT01440114|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110042069|NCT01440114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110042070|NCT01440114|Anesthetics, General|anesthetics, general|mesh-ancestor
110042071|NCT01440114|Anesthetics|anesthetics|mesh-ancestor
110042072|NCT01440127|Metformin|metformin|mesh-list
110042073|NCT01440127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110042074|NCT01440127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042075|NCT01440140|Insulin|insulin|mesh-list
110042076|NCT01440140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110042077|NCT01440140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042078|NCT01440270|Cetuximab|cetuximab|mesh-list
110042079|NCT01440270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110042080|NCT01440270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110042081|NCT01440309|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
110042082|NCT01440309|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110042083|NCT01440309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110042084|NCT01440335|Fenoterol|fenoterol|mesh-list
110042085|NCT01440335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110042086|NCT01440335|Autonomic Agents|autonomic agents|mesh-ancestor
110042087|NCT01440335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110042088|NCT01440335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042089|NCT01440335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110042090|NCT01440335|Respiratory System Agents|respiratory system agents|mesh-ancestor
110042091|NCT01440335|Sympathomimetics|sympathomimetics|mesh-ancestor
110042092|NCT01440335|Tocolytic Agents|tocolytic agents|mesh-ancestor
110042093|NCT01440335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110042094|NCT01440335|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110042095|NCT01440335|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110042096|NCT01440335|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110042097|NCT01440335|Adrenergic Agents|adrenergic agents|mesh-ancestor
110042098|NCT01440335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110042099|NCT01440335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042100|NCT01440361|Belimumab|belimumab|mesh-list
110042101|NCT01440361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110042102|NCT01440361|Immunologic Factors|immunologic factors|mesh-ancestor
110042103|NCT01440361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042104|NCT01440400|Anesthetics|anesthetics|mesh-list
110042105|NCT01440400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110042106|NCT01440400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042107|NCT01440439|Insulin|insulin|mesh-list
110042108|NCT01440439|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110042109|NCT01440439|Insulin Glargine|insulin glargine|mesh-list
110042110|NCT01440439|Insulin Detemir|insulin detemir|mesh-list
110042111|NCT01440439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110042112|NCT01440439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042113|NCT01440582|Dexamethasone|dexamethasone|mesh-list
110042114|NCT01440582|Lenalidomide|lenalidomide|mesh-list
110042115|NCT01440582|Bortezomib|bortezomib|mesh-list
110042116|NCT01440582|Panobinostat|panobinostat|mesh-list
110042117|NCT01440582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110042118|NCT01440582|Antiemetics|antiemetics|mesh-ancestor
110042119|NCT01440582|Autonomic Agents|autonomic agents|mesh-ancestor
110042120|NCT01440582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110042121|NCT01440582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042122|NCT01440582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110042124|NCT01440582|Hormones|hormones|mesh-ancestor
110042125|NCT01440582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110042128|NCT01440582|Immunologic Factors|immunologic factors|mesh-ancestor
110042129|NCT01440582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110042130|NCT01440582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110042131|NCT01440582|Growth Substances|growth substances|mesh-ancestor
110042132|NCT01440582|Growth Inhibitors|growth inhibitors|mesh-ancestor
110042133|NCT01440582|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110042134|NCT01440582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110042135|NCT01440582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042137|NCT01440608|Anthelmintics|anthelmintics|mesh-ancestor
110042138|NCT01440608|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110042139|NCT01440608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110042140|NCT01440608|Anticestodal Agents|anticestodal agents|mesh-ancestor
110042141|NCT01440608|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110042142|NCT01440608|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110042143|NCT01440608|Tubulin Modulators|tubulin modulators|mesh-ancestor
110042144|NCT01440608|Antimitotic Agents|antimitotic agents|mesh-ancestor
110042145|NCT01440608|Mitosis Modulators|mitosis modulators|mesh-ancestor
110042146|NCT01440608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042147|NCT01440608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110042148|NCT01440621|Pyridoxine|pyridoxine|mesh-list
110042149|NCT01440621|Modafinil|modafinil|mesh-list
110042150|NCT01440621|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110042151|NCT01440621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042152|NCT01440621|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110042153|NCT01440621|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110042154|NCT01440621|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110042155|NCT01440621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042156|NCT01440621|Vitamin B Complex|vitamin b complex|mesh-ancestor
110042157|NCT01440621|Vitamins|vitamins|mesh-ancestor
110042158|NCT01440621|Micronutrients|micronutrients|mesh-ancestor
110042159|NCT01440673|Aprepitant|aprepitant|mesh-list
110042160|NCT01440673|Antiemetics|antiemetics|mesh-ancestor
110042161|NCT01440673|Autonomic Agents|autonomic agents|mesh-ancestor
110042162|NCT01440673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110042163|NCT01440673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042164|NCT01440673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110042165|NCT01440673|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110042166|NCT01440673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110042167|NCT01440673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042168|NCT01440725|Mitogens|mitogens|mesh-list
110042169|NCT01440725|Mitosis Modulators|mitosis modulators|mesh-ancestor
110042170|NCT01440725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042171|NCT01440751|Mitomycins|mitomycins|mesh-list
110042172|NCT01440751|Mitomycin|mitomycin|mesh-list
110042173|NCT01440751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110042174|NCT01440751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110042175|NCT01440751|Alkylating Agents|alkylating agents|mesh-ancestor
110042176|NCT01440751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042177|NCT01440751|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110042178|NCT01440751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110042179|NCT01440790|Vitamins|vitamins|mesh-list
110042180|NCT01440790|Ascorbic Acid|ascorbic acid|mesh-list
110042181|NCT01440790|Micronutrients|micronutrients|mesh-ancestor
110042182|NCT01440790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042184|NCT01440790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042185|NCT01440790|Protective Agents|protective agents|mesh-ancestor
110042186|NCT01440829|N-Methylaspartate|n-methylaspartate|mesh-list
110042187|NCT01440829|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
110042188|NCT01440829|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110042189|NCT01440829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110042190|NCT01440829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042192|NCT01440842|Insulin|insulin|mesh-list
110042193|NCT01440842|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110042194|NCT01440842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110042195|NCT01440842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042196|NCT01440933|Magnesium Sulfate|magnesium sulfate|mesh-list
110042197|NCT01440933|Analgesics|analgesics|mesh-ancestor
110042198|NCT01440933|Sensory System Agents|sensory system agents|mesh-ancestor
110042199|NCT01440933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110042200|NCT01440933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042202|NCT01440933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110042203|NCT01440933|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110042204|NCT01440933|Anticonvulsants|anticonvulsants|mesh-ancestor
110042205|NCT01440933|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110042206|NCT01440933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110042207|NCT01440933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042208|NCT01440933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110042209|NCT01440933|Tocolytic Agents|tocolytic agents|mesh-ancestor
110042210|NCT01440933|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110042212|NCT01440985|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110042213|NCT01440985|Autonomic Agents|autonomic agents|mesh-ancestor
110042214|NCT01440985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110042215|NCT01440985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042216|NCT01440985|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110042217|NCT01440985|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110042218|NCT01440985|Cholinergic Agents|cholinergic agents|mesh-ancestor
110042219|NCT01440985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110042220|NCT01440985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042221|NCT01440998|Paclitaxel|paclitaxel|mesh-list
110042222|NCT01440998|Carboplatin|carboplatin|mesh-list
110042223|NCT01440998|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110042224|NCT01440998|Dasatinib|dasatinib|mesh-list
110042225|NCT01440998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110042226|NCT01440998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110042227|NCT01440998|Tubulin Modulators|tubulin modulators|mesh-ancestor
110042228|NCT01440998|Antimitotic Agents|antimitotic agents|mesh-ancestor
110042229|NCT01440998|Mitosis Modulators|mitosis modulators|mesh-ancestor
110042230|NCT01440998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042231|NCT01440998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110042232|NCT01440998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110042233|NCT01441128|Crizotinib|crizotinib|mesh-list
110042234|NCT01441128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110042235|NCT01441128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110042236|NCT01441128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110042237|NCT01441128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042238|NCT01441193|Vaccines|vaccines|mesh-list
110042239|NCT01441193|Immunologic Factors|immunologic factors|mesh-ancestor
110042240|NCT01441193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042241|NCT01441206|Rifampin|rifampin|mesh-list
110042242|NCT01441206|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110042243|NCT01441206|Antitubercular Agents|antitubercular agents|mesh-ancestor
110042244|NCT01441206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110042245|NCT01441206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110042246|NCT01441206|Leprostatic Agents|leprostatic agents|mesh-ancestor
110042247|NCT01441206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110042249|NCT01441206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042250|NCT01441206|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110042251|NCT01441206|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110042252|NCT01441206|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110042253|NCT01441206|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110042254|NCT01441206|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110042255|NCT01441206|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110042256|NCT01441232|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110042257|NCT01441232|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
110042259|NCT01441232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042260|NCT01441232|Incretins|incretins|mesh-ancestor
110042261|NCT01441232|Hormones|hormones|mesh-ancestor
110042262|NCT01441232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110042263|NCT01441232|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110042264|NCT01441232|Protease Inhibitors|protease inhibitors|mesh-ancestor
110042265|NCT01441232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110042266|NCT01441232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042267|NCT01441232|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110042268|NCT01441284|Pramipexole|pramipexole|mesh-list
110042269|NCT01441284|Antioxidants|antioxidants|mesh-ancestor
110042270|NCT01441284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042271|NCT01441284|Protective Agents|protective agents|mesh-ancestor
110042272|NCT01441284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042275|NCT01441284|Dopamine Agonists|dopamine agonists|mesh-ancestor
110042276|NCT01441284|Dopamine Agents|dopamine agents|mesh-ancestor
110042277|NCT01441284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110042278|NCT01441297|Nintedanib|nintedanib|mesh-list
110042279|NCT01441297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110042280|NCT01441297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110042281|NCT01441297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110042282|NCT01441297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042283|NCT01441388|Bevacizumab|bevacizumab|mesh-list
110042284|NCT01441388|Sunitinib|sunitinib|mesh-list
110042285|NCT01441388|Sorafenib|sorafenib|mesh-list
110042286|NCT01441388|Axitinib|axitinib|mesh-list
110042287|NCT01441388|Crizotinib|crizotinib|mesh-list
110042288|NCT01441388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110042289|NCT01441388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110042290|NCT01441388|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110042291|NCT01441388|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110042292|NCT01441388|Growth Substances|growth substances|mesh-ancestor
110042293|NCT01441388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042294|NCT01441388|Growth Inhibitors|growth inhibitors|mesh-ancestor
110042295|NCT01441388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110042296|NCT01441388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110042297|NCT01441388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042298|NCT01441427|Lenograstim|lenograstim|mesh-list
110042299|NCT01441427|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110042300|NCT01441427|Immunologic Factors|immunologic factors|mesh-ancestor
110042301|NCT01441427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042302|NCT01441505|Midazolam|midazolam|mesh-list
110042303|NCT01441505|Ketamine|ketamine|mesh-list
110042304|NCT01441505|Analgesics|analgesics|mesh-ancestor
110042305|NCT01441505|Sensory System Agents|sensory system agents|mesh-ancestor
110042306|NCT01441505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110042307|NCT01441505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042308|NCT01441505|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110042309|NCT01441505|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110042310|NCT01441505|Anesthetics, General|anesthetics, general|mesh-ancestor
110042311|NCT01441505|Anesthetics|anesthetics|mesh-ancestor
110042312|NCT01441505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110042313|NCT01441505|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110042314|NCT01441505|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110042315|NCT01441505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110042316|NCT01441505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042317|NCT01441505|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110042318|NCT01441505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110042319|NCT01441505|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110042320|NCT01441505|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110042321|NCT01441505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110042322|NCT01441505|GABA Modulators|gaba modulators|mesh-ancestor
110042323|NCT01441505|GABA Agents|gaba agents|mesh-ancestor
110042324|NCT01441531|Gabapentin|gabapentin|mesh-list
110042325|NCT01441531|Analgesics|analgesics|mesh-ancestor
110042326|NCT01441531|Sensory System Agents|sensory system agents|mesh-ancestor
110042327|NCT01441531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110042328|NCT01441531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042329|NCT01441531|Anticonvulsants|anticonvulsants|mesh-ancestor
110042330|NCT01441531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110042331|NCT01441531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110042332|NCT01441531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110042333|NCT01441531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110042334|NCT01441531|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110042335|NCT01441531|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110042336|NCT01441531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110042337|NCT01441531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042338|NCT01441531|Antimanic Agents|antimanic agents|mesh-ancestor
110042339|NCT01441557|Amifampridine|amifampridine|mesh-list
110042340|NCT01441557|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110042341|NCT01441557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110042342|NCT01441557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042343|NCT01441557|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110042344|NCT01441557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110042345|NCT01441557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042346|NCT01441700|Anesthetics|anesthetics|mesh-list
110042348|NCT01441700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042350|NCT01441804|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110042351|NCT01441804|Interferon-alpha|interferon-alpha|mesh-list
110042352|NCT01441804|Antimetabolites|antimetabolites|mesh-ancestor
110042353|NCT01441804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042354|NCT01441804|Antiviral Agents|antiviral agents|mesh-ancestor
110042355|NCT01441804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110042356|NCT01441804|Immunologic Factors|immunologic factors|mesh-ancestor
110042357|NCT01441804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042358|NCT01441869|Metformin|metformin|mesh-list
110042359|NCT01441869|Saxagliptin|saxagliptin|mesh-list
110042363|NCT01441869|Hormones|hormones|mesh-ancestor
110042364|NCT01441869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110042365|NCT01441869|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110042367|NCT01441869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110042368|NCT01441869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042370|NCT01441908|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110042371|NCT01441908|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110042372|NCT01441908|Antimetabolites|antimetabolites|mesh-ancestor
110042373|NCT01441908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042374|NCT01441908|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110042375|NCT01441908|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110042377|NCT01441934|Sildenafil Citrate|sildenafil citrate|mesh-list
110042378|NCT01441934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042379|NCT01441934|Vasodilator Agents|vasodilator agents|mesh-ancestor
110042380|NCT01441934|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110042381|NCT01441934|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110042382|NCT01441934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110042383|NCT01441934|Urological Agents|urological agents|mesh-ancestor
110042384|NCT01441986|Amantadine|amantadine|mesh-list
110042385|NCT01441986|Dextromethorphan|dextromethorphan|mesh-list
110042386|NCT01441986|Antitussive Agents|antitussive agents|mesh-ancestor
110042387|NCT01441986|Respiratory System Agents|respiratory system agents|mesh-ancestor
110042388|NCT01441986|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110042389|NCT01441986|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110042390|NCT01441986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110042391|NCT01441986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042392|NCT01441986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042393|NCT01441986|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110042394|NCT01441986|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110042395|NCT01441986|Antiviral Agents|antiviral agents|mesh-ancestor
110042396|NCT01441986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110042397|NCT01441986|Dopamine Agents|dopamine agents|mesh-ancestor
110042398|NCT01441986|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110042399|NCT01441986|Analgesics|analgesics|mesh-ancestor
110042400|NCT01441986|Sensory System Agents|sensory system agents|mesh-ancestor
110042401|NCT01441986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110042402|NCT01442025|Infliximab|infliximab|mesh-list
110042403|NCT01442025|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110042404|NCT01442025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110042405|NCT01442025|Dermatologic Agents|dermatologic agents|mesh-ancestor
110042406|NCT01442025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110042407|NCT01442025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110042408|NCT01442168|Atovaquone|atovaquone|mesh-list
110042409|NCT01442168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110042410|NCT01442168|Antimalarials|antimalarials|mesh-ancestor
110042411|NCT01442168|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110042412|NCT01442168|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110042413|NCT01442168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110042414|NCT01442168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042415|NCT01442272|Calcifediol|calcifediol|mesh-list
110042416|NCT01442272|Vitamins|vitamins|mesh-ancestor
110042417|NCT01442272|Micronutrients|micronutrients|mesh-ancestor
110042418|NCT01442272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042419|NCT01442272|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110042420|NCT01442311|Interferons|interferons|mesh-list
110042422|NCT01442311|Interferon-alpha|interferon-alpha|mesh-list
110042423|NCT01442311|Interferon alpha-2|interferon alpha-2|mesh-list
110042424|NCT01442311|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110042425|NCT01442311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110042426|NCT01442311|Antiviral Agents|antiviral agents|mesh-ancestor
110042427|NCT01442311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110042428|NCT01442311|Antimetabolites|antimetabolites|mesh-ancestor
110042429|NCT01442311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042430|NCT01442311|Immunologic Factors|immunologic factors|mesh-ancestor
110042431|NCT01442311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042432|NCT01442428|Dexamethasone|dexamethasone|mesh-list
110042433|NCT01442428|Naproxen|naproxen|mesh-list
110042434|NCT01442428|Atorvastatin|atorvastatin|mesh-list
110042435|NCT01442428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110042436|NCT01442428|Antiemetics|antiemetics|mesh-ancestor
110042439|NCT01442428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042440|NCT01442428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110042441|NCT01442428|Glucocorticoids|glucocorticoids|mesh-ancestor
110042442|NCT01442428|Hormones|hormones|mesh-ancestor
110042443|NCT01442428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110042444|NCT01442428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110042445|NCT01442428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110042446|NCT01442428|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110042447|NCT01442428|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110042448|NCT01442428|Antimetabolites|antimetabolites|mesh-ancestor
110042449|NCT01442428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042450|NCT01442428|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110042451|NCT01442428|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110042452|NCT01442428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110042453|NCT01442428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110042454|NCT01442428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110042455|NCT01442428|Analgesics|analgesics|mesh-ancestor
110042456|NCT01442428|Sensory System Agents|sensory system agents|mesh-ancestor
110042457|NCT01442428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110042458|NCT01442428|Gout Suppressants|gout suppressants|mesh-ancestor
110042459|NCT01442428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110042460|NCT01442519|Mitomycins|mitomycins|mesh-list
110042461|NCT01442519|Mitomycin|mitomycin|mesh-list
110042462|NCT01442519|BCG Vaccine|bcg vaccine|mesh-list
110042463|NCT01442519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110042464|NCT01442519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110042465|NCT01442519|Alkylating Agents|alkylating agents|mesh-ancestor
110042466|NCT01442519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042467|NCT01442519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110042468|NCT01442519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110042469|NCT01442519|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110042470|NCT01442519|Immunologic Factors|immunologic factors|mesh-ancestor
110042471|NCT01442519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042472|NCT01442532|Midazolam|midazolam|mesh-list
110042473|NCT01442532|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110042474|NCT01442532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110042475|NCT01442532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110042476|NCT01442532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042477|NCT01442532|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110042478|NCT01442532|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110042479|NCT01442532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110042480|NCT01442532|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110042481|NCT01442532|Anesthetics, General|anesthetics, general|mesh-ancestor
110042483|NCT01442532|GABA Modulators|gaba modulators|mesh-ancestor
110042484|NCT01442532|GABA Agents|gaba agents|mesh-ancestor
110042485|NCT01442532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110042486|NCT01442532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042487|NCT01442558|Bupivacaine|bupivacaine|mesh-list
110042488|NCT01442558|Anesthetics, Local|anesthetics, local|mesh-ancestor
110042489|NCT01442558|Anesthetics|anesthetics|mesh-ancestor
110042490|NCT01442558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110042491|NCT01442558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042492|NCT01442558|Sensory System Agents|sensory system agents|mesh-ancestor
110042493|NCT01442558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110042494|NCT01442571|Hyaluronic Acid|hyaluronic acid|mesh-list
110042495|NCT01442571|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110042499|NCT01442571|Protective Agents|protective agents|mesh-ancestor
110042501|NCT01442610|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110042502|NCT01442610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110042503|NCT01442610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042504|NCT01442610|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110042505|NCT01442610|Protective Agents|protective agents|mesh-ancestor
110042506|NCT01442610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042507|NCT01442662|Gemcitabine|gemcitabine|mesh-list
110042508|NCT01442662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110042509|NCT01442662|Antimetabolites|antimetabolites|mesh-ancestor
110042510|NCT01442662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042511|NCT01442662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110042512|NCT01442701|Triclosan|triclosan|mesh-list
110042513|NCT01442701|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110042514|NCT01442701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110042515|NCT01442701|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110042516|NCT01442701|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110042517|NCT01442701|Antimetabolites|antimetabolites|mesh-ancestor
110042518|NCT01442701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042519|NCT01442701|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110042520|NCT01442727|Selenium|selenium|mesh-list
110042521|NCT01442727|Selenious Acid|selenious acid|mesh-list
110042522|NCT01442727|Sodium Selenite|sodium selenite|mesh-list
110042523|NCT01442727|Antioxidants|antioxidants|mesh-ancestor
110042524|NCT01442727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042525|NCT01442727|Protective Agents|protective agents|mesh-ancestor
110042526|NCT01442727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042527|NCT01442727|Trace Elements|trace elements|mesh-ancestor
110042528|NCT01442727|Micronutrients|micronutrients|mesh-ancestor
110042529|NCT01442766|Donepezil|donepezil|mesh-list
110042530|NCT01442766|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110042531|NCT01442766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110042532|NCT01442766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042533|NCT01442766|Cholinergic Agents|cholinergic agents|mesh-ancestor
110042534|NCT01442766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110042535|NCT01442766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042536|NCT01442766|Nootropic Agents|nootropic agents|mesh-ancestor
110042537|NCT01442818|Hydromorphone|hydromorphone|mesh-list
110042538|NCT01442818|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110042539|NCT01442818|Narcotics|narcotics|mesh-ancestor
110042540|NCT01442818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110042541|NCT01442818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042542|NCT01442818|Analgesics|analgesics|mesh-ancestor
110042543|NCT01442818|Sensory System Agents|sensory system agents|mesh-ancestor
110042544|NCT01442818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110042545|NCT01442870|Metformin|metformin|mesh-list
110042546|NCT01442870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110042547|NCT01442870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042548|NCT01442909|Docetaxel|docetaxel|mesh-list
110042549|NCT01442909|Pemetrexed|pemetrexed|mesh-list
110042550|NCT01442909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110042551|NCT01442909|Tubulin Modulators|tubulin modulators|mesh-ancestor
110042552|NCT01442909|Antimitotic Agents|antimitotic agents|mesh-ancestor
110042553|NCT01442909|Mitosis Modulators|mitosis modulators|mesh-ancestor
110042554|NCT01442909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042555|NCT01442909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110042556|NCT01442909|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110042557|NCT01442909|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110042558|NCT01442935|Leucovorin|leucovorin|mesh-list
110042559|NCT01442935|Folic Acid|folic acid|mesh-list
110042560|NCT01442935|Bevacizumab|bevacizumab|mesh-list
110042561|NCT01442935|Cetuximab|cetuximab|mesh-list
110042562|NCT01442935|Oxaliplatin|oxaliplatin|mesh-list
110042563|NCT01442935|Irinotecan|irinotecan|mesh-list
110042564|NCT01442935|Fluorouracil|fluorouracil|mesh-list
110042565|NCT01442935|Levoleucovorin|levoleucovorin|mesh-list
110042566|NCT01442935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110042567|NCT01442935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110042568|NCT01442935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110042569|NCT01442935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110042570|NCT01442935|Growth Substances|growth substances|mesh-ancestor
110042571|NCT01442935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042582|NCT01442935|Hematinics|hematinics|mesh-ancestor
110042583|NCT01442935|Antimetabolites|antimetabolites|mesh-ancestor
110042584|NCT01442935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110042585|NCT01442935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110042586|NCT01442935|Immunologic Factors|immunologic factors|mesh-ancestor
110042587|NCT01442974|Paclitaxel|paclitaxel|mesh-list
110042588|NCT01442974|Gemcitabine|gemcitabine|mesh-list
110042589|NCT01442974|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110042590|NCT01442974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110042591|NCT01442974|Tubulin Modulators|tubulin modulators|mesh-ancestor
110042592|NCT01442974|Antimitotic Agents|antimitotic agents|mesh-ancestor
110042593|NCT01442974|Mitosis Modulators|mitosis modulators|mesh-ancestor
110042594|NCT01442974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042595|NCT01442974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110042596|NCT01442974|Antimetabolites|antimetabolites|mesh-ancestor
110042597|NCT01442987|Irbesartan|irbesartan|mesh-list
110042598|NCT01442987|Atorvastatin|atorvastatin|mesh-list
110042599|NCT01442987|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110042600|NCT01442987|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110042601|NCT01442987|Antimetabolites|antimetabolites|mesh-ancestor
110042680|NCT01443247|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110042602|NCT01442987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042603|NCT01442987|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110042604|NCT01442987|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110042605|NCT01442987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110042606|NCT01442987|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110042607|NCT01442987|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110042608|NCT01442987|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110042609|NCT01443065|Leucovorin|leucovorin|mesh-list
110042610|NCT01443065|Folic Acid|folic acid|mesh-list
110042611|NCT01443065|Oxaliplatin|oxaliplatin|mesh-list
110042612|NCT01443065|Panitumumab|panitumumab|mesh-list
110042613|NCT01443065|Fluorouracil|fluorouracil|mesh-list
110042614|NCT01443065|Rilotumumab|rilotumumab|mesh-list
110042615|NCT01443065|Levoleucovorin|levoleucovorin|mesh-list
110042616|NCT01443065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110042617|NCT01443065|Antidotes|antidotes|mesh-ancestor
110042619|NCT01443065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042620|NCT01443065|Vitamin B Complex|vitamin b complex|mesh-ancestor
110042621|NCT01443065|Vitamins|vitamins|mesh-ancestor
110042622|NCT01443065|Micronutrients|micronutrients|mesh-ancestor
110042623|NCT01443065|Hematinics|hematinics|mesh-ancestor
110042624|NCT01443065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110042625|NCT01443065|Antimetabolites|antimetabolites|mesh-ancestor
110042626|NCT01443065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042627|NCT01443065|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110042628|NCT01443065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110042629|NCT01443065|Immunologic Factors|immunologic factors|mesh-ancestor
110042630|NCT01443104|Sirolimus|sirolimus|mesh-list
110042631|NCT01443104|Everolimus|everolimus|mesh-list
110042632|NCT01443104|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110042633|NCT01443104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110042634|NCT01443104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110042635|NCT01443104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042636|NCT01443104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110042637|NCT01443104|Immunologic Factors|immunologic factors|mesh-ancestor
110042638|NCT01443104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042639|NCT01443104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110042640|NCT01443104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110042641|NCT01443104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110042642|NCT01443104|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110042643|NCT01443104|Antifungal Agents|antifungal agents|mesh-ancestor
110042645|NCT01443117|Immunologic Factors|immunologic factors|mesh-ancestor
110042646|NCT01443117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042648|NCT01443169|Analgesics|analgesics|mesh-ancestor
110042649|NCT01443169|Sensory System Agents|sensory system agents|mesh-ancestor
110042650|NCT01443169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110042651|NCT01443169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042652|NCT01443169|Anticonvulsants|anticonvulsants|mesh-ancestor
110042653|NCT01443169|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110042654|NCT01443169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110042655|NCT01443169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042656|NCT01443169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110042657|NCT01443169|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110042658|NCT01443169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110042659|NCT01443169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110042660|NCT01443169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110042661|NCT01443195|Iron|iron|mesh-list
110042662|NCT01443195|Trace Elements|trace elements|mesh-ancestor
110042663|NCT01443195|Micronutrients|micronutrients|mesh-ancestor
110042664|NCT01443195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042665|NCT01443208|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
110042666|NCT01443208|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110042667|NCT01443208|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110042668|NCT01443208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110042669|NCT01443208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042670|NCT01443208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110042671|NCT01443208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042672|NCT01443208|Antidepressive Agents|antidepressive agents|mesh-ancestor
110042673|NCT01443208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110042674|NCT01443221|Metformin|metformin|mesh-list
110042675|NCT01443221|Mitiglinide|mitiglinide|mesh-list
110042676|NCT01443221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110042677|NCT01443221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042678|NCT01443247|gamma-Globulins|gamma-globulins|mesh-list
110042679|NCT01443247|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110042681|NCT01443247|Immunologic Factors|immunologic factors|mesh-ancestor
110042682|NCT01443247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042683|NCT01443325|Lidocaine|lidocaine|mesh-list
110042684|NCT01443325|Anesthetics, Local|anesthetics, local|mesh-ancestor
110042685|NCT01443325|Anesthetics|anesthetics|mesh-ancestor
110042686|NCT01443325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110042687|NCT01443325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042688|NCT01443325|Sensory System Agents|sensory system agents|mesh-ancestor
110042689|NCT01443325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110042690|NCT01443325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110042691|NCT01443325|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110042692|NCT01443325|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110042693|NCT01443325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110042694|NCT01443325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042695|NCT01443338|Acitretin|acitretin|mesh-list
110042696|NCT01443338|Keratolytic Agents|keratolytic agents|mesh-ancestor
110042697|NCT01443338|Dermatologic Agents|dermatologic agents|mesh-ancestor
110042698|NCT01443377|Panitumumab|panitumumab|mesh-list
110042699|NCT01443377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110042700|NCT01443377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110042701|NCT01443416|Vaccines|vaccines|mesh-list
110042702|NCT01443416|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110042704|NCT01443416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042705|NCT01443429|Beraprost|beraprost|mesh-list
110042706|NCT01443429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110042707|NCT01443429|Vasodilator Agents|vasodilator agents|mesh-ancestor
110042708|NCT01443520|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110042709|NCT01443520|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110042710|NCT01443520|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110042711|NCT01443520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110042713|NCT01443520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042714|NCT01443520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110042715|NCT01443520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042716|NCT01443520|Analgesics|analgesics|mesh-ancestor
110042717|NCT01443520|Sensory System Agents|sensory system agents|mesh-ancestor
110042718|NCT01443520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110042719|NCT01443520|Antidepressive Agents|antidepressive agents|mesh-ancestor
110042720|NCT01443520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110042721|NCT01443520|Dopamine Agents|dopamine agents|mesh-ancestor
110042722|NCT01443520|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110042723|NCT01443572|Anesthetics|anesthetics|mesh-list
110042724|NCT01443572|Sevoflurane|sevoflurane|mesh-list
110042726|NCT01443572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110042727|NCT01443572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042728|NCT01443572|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110042729|NCT01443572|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110042730|NCT01443572|Anesthetics, General|anesthetics, general|mesh-ancestor
110042731|NCT01443624|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
110042732|NCT01443624|Hematinics|hematinics|mesh-ancestor
110042733|NCT01443650|Alirocumab|alirocumab|mesh-list
110042734|NCT01443650|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110042735|NCT01443650|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110042736|NCT01443650|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110042737|NCT01443650|Antimetabolites|antimetabolites|mesh-ancestor
110042738|NCT01443650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042739|NCT01443650|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110042740|NCT01443650|Protease Inhibitors|protease inhibitors|mesh-ancestor
110042741|NCT01443650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110042742|NCT01443650|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110042743|NCT01443676|Bevacizumab|bevacizumab|mesh-list
110042744|NCT01443676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110042745|NCT01443676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110042746|NCT01443676|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110042747|NCT01443676|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110042748|NCT01443676|Growth Substances|growth substances|mesh-ancestor
110042749|NCT01443676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042750|NCT01443676|Growth Inhibitors|growth inhibitors|mesh-ancestor
110042752|NCT01443741|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110042753|NCT01443741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110042754|NCT01443741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042755|NCT01443780|Selenium|selenium|mesh-list
110042756|NCT01443780|Antioxidants|antioxidants|mesh-ancestor
110042757|NCT01443780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042758|NCT01443780|Protective Agents|protective agents|mesh-ancestor
110042759|NCT01443780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042760|NCT01443780|Trace Elements|trace elements|mesh-ancestor
110042761|NCT01443780|Micronutrients|micronutrients|mesh-ancestor
110042762|NCT01443806|Oseltamivir|oseltamivir|mesh-list
110042763|NCT01443806|Antiviral Agents|antiviral agents|mesh-ancestor
110042764|NCT01443806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110042765|NCT01443806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110042766|NCT01443806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042767|NCT01443897|Vitamin D|vitamin d|mesh-list
110042768|NCT01443897|Ergocalciferols|ergocalciferols|mesh-list
110042769|NCT01443897|Cholecalciferol|cholecalciferol|mesh-list
110042770|NCT01443897|Vitamins|vitamins|mesh-list
110042771|NCT01443897|Micronutrients|micronutrients|mesh-ancestor
110042772|NCT01443897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042773|NCT01443897|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110042774|NCT01443897|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110042775|NCT01443988|Travoprost|travoprost|mesh-list
110042776|NCT01443988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110042777|NCT01444001|Vaccines|vaccines|mesh-list
110042778|NCT01444001|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110042779|NCT01444001|Immunologic Factors|immunologic factors|mesh-ancestor
110042780|NCT01444001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042781|NCT01444118|Cyclophosphamide|cyclophosphamide|mesh-list
110042782|NCT01444118|Vaccines|vaccines|mesh-list
110042783|NCT01444118|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
110042784|NCT01444118|Immunologic Factors|immunologic factors|mesh-ancestor
110042785|NCT01444118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042786|NCT01444118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110042787|NCT01444118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110042788|NCT01444118|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110042789|NCT01444118|Alkylating Agents|alkylating agents|mesh-ancestor
110042790|NCT01444118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042791|NCT01444118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110042792|NCT01444118|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110042793|NCT01444118|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110042794|NCT01444131|Nicotine|nicotine|mesh-list
110042795|NCT01444131|Varenicline|varenicline|mesh-list
110042796|NCT01444131|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110042797|NCT01444131|Autonomic Agents|autonomic agents|mesh-ancestor
110042798|NCT01444131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110042799|NCT01444131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042800|NCT01444131|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110042801|NCT01444131|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110042802|NCT01444131|Cholinergic Agents|cholinergic agents|mesh-ancestor
110042803|NCT01444131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110042804|NCT01444131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042805|NCT01444196|Desloratadine|desloratadine|mesh-list
110042806|NCT01444196|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110042807|NCT01444196|Cholinergic Agents|cholinergic agents|mesh-ancestor
110042808|NCT01444196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110042809|NCT01444196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042810|NCT01444196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042811|NCT01444196|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110042812|NCT01444196|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110042813|NCT01444196|Histamine Antagonists|histamine antagonists|mesh-ancestor
110042814|NCT01444196|Histamine Agents|histamine agents|mesh-ancestor
110042815|NCT01444248|Metformin|metformin|mesh-list
110042816|NCT01444248|Glimepiride|glimepiride|mesh-list
110042817|NCT01444248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110042818|NCT01444248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042819|NCT01444248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110042820|NCT01444248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110042821|NCT01444248|Immunologic Factors|immunologic factors|mesh-ancestor
110042823|NCT01444339|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110042824|NCT01444339|Immunologic Factors|immunologic factors|mesh-ancestor
110042825|NCT01444339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042826|NCT01444352|Vaccines|vaccines|mesh-list
110042827|NCT01444352|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110042828|NCT01444352|Immunologic Factors|immunologic factors|mesh-ancestor
110042829|NCT01444352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042830|NCT01444469|Azithromycin|azithromycin|mesh-list
110042831|NCT01444469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110042832|NCT01444469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110042833|NCT01444521|Irinotecan|irinotecan|mesh-list
110042834|NCT01444521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110042835|NCT01444521|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110042838|NCT01444521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042839|NCT01444547|Paclitaxel|paclitaxel|mesh-list
110042840|NCT01444547|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110042842|NCT01444547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110042843|NCT01444547|Tubulin Modulators|tubulin modulators|mesh-ancestor
110042844|NCT01444547|Antimitotic Agents|antimitotic agents|mesh-ancestor
110042845|NCT01444547|Mitosis Modulators|mitosis modulators|mesh-ancestor
110042846|NCT01444547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042847|NCT01444586|Rivaroxaban|rivaroxaban|mesh-list
110042848|NCT01444586|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110042849|NCT01444586|Antithrombins|antithrombins|mesh-ancestor
110042850|NCT01444586|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110042851|NCT01444586|Protease Inhibitors|protease inhibitors|mesh-ancestor
110042853|NCT01444586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042855|NCT01444612|Heparin|heparin|mesh-list
110042856|NCT01444612|Calcium heparin|calcium heparin|mesh-list
110042857|NCT01444612|Enoxaparin|enoxaparin|mesh-list
110042858|NCT01444612|Dalteparin|dalteparin|mesh-list
110042859|NCT01444612|Tinzaparin|tinzaparin|mesh-list
110042860|NCT01444612|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110042862|NCT01444612|Fondaparinux|fondaparinux|mesh-list
110042863|NCT01444612|Anticoagulants|anticoagulants|mesh-ancestor
110042864|NCT01444612|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110042865|NCT01444612|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110042866|NCT01444612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042867|NCT01444612|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110042868|NCT01444612|Antithrombins|antithrombins|mesh-ancestor
110042869|NCT01444612|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110042870|NCT01444612|Protease Inhibitors|protease inhibitors|mesh-ancestor
110042871|NCT01444612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110042873|NCT01444677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110042874|NCT01444677|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110042875|NCT01444677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110042876|NCT01444677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110042877|NCT01444677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042878|NCT01444677|Antiviral Agents|antiviral agents|mesh-ancestor
110042879|NCT01444703|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110042880|NCT01444807|Sorafenib|sorafenib|mesh-list
110042881|NCT01444807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110042882|NCT01444807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110042883|NCT01444807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110042884|NCT01444807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042885|NCT01444833|Candesartan|candesartan|mesh-list
110042886|NCT01444833|Candesartan cilexetil|candesartan cilexetil|mesh-list
110042887|NCT01444833|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110042888|NCT01444833|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110042889|NCT01444833|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110042890|NCT01444833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042891|NCT01444846|Ebselen|ebselen|mesh-list
110042892|NCT01444846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110042893|NCT01444846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110042894|NCT01444846|Analgesics|analgesics|mesh-ancestor
110042895|NCT01444846|Sensory System Agents|sensory system agents|mesh-ancestor
110042896|NCT01444846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110042897|NCT01444846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042898|NCT01444846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110042899|NCT01444846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110042900|NCT01444846|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110042901|NCT01444846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110042902|NCT01444846|Antioxidants|antioxidants|mesh-ancestor
110042903|NCT01444846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042904|NCT01444846|Protective Agents|protective agents|mesh-ancestor
110042905|NCT01444846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110042906|NCT01444846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110042907|NCT01444846|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110042909|NCT01444885|Nitroglycerin|nitroglycerin|mesh-list
110042910|NCT01444885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110042911|NCT01444885|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110042912|NCT01444885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110042913|NCT01444885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042990|NCT01445262|Histamine Agents|histamine agents|mesh-ancestor
110042916|NCT01444885|Vasodilator Agents|vasodilator agents|mesh-ancestor
110042918|NCT01444976|Anesthetics|anesthetics|mesh-ancestor
110042919|NCT01444976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110042920|NCT01444976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042921|NCT01444976|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110042922|NCT01444976|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110042923|NCT01444976|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110042924|NCT01444976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110042925|NCT01444976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110042927|NCT01444976|Anesthetics, General|anesthetics, general|mesh-ancestor
110042928|NCT01444976|GABA Modulators|gaba modulators|mesh-ancestor
110042929|NCT01444976|GABA Agents|gaba agents|mesh-ancestor
110042930|NCT01444976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110042931|NCT01444976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042933|NCT01445106|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110042934|NCT01445106|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110042935|NCT01445106|Protease Inhibitors|protease inhibitors|mesh-ancestor
110042936|NCT01445106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110042937|NCT01445106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042939|NCT01445106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110042941|NCT01445106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110042942|NCT01445119|Carboplatin|carboplatin|mesh-list
110042943|NCT01445119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110042944|NCT01445210|Ropivacaine|ropivacaine|mesh-list
110042945|NCT01445210|Anesthetics, Local|anesthetics, local|mesh-ancestor
110042946|NCT01445210|Anesthetics|anesthetics|mesh-ancestor
110042947|NCT01445210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110042948|NCT01445210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042949|NCT01445210|Sensory System Agents|sensory system agents|mesh-ancestor
110042950|NCT01445210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110042951|NCT01445223|Ritonavir|ritonavir|mesh-list
110042952|NCT01445223|Lopinavir|lopinavir|mesh-list
110042953|NCT01445223|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110042954|NCT01445223|Efavirenz|efavirenz|mesh-list
110042955|NCT01445223|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110042956|NCT01445223|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110042957|NCT01445223|Protease Inhibitors|protease inhibitors|mesh-ancestor
110042958|NCT01445223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110042959|NCT01445223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042960|NCT01445223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110042961|NCT01445223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110042962|NCT01445223|Antiviral Agents|antiviral agents|mesh-ancestor
110042963|NCT01445223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110042964|NCT01445223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110042965|NCT01445223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110042966|NCT01445223|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110042967|NCT01445223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110042968|NCT01445223|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110042969|NCT01445223|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110042970|NCT01445223|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110042971|NCT01445223|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110042972|NCT01445223|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110042973|NCT01445236|Cyclosporine|cyclosporine|mesh-list
110042974|NCT01445236|Tacrolimus|tacrolimus|mesh-list
110042975|NCT01445236|Cyclosporins|cyclosporins|mesh-list
110042976|NCT01445236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110042977|NCT01445236|Immunologic Factors|immunologic factors|mesh-ancestor
110042978|NCT01445236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042979|NCT01445236|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110042980|NCT01445236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110042981|NCT01445236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042982|NCT01445236|Antifungal Agents|antifungal agents|mesh-ancestor
110042983|NCT01445236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110042984|NCT01445236|Dermatologic Agents|dermatologic agents|mesh-ancestor
110042985|NCT01445236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110042986|NCT01445262|Levocetirizine|levocetirizine|mesh-list
110042987|NCT01445262|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110042988|NCT01445262|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110042989|NCT01445262|Histamine Antagonists|histamine antagonists|mesh-ancestor
110042991|NCT01445262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110042992|NCT01445262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110042993|NCT01445262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042994|NCT01445340|Romidepsin|romidepsin|mesh-list
110042995|NCT01445340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110042996|NCT01445340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110042997|NCT01445340|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110042998|NCT01445340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110043001|NCT01445379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110043002|NCT01445379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110043003|NCT01445379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110043004|NCT01445379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110043005|NCT01445392|Pemetrexed|pemetrexed|mesh-list
110043006|NCT01445392|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110043007|NCT01445392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110043008|NCT01445392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110043009|NCT01445392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110043010|NCT01445392|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110043011|NCT01445392|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110043012|NCT01445392|Immunologic Factors|immunologic factors|mesh-ancestor
110043013|NCT01445392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110043014|NCT01445405|Cetuximab|cetuximab|mesh-list
110043015|NCT01445405|Bortezomib|bortezomib|mesh-list
110043016|NCT01445405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110043017|NCT01445405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110043018|NCT01445418|Carboplatin|carboplatin|mesh-list
110043019|NCT01445418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110043020|NCT01445431|Mineral Oil|mineral oil|mesh-list
110043021|NCT01445431|Emollients|emollients|mesh-ancestor
110043022|NCT01445431|Dermatologic Agents|dermatologic agents|mesh-ancestor
110043023|NCT01445522|Cyclophosphamide|cyclophosphamide|mesh-list
110043024|NCT01445522|Veliparib|veliparib|mesh-list
110043025|NCT01445522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110043026|NCT01445522|Immunologic Factors|immunologic factors|mesh-ancestor
110043027|NCT01445522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110043028|NCT01445522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110043029|NCT01445522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110043030|NCT01445522|Alkylating Agents|alkylating agents|mesh-ancestor
110043031|NCT01445522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110043032|NCT01445522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110043033|NCT01445522|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110043034|NCT01445522|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110043035|NCT01445522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110043036|NCT01445561|Interleukin-2|interleukin-2|mesh-list
110043037|NCT01445561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110043038|NCT01445561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110043039|NCT01445561|Analgesics|analgesics|mesh-ancestor
110043040|NCT01445561|Sensory System Agents|sensory system agents|mesh-ancestor
110043041|NCT01445561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110043042|NCT01445561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110043043|NCT01445587|Bortezomib|bortezomib|mesh-list
110043044|NCT01445587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110043045|NCT01445600|Retapamulin|retapamulin|mesh-list
110043046|NCT01445600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110043047|NCT01445600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110043048|NCT01445639|Dexmedetomidine|dexmedetomidine|mesh-list
110043049|NCT01445639|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110043050|NCT01445639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110043051|NCT01445639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110043052|NCT01445639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110043053|NCT01445639|Analgesics|analgesics|mesh-ancestor
110043054|NCT01445639|Sensory System Agents|sensory system agents|mesh-ancestor
110043055|NCT01445639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110043056|NCT01445639|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110043057|NCT01445639|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110043058|NCT01445639|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110043059|NCT01445639|Adrenergic Agents|adrenergic agents|mesh-ancestor
110043060|NCT01445639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110043061|NCT01445639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110043062|NCT01445691|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110043063|NCT01445691|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110043064|NCT01445691|Dermatologic Agents|dermatologic agents|mesh-ancestor
110043065|NCT01445743|Vaccines|vaccines|mesh-list
110043066|NCT01445743|Immunologic Factors|immunologic factors|mesh-ancestor
110043067|NCT01445743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110043071|NCT01445756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110043072|NCT01445756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110043075|NCT01445756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110043076|NCT01445756|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110043077|NCT01445756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110043078|NCT01445756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110043079|NCT01445756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110043081|NCT01445860|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110043082|NCT01445860|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110043083|NCT01445860|Antimetabolites|antimetabolites|mesh-ancestor
110043084|NCT01445860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110043085|NCT01445860|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110043086|NCT01445860|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110043087|NCT01445860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110043088|NCT01445938|Lumefantrine|lumefantrine|mesh-list
110043089|NCT01445938|Antimalarials|antimalarials|mesh-ancestor
110043090|NCT01445938|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110043091|NCT01445938|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110043092|NCT01445938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110043093|NCT01445964|Atenolol|atenolol|mesh-list
110043094|NCT01445964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110043095|NCT01445964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110043096|NCT01445964|Sympatholytics|sympatholytics|mesh-ancestor
110043097|NCT01445964|Autonomic Agents|autonomic agents|mesh-ancestor
110043098|NCT01445964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110043099|NCT01445964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110043100|NCT01445964|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110043101|NCT01445964|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110043102|NCT01445964|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110043103|NCT01445964|Adrenergic Agents|adrenergic agents|mesh-ancestor
110043104|NCT01445964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110043105|NCT01445964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110043106|NCT01446094|Regadenoson|regadenoson|mesh-list
110043107|NCT01446094|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
110043108|NCT01446094|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110043109|NCT01446094|Purinergic Agonists|purinergic agonists|mesh-ancestor
110043110|NCT01446094|Purinergic Agents|purinergic agents|mesh-ancestor
110043111|NCT01446094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110043112|NCT01446094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110043113|NCT01446094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110043114|NCT01446107|Fluorides|fluorides|mesh-list
110043115|NCT01446107|Fluorides, Topical|fluorides, topical|mesh-list
110043116|NCT01446107|Cariostatic Agents|cariostatic agents|mesh-ancestor
110043117|NCT01446107|Protective Agents|protective agents|mesh-ancestor
110043118|NCT01446107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110043119|NCT01446120|Insulin|insulin|mesh-list
110043120|NCT01446120|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110043121|NCT01446120|Insulin, Isophane|insulin, isophane|mesh-list
110043122|NCT01446120|Isophane Insulin, Human|isophane insulin, human|mesh-list
110043123|NCT01446120|Isophane insulin, beef|isophane insulin, beef|mesh-list
110043124|NCT01446120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110043125|NCT01446120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110043130|NCT01446211|Glucocorticoids|glucocorticoids|mesh-list
110043131|NCT01446211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110043133|NCT01446211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110043134|NCT01446211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110043135|NCT01446211|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110043136|NCT01446211|Alkylating Agents|alkylating agents|mesh-ancestor
110043137|NCT01446211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110043138|NCT01446211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110043139|NCT01446211|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110043140|NCT01446211|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110043141|NCT01446211|Abortifacient Agents|abortifacient agents|mesh-ancestor
110043142|NCT01446211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110043143|NCT01446211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110043144|NCT01446211|Antimetabolites|antimetabolites|mesh-ancestor
110043145|NCT01446211|Dermatologic Agents|dermatologic agents|mesh-ancestor
110043146|NCT01446211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110043147|NCT01446211|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110043148|NCT01446211|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110043151|NCT01446211|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110043152|NCT01446211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110043153|NCT01446211|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110043154|NCT01446211|Protective Agents|protective agents|mesh-ancestor
110043155|NCT01446276|Resveratrol|resveratrol|mesh-list
110043156|NCT01446276|Antioxidants|antioxidants|mesh-ancestor
110043157|NCT01446276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110043158|NCT01446276|Protective Agents|protective agents|mesh-ancestor
110043159|NCT01446276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110043160|NCT01446276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110043161|NCT01446276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110043162|NCT01446328|Olanzapine|olanzapine|mesh-list
110043163|NCT01446328|Aripiprazole|aripiprazole|mesh-list
110043164|NCT01446328|Amisulpride|amisulpride|mesh-list
110043165|NCT01446328|Antiemetics|antiemetics|mesh-ancestor
110043166|NCT01446328|Autonomic Agents|autonomic agents|mesh-ancestor
110043167|NCT01446328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110043168|NCT01446328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110043169|NCT01446328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110043170|NCT01446328|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110043171|NCT01446328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110043172|NCT01446328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110043173|NCT01446328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110043174|NCT01446328|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110043175|NCT01446328|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110043176|NCT01446328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110043177|NCT01446328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110043178|NCT01446328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110043179|NCT01446328|Serotonin Agents|serotonin agents|mesh-ancestor
110043180|NCT01446328|Antidepressive Agents|antidepressive agents|mesh-ancestor
110043181|NCT01446328|Dopamine Agonists|dopamine agonists|mesh-ancestor
110043182|NCT01446328|Dopamine Agents|dopamine agents|mesh-ancestor
110043183|NCT01446328|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110043184|NCT01446328|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110043185|NCT01446328|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110043186|NCT01446328|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110043187|NCT01446328|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110043188|NCT01446328|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110043189|NCT01446328|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110043190|NCT01446445|Valganciclovir|valganciclovir|mesh-list
110043191|NCT01446445|Ganciclovir|ganciclovir|mesh-list
110043192|NCT01446445|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
110043193|NCT01446445|Antiviral Agents|antiviral agents|mesh-ancestor
110043194|NCT01446445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110043195|NCT01446445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110043196|NCT01446445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110043201|NCT01446484|Sirolimus|sirolimus|mesh-list
110043202|NCT01446484|Mycophenolic Acid|mycophenolic acid|mesh-list
110043203|NCT01446484|Everolimus|everolimus|mesh-list
110043204|NCT01446484|Alemtuzumab|alemtuzumab|mesh-list
110043205|NCT01446484|Tacrolimus|tacrolimus|mesh-list
110043206|NCT01446484|Cyclosporins|cyclosporins|mesh-list
110043207|NCT01446484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110043208|NCT01446484|Immunologic Factors|immunologic factors|mesh-ancestor
110043209|NCT01446484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110043210|NCT01446484|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110043211|NCT01446484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110043212|NCT01446484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110043213|NCT01446484|Antifungal Agents|antifungal agents|mesh-ancestor
110043214|NCT01446484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110043215|NCT01446484|Dermatologic Agents|dermatologic agents|mesh-ancestor
110043216|NCT01446484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110043217|NCT01446484|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110043218|NCT01446484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110043219|NCT01446484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110043220|NCT01446484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110043221|NCT01446484|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110043222|NCT01446484|Antitubercular Agents|antitubercular agents|mesh-ancestor
110043223|NCT01446484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110043224|NCT01446484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110043225|NCT01446497|Timolol|timolol|mesh-list
110043226|NCT01446497|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110043227|NCT01446497|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110043229|NCT01446497|Adrenergic Agents|adrenergic agents|mesh-ancestor
110043230|NCT01446497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110043231|NCT01446497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110043232|NCT01446497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110043233|NCT01446497|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110043234|NCT01446497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110043235|NCT01446497|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110043236|NCT01446497|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110043237|NCT01446497|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110043239|NCT01446523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110043240|NCT01446562|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110043241|NCT01446562|Immunologic Factors|immunologic factors|mesh-ancestor
110043242|NCT01446562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110043243|NCT01446679|Atorvastatin|atorvastatin|mesh-list
110043244|NCT01446679|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110043245|NCT01446679|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110043246|NCT01446679|Antimetabolites|antimetabolites|mesh-ancestor
110043247|NCT01446679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110043248|NCT01446679|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110043249|NCT01446679|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110043250|NCT01446679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110043252|NCT01446731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110043253|NCT01446731|Tubulin Modulators|tubulin modulators|mesh-ancestor
110043254|NCT01446731|Antimitotic Agents|antimitotic agents|mesh-ancestor
110043255|NCT01446731|Mitosis Modulators|mitosis modulators|mesh-ancestor
110043256|NCT01446731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110043257|NCT01446783|Mecasermin|mecasermin|mesh-list
110043258|NCT01446783|Growth Substances|growth substances|mesh-ancestor
110043259|NCT01446783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110043260|NCT01446900|Rituximab|rituximab|mesh-list
110043261|NCT01446900|Cladribine|cladribine|mesh-list
110043262|NCT01446900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110043263|NCT01446900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110043264|NCT01446900|Immunologic Factors|immunologic factors|mesh-ancestor
110043265|NCT01446900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110043266|NCT01446900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110043267|NCT01446900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110043268|NCT01446926|Vaccines|vaccines|mesh-list
110043269|NCT01446926|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110043271|NCT01446926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110043273|NCT01446952|Tocopherols|tocopherols|mesh-list
110043274|NCT01446952|Tocotrienols|tocotrienols|mesh-list
110043275|NCT01446952|Vitamins|vitamins|mesh-ancestor
110043276|NCT01446952|Micronutrients|micronutrients|mesh-ancestor
110043277|NCT01446952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110043278|NCT01446952|Antioxidants|antioxidants|mesh-ancestor
110043279|NCT01446952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110043280|NCT01446952|Protective Agents|protective agents|mesh-ancestor
110043281|NCT01446978|Vaccines|vaccines|mesh-list
110043282|NCT01446978|Immunologic Factors|immunologic factors|mesh-ancestor
110043283|NCT01446978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110043284|NCT01447043|Ranibizumab|ranibizumab|mesh-list
110043285|NCT01447043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110043286|NCT01447043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110043287|NCT01447043|Growth Substances|growth substances|mesh-ancestor
110043288|NCT01447043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110043289|NCT01447043|Growth Inhibitors|growth inhibitors|mesh-ancestor
110043290|NCT01447043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110043291|NCT01447069|Albuterol|albuterol|mesh-list
110043292|NCT01447069|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110043293|NCT01447069|Autonomic Agents|autonomic agents|mesh-ancestor
110043294|NCT01447069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110043295|NCT01447069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110043296|NCT01447069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110043297|NCT01447069|Respiratory System Agents|respiratory system agents|mesh-ancestor
110043298|NCT01447069|Tocolytic Agents|tocolytic agents|mesh-ancestor
110043299|NCT01447069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110043300|NCT01447069|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110043301|NCT01447069|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110043302|NCT01447069|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110043303|NCT01447069|Adrenergic Agents|adrenergic agents|mesh-ancestor
110043304|NCT01447069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110043305|NCT01447069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110043306|NCT01447095|Epoprostenol|epoprostenol|mesh-list
110043308|NCT01447095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110043309|NCT01447095|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110043310|NCT01447095|Vasodilator Agents|vasodilator agents|mesh-ancestor
110043311|NCT01447160|Cortisone|cortisone|mesh-list
110043312|NCT01447160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110043313|NCT01447173|Vitamin D|vitamin d|mesh-list
110043314|NCT01447173|Vitamins|vitamins|mesh-ancestor
110043315|NCT01447173|Micronutrients|micronutrients|mesh-ancestor
110043316|NCT01447173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110043317|NCT01447173|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110043318|NCT01447212|Hydromorphone|hydromorphone|mesh-list
110043320|NCT01447212|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110043321|NCT01447212|Narcotics|narcotics|mesh-ancestor
110043322|NCT01447212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110043323|NCT01447212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110043324|NCT01447212|Analgesics|analgesics|mesh-ancestor
110043325|NCT01447212|Sensory System Agents|sensory system agents|mesh-ancestor
110043326|NCT01447212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110043327|NCT01447355|Vitamin D|vitamin d|mesh-list
110043328|NCT01447355|Cholecalciferol|cholecalciferol|mesh-list
110043329|NCT01447355|Vitamins|vitamins|mesh-ancestor
110043330|NCT01447355|Micronutrients|micronutrients|mesh-ancestor
110043331|NCT01447355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110043332|NCT01447355|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110043333|NCT01447355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110043334|NCT01447368|Cinacalcet|cinacalcet|mesh-list
110043335|NCT01447368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110043336|NCT01447368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110043337|NCT01447368|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
110043338|NCT01447368|Hormone Antagonists|hormone antagonists|mesh-ancestor
110043339|NCT01447368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110043341|NCT01447394|Ribavirin|ribavirin|mesh-list
110043342|NCT01447394|Interferon-alpha|interferon-alpha|mesh-list
110043343|NCT01447394|Interferon alpha-2|interferon alpha-2|mesh-list
110043344|NCT01447394|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110043345|NCT01447394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110043346|NCT01447394|Antiviral Agents|antiviral agents|mesh-ancestor
110043347|NCT01447394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110043348|NCT01447394|Antimetabolites|antimetabolites|mesh-ancestor
110043349|NCT01447394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110043350|NCT01447394|Immunologic Factors|immunologic factors|mesh-ancestor
110043352|NCT01447485|Valsartan|valsartan|mesh-list
110043353|NCT01447485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110043354|NCT01447485|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110043355|NCT01447485|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110043356|NCT01447485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110043357|NCT01447550|Bosentan|bosentan|mesh-list
110043358|NCT01447550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110043359|NCT01447550|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110043360|NCT01447550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110043361|NCT01447563|Clopidogrel|clopidogrel|mesh-list
110043362|NCT01447563|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110043363|NCT01447563|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110043364|NCT01447563|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110043365|NCT01447563|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110043366|NCT01447563|Purinergic Agents|purinergic agents|mesh-ancestor
110043367|NCT01447563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110043368|NCT01447563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110043369|NCT01447563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110043370|NCT01447589|Nelfinavir|nelfinavir|mesh-list
110043371|NCT01447589|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110043372|NCT01447589|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110043373|NCT01447589|Protease Inhibitors|protease inhibitors|mesh-ancestor
110043374|NCT01447589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110043375|NCT01447589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110043376|NCT01447589|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110043377|NCT01447589|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110043378|NCT01447589|Antiviral Agents|antiviral agents|mesh-ancestor
110043379|NCT01447589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110043380|NCT01447654|Losartan|losartan|mesh-list
110043381|NCT01447654|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110043382|NCT01447654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110043383|NCT01447654|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110043385|NCT01447654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110043387|NCT01447797|Atorvastatin|atorvastatin|mesh-list
110043388|NCT01447797|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110043389|NCT01447797|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110043390|NCT01447797|Antimetabolites|antimetabolites|mesh-ancestor
110043391|NCT01447797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110043392|NCT01447797|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110043393|NCT01447797|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110043394|NCT01447797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110043395|NCT01447797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110043396|NCT01447797|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110043397|NCT01447797|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110043398|NCT01447862|Ibutilide|ibutilide|mesh-list
110043399|NCT01447862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110043400|NCT01447875|Propofol|propofol|mesh-list
110043401|NCT01447875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110043402|NCT01447875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110043404|NCT01447875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110043405|NCT01447875|Anesthetics, General|anesthetics, general|mesh-ancestor
110043406|NCT01447875|Anesthetics|anesthetics|mesh-ancestor
110043407|NCT01447979|Pancrelipase|pancrelipase|mesh-list
110043408|NCT01447979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110043409|NCT01448018|Ranibizumab|ranibizumab|mesh-list
110043410|NCT01448018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110043411|NCT01448018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110043412|NCT01448018|Growth Substances|growth substances|mesh-ancestor
110043413|NCT01448018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110043414|NCT01448018|Growth Inhibitors|growth inhibitors|mesh-ancestor
110043415|NCT01448018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110043416|NCT01448031|Esomeprazole|esomeprazole|mesh-list
110043417|NCT01448031|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110043418|NCT01448031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110043419|NCT01448031|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110043420|NCT01448031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110043421|NCT01448031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110043422|NCT01448070|Insulin|insulin|mesh-list
110043423|NCT01448070|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110043424|NCT01448070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110043425|NCT01448070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110043427|NCT01448096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110043428|NCT01448096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110043429|NCT01448096|Immunologic Factors|immunologic factors|mesh-ancestor
110043430|NCT01448096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110043431|NCT01448096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110043432|NCT01448109|Hydrocortisone|hydrocortisone|mesh-list
110043433|NCT01448109|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110043434|NCT01448109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110043435|NCT01448174|Atorvastatin|atorvastatin|mesh-list
110043436|NCT01448174|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110043437|NCT01448174|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110043438|NCT01448174|Antimetabolites|antimetabolites|mesh-ancestor
110043439|NCT01448174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110043440|NCT01448174|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110043441|NCT01448174|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110043442|NCT01448174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110043444|NCT01448239|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110043445|NCT01448239|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110043446|NCT01448239|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110043447|NCT01448239|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110043448|NCT01448239|Antimetabolites|antimetabolites|mesh-ancestor
110043449|NCT01448239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110043450|NCT01448239|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110043451|NCT01448239|Protease Inhibitors|protease inhibitors|mesh-ancestor
110043452|NCT01448239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110043453|NCT01448239|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110043454|NCT01448239|Immunologic Factors|immunologic factors|mesh-ancestor
110043455|NCT01448239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110043456|NCT01448291|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110043457|NCT01448291|Etonogestrel|etonogestrel|mesh-list
110043458|NCT01448291|NuvaRing|nuvaring|mesh-list
110043459|NCT01448291|Contraceptive Agents|contraceptive agents|mesh-list
110043460|NCT01448291|Estradiol|estradiol|mesh-list
110043461|NCT01448291|Estrogens|estrogens|mesh-ancestor
110043462|NCT01448291|Hormones|hormones|mesh-ancestor
110043463|NCT01448291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110043464|NCT01448291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110043465|NCT01448291|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110043466|NCT01448291|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110043467|NCT01448291|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110043468|NCT01448291|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110043469|NCT01448291|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110043470|NCT01448304|Alirocumab|alirocumab|mesh-list
110043471|NCT01448304|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110043472|NCT01448304|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110043473|NCT01448304|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110043474|NCT01448304|Antimetabolites|antimetabolites|mesh-ancestor
110043475|NCT01448304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110043476|NCT01448304|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110043477|NCT01448304|Protease Inhibitors|protease inhibitors|mesh-ancestor
110043478|NCT01448304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110043479|NCT01448304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110043481|NCT01448317|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110043482|NCT01448317|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110043483|NCT01448317|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110043484|NCT01448317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110043485|NCT01448317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110043486|NCT01448317|Antimetabolites|antimetabolites|mesh-ancestor
110043487|NCT01448317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110043488|NCT01448317|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110043489|NCT01448317|Protease Inhibitors|protease inhibitors|mesh-ancestor
110043490|NCT01448317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110043491|NCT01448317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110043492|NCT01448317|Immunologic Factors|immunologic factors|mesh-ancestor
110043493|NCT01448317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110043494|NCT01448330|Aspirin|aspirin|mesh-list
110043495|NCT01448330|Clopidogrel|clopidogrel|mesh-list
110043496|NCT01448330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110043497|NCT01448330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110043498|NCT01448330|Analgesics|analgesics|mesh-ancestor
110043499|NCT01448330|Sensory System Agents|sensory system agents|mesh-ancestor
110043500|NCT01448330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110043501|NCT01448330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110043502|NCT01448330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110043503|NCT01448330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110043504|NCT01448330|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110043505|NCT01448330|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110043506|NCT01448330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110043507|NCT01448330|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110043508|NCT01448330|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110043509|NCT01448330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110043510|NCT01448330|Antipyretics|antipyretics|mesh-ancestor
110043511|NCT01448330|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110043512|NCT01448330|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110043513|NCT01448330|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110043514|NCT01448330|Purinergic Agents|purinergic agents|mesh-ancestor
110043515|NCT01448330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110043517|NCT01448395|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110043518|NCT01448395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110043519|NCT01448395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110043520|NCT01448395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110043521|NCT01448395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110043522|NCT01448434|Plasma-lyte 148|plasma-lyte 148|mesh-list
110043524|NCT01448434|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110043525|NCT01448499|Clozapine|clozapine|mesh-list
110043526|NCT01448499|Amisulpride|amisulpride|mesh-list
110043527|NCT01448499|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110043528|NCT01448499|Serotonin Agents|serotonin agents|mesh-ancestor
110043529|NCT01448499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110043530|NCT01448499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110043531|NCT01448499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110043532|NCT01448499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110043533|NCT01448499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110043534|NCT01448499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110043535|NCT01448499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110043536|NCT01448499|GABA Antagonists|gaba antagonists|mesh-ancestor
110043537|NCT01448499|GABA Agents|gaba agents|mesh-ancestor
110043538|NCT01448499|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110043539|NCT01448499|Dopamine Agents|dopamine agents|mesh-ancestor
110043540|NCT01448499|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110043541|NCT01448499|Antidepressive Agents|antidepressive agents|mesh-ancestor
110043542|NCT01448642|Atorvastatin|atorvastatin|mesh-list
110043543|NCT01448642|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110043544|NCT01448642|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110043546|NCT01448642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110043547|NCT01448642|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110043548|NCT01448642|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110043549|NCT01448642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110043550|NCT01448720|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110043551|NCT01448720|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110043552|NCT01448720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110043553|NCT01448720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110043554|NCT01448720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110043555|NCT01448720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110043556|NCT01448720|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110043557|NCT01448720|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110043558|NCT01448720|Serotonin Agents|serotonin agents|mesh-ancestor
110043559|NCT01448720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110043560|NCT01448720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110043561|NCT01448720|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110043562|NCT01448720|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110043563|NCT01448720|Dopamine Agents|dopamine agents|mesh-ancestor
110043564|NCT01448733|Clindamycin|clindamycin|mesh-list
110043565|NCT01448733|Clindamycin palmitate|clindamycin palmitate|mesh-list
110043566|NCT01448733|Clindamycin phosphate|clindamycin phosphate|mesh-list
110043567|NCT01448733|Tretinoin|tretinoin|mesh-list
110043568|NCT01448733|Benzoyl Peroxide|benzoyl peroxide|mesh-list
110043569|NCT01448733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110043570|NCT01448733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110043571|NCT01448733|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110043572|NCT01448733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110043573|NCT01448733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110043574|NCT01448733|Dermatologic Agents|dermatologic agents|mesh-ancestor
110043575|NCT01448733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110043576|NCT01448733|Keratolytic Agents|keratolytic agents|mesh-ancestor
110043577|NCT01448746|Heparin|heparin|mesh-list
110043578|NCT01448746|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110043579|NCT01448746|Tinzaparin|tinzaparin|mesh-list
110043580|NCT01448746|Dalteparin|dalteparin|mesh-list
110043581|NCT01448746|Anticoagulants|anticoagulants|mesh-ancestor
110043582|NCT01448746|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110043583|NCT01448746|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110043584|NCT01448746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110043585|NCT01448772|Dronabinol|dronabinol|mesh-list
110043586|NCT01448772|Hallucinogens|hallucinogens|mesh-ancestor
110043587|NCT01448772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110043588|NCT01448772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110043589|NCT01448772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110043590|NCT01448772|Analgesics|analgesics|mesh-ancestor
110043591|NCT01448772|Sensory System Agents|sensory system agents|mesh-ancestor
110043592|NCT01448772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110043593|NCT01448772|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110043594|NCT01448772|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110043595|NCT01448772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110043596|NCT01448772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110043598|NCT01448772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110043599|NCT01448798|Thrombin|thrombin|mesh-list
110043600|NCT01448798|Hemostatics|hemostatics|mesh-list
110043601|NCT01448798|Coagulants|coagulants|mesh-ancestor
110043602|NCT01448837|Timolol|timolol|mesh-list
110043603|NCT01448837|Bimatoprost|bimatoprost|mesh-list
110043604|NCT01448837|Latanoprost|latanoprost|mesh-list
110043605|NCT01448837|Cloprostenol|cloprostenol|mesh-list
110043606|NCT01448837|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110043607|NCT01448837|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110043608|NCT01448837|Adrenergic Agents|adrenergic agents|mesh-ancestor
110043609|NCT01448837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110043610|NCT01448837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110043611|NCT01448837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110043612|NCT01448837|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110043613|NCT01448837|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110043614|NCT01448837|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110043615|NCT01448837|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110043616|NCT01448837|Luteolytic Agents|luteolytic agents|mesh-ancestor
110043617|NCT01448837|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110043618|NCT01448837|Contraceptive Agents|contraceptive agents|mesh-ancestor
110043619|NCT01448837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110043620|NCT01448837|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110043621|NCT01448993|Azithromycin|azithromycin|mesh-list
110043622|NCT01448993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110043623|NCT01448993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110043624|NCT01449045|Lumefantrine|lumefantrine|mesh-list
110043626|NCT01449045|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110043627|NCT01449045|Antimalarials|antimalarials|mesh-ancestor
110043628|NCT01449045|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110043629|NCT01449045|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110043630|NCT01449045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110043632|NCT01449110|Antioxidants|antioxidants|mesh-ancestor
110043633|NCT01449110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110043634|NCT01449110|Protective Agents|protective agents|mesh-ancestor
110043635|NCT01449110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110043636|NCT01449110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110043637|NCT01449110|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110043639|NCT01449123|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110043640|NCT01449123|Diuretics|diuretics|mesh-ancestor
110043641|NCT01449123|Natriuretic Agents|natriuretic agents|mesh-ancestor
110043642|NCT01449123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110043643|NCT01449136|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110043644|NCT01449136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110043645|NCT01449188|Moxifloxacin|moxifloxacin|mesh-list
110043646|NCT01449188|Ondansetron|ondansetron|mesh-list
110043647|NCT01449188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110043648|NCT01449188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110043649|NCT01449188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110043650|NCT01449188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110043651|NCT01449188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110043652|NCT01449188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110043653|NCT01449188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110043654|NCT01449188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110043655|NCT01449188|Antiemetics|antiemetics|mesh-ancestor
110043656|NCT01449188|Autonomic Agents|autonomic agents|mesh-ancestor
110043657|NCT01449188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110043658|NCT01449188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110043659|NCT01449188|Antipruritics|antipruritics|mesh-ancestor
110043660|NCT01449188|Dermatologic Agents|dermatologic agents|mesh-ancestor
110043661|NCT01449188|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110043662|NCT01449188|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110043663|NCT01449188|Serotonin Agents|serotonin agents|mesh-ancestor
110043664|NCT01449188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110043665|NCT01449253|Bosentan|bosentan|mesh-list
110043666|NCT01449253|Sildenafil Citrate|sildenafil citrate|mesh-list
110043667|NCT01449253|Vasodilator Agents|vasodilator agents|mesh-ancestor
110043668|NCT01449253|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110043669|NCT01449253|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110043670|NCT01449253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110043671|NCT01449253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110043672|NCT01449253|Urological Agents|urological agents|mesh-ancestor
110043673|NCT01449253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110043674|NCT01449253|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110043675|NCT01449344|Cytarabine|cytarabine|mesh-list
110043676|NCT01449344|Dexamethasone|dexamethasone|mesh-list
110043679|NCT01449344|Bortezomib|bortezomib|mesh-list
110043680|NCT01449344|BB 1101|bb 1101|mesh-list
110043681|NCT01449344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110043682|NCT01449344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110043683|NCT01449344|Immunologic Factors|immunologic factors|mesh-ancestor
110043684|NCT01449344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110043685|NCT01449344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110043686|NCT01449344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110043687|NCT01449344|Antiemetics|antiemetics|mesh-ancestor
110043688|NCT01449344|Autonomic Agents|autonomic agents|mesh-ancestor
110043689|NCT01449344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110043690|NCT01449344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110043691|NCT01449344|Glucocorticoids|glucocorticoids|mesh-ancestor
110043692|NCT01449344|Hormones|hormones|mesh-ancestor
110043693|NCT01449344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110043694|NCT01449344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110043695|NCT01449344|Protease Inhibitors|protease inhibitors|mesh-ancestor
110043696|NCT01449344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110043697|NCT01449344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110043698|NCT01449344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110043699|NCT01449344|Antimetabolites|antimetabolites|mesh-ancestor
110043701|NCT01449344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110043702|NCT01449344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110043703|NCT01449357|Zalutumumab|zalutumumab|mesh-list
110043704|NCT01449357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110043705|NCT01449357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110043706|NCT01449435|Methacholine Chloride|methacholine chloride|mesh-list
110043707|NCT01449435|Miotics|miotics|mesh-ancestor
110043708|NCT01449435|Autonomic Agents|autonomic agents|mesh-ancestor
110043709|NCT01449435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110043710|NCT01449435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110043711|NCT01449435|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110043712|NCT01449435|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
110043713|NCT01449435|Respiratory System Agents|respiratory system agents|mesh-ancestor
110043714|NCT01449435|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110043715|NCT01449435|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110043716|NCT01449435|Cholinergic Agents|cholinergic agents|mesh-ancestor
110043717|NCT01449435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110043718|NCT01449435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110043719|NCT01449448|Triamcinolone|triamcinolone|mesh-list
110043720|NCT01449448|Ketorolac|ketorolac|mesh-list
110043721|NCT01449448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110043722|NCT01449448|Glucocorticoids|glucocorticoids|mesh-ancestor
110043723|NCT01449448|Hormones|hormones|mesh-ancestor
110043724|NCT01449448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110043725|NCT01449448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110043726|NCT01449448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110043727|NCT01449448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110043728|NCT01449448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110043729|NCT01449448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110043730|NCT01449448|Analgesics|analgesics|mesh-ancestor
110043731|NCT01449448|Sensory System Agents|sensory system agents|mesh-ancestor
110043732|NCT01449448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110043733|NCT01449448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110043734|NCT01449448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110043735|NCT01447992|Pancrelipase|pancrelipase|mesh-list
110043736|NCT01447992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110043737|NCT01449552|Tranexamic Acid|tranexamic acid|mesh-list
110043738|NCT01449552|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110043739|NCT01449552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110043740|NCT01449552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110043741|NCT01449552|Hemostatics|hemostatics|mesh-ancestor
110043742|NCT01449552|Coagulants|coagulants|mesh-ancestor
110043743|NCT01449565|Naltrexone|naltrexone|mesh-list
110043744|NCT01449565|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110043745|NCT01449565|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110043746|NCT01449565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110043747|NCT01449565|Sensory System Agents|sensory system agents|mesh-ancestor
110043748|NCT01449565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110043749|NCT01449578|Pramipexole|pramipexole|mesh-list
110043750|NCT01449578|Antioxidants|antioxidants|mesh-ancestor
110043751|NCT01449578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110043753|NCT01449578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110043754|NCT01449578|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110043755|NCT01449578|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110043756|NCT01449578|Dopamine Agonists|dopamine agonists|mesh-ancestor
110043757|NCT01449578|Dopamine Agents|dopamine agents|mesh-ancestor
110043758|NCT01449578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110043759|NCT01449617|Aspirin|aspirin|mesh-list
110043760|NCT01449617|Clopidogrel|clopidogrel|mesh-list
110043761|NCT01449617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110043762|NCT01449617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110043763|NCT01449617|Analgesics|analgesics|mesh-ancestor
110043764|NCT01449617|Sensory System Agents|sensory system agents|mesh-ancestor
110043765|NCT01449617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110043766|NCT01449617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110043767|NCT01449617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110043768|NCT01449617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110043769|NCT01449617|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110043770|NCT01449617|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110043771|NCT01449617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110043772|NCT01449617|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110043773|NCT01449617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110043774|NCT01449617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110043775|NCT01449617|Antipyretics|antipyretics|mesh-ancestor
110043776|NCT01449617|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110043777|NCT01449617|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110043778|NCT01449617|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110043779|NCT01449617|Purinergic Agents|purinergic agents|mesh-ancestor
110043780|NCT01449617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110043781|NCT01449799|Fluticasone|fluticasone|mesh-list
110043783|NCT01449799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110043784|NCT01449799|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110043785|NCT01449799|Autonomic Agents|autonomic agents|mesh-ancestor
110043786|NCT01449799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110043787|NCT01449799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110043788|NCT01449799|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110043789|NCT01449799|Respiratory System Agents|respiratory system agents|mesh-ancestor
110043790|NCT01449799|Dermatologic Agents|dermatologic agents|mesh-ancestor
110043791|NCT01449799|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110043792|NCT01449825|Bevacizumab|bevacizumab|mesh-list
110043793|NCT01449825|Sunitinib|sunitinib|mesh-list
110043794|NCT01449825|Sorafenib|sorafenib|mesh-list
110043795|NCT01449825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110043796|NCT01449825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110043797|NCT01449825|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110043798|NCT01449825|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110043799|NCT01449825|Growth Substances|growth substances|mesh-ancestor
110043800|NCT01449825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110043801|NCT01449825|Growth Inhibitors|growth inhibitors|mesh-ancestor
110043802|NCT01449825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110043803|NCT01449825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110043804|NCT01449825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110043805|NCT01449877|Trimethoprim|trimethoprim|mesh-list
110043806|NCT01449877|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110043807|NCT01449877|Sulfamethoxazole|sulfamethoxazole|mesh-list
110043808|NCT01449877|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110043809|NCT01449877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110043810|NCT01449877|Antimalarials|antimalarials|mesh-ancestor
110043811|NCT01449877|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110043812|NCT01449877|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110043813|NCT01449877|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110043814|NCT01449877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110043815|NCT01449877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110043816|NCT01449877|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110043817|NCT01449877|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110043818|NCT01449877|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110043819|NCT01449877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110043820|NCT01450163|Oxaliplatin|oxaliplatin|mesh-list
110043821|NCT01450163|Pregabalin|pregabalin|mesh-list
110043822|NCT01450163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110043823|NCT01450163|Analgesics|analgesics|mesh-ancestor
110043824|NCT01450163|Sensory System Agents|sensory system agents|mesh-ancestor
110043825|NCT01450163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110043826|NCT01450163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110043827|NCT01450163|Anticonvulsants|anticonvulsants|mesh-ancestor
110043828|NCT01450163|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110043829|NCT01450163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110043830|NCT01450163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110043831|NCT01450163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110043832|NCT01450163|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110043833|NCT01450163|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110043834|NCT01450163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110043835|NCT01450163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110043836|NCT01450267|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110043837|NCT01450995|Sumatriptan|sumatriptan|mesh-list
110043838|NCT01450995|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110043839|NCT01450995|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110043840|NCT01450995|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110043841|NCT01450995|Serotonin Agents|serotonin agents|mesh-ancestor
110043842|NCT01450995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110043843|NCT01450995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110043844|NCT01450995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110043845|NCT01451320|Plasminogen|plasminogen|mesh-list
110043846|NCT01451320|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110043847|NCT01451320|Streptokinase|streptokinase|mesh-list
110043848|NCT01451320|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110043849|NCT01451320|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110043927|NCT01454700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110043850|NCT01451320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110043851|NCT01451489|Cyclophosphamide|cyclophosphamide|mesh-list
110043852|NCT01451489|Tacrolimus|tacrolimus|mesh-list
110043853|NCT01451489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110043854|NCT01451489|Immunologic Factors|immunologic factors|mesh-ancestor
110043855|NCT01451489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110043856|NCT01451489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110043857|NCT01451489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110043858|NCT01451489|Alkylating Agents|alkylating agents|mesh-ancestor
110043859|NCT01451489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110043860|NCT01451489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110043861|NCT01451489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110043862|NCT01451489|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110043863|NCT01451489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110043864|NCT01451853|Ebselen|ebselen|mesh-list
110043865|NCT01451853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110043866|NCT01451853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110043867|NCT01451853|Analgesics|analgesics|mesh-ancestor
110043868|NCT01451853|Sensory System Agents|sensory system agents|mesh-ancestor
110043869|NCT01451853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110043870|NCT01451853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110043871|NCT01451853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110043872|NCT01451853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110043873|NCT01451853|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110043874|NCT01451853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110043875|NCT01451853|Antioxidants|antioxidants|mesh-ancestor
110043876|NCT01451853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110043877|NCT01451853|Protective Agents|protective agents|mesh-ancestor
110043878|NCT01451853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110043879|NCT01451853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110043880|NCT01451853|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110043881|NCT01452243|Vitamin D|vitamin d|mesh-list
110043882|NCT01452243|Calcium|calcium|mesh-list
110043883|NCT01452243|Vitamins|vitamins|mesh-ancestor
110043884|NCT01452243|Micronutrients|micronutrients|mesh-ancestor
110043885|NCT01452243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110043886|NCT01452243|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110043887|NCT01452243|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110043888|NCT01452256|Propofol|propofol|mesh-list
110043889|NCT01452256|Desflurane|desflurane|mesh-list
110043890|NCT01452256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110043891|NCT01452256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110043892|NCT01452256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110043893|NCT01452256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110043894|NCT01452256|Anesthetics, General|anesthetics, general|mesh-ancestor
110043896|NCT01452256|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110043897|NCT01452373|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
110043898|NCT01452373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110043899|NCT01452373|Immunologic Factors|immunologic factors|mesh-ancestor
110043900|NCT01452373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110043901|NCT01452607|Ebselen|ebselen|mesh-list
110043902|NCT01452607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110043903|NCT01452607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110043904|NCT01452607|Analgesics|analgesics|mesh-ancestor
110043905|NCT01452607|Sensory System Agents|sensory system agents|mesh-ancestor
110043906|NCT01452607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110043907|NCT01452607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110043908|NCT01452607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110043909|NCT01452607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110043910|NCT01452607|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110043911|NCT01452607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110043912|NCT01452607|Antioxidants|antioxidants|mesh-ancestor
110043913|NCT01452607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110043914|NCT01452607|Protective Agents|protective agents|mesh-ancestor
110043915|NCT01452607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110043916|NCT01452607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110043917|NCT01452607|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110043918|NCT01453062|Ofatumumab|ofatumumab|mesh-list
110043919|NCT01453062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110043920|NCT01453283|Trabectedin|trabectedin|mesh-list
110043921|NCT01453283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110043922|NCT01453283|Alkylating Agents|alkylating agents|mesh-ancestor
110043923|NCT01453283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110043924|NCT01453283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110043925|NCT01454700|Insulin|insulin|mesh-list
110043926|NCT01454700|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110043928|NCT01454700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110043929|NCT01454869|Heparin|heparin|mesh-list
110043930|NCT01454869|Anticoagulants|anticoagulants|mesh-ancestor
110043931|NCT01454869|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110043932|NCT01454869|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110043933|NCT01454869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110043934|NCT05964413|Vilobelimab|vilobelimab|mesh-list
110043935|NCT05964413|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110043936|NCT05964413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110043937|NCT05964413|Immunologic Factors|immunologic factors|mesh-ancestor
110043938|NCT05964413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110043939|NCT05964387|Lidocaine|lidocaine|mesh-list
110043940|NCT05964387|Epinephrine|epinephrine|mesh-list
110043941|NCT05964387|Anesthetics, Local|anesthetics, local|mesh-ancestor
110043942|NCT05964387|Anesthetics|anesthetics|mesh-ancestor
110043943|NCT05964387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110043944|NCT05964387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110043945|NCT05964387|Sensory System Agents|sensory system agents|mesh-ancestor
110043946|NCT05964387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110043947|NCT05964387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110043948|NCT05964387|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110043949|NCT05964387|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110043950|NCT05964387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110043951|NCT05964387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110043952|NCT05964387|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110043953|NCT05964387|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110043954|NCT05964387|Adrenergic Agents|adrenergic agents|mesh-ancestor
110043955|NCT05964387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110043956|NCT05964387|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110043957|NCT05964387|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110043958|NCT05964387|Autonomic Agents|autonomic agents|mesh-ancestor
110043959|NCT05964387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110043960|NCT05964387|Respiratory System Agents|respiratory system agents|mesh-ancestor
110043961|NCT05964387|Mydriatics|mydriatics|mesh-ancestor
110043962|NCT05964387|Sympathomimetics|sympathomimetics|mesh-ancestor
110043963|NCT05964387|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110043964|NCT05964361|Vaccines|vaccines|mesh-list
110043965|NCT05964361|Immunologic Factors|immunologic factors|mesh-ancestor
110043966|NCT05964361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110043967|NCT05964257|Botulinum Toxins|botulinum toxins|mesh-list
110043968|NCT05964257|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110043969|NCT05964257|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110043970|NCT05964257|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110043971|NCT05964257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110043972|NCT05964257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110043973|NCT05964257|Cholinergic Agents|cholinergic agents|mesh-ancestor
110043974|NCT05964257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110043976|NCT05964257|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110043977|NCT05964257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110043978|NCT05964140|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110043979|NCT05964140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110043980|NCT05964114|Vancomycin|vancomycin|mesh-list
110043981|NCT05964114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110043982|NCT05964114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110043983|NCT05964101|Paclitaxel|paclitaxel|mesh-list
110043984|NCT05964101|Carboplatin|carboplatin|mesh-list
110043985|NCT05964101|Nivolumab|nivolumab|mesh-list
110043986|NCT05964101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110043987|NCT05964101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110043988|NCT05964101|Tubulin Modulators|tubulin modulators|mesh-ancestor
110043989|NCT05964101|Antimitotic Agents|antimitotic agents|mesh-ancestor
110043990|NCT05964101|Mitosis Modulators|mitosis modulators|mesh-ancestor
110043991|NCT05964101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110043992|NCT05964101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110043993|NCT05964101|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110043994|NCT05963711|Chlorhexidine|chlorhexidine|mesh-list
110043995|NCT05963711|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110043996|NCT05963711|Clindamycin|clindamycin|mesh-list
110043997|NCT05963711|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110043998|NCT05963711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110043999|NCT05963711|Disinfectants|disinfectants|mesh-ancestor
110044000|NCT05963711|Dermatologic Agents|dermatologic agents|mesh-ancestor
110044001|NCT05963711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110044002|NCT05963711|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110044003|NCT05963711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110044084|NCT05962255|Furosemide|furosemide|mesh-list
110044004|NCT05963711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110044006|NCT05963334|Carboplatin|carboplatin|mesh-list
110044007|NCT05963334|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110044008|NCT05963334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110044009|NCT05963334|Tubulin Modulators|tubulin modulators|mesh-ancestor
110044010|NCT05963334|Antimitotic Agents|antimitotic agents|mesh-ancestor
110044011|NCT05963334|Mitosis Modulators|mitosis modulators|mesh-ancestor
110044012|NCT05963334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110044013|NCT05963217|Cyclophosphamide|cyclophosphamide|mesh-list
110044014|NCT05963217|Fludarabine|fludarabine|mesh-list
110044015|NCT05963217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110044016|NCT05963217|Immunologic Factors|immunologic factors|mesh-ancestor
110044017|NCT05963217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110044018|NCT05963217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110044019|NCT05963217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110044020|NCT05963217|Alkylating Agents|alkylating agents|mesh-ancestor
110044021|NCT05963217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110044022|NCT05963217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110044023|NCT05963217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110044025|NCT05963204|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110044026|NCT05963204|Diuretics|diuretics|mesh-ancestor
110044027|NCT05963204|Natriuretic Agents|natriuretic agents|mesh-ancestor
110044028|NCT05963204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110044029|NCT05963087|Cetuximab|cetuximab|mesh-list
110044030|NCT05963087|Tislelizumab|tislelizumab|mesh-list
110044031|NCT05963087|Dabrafenib|dabrafenib|mesh-list
110044032|NCT05963087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110044033|NCT05963087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110044034|NCT05963087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110044035|NCT05963087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110044036|NCT05963087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110044037|NCT05963048|Rituximab|rituximab|mesh-list
110044038|NCT05963048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110044039|NCT05963048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110044040|NCT05963048|Immunologic Factors|immunologic factors|mesh-ancestor
110044041|NCT05963048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110044042|NCT05963048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110044043|NCT05962970|Ropivacaine|ropivacaine|mesh-list
110044044|NCT05962970|Anesthetics, Local|anesthetics, local|mesh-ancestor
110044045|NCT05962970|Anesthetics|anesthetics|mesh-ancestor
110044046|NCT05962970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110044047|NCT05962970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110044048|NCT05962970|Sensory System Agents|sensory system agents|mesh-ancestor
110044049|NCT05962970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110044050|NCT05962775|Ethanol|ethanol|mesh-list
110044051|NCT05962775|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110044053|NCT05962775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110044054|NCT05962775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110044055|NCT05962671|Analgesics, Opioid|analgesics, opioid|mesh-list
110044056|NCT05962671|Anesthetics|anesthetics|mesh-list
110044057|NCT05962671|Sevoflurane|sevoflurane|mesh-list
110044058|NCT05962671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110044059|NCT05962671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110044060|NCT05962671|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110044061|NCT05962671|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110044062|NCT05962671|Anesthetics, General|anesthetics, general|mesh-ancestor
110044063|NCT05962671|Narcotics|narcotics|mesh-ancestor
110044064|NCT05962671|Analgesics|analgesics|mesh-ancestor
110044065|NCT05962671|Sensory System Agents|sensory system agents|mesh-ancestor
110044066|NCT05962671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110044067|NCT05962632|Fluorides|fluorides|mesh-list
110044068|NCT05962632|Cariostatic Agents|cariostatic agents|mesh-ancestor
110044069|NCT05962632|Protective Agents|protective agents|mesh-ancestor
110044070|NCT05962632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110044071|NCT05962619|Hyaluronic Acid|hyaluronic acid|mesh-list
110044072|NCT05962619|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110044073|NCT05962619|Immunologic Factors|immunologic factors|mesh-ancestor
110044074|NCT05962619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110044076|NCT05962619|Protective Agents|protective agents|mesh-ancestor
110044077|NCT05962320|Analgesics, Opioid|analgesics, opioid|mesh-list
110044078|NCT05962320|Narcotics|narcotics|mesh-ancestor
110044079|NCT05962320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110044080|NCT05962320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110044081|NCT05962320|Analgesics|analgesics|mesh-ancestor
110044082|NCT05962320|Sensory System Agents|sensory system agents|mesh-ancestor
110044083|NCT05962320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110044087|NCT05962255|Natriuretic Agents|natriuretic agents|mesh-ancestor
110044088|NCT05962255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110044089|NCT05962255|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110044090|NCT05962255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110044091|NCT05962255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110044093|NCT05962229|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110044094|NCT05962229|Autonomic Agents|autonomic agents|mesh-ancestor
110044095|NCT05962229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110044096|NCT05962229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110044099|NCT05962229|Cholinergic Agents|cholinergic agents|mesh-ancestor
110044100|NCT05962229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110044101|NCT05962229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110044102|NCT05962216|Brexpiprazole|brexpiprazole|mesh-list
110044103|NCT05962216|Serotonin Agents|serotonin agents|mesh-ancestor
110044104|NCT05962216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110044105|NCT05962216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110044106|NCT05962216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110044107|NCT05962216|Dopamine Agonists|dopamine agonists|mesh-ancestor
110044108|NCT05962216|Dopamine Agents|dopamine agents|mesh-ancestor
110044109|NCT05962034|Aspirin|aspirin|mesh-list
110044110|NCT05962034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110044111|NCT05962034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110044112|NCT05962034|Analgesics|analgesics|mesh-ancestor
110044113|NCT05962034|Sensory System Agents|sensory system agents|mesh-ancestor
110044114|NCT05962034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110044115|NCT05962034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110044116|NCT05962034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110044117|NCT05962034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110044118|NCT05962034|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110044119|NCT05962034|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110044120|NCT05962034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110044121|NCT05962034|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110044122|NCT05962034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110044123|NCT05962034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110044124|NCT05962034|Antipyretics|antipyretics|mesh-ancestor
110044125|NCT05961761|Pembrolizumab|pembrolizumab|mesh-list
110044126|NCT05961761|Propranolol|propranolol|mesh-list
110044128|NCT05961761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110044129|NCT05961761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110044130|NCT05961761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110044131|NCT05961761|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110044132|NCT05961761|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110044133|NCT05961761|Adrenergic Agents|adrenergic agents|mesh-ancestor
110044134|NCT05961761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110044135|NCT05961761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110044136|NCT05961761|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110044137|NCT05961761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110044138|NCT05961761|Vasodilator Agents|vasodilator agents|mesh-ancestor
110044139|NCT05961709|Cemiplimab|cemiplimab|mesh-list
110044140|NCT05961709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110044141|NCT05961709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110044142|NCT05961527|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
110044143|NCT05961527|Hallucinogens|hallucinogens|mesh-ancestor
110044144|NCT05961527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110044145|NCT05961527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110044146|NCT05961527|Serotonin Agents|serotonin agents|mesh-ancestor
110044147|NCT05961527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110044148|NCT05961527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110044149|NCT05961527|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110044150|NCT05961527|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110044151|NCT05961527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110044152|NCT05961527|Adrenergic Agents|adrenergic agents|mesh-ancestor
110044153|NCT05961501|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110044154|NCT05961488|Calcium|calcium|mesh-list
110044155|NCT05961488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110044156|NCT05961488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110044157|NCT05961202|Hydroxychloroquine|hydroxychloroquine|mesh-list
110044158|NCT05961202|Prednisolone|prednisolone|mesh-list
110044159|NCT05961202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110044160|NCT05961202|Glucocorticoids|glucocorticoids|mesh-ancestor
110044162|NCT05961202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110044163|NCT05961202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110044164|NCT05961202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110044165|NCT05961202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110044166|NCT05961202|Antimalarials|antimalarials|mesh-ancestor
110044167|NCT05961202|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110044168|NCT05961202|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110044169|NCT05961202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110044170|NCT05961202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110044171|NCT05961202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110044172|NCT05961202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110044173|NCT05961189|Azithromycin|azithromycin|mesh-list
110044174|NCT05961189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110044175|NCT05961189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110044176|NCT05961007|Aflibercept|aflibercept|mesh-list
110044177|NCT05961007|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110044178|NCT05961007|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110044179|NCT05961007|Growth Substances|growth substances|mesh-ancestor
110044180|NCT05961007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110044181|NCT05961007|Growth Inhibitors|growth inhibitors|mesh-ancestor
110044182|NCT05961007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110044183|NCT05960955|Docetaxel|docetaxel|mesh-list
110044184|NCT05960955|Fluorouracil|fluorouracil|mesh-list
110044185|NCT05960955|Oxaliplatin|oxaliplatin|mesh-list
110044186|NCT05960955|Tegafur|tegafur|mesh-list
110044187|NCT05960955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110044188|NCT05960955|Tubulin Modulators|tubulin modulators|mesh-ancestor
110044189|NCT05960955|Antimitotic Agents|antimitotic agents|mesh-ancestor
110044190|NCT05960955|Mitosis Modulators|mitosis modulators|mesh-ancestor
110044191|NCT05960955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110044192|NCT05960955|Antimetabolites|antimetabolites|mesh-ancestor
110044193|NCT05960955|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110044194|NCT05960955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110044195|NCT05960955|Immunologic Factors|immunologic factors|mesh-ancestor
110044196|NCT05960955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110044197|NCT05960942|Sufentanil|sufentanil|mesh-list
110044198|NCT05960942|Propofol|propofol|mesh-list
110044199|NCT05960942|Esketamine|esketamine|mesh-list
110044200|NCT05960942|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110044201|NCT05960942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110044202|NCT05960942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110044203|NCT05960942|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110044204|NCT05960942|Anesthetics, General|anesthetics, general|mesh-ancestor
110044205|NCT05960942|Anesthetics|anesthetics|mesh-ancestor
110044206|NCT05960942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110044207|NCT05960942|Narcotics|narcotics|mesh-ancestor
110044208|NCT05960942|Analgesics|analgesics|mesh-ancestor
110044209|NCT05960942|Sensory System Agents|sensory system agents|mesh-ancestor
110044210|NCT05960942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110044211|NCT05960942|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110044212|NCT05960942|Antidepressive Agents|antidepressive agents|mesh-ancestor
110044214|NCT05960929|Calfactant|calfactant|mesh-list
110044215|NCT05960929|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
110044216|NCT05960929|Respiratory System Agents|respiratory system agents|mesh-ancestor
110044217|NCT05960864|Celecoxib|celecoxib|mesh-list
110044218|NCT05960864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110044219|NCT05960864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110044220|NCT05960864|Analgesics|analgesics|mesh-ancestor
110044221|NCT05960864|Sensory System Agents|sensory system agents|mesh-ancestor
110044222|NCT05960864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110044223|NCT05960864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110044224|NCT05960864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110044225|NCT05960864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110044226|NCT05960864|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110044227|NCT05960864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110044228|NCT05960864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110044229|NCT05960864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110044230|NCT05960721|Aspirin|aspirin|mesh-list
110044231|NCT05960721|Rivaroxaban|rivaroxaban|mesh-list
110044232|NCT05960721|Clopidogrel|clopidogrel|mesh-list
110044233|NCT05960721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110044234|NCT05960721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110044235|NCT05960721|Analgesics|analgesics|mesh-ancestor
110044236|NCT05960721|Sensory System Agents|sensory system agents|mesh-ancestor
110044237|NCT05960721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110044238|NCT05960721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110044239|NCT05960721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110044240|NCT05960721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110044241|NCT05960721|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110044242|NCT05960721|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110044243|NCT05960721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110044244|NCT05960721|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110044245|NCT05960721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110044246|NCT05960721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110044247|NCT05960721|Antipyretics|antipyretics|mesh-ancestor
110044248|NCT05960721|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110044249|NCT05960721|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110044250|NCT05960721|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110044251|NCT05960721|Purinergic Agents|purinergic agents|mesh-ancestor
110044252|NCT05960721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110044253|NCT05960721|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110044254|NCT05960721|Antithrombins|antithrombins|mesh-ancestor
110044255|NCT05960721|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110044256|NCT05960721|Protease Inhibitors|protease inhibitors|mesh-ancestor
110044257|NCT05960721|Anticoagulants|anticoagulants|mesh-ancestor
110044262|NCT05960656|Empagliflozin|empagliflozin|mesh-list
110044263|NCT05960656|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110044264|NCT05960656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110044265|NCT05960656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110044266|NCT05960656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110044267|NCT05960617|Empagliflozin|empagliflozin|mesh-list
110044268|NCT05960617|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110044269|NCT05960617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110044270|NCT05960617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110044277|NCT05955365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110044278|NCT05955365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110044279|NCT05955365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110044280|NCT05955365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110044281|NCT05955365|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110044283|NCT05955365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110044284|NCT05955365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110044285|NCT05955365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110044286|NCT05955365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110044288|NCT05954442|Everolimus|everolimus|mesh-list
110044289|NCT05954442|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110044290|NCT05954442|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110044291|NCT05954442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110044292|NCT05954442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110044293|NCT05954442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110044294|NCT05954442|Immunologic Factors|immunologic factors|mesh-ancestor
110044295|NCT05954442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110044296|NCT05954442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110044297|NCT05928611|Dexamethasone|dexamethasone|mesh-list
110044298|NCT05928611|Dexamethasone acetate|dexamethasone acetate|mesh-list
110044299|NCT05928611|BB 1101|bb 1101|mesh-list
110044300|NCT05928611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110044301|NCT05928611|Antiemetics|antiemetics|mesh-ancestor
110044302|NCT05928611|Autonomic Agents|autonomic agents|mesh-ancestor
110044303|NCT05928611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110044304|NCT05928611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110044305|NCT05928611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110044306|NCT05928611|Glucocorticoids|glucocorticoids|mesh-ancestor
110044307|NCT05928611|Hormones|hormones|mesh-ancestor
110044308|NCT05928611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110044309|NCT05928611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110044310|NCT05928611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110044311|NCT05928611|Protease Inhibitors|protease inhibitors|mesh-ancestor
110044312|NCT05928611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110044313|NCT05928611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110044314|NCT05917912|Amitriptyline|amitriptyline|mesh-list
110044315|NCT05917912|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110044316|NCT05917912|Antidepressive Agents|antidepressive agents|mesh-ancestor
110044317|NCT05917912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110044318|NCT05917912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110044319|NCT05917912|Analgesics|analgesics|mesh-ancestor
110044320|NCT05917912|Sensory System Agents|sensory system agents|mesh-ancestor
110044321|NCT05917912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110044322|NCT05917912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110044323|NCT05917912|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110044324|NCT05917912|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110044325|NCT05917912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110044326|NCT05917912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110044327|NCT05917912|Adrenergic Agents|adrenergic agents|mesh-ancestor
110044328|NCT05917912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110044329|NCT05888389|Anesthetics|anesthetics|mesh-list
110044330|NCT05888389|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
110044331|NCT05888389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110044332|NCT05888389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110044334|NCT05887726|Cyclophosphamide|cyclophosphamide|mesh-list
110044335|NCT05887726|Rituximab|rituximab|mesh-list
110044336|NCT05887726|Vincristine|vincristine|mesh-list
110044337|NCT05887726|Epirubicin|epirubicin|mesh-list
110044338|NCT05887726|Zanubrutinib|zanubrutinib|mesh-list
110044339|NCT05887726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110044340|NCT05887726|Immunologic Factors|immunologic factors|mesh-ancestor
110044341|NCT05887726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110044342|NCT05887726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110044344|NCT05887726|Alkylating Agents|alkylating agents|mesh-ancestor
110044345|NCT05887726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110044347|NCT05887726|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110044348|NCT05887726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110044349|NCT05887726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110044350|NCT05887726|Glucocorticoids|glucocorticoids|mesh-ancestor
110044351|NCT05887726|Hormones|hormones|mesh-ancestor
110044352|NCT05887726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110044353|NCT05887726|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110044354|NCT05887726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110044355|NCT05887726|Tubulin Modulators|tubulin modulators|mesh-ancestor
110044356|NCT05887726|Antimitotic Agents|antimitotic agents|mesh-ancestor
110044357|NCT05887726|Mitosis Modulators|mitosis modulators|mesh-ancestor
110044358|NCT05887726|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110044359|NCT05887726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110044360|NCT05887726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110044361|NCT05887726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110044362|NCT05887726|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110044363|NCT05867550|Rifaximin|rifaximin|mesh-list
110044364|NCT05867550|Amitriptyline|amitriptyline|mesh-list
110044365|NCT05867550|Mebeverine|mebeverine|mesh-list
110044366|NCT05867550|Psyllium|psyllium|mesh-list
110044367|NCT05867550|Calcium polycarbophil|calcium polycarbophil|mesh-list
110044368|NCT05867550|Alverine|alverine|mesh-list
110044369|NCT05867550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110044370|NCT05867550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110044371|NCT05867550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110044372|NCT05867550|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110044373|NCT05867550|Antidepressive Agents|antidepressive agents|mesh-ancestor
110044374|NCT05867550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110044375|NCT05867550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110044376|NCT05867550|Analgesics|analgesics|mesh-ancestor
110044377|NCT05867550|Sensory System Agents|sensory system agents|mesh-ancestor
110044378|NCT05867550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110044379|NCT05867550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110044380|NCT05867550|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110044381|NCT05867550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110044382|NCT05867550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110044383|NCT05867550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110044384|NCT05867550|Adrenergic Agents|adrenergic agents|mesh-ancestor
110044385|NCT05867550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110044386|NCT05867550|Cathartics|cathartics|mesh-ancestor
110044387|NCT05867550|Antidiarrheals|antidiarrheals|mesh-ancestor
110044388|NCT05867550|Anticonvulsants|anticonvulsants|mesh-ancestor
110044389|NCT05867550|Parasympatholytics|parasympatholytics|mesh-ancestor
110044390|NCT05867550|Autonomic Agents|autonomic agents|mesh-ancestor
110044391|NCT05856695|Paclitaxel|paclitaxel|mesh-list
110044392|NCT05856695|Carboplatin|carboplatin|mesh-list
110044393|NCT05856695|Durvalumab|durvalumab|mesh-list
110044394|NCT05856695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110044395|NCT05856695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110044396|NCT05856695|Tubulin Modulators|tubulin modulators|mesh-ancestor
110044397|NCT05856695|Antimitotic Agents|antimitotic agents|mesh-ancestor
110044398|NCT05856695|Mitosis Modulators|mitosis modulators|mesh-ancestor
110044399|NCT05856695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110044400|NCT05856695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110044401|NCT05854251|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110044402|NCT05854251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110044403|NCT05849753|Pancrelipase|pancrelipase|mesh-list
110044404|NCT05849753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110044405|NCT05848947|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
110044406|NCT05848947|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110044407|NCT05848947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110044408|NCT05841420|Paclitaxel|paclitaxel|mesh-list
110044409|NCT05841420|Gemcitabine|gemcitabine|mesh-list
110044410|NCT05841420|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110044411|NCT05841420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110044412|NCT05841420|Tubulin Modulators|tubulin modulators|mesh-ancestor
110044413|NCT05841420|Antimitotic Agents|antimitotic agents|mesh-ancestor
110044414|NCT05841420|Mitosis Modulators|mitosis modulators|mesh-ancestor
110044415|NCT05841420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110044416|NCT05841420|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110044418|NCT05818852|Moxifloxacin|moxifloxacin|mesh-list
110044424|NCT05818852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110044425|NCT05818852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110044426|NCT05818852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110044427|NCT05818852|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110044428|NCT05818852|Contraceptive Agents|contraceptive agents|mesh-ancestor
110044429|NCT05818852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110044430|NCT05818852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110044431|NCT05818852|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110044432|NCT05818852|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110044433|NCT05818852|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110044434|NCT05814146|Dialysis Solutions|dialysis solutions|mesh-list
110044435|NCT05814146|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110044436|NCT05801315|Glycine|glycine|mesh-list
110044437|NCT05801315|Glycine Agents|glycine agents|mesh-ancestor
110044438|NCT05801315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110044439|NCT05801315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110044440|NCT05801315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110044441|NCT05800275|Capecitabine|capecitabine|mesh-list
110044442|NCT05800275|Trastuzumab|trastuzumab|mesh-list
110044443|NCT05800275|Tucatinib|tucatinib|mesh-list
110044444|NCT05800275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110044445|NCT05800275|Antimetabolites|antimetabolites|mesh-ancestor
110044446|NCT05800275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110044447|NCT05800275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110044448|NCT05800275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110044449|NCT05800275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110044450|NCT05800275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110044451|NCT05798403|Solifenacin Succinate|solifenacin succinate|mesh-list
110044452|NCT05798403|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110044453|NCT05798403|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110044454|NCT05798403|Cholinergic Agents|cholinergic agents|mesh-ancestor
110044455|NCT05798403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110044456|NCT05798403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110044457|NCT05798403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110044458|NCT05798403|Urological Agents|urological agents|mesh-ancestor
110044459|NCT05796388|Linaclotide|linaclotide|mesh-list
110044460|NCT05796388|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
110044461|NCT05796388|Enzyme Activators|enzyme activators|mesh-ancestor
110044462|NCT05796388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110044463|NCT05796388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110044464|NCT05783596|Obinutuzumab|obinutuzumab|mesh-list
110044465|NCT05783596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110044466|NCT05783596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110044467|NCT05772429|Cannabidiol|cannabidiol|mesh-list
110044468|NCT05772429|Anticonvulsants|anticonvulsants|mesh-ancestor
110044469|NCT05743270|Paclitaxel|paclitaxel|mesh-list
110044470|NCT05743270|Carboplatin|carboplatin|mesh-list
110044471|NCT05743270|Nivolumab|nivolumab|mesh-list
110044472|NCT05743270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110044473|NCT05743270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110044474|NCT05743270|Tubulin Modulators|tubulin modulators|mesh-ancestor
110044475|NCT05743270|Antimitotic Agents|antimitotic agents|mesh-ancestor
110044476|NCT05743270|Mitosis Modulators|mitosis modulators|mesh-ancestor
110044477|NCT05743270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110044478|NCT05743270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110044479|NCT05743270|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110044480|NCT05739942|Temozolomide|temozolomide|mesh-list
110044483|NCT05739942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110044484|NCT05739942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110044486|NCT05734625|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110044487|NCT05734625|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110044490|NCT05734625|Bupivacaine|bupivacaine|mesh-list
110044491|NCT05734625|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110044492|NCT05734625|Prednisolone phosphate|prednisolone phosphate|mesh-list
110044493|NCT05734625|Anesthetics, Local|anesthetics, local|mesh-ancestor
110044494|NCT05734625|Anesthetics|anesthetics|mesh-ancestor
110044495|NCT05734625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110044496|NCT05734625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110044497|NCT05734625|Sensory System Agents|sensory system agents|mesh-ancestor
110044499|NCT05734625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110044500|NCT05734625|Antiemetics|antiemetics|mesh-ancestor
110044501|NCT05734625|Autonomic Agents|autonomic agents|mesh-ancestor
110044502|NCT05734625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110044503|NCT05734625|Glucocorticoids|glucocorticoids|mesh-ancestor
110044505|NCT05734625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110044506|NCT05734625|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110044507|NCT05734625|Protective Agents|protective agents|mesh-ancestor
110044508|NCT05734625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110044509|NCT05734625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110044510|NCT05712096|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
110044511|NCT05712096|Antiviral Agents|antiviral agents|mesh-ancestor
110044512|NCT05712096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110044513|NCT05671172|Bupivacaine|bupivacaine|mesh-list
110044514|NCT05671172|Anesthetics, Local|anesthetics, local|mesh-ancestor
110044515|NCT05671172|Anesthetics|anesthetics|mesh-ancestor
110044516|NCT05671172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110044517|NCT05671172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110044518|NCT05671172|Sensory System Agents|sensory system agents|mesh-ancestor
110044519|NCT05671172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110044520|NCT05665088|Dexmedetomidine|dexmedetomidine|mesh-list
110044521|NCT05665088|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110044522|NCT05665088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110044523|NCT05665088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110044524|NCT05665088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110044525|NCT05665088|Analgesics|analgesics|mesh-ancestor
110044526|NCT05665088|Sensory System Agents|sensory system agents|mesh-ancestor
110044527|NCT05665088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110044528|NCT05665088|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110044529|NCT05665088|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110044530|NCT05665088|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110044531|NCT05665088|Adrenergic Agents|adrenergic agents|mesh-ancestor
110044532|NCT05665088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110044533|NCT05665088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110044534|NCT05662306|Aripiprazole|aripiprazole|mesh-list
110044535|NCT05662306|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
110044536|NCT05662306|Antidepressive Agents|antidepressive agents|mesh-ancestor
110044537|NCT05662306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110044538|NCT05662306|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110044539|NCT05662306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110044540|NCT05662306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110044541|NCT05662306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110044542|NCT05662306|Dopamine Agonists|dopamine agonists|mesh-ancestor
110044543|NCT05662306|Dopamine Agents|dopamine agents|mesh-ancestor
110044544|NCT05662306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110044545|NCT05662306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110044546|NCT05662306|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110044547|NCT05662306|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110044548|NCT05662306|Serotonin Agents|serotonin agents|mesh-ancestor
110044549|NCT05662306|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110044550|NCT05662306|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110044551|NCT05662306|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110044552|NCT05662306|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110044554|NCT05653193|Interferon-gamma|interferon-gamma|mesh-list
110044555|NCT05653193|Clotrimazole|clotrimazole|mesh-list
110044556|NCT05653193|Miconazole|miconazole|mesh-list
110044557|NCT05653193|Antifungal Agents|antifungal agents|mesh-list
110044558|NCT05653193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110044559|NCT05653193|Antiviral Agents|antiviral agents|mesh-ancestor
110044560|NCT05653193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110044561|NCT05653193|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110044562|NCT05653193|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110044565|NCT05653193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110044566|NCT05653193|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110044568|NCT05653193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110044569|NCT05653193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110044570|NCT05653193|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110044571|NCT05653193|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110044572|NCT05645913|Anticoagulants|anticoagulants|mesh-list
110044573|NCT05620901|Prednisolone acetate|prednisolone acetate|mesh-list
110044574|NCT05620901|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110044575|NCT05620901|Methylprednisolone|methylprednisolone|mesh-list
110044576|NCT05620901|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110044577|NCT05620901|Prednisolone|prednisolone|mesh-list
110044578|NCT05620901|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110044579|NCT05620901|Prednisolone phosphate|prednisolone phosphate|mesh-list
110044580|NCT05620901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110044581|NCT05620901|Antiemetics|antiemetics|mesh-ancestor
110044582|NCT05620901|Autonomic Agents|autonomic agents|mesh-ancestor
110044583|NCT05620901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110044584|NCT05620901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110044585|NCT05620901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110044586|NCT05620901|Glucocorticoids|glucocorticoids|mesh-ancestor
110044587|NCT05620901|Hormones|hormones|mesh-ancestor
110044588|NCT05620901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110044589|NCT05620901|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110044590|NCT05620901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110044591|NCT05620901|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110044592|NCT05620901|Protective Agents|protective agents|mesh-ancestor
110044593|NCT05618314|Probenecid|probenecid|mesh-list
110044594|NCT05618314|Uricosuric Agents|uricosuric agents|mesh-ancestor
110044595|NCT05618314|Gout Suppressants|gout suppressants|mesh-ancestor
110044596|NCT05618314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110044597|NCT05615220|Ecopipam|ecopipam|mesh-list
110044598|NCT05615220|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110044599|NCT05615220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110044600|NCT05615220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110044601|NCT05615220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110044602|NCT05615220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110044603|NCT05615220|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110044604|NCT05615220|Dopamine Agents|dopamine agents|mesh-ancestor
110044605|NCT05615220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110044606|NCT05615220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110044607|NCT05603104|Lamotrigine|lamotrigine|mesh-list
110044608|NCT05603104|Ketamine|ketamine|mesh-list
110044609|NCT05603104|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110044610|NCT05603104|Valproic Acid|valproic acid|mesh-list
110044611|NCT05603104|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110044612|NCT05603104|Clozapine|clozapine|mesh-list
110044613|NCT05603104|Antipsychotic Agents|antipsychotic agents|mesh-list
110044614|NCT05603104|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110044615|NCT05603104|Sertraline|sertraline|mesh-list
110044616|NCT05603104|Antidepressive Agents|antidepressive agents|mesh-list
110044617|NCT05603104|Esketamine|esketamine|mesh-list
110044618|NCT05603104|Escitalopram|escitalopram|mesh-list
110044619|NCT05603104|Analgesics|analgesics|mesh-ancestor
110044620|NCT05603104|Sensory System Agents|sensory system agents|mesh-ancestor
110044621|NCT05603104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110044622|NCT05603104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110044623|NCT05603104|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110044624|NCT05603104|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110044625|NCT05603104|Anesthetics, General|anesthetics, general|mesh-ancestor
110044626|NCT05603104|Anesthetics|anesthetics|mesh-ancestor
110044627|NCT05603104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110044628|NCT05603104|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110044629|NCT05603104|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110044630|NCT05603104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110044631|NCT05603104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110044632|NCT05603104|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110044633|NCT05603104|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110044634|NCT05603104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110044636|NCT05603104|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110044638|NCT05603104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110044639|NCT05603104|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110044640|NCT05603104|Dopamine Agents|dopamine agents|mesh-ancestor
110044641|NCT05603104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110044642|NCT05603104|Antimanic Agents|antimanic agents|mesh-ancestor
110044643|NCT05603104|Anticonvulsants|anticonvulsants|mesh-ancestor
110044644|NCT05603104|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110044645|NCT05603104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110044646|NCT05603104|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110044647|NCT05603104|GABA Agents|gaba agents|mesh-ancestor
110044648|NCT05603104|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110044649|NCT05603104|GABA Antagonists|gaba antagonists|mesh-ancestor
110044650|NCT05601973|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
110044651|NCT05601973|Lazertinib|lazertinib|mesh-list
110044652|NCT05601973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110044653|NCT05601973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110044654|NCT05601973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110044655|NCT05601973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110044656|NCT05601973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110044657|NCT05593055|Eplerenone|eplerenone|mesh-list
110044658|NCT05593055|Chlorthalidone|chlorthalidone|mesh-list
110044659|NCT05593055|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110044660|NCT05593055|Hormone Antagonists|hormone antagonists|mesh-ancestor
110044661|NCT05593055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110044662|NCT05593055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110044663|NCT05593055|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110044664|NCT05593055|Diuretics|diuretics|mesh-ancestor
110044665|NCT05593055|Natriuretic Agents|natriuretic agents|mesh-ancestor
110044666|NCT05593055|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110044667|NCT05593055|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110044668|NCT05593055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110044669|NCT05593055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110044670|NCT05586789|Tryptophan|tryptophan|mesh-list
110044671|NCT05586789|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110044672|NCT05586789|Antidepressive Agents|antidepressive agents|mesh-ancestor
110044673|NCT05586789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110044674|NCT05578092|Adagrasib|adagrasib|mesh-list
110044675|NCT05578092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110044676|NCT05568550|Pembrolizumab|pembrolizumab|mesh-list
110044677|NCT05568550|Olaparib|olaparib|mesh-list
110044678|NCT05568550|Androgens|androgens|mesh-list
110044679|NCT05568550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110044680|NCT05568550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110044681|NCT05568550|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110044682|NCT05568550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110044683|NCT05568550|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110044684|NCT05568550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110044685|NCT05568550|Hormones|hormones|mesh-ancestor
110044686|NCT05568550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110044687|NCT05568550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110044688|NCT05558956|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110044689|NCT05558956|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110044690|NCT05558956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110044691|NCT05542849|Acarbose|acarbose|mesh-list
110044692|NCT05542849|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110044693|NCT05542849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110044694|NCT05542849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110044695|NCT05542849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110044696|NCT05542849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110044697|NCT05537883|Bupivacaine|bupivacaine|mesh-list
110044698|NCT05537883|Anesthetics, Local|anesthetics, local|mesh-ancestor
110044699|NCT05537883|Anesthetics|anesthetics|mesh-ancestor
110044700|NCT05537883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110044701|NCT05537883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110044702|NCT05537883|Sensory System Agents|sensory system agents|mesh-ancestor
110044703|NCT05537883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110044704|NCT05523934|Capsaicin|capsaicin|mesh-list
110044705|NCT05523934|Antipruritics|antipruritics|mesh-ancestor
110044706|NCT05523934|Dermatologic Agents|dermatologic agents|mesh-ancestor
110044707|NCT05523934|Sensory System Agents|sensory system agents|mesh-ancestor
110044708|NCT05523934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110044712|NCT05508100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110044714|NCT05508100|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110044715|NCT05508100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110044716|NCT05498233|Pyridoxine|pyridoxine|mesh-list
110044717|NCT05498233|Doxylamine|doxylamine|mesh-list
110044718|NCT05498233|Vitamin B Complex|vitamin b complex|mesh-ancestor
110044719|NCT05498233|Vitamins|vitamins|mesh-ancestor
110044720|NCT05498233|Micronutrients|micronutrients|mesh-ancestor
110044721|NCT05498233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110044722|NCT05498233|Antiemetics|antiemetics|mesh-ancestor
110044723|NCT05498233|Autonomic Agents|autonomic agents|mesh-ancestor
110044724|NCT05498233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110044725|NCT05498233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110044726|NCT05498233|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110044727|NCT05498233|Histamine Antagonists|histamine antagonists|mesh-ancestor
110044728|NCT05498233|Histamine Agents|histamine agents|mesh-ancestor
110044729|NCT05498233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110044730|NCT05498233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110044731|NCT05450562|Atezolizumab|atezolizumab|mesh-list
110044732|NCT05450562|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110044733|NCT05450562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110044734|NCT05450562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110044735|NCT05450562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110044736|NCT05434000|Hydroxyurea|hydroxyurea|mesh-list
110044737|NCT05434000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110044738|NCT05434000|Antisickling Agents|antisickling agents|mesh-ancestor
110044739|NCT05434000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110044740|NCT05434000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110044741|NCT05434000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110044742|NCT05433480|Fulvestrant|fulvestrant|mesh-list
110044743|NCT05433480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110044744|NCT05433480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110044745|NCT05433480|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110044746|NCT05433480|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110044747|NCT05433480|Hormone Antagonists|hormone antagonists|mesh-ancestor
110044748|NCT05433480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110044749|NCT05433480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110044750|NCT05428215|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110044751|NCT05428215|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110044752|NCT05428215|Estradiol|estradiol|mesh-list
110044753|NCT05428215|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110044754|NCT05428215|Estrogens|estrogens|mesh-ancestor
110044755|NCT05428215|Hormones|hormones|mesh-ancestor
110044756|NCT05428215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110044757|NCT05428215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110044758|NCT05428215|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110044759|NCT05428215|Contraceptive Agents|contraceptive agents|mesh-ancestor
110044760|NCT05428215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110044761|NCT05428215|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110044762|NCT05417646|Empagliflozin|empagliflozin|mesh-list
110044763|NCT05417646|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110044764|NCT05417646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110044765|NCT05417646|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110044766|NCT05417646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110044767|NCT05412173|Molnupiravir|molnupiravir|mesh-list
110044768|NCT05412173|Antiviral Agents|antiviral agents|mesh-ancestor
110044769|NCT05412173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110044770|NCT05396859|Decitabine|decitabine|mesh-list
110044771|NCT05396859|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
110044772|NCT05396859|Entrectinib|entrectinib|mesh-list
110044773|NCT05396859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110044774|NCT05396859|Antimetabolites|antimetabolites|mesh-ancestor
110044775|NCT05396859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110044776|NCT05396859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110044777|NCT05396859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110044778|NCT05396859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110044779|NCT05390892|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
110044780|NCT05390892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110044781|NCT05390892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110044782|NCT05390892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110044783|NCT05378113|Lidocaine|lidocaine|mesh-list
110044784|NCT05378113|Ondansetron|ondansetron|mesh-list
110044785|NCT05378113|Anesthetics, Local|anesthetics, local|mesh-ancestor
110044786|NCT05378113|Anesthetics|anesthetics|mesh-ancestor
110044787|NCT05378113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110044788|NCT05378113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110044789|NCT05378113|Sensory System Agents|sensory system agents|mesh-ancestor
110044790|NCT05378113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110044791|NCT05378113|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110044792|NCT05378113|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110044793|NCT05378113|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110044794|NCT05378113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110044795|NCT05378113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110044796|NCT05378113|Antiemetics|antiemetics|mesh-ancestor
110044797|NCT05378113|Autonomic Agents|autonomic agents|mesh-ancestor
110044798|NCT05378113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110044799|NCT05378113|Antipruritics|antipruritics|mesh-ancestor
110044800|NCT05378113|Dermatologic Agents|dermatologic agents|mesh-ancestor
110044801|NCT05378113|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110044802|NCT05378113|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110044803|NCT05378113|Serotonin Agents|serotonin agents|mesh-ancestor
110044804|NCT05378113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110044810|NCT05351801|Dronabinol|dronabinol|mesh-list
110044811|NCT05351801|Nabiximols|nabiximols|mesh-list
110044812|NCT05351801|Hallucinogens|hallucinogens|mesh-ancestor
110044813|NCT05351801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110044814|NCT05351801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110044815|NCT05351801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110044816|NCT05351801|Analgesics|analgesics|mesh-ancestor
110044817|NCT05351801|Sensory System Agents|sensory system agents|mesh-ancestor
110044818|NCT05351801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110044819|NCT05351801|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110044820|NCT05351801|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110044822|NCT05351801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110044823|NCT05351801|Hormones|hormones|mesh-ancestor
110044824|NCT05351801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110044825|NCT05315713|Atezolizumab|atezolizumab|mesh-list
110044826|NCT05315713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110044827|NCT05315713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110044828|NCT05315713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110044829|NCT05315713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110044830|NCT05314374|Bile Acids and Salts|bile acids and salts|mesh-list
110044831|NCT05314374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110044832|NCT05300048|Paclitaxel|paclitaxel|mesh-list
110044833|NCT05300048|Serabelisib|serabelisib|mesh-list
110044834|NCT05300048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110044835|NCT05300048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110044836|NCT05300048|Tubulin Modulators|tubulin modulators|mesh-ancestor
110044837|NCT05300048|Antimitotic Agents|antimitotic agents|mesh-ancestor
110044838|NCT05300048|Mitosis Modulators|mitosis modulators|mesh-ancestor
110044839|NCT05300048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110044840|NCT05300048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110044841|NCT05289323|Neostigmine|neostigmine|mesh-list
110044842|NCT05289323|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110044843|NCT05289323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110044844|NCT05289323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110044845|NCT05289323|Cholinergic Agents|cholinergic agents|mesh-ancestor
110044846|NCT05289323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110044847|NCT05289323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110044849|NCT05289323|Autonomic Agents|autonomic agents|mesh-ancestor
110044850|NCT05289323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110044851|NCT05275738|Niacinamide|niacinamide|mesh-list
110044852|NCT05275738|Niacin|niacin|mesh-list
110044853|NCT05275738|Nicotinic Acids|nicotinic acids|mesh-list
110044854|NCT05275738|Vitamin B Complex|vitamin b complex|mesh-ancestor
110044855|NCT05275738|Vitamins|vitamins|mesh-ancestor
110044856|NCT05275738|Micronutrients|micronutrients|mesh-ancestor
110044857|NCT05275738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110044858|NCT05275738|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110044859|NCT05275738|Antimetabolites|antimetabolites|mesh-ancestor
110044862|NCT05275738|Vasodilator Agents|vasodilator agents|mesh-ancestor
110044863|NCT05271552|Dexmedetomidine|dexmedetomidine|mesh-list
110044864|NCT05271552|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110044865|NCT05271552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110044866|NCT05271552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110044867|NCT05271552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110044869|NCT05271552|Sensory System Agents|sensory system agents|mesh-ancestor
110044870|NCT05271552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110044871|NCT05271552|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110044872|NCT05271552|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110044874|NCT05271552|Adrenergic Agents|adrenergic agents|mesh-ancestor
110044875|NCT05271552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110044876|NCT05271552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110044878|NCT05269849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110044879|NCT05269849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110044880|NCT05269849|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110044881|NCT05269849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110044883|NCT05269849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110044884|NCT05269849|Immunologic Factors|immunologic factors|mesh-ancestor
110044885|NCT05269849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110044886|NCT05264168|Rivaroxaban|rivaroxaban|mesh-list
110044887|NCT05264168|Apixaban|apixaban|mesh-list
110044888|NCT05264168|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110044889|NCT05264168|Antithrombins|antithrombins|mesh-ancestor
110044890|NCT05264168|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110044891|NCT05264168|Protease Inhibitors|protease inhibitors|mesh-ancestor
110044892|NCT05264168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110044893|NCT05264168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110044894|NCT05264168|Anticoagulants|anticoagulants|mesh-ancestor
110044895|NCT05256797|Rivaroxaban|rivaroxaban|mesh-list
110044896|NCT05256797|Apixaban|apixaban|mesh-list
110044897|NCT05256797|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110044898|NCT05256797|Antithrombins|antithrombins|mesh-ancestor
110044899|NCT05256797|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110044900|NCT05256797|Protease Inhibitors|protease inhibitors|mesh-ancestor
110044901|NCT05256797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110044902|NCT05256797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110044903|NCT05256797|Anticoagulants|anticoagulants|mesh-ancestor
110044911|NCT05213650|Methamphetamine|methamphetamine|mesh-list
110044912|NCT05213650|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110044913|NCT05213650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110044914|NCT05213650|Sympathomimetics|sympathomimetics|mesh-ancestor
110044915|NCT05213650|Autonomic Agents|autonomic agents|mesh-ancestor
110044916|NCT05213650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110044917|NCT05213650|Dopamine Agents|dopamine agents|mesh-ancestor
110044918|NCT05213650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110044919|NCT05213650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110044920|NCT05213650|Adrenergic Agents|adrenergic agents|mesh-ancestor
110044921|NCT05213650|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110044922|NCT05213650|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110044923|NCT05213650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110044924|NCT05213650|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110044925|NCT05203510|Treprostinil|treprostinil|mesh-list
110044926|NCT05203510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110044927|NCT05201547|Paclitaxel|paclitaxel|mesh-list
110044928|NCT05201547|Carboplatin|carboplatin|mesh-list
110044929|NCT05201547|Dostarlimab|dostarlimab|mesh-list
110044930|NCT05201547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110044931|NCT05201547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110044932|NCT05201547|Tubulin Modulators|tubulin modulators|mesh-ancestor
110044933|NCT05201547|Antimitotic Agents|antimitotic agents|mesh-ancestor
110044934|NCT05201547|Mitosis Modulators|mitosis modulators|mesh-ancestor
110044935|NCT05201547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110044936|NCT05179512|Fluticasone|fluticasone|mesh-list
110044937|NCT05179512|Tiotropium Bromide|tiotropium bromide|mesh-list
110044938|NCT05179512|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110044939|NCT05179512|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110044942|NCT05179512|Autonomic Agents|autonomic agents|mesh-ancestor
110044943|NCT05179512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110044944|NCT05179512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110044945|NCT05179512|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110044946|NCT05179512|Respiratory System Agents|respiratory system agents|mesh-ancestor
110044947|NCT05179512|Dermatologic Agents|dermatologic agents|mesh-ancestor
110044948|NCT05179512|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110044949|NCT05179512|Parasympatholytics|parasympatholytics|mesh-ancestor
110044950|NCT05179512|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110044951|NCT05179512|Cholinergic Agents|cholinergic agents|mesh-ancestor
110044952|NCT05179512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110044953|NCT05179512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110044954|NCT05179512|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110044955|NCT05179512|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110044956|NCT05179512|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110044957|NCT05179512|Adrenergic Agents|adrenergic agents|mesh-ancestor
110044958|NCT05179512|Glucocorticoids|glucocorticoids|mesh-ancestor
110044960|NCT05179512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110044961|NCT05179512|Sympathomimetics|sympathomimetics|mesh-ancestor
110044962|NCT05164081|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110044963|NCT05164081|Clindamycin|clindamycin|mesh-list
110044964|NCT05164081|Clindamycin palmitate|clindamycin palmitate|mesh-list
110044965|NCT05164081|Clindamycin phosphate|clindamycin phosphate|mesh-list
110044966|NCT05164081|Gentamicins|gentamicins|mesh-list
110044967|NCT05164081|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110044968|NCT05164081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110044969|NCT05164081|Antitubercular Agents|antitubercular agents|mesh-ancestor
110044970|NCT05164081|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110044971|NCT05164081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110044972|NCT05164081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110044973|NCT05162976|Nivolumab|nivolumab|mesh-list
110044974|NCT05162976|Azacitidine|azacitidine|mesh-list
110044975|NCT05162976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110044976|NCT05162976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110044977|NCT05162976|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110044978|NCT05162976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110044979|NCT05162976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110044980|NCT05162976|Antimetabolites|antimetabolites|mesh-ancestor
110044981|NCT05162976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110044982|NCT05162183|Liraglutide|liraglutide|mesh-list
110044983|NCT05162183|Glimepiride|glimepiride|mesh-list
110044984|NCT05162183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110044985|NCT05162183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110044986|NCT05162183|Incretins|incretins|mesh-ancestor
110044987|NCT05162183|Hormones|hormones|mesh-ancestor
110044988|NCT05162183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110044989|NCT05162183|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110044990|NCT05162183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110044991|NCT05162183|Immunologic Factors|immunologic factors|mesh-ancestor
110044992|NCT05153395|Insulin|insulin|mesh-list
110044993|NCT05153395|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110044994|NCT05153395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110044995|NCT05153395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110044996|NCT05099198|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110044997|NCT05099198|Glimepiride|glimepiride|mesh-list
110044998|NCT05099198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110044999|NCT05099198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110045000|NCT05099198|Incretins|incretins|mesh-ancestor
110045001|NCT05099198|Hormones|hormones|mesh-ancestor
110045002|NCT05099198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110045003|NCT05099198|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110045004|NCT05099198|Protease Inhibitors|protease inhibitors|mesh-ancestor
110045005|NCT05099198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110045006|NCT05099198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110045007|NCT05099198|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110045008|NCT05099198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110045009|NCT05099198|Immunologic Factors|immunologic factors|mesh-ancestor
110045010|NCT05088798|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
110045011|NCT05088798|Dopamine Agents|dopamine agents|mesh-ancestor
110045012|NCT05088798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110045013|NCT05088798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110045014|NCT05088798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110045016|NCT05086081|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110045017|NCT05086081|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110045018|NCT05086081|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110045019|NCT05086081|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110045020|NCT05086081|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110045021|NCT05086081|Purinergic Agents|purinergic agents|mesh-ancestor
110045022|NCT05086081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110045023|NCT05086081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110045024|NCT05086081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110045025|NCT05083949|Metformin|metformin|mesh-list
110045026|NCT05083949|Empagliflozin|empagliflozin|mesh-list
110045027|NCT05083949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110045028|NCT05083949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110045029|NCT05083949|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110045030|NCT05083949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110045031|NCT05083455|Enoxaparin|enoxaparin|mesh-list
110045032|NCT05083455|Rivaroxaban|rivaroxaban|mesh-list
110045033|NCT05083455|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110045034|NCT05083455|Antithrombins|antithrombins|mesh-ancestor
110045035|NCT05083455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110045036|NCT05083455|Protease Inhibitors|protease inhibitors|mesh-ancestor
110045037|NCT05083455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110045038|NCT05083455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110045039|NCT05083455|Anticoagulants|anticoagulants|mesh-ancestor
110045040|NCT05083455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110045041|NCT05083455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110045042|NCT05083429|Tiotropium Bromide|tiotropium bromide|mesh-list
110045043|NCT05083429|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110045044|NCT05083429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110045045|NCT05083429|Autonomic Agents|autonomic agents|mesh-ancestor
110045046|NCT05083429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110045047|NCT05083429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110045048|NCT05083429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110045049|NCT05083429|Respiratory System Agents|respiratory system agents|mesh-ancestor
110045050|NCT05083429|Parasympatholytics|parasympatholytics|mesh-ancestor
110045051|NCT05083429|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110045052|NCT05083429|Cholinergic Agents|cholinergic agents|mesh-ancestor
110045053|NCT05083429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110045054|NCT05083429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110045055|NCT05083429|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110045056|NCT05083429|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110045057|NCT05083429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110045058|NCT05083429|Adrenergic Agents|adrenergic agents|mesh-ancestor
110045059|NCT05078879|Empagliflozin|empagliflozin|mesh-list
110045060|NCT05078879|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110045061|NCT05078879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110045062|NCT05078879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110045063|NCT05078879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110045064|NCT05075980|Cisplatin|cisplatin|mesh-list
110045065|NCT05075980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110045066|NCT05073237|Bazedoxifene|bazedoxifene|mesh-list
110045067|NCT05073237|Estrogens|estrogens|mesh-list
110045068|NCT05073237|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110045069|NCT05073237|Hormones|hormones|mesh-ancestor
110045070|NCT05073237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110045071|NCT05073237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110045072|NCT05073237|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110045073|NCT05073237|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110045074|NCT05073237|Hormone Antagonists|hormone antagonists|mesh-ancestor
110045075|NCT05073237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110045076|NCT05063201|Cariprazine|cariprazine|mesh-list
110045077|NCT05063201|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110045078|NCT05063201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110045079|NCT05063201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110045080|NCT05063201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110045081|NCT05063201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110045082|NCT05062304|Fluticasone|fluticasone|mesh-list
110045083|NCT05062304|Xhance|xhance|mesh-list
110045084|NCT05062304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110045085|NCT05062304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110045086|NCT05062304|Autonomic Agents|autonomic agents|mesh-ancestor
110045087|NCT05062304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110045088|NCT05062304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110045089|NCT05062304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110045090|NCT05062304|Respiratory System Agents|respiratory system agents|mesh-ancestor
110045091|NCT05062304|Dermatologic Agents|dermatologic agents|mesh-ancestor
110045092|NCT05062304|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110045093|NCT05029466|Psilocybin|psilocybin|mesh-list
110045094|NCT05029466|Hallucinogens|hallucinogens|mesh-ancestor
110045095|NCT05029466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110045096|NCT05029466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110045097|NCT05018481|Hyaluronic Acid|hyaluronic acid|mesh-list
110045098|NCT05018481|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110045099|NCT05018481|Immunologic Factors|immunologic factors|mesh-ancestor
110045100|NCT05018481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110045101|NCT05018481|Viscosupplements|viscosupplements|mesh-ancestor
110045102|NCT05018481|Protective Agents|protective agents|mesh-ancestor
110045103|NCT05004259|Daratumumab|daratumumab|mesh-list
110045104|NCT05004259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110045105|NCT05001750|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110045106|NCT05001750|Doxycycline|doxycycline|mesh-list
110045107|NCT05001750|Nafcillin|nafcillin|mesh-list
110045108|NCT05001750|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110045109|NCT05001750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110045110|NCT05001750|Antitubercular Agents|antitubercular agents|mesh-ancestor
110045112|NCT05001750|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110045113|NCT05001750|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110045114|NCT04997811|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110045115|NCT04997811|Valproic Acid|valproic acid|mesh-list
110045116|NCT04997811|Bezafibrate|bezafibrate|mesh-list
110045117|NCT04997811|Medroxyprogesterone|medroxyprogesterone|mesh-list
110045118|NCT04997811|Danazol|danazol|mesh-list
110045119|NCT04997811|Anticonvulsants|anticonvulsants|mesh-ancestor
110045120|NCT04997811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110045121|NCT04997811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110045122|NCT04997811|GABA Agents|gaba agents|mesh-ancestor
110045123|NCT04997811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110045124|NCT04997811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110045125|NCT04997811|Antimanic Agents|antimanic agents|mesh-ancestor
110045126|NCT04997811|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110045127|NCT04997811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110045128|NCT04997811|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110045129|NCT04997811|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110045130|NCT04997811|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110045131|NCT04997811|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110045132|NCT04997811|Contraceptive Agents|contraceptive agents|mesh-ancestor
110045133|NCT04997811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110045134|NCT04997811|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110045135|NCT04997811|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110045136|NCT04997811|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110045137|NCT04997811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110045138|NCT04997811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110045139|NCT04997811|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110045140|NCT04997811|Hormone Antagonists|hormone antagonists|mesh-ancestor
110045141|NCT04997811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110045142|NCT04997811|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110045143|NCT04997811|Antimetabolites|antimetabolites|mesh-ancestor
110045145|NCT04979884|Cyclosporine|cyclosporine|mesh-list
110045146|NCT04979884|Interleukin-2|interleukin-2|mesh-list
110045147|NCT04979884|Cyclosporins|cyclosporins|mesh-list
110045148|NCT04979884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110045149|NCT04979884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110045150|NCT04979884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110045151|NCT04979884|Immunologic Factors|immunologic factors|mesh-ancestor
110045152|NCT04979884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110045153|NCT04979884|Antifungal Agents|antifungal agents|mesh-ancestor
110045154|NCT04979884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110045155|NCT04979884|Dermatologic Agents|dermatologic agents|mesh-ancestor
110045156|NCT04979884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110045157|NCT04979884|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110045158|NCT04979884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110045159|NCT04979884|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110045160|NCT04979884|Analgesics|analgesics|mesh-ancestor
110045161|NCT04979884|Sensory System Agents|sensory system agents|mesh-ancestor
110045162|NCT04979884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110045163|NCT04971304|Lenograstim|lenograstim|mesh-list
110045164|NCT04971304|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110045165|NCT04971304|Immunologic Factors|immunologic factors|mesh-ancestor
110045166|NCT04971304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110045167|NCT04968366|Temozolomide|temozolomide|mesh-list
110045168|NCT04968366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110045169|NCT04968366|Alkylating Agents|alkylating agents|mesh-ancestor
110045170|NCT04968366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110045171|NCT04968366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110045172|NCT04951115|Carboplatin|carboplatin|mesh-list
110045173|NCT04951115|Etoposide|etoposide|mesh-list
110045174|NCT04951115|Durvalumab|durvalumab|mesh-list
110045175|NCT04951115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110045176|NCT04951115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110045177|NCT04951115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110045178|NCT04951115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110045179|NCT04951115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110045180|NCT04951115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110045181|NCT04951115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110045182|NCT04949503|Nimotuzumab|nimotuzumab|mesh-list
110045183|NCT04949503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110045184|NCT04949503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110045186|NCT04945213|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110045187|NCT04945213|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110045188|NCT04945213|Parasympatholytics|parasympatholytics|mesh-ancestor
110045189|NCT04945213|Autonomic Agents|autonomic agents|mesh-ancestor
110045190|NCT04945213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110045191|NCT04945213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110045192|NCT04945213|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110045193|NCT04945213|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110045194|NCT04945213|Cholinergic Agents|cholinergic agents|mesh-ancestor
110045195|NCT04945213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110045196|NCT04945213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110045197|NCT04938466|Hormones|hormones|mesh-list
110045198|NCT04938466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110045199|NCT04938466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110045200|NCT04934514|Gemcitabine|gemcitabine|mesh-list
110045201|NCT04934514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110045202|NCT04934514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110045203|NCT04934514|Antimetabolites|antimetabolites|mesh-ancestor
110045204|NCT04934514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110045205|NCT04932980|Aflibercept|aflibercept|mesh-list
110045206|NCT04932980|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110045207|NCT04932980|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110045208|NCT04932980|Growth Substances|growth substances|mesh-ancestor
110045209|NCT04932980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110045210|NCT04932980|Growth Inhibitors|growth inhibitors|mesh-ancestor
110045211|NCT04932980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110045212|NCT04927390|Mycophenolic Acid|mycophenolic acid|mesh-list
110045213|NCT04927390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110045214|NCT04927390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110045218|NCT04927390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110045219|NCT04927390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110045220|NCT04927390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110045221|NCT04910711|Dolutegravir|dolutegravir|mesh-list
110045222|NCT04910711|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110045223|NCT04910711|Levonorgestrel|levonorgestrel|mesh-list
110045224|NCT04910711|Medroxyprogesterone|medroxyprogesterone|mesh-list
110045225|NCT04910711|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110045226|NCT04910711|Contraceptive Agents|contraceptive agents|mesh-ancestor
110045227|NCT04910711|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110045228|NCT04910711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110045229|NCT04910711|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110045230|NCT04910711|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110045231|NCT04910711|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110045232|NCT04910711|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110045233|NCT04910711|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110045234|NCT04910711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110045235|NCT04910711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110045236|NCT04910711|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110045237|NCT04910711|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110045238|NCT04910711|Antiviral Agents|antiviral agents|mesh-ancestor
110045239|NCT04910711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110045240|NCT04910711|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110045241|NCT04910711|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110045242|NCT04910711|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110045243|NCT04910711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110045244|NCT04909333|Exenatide|exenatide|mesh-list
110045245|NCT04909333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110045246|NCT04909333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110045247|NCT04909333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110045248|NCT04909333|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110045249|NCT04909333|Incretins|incretins|mesh-ancestor
110045250|NCT04909333|Hormones|hormones|mesh-ancestor
110045251|NCT04909333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110045252|NCT04897958|Leuprolide|leuprolide|mesh-list
110045253|NCT04897958|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110045254|NCT04897958|Fertility Agents|fertility agents|mesh-ancestor
110045255|NCT04897958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110045256|NCT04897958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110045257|NCT04897958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110045258|NCT04897958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110045259|NCT04892758|Mometasone Furoate|mometasone furoate|mesh-list
110045260|NCT04892758|Formoterol Fumarate|formoterol fumarate|mesh-list
110045261|NCT04892758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110045262|NCT04892758|Autonomic Agents|autonomic agents|mesh-ancestor
110045263|NCT04892758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110045264|NCT04892758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110045265|NCT04892758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110045266|NCT04892758|Respiratory System Agents|respiratory system agents|mesh-ancestor
110045267|NCT04892758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110045268|NCT04892758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110045269|NCT04892758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110045270|NCT04892758|Adrenergic Agents|adrenergic agents|mesh-ancestor
110045271|NCT04892758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110045272|NCT04892758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110045274|NCT04892758|Dermatologic Agents|dermatologic agents|mesh-ancestor
110045275|NCT04892758|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110045277|NCT04892732|Formoterol Fumarate|formoterol fumarate|mesh-list
110045278|NCT04892732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110045279|NCT04892732|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110045280|NCT04892732|Autonomic Agents|autonomic agents|mesh-ancestor
110045281|NCT04892732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110045282|NCT04892732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110045283|NCT04892732|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110045284|NCT04892732|Respiratory System Agents|respiratory system agents|mesh-ancestor
110045285|NCT04892732|Glucocorticoids|glucocorticoids|mesh-ancestor
110045286|NCT04892732|Hormones|hormones|mesh-ancestor
110045287|NCT04892732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110045289|NCT04892732|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110045290|NCT04892732|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110045292|NCT04892732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110045293|NCT04892732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110045294|NCT04884763|Erenumab|erenumab|mesh-list
110045295|NCT04884763|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
110045296|NCT04884763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110045297|NCT04884763|Analgesics|analgesics|mesh-ancestor
110045298|NCT04884763|Sensory System Agents|sensory system agents|mesh-ancestor
110045299|NCT04884763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110045300|NCT04884763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110045301|NCT04879420|Teriparatide|teriparatide|mesh-list
110045302|NCT04879420|Risedronic Acid|risedronic acid|mesh-list
110045303|NCT04879420|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110045304|NCT04879420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110045305|NCT04879420|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110045306|NCT04879420|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110045307|NCT04879420|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110045308|NCT04879420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110045309|NCT04858009|Paclitaxel|paclitaxel|mesh-list
110045310|NCT04858009|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110045311|NCT04858009|Cisplatin|cisplatin|mesh-list
110045312|NCT04858009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110045313|NCT04858009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110045314|NCT04858009|Tubulin Modulators|tubulin modulators|mesh-ancestor
110045315|NCT04858009|Antimitotic Agents|antimitotic agents|mesh-ancestor
110045316|NCT04858009|Mitosis Modulators|mitosis modulators|mesh-ancestor
110045317|NCT04858009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110045318|NCT04849910|Gemtuzumab|gemtuzumab|mesh-list
110045319|NCT04849910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110045320|NCT04849910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110045321|NCT04849910|Immunotoxins|immunotoxins|mesh-ancestor
110045322|NCT04849910|Immunoconjugates|immunoconjugates|mesh-ancestor
110045323|NCT04849910|Immunologic Factors|immunologic factors|mesh-ancestor
110045324|NCT04849910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110045325|NCT04848519|Pembrolizumab|pembrolizumab|mesh-list
110045326|NCT04848519|Nivolumab|nivolumab|mesh-list
110045327|NCT04848519|Avelumab|avelumab|mesh-list
110045328|NCT04848519|Propranolol|propranolol|mesh-list
110045329|NCT04848519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110045330|NCT04848519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110045331|NCT04848519|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110045332|NCT04848519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110045333|NCT04848519|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110045334|NCT04848519|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110045335|NCT04848519|Adrenergic Agents|adrenergic agents|mesh-ancestor
110045336|NCT04848519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110045337|NCT04848519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110045338|NCT04848519|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110045339|NCT04848519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110045340|NCT04848519|Vasodilator Agents|vasodilator agents|mesh-ancestor
110045342|NCT04822337|Lenalidomide|lenalidomide|mesh-list
110045343|NCT04822337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110045344|NCT04822337|Antiemetics|antiemetics|mesh-ancestor
110045345|NCT04822337|Autonomic Agents|autonomic agents|mesh-ancestor
110045346|NCT04822337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110045347|NCT04822337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110045348|NCT04822337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110045349|NCT04822337|Glucocorticoids|glucocorticoids|mesh-ancestor
110045351|NCT04822337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110045352|NCT04822337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110045353|NCT04822337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110045354|NCT04822337|Immunologic Factors|immunologic factors|mesh-ancestor
110045355|NCT04822337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110045356|NCT04822337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110045357|NCT04822337|Growth Substances|growth substances|mesh-ancestor
110045358|NCT04822337|Growth Inhibitors|growth inhibitors|mesh-ancestor
110045359|NCT04808323|Capecitabine|capecitabine|mesh-list
110045360|NCT04808323|Oxaliplatin|oxaliplatin|mesh-list
110045361|NCT04808323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110045362|NCT04808323|Antimetabolites|antimetabolites|mesh-ancestor
110045366|NCT04793529|Vitamin D|vitamin d|mesh-list
110045367|NCT04793529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110045368|NCT04793529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110045369|NCT04793529|Vitamins|vitamins|mesh-ancestor
110045370|NCT04793529|Micronutrients|micronutrients|mesh-ancestor
110045371|NCT04793529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110045372|NCT06040684|Antibodies|antibodies|mesh-list
110045373|NCT06040684|Immunologic Factors|immunologic factors|mesh-ancestor
110045374|NCT06040684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110045375|NCT06040489|Amphotericin B|amphotericin b|mesh-list
110045376|NCT06040489|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110045377|NCT06040489|Miltefosine|miltefosine|mesh-list
110045378|NCT06040489|Pentoxifylline|pentoxifylline|mesh-list
110045379|NCT06040489|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110045380|NCT06040489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110045381|NCT06040489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110045382|NCT06040489|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110045383|NCT06040489|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110045384|NCT06040489|Protective Agents|protective agents|mesh-ancestor
110045385|NCT06040489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110045386|NCT06040489|Vasodilator Agents|vasodilator agents|mesh-ancestor
110045387|NCT06040489|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110045388|NCT06040489|Antioxidants|antioxidants|mesh-ancestor
110045389|NCT06040489|Amebicides|amebicides|mesh-ancestor
110045390|NCT06040489|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110045391|NCT06040489|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110045392|NCT06040489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110045393|NCT06040489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110045394|NCT06040489|Antifungal Agents|antifungal agents|mesh-ancestor
110045395|NCT06040489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110045396|NCT06040424|Albuterol|albuterol|mesh-list
110045397|NCT06040424|Ipratropium|ipratropium|mesh-list
110045398|NCT06040424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110045399|NCT06040424|Autonomic Agents|autonomic agents|mesh-ancestor
110045400|NCT06040424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110045401|NCT06040424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110045402|NCT06040424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110045403|NCT06040424|Respiratory System Agents|respiratory system agents|mesh-ancestor
110045404|NCT06040424|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110045406|NCT06040424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110045407|NCT06040424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110045408|NCT06040424|Tocolytic Agents|tocolytic agents|mesh-ancestor
110045409|NCT06040424|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110045410|NCT06040424|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110045411|NCT06040424|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110045412|NCT06040424|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110045413|NCT06040424|Adrenergic Agents|adrenergic agents|mesh-ancestor
110045414|NCT06040346|Meplazumab|meplazumab|mesh-list
110045415|NCT06040346|Antiviral Agents|antiviral agents|mesh-ancestor
110045416|NCT06040346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110045417|NCT06040320|Rituximab|rituximab|mesh-list
110045418|NCT06040320|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
110045419|NCT06040320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110045420|NCT06040320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110045421|NCT06040320|Immunologic Factors|immunologic factors|mesh-ancestor
110045422|NCT06040320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110045423|NCT06040320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110045424|NCT06040320|Immunoconjugates|immunoconjugates|mesh-ancestor
110045425|NCT06040268|Fluticasone|fluticasone|mesh-list
110045426|NCT06040268|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110045427|NCT06040268|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110045428|NCT06040268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110045429|NCT06040268|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110045430|NCT06040268|Autonomic Agents|autonomic agents|mesh-ancestor
110045431|NCT06040268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110045432|NCT06040268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110045433|NCT06040268|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110045434|NCT06040268|Respiratory System Agents|respiratory system agents|mesh-ancestor
110045435|NCT06040268|Dermatologic Agents|dermatologic agents|mesh-ancestor
110045436|NCT06040268|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110045437|NCT06040268|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110045438|NCT06040268|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110045439|NCT06040268|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110045440|NCT06040268|Adrenergic Agents|adrenergic agents|mesh-ancestor
110045441|NCT06040268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110045442|NCT06040268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110045443|NCT06040268|Glucocorticoids|glucocorticoids|mesh-ancestor
110045444|NCT06040268|Hormones|hormones|mesh-ancestor
110045445|NCT06040268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110045446|NCT06040268|Sympathomimetics|sympathomimetics|mesh-ancestor
110045447|NCT06040255|Prednisone|prednisone|mesh-list
110045448|NCT06040255|Methylprednisolone|methylprednisolone|mesh-list
110045449|NCT06040255|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110045450|NCT06040255|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110045451|NCT06040255|Prednisolone|prednisolone|mesh-list
110045452|NCT06040255|Prednisolone acetate|prednisolone acetate|mesh-list
110045453|NCT06040255|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110045454|NCT06040255|Prednisolone phosphate|prednisolone phosphate|mesh-list
110045455|NCT06040255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110045456|NCT06040255|Glucocorticoids|glucocorticoids|mesh-ancestor
110045457|NCT06040255|Hormones|hormones|mesh-ancestor
110045458|NCT06040255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110045459|NCT06040255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110045460|NCT06040255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110045461|NCT06040255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110045462|NCT06040255|Antiemetics|antiemetics|mesh-ancestor
110045463|NCT06040255|Autonomic Agents|autonomic agents|mesh-ancestor
110045464|NCT06040255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110045465|NCT06040255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110045466|NCT06040255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110045467|NCT06040255|Protective Agents|protective agents|mesh-ancestor
110045468|NCT06040190|Thioctic Acid|thioctic acid|mesh-list
110045469|NCT06040190|Clonazepam|clonazepam|mesh-list
110045470|NCT06040190|Capsaicin|capsaicin|mesh-list
110045471|NCT06040190|Antipruritics|antipruritics|mesh-ancestor
110045472|NCT06040190|Dermatologic Agents|dermatologic agents|mesh-ancestor
110045473|NCT06040190|Sensory System Agents|sensory system agents|mesh-ancestor
110045474|NCT06040190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110045475|NCT06040190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110045476|NCT06040190|Antioxidants|antioxidants|mesh-ancestor
110045477|NCT06040190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110045478|NCT06040190|Protective Agents|protective agents|mesh-ancestor
110045479|NCT06040190|Vitamin B Complex|vitamin b complex|mesh-ancestor
110045480|NCT06040190|Vitamins|vitamins|mesh-ancestor
110045481|NCT06040190|Micronutrients|micronutrients|mesh-ancestor
110045482|NCT06040190|Anticonvulsants|anticonvulsants|mesh-ancestor
110045483|NCT06040190|GABA Modulators|gaba modulators|mesh-ancestor
110045484|NCT06040190|GABA Agents|gaba agents|mesh-ancestor
110045485|NCT06040190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110045486|NCT06040112|Lidocaine|lidocaine|mesh-list
110045487|NCT06040112|Anesthetics, Local|anesthetics, local|mesh-ancestor
110045488|NCT06040112|Anesthetics|anesthetics|mesh-ancestor
110045489|NCT06040112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110045490|NCT06040112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110045491|NCT06040112|Sensory System Agents|sensory system agents|mesh-ancestor
110045492|NCT06040112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110045493|NCT06040112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110045494|NCT06040112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110045495|NCT06040112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110046102|NCT05696847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110045497|NCT06040112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110045498|NCT06040099|Bevacizumab|bevacizumab|mesh-list
110045499|NCT06040099|Durvalumab|durvalumab|mesh-list
110045500|NCT06040099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110045501|NCT06040099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110045502|NCT06040099|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110045503|NCT06040099|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110045504|NCT06040099|Growth Substances|growth substances|mesh-ancestor
110045505|NCT06040099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110045506|NCT06040099|Growth Inhibitors|growth inhibitors|mesh-ancestor
110045507|NCT06039891|Tislelizumab|tislelizumab|mesh-list
110045508|NCT06039891|Nimotuzumab|nimotuzumab|mesh-list
110045509|NCT06039891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110045510|NCT06039891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110045511|NCT06039878|Oxytocin|oxytocin|mesh-list
110045512|NCT06039878|Oxytocics|oxytocics|mesh-ancestor
110045513|NCT06039878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110045514|NCT06039878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110045516|NCT06039826|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110045517|NCT06039826|Estradiol|estradiol|mesh-list
110045518|NCT06039826|Estrogens|estrogens|mesh-ancestor
110045519|NCT06039826|Hormones|hormones|mesh-ancestor
110045520|NCT06039826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110045521|NCT06039826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110045522|NCT06039826|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110045523|NCT06039826|Contraceptive Agents|contraceptive agents|mesh-ancestor
110045524|NCT06039826|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110045525|NCT06039826|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110045526|NCT06039826|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110045527|NCT06039826|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110045528|NCT06039826|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110045529|NCT06039826|Hormone Antagonists|hormone antagonists|mesh-ancestor
110045530|NCT06039826|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110045531|NCT06039826|Diuretics|diuretics|mesh-ancestor
110045532|NCT06039826|Natriuretic Agents|natriuretic agents|mesh-ancestor
110045533|NCT06039774|Chitosan|chitosan|mesh-list
110045534|NCT06039774|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110045535|NCT06039774|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110045537|NCT06039774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110045538|NCT06039774|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110045539|NCT06039774|Chelating Agents|chelating agents|mesh-ancestor
110045540|NCT06039774|Sequestering Agents|sequestering agents|mesh-ancestor
110045541|NCT06039774|Hemostatics|hemostatics|mesh-ancestor
110045542|NCT06039774|Coagulants|coagulants|mesh-ancestor
110045543|NCT06039592|Metoprolol|metoprolol|mesh-list
110045544|NCT06039592|Captopril|captopril|mesh-list
110045545|NCT06039592|Torsemide|torsemide|mesh-list
110045546|NCT06039592|Spironolactone|spironolactone|mesh-list
110045547|NCT06039592|Potassium Citrate|potassium citrate|mesh-list
110045548|NCT06039592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110045549|NCT06039592|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110045550|NCT06039592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110045551|NCT06039592|Sympatholytics|sympatholytics|mesh-ancestor
110045552|NCT06039592|Autonomic Agents|autonomic agents|mesh-ancestor
110045553|NCT06039592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110045554|NCT06039592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110045555|NCT06039592|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110045556|NCT06039592|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110045557|NCT06039592|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110045558|NCT06039592|Adrenergic Agents|adrenergic agents|mesh-ancestor
110045559|NCT06039592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110045560|NCT06039592|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110045561|NCT06039592|Hormone Antagonists|hormone antagonists|mesh-ancestor
110045562|NCT06039592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110045563|NCT06039592|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110045564|NCT06039592|Diuretics|diuretics|mesh-ancestor
110045565|NCT06039592|Natriuretic Agents|natriuretic agents|mesh-ancestor
110045566|NCT06039592|Expectorants|expectorants|mesh-ancestor
110045567|NCT06039592|Respiratory System Agents|respiratory system agents|mesh-ancestor
110045568|NCT06039592|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110045569|NCT06039592|Protease Inhibitors|protease inhibitors|mesh-ancestor
110045570|NCT06039592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110045571|NCT06039592|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110045572|NCT06039592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110045573|NCT06039566|Acetylcysteine|acetylcysteine|mesh-list
110045574|NCT06039566|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110045575|NCT06039566|Antiviral Agents|antiviral agents|mesh-ancestor
110045576|NCT06039566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110045577|NCT06039566|Expectorants|expectorants|mesh-ancestor
110045578|NCT06039566|Respiratory System Agents|respiratory system agents|mesh-ancestor
110045579|NCT06039566|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110045580|NCT06039566|Antioxidants|antioxidants|mesh-ancestor
110045581|NCT06039566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110045582|NCT06039566|Protective Agents|protective agents|mesh-ancestor
110045583|NCT06039566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110045584|NCT06039566|Antidotes|antidotes|mesh-ancestor
110045585|NCT06039540|Metoprolol|metoprolol|mesh-list
110045586|NCT06039540|Captopril|captopril|mesh-list
110045587|NCT06039540|Torsemide|torsemide|mesh-list
110045588|NCT06039540|Spironolactone|spironolactone|mesh-list
110045589|NCT06039540|Potassium Citrate|potassium citrate|mesh-list
110045590|NCT06039540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110045591|NCT06039540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110045592|NCT06039540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110045593|NCT06039540|Sympatholytics|sympatholytics|mesh-ancestor
110045594|NCT06039540|Autonomic Agents|autonomic agents|mesh-ancestor
110045595|NCT06039540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110045596|NCT06039540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110045597|NCT06039540|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110045598|NCT06039540|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110045599|NCT06039540|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110045600|NCT06039540|Adrenergic Agents|adrenergic agents|mesh-ancestor
110045601|NCT06039540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110045602|NCT06039540|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110045603|NCT06039540|Hormone Antagonists|hormone antagonists|mesh-ancestor
110045604|NCT06039540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110045607|NCT06039540|Natriuretic Agents|natriuretic agents|mesh-ancestor
110045609|NCT06039540|Respiratory System Agents|respiratory system agents|mesh-ancestor
110045610|NCT06039540|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110045611|NCT06039540|Protease Inhibitors|protease inhibitors|mesh-ancestor
110045612|NCT06039540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110045613|NCT06039540|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110045614|NCT06039540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110045615|NCT06039436|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110045616|NCT06039436|Thymoglobulin|thymoglobulin|mesh-list
110045617|NCT06039436|Immunologic Factors|immunologic factors|mesh-ancestor
110045618|NCT06039436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110045619|NCT06039436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110045620|NCT06039423|Ketorolac|ketorolac|mesh-list
110045621|NCT06039423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110045622|NCT06039423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110045623|NCT06039423|Analgesics|analgesics|mesh-ancestor
110045624|NCT06039423|Sensory System Agents|sensory system agents|mesh-ancestor
110045625|NCT06039423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110045626|NCT06039423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110045627|NCT06039423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110045628|NCT06039423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110045629|NCT06039423|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110045630|NCT06039423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110045631|NCT06039423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110045677|NCT06039280|Respiratory System Agents|respiratory system agents|mesh-ancestor
110045679|NCT06039280|Antioxidants|antioxidants|mesh-ancestor
110045680|NCT06039280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110045681|NCT06039280|Protective Agents|protective agents|mesh-ancestor
110045682|NCT06039280|Antidotes|antidotes|mesh-ancestor
110045683|NCT06039202|Trifluridine|trifluridine|mesh-list
110045684|NCT06039202|Bevacizumab|bevacizumab|mesh-list
110045685|NCT06039202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110045686|NCT06039202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110045687|NCT06039202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110045688|NCT06039202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110045689|NCT06039202|Growth Substances|growth substances|mesh-ancestor
110045690|NCT06039202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110045691|NCT06039202|Growth Inhibitors|growth inhibitors|mesh-ancestor
110045692|NCT06039202|Antimetabolites|antimetabolites|mesh-ancestor
110045693|NCT06039202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110045694|NCT06039202|Antiviral Agents|antiviral agents|mesh-ancestor
110045695|NCT06039202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110045697|NCT06039150|Anesthetics, Local|anesthetics, local|mesh-list
110045698|NCT06039150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110045699|NCT06039150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110045700|NCT06039150|Sensory System Agents|sensory system agents|mesh-ancestor
110045701|NCT06039150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110045702|NCT06039137|Cetirizine|cetirizine|mesh-list
110045703|NCT06039137|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110045704|NCT06039137|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110045705|NCT06039137|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110045706|NCT06039137|Histamine Antagonists|histamine antagonists|mesh-ancestor
110045707|NCT06039137|Histamine Agents|histamine agents|mesh-ancestor
110045708|NCT06039137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110045709|NCT06039137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110045710|NCT06039137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110045711|NCT06039124|Bevacizumab|bevacizumab|mesh-list
110045712|NCT06039124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110045713|NCT06039124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110045714|NCT06039124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110045715|NCT06039124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110045716|NCT06039124|Growth Substances|growth substances|mesh-ancestor
110045717|NCT06039124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110045718|NCT06039124|Growth Inhibitors|growth inhibitors|mesh-ancestor
110045719|NCT06039020|Immunoglobulins|immunoglobulins|mesh-list
110045720|NCT06039020|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110045722|NCT06039020|Immunologic Factors|immunologic factors|mesh-ancestor
110045723|NCT06039020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110045724|NCT06038968|Methotrexate|methotrexate|mesh-list
110045725|NCT06038968|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110045726|NCT06038968|Abortifacient Agents|abortifacient agents|mesh-ancestor
110045727|NCT06038968|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110045728|NCT06038968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110045729|NCT06038968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110045730|NCT06038968|Antimetabolites|antimetabolites|mesh-ancestor
110045731|NCT06038968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110045733|NCT06038968|Dermatologic Agents|dermatologic agents|mesh-ancestor
110045734|NCT06038968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110045735|NCT06038968|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110045736|NCT06038968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110045737|NCT06038968|Immunologic Factors|immunologic factors|mesh-ancestor
110045738|NCT06038968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110045739|NCT06038968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110045740|NCT06038929|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
110045741|NCT06038929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110045742|NCT06038695|Mitogens|mitogens|mesh-list
110045743|NCT06038695|Mitosis Modulators|mitosis modulators|mesh-ancestor
110045744|NCT06038695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110045745|NCT06038617|Vaccines|vaccines|mesh-list
110045746|NCT06038617|Immunologic Factors|immunologic factors|mesh-ancestor
110045747|NCT06038617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110045748|NCT06038552|Imatinib Mesylate|imatinib mesylate|mesh-list
110045749|NCT06038552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110045750|NCT06038552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110045751|NCT06038552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110045752|NCT06038552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110045753|NCT06037811|Prednisone|prednisone|mesh-list
110045754|NCT06037811|Adalimumab|adalimumab|mesh-list
110045755|NCT06037811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110045756|NCT06037811|Glucocorticoids|glucocorticoids|mesh-ancestor
110045757|NCT06037811|Hormones|hormones|mesh-ancestor
110045758|NCT06037811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110045759|NCT06037811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110045760|NCT06037811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110045761|NCT06037811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110045762|NCT06037811|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110045763|NCT06037811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110045764|NCT06037434|Metoprolol|metoprolol|mesh-list
110045765|NCT06037434|Captopril|captopril|mesh-list
110045766|NCT06037434|Torsemide|torsemide|mesh-list
110045767|NCT06037434|Spironolactone|spironolactone|mesh-list
110045768|NCT06037434|Potassium Citrate|potassium citrate|mesh-list
110045769|NCT06037434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110045770|NCT06037434|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110045771|NCT06037434|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110045772|NCT06037434|Sympatholytics|sympatholytics|mesh-ancestor
110045773|NCT06037434|Autonomic Agents|autonomic agents|mesh-ancestor
110045774|NCT06037434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110045775|NCT06037434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110045776|NCT06037434|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110045777|NCT06037434|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110045778|NCT06037434|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110045779|NCT06037434|Adrenergic Agents|adrenergic agents|mesh-ancestor
110045780|NCT06037434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110045781|NCT06037434|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110045782|NCT06037434|Hormone Antagonists|hormone antagonists|mesh-ancestor
110045783|NCT06037434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110045784|NCT06037434|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110045786|NCT06037434|Natriuretic Agents|natriuretic agents|mesh-ancestor
110045787|NCT06037434|Expectorants|expectorants|mesh-ancestor
110045788|NCT06037434|Respiratory System Agents|respiratory system agents|mesh-ancestor
110045789|NCT06037434|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110045790|NCT06037434|Protease Inhibitors|protease inhibitors|mesh-ancestor
110045851|NCT06019728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110045852|NCT06019728|Respiratory System Agents|respiratory system agents|mesh-ancestor
110045853|NCT06019728|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110045855|NCT06019728|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110045856|NCT06019728|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110045857|NCT06019728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110045858|NCT06019728|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110045859|NCT06019728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110045860|NCT06019728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110045861|NCT06019728|Anesthetics, Local|anesthetics, local|mesh-ancestor
110045862|NCT06019728|Anesthetics|anesthetics|mesh-ancestor
110045863|NCT06019728|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110045864|NCT06019728|Histamine Antagonists|histamine antagonists|mesh-ancestor
110045865|NCT06019728|Histamine Agents|histamine agents|mesh-ancestor
110045866|NCT06019728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110045867|NCT06019728|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110045868|NCT06019728|Antipruritics|antipruritics|mesh-ancestor
110045869|NCT06019728|Dermatologic Agents|dermatologic agents|mesh-ancestor
110045870|NCT06010927|Midazolam|midazolam|mesh-list
110045871|NCT06010927|Ketamine|ketamine|mesh-list
110045872|NCT06010927|Analgesics|analgesics|mesh-ancestor
110045873|NCT06010927|Sensory System Agents|sensory system agents|mesh-ancestor
110045874|NCT06010927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110045875|NCT06010927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110045876|NCT06010927|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110045877|NCT06010927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110045878|NCT06010927|Anesthetics, General|anesthetics, general|mesh-ancestor
110045879|NCT06010927|Anesthetics|anesthetics|mesh-ancestor
110045880|NCT06010927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110045881|NCT06010927|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110045882|NCT06010927|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110045883|NCT06010927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110045884|NCT06010927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110045885|NCT06010927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110045886|NCT06010927|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110045887|NCT06010927|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110045888|NCT06010927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110045889|NCT06010927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110045890|NCT06010927|GABA Modulators|gaba modulators|mesh-ancestor
110045891|NCT06010927|GABA Agents|gaba agents|mesh-ancestor
110045892|NCT05969223|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110045893|NCT05969223|Immunologic Factors|immunologic factors|mesh-ancestor
110045894|NCT05969223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110045895|NCT05954871|Cetuximab|cetuximab|mesh-list
110045897|NCT05954871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110045898|NCT05954871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110045899|NCT05954871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110045900|NCT05954871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110045901|NCT05954871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110045908|NCT05912946|Interferons|interferons|mesh-list
110045909|NCT05912946|Hyaluronic Acid|hyaluronic acid|mesh-list
110045910|NCT05912946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110045911|NCT05912946|Antiviral Agents|antiviral agents|mesh-ancestor
110045912|NCT05912946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110045913|NCT05912946|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110045914|NCT05912946|Immunologic Factors|immunologic factors|mesh-ancestor
110045915|NCT05912946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110045916|NCT05912946|Viscosupplements|viscosupplements|mesh-ancestor
110045917|NCT05912946|Protective Agents|protective agents|mesh-ancestor
110045918|NCT05910827|Docetaxel|docetaxel|mesh-list
110045919|NCT05910827|Cetuximab|cetuximab|mesh-list
110045920|NCT05910827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110045921|NCT05910827|Tubulin Modulators|tubulin modulators|mesh-ancestor
110045922|NCT05910827|Antimitotic Agents|antimitotic agents|mesh-ancestor
110045923|NCT05910827|Mitosis Modulators|mitosis modulators|mesh-ancestor
110045924|NCT05910827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110045925|NCT05910827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110045926|NCT05896163|Obinutuzumab|obinutuzumab|mesh-list
110045927|NCT05896163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110045928|NCT05896163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110045929|NCT05856331|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
110045930|NCT05856331|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110045931|NCT05856331|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110045932|NCT05856331|Protease Inhibitors|protease inhibitors|mesh-ancestor
110045933|NCT05856331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110045934|NCT05856331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110045935|NCT05852002|Hyaluronic Acid|hyaluronic acid|mesh-list
110045936|NCT05852002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110045937|NCT05852002|Immunologic Factors|immunologic factors|mesh-ancestor
110045938|NCT05852002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110045939|NCT05852002|Viscosupplements|viscosupplements|mesh-ancestor
110045940|NCT05852002|Protective Agents|protective agents|mesh-ancestor
110045941|NCT05840211|Paclitaxel|paclitaxel|mesh-list
110045942|NCT05840211|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110045943|NCT05840211|Capecitabine|capecitabine|mesh-list
110045944|NCT05840211|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
110045945|NCT05840211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110045946|NCT05840211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110045947|NCT05840211|Tubulin Modulators|tubulin modulators|mesh-ancestor
110045948|NCT05840211|Antimitotic Agents|antimitotic agents|mesh-ancestor
110045949|NCT05840211|Mitosis Modulators|mitosis modulators|mesh-ancestor
110045950|NCT05840211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110045951|NCT05840211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110045952|NCT05840211|Antimetabolites|antimetabolites|mesh-ancestor
110045953|NCT05840211|Immunoconjugates|immunoconjugates|mesh-ancestor
110045954|NCT05840211|Immunologic Factors|immunologic factors|mesh-ancestor
110045955|NCT05840211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110045956|NCT05837091|Sodium Oxybate|sodium oxybate|mesh-list
110045957|NCT05837091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110045958|NCT05837091|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110045959|NCT05837091|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110045960|NCT05837091|Anesthetics, General|anesthetics, general|mesh-ancestor
110045962|NCT05837091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110045963|NCT05820763|Dexamethasone|dexamethasone|mesh-list
110045964|NCT05820763|Lenalidomide|lenalidomide|mesh-list
110045965|NCT05820763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110045966|NCT05820763|Antiemetics|antiemetics|mesh-ancestor
110045967|NCT05820763|Autonomic Agents|autonomic agents|mesh-ancestor
110045968|NCT05820763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110045969|NCT05820763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110045970|NCT05820763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110045971|NCT05820763|Glucocorticoids|glucocorticoids|mesh-ancestor
110045972|NCT05820763|Hormones|hormones|mesh-ancestor
110045973|NCT05820763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110045974|NCT05820763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110045975|NCT05820763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110045976|NCT05820763|Immunologic Factors|immunologic factors|mesh-ancestor
110045978|NCT05820763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110045979|NCT05820763|Growth Substances|growth substances|mesh-ancestor
110045980|NCT05820763|Growth Inhibitors|growth inhibitors|mesh-ancestor
110045981|NCT05814523|Ganaxolone|ganaxolone|mesh-list
110045982|NCT05814523|Neurosteroids|neurosteroids|mesh-ancestor
110045983|NCT05814523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110045984|NCT05814523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110045985|NCT05814523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110045986|NCT05814523|GABA Modulators|gaba modulators|mesh-ancestor
110045987|NCT05814523|GABA Agents|gaba agents|mesh-ancestor
110045988|NCT05813587|Meplazumab|meplazumab|mesh-list
110045989|NCT05813587|Antiviral Agents|antiviral agents|mesh-ancestor
110045990|NCT05813587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110045991|NCT05810649|Hyaluronic Acid|hyaluronic acid|mesh-list
110045993|NCT05810649|Immunologic Factors|immunologic factors|mesh-ancestor
110045994|NCT05810649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110045995|NCT05810649|Viscosupplements|viscosupplements|mesh-ancestor
110045996|NCT05810649|Protective Agents|protective agents|mesh-ancestor
110045997|NCT05806931|Bevacizumab|bevacizumab|mesh-list
110045998|NCT05806931|Oxaliplatin|oxaliplatin|mesh-list
110045999|NCT05806931|Irinotecan|irinotecan|mesh-list
110046000|NCT05806931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110046001|NCT05806931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110046002|NCT05806931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110046003|NCT05806931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110046004|NCT05806931|Growth Substances|growth substances|mesh-ancestor
110046005|NCT05806931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110046006|NCT05806931|Growth Inhibitors|growth inhibitors|mesh-ancestor
110046007|NCT05806931|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110046008|NCT05806931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110046009|NCT05806931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110046010|NCT05806931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110046011|NCT05800015|Paclitaxel|paclitaxel|mesh-list
110046012|NCT05800015|Carboplatin|carboplatin|mesh-list
110046013|NCT05800015|Pemetrexed|pemetrexed|mesh-list
110046014|NCT05800015|Cemiplimab|cemiplimab|mesh-list
110046015|NCT05800015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110046016|NCT05800015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110046017|NCT05800015|Tubulin Modulators|tubulin modulators|mesh-ancestor
110046018|NCT05800015|Antimitotic Agents|antimitotic agents|mesh-ancestor
110046019|NCT05800015|Mitosis Modulators|mitosis modulators|mesh-ancestor
110046020|NCT05800015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110046021|NCT05800015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110046022|NCT05800015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110046023|NCT05800015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110046024|NCT05800015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110046025|NCT05799326|Levofloxacin|levofloxacin|mesh-list
110046026|NCT05799326|Ofloxacin|ofloxacin|mesh-list
110046027|NCT05799326|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110046028|NCT05799326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110046029|NCT05799326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110046030|NCT05799326|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110046031|NCT05799326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110046032|NCT05799326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110046033|NCT05799326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110046034|NCT05799326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110046035|NCT05799326|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110046036|NCT05799326|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110046037|NCT05797805|Pembrolizumab|pembrolizumab|mesh-list
110046038|NCT05797805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110046039|NCT05797805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110046040|NCT05797805|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110046041|NCT05797805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110046043|NCT05785767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110046044|NCT05785767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110046045|NCT05776875|Bevacizumab|bevacizumab|mesh-list
110046046|NCT05776875|Atezolizumab|atezolizumab|mesh-list
110046047|NCT05776875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110046048|NCT05776875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110046049|NCT05776875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110046050|NCT05776875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110046051|NCT05776875|Growth Substances|growth substances|mesh-ancestor
110046052|NCT05776875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110046053|NCT05776875|Growth Inhibitors|growth inhibitors|mesh-ancestor
110046089|NCT05706506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110046090|NCT05706506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110046092|NCT05706506|Hormones|hormones|mesh-ancestor
110046093|NCT05706506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110046094|NCT05703672|Varenicline|varenicline|mesh-list
110046095|NCT05703672|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110046096|NCT05703672|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110046097|NCT05703672|Cholinergic Agents|cholinergic agents|mesh-ancestor
110046098|NCT05703672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110046099|NCT05703672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110046100|NCT05703672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110046101|NCT05696847|Tirzepatide|tirzepatide|mesh-list
110046103|NCT05696847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110046104|NCT05696847|Incretins|incretins|mesh-ancestor
110046106|NCT05696847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110046107|NCT05691712|Tirzepatide|tirzepatide|mesh-list
110046108|NCT05691712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110046109|NCT05691712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110046110|NCT05691712|Incretins|incretins|mesh-ancestor
110046111|NCT05691712|Hormones|hormones|mesh-ancestor
110046112|NCT05691712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110046113|NCT05687032|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
110046114|NCT05687032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110046115|NCT05687032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110046116|NCT05687032|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110046117|NCT05687032|Immunotoxins|immunotoxins|mesh-ancestor
110046118|NCT05687032|Immunoconjugates|immunoconjugates|mesh-ancestor
110046119|NCT05687032|Immunologic Factors|immunologic factors|mesh-ancestor
110046120|NCT05687032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110046121|NCT05679492|Meplazumab|meplazumab|mesh-list
110046122|NCT05679492|Antiviral Agents|antiviral agents|mesh-ancestor
110046123|NCT05679492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110046124|NCT05676749|Pembrolizumab|pembrolizumab|mesh-list
110046125|NCT05676749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110046126|NCT05676749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110046127|NCT05676749|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110046128|NCT05676749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110046129|NCT05665530|Zanubrutinib|zanubrutinib|mesh-list
110046130|NCT05665530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110046131|NCT05665530|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110046132|NCT05665530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110046133|NCT05665530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110046134|NCT05646862|Fulvestrant|fulvestrant|mesh-list
110046136|NCT05646862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110046137|NCT05646862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110046138|NCT05646862|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110046140|NCT05646862|Hormone Antagonists|hormone antagonists|mesh-ancestor
110046141|NCT05646862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110046142|NCT05646862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110046143|NCT05646862|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
110046144|NCT05646862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110046145|NCT05646862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110046146|NCT05621668|Cyclophosphamide|cyclophosphamide|mesh-list
110046147|NCT05621668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110046148|NCT05621668|Immunologic Factors|immunologic factors|mesh-ancestor
110046149|NCT05621668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110046150|NCT05621668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110046151|NCT05621668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110046152|NCT05621668|Alkylating Agents|alkylating agents|mesh-ancestor
110046153|NCT05621668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110046154|NCT05621668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110046155|NCT05621668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110046156|NCT05583721|Regadenoson|regadenoson|mesh-list
110046157|NCT05583721|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
110046158|NCT05583721|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110046159|NCT05583721|Purinergic Agonists|purinergic agonists|mesh-ancestor
110046160|NCT05583721|Purinergic Agents|purinergic agents|mesh-ancestor
110046161|NCT05583721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110046162|NCT05583721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110046163|NCT05583721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110046164|NCT05564039|Dulaglutide|dulaglutide|mesh-list
110046165|NCT05564039|Tirzepatide|tirzepatide|mesh-list
110046166|NCT05564039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110046167|NCT05564039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110046168|NCT05564039|Incretins|incretins|mesh-ancestor
110046169|NCT05564039|Hormones|hormones|mesh-ancestor
110046170|NCT05564039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110046171|NCT05556746|Rifampin|rifampin|mesh-list
110046172|NCT05556746|Clofazimine|clofazimine|mesh-list
110046173|NCT05556746|Isoniazid|isoniazid|mesh-list
110046174|NCT05556746|Pyrazinamide|pyrazinamide|mesh-list
110046175|NCT05556746|Ethambutol|ethambutol|mesh-list
110046176|NCT05556746|Bedaquiline|bedaquiline|mesh-list
110046177|NCT05556746|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110046178|NCT05556746|Antitubercular Agents|antitubercular agents|mesh-ancestor
110046179|NCT05556746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110046180|NCT05556746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110046181|NCT05556746|Leprostatic Agents|leprostatic agents|mesh-ancestor
110046182|NCT05556746|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110046183|NCT05556746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110046184|NCT05556746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110046185|NCT05556746|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110046186|NCT05556746|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110046187|NCT05556746|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110046188|NCT05556746|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110046189|NCT05556746|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110046190|NCT05556746|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110046191|NCT05556746|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110046192|NCT05556746|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110046193|NCT05556746|Antimetabolites|antimetabolites|mesh-ancestor
110046194|NCT05556746|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110046195|NCT05556746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110046196|NCT05548985|Midodrine|midodrine|mesh-list
110046197|NCT05548985|Metoclopramide|metoclopramide|mesh-list
110046198|NCT05548985|Antiemetics|antiemetics|mesh-ancestor
110046199|NCT05548985|Autonomic Agents|autonomic agents|mesh-ancestor
110046200|NCT05548985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110046201|NCT05548985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110046202|NCT05548985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110046203|NCT05548985|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110046204|NCT05548985|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110046206|NCT05548985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110046207|NCT05548985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110046208|NCT05548985|Sympathomimetics|sympathomimetics|mesh-ancestor
110046209|NCT05548985|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110046210|NCT05548985|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110046211|NCT05548985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110046212|NCT05548985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110046213|NCT05548985|Adrenergic Agents|adrenergic agents|mesh-ancestor
110046215|NCT05513625|Antiviral Agents|antiviral agents|mesh-ancestor
110046216|NCT05513625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110046217|NCT05513625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110046218|NCT05513625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110046219|NCT05502237|Paclitaxel|paclitaxel|mesh-list
110046220|NCT05502237|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110046221|NCT05502237|Carboplatin|carboplatin|mesh-list
110046222|NCT05502237|Pembrolizumab|pembrolizumab|mesh-list
110046223|NCT05502237|Pemetrexed|pemetrexed|mesh-list
110046224|NCT05502237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110046225|NCT05502237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110046226|NCT05502237|Tubulin Modulators|tubulin modulators|mesh-ancestor
110046227|NCT05502237|Antimitotic Agents|antimitotic agents|mesh-ancestor
110046228|NCT05502237|Mitosis Modulators|mitosis modulators|mesh-ancestor
110046229|NCT05502237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110046230|NCT05502237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110046231|NCT05502237|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110046232|NCT05502237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110046233|NCT05502237|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110046234|NCT05502237|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110046235|NCT05484622|Pembrolizumab|pembrolizumab|mesh-list
110046236|NCT05484622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110046237|NCT05484622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110046238|NCT05484622|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110046239|NCT05484622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110046240|NCT05473741|Risperidone|risperidone|mesh-list
110046241|NCT05473741|Aripiprazole|aripiprazole|mesh-list
110046242|NCT05473741|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110046243|NCT05473741|Antipsychotic Agents|antipsychotic agents|mesh-list
110046244|NCT05473741|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110046245|NCT05473741|Serotonin Agents|serotonin agents|mesh-ancestor
110046246|NCT05473741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110046247|NCT05473741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110046248|NCT05473741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110046249|NCT05473741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110046250|NCT05473741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110046251|NCT05473741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110046252|NCT05473741|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110046253|NCT05473741|Dopamine Agents|dopamine agents|mesh-ancestor
110046254|NCT05473741|Antidepressive Agents|antidepressive agents|mesh-ancestor
110046256|NCT05473741|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110046257|NCT05473741|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110046258|NCT05473741|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110046259|NCT05473741|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110046261|NCT05435053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110046262|NCT05435053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110046263|NCT05435053|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110046264|NCT05435053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110046265|NCT05433116|Pembrolizumab|pembrolizumab|mesh-list
110046266|NCT05433116|Lenvatinib|lenvatinib|mesh-list
110046267|NCT05433116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110046268|NCT05433116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110046269|NCT05433116|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110046270|NCT05433116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110046271|NCT05433116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110046272|NCT05433116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110046279|NCT05401214|Prednisone|prednisone|mesh-list
110046280|NCT05401214|Prednisolone|prednisolone|mesh-list
110046281|NCT05401214|Abiraterone Acetate|abiraterone acetate|mesh-list
110046282|NCT05401214|Niraparib|niraparib|mesh-list
110046283|NCT05401214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110046284|NCT05401214|Glucocorticoids|glucocorticoids|mesh-ancestor
110046285|NCT05401214|Hormones|hormones|mesh-ancestor
110046286|NCT05401214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110046287|NCT05401214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110046288|NCT05401214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110046289|NCT05401214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110046290|NCT05401214|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110046291|NCT05401214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110046292|NCT05401214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110046293|NCT05401214|Hormone Antagonists|hormone antagonists|mesh-ancestor
110046294|NCT05401214|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110046295|NCT05401214|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110046296|NCT05382338|Sodium thiosulfate|sodium thiosulfate|mesh-list
110046297|NCT05382338|Cyclophosphamide|cyclophosphamide|mesh-list
110046298|NCT05382338|Lomustine|lomustine|mesh-list
110046299|NCT05382338|Cisplatin|cisplatin|mesh-list
110046300|NCT05382338|Vincristine|vincristine|mesh-list
110046301|NCT05382338|Mesna|mesna|mesh-list
110046302|NCT05382338|Antidotes|antidotes|mesh-list
110046303|NCT05382338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110046304|NCT05382338|Immunologic Factors|immunologic factors|mesh-ancestor
110046305|NCT05382338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110046306|NCT05382338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110046307|NCT05382338|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110046308|NCT05382338|Alkylating Agents|alkylating agents|mesh-ancestor
110046309|NCT05382338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110046310|NCT05382338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110046311|NCT05382338|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110046312|NCT05382338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110046313|NCT05382338|Tubulin Modulators|tubulin modulators|mesh-ancestor
110046314|NCT05382338|Antimitotic Agents|antimitotic agents|mesh-ancestor
110046315|NCT05382338|Mitosis Modulators|mitosis modulators|mesh-ancestor
110046316|NCT05382338|Protective Agents|protective agents|mesh-ancestor
110046317|NCT05382338|Antioxidants|antioxidants|mesh-ancestor
110046318|NCT05382338|Antitubercular Agents|antitubercular agents|mesh-ancestor
110046319|NCT05382338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110046320|NCT05382338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110046321|NCT05382338|Chelating Agents|chelating agents|mesh-ancestor
110046322|NCT05382338|Sequestering Agents|sequestering agents|mesh-ancestor
110046323|NCT05379166|Azacitidine|azacitidine|mesh-list
110046324|NCT05379166|Venetoclax|venetoclax|mesh-list
110046325|NCT05379166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110046326|NCT05379166|Antimetabolites|antimetabolites|mesh-ancestor
110046327|NCT05379166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110046328|NCT05379166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110046329|NCT05379166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110046330|NCT05373212|Insulin Lispro|insulin lispro|mesh-list
110046331|NCT05373212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110046332|NCT05373212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110046333|NCT05373199|Insulin Lispro|insulin lispro|mesh-list
110046334|NCT05373199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110046335|NCT05373199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110046336|NCT05373186|Insulin Lispro|insulin lispro|mesh-list
110046337|NCT05373186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110046338|NCT05373186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110046340|NCT05353361|Pertuzumab|pertuzumab|mesh-list
110046345|NCT05353361|Mitosis Modulators|mitosis modulators|mesh-ancestor
110046346|NCT05353361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110046347|NCT05353361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110046349|NCT05330429|Bevacizumab|bevacizumab|mesh-list
110046350|NCT05330429|Magrolimab|magrolimab|mesh-list
110046351|NCT05330429|Fluorouracil|fluorouracil|mesh-list
110046352|NCT05330429|Irinotecan|irinotecan|mesh-list
110046353|NCT05330429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110046354|NCT05330429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110046355|NCT05330429|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110046356|NCT05330429|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110046357|NCT05330429|Growth Substances|growth substances|mesh-ancestor
110046358|NCT05330429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110046359|NCT05330429|Growth Inhibitors|growth inhibitors|mesh-ancestor
110046360|NCT05330429|Antimetabolites|antimetabolites|mesh-ancestor
110046361|NCT05330429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110046362|NCT05330429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110046363|NCT05330429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110046364|NCT05330429|Immunologic Factors|immunologic factors|mesh-ancestor
110046365|NCT05330429|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110046366|NCT05330429|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110046367|NCT05330429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110046368|NCT05330429|Antidotes|antidotes|mesh-ancestor
110046369|NCT05330429|Protective Agents|protective agents|mesh-ancestor
110046370|NCT05330429|Vitamin B Complex|vitamin b complex|mesh-ancestor
110046371|NCT05330429|Vitamins|vitamins|mesh-ancestor
110046372|NCT05330429|Micronutrients|micronutrients|mesh-ancestor
110046373|NCT05304585|Dactinomycin|dactinomycin|mesh-list
110046374|NCT05304585|Cactinomycin|cactinomycin|mesh-list
110046375|NCT05304585|Cyclophosphamide|cyclophosphamide|mesh-list
110046376|NCT05304585|Vincristine|vincristine|mesh-list
110046377|NCT05304585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110046378|NCT05304585|Immunologic Factors|immunologic factors|mesh-ancestor
110046379|NCT05304585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110046380|NCT05304585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110046381|NCT05304585|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110046382|NCT05304585|Alkylating Agents|alkylating agents|mesh-ancestor
110046383|NCT05304585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110046384|NCT05304585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110046385|NCT05304585|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110046386|NCT05304585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110046387|NCT05304585|Tubulin Modulators|tubulin modulators|mesh-ancestor
110046388|NCT05304585|Antimitotic Agents|antimitotic agents|mesh-ancestor
110046389|NCT05304585|Mitosis Modulators|mitosis modulators|mesh-ancestor
110046390|NCT05304585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110046391|NCT05304585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110046392|NCT05304585|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110046393|NCT05304585|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110046394|NCT05304585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110046395|NCT05304585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110046396|NCT05300282|Gemcitabine|gemcitabine|mesh-list
110046397|NCT05300282|Atezolizumab|atezolizumab|mesh-list
110046398|NCT05300282|Vinorelbine|vinorelbine|mesh-list
110046399|NCT05300282|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110046400|NCT05300282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110046401|NCT05300282|Antimetabolites|antimetabolites|mesh-ancestor
110046402|NCT05300282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110046403|NCT05300282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110046404|NCT05300282|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110046405|NCT05300282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110046406|NCT05300282|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110046407|NCT05300282|Tubulin Modulators|tubulin modulators|mesh-ancestor
110046408|NCT05300282|Antimitotic Agents|antimitotic agents|mesh-ancestor
110046409|NCT05300282|Mitosis Modulators|mitosis modulators|mesh-ancestor
110046410|NCT05300282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110046411|NCT05300282|Alkylating Agents|alkylating agents|mesh-ancestor
110046445|NCT05284214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110046446|NCT05284214|Immunologic Factors|immunologic factors|mesh-ancestor
110046447|NCT05284214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110046448|NCT05281471|Paclitaxel|paclitaxel|mesh-list
110046449|NCT05281471|Docetaxel|docetaxel|mesh-list
110046450|NCT05281471|Bevacizumab|bevacizumab|mesh-list
110046451|NCT05281471|Carboplatin|carboplatin|mesh-list
110046452|NCT05281471|Gemcitabine|gemcitabine|mesh-list
110046453|NCT05281471|Doxorubicin|doxorubicin|mesh-list
110046454|NCT05281471|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110046455|NCT05281471|Taxane|taxane|mesh-list
110046456|NCT05281471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110046457|NCT05281471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110046458|NCT05281471|Tubulin Modulators|tubulin modulators|mesh-ancestor
110046459|NCT05281471|Antimitotic Agents|antimitotic agents|mesh-ancestor
110046460|NCT05281471|Mitosis Modulators|mitosis modulators|mesh-ancestor
110046461|NCT05281471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110046462|NCT05281471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110046463|NCT05281471|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110046464|NCT05281471|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110046465|NCT05281471|Growth Substances|growth substances|mesh-ancestor
110046466|NCT05281471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110046467|NCT05281471|Growth Inhibitors|growth inhibitors|mesh-ancestor
110046468|NCT05281471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110046469|NCT05281471|Antimetabolites|antimetabolites|mesh-ancestor
110046470|NCT05281471|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110046471|NCT05281471|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110046472|NCT05281471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110046473|NCT05281471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110046474|NCT05275907|Amlodipine|amlodipine|mesh-list
110046475|NCT05275907|Chlorthalidone|chlorthalidone|mesh-list
110046476|NCT05275907|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110046477|NCT05275907|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110046478|NCT05275907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110046479|NCT05275907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110046480|NCT05275907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110046481|NCT05275907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110046482|NCT05275907|Vasodilator Agents|vasodilator agents|mesh-ancestor
110046483|NCT05275907|Diuretics|diuretics|mesh-ancestor
110046484|NCT05275907|Natriuretic Agents|natriuretic agents|mesh-ancestor
110046485|NCT05275907|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110046486|NCT05259722|Alitretinoin|alitretinoin|mesh-list
110046487|NCT05259722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110046488|NCT05259722|Dermatologic Agents|dermatologic agents|mesh-ancestor
110046489|NCT05223673|Trifluridine|trifluridine|mesh-list
110046490|NCT05223673|Antimetabolites|antimetabolites|mesh-ancestor
110046491|NCT05223673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110046492|NCT05223673|Antiviral Agents|antiviral agents|mesh-ancestor
110046493|NCT05223673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110046494|NCT05221580|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110046495|NCT05221580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110046496|NCT05221580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110046499|NCT05192889|Dexamethasone|dexamethasone|mesh-list
110046500|NCT05192889|Hydrocortisone|hydrocortisone|mesh-list
110046501|NCT05192889|Cyclophosphamide|cyclophosphamide|mesh-list
110046502|NCT05192889|Methotrexate|methotrexate|mesh-list
110046503|NCT05192889|Etoposide|etoposide|mesh-list
110046504|NCT05192889|Vincristine|vincristine|mesh-list
110046506|NCT05192889|Asparaginase|asparaginase|mesh-list
110046507|NCT05192889|Dasatinib|dasatinib|mesh-list
110046508|NCT05192889|Mercaptopurine|mercaptopurine|mesh-list
110046509|NCT05192889|Pegaspargase|pegaspargase|mesh-list
110046510|NCT05192889|Blinatumomab|blinatumomab|mesh-list
110046511|NCT05192889|Navitoclax|navitoclax|mesh-list
110046512|NCT05192889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110046513|NCT05192889|Immunologic Factors|immunologic factors|mesh-ancestor
110046514|NCT05192889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110046515|NCT05192889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110046516|NCT05192889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110046517|NCT05192889|Alkylating Agents|alkylating agents|mesh-ancestor
110046518|NCT05192889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110046519|NCT05192889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110046520|NCT05192889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110046521|NCT05192889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110046522|NCT05192889|Antiemetics|antiemetics|mesh-ancestor
110046523|NCT05192889|Autonomic Agents|autonomic agents|mesh-ancestor
110046524|NCT05192889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110046525|NCT05192889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110046526|NCT05192889|Glucocorticoids|glucocorticoids|mesh-ancestor
110046527|NCT05192889|Hormones|hormones|mesh-ancestor
110046528|NCT05192889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110046529|NCT05192889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110046530|NCT05192889|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110046531|NCT05192889|Abortifacient Agents|abortifacient agents|mesh-ancestor
110046532|NCT05192889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110046533|NCT05192889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110046534|NCT05192889|Antimetabolites|antimetabolites|mesh-ancestor
110046535|NCT05192889|Dermatologic Agents|dermatologic agents|mesh-ancestor
110046536|NCT05192889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110046537|NCT05192889|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110046538|NCT05192889|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110046539|NCT05192889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110046540|NCT05192889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110046541|NCT05192889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110046542|NCT05192889|Antiviral Agents|antiviral agents|mesh-ancestor
110046543|NCT05192889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110046544|NCT05192889|Antidotes|antidotes|mesh-ancestor
110046545|NCT05192889|Protective Agents|protective agents|mesh-ancestor
110046546|NCT05192889|Vitamin B Complex|vitamin b complex|mesh-ancestor
110046547|NCT05192889|Vitamins|vitamins|mesh-ancestor
110046548|NCT05192889|Micronutrients|micronutrients|mesh-ancestor
110046549|NCT05192889|Tubulin Modulators|tubulin modulators|mesh-ancestor
110046550|NCT05192889|Antimitotic Agents|antimitotic agents|mesh-ancestor
110046551|NCT05192889|Mitosis Modulators|mitosis modulators|mesh-ancestor
110046552|NCT05192889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110046553|NCT05176639|Nicotine|nicotine|mesh-list
110046554|NCT05176639|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110046555|NCT05176639|Autonomic Agents|autonomic agents|mesh-ancestor
110046556|NCT05176639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110046568|NCT05168163|Atezolizumab|atezolizumab|mesh-list
110046569|NCT05168163|Lenvatinib|lenvatinib|mesh-list
110046570|NCT05168163|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110046571|NCT05168163|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110046572|NCT05168163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110046573|NCT05168163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110046574|NCT05168163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110046575|NCT05168163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110046576|NCT05168163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110046577|NCT05168163|Immunologic Factors|immunologic factors|mesh-ancestor
110046578|NCT05168163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110046579|NCT05150704|Methylprednisolone|methylprednisolone|mesh-list
110046580|NCT05150704|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110046581|NCT05150704|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110046582|NCT05150704|Prednisolone|prednisolone|mesh-list
110046583|NCT05150704|Prednisolone acetate|prednisolone acetate|mesh-list
110046584|NCT05150704|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110046585|NCT05150704|Prednisolone phosphate|prednisolone phosphate|mesh-list
110046586|NCT05150704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110046587|NCT05150704|Antiemetics|antiemetics|mesh-ancestor
110046588|NCT05150704|Autonomic Agents|autonomic agents|mesh-ancestor
110046589|NCT05150704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110046590|NCT05150704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110046591|NCT05150704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110046592|NCT05150704|Glucocorticoids|glucocorticoids|mesh-ancestor
110046594|NCT05150704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110046595|NCT05150704|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110046596|NCT05150704|Protective Agents|protective agents|mesh-ancestor
110046597|NCT05150704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110046598|NCT05150704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110046599|NCT05141149|Gemcitabine|gemcitabine|mesh-list
110046600|NCT05141149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110046601|NCT05141149|Antimetabolites|antimetabolites|mesh-ancestor
110046602|NCT05141149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110046603|NCT05141149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110046604|NCT05122182|Propagermanium|propagermanium|mesh-list
110046605|NCT05122182|Candesartan|candesartan|mesh-list
110046606|NCT05122182|Candesartan cilexetil|candesartan cilexetil|mesh-list
110046607|NCT05122182|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110046608|NCT05122182|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110046609|NCT05122182|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110046610|NCT05122182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110046611|NCT05122182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110046612|NCT05122182|Interferon Inducers|interferon inducers|mesh-ancestor
110046613|NCT05122182|Immunologic Factors|immunologic factors|mesh-ancestor
110046614|NCT05122182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110046615|NCT05119907|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
110046616|NCT05119907|Immunoconjugates|immunoconjugates|mesh-ancestor
110046617|NCT05119907|Immunologic Factors|immunologic factors|mesh-ancestor
110046618|NCT05119907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110046619|NCT05113784|Meplazumab|meplazumab|mesh-list
110046621|NCT05113784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110046622|NCT05113186|Lenvatinib|lenvatinib|mesh-list
110046623|NCT05113186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110046624|NCT05113186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110046625|NCT05113186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110046626|NCT05113186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110046627|NCT05109234|Brivaracetam|brivaracetam|mesh-list
110046628|NCT05109234|Anticonvulsants|anticonvulsants|mesh-ancestor
110046629|NCT05086627|Capecitabine|capecitabine|mesh-list
110046630|NCT05086627|Oxaliplatin|oxaliplatin|mesh-list
110046631|NCT05086627|Tislelizumab|tislelizumab|mesh-list
110046632|NCT05086627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110046633|NCT05086627|Antimetabolites|antimetabolites|mesh-ancestor
110046634|NCT05086627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110046635|NCT05086627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110046636|NCT05086627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110046637|NCT05069597|Pancrelipase|pancrelipase|mesh-list
110046638|NCT05069597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110046639|NCT05048797|Carboplatin|carboplatin|mesh-list
110046640|NCT05048797|Pembrolizumab|pembrolizumab|mesh-list
110046641|NCT05048797|Trastuzumab|trastuzumab|mesh-list
110046642|NCT05048797|Pemetrexed|pemetrexed|mesh-list
110046643|NCT05048797|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
110046644|NCT05048797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110046645|NCT05048797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110046646|NCT05048797|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110046647|NCT05048797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110046648|NCT05048797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110046649|NCT05048797|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110046650|NCT05048797|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110046651|NCT05048797|Immunoconjugates|immunoconjugates|mesh-ancestor
110046652|NCT05048797|Immunologic Factors|immunologic factors|mesh-ancestor
110046653|NCT05048797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110046654|NCT05047172|Aspirin|aspirin|mesh-list
110046655|NCT05047172|Rivaroxaban|rivaroxaban|mesh-list
110046656|NCT05047172|Clopidogrel|clopidogrel|mesh-list
110046657|NCT05047172|Ticagrelor|ticagrelor|mesh-list
110046658|NCT05047172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110046659|NCT05047172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110046660|NCT05047172|Analgesics|analgesics|mesh-ancestor
110046661|NCT05047172|Sensory System Agents|sensory system agents|mesh-ancestor
110046662|NCT05047172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110046663|NCT05047172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110046664|NCT05047172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110046665|NCT05047172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110046666|NCT05047172|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110046667|NCT05047172|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110046668|NCT05047172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110046669|NCT05047172|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110046670|NCT05047172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110046671|NCT05047172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110046672|NCT05047172|Antipyretics|antipyretics|mesh-ancestor
110046673|NCT05047172|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110046674|NCT05047172|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110046675|NCT05047172|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110046676|NCT05047172|Purinergic Agents|purinergic agents|mesh-ancestor
110046677|NCT05047172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110046678|NCT05047172|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110046679|NCT05047172|Antithrombins|antithrombins|mesh-ancestor
110046680|NCT05047172|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110046681|NCT05047172|Protease Inhibitors|protease inhibitors|mesh-ancestor
110046682|NCT05047172|Anticoagulants|anticoagulants|mesh-ancestor
110046683|NCT05041309|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
110046684|NCT05041309|Brexucabtagene autoleucel|brexucabtagene autoleucel|mesh-list
110046685|NCT05041309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110046686|NCT05041309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110046687|NCT05039619|Acetaminophen|acetaminophen|mesh-list
110046688|NCT05039619|Diphenhydramine|diphenhydramine|mesh-list
110046689|NCT05039619|Promethazine|promethazine|mesh-list
110046690|NCT05039619|Mycophenolic Acid|mycophenolic acid|mesh-list
110046691|NCT05039619|Prednisone|prednisone|mesh-list
110046692|NCT05039619|Methylprednisolone|methylprednisolone|mesh-list
110046693|NCT05039619|Obinutuzumab|obinutuzumab|mesh-list
110046694|NCT05039619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110046695|NCT05039619|Glucocorticoids|glucocorticoids|mesh-ancestor
110046696|NCT05039619|Hormones|hormones|mesh-ancestor
110046697|NCT05039619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110046698|NCT05039619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110046699|NCT05039619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110046700|NCT05039619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110046701|NCT05039619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110046702|NCT05039619|Analgesics|analgesics|mesh-ancestor
110046703|NCT05039619|Sensory System Agents|sensory system agents|mesh-ancestor
110046704|NCT05039619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110046705|NCT05039619|Antipyretics|antipyretics|mesh-ancestor
110046706|NCT05039619|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110046707|NCT05039619|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110046709|NCT05039619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110046710|NCT05039619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110046711|NCT05039619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110046712|NCT05039619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110046715|NCT05039619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110046716|NCT05039619|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110046717|NCT05039619|Protective Agents|protective agents|mesh-ancestor
110046718|NCT05039619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110046719|NCT05039619|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110046720|NCT05039619|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110046721|NCT05039619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110046722|NCT05039619|Anesthetics, Local|anesthetics, local|mesh-ancestor
110046724|NCT05039619|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110046725|NCT05039619|Histamine Antagonists|histamine antagonists|mesh-ancestor
110046726|NCT05039619|Histamine Agents|histamine agents|mesh-ancestor
110046727|NCT05039619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110046728|NCT05039619|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110046729|NCT05039619|Antipruritics|antipruritics|mesh-ancestor
110046730|NCT05039619|Dermatologic Agents|dermatologic agents|mesh-ancestor
110046732|NCT05011188|Immunoglobulins|immunoglobulins|mesh-list
110046733|NCT05011188|Immunoconjugates|immunoconjugates|mesh-list
110046734|NCT05011188|Immunologic Factors|immunologic factors|mesh-ancestor
110046735|NCT05011188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110046736|NCT04994132|Dactinomycin|dactinomycin|mesh-list
110046737|NCT04994132|Cactinomycin|cactinomycin|mesh-list
110046738|NCT04994132|Cyclophosphamide|cyclophosphamide|mesh-list
110046739|NCT04994132|Vincristine|vincristine|mesh-list
110046740|NCT04994132|Vinorelbine|vinorelbine|mesh-list
110046741|NCT04994132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110046742|NCT04994132|Immunologic Factors|immunologic factors|mesh-ancestor
110046743|NCT04994132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110046744|NCT04994132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110046745|NCT04994132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110046746|NCT04994132|Alkylating Agents|alkylating agents|mesh-ancestor
110046747|NCT04994132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110046748|NCT04994132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110046749|NCT04994132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110046750|NCT04994132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110046751|NCT04994132|Tubulin Modulators|tubulin modulators|mesh-ancestor
110046752|NCT04994132|Antimitotic Agents|antimitotic agents|mesh-ancestor
110046753|NCT04994132|Mitosis Modulators|mitosis modulators|mesh-ancestor
110046754|NCT04994132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110046755|NCT04994132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110046756|NCT04994132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110046757|NCT04994132|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110046758|NCT04994132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110046759|NCT04994132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110046760|NCT04975997|Dexamethasone|dexamethasone|mesh-list
110046762|NCT04975997|Daratumumab|daratumumab|mesh-list
110046763|NCT04975997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110046764|NCT04975997|Antiemetics|antiemetics|mesh-ancestor
110046765|NCT04975997|Autonomic Agents|autonomic agents|mesh-ancestor
110046766|NCT04975997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110046767|NCT04975997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110046768|NCT04975997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110046769|NCT04975997|Glucocorticoids|glucocorticoids|mesh-ancestor
110046770|NCT04975997|Hormones|hormones|mesh-ancestor
110046771|NCT04975997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110046772|NCT04975997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110046781|NCT04975308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110046782|NCT04975308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110046783|NCT04975308|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110046784|NCT04975308|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110046786|NCT04975308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110046800|NCT04964934|Hormones|hormones|mesh-list
110046801|NCT04964934|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
110046802|NCT04964934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110046803|NCT04964934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110046805|NCT04964934|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110046806|NCT04964934|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110046807|NCT04964934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110046808|NCT04964934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110046809|NCT04964934|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110046810|NCT04964934|Hormone Antagonists|hormone antagonists|mesh-ancestor
110046811|NCT04964934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110046812|NCT04964934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110046813|NCT04963296|Acetaminophen|acetaminophen|mesh-list
110046814|NCT04963296|Diphenhydramine|diphenhydramine|mesh-list
110046815|NCT04963296|Promethazine|promethazine|mesh-list
110046816|NCT04963296|Methylprednisolone|methylprednisolone|mesh-list
110046817|NCT04963296|Obinutuzumab|obinutuzumab|mesh-list
110046818|NCT04963296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110046819|NCT04963296|Analgesics|analgesics|mesh-ancestor
110046820|NCT04963296|Sensory System Agents|sensory system agents|mesh-ancestor
110046821|NCT04963296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110046822|NCT04963296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110046823|NCT04963296|Antipyretics|antipyretics|mesh-ancestor
110046824|NCT04963296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110046825|NCT04963296|Antiemetics|antiemetics|mesh-ancestor
110046826|NCT04963296|Autonomic Agents|autonomic agents|mesh-ancestor
110046827|NCT04963296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110046828|NCT04963296|Glucocorticoids|glucocorticoids|mesh-ancestor
110046829|NCT04963296|Hormones|hormones|mesh-ancestor
110046830|NCT04963296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110046831|NCT04963296|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110046832|NCT04963296|Protective Agents|protective agents|mesh-ancestor
110046833|NCT04963296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110046834|NCT04963296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110046835|NCT04963296|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110046836|NCT04963296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110046837|NCT04963296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110046838|NCT04963296|Anesthetics, Local|anesthetics, local|mesh-ancestor
110046839|NCT04963296|Anesthetics|anesthetics|mesh-ancestor
110046840|NCT04963296|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110046843|NCT04963296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110046844|NCT04963296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110046845|NCT04963296|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110046846|NCT04963296|Antipruritics|antipruritics|mesh-ancestor
110046847|NCT04963296|Dermatologic Agents|dermatologic agents|mesh-ancestor
110046848|NCT04917861|Vaccines|vaccines|mesh-list
110046849|NCT04917861|Immunologic Factors|immunologic factors|mesh-ancestor
110046850|NCT04917861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110046851|NCT04910568|Dexamethasone|dexamethasone|mesh-list
110046852|NCT04910568|Daratumumab|daratumumab|mesh-list
110046853|NCT04910568|Pomalidomide|pomalidomide|mesh-list
110046854|NCT04910568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110046855|NCT04910568|Antiemetics|antiemetics|mesh-ancestor
110046856|NCT04910568|Autonomic Agents|autonomic agents|mesh-ancestor
110046857|NCT04910568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110046858|NCT04910568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110046859|NCT04910568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110046860|NCT04910568|Glucocorticoids|glucocorticoids|mesh-ancestor
110046861|NCT04910568|Hormones|hormones|mesh-ancestor
110046862|NCT04910568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110046864|NCT04910568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110046865|NCT04910568|Immunologic Factors|immunologic factors|mesh-ancestor
110046866|NCT04910568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110046867|NCT04910568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110046868|NCT04910568|Growth Substances|growth substances|mesh-ancestor
110046869|NCT04910568|Growth Inhibitors|growth inhibitors|mesh-ancestor
110046870|NCT04884035|Prednisone|prednisone|mesh-list
110046871|NCT04884035|Prednisolone|prednisolone|mesh-list
110046872|NCT04884035|Cyclophosphamide|cyclophosphamide|mesh-list
110046873|NCT04884035|Rituximab|rituximab|mesh-list
110046874|NCT04884035|Doxorubicin|doxorubicin|mesh-list
110046875|NCT04884035|Vincristine|vincristine|mesh-list
110046876|NCT04884035|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
110046877|NCT04884035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110046878|NCT04884035|Immunologic Factors|immunologic factors|mesh-ancestor
110046879|NCT04884035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110046880|NCT04884035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110046881|NCT04884035|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110046882|NCT04884035|Alkylating Agents|alkylating agents|mesh-ancestor
110046883|NCT04884035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110046884|NCT04884035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110046885|NCT04884035|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110046886|NCT04884035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110046887|NCT04884035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110046888|NCT04884035|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110046889|NCT04884035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110046890|NCT04884035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110046891|NCT04884035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110046892|NCT04884035|Glucocorticoids|glucocorticoids|mesh-ancestor
110046893|NCT04884035|Hormones|hormones|mesh-ancestor
110046894|NCT04884035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110046895|NCT04884035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110046896|NCT04884035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110046897|NCT04884035|Tubulin Modulators|tubulin modulators|mesh-ancestor
110046898|NCT04884035|Antimitotic Agents|antimitotic agents|mesh-ancestor
110046899|NCT04884035|Mitosis Modulators|mitosis modulators|mesh-ancestor
110046900|NCT04884035|Immunoconjugates|immunoconjugates|mesh-ancestor
110046901|NCT04826900|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
110046902|NCT04826900|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110046903|NCT04826900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110046904|NCT04826900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110046905|NCT04826900|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110046906|NCT04826900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110046913|NCT04819906|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110046914|NCT04819906|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110046915|NCT04819906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110046916|NCT04819906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110046917|NCT04819906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110046918|NCT04809766|Cyclophosphamide|cyclophosphamide|mesh-list
110046919|NCT04809766|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110046920|NCT04809766|Fludarabine|fludarabine|mesh-list
110046921|NCT04809766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110046922|NCT04809766|Immunologic Factors|immunologic factors|mesh-ancestor
110046923|NCT04809766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110046924|NCT04809766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110046925|NCT04809766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110046926|NCT04809766|Alkylating Agents|alkylating agents|mesh-ancestor
110046927|NCT04809766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110046928|NCT04809766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110046929|NCT04809766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110046930|NCT04785287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110046931|NCT04785287|Nivolumab|nivolumab|mesh-list
110046932|NCT04785287|Antibodies|antibodies|mesh-list
110046933|NCT04785287|Immunoglobulins|immunoglobulins|mesh-list
110046934|NCT04785287|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110046935|NCT04785287|Immunologic Factors|immunologic factors|mesh-ancestor
110046936|NCT04785287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110046937|NCT04785287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110046938|NCT04785287|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110046939|NCT04785287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110046940|NCT04780269|Dinoprostone|dinoprostone|mesh-list
110046941|NCT04780269|Oxytocics|oxytocics|mesh-ancestor
110046942|NCT04780269|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110046943|NCT04780269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110046944|NCT04778410|Cytarabine|cytarabine|mesh-list
110046945|NCT04778410|Etoposide|etoposide|mesh-list
110046946|NCT04778410|Mitoxantrone|mitoxantrone|mesh-list
110046947|NCT04778410|Azacitidine|azacitidine|mesh-list
110046948|NCT04778410|Venetoclax|venetoclax|mesh-list
110046949|NCT04778410|Cc-486|cc-486|mesh-list
110046950|NCT04778410|Magrolimab|magrolimab|mesh-list
110046951|NCT04778410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110046952|NCT04778410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110046953|NCT04778410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110046954|NCT04778410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110046955|NCT04778410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110046956|NCT04778410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110047061|NCT04626791|Rituximab|rituximab|mesh-list
110046958|NCT04778410|Antimetabolites|antimetabolites|mesh-ancestor
110046959|NCT04778410|Antiviral Agents|antiviral agents|mesh-ancestor
110046960|NCT04778410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110046961|NCT04778410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110046962|NCT04778410|Immunologic Factors|immunologic factors|mesh-ancestor
110046963|NCT04778410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110046964|NCT04778410|Analgesics|analgesics|mesh-ancestor
110046965|NCT04778410|Sensory System Agents|sensory system agents|mesh-ancestor
110046966|NCT04778410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110046967|NCT04778410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110046995|NCT04711252|Anastrozole|anastrozole|mesh-list
110046996|NCT04711252|Hormones|hormones|mesh-list
110046997|NCT04711252|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
110046998|NCT04711252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110046999|NCT04711252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110047000|NCT04711252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110047001|NCT04711252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110047002|NCT04711252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110047003|NCT04711252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110047004|NCT04711252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110047005|NCT04711252|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110047006|NCT04711252|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110047007|NCT04711252|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110047008|NCT04711252|Hormone Antagonists|hormone antagonists|mesh-ancestor
110047009|NCT04702880|Carboplatin|carboplatin|mesh-list
110047010|NCT04702880|Nivolumab|nivolumab|mesh-list
110047011|NCT04702880|Etoposide|etoposide|mesh-list
110047012|NCT04702880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110047013|NCT04702880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110047014|NCT04702880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110047015|NCT04702880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110047016|NCT04702880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110047017|NCT04702880|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110047018|NCT04702880|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110047019|NCT04702880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110047020|NCT04696055|Pembrolizumab|pembrolizumab|mesh-list
110047021|NCT04696055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110047022|NCT04696055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110047023|NCT04696055|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110047024|NCT04696055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110047025|NCT04684368|Carboplatin|carboplatin|mesh-list
110047026|NCT04684368|Etoposide|etoposide|mesh-list
110047027|NCT04684368|Etoposide phosphate|etoposide phosphate|mesh-list
110047028|NCT04684368|Ifosfamide|ifosfamide|mesh-list
110047029|NCT04684368|Isophosphamide mustard|isophosphamide mustard|mesh-list
110047030|NCT04684368|Thiotepa|thiotepa|mesh-list
110047031|NCT04684368|Podophyllotoxin|podophyllotoxin|mesh-list
110047032|NCT04684368|Lenograstim|lenograstim|mesh-list
110047034|NCT04684368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110047035|NCT04684368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110047036|NCT04684368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110047037|NCT04684368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110047039|NCT04684368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110047040|NCT04684368|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110047041|NCT04684368|Immunologic Factors|immunologic factors|mesh-ancestor
110047042|NCT04684368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110047043|NCT04684368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110047044|NCT04684368|Alkylating Agents|alkylating agents|mesh-ancestor
110047045|NCT04684368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110047046|NCT04684368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110047047|NCT04684368|Protective Agents|protective agents|mesh-ancestor
110047048|NCT04684368|Keratolytic Agents|keratolytic agents|mesh-ancestor
110047049|NCT04684368|Dermatologic Agents|dermatologic agents|mesh-ancestor
110047050|NCT04684368|Tubulin Modulators|tubulin modulators|mesh-ancestor
110047051|NCT04684368|Antimitotic Agents|antimitotic agents|mesh-ancestor
110047052|NCT04684368|Mitosis Modulators|mitosis modulators|mesh-ancestor
110047053|NCT04650854|Rozanolixizumab|rozanolixizumab|mesh-list
110047054|NCT04650854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110047055|NCT04650854|Immunologic Factors|immunologic factors|mesh-ancestor
110047056|NCT04650854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110047057|NCT04626791|Cytarabine|cytarabine|mesh-list
110047058|NCT04626791|Prednisone|prednisone|mesh-list
110047059|NCT04626791|Cortisone|cortisone|mesh-list
110047060|NCT04626791|Cyclophosphamide|cyclophosphamide|mesh-list
110047062|NCT04626791|Doxorubicin|doxorubicin|mesh-list
110047063|NCT04626791|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110047064|NCT04626791|Bortezomib|bortezomib|mesh-list
110047065|NCT04626791|Acalabrutinib|acalabrutinib|mesh-list
110047066|NCT04626791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110047067|NCT04626791|Antibodies|antibodies|mesh-list
110047068|NCT04626791|Immunoglobulins|immunoglobulins|mesh-list
110047069|NCT04626791|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110047070|NCT04626791|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
110047071|NCT04626791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110047072|NCT04626791|Immunologic Factors|immunologic factors|mesh-ancestor
110047073|NCT04626791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110047074|NCT04626791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110047075|NCT04626791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110047076|NCT04626791|Alkylating Agents|alkylating agents|mesh-ancestor
110047077|NCT04626791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110047078|NCT04626791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110047079|NCT04626791|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110047080|NCT04626791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110047081|NCT04626791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110047082|NCT04626791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110047083|NCT04626791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110047084|NCT04626791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110047085|NCT04626791|Glucocorticoids|glucocorticoids|mesh-ancestor
110047086|NCT04626791|Hormones|hormones|mesh-ancestor
110047087|NCT04626791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110047088|NCT04626791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110047089|NCT04626791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110047090|NCT04626791|Antimetabolites|antimetabolites|mesh-ancestor
110047091|NCT04626791|Antiviral Agents|antiviral agents|mesh-ancestor
110047092|NCT04626791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110047093|NCT04626791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110047094|NCT04617522|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
110047095|NCT04617522|Immunoconjugates|immunoconjugates|mesh-ancestor
110047096|NCT04617522|Immunologic Factors|immunologic factors|mesh-ancestor
110047097|NCT04617522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110047098|NCT04595825|Antibodies|antibodies|mesh-list
110047099|NCT04595825|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110047100|NCT04595825|Immunologic Factors|immunologic factors|mesh-ancestor
110047101|NCT04595825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110047102|NCT04594772|Paclitaxel|paclitaxel|mesh-list
110047103|NCT04594772|Gemcitabine|gemcitabine|mesh-list
110047104|NCT04594772|Fluorouracil|fluorouracil|mesh-list
110047105|NCT04594772|Oxaliplatin|oxaliplatin|mesh-list
110047106|NCT04594772|Irinotecan|irinotecan|mesh-list
110047107|NCT04594772|Folfirinox|folfirinox|mesh-list
110047108|NCT04594772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110047109|NCT04594772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110047110|NCT04594772|Tubulin Modulators|tubulin modulators|mesh-ancestor
110047111|NCT04594772|Antimitotic Agents|antimitotic agents|mesh-ancestor
110047112|NCT04594772|Mitosis Modulators|mitosis modulators|mesh-ancestor
110047113|NCT04594772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110047114|NCT04594772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110047115|NCT04594772|Antimetabolites|antimetabolites|mesh-ancestor
110047116|NCT04594772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110047117|NCT04594772|Immunologic Factors|immunologic factors|mesh-ancestor
110047118|NCT04594772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110047119|NCT04594772|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110047120|NCT04594772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110047121|NCT04594772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110047122|NCT04561206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110047123|NCT04561206|Nivolumab|nivolumab|mesh-list
110047124|NCT04561206|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110047125|NCT04561206|Antibodies|antibodies|mesh-list
110047126|NCT04561206|Immunoglobulins|immunoglobulins|mesh-list
110047127|NCT04561206|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110047128|NCT04561206|Immunoconjugates|immunoconjugates|mesh-list
110047129|NCT04561206|Immunologic Factors|immunologic factors|mesh-ancestor
110047130|NCT04561206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110047131|NCT04561206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110047132|NCT04561206|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110047133|NCT04561206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110047135|NCT04539366|Cyclophosphamide|cyclophosphamide|mesh-list
110047136|NCT04539366|Fludarabine|fludarabine|mesh-list
110047137|NCT04539366|Fludarabine phosphate|fludarabine phosphate|mesh-list
110047138|NCT04539366|Immunologic Factors|immunologic factors|mesh-ancestor
110047140|NCT04539366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110047141|NCT04539366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110047142|NCT04539366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110047143|NCT04539366|Alkylating Agents|alkylating agents|mesh-ancestor
110047144|NCT04539366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110047145|NCT04539366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110047146|NCT04539366|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110047147|NCT04539366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110047148|NCT04539366|Antimetabolites|antimetabolites|mesh-ancestor
110047149|NCT04536363|Alprostadil|alprostadil|mesh-list
110047150|NCT04536363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110047151|NCT04536363|Vasodilator Agents|vasodilator agents|mesh-ancestor
110047152|NCT04536363|Urological Agents|urological agents|mesh-ancestor
110047154|NCT04501614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110047155|NCT04501614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110047156|NCT04501614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110047157|NCT04501614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110047158|NCT04481919|Diuretics|diuretics|mesh-list
110047159|NCT04481919|Natriuretic Agents|natriuretic agents|mesh-ancestor
110047160|NCT04481919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110047161|NCT04466475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110047162|NCT04466475|Melphalan|melphalan|mesh-list
110047163|NCT04466475|Mechlorethamine|mechlorethamine|mesh-list
110047164|NCT04466475|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
110047165|NCT04466475|Daratumumab|daratumumab|mesh-list
110047166|NCT04466475|Antibodies|antibodies|mesh-list
110047167|NCT04466475|Immunoglobulins|immunoglobulins|mesh-list
110047168|NCT04466475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110047169|NCT04466475|Immunologic Factors|immunologic factors|mesh-ancestor
110047170|NCT04466475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110047171|NCT04466475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110047172|NCT04466475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110047173|NCT04466475|Alkylating Agents|alkylating agents|mesh-ancestor
110047174|NCT04466475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110047175|NCT04466475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110047176|NCT04466475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110047177|NCT04458831|Dexamethasone|dexamethasone|mesh-list
110047178|NCT04458831|Pomalidomide|pomalidomide|mesh-list
110047179|NCT04458831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110047180|NCT04458831|Antiemetics|antiemetics|mesh-ancestor
110047181|NCT04458831|Autonomic Agents|autonomic agents|mesh-ancestor
110047182|NCT04458831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110047183|NCT04458831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110047184|NCT04458831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110047186|NCT04458831|Hormones|hormones|mesh-ancestor
110047187|NCT04458831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110047188|NCT04458831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110047189|NCT04458831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110047190|NCT04458831|Immunologic Factors|immunologic factors|mesh-ancestor
110047191|NCT04458831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110047192|NCT04458831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110047193|NCT04458831|Growth Substances|growth substances|mesh-ancestor
110047194|NCT04458831|Growth Inhibitors|growth inhibitors|mesh-ancestor
110047195|NCT04458610|Rituximab|rituximab|mesh-list
110047196|NCT04458610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110047197|NCT04458610|Zanubrutinib|zanubrutinib|mesh-list
110047198|NCT04458610|Antibodies|antibodies|mesh-list
110047200|NCT04458610|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110047201|NCT04458610|Immunologic Factors|immunologic factors|mesh-ancestor
110047202|NCT04458610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110047203|NCT04458610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110047204|NCT04458610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110047205|NCT04458610|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110047206|NCT04458610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110047207|NCT04458610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110047208|NCT04449874|Bevacizumab|bevacizumab|mesh-list
110047209|NCT04449874|Cetuximab|cetuximab|mesh-list
110047210|NCT04449874|Atezolizumab|atezolizumab|mesh-list
110047211|NCT04449874|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110047212|NCT04449874|Inavolisib|inavolisib|mesh-list
110047213|NCT04449874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110047214|NCT04449874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110047215|NCT04449874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110047218|NCT04449874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110047219|NCT04449874|Growth Inhibitors|growth inhibitors|mesh-ancestor
110047220|NCT04449874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110047221|NCT04449874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110047222|NCT04449874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110047223|NCT04449874|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110047224|NCT04449874|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
110047225|NCT04427306|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
110047226|NCT04427306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110047227|NCT04427306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110047228|NCT04421222|Abiraterone Acetate|abiraterone acetate|mesh-list
110047229|NCT04421222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110047230|NCT04421222|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110047231|NCT04421222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110047233|NCT04421222|Hormone Antagonists|hormone antagonists|mesh-ancestor
110047234|NCT04421222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110047235|NCT04421222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110047236|NCT04421222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110047237|NCT04421079|Resveratrol|resveratrol|mesh-list
110047238|NCT04421079|Antioxidants|antioxidants|mesh-ancestor
110047239|NCT04421079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110047240|NCT04421079|Protective Agents|protective agents|mesh-ancestor
110047241|NCT04421079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110047242|NCT04421079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110047243|NCT04421079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110047244|NCT04364620|Docetaxel|docetaxel|mesh-list
110047245|NCT04364620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110047246|NCT04364620|Tubulin Modulators|tubulin modulators|mesh-ancestor
110047247|NCT04364620|Antimitotic Agents|antimitotic agents|mesh-ancestor
110047248|NCT04364620|Mitosis Modulators|mitosis modulators|mesh-ancestor
110047249|NCT04364620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110047250|NCT04328714|Interferons|interferons|mesh-list
110047251|NCT04328714|Interferon-gamma|interferon-gamma|mesh-list
110047252|NCT04328714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110047253|NCT04328714|Antiviral Agents|antiviral agents|mesh-ancestor
110047254|NCT04328714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110047255|NCT04322318|Cyclophosphamide|cyclophosphamide|mesh-list
110047256|NCT04322318|Ifosfamide|ifosfamide|mesh-list
110047257|NCT04322318|Isophosphamide mustard|isophosphamide mustard|mesh-list
110047258|NCT04322318|Carboplatin|carboplatin|mesh-list
110047259|NCT04322318|Doxorubicin|doxorubicin|mesh-list
110047260|NCT04322318|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110047261|NCT04322318|Irinotecan|irinotecan|mesh-list
110047262|NCT04322318|Etoposide|etoposide|mesh-list
110047263|NCT04322318|Vincristine|vincristine|mesh-list
110047264|NCT04322318|Etoposide phosphate|etoposide phosphate|mesh-list
110047265|NCT04322318|Daunorubicin|daunorubicin|mesh-list
110047266|NCT04322318|Topotecan|topotecan|mesh-list
110047267|NCT04322318|Podophyllotoxin|podophyllotoxin|mesh-list
110047268|NCT04322318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110047269|NCT04322318|Immunologic Factors|immunologic factors|mesh-ancestor
110047270|NCT04322318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110047271|NCT04322318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110047272|NCT04322318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110047273|NCT04322318|Alkylating Agents|alkylating agents|mesh-ancestor
110047274|NCT04322318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110047275|NCT04322318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110047276|NCT04322318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110047277|NCT04322318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110047278|NCT04322318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110047279|NCT04322318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110047280|NCT04322318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110047281|NCT04322318|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110047282|NCT04322318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110047283|NCT04322318|Tubulin Modulators|tubulin modulators|mesh-ancestor
110047284|NCT04322318|Antimitotic Agents|antimitotic agents|mesh-ancestor
110047285|NCT04322318|Mitosis Modulators|mitosis modulators|mesh-ancestor
110047286|NCT04322318|Keratolytic Agents|keratolytic agents|mesh-ancestor
110047287|NCT04322318|Dermatologic Agents|dermatologic agents|mesh-ancestor
110047288|NCT04294771|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110047289|NCT04294771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110047291|NCT04294771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110047294|NCT04294264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110047295|NCT04294264|Antimetabolites|antimetabolites|mesh-ancestor
110047296|NCT04294264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110047297|NCT04294264|Antiviral Agents|antiviral agents|mesh-ancestor
110047299|NCT04294225|Letrozole|letrozole|mesh-list
110047300|NCT04294225|Anastrozole|anastrozole|mesh-list
110047301|NCT04294225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110047302|NCT04294225|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110047303|NCT04294225|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110047304|NCT04294225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110047305|NCT04294225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110047306|NCT04294225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110047307|NCT04294225|Hormone Antagonists|hormone antagonists|mesh-ancestor
110047308|NCT04294225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110047309|NCT04294225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110047310|NCT04294225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110047311|NCT04255433|Dulaglutide|dulaglutide|mesh-list
110047312|NCT04255433|Tirzepatide|tirzepatide|mesh-list
110047313|NCT04255433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110047314|NCT04255433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110047315|NCT04255433|Incretins|incretins|mesh-ancestor
110047316|NCT04255433|Hormones|hormones|mesh-ancestor
110047317|NCT04255433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110047318|NCT04237649|Spartalizumab|spartalizumab|mesh-list
110047319|NCT04237649|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110047320|NCT04237649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110047321|NCT04237649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110047322|NCT04237649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110047323|NCT04225988|Tacrolimus|tacrolimus|mesh-list
110047324|NCT04225988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110047325|NCT04225988|Immunologic Factors|immunologic factors|mesh-ancestor
110047326|NCT04225988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110047327|NCT04225988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110047328|NCT04225988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110047329|NCT04225988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110047330|NCT04225039|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110047331|NCT04225039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110047332|NCT04225039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110047333|NCT04225039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110047334|NCT04199728|Liraglutide|liraglutide|mesh-list
110047335|NCT04199728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110047336|NCT04199728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110047337|NCT04199728|Incretins|incretins|mesh-ancestor
110047338|NCT04199728|Hormones|hormones|mesh-ancestor
110047339|NCT04199728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110047340|NCT04191499|Fulvestrant|fulvestrant|mesh-list
110047341|NCT04191499|Palbociclib|palbociclib|mesh-list
110047342|NCT04191499|Inavolisib|inavolisib|mesh-list
110047343|NCT04191499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110047368|NCT04100135|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110047369|NCT04100135|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110047370|NCT04100135|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110047371|NCT04100135|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110047372|NCT04100135|Purinergic Agents|purinergic agents|mesh-ancestor
110047373|NCT04100135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110047374|NCT04100135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110047375|NCT04100135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110047404|NCT04023253|Solifenacin Succinate|solifenacin succinate|mesh-list
110047405|NCT04023253|Mirabegron|mirabegron|mesh-list
110047406|NCT04023253|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110047407|NCT04023253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110047408|NCT04023253|Cholinergic Agents|cholinergic agents|mesh-ancestor
110047409|NCT04023253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110047410|NCT04023253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110047411|NCT04023253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110047412|NCT04023253|Urological Agents|urological agents|mesh-ancestor
110047413|NCT04023253|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110047414|NCT04023253|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110047417|NCT04008797|Lenvatinib|lenvatinib|mesh-list
110047418|NCT04008797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110047419|NCT04008797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110047420|NCT04008797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110047421|NCT04008797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110047422|NCT04007029|Cyclophosphamide|cyclophosphamide|mesh-list
110047423|NCT04007029|Fludarabine|fludarabine|mesh-list
110047425|NCT04007029|Immunoglobulins|immunoglobulins|mesh-list
110047426|NCT04007029|Immunoglobulin G|immunoglobulin g|mesh-list
110047427|NCT04007029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110047428|NCT04007029|Immunologic Factors|immunologic factors|mesh-ancestor
110047429|NCT04007029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110047430|NCT04007029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110047431|NCT04007029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110047432|NCT04007029|Alkylating Agents|alkylating agents|mesh-ancestor
110047433|NCT04007029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110047434|NCT04007029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110047435|NCT04007029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110047436|NCT04007029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110047440|NCT03978624|Pembrolizumab|pembrolizumab|mesh-list
110047441|NCT03978624|Entinostat|entinostat|mesh-list
110047442|NCT03978624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110047443|NCT03978624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110047444|NCT03978624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110047445|NCT03978624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110047446|NCT03978624|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110047447|NCT03978624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110047448|NCT03887650|Dexamethasone|dexamethasone|mesh-list
110047449|NCT03887650|Epinephrine|epinephrine|mesh-list
110047450|NCT03887650|Bupivacaine|bupivacaine|mesh-list
110047451|NCT03887650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110047452|NCT03887650|Antiemetics|antiemetics|mesh-ancestor
110047453|NCT03887650|Autonomic Agents|autonomic agents|mesh-ancestor
110047454|NCT03887650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110047455|NCT03887650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110047456|NCT03887650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110047457|NCT03887650|Glucocorticoids|glucocorticoids|mesh-ancestor
110047458|NCT03887650|Hormones|hormones|mesh-ancestor
110047459|NCT03887650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110047460|NCT03887650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110047461|NCT03887650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110047462|NCT03887650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110047463|NCT03887650|Anesthetics, Local|anesthetics, local|mesh-ancestor
110047464|NCT03887650|Anesthetics|anesthetics|mesh-ancestor
110047465|NCT03887650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110047466|NCT03887650|Sensory System Agents|sensory system agents|mesh-ancestor
110047467|NCT03887650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110047468|NCT03887650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110047469|NCT03887650|Adrenergic Agents|adrenergic agents|mesh-ancestor
110047470|NCT03887650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110047471|NCT03887650|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110047472|NCT03887650|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110047473|NCT03887650|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110047475|NCT03887650|Mydriatics|mydriatics|mesh-ancestor
110047476|NCT03887650|Sympathomimetics|sympathomimetics|mesh-ancestor
110047477|NCT03887650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110047478|NCT03854500|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110047479|NCT03854500|Tenecteplase|tenecteplase|mesh-list
110047480|NCT03854500|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110047481|NCT03854500|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110047482|NCT03854500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110047483|NCT03794349|Eflornithine|eflornithine|mesh-list
110047485|NCT03794349|Camptothecin|camptothecin|mesh-list
110047486|NCT03794349|Temozolomide|temozolomide|mesh-list
110047487|NCT03794349|Dinutuximab|dinutuximab|mesh-list
110047488|NCT03794349|Sargramostim|sargramostim|mesh-list
110047489|NCT03794349|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110047490|NCT03794349|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110047491|NCT03794349|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110047492|NCT03794349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110047493|NCT03794349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110047494|NCT03794349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110047495|NCT03794349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110047496|NCT03794349|Alkylating Agents|alkylating agents|mesh-ancestor
110047497|NCT03794349|Immunologic Factors|immunologic factors|mesh-ancestor
110047498|NCT03794349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110047499|NCT03794349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110047500|NCT03794349|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110047501|NCT03794349|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110047502|NCT03794349|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110047503|NCT03794349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110047504|NCT03794349|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
110047506|NCT03783949|Carboplatin|carboplatin|mesh-list
110047507|NCT03783949|Gemcitabine|gemcitabine|mesh-list
110047508|NCT03783949|Niraparib|niraparib|mesh-list
110047509|NCT03783949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110047510|NCT03783949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110047511|NCT03783949|Tubulin Modulators|tubulin modulators|mesh-ancestor
110047512|NCT03783949|Antimitotic Agents|antimitotic agents|mesh-ancestor
110047513|NCT03783949|Mitosis Modulators|mitosis modulators|mesh-ancestor
110047514|NCT03783949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110047515|NCT03783949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110047516|NCT03783949|Antimetabolites|antimetabolites|mesh-ancestor
110047517|NCT03783949|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110047518|NCT03783949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110047519|NCT03777657|Capecitabine|capecitabine|mesh-list
110047520|NCT03777657|Oxaliplatin|oxaliplatin|mesh-list
110047521|NCT03777657|Tislelizumab|tislelizumab|mesh-list
110047522|NCT03777657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110047523|NCT03777657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110047524|NCT03777657|Antimetabolites|antimetabolites|mesh-ancestor
110047525|NCT03777657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110047526|NCT03777657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110047527|NCT03765229|Pembrolizumab|pembrolizumab|mesh-list
110047528|NCT03765229|Entinostat|entinostat|mesh-list
110047529|NCT03765229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110047530|NCT03765229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110047531|NCT03765229|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110047532|NCT03765229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110047533|NCT03765229|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110047535|NCT03742102|Paclitaxel|paclitaxel|mesh-list
110047536|NCT03742102|Trastuzumab|trastuzumab|mesh-list
110047537|NCT03742102|Durvalumab|durvalumab|mesh-list
110047539|NCT03742102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110047540|NCT03742102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110047541|NCT03742102|Tubulin Modulators|tubulin modulators|mesh-ancestor
110047542|NCT03742102|Antimitotic Agents|antimitotic agents|mesh-ancestor
110047543|NCT03742102|Mitosis Modulators|mitosis modulators|mesh-ancestor
110047544|NCT03742102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110047545|NCT03742102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110047546|NCT03742102|Immunoconjugates|immunoconjugates|mesh-ancestor
110047547|NCT03742102|Immunologic Factors|immunologic factors|mesh-ancestor
110047548|NCT03742102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110047549|NCT03699254|Valganciclovir|valganciclovir|mesh-list
110047550|NCT03699254|Ganciclovir|ganciclovir|mesh-list
110047551|NCT03699254|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
110047552|NCT03699254|Antiviral Agents|antiviral agents|mesh-ancestor
110047553|NCT03699254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110047554|NCT03699254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110047555|NCT03699254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110047556|NCT03699254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110047558|NCT03692052|Enzyme Activators|enzyme activators|mesh-ancestor
110047559|NCT03692052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110047563|NCT03661723|Bevacizumab|bevacizumab|mesh-list
110047564|NCT03661723|Pembrolizumab|pembrolizumab|mesh-list
110047565|NCT03661723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110047566|NCT03661723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110047567|NCT03661723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110047568|NCT03661723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110047569|NCT03661723|Growth Substances|growth substances|mesh-ancestor
110047570|NCT03661723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110047571|NCT03661723|Growth Inhibitors|growth inhibitors|mesh-ancestor
110047572|NCT03661723|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110047573|NCT03661723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110047574|NCT03646617|Nivolumab|nivolumab|mesh-list
110047575|NCT03646617|Ipilimumab|ipilimumab|mesh-list
110047576|NCT03646617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110047577|NCT03646617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110047578|NCT03646617|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110047579|NCT03646617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110047580|NCT03582124|Panitumumab|panitumumab|mesh-list
110047581|NCT03582124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110047582|NCT03582124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110047583|NCT03568656|Atezolizumab|atezolizumab|mesh-list
110047584|NCT03568656|Olaparib|olaparib|mesh-list
110047585|NCT03568656|Abiraterone Acetate|abiraterone acetate|mesh-list
110047586|NCT03568656|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110047587|NCT03568656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110047588|NCT03568656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110047589|NCT03568656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110047743|NCT03233347|Daunorubicin|daunorubicin|mesh-list
110047590|NCT03568656|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110047591|NCT03568656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110047592|NCT03568656|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110047593|NCT03568656|Hormone Antagonists|hormone antagonists|mesh-ancestor
110047594|NCT03568656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110047595|NCT03568656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110047596|NCT03568656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110047597|NCT03522246|Nivolumab|nivolumab|mesh-list
110047599|NCT03522246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110047600|NCT03522246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110047601|NCT03522246|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110047602|NCT03522246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110047603|NCT03522246|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110047604|NCT03522246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110047605|NCT03513328|Thiotepa|thiotepa|mesh-list
110047606|NCT03513328|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110047607|NCT03513328|Alkylating Agents|alkylating agents|mesh-ancestor
110047608|NCT03513328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110047609|NCT03513328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110047610|NCT03513328|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110047611|NCT03513328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110047612|NCT03513328|Immunologic Factors|immunologic factors|mesh-ancestor
110047613|NCT03513328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110047614|NCT03498716|Paclitaxel|paclitaxel|mesh-list
110047615|NCT03498716|Cyclophosphamide|cyclophosphamide|mesh-list
110047616|NCT03498716|Doxorubicin|doxorubicin|mesh-list
110047617|NCT03498716|Atezolizumab|atezolizumab|mesh-list
110047618|NCT03498716|Epirubicin|epirubicin|mesh-list
110047619|NCT03498716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110047620|NCT03498716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110047621|NCT03498716|Tubulin Modulators|tubulin modulators|mesh-ancestor
110047622|NCT03498716|Antimitotic Agents|antimitotic agents|mesh-ancestor
110047623|NCT03498716|Mitosis Modulators|mitosis modulators|mesh-ancestor
110047624|NCT03498716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110047625|NCT03498716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110047626|NCT03498716|Immunologic Factors|immunologic factors|mesh-ancestor
110047627|NCT03498716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110047628|NCT03498716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110047629|NCT03498716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110047630|NCT03498716|Alkylating Agents|alkylating agents|mesh-ancestor
110047631|NCT03498716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110047632|NCT03498716|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110047633|NCT03498716|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110047634|NCT03498716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110047635|NCT03498716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110047636|NCT03498716|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110047637|NCT03498716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110047638|NCT03421353|Paclitaxel|paclitaxel|mesh-list
110047639|NCT03421353|Carboplatin|carboplatin|mesh-list
110047640|NCT03421353|Gemcitabine|gemcitabine|mesh-list
110047641|NCT03421353|Durvalumab|durvalumab|mesh-list
110047642|NCT03421353|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110047643|NCT03421353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110047644|NCT03421353|Tubulin Modulators|tubulin modulators|mesh-ancestor
110047645|NCT03421353|Antimitotic Agents|antimitotic agents|mesh-ancestor
110047646|NCT03421353|Mitosis Modulators|mitosis modulators|mesh-ancestor
110047647|NCT03421353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110047648|NCT03421353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110047649|NCT03421353|Antimetabolites|antimetabolites|mesh-ancestor
110047650|NCT03421353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110047651|NCT03404180|Dexmedetomidine|dexmedetomidine|mesh-list
110047652|NCT03404180|Propofol|propofol|mesh-list
110047653|NCT03404180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
110047654|NCT03404180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110047655|NCT03404180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110047656|NCT03404180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110047657|NCT03404180|Analgesics|analgesics|mesh-ancestor
110047658|NCT03404180|Sensory System Agents|sensory system agents|mesh-ancestor
110047659|NCT03404180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110047660|NCT03404180|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110047661|NCT03404180|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110047662|NCT03404180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110047663|NCT03404180|Adrenergic Agents|adrenergic agents|mesh-ancestor
110047664|NCT03404180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110047665|NCT03404180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110047666|NCT03404180|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110047667|NCT03404180|Anesthetics, General|anesthetics, general|mesh-ancestor
110047668|NCT03404180|Anesthetics|anesthetics|mesh-ancestor
110047669|NCT03390686|Paclitaxel|paclitaxel|mesh-list
110047671|NCT03390686|Carboplatin|carboplatin|mesh-list
110047672|NCT03390686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110047673|NCT03390686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110047674|NCT03390686|Tubulin Modulators|tubulin modulators|mesh-ancestor
110047675|NCT03390686|Antimitotic Agents|antimitotic agents|mesh-ancestor
110047676|NCT03390686|Mitosis Modulators|mitosis modulators|mesh-ancestor
110047677|NCT03390686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110047678|NCT03390686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110047680|NCT03390686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110047681|NCT03390686|Growth Substances|growth substances|mesh-ancestor
110047682|NCT03390686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110047683|NCT03390686|Growth Inhibitors|growth inhibitors|mesh-ancestor
110047684|NCT03369223|Nivolumab|nivolumab|mesh-list
110047685|NCT03369223|Ipilimumab|ipilimumab|mesh-list
110047686|NCT03369223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110047687|NCT03369223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110047688|NCT03369223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110047689|NCT03369223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110047690|NCT03280563|Tamoxifen|tamoxifen|mesh-list
110047691|NCT03280563|Bevacizumab|bevacizumab|mesh-list
110047692|NCT03280563|Atezolizumab|atezolizumab|mesh-list
110047693|NCT03280563|Fulvestrant|fulvestrant|mesh-list
110047694|NCT03280563|Exemestane|exemestane|mesh-list
110047695|NCT03280563|Entinostat|entinostat|mesh-list
110047696|NCT03280563|Ipatasertib|ipatasertib|mesh-list
110047697|NCT03280563|Antibodies|antibodies|mesh-list
110047698|NCT03280563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110047699|NCT03280563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110047700|NCT03280563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110047701|NCT03280563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110047702|NCT03280563|Growth Substances|growth substances|mesh-ancestor
110047703|NCT03280563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110047704|NCT03280563|Growth Inhibitors|growth inhibitors|mesh-ancestor
110047705|NCT03280563|Immunologic Factors|immunologic factors|mesh-ancestor
110047706|NCT03280563|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110047707|NCT03280563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110047708|NCT03280563|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110047709|NCT03280563|Hormone Antagonists|hormone antagonists|mesh-ancestor
110047710|NCT03280563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110047711|NCT03280563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110047712|NCT03280563|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110047713|NCT03280563|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110047714|NCT03280563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110047715|NCT03280563|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110047716|NCT03280563|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110047717|NCT03280563|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110047718|NCT03280563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110047719|NCT03280563|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110047720|NCT03280563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110047722|NCT03270969|Emtricitabine|emtricitabine|mesh-list
110047723|NCT03270969|Antiviral Agents|antiviral agents|mesh-ancestor
110047724|NCT03270969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110047725|NCT03270969|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110047726|NCT03270969|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110047727|NCT03270969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110047728|NCT03270969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110047729|NCT03270969|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110047730|NCT03270969|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110047731|NCT03264131|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110047732|NCT03264131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110047733|NCT03264131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110047734|NCT03264131|Immunotoxins|immunotoxins|mesh-ancestor
110047735|NCT03264131|Immunoconjugates|immunoconjugates|mesh-ancestor
110047736|NCT03264131|Immunologic Factors|immunologic factors|mesh-ancestor
110047737|NCT03264131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110047738|NCT03233347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110047739|NCT03233347|Nivolumab|nivolumab|mesh-list
110047740|NCT03233347|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110047741|NCT03233347|Doxorubicin|doxorubicin|mesh-list
110047742|NCT03233347|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110047744|NCT03233347|Dacarbazine|dacarbazine|mesh-list
110047745|NCT03233347|Vinblastine|vinblastine|mesh-list
110047746|NCT03233347|Antibodies|antibodies|mesh-list
110047747|NCT03233347|Immunoglobulins|immunoglobulins|mesh-list
110047748|NCT03233347|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110047749|NCT03233347|Imidazole|imidazole|mesh-list
110047750|NCT03233347|Immunoconjugates|immunoconjugates|mesh-list
110047751|NCT03233347|Immunologic Factors|immunologic factors|mesh-ancestor
110047752|NCT03233347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110047753|NCT03233347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110047754|NCT03233347|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110047755|NCT03233347|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110047756|NCT03233347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110047757|NCT03233347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110047758|NCT03233347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110047759|NCT03233347|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110047760|NCT03233347|Immunotoxins|immunotoxins|mesh-ancestor
110047761|NCT03233347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110047762|NCT03233347|Alkylating Agents|alkylating agents|mesh-ancestor
110047763|NCT03233347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110047764|NCT03233347|Tubulin Modulators|tubulin modulators|mesh-ancestor
110047765|NCT03233347|Antimitotic Agents|antimitotic agents|mesh-ancestor
110047766|NCT03233347|Mitosis Modulators|mitosis modulators|mesh-ancestor
110047767|NCT03229057|Metformin|metformin|mesh-list
110047768|NCT03229057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110047769|NCT03229057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110047770|NCT03222492|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110047771|NCT03222492|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110047772|NCT03222492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110047773|NCT03222492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110047775|NCT03222492|Immunoconjugates|immunoconjugates|mesh-ancestor
110047776|NCT03222492|Immunologic Factors|immunologic factors|mesh-ancestor
110047777|NCT03222492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110047778|NCT03220035|Vemurafenib|vemurafenib|mesh-list
110047779|NCT03220035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110047780|NCT03220035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110047781|NCT03220035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110047782|NCT03220035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110047783|NCT03126916|Vitamin A|vitamin a|mesh-list
110047784|NCT03126916|Cyclophosphamide|cyclophosphamide|mesh-list
110047785|NCT03126916|Melphalan|melphalan|mesh-list
110047786|NCT03126916|Busulfan|busulfan|mesh-list
110047787|NCT03126916|Thiotepa|thiotepa|mesh-list
110047788|NCT03126916|Cisplatin|cisplatin|mesh-list
110047789|NCT03126916|Carboplatin|carboplatin|mesh-list
110047790|NCT03126916|Doxorubicin|doxorubicin|mesh-list
110047791|NCT03126916|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110047793|NCT03126916|Vincristine|vincristine|mesh-list
110047794|NCT03126916|Topotecan|topotecan|mesh-list
110047795|NCT03126916|Tretinoin|tretinoin|mesh-list
110047796|NCT03126916|Etoposide phosphate|etoposide phosphate|mesh-list
110047797|NCT03126916|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
110047798|NCT03126916|Dinutuximab|dinutuximab|mesh-list
110047799|NCT03126916|Dexrazoxane|dexrazoxane|mesh-list
110047800|NCT03126916|Razoxane|razoxane|mesh-list
110047801|NCT03126916|Isotretinoin|isotretinoin|mesh-list
110047802|NCT03126916|Sargramostim|sargramostim|mesh-list
110047803|NCT03126916|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110047804|NCT03126916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110047805|NCT03126916|Immunologic Factors|immunologic factors|mesh-ancestor
110047806|NCT03126916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110047807|NCT03126916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110047808|NCT03126916|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110047809|NCT03126916|Alkylating Agents|alkylating agents|mesh-ancestor
110047810|NCT03126916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110047811|NCT03126916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110047812|NCT03126916|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110047813|NCT03126916|Vitamins|vitamins|mesh-ancestor
110047814|NCT03126916|Micronutrients|micronutrients|mesh-ancestor
110047815|NCT03126916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110047816|NCT03126916|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110047817|NCT03126916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110047818|NCT03126916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110047819|NCT03126916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110047820|NCT03126916|Tubulin Modulators|tubulin modulators|mesh-ancestor
110047821|NCT03126916|Antimitotic Agents|antimitotic agents|mesh-ancestor
110047822|NCT03126916|Mitosis Modulators|mitosis modulators|mesh-ancestor
110047823|NCT03126916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110047824|NCT03126916|Keratolytic Agents|keratolytic agents|mesh-ancestor
110047825|NCT03126916|Dermatologic Agents|dermatologic agents|mesh-ancestor
110047826|NCT03126916|Protective Agents|protective agents|mesh-ancestor
110047827|NCT03126916|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110047828|NCT03126916|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110047829|NCT03110107|Nivolumab|nivolumab|mesh-list
110047831|NCT03110107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110047832|NCT03110107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110047833|NCT03110107|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110047834|NCT03110107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110047835|NCT03067181|Cisplatin|cisplatin|mesh-list
110047837|NCT03067181|Etoposide|etoposide|mesh-list
110047838|NCT03067181|Etoposide phosphate|etoposide phosphate|mesh-list
110047839|NCT03067181|Bleomycin|bleomycin|mesh-list
110047840|NCT03067181|Podophyllotoxin|podophyllotoxin|mesh-list
110047841|NCT03067181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110047842|NCT03067181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110047843|NCT03067181|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110047844|NCT03067181|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110047845|NCT03067181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110047846|NCT03067181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110047847|NCT03067181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110047848|NCT03067181|Keratolytic Agents|keratolytic agents|mesh-ancestor
110047849|NCT03067181|Dermatologic Agents|dermatologic agents|mesh-ancestor
110047850|NCT03067181|Tubulin Modulators|tubulin modulators|mesh-ancestor
110047851|NCT03067181|Antimitotic Agents|antimitotic agents|mesh-ancestor
110047852|NCT03067181|Mitosis Modulators|mitosis modulators|mesh-ancestor
110047853|NCT03064490|Pembrolizumab|pembrolizumab|mesh-list
110047854|NCT03064490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110047855|NCT03064490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110047856|NCT03064490|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110047857|NCT03064490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110047858|NCT03016013|Methotrexate|methotrexate|mesh-list
110047859|NCT03016013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110047860|NCT03016013|Abortifacient Agents|abortifacient agents|mesh-ancestor
110047861|NCT03016013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110047863|NCT03016013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110047864|NCT03016013|Antimetabolites|antimetabolites|mesh-ancestor
110047865|NCT03016013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110047866|NCT03016013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110047867|NCT03016013|Dermatologic Agents|dermatologic agents|mesh-ancestor
110047868|NCT03016013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110047869|NCT03016013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110047870|NCT03016013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110047871|NCT03016013|Immunologic Factors|immunologic factors|mesh-ancestor
110047872|NCT03016013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110047873|NCT03016013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110047875|NCT02988297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110047876|NCT02988297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110047877|NCT02988297|Analgesics|analgesics|mesh-ancestor
110047878|NCT02988297|Sensory System Agents|sensory system agents|mesh-ancestor
110047879|NCT02988297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110047880|NCT02988297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110047881|NCT02988297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110047882|NCT02988297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110047883|NCT02988297|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110047884|NCT02979873|Sirolimus|sirolimus|mesh-list
110047885|NCT02979873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110047886|NCT02979873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110047887|NCT02979873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110047888|NCT02979873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110047889|NCT02979873|Antifungal Agents|antifungal agents|mesh-ancestor
110047890|NCT02979873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110047891|NCT02979873|Immunologic Factors|immunologic factors|mesh-ancestor
110047892|NCT02979873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110047893|NCT02940496|Ribavirin|ribavirin|mesh-list
110047894|NCT02940496|Grazoprevir|grazoprevir|mesh-list
110047895|NCT02940496|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
110047896|NCT02940496|Pembrolizumab|pembrolizumab|mesh-list
110047897|NCT02940496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110047898|NCT02940496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110047899|NCT02940496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110047900|NCT02940496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110047901|NCT02940496|Antimetabolites|antimetabolites|mesh-ancestor
110047902|NCT02940496|Antiviral Agents|antiviral agents|mesh-ancestor
110047903|NCT02940496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110047904|NCT02828761|Calcium, Dietary|calcium, dietary|mesh-list
110047906|NCT02828761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110047908|NCT02828761|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110047910|NCT02807207|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110047911|NCT02807207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110047912|NCT02807207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110047913|NCT02807207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110047914|NCT02807207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110047915|NCT02807207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110047916|NCT02807207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110047917|NCT02807207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110047918|NCT02807207|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110047919|NCT02807207|Contraceptive Agents|contraceptive agents|mesh-ancestor
110047920|NCT02807207|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110047921|NCT02807207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110047922|NCT02807207|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110047923|NCT02807207|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110047924|NCT02807207|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110047925|NCT02807116|Rifampin|rifampin|mesh-list
110047926|NCT02807116|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110047927|NCT02807116|Antitubercular Agents|antitubercular agents|mesh-ancestor
110047928|NCT02807116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110047929|NCT02807116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110047930|NCT02807116|Leprostatic Agents|leprostatic agents|mesh-ancestor
110047931|NCT02807116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110047932|NCT02807116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110047933|NCT02807116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110047934|NCT02807116|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110047935|NCT02807116|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110047936|NCT02807116|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110047937|NCT02807116|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110047938|NCT02807116|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110047939|NCT02807116|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110047940|NCT02795156|Afatinib|afatinib|mesh-list
110047941|NCT02795156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110047942|NCT02795156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110047943|NCT02795156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110047944|NCT02795156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110047945|NCT02724579|Cyclophosphamide|cyclophosphamide|mesh-list
110047946|NCT02724579|Lomustine|lomustine|mesh-list
110047947|NCT02724579|Cisplatin|cisplatin|mesh-list
110047948|NCT02724579|Vincristine|vincristine|mesh-list
110047949|NCT02724579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110047950|NCT02724579|Immunologic Factors|immunologic factors|mesh-ancestor
110047951|NCT02724579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110047952|NCT02724579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110047953|NCT02724579|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110047954|NCT02724579|Alkylating Agents|alkylating agents|mesh-ancestor
110047955|NCT02724579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110047956|NCT02724579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110047957|NCT02724579|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110047958|NCT02724579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110047959|NCT02724579|Tubulin Modulators|tubulin modulators|mesh-ancestor
110047960|NCT02724579|Antimitotic Agents|antimitotic agents|mesh-ancestor
110047961|NCT02724579|Mitosis Modulators|mitosis modulators|mesh-ancestor
110047963|NCT02719613|Dexamethasone acetate|dexamethasone acetate|mesh-list
110047964|NCT02719613|Nivolumab|nivolumab|mesh-list
110047965|NCT02719613|Lenalidomide|lenalidomide|mesh-list
110047966|NCT02719613|Bortezomib|bortezomib|mesh-list
110047967|NCT02719613|Pomalidomide|pomalidomide|mesh-list
110047968|NCT02719613|Elotuzumab|elotuzumab|mesh-list
110047969|NCT02719613|BB 1101|bb 1101|mesh-list
110047970|NCT02719613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110047971|NCT02719613|Antiemetics|antiemetics|mesh-ancestor
110047972|NCT02719613|Autonomic Agents|autonomic agents|mesh-ancestor
110047973|NCT02719613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110047974|NCT02719613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110047976|NCT02719613|Glucocorticoids|glucocorticoids|mesh-ancestor
110047977|NCT02719613|Hormones|hormones|mesh-ancestor
110047978|NCT02719613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110047979|NCT02719613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110047980|NCT02719613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110047982|NCT02719613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110047983|NCT02719613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110047984|NCT02719613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110047985|NCT02719613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110047986|NCT02719613|Immunologic Factors|immunologic factors|mesh-ancestor
110047987|NCT02719613|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110047988|NCT02719613|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110047989|NCT02719613|Growth Substances|growth substances|mesh-ancestor
110047990|NCT02719613|Growth Inhibitors|growth inhibitors|mesh-ancestor
110047991|NCT02690558|Gemcitabine|gemcitabine|mesh-list
110047992|NCT02690558|Pembrolizumab|pembrolizumab|mesh-list
110047993|NCT02690558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110047994|NCT02690558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110047995|NCT02690558|Antimetabolites|antimetabolites|mesh-ancestor
110047996|NCT02690558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110047997|NCT02690558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110047998|NCT02690558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110047999|NCT02684006|Sunitinib|sunitinib|mesh-list
110048000|NCT02684006|Avelumab|avelumab|mesh-list
110048001|NCT02684006|Axitinib|axitinib|mesh-list
110048002|NCT02684006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110048004|NCT02684006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110048005|NCT02684006|Growth Substances|growth substances|mesh-ancestor
110048006|NCT02684006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110048007|NCT02684006|Growth Inhibitors|growth inhibitors|mesh-ancestor
110048008|NCT02684006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110048009|NCT02684006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110048010|NCT02684006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110048011|NCT02684006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110048012|NCT02621021|Aldesleukin|aldesleukin|mesh-list
110048013|NCT02621021|Cyclophosphamide|cyclophosphamide|mesh-list
110048014|NCT02621021|Pembrolizumab|pembrolizumab|mesh-list
110048015|NCT02621021|Fludarabine|fludarabine|mesh-list
110048016|NCT02621021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110048017|NCT02621021|Immunologic Factors|immunologic factors|mesh-ancestor
110048018|NCT02621021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110048019|NCT02621021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110048020|NCT02621021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110048021|NCT02621021|Alkylating Agents|alkylating agents|mesh-ancestor
110048022|NCT02621021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110048023|NCT02621021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110048024|NCT02621021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110048025|NCT02621021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110048026|NCT02621021|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110048027|NCT02621021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110048028|NCT02621021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110048029|NCT02621021|Antiviral Agents|antiviral agents|mesh-ancestor
110048030|NCT02621021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110048031|NCT02609503|Pembrolizumab|pembrolizumab|mesh-list
110048032|NCT02609503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110048033|NCT02609503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110048034|NCT02609503|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110048035|NCT02609503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110048036|NCT02542839|Botulinum Toxins|botulinum toxins|mesh-list
110048037|NCT02542839|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110048038|NCT02542839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110048039|NCT02542839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110048040|NCT02542839|Cholinergic Agents|cholinergic agents|mesh-ancestor
110048041|NCT02542839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110048042|NCT02542839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110048043|NCT02476916|Mitapivat|mitapivat|mesh-list
110048044|NCT02476916|Enzyme Activators|enzyme activators|mesh-ancestor
110048045|NCT02476916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110048046|NCT02456857|Bevacizumab|bevacizumab|mesh-list
110048047|NCT02456857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110048048|NCT02456857|Doxorubicin|doxorubicin|mesh-list
110048049|NCT02456857|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110048050|NCT02456857|Everolimus|everolimus|mesh-list
110048051|NCT02456857|Endothelial Growth Factors|endothelial growth factors|mesh-list
110048052|NCT02456857|Antibodies|antibodies|mesh-list
110048053|NCT02456857|Immunoglobulins|immunoglobulins|mesh-list
110048054|NCT02456857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110048055|NCT02456857|Immunoglobulin G|immunoglobulin g|mesh-list
110048058|NCT02456857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110048059|NCT02456857|Growth Substances|growth substances|mesh-ancestor
110048060|NCT02456857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110048061|NCT02456857|Growth Inhibitors|growth inhibitors|mesh-ancestor
110048062|NCT02456857|Immunologic Factors|immunologic factors|mesh-ancestor
110048063|NCT02456857|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110048064|NCT02456857|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110048065|NCT02456857|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110048066|NCT02456857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110048067|NCT02456857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110048068|NCT02456857|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110048069|NCT02456857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110048070|NCT02456857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110048071|NCT02453620|Nivolumab|nivolumab|mesh-list
110048072|NCT02453620|Ipilimumab|ipilimumab|mesh-list
110048073|NCT02453620|Entinostat|entinostat|mesh-list
110048074|NCT02453620|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
110048075|NCT02453620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110048076|NCT02453620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110048077|NCT02453620|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110048078|NCT02453620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110048079|NCT02453620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110048080|NCT02379416|Paclitaxel|paclitaxel|mesh-list
110048081|NCT02379416|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110048082|NCT02379416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110048083|NCT02379416|Tubulin Modulators|tubulin modulators|mesh-ancestor
110048084|NCT02379416|Antimitotic Agents|antimitotic agents|mesh-ancestor
110048085|NCT02379416|Mitosis Modulators|mitosis modulators|mesh-ancestor
110048086|NCT02379416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110048087|NCT02265770|Cyclophosphamide|cyclophosphamide|mesh-list
110048088|NCT02265770|Cisplatin|cisplatin|mesh-list
110048089|NCT02265770|Carboplatin|carboplatin|mesh-list
110048090|NCT02265770|Methotrexate|methotrexate|mesh-list
110048091|NCT02265770|Etoposide|etoposide|mesh-list
110048092|NCT02265770|Etoposide phosphate|etoposide phosphate|mesh-list
110048093|NCT02265770|Vincristine|vincristine|mesh-list
110048094|NCT02265770|Valproic Acid|valproic acid|mesh-list
110048095|NCT02265770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110048096|NCT02265770|Immunologic Factors|immunologic factors|mesh-ancestor
110048097|NCT02265770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110048098|NCT02265770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110048099|NCT02265770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110048100|NCT02265770|Alkylating Agents|alkylating agents|mesh-ancestor
110048101|NCT02265770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110048102|NCT02265770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110048103|NCT02265770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110048104|NCT02265770|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110048105|NCT02265770|Abortifacient Agents|abortifacient agents|mesh-ancestor
110048106|NCT02265770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110048107|NCT02265770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110048109|NCT02265770|Dermatologic Agents|dermatologic agents|mesh-ancestor
110048110|NCT02265770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110048111|NCT02265770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110048112|NCT02265770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110048113|NCT02265770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110048114|NCT02265770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110048115|NCT02265770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110048116|NCT02265770|Tubulin Modulators|tubulin modulators|mesh-ancestor
110048117|NCT02265770|Antimitotic Agents|antimitotic agents|mesh-ancestor
110048118|NCT02265770|Mitosis Modulators|mitosis modulators|mesh-ancestor
110048119|NCT02265770|Anticonvulsants|anticonvulsants|mesh-ancestor
110048120|NCT02265770|GABA Agents|gaba agents|mesh-ancestor
110048121|NCT02265770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110048122|NCT02265770|Antimanic Agents|antimanic agents|mesh-ancestor
110048123|NCT02265770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110048124|NCT02265770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110048126|NCT02140242|Daunorubicin|daunorubicin|mesh-list
110048127|NCT02140242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110048128|NCT02140242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110048129|NCT02140242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110048130|NCT02140242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110048131|NCT02140242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110048132|NCT02140242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110048135|NCT02131597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110048136|NCT02131597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110048137|NCT02131597|Antimetabolites|antimetabolites|mesh-ancestor
110048138|NCT02131597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110048139|NCT02131597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110048141|NCT02043678|Prednisolone|prednisolone|mesh-list
110048142|NCT02043678|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
110048143|NCT02043678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110048144|NCT02043678|Glucocorticoids|glucocorticoids|mesh-ancestor
110048145|NCT02043678|Hormones|hormones|mesh-ancestor
110048146|NCT02043678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110048147|NCT02043678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110048148|NCT02043678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110048149|NCT02043678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110048150|NCT01990196|Dasatinib|dasatinib|mesh-list
110048151|NCT01990196|Trametinib|trametinib|mesh-list
110048152|NCT01990196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110048153|NCT01990196|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110048154|NCT01990196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110048155|NCT01990196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110048156|NCT01968109|Nivolumab|nivolumab|mesh-list
110048157|NCT01968109|Relatlimab|relatlimab|mesh-list
110048158|NCT01968109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110048159|NCT01968109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110048160|NCT01968109|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110048161|NCT01968109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110048162|NCT01658878|Nivolumab|nivolumab|mesh-list
110048163|NCT01658878|Ipilimumab|ipilimumab|mesh-list
110048164|NCT01658878|Sorafenib|sorafenib|mesh-list
110048165|NCT01658878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110048166|NCT01658878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110048167|NCT01658878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110048168|NCT01658878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110048169|NCT01658878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110048170|NCT01658878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110048171|NCT01612351|Paclitaxel|paclitaxel|mesh-list
110048172|NCT01612351|Cisplatin|cisplatin|mesh-list
110048173|NCT01612351|Carboplatin|carboplatin|mesh-list
110048174|NCT01612351|Lapatinib|lapatinib|mesh-list
110048175|NCT01612351|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110048176|NCT01612351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110048177|NCT01612351|Tubulin Modulators|tubulin modulators|mesh-ancestor
110048178|NCT01612351|Antimitotic Agents|antimitotic agents|mesh-ancestor
110048179|NCT01612351|Mitosis Modulators|mitosis modulators|mesh-ancestor
110048180|NCT01612351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110048181|NCT01612351|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110048182|NCT01612351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110048183|NCT01506856|Paclitaxel|paclitaxel|mesh-list
110048184|NCT01506856|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110048185|NCT01506856|Carboplatin|carboplatin|mesh-list
110048186|NCT01506856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110048187|NCT01506856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110048188|NCT01506856|Tubulin Modulators|tubulin modulators|mesh-ancestor
110048189|NCT01506856|Antimitotic Agents|antimitotic agents|mesh-ancestor
110048190|NCT01506856|Mitosis Modulators|mitosis modulators|mesh-ancestor
110048191|NCT01506856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110048192|NCT01376505|Vaccines|vaccines|mesh-list
110048193|NCT01376505|Immunologic Factors|immunologic factors|mesh-ancestor
110048194|NCT01376505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110048195|NCT01371630|Cytarabine|cytarabine|mesh-list
110048196|NCT01371630|Dexamethasone|dexamethasone|mesh-list
110048197|NCT01371630|Prednisone|prednisone|mesh-list
110048198|NCT01371630|Cyclophosphamide|cyclophosphamide|mesh-list
110048199|NCT01371630|Rituximab|rituximab|mesh-list
110048200|NCT01371630|Methotrexate|methotrexate|mesh-list
110048201|NCT01371630|Vincristine|vincristine|mesh-list
110048202|NCT01371630|Mercaptopurine|mercaptopurine|mesh-list
110048203|NCT01371630|Blinatumomab|blinatumomab|mesh-list
110048204|NCT01371630|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
110048205|NCT01371630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110048206|NCT01371630|Immunologic Factors|immunologic factors|mesh-ancestor
110048207|NCT01371630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110048208|NCT01371630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110048209|NCT01371630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110048213|NCT01371630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110048214|NCT01371630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110048215|NCT01371630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110048216|NCT01371630|Antiemetics|antiemetics|mesh-ancestor
110048217|NCT01371630|Autonomic Agents|autonomic agents|mesh-ancestor
110048218|NCT01371630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110048219|NCT01371630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110048220|NCT01371630|Glucocorticoids|glucocorticoids|mesh-ancestor
110048221|NCT01371630|Hormones|hormones|mesh-ancestor
110048222|NCT01371630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110048223|NCT01371630|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110048224|NCT01371630|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110048225|NCT01371630|Abortifacient Agents|abortifacient agents|mesh-ancestor
110048226|NCT01371630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110048227|NCT01371630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110048228|NCT01371630|Antimetabolites|antimetabolites|mesh-ancestor
110048229|NCT01371630|Dermatologic Agents|dermatologic agents|mesh-ancestor
110048230|NCT01371630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110048231|NCT01371630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110048232|NCT01371630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110048233|NCT01371630|Antiviral Agents|antiviral agents|mesh-ancestor
110048234|NCT01371630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110048243|NCT01256593|Analgesics|analgesics|mesh-ancestor
110048244|NCT01256593|Sensory System Agents|sensory system agents|mesh-ancestor
110048245|NCT01256593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110048246|NCT01256593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110048247|NCT01256593|Anticonvulsants|anticonvulsants|mesh-ancestor
110048248|NCT01256593|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110048249|NCT01256593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110048250|NCT01256593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110048251|NCT01256593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110048252|NCT01256593|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110048253|NCT01256593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110048254|NCT01256593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110048255|NCT01256593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110048256|NCT01179009|Clonidine|clonidine|mesh-list
110048257|NCT01179009|Ketamine|ketamine|mesh-list
110048258|NCT01179009|Analgesics|analgesics|mesh-ancestor
110048259|NCT01179009|Sensory System Agents|sensory system agents|mesh-ancestor
110048260|NCT01179009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110048261|NCT01179009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110048262|NCT01179009|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110048263|NCT01179009|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110048264|NCT01179009|Anesthetics, General|anesthetics, general|mesh-ancestor
110048265|NCT01179009|Anesthetics|anesthetics|mesh-ancestor
110048266|NCT01179009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110048267|NCT01179009|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110048268|NCT01179009|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110048269|NCT01179009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110048270|NCT01179009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110048271|NCT01179009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110048272|NCT01179009|Sympatholytics|sympatholytics|mesh-ancestor
110048273|NCT01179009|Autonomic Agents|autonomic agents|mesh-ancestor
110048274|NCT01179009|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110048275|NCT01179009|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110048276|NCT01179009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110048277|NCT01179009|Adrenergic Agents|adrenergic agents|mesh-ancestor
110048287|NCT00781612|Maytansine|maytansine|mesh-list
110048288|NCT00781612|Docetaxel|docetaxel|mesh-list
110048289|NCT00781612|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
110048290|NCT00781612|Trastuzumab|trastuzumab|mesh-list
110048292|NCT00781612|Pertuzumab|pertuzumab|mesh-list
110048293|NCT00781612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110048294|NCT00781612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110048295|NCT00781612|Tubulin Modulators|tubulin modulators|mesh-ancestor
110048296|NCT00781612|Antimitotic Agents|antimitotic agents|mesh-ancestor
110048297|NCT00781612|Mitosis Modulators|mitosis modulators|mesh-ancestor
110048298|NCT00781612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110048299|NCT00781612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110048300|NCT00781612|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110048301|NCT00781612|Immunotoxins|immunotoxins|mesh-ancestor
110048302|NCT00781612|Immunoconjugates|immunoconjugates|mesh-ancestor
110048303|NCT00781612|Immunologic Factors|immunologic factors|mesh-ancestor
110048304|NCT00781612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110048305|NCT00716066|Cytarabine|cytarabine|mesh-list
110048306|NCT00716066|Prednisone|prednisone|mesh-list
110048307|NCT00716066|Cortisone|cortisone|mesh-list
110048308|NCT00716066|Etoposide|etoposide|mesh-list
110048309|NCT00716066|Etoposide phosphate|etoposide phosphate|mesh-list
110048310|NCT00716066|Melphalan|melphalan|mesh-list
110048311|NCT00716066|Mechlorethamine|mechlorethamine|mesh-list
110048312|NCT00716066|Carmustine|carmustine|mesh-list
110048313|NCT00716066|Podophyllotoxin|podophyllotoxin|mesh-list
110048314|NCT00716066|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
110048315|NCT00716066|Thymoglobulin|thymoglobulin|mesh-list
110048316|NCT00716066|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110048317|NCT00716066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110048318|NCT00716066|Glucocorticoids|glucocorticoids|mesh-ancestor
110048319|NCT00716066|Hormones|hormones|mesh-ancestor
110048320|NCT00716066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110048321|NCT00716066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110048322|NCT00716066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110048323|NCT00716066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110048324|NCT00716066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110048325|NCT00716066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110048326|NCT00716066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110048327|NCT00716066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110048328|NCT00716066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110048329|NCT00716066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110048330|NCT00716066|Antimetabolites|antimetabolites|mesh-ancestor
110048331|NCT00716066|Antiviral Agents|antiviral agents|mesh-ancestor
110048332|NCT00716066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110048333|NCT00716066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110048334|NCT00716066|Immunologic Factors|immunologic factors|mesh-ancestor
110048335|NCT00716066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110048336|NCT00716066|Alkylating Agents|alkylating agents|mesh-ancestor
110048337|NCT00716066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110048338|NCT00716066|Keratolytic Agents|keratolytic agents|mesh-ancestor
110048339|NCT00716066|Dermatologic Agents|dermatologic agents|mesh-ancestor
110048340|NCT00716066|Tubulin Modulators|tubulin modulators|mesh-ancestor
110048341|NCT00716066|Antimitotic Agents|antimitotic agents|mesh-ancestor
110048342|NCT00716066|Mitosis Modulators|mitosis modulators|mesh-ancestor
110048343|NCT00562640|Cyclophosphamide|cyclophosphamide|mesh-list
110048344|NCT00562640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110048345|NCT00562640|Immunologic Factors|immunologic factors|mesh-ancestor
110048346|NCT00562640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110048347|NCT00562640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110048348|NCT00562640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110048349|NCT00562640|Alkylating Agents|alkylating agents|mesh-ancestor
110048350|NCT00562640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110048351|NCT00562640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110048352|NCT00562640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110048353|NCT04787289|Bevacizumab|bevacizumab|mesh-list
110048354|NCT04787289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110048355|NCT04787289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110048356|NCT04787289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110048357|NCT04787289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110048359|NCT04787289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110048360|NCT04787289|Growth Inhibitors|growth inhibitors|mesh-ancestor
110048361|NCT04749641|Vaccines|vaccines|mesh-list
110048362|NCT04749641|Immunologic Factors|immunologic factors|mesh-ancestor
110048363|NCT04749641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110048364|NCT04745299|Riluzole|riluzole|mesh-list
110048365|NCT04745299|Anticonvulsants|anticonvulsants|mesh-ancestor
110048366|NCT04745299|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110048367|NCT04745299|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110048368|NCT04745299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110048369|NCT04745299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110048370|NCT04745299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110048371|NCT04745299|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110048372|NCT04745299|Protective Agents|protective agents|mesh-ancestor
110048373|NCT04742777|Sirolimus|sirolimus|mesh-list
110048374|NCT04742777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110048380|NCT04742777|Immunologic Factors|immunologic factors|mesh-ancestor
110048381|NCT04742777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110048382|NCT04730258|Azacitidine|azacitidine|mesh-list
110048383|NCT04730258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110048384|NCT04730258|Antimetabolites|antimetabolites|mesh-ancestor
110048385|NCT04730258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110048386|NCT04730258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110048387|NCT04730258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110048388|NCT04725201|Heparin|heparin|mesh-list
110048389|NCT04725201|Calcium heparin|calcium heparin|mesh-list
110048390|NCT04725201|Anticoagulants|anticoagulants|mesh-ancestor
110048391|NCT04725201|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110048392|NCT04725201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110048393|NCT04725201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110048395|NCT04724239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110048396|NCT04724239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110048397|NCT04724239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110048398|NCT04724239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110048399|NCT04724239|Growth Substances|growth substances|mesh-ancestor
110048400|NCT04724239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110048401|NCT04724239|Growth Inhibitors|growth inhibitors|mesh-ancestor
110048403|NCT04705727|Terbutaline|terbutaline|mesh-list
110048404|NCT04705727|Formoterol Fumarate|formoterol fumarate|mesh-list
110048405|NCT04705727|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110048406|NCT04705727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110048407|NCT04705727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110048408|NCT04705727|Autonomic Agents|autonomic agents|mesh-ancestor
110048409|NCT04705727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110048410|NCT04705727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110048411|NCT04705727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110048412|NCT04705727|Respiratory System Agents|respiratory system agents|mesh-ancestor
110048413|NCT04705727|Glucocorticoids|glucocorticoids|mesh-ancestor
110048414|NCT04705727|Hormones|hormones|mesh-ancestor
110048415|NCT04705727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110048417|NCT04705727|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110048418|NCT04705727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110048419|NCT04705727|Adrenergic Agents|adrenergic agents|mesh-ancestor
110048420|NCT04705727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110048421|NCT04705727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110048422|NCT04705727|Sympathomimetics|sympathomimetics|mesh-ancestor
110048423|NCT04705727|Tocolytic Agents|tocolytic agents|mesh-ancestor
110048424|NCT04705727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110048425|NCT04674683|Nivolumab|nivolumab|mesh-list
110048426|NCT04674683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110048427|NCT04674683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110048428|NCT04674683|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110048429|NCT04674683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110048430|NCT04666740|Pembrolizumab|pembrolizumab|mesh-list
110048431|NCT04666740|Olaparib|olaparib|mesh-list
110048432|NCT04666740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110048433|NCT04666740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110048434|NCT04666740|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110048435|NCT04666740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110048436|NCT04666740|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110048437|NCT04666740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110048438|NCT04662944|Ranibizumab|ranibizumab|mesh-list
110048439|NCT04662944|Aflibercept|aflibercept|mesh-list
110048441|NCT04662944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110048442|NCT04662944|Growth Substances|growth substances|mesh-ancestor
110048443|NCT04662944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110048444|NCT04662944|Growth Inhibitors|growth inhibitors|mesh-ancestor
110048445|NCT04662944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110048454|NCT04644237|Trastuzumab|trastuzumab|mesh-list
110048455|NCT04644237|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
110048456|NCT04644237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110048457|NCT04644237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110048458|NCT04644237|Immunoconjugates|immunoconjugates|mesh-ancestor
110048459|NCT04644237|Immunologic Factors|immunologic factors|mesh-ancestor
110048460|NCT04644237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110048462|NCT04635826|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110048463|NCT04635826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110048464|NCT04629781|Docetaxel|docetaxel|mesh-list
110048465|NCT04629781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110048466|NCT04629781|Tubulin Modulators|tubulin modulators|mesh-ancestor
110048467|NCT04629781|Antimitotic Agents|antimitotic agents|mesh-ancestor
110048468|NCT04629781|Mitosis Modulators|mitosis modulators|mesh-ancestor
110048469|NCT04629781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110048470|NCT04624945|Thromboplastin|thromboplastin|mesh-list
110048471|NCT04624945|Hemostatics|hemostatics|mesh-ancestor
110048472|NCT04624945|Coagulants|coagulants|mesh-ancestor
110048473|NCT04623216|Azacitidine|azacitidine|mesh-list
110048474|NCT04623216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110048475|NCT04623216|Antimetabolites|antimetabolites|mesh-ancestor
110048476|NCT04623216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110048477|NCT04623216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110048478|NCT04623216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110048480|NCT04608474|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
110048481|NCT04608474|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110048482|NCT04608474|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110048483|NCT04608474|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110048484|NCT04608474|Antimetabolites|antimetabolites|mesh-ancestor
110048485|NCT04608474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110048486|NCT04608474|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110048487|NCT04608474|Protease Inhibitors|protease inhibitors|mesh-ancestor
110048488|NCT04608474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110048489|NCT04608474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110048490|NCT04600414|Analgesics, Opioid|analgesics, opioid|mesh-list
110048491|NCT04600414|Narcotics|narcotics|mesh-ancestor
110048492|NCT04600414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110048493|NCT04600414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110048494|NCT04600414|Analgesics|analgesics|mesh-ancestor
110048495|NCT04600414|Sensory System Agents|sensory system agents|mesh-ancestor
110048496|NCT04600414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110048497|NCT04593043|Warfarin|warfarin|mesh-list
110048498|NCT04593043|Dabigatran|dabigatran|mesh-list
110048499|NCT04593043|Anticoagulants|anticoagulants|mesh-ancestor
110048500|NCT04593043|Antithrombins|antithrombins|mesh-ancestor
110048501|NCT04593043|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110048502|NCT04593043|Protease Inhibitors|protease inhibitors|mesh-ancestor
110048503|NCT04593043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110048504|NCT04593043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110048505|NCT04593030|Warfarin|warfarin|mesh-list
110048506|NCT04593030|Apixaban|apixaban|mesh-list
110048507|NCT04593030|Anticoagulants|anticoagulants|mesh-ancestor
110048508|NCT04593030|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110048509|NCT04593030|Antithrombins|antithrombins|mesh-ancestor
110048510|NCT04593030|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110048511|NCT04593030|Protease Inhibitors|protease inhibitors|mesh-ancestor
110048512|NCT04593030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110048513|NCT04593030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110048514|NCT04589663|Mometasone Furoate|mometasone furoate|mesh-list
110048515|NCT04589663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110048516|NCT04589663|Dermatologic Agents|dermatologic agents|mesh-ancestor
110048517|NCT04589663|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110048518|NCT04588311|Epoetin Alfa|epoetin alfa|mesh-list
110048519|NCT04588311|Hematinics|hematinics|mesh-ancestor
110048520|NCT04532229|Nimotuzumab|nimotuzumab|mesh-list
110048521|NCT04532229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110048522|NCT04532229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110048523|NCT04518410|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
110048524|NCT04518410|Bamlanivimab|bamlanivimab|mesh-list
110048526|NCT04518410|Gabexate|gabexate|mesh-list
110048527|NCT04518410|Immunoglobulins|immunoglobulins|mesh-list
110048528|NCT04518410|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110048529|NCT04518410|Antibodies|antibodies|mesh-list
110048530|NCT04518410|Camostat|camostat|mesh-list
110048531|NCT04518410|Immunologic Factors|immunologic factors|mesh-ancestor
110048532|NCT04518410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110048533|NCT04518410|Antiviral Agents|antiviral agents|mesh-ancestor
110048534|NCT04518410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110048535|NCT04518410|Protease Inhibitors|protease inhibitors|mesh-ancestor
110048536|NCT04518410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110048537|NCT04518410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110048538|NCT04518410|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110048539|NCT04518410|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110048540|NCT04518410|Anticoagulants|anticoagulants|mesh-ancestor
110048541|NCT04507204|Methylphenidate|methylphenidate|mesh-list
110048542|NCT04507204|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110048543|NCT04507204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110048544|NCT04507204|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110048545|NCT04507204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110048546|NCT04507204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110048547|NCT04507204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110048548|NCT04507204|Dopamine Agents|dopamine agents|mesh-ancestor
110048549|NCT04507204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110048550|NCT04486391|Tislelizumab|tislelizumab|mesh-list
110048551|NCT04486391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110048552|NCT04486391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110048553|NCT04435834|Propofol|propofol|mesh-list
110048554|NCT04435834|Sevoflurane|sevoflurane|mesh-list
110048555|NCT04435834|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110048556|NCT04435834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110048557|NCT04435834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110048558|NCT04435834|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110048559|NCT04435834|Anesthetics, General|anesthetics, general|mesh-ancestor
110048561|NCT04435834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110048562|NCT04435834|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110048563|NCT04345341|Bupivacaine|bupivacaine|mesh-list
110048564|NCT04345341|Anesthetics, Local|anesthetics, local|mesh-ancestor
110048565|NCT04345341|Anesthetics|anesthetics|mesh-ancestor
110048566|NCT04345341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110048567|NCT04345341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110048568|NCT04345341|Sensory System Agents|sensory system agents|mesh-ancestor
110048569|NCT04345341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110048570|NCT04332744|Talazoparib|talazoparib|mesh-list
110048571|NCT04332744|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110048572|NCT04332744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110048573|NCT04332744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110048574|NCT04332744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110048575|NCT04331002|Triamcinolone|triamcinolone|mesh-list
110048576|NCT04331002|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110048577|NCT04331002|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110048578|NCT04331002|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110048579|NCT04331002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110048580|NCT04331002|Glucocorticoids|glucocorticoids|mesh-ancestor
110048581|NCT04331002|Hormones|hormones|mesh-ancestor
110053075|NCT01484613|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110048582|NCT04331002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110048583|NCT04331002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110048584|NCT04331002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110048585|NCT04331002|Immunologic Factors|immunologic factors|mesh-ancestor
110048586|NCT04331002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110048587|NCT04331002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110048588|NCT04291820|Anesthetics|anesthetics|mesh-list
110048589|NCT04291820|Sevoflurane|sevoflurane|mesh-list
110048590|NCT04291820|Desflurane|desflurane|mesh-list
110048591|NCT04291820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110048592|NCT04291820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110048593|NCT04291820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110048594|NCT04291820|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110048595|NCT04291820|Anesthetics, General|anesthetics, general|mesh-ancestor
110048596|NCT04279054|Morphine|morphine|mesh-list
110048597|NCT04279054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110048599|NCT04279054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110048600|NCT04279054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110048601|NCT04279054|Analgesics|analgesics|mesh-ancestor
110048602|NCT04279054|Sensory System Agents|sensory system agents|mesh-ancestor
110048617|NCT04237935|Ticagrelor|ticagrelor|mesh-list
110048618|NCT04237935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110048619|NCT04237935|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110048620|NCT04237935|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110048621|NCT04237935|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110048622|NCT04237935|Purinergic Agents|purinergic agents|mesh-ancestor
110048623|NCT04237935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110048624|NCT04237935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110048625|NCT04237935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110048627|NCT04237922|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110048628|NCT04237922|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110048629|NCT04237922|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110048630|NCT04237922|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110048631|NCT04237922|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110048632|NCT04237922|Purinergic Agents|purinergic agents|mesh-ancestor
110048633|NCT04237922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110048634|NCT04237922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110048635|NCT04237922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110048637|NCT04233021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110048638|NCT04233021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110048639|NCT04233021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110048640|NCT04233021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110048641|NCT04229004|Paclitaxel|paclitaxel|mesh-list
110048642|NCT04229004|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110048643|NCT04229004|Gemcitabine|gemcitabine|mesh-list
110048644|NCT04229004|Spartalizumab|spartalizumab|mesh-list
110048734|NCT04126070|Tubulin Modulators|tubulin modulators|mesh-ancestor
110048645|NCT04229004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110048646|NCT04229004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110048647|NCT04229004|Tubulin Modulators|tubulin modulators|mesh-ancestor
110048648|NCT04229004|Antimitotic Agents|antimitotic agents|mesh-ancestor
110048649|NCT04229004|Mitosis Modulators|mitosis modulators|mesh-ancestor
110048650|NCT04229004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110048651|NCT04229004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110048652|NCT04229004|Antimetabolites|antimetabolites|mesh-ancestor
110048653|NCT04229004|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110053076|NCT01484613|Contraceptive Agents|contraceptive agents|mesh-ancestor
110048654|NCT04229004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110048655|NCT04228289|Oxytocin|oxytocin|mesh-list
110048656|NCT04228289|Oxytocics|oxytocics|mesh-ancestor
110048657|NCT04228289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110048658|NCT04228289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110048659|NCT04227821|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
110048660|NCT04215536|Empagliflozin|empagliflozin|mesh-list
110048661|NCT04215536|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
110048662|NCT04215536|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110048663|NCT04215536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110048664|NCT04215536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110048665|NCT04215536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110048672|NCT04215523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110048673|NCT04215523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110048674|NCT04215523|Protease Inhibitors|protease inhibitors|mesh-ancestor
110048675|NCT04215523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110048677|NCT04169347|Oxaliplatin|oxaliplatin|mesh-list
110048678|NCT04169347|Irinotecan|irinotecan|mesh-list
110048679|NCT04169347|Panitumumab|panitumumab|mesh-list
110048680|NCT04169347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110048681|NCT04169347|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110048682|NCT04169347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110048683|NCT04169347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110048684|NCT04169347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110048685|NCT04169347|Antidotes|antidotes|mesh-ancestor
110048686|NCT04169347|Protective Agents|protective agents|mesh-ancestor
110048687|NCT04169347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110048688|NCT04169347|Vitamin B Complex|vitamin b complex|mesh-ancestor
110048689|NCT04169347|Vitamins|vitamins|mesh-ancestor
110048690|NCT04169347|Micronutrients|micronutrients|mesh-ancestor
110048691|NCT04169347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110048692|NCT04155424|Eculizumab|eculizumab|mesh-list
110048693|NCT04155424|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110048694|NCT04155424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110048695|NCT04155424|Immunologic Factors|immunologic factors|mesh-ancestor
110048696|NCT04155424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110048697|NCT04150939|Immunomodulating Agents|immunomodulating agents|mesh-list
110048698|NCT04150939|Immunologic Factors|immunologic factors|mesh-list
110048699|NCT04150939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110048706|NCT04135937|Bupropion|bupropion|mesh-list
110048707|NCT04135937|Nicotine|nicotine|mesh-list
110048708|NCT04135937|Varenicline|varenicline|mesh-list
110048709|NCT04135937|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110048710|NCT04135937|Autonomic Agents|autonomic agents|mesh-ancestor
110048711|NCT04135937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110048712|NCT04135937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110048713|NCT04135937|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110048714|NCT04135937|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110048715|NCT04135937|Cholinergic Agents|cholinergic agents|mesh-ancestor
110048716|NCT04135937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110048717|NCT04135937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110048718|NCT04135937|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110048719|NCT04135937|Antidepressive Agents|antidepressive agents|mesh-ancestor
110048720|NCT04135937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110048721|NCT04135937|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110048722|NCT04135937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110048723|NCT04135937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110048724|NCT04135937|Dopamine Agents|dopamine agents|mesh-ancestor
110048725|NCT04135937|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110048727|NCT04135937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110048728|NCT04126070|Docetaxel|docetaxel|mesh-list
110048729|NCT04126070|Nivolumab|nivolumab|mesh-list
110048730|NCT04126070|Leuprolide|leuprolide|mesh-list
110048731|NCT04126070|Goserelin|goserelin|mesh-list
110048732|NCT04126070|Androgens|androgens|mesh-list
110048733|NCT04126070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110048736|NCT04126070|Mitosis Modulators|mitosis modulators|mesh-ancestor
110048737|NCT04126070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110048738|NCT04126070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110048739|NCT04126070|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110048740|NCT04126070|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110048741|NCT04126070|Fertility Agents|fertility agents|mesh-ancestor
110048742|NCT04126070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110048743|NCT04126070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110048744|NCT04126070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110048745|NCT04126070|Hormones|hormones|mesh-ancestor
110048746|NCT04126070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110048748|NCT04120987|Lifitegrast|lifitegrast|mesh-list
110048749|NCT04120987|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110048750|NCT04028765|Misoprostol|misoprostol|mesh-list
110048751|NCT04028765|Oxytocin|oxytocin|mesh-list
110048752|NCT04028765|Oxytocics|oxytocics|mesh-ancestor
110048753|NCT04028765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110048754|NCT04028765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110048755|NCT04028765|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110048756|NCT04028765|Abortifacient Agents|abortifacient agents|mesh-ancestor
110048757|NCT04028765|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110048758|NCT04028765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110048759|NCT04019093|Ethanol|ethanol|mesh-list
110048760|NCT04019093|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110048761|NCT04019093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110048762|NCT04019093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110048763|NCT04019093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110048764|NCT04003636|Cisplatin|cisplatin|mesh-list
110048765|NCT04003636|Gemcitabine|gemcitabine|mesh-list
110048766|NCT04003636|Pembrolizumab|pembrolizumab|mesh-list
110048767|NCT04003636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110048768|NCT04003636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110048769|NCT04003636|Antimetabolites|antimetabolites|mesh-ancestor
110048770|NCT04003636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110048771|NCT04003636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110048772|NCT04003636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110048773|NCT03978598|Etonogestrel|etonogestrel|mesh-list
110048774|NCT03978598|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110048775|NCT03978598|Contraceptive Agents|contraceptive agents|mesh-ancestor
110048778|NCT03978598|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110048780|NCT03975231|Dabrafenib|dabrafenib|mesh-list
110048781|NCT03975231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110048782|NCT03975231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110048783|NCT03975231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110048784|NCT03975231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110048785|NCT03972488|Octreotide|octreotide|mesh-list
110048786|NCT03972488|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
110048787|NCT03972488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110048789|NCT03972488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110048790|NCT03972488|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110048791|NCT03972488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110048792|NCT03943537|Insulin|insulin|mesh-list
110048793|NCT03943537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110048794|NCT03943537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110048795|NCT03937830|Bevacizumab|bevacizumab|mesh-list
110048796|NCT03937830|Durvalumab|durvalumab|mesh-list
110048797|NCT03937830|Doxorubicin|doxorubicin|mesh-list
110048798|NCT03937830|Tremelimumab|tremelimumab|mesh-list
110048799|NCT03937830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110048800|NCT03937830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110048801|NCT03937830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110048802|NCT03937830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110048804|NCT03937830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110048805|NCT03937830|Growth Inhibitors|growth inhibitors|mesh-ancestor
110048806|NCT03937830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110048807|NCT03937830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110048808|NCT03937830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110048809|NCT03937830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110048810|NCT03937830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110048811|NCT03936062|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110048812|NCT03936062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110048813|NCT03936062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110048814|NCT03936062|Incretins|incretins|mesh-ancestor
110048816|NCT03936062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110048817|NCT03936062|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110048818|NCT03936062|Protease Inhibitors|protease inhibitors|mesh-ancestor
110048819|NCT03936062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110048820|NCT03936062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110048821|NCT03936049|Liraglutide|liraglutide|mesh-list
110048822|NCT03936049|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
110048823|NCT03936049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110048824|NCT03936049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110048825|NCT03936049|Incretins|incretins|mesh-ancestor
110048826|NCT03936049|Hormones|hormones|mesh-ancestor
110048827|NCT03936049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110048828|NCT03936049|Protease Inhibitors|protease inhibitors|mesh-ancestor
110048829|NCT03936049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110048830|NCT03936049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110048831|NCT03936036|Linagliptin|linagliptin|mesh-list
110048832|NCT03936036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110048833|NCT03936036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110048834|NCT03936036|Incretins|incretins|mesh-ancestor
110048835|NCT03936036|Hormones|hormones|mesh-ancestor
110048836|NCT03936036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110048837|NCT03936036|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110048838|NCT03936036|Protease Inhibitors|protease inhibitors|mesh-ancestor
110048839|NCT03936036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110048840|NCT03936036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110048841|NCT03936010|Canagliflozin|canagliflozin|mesh-list
110048842|NCT03936010|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
110048843|NCT03936010|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110048844|NCT03936010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110048845|NCT03936010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110048847|NCT03936010|Protease Inhibitors|protease inhibitors|mesh-ancestor
110048848|NCT03936010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110048849|NCT03934372|Ponatinib|ponatinib|mesh-list
110048850|NCT03934372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110048851|NCT03934372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110048852|NCT03934372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110048853|NCT03934372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110048854|NCT03919448|Bevacizumab|bevacizumab|mesh-list
110048855|NCT03919448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110048856|NCT03919448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110048857|NCT03919448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110048858|NCT03919448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110048859|NCT03919448|Growth Substances|growth substances|mesh-ancestor
110048860|NCT03919448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110048861|NCT03919448|Growth Inhibitors|growth inhibitors|mesh-ancestor
110048862|NCT03900637|Letrozole|letrozole|mesh-list
110048863|NCT03900637|Leuprolide|leuprolide|mesh-list
110048864|NCT03900637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110048865|NCT03900637|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110048866|NCT03900637|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110048867|NCT03900637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110048868|NCT03900637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110048869|NCT03900637|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110048870|NCT03900637|Hormone Antagonists|hormone antagonists|mesh-ancestor
110048871|NCT03900637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110048872|NCT03900637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110048873|NCT03900637|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110048874|NCT03900637|Fertility Agents|fertility agents|mesh-ancestor
110048875|NCT03900637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110048876|NCT03900637|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110048877|NCT03893045|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
110048878|NCT03893045|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
110048879|NCT03893045|Hematinics|hematinics|mesh-ancestor
110048880|NCT03893045|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110048881|NCT03893045|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110048882|NCT03877354|Anesthetics|anesthetics|mesh-list
110048883|NCT03877354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110048884|NCT03877354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110048885|NCT03867344|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110048886|NCT03867344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110048887|NCT03821272|Vaccines|vaccines|mesh-list
110048889|NCT03821272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110048890|NCT03818737|Methylprednisolone|methylprednisolone|mesh-list
110048891|NCT03818737|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110048892|NCT03818737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110048893|NCT03818737|Antiemetics|antiemetics|mesh-ancestor
110048894|NCT03818737|Autonomic Agents|autonomic agents|mesh-ancestor
110048895|NCT03818737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110048896|NCT03818737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110048897|NCT03818737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110048898|NCT03818737|Glucocorticoids|glucocorticoids|mesh-ancestor
110048899|NCT03818737|Hormones|hormones|mesh-ancestor
110048900|NCT03818737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110048901|NCT03818737|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110048902|NCT03818737|Protective Agents|protective agents|mesh-ancestor
110048903|NCT03777982|Prednisone|prednisone|mesh-list
110048904|NCT03777982|Abiraterone Acetate|abiraterone acetate|mesh-list
110048905|NCT03777982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110048906|NCT03777982|Glucocorticoids|glucocorticoids|mesh-ancestor
110048907|NCT03777982|Hormones|hormones|mesh-ancestor
110048908|NCT03777982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110048909|NCT03777982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110048910|NCT03777982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110048911|NCT03777982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110048912|NCT03777982|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110048913|NCT03777982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110048914|NCT03777982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110048915|NCT03777982|Hormone Antagonists|hormone antagonists|mesh-ancestor
110048916|NCT03777982|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110048917|NCT03770416|Nivolumab|nivolumab|mesh-list
110048918|NCT03770416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110048919|NCT03770416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110048920|NCT03770416|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110048922|NCT03769025|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
110048923|NCT03769025|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110048925|NCT03769025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110048926|NCT03769025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110048927|NCT03769025|Analgesics|analgesics|mesh-ancestor
110048928|NCT03769025|Sensory System Agents|sensory system agents|mesh-ancestor
110048929|NCT03769025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110048930|NCT03769025|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110048932|NCT03762473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110048933|NCT03762473|Immunologic Factors|immunologic factors|mesh-ancestor
110048934|NCT03762473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110048935|NCT03762473|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110048936|NCT03762473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110048937|NCT03762473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110048938|NCT03761056|Cyclophosphamide|cyclophosphamide|mesh-list
110048939|NCT03761056|Fludarabine|fludarabine|mesh-list
110048940|NCT03761056|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
110048941|NCT03761056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110048942|NCT03761056|Immunologic Factors|immunologic factors|mesh-ancestor
110048943|NCT03761056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110048944|NCT03761056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110048945|NCT03761056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110048946|NCT03761056|Alkylating Agents|alkylating agents|mesh-ancestor
110048947|NCT03761056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110048948|NCT03761056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110048949|NCT03761056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110048950|NCT03761056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110048951|NCT03759366|Eculizumab|eculizumab|mesh-list
110048952|NCT03759366|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110048953|NCT03759366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110048954|NCT03759366|Immunologic Factors|immunologic factors|mesh-ancestor
110048955|NCT03759366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110048956|NCT03710343|Metformin|metformin|mesh-list
110048957|NCT03710343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110048958|NCT03710343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110048959|NCT03677596|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
110048960|NCT03677596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110048961|NCT03677596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110048962|NCT03677596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110048963|NCT03677596|Immunotoxins|immunotoxins|mesh-ancestor
110048965|NCT03677596|Immunologic Factors|immunologic factors|mesh-ancestor
110048966|NCT03677596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110048967|NCT03648021|Acetaminophen|acetaminophen|mesh-list
110048968|NCT03648021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110048969|NCT03648021|Analgesics|analgesics|mesh-ancestor
110048970|NCT03648021|Sensory System Agents|sensory system agents|mesh-ancestor
110048971|NCT03648021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110048972|NCT03648021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110048973|NCT03648021|Antipyretics|antipyretics|mesh-ancestor
110048974|NCT03613792|Fentanyl|fentanyl|mesh-list
110048975|NCT03613792|Midazolam|midazolam|mesh-list
110048976|NCT03613792|Ketamine|ketamine|mesh-list
110048977|NCT03613792|Remifentanil|remifentanil|mesh-list
110048978|NCT03613792|Analgesics|analgesics|mesh-ancestor
110048979|NCT03613792|Sensory System Agents|sensory system agents|mesh-ancestor
110048980|NCT03613792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110048981|NCT03613792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110048984|NCT03613792|Anesthetics, General|anesthetics, general|mesh-ancestor
110048985|NCT03613792|Anesthetics|anesthetics|mesh-ancestor
110048986|NCT03613792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110048987|NCT03613792|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110048988|NCT03613792|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110048989|NCT03613792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110048990|NCT03613792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110048991|NCT03613792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110048992|NCT03613792|Narcotics|narcotics|mesh-ancestor
110048993|NCT03613792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110048994|NCT03613792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110048995|NCT03613792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110048997|NCT03613792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110048998|NCT03613792|GABA Modulators|gaba modulators|mesh-ancestor
110048999|NCT03613792|GABA Agents|gaba agents|mesh-ancestor
110049000|NCT03612960|Nicotine|nicotine|mesh-list
110049001|NCT03612960|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110049002|NCT03612960|Autonomic Agents|autonomic agents|mesh-ancestor
110049003|NCT03612960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110049004|NCT03612960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110049005|NCT03612960|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110049006|NCT03612960|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110049007|NCT03612960|Cholinergic Agents|cholinergic agents|mesh-ancestor
110049008|NCT03612960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110049009|NCT03612960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110049010|NCT03611881|Nicotine|nicotine|mesh-list
110049011|NCT03611881|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110049012|NCT03611881|Autonomic Agents|autonomic agents|mesh-ancestor
110049013|NCT03611881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110049014|NCT03611881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110049015|NCT03611881|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110049016|NCT03611881|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110049017|NCT03611881|Cholinergic Agents|cholinergic agents|mesh-ancestor
110049018|NCT03611881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110049019|NCT03611881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110049020|NCT03595917|Prednisone|prednisone|mesh-list
110049022|NCT03595917|Blinatumomab|blinatumomab|mesh-list
110049023|NCT03595917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110049024|NCT03595917|Glucocorticoids|glucocorticoids|mesh-ancestor
110049026|NCT03595917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110049027|NCT03595917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110049028|NCT03595917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110049029|NCT03595917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110049030|NCT03595917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110049031|NCT03595917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110049032|NCT03595917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110049033|NCT03591510|Cytarabine|cytarabine|mesh-list
110049034|NCT03591510|Fludarabine|fludarabine|mesh-list
110049035|NCT03591510|Etoposide|etoposide|mesh-list
110049036|NCT03591510|Daunorubicin|daunorubicin|mesh-list
110049037|NCT03591510|Mitoxantrone|mitoxantrone|mesh-list
110049038|NCT03591510|Idarubicin|idarubicin|mesh-list
110049039|NCT03591510|Midostaurin|midostaurin|mesh-list
110049040|NCT03591510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110049041|NCT03591510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110049042|NCT03591510|Antimetabolites|antimetabolites|mesh-ancestor
110049043|NCT03591510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110049044|NCT03591510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110049045|NCT03591510|Immunologic Factors|immunologic factors|mesh-ancestor
110049046|NCT03591510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110049047|NCT03591510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110049048|NCT03591510|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110049049|NCT03591510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110049050|NCT03591510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110049051|NCT03591510|Antiviral Agents|antiviral agents|mesh-ancestor
110049052|NCT03591510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110049053|NCT03591510|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110049054|NCT03591510|Analgesics|analgesics|mesh-ancestor
110049055|NCT03591510|Sensory System Agents|sensory system agents|mesh-ancestor
110049056|NCT03591510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110049057|NCT03591510|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110049058|NCT03584516|Prednisone|prednisone|mesh-list
110049062|NCT03584516|Prednisolone|prednisolone|mesh-list
110049063|NCT03584516|Prednisolone acetate|prednisolone acetate|mesh-list
110049070|NCT03584516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110049071|NCT03584516|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110049072|NCT03584516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110049073|NCT03584516|Antiemetics|antiemetics|mesh-ancestor
110049074|NCT03584516|Autonomic Agents|autonomic agents|mesh-ancestor
110049075|NCT03584516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110049076|NCT03584516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110049077|NCT03584516|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110049078|NCT03584516|Protective Agents|protective agents|mesh-ancestor
110049079|NCT03575598|Nivolumab|nivolumab|mesh-list
110049080|NCT03575598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110049081|NCT03575598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110049082|NCT03575598|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110049083|NCT03575598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110049090|NCT03440567|Rituximab|rituximab|mesh-list
110049091|NCT03440567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110049092|NCT03440567|Avelumab|avelumab|mesh-list
110049093|NCT03440567|Carboplatin|carboplatin|mesh-list
110049094|NCT03440567|Etoposide|etoposide|mesh-list
110049095|NCT03440567|Ifosfamide|ifosfamide|mesh-list
110049096|NCT03440567|Isophosphamide mustard|isophosphamide mustard|mesh-list
110049097|NCT03440567|Etoposide phosphate|etoposide phosphate|mesh-list
110049098|NCT03440567|Antibodies|antibodies|mesh-list
110049099|NCT03440567|Immunoglobulins|immunoglobulins|mesh-list
110049100|NCT03440567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110049101|NCT03440567|Immunoglobulin G|immunoglobulin g|mesh-list
110049102|NCT03440567|Immunologic Factors|immunologic factors|mesh-ancestor
110049103|NCT03440567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110049104|NCT03440567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110049105|NCT03440567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110049106|NCT03440567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110049107|NCT03440567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110049108|NCT03440567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110049109|NCT03440567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110049110|NCT03440567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110049111|NCT03440567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110049112|NCT03440567|Alkylating Agents|alkylating agents|mesh-ancestor
110049113|NCT03425643|Gemcitabine|gemcitabine|mesh-list
110049114|NCT03425643|Pembrolizumab|pembrolizumab|mesh-list
110049115|NCT03425643|Pemetrexed|pemetrexed|mesh-list
110049116|NCT03425643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110049117|NCT03425643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110049118|NCT03425643|Antimetabolites|antimetabolites|mesh-ancestor
110049119|NCT03425643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110049120|NCT03425643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110049121|NCT03425643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110049122|NCT03425643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110049123|NCT03425643|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110049124|NCT03425643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110049125|NCT03423667|Acetylcysteine|acetylcysteine|mesh-list
110049126|NCT03423667|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110049127|NCT03423667|Antiviral Agents|antiviral agents|mesh-ancestor
110049128|NCT03423667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110049129|NCT03423667|Expectorants|expectorants|mesh-ancestor
110049130|NCT03423667|Respiratory System Agents|respiratory system agents|mesh-ancestor
110049131|NCT03423667|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110049132|NCT03423667|Antioxidants|antioxidants|mesh-ancestor
110049133|NCT03423667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110049134|NCT03423667|Protective Agents|protective agents|mesh-ancestor
110049135|NCT03423667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110049136|NCT03423667|Antidotes|antidotes|mesh-ancestor
110049137|NCT03419897|Tislelizumab|tislelizumab|mesh-list
110049138|NCT03419897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110049139|NCT03419897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110049140|NCT03406897|Vitamin D|vitamin d|mesh-list
110049141|NCT03406897|Cholecalciferol|cholecalciferol|mesh-list
110049142|NCT03406897|Vitamins|vitamins|mesh-ancestor
110049143|NCT03406897|Micronutrients|micronutrients|mesh-ancestor
110049144|NCT03406897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110049147|NCT03377049|Acetazolamide|acetazolamide|mesh-list
110049148|NCT03377049|Anticonvulsants|anticonvulsants|mesh-ancestor
110049149|NCT03377049|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110049150|NCT03377049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110049151|NCT03377049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110049152|NCT03377049|Diuretics|diuretics|mesh-ancestor
110049153|NCT03377049|Natriuretic Agents|natriuretic agents|mesh-ancestor
110049154|NCT03377049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110049155|NCT03355976|Nivolumab|nivolumab|mesh-list
110049156|NCT03355976|Ipilimumab|ipilimumab|mesh-list
110049157|NCT03355976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110049158|NCT03355976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110049159|NCT03355976|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110049160|NCT03355976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110049161|NCT03349450|Cyclophosphamide|cyclophosphamide|mesh-list
110049162|NCT03349450|Pembrolizumab|pembrolizumab|mesh-list
110049163|NCT03349450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110049164|NCT03349450|Immunologic Factors|immunologic factors|mesh-ancestor
110049165|NCT03349450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110049166|NCT03349450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110049167|NCT03349450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110049168|NCT03349450|Alkylating Agents|alkylating agents|mesh-ancestor
110049169|NCT03349450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110049170|NCT03349450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110049171|NCT03349450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110049172|NCT03349450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110049173|NCT03349450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110049174|NCT03341078|Ibudilast|ibudilast|mesh-list
110049175|NCT03341078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110036314|NCT01410214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110049176|NCT03341078|Autonomic Agents|autonomic agents|mesh-ancestor
110049177|NCT03341078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110049178|NCT03341078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110049179|NCT03341078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110049180|NCT03341078|Respiratory System Agents|respiratory system agents|mesh-ancestor
110049181|NCT03341078|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110049182|NCT03341078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110049183|NCT03341078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110049184|NCT03341078|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110049185|NCT03341078|Vasodilator Agents|vasodilator agents|mesh-ancestor
110049186|NCT03335488|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
110049188|NCT03335488|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110049189|NCT03335488|Protective Agents|protective agents|mesh-ancestor
110049190|NCT03335488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110049191|NCT03335488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110049192|NCT03323437|Risperidone|risperidone|mesh-list
110049193|NCT03323437|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110049195|NCT03323437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110049196|NCT03323437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110049197|NCT03323437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110049198|NCT03323437|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110049199|NCT03323437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110049200|NCT03323437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110049201|NCT03323437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110049202|NCT03323437|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110049203|NCT03323437|Dopamine Agents|dopamine agents|mesh-ancestor
110049204|NCT03244072|Moxifloxacin|moxifloxacin|mesh-list
110049205|NCT03244072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110049206|NCT03244072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110049207|NCT03244072|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110049208|NCT03244072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110049209|NCT03244072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110049210|NCT03244072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110049211|NCT03244072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110049214|NCT03215277|Certolizumab Pegol|certolizumab pegol|mesh-list
110049215|NCT03215277|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110049216|NCT03215277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110049217|NCT03215277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110049219|NCT03215277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110049222|NCT03214510|Hydromorphone|hydromorphone|mesh-list
110049223|NCT03214510|Bupivacaine|bupivacaine|mesh-list
110049224|NCT03214510|Anesthetics, Local|anesthetics, local|mesh-ancestor
110049225|NCT03214510|Anesthetics|anesthetics|mesh-ancestor
110049226|NCT03214510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110049227|NCT03214510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110049228|NCT03214510|Sensory System Agents|sensory system agents|mesh-ancestor
110049229|NCT03214510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110049230|NCT03214510|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110049231|NCT03214510|Narcotics|narcotics|mesh-ancestor
110049232|NCT03214510|Analgesics|analgesics|mesh-ancestor
110049233|NCT03214510|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110049234|NCT03214510|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110049235|NCT03214510|Anesthetics, General|anesthetics, general|mesh-ancestor
110049236|NCT03182907|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110049237|NCT03182907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110049238|NCT03170960|Atezolizumab|atezolizumab|mesh-list
110049239|NCT03170960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110049240|NCT03170960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110049241|NCT03170960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110049242|NCT03170960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110049243|NCT03016338|Niraparib|niraparib|mesh-list
110049244|NCT03016338|Dostarlimab|dostarlimab|mesh-list
110049245|NCT03016338|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110049246|NCT03016338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110049247|NCT03016338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110049248|NCT03016338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110049249|NCT02966756|Venetoclax|venetoclax|mesh-list
110049250|NCT02966756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110049251|NCT02922192|Antirheumatic Agents|antirheumatic agents|mesh-list
110049252|NCT02921191|Lenograstim|lenograstim|mesh-list
110049253|NCT02921191|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110049254|NCT02921191|Immunologic Factors|immunologic factors|mesh-ancestor
110049255|NCT02921191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110049256|NCT02911701|Acetaminophen|acetaminophen|mesh-list
110049257|NCT02911701|Ibuprofen|ibuprofen|mesh-list
110049258|NCT02911701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110049259|NCT02911701|Analgesics|analgesics|mesh-ancestor
110049260|NCT02911701|Sensory System Agents|sensory system agents|mesh-ancestor
110049261|NCT02911701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110049262|NCT02911701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110049263|NCT02911701|Antipyretics|antipyretics|mesh-ancestor
110049264|NCT02911701|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110049265|NCT02911701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110049266|NCT02911701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110049267|NCT02911701|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110049268|NCT02911701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110049269|NCT02911701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110049270|NCT02903368|Prednisone|prednisone|mesh-list
110049271|NCT02903368|Leuprolide|leuprolide|mesh-list
110049272|NCT02903368|Abiraterone Acetate|abiraterone acetate|mesh-list
110049273|NCT02903368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110049274|NCT02903368|Glucocorticoids|glucocorticoids|mesh-ancestor
110049275|NCT02903368|Hormones|hormones|mesh-ancestor
110049276|NCT02903368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110049277|NCT02903368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110049278|NCT02903368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110049279|NCT02903368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110049280|NCT02903368|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110049282|NCT02903368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110049283|NCT02903368|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110049284|NCT02903368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110049285|NCT02903368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110049286|NCT02903368|Hormone Antagonists|hormone antagonists|mesh-ancestor
110049287|NCT02903368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110049288|NCT02899052|Dexamethasone|dexamethasone|mesh-list
110049290|NCT02899052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110049291|NCT02899052|Antiemetics|antiemetics|mesh-ancestor
110049292|NCT02899052|Autonomic Agents|autonomic agents|mesh-ancestor
110049293|NCT02899052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110049294|NCT02899052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110049295|NCT02899052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110049302|NCT02874742|Lenalidomide|lenalidomide|mesh-list
110049303|NCT02874742|Bortezomib|bortezomib|mesh-list
110049304|NCT02874742|Daratumumab|daratumumab|mesh-list
110049305|NCT02874742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110049306|NCT02874742|Antiemetics|antiemetics|mesh-ancestor
110049307|NCT02874742|Autonomic Agents|autonomic agents|mesh-ancestor
110049308|NCT02874742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110049309|NCT02874742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110049310|NCT02874742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110049311|NCT02874742|Glucocorticoids|glucocorticoids|mesh-ancestor
110049312|NCT02874742|Hormones|hormones|mesh-ancestor
110049313|NCT02874742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110049314|NCT02874742|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110049315|NCT02874742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110049316|NCT02874742|Immunologic Factors|immunologic factors|mesh-ancestor
110049317|NCT02874742|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110049318|NCT02874742|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110049319|NCT02874742|Growth Substances|growth substances|mesh-ancestor
110049320|NCT02874742|Growth Inhibitors|growth inhibitors|mesh-ancestor
110049321|NCT02757859|Pancrelipase|pancrelipase|mesh-list
110049322|NCT02757859|Pancreatin|pancreatin|mesh-list
110049323|NCT02757859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110049324|NCT02749292|Rituximab|rituximab|mesh-list
110049325|NCT02749292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110049326|NCT02749292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110049327|NCT02749292|Immunologic Factors|immunologic factors|mesh-ancestor
110049328|NCT02749292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110049329|NCT02749292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110049330|NCT02715609|Copper|copper|mesh-list
110049331|NCT02715609|Temozolomide|temozolomide|mesh-list
110049332|NCT02715609|Disulfiram|disulfiram|mesh-list
110049333|NCT02715609|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110049334|NCT02715609|Alkylating Agents|alkylating agents|mesh-ancestor
110049335|NCT02715609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110049336|NCT02715609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110049337|NCT02715609|Trace Elements|trace elements|mesh-ancestor
110049338|NCT02715609|Micronutrients|micronutrients|mesh-ancestor
110049339|NCT02715609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110049340|NCT02715609|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110049341|NCT02715609|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
110049342|NCT02715609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110049343|NCT02714881|Certolizumab Pegol|certolizumab pegol|mesh-list
110049344|NCT02714881|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110049345|NCT02714881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110049346|NCT02714881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110049347|NCT02714881|Immunologic Factors|immunologic factors|mesh-ancestor
110049348|NCT02714881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110049349|NCT02714881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110049355|NCT02586831|Exenatide|exenatide|mesh-list
110049356|NCT02586831|Aldesleukin|aldesleukin|mesh-list
110049357|NCT02586831|Adalimumab|adalimumab|mesh-list
110049358|NCT02586831|Interleukin-2|interleukin-2|mesh-list
110049359|NCT02586831|Thymoglobulin|thymoglobulin|mesh-list
110049360|NCT02586831|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110049361|NCT02586831|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110049362|NCT02586831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110049363|NCT02586831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110049364|NCT02586831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110049365|NCT02586831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110049366|NCT02586831|Analgesics|analgesics|mesh-ancestor
110049367|NCT02586831|Sensory System Agents|sensory system agents|mesh-ancestor
110049368|NCT02586831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110049369|NCT02586831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110049370|NCT02586831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110049371|NCT02586831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110049372|NCT02586831|Antiviral Agents|antiviral agents|mesh-ancestor
110049374|NCT02586831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110049375|NCT02586831|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110049376|NCT02586831|Incretins|incretins|mesh-ancestor
110049378|NCT02586831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110049379|NCT02586831|Immunologic Factors|immunologic factors|mesh-ancestor
110049380|NCT02586831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110049381|NCT02576990|Pembrolizumab|pembrolizumab|mesh-list
110049382|NCT02576990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110049383|NCT02576990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110049384|NCT02576990|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110049385|NCT02576990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110049386|NCT02511106|Osimertinib|osimertinib|mesh-list
110049466|NCT02419495|Antimetabolites|antimetabolites|mesh-ancestor
110049387|NCT02511106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110049388|NCT02511106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110049389|NCT02511106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110049390|NCT02511106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110049391|NCT02494882|Dexamethasone|dexamethasone|mesh-list
110049392|NCT02494882|Dasatinib|dasatinib|mesh-list
110049393|NCT02494882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110049394|NCT02494882|Antiemetics|antiemetics|mesh-ancestor
110049395|NCT02494882|Autonomic Agents|autonomic agents|mesh-ancestor
110049396|NCT02494882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110049397|NCT02494882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110049398|NCT02494882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110049399|NCT02494882|Glucocorticoids|glucocorticoids|mesh-ancestor
110049400|NCT02494882|Hormones|hormones|mesh-ancestor
110049401|NCT02494882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110049402|NCT02494882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110049403|NCT02494882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110049404|NCT02494882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110049405|NCT02494882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110049406|NCT02494882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110049407|NCT02481830|Nivolumab|nivolumab|mesh-list
110049408|NCT02481830|Topotecan|topotecan|mesh-list
110049409|NCT02481830|Amrubicin|amrubicin|mesh-list
110049410|NCT02481830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110049411|NCT02481830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110049412|NCT02481830|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110049413|NCT02481830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110049414|NCT02481830|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110049415|NCT02481830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110049416|NCT02481830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110049417|NCT02425943|Mannitol|mannitol|mesh-list
110049418|NCT02425943|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110049419|NCT02425943|Diuretics|diuretics|mesh-ancestor
110049420|NCT02425943|Natriuretic Agents|natriuretic agents|mesh-ancestor
110049421|NCT02425943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110049422|NCT02419495|Calcium, Dietary|calcium, dietary|mesh-list
110049423|NCT02419495|Leucovorin|leucovorin|mesh-list
110049424|NCT02419495|Folic Acid|folic acid|mesh-list
110049425|NCT02419495|Paclitaxel|paclitaxel|mesh-list
110049426|NCT02419495|Camptothecin|camptothecin|mesh-list
110049427|NCT02419495|Cyclophosphamide|cyclophosphamide|mesh-list
110049428|NCT02419495|Carboplatin|carboplatin|mesh-list
110049429|NCT02419495|Doxorubicin|doxorubicin|mesh-list
110049430|NCT02419495|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110049431|NCT02419495|Pembrolizumab|pembrolizumab|mesh-list
110049432|NCT02419495|Fluorouracil|fluorouracil|mesh-list
110049433|NCT02419495|Capecitabine|capecitabine|mesh-list
110049434|NCT02419495|Oxaliplatin|oxaliplatin|mesh-list
110049435|NCT02419495|Nivolumab|nivolumab|mesh-list
110049436|NCT02419495|Irinotecan|irinotecan|mesh-list
110049437|NCT02419495|Pemetrexed|pemetrexed|mesh-list
110049438|NCT02419495|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110049439|NCT02419495|Ipilimumab|ipilimumab|mesh-list
110049440|NCT02419495|Daunorubicin|daunorubicin|mesh-list
110049441|NCT02419495|Topotecan|topotecan|mesh-list
110049442|NCT02419495|Olaparib|olaparib|mesh-list
110049443|NCT02419495|Calcium|calcium|mesh-list
110049444|NCT02419495|Levoleucovorin|levoleucovorin|mesh-list
110049445|NCT02419495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110049446|NCT02419495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110049447|NCT02419495|Tubulin Modulators|tubulin modulators|mesh-ancestor
110049448|NCT02419495|Antimitotic Agents|antimitotic agents|mesh-ancestor
110049449|NCT02419495|Mitosis Modulators|mitosis modulators|mesh-ancestor
110049450|NCT02419495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110049451|NCT02419495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110049452|NCT02419495|Immunologic Factors|immunologic factors|mesh-ancestor
110049453|NCT02419495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110049454|NCT02419495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110049455|NCT02419495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110049456|NCT02419495|Alkylating Agents|alkylating agents|mesh-ancestor
110049457|NCT02419495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110049458|NCT02419495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110049459|NCT02419495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110049460|NCT02419495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110049461|NCT02419495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110049462|NCT02419495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110049463|NCT02419495|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110049464|NCT02419495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110049465|NCT02419495|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110049467|NCT02419495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110049468|NCT02419495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110049469|NCT02419495|Antidotes|antidotes|mesh-ancestor
110049470|NCT02419495|Protective Agents|protective agents|mesh-ancestor
110049471|NCT02419495|Vitamin B Complex|vitamin b complex|mesh-ancestor
110049472|NCT02419495|Vitamins|vitamins|mesh-ancestor
110049473|NCT02419495|Micronutrients|micronutrients|mesh-ancestor
110049474|NCT02419495|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110049475|NCT02419495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110049476|NCT02419495|Hematinics|hematinics|mesh-ancestor
110053077|NCT01484613|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110049477|NCT02419495|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110049478|NCT02416674|Immunosuppressive Agents|immunosuppressive agents|mesh-list
110049479|NCT02416674|Immunologic Factors|immunologic factors|mesh-ancestor
110049480|NCT02416674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110049481|NCT02362997|Pembrolizumab|pembrolizumab|mesh-list
110049482|NCT02362997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110049483|NCT02362997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110049484|NCT02362997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110049485|NCT02362997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110049486|NCT02276443|Immunomodulating Agents|immunomodulating agents|mesh-list
110049487|NCT02276443|Immunologic Factors|immunologic factors|mesh-ancestor
110049488|NCT02276443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110049490|NCT02220426|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110049491|NCT02220426|Anesthetics, General|anesthetics, general|mesh-ancestor
110049492|NCT02220426|Anesthetics|anesthetics|mesh-ancestor
110049493|NCT02220426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110049494|NCT02220426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110049495|NCT02123121|Resveratrol|resveratrol|mesh-list
110049496|NCT02123121|Antioxidants|antioxidants|mesh-ancestor
110049497|NCT02123121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110049498|NCT02123121|Protective Agents|protective agents|mesh-ancestor
110049499|NCT02123121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110049500|NCT02123121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110049501|NCT02123121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110049502|NCT02009579|Nintedanib|nintedanib|mesh-list
110049503|NCT02009579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110049504|NCT02009579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110049505|NCT02009579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110049506|NCT02009579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110049507|NCT01959698|Rituximab|rituximab|mesh-list
110049508|NCT01959698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110049509|NCT01959698|Carboplatin|carboplatin|mesh-list
110049510|NCT01959698|Etoposide|etoposide|mesh-list
110049511|NCT01959698|Etoposide phosphate|etoposide phosphate|mesh-list
110049512|NCT01959698|Ifosfamide|ifosfamide|mesh-list
110049513|NCT01959698|Isophosphamide mustard|isophosphamide mustard|mesh-list
110049514|NCT01959698|Podophyllotoxin|podophyllotoxin|mesh-list
110049515|NCT01959698|Antibodies|antibodies|mesh-list
110049516|NCT01959698|Immunoglobulins|immunoglobulins|mesh-list
110049517|NCT01959698|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110049518|NCT01959698|Immunologic Factors|immunologic factors|mesh-ancestor
110049519|NCT01959698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110049520|NCT01959698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110049521|NCT01959698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110049522|NCT01959698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110049523|NCT01959698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110049524|NCT01959698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110049525|NCT01959698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110049526|NCT01959698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110049528|NCT01959698|Alkylating Agents|alkylating agents|mesh-ancestor
110049529|NCT01959698|Keratolytic Agents|keratolytic agents|mesh-ancestor
110049530|NCT01959698|Dermatologic Agents|dermatologic agents|mesh-ancestor
110049531|NCT01959698|Tubulin Modulators|tubulin modulators|mesh-ancestor
110049532|NCT01959698|Antimitotic Agents|antimitotic agents|mesh-ancestor
110049533|NCT01959698|Mitosis Modulators|mitosis modulators|mesh-ancestor
110049534|NCT01910402|Ritonavir|ritonavir|mesh-list
110049535|NCT01910402|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110049536|NCT01910402|Tenofovir|tenofovir|mesh-list
110049537|NCT01910402|Lamivudine|lamivudine|mesh-list
110049538|NCT01910402|Emtricitabine|emtricitabine|mesh-list
110049539|NCT01910402|Dolutegravir|dolutegravir|mesh-list
110049540|NCT01910402|Abacavir|abacavir|mesh-list
110049541|NCT01910402|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110049542|NCT01910402|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110049543|NCT01910402|Protease Inhibitors|protease inhibitors|mesh-ancestor
110049544|NCT01910402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110049696|NCT01042379|Pertuzumab|pertuzumab|mesh-list
110049545|NCT01910402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110049546|NCT01910402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110049547|NCT01910402|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110049548|NCT01910402|Antiviral Agents|antiviral agents|mesh-ancestor
110049549|NCT01910402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110049550|NCT01910402|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110049551|NCT01910402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110049552|NCT01910402|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110049553|NCT01910402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110049554|NCT01910402|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110049555|NCT01910402|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110049557|NCT01772420|Immunologic Factors|immunologic factors|mesh-ancestor
110049558|NCT01772420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110049559|NCT01772420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110049560|NCT01772420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110049561|NCT01772420|Growth Substances|growth substances|mesh-ancestor
110049562|NCT01772420|Growth Inhibitors|growth inhibitors|mesh-ancestor
110049563|NCT01772420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110049564|NCT01757535|Azacitidine|azacitidine|mesh-list
110049565|NCT01757535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110049566|NCT01757535|Antimetabolites|antimetabolites|mesh-ancestor
110049567|NCT01757535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110049568|NCT01757535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110049569|NCT01757535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110049571|NCT01734512|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110049572|NCT01734512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110049573|NCT01734512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110049574|NCT01734512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110049575|NCT01734512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110049576|NCT01734512|Immunologic Factors|immunologic factors|mesh-ancestor
110049577|NCT01734512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110049578|NCT01734512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110049579|NCT01728363|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110049580|NCT01728363|Rifampin|rifampin|mesh-list
110049581|NCT01728363|Clindamycin|clindamycin|mesh-list
110049582|NCT01728363|Clavulanic Acid|clavulanic acid|mesh-list
110049583|NCT01728363|Ticarcillin|ticarcillin|mesh-list
110049584|NCT01728363|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
110049585|NCT01728363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110049586|NCT01728363|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110049587|NCT01728363|Antitubercular Agents|antitubercular agents|mesh-ancestor
110049588|NCT01728363|Leprostatic Agents|leprostatic agents|mesh-ancestor
110049589|NCT01728363|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110049590|NCT01728363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110049591|NCT01728363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110049592|NCT01728363|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110049593|NCT01728363|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110049594|NCT01728363|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110049595|NCT01728363|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110049596|NCT01728363|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110049597|NCT01728363|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110049598|NCT01728363|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110049599|NCT01728363|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110049601|NCT01614197|Hydrocortisone|hydrocortisone|mesh-list
110049602|NCT01614197|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110049603|NCT01614197|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110049604|NCT01614197|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110049605|NCT01614197|Cyclophosphamide|cyclophosphamide|mesh-list
110049606|NCT01614197|Methotrexate|methotrexate|mesh-list
110049607|NCT01614197|Etoposide|etoposide|mesh-list
110049608|NCT01614197|Temsirolimus|temsirolimus|mesh-list
110049609|NCT01614197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110049610|NCT01614197|Immunologic Factors|immunologic factors|mesh-ancestor
110049611|NCT01614197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110049612|NCT01614197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110049613|NCT01614197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110049614|NCT01614197|Alkylating Agents|alkylating agents|mesh-ancestor
110049615|NCT01614197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110049616|NCT01614197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110049617|NCT01614197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110049618|NCT01614197|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110049619|NCT01614197|Abortifacient Agents|abortifacient agents|mesh-ancestor
110049620|NCT01614197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110049621|NCT01614197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110049623|NCT01614197|Dermatologic Agents|dermatologic agents|mesh-ancestor
110049624|NCT01614197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110049625|NCT01614197|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110049626|NCT01614197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110049627|NCT01614197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110049628|NCT01614197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110049629|NCT01614197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110049630|NCT01614197|Antiviral Agents|antiviral agents|mesh-ancestor
110049631|NCT01614197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110049632|NCT01614197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110049633|NCT01614197|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110049634|NCT01614197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110049635|NCT01422148|Minocycline|minocycline|mesh-list
110049636|NCT01422148|Amiodarone|amiodarone|mesh-list
110049637|NCT01422148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110049638|NCT01422148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110049639|NCT01422148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110049640|NCT01422148|Vasodilator Agents|vasodilator agents|mesh-ancestor
110049641|NCT01422148|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110049642|NCT01422148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110049643|NCT01422148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110049644|NCT01422148|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110049645|NCT01422148|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110049646|NCT01422148|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110049647|NCT01422148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110049648|NCT01422148|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110049649|NCT01422148|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110049650|NCT01422148|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110049651|NCT01341964|Aspirin|aspirin|mesh-list
110049652|NCT01341964|Clopidogrel|clopidogrel|mesh-list
110049653|NCT01341964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110049654|NCT01341964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110049655|NCT01341964|Analgesics|analgesics|mesh-ancestor
110049656|NCT01341964|Sensory System Agents|sensory system agents|mesh-ancestor
110052905|NCT01482754|Rituximab|rituximab|mesh-list
110049657|NCT01341964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110049658|NCT01341964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110049659|NCT01341964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110049660|NCT01341964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110049661|NCT01341964|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110049662|NCT01341964|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110049663|NCT01341964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110049664|NCT01341964|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110049665|NCT01341964|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110049666|NCT01341964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110049667|NCT01341964|Antipyretics|antipyretics|mesh-ancestor
110049668|NCT01341964|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110049669|NCT01341964|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110049670|NCT01341964|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110049671|NCT01341964|Purinergic Agents|purinergic agents|mesh-ancestor
110049672|NCT01341964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110049673|NCT01267812|Rituximab|rituximab|mesh-list
110049674|NCT01267812|Bortezomib|bortezomib|mesh-list
110049675|NCT01267812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110049676|NCT01267812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110049677|NCT01267812|Immunologic Factors|immunologic factors|mesh-ancestor
110049678|NCT01267812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110049679|NCT01267812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110049680|NCT01236521|Analgesics|analgesics|mesh-list
110049681|NCT01236521|Sensory System Agents|sensory system agents|mesh-ancestor
110049682|NCT01236521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110049683|NCT01236521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110049684|NCT01042379|Metformin|metformin|mesh-list
110049685|NCT01042379|Paclitaxel|paclitaxel|mesh-list
110049686|NCT01042379|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
110049687|NCT01042379|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110049688|NCT01042379|Carboplatin|carboplatin|mesh-list
110049689|NCT01042379|Doxorubicin|doxorubicin|mesh-list
110049690|NCT01042379|Pembrolizumab|pembrolizumab|mesh-list
110049691|NCT01042379|Trastuzumab|trastuzumab|mesh-list
110049692|NCT01042379|Irinotecan|irinotecan|mesh-list
110049693|NCT01042379|Durvalumab|durvalumab|mesh-list
110049694|NCT01042379|Letrozole|letrozole|mesh-list
110049695|NCT01042379|Olaparib|olaparib|mesh-list
110049697|NCT01042379|Veliparib|veliparib|mesh-list
110049698|NCT01042379|Cemiplimab|cemiplimab|mesh-list
110049699|NCT01042379|Talazoparib|talazoparib|mesh-list
110049700|NCT01042379|Dostarlimab|dostarlimab|mesh-list
110049701|NCT01042379|Trebananib|trebananib|mesh-list
110049702|NCT01042379|Tucatinib|tucatinib|mesh-list
110049704|NCT01042379|SGN-LIV1A|sgn-liv1a|mesh-list
110049705|NCT01042379|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110049706|NCT01042379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110049707|NCT01042379|Tubulin Modulators|tubulin modulators|mesh-ancestor
110049708|NCT01042379|Antimitotic Agents|antimitotic agents|mesh-ancestor
110049709|NCT01042379|Mitosis Modulators|mitosis modulators|mesh-ancestor
110049710|NCT01042379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110049711|NCT01042379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110049712|NCT01042379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110049713|NCT01042379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110049714|NCT01042379|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110049715|NCT01042379|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110049716|NCT01042379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110049717|NCT01042379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110049718|NCT01042379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110049719|NCT01042379|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110049720|NCT01042379|Immunologic Factors|immunologic factors|mesh-ancestor
110049721|NCT01042379|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110049722|NCT01042379|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110049723|NCT01042379|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110049724|NCT01042379|Hormone Antagonists|hormone antagonists|mesh-ancestor
110049725|NCT01042379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110049726|NCT01042379|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110049727|NCT01042379|Immunotoxins|immunotoxins|mesh-ancestor
110049728|NCT01042379|Immunoconjugates|immunoconjugates|mesh-ancestor
110049729|NCT01042379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110049730|NCT01042379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110049731|NCT01042379|Growth Substances|growth substances|mesh-ancestor
110049732|NCT01042379|Growth Inhibitors|growth inhibitors|mesh-ancestor
110049733|NCT01042379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110049734|NCT00544115|Cyclosporine|cyclosporine|mesh-list
110049735|NCT00544115|Sirolimus|sirolimus|mesh-list
110052915|NCT01482897|Prednisolone acetate|prednisolone acetate|mesh-list
110049736|NCT00544115|Mycophenolic Acid|mycophenolic acid|mesh-list
110049738|NCT00544115|Melphalan|melphalan|mesh-list
110049739|NCT00544115|Busulfan|busulfan|mesh-list
110049740|NCT00544115|Methotrexate|methotrexate|mesh-list
110049741|NCT00544115|Fludarabine|fludarabine|mesh-list
110049742|NCT00544115|Fludarabine phosphate|fludarabine phosphate|mesh-list
110049743|NCT00544115|Etoposide|etoposide|mesh-list
110049744|NCT00544115|Tacrolimus|tacrolimus|mesh-list
110049745|NCT00544115|Cyclosporins|cyclosporins|mesh-list
110049746|NCT00544115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110049747|NCT00544115|Immunologic Factors|immunologic factors|mesh-ancestor
110049748|NCT00544115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110049749|NCT00544115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110049750|NCT00544115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110049751|NCT00544115|Alkylating Agents|alkylating agents|mesh-ancestor
110049752|NCT00544115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110049753|NCT00544115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110049754|NCT00544115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110049755|NCT00544115|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110049756|NCT00544115|Abortifacient Agents|abortifacient agents|mesh-ancestor
110049757|NCT00544115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110049758|NCT00544115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110049759|NCT00544115|Antimetabolites|antimetabolites|mesh-ancestor
110049760|NCT00544115|Dermatologic Agents|dermatologic agents|mesh-ancestor
110049761|NCT00544115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110049762|NCT00544115|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110049763|NCT00544115|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110049764|NCT00544115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110049765|NCT00544115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110049766|NCT00544115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110049767|NCT00544115|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110049768|NCT00544115|Antifungal Agents|antifungal agents|mesh-ancestor
110049769|NCT00544115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110049770|NCT00544115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110049771|NCT00544115|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110049772|NCT00544115|Antitubercular Agents|antitubercular agents|mesh-ancestor
110049773|NCT00544115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110049774|NCT01455350|Lidocaine|lidocaine|mesh-list
110049775|NCT01455350|Anesthetics, Local|anesthetics, local|mesh-ancestor
110049776|NCT01455350|Anesthetics|anesthetics|mesh-ancestor
110049777|NCT01455350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110049778|NCT01455350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110049779|NCT01455350|Sensory System Agents|sensory system agents|mesh-ancestor
110049780|NCT01455350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110049781|NCT01455350|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110049782|NCT01455350|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110049783|NCT01455350|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110049784|NCT01455350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110049785|NCT01455350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110049787|NCT01455636|Trace Elements|trace elements|mesh-list
110049788|NCT01455636|Hand Sanitizers|hand sanitizers|mesh-list
110049789|NCT01455636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110049790|NCT01455636|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110049791|NCT01455636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110049792|NCT01455636|Disinfectants|disinfectants|mesh-ancestor
110049793|NCT01456078|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
110049794|NCT01456078|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110049795|NCT01456078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110049796|NCT01456507|Naltrexone|naltrexone|mesh-list
110049797|NCT01456507|Oxycodone|oxycodone|mesh-list
110049798|NCT01456507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110049799|NCT01456507|Narcotics|narcotics|mesh-ancestor
110049800|NCT01456507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110049801|NCT01456507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110049802|NCT01456507|Analgesics|analgesics|mesh-ancestor
110049803|NCT01456507|Sensory System Agents|sensory system agents|mesh-ancestor
110049804|NCT01456507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110049805|NCT01456507|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110049806|NCT01456507|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110049807|NCT01456585|Gemcitabine|gemcitabine|mesh-list
110049808|NCT01456585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110049809|NCT01456585|Antimetabolites|antimetabolites|mesh-ancestor
110049810|NCT01456585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110049811|NCT01456585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110049812|NCT01456650|Glyburide|glyburide|mesh-list
110049814|NCT01456650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110049816|NCT01457040|Etoposide phosphate|etoposide phosphate|mesh-list
110049817|NCT01457040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110049818|NCT01457040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110049819|NCT01457040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110049820|NCT01457040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110049821|NCT01457040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110049822|NCT01457040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110049823|NCT01457508|Edetic Acid|edetic acid|mesh-list
110049824|NCT01457508|Pentetic Acid|pentetic acid|mesh-list
110049825|NCT01457508|Antidotes|antidotes|mesh-ancestor
110049826|NCT01457508|Protective Agents|protective agents|mesh-ancestor
110049827|NCT01457508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110049828|NCT01457508|Chelating Agents|chelating agents|mesh-ancestor
110049829|NCT01457508|Sequestering Agents|sequestering agents|mesh-ancestor
110049830|NCT01457508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110049831|NCT01457508|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110049832|NCT01457508|Anticoagulants|anticoagulants|mesh-ancestor
110049833|NCT01457508|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110049834|NCT01458431|Anesthetics|anesthetics|mesh-list
110049835|NCT01458431|Levobupivacaine|levobupivacaine|mesh-list
110049836|NCT01458431|Anesthetics, Local|anesthetics, local|mesh-list
110049837|NCT01458431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110049838|NCT01458431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110049839|NCT01458431|Sensory System Agents|sensory system agents|mesh-ancestor
110049840|NCT01458431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110049841|NCT01458808|Dialysis Solutions|dialysis solutions|mesh-list
110049842|NCT01458808|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110049843|NCT01459445|Metformin|metformin|mesh-list
110049844|NCT01459445|Drospirenone|drospirenone|mesh-list
110049845|NCT01459445|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110049846|NCT01459445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110049847|NCT01459445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110049848|NCT01459445|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110049849|NCT01459445|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110049850|NCT01459445|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110049851|NCT01459445|Contraceptive Agents|contraceptive agents|mesh-ancestor
110049852|NCT01459445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110049853|NCT01459445|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110049855|NCT01459445|Hormones|hormones|mesh-ancestor
110049856|NCT01459445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110049857|NCT01459445|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110049858|NCT01459445|Hormone Antagonists|hormone antagonists|mesh-ancestor
110049859|NCT01459445|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110049861|NCT01459445|Natriuretic Agents|natriuretic agents|mesh-ancestor
110049862|NCT01460030|Cinacalcet|cinacalcet|mesh-list
110049863|NCT01460030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110049864|NCT01460030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110049865|NCT01460030|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
110049866|NCT01460030|Hormone Antagonists|hormone antagonists|mesh-ancestor
110049867|NCT01460030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110049868|NCT01460069|Liraglutide|liraglutide|mesh-list
110049869|NCT01460069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110049870|NCT01460069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110049871|NCT01460069|Incretins|incretins|mesh-ancestor
110049872|NCT01460069|Hormones|hormones|mesh-ancestor
110049873|NCT01460069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110049874|NCT01460134|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110049875|NCT01460134|Immunologic Factors|immunologic factors|mesh-ancestor
110049876|NCT01460134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110049877|NCT01460212|Fluvoxamine|fluvoxamine|mesh-list
110049878|NCT01460212|Citalopram|citalopram|mesh-list
110049879|NCT01460212|Fluoxetine|fluoxetine|mesh-list
110049880|NCT01460212|Paroxetine|paroxetine|mesh-list
110049881|NCT01460212|Sertraline|sertraline|mesh-list
110049882|NCT01460212|Antidepressive Agents|antidepressive agents|mesh-list
110049883|NCT01460212|Escitalopram|escitalopram|mesh-list
110049884|NCT01460212|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110049885|NCT01460212|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110049886|NCT01460212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110049887|NCT01460212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110049889|NCT01460212|Serotonin Agents|serotonin agents|mesh-ancestor
110049890|NCT01460212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110049891|NCT01460212|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110049892|NCT01460212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110049893|NCT01460212|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110049894|NCT01460212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110049895|NCT01460212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110049896|NCT01460212|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110049897|NCT01460212|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110049898|NCT01460212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110049899|NCT01460212|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110049900|NCT01460212|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110049901|NCT01460355|Botulinum Toxins|botulinum toxins|mesh-list
110049902|NCT01460355|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110049903|NCT01460355|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110049904|NCT01460355|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110049905|NCT01460355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110049906|NCT01460355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110049907|NCT01460355|Cholinergic Agents|cholinergic agents|mesh-ancestor
110049908|NCT01460355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110049909|NCT01460355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110049910|NCT01460355|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110049911|NCT01460355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110049912|NCT01460420|Lenalidomide|lenalidomide|mesh-list
110049913|NCT01460420|Bortezomib|bortezomib|mesh-list
110049914|NCT01460420|Immunologic Factors|immunologic factors|mesh-ancestor
110049915|NCT01460420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110049916|NCT01460420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110049917|NCT01460420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110049918|NCT01460420|Growth Substances|growth substances|mesh-ancestor
110049919|NCT01460420|Growth Inhibitors|growth inhibitors|mesh-ancestor
110049920|NCT01460420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110049921|NCT01460498|Azacitidine|azacitidine|mesh-list
110049922|NCT01460498|Decitabine|decitabine|mesh-list
110049923|NCT01460498|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
110049924|NCT01460498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110049926|NCT01460498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110049927|NCT01460498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110049928|NCT01460498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110049929|NCT01460498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110049930|NCT01460537|Gemcitabine|gemcitabine|mesh-list
110049932|NCT01460537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110049933|NCT01460537|Antimetabolites|antimetabolites|mesh-ancestor
110049934|NCT01460537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110049935|NCT01460563|Magnesium Sulfate|magnesium sulfate|mesh-list
110049936|NCT01460563|Analgesics|analgesics|mesh-ancestor
110049937|NCT01460563|Sensory System Agents|sensory system agents|mesh-ancestor
110049938|NCT01460563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110049939|NCT01460563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110049940|NCT01460563|Anesthetics|anesthetics|mesh-ancestor
110049941|NCT01460563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110049942|NCT01460563|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110049943|NCT01460563|Anticonvulsants|anticonvulsants|mesh-ancestor
110049944|NCT01460563|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110049945|NCT01460563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110049946|NCT01460563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110049947|NCT01460563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110049948|NCT01460563|Tocolytic Agents|tocolytic agents|mesh-ancestor
110049949|NCT01460563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110049950|NCT01460602|Rituximab|rituximab|mesh-list
110049951|NCT01460602|Bortezomib|bortezomib|mesh-list
110049952|NCT01460602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110049953|NCT01460602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110049954|NCT01460602|Immunologic Factors|immunologic factors|mesh-ancestor
110049955|NCT01460602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110049956|NCT01460602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110049957|NCT01460615|Hydrocortisone|hydrocortisone|mesh-list
110049958|NCT01460615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110049959|NCT01460667|Acetaminophen|acetaminophen|mesh-list
110049960|NCT01460667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110049961|NCT01460667|Analgesics|analgesics|mesh-ancestor
110049963|NCT01460667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110049964|NCT01460667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110049966|NCT01460693|Imatinib Mesylate|imatinib mesylate|mesh-list
110049967|NCT01460693|Dasatinib|dasatinib|mesh-list
110049968|NCT01460693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110049969|NCT01460693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110049970|NCT01460693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110049971|NCT01460693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110049972|NCT01460706|Edotreotide|edotreotide|mesh-list
110049973|NCT01460706|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110049974|NCT01460706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110049975|NCT01460797|Metformin|metformin|mesh-list
110049976|NCT01460797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110049977|NCT01460797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110049978|NCT01460836|Tobramycin|tobramycin|mesh-list
110049979|NCT01460836|Aztreonam|aztreonam|mesh-list
110049980|NCT01460836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110049981|NCT01460836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110049982|NCT01460888|Olaparib|olaparib|mesh-list
110049983|NCT01460888|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110049984|NCT01460888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110049985|NCT01460888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110049986|NCT01460888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110049989|NCT01460979|MTOR Inhibitors|mtor inhibitors|mesh-list
110049990|NCT01460979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110049991|NCT01460979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110049992|NCT01460979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110049993|NCT01460979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110049994|NCT01460979|Immunologic Factors|immunologic factors|mesh-ancestor
110049995|NCT01460979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110049996|NCT01460979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110049997|NCT01460979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110049998|NCT01460979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110049999|NCT01460979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110050000|NCT01460979|Antifungal Agents|antifungal agents|mesh-ancestor
110050001|NCT01461018|Immunoglobulins|immunoglobulins|mesh-list
110050002|NCT01461018|Antibodies|antibodies|mesh-list
110050003|NCT01461018|gamma-Globulins|gamma-globulins|mesh-list
110050004|NCT01461018|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110050005|NCT01461018|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110050006|NCT01461018|Immunologic Factors|immunologic factors|mesh-ancestor
110050007|NCT01461018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050008|NCT01461031|Nefopam|nefopam|mesh-list
110050009|NCT01461031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110050010|NCT01461031|Analgesics|analgesics|mesh-ancestor
110050011|NCT01461031|Sensory System Agents|sensory system agents|mesh-ancestor
110050012|NCT01461031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110050013|NCT01461031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050014|NCT01461174|Memantine|memantine|mesh-list
110050015|NCT01461174|Modafinil|modafinil|mesh-list
110050016|NCT01461174|Donepezil|donepezil|mesh-list
110050017|NCT01461174|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110050018|NCT01461174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110050019|NCT01461174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110050020|NCT01461174|Cholinergic Agents|cholinergic agents|mesh-ancestor
110050021|NCT01461174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110050022|NCT01461174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050023|NCT01461174|Nootropic Agents|nootropic agents|mesh-ancestor
110050024|NCT01461174|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110050025|NCT01461174|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110050026|NCT01461174|Dopamine Agents|dopamine agents|mesh-ancestor
110050027|NCT01461174|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110050028|NCT01461174|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110050029|NCT01461174|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110050030|NCT01461174|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110050031|NCT01461174|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110050032|NCT01461174|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110050033|NCT01461460|Moxifloxacin|moxifloxacin|mesh-list
110050034|NCT01461460|Tedizolid phosphate|tedizolid phosphate|mesh-list
110050035|NCT01461460|Tedizolid|tedizolid|mesh-list
110050036|NCT01461460|Oxazolidinones|oxazolidinones|mesh-list
110050037|NCT01461460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110050039|NCT01461460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110050040|NCT01461460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110050041|NCT01461460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110050042|NCT01461460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110050043|NCT01461460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110050044|NCT01461460|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110050045|NCT01461577|Insulin Glargine|insulin glargine|mesh-list
110050046|NCT01461577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110050047|NCT01461577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050048|NCT01461616|Insulin|insulin|mesh-list
110050049|NCT01461616|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110050050|NCT01461616|Insulin Glargine|insulin glargine|mesh-list
110050051|NCT01461616|Insulin Detemir|insulin detemir|mesh-list
110050052|NCT01461616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110050053|NCT01461616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050054|NCT01461746|Docetaxel|docetaxel|mesh-list
110050055|NCT01461746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110050056|NCT01461746|Tubulin Modulators|tubulin modulators|mesh-ancestor
110050057|NCT01461746|Antimitotic Agents|antimitotic agents|mesh-ancestor
110050058|NCT01461746|Mitosis Modulators|mitosis modulators|mesh-ancestor
110050059|NCT01461746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110050060|NCT01461759|Cisplatin|cisplatin|mesh-list
110050061|NCT01461759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110050062|NCT01461772|Carboplatin|carboplatin|mesh-list
110050063|NCT01461772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110050064|NCT01461876|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110050065|NCT01461876|Antiviral Agents|antiviral agents|mesh-ancestor
110050066|NCT01461876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110050067|NCT01462006|Sirolimus|sirolimus|mesh-list
110050068|NCT01462006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110050069|NCT01462006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110050070|NCT01462006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110050071|NCT01462006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110050072|NCT01462006|Antifungal Agents|antifungal agents|mesh-ancestor
110050073|NCT01462006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110050074|NCT01462006|Immunologic Factors|immunologic factors|mesh-ancestor
110050075|NCT01462006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050076|NCT01462058|Vitamin D|vitamin d|mesh-list
110050077|NCT01462058|Cholecalciferol|cholecalciferol|mesh-list
110050078|NCT01462058|Vitamins|vitamins|mesh-ancestor
110050079|NCT01462058|Micronutrients|micronutrients|mesh-ancestor
110050080|NCT01462058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050081|NCT01462058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110050082|NCT01462058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110050083|NCT01462149|Carboplatin|carboplatin|mesh-list
110050084|NCT01462149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110050085|NCT01462214|Everolimus|everolimus|mesh-list
110050086|NCT01462214|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110050087|NCT01462214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110050088|NCT01462214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110050089|NCT01462214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110050090|NCT01462214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110050091|NCT01462214|Immunologic Factors|immunologic factors|mesh-ancestor
110050092|NCT01462214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050093|NCT01462214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110050094|NCT01462422|Misoprostol|misoprostol|mesh-list
110050095|NCT01462422|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110050096|NCT01462422|Abortifacient Agents|abortifacient agents|mesh-ancestor
110050097|NCT01462422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110050098|NCT01462422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050099|NCT01462422|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110050100|NCT01462422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110050101|NCT01462422|Oxytocics|oxytocics|mesh-ancestor
110050102|NCT01462474|Cisplatin|cisplatin|mesh-list
110050103|NCT01462474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110050104|NCT01462487|Zanamivir|zanamivir|mesh-list
110050105|NCT01462487|Antiviral Agents|antiviral agents|mesh-ancestor
110050106|NCT01462487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110050107|NCT01462487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110050108|NCT01462487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110050109|NCT01462500|Miltefosine|miltefosine|mesh-list
110050110|NCT01462500|Antifungal Agents|antifungal agents|mesh-ancestor
110050111|NCT01462500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110050112|NCT01462500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110050113|NCT01462500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110050114|NCT01462500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110050117|NCT01462617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110050118|NCT01462617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110050120|NCT01462669|Anticonvulsants|anticonvulsants|mesh-ancestor
110050121|NCT01462669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110050122|NCT01462669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110050123|NCT01462903|Immunomodulating Agents|immunomodulating agents|mesh-list
110050124|NCT01462903|Immunologic Factors|immunologic factors|mesh-ancestor
110050125|NCT01462903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050126|NCT01462968|Heparin|heparin|mesh-list
110050127|NCT01462968|Anticoagulants|anticoagulants|mesh-ancestor
110050128|NCT01462968|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110050129|NCT01462968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110050130|NCT01462968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110050131|NCT01463046|Cytarabine|cytarabine|mesh-list
110050132|NCT01463046|Daunorubicin|daunorubicin|mesh-list
110050133|NCT01463046|Panobinostat|panobinostat|mesh-list
110050134|NCT01463046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110050135|NCT01463046|Antimetabolites|antimetabolites|mesh-ancestor
110050136|NCT01463046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110050137|NCT01463046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110050138|NCT01463046|Antiviral Agents|antiviral agents|mesh-ancestor
110050139|NCT01463046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110050140|NCT01463046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110050141|NCT01463046|Immunologic Factors|immunologic factors|mesh-ancestor
110050142|NCT01463046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050143|NCT01463046|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110050144|NCT01463046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110050145|NCT01463046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110050146|NCT01463046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110050147|NCT01463046|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110050148|NCT01463150|Clopidogrel|clopidogrel|mesh-list
110050149|NCT01463150|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110050150|NCT01463150|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110050151|NCT01463150|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110050152|NCT01463150|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110050153|NCT01463150|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110050154|NCT01463150|Purinergic Agents|purinergic agents|mesh-ancestor
110050155|NCT01463150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110050156|NCT01463150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110050157|NCT01463150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050158|NCT01463163|Ticagrelor|ticagrelor|mesh-list
110050159|NCT01463163|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110050160|NCT01463163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110050161|NCT01463163|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110050162|NCT01463163|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110050163|NCT01463163|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110050164|NCT01463163|Purinergic Agents|purinergic agents|mesh-ancestor
110050165|NCT01463163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110050167|NCT01463163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050168|NCT01463215|Ambroxol|ambroxol|mesh-list
110050169|NCT01463215|Expectorants|expectorants|mesh-ancestor
110050170|NCT01463215|Respiratory System Agents|respiratory system agents|mesh-ancestor
110050171|NCT01463228|Metformin|metformin|mesh-list
110050172|NCT01463228|Canagliflozin|canagliflozin|mesh-list
110050173|NCT01463228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110050174|NCT01463228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050175|NCT01463228|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110050176|NCT01463228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110050178|NCT01463280|Anesthetics, Local|anesthetics, local|mesh-ancestor
110050179|NCT01463280|Anesthetics|anesthetics|mesh-ancestor
110050180|NCT01463280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110050181|NCT01463280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050182|NCT01463280|Sensory System Agents|sensory system agents|mesh-ancestor
110050183|NCT01463280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110050184|NCT01463280|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110050185|NCT01463280|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110050186|NCT01463280|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110050187|NCT01463280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110050191|NCT01463332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110050192|NCT01463332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050194|NCT01463332|Analgesics|analgesics|mesh-ancestor
110050195|NCT01463332|Sensory System Agents|sensory system agents|mesh-ancestor
110050196|NCT01463332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110050197|NCT01463332|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110050198|NCT01463332|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110050199|NCT01463332|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110050200|NCT01463332|Adrenergic Agents|adrenergic agents|mesh-ancestor
110050201|NCT01463332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110050202|NCT01463332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110050206|NCT01463592|Iodine|iodine|mesh-list
110050207|NCT01463592|Interferons|interferons|mesh-list
110050208|NCT01463592|Ribavirin|ribavirin|mesh-list
110050209|NCT01463592|Interferon-alpha|interferon-alpha|mesh-list
110050210|NCT01463592|Interferon alpha-2|interferon alpha-2|mesh-list
110050211|NCT01463592|Cadexomer iodine|cadexomer iodine|mesh-list
110050212|NCT01463592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110050213|NCT01463592|Antiviral Agents|antiviral agents|mesh-ancestor
110050214|NCT01463592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110050215|NCT01463592|Antimetabolites|antimetabolites|mesh-ancestor
110050216|NCT01463592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110050217|NCT01463592|Immunologic Factors|immunologic factors|mesh-ancestor
110050218|NCT01463592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050219|NCT01463592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110050220|NCT01463592|Trace Elements|trace elements|mesh-ancestor
110050221|NCT01463592|Micronutrients|micronutrients|mesh-ancestor
110050222|NCT01463605|Nimotuzumab|nimotuzumab|mesh-list
110050223|NCT01463605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110050224|NCT01463605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110050225|NCT01463735|Vitamin E|vitamin e|mesh-list
110050226|NCT01463735|Vitamins|vitamins|mesh-ancestor
110050227|NCT01463735|Micronutrients|micronutrients|mesh-ancestor
110050228|NCT01463735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050229|NCT01463735|Antioxidants|antioxidants|mesh-ancestor
110050230|NCT01463735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110050231|NCT01463735|Protective Agents|protective agents|mesh-ancestor
110050232|NCT01463774|Metformin|metformin|mesh-list
110050233|NCT01463774|Canagliflozin|canagliflozin|mesh-list
110050234|NCT01463774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110050235|NCT01463774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050236|NCT01463774|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110050237|NCT01463774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110050238|NCT01463813|Vitamin D|vitamin d|mesh-list
110050239|NCT01463813|Ergocalciferols|ergocalciferols|mesh-list
110050240|NCT01463813|Cholecalciferol|cholecalciferol|mesh-list
110050241|NCT01463813|Vitamins|vitamins|mesh-list
110050242|NCT01463813|Micronutrients|micronutrients|mesh-ancestor
110050243|NCT01463813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050244|NCT01463813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110050245|NCT01463813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110050246|NCT01463852|Vincristine|vincristine|mesh-list
110050247|NCT01463852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110050248|NCT01463852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110050249|NCT01463852|Tubulin Modulators|tubulin modulators|mesh-ancestor
110050250|NCT01463852|Antimitotic Agents|antimitotic agents|mesh-ancestor
110050251|NCT01463852|Mitosis Modulators|mitosis modulators|mesh-ancestor
110050252|NCT01463852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110050254|NCT01463865|Anesthetics, Local|anesthetics, local|mesh-ancestor
110050255|NCT01463865|Anesthetics|anesthetics|mesh-ancestor
110050256|NCT01463865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110050257|NCT01463865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050258|NCT01463865|Sensory System Agents|sensory system agents|mesh-ancestor
110050259|NCT01463865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110050260|NCT01463956|Interferons|interferons|mesh-list
110050262|NCT01463956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110050263|NCT01463956|Antiviral Agents|antiviral agents|mesh-ancestor
110050264|NCT01463956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110050265|NCT01463956|Antimetabolites|antimetabolites|mesh-ancestor
110050266|NCT01463956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110050268|NCT01464008|Ribavirin|ribavirin|mesh-list
110050269|NCT01464008|Interferon-alpha|interferon-alpha|mesh-list
110050270|NCT01464008|Interferon alpha-2|interferon alpha-2|mesh-list
110050271|NCT01464008|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110050272|NCT01464008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110050273|NCT01464008|Antiviral Agents|antiviral agents|mesh-ancestor
110050274|NCT01464008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110050275|NCT01464008|Antimetabolites|antimetabolites|mesh-ancestor
110050276|NCT01464008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110050277|NCT01464008|Immunologic Factors|immunologic factors|mesh-ancestor
110050278|NCT01464008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050279|NCT01464060|Amoxicillin|amoxicillin|mesh-list
110050280|NCT01464060|Metronidazole|metronidazole|mesh-list
110050281|NCT01464060|Clarithromycin|clarithromycin|mesh-list
110050282|NCT01464060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110050283|NCT01464060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110050284|NCT01464060|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110050285|NCT01464060|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110050286|NCT01464060|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110050287|NCT01464060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110050288|NCT01464060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110050289|NCT01464060|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110050290|NCT01464060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110050291|NCT01464099|Insulin|insulin|mesh-list
110050292|NCT01464099|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110050293|NCT01464099|Insulin Aspart|insulin aspart|mesh-list
110050294|NCT01464099|Insulin, Long-Acting|insulin, long-acting|mesh-list
110050295|NCT01464099|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110050296|NCT01464099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110050297|NCT01464099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050298|NCT01464112|Dexamethasone|dexamethasone|mesh-list
110050299|NCT01464112|Bortezomib|bortezomib|mesh-list
110050300|NCT01464112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110050301|NCT01464112|Antiemetics|antiemetics|mesh-ancestor
110050302|NCT01464112|Autonomic Agents|autonomic agents|mesh-ancestor
110050303|NCT01464112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110050304|NCT01464112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050305|NCT01464112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110050306|NCT01464112|Glucocorticoids|glucocorticoids|mesh-ancestor
110050308|NCT01464112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110050309|NCT01464112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110050310|NCT01464112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110050311|NCT01464125|Azithromycin|azithromycin|mesh-list
110050312|NCT01464125|Fosmidomycin|fosmidomycin|mesh-list
110050313|NCT01464125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110050314|NCT01464125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110050315|NCT01464138|Clindamycin|clindamycin|mesh-list
110050316|NCT01464138|Clindamycin palmitate|clindamycin palmitate|mesh-list
110050317|NCT01464138|Clindamycin phosphate|clindamycin phosphate|mesh-list
110050318|NCT01464138|Fosmidomycin|fosmidomycin|mesh-list
110050319|NCT01464138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110050320|NCT01464138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110050321|NCT01464138|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110050322|NCT01464138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110050323|NCT01464138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110050324|NCT01464242|Meglumine Antimoniate|meglumine antimoniate|mesh-list
110050325|NCT01464242|Pentoxifylline|pentoxifylline|mesh-list
110050326|NCT01464242|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110050327|NCT01464242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110050328|NCT01464242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110050329|NCT01464242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110050330|NCT01464242|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110050332|NCT01464242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050333|NCT01464242|Vasodilator Agents|vasodilator agents|mesh-ancestor
110050334|NCT01464242|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110050335|NCT01464242|Antioxidants|antioxidants|mesh-ancestor
110050336|NCT01464242|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110050337|NCT01464242|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110050338|NCT01464242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110050339|NCT01464281|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110050340|NCT01464281|Antiviral Agents|antiviral agents|mesh-ancestor
110050341|NCT01464281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110050342|NCT01464450|Rivaroxaban|rivaroxaban|mesh-list
110050343|NCT01464450|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110050344|NCT01464450|Antithrombins|antithrombins|mesh-ancestor
110050345|NCT01464450|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110050346|NCT01464450|Protease Inhibitors|protease inhibitors|mesh-ancestor
110050347|NCT01464450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110050348|NCT01464450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110050349|NCT01464450|Anticoagulants|anticoagulants|mesh-ancestor
110050350|NCT01464476|Azimilide|azimilide|mesh-list
110050351|NCT01464476|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110050352|NCT01464476|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110050353|NCT01464476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110050354|NCT01464476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110050355|NCT01464476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110050356|NCT01464476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050357|NCT01464489|Atropine|atropine|mesh-list
110050358|NCT01464489|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110050359|NCT01464489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110050360|NCT01464489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110050361|NCT01464489|Autonomic Agents|autonomic agents|mesh-ancestor
110050363|NCT01464489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050364|NCT01464489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110050365|NCT01464489|Respiratory System Agents|respiratory system agents|mesh-ancestor
110050366|NCT01464489|Mydriatics|mydriatics|mesh-ancestor
110050367|NCT01464489|Parasympatholytics|parasympatholytics|mesh-ancestor
110050368|NCT01464489|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110050369|NCT01464489|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110050370|NCT01464489|Cholinergic Agents|cholinergic agents|mesh-ancestor
110050371|NCT01464489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110050372|NCT01464489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110050373|NCT01466608|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110050374|NCT01466608|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110050376|NCT01466608|Antimetabolites|antimetabolites|mesh-ancestor
110050377|NCT01466608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110050378|NCT01466608|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110050379|NCT01466608|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110050380|NCT01466608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110050382|NCT01466712|Formoterol Fumarate|formoterol fumarate|mesh-list
110050383|NCT01466712|Tiotropium Bromide|tiotropium bromide|mesh-list
110050384|NCT01466712|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110050385|NCT01466712|Autonomic Agents|autonomic agents|mesh-ancestor
110050386|NCT01466712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110050387|NCT01466712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050388|NCT01466712|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110050389|NCT01466712|Respiratory System Agents|respiratory system agents|mesh-ancestor
110050391|NCT01466712|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110050392|NCT01466712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110050393|NCT01466712|Adrenergic Agents|adrenergic agents|mesh-ancestor
110050394|NCT01466712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110050395|NCT01466712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110050396|NCT01466712|Parasympatholytics|parasympatholytics|mesh-ancestor
110050397|NCT01466712|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110050398|NCT01466712|Cholinergic Agents|cholinergic agents|mesh-ancestor
110050399|NCT01466712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110050400|NCT01466712|Glucocorticoids|glucocorticoids|mesh-ancestor
110050401|NCT01466712|Hormones|hormones|mesh-ancestor
110050402|NCT01466712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110050403|NCT01466829|Hormones|hormones|mesh-list
110050404|NCT01466829|Parathyroid Hormone|parathyroid hormone|mesh-list
110050405|NCT01466829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110050406|NCT01466829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050407|NCT01466829|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110050409|NCT01466855|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110050410|NCT01466855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110050411|NCT01466855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110050412|NCT01466855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110050413|NCT01466855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110050414|NCT01466959|Acetic Acid|acetic acid|mesh-list
110050415|NCT01466959|Retinol acetate|retinol acetate|mesh-list
110050416|NCT01466959|Citric Acid|citric acid|mesh-list
110050417|NCT01466959|Dialysis Solutions|dialysis solutions|mesh-list
110050418|NCT01466959|Anticoagulants|anticoagulants|mesh-ancestor
110050419|NCT01466959|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110050420|NCT01466959|Chelating Agents|chelating agents|mesh-ancestor
110050421|NCT01466959|Sequestering Agents|sequestering agents|mesh-ancestor
110050422|NCT01466959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110050423|NCT01466959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110050424|NCT01466959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110050425|NCT01466959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110050426|NCT01466959|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110050427|NCT01466959|Immunologic Factors|immunologic factors|mesh-ancestor
110050428|NCT01466959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050429|NCT01466959|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110050430|NCT01466959|Protective Agents|protective agents|mesh-ancestor
110050431|NCT01466959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110050432|NCT01467011|Mycophenolic Acid|mycophenolic acid|mesh-list
110050433|NCT01467011|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110050434|NCT01467011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110050435|NCT01467011|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110050436|NCT01467011|Antitubercular Agents|antitubercular agents|mesh-ancestor
110050437|NCT01467011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110050438|NCT01467011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110050439|NCT01467011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110050440|NCT01467011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110050441|NCT01467115|Leucovorin|leucovorin|mesh-list
110050442|NCT01467115|Docetaxel|docetaxel|mesh-list
110050443|NCT01467115|Fluorouracil|fluorouracil|mesh-list
110050444|NCT01467115|Cetuximab|cetuximab|mesh-list
110050445|NCT01467115|Epoetin Alfa|epoetin alfa|mesh-list
110050446|NCT01467115|Levoleucovorin|levoleucovorin|mesh-list
110050447|NCT01467115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110050448|NCT01467115|Tubulin Modulators|tubulin modulators|mesh-ancestor
110050449|NCT01467115|Antimitotic Agents|antimitotic agents|mesh-ancestor
110050450|NCT01467115|Mitosis Modulators|mitosis modulators|mesh-ancestor
110050451|NCT01467115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110050452|NCT01467115|Antimetabolites|antimetabolites|mesh-ancestor
110050453|NCT01467115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110050454|NCT01467115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110050455|NCT01467115|Immunologic Factors|immunologic factors|mesh-ancestor
110050456|NCT01467115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050457|NCT01467115|Antidotes|antidotes|mesh-ancestor
110050458|NCT01467115|Protective Agents|protective agents|mesh-ancestor
110050459|NCT01467115|Vitamin B Complex|vitamin b complex|mesh-ancestor
110050460|NCT01467115|Vitamins|vitamins|mesh-ancestor
110050461|NCT01467115|Micronutrients|micronutrients|mesh-ancestor
110050462|NCT01467115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110050463|NCT01467115|Hematinics|hematinics|mesh-ancestor
110050464|NCT01467141|Insulin|insulin|mesh-list
110050465|NCT01467141|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110050469|NCT01467141|Isophane insulin, beef|isophane insulin, beef|mesh-list
110050470|NCT01467141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110050471|NCT01467141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050472|NCT01467219|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110050473|NCT01467219|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110050474|NCT01467219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110050475|NCT01467232|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110050476|NCT01467258|Amantadine|amantadine|mesh-list
110050477|NCT01467258|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110050478|NCT01467258|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110050479|NCT01467258|Antiviral Agents|antiviral agents|mesh-ancestor
110050480|NCT01467258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110050481|NCT01467258|Dopamine Agents|dopamine agents|mesh-ancestor
110050482|NCT01467258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110050483|NCT01467258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110050484|NCT01467258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050485|NCT01467258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110050486|NCT01467258|Analgesics|analgesics|mesh-ancestor
110050487|NCT01467258|Sensory System Agents|sensory system agents|mesh-ancestor
110050488|NCT01467258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110050489|NCT01467297|Levofloxacin|levofloxacin|mesh-list
110050490|NCT01467297|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110050491|NCT01467297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110050492|NCT01467297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110050493|NCT01467297|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110050494|NCT01467297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110050495|NCT01467297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110050496|NCT01467297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110050497|NCT01467297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110050498|NCT01467297|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110050499|NCT01467297|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110050500|NCT01467310|Trametinib|trametinib|mesh-list
110050501|NCT01467310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110050502|NCT01467310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110050503|NCT01467310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110050504|NCT01467310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110050505|NCT01467323|Insulin|insulin|mesh-list
110050506|NCT01467323|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110050507|NCT01467323|Insulin Aspart|insulin aspart|mesh-list
110050508|NCT01467323|Biphasic Insulins|biphasic insulins|mesh-list
110050509|NCT01467323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110050510|NCT01467323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050511|NCT01467362|Desonide|desonide|mesh-list
110050512|NCT01467362|V0034CR|v0034cr|mesh-list
110050513|NCT01467362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110050514|NCT01467362|Emollients|emollients|mesh-ancestor
110050515|NCT01467362|Dermatologic Agents|dermatologic agents|mesh-ancestor
110050516|NCT01467375|Insulin Aspart|insulin aspart|mesh-list
110050517|NCT01467375|Biphasic Insulins|biphasic insulins|mesh-list
110050518|NCT01467375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110050519|NCT01467375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050520|NCT01467401|Insulin|insulin|mesh-list
110050521|NCT01467401|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110050522|NCT01467401|Insulin Aspart|insulin aspart|mesh-list
110050523|NCT01467401|Biphasic Insulins|biphasic insulins|mesh-list
110050524|NCT01467401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110050525|NCT01467401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050526|NCT01467414|Insulin|insulin|mesh-list
110050527|NCT01467414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110050528|NCT01467414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050529|NCT01467518|Dolutegravir|dolutegravir|mesh-list
110050530|NCT01467518|Methadone|methadone|mesh-list
110050531|NCT01467518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110050532|NCT01467518|Narcotics|narcotics|mesh-ancestor
110050533|NCT01467518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110050534|NCT01467518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050535|NCT01467518|Analgesics|analgesics|mesh-ancestor
110050536|NCT01467518|Sensory System Agents|sensory system agents|mesh-ancestor
110050537|NCT01467518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110050538|NCT01467518|Antitussive Agents|antitussive agents|mesh-ancestor
110050539|NCT01467518|Respiratory System Agents|respiratory system agents|mesh-ancestor
110050540|NCT01467518|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110050542|NCT01467518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110050543|NCT01467518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110050544|NCT01467518|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110050545|NCT01467518|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110050546|NCT01467518|Antiviral Agents|antiviral agents|mesh-ancestor
110050547|NCT01467518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110050548|NCT01467531|Dolutegravir|dolutegravir|mesh-list
110050549|NCT01467531|Cabotegravir|cabotegravir|mesh-list
110050550|NCT01467531|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110050551|NCT01467531|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110050552|NCT01467531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110050553|NCT01467531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110050554|NCT01467531|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110050555|NCT01467531|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110050556|NCT01467531|Antiviral Agents|antiviral agents|mesh-ancestor
110050557|NCT01467531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110050558|NCT01467596|Lidocaine|lidocaine|mesh-list
110050559|NCT01467596|Levobupivacaine|levobupivacaine|mesh-list
110050560|NCT01467596|Anesthetics, Local|anesthetics, local|mesh-ancestor
110050561|NCT01467596|Anesthetics|anesthetics|mesh-ancestor
110050562|NCT01467596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110050563|NCT01467596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050564|NCT01467596|Sensory System Agents|sensory system agents|mesh-ancestor
110050565|NCT01467596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110050567|NCT01467596|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110050568|NCT01467596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110050569|NCT01467596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110050570|NCT01467596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110050571|NCT01467648|Doripenem|doripenem|mesh-list
110050572|NCT01467648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110050573|NCT01467648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110050575|NCT01467687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110050576|NCT01467687|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110050577|NCT01467687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110050578|NCT01467687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110050579|NCT01467687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110050580|NCT01467687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050581|NCT01467687|Vasodilator Agents|vasodilator agents|mesh-ancestor
110050582|NCT01467804|Sertraline|sertraline|mesh-list
110050583|NCT01467804|Antidepressive Agents|antidepressive agents|mesh-ancestor
110050584|NCT01467804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110050585|NCT01467804|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110050586|NCT01467804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110050587|NCT01467804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110050588|NCT01467804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110050589|NCT01467804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110050590|NCT01467804|Serotonin Agents|serotonin agents|mesh-ancestor
110050591|NCT01467804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050592|NCT01467921|Oxaliplatin|oxaliplatin|mesh-list
110050593|NCT01467921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110050594|NCT01467986|Sirolimus|sirolimus|mesh-list
110050595|NCT01467986|Irinotecan|irinotecan|mesh-list
110050596|NCT01467986|Temozolomide|temozolomide|mesh-list
110050597|NCT01467986|Dasatinib|dasatinib|mesh-list
110050598|NCT01467986|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110050599|NCT01467986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110050600|NCT01467986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110050601|NCT01467986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110050602|NCT01467986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110050603|NCT01467986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110050604|NCT01467986|Alkylating Agents|alkylating agents|mesh-ancestor
110050605|NCT01467986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110050606|NCT01467986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110050607|NCT01467986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110050608|NCT01467986|Antifungal Agents|antifungal agents|mesh-ancestor
110050609|NCT01467986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110050610|NCT01467986|Immunologic Factors|immunologic factors|mesh-ancestor
110050611|NCT01467986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050612|NCT01467986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110050614|NCT01468025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110050615|NCT01468025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110050616|NCT01468025|Analgesics|analgesics|mesh-ancestor
110050617|NCT01468025|Sensory System Agents|sensory system agents|mesh-ancestor
110050618|NCT01468025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110050619|NCT01468025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050620|NCT01468025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110050621|NCT01468025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110050622|NCT01468025|Gout Suppressants|gout suppressants|mesh-ancestor
110050623|NCT01468025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110050624|NCT01468025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110050625|NCT01468025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110050627|NCT01468038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110050628|NCT01468038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110050629|NCT01468038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110050630|NCT01468038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050631|NCT01468038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110050632|NCT01468038|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110050633|NCT01468038|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110050634|NCT01468038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110050635|NCT01468038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110050636|NCT01468038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110050637|NCT01468038|Serotonin Agents|serotonin agents|mesh-ancestor
110050638|NCT01468038|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110050717|NCT01468545|Iloprost|iloprost|mesh-list
110050639|NCT01468038|Antidepressive Agents|antidepressive agents|mesh-ancestor
110050640|NCT01468051|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110050642|NCT01468051|Immunologic Factors|immunologic factors|mesh-ancestor
110050643|NCT01468051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050644|NCT01468051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110050645|NCT01468051|Antacids|antacids|mesh-ancestor
110050646|NCT01468051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110050647|NCT01468051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110050648|NCT01468155|Dabigatran|dabigatran|mesh-list
110050649|NCT01468155|Antithrombins|antithrombins|mesh-ancestor
110050650|NCT01468155|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110050651|NCT01468155|Protease Inhibitors|protease inhibitors|mesh-ancestor
110050652|NCT01468155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110050653|NCT01468155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110050654|NCT01468155|Anticoagulants|anticoagulants|mesh-ancestor
110050655|NCT01468259|Droxidopa|droxidopa|mesh-list
110050656|NCT01468259|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110050657|NCT01468259|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110050658|NCT01468272|Beclomethasone|beclomethasone|mesh-list
110050659|NCT01468272|Formoterol Fumarate|formoterol fumarate|mesh-list
110050660|NCT01468272|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110050661|NCT01468272|Autonomic Agents|autonomic agents|mesh-ancestor
110050662|NCT01468272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110050663|NCT01468272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050664|NCT01468272|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110050665|NCT01468272|Respiratory System Agents|respiratory system agents|mesh-ancestor
110050666|NCT01468272|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110050667|NCT01468272|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110050668|NCT01468272|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110050669|NCT01468272|Adrenergic Agents|adrenergic agents|mesh-ancestor
110050670|NCT01468272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110053078|NCT01484613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050671|NCT01468272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110050672|NCT01468272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110050673|NCT01468272|Glucocorticoids|glucocorticoids|mesh-ancestor
110050674|NCT01468272|Hormones|hormones|mesh-ancestor
110050675|NCT01468272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110050676|NCT01468285|Betahistine|betahistine|mesh-list
110050677|NCT01468285|Vasodilator Agents|vasodilator agents|mesh-ancestor
110050678|NCT01468285|Histamine Agonists|histamine agonists|mesh-ancestor
110050679|NCT01468285|Histamine Agents|histamine agents|mesh-ancestor
110050682|NCT01468285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050683|NCT01468389|Capecitabine|capecitabine|mesh-list
110050684|NCT01468389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110050685|NCT01468389|Antimetabolites|antimetabolites|mesh-ancestor
110050686|NCT01468389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110050687|NCT01468389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110050688|NCT01468415|Phenol|phenol|mesh-list
110050689|NCT01468415|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110050690|NCT01468415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110050691|NCT01468415|Disinfectants|disinfectants|mesh-ancestor
110050692|NCT01468415|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
110050693|NCT01468415|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110050694|NCT01468441|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110050695|NCT01468441|Cetrorelix|cetrorelix|mesh-list
110050696|NCT01468441|Luteolytic Agents|luteolytic agents|mesh-ancestor
110050697|NCT01468441|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110050698|NCT01468441|Contraceptive Agents|contraceptive agents|mesh-ancestor
110050699|NCT01468441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110050700|NCT01468441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050701|NCT01468441|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110050702|NCT01468441|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110050704|NCT01468441|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110050705|NCT01468441|Fertility Agents|fertility agents|mesh-ancestor
110050706|NCT01468441|Hormone Antagonists|hormone antagonists|mesh-ancestor
110050707|NCT01468441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110050708|NCT01468480|Calcium, Dietary|calcium, dietary|mesh-list
110050709|NCT01468480|Calcium|calcium|mesh-list
110050710|NCT01468480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110050711|NCT01468480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050712|NCT01468480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110050714|NCT01468519|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110050715|NCT01468519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110050716|NCT01468519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050718|NCT01468545|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110050719|NCT01468545|Vasodilator Agents|vasodilator agents|mesh-ancestor
110050720|NCT01468571|Spironolactone|spironolactone|mesh-list
110050721|NCT01468571|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110050722|NCT01468571|Hormone Antagonists|hormone antagonists|mesh-ancestor
110050723|NCT01468571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110050724|NCT01468571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050725|NCT01468571|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110050726|NCT01468571|Diuretics|diuretics|mesh-ancestor
110050727|NCT01468571|Natriuretic Agents|natriuretic agents|mesh-ancestor
110050728|NCT01468610|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
110050729|NCT01468610|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110050730|NCT01468610|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110050731|NCT01468610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110050732|NCT01468610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110050733|NCT01468610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110050734|NCT01468610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050735|NCT01468610|Antidepressive Agents|antidepressive agents|mesh-ancestor
110050736|NCT01468610|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110050737|NCT01468688|Imatinib Mesylate|imatinib mesylate|mesh-list
110050738|NCT01468688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110050739|NCT01468688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110050740|NCT01468688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110050741|NCT01468688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110050742|NCT01468714|Ketoconazole|ketoconazole|mesh-list
110050743|NCT01468714|Antifungal Agents|antifungal agents|mesh-ancestor
110050744|NCT01468714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110050745|NCT01468714|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110050746|NCT01468714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110050747|NCT01468714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110050748|NCT01468714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110050749|NCT01468714|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110050750|NCT01468714|Hormone Antagonists|hormone antagonists|mesh-ancestor
110050752|NCT01468714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050753|NCT01468714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110050754|NCT01468740|Prednisone|prednisone|mesh-list
110050755|NCT01468740|Cyclophosphamide|cyclophosphamide|mesh-list
110050756|NCT01468740|Dacarbazine|dacarbazine|mesh-list
110050757|NCT01468740|Doxorubicin|doxorubicin|mesh-list
110050758|NCT01468740|Etoposide|etoposide|mesh-list
110050759|NCT01468740|Vincristine|vincristine|mesh-list
110050760|NCT01468740|Bleomycin|bleomycin|mesh-list
110050761|NCT01468740|Vinblastine|vinblastine|mesh-list
110050762|NCT01468740|Procarbazine|procarbazine|mesh-list
110050763|NCT01468740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110050764|NCT01468740|Immunologic Factors|immunologic factors|mesh-ancestor
110050765|NCT01468740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050766|NCT01468740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110050767|NCT01468740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110050768|NCT01468740|Alkylating Agents|alkylating agents|mesh-ancestor
110050769|NCT01468740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110050770|NCT01468740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110050771|NCT01468740|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110050772|NCT01468740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110050773|NCT01468740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110050774|NCT01468740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110050775|NCT01468740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110050776|NCT01468740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110050777|NCT01468740|Glucocorticoids|glucocorticoids|mesh-ancestor
110050778|NCT01468740|Hormones|hormones|mesh-ancestor
110050779|NCT01468740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110050780|NCT01468740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110050781|NCT01468740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110050782|NCT01468740|Tubulin Modulators|tubulin modulators|mesh-ancestor
110050783|NCT01468740|Antimitotic Agents|antimitotic agents|mesh-ancestor
110050784|NCT01468740|Mitosis Modulators|mitosis modulators|mesh-ancestor
110050785|NCT01469143|Insulin|insulin|mesh-list
110050786|NCT01469143|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110050787|NCT01469143|Insulin Aspart|insulin aspart|mesh-list
110050788|NCT01469143|Insulin, Long-Acting|insulin, long-acting|mesh-list
110050789|NCT01469143|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110050790|NCT01469143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110050791|NCT01469143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050792|NCT01469169|Iloprost|iloprost|mesh-list
110050793|NCT01469169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110050794|NCT01469169|Vasodilator Agents|vasodilator agents|mesh-ancestor
110050795|NCT01469338|Prednisone|prednisone|mesh-list
110050796|NCT01469338|Octreotide|octreotide|mesh-list
110050797|NCT01469338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110050798|NCT01469338|Glucocorticoids|glucocorticoids|mesh-ancestor
110050799|NCT01469338|Hormones|hormones|mesh-ancestor
110050800|NCT01469338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110050801|NCT01469338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050802|NCT01469338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110050803|NCT01469338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110050804|NCT01469338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110050805|NCT01469351|Liraglutide|liraglutide|mesh-list
110050806|NCT01469351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110050807|NCT01469351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050808|NCT01469351|Incretins|incretins|mesh-ancestor
110050809|NCT01469351|Hormones|hormones|mesh-ancestor
110050810|NCT01469351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110050811|NCT01469416|Clopidogrel|clopidogrel|mesh-list
110050812|NCT01469416|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110050813|NCT01469416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110050814|NCT01469416|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110050815|NCT01469416|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110050816|NCT01469416|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110050817|NCT01469416|Purinergic Agents|purinergic agents|mesh-ancestor
110050818|NCT01469416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110050819|NCT01469416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110050820|NCT01469416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050821|NCT01469416|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110050822|NCT01469416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110050823|NCT01469416|Antimetabolites|antimetabolites|mesh-ancestor
110050824|NCT01469416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110050826|NCT01469416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110050827|NCT01469468|Simvastatin|simvastatin|mesh-list
110050828|NCT01469468|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110050829|NCT01469468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110050830|NCT01469468|Antimetabolites|antimetabolites|mesh-ancestor
110050831|NCT01469468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110050832|NCT01469468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110050833|NCT01469468|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110050834|NCT01469468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110050835|NCT01469481|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
110050836|NCT01469481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110050837|NCT01469481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110050838|NCT01469507|Hyaluronic Acid|hyaluronic acid|mesh-list
110050839|NCT01469507|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110050840|NCT01469507|Immunologic Factors|immunologic factors|mesh-ancestor
110050841|NCT01469507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050842|NCT01469507|Viscosupplements|viscosupplements|mesh-ancestor
110050843|NCT01469507|Protective Agents|protective agents|mesh-ancestor
110050845|NCT01469520|Zidovudine|zidovudine|mesh-list
110050846|NCT01469520|Nevirapine|nevirapine|mesh-list
110050847|NCT01469520|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110050848|NCT01469520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110050849|NCT01469520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110050850|NCT01469520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110050851|NCT01469520|Antiviral Agents|antiviral agents|mesh-ancestor
110050852|NCT01469520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110050853|NCT01469520|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110050854|NCT01469520|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110050855|NCT01469520|Antimetabolites|antimetabolites|mesh-ancestor
110050856|NCT01469520|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110050857|NCT01469520|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110050858|NCT01469559|Insulin|insulin|mesh-list
110050859|NCT01469559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110050860|NCT01469559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050861|NCT01469572|Everolimus|everolimus|mesh-list
110050862|NCT01469572|Pasireotide|pasireotide|mesh-list
110050863|NCT01469572|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110050864|NCT01469572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110050865|NCT01469572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110050866|NCT01469572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110050867|NCT01469572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110050868|NCT01469572|Immunologic Factors|immunologic factors|mesh-ancestor
110050869|NCT01469572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050870|NCT01469572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110050872|NCT01469572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110050873|NCT01469598|Gemcitabine|gemcitabine|mesh-list
110050874|NCT01469598|Docetaxel|docetaxel|mesh-list
110050875|NCT01469598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110050876|NCT01469598|Antimetabolites|antimetabolites|mesh-ancestor
110050877|NCT01469598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110050878|NCT01469598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110050879|NCT01469598|Tubulin Modulators|tubulin modulators|mesh-ancestor
110050880|NCT01469598|Antimitotic Agents|antimitotic agents|mesh-ancestor
110050881|NCT01469598|Mitosis Modulators|mitosis modulators|mesh-ancestor
110050882|NCT01469624|Pentoxifylline|pentoxifylline|mesh-list
110050883|NCT01469624|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110050884|NCT01469624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110050885|NCT01469624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110050886|NCT01469624|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110050887|NCT01469624|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110050888|NCT01469624|Protective Agents|protective agents|mesh-ancestor
110050889|NCT01469624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050890|NCT01469624|Vasodilator Agents|vasodilator agents|mesh-ancestor
110050891|NCT01469624|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110050892|NCT01469624|Antioxidants|antioxidants|mesh-ancestor
110050893|NCT01469702|Azithromycin|azithromycin|mesh-list
110050894|NCT01469702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110050895|NCT01469702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110050896|NCT01469884|Cyclosporine|cyclosporine|mesh-list
110050897|NCT01469884|Everolimus|everolimus|mesh-list
110050898|NCT01469884|Tacrolimus|tacrolimus|mesh-list
110050901|NCT01469884|Immunologic Factors|immunologic factors|mesh-ancestor
110050902|NCT01469884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050903|NCT01469884|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110050904|NCT01469884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110050905|NCT01469884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110050906|NCT01469884|Antifungal Agents|antifungal agents|mesh-ancestor
110050907|NCT01469884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110050908|NCT01469884|Dermatologic Agents|dermatologic agents|mesh-ancestor
110050909|NCT01469884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110050910|NCT01469884|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110050911|NCT01469884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110050912|NCT01469884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110050913|NCT01469975|Edetic Acid|edetic acid|mesh-list
110050914|NCT01469975|Pentetic Acid|pentetic acid|mesh-list
110050915|NCT01469975|Antidotes|antidotes|mesh-ancestor
110050916|NCT01469975|Protective Agents|protective agents|mesh-ancestor
110050917|NCT01469975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050918|NCT01469975|Chelating Agents|chelating agents|mesh-ancestor
110050919|NCT01469975|Sequestering Agents|sequestering agents|mesh-ancestor
110050920|NCT01469975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110050921|NCT01469975|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110050922|NCT01469975|Anticoagulants|anticoagulants|mesh-ancestor
110050923|NCT01469975|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110050924|NCT01469988|Testosterone|testosterone|mesh-list
110050925|NCT01469988|Androgens|androgens|mesh-ancestor
110050926|NCT01469988|Hormones|hormones|mesh-ancestor
110050927|NCT01469988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110050928|NCT01469988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050929|NCT01470040|Aspirin|aspirin|mesh-list
110050930|NCT01470040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110050931|NCT01470040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110050932|NCT01470040|Analgesics|analgesics|mesh-ancestor
110050933|NCT01470040|Sensory System Agents|sensory system agents|mesh-ancestor
110050934|NCT01470040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110050935|NCT01470040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050936|NCT01470040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110050938|NCT01470040|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110050939|NCT01470040|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110050940|NCT01470040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110050941|NCT01470040|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110050942|NCT01470040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110050943|NCT01470040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110050944|NCT01470040|Antipyretics|antipyretics|mesh-ancestor
110050945|NCT01470053|Mometasone Furoate|mometasone furoate|mesh-list
110050946|NCT01470053|Azelastine|azelastine|mesh-list
110050947|NCT01470053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110050948|NCT01470053|Dermatologic Agents|dermatologic agents|mesh-ancestor
110050949|NCT01470053|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110050950|NCT01470053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110050951|NCT01470053|Autonomic Agents|autonomic agents|mesh-ancestor
110050952|NCT01470053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110050953|NCT01470053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050954|NCT01470053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110050955|NCT01470053|Respiratory System Agents|respiratory system agents|mesh-ancestor
110050956|NCT01470053|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110050957|NCT01470053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110050958|NCT01470053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110050959|NCT01470053|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110050960|NCT01470053|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110050961|NCT01470053|Histamine Antagonists|histamine antagonists|mesh-ancestor
110050962|NCT01470053|Histamine Agents|histamine agents|mesh-ancestor
110050963|NCT01470053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110050965|NCT01470092|Androgen Antagonists|androgen antagonists|mesh-ancestor
110050966|NCT01470092|Hormone Antagonists|hormone antagonists|mesh-ancestor
110050967|NCT01470092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110050968|NCT01470092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050969|NCT01470092|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110050970|NCT01470092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110050971|NCT01470092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110050972|NCT01470092|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110050973|NCT01470092|Anabolic Agents|anabolic agents|mesh-ancestor
110050975|NCT01470157|Ketamine|ketamine|mesh-list
110050976|NCT01470157|Analgesics|analgesics|mesh-ancestor
110050977|NCT01470157|Sensory System Agents|sensory system agents|mesh-ancestor
110050978|NCT01470157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110050979|NCT01470157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050980|NCT01470157|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110050981|NCT01470157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110050982|NCT01470157|Anesthetics, General|anesthetics, general|mesh-ancestor
110050983|NCT01470157|Anesthetics|anesthetics|mesh-ancestor
110050984|NCT01470157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110050985|NCT01470157|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110050986|NCT01470157|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110050987|NCT01470157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110050988|NCT01470157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110050989|NCT01470209|Everolimus|everolimus|mesh-list
110050990|NCT01470209|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110050991|NCT01470209|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110050992|NCT01470209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110050993|NCT01470209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110050994|NCT01470209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110050995|NCT01470209|Immunologic Factors|immunologic factors|mesh-ancestor
110050996|NCT01470209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110050997|NCT01470209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110050998|NCT01470326|Bazedoxifene|bazedoxifene|mesh-list
110050999|NCT01470326|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110051000|NCT01470326|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110051001|NCT01470326|Hormone Antagonists|hormone antagonists|mesh-ancestor
110051002|NCT01470326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110051003|NCT01470326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051004|NCT01470326|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110051005|NCT01470339|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110051006|NCT01470339|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110051007|NCT01470339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110051008|NCT01470339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110051009|NCT01470339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110051010|NCT01470339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110051011|NCT01470339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051012|NCT01470339|Analgesics|analgesics|mesh-ancestor
110051013|NCT01470339|Sensory System Agents|sensory system agents|mesh-ancestor
110051014|NCT01470339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110051015|NCT01470339|Antidepressive Agents|antidepressive agents|mesh-ancestor
110051016|NCT01470339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110051017|NCT01470339|Dopamine Agents|dopamine agents|mesh-ancestor
110051018|NCT01470352|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110051019|NCT01470352|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110051020|NCT01470352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110051022|NCT01470352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110051023|NCT01470352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110051024|NCT01470352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051025|NCT01470352|Analgesics|analgesics|mesh-ancestor
110051026|NCT01470352|Sensory System Agents|sensory system agents|mesh-ancestor
110051027|NCT01470352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110051028|NCT01470352|Antidepressive Agents|antidepressive agents|mesh-ancestor
110051029|NCT01470352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110051030|NCT01470352|Dopamine Agents|dopamine agents|mesh-ancestor
110051031|NCT01470443|Oxaliplatin|oxaliplatin|mesh-list
110051032|NCT01470443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110051033|NCT01470456|Rituximab|rituximab|mesh-list
110051034|NCT01470456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110051035|NCT01470456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110051036|NCT01470456|Immunologic Factors|immunologic factors|mesh-ancestor
110051037|NCT01470456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051038|NCT01470456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110051040|NCT01470495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110051041|NCT01470495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110051042|NCT01470495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110051043|NCT01470495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110051044|NCT01470690|Omeprazole|omeprazole|mesh-list
110051045|NCT01470690|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110051046|NCT01470690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110051047|NCT01470690|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110051048|NCT01470690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110051049|NCT01470690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110051050|NCT01470742|Capecitabine|capecitabine|mesh-list
110051051|NCT01470742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110051052|NCT01470742|Antimetabolites|antimetabolites|mesh-ancestor
110051053|NCT01470742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110051054|NCT01470742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110051055|NCT01470794|Flucytosine|flucytosine|mesh-list
110051056|NCT01470794|Antifungal Agents|antifungal agents|mesh-ancestor
110051057|NCT01470794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110051058|NCT01470794|Antimetabolites|antimetabolites|mesh-ancestor
110051059|NCT01470794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110051060|NCT01470807|Pancrelipase|pancrelipase|mesh-list
110051061|NCT01470807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110051062|NCT01470937|Acarbose|acarbose|mesh-list
110051063|NCT01470937|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110051064|NCT01470937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110051065|NCT01470937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110051066|NCT01470937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110051067|NCT01470937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051068|NCT01471067|Mycophenolic Acid|mycophenolic acid|mesh-list
110051069|NCT01471067|Rituximab|rituximab|mesh-list
110051070|NCT01471067|Fludarabine|fludarabine|mesh-list
110051071|NCT01471067|Fludarabine phosphate|fludarabine phosphate|mesh-list
110051072|NCT01471067|Melphalan|melphalan|mesh-list
110051073|NCT01471067|Busulfan|busulfan|mesh-list
110051074|NCT01471067|Clofarabine|clofarabine|mesh-list
110051075|NCT01471067|Tacrolimus|tacrolimus|mesh-list
110051076|NCT01471067|Thymoglobulin|thymoglobulin|mesh-list
110051077|NCT01471067|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110051078|NCT01471067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110051079|NCT01471067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110051080|NCT01471067|Immunologic Factors|immunologic factors|mesh-ancestor
110051081|NCT01471067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051082|NCT01471067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110051083|NCT01471067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110051084|NCT01471067|Antimetabolites|antimetabolites|mesh-ancestor
110051085|NCT01471067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110051086|NCT01471067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110051087|NCT01471067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110051088|NCT01471067|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110051089|NCT01471067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110051090|NCT01471067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110051091|NCT01471067|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110051092|NCT01471067|Antitubercular Agents|antitubercular agents|mesh-ancestor
110051093|NCT01471067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110051094|NCT01471067|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110051095|NCT01471067|Alkylating Agents|alkylating agents|mesh-ancestor
110051097|NCT01471132|Paclitaxel|paclitaxel|mesh-list
110051098|NCT01471132|Oxaliplatin|oxaliplatin|mesh-list
110051099|NCT01471132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110051100|NCT01471132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110051101|NCT01471132|Tubulin Modulators|tubulin modulators|mesh-ancestor
110051102|NCT01471132|Antimitotic Agents|antimitotic agents|mesh-ancestor
110051104|NCT01471132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110051107|NCT01471145|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110051108|NCT01471145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051109|NCT01471145|Sensory System Agents|sensory system agents|mesh-ancestor
110051110|NCT01471145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110051111|NCT01471158|Timolol|timolol|mesh-list
110051112|NCT01471158|Dorzolamide|dorzolamide|mesh-list
110051113|NCT01471158|Maleic acid|maleic acid|mesh-list
110051114|NCT01471158|Brinzolamide|brinzolamide|mesh-list
110051115|NCT01471158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110051116|NCT01471158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110051117|NCT01471158|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110051118|NCT01471158|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110051119|NCT01471158|Adrenergic Agents|adrenergic agents|mesh-ancestor
110051120|NCT01471158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110051121|NCT01471158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051122|NCT01471158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110051123|NCT01471158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110051124|NCT01471158|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110051125|NCT01471184|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110051126|NCT01471184|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110051127|NCT01471262|Liver Extracts|liver extracts|mesh-list
110051128|NCT01471262|Hematinics|hematinics|mesh-ancestor
110051129|NCT01471275|Metformin|metformin|mesh-list
110051130|NCT01471275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110051131|NCT01471275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051132|NCT01471418|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110051133|NCT01471418|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110051134|NCT01471418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110051135|NCT01471470|Bevacizumab|bevacizumab|mesh-list
110051136|NCT01471470|Docetaxel|docetaxel|mesh-list
110051137|NCT01471470|Capecitabine|capecitabine|mesh-list
110051138|NCT01471470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110051139|NCT01471470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110051140|NCT01471470|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110051141|NCT01471470|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110051142|NCT01471470|Growth Substances|growth substances|mesh-ancestor
110051143|NCT01471470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051144|NCT01471470|Growth Inhibitors|growth inhibitors|mesh-ancestor
110051145|NCT01471470|Tubulin Modulators|tubulin modulators|mesh-ancestor
110051146|NCT01471470|Antimitotic Agents|antimitotic agents|mesh-ancestor
110051147|NCT01471470|Mitosis Modulators|mitosis modulators|mesh-ancestor
110051148|NCT01471470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110051149|NCT01471470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110051150|NCT01471470|Antimetabolites|antimetabolites|mesh-ancestor
110051151|NCT01471535|Interferons|interferons|mesh-list
110051152|NCT01471535|Interferon-alpha|interferon-alpha|mesh-list
110051153|NCT01471535|Interferon alpha-2|interferon alpha-2|mesh-list
110051154|NCT01471535|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110051155|NCT01471535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110051156|NCT01471535|Antiviral Agents|antiviral agents|mesh-ancestor
110051158|NCT01471535|Immunologic Factors|immunologic factors|mesh-ancestor
110051159|NCT01471535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051160|NCT01471613|Lithium Carbonate|lithium carbonate|mesh-list
110051161|NCT01471613|Antidepressive Agents|antidepressive agents|mesh-ancestor
110051162|NCT01471613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110051163|NCT01471613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110051164|NCT01471613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110051165|NCT01471613|Antimanic Agents|antimanic agents|mesh-ancestor
110051166|NCT01471613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110051167|NCT01471613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110051168|NCT01471613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051170|NCT01471678|Dutasteride|dutasteride|mesh-list
110051171|NCT01471678|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110051172|NCT01471678|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110051173|NCT01471678|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110051174|NCT01471678|Adrenergic Agents|adrenergic agents|mesh-ancestor
110051175|NCT01471678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110051176|NCT01471678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110051177|NCT01471678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051178|NCT01471678|Urological Agents|urological agents|mesh-ancestor
110051179|NCT01471678|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110051180|NCT01471678|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110051181|NCT01471678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110051182|NCT01471678|Hormone Antagonists|hormone antagonists|mesh-ancestor
110051183|NCT01471678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110051185|NCT01471704|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110051186|NCT01471704|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110051187|NCT01471704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110051188|NCT01471704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110051189|NCT01471704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110051190|NCT01471704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051191|NCT01471704|Vasodilator Agents|vasodilator agents|mesh-ancestor
110051192|NCT01471730|Thrombin|thrombin|mesh-list
110051193|NCT01471730|Hemostatics|hemostatics|mesh-ancestor
110051194|NCT01471730|Coagulants|coagulants|mesh-ancestor
110051196|NCT01471808|Pioglitazone|pioglitazone|mesh-list
110051197|NCT01471808|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110051198|NCT01471808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110051199|NCT01471808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051200|NCT01471808|Incretins|incretins|mesh-ancestor
110051201|NCT01471808|Hormones|hormones|mesh-ancestor
110051202|NCT01471808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110051203|NCT01471808|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110051204|NCT01471808|Protease Inhibitors|protease inhibitors|mesh-ancestor
110051205|NCT01471808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110051206|NCT01471808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110051207|NCT01471821|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110051208|NCT01471821|Antiviral Agents|antiviral agents|mesh-ancestor
110051209|NCT01471821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110051210|NCT01471847|Capecitabine|capecitabine|mesh-list
110051211|NCT01471847|Trastuzumab|trastuzumab|mesh-list
110051212|NCT01471847|Lapatinib|lapatinib|mesh-list
110051213|NCT01471847|Dactolisib|dactolisib|mesh-list
110051214|NCT01471847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110051215|NCT01471847|Antimetabolites|antimetabolites|mesh-ancestor
110051216|NCT01471847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110051217|NCT01471847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110051218|NCT01471847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110051219|NCT01471847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110051220|NCT01471847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110051221|NCT01471886|Ketorolac|ketorolac|mesh-list
110051222|NCT01471886|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110051223|NCT01471886|Naproxen|naproxen|mesh-list
110051224|NCT01471886|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110051225|NCT01471886|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110051226|NCT01471886|Analgesics|analgesics|mesh-ancestor
110051227|NCT01471886|Sensory System Agents|sensory system agents|mesh-ancestor
110051228|NCT01471886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110051229|NCT01471886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051230|NCT01471886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110051231|NCT01471886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110051232|NCT01471886|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110051233|NCT01471886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110051234|NCT01471886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110051235|NCT01471886|Gout Suppressants|gout suppressants|mesh-ancestor
110051236|NCT01471899|Ketorolac|ketorolac|mesh-list
110051237|NCT01471899|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110051238|NCT01471899|Naproxen|naproxen|mesh-list
110051239|NCT01471899|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110051240|NCT01471899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110051241|NCT01471899|Analgesics|analgesics|mesh-ancestor
110051242|NCT01471899|Sensory System Agents|sensory system agents|mesh-ancestor
110051243|NCT01471899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110051244|NCT01471899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051245|NCT01471899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110051246|NCT01471899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110051247|NCT01471899|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110051248|NCT01471899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110051249|NCT01471899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110051250|NCT01471899|Gout Suppressants|gout suppressants|mesh-ancestor
110051251|NCT01471925|Esomeprazole|esomeprazole|mesh-list
110051252|NCT01471925|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110051253|NCT01471925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110051254|NCT01471925|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110051255|NCT01471925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110051256|NCT01471925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110051257|NCT01471964|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110051258|NCT01471964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110051259|NCT01471964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110051260|NCT01471964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110051261|NCT01471964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110051262|NCT01471990|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
110051263|NCT01471990|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
110051264|NCT01471990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110051265|NCT01471990|Vasodilator Agents|vasodilator agents|mesh-ancestor
110051266|NCT01471990|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110051267|NCT01471990|Protective Agents|protective agents|mesh-ancestor
110051268|NCT01471990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051269|NCT01471990|Growth Substances|growth substances|mesh-ancestor
110051270|NCT01471990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110051271|NCT01471990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110051273|NCT01472016|Cetuximab|cetuximab|mesh-list
110051274|NCT01472016|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110051275|NCT01472016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110051276|NCT01472016|Tubulin Modulators|tubulin modulators|mesh-ancestor
110051277|NCT01472016|Antimitotic Agents|antimitotic agents|mesh-ancestor
110051278|NCT01472016|Mitosis Modulators|mitosis modulators|mesh-ancestor
110051279|NCT01472016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110051280|NCT01472016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110051281|NCT01472016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110051282|NCT01472016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110051283|NCT01472029|Leucovorin|leucovorin|mesh-list
110051284|NCT01472029|Docetaxel|docetaxel|mesh-list
110051285|NCT01472029|Oxaliplatin|oxaliplatin|mesh-list
110051286|NCT01472029|Trastuzumab|trastuzumab|mesh-list
110051287|NCT01472029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110051288|NCT01472029|Tubulin Modulators|tubulin modulators|mesh-ancestor
110051289|NCT01472029|Antimitotic Agents|antimitotic agents|mesh-ancestor
110051290|NCT01472029|Mitosis Modulators|mitosis modulators|mesh-ancestor
110051291|NCT01472029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110051292|NCT01472029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110051293|NCT01472029|Antidotes|antidotes|mesh-ancestor
110051294|NCT01472029|Protective Agents|protective agents|mesh-ancestor
110051295|NCT01472029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051296|NCT01472029|Vitamin B Complex|vitamin b complex|mesh-ancestor
110051297|NCT01472029|Vitamins|vitamins|mesh-ancestor
110051298|NCT01472029|Micronutrients|micronutrients|mesh-ancestor
110051299|NCT01472055|Fludarabine|fludarabine|mesh-list
110051300|NCT01472055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110036315|NCT01410214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110051301|NCT01472146|Doxorubicin|doxorubicin|mesh-list
110051302|NCT01472146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110051303|NCT01472146|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110051304|NCT01472146|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110051305|NCT01472146|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110051306|NCT01472146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110051308|NCT01472263|Pentoxifylline|pentoxifylline|mesh-list
110051309|NCT01472263|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110051310|NCT01472263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110051311|NCT01472263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110051312|NCT01472263|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110051313|NCT01472263|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110051314|NCT01472263|Protective Agents|protective agents|mesh-ancestor
110051315|NCT01472263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051316|NCT01472263|Vasodilator Agents|vasodilator agents|mesh-ancestor
110051317|NCT01472263|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110051318|NCT01472263|Antioxidants|antioxidants|mesh-ancestor
110051319|NCT01472315|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110051320|NCT01472315|Medroxyprogesterone|medroxyprogesterone|mesh-list
110051321|NCT01472315|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110051322|NCT01472315|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110051323|NCT01472315|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110051324|NCT01472315|Contraceptive Agents|contraceptive agents|mesh-ancestor
110051325|NCT01472315|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110051326|NCT01472315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051327|NCT01472315|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110051328|NCT01472315|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110051329|NCT01472315|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110051330|NCT01472315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110051331|NCT01472315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110051332|NCT01472406|Pancrelipase|pancrelipase|mesh-list
110051333|NCT01472406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110051335|NCT01472497|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110051336|NCT01472497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051337|NCT01472510|Ranibizumab|ranibizumab|mesh-list
110051338|NCT01472510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110051339|NCT01472510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110051340|NCT01472510|Growth Substances|growth substances|mesh-ancestor
110051341|NCT01472510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051342|NCT01472510|Growth Inhibitors|growth inhibitors|mesh-ancestor
110051343|NCT01472510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110051344|NCT01472640|Liraglutide|liraglutide|mesh-list
110051345|NCT01472640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110051346|NCT01472640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051347|NCT01472640|Incretins|incretins|mesh-ancestor
110051348|NCT01472640|Hormones|hormones|mesh-ancestor
110051349|NCT01472640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110051350|NCT01472653|Cetuximab|cetuximab|mesh-list
110051351|NCT01472653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110051352|NCT01472653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110051353|NCT01472666|Caseins|caseins|mesh-list
110051354|NCT01472666|Chelating Agents|chelating agents|mesh-ancestor
110051355|NCT01472666|Sequestering Agents|sequestering agents|mesh-ancestor
110051356|NCT01472666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110051357|NCT01472731|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110051358|NCT01472731|Immunologic Factors|immunologic factors|mesh-ancestor
110051359|NCT01472731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051360|NCT01472770|Gemcitabine|gemcitabine|mesh-list
110051361|NCT01472770|Capecitabine|capecitabine|mesh-list
110051362|NCT01472770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110051363|NCT01472770|Antimetabolites|antimetabolites|mesh-ancestor
110051364|NCT01472770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110051365|NCT01472770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110051366|NCT01472783|Veliparib|veliparib|mesh-list
110051367|NCT01472783|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110051368|NCT01472783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110051369|NCT01472783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110051370|NCT01472783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110051371|NCT01472796|Vitamin D|vitamin d|mesh-list
110051372|NCT01472796|Cholecalciferol|cholecalciferol|mesh-list
110051373|NCT01472796|Vitamins|vitamins|mesh-ancestor
110051374|NCT01472796|Micronutrients|micronutrients|mesh-ancestor
110051375|NCT01472796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051376|NCT01472796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110051377|NCT01472796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110051378|NCT01472900|Benzoyl Peroxide|benzoyl peroxide|mesh-list
110051379|NCT01472900|Dermatologic Agents|dermatologic agents|mesh-ancestor
110051380|NCT01472913|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110051381|NCT01472913|Hemostatics|hemostatics|mesh-ancestor
110051383|NCT01472926|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110051384|NCT01472926|Plasminogen|plasminogen|mesh-list
110051385|NCT01472926|Tenecteplase|tenecteplase|mesh-list
110051386|NCT01472926|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110051387|NCT01472926|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110051388|NCT01472926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110051389|NCT01472978|Metronidazole|metronidazole|mesh-list
110051390|NCT01472978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110051391|NCT01472978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110051392|NCT01472978|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110051393|NCT01472978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110051394|NCT01473043|Axitinib|axitinib|mesh-list
110051395|NCT01473043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110051396|NCT01473043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110051397|NCT01473043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110051398|NCT01473043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110051399|NCT01473069|Ketoconazole|ketoconazole|mesh-list
110051400|NCT01473069|Antifungal Agents|antifungal agents|mesh-ancestor
110051401|NCT01473069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110051402|NCT01473069|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110051403|NCT01473069|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110051404|NCT01473069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110051405|NCT01473069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110051406|NCT01473069|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110051407|NCT01473069|Hormone Antagonists|hormone antagonists|mesh-ancestor
110051408|NCT01473069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110051409|NCT01473069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051410|NCT01473069|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110051411|NCT01473147|Exenatide|exenatide|mesh-list
110051412|NCT01473147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110051413|NCT01473147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051414|NCT01473147|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110051415|NCT01473147|Incretins|incretins|mesh-ancestor
110051416|NCT01473147|Hormones|hormones|mesh-ancestor
110051417|NCT01473147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110051418|NCT01473173|Esomeprazole|esomeprazole|mesh-list
110051419|NCT01473173|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110051420|NCT01473173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110051421|NCT01473173|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110051422|NCT01473173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110051423|NCT01473173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110051424|NCT01473251|Bevacizumab|bevacizumab|mesh-list
110051425|NCT01473251|Ranibizumab|ranibizumab|mesh-list
110051426|NCT01473251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110051427|NCT01473251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110051428|NCT01473251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110051429|NCT01473251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110051430|NCT01473251|Growth Substances|growth substances|mesh-ancestor
110051431|NCT01473251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051432|NCT01473251|Growth Inhibitors|growth inhibitors|mesh-ancestor
110051433|NCT01473277|Triamcinolone|triamcinolone|mesh-list
110051434|NCT01473277|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110051435|NCT01473277|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110051436|NCT01473277|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110051437|NCT01473277|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110051438|NCT01473277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110051439|NCT01473277|Glucocorticoids|glucocorticoids|mesh-ancestor
110051440|NCT01473277|Hormones|hormones|mesh-ancestor
110051441|NCT01473277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110051442|NCT01473277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051443|NCT01473277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110051444|NCT01473277|Immunologic Factors|immunologic factors|mesh-ancestor
110051445|NCT01473277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110051446|NCT01473277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110051447|NCT01473277|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110051448|NCT01473277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110051449|NCT01473277|Cholinergic Agents|cholinergic agents|mesh-ancestor
110051450|NCT01473277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110051451|NCT01473303|Leucovorin|leucovorin|mesh-list
110051452|NCT01473303|Fluorouracil|fluorouracil|mesh-list
110051453|NCT01473303|Oxaliplatin|oxaliplatin|mesh-list
110051454|NCT01473303|Irinotecan|irinotecan|mesh-list
110051455|NCT01473303|Calcium|calcium|mesh-list
110051456|NCT01473303|Levoleucovorin|levoleucovorin|mesh-list
110051457|NCT01473303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110051458|NCT01473303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051459|NCT01473303|Antimetabolites|antimetabolites|mesh-ancestor
110051460|NCT01473303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110051461|NCT01473303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110051462|NCT01473303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110051463|NCT01473303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110051464|NCT01473303|Immunologic Factors|immunologic factors|mesh-ancestor
110051465|NCT01473303|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110051466|NCT01473303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110051467|NCT01473303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110051468|NCT01473303|Antidotes|antidotes|mesh-ancestor
110051469|NCT01473303|Protective Agents|protective agents|mesh-ancestor
110051470|NCT01473303|Vitamin B Complex|vitamin b complex|mesh-ancestor
110051471|NCT01473303|Vitamins|vitamins|mesh-ancestor
110051472|NCT01473303|Micronutrients|micronutrients|mesh-ancestor
110051473|NCT01473316|Ketoconazole|ketoconazole|mesh-list
110051474|NCT01473316|Antifungal Agents|antifungal agents|mesh-ancestor
110051475|NCT01473316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110051476|NCT01473316|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110051477|NCT01473316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110051478|NCT01473316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110051479|NCT01473316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110051480|NCT01473316|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110051481|NCT01473316|Hormone Antagonists|hormone antagonists|mesh-ancestor
110051558|NCT01474330|Growth Inhibitors|growth inhibitors|mesh-ancestor
110051482|NCT01473316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110051483|NCT01473316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051484|NCT01473316|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110051485|NCT01473472|Tenofovir|tenofovir|mesh-list
110051486|NCT01473472|Emtricitabine|emtricitabine|mesh-list
110051487|NCT01473472|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110051488|NCT01473472|Antiviral Agents|antiviral agents|mesh-ancestor
110051489|NCT01473472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110051490|NCT01473472|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110051491|NCT01473472|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110051492|NCT01473472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110051493|NCT01473472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110051494|NCT01473472|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110051495|NCT01473472|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110051496|NCT01473537|Calcium|calcium|mesh-list
110051497|NCT01473537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110051498|NCT01473537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051499|NCT01473797|Cladribine|cladribine|mesh-list
110051500|NCT01473797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110051501|NCT01473797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110051502|NCT01473797|Immunologic Factors|immunologic factors|mesh-ancestor
110051503|NCT01473797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051504|NCT01473810|Endocine|endocine|mesh-list
110051505|NCT01473810|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110051506|NCT01473810|Immunologic Factors|immunologic factors|mesh-ancestor
110051507|NCT01473810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051508|NCT01473901|Temozolomide|temozolomide|mesh-list
110051509|NCT01473901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110051510|NCT01473901|Alkylating Agents|alkylating agents|mesh-ancestor
110051511|NCT01473901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110051512|NCT01473901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110051513|NCT01473914|Vitamins|vitamins|mesh-list
110051514|NCT01473914|Vitamin E|vitamin e|mesh-list
110051515|NCT01473914|Tocopherols|tocopherols|mesh-list
110051516|NCT01473914|Tocotrienols|tocotrienols|mesh-list
110051517|NCT01473914|alpha-Tocopherol|alpha-tocopherol|mesh-list
110051518|NCT01473914|Zinc|zinc|mesh-list
110051519|NCT01473914|Selenium|selenium|mesh-list
110051520|NCT01473914|Micronutrients|micronutrients|mesh-ancestor
110051521|NCT01473914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051522|NCT01473914|Trace Elements|trace elements|mesh-ancestor
110051523|NCT01473914|Antioxidants|antioxidants|mesh-ancestor
110051524|NCT01473914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110051525|NCT01473914|Protective Agents|protective agents|mesh-ancestor
110051526|NCT01474174|Vaccines|vaccines|mesh-list
110051527|NCT01474174|Immunologic Factors|immunologic factors|mesh-ancestor
110051528|NCT01474174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051529|NCT01474187|Capecitabine|capecitabine|mesh-list
110051530|NCT01474187|Irinotecan|irinotecan|mesh-list
110051531|NCT01474187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110051532|NCT01474187|Antimetabolites|antimetabolites|mesh-ancestor
110051533|NCT01474187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110051534|NCT01474187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110051535|NCT01474187|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110051536|NCT01474187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110051537|NCT01474187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110051538|NCT01474265|Varenicline|varenicline|mesh-list
110051539|NCT01474265|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110051540|NCT01474265|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110051541|NCT01474265|Cholinergic Agents|cholinergic agents|mesh-ancestor
110051542|NCT01474265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110051543|NCT01474265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110051544|NCT01474265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051545|NCT01474304|Acetaminophen|acetaminophen|mesh-list
110051546|NCT01474304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110051547|NCT01474304|Analgesics|analgesics|mesh-ancestor
110051548|NCT01474304|Sensory System Agents|sensory system agents|mesh-ancestor
110051549|NCT01474304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110051550|NCT01474304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051551|NCT01474304|Antipyretics|antipyretics|mesh-ancestor
110051552|NCT01474330|Pomalidomide|pomalidomide|mesh-list
110051553|NCT01474330|Immunologic Factors|immunologic factors|mesh-ancestor
110051554|NCT01474330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051555|NCT01474330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110051556|NCT01474330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110051557|NCT01474330|Growth Substances|growth substances|mesh-ancestor
110051559|NCT01474330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110051560|NCT01474382|Phentolamine|phentolamine|mesh-list
110051561|NCT01474382|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110051562|NCT01474382|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110051563|NCT01474382|Adrenergic Agents|adrenergic agents|mesh-ancestor
110051564|NCT01474382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110051565|NCT01474382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110051566|NCT01474382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051567|NCT01474382|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110051568|NCT01474460|Vitamin K|vitamin k|mesh-list
110051569|NCT01474460|Vitamin K 1|vitamin k 1|mesh-list
110051570|NCT01474460|Vitamins|vitamins|mesh-ancestor
110051571|NCT01474460|Micronutrients|micronutrients|mesh-ancestor
110051572|NCT01474460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051573|NCT01474460|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110051574|NCT01474460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110051575|NCT01474460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110051576|NCT01474460|Hemostatics|hemostatics|mesh-ancestor
110051577|NCT01474460|Coagulants|coagulants|mesh-ancestor
110051578|NCT01474473|Calpastatin|calpastatin|mesh-list
110051579|NCT01474473|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
110051580|NCT01474473|Protease Inhibitors|protease inhibitors|mesh-ancestor
110051581|NCT01474473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110051582|NCT01474473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110051584|NCT01474499|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
110051585|NCT01474499|Glycerol|glycerol|mesh-list
110051586|NCT01474499|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110051587|NCT01474499|Protective Agents|protective agents|mesh-ancestor
110051588|NCT01474499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051589|NCT01474499|Cathartics|cathartics|mesh-ancestor
110051590|NCT01474499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110051591|NCT01474499|Antidiarrheals|antidiarrheals|mesh-ancestor
110051592|NCT01474642|Capecitabine|capecitabine|mesh-list
110051593|NCT01474642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110051594|NCT01474642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110051595|NCT01474642|Antimetabolites|antimetabolites|mesh-ancestor
110051596|NCT01474642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110051597|NCT01474902|Enoxaparin|enoxaparin|mesh-list
110051598|NCT01474902|Anticoagulants|anticoagulants|mesh-ancestor
110051599|NCT01474902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110051600|NCT01474902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110051601|NCT01474902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110051602|NCT01474967|Metformin|metformin|mesh-list
110051603|NCT01474967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110051604|NCT01474967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051605|NCT01475006|AMG 595|amg 595|mesh-list
110051606|NCT01475006|Immunoconjugates|immunoconjugates|mesh-ancestor
110051607|NCT01475006|Immunologic Factors|immunologic factors|mesh-ancestor
110051608|NCT01475006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051609|NCT01475019|Orlistat|orlistat|mesh-list
110051610|NCT01475019|Sibutramine|sibutramine|mesh-list
110051612|NCT01475019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110051614|NCT01475019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110051615|NCT01475019|Antidepressive Agents|antidepressive agents|mesh-ancestor
110051616|NCT01475019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110051617|NCT01475019|Appetite Depressants|appetite depressants|mesh-ancestor
110051618|NCT01475032|Beclomethasone|beclomethasone|mesh-list
110051619|NCT01475032|Formoterol Fumarate|formoterol fumarate|mesh-list
110051620|NCT01475032|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110051621|NCT01475032|Autonomic Agents|autonomic agents|mesh-ancestor
110051622|NCT01475032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110051623|NCT01475032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051624|NCT01475032|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110051625|NCT01475032|Respiratory System Agents|respiratory system agents|mesh-ancestor
110051626|NCT01475032|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110051627|NCT01475032|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110051628|NCT01475032|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110051629|NCT01475032|Adrenergic Agents|adrenergic agents|mesh-ancestor
110051630|NCT01475032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110051631|NCT01475032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110051632|NCT01475032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110051633|NCT01475032|Glucocorticoids|glucocorticoids|mesh-ancestor
110051634|NCT01475032|Hormones|hormones|mesh-ancestor
110051635|NCT01475032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110051636|NCT01475227|Zinc|zinc|mesh-list
110051638|NCT01475227|Trace Elements|trace elements|mesh-ancestor
110051639|NCT01475227|Micronutrients|micronutrients|mesh-ancestor
110051640|NCT01475227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051641|NCT01475227|Astringents|astringents|mesh-ancestor
110051642|NCT01475227|Dermatologic Agents|dermatologic agents|mesh-ancestor
110051643|NCT01475266|Apaziquone|apaziquone|mesh-list
110051644|NCT01475266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110051645|NCT01475279|Warfarin|warfarin|mesh-list
110051646|NCT01475279|Anticoagulants|anticoagulants|mesh-ancestor
110051647|NCT01475318|Letrozole|letrozole|mesh-list
110051648|NCT01475318|Misoprostol|misoprostol|mesh-list
110051649|NCT01475318|Mifepristone|mifepristone|mesh-list
110051650|NCT01475318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110051651|NCT01475318|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110051652|NCT01475318|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110051653|NCT01475318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110051654|NCT01475318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110051655|NCT01475318|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110051656|NCT01475318|Hormone Antagonists|hormone antagonists|mesh-ancestor
110051657|NCT01475318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110051658|NCT01475318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051659|NCT01475318|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110051660|NCT01475318|Abortifacient Agents|abortifacient agents|mesh-ancestor
110051661|NCT01475318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110051662|NCT01475318|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110051663|NCT01475318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110051664|NCT01475318|Oxytocics|oxytocics|mesh-ancestor
110051665|NCT01475318|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110051666|NCT01475318|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110051667|NCT01475318|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110051668|NCT01475318|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110051669|NCT01475318|Contraceptive Agents|contraceptive agents|mesh-ancestor
110051670|NCT01475318|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110051671|NCT01475318|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110051672|NCT01475318|Luteolytic Agents|luteolytic agents|mesh-ancestor
110051673|NCT01475318|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110051674|NCT01475318|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110051675|NCT01475552|Abciximab|abciximab|mesh-list
110051676|NCT01475552|Clopidogrel|clopidogrel|mesh-list
110051677|NCT01475552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051678|NCT01475552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110051679|NCT01475552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110051680|NCT01475552|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110051681|NCT01475552|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110051682|NCT01475552|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110051683|NCT01475552|Purinergic Agents|purinergic agents|mesh-ancestor
110036316|NCT01410214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110051684|NCT01475552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110051699|NCT01475617|Vitamin B 12|vitamin b 12|mesh-list
110051700|NCT01475617|Hydroxocobalamin|hydroxocobalamin|mesh-list
110051702|NCT01475617|Vitamins|vitamins|mesh-ancestor
110051703|NCT01475617|Micronutrients|micronutrients|mesh-ancestor
110051704|NCT01475617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051705|NCT01475617|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110051706|NCT01475617|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110051707|NCT01475617|Vitamin B Complex|vitamin b complex|mesh-ancestor
110051708|NCT01475617|Hematinics|hematinics|mesh-ancestor
110051709|NCT01475656|Levetiracetam|levetiracetam|mesh-list
110051710|NCT01475656|Anticonvulsants|anticonvulsants|mesh-ancestor
110051711|NCT01475656|Nootropic Agents|nootropic agents|mesh-ancestor
110051712|NCT01475708|Doxycycline|doxycycline|mesh-list
110051713|NCT01475708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110051714|NCT01475708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110051715|NCT01475708|Antimalarials|antimalarials|mesh-ancestor
110051716|NCT01475708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110051717|NCT01475708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110051718|NCT01475760|Chitosan|chitosan|mesh-list
110051719|NCT01475760|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110051720|NCT01475760|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110051721|NCT01475760|Antimetabolites|antimetabolites|mesh-ancestor
110051722|NCT01475760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110051723|NCT01475760|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110051724|NCT01475760|Chelating Agents|chelating agents|mesh-ancestor
110051725|NCT01475760|Sequestering Agents|sequestering agents|mesh-ancestor
110051726|NCT01475760|Hemostatics|hemostatics|mesh-ancestor
110051727|NCT01475760|Coagulants|coagulants|mesh-ancestor
110051728|NCT01475877|Bromfenac|bromfenac|mesh-list
110051729|NCT01475877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110051730|NCT01475877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110051731|NCT01475877|Analgesics|analgesics|mesh-ancestor
110051733|NCT01475877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110051734|NCT01475877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051735|NCT01475877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110051736|NCT01475877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110051738|NCT01475890|Cholecalciferol|cholecalciferol|mesh-list
110051739|NCT01475890|Vitamins|vitamins|mesh-ancestor
110051740|NCT01475890|Micronutrients|micronutrients|mesh-ancestor
110051741|NCT01475890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051742|NCT01475890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110051743|NCT01475890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110051744|NCT01476007|Vitamins|vitamins|mesh-list
110051745|NCT01476007|Hydroxocobalamin|hydroxocobalamin|mesh-list
110051746|NCT01476007|Vitamin B 12|vitamin b 12|mesh-list
110051747|NCT01476007|Vitamin B Complex|vitamin b complex|mesh-list
110051748|NCT01476007|Micronutrients|micronutrients|mesh-ancestor
110051749|NCT01476007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051750|NCT01476007|Hematinics|hematinics|mesh-ancestor
110051751|NCT01476124|Morphine|morphine|mesh-list
110051752|NCT01476124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110051753|NCT01476124|Narcotics|narcotics|mesh-ancestor
110051754|NCT01476124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110051755|NCT01476124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051756|NCT01476124|Analgesics|analgesics|mesh-ancestor
110051757|NCT01476124|Sensory System Agents|sensory system agents|mesh-ancestor
110051758|NCT01476124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110051759|NCT01476137|Trametinib|trametinib|mesh-list
110051760|NCT01476137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110051761|NCT01476137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110051762|NCT01476137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110051763|NCT01476137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110051764|NCT01476176|Acetaminophen|acetaminophen|mesh-list
110051765|NCT01476176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110051766|NCT01476176|Analgesics|analgesics|mesh-ancestor
110051767|NCT01476176|Sensory System Agents|sensory system agents|mesh-ancestor
110051768|NCT01476176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110051769|NCT01476176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051770|NCT01476176|Antipyretics|antipyretics|mesh-ancestor
110051771|NCT01476189|Acetaminophen|acetaminophen|mesh-list
110051772|NCT01476189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110051773|NCT01476189|Analgesics|analgesics|mesh-ancestor
110051774|NCT01476189|Sensory System Agents|sensory system agents|mesh-ancestor
110051775|NCT01476189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110051776|NCT01476189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051777|NCT01476189|Antipyretics|antipyretics|mesh-ancestor
110051778|NCT01476215|Acetaminophen|acetaminophen|mesh-list
110051779|NCT01476215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110051780|NCT01476215|Analgesics|analgesics|mesh-ancestor
110051781|NCT01476215|Sensory System Agents|sensory system agents|mesh-ancestor
110051782|NCT01476215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110051783|NCT01476215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051784|NCT01476215|Antipyretics|antipyretics|mesh-ancestor
110051785|NCT01476280|Palonosetron|palonosetron|mesh-list
110051786|NCT01476280|Ramosetron|ramosetron|mesh-list
110051787|NCT01476280|Antiemetics|antiemetics|mesh-ancestor
110051788|NCT01476280|Autonomic Agents|autonomic agents|mesh-ancestor
110051789|NCT01476280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110051790|NCT01476280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051791|NCT01476280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110051792|NCT01476280|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110051793|NCT01476280|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110051794|NCT01476280|Serotonin Agents|serotonin agents|mesh-ancestor
110051795|NCT01476280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110051796|NCT01476280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110051797|NCT01476332|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110051798|NCT01476332|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110051799|NCT01476358|Vitamin A|vitamin a|mesh-list
110051800|NCT01476358|Retinol palmitate|retinol palmitate|mesh-list
110051801|NCT01476358|Vitamins|vitamins|mesh-ancestor
110051802|NCT01476358|Micronutrients|micronutrients|mesh-ancestor
110051803|NCT01476358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051804|NCT01476358|Antioxidants|antioxidants|mesh-ancestor
110051805|NCT01476358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110051806|NCT01476358|Protective Agents|protective agents|mesh-ancestor
110051807|NCT01476358|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110051808|NCT01476358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110051809|NCT01476410|Doxorubicin|doxorubicin|mesh-list
110051810|NCT01476410|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110051811|NCT01476410|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110051812|NCT01476410|Dacarbazine|dacarbazine|mesh-list
110051813|NCT01476410|Vinblastine|vinblastine|mesh-list
110051814|NCT01476410|Antibodies|antibodies|mesh-list
110051815|NCT01476410|Immunoglobulins|immunoglobulins|mesh-list
110051816|NCT01476410|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110051817|NCT01476410|Immunoconjugates|immunoconjugates|mesh-list
110051818|NCT01476410|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110051819|NCT01476410|Immunologic Factors|immunologic factors|mesh-ancestor
110051820|NCT01476410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051821|NCT01476410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110051822|NCT01476410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110051823|NCT01476410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110051824|NCT01476410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110051825|NCT01476410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110051826|NCT01476410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110051827|NCT01476410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110051828|NCT01476410|Immunotoxins|immunotoxins|mesh-ancestor
110051829|NCT01476410|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110051830|NCT01476410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110051831|NCT01476410|Alkylating Agents|alkylating agents|mesh-ancestor
110051832|NCT01476410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110051833|NCT01476410|Tubulin Modulators|tubulin modulators|mesh-ancestor
110051834|NCT01476410|Antimitotic Agents|antimitotic agents|mesh-ancestor
110051835|NCT01476410|Mitosis Modulators|mitosis modulators|mesh-ancestor
110051836|NCT01476488|Tacrolimus|tacrolimus|mesh-list
110051837|NCT01476488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110051838|NCT01476488|Immunologic Factors|immunologic factors|mesh-ancestor
110051839|NCT01476488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051840|NCT01476488|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110051841|NCT01476488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110051842|NCT01476488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110051843|NCT01476592|Resveratrol|resveratrol|mesh-list
110051844|NCT01476592|Antioxidants|antioxidants|mesh-ancestor
110051845|NCT01476592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110051846|NCT01476592|Protective Agents|protective agents|mesh-ancestor
110051847|NCT01476592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051848|NCT01476592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110051849|NCT01476592|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110051850|NCT01476605|Sodium Morrhuate|sodium morrhuate|mesh-list
110051851|NCT01476605|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
110051852|NCT01476605|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110051854|NCT01476683|Thiorphan|thiorphan|mesh-list
110051855|NCT01476683|Antidiarrheals|antidiarrheals|mesh-ancestor
110051856|NCT01476683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110051857|NCT01476683|Protease Inhibitors|protease inhibitors|mesh-ancestor
110051858|NCT01476683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110051859|NCT01476683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110051860|NCT01476774|Buprenorphine|buprenorphine|mesh-list
110051861|NCT01476774|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110051862|NCT01476774|Narcotics|narcotics|mesh-ancestor
110051863|NCT01476774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110051864|NCT01476774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051865|NCT01476774|Analgesics|analgesics|mesh-ancestor
110051866|NCT01476774|Sensory System Agents|sensory system agents|mesh-ancestor
110051867|NCT01476774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110051868|NCT01476774|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110051869|NCT01476800|Ketoconazole|ketoconazole|mesh-list
110051870|NCT01476800|Mirabegron|mirabegron|mesh-list
110051871|NCT01476800|Antifungal Agents|antifungal agents|mesh-ancestor
110051872|NCT01476800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110051873|NCT01476800|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110051874|NCT01476800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110051875|NCT01476800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110051876|NCT01476800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110051877|NCT01476800|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110051878|NCT01476800|Hormone Antagonists|hormone antagonists|mesh-ancestor
110051879|NCT01476800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110051880|NCT01476800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051881|NCT01476800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110051882|NCT01476800|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110051883|NCT01476800|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110051884|NCT01476800|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110051885|NCT01476800|Adrenergic Agents|adrenergic agents|mesh-ancestor
110051886|NCT01476800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110051887|NCT01476800|Urological Agents|urological agents|mesh-ancestor
110051892|NCT01476813|Cholinergic Agents|cholinergic agents|mesh-ancestor
110051893|NCT01476813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110051894|NCT01476813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110051895|NCT01476813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051897|NCT01477021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110051898|NCT01477021|Immunologic Factors|immunologic factors|mesh-ancestor
110051899|NCT01477021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051900|NCT01477021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110051901|NCT01477021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110051902|NCT01477021|Alkylating Agents|alkylating agents|mesh-ancestor
110051903|NCT01477021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110051904|NCT01477021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110051905|NCT01477021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110051906|NCT01477034|Vitamin D|vitamin d|mesh-list
110051907|NCT01477034|Ergocalciferols|ergocalciferols|mesh-list
110051908|NCT01477034|Cholecalciferol|cholecalciferol|mesh-list
110051909|NCT01477034|Vitamins|vitamins|mesh-list
110051910|NCT01477034|Micronutrients|micronutrients|mesh-ancestor
110051911|NCT01477034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051912|NCT01477034|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110051913|NCT01477034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110051914|NCT01477060|Metformin|metformin|mesh-list
110051915|NCT01477060|Lapatinib|lapatinib|mesh-list
110051916|NCT01477060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110051917|NCT01477060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051918|NCT01477060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110051919|NCT01477060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110051920|NCT01477060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110051921|NCT01477060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110051922|NCT01477073|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110051923|NCT01477073|Hormones|hormones|mesh-ancestor
110051924|NCT01477073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110051925|NCT01477073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051927|NCT01477112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051928|NCT01477112|Provitamins|provitamins|mesh-ancestor
110051929|NCT01477112|Vitamins|vitamins|mesh-ancestor
110051930|NCT01477112|Micronutrients|micronutrients|mesh-ancestor
110051931|NCT01477151|Anesthetics|anesthetics|mesh-list
110051932|NCT01477151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110051933|NCT01477151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051934|NCT01477190|Morphine|morphine|mesh-list
110051935|NCT01477190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110051936|NCT01477190|Narcotics|narcotics|mesh-ancestor
110051937|NCT01477190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110051938|NCT01477190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051939|NCT01477190|Analgesics|analgesics|mesh-ancestor
110051940|NCT01477190|Sensory System Agents|sensory system agents|mesh-ancestor
110051941|NCT01477190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110051942|NCT01477203|Escitalopram|escitalopram|mesh-list
110051943|NCT01477203|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110051944|NCT01477203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110051945|NCT01477203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110051946|NCT01477203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110051947|NCT01477203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110051948|NCT01477203|Serotonin Agents|serotonin agents|mesh-ancestor
110051949|NCT01477203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051950|NCT01477242|Ondansetron|ondansetron|mesh-list
110051951|NCT01477242|Antiemetics|antiemetics|mesh-ancestor
110051952|NCT01477242|Autonomic Agents|autonomic agents|mesh-ancestor
110051953|NCT01477242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110051954|NCT01477242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051955|NCT01477242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110051956|NCT01477242|Antipruritics|antipruritics|mesh-ancestor
110051957|NCT01477242|Dermatologic Agents|dermatologic agents|mesh-ancestor
110051959|NCT01477242|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110051960|NCT01477242|Serotonin Agents|serotonin agents|mesh-ancestor
110051961|NCT01477242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110051962|NCT01477242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110051964|NCT01477268|Antidepressive Agents|antidepressive agents|mesh-list
110051965|NCT01477268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110051966|NCT01477268|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110051967|NCT01477268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110051968|NCT01477268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110051969|NCT01477268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110051970|NCT01477268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110051971|NCT01477268|Serotonin Agents|serotonin agents|mesh-ancestor
110051972|NCT01477268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051973|NCT01477294|Caffeine|caffeine|mesh-list
110051974|NCT01477294|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110051975|NCT01477294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051976|NCT01477294|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110051977|NCT01477294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110051978|NCT01477294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110051979|NCT01477294|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110051980|NCT01477294|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110051981|NCT01477294|Purinergic Agents|purinergic agents|mesh-ancestor
110051982|NCT01477294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110051983|NCT01477385|Fluorides|fluorides|mesh-list
110051984|NCT01477385|Cariostatic Agents|cariostatic agents|mesh-ancestor
110051985|NCT01477385|Protective Agents|protective agents|mesh-ancestor
110051986|NCT01477385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051987|NCT01477411|Digoxin|digoxin|mesh-list
110051988|NCT01477411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110051989|NCT01477411|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110051990|NCT01477411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110051991|NCT01477411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110051992|NCT01477411|Protective Agents|protective agents|mesh-ancestor
110051993|NCT01477411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110051994|NCT01477424|Warfarin|warfarin|mesh-list
110051995|NCT01477424|Anticoagulants|anticoagulants|mesh-ancestor
110051996|NCT01477476|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110051997|NCT01477476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110051998|NCT01477489|Veliparib|veliparib|mesh-list
110051999|NCT01477489|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110052000|NCT01477489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110052001|NCT01477489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110052002|NCT01477489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110052003|NCT01477580|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110052004|NCT01477580|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110052005|NCT01477580|Immunologic Factors|immunologic factors|mesh-ancestor
110052006|NCT01477580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110052007|NCT01477580|Antacids|antacids|mesh-ancestor
110052008|NCT01477580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110052009|NCT01477580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110052010|NCT01477606|Cytarabine|cytarabine|mesh-list
110052011|NCT01477606|Daunorubicin|daunorubicin|mesh-list
110052012|NCT01477606|Midostaurin|midostaurin|mesh-list
110052013|NCT01477606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110052014|NCT01477606|Antimetabolites|antimetabolites|mesh-ancestor
110052015|NCT01477606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110052016|NCT01477606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110052017|NCT01477606|Antiviral Agents|antiviral agents|mesh-ancestor
110052018|NCT01477606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110052019|NCT01477606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110052020|NCT01477606|Immunologic Factors|immunologic factors|mesh-ancestor
110052021|NCT01477606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110052022|NCT01477606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110052023|NCT01477606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110052024|NCT01477606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110052025|NCT01477606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110052026|NCT01477606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110052027|NCT01477632|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110052028|NCT01477632|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110052029|NCT01477632|Norethindrone|norethindrone|mesh-list
110052030|NCT01477632|Norethindrone Acetate|norethindrone acetate|mesh-list
110052031|NCT01477632|Estradiol|estradiol|mesh-list
110052034|NCT01477632|Hormones|hormones|mesh-ancestor
110052035|NCT01477632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110052036|NCT01477632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110052037|NCT01477632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110052038|NCT01477632|Contraceptive Agents|contraceptive agents|mesh-ancestor
110052039|NCT01477632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110052040|NCT01477632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110052041|NCT01477632|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110052042|NCT01477632|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110052043|NCT01477632|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110052045|NCT01477736|Botulinum Toxins|botulinum toxins|mesh-list
110052046|NCT01477736|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110052047|NCT01477736|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110052048|NCT01477736|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110052049|NCT01477736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110052050|NCT01477736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110052051|NCT01477736|Cholinergic Agents|cholinergic agents|mesh-ancestor
110052052|NCT01477736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110052053|NCT01477736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110052054|NCT01477736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110052055|NCT01477736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110052056|NCT01477736|Parasympatholytics|parasympatholytics|mesh-ancestor
110052057|NCT01477736|Autonomic Agents|autonomic agents|mesh-ancestor
110052058|NCT01477736|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110052059|NCT01477736|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110052060|NCT01477736|Urological Agents|urological agents|mesh-ancestor
110052061|NCT01477801|Cholecalciferol|cholecalciferol|mesh-list
110052062|NCT01477801|Vitamin D|vitamin d|mesh-list
110052063|NCT01477801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110052064|NCT01477801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110052065|NCT01477801|Vitamins|vitamins|mesh-ancestor
110052066|NCT01477801|Micronutrients|micronutrients|mesh-ancestor
110052067|NCT01477801|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110052068|NCT01477840|Misoprostol|misoprostol|mesh-list
110052069|NCT01477840|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110052070|NCT01477840|Abortifacient Agents|abortifacient agents|mesh-ancestor
110052071|NCT01477840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110052072|NCT01477840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110052073|NCT01477840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110052074|NCT01477840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110052076|NCT01477931|Bupropion|bupropion|mesh-list
110052077|NCT01477931|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110052078|NCT01477931|Antidepressive Agents|antidepressive agents|mesh-ancestor
110052079|NCT01477931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110052080|NCT01477931|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110052081|NCT01477931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110052082|NCT01477931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110052083|NCT01477931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110052084|NCT01477931|Dopamine Agents|dopamine agents|mesh-ancestor
110052085|NCT01477931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110052086|NCT01477931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110052087|NCT01477931|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110052088|NCT01477931|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110052089|NCT01477931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110052090|NCT01477983|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
110052091|NCT01477983|Flecainide|flecainide|mesh-list
110052092|NCT01477983|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110052093|NCT01477983|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110052094|NCT01477983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110052095|NCT01477983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110052096|NCT01478022|Ibuprofen|ibuprofen|mesh-list
110052097|NCT01478022|Isosorbide|isosorbide|mesh-list
110052098|NCT01478022|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
110052099|NCT01478022|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
110052100|NCT01478022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110052101|NCT01478022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110052102|NCT01478022|Analgesics|analgesics|mesh-ancestor
110052103|NCT01478022|Sensory System Agents|sensory system agents|mesh-ancestor
110052104|NCT01478022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110052105|NCT01478022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110052106|NCT01478022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110052107|NCT01478022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110052108|NCT01478022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110052109|NCT01478022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110052110|NCT01478022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110052111|NCT01478022|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110052112|NCT01478022|Diuretics|diuretics|mesh-ancestor
110052113|NCT01478022|Natriuretic Agents|natriuretic agents|mesh-ancestor
110052114|NCT01478022|Vasodilator Agents|vasodilator agents|mesh-ancestor
110052115|NCT01478022|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110052116|NCT01478074|Cytarabine|cytarabine|mesh-list
110052117|NCT01478074|Fludarabine|fludarabine|mesh-list
110052118|NCT01478074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110052119|NCT01478074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110052120|NCT01478074|Antimetabolites|antimetabolites|mesh-ancestor
110052121|NCT01478074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110052122|NCT01478074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110052123|NCT01478074|Immunologic Factors|immunologic factors|mesh-ancestor
110052124|NCT01478074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110052125|NCT01478074|Antiviral Agents|antiviral agents|mesh-ancestor
110052126|NCT01478074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110052127|NCT01478165|Palonosetron|palonosetron|mesh-list
110052128|NCT01478165|Anesthetics|anesthetics|mesh-list
110052129|NCT01478165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110052130|NCT01478165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110052131|NCT01478165|Antiemetics|antiemetics|mesh-ancestor
110052132|NCT01478165|Autonomic Agents|autonomic agents|mesh-ancestor
110052133|NCT01478165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110052134|NCT01478165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110052135|NCT01478165|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110052136|NCT01478165|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110052137|NCT01478165|Serotonin Agents|serotonin agents|mesh-ancestor
110052138|NCT01478165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110052139|NCT01478165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110052140|NCT01478230|Nicotine|nicotine|mesh-list
110052141|NCT01478230|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110052142|NCT01478230|Autonomic Agents|autonomic agents|mesh-ancestor
110052143|NCT01478230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110052144|NCT01478230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110052145|NCT01478230|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110052146|NCT01478230|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110052147|NCT01478230|Cholinergic Agents|cholinergic agents|mesh-ancestor
110052148|NCT01478230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110052149|NCT01478230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110052150|NCT01478282|Rivaroxaban|rivaroxaban|mesh-list
110052151|NCT01478282|Dabigatran|dabigatran|mesh-list
110052152|NCT01478282|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110052153|NCT01478282|Antithrombins|antithrombins|mesh-ancestor
110052154|NCT01478282|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110052155|NCT01478282|Protease Inhibitors|protease inhibitors|mesh-ancestor
110052156|NCT01478282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110052157|NCT01478282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110052158|NCT01478282|Anticoagulants|anticoagulants|mesh-ancestor
110052159|NCT01478308|Metformin|metformin|mesh-list
110052160|NCT01478308|Prednisone|prednisone|mesh-list
110052161|NCT01478308|Docetaxel|docetaxel|mesh-list
110052162|NCT01478308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110052163|NCT01478308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110052164|NCT01478308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110052165|NCT01478308|Tubulin Modulators|tubulin modulators|mesh-ancestor
110052166|NCT01478308|Antimitotic Agents|antimitotic agents|mesh-ancestor
110052167|NCT01478308|Mitosis Modulators|mitosis modulators|mesh-ancestor
110052168|NCT01478308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110052169|NCT01478308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110052170|NCT01478308|Glucocorticoids|glucocorticoids|mesh-ancestor
110052171|NCT01478308|Hormones|hormones|mesh-ancestor
110052172|NCT01478308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110052173|NCT01478308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110052174|NCT01478386|Hyaluronic Acid|hyaluronic acid|mesh-list
110052175|NCT01478386|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110052176|NCT01478386|Immunologic Factors|immunologic factors|mesh-ancestor
110052177|NCT01478386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110052178|NCT01478386|Viscosupplements|viscosupplements|mesh-ancestor
110052179|NCT01478386|Protective Agents|protective agents|mesh-ancestor
110052182|NCT01478490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110052183|NCT01478490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110052184|NCT01478490|Sympatholytics|sympatholytics|mesh-ancestor
110052185|NCT01478490|Autonomic Agents|autonomic agents|mesh-ancestor
110052186|NCT01478490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110052187|NCT01478490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110052188|NCT01478490|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110052189|NCT01478490|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110052190|NCT01478490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110052191|NCT01478490|Adrenergic Agents|adrenergic agents|mesh-ancestor
110052192|NCT01478490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110052193|NCT01478490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110052194|NCT01478490|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110052197|NCT01478490|Urological Agents|urological agents|mesh-ancestor
110052198|NCT01478503|Mirabegron|mirabegron|mesh-list
110052199|NCT01478503|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110052200|NCT01478503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110052201|NCT01478503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110052202|NCT01478503|Adrenergic Agents|adrenergic agents|mesh-ancestor
110052203|NCT01478503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110052204|NCT01478503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110052205|NCT01478503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110052206|NCT01478503|Urological Agents|urological agents|mesh-ancestor
110052207|NCT01478529|Mirabegron|mirabegron|mesh-list
110052208|NCT01478529|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110052209|NCT01478529|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110052210|NCT01478529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110052211|NCT01478529|Adrenergic Agents|adrenergic agents|mesh-ancestor
110052212|NCT01478529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110052213|NCT01478529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110052214|NCT01478529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110052215|NCT01478529|Urological Agents|urological agents|mesh-ancestor
110052216|NCT01478568|Desipramine|desipramine|mesh-list
110052217|NCT01478568|Mirabegron|mirabegron|mesh-list
110052218|NCT01478568|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110052219|NCT01478568|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110052220|NCT01478568|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110052221|NCT01478568|Adrenergic Agents|adrenergic agents|mesh-ancestor
110052222|NCT01478568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110052223|NCT01478568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110052224|NCT01478568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110052225|NCT01478568|Urological Agents|urological agents|mesh-ancestor
110052226|NCT01478568|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110052227|NCT01478568|Antidepressive Agents|antidepressive agents|mesh-ancestor
110052228|NCT01478568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110052229|NCT01478568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110052230|NCT01478568|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110052231|NCT01478568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110052232|NCT01478568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110052233|NCT01478607|Capsaicin|capsaicin|mesh-list
110052234|NCT01478607|Antipruritics|antipruritics|mesh-ancestor
110052235|NCT01478607|Dermatologic Agents|dermatologic agents|mesh-ancestor
110052236|NCT01478607|Sensory System Agents|sensory system agents|mesh-ancestor
110052237|NCT01478607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110052238|NCT01478607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110052239|NCT01478633|Galantamine|galantamine|mesh-list
110052240|NCT01478633|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110052241|NCT01478633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110052242|NCT01478633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110052243|NCT01478633|Cholinergic Agents|cholinergic agents|mesh-ancestor
110052244|NCT01478633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110052245|NCT01478633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110052246|NCT01478633|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110052247|NCT01478633|Autonomic Agents|autonomic agents|mesh-ancestor
110052248|NCT01478633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110052249|NCT01478633|Nootropic Agents|nootropic agents|mesh-ancestor
110052250|NCT01478685|Paclitaxel|paclitaxel|mesh-list
110052251|NCT01478685|Carboplatin|carboplatin|mesh-list
110052252|NCT01478685|Azacitidine|azacitidine|mesh-list
110052253|NCT01478685|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110052256|NCT01478685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110052257|NCT01478685|Tubulin Modulators|tubulin modulators|mesh-ancestor
110052258|NCT01478685|Antimitotic Agents|antimitotic agents|mesh-ancestor
110052259|NCT01478685|Mitosis Modulators|mitosis modulators|mesh-ancestor
110052260|NCT01478685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110052261|NCT01478685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110052262|NCT01478685|Antimetabolites|antimetabolites|mesh-ancestor
110052263|NCT01478685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110052264|NCT01478724|Caseins|caseins|mesh-list
110052265|NCT01478724|Chelating Agents|chelating agents|mesh-ancestor
110052266|NCT01478724|Sequestering Agents|sequestering agents|mesh-ancestor
110052267|NCT01478724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110052268|NCT01478737|Dexamethasone|dexamethasone|mesh-list
110052269|NCT01478737|Dexamethasone acetate|dexamethasone acetate|mesh-list
110052270|NCT01478737|BB 1101|bb 1101|mesh-list
110052271|NCT01478737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110052272|NCT01478737|Antiemetics|antiemetics|mesh-ancestor
110052274|NCT01478737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110052275|NCT01478737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110052276|NCT01478737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110052277|NCT01478737|Glucocorticoids|glucocorticoids|mesh-ancestor
110052278|NCT01478737|Hormones|hormones|mesh-ancestor
110052279|NCT01478737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110052280|NCT01478737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110052281|NCT01478737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110052282|NCT01478737|Protease Inhibitors|protease inhibitors|mesh-ancestor
110052283|NCT01478737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110052284|NCT01478737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110052285|NCT01478997|Acetaminophen|acetaminophen|mesh-list
110052286|NCT01478997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110052287|NCT01478997|Analgesics|analgesics|mesh-ancestor
110052288|NCT01478997|Sensory System Agents|sensory system agents|mesh-ancestor
110052289|NCT01478997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110052290|NCT01478997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110052291|NCT01478997|Antipyretics|antipyretics|mesh-ancestor
110052292|NCT01479023|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110052293|NCT01479023|Immunologic Factors|immunologic factors|mesh-ancestor
110052294|NCT01479023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110052295|NCT01479036|Docetaxel|docetaxel|mesh-list
110052296|NCT01479036|Epirubicin|epirubicin|mesh-list
110052297|NCT01479036|Endostatins|endostatins|mesh-list
110052298|NCT01479036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110052299|NCT01479036|Tubulin Modulators|tubulin modulators|mesh-ancestor
110052300|NCT01479036|Antimitotic Agents|antimitotic agents|mesh-ancestor
110052301|NCT01479036|Mitosis Modulators|mitosis modulators|mesh-ancestor
110052302|NCT01479036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110052303|NCT01479036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110052304|NCT01479036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110052305|NCT01479036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110052306|NCT01479036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110052307|NCT01479036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110052308|NCT01479036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110052309|NCT01479036|Growth Substances|growth substances|mesh-ancestor
110052310|NCT01479036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110052311|NCT01479036|Growth Inhibitors|growth inhibitors|mesh-ancestor
110052312|NCT01479088|Cinacalcet|cinacalcet|mesh-list
110052313|NCT01479088|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110052314|NCT01479088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110052315|NCT01479088|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
110052316|NCT01479088|Hormone Antagonists|hormone antagonists|mesh-ancestor
110052317|NCT01479088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110052318|NCT01479114|Lenograstim|lenograstim|mesh-list
110052319|NCT01479114|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110052320|NCT01479114|Immunologic Factors|immunologic factors|mesh-ancestor
110052321|NCT01479114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110052322|NCT01479179|Trastuzumab|trastuzumab|mesh-list
110052323|NCT01479179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110052324|NCT01479179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110052325|NCT01479192|Fenretinide|fenretinide|mesh-list
110052326|NCT01479192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110052327|NCT01479192|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110052328|NCT01479192|Protective Agents|protective agents|mesh-ancestor
110052329|NCT01479192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110052330|NCT01479231|Dexlansoprazole|dexlansoprazole|mesh-list
110052331|NCT01479231|Lansoprazole|lansoprazole|mesh-list
110052332|NCT01479231|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110052333|NCT01479231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110052334|NCT01479231|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110052335|NCT01479231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110052336|NCT01479231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110052337|NCT01479244|Molgramostim|molgramostim|mesh-list
110052338|NCT01479244|Sargramostim|sargramostim|mesh-list
110052339|NCT01479244|Immunologic Factors|immunologic factors|mesh-ancestor
110052340|NCT01479244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110052341|NCT01479244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110052342|NCT01479283|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110052343|NCT01479283|Cefazolin|cefazolin|mesh-list
110052344|NCT01479283|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110052345|NCT01479283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110052346|NCT01479283|Antitubercular Agents|antitubercular agents|mesh-ancestor
110052347|NCT01479296|Vaccines|vaccines|mesh-list
110052348|NCT01479296|Immunologic Factors|immunologic factors|mesh-ancestor
110052349|NCT01479296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110052351|NCT01479361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110052352|NCT01479361|Antimalarials|antimalarials|mesh-ancestor
110052353|NCT01479361|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110052354|NCT01479361|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110052355|NCT01479361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110052356|NCT01479361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110052357|NCT01479504|Cisplatin|cisplatin|mesh-list
110052358|NCT01479504|Docetaxel|docetaxel|mesh-list
110052359|NCT01479504|Nedaplatin|nedaplatin|mesh-list
110052360|NCT01479504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110052361|NCT01479504|Tubulin Modulators|tubulin modulators|mesh-ancestor
110052362|NCT01479504|Antimitotic Agents|antimitotic agents|mesh-ancestor
110052363|NCT01479504|Mitosis Modulators|mitosis modulators|mesh-ancestor
110052364|NCT01479504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110052365|NCT01479556|Pregabalin|pregabalin|mesh-list
110052366|NCT01479556|Analgesics|analgesics|mesh-ancestor
110052367|NCT01479556|Sensory System Agents|sensory system agents|mesh-ancestor
110052368|NCT01479556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110052369|NCT01479556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110052371|NCT01479556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110052372|NCT01479556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110052373|NCT01479556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110052374|NCT01479556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110052375|NCT01479556|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110052376|NCT01479556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110052377|NCT01479556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110052378|NCT01479556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110052379|NCT01479634|Efavirenz|efavirenz|mesh-list
110052380|NCT01479634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110052381|NCT01479634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110052382|NCT01479634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110052383|NCT01479634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110052384|NCT01479634|Antiviral Agents|antiviral agents|mesh-ancestor
110052385|NCT01479634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110052386|NCT01479634|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110052387|NCT01479634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110052388|NCT01479634|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110052389|NCT01479634|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110052390|NCT01479634|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110052391|NCT01479634|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110052392|NCT01479751|Magnesium Sulfate|magnesium sulfate|mesh-list
110052393|NCT01479751|Ketamine|ketamine|mesh-list
110052394|NCT01479751|Rocuronium|rocuronium|mesh-list
110052395|NCT01479751|Analgesics|analgesics|mesh-ancestor
110052396|NCT01479751|Sensory System Agents|sensory system agents|mesh-ancestor
110052397|NCT01479751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110052398|NCT01479751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110052399|NCT01479751|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110052400|NCT01479751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110052402|NCT01479751|Anesthetics|anesthetics|mesh-ancestor
110052403|NCT01479751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110052404|NCT01479751|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110052405|NCT01479751|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110052406|NCT01479751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110052407|NCT01479751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110052408|NCT01479751|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110052409|NCT01479751|Anticonvulsants|anticonvulsants|mesh-ancestor
110052410|NCT01479751|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110052411|NCT01479751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110052412|NCT01479751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110052413|NCT01479751|Tocolytic Agents|tocolytic agents|mesh-ancestor
110052414|NCT01479751|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110052415|NCT01479751|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110052416|NCT01479751|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110052417|NCT01479751|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110052418|NCT01479881|Cyclosporine|cyclosporine|mesh-list
110052419|NCT01479881|Simeprevir|simeprevir|mesh-list
110052420|NCT01479881|Tacrolimus|tacrolimus|mesh-list
110052421|NCT01479881|Cyclosporins|cyclosporins|mesh-list
110052422|NCT01479881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110052423|NCT01479881|Immunologic Factors|immunologic factors|mesh-ancestor
110052424|NCT01479881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110052425|NCT01479881|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110052427|NCT01479881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110052428|NCT01479881|Antifungal Agents|antifungal agents|mesh-ancestor
110052429|NCT01479881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110052430|NCT01479881|Dermatologic Agents|dermatologic agents|mesh-ancestor
110052431|NCT01479881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110052432|NCT01479881|Antiviral Agents|antiviral agents|mesh-ancestor
110052433|NCT01479881|Protease Inhibitors|protease inhibitors|mesh-ancestor
110052434|NCT01479920|Fluoxetine|fluoxetine|mesh-list
110052435|NCT01479920|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110052436|NCT01479920|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110052437|NCT01479920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110052438|NCT01479920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110052439|NCT01479920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110052441|NCT01479920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110052442|NCT01479920|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110052443|NCT01479920|Antidepressive Agents|antidepressive agents|mesh-ancestor
110052444|NCT01479920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110052445|NCT01479920|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110052446|NCT01479920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110052447|NCT01479920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110052448|NCT01479933|Vitamin D|vitamin d|mesh-list
110052449|NCT01479933|Ergocalciferols|ergocalciferols|mesh-list
110052450|NCT01479933|Cholecalciferol|cholecalciferol|mesh-list
110052451|NCT01479933|Vitamins|vitamins|mesh-list
110052452|NCT01479933|Micronutrients|micronutrients|mesh-ancestor
110052453|NCT01479933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110052454|NCT01479933|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110052455|NCT01479933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110052456|NCT01480050|Temozolomide|temozolomide|mesh-list
110052457|NCT01480050|Mibefradil|mibefradil|mesh-list
110052458|NCT01480050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110052459|NCT01480050|Alkylating Agents|alkylating agents|mesh-ancestor
110052460|NCT01480050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110052461|NCT01480050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110052462|NCT01480050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110052463|NCT01480050|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110052464|NCT01480050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110052465|NCT01480050|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110052466|NCT01480050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110052467|NCT01480050|Vasodilator Agents|vasodilator agents|mesh-ancestor
110052468|NCT01480050|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110052469|NCT01480050|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110052470|NCT01480050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110052471|NCT01480063|4-Aminopyridine|4-aminopyridine|mesh-list
110052472|NCT01480063|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110052473|NCT01480063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110052474|NCT01480063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110052475|NCT01480141|Afatinib|afatinib|mesh-list
110052476|NCT01480141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110052478|NCT01480141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110052479|NCT01480141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110052480|NCT01480323|Aldesleukin|aldesleukin|mesh-list
110052481|NCT01480323|Ipilimumab|ipilimumab|mesh-list
110052482|NCT01480323|Interleukin-2|interleukin-2|mesh-list
110052483|NCT01480323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110052484|NCT01480323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110052485|NCT01480323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110052486|NCT01480323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110052487|NCT01480323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110052488|NCT01480323|Analgesics|analgesics|mesh-ancestor
110052489|NCT01480323|Sensory System Agents|sensory system agents|mesh-ancestor
110052490|NCT01480323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110052491|NCT01480323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110052492|NCT01480323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110052493|NCT01480323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110052494|NCT01480323|Antiviral Agents|antiviral agents|mesh-ancestor
110052495|NCT01480323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110052496|NCT01480336|Amiodarone|amiodarone|mesh-list
110052498|NCT01480336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110052499|NCT01480336|Vasodilator Agents|vasodilator agents|mesh-ancestor
110052500|NCT01480336|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110052501|NCT01480336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110052502|NCT01480336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110052503|NCT01480336|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110052504|NCT01480336|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110052505|NCT01480336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110052506|NCT01480336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110052507|NCT01480336|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110052508|NCT01480336|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110052509|NCT01480336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110052510|NCT01480492|Telbivudine|telbivudine|mesh-list
110052511|NCT01480492|Antiviral Agents|antiviral agents|mesh-ancestor
110052512|NCT01480492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110052513|NCT01480492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110052514|NCT01480492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110052515|NCT01480492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110052516|NCT01480531|Clevidipine|clevidipine|mesh-list
110052517|NCT01480531|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110052518|NCT01480531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110052519|NCT01480531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110052520|NCT01480531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110052521|NCT01480531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110052522|NCT01480609|Ezogabine|ezogabine|mesh-list
110052523|NCT01480609|Anticonvulsants|anticonvulsants|mesh-ancestor
110052524|NCT01480609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110052525|NCT01480609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110052526|NCT01480687|Ciprofibrate|ciprofibrate|mesh-list
110052527|NCT01480687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110052528|NCT01480687|Antimetabolites|antimetabolites|mesh-ancestor
110052529|NCT01480687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110052530|NCT01480687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110052531|NCT01480713|Raltegravir Potassium|raltegravir potassium|mesh-list
110052532|NCT01480713|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110052533|NCT01480713|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110052534|NCT01480713|Antiviral Agents|antiviral agents|mesh-ancestor
110052535|NCT01480713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110052536|NCT01480713|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110052537|NCT01480713|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110052538|NCT01480713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110052539|NCT01480713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110052540|NCT01480752|Lornoxicam|lornoxicam|mesh-list
110052541|NCT01480752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110052542|NCT01480752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110052543|NCT01480752|Analgesics|analgesics|mesh-ancestor
110052544|NCT01480752|Sensory System Agents|sensory system agents|mesh-ancestor
110052545|NCT01480752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110052546|NCT01480752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110052547|NCT01480752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110052548|NCT01480752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110052549|NCT01480765|Pregabalin|pregabalin|mesh-list
110052553|NCT01480765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110052554|NCT01480765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110052555|NCT01480765|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110052556|NCT01480765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110052557|NCT01480765|Anesthetics, General|anesthetics, general|mesh-ancestor
110052558|NCT01480765|Anesthetics|anesthetics|mesh-ancestor
110052559|NCT01480765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110052560|NCT01480765|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110052561|NCT01480765|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110052562|NCT01480765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110052563|NCT01480765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110052564|NCT01480765|Anticonvulsants|anticonvulsants|mesh-ancestor
110052565|NCT01480765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110052566|NCT01480765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110052567|NCT01480765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110052568|NCT01480765|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110052569|NCT01480765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110052570|NCT01480765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110052571|NCT01480778|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
110052572|NCT01480778|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110052573|NCT01480778|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110052574|NCT01480778|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110052575|NCT01480778|Contraceptive Agents|contraceptive agents|mesh-ancestor
110052576|NCT01480778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110052577|NCT01480778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110052578|NCT01480778|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110052579|NCT01480778|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110052580|NCT01480778|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110052581|NCT01480778|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
110052582|NCT01480778|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110052583|NCT01480778|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110052585|NCT01480791|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110052586|NCT01480791|Diuretics|diuretics|mesh-ancestor
110052587|NCT01480791|Natriuretic Agents|natriuretic agents|mesh-ancestor
110052588|NCT01480791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110052589|NCT01480791|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110052590|NCT01480791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110052591|NCT01480791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110052592|NCT01480817|Sorafenib|sorafenib|mesh-list
110052593|NCT01480817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110052594|NCT01480817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110052595|NCT01480817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110052596|NCT01480817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110052597|NCT01480869|Calcium, Dietary|calcium, dietary|mesh-list
110052598|NCT01480869|Cholecalciferol|cholecalciferol|mesh-list
110052599|NCT01480869|Vitamin D|vitamin d|mesh-list
110052600|NCT01480869|Calcium|calcium|mesh-list
110052601|NCT01480869|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110052602|NCT01480869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110052603|NCT01480869|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110052604|NCT01480869|Vitamins|vitamins|mesh-ancestor
110052605|NCT01480869|Micronutrients|micronutrients|mesh-ancestor
110052606|NCT01480986|Irinotecan|irinotecan|mesh-list
110052607|NCT01480986|Octreotide|octreotide|mesh-list
110052608|NCT01480986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110052609|NCT01480986|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110052610|NCT01480986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110052611|NCT01480986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110052612|NCT01480986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110052613|NCT01480986|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110052614|NCT01480986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110052615|NCT01481194|Dexamethasone|dexamethasone|mesh-list
110052616|NCT01481194|Cyclophosphamide|cyclophosphamide|mesh-list
110052617|NCT01481194|Doxorubicin|doxorubicin|mesh-list
110052618|NCT01481194|Lenalidomide|lenalidomide|mesh-list
110052619|NCT01481194|Bortezomib|bortezomib|mesh-list
110052620|NCT01481194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110052621|NCT01481194|Immunologic Factors|immunologic factors|mesh-ancestor
110052622|NCT01481194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110052623|NCT01481194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110052624|NCT01481194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110052625|NCT01481194|Alkylating Agents|alkylating agents|mesh-ancestor
110052626|NCT01481194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110052627|NCT01481194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110052628|NCT01481194|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110052629|NCT01481194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110052630|NCT01481194|Antiemetics|antiemetics|mesh-ancestor
110052631|NCT01481194|Autonomic Agents|autonomic agents|mesh-ancestor
110052632|NCT01481194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110052633|NCT01481194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110052634|NCT01481194|Glucocorticoids|glucocorticoids|mesh-ancestor
110052635|NCT01481194|Hormones|hormones|mesh-ancestor
110052636|NCT01481194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110052637|NCT01481194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110052638|NCT01481194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110052639|NCT01481194|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110052640|NCT01481194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110052641|NCT01481194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110052642|NCT01481194|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110052643|NCT01481194|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110052644|NCT01481194|Growth Substances|growth substances|mesh-ancestor
110052645|NCT01481194|Growth Inhibitors|growth inhibitors|mesh-ancestor
110052646|NCT01481233|Colchicine|colchicine|mesh-list
110052647|NCT01481233|Gout Suppressants|gout suppressants|mesh-ancestor
110052648|NCT01481233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110052649|NCT01481233|Tubulin Modulators|tubulin modulators|mesh-ancestor
110052650|NCT01481233|Antimitotic Agents|antimitotic agents|mesh-ancestor
110052652|NCT01481233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110052653|NCT01481233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110052654|NCT01481259|Pemetrexed|pemetrexed|mesh-list
110052655|NCT01481259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110052656|NCT01481259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110052657|NCT01481259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110052658|NCT01481259|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110052659|NCT01481259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110052660|NCT01481311|Bromides|bromides|mesh-list
110052661|NCT01481311|Anticonvulsants|anticonvulsants|mesh-ancestor
110052662|NCT01481350|Sildenafil Citrate|sildenafil citrate|mesh-list
110052663|NCT01481350|Vasodilator Agents|vasodilator agents|mesh-ancestor
110052664|NCT01481350|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110052665|NCT01481350|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110052666|NCT01481350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110052667|NCT01481350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110052668|NCT01481350|Urological Agents|urological agents|mesh-ancestor
110052669|NCT01481389|Theobromine|theobromine|mesh-list
110052670|NCT01481389|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110052671|NCT01481389|Autonomic Agents|autonomic agents|mesh-ancestor
110052672|NCT01481389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110052673|NCT01481389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110052674|NCT01481389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110052675|NCT01481389|Respiratory System Agents|respiratory system agents|mesh-ancestor
110052676|NCT01481389|Vasodilator Agents|vasodilator agents|mesh-ancestor
110052677|NCT01481454|Vaccines|vaccines|mesh-list
110052678|NCT01481454|Immunologic Factors|immunologic factors|mesh-ancestor
110052679|NCT01481454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110052680|NCT01481519|Povidone-Iodine|povidone-iodine|mesh-list
110052681|NCT01481519|Dexamethasone|dexamethasone|mesh-list
110052682|NCT01481519|Dexamethasone acetate|dexamethasone acetate|mesh-list
110052684|NCT01481519|Lubricant Eye Drops|lubricant eye drops|mesh-list
110052685|NCT01481519|BB 1101|bb 1101|mesh-list
110052686|NCT01481519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110052687|NCT01481519|Antiemetics|antiemetics|mesh-ancestor
110052688|NCT01481519|Autonomic Agents|autonomic agents|mesh-ancestor
110052689|NCT01481519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110052690|NCT01481519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110052691|NCT01481519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110052692|NCT01481519|Glucocorticoids|glucocorticoids|mesh-ancestor
110052693|NCT01481519|Hormones|hormones|mesh-ancestor
110052694|NCT01481519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110052695|NCT01481519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110052696|NCT01481519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110052697|NCT01481519|Protease Inhibitors|protease inhibitors|mesh-ancestor
110052698|NCT01481519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110052699|NCT01481519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110052700|NCT01481519|Plasma Substitutes|plasma substitutes|mesh-ancestor
110052701|NCT01481519|Blood Substitutes|blood substitutes|mesh-ancestor
110052702|NCT01481519|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110052703|NCT01481519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110052704|NCT01481519|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110052705|NCT01481519|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110052707|NCT01481610|Lumiracoxib|lumiracoxib|mesh-list
110052708|NCT01481610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110052709|NCT01481610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110052710|NCT01481610|Analgesics|analgesics|mesh-ancestor
110052711|NCT01481610|Sensory System Agents|sensory system agents|mesh-ancestor
110052712|NCT01481610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110052713|NCT01481610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110052714|NCT01481610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110052715|NCT01481610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110052716|NCT01481610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110052717|NCT01481610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110052718|NCT01481610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110052719|NCT01481610|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110052720|NCT01481701|Oxaliplatin|oxaliplatin|mesh-list
110052721|NCT01481701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110052722|NCT01481714|Picosulfate sodium|picosulfate sodium|mesh-list
110052723|NCT01481714|Magnesium Oxide|magnesium oxide|mesh-list
110052724|NCT01481714|Sodium Citrate|sodium citrate|mesh-list
110052725|NCT01481714|Citric Acid|citric acid|mesh-list
110052726|NCT01481714|Anticoagulants|anticoagulants|mesh-ancestor
110052727|NCT01481714|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110052728|NCT01481714|Chelating Agents|chelating agents|mesh-ancestor
110052729|NCT01481714|Sequestering Agents|sequestering agents|mesh-ancestor
110052730|NCT01481714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110052731|NCT01481714|Cathartics|cathartics|mesh-ancestor
110052732|NCT01481714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110052733|NCT01481714|Antacids|antacids|mesh-ancestor
110052734|NCT01481831|Palonosetron|palonosetron|mesh-list
110052735|NCT01481831|Antiemetics|antiemetics|mesh-ancestor
110052736|NCT01481831|Autonomic Agents|autonomic agents|mesh-ancestor
110052737|NCT01481831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110052738|NCT01481831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110052739|NCT01481831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110052740|NCT01481831|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110052741|NCT01481831|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110052742|NCT01481831|Serotonin Agents|serotonin agents|mesh-ancestor
110052743|NCT01481831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110052744|NCT01481831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110052745|NCT01481844|Amoxicillin|amoxicillin|mesh-list
110052746|NCT01481844|Metronidazole|metronidazole|mesh-list
110052747|NCT01481844|Clarithromycin|clarithromycin|mesh-list
110052748|NCT01481844|Tetracycline|tetracycline|mesh-list
110052750|NCT01481844|Lansoprazole|lansoprazole|mesh-list
110052751|NCT01481844|Dexlansoprazole|dexlansoprazole|mesh-list
110052752|NCT01481844|Bismuth|bismuth|mesh-list
110052753|NCT01481844|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
110052754|NCT01481844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110052755|NCT01481844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110052756|NCT01481844|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110052757|NCT01481844|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110052758|NCT01481844|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110052759|NCT01481844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110052760|NCT01481844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110052761|NCT01481844|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110052762|NCT01481844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110052763|NCT01481844|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110052764|NCT01481844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110052765|NCT01481844|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110052767|NCT01481844|Alkylating Agents|alkylating agents|mesh-ancestor
110052768|NCT01481844|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
110052769|NCT01481844|Antidiarrheals|antidiarrheals|mesh-ancestor
110052770|NCT01481870|Sorafenib|sorafenib|mesh-list
110052771|NCT01481870|Sunitinib|sunitinib|mesh-list
110052772|NCT01481870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110052773|NCT01481870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110052774|NCT01481870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110052775|NCT01481870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110052778|NCT01481870|Growth Substances|growth substances|mesh-ancestor
110052779|NCT01481870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110052780|NCT01481870|Growth Inhibitors|growth inhibitors|mesh-ancestor
110052781|NCT01481883|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
110052782|NCT01481883|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110052783|NCT01481883|Hormone Antagonists|hormone antagonists|mesh-ancestor
110052784|NCT01481883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110052785|NCT01481883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110052786|NCT01481883|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110052787|NCT01481883|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110052788|NCT01481883|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110053079|NCT01484613|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110053080|NCT01484613|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110053081|NCT01484613|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110053082|NCT01484717|Nicotine|nicotine|mesh-list
110053083|NCT01484717|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110053084|NCT01484717|Autonomic Agents|autonomic agents|mesh-ancestor
110053085|NCT01484717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110053086|NCT01484717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053087|NCT01484717|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110053088|NCT01484717|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110053089|NCT01484717|Cholinergic Agents|cholinergic agents|mesh-ancestor
110053090|NCT01484717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110053091|NCT01484717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110053092|NCT01484756|Micronutrients|micronutrients|mesh-list
110053093|NCT01484756|Trace Elements|trace elements|mesh-list
110053095|NCT01484964|Peficitinib|peficitinib|mesh-list
110053096|NCT01484964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110053097|NCT01484964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110053098|NCT01484964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110053100|NCT01484964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053102|NCT01484990|Carbidopa|carbidopa|mesh-list
110053103|NCT01484990|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110053104|NCT01484990|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110053105|NCT01484990|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110053106|NCT01484990|Dopamine Agents|dopamine agents|mesh-ancestor
110053107|NCT01484990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110053108|NCT01484990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110053109|NCT01484990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053110|NCT01484990|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110053111|NCT01484990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110053112|NCT01484990|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110053113|NCT01484990|Immunologic Factors|immunologic factors|mesh-ancestor
110053114|NCT01484990|Dopamine Agonists|dopamine agonists|mesh-ancestor
110053115|NCT01485003|Natalizumab|natalizumab|mesh-list
110053116|NCT01485003|Immunologic Factors|immunologic factors|mesh-ancestor
110053117|NCT01485003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053118|NCT01485068|Paclitaxel|paclitaxel|mesh-list
110053119|NCT01485068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110053120|NCT01485068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110053121|NCT01485068|Tubulin Modulators|tubulin modulators|mesh-ancestor
110053122|NCT01485068|Antimitotic Agents|antimitotic agents|mesh-ancestor
110053123|NCT01485068|Mitosis Modulators|mitosis modulators|mesh-ancestor
110053124|NCT01485068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110053125|NCT01485081|Paclitaxel|paclitaxel|mesh-list
110053126|NCT01485081|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110053127|NCT01485081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110053128|NCT01485081|Tubulin Modulators|tubulin modulators|mesh-ancestor
110053129|NCT01485081|Antimitotic Agents|antimitotic agents|mesh-ancestor
110053130|NCT01485081|Mitosis Modulators|mitosis modulators|mesh-ancestor
110053131|NCT01485081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110053132|NCT01485146|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
110053133|NCT01485146|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110053134|NCT01485146|Antimetabolites|antimetabolites|mesh-ancestor
110053135|NCT01485146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110053136|NCT01485146|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110053137|NCT01485146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110053141|NCT01485185|Donepezil|donepezil|mesh-list
110053142|NCT01485185|Analgesics|analgesics|mesh-ancestor
110053143|NCT01485185|Sensory System Agents|sensory system agents|mesh-ancestor
110053144|NCT01485185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110053145|NCT01485185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053146|NCT01485185|Anticonvulsants|anticonvulsants|mesh-ancestor
110053147|NCT01485185|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110053148|NCT01485185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110053149|NCT01485185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110053150|NCT01485185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110053151|NCT01485185|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110053152|NCT01485185|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110053153|NCT01485185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110053154|NCT01485185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110053155|NCT01485185|Antimanic Agents|antimanic agents|mesh-ancestor
110053156|NCT01485185|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110053157|NCT01485185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110053158|NCT01485185|Cholinergic Agents|cholinergic agents|mesh-ancestor
110053159|NCT01485185|Nootropic Agents|nootropic agents|mesh-ancestor
110053160|NCT01485198|Acetaminophen|acetaminophen|mesh-list
110053161|NCT01485198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110053162|NCT01485198|Analgesics|analgesics|mesh-ancestor
110053163|NCT01485198|Sensory System Agents|sensory system agents|mesh-ancestor
110053164|NCT01485198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110053165|NCT01485198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053166|NCT01485198|Antipyretics|antipyretics|mesh-ancestor
110053167|NCT01485211|Riboflavin|riboflavin|mesh-list
110053168|NCT01485211|Vitamin B Complex|vitamin b complex|mesh-ancestor
110053170|NCT01485211|Micronutrients|micronutrients|mesh-ancestor
110053171|NCT01485211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053172|NCT01485211|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110053173|NCT01485211|Dermatologic Agents|dermatologic agents|mesh-ancestor
110053174|NCT01485224|Thalidomide|thalidomide|mesh-list
110053175|NCT01485224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110053176|NCT01485224|Immunologic Factors|immunologic factors|mesh-ancestor
110053177|NCT01485224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053178|NCT01485224|Leprostatic Agents|leprostatic agents|mesh-ancestor
110053179|NCT01485224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110053180|NCT01485224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110053181|NCT01485224|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110053182|NCT01485224|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110053183|NCT01485224|Growth Substances|growth substances|mesh-ancestor
110053184|NCT01485224|Growth Inhibitors|growth inhibitors|mesh-ancestor
110053185|NCT01485224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110053186|NCT01485315|Mannitol|mannitol|mesh-list
110053187|NCT01485315|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110053188|NCT01485315|Diuretics|diuretics|mesh-ancestor
110053189|NCT01485315|Natriuretic Agents|natriuretic agents|mesh-ancestor
110053190|NCT01485315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053191|NCT01485367|Adapalene|adapalene|mesh-list
110053192|NCT01485367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110053193|NCT01485367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110053194|NCT01485367|Analgesics|analgesics|mesh-ancestor
110053195|NCT01485367|Sensory System Agents|sensory system agents|mesh-ancestor
110053196|NCT01485367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110053197|NCT01485367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053198|NCT01485367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110053199|NCT01485367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110053200|NCT01485367|Dermatologic Agents|dermatologic agents|mesh-ancestor
110053201|NCT01485406|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110053202|NCT01485406|Immunologic Factors|immunologic factors|mesh-ancestor
110053203|NCT01485406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053206|NCT01485445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110053207|NCT01485445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110053208|NCT01485445|Autonomic Agents|autonomic agents|mesh-ancestor
110053209|NCT01485445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110053210|NCT01485445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053211|NCT01485445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110053212|NCT01485445|Respiratory System Agents|respiratory system agents|mesh-ancestor
110053213|NCT01485445|Dermatologic Agents|dermatologic agents|mesh-ancestor
110053216|NCT01485562|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110053217|NCT01485562|Abortifacient Agents|abortifacient agents|mesh-ancestor
110053218|NCT01485562|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110053219|NCT01485562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053220|NCT01485562|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110053221|NCT01485562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110053222|NCT01485562|Oxytocics|oxytocics|mesh-ancestor
110053223|NCT01485653|Mepivacaine|mepivacaine|mesh-list
110053224|NCT01485653|Anesthetics, Local|anesthetics, local|mesh-ancestor
110053225|NCT01485653|Anesthetics|anesthetics|mesh-ancestor
110053226|NCT01485653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110053227|NCT01485653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053228|NCT01485653|Sensory System Agents|sensory system agents|mesh-ancestor
110053229|NCT01485653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110053230|NCT01485679|Deoxyglucose|deoxyglucose|mesh-list
110053231|NCT01485679|Antimetabolites|antimetabolites|mesh-ancestor
110053232|NCT01485679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110053233|NCT01485679|Antiviral Agents|antiviral agents|mesh-ancestor
110053234|NCT01485679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110053235|NCT01485692|Promethazine|promethazine|mesh-list
110053236|NCT01485692|Diphenhydramine|diphenhydramine|mesh-list
110053238|NCT01485692|Haloperidol|haloperidol|mesh-list
110053239|NCT01485692|Olanzapine|olanzapine|mesh-list
110053240|NCT01485692|Haloperidol decanoate|haloperidol decanoate|mesh-list
110053241|NCT01485692|Ziprasidone|ziprasidone|mesh-list
110053242|NCT01485692|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110053243|NCT01485692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110053244|NCT01485692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110053245|NCT01485692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053246|NCT01485692|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110053247|NCT01485692|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110053248|NCT01485692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110053249|NCT01485692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110053250|NCT01485692|Anesthetics, General|anesthetics, general|mesh-ancestor
110053251|NCT01485692|Anesthetics|anesthetics|mesh-ancestor
110053252|NCT01485692|GABA Modulators|gaba modulators|mesh-ancestor
110053253|NCT01485692|GABA Agents|gaba agents|mesh-ancestor
110053254|NCT01485692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110053255|NCT01485692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110053256|NCT01485692|Antiemetics|antiemetics|mesh-ancestor
110053257|NCT01485692|Autonomic Agents|autonomic agents|mesh-ancestor
110053258|NCT01485692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110053260|NCT01485692|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110053261|NCT01485692|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110053262|NCT01485692|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110053263|NCT01485692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110053264|NCT01485692|Serotonin Agents|serotonin agents|mesh-ancestor
110053265|NCT01485692|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110053266|NCT01485692|Dopamine Agents|dopamine agents|mesh-ancestor
110053267|NCT01485692|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110053268|NCT01485692|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110053269|NCT01485692|Antipruritics|antipruritics|mesh-ancestor
110053270|NCT01485692|Dermatologic Agents|dermatologic agents|mesh-ancestor
110053271|NCT01485692|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110053272|NCT01485692|Histamine Antagonists|histamine antagonists|mesh-ancestor
110053273|NCT01485692|Histamine Agents|histamine agents|mesh-ancestor
110053274|NCT01485692|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110053275|NCT01485692|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110053276|NCT01485692|Anesthetics, Local|anesthetics, local|mesh-ancestor
110053277|NCT01485692|Sensory System Agents|sensory system agents|mesh-ancestor
110053278|NCT01485718|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
110053279|NCT01485718|Cathartics|cathartics|mesh-ancestor
110053280|NCT01485718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110053281|NCT01485731|Nelfinavir|nelfinavir|mesh-list
110053282|NCT01485731|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110053283|NCT01485731|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110053284|NCT01485731|Protease Inhibitors|protease inhibitors|mesh-ancestor
110053285|NCT01485731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110053286|NCT01485731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110053287|NCT01485731|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110053288|NCT01485731|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110053289|NCT01485731|Antiviral Agents|antiviral agents|mesh-ancestor
110053290|NCT01485731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110053294|NCT01485744|Irinotecan|irinotecan|mesh-list
110053296|NCT01485744|Antimetabolites|antimetabolites|mesh-ancestor
110053297|NCT01485744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110053298|NCT01485744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110053299|NCT01485744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110053300|NCT01485744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110053302|NCT01485744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053303|NCT01485744|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110053304|NCT01485744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110053305|NCT01485744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110053306|NCT01485744|Antidotes|antidotes|mesh-ancestor
110053307|NCT01485744|Protective Agents|protective agents|mesh-ancestor
110053308|NCT01485744|Vitamin B Complex|vitamin b complex|mesh-ancestor
110053309|NCT01485744|Vitamins|vitamins|mesh-ancestor
110053310|NCT01485744|Micronutrients|micronutrients|mesh-ancestor
110053311|NCT01485822|Travoprost|travoprost|mesh-list
110053312|NCT01485822|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110053313|NCT01485822|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110053314|NCT01485822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110053315|NCT01485835|Dexamethasone|dexamethasone|mesh-list
110053316|NCT01485835|Bortezomib|bortezomib|mesh-list
110053317|NCT01485835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110053318|NCT01485835|Antiemetics|antiemetics|mesh-ancestor
110053319|NCT01485835|Autonomic Agents|autonomic agents|mesh-ancestor
110053320|NCT01485835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110053321|NCT01485835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053322|NCT01485835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110053323|NCT01485835|Glucocorticoids|glucocorticoids|mesh-ancestor
110053324|NCT01485835|Hormones|hormones|mesh-ancestor
110053325|NCT01485835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110053326|NCT01485835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110053327|NCT01485835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110053328|NCT01485848|Paclitaxel|paclitaxel|mesh-list
110053329|NCT01485848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110053330|NCT01485848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110053331|NCT01485848|Tubulin Modulators|tubulin modulators|mesh-ancestor
110053332|NCT01485848|Antimitotic Agents|antimitotic agents|mesh-ancestor
110053333|NCT01485848|Mitosis Modulators|mitosis modulators|mesh-ancestor
110053334|NCT01485848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110053335|NCT01485926|Carboplatin|carboplatin|mesh-list
110053336|NCT01485926|Docetaxel|docetaxel|mesh-list
110053337|NCT01485926|Trastuzumab|trastuzumab|mesh-list
110053338|NCT01485926|Lapatinib|lapatinib|mesh-list
110053339|NCT01485926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110053340|NCT01485926|Tubulin Modulators|tubulin modulators|mesh-ancestor
110053342|NCT01485926|Mitosis Modulators|mitosis modulators|mesh-ancestor
110053343|NCT01485926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110053344|NCT01485926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110053345|NCT01485926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110053346|NCT01485926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110053347|NCT01485939|Lidocaine|lidocaine|mesh-list
110053348|NCT01485939|Anesthetics, Local|anesthetics, local|mesh-ancestor
110053349|NCT01485939|Anesthetics|anesthetics|mesh-ancestor
110053350|NCT01485939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110053351|NCT01485939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053352|NCT01485939|Sensory System Agents|sensory system agents|mesh-ancestor
110053353|NCT01485939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110053354|NCT01485939|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110053355|NCT01485939|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110053356|NCT01485939|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110053357|NCT01485939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110053358|NCT01485939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110053359|NCT01485978|Ramipril|ramipril|mesh-list
110053360|NCT01485978|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110053361|NCT01485978|Protease Inhibitors|protease inhibitors|mesh-ancestor
110053362|NCT01485978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110053363|NCT01485978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110053364|NCT01485978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110053365|NCT01486004|Simeprevir|simeprevir|mesh-list
110053366|NCT01486004|Antiviral Agents|antiviral agents|mesh-ancestor
110053367|NCT01486004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110053368|NCT01486004|Protease Inhibitors|protease inhibitors|mesh-ancestor
110053369|NCT01486004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110053370|NCT01486004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110053371|NCT01486017|Peficitinib|peficitinib|mesh-list
110053372|NCT01486017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110053373|NCT01486017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110053374|NCT01486017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110053375|NCT01486017|Immunologic Factors|immunologic factors|mesh-ancestor
110053376|NCT01486017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053377|NCT01486082|Amoxicillin|amoxicillin|mesh-list
110053378|NCT01486082|Clarithromycin|clarithromycin|mesh-list
110053379|NCT01486082|Omeprazole|omeprazole|mesh-list
110053380|NCT01486082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110053381|NCT01486082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110053382|NCT01486082|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110053383|NCT01486082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110053384|NCT01486082|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110053385|NCT01486082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110053386|NCT01486082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110053387|NCT01486082|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110053388|NCT01486082|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110053389|NCT01486082|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110053390|NCT01485809|Gefitinib|gefitinib|mesh-list
110053391|NCT01485809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110053392|NCT01485809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110053393|NCT01485809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110053394|NCT01485809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110053395|NCT01486251|Axitinib|axitinib|mesh-list
110053396|NCT01486251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110053397|NCT01486251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110053398|NCT01486251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110053399|NCT01486251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110053401|NCT01486381|Biphasic Insulins|biphasic insulins|mesh-list
110053402|NCT01486381|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110053403|NCT01486381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110053404|NCT01486381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053405|NCT01486433|Aspirin|aspirin|mesh-list
110053406|NCT01486433|Simvastatin|simvastatin|mesh-list
110053407|NCT01486433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110053408|NCT01486433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110053409|NCT01486433|Analgesics|analgesics|mesh-ancestor
110053410|NCT01486433|Sensory System Agents|sensory system agents|mesh-ancestor
110053411|NCT01486433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110053412|NCT01486433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053413|NCT01486433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110053414|NCT01486433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110053415|NCT01486433|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110053416|NCT01486433|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110053417|NCT01486433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110053418|NCT01486433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110053419|NCT01486433|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110053420|NCT01486433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110053421|NCT01486433|Antipyretics|antipyretics|mesh-ancestor
110053422|NCT01486433|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110053423|NCT01486433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110053424|NCT01486433|Antimetabolites|antimetabolites|mesh-ancestor
110053425|NCT01486433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110053426|NCT01486433|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110053427|NCT01486459|Lithium Carbonate|lithium carbonate|mesh-list
110053428|NCT01486459|Antidepressive Agents|antidepressive agents|mesh-ancestor
110053429|NCT01486459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110053430|NCT01486459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110053431|NCT01486459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110053432|NCT01486459|Antimanic Agents|antimanic agents|mesh-ancestor
110053433|NCT01486459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110053434|NCT01486459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110053435|NCT01486459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053437|NCT01486485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110053438|NCT01486485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110053439|NCT01486485|Analgesics|analgesics|mesh-ancestor
110053440|NCT01486485|Sensory System Agents|sensory system agents|mesh-ancestor
110053441|NCT01486485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110053442|NCT01486485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053443|NCT01486485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110053444|NCT01486485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110053445|NCT01486485|Anticoagulants|anticoagulants|mesh-ancestor
110053446|NCT01486485|Protease Inhibitors|protease inhibitors|mesh-ancestor
110053447|NCT01486485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110053448|NCT01486485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110053449|NCT01486485|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110053450|NCT01486485|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110053451|NCT01486485|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110053452|NCT01486485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110053453|NCT01486485|Immunologic Factors|immunologic factors|mesh-ancestor
110053454|NCT01486511|Liver Extracts|liver extracts|mesh-list
110053455|NCT01486511|Hematinics|hematinics|mesh-ancestor
110053456|NCT01486550|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
110053457|NCT01486550|Plasma Substitutes|plasma substitutes|mesh-ancestor
110053458|NCT01486550|Blood Substitutes|blood substitutes|mesh-ancestor
110053459|NCT01486563|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
110053460|NCT01486563|Plasma Substitutes|plasma substitutes|mesh-ancestor
110053461|NCT01486563|Blood Substitutes|blood substitutes|mesh-ancestor
110053462|NCT01486576|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
110053463|NCT01486576|Plasma Substitutes|plasma substitutes|mesh-ancestor
110053464|NCT01486576|Blood Substitutes|blood substitutes|mesh-ancestor
110053466|NCT01486602|Carboplatin|carboplatin|mesh-list
110053467|NCT01486602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110053468|NCT01486602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110053469|NCT01486602|Tubulin Modulators|tubulin modulators|mesh-ancestor
110053470|NCT01486602|Antimitotic Agents|antimitotic agents|mesh-ancestor
110053471|NCT01486602|Mitosis Modulators|mitosis modulators|mesh-ancestor
110053472|NCT01486602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110053473|NCT01486706|Gabapentin|gabapentin|mesh-list
110053474|NCT01486706|Solifenacin Succinate|solifenacin succinate|mesh-list
110053475|NCT01486706|Analgesics|analgesics|mesh-ancestor
110053476|NCT01486706|Sensory System Agents|sensory system agents|mesh-ancestor
110053477|NCT01486706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110053478|NCT01486706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053479|NCT01486706|Anticonvulsants|anticonvulsants|mesh-ancestor
110053480|NCT01486706|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110053481|NCT01486706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110053482|NCT01486706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110053483|NCT01486706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110053484|NCT01486706|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110053485|NCT01486706|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110053486|NCT01486706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110053487|NCT01486706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110053488|NCT01486706|Antimanic Agents|antimanic agents|mesh-ancestor
110053489|NCT01486706|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110053490|NCT01486706|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110053491|NCT01486706|Cholinergic Agents|cholinergic agents|mesh-ancestor
110053492|NCT01486706|Urological Agents|urological agents|mesh-ancestor
110053493|NCT01486823|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110053494|NCT01486823|Immunologic Factors|immunologic factors|mesh-ancestor
110053495|NCT01486823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053497|NCT01486862|Biphasic Insulins|biphasic insulins|mesh-list
110053498|NCT01486862|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110053499|NCT01486862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110053500|NCT01486862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053501|NCT01486875|Insulin Aspart|insulin aspart|mesh-list
110053502|NCT01486875|Biphasic Insulins|biphasic insulins|mesh-list
110053503|NCT01486875|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110053504|NCT01486875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110053505|NCT01486875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053506|NCT01486888|Insulin|insulin|mesh-list
110053507|NCT01486888|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110053508|NCT01486888|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110053509|NCT01486888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053510|NCT01486901|Insulin|insulin|mesh-list
110053511|NCT01486901|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110053513|NCT01486901|Insulin, Isophane|insulin, isophane|mesh-list
110053514|NCT01486901|Isophane insulin, beef|isophane insulin, beef|mesh-list
110053515|NCT01486901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110053516|NCT01486901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053517|NCT01486914|Insulin Aspart|insulin aspart|mesh-list
110053518|NCT01486914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110053519|NCT01486914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053520|NCT01486940|Insulin|insulin|mesh-list
110053521|NCT01486940|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110053522|NCT01486940|Insulin Aspart|insulin aspart|mesh-list
110053523|NCT01486940|Insulin Detemir|insulin detemir|mesh-list
110053524|NCT01486940|Isophane Insulin, Human|isophane insulin, human|mesh-list
110053525|NCT01486940|Insulin, Isophane|insulin, isophane|mesh-list
110053526|NCT01486940|Isophane insulin, beef|isophane insulin, beef|mesh-list
110053527|NCT01486940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110053528|NCT01486940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053529|NCT01486953|Sevoflurane|sevoflurane|mesh-list
110053530|NCT01486953|Desflurane|desflurane|mesh-list
110053531|NCT01486953|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110053532|NCT01486953|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110053533|NCT01486953|Anesthetics, General|anesthetics, general|mesh-ancestor
110053534|NCT01486953|Anesthetics|anesthetics|mesh-ancestor
110053535|NCT01486953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110053536|NCT01486953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053537|NCT01486979|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110053538|NCT01486979|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110053539|NCT01486979|Estradiol|estradiol|mesh-list
110053540|NCT01486979|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110053541|NCT01486979|Estrogens|estrogens|mesh-ancestor
110053542|NCT01486979|Hormones|hormones|mesh-ancestor
110053543|NCT01486979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110053544|NCT01486979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053545|NCT01486979|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110053546|NCT01486979|Contraceptive Agents|contraceptive agents|mesh-ancestor
110053547|NCT01486979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110053548|NCT01486979|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110053550|NCT01486992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110053551|NCT01486992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110053552|NCT01487096|Teriflunomide|teriflunomide|mesh-list
110053553|NCT01487096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110053554|NCT01487096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110053555|NCT01487096|Analgesics|analgesics|mesh-ancestor
110053556|NCT01487096|Sensory System Agents|sensory system agents|mesh-ancestor
110053557|NCT01487096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110053558|NCT01487096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053559|NCT01487096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110053560|NCT01487096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110053561|NCT01487096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110053562|NCT01487096|Immunologic Factors|immunologic factors|mesh-ancestor
110053563|NCT01487135|Moxifloxacin|moxifloxacin|mesh-list
110053564|NCT01487135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110053565|NCT01487135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110053566|NCT01487135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110053567|NCT01487135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110053568|NCT01487135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110053569|NCT01487135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110053570|NCT01487135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110053572|NCT01487226|Cisplatin|cisplatin|mesh-list
110053573|NCT01487226|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110053574|NCT01487226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110053575|NCT01487226|Tubulin Modulators|tubulin modulators|mesh-ancestor
110053576|NCT01487226|Antimitotic Agents|antimitotic agents|mesh-ancestor
110053577|NCT01487226|Mitosis Modulators|mitosis modulators|mesh-ancestor
110053578|NCT01487226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110053579|NCT01487278|Misoprostol|misoprostol|mesh-list
110053580|NCT01487278|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110053581|NCT01487278|Abortifacient Agents|abortifacient agents|mesh-ancestor
110053582|NCT01487278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110053583|NCT01487278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053584|NCT01487278|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110053585|NCT01487278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110053586|NCT01487278|Oxytocics|oxytocics|mesh-ancestor
110053587|NCT01487304|Hormones|hormones|mesh-list
110053590|NCT01487317|Rivastigmine|rivastigmine|mesh-list
110053591|NCT01487317|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110053592|NCT01487317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110053593|NCT01487317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110053594|NCT01487317|Cholinergic Agents|cholinergic agents|mesh-ancestor
110053595|NCT01487317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110053596|NCT01487317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053597|NCT01487317|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110053598|NCT01487317|Protective Agents|protective agents|mesh-ancestor
110053599|NCT01487369|Insulin Aspart|insulin aspart|mesh-list
110053600|NCT01487369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110053601|NCT01487369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053603|NCT01487382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110053604|NCT01487382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053605|NCT01487395|Donepezil|donepezil|mesh-list
110053606|NCT01487395|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110053607|NCT01487395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110053608|NCT01487395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110053609|NCT01487395|Cholinergic Agents|cholinergic agents|mesh-ancestor
110053610|NCT01487395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110053611|NCT01487395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053613|NCT01487408|Insulin Aspart|insulin aspart|mesh-list
110053614|NCT01487408|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110053615|NCT01487408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053616|NCT01487421|Insulin|insulin|mesh-list
110053617|NCT01487421|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110053618|NCT01487421|Insulin Aspart|insulin aspart|mesh-list
110053619|NCT01487421|Insulin Detemir|insulin detemir|mesh-list
110053620|NCT01487421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110053621|NCT01487421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053622|NCT01487512|Hydromorphone|hydromorphone|mesh-list
110053623|NCT01487512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110053624|NCT01487512|Narcotics|narcotics|mesh-ancestor
110053625|NCT01487512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110053626|NCT01487512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053628|NCT01487512|Sensory System Agents|sensory system agents|mesh-ancestor
110053629|NCT01487512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110053630|NCT01487564|Hydromorphone|hydromorphone|mesh-list
110053631|NCT01487564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110053632|NCT01487564|Narcotics|narcotics|mesh-ancestor
110053633|NCT01487564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110053634|NCT01487564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053635|NCT01487564|Analgesics|analgesics|mesh-ancestor
110053636|NCT01487564|Sensory System Agents|sensory system agents|mesh-ancestor
110053637|NCT01487564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110053638|NCT01487629|Bevacizumab|bevacizumab|mesh-list
110053639|NCT01487629|Ranibizumab|ranibizumab|mesh-list
110053640|NCT01487629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110053641|NCT01487629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110053642|NCT01487629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110053643|NCT01487629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110053644|NCT01487629|Growth Substances|growth substances|mesh-ancestor
110053645|NCT01487629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053646|NCT01487629|Growth Inhibitors|growth inhibitors|mesh-ancestor
110053647|NCT01487785|Gemcitabine|gemcitabine|mesh-list
110053648|NCT01487785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110053649|NCT01487785|Antimetabolites|antimetabolites|mesh-ancestor
110053650|NCT01487785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110053651|NCT01487785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110053652|NCT01487798|Insulin|insulin|mesh-list
110053653|NCT01487798|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110053654|NCT01487798|Insulin Aspart|insulin aspart|mesh-list
110053655|NCT01487798|Biphasic Insulins|biphasic insulins|mesh-list
110053656|NCT01487798|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110053657|NCT01487798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110053658|NCT01487798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053659|NCT01487811|Insulin Aspart|insulin aspart|mesh-list
110053660|NCT01487811|Biphasic Insulins|biphasic insulins|mesh-list
110053661|NCT01487811|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110053662|NCT01487811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110053665|NCT01487993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110053666|NCT01487993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053668|NCT01488136|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110053669|NCT01488136|Vasodilator Agents|vasodilator agents|mesh-ancestor
110053670|NCT01488201|Brodalumab|brodalumab|mesh-list
110053671|NCT01488201|Dermatologic Agents|dermatologic agents|mesh-ancestor
110053672|NCT01488227|Vitamin D|vitamin d|mesh-list
110053673|NCT01488227|Ergocalciferols|ergocalciferols|mesh-list
110053674|NCT01488227|Cholecalciferol|cholecalciferol|mesh-list
110053675|NCT01488227|Vitamins|vitamins|mesh-list
110053676|NCT01488227|Micronutrients|micronutrients|mesh-ancestor
110053677|NCT01488227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053678|NCT01488227|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110053679|NCT01488227|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110053681|NCT01488253|Temsirolimus|temsirolimus|mesh-list
110053682|NCT01488253|MTOR Inhibitors|mtor inhibitors|mesh-list
110053683|NCT01488253|Tacrolimus|tacrolimus|mesh-list
110053684|NCT01488253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110053685|NCT01488253|Immunologic Factors|immunologic factors|mesh-ancestor
110053686|NCT01488253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053687|NCT01488253|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110053688|NCT01488253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110053689|NCT01488253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110053690|NCT01488253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110053691|NCT01488253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110053692|NCT01488253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110053693|NCT01488253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110053694|NCT01488253|Antifungal Agents|antifungal agents|mesh-ancestor
110053695|NCT01488253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110053696|NCT01488266|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110053697|NCT01488266|Milnacipran|milnacipran|mesh-list
110053698|NCT01488266|Aripiprazole|aripiprazole|mesh-list
110053699|NCT01488266|Mirtazapine|mirtazapine|mesh-list
110053700|NCT01488266|Bupropion|bupropion|mesh-list
110053701|NCT01488266|Fluoxetine|fluoxetine|mesh-list
110053702|NCT01488266|Paroxetine|paroxetine|mesh-list
110053703|NCT01488266|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110053704|NCT01488266|Sertraline|sertraline|mesh-list
110053705|NCT01488266|Antidepressive Agents|antidepressive agents|mesh-list
110053706|NCT01488266|Escitalopram|escitalopram|mesh-list
110053707|NCT01488266|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110053708|NCT01488266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110053709|NCT01488266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110053710|NCT01488266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110053711|NCT01488266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110053712|NCT01488266|Serotonin Agents|serotonin agents|mesh-ancestor
110053713|NCT01488266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053714|NCT01488266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110053715|NCT01488266|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110053716|NCT01488266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110053717|NCT01488266|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110053718|NCT01488266|Dopamine Agents|dopamine agents|mesh-ancestor
110053719|NCT01488266|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110053720|NCT01488266|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110053721|NCT01488266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110053722|NCT01488266|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110053723|NCT01488266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110053724|NCT01488266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110053725|NCT01488266|Dopamine Agonists|dopamine agonists|mesh-ancestor
110053726|NCT01488266|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110053805|NCT01488734|Vitamin D|vitamin d|mesh-list
110053727|NCT01488266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110053728|NCT01488266|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110053729|NCT01488266|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110053730|NCT01488266|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110053731|NCT01488266|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110053732|NCT01488266|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110053733|NCT01488266|Analgesics|analgesics|mesh-ancestor
110053734|NCT01488266|Sensory System Agents|sensory system agents|mesh-ancestor
110053735|NCT01488266|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110053736|NCT01488266|Histamine Antagonists|histamine antagonists|mesh-ancestor
110053737|NCT01488266|Histamine Agents|histamine agents|mesh-ancestor
110053740|NCT01488266|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110053741|NCT01488266|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110053742|NCT01488266|Adrenergic Agents|adrenergic agents|mesh-ancestor
110053743|NCT01488266|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110053744|NCT01488266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110053745|NCT01488305|Micronutrients|micronutrients|mesh-list
110053746|NCT01488305|Trace Elements|trace elements|mesh-list
110053747|NCT01488305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053748|NCT01488344|Nintedanib|nintedanib|mesh-list
110053749|NCT01488344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110053750|NCT01488344|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110053751|NCT01488344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110053752|NCT01488344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110053753|NCT01488396|Cyclosporine|cyclosporine|mesh-list
110053754|NCT01488396|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110053755|NCT01488396|Cyclosporins|cyclosporins|mesh-list
110053756|NCT01488396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110053757|NCT01488396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110053758|NCT01488396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110053759|NCT01488396|Immunologic Factors|immunologic factors|mesh-ancestor
110053760|NCT01488396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053761|NCT01488396|Antifungal Agents|antifungal agents|mesh-ancestor
110053762|NCT01488396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110053763|NCT01488396|Dermatologic Agents|dermatologic agents|mesh-ancestor
110053764|NCT01488396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110053765|NCT01488396|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110053766|NCT01488396|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110053767|NCT01488526|Tenofovir|tenofovir|mesh-list
110053768|NCT01488526|Antiviral Agents|antiviral agents|mesh-ancestor
110053769|NCT01488526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110053770|NCT01488526|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110053771|NCT01488526|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110053772|NCT01488526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110053773|NCT01488526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110053774|NCT01488526|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110053775|NCT01488526|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110053776|NCT01488552|Metformin|metformin|mesh-list
110053777|NCT01488552|Paclitaxel|paclitaxel|mesh-list
110053778|NCT01488552|Gemcitabine|gemcitabine|mesh-list
110053779|NCT01488552|Folfirinox|folfirinox|mesh-list
110053780|NCT01488552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110053781|NCT01488552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110053782|NCT01488552|Tubulin Modulators|tubulin modulators|mesh-ancestor
110053783|NCT01488552|Antimitotic Agents|antimitotic agents|mesh-ancestor
110053784|NCT01488552|Mitosis Modulators|mitosis modulators|mesh-ancestor
110053785|NCT01488552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110053786|NCT01488552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110053787|NCT01488552|Antimetabolites|antimetabolites|mesh-ancestor
110053788|NCT01488552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110053789|NCT01488552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053790|NCT01488565|Azacitidine|azacitidine|mesh-list
110053791|NCT01488565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110053792|NCT01488565|Antimetabolites|antimetabolites|mesh-ancestor
110053793|NCT01488565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110053794|NCT01488565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110053795|NCT01488565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110053796|NCT01488656|Vitamin D|vitamin d|mesh-list
110053797|NCT01488656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110053798|NCT01488656|Antioxidants|antioxidants|mesh-list
110053799|NCT01488656|Vitamins|vitamins|mesh-ancestor
110053800|NCT01488656|Micronutrients|micronutrients|mesh-ancestor
110053801|NCT01488656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053802|NCT01488656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110053803|NCT01488656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110053804|NCT01488656|Protective Agents|protective agents|mesh-ancestor
110053806|NCT01488734|Ergocalciferols|ergocalciferols|mesh-list
110053807|NCT01488734|Cholecalciferol|cholecalciferol|mesh-list
110053808|NCT01488734|Vitamins|vitamins|mesh-list
110053809|NCT01488734|Micronutrients|micronutrients|mesh-ancestor
110053810|NCT01488734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053811|NCT01488734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110053814|NCT01488773|Montelukast|montelukast|mesh-list
110053815|NCT01488773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110053816|NCT01488773|Autonomic Agents|autonomic agents|mesh-ancestor
110053817|NCT01488773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110053818|NCT01488773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053819|NCT01488773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110053820|NCT01488773|Respiratory System Agents|respiratory system agents|mesh-ancestor
110053821|NCT01488773|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110053822|NCT01488773|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110053823|NCT01488773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110053824|NCT01488773|Adrenergic Agents|adrenergic agents|mesh-ancestor
110053825|NCT01488773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110053826|NCT01488773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110053827|NCT01488773|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110053828|NCT01488773|Hormone Antagonists|hormone antagonists|mesh-ancestor
110053829|NCT01488773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110053830|NCT01488773|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110053831|NCT01488773|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110053832|NCT01488838|Cisplatin|cisplatin|mesh-list
110053833|NCT01488838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110053834|NCT01488955|Fosfomycin|fosfomycin|mesh-list
110053835|NCT01488955|Ibuprofen|ibuprofen|mesh-list
110053836|NCT01488955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110053837|NCT01488955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110053838|NCT01488955|Analgesics|analgesics|mesh-ancestor
110053839|NCT01488955|Sensory System Agents|sensory system agents|mesh-ancestor
110053840|NCT01488955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110053841|NCT01488955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053842|NCT01488955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110053843|NCT01488955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110053844|NCT01488955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110053845|NCT01488955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110053846|NCT01488955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110053847|NCT01488955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110053848|NCT01488955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110053849|NCT01489033|Immunomodulating Agents|immunomodulating agents|mesh-list
110053850|NCT01489033|Immunologic Factors|immunologic factors|mesh-ancestor
110053851|NCT01489033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053853|NCT01489059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110053854|NCT01489059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110053855|NCT01489059|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110053856|NCT01489059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110053857|NCT01489072|Remifentanil|remifentanil|mesh-list
110053858|NCT01489072|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110053859|NCT01489072|Narcotics|narcotics|mesh-ancestor
110053860|NCT01489072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110053861|NCT01489072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053862|NCT01489072|Analgesics|analgesics|mesh-ancestor
110053863|NCT01489072|Sensory System Agents|sensory system agents|mesh-ancestor
110053864|NCT01489072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110053865|NCT01489124|Imipenem|imipenem|mesh-list
110053866|NCT01489124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110053867|NCT01489124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110053868|NCT01489137|Remifentanil|remifentanil|mesh-list
110053869|NCT01489137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110053870|NCT01489137|Narcotics|narcotics|mesh-ancestor
110053871|NCT01489137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110053872|NCT01489137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053873|NCT01489137|Analgesics|analgesics|mesh-ancestor
110053874|NCT01489137|Sensory System Agents|sensory system agents|mesh-ancestor
110053875|NCT01489137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110053877|NCT01489202|Chromium|chromium|mesh-list
110053878|NCT01489202|Everolimus|everolimus|mesh-list
110053879|NCT01489202|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110053880|NCT01489202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110053881|NCT01489202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110053882|NCT01489202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110053883|NCT01489202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110053884|NCT01489202|Immunologic Factors|immunologic factors|mesh-ancestor
110053885|NCT01489202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053887|NCT01489202|Trace Elements|trace elements|mesh-ancestor
110053888|NCT01489202|Micronutrients|micronutrients|mesh-ancestor
110053889|NCT01489228|Benzonidazole|benzonidazole|mesh-list
110053890|NCT01489228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110053891|NCT01489228|Immunologic Factors|immunologic factors|mesh-ancestor
110053892|NCT01489228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053893|NCT01489228|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110053894|NCT01489228|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110053895|NCT01489228|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110053896|NCT01489228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110053897|NCT01489319|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
110053898|NCT01489319|Sodium Salicylate|sodium salicylate|mesh-list
110053899|NCT01489319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110053900|NCT01489319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110053901|NCT01489319|Analgesics|analgesics|mesh-ancestor
110053902|NCT01489319|Sensory System Agents|sensory system agents|mesh-ancestor
110053903|NCT01489319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110053904|NCT01489319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053905|NCT01489319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110053906|NCT01489319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110053907|NCT01489319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110053908|NCT01489319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110053909|NCT01489319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110053910|NCT01489371|Doxorubicin|doxorubicin|mesh-list
110053911|NCT01489371|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110053912|NCT01489371|Interleukin-12|interleukin-12|mesh-list
110053913|NCT01489371|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110053914|NCT01489371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110053915|NCT01489371|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110053916|NCT01489371|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110053917|NCT01489371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110053918|NCT01489371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110053919|NCT01489371|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110053920|NCT01489371|Immunologic Factors|immunologic factors|mesh-ancestor
110053921|NCT01489371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053922|NCT01489371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110053923|NCT01489371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110053924|NCT01489371|Growth Substances|growth substances|mesh-ancestor
110053925|NCT01489371|Growth Inhibitors|growth inhibitors|mesh-ancestor
110053927|NCT01489410|Doxorubicin|doxorubicin|mesh-list
110053928|NCT01489410|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110053929|NCT01489410|Ethiodized Oil|ethiodized oil|mesh-list
110053930|NCT01489410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110053931|NCT01489410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110053932|NCT01489410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110053933|NCT01489410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110053934|NCT01489410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110053935|NCT01489410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110053936|NCT01489410|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110053937|NCT01489410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110053938|NCT01489410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110053939|NCT01489410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053940|NCT01489488|Riociguat|riociguat|mesh-list
110053941|NCT01489488|Enzyme Activators|enzyme activators|mesh-ancestor
110053942|NCT01489488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110053943|NCT01489566|Fluorouracil|fluorouracil|mesh-list
110053944|NCT01489566|Mitomycins|mitomycins|mesh-list
110053945|NCT01489566|Mitomycin|mitomycin|mesh-list
110053946|NCT01489566|Antimetabolites|antimetabolites|mesh-ancestor
110053947|NCT01489566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110053948|NCT01489566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110053949|NCT01489566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110053950|NCT01489566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110053951|NCT01489566|Immunologic Factors|immunologic factors|mesh-ancestor
110053952|NCT01489566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053953|NCT01489566|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110053954|NCT01489566|Alkylating Agents|alkylating agents|mesh-ancestor
110053955|NCT01489566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110053956|NCT01489566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110053957|NCT01489592|Turmeric extract|turmeric extract|mesh-list
110053958|NCT01489592|Antioxidants|antioxidants|mesh-ancestor
110053959|NCT01489592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110053960|NCT01489592|Protective Agents|protective agents|mesh-ancestor
110053965|NCT01489631|Ropivacaine|ropivacaine|mesh-list
110053966|NCT01489631|Anesthetics, Local|anesthetics, local|mesh-ancestor
110053967|NCT01489631|Anesthetics|anesthetics|mesh-ancestor
110053968|NCT01489631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110053969|NCT01489631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053970|NCT01489631|Sensory System Agents|sensory system agents|mesh-ancestor
110053971|NCT01489631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110053972|NCT01489631|Analgesics|analgesics|mesh-ancestor
110053973|NCT01489631|Anticonvulsants|anticonvulsants|mesh-ancestor
110053974|NCT01489631|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110053975|NCT01489631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110053976|NCT01489631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110053977|NCT01489631|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110053978|NCT01489631|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110053979|NCT01489631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110053980|NCT01489631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110053981|NCT01489631|Antimanic Agents|antimanic agents|mesh-ancestor
110053982|NCT01489631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110053983|NCT01489631|Narcotics|narcotics|mesh-ancestor
110053984|NCT01489631|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110053985|NCT01489631|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110053986|NCT01489631|Anesthetics, General|anesthetics, general|mesh-ancestor
110053988|NCT01489644|Repaglinide|repaglinide|mesh-list
110053989|NCT01489644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110053990|NCT01489644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053991|NCT01489683|Lidocaine|lidocaine|mesh-list
110053992|NCT01489683|Anesthetics, Local|anesthetics, local|mesh-ancestor
110053993|NCT01489683|Anesthetics|anesthetics|mesh-ancestor
110053994|NCT01489683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110053995|NCT01489683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053996|NCT01489683|Sensory System Agents|sensory system agents|mesh-ancestor
110053997|NCT01489683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110053998|NCT01489683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110053999|NCT01489683|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110054000|NCT01489683|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110054001|NCT01489683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110054002|NCT01489683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110054003|NCT01489696|Tamsulosin|tamsulosin|mesh-list
110054004|NCT01489696|Mirabegron|mirabegron|mesh-list
110054005|NCT01489696|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110054006|NCT01489696|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110054007|NCT01489696|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110054008|NCT01489696|Adrenergic Agents|adrenergic agents|mesh-ancestor
110054009|NCT01489696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110054010|NCT01489696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110054011|NCT01489696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054012|NCT01489696|Urological Agents|urological agents|mesh-ancestor
110054013|NCT01489696|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110054014|NCT01489696|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110054015|NCT01489696|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110054016|NCT01489709|Solifenacin Succinate|solifenacin succinate|mesh-list
110054017|NCT01489709|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110054018|NCT01489709|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110054019|NCT01489709|Cholinergic Agents|cholinergic agents|mesh-ancestor
110054020|NCT01489709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110054021|NCT01489709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110054022|NCT01489709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054023|NCT01489709|Urological Agents|urological agents|mesh-ancestor
110054024|NCT01489852|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110054025|NCT01489852|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110054026|NCT01489852|Estradiol|estradiol|mesh-list
110054027|NCT01489852|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110054028|NCT01489852|Estrogens|estrogens|mesh-ancestor
110054029|NCT01489852|Hormones|hormones|mesh-ancestor
110054030|NCT01489852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110054031|NCT01489852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054032|NCT01489852|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110054033|NCT01489852|Contraceptive Agents|contraceptive agents|mesh-ancestor
110054034|NCT01489852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110054035|NCT01489852|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110054036|NCT01489865|Fluorouracil|fluorouracil|mesh-list
110054037|NCT01489865|Veliparib|veliparib|mesh-list
110054038|NCT01489865|Antimetabolites|antimetabolites|mesh-ancestor
110054039|NCT01489865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110054040|NCT01489865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110054042|NCT01489865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110054043|NCT01489865|Immunologic Factors|immunologic factors|mesh-ancestor
110054044|NCT01489865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054045|NCT01489865|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110054046|NCT01489865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110054047|NCT01489904|Botulinum Toxins|botulinum toxins|mesh-list
110054048|NCT01489904|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110054049|NCT01489904|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110054050|NCT01489904|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110054051|NCT01489904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110054052|NCT01489904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110054053|NCT01489904|Cholinergic Agents|cholinergic agents|mesh-ancestor
110054054|NCT01489904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110054055|NCT01489904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054056|NCT01489904|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110054057|NCT01489904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110054058|NCT01489917|Heparin|heparin|mesh-list
110054059|NCT01489917|Hemostatics|hemostatics|mesh-list
110054060|NCT01489917|Anticoagulants|anticoagulants|mesh-ancestor
110054061|NCT01489917|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110054062|NCT01489917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110054063|NCT01489917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110054064|NCT01489917|Coagulants|coagulants|mesh-ancestor
110054065|NCT01489943|Pioglitazone|pioglitazone|mesh-list
110054066|NCT01489943|Midazolam|midazolam|mesh-list
110054067|NCT01489943|Omeprazole|omeprazole|mesh-list
110054068|NCT01489943|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110054069|NCT01489943|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110054070|NCT01489943|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110054071|NCT01489943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110054072|NCT01489943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054073|NCT01489943|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110054074|NCT01489943|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110054075|NCT01489943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110054076|NCT01489943|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110054077|NCT01489943|Anesthetics, General|anesthetics, general|mesh-ancestor
110054078|NCT01489943|Anesthetics|anesthetics|mesh-ancestor
110054079|NCT01489943|GABA Modulators|gaba modulators|mesh-ancestor
110054080|NCT01489943|GABA Agents|gaba agents|mesh-ancestor
110054081|NCT01489943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110054082|NCT01489943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110054083|NCT01489943|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110054084|NCT01489943|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110054085|NCT01489943|Antimetabolites|antimetabolites|mesh-ancestor
110054086|NCT01489943|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110054087|NCT01489943|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110054088|NCT01489943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110054089|NCT01489943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110054090|NCT01489943|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110054091|NCT01489943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110054092|NCT01489943|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110054095|NCT01489982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110054096|NCT01489982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110054097|NCT01489982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054098|NCT01489982|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110054099|NCT01489982|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110054100|NCT01489982|Antidepressive Agents|antidepressive agents|mesh-ancestor
110054101|NCT01489982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110054102|NCT01489982|Histamine Antagonists|histamine antagonists|mesh-ancestor
110054104|NCT01489982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110054105|NCT01489982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110054106|NCT01489995|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
110054107|NCT01489995|Antiviral Agents|antiviral agents|mesh-ancestor
110054108|NCT01489995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110054109|NCT01489995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110054113|NCT01490047|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110054114|NCT01490047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110054115|NCT01490047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110054116|NCT01490047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110054117|NCT01490047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110054118|NCT01490047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110054119|NCT01490047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110054120|NCT01490047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110054122|NCT01490047|Analgesics|analgesics|mesh-ancestor
110054123|NCT01490047|Sensory System Agents|sensory system agents|mesh-ancestor
110054124|NCT01490047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110054125|NCT01490047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054126|NCT01490047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110054127|NCT01490047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110054128|NCT01490047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110054129|NCT01490047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110054130|NCT01490047|Immunologic Factors|immunologic factors|mesh-ancestor
110054131|NCT01490099|Insulin Detemir|insulin detemir|mesh-list
110054132|NCT01490099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110054133|NCT01490099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054134|NCT01490112|Insulin Aspart|insulin aspart|mesh-list
110054135|NCT01490112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110054136|NCT01490112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054137|NCT01490203|Edetic Acid|edetic acid|mesh-list
110054138|NCT01490203|Pentetic Acid|pentetic acid|mesh-list
110054139|NCT01490203|Antidotes|antidotes|mesh-ancestor
110054140|NCT01490203|Protective Agents|protective agents|mesh-ancestor
110054141|NCT01490203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054142|NCT01490203|Chelating Agents|chelating agents|mesh-ancestor
110054143|NCT01490203|Sequestering Agents|sequestering agents|mesh-ancestor
110054144|NCT01490203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110054146|NCT01490203|Anticoagulants|anticoagulants|mesh-ancestor
110054147|NCT01490203|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110054148|NCT01490216|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
110054149|NCT01490216|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110054150|NCT01490216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054151|NCT01490216|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110054152|NCT01490216|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110054153|NCT01490216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110054154|NCT01490216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110054155|NCT01490216|Dopamine Agents|dopamine agents|mesh-ancestor
110054156|NCT01490216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110054158|NCT01490229|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110054159|NCT01490229|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110054160|NCT01490229|Antimetabolites|antimetabolites|mesh-ancestor
110054161|NCT01490229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110054162|NCT01490229|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110054163|NCT01490255|Amlodipine|amlodipine|mesh-list
110054164|NCT01490255|Ranolazine|ranolazine|mesh-list
110054165|NCT01490255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110054166|NCT01490255|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110054167|NCT01490255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110054168|NCT01490255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110054169|NCT01490255|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110054170|NCT01490255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054171|NCT01490255|Vasodilator Agents|vasodilator agents|mesh-ancestor
110054172|NCT01490255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110054173|NCT01490268|Sufentanil|sufentanil|mesh-list
110054174|NCT01490268|Dsuvia|dsuvia|mesh-list
110054175|NCT01490268|Hydromorphone|hydromorphone|mesh-list
110054176|NCT01490268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110054177|NCT01490268|Narcotics|narcotics|mesh-ancestor
110054178|NCT01490268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110054179|NCT01490268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054180|NCT01490268|Analgesics|analgesics|mesh-ancestor
110054181|NCT01490268|Sensory System Agents|sensory system agents|mesh-ancestor
110054182|NCT01490268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110054185|NCT01490268|Anesthetics, General|anesthetics, general|mesh-ancestor
110054186|NCT01490268|Anesthetics|anesthetics|mesh-ancestor
110054187|NCT01490333|Vitamin D|vitamin d|mesh-list
110054188|NCT01490333|Cholecalciferol|cholecalciferol|mesh-list
110054189|NCT01490333|Vitamins|vitamins|mesh-ancestor
110054190|NCT01490333|Micronutrients|micronutrients|mesh-ancestor
110054191|NCT01490333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054192|NCT01490333|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110054193|NCT01490333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110054194|NCT01490346|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110054195|NCT01490346|Antiviral Agents|antiviral agents|mesh-ancestor
110054196|NCT01490346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110054197|NCT01490398|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110054198|NCT01490398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110054199|NCT01490398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110054200|NCT01490398|Antimetabolites|antimetabolites|mesh-ancestor
110054201|NCT01490398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110054202|NCT01490398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110054203|NCT01490398|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110054204|NCT01490398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110054205|NCT01490411|Immunomodulating Agents|immunomodulating agents|mesh-list
110054206|NCT01490411|Immunologic Factors|immunologic factors|mesh-list
110054207|NCT01490411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054208|NCT01490437|Dexamethasone|dexamethasone|mesh-list
110054210|NCT01490437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054211|NCT01490437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110054212|NCT01490437|Antiemetics|antiemetics|mesh-ancestor
110054213|NCT01490437|Autonomic Agents|autonomic agents|mesh-ancestor
110054214|NCT01490437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110054215|NCT01490437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110054216|NCT01490437|Glucocorticoids|glucocorticoids|mesh-ancestor
110054218|NCT01490437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110054219|NCT01490437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110054220|NCT01490437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110054221|NCT01490437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110054222|NCT01490437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110054223|NCT01490437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110054224|NCT01490437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110054225|NCT01490476|Everolimus|everolimus|mesh-list
110054226|NCT01490476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110054227|NCT01490476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110054228|NCT01490476|Immunologic Factors|immunologic factors|mesh-ancestor
110054229|NCT01490476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054230|NCT01490476|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110054231|NCT01490476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110054232|NCT01490476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110054233|NCT01490476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110054234|NCT01490567|Donepezil|donepezil|mesh-list
110054235|NCT01490567|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110054236|NCT01490567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110054237|NCT01490567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110054238|NCT01490567|Cholinergic Agents|cholinergic agents|mesh-ancestor
110054239|NCT01490567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110054240|NCT01490567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054241|NCT01490567|Nootropic Agents|nootropic agents|mesh-ancestor
110054242|NCT01490658|Metformin|metformin|mesh-list
110054243|NCT01490658|Repaglinide|repaglinide|mesh-list
110054244|NCT01490658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110054245|NCT01490658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054246|NCT01490671|Tenofovir|tenofovir|mesh-list
110054247|NCT01490671|Antiviral Agents|antiviral agents|mesh-ancestor
110054248|NCT01490671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110054249|NCT01490671|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110054250|NCT01490671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110054251|NCT01490671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110054252|NCT01490671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110054253|NCT01490671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110054254|NCT01490671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110054255|NCT01490749|Carboplatin|carboplatin|mesh-list
110054256|NCT01490749|Capecitabine|capecitabine|mesh-list
110054257|NCT01490749|Oxaliplatin|oxaliplatin|mesh-list
110054258|NCT01490749|Everolimus|everolimus|mesh-list
110054260|NCT01490749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110054261|NCT01490749|Antimetabolites|antimetabolites|mesh-ancestor
110054262|NCT01490749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110054263|NCT01490749|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110054264|NCT01490749|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110054265|NCT01490749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110054266|NCT01490749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110054267|NCT01490749|Immunologic Factors|immunologic factors|mesh-ancestor
110054268|NCT01490749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054269|NCT01490762|Insulin|insulin|mesh-list
110054270|NCT01490762|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110054271|NCT01490762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110054272|NCT01490762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054273|NCT01490905|Ibuprofen|ibuprofen|mesh-list
110054274|NCT01490905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110054275|NCT01490905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110054276|NCT01490905|Analgesics|analgesics|mesh-ancestor
110054277|NCT01490905|Sensory System Agents|sensory system agents|mesh-ancestor
110054278|NCT01490905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110054279|NCT01490905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054280|NCT01490905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110054281|NCT01490905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110054282|NCT01490905|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110054283|NCT01490905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110054284|NCT01490905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110054285|NCT01490944|Iron|iron|mesh-list
110054286|NCT01490944|Folic Acid|folic acid|mesh-list
110054287|NCT01490944|Vitamin B 12|vitamin b 12|mesh-list
110054288|NCT01490944|Hydroxocobalamin|hydroxocobalamin|mesh-list
110054289|NCT01490944|Vitamin B Complex|vitamin b complex|mesh-list
110054290|NCT01490944|Trace Elements|trace elements|mesh-ancestor
110054291|NCT01490944|Micronutrients|micronutrients|mesh-ancestor
110054292|NCT01490944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054293|NCT01490944|Hematinics|hematinics|mesh-ancestor
110054294|NCT01490944|Vitamins|vitamins|mesh-ancestor
110054295|NCT01490996|Curcumin|curcumin|mesh-list
110054296|NCT01490996|Capecitabine|capecitabine|mesh-list
110054297|NCT01490996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110054298|NCT01490996|Antimetabolites|antimetabolites|mesh-ancestor
110054299|NCT01490996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110054300|NCT01490996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110054301|NCT01490996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110054302|NCT01490996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110054303|NCT01490996|Analgesics|analgesics|mesh-ancestor
110054304|NCT01490996|Sensory System Agents|sensory system agents|mesh-ancestor
110054305|NCT01490996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110054306|NCT01490996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054307|NCT01490996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110054308|NCT01490996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110054309|NCT01490996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110054310|NCT01491009|Midazolam|midazolam|mesh-list
110054311|NCT01491009|Remifentanil|remifentanil|mesh-list
110054312|NCT01491009|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110054313|NCT01491009|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110054314|NCT01491009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110054315|NCT01491009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054316|NCT01491009|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110054317|NCT01491009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110054318|NCT01491009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110054319|NCT01491009|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110054320|NCT01491009|Anesthetics, General|anesthetics, general|mesh-ancestor
110054321|NCT01491009|Anesthetics|anesthetics|mesh-ancestor
110054322|NCT01491009|GABA Modulators|gaba modulators|mesh-ancestor
110054323|NCT01491009|GABA Agents|gaba agents|mesh-ancestor
110054324|NCT01491009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110054325|NCT01491009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110054326|NCT01491009|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110054327|NCT01491009|Narcotics|narcotics|mesh-ancestor
110054328|NCT01491009|Analgesics|analgesics|mesh-ancestor
110054329|NCT01491009|Sensory System Agents|sensory system agents|mesh-ancestor
110054330|NCT01491009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110054331|NCT01491048|Tacrine|tacrine|mesh-list
110054332|NCT01491048|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110054333|NCT01491048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110054334|NCT01491048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110054337|NCT01491048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054338|NCT01491048|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110054340|NCT01491048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110054341|NCT01491048|Nootropic Agents|nootropic agents|mesh-ancestor
110054342|NCT01491061|Ranolazine|ranolazine|mesh-list
110054343|NCT01491061|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110054344|NCT01491061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110054345|NCT01491061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110054346|NCT01491100|Interferons|interferons|mesh-list
110054347|NCT01491100|Interferon-beta|interferon-beta|mesh-list
110054348|NCT01491100|Interferon beta-1b|interferon beta-1b|mesh-list
110054349|NCT01491100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110054350|NCT01491100|Antiviral Agents|antiviral agents|mesh-ancestor
110054351|NCT01491100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110054352|NCT01491100|Immunologic Factors|immunologic factors|mesh-ancestor
110054353|NCT01491100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054354|NCT01491100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110054355|NCT01491139|Olaparib|olaparib|mesh-list
110054356|NCT01491139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110054510|NCT01492608|Anesthetics|anesthetics|mesh-ancestor
110054357|NCT01491139|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110054359|NCT01491139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110054360|NCT01491191|Palmidrol|palmidrol|mesh-list
110054361|NCT01491191|Analgesics|analgesics|mesh-ancestor
110054362|NCT01491191|Sensory System Agents|sensory system agents|mesh-ancestor
110054363|NCT01491191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110054364|NCT01491191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054365|NCT01491191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110054366|NCT01491191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110054367|NCT01491191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110054368|NCT01491191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110054369|NCT01491191|Antiviral Agents|antiviral agents|mesh-ancestor
110054370|NCT01491191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110054371|NCT01491191|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110054372|NCT01491191|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110054373|NCT01491191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110054374|NCT01491191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110054375|NCT01491191|Hormones|hormones|mesh-ancestor
110054376|NCT01491191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110054377|NCT01491204|Paclitaxel|paclitaxel|mesh-list
110054378|NCT01491204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110054379|NCT01491204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110054380|NCT01491204|Tubulin Modulators|tubulin modulators|mesh-ancestor
110054381|NCT01491204|Antimitotic Agents|antimitotic agents|mesh-ancestor
110054382|NCT01491204|Mitosis Modulators|mitosis modulators|mesh-ancestor
110054383|NCT01491204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110054384|NCT01491217|Paclitaxel|paclitaxel|mesh-list
110054385|NCT01491217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110054386|NCT01491217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110054387|NCT01491217|Tubulin Modulators|tubulin modulators|mesh-ancestor
110054388|NCT01491217|Antimitotic Agents|antimitotic agents|mesh-ancestor
110054389|NCT01491217|Mitosis Modulators|mitosis modulators|mesh-ancestor
110054390|NCT01491217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110054391|NCT01491256|Atorvastatin|atorvastatin|mesh-list
110054392|NCT01491256|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110054393|NCT01491256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110054394|NCT01491256|Antimetabolites|antimetabolites|mesh-ancestor
110054395|NCT01491256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110054396|NCT01491256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110054397|NCT01491256|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110054398|NCT01491256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110054399|NCT01491295|Tenofovir|tenofovir|mesh-list
110054400|NCT01491295|Lamivudine|lamivudine|mesh-list
110054401|NCT01491295|Adefovir|adefovir|mesh-list
110054402|NCT01491295|Antiviral Agents|antiviral agents|mesh-ancestor
110054403|NCT01491295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110054404|NCT01491295|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110054405|NCT01491295|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110054406|NCT01491295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110054407|NCT01491295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110054408|NCT01491295|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110054409|NCT01491295|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110054410|NCT01491321|Loxoprofen|loxoprofen|mesh-list
110054411|NCT01491321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110054412|NCT01491321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110054413|NCT01491321|Analgesics|analgesics|mesh-ancestor
110054414|NCT01491321|Sensory System Agents|sensory system agents|mesh-ancestor
110054415|NCT01491321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110054416|NCT01491321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054417|NCT01491321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110054418|NCT01491321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110054419|NCT01491438|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110054421|NCT01491438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110054422|NCT01491438|Antitubercular Agents|antitubercular agents|mesh-ancestor
110054423|NCT01491503|Cetirizine|cetirizine|mesh-list
110054424|NCT01491503|Montelukast|montelukast|mesh-list
110054425|NCT01491503|Levocetirizine|levocetirizine|mesh-list
110054426|NCT01491503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110054427|NCT01491503|Respiratory System Agents|respiratory system agents|mesh-ancestor
110054428|NCT01491503|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110054429|NCT01491503|Hormone Antagonists|hormone antagonists|mesh-ancestor
110054430|NCT01491503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110054431|NCT01491503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054432|NCT01491503|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110054433|NCT01491503|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110054434|NCT01491503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110054435|NCT01491503|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110054436|NCT01491503|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110054437|NCT01491503|Histamine Antagonists|histamine antagonists|mesh-ancestor
110054438|NCT01491503|Histamine Agents|histamine agents|mesh-ancestor
110054439|NCT01491503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110054440|NCT01491503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110054441|NCT01491711|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110054443|NCT01491711|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110054444|NCT01491711|Dermatologic Agents|dermatologic agents|mesh-ancestor
110054445|NCT01491867|Travoprost|travoprost|mesh-list
110054446|NCT01491867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110054447|NCT01492062|Pancrelipase|pancrelipase|mesh-list
110054448|NCT01492062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110054449|NCT01492114|Resveratrol|resveratrol|mesh-list
110054450|NCT01492114|Antioxidants|antioxidants|mesh-ancestor
110054451|NCT01492114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110054452|NCT01492114|Protective Agents|protective agents|mesh-ancestor
110054453|NCT01492114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054454|NCT01492114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110054455|NCT01492114|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110054456|NCT01492153|Insulin|insulin|mesh-list
110054457|NCT01492153|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110054458|NCT01492153|Isophane Insulin, Human|isophane insulin, human|mesh-list
110054459|NCT01492153|Insulin, Isophane|insulin, isophane|mesh-list
110054460|NCT01492153|Isophane insulin, beef|isophane insulin, beef|mesh-list
110054461|NCT01492153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110054462|NCT01492153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054463|NCT01492166|Insulin|insulin|mesh-list
110054464|NCT01492166|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110054465|NCT01492166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110054466|NCT01492166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054467|NCT01492179|Lidocaine|lidocaine|mesh-list
110054469|NCT01492179|Anesthetics|anesthetics|mesh-ancestor
110054470|NCT01492179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110054471|NCT01492179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054472|NCT01492179|Sensory System Agents|sensory system agents|mesh-ancestor
110054473|NCT01492179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110054474|NCT01492179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110054475|NCT01492179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110054476|NCT01492179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110054477|NCT01492179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110054478|NCT01492179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110054479|NCT01492205|Insulin|insulin|mesh-list
110054480|NCT01492205|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110054481|NCT01492205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110054482|NCT01492205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054483|NCT01492218|Insulin|insulin|mesh-list
110054484|NCT01492218|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110054486|NCT01492218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054488|NCT01492387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110054489|NCT01492504|Asunaprevir|asunaprevir|mesh-list
110054490|NCT01492504|Protease Inhibitors|protease inhibitors|mesh-ancestor
110054491|NCT01492504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110054492|NCT01492504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110054493|NCT01492543|Tegafur|tegafur|mesh-list
110054494|NCT01492543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110054495|NCT01492543|Antimetabolites|antimetabolites|mesh-ancestor
110054496|NCT01492543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110054497|NCT01492543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110054498|NCT01492556|Etoposide|etoposide|mesh-list
110054499|NCT01492556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110054500|NCT01492556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110054501|NCT01492556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110054502|NCT01492556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110054503|NCT01492556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110054504|NCT01492556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110054505|NCT01492608|Magnesium Sulfate|magnesium sulfate|mesh-list
110054506|NCT01492608|Analgesics|analgesics|mesh-ancestor
110054507|NCT01492608|Sensory System Agents|sensory system agents|mesh-ancestor
110054508|NCT01492608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110054509|NCT01492608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054511|NCT01492608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110054512|NCT01492608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110054513|NCT01492608|Anticonvulsants|anticonvulsants|mesh-ancestor
110054514|NCT01492608|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110054515|NCT01492608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110054516|NCT01492608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110054517|NCT01492608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110054518|NCT01492608|Tocolytic Agents|tocolytic agents|mesh-ancestor
110054519|NCT01492608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110054520|NCT01492621|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
110054521|NCT01492621|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110054522|NCT01492621|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110054523|NCT01492621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110054524|NCT01492621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110054525|NCT01492621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110054526|NCT01492621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054527|NCT01492621|Antidepressive Agents|antidepressive agents|mesh-ancestor
110054528|NCT01492621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110054530|NCT01492712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110054531|NCT01492712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110054532|NCT01492712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054533|NCT01492712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110054535|NCT01492712|Anesthetics|anesthetics|mesh-ancestor
110054536|NCT01492725|Plasminogen|plasminogen|mesh-list
110054537|NCT01492725|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110054538|NCT01492725|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110054539|NCT01492725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110054540|NCT01492725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110054541|NCT01492881|Doxorubicin|doxorubicin|mesh-list
110054542|NCT01492881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110054543|NCT01492881|Bortezomib|bortezomib|mesh-list
110054544|NCT01492881|Vorinostat|vorinostat|mesh-list
110054545|NCT01492881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110054546|NCT01492881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110054547|NCT01492881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110054548|NCT01492881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110054549|NCT01492881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110054550|NCT01492881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110054551|NCT01492881|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110054552|NCT01492894|Cyclosporine|cyclosporine|mesh-list
110054553|NCT01492894|Sirolimus|sirolimus|mesh-list
110054554|NCT01492894|Tacrolimus|tacrolimus|mesh-list
110054555|NCT01492894|Cyclosporins|cyclosporins|mesh-list
110054556|NCT01492894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110054557|NCT01492894|Immunologic Factors|immunologic factors|mesh-ancestor
110054558|NCT01492894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054559|NCT01492894|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110054561|NCT01492894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110054562|NCT01492894|Antifungal Agents|antifungal agents|mesh-ancestor
110054563|NCT01492894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110054564|NCT01492894|Dermatologic Agents|dermatologic agents|mesh-ancestor
110054565|NCT01492894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110054566|NCT01492894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110054567|NCT01492894|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110054568|NCT01492894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110054569|NCT01492920|Acetylcarnitine|acetylcarnitine|mesh-list
110054570|NCT01492920|Vitamin B Complex|vitamin b complex|mesh-ancestor
110054571|NCT01492920|Vitamins|vitamins|mesh-ancestor
110054572|NCT01492920|Micronutrients|micronutrients|mesh-ancestor
110054573|NCT01492920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054574|NCT01492920|Nootropic Agents|nootropic agents|mesh-ancestor
110054575|NCT01492959|Insulin|insulin|mesh-list
110054576|NCT01492959|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110054577|NCT01492959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110054578|NCT01492959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054579|NCT01492985|Vaccines|vaccines|mesh-list
110054580|NCT01492985|Immunologic Factors|immunologic factors|mesh-ancestor
110054581|NCT01492985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054582|NCT01493050|Calcium Carbonate|calcium carbonate|mesh-list
110054583|NCT01493050|Calcium|calcium|mesh-list
110054584|NCT01493050|Sevelamer|sevelamer|mesh-list
110054585|NCT01493050|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110054586|NCT01493050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054587|NCT01493050|Antacids|antacids|mesh-ancestor
110054588|NCT01493050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110054589|NCT01493050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110054590|NCT01493050|Chelating Agents|chelating agents|mesh-ancestor
110054591|NCT01493050|Sequestering Agents|sequestering agents|mesh-ancestor
110054592|NCT01493102|Vasopressins|vasopressins|mesh-list
110054593|NCT01493102|Arginine Vasopressin|arginine vasopressin|mesh-list
110054594|NCT01493102|Norepinephrine|norepinephrine|mesh-list
110054595|NCT01493102|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110054596|NCT01493102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110054597|NCT01493102|Adrenergic Agents|adrenergic agents|mesh-ancestor
110054598|NCT01493102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110054599|NCT01493102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110054600|NCT01493102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054602|NCT01493102|Autonomic Agents|autonomic agents|mesh-ancestor
110054603|NCT01493102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110054604|NCT01493102|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110054605|NCT01493102|Hemostatics|hemostatics|mesh-ancestor
110054606|NCT01493102|Coagulants|coagulants|mesh-ancestor
110054607|NCT01493102|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110054608|NCT01493102|Natriuretic Agents|natriuretic agents|mesh-ancestor
110054610|NCT01493115|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110054611|NCT01493115|Insulin Glargine|insulin glargine|mesh-list
110054612|NCT01493115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110054613|NCT01493115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054614|NCT01493154|Cyclophosphamide|cyclophosphamide|mesh-list
110054616|NCT01493154|Immunologic Factors|immunologic factors|mesh-ancestor
110054617|NCT01493154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054618|NCT01493154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110054619|NCT01493154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110054620|NCT01493154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110054621|NCT01493154|Alkylating Agents|alkylating agents|mesh-ancestor
110054622|NCT01493154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110054623|NCT01493154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110054624|NCT01493154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110054625|NCT01493310|Paclitaxel|paclitaxel|mesh-list
110054626|NCT01493310|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110054627|NCT01493310|Mifepristone|mifepristone|mesh-list
110054628|NCT01493310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110054629|NCT01493310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110054630|NCT01493310|Tubulin Modulators|tubulin modulators|mesh-ancestor
110054631|NCT01493310|Antimitotic Agents|antimitotic agents|mesh-ancestor
110054632|NCT01493310|Mitosis Modulators|mitosis modulators|mesh-ancestor
110054633|NCT01493310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110054634|NCT01493310|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110054635|NCT01493310|Abortifacient Agents|abortifacient agents|mesh-ancestor
110054636|NCT01493310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110054637|NCT01493310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054638|NCT01493310|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110054640|NCT01493310|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110054641|NCT01493310|Contraceptive Agents|contraceptive agents|mesh-ancestor
110054642|NCT01493310|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110054643|NCT01493310|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110054644|NCT01493310|Hormone Antagonists|hormone antagonists|mesh-ancestor
110054645|NCT01493310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110054646|NCT01493310|Luteolytic Agents|luteolytic agents|mesh-ancestor
110054647|NCT01493310|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110054648|NCT01493310|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110054649|NCT01493336|Capecitabine|capecitabine|mesh-list
110054650|NCT01493336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110054652|NCT01493336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110054653|NCT01493336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110054654|NCT01493388|Insulin|insulin|mesh-list
110054655|NCT01493388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110054656|NCT01493388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054657|NCT01493440|Atosiban|atosiban|mesh-list
110054658|NCT01493440|Hormone Antagonists|hormone antagonists|mesh-ancestor
110054659|NCT01493440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110054660|NCT01493440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054661|NCT01493440|Tocolytic Agents|tocolytic agents|mesh-ancestor
110054662|NCT01493440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110054663|NCT01493479|Rituximab|rituximab|mesh-list
110054664|NCT01493479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110054665|NCT01493479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110054666|NCT01493479|Immunologic Factors|immunologic factors|mesh-ancestor
110054667|NCT01493479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054668|NCT01493479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110054669|NCT01493570|BI 409306|bi 409306|mesh-list
110054670|NCT01493570|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110054671|NCT01493570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110054672|NCT01493570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110054673|NCT01493622|Minocycline|minocycline|mesh-list
110054674|NCT01493622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110054675|NCT01493622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110054676|NCT01493635|Analgesics|analgesics|mesh-list
110054677|NCT01493635|Sensory System Agents|sensory system agents|mesh-ancestor
110054678|NCT01493635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110054679|NCT01493635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054680|NCT01493648|Vitamin D|vitamin d|mesh-list
110054681|NCT01493648|Cholecalciferol|cholecalciferol|mesh-list
110054682|NCT01493648|Vitamins|vitamins|mesh-ancestor
110054683|NCT01493648|Micronutrients|micronutrients|mesh-ancestor
110054684|NCT01493648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054685|NCT01493648|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110054686|NCT01493648|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110054687|NCT01493674|Folic Acid|folic acid|mesh-list
110054688|NCT01493674|Vitamin B Complex|vitamin b complex|mesh-list
110054689|NCT01493674|Hematinics|hematinics|mesh-ancestor
110054690|NCT01493674|Vitamins|vitamins|mesh-ancestor
110054691|NCT01493674|Micronutrients|micronutrients|mesh-ancestor
110054692|NCT01493674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054693|NCT01493791|Ulipristal acetate|ulipristal acetate|mesh-list
110054694|NCT01493791|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110054695|NCT01493791|Contraceptive Agents|contraceptive agents|mesh-ancestor
110054696|NCT01493791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110054697|NCT01493791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054698|NCT01493791|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110054699|NCT01493843|Paclitaxel|paclitaxel|mesh-list
110054700|NCT01493843|Bevacizumab|bevacizumab|mesh-list
110054701|NCT01493843|Carboplatin|carboplatin|mesh-list
110054702|NCT01493843|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110054703|NCT01493843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110054704|NCT01493843|Tubulin Modulators|tubulin modulators|mesh-ancestor
110054705|NCT01493843|Antimitotic Agents|antimitotic agents|mesh-ancestor
110054706|NCT01493843|Mitosis Modulators|mitosis modulators|mesh-ancestor
110054707|NCT01493843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110054708|NCT01493843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110054709|NCT01493843|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110054710|NCT01493843|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110054711|NCT01493843|Growth Substances|growth substances|mesh-ancestor
110054713|NCT01493843|Growth Inhibitors|growth inhibitors|mesh-ancestor
110054714|NCT01493856|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110054715|NCT01493856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110054716|NCT01493856|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110054717|NCT01493856|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110054718|NCT01493856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110054719|NCT01493973|Epoetin Alfa|epoetin alfa|mesh-list
110054720|NCT01493973|Hematinics|hematinics|mesh-ancestor
110054721|NCT01493986|Ropivacaine|ropivacaine|mesh-list
110054722|NCT01493986|Anesthetics, Local|anesthetics, local|mesh-ancestor
110054723|NCT01493986|Anesthetics|anesthetics|mesh-ancestor
110054724|NCT01493986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110054725|NCT01493986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054726|NCT01493986|Sensory System Agents|sensory system agents|mesh-ancestor
110054727|NCT01493986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110054728|NCT01493999|Clopidogrel|clopidogrel|mesh-list
110054729|NCT01493999|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110054730|NCT01493999|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110054731|NCT01493999|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110054732|NCT01493999|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110054733|NCT01493999|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110054734|NCT01493999|Purinergic Agents|purinergic agents|mesh-ancestor
110054735|NCT01493999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110054736|NCT01493999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110054737|NCT01493999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054738|NCT01494012|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110054739|NCT01494012|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110054740|NCT01494012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110054741|NCT01494090|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110054742|NCT01494090|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110054743|NCT01494090|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110054744|NCT01494090|Antimetabolites|antimetabolites|mesh-ancestor
110054745|NCT01494090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110054746|NCT01494090|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110054747|NCT01494090|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110054748|NCT01494090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110054749|NCT01494155|Hydroxychloroquine|hydroxychloroquine|mesh-list
110054750|NCT01494155|Capecitabine|capecitabine|mesh-list
110054751|NCT01494155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110054752|NCT01494155|Antimetabolites|antimetabolites|mesh-ancestor
110054753|NCT01494155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110054754|NCT01494155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110054755|NCT01494155|Antimalarials|antimalarials|mesh-ancestor
110054756|NCT01494155|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110054757|NCT01494155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110054758|NCT01494155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110054759|NCT01494155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110054760|NCT01494155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110054761|NCT01494259|Epinephrine|epinephrine|mesh-list
110054762|NCT01494259|Bupivacaine|bupivacaine|mesh-list
110054763|NCT01494259|Anesthetics, Local|anesthetics, local|mesh-ancestor
110054764|NCT01494259|Anesthetics|anesthetics|mesh-ancestor
110054765|NCT01494259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110054766|NCT01494259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054767|NCT01494259|Sensory System Agents|sensory system agents|mesh-ancestor
110054768|NCT01494259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110054769|NCT01494259|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110054770|NCT01494259|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110054771|NCT01494259|Adrenergic Agents|adrenergic agents|mesh-ancestor
110054772|NCT01494259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110054773|NCT01494259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110054774|NCT01494259|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110054775|NCT01494259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110054776|NCT01494259|Autonomic Agents|autonomic agents|mesh-ancestor
110054777|NCT01494259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110054778|NCT01494259|Respiratory System Agents|respiratory system agents|mesh-ancestor
110054779|NCT01494259|Mydriatics|mydriatics|mesh-ancestor
110054780|NCT01494259|Sympathomimetics|sympathomimetics|mesh-ancestor
110054781|NCT01494259|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110054782|NCT01494311|Lidocaine|lidocaine|mesh-list
110054783|NCT01494311|Tetracaine|tetracaine|mesh-list
110054784|NCT01494311|Anesthetics, Local|anesthetics, local|mesh-ancestor
110054785|NCT01494311|Anesthetics|anesthetics|mesh-ancestor
110054786|NCT01494311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110054787|NCT01494311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054788|NCT01494311|Sensory System Agents|sensory system agents|mesh-ancestor
110054820|NCT01494402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110054821|NCT01494402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110054822|NCT01494402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110054823|NCT01494402|Analgesics|analgesics|mesh-ancestor
110054824|NCT01494402|Sensory System Agents|sensory system agents|mesh-ancestor
110054825|NCT01494402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110054826|NCT01494402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054827|NCT01494402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110054828|NCT01494402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110054829|NCT01494402|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110054830|NCT01494402|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110054831|NCT01494402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110054832|NCT01494402|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110054833|NCT01494402|Antipyretics|antipyretics|mesh-ancestor
110054834|NCT01494415|Paclitaxel|paclitaxel|mesh-list
110054835|NCT01494415|Carboplatin|carboplatin|mesh-list
110054836|NCT01494415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110054837|NCT01494415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110054838|NCT01494415|Tubulin Modulators|tubulin modulators|mesh-ancestor
110054839|NCT01494415|Antimitotic Agents|antimitotic agents|mesh-ancestor
110054840|NCT01494415|Mitosis Modulators|mitosis modulators|mesh-ancestor
110054841|NCT01494415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110054842|NCT01494597|Cyclosporine|cyclosporine|mesh-list
110054843|NCT01494597|Isavuconazole|isavuconazole|mesh-list
110054844|NCT01494597|Cyclosporins|cyclosporins|mesh-list
110054845|NCT01494597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110054846|NCT01494597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110054847|NCT01494597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110054848|NCT01494597|Immunologic Factors|immunologic factors|mesh-ancestor
110054926|NCT01495104|Valproic Acid|valproic acid|mesh-list
110054849|NCT01494597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054850|NCT01494597|Antifungal Agents|antifungal agents|mesh-ancestor
110054851|NCT01494597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110054852|NCT01494597|Dermatologic Agents|dermatologic agents|mesh-ancestor
110054853|NCT01494597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110054854|NCT01494597|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110054855|NCT01494636|Lidocaine|lidocaine|mesh-list
110054856|NCT01494636|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110054857|NCT01494636|Anesthetics, Local|anesthetics, local|mesh-ancestor
110054858|NCT01494636|Anesthetics|anesthetics|mesh-ancestor
110054859|NCT01494636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110054860|NCT01494636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054862|NCT01494636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110054864|NCT01494636|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110054865|NCT01494636|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110054866|NCT01494636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110054867|NCT01494636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110054868|NCT01494688|Paclitaxel|paclitaxel|mesh-list
110054869|NCT01494688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110054870|NCT01494688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110054871|NCT01494688|Tubulin Modulators|tubulin modulators|mesh-ancestor
110054872|NCT01494688|Antimitotic Agents|antimitotic agents|mesh-ancestor
110054873|NCT01494688|Mitosis Modulators|mitosis modulators|mesh-ancestor
110054874|NCT01494688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110054875|NCT01494714|Petrolatum|petrolatum|mesh-list
110054876|NCT01494714|Emollients|emollients|mesh-ancestor
110054877|NCT01494714|Dermatologic Agents|dermatologic agents|mesh-ancestor
110054878|NCT01494727|Amlodipine|amlodipine|mesh-list
110054879|NCT01494727|Valsartan|valsartan|mesh-list
110054880|NCT01494727|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
110054881|NCT01494727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110054882|NCT01494727|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110054883|NCT01494727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110054884|NCT01494727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110054885|NCT01494727|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110054886|NCT01494727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054887|NCT01494727|Vasodilator Agents|vasodilator agents|mesh-ancestor
110054888|NCT01494727|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110054889|NCT01494727|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110054890|NCT01494740|Vaccines|vaccines|mesh-list
110054891|NCT01494740|Immunologic Factors|immunologic factors|mesh-ancestor
110054893|NCT01494805|Ranibizumab|ranibizumab|mesh-list
110054894|NCT01494805|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110054895|NCT01494805|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110054896|NCT01494805|Growth Substances|growth substances|mesh-ancestor
110054897|NCT01494805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054898|NCT01494805|Growth Inhibitors|growth inhibitors|mesh-ancestor
110054899|NCT01494805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110054900|NCT01494857|Adalimumab|adalimumab|mesh-list
110054901|NCT01494857|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110054902|NCT01494857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110054903|NCT01494857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110054904|NCT01495026|Tamsulosin|tamsulosin|mesh-list
110054905|NCT01495026|Dutasteride|dutasteride|mesh-list
110054906|NCT01495026|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110054907|NCT01495026|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110054908|NCT01495026|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110054909|NCT01495026|Adrenergic Agents|adrenergic agents|mesh-ancestor
110054910|NCT01495026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110054911|NCT01495026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110054912|NCT01495026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054913|NCT01495026|Urological Agents|urological agents|mesh-ancestor
110054914|NCT01495026|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110054915|NCT01495026|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110054916|NCT01495026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110054917|NCT01495026|Hormone Antagonists|hormone antagonists|mesh-ancestor
110054918|NCT01495026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110054919|NCT01495039|Nystatin|nystatin|mesh-list
110054920|NCT01495039|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110054921|NCT01495039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110054922|NCT01495039|Antifungal Agents|antifungal agents|mesh-ancestor
110054923|NCT01495039|Ionophores|ionophores|mesh-ancestor
110054924|NCT01495039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110054925|NCT01495039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110054928|NCT01495104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110054929|NCT01495104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110054930|NCT01495104|GABA Agents|gaba agents|mesh-ancestor
110054931|NCT01495104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110054932|NCT01495104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054933|NCT01495104|Antimanic Agents|antimanic agents|mesh-ancestor
110054934|NCT01495104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110054935|NCT01495104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110054936|NCT01495104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110054938|NCT01495117|Chlorhexidine|chlorhexidine|mesh-list
110054939|NCT01495117|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110054940|NCT01495117|Povidone-Iodine|povidone-iodine|mesh-list
110054941|NCT01495117|Povidone|povidone|mesh-list
110054942|NCT01495117|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110054943|NCT01495117|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110054944|NCT01495117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110054945|NCT01495117|Disinfectants|disinfectants|mesh-ancestor
110054946|NCT01495117|Dermatologic Agents|dermatologic agents|mesh-ancestor
110054947|NCT01495117|Trace Elements|trace elements|mesh-ancestor
110054948|NCT01495117|Micronutrients|micronutrients|mesh-ancestor
110054949|NCT01495117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054950|NCT01495117|Plasma Substitutes|plasma substitutes|mesh-ancestor
110054951|NCT01495117|Blood Substitutes|blood substitutes|mesh-ancestor
110054952|NCT01495156|Antipsychotic Agents|antipsychotic agents|mesh-list
110054953|NCT01495156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110054954|NCT01495156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110054955|NCT01495156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110054956|NCT01495156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054957|NCT01495169|Iloperidone|iloperidone|mesh-list
110054958|NCT01495169|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110054959|NCT01495169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110054960|NCT01495169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110054961|NCT01495169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054962|NCT01495169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110054963|NCT01495195|Selegiline|selegiline|mesh-list
110054964|NCT01495195|Donepezil|donepezil|mesh-list
110054965|NCT01495195|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110054966|NCT01495195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110054967|NCT01495195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110054968|NCT01495195|Cholinergic Agents|cholinergic agents|mesh-ancestor
110054969|NCT01495195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110054970|NCT01495195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054971|NCT01495195|Nootropic Agents|nootropic agents|mesh-ancestor
110054972|NCT01495195|Antidepressive Agents|antidepressive agents|mesh-ancestor
110054973|NCT01495195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110054974|NCT01495195|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110054975|NCT01495195|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110054976|NCT01495195|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110054977|NCT01495195|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110054978|NCT01495195|Protective Agents|protective agents|mesh-ancestor
110054979|NCT01495208|Aflibercept|aflibercept|mesh-list
110054980|NCT01495208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110054981|NCT01495208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110054982|NCT01495208|Growth Substances|growth substances|mesh-ancestor
110054983|NCT01495208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054984|NCT01495208|Growth Inhibitors|growth inhibitors|mesh-ancestor
110054985|NCT01495208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110054986|NCT01495260|Vitamin E|vitamin e|mesh-list
110054987|NCT01495260|Thioctic Acid|thioctic acid|mesh-list
110054988|NCT01495260|Acetylcysteine|acetylcysteine|mesh-list
110054989|NCT01495260|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110054990|NCT01495260|Vitamins|vitamins|mesh-ancestor
110054991|NCT01495260|Micronutrients|micronutrients|mesh-ancestor
110054992|NCT01495260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110054993|NCT01495260|Antiviral Agents|antiviral agents|mesh-ancestor
110054994|NCT01495260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110054995|NCT01495260|Expectorants|expectorants|mesh-ancestor
110054996|NCT01495260|Respiratory System Agents|respiratory system agents|mesh-ancestor
110054997|NCT01495260|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110054998|NCT01495260|Antioxidants|antioxidants|mesh-ancestor
110054999|NCT01495260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110055001|NCT01495260|Antidotes|antidotes|mesh-ancestor
110055002|NCT01495260|Vitamin B Complex|vitamin b complex|mesh-ancestor
110055003|NCT01495338|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
110055004|NCT01495338|Cetirizine|cetirizine|mesh-list
110055005|NCT01495338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110055006|NCT01495338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110055007|NCT01495338|Analgesics|analgesics|mesh-ancestor
110055008|NCT01495338|Sensory System Agents|sensory system agents|mesh-ancestor
110055009|NCT01495338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110055010|NCT01495338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055011|NCT01495338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110055012|NCT01495338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110055013|NCT01495338|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110055014|NCT01495338|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110055015|NCT01495338|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110055016|NCT01495338|Histamine Antagonists|histamine antagonists|mesh-ancestor
110055017|NCT01495338|Histamine Agents|histamine agents|mesh-ancestor
110055018|NCT01495338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110055019|NCT01495338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110055020|NCT01495351|Bortezomib|bortezomib|mesh-list
110055021|NCT01495351|Veliparib|veliparib|mesh-list
110055022|NCT01495351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110055023|NCT01495351|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110055024|NCT01495351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110055025|NCT01495351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110055026|NCT01495377|Remifentanil|remifentanil|mesh-list
110055027|NCT01495377|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110055028|NCT01495377|Narcotics|narcotics|mesh-ancestor
110055029|NCT01495377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110055030|NCT01495377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055031|NCT01495377|Analgesics|analgesics|mesh-ancestor
110055032|NCT01495377|Sensory System Agents|sensory system agents|mesh-ancestor
110055033|NCT01495377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110055034|NCT01495468|Hormones|hormones|mesh-list
110055035|NCT01495468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110055036|NCT01495468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055038|NCT01495520|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110055039|NCT01495520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110055040|NCT01495520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110055041|NCT01495624|Dexamethasone|dexamethasone|mesh-list
110055042|NCT01495624|Dexamethasone acetate|dexamethasone acetate|mesh-list
110055043|NCT01495624|Ropivacaine|ropivacaine|mesh-list
110055044|NCT01495624|Anesthetics|anesthetics|mesh-list
110055045|NCT01495624|BB 1101|bb 1101|mesh-list
110055046|NCT01495624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110055047|NCT01495624|Antiemetics|antiemetics|mesh-ancestor
110055048|NCT01495624|Autonomic Agents|autonomic agents|mesh-ancestor
110055049|NCT01495624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110055050|NCT01495624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055051|NCT01495624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110055052|NCT01495624|Glucocorticoids|glucocorticoids|mesh-ancestor
110055053|NCT01495624|Hormones|hormones|mesh-ancestor
110055054|NCT01495624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110055055|NCT01495624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110055056|NCT01495624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110055057|NCT01495624|Protease Inhibitors|protease inhibitors|mesh-ancestor
110055058|NCT01495624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110055059|NCT01495624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110055060|NCT01495624|Anesthetics, Local|anesthetics, local|mesh-ancestor
110055061|NCT01495624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110055062|NCT01495624|Sensory System Agents|sensory system agents|mesh-ancestor
110055063|NCT01495715|Idebenone|idebenone|mesh-list
110055064|NCT01495715|Antioxidants|antioxidants|mesh-ancestor
110055065|NCT01495715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110055066|NCT01495715|Protective Agents|protective agents|mesh-ancestor
110055067|NCT01495715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055068|NCT01495806|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
110055069|NCT01495806|Cathartics|cathartics|mesh-ancestor
110055070|NCT01495806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110055072|NCT01495845|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110055073|NCT01495845|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110055074|NCT01495845|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110055075|NCT01495845|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110055076|NCT01495845|Purinergic Agents|purinergic agents|mesh-ancestor
110055077|NCT01495845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110055078|NCT01495845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110055079|NCT01495845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055080|NCT01495884|Lapatinib|lapatinib|mesh-list
110055081|NCT01495884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110055392|NCT01497561|Isophane insulin, beef|isophane insulin, beef|mesh-list
110055082|NCT01495884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110055083|NCT01495884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110055084|NCT01495884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110055085|NCT01495910|Abiraterone Acetate|abiraterone acetate|mesh-list
110055086|NCT01495910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110055087|NCT01495910|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110055088|NCT01495910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110055089|NCT01495910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110055090|NCT01495910|Hormone Antagonists|hormone antagonists|mesh-ancestor
110055091|NCT01495910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110055092|NCT01495910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055093|NCT01495910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110055094|NCT01495949|Thiopental|thiopental|mesh-list
110055095|NCT01495949|Etomidate|etomidate|mesh-list
110055096|NCT01495949|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110055097|NCT01495949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110055098|NCT01495949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055099|NCT01495949|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110055100|NCT01495949|Anesthetics, General|anesthetics, general|mesh-ancestor
110055101|NCT01495949|Anesthetics|anesthetics|mesh-ancestor
110055102|NCT01495949|Anticonvulsants|anticonvulsants|mesh-ancestor
110055103|NCT01495949|GABA Modulators|gaba modulators|mesh-ancestor
110055104|NCT01495949|GABA Agents|gaba agents|mesh-ancestor
110055105|NCT01495949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110055106|NCT01495949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110055107|NCT01495962|Botulinum Toxins|botulinum toxins|mesh-list
110055108|NCT01495962|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110055109|NCT01495962|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110055110|NCT01495962|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110055111|NCT01495962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110055112|NCT01495962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110055113|NCT01495962|Cholinergic Agents|cholinergic agents|mesh-ancestor
110055114|NCT01495962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110055115|NCT01495962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055116|NCT01495962|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110055117|NCT01495962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110055118|NCT01496105|Lidocaine|lidocaine|mesh-list
110055119|NCT01496105|Anesthetics, Local|anesthetics, local|mesh-ancestor
110055120|NCT01496105|Anesthetics|anesthetics|mesh-ancestor
110055122|NCT01496105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055123|NCT01496105|Sensory System Agents|sensory system agents|mesh-ancestor
110055124|NCT01496105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110055125|NCT01496105|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110055126|NCT01496105|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110055127|NCT01496105|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110055128|NCT01496105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110055129|NCT01496105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110055130|NCT01496196|Tranexamic Acid|tranexamic acid|mesh-list
110055131|NCT01496196|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110055133|NCT01496196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110055134|NCT01496196|Hemostatics|hemostatics|mesh-ancestor
110055135|NCT01496196|Coagulants|coagulants|mesh-ancestor
110055136|NCT01496261|Aspirin|aspirin|mesh-list
110055137|NCT01496261|Clopidogrel|clopidogrel|mesh-list
110055138|NCT01496261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110055139|NCT01496261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110055140|NCT01496261|Analgesics|analgesics|mesh-ancestor
110055141|NCT01496261|Sensory System Agents|sensory system agents|mesh-ancestor
110055142|NCT01496261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110055143|NCT01496261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055144|NCT01496261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110055145|NCT01496261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110055146|NCT01496261|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110055147|NCT01496261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110055148|NCT01496261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110055149|NCT01496261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110055150|NCT01496261|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110055151|NCT01496261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110055152|NCT01496261|Antipyretics|antipyretics|mesh-ancestor
110055153|NCT01496261|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110055154|NCT01496261|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110055155|NCT01496261|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110055156|NCT01496261|Purinergic Agents|purinergic agents|mesh-ancestor
110055157|NCT01496261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110055159|NCT01496326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110055160|NCT01496326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110055161|NCT01496326|Analgesics|analgesics|mesh-ancestor
110055162|NCT01496326|Sensory System Agents|sensory system agents|mesh-ancestor
110055163|NCT01496326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110055164|NCT01496326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055165|NCT01496326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110055166|NCT01496326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110055167|NCT01496326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110055168|NCT01496326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110055169|NCT01496326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110055170|NCT01496417|Abatacept|abatacept|mesh-list
110055171|NCT01496417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110055172|NCT01496417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110055173|NCT01496417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110055174|NCT01496417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110055175|NCT01496417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110055176|NCT01496417|Immunologic Factors|immunologic factors|mesh-ancestor
110055177|NCT01496417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055178|NCT01496417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110055179|NCT01496443|Glimepiride|glimepiride|mesh-list
110055181|NCT01496443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110055182|NCT01496443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055183|NCT01496443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110055184|NCT01496443|Immunologic Factors|immunologic factors|mesh-ancestor
110055185|NCT01496521|Aspirin|aspirin|mesh-list
110055186|NCT01496521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110055187|NCT01496521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110055188|NCT01496521|Analgesics|analgesics|mesh-ancestor
110055189|NCT01496521|Sensory System Agents|sensory system agents|mesh-ancestor
110055190|NCT01496521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110055191|NCT01496521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055192|NCT01496521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110055193|NCT01496521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110055194|NCT01496521|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110055195|NCT01496521|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110055196|NCT01496521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110055197|NCT01496521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110055198|NCT01496521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110055199|NCT01496521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110055200|NCT01496521|Antipyretics|antipyretics|mesh-ancestor
110055201|NCT01496534|Carboplatin|carboplatin|mesh-list
110055202|NCT01496534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110055203|NCT01496677|Tedizolid phosphate|tedizolid phosphate|mesh-list
110055204|NCT01496677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110055205|NCT01496677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110055206|NCT01496690|Pregabalin|pregabalin|mesh-list
110055207|NCT01496690|Analgesics|analgesics|mesh-ancestor
110055208|NCT01496690|Sensory System Agents|sensory system agents|mesh-ancestor
110055209|NCT01496690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110055210|NCT01496690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055211|NCT01496690|Anticonvulsants|anticonvulsants|mesh-ancestor
110055212|NCT01496690|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110055213|NCT01496690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110055214|NCT01496690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110055215|NCT01496690|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110055216|NCT01496690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110055217|NCT01496690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110055218|NCT01496690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110055219|NCT01496690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110055220|NCT01496742|Paclitaxel|paclitaxel|mesh-list
110055221|NCT01496742|Bevacizumab|bevacizumab|mesh-list
110055222|NCT01496742|Carboplatin|carboplatin|mesh-list
110055223|NCT01496742|Pemetrexed|pemetrexed|mesh-list
110055224|NCT01496742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110055225|NCT01496742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110055226|NCT01496742|Tubulin Modulators|tubulin modulators|mesh-ancestor
110055227|NCT01496742|Antimitotic Agents|antimitotic agents|mesh-ancestor
110055228|NCT01496742|Mitosis Modulators|mitosis modulators|mesh-ancestor
110055229|NCT01496742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110055230|NCT01496742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110055231|NCT01496742|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110055232|NCT01496742|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110055233|NCT01496742|Growth Substances|growth substances|mesh-ancestor
110055234|NCT01496742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055235|NCT01496742|Growth Inhibitors|growth inhibitors|mesh-ancestor
110055236|NCT01496742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110055237|NCT01496742|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110055238|NCT01496742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110055239|NCT01496911|Hydroxyzine|hydroxyzine|mesh-list
110055240|NCT01496911|Levocetirizine|levocetirizine|mesh-list
110055241|NCT01496911|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110055242|NCT01496911|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110055243|NCT01496911|Histamine Antagonists|histamine antagonists|mesh-ancestor
110055244|NCT01496911|Histamine Agents|histamine agents|mesh-ancestor
110055245|NCT01496911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110055246|NCT01496911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110055247|NCT01496911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055248|NCT01496911|Antipruritics|antipruritics|mesh-ancestor
110055249|NCT01496911|Dermatologic Agents|dermatologic agents|mesh-ancestor
110055250|NCT01496989|Interleukin-12|interleukin-12|mesh-list
110055251|NCT01496989|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110055252|NCT01496989|Immunologic Factors|immunologic factors|mesh-ancestor
110055253|NCT01496989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055255|NCT01496989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110055257|NCT01496989|Growth Inhibitors|growth inhibitors|mesh-ancestor
110055258|NCT01496989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110055260|NCT01497002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110055261|NCT01497002|Antimetabolites|antimetabolites|mesh-ancestor
110055262|NCT01497002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110055263|NCT01497002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110055264|NCT01497002|Antiviral Agents|antiviral agents|mesh-ancestor
110055265|NCT01497002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110055266|NCT01497002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110055267|NCT01497002|Immunologic Factors|immunologic factors|mesh-ancestor
110055268|NCT01497002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055269|NCT01497041|Docetaxel|docetaxel|mesh-list
110055270|NCT01497041|Oxaliplatin|oxaliplatin|mesh-list
110055271|NCT01497041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110055272|NCT01497041|Tubulin Modulators|tubulin modulators|mesh-ancestor
110055273|NCT01497041|Antimitotic Agents|antimitotic agents|mesh-ancestor
110055274|NCT01497041|Mitosis Modulators|mitosis modulators|mesh-ancestor
110055275|NCT01497041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110055276|NCT01497093|Thalidomide|thalidomide|mesh-list
110055277|NCT01497093|Dexamethasone|dexamethasone|mesh-list
110055278|NCT01497093|Bortezomib|bortezomib|mesh-list
110055279|NCT01497093|Pomalidomide|pomalidomide|mesh-list
110055280|NCT01497093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110055281|NCT01497093|Antiemetics|antiemetics|mesh-ancestor
110055282|NCT01497093|Autonomic Agents|autonomic agents|mesh-ancestor
110055283|NCT01497093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110055284|NCT01497093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055285|NCT01497093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110055286|NCT01497093|Glucocorticoids|glucocorticoids|mesh-ancestor
110055287|NCT01497093|Hormones|hormones|mesh-ancestor
110055288|NCT01497093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110055289|NCT01497093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110055290|NCT01497093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110055291|NCT01497093|Immunologic Factors|immunologic factors|mesh-ancestor
110055292|NCT01497093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110055293|NCT01497093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110055294|NCT01497093|Growth Substances|growth substances|mesh-ancestor
110055295|NCT01497093|Growth Inhibitors|growth inhibitors|mesh-ancestor
110055296|NCT01497093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110055297|NCT01497093|Leprostatic Agents|leprostatic agents|mesh-ancestor
110055298|NCT01497093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110055299|NCT01497093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110055301|NCT01497132|Cholecalciferol|cholecalciferol|mesh-list
110055302|NCT01497132|Vitamins|vitamins|mesh-ancestor
110055303|NCT01497132|Micronutrients|micronutrients|mesh-ancestor
110055304|NCT01497132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055305|NCT01497132|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110055306|NCT01497132|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110055307|NCT01497145|Darbepoetin alfa|darbepoetin alfa|mesh-list
110055308|NCT01497145|Hematinics|hematinics|mesh-ancestor
110055309|NCT01497288|Fentanyl|fentanyl|mesh-list
110055310|NCT01497288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110055311|NCT01497288|Narcotics|narcotics|mesh-ancestor
110055393|NCT01497561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110055312|NCT01497288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110055313|NCT01497288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055314|NCT01497288|Analgesics|analgesics|mesh-ancestor
110055315|NCT01497288|Sensory System Agents|sensory system agents|mesh-ancestor
110055316|NCT01497288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110055317|NCT01497288|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110055318|NCT01497288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110055319|NCT01497288|Anesthetics, General|anesthetics, general|mesh-ancestor
110055320|NCT01497288|Anesthetics|anesthetics|mesh-ancestor
110055321|NCT01497327|Sofosbuvir|sofosbuvir|mesh-list
110055322|NCT01497327|Antiviral Agents|antiviral agents|mesh-ancestor
110055323|NCT01497327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110055324|NCT01497431|Selenium|selenium|mesh-list
110055325|NCT01497431|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
110055326|NCT01497431|Antioxidants|antioxidants|mesh-ancestor
110055327|NCT01497431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110055328|NCT01497431|Protective Agents|protective agents|mesh-ancestor
110055329|NCT01497431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055330|NCT01497431|Trace Elements|trace elements|mesh-ancestor
110055331|NCT01497431|Micronutrients|micronutrients|mesh-ancestor
110055334|NCT01497444|Sorafenib|sorafenib|mesh-list
110055335|NCT01497444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110055336|NCT01497444|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110055337|NCT01497444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110055338|NCT01497444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110055339|NCT01497470|Paclitaxel|paclitaxel|mesh-list
110055340|NCT01497470|Carboplatin|carboplatin|mesh-list
110055341|NCT01497470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110055342|NCT01497470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110055343|NCT01497470|Tubulin Modulators|tubulin modulators|mesh-ancestor
110055344|NCT01497470|Antimitotic Agents|antimitotic agents|mesh-ancestor
110055345|NCT01497470|Mitosis Modulators|mitosis modulators|mesh-ancestor
110055346|NCT01497470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110055347|NCT01497483|Cyclosporine|cyclosporine|mesh-list
110055348|NCT01497483|Pravastatin|pravastatin|mesh-list
110055349|NCT01497483|Cyclosporins|cyclosporins|mesh-list
110055350|NCT01497483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110055351|NCT01497483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110055352|NCT01497483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110055353|NCT01497483|Immunologic Factors|immunologic factors|mesh-ancestor
110055354|NCT01497483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055355|NCT01497483|Antifungal Agents|antifungal agents|mesh-ancestor
110055356|NCT01497483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110055357|NCT01497483|Dermatologic Agents|dermatologic agents|mesh-ancestor
110055358|NCT01497483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110055359|NCT01497483|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110055360|NCT01497483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110055362|NCT01497483|Antimetabolites|antimetabolites|mesh-ancestor
110055363|NCT01497483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110055364|NCT01497483|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110055365|NCT01497522|Vildagliptin|vildagliptin|mesh-list
110055366|NCT01497522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110055367|NCT01497522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055368|NCT01497522|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110055369|NCT01497522|Protease Inhibitors|protease inhibitors|mesh-ancestor
110055370|NCT01497522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110055371|NCT01497522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110055372|NCT01497535|Insulin|insulin|mesh-list
110055373|NCT01497535|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110055374|NCT01497535|Insulin Glargine|insulin glargine|mesh-list
110055375|NCT01497535|Insulin Detemir|insulin detemir|mesh-list
110055376|NCT01497535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110055377|NCT01497535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055378|NCT01497548|Methylphenidate|methylphenidate|mesh-list
110055379|NCT01497548|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110055380|NCT01497548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055381|NCT01497548|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110055382|NCT01497548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110055383|NCT01497548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110055384|NCT01497548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110055385|NCT01497548|Dopamine Agents|dopamine agents|mesh-ancestor
110055386|NCT01497548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110055388|NCT01497561|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110055389|NCT01497561|Insulin Detemir|insulin detemir|mesh-list
110055390|NCT01497561|Isophane Insulin, Human|isophane insulin, human|mesh-list
110055391|NCT01497561|Insulin, Isophane|insulin, isophane|mesh-list
110055394|NCT01497561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055395|NCT01497574|Insulin|insulin|mesh-list
110055396|NCT01497574|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110055397|NCT01497574|Insulin Glargine|insulin glargine|mesh-list
110055398|NCT01497574|Insulin Detemir|insulin detemir|mesh-list
110055399|NCT01497574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110055400|NCT01497574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055401|NCT01497587|Insulin Detemir|insulin detemir|mesh-list
110055402|NCT01497587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110055403|NCT01497587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055404|NCT01497600|Insulin|insulin|mesh-list
110055405|NCT01497600|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110055406|NCT01497600|Insulin Detemir|insulin detemir|mesh-list
110055407|NCT01497600|Isophane Insulin, Human|isophane insulin, human|mesh-list
110055409|NCT01497600|Isophane insulin, beef|isophane insulin, beef|mesh-list
110055410|NCT01497600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110055411|NCT01497600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055412|NCT01497626|Bortezomib|bortezomib|mesh-list
110055413|NCT01497626|Lapatinib|lapatinib|mesh-list
110055414|NCT01497626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110055415|NCT01497626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110055417|NCT01497626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110055418|NCT01497652|Rasagiline|rasagiline|mesh-list
110055419|NCT01497652|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110055420|NCT01497652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110055421|NCT01497652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110055422|NCT01497652|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110055423|NCT01497652|Protective Agents|protective agents|mesh-ancestor
110055424|NCT01497652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055426|NCT01497717|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110055427|NCT01497717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110055428|NCT01497717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110055429|NCT01497873|Topotecan|topotecan|mesh-list
110055431|NCT01497873|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110055432|NCT01497873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110055433|NCT01497873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110055434|NCT01497873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110055435|NCT01497873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110055436|NCT01497912|Atorvastatin|atorvastatin|mesh-list
110055437|NCT01497912|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110055438|NCT01497912|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110055439|NCT01497912|Antimetabolites|antimetabolites|mesh-ancestor
110055440|NCT01497912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110055441|NCT01497912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110055442|NCT01497912|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110055443|NCT01497912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110055444|NCT01497977|Phytoestrogens|phytoestrogens|mesh-list
110055445|NCT01497977|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110055446|NCT01497977|Estrogens|estrogens|mesh-ancestor
110055447|NCT01497977|Hormones|hormones|mesh-ancestor
110055448|NCT01497977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110055449|NCT01497977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055450|NCT01497990|Ertapenem|ertapenem|mesh-list
110055451|NCT01497990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110055452|NCT01497990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110055453|NCT01498003|Tirofiban|tirofiban|mesh-list
110055454|NCT01498003|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110055455|NCT01498003|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110055456|NCT01498003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110055457|NCT01498003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110055458|NCT01498016|Busulfan|busulfan|mesh-list
110055459|NCT01498016|Alkylating Agents|alkylating agents|mesh-ancestor
110055460|NCT01498016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110055461|NCT01498016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110055462|NCT01498016|Immunologic Factors|immunologic factors|mesh-ancestor
110055463|NCT01498016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055464|NCT01498016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110055465|NCT01498016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110055466|NCT01498016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110055467|NCT01498081|Tiotropium Bromide|tiotropium bromide|mesh-list
110055468|NCT01498081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110055469|NCT01498081|Autonomic Agents|autonomic agents|mesh-ancestor
110055470|NCT01498081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110055471|NCT01498081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055472|NCT01498081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110055473|NCT01498081|Respiratory System Agents|respiratory system agents|mesh-ancestor
110055474|NCT01498081|Parasympatholytics|parasympatholytics|mesh-ancestor
110055475|NCT01498081|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110055476|NCT01498081|Cholinergic Agents|cholinergic agents|mesh-ancestor
110055477|NCT01498081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110055478|NCT01498081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110055479|NCT01498380|Dexmedetomidine|dexmedetomidine|mesh-list
110055480|NCT01498380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110055481|NCT01498380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110055482|NCT01498380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055483|NCT01498380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110055485|NCT01498380|Sensory System Agents|sensory system agents|mesh-ancestor
110055486|NCT01498380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110055487|NCT01498380|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110055488|NCT01498380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110055489|NCT01498380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110055490|NCT01498380|Adrenergic Agents|adrenergic agents|mesh-ancestor
110055491|NCT01498380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110055492|NCT01498380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110055494|NCT01498406|Ergocalciferols|ergocalciferols|mesh-list
110055495|NCT01498406|Cholecalciferol|cholecalciferol|mesh-list
110055496|NCT01498406|Vitamins|vitamins|mesh-list
110055497|NCT01498406|Micronutrients|micronutrients|mesh-ancestor
110055498|NCT01498406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055499|NCT01498406|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110055500|NCT01498406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110055501|NCT01498523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110055502|NCT01498562|Gefitinib|gefitinib|mesh-list
110055503|NCT01498562|Nimotuzumab|nimotuzumab|mesh-list
110055504|NCT01498562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110055505|NCT01498562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110055506|NCT01498562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110055507|NCT01498562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110055508|NCT01498562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110055509|NCT01498718|Vaccines|vaccines|mesh-list
110055510|NCT01498718|Immunologic Factors|immunologic factors|mesh-ancestor
110055511|NCT01498718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055512|NCT01498783|Fluorouracil|fluorouracil|mesh-list
110055513|NCT01498783|Antimetabolites|antimetabolites|mesh-ancestor
110055514|NCT01498783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110055515|NCT01498783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110055516|NCT01498783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110055517|NCT01498783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110055518|NCT01498783|Immunologic Factors|immunologic factors|mesh-ancestor
110055519|NCT01498783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055520|NCT01498796|Ketorolac|ketorolac|mesh-list
110055521|NCT01498796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110055522|NCT01498796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110055523|NCT01498796|Analgesics|analgesics|mesh-ancestor
110055524|NCT01498796|Sensory System Agents|sensory system agents|mesh-ancestor
110055525|NCT01498796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110055526|NCT01498796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055529|NCT01498796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110055530|NCT01498796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110055531|NCT01498796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110055532|NCT01498809|Midodrine|midodrine|mesh-list
110055533|NCT01498809|Sympathomimetics|sympathomimetics|mesh-ancestor
110055534|NCT01498809|Autonomic Agents|autonomic agents|mesh-ancestor
110055535|NCT01498809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110055536|NCT01498809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055537|NCT01498809|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110055538|NCT01498809|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110055539|NCT01498809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110055540|NCT01498809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110055541|NCT01498809|Adrenergic Agents|adrenergic agents|mesh-ancestor
110055542|NCT01498809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110055543|NCT01498809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110055544|NCT01498835|Sunitinib|sunitinib|mesh-list
110055545|NCT01498835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110055546|NCT01498835|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110055547|NCT01498835|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110055548|NCT01498835|Growth Substances|growth substances|mesh-ancestor
110055549|NCT01498835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055550|NCT01498835|Growth Inhibitors|growth inhibitors|mesh-ancestor
110055551|NCT01498835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110055552|NCT01498835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110055553|NCT01498835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110055554|NCT01498861|Dolutegravir|dolutegravir|mesh-list
110055555|NCT01498861|Moxifloxacin|moxifloxacin|mesh-list
110055556|NCT01498861|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110055557|NCT01498861|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110055558|NCT01498861|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110055562|NCT01498861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110055563|NCT01498861|Antiviral Agents|antiviral agents|mesh-ancestor
110055564|NCT01498861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110055565|NCT01498861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110055566|NCT01498861|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110055567|NCT01498861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110055568|NCT01498861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110055569|NCT01498861|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110055570|NCT01498861|Contraceptive Agents|contraceptive agents|mesh-ancestor
110055571|NCT01498861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110055572|NCT01498861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055573|NCT01498861|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110055574|NCT01498861|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110055575|NCT01498861|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110055577|NCT01498900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110055578|NCT01498900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055579|NCT01498913|Repaglinide|repaglinide|mesh-list
110055580|NCT01498913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110055581|NCT01498913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055582|NCT01498926|Insulin|insulin|mesh-list
110055583|NCT01498926|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110055584|NCT01498926|Insulin Detemir|insulin detemir|mesh-list
110055585|NCT01498926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110055586|NCT01498926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055587|NCT01498939|Insulin Detemir|insulin detemir|mesh-list
110055588|NCT01498939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110055590|NCT01499004|Tofacitinib|tofacitinib|mesh-list
110055591|NCT01499004|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110055592|NCT01499004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110055593|NCT01499004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110055594|NCT01499004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110055596|NCT01499069|Fesoterodine|fesoterodine|mesh-list
110055597|NCT01499069|Propiverine|propiverine|mesh-list
110055598|NCT01499069|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110055599|NCT01499069|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110055600|NCT01499069|Cholinergic Agents|cholinergic agents|mesh-ancestor
110055601|NCT01499069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110055602|NCT01499069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110055603|NCT01499069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055604|NCT01499069|Urological Agents|urological agents|mesh-ancestor
110055605|NCT01499069|Parasympatholytics|parasympatholytics|mesh-ancestor
110055606|NCT01499069|Autonomic Agents|autonomic agents|mesh-ancestor
110055607|NCT01499069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110055608|NCT01499108|Liraglutide|liraglutide|mesh-list
110055609|NCT01499108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110055610|NCT01499108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055611|NCT01499108|Incretins|incretins|mesh-ancestor
110055612|NCT01499108|Hormones|hormones|mesh-ancestor
110055613|NCT01499108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110055614|NCT01499121|Sunitinib|sunitinib|mesh-list
110055615|NCT01499121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110055616|NCT01499121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110055617|NCT01499121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110055618|NCT01499121|Growth Substances|growth substances|mesh-ancestor
110055619|NCT01499121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055620|NCT01499121|Growth Inhibitors|growth inhibitors|mesh-ancestor
110055621|NCT01499121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110055622|NCT01499121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110055623|NCT01499121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110055624|NCT01499225|Doxycycline|doxycycline|mesh-list
110055625|NCT01499225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110055626|NCT01499225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110055627|NCT01499225|Antimalarials|antimalarials|mesh-ancestor
110055628|NCT01499225|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110055629|NCT01499225|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110055630|NCT01499251|Temozolomide|temozolomide|mesh-list
110055631|NCT01499251|Macitentan|macitentan|mesh-list
110055632|NCT01499251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110055633|NCT01499251|Alkylating Agents|alkylating agents|mesh-ancestor
110055634|NCT01499251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110055635|NCT01499251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110055638|NCT01499251|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
110055640|NCT01499407|Anticoagulants|anticoagulants|mesh-ancestor
110055641|NCT01499407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110055642|NCT01499433|Caspofungin|caspofungin|mesh-list
110055643|NCT01499433|Antifungal Agents|antifungal agents|mesh-ancestor
110055644|NCT01499433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110055645|NCT01499433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110055646|NCT01499433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110055647|NCT01499446|Fluticasone|fluticasone|mesh-list
110055648|NCT01499446|Xhance|xhance|mesh-list
110055649|NCT01499446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110055650|NCT01499446|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110055651|NCT01499446|Autonomic Agents|autonomic agents|mesh-ancestor
110055652|NCT01499446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110055653|NCT01499446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055654|NCT01499446|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110055655|NCT01499446|Respiratory System Agents|respiratory system agents|mesh-ancestor
110055656|NCT01499446|Dermatologic Agents|dermatologic agents|mesh-ancestor
110055657|NCT01499446|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110055659|NCT01499485|Anticonvulsants|anticonvulsants|mesh-ancestor
110055660|NCT01499485|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110055661|NCT01499485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110055662|NCT01499485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110055663|NCT01499485|Diuretics|diuretics|mesh-ancestor
110055664|NCT01499485|Natriuretic Agents|natriuretic agents|mesh-ancestor
110055665|NCT01499485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055666|NCT01499589|Anesthetics|anesthetics|mesh-list
110055667|NCT01499589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110055668|NCT01499589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055670|NCT01499602|Norethindrone Acetate|norethindrone acetate|mesh-list
110055671|NCT01499602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110055672|NCT01499602|Contraceptive Agents|contraceptive agents|mesh-ancestor
110055673|NCT01499602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110055674|NCT01499602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055675|NCT01499602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110055676|NCT01499602|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110055677|NCT01499602|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110055678|NCT01499602|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110055679|NCT01499641|Methylprednisolone|methylprednisolone|mesh-list
110055680|NCT01499641|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110055681|NCT01499641|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110055682|NCT01499641|Prednisolone|prednisolone|mesh-list
110055683|NCT01499641|Prednisolone acetate|prednisolone acetate|mesh-list
110055684|NCT01499641|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110055685|NCT01499641|Prednisolone phosphate|prednisolone phosphate|mesh-list
110055686|NCT01499641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110055687|NCT01499641|Antiemetics|antiemetics|mesh-ancestor
110055688|NCT01499641|Autonomic Agents|autonomic agents|mesh-ancestor
110055689|NCT01499641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110055690|NCT01499641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055691|NCT01499641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110055692|NCT01499641|Glucocorticoids|glucocorticoids|mesh-ancestor
110055693|NCT01499641|Hormones|hormones|mesh-ancestor
110055694|NCT01499641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110055695|NCT01499641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110055696|NCT01499641|Protective Agents|protective agents|mesh-ancestor
110055697|NCT01499641|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110055698|NCT01499641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110055699|NCT01499693|Pantoprazole|pantoprazole|mesh-list
110055700|NCT01499693|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110055701|NCT01499693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110055702|NCT01499693|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110055703|NCT01499693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110055704|NCT01499693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110055705|NCT01499758|Atorvastatin|atorvastatin|mesh-list
110055706|NCT01499758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110055707|NCT01499758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110055708|NCT01499758|Antimetabolites|antimetabolites|mesh-ancestor
110055709|NCT01499758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110055710|NCT01499758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110055711|NCT01499758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110055712|NCT01499758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110055713|NCT01499771|Atorvastatin|atorvastatin|mesh-list
110055714|NCT01499771|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110055715|NCT01499771|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110055716|NCT01499771|Antimetabolites|antimetabolites|mesh-ancestor
110055717|NCT01499771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110055718|NCT01499771|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110055719|NCT01499771|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110055720|NCT01499771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110055721|NCT01499875|Penicillin V|penicillin v|mesh-list
110055722|NCT01499875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110055723|NCT01499875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110055725|NCT01500005|Vitamins|vitamins|mesh-ancestor
110055726|NCT01500005|Micronutrients|micronutrients|mesh-ancestor
110055727|NCT01500005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055728|NCT01500005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110055729|NCT01500018|Phentermine|phentermine|mesh-list
110055730|NCT01500018|Ketamine|ketamine|mesh-list
110055731|NCT01500018|Analgesics|analgesics|mesh-ancestor
110055732|NCT01500018|Sensory System Agents|sensory system agents|mesh-ancestor
110055733|NCT01500018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110055734|NCT01500018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055735|NCT01500018|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110055736|NCT01500018|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110055737|NCT01500018|Anesthetics, General|anesthetics, general|mesh-ancestor
110055738|NCT01500018|Anesthetics|anesthetics|mesh-ancestor
110055739|NCT01500018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110055740|NCT01500018|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110055741|NCT01500018|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110055742|NCT01500018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110055743|NCT01500018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110055744|NCT01500018|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110055745|NCT01500018|Appetite Depressants|appetite depressants|mesh-ancestor
110055746|NCT01500018|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110055747|NCT01500018|Sympathomimetics|sympathomimetics|mesh-ancestor
110055748|NCT01500018|Autonomic Agents|autonomic agents|mesh-ancestor
110055749|NCT01500018|Adrenergic Agents|adrenergic agents|mesh-ancestor
110055750|NCT01500070|Everolimus|everolimus|mesh-list
110055751|NCT01500070|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110055753|NCT01500070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110055754|NCT01500070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110055755|NCT01500070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110055756|NCT01500070|Immunologic Factors|immunologic factors|mesh-ancestor
110055757|NCT01500070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055758|NCT01500070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110055759|NCT01500161|Cytarabine|cytarabine|mesh-list
110055760|NCT01500161|Fludarabine|fludarabine|mesh-list
110055761|NCT01500161|Etoposide|etoposide|mesh-list
110055762|NCT01500161|Melphalan|melphalan|mesh-list
110055763|NCT01500161|Busulfan|busulfan|mesh-list
110055764|NCT01500161|Carmustine|carmustine|mesh-list
110055765|NCT01500161|Clofarabine|clofarabine|mesh-list
110055766|NCT01500161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110055767|NCT01500161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110055768|NCT01500161|Antimetabolites|antimetabolites|mesh-ancestor
110055769|NCT01500161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110055770|NCT01500161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110055771|NCT01500161|Immunologic Factors|immunologic factors|mesh-ancestor
110055772|NCT01500161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055773|NCT01500161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110055774|NCT01500161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110055775|NCT01500161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110055776|NCT01500161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110055777|NCT01500161|Antiviral Agents|antiviral agents|mesh-ancestor
110055778|NCT01500161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110055779|NCT01500161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110055780|NCT01500161|Alkylating Agents|alkylating agents|mesh-ancestor
110055781|NCT01500161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110055782|NCT01500408|Interferons|interferons|mesh-list
110055783|NCT01500408|Interferon-beta|interferon-beta|mesh-list
110055784|NCT01500408|Interferon beta-1a|interferon beta-1a|mesh-list
110055785|NCT01500408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110055786|NCT01500408|Antiviral Agents|antiviral agents|mesh-ancestor
110055787|NCT01500408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110055788|NCT01500408|Immunologic Factors|immunologic factors|mesh-ancestor
110055789|NCT01500408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055790|NCT01500408|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110055808|NCT01500577|Nimesulide|nimesulide|mesh-list
110055809|NCT01500577|Simvastatin|simvastatin|mesh-list
110055810|NCT01500577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110055811|NCT01500577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110055812|NCT01500577|Antimetabolites|antimetabolites|mesh-ancestor
110055813|NCT01500577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110055814|NCT01500577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110055815|NCT01500577|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110055816|NCT01500577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110055817|NCT01500577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110055819|NCT01500577|Analgesics|analgesics|mesh-ancestor
110055820|NCT01500577|Sensory System Agents|sensory system agents|mesh-ancestor
110055821|NCT01500577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110055822|NCT01500577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055823|NCT01500577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110055824|NCT01500577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110055825|NCT01500577|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110055826|NCT01500590|Ramipril|ramipril|mesh-list
110055827|NCT01500590|Irbesartan|irbesartan|mesh-list
110055828|NCT01500590|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110055829|NCT01500590|Protease Inhibitors|protease inhibitors|mesh-ancestor
110055830|NCT01500590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110055831|NCT01500590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110055832|NCT01500590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110055833|NCT01500590|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110055834|NCT01500590|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110055835|NCT01500785|Vitamin B 12|vitamin b 12|mesh-list
110055836|NCT01500785|Hydroxocobalamin|hydroxocobalamin|mesh-list
110055837|NCT01500785|Simendan|simendan|mesh-list
110055838|NCT01500785|Vitamins|vitamins|mesh-ancestor
110055839|NCT01500785|Micronutrients|micronutrients|mesh-ancestor
110055840|NCT01500785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055841|NCT01500785|Vitamin B Complex|vitamin b complex|mesh-ancestor
110055842|NCT01500785|Hematinics|hematinics|mesh-ancestor
110055843|NCT01500785|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110055844|NCT01500785|Vasodilator Agents|vasodilator agents|mesh-ancestor
110055845|NCT01500785|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110055846|NCT01500785|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110055847|NCT01500785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110055848|NCT01500785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110055849|NCT01500785|Protective Agents|protective agents|mesh-ancestor
110055850|NCT01500824|Crizotinib|crizotinib|mesh-list
110055851|NCT01500824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110055852|NCT01500824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110055853|NCT01500824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110055854|NCT01500824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110055855|NCT01500837|Levofloxacin|levofloxacin|mesh-list
110055856|NCT01500837|Ofloxacin|ofloxacin|mesh-list
110055857|NCT01500837|Rifampin|rifampin|mesh-list
110055858|NCT01500837|Clindamycin|clindamycin|mesh-list
110055859|NCT01500837|Clindamycin palmitate|clindamycin palmitate|mesh-list
110055860|NCT01500837|Clindamycin phosphate|clindamycin phosphate|mesh-list
110055861|NCT01500837|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110055862|NCT01500837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110055863|NCT01500837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110055864|NCT01500837|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110055865|NCT01500837|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110055866|NCT01500837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110055867|NCT01500837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110055868|NCT01500837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110055869|NCT01500837|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110055870|NCT01500837|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110055871|NCT01500837|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110055872|NCT01500837|Antitubercular Agents|antitubercular agents|mesh-ancestor
110055873|NCT01500837|Leprostatic Agents|leprostatic agents|mesh-ancestor
110055874|NCT01500837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110055875|NCT01500837|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110055876|NCT01500837|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110055877|NCT01500837|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110055878|NCT01500837|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110055879|NCT01500837|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110055880|NCT01500837|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110055881|NCT01500837|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110055882|NCT01500850|Insulin|insulin|mesh-list
110055883|NCT01500850|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110055884|NCT01500850|Insulin Glargine|insulin glargine|mesh-list
110055885|NCT01500850|Insulin glulisine|insulin glulisine|mesh-list
110055886|NCT01500850|Insulin, Isophane|insulin, isophane|mesh-list
110055887|NCT01500850|Isophane Insulin, Human|isophane insulin, human|mesh-list
110055888|NCT01500850|Isophane insulin, beef|isophane insulin, beef|mesh-list
110055889|NCT01500850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110055890|NCT01500850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055891|NCT01500863|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110055892|NCT01500863|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110055893|NCT01500863|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110055894|NCT01500863|Estradiol|estradiol|mesh-list
110055895|NCT01500863|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110055896|NCT01500863|Progesterone|progesterone|mesh-list
110055897|NCT01500863|Estrogens|estrogens|mesh-ancestor
110055898|NCT01500863|Hormones|hormones|mesh-ancestor
110055899|NCT01500863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110055900|NCT01500863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055901|NCT01500863|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110055902|NCT01500863|Contraceptive Agents|contraceptive agents|mesh-ancestor
110055903|NCT01500863|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110055904|NCT01500863|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110055905|NCT01500863|Progestins|progestins|mesh-ancestor
110055906|NCT01500863|Luteolytic Agents|luteolytic agents|mesh-ancestor
110055907|NCT01500863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110055908|NCT01500863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110055909|NCT01500915|Ranibizumab|ranibizumab|mesh-list
110055910|NCT01500915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110055911|NCT01500915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110055912|NCT01500915|Growth Substances|growth substances|mesh-ancestor
110055913|NCT01500915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055914|NCT01500915|Growth Inhibitors|growth inhibitors|mesh-ancestor
110055915|NCT01500915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110055916|NCT01500928|Insulin|insulin|mesh-list
110055917|NCT01500928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110055918|NCT01500928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055919|NCT01500980|Chloroquine|chloroquine|mesh-list
110055920|NCT01500980|Primaquine|primaquine|mesh-list
110055921|NCT01500980|Amebicides|amebicides|mesh-ancestor
110055922|NCT01500980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110055923|NCT01500980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110055924|NCT01500980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110055925|NCT01500980|Antimalarials|antimalarials|mesh-ancestor
110055926|NCT01500980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110055927|NCT01500993|Fluorouracil|fluorouracil|mesh-list
110055928|NCT01500993|Capecitabine|capecitabine|mesh-list
110055929|NCT01500993|Antimetabolites|antimetabolites|mesh-ancestor
110055930|NCT01500993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110055931|NCT01500993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110055932|NCT01500993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110055933|NCT01500993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110055934|NCT01500993|Immunologic Factors|immunologic factors|mesh-ancestor
110055935|NCT01500993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055936|NCT01501032|Pancrelipase|pancrelipase|mesh-list
110055937|NCT01501032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110055938|NCT01501084|Exenatide|exenatide|mesh-list
110055939|NCT01501084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110055940|NCT01501084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055941|NCT01501084|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110055942|NCT01501084|Incretins|incretins|mesh-ancestor
110055943|NCT01501084|Hormones|hormones|mesh-ancestor
110055944|NCT01501084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110055945|NCT01501123|Midazolam|midazolam|mesh-list
110055946|NCT01501123|Haloperidol|haloperidol|mesh-list
110055947|NCT01501123|Haloperidol decanoate|haloperidol decanoate|mesh-list
110055948|NCT01501123|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110055949|NCT01501123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110055950|NCT01501123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110055951|NCT01501123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055952|NCT01501123|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110055953|NCT01501123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110055954|NCT01501123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110055955|NCT01501123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110055956|NCT01501123|Anesthetics, General|anesthetics, general|mesh-ancestor
110055957|NCT01501123|Anesthetics|anesthetics|mesh-ancestor
110055958|NCT01501123|GABA Modulators|gaba modulators|mesh-ancestor
110055959|NCT01501123|GABA Agents|gaba agents|mesh-ancestor
110055960|NCT01501123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110055961|NCT01501123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110055962|NCT01501123|Antiemetics|antiemetics|mesh-ancestor
110055963|NCT01501123|Autonomic Agents|autonomic agents|mesh-ancestor
110055964|NCT01501123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110055965|NCT01501123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110055966|NCT01501123|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110055967|NCT01501123|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110055968|NCT01501123|Dopamine Agents|dopamine agents|mesh-ancestor
110055969|NCT01501123|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110055971|NCT01501136|Dexamethasone acetate|dexamethasone acetate|mesh-list
110055973|NCT01501136|Gemcitabine|gemcitabine|mesh-list
110055974|NCT01501136|Etoposide|etoposide|mesh-list
110055975|NCT01501136|Etoposide phosphate|etoposide phosphate|mesh-list
110055976|NCT01501136|Ifosfamide|ifosfamide|mesh-list
110055977|NCT01501136|Isophosphamide mustard|isophosphamide mustard|mesh-list
110055978|NCT01501136|Pegaspargase|pegaspargase|mesh-list
110055979|NCT01501136|Asparaginase|asparaginase|mesh-list
110055980|NCT01501136|BB 1101|bb 1101|mesh-list
110055982|NCT01501136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110055983|NCT01501136|Antiemetics|antiemetics|mesh-ancestor
110055984|NCT01501136|Autonomic Agents|autonomic agents|mesh-ancestor
110055985|NCT01501136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110055986|NCT01501136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110055987|NCT01501136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110055988|NCT01501136|Glucocorticoids|glucocorticoids|mesh-ancestor
110055989|NCT01501136|Hormones|hormones|mesh-ancestor
110055990|NCT01501136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110055991|NCT01501136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110055992|NCT01501136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110055993|NCT01501136|Protease Inhibitors|protease inhibitors|mesh-ancestor
110055994|NCT01501136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110055995|NCT01501136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110055996|NCT01501136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110055997|NCT01501136|Antimetabolites|antimetabolites|mesh-ancestor
110055998|NCT01501136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110055999|NCT01501136|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110056000|NCT01501136|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110056001|NCT01501136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110056002|NCT01501136|Alkylating Agents|alkylating agents|mesh-ancestor
110056003|NCT01501136|Protective Agents|protective agents|mesh-ancestor
110056004|NCT01501149|Dexamethasone|dexamethasone|mesh-list
110056005|NCT01501149|Gemcitabine|gemcitabine|mesh-list
110056006|NCT01501149|Etoposide|etoposide|mesh-list
110056007|NCT01501149|Pegaspargase|pegaspargase|mesh-list
110056008|NCT01501149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110056009|NCT01501149|Antiemetics|antiemetics|mesh-ancestor
110056010|NCT01501149|Autonomic Agents|autonomic agents|mesh-ancestor
110056011|NCT01501149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110056012|NCT01501149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110056013|NCT01501149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110056014|NCT01501149|Glucocorticoids|glucocorticoids|mesh-ancestor
110056015|NCT01501149|Hormones|hormones|mesh-ancestor
110056016|NCT01501149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110056017|NCT01501149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110056018|NCT01501149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110056019|NCT01501149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110056021|NCT01501149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110056022|NCT01501149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110056023|NCT01501149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110056024|NCT01501149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110056025|NCT01501149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110056026|NCT01501214|Atosiban|atosiban|mesh-list
110056028|NCT01501214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110056029|NCT01501214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110056030|NCT01501214|Tocolytic Agents|tocolytic agents|mesh-ancestor
110056031|NCT01501214|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110056032|NCT01501253|Amlodipine|amlodipine|mesh-list
110056033|NCT01501253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110056034|NCT01501253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110056035|NCT01501253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110056036|NCT01501253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110056037|NCT01501253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110056038|NCT01501253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110056039|NCT01501253|Vasodilator Agents|vasodilator agents|mesh-ancestor
110056040|NCT01501344|Calcium|calcium|mesh-list
110056041|NCT01501344|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110056042|NCT01501344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110056043|NCT01501370|Dexamethasone|dexamethasone|mesh-list
110056044|NCT01501370|Dexamethasone acetate|dexamethasone acetate|mesh-list
110056045|NCT01501370|Lenalidomide|lenalidomide|mesh-list
110056046|NCT01501370|Vorinostat|vorinostat|mesh-list
110056047|NCT01501370|BB 1101|bb 1101|mesh-list
110056048|NCT01501370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110056049|NCT01501370|Antiemetics|antiemetics|mesh-ancestor
110056050|NCT01501370|Autonomic Agents|autonomic agents|mesh-ancestor
110056051|NCT01501370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110056052|NCT01501370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110056053|NCT01501370|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110056054|NCT01501370|Glucocorticoids|glucocorticoids|mesh-ancestor
110056055|NCT01501370|Hormones|hormones|mesh-ancestor
110056056|NCT01501370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110056057|NCT01501370|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110056058|NCT01501370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110056059|NCT01501370|Protease Inhibitors|protease inhibitors|mesh-ancestor
110056060|NCT01501370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110056061|NCT01501370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110056062|NCT01501370|Immunologic Factors|immunologic factors|mesh-ancestor
110056063|NCT01501370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110056064|NCT01501370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110056065|NCT01501370|Growth Substances|growth substances|mesh-ancestor
110056066|NCT01501370|Growth Inhibitors|growth inhibitors|mesh-ancestor
110056067|NCT01501370|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110056068|NCT01501396|Megestrol|megestrol|mesh-list
110056069|NCT01501396|Megestrol Acetate|megestrol acetate|mesh-list
110056070|NCT01501396|Mirtazapine|mirtazapine|mesh-list
110056071|NCT01501396|Antidepressive Agents|antidepressive agents|mesh-ancestor
110056072|NCT01501396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110056073|NCT01501396|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110056074|NCT01501396|Histamine Antagonists|histamine antagonists|mesh-ancestor
110056075|NCT01501396|Histamine Agents|histamine agents|mesh-ancestor
110056076|NCT01501396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110056078|NCT01501396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110056079|NCT01501396|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110056080|NCT01501396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110056081|NCT01501396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110056082|NCT01501396|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110056083|NCT01501396|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110056084|NCT01501396|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110056085|NCT01501396|Adrenergic Agents|adrenergic agents|mesh-ancestor
110056086|NCT01501396|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110056087|NCT01501396|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110056088|NCT01501396|Serotonin Agents|serotonin agents|mesh-ancestor
110056090|NCT01501396|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110056091|NCT01501396|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110056092|NCT01501396|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110056093|NCT01501396|Contraceptive Agents|contraceptive agents|mesh-ancestor
110056094|NCT01501396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110056095|NCT01501396|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110056096|NCT01501396|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110056097|NCT01501396|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110056098|NCT01501396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110056099|NCT01501396|Appetite Stimulants|appetite stimulants|mesh-ancestor
110056100|NCT01501396|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110056101|NCT01501422|Estrogens|estrogens|mesh-list
110056102|NCT01501422|Hormones|hormones|mesh-ancestor
110056103|NCT01501422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110056104|NCT01501422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110056105|NCT01501435|Fenofibric acid|fenofibric acid|mesh-list
110056106|NCT01501435|Fenofibrate|fenofibrate|mesh-list
110056107|NCT01501435|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110056108|NCT01501435|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110056109|NCT01501435|Antimetabolites|antimetabolites|mesh-ancestor
110056111|NCT01501435|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110056112|NCT01501448|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110056113|NCT01501448|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110056114|NCT01501448|Levonorgestrel|levonorgestrel|mesh-list
110056115|NCT01501448|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110056116|NCT01501448|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
110056117|NCT01501448|Estradiol|estradiol|mesh-list
110056118|NCT01501448|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110056119|NCT01501448|Estrogens|estrogens|mesh-ancestor
110056120|NCT01501448|Hormones|hormones|mesh-ancestor
110056121|NCT01501448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110056122|NCT01501448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110056123|NCT01501448|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110056124|NCT01501448|Contraceptive Agents|contraceptive agents|mesh-ancestor
110056125|NCT01501448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110056126|NCT01501448|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110056127|NCT01501448|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110056128|NCT01501448|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110056129|NCT01501448|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110056130|NCT01501448|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110056131|NCT01501487|Paclitaxel|paclitaxel|mesh-list
110056132|NCT01501487|Docetaxel|docetaxel|mesh-list
110056133|NCT01501487|Trastuzumab|trastuzumab|mesh-list
110056134|NCT01501487|Pertuzumab|pertuzumab|mesh-list
110056135|NCT01501487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110056136|NCT01501487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110056137|NCT01501487|Tubulin Modulators|tubulin modulators|mesh-ancestor
110056138|NCT01501487|Antimitotic Agents|antimitotic agents|mesh-ancestor
110056139|NCT01501487|Mitosis Modulators|mitosis modulators|mesh-ancestor
110056140|NCT01501487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110056141|NCT01501487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110056142|NCT01501500|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110056143|NCT01501500|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110056144|NCT01501500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110056145|NCT01501500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110056146|NCT01501500|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110056147|NCT01501500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110056148|NCT01501500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110056149|NCT01501500|Cholinergic Agents|cholinergic agents|mesh-ancestor
110056150|NCT01501500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110056151|NCT01501591|Hydroxyzine|hydroxyzine|mesh-list
110056152|NCT01501591|Antipruritics|antipruritics|mesh-ancestor
110056153|NCT01501591|Dermatologic Agents|dermatologic agents|mesh-ancestor
110056154|NCT01501591|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110056155|NCT01501591|Histamine Antagonists|histamine antagonists|mesh-ancestor
110056156|NCT01501591|Histamine Agents|histamine agents|mesh-ancestor
110056157|NCT01501591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110056158|NCT01501591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110056159|NCT01501591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110056160|NCT01501669|Capecitabine|capecitabine|mesh-list
110056161|NCT01501669|Irinotecan|irinotecan|mesh-list
110056162|NCT01501669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110056163|NCT01501669|Antimetabolites|antimetabolites|mesh-ancestor
110056164|NCT01501669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110056165|NCT01501669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110056166|NCT01501669|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110056167|NCT01501669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110056168|NCT01501669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110056169|NCT01501695|Tiapride Hydrochloride|tiapride hydrochloride|mesh-list
110056170|NCT01501695|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110056171|NCT01501695|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110056172|NCT01501695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110056173|NCT01501695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110056174|NCT01501695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110056175|NCT01501695|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110056176|NCT01501695|Dopamine Agents|dopamine agents|mesh-ancestor
110056177|NCT01501695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110056178|NCT01501695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110056179|NCT01501708|Voriconazole|voriconazole|mesh-list
110056180|NCT01501708|Amphotericin B|amphotericin b|mesh-list
110056181|NCT01501708|Caspofungin|caspofungin|mesh-list
110056182|NCT01501708|Antifungal Agents|antifungal agents|mesh-ancestor
110056185|NCT01501708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110056186|NCT01501708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110056187|NCT01501708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110056188|NCT01501708|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110056190|NCT01501708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110056191|NCT01501708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110056192|NCT01501708|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110056194|NCT01501708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110056195|NCT01501708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110056196|NCT01501708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110056197|NCT01501747|Acetaminophen|acetaminophen|mesh-list
110056198|NCT01501747|Cephalexin|cephalexin|mesh-list
110056199|NCT01501747|Ibuprofen|ibuprofen|mesh-list
110056200|NCT01501747|Caffeine|caffeine|mesh-list
110056201|NCT01501747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110056202|NCT01501747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110056203|NCT01501747|Analgesics|analgesics|mesh-ancestor
110056206|NCT01501747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110056207|NCT01501747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110056208|NCT01501747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110056209|NCT01501747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110056210|NCT01501747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110056211|NCT01501747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110056212|NCT01501747|Antipyretics|antipyretics|mesh-ancestor
110056213|NCT01501747|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110056214|NCT01501747|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110056215|NCT01501747|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110056216|NCT01501747|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110056217|NCT01501747|Purinergic Agents|purinergic agents|mesh-ancestor
110056218|NCT01501747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110056219|NCT01501747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110056220|NCT01501747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110056221|NCT01501760|Bevacizumab|bevacizumab|mesh-list
110056222|NCT01501760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110056223|NCT01501760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110056224|NCT01501760|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110056225|NCT01501760|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110056226|NCT01501760|Growth Substances|growth substances|mesh-ancestor
110056227|NCT01501760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110056228|NCT01501760|Growth Inhibitors|growth inhibitors|mesh-ancestor
110056229|NCT01501786|Ketamine|ketamine|mesh-list
110056230|NCT01501786|Propofol|propofol|mesh-list
110056231|NCT01501786|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110056232|NCT01501786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110056233|NCT01501786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110056234|NCT01501786|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110056235|NCT01501786|Anesthetics, General|anesthetics, general|mesh-ancestor
110056236|NCT01501786|Anesthetics|anesthetics|mesh-ancestor
110056237|NCT01501786|Analgesics|analgesics|mesh-ancestor
110056238|NCT01501786|Sensory System Agents|sensory system agents|mesh-ancestor
110056239|NCT01501786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110056240|NCT01501786|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110056241|NCT01501786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110056242|NCT01501786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110056243|NCT01501786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110056244|NCT01501786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110056245|NCT01501799|Adapalene|adapalene|mesh-list
110056246|NCT01501799|Benzoyl Peroxide|benzoyl peroxide|mesh-list
110056247|NCT01501799|Dermatologic Agents|dermatologic agents|mesh-ancestor
110056248|NCT01501799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110056249|NCT01501799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110056250|NCT01501799|Analgesics|analgesics|mesh-ancestor
110056251|NCT01501799|Sensory System Agents|sensory system agents|mesh-ancestor
110056252|NCT01501799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110056253|NCT01501799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110056254|NCT01501799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110056255|NCT01501799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110056257|NCT01501890|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
110056262|NCT01501890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110056264|NCT01501890|Hormones|hormones|mesh-ancestor
110056265|NCT01501890|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110056266|NCT01501890|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110056267|NCT01501890|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110056268|NCT01501890|Contraceptive Agents|contraceptive agents|mesh-ancestor
110056269|NCT01501890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110056270|NCT01501890|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110056271|NCT01501890|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110056272|NCT01501916|Vitamin D|vitamin d|mesh-list
110056273|NCT01501916|Cholecalciferol|cholecalciferol|mesh-list
110056274|NCT01501916|Vitamins|vitamins|mesh-ancestor
110056275|NCT01501916|Micronutrients|micronutrients|mesh-ancestor
110056276|NCT01501916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110056277|NCT01501916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110056357|NCT01502605|Dermatologic Agents|dermatologic agents|mesh-ancestor
110056278|NCT01501916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110056279|NCT01501942|Glycine|glycine|mesh-list
110056280|NCT01501942|Glycine Agents|glycine agents|mesh-ancestor
110056281|NCT01501942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110056282|NCT01501942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110056283|NCT01501942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110056284|NCT01501968|Ascorbic Acid|ascorbic acid|mesh-list
110056285|NCT01501968|Colistin|colistin|mesh-list
110056286|NCT01501968|Vitamins|vitamins|mesh-ancestor
110056287|NCT01501968|Micronutrients|micronutrients|mesh-ancestor
110056288|NCT01501968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110056289|NCT01501968|Antioxidants|antioxidants|mesh-ancestor
110056290|NCT01501968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110056291|NCT01501968|Protective Agents|protective agents|mesh-ancestor
110056292|NCT01501968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110056293|NCT01501968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110056294|NCT01502020|Imiquimod|imiquimod|mesh-list
110056295|NCT01502020|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110056296|NCT01502020|Immunologic Factors|immunologic factors|mesh-ancestor
110056297|NCT01502020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110056298|NCT01502020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110056299|NCT01502020|Interferon Inducers|interferon inducers|mesh-ancestor
110056300|NCT01502046|Dronabinol|dronabinol|mesh-list
110056301|NCT01502046|Cannabidiol|cannabidiol|mesh-list
110056302|NCT01502046|Anticonvulsants|anticonvulsants|mesh-ancestor
110056303|NCT01502046|Hallucinogens|hallucinogens|mesh-ancestor
110056304|NCT01502046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110056305|NCT01502046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110056306|NCT01502046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110056307|NCT01502046|Analgesics|analgesics|mesh-ancestor
110056308|NCT01502046|Sensory System Agents|sensory system agents|mesh-ancestor
110056309|NCT01502046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110056310|NCT01502046|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110056311|NCT01502046|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110056312|NCT01502046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110056313|NCT01502046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110056314|NCT01502046|Hormones|hormones|mesh-ancestor
110056315|NCT01502046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110056316|NCT01502202|Pemetrexed|pemetrexed|mesh-list
110056317|NCT01502202|Gefitinib|gefitinib|mesh-list
110056318|NCT01502202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110056319|NCT01502202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110056320|NCT01502202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110056321|NCT01502202|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110056322|NCT01502202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110056324|NCT01502241|Temozolomide|temozolomide|mesh-list
110056325|NCT01502241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110056326|NCT01502241|Alkylating Agents|alkylating agents|mesh-ancestor
110056327|NCT01502241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110056328|NCT01502241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110056329|NCT01502267|Bortezomib|bortezomib|mesh-list
110056330|NCT01502267|Rituximab|rituximab|mesh-list
110056331|NCT01502267|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110056332|NCT01502267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110056333|NCT01502267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110056334|NCT01502267|Immunologic Factors|immunologic factors|mesh-ancestor
110056337|NCT01502280|Ascorbic Acid|ascorbic acid|mesh-list
110056338|NCT01502280|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110056339|NCT01502280|Antioxidants|antioxidants|mesh-ancestor
110056340|NCT01502280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110056341|NCT01502280|Protective Agents|protective agents|mesh-ancestor
110056342|NCT01502280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110056343|NCT01502280|Vitamins|vitamins|mesh-ancestor
110056344|NCT01502280|Micronutrients|micronutrients|mesh-ancestor
110056345|NCT01502280|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110056346|NCT01502280|Dermatologic Agents|dermatologic agents|mesh-ancestor
110056347|NCT01502358|Vaccines|vaccines|mesh-list
110056348|NCT01502358|Immunologic Factors|immunologic factors|mesh-ancestor
110056349|NCT01502358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110056350|NCT01502592|Ipilimumab|ipilimumab|mesh-list
110056351|NCT01502592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110056352|NCT01502592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110056353|NCT01502592|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110056354|NCT01502592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110056355|NCT01502605|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110056356|NCT01502605|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110056358|NCT01502696|Interferon alpha-2|interferon alpha-2|mesh-list
110056359|NCT01502696|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110056360|NCT01502696|Antiviral Agents|antiviral agents|mesh-ancestor
110056361|NCT01502696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110056362|NCT01502696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110056363|NCT01502774|Cyclosporine|cyclosporine|mesh-list
110056364|NCT01502774|Cyclosporins|cyclosporins|mesh-list
110056365|NCT01502774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110056366|NCT01502774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110056367|NCT01502774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110056368|NCT01502774|Immunologic Factors|immunologic factors|mesh-ancestor
110056369|NCT01502774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110056370|NCT01502774|Antifungal Agents|antifungal agents|mesh-ancestor
110056371|NCT01502774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110056372|NCT01502774|Dermatologic Agents|dermatologic agents|mesh-ancestor
110056373|NCT01502774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110056374|NCT01502774|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110056375|NCT01502800|Beta-lapachone|beta-lapachone|mesh-list
110056376|NCT01502800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110056377|NCT01502800|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110056378|NCT01502800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110056379|NCT01502800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110056380|NCT01502800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110056383|NCT01502878|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
110056384|NCT01502878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110056385|NCT01502878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110056386|NCT01502904|Sirolimus|sirolimus|mesh-list
110056387|NCT01502904|Pravastatin|pravastatin|mesh-list
110056388|NCT01502904|Pitavastatin|pitavastatin|mesh-list
110056389|NCT01502904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110056390|NCT01502904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110056391|NCT01502904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110056392|NCT01502904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110056393|NCT01502904|Antifungal Agents|antifungal agents|mesh-ancestor
110056394|NCT01502904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110056395|NCT01502904|Immunologic Factors|immunologic factors|mesh-ancestor
110056396|NCT01502904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110056397|NCT01502904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110056398|NCT01502904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110056399|NCT01502904|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110056400|NCT01502904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110056401|NCT01502904|Antimetabolites|antimetabolites|mesh-ancestor
110056402|NCT01502904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110056403|NCT01502904|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110056404|NCT01502943|Atorvastatin|atorvastatin|mesh-list
110056405|NCT01502943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110056406|NCT01502943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110056407|NCT01502943|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110056408|NCT01502943|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110056409|NCT01502943|Antimetabolites|antimetabolites|mesh-ancestor
110056410|NCT01502943|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110056411|NCT01502943|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110056413|NCT01503008|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
110056414|NCT01503008|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110056415|NCT01503008|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
110056416|NCT01503008|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
110056417|NCT01503008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110056418|NCT01503008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110056419|NCT01503008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110056420|NCT01503008|Protease Inhibitors|protease inhibitors|mesh-ancestor
110056422|NCT01503060|Anesthetics, Local|anesthetics, local|mesh-ancestor
110056423|NCT01503060|Anesthetics|anesthetics|mesh-ancestor
110056424|NCT01503060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110056425|NCT01503060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110056426|NCT01503060|Sensory System Agents|sensory system agents|mesh-ancestor
110056427|NCT01503060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110056428|NCT01503060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110056429|NCT01503060|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110056430|NCT01503060|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110056431|NCT01503060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110056432|NCT01503060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110056433|NCT01503216|Vitamin D|vitamin d|mesh-list
110056434|NCT01503216|Cholecalciferol|cholecalciferol|mesh-list
110056435|NCT01503216|Ergocalciferols|ergocalciferols|mesh-list
110056436|NCT01503216|Vitamins|vitamins|mesh-ancestor
110056437|NCT01503216|Micronutrients|micronutrients|mesh-ancestor
110056438|NCT01503216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110056439|NCT01503216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110056440|NCT01503216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110056441|NCT01503242|Cyclosporine|cyclosporine|mesh-list
110056442|NCT01503242|Mycophenolic Acid|mycophenolic acid|mesh-list
110056443|NCT01503242|Fludarabine|fludarabine|mesh-list
110056444|NCT01503242|Fludarabine phosphate|fludarabine phosphate|mesh-list
110056445|NCT01503242|Antibodies|antibodies|mesh-list
110056446|NCT01503242|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110056447|NCT01503242|Cyclosporins|cyclosporins|mesh-list
110056448|NCT01503242|Immunologic Factors|immunologic factors|mesh-ancestor
110056449|NCT01503242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110056450|NCT01503242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110056451|NCT01503242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110056452|NCT01503242|Antimetabolites|antimetabolites|mesh-ancestor
110056453|NCT01503242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110056454|NCT01503242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110056455|NCT01503242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110056456|NCT01503242|Antifungal Agents|antifungal agents|mesh-ancestor
110056457|NCT01503242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110056458|NCT01503242|Dermatologic Agents|dermatologic agents|mesh-ancestor
110056459|NCT01503242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110056460|NCT01503242|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110056461|NCT01503242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110056462|NCT01503242|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110056463|NCT01503242|Antitubercular Agents|antitubercular agents|mesh-ancestor
110056464|NCT01503242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110056465|NCT01503359|Glycine|glycine|mesh-list
110056466|NCT01503359|Glycine Agents|glycine agents|mesh-ancestor
110056467|NCT01503359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110056468|NCT01503359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110056469|NCT01503359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110056470|NCT01503372|Leucovorin|leucovorin|mesh-list
110056471|NCT01503372|Oxaliplatin|oxaliplatin|mesh-list
110056472|NCT01503372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110056473|NCT01503372|Antidotes|antidotes|mesh-ancestor
110056474|NCT01503372|Protective Agents|protective agents|mesh-ancestor
110056475|NCT01503372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110056476|NCT01503372|Vitamin B Complex|vitamin b complex|mesh-ancestor
110056477|NCT01503372|Vitamins|vitamins|mesh-ancestor
110056478|NCT01503372|Micronutrients|micronutrients|mesh-ancestor
110056479|NCT01503385|Celecoxib|celecoxib|mesh-list
110056480|NCT01503385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110056481|NCT01503385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110056482|NCT01503385|Analgesics|analgesics|mesh-ancestor
110056483|NCT01503385|Sensory System Agents|sensory system agents|mesh-ancestor
110056484|NCT01503385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110056485|NCT01503385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110056486|NCT01503385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110056490|NCT01503385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110056491|NCT01503385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110056493|NCT01503398|Antiemetics|antiemetics|mesh-ancestor
110056494|NCT01503398|Autonomic Agents|autonomic agents|mesh-ancestor
110056495|NCT01503398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110056496|NCT01503398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110056497|NCT01503398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110056498|NCT01503398|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110056499|NCT01503398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110056500|NCT01503398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110056501|NCT01503398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110056502|NCT01503398|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110056503|NCT01503398|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110056504|NCT01503398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110056505|NCT01503398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110056506|NCT01503398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110056507|NCT01503398|Serotonin Agents|serotonin agents|mesh-ancestor
110056508|NCT01503424|Olanzapine|olanzapine|mesh-list
110056509|NCT01503424|Antiemetics|antiemetics|mesh-ancestor
110056510|NCT01503424|Autonomic Agents|autonomic agents|mesh-ancestor
110056511|NCT01503424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110056512|NCT01503424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110056513|NCT01503424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110056514|NCT01503424|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110056515|NCT01503424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110056516|NCT01503424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110056517|NCT01503424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110056518|NCT01503424|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110056519|NCT01503424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110056520|NCT01503424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110056521|NCT01503424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110056522|NCT01503424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110056523|NCT01503424|Serotonin Agents|serotonin agents|mesh-ancestor
110056524|NCT01503437|Olanzapine|olanzapine|mesh-list
110056525|NCT01503437|Antiemetics|antiemetics|mesh-ancestor
110056526|NCT01503437|Autonomic Agents|autonomic agents|mesh-ancestor
110056527|NCT01503437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110056528|NCT01503437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110056529|NCT01503437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110056530|NCT01503437|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110056531|NCT01503437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110056532|NCT01503437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110056533|NCT01503437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110056534|NCT01503437|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110056535|NCT01503437|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110056536|NCT01503437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110056537|NCT01503437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110056538|NCT01503437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110056539|NCT01503437|Serotonin Agents|serotonin agents|mesh-ancestor
110056540|NCT01503450|Olanzapine|olanzapine|mesh-list
110056541|NCT01503450|Antiemetics|antiemetics|mesh-ancestor
110056542|NCT01503450|Autonomic Agents|autonomic agents|mesh-ancestor
110056543|NCT01503450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110056544|NCT01503450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110056545|NCT01503450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110056546|NCT01503450|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110056547|NCT01503450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110056548|NCT01503450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110056549|NCT01503450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110056550|NCT01503450|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110056551|NCT01503450|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110056552|NCT01503450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110056553|NCT01503450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110056554|NCT01503450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110056555|NCT01503450|Serotonin Agents|serotonin agents|mesh-ancestor
110056556|NCT01503502|Imatinib Mesylate|imatinib mesylate|mesh-list
110056557|NCT01503502|Flumatinib|flumatinib|mesh-list
110056558|NCT01503502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110056559|NCT01503502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110056560|NCT01503502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110056561|NCT01503502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110056562|NCT01503580|Solifenacin Succinate|solifenacin succinate|mesh-list
110056564|NCT01503580|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110056565|NCT01503580|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110056566|NCT01503580|Cholinergic Agents|cholinergic agents|mesh-ancestor
110056567|NCT01503580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110056568|NCT01503580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110056569|NCT01503580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110056570|NCT01503580|Urological Agents|urological agents|mesh-ancestor
110056571|NCT01503593|Calcium|calcium|mesh-list
110056572|NCT01503593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110056573|NCT01503593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110056574|NCT01503658|Aspirin|aspirin|mesh-list
110056575|NCT01503658|Clopidogrel|clopidogrel|mesh-list
110056576|NCT01503658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110056577|NCT01503658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110056578|NCT01503658|Analgesics|analgesics|mesh-ancestor
110056579|NCT01503658|Sensory System Agents|sensory system agents|mesh-ancestor
110056580|NCT01503658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110056581|NCT01503658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110056582|NCT01503658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110056583|NCT01503658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110056584|NCT01503658|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110056585|NCT01503658|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110056586|NCT01503658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110056587|NCT01503658|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110056588|NCT01503658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110056589|NCT01503658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110056590|NCT01503658|Antipyretics|antipyretics|mesh-ancestor
110056591|NCT01503658|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110056592|NCT01503658|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110056593|NCT01503658|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110056594|NCT01503658|Purinergic Agents|purinergic agents|mesh-ancestor
110056595|NCT01503658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110056596|NCT01503671|Atorvastatin|atorvastatin|mesh-list
110056597|NCT01503671|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110056598|NCT01503671|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110056599|NCT01503671|Antimetabolites|antimetabolites|mesh-ancestor
110056600|NCT01503671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110056601|NCT01503671|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110056602|NCT01503671|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110056603|NCT01503671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110056604|NCT01503736|Citric Acid|citric acid|mesh-list
110056605|NCT01503736|Sodium Citrate|sodium citrate|mesh-list
110056606|NCT01503736|Ferric Compounds|ferric compounds|mesh-list
110056607|NCT01503736|Anticoagulants|anticoagulants|mesh-ancestor
110056608|NCT01503736|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110056609|NCT01503736|Chelating Agents|chelating agents|mesh-ancestor
110056610|NCT01503736|Sequestering Agents|sequestering agents|mesh-ancestor
110056611|NCT01503736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110056612|NCT01503736|Hematinics|hematinics|mesh-ancestor
110056614|NCT01503788|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110056615|NCT01503788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110056616|NCT01503788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110056617|NCT01503788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110056618|NCT01503788|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110056619|NCT01503788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110056621|NCT01503788|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110056622|NCT01503788|Anesthetics, General|anesthetics, general|mesh-ancestor
110056623|NCT01503788|Anesthetics|anesthetics|mesh-ancestor
110056624|NCT01503788|GABA Modulators|gaba modulators|mesh-ancestor
110056625|NCT01503788|GABA Agents|gaba agents|mesh-ancestor
110056626|NCT01503788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110056627|NCT01503788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110056628|NCT01503801|Nitric Oxide|nitric oxide|mesh-list
110056629|NCT01503801|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-list
110056631|NCT01503801|Autonomic Agents|autonomic agents|mesh-ancestor
110056632|NCT01503801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110056636|NCT01503801|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110056637|NCT01503801|Antioxidants|antioxidants|mesh-ancestor
110056638|NCT01503801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110056639|NCT01503801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110056640|NCT01503801|Vasodilator Agents|vasodilator agents|mesh-ancestor
110056641|NCT01503801|Gasotransmitters|gasotransmitters|mesh-ancestor
110056642|NCT01503801|Protective Agents|protective agents|mesh-ancestor
110056644|NCT01503905|Cyclophosphamide|cyclophosphamide|mesh-list
110056645|NCT01503905|Docetaxel|docetaxel|mesh-list
110056646|NCT01503905|Trastuzumab|trastuzumab|mesh-list
110056647|NCT01503905|Epirubicin|epirubicin|mesh-list
110056648|NCT01503905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110056649|NCT01503905|Immunologic Factors|immunologic factors|mesh-ancestor
110056650|NCT01503905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110056651|NCT01503905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110056652|NCT01503905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110056653|NCT01503905|Alkylating Agents|alkylating agents|mesh-ancestor
110056654|NCT01503905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110056655|NCT01503905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110056656|NCT01503905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110056657|NCT01503905|Tubulin Modulators|tubulin modulators|mesh-ancestor
110056658|NCT01503905|Antimitotic Agents|antimitotic agents|mesh-ancestor
110056659|NCT01503905|Mitosis Modulators|mitosis modulators|mesh-ancestor
110056660|NCT01503905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110056661|NCT01503905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110056662|NCT01503905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110056663|NCT01503905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110056664|NCT01503905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110056665|NCT01503905|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110056666|NCT01503905|Hormone Antagonists|hormone antagonists|mesh-ancestor
110056667|NCT01503905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110056668|NCT01503905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110056669|NCT01503905|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110056670|NCT01503905|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110056671|NCT01503905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110056672|NCT01503918|Valacyclovir|valacyclovir|mesh-list
110056673|NCT01503918|Valganciclovir|valganciclovir|mesh-list
110056674|NCT01503918|Acyclovir|acyclovir|mesh-list
110056675|NCT01503918|Ganciclovir|ganciclovir|mesh-list
110056676|NCT01503918|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
110056677|NCT01503918|Antiviral Agents|antiviral agents|mesh-ancestor
110056678|NCT01503918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110056679|NCT01503918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110056680|NCT01503918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110056681|NCT01503918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110056682|NCT01503983|Capecitabine|capecitabine|mesh-list
110056683|NCT01503983|Oxaliplatin|oxaliplatin|mesh-list
110056684|NCT01503983|Trastuzumab|trastuzumab|mesh-list
110056685|NCT01503983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110056686|NCT01503983|Antimetabolites|antimetabolites|mesh-ancestor
110056687|NCT01503983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110056688|NCT01503983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110056689|NCT01503983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110056691|NCT01504074|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110056692|NCT01504074|Levobunolol|levobunolol|mesh-list
110056693|NCT01504074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110056694|NCT01504074|Glucocorticoids|glucocorticoids|mesh-ancestor
110056695|NCT01504074|Hormones|hormones|mesh-ancestor
110056696|NCT01504074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110056697|NCT01504074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110056698|NCT01504074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110056699|NCT01504074|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110056700|NCT01504074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110056701|NCT01504074|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110056702|NCT01504074|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110056703|NCT01504074|Adrenergic Agents|adrenergic agents|mesh-ancestor
110056704|NCT01504074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110056706|NCT01504074|Autonomic Agents|autonomic agents|mesh-ancestor
110056707|NCT01504126|Propranolol|propranolol|mesh-list
110056708|NCT01504126|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110056709|NCT01504126|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110056710|NCT01504126|Adrenergic Agents|adrenergic agents|mesh-ancestor
110056711|NCT01504126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110056712|NCT01504126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110056713|NCT01504126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110056714|NCT01504126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110056715|NCT01504126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110056716|NCT01504126|Vasodilator Agents|vasodilator agents|mesh-ancestor
110056717|NCT01504139|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110056720|NCT01504139|Estrogens|estrogens|mesh-ancestor
110056722|NCT01504139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110056723|NCT01504139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110056724|NCT01504139|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110056725|NCT01504139|Progestins|progestins|mesh-ancestor
110056726|NCT01504178|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110056727|NCT01504178|Levodopa|levodopa|mesh-list
110056728|NCT01504178|Apomorphine|apomorphine|mesh-list
110056729|NCT01504178|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
110056730|NCT01504178|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110056731|NCT01504178|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110056732|NCT01504178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110056733|NCT01504178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110056734|NCT01504178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110056735|NCT01504178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110056736|NCT01504178|Analgesics|analgesics|mesh-ancestor
110056737|NCT01504178|Sensory System Agents|sensory system agents|mesh-ancestor
110056738|NCT01504178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110056739|NCT01504178|Antidepressive Agents|antidepressive agents|mesh-ancestor
110056740|NCT01504178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110056741|NCT01504178|Dopamine Agents|dopamine agents|mesh-ancestor
110056742|NCT01504178|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110056743|NCT01504178|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110056744|NCT01504178|Emetics|emetics|mesh-ancestor
110056745|NCT01504178|Autonomic Agents|autonomic agents|mesh-ancestor
110056746|NCT01504178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110056747|NCT01504178|Dopamine Agonists|dopamine agonists|mesh-ancestor
110056748|NCT01504256|Leucovorin|leucovorin|mesh-list
110056749|NCT01504256|Docetaxel|docetaxel|mesh-list
110056750|NCT01504256|Fluorouracil|fluorouracil|mesh-list
110056751|NCT01504256|Oxaliplatin|oxaliplatin|mesh-list
110056752|NCT01504256|Catumaxomab|catumaxomab|mesh-list
110056753|NCT01504256|Antibodies, Bispecific|antibodies, bispecific|mesh-list
110056754|NCT01504256|Levoleucovorin|levoleucovorin|mesh-list
110056755|NCT01504256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110056756|NCT01504256|Tubulin Modulators|tubulin modulators|mesh-ancestor
110056757|NCT01504256|Antimitotic Agents|antimitotic agents|mesh-ancestor
110056758|NCT01504256|Mitosis Modulators|mitosis modulators|mesh-ancestor
110056759|NCT01504256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110056760|NCT01504256|Antimetabolites|antimetabolites|mesh-ancestor
110056761|NCT01504256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110056762|NCT01504256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110056763|NCT01504256|Immunologic Factors|immunologic factors|mesh-ancestor
110056764|NCT01504256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110056765|NCT01504256|Antidotes|antidotes|mesh-ancestor
110056766|NCT01504256|Protective Agents|protective agents|mesh-ancestor
110056767|NCT01504256|Vitamin B Complex|vitamin b complex|mesh-ancestor
110056768|NCT01504256|Vitamins|vitamins|mesh-ancestor
110056769|NCT01504256|Micronutrients|micronutrients|mesh-ancestor
110056770|NCT01504256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110056771|NCT01504282|Mitomycins|mitomycins|mesh-list
110056772|NCT01504282|Mitomycin|mitomycin|mesh-list
110056773|NCT01504282|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110056774|NCT01504282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110056775|NCT01504282|Alkylating Agents|alkylating agents|mesh-ancestor
110056776|NCT01504282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110056777|NCT01504282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110056778|NCT01504282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110056779|NCT01504295|Metadoxine|metadoxine|mesh-list
110056780|NCT01504295|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110056782|NCT01504321|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110056783|NCT01504334|Pirfenidone|pirfenidone|mesh-list
110056784|NCT01504334|Analgesics|analgesics|mesh-ancestor
110056786|NCT01504334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110056787|NCT01504334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110056788|NCT01504334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110056789|NCT01504334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110056790|NCT01504334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110056792|NCT01504334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110056794|NCT01504347|Immunologic Factors|immunologic factors|mesh-ancestor
110056795|NCT01504347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110056796|NCT01504386|Ropivacaine|ropivacaine|mesh-list
110056797|NCT01504386|Anesthetics, Local|anesthetics, local|mesh-ancestor
110056798|NCT01504386|Anesthetics|anesthetics|mesh-ancestor
110056799|NCT01504386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110056800|NCT01504386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110056801|NCT01504386|Sensory System Agents|sensory system agents|mesh-ancestor
110056802|NCT01504386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110056803|NCT01504490|Bexarotene|bexarotene|mesh-list
110056804|NCT01504490|Efatutazone|efatutazone|mesh-list
110056805|NCT01504490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110056806|NCT01504503|Donepezil|donepezil|mesh-list
110056807|NCT01504503|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110056808|NCT01504503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110056809|NCT01504503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110056810|NCT01504503|Cholinergic Agents|cholinergic agents|mesh-ancestor
110056811|NCT01504503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110056812|NCT01504503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110056813|NCT01504503|Nootropic Agents|nootropic agents|mesh-ancestor
110056814|NCT01504516|Donepezil|donepezil|mesh-list
110056815|NCT01504516|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110056816|NCT01504516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110056817|NCT01504516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110056818|NCT01504516|Cholinergic Agents|cholinergic agents|mesh-ancestor
110056819|NCT01504516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110056820|NCT01504516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110056821|NCT01504516|Nootropic Agents|nootropic agents|mesh-ancestor
110056822|NCT01504542|Vaccines|vaccines|mesh-list
110056823|NCT01504542|Immunologic Factors|immunologic factors|mesh-ancestor
110056824|NCT01504542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110056825|NCT01504581|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110056826|NCT01504581|Antiviral Agents|antiviral agents|mesh-ancestor
110056827|NCT01504581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110056828|NCT01504620|Insulin|insulin|mesh-list
110056829|NCT01504620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110056830|NCT01504620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110056831|NCT01504646|Lyprinol|lyprinol|mesh-list
110056832|NCT01504646|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110056833|NCT01504646|Hormone Antagonists|hormone antagonists|mesh-ancestor
110056835|NCT01504646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110056837|NCT01504659|Analgesics|analgesics|mesh-ancestor
110056838|NCT01504659|Sensory System Agents|sensory system agents|mesh-ancestor
110056839|NCT01504659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110056840|NCT01504659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110056841|NCT01504659|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110056842|NCT01504659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110056843|NCT01504659|Anesthetics, General|anesthetics, general|mesh-ancestor
110056844|NCT01504659|Anesthetics|anesthetics|mesh-ancestor
110056845|NCT01504659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110056846|NCT01504659|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110056847|NCT01504659|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110056848|NCT01504659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110056849|NCT01504659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110056850|NCT01504724|Bevacizumab|bevacizumab|mesh-list
110056851|NCT01504724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110056852|NCT01504724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110056854|NCT01504724|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110056855|NCT01504724|Growth Substances|growth substances|mesh-ancestor
110056856|NCT01504724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110056857|NCT01504724|Growth Inhibitors|growth inhibitors|mesh-ancestor
110056858|NCT01504776|Bortezomib|bortezomib|mesh-list
110056859|NCT01504776|Panobinostat|panobinostat|mesh-list
110056860|NCT01504776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110056861|NCT01504776|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110056865|NCT01504828|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110056866|NCT01504828|Protease Inhibitors|protease inhibitors|mesh-ancestor
110056867|NCT01504828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110056868|NCT01504828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110056869|NCT01504828|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110056870|NCT01504906|Cyclosporine|cyclosporine|mesh-list
110056871|NCT01504906|Ticagrelor|ticagrelor|mesh-list
110056872|NCT01504906|Cyclosporins|cyclosporins|mesh-list
110056873|NCT01504906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110056874|NCT01504906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110056875|NCT01504906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110056876|NCT01504906|Immunologic Factors|immunologic factors|mesh-ancestor
110056877|NCT01504906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110056878|NCT01504906|Antifungal Agents|antifungal agents|mesh-ancestor
110056879|NCT01504906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110056880|NCT01504906|Dermatologic Agents|dermatologic agents|mesh-ancestor
110056881|NCT01504906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110056882|NCT01504906|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110056883|NCT01504906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110056884|NCT01504906|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110056885|NCT01504906|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110056886|NCT01504906|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110056887|NCT01504906|Purinergic Agents|purinergic agents|mesh-ancestor
110056888|NCT01504906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110056889|NCT01504984|Imatinib Mesylate|imatinib mesylate|mesh-list
110056890|NCT01504984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110056891|NCT01504984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110056892|NCT01504984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110056893|NCT01504984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110056894|NCT01505049|Vaccines|vaccines|mesh-list
110056895|NCT01505049|Immunologic Factors|immunologic factors|mesh-ancestor
110056896|NCT01505049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110056897|NCT01505088|Benzalkonium Compounds|benzalkonium compounds|mesh-list
110056898|NCT01505088|Dexamethasone|dexamethasone|mesh-list
110056900|NCT01505088|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110056901|NCT01505088|Methylprednisolone|methylprednisolone|mesh-list
110056902|NCT01505088|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110056903|NCT01505088|Prednisolone acetate|prednisolone acetate|mesh-list
110056904|NCT01505088|Citric Acid|citric acid|mesh-list
110056905|NCT01505088|Sodium Citrate|sodium citrate|mesh-list
110056906|NCT01505088|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110056907|NCT01505088|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110056908|NCT01505088|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110056909|NCT01505088|Prednisolone phosphate|prednisolone phosphate|mesh-list
110056910|NCT01505088|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
110056911|NCT01505088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110056912|NCT01505088|Antiemetics|antiemetics|mesh-ancestor
110056913|NCT01505088|Autonomic Agents|autonomic agents|mesh-ancestor
110056914|NCT01505088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110056915|NCT01505088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110056916|NCT01505088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110056917|NCT01505088|Glucocorticoids|glucocorticoids|mesh-ancestor
110056918|NCT01505088|Hormones|hormones|mesh-ancestor
110056919|NCT01505088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110056920|NCT01505088|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110056921|NCT01505088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110056922|NCT01505088|Anticoagulants|anticoagulants|mesh-ancestor
110056923|NCT01505088|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110056924|NCT01505088|Chelating Agents|chelating agents|mesh-ancestor
110056925|NCT01505088|Sequestering Agents|sequestering agents|mesh-ancestor
110056926|NCT01505088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110056927|NCT01505088|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110056928|NCT01505088|Protective Agents|protective agents|mesh-ancestor
110056929|NCT01505088|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110056930|NCT01505088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110056931|NCT01505127|Amoxicillin|amoxicillin|mesh-list
110056932|NCT01505127|Clarithromycin|clarithromycin|mesh-list
110056933|NCT01505127|Lansoprazole|lansoprazole|mesh-list
110056935|NCT01505127|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110056936|NCT01505127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110056937|NCT01505127|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110056938|NCT01505127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110056939|NCT01505127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110056940|NCT01505127|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110056941|NCT01505127|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110056942|NCT01505127|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110056943|NCT01505127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110056944|NCT01505127|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110056945|NCT01505218|Propofol|propofol|mesh-list
110056946|NCT01505218|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110056947|NCT01505218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110056948|NCT01505218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110056949|NCT01505218|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110056950|NCT01505218|Anesthetics, General|anesthetics, general|mesh-ancestor
110056951|NCT01505218|Anesthetics|anesthetics|mesh-ancestor
110056952|NCT01505231|Vasopressins|vasopressins|mesh-list
110056953|NCT01505231|Arginine Vasopressin|arginine vasopressin|mesh-list
110056954|NCT01505231|Norepinephrine|norepinephrine|mesh-list
110056955|NCT01505231|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110056956|NCT01505231|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110056957|NCT01505231|Adrenergic Agents|adrenergic agents|mesh-ancestor
110056958|NCT01505231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110056959|NCT01505231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110056960|NCT01505231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110056962|NCT01505231|Autonomic Agents|autonomic agents|mesh-ancestor
110056963|NCT01505231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110056964|NCT01505231|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110056966|NCT01505231|Coagulants|coagulants|mesh-ancestor
110056967|NCT01505231|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110056968|NCT01505231|Natriuretic Agents|natriuretic agents|mesh-ancestor
110056969|NCT01505283|Lidocaine|lidocaine|mesh-list
110056970|NCT01505283|Sufentanil|sufentanil|mesh-list
110056971|NCT01505283|Anesthetics, Local|anesthetics, local|mesh-ancestor
110056972|NCT01505283|Anesthetics|anesthetics|mesh-ancestor
110056973|NCT01505283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110056974|NCT01505283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110056975|NCT01505283|Sensory System Agents|sensory system agents|mesh-ancestor
110056976|NCT01505283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110056977|NCT01505283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110056978|NCT01505283|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110056979|NCT01505283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110056980|NCT01505283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110056981|NCT01505283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110056982|NCT01505283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110056983|NCT01505283|Narcotics|narcotics|mesh-ancestor
110056984|NCT01505283|Analgesics|analgesics|mesh-ancestor
110056985|NCT01505283|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110056986|NCT01505283|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110056987|NCT01505283|Anesthetics, General|anesthetics, general|mesh-ancestor
110056988|NCT01505296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
110056989|NCT01505413|Gemcitabine|gemcitabine|mesh-list
110056990|NCT01505413|Oxaliplatin|oxaliplatin|mesh-list
110056991|NCT01505413|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110056992|NCT01505413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110056993|NCT01505413|Antimetabolites|antimetabolites|mesh-ancestor
110056994|NCT01505413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110056995|NCT01505413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110056996|NCT01505413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110056997|NCT01505413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110056998|NCT01505426|Metformin|metformin|mesh-list
110056999|NCT01505426|Ipragliflozin|ipragliflozin|mesh-list
110057000|NCT01505426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110057001|NCT01505426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057002|NCT01505426|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110057003|NCT01505426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110057004|NCT01505439|Solifenacin Succinate|solifenacin succinate|mesh-list
110057005|NCT01505439|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110057006|NCT01505439|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110057007|NCT01505439|Cholinergic Agents|cholinergic agents|mesh-ancestor
110057008|NCT01505439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110057009|NCT01505439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110057010|NCT01505439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057011|NCT01505439|Urological Agents|urological agents|mesh-ancestor
110057012|NCT01505504|Mirtazapine|mirtazapine|mesh-list
110057013|NCT01505504|Antidepressive Agents|antidepressive agents|mesh-ancestor
110057017|NCT01505504|Histamine Agents|histamine agents|mesh-ancestor
110057018|NCT01505504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110057019|NCT01505504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110057020|NCT01505504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057021|NCT01505504|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110057022|NCT01505504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110057023|NCT01505504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110057024|NCT01505504|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110057025|NCT01505504|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110057026|NCT01505504|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110057027|NCT01505504|Adrenergic Agents|adrenergic agents|mesh-ancestor
110057028|NCT01505504|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110057029|NCT01505504|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110057030|NCT01505504|Serotonin Agents|serotonin agents|mesh-ancestor
110057031|NCT01505504|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110057033|NCT01505777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110057034|NCT01505777|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110057035|NCT01505777|Serotonin Agents|serotonin agents|mesh-ancestor
110057036|NCT01505777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110057037|NCT01505777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110057038|NCT01505777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057039|NCT01505790|Clopidogrel|clopidogrel|mesh-list
110057040|NCT01505790|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110057041|NCT01505790|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110057042|NCT01505790|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110057043|NCT01505790|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110057044|NCT01505790|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110057045|NCT01505790|Purinergic Agents|purinergic agents|mesh-ancestor
110057046|NCT01505790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110057047|NCT01505790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110057048|NCT01505790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057049|NCT01505855|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110057050|NCT01505855|Immunologic Factors|immunologic factors|mesh-ancestor
110057051|NCT01505855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057052|NCT01505894|BI 409306|bi 409306|mesh-list
110057053|NCT01505894|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110057054|NCT01505894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110057055|NCT01505894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110057056|NCT01505920|Lidocaine|lidocaine|mesh-list
110057057|NCT01505920|Anesthetics, Local|anesthetics, local|mesh-ancestor
110057058|NCT01505920|Anesthetics|anesthetics|mesh-ancestor
110057060|NCT01505920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057061|NCT01505920|Sensory System Agents|sensory system agents|mesh-ancestor
110057062|NCT01505920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110057063|NCT01505920|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110057064|NCT01505920|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110057065|NCT01505920|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110057066|NCT01505920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110057067|NCT01505920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110057068|NCT01505946|Thrombin|thrombin|mesh-list
110057069|NCT01505946|Hemostatics|hemostatics|mesh-ancestor
110057070|NCT01505946|Coagulants|coagulants|mesh-ancestor
110057071|NCT01505998|Amlodipine|amlodipine|mesh-list
110057072|NCT01505998|Benazepril|benazepril|mesh-list
110057073|NCT01505998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110057074|NCT01505998|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110057075|NCT01505998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110057076|NCT01505998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110057077|NCT01505998|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110057078|NCT01505998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057079|NCT01505998|Vasodilator Agents|vasodilator agents|mesh-ancestor
110057080|NCT01505998|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110057081|NCT01505998|Protease Inhibitors|protease inhibitors|mesh-ancestor
110057082|NCT01505998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110057084|NCT01506011|Benazepril|benazepril|mesh-list
110057085|NCT01506011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110057087|NCT01506011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110057088|NCT01506011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110057089|NCT01506011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110057090|NCT01506011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057091|NCT01506011|Vasodilator Agents|vasodilator agents|mesh-ancestor
110057092|NCT01506011|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110057093|NCT01506011|Protease Inhibitors|protease inhibitors|mesh-ancestor
110057094|NCT01506011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110057095|NCT01506024|Tacrine|tacrine|mesh-list
110057096|NCT01506024|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110057097|NCT01506024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110057098|NCT01506024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110057099|NCT01506024|Cholinergic Agents|cholinergic agents|mesh-ancestor
110057100|NCT01506024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110057101|NCT01506024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057102|NCT01506024|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110057103|NCT01506024|Autonomic Agents|autonomic agents|mesh-ancestor
110057104|NCT01506024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110057105|NCT01506024|Nootropic Agents|nootropic agents|mesh-ancestor
110057106|NCT01506037|Desloratadine|desloratadine|mesh-list
110057107|NCT01506037|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110057108|NCT01506037|Cholinergic Agents|cholinergic agents|mesh-ancestor
110057109|NCT01506037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110057110|NCT01506037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110057111|NCT01506037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057112|NCT01506037|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110057113|NCT01506037|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110057114|NCT01506037|Histamine Antagonists|histamine antagonists|mesh-ancestor
110057115|NCT01506037|Histamine Agents|histamine agents|mesh-ancestor
110057116|NCT01506050|Desloratadine|desloratadine|mesh-list
110057117|NCT01506050|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110057118|NCT01506050|Cholinergic Agents|cholinergic agents|mesh-ancestor
110057119|NCT01506050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110057120|NCT01506050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110057121|NCT01506050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057122|NCT01506050|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110057123|NCT01506050|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110057124|NCT01506050|Histamine Antagonists|histamine antagonists|mesh-ancestor
110057125|NCT01506050|Histamine Agents|histamine agents|mesh-ancestor
110057126|NCT01506063|Levocetirizine|levocetirizine|mesh-list
110057127|NCT01506063|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110057128|NCT01506063|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110057129|NCT01506063|Histamine Antagonists|histamine antagonists|mesh-ancestor
110057130|NCT01506063|Histamine Agents|histamine agents|mesh-ancestor
110057131|NCT01506063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110057132|NCT01506063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110057133|NCT01506063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057134|NCT01506076|Levocetirizine|levocetirizine|mesh-list
110057135|NCT01506076|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110057136|NCT01506076|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110057137|NCT01506076|Histamine Antagonists|histamine antagonists|mesh-ancestor
110057138|NCT01506076|Histamine Agents|histamine agents|mesh-ancestor
110057139|NCT01506076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110057140|NCT01506076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110057141|NCT01506076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057142|NCT01506115|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
110057143|NCT01506115|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
110057144|NCT01506115|Trioxsalen|trioxsalen|mesh-list
110057145|NCT01506115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110057146|NCT01506115|Dermatologic Agents|dermatologic agents|mesh-ancestor
110057147|NCT01506115|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110057148|NCT01506167|Leucovorin|leucovorin|mesh-list
110057150|NCT01506167|Bevacizumab|bevacizumab|mesh-list
110057151|NCT01506167|Fluorouracil|fluorouracil|mesh-list
110057152|NCT01506167|Capecitabine|capecitabine|mesh-list
110057153|NCT01506167|Oxaliplatin|oxaliplatin|mesh-list
110057154|NCT01506167|Irinotecan|irinotecan|mesh-list
110057155|NCT01506167|Levoleucovorin|levoleucovorin|mesh-list
110057156|NCT01506167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110057157|NCT01506167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110057158|NCT01506167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110057159|NCT01506167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110057161|NCT01506167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057164|NCT01506167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110057165|NCT01506167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110057166|NCT01506167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110057167|NCT01506167|Immunologic Factors|immunologic factors|mesh-ancestor
110057168|NCT01506167|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110057169|NCT01506167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110057170|NCT01506167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110057172|NCT01506167|Protective Agents|protective agents|mesh-ancestor
110057173|NCT01506167|Vitamin B Complex|vitamin b complex|mesh-ancestor
110057174|NCT01506167|Vitamins|vitamins|mesh-ancestor
110057175|NCT01506167|Micronutrients|micronutrients|mesh-ancestor
110057176|NCT01506167|Hematinics|hematinics|mesh-ancestor
110057177|NCT01506336|Sunitinib|sunitinib|mesh-list
110057178|NCT01506336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110057179|NCT01506336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110057180|NCT01506336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110057181|NCT01506336|Growth Substances|growth substances|mesh-ancestor
110057182|NCT01506336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057183|NCT01506336|Growth Inhibitors|growth inhibitors|mesh-ancestor
110057184|NCT01506336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110057185|NCT01506336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110057186|NCT01506336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110057187|NCT01506388|Misoprostol|misoprostol|mesh-list
110057188|NCT01506388|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110057189|NCT01506388|Abortifacient Agents|abortifacient agents|mesh-ancestor
110057190|NCT01506388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110057191|NCT01506388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057192|NCT01506388|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110057193|NCT01506388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110057194|NCT01506388|Oxytocics|oxytocics|mesh-ancestor
110057195|NCT01506414|Rituximab|rituximab|mesh-list
110057196|NCT01506414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110057197|NCT01506414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110057198|NCT01506414|Immunologic Factors|immunologic factors|mesh-ancestor
110057199|NCT01506414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057200|NCT01506414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110057201|NCT01506505|Aspirin|aspirin|mesh-list
110057202|NCT01506505|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110057203|NCT01506505|Lisinopril|lisinopril|mesh-list
110057204|NCT01506505|Simvastatin|simvastatin|mesh-list
110057205|NCT01506505|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110057206|NCT01506505|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110057207|NCT01506505|Antimetabolites|antimetabolites|mesh-ancestor
110057208|NCT01506505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110057209|NCT01506505|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110057210|NCT01506505|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110057211|NCT01506505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110057212|NCT01506505|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110057213|NCT01506505|Diuretics|diuretics|mesh-ancestor
110057214|NCT01506505|Natriuretic Agents|natriuretic agents|mesh-ancestor
110057215|NCT01506505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057216|NCT01506505|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110057217|NCT01506505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110057218|NCT01506505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110057219|NCT01506505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110057220|NCT01506505|Analgesics|analgesics|mesh-ancestor
110057221|NCT01506505|Sensory System Agents|sensory system agents|mesh-ancestor
110057222|NCT01506505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110057223|NCT01506505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110057224|NCT01506505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110057226|NCT01506505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110057227|NCT01506505|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110057228|NCT01506505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110057229|NCT01506505|Antipyretics|antipyretics|mesh-ancestor
110057230|NCT01506505|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110057231|NCT01506505|Protease Inhibitors|protease inhibitors|mesh-ancestor
110057232|NCT01506505|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110057233|NCT01506505|Protective Agents|protective agents|mesh-ancestor
110057234|NCT01506544|Hydroxyurea|hydroxyurea|mesh-list
110057235|NCT01506544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110057237|NCT01506544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110057239|NCT01506544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110057240|NCT01506557|Cholecalciferol|cholecalciferol|mesh-list
110057241|NCT01506557|Vitamin D|vitamin d|mesh-list
110057242|NCT01506557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110057243|NCT01506557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057244|NCT01506557|Vitamins|vitamins|mesh-ancestor
110057245|NCT01506557|Micronutrients|micronutrients|mesh-ancestor
110057246|NCT01506557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110057247|NCT01506570|Vaccines|vaccines|mesh-list
110057248|NCT01506570|Immunologic Factors|immunologic factors|mesh-ancestor
110057249|NCT01506570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057250|NCT01506622|Fentanyl|fentanyl|mesh-list
110057251|NCT01506622|Propofol|propofol|mesh-list
110057252|NCT01506622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110057253|NCT01506622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110057254|NCT01506622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057255|NCT01506622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110057256|NCT01506622|Anesthetics, General|anesthetics, general|mesh-ancestor
110057257|NCT01506622|Anesthetics|anesthetics|mesh-ancestor
110057258|NCT01506622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110057259|NCT01506622|Narcotics|narcotics|mesh-ancestor
110057260|NCT01506622|Analgesics|analgesics|mesh-ancestor
110057261|NCT01506622|Sensory System Agents|sensory system agents|mesh-ancestor
110057262|NCT01506622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110057263|NCT01506622|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110057264|NCT01506635|Timolol|timolol|mesh-list
110057265|NCT01506635|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110057266|NCT01506635|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110057267|NCT01506635|Adrenergic Agents|adrenergic agents|mesh-ancestor
110057268|NCT01506635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110057269|NCT01506635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110057270|NCT01506635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057271|NCT01506635|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110057272|NCT01506635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110057273|NCT01506713|Clopidogrel|clopidogrel|mesh-list
110057274|NCT01506713|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110057275|NCT01506713|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110057276|NCT01506713|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110057277|NCT01506713|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110057278|NCT01506713|Purinergic Agents|purinergic agents|mesh-ancestor
110057279|NCT01506713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110057280|NCT01506713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110057281|NCT01506713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057282|NCT01506739|Donepezil|donepezil|mesh-list
110057283|NCT01506739|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110057284|NCT01506739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110057285|NCT01506739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110057286|NCT01506739|Cholinergic Agents|cholinergic agents|mesh-ancestor
110057287|NCT01506739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110057288|NCT01506739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057289|NCT01506739|Nootropic Agents|nootropic agents|mesh-ancestor
110057290|NCT01506752|Donepezil|donepezil|mesh-list
110057291|NCT01506752|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110057292|NCT01506752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110057293|NCT01506752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110057294|NCT01506752|Cholinergic Agents|cholinergic agents|mesh-ancestor
110057295|NCT01506752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110057296|NCT01506752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057297|NCT01506752|Nootropic Agents|nootropic agents|mesh-ancestor
110057298|NCT01506765|Acetylcysteine|acetylcysteine|mesh-list
110057299|NCT01506765|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110057300|NCT01506765|Antiviral Agents|antiviral agents|mesh-ancestor
110057301|NCT01506765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110057302|NCT01506765|Expectorants|expectorants|mesh-ancestor
110057303|NCT01506765|Respiratory System Agents|respiratory system agents|mesh-ancestor
110057304|NCT01506765|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110057305|NCT01506765|Antioxidants|antioxidants|mesh-ancestor
110057306|NCT01506765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110057307|NCT01506765|Protective Agents|protective agents|mesh-ancestor
110057308|NCT01506765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057309|NCT01506765|Antidotes|antidotes|mesh-ancestor
110057310|NCT01506791|Pseudoephedrine|pseudoephedrine|mesh-list
110057311|NCT01506791|Ephedrine|ephedrine|mesh-list
110057313|NCT01506791|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110057314|NCT01506791|Cholinergic Agents|cholinergic agents|mesh-ancestor
110057315|NCT01506791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110057316|NCT01506791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110057317|NCT01506791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057318|NCT01506791|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110057319|NCT01506791|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110057320|NCT01506791|Histamine Antagonists|histamine antagonists|mesh-ancestor
110057322|NCT01506791|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110057323|NCT01506791|Autonomic Agents|autonomic agents|mesh-ancestor
110057324|NCT01506791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110057325|NCT01506791|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110057326|NCT01506791|Respiratory System Agents|respiratory system agents|mesh-ancestor
110057327|NCT01506791|Nasal Decongestants|nasal decongestants|mesh-ancestor
110057328|NCT01506791|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110057329|NCT01506791|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110057330|NCT01506791|Sympathomimetics|sympathomimetics|mesh-ancestor
110057331|NCT01506791|Adrenergic Agents|adrenergic agents|mesh-ancestor
110057332|NCT01506804|Methylprednisolone|methylprednisolone|mesh-list
110057333|NCT01506804|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110057334|NCT01506804|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110057335|NCT01506804|Prednisolone|prednisolone|mesh-list
110057336|NCT01506804|Prednisolone acetate|prednisolone acetate|mesh-list
110057337|NCT01506804|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110057338|NCT01506804|Prednisolone phosphate|prednisolone phosphate|mesh-list
110057339|NCT01506804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110057341|NCT01506804|Autonomic Agents|autonomic agents|mesh-ancestor
110057342|NCT01506804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110057343|NCT01506804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057344|NCT01506804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110057345|NCT01506804|Glucocorticoids|glucocorticoids|mesh-ancestor
110057346|NCT01506804|Hormones|hormones|mesh-ancestor
110057347|NCT01506804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110057348|NCT01506804|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110057349|NCT01506804|Protective Agents|protective agents|mesh-ancestor
110057350|NCT01506804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110057351|NCT01506804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110057352|NCT01506895|Darapladib|darapladib|mesh-list
110057353|NCT01506895|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
110057354|NCT01506895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110057355|NCT01506895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110057356|NCT01506921|Ketamine|ketamine|mesh-list
110057357|NCT01506921|Esketamine|esketamine|mesh-list
110057358|NCT01506921|Analgesics|analgesics|mesh-ancestor
110057359|NCT01506921|Sensory System Agents|sensory system agents|mesh-ancestor
110057360|NCT01506921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110057361|NCT01506921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057362|NCT01506921|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110057364|NCT01506921|Anesthetics, General|anesthetics, general|mesh-ancestor
110057365|NCT01506921|Anesthetics|anesthetics|mesh-ancestor
110057366|NCT01506921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110057367|NCT01506921|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110057368|NCT01506921|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110057369|NCT01506921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110057370|NCT01506921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110057371|NCT01506921|Antidepressive Agents|antidepressive agents|mesh-ancestor
110057372|NCT01506921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110057373|NCT01507064|Sorafenib|sorafenib|mesh-list
110057374|NCT01507064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110057375|NCT01507064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110057376|NCT01507064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110057380|NCT01507077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110057381|NCT01507077|Growth Substances|growth substances|mesh-ancestor
110057382|NCT01507077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057383|NCT01507077|Growth Inhibitors|growth inhibitors|mesh-ancestor
110057384|NCT01507077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110057385|NCT01507194|Ondansetron|ondansetron|mesh-list
110057386|NCT01507194|Vestipitant|vestipitant|mesh-list
110057387|NCT01507194|Antiemetics|antiemetics|mesh-ancestor
110057388|NCT01507194|Autonomic Agents|autonomic agents|mesh-ancestor
110057389|NCT01507194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110057390|NCT01507194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057391|NCT01507194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110057392|NCT01507194|Antipruritics|antipruritics|mesh-ancestor
110057393|NCT01507194|Dermatologic Agents|dermatologic agents|mesh-ancestor
110057394|NCT01507194|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110057396|NCT01507194|Serotonin Agents|serotonin agents|mesh-ancestor
110057397|NCT01507194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110057398|NCT01507194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110057399|NCT01507194|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110057400|NCT01507272|Liraglutide|liraglutide|mesh-list
110057401|NCT01507272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110057402|NCT01507272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057403|NCT01507272|Incretins|incretins|mesh-ancestor
110057404|NCT01507272|Hormones|hormones|mesh-ancestor
110057405|NCT01507272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110057406|NCT01507285|Liraglutide|liraglutide|mesh-list
110057407|NCT01507285|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110057408|NCT01507285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057409|NCT01507285|Incretins|incretins|mesh-ancestor
110057410|NCT01507285|Hormones|hormones|mesh-ancestor
110057411|NCT01507285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110057412|NCT01507311|Liraglutide|liraglutide|mesh-list
110057413|NCT01507311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110057414|NCT01507311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057415|NCT01507311|Incretins|incretins|mesh-ancestor
110057416|NCT01507311|Hormones|hormones|mesh-ancestor
110057417|NCT01507311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110057418|NCT01507337|Liraglutide|liraglutide|mesh-list
110057419|NCT01507337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110057420|NCT01507337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057421|NCT01507337|Incretins|incretins|mesh-ancestor
110057422|NCT01507337|Hormones|hormones|mesh-ancestor
110057423|NCT01507337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110057424|NCT01507363|Gabapentin|gabapentin|mesh-list
110057425|NCT01507363|Analgesics|analgesics|mesh-ancestor
110057426|NCT01507363|Sensory System Agents|sensory system agents|mesh-ancestor
110057427|NCT01507363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110057428|NCT01507363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057430|NCT01507363|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110057431|NCT01507363|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110057432|NCT01507363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110057433|NCT01507363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110057434|NCT01507363|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110057435|NCT01507363|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110057436|NCT01507363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110057437|NCT01507363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110057438|NCT01507363|Antimanic Agents|antimanic agents|mesh-ancestor
110057439|NCT01507376|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110057440|NCT01507376|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110057441|NCT01507376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057442|NCT01507389|Liraglutide|liraglutide|mesh-list
110057443|NCT01507389|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110057444|NCT01507389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057445|NCT01507389|Incretins|incretins|mesh-ancestor
110057446|NCT01507389|Hormones|hormones|mesh-ancestor
110057447|NCT01507389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110057448|NCT01507428|Deoxyglucose|deoxyglucose|mesh-list
110057449|NCT01507428|Misonidazole|misonidazole|mesh-list
110057450|NCT01507428|Paclitaxel|paclitaxel|mesh-list
110057451|NCT01507428|Carboplatin|carboplatin|mesh-list
110057452|NCT01507428|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110057453|NCT01507428|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110057455|NCT01507428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110057456|NCT01507428|Tubulin Modulators|tubulin modulators|mesh-ancestor
110057457|NCT01507428|Antimitotic Agents|antimitotic agents|mesh-ancestor
110057458|NCT01507428|Mitosis Modulators|mitosis modulators|mesh-ancestor
110057459|NCT01507428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110057460|NCT01507428|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110057461|NCT01507428|Antimetabolites|antimetabolites|mesh-ancestor
110057462|NCT01507428|Antiviral Agents|antiviral agents|mesh-ancestor
110057463|NCT01507428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110057464|NCT01507428|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110057465|NCT01507428|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110057466|NCT01507454|Estradiol|estradiol|mesh-list
110057467|NCT01507454|Estrogens|estrogens|mesh-ancestor
110057468|NCT01507454|Hormones|hormones|mesh-ancestor
110057469|NCT01507454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110057470|NCT01507454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057471|NCT01507467|Nimorazole|nimorazole|mesh-list
110057472|NCT01507467|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
110057473|NCT01507467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110057474|NCT01507467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110057475|NCT01507467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110057476|NCT01507480|Bevacizumab|bevacizumab|mesh-list
110057477|NCT01507480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110057478|NCT01507480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110057479|NCT01507480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110057480|NCT01507480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110057481|NCT01507480|Growth Substances|growth substances|mesh-ancestor
110057482|NCT01507480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057483|NCT01507480|Growth Inhibitors|growth inhibitors|mesh-ancestor
110057484|NCT01507519|Sirolimus|sirolimus|mesh-list
110057485|NCT01507519|Temsirolimus|temsirolimus|mesh-list
110057486|NCT01507519|MTOR Inhibitors|mtor inhibitors|mesh-list
110057487|NCT01507519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110057488|NCT01507519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110057489|NCT01507519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110057490|NCT01507519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110057491|NCT01507519|Antifungal Agents|antifungal agents|mesh-ancestor
110057492|NCT01507519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110057493|NCT01507519|Immunologic Factors|immunologic factors|mesh-ancestor
110057494|NCT01507519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057495|NCT01507519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110057496|NCT01507519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110057497|NCT01507519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110057498|NCT01507558|Dexamethasone|dexamethasone|mesh-list
110057499|NCT01507558|Dexamethasone acetate|dexamethasone acetate|mesh-list
110057501|NCT01507558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110057502|NCT01507558|Antiemetics|antiemetics|mesh-ancestor
110057503|NCT01507558|Autonomic Agents|autonomic agents|mesh-ancestor
110057504|NCT01507558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110057505|NCT01507558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057506|NCT01507558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110057508|NCT01507558|Hormones|hormones|mesh-ancestor
110057509|NCT01507558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110057510|NCT01507558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110057511|NCT01507558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110057512|NCT01507558|Protease Inhibitors|protease inhibitors|mesh-ancestor
110057513|NCT01507558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110057514|NCT01507558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110057515|NCT01507571|Psychotropic Drugs|psychotropic drugs|mesh-list
110057516|NCT01507597|Glucagon|glucagon|mesh-list
110057517|NCT01507597|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110057518|NCT01507597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110057519|NCT01507597|Hormones|hormones|mesh-ancestor
110057520|NCT01507597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110057521|NCT01507597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057522|NCT01507597|Incretins|incretins|mesh-ancestor
110057523|NCT01507701|Clonidine|clonidine|mesh-list
110057524|NCT01507701|Analgesics|analgesics|mesh-ancestor
110057525|NCT01507701|Sensory System Agents|sensory system agents|mesh-ancestor
110057526|NCT01507701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110057527|NCT01507701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057529|NCT01507701|Sympatholytics|sympatholytics|mesh-ancestor
110057530|NCT01507701|Autonomic Agents|autonomic agents|mesh-ancestor
110057532|NCT01507701|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110057533|NCT01507701|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110057534|NCT01507701|Adrenergic Agents|adrenergic agents|mesh-ancestor
110057535|NCT01507701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110057536|NCT01507701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110057537|NCT01507727|Tolvaptan|tolvaptan|mesh-list
110057538|NCT01507727|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110057539|NCT01507727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110057540|NCT01507727|Natriuretic Agents|natriuretic agents|mesh-ancestor
110057541|NCT01507727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057542|NCT01507740|Bevacizumab|bevacizumab|mesh-list
110057543|NCT01507740|Sorafenib|sorafenib|mesh-list
110057622|NCT01507610|Sumatriptan|sumatriptan|mesh-list
110057544|NCT01507740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110057545|NCT01507740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110057546|NCT01507740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110057547|NCT01507740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110057548|NCT01507740|Growth Substances|growth substances|mesh-ancestor
110057549|NCT01507740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057550|NCT01507740|Growth Inhibitors|growth inhibitors|mesh-ancestor
110057551|NCT01507740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110057552|NCT01507740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110057553|NCT01507740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110057554|NCT01507792|Loratadine|loratadine|mesh-list
110057555|NCT01507792|Omeprazole|omeprazole|mesh-list
110057556|NCT01507792|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
110057557|NCT01507792|Histamine|histamine|mesh-list
110057558|NCT01507792|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110057559|NCT01507792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110057560|NCT01507792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110057561|NCT01507792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110057562|NCT01507792|Antipruritics|antipruritics|mesh-ancestor
110057563|NCT01507792|Dermatologic Agents|dermatologic agents|mesh-ancestor
110057564|NCT01507792|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110057565|NCT01507792|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110057566|NCT01507792|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110057567|NCT01507792|Histamine Antagonists|histamine antagonists|mesh-ancestor
110057568|NCT01507792|Histamine Agents|histamine agents|mesh-ancestor
110057569|NCT01507792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110057570|NCT01507792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057571|NCT01507792|Histamine Agonists|histamine agonists|mesh-ancestor
110057573|NCT01507857|Immunologic Factors|immunologic factors|mesh-ancestor
110057574|NCT01507857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057575|NCT01507922|Fenoverine|fenoverine|mesh-list
110057576|NCT01507922|Parasympatholytics|parasympatholytics|mesh-ancestor
110057577|NCT01507922|Autonomic Agents|autonomic agents|mesh-ancestor
110057578|NCT01507922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110057579|NCT01507922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057580|NCT01507974|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110057581|NCT01507974|Amoxicillin|amoxicillin|mesh-list
110057582|NCT01507974|Clavulanic Acid|clavulanic acid|mesh-list
110057583|NCT01507974|Cephalexin|cephalexin|mesh-list
110057584|NCT01507974|Cefuroxime|cefuroxime|mesh-list
110057585|NCT01507974|Nitrofurantoin|nitrofurantoin|mesh-list
110057586|NCT01507974|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110057587|NCT01507974|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110057588|NCT01507974|Trimethoprim|trimethoprim|mesh-list
110057589|NCT01507974|Sulfamethoxazole|sulfamethoxazole|mesh-list
110057590|NCT01507974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110057591|NCT01507974|Antitubercular Agents|antitubercular agents|mesh-ancestor
110057592|NCT01507974|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110057593|NCT01507974|Antimalarials|antimalarials|mesh-ancestor
110057594|NCT01507974|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110057595|NCT01507974|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110057596|NCT01507974|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110057597|NCT01507974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110057598|NCT01507974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110057599|NCT01507974|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110057600|NCT01507974|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110057601|NCT01507974|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110057602|NCT01507974|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110057603|NCT01508000|Bevacizumab|bevacizumab|mesh-list
110057604|NCT01508000|Panitumumab|panitumumab|mesh-list
110057605|NCT01508000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110057606|NCT01508000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110057607|NCT01508000|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110057608|NCT01508000|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110057609|NCT01508000|Growth Substances|growth substances|mesh-ancestor
110057610|NCT01508000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057611|NCT01508000|Growth Inhibitors|growth inhibitors|mesh-ancestor
110057613|NCT01508104|Dactolisib|dactolisib|mesh-list
110057614|NCT01508104|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110057615|NCT01508104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110057616|NCT01508104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110057617|NCT01508104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110057618|NCT01508104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110057619|NCT01508104|Immunologic Factors|immunologic factors|mesh-ancestor
110057620|NCT01508104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057621|NCT01508104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110057623|NCT01507610|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110057624|NCT01507610|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110057626|NCT01507610|Serotonin Agents|serotonin agents|mesh-ancestor
110057627|NCT01507610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110057628|NCT01507610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110057629|NCT01507610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057630|NCT01508143|Misoprostol|misoprostol|mesh-list
110057631|NCT01508143|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110057632|NCT01508143|Abortifacient Agents|abortifacient agents|mesh-ancestor
110057633|NCT01508143|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110057634|NCT01508143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057635|NCT01508143|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110057636|NCT01508143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110057637|NCT01508143|Oxytocics|oxytocics|mesh-ancestor
110057638|NCT01508182|Metformin|metformin|mesh-list
110057639|NCT01508182|Canagliflozin|canagliflozin|mesh-list
110057640|NCT01508182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110057641|NCT01508182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057642|NCT01508182|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110057643|NCT01508182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110057644|NCT01508195|Metformin|metformin|mesh-list
110057645|NCT01508195|Canagliflozin|canagliflozin|mesh-list
110057646|NCT01508195|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110057647|NCT01508195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057648|NCT01508195|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110057649|NCT01508195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110057650|NCT01508260|Furosemide|furosemide|mesh-list
110057651|NCT01508260|Diuretics|diuretics|mesh-ancestor
110057652|NCT01508260|Natriuretic Agents|natriuretic agents|mesh-ancestor
110057653|NCT01508260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057654|NCT01508260|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110057655|NCT01508260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110057656|NCT01508260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110057657|NCT01508286|Ribavirin|ribavirin|mesh-list
110057658|NCT01508286|Antimetabolites|antimetabolites|mesh-ancestor
110057659|NCT01508286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110057660|NCT01508286|Antiviral Agents|antiviral agents|mesh-ancestor
110057661|NCT01508286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110057662|NCT01508364|Sorafenib|sorafenib|mesh-list
110057663|NCT01508364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110057664|NCT01508364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110057666|NCT01508364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110057667|NCT01508429|Misoprostol|misoprostol|mesh-list
110057668|NCT01508429|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110057669|NCT01508429|Abortifacient Agents|abortifacient agents|mesh-ancestor
110057670|NCT01508429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110057671|NCT01508429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057672|NCT01508429|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110057673|NCT01508429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110057674|NCT01508429|Oxytocics|oxytocics|mesh-ancestor
110057675|NCT01508468|Rituximab|rituximab|mesh-list
110057676|NCT01508468|Angiotensin II|angiotensin ii|mesh-list
110057677|NCT01508468|Giapreza|giapreza|mesh-list
110057678|NCT01508468|Calcium|calcium|mesh-list
110057679|NCT01508468|Diuretics|diuretics|mesh-list
110057680|NCT01508468|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110057681|NCT01508468|Enzyme Inhibitors|enzyme inhibitors|mesh-list
110057682|NCT01508468|Angiotensinogen|angiotensinogen|mesh-list
110057683|NCT01508468|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
110057685|NCT01508468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110057686|NCT01508468|Immunologic Factors|immunologic factors|mesh-ancestor
110057687|NCT01508468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057688|NCT01508468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110057689|NCT01508468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110057690|NCT01508468|Natriuretic Agents|natriuretic agents|mesh-ancestor
110057691|NCT01508468|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110057692|NCT01508468|Adrenergic Agents|adrenergic agents|mesh-ancestor
110057693|NCT01508468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110057694|NCT01508468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110057695|NCT01508468|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110057696|NCT01508468|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110057697|NCT01508468|Protease Inhibitors|protease inhibitors|mesh-ancestor
110057698|NCT01508468|Hormone Antagonists|hormone antagonists|mesh-ancestor
110057699|NCT01508468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110057700|NCT01508468|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110057701|NCT01508494|Galantamine|galantamine|mesh-list
110057702|NCT01508494|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110057703|NCT01508494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110057704|NCT01508494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110057705|NCT01508494|Cholinergic Agents|cholinergic agents|mesh-ancestor
110057707|NCT01508494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057708|NCT01508494|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110057710|NCT01508494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110057711|NCT01508494|Nootropic Agents|nootropic agents|mesh-ancestor
110057712|NCT01508572|Bevacizumab|bevacizumab|mesh-list
110057713|NCT01508572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110057714|NCT01508572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110057715|NCT01508572|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110057716|NCT01508572|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110057717|NCT01508572|Growth Substances|growth substances|mesh-ancestor
110057718|NCT01508572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057719|NCT01508572|Growth Inhibitors|growth inhibitors|mesh-ancestor
110057720|NCT01508611|Fluorides|fluorides|mesh-list
110057721|NCT01508611|Cariostatic Agents|cariostatic agents|mesh-ancestor
110057722|NCT01508611|Protective Agents|protective agents|mesh-ancestor
110057723|NCT01508611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057724|NCT01508637|Terazosin|terazosin|mesh-list
110057725|NCT01508637|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110057726|NCT01508637|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110057727|NCT01508637|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110057728|NCT01508637|Adrenergic Agents|adrenergic agents|mesh-ancestor
110057729|NCT01508637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110057730|NCT01508637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110057731|NCT01508637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057732|NCT01508637|Urological Agents|urological agents|mesh-ancestor
110057733|NCT01508663|Everolimus|everolimus|mesh-list
110057734|NCT01508663|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110057735|NCT01508663|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110057736|NCT01508663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110057737|NCT01508663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110057738|NCT01508663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110057739|NCT01508663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110057740|NCT01508663|Immunologic Factors|immunologic factors|mesh-ancestor
110057741|NCT01508663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057742|NCT01508663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110057743|NCT01508663|Protease Inhibitors|protease inhibitors|mesh-ancestor
110057744|NCT01508741|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110057745|NCT01508741|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110057746|NCT01508741|Dermatologic Agents|dermatologic agents|mesh-ancestor
110057747|NCT01508806|Liraglutide|liraglutide|mesh-list
110057748|NCT01508806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110057749|NCT01508806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057750|NCT01508806|Incretins|incretins|mesh-ancestor
110057751|NCT01508806|Hormones|hormones|mesh-ancestor
110057752|NCT01508806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110057753|NCT01508845|Vitamin D|vitamin d|mesh-list
110057754|NCT01508845|Ergocalciferols|ergocalciferols|mesh-list
110057755|NCT01508845|Cholecalciferol|cholecalciferol|mesh-list
110057756|NCT01508845|Vitamins|vitamins|mesh-list
110057757|NCT01508845|Micronutrients|micronutrients|mesh-ancestor
110057758|NCT01508845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057759|NCT01508845|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110057763|NCT01508858|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110057764|NCT01508858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110057765|NCT01508858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057766|NCT01508858|Incretins|incretins|mesh-ancestor
110057767|NCT01508858|Hormones|hormones|mesh-ancestor
110057768|NCT01508858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110057769|NCT01508858|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110057770|NCT01508858|Contraceptive Agents|contraceptive agents|mesh-ancestor
110057771|NCT01508858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110057772|NCT01508858|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110057773|NCT01508858|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110057774|NCT01508858|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110057775|NCT01508858|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110057776|NCT01508858|Estrogens|estrogens|mesh-ancestor
110057777|NCT01508884|Imiquimod|imiquimod|mesh-list
110057778|NCT01508884|Vaccines|vaccines|mesh-list
110057779|NCT01508884|Immunologic Factors|immunologic factors|mesh-ancestor
110058087|NCT01511029|Pramipexole|pramipexole|mesh-list
110057780|NCT01508884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057781|NCT01508884|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110057782|NCT01508884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110057783|NCT01508884|Interferon Inducers|interferon inducers|mesh-ancestor
110057785|NCT01508897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110057786|NCT01508897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057787|NCT01508897|Incretins|incretins|mesh-ancestor
110057788|NCT01508897|Hormones|hormones|mesh-ancestor
110057789|NCT01508897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110057790|NCT01508923|Liraglutide|liraglutide|mesh-list
110057791|NCT01508923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110057792|NCT01508923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057793|NCT01508923|Incretins|incretins|mesh-ancestor
110057794|NCT01508923|Hormones|hormones|mesh-ancestor
110057795|NCT01508923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110057796|NCT01508949|Liraglutide|liraglutide|mesh-list
110057797|NCT01508949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110057798|NCT01508949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057799|NCT01508949|Incretins|incretins|mesh-ancestor
110057800|NCT01508949|Hormones|hormones|mesh-ancestor
110057801|NCT01508949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110057802|NCT01509001|Metformin|metformin|mesh-list
110057803|NCT01509001|Glimepiride|glimepiride|mesh-list
110057804|NCT01509001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110057805|NCT01509001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057806|NCT01509001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110057807|NCT01509001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110057808|NCT01509001|Immunologic Factors|immunologic factors|mesh-ancestor
110057809|NCT01509131|Bisacodyl|bisacodyl|mesh-list
110057810|NCT01509131|Cathartics|cathartics|mesh-ancestor
110057811|NCT01509131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110057812|NCT01509131|Laxatives|laxatives|mesh-ancestor
110057813|NCT01509144|Vaccines|vaccines|mesh-list
110057814|NCT01509144|Immunologic Factors|immunologic factors|mesh-ancestor
110057815|NCT01509144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057816|NCT01509209|Pseudoephedrine|pseudoephedrine|mesh-list
110057817|NCT01509209|Ephedrine|ephedrine|mesh-list
110057818|NCT01509209|Levocetirizine|levocetirizine|mesh-list
110057819|NCT01509209|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110057820|NCT01509209|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110057821|NCT01509209|Histamine Antagonists|histamine antagonists|mesh-ancestor
110057822|NCT01509209|Histamine Agents|histamine agents|mesh-ancestor
110057823|NCT01509209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110057824|NCT01509209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110057825|NCT01509209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057826|NCT01509209|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110057827|NCT01509209|Autonomic Agents|autonomic agents|mesh-ancestor
110057828|NCT01509209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110057829|NCT01509209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110057830|NCT01509209|Respiratory System Agents|respiratory system agents|mesh-ancestor
110057831|NCT01509209|Nasal Decongestants|nasal decongestants|mesh-ancestor
110057832|NCT01509209|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110057833|NCT01509209|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110057834|NCT01509209|Sympathomimetics|sympathomimetics|mesh-ancestor
110057835|NCT01509209|Adrenergic Agents|adrenergic agents|mesh-ancestor
110057836|NCT01509261|Lansoprazole|lansoprazole|mesh-list
110057837|NCT01509261|Dexlansoprazole|dexlansoprazole|mesh-list
110057838|NCT01509261|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110057839|NCT01509261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110057840|NCT01509261|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110057841|NCT01509261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110057842|NCT01509261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110057843|NCT01509300|Mycophenolic Acid|mycophenolic acid|mesh-list
110057844|NCT01509300|Cyclophosphamide|cyclophosphamide|mesh-list
110057845|NCT01509300|Rituximab|rituximab|mesh-list
110057846|NCT01509300|Fludarabine|fludarabine|mesh-list
110057847|NCT01509300|Tacrolimus|tacrolimus|mesh-list
110057848|NCT01509300|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110057849|NCT01509300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110057850|NCT01509300|Immunologic Factors|immunologic factors|mesh-ancestor
110057851|NCT01509300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057852|NCT01509300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110057853|NCT01509300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110057854|NCT01509300|Alkylating Agents|alkylating agents|mesh-ancestor
110057855|NCT01509300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110057856|NCT01509300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110057857|NCT01509300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110057858|NCT01509300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110057859|NCT01509300|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110057860|NCT01509300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110057861|NCT01509300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110057862|NCT01509300|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110057863|NCT01509300|Antitubercular Agents|antitubercular agents|mesh-ancestor
110057864|NCT01509300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110057865|NCT01509300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110057867|NCT01509365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110057868|NCT01509365|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110057869|NCT01509365|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110057870|NCT01509365|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110057871|NCT01509365|Purinergic Agents|purinergic agents|mesh-ancestor
110057872|NCT01509365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110057873|NCT01509365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110057874|NCT01509365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057875|NCT01509391|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
110057876|NCT01509391|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110057877|NCT01509391|Immunologic Factors|immunologic factors|mesh-ancestor
110057878|NCT01509391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057879|NCT01509469|Caseins|caseins|mesh-list
110057880|NCT01509469|Chelating Agents|chelating agents|mesh-ancestor
110057881|NCT01509469|Sequestering Agents|sequestering agents|mesh-ancestor
110057882|NCT01509469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110057883|NCT01509521|Phenylephrine|phenylephrine|mesh-list
110057884|NCT01509521|Oxymetazoline|oxymetazoline|mesh-list
110057886|NCT01509521|Pseudoephedrine|pseudoephedrine|mesh-list
110057887|NCT01509521|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110057888|NCT01509521|Mydriatics|mydriatics|mesh-ancestor
110057889|NCT01509521|Autonomic Agents|autonomic agents|mesh-ancestor
110057890|NCT01509521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110057891|NCT01509521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057892|NCT01509521|Sympathomimetics|sympathomimetics|mesh-ancestor
110057893|NCT01509521|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110057894|NCT01509521|Nasal Decongestants|nasal decongestants|mesh-ancestor
110057895|NCT01509521|Respiratory System Agents|respiratory system agents|mesh-ancestor
110057896|NCT01509521|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110057897|NCT01509521|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110057898|NCT01509521|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110057899|NCT01509521|Adrenergic Agents|adrenergic agents|mesh-ancestor
110057900|NCT01509521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110057901|NCT01509521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110057902|NCT01509521|Protective Agents|protective agents|mesh-ancestor
110057903|NCT01509521|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110057904|NCT01509521|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110057905|NCT01509521|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110057906|NCT01509560|Everolimus|everolimus|mesh-list
110057907|NCT01509560|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110057908|NCT01509560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110057909|NCT01509560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110057911|NCT01509560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110057912|NCT01509560|Immunologic Factors|immunologic factors|mesh-ancestor
110057913|NCT01509560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057914|NCT01509560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110057915|NCT01509599|Methyl salicylate|methyl salicylate|mesh-list
110057916|NCT01509599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110057917|NCT01509742|Liraglutide|liraglutide|mesh-list
110057918|NCT01509742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110057919|NCT01509742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057920|NCT01509742|Incretins|incretins|mesh-ancestor
110057921|NCT01509742|Hormones|hormones|mesh-ancestor
110057922|NCT01509742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110057923|NCT01509755|Liraglutide|liraglutide|mesh-list
110057924|NCT01509755|Glimepiride|glimepiride|mesh-list
110057925|NCT01509755|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110057926|NCT01509755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057927|NCT01509755|Incretins|incretins|mesh-ancestor
110057928|NCT01509755|Hormones|hormones|mesh-ancestor
110057929|NCT01509755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110057930|NCT01509755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110057931|NCT01509755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110057932|NCT01509755|Immunologic Factors|immunologic factors|mesh-ancestor
110057933|NCT01509911|Gemcitabine|gemcitabine|mesh-list
110057934|NCT01509911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110057935|NCT01509911|Antimetabolites|antimetabolites|mesh-ancestor
110057936|NCT01509911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110057937|NCT01509911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110057938|NCT01509976|Triclosan|triclosan|mesh-list
110057939|NCT01509976|Triclocarban|triclocarban|mesh-list
110057940|NCT01509976|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110057941|NCT01509976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110057942|NCT01509976|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110057943|NCT01509976|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110057945|NCT01509976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110057946|NCT01509976|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110057947|NCT01510015|Risperidone|risperidone|mesh-list
110057948|NCT01510015|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110057949|NCT01510015|Serotonin Agents|serotonin agents|mesh-ancestor
110057950|NCT01510015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110057951|NCT01510015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110057952|NCT01510015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057953|NCT01510015|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110057954|NCT01510015|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110057955|NCT01510015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110057956|NCT01510015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110057957|NCT01510015|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110057958|NCT01510015|Dopamine Agents|dopamine agents|mesh-ancestor
110057959|NCT01510093|Insulin Aspart|insulin aspart|mesh-list
110057960|NCT01510093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110057961|NCT01510093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057962|NCT01510132|Timolol|timolol|mesh-list
110057963|NCT01510132|Travoprost|travoprost|mesh-list
110057964|NCT01510132|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110057965|NCT01510132|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110057966|NCT01510132|Adrenergic Agents|adrenergic agents|mesh-ancestor
110057967|NCT01510132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110057968|NCT01510132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110057969|NCT01510132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057970|NCT01510132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110057971|NCT01510132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110057972|NCT01510171|Ticagrelor|ticagrelor|mesh-list
110057973|NCT01510171|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110057974|NCT01510171|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110057975|NCT01510171|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110057976|NCT01510171|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110057977|NCT01510171|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110057978|NCT01510171|Purinergic Agents|purinergic agents|mesh-ancestor
110057979|NCT01510171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110057980|NCT01510171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110057981|NCT01510171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057983|NCT01510288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110057984|NCT01510288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110057985|NCT01510288|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110057986|NCT01510288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110057988|NCT01510366|Immunologic Factors|immunologic factors|mesh-ancestor
110057989|NCT01510366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057990|NCT01510431|Remestemcel-l|remestemcel-l|mesh-list
110057991|NCT01510431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110057992|NCT01510431|Antiviral Agents|antiviral agents|mesh-ancestor
110057993|NCT01510431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110057994|NCT01510509|Everolimus|everolimus|mesh-list
110057995|NCT01510509|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110057996|NCT01510509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110057997|NCT01510509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110057998|NCT01510509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110057999|NCT01510509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110058000|NCT01510509|Immunologic Factors|immunologic factors|mesh-ancestor
110058001|NCT01510509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058002|NCT01510509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110058003|NCT01510522|Metformin|metformin|mesh-list
110058004|NCT01510522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110058005|NCT01510522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058006|NCT01510548|Adalimumab|adalimumab|mesh-list
110058007|NCT01510548|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110058008|NCT01510548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110058009|NCT01510548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110058010|NCT01510561|Gemcitabine|gemcitabine|mesh-list
110058011|NCT01510561|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
110058012|NCT01510561|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110058013|NCT01510561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110058014|NCT01510561|Antimetabolites|antimetabolites|mesh-ancestor
110058015|NCT01510561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110058016|NCT01510561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110058017|NCT01510561|Chelating Agents|chelating agents|mesh-ancestor
110058018|NCT01510561|Sequestering Agents|sequestering agents|mesh-ancestor
110058019|NCT01510561|Immunologic Factors|immunologic factors|mesh-ancestor
110058020|NCT01510561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058021|NCT01510574|Misoprostol|misoprostol|mesh-list
110058022|NCT01510574|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110058023|NCT01510574|Abortifacient Agents|abortifacient agents|mesh-ancestor
110058024|NCT01510574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110058025|NCT01510574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058026|NCT01510574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110058027|NCT01510574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110058028|NCT01510574|Oxytocics|oxytocics|mesh-ancestor
110058029|NCT01510613|Dexamethasone|dexamethasone|mesh-list
110058030|NCT01510613|Pomalidomide|pomalidomide|mesh-list
110058031|NCT01510613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110058032|NCT01510613|Antiemetics|antiemetics|mesh-ancestor
110058033|NCT01510613|Autonomic Agents|autonomic agents|mesh-ancestor
110058034|NCT01510613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110058035|NCT01510613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058036|NCT01510613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110058037|NCT01510613|Glucocorticoids|glucocorticoids|mesh-ancestor
110058038|NCT01510613|Hormones|hormones|mesh-ancestor
110058039|NCT01510613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110058040|NCT01510613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110058041|NCT01510613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110058042|NCT01510613|Immunologic Factors|immunologic factors|mesh-ancestor
110058043|NCT01510613|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110058044|NCT01510613|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110058045|NCT01510613|Growth Substances|growth substances|mesh-ancestor
110058046|NCT01510613|Growth Inhibitors|growth inhibitors|mesh-ancestor
110058047|NCT01510626|Omalizumab|omalizumab|mesh-list
110058048|NCT01510626|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110058049|NCT01510626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110058050|NCT01510626|Respiratory System Agents|respiratory system agents|mesh-ancestor
110058051|NCT01510665|Magnesium citrate|magnesium citrate|mesh-list
110058052|NCT01510665|Cathartics|cathartics|mesh-ancestor
110058053|NCT01510665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110058054|NCT01510795|Spironolactone|spironolactone|mesh-list
110058055|NCT01510795|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110058056|NCT01510795|Hormone Antagonists|hormone antagonists|mesh-ancestor
110058057|NCT01510795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110058058|NCT01510795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058059|NCT01510795|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110058061|NCT01510795|Natriuretic Agents|natriuretic agents|mesh-ancestor
110058062|NCT01510847|Testosterone undecanoate|testosterone undecanoate|mesh-list
110058063|NCT01510847|Androgens|androgens|mesh-ancestor
110058064|NCT01510847|Hormones|hormones|mesh-ancestor
110058065|NCT01510847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110058066|NCT01510847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058067|NCT01510860|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
110058068|NCT01510860|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110058069|NCT01510860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110058070|NCT01510977|Bisacodyl|bisacodyl|mesh-list
110058071|NCT01510977|Cathartics|cathartics|mesh-ancestor
110058072|NCT01510977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110058073|NCT01510977|Laxatives|laxatives|mesh-ancestor
110058074|NCT01510990|Gefitinib|gefitinib|mesh-list
110058075|NCT01510990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110058076|NCT01510990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110058077|NCT01510990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110058078|NCT01510990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110058079|NCT01511003|Tacrolimus|tacrolimus|mesh-list
110058080|NCT01511003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110058081|NCT01511003|Immunologic Factors|immunologic factors|mesh-ancestor
110058082|NCT01511003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058083|NCT01511003|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110058084|NCT01511003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110058085|NCT01511003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110058086|NCT01511029|Moxifloxacin|moxifloxacin|mesh-list
110058088|NCT01511029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110058089|NCT01511029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110058090|NCT01511029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110058091|NCT01511029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110058092|NCT01511029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110058093|NCT01511029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110058094|NCT01511029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110058095|NCT01511029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058096|NCT01511029|Antioxidants|antioxidants|mesh-ancestor
110058097|NCT01511029|Protective Agents|protective agents|mesh-ancestor
110058098|NCT01511029|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110058099|NCT01511029|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110058101|NCT01511029|Dopamine Agents|dopamine agents|mesh-ancestor
110058102|NCT01511029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110058103|NCT01511146|Gemcitabine|gemcitabine|mesh-list
110058104|NCT01511146|Oxaliplatin|oxaliplatin|mesh-list
110058105|NCT01511146|Mitomycins|mitomycins|mesh-list
110058106|NCT01511146|Mitomycin|mitomycin|mesh-list
110058107|NCT01511146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110058108|NCT01511146|Antimetabolites|antimetabolites|mesh-ancestor
110058109|NCT01511146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110058110|NCT01511146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110058111|NCT01511146|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110058112|NCT01511146|Alkylating Agents|alkylating agents|mesh-ancestor
110058113|NCT01511146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110058114|NCT01511146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110058115|NCT01511159|Insulin|insulin|mesh-list
110058116|NCT01511159|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110058117|NCT01511159|Liraglutide|liraglutide|mesh-list
110058118|NCT01511159|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110058119|NCT01511159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058120|NCT01511159|Incretins|incretins|mesh-ancestor
110058121|NCT01511159|Hormones|hormones|mesh-ancestor
110058122|NCT01511159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110058123|NCT01511172|Metformin|metformin|mesh-list
110058124|NCT01511172|Liraglutide|liraglutide|mesh-list
110058125|NCT01511172|Glimepiride|glimepiride|mesh-list
110058126|NCT01511172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110058128|NCT01511172|Incretins|incretins|mesh-ancestor
110058130|NCT01511172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110058131|NCT01511172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110058132|NCT01511172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110058133|NCT01511172|Immunologic Factors|immunologic factors|mesh-ancestor
110058134|NCT01511185|Liraglutide|liraglutide|mesh-list
110058135|NCT01511185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110058136|NCT01511185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058137|NCT01511185|Incretins|incretins|mesh-ancestor
110058138|NCT01511185|Hormones|hormones|mesh-ancestor
110058139|NCT01511185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110058141|NCT01511198|Liraglutide|liraglutide|mesh-list
110058142|NCT01511198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110058143|NCT01511198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058144|NCT01511198|Incretins|incretins|mesh-ancestor
110058145|NCT01511198|Hormones|hormones|mesh-ancestor
110058146|NCT01511198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110058147|NCT01511211|Dexamethasone|dexamethasone|mesh-list
110058148|NCT01511211|Ropivacaine|ropivacaine|mesh-list
110058149|NCT01511211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110058150|NCT01511211|Antiemetics|antiemetics|mesh-ancestor
110058151|NCT01511211|Autonomic Agents|autonomic agents|mesh-ancestor
110058152|NCT01511211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110058153|NCT01511211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058154|NCT01511211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110058155|NCT01511211|Glucocorticoids|glucocorticoids|mesh-ancestor
110058156|NCT01511211|Hormones|hormones|mesh-ancestor
110058157|NCT01511211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110058158|NCT01511211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110058159|NCT01511211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110058160|NCT01511211|Anesthetics, Local|anesthetics, local|mesh-ancestor
110058161|NCT01511211|Anesthetics|anesthetics|mesh-ancestor
110058162|NCT01511211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110058163|NCT01511211|Sensory System Agents|sensory system agents|mesh-ancestor
110058164|NCT01511237|Lamivudine|lamivudine|mesh-list
110058165|NCT01511237|Zidovudine|zidovudine|mesh-list
110058166|NCT01511237|Nevirapine|nevirapine|mesh-list
110058167|NCT01511237|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110058168|NCT01511237|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110058169|NCT01511237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110058170|NCT01511237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110058171|NCT01511237|Antiviral Agents|antiviral agents|mesh-ancestor
110058172|NCT01511237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110058173|NCT01511237|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110058174|NCT01511237|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110058175|NCT01511237|Antimetabolites|antimetabolites|mesh-ancestor
110058176|NCT01511237|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110058177|NCT01511237|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110058179|NCT01511263|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
110058180|NCT01511263|Diuretics|diuretics|mesh-list
110058181|NCT01511263|Natriuretic Agents|natriuretic agents|mesh-ancestor
110058182|NCT01511263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058183|NCT01511263|Vasodilator Agents|vasodilator agents|mesh-ancestor
110058184|NCT01511263|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110058185|NCT01511263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110058186|NCT01511263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110058187|NCT01511263|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110058188|NCT01511263|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110058189|NCT01511263|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110058190|NCT01511263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110058191|NCT01511263|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110058192|NCT01511263|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110058193|NCT01511263|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110058195|NCT01511289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110058196|NCT01511289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110058197|NCT01511289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110058198|NCT01511289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110058199|NCT01511302|Budesonide|budesonide|mesh-list
110058202|NCT01511302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110058203|NCT01511302|Autonomic Agents|autonomic agents|mesh-ancestor
110058204|NCT01511302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110058205|NCT01511302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058206|NCT01511302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110058207|NCT01511302|Respiratory System Agents|respiratory system agents|mesh-ancestor
110058208|NCT01511302|Glucocorticoids|glucocorticoids|mesh-ancestor
110058209|NCT01511302|Hormones|hormones|mesh-ancestor
110058210|NCT01511302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110058211|NCT01511302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110058212|NCT01511302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110058213|NCT01511302|Analgesics|analgesics|mesh-ancestor
110058214|NCT01511302|Sensory System Agents|sensory system agents|mesh-ancestor
110058215|NCT01511302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110058216|NCT01511302|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110058217|NCT01511367|Fluticasone|fluticasone|mesh-list
110058218|NCT01511367|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110058219|NCT01511367|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110058220|NCT01511367|Autonomic Agents|autonomic agents|mesh-ancestor
110058221|NCT01511367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110058222|NCT01511367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058223|NCT01511367|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110058224|NCT01511367|Respiratory System Agents|respiratory system agents|mesh-ancestor
110058225|NCT01511367|Glucocorticoids|glucocorticoids|mesh-ancestor
110058226|NCT01511367|Hormones|hormones|mesh-ancestor
110058227|NCT01511367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110058228|NCT01511367|Sympathomimetics|sympathomimetics|mesh-ancestor
110058229|NCT01511367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110058230|NCT01511367|Dermatologic Agents|dermatologic agents|mesh-ancestor
110058231|NCT01511367|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110058232|NCT01511471|Ticagrelor|ticagrelor|mesh-list
110058233|NCT01511471|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110058234|NCT01511471|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110058235|NCT01511471|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110058236|NCT01511471|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110058237|NCT01511471|Purinergic Agents|purinergic agents|mesh-ancestor
110058238|NCT01511471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110058239|NCT01511471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110058240|NCT01511471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058241|NCT01511562|Cytarabine|cytarabine|mesh-list
110058242|NCT01511562|Etoposide|etoposide|mesh-list
110058243|NCT01511562|Thiotepa|thiotepa|mesh-list
110058244|NCT01511562|Carmustine|carmustine|mesh-list
110058245|NCT01511562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110058246|NCT01511562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110058247|NCT01511562|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110058248|NCT01511562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110058249|NCT01511562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110058250|NCT01511562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110058251|NCT01511562|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110058252|NCT01511562|Antimetabolites|antimetabolites|mesh-ancestor
110058253|NCT01511562|Antiviral Agents|antiviral agents|mesh-ancestor
110058254|NCT01511562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110058255|NCT01511562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110058256|NCT01511562|Immunologic Factors|immunologic factors|mesh-ancestor
110058257|NCT01511562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058258|NCT01511562|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110058259|NCT01511562|Alkylating Agents|alkylating agents|mesh-ancestor
110058260|NCT01511562|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110058262|NCT01511627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110058264|NCT01511692|Liraglutide|liraglutide|mesh-list
110058265|NCT01511692|Glimepiride|glimepiride|mesh-list
110058266|NCT01511692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110058267|NCT01511692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058268|NCT01511692|Incretins|incretins|mesh-ancestor
110058269|NCT01511692|Hormones|hormones|mesh-ancestor
110058270|NCT01511692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110058271|NCT01511692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110058272|NCT01511692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110058273|NCT01511692|Immunologic Factors|immunologic factors|mesh-ancestor
110058274|NCT01511705|Ondansetron|ondansetron|mesh-list
110058275|NCT01511705|Antiemetics|antiemetics|mesh-ancestor
110058276|NCT01511705|Autonomic Agents|autonomic agents|mesh-ancestor
110058277|NCT01511705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110058278|NCT01511705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058279|NCT01511705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110058281|NCT01511705|Dermatologic Agents|dermatologic agents|mesh-ancestor
110058282|NCT01511705|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110058283|NCT01511705|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110058284|NCT01511705|Serotonin Agents|serotonin agents|mesh-ancestor
110058285|NCT01511705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110058286|NCT01511705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110058287|NCT01511718|Ondansetron|ondansetron|mesh-list
110058288|NCT01511718|Antiemetics|antiemetics|mesh-ancestor
110058289|NCT01511718|Autonomic Agents|autonomic agents|mesh-ancestor
110058290|NCT01511718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110058291|NCT01511718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058292|NCT01511718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110058293|NCT01511718|Antipruritics|antipruritics|mesh-ancestor
110058295|NCT01511718|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110058296|NCT01511718|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110058297|NCT01511718|Serotonin Agents|serotonin agents|mesh-ancestor
110058298|NCT01511718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110058299|NCT01511718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110058300|NCT01511731|Famotidine|famotidine|mesh-list
110058301|NCT01511731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110058302|NCT01511731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110058303|NCT01511731|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110058304|NCT01511731|Histamine Antagonists|histamine antagonists|mesh-ancestor
110058305|NCT01511731|Histamine Agents|histamine agents|mesh-ancestor
110058306|NCT01511731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110058307|NCT01511731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110058308|NCT01511731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058309|NCT01511757|Fluconazole|fluconazole|mesh-list
110058310|NCT01511757|Antifungal Agents|antifungal agents|mesh-ancestor
110058311|NCT01511757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110058312|NCT01511757|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110058313|NCT01511757|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110058314|NCT01511757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110058315|NCT01511757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110058316|NCT01511757|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110058317|NCT01511757|Hormone Antagonists|hormone antagonists|mesh-ancestor
110058318|NCT01511757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110058319|NCT01511757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058320|NCT01511757|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110058321|NCT01511757|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110058322|NCT01511770|Fluconazole|fluconazole|mesh-list
110058323|NCT01511770|Antifungal Agents|antifungal agents|mesh-ancestor
110058325|NCT01511770|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110058326|NCT01511770|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110058327|NCT01511770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110058328|NCT01511770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110058329|NCT01511770|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110058330|NCT01511770|Hormone Antagonists|hormone antagonists|mesh-ancestor
110058331|NCT01511770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110058333|NCT01511770|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110058334|NCT01511770|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110058336|NCT01511822|Drospirenone|drospirenone|mesh-list
110058337|NCT01511822|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110058338|NCT01511822|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110058339|NCT01511822|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110058340|NCT01511822|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
110058341|NCT01511822|Estradiol|estradiol|mesh-list
110058342|NCT01511822|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110058343|NCT01511822|Estrogens|estrogens|mesh-ancestor
110058344|NCT01511822|Hormones|hormones|mesh-ancestor
110058345|NCT01511822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110058346|NCT01511822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058347|NCT01511822|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110058348|NCT01511822|Contraceptive Agents|contraceptive agents|mesh-ancestor
110058350|NCT01511822|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110058351|NCT01511822|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110058352|NCT01511822|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110058353|NCT01511822|Vitamin B Complex|vitamin b complex|mesh-ancestor
110058354|NCT01511822|Vitamins|vitamins|mesh-ancestor
110058356|NCT01511822|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110058357|NCT01511822|Hormone Antagonists|hormone antagonists|mesh-ancestor
110058358|NCT01511822|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110058359|NCT01511822|Diuretics|diuretics|mesh-ancestor
110058360|NCT01511822|Natriuretic Agents|natriuretic agents|mesh-ancestor
110058361|NCT01511835|Folic Acid|folic acid|mesh-list
110058362|NCT01511835|Vitamin B Complex|vitamin b complex|mesh-list
110058363|NCT01511835|Inositol|inositol|mesh-list
110058364|NCT01511835|Hematinics|hematinics|mesh-ancestor
110058365|NCT01511835|Vitamins|vitamins|mesh-ancestor
110058366|NCT01511835|Micronutrients|micronutrients|mesh-ancestor
110058367|NCT01511835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058368|NCT01511848|Deferasirox|deferasirox|mesh-list
110058369|NCT01511848|Deferiprone|deferiprone|mesh-list
110058370|NCT01511848|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110058371|NCT01511848|Chelating Agents|chelating agents|mesh-ancestor
110058372|NCT01511848|Sequestering Agents|sequestering agents|mesh-ancestor
110058373|NCT01511848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110058374|NCT01511874|Leuprolide|leuprolide|mesh-list
110058375|NCT01511874|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110058376|NCT01511874|Fertility Agents|fertility agents|mesh-ancestor
110058377|NCT01511874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110058378|NCT01511874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058379|NCT01511874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110058380|NCT01511874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110058381|NCT01511887|Ibuprofen|ibuprofen|mesh-list
110058382|NCT01511887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110058383|NCT01511887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110058384|NCT01511887|Analgesics|analgesics|mesh-ancestor
110058385|NCT01511887|Sensory System Agents|sensory system agents|mesh-ancestor
110058386|NCT01511887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110058387|NCT01511887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058388|NCT01511887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110058389|NCT01511887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110058391|NCT01511887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110058392|NCT01511887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110058394|NCT01511991|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110058395|NCT01511991|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110058397|NCT01511991|Anesthetics|anesthetics|mesh-ancestor
110058398|NCT01511991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110058399|NCT01511991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058400|NCT01512004|Tolterodine Tartrate|tolterodine tartrate|mesh-list
110058401|NCT01512004|Propiverine|propiverine|mesh-list
110058402|NCT01512004|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110058403|NCT01512004|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110058404|NCT01512004|Cholinergic Agents|cholinergic agents|mesh-ancestor
110058405|NCT01512004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110058406|NCT01512004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110058407|NCT01512004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058408|NCT01512004|Urological Agents|urological agents|mesh-ancestor
110058409|NCT01512004|Parasympatholytics|parasympatholytics|mesh-ancestor
110058410|NCT01512004|Autonomic Agents|autonomic agents|mesh-ancestor
110058411|NCT01512004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110058412|NCT01512017|Petrolatum|petrolatum|mesh-list
110058413|NCT01512017|Emollients|emollients|mesh-ancestor
110058414|NCT01512017|Dermatologic Agents|dermatologic agents|mesh-ancestor
110058415|NCT01512147|Dexmedetomidine|dexmedetomidine|mesh-list
110058416|NCT01512147|Propofol|propofol|mesh-list
110058417|NCT01512147|Isoflurane|isoflurane|mesh-list
110058418|NCT01512147|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110058419|NCT01512147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110058420|NCT01512147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058421|NCT01512147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110058422|NCT01512147|Analgesics|analgesics|mesh-ancestor
110058423|NCT01512147|Sensory System Agents|sensory system agents|mesh-ancestor
110058424|NCT01512147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110058425|NCT01512147|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110058426|NCT01512147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110058428|NCT01512147|Adrenergic Agents|adrenergic agents|mesh-ancestor
110058429|NCT01512147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110058430|NCT01512147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110058431|NCT01512147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110058432|NCT01512147|Anesthetics, General|anesthetics, general|mesh-ancestor
110058433|NCT01512147|Anesthetics|anesthetics|mesh-ancestor
110058434|NCT01512147|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110058435|NCT01512173|Propranolol|propranolol|mesh-list
110058436|NCT01512173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110058437|NCT01512173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110058438|NCT01512173|Adrenergic Agents|adrenergic agents|mesh-ancestor
110058439|NCT01512173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110058440|NCT01512173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110058441|NCT01512173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058442|NCT01512173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110058443|NCT01512173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110058444|NCT01512173|Vasodilator Agents|vasodilator agents|mesh-ancestor
110058445|NCT01512199|Paclitaxel|paclitaxel|mesh-list
110058446|NCT01512199|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110058447|NCT01512199|Trastuzumab|trastuzumab|mesh-list
110058448|NCT01512199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110058449|NCT01512199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110058450|NCT01512199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110058451|NCT01512199|Tubulin Modulators|tubulin modulators|mesh-ancestor
110058452|NCT01512199|Antimitotic Agents|antimitotic agents|mesh-ancestor
110058453|NCT01512199|Mitosis Modulators|mitosis modulators|mesh-ancestor
110058454|NCT01512199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110058455|NCT01512199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110058456|NCT01512199|Immunologic Factors|immunologic factors|mesh-ancestor
110058457|NCT01512199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058458|NCT01512355|Dexmedetomidine|dexmedetomidine|mesh-list
110058459|NCT01512355|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110058460|NCT01512355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110058461|NCT01512355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058462|NCT01512355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110058463|NCT01512355|Analgesics|analgesics|mesh-ancestor
110058464|NCT01512355|Sensory System Agents|sensory system agents|mesh-ancestor
110058465|NCT01512355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110058466|NCT01512355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110058467|NCT01512355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110058468|NCT01512355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110058469|NCT01512355|Adrenergic Agents|adrenergic agents|mesh-ancestor
110058470|NCT01512355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110058471|NCT01512355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110058472|NCT01512459|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110058473|NCT01512459|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110058474|NCT01512459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110058475|NCT01512459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110058476|NCT01512459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110058477|NCT01512459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110058478|NCT01512459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058479|NCT01512459|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110058480|NCT01512459|Antidepressive Agents|antidepressive agents|mesh-ancestor
110058481|NCT01512459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110058483|NCT01512485|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110058484|NCT01512485|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110058485|NCT01512485|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110058486|NCT01512485|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110058487|NCT01512485|Purinergic Agents|purinergic agents|mesh-ancestor
110058488|NCT01512485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110058489|NCT01512485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110058490|NCT01512485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058491|NCT01512511|Nitrous Oxide|nitrous oxide|mesh-list
110058492|NCT01512511|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110058493|NCT01512511|Anesthetics, General|anesthetics, general|mesh-ancestor
110058494|NCT01512511|Anesthetics|anesthetics|mesh-ancestor
110058495|NCT01512511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110058496|NCT01512511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058497|NCT01512511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110058499|NCT01512511|Sensory System Agents|sensory system agents|mesh-ancestor
110058500|NCT01512511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110058501|NCT01512537|Vitamin D|vitamin d|mesh-list
110058502|NCT01512537|Ergocalciferols|ergocalciferols|mesh-list
110058503|NCT01512537|Cholecalciferol|cholecalciferol|mesh-list
110058504|NCT01512537|Vitamins|vitamins|mesh-list
110058505|NCT01512537|Micronutrients|micronutrients|mesh-ancestor
110058506|NCT01512537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058509|NCT01512628|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
110058510|NCT01512628|Plasma Substitutes|plasma substitutes|mesh-ancestor
110058511|NCT01512628|Blood Substitutes|blood substitutes|mesh-ancestor
110058512|NCT01512680|Insulin|insulin|mesh-list
110058513|NCT01512680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110058514|NCT01512680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058517|NCT01512784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058518|NCT01512862|Calcitriol|calcitriol|mesh-list
110058519|NCT01512862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110058520|NCT01512862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058521|NCT01512862|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110058522|NCT01512862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110058523|NCT01512862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110058524|NCT01512862|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110058525|NCT01512862|Vitamins|vitamins|mesh-ancestor
110058526|NCT01512862|Micronutrients|micronutrients|mesh-ancestor
110058527|NCT01512862|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110058529|NCT01512901|Betamethasone Valerate|betamethasone valerate|mesh-list
110058530|NCT01512901|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
110058531|NCT01512901|Betamethasone benzoate|betamethasone benzoate|mesh-list
110058532|NCT01512901|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
110058533|NCT01512901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110058534|NCT01512901|Glucocorticoids|glucocorticoids|mesh-ancestor
110058535|NCT01512901|Hormones|hormones|mesh-ancestor
110058536|NCT01512901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110058537|NCT01512901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058538|NCT01512901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110058539|NCT01512901|Respiratory System Agents|respiratory system agents|mesh-ancestor
110058540|NCT01512914|Ropivacaine|ropivacaine|mesh-list
110058541|NCT01512914|Anesthetics, Local|anesthetics, local|mesh-ancestor
110058542|NCT01512914|Anesthetics|anesthetics|mesh-ancestor
110058543|NCT01512914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110058544|NCT01512914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058545|NCT01512914|Sensory System Agents|sensory system agents|mesh-ancestor
110058546|NCT01512914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110058547|NCT01512953|Lansoprazole|lansoprazole|mesh-list
110058548|NCT01512953|Dexlansoprazole|dexlansoprazole|mesh-list
110058549|NCT01512953|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110058550|NCT01512953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110058551|NCT01512953|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110058552|NCT01512953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110058553|NCT01512953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110058554|NCT01512966|Aflibercept|aflibercept|mesh-list
110058555|NCT01512966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110058556|NCT01512966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110058557|NCT01512966|Growth Substances|growth substances|mesh-ancestor
110058558|NCT01512966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058559|NCT01512966|Growth Inhibitors|growth inhibitors|mesh-ancestor
110058560|NCT01512966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110058561|NCT01513044|Mycophenolic Acid|mycophenolic acid|mesh-list
110058562|NCT01513044|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110058563|NCT01513044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110058564|NCT01513044|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110058565|NCT01513044|Antitubercular Agents|antitubercular agents|mesh-ancestor
110058566|NCT01513044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110058567|NCT01513044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110058568|NCT01513044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110058569|NCT01513044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110058571|NCT01513057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110058572|NCT01513057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110058573|NCT01513057|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110058574|NCT01513057|Antitubercular Agents|antitubercular agents|mesh-ancestor
110058575|NCT01513057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110058576|NCT01513057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110058577|NCT01513057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110058578|NCT01513057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110058579|NCT01513070|Aspirin|aspirin|mesh-list
110058580|NCT01513070|Isosorbide|isosorbide|mesh-list
110058581|NCT01513070|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
110058582|NCT01513070|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
110058583|NCT01513070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110058584|NCT01513070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110058585|NCT01513070|Analgesics|analgesics|mesh-ancestor
110058586|NCT01513070|Sensory System Agents|sensory system agents|mesh-ancestor
110058587|NCT01513070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110058588|NCT01513070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058589|NCT01513070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110058590|NCT01513070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110058591|NCT01513070|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110058592|NCT01513070|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110058593|NCT01513070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110058594|NCT01513070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110058595|NCT01513070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110058596|NCT01513070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110058597|NCT01513070|Antipyretics|antipyretics|mesh-ancestor
110058598|NCT01513070|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110058599|NCT01513070|Diuretics|diuretics|mesh-ancestor
110058600|NCT01513070|Natriuretic Agents|natriuretic agents|mesh-ancestor
110058601|NCT01513070|Vasodilator Agents|vasodilator agents|mesh-ancestor
110058602|NCT01513070|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110058603|NCT01513083|Trastuzumab|trastuzumab|mesh-list
110058604|NCT01513083|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
110058605|NCT01513083|Maytansine|maytansine|mesh-list
110058606|NCT01513083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110058607|NCT01513083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110058608|NCT01513083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110058609|NCT01513083|Tubulin Modulators|tubulin modulators|mesh-ancestor
110058610|NCT01513083|Antimitotic Agents|antimitotic agents|mesh-ancestor
110058611|NCT01513083|Mitosis Modulators|mitosis modulators|mesh-ancestor
110058612|NCT01513083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110058613|NCT01513083|Immunotoxins|immunotoxins|mesh-ancestor
110058614|NCT01513083|Immunoconjugates|immunoconjugates|mesh-ancestor
110058615|NCT01513083|Immunologic Factors|immunologic factors|mesh-ancestor
110058616|NCT01513083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058617|NCT01513174|Olaparib|olaparib|mesh-list
110058618|NCT01513174|Gefitinib|gefitinib|mesh-list
110058619|NCT01513174|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110058620|NCT01513174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110058621|NCT01513174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110058622|NCT01513174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110058623|NCT01513174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110058624|NCT01513200|Heparin|heparin|mesh-list
110058625|NCT01513200|Calcium heparin|calcium heparin|mesh-list
110058626|NCT01513200|Anticoagulants|anticoagulants|mesh-ancestor
110058627|NCT01513200|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110058628|NCT01513200|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110058629|NCT01513200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110058630|NCT01513499|Oxytocin|oxytocin|mesh-list
110058631|NCT01513499|Oxytocics|oxytocics|mesh-ancestor
110058632|NCT01513499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110058633|NCT01513499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058634|NCT01513525|Liraglutide|liraglutide|mesh-list
110058635|NCT01513525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110058636|NCT01513525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058638|NCT01513525|Hormones|hormones|mesh-ancestor
110058639|NCT01513525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110058640|NCT01513564|Morphine|morphine|mesh-list
110058642|NCT01513564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058643|NCT01513564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110058645|NCT01513564|Analgesics|analgesics|mesh-ancestor
110058646|NCT01513564|Sensory System Agents|sensory system agents|mesh-ancestor
110058647|NCT01513564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110058648|NCT01513603|Cytarabine|cytarabine|mesh-list
110058649|NCT01513603|Mitoxantrone|mitoxantrone|mesh-list
110058651|NCT01513603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110058652|NCT01513603|Antimetabolites|antimetabolites|mesh-ancestor
110058653|NCT01513603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110058654|NCT01513603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110058655|NCT01513603|Antiviral Agents|antiviral agents|mesh-ancestor
110058656|NCT01513603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110058657|NCT01513603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110058658|NCT01513603|Immunologic Factors|immunologic factors|mesh-ancestor
110058660|NCT01513603|Analgesics|analgesics|mesh-ancestor
110058661|NCT01513603|Sensory System Agents|sensory system agents|mesh-ancestor
110058662|NCT01513603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110058663|NCT01513603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110058664|NCT01513603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110058665|NCT01513603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110058666|NCT01513668|Acetaminophen|acetaminophen|mesh-list
110058667|NCT01513668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110058668|NCT01513668|Analgesics|analgesics|mesh-ancestor
110058669|NCT01513668|Sensory System Agents|sensory system agents|mesh-ancestor
110058670|NCT01513668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110058671|NCT01513668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058672|NCT01513668|Antipyretics|antipyretics|mesh-ancestor
110058673|NCT01513681|Lamotrigine|lamotrigine|mesh-list
110058674|NCT01513681|Anticonvulsants|anticonvulsants|mesh-ancestor
110058675|NCT01513681|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110058676|NCT01513681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110058677|NCT01513681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110058678|NCT01513681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110058679|NCT01513681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058680|NCT01513681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110058681|NCT01513681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110058682|NCT01513681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110058683|NCT01513681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110058684|NCT01513681|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110058685|NCT01513720|Lamotrigine|lamotrigine|mesh-list
110058686|NCT01513720|Anticonvulsants|anticonvulsants|mesh-ancestor
110058687|NCT01513720|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110058688|NCT01513720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110058689|NCT01513720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110058690|NCT01513720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110058691|NCT01513720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058692|NCT01513720|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110058693|NCT01513720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110058694|NCT01513720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110058695|NCT01513720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110058696|NCT01513720|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110058697|NCT01513772|Dexmedetomidine|dexmedetomidine|mesh-list
110058698|NCT01513772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110058699|NCT01513772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110058700|NCT01513772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058701|NCT01513772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110058702|NCT01513772|Analgesics|analgesics|mesh-ancestor
110058703|NCT01513772|Sensory System Agents|sensory system agents|mesh-ancestor
110058704|NCT01513772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110058705|NCT01513772|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110058706|NCT01513772|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110058709|NCT01513772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110058710|NCT01513772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110058711|NCT01513785|Amoxicillin|amoxicillin|mesh-list
110058712|NCT01513785|Rabeprazole|rabeprazole|mesh-list
110058713|NCT01513785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110058714|NCT01513785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110058715|NCT01513785|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110058716|NCT01513785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110058717|NCT01513785|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110058718|NCT01513785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110058719|NCT01513785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110058720|NCT01513811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110058721|NCT01513863|Metronidazole|metronidazole|mesh-list
110058722|NCT01513863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110058723|NCT01513863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110058724|NCT01513863|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110058725|NCT01513863|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110058726|NCT01513941|Interferons|interferons|mesh-list
110058728|NCT01513941|Interferon-alpha|interferon-alpha|mesh-list
110058729|NCT01513941|Interferon alpha-2|interferon alpha-2|mesh-list
110058730|NCT01513941|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110058731|NCT01513941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110058732|NCT01513941|Antiviral Agents|antiviral agents|mesh-ancestor
110058733|NCT01513941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110058734|NCT01513941|Antimetabolites|antimetabolites|mesh-ancestor
110058735|NCT01513941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110058736|NCT01513941|Immunologic Factors|immunologic factors|mesh-ancestor
110058737|NCT01513941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058738|NCT01514019|Acebutolol|acebutolol|mesh-list
110058739|NCT01514019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110058740|NCT01514019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110058741|NCT01514019|Sympathomimetics|sympathomimetics|mesh-ancestor
110058742|NCT01514019|Autonomic Agents|autonomic agents|mesh-ancestor
110058743|NCT01514019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110058744|NCT01514019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058745|NCT01514019|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110058746|NCT01514019|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110058747|NCT01514019|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110058748|NCT01514019|Adrenergic Agents|adrenergic agents|mesh-ancestor
110058749|NCT01514019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110058750|NCT01514019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110058752|NCT01514110|Carboplatin|carboplatin|mesh-list
110058753|NCT01514110|Everolimus|everolimus|mesh-list
110058754|NCT01514110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110058755|NCT01514110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110058756|NCT01514110|Tubulin Modulators|tubulin modulators|mesh-ancestor
110058757|NCT01514110|Antimitotic Agents|antimitotic agents|mesh-ancestor
110058758|NCT01514110|Mitosis Modulators|mitosis modulators|mesh-ancestor
110058759|NCT01514110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110058760|NCT01514110|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110058761|NCT01514110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110058762|NCT01514110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110058763|NCT01514110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110058764|NCT01514110|Immunologic Factors|immunologic factors|mesh-ancestor
110058765|NCT01514110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058766|NCT01514123|Bevacizumab|bevacizumab|mesh-list
110058767|NCT01514123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110058768|NCT01514123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110058769|NCT01514123|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110058770|NCT01514123|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110058771|NCT01514123|Growth Substances|growth substances|mesh-ancestor
110058772|NCT01514123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058773|NCT01514123|Growth Inhibitors|growth inhibitors|mesh-ancestor
110058774|NCT01514175|Ibuprofen|ibuprofen|mesh-list
110058775|NCT01514175|Ketorolac|ketorolac|mesh-list
110058776|NCT01514175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110058777|NCT01514175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110058778|NCT01514175|Analgesics|analgesics|mesh-ancestor
110058779|NCT01514175|Sensory System Agents|sensory system agents|mesh-ancestor
110058780|NCT01514175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110058781|NCT01514175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058782|NCT01514175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110058785|NCT01514175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110058786|NCT01514175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110058787|NCT01514188|Doxorubicin|doxorubicin|mesh-list
110058788|NCT01514188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110058789|NCT01514188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110058790|NCT01514188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110058791|NCT01514188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110058792|NCT01514188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110058793|NCT01514188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110058794|NCT01514227|Aspirin|aspirin|mesh-list
110058795|NCT01514227|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110058796|NCT01514227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110058797|NCT01514227|Analgesics|analgesics|mesh-ancestor
110058798|NCT01514227|Sensory System Agents|sensory system agents|mesh-ancestor
110058799|NCT01514227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110058800|NCT01514227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058801|NCT01514227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110058802|NCT01514227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110058803|NCT01514227|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110058804|NCT01514227|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110058805|NCT01514227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110058806|NCT01514227|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110058807|NCT01514227|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110058808|NCT01514227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110058809|NCT01514227|Antipyretics|antipyretics|mesh-ancestor
110058810|NCT01514266|Curcumin|curcumin|mesh-list
110058811|NCT01514266|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110058812|NCT01514266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110058813|NCT01514266|Analgesics|analgesics|mesh-ancestor
110058814|NCT01514266|Sensory System Agents|sensory system agents|mesh-ancestor
110058815|NCT01514266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110058816|NCT01514266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058817|NCT01514266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110058818|NCT01514266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110058819|NCT01514266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110058820|NCT01514266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110058821|NCT01514266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110058822|NCT01514409|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
110058823|NCT01514409|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110058824|NCT01514409|Antidepressive Agents|antidepressive agents|mesh-ancestor
110058825|NCT01514409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110058826|NCT01514487|Liraglutide|liraglutide|mesh-list
110058827|NCT01514487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110058828|NCT01514487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058829|NCT01514487|Incretins|incretins|mesh-ancestor
110058830|NCT01514487|Hormones|hormones|mesh-ancestor
110058831|NCT01514487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110058832|NCT01514695|Fentanyl|fentanyl|mesh-list
110058833|NCT01514695|Midazolam|midazolam|mesh-list
110058834|NCT01514695|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110058835|NCT01514695|Narcotics|narcotics|mesh-ancestor
110058836|NCT01514695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110058837|NCT01514695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058838|NCT01514695|Analgesics|analgesics|mesh-ancestor
110058839|NCT01514695|Sensory System Agents|sensory system agents|mesh-ancestor
110058840|NCT01514695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110058841|NCT01514695|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110058842|NCT01514695|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110058843|NCT01514695|Anesthetics, General|anesthetics, general|mesh-ancestor
110058844|NCT01514695|Anesthetics|anesthetics|mesh-ancestor
110058845|NCT01514695|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110058846|NCT01514695|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110058847|NCT01514695|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110058848|NCT01514695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110058849|NCT01514695|GABA Modulators|gaba modulators|mesh-ancestor
110058850|NCT01514695|GABA Agents|gaba agents|mesh-ancestor
110058851|NCT01514695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110058852|NCT01514695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110058853|NCT01514721|Timolol|timolol|mesh-list
110058854|NCT01514721|Travoprost|travoprost|mesh-list
110058855|NCT01514721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110058856|NCT01514721|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110058857|NCT01514721|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110058858|NCT01514721|Adrenergic Agents|adrenergic agents|mesh-ancestor
110058859|NCT01514721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110058860|NCT01514721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058861|NCT01514721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110058862|NCT01514721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110058863|NCT01514812|Digoxin|digoxin|mesh-list
110058864|NCT01514812|Darexaban|darexaban|mesh-list
110058865|NCT01514812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110058866|NCT01514812|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110058867|NCT01514812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110058868|NCT01514812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110058869|NCT01514812|Protective Agents|protective agents|mesh-ancestor
110058870|NCT01514812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058871|NCT01514812|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110058872|NCT01514812|Antithrombins|antithrombins|mesh-ancestor
110058873|NCT01514812|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110058874|NCT01514812|Protease Inhibitors|protease inhibitors|mesh-ancestor
110058875|NCT01514812|Anticoagulants|anticoagulants|mesh-ancestor
110058876|NCT01514825|Darexaban|darexaban|mesh-list
110058877|NCT01514825|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110058878|NCT01514825|Antithrombins|antithrombins|mesh-ancestor
110058879|NCT01514825|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110058880|NCT01514825|Protease Inhibitors|protease inhibitors|mesh-ancestor
110058881|NCT01514825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110058882|NCT01514825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110058883|NCT01514825|Anticoagulants|anticoagulants|mesh-ancestor
110058884|NCT01514838|Acarbose|acarbose|mesh-list
110058885|NCT01514838|Ipragliflozin|ipragliflozin|mesh-list
110058886|NCT01514838|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110058887|NCT01514838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110058888|NCT01514838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110058889|NCT01514838|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110058890|NCT01514838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058891|NCT01514838|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110058892|NCT01514851|Calcium Carbonate|calcium carbonate|mesh-list
110058893|NCT01514851|Calcium|calcium|mesh-list
110058894|NCT01514851|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110058895|NCT01514851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058897|NCT01514851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110058898|NCT01514851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110058899|NCT01514929|Moxifloxacin|moxifloxacin|mesh-list
110058900|NCT01514929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110058901|NCT01514929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110058902|NCT01514929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110058903|NCT01514929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110058904|NCT01514929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110058905|NCT01514929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110058906|NCT01514929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110058907|NCT01514942|Folic Acid|folic acid|mesh-list
110058908|NCT01514942|Vitamin B Complex|vitamin b complex|mesh-list
110058909|NCT01514942|Hydroxocobalamin|hydroxocobalamin|mesh-list
110058910|NCT01514942|Vitamin B 12|vitamin b 12|mesh-list
110058911|NCT01514942|Inositol|inositol|mesh-list
110058912|NCT01514942|Manganese|manganese|mesh-list
110058913|NCT01514942|Hematinics|hematinics|mesh-ancestor
110058914|NCT01514942|Vitamins|vitamins|mesh-ancestor
110058915|NCT01514942|Micronutrients|micronutrients|mesh-ancestor
110058916|NCT01514942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058917|NCT01514942|Trace Elements|trace elements|mesh-ancestor
110058918|NCT01514968|Cyclosporine|cyclosporine|mesh-list
110058919|NCT01514968|Ritonavir|ritonavir|mesh-list
110058920|NCT01514968|Cyclosporins|cyclosporins|mesh-list
110058921|NCT01514968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110058922|NCT01514968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110058923|NCT01514968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110058924|NCT01514968|Immunologic Factors|immunologic factors|mesh-ancestor
110058925|NCT01514968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058926|NCT01514968|Antifungal Agents|antifungal agents|mesh-ancestor
110058927|NCT01514968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110058928|NCT01514968|Dermatologic Agents|dermatologic agents|mesh-ancestor
110058929|NCT01514968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110058930|NCT01514968|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110058931|NCT01514968|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110058932|NCT01514968|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110058933|NCT01514968|Protease Inhibitors|protease inhibitors|mesh-ancestor
110058934|NCT01514968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110058937|NCT01514968|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110058938|NCT01514968|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110058939|NCT01514981|Mogamulizumab|mogamulizumab|mesh-list
110058940|NCT01514981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110058941|NCT01515020|Vancomycin|vancomycin|mesh-list
110058942|NCT01515020|Daptomycin|daptomycin|mesh-list
110058943|NCT01515020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110058944|NCT01515020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110058945|NCT01515228|Paclitaxel|paclitaxel|mesh-list
110058946|NCT01515228|Everolimus|everolimus|mesh-list
110058947|NCT01515228|Cilostazol|cilostazol|mesh-list
110058948|NCT01515228|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110058949|NCT01515228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110058950|NCT01515228|Tubulin Modulators|tubulin modulators|mesh-ancestor
110058952|NCT01515228|Mitosis Modulators|mitosis modulators|mesh-ancestor
110058953|NCT01515228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110058954|NCT01515228|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110058955|NCT01515228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110058956|NCT01515228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110058957|NCT01515228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110058958|NCT01515228|Immunologic Factors|immunologic factors|mesh-ancestor
110058959|NCT01515228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058960|NCT01515228|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110058961|NCT01515228|Autonomic Agents|autonomic agents|mesh-ancestor
110058962|NCT01515228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110058963|NCT01515228|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110058964|NCT01515228|Respiratory System Agents|respiratory system agents|mesh-ancestor
110058965|NCT01515228|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110058966|NCT01515228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110058967|NCT01515228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110058968|NCT01515228|Vasodilator Agents|vasodilator agents|mesh-ancestor
110058969|NCT01515228|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110058970|NCT01515228|Protective Agents|protective agents|mesh-ancestor
110058971|NCT01515228|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110058972|NCT01515228|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110058973|NCT01515371|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
110058974|NCT01515371|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110058975|NCT01515371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110058976|NCT01515371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058977|NCT01515371|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110058978|NCT01515371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110058979|NCT01515371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110058980|NCT01515371|Cholinergic Agents|cholinergic agents|mesh-ancestor
110058981|NCT01515371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110058982|NCT01515397|Polygeline|polygeline|mesh-list
110058983|NCT01515397|Plasma Substitutes|plasma substitutes|mesh-ancestor
110058984|NCT01515397|Blood Substitutes|blood substitutes|mesh-ancestor
110058985|NCT01515553|Liraglutide|liraglutide|mesh-list
110058986|NCT01515553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110058987|NCT01515553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058988|NCT01515553|Incretins|incretins|mesh-ancestor
110058989|NCT01515553|Hormones|hormones|mesh-ancestor
110058990|NCT01515553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110058991|NCT01515579|Liraglutide|liraglutide|mesh-list
110058992|NCT01515579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110058993|NCT01515579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058994|NCT01515579|Incretins|incretins|mesh-ancestor
110058995|NCT01515579|Hormones|hormones|mesh-ancestor
110058996|NCT01515579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110058997|NCT01515592|Liraglutide|liraglutide|mesh-list
110058998|NCT01515592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110058999|NCT01515592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110059000|NCT01515592|Incretins|incretins|mesh-ancestor
110059001|NCT01515592|Hormones|hormones|mesh-ancestor
110059002|NCT01515592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110059003|NCT01515683|Anesthetics|anesthetics|mesh-list
110059004|NCT01515683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110059006|NCT01515774|Pramipexole|pramipexole|mesh-list
110059007|NCT01515774|Antioxidants|antioxidants|mesh-ancestor
110059008|NCT01515774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110059009|NCT01515774|Protective Agents|protective agents|mesh-ancestor
110059010|NCT01515774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110059014|NCT01515774|Dopamine Agents|dopamine agents|mesh-ancestor
110059015|NCT01515774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110059016|NCT01515813|Tenofovir|tenofovir|mesh-list
110059017|NCT01515813|Emtricitabine|emtricitabine|mesh-list
110059018|NCT01515813|Efavirenz|efavirenz|mesh-list
110059019|NCT01515813|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110059020|NCT01515813|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110059021|NCT01515813|Pravastatin|pravastatin|mesh-list
110059022|NCT01515813|Antiviral Agents|antiviral agents|mesh-ancestor
110059023|NCT01515813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110059024|NCT01515813|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110059025|NCT01515813|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110059026|NCT01515813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110059027|NCT01515813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110059028|NCT01515813|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110059029|NCT01515813|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110059030|NCT01515813|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110059031|NCT01515813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110059032|NCT01515813|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110059033|NCT01515813|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110059034|NCT01515813|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110059035|NCT01515813|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110059036|NCT01515813|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110059037|NCT01515813|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110059038|NCT01515813|Antimetabolites|antimetabolites|mesh-ancestor
110059039|NCT01515813|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110059040|NCT01515813|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110059041|NCT01515826|Moxifloxacin|moxifloxacin|mesh-list
110059042|NCT01515826|Dexamethasone|dexamethasone|mesh-list
110059043|NCT01515826|Dexamethasone acetate|dexamethasone acetate|mesh-list
110059044|NCT01515826|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110059045|NCT01515826|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110059046|NCT01515826|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110059047|NCT01515826|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
110059049|NCT01515826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110059050|NCT01515826|Antiemetics|antiemetics|mesh-ancestor
110059051|NCT01515826|Autonomic Agents|autonomic agents|mesh-ancestor
110059052|NCT01515826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110059053|NCT01515826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110059054|NCT01515826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110059055|NCT01515826|Glucocorticoids|glucocorticoids|mesh-ancestor
110059056|NCT01515826|Hormones|hormones|mesh-ancestor
110059057|NCT01515826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110059058|NCT01515826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110059059|NCT01515826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110059060|NCT01515826|Protease Inhibitors|protease inhibitors|mesh-ancestor
110059061|NCT01515826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110059062|NCT01515826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110059063|NCT01515826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110059064|NCT01515826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110059065|NCT01515826|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110059066|NCT01515826|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110059067|NCT01515826|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110059068|NCT01515826|Contraceptive Agents|contraceptive agents|mesh-ancestor
110059069|NCT01515826|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110059070|NCT01515826|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110059071|NCT01515826|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110059072|NCT01515826|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110059073|NCT01515839|Thioctic Acid|thioctic acid|mesh-list
110059074|NCT01515839|Acetylcarnitine|acetylcarnitine|mesh-list
110059075|NCT01515839|Acetylcysteine|acetylcysteine|mesh-list
110059076|NCT01515839|Vinpocetine|vinpocetine|mesh-list
110059077|NCT01515839|Huperzine A|huperzine a|mesh-list
110059078|NCT01515839|Antioxidants|antioxidants|mesh-ancestor
110059079|NCT01515839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110059080|NCT01515839|Protective Agents|protective agents|mesh-ancestor
110059081|NCT01515839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110059082|NCT01515839|Vitamin B Complex|vitamin b complex|mesh-ancestor
110059084|NCT01515839|Micronutrients|micronutrients|mesh-ancestor
110059085|NCT01515839|Nootropic Agents|nootropic agents|mesh-ancestor
110059086|NCT01515839|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110059087|NCT01515839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110059088|NCT01515839|Cholinergic Agents|cholinergic agents|mesh-ancestor
110059089|NCT01515839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110059090|NCT01515839|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110059091|NCT01515839|Antiviral Agents|antiviral agents|mesh-ancestor
110059092|NCT01515839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110059093|NCT01515839|Expectorants|expectorants|mesh-ancestor
110059094|NCT01515839|Respiratory System Agents|respiratory system agents|mesh-ancestor
110059095|NCT01515839|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110059096|NCT01515839|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110059097|NCT01515839|Vasodilator Agents|vasodilator agents|mesh-ancestor
110059099|NCT01515852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110059100|NCT01515852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110059101|NCT01515917|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
110059102|NCT01515917|Nootropic Agents|nootropic agents|mesh-ancestor
110059103|NCT01515969|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110059104|NCT01515969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110059105|NCT01515969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110059106|NCT01515969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110059107|NCT01515969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110059108|NCT01516060|Efavirenz|efavirenz|mesh-list
110059187|NCT01516567|Immunologic Factors|immunologic factors|mesh-ancestor
110059109|NCT01516060|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110059110|NCT01516060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110059111|NCT01516060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110059112|NCT01516060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110059113|NCT01516060|Antiviral Agents|antiviral agents|mesh-ancestor
110059114|NCT01516060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110059115|NCT01516060|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110059116|NCT01516060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110059117|NCT01516060|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110059118|NCT01516060|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110059119|NCT01516060|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110059120|NCT01516060|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110059121|NCT01516138|Insulin|insulin|mesh-list
110059122|NCT01516138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110059123|NCT01516138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110059124|NCT01516255|Liraglutide|liraglutide|mesh-list
110059125|NCT01516255|Moxifloxacin|moxifloxacin|mesh-list
110059126|NCT01516255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110059127|NCT01516255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110059128|NCT01516255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110059129|NCT01516255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110059130|NCT01516255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110059131|NCT01516255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110059132|NCT01516255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110059133|NCT01516255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110059134|NCT01516255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110059135|NCT01516255|Incretins|incretins|mesh-ancestor
110059136|NCT01516255|Hormones|hormones|mesh-ancestor
110059137|NCT01516255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110059138|NCT01514903|Sildenafil Citrate|sildenafil citrate|mesh-list
110059139|NCT01514903|Vasodilator Agents|vasodilator agents|mesh-ancestor
110059140|NCT01514903|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110059141|NCT01514903|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110059142|NCT01514903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110059143|NCT01514903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110059144|NCT01514903|Urological Agents|urological agents|mesh-ancestor
110059145|NCT01516372|Moxifloxacin|moxifloxacin|mesh-list
110059146|NCT01516372|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110059147|NCT01516372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110059148|NCT01516372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110059149|NCT01516372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110059150|NCT01516372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110059151|NCT01516372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110059152|NCT01516372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110059153|NCT01516372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110059157|NCT01516372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110059158|NCT01516372|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110059159|NCT01516372|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110059160|NCT01516372|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110059161|NCT01516450|Belimumab|belimumab|mesh-list
110059162|NCT01516450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110059163|NCT01516450|Immunologic Factors|immunologic factors|mesh-ancestor
110059164|NCT01516450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110059165|NCT01516463|Bacitracin|bacitracin|mesh-list
110059166|NCT01516463|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110059167|NCT01516463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110059168|NCT01516463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110059169|NCT01516554|Methyltestosterone|methyltestosterone|mesh-list
110059170|NCT01516554|Testosterone|testosterone|mesh-list
110059171|NCT01516554|Testosterone undecanoate|testosterone undecanoate|mesh-list
110059172|NCT01516554|Testosterone enanthate|testosterone enanthate|mesh-list
110059173|NCT01516554|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110059174|NCT01516554|Androgens|androgens|mesh-ancestor
110059175|NCT01516554|Hormones|hormones|mesh-ancestor
110059176|NCT01516554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110059177|NCT01516554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110059178|NCT01516554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110059180|NCT01516554|Anabolic Agents|anabolic agents|mesh-ancestor
110059181|NCT01516567|Cyclophosphamide|cyclophosphamide|mesh-list
110059182|NCT01516567|Rituximab|rituximab|mesh-list
110059183|NCT01516567|Doxorubicin|doxorubicin|mesh-list
110059184|NCT01516567|Etoposide|etoposide|mesh-list
110059185|NCT01516567|Vincristine|vincristine|mesh-list
110059186|NCT01516567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110059188|NCT01516567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110059189|NCT01516567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110059190|NCT01516567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110059191|NCT01516567|Alkylating Agents|alkylating agents|mesh-ancestor
110059192|NCT01516567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110059193|NCT01516567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110059194|NCT01516567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110059195|NCT01516567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110059196|NCT01516567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110059197|NCT01516567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110059198|NCT01516567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110059199|NCT01516567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110059200|NCT01516567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110059201|NCT01516567|Tubulin Modulators|tubulin modulators|mesh-ancestor
110059202|NCT01516567|Antimitotic Agents|antimitotic agents|mesh-ancestor
110059203|NCT01516567|Mitosis Modulators|mitosis modulators|mesh-ancestor
110059205|NCT01516580|Cyclophosphamide|cyclophosphamide|mesh-list
110059206|NCT01516580|Rituximab|rituximab|mesh-list
110059207|NCT01516580|Doxorubicin|doxorubicin|mesh-list
110059208|NCT01516580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110059209|NCT01516580|Methotrexate|methotrexate|mesh-list
110059210|NCT01516580|Vincristine|vincristine|mesh-list
110059211|NCT01516580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110059212|NCT01516580|Immunologic Factors|immunologic factors|mesh-ancestor
110059213|NCT01516580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110059214|NCT01516580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110059215|NCT01516580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110059216|NCT01516580|Alkylating Agents|alkylating agents|mesh-ancestor
110059217|NCT01516580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110059218|NCT01516580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110059219|NCT01516580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110059220|NCT01516580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110059221|NCT01516580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110059222|NCT01516580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110059223|NCT01516580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110059224|NCT01516580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110059225|NCT01516580|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110059226|NCT01516580|Abortifacient Agents|abortifacient agents|mesh-ancestor
110059227|NCT01516580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110059228|NCT01516580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110059229|NCT01516580|Antimetabolites|antimetabolites|mesh-ancestor
110059230|NCT01516580|Dermatologic Agents|dermatologic agents|mesh-ancestor
110059231|NCT01516580|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110059232|NCT01516580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110059233|NCT01516580|Antiviral Agents|antiviral agents|mesh-ancestor
110059234|NCT01516580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110059235|NCT01516580|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110059236|NCT01516580|Tubulin Modulators|tubulin modulators|mesh-ancestor
110059237|NCT01516580|Antimitotic Agents|antimitotic agents|mesh-ancestor
110059238|NCT01516580|Mitosis Modulators|mitosis modulators|mesh-ancestor
110059240|NCT01516710|Hematinics|hematinics|mesh-ancestor
110059241|NCT01516723|Sirolimus|sirolimus|mesh-list
110059242|NCT01516723|Everolimus|everolimus|mesh-list
110059243|NCT01516723|MTOR Inhibitors|mtor inhibitors|mesh-list
110059244|NCT01516723|Temsirolimus|temsirolimus|mesh-list
110059245|NCT01516723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110059246|NCT01516723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110059247|NCT01516723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110059248|NCT01516723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110059249|NCT01516723|Immunologic Factors|immunologic factors|mesh-ancestor
110059250|NCT01516723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110059251|NCT01516723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110059252|NCT01516723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110059253|NCT01516723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110059254|NCT01516723|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110059255|NCT01516723|Antifungal Agents|antifungal agents|mesh-ancestor
110059256|NCT01516762|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
110059257|NCT01516762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110059258|NCT01516814|Heparin|heparin|mesh-list
110059259|NCT01516814|Calcium heparin|calcium heparin|mesh-list
110059260|NCT01516814|Warfarin|warfarin|mesh-list
110059261|NCT01516814|Rivaroxaban|rivaroxaban|mesh-list
110059262|NCT01516814|Anticoagulants|anticoagulants|mesh-ancestor
110059263|NCT01516814|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110059264|NCT01516814|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110059265|NCT01516814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110059266|NCT01516814|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110059267|NCT01516814|Antithrombins|antithrombins|mesh-ancestor
110059268|NCT01516814|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110059269|NCT01516814|Protease Inhibitors|protease inhibitors|mesh-ancestor
110059270|NCT01516814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110059271|NCT01516840|Heparin|heparin|mesh-list
110059272|NCT01516840|Calcium heparin|calcium heparin|mesh-list
110059273|NCT01516840|Warfarin|warfarin|mesh-list
110059274|NCT01516840|Rivaroxaban|rivaroxaban|mesh-list
110059275|NCT01516840|Anticoagulants|anticoagulants|mesh-ancestor
110059276|NCT01516840|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110059277|NCT01516840|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110059278|NCT01516840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110059279|NCT01516840|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110059280|NCT01516840|Antithrombins|antithrombins|mesh-ancestor
110059281|NCT01516840|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110059282|NCT01516840|Protease Inhibitors|protease inhibitors|mesh-ancestor
110059283|NCT01516840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110059284|NCT01516866|Listerine|listerine|mesh-list
110059285|NCT01516866|Fluorides|fluorides|mesh-list
110059286|NCT01516866|Sodium Fluoride|sodium fluoride|mesh-list
110059287|NCT01516866|Cariostatic Agents|cariostatic agents|mesh-ancestor
110059288|NCT01516866|Protective Agents|protective agents|mesh-ancestor
110059289|NCT01516866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110059290|NCT01516866|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110059291|NCT01516866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110059292|NCT01516996|Docetaxel|docetaxel|mesh-list
110059293|NCT01516996|Nimotuzumab|nimotuzumab|mesh-list
110059294|NCT01516996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110059295|NCT01516996|Tubulin Modulators|tubulin modulators|mesh-ancestor
110059296|NCT01516996|Antimitotic Agents|antimitotic agents|mesh-ancestor
110059297|NCT01516996|Mitosis Modulators|mitosis modulators|mesh-ancestor
110059298|NCT01516996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110059299|NCT01516996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110059300|NCT01517009|Docetaxel|docetaxel|mesh-list
110059301|NCT01517009|Capecitabine|capecitabine|mesh-list
110059302|NCT01517009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110059303|NCT01517009|Tubulin Modulators|tubulin modulators|mesh-ancestor
110059304|NCT01517009|Antimitotic Agents|antimitotic agents|mesh-ancestor
110059305|NCT01517009|Mitosis Modulators|mitosis modulators|mesh-ancestor
110059306|NCT01517009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110059307|NCT01517009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110059311|NCT01517022|Autonomic Agents|autonomic agents|mesh-ancestor
110059312|NCT01517022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110059313|NCT01517022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110059314|NCT01517022|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110059315|NCT01517022|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110059316|NCT01517022|Cholinergic Agents|cholinergic agents|mesh-ancestor
110059317|NCT01517022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110059318|NCT01517022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110059319|NCT01517165|Pioglitazone|pioglitazone|mesh-list
110059320|NCT01517165|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110059321|NCT01517165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110059322|NCT01517308|Interferons|interferons|mesh-list
110059323|NCT01517308|Ribavirin|ribavirin|mesh-list
110059324|NCT01517308|Interferon-alpha|interferon-alpha|mesh-list
110059325|NCT01517308|Interferon alpha-2|interferon alpha-2|mesh-list
110059326|NCT01517308|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110059327|NCT01517308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110059328|NCT01517308|Antiviral Agents|antiviral agents|mesh-ancestor
110059329|NCT01517308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110059330|NCT01517308|Antimetabolites|antimetabolites|mesh-ancestor
110059331|NCT01517308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110059332|NCT01517308|Immunologic Factors|immunologic factors|mesh-ancestor
110059333|NCT01517308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110059334|NCT01517321|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110059335|NCT01517321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110059336|NCT01517321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110059337|NCT01517321|Incretins|incretins|mesh-ancestor
110059338|NCT01517321|Hormones|hormones|mesh-ancestor
110059339|NCT01517321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110059340|NCT01517321|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110059341|NCT01517321|Protease Inhibitors|protease inhibitors|mesh-ancestor
110059342|NCT01517321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110059343|NCT01517321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110059344|NCT01517334|Minocycline|minocycline|mesh-list
110059345|NCT01517334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110059346|NCT01517334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110059347|NCT01517347|Interleukin-2|interleukin-2|mesh-list
110059348|NCT01517347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110059349|NCT01517347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110059350|NCT01517347|Analgesics|analgesics|mesh-ancestor
110059351|NCT01517347|Sensory System Agents|sensory system agents|mesh-ancestor
110059352|NCT01517347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110059353|NCT01517347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110059354|NCT01517360|Oxytocin|oxytocin|mesh-list
110059355|NCT01517360|Oxytocics|oxytocics|mesh-ancestor
110059356|NCT01517360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110059357|NCT01517360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110059359|NCT01517399|Digoxin|digoxin|mesh-list
110059360|NCT01517399|Midazolam|midazolam|mesh-list
110059361|NCT01517399|Caffeine|caffeine|mesh-list
110059362|NCT01517399|Omeprazole|omeprazole|mesh-list
110059363|NCT01517399|Warfarin|warfarin|mesh-list
110059364|NCT01517399|Vitamins|vitamins|mesh-ancestor
110059365|NCT01517399|Micronutrients|micronutrients|mesh-ancestor
110059366|NCT01517399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110059367|NCT01517399|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110059368|NCT01517399|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110059369|NCT01517399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110059370|NCT01517399|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110059371|NCT01517399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110059372|NCT01517399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110059373|NCT01517399|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110059374|NCT01517399|Anesthetics, General|anesthetics, general|mesh-ancestor
110059375|NCT01517399|Anesthetics|anesthetics|mesh-ancestor
110059376|NCT01517399|GABA Modulators|gaba modulators|mesh-ancestor
110059377|NCT01517399|GABA Agents|gaba agents|mesh-ancestor
110059378|NCT01517399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110059379|NCT01517399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110059380|NCT01517399|Anticoagulants|anticoagulants|mesh-ancestor
110059381|NCT01517399|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110059382|NCT01517399|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110059383|NCT01517399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110059384|NCT01517399|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110059385|NCT01517399|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110059387|NCT01517399|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110059388|NCT01517399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110059389|NCT01517399|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110059390|NCT01517399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110059391|NCT01517399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110059392|NCT01517399|Protective Agents|protective agents|mesh-ancestor
110059393|NCT01517399|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110059394|NCT01517399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110059398|NCT01517490|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110059399|NCT01517490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110059400|NCT01517490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110059401|NCT01517555|Acetaminophen|acetaminophen|mesh-list
110059402|NCT01517555|Liraglutide|liraglutide|mesh-list
110059403|NCT01517555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110059404|NCT01517555|Analgesics|analgesics|mesh-ancestor
110059405|NCT01517555|Sensory System Agents|sensory system agents|mesh-ancestor
110059406|NCT01517555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110059407|NCT01517555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110059408|NCT01517555|Antipyretics|antipyretics|mesh-ancestor
110059409|NCT01517555|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110059410|NCT01517555|Incretins|incretins|mesh-ancestor
110059411|NCT01517555|Hormones|hormones|mesh-ancestor
110059412|NCT01517555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110059413|NCT01517568|Liraglutide|liraglutide|mesh-list
110059414|NCT01517568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110059415|NCT01517568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110059416|NCT01517568|Incretins|incretins|mesh-ancestor
110059417|NCT01517568|Hormones|hormones|mesh-ancestor
110059418|NCT01517568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110059419|NCT01517607|Mesalamine|mesalamine|mesh-list
110059420|NCT01517607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110059421|NCT01517607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110059422|NCT01517607|Analgesics|analgesics|mesh-ancestor
110059423|NCT01517607|Sensory System Agents|sensory system agents|mesh-ancestor
110059424|NCT01517607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110059425|NCT01517607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110059426|NCT01517607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110059427|NCT01517607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110059429|NCT01517724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110059430|NCT01517815|Tazobactam|tazobactam|mesh-list
110059431|NCT01517815|Piperacillin|piperacillin|mesh-list
110059432|NCT01517815|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
110059433|NCT01517815|Doripenem|doripenem|mesh-list
110059434|NCT01517815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110059435|NCT01517815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110059436|NCT01517815|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110059437|NCT01517815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110059438|NCT01517815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110059439|NCT01517828|Midazolam|midazolam|mesh-list
110059440|NCT01517828|Ketamine|ketamine|mesh-list
110059441|NCT01517828|Analgesics|analgesics|mesh-ancestor
110059442|NCT01517828|Sensory System Agents|sensory system agents|mesh-ancestor
110059443|NCT01517828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110059444|NCT01517828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110059445|NCT01517828|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110059446|NCT01517828|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110059447|NCT01517828|Anesthetics, General|anesthetics, general|mesh-ancestor
110059448|NCT01517828|Anesthetics|anesthetics|mesh-ancestor
110059449|NCT01517828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110059450|NCT01517828|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110059451|NCT01517828|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110059452|NCT01517828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110059453|NCT01517828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110059454|NCT01517828|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110059455|NCT01517828|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110059456|NCT01517828|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110059457|NCT01517828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110059458|NCT01517828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110059459|NCT01517828|GABA Modulators|gaba modulators|mesh-ancestor
110059460|NCT01517828|GABA Agents|gaba agents|mesh-ancestor
110059461|NCT01517854|Sildenafil Citrate|sildenafil citrate|mesh-list
110059462|NCT01517854|Vasodilator Agents|vasodilator agents|mesh-ancestor
110059463|NCT01517854|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110059466|NCT01517854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110059467|NCT01517854|Urological Agents|urological agents|mesh-ancestor
110059469|NCT01517932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110059470|NCT01517932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110059471|NCT01517932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110059472|NCT01517932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110059473|NCT01517932|Analgesics|analgesics|mesh-ancestor
110059474|NCT01517932|Sensory System Agents|sensory system agents|mesh-ancestor
110059475|NCT01517932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110059476|NCT01517932|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110059477|NCT01517932|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110059478|NCT01517932|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110059479|NCT01517932|Adrenergic Agents|adrenergic agents|mesh-ancestor
110059480|NCT01517932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110059481|NCT01517932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110059482|NCT01517997|Paclitaxel|paclitaxel|mesh-list
110059483|NCT01517997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110059484|NCT01517997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110059485|NCT01517997|Tubulin Modulators|tubulin modulators|mesh-ancestor
110059486|NCT01517997|Antimitotic Agents|antimitotic agents|mesh-ancestor
110059487|NCT01517997|Mitosis Modulators|mitosis modulators|mesh-ancestor
110059488|NCT01517997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110059489|NCT01518062|Estrogens|estrogens|mesh-list
110059491|NCT01518062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110059492|NCT01518062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110059495|NCT01518101|Vildagliptin|vildagliptin|mesh-list
110059496|NCT01518101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110059497|NCT01518101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110059498|NCT01518101|Incretins|incretins|mesh-ancestor
110059499|NCT01518101|Hormones|hormones|mesh-ancestor
110059500|NCT01518101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110059501|NCT01518101|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110059502|NCT01518101|Protease Inhibitors|protease inhibitors|mesh-ancestor
110059503|NCT01518101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110059504|NCT01518101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110059505|NCT01516944|Capecitabine|capecitabine|mesh-list
110059506|NCT01516944|Tegafur|tegafur|mesh-list
110059507|NCT01516944|Oxaliplatin|oxaliplatin|mesh-list
110059508|NCT01516944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110059509|NCT01516944|Antimetabolites|antimetabolites|mesh-ancestor
110059510|NCT01516944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110059511|NCT01516944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110059512|NCT01518166|Liraglutide|liraglutide|mesh-list
110059513|NCT01518166|Griseofulvin|griseofulvin|mesh-list
110059514|NCT01518166|Digoxin|digoxin|mesh-list
110059515|NCT01518166|Lisinopril|lisinopril|mesh-list
110059517|NCT01518166|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110059518|NCT01518166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110059519|NCT01518166|Antimetabolites|antimetabolites|mesh-ancestor
110059520|NCT01518166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110059521|NCT01518166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110059522|NCT01518166|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110059523|NCT01518166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110059524|NCT01518166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110059525|NCT01518166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110059526|NCT01518166|Incretins|incretins|mesh-ancestor
110059527|NCT01518166|Hormones|hormones|mesh-ancestor
110059528|NCT01518166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110059529|NCT01518166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110059530|NCT01518166|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110059531|NCT01518166|Protective Agents|protective agents|mesh-ancestor
110059532|NCT01518166|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110059533|NCT01518166|Protease Inhibitors|protease inhibitors|mesh-ancestor
110059534|NCT01518166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110059535|NCT01518166|Antifungal Agents|antifungal agents|mesh-ancestor
110059536|NCT01518166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110059537|NCT01518231|Aspirin|aspirin|mesh-list
110059538|NCT01518231|Edaravone|edaravone|mesh-list
110059539|NCT01518231|Warfarin|warfarin|mesh-list
110059541|NCT01518231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110059542|NCT01518231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110059544|NCT01518231|Sensory System Agents|sensory system agents|mesh-ancestor
110059545|NCT01518231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110059546|NCT01518231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110059547|NCT01518231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110059548|NCT01518231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110059549|NCT01518231|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110059550|NCT01518231|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110059551|NCT01518231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110059552|NCT01518231|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110059553|NCT01518231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110059554|NCT01518231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110059555|NCT01518231|Antipyretics|antipyretics|mesh-ancestor
110059556|NCT01518231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110059557|NCT01518231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110059558|NCT01518231|Antimetabolites|antimetabolites|mesh-ancestor
110059559|NCT01518231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110059560|NCT01518231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110059563|NCT01518231|Antioxidants|antioxidants|mesh-ancestor
110059564|NCT01518231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110059565|NCT01518231|Protective Agents|protective agents|mesh-ancestor
110059566|NCT01518413|Irinotecan|irinotecan|mesh-list
110059567|NCT01518413|Sorafenib|sorafenib|mesh-list
110059568|NCT01518413|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110059569|NCT01518413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110059570|NCT01518413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110059571|NCT01518413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110059572|NCT01518413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110059573|NCT01518413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110059574|NCT01518465|Dexamethasone|dexamethasone|mesh-list
110059575|NCT01518465|Lenalidomide|lenalidomide|mesh-list
110059576|NCT01518465|Dalteparin|dalteparin|mesh-list
110059577|NCT01518465|Tinzaparin|tinzaparin|mesh-list
110059578|NCT01518465|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110059579|NCT01518465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110059580|NCT01518465|Antiemetics|antiemetics|mesh-ancestor
110059581|NCT01518465|Autonomic Agents|autonomic agents|mesh-ancestor
110059582|NCT01518465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110059583|NCT01518465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110059584|NCT01518465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110059585|NCT01518465|Glucocorticoids|glucocorticoids|mesh-ancestor
110059587|NCT01518465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110059588|NCT01518465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110059589|NCT01518465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110059590|NCT01518465|Immunologic Factors|immunologic factors|mesh-ancestor
110059591|NCT01518465|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110059592|NCT01518465|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110059593|NCT01518465|Growth Substances|growth substances|mesh-ancestor
110059594|NCT01518465|Growth Inhibitors|growth inhibitors|mesh-ancestor
110059595|NCT01518465|Anticoagulants|anticoagulants|mesh-ancestor
110059596|NCT01518465|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110059597|NCT01518465|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110059598|NCT01518465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110059599|NCT01518569|Urinastatin|urinastatin|mesh-list
110059600|NCT01518569|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110059601|NCT01518569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110059602|NCT01518569|Protease Inhibitors|protease inhibitors|mesh-ancestor
110059603|NCT01518569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110059604|NCT01518569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110059606|NCT01518595|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110059607|NCT01518595|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110059608|NCT01518595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110059609|NCT01518608|Alfentanil|alfentanil|mesh-list
110059610|NCT01518608|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110059611|NCT01518608|Narcotics|narcotics|mesh-ancestor
110059612|NCT01518608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110059613|NCT01518608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110059614|NCT01518608|Analgesics|analgesics|mesh-ancestor
110059615|NCT01518608|Sensory System Agents|sensory system agents|mesh-ancestor
110059616|NCT01518608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110059617|NCT01518608|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110059618|NCT01518608|Anesthetics, General|anesthetics, general|mesh-ancestor
110059619|NCT01518608|Anesthetics|anesthetics|mesh-ancestor
110059620|NCT01518621|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110059621|NCT01518621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110059622|NCT01518621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110059623|NCT01518621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110059624|NCT01518621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110059625|NCT01518634|Imipramine|imipramine|mesh-list
110059626|NCT01518634|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110059627|NCT01518634|Antidepressive Agents|antidepressive agents|mesh-ancestor
110059628|NCT01518634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110059629|NCT01518634|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110059630|NCT01518634|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110059631|NCT01518634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110059632|NCT01518634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110059633|NCT01518634|Adrenergic Agents|adrenergic agents|mesh-ancestor
110059634|NCT01518634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110059635|NCT01518634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110059637|NCT01518712|Canagliflozin|canagliflozin|mesh-list
110059638|NCT01518712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110059639|NCT01518712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110059640|NCT01518712|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110059641|NCT01518712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110059642|NCT01518725|Vitamin D|vitamin d|mesh-list
110059643|NCT01518725|Cholecalciferol|cholecalciferol|mesh-list
110059644|NCT01518725|Vitamins|vitamins|mesh-ancestor
110059645|NCT01518725|Micronutrients|micronutrients|mesh-ancestor
110059646|NCT01518725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110059647|NCT01518725|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110059648|NCT01518725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110059649|NCT01518790|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
110059650|NCT01518790|Laxatives|laxatives|mesh-ancestor
110059651|NCT01518790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110059652|NCT01518855|Amlodipine|amlodipine|mesh-list
110059653|NCT01518855|Nifedipine|nifedipine|mesh-list
110059654|NCT01518855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110059655|NCT01518855|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110059656|NCT01518855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110059657|NCT01518855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110059658|NCT01518855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110059659|NCT01518855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110059660|NCT01518855|Vasodilator Agents|vasodilator agents|mesh-ancestor
110059661|NCT01518855|Tocolytic Agents|tocolytic agents|mesh-ancestor
110059662|NCT01518855|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110059663|NCT01518933|Silybin|silybin|mesh-list
110059664|NCT01518933|Silymarin|silymarin|mesh-list
110059665|NCT01518933|Antioxidants|antioxidants|mesh-ancestor
110059666|NCT01518933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110059667|NCT01518933|Protective Agents|protective agents|mesh-ancestor
110059668|NCT01518933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110059669|NCT01518933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110059670|NCT01518933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110059671|NCT01518959|Cholecalciferol|cholecalciferol|mesh-list
110059672|NCT01518959|Vitamin D|vitamin d|mesh-list
110059673|NCT01518959|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110059674|NCT01518959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110059675|NCT01518959|Vitamins|vitamins|mesh-ancestor
110059676|NCT01518959|Micronutrients|micronutrients|mesh-ancestor
110059677|NCT01518959|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110059678|NCT01518998|Amlodipine|amlodipine|mesh-list
110059679|NCT01518998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110059680|NCT01518998|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110059681|NCT01518998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110059682|NCT01518998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110059683|NCT01518998|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110059684|NCT01518998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110059685|NCT01518998|Vasodilator Agents|vasodilator agents|mesh-ancestor
110059687|NCT01519011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110059688|NCT01519011|Antimetabolites|antimetabolites|mesh-ancestor
110059689|NCT01519011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110059691|NCT01519011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110059692|NCT01519037|Cinacalcet|cinacalcet|mesh-list
110059693|NCT01519037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110059694|NCT01519037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110059695|NCT01519037|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
110059696|NCT01519037|Hormone Antagonists|hormone antagonists|mesh-ancestor
110059697|NCT01519037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110059698|NCT01519076|Coal Tar|coal tar|mesh-list
110059700|NCT01519076|Dermatologic Agents|dermatologic agents|mesh-ancestor
110059701|NCT01519102|Hormones|hormones|mesh-list
110059702|NCT01519102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110059703|NCT01519102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110059704|NCT01519128|Rilpivirine|rilpivirine|mesh-list
110059705|NCT01519128|Digoxin|digoxin|mesh-list
110059706|NCT01519128|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110059707|NCT01519128|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110059708|NCT01519128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110059709|NCT01519128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110059710|NCT01519128|Protective Agents|protective agents|mesh-ancestor
110059711|NCT01519128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110059712|NCT01519128|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110059713|NCT01519128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110059714|NCT01519128|Antiviral Agents|antiviral agents|mesh-ancestor
110059715|NCT01519128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110059716|NCT01519128|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110059717|NCT01519128|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110059718|NCT01519154|Ketamine|ketamine|mesh-list
110059719|NCT01519154|Propofol|propofol|mesh-list
110059720|NCT01519154|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110059721|NCT01519154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110059722|NCT01519154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110059723|NCT01519154|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110059724|NCT01519154|Anesthetics, General|anesthetics, general|mesh-ancestor
110059725|NCT01519154|Anesthetics|anesthetics|mesh-ancestor
110059726|NCT01519154|Analgesics|analgesics|mesh-ancestor
110059727|NCT01519154|Sensory System Agents|sensory system agents|mesh-ancestor
110059728|NCT01519154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110059729|NCT01519154|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110059730|NCT01519154|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110059731|NCT01519154|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110059732|NCT01519154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110059733|NCT01519154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110059734|NCT01519297|Irbesartan|irbesartan|mesh-list
110059735|NCT01519297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110059736|NCT01519297|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110059737|NCT01519297|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110059738|NCT01519297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110059739|NCT01519310|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110059740|NCT01519310|Metronidazole|metronidazole|mesh-list
110059741|NCT01519310|Ciprofloxacin|ciprofloxacin|mesh-list
110059742|NCT01519310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110059743|NCT01519310|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110059744|NCT01519310|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110059745|NCT01519310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110059746|NCT01519310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110059747|NCT01519310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110059748|NCT01519310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110059749|NCT01519310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110059750|NCT01519310|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110059751|NCT01519310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110059752|NCT01519336|Ritonavir|ritonavir|mesh-list
110059753|NCT01519336|Darunavir|darunavir|mesh-list
110059754|NCT01519336|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110059755|NCT01519336|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110059756|NCT01519336|Protease Inhibitors|protease inhibitors|mesh-ancestor
110059757|NCT01519336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110059758|NCT01519336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110059759|NCT01519336|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110059760|NCT01519336|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110059761|NCT01519336|Antiviral Agents|antiviral agents|mesh-ancestor
110059762|NCT01519336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110059764|NCT01519336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110059766|NCT01519401|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110059767|NCT01519401|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110059769|NCT01519401|Estradiol|estradiol|mesh-list
110059770|NCT01519401|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110059771|NCT01519401|Estrogens|estrogens|mesh-ancestor
110059772|NCT01519401|Hormones|hormones|mesh-ancestor
110059773|NCT01519401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110059774|NCT01519401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110059775|NCT01519401|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110059776|NCT01519401|Contraceptive Agents|contraceptive agents|mesh-ancestor
110059777|NCT01519401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110059778|NCT01519401|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110059779|NCT01519401|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110059780|NCT01519401|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110059781|NCT01519401|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110059782|NCT01519401|Hormone Antagonists|hormone antagonists|mesh-ancestor
110059783|NCT01519401|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110059784|NCT01519401|Diuretics|diuretics|mesh-ancestor
110059785|NCT01519401|Natriuretic Agents|natriuretic agents|mesh-ancestor
110059786|NCT01519544|Acetazolamide|acetazolamide|mesh-list
110059788|NCT01519544|Anticonvulsants|anticonvulsants|mesh-ancestor
110059789|NCT01519544|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110059790|NCT01519544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110059791|NCT01519544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110059792|NCT01519544|Diuretics|diuretics|mesh-ancestor
110059793|NCT01519544|Natriuretic Agents|natriuretic agents|mesh-ancestor
110059794|NCT01519544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110059795|NCT01519544|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110059796|NCT01519544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110059797|NCT01519544|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110059798|NCT01519544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110059799|NCT01519544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110059800|NCT01519544|GABA Modulators|gaba modulators|mesh-ancestor
110059801|NCT01519544|GABA Agents|gaba agents|mesh-ancestor
110059802|NCT01519544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110059803|NCT01519687|Tofisopam|tofisopam|mesh-list
110059804|NCT01519687|Antidepressive Agents|antidepressive agents|mesh-ancestor
110059805|NCT01519687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110059806|NCT01519726|Midazolam|midazolam|mesh-list
110059807|NCT01519726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110059808|NCT01519726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110059809|NCT01519726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110059810|NCT01519726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110059811|NCT01519726|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110059812|NCT01519726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110059813|NCT01519726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110059814|NCT01519726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110059815|NCT01519726|Anesthetics, General|anesthetics, general|mesh-ancestor
110059816|NCT01519726|Anesthetics|anesthetics|mesh-ancestor
110059817|NCT01519726|GABA Modulators|gaba modulators|mesh-ancestor
110059818|NCT01519726|GABA Agents|gaba agents|mesh-ancestor
110059819|NCT01519726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110059820|NCT01519726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110059821|NCT01519752|Oxiconazole|oxiconazole|mesh-list
110059822|NCT01519752|Antifungal Agents|antifungal agents|mesh-ancestor
110059823|NCT01519752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110059824|NCT01519856|Piribedil|piribedil|mesh-list
110059825|NCT01519856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110059826|NCT01519856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110059827|NCT01519856|Dopamine Agonists|dopamine agonists|mesh-ancestor
110059828|NCT01519856|Dopamine Agents|dopamine agents|mesh-ancestor
110059829|NCT01519856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110059830|NCT01519856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110059831|NCT01519856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110059833|NCT01519986|Cholecalciferol|cholecalciferol|mesh-list
110059834|NCT01519986|Vitamins|vitamins|mesh-ancestor
110059835|NCT01519986|Micronutrients|micronutrients|mesh-ancestor
110059836|NCT01519986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110059837|NCT01519986|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110059838|NCT01519986|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110059840|NCT01520012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110059841|NCT01520012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110059842|NCT01520012|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110059843|NCT01520012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110059844|NCT01520012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110059845|NCT01520025|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110059846|NCT01520025|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110059847|NCT01520025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110059848|NCT01520077|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
110059849|NCT01520077|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110059850|NCT01520077|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110059851|NCT01520077|Antimetabolites|antimetabolites|mesh-ancestor
110059852|NCT01520077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110059853|NCT01520077|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110059854|NCT01520103|Everolimus|everolimus|mesh-list
110059855|NCT01520103|Vinorelbine|vinorelbine|mesh-list
110059856|NCT01520103|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110059857|NCT01520103|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110059858|NCT01520103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110059859|NCT01520103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110059860|NCT01520103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110059862|NCT01520103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110059863|NCT01520103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110059864|NCT01520103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110059865|NCT01520103|Tubulin Modulators|tubulin modulators|mesh-ancestor
110059866|NCT01520103|Antimitotic Agents|antimitotic agents|mesh-ancestor
110059867|NCT01520103|Mitosis Modulators|mitosis modulators|mesh-ancestor
110059868|NCT01520116|Timolol|timolol|mesh-list
110059869|NCT01520116|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110059870|NCT01520116|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110059871|NCT01520116|Adrenergic Agents|adrenergic agents|mesh-ancestor
110059872|NCT01520116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110059873|NCT01520116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110059874|NCT01520116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110059875|NCT01520116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110059876|NCT01520116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110059877|NCT01520181|Lactams|lactams|mesh-list
110059878|NCT01520181|beta-Lactams|beta-lactams|mesh-list
110059879|NCT01520181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110059880|NCT01520181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110059881|NCT01520285|Felodipine|felodipine|mesh-list
110059882|NCT01520285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110059883|NCT01520285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110059884|NCT01520285|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110059885|NCT01520285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110059886|NCT01520285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110059887|NCT01520285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110059888|NCT01520285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110059889|NCT01520285|Vasodilator Agents|vasodilator agents|mesh-ancestor
110059890|NCT01520298|Acetaminophen|acetaminophen|mesh-list
110059891|NCT01520298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110059892|NCT01520298|Analgesics|analgesics|mesh-ancestor
110059893|NCT01520298|Sensory System Agents|sensory system agents|mesh-ancestor
110059894|NCT01520298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110059895|NCT01520298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110059896|NCT01520298|Antipyretics|antipyretics|mesh-ancestor
110059897|NCT01520350|Aripiprazole|aripiprazole|mesh-list
110059898|NCT01520350|Antidepressive Agents|antidepressive agents|mesh-ancestor
110059899|NCT01520350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110059900|NCT01520350|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110059901|NCT01520350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110059902|NCT01520350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110059903|NCT01520350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110059904|NCT01520350|Dopamine Agonists|dopamine agonists|mesh-ancestor
110059905|NCT01520350|Dopamine Agents|dopamine agents|mesh-ancestor
110059906|NCT01520350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110059907|NCT01520350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110059908|NCT01520350|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110059909|NCT01520350|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110059911|NCT01520350|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110059912|NCT01520350|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110059913|NCT01520350|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110059914|NCT01520350|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110059916|NCT01520389|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110059917|NCT01520389|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110059918|NCT01520389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110059920|NCT01520389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110059921|NCT01520389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110059922|NCT01520389|Immunologic Factors|immunologic factors|mesh-ancestor
110059923|NCT01520389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110059924|NCT01520415|Lidocaine|lidocaine|mesh-list
110059925|NCT01520415|Bupivacaine|bupivacaine|mesh-list
110059926|NCT01520415|Anesthetics, Local|anesthetics, local|mesh-ancestor
110059927|NCT01520415|Anesthetics|anesthetics|mesh-ancestor
110059928|NCT01520415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110059929|NCT01520415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110059930|NCT01520415|Sensory System Agents|sensory system agents|mesh-ancestor
110059931|NCT01520415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110059932|NCT01520415|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110059933|NCT01520415|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110059934|NCT01520415|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110059935|NCT01520415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110059936|NCT01520415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110059937|NCT01520441|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110059938|NCT01520441|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110059939|NCT01520441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110059940|NCT01520441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110059941|NCT01520441|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110059942|NCT01520441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110059943|NCT01520441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110059944|NCT01520441|Cholinergic Agents|cholinergic agents|mesh-ancestor
110059945|NCT01520441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110059946|NCT01520467|Anastrozole|anastrozole|mesh-list
110059947|NCT01520467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110059948|NCT01520467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110059949|NCT01520467|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110059950|NCT01520467|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110059951|NCT01520467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110059952|NCT01520467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110059953|NCT01520467|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110059954|NCT01520467|Hormone Antagonists|hormone antagonists|mesh-ancestor
110059955|NCT01520467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110059956|NCT01520467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110059957|NCT01520584|Vitamins|vitamins|mesh-list
110059958|NCT01520584|Micronutrients|micronutrients|mesh-ancestor
110059959|NCT01520584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110059960|NCT01520753|Insulin|insulin|mesh-list
110059961|NCT01520753|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110059962|NCT01520753|Insulin Aspart|insulin aspart|mesh-list
110059963|NCT01520753|Insulin, Long-Acting|insulin, long-acting|mesh-list
110059964|NCT01520753|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110059965|NCT01520753|Biphasic Insulins|biphasic insulins|mesh-list
110059966|NCT01520753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110059967|NCT01520753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110059968|NCT01520766|Methamphetamine|methamphetamine|mesh-list
110059969|NCT01520766|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110059970|NCT01520766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110059971|NCT01520766|Sympathomimetics|sympathomimetics|mesh-ancestor
110059972|NCT01520766|Autonomic Agents|autonomic agents|mesh-ancestor
110059973|NCT01520766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110059974|NCT01520766|Dopamine Agents|dopamine agents|mesh-ancestor
110059975|NCT01520766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110059976|NCT01520766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110059977|NCT01520766|Adrenergic Agents|adrenergic agents|mesh-ancestor
110059979|NCT01520766|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110059980|NCT01520766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110059981|NCT01520766|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110059983|NCT01520792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110059984|NCT01520792|Analgesics|analgesics|mesh-ancestor
110059985|NCT01520792|Sensory System Agents|sensory system agents|mesh-ancestor
110059986|NCT01520792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110059987|NCT01520792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110059988|NCT01520792|Antipyretics|antipyretics|mesh-ancestor
110059989|NCT01520818|Insulin|insulin|mesh-list
110059990|NCT01520818|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110059991|NCT01520818|Insulin Aspart|insulin aspart|mesh-list
110059992|NCT01520818|Insulin, Long-Acting|insulin, long-acting|mesh-list
110059993|NCT01520818|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110059995|NCT01520818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110059996|NCT01520818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110059997|NCT01520831|Insulin|insulin|mesh-list
110059998|NCT01520831|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110059999|NCT01520831|Insulin Aspart|insulin aspart|mesh-list
110060000|NCT01520831|Insulin, Long-Acting|insulin, long-acting|mesh-list
110060001|NCT01520831|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110060002|NCT01520831|Biphasic Insulins|biphasic insulins|mesh-list
110060003|NCT01520831|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110060004|NCT01520831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110060005|NCT01520831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110060006|NCT01520896|Ketoconazole|ketoconazole|mesh-list
110060007|NCT01520896|Naloxegol|naloxegol|mesh-list
110060008|NCT01520896|Antifungal Agents|antifungal agents|mesh-ancestor
110060009|NCT01520896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110060010|NCT01520896|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110060011|NCT01520896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110060012|NCT01520896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110060013|NCT01520896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110060014|NCT01520896|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110060015|NCT01520896|Hormone Antagonists|hormone antagonists|mesh-ancestor
110060017|NCT01520896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110060018|NCT01520896|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110060019|NCT01520896|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110060020|NCT01520896|Sensory System Agents|sensory system agents|mesh-ancestor
110060021|NCT01520896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110060022|NCT01521130|Levetiracetam|levetiracetam|mesh-list
110060023|NCT01521130|Anticonvulsants|anticonvulsants|mesh-ancestor
110060024|NCT01521130|Nootropic Agents|nootropic agents|mesh-ancestor
110060025|NCT01521299|Hydroxyurea|hydroxyurea|mesh-list
110060026|NCT01521299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110060027|NCT01521299|Antisickling Agents|antisickling agents|mesh-ancestor
110060028|NCT01521299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110060029|NCT01521299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110060030|NCT01521299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110060031|NCT01521312|Saxagliptin|saxagliptin|mesh-list
110060032|NCT01521312|Incretins|incretins|mesh-ancestor
110060033|NCT01521312|Hormones|hormones|mesh-ancestor
110060034|NCT01521312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110060035|NCT01521312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110060036|NCT01521312|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110060037|NCT01521312|Protease Inhibitors|protease inhibitors|mesh-ancestor
110060038|NCT01521312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110060039|NCT01521312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110060040|NCT01521312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110060041|NCT01521325|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110060042|NCT01521325|Immunologic Factors|immunologic factors|mesh-ancestor
110060043|NCT01521325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110060045|NCT01521377|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110060046|NCT01521377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110060047|NCT01521377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110060048|NCT01521377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110060049|NCT01521377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110060050|NCT01521377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110060051|NCT01521377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110060052|NCT01521377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110060053|NCT01521377|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110060054|NCT01521377|Contraceptive Agents|contraceptive agents|mesh-ancestor
110060055|NCT01521377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110060056|NCT01521377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110060057|NCT01521377|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110060058|NCT01521377|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110060059|NCT01521377|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110060060|NCT01521455|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110060061|NCT01521455|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110060062|NCT01521455|Autonomic Agents|autonomic agents|mesh-ancestor
110060063|NCT01521455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110060064|NCT01521455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110060066|NCT01521455|Respiratory System Agents|respiratory system agents|mesh-ancestor
110060067|NCT01521455|Glucocorticoids|glucocorticoids|mesh-ancestor
110060069|NCT01521455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110060070|NCT01521455|Sympathomimetics|sympathomimetics|mesh-ancestor
110060071|NCT01521481|Anesthetics|anesthetics|mesh-list
110060072|NCT01521481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110060073|NCT01521481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110060074|NCT01521520|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
110060075|NCT01521520|Hematinics|hematinics|mesh-ancestor
110060076|NCT01521520|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110060077|NCT01521520|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110060078|NCT01521572|Albuterol|albuterol|mesh-list
110060079|NCT01521572|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110060080|NCT01521572|Autonomic Agents|autonomic agents|mesh-ancestor
110060081|NCT01521572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110060082|NCT01521572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110060083|NCT01521572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110060084|NCT01521572|Respiratory System Agents|respiratory system agents|mesh-ancestor
110060085|NCT01521572|Tocolytic Agents|tocolytic agents|mesh-ancestor
110060086|NCT01521572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110060087|NCT01521572|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110060088|NCT01521572|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110060089|NCT01521572|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110060090|NCT01521572|Adrenergic Agents|adrenergic agents|mesh-ancestor
110060091|NCT01521572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110060092|NCT01521572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110060093|NCT01521624|Metformin|metformin|mesh-list
110060094|NCT01521624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110060095|NCT01521624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110060096|NCT01521689|Rituximab|rituximab|mesh-list
110060097|NCT01521689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110060098|NCT01521689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110060099|NCT01521689|Immunologic Factors|immunologic factors|mesh-ancestor
110060100|NCT01521689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110060101|NCT01521689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110060102|NCT01521767|Tolterodine Tartrate|tolterodine tartrate|mesh-list
110060103|NCT01521767|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110060104|NCT01521767|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110060105|NCT01521767|Cholinergic Agents|cholinergic agents|mesh-ancestor
110060106|NCT01521767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110060107|NCT01521767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110060108|NCT01521767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110060110|NCT01521793|Retinol acetate|retinol acetate|mesh-list
110060111|NCT01521793|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110060112|NCT01521793|Immunologic Factors|immunologic factors|mesh-ancestor
110060113|NCT01521793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110060114|NCT01521793|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110060115|NCT01521793|Protective Agents|protective agents|mesh-ancestor
110060116|NCT01521793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110060117|NCT01521819|Ranibizumab|ranibizumab|mesh-list
110060118|NCT01521819|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110060119|NCT01521819|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110060120|NCT01521819|Growth Substances|growth substances|mesh-ancestor
110060121|NCT01521819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110060122|NCT01521819|Growth Inhibitors|growth inhibitors|mesh-ancestor
110060123|NCT01521819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110060124|NCT01521936|Vitamin D|vitamin d|mesh-list
110060125|NCT01521936|Ergocalciferols|ergocalciferols|mesh-list
110060126|NCT01521936|Cholecalciferol|cholecalciferol|mesh-list
110060127|NCT01521936|Vitamins|vitamins|mesh-list
110060128|NCT01521936|Micronutrients|micronutrients|mesh-ancestor
110060129|NCT01521936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110060130|NCT01521936|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110060131|NCT01521936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110060132|NCT01521962|Alogliptin|alogliptin|mesh-list
110060133|NCT01521962|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110060134|NCT01521962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110060135|NCT01521962|Incretins|incretins|mesh-ancestor
110060136|NCT01521962|Hormones|hormones|mesh-ancestor
110060137|NCT01521962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110060138|NCT01521962|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110060139|NCT01521962|Protease Inhibitors|protease inhibitors|mesh-ancestor
110060140|NCT01521962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110060141|NCT01521962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110060142|NCT01521975|Adefovir|adefovir|mesh-list
110060144|NCT01521975|Telbivudine|telbivudine|mesh-list
110060145|NCT01521975|Antiviral Agents|antiviral agents|mesh-ancestor
110060146|NCT01521975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110060147|NCT01521975|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110060148|NCT01521975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110060149|NCT01521975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110060150|NCT01521975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110060151|NCT01522040|Magnesium Sulfate|magnesium sulfate|mesh-list
110060152|NCT01522040|Analgesics|analgesics|mesh-ancestor
110060153|NCT01522040|Sensory System Agents|sensory system agents|mesh-ancestor
110060154|NCT01522040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110060155|NCT01522040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110060156|NCT01522040|Anesthetics|anesthetics|mesh-ancestor
110060157|NCT01522040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110060158|NCT01522040|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110060159|NCT01522040|Anticonvulsants|anticonvulsants|mesh-ancestor
110060160|NCT01522040|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110060161|NCT01522040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110060162|NCT01522040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110060163|NCT01522040|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110060164|NCT01522040|Tocolytic Agents|tocolytic agents|mesh-ancestor
110060165|NCT01522040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110060166|NCT01522092|Escitalopram|escitalopram|mesh-list
110060167|NCT01522092|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110060168|NCT01522092|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110060169|NCT01522092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110060170|NCT01522092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110060171|NCT01522092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110060172|NCT01522092|Serotonin Agents|serotonin agents|mesh-ancestor
110060173|NCT01522092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110060174|NCT01522105|Daptomycin|daptomycin|mesh-list
110060175|NCT01522105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110060176|NCT01522105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110060177|NCT01522326|Ibuprofen|ibuprofen|mesh-list
110060178|NCT01522326|Metoclopramide|metoclopramide|mesh-list
110060179|NCT01522326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110060180|NCT01522326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110060181|NCT01522326|Analgesics|analgesics|mesh-ancestor
110060182|NCT01522326|Sensory System Agents|sensory system agents|mesh-ancestor
110060183|NCT01522326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110060184|NCT01522326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110060185|NCT01522326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110060186|NCT01522326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110060188|NCT01522326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110060189|NCT01522326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110060191|NCT01522326|Autonomic Agents|autonomic agents|mesh-ancestor
110060192|NCT01522326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110060193|NCT01522326|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110060194|NCT01522326|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110060195|NCT01522326|Dopamine Agents|dopamine agents|mesh-ancestor
110060196|NCT01522326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110060197|NCT01522378|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
110060198|NCT01522378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110060199|NCT01522378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110060200|NCT01522378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110060201|NCT01522378|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110060202|NCT01522534|Morphine|morphine|mesh-list
110060203|NCT01522534|Mepivacaine|mepivacaine|mesh-list
110060204|NCT01522534|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110060205|NCT01522534|Narcotics|narcotics|mesh-ancestor
110060206|NCT01522534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110060207|NCT01522534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110060208|NCT01522534|Analgesics|analgesics|mesh-ancestor
110060209|NCT01522534|Sensory System Agents|sensory system agents|mesh-ancestor
110060210|NCT01522534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110060211|NCT01522534|Anesthetics, Local|anesthetics, local|mesh-ancestor
110060212|NCT01522534|Anesthetics|anesthetics|mesh-ancestor
110060213|NCT01522547|Pomalidomide|pomalidomide|mesh-list
110060214|NCT01522547|Immunologic Factors|immunologic factors|mesh-ancestor
110060215|NCT01522547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110060216|NCT01522547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110060217|NCT01522547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110060218|NCT01522547|Growth Substances|growth substances|mesh-ancestor
110060222|NCT01522612|Fluorouracil|fluorouracil|mesh-list
110060223|NCT01522612|Cetuximab|cetuximab|mesh-list
110060224|NCT01522612|Antimetabolites|antimetabolites|mesh-ancestor
110060225|NCT01522612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110060226|NCT01522612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110060227|NCT01522612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110060228|NCT01522612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110060229|NCT01522612|Immunologic Factors|immunologic factors|mesh-ancestor
110060230|NCT01522612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110060231|NCT01522612|Antidotes|antidotes|mesh-ancestor
110060232|NCT01522612|Protective Agents|protective agents|mesh-ancestor
110060233|NCT01522612|Vitamin B Complex|vitamin b complex|mesh-ancestor
110060234|NCT01522612|Vitamins|vitamins|mesh-ancestor
110060235|NCT01522612|Micronutrients|micronutrients|mesh-ancestor
110060236|NCT01522612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110060237|NCT01522625|Tenofovir|tenofovir|mesh-list
110060238|NCT01522625|Antiviral Agents|antiviral agents|mesh-ancestor
110060239|NCT01522625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110060240|NCT01522625|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110060241|NCT01522625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110060242|NCT01522625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110060243|NCT01522625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110060244|NCT01522625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110060245|NCT01522625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110060246|NCT01522677|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110060247|NCT01522677|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110060248|NCT01522677|Dermatologic Agents|dermatologic agents|mesh-ancestor
110060249|NCT01522729|Fentanyl|fentanyl|mesh-list
110060250|NCT01522729|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110060251|NCT01522729|Narcotics|narcotics|mesh-ancestor
110060252|NCT01522729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110060253|NCT01522729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110060254|NCT01522729|Analgesics|analgesics|mesh-ancestor
110060255|NCT01522729|Sensory System Agents|sensory system agents|mesh-ancestor
110060256|NCT01522729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110060257|NCT01522729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110060258|NCT01522729|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110060259|NCT01522729|Anesthetics, General|anesthetics, general|mesh-ancestor
110060260|NCT01522729|Anesthetics|anesthetics|mesh-ancestor
110060261|NCT01522820|Sirolimus|sirolimus|mesh-list
110060262|NCT01522820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110060263|NCT01522820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110060264|NCT01522820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110060265|NCT01522820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110060266|NCT01522820|Antifungal Agents|antifungal agents|mesh-ancestor
110060267|NCT01522820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110060268|NCT01522820|Immunologic Factors|immunologic factors|mesh-ancestor
110060269|NCT01522820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110060270|NCT01522846|Heparin|heparin|mesh-list
110060271|NCT01522846|Anticoagulants|anticoagulants|mesh-ancestor
110060272|NCT01522846|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110060273|NCT01522846|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110060274|NCT01522846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110060276|NCT01522872|Dexamethasone acetate|dexamethasone acetate|mesh-list
110060277|NCT01522872|Bortezomib|bortezomib|mesh-list
110060278|NCT01522872|Pomalidomide|pomalidomide|mesh-list
110060279|NCT01522872|Phosphoramide Mustards|phosphoramide mustards|mesh-list
110060280|NCT01522872|BB 1101|bb 1101|mesh-list
110060281|NCT01522872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110060282|NCT01522872|Antiemetics|antiemetics|mesh-ancestor
110060283|NCT01522872|Autonomic Agents|autonomic agents|mesh-ancestor
110060284|NCT01522872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110060285|NCT01522872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110060286|NCT01522872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110060287|NCT01522872|Glucocorticoids|glucocorticoids|mesh-ancestor
110060289|NCT01522872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110060290|NCT01522872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110060291|NCT01522872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110060292|NCT01522872|Protease Inhibitors|protease inhibitors|mesh-ancestor
110060293|NCT01522872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110060294|NCT01522872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110060295|NCT01522872|Immunologic Factors|immunologic factors|mesh-ancestor
110060297|NCT01522872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110060298|NCT01522872|Growth Substances|growth substances|mesh-ancestor
110060299|NCT01522872|Growth Inhibitors|growth inhibitors|mesh-ancestor
110060300|NCT01522872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110060301|NCT01522872|Alkylating Agents|alkylating agents|mesh-ancestor
110060302|NCT01522989|Fluorouracil|fluorouracil|mesh-list
110060303|NCT01522989|Oxaliplatin|oxaliplatin|mesh-list
110060304|NCT01522989|Palbociclib|palbociclib|mesh-list
110060305|NCT01522989|Antimetabolites|antimetabolites|mesh-ancestor
110060306|NCT01522989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110060307|NCT01522989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110060308|NCT01522989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110060309|NCT01522989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110060310|NCT01522989|Immunologic Factors|immunologic factors|mesh-ancestor
110060311|NCT01522989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110060312|NCT01522989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110060313|NCT01522989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110060314|NCT01523002|Artesunate|artesunate|mesh-list
110060315|NCT01523002|Pyronaridine|pyronaridine|mesh-list
110060316|NCT01523002|Metoprolol|metoprolol|mesh-list
110060317|NCT01523002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110060318|NCT01523002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110060319|NCT01523002|Sympatholytics|sympatholytics|mesh-ancestor
110060320|NCT01523002|Autonomic Agents|autonomic agents|mesh-ancestor
110060321|NCT01523002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110060322|NCT01523002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110060323|NCT01523002|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110060324|NCT01523002|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110060325|NCT01523002|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110060326|NCT01523002|Adrenergic Agents|adrenergic agents|mesh-ancestor
110060327|NCT01523002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110060328|NCT01523002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110060329|NCT01523002|Antimalarials|antimalarials|mesh-ancestor
110060330|NCT01523002|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110060332|NCT01523002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110060333|NCT01523002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110060334|NCT01523002|Antiviral Agents|antiviral agents|mesh-ancestor
110060335|NCT01523002|Schistosomicides|schistosomicides|mesh-ancestor
110060336|NCT01523002|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110060337|NCT01523002|Anthelmintics|anthelmintics|mesh-ancestor
110060338|NCT01523015|Docetaxel|docetaxel|mesh-list
110060339|NCT01523015|Fluorouracil|fluorouracil|mesh-list
110060340|NCT01523015|Oxaliplatin|oxaliplatin|mesh-list
110060341|NCT01523015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110060342|NCT01523015|Tubulin Modulators|tubulin modulators|mesh-ancestor
110060343|NCT01523015|Antimitotic Agents|antimitotic agents|mesh-ancestor
110060344|NCT01523015|Mitosis Modulators|mitosis modulators|mesh-ancestor
110060345|NCT01523015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110060346|NCT01523015|Antimetabolites|antimetabolites|mesh-ancestor
110060347|NCT01523015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110060348|NCT01523015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110060349|NCT01523015|Immunologic Factors|immunologic factors|mesh-ancestor
110060350|NCT01523015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110060351|NCT01523041|Insulin|insulin|mesh-list
110060352|NCT01523041|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110060354|NCT01523041|Insulin, Long-Acting|insulin, long-acting|mesh-list
110060355|NCT01523041|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110060356|NCT01523041|Biphasic Insulins|biphasic insulins|mesh-list
110060357|NCT01523041|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110060358|NCT01523041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110060359|NCT01523054|Metoprolol|metoprolol|mesh-list
110060360|NCT01523054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110060361|NCT01523054|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110060362|NCT01523054|Sympatholytics|sympatholytics|mesh-ancestor
110060363|NCT01523054|Autonomic Agents|autonomic agents|mesh-ancestor
110060364|NCT01523054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110060365|NCT01523054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110060366|NCT01523054|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110060367|NCT01523054|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110060368|NCT01523054|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110060369|NCT01523054|Adrenergic Agents|adrenergic agents|mesh-ancestor
110060370|NCT01523054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110060371|NCT01523054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110060372|NCT01523067|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
110060373|NCT01523067|Vasodilator Agents|vasodilator agents|mesh-ancestor
110060375|NCT01523080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110060376|NCT01523080|Analgesics|analgesics|mesh-ancestor
110060377|NCT01523080|Sensory System Agents|sensory system agents|mesh-ancestor
110060378|NCT01523080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110060379|NCT01523080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110060380|NCT01523080|Antipyretics|antipyretics|mesh-ancestor
110060381|NCT01523093|Ondansetron|ondansetron|mesh-list
110060382|NCT01523093|Antiemetics|antiemetics|mesh-ancestor
110060383|NCT01523093|Autonomic Agents|autonomic agents|mesh-ancestor
110060384|NCT01523093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110060385|NCT01523093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110060386|NCT01523093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110060387|NCT01523093|Antipruritics|antipruritics|mesh-ancestor
110060388|NCT01523093|Dermatologic Agents|dermatologic agents|mesh-ancestor
110060389|NCT01523093|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110060390|NCT01523093|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110060391|NCT01523093|Serotonin Agents|serotonin agents|mesh-ancestor
110060392|NCT01523093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110060393|NCT01523093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110060394|NCT01523119|Ondansetron|ondansetron|mesh-list
110060395|NCT01523119|Antiemetics|antiemetics|mesh-ancestor
110060396|NCT01523119|Autonomic Agents|autonomic agents|mesh-ancestor
110060397|NCT01523119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110060398|NCT01523119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110060399|NCT01523119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110060400|NCT01523119|Antipruritics|antipruritics|mesh-ancestor
110060401|NCT01523119|Dermatologic Agents|dermatologic agents|mesh-ancestor
110060402|NCT01523119|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110060403|NCT01523119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110060404|NCT01523119|Serotonin Agents|serotonin agents|mesh-ancestor
110060405|NCT01523119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110060406|NCT01523119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110060407|NCT01523236|Mometasone Furoate|mometasone furoate|mesh-list
110060408|NCT01523236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110060409|NCT01523236|Dermatologic Agents|dermatologic agents|mesh-ancestor
110060410|NCT01523236|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110060411|NCT01523314|Dexamethasone|dexamethasone|mesh-list
110060412|NCT01523314|Bevacizumab|bevacizumab|mesh-list
110060413|NCT01523314|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110060414|NCT01523314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110060415|NCT01523314|Antiemetics|antiemetics|mesh-ancestor
110060416|NCT01523314|Autonomic Agents|autonomic agents|mesh-ancestor
110060417|NCT01523314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110060418|NCT01523314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110060419|NCT01523314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110060420|NCT01523314|Glucocorticoids|glucocorticoids|mesh-ancestor
110060421|NCT01523314|Hormones|hormones|mesh-ancestor
110060422|NCT01523314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110060423|NCT01523314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110060424|NCT01523314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110060425|NCT01523314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110060426|NCT01523314|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110060427|NCT01523314|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110060428|NCT01523314|Growth Substances|growth substances|mesh-ancestor
110060429|NCT01523314|Growth Inhibitors|growth inhibitors|mesh-ancestor
110060430|NCT01523314|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110060431|NCT01523327|Uric Acid|uric acid|mesh-list
110060432|NCT01523327|Antioxidants|antioxidants|mesh-ancestor
110060433|NCT01523327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110060434|NCT01523327|Protective Agents|protective agents|mesh-ancestor
110060435|NCT01523327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110060436|NCT01523379|Parecoxib|parecoxib|mesh-list
110060437|NCT01523379|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110060438|NCT01523379|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110060439|NCT01523379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110060440|NCT01523379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110060441|NCT01523379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110060442|NCT01523379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110060443|NCT01523379|Analgesics|analgesics|mesh-ancestor
110060444|NCT01523379|Sensory System Agents|sensory system agents|mesh-ancestor
110060445|NCT01523379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110060446|NCT01523379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110060447|NCT01523379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110060448|NCT01523379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110060450|NCT01523418|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110060451|NCT01523418|Antithrombins|antithrombins|mesh-ancestor
110060452|NCT01523418|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110060453|NCT01523418|Protease Inhibitors|protease inhibitors|mesh-ancestor
110060454|NCT01523418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110060455|NCT01523418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110060456|NCT01523418|Anticoagulants|anticoagulants|mesh-ancestor
110060457|NCT01523431|Leucovorin|leucovorin|mesh-list
110060458|NCT01523431|Fluorouracil|fluorouracil|mesh-list
110060459|NCT01523431|Irinotecan|irinotecan|mesh-list
110060460|NCT01523431|Antimetabolites|antimetabolites|mesh-ancestor
110060461|NCT01523431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110060462|NCT01523431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110060463|NCT01523431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110060464|NCT01523431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110060465|NCT01523431|Immunologic Factors|immunologic factors|mesh-ancestor
110060466|NCT01523431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110060467|NCT01523431|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110060468|NCT01523431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110060469|NCT01523431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110060471|NCT01523431|Protective Agents|protective agents|mesh-ancestor
110060472|NCT01523431|Vitamin B Complex|vitamin b complex|mesh-ancestor
110060473|NCT01523431|Vitamins|vitamins|mesh-ancestor
110060474|NCT01523431|Micronutrients|micronutrients|mesh-ancestor
110060475|NCT01523483|Progesterone|progesterone|mesh-list
110060476|NCT01523483|Progestins|progestins|mesh-ancestor
110060477|NCT01523483|Hormones|hormones|mesh-ancestor
110060478|NCT01523483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110060479|NCT01523483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110060480|NCT01523548|Carbon Monoxide|carbon monoxide|mesh-list
110060481|NCT01523548|Antimetabolites|antimetabolites|mesh-ancestor
110060482|NCT01523548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110060483|NCT01523548|Gasotransmitters|gasotransmitters|mesh-ancestor
110060484|NCT01523548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110060485|NCT01523548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110060486|NCT01523574|Calcium, Dietary|calcium, dietary|mesh-list
110060487|NCT01523574|Vitamin E|vitamin e|mesh-list
110060488|NCT01523574|Oxaliplatin|oxaliplatin|mesh-list
110060489|NCT01523574|Magnesium Sulfate|magnesium sulfate|mesh-list
110060490|NCT01523574|Calcium|calcium|mesh-list
110060491|NCT01523574|Vitamins|vitamins|mesh-ancestor
110060492|NCT01523574|Micronutrients|micronutrients|mesh-ancestor
110060493|NCT01523574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110060494|NCT01523574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110060495|NCT01523574|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110060496|NCT01523574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110060497|NCT01523574|Analgesics|analgesics|mesh-ancestor
110060498|NCT01523574|Sensory System Agents|sensory system agents|mesh-ancestor
110060499|NCT01523574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110060500|NCT01523574|Anesthetics|anesthetics|mesh-ancestor
110060501|NCT01523574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110060502|NCT01523574|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110060503|NCT01523574|Anticonvulsants|anticonvulsants|mesh-ancestor
110060504|NCT01523574|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110060505|NCT01523574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110060506|NCT01523574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110060507|NCT01523574|Tocolytic Agents|tocolytic agents|mesh-ancestor
110060508|NCT01523574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110060509|NCT01523574|Antioxidants|antioxidants|mesh-ancestor
110060510|NCT01523574|Protective Agents|protective agents|mesh-ancestor
110060511|NCT01523639|Metformin|metformin|mesh-list
110060513|NCT01523639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110060514|NCT01523678|Paclitaxel|paclitaxel|mesh-list
110060515|NCT01523678|Carboplatin|carboplatin|mesh-list
110060516|NCT01523678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110060517|NCT01523678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110060518|NCT01523678|Tubulin Modulators|tubulin modulators|mesh-ancestor
110060521|NCT01523678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110060522|NCT01523847|Doxorubicin|doxorubicin|mesh-list
110060523|NCT01523847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110060524|NCT01523847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110060525|NCT01523847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110060526|NCT01523847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110060527|NCT01523847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110060528|NCT01523847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110060529|NCT01523860|Rituximab|rituximab|mesh-list
110060530|NCT01523860|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110060531|NCT01523860|Mitoxantrone|mitoxantrone|mesh-list
110060532|NCT01523860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110060534|NCT01523860|Immunologic Factors|immunologic factors|mesh-ancestor
110060535|NCT01523860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110060536|NCT01523860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110060537|NCT01523860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110060538|NCT01523860|Alkylating Agents|alkylating agents|mesh-ancestor
110060539|NCT01523860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110060540|NCT01523860|Analgesics|analgesics|mesh-ancestor
110060541|NCT01523860|Sensory System Agents|sensory system agents|mesh-ancestor
110060542|NCT01523860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110060543|NCT01523860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110060544|NCT01523860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110060545|NCT01523860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110060547|NCT01524068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110060548|NCT01524068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110060549|NCT01524068|Immunologic Factors|immunologic factors|mesh-ancestor
110060550|NCT01524068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110060551|NCT01524068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110060552|NCT01524081|Amoxicillin|amoxicillin|mesh-list
110060553|NCT01524081|Metronidazole|metronidazole|mesh-list
110060554|NCT01524081|Clavulanic Acids|clavulanic acids|mesh-list
110060555|NCT01524081|Clavulanic Acid|clavulanic acid|mesh-list
110060556|NCT01524081|Cefuroxime|cefuroxime|mesh-list
110060557|NCT01524081|Cefuroxime axetil|cefuroxime axetil|mesh-list
110060558|NCT01524081|Fluconazole|fluconazole|mesh-list
110060559|NCT01524081|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110060560|NCT01524081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110060561|NCT01524081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110060562|NCT01524081|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110060563|NCT01524081|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110060564|NCT01524081|Antifungal Agents|antifungal agents|mesh-ancestor
110060565|NCT01524081|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110060566|NCT01524081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110060567|NCT01524081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110060568|NCT01524081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110060569|NCT01524081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110060570|NCT01524081|Hormone Antagonists|hormone antagonists|mesh-ancestor
110060571|NCT01524081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110060572|NCT01524081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110060573|NCT01524081|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110060574|NCT01524081|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110060575|NCT01524081|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110060576|NCT01524094|Leucovorin|leucovorin|mesh-list
110060577|NCT01524094|Fluorouracil|fluorouracil|mesh-list
110060578|NCT01524094|Oxaliplatin|oxaliplatin|mesh-list
110060579|NCT01524094|Levoleucovorin|levoleucovorin|mesh-list
110060580|NCT01524094|Antimetabolites|antimetabolites|mesh-ancestor
110060581|NCT01524094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110060582|NCT01524094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110060583|NCT01524094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110060584|NCT01524094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110060585|NCT01524094|Immunologic Factors|immunologic factors|mesh-ancestor
110060586|NCT01524094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110060587|NCT01524094|Antidotes|antidotes|mesh-ancestor
110060588|NCT01524094|Protective Agents|protective agents|mesh-ancestor
110060589|NCT01524094|Vitamin B Complex|vitamin b complex|mesh-ancestor
110060590|NCT01524094|Vitamins|vitamins|mesh-ancestor
110060591|NCT01524094|Micronutrients|micronutrients|mesh-ancestor
110060592|NCT01524237|Ketamine|ketamine|mesh-list
110060593|NCT01524237|Analgesics|analgesics|mesh-ancestor
110060594|NCT01524237|Sensory System Agents|sensory system agents|mesh-ancestor
110060596|NCT01524237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110060597|NCT01524237|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110060601|NCT01524237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110060602|NCT01524237|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110060603|NCT01524237|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110060604|NCT01524237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110060605|NCT01524237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110060607|NCT01524315|Thiamine|thiamine|mesh-list
110060608|NCT01524315|Vitamin B Complex|vitamin b complex|mesh-list
110060610|NCT01524315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110060611|NCT01524354|Anesthetics|anesthetics|mesh-list
110060612|NCT01524354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110060613|NCT01524354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110060614|NCT01524367|Dexmedetomidine|dexmedetomidine|mesh-list
110060615|NCT01524367|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110060616|NCT01524367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110060617|NCT01524367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110060618|NCT01524367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110060619|NCT01524367|Analgesics|analgesics|mesh-ancestor
110060620|NCT01524367|Sensory System Agents|sensory system agents|mesh-ancestor
110060621|NCT01524367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110060622|NCT01524367|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110060623|NCT01524367|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110060624|NCT01524367|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110060625|NCT01524367|Adrenergic Agents|adrenergic agents|mesh-ancestor
110060626|NCT01524367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110060627|NCT01524367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110060628|NCT01524432|Clotrimazole|clotrimazole|mesh-list
110060629|NCT01524432|Miconazole|miconazole|mesh-list
110060630|NCT01524432|Antifungal Agents|antifungal agents|mesh-list
110060631|NCT01524432|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110060632|NCT01524432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110060633|NCT01524432|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110060634|NCT01524432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110060635|NCT01524432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110060636|NCT01524432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110060637|NCT01524432|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110060638|NCT01524432|Hormone Antagonists|hormone antagonists|mesh-ancestor
110060639|NCT01524432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110060640|NCT01524432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110060641|NCT01524432|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110060642|NCT01524432|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110060643|NCT01524445|Bortezomib|bortezomib|mesh-list
110060644|NCT01524445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110060645|NCT01524497|Trazodone|trazodone|mesh-list
110060646|NCT01524497|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110060647|NCT01524497|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110060648|NCT01524497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110060649|NCT01524497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110060650|NCT01524497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110060651|NCT01524497|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110060652|NCT01524497|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110060653|NCT01524497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110060654|NCT01524497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110060655|NCT01524497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110060656|NCT01524497|Serotonin Agents|serotonin agents|mesh-ancestor
110060657|NCT01524497|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110060658|NCT01524497|Antidepressive Agents|antidepressive agents|mesh-ancestor
110060659|NCT01524575|Gemcitabine|gemcitabine|mesh-list
110060660|NCT01524575|Oxaliplatin|oxaliplatin|mesh-list
110060661|NCT01524575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110060662|NCT01524575|Antimetabolites|antimetabolites|mesh-ancestor
110060663|NCT01524575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110060664|NCT01524575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110060665|NCT01524601|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110060666|NCT01524601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110060667|NCT01524601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110060669|NCT01524601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110060670|NCT01524601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110060671|NCT01524601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110060672|NCT01524601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110060673|NCT01524653|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110060674|NCT01524653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110060675|NCT01524653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110060677|NCT01524653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110060678|NCT01524653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110060679|NCT01524653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110060680|NCT01524653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110060681|NCT01524705|Insulin|insulin|mesh-list
110060682|NCT01524705|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110060683|NCT01524705|Metformin|metformin|mesh-list
110060684|NCT01524705|Insulin Glargine|insulin glargine|mesh-list
110060685|NCT01524705|Exenatide|exenatide|mesh-list
110060686|NCT01524705|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110060687|NCT01524705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110060688|NCT01524705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110060689|NCT01524705|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110060690|NCT01524705|Incretins|incretins|mesh-ancestor
110060691|NCT01524705|Hormones|hormones|mesh-ancestor
110060692|NCT01524705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110060693|NCT01524731|Dexamethasone|dexamethasone|mesh-list
110060694|NCT01524731|Dexamethasone acetate|dexamethasone acetate|mesh-list
110060695|NCT01524731|BB 1101|bb 1101|mesh-list
110060696|NCT01524731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110060697|NCT01524731|Antiemetics|antiemetics|mesh-ancestor
110060698|NCT01524731|Autonomic Agents|autonomic agents|mesh-ancestor
110060699|NCT01524731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110060700|NCT01524731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110060701|NCT01524731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110060702|NCT01524731|Glucocorticoids|glucocorticoids|mesh-ancestor
110060703|NCT01524731|Hormones|hormones|mesh-ancestor
110060704|NCT01524731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110060705|NCT01524731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110060706|NCT01524731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110060707|NCT01524731|Protease Inhibitors|protease inhibitors|mesh-ancestor
110060708|NCT01524731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110060709|NCT01524731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110060710|NCT01524744|Pimecrolimus|pimecrolimus|mesh-list
110060711|NCT01524744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110060712|NCT01524744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110060713|NCT01524744|Analgesics|analgesics|mesh-ancestor
110060714|NCT01524744|Sensory System Agents|sensory system agents|mesh-ancestor
110060715|NCT01524744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110060716|NCT01524744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110060717|NCT01524744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110060718|NCT01524744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110060719|NCT01524744|Dermatologic Agents|dermatologic agents|mesh-ancestor
110060720|NCT01524744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110060721|NCT01524744|Immunologic Factors|immunologic factors|mesh-ancestor
110060722|NCT01524744|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110060723|NCT01524744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110060724|NCT01524744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110060725|NCT01524757|Pantoprazole|pantoprazole|mesh-list
110060726|NCT01524757|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110060727|NCT01524757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110060728|NCT01524757|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110060729|NCT01524757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110060730|NCT01524757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110060731|NCT01524809|Insulin|insulin|mesh-list
110060732|NCT01524809|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110060735|NCT01524809|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110060736|NCT01524809|Biphasic Insulins|biphasic insulins|mesh-list
110060737|NCT01524809|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110060738|NCT01524809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110060739|NCT01524809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110060740|NCT01524861|Thioctic Acid|thioctic acid|mesh-list
110060741|NCT01524861|Acetylcarnitine|acetylcarnitine|mesh-list
110060742|NCT01524861|Antioxidants|antioxidants|mesh-ancestor
110060743|NCT01524861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110060744|NCT01524861|Protective Agents|protective agents|mesh-ancestor
110060745|NCT01524861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110060746|NCT01524861|Vitamin B Complex|vitamin b complex|mesh-ancestor
110060747|NCT01524861|Vitamins|vitamins|mesh-ancestor
110060748|NCT01524861|Micronutrients|micronutrients|mesh-ancestor
110060749|NCT01524861|Nootropic Agents|nootropic agents|mesh-ancestor
110060750|NCT01524874|Vitamin D|vitamin d|mesh-list
110060751|NCT01524874|Ergocalciferols|ergocalciferols|mesh-list
110060752|NCT01524874|Cholecalciferol|cholecalciferol|mesh-list
110060753|NCT01524874|Calcitriol|calcitriol|mesh-list
110060754|NCT01524874|Vitamins|vitamins|mesh-list
110060755|NCT01524874|Micronutrients|micronutrients|mesh-ancestor
110060756|NCT01524874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110060757|NCT01524874|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110060758|NCT01524874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110060759|NCT01524874|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110060760|NCT01524874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110060761|NCT01524874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110060762|NCT01524874|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110060763|NCT01524939|Immunoglobulins|immunoglobulins|mesh-list
110060764|NCT01524939|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110060765|NCT01524939|Antibodies|antibodies|mesh-list
110060766|NCT01524939|Immunoglobulin G|immunoglobulin g|mesh-list
110060767|NCT01524939|Immunologic Factors|immunologic factors|mesh-ancestor
110060768|NCT01524939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110060769|NCT01525004|Vaccines|vaccines|mesh-list
110060770|NCT01525004|Immunologic Factors|immunologic factors|mesh-ancestor
110060771|NCT01525004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110060775|NCT06053580|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110060776|NCT06053580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110060777|NCT06053567|Nicotine|nicotine|mesh-list
110060778|NCT06053567|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110060779|NCT06053567|Autonomic Agents|autonomic agents|mesh-ancestor
110060780|NCT06053567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110060781|NCT06053567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110060782|NCT06053567|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110060783|NCT06053567|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110060784|NCT06053567|Cholinergic Agents|cholinergic agents|mesh-ancestor
110060785|NCT06053567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110060786|NCT06053567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110060787|NCT06053528|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110060788|NCT06053528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110060806|NCT06053398|Phenylephrine|phenylephrine|mesh-list
110060807|NCT06053398|Oxymetazoline|oxymetazoline|mesh-list
110060808|NCT06053398|Norepinephrine|norepinephrine|mesh-list
110060809|NCT06053398|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110060810|NCT06053398|Mydriatics|mydriatics|mesh-ancestor
110060811|NCT06053398|Autonomic Agents|autonomic agents|mesh-ancestor
110060812|NCT06053398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110060813|NCT06053398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110060814|NCT06053398|Sympathomimetics|sympathomimetics|mesh-ancestor
110060815|NCT06053398|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110060816|NCT06053398|Nasal Decongestants|nasal decongestants|mesh-ancestor
110060817|NCT06053398|Respiratory System Agents|respiratory system agents|mesh-ancestor
110060818|NCT06053398|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110060819|NCT06053398|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110060820|NCT06053398|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110060821|NCT06053398|Adrenergic Agents|adrenergic agents|mesh-ancestor
110060822|NCT06053398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110060823|NCT06053398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110060824|NCT06053398|Protective Agents|protective agents|mesh-ancestor
110060831|NCT06053281|Vitamin D|vitamin d|mesh-list
110060832|NCT06053281|Cholecalciferol|cholecalciferol|mesh-list
110060833|NCT06053281|Vitamins|vitamins|mesh-ancestor
110060835|NCT06053281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110060836|NCT06053281|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110060837|NCT06053281|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110060838|NCT06053021|Aspirin|aspirin|mesh-list
110060839|NCT06053021|Cilostazol|cilostazol|mesh-list
110060840|NCT06053021|Dipyridamole|dipyridamole|mesh-list
110060841|NCT06053021|Clopidogrel|clopidogrel|mesh-list
110060842|NCT06053021|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
110060843|NCT06053021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110060844|NCT06053021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110060845|NCT06053021|Analgesics|analgesics|mesh-ancestor
110060846|NCT06053021|Sensory System Agents|sensory system agents|mesh-ancestor
110060847|NCT06053021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110060848|NCT06053021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110060849|NCT06053021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110060850|NCT06053021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110060851|NCT06053021|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110060852|NCT06053021|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110060853|NCT06053021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110060854|NCT06053021|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110060855|NCT06053021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110060856|NCT06053021|Antipyretics|antipyretics|mesh-ancestor
110060857|NCT06053021|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110060858|NCT06053021|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110060859|NCT06053021|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110060860|NCT06053021|Purinergic Agents|purinergic agents|mesh-ancestor
110060861|NCT06053021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110060862|NCT06053021|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110060863|NCT06053021|Autonomic Agents|autonomic agents|mesh-ancestor
110060864|NCT06053021|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110060865|NCT06053021|Respiratory System Agents|respiratory system agents|mesh-ancestor
110060866|NCT06053021|Vasodilator Agents|vasodilator agents|mesh-ancestor
110060867|NCT06053021|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110060868|NCT06053021|Protective Agents|protective agents|mesh-ancestor
110060869|NCT06053021|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110060870|NCT06053021|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110060871|NCT06052995|Pimecrolimus|pimecrolimus|mesh-list
110060872|NCT06052995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110060873|NCT06052995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110060874|NCT06052995|Analgesics|analgesics|mesh-ancestor
110060894|NCT06052852|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110060895|NCT06052852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110060896|NCT06052852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110060897|NCT06052852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110060898|NCT06052839|Paclitaxel|paclitaxel|mesh-list
110060899|NCT06052839|Carboplatin|carboplatin|mesh-list
110060900|NCT06052839|Pembrolizumab|pembrolizumab|mesh-list
110060901|NCT06052839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110060902|NCT06052839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110060903|NCT06052839|Tubulin Modulators|tubulin modulators|mesh-ancestor
110060904|NCT06052839|Antimitotic Agents|antimitotic agents|mesh-ancestor
110060905|NCT06052839|Mitosis Modulators|mitosis modulators|mesh-ancestor
110060906|NCT06052839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110060907|NCT06052839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110060908|NCT06052839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110060909|NCT06052826|Coal Tar|coal tar|mesh-list
110060910|NCT06052826|Keratolytic Agents|keratolytic agents|mesh-ancestor
110060911|NCT06052826|Dermatologic Agents|dermatologic agents|mesh-ancestor
110060944|NCT06052163|Bumetanide|bumetanide|mesh-list
110060945|NCT06052163|Diuretics|diuretics|mesh-ancestor
110060946|NCT06052163|Natriuretic Agents|natriuretic agents|mesh-ancestor
110060947|NCT06052163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110060948|NCT06052163|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110060949|NCT06052163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110060950|NCT06052163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110060951|NCT06052111|Fentanyl|fentanyl|mesh-list
110060952|NCT06052111|Dexmedetomidine|dexmedetomidine|mesh-list
110060953|NCT06052111|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110060954|NCT06052111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110060955|NCT06052111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110060956|NCT06052111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110060957|NCT06052111|Analgesics|analgesics|mesh-ancestor
110060958|NCT06052111|Sensory System Agents|sensory system agents|mesh-ancestor
110060959|NCT06052111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110060960|NCT06052111|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110060961|NCT06052111|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110060962|NCT06052111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110060963|NCT06052111|Adrenergic Agents|adrenergic agents|mesh-ancestor
110060964|NCT06052111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110060965|NCT06052111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110060966|NCT06052111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110060967|NCT06052111|Narcotics|narcotics|mesh-ancestor
110060968|NCT06052111|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110060969|NCT06052111|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110060970|NCT06052111|Anesthetics, General|anesthetics, general|mesh-ancestor
110060971|NCT06052111|Anesthetics|anesthetics|mesh-ancestor
110060984|NCT06051981|Listerine|listerine|mesh-list
110060985|NCT06051981|Calcium|calcium|mesh-list
110060986|NCT06051981|Fluorides|fluorides|mesh-list
110060987|NCT06051981|Sodium Fluoride|sodium fluoride|mesh-list
110060988|NCT06051981|Caseins|caseins|mesh-list
110060989|NCT06051981|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110060990|NCT06051981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110060991|NCT06051981|Cariostatic Agents|cariostatic agents|mesh-ancestor
110060992|NCT06051981|Protective Agents|protective agents|mesh-ancestor
110060993|NCT06051981|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110060994|NCT06051981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110060995|NCT06051981|Chelating Agents|chelating agents|mesh-ancestor
110060996|NCT06051981|Sequestering Agents|sequestering agents|mesh-ancestor
110061457|NCT05874570|Natriuretic Agents|natriuretic agents|mesh-ancestor
110060997|NCT06051981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110060998|NCT06051955|Sodium sulfate|sodium sulfate|mesh-list
110060999|NCT06051955|Cathartics|cathartics|mesh-ancestor
110061000|NCT06051955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110061001|NCT06051890|Buprenorphine|buprenorphine|mesh-list
110061002|NCT06051890|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110061003|NCT06051890|Narcotics|narcotics|mesh-ancestor
110061004|NCT06051890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110061005|NCT06051890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110061006|NCT06051890|Analgesics|analgesics|mesh-ancestor
110061007|NCT06051890|Sensory System Agents|sensory system agents|mesh-ancestor
110061008|NCT06051890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110061009|NCT06051890|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110061011|NCT06051851|Gemcitabine|gemcitabine|mesh-list
110061012|NCT06051851|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110061013|NCT06051851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110061014|NCT06051851|Tubulin Modulators|tubulin modulators|mesh-ancestor
110061015|NCT06051851|Antimitotic Agents|antimitotic agents|mesh-ancestor
110061016|NCT06051851|Mitosis Modulators|mitosis modulators|mesh-ancestor
110061018|NCT06051851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110061019|NCT06051851|Antimetabolites|antimetabolites|mesh-ancestor
110061020|NCT06051786|Fluticasone|fluticasone|mesh-list
110061021|NCT06051786|Azelastine|azelastine|mesh-list
110061022|NCT06051786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110061023|NCT06051786|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110061024|NCT06051786|Autonomic Agents|autonomic agents|mesh-ancestor
110061025|NCT06051786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110061026|NCT06051786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110061027|NCT06051786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110061028|NCT06051786|Respiratory System Agents|respiratory system agents|mesh-ancestor
110061029|NCT06051786|Dermatologic Agents|dermatologic agents|mesh-ancestor
110061030|NCT06051786|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110061031|NCT06051786|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110061032|NCT06051786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110061033|NCT06051786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110061034|NCT06051786|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110061035|NCT06051786|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110061036|NCT06051786|Histamine Antagonists|histamine antagonists|mesh-ancestor
110061037|NCT06051786|Histamine Agents|histamine agents|mesh-ancestor
110061038|NCT06051786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110061039|NCT06051630|Lidocaine|lidocaine|mesh-list
110061040|NCT06051630|Anesthetics, Local|anesthetics, local|mesh-ancestor
110061041|NCT06051630|Anesthetics|anesthetics|mesh-ancestor
110061042|NCT06051630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110061043|NCT06051630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110061044|NCT06051630|Sensory System Agents|sensory system agents|mesh-ancestor
110061045|NCT06051630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110061046|NCT06051630|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110061047|NCT06051630|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110061073|NCT06051474|Cholinergic Agents|cholinergic agents|mesh-ancestor
110061074|NCT06051474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110061075|NCT06051474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110061077|NCT06051409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110061078|NCT06051409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110061079|NCT06051409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110061080|NCT06051409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110061081|NCT06051370|Triamcinolone|triamcinolone|mesh-list
110061082|NCT06051370|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110061083|NCT06051370|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110061084|NCT06051370|Lidocaine|lidocaine|mesh-list
110061085|NCT06051370|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110061086|NCT06051370|Anesthetics, Local|anesthetics, local|mesh-ancestor
110061087|NCT06051370|Anesthetics|anesthetics|mesh-ancestor
110061088|NCT06051370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110061089|NCT06051370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110061090|NCT06051370|Sensory System Agents|sensory system agents|mesh-ancestor
110061091|NCT06051370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110061092|NCT06051370|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110061093|NCT06051370|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110061094|NCT06051370|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110061095|NCT06051370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110061096|NCT06051370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110061097|NCT06051370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110061100|NCT06051370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110061101|NCT06051370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110061102|NCT06051370|Immunologic Factors|immunologic factors|mesh-ancestor
110061103|NCT06051370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110061112|NCT06046248|Rituximab|rituximab|mesh-list
110061113|NCT06046248|Belumosudil|belumosudil|mesh-list
110061114|NCT06046248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110061115|NCT06046248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110061116|NCT06046248|Immunologic Factors|immunologic factors|mesh-ancestor
110061117|NCT06046248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110061118|NCT06046248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110061119|NCT06046248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110061120|NCT06046248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110061121|NCT06046248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110061140|NCT06045481|Doxycycline|doxycycline|mesh-list
110061141|NCT06045481|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110061142|NCT06045481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110061143|NCT06045481|Antimalarials|antimalarials|mesh-ancestor
110061144|NCT06045481|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110061145|NCT06045481|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110061146|NCT06044935|Niacinamide|niacinamide|mesh-list
110061147|NCT06044935|Niacin|niacin|mesh-list
110061148|NCT06044935|Nicotinic Acids|nicotinic acids|mesh-list
110061149|NCT06044935|Vitamin B Complex|vitamin b complex|mesh-ancestor
110061150|NCT06044935|Vitamins|vitamins|mesh-ancestor
110061152|NCT06044935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110061153|NCT06044935|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110061154|NCT06044935|Antimetabolites|antimetabolites|mesh-ancestor
110061155|NCT06044935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110061156|NCT06044935|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110061157|NCT06044935|Vasodilator Agents|vasodilator agents|mesh-ancestor
110061158|NCT06043323|Acetaminophen|acetaminophen|mesh-list
110061159|NCT06043323|Diphenhydramine|diphenhydramine|mesh-list
110061160|NCT06043323|Promethazine|promethazine|mesh-list
110061161|NCT06043323|Prednisone|prednisone|mesh-list
110061162|NCT06043323|Cyclophosphamide|cyclophosphamide|mesh-list
110061163|NCT06043323|Fludarabine|fludarabine|mesh-list
110061164|NCT06043323|Fludarabine phosphate|fludarabine phosphate|mesh-list
110061165|NCT06043323|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
110061166|NCT06043323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110061167|NCT06043323|Immunologic Factors|immunologic factors|mesh-ancestor
110061168|NCT06043323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110061169|NCT06043323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110061170|NCT06043323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110061171|NCT06043323|Alkylating Agents|alkylating agents|mesh-ancestor
110061172|NCT06043323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110061173|NCT06043323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110061174|NCT06043323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110061175|NCT06043323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110061176|NCT06043323|Glucocorticoids|glucocorticoids|mesh-ancestor
110061177|NCT06043323|Hormones|hormones|mesh-ancestor
110061178|NCT06043323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110061179|NCT06043323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110061180|NCT06043323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110061181|NCT06043323|Antimetabolites|antimetabolites|mesh-ancestor
110061182|NCT06043323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110061183|NCT06043323|Analgesics|analgesics|mesh-ancestor
110061184|NCT06043323|Sensory System Agents|sensory system agents|mesh-ancestor
110061185|NCT06043323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110061186|NCT06043323|Antipyretics|antipyretics|mesh-ancestor
110061187|NCT06043323|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110061188|NCT06043323|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110061189|NCT06043323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110061190|NCT06043323|Anesthetics, Local|anesthetics, local|mesh-ancestor
110061191|NCT06043323|Anesthetics|anesthetics|mesh-ancestor
110061193|NCT06043323|Autonomic Agents|autonomic agents|mesh-ancestor
110061194|NCT06043323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110061195|NCT06043323|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110061196|NCT06043323|Histamine Antagonists|histamine antagonists|mesh-ancestor
110061197|NCT06043323|Histamine Agents|histamine agents|mesh-ancestor
110061198|NCT06043323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110061199|NCT06043323|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110061200|NCT06043323|Antipruritics|antipruritics|mesh-ancestor
110061201|NCT06043323|Dermatologic Agents|dermatologic agents|mesh-ancestor
110061202|NCT06043323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110061254|NCT06005818|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110061458|NCT05874570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110061255|NCT06005818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110061256|NCT06004830|Spironolactone|spironolactone|mesh-list
110061257|NCT06004830|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110061258|NCT06004830|Hormone Antagonists|hormone antagonists|mesh-ancestor
110061259|NCT06004830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110061260|NCT06004830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110061273|NCT05973851|Sensory System Agents|sensory system agents|mesh-ancestor
110061274|NCT05973851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110061275|NCT05973851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110061276|NCT05973851|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110061277|NCT05973851|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110061278|NCT05973851|Anesthetics, General|anesthetics, general|mesh-ancestor
110061279|NCT05973851|Anesthetics|anesthetics|mesh-ancestor
110061280|NCT05973851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110061282|NCT05973851|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110061283|NCT05973851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110061284|NCT05973851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110061285|NCT05973851|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110061286|NCT05973786|Lamotrigine|lamotrigine|mesh-list
110061287|NCT05973786|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110061288|NCT05973786|Valproic Acid|valproic acid|mesh-list
110061289|NCT05973786|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110061290|NCT05973786|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110061291|NCT05973786|Sertraline|sertraline|mesh-list
110061292|NCT05973786|Escitalopram|escitalopram|mesh-list
110061293|NCT05973786|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110061294|NCT05973786|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110061295|NCT05973786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110061296|NCT05973786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110061297|NCT05973786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110061298|NCT05973786|Serotonin Agents|serotonin agents|mesh-ancestor
110061299|NCT05973786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110061300|NCT05973786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110061301|NCT05973786|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110061302|NCT05973786|Antidepressive Agents|antidepressive agents|mesh-ancestor
110061303|NCT05973786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110061304|NCT05973786|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110061305|NCT05973786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110061306|NCT05973786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110061307|NCT05973786|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110061308|NCT05973786|Analgesics|analgesics|mesh-ancestor
110061309|NCT05973786|Sensory System Agents|sensory system agents|mesh-ancestor
110061310|NCT05973786|Dopamine Agents|dopamine agents|mesh-ancestor
110061311|NCT05973786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110061312|NCT05973786|Antimanic Agents|antimanic agents|mesh-ancestor
110061313|NCT05973786|Anticonvulsants|anticonvulsants|mesh-ancestor
110061314|NCT05973786|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110061315|NCT05973786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110061316|NCT05973786|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110061317|NCT05973786|GABA Agents|gaba agents|mesh-ancestor
110061318|NCT05972018|Bupivacaine|bupivacaine|mesh-list
110061319|NCT05972018|Ropivacaine|ropivacaine|mesh-list
110061320|NCT05972018|Anesthetics, Local|anesthetics, local|mesh-ancestor
110061363|NCT05909683|Anti-Infective Agents|anti-infective agents|mesh-list
110061364|NCT05909683|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110061415|NCT05891262|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
110061416|NCT05884528|Botulinum Toxins|botulinum toxins|mesh-list
110061417|NCT05884528|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110061418|NCT05884528|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110061419|NCT05884528|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
110061420|NCT05884528|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110061421|NCT05884528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110061422|NCT05884528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110061423|NCT05884528|Cholinergic Agents|cholinergic agents|mesh-ancestor
110061424|NCT05884528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110061425|NCT05884528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110061426|NCT05884528|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110061427|NCT05884528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110061428|NCT05882357|Ivacaftor|ivacaftor|mesh-list
110061429|NCT05882357|Elexacaftor|elexacaftor|mesh-list
110061430|NCT05882357|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110061431|NCT05882357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110061432|NCT05882357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110061459|NCT05874570|Expectorants|expectorants|mesh-ancestor
110061460|NCT05874570|Respiratory System Agents|respiratory system agents|mesh-ancestor
110061461|NCT05869955|Cyclophosphamide|cyclophosphamide|mesh-list
110061462|NCT05869955|Fludarabine|fludarabine|mesh-list
110061463|NCT05869955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110061464|NCT05869955|Immunologic Factors|immunologic factors|mesh-ancestor
110061465|NCT05869955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110061466|NCT05869955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110061467|NCT05869955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110061468|NCT05869955|Alkylating Agents|alkylating agents|mesh-ancestor
110061469|NCT05869955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110061474|NCT05851924|Antimetabolites|antimetabolites|mesh-ancestor
110061475|NCT05851924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110061476|NCT05851924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110061492|NCT05840159|Doxycycline|doxycycline|mesh-list
110061538|NCT05781321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110061539|NCT05781321|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110061540|NCT05781321|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110061565|NCT05733611|Atezolizumab|atezolizumab|mesh-list
110061566|NCT05733611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110061567|NCT05733611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110061568|NCT05733611|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110061569|NCT05733611|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110061570|NCT05733611|Growth Substances|growth substances|mesh-ancestor
110061571|NCT05733611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110061572|NCT05733611|Growth Inhibitors|growth inhibitors|mesh-ancestor
110061573|NCT05733611|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110061574|NCT05733611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110061575|NCT05733598|Bevacizumab|bevacizumab|mesh-list
110061576|NCT05733598|Atezolizumab|atezolizumab|mesh-list
110061577|NCT05733598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110061578|NCT05733598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110061579|NCT05733598|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110061580|NCT05733598|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110061581|NCT05733598|Growth Substances|growth substances|mesh-ancestor
110061582|NCT05733598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110061583|NCT05733598|Growth Inhibitors|growth inhibitors|mesh-ancestor
110061589|NCT05715216|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110061590|NCT05715216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110061631|NCT05672355|Vaccines|vaccines|mesh-list
110061632|NCT05672355|Immunologic Factors|immunologic factors|mesh-ancestor
110061633|NCT05672355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110061634|NCT05663710|Nivolumab|nivolumab|mesh-list
110061635|NCT05663710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110061636|NCT05663710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110061637|NCT05663710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110061638|NCT05663710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110061655|NCT05631093|Islatravir|islatravir|mesh-list
110061656|NCT05631093|Antiviral Agents|antiviral agents|mesh-ancestor
110061662|NCT05631093|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110061663|NCT05630755|Islatravir|islatravir|mesh-list
110061664|NCT05630755|Antiviral Agents|antiviral agents|mesh-ancestor
110061665|NCT05630755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110061666|NCT05630755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110061667|NCT05630755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110061668|NCT05630755|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110061669|NCT05630755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110061670|NCT05630755|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110061680|NCT05605899|Prednisone|prednisone|mesh-list
110061681|NCT05605899|Cyclophosphamide|cyclophosphamide|mesh-list
110061682|NCT05605899|Rituximab|rituximab|mesh-list
110061683|NCT05605899|Doxorubicin|doxorubicin|mesh-list
110061684|NCT05605899|Fludarabine|fludarabine|mesh-list
110061685|NCT05605899|Etoposide|etoposide|mesh-list
110061686|NCT05605899|Vincristine|vincristine|mesh-list
110061687|NCT05605899|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
110061688|NCT05605899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110061689|NCT05605899|Immunologic Factors|immunologic factors|mesh-ancestor
110061690|NCT05605899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110061691|NCT05605899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110061692|NCT05605899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110061693|NCT05605899|Alkylating Agents|alkylating agents|mesh-ancestor
110061694|NCT05605899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110061695|NCT05605899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110061696|NCT05605899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110061697|NCT05605899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110061698|NCT05605899|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110061699|NCT05605899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110061707|NCT05605899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110061708|NCT05605899|Tubulin Modulators|tubulin modulators|mesh-ancestor
110061709|NCT05605899|Antimitotic Agents|antimitotic agents|mesh-ancestor
110061710|NCT05605899|Mitosis Modulators|mitosis modulators|mesh-ancestor
110061712|NCT05603702|Anticonvulsants|anticonvulsants|mesh-ancestor
110061713|NCT05603702|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110061714|NCT05603702|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110061715|NCT05603702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110061716|NCT05603702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110061717|NCT05602194|Asparaginase|asparaginase|mesh-list
110061718|NCT05602194|Pegaspargase|pegaspargase|mesh-list
110061731|NCT05600426|Fludarabine|fludarabine|mesh-list
110061732|NCT05600426|Cyclosporins|cyclosporins|mesh-list
110061733|NCT05600426|Thymoglobulin|thymoglobulin|mesh-list
110061734|NCT05600426|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110061735|NCT05600426|Immunosuppressive Agents|immunosuppressive agents|mesh-list
110061736|NCT05600426|Immunologic Factors|immunologic factors|mesh-ancestor
110061737|NCT05600426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110061738|NCT05600426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110061739|NCT05600426|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110061740|NCT05600426|Alkylating Agents|alkylating agents|mesh-ancestor
110061741|NCT05600426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110061742|NCT05600426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110061743|NCT05600426|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110061744|NCT05600426|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110061745|NCT05600426|Abortifacient Agents|abortifacient agents|mesh-ancestor
110061746|NCT05600426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110061747|NCT05600426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110061748|NCT05600426|Antimetabolites|antimetabolites|mesh-ancestor
110061749|NCT05600426|Dermatologic Agents|dermatologic agents|mesh-ancestor
110061750|NCT05600426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110061751|NCT05600426|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110061752|NCT05600426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110061753|NCT05600426|Antifungal Agents|antifungal agents|mesh-ancestor
110061754|NCT05600426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110061755|NCT05600426|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110061814|NCT05554354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110061823|NCT05554328|Olaparib|olaparib|mesh-list
110061824|NCT05554328|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
110061825|NCT05554328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110061826|NCT05554328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110061827|NCT05554328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110061828|NCT05552976|Dexamethasone|dexamethasone|mesh-list
110061829|NCT05552976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110061830|NCT05552976|Antiemetics|antiemetics|mesh-ancestor
110061831|NCT05552976|Autonomic Agents|autonomic agents|mesh-ancestor
110061832|NCT05552976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110061833|NCT05552976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110061834|NCT05552976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110061835|NCT05552976|Glucocorticoids|glucocorticoids|mesh-ancestor
110061836|NCT05552976|Hormones|hormones|mesh-ancestor
110061837|NCT05552976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110061838|NCT05552976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110061839|NCT05552976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110061840|NCT05548296|Gemcitabine|gemcitabine|mesh-list
110061841|NCT05548296|Prexasertib|prexasertib|mesh-list
110061842|NCT05548296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110061843|NCT05548296|Antimetabolites|antimetabolites|mesh-ancestor
110061844|NCT05548296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110061845|NCT05548296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110061854|NCT05547542|Sensory System Agents|sensory system agents|mesh-ancestor
110061861|NCT05494593|Methotrexate|methotrexate|mesh-list
110061862|NCT05494593|Immunoglobulins|immunoglobulins|mesh-list
110061863|NCT05494593|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110061864|NCT05494593|Antibodies|antibodies|mesh-list
110061865|NCT05494593|gamma-Globulins|gamma-globulins|mesh-list
110061866|NCT05494593|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110061867|NCT05494593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110061868|NCT05494593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110061869|NCT05494593|Immunologic Factors|immunologic factors|mesh-ancestor
110061870|NCT05494593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110061871|NCT05494593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110061872|NCT05494593|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110061873|NCT05494593|Abortifacient Agents|abortifacient agents|mesh-ancestor
110061874|NCT05494593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110061875|NCT05494593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110061877|NCT05494593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110061878|NCT05494593|Dermatologic Agents|dermatologic agents|mesh-ancestor
110061879|NCT05494593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110061880|NCT05494593|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110061881|NCT05494593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110061882|NCT05494593|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110061884|NCT05491356|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110061885|NCT05491356|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110061886|NCT05491356|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110061887|NCT05491356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110061888|NCT05470400|Vaccines|vaccines|mesh-list
110061889|NCT05470400|Immunologic Factors|immunologic factors|mesh-ancestor
110061890|NCT05470400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110061891|NCT05467891|Letrozole|letrozole|mesh-list
110061892|NCT05467891|Fulvestrant|fulvestrant|mesh-list
110061893|NCT05467891|Anastrozole|anastrozole|mesh-list
110061894|NCT05467891|Exemestane|exemestane|mesh-list
110061895|NCT05467891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110061896|NCT05467891|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110061897|NCT05467891|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110061898|NCT05467891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110061899|NCT05467891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110061900|NCT05467891|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110061901|NCT05467891|Hormone Antagonists|hormone antagonists|mesh-ancestor
110061902|NCT05467891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110061903|NCT05467891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110061904|NCT05467891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110061905|NCT05467891|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110061906|NCT05461053|Lidocaine|lidocaine|mesh-list
110061907|NCT05461053|Anesthetics, Local|anesthetics, local|mesh-ancestor
110061908|NCT05461053|Anesthetics|anesthetics|mesh-ancestor
110061909|NCT05461053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110061910|NCT05461053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110061911|NCT05461053|Sensory System Agents|sensory system agents|mesh-ancestor
110061912|NCT05461053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110061913|NCT05461053|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110061914|NCT05461053|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110061915|NCT05461053|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110061916|NCT05461053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110061917|NCT05461053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110061919|NCT05415397|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110061920|NCT05415397|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110061921|NCT05415397|Analgesics|analgesics|mesh-ancestor
110061922|NCT05415397|Sensory System Agents|sensory system agents|mesh-ancestor
110061923|NCT05415397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110061926|NCT05415397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110061930|NCT05415397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110061931|NCT05414201|Adalimumab|adalimumab|mesh-list
110061932|NCT05414201|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110061933|NCT05414201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110061934|NCT05414201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110061935|NCT05386810|Vaccines|vaccines|mesh-list
110061942|NCT05368090|Epinephrine|epinephrine|mesh-list
110061943|NCT05368090|Racepinephrine|racepinephrine|mesh-list
110061944|NCT05368090|Epinephryl borate|epinephryl borate|mesh-list
110061945|NCT05368090|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110061946|NCT05368090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110061947|NCT05368090|Adrenergic Agents|adrenergic agents|mesh-ancestor
110061948|NCT05368090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110061949|NCT05368090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110061950|NCT05368090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110061951|NCT05368090|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110061952|NCT05368090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110061954|NCT05368090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110061955|NCT05368090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110061956|NCT05368090|Respiratory System Agents|respiratory system agents|mesh-ancestor
110061957|NCT05368090|Mydriatics|mydriatics|mesh-ancestor
110061958|NCT05368090|Sympathomimetics|sympathomimetics|mesh-ancestor
110061959|NCT05368090|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110061960|NCT05328440|Fulvestrant|fulvestrant|mesh-list
110061961|NCT05328440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110061962|NCT05328440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110061963|NCT05328440|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110061964|NCT05328440|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110061965|NCT05328440|Hormone Antagonists|hormone antagonists|mesh-ancestor
110061966|NCT05328440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110061967|NCT05328440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110061968|NCT05300087|Albuterol|albuterol|mesh-list
110061969|NCT05300087|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110061970|NCT05300087|Autonomic Agents|autonomic agents|mesh-ancestor
110061971|NCT05300087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110061972|NCT05300087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110061973|NCT05300087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110061974|NCT05300087|Respiratory System Agents|respiratory system agents|mesh-ancestor
110061975|NCT05300087|Tocolytic Agents|tocolytic agents|mesh-ancestor
110061976|NCT05300087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110061977|NCT05300087|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110061978|NCT05300087|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110061979|NCT05300087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110061980|NCT05300087|Adrenergic Agents|adrenergic agents|mesh-ancestor
110061981|NCT05300087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110061982|NCT05300087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110061984|NCT05296577|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110061985|NCT05296577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110061987|NCT05296577|Antimitotic Agents|antimitotic agents|mesh-ancestor
110061988|NCT05296577|Mitosis Modulators|mitosis modulators|mesh-ancestor
110061989|NCT05296577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110061990|NCT05296564|Aldesleukin|aldesleukin|mesh-list
110061991|NCT05296564|Cyclophosphamide|cyclophosphamide|mesh-list
110061992|NCT05296564|Interleukin-2|interleukin-2|mesh-list
110061993|NCT05296564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110061994|NCT05296564|Immunologic Factors|immunologic factors|mesh-ancestor
110061995|NCT05296564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110061996|NCT05296564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110061997|NCT05296564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110061998|NCT05296564|Alkylating Agents|alkylating agents|mesh-ancestor
110061999|NCT05296564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110062000|NCT05296564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110062001|NCT05296564|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110062002|NCT05296564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110062004|NCT05296564|Sensory System Agents|sensory system agents|mesh-ancestor
110062011|NCT05290025|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110062012|NCT05290025|Autonomic Agents|autonomic agents|mesh-ancestor
110062013|NCT05290025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110062014|NCT05290025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110062015|NCT05290025|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110062016|NCT05290025|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110062017|NCT05290025|Cholinergic Agents|cholinergic agents|mesh-ancestor
110062018|NCT05290025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110062019|NCT05290025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110062026|NCT05269355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110062028|NCT05269355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110062073|NCT05252429|Mitosis Modulators|mitosis modulators|mesh-ancestor
110062074|NCT05252429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110062075|NCT05252429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110062076|NCT05252429|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110062078|NCT05249309|Analgesics|analgesics|mesh-ancestor
110062079|NCT05249309|Sensory System Agents|sensory system agents|mesh-ancestor
110062080|NCT05249309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110062081|NCT05249309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110062082|NCT05249309|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110062089|NCT05249309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110062090|NCT05249309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110062091|NCT05193019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
110062099|NCT05180799|Nivolumab|nivolumab|mesh-list
110062100|NCT05180799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110062101|NCT05180799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110062102|NCT05180799|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110062103|NCT05180799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110062104|NCT05176964|Capecitabine|capecitabine|mesh-list
110062105|NCT05176964|Oxaliplatin|oxaliplatin|mesh-list
110062106|NCT05176964|Tislelizumab|tislelizumab|mesh-list
110062107|NCT05176964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110062108|NCT05176964|Antimetabolites|antimetabolites|mesh-ancestor
110062109|NCT05176964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110062110|NCT05176964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110062111|NCT05176964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110062112|NCT05153239|Irinotecan|irinotecan|mesh-list
110062113|NCT05153239|Topotecan|topotecan|mesh-list
110062114|NCT05153239|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110062115|NCT05153239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110062116|NCT05153239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110062117|NCT05153239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110062118|NCT05153239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110062119|NCT05095571|Niacinamide|niacinamide|mesh-list
110062120|NCT05095571|Niacin|niacin|mesh-list
110062121|NCT05095571|Nicotinic Acids|nicotinic acids|mesh-list
110062122|NCT05095571|Vitamin B Complex|vitamin b complex|mesh-ancestor
110062123|NCT05095571|Vitamins|vitamins|mesh-ancestor
110062124|NCT05095571|Micronutrients|micronutrients|mesh-ancestor
110062125|NCT05095571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110062126|NCT05095571|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110062127|NCT05095571|Antimetabolites|antimetabolites|mesh-ancestor
110062128|NCT05095571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110062129|NCT05095571|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110062130|NCT05095571|Vasodilator Agents|vasodilator agents|mesh-ancestor
110062137|NCT05077098|Immunomodulating Agents|immunomodulating agents|mesh-list
110062138|NCT05077098|Immunologic Factors|immunologic factors|mesh-ancestor
110062139|NCT05077098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110062140|NCT05065411|Everolimus|everolimus|mesh-list
110062141|NCT05065411|Fulvestrant|fulvestrant|mesh-list
110062142|NCT05065411|Exemestane|exemestane|mesh-list
110062143|NCT05065411|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110062144|NCT05065411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110062145|NCT05065411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110062146|NCT05065411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110062147|NCT05065411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110062148|NCT05065411|Immunologic Factors|immunologic factors|mesh-ancestor
110062149|NCT05065411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110062150|NCT05065411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110062151|NCT05065411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110062152|NCT05065411|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110062153|NCT05065411|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110062154|NCT05065411|Hormone Antagonists|hormone antagonists|mesh-ancestor
110062155|NCT05065411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110062156|NCT05065411|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110062157|NCT05065411|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110062158|NCT05061420|Pembrolizumab|pembrolizumab|mesh-list
110062159|NCT05061420|Cetuximab|cetuximab|mesh-list
110062160|NCT05061420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110062161|NCT05061420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110062162|NCT05061420|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110062163|NCT05061420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110062164|NCT05053334|Omalizumab|omalizumab|mesh-list
110062165|NCT05053334|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110062166|NCT05053334|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110062167|NCT05053334|Respiratory System Agents|respiratory system agents|mesh-ancestor
110062168|NCT05041335|Heparin|heparin|mesh-list
110062169|NCT05041335|Anticoagulants|anticoagulants|mesh-ancestor
110062170|NCT05041335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110062171|NCT05041335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110062172|NCT05041335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110062186|NCT05017025|Osimertinib|osimertinib|mesh-list
110062187|NCT05017025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110062188|NCT05017025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110062189|NCT05017025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110062190|NCT05017025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110062191|NCT04973163|Midazolam|midazolam|mesh-list
110062192|NCT04973163|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110062193|NCT04973163|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110062194|NCT04973163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110062195|NCT04973163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110062196|NCT04973163|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110062197|NCT04973163|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110062198|NCT04973163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110062199|NCT04973163|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110062200|NCT04973163|Anesthetics, General|anesthetics, general|mesh-ancestor
110062201|NCT04973163|Anesthetics|anesthetics|mesh-ancestor
110062202|NCT04973163|GABA Modulators|gaba modulators|mesh-ancestor
110062203|NCT04973163|GABA Agents|gaba agents|mesh-ancestor
110062204|NCT04973163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110062205|NCT04973163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110062206|NCT04947254|Ascorbic Acid|ascorbic acid|mesh-list
110062208|NCT04947254|Cortisone|cortisone|mesh-list
110062209|NCT04947254|Methyltestosterone|methyltestosterone|mesh-list
110062210|NCT04947254|Abiraterone Acetate|abiraterone acetate|mesh-list
110062211|NCT04947254|Niraparib|niraparib|mesh-list
110062212|NCT04947254|Hormones|hormones|mesh-list
110062213|NCT04947254|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110062214|NCT04947254|Androgens|androgens|mesh-list
110062215|NCT04947254|Androgen Antagonists|androgen antagonists|mesh-list
110062216|NCT04947254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110062217|NCT04947254|Glucocorticoids|glucocorticoids|mesh-ancestor
110062218|NCT04947254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110062219|NCT04947254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110062220|NCT04947254|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110062221|NCT04947254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110062222|NCT04947254|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110062223|NCT04947254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110062230|NCT04947254|Vitamins|vitamins|mesh-ancestor
110062231|NCT04947254|Micronutrients|micronutrients|mesh-ancestor
110062232|NCT04947254|Estrogens|estrogens|mesh-ancestor
110062233|NCT04947254|Anabolic Agents|anabolic agents|mesh-ancestor
110062234|NCT04941664|Levobupivacaine|levobupivacaine|mesh-list
110062235|NCT04941664|Anesthetics, Local|anesthetics, local|mesh-ancestor
110062236|NCT04941664|Anesthetics|anesthetics|mesh-ancestor
110062237|NCT04941664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110062238|NCT04941664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110062239|NCT04941664|Sensory System Agents|sensory system agents|mesh-ancestor
110062240|NCT04941664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110062254|NCT04930094|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110062255|NCT04930094|Immunologic Factors|immunologic factors|mesh-ancestor
110062256|NCT04930094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110062265|NCT04902443|Nivolumab|nivolumab|mesh-list
110062266|NCT04902443|Pomalidomide|pomalidomide|mesh-list
110062267|NCT04902443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110062268|NCT04902443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110062269|NCT04902443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110062270|NCT04902443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110062271|NCT04902443|Immunologic Factors|immunologic factors|mesh-ancestor
110062272|NCT04902443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110062273|NCT04902443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110062274|NCT04902443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110062275|NCT04902443|Growth Substances|growth substances|mesh-ancestor
110062276|NCT04902443|Growth Inhibitors|growth inhibitors|mesh-ancestor
110062295|NCT04888858|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110062296|NCT04888858|Narcotics|narcotics|mesh-ancestor
110062297|NCT04888858|Analgesics|analgesics|mesh-ancestor
110062298|NCT04888858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110062299|NCT04888858|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110062300|NCT04888858|Anesthetics, General|anesthetics, general|mesh-ancestor
110062301|NCT04869943|Exemestane|exemestane|mesh-list
110062302|NCT04869943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110062303|NCT04869943|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110062304|NCT04869943|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110062305|NCT04869943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110062306|NCT04869943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110062307|NCT04869943|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110062308|NCT04869943|Hormone Antagonists|hormone antagonists|mesh-ancestor
110062309|NCT04869943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110062310|NCT04869943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110062312|NCT04849364|Capecitabine|capecitabine|mesh-list
110062313|NCT04849364|Talazoparib|talazoparib|mesh-list
110062314|NCT04849364|Inavolisib|inavolisib|mesh-list
110062315|NCT04849364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110062316|NCT04849364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110062317|NCT04849364|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110062318|NCT04849364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110062319|NCT04849364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110062329|NCT04837716|Endothelial Growth Factors|endothelial growth factors|mesh-list
110062330|NCT04837716|Antibodies|antibodies|mesh-list
110062331|NCT04837716|Immunoglobulins|immunoglobulins|mesh-list
110062332|NCT04837716|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110062333|NCT04837716|Immunoglobulin G|immunoglobulin g|mesh-list
110062334|NCT04837716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110062335|NCT04837716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110062336|NCT04837716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110062337|NCT04837716|Growth Substances|growth substances|mesh-ancestor
110062338|NCT04837716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110062339|NCT04837716|Growth Inhibitors|growth inhibitors|mesh-ancestor
110062340|NCT04837716|Immunologic Factors|immunologic factors|mesh-ancestor
110062341|NCT04837716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110062342|NCT04837716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110062343|NCT04837716|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110062344|NCT04837716|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110062345|NCT04837716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110062350|NCT04817254|Nivolumab|nivolumab|mesh-list
110062351|NCT04817254|Ipilimumab|ipilimumab|mesh-list
110062352|NCT04817254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110062353|NCT04817254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110062354|NCT04817254|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110062355|NCT04817254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110062356|NCT04803734|Albuterol|albuterol|mesh-list
110062357|NCT04803734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110062358|NCT04803734|Autonomic Agents|autonomic agents|mesh-ancestor
110062359|NCT04803734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110062360|NCT04803734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110062361|NCT04803734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110062362|NCT04803734|Respiratory System Agents|respiratory system agents|mesh-ancestor
110062363|NCT04803734|Tocolytic Agents|tocolytic agents|mesh-ancestor
110062364|NCT04803734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110062365|NCT04803734|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110062366|NCT04803734|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110062367|NCT04803734|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110062368|NCT04803734|Adrenergic Agents|adrenergic agents|mesh-ancestor
110062369|NCT04803734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110062370|NCT04803734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110062371|NCT04784247|Pembrolizumab|pembrolizumab|mesh-list
110062372|NCT04784247|Lenvatinib|lenvatinib|mesh-list
110062373|NCT04784247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110062374|NCT04784247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110062375|NCT04784247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110062376|NCT04784247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110062377|NCT04784247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110062378|NCT04784247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110062379|NCT04776252|Islatravir|islatravir|mesh-list
110062380|NCT04776252|Antiviral Agents|antiviral agents|mesh-ancestor
110062381|NCT04776252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110062382|NCT04776252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110062383|NCT04776252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110062384|NCT04776252|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110062385|NCT04776252|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110062386|NCT04776252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110062387|NCT04766723|Botulinum Toxins|botulinum toxins|mesh-list
110062397|NCT04766723|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110062398|NCT04766723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110062400|NCT04765059|Carboplatin|carboplatin|mesh-list
110062401|NCT04765059|Pemetrexed|pemetrexed|mesh-list
110062402|NCT04765059|Osimertinib|osimertinib|mesh-list
110062403|NCT04765059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110062404|NCT04765059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110062405|NCT04765059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110062406|NCT04765059|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110062407|NCT04765059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110062408|NCT04765059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110062414|NCT04685616|Doxorubicin|doxorubicin|mesh-list
110062415|NCT04685616|Bleomycin|bleomycin|mesh-list
110062416|NCT04685616|Dacarbazine|dacarbazine|mesh-list
110062417|NCT04685616|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110062418|NCT04685616|Vinblastine|vinblastine|mesh-list
110062419|NCT04685616|Mitogens|mitogens|mesh-list
110062420|NCT04685616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110062421|NCT04685616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110062422|NCT04685616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110062423|NCT04685616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110062424|NCT04685616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110062425|NCT04685616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110062426|NCT04685616|Mitosis Modulators|mitosis modulators|mesh-ancestor
110062427|NCT04685616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110062432|NCT04685616|Immunologic Factors|immunologic factors|mesh-ancestor
110062433|NCT04685616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110062434|NCT04685616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110062435|NCT04685616|Tubulin Modulators|tubulin modulators|mesh-ancestor
110062436|NCT04685616|Antimitotic Agents|antimitotic agents|mesh-ancestor
110062437|NCT04681287|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110062438|NCT04681287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110062439|NCT04681287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110062440|NCT04681287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110062441|NCT04681131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110062442|NCT04681131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110062443|NCT04681131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110062444|NCT04681131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110062446|NCT04665570|Acarbose|acarbose|mesh-list
110062447|NCT04665570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110062448|NCT04665570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110062449|NCT04665570|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110062450|NCT04665570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110062451|NCT04665570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110062516|NCT04593940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110062517|NCT04593940|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110062519|NCT04593940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110062527|NCT04576091|Pembrolizumab|pembrolizumab|mesh-list
110062529|NCT04576091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110062530|NCT04576091|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110062531|NCT04576091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110062532|NCT04562831|Niacinamide|niacinamide|mesh-list
110062533|NCT04562831|Niacin|niacin|mesh-list
110062535|NCT04562831|Vitamin B Complex|vitamin b complex|mesh-ancestor
110062536|NCT04562831|Vitamins|vitamins|mesh-ancestor
110062537|NCT04562831|Micronutrients|micronutrients|mesh-ancestor
110062538|NCT04562831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110062539|NCT04562831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110062540|NCT04562831|Antimetabolites|antimetabolites|mesh-ancestor
110062541|NCT04562831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110062542|NCT04562831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110062543|NCT04562831|Vasodilator Agents|vasodilator agents|mesh-ancestor
110062544|NCT04551547|Vaccines|vaccines|mesh-list
110062545|NCT04551547|Immunologic Factors|immunologic factors|mesh-ancestor
110062546|NCT04551547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110062547|NCT04551131|Dexamethasone|dexamethasone|mesh-list
110062548|NCT04551131|Etoposide|etoposide|mesh-list
110062549|NCT04551131|Etoposide phosphate|etoposide phosphate|mesh-list
110062550|NCT04551131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110062551|NCT04551131|Antiemetics|antiemetics|mesh-ancestor
110062552|NCT04551131|Autonomic Agents|autonomic agents|mesh-ancestor
110062553|NCT04551131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110062554|NCT04551131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110062555|NCT04551131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110062556|NCT04551131|Glucocorticoids|glucocorticoids|mesh-ancestor
110062557|NCT04551131|Hormones|hormones|mesh-ancestor
110062558|NCT04551131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110062559|NCT04551131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110062560|NCT04551131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110062561|NCT04551131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110062562|NCT04551131|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110062563|NCT04551131|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110062564|NCT04551131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110062565|NCT04551131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110062566|NCT04548648|Isavuconazole|isavuconazole|mesh-list
110062567|NCT04548648|Acalabrutinib|acalabrutinib|mesh-list
110062568|NCT04548648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110062569|NCT04548648|Antifungal Agents|antifungal agents|mesh-ancestor
110062570|NCT04548648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110062571|NCT04544111|Trametinib|trametinib|mesh-list
110062572|NCT04544111|Dabrafenib|dabrafenib|mesh-list
110062573|NCT04544111|Spartalizumab|spartalizumab|mesh-list
110062574|NCT04544111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110062575|NCT04544111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110062576|NCT04544111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110062577|NCT04544111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110062578|NCT04544111|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110062579|NCT04544111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110062580|NCT04541589|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110062581|NCT04541589|Immunologic Factors|immunologic factors|mesh-ancestor
110062582|NCT04541589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110062583|NCT04522739|Spironolactone|spironolactone|mesh-list
110062584|NCT04522739|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110062585|NCT04522739|Hormone Antagonists|hormone antagonists|mesh-ancestor
110062586|NCT04522739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110062587|NCT04522739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110062588|NCT04522739|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110062589|NCT04522739|Diuretics|diuretics|mesh-ancestor
110062590|NCT04522739|Natriuretic Agents|natriuretic agents|mesh-ancestor
110062601|NCT04522336|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110062603|NCT04522336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110062604|NCT04522336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110062605|NCT04522336|Immunologic Factors|immunologic factors|mesh-ancestor
110062606|NCT04522336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110062612|NCT04509674|Empagliflozin|empagliflozin|mesh-list
110062613|NCT04509674|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110062614|NCT04509674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110062615|NCT04509674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110062616|NCT04509674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110062617|NCT04499248|Bimatoprost|bimatoprost|mesh-list
110062618|NCT04499248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110062619|NCT04493138|Azacitidine|azacitidine|mesh-list
110062620|NCT04493138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110062621|NCT04493138|Antimetabolites|antimetabolites|mesh-ancestor
110062622|NCT04493138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110062623|NCT04493138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110062624|NCT04493138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110062625|NCT04452344|Analgesics|analgesics|mesh-list
110062626|NCT04452344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110062627|NCT04452344|Sensory System Agents|sensory system agents|mesh-ancestor
110062628|NCT04452344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110062629|NCT04421963|Olaparib|olaparib|mesh-list
110062630|NCT04421963|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110062631|NCT04421963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110062632|NCT04421963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110062633|NCT04421963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110062642|NCT04402346|Pancrelipase|pancrelipase|mesh-list
110062643|NCT04402346|Pancreatin|pancreatin|mesh-list
110062644|NCT04402346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110062645|NCT04397484|Lidocaine|lidocaine|mesh-list
110062646|NCT04397484|Epinephrine|epinephrine|mesh-list
110062647|NCT04397484|Racepinephrine|racepinephrine|mesh-list
110062648|NCT04397484|Levobupivacaine|levobupivacaine|mesh-list
110062649|NCT04397484|Epinephryl borate|epinephryl borate|mesh-list
110062650|NCT04397484|Anesthetics, Local|anesthetics, local|mesh-ancestor
110062653|NCT04397484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110062654|NCT04397484|Sensory System Agents|sensory system agents|mesh-ancestor
110062655|NCT04397484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110062656|NCT04397484|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110062657|NCT04397484|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110062658|NCT04397484|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110062659|NCT04397484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110062660|NCT04397484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110062661|NCT04397484|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110062662|NCT04397484|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110062679|NCT04393298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110062680|NCT04393298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110062681|NCT04393298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110062682|NCT04393298|Immunologic Factors|immunologic factors|mesh-ancestor
110062683|NCT04393298|Antiviral Agents|antiviral agents|mesh-ancestor
110062686|NCT04393298|Protective Agents|protective agents|mesh-ancestor
110062687|NCT04393298|Vitamin B Complex|vitamin b complex|mesh-ancestor
110062688|NCT04393298|Vitamins|vitamins|mesh-ancestor
110062689|NCT04393298|Micronutrients|micronutrients|mesh-ancestor
110062714|NCT04336982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110062715|NCT04336982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110062716|NCT04313881|Azacitidine|azacitidine|mesh-list
110062717|NCT04313881|Magrolimab|magrolimab|mesh-list
110062718|NCT04313881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110062842|NCT04097561|Immunologic Factors|immunologic factors|mesh-ancestor
110062843|NCT04097561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110062844|NCT04085445|Paclitaxel|paclitaxel|mesh-list
110062845|NCT04085445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110062846|NCT04085445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110062847|NCT04085445|Tubulin Modulators|tubulin modulators|mesh-ancestor
110062848|NCT04085445|Antimitotic Agents|antimitotic agents|mesh-ancestor
110062849|NCT04085445|Mitosis Modulators|mitosis modulators|mesh-ancestor
110062850|NCT04085445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110062852|NCT04074746|Cyclophosphamide|cyclophosphamide|mesh-list
110062853|NCT04074746|Fludarabine|fludarabine|mesh-list
110062854|NCT04074746|Fludarabine phosphate|fludarabine phosphate|mesh-list
110062855|NCT04074746|Antibodies|antibodies|mesh-list
110062856|NCT04074746|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110062857|NCT04074746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110062858|NCT04074746|Immunologic Factors|immunologic factors|mesh-ancestor
110062859|NCT04074746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110062860|NCT04074746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110062861|NCT04074746|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110062869|NCT04074746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110062871|NCT04038619|Antidiarrheals|antidiarrheals|mesh-list
110062872|NCT04038619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110062875|NCT03992404|Botulinum Toxins|botulinum toxins|mesh-list
110062876|NCT03992404|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110062877|NCT03992404|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110062878|NCT03992404|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
110062879|NCT03992404|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110062880|NCT03992404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110062881|NCT03992404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110062882|NCT03992404|Cholinergic Agents|cholinergic agents|mesh-ancestor
110062883|NCT03992404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110062884|NCT03992404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110062885|NCT03992404|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110062886|NCT03992404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110062888|NCT03951831|Leuprolide|leuprolide|mesh-list
110062889|NCT03951831|Cemiplimab|cemiplimab|mesh-list
110062890|NCT03951831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110062891|NCT03951831|Tubulin Modulators|tubulin modulators|mesh-ancestor
110062892|NCT03951831|Antimitotic Agents|antimitotic agents|mesh-ancestor
110062893|NCT03951831|Mitosis Modulators|mitosis modulators|mesh-ancestor
110062894|NCT03951831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110062895|NCT03951831|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110062896|NCT03951831|Fertility Agents|fertility agents|mesh-ancestor
110062897|NCT03951831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110062898|NCT03951831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110062899|NCT03951831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110062900|NCT03951831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110063016|NCT03819517|Protective Agents|protective agents|mesh-ancestor
110063018|NCT03819517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110063019|NCT03819517|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110063021|NCT03819296|Infliximab|infliximab|mesh-list
110063022|NCT03819296|Cortisone|cortisone|mesh-list
110063023|NCT03819296|Vedolizumab|vedolizumab|mesh-list
110063024|NCT03819296|Immunoglobulins|immunoglobulins|mesh-list
110063025|NCT03819296|Immunoglobulin G|immunoglobulin g|mesh-list
110063026|NCT03819296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110063027|NCT03819296|Glucocorticoids|glucocorticoids|mesh-ancestor
110063028|NCT03819296|Hormones|hormones|mesh-ancestor
110063029|NCT03819296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110063030|NCT03819296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110063031|NCT03819296|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110063032|NCT03819296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110063033|NCT03819296|Immunologic Factors|immunologic factors|mesh-ancestor
110063034|NCT03819296|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110063035|NCT03819296|Dermatologic Agents|dermatologic agents|mesh-ancestor
110063036|NCT03819296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110063037|NCT03819296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110063061|NCT03803761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110063062|NCT03803761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110063063|NCT03803761|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110063064|NCT03803761|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110063065|NCT03803761|Hormone Antagonists|hormone antagonists|mesh-ancestor
110063066|NCT03803761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110063067|NCT03803761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110063069|NCT03799445|Ipilimumab|ipilimumab|mesh-list
110063070|NCT03799445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110063071|NCT03799445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110063072|NCT03799445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110063073|NCT03799445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110063074|NCT03772834|Methylphenidate|methylphenidate|mesh-list
110063075|NCT03772834|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110063076|NCT03772834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110063077|NCT03772834|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110063078|NCT03772834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110063079|NCT03772834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110063080|NCT03772834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110063082|NCT03772834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110063083|NCT03765918|Cisplatin|cisplatin|mesh-list
110063084|NCT03765918|Pembrolizumab|pembrolizumab|mesh-list
110063085|NCT03765918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110063086|NCT03765918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110063087|NCT03765918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110063088|NCT03765918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110063089|NCT03761173|Anticoagulants|anticoagulants|mesh-list
110063090|NCT03735095|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
110063091|NCT03735095|Trioxsalen|trioxsalen|mesh-list
110063092|NCT03735095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110063093|NCT03735095|Dermatologic Agents|dermatologic agents|mesh-ancestor
110063094|NCT03735095|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110063114|NCT03726879|Tubulin Modulators|tubulin modulators|mesh-ancestor
110063115|NCT03726879|Antimitotic Agents|antimitotic agents|mesh-ancestor
110063116|NCT03726879|Mitosis Modulators|mitosis modulators|mesh-ancestor
110063117|NCT03726879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110063118|NCT03726879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110063125|NCT03726879|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110063126|NCT03726879|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110063127|NCT03726879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110063128|NCT03726879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110063129|NCT03726879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110063137|NCT03723187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110063139|NCT03691051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110063140|NCT03691051|Antimetabolites|antimetabolites|mesh-ancestor
110063141|NCT03691051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110063142|NCT03691051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110063143|NCT03689699|Nivolumab|nivolumab|mesh-list
110063144|NCT03689699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110063145|NCT03689699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110063146|NCT03689699|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110063147|NCT03689699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110063149|NCT03634241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110063150|NCT03634241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110063151|NCT03634241|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110063152|NCT03634241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110063153|NCT03630042|Rituximab|rituximab|mesh-list
110063154|NCT03630042|Pembrolizumab|pembrolizumab|mesh-list
110063155|NCT03630042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110063156|NCT03630042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110063157|NCT03630042|Immunologic Factors|immunologic factors|mesh-ancestor
110063158|NCT03630042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110063159|NCT03630042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110063160|NCT03630042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110063161|NCT03630042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110063162|NCT03565991|Avelumab|avelumab|mesh-list
110063163|NCT03565991|Talazoparib|talazoparib|mesh-list
110063164|NCT03565991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110063165|NCT03565991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110063166|NCT03565991|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110063167|NCT03565991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110063168|NCT03565991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110063179|NCT03504488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110063180|NCT03504488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110063181|NCT03504488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110063182|NCT03504488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110063183|NCT03471260|Azacitidine|azacitidine|mesh-list
110063184|NCT03471260|Venetoclax|venetoclax|mesh-list
110063185|NCT03471260|Ivosidenib|ivosidenib|mesh-list
110063186|NCT03471260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110063214|NCT03361735|Goserelin|goserelin|mesh-list
110063215|NCT03361735|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
110063216|NCT03361735|Hormones|hormones|mesh-list
110063217|NCT03361735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110063218|NCT03361735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110063219|NCT03361735|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110063220|NCT03361735|Fertility Agents|fertility agents|mesh-ancestor
110063221|NCT03361735|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110063222|NCT03361735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110063223|NCT03361735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110063225|NCT03354897|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110063226|NCT03354897|Diuretics|diuretics|mesh-ancestor
110063227|NCT03354897|Natriuretic Agents|natriuretic agents|mesh-ancestor
110063228|NCT03354897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110063229|NCT03354897|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110063230|NCT03354897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110063231|NCT03354897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110063234|NCT03263572|Cytarabine|cytarabine|mesh-list
110063235|NCT03263572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110063236|NCT03263572|Methotrexate|methotrexate|mesh-list
110063237|NCT03263572|Blinatumomab|blinatumomab|mesh-list
110063238|NCT03263572|Ponatinib|ponatinib|mesh-list
110063239|NCT03263572|Antibodies|antibodies|mesh-list
110063240|NCT03263572|Immunoglobulins|immunoglobulins|mesh-list
110063241|NCT03263572|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110063242|NCT03263572|Muromonab-CD3|muromonab-cd3|mesh-list
110063243|NCT03263572|Antibodies, Bispecific|antibodies, bispecific|mesh-list
110063244|NCT03263572|Immunologic Factors|immunologic factors|mesh-ancestor
110063245|NCT03263572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110063246|NCT03263572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110063247|NCT03263572|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110063248|NCT03263572|Abortifacient Agents|abortifacient agents|mesh-ancestor
110063249|NCT03263572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110063250|NCT03263572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110063251|NCT03263572|Antimetabolites|antimetabolites|mesh-ancestor
110063252|NCT03263572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110063253|NCT03263572|Dermatologic Agents|dermatologic agents|mesh-ancestor
110063254|NCT03263572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110063255|NCT03263572|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110063256|NCT03263572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110063257|NCT03263572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110063258|NCT03263572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110063259|NCT03263572|Antiviral Agents|antiviral agents|mesh-ancestor
110063260|NCT03263572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110063261|NCT03263572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110063263|NCT03214562|Fludarabine|fludarabine|mesh-list
110063264|NCT03214562|Venetoclax|venetoclax|mesh-list
110063265|NCT03214562|Idarubicin|idarubicin|mesh-list
110063266|NCT03214562|Lenograstim|lenograstim|mesh-list
110063267|NCT03214562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110063268|NCT03214562|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110063269|NCT03214562|Antimetabolites|antimetabolites|mesh-ancestor
110063270|NCT03214562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110063271|NCT03214562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110063272|NCT03214562|Immunologic Factors|immunologic factors|mesh-ancestor
110063273|NCT03214562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110063274|NCT03214562|Antiviral Agents|antiviral agents|mesh-ancestor
110063275|NCT03214562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110063276|NCT03214562|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110063287|NCT03199612|Vasodilator Agents|vasodilator agents|mesh-ancestor
110063288|NCT03199612|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110063289|NCT03199612|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110063290|NCT03199612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110063291|NCT03199612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110063292|NCT03199612|Urological Agents|urological agents|mesh-ancestor
110063294|NCT03186638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110063295|NCT03186638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110063296|NCT03186638|Analgesics|analgesics|mesh-ancestor
110063297|NCT03186638|Sensory System Agents|sensory system agents|mesh-ancestor
110063298|NCT03186638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110063299|NCT03186638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110063300|NCT03186638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110063301|NCT03186638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110063302|NCT03186638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110063303|NCT03186638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110063307|NCT03165292|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110063308|NCT03165292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110063309|NCT03165292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110063310|NCT03165292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110063311|NCT03165292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110063312|NCT03165292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110063313|NCT03165292|Alkylating Agents|alkylating agents|mesh-ancestor
110063314|NCT03165292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110063315|NCT03165292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110063316|NCT03165292|Immunologic Factors|immunologic factors|mesh-ancestor
110063317|NCT03165292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110063333|NCT03140423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110063337|NCT03077542|Hydroxyurea|hydroxyurea|mesh-list
110063338|NCT03077542|Pentostatin|pentostatin|mesh-list
110063339|NCT03077542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110063340|NCT03077542|Immunologic Factors|immunologic factors|mesh-ancestor
110063341|NCT03077542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110063342|NCT03077542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110063343|NCT03077542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110063344|NCT03077542|Alkylating Agents|alkylating agents|mesh-ancestor
110063345|NCT03077542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110063346|NCT03077542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110063347|NCT03077542|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110063348|NCT03077542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110063349|NCT03077542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110063350|NCT03077542|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110063351|NCT03077542|Antifungal Agents|antifungal agents|mesh-ancestor
110063352|NCT03077542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110063353|NCT03077542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110063354|NCT03077542|Antisickling Agents|antisickling agents|mesh-ancestor
110063355|NCT03077542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110063356|NCT03077542|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
110063357|NCT03049462|Mirabegron|mirabegron|mesh-list
110063358|NCT03049462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110063361|NCT03049462|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110063362|NCT03049462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110063363|NCT03049462|Adrenergic Agents|adrenergic agents|mesh-ancestor
110063364|NCT03049462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110063365|NCT03049462|Urological Agents|urological agents|mesh-ancestor
110063366|NCT03041688|Decitabine|decitabine|mesh-list
110063367|NCT03041688|Venetoclax|venetoclax|mesh-list
110063368|NCT03041688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110063369|NCT03041688|Antimetabolites|antimetabolites|mesh-ancestor
110063370|NCT03041688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110063371|NCT03041688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110063372|NCT03041688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110063391|NCT03008408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110063392|NCT03008408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110063393|NCT03008408|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110063394|NCT03008408|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110063395|NCT03008408|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110063396|NCT03008408|Hormone Antagonists|hormone antagonists|mesh-ancestor
110063397|NCT03008408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110063398|NCT02998385|Cisplatin|cisplatin|mesh-list
110063399|NCT02998385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110063462|NCT02876302|Mitosis Modulators|mitosis modulators|mesh-ancestor
110063463|NCT02876302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110063464|NCT02876302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110063465|NCT02876302|Immunologic Factors|immunologic factors|mesh-ancestor
110063466|NCT02876302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110063467|NCT02876302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110063468|NCT02876302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110063469|NCT02876302|Alkylating Agents|alkylating agents|mesh-ancestor
110063470|NCT02876302|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110063471|NCT02876302|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110063472|NCT02876302|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110063473|NCT02876302|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110063474|NCT02876302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110063476|NCT02846623|Venetoclax|venetoclax|mesh-list
110063477|NCT02846623|Obinutuzumab|obinutuzumab|mesh-list
110063478|NCT02846623|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110063479|NCT02846623|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110063480|NCT02846623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110063481|NCT02846623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110063482|NCT02846623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110063483|NCT02846623|Immunologic Factors|immunologic factors|mesh-ancestor
110063484|NCT02846623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110063485|NCT02803437|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
110063520|NCT02639065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110063521|NCT02620072|Insulin|insulin|mesh-list
110063522|NCT02620072|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110063523|NCT02620072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110063524|NCT02532257|Rituximab|rituximab|mesh-list
110063525|NCT02532257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110063526|NCT02532257|Lenalidomide|lenalidomide|mesh-list
110063527|NCT02532257|Antibodies|antibodies|mesh-list
110063528|NCT02532257|Immunoglobulins|immunoglobulins|mesh-list
110063529|NCT02532257|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110063531|NCT02532257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110063532|NCT02532257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110063533|NCT02532257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110063534|NCT02532257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110063535|NCT02532257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110063536|NCT02532257|Growth Substances|growth substances|mesh-ancestor
110063537|NCT02532257|Growth Inhibitors|growth inhibitors|mesh-ancestor
110063539|NCT02530034|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110063540|NCT02530034|Immunologic Factors|immunologic factors|mesh-ancestor
110063541|NCT02530034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110063554|NCT02451943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110063555|NCT02451943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110063556|NCT02420860|Lenalidomide|lenalidomide|mesh-list
110063558|NCT02420860|Immunologic Factors|immunologic factors|mesh-ancestor
110063559|NCT02420860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110063560|NCT02420860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110063561|NCT02420860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110063562|NCT02420860|Growth Substances|growth substances|mesh-ancestor
110063563|NCT02420860|Growth Inhibitors|growth inhibitors|mesh-ancestor
110063564|NCT02420860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110063565|NCT02408861|Nivolumab|nivolumab|mesh-list
110063566|NCT02408861|Ipilimumab|ipilimumab|mesh-list
110063567|NCT02408861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110063568|NCT02408861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110063569|NCT02408861|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110063570|NCT02408861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110063571|NCT02379377|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110063572|NCT02379377|Fluorides|fluorides|mesh-list
110063573|NCT02379377|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110063574|NCT02379377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110063575|NCT02379377|Cariostatic Agents|cariostatic agents|mesh-ancestor
110063576|NCT02379377|Protective Agents|protective agents|mesh-ancestor
110063592|NCT02357797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110063593|NCT02357797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110063594|NCT02357797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110063595|NCT02357797|Serotonin Agents|serotonin agents|mesh-ancestor
110063596|NCT02357797|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110063597|NCT02357797|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110063598|NCT02357797|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110063628|NCT02169310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110063629|NCT02169310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110063630|NCT02169310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110063631|NCT02169310|Dopamine Agents|dopamine agents|mesh-ancestor
110063632|NCT02169310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110063633|NCT02169310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110063634|NCT02113657|Ipilimumab|ipilimumab|mesh-list
110063635|NCT02113657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110063636|NCT02113657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110063637|NCT02113657|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110063638|NCT02113657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110063659|NCT01896999|Immunologic Factors|immunologic factors|mesh-ancestor
110063660|NCT01896999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110063661|NCT01896999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110063662|NCT01896999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110063663|NCT01896999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110063665|NCT01892371|Cytarabine|cytarabine|mesh-list
110063666|NCT01892371|Azacitidine|azacitidine|mesh-list
110063667|NCT01892371|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110063668|NCT01892371|Antimetabolites|antimetabolites|mesh-ancestor
110063669|NCT01892371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110063670|NCT01892371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110063672|NCT01892371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110063673|NCT01892371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110063674|NCT01892371|Immunologic Factors|immunologic factors|mesh-ancestor
110063675|NCT01892371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110063676|NCT01892371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110063677|NCT01842386|Rituximab|rituximab|mesh-list
110063678|NCT01842386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110063679|NCT01842386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110063701|NCT01415882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110063702|NCT01415882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110063703|NCT01415882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110063704|NCT01415882|Alkylating Agents|alkylating agents|mesh-ancestor
110063705|NCT01415882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110063706|NCT01415882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110063707|NCT01415882|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110063708|NCT01415882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110063709|NCT01415882|Antiemetics|antiemetics|mesh-ancestor
110063710|NCT01415882|Autonomic Agents|autonomic agents|mesh-ancestor
110063711|NCT01415882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110063712|NCT01415882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110063713|NCT01415882|Glucocorticoids|glucocorticoids|mesh-ancestor
110063714|NCT01415882|Hormones|hormones|mesh-ancestor
110063715|NCT01415882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110063716|NCT01415882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110063717|NCT01415882|Protease Inhibitors|protease inhibitors|mesh-ancestor
110063718|NCT01415882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110063719|NCT01415882|Dermatologic Agents|dermatologic agents|mesh-ancestor
110063720|NCT01415882|Glycine Agents|glycine agents|mesh-ancestor
110063737|NCT01303341|Anticonvulsants|anticonvulsants|mesh-ancestor
110063738|NCT01303341|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110063739|NCT01303341|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110063740|NCT01303341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110063741|NCT01303341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110063742|NCT01303341|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110063743|NCT01303341|Protective Agents|protective agents|mesh-ancestor
110063744|NCT01092702|Varenicline|varenicline|mesh-list
110063745|NCT01092702|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110063746|NCT01092702|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110063747|NCT01092702|Cholinergic Agents|cholinergic agents|mesh-ancestor
110063748|NCT01092702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110063749|NCT01092702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110063750|NCT01092702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110063751|NCT00967785|Plerixafor|plerixafor|mesh-list
110063752|NCT00967785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110063753|NCT00967785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110063754|NCT00967785|Antiviral Agents|antiviral agents|mesh-ancestor
110063755|NCT00967785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110063756|NCT00750841|Cediranib|cediranib|mesh-list
110063757|NCT00750841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110063758|NCT00750841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110063760|NCT00750841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110063762|NCT00667121|Gabapentin|gabapentin|mesh-list
110063763|NCT00667121|Dexetimide|dexetimide|mesh-list
110063764|NCT00667121|Citalopram|citalopram|mesh-list
110063765|NCT00667121|Sertraline|sertraline|mesh-list
110063766|NCT00667121|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110063767|NCT00667121|Escitalopram|escitalopram|mesh-list
110063768|NCT00667121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110063769|NCT00667121|Analgesics|analgesics|mesh-ancestor
110063770|NCT00667121|Sensory System Agents|sensory system agents|mesh-ancestor
110063771|NCT00667121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110063772|NCT00667121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110063773|NCT00667121|Anticonvulsants|anticonvulsants|mesh-ancestor
110063774|NCT00667121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110063775|NCT00667121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110063776|NCT00667121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110063777|NCT00667121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110063778|NCT00667121|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110063779|NCT00667121|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110063780|NCT00667121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110063781|NCT00667121|Antimanic Agents|antimanic agents|mesh-ancestor
110063782|NCT00667121|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110063783|NCT00667121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110063784|NCT00667121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110063785|NCT00667121|Serotonin Agents|serotonin agents|mesh-ancestor
110063786|NCT00667121|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110063787|NCT00667121|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110063788|NCT00667121|Parasympatholytics|parasympatholytics|mesh-ancestor
110063789|NCT00667121|Autonomic Agents|autonomic agents|mesh-ancestor
110063790|NCT00667121|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110063791|NCT00667121|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110063792|NCT00667121|Cholinergic Agents|cholinergic agents|mesh-ancestor
110063793|NCT00667121|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110063794|NCT00667121|Antidepressive Agents|antidepressive agents|mesh-ancestor
110063795|NCT00667121|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110063796|NCT00667121|Hormone Antagonists|hormone antagonists|mesh-ancestor
110063797|NCT00667121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110063798|NCT00667121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110063799|NCT00667121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110063800|NCT00667121|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110063801|NCT00667121|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110063802|NCT00667121|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110063803|NCT00667121|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110063805|NCT00591851|Cyclophosphamide|cyclophosphamide|mesh-list
110063806|NCT00591851|Doxorubicin|doxorubicin|mesh-list
110063807|NCT00591851|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110063808|NCT00591851|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110063809|NCT00591851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110063810|NCT00591851|Tubulin Modulators|tubulin modulators|mesh-ancestor
110063811|NCT00591851|Antimitotic Agents|antimitotic agents|mesh-ancestor
110063812|NCT00591851|Mitosis Modulators|mitosis modulators|mesh-ancestor
110063813|NCT00591851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110063814|NCT00591851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110063815|NCT00591851|Immunologic Factors|immunologic factors|mesh-ancestor
110063816|NCT00591851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110063817|NCT00591851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110063818|NCT00591851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110063819|NCT00591851|Alkylating Agents|alkylating agents|mesh-ancestor
110063820|NCT00591851|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110063821|NCT00591851|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110063822|NCT00591851|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110063823|NCT00591851|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110063824|NCT00591851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110063825|NCT00336024|Calcium, Dietary|calcium, dietary|mesh-list
110063826|NCT00336024|Leucovorin|leucovorin|mesh-list
110063827|NCT00336024|Folic Acid|folic acid|mesh-list
110063828|NCT00336024|Cyclophosphamide|cyclophosphamide|mesh-list
110063829|NCT00336024|Thiotepa|thiotepa|mesh-list
110063830|NCT00336024|Cisplatin|cisplatin|mesh-list
110063831|NCT00336024|Carboplatin|carboplatin|mesh-list
110063832|NCT00336024|Methotrexate|methotrexate|mesh-list
110063833|NCT00336024|Etoposide|etoposide|mesh-list
110063834|NCT00336024|Vincristine|vincristine|mesh-list
110063835|NCT00336024|Etoposide phosphate|etoposide phosphate|mesh-list
110063836|NCT00336024|Podophyllotoxin|podophyllotoxin|mesh-list
110063837|NCT00336024|Lenograstim|lenograstim|mesh-list
110063838|NCT00336024|Calcium|calcium|mesh-list
110063839|NCT00336024|Levoleucovorin|levoleucovorin|mesh-list
110063840|NCT00336024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110063841|NCT00336024|Immunologic Factors|immunologic factors|mesh-ancestor
110063842|NCT00336024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110063843|NCT00336024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110063844|NCT00336024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110063846|NCT00336024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110063847|NCT00336024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110063848|NCT00336024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110063849|NCT00336024|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110063850|NCT00336024|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110063851|NCT00336024|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110063857|NCT00336024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110063858|NCT00336024|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110063859|NCT00336024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110063860|NCT00336024|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110063861|NCT00336024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110063862|NCT00336024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110063863|NCT00336024|Antidotes|antidotes|mesh-ancestor
110063864|NCT00336024|Protective Agents|protective agents|mesh-ancestor
110063865|NCT00336024|Vitamin B Complex|vitamin b complex|mesh-ancestor
110063866|NCT00336024|Vitamins|vitamins|mesh-ancestor
110063885|NCT00133705|Hormone Antagonists|hormone antagonists|mesh-ancestor
110063886|NCT00133705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110063887|NCT00133705|Luteolytic Agents|luteolytic agents|mesh-ancestor
110063888|NCT00133705|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110063889|NCT00133705|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110063890|NCT00092222|Interferons|interferons|mesh-list
110063891|NCT00092222|Interferon-alpha|interferon-alpha|mesh-list
110063892|NCT00092222|Zidovudine|zidovudine|mesh-list
110063893|NCT00092222|Valganciclovir|valganciclovir|mesh-list
110063894|NCT00092222|Sirolimus|sirolimus|mesh-list
110063895|NCT00092222|Prednisone|prednisone|mesh-list
110063896|NCT00092222|Cyclophosphamide|cyclophosphamide|mesh-list
110063897|NCT00092222|Rituximab|rituximab|mesh-list
110063898|NCT00092222|Doxorubicin|doxorubicin|mesh-list
110063899|NCT00092222|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110063900|NCT00092222|Etoposide|etoposide|mesh-list
110063901|NCT00092222|Vincristine|vincristine|mesh-list
110063902|NCT00092222|Bortezomib|bortezomib|mesh-list
110063903|NCT00092222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110063904|NCT00092222|Immunologic Factors|immunologic factors|mesh-ancestor
110063905|NCT00092222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110063906|NCT00092222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110063907|NCT00092222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110063908|NCT00092222|Alkylating Agents|alkylating agents|mesh-ancestor
110063909|NCT00092222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110063910|NCT00092222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110063911|NCT00092222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110063921|NCT00092222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110063922|NCT00092222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110063924|NCT00092222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110063925|NCT00092222|Tubulin Modulators|tubulin modulators|mesh-ancestor
110063926|NCT00092222|Antimitotic Agents|antimitotic agents|mesh-ancestor
110063927|NCT00092222|Mitosis Modulators|mitosis modulators|mesh-ancestor
110063928|NCT00092222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110063929|NCT00092222|Antifungal Agents|antifungal agents|mesh-ancestor
110063930|NCT00092222|Antimetabolites|antimetabolites|mesh-ancestor
110063931|NCT00092222|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110063932|NCT00092222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110063933|NCT00092222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110063934|NCT00092222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110063944|NCT00025935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110036352|NCT01410916|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110052799|NCT01482117|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110052800|NCT01482117|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110052801|NCT01482117|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110052802|NCT01482117|Purinergic Agents|purinergic agents|mesh-ancestor
110036195|NCT01409395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110036196|NCT01409408|Amlodipine|amlodipine|mesh-list
110036197|NCT01409408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110036198|NCT01409408|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110036199|NCT01409408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110052803|NCT01482117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110036200|NCT01409408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110036201|NCT01409408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110036202|NCT01409408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036203|NCT01409408|Vasodilator Agents|vasodilator agents|mesh-ancestor
110036204|NCT01409421|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110036205|NCT01409421|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110036206|NCT01409603|Naproxen|naproxen|mesh-list
110036207|NCT01409603|Darexaban|darexaban|mesh-list
110036208|NCT01409603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110036209|NCT01409603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110036210|NCT01409603|Analgesics|analgesics|mesh-ancestor
110036211|NCT01409603|Sensory System Agents|sensory system agents|mesh-ancestor
110036212|NCT01409603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110036213|NCT01409603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036214|NCT01409603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110036215|NCT01409603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110036216|NCT01409603|Gout Suppressants|gout suppressants|mesh-ancestor
110036217|NCT01409603|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110036218|NCT01409603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110036219|NCT01409603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110036220|NCT01409603|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110036221|NCT01409603|Antithrombins|antithrombins|mesh-ancestor
110036222|NCT01409603|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110036223|NCT01409603|Protease Inhibitors|protease inhibitors|mesh-ancestor
110036224|NCT01409603|Anticoagulants|anticoagulants|mesh-ancestor
110036225|NCT01409616|Aspirin|aspirin|mesh-list
110036226|NCT01409616|Salicylic Acid|salicylic acid|mesh-list
110036227|NCT01409616|Salicylates|salicylates|mesh-list
110036228|NCT01409616|Darexaban|darexaban|mesh-list
110036229|NCT01409616|Clopidogrel|clopidogrel|mesh-list
110036230|NCT01409616|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110036231|NCT01409616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110036232|NCT01409616|Analgesics|analgesics|mesh-ancestor
110036233|NCT01409616|Sensory System Agents|sensory system agents|mesh-ancestor
110036234|NCT01409616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110036235|NCT01409616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036236|NCT01409616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110036237|NCT01409616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110036238|NCT01409616|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110036696|NCT01413477|Betamethasone benzoate|betamethasone benzoate|mesh-list
110036766|NCT01414231|Cytarabine|cytarabine|mesh-list
110036816|NCT01414608|Mitosis Modulators|mitosis modulators|mesh-ancestor
110037297|NCT01417754|Toremifene|toremifene|mesh-list
110037337|NCT01417923|Vitamin D|vitamin d|mesh-list
110037547|NCT01419119|Vitamin D|vitamin d|mesh-list
110037654|NCT01419847|Ciclopirox|ciclopirox|mesh-list
110037779|NCT01420822|Fluticasone|fluticasone|mesh-list
110038278|NCT01423591|Infliximab|infliximab|mesh-list
110038341|NCT01423864|Hormones|hormones|mesh-ancestor
110038391|NCT01424176|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110038591|NCT01425242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110038598|NCT01425320|Dapsone|dapsone|mesh-list
110038722|NCT01425736|Antimetabolites|antimetabolites|mesh-ancestor
110038840|NCT05385068|Niraparib|niraparib|mesh-list
110039027|NCT04425902|Protective Agents|protective agents|mesh-ancestor
110039210|NCT01425827|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110039215|NCT01425827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110039271|NCT01426126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110039339|NCT01426633|Alkylating Agents|alkylating agents|mesh-ancestor
110039459|NCT01427244|Trastuzumab|trastuzumab|mesh-list
110039520|NCT01427582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110039573|NCT01427985|Mydriatics|mydriatics|mesh-ancestor
110039693|NCT01428518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110039695|NCT01428531|PENTA|penta|mesh-list
110039888|NCT01429818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110039946|NCT01430013|Growth Substances|growth substances|mesh-ancestor
110040018|NCT01430806|Dronedarone|dronedarone|mesh-list
110040135|NCT01431495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110040195|NCT01431924|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110040258|NCT01432106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110040381|NCT01432977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110040605|NCT01434225|Bumetanide|bumetanide|mesh-list
110040673|NCT01434901|Bethanechol|bethanechol|mesh-list
110040948|NCT01436916|Vitamin D|vitamin d|mesh-list
110041040|NCT01437462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110041062|NCT01437592|Insulin|insulin|mesh-list
110041096|NCT01437748|Bromides|bromides|mesh-list
110041160|NCT01437982|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110041289|NCT05343507|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110041411|NCT04850222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110041532|NCT04329572|Azithromycin|azithromycin|mesh-list
110041665|NCT02986334|Naproxen|naproxen|mesh-list
110042062|NCT01440114|Narcotics|narcotics|mesh-ancestor
110042126|NCT01440582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110042248|NCT01441206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110042366|NCT01441869|Protease Inhibitors|protease inhibitors|mesh-ancestor
110042369|NCT01441908|Pravastatin|pravastatin|mesh-list
110042498|NCT01442571|Viscosupplements|viscosupplements|mesh-ancestor
110042618|NCT01443065|Protective Agents|protective agents|mesh-ancestor
110042822|NCT01444339|Vaccines|vaccines|mesh-list
110042940|NCT01445106|Antiviral Agents|antiviral agents|mesh-ancestor
110043068|NCT01445756|Lidocaine|lidocaine|mesh-list
110043070|NCT01445756|Anesthetics|anesthetics|mesh-ancestor
110043132|NCT01446211|Immunologic Factors|immunologic factors|mesh-ancestor
110043384|NCT01447654|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110043386|NCT01447797|Irbesartan|irbesartan|mesh-list
110043631|NCT01449110|Resveratrol|resveratrol|mesh-list
110044097|NCT05962229|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110044098|NCT05962229|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110044498|NCT05734625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110044882|NCT05269849|Antifungal Agents|antifungal agents|mesh-ancestor
110044959|NCT05179512|Hormones|hormones|mesh-ancestor
110045144|NCT04997811|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110045273|NCT04892758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110045341|NCT04822337|Dexamethasone|dexamethasone|mesh-list
110045977|NCT05820763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110046214|NCT05513625|Pritelivir|pritelivir|mesh-list
110046339|NCT05353361|Paclitaxel|paclitaxel|mesh-list
110046505|NCT05192889|Venetoclax|venetoclax|mesh-list
110046723|NCT05039619|Anesthetics|anesthetics|mesh-ancestor
110046863|NCT04910568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110047232|NCT04421222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110047670|NCT03390686|Bevacizumab|bevacizumab|mesh-list
110047721|NCT03270969|Tenofovir|tenofovir|mesh-list
110047862|NCT03016013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110048003|NCT02684006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110048291|NCT00781612|Atezolizumab|atezolizumab|mesh-list
110048416|NCT04705727|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110048440|NCT04662944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110048461|NCT04635826|Adderall|adderall|mesh-list
110048560|NCT04435834|Anesthetics|anesthetics|mesh-ancestor
110052798|NCT01482117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110048636|NCT04233021|Osimertinib|osimertinib|mesh-list
110048676|NCT04169347|Leucovorin|leucovorin|mesh-list
110048726|NCT04135937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110048788|NCT03972488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110048846|NCT03936010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110049025|NCT03595917|Hormones|hormones|mesh-ancestor
110049600|NCT01614197|Cytarabine|cytarabine|mesh-list
110050119|NCT01462669|Ezogabine|ezogabine|mesh-list
110050177|NCT01463280|Lidocaine|lidocaine|mesh-list
110050307|NCT01464112|Hormones|hormones|mesh-ancestor
110050362|NCT01464489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110050626|NCT01468038|Trazodone|trazodone|mesh-list
110050713|NCT01468519|Insulin|insulin|mesh-list
110051382|NCT01472913|Coagulants|coagulants|mesh-ancestor
110051926|NCT01477112|Beta Carotene|beta carotene|mesh-list
110052440|NCT01479920|Serotonin Agents|serotonin agents|mesh-ancestor
110052497|NCT01480336|Ranolazine|ranolazine|mesh-list
110052683|NCT01481519|Povidone|povidone|mesh-list
110053094|NCT01484756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110053237|NCT01485692|Midazolam|midazolam|mesh-list
110053436|NCT01486485|Nafamostat|nafamostat|mesh-list
110053549|NCT01486992|Nimotuzumab|nimotuzumab|mesh-list
110053926|NCT01489410|Ethanol|ethanol|mesh-list
110054103|NCT01489982|Histamine Agents|histamine agents|mesh-ancestor
110054468|NCT01492179|Anesthetics, Local|anesthetics, local|mesh-ancestor
110054529|NCT01492712|Propofol|propofol|mesh-list
110054601|NCT01493102|Sympathomimetics|sympathomimetics|mesh-ancestor
110054651|NCT01493336|Antimetabolites|antimetabolites|mesh-ancestor
110054863|NCT01494636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110055430|NCT01497873|Belotecan|belotecan|mesh-list
110055493|NCT01498406|Vitamin D|vitamin d|mesh-list
110055559|NCT01498861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110055752|NCT01500070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110055818|NCT01500577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110055981|NCT01501136|Mesna|mesna|mesh-list
110056020|NCT01501149|Antimetabolites|antimetabolites|mesh-ancestor
110056077|NCT01501396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110056204|NCT01501747|Sensory System Agents|sensory system agents|mesh-ancestor
110056205|NCT01501747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110056323|NCT01502202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110056613|NCT01503788|Midazolam|midazolam|mesh-list
110056718|NCT01504139|Estradiol|estradiol|mesh-list
110056719|NCT01504139|Progesterone|progesterone|mesh-list
110056781|NCT01504321|Moxonidine|moxonidine|mesh-list
110056965|NCT01505231|Hemostatics|hemostatics|mesh-ancestor
110057059|NCT01505920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110057163|NCT01506167|Antimetabolites|antimetabolites|mesh-ancestor
110057225|NCT01506505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110057340|NCT01506804|Antiemetics|antiemetics|mesh-ancestor
110057395|NCT01507194|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110057507|NCT01507558|Glucocorticoids|glucocorticoids|mesh-ancestor
110057885|NCT01509521|Ephedrine|ephedrine|mesh-list
110057944|NCT01509976|Antimetabolites|antimetabolites|mesh-ancestor
110058263|NCT01511627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110058324|NCT01511770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110058390|NCT01511887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110058393|NCT01511991|Sevoflurane|sevoflurane|mesh-list
110058515|NCT01512784|Vaccines|vaccines|mesh-list
110058516|NCT01512784|Immunologic Factors|immunologic factors|mesh-ancestor
110058641|NCT01513564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110058896|NCT01514851|Antacids|antacids|mesh-ancestor
110058951|NCT01515228|Antimitotic Agents|antimitotic agents|mesh-ancestor
110059005|NCT01515683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110059179|NCT01516554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110059310|NCT01517022|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110059396|NCT01517399|Coagulants|coagulants|mesh-ancestor
110059516|NCT01518166|Atorvastatin|atorvastatin|mesh-list
110059586|NCT01518465|Hormones|hormones|mesh-ancestor
110059765|NCT01519401|Drospirenone|drospirenone|mesh-list
110059832|NCT01519986|Vitamin D|vitamin d|mesh-list
110060546|NCT01524068|Rituximab|rituximab|mesh-list
110061876|NCT05494593|Antimetabolites|antimetabolites|mesh-ancestor
110061986|NCT05296577|Tubulin Modulators|tubulin modulators|mesh-ancestor
110062228|NCT04947254|Antioxidants|antioxidants|mesh-ancestor
110062320|NCT04849364|Antimetabolites|antimetabolites|mesh-ancestor
110062321|NCT04849364|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110062322|NCT04849364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110062323|NCT04849364|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
110062428|NCT04685616|Alkylating Agents|alkylating agents|mesh-ancestor
110062429|NCT04685616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110062431|NCT04685616|Immunoconjugates|immunoconjugates|mesh-ancestor
110062487|NCT04626141|Abaloparatide|abaloparatide|mesh-list
110062534|NCT04562831|Nicotinic Acids|nicotinic acids|mesh-list
110062651|NCT04397484|Anesthetics|anesthetics|mesh-ancestor
110062793|NCT04262843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110063068|NCT03799445|Nivolumab|nivolumab|mesh-list
110063232|NCT03340675|Ifetroban|ifetroban|mesh-list
110063761|NCT00667121|Tamoxifen|tamoxifen|mesh-list
110036317|NCT01410214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110036318|NCT01410214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110036319|NCT01410214|Tubulin Modulators|tubulin modulators|mesh-ancestor
110036320|NCT01410214|Antimitotic Agents|antimitotic agents|mesh-ancestor
110036321|NCT01410214|Mitosis Modulators|mitosis modulators|mesh-ancestor
110036322|NCT01410370|Endostar protein|endostar protein|mesh-list
110036323|NCT01410370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110036324|NCT01410370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110036325|NCT01410370|Growth Substances|growth substances|mesh-ancestor
110036326|NCT01410370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036327|NCT01410370|Growth Inhibitors|growth inhibitors|mesh-ancestor
110036328|NCT01410370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110036329|NCT01410630|Telbivudine|telbivudine|mesh-list
110036330|NCT01410630|Antiviral Agents|antiviral agents|mesh-ancestor
110036331|NCT01410630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110036332|NCT01410630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110022413|NCT00002802|Etoposide|etoposide|mesh-list
110054791|NCT01494311|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110054792|NCT01494311|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110017283|NCT02937558|Glucagon|glucagon|mesh-list
110017284|NCT02937558|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110017285|NCT02937558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110017286|NCT02937558|Hormones|hormones|mesh-ancestor
110017287|NCT02937558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110017288|NCT02937558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110017289|NCT02937558|Incretins|incretins|mesh-ancestor
110017290|NCT02938494|Tazarotene|tazarotene|mesh-list
110017291|NCT02938494|Dermatologic Agents|dermatologic agents|mesh-ancestor
110017292|NCT02938494|Keratolytic Agents|keratolytic agents|mesh-ancestor
110017293|NCT02941692|Oxytocin|oxytocin|mesh-list
110017294|NCT02941692|Oxytocics|oxytocics|mesh-ancestor
110017295|NCT02941692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110017296|NCT02941692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110017385|NCT02970552|Progesterone|progesterone|mesh-list
110017466|NCT03020082|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110017549|NCT03061812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110017652|NCT03107754|Anesthetics|anesthetics|mesh-list
110017725|NCT05405478|Omalizumab|omalizumab|mesh-list
110017809|NCT03607656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018324|NCT04138758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110018523|NCT03805386|Analgesics|analgesics|mesh-ancestor
110018711|NCT02345772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110019103|NCT00738972|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110019358|NCT00538980|Dasatinib|dasatinib|mesh-list
110019569|NCT00000228|Sensory System Agents|sensory system agents|mesh-ancestor
110020438|NCT00001998|Nystatin|nystatin|mesh-list
110020660|NCT00002160|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110020735|NCT00002190|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110020737|NCT00002202|Indinavir|indinavir|mesh-list
110020811|NCT00002238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110020812|NCT00002238|Antiviral Agents|antiviral agents|mesh-ancestor
110020813|NCT00002238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110020886|NCT00002304|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110020964|NCT00002364|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110021042|NCT00002400|Protease Inhibitors|protease inhibitors|mesh-ancestor
110021122|NCT00002436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110021201|NCT00002472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110021288|NCT00002532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110021291|NCT00002532|Hormones|hormones|mesh-ancestor
110021449|NCT00002592|Busulfan|busulfan|mesh-list
110021604|NCT00002658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110021605|NCT00002658|Immunologic Factors|immunologic factors|mesh-ancestor
110021769|NCT00002700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110021770|NCT00002700|Antimetabolites|antimetabolites|mesh-ancestor
110021848|NCT00002748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110021925|NCT00002784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110021948|NCT00002790|Sirolimus|sirolimus|mesh-list
110021998|NCT05751252|Ganirelix|ganirelix|mesh-list
110022251|NCT03745170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110022252|NCT03737370|Docetaxel|docetaxel|mesh-list
110022260|NCT03701490|Hormones|hormones|mesh-ancestor
110022351|NCT00978822|Clevidipine|clevidipine|mesh-list
110022573|NCT00002970|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110022651|NCT00003012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110022727|NCT00003072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110022802|NCT00003120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110022980|NCT00003264|Gemcitabine|gemcitabine|mesh-list
110023176|NCT00003426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110023257|NCT00003582|Paclitaxel|paclitaxel|mesh-list
110023355|NCT00003678|Tamoxifen|tamoxifen|mesh-list
110023408|NCT00003696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110023483|NCT00003804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110023561|NCT00003858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023881|NCT00004110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110023961|NCT00004176|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110023962|NCT00004176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110024038|NCT00004212|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110024039|NCT00004212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110024198|NCT00004368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110024359|NCT00004644|Acyclovir|acyclovir|mesh-list
110024508|NCT00004854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110024743|NCT00005574|Gentamicins|gentamicins|mesh-list
110024895|NCT00005802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110024973|NCT00356070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110025049|NCT00357084|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110025129|NCT00357942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110025206|NCT00359658|Glucocorticoids|glucocorticoids|mesh-ancestor
110025291|NCT00361686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025373|NCT00363948|Hormones|hormones|mesh-ancestor
110025530|NCT00368238|Sensory System Agents|sensory system agents|mesh-ancestor
110025531|NCT00368238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110025605|NCT00370188|Topiramate|topiramate|mesh-list
110025682|NCT00371124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110025696|NCT00371904|Rituximab|rituximab|mesh-list
110025798|NCT00373542|Ropinirole|ropinirole|mesh-list
110025838|NCT00376584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025914|NCT00378456|Vitamins|vitamins|mesh-list
110025995|NCT00381030|Carvedilol|carvedilol|mesh-list
110026082|NCT00383682|Mexiletine|mexiletine|mesh-list
110026227|NCT00422526|Progesterone|progesterone|mesh-list
110026377|NCT02996214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110026539|NCT01270074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110026620|NCT01271556|Respiratory System Agents|respiratory system agents|mesh-ancestor
110026703|NCT01278576|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110026875|NCT00249834|Hormones|hormones|mesh-ancestor
110026955|NCT00242580|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110027037|NCT03800550|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110027114|NCT02017704|Antidotes|antidotes|mesh-ancestor
110027193|NCT03218124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027272|NCT03213834|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110027341|NCT03211104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110027388|NCT01832922|Rituximab|rituximab|mesh-list
110027416|NCT01834014|Cetuximab|cetuximab|mesh-list
110027492|NCT01838538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110027493|NCT01838538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110027572|NCT01834248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027573|NCT01834248|Laxatives|laxatives|mesh-ancestor
110027574|NCT01834248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110027649|NCT01721616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110027650|NCT01721694|Loteprednol Etabonate|loteprednol etabonate|mesh-list
110027651|NCT01721694|Azithromycin|azithromycin|mesh-list
110027652|NCT01721694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110027653|NCT01721694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110027654|NCT01721694|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110027655|NCT01722396|Vitamin D|vitamin d|mesh-list
110027722|NCT01724268|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110027723|NCT01724268|Sympathomimetics|sympathomimetics|mesh-ancestor
110027724|NCT01724268|Dopamine Agents|dopamine agents|mesh-ancestor
110027725|NCT01724268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110027794|NCT01726530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110027795|NCT01726530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110027796|NCT01726530|Analgesics|analgesics|mesh-ancestor
110027797|NCT01726530|Sensory System Agents|sensory system agents|mesh-ancestor
110027869|NCT01729260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110027870|NCT01729260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110027872|NCT01729806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110027873|NCT01729806|Ipilimumab|ipilimumab|mesh-list
110027874|NCT01729806|Antibodies|antibodies|mesh-list
110027875|NCT01729806|Immunoglobulins|immunoglobulins|mesh-list
110027941|NCT01048866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110027942|NCT01048788|Tolvaptan|tolvaptan|mesh-list
110027943|NCT01048788|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110027944|NCT01048788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110028013|NCT03407196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110028091|NCT03402048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110028167|NCT02241096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110028168|NCT02241096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110028242|NCT02242812|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110028243|NCT02242812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110028244|NCT02242812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110028245|NCT02242812|Sympatholytics|sympatholytics|mesh-ancestor
110028316|NCT02244216|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110028393|NCT02247414|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110028394|NCT02247414|Vasodilator Agents|vasodilator agents|mesh-ancestor
110028471|NCT02249130|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110028472|NCT02249130|Antiviral Agents|antiviral agents|mesh-ancestor
110028473|NCT02249130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110028474|NCT02249130|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110028475|NCT02249130|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110028476|NCT02249130|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110028544|NCT02245308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110028545|NCT02245308|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110028546|NCT02245308|Antidepressive Agents|antidepressive agents|mesh-ancestor
110028547|NCT02245308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110028621|NCT00557466|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110028622|NCT00557466|Autonomic Agents|autonomic agents|mesh-ancestor
110028623|NCT00557466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110028624|NCT00557466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110028625|NCT00557466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110028629|NCT00557466|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110028693|NCT00556920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110028694|NCT00556920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110028695|NCT00556920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110028696|NCT00556920|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110028767|NCT04270344|Antimetabolites|antimetabolites|mesh-ancestor
110028768|NCT04270344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110028769|NCT04270344|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110028771|NCT04278846|Anesthetics, Local|anesthetics, local|mesh-ancestor
110028844|NCT05444556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110028845|NCT05444556|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110028846|NCT05444556|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110028847|NCT05444556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110028848|NCT05444556|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110028912|NCT05768542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110028913|NCT05768464|Axitinib|axitinib|mesh-list
110028914|NCT05768464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110028915|NCT05768464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110028916|NCT05768464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110028917|NCT05768464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110028919|NCT05768334|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110028982|NCT05767827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110028983|NCT05767827|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110028984|NCT05767827|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110028986|NCT05767827|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110028987|NCT05767827|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110028988|NCT05767827|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110028999|NCT05767723|Aspirin|aspirin|mesh-list
110029058|NCT05767255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110029059|NCT05767229|Carvedilol|carvedilol|mesh-list
110029060|NCT05767229|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110029061|NCT05767229|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110029132|NCT05631028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110029212|NCT05379686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110029213|NCT05379686|Hormones|hormones|mesh-ancestor
110029215|NCT05379686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029298|NCT05078827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110029299|NCT05078827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110029300|NCT05078827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110029301|NCT05078827|Immunologic Factors|immunologic factors|mesh-ancestor
110029302|NCT05078827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029374|NCT05019638|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110029375|NCT05019638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110029376|NCT05019638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110029377|NCT05019638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110029378|NCT05019638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110029379|NCT05019638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110029453|NCT04677959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110029454|NCT04677959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110029457|NCT04671043|Caffeine|caffeine|mesh-list
110029528|NCT04501120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110029608|NCT04288427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110029609|NCT04288427|Hormone Antagonists|hormone antagonists|mesh-ancestor
110029610|NCT04288427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110029612|NCT04288427|Urological Agents|urological agents|mesh-ancestor
110029613|NCT04280601|Vitamin D|vitamin d|mesh-list
110029660|NCT04040959|Niacin|niacin|mesh-list
110029686|NCT03965689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110029687|NCT03959423|Insulin|insulin|mesh-list
110029688|NCT03959423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110029689|NCT03959423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029690|NCT03936998|Vancomycin|vancomycin|mesh-list
110029691|NCT03936998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110029692|NCT03936998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110029694|NCT03835065|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
110029695|NCT03835065|Protease Inhibitors|protease inhibitors|mesh-ancestor
110029696|NCT03835065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110029697|NCT03835065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110029698|NCT03786783|Vitamin A|vitamin a|mesh-list
110029766|NCT03654833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110029767|NCT03654833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110029768|NCT03654833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110029769|NCT03654833|Growth Substances|growth substances|mesh-ancestor
110029770|NCT03654833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029771|NCT03654833|Growth Inhibitors|growth inhibitors|mesh-ancestor
110029849|NCT02995252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110029850|NCT02995252|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110029851|NCT02995252|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110029852|NCT02995252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110029853|NCT02995252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110029854|NCT02995252|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110029855|NCT02995252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110029866|NCT02932826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110029867|NCT02932826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029868|NCT02834637|Vaccines|vaccines|mesh-list
110029872|NCT02817360|Valsartan|valsartan|mesh-list
110029931|NCT02689778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110029932|NCT02678377|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110029933|NCT02678377|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110029934|NCT02678377|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110029935|NCT02678377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110029936|NCT02678377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110029937|NCT02678377|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110029938|NCT02678377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110029999|NCT02419040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030000|NCT02387203|Amoxicillin|amoxicillin|mesh-list
110030001|NCT02387203|Clarithromycin|clarithromycin|mesh-list
110030002|NCT02387203|Lansoprazole|lansoprazole|mesh-list
110030003|NCT02387203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110030004|NCT02387203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110030005|NCT02387203|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110030006|NCT02387203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110030007|NCT02387203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030010|NCT02387203|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110030067|NCT01850303|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110030068|NCT01850303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110030069|NCT01763671|Paclitaxel|paclitaxel|mesh-list
110030070|NCT01763671|Docetaxel|docetaxel|mesh-list
110030071|NCT01763671|Bevacizumab|bevacizumab|mesh-list
110030142|NCT00110591|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110030143|NCT00110591|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110030144|NCT00110591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030145|NCT00110591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110030146|NCT00110591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110030147|NCT00110591|Antiviral Agents|antiviral agents|mesh-ancestor
110030214|NCT01384578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110030215|NCT01384578|Protective Agents|protective agents|mesh-ancestor
110030216|NCT01384578|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110030222|NCT01384643|Propofol|propofol|mesh-list
110030299|NCT01385228|Hormones|hormones|mesh-ancestor
110031701|NCT01393769|Melphalan|melphalan|mesh-list
110032249|NCT01396564|Metformin|metformin|mesh-list
110032823|NCT05270343|Vitamin D|vitamin d|mesh-list
110033054|NCT05051150|Epinephrine|epinephrine|mesh-list
110033140|NCT04801641|Nabilone|nabilone|mesh-list
110033902|NCT02293109|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110033903|NCT02293109|Prednisolone|prednisolone|mesh-list
110033904|NCT02293109|Prednisolone acetate|prednisolone acetate|mesh-list
110033905|NCT02293109|Cyclophosphamide|cyclophosphamide|mesh-list
110033906|NCT02293109|Rituximab|rituximab|mesh-list
110033907|NCT02293109|Doxorubicin|doxorubicin|mesh-list
110033977|NCT01951469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110033978|NCT01951469|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110033979|NCT01951469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110033980|NCT01951469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110033981|NCT01940809|Nivolumab|nivolumab|mesh-list
110033982|NCT01940809|Ipilimumab|ipilimumab|mesh-list
110033984|NCT01940809|Dabrafenib|dabrafenib|mesh-list
110033985|NCT01940809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110033987|NCT01940809|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110033988|NCT01940809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110033989|NCT01940809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110033991|NCT01879228|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110033992|NCT01879228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110033994|NCT01879228|Incretins|incretins|mesh-ancestor
110034052|NCT01591629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034053|NCT01591629|Sensory System Agents|sensory system agents|mesh-ancestor
110034054|NCT01591629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110034055|NCT01591629|Hallucinogens|hallucinogens|mesh-ancestor
110034056|NCT01591629|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110034057|NCT01591629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110034058|NCT01591629|Analgesics|analgesics|mesh-ancestor
110034059|NCT01591629|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110034060|NCT01591629|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110034121|NCT00962988|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110034122|NCT00962988|Antidepressive Agents|antidepressive agents|mesh-ancestor
110034124|NCT00962988|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110034125|NCT00962988|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110034127|NCT00962988|Dopamine Agents|dopamine agents|mesh-ancestor
110034192|NCT00430040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034193|NCT00430040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034272|NCT01398033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034273|NCT01398046|Dasatinib|dasatinib|mesh-list
110034274|NCT01398046|Rabeprazole|rabeprazole|mesh-list
110034275|NCT01398046|Betaine|betaine|mesh-list
110034351|NCT01398293|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110034426|NCT01398618|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110034427|NCT01398618|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110034429|NCT01398618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110034596|NCT01400308|Mupirocin|mupirocin|mesh-list
110034770|NCT01401192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110034845|NCT01402089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110034924|NCT01402479|Protease Inhibitors|protease inhibitors|mesh-ancestor
110035002|NCT01403181|Ribavirin|ribavirin|mesh-list
110035087|NCT01403415|Analgesics|analgesics|mesh-ancestor
110035327|NCT01404598|Sensory System Agents|sensory system agents|mesh-ancestor
110035482|NCT01405131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110035889|NCT01407887|Artesunate|artesunate|mesh-list
110036112|NCT01409018|Itraconazole|itraconazole|mesh-list
110036191|NCT01409395|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110036192|NCT01409395|Histamine Antagonists|histamine antagonists|mesh-ancestor
110036193|NCT01409395|Histamine Agents|histamine agents|mesh-ancestor
110052902|NCT01482728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110053063|NCT01484327|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110053064|NCT01484327|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110053065|NCT01484327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110053066|NCT01484327|Vasodilator Agents|vasodilator agents|mesh-ancestor
110053067|NCT01484327|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110053068|NCT01484327|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110053069|NCT01484457|Pancrelipase|pancrelipase|mesh-list
110053070|NCT01484457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110053071|NCT01484600|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110053072|NCT01484600|Immunologic Factors|immunologic factors|mesh-ancestor
110036334|NCT01410630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110036335|NCT01410682|Chlorhexidine|chlorhexidine|mesh-list
110036336|NCT01410682|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110036337|NCT01410682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110036338|NCT01410682|Disinfectants|disinfectants|mesh-ancestor
110036339|NCT01410708|Dasatinib|dasatinib|mesh-list
110036340|NCT01410708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110036341|NCT01410708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110036342|NCT01410708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110036343|NCT01410708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110036344|NCT01410747|Tacrolimus|tacrolimus|mesh-list
110036345|NCT01410747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110036347|NCT01410747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036348|NCT01410747|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110053073|NCT01484600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036350|NCT01410747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110036351|NCT01410916|Eculizumab|eculizumab|mesh-list
110036353|NCT01410916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110036354|NCT01410916|Immunologic Factors|immunologic factors|mesh-ancestor
110036355|NCT01410916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036356|NCT01410968|Poly ICLC|poly iclc|mesh-list
110036357|NCT01410968|Interferon Inducers|interferon inducers|mesh-ancestor
110036358|NCT01410968|Immunologic Factors|immunologic factors|mesh-ancestor
110054817|NCT01494402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110036359|NCT01410968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036360|NCT01411072|Gemcitabine|gemcitabine|mesh-list
110036361|NCT01411072|Fluorouracil|fluorouracil|mesh-list
110036362|NCT01411072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110036363|NCT01411072|Antimetabolites|antimetabolites|mesh-ancestor
110036364|NCT01411072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110036365|NCT01411072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110036366|NCT01411072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110036367|NCT01411072|Immunologic Factors|immunologic factors|mesh-ancestor
110036368|NCT01411072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036369|NCT01411098|Etoposide|etoposide|mesh-list
110036370|NCT01411098|Etoposide phosphate|etoposide phosphate|mesh-list
110036371|NCT01411098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110036372|NCT01411098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110036373|NCT01411098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110036374|NCT01411098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110036375|NCT01411098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110036389|NCT01411124|Sensory System Agents|sensory system agents|mesh-ancestor
110036390|NCT01411124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110036391|NCT01411124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036392|NCT01411124|Anticonvulsants|anticonvulsants|mesh-ancestor
110036393|NCT01411124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110036394|NCT01411124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110036395|NCT01411124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110036396|NCT01411124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110036397|NCT01411124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110036398|NCT01411124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110036399|NCT01411124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110036400|NCT01411124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110036401|NCT01411124|Antimanic Agents|antimanic agents|mesh-ancestor
110036402|NCT01411124|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110036403|NCT01411124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110036404|NCT01411124|Anesthetics, Local|anesthetics, local|mesh-ancestor
110036405|NCT01411124|Anesthetics|anesthetics|mesh-ancestor
110036406|NCT01411124|Antiemetics|antiemetics|mesh-ancestor
110036407|NCT01411124|Autonomic Agents|autonomic agents|mesh-ancestor
110036408|NCT01411124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110036409|NCT01411124|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110036410|NCT01411124|Histamine Antagonists|histamine antagonists|mesh-ancestor
110036411|NCT01411124|Histamine Agents|histamine agents|mesh-ancestor
110036436|NCT01411254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110036437|NCT01411254|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110036510|NCT01411930|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110036587|NCT01412515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110036744|NCT01413763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110036821|NCT01414816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110036822|NCT01414816|Antiviral Agents|antiviral agents|mesh-ancestor
110036978|NCT01415765|Rituximab|rituximab|mesh-list
110037288|NCT01417572|Sensory System Agents|sensory system agents|mesh-ancestor
110037295|NCT01417689|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110037362|NCT01418118|Sympathomimetics|sympathomimetics|mesh-ancestor
110037363|NCT01418118|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110037512|NCT01418729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110037513|NCT01418729|Antimetabolites|antimetabolites|mesh-ancestor
110037515|NCT01418729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110037666|NCT01420055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037668|NCT01420094|Acetaminophen|acetaminophen|mesh-list
110037669|NCT01420094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110037742|NCT01420523|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110037817|NCT01421043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110037818|NCT01421043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110037819|NCT01421043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110037820|NCT01421043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110037821|NCT01421043|GABA Modulators|gaba modulators|mesh-ancestor
110037822|NCT01421043|GABA Agents|gaba agents|mesh-ancestor
110037897|NCT01421693|Ceftriaxone|ceftriaxone|mesh-list
110037964|NCT01421992|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110038040|NCT01422317|Vitamins|vitamins|mesh-ancestor
110038041|NCT01422317|Micronutrients|micronutrients|mesh-ancestor
110038131|NCT01422733|Hormones|hormones|mesh-ancestor
110038213|NCT01423292|Anesthetics|anesthetics|mesh-ancestor
110038436|NCT01424384|Citalopram|citalopram|mesh-list
110038507|NCT01424826|Leprostatic Agents|leprostatic agents|mesh-ancestor
110038508|NCT01424826|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110038590|NCT01425242|Amlodipine|amlodipine|mesh-list
110038734|NCT05386446|Interferon-gamma|interferon-gamma|mesh-list
110038736|NCT05386446|Antiviral Agents|antiviral agents|mesh-ancestor
110038737|NCT05386446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110038811|NCT05385861|Irinotecan|irinotecan|mesh-list
110038812|NCT05385861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110039045|NCT04203472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110039355|NCT01426802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110039356|NCT01426815|Golimumab|golimumab|mesh-list
110039362|NCT01426880|Paclitaxel|paclitaxel|mesh-list
110039425|NCT01427114|Prednisolone|prednisolone|mesh-list
110039426|NCT01427114|Cyclophosphamide|cyclophosphamide|mesh-list
110039658|NCT01428414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110039661|NCT01428427|Trametinib|trametinib|mesh-list
110039815|NCT01429545|Nifedipine|nifedipine|mesh-list
110039891|NCT01429818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110039892|NCT01429818|Immunologic Factors|immunologic factors|mesh-ancestor
110039966|NCT01430078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110040045|NCT01431053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110040121|NCT01431456|Protease Inhibitors|protease inhibitors|mesh-ancestor
110040124|NCT01431456|Anticoagulants|anticoagulants|mesh-ancestor
110040199|NCT01431924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110040278|NCT01432249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110040354|NCT01432782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110040514|NCT01434069|Vitamins|vitamins|mesh-ancestor
110040515|NCT01434069|Micronutrients|micronutrients|mesh-ancestor
110040516|NCT01434069|Hormones|hormones|mesh-ancestor
110040588|NCT01434173|Antimalarials|antimalarials|mesh-ancestor
110040895|NCT01435902|Respiratory System Agents|respiratory system agents|mesh-ancestor
110040976|NCT01437046|Doxazosin|doxazosin|mesh-list
110041126|NCT01437826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110041127|NCT01437826|Protective Agents|protective agents|mesh-ancestor
110041128|NCT01437826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041275|NCT05371275|Palbociclib|palbociclib|mesh-list
110041276|NCT05371275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110041352|NCT04955470|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110041510|NCT04502602|Niraparib|niraparib|mesh-list
110041663|NCT03098355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110041739|NCT02124902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110041892|NCT01438736|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110041901|NCT01438736|Hormones|hormones|mesh-ancestor
110042047|NCT01440062|Vitamins|vitamins|mesh-list
110042136|NCT01440608|Albendazole|albendazole|mesh-list
110042360|NCT01441869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110042361|NCT01441869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042362|NCT01441869|Incretins|incretins|mesh-ancestor
110042437|NCT01442428|Autonomic Agents|autonomic agents|mesh-ancestor
110042438|NCT01442428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110042836|NCT01444521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110042837|NCT01444521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110042914|NCT01444885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110042915|NCT01444885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110042917|NCT01444976|Midazolam|midazolam|mesh-list
110043069|NCT01445756|Anesthetics, Local|anesthetics, local|mesh-ancestor
110043080|NCT01445860|Simvastatin|simvastatin|mesh-list
110043150|NCT01446211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110043228|NCT01446497|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110043545|NCT01448642|Antimetabolites|antimetabolites|mesh-ancestor
110043625|NCT01449045|Artemether|artemether|mesh-list
110043700|NCT01449344|Antiviral Agents|antiviral agents|mesh-ancestor
110044085|NCT05962255|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110044086|NCT05962255|Diuretics|diuretics|mesh-ancestor
110044092|NCT05962229|Nicotine|nicotine|mesh-list
110044161|NCT05961202|Hormones|hormones|mesh-ancestor
110044482|NCT05739942|Alkylating Agents|alkylating agents|mesh-ancestor
110044485|NCT05734625|Methylprednisolone|methylprednisolone|mesh-list
110044567|NCT05653193|Hormone Antagonists|hormone antagonists|mesh-ancestor
110044637|NCT05603104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110044713|NCT05508100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110044873|NCT05271552|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110045111|NCT05001750|Antimalarials|antimalarials|mesh-ancestor
110045185|NCT04945213|Biperiden|biperiden|mesh-list
110045350|NCT04822337|Hormones|hormones|mesh-ancestor
110045496|NCT06040112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110045696|NCT06039150|Anesthetics|anesthetics|mesh-list
110045785|NCT06037434|Diuretics|diuretics|mesh-ancestor
110045992|NCT05810649|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110046105|NCT05696847|Hormones|hormones|mesh-ancestor
110046255|NCT05473741|Dopamine Agonists|dopamine agonists|mesh-ancestor
110046620|NCT05113784|Antiviral Agents|antiviral agents|mesh-ancestor
110046785|NCT04975308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110046797|NCT04964934|Letrozole|letrozole|mesh-list
110046957|NCT04778410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110047153|NCT04501614|Ponatinib|ponatinib|mesh-list
110047437|NCT04007029|Antimetabolites|antimetabolites|mesh-ancestor
110047905|NCT02828761|Calcium|calcium|mesh-list
110047909|NCT02807207|Moxifloxacin|moxifloxacin|mesh-list
110047981|NCT02719613|Protease Inhibitors|protease inhibitors|mesh-ancestor
110048140|NCT02043678|Prednisone|prednisone|mesh-list
110048394|NCT04724239|Bevacizumab|bevacizumab|mesh-list
110048479|NCT04608474|Evolocumab|evolocumab|mesh-list
110048735|NCT04126070|Antimitotic Agents|antimitotic agents|mesh-ancestor
110048815|NCT03936062|Hormones|hormones|mesh-ancestor
110048888|NCT03821272|Immunologic Factors|immunologic factors|mesh-ancestor
110048964|NCT03677596|Immunoconjugates|immunoconjugates|mesh-ancestor
110049218|NCT03215277|Immunologic Factors|immunologic factors|mesh-ancestor
110049570|NCT01734512|Everolimus|everolimus|mesh-list
110049622|NCT01614197|Antimetabolites|antimetabolites|mesh-ancestor
110049860|NCT01459445|Diuretics|diuretics|mesh-ancestor
110049931|NCT01460537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110050166|NCT01463163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110050253|NCT01463865|Ropivacaine|ropivacaine|mesh-list
110050566|NCT01467596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110050641|NCT01468051|Vaccines|vaccines|mesh-list
110050871|NCT01469572|Hormones|hormones|mesh-ancestor
110051021|NCT01470352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110051272|NCT01472016|Docetaxel|docetaxel|mesh-list
110051732|NCT01475877|Sensory System Agents|sensory system agents|mesh-ancestor
110051737|NCT01475890|Vitamin D|vitamin d|mesh-list
110052044|NCT01477736|Oxybutynin|oxybutynin|mesh-list
110052195|NCT01478490|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110052350|NCT01479361|Atovaquone|atovaquone|mesh-list
110052426|NCT01479881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110052651|NCT01481233|Mitosis Modulators|mitosis modulators|mesh-ancestor
110053099|NCT01484964|Immunologic Factors|immunologic factors|mesh-ancestor
110053205|NCT01485445|Xhance|xhance|mesh-list
110053259|NCT01485692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110053341|NCT01485926|Antimitotic Agents|antimitotic agents|mesh-ancestor
110053465|NCT01486602|Paclitaxel|paclitaxel|mesh-list
110053496|NCT01486862|Insulin Aspart|insulin aspart|mesh-list
110053571|NCT01487226|Paclitaxel|paclitaxel|mesh-list
110053987|NCT01489644|Metformin|metformin|mesh-list
110054041|NCT01489865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110054121|NCT01490047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110054358|NCT01491139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110054615|NCT01493154|Vaccines|vaccines|mesh-list
110054937|NCT01495117|Iodine|iodine|mesh-list
110055158|NCT01496326|Ibuprofen|ibuprofen|mesh-list
110055639|NCT01499407|Abciximab|abciximab|mesh-list
110055972|NCT01501136|Cisplatin|cisplatin|mesh-list
110056643|NCT01503905|Tamoxifen|tamoxifen|mesh-list
110056836|NCT01504659|Ketamine|ketamine|mesh-list
110057784|NCT01508897|Liraglutide|liraglutide|mesh-list
110057866|NCT01509365|Clopidogrel|clopidogrel|mesh-list
110058178|NCT01511263|Amiodarone|amiodarone|mesh-list
110058335|NCT01511822|Inositol|inositol|mesh-list
110058637|NCT01513525|Incretins|incretins|mesh-ancestor
110059204|NCT01516580|Cytarabine|cytarabine|mesh-list
110059428|NCT01517724|Bortezomib|bortezomib|mesh-list
110059605|NCT01518595|Bosentan|bosentan|mesh-list
110059915|NCT01520389|Irinotecan|irinotecan|mesh-list
110060221|NCT01522612|Leucovorin|leucovorin|mesh-list
110060288|NCT01522872|Hormones|hormones|mesh-ancestor
110060606|NCT01524315|Vitamins|vitamins|mesh-list
110061010|NCT06051851|Paclitaxel|paclitaxel|mesh-list
110062851|NCT04074746|Vidarabine|vidarabine|mesh-list
110063336|NCT03077542|Alemtuzumab|alemtuzumab|mesh-list
110063671|NCT01892371|Antiviral Agents|antiviral agents|mesh-ancestor
110063867|NCT00336024|Micronutrients|micronutrients|mesh-ancestor
110063868|NCT00336024|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110063869|NCT00336024|Tubulin Modulators|tubulin modulators|mesh-ancestor
110063870|NCT00336024|Antimitotic Agents|antimitotic agents|mesh-ancestor
110063871|NCT00336024|Mitosis Modulators|mitosis modulators|mesh-ancestor
110063872|NCT00336024|Hematinics|hematinics|mesh-ancestor
110063873|NCT00336024|Keratolytic Agents|keratolytic agents|mesh-ancestor
110063874|NCT00133705|Mifepristone|mifepristone|mesh-list
110063875|NCT00133705|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110063876|NCT00133705|Abortifacient Agents|abortifacient agents|mesh-ancestor
110063877|NCT00133705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110063878|NCT00133705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110063879|NCT00133705|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110063880|NCT00133705|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110063881|NCT00133705|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110063882|NCT00133705|Contraceptive Agents|contraceptive agents|mesh-ancestor
110063883|NCT00133705|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110063884|NCT00133705|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
